package DrugResistanceDB;

use strict;

use gjoseqlib;

our @drug_resistance_prots = &gjoseqlib::read_fasta(\*DATA);

1;

__DATA__
>fig|100226.1.peg.751 Ribosome protection-type tetracycline resistance related proteins
MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTDDGGIERRRGITIRSAVAAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLRLPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLNEVADAGTPRARVTRRPPDGRTAQALAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGLIPAATPGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGRTTEVSGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVRARHPEQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAEFTPGRVRFLERPAGTGEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPRAFHQAVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARAGTVLHEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAELRLPGLTRGEAVWSSRPCEDRPLKPGNSGPGTGVGGHSGE
>fig|100226.1.peg.770 Oxetanocin A resistance protein
MREHTADRTRTRARAELRGDCASCFGLCCAALPFARSADFAIDKDAGTPCPNLRTDHRCGIHATLRERGFTGCTVYDCFGAGQRVSQLTFGGRDWRAGPPEQRRRMFDVFPVVRQLHELLWYLTEALTLPAARPVHADLRGALADTERLAGGTPEELAGLDVAAHRQRVNVLLLRTSELVRAGTRGRKKNRRNADLMGARLKGADLAGADLRGAYLIAADLTGADLRGADLIGADLRDADLTDADLTGAFFLTQPQVNAARGGPGTGLPDSVTRPVHWTAGR
>fig|100226.1.peg.1326 Permease of the drug/metabolite transporter (DMT) superfamily
MSSVPSPSAPSPARRVLDWRLRFGLLSLVWGFSFLFMKVGTESFAPFQVTLGRLAFGTAVVAAAMAVKRERLPRGAWTWLHLTVAGFLLNALPFSLFAFSELTIPSSLAGICNATSPLWGMALSLVALSEDRPTRRRVAGLGIGFLGVLTVLGVWQGFHGLDVTGTALALLASFSYPVGWIYVRRTLAGSSHSHLSLTGAQLGLATLQLAVVTPLFTSVPTSFPVLPLLAVAALGVLGTGLAFLIQYDLVAEVGPTTAQMVTYFTPVIATAAGVALLGESLSWSTPVGAAVVLAGAALTQSRPRADRAAPAPAPAPAPETPGTTGVRQGSRV
>fig|100226.1.peg.1534 Multidrug resistance efflux pump
MNRTLQPAHPTEAVKRPGRWLALSVLVLAVLLVAVDATVLGLATPYISEDLAPSGTQLLWIGDVYSFVIAGLLVSMGSLGDRIGRKRILLIGATAFGAISVLNAYAHTPEVMIFARALLGVAGATLMPATLALIRNLFHDPRERSLAVGIWGAAASAGAAVGPVVGGFLLEHFWWGSVFLINLPVMVVLVVVGVKMLPESRNPNPGPWDLLSVVLSLVGMVGVVYAVKETAAHGFAWATLAAGLLGAAALYGFVRRQLTMPVPLLDMRLFRNRGFSGAVLADLLTILGLSGLVFFLSQYLQLVQGRRPFEAGLAELPAAVGAVVAGLIAGRAARRFSVRAVVAGGLAAVGLALAALTVIGQHTGYPLLGAALLVVGLGAGFAFTVTADVILSSVPGEQAGAASAVSETAYELGAALGIAVLGSIVTGVYRDFTGPAGTPDAAHESLGGAVEAAAHLPGPAGEALLDSARQAFVDGLTLAAGVGAAVLLAAAAASWYLLRGQRLEDGVEHP
>fig|100226.1.peg.1555 Permease of the drug/metabolite transporter (DMT) superfamily
MRAQSSATASPRIAVDATGADAGGASFGTVQAALGVVAFSLTFPATAWGLEGFGPWSLIAVRSVLAAAVAGSCLVVVGVPPRERSRAWGRVAPPERRHWLGLAVVGAGVVLGFPLLTTLALQTSTTAHAAVVVGLLPLTTALLSALRVGTRPSRTFWIAALAGAAAVIAFTVQQSGGALTSADAYLFAALLVCAAGYTEGGRLARVMPGWQVIGWALVLCLPLTVPMAAIALSLEPVRLTAHAVTGLLWVAIGSQFLGLVVWYRGMAAIGIPKASQLQLAQPLLTLVWSVLLLGEHLPVAAPLTAAAVLVCIAVTQRARG
>fig|100226.1.peg.1671 Permease of the drug/metabolite transporter (DMT) superfamily
MMTTARTSPPAPWHRRPDLLAAGAATVTVVLWASAFVSIRSAGEAYSPGALALGRLLSGVLTLGAIWLLRREGLPPRAAWRGIAISGLLWFGFYMVVLNWGEQQVDAGTAALVVNVGPILIALLGARLLGDALPPRLLTGMAVSFAGAVTVGLSMSGEGGSSLFGVVLCLLAAVAYAGGVVAQKPALAHASALQVTTFGCLVGAVLCLPFAGQLVHEAAGAPVSATLNMVYLGVFPTALAFTTWAYALARTTAGRMGATTYAVPALVVLMSWLALGEVPGLLTLAGGALCLAGVAVSRSRRRPAAVPDRAAPTAEPRREDAGRA
>fig|100226.1.peg.2258 Permease of the drug/metabolite transporter (DMT) superfamily
MTARGWFLFSLMGVVWGVPYLMIKVAVDEVSPSGVVFARCALGAALLLPFALRKGDLLGTVRRRWKPMLAFAVIEIIGPWWTLTDAERHLSSSTAGLLIAGVPIVAVLLARFFGAEERVGARRITGLGLGLAGVAVLTVPHLTGGDARSLAEVLVTVVGYATAPLIAARHLKDVPTLQLITPCLTLAAVVYAPAAFLTRPATLPSGEALAALAGLGLVCTAIAFVAFLELIKEVGPTRAGVITYVNPAVAVAAGALLLDEELTLGIGVAFTLILAGSVLATAAAGPGREARRVPWSTRQTSRAGGRVESLTGLPEERPGSTGQGDG
>fig|100226.1.peg.2309 Multidrug resistance protein B
MAGDVREATESEPDPARPAAPGEREQVSSGVLVSIGALLLGMLLAALDQTIVSTALPTIVSDLGGLEHLSWVVTAYLLAATAATPLWGKLGDQYGRKKLFQLAIGIFLVGSALCGIAQGMGQLIAFRALQGLGGGGLMVLSMAIVGDLVPPRERGRYQGLFGAVFGATSVLGPLLGGVFTEHLSWRWVFYINLPIGVVALAVIAAVLHIPRRTTRHVIDYLGTLLIASVATSLVLVASLGGTTWAWSSPQIIGLAVLAVVLAVLFVAVERRAAEPVLPLKLFRVRTFALSAVISFVIGFAMFGAMTYLPTFLQVVRGVTPTMSGVYMLPMVFGLLLSSTVSGQIVSRTGRWKVFPVAGTAVTTLGLLLLHQLDENSATAEMGAYFFVFGLGLGLVMQVLVLIVQNAVAYEDLGVATSGATFFRSIGASFGVAIFGTIFASRLGDQLTDAFRGAALPPGVSVDTLKADPRGIGALPPALRPEAIHAYASSITDVFLYAAPVALLAFLLAWLLKEDRLRGSVTAPDATQTLASNPVERSSHDEVCRALSVLGTREGRREIYRRITARAGYDLLPASSWMLLRVRKYGRVEPAQLAERSPVPLATVMAAARQVEERHLAVREGPDLVLTRQGREVAERLALAREESLAELLGDWWGPDRPTDLVRLVRELTGELCGSERERPHEGRTPARAG
>fig|100226.1.peg.2611 Permease of the drug/metabolite transporter (DMT) superfamily
MAATRPAVIALTALAPVSWGSTYAVTTEFLPPDRPLFTGLMRALPAGLLLLALARVLPRGAWWGKAAVLGVLNIGAFFPLLFLAAYRMPGGMAAVVGSVGPLLVVGLSALLLGQRPTTRSVLTGVAAASGVSLVVLEAAGALDPLGVLAALAATASMSTGTVLAGRWGRPEGVGPLALTGWQLTAGGLLLAPLALLVEGAPPALDGPAVGGYLYLALANTALAYWLWFRGIGRLSATQVTFLGPLSPLTAAVIGWAALGEALGPVQLAGTALAFGATLVGQTVPSAPRTPPVAAGAGPFSSASRNGRKDSMDLTGAALRR
>fig|100226.1.peg.2860 Quaternary ammonium compound-resistance protein SugE
MAWVLLFVAGLLEVGWSIGMKYTDGFTRLWPSVFTGAGIVASMMLLSYAARTLPIGTAYGVWVGIGAAGAAVLGMVVLGEPATAARIFFICLLLVAVVGLKATSGH
>fig|100226.1.peg.5165 Quaternary ammonium compound-resistance protein SugE
MAWLLVIVAGVLETGFAVCLKLSHGFTRLWPTIAFCAFALGSFGLLTMSLKKLDVGPAYAVWTGIGAAGTAIYGMIFLGDLVSTLKIVSISFVIIGVIGLQLSGSAH
>fig|100226.1.peg.6873 
MSATPTTPPPALRPYLTARHDMLWQEADAFATEHVAPRVARMEAAPGRAESKIADLMAARGWFAVTVPAVFGGLGAGHVARTVLVHRIARVSAAAAAILQATLIPVGAVLHFATYEQKGRWLPRVADGSLLPSIAVTEPLAGGHIGGIETTAERTGNEWVITGSKIHIGNSHLAGAHLIVARTAAAGGSTSQALTAFMVEADRPGLSVPDHRAGLGLHGFSVGRLDLDHVRVPEDNVVGEIGQGLAVAQSSSILYGRPNLAAVSLGVHEAVVDTTTARLKARPRYQGALSALPVLRDRVGDMEARLRAARILAYQAVHLLDQGLPCDAELINSKYLGHRWAMQSAQDAMELHGAHALDRDYVLQRLWRDIQYTYPPAGTGEVQRIRLADAAFGEDHIQWSERLAAEAAWARPDPTAA
>fig|100226.1.peg.7457 Chloramphenicol resistance protein
MPLAVYILGLSVFALGTSEFMLSGLLPPIADDMDVSIPRAGLLISAFAIGMVVGAPLLAVATLRLPRKTTLVALISVFGVGQVAGALATSYEVLFVSRVVSALACAGFWAVGAAAAIAMVPVTARARAMAVMIGGLSIANVLGVPAGAFLGEHLGWRSAFWAVGGASAVALVGVVTLIPRIPLPERRPRLRGELAIYRDRQVWLSIVVTALAAGGVFCAFSYLAPLLTDVAGLADGWVPTVLALFGVGALIGTTIGGRVADAHLFGVLLSGITASTVLLAALALFASSPAVVIVLSLLLGVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDADLGYEATAWAGGAMTLVAIAFVAVSLRLHTRSRVVTGGGPASETASLERAQRV
>fig|100226.1.peg.7593 Chloramphenicol resistance protein
MPLPLYLLAVAVCAMGTSEFMLAGLVPDIASDLGVTVGTAGTLTSAFATGMIVGAPLVAALARTWPRRSSLLGFILAFAAAHAVGAGTTSFPVLVACRVVAALANAGFLAVALTTAAALVPADKKGRALAVLLSGTTVATVAGVPGGSLLGTWLGWRATFWAVAVCCLPAAFGVLKAIPAGRATAAATGGPPLRVELAALKTPRLLLAMLLGALVNAATFASFTFLAPVVTDTAGLGDLWISVALVLFGAGSFAGVTVAGRLSDRRPAQVLAVAGPLLLVGWPALAMLADRPVALLTLVFVQGALSFALGSTLITRVLYEAAGAPTMAGSYATAALNVGAAAGPLVAATTLGHTTGNLGPLWASGLLVAVALLVAFPFRTVITTAAPADATR
>fig|100226.1.peg.8006 Methylenomycin A resistance protein, Mmr
MTTVRTGGAQTAEVPAGGRRDVPSGVKITALATGFVMATLDVTVVNVAGATIQESLDTTLTQLTWIVDGYVLTFASLLMLAGGLANRIGAKTVYLWGMGVFFLASLACALAPTAETLIAARLVQGAGAALFMPSSLSLLVFSFPEKRQRTRMLGLWSAIVATSSGLGPTVGGLMVSAFGWESIFLLNLPIGAIGMAMTYRYIAATESRATRLAVPGHLLWIVALAAVSFALIEGPQLGWTAGPVLTAYAVAVTAAALLALREHRVTNPVMPWQLFRGPGFTGANLVGFLFNFALFGSTFMLGLYFQHARGATPFQAGLELLPMTIFFPVANIVYARISARFSNGTLLTAFLLLAGAASLSMVTITASTPYWVVAVAVGVANIGAGIISPGMTAALVDAAGPENANVAGSVLNANRQIGSLVGIAAMGVVLHSTSDWDHGAAISFLAVGLAYLLGGLSAWRLIARPERRSAVTAAT
>fig|1002809.3.peg.669 Permease of the drug/metabolite transporter (DMT) superfamily
MKFPPQLLLILATLLWGGNFVIGRAVSGDIPPITLAFLRWIVAFLVFFPIAYNRTKKEWPALKQHWGAVIILAITGVAAFNTLVYIGLHDTTSINASLMNSSTPIIIYILSFIFLKERLTKFQMIGTLLSLAGVLFIISGGSLQSLLSFSFNKGDLIVLIAVVCWSFYSLLIKKYAGKLPGYSTFLVTIAIGAIMLLPFAVYELLTTSQAIVWNASTIGAIFYVGIIASIVAFLSWNNGVVSLGANKAGIYLNFIPLFATIFAVLFLNEQLLIAQVIGGIAVITGVFISSIK
>fig|1002809.3.peg.790 Drug resistance transporter, EmrB/QacA family
MEAPIFNVKSPKGMAAVLMISTFVGLFGETALNMALTNIMDDFGVSAASAAWLTTGYLLVLAVLVPLSSYLVRWFTTRQLVVAAVVFAVIGSLLGALAPNFAVLLAGRFVQALATGIILPLMFSVVMLIFPVQKRGAVMGIVGIILTAGPALGPSIAGLIVSSLSWRYIFWIMVVVYAVVIVLAFSKVDNVSNVTRPKIDLLSLIASTFGFGGVVFALATLAEQSITKPIVWVPLVVGFVLLVVFGIRQTKMDEPMIDLSVFKSPMFSLGVALMVATMFMILSVAILVPMFLKTVLGFAALTAGLCMLPGNILNIIMSPIVGTNFDKVGAKIFTRIGFTLILVSMIVFLTTISATTATWIIIVNLCVFFVGVSMTIMPAQTNAMNSLAPHKFADGSAALNTLTQIAGASGTAIAITMFTIGQQNYIEKFSNALPAEFLAHGVHSAFIVVTVVAVLGLVGSFFVKNSKPVGN
>fig|1002809.3.peg.843 Permease of the drug/metabolite transporter (DMT) superfamily
MFKKSTVALIALILIWGASWPINKLAVPYSPPLLYAGQRALLGGILLTVIIWKTRKAINWRENWQKYCIGAFFNTILFFGLQTAGLLYLPSGLFSVLVYFQPILLGLFAWLLLGEDLSPVKILGLFLGFVGVAVVSVDGLMVHISAIGVTLGLLTAVSWAFGVIYVKKISKEVDAYWMVALQCIIGGVFLLGTGSVFESWSAIEWNRNYLSGLGFGATIGIPLAYILYYNLVNAGEASKVGSYTFLIPIVAVLLGVLFLGETVTYSLVIGMLLVAISIYFVNFQYKTKNKSISKD
>fig|1002809.3.peg.961 Multidrug resistance protein
MKAQRAVIIALYVVAMFMVSIDGTIVNVLLPTIAVEFGVTPGATNGINIGYLVSIAVALPAAGYLSNRYGVKRMYVLSVSLFTLASLLCGWAGSLQALILARVLQGLAGGIITPVSMTLLFRTFSPPERQNLSRSLVLPIAFAPAIGPLVGGLFSEYLSWNWAFFINIPFGIIIVLIGLFALTEFEIFKAPFDTKGYMLIALGLPLLMLTLSLIASDGVSITVVFCAIVGVFLLRRFYVYERKIKEPLLDVRLYEQPLFLSSSLVAMCSMGALMGMLYLFPLMYQYAYSASALESSLITFTEALGLMVASKLLPRTSKRFGMLHTVRLGLIGTVMIFCCIAIIGPSANPWLLRGLMFAVGICLGHSVIGSQLSAFHHVAKSQMSKATTLYNMLNRVGAAVGIALVATTLTVSGRYFSEILSYQYALVATVVLLLAGLGCSLFAKEQETILKGEKA
>fig|1002809.3.peg.1102 Permease of the drug/metabolite transporter (DMT) superfamily
MEKPPIHPYIPIIIGVISVSLSAIFVKLSSADAGVIAFYRMLFSIMIMLPWFLIKYKNEIKVLSKRDWIFSSIAGVFLSFHFILWFESLNYTSVASSTVLVTMQPLFAFIGTYLFFKEKITLQTFIAGGIAILGSVLISWGDFKISGTALYGDILALIACALITGYLLFGQDVRKRLSLVTYTMVVYSVSTVTLFFYIIVKGESFGPYPAIDWMWFILLAIIPNLLGHNLFNWVLKWTSTNVISIAILFEPVGAALLAMFIFNEYLTVSQIVGGLVVILGIMLFVIDLKKFFRKKA
>fig|1002809.3.peg.1127 Multidrug resistance protein B
MPKQVWLLIIGTFVNTVGNSFLWPLNSIYIHDHLGKSLTTAGIVLMLNSLAGVFGNLVGGYLFDKLGGYKAILIGVVFNLLSITLLTIWHDWPQYIIFLTMMGFSGGIVYPAIYAIAGSAWPEGGRRAFNSIFLANNVGVAIGPALAGIVADIKFDYVFSANLFFYAVFFVLVITTYKRFDMKGLTTKPFSGNETKRRNRGPIVALSILSISLIVCWLSYSQWSATISSYTQGLGMSLSEYSLLWTINGFMIVAVQPIIRPLVTRWENKIKHQLVLGLILMSLSYIVVYFAQDFKMFAAAMVILTFGEVFFTPVIPMIANKLAPHGQEGFYQGLVNSASTIGRMIGPVFGGLMVDLYGMQILMLILSVLIIVAIIPCLVFDRTLGKEQT
>fig|1002809.3.peg.1256 Drug resistance transporter, EmrB/QacA family
MEQTKDVKTFQKPPYLMIAVLFVGAFVAFLNNTLLNVALPSIMTAFDIKDYSTVQWLATGYMLVSGVLVPTSAYLITKFRTRPLFILSMAIFVIGTALASFAPSFSFLLAGRMIQAAGAATMAPILMNVMLISFPVEKRGQAMGMFGLVMVLAPAIGPTLSGWIVEHYDWSVLFKMILPIAVLSLLLAVWKLEDVLPNRDAKIDILSIVLSTIGFGGLLYGFSTASSAGWSAVEVWGTITVGAIGLAWFIIRQFRLEQPLLDLRIYTYPSYALASVVSMVLSVAMFSGMILTPAYVQSVRGIEPFEAGLMMLPGAIVMGIMSPITGKLFDRFGPRILAVVGLTITTLATIGLGYLEVDSTYLFIISVYTIRMLGISMVMMPIMTNGLNALPNRLNPHGTAMNNTAQQVAGAIGTAVLVTVFNSHTKTRAAEIAADMQANASSAVQPTAEQIAQAQAQVMQQAMLDGITYSFFVAAAVTVVALILALFIKRVDITKREDFTGAVQEKK
>fig|1002809.3.peg.1709 Vancomycin B-type resistance protein VanW
MKTNFIYLVLFGLCLLGCEKASYSGTSETDGVKEHQIEASTSSPLSEREAIVGEYPLIYPAVITLIDPRTMEIVKSFTPQLLGYGTDRELYEANIKKVARELARGSKERTGYDQTMVLHKIGENGEIIEGNPGIVLKESELVEKILAASPKGDHIFLPLYILESNLEIDIPSLDDVTVASFTTYFNGAESGRSENIELSAKAIHNILVGDGDYFSFNTMVGERTVEKGYQPAPEIINKELVMGIGGGICQTSSTLFNAVDQLGIRITERHHHSLNIGYVPTGRDATVSYGSLDFKFQNTSGAPFLIKTYYSKGSLTIALTTSHQYKDLLKK
>fig|1002809.3.peg.1784 Drug resistance transporter, EmrB/QacA family
MSDIYGRRQILIIGILVILVSEMITPLMVSNIYHLMIFRAIQGLGGALAAVVGLIVISDIFDLANRAKFLGFYGALNAITAIVAPTLGGIFVQYMSWHWVFYSIAPIGVIGLYLVVKYMPNIPRTENAKLDYKGISILSAAILVFVAITTFGGSRIPWLSVPMFVLVTVFVLSIFGFITSQKKVAHPIVPLRLFKYRVFVVCMLSVFAVMFAATGLIFLLPMFLQNLFGFTPTETGLFMTFRGTTSFIFAAMSGFLVVKLKDFKLVAIIAMVIFASMIFTLTFFTTSASTLALTIICLIWGTSSGVLISIFHTGIQMNLPDKDISVAMSVIQLAVAVSSLLATSFLGLFLRLPNLSQGLSYLLFACLGAVVLALGIFVITLQKRNLKIEEEEPAAEQLV
>fig|1002809.3.peg.1926 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
METLQQDLMNKPVKKLFFHFFFPAVFGMLLMSVNLLLDGIFVGHGVGEVGLAGVNLAAPIFTIILAISLWIGIGGATNFSMAMGEEMADEARSSFTLALAIFTAILGVISIVGYLNLQTVAGWLGANEETLAPTTDYLGVLFALGWVLGLQQLLSIFIRNDGRPMLGMVSLGLTSVVNILLNYVFIFVLDMGVYGAALATILGGVVGVLVFVPHFFNKKVVLNKWRFNWSLPLGRRILAIGFPSLLAESGAFVLVVGYNLSVVAALGTEGVTAFSVINYLHGFMFLAFFGIETAMQPMVSYYHGSKKKAQLKETLALAEKTALILGVTLFVIGYLLAPQLVQLFGVDDPAIVQLAVEGIRLFFIGYLFIGLSFVYMTYFQSVGKVWSATLIIVMRSYIVFLIYLFVLPKVFGVNGIWLTMPIAEMTMAIVIVMFVRKRVKQTLI
>fig|1002809.3.peg.1980 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKRMIGFLLVVSGSFFWGIGGTMAQQLFSLGIEVSWLVSTRLVIAGILLLIAQAIFKDQGQIFKIWRERRDAFRLLVFAIVGMLGVQYTYMASIKEGNAAVATLLQYLAPVMIIIWVTVRGLSKFTKKDAVTIVLALSGSFFLLTNGSLSAFAVPLPAILWGLLSGVTLAFYTLYVIPLLKRFDSLVVVGWAMLLAGLTISFVQPPWDVDVSVLTGATLVYLVIVIIFGTMLAFWFYIESLQTLTAKETSLLGNIEPLTAVLATVLWLKEPFGGFQWLGTSLILVMMIYIALKADRQKDEDLDKVEDAIVEDN
>fig|1002809.3.peg.2185 Tetracycline resistance protein
MVQKTRVESSEEQTATLKSYILYPEKQKALYKRTLFVVSVSQIFGGAGLAAGVTVGALLAQQMLGTEAYAGLPSALFTLGSAGAALLVGRLSQASGRRIGLATGFMIGGLGAIGVIIAAIINSVLLLFLSLLVYGSGTATNLQARYAGTDLANNKQRATAISLTMVFTTFGAVAGPNLVNVMGDIALSIGVPALAGPFILAAAAYILAGIVLFVMLRPDPLLIARSIEASNNEKHAKTHSAITEQVENRRGIIVGATIMVLTQIVMVAIMTMTPVHMRHHGHSIGEVGIVIGYHIGAMYLPSLVTGFLVDKLGRTAMAIASGITLLLAGLTAAFAPGDSMVFLVIALSLLGLGWNFGLISGTALIVDSTTTSTRAKTQGTLDVFVALSGAAGGALSGVIMAGSSYLTLSFIGGILSLLLIPVMLWSRSAKN
>fig|1002809.3.peg.2231 Membrane component of multidrug resistance system
MQNELSEQTRKILLIVMIAGCFFSTLNQTLLNVALSDLMNTFSVSPTTIQWLATGFMLVNGILVPITAFLIKRFSTRQLFISAMLFLLAGSVVAACAMNFGMLLTGRMIQAVGAGIILPLMMTVIVYLFPEERRGAIMGKVGFAIIFAPAIAPTLAGFIIDYLSWRWLFISLIPFIVIIIVLAYKYLMNVNEGAKLKIDLISLIYSTFGFGLLLFGFSSAGSRGWDDGVILTTIGAGLIIIFLFCQRQLSSQDPLLNLSVFRYKMYSMTTIINVAITIIMYADLILLPMYLQDGRGFSALDAGLLLLPGAIINAFLSPVTGKLFDKYGAKPLFIFGLVLVALSMWLVIDLSSTTSYVYILVRTIILRIGLAFITMPLNTAALNAIPRELASHGSAVNNTIRQLAGAIGTAVIVTVYTLQLTGTSVQVNESYATAASSTYFYMFLLAIVAFIVVLFVPKHKRTMPAQETN
>fig|1002809.3.peg.2236 Permease of the drug/metabolite transporter (DMT) superfamily
MQKYKGELLMLITAVMWGSGFVGMAKGLEHWTVFQLMAGRFLLASIILSFIFYKKLKLISKAVIWKGAILGAILFIAFTLQTMGLEYTTPSKNAFLTAINVIIVPIIAYVIYKRRIDRFEFIAAGVAVVGIGFLSLQDSMTINFGDFLSILCAVGFAFDIFYTNVFVKTEDALALTIVQFYTATVLSVISVVMLGEVPTTYTSEGLGIIVYLAIFCTAVAYVCQNIGMQYANPTKSAIILSTESLFGTMFSVLILNEILTGRMLVGCVLIFFAILFAEVKPTFRRKKSYI
>fig|1002809.3.peg.2366 Transporter, drug/metabolite exporter family protein
MERLKGIAMIIVGSIFWGATGPMMEWLLQQTAMTAEFMLAVRLMIAGILILGIAAMQKKSIFSIWKNRNYSVQLLIFSVIGMVGLQFTFVKSIEVSNAIIATLLQFLAPIFIVIYTSVVGKVLPPRSQLIGIFGTLVGLFLLLTNGSVSGLLVSNEALVWGLLLGFTYAFYTLYPARLMAEVGVIIIIGWGMIIGGLMFSVAGQLWKTEQWLLLLDPVNVFLIIATGIFGSFAYILFLTSLKYISPVETSILSSFEPLTAMVISVVWLGATLYSWQYVGILLMLVFVVYLSIAGSKKATLRMSK
>fig|1002809.3.peg.2467 Ribosome protection-type tetracycline resistance related proteins, group 2
MHTTIGVVAHVDSGKTTFCEQLLYHTNAIKKRGRVDHQDAFLDNHAIERQRGITIFAEQGRIDYNGQAYTLIDTPGHIDFAPEMERAIHVMDAAIVIISAVDGIEGHTETVWHLLREHHVPTFIFINKVDREGADVAAVMSAIKKDLSPNALLFNDGFDTTVKEWLAERDEQLMEKYFADNLAENDCLESLKHAINHEQAFVCMSGSALKDEGVLAFFETIAQLMETKFDVNGPFEGKVYKIRHDHQQRLTFMKALSGVLKVRDEFTFGETTEKVTEIRLYNGNSFTTVPQVQAGDIFAVKGLAMPLIGDVIGATETNPAQFDMIPTLQAKVIYEGALHIKELHRVFREIEAEEPSLRVVWNEKFQEISVHVMGTIQLEVLTELVKERFGIEVQFGKPQILYKETIAAPAIGYGHFEPLKHYAEVHLKMELNNRGAGITFSNRCHADDLSVGHQRLIEKHLFERDHHGLLTGFPVTDIHLTLLTGRAHNKHTDGGDFREASFRALRQGLEQVKNVLLEPYYRFKMKASSDHIGRMMSDIQQASGSFEAPNLTEDTVTLYGRAPVATFMDYSTQFAAYTNGKGALTLQFEGYDVCHNSDEIIEQIGYNKNADPEYTSSSIFCAKGKGYSVPWNKAKAAMHCEVHEID
>fig|1002809.3.peg.2582 Permease of the drug/metabolite transporter (DMT) superfamily
MEFSMKKGMLLGFIGIVCFSFTLPATSIAVPYFGETIVGLGRTVIAAIIVGTVFIVKKQPLPSISQFKSLLIVAVGAVLAFPLLTTYAMKSLPVSHGAIELALLPLATAGFAMWRGGERPSKRYWIASATGAVTVIIYAIYLGLGQLHKGDFALIAAVILLGLSYAEGGKLSKEVGSWQVIAWAILIGAPFFIIPVGLGLSDRMLDAPIEAWISLFYLGIVSQFLAYVAWYGGMSLGGIARVGQIQYLQPFLMIGFSVLFLGESITWITIVLAMIVVLCVIVGKNADDKQSLELK
>fig|1002809.3.peg.2591 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENSTKELSLFKLTWPLFLELFLFMLMGLADTFMLSAVSDDAVAGVGTANQYIQIAILLLGVIGTGASIVVSQYLGSRLIAEASQIAALSVTLNLLVGLVISGLFILFSDVLMKMMNLQGAVLEAAQSYLVIVGGFIFVQALITSMSSIIRVQGWTKQTMYVSLAMNIVHVVLNYILIFGKFGMPELGVEGAAISSVVSRVLASVVFFWLLYQALEVRIEWADYYRLSKNYISKILKIGIPSALEQVLYQTNQIVLLYYVTFIGAEALSARQYAVNISMFTYLFAMAIGMATAILVGRYVGAGEKELAYSKVWFGVKSALIFTLSMVAIIILFREPFMRIFTDNEEIIQIGASVLLLSILLETGRTINITIINSLRASGDAAYPVRIGFISMIVIGLSLGYLFVFVLDLGLVGVWLAIACDEWIRAVLVIFRWRSRKWERYAIVSSDK
>fig|1002809.3.peg.2609 Permease of the drug/metabolite transporter (DMT) superfamily
MNVRSMLKLTISMAIFGSIGFFTTQTGLPAVELVFVRCICATIFLGGLWLITGGHKTEDWNRSEVMKTIVCGIFLVLNWVFLFKAFEVMSISVAISIYNLAPIFVLILGSVFLAEKMGIRSICATAICFFGSILIIGIESFTSVSQFMNSGFIWALLSAICYALTMFTSKTIHGMSSYALTYIQTITGIILLLPFCDFAAFEGLTNTNWLYILGTGLIHTGFVYYLFFDSVRDLPTVIVSVLVFVDPVVAILLDALLLSFRPDLLQVLGIVLIFGSILYTVFYPKQTINKVKTSSSQ
>fig|1002809.3.peg.2621 Permease of the drug/metabolite transporter (DMT) superfamily
MSLQGKANILMVIVTMFWGLSYTFMVMGLESLEAFNVVALRCLIAFIIAGLIFLPKMLRVNIKTILYASIQGFLLFTIFALSLLGLKTTSAGNAGFILSLTVVLVPIMTSFIEKRLPSRAVSFAVVATMIGITVLTLKESLTFQTGDLLVAIAAVCYSIYLILNSKFTKNVESISYGVYQLGIAGLFGAVFTMMFESPMFPSNSSSWIAVLGLGIICTAFCFIAQAVVQQYTSPTHTGLIFSLEPIFAALFAMIFLGEGLTAQLVIGGSFILIGNTVAQLEQFIAMKKIPAPTHSETTL
>fig|1002809.3.peg.2625 Probable multidrug resistance transporter, MFS superfamily
MELQEQTNKIFTKRFISLFFTNMSIFLVFYGLITTLPLYAIGELGKSDDDSGLLVTVFLISAIIVRPFSGKLLDLFGKKRLLILSLVLYFACTVLYLFFKPFLLLLALRFFQGIWFSIATTASGSLAADIIPKRRKGAGLGYFAMSTNLAVVFGPFIGLLIIQYLGFDMLFIVLSVLVAIGGLLALTIQTKDLPKPVVTDRSFKFSFNDLFERSALPLAALASLIAFSYASVLSFLSLYAEQKDLLSVASYFFAVFAVAMISVRPFTGRIYDTIGAKFVIIPSFFIFALGLIILGNADQEIPFLLSAIFIGAGYGTLTTSFQSLCIQSTSIQRSGYATATYFTLFDIGIAIGSYLLGMVAVKLGYEFVYYIAAFIIIVVFALYMLVLNRQKHKIEQ
>fig|1002809.3.peg.2846 
MITVTNRIQVKKGFAEKMAPQFVQPGPLQEFEGFQKVEVLVSTQFEEYDEMSVVMYWDSKENFAVWRESDAFKQSHKRPSEGEGGGHHQGESPMLGSQIVIAEVAGTISK
>fig|1002809.3.peg.3228 Teicoplanin resistance protein vanZ
MIHSFLLSMIAYCTVSFPIYCILRMFYMKNKTSSARRELVMLLFFFYSISIFSQTIIPSFQISNGQIIFDTSSAYVRSNFTPLQTIMLYYDQLNGPLANIAFYNLAGNIVLFIPFGFFIPLLWKKFRGWRIMHIVAFAIPLFIESTQYFIGRSIDVDDVLLNAIAIVIGFVLFKIFRRLRKMSAPK
>fig|1002809.3.peg.3521 Drug/metabolite transporter (DMT) superfamily protein
MKINKGVFFVLLGAGCFGFTPVFAKLGFGHGYSLGQINLVQMVISFLLLWSIAFLKGDGTKGLTKKNIIPIMITGCFIGLTSIFYYGAMQYLPASLAIILMFQFVWIGILFEWVFNKIKPAPITIFSIVLILVGVFFASNILNGDMQGLPIKGFVMGILSAFTYAAFIFFSGKVAVDVNPLTRTSLMVTGSTILVFILFMKDIPTVFPLEGSLVTSAAGVSLFGAVLPPLFYAVGAPLISGGLANILTSVELPVAILSASIILAETVKAVQWLGIVLILVAIVLNEIGPNIIRMKKRSKRTILHQHNKN
>fig|1002809.3.peg.3555 Quaternary ammonium compound-resistance protein SugE
MGWIFVILAAILETIGVIGLKKFSTSKKPKDLVTLVAGFGSAFYFLYASFEYLQVSIAYAVWIGLGTTAAVIINMLFFGESRSIGRMVAVFVIVIGVSGLKYVS
>fig|1002809.3.peg.3556 Broad-specificity multidrug efflux pump YkkC
MKKSWIYVGLTSLCELLWIYGFNVASASWHWAIIIPLITVDFYFLAKACEGLPTGTVYAIFAAIGTIGTALMDVYLFGESFTTLKIVFISIIVIGVMMLNIADTLSERKVEKGAL
>fig|1002809.3.peg.3635 Permease of the drug/metabolite transporter (DMT) superfamily
MNILPYLFVLMAAMLWGTVGTTQTFLTEGISSFAVACVRSGIGGGVLLLAVLAMRKISFRNWSWKWTILAAIAIALFQSLFFTSVRFTGVAVGTVVTIGSAPVFAGFIEWIFWKVRPTLVWAIATVLAIVGCLLLFMNQGETAINPLGIGLALAAGSMFALYTNVSKQLMKREETLPAVAMTFSICALFLLPLAAKDGFGWLTEGVNIWPILFMALAATSLAYILFLGGLKKISSSAAVTLSLAEPLTAALLGVFLVGEHLTFVSWIGVSLLLGGIIVLTFGTKKAAS
>fig|1002809.3.peg.3691 Multidrug resistance protein B
MKDYKITLGLLLLNLFIAFLGIGLVIPVLPTLMNELQISGTVVGYLTAAFAIAQLIVSPLAGKAVDKYGRKIMIVIGLFIFGISEFLFGLGKTIEVLFISRVLGGISAAFIMPAVTAFIADITTMETRPKALGYMSAAISTGFIIGPGIGGFLADFGTRVPFYFAGALGTTAAILSIILLREPERNMVNVENAPVQTSGFKRILEPMYLIAFILIFVASFGLAAFESFFSLFVDHKFSFTPTDIAIVITGGAIVGAIAQVALFDRLAQKWGEIKLIRYSLILSGVLVFLMTVVSSYFAILLVTCIVFVGFDLFRPAVTSYLSKIAGNEQGFVGGMNSMFTSLANIFGPILGGMLFDIDINYPYYFATVVIFFGILLTLIWKKPASYM
>fig|1002809.3.peg.3843 Multidrug resistance protein B
MSTTTVKQSNPVYPIMVSIGVCHLINDTMQAVIPAMFPLLERDLGLTFTQLGMISFVLNMFASLLQPAVGFMTDKKPFPYALPLGMVSSFIGLTMLILAGEYWMILVSVLFLGLGSAIFHPEGSRVSFMAAGNKRGLAQSIYQVGGNSGQALAPLLSAFIILPFGMYGVSVILIFTSIGIFLLTKISMWYKRQLEAEKRSKIKKMLVSSLPPLTKKQVGMALLVLLFIIFARSFYVTNITSFYVFYLSEQYGMSVERGQLFIFIFMAVGVVGTFFGGPLSDRFGRKNVILLSVIAPIPFCLALPFVPLPAVLVLLIIIGLLIMVSFTVTVVYAQELVPSKIGTMAGLTVGVAFGMGAIGSIVIGMLIDKMGIHFTMNAVSVLTLLLLVAFLLPRDRVGD
>fig|1002809.3.peg.3851 Permease of the drug/metabolite transporter (DMT) superfamily
MKQNWIYPLLIVIAASSYGVLSTIVKVAMQHGYTSSEAVTSQYFVGFLLALVLFVVTQRTLPKLSKKGAITLLLAGTCTAITGIVYGHSLNYLPASLAVVMLFQFTWIGLFMDCFLKRRLPTRIELISLVFLFVGTILAAGVIDVDLSQIAWQGWALGLLAAFTFAAFMQFNAQPVEGVTTIGRTFILSVVSLIIVFIFLSPEIVWNGQLTGGLWKFGLALGLFGIILPILLFSIAAPKVGGALVPILSAMELPVAITVSVIVLNESLTLLQIFGIVFVLFGMVLPSYFASKKVRVIDQKQQLP
>fig|1005048.3.peg.86 Glyoxalase/bleomycin resistance protein/dioxygenase
MIHIREIDHIVLRVTDLEQMLRFYCDALGCTVDRRLDNIGLVQLRAGSAMLDLVPVDGKLGSVGGAAPGKEGRNLDHFCFRVEPFDEATIRAHLVAHGVAAGELESRNGAEGEGPSIYVTDPEGNVVELKGPPYD
>fig|1005048.3.peg.789 Fosmidomycin resistance protein
MGSHDAEKTGFRVLGAISFAHFLNDMIQSLILSIYPLLKGNFNLSFAQIGLITLTYQITASILQPLVGLYTDKHPKPYSLALGMGFTLVGLLILSVAPSYGILLFAAALVGTGSSIFHPESSRVARMASGGRHGLAQSIFQVGGNAGSSMGPLLAAWIVIPHGQTSIAWFSAAALLAIVVLWQIGNWYKRKRQEAKSKPAKAKQHHVALPRNKVLFSVGILLMLVFSKYFYMASLSSYFTFYLIDKFQLSVQSAQLHLFVFLFAVAAGTVLGGPIGDKVGRKVVIWVSILGVAPFTLMLPYANLFWTGVLTVVIGVILASAFSAILVFAQELVPGKVGTVSGLFFGFAFGMGGIGAAALGQLADMTSIRFVYQVCSFLPLIGLLAAFLPNLEGHRRKAAG
>fig|1005048.3.peg.1085 Permease of the drug/metabolite transporter (DMT) superfamily
MSGKLQPGSRQIFLGGLAIAVAGAILFSAKAIVAKLIYRYPVDAVLLITFRMLFALPLFAAVALWKARSEAPLSNQDRMRIVVLGLIGYYLSSFLDFLGLQYISAGLERLILFLTPSFVLLMSFLFYRRRVTWLEWAALLISYLGTVLVFLHDVRLGGSNVGLGSALVLGAAISYALYLMLSGELVSRVGAMRLVAYAMCVSCAACIVQFLLLRPWPILLQQPAAVYGLSVINAVFCTVLPVFLTMVAVARIGPATAAQAGMVGPVSTLFLGALILAEPVTAIQLTGTGLVLAGIYLISKKKS
>fig|1005048.3.peg.1171 
MILELADIRIQPGKQQEFDAAIQRGIEQVISKAKGFAGFKIHKGIESPERYVLTISWETLENHTVDFRESPAFAEWRALVGPFFAVAPTVEHFTLLTQSH
>fig|1005048.3.peg.1277 Acriflavin resistance protein
MSISAAFIKRPIGTTLLAIAIFLIGAAVWPLLPVAPLPQVDFPTIQVSANLPGGNPETMASSVAQPLERQFSLIAGLSQMTSTSSLGSTQITLQFDLNRSIDAAALDVQAAITAASGQLPANLPSPPTFRKVNPADSPILVMSVQSDALPLIQVNDFADNILAQQISQIPGVGLVNIGGVQKPSVRIQVDPTKLAAIGISLEDIRGVIASLTVNQPKGTVDGAKQSFTVYTNDQLLSAEPWNDMVLAYKNGAPIRVRDVGVAVDAAENLKVAGWAYAGAAAPAGNTITNGRSIVLAITKQPGANVIETVDRIKAALPRLQAAIPPTVHVNTLIDRTQTIRASVSDVEFTLVLTIALVVLVIFLFLRNVPATLIPSVTVPLALLGTAGIMFLLGFSLDNLSLMALTIAVGFVVDDAIVMLENIYRYVEEGMAPIEAAYKGAGEIGFTIISISVSLVAVFIPLLLMGGIVGRLFREFAITVTLTIAVSVVISLTLTPMLCSRFLKSHTAESHGRMYQMFERGFDAMLNGYKRGLHVVLRHQFITLMVFFATMAATVVLFVIIPKGFFPQQDTGFVYGFAESAQDSSFASMNKRMLALADVVRKDPDVTGFGMSGGGSTFNTGNFFISLKPKDEGRTASADEVIARLRPQLAKVQGVNLFLQAGQDINVGGRLSRTQYQYTVTDSNLDELNVWAPKLLNRFRQLPQLTDVASDQQNAAAAANLTIDRARASSFGITPALIDSTIYDAIGQRQVAQYFTQINSYHVILEVTPKLQEDPELFNKLYLTSPVTGQQVPLSTFVTIDTNKTSYLSISHQGQFPAVTISFNLAPNVALGEAVDAIQKAQSEMGVPATLTGAFQGTAKAFGDSLSSQPYLIAAALVAVYIVLGLLYESYIHPLTILSTLPSAGVGALLILMMGGYDLSVIALIGIILLIGIVKKNGIMMIDFALTAERQHGMKPEEAIYQACLLRFRPIMMTTMCALLSGLPLMLGHGAGSELRRPLGYAMVGGLVLSQALTLFTTPVVYLYLDRAHYWYMRRKEARQARKAARKAAA
>fig|1005048.3.peg.1496 Permeases of the drug/metabolite transporter (DMT) superfamily
MTAGVIALVLCAALLHASWNAMLKSSGDRLWAITLMTIGSAVASIPIVLWAPLPALASWPYILMSVVLHAGYNLFLVRAYRAGDFGQSYPIARGSSPLLVSLGAALFAGEQLGILTLAGVVLISAGIISLAQIKFRRGSSVAGSRQWDAPLSAFTTGVFIAGYTIVDGLGSRLAGSAASYAGWMFLLDGLPLLMIYLSMHGSLRIALRERATWNALGGGAMSLLAYGIVIWAITLAPMGPVSALRETSVLFAALIARMFLGEALTLRRLLSCAVIALGAVMLGWSA
>fig|1005048.3.peg.1709 Inner membrane component of tripartite multidrug resistance system
MPSISSELPIKPLAGAQLIGAGLLLAAANFIAVLDTTIANVSVSTISGALGASSSQGTYVITSYAVAEAITVPLTGWLANRFGAVRVFITSMVMFGVFSALCGLANSLGLLIAFRIFQGLAGGPLIPLSQTLLLRVFPKEKAPTAVGLWAMTTLIAPIAGPILGGVLCDQYSWPYIFYINVPVALICGYLGWKMFKRYESSLVKVPIDKVGMGLMIVWVAALQLMLDQGKEKDWFASPEIMALALVATIGFIAFLIWELTERNPVVDLRVFRHRGYSASVITICLAFGAFFGATVLTPLWLQGYMGYTATHSGQTTALSGILAVMTAPFVAKLSTKVDPRKLVCLGVLWLGSVTLLRSFNSTDMTTFQIGWPLLLQGIGMPLFFVPLTGLALSSVNFSETASAAGLMSFCRTMSGAIATSLVNTSWENKAIYYHAELSGLVDQAGNASNTLVQSGLSAEQARLSIEQTVQSQSIMLSTNHIFMMAALSFLLAATAVWFAPKPKRIADTSAAH
>fig|1005048.3.peg.1710 Membrane fusion component of tripartite multidrug resistance system
MSHSDSQAVQELASTEATLKAEQAATTKKRKKLFAILGGVVLLGGLSYATYWHFIGSRYISTDNAYTAAEISQITPAINGIVADVKVVDTQYVKQGEVLVVIDNSDAKLALLQAEADLDRSQRRVQAYFANDAGLAAQVLARDAEQSRAAAQVLSAQADLQRAELDLRRREALAKSGSVSGEELTNARSALLTAQASMKVAEAGAIQAKSNRSAAIGAQQASTVLTANTTVATNPEVELARAKRDQAKLDLERTVLRAPVDGVVARRQVQVGQRVQAGTALMTVVPTQSMHVDANFKEGQLTQVQLGQPVTMSADIYGGSVEYHGTVVGLSGGTGSAFAMIPAQNATGNWIKVVQRLPVRISIDRKELIAKPLSVGLSMEVAIDTRGDKSAPAARM
>fig|1005048.3.peg.1711 Outer membrane component of tripartite multidrug resistance system
MPRPCFPPYAALSLCVLALSISGCAPFSEIGPRAVPKDISSYQAGQLAGNAVSWPDDNWWTIYRDPQLDRLIAEGLKGAPSLAAAQARLLKAQGVAQQQGAALLPQVSANASADYMKQSYNNGVPPEFVPPNYNVEGKATLNLSYEIDFWGKNRAALAAATSDLEAARADAAQARIALATSIAAAYAEFERLLSQHDTAQEALQVRIQTLDLFEQRRLNGLETLGSVKQVVARKASAEADLLSLDESIALQRNKLAALLGAGPDRGLSLQRPVLDLSKPFALPSQLPVNLLGRRPDVVAARLRAEAAAKQIKVAKAQFYPNVNLTAYLGFQSLGLGMLTKAGSDIGSIGPAISLPIFEGGRLRGQYRQASASYDEAVANYDNAVTQALQDVADAAVSEKALSGRLGKVQEAVDAAAAAAQIAQNRYAGGLATYLDVLNAQDTLLTNQRDLSTLRSRMFALDVQLVRALGGGYRQAAI
>fig|1005048.3.peg.1912 Methylenomycin A resistance protein
MAPSGLLPLLTLAIGFVMAMLDVTAVNVALSDISLNLSVPLSGLVWVVDGYTLTFAALLLVGGALADRYGAKTIYLSGLVVFMLGSLLCGAAPDGNTLIAARMLQGVGSALFMPSSLSLLTHAYEDDRVRARMLGTWSAIVAVAAAMGPLVGGVLVHGFGWRSVFLINVPVGLLGLLLAHTVIPAAPRHWRPLPAASHALGITGLASLCFTLIEGPVYGWTSSPILATAALVVIALMLLVRRERRGAEPLLPRALFATPRFAAANAIGFLINFGAFGQLFLLSLFLQQARGADALHTGLQLLPVMAVFSVGNLLSGRITARWGARLPMLGGLLLAALLAALLTGMRPHTSYLLFAMAAAIANWGVGIAVPAMTTTVMQVAGRIHANSAAAALNANRQIGALVGVAIIGSILHAAPDWDLRIPLAFGAIAIAYGGAALLVWRFIKSPGKD
>fig|1005048.3.peg.1933 Permease of the drug/metabolite transporter (DMT) superfamily
MNIAELFLLAAIWGASFLFMRVGTPEFGPVPLIFLRVGIAALVLLPVLRSAAARSHLRSKAWPMLVVGVTNSAIPFSLFAYSTLYVNAGFDAVLNATVPLWTGLIAFVWLKAPMSRAQVIGMLVGMAGVVVLVWDKIGEGQAGVWLATAAVLLATLCYGFAINYSKTRLVGVPPFVVAGGSQLAATLVLLPLAFWYWPTATVSATAWYAVLALGVVCTGLAYAIFYRLLDRVGSAYAASVTFLIPIFGVIWGAIFLKEEVTPGMVLGCVIILLGTALATGKLNLSVFLRDKTAK
>fig|1005048.3.peg.2315 Outer membrane component of tripartite multidrug resistance system
MKPIMSYPFRKSLSCLGMAGLLAACAAGPDFQAPPAPVVPQYTAGVQPLATVSSAGAGGGAQHFDPGMDIPAQWWTLFHSPQLDALVREALANSPSIVQAKAALRQASENLGGQIGATRYPQVDLQVGGVRQQIDTAALGIPNVPQAGPFTLYNASLDVSYTVDVFGADTRMLEGLQAQVDNQAAELQAARLTLAGNVVTAAIRHASLHAQIASTGQMLQLQRQQLGIMEQRLAAGGIAERDLKNQRTLVAQSEAALPALLQQQAQTSHQLAVYLGKAPAQADMPPLDLDSLTLPDRLPLSLPSALARQRPDIRAAEATLHQASAQVGVASANLYPQLTLSGSVGTEQGRIADLADSLNVWNIGLNLMQPLFHGGELRAKKRAAVAAYDAAAASYQQTVLQALQQVADSLRALENDAKVLQARAQAAENAQGSLAITSRQYQAGGVSHLSLLDAQRQGLQTALDRTVAQAARYADTAALLQALGGGWWNTVASDQP
>fig|1005048.3.peg.2525 Probable transmembrane drug efflux protein
MSDGKKTGFNLSRWALEHIPLTRYLMVVLVIGGILSYGRLGQDEDPPFTFRAMVVSAQWPGATALQMADQVTDKLEKKLQETPHIDTIRSYSKPGETLIILTLQESAPPKETADAWYQVRKKINDIKLTLPQGVVGPFFNDEFGETYGSIFAVSGDGFNYADVKDYADFVRQQLLTLPSVAKVDLFGVQDEKIFIEFSQKKFSQLGITVRDIVNQLSAQNALQSTGVLATATDNLQIRVSGALASPKDLENLQLRANNTTFRLGDFAVVKREYQDPPQTKMRFNGKEVIGLGVSMAKGGDIISLGKDMERMTAQIKAKLPVGIDLERVSNQPKIVAESVNEFLKTLMEAVLIVLAVSFLSLGFHTKPFRIDVRPGLVVALTIPLVLAVTFLFMSIFSIDLHKISLGALIIALGLLVDDAIIAVEMMVRKMEEGLSRLEAATFAYTSTAMPMLTGTLITAAGFLPIGLAKSAAGEYTFSMFSVNALALLISWLVAVLFTPYIGFLLLKVKPAAGADGHHELFNTPFYTRVRRTVNWCVEWRKTTIALTLMVFALGVFGFKFIEEQFFPDSSRPELMIELWLPEGSSFAATEAEAKKFEAYIHAAPELESMTTYVGSGSPRFYLPLDQILPQTNVAQLVLLTKDLASRDALRLRITEAFKHGFPEVRGRVKLLPSGPPVPYAVQFRVSGTDAAKVRTIADQVKSVMNGNPNIIGLNDNWNESVKVLRIDLDQDKLRTLGIGSQTVMQTVNTMLTGTTIGQYREHDRLIDIVVRQPLDERATIDALNQANVPTASGKSVPLAQVATVKLVWEPGVVWREWRNWAITVQADVIDGVQGPTVTAQIDPQLDKIRAQLPPGYIIDVAGAAHDSGKAQDSIAANVPLVIFIIFTLLMLQLHSFSRSLLVFLTGPLGVAGAAAALLLLHRPFGFVAQLGVIALFGMIIRNSVILIDQIEHDIANGVAPWNAIVESAVRRCRPIMLTAAAAVLAMIPLSRSVFWGPMAVAIMGGLIVATGLTLLFLPALYAAWFRVKKPQPENAADNHG
>fig|1005048.3.peg.2543 Permease of the drug/metabolite transporter (DMT) superfamily
MNLTTFAFIISGVCLNAVAQLLLKAGTNAVGVISLTPQNWFATGIKLATQLPILGGLTCYVISLIVWIIGLSRVDVTIAYPMLSLGYVISAVGAWYFLGEAVSAQRLVAIGVIIVGVVLLTRS
>fig|1005048.3.peg.2545 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKPELSVVIPVYNEESGLAKLFERLYPALDALGISYEILYVNDGSRDKSAAILAEQFRLRPDVTRVVLFNGNFGQHMAILAGFEATRGDIVVTLDADLQNPPEEIGNLVAKMREGYDYVGSIRRKRQDSAWRTVASKAMNLLREKITGIRMTDQGNMLRAYGRNVVDLINQCQEVNTFVPALAYTFARKETEIVVEHEERSAGESKYSLYSLIRLNFDLVTGFSIMPLQLFSLIGIVLSFASAALFFILVARRFLFGAEVQGVFTLFAFAFFLMGMILFGIGLVGEYVGRIYQQVRARPRYVVQAMLEQSSAEDKQAS
>fig|1005048.3.peg.2548 Polymyxin resistance protein PmrJ, predicted deacetylase
MPNLVRLLSKYQARATFLFSLGHDHTGWALKQVFRPGFFQKVSRTSVVEHYGLKTLMYGVLLPAPDIGKTCANYMQAVRDAGFECGVHTWDHRVWQDHVRQRGADWTSQQMQRSFDRFTQIFGQAPNTHGAAGWQMNPYAFEQLEKFGIAYASDGRAMLADDGALADQAAGPHRLQVNGKTLACIQLPTTLPTLDELLGRSFGGVELTPANIAAHILALTATPRDHVFTLHAELEGQKLAPIFEQLLQAWKAQGYDLVAMEDYYRQVKDQQLPTVPLAWAELPGRSGEMIMQASSS
>fig|1005048.3.peg.2558 Outer membrane component of tripartite multidrug resistance system
MISAAVLLLAACANFSGIHSTASTNNPDDYASASALPGQGGLWPAGSWVSTIGGSQLQQLVDEALAGNPNLQAAAARIGAARAMVEAAGATSKPQVGASLSATRERFSENSIYPPPFGGMYVTDYETALNFSYDLDFWGKHSAQLRSAISQSKAAEAEHYAARLALTAGISKAWLQLGRQYAQLDLTNQQLVLRDKLDKLTQQRFAAGLDTQSDNQQSRQQVAGLRAEQAQWQEAIALTRNQIAALMGQGPDRGLKIAPPALPADAAIALPDQLPLGLLGRRPDVVAARWQVEAAQSDIKVAKTEFYPDINLSAMAGFSSLSFSQFLNHSSKVVGIGPAIHLPIFEGGALRAQLKGRVAAYDGAVATYNQALNDAFHEVADSVQSLQAAETQGKNQQAAVDAAERGMKLAEQRQQVGTANMLQVVSTQISWLAQRKLELDTRARRADLRVNLIKSLGGGFDASAEGLNPAEASTGTASPQANAAN
>fig|1005048.3.peg.2559 Membrane fusion component of tripartite multidrug resistance system
MTTPNQTPENPSPAAAAPAPAAANGNGKRRSLLIGVTIALIIVLIAYGIWWFIYARHYENTDDAYVGGNVVQVTPQVGGTVLAINTDDTELVQAGKPLVELDKADAKVALDQAEAQLAQTVRQVRTLFVNNNALVSNVTARTSELERARADLARRQQLISTGAVSKEELDHAKVAVQGAEAALQATREQLASNRVLTDHTTVEQHPNVQNAAAQVRNAYINLARTTLLAPTTGYVAKRSVQVGQRIAAGTPLLSIVPLNALWVDANFKEVQINNMRIGQPVTLKSDLYGSKIEYHGKVVGLAAGTGSAFALLPAQNASGNWIKIVQRIPVRISLDAKDLETHPLRIGVSMDATVDIAQTEGTSLTAGTARTTPAYTTDVFDKSGQEADARIASIIAANNNAAAAH
>fig|1005048.3.peg.2560 Inner membrane component of tripartite multidrug resistance system
MSSPKPAMPARPPSQPLPPLTGGKLVMGTVALSLAVFMNVLDSSIANVSIPAISGDLGVSPQQGTWVITSFAVANAISVPLTGWLTQRFGQVRLFVTSIILFVLSSILCGLAPSMEVLIAARVLQGAVAGPMIPLSQSLLLSSYTPAKSGMALAFWGMTTLVAPVMGPLLGGWISDNYTWPWIFYINIPVGVFAAWATWSIYHKRESAVYKLPIDKIGLALLVIWVGSLQIMLDKGKELDWFNSSTIVILGAISLIAFIYFVIWELGDDHPVVDLTLFKGRNFSGGVIAISVGYGLMFGGLVILPLWLQTTLGYTATLAGEVMAPVGIFAIILSPFIGKILPKVDARWVASTAFLIFAVVFFLRAQFTENVDTFTLMIPTVIQGAAMAMFFIPLTSIILSGQPPEKMPSAAGLSNFVRIMFGGMGTSITSTFWDRRTSLHHSQLTEFTGPHSPAFTEAVHNLTAQGMSEPAAWATIERLITVKAATQGATDIFWISAVLFLMLIALVWLTKPSRSSVPADAGGAH
>fig|1005048.3.peg.2622 Permease of the drug/metabolite transporter (DMT) superfamily
MTDESKGMWLGLVGVAVFSLTLPFTRMAVAELNPVFVALGRAVVAALCSMLLLWKLKAKLPTAAQWKPLALTALGVVVGFPVFSSVAMRYVPAAHGAIVLGVLPLATALFGALRFGERPSAGFWIAAVIGSLIVVVFALSQGGGGLQAADLALLAAVLAAAMGYAEGGRLSQTMGGQQVIAWALLLSLPVLLPVTVWLGWHYGVSASPRAWLGFAYVSVFSMFIGFLFWYKGLALGGIARVGQVQLLQPFLTLLGAALLLGETLQAGNMLFALAVLVVVAFGRKMAVRRQAA
>fig|1005048.3.peg.2845 Permease of the drug/metabolite transporter (DMT) superfamily
MQPTHILLALLTVTIWGMNFVVIKIGLAGLPPLLFSALRFVFAALPLVFFIKRPAIPWRYLAGFGLFQFALQFSLLFSGMQLGIGAGLASLVIQLQAFFTIGLAVLLLGERPLLTQLLGALVALAGIVLVATHLEAQATVIGFLLVIGAGLSWASANIVTKKIGKVNPLALMAWGSLMAAPPLLLASAVLEGPAAWHVAFAHFGWTSAAAVFYQSYPNTIIGYGIWTILMRKYPAATVAPFSLLVPLVGMLSAAVLLGESLQWWKIVAGVLVLGGLALNLFGGRLMLALKARA
>fig|1005048.3.peg.2931 Permease of the drug/metabolite transporter (DMT) superfamily
MTISSASRSPNSSAKGLWFADLLLLLVAIVWGTSYGVAKDALVFYPVLGFVAIRFCMTFFLLLPSLRQLARPEGRAALRAGVPLGLILLAIFICETFGVALTQASNAAFLISLCVVFTPFVEWLVMAQRPPISAFVVAFVSLLGTWLLTIGSNLTFNLGDGLMLAAALLRAFMMVMTKRLTVDKDMSNLTLTAVQSGVVGFGCLLVASLFMQGGLPPLPSDPSFWVSTIYLVLFCTIFAFFAQNYGLRRSNPTRVSLLMGSEPVFGALFASFWLGEKLGALSWVGGALIVGATLWATLPRSMINFGAFFSTRNIKPENAPIIGAGIDSSQ
>fig|1005048.3.peg.2957 Permease of the drug/metabolite transporter (DMT) superfamily
MDKKVSGTVEMTAAMIISGTIGWFVVVSGQPVLDVVFWRCVFGAATLLAVCAAMGLLRGAITLRLLALAALGGVAIVINWLLLFISYSHASISISTAVYNTQPFMLVGLGAVFFSERLTLNKLTWLAIAFGGMLLIVLAQPGAADGGSNYLAGILMALGAAFFYAVAAIIAKKLAGTPPHLIALVQVCVGMLMLAPFAHLSALPSDIGTWSILVTVGVVHTGLMYILLYGAIQKLPTYLTGSLSFIYPIVAIAVDFLAFGHRLQLSQLAGAAAILIAAAGMNLGWSLWKPKVQMQ
>fig|1005048.3.peg.2995 Glyoxalase/bleomycin resistance protein/dioxygenase
MISHVFVGVADFQRAFGFYSAIMEVLELQLKFCDADKPWAAWMASGKARPLFIIGAPYSGAAAAGNGQMIALLAPTRTAVDKAYAAALRNGGSCEGAPGLRLEYHPDYYGAYFRDADGNKLCVCCHDAVA
>fig|1005048.3.peg.3142 Permeases of the drug/metabolite transporter (DMT) superfamily
MHSASLPAAAPAHRLLAAMPMVFVLLWSTGFVVAKFGLPYAPPLTFLLLRFAGVLLVLLPLVLLMRAPWPAGQVRHIALAGILLQGGYLAGVWCAIKLGMPAGVSALIVGMQPILTAFAAPLIGESVRPRQWLGLLLGICGVGLVVAAKVSLIGLSWQSISLCLLALLSITLGTLYQKRNCPQFDLRTGTIIQFAASIVVLLPFAIFYEHLGPSLDTVQWTPRFIGALLWSILALSIGAIFLLFALIRKSAATRVTSLLYLTPPTTALMAWLMFGEVFNLLGMAGMAVAILGVVFVMKK
>fig|1005048.3.peg.3316 Quaternary ammonium compound-resistance protein SugE
MAWIILVLAGIAEVIWAVGLKYSEGFTRNLPSLITCVGMAISIWLLAIAMRTLPLGTAYAVWTGIGAVGSFIAGIVLLGEAVSLARIASVSLIVLGLIGLKLSTAA
>fig|1005048.3.peg.3330 Glyoxalase/bleomycin resistance protein/dioxygenase
MPAIALNHYNLRAPRALLLQLKEFYCEVIGLQAGARPPFDNFGFWLYAGDQAVLHLSEARAGDIRHTDTATTFDHVAFSCVDPEQMEACLQAHALPYQVAFVPTMQQKQIFLRDPAGNGVELNFAHLS
>fig|1005048.3.peg.3470 Permease of the drug/metabolite transporter (DMT) superfamily
MRHTKSYAYLALAMMLVGANIGFGKAIIAVMPVLVFGLLRFVIAVVVMAPQFFKAAPRLERHEWLTLFGQAFFGTFLFTLCMLYGVQHTTATAAGVITSTLPAAVAILSRLILKERLQPRTLASILLAIAGIAVLNLSKSDSGDGGQTPLIGNLFVMAAVLCEATYVVLSKRLTQTLSPMRITAYSHLFGLLLMLPFGLTAALSYDFSQVTPGMWLLVFWYALAASVIAFWLWLTGTKHVQANVAGIFTALMPLAAAFIGVVFLHESLSWAHFVALALVLTGIAVASWPQSMKTVQEV
>fig|1005048.3.peg.3779 Outer membrane component of tripartite multidrug resistance system
MLLLSACADFSGIDKQSRLTDGNSLSGGATLANLSQTAWPTGAWWQNYRDPQLDTLVQQAVAGSPSLKIAQARIRQASSLAGVARAATLPKVGAEATSTRGLYSSEYIFPPPLGGSWNWDNEITVKASYDLDLWDKDRSALESALDTVHVSAAEARSAQLNLEVAVVRGYLQLATQYALRDIAVTTLAQQTLIASFAQRRLAAGLGTRLEVSQAETALPDARANIEKIDENIALLRNQIAALSGQGPGSGEAIQRPQLAARLVGADHSAPLAIGLPDNVPAHLVGRRPDVIAQRWRVEAMDKNIDVAKAAFYPDINISAFVGLQALGFTNFLSASSAVRGAGPAISLPIFEGGRLRANLGAQTAALDGAIESYNNTLVQALQSVADQIIRLKSQQQQRAQSEQALALSKQSYDLAMRGYQAGLTANINVIQTQLVLLQQQIRVAQIRASYLDSWAQLMQALGGGLGDDLPQPADAVAAEK
>fig|1005048.3.peg.3782 Fusaric acid resistance protein fusE
MKSSSIIKTLLQVAITLIVVLIAFLLVRALWDRYMNTPWTRDGRVRADVISVAADVSGIVVAVPVVDNSYVHKGDLLMKIDPARYALALAQAEATVAERRIGLSTKQRDAARRAKLDGDVISNENRENSSADASAAQAQYQAALAARDSARLNLDRTEIRATVDGWITNLNVHAGDFAQAGTPKLAVIDANSFWVYGYFEENKLPLMKVGDAVDMRLLGSEQLINGHIDSISRGITDRDNALGSYGLANVNPSFNWVRLAQRVPVRIHIDKVPDGITLAAGMTCTVIVKPGEPKPQK
>fig|1005048.3.peg.4401 Multidrug resistance transporter, Bcr/CflA family
MTNTPATSASEKLLPGWLLLLGALTAIGSLSIDMYLPSFPTIAQQFGVGSNLVQLTLASFLVGLAVGQMFYGPLSDRFGRKPPLYVGMTLYLLGSLACMVSQDVVALILFRFLQGLGGCAGMVIARAVIRDRLGTTGAARAFSLMMLVMGLAPILAPLIGGSVLKFWGWRVIFGGLAAFGLFCLLAIHYTMQETLDRHKAEPLHLGRTLKQYGRLLLDRQFVAYSLVGGLIQGGMFAYITGSSFVLIELHGIKPEHFGFVFGTNAFGLIAASQINARLVGRYSLDTILGRALWLPALLSLFIALLVACGVNNLPILLVGFFGYLACYGFISPNASAIALSQQGKQAGTASALMGTLQFTLGITSGVGMSLWHDGTALPLMVVMATCGVGGLLLHRFVARPEHRRQLQTAAHS
>fig|1005048.3.peg.4452 Permease of the drug/metabolite transporter (DMT) superfamily
MAMSLMLILCLCWGLQQVAIKVAAPNISPILQNGLRSAVAAVLVSGLMWWRGSKFSLTDGSFWPGLATGLLFAGEFLCVSIGLNYTTASHMSVFVYTAPIFTVLGLHWLVPGERFGLTQWLGVIAAFAGVTVAFAGGFDAGAGFSRTLVGDALGVLAAVFWAATTIMIKRSVLTNTAPSMTLWYQLAVAAVTLPLLALVTGQAEVVTPLTGIMWTSLVFQSLIVAFGSFLAWFWMLRRYLASRLTVFSFLTPLFGVSFGVLLLDDPIGLPFVFGAVLVLSGIVLVNWQRS
>fig|1005058.3.peg.80 Inner membrane component of tripartite multidrug resistance system
MNQTPIKGGALVMMTLGLALATFMQVLDSTIANVAIPTIAGDLGASSTQGTWVITSFGVANAIAIPITGWLARRFGEVKLFLVSVLIFVIASWLCGISHSLNMLIACRIIQGLAAGPIVPLSQSLLLNNYPPQRRAMALAFWSMTVVVAPICGPILGGWLSDDFHWGWIFFINIPVGILVILFTQITLGDRETKTYQQPIDSIGLILLILGVGALQLMLDRGREEDWFNSTEIVVLAIVAAVGLIALIIWELGEKHPIVDIALFQKRNFTVGCLCTSLAFLIYLGSVVLIPLLLQQVYGYTATWAGLATAPIGLFPLLLSPIIGRFGHKVDMRLLVTVSFFVYALTFHWRAVTFEPEMDFAAVALPQFIQGIAVACFFMPLTTITLSGLKPEETASASSLFNFLRTLAGSVGTSLTTFMWYNREALHHGEMVENITPYNPASQQYFHAMAEKGLNETQTAASLANQITHQGLIIGANEIFYISAIAFMLLFVIIWLAKPPFGARH
>fig|1005058.3.peg.884 Multiple antibiotic resistance protein MarC
MFDSFLVQFVVLWAVIDPIGSVPVYLTKTIGLSATDRKKIARNAVLIATGILFFFLITGQFLLEAMQIPLTAFQVAGGLVLLLFALTMVFSEGKAEQEMRLSSNINELAVYPLAVPSIASPGAMMAIVLLTDNHRFSFADQIVTAAIMALVLLITYLLLIAANRIQRLIGTTGAAIISRVMGLILAAIAVNHILSGIKAFFIEVIPTVT
>fig|1005058.3.peg.1088 Permease of the drug/metabolite transporter (DMT) superfamily
MQNRLTLGIFLALSAAALNSTIGIFSKVLIEQGLTIEAISFIKTIIAFVLVSIVLFRQPQKEQQQSICPHYSSTVKLWGQIAFCAFLGVFVMFFFETLAYQYGQAANVVVVLMASAAVSALIGGWLLLAEPIVFSAIVGTLIAILGIFIISWSGSGTWQAVVNASLAGIGYGLFSVFIKRFRLNGGLPLIKMLMFFGAIYLLFPFIQHFETINWSWSIALNLLALAVLPTLLGFYCTTKALVYLSAAKVQVTELSEPIFSMCLAWLFLSEIPTLYFFIGAVCIVLGIILINQLYKFAR
>fig|1005058.3.peg.1243 Permease of the drug/metabolite transporter (DMT) superfamily
MQKQKLAIPGILIGCVVFGLGSLIVAHVPVGAYAIAFWRLLIAAIIFFILAKLFKQPFPKSKQTIRYGLLAGVFLAFDLGFWHESVYAVGPGISTLLNSLQIFFLAAIGFFYFKEKQSIVQLFSLVLAVIGVYLITGSEFQHNDNALWGFVSGVVSSLLLALSMVYIRKTHEAEPCAIFPLMLLVSVGGILALIIPSLLFNFDNLYPTTALDWFWVFVYGAVMQCFAWGMIAYSVPLLSLAVTGLLLLSEPIAALVIDYSVLNKPINLIQWCGAAITMFAIYLGSVSSQPKKSKIRSLKGQNKG
>fig|1005058.3.peg.1310 Modulator of drug activity B
MKFLLLNGGKAFGHSQGKLNTTLHNTAKETLLALGHEVQETIIDAGYDINQEIEKFLWMDVVIWQMPGWWMGEPWIVKKYIDEVFTFGHGKLYQSDGRHRVNPTEGYGTGGLLQGRKHMLSLTWNAPIEAFEREGDFFEGKGVDGVYLHFRKANEFIGLSPLPTFICNDVIKNPNVEQHITEYKAHLNKLFAK
>fig|1005058.3.peg.1935 Tetracycline resistance protein C
MFLRLSRPHHHDTINILTVCYFKSIMENKNHQQENFKSTYQSLVNSARILFVEKGYQAVSIDEISGKALVTKGAFYHHFKNKKQLLSACYKQQLIMIDAYITTKTDLTNGWSALESIFEHYLDYIIDNNKNLIPIQEVMPIIGWNELEKISLEYITGKVNAIVSKLIQENQLKAYDDDVLKNLLNGWFMHIAIHAKNLKELADKKGQFIAIYRGFLLSLKDK
>fig|1005058.3.peg.2037 Glyoxalase/bleomycin resistance protein/dioxygenase
MSPLIGFHHIALIVSNYEVSKHFYINILGAEVIAETYRQARQSYKLDLRFRDGSQIELFSFPITPPRPTTPEACGLRHLAFKVDDLQQAIEYLNQHNVECEPVRIDELTGKQFTFFKDPDGLPLELYQWEN
>fig|1006551.4.peg.91 Multidrug resistance protein A (ErmA)
MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIVAVAYGIYWFLVLRHFEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDYVQKGDPLVTLDQTDAQQAFEKAQTQLAASVRQTRQQMINSKQLQASIDVKKTALSQAQTDLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTKLEQQPAVLQAATEVRNAWLALQRTKIVSPISGYVSRRSVQPGAQITTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRGGEMLASQVRSSPVYESNAREIGLEPVNKLINDIIQANAG
>fig|1006551.4.peg.380 
MIAVLFEAEVTPASQERYLALAAELKPLLNNIDGFIAIERFQSLTTPGKILSLSWWRDEEAVQAWKRNLCHQAAQKEGRESIFACYHIRVAQVLREYRA
>fig|1006551.4.peg.382 Permease of the drug/metabolite transporter (DMT) superfamily
MAFVSRNLMVDLFLTALAPAIWGSTYIVTSQFLPPDRPFIAALLRVLPAGIALLIWSRRFPLRAEWWKLIVTGILNIGAFQALLFIAAYRLPGGLAAVIGAIQPLLVMLLTWCVDRQRSPWLAVLSALMGIAGMAMLLLSPQTTLEPLGIAAAFLGAMSMALGTWLSRRWAIALPVIALTGWQLLVGGIVLAPIALLVDPPLHQVTLTQAAGYLWLCVAGAMLAYGLWFRGISRLSPVAVSAMSLLSPVTAVLLGWVFLGQKIEGLALVGLVIVLFSVLSIQRALSNKSAVAGR
>fig|1006551.4.peg.389 Inner membrane component of tripartite multidrug resistance system
MTSSRSSVIRKKWPLLALVLAAIVALILVIWQLQTSPETNDAYVYADTIDVVPEVSGRIVEMPIRDNQRVKKGDLLFRIDPRPYQAMLDDAKARLTTLDAQIMLTQRTIKAQEYNAQSVSAAVERAKALVKQTTSSRIRLEPLVPQGFASQEDLDQARTAEKAARAELEATLLQAKQASAAVTGVDAMVAQRAGILAQIALAELHLEFTEVRAPFNGVVVALKTTIGQYASALKPVFTLLDDDHWYVVANFRETDLKNVRPGVPARITVMTNHSRAFEGVVDSVGTGVLPDGGSVIEGLPVIQKSINWVHVSQRFPVKIAVKDPDPNLFRMGASASAVLQPQ
>fig|1006551.4.peg.390 Membrane fusion component of tripartite multidrug resistance system
MQSLWPFLTRELRDAPGRANYTLRLTLSCAVLIVLFMTLHIPFLAVALIVVFYVSQPNVLMIKLVSVVFVVTVSVALGGVLLIIKWTYDYPLIRLVASVILFFCAIYLMRVLGKLGLAFFVVALAVIYAQTFPSMTSQSEILVRLLLWLWVAINTAILVTLLVNACFQQAFPGYQFKARLVVMLRQTARRLSQPDDGTPPPTVTEIAGQFNQLRSLYQQAARATPEIAASPQAWQSLMAAALSCSHLTALLLPGDDHPDARRRIASQLNALADNLPAAAEVQPLIVPRDGANSAILQEIAEVLARLARGETIPLPQGEVEKAPLLLPDAWSNPAYLHFALKTLLATLLCYVFYTAADWQGIHTIMLSCVIVAQPGLGATMQKTWLRIGGALLATLIALLLIVFVQPWTDSLSGLLAMTLPVFALAAWIAAGSERIAYAGIQIGFTFALAFLSWFGPLSNLTELRDRVIGILLGVLVSSIVHLYLWPDSEAPQLKARLAQLYRQLAQTLAARDDEVQQVPLFAALTESETLINRVAAEPLGTYAHPWPEAKSWPARATFRQAEEILRLSEGYRLYAAPEDTFLARCARRLEAYASDIDAQQNTVERVQAPQPDPANPFGAPLVNALAALPTWPLASSVIPRQATRS
>fig|1006551.4.peg.391 Outer membrane component of tripartite multidrug resistance system
MTKTTPLPRVWRSLALAFALTQLAGCALIQDDPGQVPLVNPQQAELAKVIHLANSGWPTARWWESYQDPQLNMLVNRALQNSPTMQAARLRISQSQSTVELAQSAMGIQATAVAAQNRLRVTNKQFTWPYSFSLPVDKNGPWYTLNTVGVGATLNIDLWGADRARVAAAIGEKNARQAETAGIELDLASSVAQLYFAMQATFQKIELLNQLEAIARLSVQAHEHRTARGVEDSVDVANAQAELLAAQQQVITAQGTLTQYRETLRALIGADAHSMPEIHPVALPTLQETLPDSLSFELLARRPDLQALRGYVSASMSQVDAAKAAFYPHFDIKAFWGYNALSVGDLFKSSFQQINILPGLYLPLFDGGRLNANLKSTRTASNILIKQYNQAVLDAVRDVAISSSQLNDLNQQAALQQQKVTAAMVTTRSASAHHQRGLVSYYAAQEARRPAIAQQLLLLDIQAQRLSTDITLIKALGGDYRGPAQSENAPSR
>fig|1006551.4.peg.406 Glyoxalase/bleomycin resistance protein/dioxygenase
MRELVNTIAHIGYQVSDLTRSLAFYEPLGFQRQQRFSKPSPQGAIEVAFLEMAGAVLELYQLPEGTPFDAPRCGIDHLALEVSDLDAVQQRLAALGYPLDEGPIEEENVRFLLIRGPDGERLEFDAFKR
>fig|1006551.4.peg.747 Permease of the drug/metabolite transporter (DMT) superfamily
MKQQAGIGIILALTTAMCWGALPIAMKQVLEVMEPPTVVFYRFLMASFGLGAILAMKRKLPPLRIFRKPRWLVLLVIATAGLFGNFILFSSSLQYLSPTASQVIGQLSPVGMMVASVFVLKEKMRGTQVVGALMLVSGLVMFFNTSLIEIFTRLTDYTWGVIFGVGAATVWVCYGVAQKVLLRRLASQQILFLLYTLCTISLLPLAKPSQVLALSDWQLACLVFCGLNTLVGYGALAEAMARWQAAQVSALITLTPLFTLLFSDLLSLAWPDVFARPLLNLMGYLGAFVVVAGAMYSAVGHRLWGRWRKREAVVPLPRSGE
>fig|1006551.4.peg.806 Fusaric acid resistance protein fusE
MAIFRAWVYYTASPWTRDARFSADIVAIAPDVSGLISQVNIKDNQLVKKDQVLFVIDQPRYQKALAEAEADVSYYQTLAQEKRVEAGRRNRLGVQAMSREEIDQANNVLQTVEHQLAKATASRDLAKLDLERTVIRAPADGWVTNLNVYRGEFITRGSTAVALVKQNTFYVMAYLEETKLEGVRPGFRAEITPLGSVHTLRGTVDSIAAGVTNASSSSDSKGLASIDSNLEWVRLAQRVPVRIRLDQQQGNLWPAGTTATVVITGKEDRDTRQANFFQKLAMRLREFG
>fig|1006551.4.peg.1012 Polymyxin resistance protein PmrM
MGLIWALFSVGLASGAQLLLRSAMVELPPLTEIFTFLNHLLHLRAGTFGLAFGLMGYLLSMVCWYFALHQLPLAKAYALLSLSYILVWAAAIWLPGWHEPFHWQSLLGVLLIVAGVLTIFWPVKRLN
>fig|1006551.4.peg.1013 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MSVWICLVFASLLSCAGQLCQKQATRPSKSGRRGYHILGWLGLALLSLGCSMLLWLSVLQSIPVSIAYPMLSLNFVWVTLAAWGIWREPVARRHWLGVGLIVVGIVILGSRI
>fig|1006551.4.peg.1015 Polymyxin resistance protein PmrJ, predicted deacetylase
MKQVGLRIDVDTFRGTRDGVPRLLALLSQHGIQASFFFSVGPDNMGRHIWRLIKPKFLWKMLRSKAASLYGWDILLAGTAWPGRRIGAGNEDVIRAAAQEHEVGLHAWDHYSWQAWSGVWPQERLTLEVERGLLELERIIGRPVTCSAVAGWRADQRVIKAKEAFDFLYNSDCRGTGPFLPQLGNGAPGTVQIPVTLPTWDEVVGNAVDSAGFNRYLLDCIHRDAGTPVYTIHAEVEGIAFAEQFDELLTMAAQEEIRFCPLSQLLPADFSVLPRGKVVRGELAGREGWLGREQLLNSGV
>fig|1006551.4.peg.1017 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MFSYPPVKKVSVVIPVYNEQESLPELIRRTDTACATLGRQYEILLVDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEGYDVVGTVRQNRQDTFFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLFGSVIALLGFAFGLMLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASQEEDRS
>fig|1006551.4.peg.1154 Membrane fusion component of tripartite multidrug resistance system
MDLLIILTYVAIAWSIFKIFKIPVNKWTVPTAALGGVFIVSALILLMNYNHPYTFTAQKAVISIPITPQVTGVVSSVTDKANQRVKKGEVLFTIDPVRYQARVDRLQADLVTALHSINTLKAQLSEAQANTTRVSAERDRLYKDYQRYLKGSQARVNPFSESDIDNARQNYLAQDAMVKGSVAEQAQIQSQLDSMINGEQSQVVSLRAQLAEAKYNLDQTTVRAPSDGYITQVLIRPGTYAASLPLRPVMVFIPQQKRLIVAQFRQNSLLRLEKGDDAEAVFNALPGQVFRGKLVSILPVVPGGTYQAQGTLQALTVTPGTDGVLATIELEPDAAVDALPDGIYAQVAVYSDHFTHVSVMRKVLLRMTSWMHYLYLDH
>fig|1006551.4.peg.1247 Permease of the drug/metabolite transporter (DMT) superfamily
MTRQRQADLLLIAATVIAACGWIFSREAIAGMPVFAFLGLRFLFAALLLLPFCRGLRVERQQWPRMIISGLWFALNLCLWIYSVSTTPSLGEGAFIMSLSMLFVPLTAWVMMKARPARAYWECLPIAVVGLGLLSLHMPIAFHPSQGWFLLTALVQSIWFCYTSKSAREVPLIPLTTVQLGITGIVGLGISAAVESWTQPFTLPTFGWLLASIVIATSLRFGLQMKGQKYAAVASAAIIMVLEPLLTVIAAALWYGEQLPLQKIIGGLLILVAQLWFRWRMLKPLR
>fig|1006551.4.peg.1291 Multidrug resistance protein D
MKRHKNFNLLLMLVLLVAVGQMAQTIYIPAIADMAISLNVREGAVQSVMAAYLLTYGVSQLFYGPLSDRVGRRPVILVGMSIFMLATLVAITTHSLPVLIAASAMQGMGTGVGGVMARTLPRDLYEGAQLRHANSLLNMGILVSPLLAPLIGGILDTLWNWRACFVFLLVLCAGVTFSMARWMPETRPTGAPRTRLITNYKTLFGTGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMSVSILFILPIPAAFFGAWFAGRPNKRFPTLMWQSVICCLLAGVLMWIPGLLGVMTVWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMMPQTGQGSLGLLMMLMGLLILLCWLPLASRFHQHQQPV
>fig|1006551.4.peg.1974 Fosfomycin resistance protein FosA
MLSGLNHLTLAVSQLAPSVAFYQQLPGMTLRARWDNGAYFSCGDLWLCLSLDPQRRVISPEESDYTHYAFSIAEADFALFAGRLNAAGVPVWKTNKSEGASHYFLDPDGHKLELHVGNLAQRLAACRAKPYKGMVFFGEDEQAAGNP
>fig|1006551.4.peg.2389 Permease of the drug/metabolite transporter (DMT) superfamily
MRIADYLRLLLLAAIWGASFLFMRIAVPQFGAINTAFLRVFFGSTGLAVILFIFKSSFDFKDKFKSSVMLGVINSGLPFLMYCLAAKWLPAGYSAILNATTPLMGAVIGFAFFAEKLTFRKWAGMLLGIVGIIAIATIGEPLSAEKQIAVVIACLIATSCYATAGFLTRSWISNKGGLDPKIVAFGSQIGASFFLLPFFIWSTHSGPTVNWLQQEAWISVIAAGAICTAFAYILYFRLIADIGPLRSLTVTFLIPPFGVLWGYMVLNETVNNGFVIGAIIIGIAVWMVVSPEKNN
>fig|1006551.4.peg.2513 
MAQQKSVTLVISHVLDPEHGQQYEAWLGKIMPIAAEFPGHLGANVIRPAPGQNLWSVIIRFDTIEHLYAWTQSETRRQLVAEIAPLLSEGDRTEVRTEPAFWFTPPAANVRQPRRWKQFLITLLVIFPSTNLVPSITGILLPSLKGSLLLHLINDACVVALVVWFWMPIVTRLFAGWLKKN
>fig|1006551.4.peg.2576 Multidrug resistance-like ATP-binding protein mdlB
MRSFTELWPTLKRLLAYGSPWRKPLMIAVAIMWVAAVAEVSGPLLISYFIDNMVAKNSLPLKLVCGLAAAYIGLQLLAAGLHYCQALLFNRAAVGVVQQLRSDVMDAALRQPLSEFDTQPVGQLISRVTNDTEVIRDLYVTVVATVLRSAALIGAMLVAMFSLDWRMALVAIAIFPAVLIVMMIYQRYSTPIVRRVRAWLADINDGFNEVINGMGVIQQFRQQARFGERMREASYAHYLARMQTLRLDGFLLRPLLSLFSSLILCGLLMLFGFSSSGTIEVGVLYAFISYLGRLNEPLIELTTQQSMLQQAVVAGERVFELMDKPRQAWGEDSEPLRSGAMSIDHVSFAYRDDSLVLQDINLDIPSRSFVALVGHTGSGKSTLASLMMGYYPLTQGEIRIDGRPLSSLSHSALRQGIAMVQQDPVVLADTFYANVTLGRDISEEQVWEALEAVQLAALAREMENGIYTLLGEQGNNLSVGQKQLLALARVLVDTPQVLILDEATANIDSGTEQAIQQALARVREHTTLVVIAHRLSTIVEADTILVLHRGQAVERGSHQQLLAARGRYWQMYQLQLAGEELAASAQEESLIA
>fig|1006551.4.peg.3295 Drug resistance transporter EmrB/QacA subfamily
MLWMQAAIITLGAFATMLSSTMLSAALPAMAAGLGVTDTAIQWIATAYLMALAAGVPLSAWAARRFGATQLWLYGLILFAIFSAVCALSPHFEVLLAARVMQGLAGGLLVPAGQTILGLVVGRERLGRVIGTIGVAIVIAPLLGTSLGAVLLESCGWRGLFWITVPFCLCACLAGWKLLPRPTIKTDRPLSLDWLGLALVFCSLPMLMEGMKELSLNSGKYGRNVIMLSVGALFTCLFIYRSLRIESPLLHLELFKHRGFTLSAVLMAIGGAVNFGGQFLLPLYFRDVCHVTLAEVGLLLTPQLIGSAIGFPMAGYFSDKLGPRTVLIIGGLLAAFATLPLAMIDEGSRYTLVGGAIAVRGFGLALATVPAMAAGLAMAGSRHVADAAPVLNILQRVGAMAGAALVTACYVRFAHTRGSLAAFHHAGWLLTGGAVLLALCALFMVNHSTLTTQEE
>fig|1006551.4.peg.3310 Permease of the drug/metabolite transporter (DMT) superfamily
MPYLLLTLAALFWGGNYVVGHILVQGADPILMTEARWALTALLLVLLYQRQIRDSRPLFRQNGATLLVLTLCGQVSFPLTLYIGLQSTSALNAAIYMSATPCMVLMINRLIFHDRVSARNWWGVIFSTAGVLLLLLHGNLSNAEGLKGFSQGDLWAMGSALSWAVYCSLLRNKDRRIPANAFVAVSSLLGALILLPVVIFWLWLHPATSFAAYHDIAFLTGLAYLVIFPSWLAYLFWNKGIAAIGATRGEIYTHIIPLSGGILSIVFLHTQPHLYHLLSSLLILTGIAICSFAKKAAAYS
>fig|1006551.4.peg.3936 Permease of the drug/metabolite transporter (DMT) superfamily
MNALLYGLVVVIWGTTWIAIFLQQGPVAAPVSIFWRFAVASVAMLTILLVTRRLRPLAARDHLFCLLQGCCVFCFNFWCFYTAAAYINTGLESVIFSMAVLFNAINSFLFYRQQPPGRFWLAAALGLAGIVTLFWDDLWASGLNASLLLGIALSALGTFGFSLGNMLSIRHQRRGLETLTTNSWAMLYGTLVMGAIALVRGDNFAPQWTLSYMGALLYLAVFGSVIAFGAYFTLVGRIGAGKAAYSTLLFPLVALTISTFYEGYVWHSSAVAGLALILVGNLVMFARPEQWLLRRRLAWVRSDRC
>fig|1006551.4.peg.4265 Multiple antibiotic resistance protein MarC
MMDLFKAIGLGLVVILPLANPLTTVALFLGLAGNMNNAERNRQSLMASVYVFAILMVAWYAGQVVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQKAHDSMEAKLKSEELEDEPTANIAFVPLAMPSTAGPGTIAMIISSASTVKHGASFPDWVVLVAPPIIFALVGIILWGCLRSSGAIMRLVGKGGIEAISRLMGFLLVCMGVQFIINGVLEIISTYHA
>fig|1006551.4.peg.4266 Multiple antibiotic resistance protein marR
MVNQKKDRLLNDYLSPMDITSTQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLVCKGWIERLPNPTDKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSTDEVATLECLLKKVLS
>fig|1006551.4.peg.4267 Multiple antibiotic resistance protein MarA
MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHQYRITNVPGESRYLLPLNNCC
>fig|1006551.4.peg.4268 Multiple antibiotic resistance protein MarB
MKLFASAAIVLLALVSSQSYAEQTSTPVRHNNRDAMIIPSEHNDSPFDFNHMASGSDKSDELGVPYYNQQSL
>fig|1006551.4.peg.4269 Permease of the drug/metabolite transporter (DMT) superfamily
MIYAADELFGSLILFAKIPITTEAGMTRKDGLLALLVVVVWGLNFVVIKVGLHNMPPLMLAGLRFLLVAFPALLFVARPKIPLSLLLGYGLTISFGQFAFLFCAISLGMPAGLASLVLQAQAFFTIILGAFIFGERLQGKQLAGIALAIFGVLVLVEASLGGQHVPLVGFMLTLAAALSWACGNIFNKKIMSHASRPPIMSLVVWSALIPVLPFMLASWILDGPQVMAESLLHIDLLTILSLLYLAFIATIVGYGIWGALLGRYETWRVAPLSLLVPVVGMASAALLLGETLNSLQLLGAVLIMAGLYINVFGLRIVRPGMARG
>fig|1006551.4.peg.4400 beta-lactam resistance protein
MENVFNRIVELIGWIVLGVSALLLVIAHHIDNYQSPPAVDAVQTKPLSK
>fig|1006551.4.peg.4422 Fusaric acid resistance protein fusE
MKKLKYLSTLLVAALAIIAAWLVWNYYTQSPWTRDGKVRAEQVGVTPQVSGSILQLNVRDNQLVKAGDVLFRIDDTPYKIALLNARAQLAKAKAEVARAQAEQKKAASDASRRRHLSQNFISAEDLENANTALNTATTNLEAAKAVVGVAQATLDHAQWQLTQTEIKAPVDGWVTNLSTRVGDYAAVGHPVFALVDSRSFYVVGYFEETKLRNIRPGDSAQIILYSSKQKLQGHVSSIGRAIVDQSVESGGDLVANIKPNIPWVRLAQRVPVRIEFDHLPPDTILVSGTTCTVAIGAQ
>fig|1006551.4.peg.4441 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKYFIEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILFGHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSLLVMVVLWNAGYIISSMHNIDPAMAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIYGHFGMPELGGIGCGVATASVYWVMFFSMLFWVRRARSMRDIHHTERFSKPDFAVIQRLVQLGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPLSLAAAVTIRVGFRLGQGSTLEAQTSARTGVGVGVCMAVFTAVFTILMRKQIALLYNDNPEVVTLASQLMLLAAIYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYLLALTDIVVPRMGPAGFWCGFIIGLTSAAVMMMLRMRFLQRQPSSVILQRAAR
>fig|1006551.4.peg.4656 Albicidin resistance protein
MLIQVGELAKRAGITVRTLHHYEQTGLLTPSARSAAGYRLYNLAAVQRLHMIKALAQAGLELATIKDYLDRDAFSLSDLLVKQIATLDRQLQTLSTLRQRLALLREELDCGDEPDLESWLQTLELMKMYDRWFSQQELQVLPFAEQDAQRNQIWLELVGEAQQLMGERCPADEPRAIALATRWMAQLEQDTAGRPEFLTRLNEMHAAEPQMREQTGVTPEMIDFITRAFAESKLAIWARYLNAEELAFTRQHYFDRLMEWPALVAELHRACREKREPASAEGQQLAQRWLALFQSYAGKDPHTQQKFRYAMEREPHLMKGTWMTPEVLGWLQQAIGVMMRQAPGPAAG
>fig|1006551.4.peg.4700 Multidrug resistance protein D
MLGRAALVLVTALLMFPQIAETIYSPALTDISARFSVSAPQAALTLSVYFIGFAVGVLLWGGFSDRYGRRPALLAGLGVYALGCLMALWATDFSLLLAARIVTAAGAATGSVVTQTVLRDCYRGRQLAGIFSFIGLALAVSPAVGVYIGGGLTALWGMRGVFSALALLAAALLLGCLALMPETRPQNLRRGPFLHVLRRMVGDTRVALAAILVAAFNVSLFSYYSLAPFLFARFDLDALTFGYSGMALAAGSLLGALLNHRLLRRNVSLGRILAIACILHLAGGVAVYVLRESIWFVAPVALVTLAWAMAIPLVLGSALSAYGDCRGTAGAFFGLFYYVLIGAGLLAAGWGQSLGASLLACAGVSMLAGWRYIIVLNEG
>fig|1006551.4.peg.4856 Permease of the drug/metabolite transporter (DMT) superfamily
MSTRQLLPLIGALFALYIIWGSTYFAIAVGVASWPPLMMAGVRFLSAGAVLTAWLLATGHKLPARKPLLNAALIGVLLLAVGNGFVTLAEHQHVPSGIAAVMVATVPLFTLCFSRFFGIATRKLEWLGIAIGLAGIVLLNSGGNLNGNPWGALLILIGSMSWAFGSVYGSRIELPTGMMAGAIEMLAAGVVLMIASTLTGEKLTQMPSWSGIFAVAYLAIFGSLIAINAYMYLIRNVTPAVATSYAYVNPVVAVLLGTGFAGESLSAVEWLALGIIIFAVVLVTLGKYLLPARREITSCRAEK
>fig|1006551.4.peg.5200 MFS family multidrug transport protein, bicyclomycin resistance protein
MTAKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIAAQFNVPDGSAQMTLSTYILGFALGQLLYGPMADSMGRKPVILGGTLVFAAAAVACALSQTIDMLITMRFFHGLAAAAASVVINALMRDIYPKEEFSRMMSFVMLVTTVAPLVAPMVGGAVLVWFSWHAIFWILAVAALLASAMIAFFISETLPPERRQKFHIRTTLGNFATLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYININHVSPQHFGYYFALNVVFLFVMTMINSRFVRRVGALNMFRAGLWIQFAMAAWMVVCALFGVGFWALVFGVAAFIGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGALLSMATFTTAWPMLISIAFCASSSILFYLYASRRRKAAR
>fig|1007096.3.peg.517 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPKSKSYEIDMCNGPVLSKMLLFALPLMCSGILQLLFNAADVIVVGRYAGDNSMAAVGSNAALINLLTNLFIGLSVGANVLAARYFGAKREVELRATVHTAMLLALCSGVGLILAGMAGARQVLIWMQAPPAVLELAALYLRIYFLGMPAMMVYNFGAALLRAKGDTQRPLYFLLLAGVVNVALNLLLVIVFHLGVAGVAIATVVSQCISAVLVVICLARETGGFRLELKALQIQKEPLKGILRVGLPAGVQGVIFSLSNVVIQSSINSLGEVVMAGSAAAANIEGFVYAAMNAIYQATLSFSSQNTGAGQLNRINRILLTGQGLVTVTGAVLSIGVWQAGRLLLGIYTDDPAVVEAGFVRLGIVCAPYAICGMMDIMVGVLRGIGYSVMPMIVSLMGVCALRLVWIATVFQIPQYHTPECVYWSYPVSWVVTLFVHILCYLWAKRRTDLRFAAAMAERKAEKELSLFENTK
>fig|1007096.3.peg.623 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEGRQEEKYIRMTTEPVGRLICELAVPCIISMLVTSIYNMADTYFVGKLDSNSATGAVGVVFSLMAVIQAIGFFFGHGSGNYISRKLGEQDGAEARRMSSTGFTLALLAGAVLCVLGEIFLTPLANLLGATPTILPYARDYMRIILIGAPWMTASLVLNNQLRFQGSAAYGMVGISAGAVLNIALDPVFIFALKMGVAGAALATVLSQFASFCLLLWQCGRGGNLRPHLKDAQIKRFYCQEIARGGLPSLARQGLASLATICLNRSARGYGDTVIAAMAVVTRVMMFGGSALIGFGQGFQPVCGFNYGAKLYHRVRQGFWFCVKWGTAFLLVVCALGAVFAPELVALFRNDPEVIRVGALAMRCQCVGFALSGWVVISNMTLQTIGDTGPATFLAAARQGVFFIPAVLILPRLFNLWGVILAQPVSDILAFAVAVPLMLRALGKMRETGKN
>fig|1007096.3.peg.1015 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRELRRGLQAAPLSNCHRAPLQSRRENERKRVFMEERSKKLTENKMGVMPVGKLVFNMSLPIMISMLVQALYNVVDSIFVSRISENALTAVSLAFPMQALMIAVSTGTAVGINALLSRALGARDPKRAQSVALNGIFLAGLSVLAFILIGWLVSPVFFRSQTDVAEIVDGGITYLTICSCVSFGLFFGITFERILQSTGRTLYTMFTQGLGAIINIILDPILIFGLFGLPRMGVAGAAVATVIGQICSMCLSLFFCLKKNPEVPLKFKGFRPNGEIIRDIYLIGVPSIIMQAIGSIMVYGMNRILIPFTTTAATVFGAYFKLQSFIFMPVFGLNNGVIPIVAYNYGAQKKNRIMRAFKVSLATAACIMVVGTLIFLLVPGWLLALFDASDEMLAIGAPALQIISLSFPMAAVGIVCSGVFQALGNSVLSMIVSLARQLILLLPAAWLLSLSGNLDMVWWAFPIAEVVSLILTIVFFRWTYHKHIVPLAGAQS
>fig|1007096.3.peg.1090 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFSVLRQKPGFYSRLWRLALPIILQNLITTSLGFVDTFMVGLLGNEELSAVTAANTPIFLVQVIIFGLMSGLTVLVCQYWGKGDAASINRVMGVAMYVGIAISGVAALLLFLFPEGVMALVTNNAQLIELGAPYVRIVGVSYVFNAVSSVYVSMQRSTENPGFGMLVFATSMLLNTFLNYCLIFGNFGAPRLGITGAAAATLASRVVEFIIVLVYAICNKRVPLIPKALFCPGRAMLKSAAVYAGPVILNETLWGLGTTVMTAIMGHMVISADMLAAYAIMGNIDKFSTVACFGVAGATAVIVGKRIGERADKEEVYNLSCCLLLVSFLLGAVIALALLIVLPTVFIPYLYPLFSLTEKATEVAVTMCVVYIVMMPLKSYDISNITGVLRAGGDARMAAILDLCPLWLVSVPLTALTGLVLDAPIWLVCFGIYSENTCKMPLGIIRLHSRKWINDVTIHEGE
>fig|1007096.3.peg.1163 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGQSNQKIDIFERMPVKRAVLKQIAPAIAGQMITLIYSLADTYFVGMLNQSAATAAITVAFPMFLMLTAISNLFGVGGASAIARALGKKDLEKARQIAGISFWSGLVAGILYSCVFLFLGEPVLRLCGATERTFAIALGYARWVILIGGPFTILNTLLANLVRAEGSAMHASVGVSMGGILNTILDPIFVLPQFLGLGAVGAGVATAISNAAAMAYFICYAVKKKNATVVSLSPKNLRYTGRHIKEILAVGFPSAVQFALTVVSISVQSKFVSRYATEAVAGLGIVKKLDQLPLYFTMGVSNGLLPLLAYNYSVGNQERRKQAFHFGCTISLGFSVLCLICYEAFAPLLAGIFIEDPATIQYASGFLRIMVTAMPMMSLCYPIIVQFQAMGKAKPALVCSVIRKGILDIPISFVMDALIPLYGLMWVQPIVDTISLAVAGILYRKQNRRG
>fig|1007096.3.peg.1196 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQQGADLRSGKVGKLLFSLALPTVTSQIVNMLYNLVDRIYIGHIPGVGRAALTGVGVCLPIIMLITAFSSLAGAGGAPRASIEEGKGNPEESERIMGNCLTLLLIASVVLTAFFVLFNRPILLSFGASADTIDYAVAYMRIYALGTIFVQLTLGMNIFITAQGFSKVSMQTVLIGAGLNTVLDPIFIFALNLGVQGAALATILSQAVSAVWVLRFLMGRKTKWRLKRQYLRPRAKVVLPCVALGLSPFIMQATESVLAVCFNTSLLKYGGDIAVGAMTVLTSIMQFAMLPLQGLTQGAQPIISYNYGARLPQRVREAFRLLLRVCVIYSASLWALVELFPGIFVRMFNSDPELVAYAVPALRVYMAMCCIFGIQIACQQTFIALGNAKSSLFLAVLRKIILLIPLIYILPNFFENQAFAVFLAEPVADTMAVLTTAIMFAVQFKKSMKRLEAPPWEK
>fig|1007096.3.peg.1378 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTVGSPARHIFLFALPLLLGSFLQQLYNMVDSWVVGNYVGDAALAAVGVGFPVIFMFTSLFMGIANGGTVVIAQYYGAGKLDRVRDAVDTIYTTFLVSAIPVTILALLLVKPLLFLLRVDEAAYHEAWVYLMIVCAGLVGTIGYNTNAGILNGIGNSRTTLLFLAVAAGLNIALDLILVLCAGMGVAGVALGTIISQTFSWLFGLLYINRKYPQIAIHPFCFRFDKTLFRQVLGIGLPAGFQMSLVSIGVMTVMSKVNTFGTAYTAAYNVGNKLDSMAFLAVQALTNSVTAFVGQNVGAKKPERVRQGVRMTVTATVVWCLLMTVVLLVWSDRLFHLFSPEAAVAEAGNYYIRAIMPPYALFGVMYILNGAMRGAGESVFPMTVTILSMIVLRVPAVYYLANHFGPAYMFYGFGIGWIGGFVLCVTYYLSGRWKKRGSLADETS
>fig|1007096.3.peg.1426 Vancomycin B-type resistance protein VanW
MNTVEVQEQRKKHSKLPVVLLCVLGALTAGYMGLCAYAANSGAIWRGTEVLGQDLSGLTVTQAARKLDSTLPKLKIGVYLYDGSLEEAPERADTPDAKIALADLGITADTSALAQSAYQKNLKGNFLTLGWRYLTNHGVSCSAAGLISLDADKTASAAQAATDSLSYPKEDTSYEVADSALMVHMAKDGRSIDSEILAKHLAAGEWDTDLSLDVPYSTETAQTMSAQEIYDQVSGEMKNAGYDPETRSIIPERTGAEFDVAVAQSTMDSAAPGSTVEISAAIEYPAVTAEELKPVLFRDELGSYTTHVGGSAARISNVKLSSAAVNGTVLNSGDIFDYNEVVGQRTSARGYQAAPAYVQGETVDEIGGGVCQPSSTLYLATLKSNLEIVERYAHRYVPAYIPKGMDATVSWGGPNYRFRNNTNYPIKIQAVLSKGYLTMTLYGTKTDDVTVKMTNKVLSTTEYETIYEDDPTLPAGTQTVKTTPYTGYKVETYRNLYDGNGKLISSSYEAGSDYKVRNKIIVKGPALPSVPTGGTSSEPVPPETAPGTPPGTTPGTSPETGGVPSTTPVIPEETTTAPSSGETQQPEIDPNAVISPLPAA
>fig|1007096.3.peg.1790 Permease of the drug/metabolite transporter (DMT) superfamily
MQKTSFVRQNILPVLAAFIWGTSFVAQSVGADYVEPFTFNAARSAIAFIFLLALCAVFRFRRKKDFEAQAKPRPHYRRDLVIGGLCCGAALTLGANLQQKGIETTTSGKAGFITALYIVIVPILGIFLKKKVGKMVWGSVALAVGGLYCLCIQQGSSIAAGDFYIFLCSLCFSAHILIIDHFTQKVDGMELSCAQFFVAAVLSAVGMLATEQPTWEALRLCVGPLLFVGIFSSGVAYTLQILAQRDSNPTVVSLLLSLESVFATVAGAVVLGDRMSGREYFGCFLMLTAVVLAQIPVKEKQVAVVEVEEAEEEPLPPET
>fig|1007096.3.peg.2055 Vancomycin B-type resistance protein VanW
MLMQNSERPKKRSAARLRAGKLYYGALRRLLWIKMRNSFASARQEQLLPYTCFAHQTVLLRKLKDVDMWMQENKIVNLKIAARRVNGILLRPGEIFSYWKLIGRPSRGKGYLPGMILRNGSFQGGIGGGLCQLSNLIFWMTLHTPLTVLERHRHGYDVFPDSNRTQPFGSGATCFYPYGDLMIRNDTQDIYQLLIRVGADDLEGEWRISEKPQDRFEIVERNHEFRSEYWGGYTRHNQLYQQRFNLYGELLDERLAVENSAITMYAPFLSGDVPSTNVKQSNDTEGGYSC
>fig|1007096.3.peg.2064 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRLFLYPAFCFWEEKKMDLLYGNVKKVYFNYLSAAFGSALISSIYSTVDMAVVGQYQGPAGTAALAIVSPIWNIVYSLGLLMGIGGSVLLGAAKGRGDEQQKNEWFTSALIGTIVLAVISWGVVALFDTQLLQLFGAEETLLPLAKEYLFPIKFIVPLFLFNQLFTAFLRNDNAPALATVAVLSGGIFNVFGDFFFVFTLDMGIFGAGLATAIGALISVLVMLTHFFTRKNTLKLVKPHGIVGQLKRITVTGISTFFIDAAMGILTMLFNRQIVRYLGTDALAVYGIIVMISTVVQCCAYSVGQAAQPIISINYGAESWTRIKETLKYALYAVCFFSLTWTALICAIPNGFVRVFMTPSAEILRIAPFILRSYGISFLLLPLNIFSTYYFQALMKPVPSFAVSVARGLLISGSLILTLPVVAGANALWYAMPITEAVVAVAVVGLMVKYTKQLAN
>fig|1007096.3.peg.2065 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNETIYHKPLNFKNLLVFVIPTMLMTVIQSLYSMIDGVFISNLIGTDALSALTLIAPFFSILMAIAAMLASGGSAVVMKKMGEGKEQEAKEDFTMLILVNILIGIVLTLGGTAFVSQLSGSFGASPVVTAYCQSYLSTYIAFIVPELLFSNVLMYVIAAGGSKLAMASSLFGGVFNIAFDFIFIKLFGFGMMGAALASGLGMMIPCLIIMAYFFNKKRMLHFVRPKFRGCVLTRTLSNGVSEFFSNLVSGVVMLLFNRSMLHYAGENGVAASTIIFYVFSFMNAVYMGYMLGTSPMFSYFYGEQNREKLRKLKALSLKLIGALGIATTILTVLSSRQLIGIFTGPDNPAYAMALHGNRLFSAALLIAGFNTFSSALFTALGNGLISAVISFSRTFVFLAGCILILPVFLGIDGLWLSVPIAECMALVLSVCFVKKYETKYGY
>fig|1007096.3.peg.2259 Permease of the drug/metabolite transporter (DMT) superfamily
MNATKQTSLGYFFALFTVVVWGTTFVASKQLLAVYTPARIMLMRFVLAYLALWIIRPRPLKLPWKTELRFLVLGVSGCSLYFLTENTALLYTTAANVSIIVSAAPIFTAILAHFMIDEKFHRNTLFGFLVAFAGVVLVVCNGAFVLHLSPMGDLLALLAACCWAVYSVLLRRTAADLDPILVTRRTMLWGMITAIPMSIPGGAFTLSPLSSPLLAFDLLFLGLIGSALCYVLWAKAFTLLGVVPTNNCIYLIPFVTIVAAHFTLKEPISAAAILGAGLITAGVVLAQRRKIDDGAPKAELSEET
>fig|1007096.3.peg.2912 Ribosome protection-type tetracycline resistance related proteins, group 2
MKKLAIGILAHVDAGKTTLTEGLLYTGGVLRKLGRVDHRDAFLDTFALERERGITIFSKQAVLPLDGLELTLLDTPGHADFSSEAERTLRVLDCAVLVVSGADGVQGHTLTLWRLLARYGVPTFLFVNKMDQPGTDRSALLAELKSRLDGGCVDFSGPDAERGEEIALCGEAAMEEYLACGQLKDETIAALVGERKLFPCLFGAALRLGGVEELLDGLRRFAPSPVYGSAFGAMVYKISRDPQGARLTHLKVTGGTLRVKDLLCGSRDGEDWQEKADQIRVYSGAKFRAVDAAEAGTVCAVTGLTRTFCGEGLGEEEASAPPMLEPALTCQVLLPDRCDPHTALMQLRQIEEEDPQLHVSWQERTGAINLQLMGTIQLEILQRLLKERFDLDVAFGPGAIVYRETIAAPVIGIGHFEPLRHYAEVHLLLEPLERGAGLRFASACSEDVLALGWQRLVLSQLAGRSHPGVLTGSPVTDMKITLIAGRAHEKHTEGGDFRQAAWRALRQGLLSAQSVLLEPWYDFRLTLPTAQTGRAMADLQRMGGDFAPPETVGEEALFTGSAPASALRDYAAEVTAYTRGRGRLTCAPGGYRPCRNQEAVVDAAGYDPERDLENPADSVFCAHGAGYNVKWDQVPAHAHVNSGVHLGARPLDEQSPPAAARSASYVGTVEQDKELQAIFERTYGPVKRRAFQKPVPASSARPEPAAAPRPAGPEYLLVDGYNVIFAWDELKTVAAEHLDAARRELCDLMSNYQAFRRCKVIVVFDAYKVKGGIEKVEKYHNIHVVYTKEAETADAYIERTTYQIGREHRVRVVSSDGAEQIIILGHGALRVSAAGFHEEMLQTTGEIKKILEKNNLTGKVRPLREALTKALEKGSE
>fig|1007105.3.peg.140 Multidrug resistance ABC transporter ATP-binding and permease protein
MLRWFESLLNSFPPEEAPLPPRGLLPFLWACTRGSRRYLAALALLSASVSIYEAWLFAFLGQIVDLLATWQAGAPASAHERRVLWTVGIVLVASIGLVALRTMVQHQALAINLPLRLRWDFHRLMLRQSLSFFSDEFAGRVTTKVMQTALAVREVLFTFIEIVLGIGVYFVTIVALAGGFDARLTLPFIGWIILFGLAMAYFVPRLGKVGQEQAHARSSMTGRVTDAYTNITTVKLFSHTKREAHFARAAMEDFKDTGFRQMRLVSRFEIVNQALVAALIFSVGGYALWLWHSEQVGAGAVAAVTAMALRVNGMSHWIMWQMASLFESIGTVQDGIATLSRGAKVQDAPGAPALRVMRGEVEFDHVFFNYNGERQVLDGLSLTVRPGEKIGLVGRSGAGKSTLINLLLRFYDLDSGRIRIDGQDIAQVTQESLRGAIGMVTQDTSLLHRSIHDNIAYGRPDASDAEIRAAAVHAQADDFIQQLSDPQGRNGYDTTVGERGVKLSGGQRQRVAIARVMLKNAPILLLDEATSALDSEVEVAIQESLNAMMEGKTVIAIAHRLSTIAAMDRLVVMDQGRIIEQGTHAELLAQNGTYARLWRHQSGGFLAEETSELA
>fig|1007105.3.peg.147 Outer membrane component of tripartite multidrug resistance system
MIERLSLRFTSLAMALLLAGCAVGPDYQRPDVDVPNAFKEASLSPEAAKQWKMAQPADALARGRWWAIFNDPILDGLEDQAMSANQDLKVAAARVKQARALRQNAEAGLLPSLDAGFGPTRQRQSSAAQGLPEDTGSSAQTLWRAQAGISYEADLFGRIASDVDAATADAEQSAALFQSVRLALQADVAQAYFRIRRLDAEQDLYRRTVDLRGKTLELVQQRYDEGEISELDLARAKSALSSASSQALGIKRERAVAEHALATLLGKTPAQFALAPEPLGRVSVDIPAGLPSSLLERRPDIAAAERAMAAANARVGVAKAAFFPRLTLTGAFGYESSELGNLLEWSSRTFLLGPLVGTMLTLPIFDGGRREAGLERARALYEEDVAAYRQTVLSAFREVEDGLSSLRILKDQTQVQDAAVQQASRAAELSQIQYREGSVSYLDVIDADRQVLVQQRASLALDGERAQTAVALIRAIGGGWDIDRQLASR
>fig|1007105.3.peg.452 Permease of the drug/metabolite transporter (DMT) superfamily
MFAGMGACVKVAADYGASLPHVVLFRGIPSVLLLFIWTQLTHRSLVPNSWKLHIWRNLSGVSSMWLGFFAISHLPLPTAISLNYTAPLFIACWMLGWGGTQRDPVRIVAVALGFLGVLAVLRPSIAHEHLLAAALGLGAGALSAIAMMQIRSLGRVGEPEWRTVFIFSCFVCFTGSAGLLVDGWRDISLSAWLALTGVGVFGLVGQLAMTRAFGMGSALLTAALQYTTIIFAALLGIIFWDDVPDAIAWAGMGLIIASGLLSIWRTYTEDRIMRGQTVVQMQAATVDTAIEETRRV
>fig|1007105.3.peg.519 Outer membrane component of tripartite multidrug resistance system
MKSLLPIVFVAVLSGCAAIKPGEPAVVKTDAVRLGLQDSAIAWPTEQWWQRYGDPQLNQLLGQALAGSPSLDAAQARLNLANAAVSSARAVRLPQANAGYQLTRERFSENYIYPPPYGGSMQTDNSLRLDIGFDLDLWGRNRSHYAAAVSRQRAAEADAQMARNTLVSAVVQSYFNLQNALAQQQVLGQLVTQLENVLDITRQRVTAGLDTEVETNQADSAVSAARVQLSQAATNADLLRHQIAALLGAGPQRGQEIQRAKLTQTPRGVPDSIPLSLLGRRPDIVAARLRVKASDSDISAAKAEFYPNVNLSAFAGFMSLGLSNLLEGGSQTYGVGPAITLPIFHGGALNAQLDARQAERDLAIADYNQTLLTAVREVADATSAIQALQQQTLDQAASLRAITSAYKIAVNRYKSGLGNFVQVLQAQNEVQKQAILNTDMQTRAYKLDAQLATALGGGYDSPTATH
>fig|1007105.3.peg.817 Permease of the drug/metabolite transporter (DMT) superfamily
MGDNTGPPLFEFSMSFSSNQLKAYGCLALSMSLVGAYVALTKPLALVLPVFLLGWMRFGIGAIAMLRWIRKPASEPTLSVQTRWLIFLESFLGNFLFTLCMIVGVSMTSAVSAGVIMSSIPATVAVLSRVFLKEAISARVWAAIACGVLGIGLLSLTQTPGTGNALDLPGGDSSRQWLGNLLIFGAVLCEGSYAVIGKKLTAVLGPKRISAVINLWGFVLMTPMGLYTALQFDFTAVDPSMWLLLLFYGLAASVWTVWLWMVGLKSVPASQAGVFTVMLPISAALVGVLVLGENLGGMQLLAFAIALAGLLLATLPSRGMKASH
>fig|1007105.3.peg.1609 Multidrug resistance protein
MISTAKPAGLWQQAREILRQAWPVLISSWASIIFGVMDTAMAGHASAADLQVMALAASIYITVFVGLMGVVHALIPIIAQHFGGQRYIEVGRTWGQGVWLALGLSLVGAAAMLFPGMWLSLSGGVEPVVRDGITWYLRALVLALPATLVFRTIYALGTAVSRPKTVMVINLLSVGFKFFFNWILIFGKFGMPALGAVGAGLSTAIVGWMTLLAGLWAIRHDPYYLRFKPAVGRPHWPSQKELLRLGIPMGGSYLIEVCAFTFMALLIAREGMFVTGGHQIMSNLAALSYMMPMAVGIATASLTAQAIGAGDLQRARLTGRAGIGIVLLGATVTATVLVVAKQPILRLYTDDMQVAIVAGALLQLLPWFHLFDATQCIGSYLLRAYKVAVVPLILQIVALTGLGLIGGWWLGFGPAADTLKPVVTRIAPGAPMGAASMWLMALAGLALSASLLFAWYGHVVRSHMRAGRV
>fig|1007105.3.peg.1615 Multidrug resistance transporter, Bcr/CflA family
MHQMPPQQNTLTTIPSWLILMGLLTAIGPLAIDMYLPAFPAIAQGLGATHGDVERTLASYLLGLALAQLFYGPLADRYGRKKPLMLGLAIYTVAAIACGYTNDIEHLGFWRVVQAFGGAAGIVIPRAVIRDNFDTRDASKALSLLMLVMGVTPILAPILGGQVLVFASWRGIFAIMAACSALLLAAVALTMRETLQPEKVIPLGARVIARNYLALLGHKRFMCYTLAGGFGAAGMFSYIAGSPRIFIDIYQVDPRYFGLLFGLNAAALIIAAQVSARLLSRHTPEKLLRPAQIILAGVTLVAVALTLANAINLLSLMVCLMIFMASQGFVNPNSAALSLREQGHRLGAASAMMGALQMLCGAGAGLAVSSWQSPTALPLTAILAFCACLSWFFGRMALRTAAKPLD
>fig|1007105.3.peg.2137 Multidrug resistance protein B
MPAESTVSPASTPLTPKDIRSIIIGLMLAILLGALDSTIISVALPKMAADLQGINLLAWVMSGYLIAMAVATPIYGKLGDIYGRRSVLSSAIVLFLVASVACAMAPTMPVLVAARILQGLGGGGLISVAQATIADVVSPRDRGRYQAYISGAFAVASVSGPVLGGVLTAYLSWRWVFWINLPLGLIALLISRRALAKLHVPQHKRSVDYLGAALLSLGLTAILLAITRAGQQNVPGLDHNSLWMIVIAVVSLAAFGWHALRVPEPIVPLGLFRIRTVSICCLILFIAFVELVALTVLVPLELQMLTSVGADGAAWRLIPLSLGVPLGAYISGRLMTHWGTYKHIQLTGALLMPIAIFLLAFADPASTFTMAVLLSLIGFSIGLQLPTSTVAVQNAVPHRHVGVATAASAFCRSLGSAIGIALLTAFLLIWLRAGAGAIGNGMNGADIINTLIGHSHTSIQDIDLSGLAPIARLSFQKVYMLAAAIATVSILLSALLKNESLSEKPAAKSSKE
>fig|1007105.3.peg.2658 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MNALVENWRLDADHDSHVELSVVVPLYNEHEVITMMYQRLTTVLSGLAISYELVLVDDGSHDGTPNVINLLAKSDPNVTAVFLSRNFGKEAALTAGIEHAAGAAVIIIDADLQDPPELIPQMLAAWKDGVDVVCMRRRSRAGETWLKRCSAHHFYRLLNAISDVDIPPDAGDFRLLSRKAVYALQQLNERNRYMKGLFAWIGLPTAIIEYDRMPRAAGATKWDYLGLLNLAFQGITSFSTAPLRFAMGSGLLTALFGVLFTLWIVIKALVLGDPVQGYPSLISMITILGGVQLLSIGLLGEYLGKTYYEAKQRPVYLVRDVMRRGKPVQEMATDKGRSSKVKEAYASFK
>fig|1007105.3.peg.3048 Permease of the drug/metabolite transporter (DMT) superfamily
MTSNAHEAGGDREASLAIRISLLTCLSMLAFAGNSILCRLALMERHIDPLSFTALRLASGTLVLYALVYLSSHRAAARQTTPVRQSGSWAGAIALVLYAVAFSLAYVNMESGVGALILFGSVQLSMLLYGMIKGERLGALSMVGLLASIAGLVFLLLPGSSAPPLAAAALMAIAGAAWGWYSILGKGATNPLASTASNFGRAVPLSLLAALPLLATLHWDARGLSYAILSGTVTSGLGYVVWYGVMKQLSVLKASTVQLSVPILTAVMGAALLGEALTLQLILSCILVLGGIGLVLVSKGRSQA
>fig|1007105.3.peg.3142 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTMKLSIVVPVYKSQSILPELVEQIKTSFEEQGLAGQFELILVNDCSPDHSWQVIGQLAKINPFIRGISLRKNFGQHSATMAGLNHARGEVVIIMDDDLQHPPSEITNLMAAINNGADACYTRYIERQHALWKKIGSRFNDWVATVLLDKPQGLYLSSFKALSRELVQEVIKYDGPYAYLDGLILEVTRSIAVVDIKHQARHDGEGNYNLRRSISLWLRMATSFSVFPLRVATFFGFCLAAVSLIFVAVVIVQKLLDPSIAMGWTSLMATVLFVGGVQTFCVGLLGEYLGRTYLRINGKPQFVVRETTWADKS
>fig|1007105.3.peg.3320 
MAEMFLTITRANIKAGNEKEARALLEKSLLPNDGSKPGDHIPGLIGFGLMRSKKDPSMFGLATVWKDEASFDALSSNANAKTGGDWVEKFKTFTSGDVKGEGFYIESL
>fig|1007105.3.peg.3606 Permease of the drug/metabolite transporter (DMT) superfamily
MPTSQGTPLWLAAAPALFLLLWSFGFIFLKLGLAYADPFTFLALRYACVVAILAIPCLWLRPPLPATPQVWMHLSIVGLLVQAGYFSFAYLSLKQGVSAGALAIITAQQPLLVGLLAPAIASERVGAIRWAGLLMGVVGAGIVIFAKSAVEVASTAGLLYGVLALLCMTGGTLWEKRYGTEVHPISANMIQYTVGLAVAAPLAFLLEPMQVQWTIGLFASLAYLVVGNSIIAISLLLAMVRRGEASRVSALFCLVPPTTALLAFPILGEAIPVLAWPGMVLAVAGIYLVMRKS
>fig|101510.15.peg.483 
MILEHALLSVAPERVEEFESAFGRAESIISSMPGFLRLRLSRGLERPNVYLLLVEWEELEDHTEGFRQSSRYQQWKDLLHHFYDPFPLVEHYAPVREV
>fig|101510.15.peg.507 Glyoxalase/bleomycin resistance protein/dioxygenase
MEFTMSDLQHTVKGVDHVAYPTFDPAATVTFYRDVLGFPVVHSICAAGWGPEKHPDFIHFFFDIGNDDRLAFFYYFGLEPFDGGPQGDSYSRFAEDVPIFFIRSRHLAIHVDSEDDLMEYRRRLDHSAWPVEMQIQHETIESIYTHDPNGYMIEITRALRPVTPQEDLDANLTIDALVDVVTGPDPSMAALLTRKAELITERAAAWHQEQESKEMVTR
>fig|101510.15.peg.684 
MVWEIARLDIRDGHNQAFETALTEAVPLFARAHGCRGMQVQHSTEHPQRYYLIVDWNTLDDHTIRFRESDDFTRWRDLVGEHFAQPPAVEHTDRLDVGFTVESVR
>fig|101510.15.peg.1069 Glyoxalase/bleomycin resistance protein/dioxygenase
MADATIGSILLASTHPDRLRDWYTAAFSPKVERTPGEPGYDVLDFDGFYIMLDRRDDVGDTNPEPGRILLNVEVTDARAAADRIDELGATWLSPLEDRDGSWFGTAVDPDGNYVQIIQLSAQARAEMS
>fig|101510.15.peg.1550 Drug resistance transporter, Bcr-CflA family protein
MPSLLCCFMTETEERAAPTADRTTTRPSLRVILVLGAMVALGPFTIDMYLPALPDIGTDLGASSSAVQLTITGTLLGLALGQLIVGPLADSLGRRRPLIAGIGVHVVASVLAVFAPTVAVLGVLRVFQGIGAAAAAVVALAVVRDLFSGNTVAVVMSRLMLVLGVAPVLAPSIGGALLIAVDWRGIFVVLAVIGTLTALIGVWGLTETLPPERRRKSNLRAVLSTYKSLLGDRAFMVLALVSSVAMGSLFSYVSGASFVFQDQYGLDEQQFALLFSSGAIALIGASQLNVRALARWSPLQITVSALAFATVAGLALVTTAHFEFGGLVGFVVPLWFLLAGVGFVLPNAPALALGRHGEAAGTAAALLGALQFGVGALIAPLVGVLGNTGVALAITMTACAGLGLVALAAAAKAEAH
>fig|101510.15.peg.1790 Glyoxalase/bleomycin resistance protein/dioxygenase
MSSFPGLTHVAITVSDLPASTAWYTALFESAPVLDEDEESGTFHHTVFALDGGMLFGLHTHPDSGAPARFDERQVGLDHIAFQCSPDALPRWVERLDALGIEHGGIKTAHYGSGISFRDPDNIALEFFAPPVSTS
>fig|101510.15.peg.1969 Multidrug resistance protein B
MTSPTAANAAPDKLDGTVLKIASVVVLGAIMSILDVTVVSVALPTFATEFDTTYATVAWTMTAYTLALATVIPVTGWAADRFGTKRLYMTALVLFVLGSVLCSFAWDITSLIGFRVLQGLGGGMLMPLGMTIMTKAAGPDRVGRVMAVLGIPMLLGPIGGPILGGWLIEAASWHWIFLINLPIGIIALAAAFIILPSDNASPSESFDFLGMLLLSPGLALFLFGVSSIPEVGTVASARVLVPGAIGLALIVAFVVHALRKDHPLIDLHLFKNRQLSVAVITTSLFIVAFMGAGLLFPSYFIQVGGHTTLAAGLLMAPQGIGAMLTMPVAGRLVDKIGPGKIVLTGLPLILIGLGVFTQVASDSPTWLLMGALFVMGMGMGCTMMPLMTAAIVTLSNEQVARGSTLMNIVQQTAGSIGTAVMSVVLTNQLLDRGLDSQTVAMQHVPEVAAQEPPGMVDQVLSQAADAFGNTFLVATVLIALTLIPAFLLPRKKSVNPKLEAEGAPTVMMH
>fig|101510.15.peg.2208 Probable ABC multidrug resistance transporter, ATP-binding component
MDNLTFNVKPGMVTGFLGPNGAGKSTTMRMILGLDRPTAGSALIDGKPYSDLVQPLRTVGALLDAKWVHPNRSARAHLQWMAASNSLPKSRVDEVLHLVGLTEVAGKKAGGFSLGMSQRLGLAATLLGDPKVLLFDEPVNGLDPEGIVWIRKFMQRLAAEGRTVLVSSHLLSEMALTAEHLVVIGRGRLIADTTVSEFVSKSSESTVRVRSPQLDALRSALTSNGLTVREDGSDGQQALVVVDSSTDVVGGIAGSQGIVLHELASQRGSLEDAFMKLTGDDVQYHAEGVEDVMRGAL
>fig|101510.15.peg.2554 
MIFIVVNFTVKPDHADGWLDLVQPFTDATRNEPGNLWFYWSRAVEDPDLYVLVEAFRDDDAAVAHVQSEHFRNAMRELKPALAQTPRIINTTIDGTEWSLMGELEVD
>fig|101510.15.peg.2629 Probable ABC drug resistance transporter, permease component
MISAPAHTLAEPAPADLRFHPLRDSATMLRRNLDHMLRYPSMTVTLVGMPVVFLLLFVYVFGGTLGAGLGGVSGGRAEYVNYVVPAIILMTVTAAVQGTAISVAMDMTEGIIARFRTMHIARVSVLTGHVLGSVIQAMLSVAIVIGVALLVGFRPTAGVGAWLATAGFLVVVTFALVWLSVALGQVSKTVEAASNVGMPLVLLPFLGSGFVPTDSMPAGLRWFAEYQPFTPIIETLRGLLMGTPIGNNAWIALGWCAVIALGGYLWSKRLFNREYSR
>fig|101510.15.peg.3920 Glyoxalase/bleomycin resistance protein/dioxygenase
MGTTDEQERSQRFAEQRDRIRAEHLKPVAARPASSARGLHHTALISSDVERTVRFYQDLLEFPLTELIENRDYAGSSHFFFDIGNGNLLAFFDFPGLDVGPYQEVLGGLHHIAISVEPDRWEHLRTKLIDASVELVEHSEVSMYFRDPDGARLELIADPLGEMYGSHVL
>fig|101510.15.peg.4177 Glyoxalase/bleomycin resistance protein/dioxygenase
MLRGLITVSLFADDIPAAREWYCALLGITPYFERPDSENPAYIEYRIGDYQHELGIIDRRYAPHGAADGPSGVVVFWHVDDVTAAVEKLLTMGAKEHEPRTERESGFVTASVVDPFGNILGVMYNPHYLDVLGSRGEA
>fig|101510.15.peg.4385 Drug-export protein
MNTAVGQAQSATAGDELGPGTSPALAALLAGTFVGTVSNNIVNVPLNAILTDFDAGLGSGIFVVVGFLLTFAATMPLAGWIGDRFGRRRVYCAALLGTAVCSLGAALAPSLPVLVIWRSLGGIAAAAFAPAVMGLIAWLFGPPRRARAVGAWAAVNGIGQAVGPSMGGIVSDWWGWRWAFVPLVPVALIGFAATLRYIPRYPGKKMRLDVIGASTVTLGAVLLILGLTTVSMEQVPAWVSIATIGGGVVVTAGFVLHCRRAANPFVPIDLVIESRFLRSALAAFTQMFALGALLLALPLYLTGSGSSTTQAGLMLFVLPVVMTCVAPVVGRLVDRIGARVVMRTGLAVLISSQVALAITLSADVRNPVAVGAVLLVAGVGIGMVQTPAAAGSTRSPAGAVGTGLGLFNLIRFGGSAVGAAWVGVAAHLSADPYGLLFAVAALVVLAGLAGTFAGENPVAG
>fig|101510.15.peg.4565 Glyoxalase/bleomycin resistance protein/dioxygenase
MTGRIVHFEIPFDDGDRARAFYRDAFGWAIAEIPDMDYSMVTTGPVGESGMPDEPGYINGGMMQRGEVTTPVVTVDVESIESALERIESLGGKTVTGRTPVGNMGFAAYFTDSEGNVVGLWETAR
>fig|101510.15.peg.4781 Quaternary ammonium compound-resistance protein SugE
MLSGILEAVWATALGRSEGFTKLGPSAVFGVALILSMAGLAFAMRSLPIGTSYAVWVGIGAALTVGFAMVTGAESSSLVKILLILGIVGCVVGLKVLH
>fig|101510.15.peg.4836 ABC-type drug export system, ATP-binding protein
MMFRRAQTAARLRPAGGALELSHVTYSFGDYAAVKDLSLVIEAGECFGLLGPNGAGKTTTIRLLNTLLPLQGGDVSIFGYDVRTQAMAVRRLLGYVPQQLSIEGALTARENVSWFARLYDVPRPERRRRVDEVLEMVDLADVADRVASSFSGGMVRRLELAQALVNRPSLLVLDEPTVGLDPVARDSVWTRVTEMQKQYGMTVLLTTHYMEEAEALCDRVALMHRGELRAVGSPSGLVAELGPDSTLDDVFRHFTGDSLTADEKGGLRDVRSARRTARRMG
>fig|101510.15.peg.5248 Vancomycin B-type resistance protein VanW
MNDEDGDKGSKAPERSTPDPSATAESVEPENVADPPAPEPDEVPAPDEAAAPENAPASDEAPAPDAPAEQPNADDAPTTQLNLGDLGERSEEQAPDAPLWVEPPANEDVTQVIPAIPPGPVPGPTQAYTTPADEPTVVAPAAAAQIPPQPAPEPSAPAEPSAEPTKPARAPWVKIAAVTGGVIALIGIAYAADLAVSSGKVPRGVTVAGVDVGGSSREEAEAILQAQVGPRADQPLTVTAGDVSTQLVPSAAGLGVDWEATLDRADSQPLNPFTRLTSFFTTDEIGVVSTRNEAALASAVDGLRTETDRASREGTVVFEGPTPVPVDPSTGQNLNGEGAEAALTEEWAFGRTVELPVDVVPVTVTKEGVQRALAEVAVPAASADLVVTGRDGKVATAARQQIGAIVGFEPDGNGGLKPTYNIEAAIGILAPQLVSTEIAPKDATITLDGGSPTVVPAVVGDLVQWPKTLETLPELLRGNGSHTTAAVYGPVPPALTTEAAQALGVKEVIGEFTTGGFSAASGTNIRLAASEINGALVKPGDTFSLNGYTGPRGTAQGYVESGIINNGRPDTAVGGGVSQVATTLYNAAYFAGMEDVAHTEHSYYISRYPEAREATVFEGAIDLQFRNTGKTGVMIQAIGGASDLTIRFWGTKTVDVESITGNRTKPTEPDTVTLPAGDHCIASSGAPGFTASDTRVISDHATGQEISRDTRTVRYDPVPIVKCEAPAPAPKPDERTPAASPAPSESPKPTTPKPNPNDGE
>fig|101510.15.peg.5259 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDRPSLTGAPCWIDLTSSDPRQVIPFYTGLFGWRSDTNEDPQYGGYSIFSMNGKPIAGLGPQQQGNPYGNVWTTYIASEDAEATAAKAAEAGGQVMMPAMVVGDQGTMAILGDPAGAVIGVWQADQHGGFGLVDEPGAPVWHETLSRNYAAALPFYADVFGWTFRTLGDTDEFRYSQANLGDRTVAGVMDADSFLPEGVPSFWQFYIGVEDTDAAVAKVTELGGTVRRAPEDTPFGRLASVADPLGATFQITTLQS
>fig|101510.15.peg.5300 Probable drug/metabolite transporter, permease component
MTRNSTHVGATMALTSMLCVQSGLAISVGVSERVGAEGAAWLRLAWAGVLLAVIVRPRPKAFTRSSLGACVLLGVVTAAVTLLFMAAVDRIPLGTASALEFLGPLGVAVLHGRGRLKWPALAAVGVLLLTQPWAGGVDPVGILFALGAAACWALYIVLTQRVGDEVAGLNGLAVSMPVAGLVATAVGGPSMLGKMTPDLLMIGLGLAILLPVVPFTLEMLALRRLNTAAFGTLMSLEPALALIIGLVVLHQIPDHAAVAGICFVVAAGIGAARAGARTTPDQGDVTESAAPLSAPT
>fig|101510.15.peg.5597 Glyoxalase/bleomycin resistance protein/dioxygenase
MSFQGELVSFVASTDLDVSEMFYVETLGLTLVSRDEFALALDCNGSLLRVTLVQAKADTGYTVLGWKVGDLNKVVETLRSKGIEFTEYPGMDQDEHAAWRAPDGIRVAWFRDPHGNVLSLFEDPN
>fig|101510.15.peg.5918 Multidrug resistance protein B
MPTVAAALSAGPAAQTWILSSMSVGLAAVLLTAGALADDYGRRRVFHWGAWLLALGAVVGAVSQEPVLFIVGRLIQGVAGAALIAASLGAVAHAFTTPAARATASGIWGASVGAGIAVGPVVAGLLDLAGWWRGLYWALAVASLVIGQVATRALAESRSAVPKRIDVPGAVTLCAAMVLVLVALVEGRQGNIAATVLCGVGAAVFTLVFVAVERRRPFPMLDLTLFRRRDFLAATLAALATGAGIIGLMSFACTFLVKTMHVSTLAAAGVIALWSGTSVVASLLARTLPARLAGSPQLVIGLAGVGLAMLTMTGLTPDSSLLRLVPGLLLAGVASGLLNAGLGRQAVASVPADQGGLGSGANNTARYLGSSIGVTVVSIIALDPAGTVDGMMLGWNSAAVTTGLISLVGAGVVGVLVRGTAVRR
>fig|101510.15.peg.6259 Glyoxalase/bleomycin resistance protein/dioxygenase
MTISFNHTIVAAKNKQESATFFTTLFGLPDAVPAGHFLAVALDNGVSLDFAEPPVEFPPQHYAFLVGEDDFDRIYGLIVEWGLDHWADPRQTLPGTINTNDGGRGVYFLDPSGHYLEIITRPYGSGG
>fig|101510.15.peg.6691 Drug resistance transporter EmrB/QacA subfamily
MATLDNLVMTSALPVIQRDLGASVGQLQWFMNAYTLAFATLMLTLSALGDRLGRRRVFLWGIVLFALASIASALSTTSEMLIAARAVQGVGAAAIMPLSLTLLAGAVPLAKRALAIGIWGGVSGLGVALGPVVGGAVVDGVSWQAVFWINVPVAAVAIPLALYALGESKGKRQPLDPLGVVLAGAAVFLGVWGIVHGNDDGWTSATVLGALVAAAVLLAAFVVRELRTPFPVMPLRLFRSRQFSLANVIGLTFTLGMMGAVFLLSQYLQIVMGYSPFEAGLRTLPWTAAPMLVAPIAGLLAPRLGVRTLLVTGLVLQGLSLLWMASLIVPGATYGSMVPAFVMAGAGMGLTFAPNATAVLADMPEADHGTASSTNATLREIGVALGIALLTAVFLGAGGSLTPTGYIDALAPALYVGAGFVAVAVVAAALMPGRSKAVLAST
>fig|101510.15.peg.7091 Daunorubicin resistance ABC transporter ATPase subunit
MNAPTVVVEDLHVAYNKTWALDGVDLEAAAGTTLGVLGHNGAGKTTLIRTLTTLVRPTIGRVQIEGLDVVVHATEVRRRIGVTGQYAGLDEFLTARENLELIGRLTGLRRTARERADALIDRLGLQEYASRRVGELSGGSRRRVDLAASLVGSPSVLFLDEPTTGLDPLARAGLWDVVDELTDAGTTVVLTTQYLEEADRLADHIVVLRRGRVAARGTPAELKRIVGGKVLSATIPAGQLAALPFVPDTDPRVDGDRLRVSVTVGDAPAATALVADLHRGGIEVTDLDVTSPSLDDVFTHLAHTGAHK
>fig|101510.15.peg.7139 Drug resistance transporter EmrB/QacA subfamily
MTEPTGLVNDEARADDRIERRHLQVIGVLLVASFVVILNETVMSIAIPVLQVELGVHPSVGQWLTTAFMLTMAVIIPLTGYLIQRIPTRTLFVLAMSLFTAGTLIAFAAPGFGVLLFARIVQASGTALMLPLLMTTIMTLVPPARRGAMMGNISIVIAVAPALGPTLSGFILDHFGWRWIFGFVAPIALATLVLGARFVVSVSETTKAGIDILSIPLAVLGFGGLVYGLVSIGESAQKSPTIPVWVPFLIGAAAMSGFLARQFRLQREDRALLDLRVFGYRQFSISVVAMLVGMATMMGTFIIVPYFAQSVIHLDPFETGLITLPGGLLMGLAGPIVGRVYDRRGPLVLVIPGSILVSIGVWMLTTLNTSTSLWWLLLSNMALCLGLAATFTPLMTSGLGSVAAHLYAHGSAVVGTFQQVAGAAGTALFVTVMTVIASRSGHPHDSPDAIAEGVRMVFVVAGILSFVLIAACAFVRKPADPVEHAHPASVDAPALGT
>fig|101510.15.peg.7350 
MTDSNTEETHVRWRRWPLYAAGFTTAFGAHAVAANLAFDLEDLGSSLLYLGVLLALYDGAEVLLKPVFGTLADRIGARPVLLGGLIGFAAASAVFVIVDDSDGLWLARLGQGGAASAFSPAASALVARMTPTAKHGTAFGTYGFYKSLGYTLGPLLGGALVWVGGLTLLFAVMTALAVAVAGWAMGVVPALPPLPRTRQTVVDLAHRLTDRRFLRPTAALAVATAALSVGVGFLPVTGAAAGLGSIATGAAVSVLAACAAVVQPRAGRALDAGHLSAGSGTAVGLLLTAAGLGCAMLPGLPGVLLAAVAIGTGTGLITPLAFASLAGSTPQERMGQTMGAAEVGRELGDAGGPLLVAGAAAAASLTAGFAVLAALTLTAGAATTATSRPTPPAPGPHHR
>fig|101510.15.peg.7580 Major facilitator superfamily multidrug resistance protein
MSINEAPSEDGCPEGQTDGRIHGVRRQIAIVAVILLLCELNAMAVAMLVPGLRPMAAEFPVEGLAWTITIVSLVGAMVMPLGGKLVDRFGQRPVVLTACAVFLVGSLISALSSSFALMIVGRALQGTIAVMPVIAYRVFRDSLPPRVVPIALGALGTGFGVSGLLAPVIGGAFVDGLGYRSIFWFFFAFTAVLAPLSVIVLPRTPRQRSAEVGRVDILGGLLLALGIGGILLGLGQGDKWGWLAPLTLLVILGGFIALGMFVLVESRVEEPMIDLRVLRNPAVALTLTVGLVGFMACGMMAIALPQMLQTPSSTGMMYAFGLSALMVGLAQIPFGITSMVFGPLGGLLTKRFNPRAIMISSMASFAIGSTLLALAHHSLVLVLVWLCVMGVGFGLFWAAQPNLMVEAVPRKYTGVSGGIQVCSVSISTAIASAIVGAVLSSNVADVGPEGPLYNDAAFTTIFLVGAGSAVIALIISMFMRHGRQPATGGAATDLELDVEGATFARVGSADGQGLA
>fig|101510.15.peg.7935 Probable glyoxalase/bleomycin resistance protein, dioxygenase superfamily
MSAVTTNQPLGTPTWIDLGIPDLDRAMTFYGSVFGWEFDVGPEEYGRYTMCLLGGNKVAALMPNPDENATEFWWNVYLATDDLDATVARSAAAGGTLLMEPKDIADQGRMAMVRDPSGAQFGLWQGRAHVGCELVNEPNTLLRNDLVTPNPGPARDFYAAVFDFTLDGNDDLPGVDFTFLRRPDGHEIGGIVGDPAASASSWGTLFQVVDTDAVVAAARANGGTADDPTDMPYGRTADVADPFGATFTVGSPLPGGQG
>fig|101510.15.peg.8990 Multidrug resistance transporter, Bcr/CflA family
MATGVYLPGLPSIASALGTSNIGVQLTLTTFMVGLGLGQLLAGALSDSWGRRRLLLGGSVAFTVASAVCALAPTIGVLTVARLIAGFSGGIGVVLARAVISDRARGIEAARLFSVMMIIGGVAPVIAPVLGGMLLGPIGWRGTFWVLTAIGGIMTFGVATAIPETLPPETRHTGGLLVLGQNFRQVVGDRRFVGYAAAMAIGAGAMFSYIAASPFVVQKIFGFTPTQFSLVFAFNALSLVTAMTINSRLVSRISVRRLLIFGVGVVWVSGLGLLAVSLFSPTTPWPLLALLLTMMFGMGLTMGNAVALAQDQVPSVAGTGSAVIGAAQFAVAAIVSPLVGLGGESTSVPMAVSIAVCGTIALTALLTLTRDRPETRLPGFRFQKNAL
>fig|1026882.3.peg.117 Acriflavine resistance protein a precursor
MKISPSISRVIALSALLILTACQSDEQQQGAQQQESHVDVVTLAPQKVTLRSSLPARTTAFRQAEVRPQVNGIIEKRLFEEGAQVKEGQQLYQIDAALYEAEVANAKAQLMRAKAALQTAKSKEARYKNLLADNAISQQDYDDALATYQQTEADIKVQEATLKTAETNLNYTHVYAPISGQIGKSNFTEGALVTAQQTAVLTTIYQLDPIYIDVSQPSKQLLDLRKRIIARQINKEKAPKVTITLEDGTAYSETGTLQFAEANVDPTTGDVVLRAIMPNPDNLLLPGMFVKATIEEGQLDNVILAPQKGITFDREGNATALVVNKENKVELRQLELDQAVNDNWIVKSGLNAGDQIIVEGLQKVAPEASVKIDNNTLQTADSGA
>fig|1026882.3.peg.320 Acriflavin resistance protein
MLEAPIRNGKLLTVIVLIIMVLGIAAAKRIPVQMIPDLDVQTISVVTGWPGATPQDIEKEILIEQERYLRSVPNLARMESLADTGQATIELEFPFGVDVNETLIEVSNALSQVSNYPENVDQPRLYSSSFSENAFMYFAVTPLPGNPLSLDMDMVTDFIDDDVRPRMERVPGVSEVQLRGGAERQIQIHIDPAKLAQRGLSLTDVRDAIRERNRDTSAGDLDDGKRRYFIRTVGRFKDVESLRELTLAHRNNTDIKLKDVAEVRLDHYEVRGLSIVNDEAALTMAVKRETGSNVIDIKQAMLKEIDEIRQDQLHPNGLTISLIGDDVRYVQASVEKVTQNLALGAILATLILYLFLRSGRATVIGLLGMPVCTIAAFIGLLAFDRTINVISLAGIAFAIGMTVDNTIVVLESIEQARRRGLDRIQAAITGVKEVWTAVLASSMTTVLVFAPVLFVDEEAGQLYSDIAIAISTAILASMLFAVAVVPAACARVGFGDDRDHGDDLKHPGPILKMVSWLNTSPLKRLLSIVIIFTSTMGAGWYLLPPAEYLPEGEEPKAFSMMIAPPGYNIPEMRLLADDIRQHLSEALHADPQKFDNGEHRLPALKYYFQRINPGSIWILSEPVRPQDLQAMMDALTSMFKEYPGMRGFSNRGSIISSNQGGTRAVNLDISGADQESLYSTAEYAMRRAEKLFGNPQIESEPSALSLDQPLVEIRPNWDRLAEIDMSADDFGYTVAALSDGAYVDEFFMNDDKIDMFIFSTAGQNQTLSSLANVPIMTPQGTVLPLNALANIVDTVDSDQLRRVNGRRTVTLLIIPPREIALETAVNQVRTQMLPNMQAEGEVAKGVSISISGAADQLDATRESLSGNLVIALILIYLLLVAIFSHWWYPLLILATVPLGIAGGIVGLAAVNAAGPLLNLFGLPAIIQPFDMITMLGFVILLGTVVNNPILIVEQARRNLEDKAVSVRDAVNQAVATRLRPILMSTATTVFGLAPLVFIPGAGTELYRGVGIVVLVGILCSMIVTLTFLPSLLITVLNWAERFSVKKTEINEATTRM
>fig|1026882.3.peg.1124 Multidrug resistance efflux pump
MVKLKKFLLPVLIFGLTILIVVVLVATKPKATPKDAQQKAWLVNAVAAQMTTVSPQVTVYGRIETPRDATLKAAVEADVEQVLVLEGETVTQGELLLQLDKTDVELVKQQRQADVDEIIASIANENVRYRRDLALLENQKQLVNLADKAVQRAKKLEQNKLTSQAALDESSAAYQQQELALKQLQNDIAEHPSRIAQLEASKKRAEALLKQSEVNLERTDIRAPFPSRVAKLNVAVGDRVRPGDSLINVYDLNNLEVRAQIPGRYSQQIRQMMQRHQLIQATAMIDDERVKLELKRLSGEVRLDSGGIDGLFRLVNHPNNLPLGTFVELQLQLSEQHNVIELPFSALYGLDRVYLIEDGHLKAVTIERVGEVVGKDNQHRLLIRSDEIASGDLIVTTQLPNAITGLAVETKL
>fig|1026882.3.peg.1216 Quaternary ammonium compound-resistance protein SugE
MNWLILITAGLLEVGWAIGLKYTDGFTKPAASITTFLLMIVSLYMLSIALRSLPMGTAYAIWVGVGMVGTVIVGALFFNEAFSLIKLVSLVLIITGIAGLKWSTS
>fig|1026882.3.peg.1502 Glyoxalase/bleomycin resistance protein/dioxygenase
MSENKLVRPGKTGGMRHIALFVDDLAACEFFYTELLGMHVEWRPDEQNVYLSSGNDNLALHQAAEPPAPSHQQKLDHIGFIIPSMDEVDAWFDFLSANNVEIRNPPRTHRDGARSFYCYDPSGTVVQIIYHPPIS
>fig|1026882.3.peg.1791 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKAVLSGPIIPTFLRFAIPSILGLLAITTASIVDGIFVGQFVSAEGLAAINLLIPYLSLIFGLALMLSIGGAVRAGYYLGQKRFAAASDVFSQCLIAIVVIGLSFMLLSWFFADSILGFLGTPESLLTLIRPYFYIINAVLVVQISTMVMYYFIRQDNAQTLASSALISGALINIVLDALFIIVFDWGLKGAAAATAIAQVIQLIMLSRYFLRAEKTLSFSLTQQHWSEIKPAMFNGGSEFINEISGGLVILVLNWLLVSRLGVEGIAAFAVINYLIFISLMLYYGISDALHLVVSQNHGAQNVQRIRQFLLTALSCILLISISLTLCLVFFPEQISRLFLDETAEQTLLLSQQFIALLWPLFLINGVNVIMSIYLTAIQKPIPSMVIALSRGLFLPVLLLLLFSWLLPEPEFLIALPLSEWLTFIIAIVLFSWYRPSKQT
>fig|1026882.3.peg.1848 Multidrug resistance transporter, Bcr/CflA family
MNQTTTPTKALILLLAALTALTPLAIDAYLPAIPQMANDLITSIHDTEISLSLYLAGFALGQILGGPFSDHFGRRTATGSGLTIFCLGTIGIIFSQDIHSVWGFRVIQAIGGGVAVVNAAAVIRDLSHGKDSARHLSNMAVIMMLAPLLAPLIGMLILHISGWRLIFVFLLVYGLTIGIALFFRLPETRKKTTERTSMLKRYGMVLSHRCALGFIFSQCFALAGMFAFITGSPSVYMGYFEISETIYPFLFGLNVIGMMLANRLNIRLLHYYKPHFLLSLGQAAQILTSLILLSYVSVIAQPQLWFVVSLLILFITAMGLIVSNATSGTVEFFPHNSATATALLGSIGFAAGALSGSLVGLLGDGTPWPMVLIMFICSLLGPILRTLLQYGQQQPQTQP
>fig|1026882.3.peg.1994 Multidrug resistance efflux pump
MSEVSAASLENSPRLGHSLLLLITLFFICAFWWASVTELDEVTRGQGKVIPSSKVQVIQNLEGGILSEVLVNEGDLVDKGDVLLRIDDTRFSSSFRETQLKYWELLARKARLTAEVEGKPLELPEEIIKQQPSLAASERSLYQSRQLELQSSINVLEQQVKQREQELLENQAKLNKLSTSYDLSRQELEMSEPLVSVGVISEVELLRLKRATNDLRGEMETTRLAIPRIRSTLNEAKQKIKDTTLRFKSDAASQLSEVQSELAITKETTTSQQDRVRRTLVRSPVKGKIKQLKINTVGGVIQPGMDLVEIVPVEDNLLIEANIRPSDIAFLSPGQQAMVKLTAYDFSIYGGLPATLERISADTIINDEGESFYLIYLRTDKNYIDSSKGPLEIIPGMTVTVDILTGKKTVLDYLFKPILKAKNEAMRER
>fig|1026882.3.peg.2089 Multiple antibiotic transporter
MLDYTEYTKFLVSLIAIVNPLGIIPIYISLTADYSSAERAKIARTVIIAATTILLVTAFLGQWILEFFGISINSFRVGGGIMLLLMGIGMLHNTSKGLKQNHELAQQSGESIAVVPLAMPLLAGPGAISTVIINAYKGHGVAHYSIIALDIILLGLLLWILLLLVPWIARRMSTNGINIATRIMGLILAAIAVEFIANGLKGLFPALAG
>fig|1026882.3.peg.2255 Permease of the drug/metabolite transporter (DMT) superfamily
MLMWALCYPLIKLSLPYAPVMITAFLRAVTAGSVLIAIALLINRRFPNTIRIWVYIAIIGFSGTGLGLWGMFYAGKLLNPGFATVLTNTQPLIAGVLGWYVLNEKLGKIPLTGTVVGFIGIIIISTNTLFDTGETVLQGILYVFLASTGVAISNVLLKKIAGQVDVFIAMGLQLLFGSIPLAFLAFNTSHFSLLDWQLNYTLILLSLALVGTALPYVTWFWLMHRTSLYKLNVYNFLTPVFGLYLGLNFFSETLTELQWLGAGLIIVAILLVTATNGGIKTES
>fig|1026882.3.peg.2493 Multidrug resistance protein A
MKWAKLGLLSICLVGIIVGLGLWWQHQKTYPSTDDAYVEANILTVSSQESGRVTELNATENAYVKAGDVLLKIDDSDLQSAVDEATSELEKTIQKHMMAGSDVSEAIANLNAVQATLRDAELEFERQQTLYERRIISKSTLDKTQANLDKIKADRDSARAALNTAQTQLGGKTDEDPAVRAARATLKRAQIALSHAIIYAPADGWIANLTLRPGDVITAGQSLFSLVEKNDWWVTANFKETALSRIQPGQPASIEVDMYPDLKLTGKVASLGMGSGAIFSLLPPENATGNWVHVTQRFPVRIHLDYQPSPDQQQRLRAGASVTATVDTTNLDKAND
>fig|1026882.3.peg.2696 Permeases of the drug/metabolite transporter (DMT) superfamily
MEVLVVLSRLLFSAFSNVFQKQLTHRGFDSLFIVFSAYIVLAVICLPLLFLFDPFSLTATFWINIFFAALLDMAGTVYLVISLSKTDLSVFGPLNAYKVVVSMILAMIFIGEIPNLQGFFGVAVIVAGSYFLFPAKTAQQSRIWTLLKDKGVQYRFLSILLFSIGTLPLKTAVVNGGALATTVFWCLLGLPLAAMTQWFFIKGKLQENMTKAQANIQSFIYLGCLIFLMQYMTMLVFSQLFVAYSLALFQLSMVLQVFLGYRIFNEQYIWRRLSACLVMVAGSLLVLNA
>fig|1026882.3.peg.2780 Acriflavin resistance protein
MTDIKPTLGISGRIAALFQDNALTPLMALLALLLGLFALMVTPREEEPQIDVTMADIFIAYPGASAKEVESLIATPAEQVVSEISGLKHVYSVSKPELAIITAQFEVGENRTDAIVRLYNKIYSNLDWLPKNLGVSQPIIKPKGIDDVPILTLTLWRQGQQDSNQLKQLAQSLEVELKRVDGTRDIYTVGGADTVVNITLDPEAMAAYHIDSHRLSQALSAANQSAEAGTTVQNNQMTSVQAGQFIVSADTLKSLIVGVFNDQPVYLTDVADIALGPEQPRQYVWFGTGPAASDKQIRAQGEYDAVTIAIAKQPGTNAADIADAVLQQVTALKGVMIADDVQVTVTRNYGETADQKADTLIHKLIFVTVAVVLLVLFALGWREAIIVGVAVVITLLLMLFASWAWGFTLNRVSLFALIFSIGILVDDAIVVVENIHRHIQQGKLTLKQAIPIAVDEVGQPTILATLAVIAALLPMAFVSGLMGPYMSPIPINASMGMLLSLMVAYIVTPWMVLKMLSHSRSANHEKVAESQYNAVFQRILSPFLLHENAARRRKLLWGGLIMLVVVSVGLAAVKLVILKMLPFDNKSEVQIVIDMPEGSPLEKTAAVTRALTDYLSTVADVTDYQAYVGTASPINFNGLVRQYYLREAWHQADIQINLRDKHQRDEHSHALALKLREPLTAIAKKWDARIKVVEVPAGPPVLSPIVAELYGLNEQQRQNQASQLVKVFEQTDGIVDIDSSIEAKADRQIINVDRNKASLFGLSQQQIVEAIQLALTGEDVGYLHDDNVKYAIPLRLQWSIEDKANLDAVLNMKLINQQGELIRLSDVVNVVDGEHQQTLYHKDLQAVTYVTADMAGKVDSPLYGMFSVYQQLENMPIQQYLVSVPSLALQDSLKWDGEWQITYETFRDMGLAYAVGIILIYLLIVAQFRSYLLPLIIMVPIPLTVIGVMPGHALLGAPFTATSMIGMIAMAGIIVRNSILLVDFIRHAMAEGMTAEKAVIAAAATRAKPIILTALAAMVGAVFILDDPIFNGLAIALLFGILVSTLLTLLVIPLLYYSYIKTR
>fig|1026882.3.peg.2913 Daunorubicin resistance ABC transporter ATP-binding subunit
MAYKNQYAILTKGLTKQYGQALAVNGLDLSIEPGQFYGLLGPNGAGKSTTIHMLTTMTSASSGEAWIAGREVKRYPVQTRALVGLVFQDSALDRMMTVDENLQFAAALYNLNKQQAEQRIAELLSVFGLEKKRHQKLVALSGGQRRAVDIARGVLHKPQVLFLDEPTIGLDLPNRRSIWRFIEQLRKDEGMTVFLTTHYLEEAEACDHVDFIQKGQLQKGGAPKKLIKNLAAYMLEIDCADTEVVSQQMRPQFGEPLWEDQHLTYRIQDKETDFYQLQKTLGNAVNAMQWRKPNLNDVYLWTVCPPDYGVVT
>fig|1028307.3.peg.241 Multidrug resistance protein B
MSLVSSCSLDQGFEAPRRYLAAAAILIGVLMAALDSSIVNVALPSIASALRVDSASGIWITNGYQVASAATMLICASLGSRIGEKRFYTAGMVLFTLSSLGCSLAPTFGVLVTMRILQGVSYAVMISVGLGLYRVIFPPCALGTIFGLNALAFAVGTAIGPALGGFIISSLSWPWLFYINILPGGAAIVFSLISLGEDNEKEQGFDWAGAVSSAAALGLMVVAVDQIGRWEGRTLIYCAVASVALFAFFFIAQTRAKHPLLPLDIFRSRQYTLAVISSSSLFIAQGMALVGLPFVLQHTYHYSVLESAFIFTPWPVAVAICAPLAGSLSNRFNPTQISTVGVVIFCLGLGSLALLPGAATVNDFLWRTAVCGVGYGLFLPPNNKEMFANVSANRTATASGVLSTARTTGLSIGAALVAMVIALLNGLTGLAGAQFSVYVFGLACVIAAISSLASTLRLHR
>fig|1028307.3.peg.458 Transcriptional repressor of for multidrug resistance pump (MarR family) protein
MDKTHSSTPPESHESRFHKEEFPFFWVVNVYARYTQLMEIELKKIDIDLSRFRVLMLVHQYHRASISRITEYAVSKMPTVTKIVGRLRDDGLLTTHVSVSDGRVTEAELTAAGEAKVAEARALAETVFAKAFKGVTPAQEKKMNQVLALILHNLDD
>fig|1028307.3.peg.1880 Permease of the drug/metabolite transporter (DMT) superfamily
MDASFPTPSIFANKKVAYVCATLCCLLWGSSYPAIKNGYELLYIATDDVPSKIVFAGYRFLFAGLLLLLFALAQRKPIARLNGRQCGQLAMLGLTQTAIQYAFFYVGLAFTTGVKGSIMNATGTFFSVLLAHFIYQNDRLSYNKTIGCVLGFIGVMLVNFNTSLGDFNFVWQGDGFVVLAAFILSAATLYGKRISQTVDPTVMTGWQLAFGGLVLVAGGYLTGGELRMHSVTAAMILGYLTLLSSVAFALWSVLLKHNRVSMIAPFNFVIPVAGTVLSAIFLGENIFEWKYAIALVLVCVGIRWVNKNQAR
>fig|1028307.3.peg.2658 Multidrug resistance efflux pump
METLLLLCYAALCIVIFKVFRIPLNKWTVPTAVLGGVILIGMLILGMNYNFPYSEVGKQVYRTVPIVSQTRGRVTSVPVKPNQMLHEGDILFTIDPTPFQAKVDDLTAQVKAASQDALSLDAGLTSAQADLSKAVAERDRAQREYARFQAGHDKGAFSDQMVDTRRQNWKASQAAVDAARAKVAQARNDLNSVVHGENTKVASLLAQLREAQFKLDNTVVRAPSDGYVSTVGLRPGTMSTALGLKPVMTFVPTDNANSREYVAAFRQNALQRLQKGEQAELLFPSIPGTVFKAQVAEVLPAIGESQFQGQGTLLTANDLAARGRALVVLKVTDDRLANYQLPQGADVEAAVYSEHFEHLSLIRKILIRMKSWESYLYLDH
>fig|1028307.3.peg.3201 Permease of the drug/metabolite transporter (DMT) superfamily
MSSLKLSITPQELILIVITMFWGGTFLAVQYAVNFSGPFFFVGLRFATAALAVALLSLRTLRGLTWLEVKAGVAIGVAIALGYSLQTWGLQSISSSKSAFITAMYVPLVPLLQWLCLGRMPGVMSCVGIVLAFIGLILLAGPENNLLALGIGEMITLASAVAIAAEIILISAWARQVDVRRVTVVQLATASLVAFAAMAPAGESIPPMRPELLAVALGLGIFSAIIQVTMNWAQRSVSPTRATLIYTGEPVWAGVFGRIAGERLPLLALVGCLFILAGVLVSELKWKKKSRPQIAAEEAPELAERREP
>fig|1028307.3.peg.3516 Glyoxalase/bleomycin resistance protein/dioxygenase
MKVAHIALWTRHLEQQARFWVEFFAGEINEKYRSKTNPGFESYFVKIGSDVAIELMTKPGLHDSTHDNNHTGWVHLAIAVGGTEQVNALAKRAEMAGILVSAPRTTGDGYYEAVIKDPDGNLVEIVA
>fig|1028307.3.peg.3545 
MSEVKIVATLTPHPEYIDTIRNAALAMVPPTHREAGCLQYDLHESREIPDVRQLSRQGKISFVFIERWRSEDDLKQHVAMPYHDDFLAILEGKLESIQVQRLMSL
>fig|103690.1.peg.3858 Permease of the drug/metabolite transporter (DMT) superfamily
MQLKLSASKFPIAPLLLIAPFFLWGTAMVAMKGVMPHTTPFFLAGVRLLPAGVLILIAAALSGRPQPNSWQAWLWISLFGLVDGTLFQGFLAEGLVRTSAGLGSVMIDSQPLAVALLSLWLFQERIGLWGWLGLGLGVTGISLIGLPDEWIFSLLGTGAEVTIGNWQNLFASGEWLMLLAALSMAVGTVLIRFVTRYVDPVTATGWHMIIGGLPLWGISSVVESQQWENLVGSEWLALAYATVFGSAIAYGLFFYFASSGSLTSLSSLTFLTPIFALLFGHLLLSEVLSTLQWVGVFLTLISIYLINQRDNLAGQNKQSVMEEISAKSQPILAEATAKKLNPLTVKVRESEPETLP
>fig|1045004.4.peg.268 Multidrug resistance ABC transporter ATP-binding and permease protein
MVPLIVQRLIDSYERGIDYRQIIFLAAIFVMQLLFNALGLYLFALIGAIATKNYQQGTFNQVLQHRVGWFEEQESTNLANKIYNNIDLLRTLFTNSLPEMISGVLTIVGIAVVLLSLNWALTIVTLFGVLLMVGVFGLLGAPLANRIADFQDQKSLFATHTSKFFRLVKMIKANAAEKIVQKDDADDMKVLFESGRRLARINALINPLIGAVMMLIMLGIFGYGGYLLNNGSITNGVLIAFLLYVIQIMVPLGSFSEFFHGYVGAKTAMNVLMQLRDNSQNERQGGCALPRDSQSDLVFKDVNFAYDDAKTITLDDINMVFKPNTMTAIVGPSGAGKTTIVSLIEQFYAANSGVILSGTSDITQFSLFSWRQSIGYISQKADLLGSSLRDYLSFGRKENYSDNQIKDVLGKVGLLEAFNGHLDDKLLEDGNNISGGQLQRLAIAQAILKEAGIYIFDESTANLDADSEMKVKQIMEELAEKHIVIAIAHRLSTIKSADNIYFLEDGTITGSGTHSQLLANHKTQLLANHKTYARYVAEQML
>fig|1045004.4.peg.636 Multidrug resistance ABC transporter ATP-binding and permease protein
MAKKSKQQKSGLTALFKYAEIKKSLLMTGLIFSVLSAALSLVFPLFIANLIDSFRKHFSLPLVLAVIVTLLFSTLFSVLNSYTMGKASQTFIASIRKKASARLMNIPIKFFTDKQSGEISNHIANDTQSIDLLIRQNISSFISGVILVIGSIVILFLINWSLTLIVLLALIAVFLILSPISNIQNKTSASLQNELGHFSSRLNQVASEIRMIKSFNGQESQKEKLNDSVDRLYRFNMKVLKINSLLDPIEYTILFSSIFFVLIIGGLMVSSSGMTIGALVSFFIYFLQIMTPISIIAQTINQFQSANGASKWLVALLQTGEETDNQQLVPAGTFASPLVFDQVSFAYNPKADVLSNLNFKIPAGSVTAFVGPSGGGKSTIISLIEKFYLPSKGECPWLEKISKISACIIGVIMLPMCPSRVQCLLGRCVII
>fig|1045004.4.peg.637 Multidrug resistance ABC transporter ATP-binding and permease protein
MLVGTLRDNLTIGLKKEVSDEQINQALKDASAFDFVEKLPKKLDTDLSERGANLSGGQLQRIMIARAFLKQADIYIFDEATASLDSQSEFFIQQAIDKIKAKATIIMIAHRLATVKNADQILFLDHGQITGEGTHDELYKTHPLYRKYVQEQLLKQG
>fig|1045004.4.peg.703 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MSKYLKEQWAWTLFCVFLIALMSGSKVAAALINTYLLNSLISFQRNRFLLLVGLAILTWVIFAFLIYVVYSLRARLVQKMSLSLRHDISQQISGLPYSRFHAKNSDDYSSWLMNDVTMIENGGFSVFFDIISVSLDAIFSIIALLSFHWSLVVLTLLLSVVTIFAPQLMQKKLKKASVETSQANENFAASVNDTLHGFDTLFAYNLTQRIINHVDKSGRLPQTKKVQLGRTQAAATSIGVLANAGSQLITIAWTGALALARLTPIGSILSTGALASNVFNGLANLGPTLTSVKSLNPLFAKYHLGVDTSLNTSNQSTKSLADATINLTNLSYRYQDKIALKPVSIKLPLNSKVIITGESGAGKSTLLNILAGKLLNYSGSVKIAGQELKDLSSEQLRKTITYVDQIPYIFNGTIRDNLTLGEKFSDDAIFQALKRSDLFDFVMAQKQGLDSSVGEKGQLFSGGQRQRLALARGLLRNPQILLVDEGTNSLKSESAIQVEKQFLSLQDMTVIFVTHQLHEEIRPEIDQLITLA
>fig|1045004.4.peg.766 Lincomycin-resistance
MANKQVRRPFVVILGILVVNFLGLFSETSLNIALPVLRETFSVSSAAIQWLVIAYMLMIGLALPLSTLISHWFKTKDIIIFAIFIFALGSVIAACANSFTVLLIGRTIQGIATGLFIPLMFTIATIIFPSNKFGSVMGVIGVVMGFAPVIGPTLSGIIIDSLSWRWIFWLFLPFLLLSLLLTIFTMPNVIEQTHPRVDWLSVILSMLGFGLLVSSVGLISNLGIASPIVIILILLSLLILFIYIHRQLRINRPILNFKILTNSRYRNGTLIVIFNFGIVLAAMYLLPQMLQNGLGQKANTTGWILLPAGVLNAVISVIAGRLSDRFGARYLVLTGTVIFIAGLIMMSIINLKSGIPYIISAQSMLLSGSAMLFPPAQSYSLRSLSAAHSSDGSTIMNTCQQIMGALSTSITNSLLVFGGTLHPLQNTAARFMSASRFAFIFAFVLAVLILIVAFQIKGKDKTSRQTA
>fig|1045004.4.peg.1068 Permease of the drug/metabolite transporter (DMT) superfamily
MLGPFLWGLNGVVTQYLFDQVGMDVNWVLSIRLFFAGLALFIYVLVFDRQNLFNLIKDKSVRWRLIVFMIFGDFMSQYSYIIAISESNAALATILTSLSLLFVIFFYVIVQHHLPQRIDLLSLIVALAGTFLLVTHGRIGHLQLSSAGLFWGLFAALVYAFATIYPIKLVSKYGPLPVTALSLFVSGILFNCYRPFFEHVPKMSGVNWFLLIFFTIVSTAFGTAMWFLSLHLVGATTMSLLSAVEPLTAAILSITLLHLAVQGIDVLGSGLILLMMCLQAFKHQRVR
>fig|1045004.4.peg.1647 Multidrug resistance ABC transporter ATP-binding and permease protein
MENKGNPNKNLGLKWVLAQLPVSLLILIIIFAIIASLEGVISGYAIGQITAIATTHVASPALFVLRFVLIYFAVYTGLYIFILLQNRAIKYLNVALKQAFMKNAFQTDYVHQDADKLLNQVTADAKQIEQRYFSNLVNLLLSVIAIITSSVFVIAINPMLGLIDVILSFSIMIPTLFDNKKLDQYSSDWSMANQHYLGQVKEIFAGIDIIKNFRAEKTMLAANDAKLNESENRYLALNNRQFFTQYFSWLMIIISFLGPVLIGLLFRQYQLFGVTISAIVTLALSGGNVATQVRTGIQYYAGMKTTRALRQSVIPDPTPEENSAANLPDKPLLSVADVSFSYKNHPILKDVSLSLPYGGKLLLSGDSGSGKSTFLNLLTNKLDVQTGSITLGGQQIHENDFAYITQTNWVFNDTVKENLTLGQNFSNAALLASLKEVNLANELGDDPLNYQCGEGGKNLSGGQKQRIAIARALLRKRPLLLLDEVTAALDEKNSEKLRDLIYRLPQTIIEIAHHYDTDQIQANHVQHLQLSAGKISPAN
>fig|1045004.4.peg.1746 Drug resistance transporter, EmrB/QacA family
MSAKSVDIHNKRYSRFMFVLVILFATFAGMLMQTSLGTALPTLMDDFHINLATAQEATTWFLLANGIMIPVSAYLSTKFPTKKLYIFAFGLLLVGQFISYSAPVTNWTWFLIGRIIQAISVGITMPLMQVVLVYIFPAEKRGAAMGLSGLVIGMAPAIGPTLSGWILDSSHSFASFTLSNSWRSIFLLPMAVIALTFLLSFIFLRDVIPNQPVHLDFRSLVQSTLGFGLFLWGLTNVANANYGGWTDMTHVIIPGAVGIFFIIIFLWHQLEMRHPFLDIRVFAVKQFSVTTVLISLSMMAMIGIEMMLPTYLQQLRGLSPLSSGLTLLPGALLIGIMSPIAGAVYDRSGAKRLARVGFLILLIATIPFLFFGLNTPRDFITVFYSLRMFGIAMVMMPLTASAMSALPKEKAADGTASNNTVRQVLTAMVVSLLSSVTQNIANTNAPVASLKQQNIFEFGQRTLDASLKGFHVSFAISLFFALLGLILAGMLHSGKVIEQDPDLLDEKGGN
>fig|1048339.3.peg.42 Vancomycin B-type resistance protein VanW
MTESTPVSSAGGSGGRRTALRVGIVAGGAVAAVGLLYGVAVATTGGNIPRNTEVLGIPIGGKSVEDARMHLSVALPERLPDAMTVVAGDKRLSRPTGELGLDVDLEATAEKAREGWASPFRAIKTLFGAGREVDPVPAVNTETLQTAVEEMNDEVSLGFVEGGLDFSTGVAKPIAPVPGRGLDDEAVAAALTDAFLAGDSEVAAAIVDVQPEIDQAAVDRALAGIGAKAMSGPVTITVAKNAVELTPAEFGPFLSTEPADGELRLVVDAEGLVDSLEDEVEDLGRPPRDAKFRFDEEEETVEIIPSRAGIVLDARVLGDKLADVLIGDGPRTVDAGARTQAPEFSTADAEALGISDKLSSFKTEYPYAAYRVTNIGRAAELINGSIVMPDEIWSLNKTVGERTVKNGFVRGYIIKNGQFIEDLGGGVSQSATTTYNAAFFAGLKDIEHHPHSLYISRYPAGREATVAWGSKDLRFQNDSGHPVYIQATHKVGSIEVSMWGTKVWDEIESISSPRRNIVSPKTVESEDPDCEEQSPVDGFDITITRVFIKDGEEVKRETYDTHYFPTDKIVCVEPGKGTKSPTPGSSSSPDPSPSRTPKPPKSTPTPKPEPSPSATPTTTSSAPPLPVGSGDDDSGRD
>fig|1048339.3.peg.58 ABC drug efflux pump, inner membrane subunit, DrrB family
MMNPQITLSTARRVLIQLGRDHRTVAMLLVLPSALLGLMCWVYSDIPGRFDRVGPQLLGILPFVVMFVVTSVATLRERRAGTLERLLTTPMNKLDLLLGYGLAFGLVAIVQSGIAALLTMTLYGVDAETKGGWALFLSAAVVGVFGAAAGLFASAFARTEFQAVQLLPAVVIPQLFLCGLFVPRSQLDDVLNAVSDVLPLSYAVDAMNQAMQRGGLTGQVGRDLAIVGGSALLALAAGAATLRRQSA
>fig|1048339.3.peg.308 Probable antibiotic-resistance protein
MTRPKVIDAWIQPWTKEVVEGLPDRALHVFKQYGQASRLQDGISLEVMMEEMDAAQVDISLISGGPMVPMHLVLEAMERWPDRLRAVVWTDPTQTSIVRALADLEALVRNYPVCGFKMEAFALWRDPTDRVFYPLYAKCAELGIALQTQVGGTGPLYPSRTGQPLLIDEIALDFPELKIVCGHVGSPWVDEMIHVAWKHPNVFIDTSARLPKYFEPAFTKFLTSFGQDKCIYASDWPVLDFQRPLGQVDSLGLSPEVREKFLVSNAITAFGLDDLRA
>fig|1048339.3.peg.2767 Probable multidrug resistance transporter, MFS superfamily
MGGDRRGWRRHAIDLSPLEHRDYRRLWAGNAIAFVGFQVTAVAVPVEIYDITGSSFWVGMMGAVGLVPLIVFGLWGGAVADALDRRRVLLVGSVTMWLTTLGLLAHSLLDGDSVTVLLALVALQSAAFAVVGSTRGAIIPRVVPPEQIAAANTLGFTTSNVSMMAGPLLAALIITQVSLSAAYALDAVLYLAALYAAVRLPSLPPLGEISAPGLRSVIDGLAFIATRPVLLVSFAVDIVAMVFAMPRALFPARAEELGGDAAVGWLFAALAIGAVVAGATSGWVGRVQRQGVALVVAIVVWGLAVAGAGLAGNLWLAVFLLAVGGAADLVSAVYRQTMLQTYAPDEMRGRMQGVFIVVVAGGPRLGDVRAGTTAAAVGVQASWVGGGLLCAAVVLLALAVPVFRRYRAPTATDPRPSDDPT
>fig|1048339.3.peg.3351 Vancomycin B-type resistance protein VanW
MSRFLARRITIVVVAAAALLGLGLYAAAYAAAGSDIKKGTTVLGIDIGGLSRAEAESKLAAELPAVISKKVTVRAGEKSFELDTVKSGITVDAAATVAKAGERSLNPGVLFPVLFGAKDRIDPVLAVDDKALTAAVTGIAKKVNQKVREGRVKFTAGEAVAVQPREGRSLLVPETAEALRKAYETGAAEVTAALKTTPPVVGQAEVDRVMNSFAGPAMAGPITVKLDGQNVTLSTAKLDDYLKITPSGPTLNWTVDTDRMVEDLAEENPKLVTPPKDARFTFERNKPKLVPGEDGEKIEAVSFGEQMRAALVAPVPRTVEAQVVPAEPELTTEEAQNLGITEKISSFRTNYPIAPYRVNNIGRAAELINESLVLPGEIWSLNKTVGERTEANGFVKGFIIDKGQFKEDLGGGVSQSATTVFNAVFFAGLKDIEHHTHSLYISRYPAGREATVAWGAKDLRFQNDTPTGILVRATTQPGWIRVTIWGTKYYDKIESVSSDRYNYKQPKTITSAAADCTPQSPVAGFDIDVTRVFYKDGKVVKREKFFTRYIPTDRIICTNPRKD
>fig|1049789.4.peg.31 Acriflavine resistance protein
MIEKGQKILESRPVSTGMFLFGLILFGAISYVKNPISLFPNTTYPGLTVSIEYPGADVKDLEEMITIPIEESISGVGGIEEIYSFTERGKTEINVEFEKESNLEFKSLEVRERIDIVAGNFPREVHKPFIYSYDPDNRPTMILTLKSETFDFIELRTIADNEVKRYLENIEGISKISVTGGKVREVLVSCDMQKLRAYGLDLSEIQRSIRENNTTSAVANLKKQGLSSKLLLLGRYKDLNDLKTLPVFSTKEGRNILLEDLANVSFSYREEESSSRLNGKENVSLYIYKSSLGNTLSISKEIHRKLDDLKISGVNFKLIYDQSETVKKSYLNLIACGGVGLILFFLLLYYHRNYKQVRIRTTLLTQTILNFFLFQFVLYIFKLDFDIIIFSAFILGFAIWTLVSFLLLEKTPQDLSNLKQVSTLPEFSALISIVLFLSLPLYFLDREIGEASFKLGVFIVLFLVFSYFSFSPIKRFFNQIRNRYFPSFISEPLQLELKFSLFQGLEPKITRKTILLIYVVVLLASIYRVVKIDKEFYYTIENKKILGYVELPSGTGFGFTNSITKRIEEKILALSEIEEVTSKVEGGHSFLIITLKDSAIAGDTFLEKMKKQVGNTSPAFVYFSRESDASKFKEIVVDVLGEDTEKLDETVKLLAEKARKIPGVEEVILRYKPPRDELSLVLDKYKTSHSNLSNLEIGTYLKLAIQGAVVSKFIEDSKEIDIRVRLSEEYRNSEKSLENYFIKNSTGKYAPLTEISSPKESKSPIKIFRKNKKRVLSFAIRTGKISHSKILSDLKSLGEELPDGYHLELGRSLEKTVETESKIYIVIGFAILFLFGILSSYFESFILALKALVKLSLPSSISFLFLSYVFGAFTLSMYLGILILLSISSFLIIVSHKMEETKSLKSIFYAFLPVVCLFISEVLFASEGGKFLKEIEITILVGFFVFAALLPFINPKPKNNTTE
>fig|1049789.4.peg.356 Acriflavin resistance protein
MNNTRETPLGFAGKIANLFINSRLTPVISIASILLGILAVTLTPKEEEPQISVPMVDIHISSPGFVAKETERKVVEPIERAVWGLEGVEYVYSASADHGAIITVRFKVGEPLEPSLVKIHHSLMEIKSTLPPNVSEPTVRSYTIDDVPFLALTFSSETRDDYSLRSIVAPLARELSSTPDVARMELLGGRKEAVRVIAEPEKMQVYGLSISDIANGIRANQGFMPSGKNWGKDFLYDIEIGTPISNAKQVMLTPLVRRGGNVVRVSDVAEVHDGAEEKVRQSSILDKSLGPDHRNAVTILFSKRKGTDISKLSREILERSEFFTKDLPKDIAMTVLRDYGATAGDKSSELIEHLLIATFSVSVLIAVWMGIRASFVVSISIPVTLSLTLALYYFLGYTLNRVTLFALIFSIGILVDDAIVVVENIERHLKLKPGQGIVKTTLQAVSEVGNPTILATFTVIAAILPMAFVRGLMGPYMKPIPVGASLAMILSLLVAFIVTPWASVRFLKLHSKVEKKSVKDSKLNLLYESFTAWLLYSRKNAILFGLSIIILLLASFSLVALKFVKVKMLPFDDKEEFQVLIDYDPKTPLEKTTKYTRVLANSLIENSNIQKIQIFVGDPAPFSFSGMVKHSFLRNKEWQADLHIVLKNKNERNKKSHDIIESLRPSITDFGKQNNAITKVLEIPPGPPVLATFVAEVYAPTEQEREDVAIEIKKSLSLQQGVVDIDSSLRAQRPSIVFPFDYVSAGNLGVQAVTIAQASNYVFQETSLSTLSETSRPEDIAISLSLKDSIRASKTPFAKLNVTTLESGSIRADQVLDQPTIHENRIRNRKNLRSLEYVTAEFSGAEESPVYGILNLSDKVTHPTFTSEIPSVLNQAVVKWDGEWFITYEVFRDLGISFAIVMLIIYVLVLGWFQDYLVPLIIMAPIPISLIGILPGHWLLGAYFTATSMIGFIAGAGIIVRNSIILVDFINTEISSGAPLRQAVINAGLVRFRPMLLTASAVVVGSSVMLFDPIFQGLAISLIFGEVAATLLSRFAIPAIYYWFLMNRGHISKKN
>fig|1049789.4.peg.582 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MNNMEDPKKQTDNSTSPAETTPKAIGIGGIFFFSDNLKETKEWYAKNLGLEINEWGSSSFESRNINKPDEINSLQWTPFKKGDEYFSPSKKEFMINYRVQNIEGLVNKLKENGVTVLDSIATYDFGKFVHIMDAEGNKIELWESVDNG
>fig|1049789.4.peg.802 Glyoxalase/bleomycin resistance protein/dioxygenase
MKKLLIAICILITGISFWWAITSSQSDYHKIDNIDFSYATLILNSPNPERLSEFYRNALGAQRSKEEAVWSLDGSIKSVISLRTAGYDEQGPLLTILKSDKSNIESPLPNDLGYAHICFESDDIPGLIEQILKNGGKILSSFKDLEKVPAAYATDPDGNVFEIHLPFPAPVTPRTIYRSLNSLVRISFKLAPAKVDAIRFLHVNINSTDWIKTMNFYTKALGTSATGFERNYRGEFIENLTGINGAVVRGRHVELPGYSEGGPTFEIFTYNKSSSKKPRTMTEMGFVATGFQVQNLDTAIKKIISEGGTLVSRRGSQSAILKDIDGNILILAPKNKFLRINR
>fig|1049789.4.peg.1100 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIFFKIIQTLIAKVVWMEAIQKDTQLELERTSIWGELKKALTGTEADYTQISLGKAVFLLSVPMVLELVMESAFAVVDIYFVGALGPSAVAAVGLTETYLFLLYSLAIGMSTAVTAIIARRIGEGDKEQAGIAAVQSVFLSILVSLPFAIFGVWFAKDLLLLMGGDPWVIEHGSRYTQWIFGGNIVIMLLFGLNAVFRGAGDAAIAMRVLWISNGLNIILDPIFIFGFGPVPALGIEGAAIATNIGRGVGVVFQVYLLLKGGKHIRVLGSQISVHWKIISDIVRTSLGGIGQTIIGMTSWIFLVRIISDFGSEAVAGATITLRIMMFTLMPSWGMSNAVATLVGQNLGARRPDRAERSVWIVGAWNMFFLIGVSICYFIFRESLVSIFTSDAKVISIGSEWLGIVSYSYFVYAWWMVSVQAFNGAGDTMTPTIINLVFFWIFQIPFAYVLAKVLSYGYSGVFWASMITETSVGLFTLWLFRKGGWKTSKV
>fig|1049789.4.peg.1196 Acriflavin resistance protein
MRAIIESFIKNRLFFYLGTSFVFLAGIVSLLGLRRDTFPNVDMKQLVITTKFPGASPADVELRVTYPIEEKIKEIDGIDEIRSFSRNSASDIDVRVSLEEKDPEKILDEIRRAVDNAISEFPPQVTEKPKIIERKSSSYPVLEFSVFGGKDEIELHTTAEFLERELEKISGVARVDVFGKRDREWQILVNANRLKHYQLDLSDITTAIRNRNVNLPAGSVDSETAFDLRIDGEFRNPSDIYKIPIRTNDLFSKVELGSLARVEDTFEYPRFLAIANGKQGLILSVVKKERADAIDVADHVRKRLAELEKTAPPEIKTVMLSDEAKRTSKRLDIVSNNALIGFCIVFGILFLFLDFRTATITSLSLPISMLMTFAVLPFFDVSFNMISMMGLIIALGMLVDNSIVISENIYTYLGKNMDSFTASVKGTLEMLVPIFGSYLTTVAAFLPMLFMSGVMGKFVWQIPLVVIVALTASLIESFLFLPARITAFAKTPDQLKRTTGFRKTLDAFFHRMEERFSDFVAFTLRHKYSSFITILILILASFVALSRMKFILFPKEDIEIFTVKAEFPSSFRIYQTREKMKYMETIIKRIPPDELVSYSIKIGVQQTDPEDPLSRYGENLGVILVYLTPESERKRKAGEILASLESDFRKTPSLVDVYMEEFGAAPPIGAPITVSILGKDYKDLTKVSAELQTFLKTIPGVHSVRDDYRYGRKQMQVRLDEGLESFTGVSTFAAANMLRTAYDGERAGTVRKGRTKIYLRVMYDKDFRKNPDEIKHIPLRNKAGNITHLSKISKMELVDSPELLSHREFERAITVNAEIKVDQITAHEANSKIIEVFKPLIERQYPGISLAFGGEEKDTQRSMESLGKAGLLALFGIFAILALTMQNFWKPFLILSTIPLGIMGIVLGFPLSGKSISFLAMIGIIGLAGVLVNASIVLVDCIDSIQKGSTDSMDEILLEASRRRFRPILLTTLTTVAGILPTAYGLGGTDPVLVPMTLALGWGLGFGTLGSLLYVPVTLSVFHRFASKKKKVHH
>fig|1049789.4.peg.1424 Permease of the drug/metabolite transporter (DMT) superfamily
MQITSSVKFYILLVIAMISWGFAWPSAKSIVGLENPNVIIFWRFLATAISILPILLWRKESLRLPDIKSFFQVCVGGVLYTAYNQFFLLGLSSGFAGAGGVLVTTMNPIFTYILGHLLQKQYPGKKDAFGLLLGLSGGLVLLHIWDKPTEGVFQSGNIFFLLCAFSWAILSMNSHSTGQKISPLVYSFYVFTIGTIFDFIFALPYGLSNVFSLDWMFWGQIFYLSVISTTFGTTVYFFASTKLGSRIASSFIFLVPATAVLGSWIFLGEVPSLTTLFGGSLAVSAVLILNGNRTKKTEIQAES
>fig|1049789.4.peg.1659 Tetracycline resistance protein
MRKQSFILVLTVFIDMMGFSLIFPIFPETLNHFLAQAGDPVLDLLAGWTSHLLDNSGGDWKLFVALFGGIVASLYSVLQFLFAPIWGKLSDRTGRRPVLVFTCTGSFLGYLVWLASGSFSLFVLSRILTGLMGGNISVATAAMADLTEEKDRAKGMGMIGAGIGLGFIAGPSIGGILAHTDPSTLLPFFPWSKMTVFPSVALAASAAALVNLLFVLFRFRETLPITLRRKPEGRLHPILGVLDIGSREVLFLSLLNFLFLFFFSGFEFSLNFYLDQFLNFKPIQIGYTFVYIGLIIVVVQGGIIRRISGKIPEKQIGLFACGLLTLGFLLLSFTNSHTQLFLALTLLAMGSAFLNPSISAMVSLFSPPQDQGKNIGLLRSLGSLGRGISPIAFSLVYSQRGPQISFLVSAVLSAVFLILFWFLRQPKKHHA
>fig|1049789.4.peg.1965 Acriflavine resistance protein homolog
MKTILEYFLSKSIFVNLLTFLIIMFGGLTAVLMNREAFPNINFDIVSISTLYPGASPQEVEKLVTNPLEKAIKEVDGIKEYRSTSIEGRSGIVVTLDPDAKDSQKVVDDIKSAIDRVEDTPEDAEDPIVTEITTARTPVIEVSVTLKNDDGSVESEKKLKAHAKIVEQSLLDISGVAKVVRRGWRDTEMQVDLNPSGLNSRYLTGQDVINALRNRNVNVPGGNVTGSENEIILRTVGEFDTPDEISRVHVRGNEIGYAIRVQDVSKVTEGLKEADYLENVNGKKTVALTVLKRQSSDAIKVVDDVKNTVEKFRQSNKEFEYAFVNDLSKYIRRRLNVLISNAGFGMVLVTASLFFFLGWRVALMTALGIPVSFGATFILMNYFGLTLNLISMFGLVLVVGILVDDAIIICENVYRYIEEGLPPYEATLKGTLEVVSPVTATVTTTIAAFAPMLFMSGIFGKFVYSIPLVVIIALCASLSEAFFILPNHLYDINKRHVKTGEIKGESGWFARFRNTKYIPVLKFSLAHPWAMTFGIVGLLIVSFIVLANYPRFKLFPGSVDQFYVKITAKTGASLSETYRYLKVIEKEIAKIPPEDLENFATRVGIIQANPNDPFTKRGKHFGMTMAYLTAEENRKKCHKTDDIIRRLRKKTLWLLNDESRKIEEGRIKKESADKKDECDVDEPAVIPEEFASLRGKLVALEYEKLSGGPPVGKPIAIEIRGDEYDTLSKIAAEYKEVLGKVNGVTDIADDFNEGKDEVRIKVSESLASTAGVSVSRVAQAINTAFQGTVATKIKRTDEEVEVKVRFPESYRQSVGSLNHVYVSNLQGKMIPVSRLITIQKNPGFSNINHLDGKRVMTVSANLASGKNTNPSKANSESKKLADARKILEKYPGYTVRFGGENKDTDDSFKSLGLAFAAAFLIIYIILASLFGSLLQPLVVVSAIPFSFIGVILAFVSHGEYFGFLAFLGIVGLSGVVVNDSIVLVDFANSLRKNNPNKDIIEVLLETGNLRLRAVILTTVTTVLGLLPTAYGIGGFDPFLVPMALAFGWGLAFASLVTLVMVPVFYLHLYRYQTWFSGLSDRIWSAKPKSITYSFESSPIPQKQKKKK
>fig|1049789.4.peg.1995 ABC-type drug export system, membrane protein
MINFINKTLIISELEIRKIIHDPSEIITRSVQPALWLLIFGQVFAKMPFLANRTDYLSFMTPGILAQSVLFVSIFSGIAIIWERDLGLIQKMLSTPTPRTAMVLGKAISAGFRTLPIVVIIYLLALILGVSIHWDIFKILGVLLFVFLGSIFFSTFSLIIACLVKTRERFMGIGQLLTMPLFFASNAIYPIEIMPDWLKVVSHVNPLTYVIDALRSLMLDFPSNFGVLVDFGVLFIASLLVVLIGGVLYKRVAV
>fig|1049789.4.peg.1996 ABC-type drug export system, ATP-binding protein
MNILELHDLSKSFGKLTVVSSLNLMVEEGEIFALIGPNGAGKTTTIKMLTTLLPPSSGEAFIGGFNLKTQTDQIRRIIGYVPQMVSVDGNLTGYENLMLFAKLYDLPRKEQKERVKDALHFMGLDSFGDVLIQKYSGGMVRRLEIAQATIHRPKLLFLDEPIVGLDPIGRNVVWEHILALRKKYATTIVMTTHLMDEAEKICTKIALMSRGKLAAIGSPAQLKESVGGSDKSLEEVFIHYAREDLNESDGNFHSVNLERKTARRLG
>fig|1049789.4.peg.2121 Daunorubicin resistance ABC transporter, permease protein yadH
MNFREKFNAFSTIVRKETVRILRIWIQTLIPPGITISLYFLIFGKLVGSQIGDVGGHTYIQFIVPGLVMMSVILNAYNNVVSSFYGAKFGKNIEELLVSPTPAYLIVLGYSIGGVIRGILVGIIVTVVSLFFTELRLYSPWIVIVTVALSALMFSMGGFLNALFAKKFDDVTIIPTFILTPLTYLGGVFYSIQMLPEAWQIVSKFNPILYMVNAFRYGFLGVSDIDPGLAIGLLAVGTILLYSLSVFLLSRGIGTRT
>fig|1049789.4.peg.3055 Permease of the drug/metabolite transporter (DMT) superfamily
MDSKQETLLTRLSMGASEETKGFIYALLGTVLFSSKGVLVKLVYNYGVDSVTVLAFRMLFAIPFFAVVLYRESSRSDAAPIASKDYLNVVALAFIGYYLASFFDFWGLEYLSASMERLVLFTYPALVLLLSFLFLGKKAHSVELYAVALTYSGILLAFLPDAEANGQKSLVGAALVFLSALAYSVYLIGSGQMIPKLGSRRFTALLMLWSGGFVLLHFFLRKEVSSIFLQPLPVYAYGFALGFLTTVLPAFLTTAGIQRIGSNKASIAGSAGPIFTLFLSAILLNEKITWENLGGTTLVLSGVLLLSRKKKIVV
>fig|1049789.4.peg.3666 Acriflavine resistance
MGVDLFPDVNIPIVSVTTIYPGAGPEEIEELISKPLEEELSSISGLKKISSRNQEGVSVVFGEFTLSTDIKYAEQQFRDKVGLVRPKLPDGIKEPKVVRFDPADQPIVRLAVFADLGQAQLYDLAKETVKSKLEQITGVGSVKLVGGTRREIQIELDRNKLISYQMPMVVIAGRLKSAGLNTPVGKFESGTKETSYRTLGRYESISQIENTIVSFGGDVGNSVLIKELGSVRDGTEDEETLGYLWASKSDAVEEEDVALFAHPFIWTGQTFRKIKNLFSSKKKEAVEKEIKPALFIDVYKQSGGNTVAVADEVLKRIDKLNADIKPLAGNPRIRLIRDGSRWIRYNVEDVTEAIVLGVLLAVITVYFFLGNFRSTVITGLALPNSMLGAFILMWIMGFTINVMTLLALSLAVGLLVDDAIVVRENIFRKLEEGHNVLEASEKGTMEVALAVVGTSLTVIAVFFPVGFLSGIVGQFFKQFGLTVVFAMIISLFDGLFVAPMLSAYFAGKLDHSKRNKAVVAFDKFQTWLEKIYGITMKFALAHPGKVILLTFLIFVLSLVSCSFVKKTFLPANDQGEFLVTLDLPPGTSLQGTKEVADKVLLDLQKFPEMDKIAVTIGKPDGGEPNSATLAIALVSSKKRKKTTVAIKDEIRDILKNYAFARPAVSDYSAVGGGVQYPFQLVIKGDNLAEMEAYSKKVIDRLKAIPDLADIDTDFRAGKPEYQIALDNTRMQLVGVLPGVAGAELRYQIAGDTVSKFYDKGIEYDVRMRLHPDQRNLRAAYGQTKVPNIANKLIPLNAIGSGKETVGPSRINRIDRARTIVINANLAPGGAIQSATEGATKIMTTELPPPAGVRFNFQGQSEDFKELIVNILVAFGLALVFIYLVLSSLYESFITPVTILFAIPPAISGAFFALFITGEMLNLFSMIGLILLMGLVAKNSILLVDYAMQAIRDRGITRDEAIFEAGLVRLRPILMTSLAMIMGTVPIALGLGEAAKSRTAMGIAIIGGLILSTLVTLIVVPSIFGGIDRFREWIESKFRPDMGATVSHTESTTAGGNNHRETADLSEWAKAVEEPVKKPTSKKKK
>fig|1049789.4.peg.3964 Quaternary ammonium compound-resistance protein SugE
MNWILLITAGLFEVGFTTCMKLSDGFRDWKYAIGFLIFACLSFFFLNRSTQTISLGTAYAVWTGIGAAGTVVIGIFFFGESAQAWRIFFLSTLIASVIGLKFVAIE
>fig|1049789.4.peg.4097 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MIIVEGIDYIVIPTGDLDSSVKFYSELFDFETIEERTGEFAIIGLDSVNIKLLHTNGTKGALSEAKSPVLSFVLDVDDFTEAIVELESKSVQIVRGPEARDGGEFLHFLDPSGNILEINYKES
>fig|1049789.4.peg.4197 Multidrug resistance transporter, Bcr/CflA family
MYLPGLQSISRDFDTPISNVQLTLTSFFFGISFGQLVYGPLIDKFGRRTPMMAGLIIYTVSSIGCSLSVSVWSLVFFRFLQSLGACAGMVVPRAVVRDVFSPHEGAKVFSQIILVMGIAPIVAPTVGGLLLTYTNWRAIFVVLTLISIIVSIGAWLYLPETGKKDSSVSLKPGGVLKEYYEVLCVPRFNAYVIASGLSAAVMFAYIAGSPFVFMGIFGLSESEYGWFFGSNAAGLILASQLNRLLLRKFEAESIVNAISIFYVPIGILLVLSATYHWGMISMIGLIFLLVSGFGFIVPNASALAMAPFTRNAGSASALMGAMQMVSAVVATASVSLLHDGTALPMTLVMSGAGILSLLSLVILRPKSRLSIEE
>fig|1049789.4.peg.4757 Acriflavin resistance
MMMIGIILLGTIGFSRMGLSQMPDVDFPVVNVTLNLEGANASVMETDVVDPIEEVLLTVQGVVEVRSVSTDNSATITVELELKRDVDVAIQEIQTKIAQVQNKLPDALDPPILMKSNPDDTPIIWISLTAVGRTDQEKMIFVKSHLKDKFQEISGVGEIILGGYVDRTINVFLDPIRLTRAELTVNDITNTLTEQNIEVPSGRVENKSSEVSLRAVGDVPTVEQFSNIFINSRSGAAMFRPVRLREVAHIEDGLDEIRRISRFNGISAVGLGIKKLKGANAVQVGDLIKKKIAELKPTLPKGYDLSIANDNTTFIRDSVKELIFTLVLSALLTGFVCRLFLGSWSSTWNVLLAIPTSVMGTFLILYFAGFTLNTFTLLGLSLAVGIVVDDAIMVLENISRHREMGKTWFQAALDGASEIRFAALAATLAIIAIFLPVAFMSGIIGRYFLEFGVTVAVAVALSLFEALSFTPMRASRYREHKLQEHKKRGGKATIRFPEPVSDPNRFEQTIAKFKAAVAPISFFKKMDPIIERFLQFSERIYGKALDYVIAFPKIILILSTLLFVLSLGFLLLLKKEFIPPQDMGRFIIRAKMPIGSSIYRTNEAMKKVEEYLLKKPEISKYMSNIGGMGGTESNGAMFFVSVKDMGQRPKSKKTGREITQNEIFGDLRKDLKALVPECKFSVQDLSQRGFSAGRGYPVELVLSGPDWANLAKVADEIRNRLDQSGVLLDIDTDYVSGQPEVRILPNREAAALRGVSMANIGNTIGPLMGGKKVSRFTENGRSYDVRVKINKEQGEKADIIPNISVRNTYGEFVRLKDVLVLQATNTLKNITRVNRDRTIKIFGNPPVAVGQNKATEESIRIAKEVLPEGYSVDVTGSAKTAGESASSLLFALVMGIVMSYMILASQFNSLKQPLYILLAMPFSFSGALIALYFTKQSFNMYSFIGLIMLLGLVKKNSILLVEFVNHVRSQGKSIAESIREGCPVRLRPVLMTSFSSIAAAIPPALALGPGSETRVPMAITILGGLVLSTLITFIVVPAAYFLMEKESNDKLSHNR
>fig|1049789.4.peg.4828 Permease of the drug/metabolite transporter (DMT) superfamily
MEQRFAMKQFKNEGALILCTLVWGGTFTATKLSLVSVSPSLFLGIRFAIASAVFLIYALLQKPTKEFYGESKKPRLWFPILLGFWMFLGFACQTIGLKFTTATKSGFLTGTLVVITPILQTIFFRRIPNAGNLLGVIIVMLGLFFLSFDPEVGSGKLSFLFHWGDVITIAGAFFFSLYILLMDRVSREVSIQTLLLSQTLTTSILSFLLAFGLDYLGWETLMWHWETGVLPALVYNGLISSVGTTFLQTKYQKAVTPTRAGLIFSLEPVFSAVIAYYTLGERMQFVGLLGCGLVMTGVLFAELFGSSKERVSKTGA
>fig|1051632.5.peg.49 Glyoxalase/bleomycin resistance protein
MSFHFVGIDHVQLAGPPQCEETARRFYGEILGWVELPKPEHLRRRGGLWFQCGAQQVHIGIQKDFTPATKAHPAFYVRDIQALREHVIKNGLDPIEDEPLPGADRFYLTDPFGNRLEFLEWL
>fig|1051632.5.peg.212 Multidrug resistance protein homolog
MKHFPSAVWATAFATFVAFMGIGVVDPLLPLIGRAMGATHAEVEWLFTSYIAVMALTMLVSGVLGTRLGGKRTMLLGLGLVVVFATLSGKSPSIEFLAIVRGGWGLGNAFFTSTALSIIVGLSTGGMGPAITLYEAALGLGIATGPLLGGFLGSYSWRDPFFGTATLMAIAFLATYFLVKEPARRETPRTARDIFRALGYRPVLTNALIGLTYSFAFFTILAYSPLTLSHLSPVALGLTYFAWGILVAFSSVVVVNWLIARWSPMTVLKVNLAVLIGVLVLMGFLPSQDLLGLVVATGFFCGISNALFTTLAMEVSPFPRSIASGAYNFVRWAGAAIAPALAGWIGQRFGLTWPFFLAAGVLFFGWVALMPATRLLEGALRQHGDHLAREVKTS
>fig|1051632.5.peg.329 Membrane component of multidrug resistance system
MATNPGQPRVAWGITLFVLIVGAFMSILDTSIVNIAIPKLESVFSVTTDQVQWVVTIYLLALGVVVPASSYLGDRFGYHRIYIFSLVLFTIGSALSGLSWNLTALIVFRVIQAIGGGLIMPVTMAMIYRIVPRDRIGTAMGFWGLALIVAPAIGPTLGGYLVEYVNWRYIFYVNVPIGIIGVLLALRYVPPFPVIHRGDFDLPGFLMVAAGLFGLLLVFSEGQSWGWTSEASILVLMASLWALVWFVVWELGRAHPLLDLRVFKYDSFTVANLLTVIITIGMYSGIFYVPLFLQTVAGFGALKTGLIMMPAALASAFMMPISGRLYDRIGARPLALVGLSLLAITTYLLHNLTINTPIPTIILWLVLRGFGMGMSMMPITTGGMSAVPGHEVGSASAVNNILQRVGGSFGLAVMTALLTNRQAVHAQAMAATITPTANGYAVWNQVHALFAQLGFGVVPTTQLTTTELYGLVQEQSFVLAMGDIFVVAALVTAVGVFVALFLKTYRTHNGERAMSMGD
>fig|1051632.5.peg.447 Drug resistance transporter, EmrB/QacA subfamily
MNPAALRASRGVLLATFLGAMDSTVMGTIGPTVASRFHALVWEPWMITAFMLCTTLATPVFGRLADTTDNRRLYAVALTVFAAGSAWTALSPSMDFLLIGRIIQGLGAGGLFTMGLILLGRLFTGPTRATMQARQSAMWGIAAVLGPTLGGVAALGAGWRLLFAINVPLAWMAIRVMRAVELPPPDQQAPPLDRAGLALLTIVLVAVLALPTLWATGEPVKWLWAALGTALIGGSLLLAVERRIRDPLIPWALWRHPVVRRTTSLAILASALIYSLVTLVPLWTRQLWHADALTTGWVTLPIPLGWAIGSIMVGRRLKSWGFRRMGLWGTGIFGLGIASLDIAPRFPLPLIIGAGGGLLAGVGMGSVIMTGLLLVQSTASVDTLGAATGLYNFGRNLGNALGPGVLGGVAVGMATIGHPNGLRASTAGWLHALNGTWLGIVALTLGVAILLMRFPQHVPNPDPSVDTWNPVSPS
>fig|1051632.5.peg.454 Permease of the drug/metabolite transporter (DMT) superfamily
MTHQLKQPSQRVSRRGVTDALLVLVAIIWGSSYITTKDVVNHVPVLFFLMVRFGIAAIGFGLVGWQHLSRATATTWLTGISLGLFLTGIFVAETFGVKHTTAIAAGFLISLNVVLVPWVEKWILHYPIHWALMVSMVIALGGTALVTSSHGGQFVVNLGDGLILLAASLRAIQMTVTKRWVSEERIDIIALNVIQFMTVWIVCGGLTAITSNSLTIINALKSVSFWLVAGYLGLLGTVAAFVIQMVSIRHTSAARAALLLGLEPAFSALFGVIGGERLSLSSAIGGGLIVAGTLWGQQAEYRRRLEIENRT
>fig|1051632.5.peg.503 Drug resistance transporter EmrB/QacA subfamily
MRKWLVLGVVVLGLWMDLMDMTIVNVAIPAIQNDLGTSLQGVQYVVTSYLITIGVFEPITAYWADTQGMKRMYLASLAIFTVASALNGLAWSLPSLIAFRILQGIGGGMIMPLALSIVSVTFAPEERALALGLMGLPLLAAPALGPTIGGWFVQFHTWRDVFWINVPIGIVAFIAALRALQEFPTTRKPLDLGGFVLAAIGFASLLVALSNGPTAGWGSLEIVLLLQIAIFSLALFGLWEARHPSPLFDLRILRLRWYSSANVVTFFTMMGLFGVLYLLPVFLETVGGLGPMDTGMTLIPLVLSAAITIPLSGLLLPRLGAVGLTSLGLTVMGLGTAQLMHLGLSWDAGWLRLWVSVIGAGLGLGIMPAITVAYGSLPPAWMNQGSAMLNLMRQVGSALGVALYTTIIQMREPVYWTQLASTVTVTNFRAQARLAAWQQQGIAHGLSPAQAHVWALTMMAHQLQQTATLWAFHNAFGAAAVAAVIGIGPALWLWGSRQVLRPPDARHTALGEPGGVT
>fig|1051632.5.peg.695 Permease of the drug/metabolite transporter (DMT) superfamily
MRRGFLFLISATLLWSGNYVAGRVLARQMDPLELNAIRWTISAVLLWGILRAGGKTLRWRSHWAVYFLLGLLGMVLFSSLTYLGLARLPAVQAGLISGLNPVMIVLLSLWLLKETPDRSTWAGVLLAVLGVVILVETKRANWSAHLITGDVLLVLAAWAWAFYTVVGKRVAGDPLELTTGAAVMSVIPNWLLSWVGSSPSGGHLSAVGWGALIYVSTGPSVVAYWLWNLGVRRVGASRSAPTMNLLPLWTVVLGVGLLHEQLALNQIIGGVIVLAGAWLSGRPRPSAMGLAH
>fig|1051632.5.peg.796 Permease of the drug/metabolite transporter (DMT) superfamily
MKYCQLRIPRRLQGYLMVLLSATFWGVSGTAAQKLFVVGHVHPGWLVSIRMLGSGALLLLGSVMRQASTSLRLLKRAAWGPLLAFAIVGLLGVQYTYFEAIHTGNAAMATLLQYMGPSFIAVYGALTTRRWPSPVGFGALLLALGGTLLLVTGGHLAHLAVPATAIVWGLLSALFLAFYTIYPVPLIRQWGSLPVVGWGMVIGGLVAAGLTRFPDGGPSRWTPSILGLVLFVVLIGTLLAFFLYLASLTRLSPTEASIAGSAEPISAVLAATLWLHVRFTSMQMVGGMAIVAAVVVVAWLRPFEQRSSASAGASGRGG
>fig|1051632.5.peg.1017 Vancomycin B-type resistance protein VanW
MRYWIMVVWLLLWPNVPLPTFLAPHGGRQWAQLEYVPSAPVVVVPGESAARAMKLPYLLARQTTNYNHASPSQAKNIELVAQRLNGTVVKPGQIFSYYARVGPYTAENGFGWGRMFVGDRIVPSIGGGVCQGSSTLYAALLRTGLPIIERHHHGLTVPYLPPGEDATVASDYLDFRFKNNRTTPILITAQAGQRHLTVAIWGATPGPEIVVKHQILAEYPFKILKRVDPKLKPGQEQVLAPGQKGVSVKTWLEIKTPHGTETRDLGIDRYRPSPRIIAVGPKTPSADSTGP
>fig|1051632.5.peg.1018 Permeases of the drug/metabolite transporter (DMT) superfamily
MLVFWMIARVASLTGERIMFHAIGDGLDPWVTASSTYGGAALLLWLTAWTTGQAVWVPGAWLPSVVYAGSFWLYIAALSRGPVSQVTPVANASLLVAFFVRPSWGVMSVLALVLFAVGLWWLVPKTGRLSTAVWWMLLSDGGLVWGRLLDSRLAGGAPALAYAATLYSGVTLVFLAGTLIRRQGVSLGRVWRQRGASLAGASFFNGFSYLTVVMLLGYLPPSGVEAVSAIAGITGTWMGALWFHEEHVGRRVLAAVFMTAGAFLLILHHVQNAPTADLPLDRRAFFR
>fig|1051632.5.peg.1268 Permease of the drug/metabolite transporter (DMT) superfamily
MIDPEIRDRSVSPRSGGPRRTWAGLLALALVTAIWGYSNVLIRQLEHQWDPLLLLWVRYALVGLVGIPWLVTQGLSWSSWLWGGLVGAILAVTTLAQAIAMESVSVDQMAFITALYVVLTPLVMAFFRRRRPPRAVMAFALVSLTGVLLLVGHLTFTVAIGTLWSFAAAGLATLQIISTARFSRRLGAFELTFTGALGAAVILGLLLLIPGTHGPFHPVWSWRSLWRLLYLAGPGTLLAFWLQIWGQSRLTATQAAFLFNVEPVWTAVFAWLVLGQTLSPGQGIGAGLILVSLLALSRDG
>fig|1051632.5.peg.1747 Permease of the drug/metabolite transporter (DMT) superfamily
MKGYDPAGRTGGSIIQRLGGMIALAAAATIWGGMYVVSKELLTAVSPVLLMWLRYGIASVVMLGGLIARRQLQFDRDTLKWALRVGVMGYVLSIGAQFWGTALSTATLGSVITAATPAFMVLFARLLYHEGMTAAKITAVGLATLGVLLVVPWQGAARITWGSGILVAAALTWALMSVWVGYMPPTISTTRVTAYAIGIAWVLITPAAWVSLPTVSAGVWQSQAFWLGVLYVGVLSTALAFWLWSYGLRQVDPATGGVFFFFQPLSGTILAALFLHEAVDPSLVIGGVLIVAGVIVSQWAQKTPSPRPVGNRGDGEDSSVNP
>fig|1051632.5.peg.2023 Drug resistance transporter, EmrB/QacA subfamily
MMPRQTLIIVGSAAMCVGLSALDMSITTIAAPRIVASLRGPITQVALIFATYLGAAVLILPWSGVLADRWSSPGVLIGGLALFGVGSVGCLIAPNFLVFLLSRTVQGLGGGVLMVLPMTIIGQRYAPNERPRWQGILAAAYGLATLVGPPLGGWITTVFGWRWIFGLNLPLTAIALVGGSGIPSHRGSSGESPHWTNLVLFSGIVGFILLLTTRHWSAMEYGVFIVGLLILGVPFVQQVRNRQSSLWPQELEESLIISRGFLLMFLIAASIEMGAVYSPLLFQRIFLITPQQTGIWLIPMSLVAILASLWSGKWMTETGLYRRLLIGAQFIMVFGLMLATLSLVTHILGILEISTLLFGLGLGLQQPILAVVIQAATPDTYIGRMSSLLPLVWNVGALVGILISSFALALFHGLWGWVTLYLMASAILLLTVGIAIRLPYRSILDVTSHSENASGGYSV
>fig|1051632.5.peg.2526 Drug resistance transporter EmrB/QacA subfamily
MAVLNSTTLLIALPTLTRVLHMSTFLAIWVLLVYMVVQTALVLTVGRLSDVWGRKKLYVAGFAIFTVAALLAGLAPNGLLLLVIRGIQAIGGAMVMGNSTAIVTDAFPRHELGLALGINSIVIALGQVLGPILGGLLVTWFSWHWIFWFNVPIGIVGTLWAWKQLQDVVPPAREPALDYRGNITYIVSLVALLMGVTAGGIMGWTQPLAVGALLMGALGAMLFIRLEKTAAYPLLSLSLFENRVFLLSNLANFFIAMVRGAVILLFVFYFQGARGDSPLEAGLLVIPLAAAMGVIGPISGWLADHIGPRVPASLGALCVAIGFVGFGITLHRSTGYGLIAVWMILVGFGNGLFNSPNTSTIMGAVSPQSRGVAAGIRTMLFNTGGVFAIALVMALIASRLPSSVMMAVLAGETARISTSGLENLLLALRSIFLILAIIALAAALFSWIPARRQDPTPTVSRLSHTRVS
>fig|1051632.5.peg.2528 Permease of the drug/metabolite transporter (DMT) superfamily
MTAEAIIYTILWASAAIATKFGLMAGPPLMLAGFRFTFAGVILLIIRRITRHPLIPPRRWWRPLFILGALNTTVYLGASFVALTVMPAGLFNLFVATNPLMVLLVERFVLHRTITRNQWAGLILATIGLALGAGQSIWQWHTPIWSLALIVLGQTAMAIGSIYFHVRRIDLPNMAVNMWQLLIGATLLWPIALGTERTVPIHWNAEWWGALVWLIGGVSIGAMLFWFHLLRHGGARQASFWLLLTPVIGYILGWLLLHESFTWADLGATLLVIGGLILAQISIPAAPAETPSTNY
>fig|1051632.5.peg.2711 Multidrug resistance protein B
MDRKWVVALAFVAAMFMNIMDTTVVNTALPAIARQFHTTPAGADWVVIGYLLSLAVWILASGWLGDHWGTKRVFLAALAIFTGASWLAGLSQTLGQLVLSRLIQGIGGGIMAPVGQAMLYRAFPPAERARASMILTIPMVMAPATGPVIGGFLVDHWSWHWVFYINLPIGLITWIFSFRWLPEYRTFTQTRFDGSGFLLSALGLLLFVYSLSEGPLVGWAHPQIWLSGLLGVVLLIALLRIERQRAHPLVAVAALDNHLFRTSLAIGFFGRAAFLGILYVMPQFLQEARLLSPLQSGLTTFPEALGVILSTQVVGRLYPRIGPRRLMTAGLFGVALVIAAMTSLNLRSSLWEIRSLMFLLGVGMAYMIMPLQTAAFAQISHELMGRAAALYNAQLQVSGAMGVALLTTMMTSFGNGSIHQVNPYHLAFELGAALALLGSLSALWIHDHDALNTMTIKSQAS
>fig|1051632.5.peg.2945 Drug resistance transporter, EmrB/QacA family
MLAMALAAMDSTIVATAIPTIVRDLGGFSLFPWVFSIYLLTQAAMVPIYGKLADLFGRKPVLMAGTGIFIAGSVFSGLAWNMLALIVFRGFQGIGAAAIIPITSTIVGDLFTLEERAKMQGYLSSVWGLSAVIGPAIGGFFVQYASWRWVFYINLPIGLAALLMLGGYLHESVSRQAHRLDYEGAFLLMAAIGCLITALLEGGVHWKWTSPASILLLAAGLVGLALFVGQERRAPEPVLPLWVFRQRAISAANTASLGIGILTIGLSSYLPTFVQGVLERSPLVAGFALGMMSIGWPLASSLSGRLYLTVGFRATALIGSAVTILGSLGFVLLSPESSPWQAGLASFVMGCGLGLGSTSLLVSIQSVVAWNRRGMVTGSNMFMRQLGSAIGVAGYGGLVNARLSAAFHHPPATVASRLPHNLNAAGLALGRLASMPEAVSRYIRLALAGAIHRVFWGVFLVAAMTFLIEWALPQHLRKKRVPDPDRLRP
>fig|1051632.5.peg.2963 Drug resistance transporter, EmrB/QacA subfamily
MSEKGVIESRPTVSRPSTALSGRALWLSFAAATTGTFMVNVDASVVNVALPVLQHQFQLPISTLQWVITGYLLIITALLPMAGYLADALGRREVFMGGVLVFTLGSLASALAPNFSGLVAARVLQGIGGATIMANVMAIIALIFPVHERGRALGLIGSVVAAGTLAGPPLGGLLTAWYGWRSIFWINLPVGLWGLWGSWRYLPHFPPDPHASLQRFDWAGAGFFMATTSLLQFGLADLHHWTGLAFLAADGLSLAAFIRIESRNDHPLIPLRLFRVRAFSFNMLAGMAYWVLMMFPAFLMPFYLHTERHLPISWVGLSLVPQALAMIIVSPWGGRWADRRGIMGPGRTGLALFILADVLLASLPLSAPLWTIWLALAIIGVAAGLFSSPQNAAVLNSVTAHDTGLASSLLATQRNLGRAVGVALGSGILSLVWLLIGAGPNPSHTDPHYIHWLLIGIRGVFWSGIGFALIGLWLLTDPAKSPGSGGKA
>fig|1051632.5.peg.3316 Drug resistance transporter, EmrB/QacA family
MMTSRAKTWIVVSIMLAMMLTALDMTIVGTAMPSIVSDLHGVSIYSWVFSAYLLTSTTPIPIYGKLADMLGRKRVFMVGTGLFMIGSALAGVSQSMPELILFRALQGLGAAGVLPVALTIVGDIFTLEQRGRVQGLFSGVWALSAVIGPLTGAAIVEHVSWRWVFYINVPLGILVMLILWLAFHEQVESHGHAIDYPGTVILTAGVTLVLLGLLDTGTTREILLGIALVTLVGFVFWEQHFSEPVLPLSIFRHRMILLGNIMNFFGGIIMFGLISYMPLFVQGVQGQSPTVSGQAITPMMIGWPLAALSIGSLIKKVGYRVLGILGGTLVMLGTAWLGLVGDRTTLVLVGSMLAIGAGLGFSLTSLLIGVQNAVPWNLRGVVTGSTQFFRNIGGAIGVAILAAVFNEGLSRAISRAPRLHGLNTASVTETLLVPRLRDRLAPTLHQLLLSTLNHGLAAVFLTIFGIGVLAFVTMLALPAKPRAWDQEAETAPTEEVG
>fig|1051632.5.peg.3350 Drug resistance transporter, EmrB/QacA subfamily
MSSEAARAQGLRALWEALPSERFTTRPNYIWYVVGTVCIGAFMAAVDASIVNVAIPDLSRYFSAPASIVGWVLISYLLTLATLLTLFGRLADMWGRRPLYTFGFLVFIIGSAACGAAPNLLFLIVARVFQAAGAAMLQANSVAIITATVPANVRGRAIGFQGSAQAIGLSVGPAVGGALIGLFGWRAIFYVNVPVGIIGTLMAAMILPKDKLTNTGTQFDWWGALLFSPFLVSLMLALTWGPHLGWTSPTVLGLFLVSVILLVAFILREKGFRAPLVDINLFKLRVFTMGNLTGLMSYMVMFGVLFLMPFYFEKVSGYVSAVVGLLLTAVPIGMTVVAPQAGGLADRYGSRLLTTAGMGVTALGTLLLSVMMSLHADLPVLIVGLFLVGAGLGMFTPPNNSSVMGALPPTRLGVGGGILNMARSLGMAMGTAVSSSLMAIFLGIFGSHLVRGSKLVWIPTMRYALLALAIVAAVAAVLSILKTTRENASPQEKIEVPMEF
>fig|1051632.5.peg.3475 Permease of the drug/metabolite transporter (DMT) superfamily
MTKAATQATGTSPGKLESLGVVYGLAGVLVFSLTLPASKAAVGSFGVLIVGPGRALIAALFAALTLWTRHERLPQKKYLPGFIIISVGAVFGFPLLTAWAMDRVPASHGAVELALLPLATAAVSALRNGERPSWFFWSCSAGGAATVVMYTWFAGLGRIHLADLALIGAVIVVAFAYAEGGRMASELGGWQVIAWSVVFSVPALVVLLIADFSFVGVPDVWHATWTAWAGLLYLGIGSQFFGFVAWYTGMGMGGVARVSQIQYLQPFFTIIFSWVWLGEQLTIKTLVAAIVVVLWVAVGKRATVRRP
>fig|1051632.5.peg.3520 Drug resistance transporter EmrB/QacA subfamily
MQSRHTRKWWILSVVTLVAFVTNLDGTIVVVGLPRMIEGLHVSMTTGLWTLTSYIITSTVFLLPAGRWSDLIGRKKIFLSGLLIFTGSTFLCGIAPTGSFLLAFRFVQGMGAALALATATPIIVSTFPPQQLGRALGINSTSWVMGSIVGPVAGGLLVGTLGWRWVFFVAIPFALIGVVGSMIVLKDTASTPSVPTDWVGALTFGLGLLSLLLALSFGPKWGWFSTREVGLGLLTTLAFIAFIEIERRLPHPLFNLGLLAHPHYRSGLLITLSYSIGFFATTFLLTLYVQGALHRSPVEAGLLLVPLSAPQLVMGPLGGAWADRYGPSRLIALGIIGMAGGTFWLGHLSTAYRVWTIVLPLLLISASNGLAWPSLTKAVMSAAPRDKSGSASGMFFSFRNVGMALSLTVALVVAAASLPPALASQIYVGTGHVLNSRLAASLVHATNTGFQVFVGFYALAFVALLPFFRRRSDAVRPSAPPLP
>fig|1051632.5.peg.3714 Permease of the drug/metabolite transporter (DMT) superfamily
MSRLGAKIWLLGITLIWGATFTLTKGALTDVGVLPFLGARFGLAALGLAVLAWGRGADWSWPGLLRGAGLGVLLFGGYLFQTWGLTTIQPAMSGFITGLNVVLVPLVARIWLKTPIRSNAWGALGLAILGLAVLSGIHWQGWARGDGLTFVAAVFLAWQLVAVERWAASGATLSLAFVEIAVVAVLSGLGSRLTGQPVWSPDMLKGPVLRALVVNGLLGTALAFWIQTLAQQVLPAFEAALIFMLEPVFAALVAAWIGHESFSWRTIVGGAMILAAMMIADPEWRQWWKVRHHLSNTST
>fig|106370.11.peg.719 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MHHRHGPAIGAGTTTSDRQDAGPGRRWAGTTTGSHTDVSVSAIHRPEHPQAGTPVQAASGDGVAAVGPDAPYVTIVLPCYNEQDHVLLELERITAAMDASGYSYEVLAIDDKSTDNTLAVLREVAPRFPRMRVMPFRRNGGSGTARRIGTQEARGKIVVWTDADMTYPNERIPEFVRYLDDNLDVDQVVGARRTEEGTHKWARVPAKWFIRMIAQRLSGMKIPDLNSGLRAFRRDVSLPYLRLLPPGFSCVTTITMSFLSNQHPVDYIPIDYAKRSGTSKFHPFRDARRYILQVLRMVMYFDPIKVLMPVALWIMGLGFVKLIVDLIRYDFHVATSTLLAILVGFQIVVLALIGDLVARSRSDT
>fig|106370.11.peg.1227 Drug resistance transporter EmrB/QacA subfamily
MAAQTQAPAAAGGGMTGGSGDRLDPALIRLAGIVLVGAVVVQLDATITSVAINTLARSFNVGISTIQWVSTGYLLALAMVIPVTGWSAERFGAKRMWLLSLVLFLVGSALCGAAWSAGSLIAFRIVQGLGGGLLLPLMQTIIAQAAGPERLGRLMAAVGVPALVTPVLGPVIGGLIVDDLDWRWIFFINVPVCLIGLVLAWLGMPDVRTPGRHRFDALGFALLSPGLAAIVYGFSVAGRQGDFTGVRVIVPLALGAALLVLFTVHALRTAVEPIIDLRLFRSRAFAGSSGMMFLFGISLFGAMFLLPLYEQQARGRSAAAAGLLLAPQGLGMMIALIVLGRVADRRSPRLFVLVGLLLSALGSVAYTQVAADTSEVLLGVSLTVRGIGLAMALIPVMSSAYHGLRREEIPRATSAGRIFQQIGGSLGTAILAVVLSHQITGRPAGTGPADPVALAGAFGTAFWWTLGSTVLAAPFAFLLPGRPAGAEQPAPSGPPVELPRPAGAVPTRRRSGDHGELKSHETSPGRRAAVSGAEGNRHDGREYRVPAPRGGRGGGQWRG
>fig|106370.11.peg.1834 Tunicamycin resistance
MLVCPCLTILRLVPTLIWINGPNAVGKTQVAHNLHRRLPGSFISDPEHLGFAMRRMLPKPRRMDFRDVPLWRQAVSEMLHLALQGPEDPVIAPMTILDPGLLGELTASARAAGHRVEHVTLLADRTTMIRRIHRRGETSRSFSARQLDRALDVLRAPEFARHLPTDTLSISAVADDVASHTGFTLSPDTSGRLVRQGRQLAVQLRHIRLNA
>fig|106370.11.peg.2262 Drug resistance transporter, EmrB/QacA family
MDPGVRTSASRNTLMSLLAHERARPRAVRDLPGGWWLAVATVCFGAFMGQLDASIVTLAYGPLCAQFHAPLAAVTWVSLAYLLTLVALLVPVGRLADAHGRKQFYLYGLLVFTATSAACGLAPSLAALIGSRVAQAVGAAMLQANSVALVATSAPRPRMRAALGVQAAAQALGLALGPTLGGALVTTLGWRWVFAINVPVGTIALIAGYYLLPRTRQRTDPAPFDWPGLALLATATTTLLLAISAVSGLNLPSAATAILAILAPLAGYGLVQRERRAPAPLIDLRLLRIPALAGGLVGALCGYLVLFGPLVLVPVVLTDRGTSPLHAGLVLTALPGGFALAASGAGAVLPDRWSDRRRYALGAVTCTMALAAALAVPLSAPWLIPPMAMLGLGLGVYTPTNNTTIMSAIPAHASGTGGGLVNMTRGLGTALGVAMVTLAVHLAAGATGPRLAIVGLTAASLLLFTPLLTPSRGMRNIGTENSARC
>fig|106370.11.peg.2344 Drug resistance transporter EmrB/QacA subfamily
MIEPGPAAVAGQLGQRQHGHREAQPEQCGKHRQEQHAAADAANSVSPGVELRFLAAEPALGLGDLHAFPGPHPQTRGAGGELLLPLGIFRDRNFALSNVAVAAAGAAVPAVLVPLYFYLESVRAMSGADAGLVVAPMAILAMVCVPIIGIFGDLIHPRVIPSAGFALFAVTLMIFAMFMTPDSVIGCS
>fig|106370.11.peg.4107 Multidrug resistance protein B
MTRPEAHSGSADGPNPSNDLEQAGPSLVPLATTLIVGAFAALLDTTVVAVAIDTLGRDLQADITVIQWVTTSYLLAMAAVIPVVGWLVDRFGARAIWSGALGLFLAGSVLSGLAWSAGALIAFRVLQGLGGGMILPLTQLVLARAAGPQHFGRVMGVVGLVGQLAPISGPVLGGLLIDTWGWRWIFFVNVPIVVVSLLMTTRWFPREDPRTERSLDVVGLVLLPTGIVAMIYALSNVESGSTVVSAQVLVAALVGVALLAAFVLRPTTPGRPSLIDLRLFGDRSFRGGSVMLFVFGVTSWGPMFVLPLYYQQLRGLSALDAGFALAPQSVGLGLAYLATGRYADRLAPRPLVAGGLVVASAGTLPFVFATADSNLTLLGISLFVRGIGFGAASLPASAAVYRTLRTADIPGATSASNVIQRVGAATGTAVMALILQADGFTPALTWMFVLTSGALAGTVFLPGQKPAPAPRDTVPTTTATGAQ
>fig|106370.11.peg.4468 
MASERRDGGRPAGAVLEVARFDIKPGSEDDFVAAYHGVRAELVGTPGCRSARMTRGVESPSSFVLLVEWDSLDAHLTNFRESERFVRWRAALGPYFDGTPTVAHSADVPAAPGPA
>fig|1069080.3.peg.215 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFLQENQAIKAENHLMEPSDKEHTQLEIPISLINLLRFASPAIIMMLFIASYTIVDGIFVANYLGTEALAAVNIVFPFSSIIFSLAIMLSTGGSALVGIKLGSKAELQAKQYFTLLLVSAAGAGICLSAGALIFREQILSFLGAEGATLAYAQTFFTITASFAPVVILQILFENFFITIGKARVALGLTIVAGLVNAALDYLFLAVWGWGIEGAALATAAGSFFPVAYALYYFTNQQQLLAFVKPIWEWAIIKQACFNGSSEMISQLSGGIIALLFNIILLKLFGIAGVAAVSIVLYSEFLVLAIYSGFSMGIAPLLSYNYGGKERLKIKKLVRLALGIVLLLSSGIYVLLNFFTGNIVALFVPINSEVYILAKQGLTIFAVGYILAGVNIFAAAMFTAFGNGRISAILAILRTFVFIVLGLYVWPKIISGIGVWLAVPCAELLTIIFTIYYLQTNRKRYSY
>fig|1069080.3.peg.352 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKLSFAVASKRILQFMLPILLTMLTVAGMNAIDIIMSGHASTADLAGVSVGNSIWFPIYTGFNGVIIALTTIIAHLLGQNKPQEVSTALKHGLYLAILTGAAIIFFINLIISNINYFITIEPYVQEVAVGYIRAISWGVIPLCLCNTLRQFIEALNFARIISLVYLSALPLNALINYGLIFGNWGLPKLGGIGAGYATSITYTIICLILLIIITQQQPFASYRIFQIIRLDYRIFFEQLRLGLPIGFSIFLEMSIFSLTALIISKFGTVTIAANQAAFSAVTIIYMFLLSLSIALNIIISYELGANNPVTAKQFAHYGLKFSLFLSLAVIVLLFFTRAQVAALYSNDPTVQILIQDFLVYVLFYQLADAILTPSQGILRAYKDVNMAFYIALISYWLVCFPIGYILDNYYNFGAVAYWNGFVCGMSVGALISLYRINYLQKTSLPKI
>fig|1069080.3.peg.506 Permease of the drug/metabolite transporter (DMT) superfamily
MKPRDLFMALLIVTIWGANFTVIKLGLADIPPMLLAGLRYVFATLPAIFFIKRPNISWKYLALYGLTVGIGQFSCLFYALKIGMPAGIASIVLQAQPFFTVIFSAFLFKESLYRLQILGFAIAFTGLYLIGGDTSGVPLPLAAFLLTILAACFWSISNIVIRYSAIEATQKQEKLDMLAVVIWSSLLLPVPFFLLALLFNSPQELLSVVTNLKPSSLAAVLYLALGATVFACGMWNILLSKYSPTKIAPLSLLVPVTGLITANLVLGEQLSFWQTLGGIIIILALLVLNFKSLPWANAFKAK
>fig|1069080.3.peg.597 Multidrug resistance ABC transporter ATP-binding and permease protein
MQVYGKYIKKYRVPAFGAMLCVTLEAGCDLLGPTLMAKIINEGIIAHSMAEVTKWGGMMLLITICGAFFAITRSILASTVSQRIGADLRYEVFKKILNFSEASADKIATGSLITRMTNDINQLTQFINGMMRIFIKAPLVCLGSIILATLLNPQLSIIIYGFVALVATVIAISLKLSYPLYAKVQQAIDRVNSVVQEYLLGIRLVKALGTYNEETERFEQANKNLEQRSLASQMIFMVSGPLIMLLFGTATTGVLYWGSSLFAKNLANPGEISAFIIYMTQMLIAIMMITSIFNVFVRTKTSSERILEVLNSEEDFSNSGIEQKLQGSIEFSRVSFAYPNGSGLLALRDVSFKINAGENLAIIGPTGSGKSTLAWLLLRFYQANQGKILLDGVELNSLAVHNLRSQIAIVPQKSLLFSGTIEENLLWGNMQADKIQRQRALELARADFVQEFPAAEQTVLGSRGVNLSGGQRQRLSLARALLKQAKILILDDATSALDGVTEAKVLKNLQTVASNHTVIIITQRCSTAMAAGRILVLDEGEKVGFGTHSELMQQCPTYQEIYKTQIESNKVS
>fig|1069080.3.peg.813 Vancomycin B-type resistance protein VanW
MQCGKRKFYGFVALITLVTIFFVASVSFDIGEQIVENIRIQNVAVGKLTRTQALQELKQQIRKPVLKLSYKNKNYYITPEDIAYGYDYQASIEQVYQVGRIPQENIYQRYVDIYYTRQYGRSYQLVCTYDKELLHTKIQEIIREIQIQPQDAKLIGSTQQNNLQVEQIGVLVEAYGLYYQILEALHKGQDCEIRIETLNFLPGRYAQDLVKFKKMLGRQSFSSDEADLALIDCLDGIVWKKNTSISWQQQLNRIEKSTNYSIPKGNSQLMLEGFYQLSQQLQLFSERISLDEAGKLIVQKGNLDLIIRNNSNQDIYISCYKERNKIYLEFWGEN
>fig|1069080.3.peg.1269 Permease of the drug/metabolite transporter (DMT) superfamily
MTHYHPFVCMAYIFIWGTILLLPLMLVFNAFQPLVFNFFQPPNFSLLGILVYLGIFSSVYSYFIWYKAINTIGAVKTSVFMYLNPLISTITGAFFLSESLAITTMIGGACILCGVYLVNKNK
>fig|1069080.3.peg.1287 Broad-specificity multidrug efflux pump YkkC
MLILSSFLLLIRAYKLIPVGIAYAVFVGIGTIGTYIVSIYFFNEKLSFVQFIFLFLLLIGIIGLKITTQEVKK
>fig|1069080.3.peg.1288 
MAWLFILIAGLEEVVSVMAMKYVDGIKNKKPIAIMVIGFILSFFLLAQAMQEIPTGIAYAVWSGIGTIGITLVGIFRFKEHLNSGQILFLALIIFSVLGLQLSV
>fig|1069080.3.peg.1340 Permease of the drug/metabolite transporter (DMT) superfamily
MQENQLAGHLSVFITILIWGTTFISTKVLLVDFTPLEILFFRFSMGLLALMLIYPQRLKVTDNKQELYFAGAGLCGVTLYFLLENIALTYSMASNVGVISCIAPFFTALFSYCFLGGEKLRANFLLGFGAALFGISLITFNSSTSFQLNPLGDFLAVLATIVWAAYSIFTKKISAYGYNTIQMTRRIFAYGLVFMLPALFFLDFRVGLERFANPVNLFNIIFLGLGASAMCFVTWNFSVKLLGVVKTSIYIYLVPVITVVTSVIVLKEQITLLAIVGSVLTVSGVFISDSQNGLKLLANLVRKR
>fig|1069080.3.peg.1483 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNISKSLATLLVLTASIAYGTLSTTIKLAYKAGFTVGEMVFGQIFLAFLFMFCFALIKDYKFLGSIKPKTILILIGAGSISSLTTIFYNLCLQYISASLAIILLFQFTWIGILLDYIFNKVKPSRLRIIALLIILLGTYFALNISYQALAVNPLGIIFGLASAFSYSFFIYFSGNLATNIPIIYKNSIMLSGSLIISLVFFPPIFLFTPSVIPISFYLYSSYLAVLGMVLPFYFFSKGVPIIGTTSATLIGALELPTVLIGATLILGEKIVLHQIIGICLIILGIFISTRTKIST
>fig|1069080.3.peg.1765 Fosmidomycin resistance protein
MSVKYNLPILLLAIAHLVTDLTQGAVPILLPFLKEKFLLNYSQVGMIVLVQNLTSSVIQPLFGYYTDKISIFWLLPASVLVATIGIVLTGYATSYSSLLFIVIITGVGVAAFHPQASRSAMLLSSADSKGKNMGLFSVGGNLGFALGSIIMSVLIVLPGDLYNTVYFLIPGILVFAWLMQARGQLDTYTKVGSKGEKIKPAAKVAQAYYYLLMLISFIFIRSTIQMGITTYLPLYYIENLAGEPKYAANLISMFLVFGVLGTFLGASLSDKFGRKKIILASMVITLPLLILLPYSSGLSTIVLTAVLGFALVFSFATTVVLAQELLPNNIGMASGLTIGFSIGLGGVGVTALGFLADNFGLEIVFKLLMFLPLLGLVLVSRLPNDQK
>fig|1069534.5.peg.148 Multidrug resistance protein B
MMNAALIDGSDLSDIDDFAKKYDGKVSAKEKYKYVGRTVKERVKNFKRDNTGFSCSTDYKKGKLVWFSVPYDKGWDATLDGKKIEIIKSAGMMAVKVPKGEHNLVFKYHTPGFKLGIIVSIISFIVFGIYTAILVFRKRIN
>fig|1069534.5.peg.616 Multidrug resistance protein B
MTTKKKWHVMPAVVSTTIMSFCGVLIETSMNVTFPTLMKQFGIDAGLIQWVTTANLLTVAISIPLSAYLIRNVSEKNLFVSSNLFFLLGVILDSIAGNFELLLAGRILQGIGTGLALPLAMHIILEHVPLEKRGFMVGVATMTTCFAPAIGPTYGGIILHHFDWNKIFLFLVPILAISFVVGIMSIPQRKIETKTGFNFGGYFFLALGLALLLVAIERFSLWLLLLSIMALLMFYFSNKKKRLISLNVFSNHRFVWFMYGALVTQAIALGISFIFPNYLQIGLHQNTVTAGLFMLPGATFVAFLAPVSGRLMDELGYFKPIVFGMTLASLGLAFLAFVLPNAGVKLLLCGDVATKIGMGLATSSLVATSLSQLEREESIDGNSVLNTLQQFSGALSTTVVSVIFGWAQKTMSNGSMVGSRISIVLILAITLIALGLVLKLKFEARS
>fig|1069534.5.peg.624 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSILMSIMQLIVIPVNGITQGVQPIISCNYGAEDMLRVKETVVRLVSVCLLGTLILAGVAIFCPGIYASMFTNDAELVALTCRIMPSFFLGIAIWVIRAACQATFLALGQANVSLFIATLRKIILLIPLALILPKFSGVKGIYIAEPVSDVISVIVTVITLKRIFIEMEDKS
>fig|1069534.5.peg.639 Ribosome protection-type tetracycline resistance related proteins, group 2
MLNNLLCYNTFRQYERSDGTLFPQTTLKHIVTGIIAPVDSGKTTLTEALLYKAGELKKLGRVDNGDAFLDFEELERKRGITIFSHQANLTWKNLQLTLLDTPGHVDFVSQTEQVLRVLDCAIMVVSARNLITSHARTLWSLLDFYHVPTFVFVNKLDLSDLSKADIVQRLKQLDQGIMAFDGTETEELAELDDALLEKYLENDSIDRTDVLALIKQRKAFPCFFGSALKLEGIDALLQGLADFAPELESRNEFSARVFKISHTEKNERLTWLRVFGGSLHPKDMILDDQKANELRVYDAKRYGAAKEIVAGQICAIPNLNETFVGQGLGFLENDAASCMTPVLSYALNPNGCDLHACLVALKELEDEDEHLHVVWSKQLNELRVQLMGPIQLEVLQQILKDRYELDVSFEQGRTLYKETITQTIEGVGHFEPLRHYAEAHLIMEPGKPGSGLVFSSDCSLEELDKNWQNQILSCLKSKEHLGVLIGAPLTDVKITLATGRASIKHTVGGDFRQASGRAVRQGLMMLKERHGLKLLEPWYRFVLKVPEEKLGRAMNDIQQMSGTFSLDQASGTLSGLAPVSEMQSYAETVRTYTHGKGLLELSVDGYRQCHNEQEVVSNSSYDPLSDLENTPQSVFCAHGAGYTVDWSDVPKMAHVPYRSS
>fig|1069534.5.peg.1059 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSDLRTFMNYVIPSVLSFALSGVYAIVDGFFVGNTMGDIGLSAINVAYPITAVILAVGTGIGMGGAVQYSISSAQNKPKKAMNFVNGTLWLLIVSSIIITLSAGLFPEFFVSLLGAKGTLLEMGTIYIRVIALGAFLQIGSTGLVPMIRNYGGAFFSMVAMISGFVTNIILDYLLVWVLNLGMTGAGLATILGEGLTFLLAMIYLLKKSSISLKIPLSIIKKISGPVIRVGIAPFGMSLAPNISLVIINWFSIKYGGDRAVATYACISYVICVIYLILQGVGDGSQPLMSRYYGAKNLHKLKITRDMAYVFSLILALLGCFATFYAKGAIGALFGTSASVNAEIEKIIPIFLVSVPFVSISRIATASFYATEKTAFSYVLTFIEPVLMLILMLILPPLFGGQIMVWWSSVFARIISAILAYALKLVVEKSEKTQLS
>fig|1069534.5.peg.1210 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQRTIDTVQSMEKGSLFLASTSHLPQRKMKTLTKGNPIKLILLFAVPLLIGNLFQQLYSLSDTIIVGQTLGVDALAAVGSTGSIQFLIIGFAQGLTAGLSILTAQYFGAGDYQKVRQSFVTSIVITVIVTVLLTIFSLTFVGKILELMQTPAEIKNDAQTFISVIFASMVVLMAYNLLSNIIRALGDSKTPLYFLIFATIVNVILELLFLLVFHWGIAGAGFATVLAQGISVVLCIVYIIRKLPLLQIEWKDFKTITKESLGKHLYVGLPMAFQMSIIAIGAVLLQSALNGLGTTAVAASTAGGKIDQLATLPMMSLGVAMSTFTAQNYGAKKCGRILQGVRQTIIVSITVAIIGAVLIIIFGKQLVTLFVGNQAPAVLKLSQTYFNITCTFYWVLGILFVIRYTLQGLGQSIVPTLAGIAELVMRSSAALFLAKALGYAGACCANPMAWAGSCFVLIPSYVKSYKMLKQREKEQDNKSNEESGTEF
>fig|1069534.5.peg.1436 Permease of the drug/metabolite transporter (DMT) superfamily
MTDKEQHKEIFKKKNLILLILFAVFGMVPSQLTFFLAIRYGNAATATILQFLGPVFIIVCLAIQYRKLPRRIDVISLMIAVLGTILIVTNGKIGTLALSAAGIFWGIMAGVSQASYTLIPRRLLEQFDARLVTGLGMVIGSVLFWPLILTTKIPSITPFTVGSFAYIIIFGTMASYLCYLQSVKYIPASTTGMLSAFEPLTANVLSVIWFHETLGAFQTAGAVLILSTAFLQAMALKGK
>fig|1069534.5.peg.1438 Permease of the drug/metabolite transporter (DMT) superfamily
MSKRNQGIMLAIIGTMFWGISGPFAQALFAQNVKPLWLVGARLLLAGILLSQVLICV
>fig|1069534.5.peg.1912 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNDNAVMTEGSYKKKIVYFAIPIFFGSLFQQMYSTADSLIVGNFLGSSALAAVSSSGNLIFLLIGFIQGLTIGCSVVIARFIGARDHKMTSLAVHTTVALGLVSSLVLTLVGIFLAPQILRLMSTPEEIMDQSVEFFRMYFLGSAGFVMYNTLVSILQASGDSKHPVYYLIIASIINILLDLLFIGVFRFGVGAAGVATSISQTISALLALHQLMTQSGSCRVDLRKIRFQPQILKMIIKFGLPSGLQNSIIGLSNVIIQSYINFYGKNAVAGIGSYCKVEGFAFLPVTCFTMALTTFVAQNLGAKEYQRIRAGVRFGTICTLVLAEGLGILLFVFSPQLIGAFDSTPAVVSFGVARAHVCGPFFFLVAFTHVMAAVMRGAGKAMIPMIIMMICWCAVRILTLYVVGMFYQTIQTTYWVYPLTWMLSSLAFLLCYRRLDFTKL
>fig|1069534.5.peg.2097 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIGIPASLTNLMQSYNMTIINRYLIDYGSKAVAAMGIAIKVNMIIMMIMVGFAFGAQPLIGYSYGAKDNKRLQKIIRFDLLVEVGFSALAAVFIIIFAPHLIGSFMDDSAVVAYGTGMLRWFTLTTPFCGIVLVLTTCFIAMGKAVPSFVLSISRQGVIFTVVILITAACFGYDGIICAQPVADFLTAVVGIFMYAAARKSDQTLRKED
>fig|1069534.5.peg.2098 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENKQELFEKAPVWKAYFIISLPVVFSMLVTLIYNMVDTFFVSGTQNADLVAGVSQCTPLFTLMLALGDIFGLGGSSIISRLFGQKDDATAKNVSGFCFYAAVISGLIVTGLMFLFQTPILKMLGATDSTVKYASQYYFFIAWGAPLIILSLTPSNIIRTEGLALQSMIASVAGSIVNIALDPLFIFTFKMGGLAVQRLQR
>fig|1073972.4.peg.245 Vancomycin B-type resistance protein VanW
MYKILKTYKNLRLEKSISSVIFTILIILSIVFPISFVNYRISSLVNSWEGKVYSGVTINNVDVSGLSRSALKDFLVEKFSGSITNDIVEFRLNGKGIDIQSNELGITYDYDRAIDEAFSFSDGLTYTQKVNQILNPQKIKDIKLNEIFDISDYQVESLYNKLSNRFNVDPINAEISIVDGQPVIVKESYSSIEIDKESLISMISDTDPSSAFQNGMNLSAKSLNSKYTSDILGKINGKLSSYSTSYKSSSSERATNVELSASFINGTILMPGESFSFNRIVGQRTRERGFKDAAIIVGNVYESGLGGGICQTSSTLHQAVVRAGIIPTQRRNHSLPTSYMPLGFDAAVAWGSLDYVFKNTYSFPILIDISTEGRNLTVSIYGDVTAVDKTYSTVAETQESIPYSTKYVNDNTLAKGTQVVQKNGVNGSKVKVYLVSKDKKTGKVIEKKHVWNDYYAPQDKVVRVGTK
>fig|1073972.4.peg.380 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGTIQLSDKFNYKKLLRFTFPSMIMMVFTSLYMVVDGFFVSNFVGKVPFAAVNFIMPVLIILASIGFMFGSGGSDLVSKILGEGDQDKARRLFSLIVYSTIICGIIIFIVSFIFIESIVSFMGADGEMLENCIIYGKIILVALPFYMIQFEFQSFFITAGKPHMGLITTVVCGVTNMILDALFMAVFSWGIVGAAVATTISQILGATISVLYFCRPNAGVLRLTKTKMNAKALLKTCTNGSSELMSNISLSIVSMLYNFQLMKYAGENGIAVYGVLMYVNMIFLSIFIGYSTGVAPVIGYHYGAKNYSELKGLLRKSCIIICIFALIMFGLAESLAGTLASIFVGYDMELMGMTERAFKIYSISFLFSGFAIYGSSFFTALNDGVTSALISFLRSLVFQIVAVIVLPLIFGIDGIWFSVIAAEIVAVLITVLFIIGKRSKYRYL
>fig|1073972.4.peg.441 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKIFFKYSISSMIAMLVTSLYTIMDGIFVGRGIGDTGLAAVNMVLPITIMYFGLATMIAVGGGSLVSKSFGENNEIKAQNIFGQTIRLIVLLSLFLSVIALFGCHKIMYLVGARDEILYYSSEYLKYYSLFCSFNLIGIVINSFVRNDGNPKLGMIANIFGAITNIVLDYIFIFKFKWGIQGAALATGIGQIMTIIILMNHFIFKKGALRFKRASFNSDVLKSIVMIGFPSFLAEITFSMIIFFYNIALIFFVGSKALTAFSVINYINSNIYMVLLGMNFGVQPLISYSFGEKNGKDMLKFYGFSKRFGFSLTFIYVLICLIWGNNLIKIFTSDLEIIRIAYFGLNVSNLAFFILGINLTTSIYYQAMEIPRYSNVICIFRSFIFLPISLLILSRLFGLTGIWMSLIFSEGLSLLFINFVVRVKRITEKLIFN
>fig|1073972.4.peg.1181 Multidrug resistance protein B
MNKSNRQFTKIFLLNMIVYISLTMVHPITPKFINENNLPTFYFGLLQGCLNISTFISAPTFGIICNIYGKKITMLISLIGYTIGQIIFGFFPNNVSVIIARIISGIFIAGYFVSSMAYVSSITPVKLKLKKISYFNASNSIGVILGSLIGGILGINDYKLTFFTQISISLLSIILITILFKDNTPKNKDSKFTLKILNFKDLSKIKKSNKFVYLILLIMILTFLAIQGYASTISYYVEDILNLPTSINGVILGSSGMFTLITNLIIIPIVGKKFNSKSLYMFSILLSGSSILIAMSVTNQYITVIALLIFIITHTLITPTIQTLLLENSTQNQGEILGIQNGFKAIGSFLGSILSGLLFNVWFKLPFIVIGLSLILSFIILKSFKEKSPHH
>fig|1073972.4.peg.1328 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRMDLLNDDLKKIFIRYLIPGILSSLAISLYIFVDTMFVGIGVGRDGLTALNVTVPLFTLFTSINLCIGIGGSNILSLNKASGGKDSNKIFTIAFLFTIMIGIIISVLGVVFTDQIGKVLGATPDISYLFRDYFRILVGFTWAFLISGVLGCFIRNDGAPKLVMTATVVANITNVVLDYIFIFEWNLGIKGAVIATVISPIVNILILSTYFFKKNSNIKLCKVRFDFRLLSRILNNGFGTFLLEMSRGISIFIFNNILVRLGGNIYVASYGIILNVSYVIICIFSGIAQSIQPIVSMNYGHNSIKRTKTVFRYGFITSIFIGVSSFLIALMFSENISSLFINNDFELLSITIYGMKIYFIGCIFMAFNIVTIYFFQSINQSQKSILISLCSGILFIILGFLILIPILKINGVWFVYPFSEFLGCIVCLLIIKRTNIENKKELIL
>fig|1078846.3.peg.1897 Permease of the drug/metabolite transporter (DMT) superfamily
MPSNQSPAEQRNQMTGFALVLLGAFGFSAKAILIKLAYAADVQIDAITLMALRMLFSLPFFLVVAFWNNAASVAAPMTGRQWLLAIALGLTGYYIASYLDFLGLQTISAGLERVILFLYPTFVVLLSALFHKRKISLRVGLALVLSYTGMLLVFMEQLSLASANILLGSALVLASAVTFAIFTMGSGVMTHSIGSTRFTAYTMTVASMATLAHFGLRHGTEIKHLSTGVYVLALVMAVFSTVLPSFFMNAGIRRIGASSASIISTTGPIATLALAFFILDEAITGTQLAGTFLVLAGVYVVSKK
>fig|1078846.3.peg.2020 Permease of the drug/metabolite transporter (DMT) superfamily
METTQSICGTCLVLIKRAYFLAFLAMMAIAGNSLLCRLALKHAVMDAASFTTARIMASALMLISICLPRLGRYCCLAP
>fig|1078846.3.peg.2397 Acriflavin resistance protein
MHDSLVLLDSIREHEGSDKPITELIIEACTSRFRPILLAFLTNFAGFLPTLLETSPQAQFLIPMTLSLSAGLLFGMAASLVLTPVCYAMMGEK
>fig|1078846.3.peg.2842 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTIRSKQLVALTLPVALSAMLDNAYRVIDQHAVQWLGVEAQAAIASCTFILIAYYAIYSIISAGTLSLVARAVGAGQAAGQKQLMGNALAGSVLLGSMVLALSGLYAPVLTNLLGLSDSVADQASMYLRWHAVYCLPQAIMPTLNAILIAFGCTRTVLLLQIIATVLNILLNPVCIYQLGYGIGGSAMATGLSQAVAAATGLVLLRRTTPFRWSDLGLGRPVLKIAKIGLPMCWGTMMFALVYGAMLHWVISPLGAPVNAALGIGFSALEGFTWPVFWGFSMGIASIVGRSLGAGNLNEAKQAIRLAFKLLTMAGLAVSGIFFFGATLLCGLFTQDALVLGEAVRYAQILAFSQLFVAYESLAEGVLGGAGKTHSILYWSAPLNLLRIPFSWLFAVYFGYGAAAVWWVIGASTLLKAMGKWWSVRSGAWQKV
>fig|1078846.3.peg.3002 Multiple antibiotic resistance protein MarC
MLNWNEYLQLLVGLLSVVNPIGIIPTFISLTTNRPPQERRHTAIVCAFSVAMVLFISLLAGEPILHFFGIGLPAFRVSGGLLVMMMGISMLSANNDNIRHTPEEKAESYEKDSIAIVPLAIPLLSGPGAISTTIVYAHGGQSLEHFLLVGSVILSVSVLVLAALLAAPKIADAMGRTGMNVVTRVMGLFLTSIAVEFIAKGLGELFPVLVKIFP
>fig|1078846.3.peg.3097 Glyoxalase/bleomycin resistance protein/dioxygenase
MDISGINHINIVVTSAQLPDVVAFYEQIIGLRQGLRAVSKRNGAWLYCHDTAIIHLSVVEQAPYTGKDTLFNHVALSCSGVTGWVSHLNRHAVHFDIDYRPSPEMTQLFLYDPVGIRIELNFAGERLEPSA
>fig|1078846.3.peg.3728 Membrane fusion component of tripartite multidrug resistance system
MMDTVKKSRHRFKNIANLLGDKAGGQLRQWRYRRNRRLLSVTLSAVLVGVVYWAYWQRHASHFVTTNDAYVIGNLVALKAQTSGTVVDVRVDTTQYAHKGEVLVRLDGLAAKVALEQAEANLAETVRQVETLSSTAERLRQKIAAQEAPLGRTRRDLLRYRSVAQEGAVSAQQIENTEFTVRELEAGIRQTRAELGGAEALIHGVALEHNPKVLQAASALKQAYLDKVRQNIVAPVSGYIAKRHIQPGEQVHPDTPLLAIVPLDYLWIEANFLEDELTEVQPGQAAEITVDLYGSEIVYHGEVLGIGAGTGSVFGLLPPDNATGNYIHITERVPVRISLRPEELKAHPLRPGLSAVARIDTRQKGRSVLQPFTATPPESYRTDVYDTQLDGAEALVDKIVKGNRAMARAPV
>fig|1078846.3.peg.3730 Inner membrane component of tripartite multidrug resistance system
MSLDDDNTRAAWAPLTHDSLNAELAGKSSLGASQFVLLNFALLLGNVLVLFNTGAFASISLHATGELGVSPSHASWIQTYYFISLAIALPVSAWLAARFGEVRWYLIAMLAMALGSLLCSLAHDLTWFLLGRALQGFFGGLTIPLSQTLLLREYPESKKAFGISLWSMAALSPFTLGPLLGGWIADNLGWHWLFYLNVPLPLLSAALVWALLSDRVSVRSLRPFDTMGFVLLAIALACLQTALNQGQDEDWYNSAFIVSLAIAGVLALVYFIIWELGERYPLLNLRLFARRNFAIGTIGLSVSFLLMYGLLSVLLVRLQSVSGYTSFLAGAVLVPLLFFAKPMAGFFHLIVHRYDARLLVCLNMLSFALFCYMTSTYDFFQRNSWFTHTLWSQVLEGFCLGGLFVPMTTLFLSGLNAKRQTQAVELGGILRILGGSVASPLLGVLWERRTAFHQSHIVQTLGTYDALGREALTSLDTAGFHGQLTIARLAQAANQHAAILGLDDAFRLSAWIFLGLATWVWFAYPVKPITKMGKKERLRENALESLVEEP
>fig|1078846.3.peg.3768 Permease of the drug/metabolite transporter (DMT) superfamily
MRAKVWAALLAVYVVWGSTYLMIRFVVETLPPFLSAGLRFLVSGVILLGWRCLAGDAVPTLRQWRSAAIVGTLLLLGGNGLVCWAEQTVPSGVAALIIGTVPMFLVIADALRPNGTRPSLRVLAGLVIGFLGIYLLVGPSAISNGMPLNGPGVAALLLASLLWAAGSIYSKNADLPETALMTTGAEMLCGGFALMTVSALSEEWGVFSFAQVSASSWLALAYLILFGSMIGFASYAWLLQNASIPLVATYAYVNPLVAVFLGNWFAQEPLTPRILSASAIIIGSVIFMNSSYRGKPAATQGAGK
>fig|1078846.3.peg.4001 Acriflavin resistance protein
MSIETKKDSLTVAIVRLFTTSHLSLLFLIISLLAGAAALFLTPREEDPQIIVPVMDVFVQVPGASAEEVEKQVTTPLETLLRQIQGVEYVYSASRPGESVVTVRYLVGENLENSVIKTRDKVLANQDIIPPGVTNWLVKPVEIDDVPILMLSLSPQRSDMEATDLRRVADELVERLREVDNVGKSWVVGSAPRRISIYPDPAKLQAGNITLLDIQQALAKNNVNLPVGTLTEQNKEIILEAGPHYQTAEQIGGTVVKVVEGRLLTLRDVAQIIDGGADTDTYTRIGFGPAVAHMQTAGEVAKLPAVGEERPLTTIAIAKRKGSNAVSVAEQVLTVTEQLKGTLIPDDVLITITRNYGETADHKVNELVMHLSIAILTIIVLLALSLGFKESLIVSLAVPMTFAVTLLCDYLFGYTINRVTLFALILSLGLLVDDPIVDVENIHRHYKLRKEPPLQALLSAVDEIRPPTILATFAVIMSFVPMFFITGMMGPYMAPMAFNVPVAMLMSLVIAFTVTPWASFKLLKGDYGKDHGEAFDLKTTRGFKIYQAIVAPLLASKAKAWLFLLIVMIAFVASAMMAVTRIVPLKLLPFDNKNELQLIVDMPKGSSLETTDEVAAALGHYLATVNEVSSYQSYVGLSSPMDFNGMVRHYYLRQGANVGDIRIVLADKKHRDQPSHNIALRIRPEIERIAKQYGANIKIVEMPPGPPVLSTLVAEIYGPPEASYADLLHVAKRVRGDIEKTAGVVDVDDFAEAEHGKLHYLVDHDKAALLGISTAQVAQTLQLAIAGGSVGVLHIPQERQPLTIQLQLPRAARSSEADLLALSVQTSNGQLVRLSEIGSFKHEQGERAIYHKNLQRVAYVTGEMAGRSPVEAILDLFGTFDEKPLPDGYKAEMAGEGEWKITVDVFRDLGLAFGAAMVMIYVLLVGQTGSLGVPLIMMIAIPLTVIGIMPGFWFINLFTEPVGGYATPIYFTATAMIGMIALAGIVVRNSIILIDFIENIYRNNPLISLADAIVEAGATRLNPIFLTAASAVLGSMMIVLDPIFSGLAWSFIFGIIASTLFSLVVIPVVYFLIKRNMPKQIIQEQ
>fig|1078846.3.peg.4649 Inner membrane component of tripartite multidrug resistance system
MENHQADPHVTSIKRRLLLGRIIGTLIVLGALMTGTLAWRINYQHPRTNDAMIRANIVGIASEVGGRIVELHVEDNQYVKKGELLYVIDPRPYLARLAQAKAELLLAEKEVDSRRASSGSAELAIARLEHQRAAAEAEANRIEAEDEYLHNYLERIEPLAEKQYVTADQLKQARSKYAASRAELADARAKALSAQSAIEEAKSESRRAVSLIAQSGNVNARIEAAKAVVTAAELDVEYCSVRAPFDAYVTNLNTREGEYTKAGAQLFALVDDRHWYAIANFKETYLQSIRPGQEAEVFLVAYPGKRYRGVVTGIGWANSPDNIKQQGVLPEVQRTLNWVVLASRFPVRIEINERDPEHPLRMGMTAFVTVLDRLAEIPKPLSAKEDIANTPPIPQ
>fig|1085623.3.peg.424 Acriflavin resistance protein
MSNVQNKSPWYTTFFRSGHLLVLSIIIILVAGLSAVSSLPRLEDPRIDLRNVLILTSYPGASPERVEALVSDVLEDELRELYEIKEIKSTSKAGFSSLLVELQDWVDDSSNQQIFSKIRDSLENASAKLPVGASKPLLEDKRGATAFTMLISIDAANPDTTSLSVSGRLASELVDRVRNVPGTELVRLYGHPIEEIVVALNPQALAAAGLSIAQVSDRIRSADSKLPAGVLRTDQKNIRVQVAEPLENLDIVANIPLVAADGSYLRLADVATIEQSWQTPEREFAFVDGQRTIFMAARMQTTVRVDQWTEAVKSKIADFNTEFDGTSQANMVFEQNEYTQARLTELTENLLLGSLVVMLVILVFMGARASWIVGLALPLCAAFAIFSLSFFDQQIHQMSIFGIIIAIGLLIDNAIVITDEIRLNLLDQNLTRLQALEKSVKHLFSPLLASTLTTVLGFMPIFLLTGNIGDFIGAIAISVVMALLGSLAISLTIIAALAARYLPRDGGVGHAWYRRGWQMPAVSHQFSKLLGKLIKRPLLVLPLISIFCLSGFVLSQQLPSVFFPSADRDQFEIYVWLPNGASIKQTKQVAQSIDVLIREKQEVQQVTWLVGASTPSIYYNQVMSRDNSPEFANAVVTTNSIAGAAALIPKLQYELQDAYPNAQIVVRPFGQGPPIPAPIEVDIFGPDINTLNALGEQVRLAMSKVPGITQTIASITTGEPELQYDVSENDSYIAQLSLTEIAKQLQLALAGTTGGSVLQGTEELPVRVRINDYQRGSMKELDALPLMNRELIQNGASIGVASLGEFTLVPSISGITRLDGERVNKVQAFLLQGVPAIDASEQLRELLENGDFVLPQGYRIKMAGDADEQQQALGQLATYAPVLLVLMITALILTFNSVRFAAVIGMVAVLSVGLGMFSLWVSGLPIGFNPLLGSAGLIGVAINGSIVVIAAINGNAKAKSGDTKAIVEETMSCSRHILSTTFTTVGGLIPLLLFSQGSFWPPLAVVLAGGVGFSVILSLFFTPTIVAMMCRIRTSKLQKRAQRTANA
>fig|1085623.3.peg.511 Multiple antibiotic resistance protein MarC
MIEILSAATMLFLIMDPLGNLPIYMSVLKTIDPKRRRVVIIRELVIALVILMVFLHSGQALLDFLKIKQETVSIAGGIILFIIAIKMIFPRPGGIMGLPAGEEPFIVPLAVPMIAGPSTMAALILLANQEPNKMTQWSVALFAAWLISAIILTMSNTFHRVLGEKGLNAIERLMGMILVMIAIQMLLNGIGRYFQHQLS
>fig|1085623.3.peg.614 Glyoxalase/bleomycin resistance protein/dioxygenase
MPAPFHLAIPVTNLADAEAFYGTLMGCEQGRRSEHWIDWNFFGHQLVTHLVAEMPTAPAPNQVDSKAVPVPHFGVVLNMEEWTVLAEKLSTAKQSFVIEPYIRFAGKVGEQGTFFLLDPAGNALEFKGFADESQIFAK
>fig|1085623.3.peg.826 Acriflavin resistance protein
MIAWFAKNDVAANILLFVIMISGLYVATTQIPVDLFPEFEQRNVQVSMVLPGASPQEVEEGITIKIEEAIQDLEGIRQITSQSREGSASVTVEVEEGYAVRDLLDEMKIRVDAVNNFPVEAESLLVQVPQWRRDAIGVVLYGDYDSLTLRRFADGIRDELAALSSISQVEVSNVLPYEISIEIQEWSLRQYDISLEQVAAVLRQNSTDVSAGNLKTEGGDIFIRSLGQAYKADDFGDIPIITTQDGTMIRLRDIANIRDEFEETPLRTRFNGVSAIEVEVFRTGDESIIEVTSAVRDYIDAKQVDMPQGLSLDYWRDRSEPIKARLQTLSTSAWQGLLLVIALLALFLRPSVAFWVCLGIPMSFMGAFLFMPLFDVTLNLMSLFAFILVLGIVVDDAIVTGENVYSHLQRGEDPLSAAIKGTQEVAVPVTFGILTTAAAFLPLAFQTGRGSWYAAIPFVIIPVLLFSLIESKFILPAHLKHVKARNDKNSSKLSMVQQKIANSLEVLIAKVYQPALAQAMRWRYATWMAMFAILIIIIGTIAAGHTKFVFFPRVQSEVATATLVMPAGTAFESTDRIISSMTQHAKDLQKEYTDADTGESVIRNIYSISGGRNSTTGRVQIDMIPPELRTVDVTTREVVNQWRERVGQVAGAEQLNYRAEIGGWGGAPINIELKGRDTESLNELAEKLKQQLGQYAAVSDIEDSLSDGKEELQLALKPEARLLGLDLNTVARQVRQAVFGFEVQRVQRGRDEVRVMVRYPLESRQSIETLEQMMIRVGPNREVPLWQIADVLPGLSPDSILRVDRQRTISVSADFDKQGGDLSLVQSEIREWLQQEVLTYPSTNFEMGGEARDQEESSQGLLVGGIGLAILIYILLAIPFKSYLQPIIVMSVIPFGLVGAVIGHWIMGMDLTLLSFMGMLALSGVVVNDSLVLVDYINQKRKEGVALKDAVYNAGGRRFRPVLLTSLTTFAGLMPLLFEESTQAQFLIPMAISLGFGILFATVITLFIVPLNYLILEDIQRYFKRYGADMKGLVSSKAK
>fig|1085623.3.peg.915 Permease of the drug/metabolite transporter (DMT) superfamily
MENYHDNFKGVIAIVIASFLWGTTGTVASYSPDVSSLAIGAFSMGIGGVLLVVTAQKKLFIDYKLMLEQPRILLFGGASVAIYPLAFYTSMRFSGVAIGTVVSIATAPFFAAILEHLISKKHISQQWILSFVIGAIGIALLTLGRDQSNNTAYSINQQGLGILLGCIAGLTYAGYSWAARRLIESGVHSKASMSGLFGCAALLLLPSLWFTGDNLFSSSTNALVSLYMAIIPMFLGYLLFGFGLNYIDASKATLITLIEPLVATILAVFIIGEKFKVIGWIGVALVSLCLLMQTIKPQNQLRLAFKST
>fig|1085623.3.peg.1029 Glyoxalase/bleomycin resistance protein/dioxygenase precursor
MVLGLLSISLKVADIAISKAFYEKLGFNQMAGHVDQKWVVMKDPNDQVIGLFEGMLEKNMLTFNPGWDANAKHIDDYIDVRYLQKMLSDKGIDCGQMIGENNKGPANFMLTDPDGNPILIDQHR
>fig|1085623.3.peg.1297 Acriflavin resistance protein
MTDLNADNDKKVAEEQTGIIAYFANNSVAANLLMGFIIIMGVISYITIPRQMFPTIERNYINISVQYPGASPQEIEENIVLKIEEQLNDITEIKKSIGRSWRGGGRVTLEINLNEEVNEVLDKVKARVDSIGTFPAAMEPVTISQQEFRQEVMQLTIVGDLSLDDLKPIAEQIEDEILQLQNVQLANARSPDDEIAIEIKPEVLRKYNLSIEDVTQAIRRFSANFSAGQIRTESGMIAVRVENQFYNGEEFRDIPVKIGPSGSKVLLKDVATIKDGFTEGERYFKYNGKNAISLEVSATKAQSIIPVAESVKSYMEARNQTLPESVEIKVLVDMTYYLNGRLDMMLKNLVQGAILVFLMLALFLRFKLAFWVMLGLPICFLGAMMLMPIFGMTINILSLFAFIMVLGIVVDDAIVIGESAYTEVEANGGGVANVVRGAKRVATPATFGVLTTIAVFAPFTMGEGPQSDFFFNIAVVVIFCLIFSLIESKLILPAHIAHTNFKPLKEDSWRQKFNTAYFGFVNGRYRRFITLCTEWRWPVLGLFIAMLFISIGLINANYVRVVPNPKVPHDFPSIRIEMAETVSDTITIDALKTIEKVIQDVDKQIVEEYGSPMVRDILVFNNSRTEGEVMVPLVAEDDRVMDTFELARRWREAVPNIAGMKSFTVRDDVNGGGDGGEFAYLLFGADIETLNNAGRYLINLLQEEKGLFDVSSTIDPDSKEVQMTLKAVAYDLGLDLTSIASQVGASFYGGEAQRVLRNGEEVKVMVRYPEFTRERFSELKYAVIKTPSGQEVLLGDVVELTEKPGISYIRREGGYRSVYVWGSIDEQLVEPNEVTETVKEKLLPQMKERFPSVKTELGGDIKEQQEQNSEQLMFFAAGLIMVYILLAVPLKSYAQPLIVMSVIPFSFTGAVWGHYWLGLDMSLFSTFGLIAAAGVVINDSLVMTDFVNQRRKEGYSIREAVIDAGCARFRAITLTSITTFAGVLPIMFETSLQAAFVIPMAVALGFAVMYATLVTLILVPCLYIILLDLGRPFVAIKQRFFSSKVVLN
>fig|1085623.3.peg.1841 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNQTITKQAFLTEMKTLLTLAWPLLIAQVTQTLMGVSDTIMAGRYSYTDMAAVAIGFSITMPVLMFIQGVTLGLSPIISRLQGSKQTNKVANALHQCIWLSLILSAFALLLIFVVVPLLENIEMEAAVRTITVDYIIYILLAAPGFALYQSLRNCCEGLSSTRPTMIIMFAGLLVNIPANYILINGLFGLPEMGGAGCGLATLLVIYVMAFVTLLYMMIAKKLKQYDLFTKFHWPKLDLQLSQLKIGLPIAFTIVFEVTLFGVVAVLLARFGAEVVASHQIALNFSSLMFMLPMSIGMAVAIRIGYSVGNEDALNAKISVYCALVCSIVIALFTATMTVILSTEISALYTENQGVIMIASSLLFFAALFQFSDGIQVVSANALRGYKDTKAMLILSFVSYWLVGLPVGIILGLTDWFFPVMAAKGFWIGFISGLSCAAVLMFWRVKVIQKRVAHDVKAYA
>fig|1085623.3.peg.1864 Acriflavin resistance protein
MSKQYEEEHIDTEKGIIAWFARNSVAANLLMFVIILGGIFGIIRVQKQVFPTFEVNVISVQVPYLGAAPQEVEEGVILKLEEAIKDLEGIKKMTSTAREGVGSISIEVEDGYDVQNLLDEVKVQVDAIPSFPGNTEKPVVYRIKFPQDVLWVSVYGETTERELKEYAQGIRDDIANLGGISDVSVVGSRDYEISVEISERKLQEYNLTFNELVTAIRQSSIDLPGGSIRSENGDILLRANGQAYNAWDFAKIVLVSREDGTRLLLGDIATINDGFIEDRQFALFDGKPAVSIRVRAVGDQNALQISKSVNSYLDEKRKTMPANLSADTWGDSSFYLADRLSMMLKNMGFGALLVFIVLSLFLRVKLAFWVIVGLPVCFLGTLMFMPASQIDVSINMLSLFGFILVLGIVVDDAIIMGESAYSEIDKKGHSTDAIIRGVKRVAMPATFGVLTTIAAFSPMLMVSGTFGVIWKTIGIVVIMCLIFSLIESKLILPAHLVHMKLKPYDPSKATKFQKFRDIFSIGIKSFIENKYIPFLKKAVQYRYTTLASFIGLLIITIGLFASGLVRWQFFPTIPSDFMQASVELEPGSSLGQRDQAINAMLDAMYKMDDEVADETGTKAVKHVIAFDNGTLGGSVFVELTKGETRELTDVQIQDIWREYLPEIPGVKNFNIGSPGGPGGGNGLSFEFRSDNISQLENISKELRSYLGSYAGITEVNDSFSGGSDEIKLALKPEAESLGLSLSQLAQQVRYGFYGAEAQRIQRDDEEIKVMVRYPKDERNSIGNLETMRVRAPNGDDIPFSEVADIELGQGYANIIRVDGNRSVSVTAKVNADVVDTRDLLIDVQTKVIPEMLERYPAVDFRLQGNSKDESEAIVSLAQGFLFALVAIYALMAIPLKSYSQPIIIMSVIPFGMVGAIVGHLILGQAVSVLSICGIIALAGVVVNDSLIMVDFVNRARAEGRTLIEAVLKSGSERFRAIILTSLTTFMGLMPIVFERSLQAQVVIPMAISLAFGILFATVITLLLIPALYMILDDFKRVFKRKDKTMLTQPLPDNG
>fig|1085623.3.peg.2179 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLNGDIAKTLKSMTIPMIVGMIMLMTFSIVDTFFVSMLGTEQLAAISFTFPVTFTVISLNIGLGIGTSAIIGKYIGSGDTVHAKTIATGALMLSALLVGILAVVGVFSIEFIFSLMGADETLMPFIKAYMVPWYLAGIFLAIPMVGNSVLRAFGDTKTPSIIMAAGGAINAVLDPILIFGWGPMPALGIQGAAIATAIAWAVCVVWILYLLAVKRQLIESRLLSLQEFIVASKGVLKIGLPAAGANMLTPIAGGVMTAVVATYGAEAVAAWGVGNRLESMASIIVLALSMSLPPFISQNYGANKLARIKTAFDMAAKFVMLWQLMVFVILVIFSGYIAQVFAEEASVKRDITLFLCIVPLGYGLQGIIILVNSSFNAMHKPMSALVLSILRLFVFYVPIASLGSYLYGLIGLFWGCVIANVVTSVLAYIWFNRNLKNEMALQTFSPVLGSEK
>fig|1085623.3.peg.2439 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSSKYISIVVPAKNEAENIDILVDEIITHLDSLYQFEIIYIDDGSSDSTAEKVLGLMRRYPDQVRLIQHDSSVGQSTAIYTGVKQACGELIVTIDADGQNNPADMINLIKTAEAFPKGVDFCVAGYRKKRKDTAWKRFQSRVANGVRATLLGDDTPDTGCGLKVIPRKTFLRLPYFNHMHRYLPSLIKRLGGKIVVVEVGHRDRQHGESNYGMWGRLFAGLVDMLGVMWLQRRNKLPVVRELFPDD
>fig|1085623.3.peg.2586 Permease of the drug/metabolite transporter (DMT) superfamily
MSNPLLFLATVMIWGSTWIAINYQINVVDPAVSVAFRFSIAAAILGFWCWFRKLPLRMPLETHKKLILVGILFYTLDYSFLYAAQHHIISALLALLSSSVIYINVVLRRVLLGKPMRLEVVIGATFGLIGIAMIFIPEFEAMSVNEGLTVGLLFAAASFLSAGVGNVVSEKILDVGTPVIQMNFWAMSYSLIFTFGFAFISGASFTLPTVASYYYALLYLALFGSVLAFGAYMKLLQQIGSDKAAYVVLVYPIIALAISTLFEGYQWTILSAIGVIVVLFGNAVAMGKIALFMRKNAVLNT
>fig|1085623.3.peg.2618 Acriflavin resistance protein
MNLSDIGLSYNRLVMTVVLSLMVFGGVSYFSLPAQEDPSIKVREAVITTNFPGMPAEKIELLITKTVEEGVRNVDEVEEIRSISMQGTSVVYVDLYDRYFDLDQIWDKVRNELDKVRSEFPEGTPPHFINDNFGDVAILTVALQADDGIFMGDMFDMAQHARDMIYTVDGTQSVSILGAQQENIVIEVSDVKAAQLGVSPSQLLDTLQQQNVIRSGGNVNLNGKSFSIVPSGDFTSIESIKEVIFTLPNTNNSIRLEDIATVYRSIQTPEFQTAYFNGERAIVLAVAKNDRFSVTEYTPRLEKMLRALEQQMPAGISLNVITRQADQVNAAVDGVSINVIQTLAIVLAVVILFLGVRIGLIVGAIVPAVVLIVLAVLNFSGMALERMSLATLIISLGLLVDNGIVVAEDFKKRLENGEKRREIVSDIGRTLAIPLLTSSVTTMLVFLPLMLAESSSGEYTRSVSIVIIYSLFTSWLLSLMVTPYLCFLFIKDEAVKKKSGFQAKVANFFDLINPVYKSILRFVLKYRAFTMALTILLFLGAGFAMSTVPVKFFPDSDRAQVLAYIDLPAGSSMRETEDVLEKVFDVLDDKERYPYVENYAAYGGFGGPRFVLSLTPITPESSKAFVMLNLVDRQYQNETIKSLREDFANDFPKVNARVTKMFLGPSDSNKIDVQIIGPDKDYIYNTALEIEEIFRNLEGTVEIKNDWENKITQIDVQIDQARAKRAGVTSADVARSLETFFSGRVVSEFREGDDLIPIIIRGKAEDRYDISRIYGINVYSASRNVNVPLEQVADINFSPQYARIARENLFRTVTIEAKNLNMTAEDMVPILQPEFDKIRERLPPAHRLEFDGVVKDSKESQASLNANLPLCLAAVMLVLIAQFNSLRRAGIVILTVPLILIGAVIGLLSVQANFGFMVILGLYALAGIIVNNAIVLIDRIDIERKETEDQYEAIVEACMRRLRPIIMSTVTTILGLLPLILSKDALFFGMASALAFGLAIGTLLTLGVVPVLYSLFFNIKKQTAPE
>fig|1085623.3.peg.2762 Permease of the drug/metabolite transporter (DMT) superfamily
MNFRLIVGTVTAMLAFAGNSVLCRLASEQLTIDPASFTSIRLLSGAIVLTILLLSIPKLMLAEQPLSADGDANSNDVYVNKCFRLLSLKQSSWLGGFSLFAYAAGFSFAYISLPTGTGALILFAMVQITMLSYALVQGSRFSLAQWFGFAMALVGLVYLFLPGISAPPLLGATLMGIAGIAWGVYSILGKRVVNPTQSTTENFIRASIITLLLSLIFINDISISSRGALLAIASGALTSGIGYAIWYAVLPFLKAASSASLQLTVPVIATIGGVVWLGEEVSIRLALASISILGGVAIVVLLPKRE
>fig|1085623.3.peg.2905 Permeases of the drug/metabolite transporter (DMT) superfamily
MDPVKKSLISLHITVMLLGGTALFSQLIPLGSIDITFARSVFACLLLFAVAKLSGDGLRLNSNRDYFIAFGLGIIMAVHWVTYFMAMQLSSVSVGIIALFTFPVITVLIEPYFEKNRLLWQDIASAVVVLAGIALIVPDASLENDVTLGVIVGIFSAFLYAMRNLLHRHYFSHYSGAKAMAWQTLIVCPTLVFFVSDELVMIDLNTLWLLLALGTFFTAIPHAMIATTLQHLRAKTFSLVACMQPFYAILFAMILINEQPTWQTLVGGLLVISAAIYETINTHKENQKAKQCS
>fig|1085623.3.peg.2967 Glyoxalase/Bleomycin resistance /Dioxygenase superfamily protein
MLSYATIGVSDLNKSEAFYNELLAPLGAKTLIKMDRIIFIGKSMAEPMLAICIPYNEEPQHCGNGNMLAIAPGSKEKCDELYKKAISLGASCDGEPGQRIPDVFYGAYFRDLDGNKIVFNHFG
>fig|1085623.3.peg.2985 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTEASEKKEDKNSLVEGPVLPIISRLAMPMIFGIVAVFSISLVDTYFVGKLGTAQLAALSFTFPVTMAIASLSSGLGAGASSVVSRAIGADNRSHAKRLSTDSLLLASLLVVLISAIGYFTITPLFKLLGASGDVLKYIIQYMEIWYISMPFLVIPIVANAIIRSVGNALWPSIIMFFAAAVNIALTPVLIFGFGPIPAMNIEGAAISTMIARIVTFILALYVAIYREEIIQVSKPEYQVFIDSCKSVLKIALPAGAGSVINPIGIGIVTAIIAGYGDDTVAAFGVATRIESFACIPMLALSASIGPIAGQNWGAGNKHRVIQTLKYCYLICVLWSLVIIALFYGFADQFSSLLASSESVAAKSTDYLYIVAVSLVGYGWIIVSSAAFNSLGKSVTGFNYYAVRTFALYVPLSLAASIWFDEKWVYIAIAIANLVSGFLVAGYTLLWLKKAKQEDCHPDWTLNLLSS
>fig|1085623.3.peg.3262 Permease of the drug/metabolite transporter (DMT) superfamily
MKTSHLIELLVLGAIWGASFMLMKSTVPAFGVFALVEVRATLAALFLLPVVYFTRQWADLSGNWAKLLFVGAINTAIPFSLFAYTSVHLDAGLTSILNATAPMFGAVIAYFYLQDRIGVHGVIGTFLGFLGVVIISQDTQSASPVTLLPVLTALAATCCYGIAACFMKKHLSGVKPFAIAAGSQVFAALLLFPFALYAWPDVNPDAGTWGAALVLALVCTGVAYIMYFDLIAKVGASQAMTVGYLVPMFGILWGMVVLGEVLSNYAMIGGSLIIIGVMITTGILKRRRAKINL
>fig|1085623.3.peg.3273 Permease of the drug/metabolite transporter (DMT) superfamily
MHASINTLILVGKTLVLSILKPFYPVLFLLVWSAGYAMGKLALVYTEPLNLLAFRFAGAFLALTPLVILLRLPIPNFRKSYALMGTGLFLHIGHFGSIYVGMKLGASASIMALFAASQPVLVIIASALLARKIPAWNVWASLTLGLLGATLIIGVNMQGNEGYLLGAILGFTAVVGLSIGQVIEKQRKLGVHPIVATWVQYAFASAISIPFAFAFEGLVFENALPFWGAMAFLIFGNSIVGILLMFTMVRQGSIAKVASIMFMVPAVGALVAWLVADEVPKLIAIPGFILAMLGALWTNKIANKSLTEPKKPRGQVS
>fig|1085623.3.peg.3354 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein 9
MSLALWNKSDTPIQTLRATQRTRQNANSVLKLHHHAFKCKNAEETRVFYEDILKMPLVCAIVEPSDPITGAETPYAHLYFELADGSWLAFFDFPSKYEELECGFDKTDVWTHHIALEVPDEATLIAHRKNLDDHGIEYMNIDHEYCNSVYFFDPNGLVVEFTHNVDETERYFHDKARDVKQDMEHWLKVRAEHYPEKA
>fig|1085623.3.peg.3417 Efflux pump antibiotic resistance protein
MSRFPVTTVALIAVCIGYLIAPMGMAAVNVAIPVLAEDLQASAIKVSWLPTLYILANVAFMLPFGKLADNYGRKRVYAYGLLLNALSALMCAIGTDIDWILFWRFMQGAAGAMIFSTGVAIITSVTPSHKRGAALGVLAACVYIGLTLAPAVGGWLTELLGWRAVFYFQIPLVIALLILMKLKLHGEWKNEHHSRFDWIGSAIFITFACTLVYGLSKLPSLLGFALLLVSLLSLVGFIVHQSRDRQPLIRVQMFRESRVFSLSLSTSFLMYGSNFAIIFLLSLYLQYIKGFSPAYAGQILLMQALCMAIVAPFAGKLADRFQPRIIATIGCSIVAVGFLFLIQISPDTTAFYIGGSLGLVGLGFGLFSTPNNSAIMGAVKEQEVGVASASMNLSRTIGNLVGMSLVNLMMHYYIGDANFGPESNPALMSTISLALLMSLSFVIIASVISAVRGKQ
>fig|1088868.3.peg.206 Membrane fusion component of tripartite multidrug resistance system
MADAGEVMDQQSVSANEETGKSKANPLKKFLIIGVCCLLVIGAGIYWWLTRDDIDTDDAFTAGRIVYIAPHVNGYVTDLLINDNQFVHKGDLLLKIDSRDYEAAKKEAEGNLIRAQGQYIASQYMLEVAKKNYPGQLKVAQGQLGIAKAQAFKAKTEYVRQHSIVKAATTQQAIDNATAAYEQAKAEIIKAEGNLLIAQPVEANIQTSNSQINEQKGALEAAEAKLRQAELNVGWTEVRAPHDGWISKRNVEQGNYVTTGQSILAIVEPEVWVIANYKETQITNMRPGQKVKIEVDAYPFLKLKGHIDSLQAGTGAVFSAFPPENATGNYVKIVQRVPVKILIDEGLDPKIPLALGLSVTPTVYTK
>fig|1088868.3.peg.207 Inner membrane component of tripartite multidrug resistance system
MSEMVVADDGIDRSGWKPKYNPWLIAVVVTLAAFMEILDTTIVNVSLPHIAGSLSTTYDNATWALTSYLAANAVVLTISGWLGRVLGRKRYFIICILMFTVSSFLCGMAGSLGELIIFRLMQGFFGGGLQPNQQSIILDIFPPEKRGAAFGLTAMATVVAPILGPSLGGWITDNYSWRWVFYLNVPIGIFTVFAVLMLLEDPPWEKKRKERVDVIGLTLITMGLGCLEVMVDRGENADWFGSFDIRLMGVFAFIGIVGAIFWLLKAKNPVVDLHVFKDRNFAVSSILMAGLGGCLYASAIIVPQFSQQVVGYTAFLSGLVLTPGGIVIIFLLPIVGRIINVVPMRYVIAFGFFWMGSAMFFSAHLTPTLDFDHLVLFRVAQTACLAFLFVPLSTIAFMTIPAKYNADAAALFSMVRNVLGALCISGATALVTQTRQADQARIVHTMSPLNQPFNEYLAHMKAVAQQAGYAAQDQASVAMRYLYTDFQKQVAILAYNDVFMIIGFCAFLLVPICFLLDGYTAKKKKEK
>fig|1088868.3.peg.592 Permease of the drug/metabolite transporter (DMT) superfamily
MIYIIIAGIIWGLGGVVGQYVLQYKHLDAAWIISIRLWIPGVILLTLCYRKHKKAIFNPLKTPRELMILLFFSVVGIMNSQLSYFLAIQYSNAATATILQYLYPVVIAIILAFYLKKRPSFALIISIILALVGAFCLVTDGSIDKITLPPKAIIFGALCVVGSVAYTLSPIPLLQRYNTTTIAGWGMLFGGIILNCFHPFWHISGIIDFASVISIIFIVLVTGMIAFLLYLIGVKLLGSSKGSILATIEPLAAAFFSVVILHVDFNIVDWIGAACIIAMIVILAKNKV
>fig|1088868.3.peg.597 Permease of the drug/metabolite transporter (DMT) superfamily
MDFFILTILYKRVLPRMSTVQQVSNGKSKVLVATASGLLTILLWSSLAVTTTSLPNMPRFQLLWFGFGEAFIIGSIILTLTGRVREMAQPFAPWFTAFCGIFFFHLFYFVGLDFAPPAKVTLLSYLWPTMLVVCIALLSKKQFHIAYLLGALMGLIGTIFLMPADQGSVLTSGNLFGYLLGVLCAIVWTIYSIVNRKYISVPTGMMIGVCGGISLVSMMIHFAFELTVMPNSWQEMLIILYVGCGPMGIAFLAWDYATKNANLSLMGSLSYLAPLLSTLWLVIAGRAPATMGLLIAVILIVGGAVVATYPLKK
>fig|1088868.3.peg.881 Drug resistance transporter, EmrB/QacA family
MNAINQNKQNTLLPIVAAIAFFMASLDTTAVNTIIPYLATVFHSPLATTKNIIIFYMIANSLFIPLTGVLCQKYGCRIIFCAALCIFSVGSLLCGISGTLNELLIARVIQGIGGALMLPVGRLAVIQTFPKDQLIKALSLVTIPGLTGPLIGPIVGGGIASYLDWPVIFFINLPFGIAGIYFALKYFPTQKDENLRIDTWGYIIFAASIALITYALSLYSETKYYMTPTIIICVGTVFLAAYWIRSLYHDYPLFAPKLFKIRSFSVGLLGNLVARLGCGAVPFMIPLMLQRLLGLSPVACGMAMLPLAISAMMAKPFVSKAIHIAGYRNFLFINTLILSASYMSYCLVNEHSGWVLISTLMFITGFINSMQFTAMNTVTVLDLSAKRQASGSCLLSTVMQVSMASGVAVSAILLTLDETIHLHALPATHFHFTWLYLGLITAVSAFIFVLLPNKRI
>fig|1088868.3.peg.1309 Permease of the drug/metabolite transporter (DMT) superfamily
MYIESPMPSQNHQFLGIIAVIIAAILWGTTGVSASFAPQVSPIAIGSMAMGVGGLLQAAIATNIIRSYRFNLYRQWPYVLCGALSVAIYPLVFYASMRMAGVTIGTVVSIGSAPLLSAVIEAIMEKAKFSTKWIIGATLGIIGIALLSLSGQEHHADQTQHPHLILGIGLALLAGLTYALYSWIARYLMQQNIPSKAAMGSIFGIGGLLLMPVLFMTGSAFLASWSNAAVGIYMALVPMFIGYICFGYGLARIAASTAITITLLEPIVAAFLAVIIIKESLSIMGWIGVILVFTCLVCVIMPSRKK
>fig|1088868.3.peg.1516 Multiple antibiotic resistance (MarC)-related proteins
MHLTETFPLLHAFTSVSGSFLFALSALIPIADPLGSCLIFYQVTEEREDAERKLLARKIAIYAFVILAFSIFIGEFVLRFFGISINAVRIAGGLVIAVRAWTLLNAPEQNADRKQKEAEQGGRTMALPNGLDAAFFPLTMPFTIGPGCIAVAIALSSVRPTGAGNGAAIFSFYNGLILAVVVVCLTIFITYTFCDKIMKVLGKSRARILSRMAALILLCIGVQIVGTGIQGFLIPIFQQH
>fig|1088868.3.peg.2200 Outer membrane component of tripartite multidrug resistance system
MKYTFSFLSMVIVIPTLVGCAVGPDYHKEDVWTPSKWSKPTQNLQASVNSQVVMDKINPQWWDYFHDPVLSDLERRAVTANLDVQMATQRLIASRAQLMIAGSARFPSVNGSAGYQRNQYSKKGFSRAIDKIRNREPALGNMVNPSDIDVPAFNQWDDALDTSWEVDLWGRVRRQYESAKALKQMSEEDRRGILIAQQAEVAQNYMTLRGLQAQLQIVKENEKIAQDILDLANQRFNGGLVTELDVRSAEAQLEQTRADIPNLEQQIIEYINALGLLLGEPPRALSTELSTPKPIPPVPSQVPIGFPSELAQRRPDIRQAEAKLHSATAEVGVAEADFYPKVTIDARLGFQSLSLRDLGFWSSRAWSVGPSLSLPIFEGGKLKGQLTLKKAEQKEAALAYRKTVLQAWQEVDNALNAYQAEQLRQVRLQDTVKSNQRSVYLAQAQYRQGLQTFINVLNAERRLLSSQQDLVNSNTQISINLVQLYKALGGGWESTYPDSSQIASTQPQTEVQTQGQTQTMSKKN
>fig|1112215.3.peg.838 Drug resistance transporter EmrB/QacA subfamily
MTTTNEPPVATTHTSTASDPAAKRSILLLFAGLMVTMLLSALDQTIFSTALPTIVGELDGVNHMLWVTTAYILAATIMMPVYGKLGDLIGRKGLFVGAISIFMIGSVVGGLAPDMTWLIVGRAVQGLGGGGLMILSQAIIADVVPARERGRYMGAIGGVFALASVAGPLLGGWFTESIGWRWAFWMNLPLGALAILAAITLLKLPKHDNTRKPTIDIAGMILLAITSTAIVLVTTWGGTQYDWDSLIIIGLIALAVVGGFSFVMVERAAPEPIMPLHMFKERNFVLTTTSGLITGIAMFGALAYMPTYLQMVTGVNATQAGLLMIPMMGALLVSSVTAGQLVSRTGRYKWLPLTGSFIVAIGLALLSTMTPDLPIWVLCSYLAVMGLGLGMSMQILVLIVQNTFPNSQVGTATSSNNYFRQIGASIGTAVVGSLFVARLTELLGTRLPAAAASATGDTNSLTPAAVRDLPDAIREIIVGAYNDSLTPVFLYMVPLVLVSAVLLMFIKEVPLATTIDRGDKSETLDGLGVEDGTDTEGATTAADAESHELITVSDQTGATSIIRSQP
>fig|1112215.3.peg.1446 Permease of the drug/metabolite transporter (DMT) superfamily
MPLRSILAAVLVAVIWGLNFVVIDVGLEGMPPTLFLALRFMVVIVPAIFFVPRPKSRFRDVVLIGSFMSLGQFGLLYTALAIGMPPGLASLVLQAQVVLTVVFAALALRETPTRSQLVGVALGAAGLVVVGSGRGVETPVLAFFVTLAAAASWAIGNVIARRVGRIGSTFSPLAGLSLTVWSALVVPIPMLGLAFVINGADAVGFALTHLTVPQLLSTLYTAWLASLVGYGIWNTLLARHAASAVVPFTMLVPPVGMTTAWLALGEVPTTIEIVGGVMLLLGVAITTGVLGRRRRQRHTPSGEVAASADPVENPL
>fig|1112215.3.peg.1553 Permease of the drug/metabolite transporter (DMT) superfamily
MSAPVADAGRVEKHDSTSNLGTTLRFAAAGLVWGSSFLFIKIALDGVSFGQVAWSRAVLGAIALVIVFTVSRRKLPRKPIVWAHFTVLAFLFAVFPYLLFAWAEQYVSSGLASIYNATTPIMTAIFATLVFRVEKLTRSQIAGVTLGIFGVLVIIAPWQAGDISGSLLGQLACLGAALCYGAAMSYQRKFVAPYKIAGVTSATMNIGIAAVIYILLTPLIAVGPVNLTLPVVASLLALGVLGTGMAYVWNYRVLAEWGPTRTSTVTYITPVIGVILGFVILKETMSWHEPVGAVLVIIGVLLAQGRLKWPRGAARTHAALK
>fig|1112215.3.peg.2590 Multidrug resistance transporter, Bcr/CflA family
MTTVVHPGDSLSARQRLVYVLVLGALTALGPFTVDLYLPAFPLIEADLETTAAVVQLTLTATTLGFALGQLIVGPLSDRFGRRLPLIVATSVHLIASLGVALAGDIEMLFVFRLVQGMGAAAGAVVTMAIVRDLFGGLPLVRMLSRLALVQGLAPILAPLIGSQLLLITPWRGMFVFLAIYGALVLLAAWFFIVETLPPARRRDLGHATARDRYKALFTDRVFVGTAIIAGMTFSGLFAYLSSSPFLLQNVYGLDPQAFGLVFAANSVGVVVGVQASAFLMRYIGPQWILAGAGVGLLLSASTIVFLDVVNGDLFAVLIPLFFFVMFCGFSFPTTQVLALANHGGEAATAASVLGAVNFGLAGLTSPIVGWFGITNAIPMGIVMACTATVSIIIMWTVVRPRTVPALSR
>fig|1112215.3.peg.2968 Multidrug resistance protein
MTTFLQILVNTAVANITTSYLWFALTFWVYLETRSVLATGIIGGAYMLLVAAFSMVFGTIVDRHRKHVVMLFAGLVTLVAFGIAGTIYALFPESILLDLGGPMYWIFAGIILFGAVIENMRNIALSTTVTLLVPQERHANANGLVGTVQGLSFLVTSVFSGLSIGLLGMGWTLVIAIVLSAAALIHLTVLRIPEQKPEPEEGGRSPLVDLRGSITAVRAATGLFALSSSRHSTTSSAVCTSH
>fig|1112215.3.peg.2969 Multidrug resistance protein
MDPYGLELFPVEVWGIVLGVSSSGFIIGGLLVAKFGLGRNPIRTMLFLVGLMGVLGAMFTIRDWWWLYAGGILLYMTLVPAVEAAEQTVIQKIVPYRTQGRVFGFAQAFEAAAAPITAFAIAPIAQFLIIPYMDSQNGQDAFRWLLGDGAARGIALVFLIAGLLMVVVAIVAFSTKSYRFLSQQYAGTTASVPAAEPAENS
>fig|1117647.4.peg.21 Permease of the drug/metabolite transporter (DMT) superfamily
MSNRDLLIVVALMALWGLNFSAIQLGVDQINPLLLTAARFFCAVIPAILFVPRPAVAWRYLVAYGLSFGVGIWGMMTLAMDMGLSPGMAGLLLQLNIVSGLALGWWLFGEVITAQKIAGAGLALAGLLLTLLLTDGSVSWAGLGLAMIAAQCWSLMGVTVKKANTDKVFAFGVWGMAFAPLPLVLLAWGWFGAEVFYQLPDRFNGRALFSILFQAWPTTLLGYWLWNRLNRRYPMSLVAPFTLLVPLFGFLGSVVFYGEQLGPVKIAACVLILTGLAIGQGWVKLPVGRRQPV
>fig|1117647.4.peg.1038 Permease of the drug/metabolite transporter (DMT) superfamily
MLHSTRFALFMLVLVCAIWGVGFVVTEHALGKLSTQSLNALRFALAALSLLPLWYWSGNRRAFAEHGKMLLGASAGLGFVLFLAFYTQTEGLRHTSVSNAGFITGMLVPLVPLLNWLLFRQRIGKHVLIAVALSSLGLWLLTGGASALNKGDLLVLAGAVGYATHIVLTGHYARKLPVLALAMLQMVAVSVYSLLASAIFDADRSQTVFVLSVEHWANLLTPDIIGAFIWMAVLSTAFGFWVQTHCQQMLEAHKVALVFALEPIFAHIAGAIWLDERLTLAGWLGAGAIIGAMLLAELGDRKANAKLHPGDLAVAPDPGD
>fig|1117647.4.peg.1191 Acriflavin resistance protein
MTDNQPELIEQEDPTRRGIIAWFARNTVAANLLMVFILLGGLISAITMKQQMFPEIEIDWLQVQVYYPGAAPKEVEEGITLKVEEALKSLQGLERVITYSRRGMSQAYIKVAKGFDPQEVLDEVKGQVDSISSFPAGIERPRIERFKYRQEVMYLSLYGDLSPTQLKDLGRKIHEEIQSLPSVSVSEYFSGLGYEIGVEVSKDRLREYNLTFQDIAQAIRNYSSNMSAGQIKAADGYISLRVENQAYRGYQFEQIPLVNLRDGTQVKLGDVATISDGFEDGIQYQKFNGKNSVAFFIGATRDQNIMSVAQVVKNYVEKKEAQLPDGVHLETWVDMTYYLQGRLDMMKSNMWMGAALVFFLLAIFLRVRLAFWVMLGLPISFLGAFMFMPLEWVNISINIASLFGFILVLGVVVDDAIVIGESAYNEIEEKGQSVENVIRGAQKVAMPATFGVLTTVAAFFPMLLADGPSKGFSIAIGGVVILCLLFSLVESKLILPAHLAHMKQRPHNPKNPFHWLRQHVDGGLRHFVENIYRPKLQSLLNYRWAVLASFLAVLLISFGFFGSGLIRFIGTPKVPSDFPDINIEMQITASEQATLDAALAVENMIYEVDKQLEAEFGQKMIRSLNVELRSRTSARIMSMLVDPEVRPVDTFELAARWREAMPPLPGVKTLTIQDSLFGNDRDDGDISFRLESTNQEELYLAVQDLRDKLSTLKGVGDINDSRRQQTHEVQFQLKPLAYSMGLTLADVARQVGYGFYGIEAQRILRNGEEIKVMVRYPEHQRNGVALVEDTVIRAPNGAEVPLSEVADFTMVMAPAEIRRENSKRSINVWASVDAQQAEPQKIAQDIRDNFLPAMLKNYPSVKSSISGRIQEEMDDQAKQMRNFLLSMIVVYALLAIPLRSYTQPMMIMSVIPFGIIGSMIGHMIMGMDMSAMSVFGLIAVAGVVVNDSLVMVDYVNNARREGSPLIQAVVDAGCRRFRAIILTSLTTFIGVVPILLETSMQAKIVIPMAVSLAFGVLFATVITLLMIPCLYVAGNDIRGLFRRKQPSQDVAASPQSV
>fig|1117647.4.peg.1678 Acriflavin resistance protein
MNIAERSIKNSTITWVVTGILLVVGMIAFNNLSRLEDPEFTIKEAMIITPYPGASAREVEIEVSDLVERATQEMGQLFYVESHSYRDKSIVKVRIKDQYDKDGLPQVWDELRRKVNDIQHQLPPGAGPSLVNDDFGDVFGVYIALTGDGYTQKDLYEFAKFLRRELLLVQDVKKITFYGQPKEVIYVEMQRDKMTALGISPQDIYSALGAKNTAEQAGYMTVGNRRLAVSPTGEFHSEQQFAGLVINARNLQNQQVVLGDVATITRGLQDPPNNLLRFDGEPAIGLAISTTSGGNVVTMGEGLYQKVEELKPQIPLGIQLNVVSMQSDSVVEAINNFLISLIEAVVIVVVVLLFFMGLRSGLIIGTVLAVTITGTFIFMSILGITLERISLGALIIALGMLVDNAIVVTDGMRVRMEQGEDALSAARKVVSQTAMPLLGATAVAIAAFAAIGTSQDATGEYTRSLFTVILISLTMSWVTAVTTTPLLCKTFLKSGQLGSQGAPYQGVFYQRYRQFLTLAIQHRWVAIGITVALFAASLIGFGYVKQSFFPDSTRPQFMVDLWLPEGTHIHETERRLAPFEEKLKGYSNVTKVTTQVGGSSPRFLLTYQPEQPNSNFARLLVDVDDYRIINQFSQQVQNDLEFIDPDVNVNVRLFVLGPATGGKVQLRLSGPDHQELRRLGNEVLNVLRQHPNVKGIRNEWGEQVQVIKPVMSDVLASQLGIGRPEIAQATAHTVEGVRAGVYRERDELIPIVARAPEHERRNLDNLDQLPIWSPTAQRMIPLGQVVSHFDVDFENPHIWRQDRVSMLRIHFDQREGLSSELLADLKADVEKAINVDVAGYLKLAADADIDHQSSTIPIKYRDRLPIAGKPGYYAAWGGENEDSDKGSTAIMGSIPVFFGLMVFIVICLFNSLRKTAVIWLVVPLAIVGVTAGLLLFNQPFGFMALLGFMSLAGMLIKNAIVLVDQIGEELSTGKNGVEAVIESGVSRLIPVAMAAATTILGMIPLLGDAFFIAMAVTIMFGLGFATVLTLVVVPVLYATIFRFR
>fig|1117647.4.peg.1739 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRSMQPMLTEGPVSGHLREMAMPMVWGLLATMSFNAVDTFFVAMLGHEPLAAMSFTFPVVMVLTSIAIGLGAGTSSTVARAIGSDNHHLAQRMATDAMSLTTIIALVVCGIGWFTIEPLFKLLGAEDQLVPLIHDYMWIWYFSAPCLMVPMVGLASLRAMGLARIQGTLMIAAAALNLVLDPILIFGLFGFPRLELEGAALATLITRALSLVVVLWVLHKRLGMLVNPFARFDEVWASWRAILHVGVPAMVNNVIIPMASGVVVYLVASYGTVAVAGLGIAMRIEPIALIVFYALSGVVGPFCGQNLGAQKFARLDETLRVVTRFCLGFGVVLALVLWLAGELLIRLFSDQQEVIDVARSYLLIVPFSYGAYGLVMSVNAAFNGIGQPMPGVAISFMRVLGFYLPLALMMQWLWGLTGLFVATASCNFLVGLVAWLWLRQRFHTTATAATT
>fig|1117647.4.peg.2627 Acriflavin resistance protein
MRLREQKAQPDDAARKGTGEVWGALLASTATTVAIFLPVVFLKDVEGQLFSDLALTITIAVSISLLVAVTIVPLLASRWLKEEGLTDHNIGLWQRITSLVMRITHTPKQRWSLIAGLITAPLLATWLLLPELDYLPPVKRDAVDTWFRFPPATNIDTIEREIVDVINQRMAPYMKGEKEPALKNYYVLVWPGGGTMGARVQDQSRVDELLKIVREEITVNLPDTMAFSAQGNLFGGFGGDRAIPVHIQASDARQLADVAEQAVGWVREALPEAQSRVDPGTADAEPELRLLPNDRALQEQGWTRRDLGAVVRMLGKGLWVGEHFDSVKRMDVILRAQAWDDPEALINLPLATPTGGMVPLSQLVTLDRTVGPNQIRRIDRRRTLTLVVVPPETMSLEKALHALQTDVEPKIRAALPSDGNIQYGGSADNLKQALGTMGENFLIALLILFLLMSVLFRSPKDSALVLLAMPLAMVGGVLAMQILNLINFQPLDLLTMIGFVIMLGLVVNNAILLVHQTRSAEREGMNRHLAVEQALMLRLRPIFMSTLTSIFGMLPLLLMPGAGSVIYRGLAAVIVGGMCVSTIFTLVLLPCFLRMGAKSQPKLADIPPHSELRRLKSVA
>fig|1117647.4.peg.2628 Acriflavin resistance protein
MNLTAATLRNPPAAIVAIVFAVAFGLFSLNKLPIQLFPDIESPVINISTGWRAASPKEMESEIVEPIEEVLQGLPGVKEMAAGANAGFAWINLTFGMDTDMQKTLVDVISRMNRLKPLPRDAMQPVITLGGWDGGTPALTWYFLQVLPENPNKVEDYFTFVEEVISPALESIPGVARAGIGNGNGPMEELQIRFDPYRAAQLGVQLPMVAGLLGQSNDVSGGFVDIGRRQYTLRMAGRWEPEQLGQMVIEWRDGKPILLGDIAEVKVSLPDRNNLATQNGNPAIGIRIDRESGANVLATLNAVKEKIDELRAGPLKERNLTMVQSFDASVFIYRAINLVTSNIFLGVLPGCGNFVVVFAPRPRHPDCRPHHSHFAVVHVHHAAVHRPHAERDFTRRPRLCRGHGIGCGYCGTGKCGALARTKSPTR
>fig|1117647.4.peg.2649 Acriflavin resistance protein
MNSLIKWFSANPIAANLLMILVLIAGAMSLNGTDKEVFPGALVNQIEISMAYPGAGPREVEEQICIRIEEAVASLDGIKEITSVARQGTGSVVIEVASGYDTQRLLNNVKTKIDAINTFPVDAERPLVNERLFTSELMSLAMYGDVDERLLKDTSQWVRDEISVLPGVSLVEVDATRTDEVAVEIRENALRRYGLTFEQVVSAIQKTSVNLPAGVIKSSHGDIQIQARGQAYDGDAFGQTVVLSRPDGAAVLLRDVATITDGFSETDVIARYNGLPAVFVELYVTENPNVLQTSESVRQYLTGLPQRLPQGISVDISRDWSEVFSARLKLLSSNAVSGLLLVFVVLMLFLRPALAIWVCAGITVAFAGAMWLMPALGVSFNMLSLFAFLLILGIVVDDAIIVSESIYTRQQKGATGIASAQDGALKVAGPVFFAVVSTMIFFVPMLFIPNTLGDIVYPIPVIVISCLLFSLVESMLILPSHLAHLKPERAPGSKPALWLSLARQRCAEGLQHAASHWYGPFIRRCLHDVRLPIAGFFALFLVAMSIYGAGWIRQSFMPQVPSDFLHARIQLEEGVPFSRAQALLEKVEQAAAALKTDATLIAAIDGNPAFIRSVESWASPQNVRVRLALMDAETRAVGSPQVARRWRELIGELPEAKEFDVGFTINARDKAIRLRVGINENTLERQRQALDAVKAALAAYPGVNEVKDSLQSARDEIELTLLPNAELLGLGLQDVARQVRQGFYGAEAQRVPRGKEDVRVMVRYPRAERESVDSLYDMRIRTQSGDEVPFETVAQGEYVAGYTVINRVDRQRANSVTAELDSSDSGQAFAIVNAVLAEHGDTWRREFPGFRLEVAGDMKAQNEFMQELVRDFFLSLLVIYALMAIAFRSYGQPLLIMSAIPFGFMGAVFGHLLLGREISMLSMLGFLACAGVVVNDNLVLIDRINQLRARGMAVLEAVAQAGRDRFRAIVLTSLTTFIGLVPIMAETSVQARFLIPMVISLAFGVLLASTVTLVLVPCLYVAGVNLKRRAQALLAR
>fig|1117647.4.peg.2795 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLGAFSVSLAVKDIHASRQFYSALGFNEIAGDIAQNWLIMKNGQHVIGLFQGMFDNNILTFNPRWHQDCTENPDAPDIRDIQAALKAAGIALDSEVDPNSQGPASLTLTDPDGNTLLLDQHC
>fig|1117647.4.peg.3126 Acriflavin resistance protein
MSHWLDRTVGSTLKGGLPLFIFIASLLTGVLALQFTAREEEPQIVVPMVDVLVQAPGLSARQTERQVTTPLEKLLAQIPGVEHVYSVSQTGQAAVTLRFYVGQDREEAILNTYNKLYSNQDRIPGVVSDWLVRPVEVDDVPIMVLSLWSSDPGRYTDFELRRFAEDISTGLQAIPQTSEVKVVGGRPRTITLKVKPEALSARKITPAEIVSALGLSNQLQSAGLWTFNNEAIQLESGDFIRTRAELEQLVVSVIDGVPVYLQDLVTINDGPEEARHYTWIDFAPGHPEFRSANDGYPMVAISVAKQRGSNAVTVADAVHQLIATLEQELLPPEIQVEVIRDYGQTANEKVNNLTSSLGFAIITVVIFIGVFLGWRQALVVGLAVPICYGATLGLDMAFGYTINRVTLFALILSLGLLVDDPITGVDNISRFLKEGSGSKAERIVGAISELKVPLVMSTLTIVLAFVPLAFITGMMGPYMAPMAFNVPVSVIASTLVAFLVTPWLASKFLKADDYVAEPSANNESAYARMITPLLDNPRRAKGVLWIMLALFIGAALLPMFRTVPLKLLPFDNKNEVQIVVDMPESASLEQTAAMARRISAQVSQVPEVRAVAAFVGTPSPMDFNGMVRRYYQRTGNHMADLRLTLVDKTEREHQSHGVVLRLRALLAPFNTGDINIKVVEVPPGPPVLSTLVAEIYGEGLTDYATQRDAARVLMDRLAREAHVTEIDSTVEAHQSRQRFVLDKQKAALSGVATEDVNATLAMANGGYNAGFLQGYLHAERESAPLPVQLRLPVDERASLNDFLSLQVKGRPGIAQQSNPQGLETAPQPLVSLGELGGFVALDADRAIHHKDLQPVVYVMAELNGRTPAEIIADVNADQGAEPGAAQTEWQSRNFITSFFAGPGDGWQLPAGTTLKWTGEGEWRITKDVFRDMGLAFAFALAAIFVVLRMQTASTALSLIIMSAIPLTIIGIMPGFWFLNQWGERVIAGSPEPVLFTATAMIGMIALAGIVVRNSLILVEFITQARAAGNSIRDALIAAGSVRMRPVLLTAGTTLLGNLVITLDPVFSGLALAIIFGIIASTLFTLIVVPVVYLLVFGNSEHAHD
>fig|1117647.4.peg.3637 Glyoxalase/bleomycin resistance protein/dioxygenase
MQFNHFNLEVPADQLDKVKQFYQQVFGWREGDRPAFSRPGYWLYEGDLPILHLVQHRGGQTAAGNGALNHLAFRTSQLAAFRNTLDKLNIPYRQVILADAGISQLFFHDPTGLKLEVNGPAL
>fig|1117647.4.peg.3861 Multiple resistance and pH regulation protein F precursor
MFIAVTLAILVTIGLALARALAGPTTYDRIAAANMFGTKTVLLIAVLAFLSDRADLLDIALVYALINFIGVIAALKLVTRGNFHGSSDKDSGII
>fig|1120924.3.peg.1 Permease of the drug/metabolite transporter (DMT) superfamily
MLVQRVMKKSVMPQRHEWPRLMILSAMVCLGFYTTQTFAMQFVDSGLSAVLVFTMPIFIGVLAHYFLNEYLTRQKIFGLILGTLGLIAILWPQLHHLGLNLSLVGQIMLIGSGLFWAMSTVYIKKYFATYDKIKLTIWQLLLGGVVVFIGALSFEPVDAKVWLNPLNESLLIYIAIIGTGFAFALWNWIVSQVDTFVASISIMCIPILSLLFGALIWHEALTLNIVIGAAFICMGIVMSALTLTHQKTSMQYSRCPK
>fig|1120924.3.peg.34 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MQLTPFLSCVVPAYNEAENLKKFIPALAANLEQQQLSYEIIVVDDGSRDDTLHVLQSMVDHYPLVVLELSRNFGKEAALSAGLDRVRGDITLLIDADFQHPLDAIPTMVNLWKNGYDMVYGIRDRSSESWLKRILTNNYYKVLNMSSPIDIPENAGDFRLMDAKVVDAVRRLPEKNRYMKGLYAWVGFKSIGIHFSEQQRQFGQSSFNGKALFRLAMSGLTGFTDLPLRLSIYLGALLALSAMGYGIWVLIETLIEGIRVPGWATLVIGLTLLGGIQLLFLGIVGEYIARIYAEVKNRPKYIVSSEYSHVKAAHQLQDFDQHVSKP
>fig|1120924.3.peg.322 Multidrug resistance transporter, Bcr/CflA family
MSESRLNRQYSTAWIMLLALLTALGPLSIDMYLPALPQMAEDFGVSTAMVANTLPAYFLGLAIGQLVYGPISDRIGRKKPLYVGLTLYVIASASCVLADNEWSLIFARIIQALGGCVGVVIARAAIRDRLDVQGSAQAFSSMMIVMGIAPIAAPALGAFVLEFFHWQAIFWILALIGCISLVCIHFFFIETLVPEKRLRLSLNQVFTLYIAIFKDASFRFPMFAGCLTGGVLFSYISSASAVLMDQYGLSQQQFAYAFGFNALGIIILSSLNKKLVSRLSTLQRLKIGGFIQLTGALVVLVSGLLIHAPIVMVMTGLFLAVSGLGMTGPNAMALAMSQQGSRAGTASAIMGSMQFACGLLAGVLLNFLIWNALFNMGLMMLLFSGVGVIAIFVVARQLKLQTT
>fig|1120924.3.peg.367 Membrane fusion component of tripartite multidrug resistance system
MSDEQAPKVPPQAASNDNTQAQSNAQSTNSSTPTPYKPVQRVGKLIPTKKSTLFIMFFVLLVGIGLIMWAWRIGPFHTMIEQTDNSYVKGKTTVLSSQINGYIKEVLVKDFDDVKQGQPLLYIDATTYDQKVTQAESAVAQAQNTLANQTQTIAQREADIIAAQAQVDQAQAEYQLSLDQLRRYQQLGDSGAASKSEQDQIAATAKNNLAALKKAKANVKVANEALKTAQVAEVGLNAQVTSAQAQLDQAKTTKNYSVITAPMDGQLGEVTPRIGQYVAAGSQLLYLIPNQTWVIANFKETQIAHMKIGQPATFTVDALDHQKFKGHIEQISPAAGSEFSVLKADNATGNFTKVVQRISVRIAIDPNQDELKRLRPGMSVITSVDTSSR
>fig|1120924.3.peg.447 Bacteriocin resistance protein, putative
MHRESVLIKPAIEEQFRGIVRQAYDYSCGSAALTTLLNGYVGTKLTEQQTMNGLLRFGEYQRIIERRSFSLLDMKRFVTALGLESGGYRGEFSDLVNQGQPAIVPISYAGFKHFVVYKGYKDGRVYVADPALGNISFDEVRFKEIWENNTLFLIQVPEAQRQHMLALQESDMRHVEDTTINKYAFIDMQYPSFYMERIADRISTVRRAPDMDKNSYTYGQNIDTFMRLYYKRK
>fig|1120924.3.peg.538 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTPKRSLITQQKLWKTFLIFLLPLIATNILQNLSGTINTVFVGQMMGVDAIAAVAVFFPILFCMMAFIIGLSAGSTVLIGQAWGAQNIEKVRCVVGSTLFMTIIGGCIIAALGVFFSREILTLLGTDASVMHLSLPYVQWMLAGSPLLFVYIIYTSILRGVGDSITPLIALGMTSLIGLVITPVLIAGYFGFPKLGIVAPAIATIIGYLSVLAFLAVYLNKKNHPLKPDLALLRHIRHHSEISRLILRLGIPTGVQMITTSVAGLVIVGLVNRFGAHATAAYGAVNQVLNYIQFPALSIAIAASIFGAQAIGMGKSDLLARVTRTALWMNIIITGTLVILAYLFSKYLMALFITDESVVQLGQELLFIVLWSILFFGAAAIFASIMRSSGTVTVPMLINIAAILFIEVPCAYWFSTLWGLKGIWIGYALAFVCLCIMQAAYYQFVWKKKTIKALI
>fig|1120924.3.peg.660 Outer membrane component of tripartite multidrug resistance system
MHQFFSLQIRVKPSKLLSAFSLGVMGVLSGCQIVKPEPSAQLNIQAQFSQPAQYGLDAKKWETEDWKIAVPSDQLPRGEWWQIFQDTQLNQLVEQLNRENASIAQYEAQYRQATALLNQATASTKPTVTGNTNVTRAKSGESATTANYNMGLNASWEPDFWGKVRQNIWVNQDKAQASEAELNSIRLSMQAQLTTSYLQWVILGFQLQSQQESLKNLQKFLQLTHNQYQAGIVASTTVDQAQSQYQTALANYTEMQLAQIQLQHAIAMLIGQPQDQLQLILPKTLPVLPQIPVNLPSSILQRRPDVAAAERTMAAANAQVGVAKLAVFPDFSLGGNLGYKSSKLSNLFSAPNFIWSVGPTLAATLFDGGLRHAQTEQAKASYDASAAVYKQTVMSAIQNVEDNIAAQYLLSKEVAQEQQSLAAATRAEQSTTNQYKAGIVGYLNVLTAQNNRLSAQNNVWSLTSKQYQTTVNLISAMGGSF
>fig|1120924.3.peg.788 Permease of the drug/metabolite transporter (DMT) superfamily
MAISLAAETQPPAFKLYLCIAVTVFCWGYSPIGVHNALHSYTPQHIALLRFLIASFFLLLLVMKKGIQPLKWKDAPALAVLGFFSVTLHHLLINTGQQYVSAVASSILSQSIPLFTFIISALLFKEKIVFKQWLCILLGLGGAVLVVSGDHGFGVPSPYSLMIVLAAIAWGLYFNLYKKFALNYDALSMMCYIIWFGTIPLLFYSAHLPSEILHATWQANMSIVLLGIFPSAMAYVLWGYVLKNMPLTIASNFLYCSPIVAMSLAVVFLNEKPSMIVLLGGVMIVGSLVWMNWGNRRTIK
>fig|1120924.3.peg.964 Permease of the drug/metabolite transporter (DMT) superfamily
MRFSFSPVQTGSLCAVSAAFLFSTKAIFIKQAYALSPLVDATLLMALRMISALPFFLLLCWFNRHHNQAISAKDWLVLIFSGLLGYYFASWLDFMGLMLISASLERIILFLYPTLTVLASSFLYHQKLNIKTWFAIFLSYGGTVLVMLQEGKNAPSQGGFWLGASLVFASAVAFAVYLLLTPALIKKFGSWNFTGLASSVACLGTIMHYLIATPAPLTVINELPLAVWGYGISLGFFVTVIPTILLMQGIQRLGASQSAMIASIGPILTILLAVIFLNEQLNLWQWLGCVLNILGVLLITLSKTRLKH
>fig|1120924.3.peg.1482 Acriflavin resistance protein
MNIFALFVHRPVANILLGIAMTLLGILAFFRLPVAALPQVDIPTIVVRANLPGASPESMSATVATPLERAMMGVSGIKAINSSSSQNSTQVILHFDLDTDINEAAREVQAAINVAMSQLPSGMPSPPEYFKVNPSQSPIFYLALSSRYLSAGKLYELASNQLKPNLAQTSGVGEVEIDGASMPAVRIILNPNALISQGISLEQVRDAVKKSNVVQSLGVIEHQNNRWQVALSTHIKDAADFSNLIVHQTAQGIVRLKDVAEVEDSVENRYVAGFHNGEPAVMIKISRQPNANTIATIEKIKAKLPELNSMIPADAKLTTVMDGSEVIHTGLQEARETLLFSIFLVVVVVVLMLGRLRSAIVPSIAMLVTLVGAISLIYLAGFSFNNLSIMAVIVAIGLVVDDAIVVLENIERHIEQGEHPFSAAIQGVREVGFTLVAMNLALIIIFISVLFMGGVIERLFREFSLTLVFIVVVSVFVSLILTPSLSARCLQSINVQNRQPLYDYSQRMMHGLTRHYIHSLQWIIRHTYLVILLWLGAIIGSVYVYQSLPKRILPEQDTGRIESFIRGDDGFSFQIMQPKIATFSQSLLKDPAIKDVIGTSGGAGGTTNSFFMVSLKPKAEREGKTTREIAERIRQNAPWIAGAIFSARVQQDLELDDPFSGNSGQDYLLLLQSDDVALLRKWAPKVAEAIQKLPELEEVETLGDEGAQHVTLDINREAARRLGVDVESISSVLNNSFSQRQISTIYDQTNQFHVVMEIDKRFTENPEALADIKVPNQNGEYVPLTNFATWSYGITNDRVHRRNQYAAMGIGYVLKQGYTAEQAEYAIRSVLPQVMLPNQIFVATDKDVEAESLQAGLSTPMLLVTVIALIYIVLGITYESMVHPLTILSTIPAIALGGLLTLWLFNFEFTLIALLGMFLLIGIVVKNAILLIDFTLQQRRLGKTALESVVSAATLRFRPILMTNTAALLGAIPLALSTTEGSELRQPLGLVIVGGLALGQLLTLYTTPVMYLVLEKLAQIFKKFKMSNAIGYRNR
>fig|1120924.3.peg.2380 Permease of the drug/metabolite transporter (DMT) superfamily
MPTKTNIMLTYIVLVFIWASTPLAIVWSVSDLNVLWAMVLRFFIALPLAVIILFVLRVKFPTDKIAVHSYIAGSFSLIGSQVFTYIATQYLSSGIIALMFGLAPIIAGLIGCFAFGQQLNRLQWLGMAIAITGLAVICVGGASQHIHPLGIGLMLISVFTYCCSIYWVKKVNADVQPIAQATGSILISTLVSLCLLPFIWAHAPTHIPEIKSLMALLYTTIMASLIAMFCYFKLVKNIQPTTLSLTNVMTPILALVIGALFNHERISLMVVIGAMIILSGLFLYFYRDIQANRRFSQHMKQQLRQK
>fig|1120924.3.peg.2470 Permeases of the drug/metabolite transporter (DMT) superfamily
MQAWRNAFQKQLSTSVDIYGTTLARFLFSPIFAFSYLAFLYSQQPVTVHVSFSHKFWLYIVIAGISQIYATALMVKLFQQKNYAIGVGLAKSEAILAALVGVLFLQEHLTAWGWVGVSIGAVAVFLLSKGRQHSELSFKTLIIGLGSGLCFAITSLLVREASLELGMLPFLHRAAWVLCSLISFQCVIMLLYLGLFSRHTLYHMWQRIGLTFKVSVCSFLASLGWFSAMSMQTVAIVKTLGQVEILFSLLISAFFFKEKLAKTDHLGLWLVIVAAIMVIWA
>fig|1120924.3.peg.2725 Membrane fusion component of tripartite multidrug resistance system
MDELSQTDDRQEPNYTRRKKVAWIVLILLFLGILLGILYYWFVYRFYESTENAYVKSDLTWIMPKVSGEVIELLAKENQYVEKDQPLVILDNRDLQARADQAKAMLALKQAGLSVQSENEKSAQSTILEAQSARDAAQADVSRLSSDYRRYQQLLKEGVITRQRFEATQAEYLSAQAQLNKAQAAIQAAQAQFSGVQAGRAQLYADLDNAKATVKLYDVDLGASEIQAPVAGKIGSLAVRLGSRVSPQTRLMAIIPKNSLYVEANFKETQIEKMRVGQTVSLVLDAYPSLTYRGKVESFAPASGATFSMMPPDNATGNFNKVVQRIPVRISILPHPQIDLIKPGMSVEAKVDLRSQSS
>fig|1120924.3.peg.2726 Multidrug resistance protein B
MTMSSASIEWQFSPRVAWLIFIAMIFGNFMAILDIQIVASSLNEIQAGMSASRYEVTWVQTVYLIAEIIAIPMSSVLSRILSTRIYYALCATGFTISSLLCALAWNLESLLVFRAFQGFMGGGMIPTSMTALFLLFPEAKRAVPLVLFGMISTLGPAIGPTVGGWLTTSFSWHWMFLINIIPGIIISVVIYASQAIDQANYKLLKELDWLSLIGMAMFLGGLEYFLDEGGRYDWFADFGVRIAFLVSLLGAMIFFYRSYVQPKPLLDLSVFKNKNFTLSCMITFVIGMALYGLGYMIPVFLGQVREMNSSQIGHIMMVTGIVMFFFAPVLAWLIPNFDARKTVFIGMLMAAFGVWLNAHLTIQSDYDFMFWPQVYRGIGLMICLIVISHLAMSTLPEHKIADASGIYNLMRNIGGAVGLALINSRIDWLTAWHATELNSQLTPANWIFVERLAQLKAQYAELGDLSEQLAMQVIYRQVHYQALAASFNDLLKLLAIIMLVVAFLTFFMDRGKKVSF
>fig|1120924.3.peg.2771 Permease of the drug/metabolite transporter (DMT) superfamily
MNQTTKVHGWAFLLPVIAVLIWSLNIAVTRYAVDLISPASISFYRWLIAFIVLTPFMLKSVWRKRHLVRQHMGQLAILSAFGMVLYQGLAYTAAHYTTATNMGIVNAFIPVFTIFVSMLILKEIPNLFAILGSAISFFGLLYILSKGDLSQLAQMGGHWGDLLMMVAVFFYAFYGVFLKKWQLQIPLLISLYVQIGFALIYHIPFLLYFGLDPINAQNAPSLFYAGIFPSLVAPLLWMLAVQQIGPNRTSIFMNLVPVFTAIIASLWLAEQWTIEHSIGGIMILLGIIMAQKKAARVISQQAP
>fig|1120924.3.peg.3200 Permease of the drug/metabolite transporter (DMT) superfamily
MCIWGGFTIFSRLNAQWHISAWDIVAIRFAIAFCILMPILIYKKDLAFLWQREAVILALIGGIGYCLTVYSAFLYAPAAHAAIFLNGCIPLCTAIAAYILFKQPFDGHTWLSFCIMLGAITLMSFLMMQRDHVSFGVGDLLFVMSAICWGVFTVLLKQWKLSAWHSMASVAIWSAVIYLPVYLLFFPKHFTGVNPIHLMIQGVFHGVFVVIISTLAYIAAIERLGAFKTGSIVTLAPFIAAVVAVPLLNEPLSASIICGLIGMGIGALQPWRWRLKDTLTIELEKQKQKSD
>fig|1120924.3.peg.3207 Fusaric acid resistance protein fusE
MSQVDLRKIVRPVVTLLMAIVAIAVIIHLWNYYNSAPWTRDGRVRGDVIQVSSDVSGLVTEVLVQDNQTVKKGQVLFKIDVVRQQLDVEQARSDLAKAKAGLAQSQANLIAAKANLTKSEANTALAEKNAARYSSLLDGAISKQEQDQIYATRDQSRAEIAQMKAAIEQAEATIVQQKSLIEVAQSNLNLALLNMQRSEVVAPADGTLSNFGLQVGNYVKTGDAVAALIDRHQLYVVGYFEETKLNHIHIGDQATVQLMGDDQKIRGHVQGIASGIEDRERSSSSTLLANVNPTFTWVRLAQRVPVKIVLDEAPKNSLAFVAGRTATVNIVQSNSQKN
>fig|1120961.3.peg.326 Permease of the drug/metabolite transporter (DMT) superfamily
MDKDSGDTHKNSATIIGFTAVLMWALLALFTDATGNIPPFQLAFMTFFIGTLIGIIWNIGRKKPTNEEPIPLRVALAGGIALFAYHALYFGAVKNAPAVEASLIAYLWPLLIVVCSALLPGEKLDWHHVLGAFAGFAGTILIVTGGKGFTIDPAAAFGYGLAFAAAFTWTAYSLVSRKFADVPTKSVIAYCAVTTVLALAAHLMFEETTLPSTTLQWLAIIGLGLLPVGAAFYTWDYGMKRGDVQVIGASSYAAPLLSTIILIAFGRAIFSWSIVFACLLITFGAMLAAKNIIRRRKPDQL
>fig|1120961.3.peg.461 Permease of the drug/metabolite transporter (DMT) superfamily
MRRIYANLLLLFVGAVWGMGFVAQSTAMDAIEPIFFTGIRFLAAAIAVLPFAIWEQKRRARTMPESEPTLTRKNILNFAILGAILFSSLATQQIGLLTTSVTNSGFLTGIYVVMVPVLGLLVLRQVPHTIIWPASALTLTGIFLLSGGSLTGLTTGDYWTILCAVLWACHVLFLGRVLTTQRGGNTPFTLATIQFFTCAILGLVLASFFETVSWAILVAAAPEILFAGVVSGGVAFTLQAVAQQYTTAPQAAIFMSSEALFAALFGAIILGERIGFSGYIGCLLIFTAMLAVEIIPMLRLRGRTQIS
>fig|1120961.3.peg.560 Permease of the drug/metabolite transporter (DMT) superfamily
MSYARDIALTALAPAIWGSSYIVATEFLPLIDPLIVSLLRALPAGIILLIIVKELPKGWWIAKIFLLGALNFSIFWTMLFIAAYRLPGGVAAVVGSLQPFIVIFAARLIIGTPIKLLSIVAVMAGMLGVALLILTPKASLDLFGIGAALIGSASMALGTVMSKKWQPPVPPLTFTAWQLTAGGILLLPTLLLVEGQWSDFSLTNFAGIAYLGLIGAAFTYLLWFRGIARLNPSSVAILGILSPLVATLLGWFILGESLSALQLFGVGIVLVSVIAGQYALRPNRVVLKPAMSK
>fig|1120961.3.peg.958 Permease of the drug/metabolite transporter (DMT) superfamily
MFIFEAAAMLAALTWAFTSILSADPAKHLGAIAFNRWRMTIVFVALIAWATLFGTWSSITGDAFWALFWSGFIGIFLGDTALFLTMNRLGPRRTAILFSMNAPISVLLGYLFLGEALALQTFLGVSITIIGVILAIIFGKRKTQLHKWESITGTLWVGILFGTLAALAQAIGALIARPIMETGVDPVAASALRVGTAAFGLWALMLLPHKNFKQANPGSVSIWTQVALSGLLGMGLGMTLLLFALSGGKVGVITTLSATTPALLLPILWWRTKEAPAIGAWIGAILVILGSALIFNA
>fig|1120961.3.peg.1052 Permease of the drug/metabolite transporter (DMT) superfamily
MANGIKLETVAPALFVLLWSTGWIVAKYANDYAGPLTFLTWRFAIAALAFAVIAVIMSAKWPTTRAGWLHAIISGLFLHAIYLGGVWWAIKQGVPASISGLLAALQPLMTAMIAFWIIKERLTMRQRMGIAVGLFGLLIAIGPRLLSLDTDALLTASLPLIINVIAMASVTFGTIYQKRFLQEGDLIPVATLQYVGAFIFIAPAAMILEPSLVFDLNIHSILAMIWSVFGLSLGAILLLLYLIRRGQVSRAASLIYLVPPAVGIEAWILFGETPTIPFIIGTLIVVAGVWLVNHKRPVQKST
>fig|1120961.3.peg.1173 Permease of the drug/metabolite transporter (DMT) superfamily
MQNNKNAYIFLFLTTLFWGGNAVAGKLAVGHVSPMMLTSIRWGVAVSLLLLIGGKQFWQDRAIIKPHLPLLFIYGGLGFAVFNVTMYSALNHTSAINVAIEQAAVPAVIFIGNFILFRMRVSALQIFGFSLSLIGVAVVASHGSLERLAALEINKGDMFMGIGVLAYAAYSVILRYKPDLHWKSLMTTMAIAAFIVSLPFAYFELKGPNAILPDAQGWAIGFYTAIFPAIIAQVLWIKGIDLIGANRAGVFINLVPIIGTILAVIILGEVFGLYHGIAMALVVGGIWIAESSGRKAHRNAPDVPR
>fig|1120961.3.peg.1369 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDKAKMLGTACVLLVRDFKKSVDYWENCLGFTAHIWGEPPNFAIMERDNIRIMLSHAPDHTNKPNWEVGGGIWNSYFWVDDVQSIYQEFIANGAKIDYTLHEKPYGVLEFGIQDLDGHDIAFGQDLN
>fig|1120961.3.peg.1700 Permease of the drug/metabolite transporter (DMT) superfamily
MLAVRFNWTIAVLLFLITALVMTAFAANSVLARAALLGPTIDPASFTTVRLISGAAMLALLLLTRKQTSIRGLIGGGNWHSAFWLFAYAVTLSFAYIGLDTGVGALILFALVQATMIGWSVFKGDRPIVPEWAGLIIAFSAFVWLVSPGLEAPDPFSAFLMALSGIAWGAYSLRGRGATDPLKATAGNFILAVPMAIAVSAICFSQNNASTYGILLGIASGAITSGIGYAIWYRVLPQLSAMQGSIVQLTVPVIAGLGGLIWSGEPFTLRFVLGSVFILGGVALAIISKTKRV
>fig|1120961.3.peg.1879 Drug resistance transporter, Bcr/CflA subfamily
MTNFERVALYALLISITALSLDMLLPLLPTIAQEFKSSDSNQIYFVISAVIFGMIFGEIIFGPLADAIGRKPALIIGLAVFLFGTIIALTAHNLTWLLIGRAIQGIGVSGPKIATRALIRDQFQAAQMARMMSMVFFMLIGVTMLAPILGQWLGNALGWRSIFYFYLIITFVAGGWLLLRHKETLPRNARTPLLLKEMLKNLNLILKNGRVLSYTCIAGLVFGAQLTFLSVAQSIFDKTYGRADSFVYWVAALSLCIGLSSLLNSYLVMRKPMDYLVGFALSGLGFIGAILFTFSQVSDTYPPFIVFITATAFAFGCIGTVFGNINAMAMTYLGRVAGLGASVISSVSSLIAFALAAFMSQIHDGTPFALSICFMIAGLGGLTALIMARQLDEISV
>fig|1120961.3.peg.1882 Permease of the drug/metabolite transporter (DMT) superfamily
MLLKQSESRMSKPTINSSMTTIEWVMLITLSVVFGGSFFFVGVIVQDMPPKTIVFFRVLIAALALHLFMRVTGRKIPWTGTAWFAFFAMGLLNNVIPFSLIVWGQTQIASGVASILNATTPLFTVMIAHALTTDEKLTITRVSGIVAGFIGVAIMIGGGAIADGAATALAQIACIGAAISYGFASVFGKRFKGMTISPYAVATGQVTASTIMMFPIMMIFDQPWTLSMPSTQSIFALLALGLISSAFAYILFFSILDGAGATNLSLVTFLVPVSAIFLGIVFLGEILLPRHLAGLGLIIVGLILVDGRVLKRRVTA
>fig|1120961.3.peg.2118 Glyoxalase/bleomycin resistance protein/dioxygenase
MHITKLDHVNIRTTQLDVMVKWYCDVLGMKSGPRPDFPFPGAWIYAGDNAVVHLIGVENDAGAGSETLLKLEHFALSATGLAAFEEKLKSRGEEYRRGELPDFKIVQINVYDPDGNHIHVDFRTDEEVA
>fig|1120961.3.peg.2378 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDHSGISAADISKAVSFYDQAFAPLSISMLAEVPIEFTDGKRVVGYGTHRPQFWLSEGEAQKPPVHFAFAAPTRAAVDAFYEAALKAGGSDNGAPGIRAHYHENYYGAFVLDPEGNNIEAVCHKAKT
>fig|1120961.3.peg.2478 Permeases of the drug/metabolite transporter (DMT) superfamily
MTPYQKGLLITGFGGLVLTIDIPLIRLGGGDAWSAQFTRSGLGLVIALLCWIFIRLRQGKRVSLLPGRAGMVVAAFYGLSAIAFVAAVFNTTTANLVFILTSTTIFSALLGWVILRERPKTATLITMAIMVFAVFLIVSESIQSGNYFGDLCAVAASFGLSMAIVFARLSGKDMGFAPMIGGILPLILATGVLLSKGGVSAFHLDAAWWTIANGAIVIPIAFWCLATGPKYLSGPEVGMFYLLETVLAPIWVWIIFSEAPTRNTMIGGTILIIALIGHSLWQLRSERKRRSAERNELATNIG
>fig|1120961.3.peg.2542 Permease of the drug/metabolite transporter (DMT) superfamily
MNPIRKASPADLALLLFVAIIWAMAFIAIKIAVPEVGPLWLAAIRVGIGALVLAPYAIYRGMALPSSSRMWTLIIAMAILNVVIPFFLISWAELTIDAGVTSLLMGVGPFLALVSGHFFTNDDKINTRKAIGVLFGFVGVLTVVGADALSHMGDSNILGQLAALGGSLCYVTAGVLIRKIDMPPTRLAFLALLIGTVILFPVALLFADPISAMPSSNAMMALIFLGVLPTGVAYIIRFYLINKVGYSTFSMSINLIPVFGIFLGFLILGEPLRPQILIALALVLIGLFIAKSGGPKGEKIDKEAVS
>fig|1120961.3.peg.2758 Permease of the drug/metabolite transporter (DMT) superfamily
MIAAPAFFSTNLIFGRYVAPETDPFILAFIRWACVAIILLPFAIKSGGAQMVRLIRTEWPFFLFLSFLGMGISGSGVYLGLQSTTATNATLIYSTAPILIILLERVFAARKSSPGEGLGIAVAFVGIVIIVAKGSFDTIAQFAFNPGDLLIALAALSWAGYSILYRSERFSGLSSVTLFGIIAIFGAIINLPVATYAFYTGAQLPHSASAWSAVAGIIFISSLIAFSAYQYGVRALGASIAGLFMYLMTPYGVLMAVIFLGEELLPFHIIGIICVMVGVTMATFPKSMLDKFKRKAA
>fig|1120961.3.peg.3118 Bicyclomycin resistance protein
MTISADIYQAAKPKIWILVVLAAVGPLAINIFVPSMPSIALDLDAPYATVQLGLSMYLLATAAISLFSGPLSDKYGRKPVLVGSLILFLVGSTICLLADNASSFLIGRIIQAASATGMVLSRAIVRDVYPREKSASMIGYVVMGMAVAPMIGPAIGGYIDSVAGWRWSFGLLTSFGLIALLATLILLPETNTNIGQSASNQIQGYISLATMPIFWLFVGSASFTSAVFFSFLGGGPAVSSLFFGQTPFEYGMYFSLCALGYAFGNGIAGRYSEAVGLEKMMSLGAIFSFIGPVVSLLLFYLSAEPAAWMLFVPLSLIGLGNGMTLPNVTAATISVRPEAAGAASGLLGSLQIGGGGLASIIGGIVVGETGSPYGLCALLVGFGLAALIITLMAARMSRRYEAN
>fig|1120961.3.peg.3214 Drug resistance transporter, Bcr/CflA family
MFRFAVILGLLSAVGPLAIDMYLPALPLIEAGLGADVTAVQASLTVYFIAFGVAQLFFGPYSDQVGRKKPLYIGLAIFAIGSIGCALAPTIGWLLAGRFVQGIGGAVVMVVPRAIIRDQYTGTQATRLMALIMMVISVSPMLAPLAGSVLMEVASWRGIFWALAVLTLASLALTLFALPETLAHDNKVPVNVTSLMRGCGILLRDKKFMGLTFIGGFGMASFFVFLANAAFVYTSEFGLSPVQFSLAFAVNALGFFSSSQLAANLGEKFGMEKVVATATFGFLVFTGLLLGLVLAGFGTLPVIVGVLFLANACLGLVVPSTMVMALDDHGDMAGLASSLGGTLQMVAGGLMVVLASPFFDNTALPMVAAITVCAVVAFVLTRLVLNKSDIAVTPV
>fig|1120961.3.peg.3296 Permease of the drug/metabolite transporter (DMT) superfamily
MKYIIFILFTVATNAAAQLMLKQGMTTLSPSVLAQDNIILKLLMVVFSPWVFFGLATFVISMASHMFVLSKVDLSFAYPFLSLAYVLVAVLAWQLFGEELGTYKIAGIVFICIGTVLIAQSGSPTQETSISQTTTEEYNS
>fig|1121428.3.peg.571 Permease of the drug/metabolite transporter (DMT) superfamily
MNSMIGGALYLSLAAAIWGGMYVVSKFALATVPPFTLLFLRYLVAALLLVGILWRKQEKLLPDTARGLILQVGLVGYFFSIAAQFIGTKLSSAHMGAVITTLSPVFLSAFAVVILKERLTVKQAVAMAVALAGVLVVVGVPGRQGEPSALAGNLFLLGAALCWGYYSVISRKVSTVYSPLQITTWGILIATLFTFPCLYFEYGQWSPADLLQLPIVLSVLYIGIISTALAFFSWNKGLALVPSHQAGLFFFLQPVVGTLLGWFFLDEHLSGSFFIGSLLIMAGVYYNMKQTAGSE
>fig|1121428.3.peg.634 Vancomycin B-type resistance protein VanW
MNKARLTFLVTLALGFQLLVCIGLSSTATVLYYRDTILPGTSVQGVDLGGLKAAAAEQALRRALPWPSPDSLLMLVDPEGQSTHIRYSDINYRADYQATVQEALKQSRQAAAWHNIGALFGAIHQGHNMPLVKTFNQAAFSKILNQLADKYNVPARNAQFAFNGNNVILFAESKGRQLDIPGTLKQLRELPPDQHRLALQFKTVEPEVVISDYNGINTRLAIFVTQFDSSNKARSHNIELASKLINNLIVPPKQVFSLNKVLGPRSQDRGYLQAPVIINNKLTSDYGGGVCQVATTLYNAVALAGLQVVERVPHSLPVPYAPPGQDATIAGDAIDFKFLNNTDYPILISSQVQHGKLLVSIFGHRQGASARLIKIETERSITKPERKYVQEQNLAPGQVVVRRPGRDGYQLKTYEITMENDKEVDRRLLSQAIVEPEPEVIAVGPGISTKGQVKK
>fig|1121428.3.peg.727 Efflux pump antibiotic resistance protein
MEKDAALKKYTLLTACGASFLTPFMGSAVNLAIPSIGKEFNSSALLLSWVATSYILASAAFLVPFGRLADIVGRKKIFMLGVLGFWLSSVLCGFARSVEALIAFRVIQGIGSAMIFGTGMAILTSVFPPQERGKVLGINVATVYTGLSLGPVLGGVLNHHFGWPSIFYFTSLIALSVFFLTVTKLSGEWAGAREERYDFLGAALYALGLVALMYGISAVATSPWAKYILLFGFVVLLVFVRYELRVKHPVLNLSLFKHNTVFAFSNLAAFINYSATFAVGFLLSLYFQVVLGFNSQITGFILLSQPVIMALLSPFAGSLSDRKDPRIVSSWGMTLTTVGLFIFCFLDRNTPLWLIIMNLLLLGTGFALFSSPNTNSVMGSVEKRFYGIASSALGTMRLTGQAVSMAIVTLLLALYVGNVKLSQAPADLLVKGTKTTFIVFALLCFMGIFASLARGKKPAGLQKAPPYK
>fig|1121428.3.peg.746 Acriflavin resistance protein
MFLTNLSLKRPVFATVTVLALLAVGIISYIGLNINDYPEVEFPYVVVTVVQPGASPEQVESKIVSKLEEAIGQISGVKHIYATAREGVATVFAEFSLETSPEVAAQDVRDKIGTIRGELPQDIEEPIIARFDPSAMPIASLAVTGSLSQRELTTVVEDLIKRRLETVNGVGAIDIYGDVKREIHLQLDKYKLAAYGLTTAEVINSLRSENMEVPGGKVGNGDREMTLRTVGSINRVEEFANLPVARRDGVQLYVKDIATVVDGVEETDSLSRYQGKPAIGIDIIKQSGANTVEVADRIKAVLAEVKQELPPGVQLEMVRDNSVYIRDAVKDVRNTLIEGSVLAVLTVFIFLRDWRSTLIGALAIPTSIIATFFAMKVLGFTLNFMSLMALSLAVGLLIDDAIVVIENIVRHLRLGKSPLEAARDGTGELGLAVTATTLTVVAVFLPVGMMTGIVGQFFKQFGLTVVFSVLVSLFVAFTLVPMLASRCLKEEEHLPGGPVGKFLKWFNRGFDKITAFYADFLKVVLRNRKKTLGIALLLFLGSLMLIPLLGSTFVPSSDIGELYVVADLDAGLGMAAAGQVTAEMEKVLQGFPEVTKLYTTVTNERANIFVKLVDKHHRDKTIDRLAMDMRHQLNAIPGVKVTVNQQAGMSDGAAIQFRLLGDDLDQLQVYAEQAQKIMESIPGTVDVSGSYKPGKPEGQVQIKRDVAADLGVSTASVADTLRTLFNGVVVSQYEEGEERFDVRVRLAEDHRRNLADLSNIYLPGAQGLVPLSQVSETVFATSPSQINRFDRTKEIVLSCNTDGSISMGEFNKIFKERVAKEMNLPPGYSFYEGGDAERMGETFTAMLLALVTAVLFIFFILAAQFESYIDPFSIMLSLPMAVVGAILALLTVGSDLSIMSMIGIIMLMGLVTKNAILLIDFTKQERARGVERNEALRKAALTRLRPIVMTSTAMILGMLPLALALGPGAEGRAPMAHAIIGGLITSTLLTLVVVPVIYTILDDLKAKTTALKHRFMQAGDGA
>fig|1121428.3.peg.903 Permease of the drug/metabolite transporter (DMT) superfamily
MKPSIKGFFFLVGATFLWGVSGTVAKILFNHQVNPMHLVTIRLTLSFAVLLLYLAVWQPHLLKVKKSQLPYLAVLGTAGVGLVQFSYLFTISQTNVATAVFLQYLAPALVAVYAFLRQRESKSPVKLLALLLTAGGGYLIVSGVPGGGLAVNWPGLASGLVSAASLAFYTLYGKKGLATMNHWTMLLYCFGFGALVWNIFQPPWVAMVGHSLTEWYFFLYIAVFATVLPFGFYFCGLNCLTPVITSLTSTMEPVVAAVVAFLALGETLYPLQLVGCSMILIGVIAIQCVPEQEKLPDKQSVSQEG
>fig|1121428.3.peg.1465 Acriflavin resistance protein
MHITELSVKRPKMMTMVILVFVILGLYTYRQIGVELYPAVNTPFVSISVSYPGAGAEEIETQIVKPIEDAVSSLSRLKTVTSTASAGSANINLEFALSADADQAAIDVQKKMDALRRRLPDGADDPVVIKRDINAAPVMLLALSGDSGRTELYDLANDVIKERLQRLAGVSEVAVFGGLRREIRIEVDKNKLTGYGLSINQIVNRLKAENINDPSGRLDRPEAEYNVRVLGEFRSVQEIEEIAIPTASGYAVPLKAVATVTDGYQEVRVHSRVNGQNAIGIQIYKQSDASMVAVGQAVKQELAALQTQLPPGTSLKISRDNSDFVQRSVNGTRSNIIEGIITTGLVLFLFLRQWRASLIVLLAIPTSLMATVMMMYFCGFTFNMMSLMGLALCIGILVDDSIVILENIHRHLHMGKTPWQAAIEGRREIGMAAIAITLSDVVVFAPLAFMNGMIGQFFRQFGLTIVFATLFSLFVSFTLTPMLASRLYKEGDTAESARPTRKSLFDILWQHTVPLGQQIKSKYTNMLLWSLSNRKKVLVLSALAFFLSLSLIPLKLIGTEFMPRTDEGGLTVSLEMPVGTPLEKTNEVLRRLEHYIGQIPDVQYYNTMAGSGGRGGAGGANTGRIEVQLRPKQQRQKSAAQIAEEIRKQGMAVKDAKVFVAESDSRGGGGGSAVRILVAGHDPEQINLLADQVKEKVAKVQGVTDARTDWSLGQPEIQIKVDHNRAAHYGLSVQEVAGTARTAVNGQNAGVLRDGEQEVNITVKMANAQLQDIESLQNLLINSNGIPVALGQVANLEYGSGPKSIRREDKQRVITVSAGIKERPLGDVMADIRKELAGIQLPAGCSIKFSGQDQSMRESFSELISALILSVVLVYMVLVMLYESFSTPLIRMLSLPLGIVGALTALALTKNNINIFTLIGIIMLDGLVAKNGTLLIDYTHTLLERGRTLKDALTEAAVTRLKPILMTTVTMVAGMLPTALSITEGAENRSGMAWVLIGGLLTSTVFTLFVIPVVYTIFDDYKTKWRHRRFSSQVSQPAPEITA
>fig|1121428.3.peg.1500 
MKKKNIYLVLLAMVVTLAAVSFYYWYQNAHYVATEDARVDGEIIKVSPQVAGLLVELPVYEDQYVDQGEMIARLSDVTLTPGANLDLAVIKAPISGTIIKKIGHVGEIASPGVPVVMMADLQNLYITANIEETSLNKVRVGQAVDYTIDTFPGVRFTGKVVSIGNAANSVFSLLPQQNTGNSFTKVTQRIPVKISIDDYRQCRLLPGMNAVVKIHIK
>fig|1121428.3.peg.1501 Membrane component of multidrug resistance system
MGLHNQDNSSRRQNQPPPYAAEAKSIPWGALLILVIGAFMAILDSSIVNVALPRFMTLFGSSADEIQWILTGYMLTSGVVVPITGYLGDRFGNKRMYIWSVAAFTLGSLLCGLAWSTQSLTVFRVIQAIGGGMIIPVSMAMIYRIIPREKIGLALGIWGIAAIMAPAVGPTLGGYLVDNYSWHWIFTINIPIGIVAIMLAIAYLEETPVQKNLKPDLVGILLSSAGCFALLLALSEGQDKGWTSQYIVTLLVFSGFVLCLFALWELQVPNPLIDIRLLKNPVLSASLLATCLTTIGLFSAVFLIPIYAQNLLGYTPMETGLLMMPMALVTGLMMPISGKLFDKFGAFWLGMIGMSLVVAVTYYLHTLTLDTSYRHLQVILSLRAVGLGLATMPLTTAGMNTVPRFLVGRASALNNTVRQISGSMGIAYLTYVMLQRQAYHTAVLNESVSLTSPVASLAQAQIKGYLVGYGLNGEAARQGSYSVISGLLARQSFMNAISDTFVVSAVIIALVLPLMFLLSKQRVEQERIKQQNLSQGRLPA
>fig|1121428.3.peg.2139 Permease of the drug/metabolite transporter (DMT) superfamily
MTKMKQLQADLALLAVTVVWGATFVVVQDALSGIGPYFFTGIRFAIAFALLGLIYFRRLANLDRATLRAGCLIGVILFAGYAFQTVGLKYTTASNAGFITGLAVVLVPVFTSLITKQLPAPAVLLGVTGATLGLALLSLGDNLSVNYGDVLTFFCAVSYAGHILLVGRYAPRHDPVLLAILQIGTVAVISLLFGLCLETLPAQFSKPVWQGLIITAIPATALAFLIQNSVQRYTSPTHAAIIFITEPVFAAATAWLVAGEVLTTRQWVGCLLILAGMLVAELKDYLFNVTKIKQARET
>fig|1121428.3.peg.2177 Vancomycin B-type resistance protein VanW
MAEQILKRVVPVVLPLLFLISLAVFLATQMSFAPADRILPGVYMLSINLSLLDYPQAVSALKKLEQDMQKPLTVKYQGKSWLLPMDRVGLKLNCQQEARRAINIGRSGPLWQRFCERRQAYRGIRLEPEIIIDTGLLQQQVSQTAKDIILPPRDAGLIINNDDTVEISPAQSGREIDIQQLRQDIRERLLQQDTSPIELKPVEIPPARTTEEVQAMGVDTLLGMFSTQFDPNNVNRAYNISVAAAALDGLSIRPQEIVSFNEVVGPRSTEAGYKNAPIIINNELVDGLGGGVCQVSSTLYNAVLLANLEVTERANHSLPVPYVPIGRDATVVFDAVDLKFKNNTDYWLYLQSFVTGGRLTVKIFGNHRFKRDVVIRSWVEETYPPRTVVEKDYSLRLGDRVVKQKGAQGYRAASERIVMQDGKVIKVEKLPYSVYKARHQIISQGMAPPASLVKNPDPPGEAVEQDRGNPDVLP
>fig|1121428.3.peg.2372 Permease of the drug/metabolite transporter (DMT) superfamily
MVFLSYIKVRFQYFRLHEDDTVSIEFFLWGVFHHRIEIPVLMLRQKMAGFSLISRTELETGQGDPGEIMSRENQITITGVQQLLDKLRKWLLWLQVVQEDVDFFLRHLVLEKFYWRISFGTTDAAATGMLAGLAWSFAGLVTALFYHKIAPGRVQPVIKVEPDFKKAGFATSADCIFKIRIGYIMVTGLKILKKKANKQGVNFLGRTSHRRSHENCHGKY
>fig|1121428.3.peg.2429 Vancomycin B-type resistance protein VanW
MPFLIGLLGLVALVAGVVSGFWIFQLNHAEAQCIPPGIFVEGIDLSNLDRRQAAAKLQQYEQTLLSKQIQLSYQDQAWHMTLQELGFMAKSDEVLNLALQNNFSLLQQRLQAYFRPVRRDYHVTIEINKEQMTKALESVVRSIERPARNAELVISDHGRVMIQPDQKGYQVNLEQVYKQLLNTDIRQASIQVNLAVNELIADKTTADIEKLRINGKIAEFTTKFDANNVNRTVNIRTAAARINGVMLAPGQEFSFNKVVGERTGKAGYRPAAVIVANKFEEALGGGICQVSTTLYNAILLAGLTPVERHNHSLAIGYVPLGRDAAVAWQQLDFKFKNTLPGHLYLRTVVTSDAITVQVFGDTAAKKDIVVRSWVTETIMPDQVIKEYDPALPPGEEVTVAPAYAGFRAKAERIFKENGTVVKREALPDSYYQPRPKIVKVGQKTEQTDPNLQAVETEF
>fig|1121428.3.peg.2663 
MQVITFGKLQAQDGQGDALMDIIRQHMDYLKQQPGLVQGYVARCNGNSNKFLVVSVWANEEAQQAAMTRLSTDPEATKGFLQMMQLLNGQPDFGNYTVESIVK
>fig|1121428.3.peg.2764 Permease of the drug/metabolite transporter (DMT) superfamily
MISGSNMFSYAVLILATVSWGGAFVAAKMVVGEIPALVAAALRFWLAFLCLLPFMLVQEGRKAKISSKDWPALVFLGFSGIFLYNILFFNGLRVSAAMDGSLLVACGPVLTALLSAFFLQEPLHWRQAAGFLVSLGGVVVIVTKGVPAALLSWDINHGDLMLTCSALTWSFYSVGGKVIMKRLSPLTCSTYAMGIGAVMLTLAAVTQWQDNPFGRMTIVSVAGLTYLAVIASALSFVLWFAGINRVGAGKAAIFQNLVPLSGAVFSVLLLGEQWQLFHAVGGGLILGGVYLVTKPAGTVLPAGKVSRGI
>fig|1121451.3.peg.182 Acriflavin resistance protein
MNLARWCIENNRTAIALFLLVALGGAMTFVSIPKNEDPDFTIRTAVVMTVFPGASPQRVEELVTDKLEEKIREIDVIKNVKSQSMTGISIIEVEFLENIKDMDPVWQRLRNKVSDAVPTLPSEAQAPIVNDEFGDVYGILVALTGDGFTYRELKDVADYTRDELLHVPGVGKVERWGLQDERIFIDFSNSRMAAAGISPFLLGQVIDHQNTIRPSGSAKVGPERIYIEPTGEFKSVDDIASLSMRVEGMKTSMKLSDVTDVSRGFADPPSVMARYNGKPAIMLAISMAEGNNIMELGEKVTARLDELSADLYHGMEYNIVVYQPEYVETAVSDFMLNLLESFIFVVIVILAFAGFRTGLVAGSLVPMAMLGCIGLMPYFDVGLQRISIASLIISLGILVDNGVVVSEAILVRLAAGEERMNAVSNAVSELWMPLLAASMTTVFAFLPIPLAESTTGEYCFSLFVVVTLTLLCSWILSMSMVPMLCYYVLKPKVVIQTFSSRMYRAYRAMLLCCLKHRTVFLAVVLAGCVVAFWGFKFVPKMFFPPNERAQFTIDFWQPFGSDITTTAEEVGRLEQFLLADKDVVSVGTFIGHGGPRWYLPLNLEQRNDNLSTFVVNTKSIDSVDALMTRTRQELKANFPDADFSLKKLMNGPPVGAPVQIRISGPDQKTLYRLRDKIVAMLEARAGVSRVWDDWGQWTKKMVVEVDQDKAREAGLSSFDVAASLQSGMSGYQASIFREGDTNIPIVLRSEDAFRNRLDKLESINIYSYQDGKSVPLNQIAVSKLVWQPSDIRRRDQTRTMTVKADLFDGYFAMQILNSVRPEIEALTKTSQWPVGYSVAYGGEFEKSEESQASINANMPLAMGLLVLVLIFQFNSFRRPLIILMTLPPMMCGITPGMILTNSPFGFMPMLGMISLLGIIVNNAIMLIDRIEIQRKKGINLDDSIVLASLERARPIIMTATTTIIGMVPLSLQGGEMWRPMANCIMSGLMFATVLTLILCPVLYSVFFKQSYKGYNWNPAVIEHGKDG
>fig|1121451.3.peg.751 Multiple antibiotic resistance (MarC)-related proteins
MLAIFFQTYLKLFFILTPFFAISAFLSLTQEMSPAERKRTAVKVTMAVIISSVLLYLYGRYIFELFGITLDAFRIGAGAVLFLSALNMVGGGTKKFEAGNEDDDISVVPLAIPIIVGPGTIGALLVMGSTVQGYKDMVLACTALVAAVLTVGVLLFLSSGFKRLLGKRGLNIMSRLTGLIVASIAAQIFFTGLRNFMLN
>fig|1121451.3.peg.1051 Permease of the drug/metabolite transporter (DMT) superfamily
MTDRSLKADILLLITAIIWGAAFVAQRVGMDYMGPLTFNAVRFALGAVALLPLIYSLDREKKKDGTYRKVELGSFLKGSLIAGGALFLGATFQQWGMVYTTAGNAGFITGLYVVFVPVFGLFFKQKTGLPTWIGALLAVTGMYLLSVNEEFHIEFGDLLVLCSAFFWAGHVIVISLLATRVDPVKFAGGQFVACSIFSFMGAFIFENVSLAGIIDGAVPILYGGLMSVGVAYTLQVIAQQDAKPAHAAIILSLESVFAALAGYVLLGEMLTVQGMAGCALMLCGMIISQVKSS
>fig|1121451.3.peg.1414 Acriflavin resistance protein
MSVPANSENSQGLIASAVRFFLHSKLTIVLVIGALLLGVAAIQLTPREEEPQIVVPMADIMVQAPGAGVEEVEKLITTPLERILWQIDGVEYVYSVSRRDASLVTVRFFVGEDREESLIKLHNAIAKNTDIAPRIASGWVIKPVEIDDVPIVALTLFPAAGRNDISDFELRRVAEELSTRLAEVEDLSRVSLVSGRSREVRVELLPERMAGFNISPVEIAAVLEGADQSAVAGAVLAGNREITVSANSFLDSASDVNNLIVGVSESRPVYLRDVAVVKDGPEEPSSYSRIGFSRLYMTLTGQDVEESSRPAVTIALSKKKGTNAVKVAEAVLARMDRLKETVLPAGIEVEVVRDYGKTADSKVSDLLGSLGFAVFTVIILLAFTLGWREASVVALAVPISFSLALFVNYMLGYTINRVTLFALILSLGLVVDDPITNVDNIQRHILMKKKKAAEATLDAVSEVLPPVIMSTLAIIVSFVPLFFITGMMGPYMAPMAANVPLTVTFSTFCALTIVPWMAFRLLKNIQPQKVATDTGPGRIEIFYSAVITPFLDSRFRRWMLVGVIVIGLIVSMALAGFRLVPLKMLPYDNKNEFQIIIDMDEGTPLEQTDRVVRQFEEILRGVPEVTNFVTYAGEPSPMDFNGLVRHYYWRSGGHMADIRVNLVDKSLRSEQSHAIVLRLRHELEAVAARNNACIKIVESPPGPPVISTITTEVYGAEDRPYSALIEGAKQIVSVMKTESGVVDIDDSTAAERIMVDFVLDKEKAALHGVNAREVVATLQMALSGMVPATVHAEGERNPLPVKLILPFVRRADVASLSQLRVKTAAGKRVPLAELGELVEINQEQPIYHKNLKRVVYVFAEMAGRAPGEAILDMQGKLKKDPLPPFIWTDWAGEGEWQITLDVFRDLGLAFGAALLGIYILLIVETGSFGMPLLIMSAIPLTLLGIMPGFWLLNLVSAEKVQGLVGAGFVDPVFFTATGMIGMIALGGIVIRNSLVLIDFIRKSLAEGMELKAAIIKSGAVRLRPIALTAATTALGAWPITLDPIFSGLAWALIFGLLASTLFTLVVIPVGYYAFEKNG
>fig|1121451.3.peg.1638 Multiple antibiotic resistance (MarC)-related proteins
MEIKSLSAIFEIAFPLFLIMDPLGNLPVCLSMLKEFSPAKQRKILLRELLFALGIIILFMYLGAGLMKMLNIHQSTLRIAGGVILFIISMKMIFPKPEGSATEAEKDPFIVPIAVPLFAGPSLLAAVMVYGSRGDADLTVLSGTMLAWGLTFIIMMAGPTLARILGKRGLRACERLMGLVLILLAVQMLEDGVAFYINNVLGK
>fig|1121451.3.peg.1803 Acriflavin resistance protein
MAGNPVASNLLMFILLVGGLVMAFNIKQEVFPEFTMDTVTVSVVYSGASPEEVEQGIVLAVEDAVMGLDGVKEVSSSASEGSGSVIVEAEEGYDLQRLSQDIKSEVDRITSFPEEAEDPKVKIASRKRQVMTLMVHGDEEPLALRKLAEQVREELINTSGVTQVELSEVSGLQVTIEVPQDKLRAYGLTLSDVAAKLAQTSVELPGGGIKTEAGEILVRFKERKDYAREFARVPIVTGEDGTQVLLEDIADVKEDFQSDDYISSFNGDPAVRLNVYRVGTQTPISVSDAVHEKLEIINEGLPDGVSVAVRNDSSDIFKQRMDLLLKNAYMGLGLVFIFLALFLEPRLAFWVAMGIPISFLGAMLILAPAGASVNMVSMFAFIISLGIVVDDAIVTGENVFTMRQQGMSWYEAACEGAKRIAMPVTFSVLTNIVAFMPMFFIPGVMGKIFKVIPLVVISVFFISLVESLFVLPAHLGHCRGRKPGKIMGYILRHQQKISGGLLTFIHKVYRPFLDRAVTWKYLTVAIGFACLIVAFAYIKSGRMGFTLFPKIESDYAYLTVDLPYGTAKEVTLRVQDKVLDAAEQVAQENGGEELVEGVYSSIGGVGRRGSSGSHVLKVQVFLTDADSRPITTEEFVNQWRRNLGPIPGSESILFESDRGGPGAGGSLEIELSHSNIEVLKRASADLAKALATYPKVKDIDSGYSPGKRQLDFELLPTGRSLGLTSRSVANQIRSSYYGAEVLRQQRGRNEVKVMVRLPESERVSKYNFEEMMIRTPKGTDVPLREVVKIKDGRAYTTIDRRNGRRVVSVSADVNPRKETSQIMSAVVADVLPQLKADYPGLGYSLEGKQADLKESTDSLISGLLIAMMVIYALLAIPFKSYFQPIIVMICIPFGIVGAVVGHILLGYSLSLMSLFGIVALSGVVVNDSLVFIDYVNIQRRKGHCAYDAVLEAGTARFRPILLTTLTTFGGLAPMILETSRQARFLIPMAISLGFGILFATAITLLLVPSFYLIFEDIRLGLRKLFRRSDDDFRDDGITEHYPVKHCKHKSE
>fig|1121451.3.peg.2767 Permease of the drug/metabolite transporter (DMT) superfamily
MQQHDQKKAYIYGLSAVLIWSTVASAFKIALSHMEPLHLLFYAVIFSTLALLIILIIQKKIGQITLMSKRELLKNALPGLLNPFLYYIILFEAYNLLPAQEAQPLNYTWAITLSLLSIPLLGQKMTARELLAIFTSYLGVVVISTHGDLLDIKFSNGYGVFLALVSTIVWALYWIYNTKSTADPLIGLFLNFCLGLPFVTAAMFIFSGPPPVNGPAILSAAYVGLFEMGITFALWLKALKLTEKTARISNLIFLSPFLSLILIHLILGEEILPSTLVGLIFIVGGNIIQQMGKRTA
>fig|1121451.3.peg.3168 Permease of the drug/metabolite transporter (DMT) superfamily
MSSTTLLYFKLIGSVTFWGGTWIAGRILAEDLTPYSAAFLRFLFATIFMFFLVRRTTGRKPECQLADILPLAFLGLTGVFLYNILFFTGLQTVTAGRAALIIAGTPTFIALGSALFFKEKFTPGKIAGFLLAITGVATTIGDGNPISIITQGASYGDLCIVGCVFSWAAYSLAGKPVMKRINPIESVYWSSLFGTIMLLGPALYHGLLNEILNASMTDYSCILYLALLGTGLGFSWYFEAIREIGPSKTGIFINLVPVTAIILGAIILGEPVGLPLIIGGMLTISGVYITNRS
>fig|1121451.3.peg.3172 Permease of the drug/metabolite transporter (DMT) superfamily
MMSFFQSKYIAVVALLVAVFLWSSSFIALKVAMAVYDPMVVIFGRMILASLCFLFFIPSFKKQAIQKGDLKWLAFMAFCEPCMYFIFESHALVYTSASQAGMIVATLPLLMAVSARFILKEKLSKKTLSGFILAVIGGIWLSLSSSSTEASPAPMLGNFLEFLAMCCAVGYMTVLKKMTARYSALYLTAFQAFMGAIFYLPLLALPSTTLPTVFDPVAVWTIVYLGVCITLGAYGLYNFGMSRLPANQTTAYVNLIPVFTLFMGWAILDETFTSMQFAAAGLVMSGVIMSQDRKMSS
>fig|1121451.3.peg.3285 5-nitroimidazole antibiotic resistance protein
MAGENKARKGQTKDKTIIDQYLSEGEILHLALKDRIGIFSVPVNYGFYGDKLYVHSSKQGRKIQALREGGVIGFSIVVSHEVVGKDAPCKWGCSFKSIIGTGVPRILDDKEKAAALNLIMKQYSGKEWEFNPAAIDAVDVVEIMITSVSARSVEKE
>fig|1121862.3.peg.305 Acriflavin resistance protein
MNIAEYSISHRVISWMFVVILLVGGAVSFFGLGQLEFPEFTIKQAMVITHYPGASPEQVEEEATLPLEEAIQQLEYVKVIDSISSNGRSQIMVELKEQYPSSQLPQIWDELRRKINDAQSSLPPGVYPSVVVDDFSDVFGMLFNITGDGYTSRDLENYADYLKRELVLVDGVKKVSIAGARQEQVVVEMSQAKLANLGIDPAWIFSLIQNQNVVSNAGNMLVDGRSIRIHPTGEFRNVRELEQLIISPPGSTQLVRLGDIASVRRSYDETPDTLYTSNSHPALSLGVSFASGVNVVDVGERVRNRLSELTSEQPVGIELTTVYDQPATVSESVNGFLINLAEAIVIVIVVLLLAMGVRAGLLMGAVLLLTISGTFIVMKVLGIDLEMISLGALIIALGMLVDNAIVVTEGIQVGLQRGQTRLEAAKRVVSQNQWPLLGATVIAIMAFAPIGLSDDATGEFCLSLFQVLLISLMLSWITAITLTPFFCNILFKKYEKATENQETFSVDPYQGALFTLYKQLLNFSLKHRPVTLGLTLLALVLAILSFGFVKNVFFPPSNTPIFFVDFWMPEGSDIRATESELARFEQQVLSMPGVSNVTSVIGMGAQRFILPYQPEKQYTSYGQLIIEAESLEAINTLIPPLEIVLDEQFSDVEYRIKLMQNGPAAPAEIEARFYGEDPEVLRSLAVQAMTVLRNEPTATNIRHGWRNQVSLVRPHLDEASARRSGISKQALDDALLVNFTGRQVGIYREGSQLMPLIVRSPETERLNADSITDLQVWSADYNSYVPITQAISSFDTEWENPLIIRRDRKRMLSVMADPDLMSDETTDSVFRKVRTNIEAIPLPEGYTLEWGGAYELSTDAQNATFASIPMGYLAMFLITVFLFNTIRQPLAIWATVPLALIGVVTGLLVLNTPFSFMGLLGLLSLSGMLIKNGIVLVEQIKLELEEGWEEHEAIFHASVSRLRPVCMAALTTMLGMIPLLFDAFFKSMAVTIIFGLGFATVLTLVVLPVIYSLLYKINFKGFDYRKIGHH
>fig|1121862.3.peg.417 Acriflavin resistance protein
MNITRATINNNRTALVLVIVLIIAGLQAYKNLPRAYDPGFVIRVAKVITHFPGASPERVEQLITDKLEKVIQEIPELDFVKSTSRTGISIITVSIQESYTNMRPIWDNLRRKIESAAKDMPDGVIGPEVNDEFGDVFGIVVTLTGPEFTYAELKDIADQARDEFLRVPEVAKVEIYGAQEERIFIEYNNARLSELGLSPTQLMQMLENRNIVVPGGAITLDMERIELEPSGNFESVDDIRHTIVSIPGSNNVVYLEDIATVKRGYVDPASSKVHSSGQQALGLGLSMREGGNNIRMGEQVQEVLNYLNQTYPIGIDFNVINFSPKEVEDKVNDFVSNLIQAVLVVAAVMLVALGPRTGLIVASLIPMSMISAMLVMSFFDIGLDQISLAALIIALGMLVDNGIVMAESIMVQMNNGKKPVEAAIDSASELRVPLLTSSLTTAAAFLPIYLAESAVGEFTASLFLVVTITLLCSWLLSMTLIPLLCVQFLKPKKESTDYNRGFYQRYRELLTWVLKHRVISLAATAVLFAVVMSGFKYVPKIFFPPSDRLYFKTELELPLGTAIERTEAIIKELEAFITEEMKINGARTEGVISWISHIGTGGPRFVLQHSPEPASPNYAMMVINTTSSDAIGGMIDKLDSYAFDNFPDLQITSRRIESGVSITNPVEIRLYGKETDQLFSLVEQLKAEMAQINGLKNISDDWGQRIKKLKVVINQSRALRVGATSQDIAISLQSGLSGLELTQYREGEDAIPVLLRSVEADRQDIDKLETLSVYIQSTGESVTLKQVADIEVVWEPAQILRRDGLKTVSVGAQLTPGMTAAEGFAQLQPWLDEHSHRWPAGYRYELGGEAESSGKANQSIGEKLPMAAFLILILLVAQFNSLRKPAIILATIPLGMIGVIIGLLTAQSFFGFMTLLGVISLAGIVINNAIVLLERIKYEIDDNGLSAQEAIIVAAQRRLRPILLTTATTVLGMIPLYLGGGEMWEPMAVAIIAGLLFSTILTLGLVPVLYSLFYRVKY
>fig|1121862.3.peg.583 
MYAVIFEVEIKEGCKDAYLALGAKMRERVASYEGFISAERFASVVTEGKICSLSFWESEQAIARWKQDMEHLICQQQGREQLFNDYRIRIAHVERDYTMAGT
>fig|1121862.3.peg.768 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQMLSSRFHHFIDESKALLGLSLPIIVTQLATNGMNFVDTSMAGQASARDLAAIAVGTSLWLPASLLLRGILMMLTPVTAHHRGAGNNPGISKDLGQTLWIALLCSAALISYLNFSEDILVYMTVAPEIIPVGVGYLHALAFGLPGIALFYMLNSFLEGMGNTRAPMVISLLGLLVNIPVNYVLIYGKFGLPELGAVGCGWATSIVYWMMSILIFLYIRTHHRYEHLLDLRATLPDFTRIRELFRLGLPIGVSICVCGSIFAVIALLIGKLGANNIAAAQIALNFSSMTYMVPMSLSFGITIRVGHSLGKGLNDEARIQAICGILTAALIAVLSVLCILIFRQQIISLYTNDPLIVKGASVLLVCAAMYQISDAVQASASGALRGYKDTRVPMVLSCGAYWGIALPVGYAFAMTDIFGAPMGTEGFWVGIISGLTLAAGLLLGRLVRLMKL
>fig|1121862.3.peg.904 Permease of the drug/metabolite transporter (DMT) superfamily
MKYALRNINTSRQGSIAVLLSALMWGTTGAAASFISDVNPMAVGAFSMGIGGILLALTARKKLIEECLLLSHSWRIILIGSLSLTVYPQAFYSSMHFAGVAVGNVISIASAPFMTVIIERLLLNKKQITFRWLFSAVLGASGIVLLTLSDAYSTQAIIEDSSRQIGVLLGLLAALTYAGYTCAAKKLMEQGAHSTSAMGSIFCCASLILLPTLLFTGEHLFSSIENTVAVWYLALVPMFLGYLCFGFGLRFIPASKATLLTLFEPVVAVCLAVIIVKEVIALTGWFGMGLIMVCLIIQASEKDETRRGLLKEYSKAG
>fig|1121862.3.peg.1802 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVHTTDDKMTSGSTTVDFFRFVVPSILGLVALSSAGIVDGIFVGNYVGATALAAVNLVVPLYSVFFGLCVMMLVGGAVVAGKALGAGDTRKASNIFTKSLTVIVIFALIVASLAFLFAGNIAAFVGAEGEALPLTTEYIRIISPFMFFMGLAYTLSYFSRVDDAPNYALAGLVLTALTNIALDALFIKVWGWGVSGAAFASGIAYTVGTAFLVIRFFGKQARIRLIKPYGSWFELFRAAYNGFSEFINEMSGGLVMFVINWILMIEAGTTGVAAFTIVNYILWLSIMVAYGTAEALGPLVSVNFGARKPERIASFMKLGVGLAIMVGITFATVLLVYPEELASVFIRSDEVATLALTMSIIAVIWPAFLFNGINITLSGYFTGMHAATQSALIAMSRSLVLPLVLIILFWKTLGLEGAFLALPVAEILTFALSVTLFYRATPKMMVSKDVAAGNNEIDSLGGVHN
>fig|1121862.3.peg.2003 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MASIDLRSDPIPSSFFYYLLPAVSGMLVKSLYVLVDSIMVGRGVGADALAALSLTVPFFALFLALALMIGVGGSALMSTQFGRGNYTEGQNIFFQSVLLTLVISGFLVSVGFIWLDEVVLMTGASEALFTMTRDYLEIMLMFFMIYAVGWVLSCFVRNDGNPRLAMYSLVVSALTNVVLDYVFIFVFPWGVKGAALATGLSQLVLFAGVITHFVRSKGVLRLKLPSSNVKWVGKIMSTGLPTFFIESTIGVSTLIFNWVLIRHGGDLYVTAYSIVINVAVLVLFILMGVGQACQPIISFNHGAKSVSRVRETLVLGVKTAVGVGIAALMLASLETDWLVGLFVVDYPVLFDLASLAMPLYFMAFPCMAINLMIASFFQAVEKPMLATALSIVRGFGFVVLGLVVMPWLMPEYGIWLVVPFAEMITLVFSLVLYHRHHVQSSGSSTVVLSA
>fig|1121862.3.peg.2130 Multidrug resistance protein A
MDNTAPHPVRRWLLTVAVLLLAFIAGYFYFEHQKNYPSTNDAYVHGNIIYIAPQIGGRISVVNVDNYEHVHTGEMLLQIDPSSYEAQLNKAKASYQVATEENEAASEGILAASTNISTAAANLRKVQLNFRRTMTLVSEGVLPQQEADTARAALATAQDSLTSARAHMAQLIAEQGAEGEEAPAVQEAAAALMLATLNLSYTNIAAPADGELGKVNVHPGSVVSVGQALMPLVVAESFWIQANFKEDDLGRIQPGMSARVQLDMYPDSSFSGKVESISPASGSAFSLLPPENATGNWVKITQRFPVSVRLADADNQRGKEPLRVGASATVTVDTIAADHEQ
>fig|1121862.3.peg.2131 Multidrug resistance protein B
MSNNISRQAITITIILSSLMVLIDMTVANVALPDMMGTLGATSEQITWVLTSFSMAEAICIPLAGFLTLRFGERQLLLYSIAGFIVMSAMCGQADSLMEMIFFRIFQGIFGAAVIPLSQSVLMQVYPKEEQGRAMALFAIGVMVGPVLGPVIGGILTEHLNWRWVFYINLPVGGVCLLLIFRNIQISNRGKSSVDWLLIITMALGIGLLQMVLSQGNEKNWFSSDFILLSTIISVLMITAFIIRSFWTKGEIAPVWLLKDRNLAISCLIVSCFAVGTFGVLQLQPMLLQELLNYPVETSGFIMAPRGVASAVVLIMAAPLMDKLDSRILIFVGLVFNAVGVWQMSLYSLEIDPFWIVLPSIIQGAGLGLVFAPLSKIAFSTLDPAFITGGTAMFNLCRTIGSSIGIAVINTYFSYVKQLEWQSLGGSLSPDNRLLQNYAEVAGQGITNTDFLEQIAALLKQQSSMLAFVYCFTLMVFIYLFLILLLPIFRKKAPASSS
>fig|1121862.3.peg.2434 Multiple antibiotic resistance protein MarC
MELFFKDFIMLWSTIDPVGTLALFTGLTARLSKSQKRKVALKATTYAFVILLSALVLGQIILKAMSIQLISLQLAGGIILFLFGLQMIFSDPEEGTGSREPGHQLAVFPLAVPSIASPGAIMAVIVLTDNNMKTFTQQAMTAGAMTSVLLITCGLMLIADRIFRVIGHNGSAIIIRVMGMILAALSVELVMTALGVQRWMS
>fig|1121862.3.peg.2447 Drug resistance transporter, Bcr/CflA subfamily
MMDSVLNRSRPGIGLLATLLALPQLSETIYTPVLPAIAQGFGVSESMAQLTMSIYFVGFALGVLTWGWLADRWGRRRAMLAGLLCYGMGAAGALFSSEFMLLLGARFLLAFGISVGSVVTQTVIRDCYSGKALGKLFSTVGAVISLSLAIGPVLGSIGAIAGGYQTVFMMLGGTALLMTLWVGLSLPETHPGHESVKSSKGSLLVRMIRDRKIRVYSIMVAGANLVLFGYFTLGPFLIKQIGFSASVFGVTGVLIALGSALGAMFNRQLLTRHSGGQLILRGCWLGVSGALLQLIITLFLPSVPFVALLLVVAPMVLMVIAFGLIVPNLLSSALSEYKDELGTAGALFGLSYYLLIAAGLALISHHYVSFAGYMPAVFLVIFLLMLMIWFCYRQHILRR
>fig|1121862.3.peg.2679 Multidrug resistance protein D
MKQQGFFQVLFVIVVLTACGQLTNTIYVPTMSQMAADFGVVPGTVQAAIALYLIPYGISQFLYGPLSDRFGRKPLMLIGLVIFIAGSLIGSFAHSFEMLLLASFVQGMGTGVGGVMARTVMRDLYSGLHLQRANSYISMALIFTPLMAPMLGGFLGTAFGWQASFWFLTGFGVLVWLLVLGRFGETHKNVGKRSMGALASYRYVLSNVQFNGFMISLVATFAGIAVFEAAAGVLFGELMGLDPRVISVLFVIPIPGYLFGSWLAGQMAKKHSLESIIGRGVVMLVIGSGSMLVAGLMGYLNAWVILVPATLYFLGSGLLFPTATTAALEPFPENAGVAGAVLGGMQNLGGGLVTLVAASIPMASQVPVAAILCVLTLLVVMTVRILLAPAAGRATV
>fig|1121862.3.peg.2698 Bicyclomycin resistance protein
MFHITSPNKTWNYPLARTLLLMVPFDLLASLGMDIYLPALPGMGEFFSASPFMVQLTLSLYMLMLGCGQLIFGPLSDRYGRRPVLLFGCLLFVICSIGLTMTGSIELFIFFRLCQAAGGSAALVATFATVRDVYGHKPESATLYALLGGMLAFVPALGPIVGSLLIGWFGWASVFWGLAVSGSVAGVHALFSWPETHCSVGGGSIKHAFGRVITSPAFLLYTSGFTVAMGSFFVYFSIAPGILIGKLGYSSLVFSLLFAMAAVAMIIVSRFAGSIARKFGISGTLKLGMAVILAGALLMLLGSTLQLPEAPVLLLPMMVIAVGISITCSVCATGALAEFKDIAGTGVALYYCLEAVLVCLLGTAVVMLFPVGSLWPLIAFSGIGSLVVMASAAWINK
>fig|1121862.3.peg.2792 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLLWKLRFILKDYWQQYLLAFICLQIVSALNLLPPWLIGHVVDGIKDKSLTNQELFNYVAGIVVTGVAVYGFRYVWRAKLYGASIELIRKQRSRLFAHFTQLSPEFYQQHTTGDLMAHATNDLNAVEESVGVGIMTLVDSLIAGLTVLFAMVFLVSGKLTLLAMLPFPLLVWVTKRYGVALYSRFGRSQAAFSNLNEETRESITGIRAVKAHQLTDRQTQRFEQLSMEAVEANTSVARVDALFGPSISLFFGLSFVLALVGGAWLISHGQLTVGLLTSFTLYLSQMLGPMLQFGWQFNVFQRGSASWGRLEKLLSRKPKVSNAPDAQQAPDDTSLSINIQSFSYNAASDEKPVLQGISTEIAAGAFIGITGRTGSGKSTLLRLILREFDLPEGSFIQMGNIPLQQLTVESLREKLAWVPQEPMLFSGTIADNIRFSAPDASLEAVEKAAKLAAIDEEIMGFKDGYDTLLGENGINLSGGQKQRLALARALLADAEILLLDDAFSALDMKTEARILKNLMAMKGKKTIILVTQRLPELITADHILVLDRGRIIEQGNHDRLMASDQPEENTTEHWYAKIFRQQARTLLHPLEVKPDTVIKRSDVA
>fig|1121862.3.peg.2793 Multidrug resistance ABC transporter ATP-binding and permease protein
MIANDEKKTSGYRGLARLVRYAKPYQWQFLGAFLILLLATSLEMLAPWLMKIILDEHIAPGVNDTMGLAMMGSALFGTYLGSAILQYIQNVKFQENALKVVHDIRRMLFAHVLRLPMSYFDSEPTGRLVSRITNDSEVLRQMFVGVIPAILQAFFRVVGIFIAMALLDVRLMFMTAMLIPVMLLAIHLYQKISHPVIHGVRSQLANINTRVNESLNGMRIIQAMGQEAHLQQQFDKDNEEWSQLKRKNINIDSLLLMPFTHLLNGIALAVVVGWFGYQSGFSLVEVGTLYAFINYLGRFFEPFRQITMQMSSLQQSLVASERLFQVLNEETEDTQHGQSKNQTDSPEIHSGKLEFNNVTLSYDSKNMALDNVSFTVEPGQFVAIVGHSGSGKSSVINLLMRFYQHQEGQILIDNQPLTSLKEDTLRQGLGLVFQEPYIFSGTMAENISLNHDQITDEHVQAAARKVHADPFIQELDESYEHKPGPGGKALSTGERQLLSFARTIAQNPKILLLDEATANIDGETEHHIKEALITLRENRTTIAVAHRLSTIQDADQILVMDKGRIVQSGTHEELLLQEGHYRDLYLAQQTEEQLGTTQQPGLTMAAANA
>fig|1121862.3.peg.2827 Permease of the drug/metabolite transporter (DMT) superfamily
MNTTIKADLVLLLVTLLAASGWLFSKFAIGGMPPIGYIGVRYIAAALLLLPFAARQLFQLNKSQLFICVMVGLIQMAAMYLWIQAVDSSDRLGEGAFIMSLSMIMVPFMGRLLYGSRIDRFTLFALPFAIAGIALLALKGSWEFEPAQGLYLMATLFIALHFVFTNRNAPGIPSMALTFILLLVPGVLGMAISVTTESWPEQIATDTWVWVAAAVLVATSLRYFLYTWALKHSEAGHAALIMVIEPVWTALMSAIWMGESMTSQKLLGCGLIFMALLVARWRSIFKPAIAESQLVRE
>fig|1121862.3.peg.2883 Acriflavin resistance protein
MSRLSDALINRGPIAWMARNSVTANLLMLFFIVGGLLTSFQIRKEVYPNYQLNSVKITVSYSGATPDEMEMGIVLPIENAIRGIEGIKQVNSRALGGFANITAELVNNVNVDRVLGEIESEVNRTNLPAGAEKPRVTRSAIQHESMELILYGDVDPVALRETTSLVRDTLLRSPYLTQVEMHWASKYEVKVYVDKENLERYGLTLDSLSNSISRYAVTQSGGKLETAGGDILVEVDNRQEWAKDFSSVPVVSTAQGGHIYLDEIATIEDGFADRKFSFFYNGKPSTSIKIYRVGDQTPIGISEAVHDMMPQLQALLPPGILLEIVNDDAILYEQRMALLLKNAFSGLVLVLVVLALFLDLRLAFWVTMGIPTAFLGSLIFLPAMDVSINMISMFAFIIALGIVVDDAIIAGENVYDHMNQGMPFAQAAIIGVKDIAVPLTFSILTNIVAFIPIWFLPGTMGMMFQVIPLVVITVFAISWIEALFILPAHLVHLKNDNPALIFRFATALQALFNRGLNRLIVHFYKPVMRVLLEFRYLVVALGIAMLMTSISYIAGGHMGFTTMPKVEAEFSVGRATLPVGTSLEDATAIRHRLERSAQKVMDENGGKALVKGISSIQRNLDGEFIIIVRMFLQPSEVRTMSTKEVSRLWRESTGTIPGVEGIRFSSAGSGPGSDVAGVTIEMRHHDNNMLEEASNELAMMLAGYAGVIDIENTFSSGSSKLNLKLLPAGQSLGLNEKELAKQVRSAFNGVRSIRQQRGSEEVDIKVMLPDYQRASEFDLEQLPVRVGNDYVPLGQVASITRDYSASVIQRREGRRRVIVSADITPSSEAMTLSQTLSEETFPILKQSYPGLDIGFRGDQIEQKESMDSLFVNGIMVMLALYCLLAIPFRSYSQPFIIMAIIPFGLIGSVLGHVALGYTMSVVSLLGVLALSGVVINDSLILVTEANERREKDMLGVHDALLEACHRRFRPIILTTLTTFGGLAPMILETSNQARFMIPMAISLGFGILFATFITLLLLPCMYSVLEDIKGVFTNTAYEAEVPLKS
>fig|1121862.3.peg.3045 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLFHNHCILREFRALLKLSLPLMGTYLVMSLAGFIDTLMAGQYSSVDLAGVAIAYTAWIPVNVFLVGLLMGKTAFISQLYGARKLRDIVAMGQQGLLLATGSGIVGLALLSVFSELLIYVDASNAVREIASGYLTFVALGMPGVALNQALRSYLEGQGYVRSVMVAQVLGLLINIPLNYALIYGRFGLPEMGGLGCGIATAVIMWLSPLFMVAYICFNKALKSTSPFCYALDLDLEKLKALVAIGLPIAVTLFCQFLVFMVITVLLASHGHVVVGAHQIVFNVSTLLMMVPSAIGGAVTIRAAYYIGAGHSSMGGFVSLVGLSISFMVMCVLGVGGWWARFSIVRLYTQDLAVIELAASLMGLVVIYLLLTVIQQLGAAALRAYRDAFSVMWIMLVSLWGIMLPLGYFLANMDFLGAPLGVKGFWLAMVVAYFLAAIGTCCRCCLVVK
>fig|1121862.3.peg.3434 Permease of the drug/metabolite transporter (DMT) superfamily
MYSVKTKALRADLLLLMVSAIWGFAFVAQIKGMEHLGPFLFNACRFALGFLSLLPVYFLLEAFSAKKNGKKESGVESVKKYDNHLLLKWGPITGIVLFLASSFQQVGLLYTTAGNSGFITGFYIILVPILGICFGHSTRPVTWLGGAIALAGLYFLTVNDGLSLNKGDLLTLGSALMYAIQILLIGWLSRHVHPLRLSLTQFFMTALCSLLVALYLEPISLDAITQSVGPLLFAGVLSTGVAFTIQIIAQQDAASSHAAIIMSLEAVFAVFGGWLLLDEQLGSRGVVGCALMMAGMLLSQLRRPRGRSTA
>fig|1121862.3.peg.3582 Permease of the drug/metabolite transporter (DMT) superfamily
MDASLISGVQKEDNNTFLYASYVVLLGSCFPIMRYASIHFDTVNNNAIRFLAGGILFLIMVIAKYRNEVSKLLAEPVMIVKLLLIGVLMTVNMYFFMNGMQLTTALTGSIFSILGMPVATIMASIFFADERKKAANPRFIIGCLLSIAGSFLFIFNADTTGHSENFVLGSAFWVLAITIAAMQNLLVKNLAKDLHPVVISAATATIAGLIYLFIATATGKIQELSTTPDSLIIFLIMAGMFGMLVGMLMAFYIIRKSGVITFNMLQIMAPLSTAIIAYITLGETISTIQAFGAAIVVVGCTHSLKANRVN
>fig|1121862.3.peg.3870 Acriflavin resistance protein
MDIARYTIAKRTSVWVIIALTLIGGYISYLKLGRFEDPEFVIRQAVINTPYYGATAQEVSDEVTDLIEGAVQSLQELKEVKSVSKQGMSEVTVEIQLEFAKSSADLQQVWDKLRRKISDVQRQLPPGAGPSIVNDDFSDVYALFFAVTGEGFTDKQLQDYVDTLRRELVLVPGVAKTATLAEQQETIFVEISSERMAKFGLSAEQVLQVLQKQNLVTVAGSIETNSMRIPVIPDASVHSFDDLKNLQVGVGENSTVLRLGDIADLKRGYQEPASMLMRYNGERAIGFGISNVTGGNVVDMGDAVKARIAELESQRPLGMELHVISMQSDSVRASVANFIDNLIAAVAIVFVVLLLFMGVRSGVIIGFVLLLTVAGTLCIMLVEDIAMQRISLGALIIALGMLVDNAIVVTDGILVRLQKNPDEDRAALASEIVKSTQWPLLGGTVVGICAFSAIGLSPSDMGEYAGSLFWVILYSMLLSWVFAVTVTPMLCHDFLKVKAIAADQKPGRMVTAYKALLMWVLKHRLISSALLMGTLAVAIWGVQFVPPGFMPDSQRPQFVVDVYLPQGSDITRTEAIIADVEQDVKAKEGITNIASFIGGGGLRFMLTYSPEARNPSYGQLLIDIDDYTRIAPLIGELQSELASKYPDASIKVWKFMLGRGGGKKIEAGFKGPDSQVLRQLAEQAKAIMLSDSNLIAVQDDWRQQVPVLRPVYSAEEAQRFGLTTPEINQAIAQTLTGRNVGVYREGDDLIPIVVRAPEGERNHQRAIENTEVFSPKANTFIPVSQLVESVDVVYQDAILRRIDRVPTILVQADPAPGVLTADAFNLLRSKIEAIEMPPGYELTWYGEFKASKDANEGLVISAPYGFAAMILSVIFMFNALRQPLVIWLTTPLALVGVAAGLVIFQTPFEFMAILGFLSLIGMMVKNAIVLVDQADVEIRDGKPPYHAIIDAALSRARPVLLGALTTILGVAPLLIDPFFKSMAVTIMFGLLFATILTLVVIPLFYAVFFRVKIEEA
>fig|1121862.3.peg.3905 Quaternary ammonium compound-resistance protein SugE
MAWVYLLLAGMFEIGWPVGLKMAQSPDTRWLGIFTAIICIGLSGYTMWLAQKEIPMGTVYAVWTGLGAAGAFFVGIIFYGEAASLMRYMGVLLIIAGVVTLKLAY
>fig|1121862.3.peg.4015 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRTNLSAFARYRAELRELLYLAGPIMGAQLATTGMTFVDTSMAGQYSAMDLAAIALGSSIWMPVYLLIRGILMAITPTVAHLYGARQTGEIGGQVRQGLWVALLMSLLALVFIYKSDVVLQWLQVEPEMAAKTLEYLKALAWGIPAICLFQALTCYCEGMGKTKPSMVFSFIALALNIPLNYVLIYGKFGFPELGGVGCGYATAVCFWVMFLMMAGYTMLGQQHRKIGLFDHWDLPSLSIISSQLKLGVPIGLAIFFEASIFSVVALLIGKLGAIVVAGHQIALNFTSLAFMVPMSLAMGLTIRVGQALGAGKTEQAAYSSYAGIATTLVSATVSASVMMFLPGVVTSIYTQNPEVAILAAQLLVYAALFQYADGIQIAANGALRGYKDTRVPMAMILFACWGVALPLGYILGLTDWIVEPMGPHGLWIGLVTALTMGAFLLTLRLRAIIRRNRMLASEIMPMPA
>fig|1121862.3.peg.4237 Acriflavin resistance protein
MKSLLPFFIARPKIVNLLVGCVFLAGFLLLDGLRYEYNPRVDMGTVNITTTRLGSGPEEIERSITMPIEEELLKVEGIEKIFSSSMDGMSVITARLDINYHDKTLLLSDIQKAVDRAYTRLPQDLLDKPLIEEQSTQKTPVIEIHLVGNVSEEILRASARKVAEGLREVEGVSGEHRIGYRRSEVKVFLSPEKLTQLGISIDEVRKAIVSRNVRDSGGSLSSFNAEKKVISVGQFQQPKDIESVIIRAYEPGNVVRVSDVASVISGYGDWEVESRTDGRRSIILQVHKKPTSDELHTASNVRNYIERMRAQMPAGIELIDVNDISRLTIQMLDVLVSNAALGLALVLVILYVTLSPRLAFWVAMGLPFSIILTFLTIDALGISVNAINLVAIILMLGILVDDAVVVGESVQYQRELGLSGPEAAIKGTQSVAKPVMFAVLTTILAFVPMLAMGGRDGAFMKDFPIAVLIVLTVSLFESQYILPTHLAHKSGSIEQKQSRFLSRWSSIYEKVISTLIRHSRKSTLAFIVVFIGVMAFGASTINFQLYPAVDIDNVNVKIELPAGSRMTDTREVVSALETRARELIPASDLLNITSQIGHHDTDFYGATEGRSESWALMIVQLKPLSQRTVKTHEMVELLRTELKKVSPVTHLVVEPQTDIPVTDKPIQVEFISSEESRFPAAQKLLDYLEQHPAVTESWSSFKPGRDVVDLTFNYELLASRGLTVREITDAVRVAMDGLIVDELQTLDERIYYRLQYPPSRESQLSTLENLSIINHRGEQIFLNSLVEFNWRSGEADIKHYQGRRTTTVYAEMDTAVMSLEQLNQDVSDFIATQSWPQTHPDLRVYQGGALVQQADSLGRMGDAFLICLLAIFIALVLLFNSYSQPALVLLCLPFGVMGVVLGFGLQGIDMGYVALTGVLGLMGVLVNDSLVLLHTLNNQKTDRASLLSNSEIAAGAAMRFRPIVITSLTTVAGLIPTAYGIAGTNSYITPMVMAMAWGVGFGMFVTLLLLPCLYTIDRDIKAYFHRRSEAKKDLSWQNSEQV
>fig|1121862.3.peg.4262 Permease of the drug/metabolite transporter (DMT) superfamily
MQNILLFSLCSFVWGSTWYAITFQLGDVDPLWSISYRFLLAGLILMAVCFLQRAPVQFTVRQHLRIFLQGICFCGISYWLVYLSELYINSAQSALVCTSMLYLNVIIGRFWLGNPVRLPVVIGGVLGSLGIVMVFLPELASSLTTDLMKGIVMAFVGCIFFSIGSLICEINKKSGLPLLPVVMTAMMYSSIFTAVFALSLGKLPSFQWSKPYVFSLLYLALFGSILAMTSYVALIGRIGADRTAYVDIIYPIIALFIATMFEGYQWTTLSLLGVLVVLAGNYIALGVNFDKAHIAK
>fig|1121862.3.peg.4881 Bicyclomycin resistance protein
MGAIAIIPMLPITLYIPILPHIASQFGYDTEIFQLTLPLFIISQVVAMPITAMLSDTGYRLQALYWALMVFIIGTVLCIGWPSLWLFCTGRVLQAFSAATLMTVIPALINECYDTNSVARILSYVTAIGFVIPIVGPELSTLASQHWSWYSVFVFMLAYSMTTFLICRRSIGKATPPANRLTIEPLKKGLYHWKIMVQDKETQAFLVCHTGIAVVGQIYISNSAFLFLDYYQLTEISYSYLISVLYVSRTAITLINGLLLKHIPYSKLIDLSLPVLMILALCMLLLDWFYGASLIPSLILVVAFFALSGLVVTNALTGVLKNHESWSMQASALLFIVFSGTASMLNIALIALHDGTPRVLSMVSMLILILTYLLYQRIKSGS
>fig|1121862.3.peg.4984 Permease of the drug/metabolite transporter (DMT) superfamily
MLRNYLFLFGIGVIWGSQFIFQQMAVADISPVWVGAGRSLIGFLTLVIICQVMRIKSNGGQWFKFSLIGLLEATIPFILVAWGQQYLDTAIAAILMGTIPFFTVILAPLVIKGARITFAGIGSVLLGFSGLVMLFYPELMSGSSTTNLMAAGAIIVASACFSVALLLLKGVENEHPLIIARNVLGSASVQIILFAMLVAPVTEITPTASSLMAVTYLGTLCAGLVYFLYMMLIRDAGPVFASLNNYLVPMIGVLLGATINGEALSVHSWAALATIMMAVAFNQIFTGKSSKGSESSEPEEASAEGLLPAK
>fig|1121862.3.peg.4993 Glyoxalase/bleomycin resistance protein/dioxygenase
MIAENLFGPVRQWGFLVKDLDHAMSQWHDVMGVGPWWGYRNVPLETEVNGKAYEVRMDVGLAFQNGVQIELIQQTNNVPSPYSDFFLHSDEKQVFHQIAFFAPDIELALEKARNAGLVEVGLCKTPLQRFYYLNAPWLGNTVIELMEVNDSFVSGYEFCAREAASWDGSNPYRLISL
>fig|1121876.3.peg.163 Permease of the drug/metabolite transporter (DMT) superfamily
MNYLLLLLIGAIWGAQFVLIDASLIAFSPEQLALFRTFYAVVFLVLFCLILNIRRSNARSLTDWVKVASIGVLEVVIPFTLVMWAQQFLTGSMASILMGTIPFFTLLLVMLTKVERASVSKFVAMIVGFIGLLVLLAPDLLSSGLSGSVVPKLAILLGSLSFAGALIVIKSMPKENAFILSRDAFAFGTVIMFVINLAQGNLSDLHFPLIPVTTSVVLGVFCSGLVYVLYVYLIKRAGAGFCSLSNYLVPLFGSVLGVLIMNDHITLRMVVACLLILLSIAVEPFLSYLKYIVKSRQGAKSA
>fig|1121876.3.peg.368 Permease of the drug/metabolite transporter (DMT) superfamily
MSNGTKALLALMLTIIFWSSAFVGIRFIMENFSSGGLALSRYFVASIAMAIPFVFIRNKKMPSVKEALQFLIMGCLGFFIYNVLLNEGEITVSAGIANFIVSQLPLFVIIFASIFYRERINRYGAFGIIISILGTLLILLSEHQGGSFVGVVFIYVATLSAAIYSTMQKKLLVKFHPIEVISYCIWAGTLMLLIFLPVTWKNLSHATSLDYMVIIYMGVFPGAIAYALWAYAFKHIKASIASSTLYVMPISSLFLAWLFLGEHAEMLTVMGGIIAVLGAVILSKFGVKK
>fig|1121876.3.peg.502 Multidrug resistance protein D
MEKTKTGESMQSNKSLVFYPMILMIAYWVITKAGLPFVDEMSQFFAVSHQRIQQILSLSLIISSLSPLLWGPLIDYISLKRFAIIASVLSFVITILMLITTSVTIFTITYIIATSIIFSLSVCSRSFPFIYFDQLEQKQKAIGITFMGVYFCSFMIPLFSGWIGFYLGWEFGYSLVLLWLFIVFIAMYRLKSNTEPVAIEKVGFLKNAMMIFMHMRTKGFLRYALFVAILNGLAWTYIIALPFWLASIFTIGSKYLALYLFPLALPGLLCPIIVSFLERFMSKEAIMKLSVIIFLIAGVLAIFLGVKLWDSAVIYIIPGVLLNLASAMAFAIASTKVFTHVKTAFNAASGLFSLIQYFAFGVIVFVESYISIHHYYLEGVLVCIGGVFLLILQRGRAN
>fig|1121876.3.peg.549 Multidrug resistance transporter, Bcr/CflA family
MSKLTILMVLSVCIITPFANDIFIASFPSMQLAFHSDKITLIMTSFMLGLAISQLFYGPLLDRFGRKVVLLGGLVIYCIASTFILFSGNILMLLILRFFQGVGVCSTIVSAMAIARDVYKKEELVKAMATIMAIIGVCPVLAPLFGSFLQSSFGWRASFVLLLVLGIVYFFVVLFLYKESIKEKNMHALKLSMLYKNYISLLQKKAFTGYILVSACSYGVLFSYAAASSILIIKHLHYSVMSYGVLFALNASAIVLMSILTPRLSARYGISRMVIIGCIFILLGALFAILMGVLIGENIYTLMLPMWIATIGIGMIRPSASAGAIALAEHKITGSAAALFNFSSFVGGSIATYLIANFTLTVVNYGIFAFIIACIAICLSLYVYHAEFVHNFRCDGIKEA
>fig|1121876.3.peg.572 Permease of the drug/metabolite transporter (DMT) superfamily
MTIVIWSLLLFGVFLNACAQLFLKFGVDRIGEFSFTLQNLIPIGWKLATNYFVILGLLCYVISVVVWLMVLSRIPVGIAYPMVSIGYIITAIAGYFLLGESLTVTRVIGILVIIIGVYLVARV
>fig|1121876.3.peg.640 Drug resistance transporter, Bcr/CflA family
MSVNRYFIAFFVNFTIPLGGMSTDIYLPSLPAMAKYFNTSSTEVQLTVTLFALGLAIGQVLTGPISDALGRKKIYLLGIILQLASVLYILLSTTVLSLIIVRFIQGFGAALMMVPARAMLNDVFEGAALKKQYTYITAAFALGPIIAPFIGGYLQHYFNWHASFIFVLIYLVVLFIICLLFVPETINSKKNFSLSHLTHSYHTVLTNKKFVTGALLLSFFFGYVATFNVAGPFIIQNLMGKNAIFYGYIALLMGVAWFAGNMISRLFFRFKLKHKSYALLGLILLMSVIMFVINLSSLSVPRFITPVFIITMSAGFLFPIYVGECLSLFRQEAASANGLLFAIIWVSFSLFSFIAANLKVHSLMPLLSCYVIVSLILLLVYIMIVARHHS
>fig|1121876.3.peg.969 Permease of the drug/metabolite transporter (DMT) superfamily
MTQKPKQPKALYAISLLILLGALWGSGYTIARYCMTHGVHPLGYGFWQSLGPMIFLLLVIIFARIPFSLKPNYIRYYIACGVLGIAIPNTVMYFAAAHIPSGILTVLINTVPILIFPLSILFALEHFSLKRFFVVLLGFLGILLTILSNLTLPTLHNIPWSIIALIAPLSFALCAVWIAAFRPMPSNSLSLSLGMLIISSLCLVPLTLIMGAFHPISFPLQINDWLIILEIILSSLGYIVLFVLIKLAGPIYYSLVGGMASVFGLLWGKLFYGESLNSSSWLGVFCIIGAIILLTLLLKKEKEVAEN
>fig|1121876.3.peg.1223 Membrane fusion component of tripartite multidrug resistance system
MTSENETQGEQEVKKSKGWIKYATVLAVVVLCIIGFYIYVKYTEIYPSTEDAYVNANTVYISAQVTGKVDKIYVEDNQAVKKGQLLLTIEPQSFEYALQEAKANLALAEQQIQAIEDSIRLEEAKLKEAEAQEFVARQKQKRISKLVAQNMSSKESGDEALGDYNVAVASVNAAKASISQQKRQLVLQASKIEAEKSQVETAKLNLSYTKIYAPTSGYITNFSLRPGSMINQNQSLFVLVSNTGFWVDANYKETQMERMKAGQSAEVVLDMYPNVTLHGVVESISSGSGSVFSLLPPENASGNWVKVTQRFPVKVIIDPKEIKKVPQFRVGASASVTIDTRSK
>fig|1121876.3.peg.1336 Drug resistance transporter, Bcr/CflA family
MLEMQASKSAKAIFVTMILITSMLGIFVSDIYVPSLPSIGDEFGTNASILAFSVTFYFIVFAFAQLIYGPLSERFGRRKIFLSGLAISIFGTCITLFSINFTMLIIGRTFEAIGMAAPMSLGRVILRDVIPDKTSYARFMSFMGIGTLLAPVLAPIVGAFLAHVFHWRADFIFILLLSVSCYVLCYYFLIETLLSPSKRLSAKLSIQTYIWVIKNKVFIKNTTISSCVMASIIAYLSLSAFLFQQHFGLSEINYAIVFAIGEAFIMIGMFANGMALKYISIENSQRIGVILFLFSSILMIIQAFIFPDNLVFIMIAVMIFNFSAGVIFPTSSALAIVTFKTRLGAVGSLYGCLSMLVAGLVGGAAMLVPLSAIHLIAILFLITAIISFVFLFGVKND
>fig|1121876.3.peg.1407 Multidrug resistance protein D
MKTRYLGLIILFIFPIGQMSIDIYAPSLPAISHDFLASSTDVKLTVSLFVVTYAIAQLFYGPLSDQFGRKKPLITAMLIYIIGTLLATFAAKLYVLYIARFLQGIGVAGIMVIVRAMISESFKGNMLKKISSYIALLFSGSAIISPWIGGLLQYISGWRSVFILLLIYGLISFILMLSLPETHHKRAQFNLLQFIQNSKEIVTHCTFLSAICFQSVVLSFFFVFALQGTFVIQKGLGMSASAFGELALIIGFGVLIGSLINKTYSTRIATLQLIKICFSLMLLTSIIFVIFSCLFPQSLYLMVIASFIWALIATTAGPSFFSLFLSTFSMNAGLSNALSGFATYTLVGIITFIMSHFQQTNLLPICIYTLFASIIAWGSYFAIKRPLREFS
>fig|1121876.3.peg.1540 Bcr/CflA family drug resistance transporter
MSNKLKAIATPSLFILVLMISVGPFGDTIYAPSLPSIAKAFNTAYHNVQLTITFYLFGYAVSQILYGPFSDRYGRKPIMVIGAVAFLLGSIICLISTDITILIAGRFIQGFGACAGAVISSAAVRDAFSHKEQGKVFAKMNTAFAIAPGVGAIVGTFITWQMNFSILFALAIILLIAVIILFPETLKKKNKGATRPRKLISNYFSLFRTQGYFVYLCILGLSIGMVYSCLVEAPALVIDTLHLSKPWFIVIAAGIVLAFMVGSLICTMLCHRLKQNSILLVGMVISLIGSLLLLIFMSLEIVNLISLLIPVVIVFTGIAFVIPIATAQALAPFEMTAGSASAMMGFFQMGMASAITAIVTALPLRDTMTLPVSFSLLSLVSIIILASYVIKHKRKSPAI
>fig|1121876.3.peg.1885 Multidrug resistance protein B
MSEKHHTISTAAKWLITITVMLSAMIEIIDTTIVNVALKDMAGSLGASTDEISWVVTSYIVSAAICMPLTGFFVRIFGRKRLLLINIVGFLIFSMLCGLSTSLDQMVFFRIMQGIFGASLVPLSQYVLRDTFPPKEQVKAMAVWGIGIMAAPVLGPTLGGYITDWMNWRWIFYINIPVCLLAILMTLLFITETKREKVKIDWIGLALLVITISTLQIFLDRGNTDGWLSSHFILGLLLTWIIAGIIFIVRGWITPRNILNLHLFQDRNYAASCILLVLYTAGIFGMMTVQPLIMQGYMNYSASLSGELMAPRGIAAAIAMVFVTPLAKKIDLRLIILLGILITAYGNYLYAGVPLMSDPWNLTYPGIVQGIGMGFFFVPVSTMALQTLAPAALAEGSGMFSFFRNLGTSVGTSVMVTVLTQQAQVAWHSMIQKINTMNPDYHMWLQHMSWSAEDPHTLAEVVKLILPQANIIAFDDVSYLSYLLLLVAIPFIFMLKKPKNTAVSMEH
>fig|1121876.3.peg.2120 Multidrug resistance protein D
MAQFDRNFYRILFLIIILTAAGQMTNTIYVPALSQMAEEFSVNAGRMQAVIACYLFPYGLFQFAYGPLSDYFGRKPLILIGIALFTLGSLIALFATHFATLLLASFIQGSGIAVAGVMARTVMRDLYSGRALHSANSLMAIALILAPLLAPILGGFFTDLYSWRVIFLFLSAYGIALLIIQMLFFQETNLYKGIKGSFLQKYKIVLSNPNFMLNLILLIVANGGIAIFEVSSGAIFTSILQLSPATASFLFIIPLPFYMIGSFVAGKLARFYTLDRLLIIGCLVLITSGIFMVGFYYLIGVELLAIILPGSIYFFGCGIIFPTATTKALEAFPNIAGTAGAVLGGTQNLGAGILTALSALIPLHSQLPLAVILSALAISALVAIRMLPANPQDNS
>fig|1121876.3.peg.2177 Membrane fusion component of tripartite multidrug resistance system
MPALWNLIKKSKVVITIIIILIIGYLIYFYVYFAKITDNAYVVANTRSVAAEVPGIIDQVNVRNGEFVKKGALLFSLRSNLYQYRYEEAQAALNAAKAQLSETKQKIAILINDVNTSEKSLALAKERYEGDKTLYEQNLSAKLVYHESRNQYYKAQNALDNAKEQLTAANIAKARSEFQLDEASAAVKVAKHNLHATKVYAASNGVVNNLFLSPGSPVKAYEPLFAFVDTSTWWVQANFKETNLSGVHVGQKATIRLRMYLGEKVYHGVVVSTNWAVGRNETNPNNNLQSVPSENQWLLLPQRFPVLIRINNIDPHYPLHMGASAYVSLD
>fig|1122132.3.peg.255 Permease of the drug/metabolite transporter (DMT) superfamily
MSLLSRAFSWLFNRPYLLLSLTFLFWAINIVLGRYVAGSIPPVALSQIRWLGASLIILPIAWPHLKRDWPTIRSHLGLMVLLAAAGIGAYNTLAYYGLQYTEALNGLLMQSIAPLVIGVWSLILFRDRMTSAQITGVGLSLCGVVLIICRGDPTVLLHLTLNVGDIIMLVAISCSGFYSALLKKAPRIHYWSMLGFIIPVGALTILPFFALEMASGKIIQATPLTFAVLAYVIVIPSVVAYLFFNRGVALIGPNRAGPFFHLLPVFGSAIAIVFLGEQPRWYHGAGYALIIGGITIAQLSLARIRAFGR
>fig|1122132.3.peg.325 Permease of the drug/metabolite transporter (DMT) superfamily
MAMGISPIFVRLTDVGPFASAFWRVGGALPVLLAWALYEARRAGISPGSVFRLDGPILASGLLFAGDLIFWHLAILRTSVANATFLATMAPVWVVLGSGFFIGEKVGRDVLAGLALCLIGATFLIGMSWQVRPDHLDGDLFGIVTSFFFGGYFLAVRAARRTSSAGKITFLSTLVTSLALLLMALATEPRILPASLDSAASLAGLAFISQAGGQGLLAFALGHLPAAFSALVIFLEAIAAALAGWLFLGEAVSAGQAIGGALILVGIFIARPQRPR
>fig|1122132.3.peg.435 Permeases of the drug/metabolite transporter (DMT) superfamily
MPTADAEASQRLRGIALYCLAMLCFAVLDASAKFAAQYVPVLSIVWVRFAIHALLAVALFQPWRHWAVYRTRRPVLQILRALFLTGSTFFNFLAVHQLQLDQTMSIGFSAPFITAALAGPILGEWAGPRRWAAIIVGFIGVLIITMPGFGNLNPAIFLSLIAACCNACYILSTRMLTRSDSSAGMLLYSAVVPLILLTPVAQPLEAMPPTILVALCLFLTGALGFVGHWFLIRAHHHTAVPVLAPFMYTGLIWMILLGYFVFGDVPEPRTLVGASIIIASGLYLLYRERVRAPGGD
>fig|1122132.3.peg.888 Phosphotransferase (aminonucleoside antibiotic resistance)
MSKPRLVIITGAMAAGKSTVAQAVAEALPKSVHLRGDVFRKMIVGGAAVMGPVLDEEALAQLKLRHDLACDVARRYHAAGFSVVYQDILIGRYLTDVAARLADLDPQIVVLAPDAATLARRDRDRGKTGYSASFPPEILADALVRETPRTGLWIDSSQMSVTDVVARILAG
>fig|1122132.3.peg.1080 Acriflavin resistance protein
MSGINLSAWSLNHRSFVVYWMIAVMVAGIASFIGLGRNEDPPITIKTMIVHAVWPGATIEDTLNQVTERLERKIQEIPEVDDVRSSTSAGSTTLFVNLRQDVTSAEVPDVWYEVRKGIGDIRQTLPSGVLGPFFNDSFGDTFGIIYGFTADGFTHRDLRDYVEAARSRLLQVPDVSQIEIIGAQDERIYVEFSTKQLAGMGIDRTALLNALRAQNVVSPAGVLETGEERISLRVSGAFETEQDLLDINFVANGQLVRLRDIAQIHRGYASPPQPQFRVDGKPAIGLGIAMRDGGDILALGENIRKAMAEITADLPLGIQPTLVADQAVVVDEAIGDFTTSLWQAIAIIAVVSFVSLGIRAGTVVALAIPISLAMVFAVMNIVGIDLQRISLGALIIALSLLVDDAMTTVDSMTSRLAAGESKEDAAANTFKTLALAMLTGTLVTAAGFVPIGFAQSSAGEYTFSIFAVVGIALVVSWLGAVIFSPLIGAVLLKSPKQKPDPNKVSIVVRVFRAILLTAMRMRWITIALTLAAFVGALLLLPHVPRQFFPASDRTELMVDLRLPQNASIYQSGDVSARFDAIMRDDPDVERWSTYIGRGAIRFYLPLNVELPNEFFAQAVVIAKDVDARLRLEKRLETVLAEQFPDSVSRVAPLELGPPVGWPVQYRVSGPDVDQVRDISLRLAQIVSANPDTKRVNFDWMEPARMVRVKIDQDQARLLGLSSQALAAALNAVVTGTTVTQVRDDIYLVDVIARATDEQRVSLANLQTLQVPLPNGRTVPLSQFATFEHGQEYPLIWRRDRVPTLTVQSDVRAGGSPEAVVAELTDEVEALRATLPRGYDIAVGGVVEESAQSLQSVMAVVPIMLFLMVSFLMAQLQSFGRLFLVLCVVPMGLIGVVGALFLFNRPLGFVAILGILSLLGLIAKNAVILIEQIEAERKRGLPIWDAVVEATVSRFRPIMLTAISTVLGMIPIAATIFWGPMAFAIMGGLLVATILTLVFLPTLYVTFYRGREGEAAPAAATPAPVASAAT
>fig|1122132.3.peg.1396 Permease of the drug/metabolite transporter (DMT) superfamily
MSRESGSATAIGAAAIGLWACLAALTGASRTVPTFEALAITFAIAAVAALVGFTAMRGWAGVRHGLTLWPRKAWILTTVAIFAYHALYFAALRLAPPAQASLINYLWPLLIVLFSGLIPGGTTKLGGPQILGAIMGFAATLLLVGGPGPVEASGTAMAGYLAALVCAFTWSLYSVLNNRINAPGSEPMIVVCALVAVLAALCHLAIGETFVMPDFGASLSLLALGIGPIGAAFVAWDHATKHGKLALLGAMSYAAPPLSTLILVLSGQAEPSLTLLAATLLVVAGAGLAAFGSRLKRPVVSPLPEGEVDARSAAGQGLGKPPERS
>fig|1122132.3.peg.1451 Permeases of the drug/metabolite transporter (DMT) superfamily
MVLGIFLYSANDTLGKWLTATYSVGMIMLVRSIAAMCVLTPFIHKQGGLAKLRQAPRPGLQLLRVFVTVGEIGFFYWSVSLLPLADVMTYYLAGPIYVTALSAVLLKEKVDGPRWLAILAGFIGVVIVLQPSSESLSWGALIAIGGSLFFAALMIVTRQLRGTPDSTLLTFSTMATLVTGAVIAPFTWVTPTPIDFGALALIGVVALLAQLCVTRSLRLAPASVVVPYQYTMLIWAVVFGYFVFGDEPKISMLIGAAIIIAAGFYIFWREQRTGKPKPGDTIAEEVGDNVPG
>fig|1122132.3.peg.1466 Permease of the drug/metabolite transporter (DMT) superfamily
MKPSELFAYLFLAVTWGFSFLILLKVVHAFGWVGAVAFRAFIASGVLLVVAWATGRRLRFAAGWRPFAVVGATTVAGQLIGLSFATPRIGTAMAAICVASIPLFSMVIGRVWGNERMSGRSVAGLVLGFAGIVLLVGFPAVPVTPGFVLGCAAALASAFCAAFGSNYANRHLRYTGALEVTIGSFFAGGLLALPLLPAVPVPGVPGPVDYAYLLLLGGVMSAVTYVTYFWLLGRIGATRTISVEFVVTVFAVLIGAGLLGETLTLVQLVGAAVIIAGCALVLGIVPSRPLREKAR
>fig|1122132.3.peg.1678 Multidrug resistance protein B
MAGPQLPPALPEMTPRRTLGFVAMAVGMFMAILDIQIVSSSLTEIQAGLSASAQEISWVQTAYLIAEIIMIPLSGFLGRALSTRYLFAIAAGGFTITSIGCATSSSIGEMIVWRAAQGFIGGGMIPAVFAAAFTIFPPNRRAMVSAIVGLIATLAPTVGPTIGGYLTSIFSWHWLFLINVIPGVFVTIGVLACVDWDKPNLKLLQHFDYIGLITLALFLGSLEYVLEEGSANDWFQDETIAALAVVAVVAGILFFWRVLRAHEPIVDVRAFQNRNFATGALFSFMLGVGLYGLVYLYPVYLARVRGYDSLQIGETMFVTGLFMMITAPIVGRLGQKMDPRYMMAFGLSLFALSCLELVPITKDWAFSELFIPQAMRGVALMTSMMPVSMLALGTLPPERMKNASGLFNLTRNLGGAVGLAVITTVLNNRWDLHITRLHEQVQWGREAATERLDMMTKGFAATLGSDANVAALKTLTLAVKREALVMAFSDVFLVLAVMFGLIVLLVPLASKPQAAPAGGGGGH
>fig|1122132.3.peg.2579 Multidrug resistance efflux pump
MQIKQIFKSGITLTAFAIGVLGVLMVLYAWQLPPFRSSVETTNNAYVKGQVTLLSPQIPGYVVAVPVQDYMTVKKGDLLVQIDDRMYQQQLAQAQATLQQQQAELSNFAENRLAKQASLDLAKAQLQSAEAGQEKAELDDKRTGTLVDRGFSTQSSGDQTRVALLQAKSTVAQAEAAVKIAEQNLALTDAGKASLEAAVASAEATVKLAEINLGNTRIVAPVDGRLGEVAAHVGQYAAAGTQLTSITPSTVWVIANFKETQLAHIDVGLPATFTVDGLGDIELSGRVMRIAPAAGSEFSVLKADNATGNFTKVAQRIPLRIEIDPGQSTIADLRPGMSVVVRIDTADKPLPAVATLQ
>fig|1122132.3.peg.2671 Glyoxalase/bleomycin resistance protein/dioxygenase
MLDLRVHHVSIVVTDLERSVAFYQKAFGLERLARPPFKTDGAWLACHGIQIHLILYPEGTFRTGPIDNSDYHFSFHTRDFYGILDHLLEQGFREDVGEDDPMRLFVIREGLAGFPQLYLLDPDRNIVEINGAP
>fig|1122132.3.peg.2858 Methylenomycin A resistance protein
MTFAAPQKSTWIALLVAVAFFMENLDGTVIAASLPQMAASFGVEAVDLNIGMSVYMLTLAIFIPASGWMADRFGARTVFAWAVFVFTIASVFCALSDSVLTFVLARILQGAGGAMMVPVGRLVVLRNASKSELMRAIAVLTWPALSAPILGPPLGGFITTYASWHWIFILNVPIGIVTLALSFWLIPNERVAERQSFDWLGFILTSIACAGLMYGLDLVGQSHVDWVVGAGILAASALFFWVALRNSSRHPHPLPDLYGLAIQTFAVTMKGGSLFRTAVSAVPFLLPLMFQLGFGLDPFQAGLYVLALFAGNLAMKPFTSLVLRTFGFRTTLIGNGLFFVATLFGCAMLTPATPWPILMIVLFLSGAARSMQFTAIGTMAFVDVPQDRMSGANTLFSLVQQITFGLGIALGAIALRLADAWLTPDIEGLTLADFHVAFLIVGVVGLFGLYDSFALPRDAGTAVSRHRLRERAVATPRP
>fig|1122132.3.peg.3099 Multiple resistance and pH regulation protein F precursor
MIAAALFAVLVAMALVVVRALRGPTTFDRLLAANSIGNGAILVLALFGFLTGRPEFLDLGLTYALLNYVGIFAVLKFFRHGSLGAEAEVER
>fig|1122132.3.peg.3122 Permease of the drug/metabolite transporter (DMT) superfamily
MSRPDWALLLILSTLWGGSFFFIAIAGRELPPLTIVALRVGIAALILLGLVAIGGKSLPKSWRVWRVLLGMGVINSVLPFSLIAWGQTQVPSGLAAVFNATTPFWTALAVQFLTADEKLSAGKIAGIVLGVAGVGVLIGPGAFLDFGAHGWGALAILLGALSNGFAGALGRNIARLRVEPIVAATGQMVMATILMIPLALLVDQPWQLAMPGWQAWASILAIAALSTVLAFLIFYRLLARAGATNTSLVTFLVPVSAILLGTLVLGERLELQHIAGMALIAAGLVAIDGRAWRWVRARRAAEAG
>fig|1122132.3.peg.3206 Glyoxalase/bleomycin resistance protein/dioxygenase
MLAEDVAKLATFYRDALGLRVDVTEQNYVAFGGEGIRLAIFSRIGMSPNTHDHPDYRTPFTGQAFELNFECASTDDVNERFSHIVANGGRSIAAPTKKHWGHYAGFFADPEGNIHSLFAVLAE
>fig|1122132.3.peg.3566 Multiple antibiotic resistance protein MarC
MDFAFAIKIFSALFAIMNPIANLPIFLSLTTGMTEGEQRRTAILVTVTVAIGSLISAMAGTAILGFFGLDVNHFRLAGGLIVLLIALNMLNGESSPSHAGSAEEQKSFKSASNVAFYPMSIPILLGPGTISALVVYAHEAKAGGDVVAFSAGLIAFLALLGTVLISGPFIGRVVSPTIMTVTKRLMGMILAAIAMEMLVGSLTALFPGWAS
>fig|1122132.3.peg.4149 Permease of the drug/metabolite transporter (DMT) superfamily
MAEVASRTGRATDVVGLAAIATTIIGWASAFAAIRVGLTALTPVELAAARYLTAAVPAGLYLAIVRPPLPSRRDFVRLVVIGVLFISAYAVLLNTGEQTIAAGPASFIIQVNPILVALIAMPMLGERFGLYGWLGTLVSFLGVGLIAYGSGDGLGLNVGALLILGAAFCTSISTILQKPLLGRMPPLVVTAWVLLLGSLPLTPAIPETIAALRIAPATVLWSIVYLAILPTIIGYLTWAIALKRFPASMASNFLYCIAPTATLIGYLWLGEIPALLSLLGGALAIGGVLIVNLTRRR
>fig|1122132.3.peg.4259 Permease of the drug/metabolite transporter (DMT) superfamily
MMAAMTDRTMTTTTLRGSSAGDLVLIALFCLIWSSAFAAAKFALPYCPPLLLLSSRFIVAGGLLLGLAVTAGRFRRPDGATLAKLILLGGLNSALYLGLSFSGMQTVSSAFTAVLISSNPLLTALLAAPLLGEKMTPQKLGGLLLGMAGVAIVLRSRLAAGTEDWHGTLLVLAGLLSLVAGTVLFKKLKPEGDLWTGTAIQSLGAGLMLAPVALATESLGDVSLTPSLVGGWLYLVIPVSIGAYLLWFRLLQKKTATEATALHFLMPPLGLLFGWLVFREPVSLLDLLGIVPIAIGIAMVTRG
>fig|1122132.3.peg.4307 Membrane fusion component of tripartite multidrug resistance system
MATPGKLGKALGAVVGLGIVAGAAVLGWTYLRHSELNPMSEDAVIQADLVNISSTVPGRIIQIAVKDNDRVKRGDLLFAIDPVPYRLAVEQTKADLQIAEAALSTQQRTIRAETSNAAIASEQISRARVNLDLATQTLERLTALRPKGYVTAQQVDDAATAKRDATISLNQALAQREAADALVSTLDGAEALVSARRAALALAERNLADTEVRSPHDGLVAGLTVATGQFVITGQSVFTLIDTENWFVTAAFRETELSQIEVGACATGYVMANRSIPLRGRVTGIGWGVSSEEILMIPRNLPYVPKTLNWVRIAQRFPVRILLDNPPPDLMRVGASALATIHSAERC
>fig|1122135.3.peg.42 Permease of the drug/metabolite transporter (DMT) superfamily
MPQQTNGSSGLLATLAPGSFVILWSSGFVFAKMALPYAETMTLLATRFLIAVALMLIISLIWKARWPKSMTQALHIAIAGILLHATYLGGVFAAIERGLEAGVAALIVGIQPLLVAFVAGLFLKEKVTLKQWAGLVLGVSGVVLVVWSKLEDGLGTELGVAIAVIALIGISIGTVYQKRFCGEMDLRTGAVIQYTAAAVPTGVLAYFTETMVINWTGEMIFAMAWLVIVLSVGAISLLYLLIRKGAASKVSSLFFLVPPTASLMAWILYDEVFQSTALIGMVMTVLGVALVNLKPIKRFGLRSRPG
>fig|1122135.3.peg.181 Multidrug resistance protein B
MSDSSQSAGTNSQAQAEQKMTPQNILHLVIVCCGITLYALNNLITSTLLPSAVSDLQGINFINWSALVYSTAAIIFSLTGGSLKTSLGGRKTMIIAGLVFTFGALLVSQSSDMIFFLFARAIQGAGGGLILATCYTVIGDLFARHHWPKVFAWESAVWAVASLTGPLAGGFFAQTVGWRLAFYLIAGSALLFVVAVRLCFPPKARLEQETITTSRKEKLAALPILRLIILVMAISSIAIAGLEPDWSLPLLGVAFLLLLLLLQRDKLAKSPLLPREGINFTTPAGTGLLVIFLASVSTYSFVVYGPYLLQTVHGLTPLNAGYLVAWESMSWSIAAMICARISQTVRWRPLLIPIGIGTSAIGLYGISLFLFSGPLWLLTVAIFFAGAGFGIFWADLSSRIIESGPSEERDRRSGAIPTVLMCGGAFGPALAGIPAQMAGFSDTATLAVLEATAYWVHIAFVPLVLLSLFLSFRVIRPRATSVSEQGSLRGTDSFVAAKPVLPTPPDS
>fig|1122135.3.peg.869 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MKSYSMKILILVLFTLVMSLGQLLFKKASMEINWSGGLLELFNPWLIVAITLYAGATLVWVWILRTVPLNFAYPFTALAFVIVPVAASYIFKESLGWPNVVGTVLIMAGIAVISLKEI
>fig|1122135.3.peg.1403 Permease of the drug/metabolite transporter (DMT) superfamily
MERTARISSQDRFDPLLEFVLLGLLALLWGGSYLLIQISLETIPPLTLIALRVSIAAVLLGVVMKGRGEALPKDKTTWGMLFVQALFNSIGAWTVLAWGQQYVESGLASVLNSTSPVFVFFFMLFFVRGETPPLFKLLGACLGIIGVLLIVGPEVLQGLGRDALAQLAVLLGAVLYAGAAVYGKRLSHLSPTVAATGTMIWAVFCLVPASLLFEKPWQVEMSERSILAALALAIFSTGLALLIYFRLLRTLGSLGVASQSYLRAGVGVALGTFVLGEQFDLFVATGVLIALSGVVLINIKNKKKVFIK
>fig|1122135.3.peg.1417 Fosfomycin resistance protein FosX
MIEGISHMTFIVQDLDRMEAILCQILGAEKVYDSGDTSFSLSRERFFLVAGQWIAIMEGEPLPARSYNHIAFKIPETAYDDCLLRIRDLGLELREGRSRVEGEGRSIYFYDHDNHMFELHTGTLDQRLKRYAQG
>fig|1122135.3.peg.1483 Permease of the drug/metabolite transporter (DMT) superfamily
MNDAKKPLWLVLAPVIFTLLWAGGYGVAKVGLQYAEPMTLLSLRFSTVVILLVPFYLYLRPALPKRRADWLHLVVVGVLVQAVYFGFCWWAFRTGVSAGVLAIFMSLQPILVAILAPTLARENVSWKRWFGLLLGLAGVLIVIIARSDIEPPTVIGVGFSIMGLLGITSGVLYEKRFGGTAHPIVANIVQYAAGFSVVFPIAFFFETMQVQWNGEFIAALGYLAIGNSILAISLLLAMIRAGEVSRVSSLMFLVPPLAALFGWLLLGEEMPPVAWIGMAVAAVGVAIAAHKRRKSDHAPMVKQDRMKEV
>fig|1122135.3.peg.1581 Permease of the drug/metabolite transporter (DMT) superfamily
MTSLLYLGTVLIWGTTWLAIAFQIGDVAVEVSAFYRFTLAALAQIVLMSALGKLTWVPFRQHRWFILQGLLLFCVNFLFFYNATVYTTSGLIAVVFSMATIFNMINGLLFHRQIPALRSLIGAALGIAGVCALFWDDLGSGDWTGDNITGDNIKGLLLALCGTYCFSLGNMVSQHQQKQGRNVLTANSYALVYGSVTLGIWCLLQGYSFELEITARYLGALLYLAVPGTVIGFALYLNLVGRVGAEKAAYCTVLFPIVALSLSTIYEGYVWTPFALLGVALALVGNVIIFTKRKPVPVLSASTS
>fig|1122135.3.peg.1745 Permease of the drug/metabolite transporter (DMT) superfamily
MSPQKPGLRQYLLLLLLGAIWGSSFLFIKISLESITPVTLTAFRLLLAFLVMITFVFALGKKFPTGFHIWRKYAVVAISGNILPFILISWGELHIESGLAAILMAIIPLSTLVVAHFWTDDEKLSLPKLAGTSIGFAGVVLLVGPEALRGLGDSVLGQLAVAVASFSYGITSVYARKSGLTKQDPMVNGASILLLASLMAIPLAFAIETPLQLEPSGRSLLALLALAVLSTAIAYTILYYLLSTAGATYTALNNYIVPVAGMLWGYLFLSERYDAEAFTALLVIFIGIVVSQFGRRQKKQEARPCPEAV
>fig|1122135.3.peg.1819 Permease of the drug/metabolite transporter (DMT) superfamily
MRNPTFKDTFILILLAAIWGSAFLAIKITVHEVPPATIAASRLLIATVIIYGYMRSRGLSLPRSKKFWIQIFFVSFFTMAAPFTLISWAEQYIESGLTAILMATGPLLALVLSHFFSTDDRFTLFKLLGVIIGFSGVLLILGFDSFSEFGDDVPAQLATMVAAMCYAGSGLLVKRVREKSNTITTASILLVATLQILPFSLLLDAPWQSLPASSLSTLAALVYLGAIPTALAFILRFYLIREVSYTFVSYVGYLVPVFGVIWGTVFLGERLPAETLLALAMILSGIAVSRLSLGWFLALKNNYKK
>fig|1122135.3.peg.1838 Permease of the drug/metabolite transporter (DMT) superfamily
MDNLTETKIPSGGILSGLLAGISFGLITPISPAVYDAGATPMTVTLFRFILGSLAMLVILGLTRGSFLVPAKGRLPLLSMSFFIFCVTIFYLSAVQYISVGLAAIVFYTFPVIVTIIDPLLQKRTPSLLQLGLSLLAFTGITIALGPSLDSLDWRGLGFLCLTSFSMCGGLICGRKVVPLVPNLTSLFYVNVIGIALSCLYLPLDNSLHIPDNLTEFSLTGLIAGLYLLAILAQITSVGIIGPSRTAMFLNSEPVVTIAMAVLVLHEALGISQVIGALFVMLAIAGTCYRPVTRPKQQSAS
>fig|1122135.3.peg.1864 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARKPGKSRERDLTQGSLPGHFRALAVPASIGMLFNTLYNVVDTFYAGLLSTEAQAALSVSFTVFFIPIAFGIGLGQGISALVGTAVGKGDRELARTFAAQGLSFAAAFSLCLAVAGYFSIPFLLDLLGVPDSFHPLSTAYLQIIMLATPAFLIAFSANGILSSQGDTVSNQRALIGGFLANCLLNPLFIFGAFGIKGIGFDGLAVSTLVIEWCVAFFLLYQALGSRVLFGCRSADFLPCWKTISELSGQGLPATFNFLTITLGVLVIQFFLQPFGATAVAAYGIALRIEQLILLPGLGLTIALLPIIAQNNGAAAHDRIRKAFWWCLGTGGAMMLAGGVILLLSGNFLLGLFTSDPAVITVGFNYLLLAAPMLPAYLMLFAMMSFLQGVKRPIWTVWIGIYRQVIASAGFAALFIHLFGWGSWGVWAAVFASVWSGLLLSSLIVRYVARKEIGGLGTPFSSAKQSLSGKQKQ
>fig|1122135.3.peg.1867 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSARTSPPENMFLAGSLPRLFLKTAAPIILVMLVSGFFTVVDAYFLGAFVGPEALTAVTMMFPVFMLIVALSTWVSGGFSSVVARLLGARKHDEANAALVSAILLSAAVCLLLITLFLFAGTGLISWVTKGSVPLSEMGYSYISLLIFFSPLQFLLTINFDALRCEGKMGFIAFLSLLSTLLNIIFNYILIVKLDQGVAGSAYGTILAQFLSITAVGLYHLKARSAFTFSLAALPNPTRFWKRFLALGXPASLGYLGVSISSAAILYSLQQWGHEHYAATVAAYGIITRIMTFTFLPLLGLNIAFQTVAGNNQGAKLWPRVNDSLKLALLSAFLYCGSLQILFNVFAEQIAFVFVEDSMIAGETQRILPQITLFYFAFGLSMVLSGFFQAIGDAKRSAILGLSRTYLFSLPLIFTLPFFFGEPGIWFAAPMAEFLMILLSLLVLFLNAGTSGMKMGLFRQTI
>fig|1122135.3.peg.2324 Permease of the drug/metabolite transporter (DMT) superfamily
MTDLNFTRKQAGIKTMQQPQINSGILQMSLAMVLSGFIGLFVFESGQSPFNVVFFRCVFGATGLGLYCWYKGYLTKEVWVARNITLALLGGAALVCNWILLFSSFELASISVSTTIYHTQPFFLVIFGAIFLGEAFSLNKMIWLIIAFSGLVLIVNPDTESFAGNIEMLKGAGLALGAAVLYTITTIVTKRLKQMKPHLIAFLQVSLGVVMLAPFVDLSAAPSDVAPWGFLIALGLIHTCFMYIIMYSAFQKLQTPVIAVLSFIYPVVAIIVDYVFYEQNLSMMQILGIVLILLSAAAVNLGWKLLPGRNVPAKKTA
>fig|1122135.3.peg.2399 Permease of the drug/metabolite transporter (DMT) superfamily
MLIAAAIWGSTFVVQQLAMETMGPMTFTAARFFLGTLVVLPLAWRELKKRKSVAQDTARYHLTPFDWAMMVGIGVVLCIGTVVQQIGIIHTTVTNAGFLTALYVPLVPLLGLIFFRKRPHWVTWFAIACSLTGTFLISGMDSSFSLGYGDALVVSSSVFWGLHVLLVGVLAAKTTMPLTLAAVQFAVCAFLATLGGMLTETVSIAALLSTFWSIAYAGAVSVGLAFTLQVVGQSYTQPADAALILSMETVFAALAGALFLQERIGSTEAIGCALILSAILMVEIIPQLLRRKLRFS
>fig|1122135.3.peg.3345 Acriflavin resistance protein
MHSLTGWFIKNPVAANLMMAFFLFLGWLALTTIRIEGFPRIPPESISITTSYSGASTAQIDELITRKIEKALEGLEGVRSISSQSNNDISVVTLRRSGGQDLQKLLDKVRLRIDGISDFPSAAERPVIEDGGFDFPALYLNLHGQTDPVTLQKLSELLREELLSRPELSRMNIWGLYEREMQIELDPQILQRHDLTVADVVTRIRLNSLNFQSGVLRTRGGTIYLKADNQARFSTEYAAIPVVERTDGTRILLGEIATVQDNFKEGDYLFRFNGELTSGMEVLIGQKENLLRVSEVVHDVVETFRTRLPPDIKLTIWGDSADYIAERLGLLKDNGIQGLLLVLLVLSLFLNVRLAFWVAMGIPVSLMGALAVAGSKWVDYSLNDVTTFGLIIVLGILVDDAVVVGESVFEERQSAQDPFLATEKGVKRVAVATVFGVLTTIAAFFPMLLLDNPLGKVLAGFSGIVIFALVFSLIESKFILPVHLAHTNLHQQPRFFPGRLWARIQQTTQHLLLEFRDRIYAPLLVSAIRHRYATLVLFIAAATLGIGLIGLGKIRTVFFPDVPGQVITVNLEMDARAPFGLTRDNLDRIRVIGEELSKSLQQEKSLEAAPVRSMFLIISDTSTAQLFAELTPVSERPDLGIIEFMEQWRQRTGQIEGATQLQFTGSEELAGGFLLRLYAKDTDLLALASKDLREFLAGINGVNNVRDSLTPGQPELDIRVKPEARHLGFTTETLASQIGNAFGGAEVQKIMRDGTELKVIAQNTDKTRDSIDDLLRSRLRSNNGNWIPFQSVAEIRGGYVSGTIHRENGKLVNTVAASINRSLVAPEEVAQAVFEQLVPELVARYPGLEVKKAGELEEIGEIQGGMKQALLLAAVMIYVLMAVPLKSYWQPFIILAIVPLGFVSAALGHLIMDLPLSVLSFFGMLALTGVVINDSLVLITSYNQLRERGIAASDALCQAGLGRFRAIFLTTATTVIGLTPLLSETSEQAQYLIPAAVSLAYGELFSTALMLILVPVLLAITEDFRRAFLGVGQNDANDPAPPEPT
>fig|1122135.3.peg.3377 Permease of the drug/metabolite transporter (DMT) superfamily
MMPVSSENSVDGGSYGEGAMKGPRLFGSPVSLLLVTGTLIGFNFPLGKIAGEAGVSPMIWALIVSLGASAMLLPVQLLRRRLTLPKGQMLRYVIVSALISFVFPNVLLFSVIPHVGSGYAGLMFALSPVFTLTLAVLFRLKTPGRLGLAGIGLGLVGAMLVSITRGAAPEAPELIWIIAALLVPATLACGNIYRTMDWPDQAQPDGLAFWSHGFALVVYLLLLLVSEGTIPLAQLSLVPWTAVAQGVVAGLTFPVFFRLQQQGGPVLLSQIGYVAAAVGLLVATALLGEVYSAMTWFGAGVIALGIAVTVIAQVQERKEMTR
>fig|1122135.3.peg.3617 Multidrug resistance transporter, Bcr/CflA family
MNKIFLKILPESIRVMPSVKETESRLFIALLIFLMALGPISTDLYLPSLPSIAAELKADQAEIQLTLSVFLLGFATSQLIYGPLSDRFGRRPVFIGALVLYLLASLTCSFSNTIEELIILRFVQALGACAGPVLSRTIVRDVYRRDEAARIMSWMGMAMALAPAVGPVIGGQVEILFGWRANFLVLSGFSTLALLWLLLRLPETNRDLNMEAMQLPRLIRNYFGLLRNTRYMGYVLISTGSFSGIFCFISGSPFVLIDQLGLSPDVFGLYFAVIVVGYMAGTFLSAQFTLRLGLHRMIMIGSSVSFAGGLIAVGLSLFGELNLLNVVGPFAVFTIGAGLTFPNNMAAALAPFPRIAGSASALMGFIQMIFASGVGVLISSYNDGTALSMTASLAGVTGMAFASYVFLIHPHKLETLDSPTTPAI
>fig|1122137.3.peg.143 Permease of the drug/metabolite transporter (DMT) superfamily
MTADTPAPVQMGLKEWSMLGFLAVLWGASFFAIEIAVTELPPVTIVNIRVGLAALVLYGYLRVAGIAPPFKGRSDKALVLLAFVLMAIFNNIIPATLIVWGQTHITSSLASILNATMPLFTVFMAHFFVSGERLSLNRLAGVLVGFSGVVFIVGPYALEGMLSGVAGQVAILGAAFSYSIAVVIGRRFVRLGIKPVQMALGQAGTAAIILLPVTLIYDKAYLLPVPSWHVIAALVSLATLSTAFAYLLYFRLIAEAGATNASLVTLLIPVVATSLGVSFLGEVFEPAHGIGLLLIAFGLMLIDGRLGKRRPRLRAEAVPPEGR
>fig|1122137.3.peg.277 Bicyclomycin resistance protein
MHEQHTNPPATDGSKTAGSQAMIAFFTIVAGTVLGLAGIDLVLPSVPAMPAIFGTDIANAQLVLATYVAGMSVGLLMFGALAGHFGRRRLFIGSLLAFGVLSLLAVMTDNIHVLNIIRFFQGAAASGGAVLAPGLIRALFSELGAIRAVSAMGSIESLVPGLAPIAGAWLYAEYGWKASFEITGTAVLAICALVILIPSLLPHIGQKRSGSSASYWRVMKNKSFIRYGLSHALVLGGLLVFVFSTPAVVIETMDGTIEDFIRMQFVGVCLFIVSANVNGSLVKRFGNEKVIMAGTIIATLGSATLFAYALFGPNNPYHLVYMFWILNLGHGIRSGPGFVRALQTTHGEDDKGSALMILATMLTGAVGTAIVGPFIQFGLVGPTLALVLIVVPALLLMYIFPPFKEGDQPSERG
>fig|1122137.3.peg.396 Tetracycline resistance protein
MPVIIFAVFIDLLGFGIIIPILPFLTLKYGGDAFIGAALMSIYSLATFAAGPIWGRLSDRIGRRPALAATFFGSTIAYIMLAMSDSLVMLFVARAMSGMMAGNVGIAMAAMADLTDEKNRGRAMGLIGASFGLGFAFGPFIGGLLGGVGGEANVFVPGLAAAGFSFCAMVLTARFMPETSKHRVEDASDGPPEPLPHWTKVIRTHGTLALYVMFFVTAIGQSICFAITPFWANATLGWNQTQVGFLLAGVGLCVAAIQSLGVGPLFRIFGEVRSLILGAVTHLVGIIILFAAPAHPVTAIIAFPMIMSGLTISFPALNSLISQRSDKRIQGTALGLSSGVSALGRVFGPLSGGFFFEGFSPDTPYLAVALTGSIVFVWAIYEVRRLGAMRV
>fig|1122137.3.peg.493 Permease of the drug/metabolite transporter (DMT) superfamily
MQQDMSTPTPGASLGIACGLGAALIWGAWPVITTMGVKANISPVQVVMLRFLVAGILLAPFALRGPSTLRDWGKAAVFALFAGTPYALLVTSAFEYAPASHGGVIIPGTVLLVSLMAAHLWLGDRLTKLRAFGAVLILIGLGGLAGGAAGGLRTMFGDMLLMAGGLSWATYTFLLRRWPMDGLRVASRVAFLSLILVGGLALAGYGEGLTSLPLETLALQGLWQGILSATVALLLFNKAVGILGSGRASIINALTPVIAVLLSFLMLDEVPTLIEFAGLITIMAGIAIALGIRIKPIRRKRDTAHVPEVS
>fig|1122137.3.peg.607 Multidrug resistance transporter, Bcr/CflA family
MHLSKENTAGLALLLGSVVALMPLSIDMYLPAFSDIGAHFGTVQSQVELSLTVYFIGVALGQLVYGPLADKYGRRIPLIIGLSIAAVTSLACAVAPSVELFVISRFFQALGMCAGGVISRAIVRDMFEPIDVAKFFSLLMLVMGVAPILAPIVGAQLAINFGWQSIFYLIAAVCVIDILSVSFLLPETREPNPGVRLSATFSTYRDIIKDRHFLGYSMAGGAAFSSMFAYITGSAFVLIDYYGVAQEDFGFYFGANAAGFIVMSQLNRWLLKHFSYKVIFHTALKVLLGAGIALAICGVVGVPLWVFLIPLFIYIASLGVVSPNGMAGALEGEARRAGAASALAGSLQFSLSFVFSGAVGIIHAADPLPLCLIILSGAVIANLFARMTKGPARKAAA
>fig|1122137.3.peg.996 Glyoxalase/bleomycin resistance protein/dioxygenase
MLEKVAFTVYPVTDVPRARAFYEGLLGLDTHGTEKIGKEMAWIEYDLPGGGCFAIANFTENTPHATAGGTIAFEVNDLDALLAHLKSNGVEFMSDMTHSPACRMAVCLDPDGNSILLHQLKNK
>fig|1122137.3.peg.1690 Multidrug resistance protein B
MSQATRHQTPVQEIAHHRGGLIFCLMLAVSLHTIDATIVNVALPHMQGSLQATFDQISWVVTSYIMASVVLTPLVGWAAARFGVKRLIMLAMVTFTISSVLCGISLTLEAMLASRVLQGAAGAPLIPLAIATMNRLSTSPGERARMMALFGLGTMVGPVLGPSLGGYITEVASWRWVFFINLPVGIIAVLGIAATMKPGAGLPGHRLNLAGFLSLAIAVGSFQLALDRGETEDWFESAEIIAYALICVASLWVFALNSRFSNRPFLPGALFRDRNFVVGMVLILITAGNMTASVVLQPPMMQNLMGYPVLDTGILLMWRGIGMVFGMMLAPRLTQVMNPRWLLVIGGISMAAGLSPFIFLTTETPAVLLSIPPIFHGFGIGIMFVMASTIAYATIPHELQVEASSVFSLIRGLGQAACISIVVALVSRYSQINHAELVERLTPLRPYTPSGTISVLTSTPEQLAQANLLVSQQAAMIAYNNAYLALLFAAATVIIAAFLIKPRQFDDEHAVEHPVEA
>fig|1122137.3.peg.1691 Multidrug resistance protein A
MKRLILYVSVPALILAAVFYVYLTGGRMVTTDNAYVRAGILTGASRVSGEVVEVLVGRNQHVDEGALIARLDDSDARVKLQEAEVGVISSRHIVAALKANYRKSVAALEKERQSLAYETRELKRAEALARDKNLSEAALDNQRFEVEDARREIAILEEAVQMALTQLGGDADIPADQHPMVLKSLAAVEAAKVALEHLEVRARTGGTITHIDLHPGEYISAGYPIYGMTVDGDLRIEANPKETELTYVRIGQSVDVIVDALPGLHFTGKVTSIDPATGAEFAVLPAQNATGNWVKVTQRVPVQILLDNGQDLSALRSGLSAEVSIDTGHERKVSDLTSMVGL
>fig|1122137.3.peg.1966 Permease of the drug/metabolite transporter (DMT) superfamily
MGVFLAFFGCVLIWGSTWYAIELQLGVVPKEWSLVYRFGLASLVLFAICFIRKERLRIRLQNHLWMAITGMTLFSTGYVFTYWGTEYLTSGLVAVTFSMLSFLNIVNARIFLGNPVTPSTIGAALIGIAGLVLIFMPEITVLTLEDDTTLGVALCLAATVMASIGNVSAGAASTRSVPVLSFNAWSIGYGALTNLVFALASGKPIAFDPHAPYVLSLLYLSIVGTVIAFTMYIWLIGKIGVGRAAYMAVMVPVVALVISTFMEGFVWTIEAAVGLALVVAGNVLMINRKAKAVTPAAPDCVEPEKL
>fig|1122137.3.peg.2205 Probable antibiotic-resistance protein
MAAIDVWAQVTTERMAREPWMATLLRWTGREGEVIVPTIADTIAAMDAAGVDIAFLSAWHGPRGSLISNDEVAAQIAEAPDRFRGLATVDISNPMEAVREIRRVVDGKTFVGVRLVPWLLDLPPNDRRYYPVYAACVDAGVPFCTQIGHTGPLCRSEPGRLIPYLDDVLLDFPELKVVGGHVGFPWIDEVVSLALKYPNFYVDTSAYAVHRLPDDLVKFMKGPGGKRVMFGTNWPMLSPAQCLKALDSLGLTDEGKFNFLEGNARRVFGL
>fig|1122137.3.peg.2531 Acriflavin resistance protein
MSDGDDDQKIEGRGILSLVASFLENPVMTNLLMIFLIVGGLMTAVTMRSEVFPTVDVGTITVSVNYPGATPLEVEDSITRRVEEAVLGINGVERVRSYAFENRASVVLELEDFVDAYRIKDEVQAEIDALIDFPPGNAEEPIVAVTQSLSNVLTLVLVGQAAEEDLRRTAELLERDLLTLEVVSAVNLRGTRAREISIEVSEDTLRKYGFTFTEIADAVRRSSLELSGGTIKTESGQILLRTDAKARVGEQFKDITLRATTSGELIRLSDIATVTDGLTDDELVNTYNGAPAIFLDILRNESKDILLVKDQVAGYVETVDLPEGQSLVIFRDQTEILADRISLLTSNALMGFALVFLLLVITLDFKLAFWVAMGIPISFLGGFLIFGSVGVSLNMVTLFALIVVIGIVVDDAIVVGENIYAEQQAGFKGPRAAFEGVKNIFAPVLVGVLTTMAAFAPLLFQTGTFAEITRPIPIAVISILFVSLIEAMLILPSHLSHEKRWSRGALRSFQVKVSRALDSFAVGPLQRLIIKSSEFRYVTLAAAVGFIFIAFSLVGAGFVRVVFFPNIEGTEISANLAMPEGAPFDATAAAMEQMETALNKVAADIKAETGEDVIRAVAITTGAKFSQASGPGAVSSNSLASHLGQFTVELVPTDARSVSSREISRRWQQEVGSVPGAETLTFAATIGPSSVDVGYELSHADQAELQKAASDLADKLSAIDGVSQIDAGLDLGKRQFEFHMKPAGLAAGLRPQDLARQLRQAYFGEEVQRIQRGRDEIKVFVRYPRDARRDLSALANLRIRLPNGDGVPLDHVASVTEGRSPTSIERVNGRRILTVTADVDESVTTPNVVNDIIQSDILPAVMENHPGLRWQLEGGSREQREDFAALARGFMLALLVIYALVATQLKSYLQPVIIIVSIPIGIAGAILGHKVLGYDLSFISMFGIVALSGVVVNASVVLVDRYNIELKDPDTSPLDAAVRATLRRFRPIALTTLTTALGLLPIISETSPQAQFLIPMAVSLATGLLVSSALMLFVLPAIVLIVEDIRKLVGAAPPEAAVETE
>fig|1122137.3.peg.3035 Acriflavin resistance protein
MNDKSELLSQLKIDRSQKEAPRSSSKFAYLLGGGALAALIFGGAYMVIGAGGDEQPTANDAANTSAQQSAATAQSSNAGTATPSAASTTVAPSDSVLNASGYITARRMATVSAEVIGLIKDVTVEEGMAVKAGQVLATLDATLPQVDLDLAQAQIKVLEARLASTNANLAEAKRVLARASELKNAEFSSEASVTRAQADVDSLSASAASTRADIEVAKLSVLRQKERLDDYTIRAPFDGIVTVKAAQPGEIVSPSSAGGGFTRTGICTIVDMTSLEIEVDVNESFIGRVFEGQEVKANLDAYPNWDIPASVIAIIPTADRAKATVRVRVGINISDPRILPDMGVKVAFLKA
>fig|1122137.3.peg.3121 Acriflavin resistance protein
MNKLIEWWARNGVAANLLMVGIFLAGTMGFFSMEREMDPQVRFPGLEISVSWPGAGPQEVEEQVVARIEESVRDLDNIEWVRSSSGEGFGEVYILAEQSVDFTQFMNDVKIRVDSISSLPRDIEPPRVSQWVNRDEFIRVAVHGNLSERELKRLAEKLRREAAQLPSVSIVELFGVRREEVSIEVSEESLRRYNLSFSDVALAIRANSLNTSGGSVRTEAGEYQITARNMADTEHDFNNIIVRQTEGGATIRVGDVATVVDGFEDNEILATLNGEPAVLLQVMTTERMDIVKASESINEWITKRQDSLPPGAKLTLWTDNNEAFQSRMETIGGSAFQGLVLVVLVLMLTLRPKVAFWVAMGIATAYAGAFVLLPALGISINMLSTFAFLLVLGIVVDDAIVVGESIHTESQRTGGGITAAVFGTQLVAKPVIFAVLTTIIAFMPWIFLDGSTSEFTRHITWVVIMALVFSLIESLMILPAHLAHLKPREKLGRFGRLQKKIADGITNFAQRRYRGIAQWAVRNRYITFSVFVSVLILGFGLFSTGYVKKSFMPEIESDEITVNVTLPEGASYNRALDILAQLQEGERKLVEEVEARTGGKLIENWYTRSRRDSVLAIVKLSPPEERDMSAKDASIRLRELIGDIPDAKEVSVRYTTSDNDAGFELSVRHPDLDVLREAVGDLEDKLRTYEALYDVRNNLEGASEEIRITLKPGTEKLGLTLADVSQQVRQAYYGEEVQRIPREGQDVKVMVRYPRESRRSIESLKDFRVRTADGREVPLMAVAELEYAPGIKRIQRWNGNRAARVSADMKENIRSQVMEDLNANFFPEWEKKYPGIVRGAIGQAEGEARFIADVLKLYGMALFVMYMMLAIAFRSYWQPIAIMIAMPYAFVGAIFGHFTVDMTMAIFSYFGVAAAAGVVVNDNLVLVDYCNKLRERGMAPMEAIVEAGVARFRPILLTSVTTFVGLMPMMMERSIQAAFLQPIVVALASGVLIAFFVTLLMVPALYSIGDDFNRGFATTKGRIKGMFGSRSNKAPAQAE
>fig|1122137.3.peg.3667 Acriflavin resistance protein
MDFLTRLGLNRSRFTLLLMIALVLSGLLLYKDFPKREAPEITIRTAIVSALYPGMPPERIENLVAERVERKIREIAEVKEIRTILTTGRMRTYVELKDSVNDLEPIWQSLRDKMSDISRELPEGAYGPFVNTDFGEVTVASIAMTAEGFTYREMEESAKDMQRRLYTVDGIAKVELFGVQEERIWLELDARRFKAVGGQLNTLINDLQNQNVVLPAGEINAEGASILLEATGDFKSVRDIENMLTRAVGGDELIRLKDLVKVRRGYVSPPENRVYYNGRPALVLAVQMQPGYDIEDVGERLTEAMHTFEHTLPIGYELNFATYQPTEVSKTVAGALSNVGQTFIVVLLVVLAFLGVRSGLVISSIVPFAVMFALLGMNALGIALEQVSIAAVIISLGLLVDNGVVIVEDILTRVDRGSKRRTAALAAGSQYAVPLAVSSLTTIFAFTPFFLLEGSEGEYAFSLGAVLALTLIGSWITALYFLPLICARVLRKRTEGEEGIEHKAEAEDLPAFARMYENMLRPSLRAAAFVVIGTYGVVIVTGQLFTGLPKEMFPVSDRNEVLIYLDMPKSAHFEATERVALDVSNWISDGEVNPEVEDHIIYVGEGGPRFYLSLNPVDPSPSKAFILVNTKSPEQAAEFGARAKRYFYEQVPDARFTIKRLAMGASESGQVKIEISGPEHEPLLVAGREVERIFAGVPGIVQNESDWGEKLVKMVIEVDQDKARRLNMSSQTLAQNLNAYFDGFEVSNFRDDDSTIPIMLRALERDRDSLEDLLNIILPGEDSIVPLEQLAVLKPALEYSQTWRKNQQPTITVTAKSSQLPAAELYAQVKDQIDAIPLGEGYQVVVGGELKDSAEIYGKLGAGLPFALLLMILVVMYQFNSFRRIAIIFMSVPLVLVGVPFGLMITGQPMSFFAILGLISLSGIIINNAIVLVDQIDIEREEMRLMDAIVSAAGQRLRPIMLTSITTVIGLLPLYLFGGPLWEPLAVVMMFGLAMASVLTLFFVPATYMLFFRTQS
>fig|1122228.3.peg.1390 Drug/metabolite transporter (DMT) superfamily protein
MSKFSPKVIGSLLVIIASIFWGISGVSGQYLIQRGVEVPALTSLRLLISGVVLVSIVAIRRPEGITPALKSKDFLIGIALFGIFGIVANQFAYLKAIEYTNAGTATVLQYLTPIIVLLYTCIRLRIPPALLEIVSIILAIGGTFLLASHGQIGNIQLNPAGLTWGILSSFTYASSILISAAVVKKWGSLLSIGFAMLFGGVIFSLATRIWTYHFTMDMPMFVAYVGIIGIGTILAYTLFIKGTTMIGAVQGSLLASIEPVASVILTVAIFQTFFYPADFVGMVLILCSATIISTKDVIARFFTRSWHKRIS
>fig|1123236.3.peg.667 Fusaric acid resistance protein fusE
MGTVVRIIVTLIIVALAVLAGRWVWERYLHAPWTRDGRVQAHITTISPDVSGWVTQLAVQDNQKVEKGELLFTIDNARYQAAIEEQQAAVKARELAWQLAQHEYQRRTKLARNNTISQEELEVTRISAEQARAEYNLAMAKLNTLQLNLQRTRVKAPQAGTIVNLDLREGNYVSQGKPVLSLVRRGSFYVTGYFEETKLSLIHEGQRATIKLMSSNQPLTGKVVSIGEAIADTNINRNEQLLPHVQQTFNWVRLAQRVPVDIELDPVPENVRLVAGTTASIHLNEQ
>fig|1123236.3.peg.1751 Methylenomycin A resistance protein
MPSLSHKTATALLVAAALFMEILDATIITTALPIIASEFGVPAAHLSVGVSAYLVAVTIFIPVSGWAADRFGAKRVFSLAILIFVGASVLCGLSETLLQFTLARILQGIGGAMMVPVGRLVVLRNLPKEQIVKAMAILTWPALGAPLIGPVLGGWIAQTWHWSWIFFINIPLGAVALLFTHWLLSNEKGQWQKFDVVGFTLSGLGFGMLMAGLESFSARPDDMTIPALLVVAGVVILSLAVRHMLTTSNPLFSLAALRFNTFRATMTGGSIIRIALSSAPFIIPLMLQVGLGYSPVEAGTLLLWLFAGNLAIKPATTWIMNTFGFKNVLVYNTILVATGFFVLALCSESTAGWELGLILFLSGMTRSMHLTVLNTLSFADVPQTYIRDANTLSAVLMQMTRGMGITAGALALALATFIIDESRNTPVTADFQLTMVFMGVIALLSLFNSVRLKPGIGNAVLNERQAS
>fig|1123236.3.peg.3117 Bacteriocin resistance protein, putative
MKYILNKTTTAIALLLSTHLANAGMINIADDYSVRLESMVDKRFDRIYRQQFDFSCGSATLASLLSFHYNDTVDELSVFKDMFKHGDKEKIRAQGFSLLDMKRYLTRRGYISNGFRITLQQLAQAKRPAITIINTGGYMHFVIIKAQRDNRIVVGDPAVGLKIMTQEEFDAVWENDVFFLIQNNEDVAAYHYQFDKHQQPYAPANLAMPVDIQRLDILSVVAPGNWDF
>fig|1123236.3.peg.3622 Acriflavin resistance protein
MKIATYSIKNPLTVWLLMVIFFVGGIFAVIEIGKLEDPAFAIKQAIITTDYPGATAEEVEEEVTEQLESRIQQLSQLGDITSRSLPGQSQITIKLRDDFSGEQLPQAWDELRRKVEAATMRLPQGARQPVVNDDFGDVYGMYYAVIAEGFSHKQKRELSSRLRREVLTVPGVTRAQLGGVPEETIYVEVTQEKLASLGISLNQIAGVFQTESAIADTGSVRVEDRRIRLVIPPSDDSADTIRNLKFGIPGTTEQLHIGDIADVYRAETENPTQLVRHNGEAAFTLAIAGRSDKNIVDIGNRVTSHLNTLREKLPLGVEILPIYEQHKVVDQAIQDFLVNLAASVTIVVAVLLFVMGWRVGVVVGGTLLLTVLGTVLFMWIFSIQMERISLGALIIAMGMLVDNAIVIGESMLLNRQKGKNSVEAAEEAAQQTQFPLLAATVIGILAFAGIGLSQDTTGDFMFSLFAVILISLLLSWVLAVTVTPLLGHYLFKAQSGDTDEDIYDTRGFRAYKKLLSGALRHRRLTIVFLVMTTAAAVVGFGWVKQSFFPPSNTPIFYVDYYLPQGSDIRATEDDMKAIEATILQQPGVESVTSLIGMGASRFMLTYAPELPNPAYGQFIVRTEQREQIPAIMKALRERINRSHPQAEVYTRRIFFGPAEGAKIEARFMGSDPEVLRALGQKAQNIMYASDSITDIRQNWRQREVIVRPVIDEQQARIAGLSRTDIADSLEFATVGKRVGVYREEDRQVPVVIRPPAGERRSMSWLEDRLIYSDAEQTFIPVRQVVKDFEVHSENGIIHRRNRVRTLTVQAEPVGDLTAATARATVVKQIESMALPPGYALEWGGEYESSREAQAGLATKLPISFLSMILITILLFNALRQAALIWIIVPMSVCGVTAGLLLTGLPFSFTALLGLLSLSGMLIKNAIVLVDEADIRRTTADNLHDAITGASLSRLRPVMLAVLTTVLGMLPLLWDAFFASMAVTIMAGLTFASLLTLVAVPVLYSLFFSEKDMHP
>fig|1123502.3.peg.165 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MALSERMLELRDAPIRKLLWKYALPAIIGSSVSALYNIITRYFIGNADYLNDDAMSAMGLALPIMTIIAAFGMLVGAGAGSRISIYLGNEDYEKAERVVGTSLLLTLVITLTISFIFFFTLTPLVHFLGADEGSYQHTYDFLKYFLPGAIFSNLCFSFNNMMRASGYPKKAMYTMLLTLVLNGIFAPIFIYWLKWGMEGAAISIILSMFIGTLFVMQHFVNGHSVLQFKAKYIRFDAQITKAVLSIGLSPFLMNIVSSSIIFIIIQQVRVYGGSVAVGAYTIVNVLLMLVVLVLLGLTQGMQPIVGYSFGAKEIARLREALLQTIKIGVGIGIVAMVIGVFFPEWVIMPFNPSPALSDVAISAIRIVTMLFPLVGFQIVVTIFFQSIGKVKHSIFLSLSRQILFLIPGLFILPHYFGIAGVWYAIVVADLISTCTAALFLWIQIREFNRYLKGNA
>fig|1123502.3.peg.292 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MISHVSIQMVAATAASNQFFETSVAILNFIGVGCSIVVAQYLGAGDRETTRKAIHLSITLNLMLGFVTFLAIWFFGHDLLSVMNTPENILNMAYDYFHIIGICLIFEAVAIILASCLRVYGYSKAPMYVSLIMNIVTVVGNIFVLYGVFGFPQLGLSGVAGSTLLGRIVGVALLFYLLFFGIKVRLEWRMFFQFHKKILQQILKIGLPSAGENLSWTAQMLVMLAFVGKMGEDALAAHNIYLQLSYMLMLFALAIGIGNEILVGHLVGASNFNAASARTWKSLRTGMLVTFAVVVVFYFARYLVVDSFTEDPIIKELLLPLFLLSILLEPGRTQNIVMVNALRATGDARFPFYAALVFMWGIAIPVGYYFGFVLEMGLIGIWIGFLCDEWIRGLVNAWRWKSRKWETKRLNIEH
>fig|1123502.3.peg.377 Permease of the drug/metabolite transporter (DMT) superfamily
MSTEARGHLLALLTIVLWGTTFVSTKILLQHDLSPLEILGARFLLGACFLMLLYPKRLKGTTWREELCFALAGLCGTTFYFWFENHALLYTLAANAALISSTSPFFTVLLARFFLKEECIRPIFYVGMLLSFVGVGLMSFSGLQSFELSLKGDALALGAAFIWSIYAIVSKKMGSFGYNTIQTTRRTFWYGLLFMLPMISWQSLDFSHDALLNYVHQYASPVVMFNLLFLGLGASALCFVTWNLAVKILGAIKTSLYINAVPMVTVIFSTLILHEHITLLSALGILLVLMGLGISQYQRKSSNS
>fig|1123502.3.peg.379 Multidrug resistance protein D
MFPQIVETLYSPILPALSSAFAVSEAAAGQTLSLYFMAFAIGIVLWGYLCDRLGRRITFILALSVYTVGAVTALWVTDFSALLICRMLMALGAAIGSIGTQTVMRDAYSGEALRKTFAIVGILMAISPMLGIFMGTLLEMHLGYRAIFMALVLFALMLLLWTILSLPETRPHNMQRVALLPIARVMLKDGVLLRHMVMIAGFNLMLFSYYQLAPFWLTDLGYPMTLFSYTGLLLGAGSLLGALINRRCTQAHVPARTLIRIATMVLLISALMAFSLRHSLWLLLPMGIMTFCYGIAIPNILAHVLDDYHNARGTAGALLGLGYYLLLGLGLMLSAISGHLAGTLLVTALFMLCINLSE
>fig|1123502.3.peg.1001 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTQPIKISLVVPVYNEEAALPIFYQAVREAPFLKDYDLEIVFINDGSRDQTEAIINALAISDPRVQALSFTRNFGKEPALFAGLEHATGDAVIPIDVDLQDPIEVIPELIEKWQAGFDVVLAKRIDRSSDSFLKRQSAGLFYKLHNKISTPKIEENVGDFRLMSRNVVENIKKLQERNLFMKGILSWVGGQTAVVEYVRAERSAGDTKFNAWKLWNLAVEGITSFSTAPLRIWAYLGFVVALLSFSYGAYMIFEKIVFGNPVSGYPSILVSILFLGGIQLIGIGVLGEYVGRIYMESKQRPRYLLKKMGSDKK
>fig|1123502.3.peg.1053 Multidrug resistance transporter, Bcr/CflA family
MGIAHPHKMDCMNTQHTQTRIITASLIMLMALLTALDSMAIDMYLPAMPDIASDFQISSGKVQQTLAIFLAGLAIGQGLYGPLLDRYGRRLPLLIGIVIFIIGSVLSALVPNVEWMLAARFIQAIGASAGLVTPRAIVSDTCDLKDSARVFSLLMNAMMLGPILAPMLGGFVLGFGEWRVIFYIIAIIGGITLLWAWQQVPETLAIEKRTPLNLKAIAKTYGGQFTNRTFMCYAMASGFAMSGLFLYVGGSSFIFREHFALSATHFSYLFALNSAGLVIFGAVANRLLVKGLSARGLLMIGMMMHTGFALLLFILTQSMTLSIVPYALLLAGAISALGFVLGNVTALTMHYGGPQAGAVSAVMGVLQYLLPALMGYVVSLFAQSISVLPLAIGICGLMGILFIFASQDKTA
>fig|1123502.3.peg.1120 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLISGTYQLIDGFFIGHFIGPEGLAGVNIGWSYITVLLGFGLLVGVGTGSLYSIAKGAEDDETARAIIGQSIPLILIPGLIFGIILYVAAPSLVYMLGDPQYQVSKTFQTAALMAVDFIRVFAVSSPLVIGSLALPFLVRNMGNPYRATLYMAIGVTINIICSYFMIVVWEWSIFGAALASIIGESCAMFLGLYYILYQSGENLQWRHFKPRPKLLKEIIINGASTFFMYIYVGFIMMLHHMMLVKYGGTIAVSAYTITGYIVTIYYLGMEGIANGVQPIISRLYGRENFLSTRAIIRMMVIVGMTYGIGLTILLQIFPGFFTRLFTSDQELSKVTIHAINIHLSLLFLEGVFVMVTVFFQAIGEGSKALVISIGNLLIQVPFLLIVPKYFGLDGVWISMPLSSFLLAIPVVYWAYIRYRHIV
>fig|1123502.3.peg.1141 Quaternary ammonium compound-resistance protein SugE
MNNKAWFYVGLTSVFELIWLYGFNRADAPWEWALVVLFIFMDLNFLAKACQYLAAGTVYAVFAAVGTIGTILMDTFLLEQTISTAMMVCMGLILLGVLGLNLSDPSVDEEEENHG
>fig|1123502.3.peg.1142 Quaternary ammonium compound-resistance protein SugE
MANYGTWIGWGLVTLAVAAEMVGIFGLSLYTRKKNLINRLLYFGGLAASFVALYYSFHYLPVSIAYTVLTGIGTAAAVVINIMFFNESKDIKRIISLAFIIAGVCGLKFLS
>fig|1123502.3.peg.1360 Permeases of the drug/metabolite transporter (DMT) superfamily
MTGLIFVLWIANVAFDTLGQIAFKYAATIETKNDTMASYWQGLLRQKWLWIGVIAYIVEFFLWLAFLTLVPLSKGVLLAAMNIITIMIAGRLLFNEKLIPLRVIGIAFITAGVAIVGIF
>fig|1123502.3.peg.1401 Permease of the drug/metabolite transporter (DMT) superfamily
MNWAAMLYPLVAVMIWAMNAVVNKLSAGVIEPAAISFYRWVLAFLILTPFCIVGTWRNWQQLKPLLWKFAVLGFLGMAVYQCLAYYAAYTISATMIGIFLSLTPLLTIILSLLILRTPLTVGLLVGSGLSFFGITWLISGGNPAILLDIGIGKGELMMLIAASAYALYGVLTMKWKIQAQVSTWQSLYWQVIFGVLILVPLFAMTDNVAITRENVNLILFAGIPASIIAPFLWLQGVARLGASKTSLFMNLSPLFTAIISILFLHENLEPYHIIGGAICLIGVIIAQRVNKVVSLETLRKRANKKAFE
>fig|1123502.3.peg.1560 Multidrug resistance protein A
MQKMTRTLLGLGALFIALVVVLYLVAHQQKEFVLQGEVEANRVDISVRVQGRAKEVFYDLGDNVKEGDTLVILENPAMIAQQITAEAQYNVAKANRDVAYSTRPEQIEIQKALLASAEDGVTLAKQSFDRVQKAIQKGGVSQQVFDEAKTSYEVALKDKLAAEASLQLAENGASIETKHLADAQVAQAKAALNQVNTDVDTLIVKATANGQVTAKVAEVGQLYNPGTPLYSLIDLTDMWVTFNIREDFLRAAKIGDVFEVEIPALKETVEVKITALNALGQYANWRATKATGEFDLRTFEVRAKPIKNIEALRPGMSVIAKWNTRKAQ
>fig|1123502.3.peg.1789 Permease of the drug/metabolite transporter (DMT) superfamily
MLFLGLFWIFSGKLRHEKWHLPEVLRILLCSVFLILNWVYFFKAIEVSGVTVAISIYHLAPVIVMILGAFIYKERLTLIPVLAIVICFVGTLAIAEINRTASVAEFFSPGLIFGLLSALFYALLTLTGKGFKYASSYAITTIQVAFGALLLVPFVDFSAFNGLTELNWFYIAITGFVHTGIVFYLFFDAIRHLSTQMIAILVFLDPLVAILMDLFITGFIPSMEQWIGIVLIFGGMALTLMPKKKAALI
>fig|1131462.4.peg.243 Permease, MDR related, probably tetracycline resistance protein
MNSKKILLILGLAGFVVMADNWVVSPILPSISKDIGVDIASSALIITAYMVPFGLFQLIFGYLADKFGKRQVISFSMVFFTIATALCALGSGLTDLVIYRALTGIFAASVMPVSMALIGDIFPINERQSAIGTFLGISFLGQGLSMLLGGSIAYFLNWRGVFAVYALLSVIATVLLLTVGKKIPSSKSETSQVLTPYINLITNPLSLKIYLLVLFEGFLLMGIFSFLGGFIKTTYDFNNFMIGLIMTVFGLMAVAGGRISGKIASRVGRKKTILIGLICTLVGNLIFILLGNVLAIFIIGVGLLGLGLMLAHSTFLTIATGFAERWRGVAMSLVAFCMMGGGGLGTAIGSRIVGNSSYLTLFSVYGIGLIVLILAVLLVKKSFMLNSVELK
>fig|1131462.4.peg.256 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKSFEFGNKSIGKLLWQFSWPAIVGMLVNALYNIVDRIFVGRGVGTLAIAATTVAFPIMLLLMALGMLVGIGATALISIRLGEQKKDEAEKIVGNALTLLIMLPLLFMVFYFSFSEQLLVFFGANQEVLPNALDFTNIIVAGSVFGAIGFGMNNFIRAEGNPRIAMLTQILGAVINGVLNYIFIFHLGLGIAGSALATVSGQFITSLWVLGYFLLGHSTLKLRLKNLKPDFPIYLAILSIGFAPFAMQLANSVQNMLLNKSVMLYGGDLALSAIGVIMSISTLFFMPIIGVSQGAQPIIGFNYGAGQFERVKATLKKAIIASTCIAVVGYLVIHFWPEQIIGLFSDNDKALTELATHVILIFFTMFPLIGFQIICSSYFQAVGKPLQSSVLSLSRQVLLYIPLLLVLPHFWGIEGVWRAAPIADILSVLITATLITLEMKRLSKNQPAVSVG
>fig|1131462.4.peg.768 Permease of the drug/metabolite transporter (DMT) superfamily
MQKQKFAVFQALLAAALFGISTPLSKLLLSHLSPIMIAALLYLGAGTGMFALRLIIKVNRPLSKEAGIARKDLPFTIGMVILDISAPILLLVGLSTTAAANVALLSNFEIAATALLALWLFKETIGQRLWTAIILITASSMLLSLKDIQGLSFSAGSIFVLLACLCWGLENNFTKMLSLKDPMQIVVIKGLGSGTGSLLIAFVTKQMTADYSYILFTLILGFFAYGLSIFFYVRAQRDLGAARTSAYYAVAPFIGVGLSFIVAKEPITNNFIIAAILMIFGAYYAAREKHDHQHSHEVLCHEHRHHHGDGHHTHVHGDFTSGEHSHPHEHETIEHAHHHAPDMHHKH
>fig|1131462.4.peg.1849 Efflux pump antibiotic resistance protein
MNDHHDHTHDDSKTVKRTLLFIATAGSFLTPFMISSINIALPAIQKEFAADAVVLSWIATSFLLSSAVFLLPIGKLADILGRTRLYKWGIISFTAFTLITGFVPNIELLIVMRVLQGISASMIATAGMALITSAFPPQERGKALGFNVSAIYVGLAVGPFLGGFLTEYWGWRSIFLVLVPLGVLITVLTITYVKSDWADAKNDKLDIPGSLIFAVTLIALIYGSSILPDILGIILILFSIVCFVFFVKRQLKIPNPVLEIRLFQNNRVFAFSNVAALINYAGSYSVTFLLSLYLQYVQGMSSEHAGIILIIQPIIQSLISPMAGRLSDKKEPAKIASLGMAGTAAGLFLLSFIGPHTSLFLIIAALMVLGLGFALFSSPNTNAVMSSVDNHYYGIASASLSVMRVLGQMLSMATATLLISIFVGKNQITPEYYPQFIQSIRLAFLISACLCAVGIFFSFSRGKIHVNNNQA
>fig|1131462.4.peg.2462 Daunorubicin resistance ATP-binding protein
MAMIYVEELVKQYDKAKTPAVKGVSFAVNEGEFFAFLGPNGAGKTTTISILTTTLSKTSGIVTIAGYDVEKEAKQVREKVGIIFQQPSLDLQLSAEENIRFHACLYGMFSYRPTFRLMPSAYKDRVMELAEIVGIQDALFKPVKKMSGGMQRKLEIIRSLMHTPSVLFLDEPTQGLDAVSRRSLWEYINTVRKEHGTTVFLTTHYIDEAENVDKVCIVNQGRVASCCSPEEMKKSLVRQELILDADDREGLTGELSELGLFHKKDAHIIVPYQDKTAQEIIARLNTKLTLLKINEPTLEDAYVEYLNRTGGAAA
>fig|1132443.3.peg.3976 Outer membrane component of tripartite multidrug resistance system
MRLFKPVIGCLFLISGCAWIPEGDKPAEFMTAPSMDHALSEFHEKQATASLERWPNERWWQEFGSSELNSLMANGLKDNPGLKAASDRVREAEALARVEGSRLLPFIDADADVAYERVSAHGLFAALNRKEAAGAHIVASKINLLNFRYEFDFWGKNRAALEASLGEAAADKAEMADTLLRLTTAIARSYFRGVALRHQLDLATEMVKLRQDLLDISETRLRLGLDSVDPVKESSINLEQARKREALTRDQLDLQRNLLAKLIGKGPDSTQHLFLDKVNIPRDLALPDKLPLELLRHRPDLTSALFRAEAAAQRIKEAKARFLPTIDLTAFAGVNALRLTKGASTLANVLFSGSSVAYGVAPGLRLPLFEGGRLRAELSAQRAEYDKSVELYNDTLLHAIQEVADSLSGWKESLSILEAHGRLMSSQRKNQELAEDRVRAGLDDRRELLDRRHAVLEQEYVLKTLETDHLAARVDLIESLGGGYSKEIEIIQQLIRHKPEHPEGFDLYKWLIFSQKE
>fig|1132443.3.peg.3977 Membrane fusion component of tripartite multidrug resistance system
MNVSHRTIRARRKRYLQLVLLASLAGGLIYAGFWWLHARHWVVTSNAFVSGNLIPVEADATGIVTQVLTEESRYVKKGELLVQLDRHRALTALNQSEGKLGQTTREIGALFATRRQMCQKLIARSASLSRVRHDVVRLRQAAPNGSVSEQALQNAEDEMAALDAQRLEAEAEFNAVEARVGGTTPKRHPDVETAKHNFIAAYLEYARQHVYAPASGYVAKRKVQVGNRVQPGDPLMTIIPLDHLWVEANLRETELMRVRPGQAAEIAVDLYGRHLTFHGTVEGLVPGTGSVFALLPPDNATGNFIHIVQRVPVRIALRADEILKNPVRPGLSTVTSIHVEESERPPGDSLVTVSSREYATDIFAGELTEAEKRAEKIIEDNLPFSSDFAEYRCHAGER
>fig|1132443.3.peg.4003 Multidrug resistance protein B
MKTLETSSPNLILETPALEKNNGSHLGLPQWIGFIGMVFGIFMAVLDIQIVASSLEQIQAGLSATREEITWVQTAYLVAEVVIIPLSGWLARALSTRYLFALACGGFTLMSLFCALAWNLPSMVIFRALQGLFGGAMIPTVFAVIYTLFPPRLQPAMVIVVGLVVTVAPTAGPVLGGYLTDAVSWKALFLVNLAPGLLVSLSTWLFVRVDEPEWDLLDKIDFRGILYIVLFLGSMQFVLEEGVKEQWFESREIGFFALIAVVSGTAMLYRELTIEHPIVDLWAFRNRNFAVGCIFSFILGIGLYTIIYLMPVYLANVKGLSSLQIGQYVMVTGLFQFVSAFVAGPMAKILDSRWMLALGLLLYGLGTWMNGNLTYEAGYWEFFWPQAVRGFALMFCFLPINSLALGTLPAEEVKNASGLYNLMRNLGGAIGLAVANTLMIQLNKGNYAVLREKVTGGSAEAQAFLSGMKQHLIASSSPDPELAALKQLYGLAMREAEVLTLNTLFHILGLVFFAALLLMPWVRKVSAGEDPGGGH
>fig|1132443.3.peg.4004 Multidrug resistance protein A
MHSPFFKSPFFIIALVLAASAGGLLYWFKTIRPFETTDNAYLKAHISLISPKESGYVREVLFEDNRKVMPGDLLVVIDDHDYQAKVAQAEAQVMLEKATMATLETDKQAQSAMIRQEQANMAASEANVEKSGKDLQRFRNLAAEGAISAQTRDTAESAYKQAKAERDKYLSTTQEAISRLSSLDARITETQARLKAALAALELARIDLANTRIFAPFEGVIGNRSVQVGQLVQPGTVLAYLIPSDGIFVEANFKETQIARMQPGQTVEIGVDALPDQQFTGMVDSFAPASGSEFSLLPPENATGNFTKIVRRVPVKIRFRAGTSLSRLRPGLSTTVRVKVR
>fig|1132443.3.peg.4743 Permease of the drug/metabolite transporter (DMT) superfamily
MPGFFIEKFFCFRMRVCLAYVIVILLWSTTPLAIKWSGEGPGFLFGATARMVIGAGGILLALAGSRKRLPWHKSALMTYLAVALQIYGSMMTVYWGAQFIPSGWISVLFGLTPLMTALLAVYCLGERNLSLGRFLAYFFGIAGLGVMFGSALQSGRNAVMGITAVIIAALLQSLSAVWIKYINAGLPALVQVAGGLLFALPAYLLTWAVADGHWPILLPPISVASILYLGIVATTFGFVLYYYLLTRLEATQVALITLVSPVLALLLGRTVNQEPLTFRVLAGSLLILSALVLHEYFDRVVGLKRVVSNGKSRH
>fig|1140.3.peg.464 Permease of the drug/metabolite transporter (DMT) superfamily
MGDDQSDRLRCAGLPLKFPVSLQLAIATALWGGTFTAGRIAVQQLSPLAVACGRYLLATTVLLLILWQREGWPPLNRRQQLLLFGLGVSGIALYNWLFFIGLSLIPASRAALIIALNPTAIALGAAIWTGDRLRSWQWAGVGLSLIGAILLLGSRQAGALTLPGWGDLALVGCVLCWTVYSLLARQALRSLSPLTVTTGACCWGSVLLIGLWLGQGAQLPVNVSFSTGSAIAFLGLGGTALAFCLYANGIERLGAARAGLFINLVPVFGSAIGALLLQEPLSGLTLLGGLLVLAGVGLGTLQRLQPVPISTTEPVGGDRSPGPPALGHDR
>fig|1140.3.peg.986 Permeases of the drug/metabolite transporter (DMT) superfamily
MPTEIRLAPWLLLASLTATCEATKDLFAKRSLQQLSATRLAALLSLLTTLLLLPIVLWQGIPAIGPNFWWSCLLGSSLNLVAFWLYARALQMGELSLVAPIVNLTPLFLLLTSPLIVAEHLAWQDSAGVILLVIGAYQLNRRDRDSSSRLQPLIDLWQQPAQRIMVVVAFLWSITSNLDKIGVQSSDPYFWLLCLFGSTGIVLLILGRGLGPVRKYPWRSLSAMAIFNSVGVVAQMVALNQATVVQIISVKRLSTLIGVVYGAVFFGEKQLRQRFLGAALMMAGAIVLL
>fig|1140.3.peg.1243 Multidrug resistance protein B
MNQIIQKIRDFWSGTQGENHCWWALAAVECGNFVVYMDGFIVTLALPAMARHFDVGLPILKWVVVAYLLAVTVTLLPAGRLADIWGRKRIVVIGMSVIFISAWLCMLAPTVKILIACRVIQGIGGGLVLANVMAEITAVFPKQDQRKAMAVNASVLALSQVTGLVLGGLFIVQFGWRSLFLIILLVSLLGLILSIGILKLRSRTQGRASLDWIGALLAIGATSAPFIFVEELSKNLLNPSSLLLLAVGVVALLLFVFVEQRVRQPLLNLSLFRSRAFTCGSASAAFYFVSAVSCYFFLPLYAQLVLGLSPVMAGVLLIPLSVAITVTSLTIGRLGNRFSARTLSTIGLLCVSVALLGLSSLGANASSTAIIAPLILQGMGGGLFNPPNNTATLNQVPPENLSVANGFLSTSRNFGQAIGAAIAATLLAQGLSAAGAGDALAGAAGVRLSGFQLEAFLSAQRSAFQLAATLGLVGAVISVLRPRRAPTAASLKSSGTAQ
>fig|1140.3.peg.2421 Multidrug-efflux transporter quinolene resistance protein NorA
MARQRLAFFSVALNVFMDALGVTLLLPILPELLRPFGSNAFLLGAFASVYTLAQFISTPVLGSLSDRFGRRPPLILTLVFTGLAYVLLAVGSLVENLPLLFAARILAGLAGGVFAIAQAYIADRESDPLKRSTQFGWIGAAFGLGFLFGPALGGLLSGINLRLPIWFAAILAFINAALTVFTVVESLPPERRRIVPWQDLNPLKQLWAVSRNPKLRRSLASAFIYNFAFAGFTSLFVLFVQNRFGWTPLQVAGVLIAGGFTSALGQGLIFGRLLPYFQEKGLALIGLGGMAVGYLWLAQVPTPGSQLYPAQILTALFGGFVIPALSGLFSRRVTAEEQGQVLGSVQGWQSLAQVIGPLILGVVYDRGGADPFFWSLAALNAIAVLLLLPRSRQPLE
>fig|1146883.3.peg.216 Vancomycin B-type resistance protein VanW
MIFRRAGAGRVPRGVTATAPRDRGTAPGRGVATSGARRVPRGVTATAPRDRGTAPGRGVATSGARRVPRGVTATAPRDRGTAPGRGVATSGARRVPRGVTATAPRDRGTAPGRGVATSGARRVPRGVTATAPRDRGTAPGRGVVRRTTV
>fig|1146883.3.peg.2312 Probable antibiotic-resistance protein
MSTLNLDELVAIDVHVHVEQDLHGHKSMDDELLAAASKYFKGDPYHPTVPQIAEDYRAQRMAAVIFTVDSELATGHPTLSNEEIAEAAAQHADVLIPFGSIDPARGAAGVRAARRLVEEHGVRGFKFHPTIQAFEPNDRRHYPLWAELESLGVPALFHTGQTGIGSGLPGGRGFKLRYSDPMLLDDVAADFPGLTVIMAHPSVPWQDAAISVATHKANVYIDLSGWSPKYFPPQLVRAANTMLRTKVLFGSDYPLLRPDRWLRDFEQLEIKDEVRPLIMKENAVRALGLRGA
>fig|1146883.3.peg.2356 Permease of the drug/metabolite transporter (DMT) superfamily
MPCHGRRRGDRFGTVRLARVTATTSRVQTLGGPALFVLLWSTGFVGAKYGLPYAPPFTFLAVRLGLAAVLLALVAAALRSARMPDRAQYGRASVAGLLLHAGYLGGVFYAISLGVPAGVAAVVVSLQPVLTAVLASHVLGERPTSRQWVGLVLGLTGVALVVGPGVLATGSAEPLPTVGLIACVVALVSGTLGTVWQKRHGDGIPLVWGTTVQYAASAALLLVVALVTEDPSIRWTGEFVAAFVWLVLVLSIGAVLLLLLLLRRGTAAGVSSLYYLVPPATAIEAYLLFGETLAGLSLVGIGVTALGVALVVVPQRKRVDQAGSSPE
>fig|1146883.3.peg.2688 ABC daunorubicin resistance transporter, transmembrane permease component
MSAAPTAATDAADTAAVRRAIASTARPPRPGALSAALTFGWRGMLKVKHVPEQLLDVTVTPVMFVLMFTYLFGGAIAGSTSAYLDYLLPGILVMSVLFTTVYSGVALNTDVTKGVVDRFRSLPIWRPAPLLGALLGDSVRYVLAGTVIIVLGVLLGFRPDGGFPGAVSALALVVVFSFGLSWVFSVLGLLLRTPNAVMNAGFMGIFPLTFLSNVFVPPATLPGPLAAFVEVNPISILATASRSLMAGEPDLTAILVSLAVAAALALVFLPLTTRLYRSR
>fig|1146883.3.peg.2716 Glyoxalase/bleomycin resistance protein/dioxygenase
MRMIFVNLPVTDRDRADAFYGALGFRRNDQFSDERCVSYVVEENIHVMLLTRERFADFVTGAVGDPAQATSVLICLSADSREEVDRLVSTAVTAGGKPWLPPQDHGVMYGASFADPDGNVWEVMWMDPTVVQG
>fig|1146883.3.peg.3025 Glyoxalase/bleomycin resistance protein/dioxygenase
MPAPSHAVPGRSGAERIHHAGLSVGRMPSFPGIAHVSLTVTDVDTSTRWYTALLGSEPRRTMTDGPFVRRVFAVPGGQAISIVQHDGAPPADTFDPRRPGLDHLSFEVGAEAQLHAWERRLAELEVEHSTVQRADYGSVLSFKDPDGNALEFIASS
>fig|1146883.3.peg.3068 Vancomycin B-type resistance protein VanW
MLAAAYGVDLLAASGEIPRNTVVAGVDVGGLAPARAAQLLEEELAPRVVADHTVTAADVTGTLSPATAGITLDVARTVDAAEDQPLNPWTRLVTVFSDREVEPVITGEETALAAQIEGIAAQVDRAPQDATIAIEGTTPSVVEPADGRALDRDGAAEAITDALASGGDPSVPIELPVDVTRVDVDVQEAERVLEETVTPALSAPVRVVSQDGGTSAEVPVEAIAAALTFTPQDDGELAVGLDAPALQAALGDELGAFGTPAQDARFEVSGGAVTVVPSVDGTGIAPAQLVEQLLPVLDDEAPRSVTAELGPVPAEFTTAEAEALGIREEISSFTTRIGNPASGENIRVVAKEVDGAVIMPGETFSLNGFTGPRGTAQGYVEAGVINNGEFTTAVGGGISQFATTMFNAVFFAGLEDVFHKPHSYYISRYPAGREATVYYDSIDLTWRNDGDTGVYVDTAWTPESLTVTFYGTERYEIQSVSSERYNIRQPVVQDKPDSPTCEPQSGSTGFDITVTRIFRDLTTGAELKRENFVTRYAAEPIINCVPAEPPAPAPEGTAPSPAPAPGGRRPAHGRAA
>fig|1146883.3.peg.3461 
MSVVKINAITVPKDKQERFEERFRGRAGAVESTPGFEWFELLRPLEGTDQYLVYTRWSSQEAYEAWQSSQDFDRAHDGGGDTLASAAPHSAHVWTYEVLEYAGPKANQEKQV
>fig|1147128.3.peg.826 Drug resistance transporter, EmrB/QacA family
MVIVFITQLDGGAVPTMLPSITRTFGLTTMGSSWVVGLYTLGLVVGTPITSNLSDAHGARKVFLWELAFWFLGCLMTAVSPNYAVMLLGRFIQSLGDSGIMVLSMNVLLQRARRNNQGRKVSTVGIIAGLSAMVSPVLSGMLLGITHGWRAYYFMMLPFLAILFILAWFMMGDSQTDRAWKTDYLGLGSFSIALALLMVAITFLQYGTAYLALIIGCLLVTVVAGAVFLVHERGLGDSKETMPFLPIRLLKLPSYGLTLLLGTLGGMFFSLFVYIPTYVHSVFGLPVRSAGMVMVGVGLGSVVGSWLGGLLVDKFGYRTTLVFSSSLIGLMALVITLTLHNLQLFMVLSFLMGVGMGSMMSSPLQVIAGRLAGPENRMQAIGGLSACKKIGTTIAPLLFASAIELGKVGGQAGLASYRNMFLVVIVIALVNIGLTYCIPFSQKEVADD
>fig|1148.1.peg.28 Multidrug resistance ABC transporter ATP-binding and permease protein
MLLSPQSNRQVLMAYLSPQWGQVLALAIALGGSIILQVLNPQILRYFIDTAMAGGPQTILVWLALGFMAIAVVRQGLEIVATYCSETVAWTATNNLRLNLARHTLNLDLTFHKNHCPGELVERIDGDVDALARFFSQFVLQVLGNGLLVVGVLVVLWFEQWQAGLGLTLFALVALGILSRLQSLAVGPWQVYRGISADFYGFITEYLAGLEDIRGNGAVDYVMNRFYTLIRNWLRAFHQARLQSTLLWGSTVGLFTVGNAIALALGAYLWRVQGITIGTVYLLFYYASLLQDPIERIREELEQFQQAVASLYRIQDLIRQSPSPRLGRSQALPSGSLSVEGKNVWFSYPTTASLKPGDGNHELPEHRQGHHHEDADYALQNLTWHLPAGKVLGLLGHTGSGKSTFARLLLNFYAIQQGQIQLGGINLGEISQRELHQRVGFVTQDVQLFQTSIRNNLTFFNPHIPDRLILQALNDLGLEPWLATLPQGLDTELGTDGGGLSAGQAQLLAFARVFLKDPGLVILDEASSRLDPLTEQLIERAINRLLEHRTGIIIAHRLKTVERADQILILDRGKVLEYGDRPALAHNPASRFSQLLRTSSAIKLT
>fig|1148.1.peg.49 Antibiotic resistance
MSPMELTPETKAAVVTQGLTKRFDRQGAVTNVDLSIAEGAVYGLMGPNGAGKTTLIRMLATAEEPTKGEIYLFGDRLVAGADNLRIKQYLGYLPDDYPLYEDLNVWDYLDYFARLYHLKNPGRRHRIQEVLELVQLTSKRHSRINSLSRGMKQRLSLARTIIHEPILLLLDEPVSGLDPLARQQFRDIIRVLQAAGMTILISSHVLSDLAELCTAIGVMELGCLVESTTLADLYNRLGQRTISIFLLEGVEQLQDCLKNQPGVEDWQINYDQGDQPNSAPGTHCSVIFSGSPEDSANLLRNLIYAGCRVSQFHCQQEDLESIFLKLGHQQVS
>fig|1148.1.peg.168 Transporter, drug/metabolite exporter family
MRILSNVNLMGLLIVLLAAIFFCFHNVIVRILYSQQNILGIWQVGGFVTPTLSHSFLLLLLRMLWVVPLMALISQRLYGNTWREINQLKQPVNRPVIWEAMGCGFLMFLYLVLLYISISFIPTGIAITLFFTYPIFTALLAWRLFNDVPSLLRWLVIGLTLIGTFLTIPYAYGGEQQTLVLGVSTGIASGIVYAGYTVFAQRSFQRLHPVPFTWISFATTLILSILCLIIWQPHEGNLPWLAITIGSLLSALFTLAGHVLNNWGIHLIGASRAAIIGATNPALTVVLAGLAIQESLTNIQIFGVCLVTFSIALLNYEKVSPSTGKNSLK
>fig|1148.1.peg.687 Multidrug resistance ABC transporter ATP-binding and permease protein
MTKPIAPLLSLLNYSRVHRAKIYWAVTCSLLNKIFDLAPPALIGLAVDVVIKQQDSFLSRWGIVSVQSQLLVLTVASAVIWALESIFEYAYERLWRNLAQDIQHDLRLDAYAHLQQLDLAYFEERSTGRLMAILNDDINQLERFLDVGANEILQVLTTVVVIGGAFFVITPDIAWMAVVPMPFVLLGSIYFQSLLTSRYALVREKVSNLNSRLSNNLSGIMTIKSFATEAEEVERLRQDSDAYRDSNQRAIALSAAFVPLIRVIIFAGFSTILYFGGLDAVRGNLAVGSYSMLVFLTQRLLWPLTGLGKTLDLYQRAMASTQRVMQLLATPIQAHPGELSLHPSQVQGELVFQNISFAYPHRSAVLKNVSLRVPAGQTIGIVGATGSGKSTLVKLLLRLYEWDSGDILLDGVDLKKYFLGDLRRSVGLVSQDVFLFHGTVRENIAYGSADATLAQIERAANLAEAEEFINQLPQGYDTIIGERGQKLSGGQRQRLAIARAILKNPPILILDEATSAVDNETEAAIVRSLEKITKNRTTITIAHRLSTVRYADQIYVLENGMVQEMGSHESLLAHQGLYAKLWRVQTGLRSGVS
>fig|1148.1.peg.861 Multidrug resistance ABC transporter ATP-binding and permease protein
MNRASPMTQAVPGLWAVITTFWPQIRAQWRLLLVAMVTLLADVGLRLLEPWPLKLLIDGVLIPTQTQPSLSLWGFTNLNAAWLLMLIAVGVIIIAVSRAIATYWNTVSLAIVGSRVMAQVRDQLYGHLQRLSLRYHYQARSGDLIIRVSSDANRLQEILLTAALPLVVSLLTLGGMVGVMAWLDLKLTLLSLATFPLFWLAANRLSAKIRHASLTQRHQEGAVASTAAESLSAIKLVQALSLEQAFADLFSRQNQRSLQENIETKRLAANLERLVDVLIAFGTALVMGYGGHLVIEDALTAGTVLVFLTYLRNAYKPVQNFAKYTGRLAKAAASGERILNILAETPDIQDKPGAIPAPFFQGRIEFKYVSFGYHPDQAILDGLNLTVRPGEKIALVGASGSGKSTLLSLLLRLYDPTAGKIFIDGHDLRDYQLTSLRNQMAVVLQESLLFAATIRENIAYGIEGATMAEIEAAARLANAHKFILELPQGYDTVVGERGTTLSGGQRQRLAIARAAMRQTPILILDEPTSGLDKVNEQLVFEALERLAENRTTFLVTHNLQLAIAADQILYLYQGQIREQGTHAELLARQGVYADLFQRQTLATVTKSLGR
>fig|1148.1.peg.994 Multidrug resistance ABC transporter ATP-binding and permease protein
MGRMAKYIGAGDVRSILIMAGVAAGIFLVRGMAQYGQDTLMAKAALNMALTLREQTYAHLQRLSLSYFEEAKTGDLSYRLTEDIDRIGEVVNKLFHDFVPSALQLVVVFGYMFYLNWALTCAVLVIAPLMAVLIGFFGEQLLKFSRRSQTRISNLSSLLTETLGAIRLVKAFAAEDYQLDLFREEAQQHRRSQFLAERMKALQFVVVGFLEAMGVVVLFCLAAWQISLGNLTGIEFISYVTGVAMLIDPISHITSNYNLFKQGEASVDRIFEIFDLQPSVEDSPTAIAIDHLQGAVDYDHVDFAYLEDKLVLKGINLQAQPGEMIALVGASGAGKSTLVNLLMRLHNVTGGCLRIDGHAIDSITLKSLREQIAIVPQENILFSGTIAQNIAFGKTDLDLAAIEEAARIANAHQFITELSQGYYTYVGERGVTLSGGQRQRIAIARAVLRNPSILILDEATSALDSESEALVQEALERIVQERTVFVIAHRLATVRKATRIVVLERGEIVEMGSHQELMAHQGRYARFHAQQFAS
>fig|1148.1.peg.1257 Quinolone resistance Nora protein
MSSFQTLRQLSPSTQKTFALLFASVLMFWLSLTALLPTLPMYAQDVGATKQQVGWIMGSFALGLLGSRIWIGQLVDRRGRKIAIVIGALVVALAPLGYLLTATVGALMAIRAFHGICLAAYTTGYNSLVVDLSPPQQRGEIIGYMSLAVPIGMGFGPAVGAYISQSIGYEFLFIASSLLGFISLVLALQVRENRPPDQSSAEDVFGDRPRPRSIGKLLTSRSMAVPTLVLLLIGLLFGNLATFLPLFVREIDLATYAGVFYSVAAIASFVPRLFLGSLADTYGRGLFIVGSLICYLLSMVCLAQADNSWELLTAAALEGAGSGILLPTTIALISDRSSLEERGRVFSVCMSGFDGGIAIAAPIMGVLNEIFGYRHVFWLSGGLALAAIMVFGIFSNPTIGRSLRFCIGRSRDLYATPQ
>fig|1148.1.peg.1985 Acriflavin resistance plasma membrane protein
MSSPNSVFSLSGLAIRRHIATLMLTLAIIVLGVFAVFSLPVDLLPSITYPRIGVRLDAPGVSPEVAVDEITRPLEAALSATEGVVQVYSQTREGQISLDLFFEPGGNIDQALNDATATFNRARNQLPDDLETPRLFKFDPSQLPVYEFAVTSPELSGPSLRVFAEEELARELGVVPGVASVNVSGAAQEEVRINVDLQRLQRSGVSLTQVLDALQSRNVDISGGRIVGTESEPLTRTVGRFASAQEIEDLVVGTVSGLEDQSAQKVYLRDVATVIDGTEEERIFVTLNGNPAVKVSVQKQPEANTIEVVDGVKKRLEELRTEGIIPQAAELTPTLDDSVFIRNSVNNVVVSGLIGTVLAAIAVLLFLGSLRQTLIIVLAIPLATMAAIIVMKAFGLSLNVFSLGGLALGVGIVVDNSIVMLETIAEGAGMTPGKVNPLPLTKGEMRNQAIASSQTVESALVASTSTNLVAVLPFLMIGGFIALIFNELILTISFAVAASILVAVTLVPMAASRLLAIRRRSGLGNWLFFREFNRRFAGATAAYARFLSILIRHRLVAVASIFIVFGGSSLWMIGQIPQEILPRINTGQASMFAQFPPGTPLEENQRLMAIVDDILINQPETEYAFTTVGGFLFGSNVNANALRSSSTITLKPNTDVEAFTERVTAELEALNLVDIRLRMAPGQLRGLILSNSPLRNVDVDVVLQGNDADVLDEAGRAVLAELGEKVTLARFRPDADPRQPEVQIRPDWQRATELGLTTQAIGQTVQTALDGAVPTQLQRENRLVDVRVKLDNDLLSGPGDLAQIPLFIDGDRPIRLGDVATIDQGRAPGEIQRINQRPVFLIAGTLVEGASLSEALTEVDQVLSAMEFPPGVSRLPSTAAASNEQLQSSLVILGGLAAFLVFVVMAVQYNSLLDPLVIMFTLPLALAGGILGLYVTQTAIGATVIVGTVLLVGIVVNNAIIMVELANQIWAEEGISREAAILRAAPQRLRPILMTTITTVLGMFPLALGIGQGSELLQPLGIVVFSGLSLATLLTLFLIPCLYVLLHQWEGVDIEKVKTDLESRLTEEDVPTKIQ
>fig|1148.1.peg.2120 Acriflavin resistance plasma membrane protein
MLLSISNVFIKNPVLTTVCTIVIILLGAIALPLLPLAKLPDMAPKQVQVTTNYVGSDAQTAVDNVTTVLERQINGTEQVIYMNSTTDNTGTSTINVYFPVEMDRNIAQVLVQNNVAIAASSLPEVVNRQGVTTQTQSPSVTIAYGVYSENDDQGKPIYDDIFVSNFVDRVLLDEIKRIDGVGSAILIGASEYAMRFWLDPDALAARDLTAADVTNAIRSQNIQVGVGGVNLPPVTDQQRFQINARALSRFTTPEEAEQIVVKVGDDGTLIRIKDVGRATIGTQNYIQTALFNNAPAVAFVIYQLPGTNALDTANMVKEKMAELRPLFPPGLNAEVALDNTLFVTASLEEAALTLIEAILLVILVIFIFLQNWRTTLIPALAIPVSLIGAMAFALAFGFSLNQLTLFGVILATGLVVDDGILVVEAIEVKLDQGMKPFQAALDAMGELTGAVISTSLVLMAVFIPVTFFPGTTGIVYKQFAVIMASAVAVSTFNAISFSPSMSAILMRPKKEVHGPLAWFFNLFNRTFDWLKERYGNIITAILKVRLLAIPIFIGSLILTVIVYNITPTGFIPEEDQGYFFMLGNSPAGVSIEYTKDVISQATEIVSARPEVEHVLGMGGFSFLGNDSSKSLFFVKLKNWDERPGQKGSVFGLLAEINRELAQKIPDAQVFAVNAPPVDGLSSTGGLDFYIQNRGGMPLENFLDYVQQYMEKLRQEPALNPRTVFTQFTFNAPLLEIGVDREKANAQNVDISEVFNTIGIYMGSSYINQFVMESRLYQVYAMADGQFRSNPRDIGRLYVRSRTGALVQLSNLIDVKQTTYPPILTNFNIYPAVDVQASPAAGYSTGQAMATMERLSKEMFPDSIGYAWYGTGYEELQSAGAAPIIFGLAFIMVFLVLSAQYESYVDPAIIMMTVPLAILGAIGAILLRANFMVATNMVWPTVNNNVYAQVALVMLIGLASKNAILIVEFGNQAMDLGMKIPQAAAFAAKERMRPILMTAISGLVGFWPLVIASGAGAMSRWSLGTAIFGGYLISTILSLFLVPVLYTLVKEAEARFLKGEKGEGDSNPPPPSGEDNGEPVNNPS
>fig|1148.1.peg.2160 Daunorubicin resistance transmembrane protein
MSQTLTPPKITSLLAPQAAPANPPSLTVEFFQETIALTKRLFIQLQRRPTTLVAGIIQPFMWLVLFGALFLNAPQGLFGNDLNYAQFLAPGIIVFTAFSGALNAGLPVMFDREFGFLNRLLVAPLASRYSIVAASTVYIISLSLIQAAVIVGASALLGAGLPNSFGLGMIALIVFLIVLGVTALSLGLAFALPGHIELIAVIFVTNLPLLFASTALAPLDFMAHWLQVVASLNPLTYAIEPIRYIYLNGNWGLDSTVLTAPWFSLNFAQVLGVLVLFDGLVLLLIQPLLKRRFL
>fig|1148.1.peg.2161 Daunorubicin resistance ATP-binding protein drrA
MGKSYLMGVAVQVKQLRKKYGAIPAVKDISFAVPRGEIFGLLGPNGAGKTTTIRCLCTLAKPDGGELWIDGVNVLSDPRQARRRLGYVAQEVAIDKILTGRELLQLQASLYHLDAISSQKRIDQLLDILGLTAYADQKTGTYSGGLKKRLDLAAGLLHQPTVLVLDEPSVGLDIESRFILWEFLRQLRDAGTTVVITSHYLEEIDALADRLAIIDQGTVIATGTPTELKDRVGGDRVTLRIKEFTADQEAEKASQILRSLAFVQEVIVNQAQGNSLNLVVTPQSNPLSQIEKALLADGLPIFSLAQSRPSLDDVYLAATGKTLMDADLAAAAQRDLKAEKKQAMKAS
>fig|1148.1.peg.2631 Quaternary ammonium compound-resistance protein
MAWPCLSVRLVHEGKYGLFTSKRRGSLTLLTGAKRLTLTEWKTIGLLLTMVTTQVLGDIWLSRGMKVFGAVEDYSLAGLWTLFLYLLTSPWIVVGVITLLFALFLYFTATSRLDLSLVLPLFSSSYILNALLAWLILGEEVSFYRWLATFMIASGVFIVCWSEHRHRSQLMGEKFSPTPAPVVPVKSSRRSPLWLFPVGIALSRVWFGILILIFTDSAGDVLIARGMKQIGPVRLQSPLKMVKLIGRILSHPSVLGGIGCQTISFVTFISLLSWTDISLIRPAGALGYVMSLLGAKFLLKETIPLARWLGIGVITAGVALIALDEVNLVDQILLFFL
>fig|1148.1.peg.2643 Multidrug resistance ABC transporter ATP-binding and permease protein
MAAPSVKQLLRYLTPHWRAIGAGTFALFLANALGVYIPILMRDSIDDLMPPFEASDVARIVVLIVVLASLMWFIRMASRILIFGVGRQVEYELKQKIFDHLLKLEPLYFTENTIGDLINRATSDVDNIRRLVGFAVLSLINTVFAYALTIPAMFALHIPLTLLAVSVYPLMLMSVNLFSGKLRDYQLEVQEELSALSELVQEDMSGISLIKIYSQEDNERQAFQTRNQKLLQANLKLARIRNFLFPLIEGLAYLSLLILLAFGTGLIQDGSITIGDFIALIILVERLVFPTALLGFTITAYQRGEVSIQRVEAIFHTTPKILTVPQPLPFSPAQATGKITARGLNYCYPGSDLPALEQVDFTVYPGEMVAIVGPIGSGKSTLVNVLPRLLDIAPGQVFIDDYDITQIALSDLRSAIAFVPQESFLFSTTIAENIAYSDPSQTDTAIEQAAHQAHLDQEIANFPQHYQTLVGERGITLSGGQRQRAALARALILDAPLLVLDDALSSVDNQTATRILHYLARRNNTVLFVSHQLSAAAQADRIFVMDHGRIVQTGSHEELLQQSGLYQSLWQQNELEKVLS
>fig|1148.1.peg.2644 Chloramphenicol resistance protein
MSEPKPSQPNFSHLEEADYTGRMRQHDRLFGLLAIAAGLIFLQGYMIAPLIPRLAEIFDVSAQEIGFIVPAYMLAYALAALFYGILSDRFGRWPVIQISIIVFITCTALTATAQTAAQMTFWRLLTGLGASGVIPLTFALIGDMFPYNQRGAKLGLVFAAMEGGMAAGSAGGAILEPFLGWQLLFIGTATAPVIVLWRLRRYGALFDAPKATKIPALATVFAGYWAVLSNFRGMRTYGYVLCNGIYHSGVYTWLGLYLSQRYEMDTLSIGLNILGYGVPGLIFSPLIGKAVDRWGRRWLIPPGLAMAAIAGLTMVPFIPPLAVTMAILVMSLGYDLTQPLFVGIVTDLAEEDTLGQTMGLKVFTLFTGFGIGSWLFGEVLHWGFEVALVAFGVMQLLSAIAAIPLFWNEKPSPINVSA
>fig|1148.1.peg.3100 Acriflavin resistance plasma membrane protein
MRINSSSKNRTQKKLGIPSMQSPRAPRWNLSHWAIDHPRFTIGFWLAIAVAGLLTFSSLKYALFPEVSFPVVIVQSSGAGLDLAQTEQKLTIPLEEKLVTIADADVQSSTYPGQTVASVIFLMGQSLEQATTAVEQSLQGVTLPAGSEITVAPYNLNESVAVTYAVASETLSLEEMAAPLQQELMPQLQNIAGVLRVDLLGDANFRSPGVKALAQQTINPPTLTRHNGQDVLAVQVVKTAQANTLEVVDRVEQLIVEQAPKFPQLKFIEAETTAGYIREATQATIEALLGAIVLAVLIIYPFLRSGWATLISAIAIPLSLLGTFIVMAALDFNLETLTLLALALIIGIVVDDAIVDVENIARHVEAGEPPKRAAKIGTEEIGLTVSATTFSIVVVFLPIALLGGTLGEFFFPFAVTVSAAVIVSLLVARTLSPVLTVLWLRTQTPRPQSWFSRGLDALGNGYQRVLAWSLGHRWWIVALALVSLMAGLAIIPLIPQGFVPTLDRGEFNVIFQSAPPKIAGALSTPPRGNNNDTSAGGAFGWIDQLATNPEAVLLRRGRRVAEELEPPILADPAVTETFTVVGIQGNPLQGKIYVKLDSDREVTTQTVQTEVREALPEIPRVTTRVENILFVQTGDDTPLKLALLGNDLDLLQTTGKALEEKVMALPGLTQISLTGAEPDSTGILRLRGQRAVYLSASLLPNYALGDLTQQVTAIAEGLLPPGVELSVQGESARVGSVFREFALAFLLSLLGMAAIFLGLFRRLLEPMVVLLSLPLSIVGAMVGLLVTQSEFGMISLIGLIFLLGLLDKNAILLIDYANQLRHRGLSRQEALLQTGHIRLRPILMTTSSTILGMLPLALGWGAGAELRQPMAIAIIGGLFTSSVLSLVVVPVLYSLLDDVWGQKPRPEKT
>fig|1156986.4.peg.1163 Permease of the drug/metabolite transporter (DMT) superfamily
MQTQMTSLLKSQYRLPLFYLILGAVAIGFAPIFVRLSEVGPIATGFWRVALAFPLLTLFSIDQGTTQPDTSQPISWRDYAWILFAGVLFGADLATWHFSIHYTTVANATLLANFSPVILALWGWLVLGQRPQAQLVWGLVLAILGVAILVHPNLQLGQSTWRGDALAFFTSFYYTAYLLAMNRARRIFSAVVSMAIASFSSMLFLALLMWGTGEVWFPVSLTGWFVLLGLAFFSHILIAYAFPYLPATFAATTLLVQPMIAAMAGWFFFAEKLSLLQITGLLVALGGIFLAKKTI
>fig|1156986.4.peg.1716 Permease of the drug/metabolite transporter (DMT) superfamily
MIGFFNAVAYLSQTIGLQTVSSARAAFITGASVIWVPLLSPLFCLTWPTRLDFICAGLGFLGLYILTSPGQQSLTSGDLWIILTSLSFALQILFLQRLNQTITHYPLFTFYQILFTLPYVMLGLQHPTFSAALQPAALTGILFCAIFATSLAYYLQNLCPRAGFCEYIRSCPE
>fig|1156986.4.peg.1913 Permease of the drug/metabolite transporter (DMT) superfamily
MDCSIQKSTYLLFLLLAIFWSGSFVAIKAMVLWIPPLLSAMFRIGIALLFLIGLLIFLRKPVHAPFSLRWRLWVTGLFSQGIPFSLLFWGEKHIAPGLAGILNGTVPLWAFMLGLFSPKTRDISPLKCVGLIMGLIGTAVIFGPMLDTQGLQPDVLGLIAILLMAISYAIGSLLAQHLLRDTTFKLDVYTNIYHQHWASFIFVLLLTLFFESWPSSTIFTQHPIIAISALYLGIFSTALGWLIYLYLIREWDAVRASAVMYLVPIMALFWDFLFFHRIPQWTEGVRVSSSF
>fig|115711.7.peg.812 Multiple antibiotic resistance protein MarC
MLILLNLSLLFYVLFDSPGSIPVFVALLKNFSRKKQQRVILRECLFALGALILFVTFGRSFFQFLDISLYAFQIIGGFLLFTVSIKMMLAPMPEKAKDDTSKTEPIFFPLAFPVITGPAVITALLSYMEEGIYSREIIFTAMIIAWAFSLFTLLCSSFFDRLSGNFGLLALERLFGIALLLMSVNLMLKGISIAFNIGFYIG
>fig|1157951.4.peg.1405 Albicidin resistance protein
MLFQVGEIAQKTGLTIRTLHHYEEIGLLVPTARTDAGYRLYNVECLERLTQIQMLRQVGVKLKDIGKILDGHSGNMAQLLQERISALSEQMKQIAKLRYRLEQLQLQMQAGDILTQADWFSILEMMSMYDKYFTPKELEKMPLYTANTLKSQEWQQRVETVKNLMQEGVTPDSEQARKVSAEWMIALERDTGGNPDFFARLNKIHLSDNEFALSSGITEEMIEYVAKGFSEHQLAIFKSYLTDSQFAFVREHYFESGKVWPELIAGLYRAQQSGVSPESPEVQSLAKTWLNMFNQFTGGDPELQEKIRQIYRENPVISQGTWMTPEIGQYLFAALTAH
>fig|1157951.4.peg.1990 Multidrug resistance protein A
MTGYISRILVEDYQYVREGDVIAEINNQEELLNQQIAKANYKKAQQQLNNLADEIKEYDLTIEKLWNRYKAAGIEVSQMQRSPLLRKELIKSGAITSQNYLDANSDLQRLIKLEQAAKAEWEQAKQSKLLLAQQENIRLAERDIALANYQQANTQISYATITAPFDGQLNKIKLNVGSLVTPGTEIVTVTPRSQPYVIAHLKETQLKNVQSGQSVAISVDAFPDMTFSGVVRDIGAQSSGESALIPADNSSGNFTKVVQRIPVYISLLSEQSAIDKLRPGMSVIVNIDTQSTQSQGD
>fig|1157951.4.peg.1991 Tetracycline resistance regulatory protein TetR
MKTPKITRLQILETALQLLETEGIDGLTMRKLADALNIKAASLYWHFSNKLSLVEGMADHIVAEVALNECDSDDWKSNLLKITTQLRKALLQHRDGARVFAGTYAISDNVLRINNALIKTFVQSGMSADKAASCTMTVFYFILGCCIEQQAALFSNGSDLQEKLNEFNKLSNDKYPYTWEAKATLFSDNYDQRFIDGLNLIIGGLGTSK
>fig|1157951.4.peg.2082 Multidrug resistance protein B
MKLLKNHLIIGFLFGIQIISMGAMEMSGPFWPIHLQNNSSDSLLPFALTMVYVAPMIGIMLTSTFWGKVGDRMGNKAMIIRALLGLSITQILLSFCNDPWLILLLRFIQGACAGYIAPAQAYGVAVTAPRKRTHLFALLQVSTNIGSLLGALAGGLILDYLNFFWINMMAGWLCMLSAVAVFLFLPSDKHSPLLSPANTAHTTKKNGSPQTIVKQLMLLTGLLLMIRLITLPSFSLYIEKTYSTDYWVIGLIYGLQAMGVILSAQLWAKWFEHQSIVASLTRLRWIIFGCAAIAISLANASIIWFALLYFIWGILLGATTPILTALISSASPAKHQGYVLGLSQSINQFASIGGISLGSILIIYPGINMLFYYISVGYLICLSTIILLTKHIINKEQYEKKV
>fig|1157951.4.peg.2457 Membrane fusion component of tripartite multidrug resistance system
MKKRTIALILLMLILIAAAALFHSHNQFLLLQGEVDAPEVMVTSKAKGRVIERHVERGDDVKKGQLLLTLESPELTAQYAALKAARDQAKAQLAQSLHGTREETIRHLQASLAQANSQYQNASREYQRLSNLSAKGYVSANELDNARKAKEVAFQQVQGAKAQLEEAKNGDRIELRQKYEAALNEAEQKLAELQVQLDDLQVKAPVDGEIGPIPAEVGEIFNAGSPLLTMVRIPQSYFIYNLREDILVDVKKGDRVQLDVSALGDKKIEAEVRYIAPKGDYATKRATRATGDFDLKTFEVRLYPVEPVDGLRPGMSVLWRWDK
>fig|1157951.4.peg.3043 Permease of the drug/metabolite transporter (DMT) superfamily
MRQYNYLIYALMCVLIWSFIPIVSRFGQNGLDSFQFLFWSNLISAMSVILVALIAGYKPTKLFILPRDILLKVFVLGFLDCLFYLLLYYGYAIENGIAVLVIQYSWPLIIILLSVFLLKDKLAGRQIVGVIIGFIAVIITFTKGHITQLQVEDPVALLFVFSGAFCFALMSVFSRQYSIDPYISTVWLFIFSTLTSLVLLLSFSELQLPSKAAFWPTVINGVLINGVSYILWFKAMNTGHSAKIASIVFLSPVLSVLWLVVILSDPFEIAYIIGVLLVIVSGVLCVGQKRKQSY
>fig|1157951.4.peg.3161 Multidrug resistance protein D
MKRPLSLWLAVALMMFPQIVETIYSPALTGIAIAFHVNAEQASQTLSLYFFAFAFGVVFWGRMCDTLGRRPTILAGLLLYGVASIGALFVTHFYLLLLMRMLSAFGAAVGSIGTQTAMRDCYQGHELSKVFSIMGIALAISPAMGMLAGSLLVSSGGYQAVFIGLAVLAIGLLLWSCYRLPETRPANVIHSPFLTTLFTMIRDKEIVRNVILIAFFNINLFSYYQLAPFHFEQLGLSQQQFGLTGILLALGVGIGSTLNRHLLGKNWSPEKLVKLSSFVSLISGCLVFILMHSVWFIAPVIGVVIGYGIAIPNILAHALSRYSDNKGTAGAILGLFYYIGLAVGLMVAGWSQHLGGVLVIGSIILSLSSLRYRTQ
>fig|1157951.4.peg.3896 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MIAQLLLLLLVSVLTCLGQIAQKQAVVCWQGDKHNKTASAIRWLVLALLMLGLGMLFWLKLLESMPLSIAYPMLSINFVLVTLIGQFVYHEQTGLNHWLGVAAIMFGIFLMSISG
>fig|1157951.4.peg.3897 Polymyxin resistance protein PmrM
MNKGYFWVIGSALLVTIAQLSLKAGVVGLPSFTLGWHWLQSEWLLANLANLSIVFVGLVCYALSMLCWLFALKSIPLNKAYPLISLSYVFVYLLAVILPWYHEPATWLKAGGVAFIILGVWLISRPTKGQSQK
>fig|1162668.3.peg.397 Acriflavin resistance protein
MSQSSNQKPAMTLIKKYRGFSLLLTVVLSILGIVKAWNLPMTLYPSIDFPRVSVIVRSPDIPFAEMESRITRPVGITLRGVQGVRELNSRTMQGSAEFFLRFSWHEQMSLALPRVAQAIDRIRGDLPAGTSIQAIRMYPSDTPVLTVALSSTSDNLPQITRIAKTRLIPYISNLPGVWKTEIAGGKNPEIHVEVDPYKLSGAHRTFSDVISALSTQNRIGVIGPRTEEHRLKTVQIDNTMTRTAEINKIFLPSPSGVPLPIDLLATVRRGVRPSDETIRISANGSPAVLLLVYRAHGGNALTIQRALLDHMNEFRRLLPKGCTPAIVYDQGALVSDAIRHVIWALAIGLSGAMALVILILRRGYPILLMGSLLPAILFISAGILGLLGETLNLMVLGGIAAGVGLVIDDFIVIIEGGRHAHRMSGLLVPFVLSGLITILALVPLFGMNGLVGAFFAPLAISFVTLLGVSLLVNTFVTPAFIHQEKETPVPISTGILTGLSPAVILGAGTLAFALLLLPLTHLKTNFMARMDEGSFTLDFHAPVGSSINDMDRAVLRVEDHIRALPGVIDTTRRLGTEMGFYITEPNKGDFVIRLSENHPKSTFELIRELRPWVQKNEPELDTDYSQVMEDSLGDLIGVSAPVVVEVHGQNRKDLLGTARMIRDRLSGIPGLVDLHLSVRPMGDTLDGHVIAPLASLAGLTPEAIIAQTREDLMGITATTVLSPGGPLPVRVLYPSEYRNGLIPLSHLPISESDGSLIPLSQVVTFTNTPPATEEEDKNLSPILRIEGRLDHGNLGGVIKEIKAKVSSLTLPKSSWVTYSGAYKQEQKSFRTLGEALLGSVLLIVTILYGTFRKWTPPLVLTAGMAFSVLSGIAALTFSGRTLNISSFVGLILVVGLSAENGFLVANRFESAEGNASEKLKEALSDRFLPIVMTHLANAAALLPLALGGGAGLDMERPLAVAVLGGLVGSFFSSVFLIPSALSLFTRTVSPQEGLPDVQI
>fig|1162668.3.peg.447 
MLLFPSPLPNERIAMFVVANRILVAKGFEKDFEERFKNRKGLIDGSPGFIRNLILKPIDSEYYSVMTFWETMEDFKNWTRSDSFKKAHSNHPPREMFSGPNVLEIHEVISDSDKDVD
>fig|1162668.3.peg.496 Acriflavin resistance protein
MTGEKHGPGFAGWLSRTFIDSPLTPILILISLALGGLAVLKTPREEDPQIKVPMMDLFVSDPGMSATEMSRHIVAPLERHLSRIKGVKAVYSQSESGTAVVTVRFHVGEPMGKSLVKIYSEVMKSRGYLPRDAGPVLVKPMDINDVPVMAVTLYSKTESDAVLHRLSEEVATSFKRIPGTGQVTVIGGRRRTVRVVLSPSDLTAHHLTAMDVSAAIWRSNRSIDLGSFDRNNISYQVALSGTLTRVSQVRNLVVSVQHGKSIRLFQVAKVTDGPGPLESYVWIGHPATSPLSGDETAVTVAVAKKKGINAVVVANQILQKMKDLSARKIPSDVQWTVTRNYGHTANEKADDLLLHLVVATVAVILLVALGLSLRESGVVAVAIPVTLALTLFGSMVIGYTVNRVTLFALIFSIGILVDDAIVVVENINRHFHFLGGKRDRDTLLERAVVAVGEVGNPTILATFTVIGALFPMAFVSGLMGPYMRPIPVNASLAMTGSLLVALTVVPFLALRMVPPAGHVNKIMGKVDAGIRHLYRSIMLPLLNSRLRQNLFFASVLLLTVGVMAFFDTRTLLLKMLPFDNKSELDVVIDMPAGTTLESTARTAMALERVILKDPSVRSDQAYVGLAAPFDFNGLVRHYYLRRGKRVAEIHINLLPREKRSLQSHRIAEEMERKLAPVAHSFGARIKMVEVPPGPPVMAPIVAEVTGPDQKSISDYAKKVRDVFQHAEGVIDVDSTLPDPQVRYRIRVDQEKAALSGVSTEQIEKALTLGLHGETGELHTTSGKGYVPIVLDVSRKDRSSIKDLDSIMVRSNNGRLLPLGTLIDVSEEGAPAVLYRKNLRPVVYVTGNTIGSNRSPVYAAVDLSRKLPPSELSGHPEAVRQYFWGYPSSNDKISVRWGGEWHVTYVTFRDMGIAFIAAIVVIYLLIVIQFKSYVTPLIIMSPIPLALIGVIPGHVLLGSNFTATSMIGFIALGGIMVRNSILLVDFLHTKKAEGVELKQAVLEAGAVRTRPILLTALALVAGSFVILSDPIFRGMAIALLAGSMVSTILTLVLVPLLVARVEGKRWPDGRQMVSGN
>fig|1162668.3.peg.1745 Inner membrane component of tripartite multidrug resistance system
MTETPVATAAHEGDLGYPMRERILVTVCAIGATLIETVDSTVVNVGLPKMMGGLDATVDEVAWIITAYSIGNILMIPMTRFFADKIGRKVYFTGSVFFFTIFSFFCAQSTSMPELVIFRMLQGVSGAAFFATSQALLIEAYPSRLVGLANALFAIGISLGPAVGPVIGGYIAYHLSWPWMFYINVPIGIVLTALSYKVIRNSPFTNHEETADVWGILLLALGIPALQIFLENGQEFAWFDSPLIRASFWIAVISLPLFIVRQFMAKHPLIDLRVLKNRSLAAGCFGLFFLGIVYFGTLFTVPLMGQILLGWNPYKMGVVLLPGILSFTFTAMFVGGAMGKAPLLPIMFAGMGILLLSLHGLSSLSIQIGPDAVFWPLIERGIGLACLFPPIMTLAMSTLSREKVSSGAALVSMMGQIGGTVGIAFMTTMLERFEQQHRSDLSAHLSNSAPFFEQHSQMLNSLFIAHGVSPQAAGPLSFALMNQTLDAQAMMLSFGNLYLLTSISCLLLLFAIFGFERSAISHPQKATVAD
>fig|1162668.3.peg.1746 Membrane fusion component of tripartite multidrug resistance system
MNKHYLKFLAGGTFILALVLMGLWWVRDRERNVSTTDAFMTARPHMVTTRIPGVVTKIYVHDNQIVHPGDLLLELDPKDVLARLDVERADLVSVTRKIPLDVSQMRIAEQNLLKAQSDRDRGVVLSRGGYATEEDLEHLDVALRIAHHELSKAKKQISLDRAMVKKMQAALAADLLNKHYLKIVSDVSGRFTNRTASLGMYVSPGLSLATIIPFHTWVIANMKETRITHMKVGDPVTIHVDAYPDRVFKGKVESIQQATGAIMALLPPENATGNFTKVVQRVPVRIALLPDSDPDHLLIPGLSVVPTVHVDPSYHPAFGH
>fig|1162668.3.peg.1773 Drug resistance transporter EmrB/QacA subfamily
MRLSPFFSSREISPWLVLATVILGVGMPLADTTITNVGRVFIVSTLGVTSYEAGWLTASYSLALAVGVPLSHRLRGFLEEKDLYSGAILTFMLGSLCMAGSVNFTEAMLSRGIEGLSAGILLPLAPILIQESFPENLRSLAMSYFALFGAVWVTLGPTIGGFIIDNPGWQWAFAINIPIGFLAIFFAQAFLSNHPRQDPRRFDGTGFVLMATSLGCLFTGFMRAEWVGWHSSGTGFLLFSGLLLFFLFWIWSALSRDPILPTEVLRKPLFIGILAIVFMQSTQSFGRLYLLAPFLEKNYHFMAHDAGALVAVGALTEILLSLSFLFSRFLAGKWAILLTTGCILVSISNIDFLFLPATGFSLSFIVKSQLIFGAGLALTQISLPPLASKLFPQSKVRAATTYLLFAQFIGGAWGTMLGRHLVLHVKPVFSQMLPQLSTHRMGHSDIFLADRLAQSYTSNIIFYDLGIIGLIGAFLAFVLIFFLSEKRVGESDRKEKETLAGLPANGKR
>fig|1162668.3.peg.1774 Multidrug resistance efflux pump
MAEESQNHSPEKRSSLFSFAVVTPLLGFLLTVLWGISHWYGETRYVSSDDAYVQGKITYVSSRQPGRLIGLAVNEGDPVQFGEILATIDRTGDAYLRPQDTTKNLQAFTRIKRDMAKLRSLEKREKDERDHYQRAKALLSEGYMSPQKLEDLKTNWQQTHVEIVESRKLISAEQQSLDISEVHPRNRIVYAPIEGQVAQRLVNLGESVKADQPIVSIINLKDLNNIWLDAFVRETQVWKIRAGQKVQIHIDGWPKDTFTGHVLEFIPAASQAFSLLPTQNASGTFVKVVQRVPVRIVFDSLKNRILLPGMSAEVRIDRTSPLSRSGKDHR
>fig|1162668.3.peg.1832 Acriflavin resistance protein
MFLSTFAIKRPVTTLIIFIALISSGLYSYFSLGRNLFPRVSFPILSVTYLLPGVSSKVLEKTVVPPVEEALSSLPGLKHLHVVSLSGVVSLTAIFSEHSDPRLIYPRLQEKVESVSPSLPSGTAPPIISVVNPTSLPLLWVILPIPDSMDSRVITDWAMMNLVTPIRKLSGVADVKPIFPAREVLHISLHRKELTKYLVPVTSVLESLKKVGLSIPAGTMTSGKEEIMVETLDSESTVASLSSLPVPDGKGRTIPLSRIATISIGPVRETEIFRIDGTRAIGLRIFKKKGADGLSLSGKIRKIILERKAVAAVSGVNGQSIVLDPVIRMDRSEMIRKNNRELLETLLFGGALTVLVIWIFLGSFKTTMIASISIPSSVIATFLMMKMAHFSLNNMTMLGLSLVVGILVDDAIVVLENIHRHGQMGKPFDQAVSDGVGEIGMAVMATTFSIISVFAPVAFMHGIIGKFFFEFGLTVSFAVLVSMLVSLTLIPVMMNFSSGSGMKSVSSRVLDGKMDALISKYRALLIKALDHPGSVAGVGFLSIALAAGILYLLGADLVPRTDDGAFVVRMTAGEASSIDFSKTIFKDVASKIRQQKGIDSVFYQIGNSYGGSSNRGYFYVLMKPLSMRKTSEEDAIVHLRKLLLTYPAIDFSIDHLSPLGGNGTDVPIQIILQGPDRKRLASLVESLRMDLEKTKGFVDITTREGERQKLLAVVPKKNLPAGSSASELGGTLHLYLAGMDTGWARVDGRTIPVHLSMISKDLSSPSDLESLPMMTSTGKVILLGDMARVESAVQFKRRVRDDRMPSVTLESNLSGNIPLKTALDDITQWKKDHLPGNYRLRFGGSGDVMNNAIGSFMMAIGLAIIAVFMVLASQFESFVQPFIITLSIPVSLSGAALALYLTGNSLNIMSAMGLIILFGLVAKNAILMVDYTNTLRKRGYSRRDALLAACPVRLRPILMTTVAMVAGMSPMALGIGSGGPLRAPMALVVMGGLISSMLLTLFIVPVAYDFFARWNVFSQKNEVKD
>fig|1162668.3.peg.2927 Permeases of the drug/metabolite transporter (DMT) superfamily
MPLPDSTIPPEPIMARRQVRWAIMASFLFALSTPPAKVLSSEQTPFLLCGLFYLGSIFGIIPSILSTPRENGAGGWRKLLLPEKPKQKEIGIAILSVLIGGGAAPILLIWGLKHYPASLGSLLMNAEGIVTVLLAWLIFREPLNMRLSIGAILGAAGCAIASDSEGSHGFSGAIPFFLAAGLWALDSNLLRFLSGWSPVTITLWKGLGSSFLLLPLGLFLPHPPMTISIMGEALLTGGLGYGLSLILFIRSIRAIGVSATGAWFSISPFLGAFLSILFLKEPVTRTFYEASVILFVAVLFLNGPMSPKTSSDIPRHTG
>fig|1163389.3.peg.10 Permease of the drug/metabolite transporter (DMT) superfamily
MIIFKPSYASIHSSTFALSSLVYLGIFCAGIVYFLYASLIKVADPVFTSFTNYLVLFLELFLVY
>fig|1163389.3.peg.11 Permease of the drug/metabolite transporter (DMT) superfamily
MIAFARSFIGCLILCFVCYFLGLKSKSFKKDFAIYSLIAFLEATMPFMLIPWGQKFTSPSITAILTGTVLFFLLFYLDH
>fig|1163389.3.peg.27 Membrane fusion component of tripartite multidrug resistance system
MKISKLMAVVIILFIIIFLICIFLYFDASFERDAYLYANFTRVNSVENGQVQKIYIKKGSYVNKGDTLFELDCRYITKELNILQSQDKKIALELKDIVIKIKLAEKQRDLARESLIVEKRNFERYKLLIKDGAVSDQQKDLAEKNLISSESQFVKACQNVDNLKIRQNDLLSDEKITQSKIGQKEYSLSRCSIKATTDGYISNFILQKGDFINKGEDLFSIVDTHKWYVVANVKESNIRYLSVGQTISMTTSLTGFKKYTGRIVDIEKGITRPEYNNFSALYHIERNIDWVRLDYRFPVLIEVLSKDTKEFRLGGDVHVWF
>fig|1163389.3.peg.102 Multidrug resistance transporter, Bcr/CflA family
MIYGPLAKRYGDVNTLRIGLLINIVGIIICLFGGYILSMPILLVGRFITAIGSSAGFYHIK
>fig|1163389.3.peg.349 Multidrug resistance transporter, Bcr/CflA family
MSNDPFKKISSDKTVILIICLFGLMSQFATDSFTPSLPHIADYFHAAAKDIKLTVGIYFFGMTCSMLGFGYLSDKYGRKQALLAGYLVFCIASIFCMLAQSEKLLLFFRFLQGIGMGSSFVSFRAIMKDVFSDNQSLAKASLVITSIVSLTPPLSSSDYWRNYPRDYWLAW
>fig|1163389.3.peg.350 Multidrug resistance transporter, Bcr/CflA family
MFFNIQLLTFVLIRIYTEIGVASAIFGFIQIAITTISSSLVSSISLNNQFLFGLLMMVPPLLIVILKIIDLKKLL
>fig|1163389.3.peg.572 Outer membrane component of tripartite multidrug resistance system
MQVNQAKLKSLISIVNLYQALGAGYNVDNYIDPHYDNPAFDK
>fig|1163389.3.peg.573 Outer membrane component of tripartite multidrug resistance system
MIKNKIISSVLITTTFLISSCSFFDPKYERPEVKAPALWNSQDKNVEITKNWNLTKIAWWREFHDPILNNLITTALKDNNKLQVSIGNILQANAEINKANYGWLPTTSVGGGGFVAQAFDINSNSSIPQLNNVGTQTADGSLVGIIPSYTINIARQFKLGEISRLSKKMQVNLKNTTRLSIISQVSAAYFSLIAAQEQLKLQTQMVNQLELLFYYAKNQHKLGATSPMLEEVIRQQLEAQKGKVDMIKNNIVHFQNTLKILMGRNPGKIVTSRMLNDIDADVKVPVNMPSQVLENRPDVAIAEYKLQTANANIGLARSQFFPSIDLTGTFGNATLALGELATMNAWAWAAEAVTAVPIFNLSILADSDKAKAQFYQAYYDYISTLQKAFQDVDDTLSERSANRKKLYETNSFSEINRKTRKYIL
>fig|1163389.3.peg.574 Membrane fusion component of tripartite multidrug resistance system
MTEEKILDTQIPEKKQEQNVKKESKFSPKKIAIGLGIITLTTLSIYGYYKYNKVFPNTDNAYVNADVINISPKVGGYIEKVYVQNNQYVHEGDKLVQIDPKDYQLQVANANAKIIQAKGQLAVAQEQVSVAKSNLTKAQSSLDTATSMADRYIKLYKEDAGSLQDAQKYINQKIQAEKAKDEAYSSLKQALVQVEIAKAQVGAAKVGYDNASLNLSYTTLIAPDDGYVSNLKIYKGQLVSTGQPLFGFIDNKTWWIDANFKETDLDRIKPGQSVKIELDMYSHTYTGTVNSISYATGSVFSLLPPENASGNWVKVTQRFPVKIVLKNDTKYPLRVGASTIVKVDTL
>fig|1163389.3.peg.575 Inner membrane component of tripartite multidrug resistance system
MQTDNTTKIGFWSQKRTIVALAISLLALAEIVDLTIVVVAIPQIMGAIGANVETIADVTTVYIVTAAIFILLSGLIIEKYGIKRVALVSSVIFGISSIMCGLSTSLAEMIVFRAFQGMGGAFLPSIAQTYISTNFRNEEYNKMMTVYSMVIVMGPIIGPVLGGAICENMSWEWIFYVNVPLCIVAFVIIFFMMDATKIKKIKIDYISFGFMAIGVGCLELFIDNGNTNDWFSSIEMIILLSISIVSLGFFIWRGLIYSSVVKFRIFKNFNFILACFLCFMFVLLFSAAMAYLPTMLQQVYGYPVDLAGYITAPRGVAAIFGAVITQNFLVKKLGIRTTISLGMLTFGASCLMQASFSPTASEFGIVLTTAIQGPGIMMFFVPFMSVLVVGVADEDMGDMSGSFNFFRNFGSSVGTAFVATFISRNQQTTYQELSQNISYMNNSFQAWTNTLPIANNTEAIAIAKQQVLHQSSLLSYVNSFYVVGILSLLLAIVPFLLKEPPKDAAVQAMH
>fig|1163389.3.peg.799 Multidrug resistance transporter, Bcr/CflA family
MYKGIRPSIFILILMVSLGPFGDTIYAPALPEIKTILGTDYPHVQLTITSYLLGYSVSQLLYGPFSDRFGRKPVMLVGSGFFIISSIICLLSTNVDTLIYARLLQGFGAAAGGVIATVAVKDAFKVSEQGAIFAIMNIAFALAPAFGAILGVFLSPNLIFWILLVAATFLFVQVTVFFPETVKEKNIDALTLRSFFKNYFALFKDHQFFFATFVLGINISVIYACLVTAPDIFINILKLEKANFLYLLTIMVTAVVLGSIICSKLSRIIAYKHLVNFGMLCTLISGLLFIYAFHKLTGLTLSIALTGVLSLTFIGVSFSVPLLTPIALENFTATAGAASSVMGFMQIGIASVTTAVISQIDFGSEFTLAFAFVLLPLIGLIIFFPYSCYFLKK
>fig|1163389.3.peg.864 Permease of the drug/metabolite transporter (DMT) superfamily
MIPFIGSLFKVDRLTIYGIVASGVSLVEIYALSGASFDNFTIGYLWSVLCALMYAVSVVYLSYETRKDHRSEAFEDLRLLIILQVAFGIPMPLITDVSSFMYLHFNYILIIAIVFCSISTITCYYLQNTYQKHLSMSQVLLSSLLSLFLQQFLGNLSIMKKYIYQLLLEAH
>fig|1163389.3.peg.865 Permease of the drug/metabolite transporter (DMT) superfamily
MSIQRKAVFVLFIVTILWGTTFPLIKISLEYVSPGLFVAFRLGLSCLLFLPLVLRAEFNNKLYLLKVGAIFGSLEGMSFYF
>fig|1163389.3.peg.996 Zwittermicin A resistance protein ZmaR
MKLLEKFEYIKIYSEFDDFIIYFPIILSVVDNKQEGYVFQEGSTFIIVHKFGFCYILGEYYDYAKLIDRISEKLKVLVPKLRLYDPNGKLKDSRYLLHDRCTRIKYIHSLNMHNDFESQIEFFDIQDKDDSVYDFFDLELDSRYWSTCLEFRENSFAIVDEYNIGICYAAAISHGYAETDVFVNKKVRGKGLATGLVKSFVNKCISNNVIPVWDCYSNNQASINLANKTGFKRVFEYYFYNINI
>fig|1163389.3.peg.1081 Permease of the drug/metabolite transporter (DMT) superfamily
MFIASLSGSVVLFILAFIFNEQIVPTTSRGIAILLAIALFGYLLGNILYISRIKHISLAMSSLVLLIGPVFALLYGYVLFRETFSIQQLVGMFIIILSVYLGKRY
>fig|1163389.3.peg.1082 Permease of the drug/metabolite transporter (DMT) superfamily
MYILYSFLAITKDEEKLSKKSLYIAALTGFFLALDLAFYSISLIYTSIAEASLLTNPCPFITTFIAIIFLKEKVSLKYYLVLLVAFIDLLLLMSQAGLSSQHLLGNWLAIISAICLCSFYYLF
>fig|1163389.3.peg.1208 Multidrug resistance transporter, Bcr/CflA family
MYKIRKGSKYLVFFVVIFVALPPFAIDAYIPAFGNILVSLMLM
>fig|1163389.3.peg.1288 Multidrug resistance protein D
MRVISGIKRENLLAYFLTYVGYMTLTISMTLTPSLASNLSLSDYVTQIAMSLSFFYV
>fig|1163389.3.peg.1289 Multidrug resistance protein D
MFSISAILFATLTDVFTEKRVLFFSQSLSIFGLICLGLSDNIYAVYVGFVSLGLGMGCYSSIARALISRNADNNS
>fig|1163389.3.peg.1290 Multidrug resistance protein D
MKKAYSVLSVMIIVAPIVSTYLALLLIPISWRAAYFCMATIEMVLFIFSIKILTADDQRKIVISASKILSGFAHALSQPRYLLNVMIVAILFSFYLGVLMSSFKGLLVDELNMSIDVFTIVFLVTSLLYILGIFSYRF
>fig|1163389.3.peg.1291 Multidrug resistance protein D
MATGAAMSNITKGHGTAAAMITFSVALCMSIWGFLKAHFKYVKLSFYTFGFED
>fig|1163389.3.peg.1375 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MESFLRDLANKLLQITPNYTIIVISDGSSDNSVEIIQSLVGQLNIKFISFSRNFGQGAAITVGLEASEDADAAIIMDCDFQHPIEVIDEFYEKWCEGFSNIYGVRNRTDQSATRSFLSEIFFKVSNELMEVKIPANAGYFRLLDKQCIKAFNSLPENGRFIRGLFAWIGFKGYPVPFDVADRQDGTASRWGYRKLFKLAFTGIFSFPSVPLRLISIFGLLVSLVAMSYGLYIFIESLFFGGNVSGWPTIVVSIMFFSGVQLISLGVLGEYISRIFEEAKKRPRYIIDEDESRNL
>fig|1163389.3.peg.1589 Permease of the drug/metabolite transporter (DMT) superfamily
MGIYLILGVREGNVNTCSLCAIFAGVLNAASQVVLYNASKKEDVFIINLWIYTYIGIFLLLLLPFNISAISSLNEVSMKPVSIWVSVAIIIFGISSQIFRVKAFKYTKDPSLIAPAMYFSVIVAALLEVVFYDSSIGYMEMIGILMVCVSSILSLIRK
>fig|1163389.3.peg.1715 Permease of the drug/metabolite transporter (DMT) superfamily
MNSSLLQGYVKIFLALVFWASLYHIAPLPLEYVDIYLVGLIRYAMASLIFLVVHYFFTKTLFPRLNLRQWLYVIAVGFFGVFLYNIAFLWAEKLISGNIVVIIFSFSPCLITILSSYMFQMKVNQQAKIGILVALLGTIGVVMFSSNSFMECSTGINMNLGEILSILAVLCFSAYAIFGKCCVRAGVNMITINTYGAIVGMIMFAVVSLFKSDFSELAHTDIKFWISMLYIAAFATVLAYLWYLRALEEIGVYKTAVFQNTMPFLVILIGFVLYGETISILSLLLGGVVFLGVYMTNVAVSKRA
>fig|1163389.3.peg.1725 Teicoplanin resistance associated membrane protein TcaB
MKNITRDSKLFPIVLALFAALTPLAVNTYAPAIPLIASDFGVSDSTVLTTFATYFIGFSFGMLFWGAISDKYGRKKVIIIGSVIYIISTVLCSYSYNFKMLEIMRLIQGLSDSVGAVIAFSIARDCYKGAKLTNLVTSIIIILLIAPIVAPIIGTILTNLTHTWQSTFHFLTIYGVVMLLCAFLIEETLEHKDRKSSLIKLIPSYFQHLSNSRFMLATIASSTIFAALFIYISSSALIYLGNYATGSLWYCIYYGLCCIAAIFANYLIKRHSSKVQQLKFLYYSVALITISCIVSIIFNSLNLDNAFFYTLIMFVLCGNVAFSSTLIYSFAIDQIDHSFGTANSIVNFIKNMIAASGSYFISFYHGRDLVIASPIAQFIFTLATVILLFGIYKLNKKVINS
>fig|1163389.3.peg.1902 Permease of the drug/metabolite transporter (DMT) superfamily
MLMVYSNEAYAELSTANFTSIFVVIYIGVFPGALGYLFLGYAFRNIPTTVAISSLYFMPIISLFLGWIFLEETEAYISIVGGIISVVGAFIISKYGLNKKTN
>fig|1163389.3.peg.1903 Permease of the drug/metabolite transporter (DMT) superfamily
MLNGFSAGGLSLARYGIASIVMLIIFVRQKNKTKPNLKDLLRFAILGFFGFLHIMYC
>fig|1163389.3.peg.2170 MFS family major facilitator transporter, probable multidrug resistance protein
MWKYSPIKTILILGPMVFAFALAMDVYMPVLPDMREAFNTTQQMVQATLSLFLVVTGVGQLILGPLSDQFGRFKIILTSSIIFLIGSVLCAISQDIEFLIFSRVVQAVGCCGLSVCAFAIIRDAFFGKTSSMIYSFINAIISVSPVVGPLIGVQLAIHFPWYSAFIFLTILAFVSFLIIVFFVKESLPVERRKKITWSVFARYLHVLKSLQFWAYSLAAVSGVVSFFILFSMTPYIINYLGYPISEIYIVFGSAGVAFLIGSIFAGVIVNALGVYNTAFLGVVCVFIAGVLSFSIYEVWGLSLWGFFAPCFLATFGCALTAGTGASGSMEPFYEMAGVAAGLFGTMEFAISGIIGSIAMLFPATSSLPIAITMIIISIIAASLLIIVKITQTKE
>fig|1166018.3.peg.251 Outer membrane component of tripartite multidrug resistance system
MNRLILLFLLTGTAVLAQVSPPGGAVTLQPGAGTVQPSAPATAANVPVGNGASNASAAIDLPTSGVLRFSDPILADLVQLGLTNSPNLRAAVSRIEESRGRIRIAQSFLQPSIRSSALITTQSLSEHRPVAIPTATDRLPRFQLNTFQLLPVDASWELDVFRRIRGGVTVAQLQAQSFEADLNALRLTLAADIARTYYLIRGNEAEQAVFQRNIAARDSTVRIVRERFRVGLVNQIDVQRAETDLAQLRVQIAGLQRARVELVNALAQLTAQDPATFNLATGTLPASVPTFPYANIPPDLLRRRPDLLQAERAIQVADAQLLVQQASTQPRVTLVGSGGVLSGQIASWFVPTSATYLLGVNASVPLYEGRRNRETVALSKQQTRTSQQVYEQTLQVAQREAETALDNLTYLREQLGLQNQTVALARTTEQYNRELYVKGFTTYLEVLDAQRTVLSAEQQAVQLRSQEVQYVVALLRALGGDF
>fig|1166018.3.peg.2141 Outer membrane component of tripartite multidrug resistance system
MKKYLVGLSLWGLSVGGALAQPAPQVLPLDQAIQLALKNNKGLKLADSRTAAAQARAQEVKDRNLPQATASLAYSRYSLTGPFAFGEGSDGKPLFGIPAGSFPATIGGVTVSKEVFGGFAEKSAKLSADLLAQASKLDAQRNREELVYTVTEAYYNIVKLIRSTAVIEQNIRQFDEREREAKNLQKEGVVTANEVLKIQLQRNNLQLSRQQVEKSRQTALYNFGLLIGQPEDQPISVDTTLRNPATTLAPMSDFLTKAVQVRPEVQANNLRVQAADAQLRTVKSAMYPHLGVSAGYNYINPSARVIPEGNSFISAWNVGAGISYNIGSLYNMKGRLNTAKTAIDQATIAGQQQTDQIRSEVVTAYNNYQLALEQQTVIRTAVDQAQENYRLAESRFRNGLVGSTDLLEADSFLIQAQLNVINATVDAQLAYQRLLKASGINLN
>fig|1166018.3.peg.2142 Membrane fusion component of tripartite multidrug resistance system
MNTKLLLRVGGVIILVAALFFGYSEFRYLQRYETTDDAQIDGDVDPVTPKVGGYVKAIRFKDNQFVHEGDTLFVIDDADYRIRVAQAEAALQSAQAGVGVSRSQVNVAAATIQSSQATVQTARNQVATAQANLAAAQARARKASQDFDRYSRLLAEKTVPQQQFDAVQAERDAAQAQVQAAQAQLQTAQAQVAAAGTQTGVTSSQRRATESQISVVQATIKQRQTELDLANLQLSYTIVRAPASGVISKRSVQVGQLIQAGQALCSVVGNDNLWVTANFKETQVGQMQPGQQVNIEVDAFDGEKFTGRIGSFAGATGAKFSLLPPDNATGNYVKVVQRIPVRIELDKNSPLFARLRPGMSATVAVDIQK
>fig|1166018.3.peg.2143 Inner membrane component of tripartite multidrug resistance system
MKLGFDKWVVVLTVTTAALLQTIDSSIVNVTLNQMMGNLGASLGDISWVVTGYAAASAVMITMSGWLSAKLGRRNYFAASIVVFTIASVFCGLSTNVWELVFFRVLQGIGGGGLLTTAQSILIQTFPKEDIGIANAIFGMGVIIGPSIGPTLGGYITDNLSWNWVFYINIPFGILATVMTYAYIKEPAEKVAAGSMDWLALIMLTVGIGGLQIILEKGQENDWFDSRFITLMTTAAVLCIVGFIWRQLTVDIPILDLRLLRRRRYAVGTLFNFILGFGLFASVFIIPVFCQTILGFTASQTGLLLMPGSIATGLMMPVVGGLLRKNFTSPIVYAGIGFLMFFGFCFDLSFISLEAGPDYFFWPLIVRGIGMGLIFIPLTTVTLADLKPVEIPQGSALSNTIRQLGGTFGTAIMTTYISTRTVFHSSRLGDNISVYNPLSADRLRQYTQLFLSKGDALVTATSKAYRLLQGSVVKQALVMTYADAFLIIGGFFLVCVPLLLLFIGKKIEAPAHVEMAME
>fig|1166018.3.peg.2209 Permease of the drug/metabolite transporter (DMT) superfamily
MGHYTLFIVHYSLTPMQTPITASAPPRTRYWVGALCVFLAAFCFALKGVLIKVGYGYGVDSIDLLTLRMLFSMPFYGGTLLWLSQRLPPLQLPAKQWGIVALLGITGYYLASYTNFLGLLYIDASLERILLFCYPTFVLLMNATVLKRRVAGLQWLALALTYTGILIAFLPHLTSGENTHMIWLGAFWVVLSGLIYAIYLVGSDTMIARLGAQRYTCYALLAAVVPTVVHNAIENGLHLAQFPLRVYGLGLLMALVNTVIPTFLMAEGIKRVGSSNASIIGSIGPIFTIVLATSILGEHISGWQFVGTALVLAGVFLIGWKGKK
>fig|1166018.3.peg.2272 Acriflavin resistance protein D
MFAEIFINRPVTAIVASIIIVALGVLALLSLPVGQYPDITPPVVQVTSNYTGADAQTVEQTVATPIETQVNGTPGMSYVQTNATNDGRMTMNVTFDVGTDVNIAALDVQNRVGIATPQLPEEVTRLGVTVRKRNPSLFMLVAIFSPKGTHNVSFLDNYTNVYIRDALLRVKGVGDIFSRADDFSMRIWLKPDRLAQLGMTADDVTAALQEQNLQVAGGSVGGPPQPSSQAFEYTVFTNSRISKETEFENIVVRSDPARGSLVYLKDVARVQLGKFSYASNSFVDGKRAAYLLVYQLPGSNALSTAQGVYAAMDQLKKTFPKDIDYVVPFESVSVIQVSISEVVQTLLEALVLVILVVFLFLQSWRATLITLLAIPVSIIGTFALFVPLGFTINTLTLFAFVLAIGIVVDDAIVVVEAVQANIDEKGLSPRDATREAMREISAPVIAIALILAAVFVPVGFIPGIVGRLYQQFAITIAVSVLISAFVALSLTPALCTLLLREQHIDENAKGLNKFFYKFNQWFGRVTNSYSNGVQRLIKATPLVLVGLAVVYVGTVLMFRAKPTGFIPTEDEGRLIVTYEIPEAASTARSLAVLNRVMDTLRRQSYVNHFAALGGLNAITFASKSNSGTVFMSLKPWEERKERGLQADSLVVKLQRALSSINDARVQVVQPPAIPGLGQSSGFTFEIQQRETNDDVRAFDGVVQNFLAEANKRPEIGRAFTYFTAKSPAYRVDVDRDKCKKLGLSVSNVYRTIQTYLGSQYINDFIIYGRKFRVVAQADTMYRSDLKALNQFYVRNSNNQLIPISNVITTSVIENAPLISHFNLFRSVELNGAAKPGFSSSQANDALREVADKVLPAGYSYDFSGLSREEINAGSSSVYIFLLSVGFVFLFLAALYESWSVPFSVLLSVPLGALGAIIALLLFPYLSNNVYAQIGLITLIGLAAKNAILIVEFAKERVDKGEDLLESTIEAVRLRLRPILMTSLAFILGVIPLALATGAGGVARATIGRTVLGGMLAATSLAIFVVPVLYVGITRLAYGKKGLEALKKNAQKDKPDDASQAPEAGQPQQA
>fig|1166018.3.peg.2326 Permease of the drug/metabolite transporter (DMT) superfamily
MQLEATSRVRLLLAFGAIYFVWGTTYLANLYALQGIPPFIISALRYLLAGLLLGALALGKGQVMPSGTTIRDLAISGILMLVGGSGLVVVAEQYIASGATAVIVATEPLWFVLLDRPRWRHYFSNKKIVAGLLIGFAGVLLFAQFGPESQATQQNATYQLIGTAIVLAGALLWVVGTLFAARRIQPDSYNLWHTTIQLLAASLFAALIALANGEWSTFSMQSVPLPAWGGLAFLIVFGSLIAYLAFAWLITVQPPALVSTHTFVNPLVAVLVGWLVAGEGVTAGQGIALAVVLVGVVLAQLGKVRSEA
>fig|1166018.3.peg.2618 Tetracycline resistance protein
MFNDRRLLHIYAIIFLDVVVGSIIGPVLPEFVRGHTQPQLWLALGTSLFLGVQLVSAPLLGKLSDAYGRKPIFRLSALGTFLADCLLLPVRMGTYLANRLSDGLTNGLYATVRSAITDISPKEALFRNLGIEGAIISLGFVIGPAIAGLLITTLNLTEPVEQARYVVMMAVGLSGLNVLLSFLLRETHPNDGAANTRGVLWTDLKVALAQSLNVGSLLARLRQKEREHPGLLNLVLMQVALTMAVGYYNYFVAYVSLGTLQMNATDISYFFMYFGGLSVAISYGFYGFIADRINQQRWIFWLAAVGAPVLASYGLVGTSRVWLYVIVTIDCFTYSLIQGLIEGLMAQKTTDTDRGEIFGLNQAMQGLASFGTTLVFGALSIIDLRLPFAWFAACLVVVAWLARK
>fig|1166018.3.peg.2733 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQTESPLLRPPSLRTDLIDTLRLSIPIIIAQLSNMLMSVTDNLFIGRLLGPVPLGAAGLSASLSLLLSSIGIGALSVVSALVSQAHGRADAADINRQYRAGLRVALLLGIVFGGVVAIAALGIEWFGQTTAVNALARPFMLIMSASNLPLFVFIAARQLSDGLSYPRIAMVITVAALVVNALFNYLLILGIGPFPTMGVQGSAMATLLSRVFMAVAMLLYIHRSRQFRPYFELAFNQQPILASMRQIIRLGLPSGLTFFFKIALFSVAIILVGWLGTNQLAAHQIAINLVSSTYMMSMGISSAVAIRVGNAYGRGDRDGIRQAGLAAFILTGLLMGTTALIFMLFNETLVSIYLTDAPDVTRMAAMLVFMAGFFQLADGFQVVGVGMLRGLSDVNVPTVITLFSYWLVALPTSYVLGFTLGYDVLGVWVGLLVGLSVAAMLLTSRFFRLAD
>fig|1166018.3.peg.2768 Membrane fusion component of tripartite multidrug resistance system
METESSTLKTYLPRLLGVIVLLAGAYWGFTAYRHGQQYESTDNAQIEGSTAPVLARVAGYVQDVNVDDYATVKRGQPLLTIDPQEYEVALQQAEADYESTLADIRTAQADIRNAQADLATAQANSRNTQQSLRVTQSNAEVQAARRSKAQTDLQRDQNLFNDQSLTRKQLDDSKNNLDVQERTYRASEEQIALARSQQGVAQAGILKAQAGIQRTQANIQKMQAMLKVKAAAVQNAKLRLGYAKLTAPIDGKIGKKTAVVGQYVQPGQTLMTIVNNSTFWVVANFKETQLENMRVGQDVEIKLDAYPDLDVKGRVASLSESTGAKTALLPPDNASGNFVKITQRVPVKIEILNPDQLKDKLRAGLSVDAAVRVAN
>fig|1166018.3.peg.2769 Inner membrane component of tripartite multidrug resistance system
MAETALASPPVEAQPALPTGFKKWIIVITAITAAIVELIDISIVNVGLNDIAGNLGVTIEDVSWVVTAYAIANVIVIPMTGFLQRYFGRKNYYIGSIVLFALASYGCGLATNLPMLVLFRFLQGVGGGALLSTSQGLIYDAFPLSQRPTAAAIFGAGIVLGPTLGPTLGGYIIDNYHWSWMFYINVPIGLLATYLSYTFIDKKADELNIDRGSIRIDTLGIALLAIGVGSLQYVLERGEADDWFDSLAIRYLTAATIITVPLFIWWELRGTNEPVVDLRVLKNRNLTLGAILITIVGYGLFTSVLLFPLFAQRIVGLTATQTGLLLIPGGFVTLPMFAISGRLLAKGVSPRNIAIAGYIAFGTFCFIMSTYNMDATNSYFIWALIIRGIGLALVNVPLINQSVSTLEPRQLPTGIAIVNMMRQLGGAFGVAITNTYVTQRSAVHRGDLVSHLQPGDPLLTDRLNAISQGLMSRGINAFEAMSGAYRNLDLIIQKQALMLSYLDTFRLAGLFFVVSFPLLFLLKSKKMSAEAAKAAADAAH
>fig|1166018.3.peg.2770 Outer membrane component of tripartite multidrug resistance system
MRFPLLSILVLLPGLALAQQSTALPDDLRALVQQASANFPLLKQQEQQIQATALQADLARTALRPQIGLNGSYQYIDPVPKATLPVNGRDVTLQFQPNHNVNANVAISQSLYDFGRTNAAVQRAGDNLRIQQRQQELTRHNLTYQVAAAYYGIGFLQRSIVVQDSVIRTAGDNVNVLSARLRNGDALQYDVITQQVRLKTAQNRKIDLQNQLDRQRALLTYLTGNADPAVSAASQQFGEPIQPFALDGQLQTALASNKDVLAAQDRVKLAETEIRIDELSGRPNLVLQGATGFRNGYVPDVNTPKFNVAAGVAFSMPIYAGRRYRLQNQVAKLNLNANRYAVENANAQLRQQLTQLNADIAANQTRLQNLNTQVLQARKALELAQTRLRNGVITTVELESAETGIEEAQLAQLAFQYQLLLNQLELKRLLGESL
>fig|1166018.3.peg.3528 Permease of the drug/metabolite transporter (DMT) superfamily
MSATTTTHEPVINTEKRPLLAWVLLTAIALIWGSSFILMKKALAVFSAQQIASGRIFFAFLFFLPLILNQSRRPDVREALRQRWVALLVSGVVGYLLPAFLFAEAGAHIPSALSGTLNSLSPLFVLLLGTLVFGQTFRANQVWGIMLGFTGSMILVFFGESGSFSINGYALLVMLATVMYGVNTNLIAKYLAHLPALVAIPWTFAFIGPVAGISLFSTDFLSRAQQANTFIPLGAILFLGGMASGVSSVLFNRVIQLASGVFAASVTYLIPVVAIVWGLFDGEAVSLQQYVGLTISLLGIYLVNKRS
>fig|1166018.3.peg.4227 Permease of the drug/metabolite transporter (DMT) superfamily
MSQPSRTAQFIPGFLFAMLWASASVATKFGVQSVAPLVLATVRFLIAGSGMLLFAYGIQRGNPLPKGIEWRRLTIFSFLNTALYLGLFVLALKQVSAGIGSLSTATNPLFITLLSAIWLRRPLRWQEGAGLLLGLLGVVVATIPLLEQAYATVDGLLILLGSMISVSAATVYYARYEWALPTLVINGWQVLLAGFMLLPITLLTTDLSTSQFDVRFWASVGWLIGPVSVVALQLWFGLVRVDAVRASLWLFLCPVFGFIYSALFTGEPITLYTLAGTLLVIAGLWMGRK
>fig|1166018.3.peg.5090 Permease of the drug/metabolite transporter (DMT) superfamily
MTIDSPRSDVRQPDRVQLWSALGAVYLLWGSTYLFIHFMTEQMPPLYMASVRYLVSGSLLYGYARLTGSKRPTRQHWQSTALIGFFLLTIANGALTIAVQYIPTGMAALLGGLLPIFLLILNWLWFGRVRPTTLSLLGVGVGVVGIYLLIKPDRLVSTGGVHANLIGTSLVAAGNLSWAVGTLLTPRLPQPGQTLASGMQMLLGGFFLLIISLLTEPVGVFSILIAPTKALWSVLYLVIFGSIIGFSSYAWLARNATPSLLSTYAFVNPVVAVLLGVLFAGEVFSGRSLLGAGVALIGVVLLTLGRK
>fig|1166018.3.peg.5192 Permeases of the drug/metabolite transporter (DMT) superfamily
MLLFVGTITSLALLVRILANPLANVFQKKLTHQSADPLFVTAVTYTGLFIACLFVYRWETARHLRLDFWANALLMGVLAVLGNTLLVKALQTGDLSVLGPINAYKAVVSLVVGVVLLGEVPSVAGLLGVGLIVAGSYVVLQPKRGAGGGGWRLMGQPEIRWRVLALICSAVEAVYIKRAVLLADATTVFVVWCALGCVLSWGWYGSLHRSTLVGQWQLVAKHRLSYLALIALVGLMQLSTTVVFSGMQVGYALALFQTSAVVSVLFGYQFFGERQLLPKLLGATIMAIGAALIVLVR
>fig|1166018.3.peg.5470 Multiple antibiotic resistance protein MarC
MPLNFKEIISVTLILFSVIDVLGSLPVIIDLRQKVGTIESEKATLASGVLMLTFLFVGERILKLFGVDVQSFAVAGAIIIFLIGLEMILGRTIFKSEIEADSAAHIVPIAFPLIAGAGTLTTLISLRAEYQIGNIVVGVILNLILIYIVLKSAAWLEDRIGPGGLNVLRKVFGIILLAISIKLLKSNLLPANF
>fig|1169145.3.peg.480 Permease of the drug/metabolite transporter (DMT) superfamily
MEDNRFAATWRWMLVTAIAPVAWGSTYVVTRAVLPDEALWGAVIRALPAGVILLAISRRRPHGAWWWRSAVLGVLNTGGFFALVYAVAQRLPSGVASTVMAASPLVMMAAGRVILGQRPRALALAGGAAGIVGVALMLFGGADAVDGLGVVLAVTALVGSAIGYALATRWGSTDLVASTAWQLLAGGLLVLPVAVIVEGAPPALDDAAIAGFAYVTVVATALAFVAWFAGLRHLPAGTVGLIGLLNPVTGVVLGAVVAGEALSGRQLLGLAIVLSGIALGRLPKAGQLPRDSRKLRVGAKNVEPVAAVEKSRMRS
>fig|1169145.3.peg.1366 Drug resistance transporter, EmrB/QacA subfamily
MRRTTRDWLALSSLCLGFFMLLLDSTITSVALPALIAGLGTTSTLAIWINSGYLVAYAVPLLIAGRLGDRFGRRRVYLIGLAAFTIGSVLCAVSQDIGSLIGWRVAQGVGAALMTPQCLTIIRTLFAPPRLAIALGIWGAVGGAATVAGPILGGLLVGAAGWPSIFAVNLPIGVITAVAVLLWVPASERLPARIPLWAMAGNALGVAALVMGIQGTDAASSSVANIPRWLLVVMGAALVTSVVWLQRRSLDRALLPVSLFRSHGFVTASWGAAAAAFCVGSAPIPLMLALQEDRGLDVVTASIVLVPMGVVCLLAAPVSARLNNTVGLRVVAVIGGVALVLSIGGTAALVWAEAPIWAIAGVFALFGIANSFLWSPFSIATVTSVERSSIGAASGAFNSVKQLGAVLGSAATAVVLAWTGNAVALAVLALVGVLSIVAASLLRVTPTDAGDASDQDRGGILIGTVVGGAGAGLGLGFPTANLDLEERAGLPADGVYIGGFRAETWSEPLPALISIGTNDTFPGRAHTIEVHVLDFAGDLYGRRAEVTTDRLIRTQRAFASPEELVEAMRQDEREARSLLIARQSHERKVS
>fig|1169145.3.peg.1400 Permease of the drug/metabolite transporter (DMT) superfamily
MKANRGVLAGLAVVVLWASAFPAIQVAAPAFGVIGLSFVRLAVAMIALLAFAAVKRVSLPRPRDFGWIVAAGFFGMTAYQLLLNESELHVPAGTASIIVAAAPLVSVAVAFLLFREPVTRFTVVGSLIALAGVAVVCLARAGVSLSASVWIVVAAMVVQGIYHPLQRPLLKTYTGLEVATYTMVAGTAMTLPLVPFGWGRLVEASPTGWIAAVYLGLLPSALGFVLWGYAVGHLPVAIATSLLYLVPPIAVFIAWVWLGEIPLPTELIGGLIVIAGVVVISQGARLVRRAHRRQPATVSIER
>fig|1169145.3.peg.1662 ABC-type drug export system, membrane protein
MTTTALPASRPQRRNGPTFLTHTLLLTGRQLRAAWRMPAFLVMNLVQPVIWLLLFGQLFKSVIDIPGFGVGQSYLEYLTPGVVMMLALFGSAWSGTVYIQDMDRGVMDRFLTSPTNRGAMIVSTLVYQSLLAVVQSLVVVGIAFWAGARFEGGVVGILLLLLGVVLLTAVFCSLSNAVALLAREQTALIGISQLITLPLMFLSSAIMNTKLSPEWVQNVSAYNPFEWAVIVGRQALSAHPDWATLWAHAGLLAALAVVMAAWATSAFRVYQRSA
>fig|1169145.3.peg.1767 Glyoxalase/bleomycin resistance protein/dioxygenase
MAIESVLLNVTDIPRSVEFYRRHLGAEVIGAGDDSAVLDLVTAQLVLYRIDTPAESTWVGDDLQRGFRHVGFKVSDLDARVDALHDAGVPFHLEPIHAEGDVRITFFYDPDGTLLELVEGPLQYHEVYDRSAVERDWGLGDPDRPRFDHVAETVADLEATKEHYGELGYSLMSGIHQPSDDRGFEINFLRHGDSSLEIFTYDKAEKAERSPQLDAPGFVAVAFEGRTAPGTVVGTTGDREVYSGPDGLLYTVANA
>fig|1169145.3.peg.2606 Multidrug resistance protein B
MERQLKPWPALWALVIGFFMILIDTTIVSVANPSIMEGLNLGTDYNAVIWVTSAYLLAYAVPLLITGRLGDRFGPKNLYLIGLVVFTLASAWCGFAGSIGFLIAARVVQGLGAALMTPQTMAVITRIFPPERRGAAMGLWGAVAGVATLIGPLLGGVLVDSLGWEWIFFINVPVGIVAFILAMRLVPKLPTHSHSFDVLGVILSGVGMFLLVFGIQEGSTYDWGVIWGPISVWGLIIAGIVVLAAFVVWQAFNKKEPLLPLPLFRDRNFSLSNGAITTVGFAVTCMALPLVFYFQTVRGLTPTESALMLAPTAIFSGVLAPFVGRLIDKVNPRNIATPALVLFAFALFLYSRMLSPDVNIFLLLIPSALMGIAMSGVWGPISTTATRNLPMNQAGAGSGVFNTTRQIGAVLGSASIAALIEGRLAVDLPKIPGGANASEAAAGTELPQALHAGFTQAMSEALLLPAAVAFLGALVVVWWERPKPPAWARQAGGAGAGAGAGAAAAGAPAAEGAPVAAGATAESADAATHGAHAAPVPVDATPHGAHAAPVPPATDLAPGDEPPHGLHAAPVTD
>fig|1169145.3.peg.2727 Glyoxalase/bleomycin resistance protein/dioxygenase
MISSAVTLSYRDAPAAIAWLEALGFDVLQLQSGQDGSVLHSELRWADTVVMLASNDAAYDVPPLVGASTGVGLYLVTQDVDGMFARAVDAGATVVFPPEETEWGSRRARVLDPGGREWSFGSYRPGEQWSASA
>fig|1171373.8.peg.200 Multidrug resistance transporter, MFS superfamily
MTSPQQPQEQPAGAPALSTTLLAALALLSAAGPLGTDMYLPTLVRMAGELGTTSSMTQFTLSAFMIGMAVGQLLIGPLSDSYGRRRLLIGGSVVFFLTSAAAAFANSIGLVIGLRFLMGAAGGTGSVLSRAIIPDLAHGRAAARGFSVMMAIQGFAPVLAPILGGLLAEPIGWRGIFAVLAGFNLLMVAAAVFMVPESLPAARRAPGGLRRLFPSIAMISRRRVFVGHALSMAVMFGVMFSYISASPFVLQRQLGLRSTMYSLAFAANAVMVTLASILNTRFIKHFSLRGIVRTGLTLGFVGSVGLVLNGLFGPWLWVTLPLLSVTVFGMGLVMGNATALGAAQVRDAAGAGSAMMGALQFLVAGIVSPLVGLGSNPALTMAVVMLVCAVLANAAHYLVARPTSE
>fig|1171373.8.peg.459 Permease of the drug/metabolite transporter (DMT) superfamily
MTPAAAHRLGVILIAVTAVLWGTSGTAATFAPQVGPLAIGAAALGIGGLLQGLISIGAQRRAAPRLRAHAGVVAIGALTVAIYPLAFYSSMRYAGVAVGTVISLASAPLASGLLDRFIDHRRLGPWWTAAAGMGVVGSVLLCLSRGGDDAAGPGRAVLGVLLGLVAGATYAAYSWAAHRLIDAGIDRAASMGSVFGIGGLLLMPMLALTGAPILAGPGNLAVAAYMALVPMFLGYVLFGMGLVRVPASTATTVTLLEPAVSALLAVTVVGERLGARGWTGMAIIAAVLIVLAAEPGSDKAGPVPGGAAQEVAVP
>fig|1171373.8.peg.672 Multidrug resistance protein B
MSDSWTSPAPRDPRLASVDPRLNRPWPALWSILVGFFMMMIDASIVTVALPRMQRELHADLTLLAWVTSAYLLPYAALMLITGRLGDRLGLKRVYMTGLAVFTLASLLCGLSTTAGMLIAARALQGVGAAIVSPQTMSMVTRIFPPDGRGRAMAIWGATGGVANIIGPLLGGVLVDGPGWQWIFYVNLPVGLLGMVAAARFVPALPGTSGRLDWPGVLLSAAGLGLVVFGVQEGQRYSWGAIAGLITVPRLIVVGLALLVVFVAWQHHMGHEALVPLRLFADRNFSAAVVGIAAMGAIVFAQNYPLTMFLQNVRDLSPTEAALATLPSAVMSILLANPVGRWLDGHDPKPLAVTGFGCMAVGLSWLALAMSPSTPILTVLAAMTVIGVGNAFIWSPLSVTATANLSPKLAGAGAGLYSEMQQVAAVLGSAGIATLMTWRTQTRPDLARAMGDSMWLSVVLAGAGLVACLCFARPRRAADWQRG
>fig|1171373.8.peg.1245 Permease of the drug/metabolite transporter (DMT) superfamily
MVGFRSSRLAPAALMVMALLWGSTLVVMKGAYAHLSPTDLLANRFLVGALALGLLVPRAWRANARTIGKGLLLGLLFGAGQVLQAVGLSSTPASVNGFIGGLYVVVTPLLGAIFFGKRVPRQIWIAVALATVGLGSLALDPADLGAGIGVGELLTFAASVCFAAQIVALGRFATARNVASLALYQTIGAALVCAICAAPGGIRIASSGSEWFAVLYLGVVCSAAIAVLQSWAQARVEATRASVIMCTEPLWGAVFAIGLAGDPVTLRIILGGVSILAAMVMVVRPPRRRRGLTQDEAGPRQIEQAGIGDLVGDSK
>fig|1171373.8.peg.2328 ABC-type drug export system, membrane protein
MSEQVVAPPAVLAEGRNIVVVTASRIGAFCLVELQKLKHDRTELFTRAIQPVLWLTIFGTTFSRIRAIPTGRISYLAYMAPGVIAQSALFVAIIMRVPMTWNPLRWLAVFGVVMLGSAFFCCLSLTIAGIVLHRDRLMGIGQAITMPLFFASNALYPTAIMPGWVKVLANVNPLSYEVQMMRGLLLGEPADYLQDLGVLVLAAIAMIVVASSLLGRLSR
>fig|1171373.8.peg.2608 
MIITLAFLDIKPESVEDFIAASKANAEASRQEPGVTQFNLTRQLDVPTNFTLVEEYRDIDAVEAHRTTDHYLTWKATVEPMQASPRHSHRYEIL
>fig|1171373.8.peg.3007 Permease of the drug/metabolite transporter (DMT) superfamily
MRAGSIVVWKRGLMASTPQAVQSRRATAIGVAAILLWSGIVGLIRVTTQHFGATLGPSLIYTLAAALLWLTRRPKSLRGFSARYLLLGGGMFVIYEVALAMAVGLSDDAHQTIEVSIVNYLWPTLTVALAAVVNRRERRPGLLIIPGVLLATVGVVGAVGGEAGLSPTRIAANVMSNPLPYLLSLMAAAVWAAYSVFSPRLAGGRDGITVFISGVAAALWIVNLVSPAPVGDITASGVAGLIGAAAVIASGYASWNVGILHGNITLLASASYATPVLSTAVSSLLLGAVLPLTFWGNVLLVVAGSLAGWWATRRTGRR
>fig|1171377.3.peg.25 Permease of the drug/metabolite transporter (DMT) superfamily
MMQKYRGEWLLLLATLTAAFGWLFSKNAIVELPAVAFIALRFSFATLLFLPFALPQLKSLNRQQWRYAVFVGLSFCLYLFFWVMGVKYTTELGKGAFLLSLAMLAAPLIAWGLYRQRPIRRFWFALPSAIIGMYLLANNGTEQSGFQLDTLFFLFTAFWAAVQFVLNSRYAQHLPVLALTTIQLSMVAISASIYSALFETFPTQISSPTWLWLTLSVLIGTNARFLLQTWGQKLSDLGNGALIMILEPVWTLLLSTLFMAENLSTTKIMGSTFVLSALLIYRLNVMRQK
>fig|1171377.3.peg.101 Bicyclomycin resistance protein
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTLAVALLNSDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>fig|1171377.3.peg.126 Bicyclomycin resistance protein
MTKANSKFFLVLLLGVLSAFGPFVVDLYLPALPQLAEFFHTSTSMTQLTLTTAMIGLAVGQLLLGPISDKFGRKKPLILSLLIYIISTIAIMFSPNIETMIILRVIQGLSSAGSVVISRAVATDLYRGREMTRFFGLLMTINGLAPIISPILGSLLLEYINWQGIFAFLAFIGVAVTLFSLRLKESLALENRLQGSVISVFGSFRKIIKNRVFMQFVGIETFLFGAMFAYIAASPFILQSVYSLSAFAFSLCFGANGTALVLGSNFGSRLANRSALKWGVLGFCFAVVYTAAMLLIQPHWLLVELGFFFTMLMMGLPLPAISSLAMESEREYAGAASALLGFAPFFLGGIVSPLVGIGDIFYACAIVMLLCAIIGFRLYWSVKDQIKNET
>fig|1171377.3.peg.403 Permease of the drug/metabolite transporter (DMT) superfamily
MNKYSLALLKVHGTAIFFGLSGVFGVLIESSSEALTLGRAIIAFAFIALYFLFKKRPLTKLTYQEKLMQFVMGGLLALHWISFYLGVKIGGVAVGTLGFASFPAFTALFEMLFFREKPRVRDFVLLIAISFGLILITPAFEFGNQVTQGLLWGIFSAFSYGVLAVMNRHSATKLSGVESSLWQYLAIMLILLPFYSGELFFASLSDWFWIGCIGVFCTTFAYTLYVSSLDTINARTAAMIISLEPVYAILVAWLWFDDVPSLKMVLGGALIIGAVAWANLKK
>fig|1171377.3.peg.726 Permeases of the drug/metabolite transporter (DMT) superfamily
MSHDHDTPSKWEISSHAALPVVLMLFIQMLAHYIGSPANSIFLSPYLIAFFVAALLALVVLWKGQICPGQKGRLAFVLPFLAAFALGNFLYTAFFTPKHILLSLANLAALFIPLLYWRFPDDEPMQKIFSYLGFALGAIGILAYSICYWVELPSLLNWVRGNYFAQIQLGLLLLGWYMMLAKSRLDGFFKLLVQLSLIVLIFNYIWVIFVLYQELNIMPELATLPYFAFFALQFVVLAMLAWLLIGKQGKNIKNPVAWTAATFLSMLYPLTNIF
>fig|1171377.3.peg.827 Permease of the drug/metabolite transporter (DMT) superfamily
MLSRRYLILINLFYVLGIGLNIVLLRFLSQHIEPLNNNGIRFLAGGIVLSLFAIWQYPTQLRLLLTQPKNILMSILVGLMLAANMYFWLKGTQLTNAVTASLFGVLAMPFGVLIAALFYPDERQKTRYKGFWLGSALTILGALGFIWYGNSLTIGEGFMLGALFLFLSICIRNTQNLIVKSARSVSMFAFSCFTSLSASFSSLFLSMQNSTLSELHSLPVWLIVLLIAAGIYAVFAAMALAFNIIQQQGLITYQVLELLIPITTAIAAYFILGEAIHFIQLVFAIIVIIGASCALGIIKVSRHKVAASAKSA
>fig|1171377.3.peg.894 Bicyclomycin resistance protein
MNVAKREHLCFVIIMGMLAMLPPLAIDMYLPSFIDIAQDLKVSQESVQATLAVFTIGFAGGQLFWGPVADSFGRKPIILLGLVGSAIAALFLTHVENIQNFYLWRLIQGLCGAAPAVVLGALVRDLFERNRFAQMMSVIMIISMIAPLLAPILGGYLAKWFHWHSIFYALMLMGGLCALLIGFKIPETLVKEKRQPLNFSNIIKNFVALISHKPTLGYVLVGGLSFAGMFCFLTSGSLVYIGIYGVSPEHFGYFFIMNIAVMMVMTVINGKLVVKVGSEKMLRVGLVIQFTAGLWLAISATFQFGFWSMAFGVPFFVGVLSTIGSNATAAILDRYPQMAGTANAVAGTARFGLGSIIGGLLSMVTLTSERPMLYAMALCTFSCFAAYYFLCCRNKAQ
>fig|1171377.3.peg.896 Multiple antibiotic transporter
MDILNFAIYLQFFIGLFAIVNPFGTLPIFFSMTAHQYETERNRTNLITSISIAVILLVSLYFGKIILDAFSISLDSFRVAGGILIVSIAMTMISGKLGEHKQNKEEQKADLTEYENIAVVPLAMPIMAGPGAIGSTIVWGTLYHNWVDFVGFSVAIVLFALICYVLFRFSAPLVKKLGRTGSNVVTRIMGLILMSLGIEIIVAGLSNLFPGLTAVS
>fig|1171377.3.peg.1322 Permeases of the drug/metabolite transporter (DMT) superfamily
MLELILAILCSVTVGVLIKVARQKGVAIDQSIAVNYLVAISLTFALLKPDFNGQSIMEIVQTNPSSYIFFALGFLLPSVFLIQAKALEYAGIIRTDAAQRLSLFLPILAAFTLFGEAVTSNKLVALVLAFIALGCLLWRSQQGMEKGGMIAVISLALVWVGYGVNDILFKQMAKTGSAFPLTLVISFIFAACLMFIYLLLKRTQWHIPSVAVGLLLGTLNFGNILFYIKAHQAMKDDPTLVFTGMNLGVICLGTLIGALIFKEKINKINYTGVVVAIVAIVCLFYWR
>fig|1171377.3.peg.1645 Outer membrane component of tripartite multidrug resistance system
MTSFAIFSVILTACSQMQINTESGISLPERFDQAEAAKGSAQIRQWWRNWHDPQLTTLIEKGLNENLDIRLARARLSEAQANSDYAEAERGINIGASGSAVGGVSDVNTGVSNPGRSRSGGAYGGISASWEPDFFGQKRSDADAAQAVALSAQEQVYAAQLLVSSEIADNYFRIHALEQQNAVLEKNIKTMRELQRYVQGRFNAGQATAYEVNEIAAQITALQARQATLKAQADVFQRNIAILTGTVPQGFSIVKSGNPLAKIPAAPSGQLPAAVIERRPDIRANALQIQAAAAKSASARADLYPRFNLNFMGRGGRIELNNDLSHISGLSGLAGLDVQLPLFTNGRIQANIDAADARLKAALIQYDKTLLTALGEVDSAYQNHRSLTAQTRLLQKSHTQAQKQASDAQLLFKHDDKTLDVAIRARVTALNYQEQLIQSQLAQAQNLLGLYKALGGGWL
>fig|1171377.3.peg.1869 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLQWHRYPQNTKNLFKLALPIFISQLASSGMGFADIVMAGMISDNDVSAIAVSNSIYFPLLLFVIGVLNAITPTVSYLNGSNQRHLISHQVKQGSWIALLFSLPLFTVYLGSDWILQSMDTPAAFAHKAADYMAMLCIGLLPALMAVNLRCFNDGLSNPRPAMLITFFGLLLNIPLNYIFMFGKFGLPAMGAVGCGLATSIVNWVMFLLILHYCYRSSSQKDIGLFNRFWEKPNRVTQVKLLKLGLPIGFALFTEVMLFATSSLILSPLGAQVVASHQVALQTSSLFFMIPLSVSMATTIMVGQTLGAKDVQGAKYLTFHAIFTCILIAFAMAVVILSLKDWIPHIFTSDPTSITIASSLLIFSAIYQIPDSVQSVCNGILRGYKYTRPILGVTLICYWLIGMPLGIVLARTDWLVMPMAASGFWLVFCICLSIAAMFFFYYMRKIQCLSDEDLLARLERIK
>fig|1171377.3.peg.1886 Permeases of the drug/metabolite transporter (DMT) superfamily
MQQKPLRGFLYALLASMTWGTLPIAVQPLLATIDAQTLVWYRFWVAGLGLALFFVLTKRLPSARAFSPRVFKLIFLGVCGLAANFFLFSEALNYISPTTNQVLWQLAPFTMILCGVVIFKEKFGQHQKMGLILLLIGLAAFFNERMGEILQFGDYAVGILISASAAIIWVCYGIAQKLLSATFSSQQILMIIYLGCGVAISPFVSPSQLFEINGFLIGCFLYCCLNTFIGYGAYAEALNYWDATKVSVVTILLPIFTMIFSHLGHWLMPDFVPELTMNWLSYLGAFIVVAGTILSAIGHKIFK
>fig|1171377.3.peg.1887 Vancomycin B-type resistance protein VanW
MIPLFIEDNKAFIYTAVDFSATTNGIMNAETVDVINLNANISGNSFTGSANSASLSGTAKVEGKFYGENAKELGGMFKAADWVGAFGASK
>fig|1171377.3.peg.2189 Permease, MDR related, probably tetracycline resistance protein
MIFLQAKGLSMYEISILQMALNITMFLFEVPSGILSDKFGRKPPAFLGISFSIIYLIGMLYLNEFFYLVIVFIVYGIGISLLSGVDQSLIYEQLDYYGKQEIYHKTIGFYNAISIAALAVSALVGGWLAENKYWELIFYFGVLFQLMSLLFLYFIKDFYKLLPHNNKAKKSFFGIGILRVDGKVLFIICILGIFQGVFSSVVLYYQKVLDYAGVSIFYISILYSLSFVFSSFSSVMSGFVSEKIGEVKAVLLFSLLLLFSFFYLYL
>fig|1172188.3.peg.65 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEQRTYPEGVTSWVDSEQGDVDAAADFYSGLFGWTFDEATPPGVPFRYLIARLDGQDVGGLGGPATPAAEGAGGGGGDAARWHTYVAVDDAEAATGRVKAAGGAVVQPPTVAGEGGRSVIVRDPQGLEVRLWEARGRLGSQVTNVPGAWNFSDLHTDEPAAAQQFYARAFGWEFADVGFATMIRVPGYGDHLAATTDPGIHERQSGAKVPPGFADAIGWVVPVAPDAEPGWHVTFTVAERDAAADQVVRLGGSVVRTGDSDWTRTAVVRDPQGALFTVSQFLG
>fig|1172188.3.peg.659 Phosphotransferase (aminonucleoside antibiotic resistance)
MTARAPGRSPLDGGAACLLVVGAPGAGKSTVTRLVAGRLSRAALLEGDTVSRLVVSGRVWALGEPADEADRQTRLTNDNLVALAASFADAGFTPVIDWVVPDRAQLDLYVAGLGDRGLALVVLDPGGDVCRHRNELRDPEEQFDFDGQEALVATMRRGFGEVGWWFDTSALTPEETAEQVLAHAYALGRRGL
>fig|1172188.3.peg.1479 Glyoxalase/bleomycin resistance protein/dioxygenase
MSSPIQRRVGQVFVPVRDMAAAIRWYAAVLGFEPGAASHEDTIYDVPTDGETRLALDANRPDFIASGPPRFFLWTDDMAATVEHLRRLEVTITSDVEDIGSVFFVQFEDPDGNALMVCQRT
>fig|1172188.3.peg.1825 Phosphotransferase (aminonucleoside antibiotic resistance)
MSELDESGPRGRLVLVTAARPQARAALASAVAARLHGAVVVDGAALEAAVTSGAVPGWDEPPTSEQLRRRLLRWSAALAVAETYQLEGLDAVVAEDALGDRLEDFLDLVEPEPVHVVVVRDGADPATPHWGLWVDGTDPVGATAADVVSRLADALVATSAT
>fig|1172188.3.peg.2061 Vancomycin B-type resistance protein VanW
MAHDWSDDTRRERRSTVLRLLVATIVLGGGYAGLCVWSSQHVPASVSVGGIRVGGMTPESARAAIARGSRSLLDTPIVLSVPGRPAPIEVVPRDAGLTVDADRSLEGLTGFTLDPRVVWDKLTGSVRTPLLTTADDEALTAYLDRLAPGLAVAPVEGRVSFPDGAVSVDMPAPGSTLDVAATKLALRRAFPDSTQATAVVREVPPAVSADVVQQVGSQFGSTAMSRPLTLVSGATRVLLSPAEYAPMVSVVPDGSGGLTPRFDEPGLARLVAGKVTVPSRTASSARWVFEPNNGKPRLVPSVDGLTFDEDAVARQVVAAISGTERTVDVRAAVAQPPFTTEDAQKAGVTTLVVDFRSPFPTNDATRTNNLVVATKRINGTYVPPGGTFSLNGILGERTEDKGYADGTVIIDGRLTRGTGGGISQVSTVVYNLAYFAGVDFLQFSPHAFFIPRYPEGREATVYWPTIDNKWKNDTPYGMLLQTWVEGGFVHGRVWSTKTWDITSVKGPRRNVVPPKTIRTDSLKCYPQQPNPGFDVTVTREWRRPGSAALVRSEPVSTHYVPEDHIICTNPAATPP
>fig|1172188.3.peg.2492 Permease of the drug/metabolite transporter (DMT) superfamily
MAVTLLLWASAFVAIRHLGRDVPPGALSLGRLLVASVALGVLVFRRPRTWPARRDWPLLLLCGVGWFGIYNLALNEAERRIDAGTSALIVQIGPIIVALLATVFLGEKMTRWLLIGMAVGFAGVVVIARGFSSGDSGDMVGVWLAVLAAVTYAVGVLAQKPLLGRLPGPEVTWLACVIGAVVCLPWSGELVSVVRDRDPSTLWWIAYLGIFPTAIAFSTWAYVLARSDAGTLTLTTFLVPFIATLIAWALLSEVPPPLTFVGGALCIAGVLLTRRKPRVAATAED
>fig|1172188.3.peg.2634 Permease of the drug/metabolite transporter (DMT) superfamily
MEGNRASWTNVALTALPAAIWGSTYAVTQQWLPPGRPLFAATVRALPVGLLMLLWLRRLPRGDWWWRSLVLGSLNIGLFYALLFFAAYRLPSGLGATLVATAPMVTMAVSWMLLGQRPARVSGAAGLVGLVGVALLVLQNGLDKPLDPVGLGAGLLAVVLSSCGFVLTRKWAPTDDVVTMTSWQLVAGGLVLLPIGLVVEGAPPALDLPAVGALVYLGLLGSGVAYVLWFRGLAILGPTSASIIGLVNPVIGVLLGVALLGERFGPVHLVAMVLVIGSVLAAQEPVRARFSRRAPSTGERTSTRRHTPALPSGAPAGKAVAWPPTPTTLSTSSSSGSDRAVSTSPGASPSAACACSASTADSWAVSAPTGAASRRR
>fig|1172188.3.peg.2684 Glyoxalase/bleomycin resistance protein/dioxygenase
MPVHEESFAPGTPCWADVMVDDLDRARDFYGSLFGWTFEDLPPEAGGYVMARKDGHVVAGAMAKNPDDPGQVSAWTVYLATDDVDATAERAQAAGGVFFLGPMDVLQVGRLAVGADPAGAAYGLWQAKEHTGTDLVDEPGSLCWAESMSRSYEASRTFYTDVFGYRLQEIGEGGFQYSVATLDGDKPVGGIGAIPAAAPADVPSHWMAYFAVADADAAADRVTALGGTVRQPPFDTPYGRMALVAGPQGETFSVMQLPEQPAAD
>fig|1172188.3.peg.3025 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MPIKLENVGIAVDDLEATIAFFTDLGLTVLGRDTVSGEWTDTAVGLDGNHARIAMLQTPDGHGRLELFEYIHPSAIETTPTLPNEIGMHRVAFSVDDIDEALAIAARHGCHPLRGVATYEDVYRLTYLRGPSGIIVMLAQELTGR
>fig|1172188.3.peg.3297 Drug resistance transporter EmrB/QacA subfamily
MAEASTSAGSGRSGRAAAQTAASAGGVLAATCLSTFVVNANTSAVSILLPAISADTGMDVTTLQWAVTGYSLVGAAVIVTSGSLGDVFGRKRVFQLGLMLFVVSCIFIALSSSGGAVIAGRVIQGAAGATILACGLSLLSVANDGEAQLRAVSLWGAAAAVGAAAGPLMGGVLVSVMGWQGLFWVDAVIAVVCILITYRRVSESRDTTRSRSIDYAGSLLIALTLAPLILALSKGGDWGWASVATIACLAIGVAAGFAFVAVERRVAVPMLDLALLRNRVLVGSTVAILIGAGTINALMYLLSLYFQDPNALGFTTLQAGLATLPATIGLVAIAAAVPKLTARLGGRQVVAVGFLLTAIGFAVIGFVDADWAYRAFLLPLLAVAVGMGMSNGPASSASTACVPEKQVGSASGVSNMARYVGAAVATALAATIYGAVIADGTAKGRPPADALASGLATTSWVMAGFSLAGVLMAVLMGRHQAATGTIHDSAAAAASTAMTLRTTATGAVATGAAKGA
>fig|1172188.3.peg.4078 Oxytetracycline resistance protein OtrA
MDTPPTPPVRPGRTLGLGILAHVDAGKTSLTERLLLHAGVIAELGSVDDGSTQTDTLALERDRGITIKAAVVSFELGRPGDPDPLTVNLVDTPGHSDFIAEVERSLAVLDGAVLVVSAVEGVQAQTRVLMRALRRLRIPTVLFVNKVDRSGARTEVVLREVVDRLGVTPVPLGRVVDEGTRAAAVVPDGLADLGLPARGPAEREDAEPEGGDRDAAAARERVVEALSRADDRLLADWLDAPHRVDASRLRAALGEQTRRGLVCPVLLGSAMTGAGVEDLAQALPDLLPARTPDPDAPLAATVFAVQRGASGEKVALVSVTSGSLAVRDRVLVHDGRTEWSPAPDPDPRHTTSASGDDGARCREERVTGLSVHARGEVRRVARVPAGRIARVVGLERARIGDLVGDAALARPLVHEFSPPTLETVVEACDPAERALLHTALTRLAEQDPLIDLRHDEVRGETHVSLYGEVQKEVIGATLEAEYAVAARFSTTSVICRERVTGSGAAFELIDVAPNPFLATVGLRVDPGPPGSGVRFSLEVELGSMPASFFTAVEDTVRATLGQGLHGWPVTDCVVTMTHSGYWPRQSHMHQKFDPSMSSTAGDFRALTPLVLMEAVRLAGTAVEEPVHRFDLEVPSDVLGAALSMLGHVRASPRETAVLGPVTRLRGEVPAERLHELQQRVPGLTSGLGDLVTAFDGYRPVVGPAPTRSRTDLDPLHRREYLLRLAGKLSAQPHSSERPTTLE
>fig|1172188.3.peg.4145 Phosphotransferase (aminonucleoside antibiotic resistance)
MSDRPLHTAVDIPQVIVVTGVMAAGKSTVSQLLAERFTRAVHLRGDEFRRVVVRGRVDMSPHGDPEAERQLALRHAIAAHSANEYAAAGFTVVVQDLFVGTTLQPFLDRLTARPLSLVMLAPDVGTVMQRESERVKVGYGDLWSIRDFDHKVRTETPHIGLWLDSSQQTPDETVEEILARLAEARIS
>fig|1172188.3.peg.4451 Permease of the drug/metabolite transporter (DMT) superfamily
MTPAARTRLATLLLVALTAVWGSTFFLIRDLVETVPPVDFLAVRFSLSAVIMLLVFWRPVRALSRRQVLVGVGLGALYGLAQIFQTQGLATTPASVSGFITGTYVVLTPVFTAVLLRERVAGSTWAAVGLATVGLALLSLNGFSVGVGEAITLLAAALYALHIVGLGRYSASEIATGLSVVQMVVIAVLCVVGALPGGVVLPSGPRQWASVLYMVVFASILALWVQTWAQAHMPATRAAIVMTLEPVFAAFFAVTLGDESATLRMVVGGALVLTAMYAVELLARRRPGELPVEALHHEV
>fig|1173022.3.peg.2517 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSSVEKSSSPNSLLSGQNVVYAGIAWSVLALLFYLLFSISVPGEERPFWYSMGTYFFEEVPFLAAALLCFRNWRSPQIASGRNVWLGIGLGLLSFFIGNLFFGWWELYWGLDPAVSPGDLFYVLFYVCLGCGLVLAILPRRLNLEPWQWATVIASAVSAIALAIWLLSSPPANAQEASAIAQPARSAIASTPITQQRDSNTPSQTLIAQKAPNVKVTPKAPATKAPPVPANTSKNQPPGWVLSLEKVLEPLAAPLSLFYIAGDVFLLIIAALLLLAFWGGRFAQSWRMIAAAAFSFYIADMWFTYATDHITDYQSGFLLEVFWVFSGVLFAIGAALEYDNSIRSRRAGRKRA
>fig|1173022.3.peg.2687 Glyoxalase/bleomycin resistance protein/dioxygenase
MFLNSIFVTLATSQLDILVQFYTNLIGIEPESYIPQIYAEFRLNNLRLGIFQPKEANRQEFDNSGRNPISLCFEVSVLESAIAHITALGYPPPGKIINASHGREIYAYDPDGNRIIFYQSNKLD
>fig|1173022.3.peg.2817 
MIVTCVHVWVKPEHIEDFIKATKINHENSIKEPQNMRFDILQDQGDPSKFILYEAYQSDEGAAAHKQTEHYLTWRDTVAPWMAEPRKGIPYSVIAP
>fig|1173022.3.peg.4533 Vancomycin B-type resistance protein VanW
MNTNNKEKFLPSIKKIIPGELKRSLKIKSRYIGDILTGNAQSMVNFIPINEINKYQFQPQSSISQVIKTTSYSENKKHNLALAINRLENIVIQPGKLFSFWHLVGNPNSKNGYKEGRTIINNQLQSDIGGGLCQLSGLIYWLILKAGLVPTERHPHTHDIYTESTRFAPLGSDATVVYGYKDLRFINTLPVPICWQFKLLPAEIIASLCSTQKIHQFEIEFRREESNEQRIVQTVRLAQGKEEIIDTSYYLVLKN
>fig|1173022.3.peg.4649 Methicillin resistance protein
MQSWAWGDFKELEGYQTFRYGLFADNTLVGGAIFYFYTHASQANLLIAPGAPILTPPYLESGMQLLLRKAEELAKKLGAIALRIEPLWTKKPDYLSNFVRAPVDLLPSETLLIDLEVSEAEMLAAMKQKGRYNLRLSWRYGVETEFTTNPQAIPVFYDIFWETVKRQQFFGEPYCFFINLCQTLFQANMAEIGLAKWQGEILAAILVVYCGNRATYLYGGRSFEHPQVRATYALHWAAMQQAKQRGCTIYDLYGFTREPKHSYAKFSQFKSQFGGIPVTTIGAQDYFFYDQLADTLINLFKNIGGNET
>fig|1173026.3.peg.24 Permease of the drug/metabolite transporter (DMT) superfamily
MCAKHRIDRETIGLGYGFLGVLGFSLTLPATRVAVVKLDPTIVGLGRAIIAAFLAVIVLWANHQRRPARKHWRGLIIVAAGVVLAFPLLSAWAMQQLPAAHGAVVLALMPLATALAGSIIVRERPSRRFWLASITGSITVIVFAIFSGAGQMQWADVVLLGAGMAAAISYAEGGRLARILGGWQVICWALVIAAPVLSVPFAKAVLQHGLVASPTAWLGFGYVSIISQLLAFFPWYQGLAIGGVARVGQMQLLKPFLTILASAILLGEAIAPFTLIAAMIVVTSVAIGRTSAIQRN
>fig|1173026.3.peg.703 Permease of the drug/metabolite transporter (DMT) superfamily
MQIWQAPKPWQVGLVLVIGVFGISTASIFVRLAFAAVPGVSSVGFSLVLSAARLIISAILLLPAWRYLRSSPPSRTSVYYASVAGVCLALHFATWITSLAYTSIAAASTLVSSPPIWVALLSWLWLREKLSPLTLIGIGVALAGGIIVALRGSGVDSVASRPLLGNFLALFGAWMYSLYLLLGRKAQQEGLGLGSYIAIAYTTGALILLPLPGIFSVSYTGYPSIVYVYILLIAIFSQMIGHTSLNWGMRWLSPTLVTLAALFEPVGASLLAYFLLGELPGRLTLLGAAILLVGVACAIVGARQNKLGQTKLSE
>fig|1173026.3.peg.1148 Permease of the drug/metabolite transporter (DMT) superfamily
MVVYLKLILTAVVWGGTFIAGRVIVQDLDPFSAAFCRFAVSSICLLFLTLKQEGQLPRLHQKQLIQVILLGMTGVFAYNAFFFLGLQTIAASRAALIVALNPTFIALGSALFFKDKLTAFKIIGIIVSLLGAALAISRGNVVNILDDNLSIGDLFLFGCVFSWVAYTLIGKLAMQQLSPLVATTYACLIGTIALFFPALSEGILQHFFQINFVTWLVIWYLGFLSSALGFIWYSEGVRVIGPAKAAIFINLVPVSAILLAAVLLREEITLSLLAGGILVVMGVFLTNKA
>fig|1173026.3.peg.1345 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MASDRTMEQFKLGSVSNTPQDLISNGFAAIALGMALLGIAFASILTVVAQYEIGPNATTFNRLGIAAIAFAGWNGFRFVSQIHAHSVSALVYTWRDRSLLAIAGTSFAASLTLWAWSLTQTSIANSTLLNNMMPLFTTLGAWLVLGQKFSARFVLGMAIAVCGAIAIGIEDFQGANSNLFGDSAALGAAMLAAVCLLSLEQLRLKFATPTIMQWTCLIGSLGVFPVILLTQEPLFPTSGVGWCTVISLAIVCQVVGQGLLTYSLAKFSSGLVAVSMLAIPAIAAVLALIIFAEKLSILNLCAFAVVLAGVYLAISARSD
>fig|1173026.3.peg.1808 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLGAIHHIALTVSDMERSEAFYNKLLGFMGYEQGEKTEQLILWASSHSAMTISPAKQQFHQKCDRYSPGLHHLAFSADRREDIDKLYQELLEQQVTILDPPAEYDYLPGYYAVYFLDPDGIKLELAHTPT
>fig|1173026.3.peg.1811 Permease of the drug/metabolite transporter (DMT) superfamily
MKPIDLARLFLLAALWGSSYLFIRITAPVLGVFFTISLRVIIAACALGLYGVLAQQLSTLKTRWLSYLLLGLLNNVIPFILIAIAIVNLNASIAAILNATTPLFTAIVAAIWLKEPLNKRKIVGLLLGIVGVAILVGWSPLLLSLSVILGGLSALIAALFYGIAAVYARRRFRHNRATETAIGQLVGSSVLLIPVTFTSIPNTVPSTEVILAVITLAIACTAFAYLLYFQLIAKAGATQAATVTFLIPVFSLLFGKTLLGEPVNFGLIIGLITILLSIWLVFNTKH
>fig|1173026.3.peg.3594 Permease of the drug/metabolite transporter (DMT) superfamily
MNYNNAPEGANFGLLMIMVSAILWGTVGVFVQTIYTLSESNSFSIGFLRLAISLPVLFLACARTLGWQMLQIAKRDLALMLLTGAMTAFYQVCYFTSISYIGVAAATLITLCTAPVWVALLASLILHERFTLGILLAGLCALGGTSLLVNIQPEQIAVRSQILGVGLALGSALAYASVTLCSRLLSRRYHPLQSLTVSFFAGAVFLLPIALITGLVLQYPFVGWIALLYLGIVTTAFAYVLYFSGIRHTPATVASIATLLEPLTSTILAWWLLGENLGTSGIIGGVLLLIAIGILYWDLRWNQRHSRRN
>fig|1173026.3.peg.3917 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MSIAATELFTLSFVVQLTLALATYTIGVANWVLALRVVKLSVAYPLSSLNYVGILFGSYYFFNETITFTRILGVLLIFTGVLFVALSQSGRQLISK
>fig|1173026.3.peg.4327 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTVMQMPKHIHTEVREFLKLAIPLASAQVAQSATGFADTVMMGRMGAEVLAAGGLAALIFLSIMTTASGVVMGVSPLIAEAFGAGKKTRIEQVARQGLWLALLVALPLMIFTAHLDTWLSYSGQTAKNVQLVNTYLDIMLWGLFPAVGFAALRATVSALSQARPVMMIVVTGTTFNIIGNYVLGFGKFGFPRMGLAGLGVASVIALWGMFFALALYVFKNQNLRKYRIFQELHRVRLRILWELTWVGVPIGLFSGLEIGFFLVVTFWMGTLGTEVLAAHQVVFQTIVVVFMVPLGISYATTVRVGQWLGRRSRIGIQQAAWVSMGMTTVFMVGVSIAFLLFPKQIVGIYLDVQNPENAAIVAIALPLLIIAAIAQVLDGFQKAVYGSLQGLQDTQIPMLLNVLGYWGIGLSVGYGLGFWFNLGSIGLWIGQSVAIATVAGLFTWRFHKLIARQTLN
>fig|1173026.3.peg.4463 Permease of the drug/metabolite transporter (DMT) superfamily
MTAKLFAPREWQLALPLAIFLHLFYVAPLAVLLASSFQTAPDVPSFTLAQYWQFFQDAVNRKVLLDTFWLGVQVTLSCLLFGYPVAYIYANAPAKWKGLLTFLILLPLLTSSVVRTFGWVVILGRQGLVNSLLQGVGFIEEPIRLLFTHQGVAIAMTQIQLPLMILPIVASLAQIDPRLAAASASLGGGAWRTFWKIIFPLTLPGIISGCLLVFAITVSSFVTPSIIGGGQIMYMPTLIYQQGVVLLNRSFAATISAILLVMVLIVVFGLSSLGQKSRDYVR
>fig|1173026.3.peg.4694 
MPAIAKNNDVVTVIIVFTVEPEHQQQLIDTIIEFIEIAVKYQPGFVSATLHKSLDGVRVINYAQWRSLENYHAFLNNSEVQAQGKKLANFQPPDLHIFEVVSLHSDNTTLELNQDD
>fig|1173026.3.peg.5094 
MTTLINNQTLTTISQDADLVTLINVFIVEPENQQLLVDLLVKATEEVMCKLPGFISANIHKSLDGKRVTNYAQWRSVEDFRGIFNNPEALAHMPAIGKIAQSDPTLYEICYIKKS
>fig|1179773.3.peg.563 Probable multidrug resistance transporter, MFS superfamily
MKRLLGKVAIDTRPLRIPAFRRLWLSTLVTAIGSQLTAVAVPKQVYDITGSSGWVGVAAGVALVPLLVFGLWGGAIADVVDRRKLMVVTNIGIAITSVLLWLQAAFDVQNVWLVIALLGLQQVFFAANAPARSASIARLVPEDQLPGAVALGSTVMVFGGVFGPMLAGALMPVVGLSTLYLVDSIALTATIWAVWKLPPMPPLDGVVRRAGLADVIDGFRYLSVQKIVMASFLLDIIAMVFGMPRALFPEMAEVTFGDPPGGGLALGWLFAAIPLGAMVCGLVSGWTSRVSRHGVGVVVSIIVWGVAMIGFGLSNALWWAVVFLAVGGAADMISMVFRTSILQTAAPDEMRGRMQGVFVVVVAGGPRVADLLHGTTGALIGPGAATAWGGVAVVIGTVVAAIAIPAVWRYRVTLGTAGETSPKP
>fig|1179773.3.peg.804 Daunorubicin resistance ABC transporter ATPase subunit
MADVVKVYEGGRKPAVDGLGFAVRRGEVFSLLGPSGAGKTTTVGVLTTRVRPTSGRALVEGVDVVADPRKARQVLAVVPQRNTLDRALNVRQNLLFHAAHHGLGRAERTRLADGVLNRMGCRAGPAVPALHRHRPGGRPAGRPADRRAARRRGGRPGRRQAEPGGRLHRPGTARVPHAGGRPAVPAGGGGEDGVRGVARAARGGADDPDRVRCARRLVGAVGGPGGAAGDRPARRRARRSAW
>fig|1179773.3.peg.992 Drug resistance transporter, EmrB/QacA family
MSSRRLAIGAGALAVLLGALDAYVVVGVLVDMVRDLGIPVNHLERATPVVTGYLLGYVAGMPLLGQLSDRFGRRTVLHLCLAGFAVGSAVTALAGDLPLLVAGRVVQGLAGGALLPVTMALVGDLWDERRRAGALGVVGAAQELGSVLGTLYGVGVASLFNAWSVFESLEPQSWRWVFWVNLPLAAVAMLVVQRTVPGGSGRPVRIDVVGGALLALSLGLLVVGLYNPDPEHAVLPPWGWPALGGAVAVFGGFVWWEKRSPVRLLDPTGVVMRPFLASLGVSLAAGAALMVTLVDVELFAQTVLRLDSAAAVALLARFLIALPVGALLGGWLASRVGDRWVAVVGMALAGVAYVLISRWPADVPSSTLDRDLVVAGFGLGLVIAPVSAAVLRVVPATQHGVASAAVVVARMTGMLVGVAALSAWGLHRFRELTANLNTPLPFGVEPAEFTRQAEQYQRALTEALLTEYHEIFLITAVICAAGAALALLLPAKTSSPDLTATRPRTG
>fig|1179773.3.peg.1037 Multidrug resistance protein B
MLGNDVRSGPRLPGEVWVLVVASFIIAIGFGIVAPVLPAYAKSFDVGTFAVSAIVSAFALVRLLFAPVSGRLVSRFGETRTYVVGILIVALGTAACGFATAYWQLLVFRSFAGVGSTMFTVAAVGLLIRITPAPMRGRASGLWATGFLLGNIAGPIIGAALAEISIRVPFVTYAAALVLAAAVVWWFLRRSTLAALDPNVEQTTLSVGQALGSPAYRAALASGFANGWAVFGVRISLVPLFVVEALNGSPALAGISLSVFALGNAAVLMISGKLSDTIGRKPMAMSGLAVSAVGTIWLGFTTGVPWFMAASLVAGIGAGLLNPPQNAVVADVIGTKAKGGPVLAAFQMVADCGAIIGPLLAGVLVDHVSYGAAFTLTGVIMIIALVVWAFAPETLPREPSAHVAEVVANESGRLDEGPEVPTGERLAGRPRQPDA
>fig|1179773.3.peg.1188 Small multidrug resistance protein
MLKWTLLGLAIVFEVFATLCLKASDGFTRLLPTLGLLVGYAAAFYLESQVIRLGLPVAITYAVWAGGGIALVAVAGRVLFADPIGPATLAGMALIAAGVGVVSAAATT
>fig|1179773.3.peg.1469 Permease of the drug/metabolite transporter (DMT) superfamily
MGKFVLLSAIWGSSFALIKVAVDAGVPPVWVAFFRCLFGALALWAVCAVQRQGVPRDRRLWGHALVVAALLNSVPFTLLAYGETKVSSVLAGVFNATTPLMTLVFVLLIVPQEKISGAKLTGLVVGFAGVLVVLRAWEGLGDDVLVGSLACLGATFCYGAGFAYTRRFFSGGPQSASALSAVQITCGTAQLAVAAPLVGGLPSWPGWQAAAALLVLGAAGTGLAYVLNLDVIREAGPTVASTVTYVTPLWSTALGVLLLSEPAGWNTVVGGVVVVAGVLLARKPTNHPMGQKSTRTVVQVDKPGPA
>fig|1179773.3.peg.1679 Tetracycline resistance protein
MMIMTAVEVVQRRVLRVLGVTQVLGAAGVTIGLAVSTLIAAVLSGSDAVGGLAQTAAALGAALFALPAARLAARRGRRPALILGYGAGAIGAVVAACAVVLGSWQVLVAALVLFGAASSANLAARYAGTDLAHPQRRARSLAIVVWAATLGAVAGPNLADPAGQFAARLSLPVGAGPYLAAAVLFGAAALVVLRFLRPDPLTLAQSAAPVTPAHCAGGVGDTRGSAAVWRALPATGKLALGGITLCHTAMVGLMSMTPVHMDHAGASLRVVGVVISLHVAAMYAASPLFGWMADRLGRVPVLAIGSALVVAASGVAGMAPAHDAPQLAAGLTLLGFGWSAGLVAGSALLTESVSPTDRPAAQGLSDLSMNIGGAVGGVAAGIVVTAWSYAALGLLVGFTALPLLVACLFTSLQRSR
>fig|1179773.3.peg.2719 Multidrug resistance protein B
MANAVGKVAERGREPVEVGRGARNAIVAVIMLGMLLAALDQTIVATALPTIVSDLGGAGHLSWVVTSYLLAETIMTALIGKFGDLFGRKPAFLVSVALFMVGSFLCGWADSMTWLIVARAIQGLGAGGLMVTSMAVIADVVPLSERGKYQGLIGALFGVSTVVGPLLGGLFVDHLSWRWAFYVNLPLGVLVLVVGFLRLPGVRTTAKPRIDYLGILLIALAATGLTLVTSWGGVEYEWASPTILWMAAGSLVALALFVRVELRAAEPMLPMRLFRNPVFTVCCVLSFVVGFAMLGGVTFLPTYLQYVHGASATQSGLEMLPLVVGLLVASIVTGNVISKTGRYRVFPILGSLLMVAGLLLLSLLDVDTAFWEASAYMLVLGLGVGMCMPVPVVVVQSTSSYEDLGVATSGVSFIRTLGSSFGVAIFGSIYASNLPEKLAAALPPGVDPRAASNVQALHALPDQLKAPIVAAYAETLQGVFLWAAPVAAVAFVVALFLREVPLRDTARAAATGNNGVGESFAVPQSTVSSQELEKLVALIVSKERRDPTPEVLAGSGLPLTHAQAWLLVKVFRQSAHRGAATLDRLAAETKVPPGIFEPVARQLMTKGLLTESDDDYRFTPEGSATFARLVSSWRDWLHVKLVDWQCDDPEFTEAVDRVAADLVITSQSLTTRHPTPV
>fig|1179773.3.peg.3149 Multidrug resistance transporter, MFS superfamily
MAQVRTGPRRLAVVGLYAGGFLGPFGGAMTSSVLPEIGADFQVSAGAAATTLTGYLLPFAGFMLFSGTVGERWGARRTVRIAYLVYAVASVLCAVSWSFPVLLGGRALQGVANAFTTPLLLAAIAAVTPKERLGRALGVFASMQAAGQTSAPLVGGLAAEASWRWAFVGAALVAVLLAAAGVPADPPRTEQPPRLRTAWRPEVLRLAAAGFVGWGCLGGVSFLVALRLGDDFGLGAGERGLVLTGFGVVGIVCARLTGWMIDHVGPRRCVLLGTTVGSVLLVLIGVLPSLVAVGVLWAVAGAFSQAVIVGLSALVLGRGGNRGGAISVLQSFRFLGGSASPMAFVPLYHLSPAASFLAPAALVLLIPPALLLWRGRDRS
>fig|1179773.3.peg.3266 Permease of the drug/metabolite transporter (DMT) superfamily
MSSAVVRTRLAQGPLPILAACFLWGTTGTVSSLAPSSAPASAVGAAGLVIGGLLLFLTARGTRDVLRTADRRLLLLGAVTVAGYALAFYPAVARTGVAVATTVALATAPIVLGIKTRPLVTLTAVTGCAVLVLGGGDAHVDLVGVALALVAGLSYAAYSVICAHLIALGHPSRAVVGTVFGGASVITLPVLLLLGVSWLGTYGGWAVVLHLSVFTTFVAYLLFGHGLRHTTAASATTLTLAEPAVAAVLGVLVLHERLPLVSWCGMALLGVALLTLARR
>fig|1179773.3.peg.4170 Permease of the drug/metabolite transporter (DMT) superfamily
MLNRSVVRMGLLALLWGSVFLWIELALTGLTPVQITVIRCALGTAVLLVLAGFGRQKLPRDQATWGHLVVAALFCNALPFVLFGIGQQTVDSGVAGVLNATTPLWSVLIGLALRTEPRLTPARVGGLVLGFAGVVLIFAPWQRDGLASWGALALLGAAASYAVAFTYMGRTLVGRAGPMAISAGQMAAATGLSALGLPLSGPAHPNATALVAVVILGVFGTGFTFVLNYRIIEEEGATSAATVGYLLPVVSVGLGALVLGEPLTPRIVAGMAVVLLGVALTRSAAAKPPQEGSAPRPSPVLPTERDQPGGHSTEPR
>fig|1179773.3.peg.4465 Permease of the drug/metabolite transporter (DMT) superfamily
MLSPSRAGLGWGLVGVAAFSFTVPFTRVVVGGGMSPLFVGSGRAVVAAVLAAGALAATRQRLPRGGQWARLAVVAGGVVVGFPLLTSFALTSASAGHSAVVIALLPAVTAVIAVLRGRERPPRSFWVMAAVGAAAAVVFASLRGDGIGGPHWSDLLLLGAVLAAGIGYAEGGLLARELGAWQTVSWALVLSAPLMAALAGFAVVRQPPTGTPGEWAAFGYLAVVSMFLGFFAWYRGLAIGPMAQVSQVQLVQPVMTICWAALLLGEQLTWSTALGGVAVIACAAVAVRARLGATQVGTGQGLPVDREG
>fig|1179773.3.peg.7039 Permease of the drug/metabolite transporter (DMT) superfamily
MRWAALGVVYVVWGSTYVGIKFAIETMPPLLSAGTRFLAAGLVLALIVGRRLRMTWPQFRTAALLGLLLPAWGNGLVVVAEQSVASGLAALLVASVPIYVVLLRRLGGERPPRVTYVGVAVGLVGLAVLLLHDVGGSSWWGPWAVLLAAFGWALGSYLNGRLPTADPFAMSAVEMIVGGALLSLVGVVAGESVTLSEVSTTSWLAWGYLVVFGSLLAFSSYVYVLGQLPVSTVATYAYVNPVIAVLLGVWLADEQFGPWQLAGGLLVVVAVVLVVRAERKCRTEVGVSEPCRR
>fig|1179773.3.peg.7074 Glyoxalase/bleomycin resistance protein/dioxygenase
MGGATFPDMTLTIGMITIDTADPHKLAEFWTKALDTEVRHDWGEFLIIGPAVEGGLQLGLQRADDIAPGKNRVHFDAHVPDRAAEVARLVELGATEVAEHTVPGLTWTVLADPDGNQFCVGQPG
>fig|1179773.3.peg.7126 Permease of the drug/metabolite transporter (DMT) superfamily
MKPGHAALAVLTTTIWGVNFVVIKVGLDEFPPLLFSSLRFLAAAVPALWLVGKPRVAWKWIAAVAATLGVAKFGLLFLGMSEGMPAGLSSLVLQSQVIFTIAFATVLLKERPRPVQLVGIAIAATGIVLIALDYGLTSPISALLLVVLGAIAWGLSNVATRYAKPPDALSFIVWVSAFATLPLLLLSVIFEGPSAIITALGNASWAGVTSLLFVAWVSTLFGFGVWGFLLREHNASTVVPFALLVPVAGMFSGWLFLDENLSPVRLGAAALVIAGMAATTIPRPARVLTPVP
>fig|1179773.3.peg.7154 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLQAAIDFYTGLFGWTYADIAGHTVAVVDGLPVAELLPADGGFGWTLYLNTPHARATAEKAHSIGGHVLREPDEVSTLIADPTGGVIGFRHVPPDWLFGTDGHGAYAWAELNTRDGAAADEFFQELCGFEMTQIGDGHAVDYTIWAVQGDTVLGRQRMGSAFTPDTPTHWMVYFTADPEIGTDSVASRVLELGGRVTVEPYDSPFGRVTVVTDHTGAAFSVIDPSRVVPLSEEDTGAPVDDPYDD
>fig|1179773.3.peg.7198 Quaternary ammonium compound-resistance protein SugE
MHWLYLAIATVFEVAFALGTNATKGFTRLVPSIVTLVAAAGGIYFLSLALRTLDVGVGYTIWTGIGSVGTVVLGVLLFKERLTGARVLCFGAIVLGVIGLRVAAGV
>fig|1184607.3.peg.886 Permease of the drug/metabolite transporter (DMT) superfamily
MRLRDVLTTAVAPTAWGSTYFVIRHWLPAGIPLTGAALRALPAGLLLMLLARQLPRGSWWWRTALISGLTVGGFFALIYVAGQRLPSGVAATLMASSAIVLLVMGQVLLGEKAPLRKYVGGFGGIIGVGLLVGGASLTLDPIGVAASLLAMTSSSLGFVLTKRWQPPVPPLTFAAWQLTAGGLMIAPVALMIEGNPPPLEMSAVVAFTYLVIIATALAYAVWFHGLQRLPAGTVGLIGLLNPLSGTLIGLLAAHEKLSTLQVAGTVIILAGVTAGIDRKPEERGEISMESTGEKPAVPHAEKTPSDSELLCTKQ
>fig|1184607.3.peg.1886 Multiple antibiotic resistance (MarC)-related proteins
MNVIDGAVFGSVFISLLVILDPPGALPVFISLTKSYTRQERLLVAARAAGVAFGLLLTFALIGKEILDYLKISVPALQISGGLLLLIIGLELLMGKEADPTEIGRTHVALVPLAVPLFAGPGVIVTIMVSMQRATTAGQRGAIILALAAAMAVVYLSMRYAGAIHRVLREGGTILVSRIAGLLCSAIAVQMMADGVIGFVRLV
>fig|1184607.3.peg.2153 Multidrug resistance efflux pump
MTSSCFFINLPLIPLFFQSFEGAPQILLGPTLAISFALSALLGPFWGRLADQYGYRLMMQRASGLLVLTYVVTALVPNAEALFVARVLNGLASGFIPAATAYAIRATGEHKRNRTLTTLSAARNSGAVFGPALGALFAAWWGFRAAAGRKASKSSGARCPMRADPPPVVGSGGFAEGHSRKMGGGGYLIE
>fig|1184607.3.peg.2631 Permease of the drug/metabolite transporter (DMT) superfamily
MHLTVLAYVFCLVVWGLNFIAVKIQGTPVALEVSLTYRLAGAAVMFLCLAFVVRPSGRPSRQDLRGIITFGLCNFALSYLFLYYATIWSSAALVTLLFSLKTVMTPIALRISLGDRLSPRIMIGGVLGIVGVGILVYPMLAGGAQVASLKGVGFALIGTLLTAVGDASSARNARQGVDPVYSNSIGFIAASLLLLVVCLVQGQKFDIPMSISYLGALAYLTVAASFLAWFFYLKLVERIGAAVSSYMVALFPAIGGLASVAIGESEPSFHLLFGCLFSCVGAAVALGLGRVFSAARSRLP
>fig|1185876.3.peg.865 Small multidrug resistance protein
MQAWFFLLIAATFETAWTYSVKYMKFTDLKLLRWHNFYSPQIGLPILAPIVGYVVFGIANIYFFSMAIKQIPTPTAFAVWTAMALILIKLVDVFIFHANWSVTELFFLMLIGIGIVGLRLYAAA
>fig|1185876.3.peg.1011 Glyoxalase/bleomycin resistance protein/dioxygenase
MATQQFYAHQLLLPMVSYTYWSATFRVGWSELVFRQTNKPVKPYHFAFNIPLYSLEQYQNSFQLPYIDTSPSHCKVAYFPKWKARAAYFFDTNGNLVEFIERQDAGFIEPAEDIFQGISEIGLVTNDVPATTRQLSRQFGIGQFLKSQPMNDFNAIGDDYGLFILAKTGRNWLFTDVPAAQQQCKVVFQTDGEQTHSLRI
>fig|1185876.3.peg.1913 Glyoxalase/bleomycin resistance protein/dioxygenase
MDAQLIQTLQATHIAAWNEKDRTKRATLLQSIYADTITMYDKELVLHGIEAVSDFIEKLQREDPAFQFSAAKPIESVQNGVRLYGHIDTAQGRLNSMDFFVMDEGKVLHLYAFIDIP
>fig|1185876.3.peg.2141 Multidrug resistance transporter, Bcr/CflA family
MTDVIKVGLTMTRRQQFSIILILGTLSTISPFSIDMYLPGFPAIASDLNTSIAQVQLSLTAYLVGISVGQLLYGPLLDRFGRKLPLYAGLGVYVLASLGCAVSTSIETLILMRLLQALGGCVGMVAAQALVRDLFPVDQTAQVFSLLTLVIAVSPMIAPTVGGYATVLFGWHSIFVILAVITALILLAIVYVLPNGRQADASISLRPQAVLGNFYTVIRQPQFLTYALVGGIASAAPFAYISGSPDVFMNIYKVSEQEYGWIFAVLAIAILAPNQLNHVLLKRYSNQQLVSTTLVYQSVVGFFLVLGTWAGWYNLYGLLGVLFLFLLGQGLVAPNSAALTLAPFVRHTGSAVALMGSFRMGVGALVSALVSVLHNNTALPMVGVMAGCIFSGFLILLLGQRAIRYRSQHTDVGESIAEATL
>fig|1191523.3.peg.150 Permease of the drug/metabolite transporter (DMT) superfamily
MEKLKVAGGYILICIIWGSTWLAIRLGLDSIDPIISVGIRFLLASGFIYFLMKFNDVELQVDKKSVKIYLMLAFFSFIIPFGLVYWAEQFIPSGLASILFAIMPFGVIIFSRLMMPQNRVGLSQLAGVALGFAGIVIIFSENIHIEITNYLWGMIAVLVSSMMQAFIAVAMKKHGGHLHPLSMNFLPLLIAGIVLIPIAFIFETPSRWIFDAKSVGSILYLAFFGTVVTFTTYYWLLKRMNVVILSLSAFITPIIAVVLGWLILDEYFSQRVIMGSSLVLIGILFANFKGLIKYFHMRRSRVNI
>fig|1191523.3.peg.711 Permease of the drug/metabolite transporter (DMT) superfamily
MKKSGLRYALSAVFLWSTVATAFKLTLEGMNYAQLLFYSSLTSTLIFASLIFIRRKSIGETLFSKKYIKNNIALGFLNPFLYYLVLFKAYSLLPAQEAQPLNYTWPIIISIFAVIFLKNKINFRIILGLIMAFTGVIVIATRGNILSLHFHNLFGVSLALGSSLLWGLFWTFNLLDSRKEDEKLLGSFFFGTIYTFIYLAAFGSFAISSYKYLLGAVYIGFFEMGITFILWLNALRLSDNKARTATLAYLSPFISLLFIWLILGEKLLLSSIAGLILIVSGIIIQRLNDSIRS
>fig|1191523.3.peg.1700 Permease of the drug/metabolite transporter (DMT) superfamily
MISDTKTRAYLAWAAICLIWGTTYLAIRIGVEDLPPLLFAGFRWFLAGPILFLFLIKKGCRLPGWQDIKRSAVVGILLLGFGNGFVVFSEQWIPSGLAALLITTVPFWIVGIESFYVRGSNLNMKIIIGLLAGMSGVTLIFGSNIISIFDPHYIKGVAGLFVAVTSWSVGTVYSKYNATEVHPLMSAAVQMTIAGTLMTSVSLIIGEHKNLTFTPESVAAFFYLLIVGSLIGYGSYIYAIEHLPVSFVSTYAYINPVIAIFLGWLVLDEVINLELFLSSAIILSGVYLVKRGSVEARTKLSRTDR
>fig|1191523.3.peg.1868 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKFSPAHFIGEGALLLMTIIWGGTFVIVKEALNDITPMLFIAARFSIASLLVFTFLLFKRYQLNSSALRSGFLLGFFLFLGFAFQTAGLKYTTATKSGFITGSLVVMIPALQLLIEKKKPTKGALMGTALVFVGIIFLSSGSAAPSSFLAEFGKDFNTGDYLTLICALFFALHVVYMDILSPGHDFWLLFFAQLITVAALAWITAIFFHSVSFESLYLNINGNLINGILYTSVLATFVNFGLQTRFQKEVSPTKAGIIYSFEPIFAALFAYFLLNEKISNFGMIGGVFIFGGLIISEIYDYYFNGGKKT
>fig|1195246.3.peg.249 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLPFSRFEARTILKLSGPIVLAQLTQTLMYFVDTVMAGRVSATDMAAIAVASGLWLPVVLTMQGLLLALTPIVAQYYGSKQTKPISHYTLQALYLAFIMAALLFVLMLFADIPLSRLNMDPLLREKTLDYLFYVSFGLFPAAGYMVMRNLFEGLGNTKASMWIAFVGILVNVPANYIFIYGKLGMPAMGGAGCGVATSLVFVAMFIAMLVYGYTSRSTRPYRHWPEKLWLSLKDQWQIIRIGTPIAFSIFFEVTLFACIPLVIVHLGPIAVAGHQVAHNYSAIVFMLPLSLGLATTIRVGHLVGEQNLMELKKAISTAIVLSVAMSLLTVIFTLLFRKYVAALYSPDPAVIALASSLLILAAIYQFSDAVQVVAACALRGMKITTPVFFITLISYWPIGFGLGAVLGLTNWLVEPMGPHGFWTGIIVGLTCAAIALAMVLRKQINRMEHEFKTGATA
>fig|1195246.3.peg.1888 Permease of the drug/metabolite transporter (DMT) superfamily
MALLAAACWAFGSLLSAQAATHLGAFAFTRYRMLIAMSLLWLLSFATGSWQSLQLPQVLLLILSGAIGIFIGDTALFAAMNRLGPRRAGVLFATHALFSVLLAYLFLGETLWGMTLVGSGLLVGGVMIAIAFGKRREEQHQWEASPAAMKSGVALALLSALCQAVSTLMLKPLMSEGLDAIAGSAVRMSTGFVLHLLVLLLGLKVARSYLPLTWRVFWLVAVNASLSMVLGMTLILQALKTGDAGLVALFSSVSPVLILPMLWLVYRRRPAWGAWLGALLTVAGTALLL
>fig|1195246.3.peg.1958 Multidrug resistance transporter, Bcr/CflA family
MKFVSPSLWQVMLLAAVIAITPLAIDMYLPALPLMASALATTNALVQQSLSIYLAAYALGMLLFGPLADMLGRRPLALFGLAGFLVASVALSLVSSIEGFLLWRALQAFCGAAATVVIPGIVRHLYQQHTAKGMSYVSMIMMLAPLIAPAIGSGVMYVTHWQHIFSLLALYAAIMLLLCWHFLPEIKQQSGNSARPAFFSGYQQVFANRSAWPFIAISMFASFSFFTFLTAVSFVYISYFGVSEQLFALLFGLNVSALMLANFTNSRLVTRLGPMRMLSIGLVLALLAATSLTAVNAAGLGLWFTVLSIAPLMASLGLMATNADALILMQFPQHSGTATAVIGTLRFGSGALAGPLLGLLYTGTALPFSLLMLAGTLCILGSVIWAKALGH
>fig|1195246.3.peg.2591 Ampicillin resistance protein
MTLISMLLALIIERLAVRSDAWQARPYCQAYLKLTAGSGLTKLAEHQLGRYLWILLPGLLVALLLHLLDNRLLTLVVNTLVLLVGIGCWHYRQLYKQYLNAQERGDEEAAYLAMQQIRHDSRSDIDSSNGLTLVWLNFRYYAAVVFWFLVLGAFGVITYALLRHLNEQTQTEGAEPVAASSDTFAATDDALAETETGAASTADAVTVDEPVVFAETAADTPDSSAAVAKKDALSCMLHWADWFPARLFGLGFALVGHFSRASNALLGYFLDFTASNEQVVKDVARAAEPLPEEALNGIEDTSSMVQLSKRNMLFFLAFTAILTLTGWLG
>fig|1195246.3.peg.2675 Permease of the drug/metabolite transporter (DMT) superfamily
MQNILLYLITVLIWGSTWFAIEFQLGEVAIEVSLLYRFALAAALMWLYCWYRKLDMRFSLRQHGFILLLASLNFALNFLFIYQAQQYLTSAMTAIAFTTMLLMNIINTRLFFGKPVAKRIYFGALLGIAGIVVLFWPDLDGIDFTNTSLLGLILILSGALSASFGNMVSVRNSREQMPIMQVNAWGMLYGTLVLLAAALIKGHSFTFSTEPAYLLSLVYLAVFGSVIAFASYFALLKQIGPEKASYTIVLFPLVAVVLSTLFEDFHWTSYTFSGFALVLLGNAIVLTPFDRIRALLNREQPKLAN
>fig|1195246.3.peg.2732 Multiple antibiotic resistance (MarC)-related proteins
MSVTLLIDYWLIAITALFVVVNPLTTAFIFVSLLPNANAAQRARAAKRSTLVSAGIFLLFGLLGSFIFKVFGITLEAFRIAGGLILFGIAMSMMQKGLDDGEEATGKEPQTDGKLAKDVSIIPLAIPFIAGPGAIATVMILTSEAQNVWHFITVFLAIGITTFSCYLAMIYAHVLVRYIGETGKEIITRLFGLILSVIAVQFVINGVLDIYRSL
>fig|1195246.3.peg.3045 
MSKKVYCVAQFLPKAGKEAELFKVLQSLEPNTLREDGCLQYVVTRQIQSPFADGESFPIAFNEIWADLASFEAHCQRAEIKAFFEQYCLAENGLAARWNVCIYTDEPANYDAPKLN
>fig|1199245.3.peg.872 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MIYLLIFVVVLLSCAGQLCQKYAANMMPGAGTLGARLRWIATSFLLLAGAFVAWLWVLQRAPIGIVYPILSINFLLVTLATRLLWLECISLRHGIGLLLMVSGIVIMGASL
>fig|1199245.3.peg.873 Polymyxin resistance protein PmrM
MGYRWAYCSVLLVSVAQLLIKWAMMHLPPICSPLLWVDSGHTTPLRVLAGGIIAYFLSTGCWFMALRRLPLNLAYPLLSLSYVLVAIFSLMIPAFHETYTLSRLMGVALICSGVWLIYHPSGRNNK
>fig|1203568.3.peg.324 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSQSQGLLRGTPWKAIVLFSVPLLIGNVVQQLYQFVDAMVVGRHLGVLALASVGASMSLLFLITGFAWGMTSGFAIPVAQAFGANDIKGLRRSVAAGAILSGATSLLMTLVGTIFIRPLLQLMKTPPELIDDAATFGFWSFLFMFTLVFFNFLAAIIRAVGDSRTPLVFLAIACLLNVALVIVFVAVLDWGIAGAAFATAVSQLTSVLLCVTWVRWRIPVLHMGLDDWKVTMPELREHLNLGLPLGFQTSVIAIGTIAVQVRLNDLGPNAVAAFTAAGRVDGIAVTFLASLGLATSTFVAQNYGARQIDRVKHGVRQSLVVSIIVSIAIGLALFLLGAVFVELFIGNEQPVVLNLAHDALKIYSVAYWTLGVLFVVRGALQGLGHMKPPFYSGIAELVMRVFTAVVLGALFGFIGVAWGAPLAWIGSIALLIPSYIVISRKLDERTYRSGPRTEEIEVLSAPLLAEKGVVADPTILQGESFEDVRTGPIPIVRDRGETGQFPALDETYVLMDDQSTSENPEDEQR
>fig|1203568.3.peg.848 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MPAPNLFLTYVSDVERSTDFYSRLFEIEPTFTSPRYVAFEVAPGVLFAIWTGHDENLASATPRTNEIGLMIPGPASAIDDVYEEWVAKGVHVIEEPHDDVFGRTFVIADPDHNLVRVSPVD
>fig|1203568.3.peg.1216 Glyoxalase/bleomycin resistance protein/dioxygenase
MRDATFAIRQVTFDCDDPSALAEFWSSATGCAIAADYGDFVLLDSTPALGFQRVEDPTPGKNRVHLDGGGVEREALVERLKKLGATELGSHEAPGLVWTVMEDPEGNEFCVGAPTPG
>fig|1203605.3.peg.375 Nisin-resistance protein
MNPIKKTRKVKIIIASVGIVLLAVILAAVHFIGPLFGFWLIPPSPKAHGKYAISLMDRGLHANTPQWQTKRAEALDAIGKARSREEVTPIIEDALKVAGGKHSFLTTDEQRKEDETLFELPTSQADGGVVTVHLPGYSGTSEQGQQYADTVANALTASGACGAIIDLTMNDGGDMGPMLAGLSPLLPNGEVVTFNTSLGDMVVTLEGGSVKGGGTPTKTDAGATKLNIPVAIITSADTASSGEQALLAFRGLDNVRVFGQPSAGYASVNQGFPLYGGLLMQLTVGETIARTSEHFGEIPIDPDEVVSLDEAPTTAREWLASKGCN
>fig|1203605.3.peg.901 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MMRRLGATVWVDLRRQVTEGFWLVALVVALLLAAVLRAVDVEWAVWWPVVLLADLTITAFYFAAAHVLMQRVEGTLNAQAVSPLRPHEYLASLVVSLAVLSLVEMSVLVLVGCGRRLNWFAYLAAAAVAAALYVLYGFIAVSKYPSISRFLLPSGLWTAVFAVPMLPLFGAPSGWWLWLHPLHPVVVLIQVAFGWLAAWWAVPALIVAVIWVLIGFKVASARFQRFLVGDQV
>fig|1203605.3.peg.1730 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MMQIKISDHFTFAKLLRFTAPTAAMMLFTSIYAIVDGLFVANFVGNTEFAGLNFIYPMLQMISSLGMMLGSGGSALVAKTLGEAQPERANQLFSLIIRATIVLGVVASAIGAWLVPDVARGLGATGQLLEASTLYGRIFLVGLTTMMLQAVFQSFFTAGGRPHTGLWFVIGTGITNMALDWLLIVPLDMGLAGAAWATVIASLAGGLLPLIWFLRPNPSMLQLGKAVRDWRALGKACTNGSSEMMANIAMAVVGMLYNYQLLKYTGADGVAAYGIIMYAGFGFAAILLGFAFGVSPLIAYNHGARRTDELRSLFTKSVTLVTIFDLVMTITIFLVVRPVAGLFAAGNQNLLDLTVQGGRIYALAFLLIGFNILGGILFTALNNGLLSAVIAFCRTLVFECLCVLVLPGFFGVPGIWASAVVAEVLAFLVTLSIVLGARRHYGYL
>fig|1203605.3.peg.2442 Multiple antibiotic resistance protein MarC
MELVISSAVIFTMVMDPLGNVPLFLTALRNTAEDRKKRVLVRELLIALVLMLLFLVGGRGFMRLFHVEAPSLTVAGGVVLLLIALRMIFPTPERSLRERIDDEPFIVPLAVPYVAGPSLLAMEVVLVSGNPGAIGQYLIALLLSWAVSAVVLFFSASLHKVIGEKALTAVERLMGLVLVIISIQMMLSGVAEYFSLR
>fig|1206109.5.peg.275 Multiple antibiotic resistance protein MarC
MFIEYIHSVLFFFITLLPVANPIASTTLLLTLGKKIKAKERKKQIYFATLYVGIIILVCFYAGKNILNAFGVSINALRLAGGIILLYFGFDLLFNVTEKKQITEKNHLQQSHLNISFVPLALPGTAGPGTIALIISSSSSLPSSCLIHFVIWSVTALFTLMFLICLLSANKIFKRIGPSGIDAISRIMGFILISMGVQFIITGFQNMLIVLFHL
>fig|1208365.4.peg.242 Permease of the drug/metabolite transporter (DMT) superfamily
MESKDWFLLTLLAAIWGSAFMFIKISAVDFGPILLVTLRLLIAGVVFMPLLLQRKYRLLFRSHLPGILIIGIFSNALPFTLFAFASLGATSNMLGILNGTTAFLTTVIAYFWLSESISTKQVIGLCLGFFGVIILVNPANGSATLTASLCALFGSLCYAFNGNYLQKYHANSDKKVLIGWSMLFGGILMVPIAAFNLPEAMPNLNSIFALLWLAVVSTGIGYLGYIRLIERIGAVKTSTLTYLLPVFSILWGAIFLQEKITIFIFGGFIFVMMGMYFSNTTTRVKK
>fig|1208365.4.peg.1080 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIQSLSYLLIETTDLQEWADYAKDVVGLMKNDSLSDEQNLFLRMDEKSFRFHIKTGSSKKYLAAGFSLSDKAAFDNAKSELDKAKVDYEDLGHEIAKLRCVEECIGLHDPAGNRLELSYGSKDASEPFASTQDIKGFITKGLGFGHVVFAAPNLELAHRFYIDILGFGDSDYMNFPMGPAPDAPEVKLNFMHCDNPRHHTVALYESPIPPSGLIHTMVEVNNIDEVGHGLDRAMQNNVHISSSLGRHSNDMMVSFYMQTPSGFDLEFGYDGWQVDWDNFEMQKSKIPSFWGHAFSPPES
>fig|1208365.4.peg.1253 Acriflavin resistance protein
MIKIVDFALSKARTTLALALLVIIAGSIARSSLGVAADPNIQLPLVSVSVFLDGASPEDASRLIARPLETRLRSVPGVKELSSSARLSYARIVAEFEVGYSIDTALRDIKQAVEEVKFELPREAEDPQIREYSFAMFPVMNLSLVGSASVRQKVFIARELQDRLESISEVLAADLVGVPEEVLVGIIDKSKMETYGITLNQLYNAISSNNLIIPGGAQDTGSGKFNIEVPGIFETAEDVYNIPIKVTQDAVVTLSDIGEIKRTFKDYSSFAKVNGEDAITLEIRIRVGANAIDAKNKILQTVSNFQDTLPSNLTIVKTNDETVWAEMMISELEGNIITAIFLVMVLVIASMGVRVGMLVGLSIPFCFLLTFIVLKVIGIEFNFLVMMGLLLGLGMLIDGSIVVTEYADRKISEGLNRLEAYRLASKRMFYPILSSTATTIAAFIPLIFWPGFTGQFMRFLPVTVFIVLSASLVYAMIVTPVIGSIFGQRRSTLVSGDNEETGEIVFDKISAFYGKWLRVFVKNPGETLIAVLMLLWFLGYAMYGTFGKGTIYFAEVDPFAAEINIRARGNFSAVESKEIMERVETRISSVNGIENLYLTTGSQWFNSGGDTMARGFLEVKDTGDGQFTGNQVIQDVQSAVAAIPGIIVEIKPEEGGPSFSSPIELGIFGNSEQRVASVTEKIEQYMQEEVVGLKNIRSTLPHPLIEWKVEVDKQKAAQLGVSMIDIGALVQMLTNGFKVGEYRPDDSKDEIEIRARFDSELRSLSGIKDLKVNSINGLIPISTFIELIPSQNRQSVVRRNGKFFHEIGLATESGYLPSDKVKEMGAWLEMQDFGPGINTKFRGQQEETEEVTAFLSGAALTALALMLILLVTQFNNFYQSILVLSAVFMSVVGVLTGLLIMGKPFSTTMNGIAIVALSGIVVNNNIVLIDTFNRLTREFPDLIKEDVIMKTCKQRLRPILLTTTTTIFGLLPLAVGVSIDVLSREIIIGSRVVEWWTLLASSIVFGLSFSTILTLIFTPAALILPSRIKAWLQARYGLFKTST
>fig|1209989.3.peg.264 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVGNIAQQLYNTVDSIVIGRYVGDNALAAVGSALPIFNFLLVFFVAVSTGAGIMVSQYFGAKDREKLSRSIGACITLTAIVATIIMIIGPIVVRPMLVLINTPESIIDWCASYLLILLVGNWGFSYFNILSGILRGLGDSLSALMFLLISTVLNIFLDIWFVAGLNMGVPGVALATVIAQVISAVLCAMKLKTMDYVFDLNLNMLKPKKEYVVQLLKLGLPSGLTQVIFSLAMITVQSLTNTFGEMIIACNVIVMRVDGFAMMPNFTFGVAMTTFAGQNVGAKKMDRVEEGTRQGLAIAVGVSIVITIIILIFGRYLMDIFTDTAELVDLSMKMMRILAVGYVAMAVTQVLSGVMRGAGDTMTPMWISLITTIFLRVPIAYGIAYLTRSAQYPNGRPESVFVSLLIAWVSGAVITSIFYKKGNWREKVLLS
>fig|1209989.3.peg.1147 Antibiotic ABC transporter, ATP-binding protein
MDEPTASLDPLIESEVYEDFTRIGKDKTVILISHRLSAAKLCDKIIVLNNGEIIEQGSHADLMGTKGKYYEVFTLQKHLYT
>fig|1209989.3.peg.1605 Vancomycin B-type resistance protein VanW
MRIEPIIKYKQDKLAQLFDEINKVIMVKPINAVFKTDNDIVHIITDVKGQILDEDMLKEKIKEAIWTKNQTLVIPVKVWNAEMTKEDLEKMGIRVKIAEYSTEFDKTLKNRTENIKVASEMLNGCIISPGETFSFNKVVGERTSDKGYKKAPAFINNEVIYDIGGGICQVSSTLYNLALLTDLEIVERMNHSLPVGYVPLGRDATVSYGTIDLKFKNNTGGYLLLTSEITNDKLIVKFFGNKKIDKYVELFSETIKTIPSPIIIKKDFNLEKGEIRIEQGNAGYVVNLWKRYANEKNEHKVLISSDTYNPTPTLLYVGEKVKEITDDKNINATIIP
>fig|1209989.3.peg.3085 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYSNGINSKAFAEGKVEKVLLRFAFPAIISLLVSELYGMVDTFYVGRYVGPNAIGALTIAFPIQRLLSSTGLLIAAGACTKVAKYFGEKDYENLKITITNAIMLTVAVMTLMPLIIYIFMEPILLRSGASSVTLPMAKTYTAIILIGGIFQGLTFVTCYIINSLGNPKVTLYATSFGAVFNIIIDAILVINYNMGVKGAAIATVVSQIAACTFAMYNFYKVARSINLKNNFSIDIEILKSIIAIGFTTFIIEISDAIVAVVLNNVLFAHGGDRAVIVSGTIMKVSMLMYVNIIGIASAMQPMVAFNYGAKNFKRLKETIRKTLKVVILTSVFLWAIMMLFAEPIIGSFVKDEALMKECARAYRIMISIFPTIGLYYISTYVYQAMGEAKMSFLLSIYRQLVLFIPIVLIFVKHWSVIGAWLAYPATDIIAAITGFIYIRRVKEDINEYVDRAEAARLIIDS
>fig|1215343.11.peg.599 Modulator of drug activity B
MNKVFILNAHQYYGFSSGKLNAAIIHHIDEHFKRKGFEILHTHVMDKYDVKEELDKHLWADVIILQTPVYWMGVPWLAKKYMDEVYTAGVDGILCKHDGRSSKAPKDNYGGGGCAIGKKYMLSLTFNAPKEAFDDPSQYLFQGKSVDDLFYPYHMNFRFFAMEPLPTFSCYDVVKNPEIENDFKRLEEHLNTVFKK
>fig|1218108.3.peg.29 Tetracycline resistance element mobilization regulatory protein rteC
MKYFLQNILLEIHNKENKISAQSKRLIDEAYEMTLYLQDLLFSVKKYIIEEGFKNDAEEIHFFHTIKPQILGKLIFYNKVYRIETTCPVSNGKMYYSYFSTQFANLKREYIEHICNSDFYRYYRSGRTDRDDTYFKRGNINYQDGLNSIVFEIDPAFSTFFDYKIARIIANELLYSYLLTKINPDEGPDMILQKQESSKDIFWTDSKNALIELVYALHASGVISHGKIGIRKISLMFQILFHIPLGDLHHSFHRMKTRAGSRTAFLDQLKISLEEYMDKDL
>fig|1218108.3.peg.46 Tetracycline resistance element mobilization regulatory protein rteC
MNDFCKNIIRDLDDEINELSIEFNDSLALCEKAIGLTIDKIAKLKQVVLKRGFKDIEEEIHFFKHLKPNVLSKLIYYNSIYKIETKKPYGGEKVIETHLNNELFNLKRFFDNNLEFYKYYRTNSTYLDHKYFVRGKYDIKLSLDTYYFESDHSFSTSHDYKVAKIIANDLIQVYLEDNLSNNIRYSTLKSAEKIKSTLVWTASKTALIELIYALHTQGVFGNGTIDIKVIATYFEQTFNVNLGDFYHTFLELRNRKTNRTKFIDTLKEGLLRRMDEQEEK
>fig|1218108.3.peg.434 Membrane fusion component of tripartite multidrug resistance system
MEENNQEKKKINSKFIIVLGTLIILGGGYGIYKYLHGQAHEITDDAQVEAKITPVIPKVSGYIQKILVEDNQMVHKGDTLVVLDGSEFALKLQQSQDALSQAEGQLGVAHAGVSQAGAAIGVTEAGAVAANTTIETAQANVNTAQANVEAAKVQVWRTKNDFDRYNKLYQNQSITKQQYEQALAAKETAEKQLRVVQEQLGVSKAQLASTAKQAQATAKQVNTSKAQADASRAQIKVAEATIGQSKTNIENAKLYLSYTYVIAAEDGQVSKINLQPGQLVQAGQSLFNIVTVNNLWIVANYKETQLEKIREGQEAIIKVDAYPNHEFKAKVTSLSPATGAKFALLPPDNASGNFVKTVQRVPIKIEFTDKKDEMLKLIRPGMNVEADILLKSNTSVK
>fig|1218108.3.peg.435 Inner membrane component of tripartite multidrug resistance system
MEENNLIEYGSRRVIITITAIMCALLEIVDTTIVNVAMNDMKGSLGVSLTDIAWVVTAYAIANVIVVPMTSWLSQQFGRRNYFAVSIIIFTAASFLCGNATTLWEIILFRFIQGLGGGALLVTSQTIITESYPPEKRGLAQAIYGMGVIVGPTLGPPLGGYIVDNWSWPYIFYINIPIGIIAVLLTLSFVKSPKYAEKSKLSQVDFLGIILLAIAVGSLQYVLEHGQQDDWFSNSTIVILSISSFFGFILFIWRELVFDHPIVNLRVLKDNNLAVGTILSFVLGFGLYGSTFIIPIYTQSILGWTATDAGLLLIPSSLMTAFMMPIIATLLQKGVEPKYLVAGGFFIFFCYSFWSFKILTPDTGSEHFFWPLIVRGVGLGLLFVPITTLSLSNLKGQQIGEGAAFTGMMRQLGGSFGIAIITTFISRWTVGHRTDLVSNLDTSDFDVQKHVQSLQMSFIGKGFAPNEALNKAYNLLDLQVTKQATVLTYMDVFLYLGVIFLICIPFILFFIKKGAGKVISAGH
>fig|1218108.3.peg.687 MCBG protein-like (microcin resistance protein)
MGTNYHCEEEFLKLNFTETQNLSGDYENCKFINCELNGLDLSDLKFIACEFIECNLSNTILNNACFQQVDFKNCKMIGFNLETCNPFGLNVNFVHCVLNDSSFYHLLLKKSRFIECSLQNVDFSYTDLSNCFFDHCNFSDATFDQTILKQANLKTSYNFRINPNENQLKGAIFSKENLIGLVQHLGLKIE
>fig|1218108.3.peg.735 Acriflavin resistance protein
MIIVLFTILTLGGLFSYTQMGYELIPKFETNVVTISTVYPGASPNEVENSVTKKIEDAVAALENVKKVESKSYESLSVVMVTLNSDANADLALNDAQRKINAIEKDLPDDVDPPSLTKFSLSDLPIITAGVTSSKLTEKDLYDLLDKKIEPVLSRVTGVAQVNLIGGQEREIQVSLDPVKLKGYGLSVPQVQQAILTSNLDFPTGSVKTRENSTIIRLSGKYKSVDELNSLVISSMNGIQVRLSEVAFVQDSQKEVEKIARVNQSSAIIVQVVKQSDANAVAVSELMKETIQKVEADYKKEGLKIQIVNDTSDFTLAAADHVIFDLVLAVVLVAIVMLLFLHSIRNAFIVMVSIPASLIATFIGMYLMGYTLNLMSLLGLSLVVGILVDDAIVVLENIYRHMEMGKSKIRASYDGAKEIGFTVTAITLVIVVVFLPIAMSSGLVSNIISQFCVTVVIATLLSLLSSFTIVPWLSSRFGKLEHITGKNIFEKFILWFEKQLTKFTHFISDMLEWCLKSTSRRIGVFIGVFIVLFGTIGILMGGKYIGGEFFPKTDKGEFLVQMELPKDATIEESNFVTQKAEKFLRGKKEVVDMITTVGQSSEGFGAAQATAYKSEIDVILNDKSEREDNSFIYAAKVKRELQEELVGVKVKTVPVGLIGAEQAPIALVVTGPNLESAMKFAELAKHELEQIKGSSEVKLTTEAGNPEINVQVDRDKMSALGLNLQTVGLTMQTAFSGNTDGKFRAGEYEYDINIQYNDFNRSNINDVRSLIFVNDKGQQIRLDQFATVTQSSGPSFLERRDKTPSVTVEAQSVGRTTGDIVTDFKESLKKIDNKKPTGVSYVWGGDEENQSEGFGTLGYALLAAVILVYLVMVALYDSFIYPFVVLFSIPLSLIGVFVVLALTNNSLNIFTILGMIMLIGLVCKNAILLVDFTNHRKEAGETTHNALVQANHARLRPILMTTIAMVFGMIPIALAKGAGAEMNNGLAWVIIGGLVSSLFLTLIIVPVVYSLFDSAIRRFSKGEKVDYEAEMVADYEARQIKEEWEE
>fig|1218108.3.peg.760 Permease of the drug/metabolite transporter (DMT) superfamily
MENKNLLKGVLFVAMGSSFYGMLATFVKVAYDQGYTTAEVTASQFVLGIIILGIINLIMSKKNKNTPAVKPKDKRRLMLAGTSLGFTSLFYYLAVQYINVSIAIVLLMQTVWLSILVESVLSKKIPSAKKLVAMLLVLAGTVLATNLINQEIELNPKGLFWGFLAACSFTTTMFTSNRVATYLPPYKKSIYMLFGGGIIVALFVFFSQLGPYYFSGLMDLYRNFSDDVTSIHPLNLEIFFTWGLFLSLFGTVLPPILLNKGFPNTGLGLGSIVSSIELPVSVTMAFIVLQEQVLAIQWTGIAIIIFAIVISNLNFKKN
>fig|1218108.3.peg.777 Drug resistance transporter, Bcr/CflA family
MNNQNKSFLWLIIFLIGFPQISETIYTPSLADLAKTFHVSGNQIQQTLGIYFIGFAIGVFCWGIISDFIGRKSSMLCGILLYILGSYLCLISKSLEFLLFSRFIQAFGAAAGSNVSQTILRDVCTDKERMVIFSKISAVLAFSPAIGPLLGSVVAEIWNVSMVFKLLLLIGVLAFLWSSISLKETLNRDIKITDSYKSIVISICKDRYFWLYGTLIGTINGVIFSYYGEAPFIFIEDYHFSIIEYGCIGFIVAAACFSGANYCRKKIGLIDAKQILNKGNLFFFTGIAGLFILNFLPLKEKVNVSFLLAGIFLMMFGLSVILPICLSNALNNHKAYLGIAGALLGLFYYCIVGGLTIIMSMLHGTSAIAFPLFLFFCFLMNAFVISRLK
>fig|1218108.3.peg.1103 Multidrug resistance protein B
MKKILKIYIDAYSGLSQESWMLAIVMLLNRMGSMVLPFLGIYMISELGFSLESSGIVLSCFGVGSVIGSWLGGWITDKIGNFKVQAISLFLSAPLFLILPYFKTVESFAVIMLVLSTISEMFRPANSVAITRYAKKENITRAFSLNRMAVNLGFSIGPSMGGFLSNYSYDLLFYCNAGAALIAGVVFYVFFKGRKERNAATETTSEKVIIEKERNAYTDTPFLMFNLFCVLFSVAFFQILNTLPLFYKDVVHLTQTEIGLLMGFSGFLIVVFEMLLIHYTEKRFSVTQLLVFGSFITAISYFIFTFSHTLGMLYLAIGLMSIGEMLVLPLMSTVTAFRSQKNNRGAYMGLNGMSVAIAFIISPFLGTHVATDYGFSTLWIITTIVLIIVAIGYHFFTKPLLPKNI
>fig|1218108.3.peg.1323 Permease of the drug/metabolite transporter (DMT) superfamily
MILGVLALTWGSSFILIKQGLVAYTPYQVGALRLSIAGGILAIWGIPSLFKIPKNKLRYVALAGFCGNFIPMFLFPMAQTHVSSSMAGILDSLVPLFILLFGALLFNIKGTKNQVSGAVIGFLGAVLLIGGDGFSGENSLVHCLLIVLATALYGLNSLILTRYLNDVPSFQLSSALFTIWLLPSIVILFFSGFFDTFEGTEQQLKSLGFVTILGLMGTALAMILFYRLIQATGSLFASMVTYLMPIISVFWGFLVGEKITWFHLVGFAMILSGVYLTQKKEKKVEIV
>fig|1218108.3.peg.2106 Permease of the drug/metabolite transporter (DMT) superfamily
MKGNQPSKWLIIAAYFVVYVVWGSTYFFIDKALHGFSPFILGSFRFIAASTILMGYCKLKGYKLWDKQIVKQCMFTGFMLLFIDMAGIIWSEQFLPSGIVAIMAASAAIWFIVLDKPKWKQNFSSIPTILGVLLGFIGVLMLFYEQTTTAHADADQQFLNMIGLIVLIFCSIAWTLGSLYSKYVTEKQKKEVTKPKEELNIMVKTAWQMITAGVLFNTVAMFNGEYANFNLENVATEDWLAMAYLVTFGSILAFGSYVWLLQHRPAVEVSTYAYINPIVAVALSYFFTDDIVTHLQIYGLAVILFSVLLMNWNLYKNTKLVQKILHFVSRKHYAH
>fig|1218108.3.peg.2182 Permease of the drug/metabolite transporter (DMT) superfamily
MKFKGYAYGLISSISYGLIPLFILPIKQANFSIDTTLFYRFFFSALIVGVYLFVKKQSFRVHSKQIPVLIVLGLLYGISADALFLGYDYLSAGIASTLLFVYPLIVAIIMVVFFKERITISTIAAIAFVLAGIFLLSFKDGQFKLNPIGLGIVFISALGYGLYIITVNKSSAREIKGFTLSFYSFLFTTIYYAIKMLIQKESFILPSLELTFNFFTFAFVTTVISSIALIFAIKNIGSTATSILGASEPVVAVAVSVIIFGENFSMSLALGIFMIIFGVTLNVVGDAYQQKRIKSS
>fig|1218108.3.peg.2434 Bleomycin resistance protein
MFLEIHPKLPMRSKEITFKYYVDHLGFVPFLNDLEDYFMVRKDGIEIHFFKFEELVPEENYGQVYIRVADIELLYETFVKNKIQIHPNGKLQVKPWGQIEFSILDPDHNLLTFGQAV
>fig|1218108.3.peg.2748 Permease of the drug/metabolite transporter (DMT) superfamily
MKDIKLLIAISIVAIVWGTTFLGIRVAVETIPGWFVAGIRQFIAGIIMFILLLYKKELKWIGWKNLSYQLIFSSLMLIAANGLTTVAEENLSSSLAALISATSPILVFLGSIFIGLQKFSFKGLIGVLMCFCGVLFIFWDGLQELANPEFRTGILLLFCAITGWATGTIFTKKMNIQSKNISLNLFYQFIFAGIIQIIFAFIFSDNYNFGNWSTKSISAMLYLAVFGSVITFFSFHYALTKISPIQVSILSYFNTIIAIVLGWLILDEEISKKFIVATILIICGVFITNYKPEIFKKK
>fig|1218108.3.peg.2967 Membrane fusion component of tripartite multidrug resistance system
MGKQQTKGEKRMNRMLSVVAWIFITIGILAIAWFYFFSRSHVNTNDAQVRQYITPVSSKVSGFIKKVNFDENQFVHKGDTLIVIDGREFQNQIDMAEANLASTAQSVLTYEKAVETKASDISIVTANIEAAKIEVWRTEKDYNRFKNLVEEDAATVQQFEEIEAKYKQAKANLSALEQQRNAVSVSTSAEQTKVAPVRTQILQRKAQLNNAKLTMSYTYIIAPYDGWVGTRNIQQGQLIKEGQALVQVVSKEKWIIANFKETQIGEIDMDKPVIIKADAYKNLEFEGKIKSLSPASGSEFSLIKPDNATGNFVKIEQRFPIKIMLKDSKNNEKLRSGMNVIVSTEKLEN
>fig|1218108.3.peg.3026 Glyoxalase/bleomycin resistance protein/dioxygenase
MKYAYTIVYVKNVTETIAFYTKAFAFETKFITPENDYGELISGETTIAFASVELGNSNLKKGFTAIEKSAKPFGVELAFTSENIETDFKTAIDAGAIEFEPLTEKPWGQKVGYLLDNNGFLIEICTPIAH
>fig|1218108.3.peg.3031 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRQKQIILNDNLPKVMWELSWPAVVAMVLYGLNNFLDGIFVGHLISNTALAAVGVAYPLAQFAQGFGTLIGTGIGSAISIWIGAKDSSKLEKAFGTVNYLTLLFSVLITIPCYIFADKLVYMMGGREEILTLGVEYFRVTILGSFFWIHGLALNMIIRAEGRMKTAAWMIAVGLVVDLALKPLFIDTFGWGVAGAAWATNISMIIYTLLGIWYYAGGKSSFKTKFWSLKKEKEIMKETLSLGTPGFIMMIMIVIQNIVVFNALAEYGTAADITFFTAVNRFYILLNTPLWGLMRALQPVTGMNYGAKKYDRSIKAYRLFSFVGLVILLPFWLFVMLFPSEVLTIMIPDMKFLPGQLMDFRIYMSVLLALPFVFMAMVWFPAIEEAKPATLISILRQMVFYIPIMLIVPGFYGVSSIYLASAVIDWVIFFIVIFTVWKSVKKLQAKSIVTP
>fig|1218108.3.peg.3160 AcrA/AcrE family multidrug resistance protein
MVGALAMALSSCGKKDNAAQQAQGPTPYPVVDVPTKVVTSYDEYPTNIEGIVNNEVRAKIQGYITEVYVDEGQYVQAGQPLFKLETNVLTQNADALRSGVGAAQASVKAAQANVSAAQAAVNAAQVEVNKLTPLVQKNIISNVQLETAKANLAQAQAGHNQAVAALAQAKSGVTQAQANYKGAQANVDYSVVRAPVSGVVGSINSRQGTLVGPTDQTAITVVSNTAKVYAYFSMNEKEYLNFISKSEGATLKDKLNKIPPVELVLANGDIYPEKGKIQTVTGQINPTTGTIDFRVTFNNAAKLLANGNSGRIRVPKTYVDALVVPAAATFEQQGMTYVYKVKNDSAIATPITVVDNTGNIVVVKEGVKKGDKVVAQGVGKLRDKTPIKPTPSNFDQIVESTKPVF
>fig|1218108.3.peg.3265 Modulator of drug activity B
MKIFIINGGQKFAHSGGAFNNMLNNWTTDFLKEKGVEFRVTNINDEFDAFDEVENFKWADTIIYHFPVWWFQVPNRLKYYIDEVFTAGHNNGVYKNDGRSHTNPDINYGTGGLMHGKKYMVNTTWNAPETAFTMEGEFFDQHSVDEGILFGFHKMNQFAALERIDGFHFHDLEKNATHERIDAYEKIYKAHLERVIG
>fig|1218108.3.peg.3374 Glyoxalase/bleomycin resistance protein/dioxygenase
MKNYKPEQYNSLSPYLIVDNALKLVDLLVAVFDGKILRRFDREDGKIGHIEVKLDDSVIMISDSTEEYAANKTMLHLYVPDVFKTFEKAVENGCEPIEKPGDPDTRGAFYDFAGNYWAVSTQTD
>fig|122587.1.peg.167 Bacteriocin resistance protein, putative
MDFSCGAASIATLLNNFYGRHYSEAEILDKMDKTQMRASFDDMQRIMPELGFEAQGYALPFEQLVQLKIPVIVYLKYRKNNHFSVLNGINGETVLLADPSLGHVSMSKSQFLSAWKTRDGEMEGKILAIVPKNTDFVRNQMFFNKNPVRQTRFTVEQIQMRQKR
>fig|122587.1.peg.1425 Multiple antibiotic resistance protein MarC
MRRQFAASDACRTGLKEGEIMGLGMEIGKLIVAFLVLINPFSALSLYLDLTNGHSTKERRKVARTAAVAVFAVIAVFALIGGTLLKVLGISVGSFQVGGGILVLLIAISMMNGNDNPAKQNLGAQPETGQVRPARNAGAIAVVPIAIPITIGPGGISTVIIYASAAKTYGDIALIIAAGLVVSAICYAILIVAGKVSRLLGATGLTILNRIMGMMLAAVSVEIIVSGLKMIFPQLAG
>fig|122587.1.peg.1887 Permease of the drug/metabolite transporter (DMT) superfamily
MFYQILALIIWSSSFIAAKYVYGGIDPALMVGVRLLIAALPALPACRRHVGKIPREEWKPLLIVSFVNYVLTLLLQFVGLKYTSAASASVIVGLEPLLMVFVGHFFFNDKARAYHWICGAAAFAGVALLMAGGAEEGGEVGWFGCLLVLLAGAGFCAAMRPTQRLIARIGAPAFTSVSIAAASLMCLPFSLALAQSYTVDWSVGMVLSLLYLGVGCSWYAYWLWNKGMSRVPANVSGLLISLEPVVGVLLAVLILGEHLSPVSVLGVFVVIAATLVAGRLSHQK
>fig|122587.1.peg.2006 Membrane fusion component of tripartite multidrug resistance system
MKSGNSEPNLMDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFFLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAALPEMESTDWSEVDRTVDEILGQSAP
>fig|1230341.3.peg.1100 Broad-specificity multidrug efflux pump YkkD
MAWVYLIIAGLGEMFGVLMINKFHSERSVTSILLLAAGFSASFLFLALSMETLPMGLAYAVWTGIGAAGGALFGMILYGEPKDGKRIFFLSLIIAAVIGLKLVSP
>fig|1230341.3.peg.1283 Permease of the drug/metabolite transporter (DMT) superfamily
MKMRGIVLVVLAAVFWGISGGIGDILMGKGWSPLVISFYRGGVGLILFAGWWLAGKKEKPVFTPPIILFSVLAGAGVAGNFTFYFFAIEASSIAVAATLMYTAPVFVLLASFLLRIEDSTWFKWGCIIGVLLGIVLLTGAYNTDNLSGGVFGITAGLAAGVSYALFIFGFKKATAIGDPKTILSVAFLTFCLILLPFNDMTEVTYAVTSGDAGWFILLGLVGAGISFIIYVIGMRGTAPSTASMVAMAEPVTASLFGVLLLGDTLTIIQLAGMAVILFTITILSVKQSGS
>fig|1230341.3.peg.1507 Permease of the drug/metabolite transporter (DMT) superfamily
MPYFLLIFVVIMFSGNIIIGKAINDLPPYTIAFLRLVVAFIVLLPIGLRSARQYKETFFKYKKPFLIMTLTGITFFNTFIYASLQFTTSTNVSVLETIIPVVTVILSAYILKEKIYKIQWLGVFVSLLGAMWVVMDGNIFQLAAIEWNIGDAIMIGAIATWAIYSIFVKQYMPLFPNYGALLVMSGLSVLVLLPVVILEWIIHGVPAFDAGNMAGILYLGVFPSFLAISMYNLAVDKVGASKSSIFLNLLPVFTMAGAAVWLGEDVTFTQVGGALTVIAGVIVTTQGDRISRRRI
>fig|1230341.3.peg.1857 Multidrug resistance protein (efflux transporter)
MAKIPEKWLVVVSVLFGTFTVILNNSMLNPVLPRFIEIFDTTAVGAGWILTIFMVSMGMTMPLTGYFGDRFGKKKVYLVGLTLFLVGSTSGFFSSSLGMVIASRAIQGSAGGLMMPIAMALIFNSFPRNERGLAVGIYGVAAMVAPAIGPTVGGLLIQVLEWPWLFAVNIPFGLIGLLLSVKFLEQTESDPEKRFDLIGFLLVTSAIGGILFALGRGRTPEILFEPLNLGIIITGLVLIFVFVRYEIRQEQPLLNLSVFKVPTYAISILITSSASIGLFSGIFLLPLLIQNVYGLNEVWTGLLFLPAAAMSGVFMSFGGRLLDKKGPKYVLPPGLAIMGISTVGLGMLETSSPFWWILLLNAIRGAGMGMSNMPATTTGMNAIPDEYVAQGSAMNNIIRQIASSLGIVFFSIYYEVRRAQIAVGTNMQEATLQTLNEAFLVSSAVLFIALPFAFFMKGVQDD
>fig|1230341.3.peg.2100 Bicyclomycin resistance protein
MLHNPTGKERFGLALLLGMLGIMGPLNIDMYLPSFPGIARDLATTASMVQLSLTACLIGLAIGQIVVGPISDASGRKRPLTVFLFLFAIASLLCALAPNIYILIIARFLQGFTASAGVVLSRAVVRDVFDGRELTKFFALLMVINATAPMIAPMAGGAILWFPFSSWHTIFYFLSLLGLIIVFTVTWKLPETLPKERRTPSSVGASVKTIGRLLVDRSFIGYALTIGFVHGGSFAYVSGTPFVYQGIYGVSPQVFSILFGINGLAIITGSFLIGRLGGIIHERKLLQTAVITAVAATFFLLIMTITKGPLPTLVISIFIYMTCMGMVLTSTFTLAMEKQGHRAGSASAVLGMLPLLFGAAASPLAGLDESTAVPMGLILFSTSSLGLVTFFTLARPYAVKKV
>fig|1230341.3.peg.2515 Permease of the drug/metabolite transporter (DMT) superfamily
MSDRNKGILLLLISALGFSMMGAFVKLSGDLPTVQKAFFRNIVAAAITLGFVLKHKDRIFGKRENQKLLLSRSSLGSVGIVMNFYAIDNLVLSDAEMLNKLSPFILIIFSGIFLKEHARRYQIVSIIIAFLGTLFIIQPEFSVQVLPYIIGVLGAVFAAGAYTMLRVLGNKEKHYTVVFYFSFFTTVLLLPFTIFFYEPMSVQQWIFLLLAGAFATVGQFGVTLAYKFAPASEISIFFYSTVVYSALLSIVLFGQIPTLWSVIGYVIIFSASFYMFLKNNHIDKKQLARQEEKKAFRSS
>fig|123214.3.peg.455 
MIVIMTKFFVNPKHREDFKKRAIEGFGEKGIKGQKGFIKMNVLEPKNFEGMPPNDVFIIETYWESEEDFIRFTESEAFKKAHEEPPPKEWFTTFPVVEVYEVIKEVKE
>fig|123214.3.peg.958 Glyoxalase/bleomycin resistance protein/dioxygenase
MDKLPEDENSIEKGVIFRPHHVSITVKDPEKSRNFYKLFGFKEVFRWSDSSTTVIHMKLNDLILEIFSFKETESSSDQRESLEEELKIIGVKHFALRVKDIQKAKKFLSEIGIVPENTRINKGRTGILYFFIRDPDGIFVEIVQDDRNI
>fig|123214.3.peg.1176 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKKILHLAIPAALTNLLDTLQLLIDILMVGRISPEAVGAVGLSGQLIILIYSFISIFYIGTNVLVSRFYGEKKPEEAGKAVSGLLIISVLFSLPFFIYTYEFSGSYFSLMGAERSVINLGTDYTSILSLSIPFLFIGAVLYSSIVASGDTKTPLIISLFTNLLNTFLNYCLIFGNFGFPRLEVEGAAIATTISYILEVLIYFFIFLSGKTGIKPELSLSFHYVLKALKVGIPAGIEKFVSFGSFLIFVKIVTGFGTYVLAGYQIGLRIEGLAFMPGFGFATAAMVLVGQYMGAKEPEKAEKSVIQTVKLAGLFMGIVGVFFIVFPEFFVSLFTDNIKTIREGSLYLRIVGVSQIPLAVDFVLNGALKGAGATKVTLIINSLSFWIFRIIPAYISAKIFNDILIVYIVMTIETFIKGFILWTVFKSGFWKKIKI
>fig|123214.3.peg.1496 Acriflavin resistance protein
MEDKNRSYGLAGRIARAFIKSPLTPLMVLASLLLGLFAVLTTPRDEEPQIVVPMIDIIVPFPGSEADEVDKLITKPLEKIMWEIPGVDYVYSYAGDGFGVTTVRFYVGEDPEDALVRLYSKLMSNYYRMPQGAMEPIVKPKSIDDVPILALTFYSDKYSSYEIRRVVEQVEDELKQLYNISETTILGSKPKSIYIYFDPSKLNAYHILLPQVVQALQYANSSLPSGEFDKGNYRFKLRTGQFLNSVKDVENVVIGVYNNKPIYIKDVAKVEIGEGEVTNIVQFGYGIRGEGDKNKLYNAVTLAIAKKTGSNAVVVAEKILEKLETLKGKVIPADIHVKVTRNYGETATEKANELIEHLLIATFSIVLLIAVTLGWRESLIVAVTIPVTLAIALFLSEMYGYSLNRVTLFALIFSIGILVDNSIVVLENIHRWFSMRKLPNEKAAIVATDEVGNPTILATFAVIVALLPMAFVSGLMGPYMRPIPINASVAMFFSMLIAFILTPYLALRWLKHDHEHESPEALEKEDEARAGILAKLFERIYMPLFLSRIKRYIFLGFMGLLLVGSVWLFVERVVLVKMLPYDNKSELFVVLDMPEGTPLEKTYKVAKEIAEYAKNVNEVENYVIYAGIPAPFDFNGLVRHYYMREGTHYAMIKINLIGKHERKAQSHQIAERIRGDIERIAKKHGAKYVAVVEPPPGPPVLSPIVAEVYGPDYKTQLKIADEIKNIFEKAEGVIDVGIYANLPQRQYILKPDREKIKRYGFNEDMIVKTVRIALAGYSVGFIHSAEDLNPVNIVVRLDEKYRTSINDILSMKIPTPKGAIPLGSLVTVKEGSAKNDIYRKNLQKVVYVIANVDDTVGSPVYPIVDLSEKIRNIKTPDGKGVEILLTHQPHLEDRYYVKWDGEWQVTYETFRDMGIAFAVALIVLYILLVGWFGSFKMPMVIMSPIPFTLVGIVPGHFIMGAFFTATSMIGFIALAGIILRNSILLVEFTQQKLQEGYALEEALLEAGIVRTRPILLTAAAVVVGAFVIIFDPIFNGLAIALIFGTIASTLITLVVVPVLYYMIVGKTAVKLDMPPAVPVDEKPEK
>fig|1234409.3.peg.194 Permease of the drug/metabolite transporter (DMT) superfamily
MKEKQKGVLLAIIGALCWGIQGPISQFLFQEITLPTEWLMGVKMTLAGILILLFTAWKEKKAIFGPFKNKKDTIQLLLYAYVGLALVQYMYFLTIKASDAGTATILQSLGTIMIIIFTIFVYHKWPNRNEWIAVVVAIIGTYLLVTQHGTLAITKKALIFGLLLAFGGAMQTMLPVQLLKKYSSFTLLGWGMLFGGLLFSIIHPFWENTPEMNGMTISALIFIVLFGTVLSYICFTTSLKYISATSAGLLASFEPASATLGAVLFLGTSFTGTQVIGALLVLSTVFILALPIPKKKGEQ
>fig|1234409.3.peg.437 Drug resistance transporter, EmrB/QacA family
MTKQRKLIVTIALFIATFMSAIEGTIVTTAMPTIISSLDGLSVMNWVFSIYLLMSAIMTPIYGKLADLKGRKIIFIIGILFFIIGSSLCGLSQSMEFLIFSRAIQGIGAGSILPLSLTIIADLYTAEERANIMGLNNAAWGIASIIAPLLGGMIVQYLNWHWIFLINVPIGIIVIGMVFFGLKENRNNFNSVGKLDIKGAALLMIFLLLFLYAFQLFGDQGFKAPVFLLLIISVIILLLFIRIEKVTENPIISPKLFNSKSVLIINCVTLCVSGFLTGIDVYTPMWLQTLNGSSATLSGLALAPMSIFWMVGSFLAGKLLSRLEVKKILLIGSSLLFVSTIIYSIYPISTPYFVFCIIGVLLGIGFGMSITTSAVAIQESVETKLVGSATSLNTLFRTLGQSIMVAIYGTVLNMSMNSEMTKYPQIHQEDLNRFMNVQEVHNVPTGILQSLRSIMYNGLHHIFITSVVIMLLSLVFLLLWKAKNTNKNEKNEK
>fig|1234409.3.peg.481 Quaternary ammonium compound-resistance protein SugE
MYLLLLALAGLCETVMVYTMRKSAGFKVKSWSILTILVAICSLTLLSIAMTMTEVGIAYGIWVALGSVGSLLVGTILFKEHLNLGQWIGIICIIIAVIGLKMTV
>fig|1234679.3.peg.310 Drug resistance transporter, Bcr/CflA family
MKKSIETKVKAPALLLLIVLVGFPQISETIFTPSLPDIALAFQTTMGSVQLTLSIYFFAFALGVFFWGLISDYIGRRPAILYGVVLYGVGSCLCLWADSIEFLLFARFVQAFGASTGSVVTQTILRESTTGNQRHALFAQISAALAFTPAIGPLIGGFVDQYWGFSAVFLVLVVMSIGVFGYAYFGLAETLDASSRSSVALRPIFKRFLKNKKVLTYGFLIGAINGVLFSYYAEAPFIFMEYFHLSAAIYGLLGIVIALALIIGSMLSKRWLAIWQPEKIIFKGIQIMLVGAVILLTLSFFNFIPGVIQFSCYLIGIFITLIGTGTALPNCLSLALVDFQDVIGSAGGIFSLYYYLLVSLITLGMSVLHNGTLWAMPLYFIGIGIFMLILTKRFIYLLKE
>fig|1234679.3.peg.479 Multidrug resistance ABC transporter ATP-binding and permease protein
MARNKFDVDEELEQEFNKEHYQRLFQYVKPYKKPMLTTLFVILIANIATMLGPYFTKLVIDDVIPNKNMTLLGWLAVAFIVSVFVTGWCMRYRIQSITLIGQDMLKDMRSDIFEHLQKLPFSYFDSRPHGKILIRVVNYINTLSDLLSNGLINLISDVISVVITLIFMFAIDFKLTLYSLALLPVLFIFVMIIKNKQRKAYQVLSNKQSNLNAYIHESIAGIKVTQSFSREDENYKIFSEVSNEYRSSWMHAVKVQFLLWPGVQNIAVITTCLIYFVGIRGLGVEVSTGTLIAFIGYVNNFWNPVINIGNFYNSLITATAYLERIFETLDVEPDIKDAPDAFELPPIKGDVRFRHVTFRYEEGKDILKDISFHVLPGESIALVGPTGAGKTTVINLLSRFYDINEGEILIDGVDIRRVTLHSLRKQMGVMLQDTFIFSGTILDNIRYGKLDATEEEVIAAAKVVRAHDFIVDLKEGYHTAVKERGSTLSAGQRQLISFARALLADPKILILDEATSSIDTKTETLLQDGLDKLLEGRTSFIIAHRLSTIKNSSRIFYIDQGTVQEAGSHDELMAEKGYYYQLYQSQFDLLKEI
>fig|1234679.3.peg.567 Quaternary ammonium compound-resistance protein SugE
MGFISLVVAGFCELGFVVLLKKSEGFRLKSYGILSMIVMGMSLYLLSIASKTIPIGTAYAIWAGIGASASVLWGMIFFGESRSFKKIIFVTLIIIGVVGLKLTSH
>fig|1234679.3.peg.729 Quaternary ammonium compound-resistance protein SugE
MNRSWVYVIIGAILEVAWVTGLAHSTTIWQWIATIISVTISYGLFTLAAKNLPVGTLYAVYTGLGTVGTILVGIWLFNESIYPLKAFLMMTLLIGIIGLKLVEAKGK
>fig|1234679.3.peg.787 Glycopeptide antibiotics resistance protein
MFFLQNLYEFTESNFGDTINHFPLIKLIFYSVDRTLRYFLVWLLIRGIYLLYKHLKGTKIRVAREFVVQFFVFYVILLFQLTVFRGEYSITNVYIELRPLSEVNWQPFTETFKLTQGTSLFDFYYNLYGNIFWFIPLGFCVAYLSQNNHPFLRTFFIGLFCSIAIETMQFLFRTGIADVDDVMFNTTGALIGFVLYEVYFLLKKLFSKQKRRKEAV
>fig|1234679.3.peg.1013 Multidrug resistance protein B
MQMNKKERLPRDLWIVAIGMVLLYTGLSFIWPFNMLYMTENLGMSDTAAGTALLVNSGIGIIGSVIGGIIFDRVSGYVSLAIGTGILVLTTGSLFLFHGHPAFIYNIWAVSVAMGMVFAGLYTAAGLTHPSGGRTGFNTIYVAQNIGVAVGPFLAGFLAKDGLGNVYTGSFAFALIYALFFFVYFRKIDWHSNKVTSETKHKQKGTVRGKATKIGLISFGLLLLTYLFCQLPHVQWQSNLSTYMTSQKGVTTAQYGNLWSINGTLILIGQVLIIPLVARFKEKLSLQIYIGIGLFFCSFLFAMQAESYGGFLLGMILLTLGEMFAWPAIPAIAYKLAPVGQAGLYQGLVNGTATAARMIAPIFGAVVVANLGGITSLFIAIFILLGLAIVSLFLQQKTQKMMDI
>fig|1234679.3.peg.1082 Membrane component of multidrug resistance system
METKYQNSHIVTILGVIIMGTFVTILNQTLLSTALPSIMNDFSITATSGQWLTTSYMLINGIMIPITAYLVERFTTRQLYLFAMITFFIGTAIAATADVYWVLIIGRMVQAVGAGVVLPLQTIVILYMFPIEKRGAAMGLIGLGMNFAPAIGPTFSGWVVQNYHWSMLFYFILPFALIDIIIAFFVLKNVSEVGKPKLDWLSVIYSTLGFGGLLFGFSNASSHDFLSINVLGAILVGIVSMILLVLRCNRSEHPLLNFKVFKIRGFRLNMIISFIILAGMYGGIILFPIYFQSIRGWSPMKSGMILLPGSIVIAVMSPITGRLFDKYGGKKLAITGLFLITIMTFCIGFLDLNSSVTLIVSIQLIRSLGISLTLMPLQTGAFNAVPLDMAAHASAMFNTQRQLSGSMGTALFVVIMTMVSNSQSAVALGSPILASLKGFQFVFMVVGLFSLAGFLLTFLIREKRKNIEVDVLRN
>fig|1234679.3.peg.1742 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKRFFSYYRPYRKLFILDFSCAIVAAILELAFPIVVNQVIDKLLPTGNWSLIVTAALSLLFFTL
>fig|1235755.3.peg.47 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MIKKLAGVMLYVDNQEEAVKFWRDGLGFTVVSEEELPEGYKAVEVAPDGKSETSITIFEKAFIRKYSPELGMGTPSLMFETEDAGALYEDMKSKGITVGEMTEMAGSKVFNFKDGEDNYFAVSESD
>fig|1235755.3.peg.133 
MIKAVNTIRLKKGMADEVAEKFNQAKSVHTFDGFVFMEVLIKENTGEFDEIQVCTTWEDHSSFEAWRDSRATRKAHESQNNPKDGKAESPILGTELTTYEVHVQHHPAE
>fig|1235755.3.peg.220 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYHTDSKREMYAILMRILWPILITQILLYSMNMIDTMMSGRASVEDLAGVAIGSSFWAPVSTGINGILLAVTAIVANLMGADEKEKVHNTVTQAMYIAVAIAVIVLLSGLFFLDDLLRMMDLAADVHDISYHYLIGLSTGIIPLFLFSVLRNFIDAQGLTRVSLYVISMSLPLNVFFNYSLIFGNFGFPELGGIGAGYATAITYWLIFFIAVFMTFKVEMLAAFKLFRRMAVPSPEVMIHHLKIGIPIGVLLFVETSIFSLMTLLIGIMFTTDIIAANQIVLNFTTMLFMLPLSISMAMTIVIGFSAGGGRFHDARRYKMMGLATSLALISASSLLLYIFREQISYFYTDDPAVVAIASPLFLFAIIYQVSDALQALFHGVLRGYKDVIIPSVIAVVSYWPVGLTAGYLLAAYTALGVYGFWIGISLGLTCAAAGFFMRLFTIEKRNMFGQGESAQ
>fig|1235755.3.peg.402 Drug resistance transporter, EmrB/QacA family
MDNTTKYEYLSENSNVKTLPIMLSLIIGTFFAILNETLLNIALTTLMHEFDITLPTVQWMATGFMLVMGIVIPVSALLLQWFTTRQLFLGTMIIFTVGTAICAMAPTFPVLLSGRLIQAIGTGMLMPIMFNVFLLLYPPEKRGKIMGLVGLVIMFAPAIGPTLSGVIVEYLGWRFLFITVIPFSLFSIIFAFIFLVNVSEVTKPKIDIPSIIFSTIGFGGTIYGFSSVGKSDAGFMNPEVMVAITAGGIGIALFAFRQLRLDEPIMDLRVFKYPMYAHAVILFLIIIMTMFASEIILPIYMQGPLALSAAAAGILLLPGSLLNGALSPFMGALFDKLGPRPLMIPATLILSGTMFLMSRLDTDSQPWVILVGFMLLMISVSATMMPAQTNGLNQLPKRLYPHGTAVVSTLQPVAGAIGVSVFISIMNARQMNFLGNASNPDDPATIDQAMVAGVELVYFIAFTISIVAVIMSLFVYRAKPTDSMKMQQPDIQP
>fig|1235755.3.peg.466 Antibiotic resistance protein
MSETKQKIWTKDFTLIVIANFFIFAAFQMTLPTLPLFVQEIGASDRWIGIVVGIFTFSALLIRPTAGKMLDTKGRAPVFLTGLVIFVISMFSLAASYTIAILLLVRIMQGAGWGLSSTSSGTIATDLVPKERRGEGLGYYGLSGNIALAFGPALGLFLTDHISFTMLFSICGILGFTALMLALNIRYKKGEKPEQDPKTKDTYVPHFDIVEKRALPAASLLFFITVTFGGIATFLPVYTFQKGFDSQYIQFYFVIYAAFLMLSRLFAGRLYDRRGIAVVFVPGSLSIIAAMIMLGFLPNPAYLFIAAALYGFGFGCVQPALQAWAVNRSENNRRGMANATYFSAFDLGVGFGAMMYGFIAEAFGYSTIYFTSAFSVTLSLILFIIMMNRLNKEQSNAPGI
>fig|1235755.3.peg.904 Fosfomycin resistance protein FosB
MKVGNINHLLFSVSDLDISIEFYENVFNAKLKVRGRKTAYFDLDGHWLALNEEKGIPRNEIKYSYTHIAFSIEESEFENMYEKLENLGVNILNGRERHARDGRSIYFTDPDGHKFEFHTGTMQDRLDYYKEEKDHMSFHD
>fig|1235755.3.peg.907 
MDRINIITLGTRNIAESLEFYRNMGFEATVVGDEKVPDIVFFRASGSKLALFPLEKLAAETGIDPSHEVGFKGITLAYNAKSEGEVDQVLHDAESFGGKVTSVAKTTEWGGYGGYFTDLDGYTWEVAFGPDWEFDEDDMLII
>fig|1235755.3.peg.1356 Permease of the drug/metabolite transporter (DMT) superfamily
MSNMKKSAVTLLGVAVICIAFAAIFVKLSAASASIISMYRMLFASLLLIPIVYRHRSEFNRLSAREWLSLIIAGGFLALHFGFWFESLQLTSVASSTVILALQPIVAMIAAYLIYRERVARAVAISVFISFSGVLIISWGDFSFSDMSALSGNMLSFLSVVAVVCYFMIGQRSVKNLKHWVYSFVVFTFAGFFLLAFNLIAREEMMSYPPREWILFLMLAIFPTIAHVIFNSLLDAVSPTTISMSMLLEPVGASLLAYMLLSETLDVLQLIGGVIILIGVYFFLMAQRKNNYIK
>fig|1235755.3.peg.1755 Chloramphenicol resistance protein
MNKKLLITFTVGVFLLGMMELIISGILELMSDDIGISHAMTGQLITVYAVSFAVFGPLLVKMTEKFRPKPVIIASLVVFIIGNLIFGISNTFLMLSLGRVVTAVAAAVFIVKIMDMTVLLSRPEIRGKMIALVYMGFSAANVFGIPIGTLIGQQFGWRIIFWLVIIIALLVGIGILSLVPDRKGEELGEPVQDKVLDKRNVFLYIGVTMAVLIGNYIVIGYISPLMTSNGFTLESVSVALLIAGAGGMTGTYIGGLLVDRIGSKRTIIYMLILFMISMAILPLLYGTPVLFYINLFLWSVFQWSTSPSVQSGLVENVQGSAAMVFSWNMSGLNLGIGIGAVIGGIYISNFDISFAPWLSVAIVGLGLLSVSFVREHEEIV
>fig|1235755.3.peg.2123 Membrane component of multidrug resistance system
METNNNHKPDYRLIVILLSGAFVALLSNTFLNVALPSIKNDFDISTSTVQWVSTAYMLVSGIVIPTTAFLMQRFSARKLFIAAMVLFLTGTLVAGFSPVFPVLLLGRMIQASGSAILMPLLMNVMITSFPPAQRGTAMGLFSLVMFFAPAIGPTLSGFVVQHYSWHMLFFMMAPILLIVLSIGWFKLPGTDTHYTTKLDIPSVILSTLGFGGILYGFSAAGNSGWMRADVLIALFTGFVATFFYIKKQTRMDKPMLDFKVYKFPMFMLASLLIGTMNMALFSGMILMPIYLQDIQGISPLETGILLLPGALIMGFMSPVSGRLFDMFGPKVLAITGLVLTVSTTSFFSQLEVDTSYTFLIILYSIRAFGMTLVMTPVMTNGMNQLTPELTPHGSSINSMLNQVSGAIGTALLITVMQNRMNQKLSSVAPSDTAAVNQAMLDGINFAFLIATLLLAVALILAFFLKRVASDEVIGNDMTKARPIESDE
>fig|1235755.3.peg.2448 Multidrug resistance protein, efflux transporter
MAEEKVQSKGVVVVIIAAAFLLTFNQFLLITAFPTIMAEFDINATQVQWLTTAFILTTIVFIPMSGYLSTTYSSKTLVIIAITCLLAGTIIGAWSPNFGVLILSRVIQAIGAGIILPLIQTILLIVFPYDRRGFAMGLLGAVTNVAPASAPSISGIIIDYLDWRSLHWVLLPFILITFILAIFFMKNVLEQQRTKLDIRSVMLSAAGFSLFIFGLSNISVYGFLDPMSYVPLTAGILGVLLFTRRQFNIGTPVLNLTLFRNRTFTLAIILIFINMMLLLSTETILPMFAQSALGTSAFLSGFLLVPGTVILSIITFISGSLYDCYGGRTIAIIGFLCTTVSLVLLNTVGMGDSPYWIMVHFCLFMTGFGLTLMPLVTVSMSELDDRDIPHGSAIVNTVRQFAMAFGIIILTSIISITVAVMDAPQAQSTYTGTSYALAVMAVLAFAGFLMTMLIREDRYG
>fig|1235755.3.peg.2548 Permease of the drug/metabolite transporter (DMT) superfamily
MILSAAVLWGTVGTAKTFAPAGADSISIGAMRLLVGGLVLMAVAILMGKMTLKGWPLKSVLLAALSMALFQPFFFIAVSLTGVAVGTVTAIGSAPVFSGMIEWMVFKTRPAGVWWLSTFLAVTGCIILMFNSSAVTVDPLGILSALGAGISFASFTILNSGLVKNHHPIASAAIIFMTSAIMLSPFILIYDSSWLLETEGFLAAMHIGVLATGLAYYLFAIGLRNVKSSTAVTLSLAEPLTASLLGVFLVGEILDSWSWTGLLMLLMGIVLLVVRPRRKRAGAEA
>fig|1235794.3.peg.1041 Multidrug resistance protein, efflux transporter
MHLSEKGHTYALFAVVVITCALGSLTQTVMNSMLTEVCADFSIDAAVGQWVTTIYMLVMGITVPVVVFLAKRFSLKRLVFMALGFYLAGSAVGFCAPAFGVLLLARVLQAVATGITLPLVQTVAMTRFPRERTGTAMGIGGIAMGFAPNIGPLIGGALANTTGWRSFYIILVGLLAVLWAANALLVKSHGDRESQAVFDGPSFVQSTLGFGGFLLGASNAATMPLASPEVWMPALLGLACIVVFVRRQLVIPNPLICLDIFRSRHYRAGFVAQNCLFASFMGITLILPLFIQGPCGMTALDAGIAFIPATVVALFVNPLAGVLVDKVGARIVCITSAAFLTVGAASFVFVGADTPLWVLTLLQGVRAVGVSGLVGPLNSYGLAGLNRGIVMDGSAFFATVRQACASFGTALMMLIISVVGLVFAATDPADAGVTAAALPYNLAFALSTLFAAVVLVTAVWKIR
>fig|1235794.3.peg.1128 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTEQHTSREPDDARHFSPQGKEGGAAGGSAPRGEKLEARSAADDKVLRMGSASIPKLILEFAIPSVVGMLINGSYAIIDSVFLGHAVGEIGLSAMTVANPIMVVFMAIAMLVGNGGNALAALRLGEGKREEAERVLGNVVSLSLVMAVIVAFLGWFPASTDWLLSLSSATDEVRPHATVFIQIICTGFILQCIGLGVNNFIRTCGAPNRALGTMVIGLVSSVAFNFLFVIMLGWGVAGSGLATVLGWGCSCVAVLWYFCGRADVPMRLRLSTMGLRPRMDGTIVAYGFPSFCVQAGMAAVNFVLNFQLVKYGALSPIGADDALATIGVVQRIAQFSIMPLVGISIALQPLLGFNYGAHKVDRVRKTLWYGIGAATAISLLMFALVQLFAAPIAHAFGIKHDGLVDFTAFAIHLQFLMLPFVGFQIVSANYFQATGQPARSIFLTLTRQILFLLPLLYVIPLWLPAVAPQYNGLDALLFAMPIADFLSIFTTALFIGWEMVRLRRLARKYAR
>fig|1235794.3.peg.1378 Permease of the drug/metabolite transporter (DMT) superfamily
MKAHLLALFTILVWSTTFVATKVLIAAGLTPLWILVIRFTLGFLALCCLRPRRLPLADRCHERLFAAAGLAGVTCYFLLENIALTFTSATAVGAIAATAPLFCALIMLARGSRPAAPAPFALGFALAMAGIVLVGSASGKAILAGSAEANFIGCGLSFAAAVVWAIYSTIVGRIAEAGYETLAATKRIFGWGLLFMAPALLVAGPAPLAALAEPVVTGNLLFLGLGASAACFVTWNFAVKHLGAVVTSTYIYLVPALTGTASVIVLGEPLTAPIVGGLGLTIAGLALSNRSHEKKRVPKDPPSEQTCITET
>fig|1235794.3.peg.1380 Permease of the drug/metabolite transporter (DMT) superfamily
MSQWKQARWPFVAFVLIEVVIFGSGSAVTKFAYESITPLWCLAVRFGLATAVFALFFGRRMARRLHGVRVRTWLPQALCMAVSYLCCNVALDLTTATNVGFLVALPVVFAPILSTLAERGRYPKAIIPFQVGVAAGLYLLCSQGGSLAVGAGELFALASSVALAGALVFGKQALVELDAVTVAGTQIAVAFALCLGCALLWEPALNVAAVRPVAWGIIAFLALFSTCLAFFLQSLALDRLSSTTVSLLLTGEPVFTALFAYLFLGEILSPMGLAGAMLIVGTVVAATYVDGRADAPAHEAAPVPTRLPRRVVRPRLFVRRVREDRMAA
>fig|1235794.3.peg.1387 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVDMSKHFSTSALIKFTLPTIAMMIFTSCYTIVDGFFVSNYAGKTALAAVNLILPPVMMLASFGMMIGTGGSALVAKTLGEGDNARARRHFSLLIIFAFVLGSVLAVGGWFFMEPTAAVLGATGQMAKDATLYGRMMMISMPFFILQYAFQSFFVTAGKPKYGFYVIVVAGVTNIVLDFLFVGLFGWGLVGAALATNIGELIGGGIPLVYFARKRSTPLYFVRPHLRWPVIGKACANGSSEMVTNIAMSMVGILYNWQLLRFIGEDGVAAYGVIMYTAMVFAAVFMGYSIGSSPLMSFQYGAQNHTEMRSLLWKSLGLIAVASVVMFLLGQTLAAPLSAIFVSYDAALLELTAKAYRLYALCFLFMGFAIYASAFFTALNNGLVSALISFLRTLVFQVAAVIVLPMLFGIDGIWLSVTIGDALTCLVAATLMIALSGRYGYRKRGEKPAAA
>fig|1235794.3.peg.1408 Vancomycin B-type resistance protein VanW
MAPRSHVKQPMPDDRMAGARPLPEHPALGRRPRFPAASPYAAPLIAVCAVALSACMAFGNPVIWESAAQKEPAPVDEPAASNPAPAPEPEKAEEEPAPEQETIGEYQAISQSEDPGRSENIRLATEAIDGTVIEPGGTFSFNDVVGNTSAERGYQEAAVIRNGEVAQGDGGGVCQVSTALYIAAVKADMEIVERHPHSVPSDYAPIGLDATIVYGSFDLRLKNNTDHAITIHAKAVGQTVDVSIEGDPLPEGRTVDATSQIVSRYERDDAAGTLRQYYVSEAFRVYYQDGVRTTRDLLSSDIYQVDENTPVTTSEGSVDPNK
>fig|1235794.3.peg.1783 Permease of the drug/metabolite transporter (DMT) superfamily
MSQNLETARPCYDATAMVSLMRHTNVPPWVYKAALLLSAAIWGMGTVVIKSTVDAFPPSWLVGVRFLGAGLILGAVTLPRIRQAYARNKRGHLRDGAVLGALLFASYWCNSTGLTDTTASNSSFLTTLYVVIIPFLGWIIIAKRPTRFNIAAALLCVAGVACVAYGGDGAFSLRFGDLITLASAFFLSLHVLYTAKYAPGRSMTLLTVIQFVTAGILGLIVGAVTEPTPRFAALGADTWISLVYITVFASCVALGLQNMAVARVDPAQASLFLATESIFGVTFSILLLGEVLTLSSFAGFALIFAGIVISEYLPLRAEKKAAERDEGLTAPASQDYTLQAKAAAEAAALELDEADTALR
>fig|1235794.3.peg.1881 Drug resistance transporter, EmrB/QacA subfamily
MLAVLVFGAFVTVLNQTLVTPALPSIMVEMAVDQSTAQWLTTGFTLVNAIMIPITAFLQDRFSTRKLFVFSMATFAVGTLMAGVGPNFPVLLGGRLVQAMGAGILMPVTMTVLMLVFPVDRRGSAMGIFGLVIAFAPAIGPTVAGFVIDQADWHILFYIIFALSLVIIAASLFLVDNKAPANKGDSVLDPLSLVLSTLGFGLMLYGFSALGSAGLTLVPVATTAVGIVGVVWFFIRQTRLPHPMLRVDVLKNRRFLIGTIIGMLVQGALLAAGILMPIYVQSLHGLSATVSGLVLMPGAILMGVMNPIAGKWFDRHGPRRMAIVGMSLLTLTTFAFAILNLTSSIIYLTIVYTVRMFSMALVNMPITTWGMNALDNKVMNHGTSVNNTLRQVAGSLGTAIIIAVSTQVQNFATPGLGAAQGTMLGINAAFLVCTLLCLVGLVMTIMFVKDKPGEEAAVDEGGTRKSLLTSIMKTDVYSLSQEATVEEAMRLFVEKNISAAPIVDASGEPVGFISDGDILKRLSPRRSSFTDPIVLINRTVPDEEGYDEKLAKVMQMRASGIGAASPICVSVHANLTDVCRVLAENHLKKVPVLEEGHIVGIINRSDITQYSMAAYLAGNPDRAVYCGDGPSGQHECVEEKQCDCGCEEGK
>fig|1235794.3.peg.2036 Permease of the drug/metabolite transporter (DMT) superfamily
MDIASRTNGEGNRRALLIGGVGYGIICGLTFPLMISNTFLREMSLSHGAGDSFGALFFLAYAAAMLALALWHLVGRKPLPRASLVVALGAVLLGNGLMLLRYLSIIEGGWSYAIVTGLSIGFGLAVAELGWMEKIVTMGKADGTLLPRMVSLAYLVGGTAAAFIFLATGPVELTFALLTVLISGALLTRTPNVADEPPSHAPSRSDNVNLVKAISYLAVFSFVFGAVSQMVETSSHSITVIEIQATASIIGAALIFLAASLGRKRIVPISDLYGLLFPVVAGALIALPFITTPWVHGIASVLIFAAFYLSGMNVRIIVSQLCRGDRISLWVYLGCALGVGSLLVIAGVAFGAAVLSQGSPETALALIALISLFILALNPILAHRIEQRASVGADTGDSATAAVPTTQAAENAVEGFAREHSLTARESEVLLLLCQGRTRTYIADELGLSPNTVKGYIRNVYQKSGSVDKQDLLDRVELFRERR
>fig|1235794.3.peg.2352 Nitroimidazole resistance protein
MFVPMRRSKQQLPADECAAILRGATAGVLGTAGTDGYPYAVPVSFAYVPSSEDDAAPDAVRGRIFLHCATTGHKLDALDADPHVCFTVIAQSEPVPEKLTDRFCSVIAFGTARRAEGDEKAEGLWALGTKYAPGLDAVVSDEIATTAHRTEVIAIDLESVTGKEGLELLRERGA
>fig|1238674.3.peg.447 Multidrug resistance transporter, Bcr/CflA family
MARQKLGALQLFLLGILSAFGPLSLDLYLPGLPEMQQNLNTTPTMIQLTITASLIGLAIGQIIIGPWSDRVGRRRALLVGVGIFTLATVGIILTPNIYGVILFRFIQGLGGSAGIVLSLAVIADSFEGLQLTRNVALNQMINGVFPIVAPVIGGVIIALSHWQMTFIVLAVLGAVLWVAIYTSLPETAPEFDNSHAQMTPKQTFKTLWSNKGFMFMAWTQAFMMAGLFAYIAGSTFVLETIYDLSILQFSIVYAINGLGILIAAHISAKLAAKMGEYHALGVFVIISLMGGSLVWLNVVLSNHVLLMCLAFFLIVAPVGGVSSLTTSIAMQHVQTGTGAASGILGLMRYAMGGLVSPLVGLMGADSLIPLAIVIAVVQVLGTMMYLKSRP
>fig|1238674.3.peg.1194 Quinolone resistance protein
MEIKDARLALDELEFGNTYIDCHLTYSNDALRLENITLKHCTFDQSDFSQSEWQDCVISQCDFSQADFSSAIIYRTTFDHTKLMGANFTKSRLNNVQIKNCMADYAIFAEGQWQAVTFDDVRLRDTSFQATKIRQGLIFKGCLLDDADFYETSLKGVDFSQSEFSSLRFSMEQAQGAIMSAEQAVQIALNHGISVL
>fig|1248916.3.peg.619 Glyoxalase/bleomycin resistance protein/dioxygenase
MKRLHVHVGVTDLAQSIAFYTNLFGTGPTLVKEDYAKWMLDDPRVNFAISHGHAATGIEHLGIQAETADELAEVTARLNQADAPVLAEGETICCYARSEKSWTTDPQGVVWEAFHTMEQARTYGSSPMLDTLAAMAPAPAKGGCC
>fig|1248916.3.peg.872 Permease of the drug/metabolite transporter (DMT) superfamily
MASAAPEPRFTPVAWFAFIACTLIWGGTWFVIRTQLGEVPPSWSVTWRFALGAAVMFALCLVRRKSLRLSLRQHGFALLVAVTQFVLNFNLVYRSEQYLTSGLVSLTFAFLLVTNAALAALFLGQRVTGRFMLGSAIGLAGVALLFAPDIGKPGGEQIGINNTTWGLALAFAGVLSASVANVLQATPQGRAMPLEAGLAWAMGWGALIDGAVAWGLSGPPVFSTAPVYLAGLAYLGIVASAVAFSLYYILIRAVGAGPAAWSGVVVPVVAMGISTLLEGYEWTATAVAGIVLALIGLGVALKAKAQQ
>fig|1248916.3.peg.1295 Candidate antibiotic resistance protein (acetyltransferase)
MSIRPARMEDAPALAAIYAPAVLTGTASYEVEPPSAAEMAQRLMKVKSHGWPWLVHVTMGTVDGYAYVTQFRDRPAYRFSGETSVYVAPNAQRTGIGQALLMAVSSAARTAGFRQLIAVIGDSGNNASINLHAACGFERAGLLKQIGEKFGKPLDIVMMQRSLIG
>fig|1248916.3.peg.1365 Outer membrane component of tripartite multidrug resistance system
MHRKTFLLIPALAPILALCACAVPPKLGAAPMVRAPATAASTVTLAAKGAVDWPATDWWQAWGDPQLNALVAEALAGNPDMAAAEARVVAADAAARQSRATLLPSLTGNASLGGQQLSRNLGIPPQFVPPGVLESGLINLQAGWNLDLWGQGRAQLRAARREAEAVAVERTQARLFLAASVAAAYADFGAALDRLAVTREALAIRQQTLDLTANRVTAGLDNDGARAQAATRLALAQSDLAAAASQVTAARRRLALLVGAGPDRGFSITPPKIKPLPPGLPEAVSINLVARRPDIVAARLRAEAAGAREMAAGRAFLPNLTLNATIGQQSLGFGKLLEGNSLYAQFGPALSLPILDGGRRAAEARSARAARVAAVAAHDAALLRALNEVADAAGAVTVLGLQREALTQGLAEATRARNVAALRYDAGLSNQLLVLTADDAVVTARRTLADVDAFRLAADVALVRALGGGFREQEGQ
>fig|1248916.3.peg.2449 Drug resistance transporter, Bcr/CflA subfamily
MHAPSASRQPSLGEILLLGSLTGFGAVTIDLYLPTLPAIARDYGTSAAAVQLTLSTFFVGMAIGQLFFGPLSDRIGRRPTVLIGCAVYVVASLFCALAPNIEALVAGRFFQALGCCAAMVTCRAIVRDRYDHRDSARIFSLLMLVLAIAPLLAPTIGGWIAMAAGWHAVFYAFVAVGVAVAGAVAWRLEESRSAATAQAARGNDVLSTYARLLGHRRLIGYLLVGAANGATLFSYIAASPDLVVNVWGFSEGQFGLVFAAIAVGIVGSSQINRALLRHRSPDAILAWATLGAAMAGLALWLATQADAPLLIFMPILFVALSSNGLIAANASAGALNVDPLRAGAISGLMGGVNFGVGALASALAAALHDGTARPLALNVAVALLVAATAFHLLAKPR
>fig|1255043.3.peg.1146 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTDLLGSVPVLHISNAERSCEFYCNKLGFQKNWQHQFEPGFPLFVSISRGSVTFFLTEHPESSAGAFVYIHAEDVDALAQELQARGVTLGQGPVSQPWGMREIQLEDPDGNRLRFGQDIEEKIS
>fig|1255043.3.peg.1742 Permease of the drug/metabolite transporter (DMT) superfamily
MSVPAAYLGVILIWATTSLAIQWSGDGPGFLFGVAARAAIGAVLALAIARLSRLRVWRRDAFGVYMVVALGIYGATLSTYWAAQQIPWGWISVIFGFTPIATSAMAALWLPGQGLTRVRLAGALLGVGGLAAIFSGGAAAGITTVDRRAGRL
>fig|1255043.3.peg.2529 Bacteriocin resistance protein, putative
MPRSVLNRLLRPPADFRRVQRQSWPESCGAAALATLLAEVHALPVTEADVLERLGTRKVVGLDQLQQVCAQYGLRAFGYALDWDGLGRAGRPALLHLPGASAVGHFAVLRGIGPARVWLADPARGNLRLARSQFLRRWAPRGAEGRALYVAAPEADWLPLGEEALRAPPVADEDWFPARQSPQRDGVPDMDD
>fig|1255043.3.peg.2790 Multiple antibiotic resistance (MarC)-related proteins
MIEVAIVAFATFFVTVGPVDVAVVYAALTPHHPESARRTMAIRATLVATGILLAFALVGETLLGWLGISLPALRTAGGILLLLIGIDMVFARQSGGVSATPSETREASRRTDISVFPLATPLIAGPGAMGAAILLMAGAADWRHQATVLAMLLLVLLLTLVCLLAAVRIQRFLGIIGAQVLTRILGVLLAALAVQFIFDGIIASGVLS
>fig|1255043.3.peg.2949 Acriflavin resistance protein
MINPARLTVHRPVMTGMATLIVILLGLAALTRLPVDLLPDITYPVLTVTTAYPNAGPEEVEQLVTRPIEQAAAAITGAREIRSTSSEGSSNVRVQFGWGTDLREAVDDLRDRLARIASQLPEGADQPLVRQFDTQASPIMQLGVGSALDPIQLRALIDNRIAPRFERLPGVAAVDVRGGLEREIRIEVHPERLQALGIGLDTVRSALQEASVVSPGGPVVEGRREFRLRTEAQFRDLEEIANTVVRRDETGPVRLFQIADIRDTHQRPTRTFRVDGADGMVLAIRKLADANTVDVAAAVRAEVRRIERDFPQVAIQIPSDGSRFISRSIANLGQAILYGSALAVLVLLAFLRNLRFTLVAATAIPISVIATFGLVYFGGLTLNLMTLGGIALGVGLMVDNAIVVIESIARNREENPGLGIPEAAIKGTGQVSAAIVASTLTTLAIFLPLFFAEELAGQLFKPLAAVVAFALAVSLIASLTLVPMLMARRMLHSASAATATPHGLERTYLRLLEPALRHPWWVVLASLALLLFALQGYRGVGTEFLPATDEGDIRINLSMEPGTRLEVLDAVTREVEATVRERVPEAQHMVTSIGASAFGFGSPSSSNLRLNVGPRDARDRSSEEIAAALRQAIGQPPGVTVRVRASGGIFMRGFGRGDDTERLSIEVRGFDRVAMNAVALAFGEAVEDIPGVTDVRVGDDGGQPEFLTRIDRARAADLGVDVRSIAQAIETAIGGSRAGQLRTGGTETRIWVQVQDAEHRRLDELLNLTVAGAGAGGERIPLRSLVRFEPVIGPSSIQRREQARIATLFVNVAERPLGDIAADVRAALAQIPLPDEVDYQVSGDIEEQEAAFSELFLGTVLAILLVYMVMASLYESLRDPLIVMFSVPLAAIGVVLALRLTGTTLNVQSLIGVMLLVGIVVNNAILLVDRMARLQRGEGRAVRDAVLLAARQRLRPILMTTLTTILALVPLSLGLGEGGEAQAPMARVVIGGLISSTLITLFLIPALYLIVHRTATATAAPVVPPSRETA
>fig|1255043.3.peg.2973 Acriflavin resistance protein
MSEHNTQQAGEGQEPEKDLGLAGRMAQSFIHSPLSPLLLLATLAIGVLGLIITPRQEDPQISVPMVDIFVSYPGVPSEQVASLVARPLERLMSEISGVDNVYSVSHRGQSMVTVQFDVGEEMESSIVKVHDKLMSNRDLMPPGVSEPMVKPKGVDDVPTVTLTLWSHDLDDALLRQIALDTLQYLNEVPNTSQSFVVSGREEKVRVEVQPERLAGHNVTMDQIAQALQAANSERTAGSVEIGATSTPIYTGAFLRDAEDIGRILVTVEEGRPVYVRDVAEVIYGPGEVDRFVRYYTGVAGHHADEAPEGAAAVTIAIAKKEGSNGVAVANGILERLEMLKGQVIPDNVEVSVTRNYGETANAKVNELMFKLFIATAAVTVLVFIFLGLRAALVVLIVIPVVLLFTVFSAWLMGYTIDRVSLFALIFAIGILVDDAIVVVENIYRRWLMKRGVDTETTVDAVAEVGNPTILATFTVIAALLPMGFVTGMMGPYMQPIPALGSVAMLFSLVAAFLFTPWLAWRLRPTMDYLQRAEEKEHKQNEMMGQFFSKAIPGLVHNRVYGWGFLIGIVVVFFLTVMLFFTKDVSVKMLPLDNKPEFNVVINFPEGTALPQTATLTHELAMVLRDLPEVTAVQAYVGTASPFNFNGLVRHYYLRQEPWQADVQVQLVDKGDRKRTSHQIAVEARELLAPMADAAGARIQVVEMPPGPPVLQSVVAEVYGPEPEIRRRVARDLERMFDNAPHLDDVDSFLQAQYDVWHFIVERDKALRRGVTVDAVNRTLESAIGGQIVGDVKARSLVEPHLIQIRLPMAVRSDLQRLLLLPVPTMAGGSVPLSELGEFVRQPQDEPIFHKNLRPVEYVTAETVGRLAAPIYGMLEVQEQLKEYRLPRGGELDPHWVGPPPNDGTVGFEWAGEWTVTYETFRDMGIAFAIALVLIYMLVVWEFGNFLLPAIVMAPIPLTLIGIIPGHWLLGAEFTATSMIGFIALAGIIVRNSILLVDFARHAVAEGQSVMDAMIHACQARTRPILITAFALLAGSSVILFDPIFQGMAISLMFGTIVATLLTLLVIPLGCISASRTLEENATGGGSGGGAACAVQPEPGGDPGHEGPRFPSSTKMTDPSGGPVMKFIGLAGLYLRSLAASFVEGVVQLMRALARWILRLVGGDDRPPSGGGGPTGPAAPPDGSGGPAGGAPSGVETGQAESGERDGSGDRAEAADDRSRTQPGSDRVRSASGGRAGGESAAEKTPSGTAAPGAGEKQQRGSASAEPKPASARTSKPASAAAKTKADPGEASAPADRGAPPRKAGSATGAPEAESDDDEGAKAASSGSAASSARRRRGIRLK
>fig|1260251.3.peg.361 Permease of the drug/metabolite transporter (DMT) superfamily
MIARDWLLLIILSTVWGGSFFFFEVALQTLPPFTVVLGRVSMAAAALLVIARIRGEPLPFSATIARRYLLLGAISNAIPFSLIVWGQTQIPSGLASIINAMTPIWAVLVGLLIRSDERMTAGKAIGVGLGFLGVAVLMGPDLLRELDPYSLGQLSVLGATISYGFAVHYGRRFGATSALVNAAYMLTAATVWLLPVAILVDHPWTLSPGLSGWTALLGLSLICTAFAFLLYFRLLASAGATNMSLVTFIVPVSAISLGALFLGERLGPTAFAGMGILFVGLAIIDGRAARMLRTGTHALWSGLLGRRVVSKRPE
>fig|1260251.3.peg.370 Multidrug resistance transporter, Bcr/CflA family
MFNQRYRAHPDGTLMIIMLGVFTAFAPLSIDLYLPGMPAMEADFGVSAGLVQQSLSLFFVGLAGGQLLYGPLADRFGRRYPLLAGSLIYLAAGLLCALAPSIEWLLAGRLLQGFGAAAGPVIARAIVRDVYAGRRAAQVMSFVILVMTLAPLIAPVVGGWLTTALGWRANFWALVAFAVICLVMLLMALPETHPAERRPRTALRHLFAGYLPILRDRAALAYLGAGGMAFAALFAYVAGSPFVYTRVFGVAESNFGYFFALNVIGLLIGNLVNSRLVMHFGQQIMLTAGVLVMATASVSMLVMALAGITEQWLITPALFVALGTVGIIAANTVSGLLDRHPRHAGAASALFGVAQFGLGALSAVGVGLVSVGPLLTMTLVMAAAALVATASVIALWWQLRRPALAV
>fig|1278308.3.peg.392 Tetracycline resistance protein
MTTTVGAIEHLQRRTMLVLVVMQVIGMIGVGAAPSVGILLATEVTQNEAIAGLARSSSTLGAALMGLPLGSLAARRGRRVALTLGWYVAAAGAALLVFAAQFSLVVPLFIGLFAIGAGTAAGLQSRFAATDLAPVAGRGRALALVVWVGTLGSVLGPNLGVPGEWLHDRIGINVFGGAFGIAAVCLALAATVVWIWLRPDPLVTLQARAGVSTVPGAQRPRLGQALAEVRRSGPGRLALVGILVGQSVMVAVMTMTPVHLAHHGDTITVIGLTISLHVAAMYVFAPLVGWCVDRLGHRVTIAIGVALLAAACLVGAAWQHETAAIVTALGLLGVGWSFTSVASSALFSVAVSDAHRAQAQGGADALSNLCAAVAAFASGPLMAASDFSVLSLAALVLLVPLAVLLVPRRATG
>fig|1278308.3.peg.1222 Drug resistance transporter, Bcr-CflA family protein
MPHERRLTPLLLTVLGFIAAVGPFATDMYLASFTEIATALGTGPAPVQLTLTAFLFGMSAGQLVNGPLSDRLGRRPVLLVGLAVFAASSVAMVFTPNIELFIALRVVQGFAGSASVVIARAIATDLSLGNTAVRALSMIAMVTALGPLIAPPIGGALATWFGWRGVLAALAVISVTMLALALTFVAESHPPTARPTGHLLAPFRSFATLLRDPVFGGFALAFGFGFAGMMAYISASPFVGQHLLGMSQLEYSLSFAAGASALILANLANARIAPRVGAGRMLVVGLALLVAGGVGFAVLAATGALSIPTFILCAFATTAGTGFTSANSSALAFTRTGPAARGAGSALLGTGQFALGAVASPLVGLWGEGTALPMALCVLVAALVAATCGLAALRRSRR
>fig|1279017.3.peg.786 Acriflavin resistance protein
MNIIEKYSPVIISCGLLLICLGVFYGVKIPNTLLPNIDRPQIALATSWPGKTAMEIEQALVAPLEQELSSLGFLEEIQTTISNGFAWTLITFHSNADMEQMYIDVLSRLNQVPNWPSQVSAPRLYNFSNGAGATLASFFLYSTNQATEQELSQAFRDHVQPAFSKIPGVASVTVAGTPIEQRIDIEFDPRGLTQASLTINEVQSRLSDLVDRSGGNLTIGSREYALHFKGQIPIADIEKLPIATRGPHIIRLGDVAKVKNRMASDWNYFALEGNRSFYFYLMPTEDINVLNTIDMIKTLISDLNEGELGRLGMEVAISRDDSKSIRNSLQLVYSSLILGAFLACIILYWFLRDFRTLVLIFTSIPACIALVILGLYLGGRSINVISLAGIALSIGLMVDAAIIVIENIQRLRGQGASLLTSIRQGTKEVTGALTASTISSVIVFLPILAMQSATGQLFTDLAYTISSALIASLLFALLLLPALARHLLKDSPQVNPKGRTQSLNRILQRWTAISVIPIGRVTFRNCVLVLGLPVALLVTYLSSPSVDVLPDPKQAMISTFINFEGPMAVEVVEREVGQVIMDRIEQGKGRFEEQIVTYGTLCYPTMCHLYIYTQGDWDFEAFKKWIDKDIVSGLIGTRIHTQQGGLLRFAMPNSRVSQLDIKGAELPVLQAAGRDLLEHLRSEFPGAQILEGSALSNRGLRIEFEPNQDQLIRMGMTLPEFNRHLMALTDGIYIGNFYTGTNTLPFYFKAKEPANLEQLLNTEIMIAGQGLIPLRQLTSAQITQAPDSILRVGQEVSTSLNLTPPTGVAMKDFTEQVDRSVLAFLNKSQYGDLHTQFRGSANELKLFLQEFFQIFCVALLILALLMYFALRSLKLALAVLFAIPLSFAGGMLSLRLLNLFVMQNLDVITMIGFVILMGLVVNNAILLVNQFQSSINKGMHQFDAIKSAVSLRIRPIMLTTTTCIFGNLPLVLSPGDSAAIYRGLATVITGGMLFSALFVLGFMSAMLSLKVFAAHRINPTSVVRELTPEGGI
>fig|1279017.3.peg.875 Permease of the drug/metabolite transporter (DMT) superfamily
MSQAQGLPRAFWLLLIGSGFFQMIYMGGLALAYQRANMGLVYPIARALPVLLVALATVLLGQTLPWLAWLGMLLVTIGCLLVPLVYFRQWHWRAYWRADCAWALVAALGTVGYSLADKGALLHLETALDGAVRPMAMAYSYLGMQFFASGLWLLFGCLGSNGRAQLVRSLGDLKLGLVTGLMMGATYGLVLLAMAMTENVSYVVALRQLSIPLGVGFGIWLLKEPAYRPQLLGVGLVCAGLIAVSLR
>fig|1279017.3.peg.1610 Drug resistance transporter, EmrB/QacA subfamily
MKYKHISFVGLCLGFFIVMMDMTTVPLMYTTLMDEFTVSPARVAWINNIYLITYAASLLLGGRLGDSTDRKIVLIGALLVLGLGAAISGAGQTFVEVIVGRALMGIGAGFLTSQSMAYISILFAKGGRGTALGIWGAVAGIATATGPVITQLLLTTADWRWVMWINIPFVLAALVIALRCLPGDPGSGIRLSETFASAVYGLCLAGVIIGIHYISVAGILRGVGIALILIGAAVIAILIRKEVKNKSAYILSPELWFDGTFFRICFISGLLGLGVASFYLPLAFLLDVCMNFGPVAISVLMMTIALSNALVGPYAGHLSDRIKPEGIVRSGLMLFALANGLLGFIGVLMPGGTVTFIALFLVMMIGGAGTGLAFAPLANLALSRVSFEALGRAAAFFNSIRQALSAMGAVIVAILFDWIVRLKLGIDLEITATNLRESPGITGLATLVCFLLIALGLSVAAYLSRSSRQDSVQREVLNT
>fig|1279017.3.peg.1757 Acriflavin resistance protein
MKTLSRWFLDNPVAANLLMAFILVAGLLTFQNLRVESFPQIPPTEVEISVVYPGGTARQVDESITQRIEEAISGVAGIKRITSQSSKGYASLVVKKNTNVKLDRLIEDIRNQVESIEGFPALAERPRIYRSEYTNLAAFVMVYGGDNNDSLQQVSSRVERVLKKHPAISKVTNLGKRKQLLAIEPDLRKLQRYGLSLENLTERIRQWSVEYRSGELRTANGNIVLQGSSLADNLAELRNIPIITTSTARVRLSDIATVKRDYEQTDSIVRYQGQPAVALMVSTSQKDNLFHIHEATKSVLESLESTLPRNMQLDVMADMSPYISEQLDLLSSNALQGLLIVLLLLVLFLDTRLAFWVALGIPISLAGAITLMGFPSLDYSINDITLFGMILVLGILVDDAVVVGESIHQARQNTTDTKEAAWKGVEAVAVPTVFGVLTTIAAFSPMLWIENELAKVLSGFSAVVIFALIFSLIESKFILPAHLSYPNTHTQTSGAIKRWIEIAREKCNRLLNRFSDKIYIPLLSLSLANRKISISLFATFLLLAYGAMFKGHIASVFFPEIPGRYATVKVTMQHGAANTLTERNTDQLEQAIKRTANRLQQEYGLPESPVSKYIVSKEGTKTIELTAELTHDALARVESNRFLEELRLQTGILEGSYAVKFSLTEEPAGDTAIAVSASNRDQAKQVAGRLKALLAELPGVNDVYDDSQLAKRQLKITVNERGASLGIDQSHLAVLIGGAFGQIEIHRLLDKGEETLVLARFPQTETKTLEQLKATPINLDNNSYVSLGEIAQLKYEREPEVIYRRNRDEVVSIYWRQNRSVSSPENNWERLKEELVPELERLYPGVQIKAVGEFAEIVEVQAGFKKSMLLTLLLIYVLLAIPLKSYWQPLIIMSVIPMGFAGAIIGHGLLGFPVSLLSLFGMMAMTGVVINDSLVLMSRFNQLYAQGVPVKTALLQAGKSRVRAIFLTTVTTICGLLPLLAETSEQAQYLKPAAISLVFGELFATPITLILIPLLLSFGQYKNTSRSDSASLTEQSLLQEVRQL
>fig|1279017.3.peg.1957 Acriflavin resistance protein
MNELRVEDGDIDTKTGAIAWMARNHVTANLLMLVFLVGGLIFSVIVKKEVFPEFSLDLVSVSISYPGASPEEVERGVLVAAEQAVQGLVGIKEMRGSAREGSAVLNLELEGDADANLVYQNIQQAIDSVTTFPADIERPQVNLAERKRDVLDLVLHGNLDERSLRALAMQVYDKLEAHSGITQLEAQGVRDLEVAVEIRRDDLRRYDLTLAQVATIVQNAAVDIPTGSVKTDAGEILVRVTERRDWAREFGDIVVTQGGGGGAVYLRDIATVSDALEDEARNMVFNGEPAVGIKIYRVGDQTPLSVSDAAREVIDEVRASLPQGVSLTIRDDDSEIFKERLSLLLKNGFIGLLLVFVVLGAFLELRLAFWVTLGIPISFLGALLFLPGLDISISMVSMFAFIIALGIVVDDAIIAGENIHEWRQKGYSNLQAAIAGARQVAVPLTFAILTNIVAFIPLMALPGFMGKIFGVIPFVVGSVFIISWVEALFILPAHLAHSRRGYKSPRAQRFAARQERLARGLDRFVQERFRPLLEACVRHRYTTIAIAISTLLVVGGYAASGRMGFTLMPRVERDSGRFAVTFPTGTAQHQLEKARSQIIAGGNKVLEQYDRDAVFLGNRGLMGDDSVQVDFFFVPSDQREFSTGEFVRAWRKEVGVIAGALSATTASDRGGPGAGSSLTVELRHIDTAVLDQAAARLGAELAKFPNVSDIDAGVTLGKTQLDLTLTETAKSLGLSAEEIGRQIRAALYGDEALRQQRGRDQVKVMVRLPESERVSMDDVNNIMIRAGSGLWMPLTDLVVIDKGRAYATINRRAGRRVLTASANVEPSDQAALVINELDRSVIPQLQAEFPGLTISYEGRQADEREGLASLGLTFLLAMAVLYLLLAIPLKSYMQPLIVMVAIPFGVIGAILGHLVMGYGMSMVSLLGMVALAGVVINDTLVMIEYSNRLREEGVDVETAIKRAAARRFRPIVLTTVTTFCGLMPMIFETSVQAKFMIPMAISLGYGILAATAISLLLVPCLYLMFGKDIPRLFSALKNALESFTGTARAGN
>fig|1279017.3.peg.2431 Permease of the drug/metabolite transporter (DMT) superfamily
MKRKQVQAEVLLLLAALFWGVAFVPQKVAMADIEPLAFNAWRFILGGLILVPIVYWLSSRRDSQPGEVGGKHVNHRWKACLPGGAVLGFWLFLGAALQQVSLLYTTAGRAGFITGFYLLLVPVIGLSLGHKTNRWTWVGIALALFGLYWLADFAEESQLIGDLMVFASAFVFAIQVLSADHLVKRYDALRLACIQFLVCGFLSALASLFTEEATMQSAVDAAWPIAYMMIFSTALAFTFQLLAQRYAAPSHATVIMSLEAVFALAAGWLFLNEVLNARELIGCGLMLAGMLVSHYGNHNGTHH
>fig|1279017.3.peg.2842 Glyoxalase/bleomycin resistance protein/dioxygenase
MLKHPDHVTIVVNELQSSVKFFQLLNFELEVTDLISGEKVSKYLQVENVEADHLTMVLKNSSPRFEIQLLHYRNPKVKSDPSIFSLARPGYNHLCFAVDDIEKTLKFLNENGIRTRSEILEYQKRKLVYIEGPEFITIELAEWL
>fig|1279017.3.peg.2885 
MKYIFEVHIKEGFSAEEYAEAWVRASRLIQQYPGAMGTELHRKIDDPRKLLAVATWHCKEDRDAMQTQHSVEIDKIIRSVAPFVEIRSLGEFEDPQWVVNFSLD
>fig|1279017.3.peg.2983 Acriflavin resistance protein
MNGIIPWFVRNSKAANLLMIMIIIGGIFGISGIDREVFPAIQPGIVEVNISYPGAGPAEVEQQVTVRVEEAIAEVKGIKEVNSASRRGHSSVEVQAVDGYDELRLLNDIKVQVDSINTFPEGIERPIIRLQEWDTQLMMIAIGGPVSERQLKETALDLRDKLTLIPGVRSVDIWGERPDELSIEVSELDLRRYNLSFNDVADAVRRSSLDLPAGMVRSDRGDIQVQTRGQAYSAEDFERIPVVSRADGSVLLLRDVATVRDGFEEYNNVILFNGNPAMNLRVVQGEPLDVVGTAERIKTFMAEARTQLPPGMEFDIWFDFSKAFEGRMNLLTTNALSGFVLVFVMLMLFLRPALAIWVTVGIMVAFLGALWLLPITGVSLNMLSLFAFLLILGIVVDDAIIVGEAVHAAHDRGVTGLAAAEEGVKQVSAPVIFAVTSTMVFFIPMLFLPGYTAQMMLALPVVVLLCLAFSLVESLLILPAHLVGMKPEQPAKTRVGIKLQKLRGHFAGAMKTAGDKYYLPLLKKSLGNSRSTVMIFISALGLSISVFMSGYVGSSFSPQVPSDLLELRASMASGEPFHEAERVMNQVLAAADKLAADEEMLKQNNGEPFVQNSMVFNWRGNIFVILQLTDGELRDVTSKTLALRWRQLIGEMPASVEDLNIDATINDGGNGMSLNLSTASGDMDELRAAADAVKEKLNTYAGVYDVRDNLTSARRDIEIQLKPYATTMGINLADVARQVRQGFYGEEVQRIPRGREDVRVMVRYPQEERASEEQMDRVRIRTAEGEVPFSAVADAVYVPGYTTIRRNNRERTVRVFAEITPNTSSAQEILKDMRETLAPELKRQFPGFSLRTAGEMQEEEEFNGAILAFFVLSLFAIYALLAIAFRSYSQPLLILTAVPFGFFGAVVGHLLMGHNISIMSMLGFLAAAGVVVNDNLVLMDRINQLRAQGWAVMDAVVQSGRDRFRPIILTSITTFIGLVPIMFERSIQAQFLIPMVISLAFGVLFATAVTLILVPNLYKVIEVIRPKSKRLGEGEAPVSLETV
>fig|1279017.3.peg.3396 Multidrug resistance protein A
MTDKLNLNLDRTTQRKLGLILVLVLAALAVGWSLFGSGDIVETENAYVKAEKVSLAPEVSGVVTKVLVSANQVVSKGQLLIQIDRTAFELAVTEAEARLSQVRNDLLARRAEYAEADAALQQARKDADFYRRQLERNEKLGKVAFSEAELDSARQQLERARAQITINAEKLSSLRAELGGDPGSALEDQADLKVAQAQLDKANYQLSRTRIIAPVDGTIANTVPQVGEMATAGLNLLNMIGSSGLWVEANLKETELAKVRTGQQAEVTLDAYPDFEWQAQVDSMSPASGSEFALTPPQNASGNWKKVVQRVPVRLRLYPLKDAPQLRAGMSAKVRIDTSEDAKVVSARASTDESGRVVL
>fig|1279017.3.peg.3628 MFS permease (drug)
MSGATVAPSLPALENYFSQHPDSALLSRLVLSLPALMIAIFAPLAGIISDRYGRRRLLLLAVGLYGFAGTSALLQNSLEGILASRILLGVAVAGTMTSVTALVGDYFTPRERQVYMGQQGAFISLGGVVCLLAGGLLADLHWRGPFAIYGVALLLIPAVLIYLPEPKRSYTLKKSKSIAEKKIYWLGFSALLGAAMLNSLAFFLIPTQLPFLLQEIGASSPSQAGVAIAAGNLMGALASLTLFPRAHKIFGKFGIFAFSFTVMATGMGLISIAESFSGIIIAMAIYGSGMGTLIPHIFSTGLESATENMRGRISGALTASVFIGQFLSPFLSQPWVNHFGLASAFSTVALGLLLLAVIALITHWLKTKTSTEIKLR
>fig|1279017.3.peg.4159 Acriflavin resistance protein
MYQDKKTREEVLEAESEHRFNTARFFVDNPSISWALLVGVMLWGVFAYFFMPKSKDPDIPVRIAMATTTWPGQSAVKVEELVTKQIEDAIAQSEYLYQPDARSFGVKSLTLNGISMVQAQLAPHTDVTKAFNDLNLKLIDAQNTLPAGVESTQLNTEFGDTAAVLLAVASPPAGADEIALRAKTIREALSKIRAKNASNNREKEKQKVGQRVSMVVALPLSVAGINAEAALQVFSNWMELEGYGADFKILHGPGFVGVDFFSDKSDKQLAEARKLFLTQRLSAQTFFPDAWQPIIVRDLASTRARLSMVAGAKYSYRQLDDFSELVAANIRTLPQVKRVLRSGVLHQQVNLIYSQERLASYDLRPDMIAPILNARNNIIPGGTLTVENMDIPIFPSGDFNNYKEIGDVPVALSEDGTPVYLRGILDVTLGYESPPTLLNYYIYKNKQGNWHRHRSINLSVQMLDGEQIGELGKALDKVLARVKVDLPPDLIIERVSDQPRQVKESVGLFIEALIEAIILVVIVAFIGFSDWRSAVLLMISIPITLAMTFGFIQFMGVDIQQVSIAALIIALGLLVDDPVVAGDAIKRQMAAGKPSFLAAWLGPTLLAKAIFFATLTNVVAYLPFLLLTGNQGDFLHSLPVVMACALIASRIVSMTFLPFIANIILRPPKVKELSLDLKRKQGLTGHYYRLAGWAIDHRKLVLLTTTVILVCGFALKSQLKNAFFPDDVQYLSYVDIWLQNDASIDATDSVANKAEQIIRETIAQYQKEIGRDDSILEALSTTVGGGAPRFWYTINPQQQQPNYGQIIIRLSNKDLTPVLAPKIQQALTENIPGAYLDVRQLQTTPVTYPFAIRVSGRVTTGSVQEEQDILLLRQTAEKVKEIVQQSPYARTVRQDWSGESLTLLLNVMEDRAAMSGVTNADIALASSTGINGTEVATLRQGDKEIPIVARLRLDQRGQLEDINNLYVFSADSDVRVPLEQVAQTSIRFRTERIHRLEKFRTITVFAFPYAGFISSDIMADVKDELDELENTLPSGYQLQVSGDAANAKHGFLQLLMILCVSSSAIFLALVFQFSNLLKPLVVFATVPLGMVGALLALYVTGQPFGFMAFLGIVSLVGVIVSHIIVLFDFIEIRHAVGDPFREALLDAGIMRLRPILITISATTFALVPLAVHGGPLWQPLCFAQIGGLILATCGTLLLVPVLYTIMVVDLKWIRWEERGVKEGDGDIPVTA
>fig|1279017.3.peg.4226 Fusaric acid resistance protein fusE
MKKHRKYILTGGMVFLALFSLVLQFWKYLNNPWTRDGKVQADIIQVTPRVSGQVVELPIRDNQFVNAGELLFQIDPRIYEAALAEARAQYEEAIDTYNAQRENILAYEARLRESSAAIDLAQSNINALDAEIMKSRAEFERQQELLPQRATSVRSLQAAQADYESSVEYRAGAEASLAESLAVLEQSQADLARVRAQLGALGADNPGVRAALAMVRQAELNLEYTTVTAPVSGYVTNLDFRYGDQAVANQPALSIVDVSTYRIEGYFRETFIRRISPGDKAIVTLMAYPHRPLKGYVESIGWGIAQDDGTAGNDLLPRVNPTFEWIRLAQRIPVRVHLTERPESVDLRVGFTSSVLILSDTASAEQDEAAHSP
>fig|1279038.3.peg.162 Drug resistance transporter, Bcr/CflA subfamily
MSSVTAPSLPPTTPQPGLGFLAPLVLFTTVGPVAMQMFLPALPAIQQDFGVTAAEAQMTISLALLSFGLSMLVYGPVSDRFGRRRPLQIGMFLYCAGCLLCTIASSLDMLIAGRVLAAIGGAGGMTLTRAMVRDTYPPSQVAPALSQLMIGQIVPPMLAPVLGGLIAVSFGWRAIFITQTAVACLALLLVLRLPETLRERHIGASPLTLLTNYGALLRHPRFNAFTLFNAVGIGGYFLCLAGAPLVLINALHLSPADYGLIFILVPASFMLGNILTSRLARRFAPRVMIPLGAVFSLAGPVVGLVLVMFLPLTPWSVMIPAGIMTFGHGLSMSSAQAASMAVRPALAGAAAGLGGFLQMAVGALVTQGFGLIHDGTATPLLAGMAISSLSAVAVYGGCLMLDRRRSPGRAD
>fig|1279038.3.peg.356 Permease of the drug/metabolite transporter (DMT) superfamily
MPALARPSSFLWLALPFCVLWTSAFPAAKLALPDCPPLLLLTMRFLLAGALLMGWAALRGERLPGSRRVWGQLAVFALINPTLYLGLSWIGMVKASSALSTILISLNPVVVTLLAALFLREQLTGRKMLGLLLGLGGVVLVVQARLSGSGAEDPFSVLLIGLALIALAASTLLWKLWPLTTPRLMGTALQLLLAGVFFLPVALLTESPAGIHWTPRFLWAMAWIIGPVSIGAYLLWFRMLDTVSASEASAWHFLNPPLGLAMGVVALGETLQTGDLIGIVPIAAGIALVTRSTAAAPAPASAR
>fig|1279038.3.peg.372 Permease of the drug/metabolite transporter (DMT) superfamily
MPKPALLSSPPVLLLITGSILGTLAPLSRVAAGAGIPSAVFVFWTCLTAGLLLGAIALLRGQPLQRQHLRYSLIAGLISLGLPNLLIMVVVVPLGAGMTALTYTLPPLFTLGLAALIGYERLTRWRSLGILFGLAGAVTLVFSRFSLNGDSAQMLWMGLALLIPVCLAIGNVYRSRSWPAGAAPLTLAAGMLLSAALWVLPLGLYQGLLTGLPHWSVIAQGLASTLMYVAFFALQRAAGPVYLSQIGYVGATMGVLAGVVAFGERPGLPVACGVALIVCGMLCTNRRPAHP
>fig|1279038.3.peg.537 Permease of the drug/metabolite transporter (DMT) superfamily
MRPTQLDTFAMTTMVLLCATWGLTQPTVKMAAAEIGPVLQGGLRCLIAAVLVLLWCRLRGIRLFDHDGSLKGGLLVGALFAAEFAALFKGLEYTQAARAVLFLYCAPFVVALGGHFKLGEKLAPVQWLGLTCAFIGLLVGMGDSLSLPGGQELIGDLLALIAGLLWAATTLAIRMTRAGAVTPAKTLLYQLGTSVVVMIPLGLMMGETWPHFGTLSETAWGVLLFQGIIITFASYLMWFSLVSRYPVGLLSAFSFLTPLFGMAFGALLLGERLTLPFLSAAVLVGLGIWLVNRRRVKIAG
>fig|1279038.3.peg.673 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARLARFAEPADLADPRLKRLILTLALPSVAGLLINALYHVVNAAFVGGLGTPAVAAISLTLPVFSLVAALGEGIGVGVAANVGRLLGEGRSGQAGAIASTGLILATVIGLLVTGALLLAQGPVITLLGGGGETEPLARIYISILAFTCVLTLIQIVCDFIAIAEGNSRFSMYTLLGSFAVNIALDPLLIYTLEMGIAGAAWATILAKGVALGAYAVYFARRWGVVQVHTRLIRWRRRVTGPILAIGMPTTAASILTAVSFAILYHMAGRYGGESAVAAIGIAARVVLLGYFPIIGFCLGAQAVISYSHGAGDYRRLRDGVRFMLLVTTAFAAVFSAVMLLWPQAVVSLFSDDAGVQAQGASALVAFHLFFLLAGLECVLLVLLQSLGKGRLSAVVALAQRGYLLLPLLLALPLVWGMQGVIAGPAVAAGLAGLIVVPMFLWQMRTLKAQG
>fig|1279038.3.peg.887 Permease of the drug/metabolite transporter (DMT) superfamily
MSRLQAHALLLIAAMIWGSTFVVQKLAVAPDTSGGESIGALAFTGVRFLMGALVVLPLALREARAASQSLTRADWLGFLGCGVSLFAGAWLQQVGLGMTTVTNAGFITGLYVPMVPVIALLLFRRTPHWAVWPGAAGCAAGIFLLGGGHIDAFNTGDAWVLAGAVFWAIQVTFVGIFASRSGRPLALAVSQFVIAGVLGSIAAGLLETPRLELFEKAAFELAWAGFLSVGVAFTLQVIGQRYTHPATAAILLSSEMAFAALAGAVALGETMGLIQAVGGALILGSIILVEVMPTLQRRPLKAAE
>fig|1279038.3.peg.899 Permease of the drug/metabolite transporter (DMT) superfamily
MSQVSSPASSSAPTASVSDSRNLGLYAGVVAIWGTSWIALKLQVGSGVEVLPSVAYRFGLAAAVLFGWCLLRGLPLRFSRAQHLRMAAQGALMFTFNYIFFYYAALYLTSGLLAVASSTVILLNLILGLLFLGQRLEPRLVLGICLGLIGVGAVFWPEISHFSLSDAGTRGLLLSLGGTVCVALSMTLSARNQKAGLPVLQTNAFAMTYGAILTVALAIISGTPFSFAPTVAYVGGLLYLALVASILAFGAYLTLAGRIGPTRASYASVLYPIIALALSTVFEGYHWAPSAILGLGLVLIGNILVLYRKTPAR
>fig|1279038.3.peg.1025 Permease of the drug/metabolite transporter (DMT) superfamily
MPLPHIALAVLVTALWGINFVVIKIGLHDFPPLMLCALRFLFAALPAVFFLRRPDVPWKWIVALGATLGVVKFGLLFVSMKVGVSAGLASLVLQTQAFFTILLAVLLLGERLTLMRVLAAAIAFSGIGVLVSGADTAELPLTGLALAICAAVAWGFANLIQKRCAGSKPLNLMVWASLIPPVPLMLLSFGLEAGPAQAWQTVQAASLAGWGAVVFLAAIATLLGFAIWGWLMGHHPAAQVAPFTLMVPVWGMGSAALLLGESLTPAKLLAAALILSGLILNTFGDRLLQRLRPQTP
>fig|1279038.3.peg.2077 Membrane fusion component of tripartite multidrug resistance system
MAKRVLRVLVLTGVLTGLVGGAAWFWKSRQGHEHTDNAYVHGDLTVISPKISGHVVDLAVEDNQPVRAGQVLLRIDARDFQVKVDEAAAALQGAEAAILGIDRRIDAQKTVIEEAEAGIRTWQAELDLAQRELGRTASLVKEEAASRQRLDSNQAALSKARAGLDQARAKVESSRAQSAVLEADRVRQQAAVAEARAKLDAATINLANTEVTSPVDGVVGNRAVQLGQFITAGSHLLSVVPLDTVWIEANFKETQIGAMRPGQPVTVTVDAYPDLRLTGAVASFSPASGAQFSLLPPENATGNFTKVVQRIPVRISLSADNPLRGQLRPGLSVVVDVQTGAGGTGSANAAER
>fig|1279038.3.peg.2527 Acriflavin resistance protein
MNVSELCIRRPVMTLLLSIAVVVLGLFAYKKLPVAALPSVDFPVINVSASLPGASPETMAASVATVLEREFSTIAGVESITSSSNLGSTSISIQFVLDRNIDSAAADVQAAINRTLRRLPSEMTTPPSYRKVNPADAAIVLLALSSPTMPLSQLNDFAETVVQPRIATLSGVAQVLVYGSQKYAVRVQVEPNALALRGIGLDDVQKALASANSNTPVGSLSGARQQMILTSNPQLPDADAFRNLIIAWRGNAPVRLGDVATVLDSVENARTASWYNGTRAIVLAVQRQPEANTVEVVDLVRQQLPAFRAQLPPSVSIDLMNDRSTSIREAVEDVEFTLILTIVLVVMVIFLFLRRAAATLIPTLAVPISLVATAGAMYLLGFSVDNISLLALTLSVGLVVDDAIVMLENIVRYIEEGLKPFDAAIKGAREIGFTILSITLSLVAVFIPILLMGGVVGKVFHEFAVVVTIAIMVSAVVSLTLTPMLCSRFLTREKHGEEEGPVGRALEAGFDALLRGYKRGLLWSLDHMAVMGLLMIATVIGTVVLFREVPKGFFPTEDIGQLSVSVEAAPDISFDAMVEKQKLVAATVQAHPAVAGATSAIGGGASSVISSGRMFVTLKPRSERPGIEKVIQDLRKEVGKIPGIAVYLNPVQNLRIGARSSKNTYQYTLQGLDLHDLYDWSDKLQDAMRRIPQLQDVASDLERNNPQVYIDINREKAASLGVNVDQVRSTLYSAFGQREAATIYTPSNDYAVLIELDPRYQQDESALSLVYVRSSTGSLVSLDSFAAVRRTVGPLSVNHQGQMPAVTLSFNLAPGVSLGDAVDLIHEAERALAMPVTITTSFAGTAQVFQQTLSNQGVLLAAAVLVIYVVLGILYESFIHPITILSGLPSASLGALATLILFKEDLSVIAIIGLLMLIGIVKKNAIMMIDFAVAARREQNLSPREAIEQACLLRFRPIMMTTMTALMGTLPIAIAFGAAAELRRPLGLAVVGGLVVSQTLTLFITPVLYLYFERLSQWLQGLGRRPDSSDAPQAAE
>fig|1279038.3.peg.2889 Permease of the drug/metabolite transporter (DMT) superfamily
MRDAFYYAFCVLAWGSTYFAVTFLKGPVPPSLSVIYRLVIVAVVFALLHPLLRRRLTGLSARTHLWLVLFGLGNFGLSYAMMYAAVTMIPSAHAITLFAIKVVMTPVLLGLFLRERIPRAIWVGGVIGIAGVVLMFWPQLAGGDLRGDAWMGFLLTLGGAAITSFGDVASTRLIRAGGDPMTLTFWGTTYGVLFLIVVALVQGQALVWDPSLHFALAMGWLVVACSIVAWLMYMHLVKTIGPARCSNMVTLFPVVGVALSLAFEGVAPTVNVLGGAALVTAGAFLANRGKLAA
>fig|1279038.3.peg.2916 Multidrug resistance protein A
MTDSSAAAAVLPARSGGVDRLRLALFAALPVALAAGAYAYASGGAVMSTDNAYVQADMVAVSTDVSGLVKSVDVQENQPVTAGQVLFRLDDLPFRLTLQRAETKVQTVRNDLLADQAGYRDLQAQIQRAQADIAYYANELERKRQLVNSNTTPRSAFDDARHDAQTAQLKLASLTQQAAAMAARLDGRPADDVETYPAYRDAVAARDEAQRQLDHTVVRAPMDGVVTRVPSLQAGQALPAATPAFSLVATDHVWIDAQPKETELTWVHAGQPVTVTVDTYPGAVWHGTVDSISPASGASLSLLPAQNSSGNWVKVVQRIPVRVRIDTPEGLPPLRVGMSATVDVQTGHVRGLPLVGDHG
>fig|1279038.3.peg.2917 Multidrug resistance protein B
MADGPVPAAGFQPVPHRGMITACVTLAVIMQALDTTIANVALPYIQGAVAASADQINWVLTSYIVAAAIMTPPSAFLARRFGRKRVLMGSVSGFIIASVLCGIAQSLPEIVGFRLLQGLCGAALVPLSQSILLDLYSAEERGKAMALFGVSVMVGPVLGPVIGGWLTENTSWRWVFYINVPIGVLAVLGLSAFVKETARDTAARLDWVGFGLLSLTIGALQMFLDRGQQLDWFSSVEIQAEALLAAVAAYLFIVHTATARRSFVDPSLFRDRNFVVGLIFIFTIGITYLASLALMTPYLESLMGYPVVTAGLVMGPRGLGTMVFMFLVGRLIGRVDTRLLLATGMAMTAWAMYDMSGWTPDVAASTIVWVGFVQGAGLGFLFVPMSAVTFATLPLQKRAEGTGLYNLSRNIGSAVGISVMAALLTGNTQINHAEIAAHLTPFNRILEQPVFAHVYNPATAAGQAALDGLVTHQAVIIAYADDFLLLMVLSLITIPLVLLLRSPKQAAGTKPEPVVAD
>fig|1279038.3.peg.2963 Permease of the drug/metabolite transporter (DMT) superfamily
MPETAAMPALPLTSSPLRTGLLLGTLGVILFSLTLPVTRLSILLSGLSPLAVTLIRLDVASVLAALFLLLARARLPARALLPDLMAVAGGAVIGFPLFMAYAVTLIPPEQSPASHAIVVNGLLPFATAVAATLLCGDRPSPGFWLVALAGSGCVVGYALTLGGGAFSVGDVAMAAAVLSAATGYACGSRLSRHLPSWQVICWAVLLCAPLALPLTIALPWIDGPIPAAAWSLPSLASLLYLGAISQLIGFFAWYRGLSLGGTARVSQVQLLQPFLSLLGAAVLLNEVLTPLTLIMTVVVATLVMIGKRMPVKVG
>fig|1279038.3.peg.3172 Quaternary ammonium compound-resistance protein SugE
MSIHWIILLIAVFTEIAWALSLKAAQTNPGVLTIGASIALTATNMLLLSFAMRGIPVGTAYAVWTGLGAVGVVAAGIILHADPLTLKRVAFMAVIIFGVIGLKLVGDEG
>fig|1279038.3.peg.3443 Permease of the drug/metabolite transporter (DMT) superfamily
MSVRDTLLALFVMILWGANYVAVKLGVSEFPPLLLITLRFALVAVLLVPFYRITRRQVPGVLLLSFSFGSAHFALLFVALQMTEAGTSALLLQLGVPFSTLLGVVFLGDRLGIWRISGLLVAFSGAAVLAWGPHVPAFAPAALLIVSAFFWAVSNLLVKKVTDVSPIALTGWMSLFAVPQCLLWTLLFEHGQIEAIQQASLVGWGAMVYTAVGSSIIAYGLWYWLLGRYTVSQVVPISLLNPVFGVIVGAWVLGEAVGPEKIAGGLLTLGGVGIILWRQAKRGGA
>fig|1279038.3.peg.3556 Permease of the drug/metabolite transporter (DMT) superfamily
MSGGAATPPGRSLTKYLMLLAISLFWGLNWPAVKTILSQVPPLTLRAVGFSLGAVIILSLTRLTGRSLSIPRRDWPSLAAAGVCNVLVFNLCTAFAQLGMATSRAAVIAFTMPVWATLLAIPVLKEWPRRQQIAGLVCGMAGLAVLLGPNGLQQGFGPGLMLIAAVSWAIGTIVMKRHVWGGAVMAVTGWQYVISAVPMVILAALLETPPDPSGFPPQVWLAISWHLLLSLCAAQVLWFVVVSRVSVGQAAVSTLLIPVVGVTGSVVLLGDTLTPALVIALGLILTGVACVLLPAKKR
>fig|1279038.3.peg.3702 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MAIALDGAVTVASESSGQGPFLSVVVPVYNEGEALHALHSRLTAVLRQMPVSRWEIVLVDDGSRDTSFEVIRDLAAADPAVRGLRFARNFGKEAGMAAGLRAAAGDVVVLMDGDLQHPPELLPEMLQRWTDGAQMVTAVRRSRQTDPTTRRLASRMFYWLFHYVSEVEIPEGAGDFRLFDRAVVDAINSLPERNRFMKGITSWVGFRQVLIDFEPAERVGGQSAWPFLRLFRYALDGISAFSMVPLRVWSIAGVTIALLSVIYGGWLVVRTLIWGIDVPGYASLMVAGLFTSGIQLISLGALGEYIGRIFNEVKGRPLYIVADRVGQDPRSDAKTETRS
>fig|1279038.3.peg.3744 Permeases of the drug/metabolite transporter (DMT) superfamily
MSAAQTPPSSQAAGLLTSPWVMMVIPPLLWAGNAVVGRLAMAQMSPYALSFWRWSFALLLLLPFTLRSTLAHWGVIRANALHLISLGVLSVGAYNTLLYMALQTSTAVNVTLVGAVMPLVILLLSRILLGEALTVWRVAGLAASFFGVAVVLARGDLSRLTALDLHRGDGLMLLAVLAWSVFSVRMKARPLGLPPMVFLTVQMLTGLWVAVGAYLWDLGTGGGQVPMTLEALSMIAYTAIFASLVAFLAWNRGIVRLGANLSGFYVNLIPVFTAVLAVPVLGEPLQAYHFIGMGLIFAGIGLAAVRGKQQKAEGR
>fig|1298593.3.peg.419 Acriflavin resistance protein
MNLFGYIHRYKRLILALTAMFMLLGIASWLTMARQEDPSFPYRTGTIRVVFPGVSAEQIEKLITEPLDEQLAEVEELRRVKSTSRDNVAIFVVELLDRIYDTDAAWDRVRRAMEKAEQDFPKGVVEYVLEDRRMDIPAAVISIVGTADILELAHQAEILKRQLLAVNGVSRIEIEGDPEKELRIDLDSAILSQLSINRDQVVAAIQVHNQIIPGGVVRIGDHALRVDTGSDLQQKSDVESIPIRLATGQYIPLSAIAHIAFVAREPSAAQTYHNGMRSVSLGIYAKRGQVDAIVFGEQIRQRIDAVRADYQPLDIVETFFQPDYVADRLEGLQFNLLGSILIIAITVIAALGWRNGLLVAGVLPVVAIIVLALYNLGGGVLHQIAVIGIVISLGILVDNAIVVVESIVQELQAGRSRLEAVESAFEQMAFPLFTSTGTTVAAFIPLLLSKGGTGDFTRGIPVMIILSLLVSYVISVLVLPLVAERLVGIPKHDNQRWIKKISDKLIYISRYKAKLALLLVVGVMALTIMAFPLLKLQFFPQADRNQVVIDMTLPGDSSLERMAEVSADVEQKLLARDDVVGVMRSVGMSGFRFYYNLLATIDSTNSARLMVNTRDMAANQAVIDWITHDIQTALPEATIIAKRLGQGPPTPAPVELRLQSDDPSSLYQAADQVLAILNALPETTMIRSDKDSGLAELSVNIDKTIAQELGVRRDQVAASLFGQTRGLDAGEFLYSDDPITMRVRSAAGDLTTTAELSGQYIYNAAGQSVPLDAVATLKSQWTSAVIRHYKGIPTVTIHSELMPGAAYNTVLKKVFAALDENPLPGAVTLQLGGDAEGSADANRAILKSVPIGVMLLLLFMLVQFNSFRRLTIILATIPLAAVGIIPGLVLSDQPFGFQSLLGVIALIGIVVNNAIVLLDVVDARLREGADIDSAVAQSIDARTAPILLTTATTVLGLLPLAFSASTLWPPMAWAIISGLLMSTLLTLIVIPVLCRMMLKTNPVAM
>fig|1298593.3.peg.796 Drug resistance transporter Bcr/CflA subfamily
MYLPAMAQMAGSLDSDIHHVELSVSTFLLGFAIGQITGGPLSDRYGRKPIIIAGLTIFAIASLTLSMTTSLSGLLILRAIEAIGGGLATVNSTAIVRDRFEGKDIAKVLSMVAMIMMTAPLVAPMLGSLIVSFSNWRSIFMLLSVYSAFVMILLVWLLPESHPPHRRSRAKPWVGYGVVLRHKVARRFILTLACAYSGMFIFITASPYLYLDYFEQSAAQFPWLFGANVVVIMMVNRINMLLLNRFKPIDLITTGISIQVVMGCILLTLSRYFPDAFTLWTVLPLMMAYVGALGLISANSMATVLQYFRDVAGSATALIGVVQFCGGAAFGLLWGQLHDNTPVPMMAMMFLSAFCAFVALMAARYSREIYEAPAT
>fig|1298593.3.peg.993 Acriflavine resistance protein A (AcrA)
MSGIILKRFFEEGASVNAGEKLYQIEPTLYEAELASAEAQLAVAEANAYSAHLRAERYKKLSKNSAVSEQELDDSEATAKQTEAQVKAAQAAVRSARINLSYTEITAPISGVIGRSTITEGALVSAQQSTALTIIRQLSPIYVDIQRPASSVLLMRNPALPREVTLSLEDGTSVEKTGELQFSDANVDPGTGTVNVRALFENADHLLLPGMFVRANVPSSLIENALLVPQQAVMRQAGGATTTYVVNSDNVVEVRGVEVTRAIGDKWLVKSGLKTDDRVVISGLQKIKPGVTVTPEETK
>fig|1298593.3.peg.1495 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTFKAQEVKAIIRLTLPILATQLAQIGMGTIDTIMSGYVSTRDLAGVAIGTAIWMPIWMLLAGILVALSPMTAQMNAARQRDAMPRLLAAAIYLGLVAGALAGIVVAAIAYSLPSIIEDTATAIIARDYLYFIALGMPPSGIYLAYRFYAEAVNHAVFPMRIMLVALLMNIPLNYIFVYGALGMPEMGGPGCGVGSLLVILFLMVANAWDTRQRRITKEFPLWEHVRHPNMEYVKDLFRIGMPIGIAIFFEVSLFTVIALLITDLGPTVVAGHQVALNISSLTFMIPLSAGMALTVRVGHHLGSKDIIAARTTAWLGVKLNFGLALFNATIIVLGASYIAGLYSPDPLVVAVASSLMIYAAIFQISDAAQIAAAGALRGYRDTVAVMIITFVAYWLIGLTSGYWLAYGESTQLGAKGFWMGLVIGLSCAAIALCWRLYLISQRPEVISTEEKALNN
>fig|1298593.3.peg.2274 Permease of the drug/metabolite transporter (DMT) superfamily
MLNIAIFTSLLFIAIGRLPGGIAATLVATLPLQVIMIRAIFGIRPEMHHVFAAIGGVVGVACLVWQSTESLDSWGVVAALSASFIMACGILLTARWIKDIPPLQFTSAQLFISGVVLLLYVILSGREVPDITPSGMLALAWLGPIGMGMGYWLWFRAMKAIPIQRLSFLGLVNPVVAVLVGVFFMSEEISTGQLFGMCLVLLCVVVGQRK
>fig|1298593.3.peg.2315 Permease of the drug/metabolite transporter (DMT) superfamily
MFSKEALAEFPPLLFIGTRFLLAGLLLTIPGFKPLTRLTKKQWKASAGVGVLFGAAMSFWIIGLFSAKHLGEGSFITSLSVVLVPLVSWLLFRDSISRSNWIALPLAFTGLGLLSLQHGFQPEPSQLFFFISALLLSLTFILNGRAASHVPALALSAIQLSIVGIVALSLSAATETWPDHWTGNMWWWLGLSITVGTAARFFIQTYAQGMSSPSHAAVIMIIEPVWTSLFAAAWFGERMEPSQLFGCSLIFTALVVNRWNAVRKWLKRS
>fig|1298593.3.peg.3261 Acriflavin resistance protein
MKSSISWFANNPVAANLCMICILVLGFLSIPETRKELLPNVSLERISIQSKLPGASVETVESSICRPIENRIYDIQGTIDLTSYAYEGICSITLDVDEGFVTKEIVDEVKSRLEAKDLLPKEATTPDVVELTVRNRVAKLILSGPVSYSVLTASARQLRTDLLEFSAVSIVELEDMKKSEIRISIPAFNLQKYQISFDEISAMIQKQSGFLPGGMLQTSEGDVLITSDAYRDSSESYANIVIAADPDGGEVRLGDIADIIDNRFSNQPQASFDRQPAVSIDVFRVGNQNITDISDVIHNHLADSNLPQNVKVYVWQDESKNFQSRVDLLVSNAFSGLVLLFIVLLLFLSARLSFWVSLGIPIAFLGTIFILPVFDVSINIVSLFAFILVLGIVVDDAVVVGESIHLQNQKGLYGTEGALQGVFEVYKPIFFAVATTVVAFLPLVSLPGPEGKLMRAIPIVVIGTLIFSLIESLYILPAHLSGTHKNEKPGNKVLTAIQNVFSVFLDTLIKWVYTPVLTVCLRNKGLVVLTFTVVFALFMVLLSQGWIKTALFAAIEGDVVVANVAFPEGSPREKTEKALRHLIAAADQVQAEYEAKDASAIEHIYSVVAPKNTFTSYSVDKSMDHKGQVIIELPSSETRTYSGQDVLARWRELAGDIQDTTSLQYSASLNPTNPDIQIEFSGYDIDDLMSAANQLAEKLREYDGTFDIHTSQEEEKQEAEIKLKDNAVALGLTLESVIRQINRAFQGNVVQRIQTQDDEVEVWVGLPKNERSSPWYLENMHIEYAPGQYVSLSTIAAIEYRPSKTHIKRYDRKRVISVSAFVNPAQNSVKNIQTDLATNYLDGLVKNMPGIKWDVGGYQRAVTLFLDILMKYYLFAILAMYLMMAVLFSSYSQPLLVLYAIPFGLLGSVTGHILLDLDLTLWSFVGMVAVSGVVVNDNLVLIDYINTQRAKGENVFVSVCEAGRVRFRPIMLTSLTTFVGLAPLISETSVQAQFLIPMAVSLAFGVVFATLISLLLVPATYLMMVEWQTTLLRLFKQTPKGSSEDPVEAAYQRGFEQGTRNARKAVCPYKDDVLSSSWEAGLNDARNL
>fig|1298593.3.peg.3287 Permease of the drug/metabolite transporter (DMT) superfamily
MFDRPRSSVQYMLLSALGFALMAACVKGAANSGIPVLEIVAARAIVSILLSYLDIKRKRLSVWGNNKPLLVARGSIGALALICVFYAVSTLPLAQATVLQYTYPAFTALIALWFLRESVQFSTMICIGMSIAGVIVMMQPNFHEGVLASTSMLSITAALVGALGSAVAYVMVRHLSQTEDSSVIIFYFPLVAFPIASAALLSADIFVSPNIEQLGLLLLVGIFTQVGQIGLTKAMAMAKAGKVAAYAYVQVIFSVILGWLFFTEIPSFWAAVGGLIIMSGALINTFYKR
>fig|13035.3.peg.1380 Acriflavin resistance protein
MVSSSTPEQDRPLNIVGRITAYFVNSQVTLLIIVALVIFGLAAALFTPKEENPQITVPGADIYFHYPGAPAEVVEETVTVPIEAKIRELPGIDDIYSTSQTGQARITAQFFVGEDWENSLFRLQNHLFNSQDELPQGVNYQVNPLIVDDVPIVTLTITGENYSDNQLRRVGERLLRELRQIPDTGNLTISGGQPRVMRVDLNPEQLAAFQLSPAAIAQQIQAANIQVQAGDVSVGNRRIFIEGGNLLETADELKAVVVGQGENGSPIYLEDVATVSDGYDDRVTYSRLLNRKDWDVTAPYPDPSLQPEEDFEERPAITIGIAKKKGTNAVVVAQQIFDRVDELRDEIPNDITIAVSRNAGRTAARAVGDLYSSLFQAIAIVVILLIAFLGWRDALIVALAIPLTLAGTLLVGWIAGQTINRITLFALILSLGILVDDAIAVTENIHRRFEEMPDQSFSQKVRTATLAVAELGVPILLSTITVILAFIPMAFVTGMMGPYMGPIPFNVPVAMIISTSLAVIVTPYLAVRVIKVKGRSTDNNESNDGQASEEVPNRIYTFYRRIMEPLLDSATRRRFLIFFVVGLLLASFALPLTQAVKFRMLPKADEERFLVQVDAPLGTELVETDRIVREMETVLKEDSEVIQFESYVGTAAPIDFNGLLRGNTHRSGEHLADIRVHLTNDDARSVSSEDIVFRLRPQLTEIAQENNAIVKLIEDPPGPPVRSTMLAEIYGPDYERQRELSKQVADVFRNTAEVVDVDDSVKNQIPQMKLEVDRAKANQAGLSTQEIAETINMAIRGVDASTLQVPGELTPVQIQVRFAEANRQSIDDLRRIQMPTPEGNLVPLTELVTFTSTTVDQPIFHRNQVPVTYVFGEMNARSSVYAVMEQMIHFFRNPLPEGYSIKWEGEWQLTLEVFRDLGLAMLVAVILIYIILVGQFRSFKIPLIMLGAIPLALIGILVGFSLNGVYFSATGMIGVIALAGIVVRNAIVLLEFVGDRRKEGIELKEAVIEAGAVRFRPILLTSVTTMLGTLTILSDPVWSGLAWTLLTGMLTSSALTLFIIPLMYYGDQRSSRKQEQTPVNEKQLVADN
>fig|13035.3.peg.3896 Permease of the drug/metabolite transporter (DMT) superfamily
MQNLIYSNFSLAALFVLLWNSGFIGAEYGLPYTGTFTLLFWRYGALTLVLFAYLLLTKQLARQPLKTILHTSLVGVLAHGVWLSCALLALEQNVPAGIVALVVALQPLATGAFSGLVVGEQASRWQWLGLITGFLGVAIAVGTRIQVNDEASFFGYFIPFGSVIAITIASLLQRRRETSSQNYPRLSVAETLFYQSFATVLILTLPAVSIEKLEIQWNLALIATLSWLILGVSLASYGLMWKLLSRLDATRVASLFYLGPPVTMAMAWVAFGDTPQLADIIGLLVVTAGVMFVQFPQLRPR
>fig|1303518.3.peg.248 Permease of the drug/metabolite transporter (DMT) superfamily
MAFGPFTLTFVRFAPAGLILLLLARLRRRLPPIAREDLWLFLALGGIGIAATYGIFYFGLQRTTATDASLLFACEPILIALFGYLFLKERLSWLQWTGFLVGITGIWLIAGRALGDWLALAGLACECCVSVPAKRLAMRYPGLLVVAYEMLIGAALMLPLALWEWHHHPHEVSLRPLAALAFLSLVCSVFCYGIWYRLLSRHAISQMGVFILLQPLLGPLYGHFLRGETLRTNTLIGALLVFCGIALTIYRKRSSTDSLRG
>fig|1303518.3.peg.320 Membrane fusion component of tripartite multidrug resistance system
MSDENRDSRVLLEPEQKVETPSTVSDGLGAEEGEAPKRKATIKVVGLVLLFFALIIGGIVGYSYWRYASTHVSTDDAYLTTDVVQITPQVSGSVAKVYVTDNQHVQAGQLLVMLDDSTYRAAVEQAKANLKAAIAAAQGASTGVGLTQQTTLAQITQAEAGVTQAQTGVETASADVSRAEAAYAAAQTGVQTALQTAKTAQAGVVAAEAAYRKALQGVQAAKQRLADAEATLQSAKANVVAAQAKAKQAATDAKRYDQLYQEDAVSAQTRDAADTAAIAAQAALESAQQAVSQAQALVGEQQAALNSAQQEVTTAQANLQQARAQYAAALYGIKVAKDSAKQAQAQYLAAQKGVNAARARVQQAEAQLQQAETAPAQVAVQKSNAHTAAARIAQAAAALHEAEIHLQDTRIYAPVTGRVNAKTVEIGEQVAPGQALMAVVPDDDIWVVANFKETQITNMRPGQPAEIHVDAFPGITYHGHVDSLASGTGAVFTLLPPDNATGNFTKVVQRVPVKIVFDPKQPGLDKLRAGLSVEVSVKVK
>fig|1303518.3.peg.331 Inner membrane component of tripartite multidrug resistance system
MTASNLAAKNGRRVVLTDTGEELSPYRWIILVGLITTAILEVLDTTIVNVSLPQMAGNVGATTEEISWVATGYILSNVIVLPLTAWLASRFGRKRYLVSSIILFISASFMCGTSRTLGEIVLWRIVQGAGGAAFISTVQATIREIFPREQQGTVQAIYVMGVIIAPTLGPTIGGWITDNYTWPWIFFVNVPIGIVAALIIGLFLTEAKHKMQIEKVDWLGISLLAVGLGSLQYVLEEGNRNNWFDDPVITRLTILSAIALIAMVIWELSPRNTSPVVNFRVTRNRDLSAALILFLILGFGLYGGVFLYPLFAQNVLGFTATLTGLVLMPGGIATGIAAMFCGRMLNGKVMRADPRIFIWTGLTLFIYSMWSLAHLTPQSGEPAVRLALIIRGLGLGLLFTPINLVAFNSLKGVEIAQGASLLNLCRQLGGSFGIAILSTYLDNMERFHATMLSTHLYPENPYFQSRLTMLQHYLMTRGHDAVQAHKMALALISYTVQSQAATMAFNNAFLLIGISTLCVSPLVLIMRVRRKPSTNAAAEAMH
>fig|1303518.3.peg.776 Vancomycin B-type resistance protein VanW
MSRSDRHLLQRISAWRQEKGLLRLFVLLPLPLLAIGSSLLLLYSHHLHSEDVIASGVHLFTLDLSGKTPEAARGEILQWAQDRAATLLTLHAQGIANHSSVSIRARTLGLGIDVDSTLQTAEDAGRTGWLSKIVSLIRSSKPDYPIAPTVTVDQKQLHEALTHVAHLTQVPPINARIVLLPKGGFGLKHEVSGRAIDVDAAASIVTRAWQQFNTPPAPSTDTTDRDGAATTGNLEDRLELNLPTQVIQPRITYNILHTIDSKLSSYSTWYAEGKRGHNIEVATEKIDGTLLLPGQIFSFNNTVGPRVLASGFEVAPVIIHGQLQPGVGGGICQVSGTLYNAALKAGLKTVLRNHHSFPVSDGGIPTGRDATVAYGELDMRFQNSLPYPVYIVGRAHGGLLTFDIFGHADPDRTVQLVRGRLHEGDVPVEIIHDPNLPPGRRVVEQKGRPDVRTVWYQIVRVNGKVVSRDVIPSHYEGQPEIVRIGVKASPAARQPKAHPPTVQPAQPPAPG
>fig|1303518.3.peg.1132 Permeases of the drug/metabolite transporter (DMT) superfamily
MSPLKWKAAFITFIAVFAISFGEAMLSRGMKQIGDGTLWHQVGAVLHNHWVIIGTTFMAAYFFLYMWALKIAPFSFVLPITALSYPLGGLLATTFLKEHVGPLKWLGYVAIVIGVILVGLGEASGK
>fig|1303518.3.peg.2341 Vancomycin B-type resistance protein VanW
MRWTEALGLGLFALASGYGFLQIAATSPPREVRIAGYVSSLRGRSPSQRRNARLAAWAVNGAVVPPGGLFSFDKRVGSWSADHGYVQAPVSYDGELVNAVGGGVCQTSSTLYNAALLAGMQIVERHPHHFCPEYVPPGRDAAVAQTIIDLRFKNPYPWPVRIECRATQDTLEASFWAPKQPTLQAHVETQILSTTQPQRKTMILSNNSRGHGLHARLLSIGVPGYRVITYRTFTRPDGTIVRRERISDSTYAAADRIIGIYQTSLR
>fig|1316932.3.peg.466 Permease of the drug/metabolite transporter (DMT) superfamily
MFKKYFGEIILFLVTFIAAAGWFFSKHALVGLPPIGFMGGRFILASLILLPFSYRELYRLDKVQVKYSVITGLTYGIYTIFWVLGLAFSTVFGEGAFLVSLAMLIAPLLSWLIFKHTPPKIFWLALPIALSGLYFLSAEKGIFHFSLGSTIFLVSSVFGALYFVLNNQYAKQVSLFPLITIQLAIVGAVCSLYSYFMESWHFPILTEVWLWFAASVLIATNLRFLMQTLGQKYCHIGTSALIMLLEPVWTLLLSVMLLGEQLSATKWLGCSLILIALIIYRLPILRLKK
>fig|1316932.3.peg.670 Permease of the drug/metabolite transporter (DMT) superfamily
MLYLLIATLIWASSFIVGKVAISAFDPVQIMQIRLTLAAFIALPFFIPAYKKIQKNQHIKVWLISFLTFPLYVILQFSGLKLTSAASAVALLGLNPLLTVLVGYFCFKKQATRLDFILSLFACLGILIMASGSDDSGSINVLGLLLVTLGSLSFIVGMYLSKEILQSVKVIDLTKIMLVQGAITALPITLLFAENWQLPTSLSAWASVAYLGIICTSLAILLWNKGISQSSPILAGILLALEPVFGLLMALVFLSEQLSLVTWVGIIIVICTALLSVLLPMMKRYKRLI
>fig|1316932.3.peg.2559 Permease of the drug/metabolite transporter (DMT) superfamily
MISSSLKLGYFSLIVATLFWGGNFVLGKVLSGAVQPITLTYLRWLPAFLILVLLFFRPTWRVMHLLKPRLGVMWVLGLLGVILFPATLYEGLKTTTALNASLYLAISPVLVLFLNRLVFKEKISPIILSGAIISLLGVLWLLMQGKLTRLFSLAINQGDLWAIASTISWAVYCCVIRLRPQGISNTVFLTVLVGLAVLTLTPFFIYEYVAESAKNLANLTALQWSGIGYLVIGPSILSYAFWNFGIAIVGSAKGAVMTNFTPLFAAMFSIILLNESVHTYHIISAILITAGILICSYKKH
>fig|134676.3.peg.429 Multiple antibiotic resistance protein marR
MTERVMTTERTAASLAKTLREAIIRFSRRVRQARPVGDLTFSQLSALTSLQLHGALTPRELADVERVQPPTMTKIVGKLEDRGLVARTPHPTDGRQVILAATDEGRAVYTQNEDIRNEWLAGQLDRLTPEERDTLARAAEIMLRVARG
>fig|134676.3.peg.479 Multidrug resistance protein mdtL
MTTATARQPAPTVVPARLSRPAAFTAIAAILVTFAAASAVPSPLYVVYQHLWGFSPAMLTVVFAVYVVALIATLLTLGALSDYIGRRPVLAGAILLEAVALTLFLTAGDVGTLLAARVVQGVATGAALSTLGATLIDLNPAHAPGRAGLISGIAPVAGLGIGAFGCGVLVKFAPFPTHLVYALLLAGMVVAALAVAWMPETSGRRPGAAASLIPRLGVPARLRGDLFALIPIIVASWALGGLYLSLGPSVASDSFGIHDHLAGGLVVALVCGTGAVTSFLLRQVATPRVLTIAGSGLLLGGALGFAGLETGSLPLAVIGSIISGAGFGAAALASFSTLARIAEPHERGELLAVALTISYAALSIPAVIAGQTATHIGLHITALWYAAIVAALALLALVAQRLRSRSRA
>fig|134676.3.peg.506 Antibiotic transport system permease protein
MTGLGGLLRLILRRDRVILPLWVLLLGLLPRVYLTGFEKLFATDADRLNYAHLSAANAGFVALYGPLSGDSMGELVVWRAGFLPVMIGLAALLTVIRHTRAEEEAGRSELIRATVVGRWAPFAAALLVTLTGCLIVGVLVTVTMIGGGLPVAGSAAFGAVFTLSGWLFAGVAAIAAQLTSGARGARTIAVLALGVSYVLRLGGDISAQGDGRLGRLSWLSPIGWVQRIFPYGADDPWPGLLALLGTGATVAVGARLLARRDLGSGLIADRLGPAHADRALGSPFGLAWRLHRGRCSAGPPASARSGWSSAGWAPAWCSCPGRAAGSATCSAGSAAAGRSPTRTSPPPPGSAGWSSRCTRCRPPCGCATRSRPATRS
>fig|134676.3.peg.507 Antibiotic transport system permease protein
MRDEEQTGHAELILGTRASRVGWAAGHLLFVLLGPVVALAVEGLLAGLAFGEPGRVPAASLAQAPAVWVLGAIAVLLVGALPRHSAAAWGSVAICLLVLLVGGLLGMPQWVLDISPFTHVPQLPAAGFTVVPEIVLILIAALLSGAGLTALRRRDIPA
>fig|134676.3.peg.1586 EmrB/QacA subfamily drug resistance transporter
MVLSLAQLMVVLDATIVNIALPTAQASLHFSNADRQWVVTGYALAFGSLLLLGGRLSDFFGRKRMFLIGLIGFASASALGGAANGLEMLIVARALQGAFGAALAPAALSLLSTTFTEPAERGKAFGIFGAISGAGGGIGLLLGGVLTEYVSWRWCLYVNLVIAALAVAGAMLKLKDEPSGAHGRIDVPGTIAAVVGLVGLVYGLGKAETDGWTARGTLGPIIVGVVALILFVLIERRVEHPLLPLRVVLDRNRGGSYASIAIAGAGMFGIFLFLTYYLAVVLHFTPVKTGLAFLPMLGSVMLTATTAGSILAPKVGPRPLVPLGALVAAGGLLLLTRLDLDSTYASGVLPGLIVIGLGLGLVFAPTQNAATSGVEHRDAGVASAMINTVQQIGGSIGTALLSSFAATAATDYAKGKQPSQLLQLQAQIESYHTVFWWSAGFFVLAAVVALVLFRTGPLDVDPDAPPAMAH
>fig|134676.3.peg.1690 Glyoxalase/bleomycin resistance protein/dioxygenase
MPIRTITVPVKDLDAARALYTRLLGVEPYADAPYYVGFRPDGGPELGLDPHGDVAAGPIVYWHVDDINAELTALIAGGGTEERPVHDVGGGTLIATFRDADGNLFGLHQGAAS
>fig|134676.3.peg.1962 Multiple antibiotic resistance protein marR
MRLPRLIFLLFNADRAVRRWIDARSADTGIGASGAGVLFYLAGHENALIGDVTAALGASPSGMSGLVNRLERSGCVSRSPDPADARAVRLTLTPRGRESVTRARDLVDDLNQQLTAGFDEAEVAVIERWLEHVSRRDFR
>fig|134676.3.peg.2114 Multidrug resistance transporter, Bcr/CflA family
MSITQAPPTARHRARLALILGALSAFGALTIDMYLPAMPGMADELDAGATLVQLTLTVFVVGLAVGQVIVGPLSDAWGRRRPLLAGMALYVTGSLWCALSPTAGYLIGGRVLQSLGAAAGTVLARAIVRDLYQGTAMTRFFATLMVVNGVAPIVAPVIGGQLLTFTTWRAVFLVLAAVGAILLVTVALALPESLPRERRAPAHPRATLRAFRTLGTDRHYLRYVVAAALMFAAVFAYISGSSFVLQDAYGLSAQQFSLVFGLNGLGIVVFGQIGGMLVGRVTGEHTLLRVSLSIAVLGSAGVLVCAVAGLPLPLLLAFLFLPVAMLGIVLANATSLALAGHGSAAGAASSLQGLLQFLVGSLAASAMTLAGPATAITMGATMVICSIAALATLR
>fig|134676.3.peg.2243 Multidrug resistance protein mdtA
MAGIVGGALLAVVHSHQQGGATSTIVAVRVGKGDVTLDVATSGTVRPATTRELSFAVNGTVASIAVRAGSKVKAGQTLAAVDATAATAAVTDARNTLTDAKSRLTDARDQAARVTAAATACATAASDRGLLATAASDRGFLATAASDRGFLAGADVSPTATVAVNSCTTRGYPDTGNDPVLTAQQAVNRAGEAVTRAEAALAGAVITAPIAGTVVSVAGSVGDTVSSGKTFVTLADTYTMQVEAAFPEADAGSLAVGQSATITLADHDDALTGTVVQVDPVGTSDGTLVRYGAVLSFSAPPSDLLVGQSAQVAVRVGETRNVLRVPSTAVHDISGGSGTVLLRVGGRSSERTVTVGLRGDQYTQVTDGLTADDQVVRSW
>fig|134676.3.peg.2517 Permease of the drug/metabolite transporter (DMT) superfamily
MGDLLLLAVAVVWGSSYLTAKTLVAAGGVLVLLALRFLISAVALLPALAVRRSRGRFDRRELLVGVGLGVTQTSVLILETFGLSMTSATNAGVLISLTILMTPILEGFTRRRWLPPAFFGGAAAATLGVVFLVAGPGLRTPSAGDALMLAAAVVRAAHVTLSAHLTRGRSHDTATLAALQTLTGAVVCSTVAARALPAAVAAYGPAQWAAVTYLALGCSVFAFVVQLWAIRRTSASRASLLLGTEPVWAVLFGVALAGDRLTPAALLGIALVLAGTYYGQRLEGRSRAERSPTYARGNDIVRRTPRPRVGARSVRRSRGI
>fig|134676.3.peg.2884 Small multidrug resistance protein
MRYVLLAVAIGSELFATSMMKATDGFSRLWPTLVVLAGYGVSFVALSQAIKGGIQVGIAYAIWSAVGTAAIVVIGALFLDEPVTLAKVGGITLIIAGVVMLNLTGAEAH
>fig|134676.3.peg.3133 Antibiotic transport system permease protein
MRAYRALARATARSALAYKNNLFLGLGAVFVQFIAMLAVWRVVLADGSAVQGFGWPQMRAYLLVAFAAGTLVSVFGDFRTAARIQSGLVALDIIKPVDFQRARLAETLGGTWLEALVVVVVGGVTLALTGGVPTPPGAALALFAASMLMLVPLKFLIVYVSTLACFWTQNFIGVQWARIALVNLLSGALIPLAFLPGWLAAVAQWSPFAGLVSTPALIFVGQVGVGRGLALVAAQLGWVVALWFGARLIWRAALRQLTVHGG
>fig|134676.3.peg.3316 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGSAAPIAFLPSTDLERSRRFFADTLGLVVAEVTPFACVVRVGTTMLRVTKTDQLQPQPFTVFGWEVADIDAVVAGLSGAGITFVRYDGLEQDGAGVWTTPGGDRIAWFRDPDGNTLSLTQFLPH
>fig|134676.3.peg.3483 Lysostaphin resistance protein A
MATVFFAVATVAAGVFGAVQPFTGIPEEVIQLTQFGPAVAVAVLAGVWPARTRALLHGAGSGEARTGPVLLSTAVLIVAGAVGAHGVITGGVGFTRPEHPFLLIAVAQLIGACGEEIGWRCLLQPLLRTRFGPLTASVLVGLLWGLWHVPVFAEGPWYGGLFLLATIALSVVMGLALERARSYRLLLAAGFHTLINLGMLLFMNEESGAVLPIALFGASAAVAALVGTASRR
>fig|134676.3.peg.3573 Multiple antibiotic resistance protein marR
MQALMLASRAFVGITVRALAAVPGEVTLPQFRTLVVLAARGPQRSIDIAEELGVNPSTGTRMLDRLIGKGLVRRTRSATDRRVVRLRLTPDGQRLVEQILDRRRRELERLVDGNPGLWSPPVIEALTAFATAAGEQAAATERSAAGKPPAVGAQAAGPSGPDWWLGWTPGDAVGENIA
>fig|134676.3.peg.4430 Multiple antibiotic resistance protein marR
MGMTSGEGRGAQLLPVLGQLVRFLRQLEGPDNPSSIALAVLRRLADHGPGRVTDLARLTRASQPGMTQLIGRMEKAGQVRRVPDPHDGRGVLVEVTDAGRELLSRTYAYYATTLDRLFEQLTPEESDTVVAALPALERLARAGERESAGTR
>fig|134676.3.peg.4494 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSRIGDIIVDCRDPELLAGFWCGVLGYRIFARDATGVAIRGATSSPDILFLHVGDRKATKNRLHFDVCPTDRGQDEELTRLLALGARRSSIIGSGSWVVLEDPEGNEFCLMAKRIAAEPAPFHDA
>fig|134676.3.peg.5630 Multidrug resistance protein mdtH
MTVLLLATLVNAIGNGAYVTISVLYLTTVAGLSPAMIAIGLSAGAAAGVLAMTPLGYLADRHGPKRLSILALIVLAGAYTALLAVRSPLAFGLLSCVIAVATALVKGANGALAAGSVAASGRLRMRARMRTMTNAGIGLGTLGGSIPLLLQTDRAYVVILLVNAATFVVAAALLTRAPAVPPQVTPPGGPRLVALRDRPFLVFAAVDGLLSAVYNDLLGIGLPLWLAAGAHAPLWLISVTLVINTAGCVLLQVRTARDVHDLPGARRAAVRGCLILALSCAVLAATAGHPPWLAGTLITLAAIIHVVGELWLSTGSWGIVFAITPPWAQGQYQGTYFAGRGVGDMLAPPLVTACVLGLHSAGWLVLAALFAAGGAIYPPVTRWAAARITSIERTPAPA
>fig|134676.3.peg.6051 Multidrug resistance protein B
MRMAQLEPKRGGALAAVALAQFMVTLDMTIVNVALPSLGGDLGFEPTQLPWVVNVYALLFGGLLMLGGRAADLFGQRRILLSGTALFALASLAGGLAQAPWQLIAARAVQGMGAALMAPAALALLTLTQREGRERTRALGVYAAVSAVGGAAGVLSGGLLTQFAGWRWVMLVNVPMAACVVVLALIGVPGGQLSSGPRRTLDVPGAVLVTGGVGALVLGLLRTDHYGWASATTLVTLGIAVLLIVLFLLWEARGIKSDPLIRLGLLAKRNVAGANLFILLLCAGQFAAFYFISLYLQDVLHLDAARAGAAFLPLTLTVVVAINISTRLVPRLGPKPLLVTGGLLAAAGFAWFGALDADGGFLTDLLGPSLLTGLGMGLSFVPLTGAAVGGLPRHEAGMASAVLNSSRQIGGALGLAALVTAQASRTDARLAAGDPPLEALTSGFGIGLSLSGALLLAAALVALIVLPGKRAAGVPAGEPAAQRGASSSSPWPTNAPAGSPPLDAASSVTEPR
>fig|134676.3.peg.6396 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MVEIALPDSFTRRVAQCWGAPGTRWLADLPEIATRVLHDWDLHLDRPCPLSLNWVTRVRRADGSAAVLKMGIPGADHLSDEAAALEFFAGRGAVSMLAHDAARGAILLEEVRPGRPARSLVPDRDEDATAALIGVIRGLHRPAPPGIALPELAARRATFDEHLRRFPDDGPLPRHLVERAGRLLTELCETAIERVVLHGDLHHDNVLAAGREPWLVIDPHGLTGDPGYEIGAMLYNPYPMDDDTVLRLVPGRIEQLADGLDIPIERVVAWGFVQAVLSEVWNATGDGIATGRPLRLASLLLPRLP
>fig|134676.3.peg.6578 Multiple antibiotic resistance protein marR
MRRDLLDLPVLLLGAATTLVDSINEGVRARGFTDLRPAHGFAFVRLAPDGATVIELAEHLGVTKQAASQMADELVRKGYVERHPHPRDARARLLTLTPRGWACTRAADEAATEALQPWADTLGPAHLATVRSALAQLTTPGRIRPTW
>fig|134676.3.peg.6774 Pleiotropic drug resistance protein 3
MSSMSLGRGHVEVLQFLRDRTAVVFTFLFPAMLLLLFGTIFGNDYDRAGASAAQVYTASMLAYGVLTTGFVTMGSGLALDREDGTLKRLRGTPLPVTSYLMGKLILVLTLSVAEAALILLVGVVVFDMPLPPASHWVTFAWLMILSVTCCSLLGVAVSAVVRHARSAGAILNVPVVALQFISGVFINPITQLPSWLITVASFFPIKWMAQGFRYVFLPDSMKSLEAAGAWELGRVAVVLGVWCVIGLALCLVTFRWSDKDR
>fig|134676.3.peg.6971 Lincosamide resistance protein
MAGRHVSTAADVVALFDALDVHRVQACLGGGWAVDALLGEQTREHSDIDLWLPATHLEWAFRAFAALGVDRLFPTPGDRPWNFVLHDGDRRKIDLHLYETRPDGRLHYGSALTGEPFPAAALSGRGEIIGRPVRCEAPVWAVTWHTGYPPRAADRHDVPLLCARFGIPLPETFA
>fig|134676.3.peg.7298 EmrB/QacA subfamily drug resistance transporter
MSATGGAPPLSHRQILQVLSGLMLGMFLAALDQTIVASAIRTIGDDLHGLSLQAWVTTAYLITATISTPLYGKLSDIYGRKRFFVTAITIFVVGSAACSFATSMYQLAVFRAVQGLGAGGLFSLALAIIGDLVPPRERARYQGYFLAVFGASSVLGPVIGGFFAGADEILGLSGWRWVFLVNVPIGAVALVVVAKVLHLRHTRRDHRIDWWGAVALCVCLVPLLTAAEQGRTWGWTGSRTVLCYAVGAAGLVAFLVAEARMGAEALIPLRFFRNRTFALTSFAGFVTGMGMFGGLALLPLYLQIVHGASPTRSGLQLLPLTAGIMAGSLISGRAISATGRYRVWPMLGAPLMIGGMGLMHSLAVDTPYWRTGVFMGLFGLGLGFVLQPVTLAVQNAMPPQDMGVATASATFFRQMGATAGTAVFLSLLFSRVGDRIRDALRVAGADPAFQKLMADPANRRVLGGSLDDTSFLRHVDPVLARPFESGFAATIADICLVAGGVLTVALILFAFLPQVPLRGSAPAGPAELSPSSGSATDLSPSPGSATASPASSRSPHSPSPPARSVDALSLSGVVTGLDQRPLTGARLTLADLAGGQAARAVTGPDGRYLLTPEVAGAYLLICAADRHQPAAIRLTVTGADARDVRLAAGGRIEGDVVDQHDRPVAAATVTLTDAAGAVVASAITGPDGGYVLAGLYPAEYTLTGIAPGARPAARTVVLDTGGVSRADLLLAGNGTLTGQVRAAASGHPVPEASVMAVDEAGAVVATTWTDADGRYAFADLVPGAYTVTASGYPPVADRVELIGELTAHDIMLGGPREGSRLISP
>fig|134676.3.peg.7397 Glyoxalase/bleomycin resistance protein/dioxygenase
MLDHVGFQCADLAASAAFYDAVLAPLGASRQMDFQVAIGYGNGHPDFWISTLTEGDGFRESHIAFGAADRAAVDAFFAAAVASGAEVLHEPRLHPEYHEHYYGAFVRDPDGNNVEAVCHRPE
>fig|134676.3.peg.7933 Multiple antibiotic resistance protein marR
MPTEPNLADIAEQLRQSIGRLVRTTRAHADSLPRTHAETMGYLSREGPHTIGELAARRRVTHQSMSRTVAELDRLGYVSRAPNPADARGFVITLTETGAAVLDTDRAARRDWVAAAIASRLTPEEQRLLARIPALLDRLADGAGT
>fig|137722.3.peg.381 Permease of the drug/metabolite transporter (DMT) superfamily
MPADRSVPAKGLRLADQAWLLMMMPPLFWAGNAVMGRAVAGAVPPVGLAFWRWFLGMLIVLPFAWRHLRHDLTPMLARWKSVLLLATLGIGVFNTLQYIALNSTTALNCVMLQSSMPVMIVLMSVVLFRDRVGAMQGLGIVVSLAGATTLISHGDPATLLGLELNSGDLWMLAAVVIYAAYTTLLRRRPAVHGLSFVVVTFAIGALELLPFYIWESLGGHPMRVSGITLLAVGYTVLFPSIAAYLCFNRAVELLGPNTAGLAIHLVPVFGSLLAILFLGEQLHPYHGIGIALIAAGILLATRRRA
>fig|137722.3.peg.662 Permeases of the drug/metabolite transporter (DMT) superfamily
MSDASSFSVDHAQRTQRLALIALLLGALGIAFAPIFVRLSDVGPAAIGFWRTALATPLLALWMASESRSGSGRASRRPSGLADYGRLSLAGLFFAGDLAIWHTSIRYTSVANSTLLANFAPLFVAPAAWFLFKERITGRFVLGMLLALAGAVVLMGQSLRLSADHLFGDALGLLTAIFYAGYILSVGHLRGEFSTATIMTWSGAITAAVLLPLSLHDGEAMLPAGPSGWAALVGLALFSHAGGQSLIAYALAHLPASFSSVSLLMQPAAAAILAWILLNEPLGRWQAVGAAVILGGILIARRASR
>fig|137722.3.peg.1529 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSATLPTPEPLRARLAAHIGELLRLAAPVIVSRAGLMVMMAVDTAIVGRFSAQELAYYGLAHLPGNIMVGTGVGLLMGTVMITAHAFGAGTDAECGRAWRRSIPYALLLGVLFALVSLLGDPLFQAGGQTPEMAAGGAHVLAVLGLGAPGMMLYITTGFFLEGIKRPLPGMVAMVIGNLVNAALAWTLVWGHAGLEPLGAVGSAWATTIVRWGMGLGLVAYVWWMRDHDRWQLRRPVADWWSGAARQRHLGYAAGLSIGVESGAFGGLGLFAGMISPLALGAYTVGLNLTALPFMAAVGLASATAVRVGVAYGRGDRSDMALAGWTGLGVTSAILAGVGILYRSVPEALGAIYTGDPELLEAVVPLIAFAAWILIADGGQTVMANALRGRHDAWVPTALHFFSYAVVMIPVSAFLVFGLGHGAHGLFEGILIASLVSVTILSLRFAALSRR
>fig|137722.3.peg.2265 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MSVAHTLQALVVMALWGLNFVVAKWALAEFPPLFVMFLRFALVAVLIIPFFRVPRDKLWKIALLSVTLGSIHFPIMFTGLKGIDAATASLAAQAQVPFSSLLAAVVFKDKLGWRRAVGMAAAFAGVAVIAGEPRLGDQMASLLMILGASLAFAVASVQMKLLGSVNGFAVNGWMALFAMPQLLGLSLLLEHGQMEALANSSWVGWASILYMAVGVTIVAYGLWYPLIGRYDVNQTMPYLLTVPVFGVASGALLMGDPLTINLAVGGLLTIGGVAVIVKRRPRTVSETVTNPT
>fig|137722.3.peg.2368 Permease of the drug/metabolite transporter (DMT) superfamily
MEAGTAVILNVTTPIFAFLITLLLTRHEELTVGKAVGVGAVDEIGRDLPAQGAIILATVCYAGAAIYGRAFKGLDPIMPAAGSLLCGAALLLPISVVVDRPWTLAPSGPSLLALAGLSVFSTALAFVLYFRLVDSL
>fig|137722.3.peg.2956 Permeases of the drug/metabolite transporter (DMT) superfamily
MAILAAVLFGVSTPLAKLLVHDLSPWMLAGLLYLGSGIGLGLVRLARGLSASPERNERSIHGIEWFWLLAAVFAGGVAGPVLLMFGLTATPSSTASLLLNLEGVLTALLAWFVFQEGFDRRLVAGMAAIVVGAVVLSWGGAVDIAAGWGPAAVAAACLMWAVDNNLTRKVSLADPVDIATIKGLVAGSVNVGIASVLGDGLPAVPTAAAAMLVGLLGYGVSLVLFVIALRHIGTARTGAYFSTAPFVGGIVSLVIFGEPLTAGLVTAAVLMGIGVWLHLTEDHDHEHDHNEIEHDHPHVHDEHHQHGHDGPVTEPHTHRHRHGRLRHRHAHFPDAHHVHPH
>fig|137722.3.peg.3607 Permeases of the drug/metabolite transporter (DMT) superfamily
MTANAETADLLPAKADSVPYAVGCFLVAIVLFAAMDTLIKVLTAGYPVPQLMFVRSLVAFLLVGGYTLAWGGGFAAMRTRRPLGHVWRAFAGLISMGCFFYAFRELPLADVYVLSFAGPLFITALSAPLLGEPVGWRRWAAVVVGFGGVVVMAQPSAGAPLVPVLVGLTAALFYALAALAVRGLSRTETSASIVLYLLLTTTVVSGALAVPVWTTPTAAGLGLMALVGALGALAQVLLTQAFRRAPPAVVAPFEYTGMVWASLFGWMVFGDLPTAPVLAGAMVIIGSGLYILHRETMVARRRLGS
>fig|137722.3.peg.4606 Multidrug resistance protein A
MTGMRAFRWVIGGAAIAALGTTLWFATRLPPLTVQGEVSADRVDISPRVAGRVARLGADTGDRVARGTVLVELESPQLVAALSAAQAALGVARADLDRVNSTRAETITARRADLASANADVTLYQDNYGRQAQLIRSGNTPQARLDEAARNLEAAVRKRESAEAALHLAVTGASPEERALAAAQVKQAEAALRQRSVDVEELVVRAPMDGQITTKVSELGENFSAGAPLFSMVDIAHPWFTFNLREDLLSGLAVGDGFRITVPALGSKEIPVRVTMINVQGQYATWRATRATGDFDLRTFEVRAVPAEPVEGLRPGMSAIWVRQGR
>fig|137722.3.peg.5609 Multidrug resistance protein A
MTTVTDRDTETTPAAPQPVAKPVRRSRWRRWLLMAALPLAVAVGGGYEYVVGGRYVSTDNAYVQQDKVTISPDVSGRIVEVAVRENQAVHRGDLLFRIDDEPYRLALRQADAALASARLKVEQLRADLGEALAKQAAAEEKVSFQQREFQRQQDLLKTGVAARATYDSVRHDLMAAQQDLNTEKQSVVSARAALGGDPDIPTDRHPTVLEALAKKASAQRDLDHTVVAAPADGVVSQTGRLLVGQYAATGLSMVSLVMSGSSWVEANFKETDLTHMAVGQTATVVLDAYSGRTLTARVESIGAGTGSEFSVLPAQNATGNWVKVVQRVPVRLRIEAADGNAVPLRTGLSADVEVDTGYSRPLPGVIGDAVAAIR
>fig|137722.3.peg.5778 Permease of the drug/metabolite transporter (DMT) superfamily
MRASHILLAVAVAAVWGLNFVAIKVGLRDFPPLLFSCLRFALAALPLALLGWGKGPPVPWRYVIGIGVTLGVVKFPLLFLGMDAGMPAGLASLVLQAQAFFTAIFAAFALGDRPGPRQLGGMAVAFAGVGLIALEMPAGDSLLGLGLTMAAAAAWGVSNIVMKQARAPDLFSLMVWVSLIPPLPLLAMSLALEGPERIVHAVTTLTAVGVGSLLYIAVAATLFGFGAWGFLMRHYPASLVAPFSLLVPIFGMSSSALLLGETFTTAKLAGGLLVFAGLALSVLRLPAPRRAGA
>fig|137722.3.peg.6410 Bicyclomycin resistance protein
MLARLAAVRSRSPAESPFFIAALGVLMSFGPMGTDMYLPGMPAIGRDLHAAQDQVQWTLSAFFLGFGVGQLLWGALSDRFGRRIPVATGILLYAVGCVGCSLTVDVGHLAAWRFIQAVGACAGPVLVRAMIRDVFERDRAASVLSMMMLVMGAAPIIAPLIGGQILIWANWRWIFGAQAAFGAIAMLALATLPETHPPSRRTSLRPMGLFQSYRSLLTNRRYLGYAVGSSFIYAGMFAFISGSPFVYIELFGVRPENYGFLFGINIVGMMIVSTINSRAVMRFGSDRMLRIGGWLSAASGILLVACVLGGWGGLWGLVGCLFLFMSLTGFCFANSMAGALQSFPQMAGSASALAGMLQFSSGAVSGWAVGLMADDTALPMAAVIGGAALVSLALNLWLVRPIRRRLPAA
>fig|138119.3.peg.89 Drug resistance transporter, EmrB/QacA family
MNIRKTPLILSLMLAMFLAAVEGTIVTMATPTIARDLQGFEFISLVFSVYLLTSALSTPAYGKLADLYGRKNILSIGIIIFLAGSFLCGLAQSMVMLIVFRAIQGLGAGAIFTVSFTIIGDVFSLAERAKIQGALSTVWGIASLVGPFFGGFLIDVLSWHWIFFINIPFGLLSVILLQSSLKETFAKKKPSIDYAGTLTLSLAIVVFLSIFLFDRSTSPYPSLWVAGLLLLTFFLLYAFYKIEKKAAEPIIPFAIFTRTTILVNLISFLIYAVLMGVNVYLPIYLQNILGYRPTAAGLAMLPMSVSWLIVSFILGRLLVRYGGKNVILASNAVLLLSTLLLFTLGIDTPLPIILVYGFIMGIGFGGASAALTIIVQDSAEYSQRGAAVGTNSLLRTLGQTIGISVFGTIFNLYITKYFTRQGIEGINPGNLYQPDLSHTALAAEQITLSLNSSMHVLFTAFIIITLLSMILAMTMPGMKKEKQA
>fig|138119.3.peg.357 Transcriptional activator BmrR for multidrug resistance transporter
MKEQYYSIGQVAKLSNISIPTLRYYDQIDLYKPAHVDTLTSYRYYKESQLYILDMIKSLKYIGTPLTDIKTVLNYTPAELFCFLEHQEDVIEGKIQGLQEIHKNLQQTKKQLQQQMKTALATDVFEKTEDLQIFTLPVENYAPQSIPNDCYGELIKLVEAEGSRISSHYGCIYPLLDYNSMDEVRCTHIFTPLMTDRLNSHPAYRRNIRLISESRFIGIAFQYHPDRYIEHYQRLYHYIRSKELPVADHVYDLFTPTRYSQHKEEEFMVELKVQLL
>fig|138119.3.peg.494 Probable antibiotic-resistance protein
MNIIDFRFRPNTEAILKGISSNPAFKGMCQSIDFNKMLPQTLEEVVEELDRHHVVKAVISGRDCETTYGAQSNNPSVIEFCHKFPDKFIGFAGLDPHKGMAALAEITHAVHEEGIKGAAIDPYLARIYVNDAKYYPIYAKCCELGIPLIIATGPGTLVPNAVIDHVAPRYIDFVARDFPELKIIASHGGYPWVNEMITVAQRNANVYLELSEYEFFPQSSAYIEAANSILSDKIMYASAHPFVDFKLALKNYEQLPLKPEVREKVMYKNAAKVLGLSDGTFSASKAMDAQEVQMIIENVIAQLSQRGLLADR
>fig|138119.3.peg.510 Multidrug resistance protein B
MNTQYLNKFNIPRPILVLIIGGFIHSVGSSFMWPLNSIFMHNILGRSLTEAGALISLQALATLVGQFISGVLADRFGSRRVMIYGLIGTILPLILISCFPVWEVYAPGLLFYGFAIAFIFVPINALVFTLWPEGGRRGFNLLYVFNNAGVAVGTALGGFIAALSFKLVFLLNGLFFFIYLLMVLIFLSAKDIQSKPLSKSRVKVPIFKDRGFPVLIALCAAIFLMWGAYIQINTVLPVTMTNLGYSLPQYSILWTLNGVIIVAFQPVIHWIIRHWAPTLSRQFYVSCLFYAIGFLILLGNFPYPSYFIMMIIITLGEMLVLPGVPAAAALIAPEGKTATYQGVVGGAASGGRALGPILGGLAFDHYGGNMAWALALVFVSIALLPFYLYQRRERTFTQGTGAKEQAI
>fig|138119.3.peg.777 Drug/metabolite transporter (DMT) superfamily protein
MNELIVVKGEEKAQNIRTKAVRGTILTLIGGISWGFSGACGQYLFSVKGIDPHWVTVVRMLTAGLLLFCLVLFKYREQMVGLLSNKRDRRTLIVFSIFGLIACQYTYLLAISHSNAGTATVLQYLGPLLIMIFVCGMDRRLPTKTEGVAIALAVTGTFLLATHGNVSNLVISAQGLFWGLMAALGLMLYTIIPGKIINKWGSIVVTGCGMLMGGSILLVVIRPWQIPVSLDWQVFWGMLAIIVIGTVVSFTLYLQGVSDIGPVKASMIASVEPVSAALFSAFWLNTAFVWIDMVGFALIITTVILLTRQGSSRD
>fig|138119.3.peg.911 Drug/metabolite transporter (DMT) superfamily protein
MSDRNQGYLLIILSAVFYSTLGILGKYIYNTGIEMSLVIVLRLFATVILLGLFLLITRKEPLLTFSRVVLFQGIFFIATAITFFLAVKYLSAGLATVILFAHPALVAVLAVIFYHEEIGAAQIVGLILALLGLFFISGLYIESSTALSPLGLILSVLSAVAYGIYALLGQRVVKTDGIWTITFTISLMGLVISALIFPHNLPALLSITPYQLFLGFAMAFLGTILPVVLFLKGVQKIGSSVGTLISIIEIPFALILAYLLLGEVLTPMQVVGTLLILIATTMAVAVKNQKENNERN
>fig|138119.3.peg.1108 Probable antibiotic-transport ATP-binding protein ABC transporter
MMIKVEGAFYRYPGAPRDVIQDISFTVRKGEIFGFLGPSGAGKSTLQKILTGVLRDYQGWVQVLGTEMKHRKSSFYERIGVDFEFPNFYGKFTALENLQYFASLYHQKTLDPLTLLEQVGLQHDAHKRVASYSKGMKMRLGFVRCLLHNPQLLFLDEPTSGLDPANARILKDMMLEQKAGGKTIILTTHNMHDAGELCDRVAFIVDGKIRALNTPQAFQVERSGSAEVNYSYRRDGRTVDRRSTLTQLGQDDEFVKALQNGSLLRIHSKERTLEEVFIALTGRQLQ
>fig|138119.3.peg.1148 
MGVQLKSEEQQQLKEQVKGKKSRKGIVLAILTVIVLIAGCAGFYYFNENSRYFTTDNAKVTAKMYTITPNASGELLEWKVKEGDLVEKNQVLGRQAVLPYITSPIQGTVIKNNSIQGQAVTPASQLAVIADTDHLYIGVNIEETDIARIKVGQRVDVKLDAYPGVTFPGRVQEIDRATQTYFSGASSFSTSGTYAKVTQLIPVKVVIDNQDNLPLTFGMNATVKIHIKEEPVNTPSGAQGGENTDSQQAVHYSSVLEAAEQMGIIPNVAGKVSKINVSIGQRVEKGDVLFQLDSTDLELQVKQATANYNAAAASYNHNKASYDSQTAVTPAQIAYNEAMDNYIRIKALYDGGAVSEVELNNAQDKVEITHAQLQTAQNSAKGAVDAAAAQMASAQAGLDIAQKKLDDCIVRAPMAGEVAAKTIEVGMMASPQAAAMTLINTQQVKVHINVTETNIAKIKVGSTAEVKVQAINAAAQGKVVNIAPASDAKTGMFQIEILLENPDSLFKAGMICDVELR
>fig|138119.3.peg.1170 Permease of the drug/metabolite transporter (DMT) superfamily
MKYKPELGILFVTILWGASFAVSKLIMADITPNYYTFLRFAGAFLVLAICFHKRLRHIPKQTLQAGVLIGLAIACGYVLQTMGLNYTTASKAGFLAGLYVVLVPVMESFLCKCLPRYNMILGVCLATAGLALLSLERDFTIGFGDLLVFVGAVFFAVSMVLISRFASKHDPMVLAIIQIGVTALFSLVLAVFTEPGLSAVQFTPVLLGLVLFAILFGTAVNTAVQNWAQGYLTATTAALIFVLEPVFGGVFGWLLVGDVIGMKQISGSALIISGMLVTLLLKPGQRAQSKADQGVQLSGRS
>fig|138119.3.peg.1437 Permease of the drug/metabolite transporter (DMT) superfamily
MAQGCRTAQWKGRVITMAEKRMAYLAAIVYAFIIGLSFMFVKLTLTVATPLDTLAHRFTVAFLAATLFILFTKHKVNIGWHDVAQIAPLATLYPILFFGFQIFGLARTTSSEAGIIQSTVPIFTLLLAVFILKEKAGRGQLISVFLSVFGVIYLLAMSGAESQTANIVGSVLIILSAFTNALYNVLARRLTQRYSLLTLTYIMTLFGFIAFNSLAIGSRMLAGTVGEFFQPLLHWQFVVAVLYLGILSSLVTSFLANFVLSKIEAAKMSVFSNVATLITILAGILFLQEAFHFYHVIGGMMIITGVVGTNLLGARSKAKEKAKDVEE
>fig|138119.3.peg.1443 Multidrug resistance ABC transporter ATP-binding and permease protein
MAGGFRTQQPKAPALVNRPGAGNRFVPAAKPKNTKGTLGRIVKIYLRWAKSIFAVILLTAASSLVAVAIPYYVGQAFNTFHIADRSVDTARLVSLLLIILSLYLGNLLLNLLNGTMMLRLSQKLVYTLRQEFFAKMQRLPLGFYDTRSHGDTMSRITNDMDNISSTIAQTTTQLIASILTLAGSLAVMLSLNVPLTLVVLLCVPLVFVLTKTIATRSRAYFLAQQRSLGALNGVIEENILGLKMVKAFNRQEEVLRKFQEINQGLRASSYKAQVWSGCMMPLMNVINNLVFAAVAICGGILTLSQGLAVGTVVSFLTYSKQFAHPLNSVAGMFNTIQSALAGAERVFEILDYEEERADEENALEMEHPAGAVAFDEVSFSYDKTQPILKEVSFQVNPGEVVALVGETGAGKTTIVNLLTRFYDADSGEIRIDGVPVTRIKRASLRRCFSVVLQDTSLFSGTLMDNIRYGREDATEEEVIRAAQIAHAHGFIAKLPQGYGTRVSAANDTLSQGQKQLISIARALLCDSPILILDEATSSVDTKTEKDIQKALVSLMQNRTSFLIAHRLSTIRDADRIMVIGEGQILESGNHQSLMTKQGRYYEMVMSQLGSQMAKSFSLKA
>fig|138119.3.peg.1472 Drug resistance transporter, EmrB/QacA subfamily
MGKSGKAPELEPIPKNIMNIAWILVLGAIMPLLDSTMVNIAINHLSHDFSIGLDLIQWVITGYVLAMAISVPLAGWMVQRFNGKWLMIGANILFLAASIASGFSWSIHSLIIFRVVQGFSAGFIMTLVTTLCVETAGRERMGRLMSTIGIPTVLGPILGPVIGAVIVQFLSWRYIFFVNIPLGILAITLMIWKLPDFTPANIKAKFDFIGIILLGTASAALIYGITKAAKSATFNNSTTIAYGVAGIAILAIYMIYAALKKDQAILPLHLFRLKNFSAVMVGLFLAGIATNGPMLLLPLFFQNIKGFSVLNTGLILIPQGIGMLIARPLIGKLTDKWGARNVVLVSLALTIVGTIPFIFINEASSLFVVSLVLFVRGVGIGGVTIPMMTDAYTGMVKQEIAQASVGTRLMQNIGGAFGSAVMATAVSLSIQGKTPTIPLMTTAYHDGFMLALVLSLVLVIPSLFLTNKTAKQ
>fig|138119.3.peg.1558 Tetracycline resistance protein
MFKNGSDHEQNTEQTIDKKALLFGLMSVFLCGIGFSIITPVVPFLVQPYISNPEEQAIAVTLLTSVYAACVFLAAPVLGALSDRYGRRPLLLICLLGSAIGYLVFGIGGALWVLFAGRIIEGITGGSIGTIFAYFADIIPPQQRTKYFGWVSAVVGVGTVIGPTLGGLLAKFGYSVPMYFGTVITLLNVVYGLFYMPESLDKNKRLQEISLIRLNPFIQLANILSMKSLTRLLVSAFLLWLPNGSLQAVFSQFTLDTFHWQPALIGLMFSIMGLQDIIAQGFIMPKLLLKFSDQQIAMLGMAAEIIGYSFIAASALFVFYPLLIAGMFIFGFGDSIFGPSFNGMLSKSVPSGEQGRIQGGSQSIQSLARMMGPLIGGQIYVSLGHAAPAFMGMLLIAAAIPVLHKRPQANM
>fig|138119.3.peg.1757 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQITTIKLKVHQFIHILLPILISQVALFSMSFFDTAMSGQASSVDLAGVAIGASLWAPASTGLGGILIAITPIVGHLLGAKRRNEVPYNVLQGIYLALAIAFLLIVAGAMSLDGLLSLMNLEPQVRFIARGYLLAIAFGIPPYFVHQVLRSFIDALGYTRITMLITLLSLPINICLNYIFIFGKFGLPAFGGIGAGIATSMTYYCLMLIALFIIHRHPYFKEFALFKRLPPLSWKTWLKQLKIGIPIGFSIFFETGMFCAVTLLMSRFNTVTIAAHQGAMNFASMIYMIPLSFSMALTILVGFEVGARRYHDARQYSLIGLAFSFSIALLTALLLFLFKEQVAWLYSKEWDVILLAKQFLIYAIFFQFSDALATPIQGILRGYKDVNLPFITSLISYWFIALPIGYFLAAYTSFGAFGFWIGLISGITTNACCLLLRLRYILRRQVAV
>fig|138119.3.peg.1921 Vancomycin B-type resistance protein VanW
MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK
>fig|138119.3.peg.2130 Daunorubicin resistance ATP-binding protein drrA
MRKVFVTKEKKGPWRSRKKEVVAVNTLDLAIRPGEIVGLLGINGAGKTTTIKMLSTLLVPTAGSIMVDGTDAVKEPMKVKKRINMIAGGERMLYWRLTARENLAYFGSLYGLSGKALTERIHRLLQAVELEAAADTPVEQYSKGMKQRLQIARGLINNPSYLFLDEPTLGLDAPIAKHLREHIRNLAVKEGKGILLTSHYLTEVEALCERVYIIDQGELVLHDTPKRVIQKVAAGEILSLWVSGLLPATHEHLRQMLVPLEASLTILEQSDGVELRIQSKGEITAQVLKFLFEHGVIPHRLEVEKPKLEDAILKLAGREEKGREKA
>fig|138119.3.peg.2416 Vancomycin B-type resistance protein VanW
MNLTPEAVSSDPDQLPPGTFLDDLALGGMMQEEAKEKIRSWSKDKLEENLFLVYNETEIQLTPEELGITLDFERTWQNLSENTGQESPSVLAIDYVMANQVLHEKLAEFNRSAVDASFKIENDQFKITPAISGEAVNVDAFFDEIKEVSLGDLPKRISLTGVEIPAAVTTESLEALAFDGVIGEYTTKYNAGDKNRTANLITAAKKMDKAVLKPGETFSFNGTIGPRTAETGFKDAYIVINNEYVKGIGGGICQVSSTLYNAALLANLSIVERHPHAVVVAYIPLGQDATINYPNLDLKLRNDSSSYLYFRTKVEAGNLTIKIYGKKTGVKVRFEKEIEKELNYHTVRKIDPDLLPGAVIQQQSGSKGYIVKTWKIVTDAQGKETKQLLSRDSYAPTNRILKIGAD
>fig|138119.3.peg.2666 Drug resistance transporter, EmrB/QacA family protein
MLILGFIGLLFGMFSIGVMQLILATAMPFIVEEIGGGALYDWVFSSYMLASIATIPLFAKFADIYGKRKFFILGMCFFALGSLCGGFAATMPYFIGARVIQGVGAGIISPVAMAMVSDMFPAEQRGKMIGLFGLVQLLSNLLSPPLGSFITKELGWSWIFFLNLGMIAFSMLLVLLGKTVQESKSDMKLKEIDILGGLLFGGFCLLAVTLANALSHQGRFGVLGAALLPALIFTGTMLVLNERKQKNPIIKMEFLKTQIIRRSLISAVLSGAIMYGLAALLPLCGVMLSRQGFPLDESKTLLFFMVSLTSGLLGGSRLNKLQLGQVPRYLWLILSVSSVFLLYSLYTVKIVPFCLFLILMGLSAGGIMATFLINSQNAVESEDRTVLSGLVQLGRYFGASIGVTLLIGMLPEVSLISGVGEFIGAFGLLVLLCLAGVLNEIL
>fig|138119.3.peg.2841 Permease of the drug/metabolite transporter (DMT) superfamily
MRWGNKMLGQIIISVILGAFGQILVKIGAKNLELDFAPENLLRSLGAIMQNFPVMSGLFLYGVSFILWIKVLTKTELSYAYPFVSLGYIFIMAFSVMVFKENISFYRVLGTVLVIVGVIFISRS
>fig|138119.3.peg.3113 Glycopeptide antibiotics resistance protein
MLWSKNYKHISIIRELLVMAFVIYCLAVIRVTIFSLHPSAGFGQSGTPSVNIIPFAEMFRGFHPNHFSLGYMIRHLESNLIGNILLLLPLGFFLPMLWSKFRSFKRTVVIGILSSLSIETVQYILAYLGLSSGRASDIDDVILNSIGVIIGYMVFQAISCGIKCFRKYSTFTKVD
>fig|138119.3.peg.3180 Vancomycin B-type resistance protein VanW
MKRKRLTQLFPFLLPVRRTQRKLFFYTEMYFDRNHYAKAKAPEFLPFCVYETKSKLLNENTGMDMRYQENKVFNLRLAAETVNGLLIRPGETFSFWQRVRYAEKNERYKDGLCVVNDELITVPGGGLCHLSNLLFWLFLHMPLTIVERHAHEIKDFPSPDEDEPDGVDATIHEGWLDLKVKNNTNLTFQIEIAIDEPYIYGRIFMDQAKRYSYEVVNRDKSFFKKEGKTFERVSVCRQVIDNESKQVVSEKLLYTDVFEIGYVLPEGTAIADEKA
>fig|138119.3.peg.3184 Permease of the drug/metabolite transporter (DMT) superfamily
MFMPRGTPFPRGIFVLSDQRFLFSTHSLLGDLSMQQSKQASNRSIWLIALGAAMWGLDGVFIVSLLQHVSSSQIVWLEHLLLFLFAAPVLIWKRQELKQLNGGDWLAVLFIGWGGSALASILFTAGFTYGNPNVVLLLQKVQPIFVILLASWMLKERMRKDFYALFVVALIGAYLLTIGLHLPTSEVSLAQLLGSLCAIGAAALWGGSTVMGKRLIGKLSFTTLTALRFAVALPLLTVIVLVQQPNWADLGQSLHLAPVWANLLYQTLVPSLLSLLLYYRGLNGVRASHATIAELAFPATGLLVNWLILHQTIDLGQWLGFAIVWLVVLQLSRMPNAPKSAVKTSETANLAGL
>fig|138119.3.peg.3464 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPSVKMNQGNNVLGTQPIPGMIWKFAIPAIISAMTNQVYNLIAQVYIGWSVGDLGIAATNVAFPLAILITALSALFGMGGAAKFGLYMGQGKPEEASQTIGNALVLMVVSGLAVSIAATVFLRPLLYAFGATEAIMTYAIPYTLITNIGIPFGILAVGASYLIRADGSPSFSMLVVLSGVIFNLIAAPVFLFGLEMGIGGVALATTLGQMLSSAVAIYYLRVKFKSVSLKREGFQLRGAVIKGVCALGSAAFFTHLAAAAVQIVQSNALRYYGAQSIYGSEATLAAAGAVIKVMAFLMSVVIGISLGCQPIFSYNYGSKRYDRVKEAYKLAVSYATMVSVIAFLCIQIFPRPILSIFGSGNPLFYDFAVQYMHIYLFMTFANGIQPVTSTFFSSIGKARMGFWMSLVRQVILLMPLLLILPIFWGINGVLWAGPLADGIAVVLVILFAAREMRIMTGLQLKQVPDAGIARNS
>fig|138119.3.peg.3466 Daunorubicin resistance ATP-binding protein drrA
MSNAIEITDLRKSFSVKAKGRIIKVEAVRGVTLAVKRGEIFGFLGPNGAGKTTTLRMLTTLLPIDEGKGTICGYDLVGQPQEVRRHIGYVSQLGGADWEATGRENLILAGQLYGMKRHDAEQRTGELLAVFELAELADRVVRTYSGGQRRRLEIALGMINRPEVLFLDEPTTGLDPQNRANLWEQIRKLKEGGTTIFLTTHYLDEADALSDRLAIMDCGIIVAEGTPQELKEQISGDVIQIRLADDRTQQAKRLFDKVSFINEIRLEGEDIYLYAKNGAQVLPRIFEMLEAEGVQTQSVSIATPSLDDVFLKQTGRLLRDGKEDIA
>fig|138119.3.peg.3492 Permease of the drug/metabolite transporter (DMT) superfamily
MSASRFTLLIVVTTFLMGSSFAVVKIGLIYSSPLLLAALRFILAGGIMGIIVGVLKRTHPTTKGQWVKLLIIGAFQTAGVMGCIFLSLRTITASESAILTFTNPLLVVLFSTVFLKMRYRLYQWIGVILGLVGVSITMGAQIEFRIGVFFGILSAVFWAIATLLTKRWGGLTDIWVLSAYQMLFGGLILWVGSFILETPFFIVNGTALLILLWLSLISSIVQFALWYYLLQKGEPGKTSAFLFLAPFFGVLTGWLLLGDPLYPSLLAGGLLIIIGIFLVNKDFNRKRVSAN
>fig|138119.3.peg.3793 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATTLVEEKEKQKHFILSGNLWKVMADLSWPAIVAMVLYGMNSVMDAFFVGRYVGEAALAGVSVAYPLSQISVAFGSLIGVGAGSVLSIALGAKDRKTQEHLLGNVNLLSLIVTAVYMLLGLAFSTQLIAMMGGRGEALILGDQYFRITIYGAFFWVYGLAGNMIIRAEGKMKTAAVMMGFGLAVDVIFKYLFIVVFQWGVEGAAWATNIGMLVYTLVSWLYFSKGWATFHSKLASLRWDQKIGTSVLRLGASSLIMSVMSLVQAIFVFNALSKYGTTWDVAFYGVVYRIFTFLLTPIFGLMRALQPVIGINYGARQYDRVISSYKIFAVTALVLTLPFWLLSIAIPGPILGLMMKDAAFSGADLLYFRVYMAILPVLSFIFMAMTLFPSVDKGKPAAMIGIARQLVFYVPVMIFLPKAIGVAGVYYGSLAIDAVIILWTLFMVRKEFSQLRQKARSDKPESIAYSL
>fig|138119.3.peg.3803 Permeases of the drug/metabolite transporter (DMT) superfamily
MMGSNLAGAQTWQIVAVYAAYAFLVLGAVCLVFMLAAVFRQGDERRNYILTKACTHTFLIYTGIVFVMGMYALFFQKHHNFSMESTPVASLGLIAILFTGSLFLNKRKYGN
>fig|138119.3.peg.3840 Drug resistance transporter, EmrB/QacA family protein
MLGGSNMTNEQLSRKSPWFSYLGLLLGTFTMIEAMAFQIPALPVLTKEFGVPVATAALISLCYYLTATVCGPVFGNIADQIGRKRIAMIGMIIFAISEFMAAFATNYPFFLLARLCQGIGVAAVLPAGLSYASYLFPPNKRGIAVGVYTAVGTFASAMGGFLGGILIAKFGWQSLYIISGVLAVLGIALVQITVPETPTAERKPFDYIGSILLLLTIGTWLSLSVLVANFGWVSPYTLGMLGLALVFAISFWNVEKRTSHPFMDLSIFKNRYFAVPILLYFFIALCSQGSVFTNSYFVTAKPGLGTAYVGIMTGVIYLAGAVTSLLSGKLIDSFKIKTVLLIGMGTFIVGTLLYSQYTVDTPFWYIVLTLVFMSGSLLFMAPACMKMSMSAVPPEKLGSGSGTYIMIRDLGSPSGQTTMLAAFGAISASSLAAEITAEAQNSGVSQDMIPAVVEAGKTAGKVIDPALTDHLAKIGVSFQDLYAKANFDGMVIAINQMSTIIIAIAVAAFIAAVFVLPNTNGGPGGLDPKNK
>fig|138119.3.peg.3928 Vancomycin B-type resistance protein VanW
MKTKKYVGLALLFISLTLAITLGINFMLYAKDDHLFSEGITISGIDVGSLTKEQAQEKINQTLENWLAQPLEFQAGGEVITLPLAALNPQVDLETPLNEAYKIGRKASLFARTQKATTAQDARFELGLTWDEQRLAETLAESLGLLNKEPVDATFKIGANNLMEIQPEQPGQAVQADALVNQIKELEPFQDPAPLKVELQEVAPALRAADLEAKKIDGLIASHTTWFDAANLERTANVRLAAEALDGTLIEPGEIISFNGIVGERTGDKGYQDALIVVNGEFVPGLGGGICQVSSTLYNTGLLANLKIEERTNHGLAVAYVPLGQDATVVYGAIDLKMRNTTGGYLLLRSKISNGSVTIEFYGKKTSGQEIVITNQVEKVIPFETEIIHDPTLAPGTQIVKQNGQNGYIATATRTIKVNGQVVETQSLGRSSYIPSNKIIVKGPEPPAKPKPDPKPEQPAPETPQEPETPAEPDPTEPESTNSGAGASETEGEPGTEAPGDEG
>fig|138119.3.peg.3962 
MIIAITSFKTKPGQRSEFVELAQDCIKGTHAEKGNVMYEALLAPEDENTVFYIEQWENLETAVAHLQAPHYLAFSQKSVELRVGEPKVELFNAEKLTPEDFRKIFDNIPKTK
>fig|1538.8.peg.371 Permease of the drug/metabolite transporter (DMT) superfamily
MGYVFIILAAVIFSTMEIVGKLAVGLNPLQLNFLRFLIGGLILFPPTIKAMRNKKMKFKKDDLYYFLGTGFLCVVLSMSLFQLAITFTKASTVAIIFSTNPVFTVMFAYLFLKEDLNRGTIISIILSLVGIVCILNPFGTVSDVKGIVLSILAAVTFSLYSVVGKLRSEKYGSITLNCVSFLVGDIIMLVIILLSNLPVVSSIINPKGGLSFMSHIPIIYGISAANIIPVIFLGIVVTGLGYMFYFMAMDETSATTASIVFFIKPALAPIFALIALSEKIPMNTVIGICFILIGSYFSFTAKGGTRVEEVES
>fig|1538.8.peg.414 Membrane component of multidrug resistance system
MEENNNESIYSWLALIVVVIGTFMSILDSSIVNIAIPKMMAVFGVSMDDSKWILTSYTLALGAIIPLTGYLQEVFGSKKIYMFALAMFTLGSMLCGFAWNNTSMIVFRIIQALGGGMIMPVGMSIIYEIFPRDKIGLALGIWGIASMAAPSIGPTLGGYIIQNMNWRLIFNINVPIGILGVILAGILLKDSQKITFKSFDVIGFLSSTIGVVSILYVLGEWTSIDWSKVQYPLLLTLGCLSLILFVVNELTHPQPLLDLTVFKLFDFSVCQIIICVLTMALMGGVYVLPLFLQNIRGYTAMETGLIMLPAALVVGILMPVSGNLFDKIGAKPLVIPGLIILALSSYHLSVLINMNSSREMITLILCIRSIGLGFTMMPINTAGMNVVPQNLIGKASALSSTIRQIASSLSVTIMSAIIQSKTNYNYLKLSEQINVYNKPANDTINILTKSYMQEGLPQGTAKASALSTLSKLFQGQATIDAMAYAVAITSVIVIVTIVLTLMMKSKKTVKGDDHNTNTKELAATK
>fig|1538.8.peg.415 
MKQKRKILIVGILVVIAAALSSIGFYYWYENTYYVSTDDARVDADLVNVTPQISGKLLELNVDEGDIVIKNQILARQEMSDLSDSKVDQSLIRSPINGIIIKKQGTIGEIWSPGQTLATLIDPNKLYITADIEETKLGKIRVGQPVSITIDEYGSQKFTGKVKSVGEAAQSALSIIPTTTSGTFTKVVQRIPIKISLDKFNNKILPGTNAVVKIRIK
>fig|1538.8.peg.446 Drug resistance transporter, EmrB/QacA family
MEERLEESNYQQRNYNVVPITIALIMAGFLCMLNETLLNMALKNLMVQFSISANTVQWLSTGYMLIMGIAIPVSALLIQSFTTRQLFLTSVTIFLVGTVISGFSTAFSILLVGRLIQAIGTGILIPNIVNTLLIINPIEKRGKALGIFNLVMFCAPAIGPTLSGLIIQSLNWRWLFFIILPFSVISLALGYKFIENVTELTKPPIDFLSIVLSTIGFGGFIYGVSNIGSSYTYLIAAPIIISCIALAIFVLRQLHMSQPMLDMHPFKESMFSLGCILMIIMHMINFATMLILPMFLEGALGLSAFTAGLLMLPGGFINGIISPISGHLYDKFGPKALIIPGYAISTITFFLLSRFVSMSITIPVIIVLHCLSLVAVGLINTPVQTNSLNQLSPKYYPHGTAIMNTLQQIAGAFGTSLFVAIMSASQKKYLFAAGNPSNAKSQALSLVFGVKHAFTIETFVLVIALILSLFIANNAINKKSKSIKA
>fig|1538.8.peg.812 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERSVKLRDEKVGKLLLEFSIPAIIGMLVNSLYIVIDRIFIGRVVGAMAISGVSLTFPISILIMAFGMLVGIGAAARISIRLGENNKDEAEHILGNAFVLLIIVSIVITILGLIFVDPMLRGFGASDNTIGYARQFITILISVSTFQTVGFGLNNVIRSEGDPKTAMNTMLIGGICNIILDFLFIYILHFGIKGAAIATSISQGINMIWVLYYFLKGNSMLRIKKKYLRLNKDIVASIFSIGMSPFAMQVAASLVNVILNKSLAIYGGDLAIGAMGIINGISTMILMPIFGINQGSQPVIGFNYGAKLHRRVKKALLLAIAAATFISAAGGIAVQVFPTVLVNMFNKSDMNLTNITVNGIKIFMIMFPIIGFQIVSSNFFQAIGKAKISMFLALLRQVIVLIPMLLILPRIFKLNGVWMAAPVSDAVASILTALFLYFEIKKLNSNEKENLSSPEISAELTK
>fig|1538.8.peg.1398 Antibiotic resistance protein
MGEGIGYLGISQIIATAFGPEIGIEASNRFGMSKTFIVSAVLIIIAAVCMNFLPNKNQISIKNTVDKKHAIHLKDIIAFKILPLSLIGGLFFMGNGLATSFLVLLGEERKINGIGMYFTVNALFLIFTRPMSGKLYDKKGLSTVMYPALLFSITEALLIAHASALWMILLAAIFKAFGQGTAQPALQAECFHKLGSQKKGLASSTFFIGANLGQGLGPLLGGTIASSLGYVWLFNFSALALLCGIFAYAIYNKKTCSSYF
>fig|1538.8.peg.1442 Vancomycin B-type resistance protein VanW
MIQPIDRNQIIPKKRKLKRKLKINKKKMTRSLIILSILTYIIHSLWIHFLVTRYDNLIYPGVKVEGINLGGKTKDEAIDTLKRKYVNQIFKKNIIIKVQDKVYTINYSKLNIKYNLDDVVQDAFKYGKCGNTHNKYKNIKSKNGKQFNLKYSYNKKEINNTISKIENELNRAPVNASITKDEDDKFKIDLEKDGQEVDRDKLFNDIDKKINNKNMNDVYISGTIRKVAPKIKKSSLVNINTKISSFSTNFSSSDDNRSNNIEVAAKTLNGTTIMPGEIFSFNKIVGKRTKENGYKSSKIIVGNKLQPGLGGGVCQVSTTLHNAVVRCGIVPTEREHHNIPVTYVGLGMDATVDYGHIDYKFKNTLDFPIYIECLTKNKNLVINIYSNSKLNNKIYNLINKVDKASNGKATIAKVYLVTYEDGKETSTKWINTDNYIK
>fig|1538.8.peg.1498 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEIENNTLKQGKIRKLLLKFAIPSVFALLVSELYNIVDTVYVGHYIGVTTLAAITIAFPIQKLLVALGLLIAVGASTYAARSLGEKNYSEFKKIVFTSFSLVLISLTIVSLIIFIFRRPIFYVLGADNLTYPLVNKYVSILLLGGIFQSLSVVACYIMISLKKTKALLYTNLIGVTLNILINYILIVKLHFKIEGAAIATVLSQITAFTFAFYKFKNIIREFHMEFSMHSIHNSVTKEIIWGIITVGFSTFIIEIEDALVTVVLNNLLYTEGGESAIVMVGVITKISMFLFVTIIGISSAMQPIVAYNFGAENYDKVKKVLNTSIKVVLITSFALWSIFMLFPNYIIGFFLNDTTLLNKTVKAFRLCICLIPLTGIYYVVINYYQAIGEAKKSFLLSIYREIIVFIPLAILLVQLFGIKGAWAAYPITDASAVLTSFYFLNKALKEDFNQVGVSEKF
>fig|1538.8.peg.1538 Quinolone resistance protein
MVQNSNVTKVLKPKIKDNLPEVDLLQEGISDYDSISSVLVNECLVENFKARRVSFNEVIFRNVKFINISFEQVEFLDVRFENCDLSNVNLSEASIHRVEFINCKLTGSNFTEAVFRNVMFDQCSGQYTCFRFTDFKQAIFSNCQLPYVDFYESKFSKLELKDTDITQGQFCNTKLKGMDFTSCRIDGIAAGVEDIRGAIISYTQAVSLISILGVVLKE
>fig|1538.8.peg.2222 
MKFGTVINIVKNRKKVVIGILAAVLIIAIGWVSYYVYEHVYYVATDDAKVTADVIKVGSQIQGKVLQFNVNEGDLVSKDEILARQDMGNLPDSSIEQSLIKSPISGIVVKKEVNAGEVLSPGKTAVLLADPENFYVTAKIDETKIRRLKVGQPVQITIDEYGSQKFQGKIKSISEMTEDALNPTAYSTDRKHNRKVEKIPVKIIFDNSKKLKNQLTLGTNASIKICVVNQNTKSK
>fig|1538.8.peg.2731 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQKLSNEYYLENAPITKAIAHLSIPMMIGMSVGTIYNVINAFFIGLLNNTDMLTAVTLGLPIFTILMAFGNMLGAGGGTFITRLVAKQNIEKAKKIAGYTFYSSIIIGILLGIILTIALTPIVKIMGADTSAIINYTKSYSLTMFIGGFAIVMNFALEQVVRAEGASKESMLGMVVSTIFSLIFDPLFILLFKFNVVGVALSMILANIASSIYYVYYLETKSENLKGFIKNFNISLKDKIEIYKIGVSELLLAGFLIITTLLLNNYSIRYGESVVASFGIALRIVQVPEFIAMGLALGIIPLIAYNFSNENFKRLKDSIKQSALWILGLSGGVVTLVYIFRNVIIHLFSNDAAVLSVGVYIMAAMLISAFFNGFTTLFIGIFQASGQGTPSTIMSITQGILFIPVIIVLNNFFGLHGVIWSMTITEIITFLTGVILYIIFNNKLKKNQVVAN
>fig|1538.8.peg.2979 Drug resistance transporter EmrB/QacA subfamily
MNSVKSKTGVSTVIIIMLGTFISSFDINVVNTALPIMQSYFHAGMSSIEWIIVGYLMVLGATQLTFGRLSDMFGHKKIYVAGLMLFTISSLFCALSTSIVMLIIFRITQATGASMISSSGSPIIIDAVEPKNRGKSLGMIAISVAVAVCTGPALGGLLASRAGWSSIFFINVPIGIVVSILAIKVIKKDDKRRNEVQFDFAGSTLIIAAIFLILLPLNLLSKSYFNIGSIVSFLGGIFVLLLFIAFEKKSKHPILNMELFKNRVFTGSTFAAMFFYMGEFILVFLAPYYLQKMRMLTPFMSGVMMLPMSIAMIIAAPLSGTISDNFDSRYIGCIGLAVMALATLFVGGFNASTPIWMLAVVFFIYGLGGGFFQTPNTSAVMGSVTADRRGVASAALGTMRTFGMMSGEAISAALIAFSMNKSAAAFISKGLKSTLLWQAEFRFSTKVTCIVAAICVISAIVLSFMRGKSAAPCGNAVVKTN
>fig|1538.8.peg.3124 Drug resistance transporter EmrB/QacA subfamily
MNEIDEGKYKKWMIFAVTSMANLVVSFSINSLNLALPTLTKEFDVSQNSISWLALVYSLIPCCTLLIFGRTAELYGYKRQFKIGFLFFGAVCISAPLLSVNLEVLIFFRCLQGIGYSIMISITQAIVSRTFDSKERGKALGINSVFISIGMAAGPTIGGFLLTHSSWHAIFYFNVPFCILGFVATCLVMPDDRTEVSECKSMDWLGAILFSMSIGAFSVGLNFSIKWGWKSVSFLGCMLFSVLALYIFIMREKHTESPLMSLHLFKSRTFCMANVVCMLSYLVQQLITYLVPFYLVDILLLSSDQSGLIMLASPIMMMVMSPVGGSMSDKHGTRLPSGIGLIFICVSCLFMSLLKKSSNYTVVIFTLIAMGIGNGLSVSSINAAILNSVPRKHAGVASGMLATMRNLGQTLGVASSSVILTSRQIVYNKNTNLSVKDIYLFAQRDTYYFGILILIVALVFVFLLPRSITDKSDMV
>fig|1538.8.peg.3353 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLNNEKLKMMRDEKISKVLLKMGIPTMIGMMVSALYNVVDAYFVGGLGTSQMGAVSITFPIAQVIVGLGMTFGNGAASYISRLLGEENEIKANETASTALVSSLIVGIISIAVSLCFLDNILIGLGATKTILPYAREFAVIYITGSILNIFSVTMNNIVTSEGMAKLTMTSMLLSGIFNIILNPILIYSLGFGIKGSAISTVISQALASILYIWYMLNKKGSLRFSIYNFRFDSTIFIQIFKVGIPILVYQLLSSASMGLSNTAARSYGDSAVAAIGVVTRIMALGSYVVFGFMKGYQPVAGYNYGAKNYDRLNEATKVSLKWATIFCTVIALILIMVPDQIVSLFSKNDAVLINIGGRALRANGIIFILFGFEQVYMCLFLALGMGKEGGILSISRQGMFFIPAILVMPQFLGIEGVIWAQPAADLLTVILTALFMLGVNKKLNNFMNQKEYLN
>fig|1538.8.peg.3975 Permease of the drug/metabolite transporter (DMT) superfamily
MKKRLIGSMCLFLAACIWGGMYVVSKYILEFISPITLVWIRYAIAFVVLFLILMFFNYKKGRKVVIKKKDWLLIAWIGFIGYFISICLQFMGTKLSDAHMGSLITASTPVFVIIFARFILKELFTKKKMISLILATFGVIIVIGLDSMFMKHLLGNIILVGAAVTWALASVYLKIVSKRFNSLIITTYAMLFALIFTTPLMLTQHNNFTLILNNRNLILGIIYLGVVSTAGAFFLWNKGIGLMDVGIGSLFLFFQPVTGSIFGWLYLHEQLTFGFFIGGTLIVIAVIIAITKEDN
>fig|1538.8.peg.3977 Vancomycin B-type resistance protein VanW
MMSGKRKTRKSKRKSGGTLKILGLAALTIFLSISCGFIVYHYNDVKYWDNLIYPRVSINNTDLSEKTKDQAKSIMSSEYLNKFQQKQITITAGNKSYELPYSSLSFTYNLDDTIKLAYSYGKSSNIFKKYELLKNPKNVNYNLKFSYNTKVIDNMVDKIASEVDTEPVNASLEMGGVKFSVIPQKDGIKVDKEALKKDIESKIDNNSDQDLTVKAVLKTTKAKIKEDDLKPVDTLISSFSTAYGGISSGERANNISLATSSINGHVVMPGDTFSFNDVVGQRTAAKGYEAAPVIIGDKVESGLGGGICQVSTTLYNAVAKAGLTSTERTHHTMPVHYVPEGMDATVDYGNIDYKFRNDFKYPIYIQGYTSGGNIVFNLYSNSSVSK
>fig|1538.8.peg.4067 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKFERGVCKLSEKSTKINESYIENEKLGKLIMKFSIPCVLAMVVNALYSIVDQIFIGQGVGYIGNAATNITFPLVVLALGFSLLLGDGAAAFYSIKLGEKNKEEGAKAIGNAIVLMVILGLIFLAVGYIFMKKLLWSFGATSTNISVALDYMRIILIGLPFMILAAGLNSIIRADGSPEYSMLAMIVGAVINIVLNPILIFHFSMGVKGSAIATIIGQILSCTISLSYLKKFKNIKFKREYLKLDVKVSKTVMLLGISSLITQAAVTIIIIVSNNMLKIYGAQSIYGSDIPISAIGIVMKVNDLLLGVVIGIAIGGQPILGYNYGAKNFKRVKDTYFMLIKIATVVSIIGFIIFQFFTQSIVNLFGQNSALYNEFALKSFKIFLMLCMFIGFELTSCIFFQAVGKPGKAMLLTLCKQTFFIVPLMIILPKFLGVLGVLYAGPCAEILSVIVTIILITSELKKYSKLTVS
>fig|155920.1.peg.160 Permeases of the drug/metabolite transporter (DMT) superfamily
MLISSKVRTAQLQIHVCVLLWGFTAIFGRLITLEALPLVWWRMTMVVFSLVLLPRVWRGLRALHPRVMLAYAGIGALVALHWLAFYSAVKLANASVAATCIALAPVFTAVVEPCVVGRPFRARELLLGLMVLPGVALVVGGVPDGMRIGIFIGVVSALLAALFGSLNKRMVVHADPLTVTALELGSGILTLTGLMLLLSLVFPTLHEMPWQIPSAHDIFLLLILSFACTLLPFALSLVALRYLSAYSLQLVTNLEPVYSIALAIVLLGEQRELTGLFYLGVAVVLGVVLLHPMLERRGRASSPQ
>fig|155920.1.peg.1197 Permeases of the drug/metabolite transporter (DMT) superfamily
MVTQGQLPLRAAMLMLFSTLSFGMMAITIRYASTQIPTTEIAFFRNAFGLLVLLPLILGPGKPLPRTQHGPRYIARSMLGLISMLCNFWAISHLPLTQAITLSYSTPLFATILASLWLHEVVRLRRLLAILAGFAGILVLLQPWSGTFSPALLVALAAALLNAVITIQMKQLSHLDPPDTVVFYTYAFWVPLSLLLALWQWHWPEGVEWVWLIATGIFGTIGQLLWIRALRLGEVSTLQPIGFMQLPLVTLLGWWLFGEHLDRYTALGASIIIGANVYITHREAVLARRTAAETIQKGVQSNGINRAQGPS
>fig|155920.1.peg.1713 Drug:proton antiporter
MSTSPASSATLRTLLCHPGFTAVLAYRIAATLSYQIVSVTIGWHIYEITRNPLLLGLVALAEILPFFCIAPFAGYLVDHLPRRRLGMFASLGLAMTPTILLIAAFNTAPVQTTWPIYVAASLSGMVRSFIVPVYNALFARVLPREDYARGAGLGTVAFQASLVLSPMLGGILIALGGKELAYAAGVVAAIIALLALALLRVEEPAVDKPRAPVLGSIAEGLRFVFSNQIMLGAMALDMFSVLLGGAVSMLPAFIQDIFHYGPEGLGILRGTPALGSVLAGLWLARYPLQRHAGRTLLLAVAGFGICTIAFGLSQHFWVSAGILLVYGACDGISVVLRASILQLVTPDEMRGRVSSINSIFIGSSNELGAFYDGVMARFIGLVHAVVLGGFMTLVVVGITALKAPRLRRLDLRDL
>fig|156586.3.peg.266 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKPVLIILSFFAVYVFWGSTYLWNKMAVTELPPFMLASIRFTTASAIIFVIAVLSGKKLTITKKQLLNTVLAGFLFLAYGNGVFVWALKYVDSGFASLLASLQPLVLLLMMRFVQRKSLKIKSIIGVFLGLLGMYLLVSQKGLQMQEDSWIGIIMIMSCIISWSAGSLFVAKADTPSNFFITTGYQMLSAGVILAIGSWAFDESWSEPLSWQLNTQIAIICLILFGSIAAFTAFNYLLKVVSTEKVATSSYVNPIIALLLGWYFLNESITMQSMIAAAIMLTGVYFINSRKVR
>fig|156586.3.peg.714 Multiple antibiotic resistance (MarC)-related protein
MDDLLTFAFTVFTGFFAIMNPISNMPIFLTITEGADKETKQRINLKAIIVAFIIVSTFVLLGNYIFELFGITIPAFKITGGILIFFVGFEMLQSKKSNIKRLKTVNYDENIAISPLAIPILAGPGTIVTATNFVANTSSYADIAVVLLVFALMCLLNYIAFSLSDVIAKKIGDNVISVIGKLMGLIIAIIGTSMIISGLKLSFDVLN
>fig|156586.3.peg.1454 Multidrug resistance protein, AcrB/AcrD family
MLKTFIERPVLSTVISIIIVMLGVISITTLPIEEYPDIAPPTIKVTANYTGANAETVLESVIVPIEEQINGVEGMTYITSTASNTGTAEITVYFDQETDADIAAVNVQNRVARATPLLPSEVTQTGVVTQKQETSALMFISMYSESENYDATFIQNYLKINVIPAMQRISGVGDVSVFSQQDYAMRIWLNPEKLASYNLIPSDITAALAEQNLEAAAGSLGENNGESFSYALTYSGRFKDEAQYSDIVIKALGNGEFLRLKDVATIELDAQSYASNAMSMGNPAVFMGIFQTKGSNAQEIIENIKSTLEDVKADLPEGLDIFVPYDTSLFLNASIDKVITTLLEAFLLVFLVVFIFLQDFRSTLIPAIAVPVSIIGTFFFLNVFGYSINLLTLFALVLAIGIVVDDAIVVVEAVHAKMDEGEHNPKKATITAMNEISGAIISITLVMAAVFIPVTFVTGPTGVFYEQFGVTLIIAILISAVNALTLSPALCALLLKEHKDDEELKGKGPLKRFYTLFNRGFNATIEKYGKSLQFLYKRKFVSVLLLIIAVVGIYWASTTTPTGFVPNEDRGIVFANIELPPGASLDRTDAVSRKLYAQIENIEGIEAVNFIKGRSLISGAGSNYSFGIIKLKNWDEREEASLSAEAITGKLFGVAAGIPDANIIFFSPPSIRGFGNSAGFEINLLDKFGGEFTDLDQANKDFSMALMSHPEIKYATSSFSTSYPQYEMEVNVPLAKEKGVSVSSIFSTLQGYIGGIYASDFSRFGKQFRVYIQALPEDRADENALNSMYVRTDSGEMTPITQFVTLERVYGPQSVTRFNLFNSTMISGATNEGFSTGDAIRVIEEEVAKLPSNYTVAYSGLTREEVNAGNQTTFIFILSILFVYFLLSAQYESYLLPFAVIFSLPFGVFGAYISTKFLGLENNIYFQIALIMLIGLLAKNAILIVEFALARRKNGESIVDAAIHGAKSRLRPILMTSFAFILGLMPLALAKGVGSEGNNSIGSGAAGGMLIGTILGVFVIPILFILFQWLQEKVSGKPAVQTIED
>fig|156586.3.peg.1455 AcrA/AcrE family multidrug resistance protein
MMKRIRNTVIILSISIGVLSCGDKAQPKTLSEAAPSPYPVVQLQSKTVTGFTEYPTTIEGKVNSDVRAKTSGYVEKVYVDEGQKVRKGQTLFKLETQSLSQDAGAAKAQVNVAQVEVDKLIPLVEKNIISPVQLETAKANLAQAKANYSGVTANIGYATIKSPIDGFVGAINFREGALISPSDATPLTTVSQIDEVYAFFSFNEAQYIDHLQRSKGQNKAERIKNSPDLTLVLANGKEYSEKGRIQTSTGQINQSTGTIQIRAAFDNPNEILTNGNSGKIKFPIEYKDAIVVPQTATFEQQGNIMIFKLGADNKVETSILKVQGTVDNLYVVESGLEPSDKIVISGIGKLKNGMAIAPQDTSFEEAIKPVATLFRN
>fig|156586.3.peg.1462 Permease of the drug/metabolite transporter (DMT) superfamily
MKADLKKAIIFMLLSTLAFAVMNGVVKYLDGFSAYVKVFFRSLGTLIFTMPYLIFKKIPLLGNKRTLLIARGVIGAVSLILFFMSLKYLPVGTAVTLRYMSPVFAAIFAVIWLKETIKPWQWMFFLMALAGVFVLQGFDGTSSVIGLLLVLTSALCMGLVFVVISKIGKQDHPMVIINYFMIIGTILGGILALNDWKTPVGNEWLLLLGLGVVGFIGQLFMTKSFQIASTNQVAPLKYLEVIFTVIIGVLWFLEVYTLWSVLGIALVITGLVLNILYKSKQSS
>fig|156586.3.peg.1772 Acriflavin resistance protein
MKEGLAGKVAKVFMNSKLTVLLMIVFMVVGVYSSFLIPREEEPQIDVPMADIFVGYPGASPTEVESRVIKPLEQLISNIKGVEYVYSTSMKEQGMVIVQFYVGEDIERSFVKLYNEINKHMDQMPEGVTMPLVKTRAIDDVPMLGLTLWSENYSDYQLGQMAHELEAEIKKINDVAITHKIGGRERQLRVVLDKDKLASSGLDFMQVSKMIKANNAQLNAGKFDKNDTEFIVNTGDFLASTTDVENLVVGVQQNQPIYLKQVAQIIDGPEVPQSYVSLGFGQGSDKKTDFLSEYPAVTISVAKRKGADAMKIADVIIAKVEHLRKTLIPDDVQVEITRNYGETASHKVSELLLHLIGSIIAVTFVVMLAMGWRGGLVVFLSVPITFALTLLSYYMLDYTLNRITLFALVFVTGIVVDDSIIIAENMHRHFKMKRLPFKDAALYAINEVGNPTILATFTVIASVLPMAFVSGLMGPYMAPMPIGASIAMILSLFVALTITPYLGYIFLREKDKKGAVEKIEKPLEETLIYRLYNKFERPLMENRYKRWLFLIGTFVVLLGTMGLFITNSVAVKMLPFDNKNEFQVVIDMPEGTTLERTGAVAQEISQYLSTRPEVVNYQNYIGTSAPITFNGLVRHYDLRGGSNMADIQVNLIDKEKRSAQSHDIASLLRPDIQEIAAKYNANVKLVEVPPGPPVLSTIVAEIYGPDYEQQIIVANEVQNILKNTDDVVDIDRMVENDQTEYQFTINKEKAMLYGVAPQQIAYTMHLALSDRPVTNLYDEDAVQQIGIVLALDEKEKSTIQDISQFKVVSNQGTMVPIADLVEISESISAKSIYRKNQKRVVYVMADMAGELESPAYAILGMEEKLKSIPMPAGYSISEMYLGQPDFEDDYTVKWDGEWQITLEVFRDLGIAFLGAIILIYILIVGWFQNFKAPIVMMVAIPLSLIGIILGHWIMGAFFTATSFIGMIALAGIMVRNSVLLIDFINLRTAEGVPLKQAAIEAGAVRTTPILLTAGTVVIGAFVILFDPIFQGLAISLMGGTIVSTVLTLLVVPLVYYMIEKKNYK
>fig|156586.3.peg.1832 Acriflavin resistance protein
MRKVIAYFIKHSVAVNVVVVGFVIFGIFGMLSLKSSFFPLTDSKIINITATYPGASPQEIEEGVVLKIEDNLKGIEGIDRVTSASKENAGSITVEILKGYNIDFMLLEVKNAVDRVSSFPVGMEPLVVSKQEQSRPTISFALSGDNVPLITLKQLARDIENDLRGIDGISQIAISGYPDEEIEIAVNENTLLGYDISFEEISNAVASSNILTTGGNIKTDREEYLIRANSRSYYGNELSYIPVKTLADGTSVLLKDVAVIRDRFSETPNATYYDNKLAVNITVTSTNSEDLIDAADKVKLYIEDYNQRFTNVQLDIVRDLSVTLNQRTALLTENAIVGMLLVLIFLSVFLNTRLAFWVAFGLPIAFLGMFIFAGQFDVTINVLSLFGMIIVIGILVDDGIVIAENIYQHYEDGKSPVQAAIDGTMEVIPPILSAIITTLLAFSTFLFLEGRIGDIFGEVSVIVILTLLVSLVEALIILPAHLAHSKALQPRNDQPKKGLARVFQKMRVVNDYGDKAMNWMRDKLYAPVLRFSLANKFFTFALFIAALVLTFGSMNGGIIKTAFFPRISSDQVSINLSMPNGTSEFITDSIINSIEKKALIVNEQLTEEYLKGDEYGDSIMLFENIIKSQTSSSAASLSINLLPGESRPETVNSEIVSNRLRELVGEIPGAETLTFGSGGNFGGSPVAVSLLSNDINELKAATAEFKEILSNNPLLKDIEDNDPAGIKEINLELKETAYSLGLTTRTVMAQVRSAFFGTEAQRFQRGQDEIRVWVRYDRDNRNSIKDLDEFRVLTPSGDRVPLRDIASYTIERGDVVINHLEGRREVLISADLKDPSGSATDILANIKSEIIPDLQKKYPTISPNYLSGQAREADKFSQSAAVAGPIILLLIYFVIAFTFRSWLQPIMLILLIPFSFVAVGWGHWIHGFPVNILSLLGIIALIGIMVNDGLVLIGKFNSLLKEGLGFDEALFEAGKSRFRAIFLTSITTIAGLAPLLLEKSRQAQFLKPMAISISYGIGMATVLTLLMLPLFLSFGNNGKAAIYWLRTGKKATKRDLTSVAKELEEQKHNDEA
>fig|156586.3.peg.1877 Multidrug resistance transporter, Bcr/CflA family
MKVKQVDKENVSKGRKTSVILVLGTLIAIGPFSIDAYLPAFKQIAGDFKVETSAIGFTLTTYFIGIGLGQLAYGPLMDRYGRRRPLIAGLILYITTSVLSAYAWDVSSLATLRFFTALGACAGMVASKAIVRDLFDDDKVAEVLSTLMLIMGIAPIIAPTIGGFIIEHYHWDMIFYGLAGFAALMLFNVIFILPESSKPNPATSLHPVPVLKEYWTIYKDKAFFLFSTARGFVIGALLGYVAAAPFIFLDFFNMAQSDFAIIFGSNAAGLIAGSQINRFLLRRFTTFQITYTISILLVVTTLLLVGHISFFEPEFWVVYPLLFLMMTFIGFQNPNVTALALQPFTVRAGSASAFVGAVSMIFGSFASWYVSRYVTVSVLPLALMLAGCALLGYAAIETFRIKYARGYAFAKAYLKHPYVSLKRENAS
>fig|156586.3.peg.2072 Drug:proton antiporter
MTKNDPYAALRFQEFNIFLLMRFLLVFGWSMQFIVIEWQVYSLTKDPWSLALIGLMEFVPAFSMALFAGHIVDQSEKRNLLAICIGAFSLISLGLFLLTWPEVVGEWSTDSILYCIYGLVFFGGFLRSFFGPILFSLIALLVPKNAYPNAATWSSSAWQIASVVGLAFSGFSISWYGVHWSLGIVFTLVFLAFITVFLISKKPILNTKINEPIMQSLKEGLSFVLKTKAILGALTLDMISVLFGGAVILLPVFAQDILTVGSEGFGILRAAPSIGAILTMIATAYIPISKNAGMKLLLAIFGFGISIIIFGLSTSFWISVVALFFSGVTDGVSMVIRQTILQLKTPDHMRGRVASVNSMFVGSSNELGAFESGVTAKLMGTVTAVVFGGSMTLITVITTAIISPTFRKLDLREDFKSK
>fig|156586.3.peg.2208 Permease of the drug/metabolite transporter (DMT) superfamily
MDNSKLKYIYLIILSLIWGTSFILIKKALGDDGSGHLVLQPLQLGAGRTIISGCILIAIGWKSFAATDRKDWKWLFVSGLLGTFFPAFLFAYAQTEIDSAISAILNSTVPLITLIMGAVIFGIAFSRTQLLGVIIGLAGAIALVFSGMKNNPEQNYLFAGLVFIACLCYASNVNIIKRYLQNIKPLAIATGNFIFILPLAIIVFFGADGASIEFTSEPVLKSLGYIIVLCVFGTVAAKIMFNKLVQITSPVFASSVTYLMPVVGLTWGMLDGEIFSIWQVLATMVIIFAVVLVTRNKKTSN
>fig|156586.3.peg.2592 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTKPSSKSQILGTDSIPALLIRQALPASIGILVMSLNILIDSIFVGNWIGSIAIAAINVVLPVSFFIAALGMAIGIGGSSIISRALGANNYEKARKVFGNQISITLLITIPCVVFGLWFMDSLVFSFGGKGAIFEPAKIYYRIVLYGVPILALCMMGNNVIRAEGAPAHAMIAMLIPSVGNLLLDFILINQFNLGMAGAAWATTVSYILCFAYIAWFFISGKSELIGNIKDLIPEFNILKEIGGLGFVTLSRQAMSSVLYLILNNVLFELGGEESVSVFGIVGRMMMFALFPVMGITQGFLPIAGYNYGALKWSRVREVIFTSIKYACIMGIFIFMGLFFFTREIAGVFTKNETVIEQASFALKLVFIAVPIISIQLIGAAYYQAIGKVIPALLLTLLRMGFILIPLVLILPQIYGELGVWISFPIADILSTIITAWYLWIAMKKLHRS
>fig|156586.3.peg.2596 Permease of the drug/metabolite transporter (DMT) superfamily
MSKRAVAIICGFLVALFYAYNFTAAKEVTPEFVGPYGLTWYRVVITCVIFWVIATIVGPKEKVPLKELPLLALAAFCGVGFNMVTFMKGLSLTAPISASVLMVTTPIIVLLLSAIFLKERLYASRILGILIGFSGAALLIFLSNSGSNENATNPALGNFLVFINAVSYSFYIILAKKLTTRYHVFTLMKWLYLFGVIFITPFGITEGLSFDFSTANTDTLWYIGYVVLFATFGTYMLNIIAIRTLKPSVVAVFVYLQPLLATLIAVGLNKDEITLYKLIAGGLIFTGVFITSIPKKAG
>fig|156586.3.peg.2654 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MKAKVTGIGGVFFKCADVAATKAWYHKHLGLPVDDYGCTFWTGPTTDKASQQWSPFKEDTTYFNPGDQEFMINYRVDDLVKLIEQLKSAGVQIAGEIEEFDYGKFGWIIDIDGRKIELWEPANEELFEK
>fig|156889.7.peg.1535 Multidrug resistance ABC transporter ATP-binding and permease protein
MNLILTPIGRFLHRIRHLLPHYQRYRRAFVWGFLLLIATNASAALIPYLMKLAIDTLQRGEGMTDVKTYALLLALLAVLTALLRIRARTHVFRIGREVERDMRNLYHAQLQDLEAPLFDHARTGDLVSRGIGDITALRMFMGPGFLQLTNASLVYILVLPAMLWLNPWLTLMALLPLPFVVIAARQLTKRLYRYSRMVADRFGGLTAFVQESVAGMGVIRTYAREDAWNQRFYEETDKLYATQQDHARLQGMFQPLMLFSGGLGAWIILAVGGPGVVQGNLTVGDFVAFTGYLTLMIQPTVALGWILTVMQRGLAAIDRLSEVLDITPSNADHPQQALHPEPTTPYAIEIRHLNFFYQQDRRIAPRSKEAAPSHAVTTAAGDGTEPAAVQTLHDITLTVPHGHFVGLAGRIGSGKSTLLRCLSRTYPIPQGSLFLDGVDLAHVPEAQLRQHLTMTPQESLLFSRPLLENLLYGQPDEDEACAWEAARNAAFDEEVEGMPQGMETLIGERGITLSGGQRQRAALARALVVNPRILLLDDIFSSVDARTEAHILNALLDRPDRPTMVMVCQRVAALHRADTIYLMDQGRICETGNHQSLMQSSSLYQALHTEMQRKEQLEEMEQPEVQP
>fig|156889.7.peg.2474 Permeases of the drug/metabolite transporter (DMT) superfamily
MVATIDLFRVTTMFPSTALQAYLARTLSPNVRGALWLLQAGLFFSTVGALVKWIGSDLDAMQIVFLRCLFGMLLLLPLLLRKGGAILRTQRPRIHAVRAVVGILAMLTTFYAYANLPLADVTALSFTNPLFMIPLAVLFLGESIHWRRWSATLVGFAGVVVMLRPGDAPFTLALWAAILSPLLIAMVQVLFKRMSSTESTLTIIGRYAVASTLLSLPLALGVWRWPTLEALLLIALASAFGNLASAMLVWAYKVGEATAIAPFDYTRLFFATGFGIWIFDETTSLHTWLGAAIILAATLYIVHRDRLDRLPKAIAVE
>fig|156889.7.peg.2629 Acriflavin resistance protein
MNLARISVARPVFTSMVTLMVVILGLVSLSRLQIDLLPSIELPTLSVRTQYEGASPEVMERLVTQIVEEIVATVPGVVEMTSQSSEGNSTVKVSFAWGTDIDTAALDVLATLEDEINELPEDITRPRVSKFDVDSFPVVILGISSDLDPVPFTQLIEEQIRYRFARIAGVAQVDVWGGYNRQVRIELDPDRLNALGIPLADVLTAVRNANLDRPAGTLEEGQFEITLRAPAEFVDLDEIRQTVVVLRDGVPVTLGQLAAVHDRYEKLTRMVRVDDRPGIRVAIRKQAEANTVEVAKRVLAEIEAVNQAYPRIHVVPVINQGNFIERSIANVARSVLYGGGLAVLVLLFFLGSVRSTVVISLAIPISIIATFMLLYFGGFTLNLMTLGGLALGVGMMVDSSVVVLENIVRRRHEARESLHTASLMGAQEVTSAIIASTITTLVIFLPLVFVRGVSGILFQELAYVIIFSLICSLLVSLSLVPMLISKLGRGGEGSVDLPRWADRWQSAMQQSYANLLQRVLEHRWKTVLAAVTLLAGSMLLLPYIGTEYLPPSDEGEVRITGEMAVGTRLELLDQQAQRMEAIVRQAVPEIQSSVVNVGRWRGKTNAEIRLALAPVAERSRSNVEIAADLRRRLAGQIPGMKVRTRAPQGQFLLERLLAAEEGITIEVRGYDLQVLDGLAQAAMAAIADLPGVTDSEASKIAGVPQRGIHIDRAKIADLGLSVQDVTSAIETAVAGSKAGEFRAAGNAYPILVQLADAEKRGLDEILDLTLRTPAGELVAIRNLVSTVAGQGPLVIDRKDQQRLVTVSANVAGRDLGSVAAEVQERLMLIPRPAGYDLLLSGHYEEQGKAFRELIISMLLALVLVYMVLASQYESLRDPIIVMLSVPMAAVGVLLMMFLTHTTFNLQTFIGCIMLVGIVVNNAILLVDQAGRLRQAGMSGKQAVTEAGRRRLRPILMTTLTTVLALLPLALGIGEGADMQAPLARAVISGLAGSMLITLVIIPVVYTLFHPDPAPGSTQPAVEASVP
>fig|156889.7.peg.2791 Permease of the drug/metabolite transporter (DMT) superfamily
MLQNNSYQRGVVLMLLSAVILSSMGLLVRGMTQAQDWQVVLWRGIWATTGMGLVLLVQNRGGSWQRIREAGWLALLGGVFQGGGSIGFILSMLHTTVANAMFTMSSMPLFTALLAWLVLREPLHKITLLAIAVAMAGVGLMVWDGMSYGGALGNLLALGAALCAACLVVVLRYGRGRNMLPTLIFGALISVMVGGVMVPGSWMIPWRDWLLCLLLGGGVTVAGHLLFLLASRDLSGAQLTLVGLVEFALGPLWVWWFMGEEPSGWSLLGGAVVSLAVVWHTVWGAAWVKPLPGPA
>fig|156889.7.peg.3354 Permeases of the drug/metabolite transporter (DMT) superfamily
MEMIGWLPLALAVALFTALKDLLNKRSVAQLNPWTVARMQHLAAFVVLLPLLPFISVPEIGPNFWWALLGSGTINVVALLLYVQALHHSDLSLTTPMLTTTPVFLLITSPIIVGEFPSLTGVMGIVFIVLGAWLLNVQQRHIGFWAPFKALYRERGPRLMLIIAFVWSVSSNLDKVGIQNSSPLVWLLSLFAFIALGTTLAAHHFGPRESGADWRPHTATLWIQGGLFSAAALCQFLALELTMVPYVIAVKRTSALMAVVLGVWLLKEQGGRERMLGAAVMFAGFLLITLAQA
>fig|156889.7.peg.3490 Tetracycline resistance protein
MKRKSTISIIFFTVFLDLLGFGLVLPLLPNYASDPMFHASTMEIGVLMGIYSLMQFLFAPLWGRLSDHIGRRPVLIIGLFGSALSYLIYGLAESLMVLILSRALAGFMGANIAAAQAAMADLTPPEKRAQAMGIIGAAFSLGFVLGPAMGGYLASTYGISAAPLAAALITGLNAVAALFLLSETRDLSTEQQQPLSKRAHPLSLHPWKQARNYPGALMVCLFMGLFITLFAAFEMALPLWTQIIMGWDSGSQTMAENGHLFAFVGVVMAIVQGGIVRRLVPKIGEVRTAYSGLICIALGLMLLGQASNYTTLLIALGLAATGAGLVHPAFSSLVSLNTDKDKQGLMMGLFQSMGALGRVLGPLWAGIAFVSLKGNLFFVSAMGMTVLLGALIPLSRDRIKDARQIAAQDAKS
>fig|158878.1.peg.34 Bleomycin resistance protein
MRMLQSIPALPVGDIKKSIGFYCDKLGFTLVHHEDGFAVLMCNEVRIHLWEASDEGWRSRSNDSPVCTGAESFIAGTASCRIEVEGIDELYQHIKPLGILHPNTSLKDQWWDERDFAVIDPDNNLISFFQQIKS
>fig|158878.1.peg.41 Penicillin-binding protein PBP2a, methicillin resistance determinant MecA, transpeptidase
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETESRNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE
>fig|158878.1.peg.42 Methicillin resistance regulatory sensor-transducer MecR1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>fig|158878.1.peg.43 Methicillin resistance repressor MecI
MDNKTYEISSAEWEFMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDRKKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNILNKK
>fig|158878.1.peg.103 Probable antibiotic resistance-related transmembrane efflux protein
MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRVIQGVSAACIMPSTLAIMKTYYQGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEITNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVVIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYVGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK
>fig|158878.1.peg.107 Permease of the drug/metabolite transporter (DMT) superfamily
MNKLRDTTFLSYLFTIILWGSAFPMIKIALNDFSAESLSAFRLILATIILLPFVIIKKLPTPELRDIPVIFILGFCGFVIYHTALNFGETLISAGISGILVSTTPIFSSALAYIFLKEHFSKWNWLSSLVAFIGISIISISKDDYTTINVLGVFIILLASFSESLYFTFQKKYIEKYGFIAFTLYTIMASSPFMLIFIPEIINDIHGATFTSIVSVLYLAIFPTIIPYVLLAYIVKSVGVSDATMSLYLTPIVSLLLSYLLLDELPTTLAIIGGIITLLGVSLSNFFQNT
>fig|158878.1.peg.334 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLPVFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNIILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQAIVEMATFILKVTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLLIAESLCALAAMLIVYLLRDRLTVDTSELIEG
>fig|158878.1.peg.338 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MNIVGHHHISMYTKDAKRNKDFYTNVLGLRLVEKSVNQDNPSMYHLFYGDEVGTAGTILSFFEIPHAGHKQPGTETIYRFSLLVPNQAALHYFEKRLDNNGITSERLYYLGQEGVVFKDEDDLEIILLVNDSFEVPHQWQHNAYSEIPQVYQILGIGPVELRVRNAARTVEFLENVLGYRKRDNKSFDVLTLAPQGLYSDFVVIEQQGQRERPGRGYIHHIAINTPQMSDLDAIYKKLQQQTQSNSGIIDRYFFKSLYYRHNSIMYEFATEAPGFTIDTPLEQLGSQLNLPDFLEAEREQIESKLHEI
>fig|158878.1.peg.398 Tetracycline resistance protein TetM
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLTPIVLEQAFRKAGTELLEPYLSFKVYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVIIIGEIPARCIQDYRNDLTFFTNGLSVCLAELKGYQVTTGEPVCQTRRLNSRIDKVRYMFNKIT
>fig|158878.1.peg.695 Quinolone resistance protein NorA
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISFVVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM
>fig|158878.1.peg.1057 FmtA protein involved in methicillin resistance
MKFNKVKLVIHACVLLFIIISIALIFHRLQTKTHSIDPIHKETKLSDNEKYLVDRNKEKVAPSKLKEVYNSKDPKYKKIDKYLQSSLFNGSVAIYENGKLKMSKGYGYQDFEKGIKNTPNTMFLIGSAQKFSTGLLLKQLEEEHKININDPVSKYLPWFKTSKPIPLKDLMLHQSGLYKYKSSKDYKNLDQAVKAIQKRGIDPKKYKKHMYNDGNYLVLAKVIEEVTGKSYAENYYTKIGDPLKLQHTAFYDEQPFKKYLAKGYAYNSTGLSFLRPNILDQYYGAGNLYMTPTDMGKLITQIQQYKLFSPKITNPLLHEFGTKQYPDEYRYGFYAKPTLNRLNGGFFGQVFTVYYNDKYVVVLALNVKGNNEVRIKHIYNDILKQNKPYNTKGVIVQ
>fig|158878.1.peg.1761 Multidrug resistance protein B
MNIPKSVWWLVIGMALNITGSSFLWPLNTIYMKQELGKSLTVAGLVLMINSFGMVIGNLLGGSLFDKLGGYKTILIGTFTCLCSTTLLNFFHGWPWYAVWLVMLGFGGGMIIPAIYAMAGAVWPNGGRQTFNAIYLAQNIGVAVGAAMGGFVAEFSFNYIFLANLIMYVVFALVAVTQFNIEINAKVKYPTHLDITGKKNKARFISLVLICAMFAICWVAYIQWESTIASFTQSINISMAQYSVLWTINGIMILVAQPLIKPVLYLLKGNLKKQMFVGIIIFMLSFFVTSFAENFTIFVVGMIILTFGEMFVWPAVPTIANQLAPDGKQGQYQGFVNSAATVGKAFGPFLGGVLVDAFNMRMMFIGMMLLLVFALILLMVFKENNTQPKKIDA
>fig|158878.1.peg.2160 
MNLFRQQKFSIRKFNVGIFSALIATVTFISTNPTTASAAEQNQPAQNQPAQPADANTQPNANAGAQANPAAQPANQGGQANPAGGAAQPAGQGNQADPNNAAQAQPGNQAAPANQAGQGNNQATPNNNATPANQTQPANAPAAAQPAAPVAANAQTQDPNASNTGEGSINTTLTFDDPAISTDENRQDPTVTVTDKVNGYSLINNGKIGFVNSELRRSDMFDKNNPQNYQAKGNVAALGRVNANDSTDHGNFNGITKTVNVKPDSELIINFTTMQTNSKQGATNLVIKDAKKNTELATVNVAKTGTAHLFKVPTDADRLDLQFIPDNTAVADASRITTNKDGYKYYSFIDNVGLFSGSHLYVKNRDLAPKATNNKEYTINTEIGNNGNFGASLKADQFKYEVTLPQGVTYVNDSLTTTFPNGNEDSTVLKNMTVNYDQTANKVTFTSQGVTTARGTHTKEVLFPDKSLKLSYKVNVANIDTPKNIDFNEKLTYRTASDVVINNAQPEVTLTADPFSVAVEMNKDALQQQVNSQVDNSHYTTASIAEYNKLKQQADTILNEDANHVETANRASQADIDGLVTKLQAALIDNQAAIAELDTKAQEKVTAAQQSKKVTQDEVAALVTKINNDKNNAIAEINKQTTSQGVTTEKDNGIAVLEQDVITPTVKPQAKQDIIQAVTTRKQQIKKSNASLQDEKDVANDKIGKIETKAIKDIDAATTNAQVEAIKTKAINDINQTTPATTAKAAALEEFDEVVQAQIDQAPLNPDTTNEEVAEAIERINAAKVSGVKAIEATTTAQDLERVKNEEIFKIENITDSTQTKMDAYKEVRQAATARKAQNATVSNATDEEVAEANAAVDAAQTEGLHDIQVVKSQQEVADTKAKVLDKINAIQTQAKVKPAADTEVENAYNTRKQEIQNSNASTTEEKEAAYTELDAKKQEARTNLDAANTNSDVTTAKDNGIAAINQVQAATTKKSDAKAEIAQKASERKTAIEAMNDSTTEEQQAAKDKVDQAVVTANADIDNATANTDVDNAKTTNEATIAAITPDANVKPAAKQAIADKVQAQETAIDANNGSTTEEKEAAKQQVQTEKTAADAAIDAAHSNVEVEAAKNAEIAKIEAIQPATTTKDNAKQAIATKANERKTAIAQTQDITAEEIAAANADVDNAVTQANSNIEAANSQNDVDQAKTTGETSIDQVTPTVNKKATARNEITAILNNKLQEIQATPDATDEEKQAADAEANTENGKANQAISAATTNAQVDEAKANAEAAINAVTPKVVKKQAAKDEIDQLQATQTNVINNDQNATNEEKEAAIQQLATAVTDAKNNITAATDDNGVDTAKDAGKNSIQSTQPATAVKSNAKNEVDQAVTTQNQAIDNTTGATTEEKNAAKDLVLKAKEKAYQDILNAQTTNDVTQIKDQAVADIQGITADTTIKDVAKDELATKANEQKALIAQTADATTEEKEQANQQVDAQLTQGNQNIENAQSIDDVNTAKDNAIQAIDPIQASTDVKTNARAELLTEMQNKITEILNNNETTNEEKGNDIGPVRAAYEEGLNNINAATTTGDVTTAKDTAVQKVQQLHANPVKKPAGKKELDQAAADKKTQIEQTPNASQQEINDAKQEVDTELNQAKTNVDQSSTNEYVDNAVKEGKAKINAVKTFSEYKKDALAKIEDAYNAKVNEADNSNASTSSEIAEAKQKLAELKQTADQNVNQATSKDDIEVQIHNDLDNINDYTIPTGKKESATTDLYAYADQKKNNISADTNATQDEKQQAIKQVDQNVQTALENINNGVDNGDVDDALTQGKAAIDTIQVDATVKPKANQAIEAKAEDTKESIDHSDQLTAEEKTEALAMIKQITDQAKQGITDATTTAEVEKAKAQGLEAFDNIQIDSTEKQKAIEELETALDQIEAGVNVDADATTEEKEAFTNALEDILSKATEDISDQTTNAEIATVKNSALEQLKAQRINPVVKKNALEAIREVVNKQIEIIKNADADASAKEIARTDLGRYFDRFADKLDKTQTNTEVAELQNVTIPAIEAIVPQNDPDANDTNNGTDNNDATANSNANATPENTGQPNVSETTDNGKADASPTTPNNSDAATGETTVTSATDDAKDKPQANNNSSADASTNSPTMDNDVTSKPEVESTNNGTTDKPVTETDNATPAESTTNNNSTTTATNENAPTGSTATAPTTASTEAASSADSKDNASVNDSKQNAEVNNSAESQSTNGKVAQPKSENKAKAEKDGRDSTNQSMVESTTETLPSADITEPNVPSNTSKDKEESTTNQTDAGQLKSETNVASNEADKSPSKADTEVSNKPSTSASSEAKDKMTSTNVSQKDDTATADTNDTQKSVGPVANNKAKDMQTNDTQKSVGSAANNKATQNDGANASPATVSNGSHSMHQDMLNVTKPEENKANAKSDQQGKVNKPKQQAKTLPDTGMSHNDDLPYAELALGAGMAFLIRRFTKKDQQTEE
>fig|158878.1.peg.2166 Drug resistance transporter, EmrB/QacA subfamily
MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIALVAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALIISMVIIYLFIRRQFNITNVLLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF
>fig|158878.1.peg.2169 Multidrug resistance protein B
MYRRRYFMRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYIFQSTFKNN
>fig|158878.1.peg.2352 Membrane component of multidrug resistance system
MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKFKASDLDKTTDQSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTNNNGEEAVAAKNPESEEYKVNEKIKKEHKNFIFGEGVSRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWLMTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAIGAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGMFIIGIIAILVGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGNKGWGSVEIETMFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYLQNLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATWELTKLNMDTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAILVTVMTTQTTQHLSAFGEELDKTNPVVQDHMRELASQYGGQEGAMKVLLQFVNKLATVEGINDAFIVATIFSIIALILCLFLQSNKKAKATAQKLEASSNNNHE
>fig|158878.1.peg.2353 
MKKMILINVITVVVLLAIGIAGFYFWNKTTSYVTTDNAKVNGDQIKIASPASGQIKSLNVKQGDKLDKGDKVATVTVQGQDGETKDMDLKMPQKGTIAKLDGMEGSMVQAGNPIAYAYNLDDLYVTANIDEKDIKDVEVGKDVDVTIDGQKASIKGKVDSIGKATAASFSLMPSSNSDGNYTKVSQVIPVKITLESEPSKQVVPGMNAEVKIHKN
>fig|158878.1.peg.2355 Teicoplanin resistance associated membrane protein TcaB
MNDLTHFNKRSPIFIIILGSLTAIGALSIDMFLPGLPDIRHDFQTTTSNAQLTLSMFMIGLAFGNLFAGPISDSTGRRKPLIIAMIIFTLASLGIVFVHNIWLMVALRFLQGVTGGAAAVISRAIASDMYSGNELTKFMALLMLVNGIAPVVAPTIGGIILNYSVWRMVFVILTIFGFVMVIGSLLKVPESLTVTNRESSSGLKTMFKNFKILLKTPRFVLPMLIQGMTFVILFTYISASPFIIQKIYGMTAIQFSWMFAGIGITLIISSQLTGYLVDFIDSQKLMRGMTMIQIIGVILVTIVLLNHWNFWILAIGFIILIAPVTGVATLGFTIAMDESSSGRGSSSSLLGLVQFLFGGVASPLVGVKGEDNPIPYIIIIIATAVILIILQIYNMKVFKTNR
>fig|158878.1.peg.2356 Teicoplanin resistance associated membrane protein TcaA
MKSCPKCGQQAQDDVQICTQCGHKFDSRQALYRKSTDEDIQTNNIKMRKMVPWAIGFFILILIIILFFLLRNFNSPEAQTKILVNAIENNDKQKVATLLSTKDNKVDSEEAKVYINYIKDEVGLKQFVSDLKNTVHKLNKSKTSVASYIQTRSGQNILRVSKNGTRYIFFDNMSFTAPTKQPIVKPKEKTKYEFKSGGKKKMVIAEANKVTPIGNFILGTYRIPAMKSTENGDFAGYLKFDFRQSNSETVDVTEDFEEANITVTLKGDTKLNDSSKKVTINDREMAFSSSKTYGPYPQNKDITISASGKAKGKTFTTQTKTIKASDLKYNTEITLNFDSEDIEDYVEKKEKEENSLKNKLIEFFAGYSLANNAAFNQSDFDFVSSYIKKGSSFYDDVKKRVSKGSLMMISSPQIIDAEKHGDKITATVRLINENGKQVDKEYELEQGSQDRLQLIKTSEK
>fig|158878.1.peg.2357 Teicoplanin-resistance associated HTH-type transcriptional regulator TcaR
MVKHLQDHIQFLEQFINNVNALTAKMLKDLQNEYEISLEQSNVLGMLNKEPLTISEITQRQGVNKAAVSRRIKKLIDAKLVKLDKPNLNIDQRLKFITLTDKGRAYLKERNAIMTDIAQDITNDLNSEDIENVRQVLEVINHRIKTYSNHK
>fig|158878.1.peg.2434 Bicyclomycin resistance protein TcaB
MQSTKTKTKHFSFLLLITLGVMTAFGPLTIDMYVPSLPKVQGDFGSTTSEIQLTLSFTMIGLALGQFIFGPLSDAFGRKRIAVSILIIFILVSGLSMFVDQLPLFLTLRFIQGLTGGGVIVIAKASAGDKFSGNALAKFLASLMVVNGIITILAPLAGGLALSVATWRSIFTILTIVALIILIGVASQLPKTSKDELKQVNFSSVIKDFGSLLKKPAFIIPMLLQGLTYVMLFSYSSASPFITQKLYNMTPQQFSIMFAVNGVGLIIVSQVVALLVEKLHRHILLIILTIIQVVGVALIILTLTFHLPLWVLLIAFFLNVCPVTSIGPLGFTMAMEERTGGSGNASSLLGLFQFILGGAVAPLVGLKGEFNTSPYMIIIFITAILLVSLQIIYFKMIKKQHVA
>fig|158878.1.peg.2452 Chloramphenicol resistance protein
MSIMRLFTFILSIFIVGMVEMMVAGIMNLMSQDLHVSEAVVGQLVTMYALTFAICGPILVKLTNRFSSRPVLLWTLLIFIIGNGIIAVAPNFSILVVGRIISSAAAALIIVKVLAITAMLSAPKNRGKMIGLVYTGFSGANVFGVPIGTVIGDLVGWRYTFLFLIIVSIIVGFLMMIYLPKDQEIQRGPVNHEAPSHENHVTSKILRPAEVAKYLIITFLVLIANSVTFVFINPLILSNGHDMSFVSLALLVNGIAGVIGTSLGGIFSDKITSKRWLMISVSIFIVMMLLMNLILPGSGLLLAGLFIWNIMQWSTNPAVQSGVIQHVEGDTSQVMSWNMSSLNAGIGVGGIIGGLVMTHVSVQAITYTSAIIGALGLIVVFTLKNNHYAKTFKSS
>fig|158878.1.peg.2462 Antibiotic resistance protein
MKGAMAWPFLRLYILTLMFFSANAILNVFIPLRGHDLGATNTVIGIVMGAYMLTAMVFRPWAGQIIARVGPIKVLRIILIINAIALIIYGFTGLEGYFVARVMQGVCTAFFSMSLQLGIIDALPEEHRSEGVSLYSLFSTIPNLIGPLVAVGIWNANNISLFAIVIIFIALTTTFFGYRVTFAEQEPDTSDKIEKMPFNAVTVFAQFFKNKELLNSGIIMIVASIVFGAVSTFVPLYTVSLGFANAGIFLTIQAIAVVAARFYLRKYIPSDGMWHPKYMVSVLSLLVIASFVVAFGPQVGAIIFYGSAILIGMTQAMVYPTLTSYLSFVLPKVGRNMLLGLFIACADLGISLGGALMGPISDLVGFKWMYLICGMLVIVIMIMSFLKKPTPRPASSL
>fig|158878.1.peg.2746 Antiseptic resistance protein QacA
MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>fig|159087.4.peg.201 Permease of the drug/metabolite transporter (DMT) superfamily
MPQKALSLTYAKLVAAMFMWGGTWIAGRIIAQELSAPLAVASIRFVVTALALAGFALLTGKGAPAPKTTREWGVVSGLGFFGIFLYGLCFFFGLQHITAGRGALVVALNPVVIVLAAWLFGHERMNRRKALGSAIALAGCLTVIGNGNPLALVEGTVGIGEWLIVGCVMSWTAYTFIGRMATRTLSPLATTLYASLIGALLLGLAALVQGDIAPASWSWRVWTGLFFLAIFGTAIAYTWFTEAVHTLGAGHASVFINLVPVFAVLQAALLLDERLGLPVLFGGLLVIAGVWLTTKQKISLEISK
>fig|159087.4.peg.1483 Multidrug resistance protein B
MKAIISGKDEAASSLRWRLASLSLPVLLASLGTSIANVALPNLAEAFNATFQEAQWIVLAYLLAITTLIVSVGRLGDITGRRRLLLAGIFLFTLASGLCGIAPTLWLLIVARALQGLGAAVMMALTMAFVGETVPKAKTGSAIGLLGTMSAIGTALGPSLGGVLIAGLGWRAIFFVNVPLGILALLLVWRYLPGDRKGPNVDRVGFDAIGTLLLALTLAAYALAMTLGRGRFGQLNMSLLMLAAAGIGSFVFAEARVNSPLLRLAMFRNLDLSASLVMSLLVSTVMMATLVVGPFYLARGLGLDAALVGFVMSVGPLVAALTAVPAGRLADRFGAQRITRIGLLGMAAGAGTLSLLPTMVGIPGYLAPLVILTSSYALFQTANNTTVMSDVSPEQRGTISGMLNLSRNLGLITGASLMGAVFSIASAATDITTAPPEAVATGMRITFAVAAALVIVALAISAGACRWTLRKRELAA
>fig|159087.4.peg.1503 Multidrug resistance protein B
MAHLQGRFSRHRSLMPQRSGKITKKALASSEAPYTFLPANEQPTIPMRRLRPATSFDTLSQRYGERYKWMVLFILALGTVAGVLCTSSFNVAVPALSRHFRLGQDQVQWAMTGFLAAMTVGMLPTSWLLDRLGFRIIFLLSLAVLTLASVGGYFAPSFTLVVAARILQGLAAGVLQPMGALALMRLFPPEIQGRASGILIFSIALTPAIAPSLGGALLDRFGWESIFLLGTPFAVIAALCAIYLLPAPREIKRKPFDWLGLGWLTLGAIALIESVSSLQHSGLASPWTMGQFALAFVASALYYRHARLRSDPLINLDLFRQRTFAMGTLVSFAYGFGLYASTYLIPVFLQNALSFKAGAAGMALLPSGIALVVMLPLAGRMADHYSPKWITLIGLVAFGASFLIFSIRGGAIQYAEIIAATIIGRIGLGMILPALNLATLRHMEPHQLGQSSVVTSYARQLGGVMGVAVLAVFVEWRETVYGTVPPGIYSAYSQGFLLLTAVFSLAVLAACFMRTEGSRPSPK
>fig|159087.4.peg.1896 Fosmidomycin resistance protein
MTTATLPAPQRSDIEVISVIGFVHGVSHFFHLLLPPLFPWLMAEFGLSFTAIGTTMTVFFIVSGIGQASAGFLVDRFGAARVLGAGISCFALAGVLLYFATGYPMLIAVAALAGLGNCVFHPADFTVLNRHVSQQRLGHAFSAHGLSGNLGWAAAPVYITGLATAYGWRTAALGASAVAIAALALLFWRREALTDPVEHHTEKASEPAGTTFAFLSSRAVWLCFLFFLLITAAFGTIQNFASPILQALYGLSITTAALALSTYLVGGAAGIVLGGFLAQKGEHDHLIAGALGVAALLAILLAAGIMPAWSILPLMAGIGFCTGTAGPSRDLLVRRAATARFGKAAYGRVYGFVYSGLDLGLAMAPVIFGGLMDARHFSEVLVGIAILQFLAIFSALRVGKAV
>fig|159087.4.peg.2791 Melittin resistance protein PqaB
MQARPILRSIERFLLSPFSLVLAIVIAFVLNAYSLPLTDVDEGAFSEATREMMARGNLISPTLNDAPRHDKPILIYWAQAVSVSVLGVSEIGFRLPSIIASILWLLFLYRFCLHHADRRTAQVAALVMALSLAVGFIAKAAISDALLNLFIALSMFGIYDFFCSSRDGKSPQQIRRLLFFVYAMLGLGFLTKGPVAVMFPLLISGIFFVSAGAWRDWLKAAFFWPGWLLFLAIVVPWHVLVYLDQGDAFFRGFYLKHNLNRYSNTFEGHGGKWYYYLVVLPFVLMPFTGWLLAIVGQLLRKLCSVPLGLAYGEGLFERYLILWFVVVFGFFSFSGTQLPHYLLYGCTPLFILLARYRPEFERRWLAYLPLIAFTLLLAALPEILVFAAAKAGKPFEKTLLDGLVAAFSDEARWLLPLLAVAVIALTLWRNLPVWQGLIIAGLLQALVVGAVIAPRVIGVTQGPIREAAMVAKQSGGTVVAWRIIMPSFSVYRQSATPTRVPVEGELVITRTDRRHEVQALLASGLTMRDIYVKSFVTLARVEREAAR
>fig|159087.4.peg.3510 Probable multidrug resistance protein norM
MRQSRPMFATAVRGLIAHAFPILIAQLSSIGMMVVDTAVLGHVSSLDLAAVAIGGGIHVSVVFALVGILQAVAPVVAHLHGAKRDDEVAGILQQGFWLALLLSVPGILFLTHPGVALGMADMDAAVEAKVRQYLGLLAWSLPASLCYRTFWAFCNALGKPRVLMGIGFFSLCLHAVLAWGLALQGWLGEPLGVVGCALSNVLIGWLACLSGGAYLAFGPLGKRYQPFADWQSPRWPIWRELLRIGVPMGLSNLVEITSFTLIALFVASLGAPVVAGHRIVANISALIYMLPLSLAIATMAALGQAVGARDPLRARATIRAGLVLAACSSSMLGLLLWLGAQPLINAYTDDPAVRSVALGLVAYIAIYQFFDALQTIAGHCLRAYRVTFFPMLVQTFCFWGIGLLGGAWLCYRWQPPLGVAGFWLASVISLVFAAVMLLPLLGKAIQAAESTP
>fig|159087.4.peg.3683 Permease of the drug/metabolite transporter (DMT) superfamily
MLAALGFSLKAIFVKLAYPYGVDAITLLALRMGFALPVFLWVGLAGQKAGASLSRRDWGQLVLLGCLGYYGASILDFWGLEYISAGLERLILFTYPTLTILIGVLFQGKPFTRREGIAVALCYTGIGFAFIHDLGLGEPRNVLIGGALVFGSSISYALYLSGSAPMIARLGAMRFSALAMLVSSAVTLLHFMATQPFSAFIQPMPVYGWGLAMAIFATIVPVFAQSAAIRRIGAGRASLFGMVGPMLTIGFGRWLLGEHISPEQTIGATFVVIGILIVSRR
>fig|159087.4.peg.3898 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLFANPYLLLTLTVLSWSGNMVIGRGVRGDIPPLTFAFWRWVIAFALILPLALPHLKTQWPLLKKGWKPLLVLGLLGVGGYNTFAYLALQDTTATNAALLNSFIPIATIAISWAFLGKHLRRIEGIGVVVSLCGAMTIISRGDIAVLAHLNLNVGDVWMLVAVLDWAIYTVALAWRPAGVHPMLMLGATTIIGLSALAPAYAWEMAQGRVMNIHFGSLSALAYVGIFPSFLGYIFYNKGVAEVGPNKASLFIHLMPVFGTLLSFLFLGEIPFWYHYLGIGLIFTGIWLTTKR
>fig|160488.1.peg.34 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MQTLHRFPERPDPLLTIVVPCFQEEETIPEFHQRITRVVKRLPVSCEILYVDDGSNDRTADILRHYQDGSSVRCLSLSRNFGKEAALSAGIDHARGSALIFIDVDLQDPPELIAAMVDYWQRGYDVVNMQRNLRIGDSWFKRMSARAYYWVMQRLVEKVDMPADVSDFRLIGPAPLAALRALDERSRILKGMIGWVGFRTIELPYNRTVRHAGSTKWNAAGLFNLAIESIVSFSRKPLRIFSLISFGLFVSSICYMLASLVAGSFDIHHLIVGMASFMCVGVAMVGEYLGVTLAEVKRRPLYFLKHSNKADPVSLHPSMASIEGKKC
>fig|160488.1.peg.175 Inner membrane component of tripartite multidrug resistance system
MNGFFSSVPPARDWFYGVRTFGASMIALYIALLMQLPRPYWAMATVYIVSSPFVGPTSSKALYRAVGTLLGAGGAIFLVPPLVQSPLLLSIAVALWTGTLLFLSLNLRTANNYVLMLAGYTLPMIALAVVDNPLAVFDVASSRAQEICLGIVCAAVVGAIFWPRRLAPVVVGATGNWFNEAIRYSDTYLARDASADKVGGMRGAMVTTFNSLELMIGQLAHEGAGPHTLKNARELRGRMIHLLPVIDALDDALVALEGRAPAQFAQLQPVLEAAREWLKGTADSASVAHWATLHEQIGRLQPATAALDQRAELLLSNALYRLTEWADLWQDCCTLQHALRTDDAKPWRAVYRHWRLGRLTAFFDRGLMLYSVASTVLAIVVACGLWIGLGWNDGASAVILAAVACSFFAAMDDPAPQIYRFFFWTLMSVIFSSLYLFLVLPNLHDFPMLVLAFAVPFICIGTLTVQPRFYLGTLLTIVNTSTFISIQGAYDADFFTFLNSNLAGPAGLLFAFIWTLVMRPFGVELAAKRMTRFAWRDIVEMTEPATLAEHRQVGVQMLDRLMQHLPRLSQTGQDSGVALRDLRVGLNLLDLLAYMPRAGQQARERLNTVVEEVGAHYAACLRAGERLHAPAALLRNMERARLALNLDELYERGDARTHLLHALSGLRLALLPGVEVMLEPAEQPQLPPGLDGAPL
>fig|160488.1.peg.177 Membrane fusion component of tripartite multidrug resistance system
MKKPLLTLGRVVLTLLVVTFAAVLVWQMVVYYMFAPWTRDGHIRADVIQIAPDVSGLIQKVEVRDNQTVKRGDVLFTIDQDRFTLALRQAKATLGERQETLAQASREAQRNRKLGNLVAAEQLEESQSREARARSAVSEAQVAVDTAQLNLDRSVVRSPVDGYLNDRAPRNHEFVTAGRPVLSVVDSASYHVDGYFEETKLGGIHIGDAVDIRVMGDNTRLRGHVQSFAAGIEDRDRSSGANLLPNVNPAFSWVRLAQRIPVRIAFDEVPQDFRMIAGRTATVSIIEGQRP
>fig|160488.1.peg.178 Outer membrane component of tripartite multidrug resistance system
MKQLILAGLCLSLGACMMVGPDYEVPGDAAVQRNDLNGPLRQDADSVVSAPVPEDWWQLYQDQRLNELVRQALSANTELRVAAANIAKARAQVEVAESQGGFNGGVKLGAQRLQESGEAFLQPEKVPVANIGEAIISASYQFDLWGTFKRGTEAAKANADAVQAAADTARITLVADVVKAYTQVCSANEEYHIARESLDLQEQSVKLNQRLRDAGRGDETQVTRSQTQFKSLRAELPRFKAERETGMYTLAALLAKPVDQLPAGTADCAELPHLNQLVPVGDGAALLKRRPDVRQAERQLAAATAYIGVATGALYPDISIGAQVGTIGILENLGEPSTNRWGFGPQISWSIPTNGTRARIRMAEASTQAALAHFDGVVLNAIRETQTRLAQYSALLDRRDALAEAEKSAKEAADQTHRYYQAGRESFLADLQATRTYTDMRAQLAAANSQVAQGQIAVFLALGGGWKGTAKP
>fig|160488.1.peg.582 Multidrug resistance transporter, Bcr/CflA family
MNLRMVLILGALSAFGPLAIDFYLPAFPAMAQAFATDEKHVQATLAAYFLGLSIGQLAYGPVADRFGRRKPLMFGVTLFTLASLACAYAPNLDTLVVARFIQALGGCAGMVLSRAIVSDKCDPVASAKVFSQLMLVMGLAPILAPMLGGVLVNLAGWQSIFLALSLFSAGCLLAVSLGLPESLPEHIPRQPLSGALRQYLRLLADRVFLGHALTGGIAIAGMFAYIAGSPFVFIKLYGVPAEHYGWLFGTNAAGFILVAQVNARLLAKRGPAFLLGRAVWLYLVAGLVLLGVAALRPAQLWPLLVPLFICIASLGCIIPNASACAMSGQGARAGSASALMGCVQFSVAAGAAALVGLLHDGSAVPMAIVISLCGALVVSVALLTRRLQAKAPA
>fig|160488.1.peg.1261 Inner membrane component of tripartite multidrug resistance system
MTSLTAPSAALAAAPAPAAPAQTAFGLQVVVGLFGVLLAVLCAGLNESVTKISLADIRGAMGIGADEGAWLLAVYSAASVSAMAFAPWLATTFSLRRFTMSAVGLFAVLGLLQPFAPNLHSLMLLRVLQGFAAGALPPMLMSVALRFLPPGIKVYGLACYALTATFGPNLGTPLAGLWTEYVGWQWAFWQIILPSLLAMVCVGWGLPQDPLRLERFKQFDWRGVLLGLPAISCTVLGLSLGDRWGWFDSPLICWLLGGGLLLLVLFMYNEWSEPLPFFQLRLLQRRNLSFALVTLAGVLVVLSGVGSIPSAYLAQIQGYRPAQTSPLMMLVAMPQLIALPLTAALCNIRAVDCRWVLGIGLAMLAVSCVGSSLLTSEWIRGDFYPFYLLQVFGQPMAVLPLLMLSTNGMTPQEGPFASSWFNTVKGLAAVIAGGLLDVLGTLRRHFHSNHLVDSLGNAPLVDGNAAGLAKRIHDQAQVLTSADLYLVLACIAVALICLIPFVPTRVYPPRAVA
>fig|160488.1.peg.1262 Membrane fusion component of tripartite multidrug resistance system
MRWLEPWMISRTIEMTNNRKTLFIGSVLAVAVLAGIVGPWMFGSDHRQSTNDAYVTADYTVVAPKVAGFIKQVLVEDNQQVTAGQLLATIDARDYQAALDAAQAQLLVAQAQSADARATLERQDALIAQAEAAVKAAQAEVAFADHEVNRYSRLAEQGAGTVQNAQQARSAVDQARARLANAQAARVAARKQVDILTAQVASADGQLKRAEAGLEKAQLDLSYTRITAPVDGMVGERALRVGAYVNPGARLLSVVPLQQAYVVGNFQETQLTHVQPGQPVRISVDTFSGETLQGHVQSIAPATGVTFAAVKPDNATGNFTKVVQRIPVKIVLDDGQPLLTRLRVGMSVEATIDTRGDKLDGKEVSAR
>fig|160488.1.peg.1263 Outer membrane component of tripartite multidrug resistance system
MKPGLRLSPLLLAVLLTGCTLGPDFQRPDSQAPQQWAPLQGEAAASQPQAEPLELRWWETFHDARLSALIQRVAERNLDLQMASARLLQSRALRSTLAADEVPSVDVNAGYSRARNSADGLSDPSGKAGKEAFNLWQGDLVAGWELDLWGRVRRQVEAADATVEVAENDRRGVLLALLSETAGNYIQLRAVQHTLDVTQDNLRVARHSLKLSQDRQAEGVATRLDVAQASAQVASIESRLPSLEAQRDDLINALSLLAAEPPRSLQAELLQGGELPAPQQKFAIGLPSELAERRPDIRQAEARLHAATASIGVAKADFYPSIRLSGSVGFQALQLSDFGGWDSRRFAFGPQMSLPIFEGGRLKGTLELREAQQQEAALNYRKVVLGAWHEIDDVLRLYNASQLRRDHLAEAVRQNRIALETAQRQYVEGAVDFLNVLTVQGALLASEEQWIDSSAAVSQALVGLYKALGGGWQAFDEPPPNAHG
>fig|160488.1.peg.1265 Permeases of the drug/metabolite transporter (DMT) superfamily
MLIGALLILTWLVLLLRYPAKALPISLAAVCGLGLVALFVVWQDSRESSRLARLDLRLTYAPEHCPADRALQVRMKNGNDVPLTELRWRVAAYAPGDTVNLAENTYNAPRYRGPGELQPGAEWQDCLPLPPLRSGYRPQTLEFRAEHLQGTFAN
>fig|160488.1.peg.1377 Drug resistance transporter, EmrB/QacA family
MTAALPPTALRNVLTALMLAIFLGALDQTIVAVSLPAISAQFSDVGLLAWVISGYMVAMTVAVPIYGKLGDLYGRRRMILTGISLFTLASIACAMAQDMPQLVLARVLQGIGAGGMVSVSQAIIGDFVPPRERGRYQGYFSSMYAAASVAGPVLGGWLTEYLSWRWVFWINLPLGLVALWAIRRALADMPVQRREAQVDYLGAMLLILGLGSLLLGITLVGQGHAWADPAVLALFGCALLGLALFIAHERRCPEPLLPLSLFGNRVAVLCWAVIFFASFQSISLTMLMPLRYQGITGAGADSAALHLLPLAMGLPMGAFTGGRMTSRTGRYKPQILAGALLMPVAIFAMALTPPQSALLSALFMLLTGIACGLQFPTSLVGTQSAVASKDIGVATSTTNLFRSLGGAMGVACMSSLLLALLHQGGFELSGNPLLGSLKAAEVDPGTQGRLLETFRQLLMGSAVVAVLGLLAALALPDRQLRGR
>fig|160488.1.peg.1957 Multidrug resistance protein A
MLAGGGHRAPAMARTSLVDGPCAAVKFVYISGTIVPMPAQLKRRLTLFFALVAIIALAFLGHWYFKGRFYESTDNAYVQGEITRISSQLGARIETVPVEDNQHVSKGDLLVRLEAADFELAVERARAALATREAEYAQAQSRLTQQGSLIAAGQAQLAATQATFDRSRLDLSRAEKLRKPGFVSEERVTTLSADSHVAGSQVDKARADLQSQRQQVTALNAELKRLDAQIANARTDLAQAELNLTRCEIHAPISGTIGQRNARNGQVVQAGAYLLSIVPDEDIWVQANFKETQIGRMHPGQRAELLFDSYPDTPIEGRVDSLFAASGAQFSLLPPDNATGNFTKVVQRIPIKLTFHADNPLHGRIRPGMSVTATVDLRSEDEGHNGR
>fig|160488.1.peg.2014 Fosmidomycin resistance protein
MPCARGARCSTGIDMPHAGPKLLTQIAAVHFVSHVHIMLIPALLPVLPGLLGVGFVELGVALAVFNIVSALVQAPLGYAVDHYGARKVLKAGLLLGSLSFVLLAASPGYAVLLVAMAMAGLANGVYHPADYALLANGIEPARLGRSFSIHTFAGFLGSAVTPAVFLGIAAALGTRAALAAGAVFGVAALLLISIPGSGVYRVARPANKQDTGPTAATGRVRLFTPMIGVLTVLFILLNLSTSAIEKFSVAALVQGQGLTLAWANAALTAFLLSSAAGVLCGGALADRTRRHGLVAALAFALAAALTALVALGLLQGWALVVVLGAIGLLTGVIAPSRDMLVKAAAPPGAEGKTFGLVSTGFNVGGAIGPVAFGWMLDQRLPNGIFVASVVFMLLTVLLTLAQEMYSARRRATEQLARAL
>fig|160488.1.peg.2048 Membrane fusion component of tripartite multidrug resistance system
MDGTGFARVRGQARSHTRQLLEIEQDSGSHNRQPAGPIRDWKPTMNVAVDKPSPAETEQRPSAKTRRRLAVIASGSLAAITLLAFTSYWFSTGRYLETTDDAYVRADWVALSPRVAGYVAKVEVADDQPVKAGDVLVRLQNRDYRARLDQARAGVTEAQAALAAAQASQQVATERIDQQQQAILQAEAVVRSATAEQRRSELDVQRYRGLVRDDAATVQRLETASAHASQAQAALQGAQAALRQQRSQLAMAKARAAQAEAELQQRAAALARAQAHQQLAEQDEQDTVIRAPITGVVGQRRVRTGQYVVPGQPLLAVVPLQQAYVVANYKETQLARMRPGQPVEIRVDSFASQPLHGHVASFSPASGNVFALLPSDNATGNFTKIVQRFPVRILLDKPLDGPQVLPGMSVVSTVDTRPAEVADAH
>fig|160488.1.peg.2049 Outer membrane component of tripartite multidrug resistance system
MMPLLHSFPGPARLATALGMLAALAACGHQPTPAEPAVALQADPLANMPAGVSKQPLPERWWALYQDPQLNRWVQQALAHNQGLAQAEANVQAMLAGIGEFDARRWPSTDMGVAATYGRSADDQTLAEATDSNAPSQWQFNPGLELAYQVDIWGQVRAAIQRARVQAEASAAALDLVRLQVVAQTTRAYIDQCTYAARLEAAKQALQTLDQSVQLSQRQRQAGVATALDSERLLGLREQVRAQLPMLSARRQMALYELSMLSGQASVAEATTCVAIPTLSVPLPAGDGWHLLERRPDVRQAERELQAATLETDIVRADLYPKVSFGASLTSSDHHLANLGDSRAVMFGIGPLIRWEFPNLKANRARVSKAEALQRAQVARYRGVALSALKDVRQALARYDGERQRLQALDAALAHSQHSFALAQGNYRAGTVDGLALLDSEREMISLRANHTEARGRLAQAQVNLFRALGGRW
>fig|160488.1.peg.3277 Bicyclomycin resistance protein
MNSRLETHANEAEGDAQRANVLTAKVILLLAALAAISNLSTNIILPAFPEMARQLNVSSQELGLTLSSFFITFAFAQLLVGPLADRYGRKRLVVGGLMIFVVGTFWAANAATLDMLILGRVIQAIGVCAAAVLARAIARDLYEGENLARALSLTMIAAATAPGFSPLIGSMLNTTLGWRALFIAVGMSAILIALFYLRGIGETLPAHRRVTQSVPAILIAYGKLASNRLFILPALATSLLMSGLFASFAAAPSILMEGMGLSSLQVGLYFAATVFVVFAAGLAAPRLAHRWGSRAITLSGLATACTAGALLLVGPSNPSLGWYSLSMVLFLWGMGIANPLGTALTMTPFGKEAGLASALLGFLTMAIGAVSTWMVSTPKFPTIAVLGATQTSVCFLAMVLFAWYVKRKAIVR
>fig|160488.1.peg.3515 Inner membrane component of tripartite multidrug resistance system
MSNNAAAQFTPPSLLLTTIGLSLATFMQVLDTTIANVALPTISGNLGVSYEQGTWVITSFAVSNAIALPLTGWLSRRFGEVKLFIWATLLFVLASFLCGIAQSMPELVGFRVLQGVVAGPLYPMTQTLLIAVYPPAKRGMALALLAMVTVVAPIAGPILGGWITDSYSWPWIFFINVPIGLFAAAVVRQQMRTRPVVTSRQPMDYIGLLTLIIGVGALQVVLDKGNDLDWFESSFIIVGSLISVVFLAVFVIWELTDRHPVVNLRLFVHRNFRIGTIVLVGGYAGFFGINLILPQWLQTQMGYTATWAGLAVAPIGLLPVIMSPFVGKYAHRFDLRVLAGLAFLAIGTSCYMRAGFTSEVDFQHVALVQLFMGIGVALFFMPTLSILLSDLPPHQIADGSGLATFLRTLGGSFAASLTTWIWIRRADQHHAYLSEHISQFDPTTRHTLEQLGGASPQSYAQLEQILNGQAYMMSTVDYFTLMSWVFAGLILLVWFAKPPFTAKAGPASAGH
>fig|160488.1.peg.3516 Membrane fusion component of tripartite multidrug resistance system
MATPTDTPTPSVAPEPSRKRKAWLLGLLLLLILAGVGTWAWYSIVGRWHESTDDAYVNGNVVEITPLVAGTVTSIGADDGDLVHAGQVLLQFDPADSEVALQSAEAKLARSVRQVRGLYSNVDSLKAQLETRQAELRKAQQDFNRRKVLADSGAIAAEELSHARDDLSVAQAAVNSARQQLSTSSALVDDTVVSSHPDVMAAAADLRQAYLDHARTTLVAPVTGYVAKRTVQLGQRLQPGTATMAVIPLDQVWIDANFKETQLREMRIGQPVEITADVYGSEVKYSGTVDSLGAGTGSAFALLPAQNATGNWIKIVQRVPVRIHLSPDQLKDHPLRIGLSTVVEVDLHDQSGPTLAQQPPQKASYTTQVYDHQLMEADNLIARLIHENSATGKTAQR
>fig|160488.1.peg.3554 Bicyclomycin resistance protein
MNRPAGSLRRHLCSTLLILLCLLGVFPLDVILPSFPALSDEFRVDTKQIAYSVSFFAVGVAMAQIVIGPLSDGIGRKRLLLAGLSVSIVGALGCVFSTHYETFMAFRLVQALGCGSLVLGQALVQDLYSGTQRNAMRILLTSASGLFISLSPLAGAFLQQSFGWEASFTVFVIIAAIVSLLSCVLLHDTPASHDRAPSMSSYRVMLRDTDYLAHSMLSSLAFACHFSFIVIAPLLLMGRLELTAYQFSLVFIGYGLAYIVGGMAAAYLNSRVSPQTQIKAGLLLISTAGITLLMWEWVAGLSVLGALLPMIVCTTGTTLVRPAATTQALARYPRQAGAAASLNTTLLFAGAGLTSSVVAGLESELPAGLGVLFMVASLCGGWLLACTKDDGMQRC
>fig|160488.1.peg.4505 Permease of the drug/metabolite transporter (DMT) superfamily
MSPIALARLLTLAAVWGASFLFMRIIAPELGTVPTAFFRVSIACLGLIVILAAARVRWNFQGKLGACLVLGMINSGIPATFYSVAAQVLPAGYSAIFNATTPLMGVLVGVLFFREPMTLAKLCGIFLGLFGVGILSGAGPVALDMALLQGALACLAATTCYGFAGFLARRWISGLDSRLSALGSMLGATLMLTPLFGWSALTQPPASWGGWEVWLSLLGLGLLCTAFAYILYFRLLEEIGPVKASTVTFLIPVFGVLWGAWLLNEPLSMAHLYGGLLIGLALWLVLRPARS
>fig|160488.1.peg.4543 Permease of the drug/metabolite transporter (DMT) superfamily
MNLSLYLLTVLIWGTTWIALKLQLGVVAIPVSIVYRFALAGLILFAFLLITRRLQPMNRRGHQICLAQGLCLFCVNFICFLSASQWIASGLIAVVFSTATLWNALNARIFFGQRIAGNVLGGGALGLLGLGLLFWPELSHHAASRETLYGLGLALLGTLCFSAGNMLSSMQQKAGLKPMTTNAWGMVYGAVMLAVFCVVSGVPFSMEWNARYIGSLLYLVVPGSVIAFTAYLTLVGRMGPERAAYCTVLFPLVALNVSAVAEGYQWTAPALLGLVAVMAGNVLVFRKPRARVAEGVVVAK
>fig|160488.1.peg.4884 Drug resistance transporter EmrB/QacA subfamily
MPERTPLDPVTARWIPWVVAIAFFMQSLDGTILNTALPAMARSLAEDPLRMQGVIIAYMLTVALLIPASGWIADRFGTKRIFFSAILLFSFGSLLCAAANSLGFLIFARVVQGLGGALMLPVGRLVVLRAYPRSELVRIMSFITIPGLLGPLLGPTVGGWLVEILSWHWIFLLNLPVGLLGCIAVWKFIPDLRGAERTTFDGPGFLLFGAAMVLITIAMEGLGELHLPHLRVMLLLFAGMACLAAYWLRAGRDPEPLFSPSLFRVRTFAIGILGNLFARLGSGALPFLVPLLLQVALGYSPAQAGMSMIPLAAAAMLAKSIARPLIERFGYRIILTGNTLLLGILLASLGLVDEQTPYWLLLVQLGLLGAVNSMQFTAMNTVTLIDLDDASASSGNSLLSVVAQLSLSLGVACAGALLGGFTAAGSAEGVETTLGAFQLTFVTIGVMAMLAAAIFLQLAPTDGRRARRPEQHMES
>fig|160490.1.peg.168 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKDAILRYKWYALGSFFMVIGVVASSLLQPHYLKSVLSAVIQNNQEKIYEVGKPLLIIALLGLMSGAINTVLAAKIAQGVSADMREKTFRKIQDFSYANIEAFNAGNLVVRLTNDINQIQSLVMMMFQILFRLPILFIGAFIMAVQTFPQLWWVIVVMVILIALIMGLVMRQMGPRFGKFQRLMDKINRIAKENLRGVRVVKSFVQEQQQYTKFKETSNDLLALNLSIGYGFSLMQPALMLVSYLAVYVSINVVSTMVETDPTVIGNIASFMTYMMQIMFSIIVVGSMGMQVSRAFVSMARIRQILSTEPAMTFENEKEETISGSIVFDDVSFTYPNDDEPTLKHISFAIEPGQMVGIVGATGSGKSTLAQLIPRLFDPQDGQILLGGKPIKTLSQTTLRQSVSIVLQKAILFSGTIADNLRQGSAKADIDAMQKAAQIAQAKEFIDRMDSRYESQVEERGSNLSGGQKQRLSIARGVINHPKILILDDSTSALDAKSEKRVQEALSHKLEGTTTVIVAQKISSVVKADKILVLDQGQLIGEGTHAELVANNAIYREIYETQKGREE
>fig|160490.1.peg.169 Multidrug resistance ABC transporter ATP-binding and permease protein
MKTARFFWFYFKRYRFSFTVIAVAVILATYLQVKAPVFLGESLTELGKIGQAYYVAKMSGQTHFSPDLSAFNAVMFKLLMTYFFTVLANLIYSFLLTRVVSHSTNRMRKGLFGKLERLTVAFFDRHKDGEILSRFTSDLDNIQNSLNQSLIQVVTNIALYIGLVWMMFRQDSRLALLTIASTPVALIFLVINIRLARKYTNIQQQEVSALNAFMDETISGQKAIIVQGVQEDTMTAFLKHNERVRQATFKRRLFSGQLFPVMNGMSLINTAIVIFVGSTIVLSDKSMPAAAALGLVVTFVQYSQQYYQPMMQIASSWGELQLAFTGAHRIQEMFDETEEVRPQNAPAFTSLKEAVAINHVDFGYLPGQKVLSDVSIVAPKGKMIAVVGPTGSGKTTIMNLINRFYDVDAGSITFDGRDIRDYDLDSLRQKVGIVLQESVLFSGTITDNIRFGDQTISQDMVETAARATHIHDFIMSLPKGYNTYVSDDDNVFSTGQKQLISIARTLLTDPEVLILDEATSNVDTVTESKIQRAMEAIVAGRTSFVIAHRLKTILNADHIIVLKDGKVIEQGNHHELLHQKGFYAELYHNQFVFE
>fig|160490.1.peg.357 Multidrug resistance efflux pump PmrA
MNWRQNLKVAWLGNFFTGASFSLVMPFMALYVENLGTPTELVEYYAGLAVAVTALASALFAPVWGKLADRYGRKPMMLRASFVMTFTMGGLAIIPNVFWLLILRLLTGVSAGYVPNATALIASQAPKEESGYALGTLATGVTAGALIGPLLGGILAELLGIRQVFLLVGVILFLCSLMTAVYVKEEFKPVRRFEMIPTKVILKQVKSPQIMLGLFVTSMIIQISAQSVAPILSLYIRHLGQTHNLMFTSGLVVSAMGFSSLFSSSYLGKLGDRFGNHRLLLAALCYSFIMYFSSALAQTSFQLGVLRFAYGFGVGALMPSINSLLTKLTPKEGISRVFAYNQMFSNLGQVIGPFIGSNVAVVLGYRSVFYVTSLIVFVNLIWSLIIFRKYIKVKDIV
>fig|160490.1.peg.373 Daunorubicin resistance ATP-binding protein drrA
MVMIEVSHLQKNFSKTIKEPGLKGALKSFVHPPREIFEAVKDLSFEVPKGQILGFIGANGAGKSTTIKMLTGILKPTSGYCRINGKIPQDNRQYYVRDIGAVFGQRTQLWWDLALQETYVVLKEIYDVPEKAFRKRMDFLNEVLDLNEFIKDPVRTLSLGQRMRADIAASLLHNPKVLFLDEPTIGLDVSVKDNIRRAITQINQEEETTILLTTHDLSDIEQLCDRIIMIDKGQEIFDGTVTQLKQSFGKMKSLSFELKPGQEQVVSQFMGLPDITVERHELSLDIQYDSSRYQTADIIQKTMADFAVRDVKMTDVDIEDIVRRFYRKEL
>fig|160490.1.peg.374 Daunorubicin resistance transmembrane protein
MWSFWKRYRPFLSAGIQELITYRVNFFLYRIGDVMGAFVAYYLWKAVFDSSKQSLINGFTLSDMTFYIIMSFVTTLLTKSDSSFMIGEEVKDGSIIMRLLRPVHFAASYLFMEIGFRWIVLMSVGFPFLMVLSGIKVMAGLSILQVLASSCLYLVSLLLAFLINFYFNICFGSSAFVFKNLWGSNLLKNALVAFMSGSLIPLAFFPKMVSIVLSFLPFSSLVYTPVMIVIGKYSLSQIMVALSLQIFWLLVMVVLSQVIWKKVQYHLTIQGG
>fig|160490.1.peg.411 Multidrug resistance protein B
MSHHQQTVSKQTIMAIIAIALIGFSGILSETSMNVTFPTLMSVYQLPLNSLQWMTTIYLLAVAIMMTTSATLKKNVRERPLFFMATGLFTFGTILAVLTQSFAIMLLARIFQGIGTGLVMPQMFNIILERVPMHKVGLFMGFAGLIISLAPAFGPTYGGFMISHFSWQWIFICILPVPLIAGILAYYYLEDSPVSEKVPFDWLAFIALSISLTSALLAITSLENGSVNLYYLGLFILSFILFLYKNLTAKQPFLDIRILKIPSLTFGLIPFFVFQLINLGINFLTPNFIVMEKIANSSQAGMVLLPGTLLGALLAPAFGKLYDQKGARLSLYLGNALFSLSLIIMTLQTRHFMLLPFTLLYILFTFGRNMGFNNSLATAIRELPAEKNADATAIFQMMQQFAGALGTAMASLIANSQAEFTSGVQSVYLLFTIFALLDFIFFFAMFYHLGKKGLA
>fig|160490.1.peg.1428 Quinolone resistance protein NorA
MPFDSNTYIIPLKYIIFCFFCKMFMKIERSSFSMEEKLFNKHFVAITVINFIVYMVYYLFTVIIAFVATRELGAQTSQAGLATGIYILGTLLARLIFGKQLEVFGRRLVLRGGAIFYLLTTLAYFYMPTISMMYLVRFLNGFGYGVVSTATNTIVTAYIPARKRGEGINFYGLSTSLAAAIGPFVGTFMLDNLHIDFRMIIVLCSVLIGCVVVGAFAFPVKNMSLNAEQLAKTKSWTVDSFIEKKALFITAIAFLMGIAYASVLGFQKLYTSEIHLTTVGAYFFVVYALIITITRPAMGRLMDAKGDKWVLYPSYLFLAMGLFLLGSVSSGGSYLLSGALIGFGYGTFMSCGQAASIQGVDEHRFNTAMSTYMIGLDLGLGAGPYLLGLIKDLALGSGVASFRHLFWLAAVIPLICTLLYLLKTKTRQVVS
>fig|160492.1.peg.243 Acriflavin resistance protein
MKITHVAMSANRLTLFTAVLLLIAGIATFLNFPSQEEPSVTVRDTLISVAYPGMPSEQVETLLAKPIEERLREIVGIKKIVSTVRPGSVLIQLTAYDNVKNLETLWLRVRAKVAEAGTGLPTGTLGPFLNDDFGRVAVASIAITAPGFSMSEMREPLRRMREQLYTVPGVERITLHGLQEDQVYVAFDRAKLVEAGLTPGAVIQQLQAQNVVTPGGLVSASGMALTVATSGEVGSVDELRRFLVSVPGSASAREVPLSQIAQVQVMPADPPQTATVYQGQPAVVLAVSMTSGRNISEFGNTLRAALEETSQLLPVGFQQHVVTFQADVVNREMSKMHHVMGETVLIVMAVVMLFLGWRTGLIVGTIVPLTVLSALIIMRAINIELHTVSIVAIIMALGLLVDNAIVIAEDIERRLAIGENRRHACIEAGRTLSIPLLTSSLVIVLAFSPFFFGETATNEYLRPLVIVLAVTLLSSWLLSITIIPLLCLYFAKAHRAPTEDQGHNLYDSAFYRSYRAIISRVLEHKVLFIGSMLALLAVAVIVITLIPYSFLPKSDRLQFQMSITLQPGSDSRQTLDTVQQISHWFADKQINPEVVDSIGYVADGGPRIVLGLNPPLPAPNVAYFTISVHPGTDIDAVIARTRQHMHNAFPYVHAEPKRFSLGANDAGVVIYRIVGPDEAVLRQSAKQISEALSALPGTYDIYNDWQARIPRYIVHVDQLKARRAGISSEEIAQALQMRYSGVNASLIRDDGVAAPIVLRGNATERATQGNPGDTLVYSQAGGTPLPLSAIAKIENDTEPSTLMRRNLNRTITIIGHNAGMTTGEIVQALAPKVASLKLPPGYRIELGGEIEDAAQANQALLQFMPHALVAILLLFIMQFNSFRKLFIVVASIPFVLIGAATALLITAHPFGFIATFGLLALAGIIVNNAVLLLERIEVELADGLPRREAVVSAAVKRLRPIVMTKLTCIVGLVPLMLFGGPLWTGMAITMIGGLALGTLVTLGLIPSLYDMLFGLRFGKRNVVETAG
>fig|160492.1.peg.1761 Drug:proton antiporter
MKPSEPDAASARAPDAPTPAAQRRAQATLIAVLLGFFVITLDAVVVNVALPTLAHDLGASVDGLQWVVDGYTLMFGALLLSAGALVDRIGARRAFGLGLVVFILASMACGGAPTLATLVVARLVQGAGAAVMMPASMSLIRQAYPDPVRRGHAVALWAMGGSVASTSGPVIGGWLVSLDWRWIFFVNLPVGLLTLAFLARTPASPRRASPFDAVGQVTAILAMGALIYGAIEAGAQGLGATPVLAAFVLALAALAAFVWSQRCGAHPMVPPGLLAPRNARISMAVGFTFMVGYFGLPFVMSLYLQQHRGLSAPATGIAFLPMMLIGLVLTPFSARLAHRFGARTMIVSGLLSMAVGLAAVASLPASAPVGWIAALMVLVGLSGPFVAPPVAAVLLSSVPGALAGTASGVFNTSRQVGGALAVAVFGALLVQAPSFMTGLRASLWLAAAIALVTAAMALRLQSTAAPEPSSTG
>fig|160492.1.peg.2371 Acriflavin resistance protein
MSRTHHVGFSTIFIRRPIATSLLMFGVLLLGILGYKKLPMSALPEVDAPSLVVTTQYPGANAKTMAALVTTPLEHQLGQISGLDIMSSDSSAGLSTITLQFSTHKNLDIAAQDVQAAIHQAILPSALPHQPIYNRVNPADAAIITLKLTSDTLPLRELNTYADAILAQRLSQISGVGLVSIAGNVRPAVRIQVNPAQLSNMGLTMESLRNTLTQANVNAPKGSLNGKSQSYSIGTNDQLKDASQYRDTIIHYQNGHPVRLSEVADVVDGVENDQISAWANAKPAVLLEIRRQPGANIIQTVEQIRAILPQLRAVLPTDVHLDVFSDRTETIRASVHEVKFTLLLTIGLVVAVIFVFLRRLWATLIPSVAVPLSLAGTFSVMAFNGMSLDNLSLMALVVATGFVVDDAIVMIENIVRYIEQGKSGREAAEIGARQIGFTILSLTISLVAVFLPLLLMPGVTGRLFHEFAWVLSTAVVISMLVSLTLTPMMCAYLLKPDTLPESDSPTPSTKITLWTRTVALYERTLDWVLMHQQLTLVVALVTVALTIVLYVTIPKGLLPEQDTGLIIGVVQADQDIAFSQMEQRTRAVADALRKDPAVTGVSAFIGAGTINPTLNHGQLSIVLKPRNQREGLNTIRPRLQRAAAGIPGIVLYLKPVQDVTLDTHVAATEYQYSLSNVDATELATWATRMTEAMRQIPALTDVDNNLADQGRALQITVDRDKASLLGVPMQTINDTLYDAFGQRQISTIFTELNQYRVVLEVAPHFRTSTALTQQLGVASNGSGALTGSNATSFGQAVSSNSSTATGIGNRNTGMTVGTGRIIPLSALADAKVTNAPRVISHQQQLPAVTISFNLAQGYSLSHAVKAIEQARTQLQIPPQVRVQFIGKAVEFTSSQSDIVWLLLASIVVIYIVLGVLYESYIHPLTIISTLPSAGVGALLALMLCGLSLSVDSIVGIVLLIGIVKKNAIMMIDFAIEARSTGSSAHDAIRRACLLRFRPIIMTTAAALLGALPLALGDGIGAELRRPLGITIVGGLLLSQLITLYTTPVIYLFFERLSERLRLWRAHRTSVQATPQRV
>fig|160492.1.peg.2372 Acriflavin resistance protein
MNLSAGFIKRPIGTSLLAIGVFVLGLICYLQLSVAPLPKFQIPVIAVKANQPGANASTMATTVTAPLERYLGQIPGIKGMRSSSSENNSNIFLLFQSNRNIDSAAQDVQAAINAAQADLPSGLLTPSYEKANPNDDPVIALALTSDTQSMDALYNVADSLLAQYLRQIQGISSVDIVGASTPAIRVDVDMQALNALGLTMDQLQNAVRAANVTSPTGFLSNDTRTTEILLNSTISKAADFAHLVIATQPNGRIVRLSDIAQVYDGQQDAYQAAWFNHKRAVVMYVFLRTGANVVETVDRVKAELPALRTYLPSGTVITPYFDHTPTIRASLYEIQTTLLISLAMVMLTMALFLRRLAPTVIAAATVPLSLAGGAIVMYALDFTLNNVTLLALVIAIGFVVDDAIVMIENISRHLNTGMSPLEAALTGAREIGSTIVSITVSLVVVFAPFLFDHGMIGTLFREFGITLVAAIIISMLVSLTLTPALCSCFLSAHVVPEKSNGIGAWLERMYLRILRLYTVALDFSLRHALLLALTPLLLIVSTVMLAGTIKKGTFPIQDTGLIQGRADSSTTVAFQDMINRQHRITEMLLSDPAVKSVAVRLGSGRKGSRTSFNIELKTRAEGRRESTDTVMIRLSTKAAHYPDLALRLRAVQDLPSNSGDGANQGAQYRISLQGNDLKQLEGWLPKLQEALSKNPKLRDIGSDMDTAELYQNIVIDRGKAAQMGVSIGAIDGALYGAFGQRQISTIYSDTNQYTVVINALASQSATPAALDQIHVPNRSGKMVPITAIAHQVPALNPPQIKHDNQYTTMDLSYNLSPGVSSGEAEAIIEAVIKGLRMPGDIHIAEDNSFKQDLNPNSMKILLIATLLAVYIVLGMLYENLIHPITILSTLPAAGMGALLALYVSDTELSAISMIALVLLIGIVKKNAIMMIDFALVAQRERGLEPHAAVREASIVRFRPIMMTSMVAILAAMPLAIGVGEGAELRRPLGIAMIGGLLISQSLTLLSTPALYVIFSCLSQRWHAWRGKYMAARSH
>fig|163164.1.peg.87 Multidrug resistance protein
MCWLYLLLSSILEILWAVTLKFSNSFTKVVPSIATLVIMIISIYFLSLAACFLPIRLCYAVSSGICTIGITIIGATTFTENINLSQVLCIVLIVIGSIGLKLSI
>fig|163164.1.peg.88 Quaternary ammonium compound-resistance protein SugE
MNWIYLLLSSLIEVFWVITLKHSYGFTHLVPSIISILSMALSTYLLSLATRSIPIGVCYAIWTGVGAIGASILGVYLFDEPVNLFEVICFILVTFGIIGLKLFDTAKQTVDKME
>fig|163164.1.peg.222 Bicyclomycin resistance protein
MLLPFLLILSLIAKFIEIDISVPSFPDMVHYFNVPEGIIQLTIAYNFLGFCIGGLFFGPLSECYGRRRIMIIGNTLLLIGAVGCVFAPSIFWLLISRFVQGIGVSTSVVVFAIVADSYKGDEAVKFIGIMNSVLTVVMAIAPVLGSFINEIVGWRGNYATVAILCLISWVLLLLALPETKKNRDIFSLKKTMKDYRKLLSNPRFVTLSLMSSLFSAAYMSFITCGPFLYMKTFGLSSTIYALHQGAIVGCFSLISLFAGKILQKLGAIKCVISGTSVGAIGSLLLVIFSIIVPHSFYLVTLSMIIFSIGCAIFQPVIFNASINVFPEIKGTASSAVSFIRAFIMAIFIGLTSYIYNGQTISVAVLVLSAIVLELVFTVYLLRLKDPM
>fig|163164.1.peg.341 Bicyclomycin resistance protein
MKTALSQNIISLIMILSVAIVDMATDLYSVALPSIANYFKVEGSVVQLTISLNLVGFAVSGLIYGPLSDHYGRRPMMLIGMTIFTLASVMCYIADSIMLLILIRFIQGAGAGVAGVVGYAAIRDMYSGSEYSRVISKLNMVVALSPGIAPVVGSYIISHGYHWKFLFFIMSLAAIAILIFIYFKLQETLTVNKNETSITNITTNIFKQYISIFRNYRFLGFSAIHGLTFMWLWAYIANYPFIFESMGIEVQYFGYLISIIVIFYIIGTLINRRYVPKVGVSKMLIIGLVLPIISNSLLVYFYFADKLNIFILQTAWIPANIGLALIISNNVTSALETIKGIGLGSAVLSFCNMMFGAIGIYIVGKFFRYGILPNLLLTIACSTIAILMYSQLKCTEKHRE
>fig|163164.1.peg.1193 Multidrug resistance protein D
MQSLLIERNRAVVLLLIVIFIFGSYVYVKMPRESNPGIQIPIISVFVGLPGISAQDSEKLLVLPIENELRSIEGVRELRAFATNDGAHMILEFGTEYDNKEVLDNVRSKLSNIKSKLPVEAESPIINEINLSLFPILNVGLIGNLPERALTEIARKLKKEIESLPNVLKVEVAGMRKETVEVIVEPTVLTKYNIQSNEIFQAISSNNRLVGAGSLENDTGKYSIKISGLLKDIEDIMNIPIRSQGDAVLRIKDIAKVYPRFEDHQGFARINGLPSVVLGISKRNGKNIIDTVNQVKYLMDKAKDQLPENLKVVYLNDQSKNVLDVLDDLENGIIFAVLLILIIMMLSMGTRIAILVALSIPGSFLIGIIALYFMGITLNIVVLFSLIMAVGMLVDDAIVISEYADRKMICGMDKVEAFYTSVRDMFYPVLSSTLTKLAVFFPLLFWPDTVGKFMQYIPITIILTLTGSLIMALVFIPTLGAIFGKPSITSKKEIKKMSAIESGEIKNAGPIIRAYIRMLEKVLDHPKKFVCATVFVLFSFSVLYFTFGPGVKFFPKVDSDNILISVKAKESLSAKERDLILKEVEERILSIEKEIHVSYARSGAFSDNVIARIQLELMDWRFRRKAKHILNDIRSSVQDMKGIIINVQEEKPGPSADKPIQINLSGSVSSLNLAAEKILEIMNQPSSGFINIQDSRSAPEIEWNMSVDKSKATSSEVSVATIGDFIKMVTNGVLIGKYRPNNTDEEIDIVLRFPRKDRNMKTIDNLFINTVNGPYPMSNIVKYAPEKKVNKLNRIDGLRTVTISADVDTGYLVDERVKFIQNSIAQDWDKGVKIDFKGDKEDQQKSGAFLLKAFILAITLMILVLVTQFNNVYHTFIVMTAVFLSTTCVFFVFFLIQQVFVVVMCGVGIIALAGIIVNNNILLLDAFHHQIKVHKNDIKRCVINAAISRVRPILLTVATTVLGLIPMITRLNINFFTLQITYDAPSSQWWVDISTTIASGILAATVLTLFFTPALLVIQKHEKT
>fig|164546.7.peg.26 Multidrug resistance protein B
MMRVIGGIVLCILLAALDQTVVIPAVPAIANDLNGFGHLSWIVTAYLIVSTVTTPLYGKLSDSFGRRRLLMVAITLFIGASVACALAQTLGQLILFRALQGVGGGGLMSLAQAAIADVVAPRQRGRYQGYLATVWAVASIAGPLVGGWVSDHMSWRWLFWVNVPLGLLAMFMCYRGLAMLPARGGRARVDWLGALLLAVAIVAFLLAMSWGGDVYDWLSPELGALLLAAVAAVLLLTWQERRAADPMLPPRLFANRAYVLGVAASALAALDIFLCIFALPLHFQLVRGADASTSGLLVMPFLLATVAGNFIVAWLAPRVGRLRGILTAGYIAGALGLIVLALVTPAVPLAVVLAAMTLAGVGLGITMVATLMSVQNALERRDTGAGTGALLVLRSLGSALGGAVAGTLLTLEFRHALAASGVTQALDLGALRHGSEAFAQLSPSVRAVLAGGVESGFHLIFAVGAAAAVLALLIVRRMPDVELRSSVTEHAATLAMD
>fig|164546.7.peg.160 Permease of the drug/metabolite transporter (DMT) superfamily
MPSQQPQRGGAWRMVAAMVLSGTIGWFVVTSGQPPLDVVFFRCLFGGAALLGVLTLQRGWVRMTRAQAGWLVLGGVTLVLNWLALFSAYAYSGIAIATVVYHTQPFFLLMLTSVLQREPFPFARLPWLVLAFAGVMLITGLEHGAGGASMLAGIGLGLLAALLYAVTTLATRRLQAIPPGQIAGLQMVLGVLMLAPLAHPAAGSYGGGTWGALLALGLVHTGVMYTLLYGAFQRLSVVSIATLSFIYPLVAIVIDVMVFGVVLGPLQVAGMALVLLGVVANQLGWALPLRRRARG
>fig|164546.7.peg.1091 Permease of the drug/metabolite transporter (DMT) superfamily
MRDRRLPAACPMTASAPTAPTDARDKLAGVLLIAVSASAFGAMAIFARFAYAAGADVYGLLLVRFLLAAAALAWVMRTRGIALPPWRRVLALAAMGGIGYVGQSFCFFSALNHAQASLVALLLYLYPLFVTILAAVFLKERLTTAAVVALVLCSVGAGLTVGGGAGSPLGIALGLAAAVIYSVYIIVGARLTAGVNPIATTTVICTAAALVYGAVGLLRAGAGTPPQFPADAGGWLALAGIALLSTVLAILTFFAGLQRLGAAQASMLSTLEPVVTVALAALLLGEQIGPAQAVGGGLILAGVLWLTRRGSAPAPARADMQGN
>fig|164546.7.peg.1560 
MSGTYTLVGIARAKAHRRDALVSQLAALRSRGLTEPGCLDYHVGQDAEDARVFVIYMVWDSKRALESHLNRPYMRDFHAARADFVEGDFSFRWLNAA
>fig|164546.7.peg.1706 Multidrug resistance protein B
MSEGPATPEGSGQRTGLPTRQALRARYGERLRWLVLATLMLGTISSIVSSTIVNVAIPDLSRHFVLGQERAQWVAASFMIAMTLSMLLTPWLLNRYGLRRTFLGASLLLGAGGLLGGFSPTYGVMIAMRVAEGIAAGIMQPLPNILILRVFEEREQGKAISMFGFGVVLAPALGPSLGGFLVEAFGWRSIFFVVVPLTLLAVLMARRFMAVDSIMMGERQPLDWRGLGLAGIATVSLLNGVVEMRESVPAGLALSGFGVLMLAAFVMWQLRAAYPLMNMRLYSYRQFAAGAVVAFIYGAGLFGSTYLLPVYMQMALEYTPSRAGLVLFPAGVVLALTIAVAGRFTHRIPPHVQVSFGLALLSLSFLLMALGSRATPYLVLVGLAVLGRIGLGCILPSLTLGAMRGVDFTLIAQGSSCINFLRQLGGAIGVSLAGVGLQWRLAGHGALLGQAGDTAVQAARIRAFDETFLAVGVVIASAMLAAWRIRPRPVPAA
>fig|164546.7.peg.1798 Outer membrane component of tripartite multidrug resistance system
MKPVLSFRFTQPASSRKLARRAGTLALTAIAAAALAGCAALGDSHSTQTMADPAAMATSQTLPGEHGQWPSQDWVDQFKDPQLSALVDEAVKDNPSLQAAFARVEASRAMAEATRSALYPHVEFEGSLIRQRLSETDLFEGTPLAGSWQNQSRLQVGLSYDFDFWGKNRDALEAALSDDRAAEAESQASRLILATSIARNYARLAALYAQRDVAERAIAQRRDLTELSRQRLAAGLDTQVETTQARGTVAASQTDLQRVDEEIALARNQLAALLGKGPDRGLQIERPVLLAQATPTLPDNLTIGLLGRRPDLVAARWRVEAASKDINVARKEFLPDVSLSAFAGLAALDPSRLLMGISRTFGIGPTLRLPIFEGGRLRANLKGKYAGYDIAVANYNQALVDALRETADTMTSIRSVDKQIQTQREALDLAEHAYALATTRYKAGLGTQLTVLNAESNVLQQRRLATDLQARRLDLQMGLMKALGGGYQEPAEGHESVAHGQAQQPDNTKAGARG
>fig|164546.7.peg.1919 Multidrug resistance efflux pump
MNDTPQPSAAPTVTPPPAPPPPTADTSKKGVRWVLLLIVVSLAWYLLADRLTPYTQQARIQAFVVPVAAEVSGRVIKVHVRNNQDVAAGTVLFEVDPQQYRIAVDRARAELESTRRQIGASTAGIESAQASLRAARANEVKARQDSERLERLYSEDPGTISLRRLEVARASLEQAVSQVAAARAEVQRAREQEGGSDEDNAKLRSAASALEKAELDLANTQVRARAAGLVTDLRTDVGQFAAAGNPVMTLIPIHDVWINAEMTENNLGRVEPGTPVAIVLDALPGRVFEGRVRSVGYGVNVGPGTPPGSLPTVQNSRDWLRPAQRFPVIVEFDRGELAPLRGIRVGGQAEVMAFPTEGNPLNPLGRLFLYLMSWLSYVY
>fig|164546.7.peg.2319 Acriflavin resistance protein
MWFTRLSIRNPVLATMMMMAFIVVGLFSYQRLPVDQFPDITFPVVVVQTEYPGAAPESVESDVTRKVEEIVNTISGIDEIFSHSYQGTSVVVIKFDLSVDVGQAAQDVRDKIALIRPQFRDEVKDPRVLRYDPSDAPIFYLSVSNAPGASRSQRELTTIADQIVRKRLETVRGVGAINLVGGTRREVEIRIRPAQLEALGIGVDQVMNAIRNENQELPAGELRSSAAETVVQIKGRVPTPDAFRQIIVARRAGQPVTLGEIADVRDGQEEQESLALLDGKRALFLSVVKAQGQNTVDTVDGLVRMTDEVRKLVPAGVQLNVVNDTARGIRSSVKEVRSTLLEGAFLTVAIVFLFLGSWRSTVITGLTLPIALIGTFGVMYLCGFTLNVITLMALSLCVGLLIDDAIVVRENIVRHNLMGKDHRTAALDGTNEIGLAVLATTFSIVAVFLPVGFMGGIIGRFFHQFGITVVAAVLISMFVSFTLDPMLSSVWHDPDLHGTGNKRSWYGRTVGRLLDWFSASMDRLGDGYAGMLGWALKHRLATAIIAAATFFGSFALVPLIGTEFVPNADLGETQVGFTTPVGTSIEVTEAKVRQVEAALKSFPEVAYTYATINSGNASGRNNALVSVRLTERRARSLTTAQLNPLIRERLASIAGITLTMVGMPDGAGGQKAIQVSIQGDDLDELRRLSREAGARMAAIPGLTDLDSSMKDDRPTIEVRIRRELASDLGVGVAQIGNALRPLLAGDAISSWRAPDDENYDVRVRLPKDARTGMADLSALMIASSHANADGSPKMVPLRQIAELVPTTGANQISRRDLNREVELTANVAGRSAGEVARDIKAALDGVNWPAGYKYRFGGSTKSMNESFGYAVSALALAVIFIYMILASQFASFFQPIAIMTSLPLTLAGVFAALLLFGSTLNMFSIIGFIMLMGLVTKNAILLVDFANQARQGGVDSAYGREPLSREAALVEAARVRLRPILMTTLAMIFGMVPLAFSLGEGAEQRAPMGQTVIGGIITSSVLTLVVVPVIYTYLDDFGAWLRRLWQGEPRATAAAPAQAGSGQPAAGGRPAPAEASAE
>fig|164546.7.peg.2600 Permease of the drug/metabolite transporter (DMT) superfamily
MAHFPALGFRLLCMAGGLVALGVALRLRGDSLAVPRREWGTVVRLALPNMVVWHLFAICAVKLLSSGRAAILGYTMPIWAVVWGLVFFRERIGAWAWLGIGCALAGTVLLLSGEFAALTGSPAGTLLMLLAAAGWGFGTQLMKRTQTDVPIGAMTFWMLAVTLPFLALGTLLLEDGWRMPTAIEWAAIAYNAVVVFAFCHLVWFGLARSLPPVVSSLSIMFIPVVGVFSGMWLLGEQPHWQDYAAIVLMFLALSSVMLAPLLWRRLRGVPG
>fig|164546.7.peg.3574 Bacteriocin resistance protein, putative
MMKPLGILLACVPWLLATAHVPQAQAADVALYGPVGEPYSVRVTSIREARFKSTIRQQYDFSCGSAAVATLLTYQYGHPINEATVFQNMYLNGDQQKIRAEGFSLLDMKRFLAALGYEADGFELPLSKLEETQVPAIVLIVENGYHHFVVVKGVKGNRVLVGDPARGTRAMSREQFERIWDSQLLFVIHNRTERARFNVAADWRVAPSGPYWMGVNRDNLFFTVMPRHGAGDF
>fig|164546.7.peg.3690 Multidrug resistance protein B
MFGLTLGLVTGIDFSSTLMMGVASQHIQGGVGAAPEDYLYAISAYAATAVLMNMVLDQLARRITYKRFTMASLLVFIAGSLICAEFASPAGLITGKAVQGLGAGGLFAASRILVQLVSTPAERGPLMLRFGGGAFSMLAITPWLTSIFLDDIGWRAVFLFQAGIALPVLLSVALTYPAPAPRDSHPPVSTLDWPAAIAAALGALVFLHTLQEMRYTRFFSSLEMPLAALCGVALFAFSGWRLYRHPDPWIDFSRLAGRQYLYGLGFYTLYYLLSSAWSFLLPTLTQTGLGLTFRTTCMLLSTSGTVSAIGAIVITLGMALVFRKRRVIAIGFIVYACAALLLSTQLMPGAPDYALVPVVLLEGLTPVLLMVQVASMTYLDVPVEDFSHAYQFKNVCKQIASAMGTGLASVFMQDGLAQHRTHLVEHITRFNPVLQMPDALSAAGLAKLSQEVDRQATLLAGMDLLHGFAALCVAGAVFVLVQRSFR
>fig|164546.7.peg.4367 Permeases of the drug/metabolite transporter (DMT) superfamily
MPASNPSTRRIDWTTLFLLTFPPLSWAGNAIVGRLAAGTVPPVALNWARWVLAGMLLAPFAWRGVVEHRAVLRRHAGVITAMGILSIASYNALQYLALTSSTPINVTLIGASTPLFLIVIGALCFGERVRPWHVAGALLCMVGVTFVLVRGELARLAQLDLVPGDLYMLAATIAWSAYTWLLRKQRPALPLPVLLFAQIVTGVLASAPVTAWELLTLDQPLQWNGKVAGILLYVATIPSLLAYFAWDRAIARAGAQLPVFFITLTPVFAALLSTVLLGDWPRWYHGVGLAAIAAGIWLAQRR
>fig|164546.7.peg.4436 
MIKEIAQITIKPGMDKQFEHGVSQATPLFLRSHGCHGVQLFRSIEQPDQYTLVVDWETVDDHMVLFRESPEFQQWRGLVAETFAAPPHVHHESKVL
>fig|164546.7.peg.4630 Outer membrane component of tripartite multidrug resistance system
MGPDYRVPDRAAVRDAVANGPLQGAQAPHVAIAPVPDDWWRLYDDERLDRLITKALAANTDIRAASANLRRALALLHEVESENLPQGSAGASVARAQLSGESFLQQAQPPVFNLGDLGLGASYLIDFFGKLARADEAALAGAQASEATLDMVRVAVAAQTVRAYVQGCAATHALHAAGQQLAVQQRTLDATRRLLAAGRAEPAEVARERARTEALRATLPPLQAARSAARYRLALLLGQAPATLPDADVACDAEPALRAPLPVGDGAALLRRRPDVRQAERELAAATARIGVATADLYPSIRIGASAGLTGVLSHLGSGPTARWSLGPLVSWSWPTNGVRHRIHGLEAAADAALARFDGVVLRALQETETALSAYSRERERHAALHAASEHATQVAQQQRRLWQAGRVPWLAHLDAERDLAAAQAALAASAGEVAGRQVDVFLALGGGWQTARRLAVVPGTMDEKND
>fig|164546.7.peg.4633 Inner membrane component of tripartite multidrug resistance system
MLALYLALALGLARPYWAMATVYFVSHPLTGATRSKAAYRVAGTVLGATAAVATVPQLVNMPLVLMGAIALWISVLVYLSLLQRTPRSYVCLLAAYTLPIVALPAVSQPAQIFDIAVARIEEIVIGIVCAGLVGSVVFPARVAPALRARAATWLADAAAWAADILGGSPRADHSRHRLAADILQLDQLISQLAYDTEGSYTLRHARALRRRMTMLMPLLSSLESVLQALRGHADGIPPELREALAATAAWLGSDAATAPPAALEGCGVPSRPGARGWHDGLAATAADQLQRLCALYAECRALQQGIGDRSAGTPPALGESGPEAAGHHHDHGMLLFGAVSSGLAVFCAGLLWIFSGWEDGAGAVVVASIACCFFAAVDEPRRMAGAFARWSAVCLAISSGYLFLVVPHAHTFEALAAMLALPYLGIGLLVARPGFQLIAMLLSVNTAAFANVQAVFDADFLAIFNTCLASAAAMLFAPLWSVATRPFGARAAARRLVRASWRDLAQAATLRAADGDARLGARMLDRLGQLVPRLGAAGDALSADGFHALQVGYCALALRRALPDLPQPARKPVRRVLAALARHFRAQLRAGHRVPVSARLAAAVDDAMASMAASGPTGQRGTLGALVVLRVTLLPALAMTPSR
>fig|164546.7.peg.4971 Permease of the drug/metabolite transporter (DMT) superfamily
MLLCLLITYVVWGTTYLAIRFTLESFPPLFMMGTRFLCAGLLLGAWLAWRGTPMPSARQLRHCAVPALFLLVGGMGLTAIAEQTISSGATTVMIGSMPIFALIWGACFGNRPKWFEYVAIAIGSAGILVLTAGEEFQVSAGGVVALLLAVASWSFGSQLARRLDLPPGAAAFAAEMVIGGAVLMALSLLRQEPWPSAVSAQAGWAWVYLVVAGSLVAFSAYMYLVSTVSQTLAASYVYVNPPVALAMGAWLGGEQIAPQTLGAVVLILAALTVLSLGTLRAARAQAA
>fig|164546.7.peg.5085 Bacteriocin resistance protein, putative
MRDEGVVRQQYDYSCGAAALATLLRHYYGEAVSETDVLKQIAAKGPATLSTLSAAATHFGYEARGYALSLEALRQINVPAIVFLHVGNDNHFSVLRSIDAHSVELADPSLGNRIYSTTDFLRLWTTRLNRNYPGRALIVMPRDARRAANPAFMRPIPARFAGLTLRPFRP
>fig|164546.7.peg.5170 Inner membrane component of tripartite multidrug resistance system
MAGALGAAWAGAPDLAPWLHSLKVFGAAMLALGTALALGLPRPYWAMATVYLVSSPLAGATHAKGAYRVIGTLLGAIGAVALVPWLVDQPMLLMAAIACWTGTLLYLSLLEPAPRNYICLLAAYTLPIVALPTVTHPGTVFDIALTRIEEIVIGIVCASVVSAVVFPSRTAPALAARAAAWMDHASRWTTDMLAGGASAGQRHDSFSTLAADILALETQMAQLAYESGNAHTLRRARALHQRMTALLPLVLALADTADALRRHRAGMPEHVAQRLRATLAWIAGAAGSSRPPPSWYPAGRAPAAPADWHARLVAAACVYLDELGDLWQDCRLLQASLRQGGSDPAALRYRVEPAGQARHHDHAQLLFRAATAGSATLVAGLLWMASGWVDGAVPVGLAALASCFIACTPEPRLVAGRVIAWSVACALLSWYYQFVVLQLAHDFGSLAALLFGPYLVIGAMTTQPRFALFGVLLAVTAASFPGPQNLGTASFAGIFNGSLASLAALVFAALWAVLMQPFGQQLVAYRLARANWNEIALAAHPRAPVNSARLRGRLLDRLLRQWPPLTRRNHASHEQAANALADFLVEVAVLALRRATDRAVARVLAGVARHYRRCARAGHAIPPAPALAAQIDAAFAALATPAHGSPRAALAALATLRLALYPHDQDGRHARH
>fig|164546.7.peg.5282 Acriflavin resistance protein
MADHDLSRLKIDRQAAAAGVRLRPRRRWLRYAAIAVVLLALAGIAIRLASPRPVQTATVTSAFPTQNFTLLNATGYVVPQRKAAVASKAQGRLEWLGVLEGSRVKKDEVIARLESKDVAASFAQAQAQVQVAQANLALQQAELKDAEVNLRRSRILIVPNAISRTQYDADVARFDKARASVNSSRASVVSAQANARAAEVAVEQTVVRAPFDGVVLVKHANVGDNITPFSAAADTKGAIVTIADMETLEVEADVAESNIARIRVDQPCELLLDALPGLRLAGQVSRIVPTVDRSKATVLVKVRFVDRDARVLPDMSAKIAFLSRAATAQDRQPVVAVQPAAIATRDGRQVVYVVRDGKAHEMTVKTGNKLGELVAVQGVKPGDVVVLSPGDQIGDGSRVATSKP
>fig|164546.7.peg.5296 Permeases of the drug/metabolite transporter (DMT) superfamily
MPRPLSTAAWLPAAAFVLIWSTGFIVGKAIVPLADTSLFLLGRFAVAGLMFVGWSLAARAAWPPLREAPRHLLAGALMQGLYLCAGYGAIAQGLPPAIMALLGALQPLLTALLAIPLLKELPSRRTWQGLALGALGVALVVAPAMQAGLDGAARPLSPWIVLLGVLAIVSITMGTLLQKTAIATCDLRASSAWQSLGALLVAAAMVAVQAAGAPLHWHGAPALWAGLAWAAVGLSGAGTWLLVSLVRRGQAANAAALMFLAPPLAALQAWLLFGERLSGVQALGMAVAGAGVWLCQTRGRMRHAEAR
>fig|164546.7.peg.5710 Permease of the drug/metabolite transporter (DMT) superfamily
MTNNEDCAARFDAPRNTLATRTTSTALWATPLFVLLWSSGAIAARLALDHATPFALLTLRFALVCAVLGALGLARKRLLPPRGERLHTACAGLLLIGGYAVFYFLALDHGMTPGVLATVLGAQPMLTLLLTERRASAARLGGLALAFAGLAMVVADSLLLARLSPAGVLCALASLASMTLGAILQKRSTRAPAEVLPLQYGASLAACLLCLPFQPFAFEASLAFAAPLLWLALGISIGATLLFYRLIHAGNLVNVTSLFYLVPAGTAALDYLLLGNRMTALALAGMGAVLGGLGLVFRGGRNPMPG
>fig|167555.5.peg.1690 Permease of the drug/metabolite transporter (DMT) superfamily
MILPFALWGTSMAAMAPLVNAAGPEIVASLRLLPAGLVVLASVPFLKRSWNISKDDLVWFLVFTLIDATLFQVFLAKGLMETGAGLGSVLIDSQPLMVALLARILFGDAINPIGWIGLVLGLVGIICLGVPTELLENWFLLGNFESGSNFLSHGEVWMICAATSMALGTVLIRFACRNSDPVAVTGWHMVLGSVPLIVWHVFDKNWPLFPDWSAFEWTLMSYSSLFGSALAYGLFFWFASRKELTSFSTLAFLTPVFALITGGIWLGERLFLLQWIGVVLVLISVLFVSQRRRFWGNKSDNELIKEA
>fig|167879.3.peg.97 Permease of the drug/metabolite transporter (DMT) superfamily
MTVTSPRIATILLLIVCFIWGVEFVPIDLAIEVMPTNTFNAIRFAVATLSMLPLLWFVQKKNKGNSKPIDYVLLIRSGMLLGFFLFIGFYTQTEGMRFTTVTNAGFITGLCVPLVPVLGFLIFRNVVPKSVWIGVVTATAGLYMLTIGDKLVFNKGDILVLICAFGFAGHIIMTDRFVDNLPIIPLSIVQIFAVSIYSTIAIFIGPDPVFYYQDAEPVSWYQQLFTPLMIFAILVSGILGTAYAFWAQSVSQTLLKPHKVALIFAAEPVFACIAAWVFLDEVLGEKGMIGAGLILAGMLVSELGDRKKQPELRALDQTAALK
>fig|167879.3.peg.540 Acriflavin resistance protein
MNITQVAFTYRKSVFLIIAVLLINGLFAYFTLPAQEDPTITIREAIVSTSFPGMAPDRIEQLITKKLEEEIRKIPQVKEIKSSSATGISIIHVKIYDRYFNLDDIWQNLRNKVTAAHNKMPSGTHTPFVNDEFGDVSVVTLALTADGFDLGEMYDIAQHIRDTLYGVEGTKKIEILGRQEERIFLEASNAKLAQLGISPQSLINELQKQNIVRSGGEVNTGAISFIVEPSGNFNSLVEIGDTYISIPNTEDFIALKDVVTLRRDFIDPPDKTAYLNGQSAIFFAISMLPENNLLEYAPRVLNKINEIESSLPIGYNLEIATYQADQVAKTINGVSVNVLQTLAIVLVVVILFLGLRTGLIVGAIVPFVMLTTLSIMQFSDMKLERMSLATLIISLGLLVDNGIVIAEDFKRRLEDGVDRYNAMLQGSKELAIPLLSSSVTTVLFFLPLMLAEHVAGEYTRSISLVILITLLTSWILALCVTPLLCYFFITLPENKKAKVENNESTREEPGKFYRYYETFLHWLLKHKALFMTAMLALFIGSILSMKYVAKQFFPDSDRTQILVNIDLPNGTSSTETNRQMKDIFTWLEDETRFDFIESYSAYVGFSGPRFVMSLNPEDPAQNKGFMVLNVKDETDISATVLSLDEQIEHDFPNVSARVKKMFLGPSDSSTIKIQVKGPDKEVIYKKAQQIMAVLHDVPNTIDIRTDWENLITKIDVQIDQHRAKRSGLTSEEIAQALDAYFSGSKITEFREGDNIIPVVLRAEQAERQSLDRLRTLNIYSNKTGKTVPLFQVANLAPYNQFSIIHHEDLFRTISIQARNTDVAAEDLKLIIDAKIQALAADLPINHNIEYDGVIKESRAAQKALGASMPIVLGLILILLVAQFNSFRQAAVITLTIPLSFIGAVLGLFLMQAPFGFMVTLGLYSLAGIIINNAIVLIDRIKIETASGKSDYQAVVDACLTRLRPIAMTTITTVMGLLPLIIGKDPLFYGMANVIAFGLGIGTILTLAVVPALYCGFYKITDVQVEPV
>fig|167879.3.peg.1801 Multiple antibiotic resistance protein MarC
MNLLMEHALTVFMAFFAIMNPIANTAVFAGLTGDKNKLEQRKIAAKALIITFIVIASFAILGKSIFHLFGITLPALRITGGILVFIVGYHMLQGSGSKLHHTQGDDSSDSDVAVSPLAVPLLAGPGTIATAMNYSSSNGWMEIIITLSVFAALCLITFICFIFSSRILAAIGKSGLSIVTRLMGLILAVIGVQMLLVGIKAVISTLG
>fig|167879.3.peg.1823 Acriflavin resistance plasma membrane protein
MTAKSLMKSKSITSNKSILSAPSLWMIDNPIASSLLTFSIIILGLLSFNSINQESSPSFQINEILIETSYPGATPKDIEQGIILSIEHQLRDNPNIDRISANAYEGSAEIIVELIEGVNPDTILSQVKNSIEGINSFPVEMENPTITFVEELDSIVEIGLHGNVSELLLYREASQLKQAMLDALDLAKIDIQGARSPEIVIELNQVKLRQYQLTLAQVLSKVKTSVTDVPAGSINTQGGEILIRTLGRKELSEQFSDITIITDDSGNSVTLADIATISDSFQGQIRPFKVNSDAGLELKVYQNKNSKPIEISKEINAFITDYQSEIPAGLTLTILQDQSDPFSQRINLLISNGLIGMLLVILVLSIFLDLRLAFWVSMGIPISIIGTLGLMPLLDIPINMITLFAFIITLGILVDDAVIVAENIYLKIQQGITMNIALKDGVKEMTLPVVFSVTTNIIAFIPLLYVPGELGVMYKPMTLLIFAIFTVSLIEALLILPLHLRHIDKPMRFRVISNVQAHCFKRFDHLKTAIYAKWLRTSCNNPVTIIIIFLSLATLVFSWVYSGRVDSSFVPKIESTRIDAEVEFPTGAPLKNKIDIINYIEAAGIKAIESLNGQDDYKFRMQDIGSSSGSSTFMIVTDDQRNFTAKEFVDAWRINIGEVPGVKSIFFDYQVGPGGGKELVIELGHKDADILTLAAKELMNGLNRISGVTDIDSALMDGKLQYNLTPTPLGKSLGFNSDNLGELIRLRFFGGEAIRQIVAGDEVKVRVMMQRSQQYYANQLNRLIITAPNGDSVELSQVASITTTKAATSINRVDGIQLVEVTASILRQVASASLILKTIEEDLLSNLSAKYPELEVELGGEARIESKVNAEIIKGIGLAFALIFAMLAIIFRSYLDAILVLLIIPFCLAAAMLGHIVMGYSFSVMSLFGMIALSGLVINGSFVMLLKVKALRKEGMGHKEAVIEAALNRFRPVVLTAVTTAAGLFPMLFETSTQALYLVPMVISLSFGSVFSIATILLLSPAMFTLSEQFKVNNEKTESLTKSTINTSKVRAFG
>fig|167879.3.peg.2319 Acriflavin resistance plasma membrane protein
MFKSITKESATDKKAAQKYNSIAWMINHGIAPNLLMLLLIVGGLVMSFIIRKEYMPDVTLDRVGIVINYPGASPDEIESAIALPIEAIITPLEGIKEVKTIIRTGRLFIRAELEGSDNAQKIFQDVQQAITRINTFPTEMDKPRIFLASKVRDVMEIVVHGDLDAIGIKRLSEEIRDRILQSVDISKVTLHGTAKEEIHIDISQHMLNSLQTDLSTIAKKISLLTKEQSTGTIKSNSGNILVKVDERLLWADEFAQLSIMPDKNGGALQLKDVAKITEGFADSKSMITFDGQLAASLRIYRVGEQSPDKIGKAIEAMWPELEALLPPTAGLTIIDDDAKNYQKRLSLLLKNAFFGLLLVLFFMSLFLDFRLAFWVVAGIPSAFLGAILFLPSFGISINMVSMFGFIIALGIVVDDAIIAGENIYTHMQEGMPFSSAAQLGAQEVAKPLTFAILTNIIAFIPLLFLPGFMKLMFGAIPVVVILCFVISWLEALFILPAHLARINQKTTKTPGNNILSKSAYYFSFAMQKAQQNFDKALESFIQHPYLSVLKKCLSWPALTLSIASLILLWVLGYAFSGKMGFSLMPKMEGRWVKASIVLPEDFTLMQMNKVKDKLESNAKEMLSKNEIEQAVISIRSEIFENTLEVGLLLVDSEEREISSVDIKSLWREQSKLLGKQSLNNLGKLRFGSARKNSNSQIEASITLELRHNDTNVLSNAAIAAQNYLQSDQQSGQYITSITNSMEQGNPQWSLTLNENGQSLGFNGSDVAKQLRSSLYGARVTRQHRGQNEVTVLVRLPLRERQSSGDIENLLISTGDGGFVPLNEIANISKTYSPATIKRYKNQRIEQLYIEVEDETKTPQVNDFIHQQLTLRLTRQFAGLKVSMSGDQKEIAQSVSKLELGTLFALTGIYILLAIAFKSYLQPLLIMAIIPFGAVGAILGHLLLGFGLSIVSLMGMLALAGVVINDSLIMVEYANKQVTQGHKPKQAIINAGMRRFRPILLTTLTTFGGLAPMVFETSRQAQFIVPMAVSLGFGILFTTFICLLVLPCLYLITSEYNDIKA
>fig|167879.3.peg.2693 Permeases of the drug/metabolite transporter (DMT) superfamily
MEIWIYFTLLAATMQAVRTAGQKQLSGKLNSMATTGVRYVFALPFAWAYLWWMLDFRQVAVPALNNDFLQYALIACVMQIVGTVCLVAAFRYRNFAVATSLAKTEAIQVAIVGALVFGATLSGLGWFSVIVGVVGVFLVSKVRFNLRDILADSQGLIGMGYGLAAGLGLAITTLLIRESSLALNTDLMVSAAVTLVFMITVQSVISLIYVYIQDKSQLPLMMKHWRLCLFVGVTSVLGSIGWFTGASYQNAAYVKALGQVEFFITLALTYRVFKETVTLKEYLGMFLIVLSVVILLLWS
>fig|167879.3.peg.2798 Permease of the drug/metabolite transporter (DMT) superfamily
MSVSIAYLAVLLIWSTTPLGIVWSSESINPSLAVLLRMLIALVLGALVIKIRNIHIPWHKQAVKLYSFSALGIFGGMLCSYLSAAYLSSGIISLVFGLSPVISALLAKKILSEPNISGMRKFSMAISLIGLAVVCSDNFTLADDGIYGIIFILMAVFFFSLSGVLVKSVSLAIHPLATTVGALSVATPLFLVSWLLLDGTLPIETWQAKSLWATLYLGVFGSLIGFYAYFTVLQKLSASNVTLITLITPVIALTLGAVLNGEVINDKLILGAFMVLLGLSIYHFGHLLPRLKKKRARS
>fig|167879.3.peg.3142 Permeases of the drug/metabolite transporter (DMT) superfamily
MTKSTPHPSSIIKAEQQSLLYLHIAVFLFGGTALFSKLIGLPALDITVYRTGIAALALFILLTLQKKQISLSSMKDYGIAILLGCVVGLHWVTYFTGMQMAGVTVGMIAFFTYPVITVFIEPFFNRTVPKMKDMITAFVVIIGIVLLIPEISFGNQITLGIVTGIISAVFFALRNILHKNYFSHYSGPHTMLYQTLVACLMLCLFVEVPPMQVTESDWLLLLLVGVVFTATPHALFASSLRSLSATTAGLISCLQPLYGSILAIILLHERPDILTIIGGLLVVSAAIFETWSVSRGRR
>fig|167879.3.peg.3176 Acriflavin resistance protein
MNYTRAALKNPAAIIVIVVLVMVFGLLSVAKLPIQLTPDIEQPQITIFTGWRSAAPSELESVIIEPIENVVKNTQGVIRVDTSINQGFGRINLTFDVGADMQKAMLDVINNLNQVPPLPIDAIEPIVSANGGGNTATMMIKTLPDNPVEDFGQYQKLIEDVVEPRFARIPGIGEVNLASHRQREIRVTFDPVKTASLGLSIAEISSVITNSNDTSAGTVNVGRRQYVVRFSGQYSLDNLTQMIIGYSDERPIYLQDIATVDNTLADRQGFNLRNGQPSYYLTLRRQNGENIVALLDKINIAIKELNEGPLKAEGLTVDLSFDSSVHIRNALSLVQNNLGLGVLLSLVILWLFLRGMRNILIIAITIPVSLLVAFVALSLFDRTLNVISLAGLAFSVGLVLDAAIIVQENIVRLKSKGMDNHKAVLKGTTEVTGALFASTATSVAIFLPILFMKGIEGQLFSDLALTLSIAVIASLLSAITVLPIASKYLLKDVSDIDPFAHYWERLTVLVMKLTNSKFKRVTWISLLLAGSLIISFTLLPKTDFMPRAPTDGFFFSLDMPPGGNVDFIEHEMASLVKKRLAPYLTGEKSPKIKSYNFYSFGSNATGGFIYSDDPSRVEELMKVVKADVFSGLPDTEVFMFRGSMINISGNGNGRTIDIDIHGTDIEGLMEVAKTGIAAINENMPDTTAFPIPSLNLAEPELNLLPNDQRITQAGLNRSDVARAISAYTSGLFIGEYFDGNHRSNIILRGEQWETPDELAMMPMHTPLAGIQTLGELTHITRSAGPTELKRINGKRTVSIQVSPPATMSLEEATALINEKVIPKMQLDLPENSAISLSGNANQMASAISDMISNFILALLILFLLMTALFKSAKDSLMVLLVMPLATAGGVIGLSILNIFTYQSLDLLTMIGFIILLGLVVNNAILLVDQTNQGGLEGLSRCDAVAQAIRIRARPVYMSTLTSLFGMLPLMLMPGVGSEIYRGLAAVIVGGMTVSAIFTLVLFPSLLRMTQGKHASPTTNIVSISATEQELRISNR
>fig|167879.3.peg.3260 Glyoxalase/bleomycin resistance protein/dioxygenase precursor
MKLGAFSVSLAVSNIEASKVFYQKVGFEVIGGDQTQHWLILKNGEHTIGLFQGMFEGNIMTFNPGWDKDGKTLESFTDIRELLKEFEAQDVEIIQQSISGESGPSSFSIKDPDGNAILIDQHV
>fig|167879.3.peg.3458 Multidrug resistance efflux pump
MDMLIILTYTALCVAIFKTFKIPLNKWSVPTAVLGGVVLLSSIMIIMNYLHPYAKYGKEVFATIPITPLVAGNIKSVDVIPNIEVKKGDVLFTLYNEEQTIALEKADAAVEQAKNQVLQNDQALLAATGQVAKADANKDRTKASYYRYMEGHLKGGESSPFTQQELDNRREFYEAALASLDSAQATERKVRLLTESNILGENTQVAQLKAARNRAQLDLERTFVRAPVDGMPTQVALRPGMRAGILALRPVMSFIPTEKRRFAARIWQNSLLRLEKGLDAEVILDAVPGHVFKGKVVEILPAMAEGEYQGNGVLRGAGSLATHGFTIAIIELEENLDDYNLPRGVQGQAVAFNPKGDFLHTSMVRKILFRMMSWIKYVYPIK
>fig|167879.3.peg.4022 Permease of the drug/metabolite transporter (DMT) superfamily
MSKSLGFKVSVSFVNIFALPFFFVLLYGSGFVGAKLGLPHSTPLSFLSLRFMAAGLILLIIAKLIGNQLPNWREAIHISVAGSLTVCLFSVGVFVSIDMGLSPAVSALIVALQPILVALFARKLVNEQLNLAQWFGLLFGFLGVIVVVIDSIETTSFSWVAIAMSVLALFGVTFGSLYQKRYCADMEIFYGGAIQSLVSGLICLALLPFFESFKVVWTGEFIISLVYMVVGVSLGALSLLYIMIQRGEVSRVASVFYLVPVSAAVSAYLLFGETIESTTLFGASIIALGIFLTNRKSQNNMVVSMNK
>fig|167879.3.peg.4315 Multidrug resistance efflux pump
MSEQEQQKDATVQEAKTVIETQDPVRKITKYVLIITALIFVWYIIADRHAPWSDQARVQTYVIPIVPQVSGRVIEVLVKQDQIVAPGDILFKIDPSDYELAVENAEASLEMAGQEIGAGMASVVTAQAQLVVAETNVEHVNAQSSRVFEMEDKNVLSHSEGDKARAAIKASKAQVVSAEANLDKAKQSLGKEGNANPRIRAAMAQLKKTQLDLSRTVVLAPSYGGITNLQIDTGFYAKAGAASMTFIEGNNAWVQVNLRENNLANLAIGNSVEIALDVNPGTIYQGKISSIGFAVDTSSTSAVGGLATVESKTGWLRDAQRFPVMITFDDDSTKGKRRLGGQADVQIYTGDNWFVNSLGWLWIRVLSILSYVY
>fig|167879.3.peg.4769 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKQNQSKQMTGMLYSLLGVLLLTPDALILRWVTIEHSEVLLWRGIFFSLGFSFIVLVRHRSNAVRALINAGWPGIITGFFFAMNTYCYTQALQQTGAATAMMIISTAPVFAALIAWLWLGERISLPVGLTITMTLLGMAIIVSDGDDGNSLFGNMMAMGCAIFMAINFNWARRYASLDITPGLIFGGLFIIALGWFNTSVVAARPDEIGAMFLSAAIAMPIGFVLLQIAPRYISATEVSLFLLLESIIAPIWVWLGLGETPSNITLLGSVIVLVALLLYCYVVRLKAQTILTTKEA
>fig|169963.1.peg.108 Multidrug resistance ABC transporter ATP-binding and permease protein
MESMKWIWQYVRKYRLLMIGVFILIFIASGISIIYPLLGGKVIDDVVYQNKTNLLIPLLLIMIISTIIRTICRYTYQIMCERIGQNSLFRIREDLYKKLQSLDFDFFNNTRVGDIMARMTGDTDAIRHFVSWVSYNILENVFLFSFAIIIMATIDWKLTLALVIVTPLIAVLTMKMSSKAQPVFYEIRESFSRLNSMVEENISGNRVVKAFAREDFEMKKFHEHNEDFKKRNLDSADVSRTYLPVLDSLAGMLVVITLIFGGYLVIKGQMTLGDLVAFNGFLWMLNGPMRMSGWLINDVQRFIASSFKIQDMMVTDAKIPIHAEKPAPSLQGHVEFKNVSFHFEDDPNTDVLKNISLKASPGQTIAILGETGAGKSTLVNLICRFYDPTSGEILIDGVDARKWHVRELRNHIATVMQDIFLFSDTIEGNIAFGAPDATMEDVRRMARIADADHFIETMPESYDTIVGERGVGLSGGQKQRISLARALLKNPSILILDDTTSAVDMETEVKIQGELKKITENTTTFIIAHRISSVKEADEILILNHGEIIERGTHTSLLAEKGYYFDIYNKQLGTEANVNG
>fig|169963.1.peg.490 Permease of the drug/metabolite transporter (DMT) superfamily
MQKEKAPIGLYFLLIAVMASWGFNVTMTKVLVSYFPTVTMTSFRIFTAAITVIIILFITKKLRLPTKQEFGLILLASIFNIVIHHFFLSNGLKLTTGTNAGLILGSAPIVVAIFSVIFLRERIGAWRALGFLAGIFGVSLVVLSNGTGISGISLGDIDIFIAMASQAFSFIIIKKLAGSMDTGLMTGYMLFLGSVMLFGLSRFMEPDGMSELVTVHSWKLWLLFVVSAVVATAFGNFVYNYAVGKIGPSRSAIFMNFNPLFSLIGALLFLGEAIKIPQLVGFGFIIIGVLLGSGALMDLIYERKKTKVRDPEKLLEKEV
>fig|169963.1.peg.514 Drug resistance transporter, EmrB/QacA family
MQQEATGGQKIRPIPIIASFLMAGFIGLFSETALNMALSDLIQVFDISSATVQWLTTGYLLTLGILVPISGLLLQWFTTRGLFFTAVSFSIAGTLIAALSPTFAMLMIGRVVQAVGTALLLPLMFNTILLIFPEHKRGSAMGMIGLVIMFAPAVGPTISGLILENLTWNWIFWISLPFLIIALLFGMKFMQNVSVVTKPKIDILSIILSTLGFGGVVFAFSSAGESGWGSATVLVSIIVGGIALGLFVWRQLTMEKPLMDLKVFKYPMFTLGLILVFISFMMILSTMILLPLYLQNSLALAAFSAGLVLLPGGVLNGLMSPFTGRLFDAYGPRALVIPGFIVAVVALFFLTRIEVGTSALTIIVLHSVLMIGISMVMMPAQTNGLNQLPPKLYPDGTAIMNTLQQVSGAIGTAVAITIMSAGQKAYMETAQGVGPEQMVASLTAGIQNAFVFGLIMACIGLLCSLFIRKAK
>fig|169963.1.peg.738 Multidrug resistance ABC transporter ATP-binding and permease protein
MLEVKHLKKSYKLGKKNETPVLKDINVTIQDGEFAAIIGKSGSGKSTLLNIISGLDTDYEGKVLYNGEDLQDIDLDAYHFNHIGFIFQSFHLVNHMSVVENVKVPLYLNPELSESDRNARALDLLKQVGLEDFASKKPTQLSGGQKQRVAIARSLANNPDMIIADEPTGALDSVTSDEIIKLLKALAAKGTTVIVVTHDLNIADQTDAVLRLADGEVISFERKKEVVQKVTHKNEKKLRLNWWATAKISFKSFFNRKFRNLLVALGTSIGIIAILLAFGLGNGVNQSLSKIFGTTFSPNQITTYYKEDGGSKSPEPTTPLTSSEIKKIKQLYEDENITEIYERTTVQGIKFEYDGEYLKGISGEMQEANFKPSRYEDLTVKDEYLLSGKMVTSDETGAVIPSSVAKAILGKKDSDELTKSDGDKLIGKKITLVYAGRNSDTKNTVKTETTISGITNPSKEGFARGFDVSTKTMNDFIKTTGIEKPILSVDAFTKTTAEAEEIVEKYEDNKDWANYSITNANAFVDTFSQFTDIIVYLIAFIAGLSLAVAGVMIAIVLYIGVVERTREIGVFRAIGYRKRHIRGLFMMEASYIIILANVLSSLVAVTIAKIASPILETKIGFEDMIHISFWNFLVTLAITITIGFIFSIYPSNKAAKLDAAEALRSE
>fig|169963.1.peg.973 Drug resistance transporter, EmrB/QacA family
MEQTKVKAVTIAVFVATFMAAIEGTIVSTAMPTIVSQLDGIELMNWIFSVYLLTSAVTVPIYGKLSDLYGRKNIFVIATIIFIIGSSLCGFAQNMEQLIIFRAIQGIGAGGILPSTMTIIADVYPFEKRAKVLGFMGSAWGIAGVFGPLVGGFLVDQLSWHWIFFINVPIGILTILLILLYLREKVEHVKLPIDYLGASLFTVALLGLLFALQRAGESLNWTEPLVVILFAVSIVLFIAFYFVEKRAKDPIMPFVLFKNPVVLIGNLIGFLISAFLIGINVYIPMWAQGMLGHGATIAGFMLAPLSVTWIIGSFIGGKLLMTLGNRHTVGIGVLITAASGLILALFPASTNDIFFYLNSAFMGFGFGIIFTTTTVTVQDAVPRFQTGIATASNTLFRTVGQTIGVAVFGTIFNSVLTSEFRAAAGSEVNRSNLNQLISPQTSGNVSTDLVDPLRDILYSGLHTVFWVMFACCIVSYFIHFILPKKHISGEK
>fig|169963.1.peg.1838 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQQTVTYGAKWKQFLTIFTPIVITQLTLFSMTFFDTTMSGNYSNQALAGVAIGSSFWAPVNAAFSGLLMAITPIIAQLIGAKKEKQVKNTVHNGLYIALFLAFILILINFLVVPMILTHMPVTAEVADIARHFLNGICIGIPAFFISAILRSFIDSLGLTRVTMLITLCTVPFNIFLNYCFIFGNFGFPEMGGAGSGYATGITYWLVVLVSVILIQTQTRLRKFGVFKGLTALRFSKIKEIIGIGVPNGLTILFETSIFSAVTILMGAFGTETIAAHQSANSVCTLLYAFPLSVASTLTILGGYETGAKRLKDAKQYRHIGMAAAILIGCVNGAILFFFRDIIAGFYTNDPALSNLIMHFLVYAILFQFADAVLSPVLGALRGYKDVTVTSIVAFISYWLIGLPVGYGLSFTNLGPFGYWIGLSTGLFVAAFILSIRVRKTEQKLSFNTKDAEISN
>fig|169963.1.peg.2078 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKNMEILETDSVKKIYFRYLIPSLVGMLLMSLNIVIDGIFVGHKLGGVALAGINIAVPVFTIFTAISIWIGIGAATQFSFAIGEKNVAKAQTIFTNAILAVVSITVIIGIIAFIFKVPLAYFLGANDDTIGYVLEYMNILLVFGFALTLENILSIFVRNDGDPNLSMIALIVTAISNVILNYLFLFVFEWGVTGSALATMIAIIIGVLILTTHFFKKSSRLKFVKVDWNKAFFKKTLAIGLPSFLAEVGVSVFTLGYNISIAAIAGTAGVAAFSVLNYTHSVILMLFLGMGSAIQPLISYYRGAKARQKELETLKIAIVVAFSTGVGFLLVGFFGSNLLVSMFGNFSVEIRELASNGIKLFYTAYLFMGFNFVMMTYFQTSDKVKMATWITISREIIFMVIFLLVLPPIIGIPGVWLAIPISEMIVAASIVFYMKKKHILFK
>fig|169963.1.peg.2578 Multidrug resistance protein
MNSTAVERPVDVNGKSYSRSLLVVTMIIGAFVAILNQTLLATALPMIMDDLHITAATGQWLTTAFLLTNGIMIPITALLIEKISSKTLFITAMTVFTIGTIIASVAGSFPILLTGRIVQAAGAGIMMPLLQTIFLLIFPREKRGAAMGLMGLVIAFAPAIGPTLSGWIVDSYDWRVLFLILIPIAVIDIILAFFGMKKVVKLTDTKIDFLSIVMSSIGFGALLYGFSSAGNDGWGDTTVITMLIVGVVVIALFVWRQLVIDNPMLELHVFKYPVFSLSVILGSIVTMAMIGAEIVLPLYIQTIRGESALQSGLLLLPGAIIMGIMSPITGIIFDKIGAKWLTITGVTILTIGTIPFMFLTMDTPLWYIVVFYAVRFFGISMAMMPVSTAGMNALPNHLINHGSAVNNTIRQIAGSIGTAVLITVLTNVTKDNMPGKALMATDPASFAQKAQDASLDGMRAAFMVAAIFAAIGMILSLFLKTKKQEPIVKEYTK
>fig|169963.1.peg.2714 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKEQSKRLGEDSIPSLMARLSIPAFIGMFVMGMYNIVDTIFVSYGVGPSGVAALSIAFPVQMILMAMAAMFGIGGASIISRSLGAGEQKHADKVFHQVIWLVLISSIFIAIVTFIFLDPLITLFGAPADIHDIASDFLSLILLGAVFQTFAMAMNNIVRSEGNAKTAMLTMIISAILNMILNPIFIMGFGMGVRGSALATVIAQAVGAIWLLIYFLSGKSTLSLKGFSFRMDFPLIRRIMAIGFPSFIMMSAGSIVTVAVNWMLNIYGGTMAIAVYGIANRIASFVIMPINGVTQGMQPIVGFNYGSRQFERVMKAVKVSMIAATVMSLIAWGLVEIFPGLLVRIFSNDPELIAQGTTAVRFMLLAAPTIGFQIVCGGLYQALGRARISFIISLMRQIICLVPLLLILPHFFGLDGIWYAFPLADLGAFAVCLVIMSKTWRRIFKNPEIV
>fig|169963.1.peg.2902 Multidrug resistance transporter
MNTGKWITAAASLLAFMGIGVVDPLLPSIAESIGASHSQVEMLFTAYIFTMAIMMIPIGIVAGKMGDKKLIVIGLFIVTIFALLCGLSDTIGALSIFRAGWGFGNSMFMATAMTMLIALSETPGHAIGIYEASMGLGMAFGPLLGGILGNISWRYPFFATACLIFIAFLLILFKVKEPKKVAPAPTEKNEVAIKQMLHLFKYRPFLQIAFSGMFYYYCFFTILAYSPLVLGLSAIQIGFVFFAWGLCLALGSAKVSHALEIRFNSKQILKGSLLACAVILALLGFIDNTAVDIGLIVISGLILGINNALFTTTVMEHSPYARSVTSGAYNFVRWLGAAFAPLCSGLLSEALGMKMPFIVASIICLAGMGLLFIKLKPAHFTLQQSTSIKSE
>fig|171101.1.peg.50 Teicoplanin resistance protein
MLESKKTTRYVFYVYLMLLTWGILFKFETNPEFIAFFLAPRYINWIPFSEPLIVDGKIVFAEMLFNLISFIPLGVCFPLIKTNLSSLRIVGTGFLISLLFECLQYILAIGITDITDLTLNTLGVCVGLLIYQIFIRVFKSQTRKWINILGMLSLGFAYLVLLLLHLIGV
>fig|171101.1.peg.137 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MYTIIKSNIKKFSLLTIFIVAGQLLLIYAATINALVLNELIAMNLERFLKLSIYQMIVWCGIIFLDWVVKNYQVEVIQEFNLEIRNRVATDISNSTYQEFHSKSSGTYLSWLNNDVQTLNDQAFKQLFLVIKGISGTIFAVVTLNHYHWSLTVATLFSLMIMLLVPKIFASKMREVSLNLTNQNEAFLKSSETILNGFDVLASLNLLYVLPKKIKEAGILLKMVIQRKTTVETLAGAISFFLNIFFQISLVFLTGYLAIKGIVKIGTIEAIGALTGVIFTALGELGGQLSSIIGTKPIFLKLYSINPIESNKMNDIEPKEVNRDFPLYEAKNICYKYGDKEILKNLNFCFQRNEKYLILGESGSGKSTLLKLLNGFLRDYSGELRFCGDDIKKTSYLNMVSNVLYVDQKAYLFEGTIRDNILLEENYTDEEILQSLEQVGLSVKDFPNNILDYYVGDDGRLLSGGQKQKITLARGLIRNKKIVLIDEGTSAIDRRTSLAIERKILDREDLTVIIVTHAPHPELKQYFTKIYQFPKDFI
>fig|171101.1.peg.1734 Multidrug resistance ABC transporter ATP-binding and permease protein
MILLAILFTCFSVYLELEVPTYISKITDLLGSQGTNLDELWQPASMMMGMPFLAFLSVVAVGFFASRVAASYTSRLRSDIFNRVLDYSQTEIKKFSIPSLLMRTTNDITQVQMLITMDLQVVTCGPIMAIWAIGKILGHSEYWLWAVLVAVIVNVLMTTVLMTLAFPKQSLIQGLTDKLNSITRESLTGIRVVRAYNAEDYQNEKFAAVNDELTR
>fig|171101.1.peg.2134 Drug/metabolite transporter (DMT) superfamily protein
MSNSLKGTLLTVVAGIAWGLSGTSGQYLMAHGISALVLTNLRLLIAGGILMLLAYATAKDKILVFLKDRKSLLSLLIFALIGLFLNQFAYLSAIQETNAGTATVLQYVCPVGILIYSCIKDRVAPTLGEIVSIIFAIGGTFLIATHGQLDQLSMTPAGLFWGLFSALTYALYIILPIALIKKWGSSLVIGVGMVIAGLVALPFTGVLQADIPTSLDFLLAFAGIILIGTVFAYTAFLKGASLIGPVKSSLLASIEPISAIFFAFLIMNEQFYPIDFLGMAMILFAVTLISLKDLFLEK
>fig|176279.3.peg.1878 Chloramphenicol resistance protein
MKDNKMLFIIFMIGTFTVGMAEYVVTGLLTQIADDMKVSISSAGLLISVYAISVALIGPLMRIITLKVHAHRLLPILVAIFIISNLVGMLAPNFNVLLLSRLMSAAMHAPFFGVCMSVAATVAPPAKKTQAIALVQAGLTIAVMLGVPFGSFLGGFANWRVVFGFMIVLAIITMLGMIKFVPNVSLSAEANISKELTVFKNPHILIVIAIIVFGYSGVFTTYTFMEPMIRDFSPFKIVGLTVCLFMFGLGGVIGNLITGNVPEDKLTKNLYLTFLLLFVTIILFVTVIQNSILALIICFLFGFGTFGTTPLLNSKIILSGKEAPLLASTLAASIFNVANFLGAIIGSILLSIGLPYIQITLISGGIIVLGMLLNLVNQLYEKKHITFNEYS
>fig|176279.3.peg.1946 Multidrug resistance protein
MLEITVLVFITIFGVGSQFFSNLAYSLNQGILQTSFGIGSQYLIIPSVLANFTFALGIPLGHTLTHKYGFKRNYLCFVFIFLIGSILGLLSFNLIILSIAKMIQSFSSGVLFFTLLPKLFLNFPKQYRNVFLLMVIVGLFGSNALGGLSGSLSLELDRWHWIFVVNIISAILCLILGNVILRKNEYHQTSDIHISRSMMITLVLSTISLMIPMSLLTQKGYHSLWVWPILLIAIFFIVNFIITNRQATHPIVHFHTLFSKKPFVGATMAISSHLTLLTGIAGINVYIVRILKLPFDISLHFYFFFFVGVIITGILKMFFYSSVGAGFLGTLGSSALLYVSIHWIILGNTINIPLLYIQGLLLGFGASMTLVSGSMATLLDGDLKEAAQRSQTMHTIRNFSAAMLIPIIAYTIKNHIQKGTQSIYAENITDKMIYLKKLQDVAIDADHQIFLLMIIFNMVMFVSSIIQMILGKGRRITPPRES
>fig|176299.3.peg.55 Permease of the drug/metabolite transporter (DMT) superfamily
MTRVQANMLLLLAAAIWGGGFVAQSSAMSSIGPFWFVGLRFAIAAIAVLPFALMETRSLKSPPRRREIGSFILVGLALFGGATTQQVGLLTTTVTNSSFLTGLYVIFVPVIAVVLYRRHPHWVVWPCALMMLGGIFLLSGGAFETLTTGDILSIICAFFWAIQITLAGRFVSESGRPLALSFTQFAVCSLLSCMIGVVFEPISMAAIEASMMEILYVGLVSSGLAFVLQVIGQRYTTAPQAAIFLSSEALFGALMASIFLKETISSAGYVGCLIIFVAILIVELVPELTRKRQKTVAEAS
>fig|176299.3.peg.222 Permease of the drug/metabolite transporter (DMT) superfamily
MALPHIFLALITVFLWGFNFVAIKVGVADMPPLFLTGVRYLFAAVPLVFFLPKPNVPWRHMIVYGMAMGFFQFGLLYPAIKLGLPAGLASLVMQSQAFFTLALAVVFLGERPLPSQIAGAIVAFGGLAVIGMERMTAAALIPLLMGVGSAIAWACGNIVNRRIGQVNVVSFIAWTSLVPVLPLVLLSLVVEGPDAIVEGLQNATPTMALVVIYMAYGATIVGAGIWSYLLLRYPAGTVAPFSLLVPIVGFISAYLAFAEHITIFEIIGAALVILGLALNVFGRRIGVSRFWVRSPQG
>fig|176299.3.peg.1128 Glyoxalase/bleomycin resistance protein/dioxygenase
MAAMMRFPLVCRPEDDKIIVYGRPSSHRPACATKETLTIIRNALVPELAVSDWQKSRAFYCDLIGFHVVYERPEEGFAYLALGDAQLMIDQIGATRTFVSGNASLEPPFGRGMNLQLAVPSLQPILFRLERALIGLVLEPEEKWYRRGTVEVGNRQFIVADPDGYLIRPFESLGERAFRFG
>fig|176299.3.peg.1364 Multidrug resistance protein B
MTSMALEVLVCPPCRKNGKDTALSSMEMVEKNGWGELLSGANLSLLTVISSGIGLHAFNQFAVVTALPVAVNDIGGAGFYSWAYSLYFVGSVAGGVTAVLFRERFGARAILLLCCLIFSFGSVLSAIAGDFLWVVVGRALQGVADGLIVAVCYSLIPAGFRSGLLPKVFAIEAAIWAVASFIGPLTGGFATQHISWRATFLLSAPLIIVLVVYTVVAVSAERPVVATRRPLVPLLLCLVGALAFSAPSAFEDASLRAISLLAGAALLWASLRAGIQPSSGLFPRDSFRLKTVLGSGFWVLFLMSYAHALGSVYLAYVAINLWQHEPTFAGFIVVTMPLAWSFVAMLIGSLRSNRLREICLHYGPYQMVPGCVLLGLGLATGNWGEMLLGQTLIGSAFGMSWAGISQAAMEAAPEEERKMTGALLPTVATLGSAAGAGASGTVAAATDLVVQIDRADVTTPMLYLYGLGVVVSLLAIMTARGLRGERR
>fig|176299.3.peg.1688 Ribosome protection-type tetracycline resistance related proteins
MRTLNLGILAHVDAGKTSLTERLLFDVGVIDKLGSVDTGNTQTDSLELERQRGITIRAAVVSFTIGDTVVNLIDTPGHPDFIAEVERVLGLLDAAVVVVSAVEGVQAQTRVLVRALQRLAVPFLFFINKVDRVGARYDEVVRDLADQLRVRPVVMSKITGAGSKHVQVAATDTECEPLFTILCETLAENDDELLRDYLLTPDRVDAGRLSLLLGQQTACGVVHPAFAGVAMTGAGLPALIAAITEMLPARDPDPEGEISGKIFKIERGWGGEKLSYLHLASGTVRLRHILPLPQGPARLTGIQLFKDGRVQNANSLGAGQIARVTGLAGARVGDSVGVDAVADGAFHFAPPTLETRVVSRRPSEHAALWLALNQMVEQDPLIGLRRNDETNEVFVSLYGEVQKQIIQSELSTGFGIEAEFEDSTVICVERLSGSGQGLQTIFREPNPFFATIGLRVEPRPDGAGNSFALEVEFGQMPASFYRAVEETVFDTLKQGVFGWQVQDCHVAMTAARHTSPSSTAADFRKLTPWVLGTALKQAQPFVCEPFDHFHIEAPAAAITRLISLLAKAGAATKNSVISGGVATLEGTIASAAVQGVQQQVPGLTSGLGGMETSFSHYAQAESPPSPRRRSGPDPFNECDYLLRMRRNAE
>fig|176299.3.peg.1896 Drug resistance transporter, Bcr/CflA family
MPPEPIMSTKRTAILGALLTALAPISMAIYTPAMPELTRVFATNESAIKLSLSLYFAGFALAQLLAGPASDAFGRRRASLVFLSVFLGGGLLAIFAPTIEVLLLARLIQGIGASVGMTVARAIVRDQFTGAEASSIMNLIGIMLAVGPALGPTIGGLSLAAFGWKSVFFLMAGLGAAAIFSVVIFLRETTVPDKSLIRPRRLLSAYGNLLTEPRFLLAALVLGGSIGALYAQATMLTFILINTVGMTPTAFGIGMLMQTGAYFFGSIALRYIAPRLGDRRSVMLGLCFSGTGGLLILLSVFLIPPSFFSIMGPVAVATVGIALLTPSMVTAALAPFPHIAGSASAMMGFIQMGSGFAGGTAASLIGSPLTGFGIVIPVMEFTAVASYIGFRIVSRSKT
>fig|176299.3.peg.2585 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTPPFSLVGIDHVVFIVDDMTRALDFYRNVLGCTDGYSYPALGMEQVWCGNALIVLWDVTHPGGTKAAPPVAGGRNVDHICIATGPLNHDALRAHLAKFNVTIEQEAFHGGARGMGYSFYFRDPFGNKIELKGPAEYPDGRAENA
>fig|176299.3.peg.3739 Tetracycline resistance repressor
MAIGRDRIVDEALRLLNEVGIDKLSTRKLAERLGVQQPALYWHFRNKAELLDAINSEMLLRYHCDRLPKPGQDWITFTLANARSIRKTLLTVRDGARLTAGTRPSVAEFADVESVLQLYVETGFSAEEAFGIAICITRYVVGYVLEEQGERERDRMDQHSPNTDIMAELAQFPLLAKALESFPTVGTVNTEAVFESGLSYLLAGMKEKLREKQSR
>fig|176299.3.peg.4861 Permease of the drug/metabolite transporter (DMT) superfamily
MPVKYLLFSLLAVLIWVGNTIVSKLAAGAIAPGTIAFERWFIAFVILTPLVYRDAWRHRRTIAAHLPKLILLGLLGMAACQGLGYYAAGLTTATNMAIMLSLVPLLTLILSAVFLAERPSSLAVIGGIISLSGIFIVLGQGDPSRLLSQGVGRGDAMMLAAVLAYAGYGILLRRWAIPLATWTSIYVQIGAAVVLLVPSYLLSAPSALTLPNTAMVLYAAIPGSILAPFVWMTAVKHLGAARTAIFMNLIPIFTAIVAAIFLGEALYIYHLLGGGMTVAGIILVQRKPFREKSGQKAVVARAQ
>fig|177437.4.peg.225 Glyoxalase/bleomycin resistance protein/dioxygenase
MSIKSVNTILYCTRWAETVEFYDKSLNFQRLTTREWFVEFFLTESARLSIADESRCSIKGARGMGITISLAVDNLGAAHRKFQIKKLSPTPIKDLWGARVFYLYDPEGNRIEFWE
>fig|177437.4.peg.547 Permease of the drug/metabolite transporter (DMT) superfamily
MTYLKLLLTAIFWGGTFIAGKFLAGDVNPLDAAFVRFAIASIFLLVITRKLEGRLPRIQAKLILPLILLGATGVFAYNILFFSAFHHINAGKAALIIATNPILISLLSALLFKERLDLIKGAGIIMSVTGAMVVISNGHLTDLVSYEIGRGELLIYGCVASWVAYSLIGKSVMGSLSPLASVCYSSVIGTVFLGIVSIFKGDLTTMGAWSIIDWFSLFYLGFFGTVLGFLWYYEGIREIGPMKASVFINFVPISAILFAWLILGEPVTASLLVGAALVVSGVYSTNASGIIKRYLTAKG
>fig|177437.4.peg.1027 Permeases of the drug/metabolite transporter (DMT) superfamily
MVSALLFGGATPAGKALLGGVEPQALAGLLYLGAALGVLPVVMGERAFQWPWHAGRNTFLLLAGAILLGGILGPFLLLLGLKIASSGSVSLWLNLELVATVLLGHFVFQENLSRRAWVAAGGTLIAAMLLAGNDAGGFFPGLLVFLGCICWGFDNHFTALIDGISPAQTTLWKGSVAGVFNLVLGGAVAGGIGSPGVVIMALLVGVVSYGCSITLYVMAAQGLGAVRSQMVFSVAPFFGLLLSVTVLGETFTHVQAVAALLIVVSLFVLFSEQHVHNHRHIAMSHQHSHSHDGLHHNHGHEGFDPKESHVHWHDHAPEEHTHKHWPDLHHRHDHKKEP
>fig|177437.4.peg.1294 Permease of the drug/metabolite transporter (DMT) superfamily
MPLFAILRCFIKRLKGKFLKNWKPYLAGVLVVLIWSGWITISRYGVHTRLTPADITLLRYCTAFSVVLPFAVRYPWRKFTLYQYLVVGLGVGFPYTMVSFYGLIEIRAAHAGVLVNGMLPVFGAIAALLYFKQRVSAVCYGAIALIFAANIVMIGGNFFSSEHLLGIVLLLCAAVIYTFHMVGVRLWGFTWKDVFVVVPVVNVALFLPLWFFFPSTGFKVPVPEMVLQATYQGLVVNIVALSCVAYAIRHLGTITVSLFMSFVPVITAIFAWLLLGENLTGQEITGIVGCTGGLLIYSRG
>fig|177437.4.peg.1736 Multidrug resistance ABC transporter ATP-binding and permease protein
MHGHRNNIFSVQVGEGVARDLREALFVKIQSFSLGNLDNLKTGELMVRLSSDTSAVQRLVLISLRIGTRAPLIMVGSLILMVNTSLGLALTMVPLLMMSRLSNVWANGMASSKWIYGLISTWFPGFTRSTTAGSPLTKQIS
>fig|177437.4.peg.1739 Outer membrane component of tripartite multidrug resistance system
MALSGGCVPVGPDYVAPGFNRMPGRWTPEMTGGMSAVPLDSKALASWWIVLDDPVLTGLITRAIDVNLDLRKTRAVLREARARLLISGTDAFPTIKTDASAVRRYQDDESGSSYNAGFDAFWEMDVFGRVQRAREAATADLEADQESMGDVRVSLVAEVALNYIGVRSFQARLAIAQKSLAVQEETLQLTQWQRQAGLTSQLDVEQARSSLEETRASVPDLQTGLGQVMNQLALLLGQYPGTLYKALSVPAPVPVAPMEIAVGVPAEVLRRIPTVRQAERQLAAQTARVGVATAEQYPQFTLNGSIGFDALSIHDLLFESASRIFSIGPAFSWTLFDAGRLRQNIEVQNALTQQAAIEYEKAVLTALKDVEDALVAYGGEQVRRQSLLGASTAQQDALDLARDQYASGMVNFQVVLDAQRSLLSLQNQLAVSNGAVTSDLIRLYKALGGGWTPLSASGATKAH
>fig|177437.4.peg.2213 Fusaric acid resistance protein
MRRQNKGNGGLYAVWFIILVATVAITRFYGLESSNFYGIAETREIVVNFEGAVEIKKINVTEGQSVEQGMLLVELSSPDLMLKINQISHQLDQLKAQKGVDKSEIQSRLRQLKAEKAAKESELRNQIAQLENQYKINKSLLSGLKSISGNGGYGNAEGSSPMELKIKSLKEELSLCVNPLAIQIELFEKILANSKNPVKIQVERLEQELTLLANENNKLNIYAQISGIIGSVNFKPGAKVSPFAPILTLHTRTPSFIKGYIYENAYADIAMDEHVNVASLAIADRNITGVVIGIGARIVAYPERLRKHPDLQMWGREVVIQIPENNHFILGEKVLITSSVKKPGGVEQLKRLFTPSESVADVLLACKNFLFEEDILPIIPLETQGIEASALLYLKDIDRYMVLSDDTPGNAPLVMLMDSHGRITRETAIAGLEKIDDMESVAEADQGILYISSSLSTAKNGKVKETRKNLVSVQRQGNHFTLVKTIDLYSQLMTHAQREAGQPWADFILGAISKKNLDMEGMMYREGSLFLGFKAPLMNKESVILKIDEIDCAMETQTFKPHQISIWRSFSLIPGKGQLQEGISDLLYFKGILYLTGTPLMKDKGSRSGTLWKLDEATGTPVCLAHFNDLQPEGVASGKEKNSLIICFDQGHKTKSKTCKIKVN
>fig|177437.4.peg.2275 Fosmidomycin resistance protein
MTENTKLNVKVVAALTLVHFTGDFYSSFTSPLLPVYVDKLALSMAQVGLLTGMIRLLAFVVQPCVGYLADRYQTRAFILWGVFLTVTCIPFSGIAPNFYVLMAVLAAGSAGSSMFHPSVTGMLPLYSGPRRGLCMSIFNTGGTLSFAIGPVFISWYVGRFSLEAMPWTMVLGLMSILFCLRAIPMPVSEGMQNSGFWGSLNESLGHVWKPISLIWIVMVLRAVAGQSFITFMPIFLVQKGYDLISVGFIVSLFILAGTVSGLLSGSLSDSMGFKRIFFVTHLLMTPALLAYLFMPGAFVYAGAFIGGFFALATMPLGVLMAQRLAPKGRSMVSSLMMGLAYGLGGLFSPLVGKLADIYSIETVLFWTAFVPLITLIPIVKFPQLEKEA
>fig|177437.4.peg.2458 Permease of the drug/metabolite transporter (DMT) superfamily
MKIKNRLENSQILTGYLFAIAATAIWSGNFIVARGLNETIPPITLAFCRWLVAVIVFLPFALKPLIAQWGILKKNMGYLSVTSLLGITIFNTLIYFAGHTTTAVNLSLISITFPIFIVIFSRIFFRERLTLNKGIGIVLVVTGVVLLITRGALSSLLNISFAIGDLWMLLAAIIFAVYSLLLRSKPQQLSIWAFQAATFILGLIFLFPFFVWEYTITPSIPFDTKAVVSILYVGIFASFFAFVLWNKAVVAVGPSKAGMVYYTLPLFSGFLAHFFLKENVTIIHFYSVLLIASGIFTANYEFKGLKRISTAQARP
>fig|177437.4.peg.3442 Multidrug resistance ABC transporter ATP-binding and permease protein
MGPFELIRPYFIERRAYLAAGLFSLLVVDLLQLFIPRIVKRAIDGIASSSLDAGALLRYGGYILLAAIFIGVFRFSWRYCIMGTARRVEEGIRERLFNHVITMPAPFFDRVSAGDIMAHATNDITNIRMALGMGLVGMTDTVVLGLTAVVFMGYINLELTVLALFPMPFIAIFTKILSKRLFLAYMAVQESFSRLMEASRERFAGIRVIKAFNREDAETLSLTQESQAHVDANMHLVRLRGLIFPMVTLLTSISLAVVVGLGGRKVIQGTISPGDFVAFIAYLGLLTWPVMALGWVTNMIQRGKVSIDRINTILNTSVAMGNMDNALTPQKITGNIQIQNLVFHHGSGKDRTRILDNVSVTAGPGGILGIAGPPGAGKTTLVGLIPRIYDPDSGRILIDGMDVRNIDIHCLRRFISFMPQEPFLFSGTILENLKLADALAGQDQINGVIEMAGLTKTIESFPKGINTMIGEKGVMLSGGQKQRIALARALLKRAPILILDDPVSQVDIRTAAGIIDTIEALSTSITVIIVSHRFQAFRRADNIIVLDKGRIVESGNHEQLVAQGGYYARAQVMQSGGES
>fig|177437.4.peg.3509 Acriflavin resistance protein
MNPARFALNRRTFLAILTLLLIGGGLLAFEHLGRLEDPTFTIKTALVITPYPGATPLEVEEEITEKVEEAIKSMGQVKEIYSTSQEGISFVYVEMKDAFNKRELPQIWDELRRKVADIQATLPPGAGPSQVNDDFGDVYGVFFALTGDNYTLAQLKDQAEYLKKELLLCKDVAKIDFWGIQQQVLYIEFEPSKLAGLGISPDLIYQTLHLQNVVESSGKVDVNTEYMRISPTGEFKSETMIADLLIGGAGSMVRLGDIATITRGYWEPPRNMMRYNGRPCIGIGVSTVDGGNVITMGDSVREKLHELEARQPPGMALNTIYYQSRVVTESVNAFLINLAEAVVIVVVLLMIFMGWQSGMLIGIILLLTILGTFMGMLLMGIDLQKISLGALILALGMLVDNAIVVTDGILVRVTRGESRESAAVQVVRENQWPLLGATFVAILAFAAIGYAPGNVGEFCRSLFQVMALSLLLSWLFAVTITPLFCVWFLKTPESQAMKDPYGSRIFRIYRRMLHLALRWRYLTLVVVSLLMLLSIIGFGSIPSAFFPDSTQRYFYVNFWKSQGTHINHTADDLAKIEQFVRQMDGVKNITTFAGEGALRFLLSYDYQIPNPSYGQLLVEVDDYLQINGLVKQVNAYLAANFPDAEPYARKIVSGPPVTFQVEARFRGPDIKVLQDLADQAGKIMEQTPNTRDVRTDWRQQVRVIRPEFSQSQARRSGVTRSEFSSALKWQFTGVVAGLYREGDELIPIITRPPEKQRNSVGDLDNVQIYSHANRLFIPINQVITGVKTVWEWPLIGHRDQQRAVTVQCNPARGLAAPLRLAMAQKIEALDLPPGYSLEWAGEFEASNDAREPLGKIFPLCVLGMFVIVVGLFNSVRTPLVIFLTVPLSIMGIAAGLLIMDLPFGFMAILGFLGLSGMLIKNAIVLIEQVEIFLKEDYPPYKAILDSSVSRMRPVIMASGTTILGMLPLVFDPMFATMAVTIMGGLFVATFLTLIVVPLLYCLFYRIKSEKRYL
>fig|177437.4.peg.3643 Multiple resistance and ph regulation protein f
MDTYILYSAIVLSVFMAIPLYRSVVGPTVQDRIMGVSAIGSKTTVLLIMIGFIFERVDMFIDIALAYALLNFIAVLAASRYFHKRKGLYQEMDR
>fig|177437.4.peg.3651 Permeases of the drug/metabolite transporter (DMT) superfamily
MGSLTAIHLAVVLFGFAGLFGKFLTCTPLVIVFGRTAFAALALLPLVLASKANPLGEKTPRLKVYILQGVLLAVHWCTFFLSIQISTVALGLLTFSTFPLFTTLLEPFFFKQQIKQKDLVMALIVFAGLILVLPSFDFSQKPAQGAVWGTVSGFTFALLAIFNKKNLTFEPPVRLAFFQNLFAAATILPIFIFVPQTVPAPGEIILIATLGIVFTALAHTLFISSLEGLRATTVSIITCLEPLYGIILAALLLHEIPGLRMVAGGTIIVLSTLFASLNRKHSQ
>fig|177437.4.peg.3972 Ribosome protection-type tetracycline resistance related proteins, group 2
MTITPSGVIYRETVIKNAQATVRYTMPKPCWAVMTFNVEPGALNSGDFLLATPMGIMAALKNAGTRLLEPFYALDIKAPQKLLGTITNDLNNMRADLGIPRFEGNLFALGGTVAVAPAMDYSIRFNACCSGKVRLKLTLGGYQFSTSSQWTLENLTFSGLEGHGGVTIGWGSDNLIRRADFPARITEIQKIHGHPPVQ
>fig|177439.1.peg.80 
MQSSASEKRPSLRQLLLLVAPSFKRYRLRISLGLMALIIVDILQLLIPRILKQGIDSISTKAETTNLAQLAIFIICIACTVIILRFCWRYMILGFSRILECTIRNSIFSHILQMDATFFEKNSTGKLMAHSSNDLSAVQMAFGMGTVAAVDSSVMLTVAIAFMLSINVKLTILALVPLPLLAISTKILAGQLHTRFETVQEQFSHLTEFSRSAISSIWLVKAYTMEDLQTNQFDALGKEYVRANLKVGVINGLLQPLSTLVGNLGILSIFFFGGRMVIQEVISLGDFVAFITYLYMLIWPMMAIGWVTNLAQRGLTSLQRIRLLMEQKSMMLDGPEKASRETKGARIELCDLSFTYPNASQPALHHINLTFLEKTYGLTGRTGCGKTSLCRILCRLYPVEDGMYLHNEIDVNRQGLNELREQISYVSQESTLFSDTVKNNIRFGNEEASEEEITEAARRADIHNNISELSNGYDTLIGEQGVKLSGGQRQRIALARALLTKRPILLIDDGLSAVDVETEHQIFSRLREGENKTIIIISNRIKLLSMTDEIIILDSGEIADRGSHQHLLRHNSLYQSMAKKQQEQREEKL
>fig|177439.1.peg.119 Permease of the drug/metabolite transporter (DMT) superfamily
MPEKTARPLLIYLYLTLTMFFWAGTFVAGRILGQNLPPSVAGFLRFFVASSSLFLVLRIKFGAIPRPEKEQLLPLLLLGFTGIFAYNIFFFKGLQHIEAGRAALFIAATPLMITITATLFLKERLSLKGFLGVLLSFTGAVIVISNGHPEKVLQGGFGIGEQSLLGCAASWAAYTLASRKVLISMSPLSAVCFSCMLGTAMLFPFAIGDGLFTLMPQITDLGWICVLYMGVGGTALGFCWYYKALKAIGTTKTSIFLNLVPIFTLILGHFILGEYVNISVLAGGLLVLTGVTITNFQKDN
>fig|177439.1.peg.153 Outer membrane component of tripartite multidrug resistance system
MFASQLRRSLLLLLTPLLLLSCSMIPPKEAHHQQLLTPEEIGIRAEMQIRTCRWWEDFRDPQLNTLIEMGLRQNLNLQQVSYRLSLAKQQVLLNQAGQKVQANLKLNGGGLAAKGDFPSQNSAFALALPMVGYNLDFWGKIENRVLAASNREKAAQVNVTQARLALAVSIAQSYLNLQNNRQQKQVLHRMITNQKAAEEIIVGSVKRGFLPYEELLQSQSYSHLLRAELTGAKAQEILAKNQIALYLARTTEQLAPLVDGKLTLIAPLQEVLSIPMNLLARRPDIQGKKWIVQAYAAEIKVARTAFYPDFNLMLGGAFLAMTNIHPDKLSLLSGSIATSLPLYDGGLRDAGLSIANIMYDRAVLDYNQSLLGAVREASDAIILLKTSQEQEMLTGISTEKQRQAYDIARKKYQRGISPYLLMNQAESRWQQTFLNLIKTETATLQSQLRLIMALGGGYSPKAATEK
>fig|177439.1.peg.154 Membrane fusion component of tripartite multidrug resistance system
MPTTSQENKPKRNLLIAIFLIAIAIGIVIWIFLSQRQQESTDDAYVIGNTIIISSKIAGTVQKISVSNTEFVDQQQILIELEQNDLLIQEKIAEANLTRIVRTVKSQYLTTGQLKDNIRATDFKIAELEADLARRAGGDLDGTVTLENLQHMGQAIKIARAQRDSARQGLEAKQTIFPGEELQNNPEIKLATAHLQEIYLARINSTIIAPMHGLIANRSIQAGERISPGQPLMAVIPLDNVWVVANFKETQLGDIRIGQAVELISDIYGKKLPFEGIIAGIGAGTGSAFSAIPAENATGNWIKIVQRVPVKIFISPDQIKKHPLRIGMSMTVRVDTKDQEEKSFQHIQQHDDISAIYQSHRQLAEQQARDFLNTLLIHNNK
>fig|177439.1.peg.155 Inner membrane component of tripartite multidrug resistance system
MANSPQSTQWLQGIKLTAATFSLAMAAFMMVLDTTIANVAVPTIAGNVGVSVDQGTWVITAFGAANAISMPLTGFLSHRFGEVRLFLFAVIGFTLTSFLCGTATSMESLVIYRILQGAVSGSIAPLSQSLLLRCYSKEKRGTALALWTLTIIVAPIVGPILGGYLTDNYHWSWIFFINVPIGIFVLISCSMLLKGKETTRSRPSIDYIGIGLLVFAAGSLQMLLDLGKQHDWFQSTFIIGLGLVALVSWGVMIIWEYYHDNPVVNVRLFKNRNFSLAVLIMGLGYGIYFGSSVLLPLWLQGVMGYTATWAGLATSPSGILAVVSAPMMAYLTRKVDLRLILTYAFVNFAIVGFWRANFSLDNSFFIIFLPQLVVGAATMPFLVPLQRMIIDGLPSSQIATAVALSSFFRTLSGSFSSSVVTTAWDDRMTFHYARIAENFTVYNQYSMGYLRDVHGNISLMSKIIMRQAYMLSTVDLFWATGVICLCLVPIIWLTKPINIEIE
>fig|177439.1.peg.196 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNSFFSRPWSKFDFIKFVTPSILSLVSISLYMAVDAIFISRFIGTLAMAAVNIIMPLFSISIGIGVMVATGASATIGIELGQGKRDRANAHFSFVFCFLFLVFIGLIISQWAIGPERLALWLGASKLLLPYCVQYLNIFLFGISALVLQMFFEFFMRLDGKPSWALYSSLLGGATNILLDYILIVRYGMGVDGAAIASCAGIFISCLNGAIYFLFKAKTLRFIRPLIDWPFLFRSMFNGFSEMVTEIAAAVQTLVFNYLMLGYAGEAGVAAMSILMHLYFLMSSLYIGLGMGVSPLISFNYGCRNPGKISELLTRAIQLTLFFALFSFAMAFCFGDNLIQIFAKGQVSVVHIAEGGIKIIAFSFLLNGMNILASAFFTSVNNGKISTLISSLRTFVFILGFALLLPPLIGVTGIWLSLPMAELSTLLISLFFMKKYRQHYLLPATTGEVKEKNSMQLIKKKEKEEA
>fig|177439.1.peg.290 Permease of the drug/metabolite transporter (DMT) superfamily
MKLIFNSKYTPVIAIFVAMIIWASSFIALKIAFRSYHPMVVIFGRMLIATLCFMVFYKYVFKGFKYHKGDYKPLLFMAFCEPCLYFIFEAIALKNTSASQAGVITATAPIFILAAASLFLKEKYNLQSWLGALAALAGVCWITLASATSESAPNPIFGNFCEVLAMACATGYTVCLKSLTKRYSPLFLTSTQALMGTFFYLPMLFLPFVEMPTEYVALPSFAIIYLGAVVSLIAYGLYNYALAHMPAAQGASYINLIPIFSVAMAWLFLGETLNLSQGFAAALIIASVWVSQKGMAKAHDEKHSLKNK
>fig|177439.1.peg.671 Permease of the drug/metabolite transporter (DMT) superfamily
MSRLQANLLLSLAALIWGSSFVVQQIGTGNLDAASFTGARFLLGSLVVLPFALRQFLHVQREVRAFTLRDGLGIALTGSVLCVAAALQQYGILRTTVTNSGFLTALYVPMVPILALLVFRKKPHWSAWPASICCFVGTYIMSGAQNVVLASGDLWVISSTIFWASHVLLIGIMVQKTEAPLVVACGQFFICGILGLFLGQYLESPDLNVFAGALTGILCMGFFSVALAFTFQVIGQRYTPAPDAAIILSSETVFAALCGAIFLGERVSDFQLAGGLLIFGGIIAVEILPMLKTARILS
>fig|177439.1.peg.1054 
MNYKKFRKSDVFTISAAHMLHDTYSAFLAPLLPLLIEKLGMSLSTSALLEIARRIPTLFNPFFGLLAEKTEVKYFVIFTPAITAIAMSLIGLASSYTILFILLFVSGISSALFHVPSPVMVKEASGNRIGTGMSWFMVGGESARTIGPLLVTAAVSLWGLEGIYKLMPLGLVASFILYLKLKDFDFDRPVSKAKEKGDTRKLLKRYTPFFTVLASYLFFQAGMKSALTLYLPVYLISQGESLWHAGFSLSILQFFGVLGAFFAGNLSDRIGRKNTLVITSIGSALCMGLFIHFGSIYILAFLGLFLLSSGPVLMASVQDTNTHMPTFMNSIYMTISFSITSLVVFAVGLSGDNFGLETTYIICNVFAIGSIPFAFLLRKFL
>fig|177439.1.peg.1861 
MSIKQKNGEASTIILVSIVQFITPFMASGVSVALPTIGRHFSASAFQLGLAEMIYILGVSIFLLAAGQLADIFGRKKIFLMGICGFIISTFAITATRSMGQFLLVRFVQGLSVSFIATTTFAILSSVVPRERRGKSMGIVLAFVYAGLSAGPALGGFIVFQFNWHWLFVFAGLLASLALLLCLKTLKGEWWGSPEQKFDYRGCAVYMLSLSFLVVGVAGHTMVGGYAAALVVAGIVGLSFFFWLETRVKSPMLDVRMIFANRVLFFTVLAALINYGASFAIIFFFSLYLQSVKGLLPQVAGSVLILQTLVQCILSPLSGKLADKIYPGKIATLGMFVGTIGLGMASLIEQESSVAMVALVFVVVGVGFGLFASPNMTIIMNSVPQEAYGQASSLTATVRTLGMLTSMAIASLLVSHFMGDTPINKESIPLFMKSLQGAMLTFTLMSLVGVFLSLGRAKAPTNEP
>fig|177439.1.peg.2838 
MPGRTLITLLLSIFIALLGIGIIVPVMPIYAETLGAGGFALGMIIASFSVSRCILQPIIGNLSDSLGRKRFLIAGLLIYALVGLLIPEAESIQSLIFIRLLHGMGSAMIVPIAMAYVSQMAPYGHEGRYMSFLNIAIFSGMGCGPIIGGIFFDTLGFKAVFYMMAAMSFLAAILITANLPNREETKSIKLQASLLSSMKRMVANRHTRGVLITRYATMTALVPSMAFLPFIMTESGYSSGTLVGLVIACRTLVNAALQFPCGKLADRYNKLTLLFIGVWVMVIATSLIPEAEKITSFFLIYALLGCGEAIVWPTLAAYASLDGRENYGHGTMMGVFNLAMSGGVFTGALLAGYSMDSIGLRWAFYIPAITIATIASLGMALIYRAERQRSEALISTQGDKVHK
>fig|178306.1.peg.1656 Drug resistance protein, conjectural
MESTSLGTSTSRADLRAYAIFSAPYSLVVFLLPFYIFKLGGGGVEVGFAFSIYATAVVAVRPVAGYLTDRLGRRSANLLGGLILASAMILLGASYGVFHIYISLFLAGAASSLINVATVAYITDVGGLENPALYSKMRIAAAIGAVGGGAFIPIAYFLDKLWGYEVAFRASALALAFITLTALPLLPHETMQLAARYKQGNLGLATCVTILAFLLGLASGLYGPQVLPYIYTKYNLSPFSAVLAYLPAVFSWLYGPRLARPAPTRVILGVIAMATGLLAMYNAPNPLLFSMSWVLESLGYAIVSTSLDQSLSRYVSGAYWGRGYGVYQAVNNLGYAIGAAFSGYVPNPFYNAIAPLIFMLPLAVICVKSRRISPRVSTSPLPS
>fig|178306.1.peg.1786 Tetracycline resistance protein
MRPIFTLLGVVAIHMLGFGIVIPVMPYVVKELGGGSEAYGVLVSIFSAVQMVSAPLWGALSDRIGRGPVITLGLALAAIGSAMAYGARSLAELALARAVSGMGGGTLGAVQALIADLSPPERRASNMALFGVAFGIGFILGPVVGGLLSVWGVRTPFIAAVIFSAAAAALSTSLPRVRGRVGFSISLQFGAVAGLVLALNLAFSMFESMLVYYAADVFKMAPSDLGVLMLIIGLAVASAQPAVRRLEGRVAYTTSALAGFVATGAGIGVLPALGELGLYLGSAVAAVGQMVASSSLFALFSQGERGRGIGFGALQSTASLGRIIGPSLAGWIYLKLGPSYVFYAAALLLLAASPAFWFWRR
>fig|178306.1.peg.2372 Multidrug resistance transporter related protein
MDSYDIKYAWRATPLLGSVALLVMYTEAMLMPSLPKIQAEFNVTPADASWILTIYLISGTISAAIFGNLGDIYGKKRVLSLVMLAYAIAVTLTGYAPNFETLLLSRAIQGLGMAMFPLAFSLIREEFPPHMVPTAQGVVSAMFGVGIIIALPVGAYIAQNYGWRATYHTATPIAVLLTFLIMIYIRESRYRTPRSIDFVGIGLFATMAASFLLAISKGPDWGWLSPRITSLLALSAVSAAVFLIHELTTDNPFIPRDIFNRNVIAATIAILIVAYAFQMNSQNLSYLFQMPPPYGYGLTVLQTGLYMLPPAVVQIIVAPISGRLMWRLGAKKIATIGVVFAVIGYQLAAAHLYSGVWTLISYVTLGFIGLTLLNVSLINLLTFSVPRQRLGAATGLNTVFRNFGSAIAPTVAGTVLTNFNTYVYYNTPAGPIYFSVPAKEAYVINIDIATSMFIITLLPILFSKEVLGGNATPK
>fig|180281.4.peg.359 Multiple antibiotic resistance (MarC)-related proteins
MEDLNRSVITLLALINPVICAVMLLERTPGVPHRRRLLLIGNVVLRTGLILLVSAAIGPQLLKRLGISLDVFQIVGGVVITSIGYGMFAPSPAPAAATGQESGSPENASLDPIVLFAASPGTISTVLALSVMHGPDQGLLPTSLAVLIALAITAVVMAVMVLRPGASTRSNSSLVSRFLGLILIAMGLQFVLTNLRTFFQAAG
>fig|180281.4.peg.814 Glyoxalase/bleomycin resistance protein/dioxygenase
MVSHFDHVTVVVQDVEAARRFFALLGFEEDKALVISGPTFSSYMGVDGIEAEHVTLVLPHATPRLEVQLLKYHHPQVHPDPEIANLCRLGFNHICFAVDDLEAEVARLTAKGVQLRNQMMTFNTRKLVFLSGPEGITVELAEWR
>fig|180281.4.peg.2227 Mitomycin resistance protein
MGPAIAKALLSLGYRVPADLNGADPLDLYNRLGDLRGCRQDPCVLDVFIAITRFLNGEPARPWWAYSEDRRRRHPDL
>fig|182217.3.peg.677 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MGNTEVRPGAMTYVIFLLGILFLSFTAPWQKMSNFDPATGAFLRCLGGALCLVPFAFIEAKKKGWLNKKGIWLSILAGLVLGIDFTAWNYSIFFVGSGIASILLNIQVIILPALALMIDKEKIPLSYYILAPIMLTGVILAGGALEHGIVDPNGPQEVFGMSIMAVGTICGLTSGCCYGVYLFASRRAGRINQGQIVQPIMIASFAQLVAPLIWAYVITGNGFDMATGVMVETAQSLDIGEMIRGLREMHLPKDEIEQLTSVAHAVTAGDPINGVSWFWMFIECVLGQACAWTFAQYGSVKLNPTLGAGLLILSPVATVAIIAPFLFGETLSTLQIVGVVVALLAVAYQNGLLKAIFTKKIS
>fig|182217.3.peg.1605 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKVFKRIGAYSMLKAKIDLHKDSIRKLFFYYFIPLAFSMISLSTYSMIDGMFVGKKLGKEAIAAVNIAWPIFPSLVAYELLFGFGAASIVGYFLGRGKTHRAKLVFSSVFYFVALSTFILSMALLPFSETIARLFGSNDALLAMSSRYIEIILMGAVFMVLHPLADVFVVNDKRPILAMVAMLIGSLTNVFFNYLFIFVLEVGVQGSAYATIIGHGVGFLVLMQHFLFKKGQLSFIKRFSFPAVISSAKSGVPQSTAELSFALMILIFNATIMHTAGERFLSMYGIIMYNAIIFWTTLFSISQGIQPIASFSYGARNLERVKGVFLFGLKVAFLVGVVLYGIYYFLDEFLIKMYLQANEQDLDFIQETKQAMNVYYLGYIFLGMSILCAVFFQSIQCTRSSFIITLSHTLIFIVVLLPLMSHFYGIKGIWATYPIAQFLAFLSAMGVTYYEIKKGVFTTYREQSLINGAKK
>fig|182217.3.peg.1697 Tetracycline resistance protein tetA(P), putative
MKTLRKNILAYYGANFLLTLAQSLPHAILTPLLLSKGLSLSEILLMQSFFSFCVLVAEYPSGVLADLMSKKFLFLFSNLFLIASFCCVLFFDSFMLMLLAWGFYGIANACNSGTIEATLITDIKENKQDLSKFLARNNQITYLSMIIGSSFGSFLYSKMHASMYMVAILLVLLCMLVVIFYFKENKVTPKNQKSLSLLKEQVKSSLKELRDNPKLKILLVGHLIVPLFFMSHFQMWQAYFLAQGIKEQHLFIFYIAFQVISILVHFLKASSYSQKITLSFLVVLLSVSPLLLTNMPYLFIGVYALMVAFFTYMSYCLGYQFSSFVSKNNISSLSSLMSSCVRVVSVLVLSLSSLELHYFSPLSIITTHFAITLLILFFFLYKAKVFSV
>fig|186497.1.peg.35 Daunorubicin resistance ATP-binding protein
MTMVDVISVTKTFSTPKGKVVAVDNLSFKVKRGQVFGILGPNGAGKTTTLRMMATIYRPDSGRILIDGIDVVENPNEARKRMAYMTQEPDLSPTLSVRDYITYYFRFRGLSKREARERCSYALKTFNLEEHANKKPFQLSTGLKRRVQLACVLSSDAPLVFLDEPTAGVDPKSKRDAWELIGEMVREKDMTIILSSHDLYEVEYLADEVLIINYGKAVAQGRPSELKRRFGKTLRIVTKNPILDFEKLRDTLTSIEMVENVRAITKNSFEVKLNSLDAPINDVLQATMSLGLEIVDAFTATLTFEDVYLSIVDVGGEINGKR
>fig|186497.1.peg.36 Daunorubicin resistance membrane protein
MGRGKEFLSSFYVAMSRETKVGIDLEFWLGTMFEPLIYVLLFGPLMEKLVGGVNVGGEEISYLAFMFPGVLTLVGINQGFRGATTFIRDRFYGGLETLFTLPVSRSVLFMAKILGACIRAFVAMATLSVLVIIVEDVSLTPLSFIQSFLVNSTLVVMLSSLMIWLLSKGENPNLPVAISGIIMLPMMFLSTIFYPKEVFEGSRVMSLVVSLNPMTHASTLTRSFLYGISLPLSEVGISLAYLAALRFLGFVLGLRGFTRALER
>fig|186497.1.peg.146 Quinolone resistance protein NorA - like protein
MLKSLWYLNFSTLFFFLGVSILNPLVSPYAITLGATPVIVGIVAGTVSIVSLSSKPLGGYLGDRGFKFHAMFIGNIIGIIAVLLYVLSNILGNIWVFALGRAVHGFAMGIFFPSSLALAVDLAPKGRVGESLGWRGMMFSLGNIVGPGIGGFISDNFGFVSAFIFSGIFSFIGSLFVLIVWREIGSVKSEKASERGNYRELLRRSFVSASVSLFLISMAYSGVVTYLPALYKVSGFGQSVFGMYMMFVGIASFIMRVFGGKIADIKGPIPVARVGILILGSSYLALAFNQYPPFSFIVGVVSGLGFGLLIPALQYMALANLPGNIRTMGSSIYTMFFDLGMLSGQLAFGVVAEVRGYEGIFPFIALLPFVSLITVHFPLLRREGNEG
>fig|186497.1.peg.316 Daunorubicin resistance ATP-binding protein drrA
MQGERVDFSCGWIRNRVHWRILKDFRSSTFWSYARNSWCHGGEKMKAIVVEDLEKDYGKVKALKGISFEVKEGEIFGLIGPNGAGKSTTLKILATLLVPTGGRAEIFGYDVVEEAEEVRKLISYLPEEAGAYKNLTGYEYLEFMAKLYAKTGKDYKKMLETGVELSGLGERLKDRISTYSKGMTRKLLLARALMVEPKLAILDEPASGLDIINAYSIRQTIKQFAREKGITFLLSSHNMLEVEFLCDRVALINKGRIVEIGTPKELKEKYNAENLEEVFMSIVGGKKVE
>fig|186497.1.peg.323 Permease of the drug/metabolite transporter (DMT) superfamily
MNERRKAELVLLGATFIWGSTFPVMKIGVEDFPPITFIALRFGIASFVLFLALRKHIRKDALFPGLILGFTLFLGHGFQIVGLKYTTPSNSAFITSLYVVFTPFIAFLFFRKGLKMFDAFSLSLAVIGLYLISNAELRLNYGDALTVVAALSFAFQIVLVEYFGNLGVGLAFWQIFWNFILSTVYAGIFEGISLPSDPKVLGGIIYTGIFATALSFTLQVKYQPKVESYKAAIIYSSEPIFAHLLALAFLNDRLPPKGYLGAFLILLAVWLELYQERKNY
>fig|186497.1.peg.595 Daunorubicin resistance membrane protein
MNVFSTMIYRELKRFVRSPSRIMGSILNPLIWLIFFGKGWSGVFNFPMATRIFGGVDYMTYLVPGVVVMTVFNMSFMQGLTIIWDKQFGFMKEILVAPASRVESILGRITGGAIVAMIQGFIMVALSFTIADLKVSGIIPALVLAFFVGIAIAGLGVALALRMSSMEGFQVIVMMLMLPMMFLSGAFYPVKTMPNWMQWLAKINPLTYAVDGVRYYLAGVTPTFGIINDWIVLIILALAFAGIAGLEFRKAYLS
>fig|186497.1.peg.716 Drug resistance protein
MMPIIALYAISLGASLPQAGIIAALYSIAAIPASIIAGLLVDRIGRKRMLTLGLMWDAFVVFLYGYVSSYHQLAILRVLHAFGGSLVFPALFTMARESDCEGKTIS
>fig|186497.1.peg.728 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEKTTKGVQLLRGDPKKAIVRLSIPMMIGMSVQTLYNLADGIWVSGLGPESLAAVGLFFPVFMGIIALAAGLGVGTSSAIARRIGARDKEGADNVAVHSLILSLILGVTITITMLPAIDSLFRSMGAKGEAVELAIEYARVLLAGAFIIVFNNVGNGILRGEGDANRAMLAMVLGSGLNIVLDPIFIYTLGFGVVGAAYATLLSMVVTSLFIAYWLFVKRDTYVDITLRDFSPSREILKDILRVGLPSSLSQLSMSIAMFFLNSVAITAGGENGVAVFTSAWRITMLGIVPILGMAAATTSVTGAAYGERNVEKLETAYLYAIKIAFMIELAVVAFIMLFAPQVAYLFTYSESAQVIKGDLISALRTLPVFLVLTPFGMMTSAMFQGIGEGEKSLILTIFRTLVMQVGFAYIFVHYTTLGLRGVWIGIVIGNMVAAIVGFLWGRMRISALKKTSATGGKR
>fig|186497.1.peg.753 Daunorubicin resistance ATP-binding protein
MVELENVRKSINRKEVLRGISLTVKPGEVHAYLGHNGAGKTTAFRPILGLRYLPEYDLLYPSLSVWDNLKRYASLKGVYDEKELRELLEFFELLECARKKVSALSSGTQRRVAMARAFLGSPEVLILDEPTRELDPEWRLKFKRFLERYVKERNTAVLFSTHILSDVDELCEKITVIKEGRVLFSGSLKEFKRGFPTGASISLKVENIKMVAEVLEDNGYYPNHERVHPAGKCRAVGNQHAPREREYNR
>fig|186497.1.peg.850 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSREKIEANREKILNGPIVPTLLVLAYPIIINQLVHVLYNLTDTFWLGKLGRIELSAPGTAWPLVWFLMSIGSGFVVAGFAFVSQYIGAGDYEKANRYAGALYSLLLIFATGMSIFGIVLAPYFLRFMKVSETIFPYALTYTRIIFAGIPFSFTLFAFNFLLRAIGDTKTPVKINIGTIILNIILDPFFIFGWGPFPRLGVAGAAIATMLSNSVGSLIGGYLLFTGKVGIHLTLENLKPDLKFYSRIFRVGLPSSIGDSTSALGFVVLTRVIFTVGRIYGEAHGIKGYEDVAFPTYSITNRLTNFMFAFSDGISMAMGTMVGQNIGARKYERAKEIAEKAMLINFTILSIGTLLFAIFRVPIFKFFVNDPMVIAESKKVVMYFSASLPFFGIFSAVNQVFNSAGHTKKSMVLGIIRLWILRIPLSYWLGVAMKDTAGMWLGMGLSNVIGALIGLAWFLKGSWLRGVIEEHH
>fig|186497.1.peg.862 Daunorubicin resistance ATP-binding protein drrA
MEAIAVEDLTKSYGEIKALDSLTFSVQEGNILGIIGPNGAGKTTLIRILSLLLKPDKGRILLYGHEVNSRKSEIKNFFALLPQEAKAHFYTLTPFEYIYHYLRMRGFSRKDAKIRAGKAVEEFGIDYADKIMSTLSGGMVRKTLLAMILSADAKIYYLDEPTVGLDVENRLKLWEILREKSKNSTVVITSHYLNEISSVCDNVLLLKKGRVVAFGKPEKIARQYLSQFHSKIVVFGEFTKEDYTTRRAGKNTFVYAKSKSEEREVIEELKDTGIPFKREELTIEDIFLVGNLR
>fig|186497.1.peg.1047 Daunorubicin resistance ATP-binding protein drrA
MIIALEIKGLKKRYGNVEALKGITLEVYEGEIFALLGPNGAGKTTLIRILAEGLKYDEGEIKVFGRTLSRETRRLIGYVPQESIAYDLLTVKENLEFYADIYNAPRERIKELIELFSLPEKKKAKELSGGFKRRLNLAIALLYDPKILILDEPTTGLDVPSRRDFWEIIRGFKKDGKTVLLATHYMEEAEELADRVAIMNEGKVISIGTPEELKRLIGEESIITIKGLLKGLEEISYPFIEKDNEIRVRVRNPREALPKIVENLIKAGSIIKEIRVEEPTLEDVFIKLTGRRLE
>fig|186497.1.peg.1938 Daunorubicin resistance ATP-binding protein drrA
MKVVEVKDLRKLYPKKIPLPFRKVEYFEALKGITFSVKKGELFGLLGPNGAGKTTTIKILTTLLEPTSGVAKVLGYDVVKEPREIRRRINLVAEGERTLYWRLSGYENLRYFASIYYVPRREAEKRIKELLEMVGLWERRNDLVMNYSRGMKQRLAIAKALINDPEVLFLDEPTLGLDVQSAVFVRELVRKLVDEEGKTVLLTTHYMQEAEELCDRIAIIDHGRIIALDTPEGLKKMVRDNTIVEVKVRNYPGSNPFGLAKVEEQEGVAILRGSIDEEEIPRLVEFLVKNNAKVLSVEVEEPTLEDVFIKLTGRGLRD
>fig|187272.6.peg.686 Permease of the drug/metabolite transporter (DMT) superfamily
MPVSLSLRNPVVLAVLGLVATTLFWGGNAVVARATSEWFPPFTLSFLRWVLALLIILPFAWGQIRAYRETIRRHWRILWVLAALSVGLFNTLLYLAAQFTTATNITLVNSTMPVVIGLMALLFFGQRPRSHELLGIVLAFLGVLAIVSQGDREVLLNLELNPGDLVMLLAVCCWGLYSLLLKRYGPDIPAVPMLAVMVAMGIPVIVPFLVWELIMVGPVQGTVMEMLPPLIYVGIFPSLLAYLFWNNGVHVLGPARTALFIYLVPVFGSALAILFLGERLEPYHGVGAAAILAGLYVATRGLPGRRPVEEEHP
>fig|187272.6.peg.1018 Acriflavin resistance plasma membrane protein
MIRWFAAHPTAANLVLVILVAVGLFAAPTLQRETFPDYRPGEVSIEVAYRGASAADVEDNICRRLHDAVKGVEHLDEFVCTAQDNRASATASMAPRGTMARFLGDIDTEVKAITDFPERADPAVVRELHRTDLVAAVAITGDLSLVDHEAYAQRLEDRLIALPGVADVITHGLSQRQWQVEVGHDALAQHGLSAIELAARVAAQNIDSPLGTLETPDREILLRFTDERHDLVGLGELVVLSDEGGGELRLSEIARLSEHREHTEEKVLMNGRRAVLLEVHKATHADALDVMEAMQGLLETERARWGEALTLTVTQDATSIVRDRLQMLVSNGLLGLILVLLVLSLFFRPRLALWAGIGLPVGFLGAFTVMALTGLSLNMITLVALLMAIGLVMDHAIVITDNISARARAGSRALEAVVEGARQVLPGVISSFLTTVVVFTPLSFLAGELGAVLQVLPVVLIAALTASLIEAFLVLPHHLRGGLDRIQSKGNSRLRQGFDRAFDRFREGVGSLADRAIRFRHGVLAGTLVILLASAGYLVGGHLGTEAMPDIDGDVLEARILMPQGTPLSRTEAVAKQVSEAMAELNERLTPEQPDGASLVRNLQVRFNHNPSAGEPGPHVATLSVDLLTAERRTVDLETLTAAWREAIGPIAGVHSLVIQEPGFGPAGTPIEVRLSGDDLDELQQASEHLKETLGTYQGVYNVLHDLRPGKPQYQFRMAEGAHGLGLTAEATARQLRAAILGELGGTLRIGAHDVEILVRHTERDRNRLDALEELTVLGPDGQRIPLAVATERKAAREWARITRVDGQRTVTVEANVNPRVANAQAIVNDLQNHWLPDFKAAHPTLAVGFEGQVARSAETGGSVRRALLIGLIGIYVILSFQFRSYVEPLLVMVAIPLAFMGALWGHVLMGYYLSMPSLVGAASLAGIVVNNAILLILFIKAHRDAGLSAVRAAGQASRDRLRAILISSGTTTAGVLPLLAESSTQADAIKPLVISVVFGLATSTVLVLFVIPALYVIFDEHRARRLRSSAEEHP
>fig|187272.6.peg.1119 Permeases of the drug/metabolite transporter (DMT) superfamily
MSDAVRRGATLIIIAELLLATMAATIKAASAELPSEMLVFFRNLFGLLLLLPLLVRGGRRGLATRVPHLHLLRGLAGVGAMYCFFWTIAHMPLAEALLVKLSAPFFLPLIAWLWLRETLSGRTVLAIAVGFLGVYFILQPNGAMQGAALQVGAVGLAGAALAALAKVTIRRMGPEESSRRVVFWFGVTATTVSALPLPWVWQTPTGQTLVLLVVLGACATSAQLLLTRAFAIAPSGRLGPFTYISVVFGSLYGWWIWGELLGPMTLLGMALVIGAGLLNLTLRRPAAPPARRPAEEHP
>fig|187272.6.peg.1125 Multidrug resistance transporter, Bcr/CflA family
MPHYQLAILLGMTVALGPLALDAYLPAFPAIAGDLGVSKADVGLTLSAYVFALGLAQLIGGPLSDRYGRQRVLLLGLAVFAAAAFMVAQADSLNEMLAWRVVQGVGGAFCAVSVPAIVRDQCRGNEAARLFGLIGLVMFIAPASAPALGSALLAVSNWPAIYYALGGYALLLGVLLHYRLFRRIPVRVPARTPVQSLVTNYLLVLRHRVAMRFIALQTLAFSAMLVFITHASFIYQGWFGFSSSAFAALFAANVAAMAVLNLVNRRLLLRFPSVHILRTAVATQHLAIALLILLVLLDAPSWAVVACLMAVTGCMGAIVPNSLAGALDYFPNLGGTAAALLGATQFTVAGAVSALSTRLAGEALLPIVLIMAVCSLGAVLLANGAPRAVQRQAAMQATPQGLDAPTPPSTPR
>fig|187272.6.peg.1158 Acriflavin resistance protein
MIRGDRAGGLAWFSRHPVAANLVLILMVVGGLYSVTQLNTQFFPNFELDIVNVEVEWQGATAEDVADGITRPLEDELRDLDGLREMVSTSAEGIAVITLEFAEGTDMAQAVEDAKERVGRVRNLPPDSETPTINRITRYDPIARVLLTGEVQPDELRGLARSLEESLLQSGVARVQVTGLPAEEIRITTRNERLLDLGLSFDRFAGLIASQSRDLPAGEVGEADVARQLRSLEQRRSVAEFENLQLAIDGRNILLGDIARVERLPRDREVEVYFQGRPAVELLLERAEQEDALDSARILEEWVAETRPTLPPGVELQVFDESWELISERIGLLVKNGLGGLILVVGILFIFLSGRVAFWVTVGIPASFLAALTVLWLVGGSINMISLFALIMTLGIIVDDAIVVGEDGLSHYQRGESPFQASEGGARRMFPPVIASSLTTVAAFLPLMAVGGVIGNILFDIPLVVVCVILASLVEAFLVLPGHLRRSFEAMQRADGGWSGRIWRLLRRQRRQPAAEAGGRTGPPGPGPVRRRIDGAFDTFRDRYFIPAVRRAIAFRWTTIAVGIALLIGSVGLVAGGRIAFTFFPTVEGTILYGNVSFVAGTPRERTEAYLGELEQALLGAEEALGGDLLRGHLVYVGKKQSDGAGTQDRGDHYGAIMAELVSPDARTVSNREFMAAWRERVPEAAGLERLVVQERMAGPPGDDLDIRLIGPDVQRLKAASEALQDALASYTGVSAISDDLPWGQEQWVYSLTDEGRALGLDVAEIGSQLRATYLGELVQIFHERRDEVEVRVRLDEEERRGLAALSDFRVQLPEGGAVPLDSVAVLDSRRGFEALRHVDARQAVTVTADVDASVANANRILADLEARVLPELAARHGLEYRFGGRAQDQEETLADMRAGLVLALTLIYIILAWIFGSYGWPLVVMAVIPFSLVGAFLGHWLMGLDLTILSLFGLFGLTGIVVNNSIILVVFYRQLREQARMAADEALLEASRQRLRPVLLTSLTTIGGLVPLLFETSVQAQFLIPMAVSIAGGLAGATLLVLFLVPAMLSVYERAAERLQGDANRFREATDHG
>fig|187272.6.peg.2048 Bacteriocin resistance protein, putative
MPKGFCKGGDIVTLLKHRSFNRAQAGRDFSRVIPQSRPDSCGLAALATLMNEVLHLPTSEAALQARLKHRRPASLTDLSKLSRQAGLKAHAYAVDLDLLLRVQRPAILHMGASRRIGHYVVVRGVADDKAWLADPMRGNVHLDLTALKKHWYVPRKPFGHVLYVAGADEEWLPLNEEHLPGSPPETVSDWFPPPAGR
>fig|187303.17.peg.49 Glyoxalase/bleomycin resistance
MKQPRPRVAPYLTVSPAAAAIAFYTGAFGAQQRALMPSVDGLRIAHCELLINGGSVMLADIFPEFGQTRVPMPGEHVTVSISLEYDKAQDVDDVCARAAKLGGKVETAPTNSFWGTRYASLRDPFGHRWILNAPLET
>fig|187303.17.peg.1071 Membrane fusion component of tripartite multidrug resistance system
MAPLERGRAESDGPPSSAARRVGFVRRHPALILLGALALIMLGVGGFIYWDYASHFETTDDAFVDARQYSISPKVSGYLTAVEVTDNQHVSPGDVIARIDQRDYRIALADAEAQLAAAQASAKNLDAQIAAQRAQIGASEAQVEQSQAALRFAQQEATRSRTLVQRGTGTVQRQQQTSSQLGQEQARRERAGDTLQAARAQVQSLEAQRATAEARIGQASAQVDKARLDLSYTTVKAAESGRVVRLTAAVGQLVQAGTSLAMFVPDNIWVTANFKETQLDDMRPGQPVQMRIDAYPEREFRGRVVSVQPGSGTAFSLLPAENATGNYVKIVQRVPVKISFSDLPSDVVLGPGMSVVPSIRVRPQLSIYERLRTRL
>fig|187303.17.peg.1072 Inner membrane component of tripartite multidrug resistance system
MSVADDVGAAGEASDSPNPWLIAMVVSVATFMEVLDTTIANVALPYIAGGMGVSPDEATWVVTTYLVSNAVILTASSHLAKALGRKPFFLVCLALFTASSILCGFAWDIRSLLFFRVLQGLGGGGMVPVSQSILADAFPPEKRGQGFALFGIAVVVAPVIGPTLGGWLSDNYSWHWCFLINGPIGLLSIAMVAVVLREPEDRPSAAPFDLVGFLLVSTFLGSLEVVLDRGQREDWFGSNFIVGFAILSAAAFAFMIPWEATRENPVVDIRMIATRQFGACFAVMMALGAVLIATTQILPQLLQLSFGYTATLAGLVLSPGGVVTMAMMIVVGRLSSLVQPKYLIMAGAAIVALSIYNLTSFYGDVDFWYFARTRIYIGIGLPLIFIPITTASYQGLPPEKTDQASALINVARNVGGSIGVSLAQNVLAHREQFHLNRLAENTIPSNIQFQETLRRATEHFLALGGTASEARRQAVIWIGRQMQTQASHLAYIDVFYALTLVAATIIPFALCLRRVRLGASNSAPAH
>fig|187303.17.peg.1838 Acriflavin resistance protein
MAGVNLSRWAVQRPTLMLFLMIAISLTGVYSYMRLGRAEDPSFTIKVAVVTASWPGATATEIRDQVADLMEKKLQELPFLDKIDSYTKPGFLAMQVTFKDTTPPKDVPQLFYQLRKKLDDIAPTLPAGVRGPQVNDEYGDVDTVMYAVTGDGADYDVLDKVVQTLRQRLLAVQDVIKVDVYGDQGRRIFVEFSEAKLASLAIQPQAVFDSLAKQNAINDAGVFETSSNRVRVQVTSDLKGADAIAAIPIEANGKVVRLGDIANVYAGFEDPPSFLARFKGRPAIVVGVVMGKGANVLRFGENVGAAVEEIRGKTPVGVDIDQIADQPKVVDEAIGEFTRSFLEALVIVLGVSFVSLGFRTGIVVALSVPLVLAIVFIFMGPLGIDLQRISLGALIIALGLLVDDAIIAVEMMMVKMEQGFNRIKAATFAWDSTAFPMLTGTLVTAAGFLPVGFANSAVGEYTGSMFWVLLVALIASWFVAVMFTPYLGVKLLPDFAKLHPHHDPDEIYRTPFYRWLRAVVTWAVDYRGVVIAGVIGVFALAVFGFFVVPKQFFPYAERMELFLQLRLPEGSSIGASLEAAKQAEALLKDDPDAALYTSYVGQGPPRFWLGLNPQLPNEAYSEIVIVAKDIAARERLKKKLETAIANGALPQARARVDRFYYGPPVGFPVQFRVVGSDPATVRAIAYQVRDVMRGDEGVDDPHLNWNEQTPRVRLVIDQDRARLLGLTPQDVSNRLRLAISGVTIATLRDGIDQVEVVARAIPQERGDLSRIGDMVIYARDGKAVTVSQVAKIVYDHEEPIFWRRNRDMSITVRSGVKDGVQAPDATMRIWPQLAQIRERLPPGYRIEMGGAIEESKKGNASIFAVFPLVGLVMLTIVMFQLQNFTRVALVMMSAPLGVIGASLALNVAHAPFGFVALLGLIALSGMDMRNSIILVDQVRQDLERGEKYREAIIGATIRRVRPVALTALAAILAMIPLSGSAFWGPMALTIMGGLFVATFLTVLFLPALYATWFRRHLGEGLAEAKGARARTLADGLARGAAE
>fig|187303.17.peg.2560 
MASHEVAKIDADAACVTLINVYEVEPEKQADLVRLLSEATETVFRRQPGFVSVSVHSAMDGKRIVNYAQWASKEHFEDFMKKPETQQKLKQFAALVKTVSPGLYKVNAVHAE
>fig|187303.17.peg.3387 Permeases of the drug/metabolite transporter (DMT) superfamily
MSRIRADLLLVLAAFIWGTAFIAQKNAGELMGPITFVGVRFLLSCVALAPLALYEGRHSEAALKKGDLPLAGLIGFCVFAAAALQQVGLATTTATNGGFLTALYVVLVPAFVFAQTGVRPRQVVLVAGLASILGAWLLTDSGRLQSWTSGDALVLIADIAWAAGISLVPTFLARTDRPYFLAFAQFGVIGVLGAVVGLAGEPFSLDGLIAALPSILYAGLCSGGIAFTIQIVALKYTPAAEAALIMSLESVFAAVSGAILLSERLTGPAMLGGALILLSAVLVEAGPAAQTIWLTQYWTWLAQVWSRAR
>fig|187420.1.peg.193 Efflux pump antibiotic resistance protein
MNEYNDRSLRLYVLIAATLSSFLTPFMGSSINVALPVIALQFKIDAILQTWIPTAFLLAAAIFAVPFGRLSEIYGMKRVFVYGNIIFTVSAILSAFSPSAMALIVFRAIQGVGSAMIFVTGLAILTRVFPPYERGKAIGINTAAVYIGLSMGPVLGGFLTRFLGWQSIFLSTVPLTVIVLAVSLLRIDGEWADAAGETFDIPGSISYCIFLFLLMYGFSALPDTMGALMILLSIGAFAVFLRMELSSTSPVFNVRLFRNLTFSFSSLAALINYSATFAVSLLLSYHLQYIKGLDPGSSGLILVTQPIVMALVAPVAGRASDRFNPQTLAGIGMAVTSLALLSLSILDRTTPVPMIIVSLFVLGLGFGFFSSPNTNAIMGSVERKDYGIASATVSSMRLIGQAFSIGIVTLIFAFLIGRVPISPANYDLLIESTRICFLIFGVLCFVGVFAATARRNDG
>fig|188937.1.peg.168 Class H tetracycline resistance efflux protein
MNMETDPESVRQENRPDPSARERISLLPLLTVNFIGTLGFSIVLPFLVFLVNRLGGNAFIYGLASSMYPAFQLIGAPILGRWSDIYGRKKILLFSQVGTLLSWIIFLGALFLPVVTLFQVDSEVLGTFAFTLPLAALFFARAFDGLTGGNVSVANAYLADITEEKDRNRNFGKMSISSNLGFIVGPALAGLLSITAYGEAAPVIGAVVISLIGTLLIIFYIPENKECSLEGPVEAKNIRKVFGYEIKECRTVRETGKPSFREVFKLPNIPYMLGLYFLIFLGFNIFYTAFPLHAIAALDWGIAEMGVYFTILSGLLIIVQGSILPRLSKRYSDASLIIFGSLMLGTNFLLLIPGNLFLTYLATGFFAMGDGLMWPSFLSLLSKIAGKNYQGTVQGFAGSFGGLASITGLILGGLLYELLAGRAFLLAGMIIYVVFLLNFRLRRFEKELKY
>fig|188937.1.peg.333 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDERSQMLANEKISKLLLKLSVPAMVGMLVQAFYNLVDTIFVGHAYGADSIQAIGGIAVAFPIQMVGMAVSLAIGIGGSSIISRRMGEREMKKANKTFSNLIFLSILSSLLITGAGISFIVPLLKLFGATETILPYSLEYLEVILYGTVLFSLAMVTNSIARSEGNAKVAMNSMMMAGGLNIILDPIFIFGFGMGIRGAAIATVLAQGIGVLYIARYFLSGKSTLRFHPADLKPDSKIIKEVLAIGASPFARNVSSSFMIIILNNLLAFYGGDIAIAIFGIISKLLMFTLMPMFGIIQGLQPIVGFNYGAKNFGRVRESVKLAIIITTGMSIAGFLVLYLFPEQLFGIFSGDHQLIVEGKNAVRIVVLATPLIGFQVVGGALYQALGKARPSLFLSMCRQVLFLIPLVLILPKYLELFGVWAAFPLADTLAFAVTLIMVIREFKVLAEEGENMRNDPMRNDPLAGN
>fig|188937.1.peg.497 Antibiotic resistance protein McbG
MEYQNEEFEAETFKDTDLTDVSFKDSRFIDCDFENCNLSNVDLDNTKFQNIRFKSCKILGLDFSKCNDFILAFGFEDSFLSLSVFSNMNLENTDFTNCQIYDCDFVNTNLTNANFENSDLKNSLFKKSNLSFTSFKNAKNYDINPNENFLKKTVFSIPEVISLLDIYDIVLG
>fig|188937.1.peg.2619 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVSDEELRSGNIFNLFWKFTFPAVVGVIIVGIQEIIDGFFIGNAVGNQGLAGITLAYPPYLIIIGAGIIIGIGSSSLTALKLGKGNKKEAFEIVHNAFPLSLLTGAIFTVGGLIFCETSLGLLGTDGPALFFAREYLRIIFAGSVFMVLAISLDPLVRNDGKPRLCMHIMAAGVVINIVLDYFFVMRMGMGMPGAAAATILSFVLPAVLLMRYLFGSEAKLKLRLRSMSFKPVTVLQIFKAGTPSFAMQISFALLLFAHNYMLLRYGSELAVSAYGIIGYVFSIFYMLFEGIALGVQPIMGFNYGAGSYERVSKTLKLTMLSCILVGVFGFMLICLFPETLVQLFSQNDPELLEITLRGMNIGMFSLLVEGIVLLTSIYYQSINRVRAALFINLGKIFIFLFPLLFILPLFFGLDGVWSASPVAEYFMVILVMVMLSKEFRFLRESAKAVTGKPADLKTNAKANIRASTKAEAKYAPSVSRSSVKAGSKESTGFVAFKHAENAESS
>fig|188937.1.peg.3100 MATE family drug/sodium antiporter
MNKKHASPKTAGKMSMETAEEKGNTEEKKAKKEKLEESRDGKEKTGSIPSQKVTEGVDVLLGDPKKAVVKLSIPIIVAMSVQTIYSLTDTFWVAGLGADALAAIGFSFPFFVIQMALTSGLGVGGGAAISRRIGARDKAGVDNVAVHTFVLMVILTVALTIFGLAFVRDLFMYSGAGGTTDLGVAYARVIFAGSFVFFFANVSNSILRSEGDAKRAMQSMILGSVLNIGLDPIFIYVLGLGVAGAALATVVSFACSGLLMFYWFFVKKDTYVSFDFHSFKFNLAIANDIFRVGIPSSVEQVALAMTALLMNLIIVNVSNTDGVAVYATGWRVASIAVAPLIGVSISVVSISGAAFGEKNFKKARHALIYATEIGFLAEALIGIAVYVFAPQISAVFTQAETAARIAPELTRLLKIMTVFYPAVTFGMLSASLFQGAGKGTSALIATLLRSLVLTPLFAVLFAYELGWGLLGVWWGLVAGTVIGSLITFAWAQVYLGCMIKEEGIGEKC
>fig|188937.1.peg.3324 Multiple antibiotic resistance protein
MVSENLGFFIYVFSSIFVVVSPVGGVVTFISLTSKMTRKEKNEIAKKAVILACSIALFFAITGSMILNLFSISVDSLRVAGGILLFTIAFDMMQAKVSRESITEEEITQSQEREDIWVFPIGLPLLTGPGTISTVIVLMGMADGVQQKGVVLVSIIATFLICLIVFHFSRRLHKFIGYNGMLVFTRLMGLLLAALAVDLTSTGIINIFGLGT
>fig|188937.1.peg.3492 Multidrug resistance efflux pump
MNTCNLQKNVFPEFFGNINHELYVLSFSRFCEDLGSGMLVALIPLYISDLGASFFSGLPLVTRAGLVITVFGLFSALTQPLMGRLSDRLDRRRPFILFGLIGYTFFSFLYSQVTSYEQLLFIRLLQGITVGATIPAVIAMVTHISTSETRGKAVGVYTTIRGVGFGLGPVVGGAIARYWGFDAGFYFCALLGVVSLGLVTFFVKETRGSPEPVSRKISGKKSYASVYSLAGAMLMMMVGIMMVVALLPEYEVRLEASELSLGVAVSAYIFARLLFQAPLGSLSDRIGRKKLIVGGLFLSAPLVVGMGYIASVGQLIIFRAFQGLLVAAIDTPAMALAADLSDGSSLSSRLSIITTAQAAGMAFGPIFGGFLAGYMTFVTPFYACALLMLLAGFVVIKKVEEPEKVI
>fig|188937.1.peg.4097 Antibiotic resistance ABC transporter permease protein
MSFQFRAIYWRDMLKFFRFKSMLISSLVQPVMWLAFFGLAMSESFDQLTSLVPPMEGVQNVDYLTFMGAGIIAMDVLFSSLFGGTSLMFDKKFSLLRETLASPVPRFHIILGVGLSGVTKAFIQTSMIIGFGKLIGMDFFKGYTLTETLISIIGIFLLVGIFTLGFLFLSGSIAITIENPEGMQSILTLLSMPLFFVSNALYPIESFPAILKFLSMFNPLTLLADGIRYFALGDNFTVIGIHYVYTLFDISMSFLGLMIFALAMLATSLWRFNKVDV
>fig|188937.1.peg.4098 Antibiotic resistance ABC transporter ATP-binding protein
MTANVIEVNGLEHSYGSVKAVDNISFAVKEGEIFSFLGPNGAGKSTVINILTTLRKIQKGEAKVNGYDVERESKHVRQSIGIVFQMLCIDHEMTVCENLEYHGKIYSMSKKERKERIDELLKLIELEHKRDTLVKDLSGGMKRRLELARGLMTKPAVLFLDEPTIGFDIQTRMRMWEYLREIKREGTTIFLTTHYMEEADQLSDRISIIDHGKIIVTGTSEELKNKLGKDLIYLETDDNNTVAEILRTIGSVKTVTEDTKSLRVMIGEDVTHVLPQIIDKIRKAGIDITTINIKKPSMDDVFVHYTGHGLREGEPQEKVEGLEPMGEPMGVSA
>fig|188937.1.peg.4503 Multidrug resistance protein
MKTDGIASDSNILNGKEYLVAVGVVLLGLFMSVMDTVIVNIALPSITAYFGNTISESQWVVTAYLITITAFMIVFGKLSTYTGLKKMFLGGIALFTVSSLGCGMASSLLMLITFRITQAIGGAMASSISMALIYRISPPDKQGKAIGIMGATVAIASLAGPGIGGILIEMFDWRAIFHINIPIGIIGLFIGIPYLKVTDTKKKGENIDWIGAVSFAVGITSLMVLFNAITTKGLYSMEVLVTFTVMFFAFMLLGWNERRQIDPMLDTGVFREPMFFLPLLSTILFFAAVFMLNITMPFYLEEVLEFTPLHVGMLMMAIPVVLIVGSPIVGWLYDHYLWQHFSTMGLLVAFSALLICAWAILDERLGIILFSMGLFAAGYSLFQSPNNIEIMRGLHKDRAAIASSIANTGRYFGMAIGASFASVILSIQFLSTELTKALPEIDINSLTLSSGVTLAIAALLCIIAAWPSYIRNRNN
>fig|190304.1.peg.3 Multidrug resistance protein 2
MAILYDSVITAFLLQLGLKNTQIGLLWSVVLLTQMLFDYPTGSFADRYGRLKIFTIGMVLTGSAIVMIAYSVSISMLYISAILMGIGESQISGTLFPWFVNSLDKVDNLQEKEEYILKSNGQVQYSTNIIGILTGFVISFLNLDYKFILILAGTFQAINGIFIYFSFQDNKSTETNLIKIGKKSFQIFLKDYKLWIYTLTMTIHYSFYSVHLFIWQPRANLLGVIGSKLTGINSVYLSCLVISGLIIKYKKEIKNYLYVLYVILIPISLIIIYQSQNLILYILGTILLGISNGMVAPQIMSTVHYFIPDEVRSSVISLLSSLSSIFLIFLQVIIGKILDIKGNYYLEILCVLFGIIYIVCIILILKWLKENRNR
>fig|190304.1.peg.221 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENKHNFMETESITKLLIKFSIPAIVGMFVNALYNVVDRIYIGNIKDIGHLGITGIGVVFPVVILIFAFSLLIGIGSAAAVSLKLGMKDREEAERFLGVAVFLSFIVSVVLMIIIYFNMDKIIYFIGGSNETFIYAKDYLFYINLGVPAAILGLVLNSVIRSDGSPKIAMGTLLVGAITNIVLDPIFIFGFGMGVKGAAIATIISQYVSMLWTIYYFTSNKSKIKLVKKDIKFNFYKAKEICLLGSSAFAIQLGFSLVTYILNTVLKKYGGDTSIGAMAIVQSFMTFMAMPIFGINQGIQPILGYNYGAEKYKRVKEALYKGIFAATIICIIGYTSVRLFSDTLIKIFTTKPELQEITKYGLKAYTMVFPIVGFQIVSSIYFQAVGKPRMSFFISLSRQIIVMIPCLIILPIFFGLNGIWYAAPTADSIATLITYILVRKEIKKLDKLEEMLELRNI
>fig|190304.1.peg.937 Permease of the drug/metabolite transporter (DMT) superfamily
MKNIPAFIFAGFSGYAGYIALFNIATLFSSPSTLSVINALAPAITAIVAYFIFNERIKLIGCLSMGISFCGILILTLWDGVLTVNKGILYMLAGCLLLSLYNISQRYLTKKYSSFDVSMYSMLIGGILLVIYSPSSITNMFSISFTSLILIIYMSIFPSIISYFFWTKAFELAKHTTEVTSFMFVTPVLATLMGIIILGDIPKLSTLIGGVVIILGMILFNKTK
>fig|190304.1.peg.1050 Acriflavin resistance protein B
MLIERGNKMKLIKIAIKRTIVTTMISISLLILGIFAMKSMRTELLPDIEYPVVKIITHWSGASAEDVEKQITNKIERILPNVEGIENISSESSYENSSISVEFNYGVNIQDKVTEIQREVFQIKNDLPNSAKNPIIKKTEVGAGAITLFLTFVSPDKKALFSYLENYVKPNLETISGVAEVSILGGTKKQLQIQIEPAKLASYNLTPMDIYQLIRKSSMVIPLGSLMNGREEYVIQALGELESVEEYENILLHSNGDTLRLKDIANVVLTEEDPLNLGFNRGKPATTIAISKSSDGSTIEINEKIMKAIKNMEETMPSNITYFKIFDSSESIKKSINTVGKSALQGLILASLFLWIFFKNKKMTLIVSFAFPLAISTTFILMKGIHSTFNLISLMGLAIGVGMLTDNSVVVIDNIYNHIQEEKNSIEAAFIGTNQVFSSVLASTLTSIIVFLPIIFTKGIFKEMFQDMVWAIIFSNVAALLVSVTFIPMLASKFMKKNIIQTEGKYFSKIQRKYQKFLSISLKHKKKTVLISLLFAFLIFGIGGKFVKFGFLTKQDYGYYSVIAEFQNGSDFEKIQELRNEIETIIKKESHTKSYFSIIQKRNGTISVNVDVGFKEKRKESIFEIVKKVRKEVEKIPDIRTTFFYEYAKGKPKKDIEFQIVGTDLETIQILARQIYKDVLKIKGVTDVSSTLDSGGKKLEIIFKRDKIQSLNISIKQIEETISYYLLGGDRANTITIKSGNEEIEVLVRLSKDNRKSIKQLENLKIKVTDNSFINLSEIADIRKVENQLSIDKINRFYSVSIYVNDGGIGTQKIQEELVKIFSEKNKDSSIQYRWGGDAEKMQRAMKELMLTFLIAIFLIYALLASQFESFLFPFLVMGSIPFSLVGVIIGFLITQHTLDAVAMVGIILLIGIVVNNAIVLLDFIQQEEKESKNKKEAIEKACNLRLRPILLTSLTTIVGMIPLSLGIGDGSEVYQGLGISIIFGMSFSTLLTLIFVPTTYYMLTSIFSKKL
>fig|190304.1.peg.1092 Acriflavin resistance protein E
MKIKYILLFLIIFIFTACKKDAEEEIIRPVKIQEINSIQDENFNIDFPAQISPTQKTVLAFKYAGKIKSINFESGDFVKKGQVIATMDNKDYMVNLEAFSKKYEAAKAVAQNAEVQFSRAEKLYKGGALAKKDYDNALMQKNVAISTFKEASAGLENARNTLNDTKIIAPYDGYIDKKIVEVGTVVPEGGPVISFISNEITDISINASLKDVENIRNAKNIVFKDNSSEKVYPLEIKNIAQNPDSINLTYPVIFTFSNLGKDEKFLSGQTGTVTISVKNNGNQEILIPLDALFEDNGSNVYLFKNGVAVKTAVEIGELRETDKISIIKGLKSGDKVIVAGVHKLVDGEKVKLLGGTK
>fig|190304.1.peg.1250 Permease of the drug/metabolite transporter (DMT) superfamily
MQENHKYNIYMFIATIFFGMTYVLTKICLKYSTEFHIISFRFLIAFVVSLIFLQKKIFPVKRTEFLYSLLLGALLFLVFIAMTIGVKYTTATNASFLISLSVIFIPFFSWFFNKEKPKKRIFVVLIIALIGIILLTLDKNLEFHIGDILCLICATLFTFYVIMTEKIVKNNNPTALGVLQFGWVFLFSFLVQYPIESFVIPKNKFFWLSMVLLGIFCTAFGYIAQTIAQKNLSSTVVGFILSLEPVFSGIFGYFFLNEYLSFQQYIGAFLLLISVIYVSVKN
>fig|190304.1.peg.1520 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGEERKELNPLGYKLIGKLLKSLAIPAIIANLVNALYNVVDQIFIGQRIGYLGNAATNIAFPITTMCLAIGLTLGIGGASNFSLELGKGYPEKSKHTAGTAASTLIIIGIILCIVVRIFLEPLMLDFGATDKILEYSMEYTGITSFGIPFLLFSIGVNPLVRADGNAKYSMIAIVTGAILNTILDPLFMFVYNWGIAGAAWATVISQIVSALLLLIYFPRFKSVKFSLNDFIPQLHYLKRIISLGFASFIYQFSNMIVLVTTNNLLKIYGKNSIYGSDIPIAVFGIVMKINVIFIAIVLGLVQGAQPIFGFNYGAKSYHRVRETMRLLLKVTFSIATILFIIFQVFPKQIISLFGEGDKLYFEFATKYMRIFLAFISLNSIQISIATFFPSIGKAIKGAIVSLTKQLIVLFPLLLTLPIFFGVEGVIYATPLTDLIAFTVAIIFLTNELKHMPKK
>fig|190304.1.peg.1614 Permease of the drug/metabolite transporter (DMT) superfamily
MMNKKRYFGDLMLFLAAFIWGTAFVAQVTGMDRIGPFTFNMARSIIAIICLGAYLIITKSKLPKDIGVLLQGGLVCGFFIFMGTSLQQIGLQYTTAGKTGFITSFYILIIPFLTMIFLKHKIDLLTWISIIIGFIGLYLLAIPNLSDFTINRGDFIVFLGSFCWGGHILIIDYYSKKVSPVQLSFLQFVMLTILSGICALLFENETATMNNIFLSWKSIAYAGFLSSGIAYTLQMVGQKYTNPIIASLILSLEAVFAALAGYIMLDEVMTSREFLGCSIVFLAIIFSQIPKDIFKKKYVSLKK
>fig|190304.1.peg.1851 Acriflavin resistance protein B
MSLAGISIRRPVATTMVMVSFIFIGLLAMFSMKKELIPNIKIPVVTITTTWTGAVSENVETQVTKKIKDSLSNVDAIDKIQTVSAYGVSNVVVNFDYGVDTDEKVTQIQREVSKIANNLPNDANTPLVRKIEAAGGNMTAIIAFNADSKTALTTFIKEQLKPRLESLPGIGQVDIFGNPDKQLQIQVDSDKLASYNLSPMELYNIVRTSVATYPIGKLSTGNKDMIIRFMGELDYIDQYKNILISSDGNTLRLKDVADIVLTTEDADNVGYLNGKESVVVLLQKSSDGDTITLNNAAFKVIEEMKPYMPAGTEYSIEMDASENINSSISNVSSSAIQGLVLATIILFIFLKSFRTTILISLALPVAIIFTFAFLSMRGTTLNLISLMGLSIGVGMLTDNSVVVVDNIYRHITELNSPVMEASENATEEVTFSVIASALTTIVVFLPILFIPGLAREFFRDMSYAIIFSNLAAIIVAITMIPMLASRFLDRKSMKSEDGRLFKKIKAFYLKVINKAISHKGLTVLIMVVLFFFSIFVGPKLLKFEFMPKQDEGKYSLTAELQNGTDLNKAERIAKELEEIIKSDPHTQSYLMLVSTSSISVNANVGKKNTRDDSVFTIMNDIRNKTSKVLDARVSMTNQFSGGQTNKDVQFLLQGSNQNEIKQLGKQLLEKLQSYNGMVDISSTLDPGIIELRVNIDRDKIASYGISPTVVAQTISYYMLGGDKANTATLKTDTEEIDVLVRLPKDKRNDINTLASLNIKVGDNKFVKLSDVATLQYAEGTSEIRKKNGIYTVTISGNDGGVGLGAIQSKIIEEFNNLNPPSTVSYSWGGQTENMQKTMSQLSFALSISIFLIYALLASQFESFIMPIIIIGSIPLALIGVIWGLVILRQPIDIMVMIGVILLAGVVVNNAIVLIDFIKTMRTRGYDKDYSIIYSCETRLRPILMTTMTTVFGMIPMALGLGEGSEFYRGMAITVIFGLSFSTILTLVLIPILYSIVDSFTSKLMTRIKVISRKSKKKEAK
>fig|190304.1.peg.2038 Permease of the drug/metabolite transporter (DMT) superfamily
MLRKERIFLFLVLLLAIIRGSSYIFIKNIIDNQSPFEIIFFRFFLTEIILLIFYIKEFKTLNHYDLIFGLLAGIFLFSAFAFQTYGLKYTTVSKQSFLTSLYIVIIPLLDFIFFKNKIKKNVIALFFLILVGLLFISFKDFKNFEFYLNFGDILTILCALGFALNILLFSKIKKFNINVINITIIQMLTIGILAFIFQIIFEKKVINFSMNFSLIYLILICTMLNFTIQNISQKYVPAHIIGLILSLEAIFGTVFAIIFLNETISQNFIIGTFLIAIAVILIQYFENKRGD
>fig|190304.1.peg.2042 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFKKKIFKTIFKYAIPNVISMWIFTLYTMIDGVFISRFVGSTALAGVNLVLPLINFIFSISIMIGVGSSTLMAIKFGENKYDEGNKIFTLSTFLNLFLGIFISAIILLNIDRVINILGANKSQEVYRYVKEYLTIIVFFSVFYMSGYAFEIYIKIDGKPSYPAICVLVGGLTNLVLDYVFVVIFHYGVTGAAIATGISQVASCTMLLLYITLNAKYVKFIKLNKINFEKISKIFRTGFSEFLTEISSGVLILIYNLVILRKIGVLGVSIFGTVSYITSFITMTMIGFSQGIQPVISYYLGKKNYKNLKEILKISIIFLGVLGIFCFMFVSLFSEYIGKIFFREQDMILYVKRVLRIYSLSYLIIGINIFVSAYFTAIKKVIYSALITFPRGILFNSILLLILPNIFGNKVIWIVSFLSEVLTIFICIYLLKKIKRKGILN
>fig|190304.1.peg.2050 Permease of the drug/metabolite transporter (DMT) superfamily
MRKDYFTRFFYIILMGFGFPIMRFMSIHFETVNNNAVRFLSGGFLFILICIFKFREELKKILLESKIILKLLLLGIFMSGNMYFFINGNKVGESLNFLKGTLFLGTAIFIQSIQNLLVKNVAKKLHTIVISASTATLSGIIYLILSIHTGKIIQLKEVGEGMLIGLSLAGIYGMLTGMLMAFYIVQKQGVVIFNIIQLLIPVSTAIVGYFTLGETINFYQGIGAIIAIFGCIIALKI
>fig|190485.1.peg.1377 Outer membrane component of tripartite multidrug resistance system
MNAASSFLQRRHPRAVRRLRPILVTTLALALAACASSRGLAPQGTVLEPGAVHAERTFGQAQLSPAAWPASDWWRALGDPQLDALIAEGLQHSPSLAAADARLRQAQARTGTAQADRGPSLSVSGGYAGWQLPESMVGEERGGSYAGSAQVVLDFRYGVDLWGGKRAAWEAAVDQAHAAEVDAQAARLNLSAAIAEGYAQLAYAWDLQDVANDELARAQKTLELTQRRRGAGIDSELQVRQAQARVPAAQQQVQSAQQQIDEARNALAALVGQGPDRGLDIARPVLSQSLPPQLPSALPADLLGRRPDVVAARWRVEAADKDIAVAKARFYPSLNLTALGGVINSDVGKLLESGSVLGVVAPALSLPIFDGGRLKAGLAGSDAQYDLAVADYNQKVLDALREVADQVNAVRSLEQRARAQNDAVQTASAAFGLAQQRYRAGIGSYLEVLSVQEQLLTARQRMAGLHSQQLMASVKLRRALGGGFTPEPARDTAHTATSSAQPHS
>fig|190485.1.peg.2300 Outer membrane component of tripartite multidrug resistance system
MQCTDSLRLARMPLAAALASLLLGGCMLGPNYTKPPAVAETAVQAPTLHRASAADVVAAAPLNHWWEDLRDAQLTQLVTQALADSPNLRAAQARLRANRALANQRRAERLPKLNASALYAYAEPPQTIVDTLGGLQNGQQGQPPAQGSQALNLEKTELYTAGFDASWELDLFGRRRRAAEGALAQAQASEAELADAQVQLAAEVGQVYLNYRGLQARLAIADSNLDKIRQSLALVQQRRGQGAASDLQVEQIATQVQQQQAQRLPLQMQQQEALDQLALMVGREPGALDAQLAAPQPLPMLPTQVRVDDAGALIRRRPDVRKAERELAASSAQIGEALNGYFPQVSLLGGLSWVAGSPSDFNSDALTKLAVPMLRWSIFDFGRTRAQVEQARAGNAGREAAYEGAVLAALQDANTALSRFGSARQQLVVARQAEASATRSAGLMQQRRDAGATSSIDLLDVQRQQLSAQDAAAQAQVQLLVYYVALQKSLGLGWSEPPQAAAR
>fig|190485.1.peg.2301 Inner membrane component of tripartite multidrug resistance system
MNAAAATGERAGGSAGREKAEPGAWLAVLAGTIGSFMATLDISIVNAALPTIQGEVGASGTEGTWISTAYLVAEIIMIPLTGWFVRTLGLRNFLLICAVMFTAFSVVCGLSTSLTMMIIGRVGQGLAGGALIPTALTIVATRLPPSQQTMGTALFGMTVIMGPVIGPLLGGWLTENVSWHYAFFINVPICVGLVALLLLGLKHEKGNWAGLLDADWLGIYGLTAGLGGLTVVLEEGQRERWFESSEINTLSVFALSGFLALVISQFGQRAPVIRLSLLLHRSFGAVFIMIMAVGMILFGVMYMIPQFLSVISGYNTEQAGYVLLLSGLPTVLLMPMMPKLLEVVDVRILVIAGLLCFAAACFVNLSLTADTVGMHFVAGQLLQGCGLALAMMSLNQAAISSVPPELAGDASGLFNAGRNLGGSVGLALISTFQERRMTFHTETIGSAVTANASRAQDFLAGLNAQMQGSAGGEAAIRAVAQLARLVQQQALVMTYSDLFWIFGVIVVCTIPLAFLLKPLPKGTHLAMH
>fig|190485.1.peg.2302 Membrane fusion component of tripartite multidrug resistance system
MSNHDQQSTDGQSTAADGQGNASRDDDAKKPSPLKNPKVKWTLIIVGVLVVVLLVIWLAYYLIKGRYMQDTNNAYLQADSVAVAPRVSGYVTQVMVGDNQIVDAGQPLLQIDDRTYQATLQQAEAAIAAREADIAAATANVAAQESSLVQARTQVASAAASLRFAQAEVKRFAPLAASGADTHEHQESLQHDLERARAQYEAAQAQAKGAQSQIQASSAQLEQAKAGVKQATADADQARVAVEDTRLTSRIHGRVGDKTVQVGQFLAAGTRTMTIVPQQSLYLVANFKETQVGLMRPGQPAEIEVDALSGVKLHGKVESLSPGTGSQFALLPPENATGNFTKVVQRVPVRIRVLAGEEARKVLVPGMSVEVTVDTRSAKDAKQRAEEESDRVQAQERAR
>fig|190485.1.peg.2321 Drug resistance translocase
MSSSVSEAGAAPAPRYPDYRIISLILACAIFMEQMDATVLATALPTLARDFGVAAPAMSIAMTSYLLALAVLIPASGAIADRFGLRRVFSASIWVFIGGSILCSLADSLPTMVAARVLQGAGGAMMAPLGRLILLRTVERRHLVSAMAWTLVPAFIGPMLGPPLGGFFVSYLDWRWIFYINVPIGITGFLLVRRFIPDIPSESAPARFDLRGFVLCGTALGCLLFGLEMVSQEDGIPRASWLLAIGGATALGYLWHARQHPAPLLDLSLLRIDSFRLSVIGGALMRITQGAHPFLLPLLFQISFGFSAARSGRLILATALGALLMRSITPQLLRRFGYRNSLIGNGVLASLGYMVCALFRPDWPPALMFGLLLCCGAFMSFQFAAYNTIAYENVPAARMGRASSLYTTLQQLMLSVGVCAGAMILKLAMLAGDHPQPQQRDFSLAFCVVSLISLSATWWHVRFDKHAGQEMSGHRA
>fig|190485.1.peg.2579 Permease of the drug/metabolite transporter (DMT) superfamily
MSAQPSLQPALGVRDWRTPLELVFLGIVWGCSFLFMRVAAPHFGAAALVEIRLALGATVLLPFLWVARSRFPLHRWPMLAAIGVLNSALPFLLFAWGAQHAPAAVGAICNAMTVLFTALIAFVFFGERIGTRRAVALLIGFIGVLVLATGKSAGLSVGPAALAGATASLLYGIGYNLVKRHMGDLPPAASAASTLGCSALLLAPVAWWQWPSAPVPASAWACAGALGVVCTGLAFLMYYRLIQRIGPARASTVTYLVPVFGALLAWALLGEALTWTMLLAAVLILGSVAFSQRAR
>fig|190485.1.peg.3335 Permeases of the drug/metabolite transporter (DMT) superfamily
MSVAAAPPEAASRRAIWQLLLAEVLIGSVGVFVHESGQDPVTAVFYRCLFGALFLTVCGVLGGHLRGLWRERRLLRDAAISGVLLVLNWVALFAGMARSSIGVATMVYHVFPFVMLILAAVVQGERTRRADLGWTLLAFIGVACSADPLRLWQSADRSYLLGIGLTLLAALLCGASLLMSRRIGRERPLAVVTVQCWVGTLLLMGFSSSAALHPGLHWAWLVGLGVIHSGIVYVLFYSSYRHLHVATIAVLAFVYPLVTLLLDYLLYGHALAPVQWLGLGLIVCGTLAVNLKWRWPRWATGKAVLQR
>fig|190485.1.peg.3360 Nisin-resistance protein
MQIPEQANRLAIGVVLAGDGAVEVTALRLMAQPVVDAASAAAILDVAIPAIREHALQRSRIDWATREPQLRAQAASMRKADAYAAIEALIAELDDGHSALLRPSTLRDVEAHATHATVQARLLQPDVGYVAVPGLMTSSSDVRGDYQRALSAALDGMASQARCGWIIDLRQNSGGTMWPMVNGLQPLLGDHVLGYFLNADGEQTPWRARAVPPMSGVRVAQTDRPVAVLIGPNTASAGEMVAIAFRGRPATRSFGQPSAGQTTSNRTVDLPGGGVLAVASSAMQDRNAQRLDGALQPDMALDPQADAIDAAAQWLRMQRCAPAQ
>fig|190485.1.peg.3610 Daunorubicin resistance ABC transporter, permease protein yadH
MNLHAIGAIYRFEMARAFRTLTQSIASPVLSTSLYFVVFGAAIGSRMGAIDGISYGAFIIPGLVMLSLLNESISNASFGIYMPRWAGTIYEVLSAPVAWWEIVIGYVGAAATKSVMLGLLILLTARLFVPYEIAHPVWMLGFLVLTALTFSLFGFIIGIWADGFEKLQVIPLMVVTPLTFLGGSFYSINMLPPIWQKVTLFNPVVYLISGFRWSFYGKADVHIAVSTGMTFLFLLVCLGVVAAIFRSGYRLKA
>fig|190485.1.peg.3796 Mitomycin resistance protein
MHPAKVDRAHLLRLTDLPNVGPACEKDLQQIGCRMPAQLHGRDAYDMYAQLCLRTGVTHDPCVIDVFLSLVRFMQGEPARNWWDFSAERKATLAAERTGTRATAPPPGRRVANTSTSTGASSDGKHRP
>fig|190485.1.peg.3862 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSHNAAAPAPARNGLVVLALLLVYVVWGSTYLVIRFALAGGAQPLTMVSGARFIVAGTLLYAVLRWRGVAAPTPAQWKNVAFMGAALLLLGNGMVVLAERSVSSGLAATAVASVPLWMALFGALRGQHASRGEWLGIVIGFLGVVWLNAGSSLTATPGGLVLLLIAPIGWAFGSVWSRGRDLPTPFMTAAGQMLCGGVLLVSTGLLLGERPHAWPTTQGLLAVAYLCVFGSIVAFTAYVWLLHHVRPALAGSYAYVNPVIAVSLGAWLGHERFSAHDIGAMAVILCGVLVVTLAKARR
>fig|190485.1.peg.4053 Bleomycin resistance protein
MHTAWAVTPPMIAVMCSALIPSTEETRMNASANVGDQTIPILPRRSIAQTLTFYRALGFAGDAHPHDAGYAILQRGDVELHFFAHPDLDPAACYAGCYLRVTDVDGVYAAMRAAALPAQGIPRIDPVGDKPWGMREFAIVDESGNLLRIGQQLEP
>fig|190650.1.peg.105 Multiple antibiotic resistance (MarC)-related proteins
MTEANLAVNFFVALFALIDPIGNVPLFAAATLGAAAAGRRMVAVYIGLFMAAFLIFFYFTGVGLLEFFGISMPAFRIAGGIILFILGLDMVRDDFTTMFADAAEGIEDQSPRAYAKQRFERLIVPFAMPLLIGPGSISTVIIYAAEAKDFGAAGMGIGVAVIAAVSLVTVLTFWASPLVSKVLGRIGMSIVVRVLGLILCALAVQFVLVGVADATRGLIKNDAKAPYAESHK
>fig|190650.1.peg.380 Multidrug resistance protein
METRFVTPFHHLLVNNLVANITNFTIWFALTFYVYLETKSVFATGMIAGVYLVLTAACGIWFGSLVDHHRKKLAMAGSSLASLLLYALALAVLLLAPKGAIADVGRPWLWALIGLSMLGVIAGNIRTIALPTLVTLLIPEDRRDKANGLVGMVSGVGFLTTSVISGFLVAWGGMLAALTFALGFTVAALVHLLTVPVDEPRVEAEHGAPVAPRRIDLAGTIKVVAAVPGLFALILFATFNNFLGGIFMALLDAYGLSMVSVQAWGLLFGFLSVAFIISGLAISKTGLGKNPLRTLLLVNLISWAVCCVFPLKSSIVMLAMGCFVWMLLGPYAEAAEQTTLQKVVPFERQGRVFGFAQSVEQAASPLTAFLIGPLTQFIVIPFMTHGAGAAAIGDWFGRGPDRGMALVFTLAGVVGLIVTLLAFGSKAYRQLSAAYAQGEPAPAA
>fig|190650.1.peg.1274 Tetracycline resistance protein
MWRARRGELSNCCVSSHRRLARGRVRRLRRRHRRLVAAQWAVRLHAALAGRDGLRGWPAGGAFAQWQGVRGRRRQRLGARRATGVRLASGRLHPGHEHRGRGPFRSGGRGDPRHGRASRLGQRACAARGASWLSQCGFPGPTWGMVAQPSGRACGAGQQRPPRGGRRGAVMNTTITGGRRQAALGFIFVTAILDVLSLGVMIPVLPNLVKAFGGGDTAAAADWNVLFATTWGVMQFICSPILGLLSDRFGRRPVILTSIFGLGIDFLFMAFAPNLWWLFIGRIFNGMTAASFSTASAYVADVTTPENRAKGFGLMGAAFGIGFTFGPALGGWLWEFDHRAPFLVCAALALTNWLYGFFVLPESLPPERRQPRFDWKKANPIGSLQLLRHHPGLMGLAGVGFLFQLAHNVLPSVFVLYMGFRYGWSPQTIGLTLMASGIASILIQAFVVGPAVKRLGERGVLLIGLFAGFLGFSIYALAPTSLLYLAGLPIFAFSGLIQPGLQGLMTRRVGPNEQGQLQGANAAMMGIASIIGPPLFLIPFAFAVRHDATLHLPGLPILIAAVLMLAATLLAYAKAKPAPAPEPQPA
>fig|190650.1.peg.1512 Antibiotic acyltransferase
MFNAGTGFAQASATPVLSRDGPLDALRFLAALFIVLYHVAERAPVSLFSLSPAFGRGYLATDFFLMLSGYVLARTYGARVANSEVDTWTFLKRRVQRIWPPHLVMLALFVAFFLATTAVGLAPQNPQWFQWDPLLPQIFLVQAWFVPGTSGWNMPTWTLSALIVAYALFPMVWRKVAASSRPLRLLAMGVCAWVIIDQAALMAFGVHGYQLPLRFGLIRGVPLFLIGVLVARLPVTRLAEQQALPLAVTSLAIVIGVQALGNFDYFSLALLAFLIYAAGASKPRAWRWAGAAGRLSFPLFLTNTLTAVVWFGLVRMLDAKLGLPIAAQWTLWALAIPATIIAAWLFERLVDAPLQTWIKSRSRSGGALAVGKMREASA
>fig|190650.1.peg.1613 Antibiotic hydrolase
MHVTRDVMVTMRDGVRLAIDIYRPAIAGEPTHAPLPVLLERTPYDKRGTNHGDRTRDDPIPKSKPDLAVQFVRGGYVVAIQDCRGRYASEGVFEKYLGEGADGYDTIAWLAAQPWCDGRVATYGLSYGAHVQSAAACLAPPALAAMFLDSGGFSSAYHSGIRQGGAFELKQATWAYKHALLSPETQRDPARLAALEAQDLKAWFTRMPWMEGHSPLSAAPEYEKYLLDQWRTGLFGPYWTQTGVYARGAYDTYADVPMVHMSSWYDPYAVTATENFLGLSGRKRSPVKLILGPWTHGQRSVTHAGDVDFGPEATLDGALAKDYVALRLAWFDAWLKPDQHAKDPLPPVKLFVMGGGSGRKTPEGRLDHGGHWRDETAWPPQGARVTDFFLSATGGLSTAREVVDEAFLEYVHDPLNPVPTIGGAIASGAPVMEPGAFDQREGPHIFGCLPPYRALRDREDVLAFETPPLETDLEVIGPIRARLFVSSDGVDTDFTVKLIDVHPPSEDYPDGFAMNLTHGILRARYRERFDWETWMTPGEVCFIEIEAFPTANRFLKGHRIRLDISSSNFPHFDVNPNTDEPEGYGFTPRRAKNRVYMDAQRPSRLLLPIVTR
>fig|190650.1.peg.1652 Multiple antibiotic resistance protein MarC
MDFSPLPTSSLIGAFLLAFPALFSIVNPVGAALIFDQAMGGRSRPERLKLARAIGFYAFLVLLGSLLLGGYILNFFGVSIGALRVAGGLVVAIRAWGLLMDPEQNEDRKVNQTESAQSHHDVAFFPLTMPFTTGPGSISVAIALSSQRPTEGDAVAPFFIGASLAAALVAVLVWLCYSASGQVMRLLGPSGARVLSRLVAFLLLCIGVQIIASGVENLVAKFLLAHPG
>fig|190650.1.peg.2761 Bleomycin resistance protein
MTDHATPNLPSRDFETTARFYAALGFEQGWRDDGWMILERGSLTLEFFPYPDLDPASSAFSCCLRLDDLDGFYAVCKATGLPETTLGWPRLHPPRDLGPIIMAALIDPDGTLLRLIGNDA
>fig|190650.1.peg.2870 Bleomycin resistance family protein
MTNFIQVTPFLHVPDLEAALVFFVDLLGFEVPYRQPGYAYVHRETVGFRLLQADEATVTPRGAGGFAYYIDVRDVDAVVAELTPRLAALPPEDVHGPVDQSYGQREFMIRAPDGGLLVFGQAIDD
>fig|190650.1.peg.3644 Permease of the drug/metabolite transporter (DMT) superfamily
MRSRGEPLPAGGRMKTLAFVALALAGISWGLGFPTGKLILRETDAAHMVLLRFLVAAVAAAPFALRRPEVRALFRSPIVLLAGALYGVAFLVQFEGLAHVSVTVAALLVGAMPALIAVSARVLGEKVSRLSWAGVAAATLGAALIAGKPDGASSPLGVALSIAALFLFLTWLLVLRRAPPAPNPMAIPAVSIIVAALVVLPIALIMHGPPKLALSAPAWTAIVAQGVLATLLATAAWQYGAAQVGAASAGVFINIEPLMGAACGVLLFGDHLTAALFAGGLLIIGGSFAVVMGERQAKPGEIQATVAPTP
>fig|190650.1.peg.3688 Membrane fusion component of tripartite multidrug resistance system
MDDCVHLSLVCCAGPDYPARLLSFDKGLAMAASEKKKLVPLIVGGVAIAAVLVGGTLWFLDKQHFESTDNAFVQADTVQVSPQVSGYVAEVLVADNQRVEPGQVLAKIDPSTFQARVDQAIANAAAADAAVRAIDDKNSLEQAVIAQRAAGVTSAQADASRAKADLDRYNALADQGWVSQQKVQTTRAAATQSAAGVASAQAALEAEKRAAQSLGSAKAQAIAQAAAAHAAVEQAKLDLERTVIRAPVSGVVGARAVRPGQLVQPGVALMSVVPLGQAYVVANFKETQVARLRIGQPVEIKADAFGKEKIVGKVDSFAPATGQEFALIPIENAVGNFTKITQRLPVKIAVDRSQLGAALRPGLSVEIKVDVRDRSGPSFAEAAQVTPQVARQGAAR
>fig|190650.1.peg.3689 Multidrug resistance protein B
MADAALPADSPSAPATPGATAPVDWTKLFLGFGAMVIGQFMAILDIQIVAASLPQIQAGVGASTDQVSWIQTAYLIPEVVMIPLSGYLSRLWGTQKLYLASCAGFIVMSILTGLSTSIDMMIITRALQGFIGGAMIPTVFAVAFTAFPPERRVTASVIMGLIVTLAPTVGPTLGGHLTEWLSWRWLFFINVPTGLIVLFGVARWGDFDKGDPSLAKGFDWFGLAVMAVFLMSMQYVLEEGAKEDWLSDSLILWLTVVAVFGGVVFVWRQLTYRNPIVELRAFANRNFTVGVLMTAVSGASLFGGTFLLPQFLGRVRHYSASEVGTTMVISGLSMFLTGPIAGRLVRKTDPRLPMCVGFLLAGFGMYMAHGVTKDWGFWEFAGVQACRGVGVMIAMIATQQITMSTLPPHMVKNASGLVNLSRNTGGAIGLALLATSITQQTALYYDDLTSKVTQGSAAAGMIAGLTERMMQLGVADPAGAARKAVGGMMQQQATVMAFGDSFTLLAIGCFIAAAVSLLAAPVKNAPPPPSDAH
>fig|192952.1.peg.702 Multidrug resistance protein B
MHPDRRLIYVAVFAIMGLSNAVIPILPELAARYHSMYGEFASSLLFSGYFLGALATMLPFGILSDRFGNLKFIGLGIALTVVSGVFIFLSENLWILIFSRFVEGAACGAFFPAAFSSLSKCKDPGRCMGEFTFLFNAGLAAGALFSGLLADIFLKSAVLIFTLFALLSGIPLLYRLEELFNPKKTGTNPKSLSGQDSLKSHFKHSFIKITGLISRRNSGIWLGSFLLNGAVGVLIAYYPDYSLEILSKARLGGAIASLYICAMVTSLLAGRFKVKEKTIIRIGLAFSALGAFFAIKYPFFGFSSLGGGSGVAMVGFALAVARMNADRGLAMGLFNTTIYAGLSLLPIVAGFLTETLSLKELFLVNGCILTVALLLKN
>fig|192952.1.peg.2552 Quinolone resistance protein
MKTSIPGDGSMLESRIIAAQSDDSYIERMRFEGDILSDVDIARIEFESVQFIQCQFSKCDFSKASFYNSVFDNCNFANCIFMESYWKGSRILTCKGDGSNFSKSHMKETFLADGSFRYADFSSSLMENCSIRDCNFTEAFLSEIRLKKPTLKAVNFAGADFFKTLLKGIDLSDCIIDGITVSDTRNELRGAIVNAGQAIELAARVLGIKIV
>fig|194439.1.peg.104 Inner membrane component of tripartite multidrug resistance system
MSSTATTIPGAQALEHHYETGARKWIITATVIIAAMLELIDTTIVNVALNHISGNLGASIEDVSYVVTSYAIANVIVIPLSGFLGNLFGRRNYFVASIVLFTGASFLCGISTNIWMLVFFRFIQGIGGGGLLPTSQAILYETFRPEERGAATGIFSMGLVLGPTIGPLLGGYLVDYFAWEWCFFVNIPIGIAAAWASLTFVKEPKVKPVVEKIDWAGIGLLSVGIGSLQFVLERGEQKDWFETDYIVWFTIIAVVSLIAFVWLELHTDHPAVDLSVLARSKNLAIGAVLTFIVGFGLYGSLFIFPVFVQRLLGFTALLTGLVLFPSAMLTGIISMPLGIALQKGASPKLLMTVGMVAFFWFCWELGNQTLMSGAENFFLVLLIRGFALGFIFIPVTLLAVTGLHGKDIGQATGLNNMVRQLGGSFGIAITNTYVTQRVAAHRIDILSHLSPYDPAAVQRLQDMKQALGQYMSSPVEAGQAAMAALEGIVVRQSYHLAYMDAFKMIAILFAVCLPLLLFIRVDKKETVDMSSVH
>fig|194439.1.peg.105 Membrane fusion component of tripartite multidrug resistance system
MAETQQSNIEAPDNEKGKPKPERSMGRLVIFGILLAIGLVWGGMKLIRSLSYEETDDAQIAGNIYPVIPRVPGKVVEVLANDNQMVKKGDVLIRLDPSDYQIKRDMAEAQLLKARAAVSGAKADIIAAAAAQIKLAADLRRSQNLQKQDVISRAELDAATAGATAASAQHAAAGDNYKAALAQAKLAEAELKNAELQLSWTTITAPADGKVSKKNVQPGQYVTPGQQLIAIVGSGDLWVVANFKETQLEHMRPGQKVIIKVDAFPGKELKGHIDSISAGTGAEFALLPPDNASGNFVKVTQRVPVKIVFDEKTDLPLAAGMNVIAEVKVK
>fig|194439.1.peg.107 Outer membrane component of tripartite multidrug resistance system
MIAVSFSAGEPLLAAETSGAPLTLDEALRMTREHNPKARQALEELNAADAKVTESRSAWFPQISGKAGYTYLDPVSEMTFGGLAMKFMPNNNYNARFTAEMMLYDFGRTASTVDLAKAARNSARLRQDMTLRDLSLATVQAFYSVLFLQEAVRVQQKEVAALQTNLDHMQKRYDQGAATRFDLLTTQVRLAGAANREIDYQNQLRNQEITLRRLCGLDEKAPLSLKGSFDITAADMDADKLAASALDHRPEVMLARENFKAASYKKNLATREFLPKIVGSASWGSTNGYVPDLDKMRTNVAVGVELQVPIFDGFRKSAALREATAMKRSAEQQQLDAEQVSQAEVRQSVNDLKSSAEKIQTTRLQVSQADLAAKHARIRYDNGLATTLDLLDAEAALAEAELANLQARYEYVMNAYSVRRAAGDLIER
>fig|194439.1.peg.360 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKLSVVIPLMNEAESIGPLFDALASALQGIDHEIILVDDGSTDSTVAEIKRLAPANARLVVLNKNYGQTAAMSAGIDEAQGELIATMDGDLQNDPADIPMMIAHLESKGLDVVAGRRAGRKDGMVLRKIPSKIANAMIRNLTNVHIRDYGCTLKVFKRDVAKNLGLYGELHRFIPVLVQLYGARMEEVDVRHHARKYGKSKYGIGRTLRVLSDLFFMVFYQKYAHRPMHLFGSLGFVTLFLGLGINLYLLVLKILGNDIGGRPLLSLGVIMTFIGIQLITTGFIAEFIMRTYYESQNKKPYIIREIIDKSK
>fig|194439.1.peg.1268 Multidrug resistance protein, FusA/NodT family
MKKRNQVMKRAVPLLLMTLLATIGLTACSPVGEYRRPEVRLPESYPGQTAAGKEMAAVPYRKFFADPDLLELIDSAVENNHDLLIAMKNIDYAGKTLDVAKLWFLPEVDLSATYDYSRGSRNSASALKGQARTSRNYTAQLNVSWEADIWAKLRNAKKAAVAEYLRSADVARAVRTTLVSNVAQGYWNLKMLDEQIDITKRNIALADTTLTMMRLQFDAGNVTSLAVDQQESQLLSAKATLPKLEASRTAQENALSILAGRMPGTPIRRSTGYAPFVMPDSLGAGVPLALLSNRPDVRAAEESLMEAHALTGVNKAMMYPSITITAQGGLNAIESSKWFSTPGSLFNALQGSLLQPIFQHGQLKAQYEQSKIKRDQAELTFRKTLLVAVGEVSNALAQVEKTGEQETFAKARVAALRKAAGNSRLLFNSGMATYLEVIAAESSLLQSELELADVQRSRLSAIADLYRAVGGGWRE
>fig|195099.3.peg.345 Multiple antibiotic resistance protein MarC
MGSELYLMFFAAITLLAILNPFGNLTQFLAMSDGLPLMLRKKLFRTILYTAFTIVLVFLLSGPLFMNYIFRVSLDDLRVSGGLVLIIMAIKNLLFSTKIATKDFSSYQDMDDKEILRQSLIPMAFPMLVGPGTLASVIVIAEDGGLDVALGGVMIAFIFMFILFHFAATIEKIVGKLILHVFSRIAQVFIVAMGFKMIIVGLKDIFNL
>fig|195099.3.peg.699 Broad-specificity multidrug efflux pump YkkD
MEWFYLFLATACEIFGVVIMKELVNTKNKLYFLALIVCFGFSFTFLSLSMQNIAMSVAYAIWTGAGTAGGVMIGVLFYKESKSFLKLFLITVIIACTVGLKFLS
>fig|195099.3.peg.700 Quaternary ammonium compound-resistance protein SugE
MNEKFNINIAWFLIILGGIIECFWVSGLKYSTEIWHYILTAIGVCISFTCFLKACERLEVSITYSVFVGIGTIGVVLNEMFIFNEAVSIIKLVLIAILLLSIIALKWVSKEA
>fig|195103.9.peg.85 Drug resistance transporter, EmrB/QacA family
MEHVIKKGENAQEVKYNKWAILFCVVTMTFMSCIDGSIVNVALPKISYDLNKPILDTQWIVTTYLMVISALVLLCGRIGDIKGKCKVFKVGVLIFTIGSFFSGLSKTLPLLIVSRAIQGVGGSCAMATGMGIITAFFNEKERGKAMGLSASAVAMGVMVGPALGGILVSIRWDLIFWINVPIGIIAFLLSMVYLPKMETNSKEKIDIRGTIVFAIFIVSSMLSITKGEVLGYTDKYIMLGFIVSIVSFTVFIYLQKTVESPVLDLNLFKTKLFSLSIVCSALSFLAISSMNIIIPLYLEQALQMSSLHAGLFLMIYPLCLSIVAPLSSSLSDRFNGRLISLIGISLLTVALFFMGRININSTLIYLGTCCAIMGVGNGIFKSTNNALVMEKVPKHRLGIAGSVNSLVSNLAMAYGFTFATTILYGRMSYRLGYKVTNYIPGHEEAFLYGLDCVFFSATIMCLIASVVAFIRYRRKDI
>fig|195103.9.peg.161 Daunorubicin resistance transmembrane protein
MDFFKTIRVYSSFAKGTFKALSSYKANLLMGLIGQLIMISVTYFLWIAIYSSSQEGIMNGFTLKEMLTYVMITLLIGIVTSNDISQEISFEVRDGSISTNLIKPINYRLRIIFIGIGNFIFFFLTLFLPGAILISTYAILNGININLASILIFSISIILGCLINIYYSYIFGLLSFKFYNIWGISQIARAIIMLVSGAMIPLTFFPEIVQKLFNFLPFSSIIYTPAMIYLNKLSYAQIAKSLGLQLIWVVILMVLSKIMWNKVIDKLTIQGG
>fig|195103.9.peg.723 Permease of the drug/metabolite transporter (DMT) superfamily
MKLKGIILTMLSSITFGFAFTLGPMTYGLEGSNPVTLTFLRNFLSLPFLLVIILLLKIDLRVTKKQLRDLIILGFVGNAITTLMLNMAFACIDVGIVTPIHFTYPIFVTLGCVIFFHEKLSKQKVFALIIAMSGIGCFFITALNSASFGKSTLLGLILAVASGMFYAFYIIFMDKSGLKSEPPFKITFYVAIASTVGMFIYGMLTKELVLSSLTHKAWGLSAIFAFLCTVVALSLLQVGIKYIGASEAAVISTFEPITSVIFGAILLGEEITLMKIIACSLIFAGVLILSFAKEKSKSNIKIKESVTN
>fig|195103.9.peg.1399 Drug resistance transporter, EmrB/QacA subfamily
MNNANENSKNTEDLVYKNRWFILAVLVMQPFMACLDSSIVNVALPILQKELGATMAGTEWIVSSYLIIISASILIFGRLGDMHSKSSVFIKGILIFVLGSFLCGISPSLPILVLSRVVQAIGAAMLMSTNQGIITDVFPPKERGKALGISGSFVALGSILGPALGGFIVTYFTWHYIFLINVPIGIICYIFAKKYLPIRIPKESESMDKPGATMFFIATILIFTSILISQHLGFTSIYVILGLIIGLIILALFLIYENKIKNPMLHLSLFKKPIFSVSLICAFISFTAINTINVIQPFYLNDILGYSPGKISVIMTAYPIVLFVIAPLSGTLSDKIGSKILTLIGLFLTGVSMILLSSLNSNSSETSIFLMLSLLGFSNGLFQSPNTNLIMSSVPKDKLGIAGGTNALIRNLGLAFGVSASTSILYAKMSKLAGFRVLGSVPNRPDIFISGMRFVYILVAISCFICLIISIAEYIQSKKNNK
>fig|195103.9.peg.1433 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNQYELKNEKIGRLLLKYSLPAILSMMVTSLYNTVDRAFIGSIKDIGAFAISGLGVTMPLFTILGAFCVAISVGGSTNISIKLGEEKKEEAERILGNTFILSIVVALIIMIFGFSFLEKILYFFGASKETIIYAKDYMRVILIGAWFNFPGFALNNAIRAEGNPKLAGKIMIISCVLNIILDPIFIFLFHMGIKGAALGTIICQFIVFLWTMYYFTLGKSNLKLRIKGKILNKNILRAIILIALTPFFMELAAGFIHLITNRVLKDYGGDLAIGAMTSITSIYLLFLMPVFGLSQGMQTIVAYNYGAKEYKRAKKTLLMTIIIATLILTLGLVLIRIYPREFINIFTKDKELINIALNGLKIYTLALPTLGVSILGAVYFQSIGNVKKSIFLSLLRQVILFIPIIFIIPRVYGLNGVWISQPLADILATVLILIFLIKEFYIRDTHDLICRAERT
>fig|195103.9.peg.1469 Vancomycin B-type resistance protein VanW
MKEEKKKSSTGLLKSKKKIIISIVIVLAIIIGSIVAYIVSIQKKVEEWNDKIYPNVYVENVNLSGMTKEKAIEVLEKDVKEPVEHKTIKVQAADKSIEIKYSDLSPEYNIDETVNEAMNYGKDLNLFEKNNLINGKDKKELNLDFKYDESKLTDYEKKLTEMVNQNAKNATISINGSNISVIEGEDGRAIEEDKMVSLVKEAINANPEDNSVVEVPVEVTKPKITKEMLSKIDGVIGSFTTSYTSSDANRSANVEIAAKTVNGTILMPGDTFSYNNTLGERTTAKGYRDGAAYVGNKVVMVTGGGICQVSTTLYRAVLRAGIMPTERHNHSMTTTYSGPSEDATVSWGSLDYQFKNPYDFPIYIQGYTSNKHVTFNIYGNVQGMDGKTYELQTVVNETLKPSVKTVDDPNLPEGQKVVEQRPVTGYKSSGYLVTYQNGKEIDKKLIGHDVYKQKDEIIKVGTKKAEQPKQEAPKQEQPATAKPEEPKQEATQPSTSQPATNQAPDATPQTPNAGQTPPAQ
>fig|195103.9.peg.1678 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKKLDLLQDKESTLLRKYMIPSVAGMLGLSVCILFDTMFIGHKIGELGLAALNIALPIYNLYSAIGLTIGVGGATALSVAMGQKKFHRVNRIFTSAVFATIIFCIIISLLEVFFLDKIVYMLGASEATFPLAKEYLKIILAFNPAFIFASAFIVFVRNDREPKLAMYAVIGSNTTNIVLDYVFIYIFNLGMFGAALATSIGQLVALGVLSIHFIKKNNTMHIELGGINLDNIGKVLKNGVPSFLNEISAGFVIFIFNIVIYKFEGDLGVSAYGIITNIVLIFMAVFNGVSQGVQPLISVNFGAKKEERVKEFLRLTRIIVLILGVGFLGMGLLLPNQMIGLFTSDRGRLLSITRQGIYLYFIAFLFNGSNILNIAYLQAVEKSKESSLLSTLRGLVFVIIFIIVLPRIIGVYGVWLTIPITELSTLLLFLIFEIKSKRKNI
>fig|196162.6.peg.203 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MMEPTTTSHEASGSAIELTGLAKTYGRGATARPAVRPTSLSLPWGQVLGLLGPNGAGKTTLIKMICGLVTPTAGTVRVGGWDLAADRSRAVLQIGAVLEGSRNVYWPLSAWENLLYFGRLKGLRVAEVRPRAERLLRDLDLWERRQEQVGSYSRGMQQKVAVAAALITDPPILLLDEPTLGLDVESARIFKDWIAHLARDDNKTILLTTHQLHVAQELAGRSAVIRTGEIIADLPTGELLSRHAENRWEIRLAGSIDRIADALPGGAVTSTEHDQTRVLLPDDTTTLYAALDRLRAADARLVSVQKAQPTLEEVFLRVLRDDAAPSRIAEEVASS
>fig|196162.6.peg.390 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLVQIAQRADDLERATAFYTLLLGSPPVATYEPPGLVFFDLGGVRLLIEHGAPSATVYLRVEDIDAAVAQAREAGTEVASEPHVIFAHADDTLGPRGTDEWQAFIRDSEGNLVGLVEHRPR
>fig|196162.6.peg.1052 Glyoxalase/bleomycin resistance protein/dioxygenase
MLNRLFHIAINSTDLDRSVAFYQRLGFQALQDRSVRNDMVKEAFAVPSGDLRFVHLRLGEDDNATILDIVQWFHPDTEDTGTEPVAQHQRGLTRFSVLTDDTQAVYDELAAEGVEFITKPTVVMTPEGGWKVALVKDPDGVVVQVTELLAAPAAG
>fig|196162.6.peg.1088 Tetracycline-resistance determinant tetV
MGPRSLLGGEKGLWAGSGVGRVRVRVQLESDGLGVAAVLVGDGDLVAGPVGPDGGDQGVGAADQLVVDLGDDVALRQAGVVRGRAGVDVLDLGALGHLGSGPARDVGDGDAEAGVGRGLAVDHLVDDRHHLVHRDGEAEPDRAGLPLHGAGGADRGVDADDVAVEVDERAAAVARVDRSVGLDRGVRRAVALAVGADVHRPVQRTHDAAGHRRVEPERGPDRHDALADLEVARLPDRRGRQPGDVLGLDHRGVRQGVGAEDLGLRGGAVVEGDPDRPVVAGELHHVVVGEDLAVGAEDDPRARTGALGAGHVDLDHRRQHLGSDLLDGAGRCLGVGGVDDLRRRAAAGAARARRASIVERAPGGGAADPCRAAGHQRGRDDRGGEAGPARTTLPRLRVRRHPGRRALGRRTQRRRGGEVRVRRSRRRTGGLVVHVSTMGGQPVTFLRPFWGGTKNSTPVRREFRATAGGGTGLNAPVTSLDSLGTREDRLGPLRFRNFRLLVTGSATSSLGNAIAPVALAFAVLDLGGSATDLGLVVAAYALAEVATVLFGGVLGDRVARQLMMEGSNAACALSQATVAVLVVGGWATMPVLAGFGVVNGCLGALSGPSSSAMTRMTVPAERLASAVALRGLLQTSAAVVGFAVGGVLVAAVGPGWAIGVDAVTFAVAALCFGRLDVPHTRPEGARPSFVSDLGEGLREVLRHTWLWLLIGQALLYHLFYGGAQSVVGPIVMEDGFGRSSWGLALGTLMAGFVVGGLVCLRWRPRRLLHVGTALLSLTAAFPLAMALSDRLGPILVGAFVHGVGLQVFDVFWQLAIQENIAEDKLARVYSFDLVGSFIARPVGLVLTGPVAQAVGFHRWLVVVGCVMGGSALLSLLSPDVRRLERRS
>fig|196162.6.peg.1169 Glyoxalase/bleomycin resistance protein/dioxygenase
MALTESAVAVMLPTKDAARAQEFYEDRLGLPFAGSNETTGETTFRLSGGSQLVLRLLPDAAPSPNTAMSFEVDDIGAEIATLEGRGVAFEDYDLPGFATVDHILDQHGMKAAWFLDPDGNVLCLHQPG
>fig|196162.6.peg.1358 Vancomycin B-type resistance protein VanW
MARVNQQPTVPAREKEGGKVVLLMLAGLVLLAGAAYGALYLAAGDKVPRGTTVAGVDIGGRTPADAEEVLRTGLADRVDRPITVAAEGARSTLDPGEAGLTVDYAASVAEAGGGRSWSPGRLWDYWTGGDDLDPVLDVDDAAFDAALDKLGEDLGTPPVEGDVKFRDGKVVVTDPATGEEIHPEAARLAITTAYIAEDATDVELELRPADPEVDAADLQEALEAFANPAMSGPVTLVFGDSPVRLDPADFGKVLGMGAEDGELVPDLREKKLVKLVDRGISQDGAPVDATVALVDGKPKVIPAKPGVTYKPSDVSDAFLELVAREGDREMKVPSTVAEPDFTTKDARALKIREQVSTFTTYYPYAEYRNINIGRAAELIDGTVLKPGDEFSLNGIVGERTRENGFTEGFIISDGIFKEDLGGGVSQMATTTFNAMFFAGLKDIEHKPHSFYIDRYPVGREATVAWGAVDLRFENDTPYGVLVHAHVTPATSSSQGVVTVSMYSTKYWDISTTTSDRYNYRQPATRTLTTPDCYPNTGYAGFDVDVTRTFRRHGEDAVDHTEKFHTAYTPSDTVICKKPKQRGD
>fig|196162.6.peg.1427 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNVPGAPTWIELFAADTDTARTFYGELFGWTVQGSGPEYGGYAQFLRDGAPVAGLMRNEVGLPDTWSVYLRSTDVAATVASARQHGGQVVVEPMQVGDLGHMAVVADPSGAAVGVWQPLAFEGTAVRAEVGAPSWFELHTTDYPAAVAFYRDVFGWSTHQMSDTPEFRYTTLGRDDDALAGIMDATGHFDGAPSTWVFYVQVADADATVARAVELGGSLLPDSGPHDTPYGRLAVLADPAGVQLSVVGPNRG
>fig|196162.6.peg.1799 
MFVNLVRFPALVEGREAAFVEWFERSNKVYRDFPGFVLRRLLRSADGSYAAVVEHASELTFMAMHTSPERQQMWDEVEPLLQGRPEPAFFEVVDEVLPESCSLEDRS
>fig|196162.6.peg.2031 Permease of the drug/metabolite transporter (DMT) superfamily
MSKRTSRWALAAFAVVGFIWGSNFLFMKWAAEEISPRQIALLRVAFGLLPVLALGLARREFRRWHLRHTVHFAVMGVLATSLYYVLYAAGTERLPSGLAGALSGAIPLFAFMVGAVALPTEPMTPRRVLGAFLGLAGVVMMARPWNVHGSVDPVGVLLMVTGSACVGASFVYTRRFITGLDIPPTALTTYQMALGLVALLPLTDLHGIGAIRGDHRALVGLVLGLGLVGTGLSYVIFYYLIAELGAATASAASYLPPVVALAIGWIGLGEPLRHADLAAVALILLGVAIIRAGARTYRAERGTQ
>fig|196162.6.peg.2738 Permease of the drug/metabolite transporter (DMT) superfamily
MTATLRRELPSVRIGLLQVFAAGVLWGTGGLVVTVLHERDGLGAMTVSAWRMALAAAALIAFSALTGRWARTRAALRAHPVLAVLVGGGTAAYQGLYFLSVLMVGVSVATVVSLGLAPVLAAGWEHLVERSTPSAREVLVLAAALGGLLLISGTAGDRADAPGDDPTLGLLLAVLAGVTYAATTVLGHTLAKRVDPVALTTCATGAGAILLLPFFAVAAARGEPVLSSDPVSTTLLIYLGVATMALSYGLLYAGLRTTSGSAATIATLVEPLSAALLAAVLLGERLPWPALAGGVLILAAVVALRPTEDLSPVGAP
>fig|196162.6.peg.2940 Glyoxalase/bleomycin resistance protein/dioxygenase
MEVGPMSDEGSYGSVRYVVRDVQAAVDFYTTHLGFTVRSHPAPPFADITRGALRVLLSGPASSGARATPADVDGPGRNRIHLLVDDLAAEVERLSAAGVPLLTDVVSGPGGQQVLLADPAGNLVELFEPAVAPARIGP
>fig|196162.6.peg.3399 Antibiotic efflux protein
MTSLAEIVAPRRLGTGFRWLLASSWVSNLGDGLALAAGPLLVASQTHDPFLVALAALLQWLPPLLFGLYAGALADRLDRRLIVVTVDLLRAVVLVLLTLAIATDLVTITLVLVTMFLLGTAEVFADNTASTLLPMLVHRDDLGVANARLTTGFITVNQLAGPPIGAALFAAGHAVPFVAQAVVVALGALLAAQIALPPHGRSRDERPQLRQDVVEAFRWVLHNAAVRTLVLTIFVFNITFGAAWSILVLYATQRLGMGEVGFGLLTTVSAIGGLIGTLAYGWITRRVSLANIMRAGLVFETFTHLALALTTRPAVAMAIFFVFGAHAFIWGTTSTTVRQRAVPGELQGRVGSVNLVGVFGGLVIGSGIGGGLAQHWGVTAPFWFAFAGSAVFVVLIWGQLVHIAHADEQGQPAGA
>fig|196162.6.peg.3936 Acriflavin resistance protein
MRNAAGPARPARPHHRHGALQDLPVRRLRRPSHTPLGAQPDAADHRPRPRRAHHRRRDHDARGVRPEPDVRQPRRHRPVRARRPHRHHAARRPPARTGRHRPAGPAVPRRAEGPGALGPVDRDRAGGPLDGLVDPGPVDRPDRAAHRRPAARRAGPDRRQRRRRPPVLDRPRYPARRGDRTDADHRAGPGGGARGVRTHRPLAAPGTGGR
>fig|196164.1.peg.2608 Multidrug resistance protein
MQHFHKVLVNTLIFNVVTGFLAYSLLFWVYLETRNVALAGILNAGYMGALAVTSIFFGSIVDHNRKKTVMMASSCMTLVLFALAGVVWVLWMDSATISLDSPALWVFSILILIGSIVEHLRNIALSTVVTLLVPEDRRDKANGLVGVVHGMSFLVTSMMAGMAIGFFGMETTLWVCLVLTLLAVLHLITVEIPEPEIVTQHADATVPIAPAPSADGEVFTPNPVPSDLHTVSRGLDIRGSLAIIRGVPGLLALILFTCFNNLVGGVYTALMDPYGLELFSPQVWGVMLGLTGLGFIVGGMIIARVGLGSNPVRTLLLVNVGIAIIGIVFTIREWGWLFVAGIFVFMLITPAAEATEQTILQRVVPFRQQGRVFGLAMAVEMGANPLSAVIVAVVAQAYLIPWMDGPGADTALGVLLGDGTARGMALMFMLSGVITLIVVLLAFASRPYRQLSRYYASSSQDIAGQTAQ
>fig|196627.4.peg.1955 Permease of the drug/metabolite transporter (DMT) superfamily
MNDAGLKTRNPVLAPILMVVNGVSLYAGAALAVGLFESFPPALVAWMRVAAAAVILLVLYRPAVRNFIGQTGFYAAVYGVSTLAMNITFYEAIARIPMGTAVAIEFLGPIAVAALGSKTLRDWAALVLAGIGVIIISGAQWSANSVGVMFALAAALLWAAYIIAGNRIAGDASSSRTGMAVGFTWASVLSLPLAIWWWPGLGATELTLIEVIGLALGLGVLSAVIPYGLDQIVLRMAGRSYFALLLAILPISAALMGALALGQMLSVAELVGIVLVVIAVALRRPS
>fig|196627.4.peg.1956 Albicidin resistance protein
MLIGEVSKLSGVSARMLRHYEKLGLVEPKQSTAGYREYSEGDVRRIFHIEGLRSLGLSLKQVGDALEDPDFDPQAVISEMIAETSARISMERELLARLKAVRHAQASDWESALDAVQILRRLRSGDPAQRQAVAYDSVSGKEAVALETLVESALGESHLNAEGALSWAVVQRGEEAVALAARGLRSRDAAVRLRAVRIVASAPSAVADRVEWLRPMIRDPDALVRAETALALGKSGDESAVEQLVSMVLTGLRDVEAAELLAGFGEPVQLDVFKKFARTLDDEETMSPTRGRIAQALAEFNLAPVAFLVEQLVDDDNPTVAFTAAAIIKAKGLK
>fig|196627.4.peg.2691 Drug resistance transporter, EmrB/QacA family
MTSETLQAQAPTKTQRWAFLAVISGGLFLIGVDNSILYTALPLLREQLAATETQALWIINAYPLLMAGLLLGTGTLGDKIGHRRMFLMGLSIFGIASLGAAFAPTAWALVAARAFLGIGAATMMPATLALIRITFEDERERNTAIGIWGSVAILGAAAGPIIGGALLEFFWWGSVFLINVPVAVIALIATLFVAPANIANPSKHWDFLSSFYALLTLAGLIITIKESVNTARHMPLLLGAVIMLIIGAVLFSSRQKKIEEPLLDLSLFRNRLFLGGVVAAGMAMFTVSGLEMTTSQRFQLSVGFTPLEAGLLMIPAALGSFPMSIIGGANLHRWGFKPLISGGFAATAVGIALCIWGATHTDGLPFFIAGLFFMGAGAGSVMSVSSTAIIGSAPVRKAGMASSIEEVSYEFGTLLSVAILGSLFPFFYSLHAPAEVADNFSAGVHHAIDGDAARASLDTAYINVLIIALVCAVAAALISSYLFRGNPKGANNAH
>fig|196627.4.peg.2753 Vancomycin B-type resistance protein VanW
MKNSGKNSAKNRTKGILIGVLVGLIAIFAGIYAVDVFLNKDNIPRGTTVGGVSISNLSAQEARTKLETELANDVVQPVTVTAGEQSTTFDPVASGVGIDWDATIEGTGEQSWNPITRFVALFKESESPIVSTVDPAAFGPTLDRMVGELYRDPISGNLHIDAGTLVVNDTIDGQAVDRTILEQAVTENWLNPEGVKAEPYVVPAAISQDTIDKLAEGAGAKAVSSPFVVRGDDGIEGTIPVERMGEVVSFPEENGTIRVDINAEAATAMLAEGLKETEIEPTNAQISFSSGSRVVTPEVTGHGINWEETLADLPNNLTGDGPRTIDAIYEDTPATFTATDAQNATFNEVMGEFTTGGFSAASGTNIRLTAQMVDGAVVSPGDTFSLNNYTGPRGAAQGFVDSGIILNGRSDTAVGGGISQFATTLYNAYYFAGLEDITHTPHSYYISRYPAGREATIFDGAIDLQFRNNSPYPVMISTSADASNVTVRIMGVDTTSVESINNGRWSTTQPNTVRVSGSDCVPSTGAPGFTTSDTRIISDLSGNEITRETVTTVYDPSPNVVCS
>fig|197221.1.peg.2240 
MVVLLKLAPPLRQTLLRLILAGLLFWSSIAAMLPTLPLYIAQKGSTPHQVGFVMGAFAVGLLGSRSWLGPLADRRGRKITLLIGLAVAAIAPLFYILSHNLPLLIAVRLLHGVSIAGFTTGYMALVTDIAPPQHRGEIIGYTSLVHPIGVALGPSLGSWLQMHYGHDWVFIVASTLAALGCMAAAGVRAVNRAQESGELPAETTLFWRLLLSERLRIPSLVMLSVGLTFGTIATFIPLFMAAEQLGVSPGLFYSVAAIASFIGRVLTGAASDRWGRGIFISASLAAYVVSMVLLAQAQTPLDVLWAAILEGLAGGVLIPMVAALMADRSTPQERGRVLSLSLGGFDLGMALAGPLLGGLVEHWGYRVIFRMGAVFSLLGLAFFLTASSKSLPDSLRFALGMGRDRYAL
>fig|198094.1.peg.173 Multidrug resistance transporter, Bcr/CflA family
MNEVNQEIYKPVKTNRLWMILVLGTLTAIGPLSIDMYLPSLPKLTDDLQTGASLAQLTLTACLLGLSVGQLFVGSISDIYGRRKPLIIALIIYVASSLLCAVAPSIWTLVLLRFLQGASGSAGIVISRAMVRDMYSGSEMTKFFSLLMLVNGAAPILAPIIGGQLLQFTTWRGVFIVLGAISVFMLISATFVLRETLPPEERETGGLSGTLATYGKLLKDRLFMGYALSQGLVTAAMFAYISGSPFVLQNIYGASPQQFSLFFAINGIGIIIASQVTGRLAGKVNEKTLFVSGIVIAAVGGLSLLLTILLGIGLIGVLCSLFLVVSSVGVVSTTGFSLAMRNQKQAAGTASALLGLLQFISGALVAPLVGIGGSNTALPMGIVIALCEIGAVLCYLFMARRSEKQFELQARQNLEV
>fig|198094.1.peg.564 Vancomycin B-type resistance protein VanW
MKLSKILIGSAIAGGILLCVGGVSGYQYVSKLNNQLDTTALPNTTFEGISLDGKNKKDIQAIINQKITELDQKSLTYIFQNDKQTYTWKDLGINYKEKDIIDKIFKEQEGNAINRYKMRKQAENGELKRDYKLTPQLNTTAYESFMKDKYNKTLKNPVNAELSIEGTTVNISQSQNGEKIDKGKLTDLTKQAITSGTSDITLPVTLLKPERSTEDIQKMGIKEVIAEYSTPMAGRNGNQSFNVNKSANTLSGVIVAPDETFSFNGRVGVTDAAHGYKSAAVYSQGKVIQSAGGGVCQVSSTLYSAALRADLGIVSRSNHSMPVNYLPLGQDAAVADYGPDLKFKNNTGNHIYIQAFSNGGSITTRIFGTNTGKNVEVSSQVISRTNDKITAVTYKKVTQNGEVISNGQISKSVYKSAPKQ
>fig|198094.1.peg.696 Drug resistance transporter, Bcr/CflA family
MKKSKLTFILYVVCMSALLGSFAQNIYTPILPMIQNSFHTSLYLVNVTVSLFTFVLAIMQLIYGPLIDTKGRKSVLIPSLIISTIGSIGCAFSANIYLFLFFRAVQAIGIAAIPVVAATIIGDLFEGKERGEAMSLYQMLLALAPAIGPLIGGYLGSINGHVSVFLFLSILGILLLTINISLLPETKPTVSQQPQSKKNHWFILKNKTGFSITLIGFIQFCIYFCFLVFLPSISTNLFHLTASEIGLMFVPMSLSIMLGSYCFKLLQKRFTTKQALFITSFFNIICVTLFSFTYSINIPFIIIVTSLYGFSMGLSMPTHTTLLTEEFVQERATAIGMYNFIRYLGMGTVPLVGGFLVFNQNYFWIFFLGAIMFLLIILYAMKMLRFPTTQKVK
>fig|198094.1.peg.774 Permease of the drug/metabolite transporter (DMT) superfamily
MPYFYVFLLLLTSLLWGGNFVVGKSLVDHASPMTLTSLRWIIAIVCLLPMVWFKEKKIIPPRAAILPLILMGISGVALFNIFQFLALEKTSATNVGLISTLNAISIALFSVLFLKEKVNTLQILSMILSFFGVILVLLKGNFALLFSLHFNSGDLWMIAAVCIWGIYSVCSKWATKTTTPLMATLYSGIFGVILLLPFNIGSFTVTNINTSFITSLLYTGLISTVLCMVFWNIGVQKLGATTSGIFLNFNPIFTAILAFLFLGEELTWIQIVGTMIVMTGCYLFSHFKTVTVQPTGTLLRKHS
>fig|198094.1.peg.877 Drug resistance transporter, EmrB/QacA family
MNMTTKSPASGKVDTSNMKHTPILIALLLGTMVALLNETLLGNALTVLMKEFDVTASTIQWLSTAYMLVVGVLVPITALLQQWLTTRQMFLIAMVTFLVGTLIAGFAPTFSVLLVGRIVQAVATGLISPLLMNTILIICPPEKRGATMGLIALVMMSAPAIGPTLSGVIVDSLNWRWLFYIVIPIVIISIMIGMKYIQNVSEITRPKVDYPSILLSTLGFGGLVYSFSASGDLGWSDTKVYGALIVGLISLCIFIVRQLKIDNPILELRAFKVPMFTLSVGLIVIVMMSLFSTMTLLPMFLQTVLLVTAFKSGIIMLPGSVISAIMGPIAGKLFDKFSPKVIIVPGIVLVGIAMFLFKGITPDTSIVQIIVMHSVLMVGLMFVMTAQTYGLNQLTPDLYPHGTALFNTLQQVAGAIGTAIFISKMSSGTTSYMESSANPMDPVEKLNGLTSGFQGAFALGLVFIVVAFIVSLFLKEEKKGVLQNEN
>fig|198094.1.peg.1030 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MFQKLECVSIHTKDIEKSVSFYKEMGMEQNWVIERELEEGAIWTLIGLKFPDEKSSELVISNHPDINCIEVEVLVEDVQQTYESLKDNKDVKWIREPFPTESGHVAVMEAPDENVFVLVGK
>fig|198094.1.peg.1497 Permease of the drug/metabolite transporter (DMT) superfamily
MSVKKDWIAPLALLFVSFIWGATFVVVQNAMSFVGPFTFNGIRFLFAGIILLFVQILFSKKASKQHIKQSSLAGLIVGFFLCIGYVLQTFGLLYTTSSKAGFLTGLSIVMVPILSFIFLKQKATIFIVIGIAVATAGLYLLTAGDSFQLNIGDILVLGCAVAFAAHILVNGFFSKKISPLLLSTSQVLAVGLFSSICAFLFEDWEKLFSVALWTNSSFLFALFLTSLFATSIAFFIQTSAQKHTSPTRVAIIFAMEPVFAALTGVLVANEQLSISAIIGCLCIFLGMVFVELPSKTKKEAQAA
>fig|198094.1.peg.1517 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEVTEKLREKPIKSLFITYLIPAVLGMVLMSVNIVIDAVMISRGVGANGLAGVNVAIPAFSIFFSISLWIGMGGATLYSIALGENKIERARSIFTQSMTVAVIIVGILAAICLWRIEDLAYLFGANEVILPYALDYLHVLLTFGMIYVLENILSTFIRNDGNPNLAMAGLVVTAILNIVFDYIFIFIFGWGVTGAASATILSAAIGFLVLLTHFFRKSSILKWTKFHFEWDTIKQIMIIGFPSFITESTVAIVTIGFNIAFVQYAGEVGVASYAMVNSIHAMTLLLFFGVGAALQPIASFHYGANLSERLREGLQFAVKIAVILGGVAIIVGLFFGKYIIGLFDVQSPQLLELTLTGISLFFIQYVFLGYNIVYGEYFQSVRQTKKSILIIMSRGLLFIIPLLWIMPKLFGINGIWLVMPVAEVITAIILFTMNRMKHPVPLNMAGEKEVI
>fig|198094.1.peg.1677 Fosmidomycin resistance protein
MQAVSQKNTVETPTIYRILFAISFGHFLNDSMQAVVPALFPILEKTMNLSYMQVGWIAFALNMTSSIMQPVFGMYSDKKPSPFLLPLGMFSSMLGMIGLAFAPNFIIVIISVLFIGLGSAVFHPEGARVAYMAAGTKRGLAQAIYQVGGNTGNSLAPIFTALIFVPLGQIGSLGFTAFAAVGIVLLIFVSNWYRNELATGAVRRKKRAALEAENAIVSTHIKFVIVLLVFLTFVRSWYGAGIGNFYQFYLIEHYGLSIKNAQYFVFAFMIAGVLGTFFGGPLADRFGKKTIIVFSMLGSAPLALLLPHVSLVWVVPLFLCIGFISSSSFSVIVVYAQELVPGKVGMVSGLIVGLAFGLGALGSVVLGKLADIYSLQFIMLLCSCLPLIGLTSWLLPSDKKTIE
>fig|198094.1.peg.1752 Permease of the drug/metabolite transporter (DMT) superfamily
MTQLSRTKTAIILTFLVFMWGINWPLSKFALHYTPPVLFAGVRTLIGGFILLLFALPKYKELHLKETWHLYVISSLLNIIIFYGLQTVGLQYMPAGLFSAIVFLQPVLLGIFSWIWLEESMYGLKIFGLILGFIGVGVISSSSLTGHISIIGILLAIGCAIGWALGTVFIKKTGHRVNSIWMVTLQLIIGGLCLIGFGSEFESWSSIAWSMPFVSVLLFISFFVIAMGWLAYFTLVGAGEASKVGAYTFLIPLIAIIVSSIFLHEAITISLFIGLLFIVVSICFVNIKPKTLAVGQRVEVK
>fig|198094.1.peg.2247 Multidrug resistance ABC transporter ATP-binding and permease protein
MKSFRKLLQYLKPYMFFAIIGPLFMVLEVAMDLIQPTIMQHIIDVGIANRDLNYVIKMGLLMIGAAALGLVGGLGCMMYSTKAAVNFATDIRKDVFAKIETFSSENRDSFGTGKLLTIVTNDITSIQSAMTMTLRVLVRGPLLFIGSIIIVFVTARELFPILLVVVPILLLAIIYIASRASGTFKKVQEALDKVNTKLQENLSGVRVIKAYVRQKYEINQFGKVNTNLTKINIRAVQLISLMMPIIMLVVNGGIVATLWVGGEKVFNGTLQVGAILAFINYLNIILMSLMSISMVFMQIARAFPSADRVQQVLNTDVDITTPKNALAPKRIEGQIDFKNVSYSYTKNNEYVLKDISFRIGKGEKVGVIGSTGSGKSTLAKLLPRLYDVDQGEICIDGINVKAYDLQKLRGSIGFVPQKALLFSGSIEENLRYGKEDATKEELEVAASSACATEFINKLEDSYQYHLTQGATNLSGGQKQRVSIARALVRKPSILVLDDSTSAVDAKSESNIQSALRREYKGTTTLLIASKISSIIDADKILVLDNGELVGDGTHEELLEQCEVYQEIYLSQGGNLHKEGGKEHA
>fig|198094.1.peg.2248 Multidrug resistance ABC transporter ATP-binding and permease protein
MRNFQGQFANKGGRNAPKIDKAKNTKGTVMRVWNYMGYQKAALTFVIFLVLVTTLLGLLGPYLMGVIIDQYIVPKDVSGTARMCLLLIAIYGVTVLLTWLQTFVMVNVALKTIQKIRQDIFKKIQTLSLRFFDVRSQGDLMSRVTNDIDNLNQALTQSVVQIISSALTFIGVTIAMFALDWILAIVTLITVPIMFFVTKKLVAYSGKNFAKRQKDLGELNGFIEEAITGADVTTLYGKEKETVQKFNKINEQLRVSATKADTFSAFIFPSMNFINNLGMGLVIGTGSVMVLNGMTTVGVIAAFINYSRQFSRPLSQFATLMNTIQAAVAGGERVFEIMDEVPEIKNKKDAFVIQNLHGHVALENVSFGYEENKTILKEVSLKARPGETIALVGPTGSGKTTIINLLTRFYDVQQGQIYIDEKNIKEYDLNSLRSKIGVVLQDTYLFAGSIMDNIRYGRLDASDEEVINAAKAASAHSFIKHLPNQYETKIATEGSNLSQGQKQLLAIARAILADTDILILDEATSNIDTRTELQIQEGLNNLMRGRTSFVIAHRLKTIEKADQILVIKDGSILEKGNHESLMEDRGFYFDLYTSQFKI
>fig|198094.1.peg.2459 Permease of the drug/metabolite transporter (DMT) superfamily
MNYKKWDLRIICAHAFTILIWGSAFPAIRMGLESYTPEHLTLLRLLIASVILLLFSFIYKLRLPDLKDIPAIFIFGALGFTFYHIALNYGEKTVNAGSASLIVSVTPIVTAIFASVFMNEKMKLNGWIGGVISFIGIAFISFSQGDAIQLNSGALFILLAAISESLFFVFQSSYLKKYGFLPFTIYTILSSTVCMLIFLPGMYQEILAAPLEVNLSVIYLGVFPTVLPYIALAYIISRAGASEATSSLYLTPITACFVAWIWLGEVPTLVSIIGGGITILGIVIVHIPVLRKEKHSNLANNQSV
>fig|198094.1.peg.2514 Permease of the drug/metabolite transporter (DMT) superfamily
MVIFNYILVCIIFGTTFLTIKIGIEAGAPPLFSAGIRFFLAGVILMIIFKLKRKEIMPHIFSRRIIYAGFCLTFMTFATLYWAEQYISSGLAAVLSATGPMMILLLQTKRNKTKLKKEQLLALIIALIGVVFVSLPGMHQEISFIWSIACFVLIIGELFYGIGSIRSKEILSDLQSVSLFLINGIQMFYGGVLLLIVSFIVEQPNVTVLASWSVQWPILYLIFIGSIGGHGLYYWLLSKTNPVFPSTWLYVSPLIAIIVGYIILGEPLNPIMGIGACFILVGVFLANRSTLRTYFKQGRLFEKEM
>fig|198094.1.peg.2646 Drug resistance transporter, EmrB/QacA family
MVEKNNKLGFVVAGLLLGILMASMDNTIVVTAMGTIVGDLGGLENFVWVVSAYMVAEMAGMPIFGKLSDMYGRKRFFIFGLIVFMVGSALCGTAENITQLGIYRAIQGIGGGALVPIAFTIVFDIFPPEKRGKMGGLFGAVFGLSSIFGPLLGAYITDYISWHWVFYINLPLGVLALIFITFFYKESRVHRKQKIDWSGAITLVGAVICLMFALELGGQKYDWDSTFILSLFVGFAILIISFIFIERKVEEPIISFEMFKQRLFGMSTIIALCYGAAFMSATVYIPLFIQGVYGGSATNSGLLLLPMMLGSVVTAQLGGFLTTKLSYRNIMIISAVIMLIGLFLLSALTPETSRALLTVYMIIIGFGVGFSFSVLSMAAIHNFGMEQRGSATSTSNFIRSLGMTLGITIFGMIQRTGFQDQLEEVFKGMSGGMNTNALGDSRAILSESARSQIPPQILDKIIDALSSSIVQTFMWALVPAGLAFIFIFFMGNERMVMKKQQKNKKGEISKV
>fig|198094.1.peg.2801 Ribosome protection-type tetracycline resistance related proteins
MTTINIEIVAHVDAGKTSLTERILYETNVIKEVGRVDSGSTQTDSMELERQRGITIKASVVSFFIDDIKVNVIDTPGHADFIAEVERSFRVLDGAILVISAVEGVQAQTKILMQTLQKLNIPTILFVNKIDRTGANTEKVVKQIKTILSNETFPFYSVQNEGTKEARIIEYKSYDDCIERLAPYNESLLESFVNNEIVTDTLLREELEKQIQQANLYPIFFGSALTGIGVTELLEDIPALLPANNPSQDEELSGIVFKIEREPSGEKIAYVRVFSGTLHVRKYVHIQRDGSLPHKEKIKKMCIFHNGNAVQTSTVPSGDFCKVWGLNNIKIGDIIGERTDYIKDIHFAEPQMEAAINAVPKERIHDLYAALMELCEADPLIKVWKDDIHNELYIRLFGEVQKEVIETTLYEKYNLQVTFSSTRVVCMEKPIGIGNSVEVMGEKANPFYATIGFKVERGELNSGITYKLGVELGSLPLAFHKASEDTVFQTLKQGLYGWEVTDISVTLTHTGYASPVTTASDFRNLTPLVLMDALKQAETYVYEPVNEFELTVPEHAISTAMYKLAAILATFAEPIFNNDSYQLTGSLPVAKTESFKRMLHSFTEGEGVFTTKPAGFTKLMAPLPTRKRVDYNPLNRKDYLLHVLKAY
>fig|198094.1.peg.2819 Permease of the drug/metabolite transporter (DMT) superfamily
MKRWQMEWLLVSVALVWGANYTIGKYGVAYMSSIQFNSLRFLVASPVLLLITFLMERSLRIERKDWLRLVAVGIVGTTMYQTMFMLSVKYTSATNASLLIAMSPIFTGILAVLHKQERFSMKVQIGSIVAFIGAAFVLLTGHTGGATYEYAWLGNIIGLVAAIAWGWYPILAQPLITKYSAMRVTSWSTLIGIVPLVIYCLFNVNSLTWPVDTLSWGSLAYSIIFATIFGLAMWYVGISQIGSTKVMVYMYLVPLFAVIFAAVTIGEQINMMQLVGGLIIFVGLYVVKKGGIKKPALNLKKVS
>fig|198094.1.peg.3217 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MITPIFRIFDIEKAKLFYVGFLGFKLDWEHRYEEHMPLYMQISLHDAVMHLSEHHGDASPGGAIRIKIDDVKDYHSVLLSKEYAYSKPNIEKTPWGTIELTVIDPFSNRIIFYEERV
>fig|198094.1.peg.3344 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MSENHNFYDRKEMKGNGFELIIVVDRIEDVYERCKEKRCTIQEEIQTYPWEMRGFKVVDPDGYFLRITSK
>fig|198094.1.peg.3367 Multidrug resistance ABC transporter ATP-binding and permease protein
MKEYKRILLPLQKEKILVIAAVCSGIFAAILNLSRPLFMGLIVDNLIQRELKEAYFYITLFTVTRLLMWVNNLSFDYVSSKASQRILREKRIDVLRHFFLLPFEESEKIKQGELETLVVSDIPNWVRLYDSILIEYIHAIAQFIGAIIALQHIDIQFILWVTPFLFLSAMVPMLLGKKVRNIASIAQKNQSTVVEMMSQFVKGAQDLRSLQKEKWAIRLFKGVTAQSYKSEVKKTMMQHCIGVVGTVIETGAYIVVLIIGAQKIMQGEMEVGSLVAVLATIEMLFFPVRYVGDLLMMSQVAVASASRVFSFLDKRVANSNVERAMGMTITNVSFQENDEEKCRIYNIDLQIQPGELIIIVGESGVGKTTLLKLMTGLYKPSNGSITYYGNEAQLTTVWQEPRFFRVTVKENMYFGEERLENELEKNAELVNVTPIIRGLPEGLQTVLHKSGEEFSGGERKRLALLRAIVSNPHLIILDEPTAGLDPNNQEFVWNMIEELGSEVTRIVATHDVEKVILADRVVIMKEGSIVACGSPEKLINSHSFFKRCE
>fig|198094.1.peg.4082 Permeases of the drug/metabolite transporter (DMT) superfamily
MNGRSFTFAIFVLIIGLAIFGLVSSVITNPMGVLRNIGIMLAVVGIFYLLYKMFTNSSGSANSQSSYKRAAKQSSRKHGKQNVAPLSNSFFKSNTSNDKGKKGNPSSLKRKRKQSHLTVIEGKKNKKKDRASF
>fig|198094.1.peg.4444 
MNQFRRMVIINIITLIVLVGGGIGGYYYYNQAENYLKTDNAKIDGKVIPIASPVAGKLTDWKAEVGKNYNENDKLGAVTVAAANGEQTVDVTIPQNATVVQSNATTNAFVGAGSPIAYAFDMNNLWVTANIEETDVDDVQKGQDVDVYVDAYPDTTLTGKVEQVGLTTANTFSMLPSSNATANYTKVTQVVPVKISLDHSKSVNIVPGMNVTVRIHK
>fig|198094.1.peg.4497 Zwittermicin A resistance protein ZmaR
MKKLSVAEYRKILPILESHTKTTTFAYAVCDQVIDGEVFVNEKLTAGLIRTANGIYYVFGHTDDQNYNEDLFLFIKKAIEKTEKRFTLFTSSEEWEMMIEERFSNVLRNIPRMKFQSATFEERKRDCNKNTYEVKRIDRRDIERSSEFTEEYYKEYWGSKETFLNGGFGFCIEQGGMIVAECVSIFSGNGFAEIDIVTHKAYQGKGLAQAVAARFIEHCIQNDIIPCWDCYVDNIPSQKLANKLSFHNPIEYSLFVRKKTGE
>fig|198094.1.peg.4584 Drug resistance transporter, EmrB/QacA family
MRKKVMMSLMLMTFLSAVEGTIVSTAIPRITSDLSGVELVSWVYAIYMLATAVSTPIYGKLADLFGRKKVLLIGATIFLVGSALCGVVTSMEQLIFFRALQGIGAGAVMPITMTIIGDLYSEAKDRAKAQGWMSAVWGVSGVIGPLVGGFLVDSLSWRYIFFLNVPFGIIACLMIAIYYKESIKPAKHHIDYLGATVFSLSMIALLYALLTGSSKQNWGDVTIIGLLIFAVVSFIIFLFIEKKSPEPLIPLALFSNRTLSTINILTLIAGAMIISITMYLPIWSQGVLGKNATEAGLILMPIPVMWTFGAIFSGNLVGKLKTKQIILLGASILSVATFLLFTLSTNSPSFLIYVAVGLFGLGMGLVTPIYMVTIQAAVPAHTRGTAVGLNTFINTFSQTLGAAVFGTIFNTMIHARGIKNLDLVSGGHGGATANVVTESQSALASSVHVIYMSTFVLAVCTLIIAWLLLKPATQTSEQ
>fig|198094.1.peg.4822 Teicoplanin resistance protein vanZ
MQSSTQKYVEWIGWGLFLPYSFVLLFKLLLGRSAFYFGNLTYFFETGDWHSIHGGLINLVPLKSTINYLSGFDTTHLLDPYNIDIVLMNTLGNVIIFIPFGFLLPLLFKQINNVKMASKIFIKFILLIESLQLLTFTGVFDIDDIMLNMLGALIGYGSFVGIKYILERVRSVDKVDTI
>fig|198215.1.peg.392 Acriflavine resistance protein E (AcrE)
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQGYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATVLATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>fig|198215.1.peg.3097 Outer membrane component of tripartite multidrug resistance system
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDAIHLDTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAEHVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAAPVVEKK
>fig|198215.1.peg.3098 Membrane fusion component of tripartite multidrug resistance system
MTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPNRAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRLSESEAVAARECNLENICQTLLQLGQMNPNTPPTPAAKPPSMVADAFTNPDYIRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAMIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPTSQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ
>fig|198215.1.peg.4255 Polymyxin resistance protein PmrD
MQWNGWHKKSCCNKQDNRHVLMLCDAGGAIKMIAEVKSDFAVKVGDLLSPLQNALYCINREKLHTVKVLSASSYSPDEWERQCTAAGKTQ
>fig|203119.11.peg.316 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKETASIKKMSVFALTWPIFIETLLRTMLGNVDTFMLSTYSDDAVGAVGVVSQISYILIMLYNVVSSGTLVLISQYLGAKKKKEASVVAVTSIAGSLIFGLFVGLAVFLFRSQILTFLNLPPELMGYAMTFLGIVGGFSFTQALIATLSAIIRSYGNTRITMYISVGMNILNIIGNSIFLYGLLGAPKMGVTGVAIATVISQAVGVVAMLIVMLTGLNQKFSFRDLVPLPWEILRDILKIGLPSAGEGIAYEASQLTITRIITVLGKVALTTRVYTLNIMYFVMVFSVAVGQGTQIVVGHLVGAGDNEKAYKTCIKSLRYAVVVAIILAGIVSFFSEQLLGIFTDDRAIIEMGSKLLLIAVILEPGRVFNIVIINSLRAAGDARFPVIMGIISMWGIGVLLSYFLGVACGLGLIGVWIAFASDEWFRGIAMLLRWRSRVWYKMALVKNQNIEMPA
>fig|203119.11.peg.927 Permease of the drug/metabolite transporter (DMT) superfamily
MRKFNFGYLFILVTVVFFSTYEVVSKTIIGKVDPFQINFLRFFIGGSLLFLFLLIKRDVKIDRKSLMIVSAAGILNVVFSMNLLQLSLNVAYAKAAVVAVIFSSNPIFVSIFAAVMDKEKITLFKAAGMFLGMLGIAVISINGQAFRDINILSPLLALMSAGLYGLYTVVGRRASSKIGSIKMNAYSFLIGSLILLSVLLIKGLPAFKFDCSAWPQVVYLSVFVTGIAYLIYFMGLVRTGAGSGSVVFFLKPVLASVFAIVFLGEKITLNLIFGTFLILLGMAVMFYWEKIRQRFV
>fig|203119.11.peg.1119 Vancomycin B-type resistance protein VanW
MLLDFFSKNKTKILIFAASLLLLVIASVSTYVVVVLNRKTFYDGIAVEGIDVSGLTVDEAREKVEKKLDRIVYENSLLLNYEGMTWRIGLSDISYDFLVDDAIKRAYSIGREGSVLKRLKTIRNLKSDKKNVLAKVVFSRPLLEEYITSIKKQVDENPKDATVTYQNGNIMFEKEIIGRFVDVDKNLGLLENKLIKRDFSPFELEVTNVYPKIMYKDISHIEEVISSFSTVFNSANVNRSHNIKLACERINNTVLLPGETFSMDASLGSRTKENGYKDAPVIVKGRLIEGVGGGVCQVTSTLYVAVLKAKLEVVERVKHSMPLGYVEPGQDATISEGYIDFKFRNNTDRACLISASVVGNRIDIKLLGAKRNSNYDVRLKSVVVERISPPEDEIIVDKSLPKGAVKIEREPVQGLKVIVYRETYENNRLIEREKISEDIYKPVQGLKRVGPYDSNDTEGGEETVKEEAMEEQTI
>fig|203119.11.peg.1534 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDISANTSSSGNPLGYAPVLGLIGKFAIPSIISMLVAAAYNITDQIFIGRLVGMLGNGATSVAFPVVTFTTAFAQLIGVGTAANFNINMGAKREKEAKHFVGTGITLMPTVGLLIFCIVFVLKKQILLLCGATENVLPLAMTYLGITAIGLPFQLFTTASSSLIRADGSPTYSMICNVTGAILNVFLDWLFMFVFGWGIQGAATATVIGQIVSFLLCAIYYFKFRTFQITRRMLGIKWYYAKRIAKLGTSNFINHTIMMLVNIVLNNSLKIYGAMSIYGSDIPLAVSGIIAKLNSVLSAFSIGLAQGCQPILGFNMGAKNYSRVKETYKKAVSIAIGISVLAFILFQCFPRQITGIFGSGDELYGDELYFEFAEKYLKIYMFMVCVFGIQPVTINYFTGTGNVRQGIILSLSRQGFFLIPLLLILPQFLGLTGVLYAGPIADFMACLLSLTMITLNFKKLDSGREVADK
>fig|203119.11.peg.2540 Vancomycin B-type resistance protein VanW
MTFDDVCNLLKSKYSEKAKDLKVVLNHEGMAAEVDLSEIDLEYKIEEAAQKAFDVGRKGNIFERLSEIFNTSREGVRLSLEYSYNLGKVNEIIDDFYSKTLISVKEANLSIQDNKVTLTTGHPGKSIDKEKALEIIDNSIKTCEGGTFDVPVITTMPKAIGVDDIYNQIVVQPVDAKAVVENNKVRVVPHELGREISKSELADIIKENENTTDKEILLPVKFIQPKVTTDEVNAKLFRDVLASSSTSFSTSGQNNYNRGINIGVAASKINGKILAPGEVFSFNDVVGPRTVANGFKIAKEYVNGKIVDGVGGGVCQVSSTLYSAVLFADLETVERQNHMFTVSYIPLGRDAAVAYNELDFKFKNNTNWPIKIVSSVKNNTVSFTIYGTKEEPGKTVELKHVQVSSQPSPVKYIDDPNLEEGKTVVVQSGYTGYTIDTYKIVKINGNVVSNNKIHRSIYRPYETIIKRGTKKVEKVVQTNSPAPETVLSPTSDPTPDPAASNEVVDETLVE
>fig|203119.11.peg.2908 Vancomycin B-type resistance protein VanW
MGQKNGLKEIFAVATTIFIAVLSVSCSFGERKVENNVYIKDINVGGKSKAEVEEIIKKMSDSIDVEPKDAILNEDTLEIAPEEPGRKLNVESTLKAVLNAKEGDRIEPVVEEVLPKITREDVEKRIVEIGSYSTPLLDESENRVDNIDTASDYLNNEKVLPGEEFSFNETLGKRTAEKGYKKAPIIKRTESGSIKGYGIGGGICQLSTTLYNAAEKAGLEITERHSHSKKVPYVPQGKDAMVSYGSSDLKFRNNRQNPIVIKSEISDGKVTVRLYEIRK
>fig|203120.4.peg.537 Permease of the drug/metabolite transporter (DMT) superfamily
MKKQGIICGVLSATLFGISGILASILFRNQNINPEWLVGVRMSLSGIILLIVLFCFSGRRVFEIWLNKRDVVLIILYGIVGVLLAQSSFFLSVYFGDAATATILQSLGPTIIVILLSLATRTLPSRLDIWSILIALTGVFLLITNGNINQLVVNSKALFWGILSAFGLAAYTLIPKPLLEKQSPLVVVAWGLLVGGTAENFFHPIWYIPSQVSTKDWIIMVFIIIAGTLLPYALYVMSLSQLKPTTASLLSTIEPMVATLLSVTLLHVHLRMFQVLGILFIISTIFLISLPLERIFKKRLSDPKIN
>fig|203120.4.peg.947 Multidrug resistance protein B
MENKVSTKNAMAIIAVALVSFSGIMAETAMNVTFPVLTRYFSTSLNSIQWVTTAYLLSVTIMITTSAYLNKRYNTRYLWLASLIFFATGTLVGGLASNLPVLLIGRVLEGLAAGISMPLMFNLIVQLVPRSKIGVWMGIGSMVVSLAPSFGPTYGGALIDTLGWRSIFFILLIVPIISLLLGWRTIDNSKETQANVSFDVLAFGLLSVSLITALILINQLENGTVNILLLGVTIVSLTGFVIRSLTSKQTFLNIRLLSNSKFLFLLIPVVLYMFANLGINLLLPNYSQKILNTSSFWAGFSLLPGTLLGGILNPYFGHLYDKHGDKTPLLVGNTIFGISLLVMAYFTKNLGIIAFIIMYMIFTFGRNMAFSIGMTASIDELSRDKKTDATAILQSAQMFMGALGTTVAALYGAQKSGLAVGFQHFLWLLFFISLVIFIMFFARQKTGNK
>fig|203122.12.peg.726 Permease of the drug/metabolite transporter (DMT) superfamily
MRVALAYACVVLIWATTPLGINWSNSTLSFAAAVALRMCLALAICWLALVVMRERLVQQRSDWKAFFAGAIGLYPNMLLVYWSAQFIPSGLMAVILGLYPFTAGLFTYFILKEWVFTPPRIVALALAVTGLGVIHYEHLALGSDAIYGIMGMLGSTFLFGLSSVWLKASGAAVEPLRQSTGTLLLSTPFFILSWVVTGVNIPAAIDVKSIVGVSYLAVAGSAIGGTLFFYVLKKCSMSSVSLITLMTPMMALTIGMLFNNETVTQLEFIGCIIILFSLAIYQGALRVVVKQINRLLAVGKQPVQLP
>fig|203122.12.peg.1022 Permease of the drug/metabolite transporter (DMT) superfamily
MNPQKTGLLSLYFGIFLMSLTGLFAKSIPLDATSITQLRSTVAIVALFIYCMLRGSSLRLKSFKEAAGIYGLGIFMAIHWVTYFHAMQVSTVAIGMLSLFSYPVITVLLEPLFQKKLPARADLIAGALSFTGVVILTMDDSTGLGGAALTGAAWGIFSALIFSVRNILQKYTYPDVPSGTLMFHQVVATAVILIPFVDFGSVASLELDKWALIVALGVLCSSMAHTLLALSLKRLPAKSVAQISCLQPVLGALLAWFVLKETIAPQVLGGGALILAVAAWESYKQSYRPRAVS
>fig|203122.12.peg.1544 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLWIAFTLMAVVMQAVRTAAQKDLSRALSPMATTLTRYLYGIPFVALYLVVLLQTNTEWANSFNYAQLNNARFLVFATVAAIVQIIATAFMVKMFTLKNFAIATSFAKTEAIQVALFASVFFQDHLNVYGWVSVFIGVVGVLFVSGLKIGKPQSISSATIFYGTLSGALFAWTSLSLREASLSLDLPLVYSAALTLMYMVIIQTAICAIYITFKERKQWQKLMALQKRGLFVGATSALGSVGWFTAMSLQNPALVKTLGQVEFFITLGITHFYFKERIKWQEMVGIMCIFASILLILYV
>fig|203122.12.peg.2443 Acriflavin resistance protein
MENKQYQQGDSSGGLSGWFVMHPNAAKILLMVIMLAGFVGVNSLPQEVFPPFAPSRVDIDIPVRGGTASDVEELVVKKVEESLEGLAGIERIVANSTDNGARISVELVNGADQQSLLSLIKSRVDGISGLPISSEPPVFSLPEPVGPVQFINITGDVPLPALLGQAVKFKSELSRLEGISYAVIENEPELPLYIDINPDKLQQYQLSLTDVADTVARYSVNVAGGTIQTLGNRYQLRANTLGNMASDFIDIPIVSAASGVVVRLGDIAEIQLAPHDDYVAGKFNGKPSLMLSVYRDPKVPFSTASESINALLDAKRAALSPAIELIAWQDESREFTTRISLLVKNGVGGFIIICLLMGIFVNPQIAIWTAIGIPISILGAMGLMHFAGLDLSLNAVTLLGFIIALGMIVDDALVIGESIQYETAQNGHSMHSVVTGVNRVAIPATFGVLTTIAAFFPLTLTEGDMGSKLGGVGMVVICCLIVSLVESKFVLPSHLRKPSKILQKPAFNKLNALSTGATKKMDGFVERYYKPALDWVVVRPVRTISAVVGVLVISLAMIPLGLLKMAIIPNIADFALQASFQFHPSVAPSIRETIGDKATEQLRAVSEEVKQKYNLDYQPVKHISQHYSGSELVVDVELEEAFNAPYDAYDIQQMWRDSLPYTPGISSLSIDAGSGSSEKIAIELSGENIESLRALSKELREHLASQDDVVDIRDSELANMIEYRFKPTDLAKSLNISDAEIITQVRAAFYGQEAQRITVGEREARVMVRLEDEYRHSLTGLNAMLLPIQSADGSKQYIPLSQLVEIEQNVVPSEIRRINKQRTITVYANTKMNTRSPEDVAEEMGESVLPEMVKAYPGVGFSIEGEAKEANKSLSSILSSAGLAGFILFALMALPLGSFRYPALILCLIPFGMIGAVWGHIAYGLTFSLMSIFGVIALAGVLINNGLLLVDQYRENIRLGQDITEAIKQACVRRFRPIVLTSITTLAGLMPLMWEGDPEALWLVPIAISLGVGLLVATAITLIIFPAMLLLLDRNKVHEQQEEFTSGIQPKEV
>fig|203122.12.peg.3480 Drug resistance transporter, EmrB/QacA subfamily
MSQANLGCIQVESTHNKWAVALSVSMGGVMSSLDTFILYVATPNLRGVFSATVAEVSWVSTSYAIASMMCMFLSGWFVDRLGSKRVYQAGLVLFVIGSALCAMATSLEQLILYRVIQGLGAGILLPVEGVILRRTFPPVQHGLVMGLYGTSIMCGPAFGPMLGGILIDQFSWHFIFIVNIPIGIISFVMVRHYLIDDPIGADTPKRTFDAPGILWLLFGVVGTVWLLERGDRTYWFEDTQNVVLLVVALASWAMLCAHSLTIKQPLLDLKVLKHKTFTAANSLNFLAAFMITGTLFVLPIYMQELLGFSPTQAGTTMAPRALVMMLAFPLVGWLFNRVPMRLLITTGLVLGIGSGVMMAGFTFETGWHDMILPQIIQGLGAAFILGPVTTAALISIPKATMPAAAALESTTRLLGSTLGIAVFASLITHYELRTWELLRHNVTLSSTVLYKRFGGVVEFYYSETSSQLHALEKAYRALNGRVTEQVLSITYMNLFQLITVGFIAMLIISAFISLKKQQQVA
>fig|203122.12.peg.3486 Permease of the drug/metabolite transporter (DMT) superfamily
MKALTVLPSDKQRLLGIAAACAVVAIWSGWIVSSRWGLNSNIAAIDLTWLRFTTAALVTLPLAIKYNWRHLPLGKALVVAFGCGFPYVLFAYLGLQFTPSANASVLINGLLPVVTSLLGYFFLSGKMTKPLLALVAIACISNIIIASSGAQFSVKYLTGIGFLLSATLVLATYMVAVKAWNISMHEIMVWVPIINALCVTPFWFVFSDGLSALHTIPTTDLLFHIVYQGVIVSVAALFLFSYAIKCIGALSASLFMAFVPTTTALLAFISINEQPTSGQWIAITLCTLGLVGYNFYSRKEEKSTSK
>fig|203122.12.peg.3493 Permease of the drug/metabolite transporter (DMT) superfamily
MRQALLRLSVNHTKLLGVLAAFTMMLIWSGWIVSSRQGLTTTLSPLDITWMRFVVASLVTLPIALSYHWRTFPVRKACFIALSYGAPYAWPAYLGLIITPSANASVIINGGLPVATSLIAVFFFGARVTKGVILLIGFIFLANILTFMDAELFNRRYFIGVSLLAVATVSLAIYMAAVKAWEVSVKDIMVWVPLINTAVMTPIWLVFSDGLTSFTSLPVNELLFHVIYQGVIVSVVALFLFSFAIRAIGAVASSVLMAFVPSVTAVLALLFNNEVPNSLQWLGIACCSIGLIIYSSWDVFRKKLRAP
>fig|203123.5.peg.94 Drug resistance transporter, EmrB/QacA subfamily
MNQKEGIIDKTTMTTAWVLVFGALAPLLDSTMINIAVHSLVRNLHSSVSTIQWAVTGYVLATAIAVTFSSWLLNQFDGKKVFLAGEIIFAFGSVLSALAINAQFLIGARLIQGFAGGIIMPLLTTLLVQTAGQKVMGQMMATVGLPIIIGPLVGPIIGGIIIKYLSWQWIFWVNVPVAVISILLILWKMPSYPAQNKSAKMDFVGIVFLAGATTSMIYGIVKAARKASFANKDTLLFIGLGLALALLYVFWAMRIKDKAVLPLNLFKYRSFNGSVLGLLIAGTVLNGAMLALPLFFQEVRGMSVMMAGLALIPQGAGMLVSRTLTGKLTDKFGAKYVVLTSLIITFIGTIPFYWFNHETSYWIIALVLFVRGIGAGGILMPLMADSYTGMQGALIPAASIGSRTIQNIGSAFGTAIITTLITAYSNAKIKGFKQNISSANYHVKAANMSQFVARHLDLIQIHAFQYGFFCISIAALLIALPTFLLTNKIEKNQ
>fig|203123.5.peg.97 Drug transport protein
MKNKLFIATLISYLGIYITMPVLSAISTKAHMLPGQIGVMISLGAIAMLVFAPVWGKLSDKLGRKTVIVAGLMGMGVMFILYTALFRLSISQSKTITILVILLMAVRFLLGIFMTTAPTAANAYMADISYPENRAKDMSSLGLATGLAMVLGPIIGGILSSIGTLYLPFYISIIMLILFGFIFITILPKKDQEKTIPKKLIISKQLLKIRKVFLLSNYLGG
>fig|203123.5.peg.1051 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKRLLIQTHRLNNLLLASIFCGAISTLLQIFIIAAAFYLIIQHQFSWTYALILLFVALALGFSRFGEQYLGHFIAFHLLADLRTQLYDHLLSLAPAKLDDKESGKILKLLVKDIEQIEVFYAHTIAPVVIAVLLSFLQSFLIFLFSPLMGTLALLSYFWIGFVLPLFRKKKIENTSSSLSKYETENDQLLSETVNGKSLLQQFQKIEQRISLLDKQRDLIGNTIKKGTFSDSAAATATQLSLLFFSIAMGYLAFNFSVGNTLCWVIAFTFPFSFGRVLALANLPSSLGNALLSAKNIFKILDEKAVSNLSENQEISLIKQSRFVDVNFSYPLRPNKTVLKDASLIGKKSEVIGIIGESGERKSALMKLLMKWYQPKKGLIEVYNHDLRKIKKSGLRKQINYVAQNPLILSGTIRENITLKNNSFSDSKIWESLKKVELDKTVKKMPKELDTKISRLEQRFFFRRIAKTGNCQSIAVPEFNIDFRRTDKQLGHP
>fig|203123.5.peg.1354 Multidrug resistance ABC transporter ATP-binding and permease protein
MRNPAARMSGNGNGPRPMARVAEHPHNFWGTTVRLFKYLGRNRIGVVFSVLLAIGSVLLSVSAPKILGRATTIIYKGVVAGLKSEKYQISYQPIIKILIEVSIIYVLSALMSFLQQVIMTRISQKTIFRLRSEFKAKMARLPIKYYDQHQNGDIMSRVVNDMDNISGTLQQALIQIVTSALTFLGVVFFMLTISWSLSFIAFITVPISIFVVRFIAPHAQKLFARQQAVLGIMNGQVEETFSGHEVIKTFDREIPVIDRFEKQSQKYYQAAWKAQFISVLIFPAMQFLNNLDYLLIAVFGSIQVANGQLPLGDIQAFLQYTNQFSQPITQIANLSNTIQSTIASAERIFEILDAKEMTNDFKNLPKNIKNPKSLLSFDHVKFGYSDNLLIKDYSLKVDKGQMIAIVGPTGAGKTTIINLLERFYDVKDGSIRYKGFDTRTLTRPEARSHFAMVLQETWLFTGTVFDNIKYGNEQATEEQVVSAAKEAYADGFIRQLSKGYQTILNESASNISQGQRQLLTIARAFLADPEILILDEATSSVDTRTEILIQRAMEKLQSSRTSFVVAHRLSTIQNADNIVVMNHGSIVETGTHEELLDANGFYADLYNSQFSNGAI
>fig|203123.5.peg.1355 Multidrug resistance ABC transporter ATP-binding and permease protein
MFFQVAADLILPSITANIVNIGVVKHDISYIWKTGLVMLIVSFFGIVGAICNQLLAATSSQKLGVKLRSFMFRKVTKMADGDFEKLGQASLITRTTNDVVQMQNATYSMLRMMIRSPMMLIGASVMAYFKSPRLMLVFAAAMPVLALVVILVMTKSVPLFKKIQALTDQINLVFREGLTGVRVIRAFNQDEFEQNRFKKANINLTQNAINAYVITSLMSPAMTFIISASNIAIVWFGAHLIAGSLMPVGNLLSFITYATQMLFSFMQLSMIFVVVPRAQASAQRIQQVLDIKDTINDPIKPKKLDPIDDLKFSHVDFTFSGSSKKVLDDINFEIHKGQTLAIIGGTGSGKSSLINFVPRLFDVSGGKVLINGDDVRDFSQSDLHKHISFTSQKSFLFEGTVRGNLKYGNSQASEQDMNRALEIAQANSFIQEQGGLDAPVEQGGNNFSGGQIQRLSIARAVIKRADIYIFDDTFSALDFKTDANLRQALSEDKKIKNAIKIIVAQRVSTVADADQILVLEDGKISGLGTHQELLKNNSIYKEIVDSQLHKNDILAKSGGKIYA
>fig|203124.6.peg.354 Multidrug resistance protein
MSKKTVSQNIKNSIKIYQDSNFQIIIGIISMAILGGPGISPLLPSIAKNWNISPEHIGWVISAFFIPITIGTPISGILADRYGRKQILIPALILFAISGTLCSLAPNFQTLIGLRFVQGIGAAPLESLTLTLISDFYSGKLLTTAMAFKTMSVGLSLVIYPLISSGLTTWGWRYPFLLYLIAIPLSIWILFSLKNPAIPKQKSFNLKKYLRNIWQSFNNYQVRSLLIVIIVNFIFSLGPCLTYIPLFADRQLGASYIVIGIILASRGIFLAFASSQLGIFAKYLSELTLIKISFIIYCIAFIMIPTINNIWLLFIPGILLGLAHGMLVPSTQSLLGQLSPENYRAGFMAVTSSALSFGRTLGPILAGSMFYIGGMAGVFYSSSIVSLVIFVFISYLVINTQSIKS
>fig|203124.6.peg.3596 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQKLTEGKISTLLLKLTLPTVWGILALLGFSIIDTYFVAQLGTKELAAISFTFPVITFLNSVSIGLGIGVSSCISRAIGKRVQTPVLDRDDYKVKRLTTDSLILSLLVGAILVILGLATIEPLFTALGAKAETLPLIRQYMKTSYLGGIFAVVPIVGNSIIRATGNTFVPSVVMTVAGIVNLVLDPILIFGVGPISGMGLQGAALATVISMVATLAASLFFLHYHQQMICWKLPSFKLLLRNWQNILSIAIPNIGQNIIIPISVSFITSLIATYGTAAVAAFGIASKIEVFCFIVFLALSSSFIPFVGQNWGAKQYNRVYLGGNLGFKFSLFWGAIIAIALAIGGSWLVSIFDSDPEVIEVATKYLLIMPISYGTLGITLISSATFNALGKPLPSVMMSLIRVLFLYVPLTYLGSWLLGINGIFYGTCFANLVVGIGAYFYFNKTFKFNN
>fig|203124.6.peg.4212 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MEITWKDSDWAYLKAGDDGLALLSPTYEQAGPHFGFVFSDRSEMEMAYKQLQAKEVEVSPIHEHRDGTASFYGRDLDGNWFEYLYEPVN
>fig|203124.6.peg.4627 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSTSKKLSTLTKSLFSAQIIVMTGLIWGVLALLFFLLFSVPLPGEELPSWYSVGTYIFELGAYLIATIISFRNWQSPQMVSGRNVWIGISLGLLFYFIGGLVFGCWELIWELDPDVSLADIFYVFSYIFLAWGMTLAITAKKLNLEFWQWVVLALVAAGGVLLAIFVADPSFFGLLSTPDTTVLEELDTIKIESAQLAPSWVLALDNKLEPFSFWLNLFYIIADVFLLIIATALLLAFWGGRFSQSWRMIAGATFSLYIADMYFKWADSQTTGEYESGGLLEVFFVFTAILFAIGAVLEYDISTRSRQSRRSRRSSSS
>fig|203275.8.peg.258 Tetracycline resistance element mobilization regulatory protein rteC
MNMKRRKDDSRTYFLDELREELNRRMKESDLKGGKFKKR
>fig|203275.8.peg.345 Acriflavin resistance protein
MDNPMSAKKSISAFTVIVAFLSVALMGLALVPLLPVKLAPSHTLPGLTVYFSMPNNSARVIEMTATSKLEAMLARIKGVKNIYSTSGNGWGSVTLELDKHTPIDAARFEASTIVRQTWHDLPREVSYPYISVRRPDENAARPFMTFTVNSAAVPVVIQQYAENNIKPRLNDIAGLYKIEVHGATPMEWQLMYDNDRLQALGVTVNDIREAVSQHYTTDFLGMAETRSADGTAAWMRIMLMSGSRNDAFDATAITVKNCDGALIRLDQLVEVVHTEQEPQSYYRINGLNSIYISLTAEESANQLRLSERVQETMDEIRRLLPPGYEIHSSYDATEYIHAELNKIYLRSGLTVLILLLFVLLITRNVRYLFLITVSLTINLAIAVIFYYLLGLEIQLYSLAGITISLSLIIDNTIIMTDHLMHHGNRNVFMPVLAATMTTVGALSIIFFLDEKIRLNLQDFAAVVMVNLCVSLAVALFFVPAMAEKIRLKKRISRTRILRWFPLRPKRLIVWFNRFYGAMIRLLSRRKWIPFTAIVLTFGLPVFLIPDKIEKETKFAEQYNRIFDNATYKEKVKPIVNKVLGGTLRLFVDKVYQGSYFTRNEELILTITASMPNGTTLAQMNALVEKMEHYLSSFSEIRQFQTHIPNPRRASIRVFFTKAAERGGFPYLLKSNVITKALELGGGSWSVYGLQDQGFDNSVREFAGNYGVKFYGYNYDELGAWADTLKNTLLLNRRIKEVTINSDFSWYKDDYREFSFDLKKERLAADGFLPGDLFASLQPIFARDMWAGSLIIEGEREDIKLASHQGKHYDIWALRHVAHRMGGRMYKLDELADISQGQAPQEVAKENQQYRLTLQYDYIGSGTQGRKMLEREVKALSERLPMGYTVEQRDTQWGWGHKDKKQYGLLGLLIIIIFFTSSVLFNSIRQPLAVIFVIPVSFIGVFLTFYWFRLNFDQGGFASFILLSGITVNASIYILNEYNRVRRLRPRLAPIHAYLKAWNAKIIPIFLTVVSTMLGFVPFMAGTEKEAFWFPLAAGTIGGLAMSILGLWIFLPLMTIRGKKAIK
>fig|203275.8.peg.458 
MKKIGLLLMVIALIGTMSCNGGKSVDTDTLCAEKVAAAVQAACDSIRAAQPVRETKIIVARATVKSGKEKAFLEIAKKLVEATRAEEGNVSYTLYQSPEQPTTFIFYEAYKDAAAFETHASSEHFKAFADAITDLLDGDLLVEKF
>fig|203275.8.peg.1110 Tetracycline resistance protein TetQ
MNIINLGILAHIDAGKTSVTENLLFACGATEKRGSVDKGDTITDSMDIEKRRGITIRASTTSIVWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFKTLQKLQIPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGVVYPICTSTDIRAEHKEFVCNHDDDILELYLADKEILPADYWNAIIALVAKAKAYPVLHGSAMCNIGINELLDAIISFIFPPASVPNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRTVIKVNDSEKFIKIKNLKTIYQGKEINVDEVVANDIAIIEDIEELRIGDYLGVKPCLIQGLSHQHPALKSSVRPDKPEERSKLISALNVLFIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKTHFDEIKTIYKERPKKKVNKIIHIEVPPNPYWASIGLTLEPLPIGSGVQIESEISFGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTYALYYSPISTPADFRQLSPYVFRLALQQSGVDILEPMLYFELQIPQVASSKAITDLQKMMSEIKGISCNKEWCLIEGKVPLNTSKDYASEVSSYTKGLGTFMVKPCGYQITKGGYSDNTRMEEKDKLLFMFEKSVSSK
>fig|203275.8.peg.2442 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVQKPLSALETEPVGSLLTKYALPAIIAMTAVSLYNMVDSIFIGRGVGAMAISGLAITFPFMNIAAAFGALVGVGASTIVSVRLGQKNYGAAQQVLGNVVCMNIVIGGVFTLVSLIFIDPILYFFGAGEQTIGYARDYIVIILSGNIITHLYLGLNSVLRSSGHPIQAMMMTVTTVVLNTALDPLFIFVFGWGIQGAAIATVLSQCVTLMWLLFLFSDKKRLLHFRKDMLKPRIGIVKDILAIGMAPFLMHLASCMIVILINNGLKRYGGDLAIGAYGIVNRFAFMFLMIVMGLNQGMQPIVGYNYGACRINRVQKAFRLTVFFATLVTTFAFLLAQLKPEWIVRVFTTDEELIRLSVYGMRISVMVFPLIGAQMVITNFFQSIGMAKKSVFLSLTRQVIVLIPCLLIMPKLFGIAGIWMSMPVSDTVSALVSIAMIYVQLGKFNAKQ
>fig|203275.8.peg.2815 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNAVNILQEGSMMKALTKLGIPIVIAMLIMAIYNVVDTFWVARLGTLPVAAVSVVFPLSLLFLGIGLMFGVGGGVYISRLLGAKQIVKAGQVASVSVITSVILAALIALVCNAFLPDILLFMGANTGMMHLAEAYGRLFVISCVIGALNVSMSNIIVSQGASKTSASAMIIGSVVNVTLDPLFIYTFGWGVEGAAWATILSRIITTAIYIRFLTKAEVKVSFALFVPTIRMYAGIIKIGISMLFLQSLQTLSISLLQRAAVKYGAEAVAAVGIVLKIVTLGTNVVFGFVKGLQPMAGYNYGAGNFQRLKEAVHCSLILTTSFCVLWSILIMAFTSPVISCFGKDETMQEIVRIALRANTIMFFTFGFQFVYSTLYMAIGRARQSLLLNIGRQGLFFIPTILLLPSYWGLNGVLYAQPVADVFATLMTLLFAVRIHREIGHQSHLTTENL
>fig|204536.4.peg.683 
MIVVLTKFPIKSEFMKDFEERSKERFGEHGIDKMEGFLGMKILAGRSFPSMPQNNQVVIITYWKDMESFLNYTKSQAFAEAHKNPPPKEWFVGNPSVEIYEVIKEV
>fig|204536.4.peg.1198 Acriflavine resistance protein E
MNKKVITAISVVVIIAVAFFILKSIEKKSKSQTDQRPQKPAPAVKVIIPEKQEVPIYYTANAVLQAKTSAKLKPQVSGRVEKIFAEEGSFVKAGQPLAVIQPEKEEYQIESQLAVINQLEANYLNKKSIYERRKQLYEKELIAKEELDNAKTDMEVALNQLNSAKATLKEYKRQKNETVIRAPFDGYLDKRYVSIGDYVDSQKDMFYILKLNPIWAVFELPQQYVKNLSLGKEVEIDVDGIGAVKGKIDYISSSLNENNLIVVKVLLDNKDGLLRENMYGKAKILVDKVEGYKLPEDAVQLAGNDNFVYKVVDSKAEKVLVNVLKQEYGYVYVSGDLKQDDKVIVSNLMNVKHGMPVKVIQQPEVAK
>fig|204536.4.peg.1203 Membrane fusion component of tripartite multidrug resistance system
MNGKGKKVGLIITVLLIVVFLIYAVKWINHRMKYAISDAVFVESDYLSNIGFNRVSGRVVQLYKKESDEVKAGEVIAKIDDTDYKLQIEALEKEIEALTYQKKQLESQLQRVARETDINESISALTVEEISKKLESLKAQKDQIESQIKLAKKDEERYRNLLEKGLVAKRKYEEVHTNLEVLEKQKLAIEKNISELKVSMEKSKKSVEYAKTQKSITEELQNQINAISSQIESLLKKKQDLENQLQYTELKAPFNGVVAKKFVSIGDVVKAGQPVYAILKSDSFYVKVLLEETKLEGVKVGNKAYIKLDAYPDKTFEGVVESIDVASAAKFALVPRDISAGEFTKLAQRIPVKIRITKGDISLLRVGLGGEVEIEKSR
>fig|204669.6.peg.497 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MEYVSYSIVIPAYNESDRIQESLTKIVAFLAEQSWTAEVLVVNDGSRDNTAEVVKRFAAQHRFIRLIENPGNRGKGYSVRNGMLQAVGDVVLFTDADLSAPITEAPKLFSEIQKGVDVAFGSRWLVAKMQTERQSIMRQIAGRMYNVIMRIVLGLNFKDTQCGFKAFNRKALETIFTRQHVERWGFDVELLFLARKFKLKIEEVPVEWAHDDRSKINPLVDGIKMFGEMLSIRWNSIVGRYTNPHLPKPVVTDATPVVKIAK
>fig|204669.6.peg.594 Multiple antibiotic resistance MarC-related protein
MAADAGVADFDVFDALAPFNSHFLPFGLAVLTRGRFLCEDRSVGTIVFQVGHIMRGAFEAHIVQFTLVALSSVFFLVDPFAIIPTFLVMTARHDPITRRRMAARACWTAFIVLTAFAFAGTAIFKIFGITLPAFEIAGGLILLLIGLDMMQAERPTQEGSPETAEGSVKDDVSITPLGIPMLAGPGAISTVMVLNGTARDWSTTIPVFAAIALTCFASYWILRGAERVSQKMGQTGIRVLMRIMGLLLMAIAIQFMINGLTNLGVIHAD
>fig|204669.6.peg.1047 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MRVTGFGGLFFKSPDPEKLYQWYETHLGIKRSEWGVSFKWADDPHAADGQTAWSIFKSDTKYFNPSQASFMMNFRVEGLKDMLAKMRSEGAQVDEKYEETEYGNFGWVMDPDGNRVELWEPKD
>fig|204669.6.peg.1425 Permease of the drug/metabolite transporter (DMT) superfamily
MSRSLKAHILLIAVTFVWGSTFVLIKAALADVTPLLFNAVRMTLAGLALGLVYWKALRKMNRAEFIDGMLVALMMYFGYEFQTSGLKLTTPSKSALLTGMSVVLVPLILHFGWRKHVSKWTIFGVLIACVGLFLLTVPAGTSRGFSLTEMNLGDLLSMGCAVCFAFQIILVGRASERHGFEPIAFLQVAGAAVLMFATVPIAEHAHVTWSSTVIWAILVTGLLGTAAAFTVQAWAQQFMPATNTALIFLLEPVFAWATSFVILHERLNSRSSLGAVLILVGVVLSELLGSQDHPSEEIRVS
>fig|204669.6.peg.1465 Multidrug resistance protein B
MSSAAVQQQEASATSPWLIAIAVMLATFMEVLDTSIASVALPHIAGSLSATNDEATWVLTSYLVANAIILPASTWFALRFGRKRFLIICIAIFTVSSFACGAATSLWMILAARAIQGAGGGALQPLSQAILLESFPPQKRGLAMAVFALGVVVAPVLGPTFGGWLTDTYSWRWAFYINIPIGILAVFMILRYVVDPPYIKNAKPGRIDAIGLGLLAVWLGALQIILDKGQEVDWWSATWLRWATLVLLVTFIAFLWWQFTAEKPLVNLRVFTHRNFTLGCIMIGLFGAVIYGMVTLLPLFYQELMGYTALNAGIAVSPRGVGAIVAMPIIGILTSRIDNRWLIAFGFALFGICSIWFGEVYLGIGPWTFIWAIILSGFASGCVFVPLSTTTMAGLRNEEIGNASGLYNLLRNIGGSIGISIVNMIVARHSQTHRNDLVHNISAQNPNFHNQFGAIANGLKDAGSGGNGAPLWDSTTRAWGVVNGMVERQARLWSYVDDFRYLALVCFACVPLVFMLKKAVAKKGAVGAAH
>fig|204669.6.peg.2304 Permeases of the drug/metabolite transporter (DMT) superfamily
MSFKRYLILLGVIVFGALGDCFLSRGMKELGSISLGNWHMAFQIFGNPWVVSGVICLLCYFASYLTSLSWADLTYVLPASAVGYILIALIAKFFLHEQVSFVRWLGILLIVAGVCFVASGSHVTPRESETPAEAVEVRG
>fig|204669.6.peg.2305 Permeases of the drug/metabolite transporter (DMT) superfamily
MKNVYTWSFIFAVVFASTAGDILQSHAMKKIGDVGKLRRERGIPYVILRVVTSPSFMLGLMFMAIAFYSLVIALSWGDVSLVVPASASMTFITNAFAAKVFLKEDVDKKRLVAAVLVAAGVALLAY
>fig|204669.6.peg.2625 Permease of the drug/metabolite transporter (DMT) superfamily
MTSEHSSHPLRGYLYVAAATLCWGISASLGRAAFTGKLLGGLRPIDPLILAQARTTIAFFLVTPILWTLRGRSSTKLPRREMLQAFLLGVFGLAFSNYAYYLAIQKTTVATAIILQYVAPVWVLLYMVFTRQQRATASRVWGVVLAVLGCVFAIGVFAGVGHFPFLAIAAGRIKLNTVGVLAAQVAAVSFAFYSIYGRHLLQVYDRWAVLTNSLLGAALFWIIVNPPWKIIAAHYAPKQYAFMVLFSITSAAVPFSLYFAGLHHLDATRVIVTAALEPVFSVVIAAIFLGETVTLVQMAGMAVVLSAISFVQRSDGTAPAIVVDPIE
>fig|204669.6.peg.3097 Multidrug resistance protein B
MEVWVSATTAPPGVLATEAGGVREINPWWVTAAVMMAVFMEVLDTTIVNVSLPHIAGNLSASVDESTWVLTSYLVANAIILPMTGWLANHFGRKRILMSSIIGFTLASVACGMAPNLSSLIFFRVVQGATGGGLQPLSQAIMLEAFPGKKRGKAMAIWALGIVVAPMLGPMLGGWITDSYSWRWIFYINLPVGLLATMMSQWFIFDPPYIKRSSDVVDYWGIGFLIVGIGSLQVMLDKGQEDDWFGSHFITTLAVLTVVGLILFIMRELMAEHPIVDLRVFRVRTYATGVFLMTILGFVLYGSTVLIPIWLQTLMGYSSLEAGFAVLPRGLGSFLFMPLVGVLMGFVEPRKLLATGLITAGGSLYFLSLLNTQAGYWDFFWPQLIQGAAMGLLFVPLTTITNDPIAPENMGNATSIFNLMRNIGGSIGIAMTTTIVARSQQLHYNNLVHNMSSYNPKVQQMMAGARGMFMSKGMDAHSAGLQAYHSLWGMVMQQAMMLSFIRAFQILSGLFFICLPLILLMRKPKHNEKGGGGMAH
>fig|204669.6.peg.3099 Outer membrane component of tripartite multidrug resistance system
MSFSVNPKSCFWKLTKRLNLALIAFICLGIAVSANSQAPGGGLTASPAESPAAQSPSQSLSGSPLSGSVVVLKPTGDVLNLSIKDAIQMGLKYNLGVLLSTEGNEAARGAKIRALAELLPNLSARVGGAVQQVSLAQFGFPATLTGGKLVIGPFAYFDARTYLTQSVFNYTALQNNHAADENLKAANLDYRNTRDLVVLVSGASYLQAVAATSRVDAAQAEFTTAKATYDRAVNLHTAGVIPAIDVLRAQVQMQSQQQRLLAAKNDFERSKLSLARVIGLPTAQQFALSDKIPYAPLPPVSFDDELKRAYDNRSDYKAAQARVKAAEDQRKAAVGERIPTVAINGDYGVIGPHFTQANGTFTAAGGINIPIFQGGRARGDITQADALLKQRNSELENLRGQIEYDLRTAFLDVQTAAEQIDVAGSTVKLAHDQLEQSQDRFSAGVADNLEVIQAQQAVAVANENYISSLYAHNFAKLSLVRAVGVAETAVMNFLGGK
>fig|204669.6.peg.3678 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSAETAVTTSVSTGKPQRAALAFSFLSTWIIWGSTYLAIRYAVETIPPLVTAGVRHFTAGSVLFAYCYFRGFRPTAKHWKGAFLIGAFYFLGGHGTLHWAEQRVSSGLAAVLIATEPLFIAAIMIFTGKERFSYWTLLGMLCGISGVAYLMGGEALHAPGQMVGILAVLAGSLSWGIGVCISPNAGLPEDPVASAGMTMFCGSLLLLTTAGVTGEIAAFHPHQVAMRSVLGLLFLIVFGSIVAFSAYVWLLGQVSPTMVSTHTFVNPAVAVLLGWAMAGEALTARLLVATLAILGSIAFIRRGTRAAAH
>fig|204669.6.peg.3977 Permease of the drug/metabolite transporter (DMT) superfamily
MTEVQSRHRLQVILAFGLVYVFWGSTYLAIGIADDEKIPAAAICAMRFLIAGTLMLGACALMRKKIRVSWEEFGRLAMVGFLLLVCGNTGLTWAEKYVATGFASLIVAITPIWIFCLESFVYKGDKTSGRGIIGLALGVVGTGVLFWPKLMNPEIRGGMQLLGAVSLLGSSFCWANGTVLSRRWKSKFTVDPITATAYEMIVAGTVNLCISLALRQHNIRWTHRGVGAILYLVVFGSWVGFTAYIWLLKHVPTPKVATYAYVNPIVAVFLGWAVLHETIDRYIVAGSVVIVAAVAMVTIAKVKSAPAVQMVEVETTGD
>fig|204669.6.peg.4464 Permease of the drug/metabolite transporter (DMT) superfamily
MNLSTQTSVNTAPTRGSAGALAITALVLSGCCWGTGFLFGKIALEQMSVTENVAWRFIFGSLGLLPIIFLRWQPYTRRDWVSLLIASFVGVPIQFLIQFKGLQLTTVSHASLMIGTLPIMLAMSSVIFLGERLHWQEWFSLAIATFGAVLIALSHGNGVGSPQASVVGDVLVVLSLLAAVVMVMITKKLIGRHDSLHVTSMMIVLGTLMLIPWAVLTHPMRFDFSTSTWIGVAAQGFIATSGAYLLWNWGLAKVPASRAGVFLNMEPLVGALLGVTVLHEHLGWPALLGGAMVVGAAIHFSKTS
>fig|204773.3.peg.212 Multidrug resistance ABC transporter ATP-binding and permease protein
MLTATIPRQKHKPFENFSPMRRSSASSEPAPLSSGNRNDWATLKTLIPYLWTYKWRVALALLFLIAAKFANVGVPLVLKRLIDGLTIDPASPHALLVLPVGILFAYGALRLSTTLFTELREYTFAKVTQRAVRTIALQVFRHLHALSLRFHLNRQTGGMTRDIERGTRGISSLVSYTLFSILPTLVEITLVLGYLVLHYDIWFSIITAVALVSYIAFTVVVTEWRTHFRRTMNDLDSKANTKAIDSLINYETVKYFGNEDYEAKRYDEGLKRYETAAVKSQTSLSVLNTGQSSIIAVAVTLILWRATQGVISGTMTLGDLVLVNAFMIQLYIPLNFLGVIYREIKQSLADMERLFSLLDQHREIADKPNTQALVVQGAEVKFSHVGFSYEAKRQILFDVDFTIAAGTTTAVVGHSGSGKSTLSRLLFRFYDVNEGAILIDGQDVRDVTQASLRNAIGIVPQDTVLFNDTIEYNIAYGKPGASKDDIVAAAKSAYIHDFIESLPDGYATMVGERGLKLSGGEKQRVAIARTLLKHPAILIFDEATSALDSKAEQAIQAQLKEIAKDRTTMVIAHRLSTIVDAAQILVLDHGRIVERGTHAQLLAADGAYAQMWARQQARQDESPASPTDDDAVAESLLHELHTDMLPDA
>fig|204773.3.peg.368 Probable drug resistance transport protein
MSLALENVNVILAGNPVLRDISMHIEPGELVCLVGRNGAGKSTTFRSIMGFQPLKSGAIKWKRSAINGMQTHKIVELGLGYTPEGSDVFGDLTVEDNIALPTWTRKSGRSAQERIDEAYAVFPKLKQYLHRGGQQLSGGERKMVSIARALALDPELLLLDEAFEGLSPAIIPTISEGLQSILKQGRGVLLAESNFYHLPPFADRLYVIERGEIVFEGTLAQAEADAATMKIIKGA
>fig|204773.3.peg.369 Probable drug resistance transport protein
MSTNDVLLQAQQISRHYGDFIALHNVDLSVSRGEFVSVVGPNGAGKTTLVNVLTGLHQPTTGNVHFNGSNIAGVGAVDLATRGLARAFQLTSIFPELTVRETIAVSACSYLNMRWNGFGSLFGSRKVNDIVVRTADAFGLAPWLDTKGSSLPHGRRKLLDVASAFALHPKVMLLDEPTAGVSTADKHGVMETLLRAAKHMGIEAIMLVEHDMDLVSRYSTRIIAMQAGKKIADLPRDEFFANEEIISIVVGKGAH
>fig|204773.3.peg.990 Glyoxalase/bleomycin resistance protein/dioxygenase
MQPRISVITLGVDDLEKSLQFYRDGLGLQTQGIIGKEFEYGAVVFFDLQAGLKLALWPRKSMTHDSGIAVAPVSATEFTIGHNVSSKDEVDAVMLQAQDAGAIIVKQAQTTFWGGYAGYFQDPDRHLWEVVWNPAWAAPD
>fig|204773.3.peg.1367 Permeases of the drug/metabolite transporter (DMT) superfamily
MTQKITPSTALLLTIAPLMWAGNAIVGRSINALVPPLTLNFFRWSIAAIILLPFASWIFRRNSALWTHWRRFALLGLLGVGLYNSLQYLALKTSSPINVTLVAASMPVWMLMIGSMFFGVRVSAKQALGAVMSIAGVLLVLSRGELQQLLALRLVPGDILMILAAIIWSFYSWLLTLPKDPAQIRANWIAFLLAQVAFGAVWSGAFSAAEWTFADPHIVWGWSLIAALIFVAIGPAIIALRCWGLGVQRVGPTVAGFFSNLTPLFAALMSAAFLGETPHLYHGLAFLLIVGGIVVSSRH
>fig|204773.3.peg.1378 Multiple antibiotic resistance (MarC)-related protein
MLILFFKAAILIPITLVPILNPFGNAAIFASLAGDIDRDAEKRLARQVAINCFVMLLGTMFIGSHVLMFFGISLPIVRIGGGILVAATGWRLLNDKGQDDIRTQVASKPREVWSEDDFKVRSFYPISFPLTVGPGTIAASITLGASAPSRLSNLFVSIGSAALGAAMTALVIFLCYRYANKMVRLLGRLGTMVVLRLSAFILLCIGIEIFWQGMLGLLAEAGITLH
>fig|204773.3.peg.2545 Multidrug resistance transporter, Bcr/CflA family
MPDTPKPSIRPAATVAIASSALAIMLAALSMLGPFSIDTYLPAFPNIQTSLGASALEVQQTLTAYLFSFAVMILWHGALSDAFGRRNIILVSLAVFAVATLGCAAAHSIEYLWAFRMLQGISAGAGVVIGRAIIRDLYAGAEAEKLLSLVTMIFSIAPAIAPMLGGWIVKRMDWRAIFLALFAYAVLLLLYCYKRLPESLPPEKRHPFNPQFLYQSYKRVFRSPLFHLKAGAVAFNFAGMFLYVAAAPVFLVEHLGLGPDQFGWQFVPTVAGIFCGALSANRLAGNIPLDRQVLIGFALLVGASVFNVVYHALYPPMLPWSVAPLFFYTFGMSMVAPGVTLMVLDLFPHIRGIVASCQSFVLMLLGALVAGIIAPVLSHSPVSLAAGQLLCAAIALSLWLGGRSYRRALDMRKKANAWETVE
>fig|204773.3.peg.2962 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MLKMGMSAPAIQQAMSNGMRSVYWLALTSPLIWGGMVCFGASAGLWLLVLGKLEVSMAYPLISLGVVLTTLAGIFILGESVSIYKVLGVSLVIAGVLVLSVKS
>fig|205914.5.peg.27 Tetracycline resistance protein tetA(P), putative
MRHYEKIITSCVSTSATRMLIGAVSTIYMLVSGINLYEVGLIKSTQAILIFVLGFAVGILSDRIERKWLHITALIFSTFWLYFFYLAGLYKSFNLFLLAEILNAISLCVYQNNTNAYLVDQFYHEQPKGELSLALGKLGKWEFSLMAFSALLGGVLYSTLSENLFLLTTIIMSTVTVASFILLPKVSRRATHKTLPFIQKQDFLILIRKFSRYKQAIFLFVVLSLYFQIIIQYWQAVVYAINKSEQNGLILGGMLFSMFMVQSWAGKAIEVKYPFSRLTLALSFLSSMVLSFFAERWQSVFFYTIAICLALFVVRYTVIQTDTELHRHLLSRFRAKYDMLLNSLVRILTAVVLLIIGYISNLYGIQAIQIIGLIIAIIFTLFALITSQNVK
>fig|205914.5.peg.1331 Permeases of the drug/metabolite transporter (DMT) superfamily
MEHSMLTEQSKKHTALLSFLPVLLLIAIDFFTMSLQAQAKAISHLSLAVLVTQLLCILVFAKGEICNGQRFRLVKVNLYFLIYWGVWLFISLFSNYHYVLTDIVCLCGIALTLAIWQQPQDLQMRKSLLVLGTLVGVLGIVTYCLMFIDLPLLYFSQYNPVAQALLGIILANLLLVIAKNRLQGFIILLPFLMLITLLLNAIIVLGILFFAISQQVVFSNEFSWGLYFILHLVITCIIAIHLFYKWKFEYYVLLIMSFIVMSFPLWVSFAYVF
>fig|205921.3.peg.1069 Multidrug resistance protein B
MTKKGWRIMPAIITTAILGFSGILIETSMNVTFPLLMKEFGVNPAVIQWVTTGNLLAVAVTVPLSAFMIKNLSERQIFTLANVLFLSGVLIDSFAPNLPILLVGRVLQGVGTGLALPLLFHIILTQIPMERRGLMMGVAAMVTLLAPAVGPTYGGVISGMLGWKMIFMLLAPILIISTFIGLASIPKRQVRINDKLNFPAFVSLGIGLATLLLAIEKMSIFYLLVAIVSFVIFYYLNKQLEFLNLNVFKDKDFSILLYGVLAFQMIPLALSFLLPNLLQLVLHQTSTKAGLFMFPGAIAVVFLSPFAGYLLDKIGAFKPIMIGISLSLIGLIGTAIFIPAKSVVVLLAFDILTKIGMGIGASNMVTTALTKLKPAQSADGNSILNTLQQFAGAFATAVASQIFTIGQVAIPKNGAIIGSQFAVLFVIVVVILAIVGLTYLRKRKAI
>fig|205921.3.peg.1249 Multiple antibiotic resistance protein MarC
MISKFILAFMAFFAIMNPISNLPAFMALVADDDQKISRRIAAKGVLLAFVIIVIFVLSGHLLFNLFGITLAALKISGGILVGIIGYKMINGIHSPTNKNLEEHKDDPMNVAVSPLAMPLLAGPGTIATAMGLSSGGLSGKLITILAFAILCVIMYVILISANEITKFLGKNAMTIITKMMGLILMTIGIEMLITGIKIGFHLT
>fig|205922.3.peg.264 Tabtoxin resistance protein
MNPAQLRRVNAESFAHYRQGLIELLLDAVGYGASVGFMADLDATQARAYFDEVQDNLNKGNVLLWVVVKDEQVQASVQLGLCQKANGLNRAEVQKLLVREHARRRGLGQQLMQALEQTARQYKRGMLYLDTEAGSPAEDFYKALGYTRAGEIPDYACDPNGTYRPTALYYKVLQGAN
>fig|205922.3.peg.643 Bicyclomycin resistance protein
MNPSLILLITCSTVFLAQLGMSIYLPALPQIAKHLQVDATQVAWGLSLYLIGMALPMLLWGSLAQRIGRKPVLLAALGIYGLANLALPLGATLESFLLLRLLQGIGASGISVMARVLIRDSFRGDLLAKALSWISISFVVALGIGQYAGSLIQVTLGWQAIFYLLGAVSLLMAAIVSRLSFPKLVEAPTTASPWEVYRTILIHRAFLLPALAGGLGYGVIIAFNSAAPLILQGPFNWSATAYGLLGWPISAAYFLGALAVNRFVLRTGQHRLMTLGVSLVMAGTGVMLAGSLLASSMAWLLWLPYCVAVFGQSLNYPISLSRANDGAPIAGAYAMALSGFIHQLMAALIGAVASLLASPQAWPLSMLCCVLAFGAVLCTRLTPDHQPA
>fig|205922.3.peg.789 Melittin resistance protein PqaB
MSRAASSLLLLAALLFFFALGSHQLQGSTEARVAGIAMEMHLDNDWVTPRLFGEPFLEKPPLSLWLDAGALRVFGVSPWAVRLASAVAGLLSVMLLYAMLRRFERPKAIAWTAGILLATMASYWSNVRGVGEDALLALGVTTALLAFFQAQRASNPGNSLLFVVGIAIATLSKGVLGLAMPGVVIFAFLLADNLMDKRFKLTDWLRPGLLTLVGLIPLMIWLAVLYQRGGVQAVSEVLLTNSVGRFSGSFVEAGHYEPFYYYLAKLPQAFLPWNILVYLGLWHFRKELKANRYLLFFSLWIIAQFILLTLASSKRTVYLMSMTPAAAVIAAEYAGVLFDRLKDHRNGFVGRIARHRQTVAAGILAVVIASYLGAAQWALPNADKHLSFLPLTEHIQALQASGNQVALFQANERVGGASVFYTQSVLKGLDTDAQLREFLSASPSNIAVISGDSEPAAPLKVHKTMMVGRQAYYFVGY
>fig|205922.3.peg.1000 Inner membrane component of tripartite multidrug resistance system
MAYRSKVALVYLLGFALDLLNMFAASIAYPDIAAQLRASVTQLAWITNAYMLGLTLIIPMSVWLAAKVGERRLILGSLLVFGIASGLIAQASSIESLIGWRLLQGLGGGLLLPVGQALAYREFPATQRAHFTGVVLLVALMVPALSPAAGGLIVEALSWRWIFLLNMPVALFAFGLGLRWLKADQAASERPKLDARGLLLAVAALSLLLMAVSLASAPATRHLAGGVLLLSVITLWIYLRDGWNKPGAVLDLQLIKNPSLRLAMLIYLFVPGIFTGTNMIAVLYLHDLGFGAAQTGALMLAWAAASGVAIMLGKRSFNRIGPKPLLIAGMLLQCLGIVVLMQIDQPASGPLILAYALMGLGGSLCSVTAQTLAFVGITPEKMGHSSALWNINRQLGFCLGAALLSSLLDALGANGFKYCFLAAALLTLLPMAAVLRFDSTKVLALLRSTHLQEKST
>fig|205922.3.peg.2452 Vancomycin B-type resistance protein VanW
MRRPFKFKEDNGPRRSPRMKPLSLYHPTLYWLRVWQKRLFRHIAWHCSSKRYARPATTSERLPYRYLKHTSKLIRKLGESDLALQHNKVINLKLAVAAIDGVTIAPGEYFSFCRLVGRPTRERGYVEGMELSFGEARTGIGGGICQLSNLIHWMAIHSPLVVIERANHSFDPFPDDGRVLPFGSGAAIFYNYIDLVLHNPTDRSFQLKLKVGETQLEGELLCDRERAYRYHVFEVGHRFVREGERVYRENEIWREVREKGQVGALVERERLYGNRVVVKYEVLEGMIEGG
>fig|205922.3.peg.2749 Permease of the drug/metabolite transporter (DMT) superfamily
MSCHEPVRPAASDMPVYLNLALVTMIWGGTWVAGRFLAGSLSPVFAASLRFLLASVALLGFLRLARIALARPTPRQWLQLALLGFFGIFFYNLCFFYGLRYINASRASLIVALNPAVIGLASWLLFKERLSRLKVIGIVICIGGAGVVIVSRHPQLLSETPDAWIGDLLILGCVLSWGVYSLFSRSLNQSIGPVQTVTFSILLGTLMLWALALSRGEVDVAALAALGSRQWLSLAYLGVLGSALAYIGYYDGIRKIGATRSGVFIALNPLTAVLAGAILLGEQLTLAMCLGGALILTGIWLCNKPLAPAGKKRIL
>fig|205922.3.peg.2816 Acriflavin resistance plasma membrane protein
MNLSGPFIKRPVATMLLSLAIMLLGGVSFGLLPVSPLPQMDFPVIVVQASLPGASPEVMASTVATPLERSFGAIAGVNTMSSRSSQGSTRVILQFDLDRDINGAAREVQAAINASRNLLPSGMRSMPTYKKVNPSQAPIMVLSLTSDVLEKGQLYDLASTILSQSLSQVQGVGEVQIGGSSLPAVRIELEPQALNQYGVALDDVRKTIAEANVRRPKGSVEDDQRLWQIQANDQLEKAKDYESLIIHYNGGAALRLKDVAKVSDGVEDRYNSGFFNDDAAVLLVINRQAGANIIETVNEIKAQLPALQAVLPASVKLNLAMDRSPVIKATLHEAEMTLLIAVALVILVVFLFLGNFRASLIPTLAVPVSLVGTFAVMYLYGFSLNNLSLMALILATGLVVDDAIVVLENISRHIDEGVKPMKAAYLGAKEVGFTLLSMNVSLVAVFLSILFMGGIIESLFREFSITLAAAIVVSLLVSLTLTPMLCARWLKPHKPGEENRLQRWSRRTNDWMVGKYATSLDWVLRHRRLTLLSLIITVGVNVALYVVVPKTFMPQQDTGQLIGFVRGDDGLSFSVMQPKMETFRRAVLKDAAVESVAGFIGGTNGTNNAFMLVRLKPIKERNISAQKVIERLRKEMPKVAGAQLMLMADQDLQFGGGREQTTSQYSYILQSGDLGELREWYPKVVTALRALPELTAIDAREGAGAQQVTLIVDRDQAKRLGVDMEMVTAVLNNAYSQRQISTIYDSLNQYQVVMEVNPKYAQDPVTLKQVQVITADGARIPLSTFAHYENSLEDDRVSHEGQFASESISFDMAEGVTVEQGSAAIERAIARLGLPEDVIVKMAGTADAFAATQKSQPFMILGALLAVYLVLGVLYESYIHPLTILSTLPSAGVGALLSIYVLGGEFSLISLLGLFLLIGVVKKNAILMIDLALQLERHQGMAPLESIRSACLQRLRPILMTTLAAILGALPLLLGRAEGAEMRQPLGLTIIGGLIFSQVLTLYTTPVVYLYLDKLRHRFNKWRGVRTDAALETPL
>fig|205922.3.peg.3020 
MIYEIALLPVHAERVDEFRRAFAEVAPLLRRANGYGGHMLAQGIETPERFNLIVRWDSLEAHTDFEAGEDHRVFMLGLERYFSEEPQVYHIEGAAFNAREGDGAPWP
>fig|205922.3.peg.3184 Multidrug resistance efflux pump
MKTLLTRLTTLAVVLLAIVLGWFAWEHYTRAPWTRDARVRADVVTLSADVSGRIVTLAVQDNQHVDKGQLLLEIDPARYSLAVEHAKRSVEVSKATLGQSQAAIVASEALLKQRQSEERRRRTLKQGFAISGEEWEKSSTDVAVAQADLLRNQANLGLAEANVQLAIAALTQAELDLQRTRVEAPVSGYVTNLLTRQGDYAVAGSALLALVDSSSFYVSGYFEETKLPRIEEGDRVRIELMSGEKFGGTVQSIAFAIADRENAPGSRLLANINPSYTWVKLAQRVPVRIGIDPDYSGKDRLRAGTTATVTVLENPERQAQKSPATE
>fig|205922.3.peg.3467 Membrane fusion component of tripartite multidrug resistance system
MTSMPTVEPDLAVPVSAPKPPLLKRLLLPTAGLAALVLAGLYAVHWWGTGRFLEETDDAYIGGDVTVIGPKVAGYIEEVLVSDNQKVKAGDVLIRLDARDYRANLAKAEGAVAAEEALLANLDATEQLQQAVIGQARAGIDAASAETARSRDDNARYKRLVTTNAVSVESAQRADATFKTAQALSAKAQAELLAAQRQLTVIETQKQQARAALQQARAERDLAQLNLGYTELRAPVDGVIGNRRARVGAYAQAGSQQLSVVPASGLWVDANFKEDQLARMKPGQRVSIRADVLSGQEFHGRLDSLAPASGSQFSVLPPENATGNFTKIVQRVPVRILLDPADGVLGHLRPGLSVTAEVDTRAQPETTAVASAP
>fig|205922.3.peg.3468 Multidrug resistance protein B
MSTALTAAAQPFNAAEMATATKVFAFATMCIGMFIALLDIQIVSASLRDIGGGLSAGTDETAWVQTSYLIAEIIVIPLSGWLSRVFSTRWLFCASAVGFTLASLLCGIAWNIQSMIAFRALQGFLGGSMIPLVFTTAFFFFTGKQRVIAAATIGAVASLAPTLGPVIGGWITDISSWHWLFYINLVPGIFVAVAVPMLVKIDQPELSLLKGADYLSMVFLALFLGCLEYTLEEGPRWNWFSDQTILTTAWISGLAGLAFVGRTLHVANPIVDLRALKDRNFALGCFFSFVTGIGLFATIYLTPLFLGRVRGYGALDIGLAVFSTGVFQIMAIPLYAFLANRIDLRWIMMAGLALFALSMWEFSPINHDWGAGELLLPQALRGIAQQLAVPPAVTLTLGGLAPARLRHASGLFNLMRNLGGAIGIAACATILNDRTNLHFTRLAEHLNSSNEAVNQWLAQVGGNFAALGQSGDVGLTASLRQLWLLTYREAQTQTYGDTFLMIMVCFGIATAMVPLMRKVQPPAAPSADAH
>fig|205922.3.peg.3993 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase (EC 2.4.2.43) @ Melittin resistance protein PqaB @ Polymyxin resistance protein PmrK
MTSENNPLRHTALFPSTTAVERWAIPGLILAFVMFYLLPLMSHGLWIPDETRYGQISQEMLLSGNWVAPHFMGIRYFEKPIAGYWMIAIGQAIFGDNLFGVRIASALSTGVSVWLTYLLARRLWNNPRINAASALLYMSFGLIAGQAGYANLDPQFTLWVNLSMVAVWFAIDNRTPRARLGGWALLGVACGMGLMTKGFLALLLPVLIALPYMLWQRRFGELVRYGLVAVVVCALVSLPWVLAVHYREPDFWRFFFWHEHIRRFAAGDDAQHARPWWFYLPLLFASTLPWALLLPSTLLRMWREKREAKMAYLALWFLLPLAFFSLSSGKLPTYIMPCLLPVALLMGQTVVKWLDQRSGRFLRLNGVFNTVLASVALVALLYLQATKEIYENTEMFSLSLAYIVVVGWIIANALQVLRPLTLWAMPALGIGLLVALLPAAMPAQIVNSKMPDQFIAEHQRELSETASLLSNDLGAASALAWRLKRPQVDLFNTIGELKYGLEDPAMEARKVTMDGVGQWMTEARKKGAVGVVLRVNSTQEEQEVELLPVDGKHYRRGNLHIFIFAQKQP
>fig|205922.3.peg.4073 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MSLWLLLLACLLTCLGQVAQKCAVENWRGADLSWSRKWRSPWLWLALFALGSGLLVWLLVLQRLPVSVAYPMLSLNFVIITLIARFVFKEPVDVQHWFGVLLVIGGVALLGQQS
>fig|205922.3.peg.4074 Polymyxin resistance protein PmrM
MNRRRGILFALASVLLVSVAQLSMRWSMTRLPRPDQWLSVPSVDSVALAVVLAAIFAYALSMLCWLAALRDLPLGRAYSLLSISYALVYLLAASLPLFNESFSFSKSLGVALVMLGVITINTRPARAPELRSSP
>fig|205922.3.peg.4076 Melittin resistance protein PqaB
MIKLSCTIRRQSLIAGLLAFVLFIAGVYGQAPIGFDSRFVLFAQEMLRHGPSVFPTTYGEPYADYSALSTLFIWLLSLPFGTVNSLTAWLPSAVAGAVIVTLMYRLLAPSSVRWAIVSIALLMLTSTFITETRAVSQDLMLAAVAFSVFYLGYAHDHFAAGRRWPLVFILLLLGFGIRGPIGLVVPTGMLCSYYLLDRQWSRLLLFGVLASLLLAACVGLLLWLAEVSGGPAFRQDVIRMQFMGRMDGSEGVSGSLYYFTSSLGNYALAYPLALLALAAAWLSKPSQRGPALRLVQYCAAAGLIVMLGLSIPQAKKARYLLPMLPMAAIIAAYPFQVLHGRVFAWLRVGMQGLWLLIPALLIVLLWVAQRRFPESLTDLTPVMIVLGLLQLAASSRLWLPRWRTEVLAFSAVLAVWSAYALVFEPVERQLYDTRSFSQAAMVRIHEQPAPLVLHGMGKDAKAIKFMVNVEQDLQPLFTETTQALEALKAPAWLMMDRSDFQALQGTPLGALQPTLSGPFDKNDYVLLWLTP
>fig|205922.3.peg.4086 Multidrug resistance protein B
MIVSLTIVVSRAITSPLLTLFLSKKLGLNQQDVGLLLGIAVFIATLLALYGGYIIDRLEKRRLLILAMLSSAIGFVLLTFAKDLYLTTATLVITETASALFLIGSKAILSENLPMGQRAKAFSLRYTLTNIGYATGPMLGVVIAGVYPIAPFLIAAGIAFGSIFLMIGIPKDASPIAAIGQPQSFLKTLITLKNDRTLIMFTCGCLLSTVVHGRFTLYLSQYLLVVEDSQRALQTMAALLACNAIAVILLQYQIGRFLNREKLRYWIAAGTSLFILGLIGFSLADSLVSWCIAMFIFTLGEMIIYPSEFLFVDTLAPEELRGSYYGAQNLAALGGALSPVICGFLLMHTPAPTMFYALSALTAMGGFLCFMSGRRVALLHK
>fig|207559.3.peg.118 Permeases of the drug/metabolite transporter (DMT) superfamily
MSTQSPENRHGSASGTERGKTADTGGCAPALRGSAAQAAGETAHQLDMKALLRVMAGAVMISFSAVFVNVLETSPSASAFYRVLFGGMALLAVALWRRERLSTSPLVLATIAGAGVFFMLDLECWHRSILYIGPGLATILGNFQVFFMAFAGAVFFREALSLRLVVALPLAVCGLWLLVGVDVDNLPEGTVMGVIMGLLTAVWYTGYILLLRRSQRMACRMPVMMNMALVSLCTAAACGVSTLLQGASFAIPDTVNGMYLLGYGVLCQGVGWLLLSSGLPGLPAAVAGLVMLTQPTLSFVWDVLLFDRPTGPLGVAGAVMAIVAIWMGLSGQNAAQRRRALKLAGRVSTAPEK
>fig|207559.3.peg.341 Permeases of the drug/metabolite transporter (DMT) superfamily
MQNTMSFSLRSPLNGLRFSGASAGYLSALVAAVVMSLTGIIIKHISDEYALPPAQLAFWRNALVFLTLLPVLTLLRVPVRVHGKADNRLLVAYGFMLASMNLDWTIAVIETGASVATVLSYCSAAYSGILGWLLLGERMSRSLALAVVICLSGCALVCGVLTPEVWSGMSTLGLVTGFASGLLYAGYGMMGRLAACRGEVPYR
>fig|207559.3.peg.446 Acriflavin resistance protein
MKLPEISVRRPVTTVMVFAAITLLGCVAFFRLNLDLLPDIEPPAVSVITPYPGASATDVESEVTKYLEDQLSTTPNLDRLESKSKDNIAIVNCIFNWGTDLDVAVNDIREKIDLAKPDLADGAEDPFIFKFSSSMVPVLIMTVTAEESSPDLYRIVDKQIADPLKRVPGVGAVVYIGGQERQINVHFDREAIDAYHISVQQIRNVLAAENLNLPVGTVKIGRNELQIRVAGRYRDAAEIANTVIGSNGDALVRLRDVATVTDAFEEPQEWARSGKLPAIALIIQKQSGTNTVNVIEAIKDRLKTLKTEVPADIEIHGILDNSDHIYAMINSLTEAAVVGGLLVIVVCFLFLRRFRTSLVVSMAIPFSIIVAFIGLFVMDYTINVISMMSLAIAVGMVVDDAIVVLENIVRHVDDGKPPQLAAVEGTSEVGMAVAASTLTIVAVFAPLLLVKGIAGIIFGQLAFMILITILASLFISLTLTPMAASRLLRSRDQRKLNPVFVWSERLLNGIEAGYSHVLGWGLRHRNILLSLIVIVFIGSLALIPLVGTEFFPEVDSGEVEVVLEMAQGTRVEVTAGTTEEMLNAVNAIPEMEASYALAGQTKKGFLTALGFEEGTGIGRIGGRLIDKKERSRHAKEVASELREQVIKLPGVENFSASAVSVIQKAFLGGGRPISIDILGHDIETTDKAAAKIQRIVETTPGAVDVSVSRKRPRPEVRICLDRDKAASLGLNVALVADALRTNYYGFDDTKFREAGDDFDIELRLKKDQRETIREIGETPITTLTGQTIKLRNVASVRETFGPVEIDRKNRTRVTKVQAGVQGRVLGDVVRDVREKMASLDLPPGVSIEWGGEVEEQRKAFRDLTLLLILGIVLVYMVMAGEFEDFVDPFIIMFSVPFAFAGVIWAFVATATPLNLMSFIGVIMLMGIVVKNAIVLVDYTKQLRAGGMTLNEAVVTGGKTRLRPVLMTSLTTIFGMVPLALSRGEGSEIWNALGITVIGGLSVSGLVTLILVPLMYSLVHRGKAK
>fig|207559.3.peg.967 Acriflavin resistance plasma membrane protein
MKSVVRFTLRQTVLLNLLFVLLMVVGVFATFSLPVERYPNVDMGKVVVVGFLPGASPQEVEALVTTKIEDALDGLENVEFVRATSYRQRSDVIVKFLDDTDYDAQYDELRFRVLSVQNDLPDAMDPPQFIKIDMDTWMPVMSVNLVGDRSNRALTLMAEELKIYLERLPGVKEVTIEGEYTREYHVELDPHRMSRYGVTFDEVAAALAAGNVSVPAGDFSSHGKEYALLVDERFRSRDDIAGTIIRRDGDGSFVRVGDVMSGAFVSYREPEVIASVNGRDSVAVNVIKLDNGNALDIGKAVEAVLAEYAPVLEREGVEAVITRDQRSHIDQAMSTLGSNLLLGIVLVCAVIWLFMGFRNAMVTSVGIPFAFLVTMVLMKLTGNSLNEITLFSFVLVAGIIVDDAVVVVENIYRHVQAGSPLREAVVNGTAEVALPIVSATATTVAAFLPMLIMTGSTGQFFALIPKAISFALVASLVECLFILPLHFLDWPGRSRLASGDADHTREKPFMIALRNLAERLLRFSMRFRWLTLGAVLAAFSVAVFIFGVSMSGVMPLMRIKFFPDNYTTFYISVEAPEATPISETSRVIRGFAQFMDSLGAGMTRSASGVAGYYLDDDYQTVHGSNLGMVTVELPVTGQQHFADYPRNDPQAHLDDVRSRIAQHTPAGWRVRVRAEKDGPPVGKDVNVRVLGSDPASVSGLAAAMQTFLEQRADIAPHLMDLGDDTGQPSYVFRFRPREERTAEYGLDTRTVAGLAGSVLDGRFVGEFRLADEDVDLRLKIDNVFLERPEDALDVPVLEHSSGPVRLGDLCTVSSYREVGQLNRYQRQRAVTLTANIRPDAAISPQFVIHAVQEHYRKIENDFPGATLDFSGEFASTQRSFQSLMMAFVLAVLIIYVILATQFQSYVQPLIILSAVVFALTGVVFGTFFTRTLFTVNSFVATVGVTGVVVNDSLVLVDFMNKLYRDGLDRTAAAIEGMRIRLRPILLTTLTTMLGLLPMAVGIPSYSLVWGSMASTFVTGLCTATFLTLFVVPVQWHLLMGYQEWRSRRFGRAMHE
>fig|207559.3.peg.1510 Permeases of the drug/metabolite transporter (DMT) superfamily
MSYRMILAALAVVHIVWGGGFIVLKVVQEHLALEHILLGRVILASLLYLLLWKRIPSPCYRKGDWKVLLLLALCEPFLLFTFETLGLRYTSASQGGMIVACVPLTVALGAFAVYREKIGRRCLAGIVCAVCGVVVVSALATAGDQAPAPLLGNFFIFCAVLASTCYALSVKHLCARYHYMYLAGVQVFGATVLFVPGALMQPLPPAHVLFSPQVAGSLLYLGLGITFLVYFVINYALTRIKAAVVIQFANLIPVSTLVFAYIFLGERLSPTQYAGVGLVLAGVLLAGASGSGELNTGKTQGEAHAQKACAAEGAAGD
>fig|207559.3.peg.2778 Melittin resistance protein PqaB
MTQTENTPDAGQHDLHSQTVTPDASTEAAPAAPQRTVCERILDILAFQPLIPLTILLALQTVFMLDARALWYSDEVRYANVFEHVVNAGKWIVLHLNGVPYPDKPPVYFWLLEGIRQGMQAAGIAGDAPQGIGPRLFFSGAAVSALFYIWATYALARRVAAADKRTALGAGLVLLSVFYFIGVSHYSRMDLLFAALITLSHICLFTGWKKEKSTFWIVCGFAFAALATLTKGPLGLAFPLVTSVLFLLWRGKPRRLAGADVAAGAGVMLFILLAWVMGAYLTEQPDFLYNIFHDQIYRRATHTWHHSQPWWHYMATLPAAWMPWTLLLPVLPFGFLLSKKGARAVAASRTPEKEGMAYLWIAFLNGFAILSAVSIKIIIYLLPLFAPLAVLTAGGILSLSRARAKWLMRLMALLLLALAAALVTLQLGQMFGWEWLTKAVRWPLALEGLWILAAVSAAGAAIMWVAAPAAGGAGALLLAVLFTTVWIQPLGLITAPSMDNVMSPRMQGELIGSYIEKGYTPVTYKVYSGTYTFYAGADLLELDEWADVDAAVSAHRKTVVAMRTKHWDTWENKPADMREVSRQWIVDQEYVVAVRETSSPDQTEVSAGTEVSAQTEVPAESGQTGEHADLPADSATAPVQLPAANATDSTATQQSAITPSADMPADDASQADTAAEEGHETSPADAPAQGNATTI
>fig|207559.3.peg.2782 Permeases of the drug/metabolite transporter (DMT) superfamily
MLWFVLALATAFFSAGEAVLFKRFFGDRPPYEMIVWPMAWSLPLFAGYLLLSDAPEVQQGFWSVMAVMLPLNMAAFLIQTWAIRLSPISLTVPFLSFTPAFMLGTGYVILGEAIPAQGVAGIACIVAGSWLLNRAPAASGRTCGAGAALLEPFRAVYREKGSMLMLLAAFIWSLTAVLSKKLALLGTPMYTAAMFFAIHNTLMLLLIFGFTRVSPRCLRERPLAGAALGVCMFGQIVFHYLAITLVAAAYMIAVKRLNGIISVVFGRLVFGERVTLWRTAGACVMGAGAAMIALAG
>fig|207559.3.peg.3218 Permease of the drug/metabolite transporter (DMT) superfamily
MPQSRSAAAAPFALFIAVTLWGSSFVATKIGLRQLEPLSIVWLRQLVATLAILPFWLPAWLRHRHAATVRRSDTGLLLLLAFFQPCLYFVCESYALQLTTASQAGVVSAMMPLMVAVVAGAMLGEQVTRRMWGGFALSVTGVVWLTLASAPEESAPSPMLGNMLELAAMACGVGYTIACRKLGSTFSPVIITGVQILAGFLFFLPGAFMLPAGFTSMAAQALTTPGSDAAISLFAVGYLGLFVTLGAFALYNFGVSALSASKASAWINLVPVVSIVLGHLVLGETFSPYQAGGALLVLGGLYLCQRTPAPPRHGIMQVQKPQRAGALEKE
>fig|207559.3.peg.3718 Permeases of the drug/metabolite transporter (DMT) superfamily
MQSALGYVYVALAALMWAFIGPLAQICFNEGTTPMEVAFWRCLTGALFFMAHAAVTGRWRAGLRDAPVFTAFGLVGIALFFGSYQISVREGGAALASIMLYTAPAWVALLARICFAEALTPHRLAALALAMSGTMLVSLSGGAGSGSVTAGVLWGLVAGFSYSLHYVFGKNYLHRYSSVTLYSYCLPAGALALLPWVTFSQHSALGWFALIMEGFLCTWLAYLAYCAGLKRLAASRAAIVANLEPVAAAVLAYWWWNEILPPVGLAGSALVLSGVFVVVREKNTAATA
>fig|207949.3.peg.631 Permease of the drug/metabolite transporter (DMT) superfamily
MSIDSKAKGYVFGLTAVLIWSGFVLASRQGGLSELNHFDVIALRYGTCALLLLPLWWFKYRFNVFQTKYIAIALVGGLAYALCTFQGFQLAPASHGALLLPGTMPLFIFILAVIVGQIRVEAIKLFGIVLISSGVALLFTQQLMMDGDNNSVLKGDVLFLLGALCWGVFSILIKHWNIPPWHAVISLALLTCLVYLPWYVMFSPKNIDVAGANSILLQMFYQGFLATIVQLYFYGRAVAVLGASGMGSLMALVPVIAGVSAIFVFDEPVTLYLIVGLCVVTIGAWLTQLEKIQWKRKFAS
>fig|207949.3.peg.1214 Permease of the drug/metabolite transporter (DMT) superfamily
MSSVQGVPVKYQLMLIFAMAVWGSTFVAMKLVVTGMPAMVAVFIRMCLAVAAFAVLIKYVRKGVVYRKGDWRYLVLMALFEPCLYFLFESQALQYTSAGQAGMITSLFPILIAVSAFFAFGERLYRRQWLGLFIAVVGVIWMTLAGEESDQAPNPLLGNLLELAAMGAAVGYTLLVKHLTSRYPALFLTAMQACVGVVFFLPFALDSQWPDSIGVDMWLLLIYLGVGATLGAYGLFNYALTHVDATVAAGYVNLIPAFAVLFSVVFLGDEINLWQWLAIALVFVGVYLSRDSKVDAQAKDNIPAA
>fig|207949.3.peg.1511 Permease of the drug/metabolite transporter (DMT) superfamily
MNKTAHFWGWVLLFVCFVWGVEFSLVHMSLDSMGAHTFNGIRFLIAFITLAAWFIYSKHGFWRRLDKWLVIHGVVLGFLLFTGFATQTIGLQYTTASNAGFITGLNVVMVPIIAWLWLRQTQHWYVWLGVALATIGTLLLTGGLSGFGEGELWVLICALGFATHIVYISRFAQTIDALSLTQVQMITVTVLSFLSAFWWEAESLAGVTQVLLSEGSFVPWVALILGGTLGTAFAYLAQTLGQQSLEAWRVALIYSTEPLFAALGGFVLLDERLAMLAWIGALFIIAGMLIAELVDDDVVEELLDEPNADVK
>fig|207949.3.peg.1629 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARDLTQGSIGRWLYRLTAPMVVGILSIFLFNLVDTYFISLLGTQPLAAVSFTFPINMLVMNVAIGLSIATGAVVARALGQKNHLQAQSWVTSSLYLTICIGIGIAILGILFHPFIFKLMGATDELIPIISEYMVWWFSGSTLLMVMIVVNASIRASGNTKLPSLAMMASAGINVILDPILIFGLGPIPALGVQGAAIASVLSWLAAFVFMFRYLQQNRLVEYRLPEGLMRLWQKLFTLAVPAAITNMLGPIANSVLIAWVAGFGTAAVAAFGVGMRIEPLAMIVVMAFTSSLPPFVGQNHGAGEVDRIGLALRKSLTFILFWQTAVYLLLILLAEPLSRQFSEEKAVQEIIQTFLFIVPLSYIGVGFTLLTTATINALHKPKISMKIHILRLFVFYLPFAWVGQAFYGLEGLFIGCALGNVAIGISVLVMIRHVKKSDQWQQRLLTIQS
>fig|207949.3.peg.1671 Permease of the drug/metabolite transporter (DMT) superfamily
MLPVIAVYAAVVLIWSTTPLAIRLSVDSVDFVQGSALRMWISLALCLLLLPLFRLKLSFNKLAMQRYMASALGICFAMLCVYWSAQTLPSGLIAVLWGLTPILVSLQSRCLIAGTRLDGLRLLSMAIAVLGLYVIFAQQIALSPTMAVALAVLLLAVNFHSLSAVLLQKLQLKQQSSEDERMHPLVQTTGGLLVSAPIYAIVWLLMSGPLPEVMSWTSIGAIAYLSIIGSAVGFIGYFYLLTKMSAADASLITLMTPVIALFLGTSIANETLSDRTLMGAGIILFALFIYHLKNIRLVLVRLAQKD
>fig|208964.1.peg.240 Permeases of the drug/metabolite transporter (DMT) superfamily
MNASTSPLPASDQTLRGILLICAAVFLFASHDGLSKFLSGFYPIVMVVWARYLVHTLLMVAVFVPRNGLAVIRSRRPLMQLARALCLIGTSLFFTTGLRYLPLAEATAVNFLAPLLVTALSVPLLKEKVSLGQWLAVLTGFIGVLFIVRPGGALFTPAALFPLGSALCFGLYQLLTRMLANSDSPTTSNFLAGIFNTLIMSLLVPFFWQTPSLLHGLMMIALGGCGMGGHLLLTQAFRHAPPATLAPFSYGQIIFAGLLGLLVFGHVPDAWALLGILVICASGLVVAWRRGR
>fig|208964.1.peg.1239 Outer membrane component of tripartite multidrug resistance system
MPLASHLRCVALALGISTALGCANRNQPAPRAESLDPGLSRVAGTRGDALPAQWWTLYQDPGLNHLVAAALRHNRDLAAADAHARALLGHLRGAQGERWPRTEVGYGYQYGRDGDDQTLAEATDEDLHSQWKHTVRLDLSYQLDLWGEVRARIAAAKADAEAAQAARDLLRVSVASQTTLAYVRACALARRAEVQRRSVGLLDASLALSERQLAAGLSSELQRRRLLALRERTRAALPMLEARRRAALYELALLSGRSPRQLDAPAATCAGIPQLRRALPTGDGWSLLARRPDVRAAERRLAAADARRALAEAELYPRISFAVGAETSAATLAGLGGSGALAYAAGPLLSWRFPNRESARGRLDSAAAERDAALARFDGAVLGALREVERALALYAGERQRRADLQRALDEQRHAYRLARSNYRAGALDALELLDSQRSLVADRARLVDAEMRVAERQVELFRALGGGWQAASSPSHQENGQ
>fig|208964.1.peg.1266 Permeases of the drug/metabolite transporter (DMT) superfamily
MRATTCTPRAMPGATRLLAVQLGMVLAWSSGFVGYRYAMEQAPVFLTSFWRFAVCLALLLPFAWAGLRRLSARQWRRQALIGALAYAGYIAPIAKAIELGVSPGVAALMADLLPLLVALLALVLPGQRTRPGQWPGIALGVAGVLWAGHAALALGRAPGWAYGLPLLGMLALALATLLQKRWDDAPGSLAVVLFVQIGAALPAFAGLALAEGSLRPPLSGGFLFGLAWLVLLPTFGGYGLYWLGLRHLSAQGGSAALYLSPALTLLWAHWMFAEPLTPMLLGGLLLSLAGLGWLYRAERR
>fig|208964.1.peg.2101 Permease of the drug/metabolite transporter (DMT) superfamily
MASLVTAVLFLVVCISWGTTWLGIKIAVESVPPLTAAGLRFLIAFPLFLLFARLRHETIFFPRRLLAFFVFVTLGYFSVPYYLLNYGEQYVASGLTALLFSSMPVFILIFSAIFLRERIYLSQILGIAIGFGSLFMIIRSQGLHLDYTELLGVLAILLAAIMHALSYVITKRQGADIGVITFNTLPIGIAGLGLFMAGLVMEHPNLSAVTSRSWAALIYLGLVASVGGFIVYFFLLKRLSPVVLSFVFIIFPVFAVIIGAWYEGVAISRELIGFTVLLLAGFAITKLPIEKLLGRR
>fig|208964.1.peg.2628 Permeases of the drug/metabolite transporter (DMT) superfamily
MAMAGSQPQRRNSPTQGAAMLALSALFFALMGGLIREASSTVNNETVVFFRNLVGVLFFLPLALTRGIGPLRTRRPLSHLLRTTYGLGGMYCYFYALAHLPLTDAMLFSYAAPVFTPLIAHLWIKEPLTRRMMVATLVGFLGVLLVARPSGAVVAPIALVGIASSLMAACAFVSIREMSDSEPAYRIVFYFALFGTLFSAVPLAWAWQPLNGQELLLLLGAGLFASLGQLTMSQAYALASPGVIGPIAYMAIVFAGVIAWLRWDELPSHTSLLGAALIFAASLIPLLGNRPAERPR
>fig|208964.1.peg.3222 Permeases of the drug/metabolite transporter (DMT) superfamily
MNRRSALAALHGGALLFGLTGVFGKLASASPGVIVFGRALFAVLALGLFARLAGQAWRALGPAQWLRLALCGLLLAGHWVSFFIAVKTAGVAIATLGFASFPAFTVILEGLLFRERIHLAEGLLVVLVSLGLVLVTPNFDLASGATLGLLWAILSGLLFALLSLANRSNSGQVGPVQAALWQNLVVALCLLPFAVSELPALPALDWLWLALLGVFCTGLAHSLFVASLAVVKARTAALVFALEPVYGIAFAWLLFHETPGPRMFLGGALIILAIVLSARLGARGRKTAVGDERGDPERA
>fig|208964.1.peg.3304 Fusaric acid resistance protein fusE
MRASLRVVVTLLVVAAAVLAGIWLWRYYMLSPWTRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQERYQANLEQARAVAETRHQQYLLRQNEAARRSRLGIGAISAEDKENAQINAAIARSEYQEALAQVKIAELNLKRSELRAARNGQVTNLRLAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQVRLMSGDQPIDGTVESISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVHLSAGMTASVTVQGD
>fig|208964.1.peg.3605 Permease of the drug/metabolite transporter (DMT) superfamily
MADPPRPVERAMRSQALRADVLMLITAMIWGVSFVAQRLGMDAIGPFLYTGLRFVLGALVLVPLLMLRSRRDGAQPFNRGQLLAGVILGVALTTGINLQQVGLLFTSVTNSGFITGLYVIVVPLLGLLFGQRTGAGTWLGASLAVLGMALLSIGPGFQVASGDWLQLAGAVVWGAHVLLVGLFASRYDPIRLAFLQFATCAAVSLLLALVFEEIHWDAIVQAGPALLYGGLLGVGTGFTLQVVAQKHAIASHAAIILSLEAVFAAIAGALFLAETLHLRGYFGCALMLAGMLVAQLWPRKLAAEARPA
>fig|208964.1.peg.3893 Outer membrane component of tripartite multidrug resistance system
MVGSFVGFLVVFSAISGCVSTGDIAPEAATLDANALATDHAIQAAAREAGWPQAQWWKVYADPQLDAWIEKALDGNPGLAVAHARVRQAKSMAGLVESIESPQIEGKGSLVRHRWPDDYFYGPGDLARTTSWNNSTEIGLNYKLDLWGRDRSDSERAVDLAHMAAAEARQAQLELEGNIVRAYVQLSLQYAEMDIAKAMLQQQRDILALAQRRLRGGIGTHFEVSQAEVPLPETERRIEVIDEEIQLTRNLLAALAGKGPGEGRTIRRPSLNLAAQPSLPSALPAELLGRRPDVVARRWQVAALAKGVDVARADFYPNVDLMASVGFSAVGGGMLEFFRSAKYTYSAGPAVTLPIFDGGRLRSQLGEAAAGYDAAVEQYNQTLVDALKNISDQLIRLHSVDIQKDFAAQSVASAQKTYDIATLAYQRGLTDYLNVLNAQTRLFQQQLVQEQVQAARLAAHASLLTALGGGVGAGADTPAQRKLAPENVPVRAVSSR
>fig|208964.1.peg.4831 Permeases of the drug/metabolite transporter (DMT) superfamily
MVLDLLKSGVLLAVLASFTFSVMNALVKEASATLPAAEIVFFRSAIGTLLIYLLMRQAGVALSRQGVPMLLVRGVMGALYLVCYFYAIAHIPLADASILAHMSPFFVILFSALFLGERIPRAVYWLLLVVVLGALMIVKPFSYSSYSVYAVVGLLSAVFAAGASVAIRQLSARHHTYEIVFYFLAVATLVAIPLMWNDFVVPATLREWGLLLAIGVVSLLGQVFLTRAFSHESATIVAVTRYIGIVFNAGWGWLFWSEVPDALTIAGGVLIVVACIALSRTKKG
>fig|208964.1.peg.5155 Outer membrane component of tripartite multidrug resistance system
MPFPLLHPWPQRLALASAILLAAGCVTSEGLEPNARLQPAGALQAGRSLDGVALSPAAWPRQDWWTGLGDRQLDQLIGEALQGTPDLQIAEARARQAAATAQAQDAARQPTLDAKASYSGIRAPTSVAPAPLGGRYSAIKYLSLGFNYDFDLWGGERAAWEAALGQANAARIDSQAARIGLSASIARAYSDLAHAFTVRDLAEEELKRSQRMTELSQKRMSAGLDSKVQLQQTQTQLATARQQLSAAEQDIASARIALAVLLGKGPDRGLELQRPQPLNPASLSLPSVLPAELLGRRADIVAARWRVEAARRNIDSAKTEFYPNLNLGAMAGLAALHTSDVLQAPSRFFQVAPAISLPIFDGGRRRANLAERDADYDLAVGQYNKTLVQALGEVSDDLGKLRSLEQQVIDQRQARDIARSNFDLAMRRYGEGVGSYLDALSVQQQLLVAERQLASLESQQIDLSVQLVQALGGGFQPDSRSAALATAKAPAE
>fig|208964.1.peg.5483 Multiple antibiotic resistance protein MarC
MDMFGVAVLIFLVTDPFGNIAVFLAALKGVAPGRRLRVAFRELAFALGLLLLFLTLGEHILSGLGLSREATGIAGGIILFVIAMRLIFPSPQGLLGEVPDGEPLLVPLATPAVAGPSALAMLITLRTTFDGPLWELYLAVVLAWAATALILLQAAFLQRFLGPRGLTAIERLAGMLLIMLSVDMLLDNLRSVLHIAA
>fig|209261.1.peg.951 Permease of the drug/metabolite transporter (DMT) superfamily
MRKVSISILFMLVSLTWGTTWLAMRIAVETIPPVFATGMRFMFAAPFLIIIAWLRKKNLLFPPGQRLFQFVICIFYFSIPFSLMIYGETYVNSGLAAIIFANMPVAVLIASVLFLNEKAKLMQIAGLTIAITALTGILLEETNTSTESHWQGITALISAVLIHAIIYTQCKKRSCTVSVITFNALPCLLAGLILSATGWFFERPQVSTFSVHSILATLYLGAFAGVFGILCYFALQQKANAFQASLVFLIFPLIAVSLEDYIYGYAISTHSMLLIIPLAIGIFLTLVARNIPVTSRCRDNSSQK
>fig|209261.1.peg.1347 Multiple antibiotic resistance protein MarB
MKMLFPALPGLLLIASGYGIAEQTLLPVAQNSRDVMLLPCVGDPPNDLHPVSVNSDKSDELGVPYYNDQHL
>fig|211586.9.peg.640 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDRHGLLSAPIGRVLLNMSLPNLIGIMTILGFSLADTFFISQLGTEALAAISFTFPVTLIISSIAIGVGAGVSTNLGRLIGSGNAPQAKVFLHDALLLTFILIASLSALGSIFIEPLFSLLGANETSLPLIHDYMMYWYVGAPLLVLLMVGNQGLRSTGDTRSPAMIMTLAAIINLILDPLLIFGIGPFPRLEIQGAAIATLFSWLVALSLSGYLLIIKHRMLERAAFDIDRMRANWSKLAHIAQPAALMNLINPLANAVIMAMLAHIDHSAVAAFGAGTRLESVLLIVVMALSSSLMPFIAQNLGAGQPQRAKQALLLSLKFILVFQTLLYIPLAFFAQPLASLFSTDPQVLEWLSFYILVLPCAYGPLGIVIIFATALNAYHRPMSSLVINLCRLVLLMLPLAALGSYIDGVKGLLLALPITNLLMGIACYYLAQRICEPVKATTADTL
>fig|211586.9.peg.1360 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTAISHSATDQRLLQEPIAKLFWRYTIPTIASMLVTGVYVTIDGIFVGHYLGETGLAGMMLAYPVGAILYAIGAMIGMGSAALVSINLGQGNVAKARKLLGNAFSLCLLAGAFFALVGGVFSRDILIALGAEGEILENANEYLFWYFALCHFPIISMAFTTLLRNDGRPSMVTFVLILGGVLNTFLDWLFIVVFPFGLAGAAIATMLSQAVTGLLCLQHFFGARTQLKINLEQMKLKLDNCINIARVGLPSFLMNLYLSIVLTLHNTAFLWVGGPLHVAAYGVVSYTEAFFYLIFEGIALGTQPIYSFNAGAGRFDRVKQARNIAFSMTLLTAALGLVLIYSRPEWLVYLFAGDNPSLTPVAIEGMRWYFWGLPMEGLILVGASFFQAINCSKQASILTGAKLILIAAIIYCFAWAFGVIGVWVSLATCSTMLVIWMFIAMQRLKVNA
>fig|211586.9.peg.1724 Acriflavin resistance protein
MNLTRLAIKLPVTTSMFFFAILLFGLASSRLLPLEMFPGIDIPQIVVQVPYKGSTPAEVERDITKVLEESLATMGGIDELESESSQEGAEIEINMKWGENVATKSLEAREKIDAVRHLLPRDVERVFIRQFSTADMPVLTIRISSDRELSGAFDLLDKQLKRPLERVEGVSKVSLYGVEQKQIEVRINANRLAASGFSATELQARLARENFVLSAGTLRESNLVYQVSPKGEFRNLEDIKALVLVPGLTLGDVADVQFSLPERSEGRHLDQHYAVGLDVFKESGANLVEVSDRVLKVIEQAKQDQQFQGIRLFIMEDQASGVKSSLTDLLLSGLVGALLSFIILYLFLRNFKMTMIVVSSVPISIGMTLAAMYLLGYSLNILSMMGLLLAVGMLIDNAVVVTESVLQEKQGNSVNSNPQDNENAVMTGVDKVSLAVLAGTLTTAIVFLPNIFGVKVQLTIFLEHVAIAICISLAASLLVAKTLIPLMLTKFHFDIEPDNTTGKLQNFYNRSLNWVLIRPWRSGLISIAILASTALPISMVKQDQEDSQSKERIYINYQVEGRHNLNVTEAMVNQMEDYLYKNKEQFHIDTVYSYYAPDDASSVILLKKDLPMPLDELKQKIRSGFPKYSIAKPQFGWGDDNSGVRVTLTGRSTSELIHLSEQVLPLLKNIKGLVDVRSEVNGAQQEVVIRINRQMAARLDLKLNEVASSISMALRGTPLRSFRHDPSGELRIEMAYEKEWQKSLDKLKQLPVVRIDQRLYTLDNLASIEIQPRFDTIKHYNRQTSLSIGANLDNLTTEEAQTKIKQVMENVSFPDGYNYSLRGGFERQEEDQSIMVINMLLAIAMIYIVMAALFESLLLPTAIITSILFSITGVFWALLLTGTPMSVMAMIGILILMGVVVNNGIVLVDQINQMTPELDKLSDTIREVCITRLRPVLMTVGTTVLGLVPLAMDDTQIGGGGPPYYPMAIAIIGGLSFSTLTSLYLVPLCYQLLYRMRYRAVLQLGESHRFAQKLLPWTAR
>fig|211586.9.peg.1725 Acriflavin resistance protein
MSIISTSVKRPVTVWMFMLAIMLFGMVGFSRLAVKLLPDLSYPTLTIRTMYDGAAPVEVEQLVSKPIEEAVGVVKGLRKISSISRSGMSDVVLEFEWGTTMDMASLDVREKLDTIALPLDVKKPLLLRFNPNLDPIMRLALSVPNASEAELKQMRTYAEEELKRRLEALSGVAAVRLSGGLEQEVHIQLNQEKLSQLNLNADDIKRRINEENINLSAGKVIQGDREYLVRTLNQFNSLDELGQVIVYRDAQTLVRLFEVATITDAYKERSDITRIGSQESIELAIYKEGDANTVAVAKKLRDELVKINKDPQQNKLEVIYDQSEFIESAVSEVTSSALMGSVLAMLVIYLFLRNIIPTLIISISIPFSVIATFNMMYFADISLNIMSLGGIALAIGLLVDNAIVVLENIDRCRSEGMSKLDAAVTGTKEVAGAIFASTMTTLAVFVPLVFVDGIAGALFSDQALTVTFALLASLLVALTSIPMLASREGFKILPELMKKTPKEKPTTKLGKLKHYSATVFSFPIVLLFNYLPSALLTFVLIIGRFFSWLLGLIMRPLSSGFNFVYHSTESIYHKLLAIALRKQLATLLLTTGITGACISLLPRLGMELIPPMNQGEFYVEILLPPGTAVGETDRILQQLALSIKDRPEVKHAYSQAGSGGLMTSDTARGGENWGRLQVELVDHSAYHQVTQVLRDTARRIPALEAKIEQPELFSFKTPLEIELTGYDLALLKRSADSLVNALSASDRFADINTSLRDGQPELSIRFDHARLAALGMDAPTVANRIAQRVGGTVASQYTVRDRKIDILVRSQLDERDQISDIDTLIINPDSSQPIALSAVAEVSLQLGPSAINRISQQRVALVSANLAYGDLSDAVADAQQILAAQVLPTSVQARFGGQNEEMEHSFQSLKIALILAVFLVYLVMASQFESLLHPLLILVAVPMALAGSVLGLYITQTHLSVVVFIGLIMLAGIVVNNAIVLVDRINQLRSEGVEKLEAIRVAAKSRLRPIMMTTLTTVLGLLPMALGLGDGAEVRAPMAITVIFGLSLSTLLTLIVIPVLYAMFDRKKFDHTNIVSTAEQDATTLTVETRP
>fig|211586.9.peg.2114 Multidrug resistance transporter, Bcr/CflA family
MKTSSNIFVNMKFFIFLLYLALLSMLGFIATDMYLPAFKAIESSLNSSPSQVAMSLTCFLAGLALGQLIYGPLVSKLGKRYALLIGLAVFALSSVAIANSDSVMMLNIARFFQAIGACSAGVIWQAIVVEQYDAEKAQGIFSNIMPLVALSPALAPILGAYILNEFGWRAIFISLCVIAFLLVLMTLYFVPGKSKHQDIKPSAVSYGQILKNTRYLGNVVIFGACSGAFFAYLTVWPIVMEQHGYQATEIGLSFIPQTIMFIVGGYASKLLIKRIGADKTLNVLLSIFGICVVSIVLFTLLFKTITIFPLLISFSILAAANGAIYPIVVNSALQQFTQHASKAAGLQNFLQITIAFGASSLVAMWANFGEVAIGWGILCCSLLVILGYVLKTEQTWGDFAHHFTAPDPARVGIVANAKQNQAD
>fig|211586.9.peg.2128 Multidrug resistance protein D
MMSGEKPSLISAKASTPSAGSATRLLFMLVFMVACGQMAQTIFVPALPLIAQGLAVDASKLQAVMACYLLAYGLFQFIYGPLSDRYGRKLPLLIGIGIFIIGALLATQATSFNQLICASLLQGLGTASAGALCRSIPRDHYFGDNLLKFNSYVSMAVVFLPLVAPFLGSLASAYFGWQAVYWVLFGFGVFVWLLLCFGFKESLPKDKREQQPVLASYRHVLRHRSFRAYLFSLIATFAGIAAFEAIAGVLYGQYLQLTPFMVSCYFVAPIPGYLLGALIAGRQKQAQRSVFQGVALLGAGALFMLIPGLFQLVVGWSLLVGSILFFSGAGMLFPTLTSAALEPFPRQAGIAGALLGGLQNFGAGLAALTMSLVPMGGQLSIGLLSAVMVLLVIVALHYARDQNDTHQTLLPQKT
>fig|211586.9.peg.3151 Acriflavin resistance protein
MLSQFFIKRPIFAAVLSLLFFITGAIAVWQLPITEYPEVVPPTVVVTANYPGANPKVIAETVASPLEQEINGVEDMLYMSSQATSDGRMTLTITFAIGTDVDRAQTQVQSRVDRAMPRLPQEVQRLGIVTEKSSPDLTMVVHLLSPDNRYDMLYLSNYAALNVKDELARIKGVGAVRLFGAGEYSLRIWLDPNKVSALGMSPSDIIAAVREQNQQAAAGSLGAQPSGNADFQLLINVKGRLTELSEFEDIIIKVGQNGEVIRLKDVARVELGAISYALRSLLDNKDAVAIPVFQASGSNAIQISDDVRAEMARLAKSFPEGLQYEIVYDPTVFVRGSIEAVVKTLLEAVLLVVLVVVLFLQTWRASIIPLVAVPVSLVGTFAFMHLMGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIASGLSPIAATQKAMKEVTGPIVATTLVLAAVFIPTAFMSGLTGQFYKQFALTITISTFISAINSLTLSPALSALLLKGHDAPKDALTRLMDKLFGGWLFTPFNRLFNRASEGYGYLVRKVIRFGGIIGLVYLGMVALTGVQFVNTPTGYVPGQDKQYLVAFAQLPDAASLERTDVVIKKMSDIALNHPGVAHSIAFPGLSINGFTNSPNSGVVFVALDDFELRKSPELSANAIAGQLNQQFAGIQDAFIAIFPPPPVQGLGTIGGFRLQIQDRANLGYEALYQVTQQVMYKAWADPQLAGIFSSYQVNVPQLELDIDRTKAKQQAVSLDQIFQTLQTYMGSTYVNDFNRFGRTYQVNMQADEAFRQSPQQISQLKVPNVNGDMIPLGSFINVSQSAGPDRVMHYNGFTTAEINGGPAPGVSSGQAQAAIEKILAETLPIGMTYEWTELTYQQILAGNTGLLVFPLVIVLVFMVLAAQYESLSLPLAIILIIPMTLLSALSGVLLYGGDNNIFTQIGLIVLVGLATKNAILIVEFAKEKQDHGMEVMESILEAARLRLRPILMTSIAFIMGVVPMVFSTGAGAEMRQAMGVAVFAGMIGVTIFGLILTPLFYYSLVKRGRRKRTLEV
>fig|211586.9.peg.3603 Acriflavin resistance protein
MRLPEVCIRHPIFASVLSIMAVLLGLIAFQKLDIQYFPEHTTHSASVNASIAGASADFMSSNVADKLIAAASGIDKVDTMSTDCSEGRCSLTIKFNDDTSDIEYTNLMNKLRSSIEGINDFPQSMIDKPTVTDDTSATDSASNIITFVNSGGMEKQAMYDYISQQLVPQLKQVQGVGAVWGPYGGSQKAVRVWLNPEQMKALNIKAADVVGTLGSYNASFTSGAIKGKSRDFSINPLNQVETLEDVKDLVIKVSEGKIIRIADVAQVVMGEESLSPSMLSISRHSAMSLQILPLSNANPVKVASNIKAEIARMQKHLPQGLEMHLAYNQADFIEAAIHEGFAALIEAVILVSLIVVLFLGSLRAASIPIITIPVCVVGVFAVMSALGFSINVLTILAIILAIGLVVDDAIVVVENCYRHIENGETPFNAAIKGCQEIIFPIIAMTLTLAAVYLPIGLMSGLTADLFRQFSFTLAAAVMISGVVALTLSPMMSAYLINTTEQHPRWFSRVEVQLQQLNHLYINELNKWFVRKRLMFGVAVVLVGLAGIAYWQLPKILLPAEDSGFIDVTANGPTGVGRQYHLDHNRELNSVIDGHPAVGANLSYIEGEPINHVLLKPWGERSEGIDEVIEDLIAKSKQSVSAYNMSFSIRSADNLNIANNLRLELTTLDRNKDELSQTAAKVQKLLEDYPGLTNVGNSVLRDQLRYDLSIDRNAIILSGVSYGDVTNALSTFLGSVKAADLHATDGFTYPIQVQVNLDKLSDFKVLNKLYVTSESGQALPLSQFVSIKQTTAESNIKTFMGLDSAELTADLMPGYSTDEIKAYLDEQLPSLLNDAQGFKYNGVVKELMDSQAGTQSLFLLALVFIYLILAAQFESFVDPLIILLTVPLCIVGALLTLAVFGQSINIYSQIGLLTLVGLVTKHGILLVEFANKQQAQGMSAIEAALSSAKWRLRPILMTSLTMILSAIPLALATGPGSLGLANIGLVLVGGLLAGTFFSLFVVPVAYVAMSELKARDVVAHLRSA
>fig|211586.9.peg.4056 Permease of the drug/metabolite transporter (DMT) superfamily
MPFVIALLAPVFWGTTYALVSLYLQDMSPYWVAVWRALPAGVLLLMLRPRLPTLAWSKLSLLAFCNIGAFFTLLFIGAYRLPGAVAGTLGATLPLIFLILAWLIDKKRPGMKWLLLGLMGLGGVILLLNPSADLDPIGVLCMLSATTLIAFSSRWMQRWDVGDFLVLTAWQLLLGGLMLIPLAWLMAGPPQIPSMDVVPSLIWLATANTAVAYWAWLWSMRNLGPEIMGMVALVNPVVAVSLGVLIVGETLDMRQWAGILVILLSLLLMKLPQKLRWNPLKARG
>fig|211586.9.peg.4078 Drug resistance transporter Bcr/CflA subfamily precursor
MRRNLLPILMSLVLLSPLAIDIYLPSMPTMAAEFAVSASEVQSTLVLFLFAMGVGQILIGPLADRYGRRPVALFGVLLYGASSLLAAAAIEFHWLQIARVLQGLAACSTSIVVFSAVRDCYSPKEGAKIYSYLNGAICVIPALAPTLGGLLAMQFGWRSTFVFMTLYAILMMLLVGYRLPETRPANTVSTGPLYRWSRYKPVLSNTHFLFYAFACMSAMAAILSYVSYSPVWLIGHLGVSELAFSGLFGLNALVNIVACFAAPVVIRKLGNRPTAILALALLVLSAVFIIAAQAFGPSAGMAAAFAFMLPMMLLCIGFAFLLGPATSMALSAFGERAGTATAMLGFIQMSGASVIAGLVQQTNLTAPYAVALVMGFFSIGLLSMMAISRFDHWHQEQLAAEH
>fig|212042.5.peg.158 Bicyclomycin resistance protein
MVMLVLRETVVLFLVIMSITICDISYDMYAPGLPQIGAFFGVAQTIVQLTVSMNLLGGALSGLIYGPLSDHYGRRSVMLWGIAIFVIASIGCCFAWSIGVLIVLRFLQGLGAGVAGVVGFAIVNDIYVGEAAAKNLSIVNMVVSLSPAVGPIMGSYIVSLGYGWRLLFVLVSMISVLLLLALIFGLTETIQNRREKLSLSSILAEYGALFRNYRFLCFALVQSLTIMWVWASMANLPFVFIEGMHLPVEYYGYLVAMSVVSYIAGTIVNRRLIGKLGMMRMIVLGLLSVMIPDVIVIICHYAFPAFLTPLFIEMIWLPSSFGIAFITSNSVAIAFGEVRDKGAASAFISFGQTIFGACGIYIVGKFYNGTIVPVSVLPIVCCLLGMTIIWLLTKREGMFPREKTV
>fig|212042.5.peg.434 Multidrug resistance protein D
MVDSACRFCLLDHKRLYNINNMNVIADYFLKNNRFTLFLLLFIAILGVHSYWMLPQERTPTIKIPVISVRAVVNGISAERAEKLLAIPMEKELRAVSGIKKVLSEVRDGHVSVALKFNHDANMRIAMEDVRNQLDVIRPKLPRQLTSLTVQEMDLGSMPILHLAIVGDIEAVVLSKVARELKSKIEPLRDVLSVETEGLHEYVLELNFSPELVNYHGIQIQDIQRALSSSYAFVEYGMLESDVGSHKVKLEGELDSYKKIMDLVLKAGEDQFVTVRDVATVRFARKDNHELVRVNGKPAVVLKVAKREGSNITEVVKRVEHICDSAARFLPKDVSLLFLQDQSEEVKSALRELENTLVFSVILVSVVMMIFMGIRTAILIAVAIPVSVLFSITVVYLMGYTINIVILFTLIMVIGMLVDDAIVVSEYADRKMAHGFSRLEAYRLAATAMFWPVATSTMIRLSVFIPLLFWPGFTGEFMKYIPVVSISALVGSWITALIFTPVLGAMFGRGSATSPGELARVNAIEDIDIENLGKGARFYTKVLGVVLDHPIKFVSIVSGVLIFSTVAYFTLGPGGEFFPDIEPDQATITVKSDSNLSLKEKDFLMKEVEGRISEVAGIKYLYTRLSDSKASTSSEVLGVIHVEFVNWYLRAKSSKVLRNIETLLKDMKGVFFDIAQYSMKPSVGKQLEISLRADDPALVQKAARVLQKEMSASQGFRGVSSDNPVSGMEWVMMVDRKKADVAAVSVSMIGQYIKMLTDGLLVGTYYPKDSTDGVDIIARFQEKHRSLKYLDNFLINTMYGPRPVSSFISRKARSSTGTINRIDGLRAITISSDIAPGYSIADRVRYIKEVLDREPRVEVAFLGDMEDQAESKTFLIKSFFLILLMIALVLIAEFNSWYYVMVVMTAVFLSTTCVFLGFLLTSKVFGIVMGGVGIIVLAGVVVNNNILLIDAFCANIKSGLSYRDAIIKSALSRFRPIFLTVITGVLGLMPMVLRLSVDFIGRNILYDSPTSQLWFELSTTTSMGLLFATAVTLLFTPAVLMCGGRQKSSHKVL
>fig|212717.8.peg.101 Permease of the drug/metabolite transporter (DMT) superfamily
MKKQNLWADISLLIVAIIWGSGFVATKNALDSISPFFITTLRFSISTLAIGIIFFKRIKNIDISHLKAGFIIGFFLFSAFSTQTIGLLYTTASKQAFLTGTNVVMVPFFYWFISKEKPNLYNITATFLCLIGISLLTLDGSMHINKGDLLTLICAIFFACHVVATGYFTKKYDPIILTFTQFFVTTILSFLSMIILEGVPSAIPKEGIFPVFYLGIFSTFIAFLIQTIAQRYTSPSHTAIVLCLESVFGTILSCILLGDKFTYKIFIGCVLIFLAIITAETKWEFLRDINKNVQAQEE
>fig|212717.8.peg.327 Vancomycin B-type resistance protein VanW
MAKRKKRKKNSSKKITICLIIAAVLIGLTSVKAGYSYNNIKHYENLFYPGITVGNEDISGKTLEEGRKIIKEKYANKLLNKKITVKIPEGEYSITFDKIEGKYDIDNSLKKAYDYGKDSNAFSKYRIIKKAEKKPFELMFSYNEKKVIDFINDVEKKVNKDATNAKLIKKGENFNIIPESVGKKLNKEKLQKDILTNINGDISKDLVVNGEVKNVQAKVTSDKLTSVNSLIASFGTNYANISSQQRANNIRLSTESINGTVLMPGEVFSFNGAVGERTADRGYQAASVIIGNQVEDGLGGGICQTSSTLYNAALKANLKSVERAHHTLPSSYVPLGRDATVDWENIDYKFRNDYSFPIYIEGLTQNGEVRFNIYSHSSVKNRRYEITTDVYENLPTDTKTIQDANLSKGTTEVVQKPYQGFKVKVYRNIYENEKFINKELISNDFYRPIQGIIKVGTKK
>fig|212717.8.peg.388 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNTISTAEMMEKESISKVLLKLSVPAIIAMLINAIYNIVDTMFVGMLDNTSAIAAVSIVYPLFMFIGAIGVMFGAGGASYLSRLLGEKKKEEADKTLTSTIIMGCIFSLIFTVIATVFLDEFLLMYGATETIMPYAKEYGYVIVLGSIFTIGTAIMSNTIRAEGNSRYSMIATCVGAVVNIILDPILMFNFNMGIKGAAIATVIAQLTSFIFLLRYYYSNRNYINFKINLFKPTFNMFFEILKIGIPIFVTQVLASFALGFMNLGAKPYGDAAVAAMGIVFRVMSIGFYIVFGIGQGFQPVAGYNYGAKNFTRLEESIKISIRWSTIAAIITSLLFIIFAKECMLIFTRDREVIDIGIKAFRAASLLFPLFGYVNTYAVLFQALGKAVGAFILSISRQGIFYIPLMYVLPKFMGLNGVMFCQTAADGLAFLETIIMAIWLKKQFKKEVSQESTLGDVKEIS
>fig|212717.8.peg.961 Permease of the drug/metabolite transporter (DMT) superfamily
MKDVKKAHFLAIILMILWGMSYLSIKVVVHEIHPVLSAFYRFLIAAIILFIYLKVRYPEEKVLKEDKIKMALGGFFGVAMYFLFENYAVYFTTASNVAIIISSIPIFTLISQRIIFKEKINVVKAIGASLSIIGIGIILLSKGKVSLFSKGTIGDLMGIGAALCWVAYTVVISKLKGNYRSIVITTYQTIWGCIFLSPSIFIFQHSIMPSTKAIANLLYLSFFCTCIGYAIYIYCQNKLGATVITTYINLQPIVSIISAKILLNENINSKQILGSAIIIIGLFLASKSEKINKQIIEALKG
>fig|212717.8.peg.1846 Vancomycin B-type resistance protein VanW
MKKLSIWHILIFILIFFSLGFYIFLLYTVKNLNDKIYPGVSVNNIDLSGKTKKEAASIIEKSLTNNIKGAFKLKSSNKTYVVSFEDLNLKHDLNSTVEEAFSYGKNFSSFKKFSLLMNSKPVNISSKVLYNKNKLQNSIFSIEKEINKNAIDAKINGITSGVLSFTPGVEGHRLNKEDLLEEINGNLSTLQNPNSIVEIKLKVDTYPPKINDKNLRKINSLVSSFSTTYENSSKERKNNIKLATNSIDGTLLLPGDVFSFNEVVGNPTTEKGYKESNIIVNNKLEKGVGGGLCQVSTTLYNSIIRSNIKSLERKNHSIIPSYVEPGLDSTVSYGNIDYKFKNTLTYPIYIEGIANNEKVTFNIYSNSSLNKIKYDLISEVHDKIPFKTVYEKDDNLPLNSEKISQNGSFGCRVNVFLVAYENGKEISKELIYKDIYNPGNKIVKRKKL
>fig|212717.8.peg.1869 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKKAIKEVLSIALPAVGEMFLYVMIWFFDTAMVGKYGGQVAVSTVGLCSEMMAGIINIFIILGICVGSISLISRSLGGNNFDLAEEYTSISFFIGIMLSFLISTMAYTFAPKLLHFAGAKDQVLSLGIVYLRITSIGLFFNMLMNVLNSVLRGTKNTKTPLFASAIVNVVNIFLDWAMIFGKAGFPELGVKGAAIATSIAHFTGFLFIVIYTFKYSPLKPRLIHIKNMSLPKLKNLIKLSIPSSLQEAAYSIARIWGIFVMMGLGEASFAANQIATTVESISYMPGTGFGVACTALVGHKIGEGKFKEANEYAKTCAFLSLIFMSLCSATFLIFPKFIVSLFINKNEVEVIKLGMLCIMVAAAEQPFMALYLVFGGALKGAGDTKTPFYISLIAAWAIRVPFMLYFIGHLKVSVHYNWWITAGQWAFQGIAIYLVFKKRFSHPKKLQDNYLVNG
>fig|212717.8.peg.2518 Permease of the drug/metabolite transporter (DMT) superfamily
MINTKVLATITAISYSVIFGLSFLFTKKALIFATPFQLIAFRFLLAFIFMSILIFSKILKINYENKDIKGLFFLVLMQPIGYFIFETYGLKLSTSSQAGILTALIPIISSIVAVYILKEIPSKKQWFFIILSVIGVIFIVIMDKNSDSGNSLLGTFLLLGAIICGSFYHVLSRKVSSTFTPIETTYFMMGVGAVTFNFISIITHIKDNDFSNYFHLLYNKDFLIPLLFLGILSSVIAFLFVNFSLCYLEASKCAVFSNLSTVISILAGVLFLDEKIYWYHIIGSITILIGVYFTNYLNSNNKNTSSEKDVDLDESNKERAISK
>fig|216432.7.peg.504 Permease of the drug/metabolite transporter (DMT) superfamily
MNNRILALLAAFAASAIYGANHTIAKDLMPTVIQPFGFILLRVSGAALLFWVASLFLPREKIDRKDWLRFVACALFGMAINMLSFFKGLSLSTPINSSVVITLSPVLLLVLSAIFLKERVTLLKSIGIGLGLAGALLLILFGMKEQPNAPNIPLGNLLFVLNASSYSVYLILVKPIANKYRPVTLMKWFFLFAVIINLPIGLSEFTQVEWTALSLGSIWRMLFVIIGTTFLTYLFNIYALKILSPSTIGAFMYLQPLLATLIAVLVGSDILTTLRIFAAALIFTGVYISSRKPKKRLQSNNIQH
>fig|216432.7.peg.1384 Probable multidrug resistance protein
MKFFKFYADSFKGLSREMWYLSIIMFINRAGAMVIPFLSLYLTKSEGYSLPQVGWIMSAFGIGSVIGAWVGGQLTDTIGHYKTMVLSLILGGLGFIGLQYLHTFWTLVIGVGVVMIFVDSFRPAAFTAINAYSKPENKTRSVTLLRLAINLGFSMGPALGGLIITSLSYSGLFWVDGVTCVIAGFLLIKLLDPKTAREEHQEVVQHPLSPYKDFTYLWFILAIILFSLAFVQYFSVMPLFYTNIYALSEDEIGLLLALNGLVIFLLEMPLIKYLETKAVSVLTYIIWGTILTAFSFLILNVFSWIGVLIIGMLLMTVGEMIAFPFTNKFALDRAKGGKMGAYMALYSISFSISHIFGHNTGMNLVSNFGYTATWFTMAALLGIAVLIFLSIKLKQR
>fig|216432.7.peg.2319 Tetracycline resistance element mobilization regulatory protein rteC
MEAALNKLLNQFINIIEEHYSINQINLPIISIAIDCCEKHIIDIRKVFGTYNFDSTNAEVKFFKYQKPVIYGHLKYYLHIQSYLIYKGSGSITQQRQLVDNNIKKLKKGLKPFAEFVTYCKQGRSELDEYYYLRKNKSLWPITYRSACIYDPDFSTSHDELRAEIVAYDLIMKFYEKELETLRIKELNAYVVDSSNENKFNLEWTSNKIDLVELIYALQTSRAIQNGKISITTLANVFGTVFNTDLSNIHRTYVELKSRKKDRCKFMKYLMVALENRVITEES
>fig|216596.11.peg.323 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDMSDTSGSFRKRQRLAPEDLASPELLRLLLRLGLPAMFGLSINAAHHTINMIFVGMIGDDQIAAIMIVLPVLMLVAAFGEGIGVGVATEVGRTLGAGNRSRAGAIASISLAAGVVFGAASAIAILAFPDLLLFGATPALQPLAQHYLMIIAVSVPLTMAQIILDFLAIAEGNARFSMWTLVACFALNMILDPIMIFGFGLGLQGVAIATILSQLVALCIYAAYHARRLGTVRLTFGWRWRDIGYLRPVLAVGAPTTLTSLATAGAIAAVVSLAGTYHGEAGIAGVGIALRLLAVGTLPVIGISLGAQSILSFAWGRGDTTRMLSAARILTVVTSAVSGAYGLGALVFSEELASFFTDDATVIGIAGQAIIATHLPLLLFGLRQTVLILFQAQGRPKAAVAIGLAQNGYLLFPLLALLPPFFGFSGLLAAMFLASALTGLLSAGCLARTLSALRQRAADHLTSIRPYPNFCP
>fig|216596.11.peg.747 Permeases of the drug/metabolite transporter (DMT) superfamily
MTTKTGVANAGNLIMTGVVLMLLGDLLFALNDAMGKWLVASFAVGQVLVIRSVGAFIVLGPMILRQGPMALFRVEQKGLQFIRVLMATCDVALFYAAVAYLPLADVMTFYMAGPIYIAALSHFFLGEKIGWRRWLAVLIGFAGVVIALRPSTAMLSLPSLFGLAGSLAFALSLVMSRYLRSTSDTTLVTWQTIAALVTGIVLSIGHWQPATLIDWSGMLLLGIVATCAHLLITRSLKLAPASLLAPLQYTLLLWAIVLGYLFFNDIPDTQIIVGAAIIVVAGLFIFHRKNLKETVPVEAVPPDGH
>fig|216596.11.peg.1683 Drug resistance transporter, EmrB/QacA family
MSNAAQRSNRVLIVATIMLATFMVAIEATIVATAMPRIVGELGGFSYYSWVFSAFLLAQSTTTVIYGKLSDIFGRKPVLIGGILIFLVGSLLCGLAWSMMSLVLFRLLQGLGAGAIQPVTMTIIGDLFKLEERGRVQGAMATVWATSAVVGPLAGGIIVDNISWAWIFWINLPIGVISIIAFMVFLKEDVAHKQAKIDYLGSVLFSISIVALLVMLTETDASAWILLSLFAVFVVTGLLFLAQEKRAPEPIISIPLWSRRLIATSNTATLLAGMALIGLSTILPLYVQGVLGRSPLVAGFTLTMLVVGWPLAVMLSSRFYKAFGIRRTLRVGSLMFPFGACFLLFLTPDSSPVVAGAGSFFMGFGMGLISLTSIVLVQDSVEWSMRGSATASIIFSRSLGNTLGATVLGAILNAGINHYASGDAAAGLHEALNQPTGLSALAADPAIRSVFNAALHWSFWGVVVVAVLTFFTTWLIPVGHGQKGEGAAVPSEAASH
>fig|216596.11.peg.1833 Permease of the drug/metabolite transporter (DMT) superfamily
MSQAAPTLSEASPSNRFALAALLLGGAAIGGSPIFVRLSEVGPMATAFWRVALALIPIVIVSLMKKERGPKPQSLSDYAMLVLPGVMLALDLAAWHLSLTMTSVANATLLANLAPVFVTLIAFVFFSARISRVFVIGLAVALSGVVILKGGPAAIGNGDLRGDGIAMIAAFFYACYILAIGRLRSRFDTIRIMLWSTACAAVCIFPIGLIYEGHMLPATVYGWSIVFGLAFISHAGGQVAITYALAYLPPAFSSLTLLLQPVVAAILAWALLNEAIGTMQALGGAVVLAGIMIARTSRVQV
>fig|216596.11.peg.2655 Permease of the drug/metabolite transporter (DMT) superfamily
MTTIAFTNDKSPSQVLGYAGGTITVLIWATWFLVTRHSAATPLGSIDIGLIRFGIPALVLSPVWLKTGLLPKGLPLHLLAIMVSGSGAVFFLLTTLAIHSTPAASSGILLGGSMPLAAALIGIALFRERPDGTRIAGLIAIVAGVLILLTRSLADASLPWTSFVLLPAGAVLWASYTHAFRRSGLTAVQASALIAVWSFLIMGTLALVFGVSLPQATLPEIGLQVLSQGVLSGLVAMVAYGTAVRTLGGTQAAAFTALTPVLATLGGGLLLGEAIGMTEISAAVITGIGVALSTGIATPRR
>fig|216596.11.peg.2689 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDLSEGNAFLTGWLPGVFIKTAAPIVAITTVSGLFTVVDAYFLGAYVGPDALSAVSLIFPGLMLLVALQSLVSNGMASILARRLGAGDRQGARRVFASAHALAFAVTLILNLVYWTLGRQIIDAGAAGNAAVADGARLFMGAMTACAPVGFFLSLHLDGLRCEGKIGFMTLVTLSASLLNILANWLFMAVMHWGVLGSAAGSIASQFVCLAAVLAYRWRRPAILRPSRGLALAEWRGIVAFGAPMSLGFIGISLASAAILLNVSLWSTHDYVATVAAYGIITRIMTFTYLPLLGLSIALQTIVGNNHGAGLGLRVGRSLQIAMLAALVYCTLVEITVELLAGRLGAVFVADPAIIAEVRRILPWTIGAYFLFGQMLILSSYFQSIGDAPRAAIFGLSRPYLLTLPLTFLLPFVFGEQGIWMVPVFAEAGMFILAFLVLSQNAKRRGWRYGLLPA
>fig|216596.11.peg.2823 Permeases of the drug/metabolite transporter (DMT) superfamily
MFPTALSDHRKGLLLTAIGGLALSVDIPLMRLADGELWSILAARSIATLGVTLLVATALRIAKGRWPVLVPGWPGLVTGLLYGLTTVVFLLAVFNTSTANVVFIVAFNPMFAALLSWIFLKERPAPATLIAMAAMIFGVGLIVRDGLSGGHLFGDTMALLTAFIIAAAITISRASRREMGFVSLLSTVLPAAIGLISVMPAGGFSIEHPAWILFNGAVMMPLAFWCLATGPRYLSAPEVGMFYLLETVLAPIWVWLIFAETPAPMTLVGGGILVAAIAAHSVWIVRRKSIAQMAG
>fig|216596.11.peg.4136 Multidrug resistance efflux pump
MALALFVFSIFMERRTPSTSQAQVQAYIVGIAPEVTGRVVEVGVTDNSRVEADQLLFRIDPERYELAVSEAEASLASVGQSMGASTAAVDAAQAKLVTAQVDRDNLREQAARAAELEKRGVYSKARADSTRSAFGQSEAAVIGAEAELAKAKEQLGPSGNDNPQLRAALAALEKARLDLVRTTVQAPSAGVVTNLQLTIGKVVSAGQSAMTFIDVGTIWITAAFKENSLEKVAVGNRAEVLFDALPGRLFPAQVESVGFGVSQGSTDPNTGLPTIRSDSGWVQEPQRFPVRLIIEEAQRPKGGVRYGSQATVVIYTGDNPVTNAWGSLWIRIMSVLTYVR
>fig|216596.11.peg.4294 Permease of the drug/metabolite transporter (DMT) superfamily
MAMNVLAVHRDTVGTEQAAGNSLAAAYSVGVLCWLLSAGVYIAAKWVSSEMPPWALCFWRVLIAFAILMPIVRRHFGDMVALVRARALELLAIGGVGLAICQGMIFVGLEHADATTAGIIIALIPIITMILARLMLAEPMGRWQVIGSILAFLGIVVIIIKGSPAALMRLDFNPGELWIVAGAFCFSLYTVLLRRAKFDLNRLALLVLLLGAAVLTALPFYLSELFSDERSTLNGNGLIALAYVAIPGGAVMYYLFNRSIEALGAARAGVLLYIQTIFIAVLAYLILGEQLQRYHLEGAALIIAGLLLIILLKPKIKAEAATA
>fig|216596.11.peg.4298 Acriflavin resistance protein
MNTTSEHDRDLAAKLRSLSIEPAAFKTEPPEPRVRRRVIPGAMLALAATASLAVVLLYRPDTLARIETVLAGLIGKDEAAISVDGTDVPAAGPIRALPSNNPADRALPSREVTGSGYVVAPDIATIFSKYEGRIAAVEVEAGDRVVSGQVLVRLDDAGARFALQGAEITRQSAELALTAKTIELAQARSSLTRTERLAGRDAMSAQTLEEARTAFDTAENAAQQARQDVAKADLDIDRAREQVEALTVRAPISGTVTRLTAHVGDTVLSREDSVRENESLLAIADMTTMVIDADVAEANIALMRPGLRGESVLDGFPDRPFAVEVSKIAPMISREKGTVTLRLSLSSPPSDMRPAMAARIRLLVGEAGDSTDHQQGAER
>fig|216596.11.peg.4681 Permease of the drug/metabolite transporter (DMT) superfamily
MSRQVQGYVYLALAMLTVGSTVVASKLIASGLPPFGATALRFAIAFPVLLLLMWATGARLPRFSRHDRLILVIQAGAGSVGYTTLLISGLSLTSAADAGVIIGTLPVVSAAISILLLRERPQRALLLAVALATSGVLSIAFTPDAAGGSLTGNALIFLAVVCEGLFILLNKRLKTEIAPLALSTLMAGIGFIVAAIPAIFEAPFADGISASAVAAVVYYALVPTVGGFLLWYAGAERVSGTEAALFTALAPVSAVMLAFIILGEPVGLSQIAGIGCVLAAVLGLAFAGSRTVKLAGGR
>fig|216596.11.peg.5082 Permeases of the drug/metabolite transporter (DMT) superfamily
MQATAYICLVIATLCWGGNSVAGKLALGHISPMMLTFLRWFLAVAMIAVISVPQLRKDWPVVRKNLPLLLFYGVIGYTLFNAMLYSAVQYTTAINVAIEQAGIPMLIFLLNFMFFRTGISLAQCLGFGMTLIGVALTAAHGDLATLLQLSLNRGDGLMLIAIAAYSVYTIFLRWKPPLDWRTLMAVPALGAMLTSLPLLLWEAGRGAARWPDQAGWVITLYTAIFPSLVAQILYIKGVVAIGANRAGLFINLVPVFGTLLSVALIGERLQSFHVIALVLTLGGIAIAEKGRPKASSPTVTASPVD
>fig|216596.11.peg.5507 Membrane fusion component of tripartite multidrug resistance system
MAMSSNQKSNVARIVSENAGTEEVKAEVAGVEAPTAEAREVPSAPAQSAPASVAAPAAPKKRRSPVLPIVVLALLAGGGWYGYEWWTNGRFMVSTDDAYIEGDIATISPKVTGYVAKVNVVANQEVKAGDVLATLDNGDYQNALDLAQAQIVTEQLSLQRIDAQIEGANASLVQAQAQKVALEAAVRGAEITQKRQSDLQAKSVGTAADLDNANIALDQAKANLAGGDANITAAQANITILQAQRKEAEGSVRSLEISRDKAVRDLSFTVLKAPYDGIVGNRSVQEGDLVSPGQRLMALVPVRQLYIDANFKETQIQHLVPGSKVNVQVDAYSDHPIVGTVESISPASGSVFSLLPPENATGNFTKVIQRVPVRIALPQDALDSGRLRAGLSVVVDVDTRTAPSK
>fig|216596.11.peg.7355 Permease of the drug/metabolite transporter (DMT) superfamily
MQVGPVPVLVSVFYRFAVAAVILAAILAVMRQLKLPALRDQPFILAQALCLFSLNFICFYNAAASIPSGLISVIFSLATIYNAVNARLFFGDRITGRTLLAAALGATGLLLLFGQDVVVDFDMGTLKGIGLAALGTLFFSLGNMASRRNSAVGISPLTANAWGMTYGAIVLLFLIAVTQTPIVAPPDITYLAAMLYLAAIGSVIGFTTYLMLVSRIGSSRAAYATVLFPIVALSLSTVFEGYHWSGLGLIGLALTLLGNVVIFARPLARRPPRSDARLPAEVR
>fig|216596.11.peg.7368 Inner membrane component of tripartite multidrug resistance system
MSERLESARPDETPAIVWLGFMAMCVGMFMAILDVQVVATSLPTIQSALDIDPDQMSWIQTAYLIAEVVAIPLTGFLTRLLTMRWLFVTAISLFVAASAGCAMSGSFGELVAWRVLQGFSGGTLIPSVFSAVFILFRNERQALATTIAGVLAVLAPTVGPIVGGWLTETYSWHWLFLINILPGIASAILAARSLPRQATDPSELRHLDGLSLLLMATALTSLELSLKEAPTSGWISAYVLSLLAVCLASGGVFIWRTLRRNRPIVDLGNFGDRNFLVGSVLSFVLGIGLFGSVYLMPVFLAFIRGHDALQIGMTMLVTGVAQLITAPIAVALEKRMDARLLSAAGFALFAIGVGMSAFQDPRSDYDAMFWPQVVRGVAIMFCLLPPTRLALGTLPPDRIPDASGLFNLMRNLGGAIGIALIDTIIYTRSEPLGQGLWTRLQAGDVEAATFVGAPLQTISGHSGSFDADTTALLDPLIQTAASVQAINEAWMVIAVLTGCALLSVPFARRPKST
>fig|217.1.peg.130 Bacteriocin resistance protein, putative
MKSLFFFLQFISLSFAHTFFDNNFFFFEKPLQSWVEIKSKNLIKQQYDYSCGAASLATLFTYYLNTKVDENDVLDYIFEKKNLEKKKQQKIEISFLDLANFSESKGFKALALGLDFDTLLQIKIPVILYLMTRKSPHFSVFIGTDKKFIYLADPSLGNIKIRIQKFKEMFAQRDTKKHSGSILAILPKDEGSKTRLKEPPKNHEEIFQEAIKNQIIHPF
>fig|217.1.peg.195 Tetracycline resistance protein tetA(P), putative
MQIALIANMPLKRNILVYYASILTAISAQALPHAILTPLLLAKGLSLAEIMWVQATYSMAMLLAEYPSGVLADLMARKRLFLLSKLVLMCSFSIIWLCEGLTWMLLAWALYGLASALDSGTIDASLINAIKEQKANLSRFFAIDKQLRFAGMILGSVLGSFLYVRYGASVYIMGLLLLALCMIIVFLGFKEGEVLVHSKSLELLKRHIKEGFLELGQKPHLKKLMICSLVLQVFFQTHFQLWQAYFLAKDIATSHLFYFYVGFQILGVLIHFIPATSAVSKKSWILLAGLPLILGLLSSVPIVFIALYALVVAIFSWIAYCVDYHFSLCVSKQKISSLISLKSSISRLASVAILILSSAELAFVSVGYVVVWHFLLALVAVAFLLKWTNLQSIGNKPS
>fig|217.1.peg.507 Permease of the drug/metabolite transporter (DMT) superfamily
MLLNRIQRIQTLQKPHHPRNLTNRNFLHFTPPVFLKNHPTSIPTPHQKMHPKNPSLMPNPRPLKPQTSPKVKNSKAQKHHLKRNINITQKSRFMPFPLLFFLALLAEAFIVYASVLVKIVDLPPILLGFYRVFLAIPIFFLFALRKGNLSKIPIKDIALMLLAGVFFGLDLVFFNTALHHTSVTNVNLICSLVVFVLAPIGVFFFKEHLHKSFLLGAGVAVIGIFVLIKGKSDTSIATPYGDFLALLSNVSYSIFLALIYGLRKKYTAMALMVYVCIGSSLLLGIIAEIKEGFMLPNSANAWIYVGLIVLFGQILGQGFFGYIMGKINTQVSSLIMLFSPITAAILGFLILKESIGIFEILGMFIILFGVYIAKR
>fig|217.1.peg.977 Acriflavin resistance plasma membrane protein
MNSWIKFCLKNPVGVFVCAIFLLLFGYIALSKIPYQLLPQVTHPVVSVYTIWKGATPYEIEKEITQRQEKTLKNTPNLLAMTSTSKEGMAIINLEFAISTDMKTALLNISSRLDEVRGYPADVEKPIIKPTGENIPISVYLFAKSINPHLDINTAKNFINDEILKYYERIEGVGEVYVSGGRKKQIFITLDTQKLAFFHITMDEVIASIKKQNVNISAGSMDFFQRSYRISTNGEYTSLDAIRNTVVKTIDHKNILLRDLASVSEGYEKLTSYNVHNGSNVISLQIRPTASANILDLTNRVEKLTHRLNEDFLKKRGIVMEWGRDQRQYIKSSISLMRENIFVGILLAIGVLFLFLRNLMSLVVISLVIPLSIMGSLIFLQAWGRTFNVISLAGISFAVSMIIDSAIVVLENILRQAKIQKNFFLACVVGTREVGGALFASSVTTIAIFVPIIFVKDDAGRLFVDIALASSSIILLSLLVCFFMIPTFLYVLLKRSDFGRKKGKVDAFLVHLGRVLSFWIMQSVRFCVRNKKRQIITVVGFVGICGIFSYAAFPKTDYLPRGNQNFIFANLSIPPGLSLKEKKRILDALQADFYPFLLENHNSHAKIPAIKDFFISTGERVSFYLVSADKKKIPELMDYAQEKIDSIPNVRGSILQQEIFSGASSSSIDINITGGNLDSISKTAGKLIASIKKNLPKVSISVVPARESNNQEINLYPDKSALALNGLNVESFGIMVGVILNGKKVGEYRKDEGILDMILDSKKSLKNDGKTSPEDIFYSQIYTPNGGVLPLNTLATIKHEYGVSRIRHFEQQRNILLILNIRDNTPVETLAQILQEKVIAPIAAESENDITLSGSAGKLQKLKTELLHGFLLAIVITYLILCALYGNFLYPFIIILTVPLATTGGLIGLYLVNHFIAKQNLDVLTMLGFIILVGSVVNNAILIVYQTLNNLKKMQPRRAVFLATKTRLAPIYMSMLTSVLALFPLVIFAGDGSEIYRGLGAILIGGMIFSTFITVLIIPALLLLCIKAKQKA
>fig|217.1.peg.1456 Multidrug resistance protein
MSIETKRTYHELLLFFTESKLFKAALFSISATTVLGATIIAPSLPALEKHFSDIGPSAEILSKLILTIPSLLMVFFSPIAGFLFERFRRLNIIFFALMIWSLAGISGFFLNNIYLVLTSRAILGIAASFLMTGIGVLLADYYSGARREKALMLQNFFMAFGAGIFLTLGGFLASMSWRYPFLVYSLGFVILIFGIFELFEPIKFHHKTHANPTKFTFSKFIPMYLLGMFIMICFYIAPTQMPFFMTDYLHIDQTRVGVSLAVVSVAMAIGSLFYMQLRKLFSLYEIFFLALSFFALGFACISLVHNYLSVLIGFCFLGASLGISLINTNAWLFHIAEEGERSRAYGFLASSVFLGQATSPLITQTFVSHLGIVKMIAIFTLMLFSVSFLFLFMSWRSQDRKF
>fig|218491.3.peg.1636 Polymyxin resistance protein PmrM
MTNKGYFWVVASLVLASAAQVLMKSGMLALPSISMTHWPSLSTLMAGWPVVAVLVGIICYGLSMVCWFMVLRYLPLSRAYPLISLSYAVVYLAAVFLPWLNEPMSLRKNLGVLIILLGVWLVSRDAQATK
>fig|218491.3.peg.1771 Multidrug resistance protein B
MKTENNQKQTPVPHRHWILIACMLAMFTAAIEVTIVATALPTIIADLGGFSLLGWVFAGYLLTQSISIPIYGRLADLYGRKKIFFFGMIVFLLGSILCGFSTQMGWLIVFRTLQGLGAGAITPIAFTIVADVYSSTERPKIQGYLSSVWGFSAIIGPLLGAFIVQHFNWALVFWVNVPIGLFSIFLLARYLPTINVVRQHQLDWTGAFYLVVSVASLLMALLQAEVFGYWVIPLLALSVVGGILLVRQEKRTQEPLFPLALWRNRVIIAGNLGGLVVGAAMMGVSAFLPTFIQGVMGKTPLEAGSILAMMSIGWPLASTLSGRLMLWTSYRFTAMCGGIVLIIGSLTLLTVQPDSNLMWARLAAFLIGSGMGLSSTTFLVSIQNSVDYSIRGIATASAMFTRMLGSALGTAILGATLNINLHWRLPEVSDPLQTLMDPAKRILLSVNQLDTLASQVASSIHGVFIVSALIAAITLLSARMIPASQRPGQT
>fig|218491.3.peg.2237 Chloramphenicol resistance protein
MLAMPLVTQTFNHKALMRIAIVMAFIQFTNALEYMALTPVFTFMADEFSVPVSFSGYVSGMYTLGAVLSGIIAFYWIDLFNKKQFLIKNMVLLGALTFLSTLTTHFGTLLVLRFCAGLVGGTTMGVGTSILINCAPANLRGKILATVITSFSMVSIVGMPAILFLCTHYGWHTALWLISSLCLLSLPLIVFIIPKDTVQSGVKAKLSIDAQTLLFASCSALVQFSPMLIIPILTPLMLQYMGAQQTLLPLLFLSGGIAGYLSTKITGVLTSHLSALMLATISTLFFVASLLIPAMGYHNAVLFITLFLGASYSRLVSASSVAVQYPENEQRASFSSLQTAMMFLITTLAFFLSSLLLPDQGITTQNLNRLLVVSALAASGFPVMVIILQKKLAKRTLQPDRPIID
>fig|218491.3.peg.2564 Daunorubicin resistance ATP-binding protein drrA
MTYALELAQLTKTYAGGVKALRGIDLNVEAGDFYALLGPNGAGKSTTIGIISSLVNKTAGKVRVFGYDLELDKVNAKRQLGLVPQEFNFNPFETVLQIVVNQAGYYGVKRQDALPRAEKYLKQLDLWGKRDEKAMMLSGGMKRRLMIARALMHEPKLLILDEPTAGVDIELRRSMWGFLKELNAQGTTIILTTHYLEEAEMLCRNIGIIQRGELVENTSMKQLLAQLKSETFIFDLAAKSPLPQIEGYAFRLTDTSTLEVDVMREQGLNALFSQLSAQGITILSMRNKANRLEELFVSLVNGDGVNGKGEKA
>fig|218491.3.peg.3000 Multidrug resistance-like ATP-binding protein Mdl
MRLFAQLSWYFRREWRRYLGAVALLIAIAILQLLPPKLVGVIVDGVTQHGMSMAEMMQWIGVMLLTAVMVYLLRYVWRVFLFGASYQLAVELRADFYRQLSRQHPAFYQRHRTGDLMARATNDVDRVVFAAGEGVLTLVDSMVMGCAVLIVMCTQISWELTLLALLPMPVMAIFIKRYGTQLHNRFKFAQAAFSSLNDQAQESLTSIRMIKAFGLENYQSARFAQVAADAGAKNMHVARVDARFDPTIYIAVGLSNLLAIGGGSWMVINGSITLGLLTSFVMYLGLMIWPMLALAWMFNIVERGSAAYGRIRQLLAEELVVKDGEESLPAKRGILEVNISAFRYPDNTRDALQHVQFTLAPGNMLGLCGPTGSGKSTLLALILRHFDSQSGEIRYHDRPLDAIRLDELRNRFAVVGQMPFLFSDTVAQNIALGRPDATQQEIEQAARLASVHDDILRLPKGYQTEVGERGVMLSGGQKQRIAIARALLLDAEILVLDDALSAVDGRTEHQILQNLKTWGEKRTLIISAHRLSALTEANEIVVLQQGQTAQRGTHRALAAEPGWYRDMYRYQQLEAALDDVPQLEGTKNE
>fig|218491.3.peg.3511 Acriflavin resistance periplasmic protein
MAVGMMRPLLLMSALSLPLWGQAATTGDIRVQLSAQRYTVLSSEIAGKVTDIAVKEGEHFKQGDTLVTFDCTVLREKLNYSNAAENAARKKLAIADRLDKLNSISLSDVDQARSSVSMAQAESGVNRAMLQRCVIKAPFSGRVTETKVKRWESVAEGKELLAIYDDSAFELEMIVPSRWLVWLKQGSAFQVTLDETGLSYPAEISRLSSAIDPVSQSVKAFGRITQSTAGLLPGMSGVAQIASPDAAGSVSP
>fig|218491.3.peg.4068 Membrane fusion component of tripartite multidrug resistance system
MTQSPSSSRSTRKWILQAILVIVVVWIAYRFWLAYQPEPIRLQGQIEAQQYSVSSKVPGRIADVRIEKGQQLDVGDLVFTLLTPELDAKLEQAKAGEAAAGAVALEAKTGAREQQIAAAKDQWQKAKAGSELSNKTYLRVQNLYQEGVLPLQKRDEAKASWDAARYTEGMAWQEYQMALEGTRKETLVAAEEKARMAAGSVAEVEAYLAEARVVSPHSGEVSNVLLRNGEIAPQGFPVVTLLDMSDIWIQLAVREDLLERFAMGTEFEARIPALNNQTFRFKVSYVSVMGDFATWRATDTRQGFDMRTFEVEARPVQPISGLRVGMSALVEM
>fig|218491.3.peg.4155 Multidrug resistance transporter, Bcr/CflA family
MTHVQTRSEKTSGLLFIAILSALMAFTSLSTDIYLPAMPIMAKDLQGDAELTITGFLMGFCIAQLVWGPLSDHLGRRTPLFIGMVLFIIGSVGCALSTDISQMVFWRVFQALGACTGPMLARAMIRDLFSRTRAAQMLSTLIIVMAIAPIAGPLLGGQLIKVTSWHAIFWLLAIIGIMMLISLRWLPETLPEDRRVKASLPSAFRNYYALLTNANFMRFTLCLTFYYVSAYAFITGSAFVYITYFGVEPQHYGCLFALNIVGVMGMSMVNRRLVQRYPLETLLKFAVLIATVASFILAIGAKLNIGGMPLIVISVFVFFSMNGIIAATSTAAALDAVPNIAGSASALIGALQYGSGIISSLLLALLSDGTPWTMAWIIALFTTASAITALTTRVTKSSS
>fig|218491.3.peg.4156 Multidrug resistance protein B
MAINSLGEPEKNKPGITITLALSILSASLGTSIANIALPTLTAVFSAPFAQVQAVVIAYLAAMALSVVIAGRLGDRYGLKPVFIAGLVLFAVASLLCALAPHLWQLIGARTLQGIGAAFLMTLGMALLRQTAGEKHVGRAMGVLGTVSALGTALGPSVGGFILTTAGWRSLFWVQIPLVAIVLFLAFTLLPTASVKEKVLAQRVSPIRNPTLLSNLTINAAVTSVMMTTLIVGPYYLGPGLGLKETLVGIVMAIGPATAIFCGIPSGRLVDTWGFGRALTAGLSLVVTGTLMLAILPPLLGVTGYILSVIVLTPGYQLFQAANNTATLADVPGNQRGTVSGLLNLSRNIGLIAGASVMGQAFALGVGTEDFTHATPASLANGMQLTFFLSGGMILAVLAFTHLPRWKRVTR
>fig|218491.3.peg.4458 Bicyclomycin resistance protein
MNDNKMTSGELRATWGLGAVFSLRMLGMFMVLPVLTTYGMALQGASEALIGIAIGIYGLMQAIFQIPFGLVSDRIGRKPLIVGGLLIFAFGSAIAALSDSIWGIILGRALQGAGAISAAVMALLSDLTREQNRTKAMAFIGVSFGVTFAIAMVVGPIVTHAFGLQALFWGIAVLSLAGIAITLTLIPSAPEHVLNRESAMVRGSFRKVLGNSRLLKLNIGIMCLHILLMSSFVALPRAMESAGLAPQEHWKVYLVTMLVSFAGVVPFIIYAEVKRRMKQVFIGCIVVLIAGEIVLWASDNHLWQIIIGVQLFFLAFNVMEALLPSLISKESPAGYKGTAMGVYSTTQFIGVAIGGSLGGGLFELYGASTVFMAGAAIAAIWLFVSFTMQEPPYLSSLRIALSDLALQDSELEQKIRTQPGVAEVVIVPDEFSVYVKIDNKKTNRQQLEQVVGQA
>fig|218491.5.peg.2966 Outer membrane component of tripartite multidrug resistance system
MTQARAGLGAATAALLPSGNVSGQATRAYQSVETAQGRLLNSVPGYNRYGNAYETDLNASWEIDVFGGLRRDRQAALADYQASEAGVTATRLAVAAQTADIYIALRGLQTRLKIANRQVNTQQELLEKVQLLHSKGLAAEYQVRQTEGSLSQVQATVPVLQTGIDAAMNALDVMLGTPPGTYRNQLASSGPIPQPPQLISTGTPADLLRRRPDIIVAERHLAASNARIGVAISEYYPKFSLNALLGSATSVSSGNLFSNGASQSAGVLGLRWRLFDFGRINAQIDQAKGQEAEALAAYRLSVLSATEDVENALSALLNRETQTTTLTAGETALASARQSSFIAYQKGTASLIDVLHNDETLLQTSDARAQAQTESARAAVATFRALGGGWQPPETAAKML
>fig|218491.5.peg.4545 Antiseptic resistance protein QacA
MQSPKKWLILAIVSSALFLIVIDMTVLYTALPTLTHDLHASASEKLWIVNIYALVASGLLLGMGTLGDKLGHKPLFISGLVVFGAASLFAAYSPTPSMLIAARALLAVGAAMMMPATLSIIRLTFTDEQERALAIGIWAAVASGGAAFGPVMGGILLEYFWWGSVFLINVPVVLLALIMGITMIPHRPGNASHRWDFIGSLLIMVGLIGITYAIKELGKRAPSYEDALIALLIGVTFITLFVQRQRNSKHPLVDFSLFRLRPFSAAVAAAIVAAAALIGMELAFTQRLQLVVGLSPLQAGLFILPLSLASFISGPLTGKILPHVNSGTMLAAGLLISGLGMGSYLLLHNASIIIQVISLTVIGAGVGSTMTAASSTIMQVAPAEKAGMAASIEEVSYELGGATGVTLMGSLLSFAYSATFMLPAGFSAPDTAYDSLDEALIFAESLPENMQRILTAQAHSAFDSGFSAVLATATLILLLTSAFVWTTRNNKQQRNQAADA
>fig|219305.4.peg.1697 Permease of the drug/metabolite transporter (DMT) superfamily
MPQVVGEFDMAPVVVDTVPGNRATSSYPCGRVSGVKPDTTPDRAALRSWLPGFLALAAIWGSSFLFIKVGVRELHPVHLTLYRVAAGALTLLVALPLLRDRLPREPRTWAHQFVVAALGVAVPFTLFGYGEQRIESMLAGIWNATTPLIVLPMAVLVFRTERLTTRKAVGLGLGFAGVLVVLGVWAGVGGAHFAGQLMCFGAAACYGFAIPYQKRFVAGSAHSGLSLSAAQLVLATAQLAVVGPLVAGAPPVPTDLSGGALASVLALGALGTGLAFVINLRNIRVAGASTASTVTYLIPIFAVLLGALALGERLTWHQPVGALIVLAGVAVTQGLLGRRRRPGAVGVAPPAPPAAPVGTR
>fig|219305.4.peg.1701 Vancomycin B-type resistance protein VanW
MTLYGETRPPADDRPTIKVTAVSWPGDEPDPAAAAAPGPPDTAPARRHRRLRVLLAAGISTAVLGAAGGVGAYAYAGDVPRGTTVLGTELGGRSRTDAIRALRAELERAGTPSTPLRVTVGEKSLEFEPADVGLAVNVEATVDAAAKAQAHPVSRLVGSRAVAPVVTVDAARLDAALRKAAGDQTREWTVPAIIFTGTTPKAVRPRSGLALDPQRSAQAVRDGWLSGQPVTVPLVENTPATSAEEVDRLLDELAHPAVAAPVTLSTDKGSVTIPPAAIARSLRFTADDAGKLTPRVDVKRLRAALGDKLDTIEVAPRDARMTVTGGKPKPVNGRPGQQLDTEALSRDLLAVLPRADDRKVTGRLKETQPKLTAEKLAGLGISERVSRFTTHFTGGLSSPRSQNIVQIAKEVDGTVVLPGETFSLNGHTGERGYAQGYRDAPVILDGKLVPGVGGGTSQFTTTLFNATYYAGLEDVEHKPHSYWFSRYPPVIESTIFWPNLDFKFRNNTKYGVLIDTSTTASSVTVSIWSTKIYDSVKTEYGPRRDVTKPKTVRLKPGPSCIPSNGIDGFTQDAFRVIKKDGKVVKREKFTWRYLAEPRFVCGGSAD
>fig|219305.4.peg.2002 Permease of the drug/metabolite transporter (DMT) superfamily
MAIVYVLWGSTYLGIRVAVESLPALASAGLRFGAAAVVLALVLRVRRGAGALRVDRRQLGSAALVGVLLLAGGNGLVVLAESGPPGTAVPSGIAALLVATVPLLVVLLRTVSGDRPRLWTFAGVTLGFLGLILLVLPTGGSGAVPLAGALTVVAGATCWSAGSFLAGRLRMPTDPFVATVYEMVAGAVALAVLAAARGELRDFDPGQVTGRSWLALAYLMVAGSLVAFTAYVWLLHHAPISLVSTYAYVNPVVAVALGALLAAEPITAQVLIGGAVIIAGVALVVSTERLGRPTGAAARPARR
>fig|219305.4.peg.3607 Glyoxalase/bleomycin resistance protein/dioxygenase
MMPELAGVQHVALTVTDAARSADWYAEVLGLRIVVRFEEGGGERYKIILADRAARILVGVVEHRGAPPERFDERRPGLDHLAFAVDGRAELDAWAAHLDALGVPYSPVAPATLDPRNSVLVFRDPDHIQLEFFAVPAEN
>fig|219305.4.peg.3718 Multiple resistance and ph regulation protein f
MTVALATVLTVLLSVTALLALARMYRGPSLLDRVIASDVLLNTMVGAVGTEAAINRHATTLPVLVVLSLLGFVGAVALVRFAVGEES
>fig|219305.4.peg.3729 Tetracycline resistance protein
MATDLTAPAPSRADVAPIQRRTLRLLFVTQIIGGVGVTIGISVGALLAARVAGTAVAGLAQSAGVVGAALLAVPVTRIMTGYGRRPGLVTAYLVGAVGGVLVVLAAATRQVPLLFLGMLLFGGGSAASLQARYTAVDLAEPARRGRQLSLVVWATTVGAVAAPNFAALADRTTRGWGLPSLAGPFAFSAVAFTLTAAVLLVLLRPDPLLTARRLTAAEAPAAADVVPDAAGPTVTGRRGAGMRATWRVVRERPAARLGIAAVAVGHLVMVAVMSMTPVRLGEYHDDSVVLGVVGVVLSLHIAGMYALSPVVGWLTDRLGRRQVIIGGLAVLLAACAVAGSAGHHTPGLSVGLVLLGLGWSGTMVAGSTLLSESVPAAVRPSVQGLSDLTMGLAGAAAGALSGFVMQVAGYPTLALLAAIATVPLLALALRVVPTRVPDEED
>fig|219305.4.peg.5363 Glyoxalase/bleomycin resistance protein/dioxygenase
MHDPLGGSFRVSAGTDVVVPGPGRPSWYEYMTTAPADADRFHADALGLRASAPPDAGDDSYALLLAAGRPVAGRLALPPPLAALLPTGWMVYFAVADPDAVAGRASGLGGRLLVPPRDVATGRVAALADPAGAVFTVIRPAPAPE
>fig|219305.4.peg.5800 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTVRVRELDHLVLNVEDVERSLAFYCGVLGLGPVRVDEWRAGRIRFPSVRVSPDTIIDLVQRHRGESNVDHICLVVDPLDWHDVIASGVFTVLEGPVSRSGARGQAVSLYVQDPDRNTVELRWYPADAEPTTPPTP
>fig|221109.1.peg.72 Membrane component of multidrug resistance system
MKDRSTYLDATNLPKVPIIFVMVMGSFIAILNQTLLNVALPVMIVDMNMSANQAQSLTTIFMLVNGILIPITAFLMEKFTTRQLFLTAMSLFALGTLVCGLAFGYPSLLVGRVIQAAGAGIMMPLLMNVILSLFPINKRGSAMGYIGLAMMFAPAIGPTLSGLVVQNYSWRVLFFIVLPIAIIDIILAFFFLRNVTKQSNPKVNYISILMSTVAFGGLLLGFSLAGEMGWKHVEVIAPLMIGAIVMVFFIRMQLKLKNPILEFRVFKFSMFSLTTVISVVITMSMFAAMILVPIYLQNLRGFSPLASGLMLLPGALISAFMSPITGKLFDRIGARPLAITGLGITAITTFLFSDLSNETGYYYLMFVYSLRMVGISMIMMPIMTAGLNQLPQRLYSHGTAMANTLRQMSGAIGTAFLVTVMSSQTVKHMDEMTQTVVSEEQLKVIENLATIEGINDSFMIATLFAIFGFILSFFIKRRYPPEESVETVSKEQKRKQPFRNVASGTNQLR
>fig|221109.1.peg.492 Multidrug resistance protein
MNQIHRPTVVALLLAGSFIAILNQTLMITAIPPIIIEMGITANSAQWLTTVFMLVNGIMIPVSAFLIERFTTRQLFMSSMGIFAIGTLVAGVAPVFEMLLVGRVIQSIGAGVMLPLMTTVFLLIFPINRRGSVMGLIGLVISFAPAIGPALSGWVTGHFSWRYLFFIIFPIAVIDMIIAYFALKNVTEVKKTKLDIPSVILSSFGFGGILYGVTNAGNYGWGASITLITLAIGVISLTLFILRQLKLTHPMLEFRVFKYAIFPFSVFIGSITFMGLIGTETLIPLFMQNMREFSAFQAGMAMLPGALVTGFLAPIIGRMFDRYGGKWIVLPGVVIITLATVPFIFIDTETTFAFITTLYAVRMLGLALIMMPIQTAALNQLPNNLIPHGAAMDGTMRMTAASVGTAVLVTVMTSVESMAENQVARPDILGVNVSFSVIAVLGLCTIIAYFFIKFDPSPAKIAKMEEDKSN
>fig|221109.1.peg.983 Tunicamycin resistance
MIIWINGTFGVGKTETAKILHKRIPNSYLYDPEEVGFLIRKQLPVELCEEDFQDHEEWRMWNYHLLKKITTETEKIVIVPMTLTNEQYYQEIIGRLKKEGIQLHHFTLVAEPQTIIDRLKKRGDEDNKFIVNRIEKM
>fig|221109.1.peg.1041 Multidrug resistance protein
MSESHVGGSTEKMSRVPILVVLLSGAFVAILNQTLLGTALPHIMSDLELEANTAQWLQSAFMLVNGIMIPITAFLIGTFTTRSLFLAAMSSFAIGTLICGIAPNFELLLTGRILQAAGAGIIMPLMQTIMMLIYPREQRGSAMGMFGLIISFAPAIGPSLSGYIVEHSPWRTLFFMVLPIAIINIGIAYFLLKNVTKRTFPQLDKLSIILSTLGFGGLLYGFSIAGSAGWLSNQVIISMIVGIIALAWFILRQLNLKTPILEFRVFQYKIFTITTILGMVTFMTMIGAAVILPLYMQDMLGFSAFESGLALLAGAVLQGIMNPVTGRLFDRYGSRYLAIIGLGLIVVTTFMFGMLTAETSFTYIATIHAIRMLGVAMAMMPVTTAGLNSLPDEFIAHGTAVNNTLRQVSGAIGTALPITIMSTAAIPSEGLQGLIHGVNVSFIVTAIISIVGLILAFFIHDEKKKRISSR
>fig|221109.1.peg.1196 Antibiotic resistance protein
MNLEKIWTKSFISISLVQLLIFLSFYALLTTLPIYVMDQLGGNEAEGGLVVTVMLLAAIIIRFFSAKLLDKIGKKRGLIISVALFMITSFLYLLVETYTSLLALRFLHGFSFGIITTATGAIAADIIPASRKGAGLGYFAMAMNVAVVLGPFIGLTLIQYVSFHTLFFILGVLMIVALINSMMVQVEEQIVEVNDNRQRLSIHDFIETRALPIAIIASLVSLSYASVMSFISVYASSIGLASTASFFFLVFAAVMLITRPSIGRSFDLKGPRFVLLPCLMIFSVGLIALSITNSSWMLLLAAGLIGLGYGSILPGFQTIAIQLSPDSRSSHATSTFFILYDLGIAIGSFVWGLIVSEIGFSNLYLVAAAIVVIALFLFEFYYRRPSKKEVNIADVQ
>fig|221109.1.peg.1411 Multidrug resistance ABC transporter ATP-binding and permease protein
METFKKLKRFYWPYKKYFIWSILFMLVVTSITVVYPIMLQITIDDVVVQSRYELIPWICGLFLGLMVIKGFSTFSFQYLGDLFGMTSVYKLRESLYDKLQTLAFKYYDNAKTGDIMSRLTADVEGFRFFLSVGFAELLRIISLILISLSIMFYYSVPLALVTMAAMPFLAIVVFQFDKRVHPAFRNVRKSFGQLNTRVQENISGMNTVKSLSREDFEIGRFSNSNDNYRQKYLFTSKLWARFFPMMEFIGNVSAVVLLAYGGYLVINETMNPGELVAFFSLVWYIMGPLMNLGFIINQFSQAKASGERLLEILEAKEDIVEKESAIETTIKGHVEFNDVTLTYIKDDDEALKNISFDAPPGKTIGLIGATGSGKTSITQLITRFYEPEQGEVLLDGRPVSDYKLKTLRSQIGFVLQEPFLFSTTIRENISYGNPEVTEDQIVQAAKMAQAHDFIMELPNGYDTLLGERGMGLSGGQKQRIAIARAICIDPSILILDDATSAVDMQTEFKIQKALREVMKNRTSFIIAHRISSLKHADEILVLEDGEIVERGTHDDLVNNNGPYERIFNIQYQDREEILSAVK
>fig|221109.1.peg.1412 Multidrug resistance ABC transporter ATP-binding and permease protein
MAKNKDNLKSESKHLQRFHYTIDQAIEKPFNWQQMWRLLQFLKPYSKTYLPGAVLAMMVSTAIRLAIPILIGKVAFDVAIANKDTTLLTYLVIGIAVLYSISFVANTFRIKWVNILGQNVIYDLRQKLFSHVQRLSHRFFDSRSAGSILVRILNDINSLQELFTNGIINLLMDLLMLSGILVILFVLSPPLALAVIIIIPLMFLISTTLRRKIRRSWQVVRLHQSRMNSHLNEGIQGMRITQSFSQEKENAEFFDGVNSGFFQSFRDAAKKSAMFRPLVDICDAAGTIILISYGAYLILNGTITVGTFVSFAFFLGMFWEPISRLGQMYNQLLMAMASSERIFEFLDERPNVAEKNNALQMEEMRGEIEFDKVEFSYNKDRIALKKLSIHIHAGETIALVGHTGSGKSTIANLISRFYDPTSGAVKIDGSDLRDVTIDSLRQKISVVLQDTFIFSGTIMENIRFGRPNATDEEVIDAAKVVGADDFIQRLADGYQTEVEERGNILSAGERQLLSFARALLANPSIIILDEATASIDTESEVKIQQALKRLLKGRTSIIIAHRLSTIREADNIFVLEQGEVLEQGNHQSLIQQKGKYYELVKSQFTMLDAM
>fig|221109.1.peg.1709 Multidrug resistance protein
MGKNHTSTAILSLGSIPFITTLGNSTLIPILPEMKEALGISNIQVSLTITLFSIAAAICIPVAGYLSDRFSRKAIIVPSLVIFGAGGLLAGIGAAFFSSAFIWLLIGRIIQGIGAAGTFPIAMALIGDLFKGSEQSKMLGIYEASNELGKVLSPIIGAAFALITWYFVFFTFPVISFLCAILVFFFIKERRNRQTPPPFYQYVKGLFLVFKQEGRWLFTVYLAGGTCLLTIFGILFYLSDKLETENHIIGVWKGLILAIPLLILVATSYRTGSRIGKNFVKMKRLAVFGFLLMTLSYLSLIWIEPLVWFIFALCFSSIGAGLVLPCVNTMIAGAVGKEKRGFITSLYGSVRYIGVALGPLLFGWLMDWSRTGLFLSVACFTFFVALLVLFLLHVNGMDGRDKRTKITYNYY
>fig|221109.1.peg.2135 Daunorubicin resistance
MISVQNLRKSYKKNVVIDQLSVDINSGDIVGLVGENGAGKSSFLRILATLSKADKGTITWNDVSYEKETKKLRRDIGFVPQEISIWEDFTVEENMKFFEKLSWVNRSESELKQLCLDMKLSKWKEPVHTLSGGMKRKLNMAISFIHDPKLLLLDEPTVGIDLKSKKEIGEYLYKQSKEHHKTIIYTSHDMDEIISLCDWVICIGKDSFYENLLKSRGKEIFTI
>fig|221109.1.peg.3060 Multidrug resistance protein
MWLANFFISGSMTMVVPFISLYIESMGDFSEGYVQTWSGLTFAVTFITAFIFSPIWGRIGDRYGRKKIMIASAFGIGFSVFLMGFADTVWQLFLLRLFMGIVTGFIPMSQAFIATQTPKEVAGKVLGTLQTGTITGSLMGPLLGGALADAFGYTSTFKWVAITIFISGLLVLFGVKELKMKFSNNENDTKKYSRKEVLQHILQKPVLFVVMLLSALVQIAHFSIQPILSLFVAEIHGPVNLAFFAGIAFSAAGLGNLLMARRWGIIGDNHGYVKILIILLFAAGFVYLPGIFVTNIWQLVILRFLLGLSIGGIVPLRIAYIRQEAPLSMQGEVLGYNTSLRFLGNIIGPALGGTIAASFGFSAVFIITSMLLILSGMIMLYVWYRHEYESTSSHSYSSK
>fig|221109.1.peg.3265 Broad-specificity multidrug efflux pump YkkD
MNWIILILAGLSEVVGVNGIQKVSAGKKKSGFAFLIIGFAVSLTLLSIAMSTIPLGVAYAVWTGMGTVGSVVIGMIFYNDSADRKRIFFLSLIVVAVIGLRIVSN
>fig|221988.1.peg.741 Fosmidomycin resistance protein
MQNKFAVYLAAIGHLVTDMAQGALPALLPLFIKNYGLTYQEAGGLIFANTVLASIAQPFFGYLADKRSMPWLIPLGMMLSGCCIAAMGFVHSYPGLFFFAMIAGIGSALFHPEGARLVNRMSGGEKGKAMGIFAVGGNAGFAIGPMFAGLAYLFGAQTLSIFALINTIIALIIFLQLPKLTVENVVNKAKNTASTTLQNDWRSFAKLSVIIFVRATNFTVLNAFIPIYWIHILHQQETDANFALTIFLSMGVAITFIGGLLSDRLGYVRIIRYAYLIFLPTILIFTQSENLWLSFILLIPLGLGVFTQYSPIVVLGQTYLAKSVGFAAGITLGLGITMGGIFSPIVGWIADHYGLQIALQTLSVLSLLGLIFSYRLKITDTEKPEKK
>fig|221988.1.peg.1644 Permease of the drug/metabolite transporter (DMT) superfamily
MLFQIIATLIWASAFIAAKYTYEMMDPVLMVQCRFFIASIIMLPGFFAAYKRVPKERLKIMWLLALINFPLMFLLQFIGLYFTSAASAVTMLGMIPLLTVLIGFLFFKRRINKIDLLLSLVALAGIILTVVGGGEDNLINPWGCLLVLGSAVSFCFCLYLSKDVMQEMAPKDYTNVLVILGSILCLPFTCVLVRDWSIVPSVKGMISLFYLGIGCTWLAVVLWFKGVQKTPTYISSILTTLEPIFGVILAILILDERLSTVSAMGILLTLGAAAVSVLIPVLMKKSP
>fig|221988.1.peg.1645 Permease of the drug/metabolite transporter (DMT) superfamily
MFYLIAAVLIWASAFIAAKFSYTMFDPALTVMLRLILSALLVLPTFFRSYRKIPKQYRLQLWGLGLLNFPVVLLLQFTGVHYTSVASAVTMLGTEPLVVTLLGHIFFHKPARLLDWLLGIVALTGIVFVVYGSESGGEVTLLGCTLVLLGSIAFSFSIHLAQSVMKAVEAKAYTDVIIMTGAISCVPFSLLLVQDWQIHLNIEGISAILYLSVGCTWLAYRLWSKGLRVSSANTASILTTLEPVFGVLLAILLLGEHLTLTTLFGICLVISAAGISVLSSMLINYIKNKVTIL
>fig|222891.5.peg.51 Bicyclomycin resistance protein
MNRFLHVVLITFVVFVADVAVEIYVPALPSIGVFFSATAMAVKASISSNILGLALSSLFWGTVSDLWGRKLALLLGSLVFVVSSVLCIFSASIDALVFFRFLQGIGQGVAVVVGFASVKDFYSGEKCAQVISKLSSVVAVSPTFAPILGTVILFYFSWHYIFLFLASLGLVCLLLLVFFFQDTLKERNPASLRGLLNSYIRIATNKSYVLYSAITVITFMWLWNVISSAPFLLLEDMGVTIQEYGYLVAINVMGFLLGTILNSKYIPKVGLKKLVAFGLALPLLSEVLLILLHYTTGFSPLILECIWFFSAMGLAFVIGNSTTLALDQVGESNNGKATALLVCSEMALGSLSVYLNAPFYDGTIVPLSLFTIVSVLASMIVFYYAVRNPGNTVKPAR
>fig|222891.5.peg.146 Multidrug resistance protein D
MDLQMLDFLLERNKAVLVLWFILIAAGLYSCFVISKEQTPNMEIPYILVNAVLTGVSAEDSTRFLSKELEDSLRSIEHLKSITSQSVENASSILMEFEVGFDSAKALASIRDKLDQVVSKLPKDTLRPTVEQVSTALIPAVVVTVSSNLGVEATQMVATKLRDRLNTLANVLSTKIIGKRKKIVEIMIDPKTFSRYNIGLHNIVNTLHQNNTLILSGSFPSNEYLVSTNGLVTHLNKLKELPISLNNGNILTLKDIADVNGVFEREKALSRIGGMDTVVIEVSKAGGKNLLETVKQVQEEVSKMQATLPEGFSLSTEFDTSTEVKEVLTDLKNSIALTVVMVVAIMVVYIGWKMALMTAFTVPGSIFIAILLLYVGGFTMNIVVLFSLIMSVGMIVDAAIIVNEYADRKMLMGSSAREAYTLSARKMFWPVLSSTATTLIVLVPLLFWPGLAGEFMKFLPITLIFTLSASVLMSVVFTPVIGSMIGTPSTSDPVEISKIFAIDQADPSAMGKISGKYCRLLEKLLDHPKAVVAGISVFLVLSIGGYYIFGKGLQFLPNVEPKSSTILIKAVENLTLAQKRTIVETAEKTICETPEIKTCYTKIGTLGNDVIGSVQVEFAHWKKRRKIAAINDDIERRMQSIKGIQFELFTQKDGPIQEKPIKIVISGTSYGEVAQAAASIEEMLSKINGTKSISDDTSVQKLAWEAVIDRNKAARYGVDVATVGQYIALATSGITVGEYRGNDHEEKLDIVLTLPEEGKSVSSILGMMIPSQKGMIQLSSLMKVKPIAKTTTVKRFNSEPTIHVYSDVQPGFLSHNIVKSLRKEIEKHKELSQLKISFKGEQQDQSETTRFLVVAFLVSTLCMVLILLLQFNSFCQVLIILTAVALSTGGVTFGLLITHQPFIVVMSGIGIISLAGIVVNNNILLIDAYNDYMSESTDKKRSIIRAAISRFRPILLTSGTTVLGLLPMVFCITINLVDFTISYGAPATQWWQSLATTVAGGLSFTTLLTLILTPALLMLSPTPKLNTRT
>fig|223926.6.peg.1156 MFS family multidrug transport protein, bicyclomycin resistance protein
MTEKAQSAPQSQISFLLFLVLGAIGALTPLAIDMYLPAMPTIAKDLGVAPGAVQITLTAYTAGFAIGQLIHGPLADSFGRRPVLILGVLFFGLAAVVSATTNGIDALTYVRTAQGFAGAAAAVIIQAVVRDMFDREDFARAMSFVTLVITIAPLVAPMIGGHLAIWFGWRSIFWVLAIFAVVVILLVFWKIPETLKPENRQPLRFRTTLKNYARLCSSSEALGLMLSGAFSFSGMFAFLTAGSFVYIDLYGVRPDQFGYLFGLNIVAMIIMTSINGRLVKKVGSHAMLRFGLFVQLLAGIGLFVSWLMDFGLWGIVPFVVLFIGTLSTIGSNAMALLLSGYPSMAGTASSLAGTLRFGIGSLVGALVASLPGNVAWPMIIVMFACSVLSALFYWTLGRKA
>fig|223926.6.peg.1682 Permease of the drug/metabolite transporter (DMT) superfamily
MNILLAMIPAFFWGTTYAVTQFTLPDWPPVLLGALRALPAGLLLLAIKPSLPKKHEWKVLLVLGTINIAFFFGLIFVMALTLPSAISGVGMISVPVFAMLFGWAVYKRQPSAIQGISGAVLIALAWFLFDPSSISLNPIGLGAMLAAIMCIVIGSSVTKSLGTKMHWWTVLTWQLILGGVLLSIAAAVLATINPQPYVHAVQNIDMTNTLGLLWVIVLNTALGYGMYVWLLQRMSVVDFTFGGIANPIAGIVSGLLLLGENFTPLQYSLMVGMIVMSLLPQILTSLRARKEAITV
>fig|223926.6.peg.1901 Multidrug resistance efflux pump
MTADQKFKHWMRTLIVLFIVLFLYIIIADRHAPLTTEGRVQGYVVQVAPEVSGKVTDVLIENNQSVQKGDVLFTIDDRKYKIALEQAELSLQSAYEKEATLYSQREAALANIARAQATFDNAHREYTRLLTLSKQKVISQSTLDNAFAQNQVSRAALKAERQNLKVIEAQLGDQKGQSTAVRIAKNGIEKAQLDLANTAVLAPSDGVVTNLQLEVGTMANTNMPLLTFVPTGSLWVAADFREKSVANVDKTFHALVTFDANPGSVYDFDLASRDYGVAAAQQTPNGALTKVEVNNRWVRDAQRTRVNLTSSEELPPALFVGSRATIVLYPDNSIFWQLMAQAQIHLASWFHFIY
>fig|223926.6.peg.2350 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNSIYKQFWKYTIPTVAAMLVNGLYQVVDGIFIGRYVGADGLAGINVAWPVIGSILGIGMMVGVGTGALTSIKQGEQDQQGAKRVLTTGLLFLLALMPIVATILFFFADDFIRWQGAQERVYELGLQYLQILIVACIFSLGSIAVPFLLRNDNSPNLATILMVIGAIINIVLDYVFIAWMNWELTGAAIATALAQMVVTVLGVGYFFSSKAKLRLTFRELKVQLDAIPKIVLIGTSSFFMYAYGSTMVALHNALFAQYGSPLLIGAYAILGYIVTVYYLVAEGIANGMQPLVSYNHGARNQDNIRKLLQIAMGTSVLGGVVFVVLMNLFPYQLVSVFNDADQQLIESAVMGIRLHMFALFMDGFLVVAGAYYQSVNKGSKAMFVTVGNMLIQLPFLFIMPKLLGVTGIWIAFPLSNIALSLVVMSMLWRDIKKLMVDSPVEPSIQAS
>fig|223926.6.peg.2719 Permease of the drug/metabolite transporter (DMT) superfamily
MGYEWLALCAAFLWAVSSLISVIPAQHLGAFSYSRWRMGCTAVILSTMAWITGGWLSVSWEHITPMMASGLIGIFIGDTALFACLNRMGPRQAGLLFSCHAVFSTILGYFLFSESMTAIELLGSALVFSGVVMAIFFGRRGQTNNVLEEIKGNIWVGVSLGLTAAICQALGGIIAKPVMQTSVDPIAASAIRMISAFVAHCLLLIVGVKVARSTQRITWRVFGITALNGFLAMAVGMTLILYALREGNVGMVALLSSTTPIMLLPLLWVYTKRRPNRFAWLGAALAVIGAGILVQ
>fig|223926.6.peg.2746 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFNMLEKNKPENHATDKHGLLSAPIPETLRKMTVPMTMGMIAILMFNLVDTFFISLLGTHALAAISYTFPVTFAVNCITMGIGMGLSTNIGRLLGQGHAPQAARFTTHGLLLAVLLVAIASSIGFATIAPLFRFLGATDDLIPLIEQYMQVWYLTIPLLVIPMAGNSAIRATGDTKTPAKIMMLAGLINGMLDPLLIFGYGPFPELGIQGAAIASAFSWLGALCGSFYVLVKREKLLAQPQWASLKQDWQQTLKIGTPAALSNAMNPLSGAILMMLLSSHGTAAVAAYGAAQRIESILILVLMSLTSALTPFMAQNLGAKNPQRAFSGLFLSMRFAVVFQGFIFLMMVPLSIPLAALFSQEETVKNLLWHYLLVVPFSYGFQGIVMMLVSGLNAMHKPLRAFQWSFMRLFVFTLPAAWVGSQVYSIEGLFIGIALGNTLGGLLGYMFALRERKLTLIEQNSAS
>fig|223926.6.peg.2902 Multidrug resistance transporter, Bcr/CflA family
MSSHISNSKKQMALLTLLVLFSPLAIDIYLPALPLIASTFQVDNALAQDTITWFLFAMGVGQLFAGPLADKLGRRTVALGGITIYAMSALLAWSAQNIEWMLMSRLLQGLGACATSVAAFATVRDIFGPEKSGKMISYLNGAICFIPALAPILGSWLTQQFDWRANFSFMAGFAVVSGTLMFLMMKETNPATEKQAVFKVSRYWSVLSTPSFIFHASLCLMAMAVILAYVTSAPSVLMTGMGLSMNEFTFWFGINAVINIAGCMLAPKFMERFGTHNTLVVGISTLALAGVVMLVMNGQNTALSFMLPIFMSSVGFALILGGAAGKALEPFGDKAGTAAALLGLFQMSGSGLLVGTLQRLPFDPQTLIAIHMWVLLPALVILFSKAGKSWHARFANA
>fig|223926.6.peg.2950 Multidrug resistance protein
MLGFVATDMYLPAFKAMEIDFATGPEQIALSLTVFLVGMAFGQLMWGLASDKFGHRNTLAAGLVLFTIASFGLAFCDEVWQLLTLRFVQAIGVCAPAVIWQAMVIKRYSSSSQQIFATIMPLVALSPALAPQLGVVLADSFGWHSIFIALTLVGVVLVAATMAQKNEQAEIKQTSMSADIKALLGSKTYLGNVFMFATASAAFFAYLTGMPEIMAQLGYEAKDIGLSFIPQTIAFMAGGYLGKVGVRKFGDEKVLRQLIGLFSVAALLIFVASQWELTSIWPILAPFCLIAVANGALYPIVVNRALASAHQSPATAAGLQNSLQITVSSLSSALVAAMASQAQMVTGVAIVICMGGLWMGYILSNRELSKHFTTPDNARVVSEDEL
>fig|223926.6.peg.3057 Multidrug resistance protein A
MYWSWQYSDSHPSTEDAYVRAKILSVAPQVKGQVVSVDVKDFQSVNKGDLLLKIDSRPYLLAVKQAKAAYQLAVQQHDVADKQVTEAVAGLDAARSNLTEAQVEYKRTDSLVKRKLASDQDLDTAKNKLANAQASLEQARATVEKAIANRGEEGAEAAVVQQAAAQLAQAELNLSYTDITSPVDGIAGEINTHVGSVVSVGQTLFPVILKDSYWVRANFKETDLTHIKPGMHADVVIDMYPDVVWKATVEQLSPASGTSFSLMPPENATGNWVKIKQRFPVRLALEVPADAPQLRVGASSEVTIDLQSSVQ
>fig|223926.6.peg.3079 Permease of the drug/metabolite transporter (DMT) superfamily
MLIRAIPFVFVILWASGFVGARFGLQYAEPATLLSIRMAFNVLLFLVLVAVLRRRLPTGTDFWHSCVVGALIHGFYLGGTYFAIALGMPAGLSSLLVGIQPILTAALLVAFVREEFKPSQWLGLALGFVGIAMVLMGKMEWQSEQHKVLAIGLCLLALVGITLGTLYQKKHCQQVDMVGGATVQYLAALIMFLPVAMQFETMQVQWELEFILTVLWLVVVLSCVAILLLLYMVRNGASSSVASVFYLVPPTTAIQAWLAFGESFDWMGISGFVLAATAVYLVVKKPDLTIKKAIKTEYT
>fig|223926.6.peg.3126 Multidrug resistance protein D
MYVPSIGHMAGEFLVSASSLQAVMACYLIPYGLSQFAYGTLSDRLGRKPIIIVGLLIYILGTLVALFAHQFEWFLAGSFIQGLGIGCGGAMSRTLTRDCFEGAELHRANSLISMCVIFSPLMAPVLGGYLTEAFGWRSSYLFLALFGIAVVITMMTSMMETLPKEKRKFEPVAKSYKHVLSDRRFQGFLICLVATFAGVGVFEAAAGVLLGGVLALPATTVSLLFILPIPGYLVGAGLSSYIAQRRSERRALNVGLVSIFIGSAVVLIPGLFGVTTALTLIGGATIYFLGAGILFPAATTGAIAPFPYHAGTAGATLGGMQNLGAGIATLLASLFPAHNQMPLGVLMMAMSIVAMLGLLWVHRAHDHSNEMPQVI
>fig|223926.6.peg.3196 Permease of the drug/metabolite transporter (DMT) superfamily
MDFLAIALVVFSAVLHAGWNILGKSHSGSGVAFTMAASLSACGVLTPYLIWYLTTLGWTSLPVEFWGMLAFSGIAQIVYLVGLIMAYKHADVGVIYPIARALPVMMVGGFSVALGHALSSQQWLGFVLITFGCILVPLTHVRQVSLVAYLNVGVFWALIAAIGTTGYSVVDKEALTLLTQQASTIFNDQYSAIFYLGAQFWAMGLPVLLWCLITRNDQELQAAWRIRKSASMAGIMMASTYGLVLFAMTMTDNVSLVVALRQISIVFGLLMGIWLLAEKWYLTRGIGVAFILAGIVLSLEGA
>fig|223926.6.peg.3265 Permease of the drug/metabolite transporter (DMT) superfamily
MKVTSVGAAMLLLIVGNLIAVLSDSLIKSVANEVPMFQFVFFRQISAVMFLLPVCLLAKQTNFMEGFKWHAVRAHVWLLGAVFMVMAISSLPLATANAIFYAAPLIMLPLAAIFFGEQLSKQSVAAAVMGFAGVLVIIRPDQIDWAAISAFVVALTLAINNLLIRKLPKNQSVMQTLLMTNLAGIPVALLLVLIEDQPWQWGAFPVAAGSSLFIMIYAATCVLAYRSIDSNKIASAEYSGLIGAVVVGFIWFGEIPDIFMAIGTVMIVVPLIWLSKRERRKQKEHAQLQAQKEHEQQQAHVA
>fig|223926.6.peg.3308 Acriflavin resistance protein
MINLAEFAIRQRKFVLFFIVLSVIAGIYSYFDLGKLEDPSFTVKTAVVVTLYPGASAEEVEHQVTDTVETKLQEMAELDRLRSLSRPGLSMVFVDLKESLNSKALPQEWDLLRRKVDDVKLQLPSSAQISVVQDEFSEVYGMLFSIHSTDAAPEELRRYAEELQRQIKAVDGIKKIELHGVQPRVVHIDMPDERLAQYGLSIAQVWNQLSTQNSTFEAGKFDAGTERIRIAQTSEFQSLEDIRNLIINGGTGEFGSGLIRLGDIADITMGYQTPALAENRYNGEPAVTLAVSPVQGINVVSLGDTIQDIIANYQASLPLGVDISTVAYQPEEVQKSIDDFVGNLLESVAIVFVVLLVFMGFKSATIVGASLLLTILLTLVYMNIASIDLHRVSLGTFILALGMLVDNAIVITDMMIAKLNKGIERTRAAIDSVKETAVPLLGATVIAIMGASPVLFSKTDSAEFASSVFYIVASSLLLSWIVAMTFTVLMAWMFIKPKANNEETKPSRYKQLVFWTVDNPRKALAALVPLILVTAVAIPYVAVNFIPQSDRSIVFLDYWLPNGAKIEQTSADMRKVEEWLVAQPEVESISSYVGTSAPRFSVTVEPEPLDPAYGQILINTKDYESISHLVTRGDDWLKEAFPDAEPRFRALKLATKDKFAVEVRFSGPDETVLHQLAAEAKTIFASNPDAKYIRDDWRQESKVLKPILNQDKMRQAGINRADVAFALKRASDGMPLGQMNLNDELIPIQLRGTSQNMASLETLPVRSLLGFNSVPLGQVVDGFELVTEESMIWRRDRVKTITVQAGVSRDSTPANVRNAIKDQVEAIQLPAGYSMEWGGEYYDEDKAVTDIMKQQPKAMLIMVIILVAMFNGFKQPIIILATLPLAASGAVFALLGFDKPFGFMALIGAITLTGMIIKNGIVLMDQIELERTNGKSLSDAIKEATVNRTMAISMGALTTALGMIPLLSDLLFDQMAATIIGGLAAATILSLFVMPALYRLVYKEKAPSTQTNAELEEASS
>fig|223926.6.peg.3346 Permease of the drug/metabolite transporter (DMT) superfamily
MVYLLPFFTVMIWGGNSIVNKMAASTIEPSAMSFYRWFVAMVLLTPFCLPAVIKQRHVIRPYLTKLAFLALLGMVLNQSLGYYAGLTTTASNMALITSLVPLISVFLSVPLLGKSVSMLSIVGGVISLGGLAFMLGHGDVTYFLHQDMTQGDSLMLLAALVYAAYCVLLKRWKMPFNSLTLVYMQGFFSVIMLTPLWLSSEQLLPSQEALPLIAYAGIAASIFAPLMWVKAIDLIGADSSAMFMNLMPVVSVALASTLLGEEIHVYHIIGGLMVISGVILSQIKVRKKQDLVVSESLTTTTR
>fig|223926.6.peg.3463 Multidrug resistance protein D
MRKTPLLLAMMIIATGQVGVSIYLPSLPLIGHDLNLPQPSIQSLVTLFLVGFGVSQLFYGPLSDAIGRRPVFILGQSICLIGTVICIVFGDNISALEAGRLLQGLGAGSASVLGRSVLRDSYDGMQLTKALSYISVTASVMPIVAPLFGGWIAYHFSWQAVFVFVLLYLLAIFILGYLVLPETLPYPKRKFEVRQVMVNYFYLLTNKQVIGSASYNWLSYLSGLVTLSLYPFLMQQELGLTAADYGSLMIIPSAGLLMGSLVLNLINNRYKAQQILLMSFAIVALSGCLLLVTPFTVASLLVAFTCLSFAQGMSFPVSISLLLSPHKQQAGAVSALSGSIQMCLAGLFGGYLVEKWVTDQHQLGIFYLFIALISCIVLVVSQYRRAPRQTAQPEASS
>fig|223926.6.peg.3509 Permease of the drug/metabolite transporter (DMT) superfamily
MLYSLSSIFLLIVVGIPKLSYFSPKYLIVGGAMFVCYEIFLALALGYSNSRAQAIEVSIVNYLWPALTVLFAVLGSNKKPNWLLYPAVTLAFIGVAWTVSGDNGLSPTQIISNVSSNPLVYFMAFTGAVIWAVYCNLTQRQQSKHNAITLFFIATAVSLWVKYAFADEPTMTFSWSALGYLFASAALMAGGYGLWNIAIVGGNMVFLATLSYFTPIFSALFSSLILGVTLSNSFWQGVVMVTVGSLLCWLVTKEKREAAG
>fig|223926.6.peg.3552 Permease of the drug/metabolite transporter (DMT) superfamily
MFNSERKATVILVATTMIAALGWIFSKETIQGLPPFGFIGLRFTIASLCLLPLCFRPLKAARLKDVLAASGVGLLLGGAVMTWIYAISISDTLGEGAFIMSLSMLFVPIVAWVMFQQRPQRIFWISLPIAVIGLACLSLAGGWKQSASQLWFLGAALILALHFNVNSKYSQKLPVLLLTCVQLFSAGCLGLLVSFLMESRPEQVDSSIWWWFALSTLLATSLRYVMQTMGQKFVQAGNAALIMILEPVWTVVLSILWYGEVLTANKLVGCLLILFSLVIYRTGGRFRFPKRA
>fig|223926.6.peg.4143 Permease of the drug/metabolite transporter (DMT) superfamily
MILGYAAILVTVLLWSGFFISLKGGAISALQPADIALVRFLVPSLILLPFVMKHKAALKVVPNKYLTGIVLGSGLPYLLVAGTAMHFAPVAHGSALIPGTLPLFVSAIAVLFYQQSLSHHRIIGLSTVLLGIFVFLLSNIGEEYNWSQLQGHAMFLVGSLMWAVFTISARVANLNAYVCAGFVAIVSLLMLIIAVGFGWIDSYLAVTPISSWPWEELFSHAMLQGVGAGLIASFTFIYAIKIIGAEASAAFGSLTPVVATLLAVPIFGEQPDSLTWIALILVTCGSVVASQIFMKHELTQTYRPPLHR
>fig|223926.6.peg.4155 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPSTSTNAQPTLAKQLFTMTWPMLFGVLSLMSFQLVDSAFIGQLGVLPLAAQGFTLPLQMVIIGIQVGLGIATTAVISKALGANDARYAKQLGGLVLMIGSIGVAVFGLLIWLLRYPILSLLSAPETVMPIIDSYWPWWLLSSWAGAVLYFYYSICRANGNTMLPGTMMMVTSGVNLVLDPLFIFTLDLGINGAALATLVAFGFGILVVAPRVKRNHWATTQWQDLNVMKSVTSIGNIMGPAMVSQLLPPLSSMLATKLLASFGTAAVAAWALGSRYEFFAIVSVLALTMSMPPMVGRLLGAKNYRDIQSLVGIAVKFILGFQLLIAAITFLLANPLALLMTSDTQVEQVLHMHLMIVPISLGSLGVCMLMVSICNALGKSYTALTISALRLFVFFLPCLWLGAQLDGIRGLLFGACVGNIMAGISAYLTYRKTIHKLAIKQATA
>fig|223926.6.peg.4452 Permease of the drug/metabolite transporter (DMT) superfamily
MNHVHKPIVFMLMSTLSLSVTGLLAKQLSEALSVTMFSFLRFFLPAVILLLVLIPKGIKLPKSTELKPTLLRALCIGLSQLCFIASLQTLTLVESVVLFATGPLFMPVIEKLVWHGKIRASIVFGIVMAFSGVVLLAGTEGEFTLRYDLLLGLAGGLFNSGSQLTLYKVSKSNMSPLEINFWAFSFAALFILPLALINDGSGLLGAHSFSLSVEPSVLWLLVMSMLIINTQVFRAKAYQLASSGSQLAPLIFTNLLFTAVWQSLFFADVMSRTQIAGMGLIVLATVLNGCWDVLVKHHQSKALQTRTS
>fig|223926.6.peg.4497 Permease of the drug/metabolite transporter (DMT) superfamily
MSTFLLTAITMLAFAANSLLCRLALAEGLIDAGSFTLVRLISGAITLIALLVVRGQWKTDRPTSRFRFFAGVALFGYAALFSFAYLQLATGTGALLLFGAVQLTLLVIYWWQGERFQFLEIIGIGLSIVGFVWLMLPSTTRPDISSALLMLISGVCWAAFTALGKQAPSPSSGITWGFIAASMIGILLSPLMLSSIHLSLSGILLAITSGAIASGLGYTLWYQVMRKLSLLQAAVSQLSVPAIALLLGTVVLHESLSLHTLLTSGIILGGIALVFLSRSKKTSKQLASR
>fig|223926.6.peg.4499 Outer membrane component of tripartite multidrug resistance system
MMLPKLTKPSLAILSLLGLSACTTVGPDYVHPPQTPLPSDWSVQKAAKDTQQSEQQLQQWWQQFNDPTLNRLVELANEQNLDIEAAGLRIVQARSLLGISTGLQYPQVQTVSGNLARAYVNDQGVNNAALSFDAAWEMDIWGKYARGIESAEAGYYASIASYHDIMVTITAEVARNYINYRTFQERILLSRRNIEIQERVVHITQVQFDSGNVTELDVQQAKNQLYTTKAAQPSLEVAMKQSRTALALLLGVLPEEVEKLLQSDGLTQQIADYEAQFKSTGRKSALSGTDEHSIVPRPPLLDTQVDANLVMRRPDLQVSEMQARAQSAQIGVAETALYPSFSLFGSIGIDSTVPDGSSFSFSDSLTMVVGPTFSWNIFQYGRVKNNIRFEDARFQETLTNYNKKVLQAVNEVTNAIEAYDLYLQQKDLRLQSVNSSIRAFNISMTQYENGQISFERLLNSVEKMTRAEDSYAQIKGNVANQVIALYKALGGGWQAQTGKPFLEESIAKQMQDRTDWDGYLDEENRTLPPLPIETPTENGDKNKTEDL
>fig|223926.6.peg.4501 Fusaric acid resistance protein fusE
MKKLFVIALNLVILGGAAWLGYQKFEEYFNNPWTRDGQVRANVIKVAPRVSGPIVNVSVQDNQEVKTGDLLFEIDPTTYEVALSQAEVALEKSIVSSRGKKIEYDRLKDIRAKDRGAVSHKDLIRREIAYEESLLQIKSAEEQLKSARLNLSFTKVYATVDGFVSNLDIRNGTQAVANQPLLALIDKNSFWVFGFFRENQLAQIEPGSRARVTLMSHPDTPIDATVDSIGWGIAPKDGTVGYNLLPNVNPVFQWIRLAQRIPVRISIQELPEDVDLRFGLSASIMVMKDSSAENEQ
>fig|223926.6.peg.4566 Multidrug resistance protein D
MNRPINFRTILLACLIISVGQLSMGLVMPSLPWIAKDFSVSLDQAQLLVSIYLLGFGPSQFIYGPMSDALGRKKVLLAGLLIAMSGLLMIIFWSHTFTGMVLGRFLQGLGTGCCAVLARASTRDQFSGNELPVAMSYIAMAASITPLIAPVIGGFINFHFGWSMVFISLLGYVSLAWIIIAFRFKETITRRSAIPSPAKMLVQYRDLLSSRYFMSFASISWLNFSLMITTVSVMPFIMQDQIGMTSDEYAMWALIPALGMLGGTTICNRIRPVIGNKKMLLCTPVLHISAALWLFFCPVEPLYLMIGQLLMILGNGIALPCAQALVMQPYKEQAGAAAAMSGGGQMVVSSLVSMTLVQLGLSEAWHLSLVVVLFTAITLTNILRGFNTEEAQQHREVAEKAS
>fig|224308.1.peg.189 Chloramphenicol resistance protein
MSNTWKIYILAIVSFLVGTSEYIISGILDQIAHTLGITLAAAGQLITIFSLVYALSTPVLMALTASMDRRKLMMYALGLFVFGNVLAFVLPGYGWFIAARIIMAMGAGVVVVTALTIAAKIASEGKQGSAIATVVMGFTASLIIGVPLGRMIAVALGWKSVFGAIALLGLIAMVVIFFTLPYTEGDKPVPLLQQLALFKKRKVAMGLSITFFWLGGYSVAYTYLSPYLLNISGINGKLLSGVLLIFGIASLVGSKFGGYSTDKWGVPFTLVGGMTLHIVTLILLSLVTHSYIGVLVILILWSFAAWSTGPTQQFHLATIEPEMSGVLLSMNQSMMQFAMAVGAGIGGVFVENVSLASITWVGALGVMIAIIASLLIFNSQPKQALKDINQ
>fig|224308.1.peg.255 Permeases of the drug/metabolite transporter (DMT) superfamily
MRAEEQSKIREAAAGTIFLLIGTVCFASKSIWIKWAYQMGAEPDAVLLYRQLLAVPLFWLIFLIYRPPMPDGKKKGDLWKACGAGVFCFFLSPLLDFIGLNHVSAMVERILLMSYPLFVFGFTACRDRKMSSIQDLFAVLAVMFGLFLALGGWNAELFQANMIGAVFILLSSAVYAGYLVLSGHLVHQIGGIRLNAYGMTAAGAAMMLYTGIKSAAGMNTPMAAYPLSMYGLFAVIAVVTTVIPFVLMLEGIKRIGAQRAAAISMAGPILTIFYGALFLGERLGLIQVIGCGGVFFVITGMEYRKLKTGKKE
>fig|224308.1.peg.315 TmrB protein, responsible for tunicamycin resistance
MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPQKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK
>fig|224308.1.peg.721 Permeases of the drug/metabolite transporter (DMT) superfamily
MKKRLSLDRRFLPYIKKAGGVLVKKQMGAYVSLAAAMAIVGSSVVVGKLMVERIPVFLSSGLRFLIASVVLLMLLFCIEKGFPALTKKDVFVLLVQSFTGVFLFSICLLYGVQYTTGTESGILTSTTPMLIGILSFFLLREKIEKKTLIGILLAVCGVMAINLFGAGSQDGTPHALFGNMLIIAAVIGEALFTLMAKLLSPHISALAISTFVSLFGFLFFLPFALFEASSFDYSVPTVLDWSYVLYYALFVTVLAFYLWYSGVTKVPAGVSGIFTSVLPVSAVILSGVILKEPFEFVHFIGIACVIGGIFVTVIKKKQPDAYPAAEEKTL
>fig|224308.1.peg.821 Multidrug resistance ABC transporter ATP-binding and permease protein
MQKALSFLKPYSLLAGIALILMLTELAVELMQPLLIAKIIDDGILKQDLRHVWIWGTVMIGLTVLSFAAGMLNSFYAAHVSQSFSYDTRKGLFQKIQSFSYSTFGQFSSSSYITRLTNDVTQVQNMIFMSLRFMLRAPLMIAGGIVLSLAVNVKLGFFLLVTIPILILFLLWVLRKGGALFRSVQKRLDQVNTIMQENLIAIKLIKALLRGSHEVKRFIKANTRLMEKTVSAFQLVEFTMPVLMLLMNLCILLILWAGSYSITSGSTQVGDVVAIINYATRITGALSMFPFLIMIFTRAKASGDRIGEVLETEGDEREEGTISDRLSGRIEFQHVSFRYPEMDREALRNVSFSAKPRETIAILGATGSGKSTLFQLIPRLYQPDSGRIYIDEKPVQDIPAEGLRRQIGYVPQEVLLFSGTIKENIAWGKENASLDEIMDAAKLAQIHETILKLPNGYDTVLGQRGVNLSGGQKQRISIARALIRKPAILLLDDSTSALDLQTEAKLLEAISTYHCTTLIITQKITTAMKADQILLLEDGELIEKGTHSELLSESQLYKRIYESQFGREGSESC
>fig|224308.1.peg.822 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKDIRKPFQYPKLPIDKKEGAKKRAKAKDTKGTLRRIWSYLAERKGLLILVMLMVVISAIFGLLGPFVIGKAIDHFIVGKTVSGLIPVLLLLLAIYIIQSLSLWFQNYWMITISQGTVFRMRSELFTHLHELPIPFFDKQRHGELMSRVTNDIENVSSTLNTSVIQILSSVITFVGTIAVMLYMSPLLTLITLTIIPVMAASLKWITNRTGKLFKEQQKNLGDLNGYIEESVSGAKVIKAYSREKQITAEFLEKNAALKTSGFWAQTISGFIPKVMNSLNNLSFTMIAAIGGLFALKGWISIGSIVVFAEYSRQFTRPLNDLANQFNTMLSAIAGAERVFDVLDEKEEREDEKNAVHQPIQTGSIEFRDVSFGYDKGQQTLKHLQFTVPAGQSIAFVGPTGAGKTTVTNLLARFYEPNDGKILIDGTDIKTLTRASLRKNMGFVLQDSFLFQGTIRENIRYGRLDASDQEVEAAAKTANAHSFIERLPKGYDTVLTQNGSGISQGQKQLISIARAVLADPVLLILDEATSNIDTVTEVNIQEALARLMEGRTSVIIAHRLNTIQRADQIVVLKNGEMIEKGSHDELIRQKGFYSDLYESQFEK
>fig|224308.1.peg.840 Drug resistance transporter, EmrB/QacA family
MSEALTEQKSQKWAISLFTIGVFMAALDNGIISAALTTINESFSVSPSWGSWGITLYTLGLSVSVPIVGKLSDRYGRKKLFLIEVCLFGLGSLLVALSQSFPLFLISRLIQALGGGGIFIIGSSHILATLPKEKQGKALGLLGAMNGMAAVLGPNIGSFLLDWTGSWHWLFLINLPIAVLLVVFGACFIAETKAPEAKRLDAAGIFLLSLSILAVMYGMTNLDGANLLHSLGNPEVYGCIIFGILCFAALISYEKRVEMRGGDPILAYSLLRNHMFQRTLIIGLLSGGLLAAVIFIPSYVEQYLGVPAAKAGYWMTPLALASGIGAWLGGALTDKKGPVKTVILSGIISCAGFALFPLWVTEKWEFVIASVAAGIGFGFLLGAPLNVLVSEAAKTNKGTALGTLSLVRQIGLTLAPTLYAGFITAGFDQIGDEINSRLSDSGYSEKAMQMIPEIDSSEVSSLQEQIERIPVPEVKTAISDAIHASVASGYDHLYAAAAVVSLLVIAAISIPAFRRQKR
>fig|224308.1.peg.900 
MIEDETKGENKMNRGRLILTNIIGLIVVLAIIAGGAYYYYQSTNYVKTDEAKVAGDMAAITAPAAGKVSDWDLDEGKTVKKGDTVAKIKGEQTVDVKSIMDGTIVKNEVKNGQTVQAGTTIAQTIDMDNLYITANIKETDIADIEVGNSVDVVVDGDPDTTFDGTVEEIGYATNSTFDMLPSTNSSGNYTKVTQKVPVKISIKNPSDKVLPGMNASVKISE
>fig|224308.1.peg.901 Membrane component of multidrug resistance system
MATGKEKNAKNPMSLLIVLMAGLFLAILNQTLLNVAMPHLMTEFGVSATTIQWLTTGYMLVNGVLIPLSAFLITRFGQRSLFLVAMFCFTLGTLVCGIAPNFSTMLIGRLIQAVGGGILQPLVMTTILLIFPPESRGKGMGIFGLAMMFAPAVGPTLSGWIIEHYTWRIMFYGLVPIGAIVIIVAFFIFKNMVEPQKIKLDTLGAILSIVGFASLLYGVSEAGSDGWTDPIVLSTVIIGAIAIVAFVVQQLRHDDPMLDFRVFKYDIFSLSSVINIIITVALYTGMFLLPIYLQNLVGFTALQSGLLLLPGAIVMLIMSPISGILFDKFGPRPLAIIGLLVTVVTTYQYTQLTIDTPYTHIMLIYSIRAFGMSLLMMPVMTAGMNQLPARLNSHGTAMSNTLRQISGSIGTSLITTIYTNRTTFHYSQIADKTSTADPNFLHAFQNAVSNLMVNMNVSYDTAKTYVYSHIYKHASLDSNVMGINDAFMWATLFCVAGLILSIFLRDVRKDKLRKKKKEELSLLPAPKEAKES
>fig|224308.1.peg.1119 Multidrug resistance protein B
MFFASSLIFPFYILFVKNIGSSYTQFGFSYGLFGLSGALIYPLLGRLSERFDSRYFLLLNSWGMAVLLLYVPHIGSVVQVYIVQVLLGLFGAMQKHGEKVLIANFTDSGERGKKIGNYHFWTAVFSAAAIMLGGFLADFFTVQMIFYASSILYFLSGLMMMKTG
>fig|224308.1.peg.1686 Multidrug resistance protein
MVAGFIRSSLSGVSLCFWLFGVLFYLSDTLENKYAIDGVAKGGLLAIPLLFLSTSSFIAGKKIGKDKGRMKFCVVTGMILLTLSFIALWWNHSFYFLFVFLSFGGIGIGMALPALDALITEGIESEQCGTISSFYNSMRFIGVALGPPVFAALMSNANWIIFILSAFCSIVSLFLVLFTVDAKKSEEEKNLGTV
>fig|224308.1.peg.1733 Multidrug resistance protein EbrB
MRGLLYLALAIVSEVFGSTMLKLSEGFTQAWPIAGVIVGFLSAFTFLSFSLKTIDLSSAYATWSGVGTALTAIVGFLLFGETISLKGVFGLTLVIAGVVVLNQSKAHAEDKKQTACE
>fig|224308.1.peg.1734 Small multidrug resistance protein
MLIGYIFLTIAICSESIGAAMLKVSDGFKKWKPSALVVIGYSLAFYMLSLTLNHIPLSLSYATWSGAGTVLTTVIGVKWFKEDLNAKGLIGILLLLSGVVLLNWP
>fig|224308.1.peg.1880 Permease of the drug/metabolite transporter (DMT) superfamily
MVKVMLGIISVTLIWGYTWVAMKVGIHDIPPLLFSGLRLFIGAVPLFLILFIQRKKLSIQKEHLKSYIIMSLLMGLGYMGILTYGMQFVDSGKTSVLVYTMPIFVTVISHFSLNEKMNVYKTMGLVCGLFGLLFIFGKEMLNIDQSALFGELCVLVAALSWGIANVFSKLQFKHIDIIHMNAWHLMMGAVMLLVFSFIFEAVPSAEWTYQAVWSLLFNGLLSTGFTFVVWFWVLNQIQASKASMALMFVPVLALFFGWLQLHEQITINIILGALLICCGIFMNTFTFSRRKV
>fig|224308.1.peg.2378 Multidrug resistance protein B
MKKWKDIHPISWTIIIGTIFGRMATSMSIPFLAIYLTAVQGASASYAGLVIAASSSVGILASFYGGYISDKFGRKNMMLVSIFGWMLVFAGFAAASNLWVFFVVNALNGLCKSLFEPASKALLSDMTEEKTRLLVFNLRYAAINIGVVFGPVLGLYFGSSQSTTPFLVPAVIYGLYGIVLALQFKKHPSLSAPAQSRNMSVREAFMVTQKDYLFTIALVGITLCTFGYSQFSSTFPQYMAQNPLIGNGTKLYGLMLTLNAIVVLATQFPIVHFAKRFSPLCSLMLGNVMVSISMAIFTVSHGVPSIVMIVITFTIGEVLLFSMMDLYVDQIAKPGLKGTYFGAIGFPQLGNVIGPWVGGICIDLFGAGRPIYIFSVLSGITLLGLPFLAFAYRQMKMETTKHRSRLEKPL
>fig|224308.1.peg.2406 Transcriptional activator BmrR for multidrug resistance transporter
MKESYYSIGEVSKLANVSIKALRYYDKIDLFKPAYVDPDTSYRYYTDSQLIHLDLIKSLKYIGTPLEEMKKAQGLRDGRTVCFLYRAGEANQGEIRLFISPGANHFIGEKADETADGISRRLGEVFVLDEEEIRIIQTEAEGIGPENVLNASYSKLKKFIESADGFTNNSYGATFSFQPYTSIDEMTYRHIFTPVLTNKQISSITPDMEITTIPKGRYACIAYNFSPEHYFLNLQKLIKYIADRQLTVVSDVYELIIPIHYSPKKQEEYRVEMKIRIAE
>fig|224308.1.peg.3116 Multidrug resistance protein
MKTKHYWVISLLAVLAVGPGLMSNTALSSVQGLVQKTVGTSVFTSVNPILIGNMAFALLVPAGPLLRKKFGARPVYLASLPVFILGSLLIACSGDIALMAAGRFLQGAATGVMLMIMIPMLVLSFPIERRNYALLVLIGGFYGSVIIGTILGTIATSCGHWRWLFFIFGTLSLIGVAVSYFFLHDEHHGAADQEQPLDRAGILLSVFLAAASAVSFIFLQKWGLSSGYVWIGFGVTLCLLIGLLIVEYKVKNPFISIKLMLLPKPVLGLLIIAAGTITVAVSLSAFQGLLRQMYDISQEHLILLSLTLLIGVAIAAILSALLYDKVGPGMLGIIGGLILVFVNFQWLHIQDRSSLYMFAALFIMLAAGTGLTVAAGLMGAAMGGPLPDLVKRMTAVQFLRLFVYMGVPILIGFFTKKDAARQSGSVQDSMMTAYHDLFFISFILSVLLVCLSFCMNATGMGHKLAHKPHDKAKTAPEKPAVSAQGLSKATVKSYKVINDTEYRNALRNLQK
>fig|224308.1.peg.3363 
MNWVFLCLAILFEVAGTVSMKLSSGFTKLIPSLLLIFFYGGSLFFLTLTLKSIDVSVAYAVWSGMGIVLITVVGFLFFQEHVSVMKVISIGLIIAGVVSLNLIEHVAVSEPVHKSGQYK
>fig|224308.1.peg.3391 Multiple antibiotic resistance protein MarC
MMFSFIVHVFISLFAVSNPIGNVPIFLTLTEGYTAAERKAIARKAAILSFFILAAFLVFGHLIFKLFDINIHALRVAGGIFIFGIAYNLLNAKESHVQSLHHDEHKESKEKADISVTPLSIPIIAGPGTIATVMSLSAGHSGIGHYAAVMIGIAAVIALTFLFFHYSAFISSKLGKTEMNVITRLMGLILAVVAVGMIGAGLKGMFPVLTS
>fig|224308.1.peg.3527 Drug resistance transporter, EmrB/QacA family
MSSRKEWALIVSLLLGAILVPINSTMIAVALSSISHTYNESIASITWVVTVYLIVMAVTQPIAGKLGDMYGNKTMYLWGVGLFLIASLGCALSPSLLLLIVFRALQAVGGALLTPNSIAIIRHVVSEKRLPKVFGFFGLGAGLGAALGPFIGSILIDSFSWHSIFWVNIPFLAIALFTALTMFPQYKENKSDAPLDIIGSLLLAGSIVSIILLTKNEAPWGYTVYSVLILLFVPLFFRREKRTQHPIIDFALFKSSTFTNANLSVLLSNLMMYAVLLIMPLFMTNQFGLNTSNSGMALSVFSIFMSASNWVGAQLHHKWGAKKIIFLSFAMMAGANLLFLLLSSSHSVLFLMLSLILGGLASGVGLTSMQVSSLATVDPGMSGVASGIFSTFRYFGSIISSALIGLISGYHTLFMILFAVSIIGVFVSLGIKSDETARIEKNSA
>fig|224308.1.peg.3763 Methylenomycin A resistance protein
MKNSGSIQESTSSTGISVLIVLALGFLMATLDVTVVNVAMADMKNTLSMSLSGVTWVVDGYILTFASLLLAGGALADRFGSKTIYILGLAVFVMASCLCAASINGQMLIAGRLIQGIGAALFMPSSLSLLAASYLDERARARMFGLWAALVSAASALGPFIGGVLVQLAGWQSIFLINVPIGAAALISAYRILSRVPGKSSRVNIIGHLLGMMALGFLSYALIQGPSAGWRSPVILVAFTAAVLAFVLFLLREISAKTPILPASLYKNGRFSAAQFIGFLLNFALFGGMFMLSLFLQEAGGASSFMAGVELLPMMAVFVIGNLLFARLANRFEAGQLMFVSMAVSCIIALLLFVLISPDFPYWQLAVLMSVMNLCTGITVPAMTTVIMQAAGQRHTNIAGAALNANRQIGALVGVAITGVIIHLSATWYAGAGFAFLMMGAAYSLAALLVWLFLAAHNGTAASEKM
>fig|224308.1.peg.3998 Tetracycline resistance protein
MSIFYSFSALRGLAMGIFSPIWILYLISKDYDFLQIGLMGAVLEIAKLIFEVPSGVFADRYGIKISIASSFFFSILTWAFFPFIDSAAICILAMIIWALSDSLISGSFETWMSRVAGEDRFGKEMMKNTQLLITFLIIGSIASGYLYSLNIYFPFLLVMVIYLLLFIWMSVFIKVPSVSETNHGDQNQHDSIKIIKESLKIIFNKKRVLLIVIAGFFTATAYDTISRYWQPFLSDLGFSEKSLGYIFPLGGFTALVLLTLTIRFEKKIEKNPYLALTSLDSMGMVMTFLLSRAFRPLGIPCTAFLLAIEDIHHPIVTSYLNKFFPDSYKNTLFSLNSGVGAIGEILSGVIFGIISAAFGLSAMFVVVAVFLLIPIILYTIVPKIKDNDMKVQIEKSQQV
>fig|224308.1.peg.4084 Tetracycline resistance leader peptide
MKCNKMNRVQLKEGSVSMTL
>fig|224308.1.peg.4087 Permease of the drug/metabolite transporter (DMT) superfamily
MKHLNIYIMLLGFSIFTGATFNLAKYTVGYFSPSSSAAWRFGLAAAVMLIILIFTEGIKKSQLRKNAVSYIVLGIIGIFGFNALFFVGLKYTSPVNGALIMGLNPLLTAILARIILKDNMTKKQVLGIFFAFIGVLLVITQGSIETIKTLSISGGDLIIFTGNVCWALYGVLGRRFVKDGTPLSTTTYTMVIGAVSLIVVSLFTSKPVSLSNIPIGVWGAIAFMAFFTSVLGYLWWNQGIKEIGASKTSLFFNLVPVVTMIISFAVGTPIKVFQVIGAVLVILGVLTASGVIRIPKYNTKEQSAI
>fig|224324.1.peg.394 Multiple antibiotic resistance protein MarC
MIITWMEEFGVLFVKAFLSLLAIMNPFSSVPVVISLMNEYSKEEIRVIALKASVYAFFILTFFLISGDLLFRFMGITLPAFKVGGGILLFLIALNLVQGEVTKEKGKAHEIEAALRRDNIALIPLAMPLLAGPGSITTVLVLRGYLNTLEGKVALFCAIFLSSFTAFVVYSLSTFFYRVLGRTGINLITRISGILLLAISVQFVVDGLKNLLKH
>fig|224324.1.peg.860 Melittin resistance protein PqaB
MFYILIILLATFSMIPNINEFAFRFEETTRAVVAFEMYHSGNYFQPTILGDPYYNKPPLFNWFIIISSKFFGWDIVTARAVSVFFTLANAFLIYFFSSKVLKNKEKALLSSVFFITFADVLFWYGWLAEIDVTLSFFVTLLFIQIYKLWEEGKPIYYYTSALLTGLIFMIKGFPAFAFYGLSLISLSIFKRDFKVLLNFHAFASYFLALIASFWWLPFSENPEFYFRRLWEESFSRVESSKDLEKFLIHLITYPLLNVKQLLPASLFVIPLIFTKRISLPRELKFLLFLVIFNYIPYIISATSRGRYVLPLFPILAVIFAHLIHEYLSKNWKKVLLFSLIFVIILRFIYGIFFLPYVNHRKGEPKLQAKVAYELTKTGKVACDCPKIKDFCLYIGFLRGEPLLRPKYTKAWDYLVDCKERKDLSLIKKFYVNKKEVYLYGRFASGFAINTFNRSRGSKVFEGMSGARR
>fig|224325.1.peg.263 Permease of the drug/metabolite transporter (DMT) superfamily
MKKWIVLALTVTFWGLAFTAIKYSVRFLSPIAIASLRFAIANTLFAVIIILGKRIKWKDLPKVFALGIFGVSVYHVFLNLGEVYISSGVASVVISLAPIFVLILSAIFLRERITYSKVVGIIIAFLGVVVISEPSYANIYGIALVMVSTVAAAIYTTFGKSLLSKYNPITLTSNAMVLGSIPLYPFLPDSIRSLGGDLNLIGSIVFLGIFSTFFGYLGWYYFLEKEEASRASVFLLAIPVVSLLAGNILLAEPLTLRTVAGSGLVLLGIYIVVRKR
>fig|224325.1.peg.505 Permease of the drug/metabolite transporter (DMT) superfamily
MNSKTHLLLALTMLIWAGSFIFIKIGLKELDPFNLAFYRFLLASPLLMAWVFWKRGLAKPSGSEWLHLSVLALSGVTLLYAFQFLALKYTTATNASILINTSAVFVALWGLVKGEANPRKLAGVFLSFAGVVLIVSKGTLEFFSSKTIFGDVLMIVDGFLWAVYTVLGSKMLLKYDHETLTAYAFALGTIFLIPFALMSGFANPVTFNPETVAALLYLSILCSVFAYVVWYYALTNADSTSVAVYVYLVPLFTAIFAFYALNEKPDFFTAIGGIITIAGVYLTTAKQHQ
>fig|224325.1.peg.781 Permease of the drug/metabolite transporter (DMT) superfamily
MGEDRRSLRVDYDDNFLRNNICSLKVSFIKQQGGAEGVKRLYADLGLALVALIWGSTFPVVKIALDSMSPFAFNTVRFFIACLFFLPFLKGWDFKDGFKIGIASFLGYTFQTVGLDYTTATNAGFITSTYVVLAPIISWLVYKDVFDKRDVSGVLLAFVGFYFLSGYSGFNIGDILMLFCALFFGAEIAMISHYSRLSNPTMLAFWQSFAIFILSAPFAVFTTTKFEINTTVILCLLITAFFATFVAKMLQNWLQSYTKSSDAAVILSLEGVFAHLFSVAVLAEILTPVQYFGAFLILLAVIIVSLRV
>fig|224325.1.peg.1315 Multidrug resistance protein
MLRLILSGFFAYASLSCVIPIIPSYASSLGASVFLSAFAAGVFALFPAIAMTPFGMLSEVYGRRRFLVAGAVTSLLASLLYLQSSTAELLVFSRTLHGLGSALYIPSINALVADISEESRRGEAMGKLQTALMLGFFAGPLAGGFVSDFFGVKAVFLLALVFSAAALVPVVGVRERSKGGEIGKQFIFPRKLAPLFAVMFVGMATGSSLALFAIPFYAPELNISQQQAGLLVAVLFLFSAIIRVPAGILADRAGRNVTALLGMVVTGLGLFSAFKPDFPFLFLASLLCGAGNGIVNTAVFAAASDYENRGYAMGVANTVLNAGIFAGTTLAGFMAGFLSFQSMMLILAAATLLFSPISLSKGFGSISEVER
>fig|224325.1.peg.2244 Multidrug resistance protein
MSDDDQSVLKAWIAFLPVSAGLFMVLLDVSVLNVALPRIAEDFGAKMSDLQWIMNAYTLTMVVLLVLAGRIGDMVRRDRFFILGMVIFVLGSFLCAQSWNTQSMIAFRTLQAIGGTILSGNVLAIAAELFPPGRRGEVMGLNAILTASSFTLGPIIGGWLTTHLSWHWVFYINIPIGIVAIAAAWFTLPPLGGREKVPIDWVGAVLLSIGLGALTLGIIEGQNWGWWDEKTLSCFIIALPYLLAFSLWELRTPYPMLDLSLFKIRNFSVGVVATAILFFGVSASLFVFPYFLQGLKFLSAEEAGYWLVAIPIMNTFVAPVAGRLSDRMNPKYLMSLGPLFFAIGLINITSIDVDIKYWDFFAKIAPMGIGMGMLMSPSFNVILSSVPLEKVGMANGTVRSVNTLGQAMGIAVGGVLLTTRMSDWIPGYANQIPDPGTMKILIEYAKYNPAPLVEMVEGFVDSMHFVFSTMIVFPILTSLIIALFLHGDEHVRRARAARKGVVA
>fig|224326.1.peg.524 Acriflavine resistance protein
MLVKRIVGKPITMLILFSLLLMISLYTFSRLKVDLLPGIDIPQISIHTVYPGASPREVEESVSRVLESGLSSVKNLKNIYSVSSKESSTVSLEFYHGTDLDLVLNEIRDALELVKSSLPSKSQTPRIFRYNLKNIPVMEIVINSVRPVSELKRYADEIIKPGLERLDGVAIVTVNGGSKKRVLIEVSQNRLESYGLSLSRISSIIASQNLELSAGNILENNLEYLVEVSGKFKSIEEIGNVVIAYKIPDISSGINLSPIEIKLKDIANIKTDFEDLSEYVEYNGLPSISLSVQKRSDSNSIAVSNVVMNEIEKLKLSMPKDMKLEIASDSTDFIKASISTVVNSAYFGAMLAIFVIFFFLRSFRATIIIGISIPIAIVLTFCLMYFVNISLNIMSLAGLALGIGMVVDCSIVVIDNIYKYRQKGAKLISSSILGAQEMMLPITSSTFTSICVFGPFLIFKSELGVYGDFFKDFTFTIVISLGVSLLVAIFLVPVLSSHYVGLYTSFQKNIKNAFIRKIDAFFASIYYFLEFLYINLLNIVLNHKLIFGLIVFFSFIGSLLLGLLLDVTTFTRGKENSITINLNFPHKTNLEYAKFYSNRFLEIVKSEAKGYKSIIATLRADRITFNVLFPLKEESRDNLTQSVDYDSIKYKIMNRIGNLYPEFNIEPSISGNALGGGDSIKIKISANDFEYIKDYGKILVSMLKKEIPELVNPRLSISDFQLQIGVEIDRALVYNYGIDMNTILNELKANINGVVAGQYVEKGLNYDIVLKLDRMDVKNLKDLEKIFITNSSGVKIPFSSIATFEKTNKAESIYRENQALTIYLNAGISPDDNLTQVTAKVVDFINNKVPHKEGITLKVEGEYNEFSNIMNQFKIIIMMAIIVVFGIMASQFESFLKPFIIIFTIPLTAIGVVLIHFLAGEKLSIFAAIGMLMLVGVVVNTGIVLVDYTGLLIKRGFGLREAIIESCRSRLRPILMSSLTSIIGLIPMAFSSGSGNELLKPIAFTFIGGMTASTFLTLFFIPMLFEIFPTCFKFQI
>fig|224326.1.peg.857 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTDKSKTRELILNGNLYKVLFLISFPIVITNIIQAFYDLTDMFYVGKLGAMPLSALSLAGPVNFFIIAIAMGMATGSISLMSKCIGEGNFSRFSRYAGQLIVLNFVLSLFVTICAFFFIDHLLDLLGVKGELKELSRVYFYVTIFAIPIMFLSISITYILNAQGETILSMTIVLFANIVNFILDPILIFSFNMGITGAAWATLFSKLLTVVFYLFLTYRLNYGLKIHLKDLVIDIRSIKEIVNLGLPSTFGQIMVSLSFFIFNYIVIEISPKFLAAYGLTNTIISFLFLPAMGIGTGIISIVGQNLGAKKVNRVEEVLKKGFFISLAILLIINSIVIFNKQFILRLFTNDLEVLNYANNYLLLTTIGTFGYGLQQVFFGGLIGSGRTKIAMIVIFIRLWLIRLPVVFIFQYFGIMENSLGYAFIISNYLAIIILIAFTCTRYWVKPILIKKYK
>fig|224911.1.peg.932 Multidrug resistance protein A
MADQVIKFQPEQKIDSGKPTKKAGTDPRRRIIAGLRRYRRFLLMVVLPIVAAIGGLTLYLNGGRYVGTDDAYVGAQKVLVTPDISGKIEKVVVREGQLVKQGDELFEIDPVPFRLAVDEARAQLAQAQSTYDNLRANIKIYGDMLSLAQQGVDLKQRDVERKQALVKNSYGSQLDLDNAANALVTSGSIAQYVKQQISAAKTQLLGDTDLPLEKFPPYAQAKSKLDNAERNLDHAVVRAPMGGVATQVEQIQLGRYVTAGTPVFSIIDVAHPWVDANPKESDLTYVTEGQPVTLEVDAFPNHVFKGKIGSLSPGTGAQFAILPPQNATGNFVKVVQRVPIRIYFDETDKYVRKLKAGMSVYATIDTGHRRSLAGLFGLSATAGQDKD
>fig|224911.1.peg.935 Permease of the drug/metabolite transporter (DMT) superfamily
MSSPQAIPSAGRPLSAGAIALMLMLCLTWGFNQIAVKLVLPDIPPMLQAMIRSMGALPVLFIIGTLRGVKFFEKDGTWKPGLIAGLMFGIEFVLIFQGLRLTPASRAVVFLYTAPFFVALGSYQVLGERLGGTQWLGLAVSFAGVALAIGVPQPDVDAKVLLGDLMIVGGAALWAATTLVAKGTRLRFAAPEKALGYQVATSIPILGLAAWLFGESITHTPAPLSLALMAFQAIWVVGTTFTLWFALVKAYSASKLSAFTFITPLFGVVGSYFIMHDTLSLTFGAAAVLVIAGLFLVNRPSQTAAAPRDALLNVTKT
>fig|224911.1.peg.3407 Permease of the drug/metabolite transporter (DMT) superfamily
MTKAKTRLAYMGAGVAVVIWGATPAATAIVARELSPGLIGLARLLLSATILIPIAVSLKPELPSDRGGWIALLISALVGFAGSFVLQGVGIARTSTSHAALVLALAPIFTATVHFLLSRCWPRPLWWLGSAIALMGVAILIPGRNPAGSVAAPTLFGDLLVLAGTVTVSVGYVAGARLSARIGLFAATCWSLLLAGLITLPAFPALASALGQLSFAVWGALGFLAVFCTLIGFAVWFWALEHGGVTSIAPLQFGQPLVSLVIAVAFLSEDIFPATLLALSLVILGVHLSRRAA
>fig|224911.1.peg.4275 Permease of the drug/metabolite transporter (DMT) superfamily
MLDSTRPVLRPRIAPAGLMFLAITSIGWGFNWPVTKFLLAELPPLTLRGVTGVLGAGLLAALALVRGDSLKVAREIWPRLLTAAVLNVTGWMVLMGLALLWLPASEAALIAYTMPVWASIIAWPVLGERPTVLRTLGLVMAFVGLASIMGGNGIAASTEKLPGIIMALFGALGFALGTVFSKKYPIRLPPITAAAWQIGIGCLPISIVGLLIETSHLELVTPVGWWLLVYSTVVQFCIAYVSWFAALARLPASVAAIGTMAVPVIGVVASAIALHEPLGPGQIAALVFTLGAVVLATR
>fig|224911.1.peg.4311 Permease of the drug/metabolite transporter (DMT) superfamily
MPPNDNRIDARDWSLLAVLSILWGGSFFFNSAGLRELPPLTLVFLRVALGAAVLLPLLHVQGISFPKGTLGWKPFFVIGLLNNVIPFSLIVIGQTIIPSGLASILNATTPLFTVTVMAMAGEEALQMRRVAGVVLGVVGVVILRGWGIETRPGQGFGILLCLGGACSYGFAALAARRLLKDSAPLGTATFQLMASTVMMAVVAAVMEQPWHLPAPGLTTWLAVLGLAGLSTALAYIVFFQILRRSGATNVMLVTLLIPVTAILLGWLVLGEPISMREIAGAIVIGSALLVIDGRALRMLQRVA
>fig|224911.1.peg.6257 Multidrug resistance protein B
MSTTVPSTGAAGDHRAISAAALIAIYMQAVNISIPNAALPHIQATLSMANDEVGWVFSSYIAASAVTMSITQWLAGRYGRKAVYQAALAIFTFGLVLDTLATTSIQFVLARILQGAASGPLAPLSLAILLEVTPARHARMSLASTVCSLLGISTGPAIGGWLSEYYGWASIFYVSLPMTAFIFMTMASLLSEKRAERSQPFDFFGLTTFSVGMIGLQMLLDRGERLEWFASTEIWAEAVASVLGFYLFSVHVLTTREHFLRTALFRDRNLVLSTVISFALGFVLLPTLALTSPMLEELLNYPVDTTGYMTIPRGVALVGALVLTSLVPGQVDYRPFLMGGMALVVYANWLMLGYSPAMDWRPVVEAGMLQGAGLGMLLPALARAAFGTLDPKLRPEGGALINLSRLYGSTIGIAVVQLFFYANTQAVHVALAKHLTPFRVAAHGAGPIGKPSLAALNGMVTHQAATVAVIDQFEILMFAMLVVIPLVFFLRKPRPAG
>fig|224911.1.peg.6258 Multidrug resistance protein A
MRLNFAPIAGWLGDRSFRGSEGAVPLFGADLGRRLRRPLMLALPTVVAVFGAFMYLAQEQYVSTDDAFVRAAKVTINARVSGQAVEIAVRDNERVRRGQVLFRIDPEPYQIAVDQAEARLGSARLQIDSLKATHRQQQAELQSARESASFDEREFDRKKMLVASDFTPRAVYERAETDLKVARHRMASIEQQIANTVVALNGDPDIDADRHPTVRAARAQLDRARLDLSYATVIAPDDGIVTKVDDLQIGGFVNAGAPTFSLMSSRDIWIEANFRETGLTHMRPGQEATIDVDAYPDRKFRAHIVSMSPGTGSDFSVLPPENATGNWVKVVQRLPVRLELDDLDPTRPLFSGISVTARVDTGHRRSWPHLLQGALATEVK
>fig|224911.1.peg.6622 Multidrug resistance protein A
MAVSRDQAARVLRQDTVETNSANGEPVTETSAVLAEQLRSHVAEEAKRRSDAPGKPVTDKPATPGSDAPAASGTPKSGKRKFVLVGVGLVLALAAAGYAGYYTLVGRFYIATDDAYVRANNTMLGARVAGHISSILAGDNTTVRAGDVIFRIDDGDYKIAVDAAATRIATQQATIDRIGRQIAALESQVAQAKAQLVSAEAGLKRADLDYERQQALSSKGFASRATFESSEAGRDQGAAAVKAAQAAYDVAVSNVDVTKAQQAEAQAQLAELKTSLAKAERDLAFTAVRAPVNGTFSNRLVSAGDFVAVGQRLGNVVPLDDVYIDANFKETQLKRIRPGQPVTIKVDAYGMRKFSGVVDSIAAGAGSVFTLLPPDNATGNFTKIVQRVPVRIRVPKSVAKQNLLRAGMSVYATVDTNKGAADADSEVDLDDPTMIHPQ
>fig|224911.1.peg.8172 Permease of the drug/metabolite transporter (DMT) superfamily
MSTQAQQTTSGQTTLAFEIGLLLLLALIWGSSFTLIKVAIPSIPPFTMVAARVTIAAILLLLIARAQGHALPRRGSVWAAFLVQGLLQSALPFTLISWGETHIASGLAGVLNATPPMFVLAIALTTGRGRQTVSGRKIIGVALGLAGVAVTMGADALSGIGTTAPLAQAAVLCASLCYAVAPIWGQRFSGLPAIVTAAGAMSCAAVLMLPAAAVLERPWTLAPPPAQAIAAVIALAVICTAFAMVIYFRLIHTLGPLGTTSGSYLRAGFAVALGTAWLGERFSWSSLAGMALILAGVVAVTVPAPARTGKTATGAPSRN
>fig|224914.1.peg.187 Permease of the drug/metabolite transporter (DMT) superfamily
MKRRMKLMESAPFLLIATGTLLGLILPLGKIAAQAGIPPEMWTFLFSASAGVILFAVLCLRKKRLGFSGGRLRYYICTALISYALPNFLILSAIPHLGAGFTGIMYTLSPVITLLLSMGFGLRRPNALGIGGIAIGFVGAAMVAMTRGEVGKPTDLLWIAAALLIPVLLAIGNIYRTLDWPKNSEPTELAAGSHLASAFILFICITLFTGRFPLESFALAPFAALAQSLAAAGMFALFFRLQAVGGPVYLSQIGYVAAALGLVSGTLFLGEHYPPLTWIGAAVIAAGVAMTTRAQKG
>fig|224914.1.peg.402 Multiple antibiotic resistance protein MarC
METGMIVGKLLPLLFNMMGPIGLMPIFAAMTVQMDKPTRNSVAARAAIFAALGILIAIFIGDPILQSWGISKPALILAAGVILTLSSIRAVLMPPAAPSQPAAAGDPKALAIRPLAFPTIVSPQGVGVLIIFVAFLSSLSSTITILTVAGVIVLLDYGAMRIAHWFMATVGMVPLLVLGAVFGVLQVALGIEMMLSGLLLVLNS
>fig|224914.1.peg.925 Multidrug resistance protein A
MFRFPAGQTEPPNEIVVHAEIVHRRPKIFRCTAPEDTVAETNTSPSPAQDQSPKHPMLRRILLIVGPVVAIAIGLWIYFSGGQYVSEDDSYVGAAAVAITPQVSGQVIRVAVGPNQPVKEGDLLFEIDPQPFQIELDQAKANLAQASEKLAGLVLTYKQQLASVAQAKDDVTFAQEQSPTSRCPICREALRRQAARSIGC
>fig|224914.1.peg.2340 Multidrug resistance protein
MADGMKHKTAIQQGVSLAPDGLPRPRIYWAWATLMVGLTLAVIDGTIANVALPTIAADFSAGPAASIWIVNGYQLAIVITMLPLAALGEIYGYRRVYVAGVALFTIASIGCVFSRSLEALTLARIIQGLGAAGLMSVNTALLRYTVPQAKFGTAIGLNALFVAVSSTIGPSLAGVMLSSLSWPWLFVINIPLGIAAVLMGLRSLPDNDRSARKFDVVSAILCAVTFGLLITTIDSAGNKIGSLAVMLQALCCLLAGIWLTRRSFHMSDPLLPLDLLRIPVFTLSICTSIMSFLAQMMAFISLPFLFQTVFGFRPIEVGFLMMPWPIALALVAPLSGKLSDKYSPAILGLLGLITFSVGLALVGLLPGHPTIPDICWRMAICGIGFGLFQAPNNRMMITSTPRARSGAASGMLGTARLLGQSVGAALVAFLLSQWGVEGTPYILFLASGFALFASVISISRLRH
>fig|224914.1.peg.2575 Multidrug resistance protein 1
MNHRHDMSTTQAAAGDASQMETPHPNGSFTQSNADENHEQYWKQNLVICLLGSFTTLIAMSLLLPFLPLYVEQLGVISHAAIVQWSGIAYGATFLAAAFVAPLWGRLGDRYGRKLMLIRASLGMVTCVWQLVALRLFVGIAGGYSSGSMILVATQTPKDKTGWALGALSAGIMAGIMAGNLAGPLLGGALPPLIGIRATFWLAGGVIFLTFLATTFLIREERKPPKPTREEKTQSIWAAIPDKGPVVAMLVTGILLLFANMSIEPILTIYVMQLMDDQTKVTLVSGVVMAAAALGSILSSSRLGQLADRIGHTRVIIGALAVSALLLVPQAFVTDAWQLIGLRFLMGLALGGLLPCITSVIRHNVPDRVAGGILGYSVSAQYVGQVAGPVAGGFVGGHFGMRAVFLGTCLMMAAGAIYNWAVLRNSKTR
>fig|224914.1.peg.2656 Drug resistance transporter, Bcr/CflA family
MNRIIPLVLAIALFMEQMDSNVISTSLPAIAADIGTSPIALKLALTAYLVALAVFIPVSGWMADRFGAKNVFRAAIAVFVVGSIACAASNSLPAFVIARFLQGMGGAMMTPVGRLVLIRSTPRNELVSAMAWLTIPAMVGPLVGPPVGGFITTFLTWHWIFLINVPIGMIGIWFATHFLPDNEERIIKRLDWPGFFLSGFAMSGVVFGLSVVSLPALPPVIGFATLAVGMLCTVLYVLHARRTPDPLLNLRLFDNQVFRSAVFGGSIFRFGIGAIPFLLPLMFQLGFGLTPFQSGMMTFVSAIGAISMKFGAKRIFTRISFRRALMGGSLISAAFIAVNGTFTPATPYWIIIGFLLVGGFARSLFFTGVNALAFAEIPNEKTSQATPLTAVAQQVSIAIGVALAGGILEISTMLRGAPLALVDFHIGFFVVACVSVLAFFWFARLAPDAGKELATPSVIRHHGKPVTTA
>fig|224914.1.peg.2854 Multidrug resistance protein B
MPRCCIGSISWYTFIAIGFGALVVVLVQGKNYWWFEAPWIGVCLAISILSLAIAAAIELNRDQPLMNLHWLASPEILRFTLILLVFRMVLAEQTSGALGLFQVFGLQDAQSKGLYTLILLASFAGGITCGALLKVERVPVIFGFALLCIAVGAFLDSHATNLTRPHNVYVSQGLIAFGGALFLPPAMLAGITKAMKQGPAYMTSFIVVFLFTQNIGGLIGSALFSTFISIREKYHSAHLVEQLVMSDPLVAQRVQALSGTYAKVLADQGLTKAEGPVLLGQQVTKEATILSYNDAFLAISVIAAIALCCQVTYRVYEAFRARRSALAVMS
>fig|224914.1.peg.2855 Multidrug resistance protein B
MSIIYIAASMLLWSTRGLSMYFISANTQQIQGSLGASLTETTWLVAAYMAPFASLTILLLKIRTQFGLRRFAEVAIAVFLVASLLHLLVYDVWSAIPVRFIAGAAAVPISSVGFLYMLEAFPPDKKRTWGLSLALTCSGAAGPFARIISPMLFDIGQWQQLYMLEIGLALACFAVVYVLPLTQIPRAKVLHWLDFVVYIYRNRLRRPCCGACPGQELLVVRGALDRCLSGDINPVACHRCGHRA
>fig|224914.1.peg.3161 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MNAKTLCIIVPVYNEAEGLSDLLDRLHSAADNIASQFTLNIEFIFIDDGSSDGSFALLKAHDFGSRPVRLLRFSRNFGKEAALSAGIDAAEGADAAILMDADLQHPPEMIADFVRIWQEEDADSVYAYKASRLASEGPVKAALSRAFFWVINRDQRYKIPPGAGGFRLVNRRFMAALRSLPESDRFMKGLYGWVGFNQVGLPLQPPPRMRGTSYYNPLQLLLMSLGAMTSFSTTPLRLMALAGIVVAGLSAAYGLYVLSEYFFFPGVPVGLTSILALTAFFGGIQLMFLGLLGEYIGKSVLEAKKRPIYILAEDIRRKESDDADRG
>fig|226185.1.peg.598 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQTQQNHFTALFYKNVLLGILSMAAQSIFILADTFFIANGIGTEALAGLNIVLPLVNIINGLGWMFGVGGATLFSTTVAQKEIKKANQYFSLTIGLVFVIGRLFTLVSLIFSDQIIRGLQGTGVLFGLAKEYYMIYLSCSLLFILNNCLITFLRNDHNPRLATIAFVSGGIVNIILDYVFIYQFGWGMAGAAIATVMSPLTSLILITLHKWSPQRVLRFEKFKVKFQDVREIMSIGFSSFLNEFSSAFVMFLFNIVLLNLVGHVAISAYAIVANLNIIVIAIFTGIGQGAQPLLSRYYGLGETKVLRKFVKLSFITYLVAGFLFFLISQVFTGQIIEVFNSEGNDQLAQIARTAIRLYAISFLFTGLNFMGIYYFSAVRKPKMALMISSLRGFFLIVPVLFILVKLLGLTGVWLAMPVVEFVTFGLMLVGYLAYRNYLKKREAVT
>fig|226185.1.peg.715 Drug resistance transporter, EmrB/QacA family
MAKETNVKLVTVSVFVATFMTAIEGTIVSTAMPTIVGSLHGMEIMNWVFSIYLLTNAMLTPIYGKLADKIGRKPVFMIGIIIFILGSSLCGFAQDMLTLIIARAIQGVGAGAILPVALTIIADMYTLDKRAKILGLNSAAWGIASIFGPLAGGFIVDTVGWHWIFFINVPIGLVLLGLISIFLVEPKRERTKMPMDILGSVTLMVVLLTLLLGFQMISDNGFTLVTFGCLSLSVLFFVAFVMIEKRAQDPVIDLHLFNQPTFVLVNLIAALISGFLMGIDVYIPMWMQGVLGKSAGIGGLVLAPMSLLWMAGSFIASSFMEKYAMKKVLTIGLSILLVGAIFLVVMPMAVPFWLFFVVSSVLGVGFGITITTTTVTAQSTVEPEKMGVATSFNTLVRTIGQTVMVSIFGVILNAGMFAKLEASALNVDADVMNQLVNPHTANLIPAALLKPLRGILYAGLHNVYLVGAGLVVVALLLNIFAKAQRAKV
>fig|226185.1.peg.1276 Drug resistance transporter, EmrB/QacA family protein
MEKIKSYQEDSEVQKNRWWILVSVAMFTFMSTLDSSIVNIALPTISKEMSVPMNQAEWVVSIYLMVVCACLLLFGKIGDSFGKIKVYRIGTVIFTIGSLLCGFNQSLSFLLFARVVQSIGASMTMATNSGIITEVFPLNERGRALGAVGAFVSLGAIAGPGIGGLILSNFSWSYIFWINVPVGLVTILIGEKFLPKDITKTKEKIDFSGFACIAIAIMTFFGGIFLGQESGFGSLQSYLLFIIAVIALGLFIMVERKRKSPLIKFAIFKNKIFTLSLLSAVLIFASNFFVNVVIPFYLQDARKLSASYAGLLMMVFPLLMVVGAPLSGYLTDKIGPGILTFGGLLLLCCTSLMYMFLDMNSPIWYYVIATAIMGLGNALFQSPNNTMVMSSVEKQDLGVAGSMNSFARNLGMVIGIALSTTILYRGMSEAYGERVTTYLANRPDIFIVGMRETFFVAFLLCVAAFILTILRFRKTTK
>fig|226185.1.peg.1697 Drug resistance transporter, EmrB/QacA family protein
MLERTVFMIDRKKVILYTCCMSLFVVTMDVTVVNVALPSIQSDFHTNLSTLQWVTDGYTLMVASLLLLSGSTADRIGRKRVLQLGLACFGLASFLCGISQTPGQLIAFRMLQGIGGSMLNPVAMSIITQVFTEKLERAKAIGLWGSVTGISLGMGPIIGGLIVSYFSWRYVFFVNVPIIAAAIILTQKFVPESKVEKTVKNDFVGQALMILFLFSSIYSIIGLPRKGLFAPDILSTGIIGCLAIVIFFIYEYNIDNPLINPRFFLSIPFTSASFLAIFGFIIYNGYLFLNTLYLQEMRGFSPLEAGLSTIPLAFVSFLVAPRAGEMVGRIGTKRPIMLCGISMLAVSFLQLFVTKTTPMIILFIIYIFLGIGFGMLNSPITITAIEGMPLSQSGTAAAIAVTCKQIGNSLGVALPSLLITKPITSSLTRTPFTNVWLLFGCCAIAIIFLSYLSNSPLAKKSLRRVRFYF
>fig|226185.1.peg.1807 Drug resistance transporter, Bcr/CflA family protein
MKNTRNTVPSLLIIILLVGFPQISESIFTPILPALSSAFNIHDSVAQLTMSIYFVAFAVGVLFWGILSDTIGRRPAMLLGILCYLIGNIGLFLSPTFPWLLFFRLIQAFGASVGSVITQSMMRESFNDLQRGKIFAQTSAALSLSPAIGPLVGGLVQTYFGYQHVFSTLIVMAVLLLFYSFYRLPETFHLGNTLTKAPFWSVAKRLSFDSKVWCYGLLIGGINGLLFSYYAEAPFIFINHFGFSSVQYGFLGLVLAVSSILAAVLINWLLGYWSAEKIAFAGLLLSIFAACCLLIMTQFETIIGLILFIFLFFLGINITLPNALSMALKGYESVIGTASGIFSFVYYLFVSFFTYLISYFHNGTIWVLPLYFLSFACLLAFSYYVIVYRKTLK
>fig|226185.1.peg.2722 Multidrug resistance ABC transporter ATP-binding and permease protein
MKHAFSSMKRIGRYIKPYRVTFYLVILFTILTVAFNAALPYLTGLPTTEISRNIAAGESINFDYVIQCLIWILVVGTGYCVAQFLSGFLMTNVVQQSMRDLRRDIEEKINRLPVSYFDKNQQGNILSRVTNDVDAVSNAMQQSFINIVSAVLGIVMAVVMMFLINPLMAIFSVIMIPLSLIISRTIVKISQKYFQGMQNSLGDLNGYVQENMTGFSVLKLYGREKETLEGFKQVNHRLNGFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHRLSTIREADLILVMKQGEIIEKGTHHELLEQGGFYEKLYNSQFAEEGDYEE
>fig|226186.1.peg.110 Tetracycline resistance element mobilization regulatory protein rteC
MNSEIEYENFIKNIDLVIYDKIDIDNWNISIDLIFEVVEFLQKSLEELRTIIIEHPFESKEEEIYFFKYIKPEVLGRLLYFTDVYNAEMRKPNGSIEVVKKHYNDRLDELTSYFESNLDFYQYYRSKATHLDNHYFVRGHIDFKLCPNCTPYDRDPEFSTCYDHKAAQILANDMLSIYLNKRLHYVDKQIIIEESRAFLSEHPFRWTAPKIALVELGYSIYAACVLNNGKADIKEIMTYLEASFKVDLGDYYRTYITIKDRKKDRTSFLSNLIKCLLKKMDEDDNL
>fig|226186.1.peg.696 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKNDPHILGKESIGKLLLQYSIPAIIGMTITSIYNIIDSIFIGHGVGAMAIAGLAVSFPLMNLVVAFCTLVSAGGSTIASIRLGQKDMKGATEILSHTLMLCITNSFFFGILSFIFLDDILTFFGASPDTLPYARSFMQVILLGTPITYTMIGLNNVMRATGYPKKAMLTSMVTVVANIILAPIFIFHFEWGMRGAATATVISQLIGMVWVVSHFCKKDSTVHFEGKVWKMKGRIVESIFAIGMSPFLMNVCACAIVIVINNSLQEHGGDMAIGAYGIINRLLTLYVMIVLGLTMGMQPIVGYNFGAQKIDRVKQTLKLGIISGVVITSSGFLICEFFPHAVSAVFTDSDELIGLAVDGLRLTVLMFPFVGAQIVIGNFFQSIGKVKISIFLSLTRQLLYLLPCLLLFPHWWGLKGIWISLPVSDSLAFITAVISLMIYIKKVSKEHPIADKVAE
>fig|226186.1.peg.1108 Multiple antibiotic resistance protein MarC
MQNLILQNAIWYVFCDIIIDNKLYVIMDIFVYLTLCFTSLFTLMDPLGVMPVFLQMTDGMDTKERRYIALKACTIAFIILVLFTLSGRFLFHFFGISTNGFRIVGGIIIFKIGYDMLQAHFTHVKLNETERKEYSKDITITPLAIPMLCGPGAISSGITLMEDASEYTFKIVLLGVIALVCILSFFILCASTQLLKILGETGNNVMMRLMGLILMVIAVECFISGIRPVLIEILKQAHACS
>fig|226186.1.peg.1248 Inner membrane component of tripartite multidrug resistance system
MKELGVPVRSWVPDWLGFCCIFIVILPVTMLNGSYTGSMLEVSNTLGTNSEDITMGYYAASAGMAIAYPIIPKVLAAVSVKFLLLIDLLLQFFLSWICARSQNADILIACSFAIGFLKGFLMLWFIRYAQKIFSAKNIRSEFYSYFYPLVYGGGQASMLVTAQLAYHYNWKYMYYFMMLLILVSVLFVIICFRHNRPIKSVPLSDLHIREMFIISVGLLMLIYVINYGKVLDWMASAKLCAYIVISPILIALFIWIQHHSKNPYVSLAPLFQPKAIIGYFYMMLVMFFSTSTTLLTNYLSIILKVDSTHTYSLYIFLLPGYVIGAFICFWWFRWQRWRFRFLIAGGMSCFVIFFGVLYFGIAPNSTYEMLYLPIFFRGLGMLTLIIAFALFAVEDLNPKFLLSNAFFLIIFRSVLAPIMATSFYSNMLYRLQQKYIYSLSETITTADPLAASRYTQSLNNALAQGHRYDEAVQIATHSLYGTLQEQSLLLALKEILGYLLVISVIIAVISRFIPFHKTIRVTFAKTGDDMV
>fig|226186.1.peg.1249 Membrane fusion component of tripartite multidrug resistance system
MRARNIILNMVCVCLAVSGLWWTITYFWRYINYEVTNDAFVDQYVAPLNIRASGYIKDIRFKEHQYVRQGDTLLVLDNREYQIKVKEAEAALLDAHGLQDVLHSGIETSHTNIAVQDANIAEAKAKLWQLEQDYHRFERLLKEESVPEQQYEQTKAAYEAAEARYQALVAQKQAALSQYAETSKKTTGVQAGILRKEADLDLAKLNLSYTVLTAPYDGYMGRRTLEPGQYVQTGQTISYLVRNKDKWITANYKETQIANIYIGQQVRVKVDALPGKIFNGEVTAISEATGSKYSLVPTDNSAGNFVKVQQRIPVRIELENISSEEMAQLRAGMMVETEALRK
>fig|226186.1.peg.1250 Outer membrane component of tripartite multidrug resistance system
MFLKTYRVYLMGPLCLMFAGQPAKAQTDSLFLSVDQLFERGVQHSLQLQADALKEAMAQERTRTARTSSLPDLQVGLKGGFVGQPVVWERGLSGPTYPDIPDWSQNYAIDFSQPLYQGGKIRRTIHKAEMEKQVAELQTLTDQAEIKLGLLNQYMNLFSLFKQHEILMRNIEESELRLRDIRRMKKEGVITNNDVLRSEMQLTNDRLSLQETENSIVLVSQQLDILLGQDENLLLKPDTTLLHQAVALEAYDDYITLAYTNDPAMKLLRKQTELARNEIRLAQSLSLPSISLYASNTLARPVSRTLTDMYNNNWNVGLSVSYPLSSIYKNSHKIKESKLMVSLRKNDEEQKMQRIRMDVRTAFLRHQEALQRVEALQLSVRQAQENYRIMQNRYLNQLAILTDLLDANSVRLNVELQLVTARTRVIYTYYQLQKACGRL
>fig|226186.1.peg.1427 Tetracycline resistance element mobilization regulatory protein rteC
MENFVRNSKLNIEKEIKRIEQQPIALLERIKQIIDVIQTSLTLLKRAVAEYQFQNPEEEIQFFKVWKPQISGLLMFYIRLYQIEKNRVGKSLSAQCKYLKMELENIQKSFLNNSFYDYYRAGQTELDNQYFIRENYDILSDVHCHLLDRDSSFTTLHDSSVAMILANSHLIEYVSDEIDSLSDKLHLKFTSIVDSKLLQWTDSKVALVEFIYAIYAGKCFNNGNTSLKDIAFCCEILFNIEIGDFYRIFLEIRNRKKSRTQFLDKLKDKIQKMMEELDR
>fig|226186.1.peg.1966 AcrB/AcrD family multidrug resistance protein
MNLRTFIERPVLSAVISITIVVVGIIGLFSLPVEQYPDIAPPTIMVSTTYYGASAETLQKSVIAPLEEAINGVEDMTYMTSTATNAGTVSITVYFKQGTDPDMAAVNVQNRVSRATGQLPAEVTQVGVTTSKRQTSILQMFSLSSPDDSYDENFLSNYISINIKPQILRISGVGDLMIMGGEYSMRVWMKPDVMAQYKLIPSDITGVLAEQNIESATGSFGENSNETYQYTMKYKGRLITPEEFGDIVIRSTDNGEVLKLKDIAEVQLGQDSYAYHGGMDGHPGVSCMVFQTAGSNATEVNQNIDELLEEVRKDLPKGVELTQIMSSNDFLFASIHEVVKTLIEAIILVILVVYVFLQDFRSTLIPLVGVIVSLIGTFAFMALAGFSINLLTLFALVLVIGTVVDDAIIVVEAVQARFDVGYRSSYMASIDAMKGISNAVITSSLVFMAVFIPVSFMGGTSGTFYTQFGLTMAVAVGISAINALTLSPALCALLLKPYINEDGTQKNNFAASFRKAFNSAFDILIEKYKNVVLIFIKRRWLAWSLLVCSVVLLVFLMNTTKTSLVPDEDQGVVFVNVSTAAGSSLTTTDEVMERIEKRLMDIPQIKHVQKVAGYGLLAGQGSSFGMLILKLKPWDERPNDEDNVQAVIGQVYGRTADIKDASVFAISPGMIPGYGMGNALELHMQDKMGGDINEFFTTTQQYLGVLNQRPEIAMAYSTFDVRYPQWTVEVDAAKCKRAGITPDAVLSTLSGYYGGQYVSNFNRFSKVYRVMIQADPQFRLDETSLDNAFVRMSNGEMAPLSQFVTLTRSYGAESLSRFNMYNSIAVNAMPADGYSTGDAIKAVQETAVQSLPKGYGYDYGGITREENQQSGTTMIIFGICFLMIYLILSALYESFIIPFAVLLSVPCGLMGSFLFAWMFGLENNIYLQTGLIMLIGLLAKTAILLTEYAAERRKAGMGLIASAVSAAKARLRPILMTALTMIFGLFPLMLSSGVGANGNRSLGTGVVGGMTIGTLALLFIVPTLFIAFQWLQERLRPVQSRPTEDWQIEEEIKVSEEEKSKAGKK
>fig|226186.1.peg.2101 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDSIDFGSMDISTLFRKLLVPTVLGMVFSAIFVITDGIFVGKGIGSDALAAVNITAPLFMIATGIGLMFGVGGSVVASIYLSQGKRKAANINITQALVFSTFIVLVMSALCFCFVGPLGCLLGSSDRLLPLVIEYMIWYLPFLVFYELLSTGMFFIRLDGSPNYAMMCNAIAAIFNIIFDYIFIFEFGWGMMGAAFATSLGTVVGGLMTVIYLTRFSRNIHLHRIKLSLKSLMLTLRNGGYMIKLGTSAFISEASIACMMFLGNYVFIHHLGEDGVAAFSIACYFFPIIFMVYNAIAQSAQPIISYNFGAGQPDRVRKALHLAIRTALICGISFFIITFLCRQNIVSLFIDRSCPAFDIAVNGIPYFGVGFIFFAANMIGIGYYQSIRRGQRATIITLLRGVVFMLIGFFVLPLVLGVPGIWLAVSLAELLTTLYIIGIYFKDRFMVHRL
>fig|226186.1.peg.2377 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNKYEERLGTERMLPLVFKMALPAVAAQFVNLLYSIVDRIYIGHIPGIGTDALAGVGVTTSLIILISSFSAIVGGGGAPLAAIALGQGDRVRAGKILGNGFVLLILFTLLTSVIAYTFMEPILLFTGASENTLEYAVDYLSIYLLGTIFVEISTGLNSFINAQGRPAIAMFSVLIGALLNIILDPIFIFWFDMGVKGAALATVLSQACSAVWVVSFLFSRRASLPLEKRYMGLDRKIILSILALGVSPFIMASTESLVGFVLNSSLKEFGDIYISALTILQSSMQFASVPLTGFAQGFVPIISYNFGHGDKQRVKDCFRIVLVTMFSFNLILMLFMILFPSTVASAFTSDERLIETVRWTMPVFLGGMTIFGLQRACQNMFVALGQARISIFIALLRKAILLIPLALILPNFMGVTGVYAAEAISDATAAICCTLLFFGQFPKILGRIKGNTLRVE
>fig|226186.1.peg.2792 Inner membrane component of tripartite multidrug resistance system
MPSCPRNYPFYNWVPKPIGIIILLFFFLPILSVGGVYSVNSTEMMSGLGIISEHIQFANFVTSIGMAAFAPFLYELVCIRREKLMCIAGFALMYVFSYVCAKTDSIFLLALCSLLTGFLRMVLMMVNLFTLIKYAFGMEATRNITPGMEPKDATGWNKLDIEKCISQPVVYLFFMILGQMGTALTAWLAFEYEWKYVYYFMMGILLLSILILFITMPNHGFAGRFPINFRKFGNVTAFCISLTCITYVLVYGKVLDWYDDPSICWATAISILFAGIFLYMDVTRRSSYFILGALRLRTIRMGALLYLLLMIINSSAMFVNVYAGVGMHLDNLQNASLANWCMVGYFIGALISIVLGSKGVHLKYLFALGFFFLALSAGFMYFEVQTAGLYERMKYPVIIRTIGMMILYALTAAYANQRMPFKYLSTWICIMLTVRMVLGPGIGGAIYSNVLQERQQHYITRYAQNVDLVNPEASASYTNTVQGMQYQGKSETEAHNMAAMSVKGRIQVQATLSAVKEMAGWTIYAGVICMIFVLVVPYPKRKLLT
>fig|226186.1.peg.2794 Outer membrane component of tripartite multidrug resistance system
MDSPILSQPIKFVPEYRAIIMKRLLFIFTFFCLLAIHGGAQNILTLENCLRIGIENNLSLQGKRKAMQKSKYGISENRVKLLPQINGFANFNDNIDPPVSVTDGSSYGVPYNITRTLQYSANAGIELQMPLYNQTLYTSISIAEIVDEMSRLSYEKAREDLILQISKMYYLGQVTAEQIALIKANITRLEELRDITQAFFDNGMAMEVDLKRVNINLENLKVQYDNAQAMMTQQLNMLKYIMDYPAEKEIGLLPVNTDSIATVALTGLSENLYELQLLQSQVQLAERQKRLISNGYIPSLNLTGNWRFAAYTDEAYHWFHSGPSNHWFRSYGVGLTLRIPIFDGLDKKYKIRKAMIDIETMKLSRLDTRKNLQTQYLNAVNDLMNNQRNFKKQKDNYLLAEEVYTVTTDRYREGITSMTEVLQDEMRMSEAQNNYISAHYNYRVTNLMLLKLTGQISSLFK
>fig|226186.1.peg.2939 Multidrug resistance protein
MITVNKKWIRLIGIVGCTVWMASCKQAPDAGVKSSYAVMQIEPTDKELSSSYSATIRGRQDIDIYPQVSGTIEKLCVTEGQKVRRGQLLFIIDQVPYRAALKTATANVEAARAATSTAELTYKSNKELYAQKVVSEFSLKTAENSYLTAKAQLAQAEAQEISARNNLSYTEVKSPSDGVVGALPYRAGALVSANIPYPLTTVSDNSDMYVYFSMTENQLLALTRQYGDMDEALKNMPEVELILNDNSVYQKKGTIESISGVIDRQTGTVVARVVFPNESRLLHSGASGTVVVPSIYKNCIAIPQTATVRMQDKTIVYKVVDGKAVSTLITVAGINDGREYVVLDGLKAGDEIVSEGAGLVREGTQVK
>fig|226186.1.peg.3289 Permease of the drug/metabolite transporter (DMT) superfamily
MNKVNGFLYGLLSSASFGLIPLFTIPAMQAGMQFESILFYRFLFACMALGGILLINGQSFRISRRDIPSLLLLAILYLMSAVFLFWGYKFMASGVATTIHFMYPVLTTLVMMLFFKEKKSGWRIAAIASAVIGVYFLSGGNTETGSFSFFGLFIVLLSALGYALYLVTMSQLKIGRMKGLLLTFYVFLFGGIFLLIGTSSISHLQPIREWHTAGNLILLALIPTVVSNLALVRAVKSIGSTLTSVLGAMEPVTAVCVGIFLFGEAFTTSIGVGIALIIVAVMVIILKR
>fig|226186.1.peg.3336 Outer membrane protein oprM, multidrug resistance protein
MKKQILYMLCATALLSSCHIYKSYDRPEDITASGLYRDPAADNDTLASDTTNFGNLPWREVFTDPQLQSLIEQGLKQNTDLLSAALNVKAAEASLMSARLAYAPSIGLSPQGTISSFDKNAATKTYSLPVTASWQVDLFGQLLNSKRNAQVTLKQTKAYRQAVQTQVIANIANMYYTLLMLDRQLEITQATAEVLKRNAETVQALSERSTYTSAALAQSKAAYAQVVASIPDIEQSIRETENALSTFLGEAPHAIKRGVLEAQALPEELSAGIPLQLLSNRPDVKAAEMSLASCYYNTNSARAAFYPQITLSGSAGWTNSAGSAIINPGKLLASAIGSLTQPLFYRGTNIARLKAAKAQEEQAKLSFQQTLYNAGSEVSNALSLYQNTSKKAESRQMQVESAKKASEDTKELFNLGTSTYLEVLSAQQSYLSAQISQVSDCFDKMQAVVSLYQALGGGRED
>fig|226186.1.peg.3902 Membrane fusion component of tripartite multidrug resistance system
MAPIKSQNSNMLLAFLTLLGVIAIVAVVGFFMLRKGPEIIQGQAEVTEYRVSSKVPGRILEFRVKEGQSVNAGDTLAILEAPDVVAKMEQARAAEAAAQAQNEKAIKGAREEQIQAAYEMWQKAQAGVTIAEKSYKRVKNLYEQGVMPAQKLDEVTAQRDAAIATEKAAKAQYTMAKNGAEREDKMAAEALVNRAKGAVAEVESYIKETYLIAPAAGEVSEIFPKVGELVGTGAPIMNIAELNDMWVTFNVREDLLKNLTMGAEFEAVVPALDNKTVKLKVYYLKDLGTYAAWKATKTTGQFDLKTFEVKASPMEKVENLRPGMSVIINK
>fig|226186.1.peg.4049 Permease of the drug/metabolite transporter (DMT) superfamily
MGNNKNLHGHLFALTANVMWGLMSPIGKSALQEFSAISVTTFRMVGAAAAFWILSIFCKQEHVDHRDMLKIFFASLFALVFNQGIFIFGLSMTSPIDASIVTTTLPIVTMIVAAIYLKEPITNKKVLGIFVGAMGALILIMSSQAASSGNGSLIGDLLCLVAQISFSIYLTVFKGLSQRYSAVTINKWMFIYASMCYIPFSYQDISVIQWTSIPMVAILQVLYVVLGGSFLAYLCIMTAQKLLRPTVVSMYNYMQPIVATIAAILMGIGSFGWEKGIAITLVFLGVYIVTQSKSKADFEKAGKEL
>fig|226186.1.peg.4502 Probable multiple antibiotic resistance protein marC
MSLSSLLIIFSSSFMALFPVINPLGNGFVVNGFFADLDPSQRKTAIQKLTINFIMIGVGTLLIGHLFLLIFGLAIPVIQLGGGILICKTAIELLGDSNSSDKEGTSQNVDSFKWKSIEQKIFYPITFPISIGPGSISVIFTLMASASVKGKLLHTGINYLVIALVIICMAGILYVFLSQGQRIIQKLGPVGNQIINKLVAFFTFCIGIQISVTGISQIFHLNIL
>fig|226186.1.peg.4571 Quinolone resistance protein
MIKRNAAKPVRVAPPMMEEQEVSTSTLQELLEKEETVSNLIFSKGREEGISKSYKSFKNCTFRNQTFSECKFRSSQLADIRFENCDLSNISFAESSLYRVEFIACKLLGTNLSETTMNHVLLHDCNASYINLAMSKMNQVRFSHCHFRNGSFNDCRFSSVAFDSCDLVEADFSHAPLRGIDLRTSRIGGITLNISDLKGAVITSLQAMDLLPLLGVIIED
>fig|226186.1.peg.4740 Tetracycline resistance element regulator RteB - Bacteroides thetaiotaomicron
MTRATSSVSFALRNDAENKERIFRTLKQANRK
>fig|226900.1.peg.182 Multidrug resistance protein B
MMAGSMVFPFYILLLRNVGNSFSQFGWAYGLFALTSALVYPLVGKISDQVGDKKLLIIYAWSMAILMLCFPIATEVWHVYILQIVMGILGAVQRNTEKTSLARKVAQEKAGYEIGKYHVWTSIGGAVAVIATGYLVDFFTIGTIFYIASILYVVSGIVLSSKKI
>fig|226900.1.peg.205 Permease of the drug/metabolite transporter (DMT) superfamily
MRRGQMIIGALACLIASMSWGAMFPVADHALEYIDPFYFSLIRYGAVAIMLIVLLLVKEGKQAFCLEGRGKLLVFFGTMAFTVYNVLIFLGQMLMGKSGVMVASIMEALMPMISICILWGYKHIKPKKYMITSMVIAFVGAVFVITKGDMSFFVTLKDNMFPLAFIFIGVVGWVIYTMGGQTCSDWSTLRYSTLTCVFGTTVTGIITVIITSLGYISVPSMGTISIVKYDLLFMMTLPGIVALLAWNYGVKILSSINGILFINFVPITTLAIMMMQGYQITMFDIIGTVLVIAALIRNNVCQRKEENINKRVLQEEQLRQAV
>fig|226900.1.peg.236 Multidrug resistance protein B
MDRNVWIRFIGETLNGIAMMMLMPFFALYLKDKVDSLLEVGVIMALSPIAASFGSLIGGRIADIYGRKPIMIFSMASNALLMLGFLFIEGFIPYAILSIFLGLSNSLFHPAASAMVADVTAPEKRTEAYGLLRMGHNIGAAIGPIMGASVVVLSKNLVFIIASSTMLFYALLVLLLIQETMPKRTDKEEHKEKEAGTVWKIVMRDKVLMIYLLAGIIISMGFSQTEGMLPLHFDNEMKHIFGTNNPYPYLMALNGLLVVLFQFQISKWATDKPVGKTMLYGACLFGIGLFFIGWLPKWFGEFNTNATIILITLLFVYALYTLGEMIMSPVQMTFVANLAPEHLRGTYMGAASLQWITGSAFGPLLGGFLLDRLLGHFLFTILAVGCVVAGIVYVSLDRLVEQRQKDTLTKQSS
>fig|226900.1.peg.272 Permease of the drug/metabolite transporter (DMT) superfamily
MKEICMLLVAVILWGTAIAPTKWALESIQPFTLLFIRLFFAGGICMIFSFKELQKSVVHKKVPWKRMSLLAFTGVAGYFMFTSYGISLTSGLHVSIIDAALPLVTILFSALFLKEEIRLNYWIGIILGAIGVLFITIPSKSANQEVSLIGDILILLSTFLFAFYTVLLKRPKQEQYLSNEVFTTLTLIIGAVILLPFALVEIFYYGLPKVETWKTVLSVIYLVIGATILAYWFWNKALERVSASVSGLYLNALPLISIITSIILLNESLTWRVIMGASLVLIGVGWADKQKLCNLLKGNKVENRDC
>fig|226900.1.peg.405 Permease of the drug/metabolite transporter (DMT) superfamily
MKTEKFFTHPIGVFIAAIVATFLWGSAFPFIKLSYVELGIQPQEVGEQILFAGYRFFLSGFMLLLFFKVLGKDMSFKKGTGKQLIQIGLFQTFLQYICFYIGMSYSSGIEGAIISGTSSFFQILLAHFLYKDDALNMRKIIGVSIGFCGVVLVNMPSDGSLSFHFGIGSLLLLSAAMLYSYGNILAKEGSKTLDVGYMTAYQMMFGSIGLLCIGALQVGVMPFTFSLHALLMLIYLSFLSAAGFCIWNTIMKYNKVGKVSMYMFFIPVFGVLLSSMILGEAIHSFVLLGLACVAAGIIVVNRTPAKQKIEKEKQVA
>fig|226900.1.peg.462 Daunorubicin resistance ATP-binding protein drrA
MKSVIEVQGLRKEFTAYSSRPGLKGAFRDLLNRNYKIVPAVNDVSFTVKQGEMVGYIGENGAGKSTTIKMLTGILTPTSGQITVNGMNPHNQREEFVRTIGVVFGQRSQLWWDIAVQESFRLLKKVYGVSDAQYKEHMEHVIETLDIGPLLDKPVRKLSLGQRMRCELAAALIHNPPLLFLDEPTIGLDVLVKLKIREFLKEMNERYKTTILLTTHDITDIEALCERVIMLDEGNIMYDGSLNNLRTQWGAEKEIHFQFVAPVSYQALSMVMPDNHVVWSKAKEENAWVAKIPNEEVIISMLISKVVQAFQIKDLKINEVSTEEIIRNIYEEGITHG
>fig|226900.1.peg.463 Daunorubicin resistance transmembrane protein
MGKYIEMIRIRFLMMLAYRTNYYSGILIYTINIGAYYFLWQAIYSGKENIESLSISQMTTYIAIAWMARAFYFNNIDREIAMEIQEGRVAVELIRPYNYLGMKVMQGLGEGIFRFAFFSIPGMVIVTLLFSLQITTNFQTWLYFFLSLIFSFIINTQINLMTGMLTFFLFNNSGIMYAKRVVIDLFSGLLLPISFYPLWAQKAMMFLPFQAISYIPSMIFSEGIQGSKLYEALVFQVIWAIVLIIPIVLMWRTARKRLIVQGG
>fig|226900.1.peg.511 Permease of the drug/metabolite transporter (DMT) superfamily
MNNGRRIGLIMIITGATLWGLSGPMIQWLFQHTNVSSIDFLTIRLLLAGIFILSFLLIKKQNIFQIWKHPRYSIQLIIFSILGMLGAQYAFIETVHISNAVTATLFQFLGPVLITMYVAFEQRKFPASMQLFAIIAALIGTYFIITNGSIENIVLSKEAIIFGLLTAIGFAFYTLHPASLIKECGTTVVIGWGMLIGGIALLIYNRSFGWNQFSQTLTLKTFSMLILIIISGTLSFLLYIGSLKYLAATETSILSSIEPLVAAIVSITWLNESFGTYQLLGGVCIVLSVIFLTMPQKETEPTYTTEQI
>fig|226900.1.peg.592 Bicyclomycin resistance protein
MKYFIYFIVIVAFLDTFSQLPIMSTFAQSLGGTPLIIGLVVGMYSFANMIGNIIAGAAVDKFGAKKILYISMGITSFIVLLYTVVQSGEQLLVVRFMHGFSDGFLIPAAFTFLSKQTNAKRQGKAMALSGAAVGTAAIVGPAFSGIMKATAGVEWVFITISILMALGTIVSLFFLPNNVSRKDTSRTQMMNKEDMVELLKSEPLLQAYIGAFTLMFSQGIVTYMLPVKVEALALKASTTGMMLSVFGITAILFFLLPTNRIYDRFNRSKLMLIGIAVMAFALSLLGLFATKGMLFIVMMIYGIGFAILFPSINALLVENTTDDNRGKAFGLFYAFFSLGVVAGSFTVGAIGASPSVSFIIGTAFLLTFAGMIYVRSKVKKTMMG
>fig|226900.1.peg.638 Acriflavin resistance plasma membrane protein
MDRLTKFSLKNRAAIIIMIFLISILGVYSGSKLPMEFLPSIDNPAITVTTLSQGLDAETMTKDVTDPLEKQFRNLEHVDTITSSTYEGLSRIDIAYTSKANMKDAAREVEKAVNTIKLPKDVTKPVVSQLNTSMIPLAQITIQKQNGFSKADEKQIEKEIVPQLENIDGVANVMFFGKSTSELSIVLDPNQLKNKNVTSQQVLTVLQGKETSTPAGAITVNQEEYNLRVIGDIKNVNDIKNITVAPQVKLQDIAQIEIKQHYDTISHINGEEGTGLIIMKEPSKNAVAIGKEIDKKVKEIDKEYKDQFSIKLLASTHEQVENAVTSMGKEVILGAIAATLIILIFLRNFRTTLIAVVSIPLSILLTLFLLHQSNITLNILTLGGLAVAVGRLVDDSIVVIENIFRRLQKDSFSKDIILDATKEVAVAITSSTLTTVAVFLPIGLVSGAIGKLMLPMVLAVVYSILSSLIVALTVVPLMAFLLLKKTKHRKPSSSSRYVATLKWALSHKFIILLTAFLLFVGSIAAYILLPKANIKSEDDTMLSINMTFPAHYNAESQKQKAFDFEKKLLSNSDITDVILRMGSSAEDAQWGQTTKNNLASIFVVFKKGSDIDQYIKELKKENKTFEPAELDYIKTSYSSSGGGNNLQFNVTATNEADLKEAATIVETKLKSMDDLSKVKTNLEDSKKEWQIHIDQTKAEQLGLTPEIAAQQVAFLMKKSPIGEITINNEKATIMIEHKKENINKQEDILNTNILSPINGPIPLKDIATISEKQTQTEIFHKDGKETIQITAEASNEDLSKVNTAVNKAMTDLDLPGGAKVNIAGATESMQENFTDLFKIMGIAIGIVYLIMVITFGQARAPFAILFSLPLAAFGGILGLIISRTPVDVNSLIGALMLIGMVVTNAIVLIERVQQNREHGMETREALLEAGSTRLRPIIMTAITTIVAMLPLLFGQSQAGSMVSKSLAVVVIGGLAVSTALTLVVVPVMYELLDKIGRKRRSRRKISTSTETLDI
>fig|226900.1.peg.756 Modulator of drug activity B
MKNIFIINGHEKYGTKEGRLNRTLVDYMVTVLGENHHVKTTTIQDGYNIKEEQDKFLWADVVIYQTPIYWFSVPGLFKTYMDEVYEYGLFFKGADEYGTGGLLKKKEYMFSTTWNAPEKAFGDKTKFFEGESLESALSHLHRVQKFLGMSPLKSFACYDVVKNPDIEKFLVNLKDHLDGVIK
>fig|226900.1.peg.758 Multidrug resistance protein B
MGFWSMHRNIKIRIITSFLTRTVSTMIFPFMAIYFSIKLGSAVAGALLLINVIVSLVIGLYGGYVGDLLGRKKVMIIGQSIQVISIACMGVANSDYVDSPWLTFIFMLVNSLGSGLMNPATEAMLIDVSTPENRKVMYSINYWAINLSIAIGAIFGGLLFENYRLQLFIVLTLVAIITLYVMAVYMEEVYVARKTVEKKNVLKGMADSYKVVMKDKAFLIFCAASICTLSLEFQINNYLGVRLQKEFETVHFFFGNGVTFDLTGIRMLSWISAENTILVVLCSALLIKMLKSFNDLKILYVGLFIYTIGFTILGTSNSLWILLIAGLFQTVGEMMYVPVRQSIMADMVPNEARGSYMAINGMVFQVAKMNGALDVMLGSFIASWGMSALYFIVGMSSILLFMKAIGKEKYEDERNVSQIG
>fig|226900.1.peg.768 Multidrug resistance ABC transporter ATP-binding and permease protein
MLSVLLKLKWFFREHWKRYSIAIGALLIVNIVEVIPPKVLGVTIDNIKTGTLSNEAIIQSILILIGVTIVGYGLTFVWQHQLFGGAFVLEKTMRSKFMGHLLKMTPTFYQKNRTGDLMARATNDLKAIAMTAGFGILTLVDSSLYMLTIVFMMGFTISWELTFAALIPLPIMAYAMNIYGKKLHERFTVAQDAFGDMNDKVLESIAGVRVIRAYVQENADEERFHHLGDDVYEKNMKVAKIDALFQPTVKMLVGLSYLIGLVYGAYLVFQSKVTLGELVSFNVYLGMMIWPMFAIGELINVMQRGNASLDRVNETLAYEPDVKNPKHPKLVQEPDYIQFDDVSFSYPSSTEENLKKVSFTLKQGETLGVVGKTGSGKTTLVRQLLRQYPLGDGDIAVSDVTLDKMTNENVLGWIGYVPQEHILFSKTARENILFGNREATEEELEKAIEIAAFKKDLEFLPEGLETLVGEKGVSLSGGQKQRISIARAVIQNPEILILDDSLSAVDARTEAAIIENIRTERSGKTTIITTHRLSAVQHADWILVMDEGAVIEEGTHDQLIQKGGWYAEQFERQQGESESADSGVKI
>fig|226900.1.peg.769 Multidrug resistance ABC transporter ATP-binding and permease protein
MYKAKALTKEEVFAFYKPEINRLLLLGGGYFALLVVVSLFAYGKQFFLQKAANKIIQIMREDVFSHIQTLPIRYFDHLPAGKIVSRVTNDTEAIRDLYVTVLATFVSSIIYIIGIFAALFLLDVKLASLCLLIIPILIVWAILYRKYASVYNHKMRSRLSDINGTVNESIQGMPIIQAFRQERETKKEFEELNGDYFKYQNKILNLNAATSHNLVAVLRNIAFTGVIWYFGGASLSATGIISLGVLYAFVDYLTRLFSPITNMVNQLANLEQARVASERVFELLEEKGEPVEEERMPRLKGNVKFDNVSFSYNGKDEVLKNISFEAKQGETVALVGHTGSGKSSIMNVLFQFYEFEKGKLTIDGHDVKEMPKQATREHMGIVLQDPFLFSGTVASNVSLENEKISKERIIKALHDVGAERFANNINEEITEKGSTLSTGERQLISFARALAFDPAILILDEATSSIDTETEAMIQQALEVVKKGRTTFIIAHRLSTIKSADQIIVLDRGTILEKGSHDELMKKRGRYYDMYKTQMEGNQSA
>fig|226900.1.peg.876 Teicoplanin resistance protein vanZ
MHTEVLMSYLYTYFFTIMFCILFQIGFYFKAKRNISIRHFLWVYVFLFYLSLVYKVTQIATVWDISRYETWIRVSQINLTLFDTAGSTTYLLNIVLFMPFGFLLPMIWPYFRKIKNTVCAGFFFSLAIELNQLLNNRITDIDDLFTNTLGAIIGYLLYRALKMIFKREGEKLDTSSSLVIKYEAIFCLVCSFVGAMLIYHPALFGRPVIIQ
>fig|226900.1.peg.936 Teicoplanin resistance protein vanZ
MSEFDEYIKSILAYSELSDIEQDELFLEMYDHLNSLKEEYMEQGMNEKEAIYKAIQSFGESKVIGVEINKSVYEVPRPLKVLSKILCIPYIIICFIVFLGTFISTSTFDSVRSLTGGGTVYHPIEFWQQFLHISDLETLLQLFGITLWQVKDFIAHPGPWGNSTYWLSVLQHIILVVPFGFFVPVLINKVTNYKKARKWYVMTFLVWEILHLLTLSDVFDVWQIAINMLGASVGYLLFISIMQLDNKFRVMRKKIFEN
>fig|226900.1.peg.1123 Permease of the drug/metabolite transporter (DMT) superfamily
MKQEKSIALPLAISIIAISFAAVFVKMSSAPSSILSMYRLWIIVLIMLPIVWKKREEFNRIQMKDWGFLIGSGFFLALHFLLWFESLKHTTVASSTIILALQPIVSLVGGFFLFKERTTYSAIATMGIAILGVMCIGWGDLGLSKQAIYGDILSFLSVIAVVGYLFIGQTTVKKVSHWIYSFTVFAFAGLFMGIYNVILQVPFTGYTRWDWTVFLLLAIVPTVSHVINTWLLNYVNATPISMSILGEPVGASILAFCLLGEKLNAMQIIGSMLVLFGVSVFLLQQQKRTAKNVVNEPVYTQEL
>fig|226900.1.peg.1272 Gentamicin resistance protein
MDSYKHYIKEALPNLSIHSYKQNEEGWDNVAVIVNDELLFRFPRKQEYAMRIPLEKELCAILTQSLQEIEVPQYHLIYKNESDEVPLCSYYTLIHGEPLKTETVATLEDPKLKAIITQLATFLAVLHSIPLHQVTTLCFPIEKTCTYWKELQTKLNQYLTTSLTSLQKLALNRLFENFFACLATSTFQNTIIHADFTHHHILFNKHNKSISGVIDFGDAQIGDPAFDFAGLYYDFGHEFTTSVYEQYSTLISHHDPLLIHRITTFYQYSPLLHNIIYNFESENELEFITGTEQLKTILQG
>fig|226900.1.peg.1568 Tetracycline resistance determinant tetV
MKIATRNIILMMIGKMTSLLGAGIYTFAMGLYVLKTTGSGMGFAITLVCGSLPRMICGPIAGAVADRVNRKWLVIGTDLLSSLTMLSMFILATIFGPSLLFIYISAALLSICASFYSVALTSSIPSLVDEGRIQKASALNQTAASLSNILGPIIGGVVYGFFSIKSFFLLNSITFFLAVILQLFIVFDLYKKEVAESTEHFLTSIKEGFLYVKRQREIYGLMKIALWVNFFACGLTVALPYIIVHTLHLSSKQLGTVEGMLAVGMLMGAIALSVRKEVNNPFRSIYTGLFLFAGLSLCTAFPLLVIIPKVASFIYYIAFMMLTGIAIMIVNIPMQVHMQKTTDPSYLGRVFGLLETIATAIAPLGMIVYGLLLDMLPTSIVMMTIGGGLLLVVLVGVKQHMAKKQVDVSA
>fig|226900.1.peg.1621 ABC-type multidrug transport system (daunorubicin resistance), ATPase component
MMNTLEIKNLTKKFGNFIAVDNMSLSIKEGEIFGFLGSNGAGKSTTINMIAGLLRSNEGEISILGKNIKKHNRFAKMNIGIVPQDIAIYEELTAYENVKFFAGLYGLRGAELKARVEEALKFVGLSDKQKSYPKNFSGGMKRRLNIACAIAHRPKLIIMDEPTVGIDPQSRNYILQSVRKLNEMGSTIIYTSHYMEEVEEICTKIAIVDHGKVIAEGTKEQLKAIITDTKDIWIEVKSVENLDVEKLKEINGVKAVQIEENVIKVNSDAGLNNLNKIIQHCINHDIEIRSLEEQAPNLETVFLTLTGRNLRDK
>fig|226900.1.peg.1644 Drug resistance transporter, EmrB/QacA family
MEQSKGIKIVFLMCLGIFLCMIDTTIMNIALPAIQSSVNTSLEKMSWVLNVYTMTIAVLAIPLGRIADIFGKAKMYILGLVIFGGGSVLCAFANTGDFLIFSRFIQSIGAAILFPTSMVIGVSAMPLAKRHVALAILGVTQGLSAAMGPVIGGIITQHLGWRWVFFVNVPVCIIGIVLCCIMLQIKNEERIISKIDWIGLLLSSTAIFSFTLILVKGNTWGWQSNIALSCYAISTISLILFVLVERKIHNPMVNLKLFQDRMFVGASIVVILSNLFLIGVTVLLPTFLTKLQGRTEIEAAFLVTPISAMIFFVSPVAATLIKKLGKVTIILSGFLIMGLSYYWLQMIDVHSTNIEIIIPCMILGVGYGLVVGPITVLSASSFEGELLTASQSVVSMLRQVGIVLAVAIFVSNLTHNLTVNKEKVYRYAEEKVRTIHVNSTEQTEILQMTKEKIENQSLESNINKKQNAMTMGLSKEKKEELIRDKTDEILRKVPVEYRDVKREEVMRQVTKEVEKQEESIKKEVLTFSNDVNHYAKNQMAMSFTDLYKASVPIILICAFVSLLFWEGKALSKKRKGRIVEEA
>fig|226900.1.peg.1714 Quinolone resistance protein
MKIDRPKISPELSSKNFQDIFYEEDPTLEVCEIIDSTFENESVDRVRLYDAVIKNCKFTNTDFSNIDITDVCLENCDLSNVNLSNSSVHRVEFKNSKLIGVNFTESSLGNVKFENSILNLAAFGNSKLEKIIFNETSLNNADFFDCKLKKVEFQLCSLDEANFDQTSLKGIDISSSTFDTLTVSVNDLRGCKVSTYQAVQFATLLGLIIKD
>fig|226900.1.peg.1941 Multidrug resistance protein B
MAFVNMYTVLGNYLSSPTYNLTAEQILYFRLAGLFGMLLSPLAGRLTKRFEVRKVLQGGLLIAIFSLSSIGFVSYLSLLVMMSVCFVIGIAISVPSLVSLVGQLGGEIRNDTFYWFCSFSIYN
>fig|226900.1.peg.2224 Permease of the drug/metabolite transporter (DMT) superfamily
MKSPILSYFILFFGVFALSTSAIFVKLADAPATIIAFYRLFFATLILLPLLLFNKNSRNELKTLTKKQWTFGFISGLFLAAHYVLWFESLQYTSVASSTVIVTLQPLFSMIGGYFLFKERFTKGAVIGCLIAISGSIIIGWQDFQISGEALYGDILAFIAAGIITAYFFISQHVRKDLSLIPYSVISYGSSAGFLGIFAFTQQESFIHYFTQTWLCFIGLAFIATILGQTIFNWLLKWMSATVISMSILGETIGTCILAYFILHETISLQQGLGITVIFIGLVLFLLQPSSNKKA
>fig|226900.1.peg.2391 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MITHISDIKLQTVSIEGVKQVYKDILSFPIKKETASFIQFEVTPYTTISFQEVYEPIAPAHFAFEIPYSKFHETAKWLKDSGLLIVKWQNGNVIGEENGLFNLYFKDGDGNLLEIIAHSYVKEDVLVPHSPLNILYVREIGLPVKSVPVFTEWLKSNLNMKTMEDGDIFNFVIGGTAYIVATWWQRPWIPIAMKALSPKVYVSFGTPDVAFLQRIQNNFKKNSVSFECKRNEVSFIEQGYTFSIVHTSEFHSDIPKQLNLPLSI
>fig|226900.1.peg.2532 Teicoplanin resistance protein vanZ
MINGSLFIILGVICYLIVRGILIGTKNKKHVIWWKEIVSFLFVVYICMVVAVTLFPLPIGFPSNVENLNRSVNIIPFASIIKDINQIGSAYDGDALFMIGLIVRNVGGNILLLMPLGFLAPILWDKYKKFKNTILLGFSISASIELLQLIESLFSGVGRITDIDDVICNVLGSIFGYCIYNIFLKAINKFNIRVLGKTNSKGVELVDK
>fig|226900.1.peg.2557 Quaternary ammonium compound-resistance protein, C-terminal
MITTIISSVVAFATTNIDDIFILLVLFSQVRTEVIRKEGRAVREKATRKKLYIVIGQYLGFSMIIFLSIIGSLSSFFIPVSWIGLLGFVPIYMGVKGLLSLRSYKSNEVIDNVTVSLFKVASITLANGADNISIYIPMFASQTLETNIVTLVIFFSMIAIWCFISYKLIKAPILAKVLEENCHIIVPIVLIGLGMFILFRSGTIGLFS
>fig|226900.1.peg.2737 Zwittermicin A resistance protein ZmaR
MIYEANIHTRKKLVSMFEDFNNVVLLSYLQGHMGTAWVNDLENPKVAQVTVGIFTFYAGDPNTKETEELLRNIPERILVIVNSEEWKQRLETFHERKIDKFLRYKFKRNPEVFNRSKLKSFISALPKEYELRRIDEHIANSPTLHKISEDFTSQFHSVEDYINRGIGYSILYNGEVVCGASSYSIYNDGIEIEVATDHNHRREGLATVVSAALILDCLENGKYPNWDAANTTSAKLAEKLGYEFDKAYDTYFVDNR
>fig|226900.1.peg.3004 Zwittermicin A resistance protein ZmaR
MICELSKDDFYRCNRLVNEQGQLEVRAVIAGVNPGRIFVDNVTSPNSGLIWLGNNDGFFFIGDAENEEFNKEVNRFINHVIVPEARKVGLDCFEGIGNHSKWNKTIERIFQHRKLKSWNQRVYMLGKEDYENHHEPKFEQRYTVLKMSKALYENNNNTFKNIDFLQSKILEFWSSPDSFFNEGIGYCIVYDDLIVSVCFSGFVFENIHCIDIETIEGHQGRKLAQKIAHSFVKDCLENDIIPYWDCMELNKPSVAVVENVGFTNVFNYVGYYFLFE
>fig|226900.1.peg.3015 Bicyclomycin resistance protein
MSNFKNKAIDKDISSGLIILLATACGIIVANLYYAQPLIGLISNEIGLSNSSAGLIVTLTQIGYVVGLLFLVPLGDIVENKKLILILLFLSAFALISMVFVKSATLLLIASFFIGLGSVAAQVLVPLVSYLSSENARGRVVGNVMSGLLLGIMLARPISSLVADMWGWNAIFALSATVIIVLAFVLSKVLPTRKPKAKTNYIALLNSMWQLLRTTPILRRRAIYHACVFGAFSLFWTTVPLLLFSPAFHFSQTAIALYALVGITGAIAAPIGGRLADLGWTRPATGIALTVVIISLILPLFIQSSSSFGIAVLVIAAILLDMGVSANLVLSQRLIFSLSPEIRSRLNGLFMAIFFLGGAVGSFIGGWAYALGGWNLTLWIGIAFPTIALLYFAREE
>fig|226900.1.peg.3044 Permease of the drug/metabolite transporter (DMT) superfamily
MKPIKANLMILLVTMTWGTSYLFMKIGLETVPSFSLVALRFGIAFFVCAAVFFKQFRSIHFVTLKYGFILGFLLFVVSASVILGLKTTSASNAGFLASLTVIFIPLLSIVLFKDRLSYRLIISSLVAMTGIGLLTLNNQLTLNSGDLLCILAALFYAFHIIVTGRAAKVANTLQLGILQLGFAGGFGVLSALIFEEPQLPSTKESWIAVLVLSIFCSAFAYIIQAMAQKYTTPTHTGLIFSLEPVFSALFAYLFMNEVLSLKGYIGALLILSGVILAEIKVKRKSTLLL
>fig|226900.1.peg.3240 Chloramphenicol resistance protein
MNSYTASSSEVQTNRRSIFALLALAISAFGIGTTEFVSVGLLPSISEDLHVSVTTAGLTVSLYALGVAFGAPVLTSLTANMSRKTLLMWIMIIFIIGNGIAAVATSFTVLLIARIISALSHGVFMSIGSTIAAALVPENKRASAIAIMFTGVTVATITGAPIGTFIGQQFGWRTSFLAIVVIGIIALIANSILIPSNMKKGASVSFRDQFKLITNGRLLLVFIITALGYGGTFVTFTYLSPLLQEVTGFKANTVTIILLVYGIAIAIGNVIGGKLSNHNPIRALFYMFFIQAIILFVLTFTAPFKVAGLITIILMGLFAFMNVPGLQVYVVMLAERFVPSAVDVASAINIAAFNAGIALGAYLGGIVTNSLGLIHTAWVGGIMVVGAVILTAWSMTLEKRDQVK
>fig|226900.1.peg.3281 Daunorubicin resistance transmembrane protein
MKSKTGVLLGRLMRNIMRSPDTIITVAITPIMMMLLFVYVFGGAIKTGTENYVNYLLPGILLMAIASGVAYTSVRLFTDVKSGLMARFITMPIKRSSILWAHVLTSLVANVLTIVVVILVALLMGFRSSANILDWLAVAGILGMFTLALTWLAIIPGLKARSMEGATAYSYPLVFLPFISSAFVPTETMPKIVRAFAENQPVTSIVNAIRALLYKGTVGNDIWIALAWCVGIMIISYFFASKAFKRQLG
>fig|226900.1.peg.3282 Daunorubicin resistance ABC transporter ATPase subunit
MSHAAISVKGLKKSFKDKEVLKGVDFEVQRGEIFALLGSNGAGKTTTVNILSTLMKQDSGEVSICGFDVQSQSDHVRQSISLTGQFAALDGMLTGRENLIMIAKLRGVSNPAQVADNLLARFSLTDAANQRADQYSGGMKRRLDIAMSLIGAPAVIFLDEPTTGLDPEARIEVWDTVKELAGSGTTILLTTQYLEEAEQLADRIAILHGGKIITTGTLAELKEMFPPAKVEYIEKQPTLEEIFLSIIGKKEEM
>fig|226900.1.peg.3378 Vancomycin B-type resistance protein VanW
MVGVLCVAIMSGCGAKVSDVALVSDIGGHTVEAKAEVQDTISLVDGRTGTEVKKLDLSSLGYFEDEAKFKKSVTKVVGEVGKSVDKKMVPSRIAPDGSWQEGKPSYELMEKELVDKLLNVGMWDATYQLPIVEKKPVATLSDAQGNGTVIGRYETNLGGSTGGRIENIRLSAASINGVVLAKGDRFSFNSLIGDTTPDKGYQLGKEIVDGKLVDGYGGGVCQTSSTLYNAADQAGLKMVERTTHSKTVGYVPQGRDATIAYPYLDLVFENTNDAPVKLYMGIQGGKLVAEVHKMR
>fig|226900.1.peg.3503 Permease of the drug/metabolite transporter (DMT) superfamily
MLRYSLLVLLGACSYGILAIFVKLAYAEGFSLGEVIGSQYLFGWIILLAITLLFSRHRVPLKQALLLFVAGTSASFTGIFYYASLKTVPASIAIILLFQFVWVGIIIEAVATKTLPSREKVISVIFLLVGTFLSSGLLEQSAGAFDTTGIILGLLSAVTFATYIFVSGKVAVEVPSLPRGVLLMTGALTLVMIVFPPTFIFNGAISQGLWKYGLGLGTFSIVIPSIAFTIGIPKIGSGLATILGAAELPVTTIMSVFVLKEAVLSSQWFGVSLILIGIAIPQIAYAMRGRYRKHHTHKKVAA
>fig|226900.1.peg.3518 Multidrug resistance ABC transporter ATP-binding and permease protein
MKPYKGLLSLAFIFLVGATVTEMMGPFLIKQFLDEHLVPRDFERSALVTLFVIYIVAHLLKVLFTYLNLLYFQNIAFKIVQDMRVEVYEHVQKLSLSFFDRTPIGTLVSRITNDTEAIKDFYVSVLSTFVKNVVFLVGILVAMFLLDVKLALFSLVLIPIMFAIMVLYRRKSAAFYLEVRNQLSVLNAKLNESIQGMNIVQVFRQEKRMRKEFEEVNNKHYSAGRRTLKLDALLLRPATDLVHIVAIALVLGLFGIDALKSPVEVGVLYAFVNYIHRFFQPVNEMMMKLSFFQQALVSSSRVFHLMDEKDLAPVQKGNENPQIVDGDIEFKNVTFSYDGKRDVLKNVSFHVKQGQTVAFVGHTGSGKSTIMNLLMRFYNIKSGNIVIDGVDLEKFEEREIRKKIGLVLQDAFLFAGNVKQNIRMYNEEITDEEVKEAARFVQANTFIEKLPKQYETEVVERGAAFSSGQRQLIAFARTIATNPKVLVLDEATANIDTETEEAIQTALQQMRKGRTTIAIAHRLSTIQDADQIFVMHDGEIVERGTHQELLSEQGLYYNMYLLQNKVSLQKAL
>fig|226900.1.peg.3519 Multidrug resistance ABC transporter ATP-binding and permease protein
MFMNLAWFFKQEKRAYITGIILLFGVALLELVAPKVIGIVVDEINDGTLTTDKLLKWVVLLVIVGITMYILRYIWRIMIFGSSLKLARQLRKNLYEHFTKMSPSFYQSNRTGDLMAHATNDIQAIQQTAGAGVLTLVDSLAVGGCVLVAMGFTISWKLTLLSLIPMPIVAISTNYYGTLLHKRFHKAQQSFSEINDKVQESMSGMKVIRSLGQEKEDLQAFRRKSEDVVHKNVLVARIDSLFDPTISLIVGFSFLIAVCYGSVLVVRGELTVGDLVTFTTYLGTLVWPMLAFGWLFNIMERGRASYDRVEKILSQKSDVVNSENAVHTIASGNVSFAVDSFSYKKNELLHLNDIHFDLKKGETLGVVGRTGAGKTTLLKCLIREYDHFNGELKIGERDIRDITLHGVRSAISYVPQDHFLFSASIGENIAFGKADATYNEITQAAEIACIHNDILQFSEGYETVVGERGVSLSGGQKQRISIARALLTNAEILILDDCLSAVDAKTEETILSALKRERAGKTTIITAHRLSAIQHANLILVVDEGRIVQRGTHEELMKEKGWYKEMYESQQLEALVEKGGV
>fig|226900.1.peg.4469 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNQMLLGSFLCLLAVTAWGFMFPVMARALQFIDPFFFTTLRYGSAAIIFLILLLITEGKTSLRLEKRTLSLFFYGTVGFAGYGFLVFYGQQLAGPSGAIHAAMIQSLMPLIALSLQWITQNRRPQNYTFLCMFVALLGVMLVISKGNIELLFGAASHLSTNILMLCGVTCWVIYTNGAARFQSWSPLRYTTLTCLFGSISLIVIVTFLTYTNIVTMPSLRTVVSVRFELFYMSIIAGVIAVFCWNMGNRYISSINGILFMNLVPILALIGSIFRGYTVDKIEIAGAALTIIALLCNNLWQRKVNIKIPTSVR
>fig|226900.1.peg.4581 Permease of the drug/metabolite transporter (DMT) superfamily
MRRWGIELLILSVVIIWGINYTIAKYGLLEFTAIEFTALRMMAAAPLLLLLTFCIEKSVYMERTDIPRLIIVSVVGIVLYQTLFMETVKYTSATNASLLISISPIFTTAFAIFLKQEKFSSRKLIGSMTAFVGAALVLVAGHSLTSSFYGNGIGLITSICWGLYPVLAGPLIKKYSALRVTAWSALVGAIPLLLLSGPHVFVMPFHITHGMTLFALLYSIFFVTVFGLVMWYVGVQKIGASHTMVYMYITPLVAVLFAAVWANEYVSFQQIIGGIIIFVGLWFVKSEKVKVHSIAGEPISK
>fig|226900.1.peg.4872 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MIKELDHVMIKVQNLEESITFYSEQLRLQIIWEYDNYVGFHNGIVIHDSKNSENLTSFFKVDSVEETVKILKESNVKIILEPTPIPTGYTAAFQDISNNIIHIVDNINLS
>fig|226900.1.peg.4954 Pristinamycin resistance protein VgaB
MTILFARNIEKSFGDRTLFTLPSLEIQAQDRIGIVGVNGAGKSTLLQILSKEIEADRGIVTHHSSIAIILQLSEELPETASSLAKGKWSISNVTDAMSGGERMRLKIAHALEQNAGILFADEPTSHLDMVGTEQLEKALSSYKGALVLISHDREFLDNICTKIIEIEDGIIQEYKGNYSNYRKQKERERIQKQAEYEQYIQEKNRLEQSILQRKQRASNMEKIPTRFSSSESRLYRLSGAHGQEQVSKAAKALETRLEKLEKKEKPKDLSQAQFDVQYHTPIHSKVAVQFNKATKKIGDRILFKNMNGTIAPGAKLAVLGANGSGKTTLFNMLLTNERGMQLSKSCKIGYFEQTLSILKTDKTILENVLEETNYTEAFVRTILARLLFRREDVHKPVHVLSGGERMKVALAKVFLGNYNMLLLDEPTNYLDLATQEELETMLQEYPGTILFISHDRAFIRSVADHILQVDESEPRVFHGNYEQYTKRTTGDSVNVTEQELLRLQTKLTEVIGRNSIPNHHNDISSLEQEYETLLVKIRKCKEAL
>fig|226900.1.peg.5204 Multidrug resistance protein B
MTSEVNKRTFFTKSTLIIIPLLIICAFAFHYFFLKSDNVFSSTGDALSQFSFFTFLLQHAFKDGNLFWSWDYGLGGDLFGEFSYYYSTAPFFWLTLLLPKLNFDQIFEMKLYMSILKSTLAMLFMYGSLRYHNKTIFSSFISAIIYGGCVTFIRHSLLWDFMADAIVFLPLVIWGLDKYILERKKGLFLFATALMLASNFYFAFITSIFIYIYAFFQYFATQQNKTIKTFIIYYIRIAFLYALSLGLSAVCFIPSVNGVFSSDRLATKFTIPLFFEGTFYKNLMESIFFINNTEDYQLAFPVFILFLITSALLIRNKLVTNKLTFTGFMLVLYMLPYTYSVFNGFSAMQYRWFYLFAFVVAQTVAYILDWMLLNKQKVNSLIGPLLATTLFIYAFYRKVNINAQPLQTIDKILICTTVLSIITILLWRYLSKVALQCFIVLNVLVNVIFINYFYSDFALSKHFNQAGVTKESLHGPGLDNKDEIDAIRYIQNQDKDFYRIINPNNNYKNTPMLQGYHGTSTYQSLVNYHVHDFMKNKYNVFQGYDSPSMFFQLDKRLFLENMLGVKYYVLSEGANKTEIPYGYKHLQQVGPYNIYKNEFALPLGYVYEAGISDEEFSKLNFAEKDQLLLDAVVVNDVGSLPLKQFNTKQLDSKQIKINPNKMKWENIEKEKDILTVHENGRIIVPIDNNDMLGDLLVEIKIRNINKVSFGVTVNNKSMIKGNEDGAYAYPLERFVYNLGKDAKPTELIISIPTPGQYELKDLQINSTNYQTVPKKVNTLKENSLQNIYYEGNSLKGDINSTKDGLLYLSVPYSKGWSIKVDGKETEFTKANSAFIGVPISKGQHVVEMKYVTPYFKMGLVISIISFIICISLLVLGDTKRYSKLKSRFKKRY
>fig|227882.1.peg.1994 Permease of the drug/metabolite transporter (DMT) superfamily
MSSIAVPGALAPRRAWLTDLPVLLVAVVWGASYLAAKDITTARTVIAVLVLRFGVVLPVLVIAGRRSLRALSAAQWRGAALLGLILSGIFLLETYGVVHTSATNAGLIISLTMIFTPLAEAAVTRARPPRAFLAAAGVSVLGVVLLTQGGGFTRPSLGDLLMLLAALARTVHVLAMSRVKSVQGADALPLTTVQLGAAVAVFAVLSTGTDATVWGTAAGFGAREWGGLLFLAAFCTLFAFCVQMWAVRRTSPSRVSLLLGTEPLWAAAAGITLGGERLGALGLMGGVLVLAGTAWGRRAAG
>fig|227882.1.peg.5649 Drug resistance transporter EmrB/QacA subfamily precursor
MTETLTSPTTRSPVAPPVLGGLGLFTVLLGAALPLIDFFIVNVALPTIGRDLHASETVLELVVAGYGVSYAVLLVLGGRLGDLFGRREFFLGGMAAFGLTSLACGLAPSAWTLVAARVAQGAAAAAMLPQVLATIQSATEGPRRAKAMGLYGATAGLSMVAGQILGGVLVAADIAGTGWRSVFLVNVPVVVVGLFLAARAVPETRSQRPEPVDGPGTVLLAVSLLTLLVPLTEGRAAGWPLWTWPALAAFPFAAWAFYAVERRADRQGRTPLVPPSLFALTSLRRGLVMIVPFSIGFSGFMFVIAVALQRGAGLGPVPAGLALAPMAVVFFAVSLCGPRLVARYGTRVVTAGGLIQAVGVTLIVLAALRSWPDLGVLELLPGAAVAGAGQALQLPVLFRIILSEVPPTRAGVGGGVMITTQQSGLALGVATLGSLFLALVPGWGMRDALVTTLLVQLAGVALTTALSLRLPRSIS
>fig|227882.1.peg.5651 Drug resistance transporter EmrB/QacA subfamily precursor
MPELSPRRRLLVLAICCLSLLIVSLDNTVLNVALPSMQKELHASVAGLQWTIDAYTLVLASLLMLAGSTADRIGRRRVFRTGLVLFTIGSVLCSLAPNLESLVAFRMVQAVGGSMLNPVAMSIITNTFTEPRERARAIGVWGGVVGISMAAGPIVGGLLVDSVGWRSIFWINLPVGLVALLLTWRYVPESRAPKARRPDPVGQLLVIALLGSLTYAIIEAPSSGAAEILAFGGTALAALIALLWYEPRRAEPLIDLRFFRSVPFSGATVVAISAFAALSGFLFLSTLYLQNVRGLSALHAGLWMLPMAVMCFVCAPLSGRLVGSRGPRFSLLTAGIAMTASGVLFAAFEAETSDVTLVIGYVLFGVGFGFVNAPITNTAVSGMPRAQAGVAAAIASTSRQIGGTLGVAVVGAVLASGVRTGPYRQVFESAARPGWWIIAGCGLSVLVLGALSSGAWARATARRTAQRLESTEVRDEAGVNA
>fig|228405.5.peg.473 Permease of the drug/metabolite transporter (DMT) superfamily
MLPMSPVAQLRRMRLYPPLQSGGGGRRRSRLTEGGSQAVPPPHSSPAALTRRAPCPLSQNPDRPEPIMAIRDFILLCAVCLVWGLNLVVTRWAVADMAIPPIFFAALRFLGVAVCLVPFLFPRPPNLRTLFFVSIMIGSVHFSLLFIGLQHADASAAAVTGQLGVPFSTLMSMLFLGEVIRWRRAIGITLAFLGVIIIALDPANFSVSFGLLYIIASAFIGSAGGIVMKRMPQISGLRMQAWVGLFSFAPLFALSFAIEENQLATYIDGGWMVWAASAFAILGVSVFGHSAFYTLLKKYDVSLLSPLTLMTPIWGVIFGIALLNEPLTPRLILGAIVSLSGVLVIALRPNEKMPEAALGKKAGAGDS
>fig|228405.5.peg.696 Probable multidrug resistance protein norM
MLPSRIARKIIIGISCPPFAFEASRPAAQKSGTDLEKTKGRAVMTATSRLPAWARPKDIADLIRLSVPIAVSRMAMMLMGLTDAIVLGQYAPGELAYVLSAWLPISISLGFGVGILLGIQVLTSELLGTGREAGSGRVFRRGLWWAVVMGAVLTAVLLPISDPFFHWVFVTIAPASDAPSAVTPEIVASSTASVTRILALGLAGHMISQACSYYLEALRRPLLVTVVMYVGVVINLFANLALVAGWWGFPQMGAEGVAWATTGTRWLITIVLLIFVATLTPAFRRSPPAEKGESRRQLAVGVGTAISNIAEYGGFNITFIIATWVSIAANAVYGYSVQVIGVCFMFYLGIATATSVRVAEAIGRGSQEEVRNAGRLGVAATFVMGIILGVLLVLLSGPISRLLVREDAVIGGIAIAPAIAALLWLAAAVTVFDGLQATASFALRAQGMVWLPSAIHISSFFLVMIPVCYWLAITLGRGAAGVLEGAFIAVFVAGMAQFILLEWKAARPDVERAA
>fig|228405.5.peg.2319 Multidrug resistance protein B
MTVAPGIPSQSGPGTARKPLPDDIPAMAGPSVRAQFERFGGIYRWILLFTMLTGSMATMLAATTINVALPAIIGAFGLGQDQAQWMSTAFLASSTIAMLANAWAMTTFGPRATYTFGMVVFVFGSLLGAVSNTLELLIVSRGLQGISAGLLQPMSMFLIFQTFPDSRRGTAMGVFSIGVVLAPAFGPALGGIAVDLASWRLVFVATLPLALVALGIAPFLMPKGDRNRSTPRPPLDWVGLSLLAVAVIGLLAAFAGGNRDGWDSDQTYLRFAIAILAAIAFFFWELRHPFPALNPKVFTYRQFWSAGLIISATGIAIYASTYLIPLFVQLVQGYSPTAAGVMMIPAGIAMMIGFPIAGRLTDRVDPRWLLGFGITTFAASAWLLSHVSAMTPYWVLVGWILLSRIGISFCMPPSNTTAVRAVPPHLLASATGGVSFLMQVGGAFGVNILAIILQRRTIFHGEHLSTAMNETNAEMMYQHALQAQTLEMTGMTQVQAFQSAFGLLNQKVAMEASVYAFRDCFFIIFVWFVIVLGALALMPKPKMIQPAR
>fig|228405.5.peg.2958 Permeases of the drug/metabolite transporter (DMT) superfamily
MQVMSSGLDCTLAPDMRAPHPILLVCFGVVFGCGIDALMKSVMQGSTSVLTATTWRYVLGSVIMIALSLQARRSMPTLPAIRFHALRSLAQVISAFCFFYSLTQIALAEAVVMGFTAALMIAPIARVILGEKMSPVTIGASLIGFCGAALAATAESSGAPVEGNRLYGTVAVLASAVLYALNIVLLRLRTREEDSLTLVTFMNIFPALFLLPFMLVFTDPMPAEGAWSMLIGAAVFGIGIWWLMTMAYGRAKAQTLAPFEYTGLIWSALLGYFFFQEIPGWRVWAGAGIIIAACLVVAFETHFIARREAKMPASDILT
>fig|228405.5.peg.3043 Permease of the drug/metabolite transporter (DMT) superfamily
MALDAAGRTTMTEASLPGAKIARPAIVWILFATLTTLWAGAYGLTRVAVGKGTLEGLPPEWVLPGRLTGGAIVLLTLMLVMGKRLPPFSDLRRWGVIGAMGVVGSLVPFFLITVAQQTVDSSLAALYTAAAPVFVVLGATLFFADERMTRNTGLGVLLGFAGVLALFGPDAVRHFGSASVTAQLLLLLATLSFSASTLIARAAPKMDAIPLAAGFVTVSAVVSWPLALTVHPSEVEADWHHWAAVAGLGLGPSGIAQALYMALVARAGATFQSLTGYSVPVVGAAFGWLFFRETQSWNAALAFALILGGVWLARQGGRGRVG
>fig|228405.5.peg.3118 Multidrug resistance protein 2
MSLLGRRGPHQMDDTETPLHPLSPFQRGMLMLATIAMGAGMSINFVVVAPLTRKAGLGEVEVAAILTLSTLLYAVMIPRWGRIADRVGRKRVMVFSLIAMGVTNMAFLFALEAGLAGVITGTSLMLTLIFVRLWFGLLTPGLQPASMAAMTDATTIRDRAAGLGMLGAGMSIGSILGPAGAAALAPFGALAPLWGTIVFCILIGILLGFSLPRTVKRPRNAARPKPLSMFDARVRPHLLFLLSYFIGVGMVQQTLGWFIEDRYALAGDDPAAVGQTAVLYTGIVFSCMAVSTIAVQFGYISRLKPDPRKILWVGLALVAVGYTAADVFHAFPVLCAAFLLIGAGSALAIPSANALGSLSVSREEQGAAAALMSAAPPAGFIFGPLMGAGLYQVNHALPLIASAVLVGSLAVYAMLVTARRPLAEG
>fig|228405.5.peg.3334 Permease of the drug/metabolite transporter (DMT) superfamily
MTQTPPATAPLPVSLPPARSWIGPLMVLGGGVAIGFAPIGLRIGLQEYGGELGPQAIAMWRYIFATPILFGLVLLIHRRLPRPPNRFIILAGTFFAIDIALWHWALTMTSVSNATFIVNLGNVGVGIVAWLFLKERPGMHWFVAASLAICGAAALSLGGAALHTGGLKGDLFALAAAGFVAGYMMFSKLGRRNLSGIEAIFWLSVVESLVAFLIVLLAGERVLPMTANGFIVPVFLAIVAHVMGQGLIVSGLGWTNTAVAGILVLAQPVVAAAIAWKLFEEPLTALQAAGAATILVAVWLAQRQTVPPAG
>fig|228410.1.peg.2100 Permease of the drug/metabolite transporter (DMT) superfamily
MTNTRNENLGYVYGLIAVTAFALTLPAMRAALSALDPVFVALGRGAGAAVLAAVFLWFTRQRLPTREEAKGLIIVAAGAVIGFPLLAAWAMLYVDASHGGVVLGILPLATAVAAALFSNERPSMKFWLFALIGAGLVVGYSLSRAGGTLHPADLALFGSIVCAGVSYAEGARLSKSLGGPQVISWALVFSFPILIIPAIHYAPVSLNLPLESWLGFIYLTVISQYLGFFPWYHGLALGGIAKVGQTQLLQPFLTIIASVLLLGEHADLMTWLVATLVVAVVAVGKHAQVKHNDPESATIADTSPHS
>fig|229193.1.peg.267 Permease of the drug/metabolite transporter (DMT) superfamily
MNRLPTLYGIIAILLWSMSVALTRGLAEALGPFGAGSAIYSVSGILVWLVAGKPRVRGQHPAYLYGCGLLFVVYMVAFALAIGMANDRQQTLEIGLINYLWPSLTLLLAVPLLKLRARWWLWPGAALALFGVIWVVSGGEGLDVKTLAVNISSNPLAYSLALIAAFTWAGYSNLVRLYSQGPGALPLFLIACALCLWLMFFMWTPGKLHFTPRAIFELLLMGANTALAYQCWDRAYQCWDSAMKKGNATLVAALSYFTPLLSILIASVWLNTLPSAAFWPGVAMVVAGSLLCWSASRNPLRT
>fig|232721.5.peg.348 Permease of the drug/metabolite transporter (DMT) superfamily
MNTASIRSIAMVLLAAMLWGTTGTAQSLAPAGLSPYWVGALRLVIASAFFALLAWPAWRARRGGGLRWGPVLLAGACVATYNLSFFAGVKSAGVALGTALAIGSGPIWAGLLQTVAQRRLPAPVWWLGTLLGVAGGAAMALDGGSTVRAPWTGIALCLLAGLAYAMYALTNKRLVAQAGAAVVNLAVFGMAGLLSLPVALLLGGAPTVAPGALGIVLYLGLVATGVAYLLFSTALRHISGATGVTLALAEPVTAFALAVAVVGESPSAMAYGGLAAVLAGLLLVIWAELRTTRPAVGAAAA
>fig|232721.5.peg.389 Permease of the drug/metabolite transporter (DMT) superfamily
MRSERQGLLALLLVVAVWGTTFPAMKMMSAHLDALQIIWARFAIALLVLAPLWRGLRRTELRWGLLLGALLFLAFWLQIEGLARTSSNRNAFVTGLNVLVVPLLAMAVLGRRYGAALWAACAMALAGMVLMFHENEPWNLGDTLTLASTLFYAIYILTLEECARRTAAQPLRATRMAAVQALVMFAAASVLLLARHGEVATTLQALADLPAHALTALAYLGVVASVLVVTLQAWGQQRVDAMRSAIVFGLEPVFAAATAWVLIGERLGAAGLAGAALIVAALVVSQLPPPRALARPSTP
>fig|232721.5.peg.404 Multiple antibiotic resistance protein MarC
MDLKPLITLLAIVNPLAIVPFFIHYTSGFNAAQRRRTVQVAAFSAFCVIAACALVGLQILDFFNISLQSFQVGGGMLLLISAMNMLNAQPAEAKPHTHELEQGAEKAAAGSSIAVVPLTIPLLTGPAAMSTVVIYADRAQSIWQHLALVGYGVVVGAATALCFALAEPIERVLGKTGINVMTRLMGLILAALAVEVMADGLSKLFPVLAARS
>fig|232721.5.peg.409 Outer membrane component of tripartite multidrug resistance system
MKNHLSPSSAPALTPPTAPRGSALLYGATLAVALLALPLLSGCADMAGIDSHARMRDPVSLGLAAAPSSGADAAVQPQTAVSADWWRSFGDAQLDALITQALQGNPGLQQAAARIARAEAFADTARAAQSPQVNGSLDATRQRYSANGPYPPGQAGAIRSVETARLSGSWELDFFGKHRAALAAALGEAQAARADAEAARLLLASRVAQGYFQLARLQAQRAVAERTLQQRTEMLQLVQRRVQAGLDTQLELRQSEGTLPEARQQIEALREQEALARNALGALIADPQTAQTLTPQALAAIHFSETPAAVPADLLGRRPDVAAARWRVEAATQDMGVARAQFYPNVSLTAFVGLASVGLDRFIEAGSREWGVGPALRLPIFDAGRLRANLRGKAADRDAAVESYNAALLEAVRDAADQLASSSSIARQITEQRQAGESAQAAYGIARRRYEAGLGTYLQVLTAESQVLAQRRLAVDLAARRLDNQVGVMRALGGGYAATPPPMAQAPQAAPTVAAAR
>fig|232721.5.peg.1181 Permease of the drug/metabolite transporter (DMT) superfamily
MSTSLSRADWAKALVVVVVWGLNFVVMKWGLATLSPLVLCALRFLAASLPFLLFVRPPRHLSWGVMAAYGLVQGVGQFGLLFTGMQLGMPAGMSSVVLQTQAFITMLMAAALLGETPHRWQWLGLCIAIGGLVFIGAAHGDGASGMTLAGFLLTVGAAAMWAGSNLLTRVAARQGPYEPVSFIVWSSVFPIVPLLLLACVVDGTEAVVQQLRGLGGRELGVVAYLALLSTLLGYGLWTRLLQRYAASTVAPLSLLVPVVGLLSAMLLLGERPTAWQWMGTLGVLAGMVINQFGGLWAKRRRGVASI
>fig|232721.5.peg.2086 Permease of the drug/metabolite transporter (DMT) superfamily
MTAPHTSAEALSPHAPAWVGEFVLLSSLWGASFLFMRLGAAEFGPLPMAGLRVLMAALFLWPFLLHRGEWPALRRHWRPVLFAGLINSAIPFALFAWAVMHIATGLTSILNATVPLFGALVAWLWLGDRISRLRWAGLALGFVGVALLAWRAPAGVGASGSQAGWAIAACLLASTCYAVAASYARRYLVGIPPLATATGSQVGAALGLALPMWWAWPAQTPSLRAWAAIAAIAVLCTGIAYILYFRLIANAGPSRALAVTFLAPVFAVFYGAVFLGEAVTPWMLGCGVIIACGTALSTGLVGGAVRPGTKTP
>fig|232721.5.peg.2952 Membrane fusion component of tripartite multidrug resistance system
MAMPKKAKITSAVLLLAVAAGCVIYLNRPESSASTQSTDDAYVQADFTLVAPQVSGVIGKVLVEENQPVKAGDLLAAIDDRDFIVAVDAAKAQVAAAEASVAGLAARVAQQETAIRQAQAAVAVDDAELKLAEANQKRYRNLAADGSGSIQAQQQAEAQLAIRLASRDKNRAGLQAARQQTDILKADLEKAKAALSQAQAAQAAAELKLSYTQITAPINGMIGQKSVRVGAFVNAGKPLLAVIPLDALYITANFRETQLARVRAGQSVDIKVDALPGAVLKGTVESLGPASGVSYSAVAPHNATGNFTKIVQRLPVRIRIDPDQLDAANLRVGMSVTPKIRIGE
>fig|232721.5.peg.2954 Outer membrane component of tripartite multidrug resistance system
MTSQPLLTQLLRQAGTALCTISLVGCAVGPDFVKPDDRLATVQLSPRADYAQPNETSAANFPSSWWTLFNDPVLAGLQSRAQAGNLNLQIASERIEQSRAQLGIASSLLLPSVGVSAGYSREAISEHGKFAALGAPTSASDFWQLGFEASWELDLWGRARRSREGAAAAFEATVYEREAARVALSAEVARAYLQLRGAQAQLDITRQNLEVADRTLRLAESRERNGVATRFETSSARAQLATVEALVPELVQRRNTLMNALALLLGEEPRALDAQLLEAMPLPSLPSNVPVGLPSELAHRRPDIQRAEAQLHAATAAIGVAKADFYPRIGLRGRVGVEAFEFNDLDSWDSRFFSVGPTVYLPIFQGGRLKQRVALNEARQRTAAIAYRQTVLQAWHEVDNALDAWAAQQNRHAELRVSYEQNKQALHAAERGYQEGAADYLNVLAAQRGVLASQTSLNASATNAALTLVNLYKSLGGGWDPDALTSGRQAGGDAPLTTTTSPASLQSKVDQ
>fig|232721.5.peg.3126 Multidrug resistance transporter, Bcr/CflA family
MSVPSAAIGPQQAPAVPVPVPPGLAILVLALLLSIQPVTTDLYLPALPALTRSLNAPVAAGQLTLSALLLAFGCSQLAWGPLSDRFGRRPVLLTGLALYTLAAVGAALAPSMAVLIAWRTAQGVAMGAVVMCARAIVRDLYTPLAGARAMSKALTGLGLVACLCAPLGGLLTEWFNWRAALLALTGYAMGTLALVALRMPETLHQRNPHALRPAMLAGTAAQVLRTPAFWAFSLLTTASYGGLFTFLAASSFVYLDVLGISRTQYGLALLSTAVAYLLGTLLCRRLLARQGLKRTVAIAGALSASGGLLMLLAAALGWHSVAALLPPFYLYMVGHGIHQPCGQSGAVGPFPQAAGMASALNGFMMMLAGFAIGQWLGGALDGSVWPLVQGVALWSLLLAAIAWTLVQRHAPQEVTHAR
>fig|232721.5.peg.3151 Multidrug resistance transporter, Bcr/CflA family
MRASPSPSAGAPPLWLLVLITLSGTLAMHMFVPALPDAARALGVGPAAVQATISIYIVGLALGQLVYGPLSDALGRRPLLLGGLALYAAGSIAAMLAPTAPALIAAWFIQALGGCAGLALGRAMVRDTNGPVEAVRALALLNLMMMVGPGMAPLAGSGLVALGGWRAVFVALALAGVATLLLSWRKVPETGTPTGRVSPGRLARAYAALLRSPTFLAYAVGGGCATTAVYAFIAAAPFIITEQLGHPLRDVGIALGVVMVGMAIGNALTRRLALSMRLGRLLVWGNAVSVACALVFLALELLGYLTLEATVGLMLLFVLGAGMASPAALSKVLTVDARHVGAAAGLYGFAQMALGALFTLLVGWGSNPALASSCVLLGAALVGQGCLQFALRREKRARGERVRGERARGERARGE
>fig|232721.5.peg.4052 Permease of the drug/metabolite transporter (DMT) superfamily
MPALSRRQLVVLALLTLVWGLNWPVMKMGVAHFPPLTFRMASLWLGLPILAAVIGVRKLPFTIARTHWGRVALLALTNMVLWHVLMILAIPQLSSGRAAILGYTMPIFSAVLGALVFGDRLAGRAWMGVGAALVGVVLLLWHEVGALGGRPLGVTLMLVSAASWAMGTQLLRRLTVPVPLLTLSFWMVAITCVVLTVLAVAFERERWVAPDAQAWAAILYNGLLALGFAQTAWFFLVRTLPPVASTLSVMMIPVLGVFSGALWLGEVLHWQDWTAVGLMAVAIGTVLWPARAVQAQEFK
>fig|234267.9.peg.427 Multidrug resistance ABC transporter ATP-binding and permease protein
MHRSHTKGYGYHTSARRRHPVYRHRSRLEEVEEEVLGKAYDGRLMRRLLGYMRPYRLLVALSLVFLLLQSALQVLGPLLTKTAVDRYIAPTGGQIPEFLARFLPADAWDGLTRIGLVYLTVLAANFVCEFIQMYVMQYTGQLAMFDLRRELMEHLQGLDLAFYDRNPVGRLVTRVTTDVDVLNELFASGLVTILGDILVLVFILAIMFSFSPTLTAIMLTAMPFVILTTVIFRRSVSQSYRRIRVAIAKINSFLQEHITGIAVLQLFNREERSCKEFEQVNREHMEAFKDAITAYGWFYPVVEFLSMMALAGILTYGGFRVQAGRLSLGVVAAFLQYGLRFFRPIQDLSEKYNILQSAMASSERVFKLLDTEAAVLPPESAQPAPAGIAPIEFDHVWFAYKDEDWVLRDVSFTIAPGETIAVVGHTGAGKTTLISLLLRFYDVQRGSIKVGGVDVRLYGPLDLRRMFGVVLQDPYLFTGTLEENIRLGTENIRAEEVEAAAEQVNLMDFIRTLPEGFGHTIRERGSGLSTGQKQLISFARALAHNPRYLILDEATSSVDTETEFRVREALNRMVAGRTSIVIAHRLSTIQRADRILVMHKGHLRESGTHQELLAQRGIYWKLYQLQYKDQERVAAD
>fig|234267.9.peg.623 Drug resistance transporter EmrB/QacA subfamily
MIIDNRYHVNCGLQNAFDRYIIGNQSSAASCPYQNRTGPPGHSPPDPYRDVASGRAAAGRQTIQGTGRFPGDRQCRLAGPSQSGPGQQAPEPLHQRQPLHVGGYRETLCGPRPAGAGRRCRALRHLVRRSAGFPAGTGEPDAPRGAHQRPLEVGHRRLHLSPGNLQTQRQSLSDAGRPGDCCRAVRLYPLRSPGGAPHRLPRHGGRPPGGAHGDRRRPGGRGARDPAFLGGVAQPLAARPARSFCERQPRGSAANRSTQGPGVTASVGEWSMGSIARPPCDEAAIRAGACEPQATVNGSWILAATILGSSMAFIDGTVVNVALPALQSALRATLADVQWVVESYALFLAALLLTGGSLGDRYGRRKIFVIGVVLFSIASAWCGMAPNIRQLVLARAVQGIGGALLVPGSLALISANFYQAERGRAIGTWSGFTSITAAIGPVLGGWLTEHGSWRWVFFINLPLGIAVVALSLTKVPESRSGTESRRFDWQGGLLAALGLGGIVFGLIESAPLACVAGAIALIVLLYWEGRAPSPMIPLRLFGSRDFSGANLLTLFLYAALSGVLFFFPLNLIQVQGYTPTQAGAALLPFILLMFLLSRWSGGLLDRYGAKLPLVVGPIIAATGFALFARPGIGGSYWTTFFPAVLTLGFGMAVSVAPLTTTVMNAVDESYAGAASGINNSVSRVAGLLAVAVFGALLSGVFQNTLERRLDAGTVPPPVRAELEAQRSKLAAAVTADPRGRRAVQEAFVEGYRVVLWVAAGLALASSLSAAVMIKASGSASPRRS
>fig|234267.9.peg.736 Permease of the drug/metabolite transporter (DMT) superfamily
MISWCMAPTPSPSIRRRPDIVPLLLAFAAIYFVWGSTFLAIRFAVETLPPLITMGTRHLMAGGLLFLWLRFRGEPLPEPRLWRPALFSGAFCFLGCHGLLAWAEKTVPSGLAALLSATLPVWMILLARMLGQGSELTLKVMGGITLGFLGVAVLVPFHSGARDGIPWTSLAIIVCEIFWAIGAIFSRGVKGTVPPATFAAMQMLCGGVLLWTLGLILGEGSQLHPESFTTRSVVSLAYLIVFGSLITFTAYVWLLQVCSPALVSTHSYINPVVAIFCGWALGGEPLTARTLAGTAIILASVALVSVRKS
>fig|234267.9.peg.765 Permease of the drug/metabolite transporter (DMT) superfamily
MSRHPLFKAYIALVAVCFFWGTTYLGIRMALESFPPMVLVCVRYMISGSLMLLFARVRGLYLPKGKELAWACFSGLLTLGIGNGALVYSETMVPSGIAGLIVTISPFWMVGAEALLPGGARLHAPTIGGMAIGLAGAAMLFTPDPGTHGVDHKLVIGFLVLTFGMAGWSFGSIIQRRKTGKAHPVVAGGVQQLAAGLAMIPITLASGDLTIHWKTRGVTAILYLVTFGSLVGYSAYVYAMDRLPVAIVSIYPYVNAVVAVALGWLFYREPFGIRETLSMIVIFAGVAVVKRYSQKPPEKVLSAARR
>fig|234267.9.peg.1715 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MNGRFPSLSVFFPAYNDAPSLPGLLAKTFHALEEHVADYEVIVVNDGSYDDTGKVLEELRQKYHPYLRVVTHEQNRGYGGALRTGFESATREFVFYTDGDGQYDAGELPKLLELMTPDTGLVNGYKLERHDPAHRIWIGSTYNFCARLLFGIRIRDIDCDFRLIRKSRLQEIRLTSTSGTICVELVRKLELTGCGVVETGVRHYPRLHGKSQFFRLKSLATTLGELIRLWVRVVLLRGKKY
>fig|234267.9.peg.1768 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MLRARREFVALPHGRGSLACNISYTDVRRWEECLLVRLNAAAAFLRIETLYNPPMHRIPWSTIGLGSLLLISVCSKGGQEVQSQQPENAKPPVKTEQRGRILGIGGVFFKSANRDQMREWYSKHLGLTDKGGGAMLPWREHDDPKKEHVTVWSIFPASSNYFDPGHAQFMVNYIVDDLDALLDRLKKEGVKIDDKRMDESYGRFAWIYDADGNKIELWQPIAKP
>fig|234267.9.peg.1800 Multidrug resistance ABC transporter ATP-binding and permease protein
MLTKCWLLGFSGEGLPRMTNIAEDRAGDESEKSPFDRRVFRALFDIAKQYKRQFIVVSLFSFLYTGLDLLQPLVYRRAINAVAGMFVNQVPAAAPGLGNLAAQTPEQTLHTLLVSVVLLFFIAVISYYFYQRASYYGARVASYMESKLIVQTFGHVLRLPLSFFNHQASAGLARRIDQCDQVAPVVHAVSQQIAPEAVRLVAICAIMLTQNWEMSLMAVCLLPPYVWLARRAALRLQSNLDPYYQMWEDISAHIADAIGAVKTVKLSGAEAREQDKLREKSIAAYDVYLRRIRTSQKYYLSQVALSNLSKSLLLGYGGWLVLRHMLTPGDVVMFAAYLDRLYSPIDSLNGLAVSLQENLTSLRRAVDLRDSGRPEPGGAALPEGQGHVEFRNVHFGYTPEREVLHGINLTLQPGKITALAGPSGAGKTTTADLLLKLFEPSSGEIFLDGQPLSTAGCASIRAAIGVVASDGTVFRGTLADNIRYKRPEASLEETHRVALAAGLGRALERLPEGLNTQVGERGVGLSLGERQRLQIARMLIDRPRLLVLDEATANLDYATELDVRSALEQMSPKPTMLVIAHRYTMMKNADYVYVLKEGEVVEEGPPAALLKGQGWFADLARESGEVPSFV
>fig|234267.9.peg.2272 Nisin-resistance protein
MFKARLYSIGTLIVSCAACAAQSTVADATRSDPIEYLHRALDEMHARSLRRDRIDWPLLRKETLARAAGAEITVDTYDAIRFALASLEDHHSSFHPTPALEDLEKKRKATRRPAPAPIPQSPPSSPFTGRYEPEGRLVTSGGKTFAFVVVTKCFPETDGQFIAYETKLQRILADLDKSHPTGWIVDLRGNVGGNMWPMLAGIGPLLGEGDHLGEFFTLDSHSTWKYRDGVAAEIENGKEQRYPAVAGVPYKLAGTPKVAVLIDRRTGSSGEAIAIAFRGRPQTRFFGEHTEGVSTANDVVKLSDGASMWLTIGVDADRTGKQYMEGFDPDEVVGAGDKILSDGQDPVLQAALRWLSRS
>fig|234267.9.peg.2369 Permease of the drug/metabolite transporter (DMT) superfamily
MPRRRPVRRDAPGFGPEIVDQCRSHRRRHRRQRDCSNGALQGGYPLRKQRAHGPTGGRAGERRGPRTRLGKPARQRRTGRGQNQGDRLAAGRDAARTGAHPAICARGGFAPRYSVAPGLFFHRCQHPARHGHPRARHGRRRTRRRRPYPAGMVQPRWTRSWPQTHPAHSPAPDPRPRGQREVNRRKADLALLFNAFIWGSTFILVKSSLSYISPLLFLAIRFSLATAALGLLFRGTWKWRRRATPAMIGAGCLAGVFLFAGYALQTIGLRLTTAPKSAFLTGLATVMVPLLGALVYRIRPQLSEVFGVLIATFGMALMTIEGPIDSIGRGDLLTLGGAIAFAAHIVTLGHYSEKIGYELLSITQVGAAAVSSLTMFWWAETPRFHWNPVVLWAILITGLFCTALAFTIQAWAQRYTTATRTALIYALEPVVAWTTSFLVVGEGLSGRAAAGAGLILGGVLLVEMKPLKPREHQSR
>fig|234267.9.peg.2504 Inner membrane component of tripartite multidrug resistance system
MPIDESQGWHPGHSPWTVALTVTIATFMEVMDTSIANVSLPHIAGGLSAGVDESTWILTSYLVSNAIVLPISAWLSNRFGRKRFYMTSVAIFTVSSLLCGLAPSLSLLIFFRILQGVGGGGLGPSEQAILTDTFPAAKRGMAFAVYGMAVVLAPAIGPTLGGWITDQYSWRWIFFINVPFGILSLFLTNHMVQDPPDMERAKQDAKKAPVDFLGLVLIATGLGAFQIMLDKGQRDDWFASPFITACVIVTVGALGAFVIWEWNHRHPIVELGLLKNRSFAVACMLMLVTFAVMLGSTLLIPQFAQLELGYTARQAGELLSPGGFTILILMPMIGYLVSRVDARYLIGIGYLIFAASLFHMTNLYLGVDFRTAVMWRVYQAAGMAFLFVPTNTIAYTDMTPGASNQVSALTNLMRNMGGSVGISAVTTLLARRQQTHQVFLVRNVTSADPHLKQMLTQFANRFSLRTDSHHAMQQAYGAIYRQVQSQAAVLAYIDVITIMGALCLAAILLLFFAKKSKPGQAAVAH
>fig|234267.9.peg.2505 Membrane fusion component of tripartite multidrug resistance system
MVDDRTPYASHQEIEQLRDELRRLKEEQEKQKNGRHEDGQPKDEKKEESGEENEKPEEPKKPHPVRKFILIALVLVLAIGGLLWWLHARNFESTDDAIVDGHTSGLAARVAGTVIAVYVEENQFVKAGQVVVDLDPRDYEAAVASARGQLQQAQAQQQAELPSVPVTRVTSQTNIANAGSSIASAEAGVAAAQRNYEAALDRVREAQATAAKAQSDVDRYRPLAEKDEVPREQFDQVVATATSSAAAVAANQAGAQAALKQVDQARAQLAQARQTAGEVANNAPRQIAIQQANVRSRAGSAQMSRAQLEQALLNLSYCKIQTPVSGIVARRVAEIGQHVAPGQEVLLVTRLDDLWVTANFRETQIRRMVAGQSARIHVDALAQDFDGYVESMPAASGSITSLLPPENATGNFIKVVQRLPVRIRFKQGQNGLDRLRPGMSVEPKVRVR
>fig|234267.9.peg.2506 Outer membrane component of tripartite multidrug resistance system
MRWHTLFFLIILSTPSAGQIGAPQSPGQLPRAQPVPLSGKPQIGSVVPQQTPTPGATNSVNTINPSVQVQGAYQGSVPAGTSTSTPLALSLEDAVKRGIQYNLGSVTASDATRQARALRLAALAELLPDLTGNVRETVQQIDLAITGLRLNLPLPGFRFPAIVGPFNYFDTRANFTESLSVTGVRNWQASRENLSSSEFNIQDSRDLVAFAVAGTYLQILASAARILTANAQIETSRAVYTQAVDRNRSGLIAHIDVSRSLVELQTQQQRLTSLTNDFEKQKLTLARLIGLPMAQPFTLSDAIPYREMPPVDIAALIHTAISARHDVQAAAAQVKAAELSRKAAVAEHLPFLDVAADYGITGINPSQSHGTFAVTGSVRFPIYRSGRIRADIEQADAALSQRRAEYEDTKARAEQDVRNAVLDLNAASQQVRVAESNRGLAAETLQQSRDRFRAGVTDTVELVQAQESVATAEQDFISALFAFNLARVALARATAQTEQGVTRLLRER
>fig|234267.9.peg.3505 Permease of the drug/metabolite transporter (DMT) superfamily
MGGEKKQAPPRVVYGWLALLLMLWSSNFIFARFALRELPLGVVLGFRYVFSAALMLPVIALGGGQSRVKHPWNWHDLPGLLTIGLLGLVGNQALFVVGISMTSVAHAGVITALSPVLVLLGSAALGHERISGARIVGLLTAACGVVVLQFSRGAAGAATLKGDAVMLASVVVFAGFNLAAKPYAERAGTVRVNAIAYFAAGLLALPLALWSLSRGAHGSLLAWCGVAYMAAGSSVAGYLIYAYALRHLAASRVSVVVYLQPIVVTLLAIVALGERPGAGFLPAVGLVLAGVWVVERRG
>fig|234267.9.peg.3637 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MQSSYSGKSKMAAAPHTGEAGRIIAAPTGPLIVAAANAGDDAPELSVVVPTLNESENIVDFLAAVRRTLDASLPGRYEVIVVDDDSADGTGTIAASLMCGFPELRVVRRQNEGGLAVAVIRGWQVARGKMLGTINADFQHPPDVLGRLLEREAGADLLVATRHSDGGGLGDWGLTRRITSWGAAQIGKWLLPEVYARVSDPLSGCYLVRRSAIAGAVLRPLGYKSLMEILVRGNVREIHECGYEMRKRERGQSKVHVLHPLQYLRHVMRLRAAARERGR
>fig|234267.9.peg.3861 Multiple antibiotic resistance protein MarC
MIAEEAFGELTKTTLLIVGALFPIVNPIGNTPIFLSLTHGLSSQGRTVLARMIAINGLILILASIFIGTHILAFFGISLPVVQVGGGMVVIATGWTLLRQPNDDGSGDSGARDECHEADYKRQAFYPLTLPLTVGPGSISVAITVGANRPEGAEWRWPLIGGMLLGSALIAVSIYLSYRFAERLAQTLGDSAMNVMIRLSSFILLCIGVQILWNGLSALLRTVVH
>fig|234267.9.peg.5700 Daunorubicin resistance ATP-binding protein drrA
MQPHEPIIETRDLTRRFGQLTAVDHLNLSVARGEIFGLVGPDGAGKTTTLRMLCGLMEPSEGSARVAGHDASRESQAVKDQIGYMAQRFGLYQDLTVEENMVFYADLFDITGPRRDELTAQLLRMTRMEPFRARQAGRLSGGMKQKLALMCTLLHRPQVLFLDEPTNGVDPVSRRDFWTILYQLLKDGITIFMTTAYLDEAERCNRIGLMNKGRLIRCSTPEVMKAETGSATLEGAFIKTIHEVEGVARS
>fig|234267.9.peg.5701 Daunorubicin resistance ATP-binding protein drrA
MNSVEIHDLVKTFGSFVAVDHVSMEVEKGEIFGFLGPNGAGKSTTIRMLCGLLTPTSGRALVNGFDVASQPEEIRRTIGYMSQKFSLYDDLTVEENIDFFTGIYGVPQARRTERKDYVLEMANLTDRRAAMTRTLSGGWKQRLALGCAILHEPAVLFLDEPTSGVDPLARGAFWHLIHDLSEAGHTVFVSTHYMDEAEYCHRLALMYRGKVIALGTPAELKSGLKDQSLLNLESSDPLATMRALEGVAGVHDVAVFGGGLHITVDNAETGAARIRERLAASGIEVRKLEPIQPSMEDVFVAMIEAEERKAA
>fig|234267.9.peg.6014 Membrane fusion component of tripartite multidrug resistance system
MADTLVETPKTETPPPRIVRKPKRHRGALIAMLVLLPLLVGGYFLWKYLGTYESTDDAQIDGHIHAISARISGHISQVLVEDQQIVKAGDVLVVIDPRDYDVAVAKAEADVADARAALTGSQTEIPITSTNTASTLQTAQSTLADSRAGLLSAQRQLSAAESRLAAAEAQVTEAQANYKKAADDERRYKQLVDKEEISQQLYEQAAQAAAAAKATVDTRIASVNEARHNVAVAEAAIQQAQAKVPQAEASIQSALTAPQQVAISRSKAKSSEAKLAQQAALLAQARLNQSYTTIVAPAAGIIGKKTVEVGQNVSPGQQLMAIVQLDDVWVIANFKETQLRRMQPGQRVRFSVDAYSREYQGRITGIGGASGSRFSLLPPENATGNYVKVVQRIPVRIDLDPGQNADHHLRPGMSVDPKVFLR
>fig|234267.9.peg.6015 Outer membrane component of tripartite multidrug resistance system
MPRTSLPRAKKLLKMDDSQPGDRRALPHFEIGMGPARIGCHVQCTHRRAVSSTPLFVCLALLFSSVLAAQENSPFQGSVPTGNATTTPLGLKLDDAIQRGLRANLGLLERGTASQAARAERIRALSALYPQVTGSVGETVQQLNLKTLGFGTLGIPGLSGLPSIAGPFSYSTAQANVSATVFDWSKRKNLSSARDTEEASKLSIQDARDLVVQAVAYAYLQIIADNSRVESIQAQVTTAEAIYNRAVDQKKAGVAPAIDVLRAQVEFKTQQQRLLVEQNQFAKDKLTLGRVIGLPPGQPFYIADATPFTPFSGLTLDQALRTAVAQRADYQSARKLFLAADDALKAARAEWYPTVDLNGYYGVTGPTPGNSHGVFLVTGALNFNIFNGGRIHGDIEQARAAKQQRADELADLGGQIEVQVRTAFLDIQSAADQVAVAQSNVELAAQTLQQARDRFASGVADTIEVVQAQESVATASDNLISASYAHNLAKASLARALGLAEQGIKKLIEVK
>fig|234267.9.peg.6125 Permeases of the drug/metabolite transporter (DMT) superfamily
MILLDLSSHSGTEATRLRWKTWICVVVVVFSNAFGDFFMKRGLPESARLATPLDYIATLFQPWVALGVGLLILWQLSRMALLSWADLSYVLPVTSVGYVVVALIGKLLLSEAITPRRWAGIVLIMAGVALVSIGSPSTVEAAVDADRVVGK
>fig|234267.9.peg.6126 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MKWLLVAMMVGATTAGEVLQAAGMRRHGEIRDFRPGALGRAAAMLARNRFVIGSAVCMAISFFAFMKLLSVTELSFAVPVSAVSYVMETVLAKYVLKEQVSRRRWAGALLVIGGVVLVST
>fig|234267.9.peg.6633 Chloramphenicol resistance protein
MSLTRDGRLLFCTRFLRLFSYGALSVVLVFYLTGLGLSQQQTGLLFTLTLLGDTAISLALTTQADRIGRRKMLIAGAALMAGAGLAFALTRNPLLLVIAGTIGVISPSGNEVGPFLPIEQAALSQVIPSRDRTSVFAWYALTGAVATAAGSLFAGFFTQSLQSARMTPIASQRAILYLYAAMGLLLGILFTRLSATSEIARDPDRPAIATLLGIGASRPVVLRLSALFALDAFGGGFVVQSFAAWWFYLRFGVQPATLGGIFFGANLFAGISALLASRIAARIGLVRTMVFTHLPSNILLILVPLMPTLPLAILVLLLRFSISQMDVPTRQSYTMAVVAPEERSAAAGITGVARTTGAAFAPLFAGLLFAHPATISVPFFLAGTLKILYDILLYRAFVNLPPMDGLR
>fig|234267.9.peg.7509 Membrane fusion component of tripartite multidrug resistance system
MANVVDDLPKAESRKVEAAPTVAAPRKSPVKYIVLGMVAIGAAVGAWAWFHFRDQVSSDDAQVDAHIVAIAPKISGNVTEVLVRDNQQVKAGEVLVRIDPRDYQARVNAARAALLQAESQVVTSRTMVPMTNESTQSGVSGAAAQVSDAMAELDRARLNYEQAASSDIAEAEAKVRSKQASNDRAQADLARMKPLLDKAEISRLQYDAYQAQARVAESELNAAQEQLKSAQNNANMRKAAVAAAQSRVNMAQSQVQASMANRKQVDVRRAETGTASAGVEAARANLAAAELMLSYTTIVAPSDGVVTRKSVEPGQIVQPGQSLMTLIQLQDVWVTANFKETQLAQVRAGQKAEIHVDMYGKSVAGHVDSIAGATGSRLSLLPAENATGNFVKVVQRIPVKILVDNTNGLVLRPGMNVDATIFVN
>fig|234267.9.peg.7511 Outer membrane component of tripartite multidrug resistance system
MKLRIAIAVALAGSAFGQQPAPLKLTLHDAVQLALKQNPQVILANLDVQQSQEDRNLARSALLPQVHGAASETVSRVNLEAAIGFRFPGFSQHVGPYRYEQAGVNLQAPVFDLTLWRRYRASVVGIETSRIQELGVREESVLLVVSQYLGSQRAAADVQAAQSRVDLAQALYDQAADLQKNGVGTGIDTLRANVQLQNEKQRQIVARTQLETSLFGLARLLNIDPRTRVELADQVSFFDTPTIDVNQTLEQAWQVRPELRQVLSQEQRAELDLQGATDARLPRVAVNGFWSQQGLNSSTAIPVYTYQATVEVPIFTGGRIQADRAKAEITIRQLKQQEQEVRNRIALEVKNAIAQLASARNEVDVANLGIQLARQEVDQSRDRFQAGVTNNVEVIQAQDSFARASDNQIAALYRYNQSRADLAHSIGQMEALYAR
>fig|234826.3.peg.243 Bicyclomycin resistance protein
MLLSSLAFILAVLSVVLVDITNAMYANYLTQVGAFFGAEQTVTQFTVSCEMLGYSTSGLIYGPMSDRHGRRPVMLFGMAVFLITGLWCYFANSITVLIIARFFHGVGAGVSAVVGYAIICDTYSSEECSKRISLMYMCAVTGSAFIAPGMSSYMIEHGYGWRTVFVVSIVLSAALLSWLVCKLPETISERRAGCNPITIVSGYVALLRNRRFLAYCFIKVLTMTYTLASVGTLPFVFIEGMGLQAKYYGYVAAIGGVSFIAGTMANVKLVGRFGMRRMIAVGLVLTVASDVAAIMADYYFALTPVLVEAIWIPSSFCISLIASNGAVLAFREVSNKGAASAFIIFCQTVFGVVGMYVVGKFYNGTIVPICLLTFTCCGISSVILCVCTPRSEA
>fig|235279.1.peg.167 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSAVSVNDKVDMRKDSIYKLFFYFFIPNLCAMLALSTYSTIDGIFVGKKLGENALAAIGLCWPIFPALIAFELLFGLGAASIASYFLGKGQDNRARLMFSSVFYFATLSSVIIGVILFFCVEKVALALGANELVLPYVVEYLQVIFLSAVIMVLHPLLDIFVINDKRPILAMMAMIIGSASNIVLNYIFLFVLELGMFGSALATAMGHGLGMMILLSHFVRKRGRIYFVWRFSLNAVFASAKNGVPQSISELSVAFVMIMFNHTLKALAESEEMKVSYLAIYSIVMYVGVVCFTILLSCAQGVQPVASYNYGAGEMKRVRGIYAFGVGFATALGILVYAVFMSIDSMLVKLFLKSGQEMILEPTLEAMKVYFIGYIFLGFNIVSAIFFQSIQRPKSSFLITLSYNLIFVSILLFVLSYYYGVFGVWLSYPLSLVCSSIVVIGVIFYESRYGVLGKKVS
>fig|235279.1.peg.684 Multidrug resistance protein (msbA)
MRTILEFFKKFFPYIKGHKLSFAIAIIASLVVGLCTAGTAYLIDPLLDTLSGKVPRANPFFSFDELAQNNTLTFAMMFMIIGTYLGKSLGTYVQAYFMNFIGQDIVRQVRDRMLRHMLSLEMVFFNKMRNGELMARITNDIGIIRSAVSNYITEFIRESITIIGLVAIVIYQSPKYALIGLVIVPLALIPINLIIKKLKKYSRNIMEKNADITAKLHEIFNNIEVIKASNGERLELKKFKLQNLTFLKISMKAVRVGELITPLMELLGAIMLALVVYMAIIDISKGELSVAQFSSFAGALLFIYTPLKRLVNLYGQMQSAIVASDRIFEILNQTQQIRDGGIQLQAPINEIIFKDVHFRYNEETHALKGISMCFAKNKITALVGKSGSGKSSIINLLLRLYEADSGEVLINSQNIKNYTQKSVRNNMAVVTQRIFIFNDSILHNVAYGSKIDEKKVIEALKFAHAWDFVQEMPQGIHTILDEFGSNLSGGQRQRIAIARAIYKNPEVLILDEATSALDSQTEEAIKESIEHLRHNKIIIIVAHRPSTIELADEVLHLQLGQIIKQETRSKK
>fig|235279.1.peg.1464 Drug resistance transporter, EmrB/QacA subfamily
MNLILFTILLAVFVVPSSISGTAIALPYIAEDIGSDTTLLQWVVNSFNLFFACFTLIWGAISDRLGAKTCLIAGVATYLLGSILSFLAPSLLWLDVGRALAGIGGASVFACGSAILIRTFEDKERVKAFAFFGTTAGLGITLGPTLSGFLIDLFAWRAIFVFHFLTLGVVLLLSPMLPKDPQKQQKAFKFDKMGALLFIAFMSSFMLFITKIHAFKEPQTLGILAFCLIVGIVFGVHQRSLHYKNITPNPTLHIPQPLLDFEVLKNASFFGFSLVAVIAGFSFVVLLTYFPTFLSINFGFSASFSGLFMLSLTTPMLFCPILAGKMLNKGVDSKALALAMSLMMSLGIFALLIILHTLSGVTLQLMTLLVLFVIGCGMGLHAGAIDGLALGSVESAKSGLGAGVLNSLRLGSEAVGVSLYGALMVVFITANLSYLLDSEDSVYPIVESIASGNLSAVENPLISANAPSIYLQSFSYTLGILGLISLALSLGVWRLLGRVK
>fig|235909.3.peg.1858 Multidrug resistance protein B
MNWKRSVRVLWLCNFMVSAGMTMVIPFLSLFLWQMGVTEHHALSIWTGLVFSVTFLSAAVMAPIWGVFADKYGQRANLIRAGIGMGLITGCMAFAASPMTLLALRFLVGFFSGFITVSFSYLARVVPRDHSGEALGTLQTGSIAGNIIGPLIGGALSDLFGFRPVFLVTGLCILLTLLPVIFWLEKDPVVPQTKENKASFKEVFRHRPLIVLFIATFLVQIAVLGVNSMMTIFVQSLIGHSSNLAFLSGLASSITGIATIIGAPYLGKLGDRIGQEKTLPILLVLSGLFALPQVWTDNIYELYVWRFLQGLVVGGVWPSIQALINAQSPRRIQGRVFGVTASSRFLGNLTGPTAAGAIAGFFSISSIFVLSGLLLIATGALVGYATHDRAWREEMKEKIAAWTHRLHSRY
>fig|235909.3.peg.3243 Drug resistance transporter, EmrB/QacA family
MEKALTVPASTIRHRPLLITGLIIAMLFAALDGTIVGTAMPRIVGELHGLGIMTWLTTAYMLTSTTVVPIAGKLADLLGRRIVYVSGLVIFMAGSALCGMANDMTELIIYRGIQGLGGGIMMPMAMIVIGDVFTGKERAKWQGVFGGLYGLASVLGPQIGGFIVDHLNWRWVFYINLPVGILATVLIAMGLSKYKAEGPVKFDIAGMATLTAGVVSLLLGLTFGGDRYPWGSWQIVSLFAAAVVFFALFVWAEKRAEEPIIPLRLFRNRTFTLLNGIGFFMSVGMFGAIMFVPFFMQGIVGVSATQSGTIMTPMMITMIIGSVLGGRLVYRIGVKPQLIIGMAVMASAFGLLGTMDVETSKWTATMYMIILGLGTGLVMPILTLALQESFPKSELGVVTSSSQFFRSIGGTFGMTVLGAIMNHRSSALLDERLMPKLEALPAQAKGLVDRFAGMIHDDPQGLYSVLLSPEAMAKIPALLRDMFVPVLKQSLVDSLQSVFLFGLVFIAVGLLLVFGLKRITLSDRTEAMKQLKQAEEKA
>fig|235909.3.peg.3319 Permeases of the drug/metabolite transporter (DMT) superfamily
MRKSFIYALLVAIMVAWGLNVTALKILVEHFSPVALTALRILTAGLVVLLFLWGIGKLQKVSWNEAKQIGLAALFSVVAHHFFLALGLARTTAVNAGLVLGMVPLVTALLAIVFLGQRPTLFRLLGIALGFFGVVFVVANGDGGLGHLSIGDVYIFLAVLAQGISFIMIKKATVEARVMTGWMLVFGSLWLFVLSLVLEPSGLSSLKEGTLPLWLIFLASAVVATALGHMFYNQAVQHLGPAESAVFINLNPLFSLLGAHWLLGEPISWMQLAGFLFIVAGVMFGSGGMDDVIARFRRAKAVEGGRKAGM
>fig|237727.3.peg.984 Tetracycline resistance protein, class A
MSEHAAQPHANTTTLFFVALIVFIDMVGIGLIVPVLPGLLEEVTGETLDQTAQIGGWLLFAYAVMQFTFAPIIGGLSDRFGRRPVLLFTLFMLGVDYAIMAWAPTLFWLFVGRILSGIMGASWAAANSAIADVAEPEERGKFFGIMGAAGAAGFVIGPGIGGLLGSIDVRLPFIAASLLAIGGAIAGYWLLKETLPSGRRRGFSITRANPLGTLIQMARHPVVFGFLTVIFFMQMAAQSHQSVWAYHTELVFGWSTLQIGLSVALYGVMVAVTQGGLTGMIIARIGAARTVLIGFIISLPANLMFAFAPAGYFMIIGIVIGSLGAMAFPAIQQMMSERIADDAQGELQGAVASTMSITSIIGPLIMTRAFGTFADSEGLYFPGAPYLLAALFGATALGIAAWNISRIKAAPDPAET
>fig|237727.3.peg.1712 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNANGPRVTGLGGVFYVAADPEATRAWYREKLGVDGEYGPQFAWADEPKTNPYSLISNFKDDEYIKPGKGGFMINLRVHDLDGFVEGLKAKDVHVLDTADEGYGKFAWILDPNGVKIELWEQVAEELP
>fig|237727.3.peg.2091 Drug resistance transporter, Bcr/CflA family
MRKEQWSSGEPQGKGAAMATAAPISAPTKRLGETEMIWMMALLMALQAFGIDAILPALDELAVSLSVQGNDRQFVVGVYLLTAGIGALIPGALADRFGRRPILLGSIAVYIVLSIASALVTTYEALIAVRAAQGFFGAGIVALPPAIIRDRVGGDKMARMMSLIFVIFLMVPAIAPSIGEVILLIGDWRMIFGAMALQGLIIGAWVYFRLPESLTEENRQEIRPRVIGGNMLRAVSMPSIIGYVIGSSLVFGALFGFINSSQQLISESFGAPDLFPIIFGICAGSMAFASWSNSRIVERFGARRVSHTALLTFIFVASLQVYFAFQPNETLWQFVPLMAINMMLLGFIGSNFGSIAMNPFFDIAGAASSVHGFIRLTVAALLGAAVGYAYDGTPQPLALSLLAAGLACLALVLFSEKGKLFGPPEPEMGLGAKEA
>fig|237727.3.peg.2536 Permease of the drug/metabolite transporter (DMT) superfamily
MGHPRGSRGRAGQGHRQLVSAATPQVLNWRVIVPFVLTGTIWGSTWLVITGQIDGVPAAWSVFYRFLLATPALFLVAFFMKRRLKLTGPEHRLALLVGIFQFSGNFLFVYHAELYVTSGIVALMFGLMMVPNALLARAFLGEKVQGGFMLGSAIAIVGVSFLLIHEWTSNPNAGVIGGNVGLGIILALLGILAASVANVIQANPTGRAVPMVSLLAWAMLYGTIFDLGFALLTAGPPPLPTNPNYWAGIVYLALIGSVITFPLHYNLVREIGAGRTAYNAILTISVAMLLSTVFEDYRWTSLTITGMGLAVIGMVLALRSKQRR
>fig|237727.3.peg.3231 Multidrug resistance protein
MADADPSRDSIPRTENASASGAISNGRMALLFTVMLVTAAGNTAMQSVMPSIGTALEVSDVWISLAFSWSALLWVVCAPIWARRSDRRGRKAMMSLGLVGFVASMVICGMVLWAGLAGWLGAFATLILFAAARSLYGGFGSAAPPAVQAYVASRTPRAERTNALSLIASSFGLGTVIGPALAPLMVLPFMGLGLTGPFIGFALLGIVVLVLLHLQLPNDQPQFAARGMATSYSGPSETLSEEELEDEAETGGVTGEMVGEPPRLKWTDPRIRAWIIAQLLGGHAQAMVLGITGFLVLDRLALRDTPAEGAGPVGLVLMAGAIASLLAQWGIIPRFNLGPRAATLAGVLTAALGTALLAAGTQLHVIALGYAIASLGFGLFRPGTTAGTSLAVTRAEQGQASGVVASLAGFSYIYAPALGVWLYGYSDWGAFGLIIALCLAVAVHGWRGLQADEDLTTERR
>fig|240015.3.peg.272 Permease of the drug/metabolite transporter (DMT) superfamily
MIKSALADISPLLFNLIRMTIASACLLAIYGRRLRRLRWATLGAGALTGLCLAAGYQFQTAGLRLTTPSKSAFLTGLVVVLVPLLAGIPGLRPPGASLPKWNAWLGVVAAFVGIVLLTAPQGSGWSILMLREINPGDLLTLACALGFSLHVIALAHFSPRFDFEQLAILQIVFCTLAMGVTTPLLEKCWVHWTPRVVIALVVAAVLATAAAFTVQAWAQQILPATHTALILALEPVFAWVTAFLVLRTGLHGREIVGALLILAGIGVTELMPSRMQPTMPEMPSI
>fig|240015.3.peg.566 Glyoxalase/bleomycin resistance protein/dioxygenase
MLSSSRLTAFLTVPDAALARNFYRDTLGLTLTHEDRFALAFDANGTPLRVAIFPDFKPQPFTVLGWQVPDAVVMSRQMQSAGIAFERFDGLAQDEHGLWNAPGGSRVGWFRDPFGNLLSIHDAAAAMAI
>fig|240015.3.peg.1259 Multidrug resistance protein B
MPAKQIRPVLGIFAVLLGASLATFFGRLLSVGTADLRGPLGLSADASSWLGTAYNMGMMFIGPFSVYLGGVLGPRRVLLWCACIFTLATFFMPFAGHLSWLITLLAIAGLTAGSFYPLTLSFILRNLPQKYMLYGIAAYAIDIVVTTHVADSYEAWVMRDLSWCWLFWSITAATPFMVWLVQSGIPTQPIPRSAPRQPRISWRGFLYASLGAALVFGALDQGQRLDWWHSGTFAAMALSGSFLILAAVVRHFCQPHPLVNFPFLRRRNTLLLGLTVMVFRFVLLASVVLVPGYLSAIKGYRPDQVGPVLLWLAIPQFLAGIFAVYLLGKVDTRLVLAAGFSLIALGSLMDSHLTTAWAGNTFTVSQLVLAMGEGLAFNSMVGAIILDILNSGSLNKPADVLTFAGFFQTIRLFGGEVGATFIRHFLHVREVFHYNLLASGVQGGSAPLLARERALLPVMQSRALTQNALAGRSVELLVVSVRQQAFTLSLADSFTLIATVAAGCLLIAASLRALKLGFPQIIATPGAGKSTT
>fig|240015.3.peg.1260 Acriflavine resistance protein a precursor
MKKWSFVIPVAVLATAAFLILAIRGHWTSWQSDAVVQKTDDAYVTANQIPLSTRISGTVKAVDVHDYQGVRAGEPLIVLDDADYQAVVSEAQAAIAAAQAELAANQAAKHAADAQVQSAASGIAQAQAAARAAQDAIAAAQAQADDAASEYRRVHALYANQAATQEQYDHALAARESTQAALQAKQAQAAQAQAAIASGETARAAALEQRAGLNAKDRALEAQIAAKKAQLIVAQVNLSYATISAPASGRIGKLQVHPGQLIGAGVEVVDFVPHDPWVEANYQETQLRRIRVSDRADVHIDAFPGRTFHGHVQEIAPASGAATALLPPDNATGNFTKVVQRIPVKIVLDDLPPGDLLRPGLSAEVAIHTNDVQRAAQTAATSN
>fig|240015.3.peg.1290 Acriflavin resistance periplasmic protein
MSGSLHFNNFINCKQEAFIVMTERNRRSMSRISSALLTPIVGAALLPLLVAGCSGKKQAAANPHAMGPFPVTVMAVQQKNVPIYGDWIGNLAGYVTANIQPQVSGYLIRQDYKEGSPVHKGQVLFQIDPRPFQATLDQAKGQLAQVQAQLQLANINVNRDSPLAKAHAIAQSTLDNDLQQQAAEKAALESAKASVETAQINLGFTKVRSLIDGIAGLAATQVGALVSPTTTLTTVSQVNPIKVYFSISEQEYLALSTSVRAMGKADLLDSGNAVPLQLTLANGQVYPHEGRIIFVDRAVNPQTGTILIAGSFANPRGLLRPGQFGHIKAETHIAENALLIPQQALNQLQGNYVVAVVGSDHKIHMTPVQLGPEVGNMQVINKGLQPGDLVVIQGIEKLRDGMPVVPHQVSAPAPDTDGAQSTEGN
>fig|240015.3.peg.1350 Multidrug resistance protein B
MLAQMDATVVNVSLSQLAADLHASLQWIQWVTSGYLLALALTLPLNGWLVERLGAKRVYLLCFTGFTLSSALCAMSWSANSLIGFRILQGMSGGLMAPMAQLMIAKAAGKQMARVAGYAIVPVLLGPVAGPVLAGTVLQYATWHWLFLINVPIGVLGIVLAILFLPRDGHEERSSRKLDIGGLLLLSPALVLLLYGMEHLNEHAGLAAFGLSLALLAGFFYKARRDGERALLDLKLFRRRVFATAAITQFTGNGLLFAVQMLVPVYLMRGAGESPSMTGWLMAPMGMGMMITSPLVGRLTQRYGIRGTSSRGAMLALVSTLMLIYLSIERLNPWLVGMVLFLRGMGTSAVGIPSMSAAYASVPRAELPMATTSMNIVQRLGGPTLTTLCAGFLGWRLGGAQIGAGRPGAFPESFALLCGLQLLLWLATLRLPRDMEEAEESKKTAAAA
>fig|240015.3.peg.1899 Inner membrane component of tripartite multidrug resistance system
MSQSSVAPRPAAAASDQDFHYEHWTPRFNPWVITFTVTLATFMEALDSSIANVALPHIAGSLGASQDEATWVLTSYLVSNAIVLPISGWISNRIGRKRFYMACVAAFTLFSFFCGLAPTLTWLVIFRVIQGAAGGGLQPSERAILADTFAPEKRSLAFSLYGMAVVLAPAIGPTIGGWITDNYTWRWIFFLNIPVGILSLLLTSRIVEDPPYLKRQLARLKESVDGIGLGLLALCIGAAQIVFDKGQQDDWFGSHFIVGCTIVAVVCLVLFLYRESTVEHPIVDLKLYRTRNFAMTQIVMLLIGAALYSTTVMIPQFLQVLMGYTATQAGLALSIGGVVLMILFPIMGFLGQKMDPRLMITLGFAVLTFGIWRISDLNLNISFGTALSWRAVMVLGMPMLFVPISVMSYVGIPQEKNNEVSGLTALARNIGGSVGISFVTTLITRRTQVHENYLAAQVNPSSAQYQSLAQGMQGFLAQAGAGTGNAAHAAAAQIYNIMKQQAAALAYVDTVHVLVLLTACLIPIGYLMKKPRYRKRS
>fig|240015.3.peg.1922 Permease of the drug/metabolite transporter (DMT) superfamily
MTRVLGYGACALAGCLWGTGFYFGKIALTELPVGHMVLYRFLFACVGLLPVVRWPRFTRRAWAWLLTASFVGIPVQFLVQFYGLSMTTVSHASLMVGTMPVILAVGAWLFAGEKLDWKGWLALAGSTTGVALIVLGGRHGAAGGKGPSLAGDLLVVLAMVFALGWILVNQKLMREGHSPLSVTVWGLLTGTAMLAVWVVWRQGMPPVHGLSGQVWFALAASGLACTAATTLLWNWGMHRVPASRAGVFLNIEPALGSILGVELLGDRLGPGAWLGGALIITAAVVLTMTGHVEPDSVLE
>fig|240015.3.peg.2125 Permease of the drug/metabolite transporter (DMT) superfamily
MPSSSSHAGPARLAVLLAFGSVYFFWGATYTAMSIGVHLLPAPILAGTRMLIGAALMLLFCKLRGKKIFYSRGVMARLGLLGVMLLFMGNVGLVWSEKYLASGLAALIVAIVPLYVAVIEAVTGGEQLRRRGLFGLFLGFLALIALLWPSFHEALLPRHGSSMQIIAAIIVLLGALSFASGSVLSRHMQLPVPPLVAAGWEMGAAGLANVVLATATWQWPHATWNWHSLAAIGYLILFGSLLGFSCYIWLIHHVPVAKVATYAYVNPVVAVILGVLVLHEHMQPTEYFGMVAVIASVALVTSSQMKSGKPAAAPAPVENEA
>fig|240015.3.peg.2816 Inner membrane component of tripartite multidrug resistance system
MAATATLLPETLAPKKLAARAAINPWVIALTVTLATFMELLDTSIANVSLPYIAGGLGRSYDEVTWILTTYLVANAVVLPMSAWLSRVFGRKTYYMACVALFTVTSFFCGIAPSLNVILIARILQGIGGGGLAPVEQAILVDTFPANKRASAFALYTVAIVTAPAIGPVLGGWITDNFSWRWVFFINIPIGLLSLFLTNRFVHDPPQFQEERRSARIAGKLRIDGVGIALIGIGSAALEVTLDRGQIDDWFGSTFICWALSIAITCLVAAIVWELRQKDPIIDLHLLRSRNFAIASFLYFLFGFGLFGSTTMIPQLLQSLYGYRATDAGLVLGPGAFVITMLAPVGAQLVQRGIVAARTLLFFALITVGLSFLYYSHFNLATDYDHYAWARALQGLGYAFFFVPLSVITYSQLRPDQNNRASSITNFFRNWGGSFGVAFITTMTERRQNFHQAVLGASLTGPSLWLQQAVHRMAGYLAARGLSPGDALHYANAIYYQRLEDQARLLAFMDCFHVMGILTLIAAPLVLLTRSFRAGGKAPEGH
>fig|240015.3.peg.3307 Membrane fusion component of tripartite multidrug resistance system
MADQNPEQKNTPADEQQLDKPENLRPKSRKRFILFGVIAIVLIGGGLYWWHSTFYENTDDAQIDGNIIQISSRISGHVLNVEVQQNQSVKKGEILVELDPTDYETAVKQDEADLASAEANYEAATVNVPITHVSTSSTLSSADATVLSARDSVAQAERQLQAARAQVLSAQANYTKAKLDLKRYTSLVQKDVISRQQYDAAVATATADQAAVQQAEADVQAYQAAVSVAHAKVAQAQASYRNAQTGPRQVAIQKAKADQAAAQVKLAEAKLQQAKLNLSYCIIRAPESGIVTTKSVEVGQNVSIGQNMATLVSLDNVWVTANFKETQLDNMKVGQPVTISVDAYGGKQFDGKVTEIGGATGSMLSLFPPENATGNYVKVVQRIPVRIDFTNPSQDKDHMLRPGMSVEPKVRIK
>fig|240016.6.peg.509 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTPEKNPALNGAVLPTFFYYAVPSMVGLIALTTTSLVDGIFVGNYVGADALAAVTLLVPLLTVLYALALMFAIGGSVGAGTHMGAKDPGTASSVFSQTLIATVATTTLFTLASIVFEPWLFRLLNIPTELVPMVGEYFGILRWTLIIQLTTMVLYYFVRADGHPILATISLLVGSLGNIGLDVFFVCQWGWGLAGAAWSTAIAQVAQAAVLCIYFFSRRRTLHFIWRQTRWSHLFKACYNGVSEFINEISAGIIIWLLNFLLIGRLGVDGVAAFSVVSYYIYLSLMLTYGVADALHLLVSQNFGAGNHQRIRQFLSTALIGSSGIGLSLAVSLLLFGDQLTGWFLSGEDAAIVEEASRLAFAIWPLFLVNGVNVILSCYLTAIHRPTPSAIVAILRGLILPACFLLGLAHLFDQAALRDSSSQWSFLWALPLAEWITFAVAIAFCYRHRPDRFEPAFPIQPVED
>fig|240016.6.peg.637 Permease of the drug/metabolite transporter (DMT) superfamily
MAPSSSSAGTASSPTLSASPSLTEAAARPPLLLILLAFAAVYLIWGSTYLGIRLATDTMPPFLMAGSRFVLAGAFLYGVLRWRGEAKPPTVAWKDAAIIGGLLLLGGNGGVSWAQQYVPTGVSALIVASVPLWIVVTDWLRPGGTRPRATVMIGLALGFFGVVLMVLGKDSKGHPVVIPLGAAVLVLSTITWALGSIYSRHAKLPGSALMGISMQMMAGGGLQLLVGTLLGELPRLRFDLISATSAWAFVYLTLIGSLVGFTAYVWLMRTCSPALVSTYAYVNPLVAVALGSLVLKEPVPHAMATAGGLILAAVVLITLTSKRRAKGGDATQAGGDSLRSSG
>fig|240016.6.peg.2365 Permease of the drug/metabolite transporter (DMT) superfamily
MSRSFKSSLVTFLIVAGSSLFFCSKAVFVKLAYRYGLDAVTTLALRMAMAFPFFLIGGIWASSGKQVHPLTSRDWARLALLGFCGWYFSSVINFMGLEHVSVGLERMILYTYPSIVLLGSVIVLRKPLRWGVAGAMLLSYLGILIGYYGEASAKTGGETWLGALLVFGSAISYAIFVLMSGEMIARIGPIRFTSCVVGFSCLYVLIHFVLTHPPGAILKLPPGAYGCGVALAIAGTVIPSYLFGIGLKRAGAQAFAVIGMIGPLGTVGLAWMLLGEAINPVQVLGLALTLAGGAMVAVRK
>fig|240016.6.peg.2401 Outer membrane component of tripartite multidrug resistance system
MNCLPPQAVAPLLLLAFAGGLVGCVGSNPDRAQSELKVPGKWKGAARSGFPQRPLNTAALPKWWERFHDPVLNQLVSTALQNSTDIRTAVSKVRESRARRGVQAAGLFPTVDAGFSARGERTDNRNTGVSSSENYGASIDMTWEVDLFGKQRQNIKAATEDLREAGENLYAAQVSLAAEVADTYVSLRQAEAQLAVVERTLASRTETTQIARWKEEAKITGSVDTQQAISTLEQARAQVPSLKQTISQTQNQLSLLASLPPGALDKLLARSDKMPSPPARIAIGIPADTLRQRPDIRAAERRVDAAVARTKSAVAERYPDLSLSGSIGVDALKAGRIFSPENVAASIAGSLAAPIFDAGRIRQDINIQSELESQALIGWEATVLTSLSEVENALIGIQRTAERLVILEQALKAARQAEELSTQQYEAGLVDLLVVLEAQRTLLSLEDQEVTTRANQASAHIQLYKALGGGWSS
>fig|240016.6.peg.3293 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTPYRPEGFSAITPYLIAPDAARLIQFLVEAFDAKEKILVHDDAGKVRHAGFQIGDSHIELADGNPQWKPMAAGLHLYVQDTDAAYLKAIAAGGTSLYEPTDMHYGERSGGVMDPAGNHWYIATLLPS
>fig|240016.6.peg.3327 Acriflavin resistance protein
MQWLAAISVKRPVFATVLVLVFVVVGALGYTRLPVDRFPKVDFPTVSVVTRLDGATPKEIETEITDKIEEAVNTVSGIDELRSVSTEGISQVLVAFNLDKKVDVAAQEVRDRVNRILPNLPEDVDTPIVEKLDPDAEPIMSISLVAEKPVREISELADKVVRRQLESVAGVGQVTLLGARKRQINIWMDPVRLKAFDLAAVDVERALRQQNVQIPSGNVKGNGVEAGLRVLGKAQSVDDIGRIVVREKDGGLVRLADVARVEDGAEDLQTVARRNGQPTVTLSIRKQSGENTIAVVDAVKERLEEIRPTLPEGYKIEIVRDNSLIIRTSTHAVKEHLVLGSIFAALIVLFFLGNGRATLISALAIPTSIIASFGVMWVGNVTLNSISLVALALAVGIVIDDAIIVVENIFRHLHEKNESPHDAAINGTKEIGLAVMATTLSLLAVFIPVAFLSGIVGKFLSSFGLTMAFAIAVSLLVSFTLAPSMSARMLKITKPNWIERGMTYLVNIFYTPLEGLYMWMLRLSMRHRWIVVLACVGALYSVGPMMGKVQKALLPPAEEAEFLVNLRTAEGTTLEATDLVAERVARDIRTIPGVEYTLLTIGDNDQRTPNKAGIYVRLIDPAKRNDSQEQIMDRVRQQIVPKYPKELRMTVLQVPPFSTGQSSATVQFIIAGSDLDRINQAAENALKEIPNIPGIRDVDSTLVSGKPEIVASVDRAKAGQLGVNIADLSSTLRLLVGGADVSTYNEGGEQYDIHLRSEAPYRNSQEALSLLSVPSGRGGTVSLSNVVKLERREGPAEINRADRRRQVTIMANPAPGVGESQIADAIETIVKKQNLPPDYEVGPTGRSKELKKAGLAFVTAFGMAFIFMYLILAAQFESWLHPFTILLALPLTLPFAILSLLLFNQSLNIFSVLGILVLFGMVKKNGILQIDHTNQLRERGMNRLEAILQANKDRLRPILMTTLAFVAGMVPLMFSKGVGAAFNNATAGVIIGGQMMSLLLTLLATPVFYSLFDDVIGWRKRRADRREAKRAAREAAAHPAPQPAH
>fig|240016.6.peg.3750 Multiple antibiotic resistance (MarC)-related proteins
MRPTDWISALVLLLIVLDPLGNVPVFSSLLRQVEPARRKRVILRECGIALVVLFLFLAFGGGFLKLVGLSQSSLGIAGSIILFMIALRMVFESTEKVFGGLPQGEPFIVPMAIPMLAGPSALATVILFTTREGISTLGAVGAISIAMGVTCIVLLLGERIIRLVGERGLAAMERLMGLLLTAIAVEMFLRGVKEFMK
>fig|240016.6.peg.4282 Glyoxalase/bleomycin resistance protein/dioxygenase
MLPSAILETALSVADLNLSREFYARLFGHPILASDERLCAFDVQGRQVLLLFPKDSDPEGTTMPFGGHIPAHGSHGRSHVGFAIPAESLDEWRQHLHHLSITVESEFTWPRGGRSLYFRDPDGHLLELLTPGVWPTY
>fig|240016.6.peg.4587 Acriflavin resistance protein
MISWFARNHVAANLLMLAVVAAGAWTLFSGKIPLEVFPDVPSRMLSVSVPYPGSTPEEVEEMIVLKIEEAIQQVQGIKHINSTASSSGANISIEVEEGSDPRQVLEDVKIRVDAVPQFPEEAEKPVVQLDDWFMSVITVVISAEMADRDLRRLGEQVRDEVGALPGISHVSLGGIRPLEISMEIPEATLRKYGLTLESISRAIQSAAIDLPAGVVQTESGDVAIRTRGRAYSGDDYAKVVVLTREDGTKLTLGDIAMIEDGFNENPLIARLNGKKCVVVNVMREGSQNAIKIADDVKGYIEAARSKLPDGVTIEYWNDRSKIVKGRIDLLLGNAQSSLILVFLCIGLFLRLDSVIWVALGLPVAFLGAFALMPWLGITINTATLFGFILVLGIVVDDAIVISEHVDKLQRQGLPPLQAAIEGTRRMAVPITFGVLTTVMAFLPMVFEKGDWARMFQPIALVFVTVMLIALVETKIILPAHLAHPFMEPVMKHLAPFYNFTDGCLQWVITRLYRPSIRWSLDHRYTVLAIFFGGLLLLCGFFFGGRILFVKFPRIDSERIEARLTMLDGTPFEVTDRHIARIYEIGEQLRREYVGPDGRPVIRHILATTGTTRLTGSTGGSGGVSHLGEVNMECYGPEERSLKIRTPDIANEWRRRIGQIVGAEELNFRAEILRSGDPIDVQLSGTNPQELLALSSQIKDKLGQYRGVFDIADSLDSGRNEIQLRLKPEARQFGVTVNDLARQVRQAFYGFEVQRIQRGRNEVKVMVRSPRNERRNLATLDTMRVRLADGLELPFSSVAEIKVDKSFTSIRRVDRRRALNVTADVDKSSTDVAVVRAGLSEYLNELMAAHPHVHWSFEGEARSERESASAGWMALITVGLGLYAMMAIPFKSYTQPLIVLLVIPFGVVGAVLGHLFHGMPVSMMSLFGMLAVSGVIVNDTLVLVDEINSQRDETGDLEMAAREGGAARFRAILLTQITTFFGLVPLIFDNSPQSTHNQFLLPVSVAMGYGSLFATVITLYLVPLSYLAVDDLLGLFRKQPRKAATIASPDDNGAVVRA
>fig|240016.6.peg.4818 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MPDIQPQISVVVPLYNEEENVAELQRQLSQALAGHSYELVFVDDGSTDATSAHVQKSDQVRLICFRKNSGQSAAMYAGIMAARGEVIVLIDGDLQNDPADIPALVGKLQEGSYDLVCGYRAKRKDTAFKRLQSRIANAVRSRFIGDGVRDTGCSLKAMRRECRRALLPFNGMHRFIPALIRHSGYKITEVPVNHRPRIHGVSKYTFANRAWRATKDMVGVSWLLSRMVKIDAEER
>fig|240016.6.peg.5115 Inner membrane component of tripartite multidrug resistance system
MGGGVLLANAQSVIFESFPPERRSLAQAVFGLGVITGPAIGPILGGYLTDTLGWRWIFFINLPVGIVSVILAITFLPQDDASQKKTGESVDWLGIVLLTIGLGSLQTLLEEGQQDDWFASRFITGLAVTSAVAATLFVWRQLTVSHPVVDLRVLRHRSVAAGSLYSVVLGAGLYGVIFAVPVFAQNYLHFNAMQTGNLLGPGAITSAVVMIMLARVTKFVDPRILVAMGGLLTALVAFQLSHITTQSGANELFWPLVMRVGSSVLMFLPLALLPPDNASGNFTKVVQRVPVKITFDPTTLSGIRQQVRPGLSAIVSIAVK
>fig|240016.6.peg.6450 Membrane fusion component of tripartite multidrug resistance system
MSSRVISLNELPKRGFSPAPNVEHNGAAAPQTTTPAESEPRPPQSTGHRSRKPLLIGLPILLVVATTVGFWLHYAAQFVETDNAFIEADVHPVSSRVAGNIQSVLVEDNQKVEAGQPLAQLDPRDYEMKLQSARTALEQAAAQVPQAEAALAQAQAISAQTEAQVNASAAQLEKYRLDFDRAQKLRNLTGKAISDQDFDATKAAYVAAQASHASTQAARQAGEAGVKTAEANLAVARAGQHHAQAAVSDAELQLSYTTVRAPAAGTVGKRTLQVGQQIQPGQALLAVVSPDHWLVANFKENQLATMKAGQPVEIKIDAIKGQRFEGRVESFAPGTGAKFSLLPPDNATGNFTKIVQRVPVKITFDHNANTEANHDRITPGLSAIATVKVK
>fig|240016.6.peg.6451 Inner membrane component of tripartite multidrug resistance system
MNATATLPQTGARDSTNPGTSLRNWIAVLGALLGAFMAVLDIQISNSSLQNITGGIGATLEEGSWISIAYLVPEIIVIPLCGWLAQVFGLRRYLMWNSVLFLVFSMCCGFAWNLESMIAFRAFQGFTGGALIPMASTMVMIMLPAEKQPVGFALFGLSAMFAPAIGPSIGGWITENYSWPWIFYLNLVPGIILISAIGYGLNSTPAKLDLLKKGDWWGIAFMAVGLGSLTVFLEEGTRKDWFGSEFITTLAIIAAITLPVFVILSLIKRKRTPAVNLRLFSRRNFLLGCIVNLVVGLCLYGMMYLLPLYLAQIQGYNALEIGRTLMWVGLPQLVVMPFIPKIMQWVDKRVVVAFGLGMFGLSALLMSSMSADTGHDQLIMPQIIRAIGLTCTIVPLSLITTGGIESEQAASASGLFNMLRNLGGSIGIALLSALLTNREHFHSHHLGEAISTYNPLTNERLTAMAQNFMNQGLDAVTAQSRALGLLDLGVRKQAYIMAYNDSFHIASLLLFAMIPLIFLTRKATGPAPAGAH
>fig|240292.3.peg.727 Multidrug resistance protein
MPQKSAALRFVILLGFVSLCADATYEGARSITGAYLQVLGASGTVVGLVAGFGELIGYGLRLVIGYLSDQSRKYWGITTLGYILNTAVVPLLALTGRWEAAAGLMMAERTGKAVRTPPRDALLSHGASQIGRGFGFGLHEAMDQTGAVMGPLAVAAMVYFQGEYRHAFTILIVPAVLGLVVLLVLQFLYPNPSDFEEETEEQKQQEGLPRIFWIYLGAVAVIAAGYADFPLIAFHFQKSGIATGETIPLFYALAMGVDAIAALIFGYVFDRLGISILIIAAFISCLFAPLVFLGDTNLALLGIAFWGIGMGAQESILKAAIAGMVPKHKRATAYGIFSTGYGLSWFLGSALMGILYDHSITTLIVFSSATQLLAIPFFTWVKLKADDSPKTITNQAS
>fig|240292.3.peg.824 Permease of the drug/metabolite transporter (DMT) superfamily
MIKFRGRSRLIHRVSGQVYLWLAIFIFGASSAVTRKLTEIGARHFIDGRNPISLCNVLFVGNLCALMVMLLIYNRQWNKATLAQLSKKDWLGLTAVAILSGALAPGLIFQALSLTGVNNVILVGRLEPTLALALSVWLLKERIGFGEFIGAIAAFTGVILTIILQPPGSDMMNMGGWQLGLGELLVALGSITLAISTIIGKKYLTHIPLGIYSIFRTALGTVIFFFIALLLYGRDHFADVFSPFLWQWMFLYGGVIVVVGQSFWIIGLKSSTVSTASLVASFTPIAGIMAAYFILGEVPTMAQYLGGSLIMLGIFLSQVSKSRQTSHKSPIASTPTEQKVEMDIGFKGI
>fig|240292.3.peg.2142 Melittin resistance protein PqaB
MRPITQKKLLLVLLVAALALWLTFLGNLPLRDWDEGTIAQVARDIWQAPVGSMRWLYPTLAGEAYHNKPPLMHLLIAWAYSIGGINEWTTRFPGAFITALGVPLLYLLGRSLFNRSLPALFAALVYLTMLPVVRHGRLAMLDGTLITFFLFVLFCLLKARQNQKYALGVGIGLGLIALTKGMMVLLLGGIAGLFLLADRQLTLLTSPYLWTGLFLGSAPAIAWYLAQWQHYGGSFLQINLQSQTFNRVFQPVEGHSGPPWYYVLEILKYGFPWLLFLPGGLYLAAKKRDTSWGCLILVGTIVYLASISVMRTKLPWYVMPIYPFLALAIGAKLADVWQYHHVKSTTLVVFFVILAIAGLGGCVYFATTETQPVLIAMSLVLAVSMATVAWLVNQGDRNFIPVLFTGMYLVLIMFVSSQSWIWELNEAFPVKPVAALIRQHVLPGTKIYTSFAYNRPSLDFYCDCQVLTEPSISQQMAKRNDYLLLDNTTLEKINLSGNEILGTVENFTLIAPSKN
>fig|240292.3.peg.2550 Melittin resistance protein PqaB
MQEGSFIWGHLERQHRAVDKWIDRLWLVVLLIAALLLFSVNLGGLPLQDWDEGTIAQIAREITQESANSIRWLYPTLRGQPYHDTPPLMHIVIAGAYHLGGVNEWTTRLPGAILTALSVPLLYCLGREIFRQRWAAIYSALIYLTMLPVVRYGRLAMLEGAVVSFLLVMMLCVLRSRRDLRYCLGIGLSLGLICLTQGLSGFLLGAVVLVFLFWDTPRLLTSYYLWIAIAIGILPVAGWYSAQLLHYGNDFVQNGLLLQSLQQAGIVNHKNAQPSWFYIVELLKWTWPWLIFLPQTTKLLWENRNLSWARLILVWSIVYLLLISLMSVKLAWYIFPIYPSLALAFGAQLAEIENLPLLSSYPRAWVAGLSILAVVASAASIHFSWGIAAKTDLQLIFAAVALTMIMGAILAERGDGQFLKILFWGSYISLLLLMKSNYWVWELWQAYPVKPVAAMIEKVNPAAKKIYTSFPYHRPSLDFYSDRHIIPASAEELKHHWHYDRQPYLLISSSDFQRLQLDSVQILDKTEGWQLITKETNRL
>fig|240292.3.peg.5031 Multiple antibiotic resistance protein MarC
MDTSILIQTFIAVFVLADAIGNIPIVLALTKGMEPEDRNRVIDKASIVAIAVLLLFAFGGQYILTYLEISMASLRVAGGLLLLLIALQMLRGELETPTIEEGRDVAITPLALPLLAGPGTLTTVMLFMSKSQSPHLAVVLGILAAMFVTWLILRLANPIEKRIGLEGGVIVTQLLGFLLAALAVEIGSTGIRELFLQ
>fig|243090.1.peg.181 Drug transporters
MLASGTELKIANLFSRRSDAFSIRRMPANQALAAAAFVTMTFGGASMLLADDAKSKPIVIEGAQTTLVTDLTLAAPIAGRVMSVTATEGQQVSKSDVLVQLDDRRAKAELAAAESAAKAAELRSTSDVDQRYAERTREVRMRELEQSIDANKRYQNSVTATEIDRLQLVIDQAGLSIEQARKELEVAEAQADEKLSLVEMAKLRLSEHRVDSPVVGNVAETMVSVGEWVEAGAPLLRVVSLDPIRVSGFVDGRVHGGELKGRPVEFEWTQSIGGEDQSIVLSGEVTFVSLEVHPVNSQVRMWATLRNPDQLARPGVRGTMRILPAVGEAKTPAE
>fig|243090.1.peg.2374 Drug transporters
MRFRRLRLKQRPCQRSWGVAQRRRVATTDTRSAIGLMTPASVSFRSDWLIKATNALNVRVSSPLPGRVRNWAAGACPWPWSFRCEKLVEDIVFSCLRCHVGRREAVARVSLAKSRIGCVLALHFLSQRVIAFRSTTSRRDPRTFHLFYFAGPGGWPLSSLSQESMTESPRRIERDAYGYRAMVAVAIPLAATVGCFSITLFTDRTLLMWYGPTSSAASMAAGNLYWAIACIPVTAMGFITPLAAMAMGRKRGRGAVALRVWSLLWQCLWFTLACVPAFALIGWMSPNLFEAFGHDVELAKQEARYFQTLLLVAPASMLEAGLTAFFVGRRVTRPILQTNIASSVLNVGLDYWFIFGGLGLPAMGVFGAALATTIAMWFKVAVFAVMLMRLNSFGRHFRAAWRPSRHVMTEIIVPGSAIGLQQLIRSGLFSFVLLVIGAASVTGLAATSAALTMYQLLSIPAIGLGTAVTVVTGQALAAKGIGLASDTIRRGMGLGVVVALTLAIALAAFPETLLQIPLGGISDEERAEIQPLAIRLMWFAAIYALVDVASLLLAASAKGIGKSFVILVATAVPGVLVVAGGWLLAPDGWLRAGSLVRENQIVIHWWSALVLWSTAQAFVLAGSLFWSTNALLPVRVGQAPPSQPDA
>fig|243090.1.peg.3638 Drug transporters
MAEPTKHSHSGELKIGLVCALLAHTMWGLFPIYWRQIGNADSTELVCHRIVWSFVTLGLVLPVMLWRGRWGGFRVVYQQLRSRKVWAVYSIAAVMIAINWLAFIWAVNNNRVLEASLGYYINPLLNVVLGVVVLGERLRWPQWMAVGFAAVGVSVMAIGNGGLPWVSMAMATSFAIYGLVKKKASLPVLLGLMLEVTLLVVPAAIYLGMRLADGVSTMQTGTTIEFGMLLGAGLITIAPLAFFAAAVQRVDLSLMGILQYIGPTLQFLVGYVLFGETLDLPRKIGFVFVWTGLLIFLLASQFKRRRPTLVAEAS
>fig|243090.15.peg.998 Permease of the drug/metabolite transporter (DMT) superfamily
MVTIFDDTFGGEPLIGIVFAMLVVLSIPIGILLTTFSFAKDHKREHWPIAAVSSALLVMIGLASYNGAWPLAKLLTADFVRGTAFTNNPRFWWMMAREVRDAGFYLLCIAAIVAFGNLLIYAVHRFCGNIPRPSDSTQS
>fig|243090.15.peg.1089 AcrA/AcrE family multidrug resistance protein
MHNQFLEMISIIRSMLNRSIPILIFVVIPCAFLGCDTMSGSRPAQIISGSHPSSHSKQHTTTGQANSHHNESHHGSSEPEVTNAHHATGEHHAQHKIVVTSPVARDVTLTRQYVCQIHSRRHIEVCALEGGYLKDIHVNEGQAVTKGQTMFHILPTIYEAKLDADMAEAQLAQVEFDNTKSLVQQNIVSTQELKLAEAKLAKAVANVKLAQAEMNFANIKAPFDGIVDRLQEQEGSLVEEGAMLTTMSDNSVMWVYFNVPESRYLEYQEAMNAGQNQDALDVQLRLANHKIFDQPGKIGAIEADFDSETGNIAFRADFPNPNGLLRHGQTGTVLINQVAKNAVVIPQRATFEILAKKYAFVIDVDDIVHQREIVIQNEKDDIFLISEGLQPGEKIVLEGILQVRDGEKVEYEYRDPDTVLGNLKYHAE
>fig|243090.15.peg.2640 Probable multidrug resistance efflux pump
MGAAIYGYTFLGERQRPQRSKPAKSPVTIVATDDIRFHSGPVVIDVNGVVVPLRELRLASEVAGRVVELSENVRAGRKVKQGEVLIRLDATEYELEVKRLQALAQQEAAEENSVQVGIENTLQLQSLAQKQLEIARQERERINALVAQRAASASEVDTARRAELAADASLVELENRRRELTAQLQLVTEKRSLTEVLLERARLDLSRCEIKSPIDGRVVSSEVEEQSFLPTGTTFITIEDTSAVEVRASLTADQMFWIWNSRSVLSTLAASDPAQAEKAVTDADRFNSAVSATISSVIGSESHQWSAVFERLDGVGIDLNTRTYPCLFRVESPESSLEGSASRQLTRGMFVDVSIETQPNQVLVRVAESAVRPGNRLWLNVDGKLRIVPVTIVSRTGDDVVVQIQPELDHLCTLASTRIIVSPISDPVEGMPVGGQPPSPSGEGAGPGKTGQSDSPPIGDTTSNPIQANSSLRVDG
>fig|243090.15.peg.4571 Multidrug resistance efflux pump
MSWILGGVYCGIIWLVFAKLKLMRLSLPLAIILASVGPGLIVVLLFCAQYFHPYTKQAIVIAQIDPITAQLSTNGRVKEVFVSPNVPIQAGDVLFTVDPIPYENAVEVAKAGLEQAKQNVQLSESTVELSRATLVRAKADLTYATNDRDRYQKLRESGGASQDELERAVTLFQQSDAALTQAEQSLKQAGISVGVAKAKQTQAETTLANAEYDLQQTTVKAPADGYVTNLQVHPGMLLGPATGPVMSFIRDTDERQKGVVVAVFVEKNFLRIRTDQYAELAMDAYPGEILTGRVLNSINVSGKGQLVAGGMVPTDLADGKPTQFAVRIQLDDVDSYPLPGGAQGQAAVYTGDVQIAGIPIMFLIRANSWMNYLF
>fig|243090.15.peg.5396 Acriflavin resistance protein
MTSLSKMVPEGGPIAWMARNSIAANLLMLLLLGGGIWSAFAIQKEVFPQFQLDIVEVAVGYPGAAPEEVEQGILRPIEEAVRGVEGIREVTSEAREGRGELLIELVGGEDRMKVLQDVDQAVSRIRTFPDQIEQPEVRLQSRQQEVMQVAIYGPIDVWALRKLAEQLRDQLQSKEQITQVELRRVPAYVTHVEIPRQRLREYGLTLPDVAEIIRTSSQDVAAGSVQTTAGEILLRVKARKQWAEEFAGIEIVAGRDGPMVTLGDIATIRDGFEEVGFHSQFSQTPSVELDIYRVGSQSPMDVAEAVQETMEEFETALPPGVKWRIDSNNAEEFRRRLMLVAENAAMAVVIVLVILSLFLEFRLAFWVMMGMAVSFIGGVLLLPAAGVSINMISLFGFLVVLGIVVDDAVVVGENVYEKRQTLKDHEAAAVEGTKEVSGPVTFSILTNIVAFVPLLFIPGETGKFWGPLPVVVIIVLALSLVESLFILPAHLAHARDAGRDPNSIGARLHHLQQRFSQGFNRLVEFFYRPVLILSLRHRYVTASLALALFVVIGGYATSAHMGLILMPEVSADEIEAGVRMPVGTTQAQAAKIADTVTKASIKMFEEHNLYEVAEGIKTNVRGQSFIDVEIVMKPPDQRDMTANEVIDLWREHIGDLPGVNQVTFEAERGPGGHRRDISIDLSHSDIDVLEQAATAFVDRVKLYSNARDVNDNYNKGKTQYDFRLRPEGRSLGLTDEELGEQLRGAFFGSLALRLIRGTNETEVRVKLPEEQREDIHSLEDLIIRTPSGAEVPLLDVAEVEETLAFRSINRRDGRRTISVSMDVEPKRAATQVIEALQNSELPKLREDFPGITWSFEGSDAEMRQATASLWGSFGLALAVIYSLLAIAFKGYVQPLIVLVAIPFGVVGAIIGHIMLGYDLSLVSLMGVIALSGVVINDSLIMIDYANRHRKNQSAFDAISQAGLRRFRPILLTTLTTFGGLMPLIFEDSLQAQYIIPMAISLGFGILFATAIILVLVPCLYLILEDIQKTFTPDTE
>fig|243160.4.peg.22 Outer membrane component of tripartite multidrug resistance system
MKTFPLSACRTAVAVAVAALALAGCANYFGLKNDKAIAPAAQFESARSLPAQGGQWPSLDWANQFGDPQLPKLIDEALEGNPTIAQAQARIAKASSYIESSRSTLLPKADAKYSWTRELYSGNALFPPPYGGQWYSENNALASASWELDLWGKNRARLNAAVSQEKAAEADLQQARVTLATSVARTYNQLAQLYALRDIAGREISNRQTVDKITDGRVGAGLDTNVERQTARGNIATSQSTLSDLDGQITNVRYQLAALLGKGPDRGLQIAAPVLSAGGAVALPENLPADLVSRRPDLVAARWQVEAAMHDVKEAKAEFFPDINLAAGFGFDAFGWGRFLNFASRQAQFGPAIHLPIFDGGALRAQLKGRYADFDLSVANYNQTLINALNDVATQVASIRSVDTQMGDAQRALDASTRAYELAVIRYKAGLSPQLQVLNADSNRLAAEQTVTNLKMRRRDLQIGLVKALGGGFDAAGTRLAAPAPASAPAAPAQHASN
>fig|243160.4.peg.601 Permeases of the drug/metabolite transporter (DMT) superfamily
MAILMGLLSALCWGSTDFLAGHAARRVGVTKSLFYSQSFGFLILTASLALHPSSLRITAIDMGFAVGILAAVCNLIAMAALLRALAIGKASVVAPIVSLYGAVTTILSLATGQSITRLAIAGLVLCIVGASLASISKAADGKTESPASIGFALLSAAMFGLGFWLQGAFAVKSLGVVSALWIYYLTAVVILFATLARARNLSAPPGSIVLLILSISVFSLVGFFSLAYGSTTGHVAIVTVLSSLASGVTALLGFFVRGERPSALQWAGIATIIVGVVMLKITPQALAA
>fig|243160.4.peg.793 Permeases of the drug/metabolite transporter (DMT) superfamily
MQENERRSAGWPTLAILVGASVWGLIWYPLRLLAALGVTGTVASAATSIVACAFVLIVRRKSIATVRRHWLLPALGVAAGVTNLGFVWGTIHGEVLRVMLLFYLTPAWTAICAHFILRERLTAAGAALAALSLGGAVLMLWSPRLGVPLPSNPAEWAGLAAGMSFAMSNVLVVKASRELPRMKPEMRTATLFAGAAAMGVAAAFVEGLPPLPAGGELGRAALLVVGIGVTVAANNMLVQHGLARVQANRASIIMLFEIVVTALTAWLFANEVPSAREWAGGLCIVVVTLLSSRVHRARPAEDEPLEPRDGARAMV
>fig|243160.4.peg.1258 Albicidin resistance protein
MRLKIGELAKKVGLSVRALHHYDAIGLLSPSQRTDGGARLYGRDDLIRLHRIEALKRFGYSLPAIQASLDGPPAGAPLQILRRQIAALDAQAARAQRLSRHLQHLVAMVAAGGETAAIDWLNVLELMNMYQKHLDDNELDTLLASGPDTVAPMDPSWVGLVDEVRDAMRRALPADSDAAQALAWRWSRLMNRMTRNDPALAGKLMGIQLGEPRAQHIVGITPAMLTWIGEACAHARCTLFAKYLNPAQIAEVRRRQLADTHMHAWLALVAELRAHMEAGVDAGAAPVQAIVARWQQLFRDSFCGEEEGLEAKVRDALMREPDLQLGGGFDEALLVYLNKAHIAGRDIASGDDGPKPSALMVAKQRAAHQLLDRPLVLDDPIALSILGAAEEQALRADLDRFRYPASLGMRSSVVVRSRLADDMRAEAIGRGVRQYVVLGAGLDTSAYRHPEAPGRLFEVDLPATQRWKQARLREAGIALPRSLRFVPVDFEHVSLADGLARAGFDPGAPALFSWLGVTMYLDEAAVVETLRFIAGCAKGSAVLFEYVTPLSGLPPMMRIAMEQLTAQLAARGEPWKCFFEPAALAEMLIGLGFGSIGAWSPDELNRRYLADRADGLHIGATPARLILATV
>fig|243160.4.peg.1676 Bicyclomycin resistance protein
MPHVARRRPDGRLILLLGALAACGPIATDMYLPSLPAIAGGFGVTAAAAQRTLTSFMAGFSIGMLLYGPLSDTYGRRPVLLGGIALFTLASVGCFVAGSIDMLIAVRFLQAFGAGAASVLARAIARDAHEPADAAKVLSMVAIVTAIGPLLAPLIGGQVLRFSGWRGVFVVLALFGAVCATAAYLRVPETWPREKRASSAVLNSFAAYGRILVDPVAWGHMLCGGMAFASMFAYITATPFVYIDYFHVSPQHYGLLFGLNVIGIMLGNFLNARLVGRVGSLKIIAGASLLSGAASFAVAFFALTGLGGLWSIVASLFFVVGILSANCTTDLMLRYPHNAGAAAAVFGAMQLALGALANGAPFAMGVTIGATGLLCLGGRMLVLRWHGRPVKGALGRVDAA
>fig|243160.4.peg.2029 Multiple antibiotic resistance (MarC) -related proteins
MESNFLSATVLLILITDPLGNIPLVIAALRDVPRERRVKVILREVAIAFVILLFFMVVGDRFLRMMSLTDLSLRIGGGIVLFLIALRMIFPHPDGALGSDPRAGGEPFIVPLAIPALAGPSALATVMLLTSQAPGKTLEWAGALTVTMLVCAVTLVLAERIQQWLGERTVIAFERLMGLVLVAISVEMMMAGIRAFVHQL
>fig|243160.4.peg.2712 Permease of the drug/metabolite transporter (DMT) superfamily
MTPFDRFLAFVARHPPRLPQSRSGRVALALVFIYFAWGSTYLALHVALESFPPLLLSGLRNLLAGVGLFVFAMRRRPVRPTLVEIRNAALVGTMLVTMSSGLIALGMRTVSSGSAAVMVATVPLFATVIASVAGRRVTGGEWGAVALGMVGIVVLNSGGPSSPGSTLGSITVLAGALFWAGGAHLAARLALPHDLFLSTALQIGLGGAASTCIAWVLGERIGHVAWVPGAAFVYLMLAGTMAAYVAYGYLIRHTSPIIASSCMYVNPVVAVALGALLLGEPVTAATVIATIAILGSVGLSFVFDPARRRAQ
>fig|243160.4.peg.3389 Outer membrane component of tripartite multidrug resistance system
MTQTATHAATRTTTLPVRRPARRLAALALAWALAGCVPSGLKPTLAPRTPGDDALAHTTGGATHGAWPSPDWVRQLGDPQLDALVDEALRQNPTLQAAQARIGVAQSQLQQFESLTGLTATAGASLSKAHVPRSGGTLNTTLNGLPVSVPLVGESVVSSSSLFVGLNYQLDLWGKNAAATRGLLSMRDAARVEAEQARLTLSVAIVTLYGELDRAYALRELLQQKRRASEQVEAVLRERAARGIDNGYDADDAALKRGKLLEQIALTDEQIQLQRLQLGVLSGRGPERGLSLARPKLAPLADAPLPARLPARLPAGLLGRRPDIVAARLRVEAAYAAIDGTRASFYPDVNLAALGGLFALTPASLFRHDALGGSIGPALSLPIFDRSRLKAKLGGDVANADMALALYNQTVDAALGEVARQLTSLATLDTLLKAQQQALRAAQRMVALAQDRHRRGMGMRKDIDVAQLTLLDERAHVVELQARRRTLRVGLIGALGGGFDARPASGAPPAQAGQPFAAASRPVAAHDAQPD
>fig|243160.4.peg.3427 Permease of the drug/metabolite transporter (DMT) superfamily
MTQRLLAAAWRRPVWLLWVPPAFWAGNVVLGRAFSTSFPPVSLAVGRWLVALVALAPFVWRDVLRERRLLLRHWKLIWACGALGIAGYNALAYVALRTVPAASVAFLNSTLPLMVPLAAAMLGVERITSRAIVGIVVSFGGVAWIVARGHWEDLVALRFDHGELIVILATANYAIYSVLLRRKPAAIGPLAFLAATMAAGLAVLAPFWALELAGGARIPFDPKAIGAVLYIGVFASLIAFILWGHCVQVLGATVTGVSFHLVALFTAVLAALTLGEPVRSYHLVGIALILFGFFVATRAAPGVRSAPNARSL
>fig|243160.4.peg.3582 Tetracycline resistance protein
MDLHERTLDAPGAPAAAAHGAGSRLSREVWIILLTLAVDAVGLGVATPVLPDLLRAVGERPAHVPVMLGSLITCFYFMQFVFGPIVGALSDAWGRRPILLIALGGGALSYAIGATARSYGGLLAAHMLAGIAASSAAVATAYLADVTPPALRARRFALASSVLGLGLIAGPAFGGVLGALGPRVPFVAAGAIAALNFVSAACFLRESLPARRRVPVSWARANLFGSLRLVREDRVFRDLLAAVCLGMLAYGIYLSCFVLANAARLGWGPRENGLALAGLGLGITLTQTLLLPRLVARLGEHRTALVGFGAFVLAYGLYSRADSVALVAAALAVHALSLISDPSVRSLISVHAGPQRQGEYQGALVCLTGLASSIAPLVGGNLFAFFTRAGASTYFPGAPFLAAAVLYALAMLAVWRAMAGAARRRSASH
>fig|243160.4.peg.3703 Multiple antibiotic resistance protein MarC
MARPRERPPITLVRPSRFPMIVDRLISEILFGFTGLMGIINPFGIAFLFLERTESLTEAQRAALARKVAINAFIVLLAAFFVGISLEALRIGGGLAVAVAGWQMLNEPDVPTGGDTAAQPVEPRNAMARAFFPLTIPLTTGPGSIATAIALNANRTHKLSEFVLSSIVSVAVSALAALVIWQTYSRAAFLARYLGTEGTKVAMRVSAFLLLCVGVQIMLTGFSEFLRPIADQVK
>fig|243160.4.peg.3704 Multiple antibiotic resistance protein MarC
MDARKRAAARPSRPRRWSRKRSRFFAGGAGAFLYHTDWSVCGPRLDRARRHRAIGGAPPMTRPSCPAGALEAVETASRDERRVLQRARLKGALRRASDHVAHYQPLLRCGGRASGDVLKTLADRARVRAVTRVGIGRAVARRESCAAGCQMPDAGCKARAERHEAQRAGPHARSLRSDRLAGAGAPRSARRRVGCAASAKRPPASGG
>fig|243160.4.peg.4101 Bicyclomycin resistance protein
MHPLRSILPLALFTAVGLLATDLYLPAVPSLPQQLGGSIESAQATLAAFSAALAVSQLVWGAAADRFGHRRTLAFAVLLQLVAGAACALAPSMGALIGARLAQGFGVGAAMVIVPALVRQSFGDGGAVRALAWLGIVESAVPGLAPLVGAALLVVADWRTSFWIIVALSAIAAPLVFRVIPTARAMRACAPANVGAHAGGYRRLLRSPVYLGYALGHALCFAALLAFVASAPQVVEIWLGAGPSTFSLMQACGVAAFMLSAARSGKWSDALGLDRIIALGALLQFAASAAFLLLAYADWRSTPLVVASWMLFCGSLGLRGPASMARALAAEPAVAGRAAGLLMFFGLGGAALATQAVAPFLRLGLAPVAWMCAGFTLASGAVVLWGIAIRGRHRAAATEIA
>fig|243160.4.peg.4140 Methylenomycin A resistance protein
MDTHLPHPALSRAALVRIVSTVSAGFVITQLDVTIVNVALARIGIDLHTSVAGLQWIVDAYTLALAGLMLSAGALGDRFGARRPFAAGLALFAVASFVCGIAANAATLIAARALQGLAAAAMLPNSLALLNHACAHDPRLRARAVGWWTASGAISIAAGPVIGGVLIAQFGWRSIFFVNLPLCAAGLAATRLWIDSDDTRAAAASSASSASSASSAADGAHHSHPAADRRASGPNACAPAPKRAAGAGTRGLDLPGQCLAVVALTLFTGAVIDWHPALVAIALAAGAAFVFVESRSAHPMMPLALFRRRTFSVAVLFGVCMNLSYYGIIFVLSLYLQRVRHNTPLEAGLAFLPLTGGFLLSNVASGWATAHYGPRRPMIAGALIGATGFALLSAVRADTPIAMLVVPFLLIPGGMGLAVPAMTTTVLASVERARAATASAVLNTARQAGGAIGVAAFGALASGARPPDIVSGLHASAYVSAALFVFASAMAAFVHGAPQPAAGKPANANAR
>fig|243160.4.peg.4597 Antibiotic transport protein
MLTSVAPPSATSEAVSHRNTAVLVVFTALTNLADGVTKVALPLMATALTHSPARISGVSLTLTLPWLLVALHVGVLVDRFDRRTLLWLANAARMAAMALLIALLPSGRVTLPVLYASGLTLGLAEVVALTSAAALIPDAVAPSSRERANAWIAGAETVCNEFCGPLTGGMLVAAGTAIALGAVAVGYFGGGVALFFLIGRFRVAHAPHGRPPPVRLQIAEGLGCLWHQPLLRLMAVALTVLCMCWGAWLALMPLFATTVLGLDSRGYGVTVSALGVGGFVGALSVTLLNRRFGRRTVMLTDLLGTFAMMAVPVLSTNLWAVAASAFAGGLGGTLWTVNARTISQHLVPGPLLGRYNAAARLFSWGAMPIGAGFAGAIAELLGMRAAFAALAVAALLLIVPFLRVASAQALRIGPERRH
>fig|243160.4.peg.4696 Bicyclomycin resistance protein
MSDRGWLSLLMLVVCLPRMTIDAYLPSLPAMADALHGTDAQMQLTLTMYMAGYALSMLLSGPLSDRYGRRPVLLAGMLVYLGASVACATATSVQGIVVARIGQALGGCCGTVIGRVIVRERFGTAMQAAMLSRISAGMALSPVVAPLAGHVVAQWLGWRGVFALLAFGGGAAALMVHRFLPETRVRAAASERGAGLAKTYLSLLRDRRFVRYSLAIGFVYCTYFPFIAESSALFQRTLRASGAVYAAIFGITVLGYLIGSSVFRRASGRFGIDAIIASAAFVNLVGAAALWIGTSVAPPSVWSIALPMFVVMVSVGVSIPACQFAVLQPFAKLAGTASGLFFFIQMAMTAGCGGMLSRLSDGSARPMAVVTAASSAAFMAVVMLVRTRGVNGRRG
>fig|243160.4.peg.5238 Outer membrane component of tripartite multidrug resistance system
MSLPIFEGGALVANLRLSQAQQAQAALGYRRAVLLALRDVDNALAAYRTDQTRRDALRDAAAAERTTFELARDSYRHGLVSFIDVLDAERELSQARQQYVQGSLQLTTDLVSLYKALGGGWQPVPAAQTPAPAALDAPTQDTPLGATAPARR
>fig|243164.3.peg.772 Permease of the drug/metabolite transporter (DMT) superfamily
MPRHILIALIFTILFWSSAFAAIRVSLADYSPSHLALLRFLVASLALVIYALITRMRLPDKRDLPAIFLLGLIGISLYHFALNYGEKTVTAGAASLIIASAPIFSVLLARFFYKDKLTPAGWLGILLSFGGIAVITLGEGQTLSFEPHAFWVLLAALFTSIYIVFQRPLLKKYSGFEFSTYAIWAGTLLLMVGAPGLLKEISEAPASSTLAVVYLGIFPTAISYLLYSYALSKARISQVISFLYLNPVFAIGIAFLWLGEIPAPISLLGGLLALAGVILVNRYGHYR
>fig|243230.1.peg.194 Vancomycin B-type resistance protein VanW
MTKFVSAPLICGLALLGALSAAHAQTGIPALPPIAQPLPVPAPAPVTPPAPTVPVPQEPAPVPQPPMPQPSVPQTPAPQKPVTPRPAPAPSRAPLLIQARANVPALVAGKKTTVPVLKTLTIPAERAAQLRQRGEVSASLQADLDTFLKSLAAPRDARFEQQDDGQWAVVQPNGLKVDAQATRAAVAKVLRDPRGVSANVVVTGQVAPQRTLDFFASRGITTFLATGFTSYYGSSPERVKNIHVGAQNFKDRLFEGDVFSFNKFIGPVSERNGYVPGLVIAGDQTASGVGGGICQVSTTVFRTLYGAGLGIVQRQNHSYQVFYYDPQGLDATIYQPQLDLKFANTTGGPIWFQTEWDDQEATLTITAFGQARDYQVQVDAPKTLKTVAPPKDRLIPDASLPAGQRKQVDWAAPGATIEVTRRFTRGGKTFKQDTLRSVYRPWPNIFRVGTKK
>fig|243230.1.peg.210 Vancomycin B-type resistance protein VanW
MKRFLLPLLLTWPGAALAAQPAPQLALAQDLQLTFKGELKKIDDGQLVTAPVTKSWTLPAKWVARSREYNKLSSYLTPYLDRVEKETFVRGRPAKFEQVGNKWVATDQPEWKLDRPATEAKLLEAIRTGATTLPVVFSEKVPQRSVALLAERGVMRNLASARSSFTGSPDFRVKNIVVGSSKLDYQWVAPGEDFDFNKSMGDINAANGFVPGYIISGGTLALEDGGGICQVSTTIFRALWEAGLPIVERNQHSYRVHYYDPVGYEATVYAPSKNLRMKNDTDAYIFIQASWNTATQKLRFDVFGPDTGRKTQISAPVVTDVKPAASPTFTPDKRVVLGQQRLLDQPMEGMTSVITRTVTFRDGTSQQDSIKSVYKPWGAVYGVHPSDPRLKQTEAQAKK
>fig|243230.1.peg.294 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MPLLNGLDHVQLEAPAGCEVAAREFFAGVLGLPELQKPEALRKNGGCWFGLPDGRQVHVGVVADYVPRRKGHFALRCDDVGAVARHLAAHGVACTPDKEAGVPRLFLQDPWGGRLEIVQGAHPSRPLS
>fig|243230.1.peg.694 Permease of the drug/metabolite transporter (DMT) superfamily
MLTPMTSAAPVQGRLDPLSLGAIVVTLVFWASAFTGIRIGLEHFSPGHLALYRFLVASVTLLLVMAVTRLPVPAPRDLWQIGVLSVAGISLYHVLLNMGERSVPAGTASLIIAAGPVITALLAARFLGESLNPLGWLGTAVSLGGVALIVLGQGQGLGFSAGALLVLGAAFFTSLYFVFQKGVLARVGSLRFTVWSLILGTVPLLVFLPGFGTELRAAPLPAHLAVLYLGVFPSALAYLTWTFAISRVGAGVTSSFLYVSPVFALLMAWALLGEVPGAVTLLGGVIALAGVLLVNTRGRPQ
>fig|243230.1.peg.1406 Multidrug resistance protein-related protein
MTGAAGLRARVPLRPGTLRRVLAGVLLLSCAEFVRSGLYAGYLPQAASKLLGLPKADAVVFGASAFTAHFIADTAMRGPAGAALLRFGLRPVVLAGAALSLLALVLMSVTHTGWVLLLAAALHGIGFSPLWPAVMSLTTDSAQPTHQGRVLTAVSMSVMPFVGLSVLTLGALADAPRSAVFGLCLGLLTASLLLSLLLPQRLRTAPAPTQNPAAPTDRRQGVKVAAQALAPLIPAAFLQTLTMTLLGPLMFTLYKELGLTYWGLVALLGLGGAVAFGSMPLTGKLADQGRARLTVTLGFASLALALGGIALRPAVWALYPLAMLAGLGYAFIAPGWAALVAQRLPEAQRPAAWGTLMTVENLGTSLGPLLGGFAYRTLGVPGPFIAGSGLALLATLGYVLFRRAFDTPAGGPLDPEVASAPPSETPQL
>fig|243230.1.peg.1601 Antibiotic resistance protein
MTPMRSPIIWINGPFGVGKTHTAHTLHERLPGSFVFEPEEMGQALRKLTPGFSGDPQEHPMWIPLMLDALQYASREAAGPLIVPVSISDTARHRRLMSGLKDRGLSVHHFTLIAPLNVVLERLRRDGQPQVNVGTVEDRLNELRGEQFQTHIDTAGLGTQQVAEQIAAQVGLTLAPPPQGALHWLRGALGRRREN
>fig|243230.1.peg.1801 Vancomycin B-type resistance protein VanW
MSAQADKLAPGLRVGGVDVGGMTPDAALIAVREQTQAKEPKIEVQATGTGKSWTLSAGKLGYQVDPQASLAAARKLSDARPWTERALGVLGQMNLTQPKAQDVPLVTKVDPAVAQATIGKLTADLATQPVNATVGFDPKTRRYAVLTPDTPGRKANAEAAAKAFAADPSQRVLKVPLTEWPAQYTAAELSKHAELGNKLMRGVTVKLDGSDRAGSLGPLQVANLYWVKPEGIVLDDKTLKGAFESLSYQLDQPAQNARYAWRDGVWGKVGEKPGRVTDPQKGLEAFRKGLLDPTKTTITFPSVQQQPAIKLADLPSPAKLQLIASGSSTYYGSSAERRTNVANAAAKIDGTVVAPGENFSFLQSLGGISPENGFVGGLIISGGRTVDGLGGGVCQVSTTAFRALYQAGLPVVERNQHSYRVKYYEPEVGFEAAVYDPGVDLKMKNDTGAPILIRTVNNNNASRLEIQVWGTKPQRTVSVSPAVILSRSPHPAPQYVFNPNLPAGASKQVDWAQDGYNLYQWFVQF
>fig|243230.1.peg.1884 Kanamycin resistance protein-related protein
MLSPTPPMTPDVSLKPVLDFTPAEWRTLYSFFRDRELAAWNDAKPIRMPEWLFRRVMQEEEKTGERAGFGVMDAAGRLIGNAELYDFRPSPPLTATTATLGIMIGFPALWGQGYGRAGVRALLHWAFAVHNPALQRVRLTTFGHNRRAQRAFAACGFREVGRRTYPERVDVHMEITREEWQSGAGADA
>fig|243230.1.peg.2351 Drug transport protein
MVGPSLLMKTSNLPSGKLEVYTFGMTATSPAPEPDASTKGRTKIILFLTIFIAMLGLSVLFPIIGPLGRQLGLTPAQIGWFSTSYSLMQFIFSPIWGNRSEHHGRRPTLLMGLVGFSVSFGLFGLFAQLGMNGGLALGTLFALLVGTRIIGGIFSSATLPTAQAMMADISSEDDRAASMGLIGAAFGLGVVFGPAIGGLLSGISLVAPVYFSAGLGLFTAALAYFMVPETRHPGQTRTATVDRRSLLSRGGIPLFLAASALTTLASVGMEQTISFYVQDVMKLDPGETAKTVGKMLAIFGILAALVQGGAIRPLSKKLPPTPLILVGLVIMAAGMFLLPQMATYWPITAALALIGVGSAILSPTLSAALSLSVGKDGQGAVAGLNSSALALGRMVGPLLGTNLYQHVGHGAPYIASGSILAVLFVVMLIARPQVQPQTPAA
>fig|243230.1.peg.2523 Multiple antibiotic resistance (MarC)-related proteins
MDWSEVITLSYRTFLTMLVIMDPVGLAPMFIALARDRPAFEKKRLALKATLVAGGIIFVFGLFGRALLEHLGISLSAFRIAGGILLFMVALDMVSARQSATRETPEEEREAQEREDISVFPLAIPLIAGPGTLASIMIQTNAAHGNPILMFAVFLVTGIVLALCYLALRLSNQIAKALGLTGVNVVTRVLGVLLGALAVQYIADGTLELMRGGLPLN
>fig|243230.1.peg.2573 Permease of the drug/metabolite transporter (DMT) superfamily
MTSHLRGILLLLLVTAIWGSTFAVVKELGALLAPPVLLAWRFSIGALVLLPLAALRRTPAPTVTVTQADGTSLWSDGMVLGLWLIAGYGTQTIALQTTTANRAAFFTALSVVLVPVWLTLVQRRRMPAVLWAALPLAVAGLALLSWEGGAWVSGDAWALACAVTYAGFILALEKLASRHAALPFTLAQVLSVALVAWGWALLSGAPLWPPQAAWAPLFYLGVVATAGTTLLQTLGQRHVSAAEASLIYALEPVSAALFSFALIGERVGARGALGGALVVLATVLSSRAGETEPVARVLDSSQDD
>fig|243230.1.peg.2616 Permeases of the drug/metabolite transporter (DMT) superfamily
MWAMNPVFSGLFSALTYGVSDFLAGLASRHDSPLRVVALSHTLSAVALVLLAVGLGQPMPGQTALLWGAGAGLLGMGAVVAFYRALALGPMGAVSVGAGALSAVVPVGAGLLAGESLGRLGSLGALGVLLGTALLSFRPGGAGKEGNSGVGLGLLAGLGFGMFFLLLGQAQSPGVLWVLAAARATSALLSLMIAASTVGLRPRAPALILAAFPGDMLGSLFYLIAVQGGGLALGALFSSLYPAFTTLMAVAVLRERLRAAQWVGVGFALVGAVLLSQR
>fig|243231.1.peg.263 Multidrug resistance transporter, Bcr/CflA family
MEITSTAPAFQPADMTRRELARLVLILGALTAFSSMSIDMYLPAFPQIARDLGVPLGTVQLSISAFLFGSAAGQLVYGPLADRWGRRTPLLGGLALYVAAAFGCAAVHTGEGLLFWRVVMALGGGAGMVISRAVVRDLYDTAEAARMFSLLMLVMGAAPILAPIAGGQLLLITGWRGIFGFLGIFGILSLAAAAACLPESLPPERRSTRGVAEMAAIYGHLLRNRRYLRYAIALGCVAGVNFSYISGSPFVFIELNGVSPQQFGLFFGANAFGLIGASQVNRRLLRRFSAQRILNVAFTVNAAAALLLTVAGFTGVGGFPAQVVLLFVCLCMTGFLYPNVTALAMAPFDKAAGSASALLGTIQYTLGASAGALVGMLHNGTAVPMTAAMAACGLLGWCAAVAGIPRAQVDH
>fig|243231.1.peg.541 Permease of the drug/metabolite transporter (DMT) superfamily
MIQAQTAAPPHAKVTAILLFTTLMWGGSFLFNKIGMREVPPVHFFFFRFALAALLMGGVCLPRLARLNRHIAVRGAVVGLALAAVNLTFVLGVSGTTISRAGYLNNLFVLFIPLLTFALWRERVDRVTFGGIALAVVGLWALASGGAEGFNQGDLLSTVCALFIAIHIIAVSRVLRDEDVYLVTFVQFVTVAAVGLVLCLVLPWPEFTIGRAGAWSLAYCALFPTVICFTLQNAYQRFTTPTRAGLIYTLDPVWSMLFGVFILGERLTPRELAGCVLILMAVAGPLLARLYLEQRHRRLYRLDGAEGT
>fig|243231.1.peg.1143 Permeases of the drug/metabolite transporter (DMT) superfamily
MFKTVIIMLMAVSAGTIGDILLAKGMKELGDLSAMNLRGILNVAGQALTSPKLIFGTAMLAIFFFLWLAVLSWEDLSVALPMQALNYVLVAFLSQWFLGETVSPLRWTGTIMVCVGVMLITKSGTP
>fig|243231.1.peg.1470 Membrane fusion component of tripartite multidrug resistance system
MTTEQELPDRGENREAPSAQTAPQGKGSGGKRRRAGIFLLILFVVGAVIGLRWLVHGITYISTDNAFVESHIHAVSSRVPGTVAAVYVTDNQAVKKGDLLAELDPSDYRTRVSEATAALAMARNETSGDYAQVEAARAAVDHARARLAQADLDLTRGTALLAKEVIPREQFDRLETAKRVAVAQVREAEEQMRKAQAEIGLSGSGSREARVALRDAQLATASLNLSYTKILAPADGYVTRKSVEPGNTVQAGQPLMAVVDLDDVWITANYKESQLTHMKPGQKVTFTVDAYPGRTFSGRIDSIMAGTGAAFSLLPPENATGNYVKVVQRVPVKIAVDRASDPGHLLRVGMSVVPSVDVERSLGDILHGLWPF
>fig|243231.1.peg.1471 Outer membrane component of tripartite multidrug resistance system
MKPLPIRSIPFLILALCAATPAMASALSLKECLSLAAAGNYSLAVTASDRLIAQEAITQARSGFLPRVDFQGGYTLQAKPQAVNFGERGSIETQDGTYGFFNLSVTQTIYDFGRTSSRRQRASLLHEATAQQYAAAEKDVFLQVVEAYFGILEARRLLGTAEEEVAQRTDHLRIATNLFEQGVVTRNDLLQAQVRLAESSQKRLVAANRLENRWMYLNHLTGRPLDQRDELEEGTESAMPDTAGAEERAFANRPELTALARSADAADAEVSEARSGYYPELYAKAGVDYVENSKVREQAIYAATVGLKINLFEGFATESRHRQSVERLTRSRDALRLAREQVRLELATALNDARVAEQRIKSVETAIRQGEENLRINRDRYQAQVGTATDVLDAQTLLTQIKTDYHRAVFDFQVAKARVSKAMGEL
>fig|243231.1.peg.2537 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKISFVIPVHNEQDNLLPLFDEITRMADAERYEYEIIFVDDGSRDNSLQVLKSLARGCPAVRYLSLAANRGQSAALGVGFAHAAGDVIITMDADGQNDPADVPAMMARYGEGCDMVTGWRRNRRDTLSKRVGSRIGNGIRNRLTGESIHDTGCSLKVMRADMVKRIKMFKGMHRFLPTLMRMEGARVVEMEVNHRPRRHGTSNYTNWRRAREGFFDLLAVRWMQRRYQPATIGEKHV
>fig|243231.1.peg.2541 Polymyxin resistance protein PmrJ, predicted deacetylase
MERPTIAIKVDADTFVGTRDGIPRILDILGRFGVKATFYFSLGPDNTGKAVRRIITRRGFLRTSLRLNAPALLGPRTLLSGLLIPPPIIGNRLADTIRLTARLGHEVGIHGWDHVKWHDLLPWIPKKMIALELGRACALFEEVMGRRARTAAAPGWTVSADSLEIQDSMLLSFCSDCRGRTPFYPVVDGRRFGTLQVPTTLPTLDELLGGGIATEREAVDRLMGLVGPGLNVHTVQAEIEGKRYAPHLASLLDRLTGTGARFVTLGEAADEAKRATVPVCRLTMEEIPGRPGRVAVQGEEWSEPGPAAGEP
>fig|243231.1.peg.2647 Acriflavin resistance protein
MILSDLSIKRPIFATVMMLVLVTLGAFSYRLLSVEMYPNVEMPVISIVTKYPGASPETVEREVSKRIEEAVNQIAGVKHVVSTSRESVSTVVVEFRLEERTNEVAQEARAKVNSVRGQLPAGIEDPIIQKLDFNALPVAALAIQSKTLSQRELTTLVDKRVRKRFESVAGVGKVEMVGGAKREVNVQVDPVRLESLGLGANDVVRGLQNENVNTPLGRITREGAEYPLRIDGKPDLVGGYRSMVVAQKGGRPITLGEVAAISDGVEERRTLALVNGVPAIGIDIYKQSGANQVQVVDNVRKVMEKIRKELPPEVSLTLVRDSSIMTRQSLADVEETLIIGGILTVIIVFLFINSWRSTVITGVTLPISVISSFIIMNAMGMTLNVMTLMALSLSIGLLIDDAIVVRENIVRHLEMGKDHMEASRFGTSEIGLAVFATTLSILAVFVPVAFMRGIVGRFFFPFGITVSFAVLVSLFVSFTLDPMLSSRWHDPAVHAHGKRRGLARWLESFNDWFDRAADRYRLAIAWALDHRRTVIATAALTFFLGIAVMGTLESSFMSEEDTSEFQVSFKAAPNASITESEGRLKAMLAAIGDIPEISHTYSTIGAGDGGTVRDGLLYVKLREKKERERGQFEIERVVRQRLQQIAGITFSIEKVGNVGGAAKPLNVNLKGDDIGLLKSYAAQLKEKMYAIPGIVDVSATLEHDTPEYRLRVDREKALSAGVTSNDVVTALSRLVGGEAVTTYEDEDGDAVDVRVRLPEVLRQNPAQVRDLKISVPDSDGGTKLIPLASVSTESVAATPSEVNRRDLSRLVTVSANLDGLPIGTAVKKVEEVSKTIAMAPGYSIGFSGEAEDMAESFGYMGESLLLAVVFVFLILAAQFESFFEPLAIMLSLPLSIVGMAGMLKLTGDTINIMALIGLIMLMGLVTKNAILLVDYAKVLRRRDGLPRREAVIEAGRTRLRPIVMTTLAMIFGMLPLFLGIGAGGEGRAPMARAVVGGLITSSLLTLIVVPVMYTYMDDLAVRLRRWWLGNAEGALAVGPASDGLVASILKKARGISLKKFFGVFACLITLGTGAFSAEAADIRVLTLDQALAMADERNRDIAKAREFFRQVEGRYVEERSAALPQFTITGSASWLDDRSQKALAGGFIPTRQDVRAAGVELSQALYTWGKVSAAIRAADLGFRTADEQLRTARQDARRDVAVAFYDILLAREQLAISRQNLEQKERHLDEAQRKYAAGVATDYDVLAAGVSVENARPEVIRAENLTRLATDRLRYFLALDQEIEVEGALSFEPATVPSHAEALAVARRQRPELEELRRRIDMAGELVAVADAEDKPRLDLKAGYGWRQLETGDGRGDGAAWNVGLYLSFPVFDGLKARGKVAQAESERRSLRIEEAKLMDSVSLEIRDAVNNVREAREIVSALEGTVAQAERLLTMAEQGFELGVKIRLEVDDAELNLRQARGNLAKARRDYLVARVNLERVMGVLGEEGADQNKM
>fig|243231.1.peg.2660 Permease of the drug/metabolite transporter (DMT) superfamily
MALESLHTTRQDRVSHSLVGPRLAGAAFVAASAVGFGALGIFGKVAFASGASTAVVLFLRFLVAGVLMAALMPVLRLSWPRGRDLWILVGMGAIGYVGQAFCYFTSLRYASAGLTALLLYLYPALVTLASAALGRQRLTPLKVAAVAASLIGILLTVADGLTGSLSGIAFGAGAAVIYTGYILVGEQVSRRTGAIPAATVIMLAAATVYGCAVIWQGPHWPTGLAGWGAVVGIALFSTVVAMVGFFAGMQRLGAADAATLSTLEPVVTLVLAALILGESLGGVQLAGAALVLGAVVALARAK
>fig|243231.1.peg.3385 Permease of the drug/metabolite transporter (DMT) superfamily
MNKAKAIVALLLTTFFWGITFTIVKDAVAQVDVFVFLAQRFLMAVVLLVPFCACRRVPLTMQTVRHGLFLGLFLFGSYAFQTMALRFTTASNTGFLTGLSVVLVPMLGALLFRQAVSQGIKWGVALAVPGLFLLCTNGAFVLNIGDMLAAICAVCVSLHLILTGKFARDNDVWWLTAMQLSTVALLSFLVAEVGGHRTMAWHPEILWALLICAVFATVFAFLVQTSMQRFLSPAHTALIFCLEPVFAALYAFWAADERLGTLGYLGALLILAGMVISELAPSGESPEASTAT
>fig|243232.1.peg.731 MATE family drug/sodium antiporter
MKNVEILLDDPKKAVIEVSKPIIVATFIESIYSLVDSIWVSGLGADALAAVGASFPILISIYAVSWGLSIGISSGIARRVGAKNKEEADKVANHAIILALIAGILYIIAVYPNLDTLFSLMGTYGDCKSLAIKYSSILVLGTVIFTICDALYGIFRGEGNTKIVMIASVIGTLTNIILDPIFIYMLNLGISGASYATLIAIIISLLILAYELFIKKSCYVTVKLSKFKPDLKIIADLIRVGIPSALIEITVAVSFFIMTSIIMMVGDSRGLAVYTGALRITEFGFIPMLGLASGATSVIGATYGARSFEKLKTAYFYTIKIGVLMEIIIVALIMLLSPILAYLFTYTKTSMGIHEELVKALRIVPLYLLFTPFILTTSAMFQGIGKGEKSLIISIFRSLICHISYAYLFAVILGLGMFGIYSGLVVGEFTAGIFAFLFGVLAIKALIKSK
>fig|243232.1.peg.1004 Multiple antibiotic resistance protein MarC
MVGYSGEHFIFNVVKYMDILNFYIYGFVSLFITIDPIGLIPIVHSLTYPYPKEQRIRIIKKAIISSTVVLLLFALFGNYIFGYFGITIDAFRVAGGILLFKIAWDMLHAEIPKTKHKPDERLDLEDIDSIVYVPLAIPLISGPGAITTTMILISKTQSILEKGVVVLSILSAMLVSGIILSLTDFIIRRVNIYGINAFVRIMGLLLVAISVQIIFTGIVGLYNSISVQ
>fig|243232.1.peg.1354 Multidrug resistance protein
MVRKVAEQNLQKNNENDRELSKNVYLLGFTSFLNDMSSEMIMPILPMLITSVGGGSLSIGLVGGLREFISNILMVLIGYCSDKVRKRKIFVVLGYLTSSMFKLLLGLSKSWLGAVIFSSLERMGKGIRTAPRDAIISESMPKTLGKGFGIQRAFDTAGAILGSTLSLLFILYLQYSFNQIILIAAVIGFLTLIPLYFVKEKPSPSNNKITFRVGIKNLPKELKLFILISAIFTLSNFSYMFYILRAQEFLMIVDEKMAIIIPIALYILYNIFYATFSIPFGILSDKIGRKSVLTIGYIVYGIVSLGFAYFISQKSLILLFALYGIAYALFAGNQKAYVSDLSSEDIRATALGLFYTVVGLTSLPASLIAGYLWKISPEMTFLYGSVLAIISGLLLLFI
>fig|243232.1.peg.1724 Multiple antibiotic resistance protein MarC
MDLQYFILAFSSIFSILNPFGAVPVFITLTESYPKKERDLVAKKTVIYALAILLAFALFGEWILKFFGISLDAFKIAGGILLLLISLDMVRGQQEAKIHRKEIEAAYEIDEIALMPLATPLLAGPGSITACMVAMAEASDIGDKFLVILAILLSLGITYLTLLSAESVLDRIGRLGIRILTRMMGLILTAIAVQMIVNGIRGALL
>fig|243265.1.peg.177 CpmF protein involved in carbapenem resistance
MKYIYLFLSIIMSSKAYSFDNMKLSFVEGGDFYVGSVFGAQNYESHSNVTLNSFYIMKNEVTYSEYKEVYEWAILNGYDFDDGCNGSHYEDCLPPEQDEGRHPVTSIKWLDTILFSNALSEKLKLTPVYFQKGNKIIRKKDKNLEIFINTNANGYRLPTLNEWHVAARGGEPALRLGRYGYYHSGSNDSKKVAWYPEFNTSNFGTQVVGKLSPNDLDLYDMSGNVSEWVYDSYELGTVKLYYFCGGSYLSHANSLSSCDNHSSGYIMPDVGFRLVRSYLNEK
>fig|243265.1.peg.178 CpmG protein involved in carbapenem resistance
MKNKFYLIFILLFSFEAFSHCGNKVNLKDGINLIDLNGDGKKDVIFYAKFENNTSHPSNTLTVFIKNKNGKFNIVPLPNDTGFTWFDFKLSASEIKIQDYELGVKNGVYYIIFFRKKNNDDDIFGEYPVEFIKYDIKYNNEVPGISNYYWDYTKSYLTKKKYKNVSDAMTEYNMECSL
>fig|243265.1.peg.179 
MKFFLFFFVFLSFFCHSGENESFRKKIQKKIDDKILLCLGETEWPVSINENSIWVNANMESLVDAGLVKLDFKRGKNKLWNLTKLGKKEFNKNGDFCYGRMMLKDILNINYINKKRGFIVFNYYVHLLPEWAKNKSIRFAYSYLDNIITGIDNEKYQIEFEKSDTGIIKIISDPIQLEILY
>fig|243265.1.peg.1331 Multidrug resistance protein B
MKNFSLSNYTSIPACIWGLFLGTFVTRSTSMMVWPFISIILYTKFHFTASMIGLVLSLSIAISSILSFYAGYFSDKVGRAKIIIIGCLISSLAYLILWLSEHQSGFIIGTLLANISWALVNNPIKAVIGDIIEEKQVRENAMYLRYLFLNAGAVVGPYLGVKLSLDINSISFLIVSLSYVIFMIPVYLFGKKIKIKLTNNDDFKGTMKVLLNDRVFLMLVINNILMMFIFGHFDSTLPQLITSLGFNGYAEFIASLIMLHAVTIVVMQLPFSILTQKMALETKINVGSVLLILSEFMFFISFKYYDVYLLWYVAAFIMSISQTILFPCVNVFIDRLAPNDLRGAYFGAASLYSIGFSISPLVGGTVIQLFNGGVLFQLLAILSVLMLVIFCRMFKLRDKHEINIRRSLKS
>fig|243265.1.peg.1433 Multidrug resistance protein 2
MRMLVGATSTIFILNHGLTLVDIGLMKTIQSFIYFLFDIPSSYLADKFGRKFAIILSTTFGGVWLIITGIADSKYLFYIAEIFNSISLTILGGVFYSYLIDNSLNDNDTHKILGESNKLQFLFMAIFSIIGSLITDFDDRLVWLIAGSGCIILSVSLSWFLPKSITKNRQPNLSFLKEIKTSIAMLKDNKNYLFITSISLSSSLLYFQIILQYWQPLINYIIEELGVSIFFGIVFSAILLSQSISGWIISKNEDNNKNHLYSIVILLVCSLTCIYGVYEKNHITTISTIIMFGANQVMTTSLRSNYHQIIPSELRSTFDSFISTITRLIAVIVIPLIALITENFGWIYFPILISLIISINILCYFFIKKHHKRKPTWNPKS
>fig|243265.1.peg.3357 Probable multidrug resistance protein norM
MAKFSNWRELKQLLFFSFPIIVSQIARTAMSFVDIVMSGHYATADLAAVTLGSSIWFPIFVLGYGTIIMLAADVAKQKAQHDDEGIKDSLKNYLFLAVILSIPIIILLMLVSWLLSFIGIDEHILEITQGYVIALACGVPSVMIFNVFRSFLQGLEDTKIAMYLSAGALLLNIPLNYILIYGKLGLPEMGGIGAGITTAIINNLIAVCLIIYFLLKKEYRRYRPDFSLPKYNSLIRTFYIGMPSGLALFVEMVFLDVIAITAAPLGAQVIAAHNIMLNITSIIYTITGGIAAAVTVRVGSYIGKRDKISLTGTIKISIALILSISAVIGVLIYYFAGSFISLYTNDNGVIIIALNIIFLLCLFQFFDSCQAALSGILRGFHDTRSVFYAPLFGYWLVGLPLGFILALTDWVTERMGIIGFWYGLVLGLFVNAILLFIILKVRQRGMISRLISY
>fig|243265.1.peg.3899 Bicyclomycin resistance protein
MKNKSLLFIVLMAFLSMGGLVSSDIFLPALSKMGNYYHVSESSIQSTITIFLFGIAFSQLIYGPLSDCLGRKTVLISGMIIWLISTIGIFYSTHISELLLLRLFQGIGACAGITLSRAIISDLMEKEEAANLYLIIFPFVGMSPAIAPMIGGMLSEYYGWRSCFLFLTLFITVTLILCLLVLKESLPINKRQKLSIKNVLVSTYQVIINKEFLYYAAIPCFAYTAYFSYLIESPFILTAMGLPEKYVGYTYIMLSLSYVLGNLIAKKLSRRQGVRKTISHGYLIFVVGGIAFTIQMFFSSYPLITSVLTISVLTFGNGFLLPLGTASAIATHSQAAGTASGVMGTLQLGSAGLASLFIGYISHHEPIKVASIITVVSLVGSIIYITGNRGGKENK
>fig|243265.1.peg.4055 Bicyclomycin resistance protein
MPPLILRLLPIILIIGMVPSFIEVDITLPAFPQMLNFFSAAESAVQFTLIVNFLGLCIFTPIFGPLSESYGRRKIILIGATLFFIGSIGCSTVVDLNQLYLFRFIQGAGCSAIWIVGFIICSDIYKDEESVQVFGILNAAISMALIIAPIAGSLIVAHYNWRFTYHLVALLSFLSLMAVFIVPETNRNTVKLSVNKVIKNYCQLIFNTRFLIYSFTPGLLVSACIAYVSVVPFLYIDKMGMSYYIFAVHQAILGICLSVAGFYSGALNRKIGSANCIYLSIIICLIGCGSLMIFSHIYPESAILFTLSMAVICIGSAFQYSMVFSRSLALHPELVGSASSLLTFFRLIFFSFSVLISGWAFTGKLFNSAIVVSSIIAMGLLFSLFVLIDLRNNVVNRRINDESHVS
>fig|243274.1.peg.283 Multidrug resistance ABC transporter ATP-binding and permease protein
MKTLARYLKPYWIFAVLAPLFMVVEVICDLSQPTLLARIVDEGIARGDFSLVLKTGILMLIVALIGAVGGIGCTVFASYASQNFGADLRRDLFRKVLSFSISNVNRFHTSSLITRLTNDVTQLQNLVMMLLRIVVRAPLLFVGGIVMAVSINVKLSSVLIFLIPPIVLLFVWLTKKGNPLFRKIQESTDEVNRVVRENLLGVRVVRAFRREEYENENFRKANESLRRSIISAFSLIVFALPLFIFIVNMGMIAVLWFGGVLVRNNQMEIGSIMAYTNYLMQIMFSLMMIGNILNFIVRASASAKRVLEVLNEKPAIEEADNALALPNVEGSVSFENVEFRYFENTDPVLSGVNFSVKPGSLVAVLGETGSGKSTLMNLIPRLIDPERGRVEVDELDVRTVKLKDLRGHISAVPQETVLFSGTIKENLKWGREDATDDEIVEAAKIAQIHDFIISLPEGYDSRVERGGRNFSGGQKQRLSIARALVKKPKVLILDDCTSSVDPITEKRILDGLKRYTKGCTTFIITQKIPTALLADKILVLHEGKVAGFGTHKELLEHCKPYREIYESQFGNGVMNDA
>fig|243274.1.peg.284 Multidrug resistance ABC transporter ATP-binding and permease protein
MPEIRRRPHGPILEKPALKNPTATLRRLLGYLRPHTFTLIMVFVFVTVSSILGVLSPYLIGKTIDVVFVPRRFDLLPRYMLILGTIYALTSLLFWLQGKIMLTLSQDVVFRLRKELFEKLQRVPVGFFDRTPHGDIISRVINDVDNINNVLGNSIIQFFSGIVTLAGAVIMMFRVNVILSLVTLSIVPLTVLITQIVSSQTRKYFYENQRVLGQLNGIIEEDISGLTVIKLFTREEKEMEKFDRVNESLRKVGTKAQIFSGVLPPLMNMVNNLGFALISGFGGWLALKDIITVGTIATFIGYSRQFTRPLNELSNQFNMIQMALASAERIFEILDLEEEKDDPDAVELREVRGEIEFKNVWFSYDKKKPVLKDITFHIKPGQKVALVGPTGSGKTTIVNLLMRFYDVDRGQILVDGIDIRKIKRSSLRSSIGIVLQDTILFSTTVKENLKYGNPGATDEEIKEAAKLTHSDHFIKHLPEGYETVLTDNGEDLSQGQRQLLAITRAFLANPKILILDEATSNVDTKTEKSIQAAMWKLMEGKTSIIIAHRLNTIKNADLIIVLRDGEIVEMGKHDELIQKRGFYYELFTSQYGLVVEKE
>fig|243274.1.peg.580 Permease of the drug/metabolite transporter (DMT) superfamily
MILERFFAWLVVVFWGISFLATKVVVQVLDPFFAGFLRFIFAFFFLFLISGGRPKLFNKNIVMAGFWGVFSYFAFENSALMFTEPTNAAIIVSSAPVFFLLFSHLVQKKKTTSKMYLGVILSFLGVALVVLNGRFVLKLNPLGDLLAFGAALSWVFYTHHIESLGSLSFRENAGIMFWGVVFFLPFSAGKFQQIREMNSIVVISLLYLGLVCSGLAYFLWNKAIERLGSRTTTNMIYYIPVVTAVAEHLLKLKLPSALLVGGVVLVVIGLLIFEREVHYETEDSTRGMRKDRTEETRPSAD
>fig|243274.1.peg.721 Permease of the drug/metabolite transporter (DMT) superfamily
MWRENKALAFLVLTAVLQGSTFPLQKLVLGGVSPFVYNTVRFGSAALLSLFVFGPGRFVKGFLLGLVLCGAYIFQLWGLKFTSAVKSGFIVSSFVFLVPLFAFLLEREKLRKIHFISFTSGFLGLYLLTGGVSQITLGNLFQFFCAVLFALHVVLITRFSRSEEEKNMLFWQFVTVGAVNFLFGLGERWHLNLEAISVGIYSGVFATTLGILWQMRYQKEVGNNTTALVYMTQPFVSLVLSFLLLGERMSFLQLLGGILVLVALFTGTTLRPRESN
>fig|243274.1.peg.1007 Permease of the drug/metabolite transporter (DMT) superfamily
MDLRVLLSGLAYSTIFGLSFLFTKNALDYVTPLTFLSFRFIVAFLSYLLLLITGAVKLGKKPYWKLWKLVLFQPVLYFLFETYGLQRVNSSEAGMIIALIPIVVNLLAPFILKEKGDLLHYLLVGMGFLGVSLIVGFNITPGNIVGKVFMLLAVLSGAMYSVFSRKFSKEFTPTEITFFMMMTGAVFFTLLSLSTGDFRPVFNVDVVIGALYLGVLSSTVAFFLLNYAIRKLSPIFTTLFSNFTTVVSVIAGVVFRNETVGIQQIAGMGLIISSLIIMSLRRSYKRLSRAQKL
>fig|243274.1.peg.1705 Permease of the drug/metabolite transporter (DMT) superfamily
MVKALFSLLFVAFIWGSTFPIQKIVLVGVSPTFYIAVRFFIAALVSYFLFGKGNVKYGSILGTLLGIAYTTQTWGLTITTSTKSGFITSMYIVFVPVFAYLLEREIPTIFQIVSFFAASLGLYMISGGIKDFNFGDFLTLICAVSFALHVVLITMFSKRVKEVDLLFPQFLVVGILNLILNFFWKNWNFTLPALGSAVFTALAATILAIYLQAKYQKALGNNVSAIVFLGEPVFAAVVSYFMLGETMAGKQLLGAALLLISMLFSSLERVKIVRDANQKGRDECEDSL
>fig|243275.1.peg.330 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDKREHLISGNMFKLMLELSIPGIIGMFVISLYSFVDAIFVGRYVSSVALGAVSLAYTFTLINNGIAVLVGIGSASVLSRAVGRSDQETVDSIMGNVLLLTLLFSLGTMTIGLIFAPQLLILIGAEGEMLRLGVSYLRIVYIGSVFVNFGQAANMVMRGEGRMGLAMLLMGISAVLNIILDAVFVIVLKKGLEGTAIATVISQVVLAICNFCYFAFFSKNVKFKHFKLQKSIVKETLSIGFSAMLMQVFALLQQAVMYSTLKRYGGEDQVILMGAFFRYMMLSFIPLWGISQGYQPFAGTNFGAQKFERVKKGTFLFYGFGLFLSLIFWLVFLIIPEQVLGLFLKNKELISLGRTNAMLAMSLFPLSAIMIINLTLFQALGKAKYAGILVIARQFLLYIPAVLILPVFFGTRGVWISTPIIDTLVTVLSAFIVIKLFKKDLSPKDKPLSA
>fig|243275.1.peg.347 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDSKELRRFNILTKPIFPLLVKTSIPTIIGMLISVIYNLTDTFFVGRLNNRAMIAAIGIVFSFVSIIQAIGFWFGYGSGNAMSKKIGEQDYAEAETISSVGIVFAIIIGILIAIGASIFILPLSKFIGGSASQDVLTFTVQYLRIIIISIPFSLYALTVYNQLRLCGNVRDGMVGLLSGMLSNMVLDPVLMFIFKQGFIGAGYATLIGQIIGCIVLTLLAKRHESISFNLKKVQYSKERMYHILAGGMPNFSRQAITSAALVLLNVKAAQYGESMIAALTVSSRVAALAYMIMIGWGQGFQPICAMNYGAKQYSRVKKAFITTVLIGTIFLTAASIILFLFAEQCIGVMSKDDEVIFAGIKILRMQCFSLPLLSFFAVSSMFMQNIGHYFSSLLISISRQGFFYLPLLYILPALYGKTGIYLLQPFSDVLSFLFAVAVVYRWYSSGAFSSALNAG
>fig|243275.1.peg.669 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNIIAIIYAVAAAAFYALNVPCSKILLQNISPVFMAGLLYIGAGLGVGILYLFNFKKEQKSERLDKNYLPYTIGMIFLDIVAPILLMLGVKYGTSSNASLLGNFEIVATALIALIIFKEKVTWRLWIAIFFITASSIILSFENIEGLNFSIGSLFVLGATICWGLENNCTRRMSDKSTYQIVTIKGLCSGFGSIIVAFVSGETDFTLKYIPFALLLGFVSYGLSIFTYIRAQKYLGAAKTSAYYSIAPFIGTFLAFVLLKEKISTKYISALFVMIIGTAFAVYDTLIRKHLHGHRHTFTHTHNGITHTHTISHSHLHNHFISDSKHGHHHSIEELENELKNEIGK
>fig|243275.1.peg.804 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENEKQKEFILNGNLWKVIFDLSWPAVIAMILLGANNVLDGIFVGHFAEEGAFAGISVALPPIITIIGLGILIGSGAGTLLSIAIGAEDKNIQKKILGNVNFLTLIISVIVMTLGFLFSEQTLFLMGGRGNALIHGSKYYRTILWGTPIWIYAIALNNLIRSEGKMKTAAAIMGISLIVNGCANYTLMVIFNFGIKGAAIGTNIGMAVQAIISTLYFAKKNPDSPVSVFTIRIDGEIISKIISMGLASFIMQFMGTIQMLLVLNVLNHYGSQDDIAFYGIITRIFSFILQTIGGFMIALSPIIGINFGADKTERLISAFKRFVFAALILIAPLWILILIFPQTSVSLMMKNPHLSIHNISYFRIYMALLPVMPLVFFALAFFPAVNKGKISSILGILQQIVFYIPIMLILPIFIGIAGIYYGTFLIEILSAIPISILIIREFRLLRSGITKWQKN
>fig|243275.1.peg.1869 Permease of the drug/metabolite transporter (DMT) superfamily
MSFKLKSGSRIRILSRLALLSATLLWGSTFVAVSSTNDFFKPNFLLACRFLPACLILCAVFFKRLKQLDKRYVKAGMILGLIMFAGYSLQAIAITTAGGLPGRSSFLVATYCVLVPFVNAVVLKKRPDKFNLFAAFLCFAGILAISMPDLISESQKGINWGDVLSLISSFIFAVYIVLLPKFMEELDVPLITLTQFAFAGTYALIFSLLFEDNSNTVWNYQSVFTLVYLTVLCTALCVLLQAVGQKNTPPTTAALIFSLESVFSIFLSIMLTDEKFTPALALGCSFIFIAIIISETKLSFLKKKSVEVNC
>fig|243275.1.peg.2452 Permease of the drug/metabolite transporter (DMT) superfamily
MFQHRTIFCLYKFRLVFFFVFLYNADLSYNTPFQKGKLVPGLFEAFCICRFTDDAKEFILTNTKINVLSRLALLIVAIVWGSSLVVVSETTDFFKPNFLLGLRFSIACFLLCLVFYKKLKLIDKDYLINGGIVGFFLFIAYSSQTFGVTTAGGLPGRSAFLSASYCVIVPFLGWLVNRIRPDRYNASAAVLCILGIGLVSFKDLVLSSSVGITLGDFYALLSGLLFASHIVSITRLSKRKDPILMTIIQFGAAAILSWLVTLIFEDNSAIVWSYSSVGSVLYLAAICTGLALLLQNIGQKHTDASSAAIILGLESIFGIIFSVIFKGESLDVYSVFGFILIFIAIIISETKLSFLKKEKA
>fig|243276.1.peg.983 Multiple antibiotic resistance protein MarC
MLCMLEMDSARQRFVRDVEHIRHEDMHEMGICARRGFTCSDTHPHRKRHSQKKCCTRAVPTQGNGDCRTRGSSRILTPRMSTWTHIWSTAFTLLFIIDPIGNIPVVLSVLRTVPAERHTRIIFRELLLGLVLMLSFLFCGKVFLSLFQLETGVMKMAGSVILFLVGIKMVFPDQHALPSTTEEEPFIVPIATPMIAGPSAFTTLVIMGETKGTSRLATCAALLVAWTLACLIMISAPCLYRLLKEKGITALERITGILLLILSIQMCVEGARGIIATS
>fig|243277.1.peg.1393 Outer membrane component of tripartite multidrug resistance system
MKNSVQTVGLLHKAAPYFTASLLSAFVLTGCSVPDHYPDLATMWEANELSSTNTFSHQAEMDWPSANWWQRYQDAQLNHLIEEALQHSPSLEMAMARLKGAQGFARQAGAIRSFDLGLAASATESKVSERYQSATPPDGWNDYGTLTLNFQYDFDFWGKNRAAVVAATSELAAAEAESVAARLMISTSIANAYAELARLYANQETVHAALQVRNKTVELLEKRYANGLETLGSVSQAKAVAASVEAELLGIQESIQLQKNALAALVGQGPDRAASIEEPHITLTSRYGLPSEAGVGLLGHRADITAARWRAEAAAQQVGIAQAQFYPDVTLSAFIGYQAFGLDHLFDSGNDAGAIGPAIYLPLFTGGRLEGQLTSAEARYQEAVAQYNGTLVQALYEVADVVTSSQALQARINKTEQAVQQAEQALHIATNRYQGGLATYLDVLVAEESLLNNQRALVNLQSRAFSLDLALIHALGGGFETTES
>fig|243277.1.peg.2832 Permease of the drug/metabolite transporter (DMT) superfamily
MSLVNLLQLLCLAAIWGGSFLFMRIAAHSFGPAYLIEARVGFAALSLFLVAQLLRRSLPIRQHWPHFLILGLINTAVPFLLFAYAALTLNVSTLSILNSTAPIWGAVIGFLWHGTPLSRKAVAGLLLGVSGVAVIVGWDMVAIGHHAALPMVCAALAAASYGLATNYTKQAPQLSAFENAHGSMWAACLWVAPLMWFVPLRETPSSLEWGAVILLGVICTGLAYLIYFRLVKAIGAASTLSVTFLIPVFGILWGYWILDEPIGLNTLFGTLLVLAGTMLVTGFSLRNARLSRQPQPH
>fig|243277.1.peg.3688 Permease of the drug/metabolite transporter (DMT) superfamily
MPNHVLPVLFMLLSTFSLSLTGLLTQYLSHIIPITLLGFLRFIIPALFLLVAMKLTHFRWPQRNMWFSLLIRAVCIAGSQLCFIYALQSLSLVESVVLFSTGPLFIPLLEKWLWGGQLAWRTVLSVCIIFVGVVMLAGNTGSIEWRPELLAGLSAGLFNAGSQLSLYRAAQSDMRSIEIHGWTFLVAALLLSPLLLLVPWSSDVGASLGMSWDISGAVTFAALLLSAILVVNTQVFRAKAYRLAKSGSQLAPLIFTNLLFSALWQVLFFDVDYTLAQQVGLAVIIVTTVINGILPRLTERKTRLKSA
>fig|243365.1.peg.122 Probable multidrug resistance protein
MSHSSLAVRQSNPATAAAILLILFNPLGVDLYLSALPALQRHFQADVSASISVFVFCLGLGQLLFGPLADRAGRRPVALGGLLAYALGSALASLSDSMGSFMLARMLQGLGASASSVCAFTIIRDCFSGNAASQRYSLLNGALNIVPALAPALGGVLTELYGWQSCFLFLAVSALAALALLSRLMPETRPERLEDAAGPGFLQVLRHPALLRNGACSSTALGLIVSYVTLAPTVLIERGGLSAATFGLLFGANALLIMAASFVGLGLIGRLGPRRVLKTGLAIMLAAGALLPALAHQAGAWHYMLPVAVLSVGFAFTLGPAAGLAMAPFAESAGRAAALLGCAQMLFASALSALLAALPVAGELALGGAVIALSLLCLALQWRAPARG
>fig|243365.1.peg.219 Permease of the drug/metabolite transporter (DMT) superfamily
MRVAAPAFGPLPLIALRVGLAACLLLPLLLWRGLWPLWRDNWLPVAAVGVFFTAFPFSLIAWAQLSLPAGMASVLNATTPLMTALWAWPLAGERLSPRRMAGLGLGLAGVLALLAGHGARFEVRSLAPVLAMLGATASYGWAGHMARRWLPGMPPLVTACGGLASGALLMLPLAWLSWPALPPPPQAWTALLLLAAFCTALAYLIFYRLINRLGATRASGVTYLVPVFGVLWGALFLGEAIGAGMVLGAALILAGVLALNARR
>fig|243365.1.peg.719 Methylenomycin A resistance protein
MPHAQSVRTGLPTLLALSAGMFMAVLDTNIVNLALPALLRSLDASLSQLTWIVDAYALGFAGLMLSAGWLADRFGPRRMLAWGLALFVLASLLCGLAPGARTLILFRLLQGMAAALFIPSSLGLLRHAFPHPAERARAVGLYGGLSASAAAAGPVLGGLLLAPLGWRGAFLINVPIGLAALLAIPFVVPHRQAMPTRGADLPGQAAGMLTLLLASYALIEGPRLGAPVLFALLLAVAGCGRLFWQLENANPQAMVPPELFRNPVFAAANWVGFAIGVAYFGTLLLLSLYLQQGLGLDALHAGLAMLPLAGCLIIGNVAAGRLLPRLGARRQIRGGLLLSAAGYLLLALADGHALAWSLLAMLPLALGTALAIAPMTATVLESAPPHLSGTASAVLNAVRQTGALVGAAGAALAVGYGADLRHALAIGLSVAALASLSGALIAGWIPRAGQQAAPEPAPAAR
>fig|243365.1.peg.768 Outer membrane component of tripartite multidrug resistance system
METDKVNKKSWPQTAGVLLISAVLSGCASFGPDAAPDQMVGADQLKLAVAGQQNVRADWWRQLNDPELDRLVEATLKDAPSLKLAAARLRQARAAVGIVESKDGPQLDAMANAVQIHADPLKALPHNDKDYINAYTAALVGSWEFDFWGKNHAAVSAALGQQQAVAYEGQQTRLLLTQAVVAQYTQLQRSLAQSRLLSQRLAIAQSRQKLTQARVNAGLLPGDNQRGNEVSIERLQQQQSALDNDIARSRHALAALTGQGPQQQDSLNPGKLDAAPQPALDKLDANLLGRRPDIAAQRARVESMTASVKEARAEFYPNVKLTVFAGQSSLKMDQLWKSESSLWGFMPAISLPIFHSGQLQSNLSKQQAGYDMAVQQYNQTVLDALRDAADAVSGWQNSQRQLQQSERALQSSRKANDSMAARLRAGLVNKLSLLDSQDALLSQQSANIDAQAANRLAWASLNTALGGGFDNQAASR
>fig|243365.1.peg.771 Multidrug resistance transporter, Bcr/CflA family
MSRTSRNHFGLAALLAALSTLGPFSIDTFLPAMRAIGDTLSASPLEMQQALTVYLFCYALMMLWHGSISDAVGRRPVVLATTLLFGLASVGCALSNTLGQLLLFRALQGLCGGAGLVVGRAIIRDRLEGAAAQRLMSQVTMLFSLSPAVAPVVGGWLFGAFGWHSIFAFMALIGFALFALCWFGLPETHPKAARQPLHPRPLLASYWRVGRTVNFQLLTAAVSFNFAGFFLYVPSAPVFLMQHLRLGPTEFLWLFGPAVSGIMFGAYLSGRMAGHFSSREVVSRAYWLMFAAALANLVYNLLAPEQALPWAVLPLALYTTGMSLAAPSITLNLMDQFPELRGTASSLQGFCQTMVSSLVAGVIAPLAWASPLRLALVMNLLLLLGFICRMGYRFRQLGKDENKPAV
>fig|243365.1.peg.1135 Permease of the drug/metabolite transporter (DMT) superfamily
MPYLALTLAMFLWSSAFIVLKYVFQFYHPLAVLFARMAIATLCLLPLAMGGRIRWRYRQGDWPWLLAMGLCEPCLYFLFEANALMHTSASQAGVITATLPMMMAAGAAAFLHERQPRQVWLGIALSFAGVIWLSMDSQAGPGAPNPLLGNALEFCAMVCASGYVLIAKRLSARYSPLALTGVQTLAGCAWFGLAMLTPWGAWPDALLLVPSLWVLYLGAAITLGAYGLYTWAVSRIPVARAGAFNNLIPVFTVAMAWLLLGETPQPWQGAAGALVFAGVWLSQRRPT
>fig|243365.1.peg.1160 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTDARNFVPPYLLELHAAERPADPLVSCLIPAYNESENIVPMLETLHRLLSAHGYRHELVVVDDGSRDDTVPKALEAAKRLPVTLIQLSRNFGKEIALTAGIDNIGGDVAVLIDGDFQHPPEMVPVFLAKWREGYDMVYSVRANRDGETLAKRAFTRVFYALLNSGAPLKIPENTQDFRVLDKSILEALRRMPERNRFMKGLYNWVGFTQLAMETQTRERRAGKSSFNFRSLFNLGLTGLTAFSNMPLRIWTLVGCVISLLSIGYAIWELVHTLLFGNPVSGWPTLAVAVTFLGGVQLLSIGILGEYVGRIFNEVKGRPTYLISRIAKPRDERDE
>fig|243365.1.peg.1179 Probable multidrug resistance protein
MDLRSPVVRRVLLSSFLLSLSRAVISPLLVLALGKQLQLSVQATGTLLALVLLGSALFGLYGGYWLDRLPRGPALRGAALLMAAGSVLLPYGHGYATVVTALAAGELAMVVYSIAVKAILSDVVAERWRSKAFSMRYTLANVAWALGPMLCAGMLFWHETAPYWLGGLLALAGLAAQPRLPQRRHDPAALPDGFAATLRTLAGDRVLVWFTVSSLLAYVVYGRFSGYLPLFLLTRMDEAEAMRWMSALISCNAVVVVLLQYPLGRLLKPNRLMRAIVGGFLLIGAGMLWLGNVDSLPLMCAAIALFTLGEIVLVPAEYLYIDAIAPDALKGSYYGAQNLASLGGALGPAMVGALLSRGPSWVVFAALALLCVAGAGLALYSERLRLRGLRLANRIDASALPGSLS
>fig|243365.1.peg.1361 Permease of the drug/metabolite transporter (DMT) superfamily
MLNNPMPLALGAILLWASLATLGALTRTLPPFFVVGVSLCVGSLLSAHRIRDWKVPPLTLLTGIYGLFGYHFLLFFAFRQAPALEANLLNYLWPLLIVMLSPLLRPGTRLTRRHIIGGVMGFIGAGLIVTGGKLALSQQYLTGYLLAISAAMVWSTFSLLLGRLPAFSGSAMGGFCLASGLLSLLCHALFESPAHPSASQWATLALLGLGPMGGAFFLWERALRLGDPRQIGSLSYSTPLLSTLLLSASGQGQLNSLAAVAILLILGGALLGTLPGRRHAQTQAT
>fig|243365.1.peg.2455 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDLLPVSTLFWRYAIPSIAGMLVTGLYAVIDGVFVGHYVGSHGLAAINLAYPLVMLQVGLGAMISMGAATRIAIQQGAGDMRAARGTLLTALALLLLLSALIPALGLPNIDLLLAWLKADVQPQVAEQARDYLLLMLAGAGLTMGPMLLTYLVRNDGRPKLSTALMTLGALLNIGLDYLFVGVMGKGLAGAAIGTLLAEAVVLILALAYFLSPRASLRIRADRLRPDWRGLWPILALGAPSLLMELNLALLLYAHNHQLLVWGNDLSVAAYAVAGYSESLFTLVIHGLAVGMQPLLGHAIGAGQAERARDALRHGVKVGLIIGVAAWAAVQLFPAWIAGWYSDGSAALVEEGSRALRLHLLAMPLDGLVIVGTTALQAMALTRLALGVTVGKTALLLPALGLLPLAMGLDGVWLAMPLVNLLLGTAVALLLWRQFGQLRGRSLAAQA
>fig|243365.1.peg.2550 Probable mitomycin resistance protein
MHPSRCPPPDAATDLLQLPNVGPRAAADLRLLGFNHPADLRGRDPHQLYLRLCDATGERHDPCVLDVLMSVCHYMDTGEARAWPSFTAERKRRWTV
>fig|243365.1.peg.2729 Probable multiple antibiotic resistance protein marC
MQLLSTFITKFLFVMAALLPIMNPPGLVPIFISMTARNTPQQRRYLARRIAIYCALLLVGSMFVGGYVLSFFGVSLPVVQMSGGLLITFAAWRMLNDTPAESSQPSAEQARVDSQAELKQRAFYPLTFPLTVGPGSVSVAITIGATLTGSGKGLVRFVISPIAGLSAVLVGSTLVYLCYANADKLLRYLGQTGSVVFLRLSAFILLCLGVQIMWDGFGELASQWLRDNAGLLH
>fig|243365.1.peg.3243 Transmembrane multidrug resistance efflux protein
MQPSVNNESLFSQGRTAACIGGIALISLLAFESIAVAAAMPAVAAALGGLDFYAIAFGGTLATSVAGMTLGGEICDRYGAARSAWLGLAAFIAGLLAAGAASDMYTLVLGRLMQGLGSGLLGVAIYVGMSRAVPPALHPKLFAMFAGAWVVPALIGPGIAAGLVHIFGWRAVFLAVAALAPVAGALLLPALSRQEAPAGAAKPMRWRRLGWSLLAASGALALHGGSHLPQTQYILPMLAAGFALAFFAARRLLPAGSLRAAEGLPSVVAMRGLIAAAFFASEAFVPLILTTRYHWSLGSAGLALTASAVMWSLGSATQTRLRGDAARRRGLTLGFAAMGAGLCFALGAASLSLHAGWVVAGWAVTGLGIGLSFPMLSVLTMKLSRPDEQGSNASALQLSDALSSSIALALAGLLIHALSRPSAPPDALPILAMSALLALIGAWVSPRAFASAAPARAEAGAGQLS
>fig|243365.1.peg.3479 Permease of the drug/metabolite transporter (DMT) superfamily
MAMLFPLLAVLIWAANTIVSKAAAQVLDPAAISIYRWLLAALVLTPFCLPVLRRRMGELKPWLGKLLVLAMLGMVMFQCLAYYAAHSTSATNMGVITALVPLLGLLLNAAVFRQKVAALAWLGVAVSLSGVVYLLGKGDPASLLANGVNTGDALILAGAASYALYGILLRRWAPPFGAWLNLYLQASLAVLLLLPLTLTAQSMAIPAKGIGLVLFAGIGSSLVAAYFWMRGIQKLGSERTAIFMNLLPLFTALLASALLGETIHHYHWLGGGLILLGVALGQGLLRLGGAKRPAFVNK
>fig|243365.1.peg.3736 Probable multidrug resistance protein
MPQAALLRRLSRPYRGLPPSVYIQVVCSFINNVGGISKLFLPLYLRESYQLPYNQIGMLMAFYGAGMLAGSLKGGSLTDRFDSRALGVLALAVSGLCMVLLALRIPVWLFMPVLVLSGMADGGFRPINQRLALEPCAPQQRPVAQGMMRVAFNLGVAIAGVSSGFLAAYGYQWVYAANAAGTLLGACWMACSYARRVESTRPQRRRADDEDALAGPWRDASFLRSILALVLITLAFDQMYVTLALFLREHYQLGPQWVGYLFTLNGLMVVALQIPISRRILRWGLARSTQLGVLLTGCSFLWLNAGHGVPWAVLMMMTLTFGELLLSPSYAHLVMHRSEGRLRGSYLGLYNAAWNGRTLVAPALGTALYGQFGGQMLWWLCALAACLGVAIQHGALKAMLAPAAERG
>fig|243365.1.peg.4365 Probable multiple antibiotic resistance protein marC
MFKTLSLQFLFGGLLSLITITNPLSKIPLFITLTREMSDSHRDSQARRACVFAAAIMAVSLLAGNLIMAAFGISYGALRIAGGFVVAVLGYRMLFLSQDPGQAPRQSGEREDYAFFPLAMPGISGPGTIAVVIGISTEIAELSTLPAKALAFAMTFAAIGLTCVGMWLTLKSSLLISERLGRGGREVMTRLMGFLLICIGVQFVGSGIRTFMAGS
>fig|244592.3.peg.585 Multidrug resistance efflux pump
MFEKKFLVVFVAVLFLILIGNEISRHFFAYTSDAYITSDYASMSPAVAGTLAELHVTNDTEVRKGDPLFTLDQTPYKLAAESAAANVAVSEQALQVAKDGVEEAKTNVTATKAILDDAEATQRRLSTLQESGVVTEQRLDDATRDLAEAQANYERALAARTGAQDQLKQKAAELRQATAEKAVADYNLEQTVVRAPFDGQVVPFNTKTGQYLDAGDVVLILVSRTGYRIVANVHEQHVQFIKPGQPVYYMVSTAPWVFFEGSVRGISKGIARSTLETQALPYVDPETDWIRLSQRFPVEINLSVHPDDRQAFMGADARVLILNTDPPPPTGSSHGSGQ
>fig|244592.3.peg.1525 Permease of the drug/metabolite transporter (DMT) superfamily
MVGRASLPGHLIEELRKLPIKLSSIPVLVHFIAAQDKPAHPTFARFSGVGNRKHMVPGRHSPGWSSLMKLQHWILLICLGAIWGGSFIFAKVAVAEIPALTLVFFRVASACLALWLVLWAQGTLEQFPLKMAASFLAMGLLNNVIPFSLLFAGQTVIGAGLASILNATTPVFTVLVAGVLFRQETLGIHKIAGIALGIAGVATMLSGSLSGIVSDPLWAQAACLGAALSYAFAATFAKRFKGLPPLISATGQLSGSTLIMAPIALFASRSWSVADPSVIAWLNVLALGIFATALAYLMYFRLLAEAGATNASLVTLLVPASALFFGWLLLGEELSAIQLAGFALLLSGLVVLDGRLFARFKPVSTSAK
>fig|244592.3.peg.1799 Outer membrane component of tripartite multidrug resistance system
MVGPDFERPEAPVLDSWGKGANLSVDHRTGFTTRSAASVPWWHVFKDEALNGLIAEAYRQNVELQAAGVRVYQARAQLGIARGELFPQVQQLKGNSENIRFSTQDPIIRDLERAGLVDSHISRVSAGFDAAWEIDIWGKIRRDVQSAKANLNANLASYDDALVTLTGDIAATYVTIRELQQLAASSRKNAALQKKSLNLTQLRLENGVASQLDVHEATVLYNNTLAAIPGYEAELAQAYNAMSVLLSEPPGKMKARFSGRSGFPRVPAEVAIGVPADMLRRRPDIRQAEYIAGAQSAQIGVAKADLFPAFTISGAIGVRADDFSNLFTGGATTALFNPGFSWNFLNYGRIRNNVRVQDAKFQEALLTYENTVLSAYAEVENALTGFLRSKQQALYLRRSLRAARSSVGEVEAQYEDGTASYNRVVDAQKSLLVAEERLIAAEANVLTNLVAVYKGLGGGWAPENVRGLISDETRAQMADRTRWGQLLDNPVGPSGKS
>fig|244592.3.peg.1807 Multidrug resistance transporter, Bcr/CflA family
MTAAPATLMSARRTALLGAGLVAVGPISMALYTPAMPALVEFFGTTDGAVKLTLTSYFAGFAATQLVCGPLTDAFGRKPVTILFLGIYLISSVLATFSPTVEFMVAARALQGVGAAIGISVSRAIVRDQFTGQASARIMNTIAMMLALGPAISPTIGGFVLELFGWREVFWCMVIYGVALMVAVTVFQVETNPSPGKHHLNPRQLAINYTTLLKDPRFLAPAILIGCGLGNIYALATVLPFVLIYEVGLSPSVFGLTMILQSGSFILGTVITGQLLKVTDAHKLVPFGLAMLVVASVLMCAMTLTQEPSVASVMAPVGLFVFALAFVLPASFTDSMAPFPHIAGAASSMLGFLQFGGGVAASLIVAMVGDPVLGLAFVLPAMPVAGVVCYLLLRGQDTQHAAAE
>fig|244592.3.peg.2796 Probable phosphinothricin acetyltransferase (antibiotic resistance) protein
MPLRDAEPGDIPAILALYNQAVRETTAAWTSQEETLDERITWFETRQNAGWPVIVATSPEDKLIGFASYGAFRPREGYRKTLEHTVYVDPDFQGQGIGAKLLQQLIDKAQAQEVHVLVGVVDGDNTASIALHKKLGFEIAGRLPEAGTKFGRWLDLVFLTKIVTPGLDSPDV
>fig|244592.3.peg.3619 Permease of the drug/metabolite transporter (DMT) superfamily
MQARDFLLWSLLAALWGSSFLAIGVAVKDINPATLVFARMAIAAPVLGCVLLLRGGGFNLGVRGWIIAAIVGLSGNVLPFLLISYAEQEVNTGLAALIMGIAPIITLVAAPLVHFEDSLTRLKVFGALAGFAGVAVLAAPDLSEGRIGSLLPELCLVVAACCYAFTALFSRRFPYPEPLKMAAASVFVGLLALGGYMALFASEPGLPAAPVPALAAVLYLGLGPTALAALIYFYLIPRIGAARLQQVNYAVPVIGTLLGIAVLGEQPGWTAWPALGLIVFGVYLVTRPDKTEPAPARPMGEPAE
>fig|244592.3.peg.4855 Bicyclomycin resistance protein
MASDLTAHTTREPKRIAFVVMLMGISTLSPFAMNIYLPSVDGMMSAFSATAAEIQLTLAFYFIAIAVAQIFLGPISDQFGRRPVIVAGMVLFVIGSVLCLMAPTVEALIAARIVQAIGGGAGLVLARAIVRDVYGRDKAASMIGYVAMGMAVAPTIGPAIGGFLDAHYGWRGGFVLMLIFGIGVTICAWLFLPETNQHKKAVSLKQIGQGYADLFKEKMFWVFCGASTFMAWLYFAYLGGAPFVAAGVFNMAPAEIGLYLMVVSIGYIIGNFITGRIAARAGIARMIALGVITGVFGVSLLVVGTLTDSLTGPLFFMPMFFIGLGNGLGIPSAISGAVSIRPDLAGTASGMLSFLQVGAGALVSSAVAYMFSADIAGGGEMPMILVMVVGGVFGLACVLAVFLGERQDTQYEDR
>fig|244592.3.peg.5109 Drug resistance transporter, Bcr/CflA subfamily
MNLTVLSPAGSPPRQISLILLSAISIVSLNMHIPSLTAMSADFGVSYADISLSISLYMVLTACLQIVAGPLSDRYGRRPVLLAAVTIFLAASAGCALAEDFWVFMVFRLVQGAIATAAVISRAIVRDSAAPQNAAVRLGEIGMAMALAPMLAPMLGGLLESGFGWRSTFWAFALAAAALWLLSWKDVGETNASRHSSFGDQLKGYPALAADPAFWSYTLCMAFSVGVFFVYITGIPLVATGYFGMSPVGTGVVMGLPPVGFMLGNWIVIRLGQKVPLSLLMMTGRLVTLVALLIAALLLSLGRADALSFFPWMIAIGIGNGLTMPSANAGVMSVNPKLAGTASGLSGAITILMGAGAAAATGVALDAIPGPATLLSILIGFSGVALVLAHAARGAEQRVSNAI
>fig|244592.3.peg.5277 Permease of the drug/metabolite transporter (DMT) superfamily
MSERTTGILEMTFAMTLIGTLGIFVVFSGESPVTVAFWRCLFGAIGLALICSLKGAFAFKISPKQFLLAVLGGIALTTNWVMLFYAIGHASISLTTAIYNTQPFMLVCFGVLFFGEHLTLRKLCWLGLAFCGVVVIAQSKPELAYANGNFAVGVALSIGAAFLWAVAVVVTKKLSGIPSHLIALIQVSAGAILLAPFASVSDLPSQSTAWASLLTLGFVHTAMMYTILYSAVQKLPTDLQGALTFLYPSVAYVTDYLVLGQKLGTVQILGVAVIMLAAAGMTLGWRLPFFRKEKSYHQA
>fig|245012.3.peg.208 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKTMRETLTAGRSIDLTSGPVARSMWLFALPLMTGNLLQQFYNVADTLIVGRFLGAGALAAVGSSYTVMTFLTSVILGLCMGSGVLFSMLCGAGETERMKNSFVQSFFFIALVTGLVEGLALLLIDPMLAVFQIPADILKDTKAYLQIIFIGLVFTFVYNYFAALLRALGNSLVPLMFLAVSALGNIVLDLVLILEFHMGTAGAAWATITAQFLSALGIGIYVWVKMPHLLPGRRHFYRDSEILKKITRYSLLTCVQQSVMNFGILMVQGLINSYGVTVMAAFAAAVKIDSFAYMPVQDFGNAFSTFIAQNHGAGRKERIRLGLRAAVLSSGAFCLVISFVVVAFGGRLMTIFISPEETQIIRIGAQYLHVEGACYVGIGCLFLLYGLYRGLGHAGVSVILTVISLGTRVALAYLLSPIPSVGLLGIWWAVPIGWFLADIAGFAYFWKLDRKEKREAIS
>fig|245012.3.peg.223 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTYLYNMTAGIIRSLGDSRTPVYFLLLSSVINIVLDLFTIIVLKMGPAGAAWATVISQGVSGVLCLLYMKKHFEILRLQKDERKIDGQIMKILCKMGIPMGLQYSITAIGSVILQASVNTLGSMAVAAVAAGSKVSLFFCCPFDALGGTMATYAGQNVGAKKLERIRQGVKSASVIGCIYSAAAFLVLLLFSGKIALLFMDAGETETISRVSLFLTANSAFYIPLVFVNVVRFAIQGMGYSTFAILAGVFEMAARGLVGLFLVPVFGYIAACFGSPLAWVFADIFLIPAFSHCLRRMKKNFEENEEKYTAGQLSK
>fig|245012.3.peg.486 Multidrug resistance protein
MGSSVLMPLYVQSVMGYSAVISGLVTLPGSLATTLVSPFAGRIYDKMGIKRLFVIGSAIMLFSNIGMYFLTMSTPLWTAAVLNVIRNVSIGSLMMPLLTWGTSSIQIKKVADASSLLTSFRTIAGSIGSAVFVGIMTAVSEGSAAAYGEGALMHGMNIAFLCMAAGSVILLLISVFGVRKENICNREGTETNG
>fig|245012.3.peg.508 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSQAVKAKKKTCSMLTDHPGKALLLFAFPMILGNLFQQFYNIMDSVVVGQFVSENALASVGASYAITNVFIAVAIGGGTGSSVIISQFLGAGQITKMKTAVSTTLLNFLVISVFLGVFGLAYSDRILALMNVPGNIFEDAALYLSIYFLGLPFLFMYNVQASVFNSLGDSRTPLWLLIFSSLLNIVLDLLFVIQFGMAVRGVAVATLIAQGLSAVLSFCLLMRKLRGYEHRREEFRFYDRGMMLSMVKVAIPSILQQSIVQMGILLVQSVVNTFGSSAIAGYSAGTRIESISIVPMLAIGNAMSTFTAQNIGAGNEKRVREGYRTCYFALAAFAAALCVLTQSFGSLFISAFLDAEVSEEAFSVAMSYADFISFFYILIGLKATTDGLLRGAGDVTVFTVSNLANLTIRVFVASFFAPRYGLEFVWYAVPLGWATNYAISFGWYLTGHWKRIRLIEGGEKRPYRA
>fig|245012.3.peg.533 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MWGICGYFSISSSQQAVRESGLQYTHIVFLFSFGLFAEANATKLLQAKGNTVLPMLAQIAGAVLNILLDPILIYGLFGLPAMGIRGAAVATVLGQWLAMFIVILPVFRRFPVFSGRVLPADCIRIYRAGLPAIAMQSLNTLYIVGLNLVLKQFSESAVLVLGIYYKLQTFFFIPLMGLQQVILPLISFYHGAEQPQRERQVLGCSIKLSLAVMLTALGAFMIRPRRPSFHLHSRTGCPLHRLHRASDHLPQFPVRRPGNDVYRIFSERRARENQPAGDCASPGRSPGPPGLAVPL
>fig|245012.3.peg.543 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKHETKALQSGNPLEYKPIPQLLLAFSVPAIISCLINSIYNIVDQIFIGQGVGYLGNAATTIAFPVMTIILAFGTLIGAGSSANAAISLGERRNRRAEIILNNAFALALVSGIILMAVGLLFLRPILSLFGATEASMPYAVDYTSIILLGTPFNLIGIVLSNLARTDGHPRLSMYGMMIGAGLNTILDPIYIFIFHWGVKGAAIATITSQIISAIILTAYFLRANKNPQHMRLRLRSMRFAGPIVSRSLTLGVSSGITQSVACIMQVVLNNSLVHYGNLEAAGGGDIALSAMGIVSKISMILASLAIGFGIGAQPILGFNRGAGKYDRIKTTYKICSIMASVCLITGWVLCQLFPEQIISLFGHESAAFTDFAVKCMRIYLFGIFCAGFQIVSTNYFQATGQPLKAAILSSLRQLVLLIPLILILPLFWGLDGILFAGPVADISSTIIVSLFVIPEMKKLNQKISEMRTAAQ
>fig|245012.3.peg.664 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGVRGAALATIISQFFSAVWIVRFLTGKRTILRLRLSCLRPQWKRIRAIVGLGMSGFTMAITNCTVQIVCNATLQTFGGDLYVGVMTVINSLREVASMPVQGVTNSAQPVMGFNYGAKEYGRVKKAIVFTSLFSIAYTTLAWAFLHGFPEFFIRIFNQDQALIEAGVPALRLYFFGFFMMSLQFAGQAVFVALGMSRQAIFFSIFRKVVIVVPLTLLLPSVFGMGTNGVFLAEPISNFIGGAACFGTMLLLVWTELTRRERAKTV
>fig|245012.3.peg.825 Acriflavin resistance protein
MPAQVAQSVYLMISGSEATTLDQDGEEISVNVEYPDGWYETVDQVKGIVVSGAAGNSVALADIADIYFKDSPQSITRKDKEYQVTISGDFVNGTQEEQMDAIETQIYDEEVAPRLTENVTRAQNAMDESMAEEFASLGGAIAMAIFLVFVVMAAQFESPKFSLMVMTTIPFSLIGAFGLLFLADASISMASLLGFLMLFGTVVNSGILYVDTADQYRAEMDRDTALVEAGATRLRPILMTTLTTVVSMIPMAMAYGDSGETMQGLALVNVGGLVASTVLSLLMLPIYYTLMNRKPKYDELDVD
>fig|245012.3.peg.1500 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKGEQKMKIENDLGRDDVRLLVMRIAIPSMLAQFVSVLYSVVDRMYIGNIPEIGETALAGVGVCGPIVTLITAFGSLVGVGGAPLMSIRLGEKDEKGASQILANCFLLLSAISLIIMAAALLLKNRLLVWFGASEAIFPYANDYITIYLLGTIFALLSIGMNQFIICQGFAKVAMKSVMLGAVVNIVLDPVFIFGFDMGVKGGALATVISQMASAAFVLAFLFGKRVPIRITFGNYQWRIMRKVIFLGLSPFLIVAFDNVLVIAMNASLQHYGGPEGDMLLTCNTIVQSFMLMVTMPLGGITGGTQSILGYNFGARRSDRVLAAQQWIVTLALIFTAVMFIIAQAVPQYFVRIFTREPEYVELTVWAIRVFTLGIIPLSIQYGIVDGYTGMGIAPIAISLSAFRKTLYLLGVFLIPMIFGVRAVFYTEPFSDFLGTAVSIAVYLLTMKKILRRRENGAL
>fig|245012.3.peg.1525 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVPALKLFSSAYLIRWFSFATQSYMSAVEKPVPAMIISVCTAVVFPLLIIAVLWPMGLNGLWLNVPATSLLAAILAFFILNRFERKEMREAAR
>fig|245012.3.peg.1528 Acriflavin resistance protein
MEDLKNVPITTSSGEIIMLQDVANITEAKEEQGGISRYDGQETISISITKNQSNTAMEVSNAVKETIETLTADDSDLTIEIVNDSADTILDSLKDVAVTMILAVVISMIIIFLFFGDVKASLIVGSSIPTSILLSLIAITSAGFSLNVITMSALTLGVGMMVDNSIVVLESCFRVTKENWDKGIVGYAKSALQGTNVVFASIIGGTATTCVVFIPLASLQGMSGQMFGPLGFTVVFCMIASLLSAVTVVPLCYVVYKPREKEGAVLSRPVERLQDLYRRIMKRLLRHKAMVMSVSVAMLVATVYLASGMETELITADDTAQISIDIEARPGILDEKADTALEEIEQIVSS
>fig|245012.3.peg.1529 Acriflavin resistance protein
MGITKFVLKRPVTIVMALLCLLVFGISSVFNATLEQMPEMETPMLIISTRYDGAGPEDICELVTEPIEDEVSTLEGVKSVSSTSSDGSSMVMLEYDYGTDMDEAYSDLTKKMNSIERQLPDDAEEPTVMEMSMDASTTMMLSISHRTQSNLYDYVDQKIVPELEKITSVASVEATGGSSEYIKVELISEKMAQYKVTMSQITSAIEAANLSSPSGDTVVGNLELSVTT
>fig|245012.3.peg.1554 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNYKELFSKTPPTKLFFTAAIPGSIGMLASALYQTIDGVLVGRILSGNAFAALNLAMPLVIINFSLADLIGVGSAVPISVRLGEKKEAEANNIFTSACLMIVITGLILGLAIFLAAPALIGLMGAEGELAKLAVQYLRVYCLCSPVTTIVFAMDNYLKICGRVRSSMALNIVISVLSAVLEFIFLFVFRFGIWAAALATCTSMFLCALAALYPFFSRKMQLRFVRPRLNRTMIKTIVTCGSPNFLNNVAGRITSIIMNMILLRVGGATAVSVYGILMFADGFVQPLLYGMCDSLQPAVGYNWGAGALKRVKDIEKRCFTAG
>fig|245012.3.peg.1559 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLAISCCILADTFFVSQRLGTDGLAALNLAIPIYDVIHGTGLMLGMGGATRFSICKSRGEDREANLMFTNTLFLAGACSVFFVLSGLLFSERLAVLLGADEAVLEMNKYVNLKVLMLFSPAFLMNDIFLCFVRNDKNPGMSMAATIGGSFSNIILDYVFMFPLGMGIFGAALATGLAPVIGIAIMSPHWLKRSKGFHAVKTGLLPNR
>fig|245012.3.peg.1560 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNASLGFPSLLAQLSSGVVMIVFNKIILELEGNTGVAAYGVIANIALVVVAVYSGVGQGIQPLVSREYGYGRKEREVQLLRWAAAVVLALSVLIYGGLFGLAEPIVGIFNSENSVRMGQIAVIGLKLYFISVPFVGLNIVLTTYFSAVEQAVPAQVISLLRGLVLLIPMAFFMAEAGGLTGVWLAVPVTEFLSVVLGGWLYFRMEKGGAKRAKNRLPEDI
>fig|245012.3.peg.1774 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENFNGIAGIGIGIGMMTVVGQCLGAGRPDEARYYIKKLSYAAEAAVFVSCILIFLLSGPITRLAGLEAESASLCLFMVGWITVVKPLVWTAAFIPGYGLRAAGDVKFSMLLSCLSMWTCRVTLCIFLIRVCGFGPMAVWIGMFTDWAVRGFFFVRRFRSGKWLEHEVAD
>fig|245012.3.peg.1775 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNQKESAPSGAGHLYSNRQLFALMVPLICEQLFTSFMGTVDSMMVSNVSEAAISAVSLVDSINILVIQAFYALAAGGAIICANYMGQKREEQAKRCADQLLFIVLAISLAVLAVCQLFRGPILGLIFGSVEKEVMDSAMVYFFYTSLSFPFIALFDSGSAIFRAQNNSRLPMAVTVATNLLNIFGNAVLIWGAGLGVAGAAISTLVSRIIAAVCVLLFLRRKSGQIIIGNFIFLRPDGRLIKNILRIGIPSGVENGMFQFGKLAIQSTVPLWEQRPLPPRP
>fig|245012.3.peg.1875 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKENTSGSRSLNNGLNNNSDNRSHNNTLLTERLPRLFLLFVLPAVISMVISGTQSMIDGIFLGRFAGVNAMASVNIAGPYMQIITGCTMVICIGTFSYLGRTLGENTNPQKAKDIFRTAVVSLAACALILMAAGLFLSRPLALLLGANEVLLDETALYIRTVAVFIPAICFMMHFGFTARLLEKPHLYLIATLCCVSCNVIMDYLAVK
>fig|245012.3.peg.2179 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTEMKKQVDLLNGKIISALTELAIPIMGTAAVQMAYNLTDMAWIGRVGATAVASVGAAGMYTWLS
>fig|245012.3.peg.2284 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEERENTMGSRPVFPLLMSMSVPPMISMLIQSLYNIVDSIFVARISDKALTAVSLAYPLQNLIIAVAVGYGVGINACIARSLGAKRQEETNQTAAHGALGTALHCILFILVGVFLTEPFLRLFTDDPEIFSMGCSYTYIVVCFSFGSLFHIYIEKMFQATGNMVMPMILQGVGALINIILDPIMIFGLFGFPAMGVTGAAAATVAGQILACILAVTLFNLKEKNIRVSFRAFHFDRRIFFRIYSIGIPSCIMLSLPSLLVGILNSLLVGLSSVAVAVFGLYFKLQSFVYMPENGIIQGMRPIISYNYGAGHLDRMRETVRCSMISCGAILAAGTLLFLAVPDYIMMMFGAEGEMMEMGMSCLRIISLGFIFSAAGTVFSGCFEAIGRGLHSLAVSLVRQLVVIPPLAFLLAETMGVTGVWIAFPAAEILAALLGLVLYRGQMRKVKLELLGSLKKEERR
>fig|245012.3.peg.2560 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERDLTKGNIVFTLAGFSLPLILSGVLQQLYNWADAFIVGNIEGELALAAVGATGTITNLFVMVITGLTLGLSILAAQKYGRGERESLRRILSTFSIVLGVLFLLTAAAGLWLSDGILRLLHTPEDIFDISEGYLRIILTGIPFSTIYNVYSAVLRGLGDSRAPFLSVLVSAAANVILDLAFVGGLRMGAPGAAAATVISQALMTVFIVCYAGRKYEILRFSREEKLVDKKILVQGFQLGLPPAIQSSVNSCGNLLLQNFMNSFGTQTVAAITTAYRVDSILLLPIINLGSGISTVTAQNMGAGNRARAKKVLFAGSVMMLCVSICLTFLILSAGGPLIALFGVTEESTAIGASFFRSIAGFYTVYGFAMAFRGFLEGCGDVLYSSIAGIAALASRILISYLCVSVWGNMVIAYAEGISWILLLALYLVRFLWKQRKPCGRREETER
>fig|245012.3.peg.2713 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQTPNLYFRIYFLGATFNLVYNMGAGILRAVGDSMRPLYYLCVSSVVNIVLDLLFVSQLHMGVDGVAWATIISQLISAILTVRALMTSDDIYRLELKKLKIDFRMMKRILNMGIPSGIQQSIISLSNVIVQANVNVYGAMAMAGFGAYNKVDGFVVLPMQSFCMAATTFTGQNIGARRMDRVKKGLFQGMVICSIYTVGVSVLLFFKAHSILEIFSSDPGVISYGLKTMIVMVPFYLLLSAHQILMGTMRGAGKSMQTMLISVGNMCVLRVIYINLFVPLFPSFDAVMWCYPITWATTVLMDLAYMKWGRWLGQAGDRKKKRH
>fig|245012.3.peg.2714 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKQKKNSVLMTEGVIWKQLIAFSIPLLIGNLFQQLYNTVDSVVVGQFIGSEALAAVGSSNSLINLIIGMFMGISVGAGVIISQYYGAKSAEKMSWAVHTSMALSLVGGVVLTVVGEAFSPVILRWMKTPEEVLANSQSVFQDLFSGGHLQSGLQYGSGNSEGGGRFYETSLLPVRVIGSKHCPGSSLCEPASHGSGRRGMGYDYLPAYLSHTDGAGADDLRRYLPSGA
>fig|245012.3.peg.2761 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAYPLTTICLSIALLIGIGSASRFSLELGAGRKESAAQAVGTAVCMMVLFGVIYVVLIELFLHPLLTVFGATKDVMPYAESYTRITAVGMPLLILTNGISNLARADGSPKYSMTCMLVGAVINTILDPIFIFVLHQGVAGAALATVIGQVFSCLMALNYLRRFSHVELRRSHFRLRLPVCLKIASLGMSNSLNQLAITFVQIVLNNSLTYYGAHSVYGSEIPLASCGIVMKTNAILLAVIIGISQGSQPIIGFNYGARQYERVRGIYRLAITCNLIISGIGFLLFQLFPRQIIALFGTGDALYFEFAIKFLRIFLFMVIINGVQLISANFFAAIGKPVKGVVLSLTRQVFFLVPLILILPLVWGIEGIMFAGPIADFAAFITTMILIRREMGHIRAAQAELEAA
>fig|246194.3.peg.77 Vancomycin B-type resistance protein VanW
MKKSYIILTVLIALVIMFLAGIVGFSYYTYIKPYQGKIAYGVTVEGEPVGGMTFKEFKRYLEGLNNELQNQPVVLTLGNKTWTYKKGDLGISLNTAEMYRKAYELGRKGSLLKQIMERRQLNKAAVDIKYLVRLEERKLLAKLDQINKEIYVEPKNAEFRLLPNETFAIIPHKTGIALDSEQAVKDVRANLLENPLKVSFKLKEVLPDKTTEDIKKMRLTGLLASFTTSFDVRKVNRSYNIGVAAGKLNGILIAPGEVFSFNKTVGPRSAKEGYKNAPVILRDQLVEALGGGVCQVSTTLYNAVLLANLPIVERHNHSLPVAYVPPGRDATVTDGGKDFKFKNNLPCYLYIKSYVNGNRITFKIFGDASLKKHVVIKSWVTKTIPYKTIIIKDSSLPEGKKVVKQEGALGKYAKAQRIVYQNGRVVKVENLRDSYYKPMNEIILVGTKKVPNSSAKESSVTENVY
>fig|246194.3.peg.256 Drug resistance transporter, EmrB/QacA family protein
MEYRWRVMWVVALGTFMAPLDASVVNIALLSIIKDFKASLATGEWVILIYLLFISTLLLTYGRLGDLYGKKLVYVTGFVVFTVGSLLCGLSPTLGFLIGARVIQSLGAGMMMAMAPAIVTEVFPSQERGKALGINGMMVAAALAFGPSAGGFLTHFFGWRSVFFINLPIGLIGSILAFKIIKNDFTREKHSFDFLGAFLSFLGLGSLLILLTFFEKYGFTHPLMIGALVISILAFLLFLYTEKKVSEPMVDLGLFKNRDFSFSNLSAFLSYVALYQVVFLMPIYLQQLRHFTPEKAGMVMSVHPLLTMIVAPLSGSLSDKIGSKVLAPLGMTVMALGLFALSRLNSETTVGIIILSLMLIGLGSAIFQSPNNSTIMGSVPKNRLGTASGFLATMRNVGMVMGVAVAGAVFTGRRTYYLTYYLQNHYTKELATVKAFVLAFREAFLVGAFIALLSAAASLVRSRGRKEKLLQK
>fig|246194.3.peg.914 Permease of the drug/metabolite transporter (DMT) superfamily
MGDNERIKGLVLAILATSLWGINGTVTRYLLINNLDPVVLVQIRLTVSALLLFILLFILKINVKISRDDIISLLILGIFGLSLVQMTYFYTISLTNVATAVFLQYLSPVFVALYGVFFKAEEITGSKLTAIGMSLLGSFLIVTQNGEIQLPFMGLLSGLLSALSQSFYIIYGKKVLNRFSPITVLAYGWLFGAVFWWLLIPPNKALMHQVFTLRDVFGISYVIIFATVIPFLLYFESLKYLNSTTMSVVSLVEPVVAVIVAYLVLGEKLTPLSTLGAVLILFAIYKITRS
>fig|246194.3.peg.1031 Permease of the drug/metabolite transporter (DMT) superfamily
MELKTKQLLADISLIVVTAFWGTTFVIIKNILANIEPFSFLSFRFLLSTFFLLPLLLQKEGFSPKGVFFGSIAGFFLWLGYILQTIGLKYTSAANSGFITGLAVVMVPVLSSILNKKPVTPGVIFGTGLSFLGLFIMSFDFKAGFNTGDLLTLAGALFFSMQIVSVERFSPNFSATSLTLGQIATVGVLSLPAALWLEEPFKPYPNEVFYAIVFTAIFATVLAFLVQSKAQQFTSASHVALIFTLEPVFALLFAVLFGGESLVAKQGIGAFFILAGMLTAEFLDQYWPKAKDEKKANL
>fig|246194.3.peg.1047 Fosmidomycin resistance protein
MGEVILLEKAVKSAKPNLGVLLLLSMGHLVTDMAQGALPALLPILKQAFALNYAKTSLLVLMSNIASSVIQPFFGYIADRRPARWLLPLGCLLAGVGVAVTGRMPWFSLLLIVVTIASVGVAAYHPEGSRVANLASGVRKGRGMAVFSVGGNLGFGLGSIYMAWLLSKGGLKATVFFLLPSLLIAVLFLFSWPRLTSLRDEVVEKKAKGNGQGSGQEIKAESKKRTIAAFFLLLLYIVFRTWMHAGLYTYVPLYYTDYLKGDPHLAGYIVSVFLLAGAVGTLLGGPLTDILGAPKVMAGSMALLIPLIFFFSRTNNGFVYFVLLALVGATLISTFSTTVVLGQQLIPHRKGLASGFTMGFGVGMGGVGVTLLGVLADHLGVPAVFHVLNILAVGGFVLALILIRYFPWSSKTME
>fig|246194.3.peg.1488 Fosmidomycin resistance protein
MNYNYNKIRYAIAFGHFWIDFYANVLASTMYLLARDLHLSLTRQGILVAVVSFAGSVMQPYLGYLVDKKGKSTHLLFSLLLMGLLTTATGLFQNFYPVLILFTLGALGSALYHPLGSVLTTSISEKKNTAVSFYVTWGNIGYSIAPVILVPVVEALGRKGLLLFSLPMFLALIFLYLSKSHQLPLPHEERKETLPSFRATIKSAFTGLLLLNLIVWGRAWIQVALGNYSIQYFLHQGLSANQSSILLSAYLLAGTAGVVAGGFVSEKHGERFTLLATFLLSGATLIMMFFTPPPFSYLGMLITGFLLNMSFPATIVMGQNLIPENAGMVSGMMMGLAFGLGGMGAMLTGTVADYTSLAFSLKLLVVIPFIISALTLVYFQKISLPKPKIK
>fig|246194.3.peg.2429 
MPELKKKFLAIVLVIVLLGAGYGIYAYLDSKNYVTTDDAKVTADIYSIGGKTGGKVKEVKVQEGDEVKAGELLVKFEDDLAKAQLEQAQAGLSAAQMQLKKVLKGARVEDVNAARALYEQALAGYNGAKESYEQLSKDIDDLQKKYDAVKPLLANPATPQEVKDQANELLKQIAQLKYQQLAAKTQMNTAQAGVKAAKSKLDLALNGAQLEDVKAVEAQVKAQEAALKLAKLNLDATEVKAPVKGEVVKVWVKPGEILAPGQAAVSLADFNNLYVTANILEKEISGVKVGASVKIYVDALGGKVLSGKVESIGRATQSTFNLFSADSFTGSFTKVSQRIPVKIKLLEKPEGLIPGLSVTVKIKK
>fig|246194.3.peg.2430 Inner membrane component of tripartite multidrug resistance system
MEHQRHNFGENKWLTMFVVVIGTFMAILDTSIVNIAIPKMMQVFAVGTEEIQWVLTGYMLVMGVVIPVTGYLGDTYGYKRLYIAALFFFTLGSALCGFAWSNNSMIAARVVQAIGGGMMMPASMTIIFNTFPKEERGMALGIWGISVMVAPAIGPTLSGYLVEYFNWRLIFTINIPIGLFGMVMALLFLKESVRRPHATFDLPGFITSSVGFFALLLALSKGTDWGWSSAKILFLFWLSALSLTLFTYFELKSPEPLLDLSVLKNPTFAMSLVITMINTMGLFGGLFLFPIFFENLRGYPPMDTGLIMLPAALASGLVMPIAGRLFDRFGAKPVVLFGLTLAIISSYGLSLTHINTELWWLQTLLIIRAMGIGFSMMPVNTAGMNALPNYQVGRASAINNTLRQVSSSLGVAIITTITQQRVAFHTARMVEGLNQASPVFQNTVNFLKSGLSFMGVSPLVSVKGAMGVIAMRLYQVAYAKAITDAILVTAFIMVFGVILTFFLKEERKNQEEKEKLPVAEF
>fig|246194.3.peg.2433 Permease of the drug/metabolite transporter (DMT) superfamily
MNKSYLYLGITVVLFSTYEVVGRALAGLVNPFQLNFLRFFFGGFVLLPVALSNIKRKNVKLTGSDFLFAFLIGLLNVVLSMSFLQIGINMTKASLAAAIFSSNPLFVVLFAYLILDEKLNFQKILGLFIGIVGVVIVFYKDLELGISHVYGILMLILAAVTYGLYTVLGKRFSQKTDSVIMNSFSFILGSVFLLPIILLKHYPLFSLQPKAILPMAYLTFFVTGLAYYTYFLGLTNISAGNGSMVFFIKPVLASFFAWAILGEKITFEFIAGTMVILLGIYIVQWAGQVNDGATCEKLRTLEK
>fig|246195.3.peg.500 Drug resistance transporter
MMTEPATQQPSRYLPCLLTLAIFMQMLDTTILNTALPSIARSLHESPLSMQSAIVAYALTVALLMPLSGYLCDRYGTRKVFANAMLLFVVGSVLCAAAPSLTFLVLGRMIQGMGGAMLSPVPRVVVMRAYPRNQIVSMLNLIVMPALIGPIIGPLLGGYLVEYAHWSWIFLINLPIGILAILATHRVMPDFTGAANPRLDIVGFLLFAGGALGISLAMETVLHPAGKLFSSLTALLGIVSFYGYWHYARGNPDALYAANLFKVRTYRVGLSGNLVSRLGMSSVPFLLPLLLQVVFGYSASAAGWMLMPIAFAAMFGKMVTLPLISYFGYRRLLIINTRLIGILIMSLALPQPHTSPWLLMPLLAGIGLSNSVQFTSMNTISLADLRIYQTGSGNSLLAVDQQLSISMGITLGAAVLTGFRSSQWIGDDLHLAFRLTFIVIGCITFTSSWVFARLHPYDGQNLLPSEKD
>fig|246195.3.peg.851 Multiple antibiotic resistance (MarC)-related protein
MSLTAAILTLFLIINPLGNVPVFLSILKNLSPKRQRIVLLRELCIAYAIMVVFLFGGSSILHGLNISREAVSISGAIVLFIIALRMIFPLRSGSVMGADDTEGEEEPLIVPIAIPFVAGPSLLATLIMMVESDPSLTTRWFFAMTISWFISLLIFLCAPFFFKILRKRGLKAVERLMGMILISISVQMMLNVYMALQATGA
>fig|246197.19.peg.93 Drug resistance transporter EmrB/QacA subfamily
MLARCGASPGARPLAAPERAQSCRRTETAGAAKGLCRWPSGRNVPTFPLAPLTREPPRHMAPSAAPATANAPPAFPAFTRSQKVFTLLGAVLGLLLAALDQTIVATAGPAIQADLRIPASLYPWLTTSYFVASTTMVPVWGKLSDLLGRRAVLAAGILIFLAGSFLCGVARSTVALILFRAVQGLGSAALFTAALAVVADLFEPRERGKYQGLFGAMFGLSSVVGPLAGGFITDHLGWHWVFFINLPVGAVALALVLSRMPRLKPQRVSRGGLDLVGAFTLAVALVPLLLALSLGQTDGGDWAWTSWRILGLFALSAVGLVAFLWAERRAPEPLLDLTLFRLRAFSAGNAAVFIVGGAFLSGIVFLPLFMVNVVGLSATRSGLTVMPLTLGVVAGNVLSGQLVSRVGRYKALLLGSLVLLMAGFAVMAFTLTPDSTQAEVTAKMVLVGLGLGPSIPLYTMAIQNAVPPDQIGVGTAAATFFRQLGMTLGVALLGTVFASTLSSELEARMAQATSALPDSVKAEVTRAAPGVSGEGGPTGQVFRADEVKARVRAEFDAERRRAETTAAPEARAKVDADERQALAAVDAADRALKMAFTRGVSAVYHVALFIAGAALLVTLFLPEQHLRRKRRRIESRASAPEQ
>fig|246197.19.peg.179 Permease of the drug/metabolite transporter (DMT) superfamily
MTRAPGWSRVRPPAMSRTAGFLIVALSGVCFGALGLFGRLAYAAGTDVATLLFLRFSIAGAVLASVMVLRRQRWPRGGVLVVLMLLGAAGYFSQSGVYFFALQHAPAGLVALLLYSFPALVALVQRVVFKEHLGRVKWLAVVLSVGGTVLTADLSQGGATLPGVLLGLLSALFYTVYVVASGRVSGRAGPLASSTVILCSAGFSFGVAMLVRGPAFPGSVTGWAAVVGLALVATVAAVLLFFVGIQRIGPVNTSLVSNLEPLTAVVLGALFLDERLTPRQVLGGVLILGAAVMLARADVPRASPEPPAGGGAPGAVPG
>fig|246197.19.peg.1413 Drug resistance transporter, EmrB/QacA family
MARRPARATSRKARSCSEVMRIPQKAYAEDAVSAWGPGAYREVMDGSGVTAEPMVSARPGVARRTATGAVLLALVVSAFEGTVVTSAMPTITRELGGQHLYSWVFSAFLFASTVGVLVSGKLADRLGRKPVFFSGMGLFLVGSALCGLADSVPGLIAFRVIQGLGAGALQPTTLTISADLYTLRERVAVQGLFTGAWGAGNVVGPLIGGWLVMHASWRWVFLVNVPVGLFAAALLYLSYRDPPRRPEVRMDRWGPVLAGSSAALLLFSLEPGAASLRWACALAAVGAGWLLVWQQRTTVSPLLPAELLRDRAVLSGIVGGIAGGSLLYSMAAWVPLWMTEQGGHTPLAAGLALLPMLLGWSVGSTFGVKLLVRGGMRLSAGVGFAVAALGAGWLSLAAARGWGVPAALMGLAVLGLGLGPAASTSLIGPQSRAPWHHRGIVTSALYATRLLGGSLAVALLALASGHFALQFGIAAGLTAVAALGLALLAPGRTEPAASGA
>fig|246197.19.peg.1493 Membrane component of multidrug resistance system
MSGFGLALQRLPPPMHSAAEPTVPRFWPFMFTLFVGSFMSVLSSSTITIAIPELQRHFGAELSSVQWTLTGFMLAMGTSAPLTGYLGGRFSFKWVYVASLVAFLVASVLCGVAWDTRSLVAFRFVQGAFCGAIMPVTMTLIYQLLPRERQALAASLWTLSSMLAPAFGPTLAGWLMTLGNWRWLFFMNVPLGLAAVAMAVRAVPYYRLEVPKAFDFPGLLTVITGTLALLIALSQGRAWGWTDSKTVSLAVLGTVSLVYFVVRQLRTHAPLLDLRVLANGRYVVTLLISSIITISLYSGAFLIPLFLQEIQGVTPLKTGLILLPASLSMALLMPLVGRMYGKLGPSTLMTAGVLLIAGGTYALSRLTPDVSHTYVLMWMLVRNVGISLSIMPASNAGMEQLSRELSGHASSISNWLRNVFGAFSIAIFTSLLSSFAAREAQVLAREGMTERRDIELLSFVTGINQVYLVATVIALVAVPLSLMVRKYVSGLEASRGAR
>fig|246197.19.peg.1938 Multidrug resistance protein D
MSPRPPFLLAILLLSFPQIVETIYSPALPLIATAYRVTPAETGQTLSLWFAAFAFGVVAWGRLSDLWGRRPALLAGLALYAAGAAWAMVASDFSHLLAARLISAFGAAVGSIVTQTALRDSHAGPELGRVFAVLGLALAISPAVGLFAGQLLAAKAGHSGVFAALGLLAAFMLGLSLWRWPETRPATLSVAPFWPTFRVMLRDPGIWRCTLLIAAFNAAIFAWYQLGPFLFAGLENPWLSFGQSGFLLAAGALAGALMNRALLRRGWTAEALIALGVLLLGAGTALVILLTALLPQSLAFLSGVTLISSAYAVAIPNVLGIALRAYADRFGTAGAVLSLFYYNLLGAGLVIAGYGQRLDFALAVCALLAAIVSVRPMRCRGALSEESPPGGKSRIPCSSSGGGRS
>fig|246197.19.peg.2958 Permease of the drug/metabolite transporter (DMT) superfamily
MPGSKRRLARATPRAYSPAAVSTPTTAVVPAPSRGISASDLAIVGVVIAWGTNYTVVKEAMETLPPLAFMSLRFTIAALAMGALLLGVEGWKPLPRPVFLKLLGLGLVGNTVYQVCFIVGLANTSVANSGMLTAVTPVLVATLGAVFGVDRLTRPLIAALALGVVGMLLVLGGRGASEHGASLIGDGLIVGASLCWAIYTVGIRTVGPEVSALRITAISMLTGAPGVVLVGVPELLRLETENIRAGAWAGVVYSALVPLVLAYFTWGRTVQKVGSSRAGLYNTGIPVVAALTAWAVRGEQPTWMQVLGAGLVLSGVLLSRRKS
>fig|246197.19.peg.4119 Drug resistance transporter, EmrB/QacA family
MPGHPASSSAEAGGDAPRGSRLASIAVASALFMEFVDSTALSTALPRLSLAFGTDPIHLKLALTSYILALAVLAPASGWVADRFGPRRVFMLAMSVFLLGSVLCGFSQSLTQLVIFRTLQGLGGALMTPVGRIIVVSSAPRERLVAALSWFTMPALVGPLVGPPLAGLILGVADWPWIFFINVPVGILGMLAVARFVPPLHQPDPGPFDTRGFVLVAVAITTLIGAAETVGIGLMPLSLQLGLAAVAFLSLGAYVWHALRVERPVLNLRLLRIDTFRASMIGGTLTRMGLGASPFLLPLLFQVGLGWTPVEAGLVTIGGGVGALACKSVAPYIIRRFGFRQTLIFANLTSAVLTAMPAFFRNSTPIPLIVGVLMVSGFMRSMQFTAINTVAYADIPPDTVSNASTLSVVTMQMALGLGISFGGLMLHLARGAGEAPLTPDRFVLPFIAVGIMSSLAGPLYRRLSPNAGAHIGGRRVG
>fig|246197.19.peg.4331 Drug resistance transporter, EmrB/QacA family
MKPPGPAPTHVGVGPSFVSESVCARTLSDHPGREAACCWRPPPAAVKEGLSRVGVFMRTTHRPLTTLALALSLFMAALEATVVSTAMPTVVGELGGIQHYAWVFTAYMLSSTITVPIYGKLADLYGRKPVLVFGIVLFLVGSIASGLSTSMAMLIGFRTLQGLGAGAMQPVALTVIGDIYTLEERAKVQGAFSAVWGIAGLIGPITGGFLVKYLTWHWVFFINVPVGVGCLVLLLSYFHERVERKPQKLDYAGAALLTGWVVALLVGVQGVGVNLWGLPVAAVLLAAFVAVERKVAEPIIPMSIFKVPAIVISSIAGALFSAAMFGATTYVPLFVQGVLGGTPTEAGGMITPMIVGWPLAALVAGKLLLKTGFRPLIVGGLGLTVVGTSLMALLLGPQAPRLLPEVAMGLFGIGMGFASTALLIAVQTSVGWELRGVATASNMFFRTIGGAIGVGLMGGVMVSQLLKDPTVPISAANALMSPDHGQDLPADLLATLSGALGTGLSINFWLICAFTVAAFAAGLFFPKVSRTTTVSSTEVVAPH
>fig|246197.19.peg.4462 Permease of the drug/metabolite transporter (DMT) superfamily
MPSARTVREPQAEVGCAPAGAGVRAGVTRSHTVRYFAMVAAGATLWGCWALFFRPAGLAGPQNAFLVLLAMSLPAPFLFRRDALRDRRATLAMLVVALADAANTALFFAAMERGPVSIAVLTHYLAPLLLALLAPWVLGEERSTRALIGGPVTLVGLALLIGRPDGDFSGLTALLGAGSACFYAIIVLAAKQAARAYSPMAVTSLHAPISAGVLLLCFGDRVLPPTVDGGTLLVLVGGIVCGLIGNILFHTGLRHVPTAATAALTYLEPLTASLVGWAFFSETLTPVALGGGLLVLVAGAWVAAERRATLQAVPLRAAAR
>fig|246197.19.peg.4466 Vancomycin B-type resistance protein VanW
MVSDPGVSFPGAALAECSDMPSPPIAPRLLELSAHALLWRRSKQWMLQANRLVRWSATPERWPRPLLAPTHEKGVLLGSHTVNLERSDSDADPVLEAGKQHNVRLAAPAFDGLLLAPDRPLSFWRTLGRLTERKGYRHGLALSGGCLTPSIGGGICLLANALFEFGARQGWHILERWGHTMEAVPPPPGALWGMDATVAWPYVDLVMAPREGAVRLGARVSDGKLRLSIHGAEAPRTRSRLWSEDESLLELAEGTLRINRVVRRVEDTSSGAVLEERTIAENRRRLLNPEARKRTCLTCGETACHARVEVPRSEVRAP
>fig|246197.19.peg.4793 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MVISRYHRHATICDPCNWIKTGFSASEPPTSQVRPPRSLVAQYPSISLFFPAWNEEDYVERAVSRALEVLPALTDDFEIIVVNDASTDRTREVCEALAQKVPQLRVIHHPVNLKLGGAMRTGLAASTKDIVVYSDVDLPWDMRELERALHLMSYLEADMICAFRFDRTSEGAKRIIYSFVYNMLIRSLFDIQIKDVNFSFKVMHRRVLEAMELHSQGSFIDAELVVKAIRQGFRVFQMGVDYFPRTRGVSTLASPSVITKMVRELVKLYPKMRAPQPPVHPVRLPPSVQQLHAVPPGRTARG
>fig|246197.19.peg.5288 Permease of the drug/metabolite transporter (DMT) superfamily
MRRRRLRGRPGCVKKPAAVAAVTSPGEPGVILSGGPRDMSTSTSDMLGGGTEPSSRSQRLRADGALALITSFWGITFVVVKDALGHGDPFSFLTLRFIVGAVVLSVLAGRQVLIARNLRIGSMLGTFLFLGFSLQTVGLTTTTPSRSAFITGLCVLLVPLLSMVLYRKAPKFTSLLGVGVAAVGLYFFTQPDGGLGSGGLSSGDVLSLGGAVAYACHILMTERHAPKQGVMGLVAVQLWTVALLSALCLPFVERRVAWHPSFVGAVLVCGVFASAVAISLQTWGQARTTAVRAALIYSLESVFAALYSVLLGYETLGPREWLGGALILSGVLMSEVGAAAWVWWRARAPAR
>fig|246197.19.peg.5308 Permease of the drug/metabolite transporter (DMT) superfamily
MGAPSARPLTSTSPQSLGPVYAGLMLQVLISAGTYLAGKRAMSELAPLTVVLWRFVLSGSVFMLLLCFLPGPRLPPRNEWGRVLMLGLLAGPVNQVFFFYGLSQSTAAHAALLYALTPLGVYLLSLGRGHERASFRAMGGIVTAFAGVVVLLLGRGLADASGSLMGDLLILGAVMSWVVYTTEGKPFVAIHGPIRATSWSMVASTLMMMLMAPFFAKPEAVLAASSAARYSIVYLGLLTSVVAYLLWYFALSRVPASKVAVFSNLQPAATALAAWVILDEALHWEIAVGGVLVLLGVRLTQAAHVRPPAVAPAAPERPPVSSSVG
>fig|246197.19.peg.5977 Glyoxalase/bleomycin resistance protein/dioxygenase
MKKPAVGSVGWMDLTVKDAVAVRDFYKDVAGWSATGLDMGGYEDFVMMPPGGGETPAGGICHARGKNADIPSGWMMYITVADLEQSLERVTAMGGRVLGTIRGSAKTGRFCFIEDPSGTACALYQSGSD
>fig|246197.19.peg.6668 Multidrug resistance transporter, Bcr/CflA family
MYSHGVPFQQPCFWVRGTFTVRRPEAGYSPGLGPRPRESMTTPSTQSIEKGTLGLELLLGTLTAFAPLSIDMYLPALPRIAEDLQSTAPAIQLTLASCFAGLALGQLFTGPLIDRFGRTRPLYAGLALYVLGSLGCALAPSASMLVAMRFVQALGGSVALVVPRAVVRDLWSGANAARTMSRLMLVMGVAPILAPLLGGMVLQYSGWRAIFVVLAAVGAVALAFVLKSLPETAPPHVGAQSMRSRMGALMKDPDFVGPALAGGFAQAGMFAYIAGSPFVFISLYGIPEEHFGWFFGVNAMGLIAVAQLNRKLVTHLPLHRLLRLALSLCVVAAVAVLAVAWTGFMGLWGIAVTLFFFVSAMGLVGPNAAAIALERHATRAGMASAALGALQFTAAAGASWAVSTFNNGTAMPMAGVMTAMALLAWLAAFFGLRARTRQQEAGEGAQAHGPRIVSSSSAP
>fig|246200.3.peg.1512 Bicyclomycin resistance protein
MQSPPAPSHRSPPALATLILLSGLSALGMNIFLPSLPNMTEYFQTDYRLMQLSVALYLAVNAAMQVVIGPLADKAGRRPVILWGLVLFLFVTLGCIYAPTVEVFLFFRMCQAVIAVAIVLSRAAVRDMYQQDEAASMLGWVTMGMAVVPMIGPALGGVLDQYFGWQANFWILFVLGVAALILTYVDFGETALKSGKTLIQQFREYPALLTSPRFWGYSLASGLSSGAFFAYLGGAPFVSTEVFGMEPARMGLFFGAPALGYFAGNFVSGAFSVRVGVDRMVLWGCLMNALGVTLSLVTLLAGFGSEYSFFGFMTLVGLGNGMAIPNATAGALSVRPHLAGSASGLNGAIMLGGGAALSAWAGALLSPETGAMPLLLLMLATALLGVVAIFSVIWRARRLGL
>fig|246200.3.peg.1776 Permease of the drug/metabolite transporter (DMT) superfamily
MTQSPDITAKSWAMVATLGFVWGGTFLINELALEGITPFWLAAGRVCFGALLSTLVWRAMGGRLFSAPLSGSERLSLVIIALLSSAVPFSLIAWGQQYVTAGFTGVSMASIALMVLPLAHFFVPGERMTWRRALGFAIGFAGVALLMGAQAFESSGAALELPGRLACLAATACYAVASILMRRLPAVDPMGLSTVLLLIGVVAVLPMAWIAEGPPPSTDLRTLGLIVFLGMVPTAAANLLRVTLIRSAGPVFMSLTNYQVPIWSVLLGAALLGEPLPPVLLWSLLLILGGVGLSQYGALRRLFTRQ
>fig|246200.3.peg.1840 Antibiotic efflux protein
MAAPLVIRNRNFRLLFTAGALTNLGDGVLVLAVPWLAALMTRDAVAIAAVAAAARLPWLLFALPAGVIIDRSDRRKLIARADLMRAGIVLAILLLALGDPAPGAIWALAGLAFLLGSAEVLRDNAAQTILPALVDPDDLEAANGQLWSTEQLTGQFIGPPLAGVLISAGIAVPFGLDVAVLVLAAGLVWLISLPPQVPSRARFAQALAEGIAFMRGDALLLRLAVVLGLANFIAMATITVQVLFAQEVLGLGAAHYGMVLSAGAVGAICGSLLAPRAMRLIGTQACLFLSIAVWGAGYASIGLSNSGWVMGLALTAIMAAAMLWNVITVSWRQRRIPPAMLGRVNSIYRFFGWGSMPLGALAGGALVVLAEQQMSREMALRAPFLLAGLCCLALLIYALARLRLE
>fig|246200.3.peg.2378 Permease of the drug/metabolite transporter (DMT) superfamily
MSDQKTLSPRAWAELLLLGLIWGASFLAIRVALDEVPVVTAVLHRTFWAALLLWLVVWASRIALPRDPRVWGAFLVMGLLNNVIPFGLMAWGQLYIETGLTSILNASTAIFGVLVAAAVFADERLTPRRLLGVSIGFAGVVITIGFEHLTRFDPRSTAQLAVLAGTLSYAFAGAWARARLGGLAPQLAAAGMLTGSSLILLPAALLIDGPVTLSLQPVTWAAIGYYALVATAGAYLLYYRVLAMAGAGNLMLVTLVIPPVAIGLGAWIRDEALPANAFGGLALLALGLMLLNRRPRRRD
>fig|246200.3.peg.2834 Bicyclomycin resistance protein
MGWSGARDRDSADLPSKPPDPLMRHASNPPHLITLVLLTALSVLTLNMFLPSLAHMGQDFEVDYGLINLAIAGYLGVSAILQLIIGPLSDRFGRRPVLLIAMAIFLVASIGCVLAGSIWVFLGFRLLQAAVVAGPISSSASIRDQYPPNEAASKLGYVAMAMALAPMLGPMLGGALDMLFGWRAGFVLYSILGAVMLALLWVDFGETNTERSVTFKAQWQQYPHLFRSRRFWGYALCASFSIGGFYAFITGAPLVAAAWFDLSPALLGLGIGIITGGFMVGNFVTGRIAARTRLTTMILLGRIIASTGPAIGLILFLTGAGSVWVFFGSAVLVGFGNGLTNANAVAGLMSVRPRLAASAAGLSGALTVALGAVLTTVTGIVVSAENAPFAVLGLMSGSSFLGLLAVLYVRWVDLREPLPDT
>fig|246200.3.peg.2871 Drug/metabolite exporter family protein
MCRTRPSCGRMEEKRPVDAAGAVALIGIAALLAFNQVVIKVTGGGFGPLFQAGLRSALGLVFVLIWMRLLRKPIVFPRAALMGALITGLLFTVEFMALFAALDLTSVSRVSILFYSMPVWLALGGHFLLPGERLSGMRVLGLMLAMGGVVLALLERDAAHVSLLGDALAVFAAMCWAAIALGVRLTPLGRVPAEMQLMSQLVISAPLLLVLAPLTGETLRTPGLLHWAGLLFQAVGVVGLGFLIWFRLLAVYRANGVASFSFLSPVLAVILGWLLLGEQVGPLVWLALGLVAAGIVLINRR
>fig|246200.3.peg.4191 Permease of the drug/metabolite transporter (DMT) superfamily
MDLRAIAMGLAFAFMWSSAFSSARIIVADASPLFSLACRFLISGLLGVIIARAMGQTWRLTRNQWKATIVFGICQNALYLGLNFYAMQTVEASVAAIIASTMPLLVALASWGLFGERLPALGIAGLLAGFLGVALIMGARIGAGVDLFGVLLCGLGALALAAATLALRGATSGGNFMMVVGLQMLVGSAVLFLATPIFETVHVTPTLPLALAFAYTTLVPGLTATFVWVLLLNRIGAIRAATFHFLNPVFGVAIAAALLGERLGALDAIGVAITTAGILAVQLSRQASARKP
>fig|246200.7.peg.100 Permease of the drug/metabolite transporter (DMT) superfamily
MVLAILLSLLALVLFDMMGLIIKYLSPRYGAAELSAYRNFFGVFPSVIALWSSPGWHRAGRPWRIRQWRLGLMRGVYVTFAQFLFYYSLGKLAFATASTITYANAVFMTALAVPLLGERVGLMRWAAVLLGFAGVLLVMKPGSDSFTPDALAPLGAAFLYALTGVSARQMDSAVPSALINLYSVVAALVGALALALLSGGFTPLAQWSDLGWIAAMGGFGGTAVLCLVASYRMTEQSNLAPFSYFGIPIAFVAGWLVFDETPWADLFPGAFFIAGGGLMIVWRERIRSRAGRRISN
>fig|246200.7.peg.1464 Permeases of the drug/metabolite transporter (DMT) superfamily
MSLWIPVTLAAALFQTVRFMLQKSLATVKLSASGATFARFLYSAPLALAGLLIATTAGGYDLPALGARFWIFVAIGGTAQILATICVVALFKQRNFAVGITFKKTEVIQTAIVGFVILGEGVSFGALGAILLGLVAVLLLSKTPGGSGAWWRHLTNRASQLGLGSGVLFAFSAVSYRAASLELGDLTPWFRALVTLAAVVSFQLVSMALWLWWRDRAQLAAVWATRNTGAFVGLTSLGGSFCWFLAFTLQNAAYVKALGQVELIFSLMASTLFFREKITTREIAGIGLLGLSILALVLAI
>fig|246200.7.peg.1547 Acriflavin resistance protein
MSEGSQNTPLGIAGGLTRGFIGSALTPLMILAALAMGLVALISLPREEEPQISVPLVDIHIQAPGLKAEDAVKLVTEPMETIVKAIGDVDHVYSQTGDDYAMVTARFLVGTPADTAILRVHDKVRANMDRIPVGIGEPLIVGRGIDDVAIVSLTLSPRDGAGDVSANDLTRIARELQVQLAKIGDVGLTYLVGEAPEAIRIAPDPERLALYGVTLQQLAAKVEGANRALATGLVRDGGEQIALVAGETLHAPAEIANLLLTTRDNRPVYVRDVADVRFVPDTSERIVANVTRDDSGGFRRSPAVTLALAKRAGANAVVVAEEILHRVHLLEHDLIPDSVEVTVTRDYGETANEKANELLFHLGLATVSIVVLVLFSIGWRESIVVAVVIPVTILLTLFAAWVMGYTLNRVSLFALIFSIGILVDDAIVVIENIARHWAMPDSASRTQKAIRAVAEVGNPTIVATLTVVAALLPMLFVSGLMGPYMSPIPANASAAMIFSFFVAVIITPWLMVKIAGRAPAHAHDAAAQHGGALGRLYRAVARPLLRTKSGSGLFLLVAAVLSFGSLGALYTRDVTVKLLPFDNKSELSVVIDLPEGASVEDTDAVAQQVARRVLELPEVISAQTHAGDAAPFNFNGLVRHYYLRARPELGDVQINLLPKDARTRTSHDIALDIRERLSTLDLPEGTVLKTVEPPPGPPVIATLLAEVYGPDADSRRAAATRIREAFESVPFVVDVDDSFGTQARRLRATVSTDQLEFFGVQERDVFSTLAILNAGQTVGYSHRGEGRRPIPIEVARDSADRVVDERFLSTPVPANVLPGARGVVELGDVVELREERASYPVFRHNGRAAEMVMAELAGDFEAPLYGMLAVAEALDAMDWPEGGKPQIRLNGQPEDESVITLLWDGEWEVTWITFRDMGAAFGVALLGIYILVVAQFGSFRLPLVVLTPVPLTFLGIIIGHWLFNAPFSAPSMIGFIALAGIIVRNSILLVDFIRHANPERDKIETLIEAGAIRFKPILLTAVAAMIGAAVILTDPIFQGLALSLLFGLLSSTLLTVLVIPAIYRVFKT
>fig|246201.1.peg.1787 Permease of the drug/metabolite transporter (DMT) superfamily
MSSGWITSMRLTLAGSLVLIWSAVQLKSQVLDIWRDKKNYLPFLAYAILGIFSVQYFFYLCVEYSNAATATILQFISPVFILFYNRLVYQKRASKSAILYVLVAMLGVCLMATKGDLSQLSMTPLALVTGLLSAMGVMFNVILPQPFAKRYGFVPTVGWGMILAGLFSNVLSPVYQLSFTPDIWSILICLIIAFFGTAFAFFISMKAVSLVSPLVVSVISASEPLSSALLSVLFLGLVVDWSLLLAMALIILPMIFLSIEEAKESK
>fig|247156.1.peg.887 Permease of the drug/metabolite transporter (DMT) superfamily
MASGLAFASSGPLAKSVLAAGWSPGAVLAVRLTGAAAVMLVAAALADPRGLARSPRHLRTIGGFGVVAVAGVQATFFLSLQHLQVGVALMIQFLAPVVVIAWDWVVRGRRPTPLTLLGAAVALGGAALVIDVFHTEGLRPVGLAWAALSMLCNAAFFLLSARTSDSLAPVTLLGAGLGVAAVTSWALGLSSVLPLHFGTGTAVLAARELPVWAALALLITISTVVAYACGVAGAARIGSTLMSLVLLSEVLFAVALSRILLGEAIAPIQMVGALLVVGGIALARSGGQRRPAASEVPAPGPQAT
>fig|247156.1.peg.1442 Drug transporter
MTTVSQRTQRPPNLARRTLLIACGATFIALLDLSVVNIAFPSLARDYPDTPVTTLTWVVSGYGVAFAALLTPAGRFADALGRRRLFLIALAAFALTSLLCGLAPDAATLIAGRVAQGAAAALMMPAALGLILAVTPRERIGAAIGAWSAAGSFAAVVGPPLGGALVEAFGWRAVFVVNVPIALALMLPARGLPETGLRPPGSGLPDPVGTIAVALGLGGLVVGVTEGQRWGWTAPTTLLALGVGAALVAVAIARSARLTVTGRAAGAALAVGLWRSRPYALANAASFVFAGAMYSWLMAGPLFLDAVWGYSVLGSAGAMTAGALTSMITATAAGRITAPAVRRWAGVLGALLFAAAALWMSSDSFGPDPALWTAWIPAGVLGGGGIGLVLTALGTAAAAALPPEQFAAGIGMNLTARQVGGALGVAVMAAVLAAHPGDALTGLHTHFAVCAAIAALTAVLTALPSRQEQP
>fig|247156.1.peg.2923 Multidrug resistance protein B
MSSSVETGTRPDPDAMTHREVLEAMTGLLAALFTALLSTTIVATALPTIIGDLQGSQTAYAWVITTALLANAASTPIWGKLADLFNKKLLVQLSIVIFVAGSILAGVAHSVDVLLAARVVQGIGMGGLTALVVAIIGSIVAPRERGRYSGLMGAVMAVSMSGGPILGGVIVDSPLGWRWCFFVCVPLAVIALFLLQRTLRLPTERKDDVSIDWLGAVLLTAGVSVLLIWVSFAGKAGYYDWVSRESVLYVGGGVLLLAATVWVEARAKAPIIPLKIVTERTTGLAIIASIAVGVGMFGATTFLGQYFQTSRAYSPTIAGVLTIPMVAGMLVASVVSGQMITRFGKWKSFVVSGAALMVVGFSLLATIDHATNLWLVGIYITVIGLGMGMMMQNLVLAVQNTVSVQNIGAASSSVAFFRTFGGAIGVSVLGSVLATRVSELSAEGFARLGIRPSGEGGSNLDLSGLPAPVLDVIRASYGDATGRIFLIAAVATFVALLAAAVLPNRPLRRTIDIDPAQDPMRTGVPAAPEERDGVELEKARTS
>fig|247156.1.peg.3258 Multidrug resistance protein B
MTSSTPKPSPETTASVAEMPVSEQDSGWRGLFSRPHRTAVIVMAGGVGLYAMNLYFTAALMPTVVGELGGQQYYAWAATAYLITAVTATMIVSRMLAVRGSGGSYVVAYLLFAGGTVVGAGSPTMEFFVAGRAIQGLGAGLLTGLGYATIRRVLPPQLWTRATGLVSAMFGVGTLLGPALGGVFAEGGAWRAAFATLTGIAILLLLVTVRALPTRRPEEATRTPVPVASILALALTAALLSLRSALSGVWVPVTVAAGLLLLIAFFVIDSRDPDGVLPRLAYTPGNPLKWVYVTVAALCAGVMVENFIPLFAQQLADATPIVAGLLGAVLSLGWTLAQLFSVAAAERTARILVRTGPVLLTAGLAAYGLLQADGAGWLHLTVWAVLLFVAGAGIGLAFPHLSVAAMRAGKDEAEGAKAAAAVSTTQLIAFTLTSALAGNLLALGGDSPLASARWLILGIAVLTAIGVATALVATRTATTRSRLHQW
>fig|247156.1.peg.4681 Probable multidrug resistance protein norM
MTPFGPDTRRLAALATPIALTQLAQIAVSTTNIALMGTLGVGAVAAGGLALVLFNQIRTMCVGLVTGTGNQVAAAVSAADKRGDSPAGEVREIVRASFLVATLAGLLGGAVLIGLGWSLQWLGQDASVLAEARPLLVALAPGLLPCLWFQVLRQYTVGMQRPQALLLVTLASIALNLVLALAFIHGWAGVPALGLTGVGVATSLVFLITFGVFWAMVRHDERLGAMLSVRPWPVRGRTVLAELRLGTPIALTYGSEAGMFSVLALVMGSLGPAALAAHNVVYQIIYIVFQVAIGLSHGASILVSHAVARDEHAHARHVAWLALRYAGVVAAVTGALYVLAPQLVLRPFLDPADTATLDIARALLLIGIVLQFFDAAQNIGTGLLRGLKETGAGFRLSLIGYWLVGLPTALVLALPVGLGAPGVWWGLTAGLAATAILMVRRYFVLLDGLALPRPRPLPQAVGTA
>fig|247639.3.peg.1038 Permease of the drug/metabolite transporter (DMT) superfamily
MTGPRYMLLSAFAFALMGAMVKIASAEGLPLLQIIFVRAIISVLLCLIAIRRSGSNPLGRQRGLLLARGVVGFMALTGVFYAFINLPYAQATVLQYLHPVFTAGLAFWFLSERPTPATLICIALSLLGLGCVVYPYLQSTNTSVMPIAAVLAGLGGALGSGIAYTLVRKLATTEHPSVIVLYFPMVCVPATLLLGAGDFIWPSQIGWLTLLGVGCFTQLGQISLTKAMQTDSASRATSLSYLQIVFAASLGWLLFKEVPATATVIGAAFILFGALISAALQPNPDKKRGAGNA
>fig|247639.3.peg.1525 Acriflavin resistance protein
MKGLISWFVRNPIAANLLMFSLVVGGLLGLIEVRKEEFPNIDVPTITVSVPYLGAAPSEVETGVCIRIEEAVQGIEGIEKIKTQAAENRCVVALELTNASYQDRALDDVKAQVNAISTFPANTERPVVALVSLRSVVMYIAVSGETDERSLKNLTESLREEILEIPSVSLVDTMYVRPDEISVEIPEFTLRRHSLTLGQVAEAIRQSSIDIPGGSIKTESGEIRLRGTAQRYSGRELEDIPIITNADGTRVLLRDIAVIRDGFEQQDLSAMLDGRPTQLLKVWRLGKDNTLAMARDLSEFLEVKQRSLPSGLELRIWSNEADELVSRLSTLINNATGGLLLVILTLALFLRLRLALWVTAGIPVSILGAIAFFPSADLGISTLSLMGFLLSLGILVDDAIVVGERIHTHEGFTPDSREAAINGTTEVAIPVFFGVLTTMAAFIPIVTVDSMLGSFFGAIGWTVLLCLVFSLIESQLVLPAHLAHRNRERGKSAIGARWENFQENVSGGLERFAQQRYQPALRLVLKYRYVTLGAAVAALIIIVGLLASGRIVFQFFPTVSGNEIYASVELPEGYPVERTATALEVIQASADQLIVELNEGLPEGATAVVNQFKTIGLPISKSTISGSEESGSHIAEMSITLYPHDERGGMTPKQAAKRWRELTPDIPDVIEKSFTASAVSLGEDINIQIRGKDLEVMSAAASALTKILSSFDAIYDISDSYRAGKQELVLRVRPEAESLGLTQADLGSQVRHAFYGAEAQRVQRGRDDMRIMVRYPEADRRSLDDYNQLYIRLPNGAEVPIESVASTQLSTGNATIRRVDGQRTINVTAYADRTRIAPETVLRLVEDQHIPRLEAEFPGTTFSLAGEAEERASALTGLARTSLLALIIIYTLLAVPLKSYLQPLVVMASIPFGLIGAILGHFILGYDLVFFSILGIVALSGVVINASLVLVDFINKRRLNLEITVAEAVTRAGVARFRPIFLTSVTTFVGLAPLMLNADLATAPFVPLAVSLGFGVIFATAVTLLLVPALYLILDDFSGPPDNETNTDHGSKQGEA
>fig|247639.3.peg.1607 Acriflavin resistance protein
MQGPLSWMIKNPIAANLLMLLLIVGGVLTTPSLDKQFFPTAQINQVSVTMPFPGAGPAEVEEQISVRIEEAIHDLNGIKEIRSTAVQGLGTVMVEATQNYPMQRLTSDIKTRVDAINSFPADAERPIVTEITYRHLMTVVQLSGDLDEYELKELGEALRDDLARQPWVSMVDLITARPYEVSINISETMLRRYGLTFDQVVAAIQGTSLNLPAGAIKTQEGDVRVQTRGQAYGRADFERITLLTQTDGTELLLGDVAIIEDGFVDLDLNVTFDENPALGLRVYVTSNPDVLKTNQVVKDWVAEQQLSLPPGVSLTIWRDISKSFRGRVTTLLENGIGGLLLVAAVLVLFLRPKLAFWVGSGIAVAFLGTLFMLQFTGISLNMISLFAFLLVLGIVVDDAIIVGESIHTHQARGERGHVGALLGVRGVFKPVMFAVISTMIFFVPMLLLPGDWSTAARSIPVVVLLALAFSLVECLLILPAHLAHLGPEKEPKTRVMQRLAGWRQACASGMVWFARYRYRPFLRWALSHHYAAAGVFLVAFSMSIALYGGGWVRSAFFPKVNSDYVVASVEMPEGGPYSDTVALRDRMVAAAQVLKADWNARPEFFVTPAISHVSATTNDNKINIEIGTVSEGVDTEQIALDFRDLVGPVPQAKEIRMDFTIQDPGKQIKLLFASRNTEDLEGLAPRVRAALLAYPGVFDVSDSFDSPRDEVVLDLKPAAEALGVTLASVAKQVRQAFYGAEAQRIPRGREDVKVMVRYPESERRSLANLDEMYIRTPTGKEVPFGTVATYRIEPGYQKLERLNRMRTLEIGADVRADGASPRAVVDGIVVNKLPLWQQEYPGLELNLDGELQEEAEFKSSMLMFMGLAMLVIFGLMAIAFKSYWQPFLVLTAIPFGIMGAIFGHALLDWEVSIFSMMGVIACAGVVVNDNLVLIDRINHLREQGYELWDALLQGAEDRFRPIILTSLTTFVGLLPIMSETSVQAQFLIPMVTSLAFGVLFATGVTLVLVPALYLVGDDVTGFLQRLLGGDKVSAATDSSVVTTAH
>fig|247639.3.peg.1700 Permease of the drug/metabolite transporter (DMT) superfamily
MILRSYYWLLLASTLLMASAFVVSKLFIVDGIHPLVLVASRFTLAGALAIIWLSLRRQLETPKTLSDVGGVFLVGTLQTAVLFGTGFIAMEHLSAATISLLTLTMPIWVTGMLALMNRKFPPLLQLIALGVGMAGVALIIGSGVSEAGMGELQWFALALVGAACWASATVFTKTSGLSITGWSLNAWQMLVGGGEVLILALAMDLPGIKLVLVSDILLFIWLVVPASILSFGFWFSALKLGGAAVTSGYLFLIPLFTALISVPVLNASFAPMQLLGGVAVAAAVWLMSRSST
>fig|247639.3.peg.2222 
MAIGLIATIKVQEGKNEAFETAFLELAQRVREDEPGNMLYALHRSTTDAQTYKVMEQYVDAAALKAHGETPHFAAAFQQVGALLAGAPEVEQLDVIG
>fig|247639.3.peg.2328 Glyoxalase/bleomycin resistance protein/dioxygenase
MSVEVIASEKAEAADSLWGLALKTADIDATHQRLNEAGVEVSEVRDGRKKDTRVCTVKSHALNVPTLLIEHPVK
>fig|247639.3.peg.3295 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAAAKLMTVTLFRREMRQLLRFAFPLFIAQSAQMGTGVVDTIMAARYGEQDLAAISIGINIWLPVYLLILGTVFATATIVAQDFGGGRIEKIRQQLPQSLWVAVFLGLTLSPAIWYAGPILDLLGLNPTTRQLALDYAQMVALGMPATAIFQALRYHTQGLGITQPFAFAAVAGFLINVPLNYAFIFGEWGAPELGAKGCGIATAISMWLSVFLIGAYVLRSKKIRLYLPEWKPVAPDWAKIREILSVGAPIGLTFFLEMGVFSVIALLVASLGDTAISAHQIAFNVWDLYYIPMLAIGTAMSTRIGHAIGAGWREGIYRAMIVGGAISAVVAIGTMLILLSFPGAIIGIYTDAPDIQLLATRLLTLSAFFILIDGAQIVGSFILRAYKETQFPFIMMVVSYWLVALPLGWWLGIEVPDNPNDGAAGFWYATITGISVCTVLIGARIWVILRRELPSTAAE
>fig|251221.1.peg.268 Drug resistance transporter, EmrB/QacA family
MKTRRPSFGRYHRKCALVTGDSVVQYQRPIDYTTALDERTKRLVMGAVLIALFLTSLDQTVVVAALPKIVADLGDLDLLAWTSASYLLVSTTSLPILGKLSDLYGRKNILLIGIAIFLLGSFLCGLAPSMLMLVVFRGIQGLGAGAITSVALTIPADLYVPAERAQLQGIIAAVFALSSIVGPLLGGVLTDTLGWHWIFFINLPFGLLALAFIVAFMPRLNSGLTRSIDYWGAVLLMLTVVPLLVALSLEKEKYAWDSPLVLGLLAAAAVSFGLFVFAELRAKEPILPLSLFRIPIFSLICAMSVMVGATFIVAILFLPVFLVNVMGASATEAGVALIPETLGLLVSSFISGLVVQRTGRYKAAMLVGLVLMSIGIFLLTQLSLTTTIAQVWFSIAIFGLGAGATFPQANLALQNAVPFEYVGVATAGRLFFAQLGQTVSAALYGALLVAYLNTALVDSLQPVAARLPASLATHLDPGRLRNGGEQAAAELAALGTEMAPRFTPEVRRRTEAQVRTAVRRSFAEAVARVYQASLPLPLIALLLGLLVPELPLKRSNSPDTPPAAVHE
>fig|251221.1.peg.2822 Drug resistance transporter EmrB/QacA subfamily precursor
MTKQVARNTTRDLGAQPDNKWAILLAVSIGTFLVPLDITVVALALPDIESSLRTSFADLQWIINGYNLSFTAFLLAAGTLADRFGRRRLFLVGLALFTLTSLTCGLATTPLTLTLARSIQGLGGALLLISSLAILSQTFREGPERANAFGVWGLVMGVGASLGPMIGGLLVDLLSWRWIFLLNVPIGVGLVAFTLSKVDESRDPGAARVDWLGLTTFTSALFSLCFALIQGNELGWTSAAILGLLAAAAVLLFAFALIERRQSQPMFDLSLLGNPAFVGTSLLAASNGASFWAMIVYLPLFFQNVLGYSPLQAGLMLLPLTVPLLVCPPLGGRLAQVLPARLLLSGGMLMVGLGFVWMYGVNAGSPWTAFLPGFLLAGIGAGLINAEIANVAIAVLPPQRSGMGSGITSTFRHGAHALGIALLGSLLTQRVATSLEQSTLPGLVTERSTQLASQIAAGDLIGVVRTLPPELQNAFAAAAQNSFIDGFNLIVLLAAATALLGALATFVLVKDQRSQSQLQRQERPSASKS
>fig|252305.5.peg.1593 Multidrug resistance protein B
MPSKTEHPVTPPPDLPGPDAATLRVLLITVATTLFLASTGNTIVTTALPRIVSDLGGLAYISWVVTAFLLASTVGAPIAGKLGDMYGRKIVLQVAIGVFLLGGLICGVARSMEVLIAGRFVQGLGGGALIVVSMAVVADVLPPRERGRVQGALSSVFGFSTVVGPLIGGFLVQTVGWHWIFFVNFPIGVVAFVILTRTLKSSTEKVPHKMDFVGSALLLILLSSVVLIANLAGSVYAWTSLTVLFLLALAPMALVGFVSAERRAAEPVMPLDLFRIRNFQAANSVNFLVGMAMFGTIAFIPMFLQVVKHVGPVSSGLYLVAMMGGLIGTSFAAGRVISSTGRYKVMPTVSTAVLAGAMLLLTTINPETPLAVITLYLFLVGAGIGPTMSVGIVSIQSAVPREHLGVGTASANMFRLIGGAIGTSVFGALFTLGLGRHVQPLMPQVQEVRELTSAMVDRLEPAAQAAVLQGFSDALMPVYFVGAAVAAIACLASTRLVELPLGPVPRDRRGTPAE
>fig|252305.5.peg.2558 Drug/metabolite exporter family protein
MRAMRKDHLDPAGFAALVLFTTVLAGNQIVMKLTNAGLSPIFQAGLRSLLACLVVLAWVRVRGLGLGPFRRNFWPGLALGLFFSIEFAALYTALDMTSVSRASIIFYTMPMHLSLAAHFLIPGERLTPQKVAGLVCAFAGVVIVLADRSGGEASLLGDVLALVGALGWAAIALTVRITRISEAPPEAQQIWQLSVSAVVFLAIAPLFGPVLRDPGPEHIWLMAYQVLLVASLGFLAWFYLLKRYPAATVASFSFLTPVLAVFMGWALLDETLRWSVLLSLTLVSVGIVLINRKPRARGNGRARAAATPPT
>fig|257309.1.peg.1871 Sulfonamide resistance protein
MLRSRVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRNARDRGLDHA
>fig|257310.1.peg.62 Permease of the drug/metabolite transporter (DMT) superfamily
MGERLVRCCPYQPRRRDPVASHPSSHYVSTAIASPANVGRVYLQLLLVMAAWGVNLVAVKYLTFHMDVQVVAAVRIVVAFVAVSAILLWRLHGVPRLSLRQFGWLACAGLLVVYAHQILLVNALRLTPAANATLIMATSPLFSVVLAAFFYRERLTASRIGGAALGLGGVALVVAGGDGVLASVGRGDVLALCAVIVFVIGGLIIQRVSRALDPLTILWYMYLVGAVTLSAHAAFSPATYLASSWTLEPWPWLVVLFSSVIASGVSNLLWNAGIARLGMSRAAMFVNWLPIFGLLAAAVFLGERITALHFAGLACVLSGTWLGLRTAPAPAAGQADARPARARRA
>fig|257310.1.peg.118 Multidrug resistance protein B
MSAPPTQDPEITTTTQESPHSRRDLLRAMAGVSATVVLVAFDSTIVTTTLPRVAAALNGMALYAWVGTAYLLATAASILIFGRLGDMYGRKPLMLVSVSLVALGSIACGLAQSMPQLIAFRTLQGIGGGMMIATAFAAPADLFPDAGQRVRWMALVSATFAMASGIGPVLGGAATQALGWRAAFFISPLAAVAALFLLARYFPRIRPAQTASRRIDWVGGLLLIVVVGAPLAAIELAFAPGDGAHPRVALALAVAGIAAVALLVPIERRVRSPIFPLRVLAGLEPRLLNLAAVAVGATMFILIFYSPLLLQHELDYSPSEAGLLLTPLVAAISFGSIINGRLFPRQTEPQRLMVFGSCLLAAGSAMMLAVSAGTSAWWIVAAFFVNGTALGFLLPNLTLFMQMLSERRDVGVASALVQTTRAMGSAAGTALVGIAISHSSVLDGVRAGLILCVLLSLFSAVVAHRVKMKNVAATPAA
>fig|257310.1.peg.3048 Probable antibiotic-resistance protein
MIVDMRLRPPIPGFARSTLYQAGPKTSHPDFPVEPSVGQCSLPLLISEMDAAGVAVGVVPGRYSMEPFGIVSNDELATLFADHPGRFVGFMGLDLGWPMQRMLDEIDARVGTPGFRGVALEPTISADASFCGMNDKRLYPIYEACVKHGVPVSVTLSAVLQAFTKRPYEHSNPVQAYQVAIDFPSLDIVIAHAAYPWVMEMIGVCLTCPNVWLSPDLYLTNVFPGAQEYAKAAATYLPRRTLFGTGYPAKPFKPMIDAYAAWGWPQDVVAAILGGNAARLLRLADQ
>fig|257310.1.peg.3064 Inner membrane component of tripartite multidrug resistance system
MKLPTADEAVFSIKCYLGAMLALYLAYSIGLPRPFWAMTTAYVVAQPWSGAVRSKAVYRLGGTFFGSAMTIYTVPRLANYPVLMTLAMVLWVGLCLYIAVLDRTPRSYLFMLAGYTAAMIGFPSVTDPALVFDTALARVEEISLGIICATLVHSVVLPRGIGRAMMGRLDATVRDARSWIQDVLNQRGAAQHARDRRALANDITQLRLLSTHVPFDTGNIRWTANALRAMQEHITALTPAVSAVEDRLQALQAQGRALPPPAARVLADISAWMDDSAHATREQAVQLRAALTRLAPAIDRQSGWHDALLASLVARLRELVDSYDACLVLRQDIHAGLGGAPTGRTRRLTRGAALHRDHGLALLSALAAALAISVCCLFWIGTAWTNGATAAMMAAIFSCFFAAQDNPVPGIMQFLTYTIYSIPLSALYLLGIMPALHSFEMLALAIFPVAFVTGVYIARPTTTGKAMAVFFGLSGTLALQDTHAADLVSFVDTIVAQIIGVAVAAIIAAVFRTVSAEWSARRIQAANWKELAALAGAGRAPARLDFTARMLDRIGLLQPRLALSKRRDDQLADDALQDLRVGKDIAELQRARRHLPMADPAIQPVLRTLAGLFRKRPGRLGGERPAELLQTIDRALYSVSNTPVAHAARERAVVALVGLRRAFFPEAAAYRPGRDVESPAS
>fig|257310.1.peg.3067 Outer membrane component of tripartite multidrug resistance system
MSIRSLLPLIPALALAGCAAVGPDYRLPEQAAAKRPAAAAPFVQAREQAVYRQDELPPHWWRLYQDRQLDSLVEQALAANADLRVAAANLERAQAVTRQAQARQQPTVDVSAAPAFGHASGVQELQPGLRPQDSWSYSGGLGVSYQLDLFGQIRRAIEAAQDDAQAAQAAYDAARVTVAAETARAYADLCAAGMQLDSARHSVQVQQQSVDAVQRLLAAGRGTTLDVARARSQLEQLQAELPPFQAGQRTALYRLAALTGHAPAELPQSLLACVRPPRLAQAIPVGDGAALLRRRPDIRQAERSLAAATARIGVATADLYPKISLGLSGASAGPAALFGEPGTFSWSVGPLISWTLPDTGAAQARIAQAEASTKGALARFDATVLNALRETESALVTYARQLDRDAALRAAREQGAQAAAQARQLFRLGKTDYLTVLDAERTLAGNESALAASQAQLAGDQIAVFLALGGGWE
>fig|257310.1.peg.3565 Multidrug resistance ABC transporter ATP-binding and permease protein
MKKPQNLAGAGRREVPAEWRDAIHSHLDAGETVLAWLETDLDARLRFETGMVLATDRRILACAPGRREWSSWPYSPDLRLALHDHAGAASLELDAGARRLASWRFTLGRNPAAQRLLEQFESLQALRLAGAAPTAGESPRPCPTCQAPIPADREDCPECSQEPAAPPATWALLRLWRFARPYRGALLAGFLLTLLGTAATLVPPYLTMPLMDDVLIPFQNGAPIDYAKVRLYLAGLLASAVLAWGLGWARTYILAWVSERIGADLRTTTYEHLQQLSLEYFGGKRTGDLMARIGSETDRICVFLSLHLLDFATDVLMIAMTAAILVSINPWLALATLVPLPFIMWMIHVVRDRLRHGFEKVDRIWSEITNVLADTIPGIRVVKAFAQERREVQRFREANNRNLEVNDRVNTVWSLFSPTVTLLTEIGLLIVWIFGIWQVSQKHITVGVLAAFLAYIGRFYTRLDSMSRIVSVTQKAAAGAKRIFDILDHVSSVPEPHKPVHLPRVNGHIELRDVGFRYGNRSVIRGLDLSIAPGEMIGLVGHSGSGKSTLINLICRFYDVSEGAVLVDGVDIRSLRIADYRRNIGLVLQEPFLFFGTIADNISYGKPDATRAEIIAAARAAHAHEFILRLPHGYDSLVGERGQALSGGERQRISIARALLIDPRILIMDEATSSVDTTTEKEIQKALDNLVRGRTTIAIAHRLSTLRRADRLVVLDRGQIVEEGAHEALMAREGAYYRLYQAQQTRQAEGGDDGSDAIAAIA
>fig|257310.1.peg.3706 Permease of the drug/metabolite transporter (DMT) superfamily
MNRAAFDRVGLGLMLLTIFVWAGSWIAMKLVVPYIGPFDFIAVRYLSGAVVLFSILVATGRPLGMPPWKLTLLAAATQITGFQGFVQTALISGGVGKVSLMAYTMPFWVVLFAWALQGERPTARHWGGIALAAVGLVCFLDPWAGLGDLAPVALGLCSGLCWGLGTVLSKRMFERHAPDIMTFTAWQMLLGGVVILPFAWLVPQIPAQWGGWRLWLGMSYIVLVATALGWILWLLVVRRVPASIAGLSSLGVPVVAVLLAWAILGERPTLTEMAGMALILFGLWVVSRAARPAPRAVS
>fig|257310.1.peg.4251 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MFMYTEFRSQLLAGAGTSAAGQSARMAVLAGDGATGVQVSCVVPGLNEAANLRVLVPALRACLEQWCASWEIIVVDDGSTDDTAELMAQWSAVEGIRYVQLSRNFGKEAALTAGLEAADGDAVICLDADMQHPPELIGDMLAAWRNGAEMVYAVRRQRDDEPWFKRVGARAFYRLLSTARGVEVPPHAGDFRLMDRRVVEALVALPERTRFMKGLYAWVGFKSQAVPYTPQARRHGASHFSAWKLFRLACDGLTAFTTWPLRLVSLIGVLFALLSLSYGGYLVADYLISGNAVSGWTTIVTALLFFAGINLISLGVVGEYVARIFDEVKGRPLFIARQRRGRAKRAAKARSQ
>fig|257310.1.peg.4422 Multidrug resistance protein B
MSADPATAAAPPPLANPDAARAARMIPFIVGCALFMQMLDSTVVATALPAMAAALGSTPVRLNVAITSYLLAVAVFVPISGWAADRFGARRVLIAAIALFTLSSVGCALSQNLGQLVVARIVQGMAGAMMVPVGRIILLRTVPKQDLLKAMSFLSIPALLGPVIGPPVGGFMVTYMSWHWIFLINIPIGILGIALVLRFVSEIREENAPRLDLPGFLLSGICLAALVSAFEALGHGLLPPLELGALIAAGLLCGVLYVWHSRRVEHPILDLSLLRTPTFAISVLGGNLCRFAVGAVPFLLAMLLQVGFGLSPFAAGMITFASAAGALLMKFVATPIVTRYGFRRVLTINAILTGLFIVACAAFTPVTPAWAMIAVLLAGGFFRSLQFTAVNTLTYADIGPERMSRASSFAAMAQQLGISLGVGVAAVTLNVSMAARGAASLAIGDVVVGFMVVGALCMLSVLSFRRLAPSAGAQLQNVKVPRDGK
>fig|257310.1.peg.4672 Probable antibiotic-resistance protein
MKIIDFRLRPPAMGFLNARIYTRPDIRNRFTRQLGFEPAPSAEEKSLELMFEEMAAAGIEQGVCVGRNSSVLGSVSNADVAAVAKAYPDKFHPVGSIEAATRKEAMAQMQEILDLGIRIVNLEPGVWATPMHVDDRRLYPLYAFCEDNGIPVIMMTGGNAGPDITYTNPEHIDRVLGDFPDLTVVSSHGNWPWVQEIIHVAFRRPNLYLSPDMYLYNLPGHADFIQAANSFLADRMLFGTAYPMCPLKEYTEWFLTLPIKPDAMEKILHGNAERLLAQAGR
>fig|257311.1.peg.4335 Inner membrane component of tripartite multidrug resistance system
MSHQQALTVINGMIDTQAYTLSALDVFYASAAIFLLLTGLVWLARPKSAKSAGGGAAEAAAGAH
>fig|257311.1.peg.4414 Acriflavin resistance protein
MTLTLAAVYAPIGLMGGLTGSLFKEFAFTLAAAVGVSGVIALTLSPVMSSFLLNSRVSEGWMARKAEHFFQRLGDAYGRVLDVSLRHRWVTGLIAAVVLASLPVLYGSAQRELAPVEDQAMILTAVKSPQHANIDYVEKFGQKWDAVMQEIPEQNGRWLINGSDGVANSIGGVNLVTWQARKRSADEIQGDLQNRVNAIEGSNTFAFQLPSLPGSTGGLPVQMVLMSAADYRVVYDAMETLKQAARASGLFMVVDSDLDYNNPVVRVDIDRAKANSLGVTMKAIGDTLAVLVGENYVNRFGMDGRSYDVIPQSPRGMRLTPQSLGQFYVKSASGAQVPLATLVKISMGVEPNRLTQFDQLNSATFQAIPMPGVTMGDAVQFLTEQARLLLPGSSHDWQSDARQYSQEGSALVVTFLFAIIVIYLVLAAQYESLRDPLIILISVPMSICGALIPLALGMATINIYTQIGLVTLIGLISKHGILMVEFANEMQAHAGLDRRAAMERAARIRLRPILMTTAAMVVGLVPLLFASGAGAHSRFSLGLVIVVGMLVGTLFTLFVLPTMYTLLARDHRAAGQSARARELARLDAQAGAASPAHETAS
>fig|257363.1.peg.141 Multidrug resistance protein B
MPNNDLKKLPLSKKQLLAFFGMIVGMFMSVLDIQIVASSLSVIASGLAASSNELSWIQTSYLIAEVIIIPITGFLARLLSTRICYFIASLGFTMMSVLCSLANNIESMIIFRALQGFCGGAMIPLVFSTVFIIFPASQRPTVTILIGLIVTVAPTLGPTLGGYITEILSWHFMFLLNVIPGIFVCTVVFLYVDFDKPNYQLLKNFDFLGILLMSLTLGLLQYVLEEGNKAGWLDNKLILFLSITVALGFILLIIRELTFINPILDLNTFLYKDFTFGCIYSFILGIGLYGTVYILPLFLFTIAKYDTLQIGATMMVTGVAQFLSAPLAGRMLGLGIDSRLMLTIGLGGFALGCHLNSFLTTDSKFAAFVLPQFIRGFSLMFCFIPINNIALCNMPKEKIANASGLYNLTRNLGGAVGLAIISTILSNDTKIFMQYLSENISYTSIMALTKLDYYTELLSWKVLNPEQGAYLLLADKLNNDAFVIAINNIFNMIGLLFIFIMLLIPFTSNIELTGNVNVH
>fig|257363.1.peg.226 Multidrug resistance protein A
MFSVLQQVIYKYKYHSFIKYVIIIVLIVFTYFGYRIYVWANTQSTDNAYIDADISNVSTEVSGVLTKLFVTNNTRVNKGDLIGEIDDRDYKARLAALDASIQACIKNIEIIEKKISIGQMRLEQVTEKLKLTKISFDIISIDLTRVQALSNAKFVSSKTLDDSKNGYQKVKTEYKQAQLDLDISKHNLQLLELEKAAAQEKLKELIENKKVTLRSLQNTKIIAMVPGIFSNSNLAIGNYIVKGKVLFSIVQDNTMYIKANFKETQIKNFKSGMKVKIVFDALPAKVIYGKIRNIAPATGAKFSLIPPDNATGNFTKIVQRVPVLIDFAPTNDTLVPGMSARVSIRTDQST
>fig|257363.1.peg.566 MFS-type bicyclomycin resistance protein
MKIIVKIPVWMLLSLFILSPTTETIYTSGLPSLTKYFSIDGCITQITSTLYFLGFAVGILSLGRLSDIYGRRPIVLLGLFIYIVSSIISIFSVNIEMLMIARFIQAFGVSVGSVIGQSMARDSYQGAELSYVYAILSPWLLFIPSLGSYIGGYIIEYSSWHYVFVFFSLIGTILLALYYKILPETNYYIDFSQSSKYFEVFNIIIKDKILWLYAFIIGAFNGIYYGFFIEAPFILIDKMKVLPSFYGKLAFLLSFSAIFGGFLGGYLIKKRQVHDKKVMSIGFIFSLCGCILFVVNAFILEFILVSNGLAISMIFVPMMIHIIGHSLLIPITLRYALEDYAKVTGTAGSIFGAIYYIVIAAVTYCVSKIHGETISNFSLLCLVSSISSVISFYYICILYKKKSIVANEK
>fig|257363.1.peg.662 Bicyclomycin resistance protein
MKLLITVIIMEILAGSEIDLFIPSFPEIQDTFNLSTFMTELLLGVNLIAYCITSLIVGNLGDKYGRRPIIILGLLIFNLGSLFCVFANNYETILFGRFFQGCGIASVAVLVYVVLADIYSIQEQQKLMGVLNGTIALSMAVAPVIGSYVNLFWGWHANFILLLSVGLISLILGIFFIPKGQVNKKTRISLKEYIPIFKSPKAIYYILTMIFLAQGYWIFIGIAPILYMQDLGVTLEYFGLYQGAMAALFSIMSFSSGYCFKKFGIKNCFYFGVIFIILFLLGNSILIVYNINNPLTITIVTLLLSLGVIYPINILWPLLLEAVADGKARMTAIFTAARLILTAFGLQLVGFLYNGTFTPIGITISIVTLFGLVTLNQLFKYDKIFEIYEIV
>fig|258594.1.peg.1913 Drug resistance transporter, EmrB/QacA family
MTVDHPPATSHVPQTAAKTRPSALALTILLLGGFITVFDLFVVNIAIPSMQADLGVSFAEIGFVIAGYELAFGVLLIAGGRLGDRHGRRRLFALGMAGFAITSFLCGIAPDATSLIVARLLQGATGAILFPQVYALLRVMYDDAGRRRAFGLLGMTLGLAAIVGQVFGGLIVESDLFGLGWRIIFLINLPIGIIALLSARIIPESRSSDAMGVDWPGIGLATAGLLLLLLPLLEGPNLDWPLWTWASMAVSVVLLTAFLVWEHLVARRGGDPAIDLTLFRNTGFSVGSVVVLLIYSTATSLFLCFALLVQSGLGLTPFAAGTLFAPASVGFVVASLVAPKLVARFGNIAIAGGTLVYAAGIGWLIVTAAGLGDGAGIFALLPPLVLFGFGQGLSMTPLLNLVIGYVEESHAGMAAGFISTMQQVGGAFGVSVVGIFFVGILGKDAGEGVSQAGRYADAFSGAMIYNLAAVIVAAALIALIVRKSPARQ
>fig|258594.1.peg.3679 Multidrug resistance protein B
MTASQAKQPITPLVGVPRSLAAVTFGLASFMAVVDITVANVSVPTISGNLGVSPEEGEWTITFFAISNAICIPLTGWLGRRFGQARLFAGSVAAFTLASILCGLAPTFETLLIARVLQGAVAGPIVPLSQALLVAVFPPEKRTFAVAMWAMTNMAGPVAGPMLGGWITDQFSWPWIFLINAPVGAFVVVSAGVLLRGKDTPTVRLPVDVVGLALLAIAVGCLQVTFDRGRTLGWFASPLICATATISVVGLVLLVVWELGEAHPIVDLRLFEFRNFAIGTLSVAVGFGLYFAALVLVPLWLQTDLGYSSTWAGVATAPMGVFGIVLAPFLGRWVATHGPRLYASIAFAAWALVALWRSTMTTGVTIADVALIHLAQGIGIAFFLTPVVSLSLAGLPPDKLASASGLQTAIRMMAGSLCASIAQTFWDERARFHRNHLVDAVTELSGRAATALNQLRSAGLTEQQSWTVINQQIDVQARMLSLNDFFYVSAFAFAAALGIIWLARGPKQST
>fig|258594.1.peg.4084 Membrane fusion component of tripartite multidrug resistance system
MASEPADGNKRSRESGSHDQEQAPPPTDHDDTQGKLAPSMLSNPWLRWGLITAAILLLLGGTGYGWYWWTTGSYFQSTNDAYLKADQVSIAPNVSGYLVGVPVVQNQTIAAGDQLAKIDDRSYRVRVEQAKAQLDQARAGKARAEAELNRQYAQIEQANAQLGQSEVSLAFAENQVARYRPLAASGAEATERYDQIRNQRDQARAQVALNNAQVESARRMVPSIEAQIAEAQAAIEQAEAQLHQAQIDLDNTVVVSPIAGRVGDLTARVGQFVQPGMRMMTVVPLHDLYLEANYKETQIGLMRVGQPATIEVDALPNEKLHGEVLSFSPGTGSEFSLLPPQNATGNFTKVVQRVPVRIRIDAGPEARKVLVPGLSIVVDVDTRNAKADIDRQRGELQDSRKAAQ
>fig|258594.1.peg.4086 Outer membrane component of tripartite multidrug resistance system
MAGDPRSHATELIERALADSPSIQIVEARVRQARASAREQYANLLPSGSVAGAYLHNRIPLGDARRGLENVAGGQAIAGQIPDGTNLDLYDANFDASWEIDIFGGRQRAAEQAVAQADAAVARFADAHVQLAAQVAQSYVGLRDAQHRLDLTLQSVKLQQEAIDLTAQRLGGGTTSDLDLERLRTQLASTEAMADPLRATIDQNRGQLAVLVGLEPGTLDSQLRRPRPVPVPPRPLRIGDPAGMLRRRPDIREAERNLAATNAQIGQAVAGYFPRVTLLGNVGSLSTSTAVFGTAGSLIGNVGPTLQWNVLDFGRTLARIRQAEAGSDAAIAQYQNTVLTALQDAESSLSRFGHQRNQVTKLARASASADKAAELMRQRNRAGTVSVIDLLDVERQRLQTVQSLAQAQAQLMNDYIALQKSLGLGWSDDPVFEVASSKAPDQ
>fig|259536.4.peg.422 Multidrug resistance transporter, Bcr/CflA family
MSAPKFPLPNKPVAADRVRSADLPVAWIMMLGLIVAVGPLSIDMYLPALPSMADDFGVSTAFMANSVPAYFVGLVFGQLFYGPFSDRVGRVKPLYIGMVLYVIASIICATTNNEYVLFTGRTLQALGACVGAVVTRAAIRDRLTAKQTAKAFSIMILVMGLAPILAPSLGAVFLQFFSWHSIFWFLAAFGTLNLLLTKFFFFETLSEENRNVRPAKEILSQYWELLKDPTFNYPAIGGGLLMGAMFVYISSASELIMDTYGLSATHFGWLFGMNAAGFVALTQLNQWLTNRFRILSILRFGAMMQVISAGALFTLGIVFGTDAWLPLVLACIFFCIAGLGLTQPNSSAIALAFQQRRAGMASALQGSLMFSVGIFGGLLLNLFPVNPVLKIGIAMFSLMSLGCYLIWQIDRNLNLDNAD
>fig|259536.4.peg.689 Permease of the drug/metabolite transporter (DMT) superfamily
MTPIHIALAVLVTFIWGVNFTFIAWALESFPPLMLTALRFFFTAVPLVLFLKPPKFNRTLFIYAIGTFVMQYAFVFTAMHLGASAGLTALLLQVQIFITVLLAYVILGEAVSRMQIIGMLVGVLGLGVIALNLGGDMPLVGFICILIAAIGWSFGNIASKQASTQQSTSNISTASPVDSNNRTSALSALSLVVWGGLIACVILTLSSLLFETEAWHLTTFTHASFKSWLSLGFIVYVSTLIGFGLWAHLLSQNIASKVVPFALLVPVFGMATSVLLIGEVVTWWKVLAMVLILSGLILANVKIGLGRRSAHA
>fig|259564.8.peg.598 Permease of the drug/metabolite transporter (DMT) superfamily
MFGSVFSWVFYTTIIDKFRSKDMVILSRDITMFGTIFLFPFALLEARDMRVDIVSQSDLVVAIVILMYLAILGSALGFLLWNKAIDLAGSSTTTNGLYFVPPIAIFGDSIILGNLPNLYVLVSAVLVFVGVYLSEKA
>fig|259564.8.peg.2212 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEDELAVESIGKLFRKFALPAVVGFIIGGVQITIDGYFIGNGVGTLGLASVTLVYPLLIGMIATAMLIGTGGASLVAIELGKGNRKRAHRIASDMLPLMFVLGTFFAILGLFFTEPLLRMVGATGTVFVMANDYLRIMFIGSICLIAGIGLDPLVRNDGRPNFAMKMMVVGAMTNVVLDYLFVMCWGMGMQGAAIATIIAFAVSMIAFVSYFFSRYAQLRLYLSDISPDIKIIAGILKTGFPAFVMQASLGVLVLSYNYMLLRYGSEIAVSSYGVIEYSFAIFFMIFEGISAGVQPIIGFNHGAKLYDRVYVATKMAILSCFLVGLSGFILLYTFPETIIQLFNRNDPELLATAVEGMRIFIFGIIVEGVIISVAVYYQSVNKIKPSLFIHFGKIFIFILPLLFILPRYYGLTGVWMAAPVGIYLMLIVVGVMFLKEIKILKHPPTEVNE
>fig|261594.1.peg.2143 Multidrug resistance protein
MKRVLAVFFTIMFMIGTDTFLISPLLPTLQQVYHISTELSGWMVSSYALGYAAFALIAGPISDSINRKKVMVIGMSFFALSTFLCGIAPSFLWMLIFRFLAGVSAAFVSPQVWASIPLLIEKEQIVKAIGIATAGLSLSQILGLPVGSYLAMIHYTTPFFIIGILSALLVILIYGVLPEIQPVHIRENKTNILKRYKQLLSDSKVSLSYFAYFVFQTGNFAAFSFFGVWLSIQFGLQIHEIGTAMLVLGLGNLTGNIFGHRIVNKIGYNLSFYGGIIFIAVLYALLPHVNNIIIVELLFFVLFFVTGILFVLMMRHLQNISIVARGTGAALANASMYIGQMIGAAIAGMLFAASHNFIFVGSFTALLYILALFLFRKSEKLTENRETGIAS
>fig|262543.4.peg.428 Quinolone resistance protein
MKKQIIQLPELPQQLTSETFADVEIDDPYLYQTLYEKETLPVELTERLDVNQVCFRNVSFAGLVFERASFENVRFEQCDLTGCQFQDSRFHRVVFEDCRLTGIHFESNTIDHVTIKDCQANYAQVIRTALRHVTLEQTSMRESHFFEMKPIDFRLHEVDLSESQWVETALKGLDLRQADLSGITIDPRFLPGAIVTESQAITFARLLGLVIPSHG
>fig|262543.4.peg.511 Permease of the drug/metabolite transporter (DMT) superfamily
MNRSKATLFVLIGAISYGVLSTIVKLAYGAGFDSAAVSGSQFFFGWLMIFVLALLSKNLRLHPKTALTLMAIGISSGTTGYLYYQSLQTVSASVAIILLFQFTWIGVVIDSILAKRLPSRSHFLSAVLLIGGAVLASAAYTSALDVRGTLFGLGAAVSFSIFLLASGRVANHVPVIKKSFYMMTGGLLFVMIMYPPTTFLTATNFEQGLIWYALPLGLFALILPPLLFAAGAPHLSPASVSLLGAAELPTAVICSVLILGEHLSGSQWIGIIIILIGIFYPIYVSSLKQSTTSVPRQNDLS
>fig|262543.4.peg.900 Permeases of the drug/metabolite transporter (DMT) superfamily
MIRQRIGSTFALVVLLFAFVGFGYKLANDPGSLFSQLLFFAITAGIIFLLFKFLTRNSVNSSTNSQYRKSVAQSKKMYAKNNPSPRRTDFKKKPVKTTKTAASSKVRPLRDRSKAPHLTVIEGKKGKKKKRAF
>fig|262543.4.peg.963 Drug resistance transporter, EmrB/QacA family
MRKNVTIALLLATFLAAIEGTIVATATPVMASELNGAKLVSWIFAGFLLFMAVSTPIYGKMADLYGRKRVLLFGIGVFTVASLACGLAQSMEMLILFRAAQGIGAGAVLPIAMTIIGDLYTYEERGKIQGVLSAVWGISGVAGPLVGGFLVETLSWRYIFLLNVPFALISFIMIVLFYKENVTETSRKIDYRGAILFATGMSALLYGLLSGSESESFAETLILISFAVSVILLFWFYRVEKKASDPLLPPAVIRHPVILVINLAVFFSAWVLVSMSAYIPIFAQGVLGKSPTEAGFMLMPLSLFWTLTAIVGGRTIGIASPRYRTMTGMGLLVIGMAILIGIGRESSDVFIYLAVSLIGIGFGLAQPVFMVVLQTSVDWSLRGSATAVNSFLSTTGQTLGVAIFGTLFNVSIIQAFSDSKLLSGYSIDPFFQSGTASRYGADVQSAAEQALANGLHLVFIGGLVCAILAFFMTFRLPKVRPEDPTN
>fig|262543.4.peg.1119 Multidrug resistance protein B
MFTALKQLDRNIWIRFVGETITGVMMFMIAPFLVLYYSEQLDSYFLVGLIMATGPITSLFGSFLGGYLADLYGRKPLMVISIVGDVIALIGFSFADSFWPLLLMNALLGLTNSLFHPAASAMVADVTPPERLNESFGLLRMGHNVGAAFGPLIGSAVLFIDRSLIFYAAAAVFFLYALVLLVFIQETKPEQIEHTHDEPKLSAFTVLRKDHVFVIFIAAGVFISMGFALVESMLPVFLKEALPGLPNDKNPFPYLMGLNGIMVVLFQFPVAARLSGKAFGKVMLLGASIFGLGMILLAFIPSYLFSLGTGYIVLVTILLVIYALYTLGEMIMSPVQMTFIALIAPEHLRGTYNGAASIQWLIGGVTAPLLGSLFLDSGNGQYALAGVGVACCLSGLVYLALDRSIQRAKRLSQSA
>fig|262543.4.peg.2345 Multidrug resistance protein B
MQRLKQLHPLTVGVLLGTFFARLGTFITMPFFAIYLSVVLKFSPVDVGWILSISAIASLVMSFVGGTLSDRYGRRTMMLSGTFGFVLVFIGLAQVETFWAFFILSALNGIFRSIFEPSARALISDTTEEENRLFVFNIRYTCINIAAAIGPGIALLLSAGNTSITFYITAFVYFGYGVAIFILFRRHPITESHGGKKVSFGATVRLLKTDVAFTFALAGIIFGVFGYSQFNSTLPQFLTTTTLLSGGTSLFALLITINAITVLVVQYPIMKFGVKTSPLVSITVGIATVAVGLFVMGTAGTVWLMIGAMFIFTCGEVMMFTMTDILTDSFATPELRGSYFGAMGLTSIGQSVGPVIGGQLLLYFGPERPLPIFGILALLTVLGIPLLLLSQRVHRQTKPEEEKEVVSL
>fig|262543.4.peg.2850 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHPSGEATNLNENLCPCFEKKEALLMMNKNTARLGEAPINKLLIGLSLPAMIGMLVTALYNIVDTIFVAQGIGTVAVAAVGIAFPVQLVLMAISNSVGIGGAAIASQRLGQKNLAGASRAYANVLMTVFVVSMLAIITAFIFVEPLLRVFGATPEITPYSIDFLRVLLLGSPFFMLTMASSAMLRAEGRASYQMRVMLTTVAINIVLTPLFIFGLDWGIQGAALGTVVAQIVGSVLIFRFFFTKSKKTSLVLDREAFRFDPKLVGRIGQIGSSSFIMQVSQSILFITVNHMLVRYGGTTELATFAVINKFMALVGMPIMGIVQGMQPIVGYNFGSKQFDRMSQAIKLAIRYGLTLSITLWLLIQLFPRFWVGMFTEDATLLNEGSTAMRILFAISFVYGIQMIVNGMYQSLAKARIALFLSLSRQTLYTIPLVLILPMFFGVQGVWFAFPIADLMAVLTAVVFAYRDRIMLFKPDEYAAPEEQEKAAQAK
>fig|262724.1.peg.163 Permeases of the drug/metabolite transporter (DMT) superfamily
MDASLLLPLGFGLLSALTWGAGDFGGGMASRRAHAQAVVLWASGIGLLLFLLLAQVFGEAPQGRDLPYALLGGASGALGLLAFYRALAQGEMGLAAPVAGVVGAALPVALGALLEGWPGLFPALGMGLGLLAVWLVSRPEGRARPGNLGLALLAGLGFGGFYAFMDRVEGLFYPAAWAKLTAFLLVLPAALRARPWPGGREAPWVLLAGLGDAGGNLFFLLAAQAGRLDVAAVLSSFYPVFTVLLAWLVLKERLSRRRLTGVGLSLLAMALIALG
>fig|262724.1.peg.377 Acriflavin resistance protein B
MRENPLVAFFVERFVFATSIFVGMVLVGLLLGLGLGVELLPRFSVPVIAISTSYPGAGPEEVAEQVSKPLEDALSTLTGVDVIGSSSTEGFSLVFVQFKQGVDVDQGAVEASQKVAAIRSTLPKDASAPVVQKFDPSASPILYLALEAPGEDLAEVLRYAERTLKPRLQLVSGVADIRLTGAPKTAIKVYLDPDRLQALGIPPLQVVQALSASALNLPLGALTEEERRLVYTLRATPRTASEVAEVLVDPGRGIRVRDVARVEEAREAPTTLNRVNGRPAVVLAVVKTPDANAVAVAQGVRRALEETSLPPGYRAEVALDTTRFIQAAVEDTVREAFLAALAVSLVVLVFLGKLNSVFSVILAIPITLSGAILLFGVLGFTYNLISLLALTVAVGIVVDDSIVVAENIDRYRRMGLGLKEAVLKGASEVSAAVAAATLSLLAVFLPISFLPGLIGQIFQQFGLGMAAAIGVSWLEALLFLTVRLAYFPDPDPPTLKEALRAALLLPKDLAWAYRRGFRTALGLLLGLGAAFLLYRQGPLHLLLLVLYPALLGLGRYLGRLLLDLAGALARLLHEATEGGVRRLTEGYARALEAALARPYLVLGLAGLAFLSVFPILPRIPFNFTPRADTGVLTATLLLPKDTPLSVSDRAARALEAYFLAHPAVERVVTTVGASATGGAQVGDPSRVQLQIVLKPKGERPDIFTLTEVFNREGKEALKDFPGADLRVLAQTGPEAGDADLQFFVTGPDREALEARVQAIVDRIAEKPYVLNVKSTLEATQRERVFVPDPARLSGTGLTPQDVAQTLRLYLSGTQAATARRSGEEYPVVVQADPLRYSGEGGLLSLPVYAPALQAFLPLGSLGRFEERPSPTLISRRNQAYAAGININLKPEAPGALQVQAELEQDLRAAGLLGDGVELVASGLGSFTEELASLAPLAFGLALVLNYLVIASQFNAWRYPLYLLLPVPLALVGAFWLTYFLGTGLDVISVLGVVMLIGLVTKNAILLLDFASRRMREKPLKEALVEAARLRLRPILMTTLTVLIISLPLLLGAGEGSEYRRPLGVVILGGMLSSTLLTLFVVPAAFFAVEGRLARKGGKG
>fig|262724.1.peg.525 Multidrug resistance protein-related protein
MFRFLPWRREGLSALLRLILVVGLLEGVRSGYFAGLLPFYAPEHLGLGPAAFTLAFTLHQLAENLSKAAGGLLAERLGYGLTVTLAAATGLLALLLTPRADSAWILWTLGALWGLTFSSLYPGLMTLASRIARPGMDARALAFTLSLVMPWVGLGLVGVGQVAQRHPLQALHLLLAAQGLALLVALSLVRFRIPVPPPSRERYPLYRLLLFVPAAFGQTFAPGLVSLFLLRFAKEELGLEPLALGGLLVLGGGAAFLLLPFTGRLVDRRGYQAALVLGLFLLALVMARLGTGPHPYELPAAALLGGLGFSLFLPGWNGLLAKNLPQENRAAIWGSLMTVEGLGLALGPVAGGLLWEAFGLPAPFLAGSGIFLALSLFYLLLFRVRKLWRR
>fig|262724.1.peg.625 Multidrug resistance protein B
MNFTPDAKEVRYTMVGILLGLFLAALDQTIVSTAMPRIVGELKGAEYYAWVTTSYLLASTVSAPVFGRLTELFSRKAVLVAAVLLFLLGSALSGLSQNMVELVLFRGVQGLGGGALFALALTTLAALFPPRERGRLAGVFGAMFGLSSAVGPWLGGLLTDHFSWRWVFYVNMPVGAVALWFILRHMPRLSPGKREPFDFLGAFLLAAWAVPLMLAFSWGGSTYPWDSPRILGLFALAAAAFGLWVLVELRVPHPLFDLAVFRIPTFTYAALASFFYGPAFLGAVAFLPLYLQVVKGVSASQSGVTVLPLTFGVILGSVGGGQLAARHGRYKGLVLGSALFLLGIFLLFHFLLRVDTPLWLAVFLFFLAGLGLGPAQSLLNIAAQNDVPMNRIGSATSAVQFMRQIGATMGVAFLGTVLASALSDHLKAAFPQGAAGAPVLAQGGEGMALDLDREFARLEDLLARALRGDEAAYRALLQDPMVPKAYLQGLSPGGLPARFAALKEEVRAALAGDEAARRALLQDPALPEDLKAFLRAPRGALGPEAVEAALAQAEARALEEATRQAVAGLEAAKARLKEALSFGITEALRRIFLYSALFTLGALVFVLLLPDRELKGRPAPVE
>fig|262724.1.peg.970 Multidrug resistance ABC transporter ATP-binding and permease protein
MTEDTYSKAFDRALFARILRYVWPYRLQVVLALLFLLVVTLAAAATPLFFKWAIDLALVPTEPRPLAERFHLLLWISLGFLAVRAVHFAATYGETYLIQWVGQRVLFDLRSDLFAKLMRLHPGFYDRNPVGRLMTRVTSDVDAINQFITGGLVGVIADLFTLVGLLGFMLFLSPKLTLVVLLVAPVLLAVTTWVRLGMRSAYREMRLRLARVNAALQENLSGVETIQLFVKEREREEKFDRLNRDLFRAWVEIIRWFALFFPVVGFLGDFAVASLVYYGGGEVVRGAVSLGLLVAFVDYTRQLFQPLQDLSDKFNLFQGAMASAERIFGVLDTEEELKDPEDPTPIRGFRGEVEFRDVWLAYTPKGVEPTEKDWVLKGVSFRVRPGEKVALVGATGAGKTSVVSLIARFYDPQRGCVFLDGVDVRRYRQEELRRHVGIVLQEPFLFSGTVLDNLRLFDPSVPPERVEEVARFLGAHEFILRLPKGYQTVLGERGAGLSTGEKQLLALVRALLASPDILLILDEATASVDSETEKRLQEALYKAMEGRTSLIIAHRLSTIRHVDRILVFRKGRLVEEGSHEELLAKGGYYAALYRLQFQEA
>fig|262724.1.peg.971 Multidrug resistance ABC transporter ATP-binding and permease protein
MTGRSAAPLLRRLWPYVGRYRWRYLWAVLAGLVSIFFFVLTPYFLRLAVDAVQAGRGFGVYALAIVASAALSGLLSYAMRRLAVVASRQVEYDLRRDLLHHLLTLDRDFYHKHRVGDLMNRLNTDLSAVREMVGPGILMGSRLSFLVLLAFLSMYAVNARLAFYLTLILPGIFLAMRFLLRLIDRRYREAQEVFDRISTLAQEAFSGIRVVKGYALERRMVAWFQDLNRLYVEKSLALARVEGPLHALLGFLMGFAFLTVLWAGGAMVVRGELSVGELVQFNAYLAQLTWPILGLGWVMALYQRGLTSLRRLFELLDEKPAIRDEDPLPLALEDLSGEVRFEGVGLKRDGRWLLRGLTLTIPEGMTLGITGRTGSGKSLLAALVPRLLDPSEGRVYVGGHEARRIPLAVLRKAVGVAPQEPFLFSETILENIAFGLDEVDRERVEWAARLAGIHEEILAFPKGYETVLGERGITLSGGQRQRVALARALAKRPKILILDDALSAVDAETEARILQGLKTVLGKQTTLLISHRTAALRHADWIIVLDGGRIVEEGTHESLLQAGGLYAEMDRLQKEVEA
>fig|262724.1.peg.1626 Fosmidomycin resistance protein
MLPLLLAWLHTTNDLFSNFLTPLLPKLMDRFGVGLGTAGLLVSAYSLTGSLLQPFAGLVADRVDRRLLAALGPVLVALGMGSMGLWPRFEALLFVLALAGVGSALFHASGASLVGEYAPKERRGFWLSFFGSAGNLGLSLGPIVALYVAGRWGLEALFWLTPLVLLPALVLLRLPPVRRAGRPAGFRDFLRVFRGDVARLWGMATLRSLVFLSFSTTLPYWYATKGLPDGYTALSLSIYSLSATLGILVGGTLSDRLGRKAVLVGTLTLGLPLYLGLLFFPAENPLYLLLLAATGALMNAGIPVAVALAQELEPGQTATVSGLLMGFTWGFAGLFYAPIGRLIEAFGVLPVLLGLGVLLLPAWALARGVREPARTMGV
>fig|262724.1.peg.1716 Multidrug resistance protein 2
MSPLALLFLTLFNSVLGLSILFPILGPLGRALGLTEVQVGLFSTGYALMQFLLSPYWGRRSERGRKPVLLVGILGFAASFLLFGVFALLGERGLVPPGLLFFLLLLARLLGGAFSSATLPTAQAYVADVTGRENRTAGMALLGAAFGLAVILGPALGAGLAALFGLLAPVFFSAGIALLNALFVYLVLPESRPRGQEAGARLSPFDPRVFPLLLLGLALNLSSVALEQTIAFYFQDRLLLGGVETAQKVGLALVLYGVVAVFVQGVLVRKTGWPPRVLLSLGLPLGILGFVLLVYAKTFWALALGLALQGAGQGLALPGVTAALSLAVGEGEQGLVAGLNSSAQALGRMLGPIVGTGLYRLAPEGPYVLGASLLLLALLFLPALFRRARL
>fig|262724.1.peg.1927 Vancomycin B-type resistance protein VanW
MRPFVLLILLGLALGQSAPLEAVLVLREDVLEEGRLVAYTGTQRYPVASEAELLRLLDRLARPPRPPRFIYQDGRWRGVEKKGLAFDREEALKAFREARAQGKKRFLLPVRYTPPSPSLKDLYALGVREHLATAETGFWGSSPERVHNIRLAASRLDGLLVPPGPFSFNRALGPIALETGFKEAYVIVGDRTETGVGGGVCQVSTTLFRAFFFAGLPILERHAHSYQVAYYKPPGLDAAVIQPYKDLKVLNDTPGALWIQASVQEGRLRFHLFGTKDREVAWEGPFITDRKPPLPPREIPDPTLPPGARKQVDFAAEGAKVVVRRRVRYGDGRVREDQVVSVYRPWGAVYLVGPSPAPEAPPAPPEEAGAAP
>fig|262724.1.peg.1981 Permease of the drug/metabolite transporter (DMT) superfamily
MRGYVLGLLALNLLTLIWGTTFVVVKGAVEGMAPSLLILLRFGVAALFFLPWLFRLPVGVFGPGMELAFWLFVGYASQTLGLAHTSASRSAFITALSVVLVPLLLRLAGREVGPAFLAAFLALAGVGLLSYDPYQPPFNVGDLWTFLTALAYALYIVRLEVHARAFPSLPLTAVQVLGTALFALPWVLAEGGAWGPVAWGAVLYLGVVATALTTWLQTWGQRHVPAPQAAILYTLEPVWAAFFAYLALGERLSPSGLLGALLVLLATLLAIRRSPA
>fig|263358.5.peg.348 Glyoxalase/bleomycin resistance protein/dioxygenase
MLRRCHDAGEGGRAAATAGSRGVAVASVPSGTPCWADLATPGLDRARRFYPELFGWTGRVDPEPEAGGYTTFQLDGRAVAGVGPPAVPDQVPIWSTYVATDDADLVTGRVERAGGQVVVPPFEVFDRGRMAVFSDPAGAAFSVWQPMAFSGAEVFDVPGAMCWTELVTPDTDGARIFYELVFGWQPEEEPMGQTSYTGWRLGDRMVAGMMPPREEAFAADSPAYWTLYFSVADADATAARAAELGGTILVPPRDIPAGRVTALRDPDGALFSLIALTP
>fig|263358.5.peg.535 EmrB/QacA family drug resistance transporter
MTPSRTRPSPSPAETPADPPAQPAPIAGRARTIALVAVLVGLLLDLLDIVIVNVALPTIQEEIGASSSDMQWMVGGYTLAFATMLVTGGRLGDIYGRKKIFIIGMVGFAAASLVAGIAANPEQLIVARFVQGGMGALMVPQVLSILQVMYPPQERGRAFSALSVVFAVGTVAGPIVGALLTAVDIAGLTWRTIFLVNLPIAAVCLFITVKLVPESKGESAQRLDVKGAILVGLGMLLLVFPLIQGPEQGWPAWTLISLVASLLAFAALVAVQRRQTESPLIPISLFSHRSFRGGLAVSLLFMSGVMPFFLVNTLYLQFGQGFSVIKAGLIGVLWGFAVPLFTAISARHITPKLGRLGLQLGLVMLIAAMVILITVIHQFDTITPWALAPGLILGGAGMGMTFAPLLTYTLNDVPLHSAGAASGVFNTVQQMGAAIGIALSSMVFFIALAVQSPAVGDDLRNTVKEELSARGVPVAAVDAAADSARACFDERIKAANPEADVAACRAVASQSGADVADRHDELQFIANRTAYQQTTVRALVYQIVVFTLAIAASFLLPRRVEHQG
>fig|263358.5.peg.547 Glyoxalase/bleomycin resistance protein/dioxygenase
MSERSFSPVIPFLRYQDPTAAVDWLVNTFGLERFDVTEVDGKVVHAELSWGNSTIQLGGGGPHDTLGMVSPRELPATSGGIYICVGDAADVDKHYERTVQAGAKLVYELHDTSYGSRDYGAYDLEGHVWSFGSYLPREASA
>fig|263358.5.peg.561 Glyoxalase/bleomycin resistance protein/dioxygenase
MAGEPSFIEFAVPVPERTRDFYEALFGWKFTMLTHGSYIEMPGAPAGLEAGSHPDTDPPHIIVYFAVDDLAAAVERVKELGGEVGPLRPPSPDYGAFAECRDNQGVAFGLRELPKAS
>fig|263358.5.peg.569 Glyoxalase/bleomycin resistance protein/dioxygenase
MANDSVPPLNGGTHINLTVRDLDRSTDWYCRALGFTVVRDARPVESGFTFRTLLHSRALTSIVLGQADRPVEEPFDEHRVGLHHLAFHVPERDDLHTWVAHLDAVGVEHGGVQELFLEAGHGVWLRDPDNIWLELYWLNADYFMQRMREHHRARRAERVGGQQ
>fig|263358.5.peg.1140 Bicyclomycin resistance protein
MPQTATPSTAPDRVAVPTGRAAIGLLVLLGSLTAIGPLSLDTYLPALPDMTRDLSASQARIQLSLTTCLIGVAVGQLVTGPLSDRWGRRRPVIVGLAAYTLLSLLCTLAPSAETFAAARFFQGFAGGMGTVVARAIVRDLYAGRAAAKYFSRLTLIFGLAPMIAPAFGSLLLNFGDWRVIFVALTVIGALLATVVAWRLPETLPVARRNTGGLLSIARIARVLITDRIYLGYTLTQGLAFAGLLGYLSGSSFVLQDVFGLSVGMYSLIFGVNSLAFVAVGQLNARLLDRHGPRQLLITALGLGLLAALGLIAGALLQALPLVIVAMLVFLGSLGMVMPNGTALALDRHGAHAGTAAALLGGIQAVVAAGAAPLVGIGGEGSALPMALVIAGAAAGSLLVVLTLARRR
>fig|263358.5.peg.1357 Glyoxalase/bleomycin resistance protein/dioxygenase
MIGRLRSTVIDCPDPRALAGFYAELLGLPLMEEDSEGNGWVVLGGPPGHQPRLAFQRAPDLRPPDWPDPERPQQLHLDVTVDDVEAAERAVLALGARRLPGEGDGFRVYADPVGHPFCLCWD
>fig|263358.5.peg.1520 Glyoxalase/bleomycin resistance protein/dioxygenase
MGMSQPTTHRHHCIDYIEFTVTDLAEAKRFYAEAFGWQFTDYGTAYAGIRGGSGAEVGGLRQEQQARTGGGPLVLLYSADLEQSVEAVEKAGGTVVAGPYEFPGGRRFHFTDPSGNELGVWAEA
>fig|263358.5.peg.1642 Glyoxalase/bleomycin resistance protein/dioxygenase
MNWTLEVVVVPVSDLDRAKAFYAERLGFTVDHDTVVNDDIRLVQLTPPGSGCSIVIGKGAVPQMPPGSLKGLQLVVPDLHKARTQLLERGVEVSEIQVMGENPRPVPDPLDNVGFIHFADPDGNAWAVQQISSRA
>fig|263358.5.peg.2119 Tetracycline resistance protein
MNPLSVRQVRRRYLVLHGLRWLPVGLLIPVTILLMQERGLTLTQIGLAIAAQGVVVLALELPTGGFADALGRKPVLVVASLVGLVSTGLLVVADSFALLVAVWALQGVFRALDSGPLESWYVDTTLAADPDARYENGLGQGGTVLGLAMAAGALLSGALVALGPIGPLSALTGPVIAAVGLQVVYLVALLALLTERRAVTGPAALRASVREAPRMVGEAFGLLRRSRVLLALVAVELFWGFGMATFEGLLPIRLAEVVADADRAATLLGPASTAAWLASAGGAALTPLLIRRLGAAPGAALLRILQGITVVGMALFAGPTGVLIAFVACYAVHGASNPLHMGLLHRQVAGPYRTSLISLNSMVAMPAGALGGVVLGYIGDRAGVSTAMLVGAVVLAVAAPLYLPAWRAGRQSADDGRDAGVPDTGPSPGDGESAARPSGDSVPAAGPPGVPVARLAGDGEPAAGQAQRTEVSGKAAV
>fig|263358.5.peg.2422 Multidrug resistance protein B
MTQSPSDRIDGPLLRLLGVMVLGGVMSYFDATIINVSVETLTAHFDATLGTISWVATGYLLAVAVAIPLAGWAVARFGARRVWLAALTLFLVASALCALAWDVGSLIAFRVFQGFAGGLLEPIMLTVVATAAGPSRMGRAMGLISIPITLGPVLGPIIGGLILQNLTWQWIFLVNVPIALLAIALALLIMRDDRPEPGAAPPLDLIGVALLSPGFAALIYALSQAGTAGFGATRVIVGLAVGVVLVAAYVAHALRSAQPLIDLRLFRSSGFTSSVLTMFLLGGMLFSLLFLLPLFYQQVRGQGVLAAGLLLVPLGLGTMVGMPVAGKLADTFGPRRLVPTGALLIALSALVYTQAGPDTSQVLLTAAQLVTGFGLGLVGAPTMGSVYRTVAPEAVGGATGTLFILNQIGASLGVAVVALIVQSGLTDGRTPADSFDQAFWWTVAGGVIVALASRFLPGRPQPVTPTPADAETAAA
>fig|263358.5.peg.2746 
MTIDTTTAIRVILWYRTPERDVAGLAETYRQIGEHLAGTPGMVSSELLVSRDEPGVLMVTSRWRTAEDLQRWVHSDTHRHTTPLRPYLDTGRTRPWETFSVVSET
>fig|263358.5.peg.2763 EmrB/QacA subfamily drug resistance transporter protein
MADRRIMVPLSGVVLAQLLAMVDLNLTAAALPVIAADLGGTDRFAWVVTAAVLASTVTTPLYGKLSDVYGRRALLVAALAVLTLGSLLCGLAQSMNQLIAARAVQGAGAGGLMISAYAVYAELLDPRRLVRYQIVTATLVNIGTAFGPLAGGVLTDSFGWRWVFLATVPPSVLALLLVATLRLPPVAAGGRVDYAGMLWLGAALTTLVLLAGVAGTQWAFASPGVIALVVAAAVLLALWWRSAHRAADPVLPPALLRDRVVRSVAVQGWNTGAGMLVVVTFLPIVFVSLGASAADAGMYLLTLTFGTLVVSLAGTPLLARAARTQWFGVTGTVLLAAGTAWLAFTHPDLGPGGWAGWALATMAIGVGIGLGFQVYTLTLLRHAPRVHLGAALAMQSLSRQVGGSLVLAVLSAVFHSRLAAGGSTSTLDAAQTVFGLTALLLVVGVVAAVRLPVPSLTVAERSPVTTVETG
>fig|263358.5.peg.2817 EmrB/QacA subfamily drug resistance transporter protein
MVENFSGASTARLGARQWLAIGALGASFLVVAADSTIVYAAIPSIQRALDLSTATVQWLMSAFLISFGGVLLLSSRLAELFGRRRLFTIGLALMTAASMLSAVAWAGEVLIGARVLQGIGAALIATTALPLLAIALGPGPARVRALGLWTLIGAFGGTTGLLLGGLLTDTVGWRWVFLVNVPVGIVAALLAPILPADRCGGSGHPLEVAGGVSLVGALTLIGWTVVAAFAPGSSTGPALLRLAAAAVLLLLFLVIEARTGRRLVRPGLLRSRTRLGGLVVLFAAGTLIDAVLLLVTLYGQGALGLSATRFGALMVALTLSSVVGSYVGQVVVVRHGLRLVALTGMSVAGAGLLALAMVNGPLDTVDFLSVLPVVGVGAGAAFVAAQIAVTLGASDADSAAASGLSDASFSLGGALGLAAVSAVLVANQTELPVPMGAALPMAFTVTAGLAAIGLVAALLLMGQQRTPVPSQGT
>fig|263358.5.peg.3073 Antibiotic efflux protein
MIAVLHGRFPAGRPPCTGGVEQGREVCDDLPVTGVDEPVATARPAGSEQTGTGSGGLGGRYWRLWSASAVSNLADGIVKIALPLTAVGYTTSPVLVAGVAAAFSLPWLLFALPAGALVDRLDRRQVMLAANSLRAALLGTLALAVALDAGSIWLLYLVAFGAGTAETLYDTSAQSILPQLVPRAALPRANGRLYAVELAANQFVGPPLAGFLVAGGVAYAMLGPAGLWAAAVVALLLVGGRFRVARQGTSTLRADIAEGVRFLWRHRLLRTLALMVGVSNLTTTATFAVLVLYAVGPNSAIGLSEPGYGLLLTTLAAGIVLGSLVAARIERLLGRARALGVAMVAIAVVVGVPAVSTNPFVLGGVFFVGGILLTSWSVITVSLRQQITPDRLLGRVNSGYRLLAWGSMPLGALVGGGLAEVFGLQAVFVIMGVLALILLVGMFWVTDAAIEAAERAAA
>fig|263358.5.peg.3098 Glyoxalase/bleomycin resistance protein/dioxygenase
MLKCREPEVLARFWCEVLDFVVLDREGEGCIEIGPREGFGGPQPTIFLIRTDEPTIGHARLHIDVNATDRDQDAELERLLGLGAELVDIGQPVEASWHVLADPEGNEFCLLKRRLDPV
>fig|263358.5.peg.3608 Glyoxalase/bleomycin resistance protein/dioxygenase
MITNVSLTSVFVKDIDAAKAFYIDVLGFVERTDITIGDGSYRWCTVGHPGQPELEVHLQLPGPPLSPEVAELFARARDEGSLFALGLAVDDCRKTYDDLRAKGVEFLQEPADRPYGVEAVARDNSGNWLVLVEHKEFSPADFD
>fig|263358.5.peg.3820 Glyoxalase/bleomycin resistance protein/dioxygenase
MTPELDLIGMVSTDLARTVAFYRRLGIDIPADAEREPHVEVRLPNGLRLAWDDVATIRSFDPDWTPPVGGARTALAFRCADPAEVDRWYAELTAAGGHGHRPPWDAVWGQRYAVVHDPDGNAIDLFAPLPPAES
>fig|263358.5.peg.4308 Glyoxalase/bleomycin resistance protein/dioxygenase
MIHHVQLACPRDSEDRSRAFYVDLLGLTELTKPPTLAARGGCWFSGYGAELHLGVEDDFRPARKAHPALLRPDLDALATRLTAAGCPVTWSDDLPGLRRFHTTDPHGNRLEFLTPTHPTPSPR
>fig|263358.5.peg.4775 
MLVTNRFVVDDDGAQDFTERAHAALAALAARPGYLRGQLVRALDDPRHWCLVTEWESVGTYRRALGGFDVKVTAIPLLAESIDEPSAYETLASAAPDGDVVVVDSDRAAGPYR
>fig|263820.1.peg.449 Multidrug resistance protein
MRRIALFVIVLGLMMTGVDTTAVILALPDITTDLHSSLSTTIWVIIMYLLVIAVMTTQLGRIGDSLGRGKMYNSGFIIFTLGSALAGTSIFADELIFFRAVQAFGGALMQANSGAIVADIFPVNERGRAYGYTSIGWTTGATLGILVGGLITTYIGWQYIFYINVPIGIMAAVLGIMNIKDDKRQESHSDIPGFLSLLASLVLIAYGASNITGYGVDKFNILLIITGIAILIFFIFIERRAEYPIINMKIFKNHIFSFSILASFFQSMGYLSVVFIVIMYLQGIRGLSPLNASLLLVPGYVLGSVIAPFAGRLSDRIGSRIPATLGLSMMMAGVLIYMSFSVTTPLYFVIIASLVGGLGTSLFYPANNSAVMANAPRGFYGVSSGILRTFANIGTLISYVLAITIASITVPRYVAFEVFLGLHNIVGTIAGKFMTGIRSALIMSFIILVIAVILSISRGRENRAEKAVKLKT
>fig|263820.1.peg.597 Multiple antibiotic resistance protein MarC
MNYAYLFISSLVTLFAIMNPIGAVPILIALTDGYTKDERNNVILKSVFTAAGMMLGFMLIGVYIFQVLRISIYDFEIAGGMLLFKVAFDMLQGRTSPTKITSTEKEESVEREAIGVAPLGTPLLAGPGTITTAIIFFNGNGNAIMTRFVVIMSVIILIILTYIILKFSIPIFARLGKTGSIVITRIMGLLLASIGVQLVASGIINVFHI
>fig|263820.1.peg.630 Permease of the drug/metabolite transporter (DMT) superfamily
MDRRIFYLLLLIFVVFIWGLTFPFMKITLYYISPVVLLAFRFIISSILLIPLIKKRNFLLEKKHLKYGLSAGFMLFLAYYFQTVGLKYTTPSQSGLITGLYVVMLPLISYFYLHIKANRGDLIAVMLGTAGLIIMSKIDFSGSYLFGDVLTLICAFFYAMQTAYVFKYSRDLDSGVFTFYQLIVVGVLSAILISYNPDISGLVVPIVIFTLIFTAALAGTFAIYINTRALMYVEPTAAGIIYVGEPMFAVLSSIIILGEIPNIYTIIGGIIIISGMLVESIDKYLAAKTTF
>fig|263820.1.peg.729 Daunorubicin resistance ATP-binding protein drrA
MIELINLSKTYPDGKVAVDHLNYKIDSGIVSIIGRNGAGKTTLLRMLSTQLRPSSGDALIDGISIVREPEKVRKKIVSIPQEASPIGILTAYEQVNMFLAARGFSFHEAKNAAIKALKDVGLDAMHKPTDTLSGGMKRKMFVAIALAANADTVFLDEPTTGLDPLSRFEVWSAIKKLNGNVILTTHYMEEAEELSKKIYMMESGKIIKSGSVDELISNMRNLVRIESYKPMENSYTIGSLYIKYVDKSEVYRYIKMDYNVKPVSIEDLFIMRGVTLES
>fig|263820.1.peg.730 Daunorubicin resistance ATP-binding protein DrrB
MNLRFILLMAWYYGIKAIKRGPSYLIASLATPLTLLFLVFVLSHGTLVKYAIVGGLIAFVGSVGLSSAGDAAFMRLQLRVQDMYVASNIKPFDYMMAFTLSYLVFSVPGIILYIALGMHYHLFNLYNSIYMLLIMISLILTTTSISFIIAGSINHLRNIWGITGILSILTSILPPTFYPYYYVPRPFLYLLSLSPTTPAAVLVQGVFHLAPLFKNMIYIIIIETVFYTVLGRFAIRWREN
>fig|263820.1.peg.914 Involved in antibiotic resistance
MINLENKRIDEFNNQKRDLVNDFVDLISSRTFKSTLRIAIIVLLGINGPLTFTDLQRSLRIGKGSLKNHLDVLETEDFIKGRNVITLNGPRLVYQITDKGREFYNKYIDLFDRFKLL
>fig|263820.1.peg.976 Multidrug resistance ABC transporter ATP-binding and permease protein
MNNYSIRRVLRDLMIYKKRLYLVSMAIIGSSIVAMIGPYIIGLAVDAITHRDLSLILDFGIIYIIIYIINYAFERLRTYNMTYISQGFIMNLRNREFERLQYVPLGYYTYRKAGEIISRITNDGEAMSDFLTFQMPQVLAGVIGIIFSMAIMLYLDWNLALYSFIVIPLLLITVFSISGKIRNYYNETRIKIARLTGFASESINGISSIKEFGSEQRFIDEFSVKNYENYLANIRANRLGSIFSSLVDIIQALGIIIVIGVGATQVINHAIQIGLLVSFIVYVQSFFNPLAQLSQFYNSYQSSKVAIKRIYSIIDEEQDDNKYKYKIEDFGSEIKFENVSFSYGSKPALKNINFSLKRGEKLAIIGKTGAGKSTLINLLLRFYRPESGEIKIDNININDVDIYSYRSLFGVILQEPLLFNGSIMDNIKFNGNYTDDDVINLIKRFNLEGIFSEKDLYENVGENGHGLSQGQRQAVSILRAMIRNPEIVIMDEATSQLDPETEEIIQNAIRSVNKTFIVIAHHLSTILDSDQAILLENGEIKSTGTPEHVLKINGLLD
>fig|263820.1.peg.977 Multidrug resistance ABC transporter ATP-binding and permease protein
MVLISGILSSYLTILVPVFIGDAIDSVPRYYKIFDYIILILIVSSLSSLFGFILEYYSSKTGNIFARRIRDMSFKRVLSNSYDKLENQDSGDLLSRITMDVDASRRFVTISISNLFSTTALLFIALYELTRIYYLFSIIFLIVMVPTIYLTFKMQRMQRGYWRSLRKKYGNMNSKIGENISGMRVVRSFNAEDFEIKSFKDKTQDYFSDYVGIAAVRSFYTPLLAAIISISIGFIIITSGISSAAGIPIGSIVAAINIFTLVLRPVRFYGRYISFYENGMASLERLSEIDYSNENYSKKEPTGYDIIIENLSFFRNNKKIINNISLNIHENEHIALTGGTASGKTTFLNLISGLYKNYDGSIRLGGIEIRDISPGLLRRIIGIIPQNPFIFSGSIFYNIDFGRGYSLSQVINAARLAKIDDFIETLPDKYNTVIGEHGINLSGGQRQRIALARALIGDPKILVMDDFTSSLDIVTEEELINDIRPLLDGKTVVISGYKKKTLELADDVYYMSNGALLPVESGVNE
>fig|263820.1.peg.1080 Multiple antibiotic resistance protein MarC
MPLLVVIDPFGSLAIFVSMTASYNKDTKLSISRDAVLYGGMILIIFAALGEIIIQFFGISIEALEIAGGIILLLMGIEMVREGAKPESSSGSKNLGIVPFATPLLAGPGAISLVIILMKGSLTTKIFTIVSILIVLALVYIFFIFSSKILEILGEKIMTAITRIFGLLLAGFAIQYFLDALISLGLIK
>fig|263820.1.peg.1096 Daunorubicin resistance ATP-binding protein drrA
MENIIETKNLTKIYKNLRAVDNLNMTVRSGEIFGLLGQNGAGKTTTIKMLTTIIKPTSGTAIVDGHDIVKESMKVRDSIGIVPQELTTDEDLSGYENLMLIADFYNIKKSDARAKALELLKMVDLEDAARRPVSTYSGGMRKRIELIAGLVHSPKVLFLDEPTLGLDVQTRTNLWSYIKAIKENLGITIILTSHYLEEVDALADHIAIIDHGRLLKVGTSEELKEGLGGDIISMELNSESEVNLLKDFPAKETSINGSSIRFKVENSDAILPELMDILYRNHIWPRKMTVEKPSLDEAFLEYTGRKINDETPMDYGKTMNYMRRISR
>fig|263820.1.peg.1097 Daunorubicin resistance ATP-binding protein DrrB
MSGLLPLTGRELKKWYRNPTYLIVSVIQPIFWILLFGSAIDIAKFAFPGAPVSSFFNGAPDYITFLLGGILTVLSLFTAMFSGINIIWDRRLGVLTRFLASPIHRSSIVFSRMLASVVKIAVQAAILIGIAAVIPDGLKFPHGFTVFDALILFTAMLLISVIFGSIFSVIAIKMTQVNTIMGIVNLVNLPLMFASTALFPGAIMQPWLHHVAMYNPISWSADTIRTVIINGDLNAAQMHSVGLDLLYLFIFAVVMILITYFASEKGIQN
>fig|263820.1.peg.1498 Multi drug ABC transporter permease protein
MGNLYNVYMQYVKNYYRSKSFYLMLTLILVISILMTYFSLKYVNDLPAFLGRNVSFHLKKILFYFIWSFVLINIPVFSSVFFGSPAISSEIENKTAYYIFPLPINRYKLYIGKYLSAFTVTFIIVLIYSSFEVIILHYLFGSIPLSFYYSIGLLAIFIFTILSITFMISSIFNKNTYAYITVFIIYYIVFEAGSLIINLLYKITPIYLLNEAADIVEKVYLNINTSSFVTSPSLAPATNTEIYTSVLIMIIYMIISFVAGIIIFERKEVS
>fig|263820.1.peg.1499 Multi drug ABC transporter ATP binding protein
MEISIRNLTKRYGRILALNKINMHASGPGCIAILGPNGAGKTTMLKLISNIIKPTDGSVLINNINVSDYPERALKYLGALIEQPEFYYYLNGYEILKFAAKVKGLKNNIDDEIKRLADLTDMNDYLYRKTGTYSRGMKQRLALAVAMIGDPEIIILDEPTFGLDPKGMAYIRDLIKNLSREKLVILSTHLIYEAKEVSNRTLIIDHGEIKYDSINSDNKRKILVTFDGSISNIKSDFIRDFVIDKNRIIITPREDADNYNIIYDLIKNGVKVNSAQDYDDLEETYISITS
>fig|263820.1.peg.1530 Tetracycline resistance protein
MDKGILPLFVTAMIDFIGFGIIIPIAPFYTRDLGATPFEFSILLVVYSLAQFIASPYLGRLSDRIGRKNVLVLGLSGEIAGYLIFGLSPVLSLLYIGRAITGATSGNLPVIYSFVSDKTSSDNRTRAIGMIGAAIGIGFVIGPFIGGSLSIFGYRVPILFAAVLSFINMVLVLRIKEERKKTNYKKGSILKAFEIAPYIFISITFIALGFVMLQTTLAYYGQALYSWGSLAVGIILGIVGMEQALFQLLLVFRLTRRIGSIRTVMLGIISFTMAFLILSFRVNEYIAIFSLTLFSLGYSLFQTPVISIISDIAPVEIRGSTLGITQSAQSLSNIIGPLIAGYTFEFISIYSPYMLAAAFGILSLLFISIFIIKSGSALKDIGYT
>fig|264198.3.peg.748 Outer membrane component of tripartite multidrug resistance system
MTQGQPFPPARRFGRSLAVLAATAMAASLAACAFGPDYHAPAPDLPAAYAHAAALQAQEAAPAAPALDSWWKGFDDPALTRIIERALAQNLDLAASVARVDQARAAADYAGAALLPEGSLSGSVARQRQSLESPLGKIASKSPGFERNNTLYNAGAGASWEIDIAGGLRRGAEAADAEAQAAEAEHLGVRVLVAAEAADAYFRVRGAQQRITIAQQQVQTNARLLDLVKLRLADGIGAERERAQAEARLAQTRVTIPPLQIELDTQLNRLDVLMGAAPGTYAAELATPGARTGVPQIPLAQGPAALLERRPDVIAAERRLAASSARIGVATAEYYPKLSLAALLGFESLSASKMFTAATFQPAAMAGLRWRLFDFGRVDAEVAQARGANAEALATYRKSMLRATEDVENAIVTLTQLQLQSQDLTVEVDAQARSRGAAEEAYKGGAVSLFEVLEEDRQLLAARDQQARAGTDNARAAVAAFRALGGGW
>fig|264198.3.peg.4312 Drug resistance transporter, EmrB/QacA family
MTSTAQSGHGSGQVLPFRESLLAMLGVAFVSMLVALDQTVVGTALPTVVAELQGFEYYAWVATSYLLLSVITVPIFGRLGDYYGRKPFVLASIVVFSVASALCGMATSMPFLVAARGLQGIGGGMLVGTAFACIPDLFPDSHVRLRWQVLMSAAFGVANAIGPSLGGILTEWYGWRAVFYVNLPVGVLSLWFVWRYLPHLRQQSHSGPIRVDWLGALLIGVGLGCMQMSVELLPQRGVDWLTAGLLAVAVAALVGLWQWERRCANPILPLDMFRNPGVAPLLQLAVLVGFTMFAVLIYAPLLLQGGFGYSPRDAGLLVTPLVVCITVGSIVNGRIITRIRRPNAMLFAGFGMLAAGCLALSQATRGMPHSLLLAIMLVAGFGLGFIMPNLTVFAQQTVGREHLGIATAMLQSLRMVGGMIGTAMVGTMVSRSYTAGVEQSLAAVNAQGWLTRMADPQVLIDKAAQAGLLTELQQAGHNGALLLEQARVSLVTAIHFGLVIAAAAALIGLWRARRVPPVRLVRAGQQPAMAAD
>fig|264198.3.peg.4993 Multidrug resistance protein B
MSVGSRWQSLWQLRLSVRWLRWLSHRQRQTLLMMLLALATGVEFLENIMFVFASSHIMGGLDADPRSFALAQAAYAVGSMLMILKQQWLSRRFGYRYYLTGALLIFMAGTLGAATSHSLAQLVGARFVQGFGGGALFTSCRILVAVLFGPADRPRASRIFMTGIFVASALGPAFAAELVDHGVWQDVFYGALPFAALAALGAWVLLPDAEPRRPAPSPGLGPLLLFGAAVVTLQAALTEARFDIFSHPLRLALIAAAGLGLLAVFLWHQWHHETPVLHLRALRNPIYLAGIGMYFVYYMINNLSAYVFPIYAEQALRIPLATTGWLNTFAAIVSLVGVIIYLRYGSRLTRKKPLMVTGLMMMAATAWWFSRMPPDAGPPALAWGLVGKGLFGVMVIIPIAGLTFRSLSGEEFAHGYRSKNLMRQIASSFASAIGAVLLQNRQFAVHDSLVHALGQRVAETQLWMQSVQAALAARGFDEAQARHGAMAQLAGLVEQQARLIACEDIYRLIAVLALTAAVYMLLQRRLD
>fig|264198.3.peg.5092 Multidrug resistance protein B
MPNPIITISARESHSGANYADRNASYWKRNLAVATFGSFTTLVSLSMLLPFLPLYVEQLGITAQNEIVQWSGVAFGVTFLATAVTAPLWGRLADRFGRKPMLVRAAVGMAIVMSMIGLAHNIYELVALRFAAGLIGGYASAATVMIGTQAPAERAGWALGVLSSGALVGNLVGPLVGGLLPNLIGIRGTFFAGGAMISVAALLTIFLVREDFRRPAKRTLSHEAIADRHERSSRVPLVALLVTATMVLFSNMSIEPIITVYIGQLGVPRAQLSTIAGIVMASSALGSVLTASRLGALADRLGAWRVIIGCLVATAVVMIPQAFVTNWWTLAILRGLMGMTVAGLLPAIGKLVRQATKEHQSGKMLGYLQSAQFAGQVTGPLIGGQIGVHVGMRAVFFVTSAVLLGCAAFDRWAKTR
>fig|264198.3.peg.5258 Outer membrane component of tripartite multidrug resistance system
MNAADFSMRASILAILACLALAGCAVGPDFERPTPSAPDVFHRIQSAQASSKAVDAEFNVEWWTLLNDPLLNNLESRLVDANLDVAAASARLRQSRSTQQVVGAAQLPRLDGAASYYRERGSPNGIVSLLGVSPTGSPPQPASGSSPLGVAPVPGSSGSPPFDLYQFGFDASWEIDIWGRVRRSVEAAGALTEASFEDRNAILLSARAELARDYVELRDLQSLLEITKQNLEIARDTARLTQVRAREGVTTDLDVANAAAQVASIESLMPTLEARLEAAINAIGLLLAEEPGALRQELAERREVPELPERVPVGFPSEIVQRRPDIRRAEAQLHAATASIGMAKADFYPRISLNGSAGFQSLQLSSLADWASRQFVVGPSITFPIFEGGRLKGTLHLREAQQQEAAIAYKRTVLDAWREVDDALVAYDAEQRRRDRLVTVVSENQRALAIAQRRYKAGAVDYLDVLNVQRQLLRSQSNLEQSRATAATNLITLCKVLGGGWESAYARTPTAN
>fig|264198.3.peg.5816 Bicyclomycin resistance protein
MEMKGSRADERAAPGVLTAQSDPQPKALPGIAAMAAIAAGLSMLGQFAIATYLPAFAIMSDALHATNAQVQQSLTAYLLPFALMLPWHGAISDAVGRRRMVLLGCALFTIGSLVCAGATGIDMLHAGRVLQGISAGIGVIVGRAMVRDVFDGMQAQQVMALVAMIFALAPAIAPVCGGWLLLWTGWRSIFVFLALVSASLLVACWRWVPETLPPARRHPLHPALLARGYGSMLTHWRFVALTLANAGVNVGIYVYIFAAPTFVTRHLGLGAQSFGWLFIPIVAGIMLGSLVSHRMAGRISPVRSVLLGHAVMLFAGILNIVLTALHAPAMPWALIALPVYGAGMTITQPSLQLLALDCFPERRGLASSGYVTVQQLGNFLMSALLVPLLLDSTVKLAVCMAALQLFGLAMFMGGQRDRAVVVSS
>fig|264198.3.peg.6318 Permease of the drug/metabolite transporter (DMT) superfamily
MPMAICALLIWSTLAVSVVSLSEMSLLLTTGIGLAGGGLIGLPWVPWRSLRPRAVAVGALAMFGYHALYFVSLRTADPVAANLLHYLWPLLIILFSPIMLKGVRMEVRHIVAGVLGFAAACVCLAPAVSIQGSQIGGLSVALMSAAIWAYYSVWSGRFPEIPTAAVSLYCLLAGIGSLVAYLALGALPDLDAWQLGGRFGAPTPGQWLMLGYLAIGPLGGAFYLWDHAMKKGNPHQIALIAYAVPIASTTFVSLFLGRGLEIATALGAALVTLAVAVGGRPSRAKPPYTAETGIQDG
>fig|264201.1.peg.127 Multidrug resistance protein B
MPVKTLSPAALIILTLALGLGTFIQVLDSSIANVSISHIAGDLAVSPNQGTWVITSFAISNGIVLAITGWLAARFGRVRLFIWSTSLFSITSWLCGLAWDLNVLILFRTLQGASAGALIPLSQALLLTNYPEEKKGVALGFWSMIVIVAPILGPIVGGYITDNYGWPWIFYINIPIGFLSAWMTGLLIQDPPHEGKSKVPLDLTGLLLLTIGISSLQVFLDKGQELDWLNSLTIRVLIVTCVIAFTIFIPWNYYAKHPVMNFSYFRHRNFTIGTILGAIGFLMFFGSAVLLPLWLETEMGYTAFWAGFAVMPIGIIPLFLSSTIGKSVSRFDPRIMTTFSFISFGLTFFWFSELTPSVSLFKLMLPRFFQGIGLSFFFIPLVTISLSPIPNHELAGASGIFNFIRLIAGGGFGTALYVTLWDRREIFHHSRLTEATTIYDPLTWEFYENLKQSLSLSQPESNLILEDLLSAQSYLLAVNDVFWLTGWVFLACIPLIWLCKKNTTNKTQQVAMD
>fig|264201.15.peg.1902 Permease of the drug/metabolite transporter (DMT) superfamily
MFYVILLYALFASVFTIAKTGLEYSQPFFLVGTRMLLAGCLLLGYQKIVNKEHFSFDKQTWWRIVQLAAFNIYLTNVFEFWGLKYLTSFKTCFIYSLSPFLSALFCYTLFSEKLTTKKWMGLLIGFMGFLPILMNQTSSEEATGHLLFFSWAELSVMMAAICSVYGWIVLMQLVKENNLSPITANGTSMFIGGAFALCHSLLVENWSPIPVTNIPIYLECTFLLILISNLICYNLYGTLLKKYSATFISFAGFTTPLFTALFGWVFLGEVVTWPFYISFGIVFLGLVLFDKEELQQSYRGKLLSQPQLSE
>fig|264203.3.peg.208 Permease of the drug/metabolite transporter (DMT) superfamily
MNEAERESQPESKLTSPKVFLPFLLVILIWSTTWIVIRDQLHSVPANWSICYRFFVAGLLMMLFCRIKGYKLALDRGNQFFCITVGLLLISVDYGFLYAAEKHITSGLVAVVFALIIIPNSFFARVFLGKKSSPYFILGAVLAGIGLGLLFRSQLAYLPDRTEMKLGLGMSLLAVLATSLGEILLSTPRGKSQPMPVFLAWSMLWGSLGIGSAAFFLDGAPVIGGIAYLGGLLYLTLFASVLAFVLYFYVLHIIGPDMAAYAHVLSPVLAMVISTLYENYIWSSSAIAGSIMVLAGLLLAMKSQKKSIRSVMVKARID
>fig|264203.3.peg.269 
MLFNLRQAAFALNCYIAAMLGLYVSMRIGLERPFWAMTTVYIVSHPLTGAIRSKSFYRVIGSFLGATFVLAVVPKFDNAPLFLCMILGLWASFCIFIVVLDRSPRSYIFFLGIVTASVIGFLSVENPINVFHIASLRLQEICFGVVSAGFVHSVLFPHSVSNLLSRQLDQILHDCERWANHALAGDMTDIDAKDRQNLTVDLTNVHFLGTHIPYDTAGLRPTRMALAAVQDQIILLMPVIAAMEDRTREIDDAGGMSEEITAYVESVRQWVADPPVDDAAEASRLIARGNALGEKLKVENWRELLELNMIGRLRHLIEALQSTRLLVEAVSHPEDHPPAMIAALSSAHRVRSMHRDYGMAALTALTLFMVIMASSIFWIMTSWPNGSTGCLLAAMSFGLSAQAGDPVKQQGHYLLGAVIGVIVAGFYVFAIMTQIHEFELVMLTMFPVLFIIGYLTADQNYLPIVRPFMVVFNLTMAIHPAYSADFELYFNNGLAIITGCGISLVGFKVMRVIGADVMVRRLLQSGWRDLSATLKRPGAPDIVDWSSRMLDRIGLMAPRVSATGTDQNVIRDDGIRDLRIGICMLRLRQLAARVDENVRHQISTLAQAIAGYYDELSRSPNAESSDIILTDIDRVIDSFVDLHNSIDRREGLTALVSLRRNMFPDAPGFIKQRSPA
>fig|264203.3.peg.1774 Permeases of the drug/metabolite transporter (DMT) superfamily
MNRLWNNAWITLSLAAFMWASNFVIGRIIPPSMPPVSLSFWRWTLAACILLPFVWSSLKKEWRVVLRHWPIILLLGTTGQAGSNTLAYYGLHSTGATVALLIQSATPVVILLFAFFLYGEKPSPKRIVAMLFAFGGILFVIAAKGNGGAASTIGGTLLLTATMLCQALYATILRHKPPTTPLVLLFSCFVAASLVLLPFQIPYGVGLPFHDSHSLSAIIYLAIGPSIFAFLFFNRGVHIIGASRASIFLYLMPVFGSLIAVPFLGERLGWMHLTGFLLVGVGFVLSREKVKSILSR
>fig|264203.3.peg.1802 Outer membrane component of tripartite multidrug resistance system
MHLKRPLITSISVAALLLTGCASIPKLGKAPKVKDVHDYATAQSLAGNGSAWPGEGWWKSYGDPQLDQLMTEALAKAPDMAIAKARILSAAGSKQRAGAGLLPSVNGFVGTGAGHLMRDQEIRQVTGRNDEFKDWGDGGSSFLTIRYNIDIWGGYRAKLAAATSEAKAAIVDSHEAALTLTTSIAAAYANLSRLFEERQVLNRTLAVRSHVLELTQQRLGHGLDNDSTMQDASARLANAQADLTANQESIDLVRHQIAALMGAGPDRGMAITRPQSVKLRAVGLPDNAALDLLGRRPDIVAARLTAEAAGYRVKVAKTQFYPNVSLNGIVGYQTRALEHMATHGLALGAASAALNLPIFRGGSLSGQYREAWATYQEAVASYDKTLSQALQQVADAATSQKQLNLQLDQTVQALNHAELSYNVLANRYKSGLVTYIEVLQGEENVLTLRKAVADLRARAFQLDVSLIQALGGGFTAA
>fig|264462.1.peg.238 Permease of the drug/metabolite transporter (DMT) superfamily
MPARFENLILYAICTLIWGSTWLVITFQIDAASPVTSVFWRFLLSTAILLLFCFWKKQNLKYSRQDHLLFAGQGVLMFSINYMLTYVAETMVSSGMVALSFTLLVYYNMFGMRLFFKKPITQNVIWGSLLGGVGIVFIFLNEILNFDPSSRTIWGLLVGFLATLSASLGNMVAQKSYQKRIPVVVTNTWGMLYGSLFTLIVALVLQHDLSIPLNARFLGALFYLALFGSVIAFGAYLSLAGRIGAEKAAYTSVLSPVIALTLSSFFENFHWTPYIILGVVLCLLGNVLTLTKRAG
>fig|264462.1.peg.359 Drug resistance transporter, Bcr/CflA family
MQSSAKPNTPFALLILLLASLTAFGPLSIDMYLPAFPAIAENLNVPLSSVQMSLASFFIGLATGQIFYGPITDRFGRKKPLYVGLGIYALASLVCAFTKNVEMLILFRFLQALGSCAGVVISRAIVRDLFTHQETARVFSLLMLVMGVAPILAPFFGGYISEFFGWRAIFALMVIISTSCIVMLAIFLPETHQPDQRVHIKDSLKNYVQIIKDRHFMGYALAGGAAQAGLFAYITGSSFVFINLFEIPAKSFGWVFGSNAIGLIACSQINARLLKRLSYDVILEKIFVVLGVLGVILAMAGIFNWGFWGLAIPLFLFIAALGMTFPNATAGAMATQRKAAGSASALLGTLQYGIAALSSAAVSRLHDGTTLPMCAMIGFCGVLALALHRLLVKKAA
>fig|264462.1.peg.419 Multidrug resistance protein
MTATSNKSQLAIIFFTVFLYLVGFGVVIPILPILSRNFGATALETGLLLSVYSLMQFLFAPFWGRLSDRMGRRPILLFCLVGETLSYIMFAWARSLEWLFVARILAGFFGASLSTASAYISDITPKHERSKGMALIGAAFGLGFVVGPALGGGLAVWGQHINPAPHFDTSFASYWVAALCFANFLFGVKFLKESLSEKSESAAKRKRFSIMWQYLNKKTVGPLMTVFLLSSLAMSSMEATLILFMGEKYQWDVKQVSFGFAYIGVIIIFTQGFLVRRLLPKWGERKVLRLGVLLLALGLTGIAIADSITGMAITMTLLSLGNGLANPSTLGSISLLSDANEQGAAMGVTQSMASLGRILGPALGGALYGTVAITAPFWASGLMAFLGLAIVIIIYKFIPEHGRVG
>fig|264462.1.peg.1432 Multidrug resistance protein
MKKLSALGHLNTTTFSAIQMMTFTLIPFIAEKATLSLSSVVLSFSVGSFLFLWSSPFWASRSDSWGRMKVLSVGMLGLFLSTGILTAVLMAPGTYWMNELAVWGSRLLYGLTAAAIVPVSQALQIDQHPEQTPLKSMLSNSMSLNVGRALGPLYLLLGGGSNMLLILQSTVVWALVVLGLNLFGITQSEAPKATQTERISILEWKSALRHISDIFSLAILFTSFVGILNFSLASILKKSFDLTSVDSSVLMAKLLLVSAILAVLTQALGKVLFKNPWQGAMIVGVATLLGASLILGDLGGWAQLWLAIVLLSVGLSLIPPCYMALMATRGPELQFGRRAGLAAAANTLGYTFGGGLAALTFKLDLFGIESVMTALVVVMALNIALLYRRREAVYA
>fig|264462.1.peg.1946 Daunorubicin resistance ABC transporter, permease protein yadH
MTGFVTIFQREIARFLKVLVQTVITPFISSFLYLLIFGVSLGQQMASHQGVSYLSFLIPGLMMMGLINNAFQNSSSSIVSSKFSGDLEDLRVAPITDQEIIWAMSLGALVRGSIVAVITYGVGSLFMYYQQGEWLLVAHPLAALFFVVLAGLIFGMIGISIAFWANTFDQLSAFSAFILLPLTYLGGVFLSIEHLHPFWQTVSKANPLLYLINGLRYGILGVSDVNVWTAAVISLIGFGVFYAVALVSLRKGSFQRW
>fig|264462.1.peg.2047 Permeases of the drug/metabolite transporter (DMT) superfamily
MGFDTIKRHGAAVFCGPALWKGFKTTTMTLGPLLLLLSALLHAAWNGLAKASKDKESFLFLTILLSGLLTAASLPISGTGFIFPDNRAFAIAVLSGVFEGFYFLTLSKALRASSLGKSYAIMRGGAMVLVWMYSTVLLGERAHGLQFLGAVFVLLGILAMNFQDLLKGKRQNLKNDIWAYISAIFIAGYHLAYHEALTENTDPKPLFLVAMIVSLPFLLYGIRSAPWQRLKATMTSHPARVLLCGSFATASFLIFLYGLKVSAPGFAISLRNSSIFFAVLFSVFLKESLTRTQILGATTIGLGALLLSL
>fig|264462.1.peg.2230 Permease of the drug/metabolite transporter (DMT) superfamily
MVLTKQESGPRRLTKNRAAVELIFAGVLWGFGFVATVWALEAFSPVETLFFRFVIASVVGEILYLILKGPNFTSLREEIFRALPAGLLLGGMLLLQTIGLKYTTATKSGFLTSLYVILVPLFNAWLFKSPSSWKNYALTALALAGTFVLVNANLSGINTGDLWTLGCSVFAAFHIIYIGKISNKVGNAFRFNNFQSAWCLLALTPLLLTQERSDWNLLSYKPLLGILCLGLGSSIIAFYLQIRTQKVLSDSTASMLFLLESPFAALFGFLILSERLSWFQASGAVIIMIASVLQIAVDPGQKPQETTSPRV
>fig|264462.1.peg.2992 Permeases of the drug/metabolite transporter (DMT) superfamily
MKNMNPRLRGSLEISVASVGFGFLGIFGKWAFQSGLSVGELLSYRFALAAVLLWIFLLLFRPSWVRLSVRQIVIAALLGIFGYAFFSTLYFTAVDGLSITLAALLLYTYPFWVNVFSHFFTQDKISGKEALCLVAASSGLVMLLWGHIEVKNIWAVAAGLGAAISYAIYVLLSGRLQKNVRPITSALYVITFGALALSLFHHPHYSAISNLSDIQATSILGLAFVCTIIPLTLELAALQKLKSTEVALLMMIEPITAALMGALIFHERLTPVQLLGALVIGAALVTNTLYSRPTPSAD
>fig|264730.3.peg.1729 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDHLDHLVLTTADVDACKDFYVRVMGMAPERFRQGRLAFRFGNQKINVHERGKEFEPKAHLPVPGALDLCFIASIPLAQVIAHLQEQDWPIVEGPVERTGATGPIRSVYVRDPDLNLIEISELA
>fig|264730.3.peg.1864 Permease of the drug/metabolite transporter (DMT) superfamily
MSMNQHLSISPSVTRPAWHQAIPLILLEAALVLTWSSGFIGARFSLDYAPPLLVVFWRCVVVTLILMPFVTRQLRSIPLATLLKNAGIGLLAMAGYVAGVTQGIALGVPAGLAALFADLLPMGMALLAAAVLGQRLVWQIWAGLVVGLVGVVLVTYSTLAVGDAPLWAYGLPLLGMLSLAIATLWQKHSTHMQPMDLLPNLWLQCFISSFAFAIIQGTQGSLAPIPSTGFALSVIWTVGLATLGGYGLYWVCLRRASATRVASVLYLSPPVTMLWAWVMFNEPLSWQMASGMAVSGVGVWMVVRAEARQVAS
>fig|264730.3.peg.4236 Permease of the drug/metabolite transporter (DMT) superfamily
MQYAFPLITVLIWAINTAVTKASAGVIFPAEIGFYRWALAGLLFTPFMLRPVWANRAAIKPVLGKIFILAVLGTAMYQSLAYFAASLTTATNMGIIQSLVPMMAQGLSIACLGNRLTRGALLGAVLSFVGVVVVVSAGNPAGLIDHGVNRGDAMVLVATASYAVYSTLLKKWQLCLPPLQLLYVQILLALIVLLPPFILSAKTGLNASNIPMVLYAAIPTSMLAPWLWMTSIMRLGPSRTTLFFNLMPIATALIAAATLGEQLALYHLFGGALTLCGVILAERWTTPLRSKTS
>fig|264730.3.peg.4286 Permease of the drug/metabolite transporter (DMT) superfamily
MEDKNQSQGVIQLSLAMLISGTIGLFVVESGQSAINAVFFRCLIGGGVLLAYIFYKKMLKASYFSKKNVVCLLVIGCSIVINWVTLFNSYTHISIGLATTIYHVQPFLVFFGGALFLRESLSKHRLVYVCIAFAGVLLIVNPGGESQDSNYLVGCGLALFAAFFYAVATIATKKMDKIPPHIVALSQMAIGVVVLLPLANFDKLPSTAVQWSLVLTLGVVHSAIMYIMIYSAYQKLPTSKIAVLGYVYPLMAVAVDYLYFGRALNSLQVLGGVMIIFSGLMGTLNANPFVRKTKAVNI
>fig|264731.4.peg.254 Acriflavin resistance protein
MEHYSITLLIIGILFVMGIYGMYIMPKDEFPHATIRQGVVVAVYPGATSEEVEQQVARPLERYLFTYGEVNRVKTTTQSQNGMCIVMVKLNDDVNNKDEVWSKIKHGLNGFKAQLPSGVLAIVVNDDFGNTSALLIAIESDQRSYRELKQYSDDLSDRLRRIPSVANVKLFGEQKEQISLYIDRQRMQAYGIGQQMLFSRLQAQGITTMSGAISDDDQQIPIHVEAQENSEEEIANQIIFSDPVTGKVARVRDVARVVREYEPNASRIEQDGHPCVLLSMEMTPGNNVVQYGEQVDKVLKEFSLNELPEDVKVTRIADKPKVVAMSVSDFLRDLLISMAIIILVMMVLFPLRSAIVSAITIPLSTFVSVAIMYIMGIELNIVTLAALIVVLGMIVDNSIVVIDGYLEYLGKGFKPFDAAIESARQYFMPMLLATICICAIFYPFLITMKGMFHDCLEDFPVTITINLMVSLVLAVTVIPFLETRIIKPGKVSTDGNAITKWVQKTYNKVLDFTFAHPWLTIGGGIGVILLSTLIAPTLKIRLFPYADRDQFAVEIFLPEGKGMAETEVIADSVQHVLAKDERITGITGFIGCSSPRFMDAYAPQMAGNNYAQFIVNTKSNKATLDLLAQYQPQLSEAFPNAYVKFKRLDYLEVSELEYRFYGDNLDSLHVVVERLMERMRKMPELEWVHTDYLQPYPIINVELDPVTSAQLGITRTTAQLALSATSSDLRVGQIWEKDYELPIVVKDDADMTFSDIANLGIASPASMVSGGLRSTNSTVPLRQIAKVQPKWSESRIMHRGGERCITVTAQFAQGVYTAPVEKEIARMMNEEIKLPQGVRAEVGGEIEYGDEAMPQIIGGITIALIIVYFFLLFNFKKYGVTTVCMAALGLMIPGALIGLGLMNRALGLTSIFGLITLMGMIMRNEILIFEHAIDLIKKHVAEHGDWKTDRQAYNAAVRQAAYDAGKRRMVPIFLTTATTAVGVVPMIIAQSSFWMPVGVTIFAGGIGSLIMVVTMLPVIYWKVSTK
>fig|264731.4.peg.310 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDQRLGTEPIRRLFVSMTVPVVLQQLLMLLNNVVDRIWIAHIPDVGQLAFTASGVCVPIVYMIIALAELTGTGISSRVGLILGQGHHHQAERTLGSMMAFSILLAILTLLLVEVFCPELIRIFGGSPQTAAMAECYLRISTPGNAACIISSMLAPFLLVQGYSNEALFVIGSGIVINMILDPIFIFLFGWGIAGAAWATTVAEVTSAVVAIVMLARVGNLRIRMKLLSLDWRHIVPCLALGTAPMAMMLAETAQMGVYNQTLYHLAGDWGVGTMALVIMLHDFLFFPVRGMAYGSQPITSYNLGAGKWQRVWDNVKLLLAFTLVWSMMVCLLMMILTEPVVRLVVGDGPMVDYAVPMVRLSFVVFFVATVQFASQCTLQAMNRPVLTFWIGISRTLLLLVPFVWLLPRLLTDHADMGVFLAQPATDVVVGTVTVIILFKLLQNYKNIQNNKV
>fig|264731.4.peg.395 Permease of the drug/metabolite transporter (DMT) superfamily
MTQQSIFQRPVWAALMAFTAAFLWGWAYPFIKLGFAEFEITADMTGSKMLFAGIRFCISGLIILSIARFTHRSFQFNEAAKPNLIGSALFLLGFTLLNTTLHYAAFYIGLSHSQGSRAAILNSLSVFTLVLLACMFFKSDKLTTRKILGCTIGFGGILSLNLGGEGSGQFTLLGDGMIILNALCGAFAGLMTRGVNKRVDVFVGTGYSLGIGGALLIIPGLLLGGTLPHVTLLGLFYLLMLIGISTIGFALYNKLLTCNPVGKIAIWNSLIPVVGAVTSCLCLGEPFLPKYILAATLTTAGIYIINKGKV
>fig|264731.4.peg.483 Membrane fusion component of tripartite multidrug resistance system
MEKNKITTYIYNAIVILCIVGGAVYAASQFMHFGGGEVTDNARVCQNIVPQNCRVQGFIREVRFNEFQEVKKGDTLVVIEDAEFRLRLAQAEADLTRAERGSQGTASSIHTTKTSIGVTEAGIEAARVQMENAKREDARFQKLLEQDAVTQQQYDNVHTGYLSAKAGYEQALRSRNTQTAVVAEQGHHLSASEAAIELARAQVEIARLNLSYCYIIATCDGVVGSKDIHVGQLVNPGQTMVSIVDKHEKWVEANYQESQMPNIKVGDKVRFTADAVPDVEYTGVVERISDATGSAFSLVPIDNATGNFVKVEQRVTVRVKIDVNDELQKLHGGYNVVCKVEE
>fig|264731.4.peg.484 Drug resistance transporter, EmrB/QacA family protein
MGKLTEFLMKAPPPPAGMGFAMPMMKGWVPRKLQPWIYVLTALCFQFSGGIYLGALDEIRGTTNFMIEDVMFLLYATLAGMAVWFPMLFRMKFRFTNQQLLCTSAIVMGICNVITMHSQSMPVLMLACFIAGIAKIQGTFECMSNIQLWITPKRDFAVFFPVLHIILLTAIEGGGWLAAWMGHHFTWQMMHTFTVGTMSFVLLSQIVLCRPFCPMPNRFSLKGTDWQGALLICVTMLLFSYIFVYGDHYRWFANRHIRMVGAFALIFAGLTLYRLIHNRYPYVELRLLKCRNVVPILIVTILAELAFGAEHTLEEILYTEVVGLEELTKESQYMWALPGMFLGIAFDLYWLKVQKWKVWKLIGIAFLSISAYALLMYSTLGMAVNIEQYQLSIMLRGFGYGVLAPTLMWALDESVPSLEMFFMGLFVFNIPHMYLGGAMGYGFYTTIFSHFLNEDMMNYGRQLTLTNLDLSQFDFGAFMGNSYLHSMMLVAIKQVYGYVIWFALLLASVFLLCDIPAVRTNIRKVPLWPVLAIEYLARKHKNA
>fig|264731.4.peg.543 Permease of the drug/metabolite transporter (DMT) superfamily
MFKVQNSKLQAHSAIFLANTIFGLGVPVTKLLLDEWVTPMGYMASRSLGACIVFWAIAAFLPKEKVERKDLITILLGGLLGFVVSQTLTAWSLDYTSPVYFSLIATLTPVAVMLCAALTIGEKITPMKSIGVLLGIAGAVLMVLMSQSMGSGKNDLIGIVLAILSVLTWAIYLIITRNVASKYSPVTQLKYVFLISAIVTVPIAWPELSANALYTPEWGWDGVAEMAFIVIGATALGFFLIPFAMKYLQATTVSIYTNLQPVIASFVAILLGQDVITWDKPVAGALVLISAYIVTVVTEKKNS
>fig|264731.4.peg.2063 Multidrug resistance ABC transporter ATP-binding and permease protein
MNYIAWLWHHSRGIRFNTVVRIVTGIGQVALGLLMVWLSRKFIDETIRTGTADDVLRMVLLLVLTVLGGVALRQVGYWLTTTAGVHQSNALRLRIFSSLFRRQLYTEQELHSGDVTSRLVKDIETISSVCTDTIPQIAITFIQLCGAFLLMRWFDARLAWALLLLTPMAIVFGKLISRRLRKMTLDIREDESRIQMQVQESMEHNAVLRSLGSEQWVTDRLESMQQRLKGNVMRRMRFTVAMRIVMGCVFGLGYLLAFVWGGISLRNGTITFGVMTSFLQLVGMIQHPILQLLNMVPTVIHCTASIDRLEELSVQDKKEIRDNPCNSVPNKMVRLDDVSFRYANGDSEILQHFTHQFAPGTKTAIMGQTGIGKTTLFRLILGFIQPTSGRVEVGGNICYVPQGNTLMSGTIRYNLQLAKPTATDDELRQVLHTACADFVFDLEDGLDTELGERGCGLSEGQAQRIAIARGLLHDGDILLLDEISSSLDESTEKDLYHRIFTALPQKTMIFITHRSTVCELCDDIVLIENEKKQFASHS
>fig|264731.4.peg.2335 Permease of the drug/metabolite transporter (DMT) superfamily
MKRFLPHLIAFIVVAIWGVTFVCTKLLLLGGLTAAQIFILRFIIAYLLLLGYSLSKGIHWLSNSWRDELNMMALGVFGGSLYFLTENSAMNYTTTTNTSIIVSLCPLFASAIIGAFYKTERLNRWQTAGTVMASLGVIMVVMNGHFVLHLSPLGDALAFGACMCWAFYSLLIIPVSKRYPTVFITRKVFFYGLLSMIPYIILHPDLNIQLVINKPTLLANLLFLGCVASMLCYVAWNWVLKRLGAVVATNYVYLNPVTTIVFAWMVLNEQITVWFIIGTVLILYGMYLVNTKRPKLSA
>fig|264732.9.peg.664 Vancomycin B-type resistance protein VanW
METALIRLPDDGQREMENLLRSFYWLVVLVAFFFAWPVLEPALAADPVVAYEDPDTQRAMIAVRDFSTVLGGEVDWEAATSTVSIRVYGRPALYLDVKAGTLAGVPLQPRPQIKDGVTYAPLRQVAEALGARVDWREDGIHVYTPAGEQVSIKYIHLLGRYTITFPEKEAGSPSLHNARLAGQYLNGLVVPPGGVVSFNNVVGPRTGARGFVPGIIFMGDQKVPEIGGGICRTATLLHNAVLSAGLEVVERHRHGLPVTYVPPGYDATVYYGVLDYRFRNNRPVPIKLEFTSQGSSITMAIWELG
>fig|264732.9.peg.979 Multidrug resistance protein related protein
MLAKTKENYKWYALSCTTLGALLSVLNSNTLLIALPVIARALHASLETIIWTLMIYMLAVTVMVPAIGRVADIIGRKKLYVSGFALFTVASLLCGLVQSGGQLVAARFIQSVGGSLMLANSTAIVTDAFPKGQLGRALGINSMVIGAGAVIGPILGGLLTSWHWRWIFFFNVPLGIIGTLWAAIQLREIIELPEGQRFDWLGTSLFTIGFTFILLALTFGDMVGWHTPWIVASLVGGSLLMLLFIYIENHVDQPMLDLSLFRQRLLAAAYASNLLNGIARGAVTFLLIFFFQGIWGIDPLWAGILLTPFALAMMFVAPVSGILSDRYGSRELSSLGLAVSAIGLYGLTRLQINTPMTVVILWMVIMGLGSGFFFSPNTNAIMGAVAAERRGIAAGTRTMMNNAGMVISIALGLAMTASSMTPEAMQGLFAGTQVGSQGIAVQEFMNGLHRAFWLSFIISIVAAVVALMRGPHEVYYQETGSGSNKA
>fig|264732.9.peg.1090 Permease of the drug/metabolite transporter (DMT) superfamily
MGINREGYMKKAKDSSGEGRGLFLAVLAAAALGLEGISAKLAYAGGANILSILAIRFLAAGILFWGSLIVFPLDWKLNLGTMVRLTVLALGGQATTILLLFYAFERIPATVAMLFFYLYPVIVSLLATVFLKETLTRAKIGALVLAFTGLAIILGVPTGNLEIWGIVTALLAACTNGIYMVGQTGLLKTIEPRVFNAYATLTIGVAYFILAIVTGTFSLAFNSQAILAIATLSLICTLLAYTAVAWSLKYIGASRAAIISTLEPVVTAVLGFLILGERLHPIQLLGGALILAGVTVQQVLTSKDSGEGHGYGIIKQ
>fig|264732.9.peg.1200 Probable multidrug resistance protein
MLQNDAYPAPNPRRWLILFAVMAAGIMGPIDGSVVNVALPTIGRVFNVDLNTVGWVSMAYLLVLGSLILTYGRLGDMYGFRRVLLTGIVIFTIASGICALAPNIWVLIVFRAVQAIGAGMFMAMGPAIITSVFPPYERGRALGTNGMIIAVGLALGPTLGGFLVTVAGWEAIFTINIPIGIISYIMCRQVVPESRDLKPQQFDLIGAAMGFISLSAFLLAGSYGEEWGWTSPATLVLSVVFLVGGWLFLRWEKRVQEPMLDLTLFHNKVFSAANFAALMNFMSQYALIFLLPFYLQQILNYTAGHTGLILTASPLVVLMLAPVSGALSDRLGTRWLAFTGQAIVSLALFLMVGLKVTSRAFDIIWRLCLFGLGTGIFQSPNNSAVMGSVPRHRLGIGSGVLATVRNVGMVLGIAVSSGVFTWQRSAKLVAWGPGSATAAFMAGMKSAFLVGAILAAAGAIASLVRSDNFPPGEH
>fig|264732.9.peg.1204 Permease of the drug/metabolite transporter (DMT) superfamily
MSLPLPAPKTSTSIKDHLSLLLTVTIWASTFINIKIVLLQVPPNTLAFLRFLVASIVLGLHLIWRRQPFVKRQDWPLAGLTGLTGITLYNFLQNQGLKYAGATDAAILAAMAPVFIALLAWLLLRERISRRQVAGIIMAFSGSVLVATNGSPEGLVLNPARLYGDLLVLLTGLSWAVYSISLKRLLNRYTPVTVLTCSTIAGTIFLFPLALLESPINWAAVDISCWLNVLYLGLLASALAYLIWNTVLTRVPAVTAGVYLYLLPVITAIIAALFLREIPGTFTITGGIIVLLGTYLAGK
>fig|264732.9.peg.1524 Fosmidomycin resistance protein
MRKRILYLLSLGHMVTDINQGLLPIFLSVYKDQYGLSYAAAGLVVFLSNISSSVIQPLFGYWSDRHQLRWLLPAGCLVAGLGMVAAGYAANYYLLVAAVFISGLGVAAYHPEASKSAHYISGPMQASSMSIFSVGGNVGFGLGPLIATFILSHGGLRASWIILIPTSVTVALLSHTLPALGRAMAGGHQAAPAGNPRAKTSQAPLVAITLLVLVVIMRSWLQSGLTYYIPFYYLNFLHGNEHFASSMLSIFLIAGAVGTLVGGRLADYWGAKRMIIGSMLVLIPMVVTFPYVQGAWVAILLALSGFALVSTFAPAIVLAQNILPEHVGMASGLMMGFAIGTGGLGTFLLGGIADAHGVPFTIQIMAVIPAIGAALAFFIPDLRQQPSARQVRVEPVPEEKNSRA
>fig|264732.9.peg.1638 Vancomycin B-type resistance protein VanW
MARWKLGVLLFFLLGLALLALARFYFSGRILPGVAVAGRPVGGMDLERARKVITELAAEVENRQVSLRLGEQVLASTPGALGLEVDVEATLARAYALGRQGPLVKRLVLLSARKRRVEPVTHLDQQRLQAGLERLGGAWRREPADARIEIVAGGQPRLVPAVTGWQVDAAILKSRLEEATTGQTIDIPLNRLEPRLTTAELAARRITRQVASFTTLFDPAEADRTHNIRLAAGTLDGLWLPPGGEFSFNRTVGPRTPDRGYRDALVVEEGNFVPGTGGGVCQVSSTLYNVALLAGLTITERQPHGLPITYVPPGRDATVAYGLIDLKFRNDTPYWYLLKTGVEAGKLTMAFYAADEAPRAEVTSQVLETIPPLEEIEWEPDWPPGRVELKREGKPGFRTQVIRIIYQDDKKGQPEVVSRDLYPPQPRIIRKGGQGG
>fig|264732.9.peg.1854 Permease of the drug/metabolite transporter (DMT) superfamily
MAIKEAAIRPITSGCAAGADRRLGYIAIILASLLYGGNVIAGRVIAPLVPPLALAAARGLLGLPVLLLFALKAGGKPRLADLPYMALMGFLGISIAYGTFSWSMQNSPAVNAAIIFATFPAVTLVLLAIGWHVKPSRYQVAGIIMAFIGLALVSTRGSLAQLLAMRFQPVDLVLLANVTAASLYNILGQRMVERYSPIVTSTYSLFFGTLFLLPAGFWEVSRQGWYLPPSGWLLLIYMGCIIAGLAVLLTFEAVERIGCGPVAMFNNLNPLFAIALAALFLGEKLSWYHWAGIILVLGGVCISLRQQPGRQQGQKQGQQ
>fig|264732.9.peg.1943 Multiple antibiotic resistance protein MarC
MSVFFLHAVVSILAILNPIGNLPIFLSLVEGEATADQIATARRATLAAFGFLTLFVLLGNNILLFFGITLAAFRVAGSIILFSIGYKILQGRNIHSRSLAPDIHEDIMARDDVAITPLATPILAGPGSITTVMLLVGSEWRLRTILLTVAAIAVVTLGTYLIFRYATLITRHLGPMEMNIISRVMGLLLAVIAVQMGASGLLELFPGLGR
>fig|264732.9.peg.2253 Probable multidrug resistance protein
MYSPTVLIPFFYQKVLGFTPQKAGFLMMAFLAAMAITASFSGWLSDKIGYVLLTTSGLVLNGLALVALANINLQTPLTLIIIYIAVMGTSLGMFQSPNNSCVTGSVPKNKLGAATGISQLIKNLGMVIGITFSVAIFSSRMAGMPVEYNQAFVKSMGFVYYLAAVLSFAGAVISSRRSK
>fig|264732.9.peg.2259 Permease of the drug/metabolite transporter (DMT) superfamily
MVYLLVGLNILLLVSGQILWKLGVARDAGFKAVLASFFSPLVLAGLALYVLATVIWLYVLAREQFSLLYPLQSLAYALGVVVAWLVFKEAVPLTRWIGVLVIMAGVALVAMK
>fig|264732.9.peg.2348 Permease of the drug/metabolite transporter (DMT) superfamily
MQPKHIYALILVALIWGLTFPAMKIGSFYLPPLSFAAWRFFLGALCLLPLAGRRQGKLWHAGRDFWPLFLLGLLQTAIMGGALHLGISMVKSGITSVVLYSYPFFFTFLAFLLLREPLTGKQMAGLIIGFAGLILVVDPWKMHPTHAEFIGILVLLGGSIGWGLASVYLKAAFKTRDKLEVTTYQMFYGSLVLMLVAAFADHGLRFSWTAPGLGIMLYTALLTSALGFVILLTIQARYPASQTSVYLFLVPVFGVLFSSLLLGEKLTLNLLLGLALVAAGIITVNLGAPVQAREKTDCVASGK
>fig|264732.9.peg.2359 
MSRRLVVILVLVLALAGAGAIAFYYYYENLNFASTDDARVAADTVTVSPEIAGKLLEWRVQEGDEVKAGQVLGRQDLESSLTSSAVNPQALGTAAGVMAQKAEIKSPIDGQVIQSKALVGEMAAPGMALAIIADTEHLYISANIKETVIEKVKVGQVVDVTIDAFPDRHFSGRVTSIGRATTSVFSLLPAQNSNGNYTKVTQVIPVKIQLLDASDVKLLPGMNATVRIHIR
>fig|265072.7.peg.175 Outer membrane component of tripartite multidrug resistance system
MKTPPPLPFPRSRHQHWQIAIAALCLALAGCQSMAPDYERPAAPVAEHFPQAGTGTADAPSLAWQDYFADTTLQDLIQEALANNRDLRSAIQRVEGARALYGVQRADLFPGLNAQGSFGRSRTPEDMSLIGRPMVLSEYRVGFGITNWELDFWGRIRSLRDAALETFLAAESAQRASAISLVAQVANSYLNLRELDQRILIAEKTIESRQESVRIFQRRFDVGSTSKLDLKQVQALLAQAQTLRYQLQQSRAIELNALTLLVGKPVDLPPASHAFSETKMLHQLKPGLPSDVLTQRPDIIAAEHILKSANANIGAARAAFFPRVTLTTSLGTASRELDGLFDTGSHAWSFAPSISLPIFDGWRNRSNLELANVRRDLAVTSYEQTIQTAFREVADALAAQHSIRQQLVSQQEMLDAQAERARLAKLRYDHGATSYFEVLDAERSLLEVEQQLVQMQRALFSSQVSLYAALGGGSHSITVPPPSTTPAARQPSN
>fig|265072.7.peg.374 Multidrug resistance protein, AcrB/AcrD family
MVYAIIQTPPGSTLEVTNKIARQLQGIASKVEGVQSVSSLAGYEVLTEGRGSNAGTCIINLKDWSERKQSVHQIIEELEEKTKDFGAVIEFFEPPAVPGYGAASGLALRLLDKTDNTDYHEFDKINQDFMKALAKRKELTGLFTFYAANYPQYEIQIDNKLAMQKKVSIAKAMDNLDILIGSTYEQGFIRFNNFFKVYTQAGPEFRRYPTDILNYYVKNEEGEMVPYSAFMKLKKMQGPNEITRYNLYNSATIRAMPADGYTTDDAIKAVEQVAKATLPHGYDIGWEGLSFDEANRGNEAIIIFGVVLVFVYMVLAAQYESFILPLVVVLSLPAGVFGSFFMLKALGLANDIYAQVGLVMLVGLLGKNAVLIVEYAVQKHAQGLSIKDAAIESARVRFRPILMTSFAFIAGLIPLVVATGAGAVGNRTIGSSALGGMLFGTIFGVILIPGLYYIFAKLSDGKSMIRNEEFEPLTETYHYSKSDDDQE
>fig|265072.7.peg.449 Multiple antibiotic resistance protein MarC
MTGQPGTARVRHDGQHVAAYRLVDAAPARHRHTVLECILTVIFNNKKRTGTMSILEALKYISIVVIGLLPIMNPLTTIPLYMALTQRMTPETRKLQARKACIYAFFILTTFLLLGNGIIALFGISMAGIRVAGGLIILILALRMIFSGLDSSSSVDSEPEEIKSANLDYSFSPLAMPSLAGPGSIAVVMSFGSQIPEGSHLIGDPIVIAGIAITIGIAYLALSSATHIEKMLGEHGMQAVTKIMGFLLTCVAVQFLASGIRDFYIEFSTI
>fig|265072.7.peg.1404 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTTDRSQSNPHISVIVPAFNESSAITSTVENIANQLATLSPHWDIVVIDDGSRDKTADIVRGLPAYLRTTLVRFSRNFGKEYAITAGLEYASGDIVICMDADGQHSPALISEMLEKWRAGYDMVYAVRQNRHIESGFKRWGSKLFYEIMTLGERITIPRDAGDFRLMNRNVVNALRKLPERNRFMKGMYAWVGYKSIGIPYTPLPRSHGVSTFSRLKLIQLAWTGITSFSVIPLRLASAVGGLLALLAFIYGIWVILEKMFFHESIPGWPTVVASLMFFSGVQLLFIGILGEYIARIYDEVKGRPPYIVAEVSASYQGKESQL
>fig|265072.7.peg.2382 Permease of the drug/metabolite transporter (DMT) superfamily
MKAGTSTTLRAFAALLLLAVLWGYNWVVMKHALDYAGAFQFGAMRTFYGAVCLMALLVLMRKPLKPREVPTLIWLGVLQTCGFTGLIIWALVEGGAGKTAVLTYTMPFWVMVLAWPLLGEKIRGIQWLAVLFSVMGLLFILDPLHLGSDLFSMSLAILGGVFWAISVIVAKKLHQRVPDLDLMSLTAWQMLFGSLPLVAVAFIVPAPPIDWSINFIGAVLYNAVLCNALAWLLWLYALQHLPAGIASMTSLLAPVIGVLAAWWQLGEEPERGEVIGMILIGVALLIISLHSMKRREVVNPAMGQD
>fig|265072.7.peg.2506 Permease of the drug/metabolite transporter (DMT) superfamily
MPPFLAKFFSSRQQALGVLFALVSAIGFSAKAIFVKLAYVEPVDAVTLLALRMAFSVPFFIVAMFYGQEKAVAMQRRDWLAVLVLGFIGYYLASFLDFLGLQYISAGLERLILFLYPTMVVLISALLFRERIGRTVMVALLLSYAGIVLVFVHDFSMSGDGLFLGGGLVFASAFAYAVYLVGAGHTIARIGAMRFTAYAMTVACLACIAQFLLTHPLDALRQSGRVYVLTANMALFSTVLPAFALAAAMKRIGSMQTSMIGALGPVATIYLAYVFLGEQLSLIQFLGSVLVLVGVMMISLRKKK
>fig|265072.7.peg.2607 Permease of the drug/metabolite transporter (DMT) superfamily
MSASSRDADAWGGMVSDDQPMTRLLGKSCSIVHHKLAYTMRLMQKPAVSPFTLYLILILPPLFWAGNFVVGRAVHTDIPPFTLSLGRWVIALLCILPFAWPTMRRDLPLYWQYRWRLLAVSVVGVAAFNTLVYSGLHHTTATNGILLNSCIPILILLFGAMFYRLRLHSLQLLGLALSFFGVLTIILHGEWERLLSLAFSSGDLVIFTAMICWALYTLWLRDLPASIHRLGLMGAQIMVAVIVLLPLFIWEQAHGQHARWGQETWLALAYVGIFPSVIAYTLYTIGVEKAGAARAGLFIHLMPVFGSLLSVIFLGEHLHLFHAIGIAAILGGLALSNRHQHP
>fig|265072.7.peg.2613 Outer membrane component of tripartite multidrug resistance system
MHRNILKAFSTAVIAVLPGCMSMSGISTTAQPKDTAQLEAGHDISEARHDLPWPGEAWWQVFQDPQLDALVNHSLQQHPDIRAARSRTAIAEAQAQAAGALLAPQASANGTLVRERFTSLQFIPPPWAGHTEWNNKATLNLGYDLDLWGQRAQQWQSALDRTQATAAEAQQVKLSLTTALVMQYIALSRAHALHDITHHRLDIAHQQLDIRKRALAAGLGTEIEVTEAESLIPALRAQLEAGDERITLLRQQLAALAGEGPGYAERLHPPKLSLDADIGLPDALPANLVGRRPDIVAAKWRIEAARHNIASAKAAFYPNINLLGFVGLQAMGFGKILTESGMVAGVGPALSLPLFDGGLRRGNLAATTADYDLAVEQYNSILLQSLQEISAQLVTLRSNAIQHAELLDALRLAQRSRKLALTHHQAGLANYLQVLEAEHHVLTQHAALVDLEASRLSAYADLMKALGGGAGQPQ
>fig|266117.6.peg.200 Permease of the drug/metabolite transporter (DMT) superfamily
MAWRKGGFFGVLLVALGASLWGTDGVLRVPLLEDMSPLSIVFAEHLFLAAYSVPAVVIGRRAFRGFGLPQWGALLVIGWGGSALATLLFTAAFAVGNPTVVILLQKTQPLFAIALSALLLREPLGWRYWPGFAVAMVGAYLVSFADLSPFRQLPGAEALTAALALGAALLWGSSTVLGRLVLREVPFHTLTGARLLLALPLLAGIVLAQGTLGQAAQGLAGHPGRLALLALLPGLLALLLYYRGLSSTRASYATLAELTFPATAVVLNWAVLGVGIGASQLAGFLLLWGAVLYLSHLNARSPSPEGPALEPGRG
>fig|266117.6.peg.377 Daunorubicin resistance ATP-binding protein drrA
MVEALRMRGVRKRFRRRRGEVVCALEDVSLEIRRGEVVGILGPNGSGKSTLVRVISTLVLPDSGSVEVFGVDALRHPKRVQRSMNRVSVEASFFKKLSAMENLLYGAKLYGVSDREARPRIEEIMGHIGFDYKRAAEPMEHLSRGMQQKVALARALLTSPMLMLLDEPTTGLDPRSRRDVQAFIRRIREAHDSSILLCTHDMGEAEELCDRVGIMVGGRIIALDEPRRLKERYASGGRLPDLEEVFMAATGYTVEEASAEEGER
>fig|266117.6.peg.551 Multidrug resistance protein B
MSAAGHKNIIFIGVALGMLSAAAAQTIVSPAMPRIVAELGGMNHYSWVATAALLASAVTVPVVGKLSDMYGRRGFFIWGLVVFMAGSALSGAAQGFWWLVAARAVQGLGMGTIMPLAQTIIGDIISPRERGRYVGYLGAVFGVASITGPLVGGWITDNFSWRWLFYVNLPLGVAALAFVVAYLHLPHTPRRHAVDYAGFATLAVGLSAVLLATSWGGTEYPWGSWQIVGLYGLGAAVLAVFLVNEHRAEEPVLPLRLWKSGVFTFSNIANLAISMGMFGAIYYIPVFAQGVLGVSVTNSGAITLPLMLAALPVSVLVGRMITRTGRYKLFLLAGVAVMWLGYLILSNLDYGSTQAELTLAMVVVGLGLGAVMQTFTLVVQNAVTREDLGVATAATQFTRSTGATVGIAVFGTIMTNRMQTEIPAHLPPAARRHSAALFGDSGGGVGAVLDPSSLSHLPAPVVEGIQQGLAAAMHPVFVAGLPVLAVAFLATLLVKELPLRTVAFADMDRAVPGGRDDEARRLLLSGVALDWAARRIESANGDAPHLLRAAASLVGPDGGRSERERALRASREVIRPAARLLLAGYLLRRRPASGAAAGENGREEVVR
>fig|266117.6.peg.670 Permease of the drug/metabolite transporter (DMT) superfamily
MDSAGRRGSAWAELSLLLTAFFFGTNFVAVKHVVEEVPPVLFAAARFTAAGLLLWAVLRLFEPASRLKRADLPPVAGLGLLGITATQTVFTIGVHHTTAANTAVIYSTAPVWGMLLGFALGLERPRLSGVAGVAMCLAGVAAIEGGGLRLAGTSLLGDALILLAAVFWGSYTVLSLPLLRRYTPLAVAAYPMLLGGLAAFPLAALDLRVEPSALGGSVWFAALYSTLFSSAFGFVGWQKGVARVGANRVLVYQYLVALSGVAAGMVVLGEGFGPLQALGAAVVLVGVYLARRRA
>fig|266117.6.peg.928 Permeases of the drug/metabolite transporter (DMT) superfamily
MKGSGRPGALLLLFALLVLFWGTAFAAIKIGVSYCPPLLFAGLRALLGGAVMVPLALARDGVPDLRRGWRAFALLSLLNVVLFFGLQTYAVLLLPSGSAALLVYLQPILVGLLAWPLLGERLSAGGVAGLLLGFAGIAVVGAGSLSGGLEALSPAGVALGAASALAWAAGTVCFKMVQDGVSTLWSVAVQFVAGGGVLTAAGALVEGWGRVAWGAGAFWASLLYASLVGVSLAWIIWFSLVRAGEASRVSAYIFAVPLTAVAVGVIFLDEPFGPALLLGAALVVAGIYLVNRSGRVAP
>fig|266117.6.peg.1124 Fosmidomycin resistance protein
MDRRAMAALSAGHLFTDVNQGAVAAIIPFLVSQRGISLAAAGALVLASTVSSSVVQPLFGVLSDRRPLPALMPLGVLVAGLGMALVGVAPGYAAVFACTVLSGVGVAAFHPESARFANYVSGSRRARGMSLFSVGGNVGFALGPVLTTPLVLLFGLPGTLFLALPAAAMAAILIYELPRLNAFRPGRGIEAGGGGEAAAEDRWGPFALMAGVVVLRSLIYFGLVAFVASYYVRVLGTSEAWGNTALAVLTGAGAAGTLALGPLADRFGRRTVIVCSMLVLAPVLFAFAHAGPVSGMVLLALAGGAIVGTFGVTVVMGQEYLPRSIGLAAGVTMGLSIGLGGAGAPVLGYFADHYGLHATMLLISGLPLPALLLALALPGGGRV
>fig|266117.6.peg.1146 Vancomycin B-type resistance protein VanW
MSLKRVAGRDAPRRGGRDDAPWERGSSGRAGTGGARRFVGPFIIALAAVAVLVALDYWMNAGRIYRGVEVGDVALGGKTPEEAREIVLRRAEGALERVELRGGPEGEISFDARRMGIDYKVRETVQAAYAVGREGNLLERLGERLRAAYGTVQIEPRVDYRPSVARQRIEEVASRLDRPPRQAEVNVYGSEVDVVGSREGYRVDVEATMRSVGEAVEDMSGEARLVGRVLEPEYTTAEAERAAERARRALDGELVLTYEGRRWTVSPAAIGDSLDITARDGEFRVGVDRDRLRENLSGVYAAINQEPVEAGYEISGEQITVTPSRTGRAIQDEKLLGAIEEGIFEGRREYRIPVAVDRPELTTAEAERLKPTDLLATYQTNYLTYDDSPGRVENLEIASEAVDGTLLAPGEVFSFNELAAPLDYHDTKVIINGRVDTAEGGGLCQVSSTLYMAANLAGLDVIERHPHYAELPYIRPGFDATVWFGALDMKFKNTSPGYILIREWVDRSTGTVNAAIYGRPSGIEVDMRSEKVSETVDEEGNPVTTWITYQTVRKNGEVVFDGVLHKDVYKYLKPAAPDAPYDERPVN
>fig|266117.6.peg.1151 Permeases of the drug/metabolite transporter (DMT) superfamily
MVAVGSAAVLIRLAEAPALAVAFWRCALGAALLLPFALARRERFPRGRELRVGVASGVALGAHFGLWISSLDYTSVAASVVLVSTQPVFVAVLAYLLFGERTSALSLAGILLAIAGTVLIAADRSAGQAAPLGNALALAGALAVAFYVLIGRSSRTGGLGVLPYSVVVYSSAALVLLAAGLAWGVRMWGFPPETWLWLWAITLGPQLMGHTVFNWALRYVEASVVSGSILAEPVIAALLAWAVLAERPGWPTLAGGAVVLLGLALLLRGHRRGAAGP
>fig|266117.6.peg.1956 Drug resistance transporter, EmrB/QacA family
MGLSRRRKILVTLATLIGTFLAALDSTVVGTAMPTVIGDLGGLGLYPWVFASYLLAATVTGPLFGRLSDAYGRKPVYLAGVSLFLLGSVLCGTAGSMGALIVYRTIQGLGAGAVQPVAVTIVGDIFELETRARIQGLFGAVWGVSAVVGPAAGGLITDYLSWRWVFYVNVPFGLAAGALLALALRESFERRPGRADYPGVFLLTGGLLAVLLAVLGAGSLLADLALLAGGASALALFVLAEARAPDPIVPLELFRERLFAVASAGNAALGGVLLGVSVYVPLYVQGALGGTALTAGTVVAPLSIGWPVGSFVGGRMLLRAGYRTTLLVGSAFVVAGSAMCLALDAATPLAYVILSVFVIGLGMGFSSTSYLVSVQNAVPWHRRGIATSSVVFFRTIGGSLGVAVMGALLDLSLGERYRAAVERAAGENGALARLLSDPNALLQPALRAKIPEGAYGELASALASALSPAFWAVAVMAVAALAVSALFPAGRAEDFVKREPRP
>fig|266117.6.peg.2302 Kanamycin resistance protein-related protein
MAGREKEGADIHAEELDTLRGGEVSLRPPREEDVETVYEWDRDPELAAWNGRAPVSVSLEAARRDYLLRWEDPGVKTFIIEAEGRPVGLATLYDFRGGGCELGIKIGPEELRGRGYATEAVRLLVDYAFQRLGLRVVRGSTLAHNRRMRRVFEKCGFERVGEGSILSRYDNRRYAEVFYERRRH
>fig|266264.4.peg.4109 Glyoxalase/bleomycin resistance protein/dioxygenase
MEPAHPASPRDAWQFDHLNVSIGADHALRALFEGVMDMHPGYRPPFPFPGLWLYEGDQAMVHAVDDDSLSASSGEVRMGHIAFRSQARATDVIARLQAAGLRFRVAHVPADGTIQIFVPLPGGLVVELDVPGDPDIATSHQYSAERRAPDASDI
>fig|266264.4.peg.4941 Permease of the drug/metabolite transporter (DMT) superfamily
MSATVPSTASSRAPATTGFRSFLPLIGAVVIWGGNWPVMKMGLAHISPLWFAACRFGSAALISFLVLGALRRLRLPSRQEWPLVIGVGLLQMGAFTALALWALQYVPPGRASVIAYATAIWVIPLSSLVLGERPSRLQWLATAFSYAGIAVIVAPALGGWELHTVMGLTMLLGASLAWSVSIIQLRANRAIRLGADMIPWECAVATVPLIALAWLRDGAPDLGAMVDIWPVIAYTGPLATALTFIVVLNVTQSLPPAATSIAMLGVPVIGLVLSTVAWHEQISLDLSIGLALIGMGVVTTALAPRLGRLAAR
>fig|266264.4.peg.5001 Multidrug resistance efflux pump
MDALILGVYALAVWLVFFKFKWLPWNTPTMVIVVTIPVVAMTVLVLTLNVVAPSSHDVRVVGKVLQVVPQVRGRIVELPAEGNRSYKKGDVLLRIDPTPYQASVRQLEGRLMADDAALAEAEAAARQLSESVRGAAGRVSAVQARLSLARRRVSEHDALLSAGAGSKFDREEASAREHELEGDLLSAQAAEEEARQKLSAKSQGEFVAIATARAKRAETEVMLENARWELEQTVYRAPSDGRVVNLQVRVGTMLVPFPFSPAFSFVEDQQEVLAFYHQNELYNVKTGDLAEIYLPTAPGEIIKARVDSIVWAQSQGQFAQGGMIPNTGATDVVPNRFAVKLALRDESSGLTLPVGAVGAGAIYTERMEMFHIIRMVFLRVSSKLNYLVFKLH
>fig|266264.4.peg.5174 Inner membrane component of tripartite multidrug resistance system
MGSWPSARDWVFSIKAFVAAMLALWIAMYLGLPRPYWAMGSVYIVAHPLTGATRSKALYRVLGTLLGAAAGILMVPPLVNAPPLLMGAVAIWTACLLYVALLHRTPRSYVFMLAAYTLPLVALPSVDNPAGIFDLAVARSEEICLGILCASVVGAVVFPASVANVLRDKSRQWMADATLWASDMLSASPGKQVSRHHSRHRLAADILALDQLISQLSYDAESAQRVRAARELRGRMTMLLPVMSSLATVVESMQSAGGVPEPLAAQMRAVKAWIQAGAAEGERPELTSTPVQAGWDAALVAAAEDRLQQMAALWHDCVSLCRRLGEKHIEGEWLPEFLRWDVGRARHYDHGMLLFSTVTVALAIFAMGMIWIHTGWADGAGAVALGAISCCFFAALDEPAPMIQSFFNWNVVCLLISMVMLFAVLPIAHDFEMLVLMFAVPYLIIGLLVAQPRLAMIGMPLAVVTANDIGISGAYSANFQSFFNSNLAGIAGIAFALVWTLAVRPFGTRAATRRLVRSGWSDIAENAVSTRPESHSTLRARMLDRLAQLVPRLAASESEVSADGFSEVRVELCTLALQREMAELEADEQHAVNRVLRSVSGYYQSRLKGAIDAPPPALLTRLGKAQQKVRSRIALAALVDLQVALFPPVVVPATVSGKA
>fig|266264.4.peg.5622 Drug resistance transporter, EmrB/QacA family
MSAPQAPSAPHSPPDVPVMQVIFGLMLAIMLGALEQSIVAVVLPEIALQLNGFEDMAWVISAYLVASTVVTPIYGKLSDVLGRRSVLTFSIVLFVLASIACAMATTMPMLIVARILQGLGGGGLISVSQATIADVVPLRERGKYQGYVSGVWAVASMAGPVIGGYLAHFLSWRWIFWINIPLGLIALIVVRRALRHLPVSGRKHRIDYLGALLFGGGLSGVLVFLTRMGQGHSPLEPQTIGLLAAGLIGLVLFIWQERRAVDPVIPLKMLAVPTVAICCLTLFLCFFQLIAMSVLLPLRFQVVGGAGADTAALRLVPLTLAIPFGAYASGRLMSWSGRYKPLQLAGCLVAPIAIVGLAFVPPQAVVPAALVMIVLGLSIGLQLPSGLVATQNSVPPQQVGIATALTAFSRLLGGAVGVAVLTTVLIALLRHSGMAVSDLHGGEDVLMSMFRRAMDAGDQGDAAAVREAAEHAFRLLFLMSAGVSLIAPFFVMRLKEKTLRGSPAGAAASAAAE
>fig|266264.4.peg.5968 Outer membrane component of tripartite multidrug resistance system
MSVSFRATLLTLAAAMFAAGCTVGPDYRGAPQVAGNAIDTGKFPRAGEGTDSQTPRVADWWHALGDTQLDGLIESALKQSPDIRVARARVRQARAGLAGNKANLFPTVAVDAATLRTRSPNLSALSGQGSSNAGRGPLSLYIAAFDASWEIDLFGGTRRSIEAASAEADAADAQLADAHVQLAAEVAQAYITLREQQESLAHLTSSEQLEAEMFELTQQRRARGVASQLEVERLMTQLDNTRAQMSPVQASIAESLDQLAMLTGRSPGTLDAELSAPKPLPGVPETVAVGDPGALLKSRPDIRAAERRLASSTAQIGVRKADWFPKLSLLGSLGFAATDPSHLARKENGTWMTLPRLQWNILDFGRVAAGVEGAEGGRDEAEASYESVVLKALRDADVALSRYGHQREHVVVLRRVEASAERASTLQQQRYRAGTASMLEWLDVERTRVVAQQSRISGDADLLKDFVSLQKSLGLGWQSSAAPAS
>fig|266779.9.peg.1518 Permeases of the drug/metabolite transporter (DMT) superfamily
MSALIKAAGNVPAGQIVFFRSFFAIFPIVVMLAWQRELGTAFHTKHPMGHVLRAIVGVASMGFGFFGLTRLPLPEAVTLSYAQPLLVVVFSAIFLHETVRIYRWSAVLIGFVGVVIIAWPNLTLFAGDGPGMETEQAIGVIATLVGAAFSAVAMLLVRRLVHTEKTSTIVMWFSVTATVISLGTIPFGWVWLSFWQFLFLAGAGICGGIAQIFMTQCYRHAELSTIAPFEYTSMVLAIVVGYFAFSDIPTIYTLVGGLIVVVAGLLIIWRERRLGLKRVAARRFVPPSP
>fig|266779.9.peg.2208 Permeases of the drug/metabolite transporter (DMT) superfamily
MLQALPLAVTMGAAMVLAEPVGWRRWSAISVGFVGVMIIVRPGLGDFSAWSLLALLTVGFCAVRDLSTRLIPQDIPSVGVSVATSAGVTLSGAALLPFTGGWQPVEVPSALSIFLAGILVVVGYQFVIKAMRQGDISFMAPFRYTSLLWAILLGFLVFGDVPDALMLFGSALVVGSGLYALYRERIVGHDLPITESTAPAITTSGLDTKPVHDRRI
>fig|266779.9.peg.2500 Probable antibiotic-resistance protein
MRIFDCRLRPPFGEFLTTSYFTDVPRITRMAAEMGLEAPASLAETSMELLFTEMDAAGVGVGLAAGRISPGLGNVSNASVRELCRLWPDRFVGLAVVDPGKAAEASAEIDRAMRDGFKGALIEPGLLGNALAIDDRRIYPFYSHCEDAGIPLFIMAGGNAGPDLSFTNPEHLDRVAADFPRLKLVSLHGSWPWVLQILHVCLRRQNVYLCPDMYLAGRMPGFEEYVRAANGFLSDRLLFGSSYPVLALDRAVKSVQQIGFRPEVLERIFFRNAAALLGL
>fig|266779.9.peg.3340 Acriflavin resistance protein
MNVSALFIRRPVLSTVLALLILLLGIQGLFNLSVREYPEVEETVITVTTTYPGASPDLIQGFITSPIAAAVSTTENIDYVSSQSRPSTSVVTVQMQLGSDSDAALTEVMSKVQQVRGQLPSDADDPTIVKGTGMQFAIMYIALQNPNMTPEQLTEYIERVIRPRVSTIQGVAEVQIIGAQNYAMRIWIDPIRLAARGVTAGEVVSAVNASNFLSAPGKTKNEYVAYPITTETTLQTPDAFAALPLKSEGDEVVRLRDVADVELAAESTETIVNFNGRPGTFIGIFPTPSANPLDTADAVIAEMPAIQATLPEGMNMEVVYDATESISASIEEVFKTIGEAVAIVVIVILLFLGSFRSVLMPIVTIPLSLIGVCFLLFLAGFSINLLSLLAMVLAIGLVVDDAIVVVENIHRHMEEGMSPFQAAFTGMKEISSAVVAMTITLAAVFAPLAFTGGLTGSLFREFAFTLAGAVVISGIVALTITPMMSARILKSGSHSRFQSFVDRTFTRLENRYERLVSGSLKYRPVTLMIVIALVSLTGFLFFKTSSELAPEEDVGALFSIVNAPRYATSEYTNLYTTQMRDLTEDLPELRVDFSIVGFGGSTNSAIALWAFKDWADRNRSQKEIQQDIQQRISKVAGVEAFVFAPPTLPGTGGGLPISVVIQTTGDPSQVYEIAEEIKNKAQQSGRFIVVQNSMAFDAPQVTVSVDRERAAALNIPASEIGRTLGALVGGGSMAQFDRDSNSYDIITQVPEAYRSNPESLGGYFVRSATGGMVPLSAVVSIKTNASPAAIEQFNQLNSATISALPRPDVTTGTGLQTIEEVARTTLPEGFFLDYSGQSRLEKEQGNTILVAFILAVVVIYLVLAAQFESFRDPLIIMMSVPLSIFGAIVPLNLGLGTLNIYTQVGLITLIGLITKHGILLVEFANQQREVHGLSRREAIVASARVRLRPILMTTAAMALGVVPLILAQGAGAAARYSMGLVIFSGILIGTMFTLFVVPMFYTFISSRDIHVRGQVPEDAAPAHA
>fig|266779.9.peg.4090 Acriflavin resistance protein
MDIVRLAIRNARLTLSILLFFIVAGSLAYINIPKEAEPDVPIPIIYVSLAYQGISPEDSERLLLRPIETALKSLEGVKEMRSAAYQGGGFVLVEFQAGYDFSNAIEDVRAKVSDAKGELPEDAEEPTVNEVNVSEFPILVVTLSGNLPERQLTIAAKELRDRIEEVPGVLEGALQGSRDELLEVIIDPVKLSSYNIQLDQLISGINASNSLVAAGALQGQEGRYAVKVPALIENSEDIANLPIVATRDAVVRARDLASVRSTFTDAETITRLNGHSAIAIEVKKRVGANLVETVDAVKKISEEFVTAMPEGVSVTFSQDKSTMIRDMLDELQNHVVIAIILVFIVVLYTLSGRASFLIGLAVPASFLMGIFALSMLGYTVNMVVLFSLILAVGMLVDDAIIVTEFAERRMNEGMPRAEAFELAAKRMAGPVIAATMTRIAAFSPLLFWPGIVGEFMKYLPITLIVTLAASMAYALIFAPTLGAMFAKAHVEEERKRDGWYIRLVKQAVRFPKTVLLLTIALLVGVQWSYSKWGAGVEFFPSVEPEYGLMYVHARGNMSLDEMDRLVRPAEEKLLNWPGIESVYTRVGQTRGGGQDIDEDVIGIIQYEFVDWRERKPASEILNDLRAEMAGMPGAEIEVRVPDAGPPTGQPIQIQLSAADPQYLNDQAAMVAERIGQIDGVIDISDGLPPPGVDWALEVDRAKAAQFGVSPVAVGTVVQLVTNGLKLSDYRPAGADDAVDIRLRLPEDRRTLSMLDQLRVETPEGPVPISNFVTRQPERSTGILNRIDAQRTITVTANVASGYQVAEVQAQVTAALQDMNLGATRWKLAGSSEESDAAASFLTNAFGAAIFLIFVVLLAQFNRFTSVFLVLMTVVMATIGVFLGLLITGQPFGIVMSGIGVIALAGVVVNNNIVLIDTYDRLRDEGMSKYDAIIETCRERARPVLLTAFSAVLGVLPIAFGLGLELFHHEVTIGAPSTQWWISLSSAIVYGLTFATVLTLIVTPSALMVFTREKRPAGQKRGGLISRLFRRRKGEKAADEEKPDADHGGFTAFPKAAE
>fig|266779.9.peg.4652 Permease of the drug/metabolite transporter (DMT) superfamily
MITRFTPILVLVAFLNALCFPLITVGLEHAPHMTFAALRAIVAGMSLALVAALLRRPIPMDLRMWMALGAMGMGATGFAYFGMFHAAEFVSPGLATILTNTQPLIAAVLAFAFLSERLRPSQYIGLGIGFLGIVTVAMPRLGIGNGPGELFALSYLILAASGLAVSNVLMKTVRSRIDPLVAMAAQLLLGAVPLAILALLTEQPSDIHLSADFVIALTLLALPGTALSYWLWFWVLDRISLSHANAFTFLTPVLALLLGVTMFDEQIGPPLILGLLLTGIGVVIVERNSRSRIAPTT
>fig|266834.1.peg.595 Multiple antibiotic resistance protein MarC
MLTIKSLAIAGLLGRTMLENFEISLPVLAMTGGIILFLVALRTVLHQSSSLPDQTTEPGQPSDLRLALTPLAFPTILAVIVFATLAGGRQAEGRTVAAIVLLILAMDWAAMIFAESILRWIGTSLQVLAVVLGVTQAALGLQIILHSLSTVSW
>fig|266834.1.peg.1065 Permease of the drug/metabolite transporter (DMT) superfamily
MSARILCQQMFVWHTARMNKNAADIPMTPFLPALAIAGTVITWSFSFAAIGYALREVEPLPLAAIRFALAAVFAIAWIAWRRPRWFLPRDFVVLAISGLLGIAAYNVLLNLGQAAVSAGAAGFIVNTQPLFMVLLAVLFLKERFGRWNWVGTIVGFSGVALIASGQPGGLSFGTGSTLIVLAAACAAAYSILQRPLFARAEPLDVTGARHRCRRSRPHALATGRRLPIDARASGHLADDHVPGRRSGHYRSKLLDLRTQEFRCRAGRSISLFGSTVLCWTGVAPAR
>fig|266834.1.peg.1221 Glyoxalase/bleomycin resistance protein/dioxygenase
MRKTPIKCQTTPGCPVSGHLKRPLLDQTIPCRLERHPGDWNVALKRMDNVGIVVEDLEGTIEFFRELGLELEGKATIGGEWAGRVTGLGDQHVEIAMMRTPDGHSRLELSRFLTPPIVADHRNAPVNSLGYLRVMFTVDDISETLERLRTRGAQLVGEVVDYEDVYRLCYIRGPGGLLIGLAQELG
>fig|266834.1.peg.1474 Permeases of the drug/metabolite transporter (DMT) superfamily
MAAAAKRVYHHPMRSKTNGYVFALLAIVIFSIQDGISKHLGAIYPPVFVAMIRYWAFAGFAAAIAARAPGGFAATAVTRKPLIQLLRGVLLPVQIVVVITSFTIVGLAHSQAILAATPLFVALLSMPLLGERVGWRRWSAIAVGLLGVLLILRPEDGSFDLNFLLPLAAAVMFAFYVITTRLASREDSAMTSFFYTGIVGAFAISLVGPFFWATLSGADWVWMVLLCITGTSSHYFLIRAYDMLDAAAVQPLTYLQLVFASIMGVTIFGETLTTGMIIGSVLVVAAGIFTLWREHVVGRQKSRLPPR
>fig|266834.1.peg.3498 Permeases of the drug/metabolite transporter (DMT) superfamily
MSELSLSKAAIDHNRISYGLTLMVLSVLLSPLIDIFSKLAIATVPSAEITAARFLLQIVFILPIVLVRGTLFDLTWRKSALHALRGGLLVVTMLSFITTLKVMEVADAIAIFFVEPIILTILGSIFLKETIGWRRYTACAVGFLGSLLVIQPSMQEVGLVALLPIVAAFGLAVFLLVTRMVAQNEDPWSMQFHAGIWGGLFCLALLWFGEGSGSSVFDPVWPDGRAWYYLLGVGVTATISGVLGVYAYRAAPASVLAPLQYLEIVSATIFGWLVFGDLPDALKWLGIAIIIGSGLYIIWRERQVQKTAGIAPVSPAI
>fig|266834.1.peg.4253 Permeases of the drug/metabolite transporter (DMT) superfamily
MSVDATVAPAAGGLPRNLRAAALGFLAFAVFSGTDVLVKLLAERFEVPQVTFMVTLAALAMLAVYAGVTGTTASLRPRHPGLALLRAFLLAVDTLLIHYAFSVLPLSEAYLLAFLTPVLVAVLAFALLAERLSMLAWCGVVVGFLGVAVALRPGIAPLNLGHAAAAGSALVFALSLVLLRRAKATESDLALVSTLLVVLAAVALAVASIGGGLAPVGPGDLLIAFFAGLFMLGGHLLLVRAFRMGDASVVAPFQYSQIVWGCLYGALFFAAPIELHTVAGALVIVLSGWLVLK
>fig|266834.1.peg.6040 Multidrug resistance protein B
MTIATATPSRDISMAGGLLVAGIVLATLTEAIASTVLSLGRGDIIGDTYATPDEFAWLDVGYTTFKLIGFMAASWLMSRFDPRNLVVGSTLAMGMACGIAAMTARLDLLVALRMIQGFSGGTLLVGGQAIIFLTFPHSRQPLLQAFFAMGSVVAPATIAPALQGLLLDSQSWTWIFFSIIPLALAAAGLLLLADGPVATRAQRRPFDWIGFSLISAALFCFTYVFSQGSRWDWFEEPRILWLAVIGTATLLAFLGQQVLAKGQGLFDFTLFETEDFCFAFIVSFVAGAALFGSAFLIPSFAVSVLAFTPTDAGQLLLPSGALFIGALLIAAFLMQLRRVPPVATVPFGILMIMAAMWMLSGSTSESGAGDMMAAILLRGAGLGFLFLSITLIAFSNLNSRNLASGIGLFNTGRQLGGLIGVSALQTLIEHNVSHNLAVLGANVTAGAPAVADRLTTTAALLTAKGMDAAAASRGAASLLGRAVAGQSTVIAFDTAFNAIGLLFVIAAPVLVGIKIGLARYAKARAEKGRAGVAAKPSGHHTLPIKRVPAS
>fig|266834.1.peg.6041 Membrane fusion component of tripartite multidrug resistance system
MESLEEKVAIITGARSGNGVAVARPNRKKMIGLALCLGAVVVVVAGWTWARESGAASTDNAYVRGDVTSLAPKVAGYVTAVEVEDNQAVRAGDVLFRIDDRDYRAKLAQAVANVEAAEARLTNVDAEMALQHALIRQAEAQRRSVVAELNLAAKAYDRRRELIRSETISQAHVDESDAAKSRAEANVLAASATVEAQQQRIAVLAAQREAAVAAVAQAEAARDLAGIDLESTVVRAPVGGVIGNRQVRVGRLVAPGASLLDIVPLDNVWIVANFKETQLEHIRPGQRASITIDGYKSGALEGVVDSFAPGSGSAFSLLPADNATGNFVRVVQRVPVKIRFAGNPLSGRLLPGLSARVEIDLEGGS
>fig|266834.1.peg.6058 Permeases of the drug/metabolite transporter (DMT) superfamily
MTHQPISLSAPRHHRLLWPMMATLLVVGWSSGFVGIRYASEEAGVMLVLFWRTLLSGVILLPFALTIGPLLRMRGIAEQMLFGVMSVFLYLGGFALAIEQRVPTGLVALISDLLPLAIAALSQPVLGERLSARQWFGTAIAVFGVLIVSFDSLSFGAAPLWAYGLTVGSMLVFALASVLHKRRRTQHMPVHQSLCIHTLTGSVLFGLCAMMQGDLAPPLTRAFAVGMVWLVLIATFAAYSIYYTSLRLFPVAQVSAAIYLSPPVTMLWAWALFSEPLTAATFIGLTATLVGVWMTSRS
>fig|266835.1.peg.204 Permeases of the drug/metabolite transporter (DMT) superfamily
MHFIPASIRGPLFMIVSTGSYLVNDTMMKLATAGLPSYEVLFLRGVAAALWGFPLLFLLGYGKQIPLIFDGHVLRRNLLELAAILCYVVALANMQIADSTALGQITPLLMLVGSSILFGERIGGQRMALIGLGFIGALMVAQPTMQGISVYALLALGNAALSAARDLAGRRVSAEVPGMIVAISAVVVVLIGAGAAHLVSERWVMPEARHLLLMAGAGFFLIFGHFFIFMAYRVGPTSAVAPFYYCFTVWAVISGLLVFGQFPNALAVCGILLVVASGLTIVSLDQRKRRLTVVA
>fig|266835.1.peg.1997 Permeases of the drug/metabolite transporter (DMT) superfamily
MKSSSLAGAVSPMIPVLVCAFGIFLLSGMDAAMKVLVIAVGVYNTVLWRSMLATLIAGAGWLAGPRSLPTAAVLRLHALRAVVVGIVLMSFFWGLARLPLAEAVGLSFVAPLFALLLAALLLGERIQRKAIWASLAGIAGVAIIVAGQFGQKTYAGDALLGTAAVLVSTVFYAYNLILARRQAMLAKPIEIMLFQNLCVAVMLGLAAPWLAISLPSNLWLPLAGVTALSLAGQFLMSWAYARAEAQYLIPTEYSAFIWAIALGWFFFDEAVTWTTLAGAGLIVASCLIAARSNPRLAEPIEVAV
>fig|266835.1.peg.2001 Multidrug resistance protein A
MNKVLSAAELQPAQPSAVQIPAPAKSRRKPIVMLGAAIAIGVAGWYGFQWWQAGRFVMSTDDAYVGGNVTPLAPRVAGHIDQILVEDNQHVDAGQLIIRIDDRPFKAAVERARASVQQQQSALDNLRAQVSLQNSLIEQAEADLEAKSAAATFTTQDAKRYEVLASTRAGSQQDAQRSLAADGQAKASVSASRAGLAAARQQLDVLNTQISEATAAVLAAKADLDTAELDLGFTQIRAPIDGLVGNRLAQVGTYVSPGSYLLTIVPQSGLWVDANFKEDQLRRMADGQAATVYTDIAPDQPLKGHVSSLGPATGAIFSVIPAQNATGNFTKIVQRVPVRITIDPDQARKVALRPGLSTVVTVDTGAH
>fig|266835.1.peg.2080 Kanamycin resistance protein
MSSRPAETGLPNGLRQLVSGYRWHRQTIGQSQAGVFRLAADGRPALFLKCERSGPFAELADEAARLRWLTGQGVACPDVIALESHAGYDWLLMSAVAGEDLASAAIDQADVIGIMASALRDLHAIDIRSCPFDHRLIRRIAAARARMEGGQVDESDFDEERQGRTDAEVFAELEALRPATEDLVVTHGDACLPNVMTAGGGFSGFIDCGRLGVADRHQDLALACWSIRYNLGQVWIEPFLKRYEPPETEPAKLSWYRLLDEFF
>fig|266835.1.peg.2121 Permeases of the drug/metabolite transporter (DMT) superfamily
MKDLPTSRFPAASLALAMMIAGTVGAFVTEAGLHPVTIVFWRCVFGAMFLGAWCLLRGYLPDRTLSPSRLALAALAGACMVLSWTAFFAGFAMTSIATTTIVYHVQPFFVVIIGVVFLKERISLDQMLWMLGAFLGVVLASGLVVSHAQASAAWALGIALTLVAALLYAVATILAKGLGQQRAEVTVLCQTIIGIVMLAPFAGIGQHVPAHSWGWLVSIGVLHTGIAYVLMNSAFPRLTTPVIGIITFIYPVVAIIIDWAVYGHPLGPAQAAGMALIALATLGVRLGWRFPLRRVSAA
>fig|266835.1.peg.2706 Permeases of the drug/metabolite transporter (DMT) superfamily
MKNRMVRGILSLCLGVLVFSLQDPLVKAVSSGYPVTEVMAIRSIVALPILIILVHADVGLRAILSKRFGLLTIRAFIQFTSYTVYYLAIAALPLADAVALYFMAPLFIMALAGPYLGERVSWRTLATVLIGLFGVIVMVRPGAGLFDWAALLSLGSAALYGFSQLMARKIGDTESSTVMAFYQNGAYLVGAAVVAGTFHLAGINHAVHPSIEFLVRPWIWPTLPDFLKMAACGFVASAGMILLSQGYRLAPANRVATFEYTGILWSPLWGFLFFAEVPRSTTVIGAALIIGAGLLALNTARRRSAAPVLAAADPV
>fig|266835.1.peg.4097 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSGCAPSASIFKLLSPRKWKNVPNGILLALLAYASYSGSDAVIKSLGGQFTVFEIGFFVTLFAGFFLFFARPAGERWRDFWRMKRPWAVQARAWAGIASGVLSVYAFTHIPLAEVYALIFLAPLLVTILSTVILKEKVGPWRWLAVVAGFAGVMLVVRPGFRELNLGHLAAFVNAFLAATSVILLRSLAQQEKRTSMLGVLVGYGLLFNGAGAAATSFTLPNAVQLVWLAMAGAFTAGGQFMQLLAAKYAPANRIAPTHYSQIVWAVILGALFFQEYPDWLTLVGLAIVGGSGLLTMVREEVRLGTVRWNPFARTRL
>fig|266835.1.peg.5120 Permeases of the drug/metabolite transporter (DMT) superfamily
MTDAASSPGLVASTFSPREERVGMLLVFLSALMWSFGGTIARFITVGDSWTIIFWRSVWAAAFLVLFMTWRDGWRGMLRSFRDMGLPGLGVGFCFAIASTAFVVALAYTTVANILLMQAGVPLLAALLAWALFRERVGVVTWVAIAAVIAGVAIMVSESLDGAVSPIGDGLALLIAFMFSIATVITRRFASVRMTPATCLGTLLAAGFAASQAAAFTVSAADMGFLFAFGVVNLGIGLAFFATGARLIPAAIAALLGTFEPILGPIWVWLIHSEVPSGRTIVGGAVVVTALLVHIGFEFKRQARPRRAGITGVPSPN
>fig|266835.1.peg.6162 Permeases of the drug/metabolite transporter (DMT) superfamily
MTDAAAAKPEATERTLGIILVSSSAAVFGLTGVLTKSIHADPLTITCWRGFVGSILISLYVLWRHHRSGNRGTLRLGWRGWLLAVEGALASIAFISAFKFTYVANVAVIYATSPFIAALLAWVLVREPFRLQTMLAAAVSMCGVGIMVWSGFGTGHLFGDGLALLMTAGSALYMIMVRAFRDTPVVWAGAVSAFLLFILGWFITDPLAVSARDAVLLVTFGASFALSSILWTEGARLIPAPESGLLGSAEVPFAILFAFLFLAEIPPVASMVGGAIVLCAVFVHAGRDWLAARSHQAASNIS
>fig|266835.1.peg.6234 Permease of the drug/metabolite transporter (DMT) superfamily
MVQHRDRAPGRLFRHGSSSISALVFAAGAVALWSTNALVGKSLLATHPVSQVQFLQFAGAALVFALIRFMSREAAPSVAPRAAVAALAVGIIGLVGTMVLQYIAFASMPVIEANLVAYTWPLMVAAAVIAFDNPRRPALLGLAAVLGFVGVALVISGGRENNWFQGDLVGYFAAFGSALCMAFYSVMVGRLATSPDRLLLPSSLVGVALALLWSAGEGVAWPAGMDLALGLYLGAGPMGLGYYFWSRALKLEGSGKVAVVAYLTPIASTLLLTLSGEQLTTTAIAGAVLVIGSCIAVGLERSEAQDYV
>fig|266835.1.peg.6505 Permeases of the drug/metabolite transporter (DMT) superfamily
MSAMTGTLNQTQRMDTTAAIAVALTVVGWASAFPAIRAGLAAFGPLELGALRFAIAAVPAAIFLAVKRPALPRLDEVWRLVFGGAIFVALYTAMLNFGELTVSAGAAGFIINVSPIFTAIMAMALLGERFSRWAWAGTAISFAGIGVIAMADGQGLHFNAGALLVLGSALCSAVNTIVQKPLFARHHPLTISASNMVLGALCLSPFLPSGFAQAAVANTAGLGAVIFLGIVPSLIAYAAWATALSRLPAARASNFLYLVSPMSALIGFFWLGEVPTLLGILGGALALGGVIVVNLKR
>fig|266835.1.peg.6645 Streptomycin phosphotransferase, streptomycin-resistance
MDAPALPARWKVSAPELIAETFSSRIWKVVRDDGSPAVVKALKPFDDVADELRGEHFLAWRRGEGAVRLLGRDGHSMLLEYAGETLLTQVLDEQGDNAATAIAAELMTKLFSPSQHPYPPELQPLTERYTSLFRKAATDRGAGHASIYVEAAAIAERLLDNPHDIRPLHGDLHHDNILHGPRGWLVIDPKGVLGNPGFDAANMFYNPLDRDDLCLDPERIAHMAEVFAKTLGESPAAILDHAIAYGCLSAAWHHEDDNAVEENRELSIAKAIRAMRANF
>fig|266835.1.peg.7242 Permease of the drug/metabolite transporter (DMT) superfamily
MVISPMTGSSREKLAIVCGFAAIYLIWGSTYLALAVAVQTIPPFALMGTRSIVGGVILLAYSKAKADDGGSIRSWIRASLCGVLFFVGCHGVLAYAEQRMPSGLAALLLATIPFWIIVGRSILGRSDKPLVRTILLLLPGLLGVVLVAWRSVAGPAALHLSDILLLLMASASWALGTLIAEGHNNKGSSVALAGRELITGGAALMFLSLARGEPIGAVEQISLSSFLGWSYLTLAGTVVAFGSYIWLLKKISPALVATYTFVNPVIAMFLGWAFLGEEVSVTTVIGGFLVVASVACLLVANRNSTHKEAASWSTPPKTAAAIAKG
>fig|266940.5.peg.2801 Drug:proton antiporter
MMLPASMALVREAFPDAARRARALGVWAVGGAVSALVGQPLGGLATSIDWRWVFSINVPVGAAMLLALLAVAPSPTRPARFDAAGQVLSVLGLSALVYGLIEGGHAGFGAGPVVAALAVAAAALAAFVAVQARGRHPMMPLNLFHARGFRLALPVGFAFMVANYGHVFLVSLFLQQQLDLSPTHAGLVFIPAALFAIAGNLTSGPVTNRFGARVPVVLGQSCMVVGLLALIPATAQRSPWLVALCLIPIGVGGSLAMPSVTSVVLEGVPSERAGTASAVFNTFRQVGGAVAIAVFGALIADPDTFTGGLRTSLLVAATLLTVTAVLSTRIQPRAHVG
>fig|266940.5.peg.2859 Nisin-resistance protein
MPSAARLCTRRSSRRLSGSELSPGRDAPPAAEARPSSRSSSSGPARTPGSRAEGRHERDRDVRHGPHDDDRERQSRLRPPRGTGWSNSDPTPRAPTAARGSPGPTPAPAPRWVPQRFGHHRGRRAPLHRGLPRRPRPRDRLPGPSAAAVRRLRHRWGQPQPRTARGQQYPVPPGGCRPRRPADGFRTSAAPRRHRRPAHRPRAHRRCVGGLDGFPRPPACSTVLVMPTTDVETYARRALRAIETRALHLDRANWPEHRAEVLGAARTATHPAQLHPLLRQAVRHAGGAHSGLIEPGRRSLFDAQDHPLPTARLIGTTAVLSLPACPAGARGADAYVRAAAAALHHVGERAGAAGARGWVVDLRGNLGGSMWPMLAAVAPLLGGEGRIGAFVDRDGHRTPWRLSRGCVGTARWALRRRALARCSDPRPLPGPVLVLTDERTASSGEAVVVAFRGAPGVRSCGRATHGSSTANDVVVLPDGATLLITCAALADRTGTVHTGRLHPDHPLQGTARTSGPAPGAASGGADAAGPAPDETLLRALELLP
>fig|266940.5.peg.3527 Bicyclomycin resistance protein
MPTPLAVPTGRPRLGVLPGFLAALSPLSQLGFTPVAVVLGDRLGLSVGQVGLTVGIYAAAAAVATLVLGPLFDLVSPRRVLPVAVAANVVLSASLLLEPGFAGILVSRVLSGLTNSALMLCASVVVADANRGDGTARERGFSRLQTFTSLGAVAGLGVGATAAGLGAPQVWSWTVVGYGLVVLALTPAISRRLPAALPGVAGAGPGARVSAVLREVGAALRVPRTALLLVAAAGVGWAIQAAHYAVSLLSEQLHPPLWQRVLLAVMIPAGVFLGSSANQVLLGRRSAARVFSRAYPALPVSCAVLALVVGAGGGWGVVALLTTLVVLGAVLGTLMPLSPAVLVGWHPGLRGSVTAADSVAKGLGSTVSPVVLGAVAAATSLGAGFLVLAAVAALAAVCARAATPGPPQRG
>fig|266940.5.peg.3627 Drug resistance transporter, EmrB/QacA subfamily
MRPHRTSGDVAGHHDPHPGEAVAGQRMSTTTPTTSTQPAPGVAPKMSHKEILEALSGLLLGMFVAILSSTVVSNALPRIVNDLHGTESGYTWVVTAALLATTISTPIWGKLADLFSKKLLVQIALVIFVVASAIAGLSTSMGMLITLRVFQGLGGGGLLALAQVILASMVSPRERGRYSGYLGATFALATVGGPLIGGVLTEHLSWHWCFYVGVPFAVIAFFVLQFKLKLPEQPRREVSIDYLGAILLALGISALLIWVSLAGTEFDWASWWTVALVAAGVVFLALAVLAEHRAKEPIVPLKFFRNPTIALSAAASLFVGVAMFGATIFLSQYFQLARHESPTMAGVMTIPMIAGLFLASTVAGQAITRTGKWKAWLVVGGVLLTAGLALMGTIEYDTNYWVVAPYMALIGLGVGMMMQNLVLAVQNVADARDMGSASSFVAFARSLGGAIGVSALGAVLGHRVTSHLETGLSTAGIDPAAATSALGSSTGVPDLDAIPAPLRAVVQAAYGSSIADVFLLAAPFALIAFVITLFFKERALRSDDGTGQDVAEATTSSPDRVAATTTGTPGAHGAARPDREETTSVPAQPTRTDTGLSLSGAVRHHDQRPLAGAVVTLADQSGQQVSRTSTGADGSYRLALPTGGTYLLIVAAAHVAPSATLVGVGDTSITRDVTLSGRSAITGRVLAHEVTGDVDAGDHHGVRGALVTLTDVTGEVVGSTRTDGGGSYAFDQLMGGSYVLTAQSESHRPLARGVEVPDSGALACDLVLTGGGRLTGTVVAASDGRVLKEAAVTLVDSSGEVVGSVLTGADGSYSFEDLAGGHYTLTAAGFAPVATSVDIEEDTVSAAQITLGSGDAPSTLDLTRFEDTSRVGEDRR
>fig|266940.5.peg.3990 Permease of the drug/metabolite transporter (DMT) superfamily
MTRRAALMFAALGFAWGIPYLLIKVVGEELPPSTLVLARTALAALVLAPIALSRKDVRAGLPDLLRRWPALAAYTGFEIVGPWLFLARAEQDLPSSTTAVVISAVPVVGVLVAFAGGRAERLGRTGWTGLALGTLGVATLVGFDLVPGQFGAVAELAVVVVGYAVGPAVLSRHLGDLPGTTVVLASLVLAALVYVPVVLLGPGLPAALPSGQVVASLVVLAVVCTAGAFLLLFALIGEMGPVRATAIVYVNPVVAVLAGAVVLGERITATTLAGFALVLAGSFLATRKPANRPEQPAAPLTVEV
>fig|266940.5.peg.4605 Drug resistance transporter, Bcr-CflA family protein
MRCTLDEAPEDTLRMTAPPTEPSTQPTQRTRRTAAARPAPRTPSTAGLVVLLGAMAALGAVTIDLYLPSLPEVAVDLGTTEARTQLTITGVLVGAGLGQLVVGPLSDAYGRRRPAAVGFVVYVVATLLCAVAPNLPALVAFRVLSGVGASAGAVIGMAVIRDLFVGPAAARLQSRLVLVIGVAPLFAPTVGGAIAAHTGWRPVLALLAVAGLGVLIAVWRRLPETRPELTDTPAQARAEEERAPVTPPRGARVLRTFTGYGALLRDRRFLALAAMPGLALATIMAYVSTSVFVLQDGFGLSGTGFAVYFAVNGTALVGGSQLNAALVGRFGSARLLRVGVAAAFVFGLALAGVLMARTDELLLFAVPLYLLLLVLGLIMPNAVTLALEPYGDSAGAAAALVTALQSGIGGLVGVLVGVLGGDEHATGLVIGAAVVLNVVLLLSVSRSIRPSVRT
>fig|267377.1.peg.166 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTTKGVQNLLGDPKKAIVKISLPMVIAMSFQSLYNVIDAIWVAGLGSDALAAIGLFFPFMFAIMAISNGVGIGGSSAISRRIGQNNKDAADNIAVHSIVLGIIIGILLIGVIPFLGAIFSLIGASGITVTMAVEYSTILFGGAVVLLFTNIANAILRGEGDTKRAMYAIILGSVLNIVLDPIFIYVLNMGVAGAAWATLLSLVITGILFVYWLFIKKDTFLKISFEKFKLDINIIKEIFSIGLPASISHLTMAFSMFLLTAIVAKAGGNDGIAVFSTGWRIVSMGTIPLVGLATGVTVVTGAAYGSANPEKLEISYKYALKMGILVETIIAALILIFENQITYLFTYSENSVHILEGLLVFLKYMFLFYPTLPLGMLTAAMFQGVSKGNNSLFISLLRTIILQIPMAYTFGIIFNQGLTGVWFGMILGHVIAVSIAYLLGIYTIRQFKTTLTPETVKFK
>fig|267377.1.peg.266 Multiple antibiotic resistance protein MarC
MDVQFIILAFTSLFSILNPFGVIPTYLVLTSQYSKVEKIKIIRKSMLAAFALLMMFALLGNQIIGFFGISIPAIKITGGVLLFLIALDMIQGNTSKVEKSPKLESHLKSHSEEIEDMDEIAIVPLTVPLLTGPGSISAVIAMMAQTSDFDGKLSVIIAISLCIIISYFVLKFSKDLEKMLGKIGFKVLTKMMGLVLTAISIQMALDGILMVFG
>fig|267377.1.peg.552 Transporter, drug/metabolite exporter family
MNKVKGTAYTIYSSVAFGIMPFLTKFAYDGGANAVTTLMFRFLIAGLILYVFLKFKKISLKISRHNFVEILFYGAFLYALNTVFLYEAYNYIPTGIATTLHFIYPVTVTLLMISIFKENLGINKVLALIFSFLGMYCLLGGNCAGFDIYGVLLAAGSGLVYAGYIVSAGKCKYSKIDSYVTIFYLSILSSVLLFIYGLFTNTLTLNMAFSSYASIGLISIFCTVLALIAFLEGIKLIGPSNTAILSTLEPIVSIILGILLLNEVLSFKIGLGSVLVLISVIIVTIEKSKVSDTVKN
>fig|267377.1.peg.670 Permease of the drug/metabolite transporter (DMT) superfamily
MNDRSLGILLMFLTVIFWGISFVSTKIILEFIPPITIGFIRVVIAAVILIFFIRNFTKYSKEDFVYIVLAGFLGITSYYLFENVALKYTTATNASLIAATVPIFYLIVSDIVEKKIPSKIKYFGSLIGLFGVFILILNGKFVLELNPLGDILMFGAVCTWVLYTFVIQKLQKHDDLKVTRDITLIGAVFFIPFTIMELGYNGMFEFTILLNPYIAFSLLYLAIFCSAIAYLFWNMAIRLAGASTTTNGVYIIPIVAMITDAIILKNIPNIYAIIGAVLVLFGVYISENGGKLKINL
>fig|267377.1.peg.699 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAYKSEFLGTEDVKKLLVKLSVPAIIGMLIMALYNIVDGFFIGRWVGTAAFTGIALIFPFQMMIMAFGVTFGIGGSSLLSRKLGEGNLDFARKAGGNAISSVLILSVLITIVGVVFMVPILNLLGTSADIFPYAKDYYEIILYGTIFNSYLVAANNLVRAEGMAKVAMFAMVVPAIINIILDPILIIVFNMGIKGAAIATVLSQIIGVIYILKHQFGKNTSIKYAMNDFLINLKILKETVFIGASEFAKLIISSILLILGNNLLGIYGGDIAIAIYGVIMRIAMLLLMPVLGIVQGFQPIVGYNYGKGQLNRVSESIKLALVGTSGLCLLGFILVMIFPEKFIQIFITDPEVISQGVFATRIFFMFSFLIGAQMTIGGLYQSLGKAKPAFIISCARQTLFLMPALIILPLFFGLNGIWFSFPIGDLLGFTLASGIIFKDRKSLNLSS
>fig|267377.1.peg.733 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQVKKLENEKINNLMIRYVIPSIAGTVIIGIYGIIDGIFIGRTIGAEGLAGVTFSFPVLIAISSIGVMIGAGSSAIISISLGKKDYKKASCILKTALTYIILISLIITCFGYLLIDPVISFMNLSKNLESYVVGYSKIIILGAIAQIFAISLDPILRNDGFPKKSMIILALMSVFNIILDYMLIVVFNFGVMGAAAATVLAQGLGSILYLKHFLSGKSNVKIGKNSPFLEFSLIKRIAKTGFSPFIMELAFGILMIVHNIQFMRYGSSLDVSAYGIVIYITSFLYMVYLGISEGVQPLISYNHGAKKFNRVFEILKKAVFVNAILGICSFLTILKFPNLLIKIFNPHDTNLIATTTIGLEIHNFAILIMGVSMVLMMYFLATEQPKIAGFLSLGRTLIFILPAIILLPIYLGIKGIWWATVFSEYLSFIITIYFITKEFKKIKYEKIRG
>fig|267608.1.peg.614 Permeases of the drug/metabolite transporter (DMT) superfamily
MLLGTIGVFVHQANAGPLTATWFRCAFGLLGLTLWVLLRRQTGFLRLTRATGPWILSAGVLMVLGWGLFFTAIERTSAGVAIVLFHIQPLWVLVLGAWWLKEPISRRRIGSVCAAMLGLVLATGIPEHTALFGASEMLRPGDWLGVASCLIGAFCTACVTLIAKRLRDLPAGILAWWQCAVGTLVLWVWPMEHGWPAWGMAWMWLAGLGLIHTGLAYTLIYVGMARLNTGRIAIFQFAYPAVAIVIDWLFFDQRLDGAQLFGIALMSVAIRFAERAPKAGVPRGMTGPHSASR
>fig|267608.1.peg.3573 Permeases of the drug/metabolite transporter (DMT) superfamily
MRSRMPLANRASRTFEPTILTRSQHPLQGIAFLIAAVAFFAVFDTLTKYISITVPVVMALWFRYLFQMVATGATLLPSRGRSLLRTRRPWLQVVRGLLLLLVSLFSFLSLRRMPVGDVTAIVMLTPLVVTFVAAVSLGEQVSATRWIFMAGGFFGALMVIRPGGAAFDWGMLLPLGMVVANAAFQVVTSRLANVDEAGTTQFYTGAVGALLLTCMLPFGWQALGGKWWWLLILIGIVSSSGHALLIMAYTRAPVAMLTPYLYMQIGFAMIGGWLVFSHVPDGWSVAGIAIIAMCGAAGTWVAARERRMAMLVAVDV
>fig|267608.1.peg.3881 Inner membrane component of tripartite multidrug resistance system
MLLAAILSGLNNRVPGLALADVQGALGFAQDDASWLNTAYAAGELAAMPFATWFAVTFSMRRFHLAMLAGALVLSAILPFVQSLSLLLALRALQGLLSGALIPMLMMSALRFLPPPIRLHGLALYAMTATFAPNVALWLAALCVDRLEDWRWVYWQAIPLGLVAMGLVAWGVPKMPPALSRLKQGNWLGMALGVPGLALVVAGLDQGVRLDWFHSPLIVAALGVGIVLTALFLASEWRHPAPFMQLQMLGRRNLGVGFSVFVCLLMTMATAVTLPASLLGRLQGFRMEQMASIGLIVGLPQLVLGPAVALLLYQRWVDARHVFAAGLACIAAACWLGAGITSEWMVPQFMWAEILQAIGQPMAVIALLFLATSVVQPMEGPSVAGIVNTFRAFSSVLGGALIGQLTTVRSHFHADMLLDHAGHLLPRLPPSDPGALTLAAMVAQQAGVLAAADVYRVFGWLALLLIPIVLKLQYIPAPAQTRTPQATPPAGTQTGTAH
>fig|267671.1.peg.58 Drug:Na+ antiporter of the multi antimicrobial extrusion family
MSRKELNTLLPKDLSISIETRHKFYKLTFYNILANITVPLTGIVDTSILGNLNTYVFMAGAALSGILFDFMFWMFGFLRMGTTGLTAQAVGEKNEKESIFILVRSISLACFFGAMILIFSPWIREIGFQILEGSSEVKMAGISYFDARIPGSIAVLCNYVFTGWFLGRGKSSVVLIATVVGNGINVILDVWFIFKLGWEAYGAGLATSISQFGMLLIFIFLFFIELKIQNISKFLFLNNKNLFSVQGFSSLLHLNKDIFLRTFFLIITFSIFRNFSSEAGTEILATNSILLQLILVSAYLVDGAAFATESLAGNIYGKKNWKLLKELLYLAFYNSIFFTSIFLGSVFLFPNFIFGMITKSDKVLSLLIDYRFWLFPVLEVGAIAFILDGFFIGLTKGKILRNSMLISTAFFFFPIVYLGKIQKDNHLLWLSLVLFMVGRALTLSFQAKKIFENSKLQNVN
>fig|267671.1.peg.474 Acriflavine resistance
MNENRLPSKITTQMIIGAVLLFGVISAFMLNYSLFPVVKNPALSIVVDYPGTDAETVENTITIPLENQVSTIGGISEIRSTSEKGKSLIRLDFENDTNIDVKTLEIKERIETIINTFPKEVRKPRVLNFDPNEMPIAVISLNATDSRSLGELRAFADSIVKKDIEGINGVSKVTVSGGKIKEILISFDIRKLNSYNIRLADINEAIYFNNRTSTIASVEEKGGLYQVRLKGKFSKLDDLVDLPISSPDIGKSITLGNVANIQNSYRDEDSTYRVNGNQNIGIYVYKKYDANILSISSEIKKTVSHLSQDGTKFDLLYNQADNIRNTYFNLICIIAVTIAILFFAAKKKGNIDIPKFIGTILSQLILSFLLISFIHFILKKDFDLLCVLSIYLSFAIWIVFYFNFIQNHTIDSIGEKKLLLFITPSIPILFFPGILLNNTVAVNLIRMAIMTSIGVLNNYIVYKYFYQNLSTNKLDKFPTIITIPEKSKTQSVLYEPQKNKRDLILNFLLIIVPIVMIFALIQSSKEVYFNVEDDRIYGYVELPADSNFEYTDEIVQKIESKLVANPNVKDVISQVEPSHAFLIINYHKSFFSSDSIIPSLNQSVGRQNPAFCYFTKESDLGRMKEVSLDIVGQSHSDLNKSVPKIANLITNLPGIHEVILNFKQPRNELQLDLNNRDPLLQNSEIGSFLRTVVQGSVISKYNENNNELDIRVRASKEFRDSEKQLNKFLIKNNSGEFSSIGSSFTQRETLSPIKFFRKNKRPNLSISVRTDSYNPNTLLKLVQNSSQTLLNNNERIELNHRIEKLSKSNTNFTVYIILILLTCFFFFIIYTESLKTSFIYFCSLLFFYCIFASIYLIIFKTYDIGFHIGSVIVLISLLLHILSNFPEIKRQNTIPINWDFYLVAIALFLPLLILSTPELNVFKKVFGLFMISLILSRFLLIHFNFRFANVFEKVLSTNNISKISGGKNVRR
>fig|267671.1.peg.475 Acriflavin resistance
MKSVVRFCVSKPITVLMAWFAIIIFGIIGLKNAKITLLPEIVFPKISVITGYPNASPEEIENLITKPLTDSIGTVGGIEKVTSESLEGISIITVQFSFHKSVDFAMIELREKIDLIRDQLPQDASKPIATRFDPAQSAFQEIIIFPKNESDSKSLKSFIEENVKVFLERIEGMAYVQISGGFEKEVRVEIDPERMTTYGVSIPEIQKSIVSANINVPAGSLPVGNKDLLLRTVGEYKSLEDIKETIIATNNTGIPIPIGSVASVYRSYRERTGLARYNGKDCIVLYLYKESGRNSVELADKVTKELESINTTFADKLSAQLVYDESVFIRDSVWGLVWSLILGAFLAFLILMLLIQSFRAPLILLIIIPASLLATFLLFYIFHISLNMMSLGGLALGIGMLFDTSNVVFSSIERNLTKRKSILESSIEGTSEVAGSILSATLTTIIVFLPIIFIKSFIGILFSEMAIAIILSISISLFASVTIIPTLYVLFENTNFDSKLIDHPIFAKSADLYQTALITYEKKLIEYLERPKKLFSILLTGIFFSSIFLFILPREFMPTVDNGEFTINIENVPNSTLNSTTGIAEVIEKILLSNKDIKSVISKIGSDNDDFIAKVNGNSGTNIAKIRVILVSNPKHTTTEIIEEVRRRISFTEDIRINFDANGDIIGKILDPNGSRLNLEIHGEDLKTLSTIGKNLIDKLKKEQVATDLRNSLETKKNEYVIEFDPIKASSLKLTNDYISQYVKVASYGSNISKIKYQEDDLNIRLLIKKDSIDNLNKLQNLNIKTPTGEFIKLSQLANIQENTSSSSIKRSGNSRINVVQGNLNSNKSIDSIIQNMKLPLGYRIKIGGESENMEKSFKELLFAFALASILIYMLLSSQFQSLKLSAIMICTIPLMFIGIFPALFLFGKSFNISAFLGLVLLLGVVVDNASLYYEYLIISLNESKELSKAIIESGKIVFRPILMNNLTTILGLIPVAFEFQKGAEFQSPMAIVVIIGLLSSFAFSLFLLPILFFYILQKQKFKTIK
>fig|267671.1.peg.956 Permease of the drug/metabolite transporter (DMT) superfamily
MFHIRHEIYLILCTLIWGGTFTMTIFGLRDTSPSIFLGLRFGIASMIFLPFAWKEFRKGKIWYPGAFLLGMFLYLGFACETIGLKTTTATKSSFLIGTLVVITPIFEAILKKRMPGKGNLLGASVVFTGICLIFAGEIGMEGTLTITNGDWITLGGAIFFSLYIIQMDRVSIQIPIRISVFYQSFVAGFFALISVIILHFVGIEKIRLNPSARLIPGVLYNALLASVLTTFLQTKFQRYVSPTRVGIIFSLEPVFSSIIAFLLLGEKSGPVRIVGCTIVFLGLILAESIGKDQNLSMENTN
>fig|267671.1.peg.2318 Drug/metabolite exporter
MDFMEVSESKWKPFLGTCIVLIGAIFFSAKAIFVKLVYRYDIDSITALTLRMLFAIPFFAWIAFRSKNTKTSVNLTKKDWGLIFILGFLGFYLASLFDFIGLEYISAGLERLTLFVYPTIVLIIGSFLFKRKIKKAEVFAIFLTYSGILVAFIGDIQTEGPNATKGVLFVLASAISYSLYLVGSESLIPKLGSVRFTSYLMLISGLIVVIHFFIVRNPKNLIQPPNVYLYGLALGILTTVIPAYLTTEGIRMIGSGRAAIIGSTGPISTILLAWIFLEEPITSSGIAGTILVLTGVLWIGRKKTDLKND
>fig|267671.1.peg.2514 Drug proton antiporter
MTQTQIKHDPFQALRISDFRSFLFGKFTVTLSISIQTTVVGWQMYHLTGSNLHVGFIGLAEAIPSISMALFSGLVIDSFPRKKIVVSALCLLSICSLLLLTLVIPNINWILRDFGVYPIYAVIFLSGIARGFLNPATAAFQTQLVDKETFPNAATWSGIAWQTSLVLGPLAGGVLIVLGLYFAYSVDLILMSLGLIMVLFVKGKPVPSKPESSESIWESLSGGWKFVSTHQIILGAISLDLFAVLFGGAVALLPSFTEKILGQSPEIFGILRSAQGVGAVLCAFFIAAKPPKKHSGWILLSCVFGFGICIILFGFSEDYRISFLCLAAAGAFDMVSVVIRHTIVQMHTPDHMRGRVSAVNHIFIGSSNEIGEFESGVTAEWLGIRRSIVAGGILTLLTVGLVGAITPRLRKMQLKDIL
>fig|267747.1.peg.170 Multidrug resistance ABC transporter ATP-binding and permease protein
MTGKDAQQAPTRNEQAEIARASSQQGHRGSQVTEKPISFGPSLKRLLGQLKPHRITLTIVVIMATISVAFNVIGPKILGRATDVIFGGIVGKQIGKHIPAARGMTAETFINTLGQASHGGDRGKIITLLQQYPHVVIGSGIDFHRLGVIIGWALGLYACAALLMFLQGFLLNTAIQRSMYDLRRQVSAKLDKLPLSYFDGQPHGELMSRMTNDIDNVSQTLLQTLQQLLNALLTIIGALIMMFWISPLLAVISLVVIPIAGVIAGLIGKRAQGQFAQMWKATGELNSRVEEAYSGHALVKTFGRSRAVAQEFHERNEELRQATAKAQFVSGLIQPVMFLLGNANYAIIVLIGCLRVAKGQMPLGNVQAFIQYSRMFTQPITQIASMANLLQSGVASAERVFQVLDADELSTDAHGSLPATKGRVVFDHVRFSYNPDKPLITDLSLVAEPGQTIAVVGPTGAGKTTLVNLLMRFYEIDDGTITLDGVDISAVPRAELRSRLGMVLQDTWLFSGTIHDNIAYGCPEASEEDILNAARAAHVDHFVHTLPDGYDTIIDDDGSNVSVGQKQLITIARAFLAAPDLLILDEATSSVDTRTEMLVQEAMANLRKERTSFVIAHRLSTIRDADLILVMEHGDIVEQGGHSELLEHQGHYYELYQAQFAAASHE
>fig|267748.1.peg.350 Unspecified toxin/drug ABC transporter ATP-binding and permease protein
MLFKYMKIKVQNDLKECGLVVIQSFYKYYFKTWLDINFLKAISKFNQKGLSIYDLNLLAKQINLKTTSYEIKYSDFQNLKITKPIIVLLKENNYIHFVIVEKKSNHNYLILDPIEGKYFLDEKSFEKMYLNIVIEVEKLKDLVIVEKVKSNFKLEIKNFYTSWNILLSIFMLIFSFCFTFLLKIIFEEIFPSKDENLLWQIIILFFWISFLNIVLNLIKKLIISKTINKLSKLNLGIYFQKYNTLNLNYSNKITNIDHLKRIEILDSYINFKTNLNYFLIVEFINLIASSIFLIYINWEIFIISFCVGFLILNTNFLFNKILKNNYVKIQKSNINFSTSIIDKIYSKQELKNSTQNQFLDNKINEFKIELVKSNFKFLLKSNFKEFLLKTISSLSSILIIYLMSLRVINNSISLGELLLFLSVFNFFLNPFYSFSDLISEIPLQKENKKILDFILNGQFEKNYSQKPIEKINSISLKNFSFSYTSEQEIFKNINFYFEKNLQLKGPNGSGKSTLMKIIALSNLEDFSKILVNDLSVDNYDIDSVRTNILYLYNDFYFFKSTLIDFVTLKNLDYLNTFNSNIIQFNLMEFLDRLNLNLNTPIESNGINLSSGQKQLILLLRLFVKKFDVILLDEVFENLQSSIFYEISKIIKDYQNQAIFLEISHNENFLYKGNELYI
>fig|269483.3.peg.31 Permeases of the drug/metabolite transporter (DMT) superfamily
MNGNERFAGIGYGLLAALIWGGFPVVTRLGVTHSALDAYDIAFIRFVVSGTLLLPVLLRSGLGTLRPASIALMVIGAGAPYILTVAAALGHAPVGYFALTPGSMIALTAILGRQVAHERLSAAQVAGIVTILAGIALAASDALRGAIGLPALVLFMLGGLLWAVYNVTTKRAGAGALHATAVVSVGSAVLYCPLYLAARGGAVLHAPVAAIATQAIYQGVLMSVLALYCFSQAVVALGPAIGATFAALMPLLATLEAMLLLDERPHAPALAGIAIVTAGMAVSLASRWRTGHAPAIRRLNSAAHG
>fig|269483.3.peg.193 Permeases of the drug/metabolite transporter (DMT) superfamily
MQLFLLQLVFVLSWSSGFIGAKLGAETAGAFNLLFWRFLLVTLCLAIVLNRQLGRLTWEKLRYHAVIGFLSQFLYLTCVYIAIQHGLPPGIAAIVAALQPLITAAMTSLEGSERSGARQWAGLVVGFVGVGIVIGGQYALPAGSVGLVMYLLPLVSALGLSIATIYQRRRALTAARSNEDGLFLPLFVQGCVSLVLFAACGIGTGNLHVPTQPNVWISVVWLTVFSTFVAYLSLWALLKRMPATRVATLVYLEPPVTLMWAAWMFGDRIEVTTYLGIVVVAVGVWLAGKHVERPARARRANMEAAGR
>fig|269483.3.peg.553 Bicyclomycin resistance protein
MSHFSLILVVSLLSAFGLIASDVYLPAMPSMAHAFSIGAWQMPQTVSAYLIALACAQLFYGPLSDRWGRKPVLTVGILVYILGSIGCASASGFASFLGWRVLEALGAASGLVIGRAIIADTCDKHASAKVYSIVYPLVSLSPAIAPAIGGYLAAWFGWRSDFIFVAAFGGVALVLVQLLLKETRPPVTPGQQRAVPLAGFADVLGDRAFIRYTLVVCAIYCAWFVYLTQSPFIFSGLGLSEQQSGWLYLPLTAGIISANLLSRRMLDRMSYDAIVAAGVGCFVAGGIAFALCESSQVKGIIAIVMPMFLVSLSNGSSLSLAVSGAIASEHGRAATASGLVGFFQIGSASLAATVSSSLLGTGSHVLATAMPFFAIVAAVAIVPRWYAARRTLSMRKAQPR
>fig|269483.3.peg.934 Drug transporter
MPRYRRAALVLAACLGTFLATLDISIVNVALPTLQTALDTDIGGLQWVVNAYALALSAFMLSAGPLGDRYGHKRVWLASVILFTAGSVVCACAGSIEPLLIGRAIQGLAGALLIPGAMPILTHAFPDARERARAIGGWSAFSALALILGPLVGGLLVEHGGWQNIFLVNVPIGIVTVLLGAWGIPERRHPQHAAFDPLGQVLSVIWLGLLTYGLIGIGEAGAWHVKVLVPLAGAAVAFVAFVQVETRVERPLLPVWLFRDRRLVRANLASFVLGFSGYSSLFFLSLFLQQAQGRTPAEAGWQLMPQFVMTAITSMLFGRIAARIPLHALMVAGYGLIGAMLAVMAGFGAGTPYLPVGIVLAVLGVGMGLAVPATGMTVMELAPAERAGMASATMNALRQTGMSMGIAVLGSMMSVGALHRMTGAMQAAGSAHADTLARQAVMEHVFAAGRPALLGAYRDAMAYGFSIAVLCSGILSILIAAMLMMRRETKQQSGRAAACVTSSQPE
>fig|269483.3.peg.1004 Permeases of the drug/metabolite transporter (DMT) superfamily
MNNATLAMPGANAYGKGVAACVAATILMGVMFPVMTDALRTIDPFTFTSLRYLIAGAGFIALLRIVEGPGAFSSAGEPVALAWLLGSIGFCGFGSFVFLGQQLAGDEGALTASIMMATQPMMGLLLNALVRRVAPAPVSVLFVVLSFTGVALVITRGDLIGALHEPQHYAANALIIVGALCWVVYTFGAARFTRWSALKYTTFTTWLGLTTIVAVNLVLIVTHRIAAPSLAAVHAVLPHLVYMGPVAGFGAILLWMTGNRMLGPMNGTLFMDIVPITAFIVSAFTGLVPNHAQIAGAALTGTALILNNLYLRRRARRIDTAPARVPSASA
>fig|269483.3.peg.1691 Permease of the drug/metabolite transporter (DMT) superfamily
MNAPAPPAALVATRPHAAIYVKLTLVALFWGGTFIAGRILAASMPATTAATGRFAIAALLLVVLTWKIEGGLPKLSSRQVVTTFGLGATGIFLYNVCFFAALARMPAGRTALFVALNPVATAVLLSIVVRGERLSLSRWAGIAVALFGALVVISRGELLRVLTDLGNTFGAGERYMLCAVLSWAAYTVIGRRALDGLSPLAATTYAALWGLALLIVAHLVGSPAGSTTPLTWQAIASMLYLGAVGTVVAFVWYSQGIRELGPARAAVFTNLVPVFGVLLSVALLGEPLSPSMLAGGALVIAGVALTNRARR
>fig|269483.3.peg.2411 Outer membrane component of tripartite multidrug resistance system
MKKLLVALAVSALAAGCAVQPAQHPALQDSVRTLAPDGWDTDVPRADIDAAAWWAQFRDPVLDRLIATVLNDNLDLQAAAERVKQAQALTVQKRAVLLPELDATAHAADARQNTPPPLGYVRQAGAGLALSWSPDVFGGERLDLLAAQAELVGQKHAEDAMRLALAADAASAYVDLRWAQQELKILQDNAKIRQHALELTRKRQAFGLSTELDVTRAQNQLDALEARIPPTQAQVSHQLNLIAVYSGRTPESVDRLVLAQAGEIPAPPVGSPGTLPSQALLRRPDVLTAYAQVERRAAQVGVAKAERYPKFSLNLTDGILAASYLGLPTLTDNLFSAALSATSPIFNAGRITADITQSESRMRESELGLRQTMLQALREVEDARANLVSSDEASRRLGSALAASDKALGLANQLYKGGATDFLDVLSAQEVYLRDSDSLNQVKREHALAAVALYRSLGGGWSRNEAAGGPEVEAVAKN
>fig|269483.3.peg.3014 Outer membrane component of tripartite multidrug resistance system
MHASSFPPVSFRSSVAAALLSAAMLAACSVGDPYRPPVADAARAAPFDAAADAPVASGGTLPDRWWQLFDDPVLDALVREALAQNRDLAVAAARVARARAVLDEAGAARLPDTTAGFGVDYGKHAPDQIVASAKGTDARTRWGFAPSFAVSWEVDLWGRVGHLVDAARADSEAVQAASDAMRVAVAAETTAAYAQACAYGERIDVAERSVAIADRLAALTARQRAHGLVSDLEVARSRAFADDTRAELPALAGARRAALVELAVLTGHAPGAIPDAAARCHATPALARPFPVGDGAALLRRRPDLRESERRLAASNARIGVATAELYPSIVLGGSVNWLSTTGDPSSLGDKYAIAWGVGPLITWRFPNLAASRAQLAQARADDAAARASFDAQVLRALKETEQALARYGAEWRHKAALDTARAEHARAYRLAELNYDAGALDFLGVLDAQRSLVAVDAALAASTQQVALDQVAVFKALGGGWQR
>fig|269483.3.peg.3193 Permease of the drug/metabolite transporter (DMT) superfamily
MAFPTTPDPCQDINPSNAMNKSPFLFPFCAIALWAGNVVVSKLSASTIDPSAITFYRLLLAVALMSVFTLRPAWRNRAALVAHLPKLAVLGFLAMALFQSLSYEAAKTTSATNMAIITALVPLMTMALSSLLLGDPPSVGMIGGGVLSLAGVVYLIAEGHPTTIAARGVHTGDLLMLAASAAYALYGVLLKRWRIGALPAWQSTYVQALAALVFMVPMLLRLPAQAAWPTRASVPLILYAGVLASVVLPYLWMQGVRLLGPSRCAMFMNLLPVMTAGGAIVLLGESLKLYHLIGGGVALVGVAIAQRFPFQASASQGVRQ
>fig|269483.3.peg.3764 Membrane fusion component of tripartite multidrug resistance system
MPPPAARLSEHRMSTEQFASSNLQRLAGFIGGEVRPYPGRMNVMLRCLLTSALVIVTSMALQVPLLPVSLIVVFFVTQSNVVVTRLTGVLFVVGSTIAVGSTILVLKFTYDYPLLRILLAGTLVFLSVYMMRVAKIGVVFFIVGLTVIYGQTFVDSTDQAELLVRAELWAWVAVTYAIALTLLINTLFLPVEPMRQLCSAMGGQLKAIDTSLAGLEHWALVASAPGAYEIQVGALTLKKLLRFATMRDAAYRANQALHLARVATVSRLYAATGHLPASSAGLTVDAIPVLRDAIQRLADAVEADGQFVAPGALIDLGGDGLPGALAEMRDALLEFSGRSAAPQGVQSPAEKERLLVPDAVTNPVYAQFALKTLMAAMISYLFYIATDWQGIHTMMLTCLIVAQPSLGSSVQRAVLRIGGAAVGSVLALAMVVWVMPHLDGVVGLLMMVLPVIALAAWVSAGSEHISYAGTQIMFTFSLAVLEQFGPAINLTEIRDRMIGILFGVAVSAVVHACLWPEAEGEALRQRAAKLLRRIGAQLRSDGTGPIPVTLWAELSDSEAMSARVALEPGWQMADGEQESLTLRMQTLLARVREILLATDAFGAERNAQKLPGGIATATTAFQAELAGLLDGYASALAERPLTINAPPCASLAALSDCCAAELSTLPTDALRAAYDRLLTRASNLAVQVAGLPAWAPGSVGTVLTSRAS
>fig|269483.3.peg.6041 Outer membrane component of tripartite multidrug resistance system
MKRASALIAAYALASCTIVPRPLVPVPVGHDTFRHAGTPLAHEAALTDWPALFGDPQLSALVDAALTHNNDIRAASARIDQAQALLGMHEASLLPSVTVDPSFSRARVSGTVDNALPKRMMHNWSAPVTASYEIDLWGRVRGDVDIERENVLQAIADRDAVRLRVATDVASDYLTLHYVEQDLNALTRVIDLRYTALDVISARVRAGAASDLDSLRAAADLDTARADLADSQRTRENLIDALAILTGVSPTAIAIDPTAVNLRVPDVPSGLPSALLGHRPDVFAAERRVDAASLELGIARKAWLPTLSLTAQGGFASRDLRTFLDRNSSLWSFGLSMAETIFDGGKRDAAVAAAQAGVTVADANYRSIAIGALREVQDALNNIASEKERIARLDSAARTTEAAARLSVSRYEHGYVSYLEVIDADRDALNAQRQWIHSRQAYSVATVSLVRALGGGWIPPVPADAR
>fig|269483.3.peg.6042 Membrane fusion component of tripartite multidrug resistance system
MVTQTPQDTPSEPPERGRRLPIVLIAMFAILLVTVLIYEFEVRDLSTDDAYVTGHLHVISPRVSGTVERVLVNDNQFVHAGDPLTLLDPRDFDVRVALQRSRVAQAQSDAARARALVEQAVATRISAQADADKAELDYARANELTRETPRGLSKQEYDAADAARKSARARIVAADAQLRSTRAAAQAADAVSGQNDAELRDALLQREYTTVIAPSDGYVGKKTVETGEHVAPGQALLTIVEPHPWVVANFRETQLRHVRVGEPVRLHFDALPDVEFVGHIDSQSPATGSQFSLLPPDNATGNFTKVTQRVPVKILLDGRAAIEPRIHPGLSVVVTLQRGRHSP
>fig|269483.3.peg.6043 Inner membrane component of tripartite multidrug resistance system
MSTMLVAGGGTPEASPVPGATVPPFRSIAAIAAVLFGAVISTLTSRITSLGLADLRGALGIGFDEGAWINTAFIASQMFIGPLAIAAAFLLGTRRVLLAGAVVFLVAESVLPLCPGFGSLIICQSVAGLASGVFVPLTVGFIVRTLPSRFIPFGIAAYAMNLEMSLNLSATLEGWYSEHLNWRWLFWQNALMTIPFIVCLLLSLSNEPIKRFASGADYRGMLLGASGFTCLCIALDQGERLFWLESPLIVTLLCISIVTISTFLVHELVSKQAGLNLGYLVRPNVLLLMLLVGLVRFTVLNTSFIPSLFLASTYGLRPLQIGDTLRWIAMPQFLFAPCVALLLQRFDSRRLIVIGFVMVAIAFALGSRLTSVWAEPDFIPSQLLQALGQTMALTSVIFFFGKHVTAEHALTFGAVVQTTRLLGGQLGTTSIAVVQRIMEATHSNRVGLHVALSDPVTLERLRVGAASLVTHGATFATGDSGTYVLLDRAVRVQATTLALADNFRVAMTCAMVGALIGMMLRPVRAPRSS
>fig|269483.3.peg.6523 Permeases of the drug/metabolite transporter (DMT) superfamily
MNDNARKTGYLIMATLCWGIAIPFSKMVLPALSPAWLIVLQIAASVAVLACLAAVQRVSLQGIAPAQIAVVALIGMLEPRGAYYLGFVGMQSTSALHTAVIFALEPLGILAFNIVLFRFRVDGRLLVAGVVALMGVVVITLGDASADGHASLRGDAFVFAGVMVAALYVSLSTQAVTLPSATAMLLIQQAGSLLLALVLLGIDAGGSGPHRLPAWPAVWPALAIGVLQFTLAFLFYFRGARDNASYWSVVVLNLIPVVGIAASILILGESASPIYFVGGAITIGAALYTHLRERRSEPGPARA
>fig|269796.9.peg.245 Probable multidrug resistance protein norM
MAGNLDVLTLGTVATGAALWVPMMIFLLGLLYGVTPTIGKMLGENASEAVSGVAARGLLVGLLGGALLGALLFWMSTPLFRLFGVAPELIPEASAYLNWMALAMPGMGLFLAFRFVIEAHHVGWIVTVVAVLGVAAKIWLNDALVHGHAGLPALGTGGFGAASVALYWGMAVMLAGATFLHGAVKPLWTHRLSGADLSLAAIGRFLRFGLPIALNFLSDYLIMAVVAVFIATLGAVAIGAHQITFNILMVLLMMPTGLSMAATILISRSPGGGHTATLGPVMSWTLGIGVAFSIVLAVLLAAFDAPVIRLYTDDAEVIALALDLLGVVVFILTIDVVAIALGFFLRGLGDPGSPFLILLAAHWLISLPVGYVLCFTDWVVAPQGPLGWWYGLSTGLLVACCLLGLRLRQRLSRAAQPVCSPAEATVAGVAE
>fig|269796.9.peg.267 Permease of the drug/metabolite transporter (DMT) superfamily
MSQPSALPAADSLAALHPGFKSSALVWLGVMVALWGFSWPVMKICVGLAPPLWLAAIRFTSSGLCLFAFLACRGELRLPPRADWPIVASVGGLQMMAFTGLGLVAMQYTDAGRAALLAYTTPLWAVVTAWIAFGQRPTAAQGVALCVGLSGVAVICSPADMDWGDSTVLLGNALLLLSAMCWSFVILHVRRHRFTARPIDLAPWQMLLAALPLIVIAASVDGSPLTIAWTPELIGFLIYFGPIATSACFVISSEYGRRVSAFAMSNITLGVPVIGMLSSIFLLGERVTVPLIIGLTLIVSGVALAALAVNRKAAAGRADTALRSQAGKANWPTA
>fig|269796.9.peg.387 Permease of the drug/metabolite transporter (DMT) superfamily
MSAPASGFSAPRSPKAPVDWAPWMVLISTIALSFKGISAKYAYDAGMGVGMVLILRFVLAAPFFWVGERLLGAGRPRLPLGWAEIRPCILAGVLFSVATYSDFSSVQLIGAGLSRVILFTYPAVILIIGAFSRRTWPARRQMLAFAITYLGLLIIIVPSVGLVAVDVMLEGVAMSLLSSVTYGSFLVYSQSLTGRLGSARFTAISNTVTMLMIVPFALAMGGDLTIPNTTALIWAVVIATVCTVLPFFLLFEGIRRWGAEKTGLMTLSGPALTIAMAWVLLDETLTPLQLIGFAVVMAGVGALQGVDRPLLRLLRRGRRAEA
>fig|269796.9.peg.590 Permease of the drug/metabolite transporter (DMT) superfamily
MSVILFCVVVLCWGFTWFGIHLQLGTIAPEVSILWRFLLAAIVLAFGLAASGRFKPAPLAHHPWFALLGLCLFSTNFVLMYSATQYIASGIVSVVFCMATVFNAANQWLFLKRVPAVRTVGGALIGIAGIALLFGESFLHVEASADTALGVALALGGTYVFSLGNLVSLRATASGTDLPNAVVRAMAWGSVFLALFVLARGVPFAMDWSARYVGSLLYLAIPGSVIGFTAYLSLVSRIGPDRAAYSAVLFPVVALTVSTLFEGYQWSAWAMAGLPLILIGNLVIFARLPARWRRAAA
>fig|269796.9.peg.731 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSARHAAQQVNPFLTVPIGRLFVSNALPMAVVMSMGGVLNVVDGIFVGHFIGSDALAAVSLAFPVAMVLSALTTLTGGGMSSLMARYLGAGDRGAAGRIFAETHGLVLAISVGLVVLWAVVGAALVDSMAAGNPKVAGLAQDYLQIMILGAPAQLMLGVHADALRNEGRAGLIAALSVLVNLFNIGANGLGIVVLGLGISGSALGTVAAQALGLALVIGVRGHSKGLLPLSVLRARNWLGAWSQIIRLGLPLCLSFIGIAMVASVVIVSLRLSAGTDYNALVAAYGVVTRLLGFAFLPQMAIALATQSITGNNAGAGRTDRARAALRLALGAAFLWCLPVVLAGVFAGTTLGSWFSDDPAVIDAVAEILRPMMLFYAASGPVLVLALYVHALGQPGRTAALTLVKPWLLTPLLILALSIGFGVSEMWLAFPMADAIILMLAVMIGRNVLHTAGTRAAHAEEGA
>fig|269796.9.peg.915 Outer membrane component of tripartite multidrug resistance system
MNMAFLVAPSLIALILGGCAPWDGIDRQSAMTDAKTLALSAPSDPIPEVAPWPEGEWWRGYHDAQLNQLIGEALAGNPSLKVAQARLRRAGALAGLAEAALSPHLDGGASIIDQRFNEGGLYPDSLAGKVKTENKIALEGAYTLDLWGGREAEYRSALGELRASEIDAQAARLDLAAAIAQSYARLAAAFDQRDISHEVLRQKQEIQALTARQVRSGLVTEVETRQADAAIAAARADIAGDEERISLLRRDLAVLTGAGPDRGAAITRPGLSMRAGVGLPSTLPADLIGRRPDIVAHRWRIEAATRSIDAAKARFYPNVDLTAFLGFKSIGLANFMTAGSFMAGAGPAITLPIFDAGRLRSQLAEANATLDITVELYNGAVLEALRDIVGSLTSWRANQARLAEKSLAVASLEEAYRLALLRYREGLANYLTVLSAETALIAERRQEAEFRNRQYGLSIALAHALGGGFAPQGPPPSRAASGDPAPRAPL
>fig|269796.9.peg.1952 Permeases of the drug/metabolite transporter (DMT) superfamily
MLMVCGAFLLVGSSVVASKVVTAAFPPFTATAVRFAIAVGLLIPWMVLSQGWPAWPGRRAVLALGLQALTGCVLFSVLLLEGLRRSGGVEAGLTLGTLPAVVALLAVPLLGERLDRRIGVAVLLAAGAGALLHGGKGAGGSGWLGPVLLFGAVVCEALFTLLGKRAVVHLSPVVTATAVSFASLALSLGPALTEQPLAALSSAPAAAWLGALWLGAPVTVGGFVLFHAGVAGTSGGAAGVASALVPLSAAGLSALLLGEALLPTDLMAGALVLGAILLLALPTGKAG
>fig|269796.9.peg.3389 Permease of the drug/metabolite transporter (DMT) superfamily
MDLGYLKSKESGFIAGMILCTAFMGSSFPSGKYLISEEAMPAFYAGGWRFLLAGGLILAFCAAKDGLGAILPASGGSVIKGALFVLVVGCLQTAGTMGFLNLALTTLSASMASLLLFTNPLWVAILAHFALGETLSWHKVVALVCGILGVSLCLGGGADHGLGGIVIALAGSLCWALCTLISKKHKFDKSVFVFTGWQLTLGALVMLAISKLSGEAYDIDRITGWGIACFIWLVGPASIGSFGLWFTALSRRGATVTSSYLFLVPLFSAVFSMMVLGEAVSPHSLIGGAIIIVALWLINLPQTVSAVWRERLGL
>fig|269796.9.peg.3484 Permease of the drug/metabolite transporter (DMT) superfamily
MVDPAVSLVWRFGLASLIMVAWALARGQSLRFSLRDHAWLALQGISLFCANYLLIYTATGLLRSGLVAVACSTIVAMNIVLGAAFFGQPIRPRVAAGAGLGLVGITLVFSPEFSHLSLGDEALRGFVFCLIGTAFASLGNLLAGRNQRTGIGVLAGSGLGMGYGALAMALFAALSGKAFLIDLSLPYLGSLLYLAVFGSVIAFGCYLTLLGRIGADRASYCAVVYPVVALGLSTAFEGYRWSAAGAAGLALVLAGNLLILRRPGAAAPGAGSLTTSLSPRGGGR
>fig|269797.3.peg.1328 Permeases of the drug/metabolite transporter (DMT) superfamily
MENMMLWLAFAILTAFSESIKDVLNKRLLTQVNEYLLAWSLVLFALPWLVLSLFFTGIPPLKTEFWSYLIIDSILNIVANLLYIRAIKHGDLSSTVPIINFTPLFLIVTSPLILGERLNIFGCIGVLLVLTGSYFINFQVRDKGYLYPFHMLLKEKGPRTMLCVALIWSITSTMDKIGVINSSSFFWAISLNICIFALMSLFLLHNSKVDSKKINHNLKDFVFLGFFYALGWLAQMTAISLISVAYVISIKRSSTLISVILGYLLFKESNIKWRLPGATIMFVGFLVLALS
>fig|269798.12.peg.1245 Drug/metabolite exporter
MTAIPNSIQKQYLGVFLGVCSAACFSTKAIMVKIAYMYGADTVFILFLRLFFSLPLYIILAVIYSKNADMKITRIQWIWIVLLGFIGYYISSLFDFMGLSYISASLERLILFIYPTLIVVLNTLLFGSKLQRKDYLALVLTYIGIFFIYLGNTESTTENLIKGSILVFACALTYAFYIVGSGRLIPVIGAQRYTAYAMLVSTLSVMIHQGLVNGIPDLTHTSSEILWVGFAMAIIATVIPSLTLAQSIKLIGTEKSSIIATLGPVFTIALANIILKEPFTLRQGIGTAFIITGVWIVGKKDS
>fig|269798.12.peg.1339 Multiple antibiotic resistance protein MarC
MSIDWSFALVVFTGLFAIINPIGNAPIFISFVDHLDKHQQKAIALKSVTVGFIILAIFVVFGYALFNVFNISIQAFRITGGLLVLKVGFDMINSKPKDAATLVKNSEATDTGFAISPLATPILVGPGTLSTAVSFVGVGNKIENSIIIICSSAIILTITYFVFISSTTLIAKIGKEALNVVTKIMGLLIASIGIQMIITSIEELIHNYKL
>fig|269798.12.peg.1787 Multiple antibiotic resistance protein MarC
MDLIFATVAALLPIINPFSTAPMFLSLTQGDTKSYRNAQATQGVIYMLAILLVSLVGGSFIMNFFGLSMPGMRIAGGILVAGVGMKMLKPNDEIETTEAETKEAENKKDISFTPLAMPSLSGPGSISVVIGMSSLAKNISDYCYIALGIIFVACVVLLVLRSSVGLVKVLGVNGLHAMTKIMGFLILCVGIQFIIHGTMDILTGNEMLEFLKKVHQNV
>fig|269798.12.peg.2075 Multidrug resistance transporter, Bcr/CflA family
MRHTQNRHLITLILGMLATVSPFAIDFYLPAFSQIANELGTTTARISLSVSSYFIGMALGQLLYGPLLDRFGRKPPLYAGLIIFIIASIGCCFSTGVEMLITLRFIQALGGSVAGVAAMAMVKDFFPPEQNHRIFAMLILTIGLSPLLAPSIGGFVATAFNWKFVFVLLALIALFAITIVFLFLPEGQEPDKTVTLQLKPMAKTYLSILSDTQFFTYTISGAFAFASLFIYVAGSPIVFIDLFHVSKQMYGAIFAFLSIGFIGASQLNILLVQKFSSASIFRFAMRLQVAAGMVFSIVAWNGWMDLYTTILMLFVFLSCVGLINPNASALALAPFTKNIGSAAAMMGCSQIGIAAVASIAVGMFDAASVLPMVLSMSATACIALALLMWGEKKMAGKIVAADASKGVVVH
>fig|269798.12.peg.2312 Permease of the drug/metabolite transporter (DMT) superfamily
MNRIARAHIFLSILTIISGFNYTIAKIAMPVPIQPSSIIWIRMCCTTIFFFFFILLAKRSFFIAAEDRLRLFLCAIFGITINQIFFFEGLSRTMPINTSLIMAGIPITVFILSAIFLKEKMNWMNTLGLTLSAAGAALLLLDSKGKLNGLFIGDLFILINAISYGIFLILARQLMQKYDSVTVIFWIFLIGACLTFPYSYANYTHTDWAHLPVLVWLAVGFIVVFATIVNYYIGVDVLKDVSPAVSSMYVYIQPIFTTAIAMYFGSDKMDAQKLFYALAILLGVYLVSKSTGKKTLVDDKKGPA
>fig|269798.12.peg.3318 Permease of the drug/metabolite transporter (DMT) superfamily
MLLSIVSFSLMHLCVKAIPDIPVVQTIFLRSVFSIVFCCIAIKQAKVSVWGNNKTFLVLRGLVGMLSLICFFYSIQMLPLGTAVTIGNLVPFFTLFLAFVFLKEKIPHIKWLFFAVSFVGVLLMKGLDDELPALGIILGLCAAFFTATAHFVVRKLRDTDDTSVIMFYFPFITIPFMLPFAILQWETPDAREWLFLVLIGITTHVGQLFLTKAYKHEEVKNISYVYYLGIILSFVYGVSFFGEFISVKSSVGVGLVILGMVLNMLG
>fig|269798.12.peg.3630 Permease of the drug/metabolite transporter (DMT) superfamily
MFFWGLSWPSGKVAASYGSPVTIVLIRYIVVFAGFLPVFFFMKAPLTIHRKGIPSLLAAGLLLSAYTYLFFYGLKNGLAGAGGVLVTTMNPIMAYSIGLVLNRKKPSRNETIGLVLGLVAGATLLKIWGSLDELFASGNIYFLLAAFVWAVMSRITSKASTYGSSMSFSLWMYLATVLIMIPFVNLTDLNNILHNADQYFWWNILFSGIFATSLATSYYFYATTTLGPEKASSFIFLVPVSAAVSSWVFLNETLLLHTIIGGVLGIAAVYMINRKKEIM
>fig|269799.3.peg.3236 Permeases of the drug/metabolite transporter (DMT) superfamily
MSTLAFTLIVISAVMHALWNLLVKRSRHKTVFIWWMFVASSSLFTLTIPFLPERFRWPDPATLLLVTAGAVCFVLYHLLNGRAYRGGDLSVVYPLSQTSMVYVPIWGMSILGERLTMPGIAGILLVILGAFSVQMERLSLAEFLRPFRNLGSPTVRNALAAGFIYSLGSIAEKVGVRDYTPLYFTYFLVLIMLGLMSVNLLRPCYRPLIVAEFREHWPLILVSGPVMMASFLTFRYGLNLSPMSYAVPVRQVSILMGVLIGILFLGESCGRIRLGAALVILAGAIMIRLG
>fig|269799.3.peg.3428 Permeases of the drug/metabolite transporter (DMT) superfamily
MYSGQFLAVISAALFGISPVLCKLVIGEMSPALLAGLLYLGSGIGLHILLLFQGKKSIEEVKRLSPKKRLALLGSILSGGVVAPLFLAYGIKFGTASEVSLLLNIETVATTLIAWFVFREHVGLGVWGGKALILLGSVFVILKNDGSLAFSFAGLLVLLACAFWGIDNNLTRDIEELPATVLASIKGFGAGAFNTLLALALSTGTATVPQVAGSLLIGAMSYGMSLVLFVEALRRIGSARTSTLFAIGPFVGTFLSVLILGERPPATYWVAASLMLAGIALLQREMHGHPHTHEELSHSHKHLHDEHHQHEHAEGEGTEPHDHPHLHEPLTHSHVHWPDIHHRHSH
>fig|269800.4.peg.243 Permease of the drug/metabolite transporter (DMT) superfamily
MSLPRSSPPSALPRWRGPLLLALAGVLWGTGGFAGAFLQQLTGIHPIATACYRLLAGGVLAIVALGVSGQLRGLPRSPAVLRRVAAAGVLLAAFQACYFAAIAVSSVSLATLIAIGSVPVFVTCAAAVLERRLPRPTLLAAVCCGVLGLVLLSGDPGGDVPPGRVALGVGCALGAGAAFAALTLVNRRPVPGLDPLRVTALGCLLGGTLLVPLAAATGMTFTPTLPAVGVLLYLGLAPTALAYLAYFGGMRTTPAPVAALAVILEPLTATVLSLLLLGEVLTPTGTVGAVLLFGAILLEYVRPPRR
>fig|269800.4.peg.2011 Bicyclomycin resistance protein
MSLTALRSRTPVISAVLRAPAPRRPTSAPRPQQRPQRSAALLVFVLSLLTATSALATDLYLPAFPEIAADLGATESQVQLTLTAIMVGLAVGQLVLGPLSDRWGRRLPLLIGAAVFTLSSLASAVAPSTEVLSALRLLQGFSAAAGAVISRAVVRDIFHGEDSARFFSRLSLLTGVAPMVAPMLGGQLLLAGSWRLLFVVLALIGVANLVLVYVALPETLPRTPAAGRGTQRGSVLGALLRLQLDPRFMGPTLVMSLSFAMTFTYISAFSFVSESEFGTTPQQFSLIFGVNSLGMVLGNQVNTMLINRMDGPRRLLAGLLGALASVAVLVGLAISEQANVVVVTAALFTMMFFTGLISPNATTLAIASQPSSVAGTGSALLGALQFAIGGGLAATTGMGEGGEASLLSMSVVMLVTAAAAGAVFAGWAFLARRVPAPRTA
>fig|271065.3.peg.1585 Acriflavin resistance protein
MDQVKLDGLFAWFADNPVAANLLMLVILAGGAFGMIDVDKEVFPRFSPHQIEVTAIFPGAGPAEVEQSVCIPIEEAVHDLSGIKHLHGEIRGDTCTIGVEILPNRDREQMMALLRSRIQSIRRLPKQLENIDVLPSDRKDDDGVIWVALHGETDAFSLQRFGDRIQQQLATIPGVSRVRNYGEIGYEISVEVAPEQLRKYRLTLDDVAGAIRQASVELPGGLVKNPDGELLLRVDSRAKDADAVGSLIIKTLPDGNRLRLDQIATIKDGLEERLYTWRHNGQTAQGWEIHTEQDSVAVARQVKSTIEAMRANLPEGLRLITWWDDSQAYDERIGALLENGLIGFLLVCSVLTLFLRLRVALWAGAGIFTSILGAFWLMPMLDISLNMLSLFGFLLAMGVLVDDAIIIGESVHSRQMEGRETPLQAAVNGVKAVALPVTLSVLIVLAAFLPGLYLPGWAGQMMRPICLIMILTLVFSLIEALLILPSHLVAAVESNANPTRLQKLRTKLNQGMDRFVDRVYRPLLKIALSWRYLTVALFAALLILCSGLVASDRVRQSINPDVTKDSFWVSIQLPQSAPYSEAQALATRVENALFALRDELDGVAEAGRDANNRDNVTQMYERSVIVGIETIIWEHGAGIWLELSSEGRQRIKVENFIRDWRQRIGDIGRGKVDFIFKEGDEPYDIELMLGSDQPNILAPAVEQLKQQIKAFPGVYDVIDSAEPGKPEIHLTLKPDAERLGLSLEQLAEQVRQGYYGAEVYRFMRGRKEVKVMVRYPLHERRSLDQLKAQPIRLPNETSAPLTNLAEVDLIQGYSRIHREDRQRVLKVQARVDPTLTDANELYVLLEKDVFQTLENQFPGLNIQTGQQRQEQKALLAAFSKNTLIALLVIYALIAVPFRSYSKPIIFLLAAPVAWCGAVLAHWAVGLPLSMESLVGMIAASGIVINDSLVLLYCIRQSGDDRDPPVEALIIEACASRFRPILLAFLTTFAGFLPTLLETSAQAQFLIPMTLSLSAGLLVGMLASLILTPVCYTILDRRRSPVVPDAHATLSFD
>fig|271065.3.peg.3148 Outer membrane component of tripartite multidrug resistance system
MTDNLAKQHTVSACLLGGTLLIAGCAWFPESTQRAVMNALPEIGQTISEAQQRLPATDRWPDPAWWDIFNNPQLQTLIEASLESNPDLKATAARLSQAQSMVDAQAAELYPTVHANITFNAQRFSANSVQVKFAGENFRHMLINPLILRYHLDFWGRDKAALQAAVGRAVAVENELADAKLLLSATVAQGYFDLSESAEKLKLIQQIVRHKEALLKLEQTRLELGLVERSAPLTTGIELNAAREIEAAFRAKVDLQRHLLAALAGRGPDWGQSIAADPSLFPKRLNLPADLPLSLLAHRPDIAAARLHAEAAAEEIKVAETAFYPDVNLIAFTGLHSVSMTDVMLQGASLAYAVGPSIEFPIFEGGRLRANLTYQEATYDAAVERYNASLLHAVQEVADALTRWQEIEDRLAKHQHSLEAAQSNESLAQTLNRAGLNNRSDLLEARIQVLDQRYHLATLENERFKTAVQLFKALGGGYTENDKL
>fig|271065.3.peg.3149 Membrane fusion component of tripartite multidrug resistance system
MTTAVPQKIRPREILRKRNRRLKGVTLAILLAGLSYFAYWWYMNRDWVATDDAFVAGHLITIKALTEGIVVEVAAENTQAVQAGDLLVRLDGNHAEVALQQAKAELAETVRNIVTLKAQIDTLNHRVIARQASLATVRHDLKRYESALFEGAVSEQQVQNARDRLRELEAAISEAEAEKSGIQAQLLETDIDHHPSVEKAKSRVKKAYLDYRRSNIFAPVSGYVSNRRAHVGDHIKSGMPLMAIVPLDEVWIEANFLETQIASIRPGQSAEIKIDAYGGERLYHGTVQGLNPGTGSVFAVLPTNNATGNFIHIAERVPVRIGLDPKEIQEHPLQPGLSTLTRINISETGEPLLTSSVSIRSEFYRTTIFDNELEEAERLIREIIYKNQPNNNRLNE
>fig|272557.1.peg.19 Antibiotic resistance protein
MPSLSPGEESRIHLTTKALSLALTAFLVMYVEAVLYTSVPAIQAELGISPVEASWIFTSYLVTGSVLIPLMGRLGDAVGRRRTLILILIIFGISLLLGGSVNSFRLLLGLRAAQGVGMTALPLIYAIVREEFPPNRAPVIQGILAAMNGIGLLIALPAGGWVTENLDWRLNFVLISPLALLSILLNIALLKDTRDLSLDKSLSGMRVSVASVLSFAALVTSLLILITIHTTGESGEYAQGLLLAIFIVSLLAFRWSERRSSAPLLPISTFNRSVRLGVFCASIIAVTFQLVLFVLPYLLQTPHPNGFGLTPTESGVYMMLLIVSYAISSPLAGYLVVRVGMKRIAYAGSLLSAAAYLAVAVKPLQSPLLEVTLVSLGFVGMAFINNSLINIVVYSADKSYLSTTTSLYTLLRTLGSALGPLIGGLIFSMCSYSEIKTTQITSFSIDPLSYSLAFAAASSLFLIVLAMVLQIDEPSLLKDLSPSRVLT
>fig|272557.1.peg.51 Permeases of the drug/metabolite transporter (DMT) superfamily
MSVGVWLYGCGCGMDRRSSELLGVAAALTAALLWSTIGVVQRLAEARGADTETLIVGRTLGGSLLALALLAIYRAVPTRRSFAVAVLGLAPLYYTYMMSVSIVGAAVASLLLYTAPAWVALLGTVFLGETPSVRDVVTIILGLAGAALVSLGGEGKAGELRLLGIVLGVASGFFYALYIVMARFFQSRGAGVMEVSLAPIALTGPLLGVALKPSLPPNSVEVAASIYFAVFTMVTPYLLNVYALRRIEAHRVSVMSLIEPLSAVLLAVLLLGEDLTALQALGGVLILAAALGASFK
>fig|272557.1.peg.1758 Multiple antibiotic resistance protein MarC
MADLYTVVSSIILLFIVLDPVGVSPYVASIVARRPEGERERIVRTALASAGAILVAFTLIGVAVLDILGVSMDEFKVAAGLLLLIYATADLFEIKIGYSEPSGDEVAIFPLATPLLAGPGSIATVMYIMGSSGIAVALIAILVNLVLAYPILHASLKLVRLLGRHGSLLVAKFTAFLMVGFAVSIIFDGLRGIVPGVFS
>fig|272557.1.peg.1760 Antibiotic transport-associated protein
MARYHILIFIAWFIVTALLLPYALALDEVLVTETESFLPETAESRMAEEKVKEILAAEGYGGADSLLGLLGSANALIMVTGLREPLDPSSYQLLKEQGYDELRAEYNLFSWIDIVDKAMENLEPALEEAVRGGVQAFEGGYSIWNSYLEVSQRLSNLSQSVDGLSLLLTESDKAYSTLASSWGELAALRGVLESASTPLIDVCTAIAPVYSTVYLDVVRTEGALEFYTNAYATGLQDVDITVVTLLTYVPEAGLEPVDRGFVVYVYTETLSLGGPGAFNNAAAAEITYTIVQARIGDSSLLQAYHQAWLHAVSETPELKLFMAEDAKVGQIRLKAAVEDIADQVTEATVMALAEEASSIMPDDIKPIYTIYVESLIEEGCTEEAKERALQTAITQLLKSRGLPEEHASTLASAFARGDYNSYLQTAALASATLALAEANMTELQPEDLASVLVAFDPEASGAIASGETLEDALSVLLSRIAGLTPDTARLIIEERIEEAAAEIVLSNTPPQAADLAQALLAPAPPATEEEALQRIRSYLEQQLASQGMPEDLAVKAAEAAEEAWREGIVDAVIQRLVGEVAHDAAKGVLDELRGVLVEDDMGGFLIAYLGGGGYEGAKAAAEDVRRLVNEALDGDARVMLAGEEALRKELQEAVVEDLRRSDAASSIIVVAILAAVIGTILGVIIPFIGIGAGLTAALAILYFLASNDLVDVTSQSRAIVFTTGLGLGIDYSAYVTKKFRDNIRGSRGAWEAAGKAASNSVRPVLAGAFAAAAGFSSLMLAFEFPFVKSIGATVPIAILSVAVASLTLTPAILALVGWAGILWFPTCPYKAYQPGSRVFKSLVSAAGKAAPVLLPLLVVAGLAGVYYAATSFEGSFDILISIPRETGVYESMQHLVSEYDASRLFPQYIVASSSTLAPDVADAADDLECVREAETDGRLIYVVLDTNPLNTEAVKCVEELRGKVREVDPGSLVGGTAAVNLDLRDYLYRAFYNRVIPAAAVLVAAIIAVFYGSIPAALAGVASILFAAAWSLSIVSILSGWTGIEAPWFAPVLLAAALLGVGMDYISFYVNHAREAYLRGEHSRYYVEAASTGTGLVIGLAMIMGGAYAGLTLSRVEALQAIGVSLSLGVILAGLLASLLLIPPVMALLKARFWWPLARGRKSGGAGKVERG
>fig|272557.1.peg.1785 Permease of the drug/metabolite transporter (DMT) superfamily
MSGWEYLVLALAVANVSTASILVRLAGVHGFAAATWRLVLSTILTAAILVAAYAVKKHRKPVLPGGVDLLLVAASGVALALHFDLWMASLFHMSVAMSVTVVDSYPAVLAIVGFRLFKEKYTPLQLLGAVIAMVGVAGIAFYSSRGASAPPGGDPIKGFLLAFAGMLAVAAYFSIGKGLRSKYSTLEYTLPVYGFAAIVSLLLTTLVVRAPLTGYTAETYLYLILLALLPMLGGHTLINLLLRRLSLLAATVPILGEPVGAAALAWILLGEKVSTLEALLMVVVLAGIGLVLYEENRVKKEIKQGLASEGP
>fig|272558.1.peg.290 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLEIKSVTKKYKEKTAVHDFSMDLLSGECVGLIGPNGAGKTTLIKMITNILDPTRGDILLNGKRISEMKREIGYLPQYPDFYQWMTASETLLFMGQLSGISKKKLTKSIPEILSKVGLRGEENSKVSTFSGGMKQRLGIAQALLHKPSFIVMDEPVSALDPIGRREVLNIIEEIKKDSTILLSTHILADAEEICERLVMIKNGEKIEDTTMMELLNRNSKNKIRVEITDESKDWIEVVKKLNYVQDVEVTGNKVNVEVKNIELHKNMLLANALKHDVNIVKFELDHDTLEELFLKLVVGE
>fig|272558.1.peg.390 Permease of the drug/metabolite transporter (DMT) superfamily
MNQTISAQLKIMFAMVIVGSSVVAGKMLVESFPVFLASELRFLIAALILVPMLLKKEGIPTFSKKEVGILFLQALSGVFLFSIFMLYGLMYTTAMEGGIIMSTLPAVVALMAFITLKEKLTRLTIIGILLAVGGTLAINTSGTLSDVERGVAPLLGNLLIIGAVISEALFIIFGKSISQRVSPLAISTMVSVFGVVLFLPFAIYEATRFPLTDVSLNDWLIIFYFGVVVTVIAFVLMYQGIEKVPASTVGVLTGVLPISAVLLSALILKESFSTFHVAGMGLVLAAILLISIDSNVEKKEVASLKKKKGIS
>fig|272558.1.peg.396 Permease of the drug/metabolite transporter (DMT) superfamily
MRLYVMLLSLSLIWGFSFVFIEHLLGIVGVWGTVVVRCFAGAIILLPILLMRRKLFYRPAPWKALMIVGIFNAGLPWGLIALSQTEIYSSTAAVLNALTPLFTGLIGFLLYSNALSRQQWGGIVLGFSGVVVLTGFQLQLLAPEHFVGVGTMILATICYGFASQYVKRHLHDTDVVLITTFSLLFGGLVGLIGMWITDSLHVVRVPLTIDWLSLISIIGLGCLGSGMAHLLYYDLMKKGGPEFATTVTYLIPMTAIIWGKLFLDELITKNIVIGMLMILMGVYFTSRKRNVCSKANEDSNKGELA
>fig|272558.1.peg.1403 Multidrug resistance protein
MTRVTDTLLYVVLGMAPLLMVLGNSMFIPMLPTIQAEWGLSVVQGGWLLTSFTVPAALLIPISGILSERYGQKRIGLASLVILGTGCVLSSIAVVIETRPFWLLLTGRIIQGLGTGGLTPISLMVASELFSGKKRNEALGFLEVSNGIGKIISPIIGGLILLASWYYSFVVLFALALLAFVGFYTLVNEPKKHETTLSARAYTKKLSQSLQENWKMFVPIFIIGSLGMLILFGYLFAVSNMIGEVSPFWKGVILAVPFLLFAVASFWTSRWLTPEFASFQKAMMVGTTLMTGAMFLMLWQHDRTILFMLVSLFSLGLGMFFPPASAAVAALTNNVSRSVIMPLYSMARFLGVAVGPVIFGFWLERNISIHTMSFFIISLSFFIMCVLWYSGFLRKTNLSHESS
>fig|272558.1.peg.1741 Permease of the drug/metabolite transporter (DMT) superfamily
MNRWLTYFLVFFVMVLWGLNVVMLKLLVTSFPPVTMTALRIFVAGFVVLLVLLLLKTFRQLTATEWKYVILAAIFGVLGHHFFLSIGLTMTSASNAVLILALLPLTTSLLAILLLGDMLTRWRGFGIFLGLIGVCTIVLFGEGGLAGIRTGDGVIFLAMMIQALSFVYIKKATDTLDAKQVTGMMLLIGSLLLFVTSFIIEPNGLASMGDKALWIWWVFVISAVFATGLGHIIYNQAIHQLGTGETAIFNNLVPFFGLLFSALFLGEAIALAQIAGLLFIVAGVILGTGHVDAWMQKRKRRFDQVG
>fig|272558.1.peg.1937 Permease of the drug/metabolite transporter (DMT) superfamily
MRIKFITAVFLGACSYGVLSTLVKLAYENGVPTAVVTSSQFLIGWFLLATLLAFTQKKRRLTMKEKIQLMLAGIPTGLVGIFYYLSLVTIEASVAIILLFQFVWIGVVLESLINRQFPTKKTVGSLIILLIGTVLASGSPWFNQGTVHWLGVLFGLLAAVSFALFILANAKVLPQLPTVQRSYYMVSGSLMAVLFIFGPQLFYQPLTTYGQLGWYGVLLGFFGVCIPPLLFAYGMPQIGSGLGSILSSIELPVAVLLSVIVLKETVILSQWIGVFFIFLAIILPNIEWKKEQLAKNPL
>fig|272558.1.peg.2098 ABC transporter (ATP-binding protein) (daunorubicin resistance)
MLETINLCKTFKGQPAVQEVNMYLNSGESVGLLGPNGAGKSTTISMISTLIKPTSGEIKLNGINIISHPGDIRKILGVVPQELALYQELSAYENLKFFGSTYKMKGKHLENRIQHALEIVGLKDRQKDLVKTFSGGMKRRINIAAALLHEPKILILDEPTVGIDPQSRNHILETVRTLNENEGTTVLYTSHYMEEVEQLCDRLYIMDHGEIIAAGTKEELLSILSTEDTIKVELSKIDETFVQNVKMIEGVRKVEASHSQLKMIAKKGSHLIRELVHLTDQHQIQMIHFHTETPSLEDVFLHLTGRTLRD
>fig|272558.1.peg.2116 Chloramphenicol resistance protein
MSNKKTALTIFLLSLGAFVTGTAEFVFSGILEIISLDLGVSIAAAGQLLTMYSLSYAAGALILVLLTAKYNRKKVLMYAIFTFLIGNLIAFVSYSYSLLMFSRVVMAMSGGLYIVVATNYAAQIVSPEKRGSAIAKIITGFTVSLVLGVPIGTFFSAYVDWRYIFLIIALISLFLIISLYKLLPEIQANKPLPFTTQLQIMKDRRLMTGLGTTIFWILGYTMVFAYISPLLSREAEMPLEMISVALFVLGTSAFIGSRFGGFAVDKWGPARTISISLIILQHSFRS
>fig|272558.1.peg.2163 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQKQQSERLGTEAIPKLLRSLSIPAMIGMFVMALYNVVDTIFISYAVGIEGVAGVTIAFPIMMIMMSMAGALGIGGASVISRRLGERRGEEANQVFGNILTVILVLSVIGFISAFTLLGPALQLFGATSVTQGYATDYLFPILLGSIFFFFAFAANNIIRSEGNATFAMVTMIVPAVLNILLDVLFIFGLNMGVLGASIATVIAQASVTGLVLRYFLTGKSTLSLHWSDLRMKGSVIKEVCLVGLPAFVQQSSASLMMIAINSMLLRFGSDFYVGVFGLVQRIMMFVMMPMMGIMQAMQPIVGYNYGAKQYSRLRETVMLGFKVATIFSIGIFALLMLFPEALLRVFTADREVIQAGVSAMHILFCVTFLIGAQIVAGGLYQSLGKPKQALILSLSRQIIFLIPLVLILPHIFGLSGVWWAFPIADVLSFILTVVLLYRDRNVFFLKTKEERELDLVKTASST
>fig|272558.1.peg.2592 Multidrug resistance protein B
MKGWKRNLYILVVCQFLVVSAMTMIIPFLPLYLQELGVTDPSEVSLWAGIIFAANFLTAFLFSPLWSRLADRYGRKMMILRSGFGMALIIGLTGFAQGPLSLLCLRLLNGVISGFIPASIGLVATNTPKEKAGYALGFLQAGAVSGGICGPLIGGIMAQAFGYRMIFFLTGLCIFIAALVVLLFVNEQFTPNPKEEKTNTWGEFKKITAIRPIFSLYVVVFLIQFAVMGVNPLISLFVEELVSGVNVALFAGLAISATGFANMLSSMQLGKLSDKAGAHHVLFFCLLGTVIFMIPQAFVQQLWQLIVLRFFVGLSLGGLLPAANALVRMHAPKGMESRTYGFSTSALYLGNMVGPTVGGAVVATVGIRGLFLISAFTLLLTVWIVKGKVMPASDKQFRYEQNERKIASS
>fig|272558.1.peg.3211 Multidrug resistance protein
MNIGFGMVVPYFAIYLGTYTGLDPVSIGLIVGTTSIGSLVGGFLGGTLSDQFGRKKIMLVSLVVASAIYAGFMLQDYALLLVCLTLVMGFCTSFFEPCAKALMADFTESKKRMKAFSLRYIGANIGFAIGPLIGIVAGVTASSRLPFIVVSTILLAYALFLQWLFRAFGVQEISIGEKEHVNLTGAFKAIQSDRVLLLFLFGGLLATVVHGQFSVILSQYFELEFQSGLAYLMLLWSVHSGVIVICGIPLVKVMERLSPLRAIVIGSLFFAVGVIGFAFSFNFMTFCLAMIVFTIGEMFLIPAEYSIVDEITPNHMRGTYYGSLNFTSLGSFIGPWLSGILLVHFGGKFMFIGLALICALSLFFFIAGHLKRRAYTVGEAVREAERGL
>fig|272558.1.peg.3496 Transcriptional activator BmrR for multidrug resistance transporter
MKNQFPIGEMAKLHNTSIKTLRYYDEIGLLKPDYIDPNNGYRYYSTEQFEHLNTIHYLKELGFSLKEIKKHLEDRDIDGFLTLLEKQKELTEAKIKELERINRRFENRIHDIKWARHIEELGIVTIKDMEKRKIVRLKETIRSEPELEITLRQLENKSKMTSSIFIGGVGLTVSMRNIKSNKFNEYNSIFILIEDDIQNPLVATLQEGKYACIYFRGNHHDSPKYYKALLNYIQTNNLHMIGDAIERTIIDHYISESKDDYLTEIQIPIKY
>fig|272558.1.peg.3856 Quinolone resistance protein
MKQKIKAPQLPSSLTSATILQLEEGDDQIGSIQLIGDETNGLICPDHLEIRQSSFKQVTLLNSSFSRSDLSDVVFEKCDLSNVQFQDAIIHKAEFRRCRMTGFNGSGASFRHVRFIDCLLDYSAFGFSNMKNVAFSHCSLQEADFYQSVLKHTEIQDCQMHGANFAQTDLSDMDLRTCSFQQLTVSFDKLQGCTVTSEQAIGFAKILGLNIEDH
>fig|272558.1.peg.3880 Multidrug resistance protein
MKTTKKRETLWQQPGYKKLFTSYSISMVGQWFDLVALLVLFGYVWNADPLLLAFIPIAFALPQMLFGQFAGVFVKKYHKVKVMAVADGVTSLLTISLLFTGHPLVVLGIISLRATVNVVHYPAQQSLLRQLIRDDLRLQAITWNGAVSQAAKIIGPMGGGALLTAFSPHTLILLNGIAFLLSALLLTTLFRNVKVVEKDTSLENQSSFWASWKAGWQVVFKRKVIYFSFAIALLGMSVIQMVDIQFPVLFRQIAAAQPQMVAWIMAAIGTGAIAMMAFLGRMKQLRNVGMWLAGAMICIGIAFLGIGMLQEGFLMMIPIGLGLIAGLGTGTSMVVSNYIIQTEPREQEVSQVAGIYQSLISMAILLPPLLGAWLIHLIGVILLFQIVGAVLLIIGGIALCFHPILFTTKQGTKEAGTKLLIVKE
>fig|272558.1.peg.4045 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEMSKQLGKKFNLLTLLAYAAPTMALMLFMSIYTMVDGMFIARYVGATALSAVNIFFPIYGLIIAIALMLGTGANAIIAKKIGENNEEEAKENFTFIVICGAVLGLVITVFGLLLMEPILLMLGAGATEELFDFTYTYAKIILCTSPFMILQMLFQNFFVTAGKPNLGLTITVVGGVANIVLDYVFIVLLQMGIAGAGIATAIGIFIPAAYGFVYFIYNKESGLHFVKPKVDGKVLLNSCINGSSEMVSNLASSIVTFAFNLLMIKHLGVDGVAAITIMLYVMFILSSISMGYSAGVAPIISYNYGSKNSSQLKRVFNYSLLIIVIGSVTMYGVSMMFGAYFIQFMAPEGSAVYHIAIEGLNIFSISFLFMGFNIFSSMVFTAFSNGKISAAISFLRTLVFVLASLWILPAILGVTGIWLAIPLAEILSVIVCIFFLTHYRNDYHYA
>fig|272559.3.peg.71 Permease of the drug/metabolite transporter (DMT) superfamily
MMKNKKVEANLSMVVSKTFSGLNMNALKYLLPVWVSPLSGVTLRCVFAAIAFWIIGMFVKPEISTRKEKIFLFLLGALGIYGFMFLYLMGLSKTTPVSSSIFTSLQPIWVFVIAVVFFKEKISAMKIAGISLGLGGAILCILAQKSDDLASDALTGNMLCLLSSIAYAVYLVASNRILKSVGMFTVLKYTFAGAAFSSIVVSAVTGFHAPVFSGPLHWFPLSVLLFVLIFPTVVSYLLVPIGLKYLKTTVVAIYGYLILIVATIVSLLVGQDRFSWSQTIAIGMICVSVYLVEVAETKEKPVSNSDKPSSLPPHGS
>fig|272559.3.peg.782 Bicyclomycin resistance protein
MTDRQNSRRFLLLFLGVLSAFGPFIMDMYLPTLPAMADFFHTSSSMVQLGLTTSMIGLAAGQLIFGPLSDKYGRRPPLLLAMILFLLATVGCIFSHTISQFVTSRFLQGIAGAGGVVISRSIATDEYSGQQLAGMLAVIGGINGIATVIAPIGGGILAQITSWQGIFICLFFMGVVLLSGSLHLNESLPAKHRQTVSWQDLYHSFGEVLHNRRYVGYVLQYGFTMGILFVNISSAPFIMQQHYGLSPLSFSLCFGINAIAMVISSAISIKLPTMERALYIGSRGMLSVSALLMVFLSLRCDFWIYELLIFALLSMIGMTFTASNTLAMECERRNAGIASALLGATGFAFGGIVSPLVSLGDMMTSTGILFLAGSACAYACTRYVLSQSVQPSGVLYH
>fig|272559.3.peg.1185 Tetracycline resistance element mobilization regulatory protein rteC
MKEVVDRILEQVEADISEIDLYGYNIIETSLSMVHRLQTVLNDLRTKIQTYVFLTKEDEILFFKTQKPEILGRLLFFYKIYKIETQCPNGSDEAIRNYINRELDNLTYFFNRNLDFYQYYRSHSTVYDEYYFVRGKADLRLCTDSAQFDKDPNFSTGYDYKVAKIIANEMLRIYLNKRLVKLGTNNQIEDNLQKCFKYPFRFTGKKAYLIELGYSLVSSGDINNGNVEIKEMMNFLSTIFHIDLGDYYASYIAMKERKDRTAYLHHLIDSLIKRMNEDDMKC
>fig|272559.3.peg.1195 Permease of the drug/metabolite transporter (DMT) superfamily
MKSLKGIIYAMISSGTFGLIPLFTIPLMGNMEMNESNILFYRFLFSTLMMGAVCLLHKSTLKINMKHLISIIGLGALYALTALFLIYSYHYITSGVATTIHFLYPICVSFLMVVFFKEQKSKSLFLAASLSLIGVALMCWSGGGSIRLMGIGLAALTILTYGIYIVALNQLDIGKLPAEVLTFYVLLGGCVIFFIYSLFTAGISSIPSTKAGFYILALAFLSTVISDLTLILAVKYAGSTTTAILGSMEPLVAVVVGVLVFSEHFTLQSLIGLLLILMSVIIVILADQQKKSKRITEQKIIKPH
>fig|272559.3.peg.1654 Tetracycline resistance element mobilization regulatory protein rteC
MEEYFNGLLKEVDQRMATTAPGMDGKEVIGVCREMVSYLKGKNRELKEYALAHPFAGDAKEILYFKYYKPALTGRLLYYYRVYQIESGCPACLRVAEPYYRKAMERAERMMERYLPFYQYYHSGATYRDSYYFLRAKGELSPESGSFVLDEEAEFSTGYDILAARLISVEMLLVHLSRRMERAAQGTETEAVPEKEHRWTNTKVAAILLVYGIHVTGSVDEGNAEIGELAALFEKHFHVDLGNVYHAFGRLRGQQNPTAFLDEMKERLLKKMRDMDSR
>fig|272559.3.peg.1875 Permease of the drug/metabolite transporter (DMT) superfamily
MKTTQRTAGWYHVMAAVTVMIWGTTFVATKVLIKYGLSPVDILFYRFLLAYICIWFFSPRVLLAKSWQDELRFVGLGLCGGSLYFVAENTALGMTLASNVSLIICTTPILTALLAPFFYKGDKLKARLIGGSLMALIGVGLVVFNGSFILQLSPAGDILTLIAALMWAFYCLLLRRMNTHYPTLFITRKVFFYGLVTLLPLFLVYPLQTDIHILFRPVVALNLLFLGVIASMLCYIMWNTAVKQLGVVCATSYIYVVPLITLLTSAIVIDETITIVALLGSALILSGVYIAERGVNLKK
>fig|272559.3.peg.2680 Multidrug resistance protein B
MGNIMIGTFMAVLDSTVVNTGLPVIMGTLGADINVAEWVLTGYMLSMASILPAAGWLSERFGYKKIYFLSLLVFTAGSFMCGSSSTIEELIFWRVIEGFGCGMLLPVGMAIVSDVFPPEQRGTALGFWSIASAASVSFGPAIGGYLVDYMDWNYIFYVNIPIGILALIVTAIVQKEHVKGTGVPFDIPGFITSAIFLPVFMYGLSEVNSSTNSMGWSSPVVLGAMWIAVVTFILFLYFEFTVKTPLINLRLFVDRDFALSNLILFVFGIGMFGSTFLIPLYLQDNLGYSALQAGMFFMPVGIIQGVASPLSGKLMQRINPKVFIVSGILLMALSFYMNYYLSFLTEKWYIILSLYLRGLGMGLLFTPLLTLSLVNIRNSDMAQASSITNIVRQMGGSFGVAIFSHLLTQRTAFHTQRYGEALNYTGDVYRQTLHSLSRFIEHTGGRTPDTAKEVAEMLILKRIDLEGYISAINDDFFIAFIVTLLCVVPVLFLRTKKG
>fig|272559.3.peg.2985 Permease of the drug/metabolite transporter (DMT) superfamily
MNIIMNINSKAKGFVCGAVAAATYGMNPLFTLPLYKEGMSVDSVLFYRYGFAVLILGILMKVQGQSFALKKNEVLPLIVGGLLFSASSLLLFLSYKHMDAGIASTILFVYPVMVALIMFLFFHEKVSLLTVFCILLALSGIGLLYKGEGGETLSLVGMLLVILSSLSYAVYIVGVNHSTLKLMSTAKLTFYALLFGLSIYIVRLNFCSDLQAVPSLPAWGNILAMAFLPTVISLVCTAVSIHTIGSTSTAILGALEPVTALFFGVMIFGERLTPRLMLGILMILVAVTFIVVGKPLMTFLKEEVAGGMKRKLTR
>fig|272559.3.peg.3009 Bicyclomycin resistance protein
MTKRIGNSRLYILIFIGIVSAFGPFVTDFYLPALPVLSEYFDTTASLVQLSLTFSMVGLAVGQLIIGPLSDKYGRKLPLMVSLVIFCISTVGCLYSPEIHGFIFARLLQGLSGAGGVVISKSIAIDLYQGKELTRFFAMLSSVQGLAPVCAPVLGGILLGAMDWKGIFWILLAIGILLIVALSAFKESLEIKKRQKGNVFSTFKYYLPVLRNRQFMRYVLIQAFAMGVMFTYIAASPFIFQNHFGTSPFAYSLCFGVNALGIMLGSLAVSRFKDATAALRFGVAGFTTMSLPVAAALIFSPSVWIVEGTLFFLLAFLGLILPGSTTLALDMERKNSGNASALLGFLMFVFGGLLSPLTGIGNMLYSTGIIIVACCVGTWFFTYKATSSAR
>fig|272562.1.peg.85 Permease, MDR related, probably tetracycline resistance protein
MKSSKLSIIKYYLYTFGVQMRLTRIVNILYLVQCVHISIVQFTLLQSIFSITQFVMEVPSGMLGDFFKKKNITTYGLILSATAQLLICSRLVVNAENPFVILAFAFAIEGIGRALISGADDALFYENIRADGYAAEYDKIRGRYQLISSISVGIVTSLGTILYTINNSIPYIGQCIMTIISIGSIMTVKEHNVKKTLRKNENGKNSIKVFLTSILQVRNSPHIVFMMCLVCLTFGVINTVFGIMPDYISEIGFSNTQTGTVFMLLSFIGGIVATQAYRISNKRYGQLVLVTVLCMSSGVSLVGLRGNKEMIFIGLALLYVIIDVLDPIAMKSFNAYVDDSIRSTFLSMVSFMVSTSTMILYPIAGIIVEAFGMLTLLIAISAVVIPLLGVSCIIYKKYSVN
>fig|272562.1.peg.122 Permease, MDR related, probably tetracycline resistance protein
MNTTINNSNLKYNNLILILGLAGFVSAADNWFVSPALQPIASELSISVSTAGIILTSYMIPYGVMQPVYGFFSDRWSKASVLKIIVGGLAIGTAGSAFVRALPLLCLFRIITGFFAAGIIAVSLGLIGDTIPKLERQIYVGRFMGIVFLGQGLSAGLGGLITKYISWRGAFVFFAVVAAISDIILIKGLSSDSKKISFNCKQNNFFLQTKIAICTPAGRKIFPLALISGFLLLGLYSYLGSFLHDVMHLDYLECGVLIMFYGFACLIGGTKVGKLSKRYGKKNIILLGEGFALITALSLYFFHYWEIALVATVFLGFGYICIQSTLATLAFDVNPENTGLPSGLIGLGLFGGGGLGSLFSGWLLSIDGYEAIWIVFASFIVVISLITLKIKLN
>fig|272562.1.peg.818 Teicoplanin resistance protein vanZ
MSITIKFILSVILIKLFNDIVNKKSKQEKNEVPLKYYIMKCVFILYLIVVLDVVGFPSLWEWKMMMSLSQPIFNPHINLIPFKEMGIEDALNIVLFMPFGFFLPTLWKRYHKFWMTASFGLAFSLTIELSQLFSRSRVTDIDDLIMNGLGTVLGFMIFYIIRKKNYHTDEKEENNLFVKVEPFVCIIIVIICNFLF
>fig|272562.1.peg.827 ABC transporter ATP-binding protein (multidrug resistance protein)
MKYSNINKKLGSFLSSSKNIIKTVKLLWKSSSLSFIATLIITVLNGIIVPINMVISKYLIDSVVNALKNKSPIDSLNKVLFWLVVEFGVIAFSYVIGRVNTYFSTIQSKCLNNSISELLIKKANELDLSYFENDEFYNKIEKANSQAVGTTIQIVNGLTQIVKNFTTLVGAIVIVFQLSPIILLLCIMTSIPMFIINIKIYKQKYNIYSKRIEKTRLAHYLQMVMMDYIPVKEIKLNRIGDWLEKIILSIYKDNLNQDKKIEKKQLLIMSIVDIFNTIISYGYKIYVIFITLTQRLSIGSMNMYISALTNLEDSVKNTLDNFALLYSNNLYIENLFYVLDLKPLILNNNSGKKEFINEIRDSIEFRNVSFKYPNSKKYALKNVSFKIEANQNCAIVGLNGCGKTTLIKLLTRLYDPTEGEIYIDNINIKEFNIESLYKGIGIVFQDFMKYPFDVKKNIGFGNIDNLDNFELIKTAAKKANAYTFIQGLSNKFDTKLQKMWSNGVDLSLGQWQKLAISRAFMSNACLLILDEPTASIDAKSEYELFKDFKELMGEGTSILISHRFSTVKMADKIIVLKDGEIVEQGNHDSLIKSDGLYAELYNMQADAYLVNEDKNIDVSKDKLKDIV
>fig|272562.1.peg.857 Vancomycin B-type resistance protein VanW
MKKVVIGAFSSAIIIILIVLSSIYIKVKKWDGLVYRGVTIDRVDVSSKTKKEVQDIVKKKFDKIVQNRTINMVTDDNKTIPLKYSDINVKYDIDKAVSGAFDYGKSLSIYDRYKLLHNPKKLEISVGMTYDKNALENSIKNLSNTLNKKAKDATIVKTASGFQITPEADGKKVNEDKLKADIEGKITDNNITDYNVKINMDAVKANATQDKLKGINTLISSFNTEYASLSSPQRANNITLATKAINGIVLMPGDSFSFNGVVGERTAAKGYQSAPVLIGNKSDMGLGGGICQVSTTLYNTVLTSGIKATERHHHTLPSHYVPVGYDATVDYGTLDYKFKNTLSFPIYIEGNTDNGHVTFNIYSDASLLSKTYKVSSENISDSVPKAKVYLETYENGTLISKDMIANDAYSK
>fig|272562.1.peg.994 Teicoplanin resistance protein vanZ
MKKIKNKKKIFKVILFGLFIIYIIALFKIILFKSISFLQIFKGYNKSRSINLIPFKSIIQFIDTYKEMGSFRAFANLAGNLIVFMPFGYLVPTLNKRFSRIRSTVIASFGLSLFFEVTQYVLEIGSSDIDDIILNTLGAVAGYSVLTCLRKISSKVVIQNFCIMCITVIFLITGSIVAFREYGVMLNLTKLKEVINGGRDIPKISADAVGHTVQIKENDIKLEKVSIYNKNKGGKSHDKGERNIDIVFNKSTKVYFERDDYKDNTMTITNIKVNEKKLYTLKKNSMISVWGNNREGKLFANFIIVYLK
>fig|272562.1.peg.1012 Probable cation efflux pump (multidrug resistance protein)
MKLLQLFNDKKFFKAAFGLAIPIIIQNFILSSLNLVDNIIIGGLGETAIAGVGLANQYFFLLDLALFGTASGASIFTAQYWGKRDTKNIKRVLGICLITTIILSGIFTIGALAFPNIIIGFFSQDKNVISLGANYLRIICFSYIVTGISFAYSIILRTVGQVKIPMIVSGTALAINTFLNFSLVYGIGSFHGIGVYGSAIATLIARFIEFFLMLLAIYKLKLPIAAKLHELLDLSTTFVKRFFKVAVPVMLNESMWGLGVTAYAAVYAHMGTAVIAATNITSTIDRLSMVVFFGFGNAAAIMIGNRIGQKDEKTAFLYAKRFIILSPFIGIFMGIILYTSSPAILYAYNINSQVHMYSKEILHIIGMFLWIKIFNYTNVVGILRSGGDTKFCLMLDMGGMWLVGVPFVALTGIYFKLPIGIVYYFVFMEEFVKLLVGLPRLLSKKWINNLVSKPSEVSI
>fig|272562.1.peg.1210 Permease of the drug/metabolite transporter (DMT) superfamily
MKKGYMYIALTTIIFSTMEIALKLVSKSFNPIQLNFTRFFIGGLFLVPFALNTLHKRHLSISTKDLRFFALLGLLGTVISMSLYQLAVQNTKASVVAVLFSCNPVFVTILAFFLLREAIHKNNIAALILEVIGTIVIIDPLNTKLSILGLALTIASTLIFAAYGVFGKKKCAKYGGIVVTCFGFLFGSIEMLVLIGITHITPIANLFSSNGIAIFSNIPLFTGYSLKNLPLMCFICLINTGAGFACYFKAMEETSAQTTSLVFFFKPILAPILALILLHEIIPVNMIIGILFILAGSISSILPELLAQRQTKLEKTA
>fig|272562.1.peg.1237 Permease of the drug/metabolite transporter (DMT) superfamily
MSKSTKVDLVFLFFTAIWGLSFPLTKNVLGYTSIFAFLSLRFTSAAVILIIIFWKKLKLINTKIILYGSLIGLMFFGSLAFQVASLRFTTSSNSSFISALSVVIVPLVSAGYYKKKIDFSCVLGVLFAVVGLFFISGGVNFKLNIGDLFSFLCAICITFQIIFIDIFCSKCDSALLSLIQVVFCAIFYNIVLFIIGTKPIVFNTQLTVSIFITGILGTAVAYTGIVFLEKFTSPTHTALIFCAEPVFATIFAMFIPNNNGSCESITINTFIGCGVILLSMVISELKIGNNIPQKIIKL
>fig|272562.1.peg.1605 Tetracycline resistance protein TetP
MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGSVDSGNTQTDSMELERKRGITIKSSTISFNWNDVKINIIDTPGHVDFISEVERSLSVLDGAIIVISGVEGIQSQTRILFNTLKELNIPTIIFVNKLDRIGADFNKVFEEIKKNISNRVVRLQEAYDMGSKDVYIRNLSDICPINNDAVDVISDLDEVFLERYISGVEPNKEEVQEKLSLYAREGSLYPVFCGAAAIGLGIGDLLDGICSYLPFAGDECEGNLSGVVFKIERTSTNEKKVYVRLFGGRVSVRDRIQVPSKEIVEKVKKINSLENGRIIETQSIEAGDIGILYGLTDFQVGDVIGVSNNKIKNISIAKPTLKTTISAIDKEENQELFKALTLLAEEDPLLELEMNDIDEEIYVNLFGEVQMEILSSILDGLYGIKVEFSNIQTIYKEKPKGVGMSIMRMQEDLNPFWATVALKIEPKGRGEGLRYISNVSVGSLPKSFQNAIEEAVVKTSKQGLFGWEVTDAKVTLTCGEFFSPASTPSDFRNVTPMVFMEALYRAQTVLLEPLYEFELRIPQDVLSKAIWDLETMRAIFDSPIVIGDEFSIRGLIPVENSKEYKMKIASYTKGKGMFTTKFYGYKEVSAKFAKARPKTTYDPLNKKEYLLYKLNAIRD
>fig|272562.1.peg.1694 Permease of the drug/metabolite transporter (DMT) superfamily
MNGKQKILPYIAATVSSTIFGLSFLFSKMALKVAGPLSLVALRFLLAFIIMTILVLFRVIKVDYRNKPIGQLVLLGLAEPVIYFIFETYGVKNISSSMAGLMLALIPIVVTIMGSYFLKEVPSLKRTSFIVLSVSGVALIGVMGSSGGSGNSPIGILFLLGAVTCAGAYSIISRKTSVHFKPVEITYFMMFFAAFCFNIMAAIQLLAEGKINEYFSPLKSSTFVISILYLGILSSIVAYFLTNFTLSKIQASRSSVFSNLSTIVSIIAGVIILKESFHLYHLVGSVLILTGVWGTNKFK
>fig|272562.1.peg.1767 Probable cation efflux pump, multidrug resistance protein (FS)
MALVRKDVVKLAAPIFVEQLFVTLMGMINTMMAGHIGKEAVSAIGMIDSINNIFIAFFSALAVGGTVVVAQYIGQNNIKKANESTKQALYSTIIIAFVITIIMAILKGPLLGFLFGSAEKEVILDANSYFGITLLTYPLITIDLVSNGILRGAGDTKTPMKISILMNVLNVAFTALFIWGIKINGTVVVKSLGITGAALGIATARTIGGIIILIVMVRGSRIVQLKKLTEFKFDMTLLKPIFGIGVPASVESLLFNGGKLIMQIFIVGMGTVAMASNTIVNSISNFLNIPGNSLVIAATALVGQHMGRDDDKGAEKCLSYITKLSTVLLAIVGILSILFSRHLPSPVYWK
>fig|272562.1.peg.1768 Probable cation efflux pump, multidrug resistance protein (FS)
MVSYLFFFQDIYLPLYTGNNDIIKLSSKVLIANAFAMIIWSSAFTLPAGLKGAGDAKYTMVTSIIGMWLFRIVLGNFLGNTMKFGLLGIFLGMYTDWLVRGILYIIRFRSGKWKNHVVVKRVKTSVKA
>fig|272562.1.peg.1812 Quinolone resistance protein
MQRKKKLKIVNPDIYEELEEVLEGEIIVEDDSYIELKSFENVSLENKQAKKVSISQSIFKNVSFNNTSFKGIDLTDVIFEKCDLSNADFTESVIYRTQFKNCKLMGINLSEGTLNNVTFDNCMARYSICTLLRCKNVLFKECTFTSTDFYKSQFTNVEFLNSELIEAQMHETSLKGIDLTSCSIDGIGLNIEDLKGCIVGPEQLMCFANLLGVILK
>fig|272562.1.peg.2536 Multidrug resistance ABC transporter ATP-binding and permease protein
MKKGTLFRLASYVGKYKMYMFISLIFALISNVLIAFMPLIVGKGIDNIKSQGKVDFNNLLKIIIVLAAVYLISSIFTWLFTAVANILAYNTVRDLRNEALSKISTLPLKYFDVNPHGDIMSRLTNDMDAISDGLFQGITQFFPAIVTIISSILLMLSLSIKLTGIIILMTPLCFFIASFITKRSNKMFKQQQNTVGELNGYIEEIIGNEKIVKLFGYEKRAEKKFSEINSRLYNCGQLAQFYSSLTNPSTRFVNNITYVLVGAVGGLLAVLSGLSIGTISSFLTYSTQFSQPINNVTGVATQLQAAFASAERVFSILDEIPEKKDNEGAKKFEHCEGNISFNNVSFSYNKKQPLIENFSVDIKKGSTIAIVGPTGAGKTTMVNLLMRFYDIDGGKITIDGKDINKMKRNDVRGQFGMVLQDTWLFEGTIKENIAYGKPDASMEEIESAAKKAYIHNFIKRLSDGYDTRITESGGNLSEGQKQLLTIARVMLINPPMLILDEATSSVDTRTEIKIQNAFLKMMEGRTSFVIAHRLSTIKDADLILVMKNGHIVERGKHEELVNSEGLYREIYESQFKNAV
>fig|272562.1.peg.3475 Probable cation efflux pump (multidrug resistance protein)
MKSLATDMTEGNVSKHLIKFAIPLILGNLFQLTYNASDSIIVGRFVGKNALAAVGIANPIMNIVMFFIVGICLGASVLMSEYYGAGNVKKLRREISTTVIAGFIFTVLIIIICVIFTEPILGLVKTPKEIIPEAAIYLRIIFISLIFTFFYNIYAAALRSIGDSKNPLLFLMISAVLNVVMDIVFVVWLKMGVAGSAIATSVAEMMSCVFCIVYVHFKIPILKFSFKDMVIDKGLLRSTVNYSWATAMQQTCLYVGKFMVQGAVNPLGVNSIAAFNAVNRVDDFAFAPEQSISNAMTTFLAQNRGANKYKRIKKGFLTGMKLETLYWCILVGIVYLGSTAIMKLFVSGSEVKVISIGSYYLKLMAFFYLLPSWTNGVQGYFRGMGDMKITLRSTFSQIVGRVAFSYILAPRIGMVGIAFSCLGGWIVMLAYEVPCLIKYRRNFNNKLSESSI
>fig|272562.1.peg.3489 Multidrug resistance protein B
MSKDKKRIIALAIFLLGIFMGAIDSGIVSPARDVIRSSFGIGESLSVWMVTIYTLAYAVSMPIVSKLSDRYGRKKVYVISIATFALGSFLCGVSNFYGNYTFFLVARVIQAIGGGGIMPIANAFIGVSFPPEKRGTALGFVGGIYGIATILGPTMGSSVLNLAGNNHWGWIFFINLPISLIILALSVNLKENLGEAKKKMDLKGSIVLSAMILSLMYALTNLNFSDIVKSLRSSVVYPFLIVFFITLPIFIVIEKKAEDPILNLRYFKEKQILLTLILGFITGVGLMAVIFIPQFAENILKLKTGNGGYLVTFMSVFAGVSAPLGGKFIDKYSAKLVTALGMICTVFGTFFLAFYTTSNPNFISIMIGLVFVGFGMGFTMGTPLNYLMLSFVDEKESASALSTLSLIRSIGVAVSPNIMINFISEAGKRVQGNIMSVMPQISVPVFLQGKSAVRTIDISKLSGSGKISNAAISKFQSADVTNIVKVLKEFAASIIDKMLPGIKAQILRQMGPTSKMAPHIDLNKVFSSWKADYLNKIDQKRAVIESTFQSTISSGYKNMFIAAGIIALVGFIAALMLENKKMRVKNNI
>fig|272562.1.peg.3563 Probable cation efflux pump (multidrug resistance protein)
MLNVIKNINQRKDMVISIFALSWPSILEQLLETAVQYVSSAMVGQLGAEASAAVGLTTTATWLINSPSFAMGIGVLSYISLSIGAKKFRRAKIAAVQSIIITLILGIFMGIGTLAISPFLPKWLGAAPEIQRNASLYFGIICIPMIFRVAIIVFGAVIRSTGDMKTPMKVNLIMNLINIVLNFILIYGKQTISIGSFKITTYGGNLGVVGSAIAAATAYTVSGILMFLALYKNKIVSPKGEKLKLNIPIMRRCVNVGFPVTIERVATSLGQVVFSSLVTRLGTLAFAAHSIAITAEQAFYIPGYGMEATASTLAGNALGEKNEKKLNQISVTIIGMAITIMTVTGTILFLFPDFMMSLFIKDPVVIKSGSSVLRLVAISEPVFGALIILEGIFNGVGETKTPVLVSILSMWGVRILSTSICIYVFHLGLKSVWICMIADNVFRFTILFIRFLNGAWKKKLNL
>fig|272562.1.peg.3590 Multidrug resistance protein B
MKTKNYFDLKKVLPAVLTIAVGMLLVMMDTTIMNVALPHIQSTFNTNLATSQWAITAYTLAMAAVIPYSGWLADRFSAKKIFGIAILFFTIASLLVSISTNIEQVIFYRILQGLSGGIVGPIGIAISFKIIPIEKRGSMMGLLGLPMLLAPTIGPALSGFLIKYYNWHTIFLINIPIGLLSLILVFLFLPNFKSKHNTKIDLRGAFLSPLAFPLLIYGVHVGSDKGWQSPISIISIALGFLMLLTFIFLETKTQTPLLEVKVFKISEFRKGIILMWLNQIAVFGSMLLIPLYLQNIRNYSSLEAGLMMVPQAIASFIGMTVGGRLFDKYGTKSAAIPGFLLTGFSLILLAQITNTTALAYLIICIILLGLGQGLVNMQVNNHALQSVPLNLINRVTPMTNELLQVINSLSIAFITAFLSNQIKTAFRKHSLAVSGNIAFHNTFILLTIFIAIGLGLTFFLKNKKSKEAS
>fig|272564.4.peg.581 Acriflavin resistance protein
MNNKKGLLYHIISNWRFTIFFTILTMALGIYSYYIVPKQESPDISAPFAVITTIYPGAAPEDVEKLVTRVIEDEIREVPGYKTSQSITKNSLSVVVLELHNDVDVKEAWNELGQILDGAQGKIPAECFDIEADTKLSETAGMIISLSGAGYTYEQLADYAEQFKSRLAKIDGISRFTVTGVQNKAARIEVKIAELNKYNISLDELVSLIQAQNLQIPSGSLSDQRVKVNVSSPGLFTSLSDLENMIIDVSAETGAPIRLQDLADIRWDIEDADYQLKHNGQNAIMLSGFFKENRNILLVGEDVRAELDRLKAELPPELIVDEVVYQPTDVDKSVAEFFKNLLEGMALVLIVVFLGMGFKNALVASTAVPLSIVITFIAMHLLGIQLQEISIAGLILALGILVDDAIVIIDAIQVHIDQGLEKMEACIRGMKQAMIPVFSATLTIAAAFSPMLFVPGPAGEFLRSLPQTVIIAVSASFLVAITVTPVLAYLFFDKLKKEDDKRTPLRRVYGYALQIGMQYKKSTVCAAILLIAIAGYGALQLQIEFFPKADKNVFYINLYSENASDISATARLAEQVEGILQENEEIVSYSTALGGGLPKFYITLPKATPAKDFGQIMVKVDLDKGEFANNEDLALHLQEQLDQHLIGGSANVLLLEKAMPGDPLEVRVSGADPLQVRDGVALIRRELEGVPGTMKVADDYVAGEYEFVVDVDTERATTMGITNYDIQRQINIALSGAEASLFRIAGNEYPILVQSDVKSKEDLENLAIKSSLTGHKILLKQLGNIHLQATVPTINKYDGVQAVTISGKVQPGFSAVTIENTLKQRLTQSGFDFSGLTVSYEGEAKDIKDNFGSLGTTAIFALFLIYVILMIQFRSFLQPAIIFITIPLSVIGVVAGLMLFAQPLSFTALVGVVSLMGLVIRNAILLIEFINLAREEGMSIDEACHFAVNRRYRPIILAAVTTVIGLVPLAFSGSDLFTPMSVALMSGLLISTLFTLVVVPVLYSLLVREGKGTAPGASAAGKREMGQSV
>fig|272564.4.peg.2257 Multidrug resistance ABC transporter ATP-binding and permease protein
MSAAEKQTGFGPGRQGPGGGRGFFGGPPGGPGGPGGGEKARDFNKTLRTLTGYLTPHKTTISIVVFFALFSTVFTIVGPKLLGKVTTKLAEGLFAWYNQTGLLTDFNYIGKIIGALVVLYVISSICSYVQGYLMSGVAMDVTYRLRKEIAEKMSRVPLNYYDTRSHGEVLSRITNDVDLINQTLNQSLNQIITSAASIVGILIMMLSISWMMTVAALLVIPLSLGIVGVVIKRSQRFFREQQHSLGELNGHIEEMYGGHTIVQAFNGEAESVAFFERVNDQLYHSAWKSQFVTSIMMPVMSFVGNLGYVVVSILGGYLAVKRVVDIGDIQAFIQYMRSFTQPIAQLSSISNTLQSTAAAAERVFEFLAEGEETPETAHPVTLDQFSGHVRFEHVSFGYSKDKQIIHDFSADIKAGQRVAIVGPTGAGKTTIMKLLMRFYEIDSGRILISDHDIYDFSRHDLRSLFGMVLQDTWLYNASIKENIRYGTFAATDEEVMEAAKAAHCDEFIRALPGGYDMVLNEESSNISQGQKQLFTIARAILADPKILILDEATSSVDTRTEILIQKAMENLMRNRTSFVIAHRLSTIRDADMILVLKDGDIVEQGNHEELLAQNGFYADLYQSQFEEAEAV
>fig|272564.4.peg.2540 Daunorubicin resistance ABC transporter, permease protein
MSGQVLTRKKSRIYREASTVLAIFAREVTVALKSPGTLIMSLAMPMIMMGMIGGNLMQNMAGGLGFQFGTFMLVGMLVNMLFMTTTMGVASLVDDHDSNFSEEMLIAPVSRYGIVIGKIFGSMFGAVLSMVGTLIVGLVMGITLPFTQLLLILALSPLICLSAGALAMILIGLIQNRKTANLAVMLITMPQMFLSGAIIPINHSSGVLLVLSRMMPMTYCLDLVRAVVYRGTPEYSSVVMFNPVVNFAAIVGLTVLCLIIGTFFFARSEKNR
>fig|272564.4.peg.2599 Drug resistance transporter, EmrB/QacA subfamily
MPTIMEELHIEATTAQWLVSGFTLVNAIVIAISAFLMDRFRTKQLFLSIFVLFLAGSLLASWGVNFTVLLIGRLLQAICAGIMMPLSMTIILLLFPHEKRGSAMGMYSLVIMVAPAIGPVLAGVLTDKVGWRIMFLVMAVLAGAIILLASLIMKNYGDVKQTTLDKPSFTMASLGLLALLYGFSLLGNISMILTASALVLAGVVILFLFVRRQLSLTQPFLQIKVLGNAQYRNGTIILMLIQASLAAATITLPIYIQTVRGMSATVSGMVMMPGAILGAVFGYFAGKLYDAFGARYVGLFGGFLLLLGSLGMALFDFDTTIGFMTAAYTLRSVGLMLANTPINMWSIKKLPDEILHHGNAVGITLRQVATTLCTAVMVSVMSFASSVYAAKGEIQSQMYGISMTYWLSVVIGLVALILVAVKVKNRKKTVAAVTEAVYELDIAMRADPYTVSCDDNLKQVVEKFIGYKTSGLPIIDAQKHLIGFVSDGDVMRYFTKQDLRFVAEFYSAVIPDTDTLNSKARKLLSMNVMEIASPNAIAVSHDTPLLEVCEIFSRRKINKLPVTQNDILIGTISRGDIMRALMTRLPLGGED
>fig|272564.4.peg.4245 Permeases of the drug/metabolite transporter (DMT) superfamily
MDMRQTEHELEHKISAYIDALFAGVGASQQLFDLKEEITTNLNEKTLDYKNRGISEDQAFKEAIVSLGDLSGLVAEMRQIGQDKAKQAVYSTMTARISLAGTIAGSLIILFGFFNVAMLYFMKLDAVSISGSGIFIVAGGALLTYSLLTRETRQKYAMNKIRAGLYALSVGLLLFGMFSAAVAGFATGEVFIAIASLMMFFLVGFGVFLFLILTGPDRRKR
>fig|272568.11.peg.1436 Outer membrane component of tripartite multidrug resistance system
MLLAAMVPAACDLAPRYAPPVAPVPASFKERDGWALAVPGDDVPKGPWWRIFHDPVLDALEDRVTIANQDLRVAVAQYDEARADARTAQAGYYPTLDFTGSASRSGLSRETANVFNKSTFNSYSLGLDLQYEVDVWGRVRNTAKAGRARAQASAGDLATVDLSLHAELATDYFTLRGYDAMQAVLDQTVGNYRHALALTQAQFDVGYAAQPDVSAATAQLDGLLTQAADNRLRRAMLEHAIAILTGQPPATFAVAARSLDSAPPPIAPGLPVALLQRRPDIAAAERRVAAANADIGVARAAYFPAFNINAMMGVQAAMPNHLLVAPAQAWSFGPEALLNVFDGGRRAALNAHARAVYDEEVARYRQTVLDACRDVEDSLVSLRRLAEESATQQQAVIAAQDATHRAGELNTGGLASYYNVILARNIELSDRLSEVDIRVRRMTASVALIKALGGGWGG
>fig|272568.11.peg.1696 Outer membrane component of tripartite multidrug resistance system
MPHWHRGLPDAESHPEESPADPQWWTIYRDPVLTALEQQVASANLDLRASAYRLAESLAERRIASAAQFPHVEGNASYARERASTNGILGLLGTLERAGAGDVASGAQGFGPVAVPGTVGNPSFNLPQYGMSASWEVDLWGHVRRQVEAANAAVKATQDMQRDVLVSLMAETAQDYLDLRGVQAQIAIVGRNIDTARHSVVLTGLRFAQGASTQLDVADSRGQLSEFQSRLPILQSQEVHLINALSFLVAREPGALRAQLATPAPIPPVPDAVPVGLPSELAERRPDIRMAEEQLHVATASIGVAVADFFPRVTLSGSLDVQALQFSGLGSWASRQYGFGPTMTLPLFEGGRLTGQLRLRRAQQKEAAITLQRTILKAWQEIDDAMADFSAAQQQRDRLKETVAQNETAVRLAQQQYVQGASDFLNVLTLQNALLASQNQLVRSTTAVSVSVARLYRALGGGWEARYPVATAQRAAIRQEGQGGRQG
>fig|272568.11.peg.1799 Outer membrane component of tripartite multidrug resistance system
MLLAATMLAGCTVGPRYQPDRMKLPPGFAEDEHAATPAEIARTNAELKDWWHRFGDAELDRLVDRAIAGNYDLQIAGQRILAERALRDVQASAWYPQVDANTTDGDSRYSINVDNWPLRPGDPANRPGASYLSYGVSASWQIDVFGRIRRAVEASEHAVEENVEERRAVLMTMLSSLVSDYMVLRDTQLRLEISNRNIGVAQEAYDLTRRLYLEGVGNTLQIAQAKAELDAQQAAREPLRTHIAQITHAIDVLMGQVPGTTEAELKVARPLPQVPEFPATVPSIVLGNRPDIRRAERAYAEATARIGVAVAQMYPNFAIPLNFNPNASAMYQVFEAGALSWQFFMLASLPLMHGGKLTGQIRTAQAAAEASRLTYRQTVLGAFREVEDAMAAWHDDVEHTELLHRAAEDSRLASDRARKLYAAGLVGFLEVLTTERTALAAENAEAVARLERLQDAIDLYTAMGAGWQGVGVTASALPVSLEKQNVLARAFQD
>fig|272568.11.peg.1809 Membrane fusion component of tripartite multidrug resistance system
MADEDRNGNRGHTDSKQKHGSPVMRGLFIGGGAVVVVFIAVVLAIIFVPTRRVWTDDAYVTAHYTVVAPRVSGQVVAVNVTDNQSVKAGQVLVELDPRDYRTALDQARATLERDRSLVQDAASAVTRQPSIIDESVGAAARVRAQLIFARQNAQRYANLAKTGAGSTQENQQSTATLRDMEANLQSLEARVAAARAQLPILQARHKAAQATVDLDNARVRQAELNLSYTRIRALEDGMIGERSVQTGNYVSPGAALMALVPLDQIWIRANYRELALRHMRPGQPVRIHVDAYDVTLNGIVDSIPPASGAVFAPIAPENATGNFTKIVQRLPVKIILAPNQPLAKLLRLGFSVETTVDTGFADVVGAQGHDAAATVTGREGAGP
>fig|272568.11.peg.1810 Inner membrane component of tripartite multidrug resistance system
MSVSPWLAVTLTLRRFSLAVPWLAVLSSSLIPLTGNLTLLYILRIFQGLSGGFTVPLLMTTALRVLPPPIRLYGLAAYALTATFFPSLSTAFAGLWTDLVDWRFVFWQSIPLCTIAFVLLWYGMPVEQPRHERFWRFDWQGFLLVLIGMGAFSTMLQMGDWMDWFNSPAICVMALLSGVCIPLFVLNEWFHPLPLFKFQLLERRNFAYGASTLLTFMIISLSSSALPADFLREAAGYRPEQTYPITLEIAAIQIVMLPLMAVLLNRKGVDSRIVSLIGMACILTACIGDFFVTSNWNRDQFYLWQAFQGVGNAMIVMPLLMMSTNALVPEEGPFASAMVNTPRAVAEAVGIWLIQLVHRERGALHSDRITDRLGQDRFQLVQGMNPVLQRPAALTPDGLPAFPGSMTALHAQVTRQTATLTYSDDWLIIAGIVVCLMVWVCVLPVRTYPPRIVFQSK
>fig|272568.11.peg.2182 
MTAPGCTLTATLRARPERREELLALLSTFIDKSRSEPGCLEYQLQVSKDDPLVFMFYENWVERADLDRHMALPYQQDWFKRQPELLAQPAEMKFFDMVSDYDR
>fig|272568.11.peg.2700 Outer membrane component of tripartite multidrug resistance system
MPPACRNWGPRRAIRASGWARRDCSRCWGGAGSGTGQPAFLVGIGGLTQGTDLYQVGFDASWELDLFGRVRRSVEQAHAQVAAQVARQGDARLTLQGDVVRAYLQWRAAQALLDLAGEVAAARARAVVLRAFQRRLGLADGTDVDLARAALVRAQGQAAGFQRQAGQALNRLAILTGQPPGALDGPLVAVRPLPDPPPRVPVVLPAALARLRPDIRAAEADLHAATAGIGAAVAQLYPDITLSGQVGQRTLTLGSLADWGNTFYQFGPAISLPLFQGGRLRAAIRLARARQQEAALAYRQRVLDALGEVEDALVALRTDGAARESDRAAMASVTDRLALARTRYRDGTGDALAVLDARAELGGAGQDDIQARLAVLLDVVALCKATGGGWPEAGD
>fig|272568.11.peg.2710 Outer membrane component of tripartite multidrug resistance system
MIVRSLRRTVMSGGAMLSLAALSACDLAPTYHPPTYVVPASWHGQAPFATATPADTQLPSNWWTMLHDPQLDALEDKATAANADLQAAAERFVQARAMVMQARADLLPHFGLAFGASDNKQSADRLFRYKGATTATDEFYGGLASWEPDFWSEIRNQVRMAKYSAQEKAADFAAARLSLQAELANDYVALRGYDAQDAIYRKSIAYYERAVSVTQTQLANQAAPKLDLARAQNRLYVTQAAEMDILAEREVTEHAIAVLTNSAPSSFHIAPVDTLTFTRAAIPVGVPSDLLQRRPDIAAAERQMAQANRSIGVSRAAFYPHISLNANGGFDANGFDLANLANSMWSYGASASMPIFEGGLRRAALQASWSTYRETRDHYRSSVLSAFREVEDGLSRTDRLWAENDRLKAAVSAALDMQNMTMTLYKGGLSAYLDAIIAQEAALDAQISQVQVETRYVQAEVGLIRALGGGWNDRLLPTPDQTMTFSILQYDGLHHPTPAGGIDTPGDTDTRYDDLTGATTLRTGTVPVSGR
>fig|272620.3.peg.1873 Glyoxalase/bleomycin resistance protein/dioxygenase
MGELSMQSVDVGFTHVAFTVRCLASSIDFYTRYTAMTIIHQREPDLPSARKVAWLSDRTRPFALVLVQSDDPADTPLGPFGHLGVACATQAEIDEKVALARREGVLRREPEQLGDPVGYFAFFADPDGNTLELSWGQRVGLEVILAGKPGE
>fig|272620.3.peg.2453 polymyxin resistance protein B
MEWWVKKVQDNASASLCRVVLQSGALEMIAEIEACRLRLREGDKLTPLADARYCLNNNPTQTLKIRNATHYSSERWTNAGK
>fig|272620.3.peg.3717 Acriflavine resistance protein F (AcrF)
MSKFFIHRPVFAWVLAIIMMIAGGLAILQLPIAQYPTIAPPAVAISATYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFKSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSFLLVAGFISDNPTTTQDDISDYVASNVKDPISRLNGVGDVQLFGAQYAMRVWLDGNLLNKYNLTPVDVINALQVQNDQIAAGQLGGTPALKGQQLNASIIAQTRLKDPQEFGKVTLRVNADGSVVHLKDVARIELGGENYNVVARINGKPASGLGIKLATGANALDTATAIKAKLAELQPYFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAVLSMFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMVEEKLSPKEATEKSMSQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALVLTPALCATLLKPASAEHHEKKGFFGWFNARFDRSVNHYTNSVSGILRGTGRYLVIYLLIVVGMAVLFMRLPTSFLPDEDQGVFLTMIQLPSGATQERTQKVLDTVTDYYLHNEKANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEARSGDKNSVESIIKRATVAFSQIKDAMVFPFNMPAIIELGTATGFDFELIDQGGLGHTALTQARNQLLGMVKQHPDQLVRVRPNGLEDTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADAHFRMLPSDINNMYVRSANGEMVPFSAFVTSRWIYGSPRLERYNGLPSMEILGEASPGKSTGEAMALMETLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGIIEATLEASRMRLRPILMTSLAFILGVMPLVISHGAGSGAQNAVGTGVMGGMLTATLLAIFFVPVFFVVVRRRFTRHAE
>fig|272620.3.peg.4282 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MGYAMARKSDPLAFGGLALLTLIWSFSWIAMKQVTSYIGAFDFTALRCIFGAVVQWIVMLIRGKALKPTPFGYTLAIALLQTCGMVGLAQWALMSGGAGKVAILSYTMPFWVVVMAALFLGERMRRWQYIAIGVACVGLILVLQPWQLDFTSLKSALLAILSGVSWGAGAIVAKRMYTRYPQVDLLALTTWQMLYAAVVMSVVAWLVPQQAVDWQPDVFWALAYSAILATALAWSLWLFVLRNLPASIAGLSTLAVPVCGVLFSWWLLHENPGKVEGCGIALIVLALAMISIKRRGA
>fig|272621.3.peg.291 Multidrug resistance protein
MGVKMAEKRNKKIILMMATLLLGSFITTLAETLMNNGLPMIMEETHISQMNAQWLNTGYMLVAGMVMPLATFFMHRFPLRHLFTATMSIFLLGSLVATFAPNFLFLLIGRLVQAMVVGINMPLVTNVLTIIIPAKNRGLAIGIAGIIINLGPAIGPTLSGVILEFYSWRMLFIILLPFTVLTLICT
>fig|272621.3.peg.726 Glycopeptide antibiotics resistance protein
MLFFGPLYSFLAKQYATNINHFALVKLTLLALDKTVFYFLIFAVIRLIWLLFVRRRRSIKSEAGVWIFAFYLILILMLTTFRDTYFPWQPNLNFSRPLSDVNLIFMKETWKMIYAPSRLDFFYNSFGNVLCFVPFGILFPIVFSKKESFLKTTISGMFLSIGIETLQFLLMTGVSDIDDVFFNTCGAILGYLIYILFKKR
>fig|272621.3.peg.1405 Lincomycin-resistance
MENTQMGMKARIDVKHPWLAILPLMIGSFVGMFSETSLNIALPQLMKALQVGQSSIQWLVTGYMLVIGIILPLSSLFTKWFTTKKLVLFGLAAFIIGSLISGFGINFSMVLMGRMIQGIGTGIILPLMFTIAMLIFPPNKLGTVNGVLALVIMFAPAIGPTLTGLILAVGSWRDIFFTFVVFLVIAFVIGLFTLQNVSQITKPKVDFISIILSIIAFSGLIAGASFASELGWLSIQVLACLIGGIIALIFYVKRQLKLTVPVLNMRVFEHRNFTLGAVLVMIDFGIILSAMYLLPQYLQNGLLVAVALTGIIMLPGGIINALVSALAGRMYDNSGAKWPTRIGFTIALIGAIMLSLVTTHSASWYVILAHVVLMIGAPLAMSPSQTSALNSLKGLESADGSAILNTMQQIVGALATALATSFLTLGRNAVNGSAAFKFTNGVHYGMYFTCALAIIGMIISLFVTDDGKE
>fig|272621.3.peg.1778 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MNINFKWIIKNLPFWLLILIVITLIAGGFEGVINGIILGQFPNLVGKSGTDLILFLIRSTIIFVATYTAIVLQNIFLNMARKRLRVKLKKTMLINSFALKEDAASGLNHISNDATKIDDQYFAVIAGILSTGTAAVISTIYVLQVNLLMGIIFVAFSCLSLIPMLFGKNELGKLGEQWSNENSQMMRSASDWFKGLRDILQYQAQKPFFKRVSQDVETSENTLLKQENLQWWIQYANLLFTVLAIIAPWAIGFYFITTHQFGVTISALLSLTLSANSVVQNFRGLMQYWAQVASTTEIRKIKVAKYDIFKDIKTENEKPDIKFDNVSLTYKDHPIYQNLNFDLAYGKKVLLQGPSGSGKSTLLNMVSGLLKPTRGTIKIGGEDPNPAQSVYIAQTPWLFQGTIKDNLCLGESFTDQQLLKVLNEVGLADELGKDPLNRVIHPEQEDLSGGQKQRLVIARALLRDRPIILLDEITAALDEKNSDDIREILYNTPKTIIESAHHINFDLIKKYGFESWKISDHQVAKS
>fig|272623.1.peg.133 Multidrug resistance efflux pump
MKESWQRNLIVLWFGTFMTGIGSSLIAPFISLYISTLGHYSKTELNIWSGLVFSSTFIVLAIVSPLWGRLADQKGRKLMLLRASLGMAISISLMAFVTAAWQLLILRMLLGAFSGFVSNSMALMASSAPKEKSGAVLSLLTTGSVAGTLIGPIIGGILVNITGYRRVFSVTGIIMFLVFFLALFFVKEIFKPVEKKNMLSYKQVWEVVTHPAIIWGMFFATLITQMTNQSINPVLSLYVQELMHGQGNITFMAGIVAAAPGIVTLVAAPFLGRLGDKVGQRKILGFGLFFSLIVFSITAMTTNVWFLIVMRLLVGVSDAAILPSVQAILAKESPQAITGRIFSYNQSAQSIGAFAGPLLGSAIAGFIDYRYVFVGSAILVVFNLINYFTHTKSLAVKN
>fig|272623.1.peg.246 Drug resistance transporter, EmrB/QacA family
MNKIQEKRSIRAFMLSNVMAGLEGSIVATALPAMMAELHGIKLMSWVVTIYMLLMAVSSPIWTKLAERFEYKQMFVLGTLLFTIGSLGEGLAINMLMVIVARALMGLGAGVMIQLPFVIYGMMYQADERRRVIGNTVAAYSFSTIAGPIVGGLIVTLLDWRWVFFINIPIGIYMAFIVWKNFDLKTDHTKKSIDFAGSASLSIAVIAIMLHFQMMGNAVINLPLLLILLVVSFLFFIGFYFAEKRAVDPIVPLELFKNPSFIAKNIMFFMQYGFFGFYTNYLPTWGQGVMGATALVGGMVLIPSAIMLVIGTRNVNHLIQKVGEKKTIYIGFSIMVLGAIFLFSLPEHASIMMLFVATAILGTAFGIVNITLQVAVQESVAKHLIGAATAVNALLRTMGTTLVLSGLSIALNRTFTEATAHNPKLTTTLLNQISDAKALKNIPVNLIAPLRHTLFNGMHLLALISGLLLFIALFVNWLDPWKKGLE
>fig|272623.1.peg.388 Efflux pump antibiotic resistance protein
MSDRIKALIALGIFTFMSTLDGSIVNIALPTMSKELHVSTSQITWVVTIYLIVISAIVLIFGRLGDLIGKSRIARIGWGIFILGSALAGLNFGWGLGFLLFARVIQAIGASMFMATGFGIISEIFPPESRARALSISAMFVSVGSIAGPALGGLILQVASWNYIFWINVPIGILAWIFGNHALPKEKTSGKWSDIDFKGGTLMTSVIVLLFLALNFGQALGWTNPLIIIGALLGFILFGIFILTEKKVAQPLLDLGIFKSKLFSMSIIMALFNFTVAMFSSILLPFYLQDFRNYGPGLAGMIMMAYPVAMLIASPLAGSAADKMDKEIVTFVGISGIVLSQLGYLLINPHSAPWLVVVILLIQGMSMGIFQSPNNALIMETVDRKYLGIAGSVNSLARNMAFVLGTSLATLILFTAMSNQLGYKVTTYLHNQPDVFLHGFHVAFYFSTFLVLVTWVLGLFRLLGRKK
>fig|272623.1.peg.599 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MAFNICVNLYVKEVEKEVDFFRSIGFLEIERHKMENSDSVVISPLSDGNAFLQIWDIEFIKKVSPEVANDKPSLLFTVYNIEEMNEKLKKITPTTSDLMDANGKKAFNFQSPSGNYYAFMEI
>fig|272623.1.peg.624 Drug resistance transporter, EmrB/QacA subfamily
MAKSKKNEKEKLPKELTRNAWILVVGAIAPMLDSTMVNIAINKLQSDLHTSLDMIQWAITGYVLALAVAVPVCGYVVNHIDGKKVMQWSLLSFGLFSFLSGIAWNIDSFIIFRAVQGFSAGFITLLMTTLLMQITPPDKLGQLMAVVSTPIILGPIIGPVLGGAIVSGANWHWIFYINIPVVIIAVLLNHFYLSSFKPFNPKAKLDWFGTLLLAGGSVGLIYGMMKGSTNAKNFFNSQMITFVIIGLALFVIYGIYNRIRKNNTVLPLRFFKSKNFTAANIGIFLAGIASNGPMLLLPLFFQNTKGFTAVEAGLMLIPQGLGMMVTRPLIGKMIDRMGARPVVLVSLAISLLGTLPFIFVHENTNLIWLGLVLFVRGMGIGGLQMPMMTDIFIGLDKQDIPGASVGQRIIQNVGSSFGSAVISAVVTAVVTSEIAGQMTTKLHQLAAMHTNLTPTVIAKAKTSVEKAVTLNGYQLGFLVSSIVLIVIAIPAMFLSQKKVNK
>fig|272623.1.peg.774 Quinolone resistance protein
MTINQRTIFSGCSFKNTTFEFTDNTISEFTDCLFEKCDFSNLNFNKIGIYRSIFKSCKLLGTDFTESHLQDLQFTENLMTYANFSGSTLKSVRFLENEAKETFFTACNFKNVELLKNQLEAANFWETALAGIDFSTNQFERMEVTPQLAKNMKISLSQAPFFTSLFGIEII
>fig|272623.1.peg.924 Permease of the drug/metabolite transporter (DMT) superfamily
MNPLDVWYNIKMNVKKQIFKGTLYAVVAGCMWGISGIFGQLFFRDYHGSPLWITSTRLTIAGIILLAMSFSRDHKRFFDVWKSKKNMPTLFLYVFGGVFSVQYFYYVAIQLSNSATATILQYTAPVFIMLYLLIFQRQVPKPKSVLFVILAMIGVFLLITDGNIKHLSISPLALVTGLLAGVAVVIYSIIPRPLLDKYGALNMTGWGMMLAGIACNIFYPVWRIDFRIEPLSIFYVLTISIVGTALAFLLLLRAFQLISPLVVSVATATEPLTSVFLSIPLFGLKLTPLELLGIVMVIVSVILLSKSEQA
>fig|272623.1.peg.1383 Drug-export protein
MNKNNHFHLLGAVIATGILSFSGVLIETAMNVTFPTLINEFGLSTSKIQWVTTIYLLVIAITIPLSSYFNERFSARKLFLVANLIFLVGVLTNCFSPNFAMLLFGRLLQGVGTGIGLPLMFHLILTKAPLHKRGMMMGIGTLTTSIAPAIGPTYGGIISNSLDWRYIYIFLLPLVVISLVLGLACLPREGEKTPKKLALRPVIALSIMFFAFISALSAEHLMTFALLFIVGLVGAFLFVQFNRKESLIDLGILKNHRFVALIFSLLVYQALLLGLSFVLPSFIQVSAGFSSSVAGLFMFSGALIGAVLAPISGKVLDQIGARKPITTGLILAALGLALIFVFLPTKSLALLLGAHIVLMLGLGISYSNLMTCSLSTLATDQLSDGNALVNTLQQFIGAVATAVVATTLSIFQGLNGFKVGTSHGTSIILALFFILIIVSLIVSFPNLKKIRANH
>fig|272623.1.peg.1519 Permease of the drug/metabolite transporter (DMT) superfamily
MTKFKGIIYASLGAAFFGISSIIAGLLFNRCSIEPGWLVTTRMLFSGLLLLAWLAITKHNIFSVWSSVKSSLRIVAFGIFGVLFAQSSFLLSVYYGNAAIATILQSLGPSIIIIILAIKSKAIPRRLDIIAIFLSLIGVFLLVTNGNIGELSFSASALVWGLLSALGVCAYTLIPCPLIKEHPPLSLVAWALLIGGVISNFLHPVTNLPKNFDQTDLLLVSLIVVVGTLLAYSLYINSLKYTEPHIVGMLGMLEPVTAILISTLFLGVSFLGFQQLGIFVVFLSLFLINFPAKKK
>fig|272623.1.peg.1580 Drug resistance transporter, EmrB/QacA family
MNTELETNTANHKISAKTRFSIVAVALVAFMGILAETSLNVTFPTLEKTFGLPLSTVQWVTTAYLLVVAIVMPTSSYISQRFQNRTLFFSGLIFFTLGDLLSLISPNFTILMAGRLIQGIGTGIAIPLMFNLVLTKIPRERVGLWMGFAGMILSIAPALGPTYGGLLTGTLGWRMIFAIILIIPICLFPLGAWAIEKSEKKRPGKFDFIAFIFLSLAMTSALLALDSLSSAHFSWIWLVVFILGLIAFIWRSKTSTLNFIDINVFKSPTFTLSVLVYCILQFVNLGINFIIPNFLQVSLGTTSTLAGFALLPGSLIGSAAQGPIGALYDRKGAKGILYSGNTVFFIALVLLTIFTKNLTLLGVMGLYVVFTIGRSSSFATTMTNSLAQLPHDKAASGNAWFTTTSQFAASAGTATASLIATKSSNLTTGTQHVFMFFLCLALLNFVFYTLILNKKIK
>fig|272623.1.peg.1822 Drug and analog sensitivity
MEFRLAKKSDAKRLLEIYKPYVEKTAITFEYEVPTIAEFEKRIEKIGSRYPYIVAIENDKIIGYAYAGAYRERAAYDWVVELSIYLDENERQHGAGSALYQKLLTALSVLNYQRAYACITYPNPASVAFHKKFGFEQIGLFPKAGYKFEQWYGIVWLERSLQTTDKVTAIKLLTDLSENELEKILAN
>fig|272624.3.peg.3 Multidrug resistance efflux pump PmrA
MKEKFATWYKIVTKHIRFFFSYSIPMFFKKAKNYINLPIIVVGLALIIGLFHLFSYLIPFTDNAFVVTNVTPVAADVSGFITEIYVKNGQKVKKNDPIFSVYRVPYELAYQQAMADYKEGLKKIDVFQKQIERTVALIKATDAELEKAQFALGLKKNKNVAEAVSVLELKNLGYDVSTLSNKRNALQQEVAVLQAKIEQQRHTVASLKAKMDNAKVNLDLTIVRAPGDGVIDNMYVSPNTPIEIHKPVFSFIDTANYYIQANFNETDLRNVRQGDKAYIILRMYYFDKIFHGVVVNSLWAAERQSTAPKSQIQVVTNQNEWLLLPQRFPLQIKILDPDPDYPLNPGASAYVYISTKR
>fig|272624.3.peg.105 Drug resistance transporter, Bcr/CflA
MKKNALLIVLLTWFLGNMDIHFLTPALPSLVDYFSVTPNTVQLTISLFLLGKALSMILWGLLSERYGRKPIFIGGLLLFILSNFLIALNHSILPFLVCRFLQGISVGATLLMGRAMINDTHNEQNATKYFAWLFTLAGLFICFLPFFGGLINSYWNWQIASLIIAAYGLLLLPLCRGLKETKPHYVKFPRLGHSIMVVFNHPLFVSYLLISALMMAGESAFNTSASFILIKGENFTSAQYGTIKTTMAIMHLLGTACCGLIAKYYHSIQLTKLGVRFFIFAAFLMWLFVFSAENIYLTFIVPMVIYYFGTGFIVASATASAVRPFPQQMALALAITLFCQFNCSAFFSFITSMIGIQQVETFMFLLSLVSILSFLALLKLQRMEPC
>fig|272624.3.peg.106 Multidrug resistance protein B
MNKLVQKMMLSGQFLMILALEMTNPFLPLLIAHQSNTPVPSVVIYNTLSLVLPMLANILLTPIWGLAADRYGYKPMLMRASWALVLTQASMIFVNSVFWILIIRLLQGAFAGFLVAMQTYALSITEWQSKSTQLSRLQSSKAIATSTAGFLGGLALSFTNYQGLFGLATLICLGTTVVMHYKLPSPPKQQIKKRSQTLNHSYTSKSVFFFLCVLIMLTQIAKFLPDPGFTLYLNKYCSNNLVLIGFLYSLPAMGMLCSSVWCGKQFDYCRSQPSLVNQYLIRYSVFGAILMIIQANVDNFYLFALIRILWGIVLAALLPALFALCSDRNLLPGYALGLANSFAKLGNLIGLLLGGLFAFYLPYPAIFMIIAGIYSLFAIFVYGYDRLNVRQMTDFSNSYFNVKS
>fig|272624.3.peg.435 ABC transporter ATP-binding protein Uup, erythromycin resistance
MNHKPIQFKDLSLIYPHKTCFQDFSGEIHFADRIALIGRNGSGKSTLLKMLCGLFLAPAGEIKIPHDVRFGHLPQVLENCPDLSGGQRLNRVLSKILSYEPNVLLLDEPTNHLDRRNRCSLMRMLEHYPGTLIIASHDIELINTVTDTLWHIDLGQVTVFRGTYFDYQQILEDKKASIEQELSRIVRQKKESHLALMKEQERNKRARVQGEKKITQRKWPTIRSHTKLGSAITTGNKRLSHINYKKQQLLEELSSLNYPEVIKPKFRLKGLGHHKPLIRIQDASVAYEAVVILENIHFHLSGCERAALYGKNASGKSTFVKAILGESQIKRTGEWAVPDCNTIGYIDQHYQHLNFNETVLDLMRSSMPHAFHTEIRAHLNDFLFRKNEEVEIKVKNLSGGEKARLSMALIAANPPKLLILDEITNNVDLETRTHIIQVLREFQGAMLVISHDYDFLESIHIETRYQIHQGKIHHFNEKQLEVVHHD
>fig|272624.3.peg.733 Permease of the drug/metabolite transporter (DMT) superfamily
MNSQEQRGSFYAILSGFLYGFIGYFGISAIHGDLSASNMLFWRFLISSIFILIVLIPQLKNINDTYKSMFTAFLSGVLYYGLSTLLYFYASLYIGSGLSMVIFFTYPVIIMVFNYFFYSQTIPKIYYLAISVILIGMALLIDVNEIAFDLWGIFLGLASAFFYACYIVSSKNNEISPNVSTLMVCLGCMTTSLIVACLDHTFKVPTSFPVWLNLFGIGLVATVIPILLMLHSLKYISSEKASILSVLEPVFVVIFGVVLLGEELKPWHALGIVLVLAGALITLFSHRINLNQWLGAIYKS
>fig|272624.3.peg.1081 Drug resistance transporter, Bcr/CflA family
MNSDRRFAIGIFYFADVEANALFSNTFVLLVNNDIVISLVRNHSKGYLMHQEHPGQTDTPKIDPWLIFVILMLMALMQTTTDQYIPSLPAITTALNSTEASIQLTISMFMLGLSLSHIFYGPLSDKIGRKPPLMFGVGLSILGSLVCFVAPNVSVLILGRFLQGFGIGCCNSVGRSLVRDLFTDRLLAKIGSYVGVVSIFIMAASPTLGGFIQEMAGWKANFMFLFVFGILVWLLAFCILPETNKHLNPEATKIKVMAKNYFTLLRSKIFVGYTMCACFAFAGMVSYLTIAPFLFQNTMGLSPLEFGRLTFFIAGAICFSGIVNSQLVMRKGISFMVCTGVLFMIVGGLSLLLITILGWSQIYFIMISMTLFSAGAGFTFINAFAGAFHPFPQMAGTVGALYASMQDLSAALTSGFIAGIKGYGQYSLAIILLILGLSSLVAWYYLGLQDDAISN
>fig|272624.3.peg.1220 Multidrug resistance protein
MLSVLSYRLSLLPKLSKTCYLLLLFSFLECVAGGIAYYLSLYLGTSTPLTKLQIGQVGSIVGFGALAGALCSTYITDKLNNKNIIIASFLFLGLGFFCLPQSMSFLLISGCVFIIGFATSIFLTTNNTLLLQNAPQDQNSLRFIQSMKIVSENLGNSFSILLIMFFAAQYYGQIFEVIGLFFFLFALNTMKYLNVKQNSLEDSSYEEKETNQQGNNKRLYVTISAVFIVGIIYAQQRIAYPLFLHEAFSSFTITAILFWLDPIIVSLFQVKITKIVSPLKISHQLAIGGLLLGTGLFALLIVDSIGGAIMACLTFILGEMLFMPTSFVRCYESAGNKRKGMVAGAWRSAYSSGLIVGPVLSGFLMEYYSYNACWILAGILGFFLFILFSVKK
>fig|272624.3.peg.1227 Permease of the drug/metabolite transporter (DMT) superfamily
MANLFSFLFLGTLGWGMSLYLMKILLVSLTPTEIVLYRMAIGAASLFILAKLFKLKTDNIRGLILDGIIVGTFNMTLPFYLTTYAVKTVSSSLASVINGLTPLCTLILGMVFFSSKQKLGVLNLLSIVLGFIGIIIINSDVSIYQGSAVEFIALLATTISYGVTANYFKYHARTKEPILVSAVSAFVSAITMLIFKCATESSINSWGIPQGMNQIIALLWLGIIGSGFCLYLYCSLIQNAGAVFASMITYLMTITGVIMGMIFLHETISHQVMIGCIFIFFSLILVNHAPLLEKILVSISRQISLKSARRYELNQ
>fig|272624.3.peg.1303 RND efflux membrane fusion protein, acriflavin resistance protein E
MNKRLTIMGIILLVVFGGIIAFNLIKAYMIKQFFASYAPPAVTVSSAVAQAVDWKPTIDAVGNFVAINGVDVNSEASGNVVQIHFESGQYVEKDEPLITIDDSIDQALLKFNQSELTLKELSYKRQTDLFKRGATPSSSVDEAKANLQQAQAKVEQIQAQIKQKHIGAPFSGRLGIRQVNLGQYVTPGQTSIVSLQSLDPLYLEFYLPEQYYKRIHLNQPVTFRVEEFPNILFEGVIHAVNSKVDLTTHNVQVQALLPNCPADAIQDPTKSPLIKARKQVRGDKLIVACSTELNKQNKIRNFVFIPGMFASIEVDQPAEPNTIIVPSTAISYSLYGNAVYIIEKSKEGKKNKDGTDQLVVNRVFVTTGEQQGNYTVIKKGIKAGQLVVSTGDLKLQNGTPVVINNSVKLDTDSDPNQLGQ
>fig|272624.3.peg.2285 Glyoxalase/bleomycin resistance protein/dioxygenase
MTQAAFGEFCWNELATSDVKKAKDFYGKVFGWQFREIESKEMTYTLIQCNDKEMAGIWQIPKDQQSHIPPHWMAYIYVQDVSEALKKAKQHGAQEVKGITQAGEMGRFAIIVDPTGAHVALWESFE
>fig|272624.3.peg.2500 Permease of the drug/metabolite transporter (DMT) superfamily
MVIDVKKSNTYFIQGMLFLIFAQIMVGINIVFSKYVLSSIPVLYILALRFTLAAVILLLLHWLTPAKKLPMYSYFLQLKRRDWFFIFAQALSAGVLFNFLILWGLQYTDANVAGIITSALPAIIAIMSWLILGEKISGKKAICVGFATLGLVVIACDKLGDINVSHSFLGDALVLTSLLPEAMYYILSKMHVNSLPVFLISSLLNGINAILLLFCLSFSTWDSFTIHTLDWLILIILGLSSGLFYVFWYFGCQTVDGVMASLSTAIMPLATVTIAWIFLGEQLTIGQIIGMGMVILSITVYAKR
>fig|272624.3.peg.2781 Bicyclomycin resistance protein
MFIRNLQLFIVVASCILVLIGTDILLPSLPNIAHALSVSSNEAKMLISIFMIGQFSTVLIWGVIADRLGRRKTLFLGMLIFFIGSIFSLKADSIQLLLACRFLQGTGAVVVPVAGWALVQDLFPKDEGARIMTWIGTLTAVIPLFAPALGGQLDVLYGWRSNLYCIAFYSFILCVIMLFLPRTIPVQKTTTADLKETLSIYIRIIKNKTFISYIALFGLLNCGEWCFLTVAPFYYSHAHIAADTMGILLMITSMGFVCGSLLASRLFNRLGIDKIIALGIQLAVMSSLMLLIGEYFHWSKYQLYNAITIGVYILSSALLWGATTSRALQCFDDCRGSASAIRSLILLCFAAFGTYSGRLVNHNSLFPVGLFLLFMAFIAFIVFNNKELKTERHMEGIPI
>fig|272631.1.peg.1262 Probable multidrug resistance pump
MELRPFYPSVNWGYALPDSLWWIAKAWAISAACVVVLVMLSFITRWGRQYWRITRGYFIGPQSVGVWLMLAVLLFSVVISVRLNVLFSYQSKDLYNALQAAFEGAGAQNDLVKQSGMHGFWMSLGIFSILAVIFIARVMADIYLTQRFIIAWRMWLTNHLTTDWLDQRAYYREQFIDNTIDNPDQRIQQDIDIFTAGAGGTPNGPSNGTGSTLLFGAVESVISVISFTAILWNLSGRLAVFEFEIPRAMFWIVIVYVLLATIITFWIGRPLIGLNFANEKLNAAFRYALVRLRDAAEAVAFYRGEEAERKQLEQRFTPIIDNYRRYVSRTIRFLGWNASVSQTIVPLPWILQAPRLFAGKINLGDVGQTATAFGNIHDSLSFFRNNYAAFAAFRAAIIRLHGLVVANARSRELPHVTAKSTNDGTVHVVAVEVRTSAGEQLIDPLDLQLNCGSSLVITGRSGVGKTTMLRSLAELWPYASGTLSRPDGKNETMFLSQLPYVPLGNLRGVVCYPNAPADIPEDTVRDTLTKVALNPLCDRLDEERDWAKILSPGEQQRIAFARILLTKPKAIFLDESTSALDEGLEFALYQMLRSELPDCIIVSVSHRRAVELLHAQQLELLGGGQWRLGPVEKEPLHV
>fig|272631.1.peg.1655 Multidrug resistance protein B
MCAAATIGAASLLGLLAGRRAGLAVDFFINVRRYLSARPWRFGLGLVLSTQGHRFDLISVGLSESGTFLIVFRL
>fig|272843.1.peg.1049 Permease of the drug/metabolite transporter (DMT) superfamily
MTKLSIQRDNLICLSYVALMGFGFPIMRYMSIHFDTLNNNAVRFLSGGSVFILACFFYYRAELTRVFHQPKLLLSFLLLACFMTANMYFFINGMKYTSALSGSIFGVLAMPLSIFMAAIIYQDERKKVMQIPFAVGSSILILGSLLFVLYGQHSASDSDFLLGSLFLTLAIFIQSIQNLVVKQVARGTNVVVLSAFTAFLSGMIYLVWALKSEIIFRLAEVSIGALVELSLAGVYGMMTGMLLAFFIVKTQGIVRFNVIQLLVPISTALVGYVTLGEVMNVYQGIGALCVLLGCILCLRIRT
>fig|272844.1.peg.223 Multidrug resistance protein
MERDAKVLVIANAVGQLFLQFSWFVMPFYLKVLGYGMDKMGVLFSVQTFIGGLSFLLAGQISLRIGYKRTLILAALLGLLGRILQVIGYNFYILILGFFLVGINMGLRDPNYSALLSEKVKSEEERHRIFSYSFGLGTLMNAIGVLVAGYAPGYLISLGYRKEIAYRLVIALALLQFLVVIPALMLVKDVPVKESRIKWRKDLIVRILKFSLPSAIIGLGAGITIPYMSIYFNLRFGRDIKEISWVFFGQQLVMGLGSFILPELVRKIGAVKVITYFQWSAALLFLIFPSIPTFILASIVYVIRSILMNIVWPVNDSFMMGFFSTEEKATAAGIRRAFSTFMRGAGNYIGGLLFAVSLSYPFYATAILYIFATAMFYAFFIKHN
>fig|272844.1.peg.1139 Multidrug resistance protein (multidrug-ef flux transporter)
MNRNFWLFVAGRFISQLGWAIQEVALPLYVLDVTHSAKIMTLFVLADLIPSIITTPIAGVFGDRYDRKKIMVGFDLIRGVLLFLVIAFNFLTIRCLLVVQVIMAIMNAFFSAGTGAMYPDLVKPEELERANSIVMSASIISRLVGPAIGGFVYGFGGIKLAILMNAISFFGSGLFEIFIKYEWKTRNIEGFSDFVRDIKEGLKFIMSNSFISTLIGLVILLNALGAPFASIIYPYAMREILKFSSQQFGLVESAFMLGALIGNLIVGAFLGAKAGRYIFRLFLVNGAVELIFILIISPFLALPRNSAFMLLLVLGATMGMAGAMINVPLASKLQRAVPSEIRGRVFSTMEMLARIANPLSLVVVGPLVDTIGAWKTASFLWLGSGVVILYYWIFKGKELTSEEESKLVENFPGVPPED
>fig|272844.1.peg.1385 Multiple antibiotic resistance protein related
MLEVLKTFAVLYVGLFAITNPVGAVPIFMGVVSHLAPDKRHEVAEKVSITVLVTLLTFALVGKWIFKFFGSSVDAFAIAGGILLFRMGMEMLSGKLSSVKIDEEDVTLEEVAVIPLAIPLISGPGAITTVMLYMTRESPPIVIATIIAIGISVYIILASGNKIIEKLGRVGIKVTTRMMGLILTSMAIQMIINGIKGAFGI
>fig|272844.1.peg.1459 Multidrug resistance protein
MRPRELAILQGLQEKSGKIRKITMRKNILMFAIGMFFADFAWGLGFPYLGVYMKLIGGTMFLVGLLSVVYNLTSTIFQYPFGYLSDKTGKRKPFIILGILASGTTYGLVALITSPILLLGLRAFQGALGASLAPAHSALISELSPRIGSMFGFFGFVENLGFMAGNFAGGYIVKTLGMKMMFIITSLVSLIGILFLLKIKERGRAKAGGDRLIIVKEGRESDRVELKEIAFKKLMKGRLGIFYVAVLLAMIASGAVYATVSVYFEEKFGEEFVGYLFGIDSLSAALSALIIGRLIDKYGEKLFFRLSLVGYIITFMGYALANSVIIMALISILSGLKWTMLTNSSSTYVARRVPTSERGQGMGLLNTMMTLGWVIGPLIGGILADNFGFAVMLYSTVPILFLGFLLSFRI
>fig|272942.6.peg.926 Bicyclomycin resistance protein
MAFLNRKTPPHIVTLVLATGVAALSLNIFLPSLPGMARHFGVDYGLMQLAVSAYLAASAVAQFVIGPISDRYGRRPVLLWVVAIFTLASVVALFAPNAHAFLAARFVQAVVATAFVLARAAVRDMVPGPGAASMIGYVTMGMSLVPMIGPAVGGLLDGLFGWQANLAVLALSGALLFALVWADMGETVSGGGLGFGAQMRAYPILLRSPRFWGYALSAAASAGLFYAYLGGAALVGEQAFGLSPVEVGYFFALPSLGYLIGNWISGRFSLHLGMDRMVLSGTVLATAAIAVALIAKAAGVLGPITFFTAVGVTGIGNGLSLPSANAGLMSVRADLAGTASGLGATMTIGTGAVLASLTATFLGAEVEVARLLWVMFGSSALSVAAILWVMRRPQ
>fig|272942.6.peg.1353 Permease of the drug/metabolite transporter (DMT) superfamily
MSDVFSAPRPRAETAAFALSALAAVFWGSNFEATRVVLQEMPPWTAAAGRFLIAALAILGWLWLAEGSGLPALRRNWKVFLGLGVVGVAGFNAALFLGMRSSSPVTAALIMGTSPLTTTLIEAALTRRWPKAGTLAGMAISLVGVALTVGAFSGARLAPGDGLILLGSLAWALYTVGCRRWVVAASPLETSVWTMLAGALALLGAAFALETPVASVLAASPAAWGATLWMALAGSVLAYLFWQVGIQIRGPGATSVLFNLVPVSALAIAALFGRTPELSQLAGVALAILGVLLASGRLTVPRR
>fig|272943.3.peg.158 Permeases of the drug/metabolite transporter (DMT) superfamily
MENLRGIVMMVVSMAGFAMEDMFVKLAAANMPTGQILMLLGLFAAPLFWALARREGKAVLSREALAGPILWRNGGEMVGTAGFVTALTLGQLSSVSAILQAAPLVVTFGAALFLGERVGWRRWSAIAVGFVGVIVVIRPGLDGFDTASLWAVLGVAGLAIRDLATRRVAPSTSTMQVGAWAFLTVAVLGAMMLAVGGGATWPTPGQAALLLGAVSFSFVGYWTLILATRVGDVSAIVPFRYSRLVFAMLIGFLVFHERPDGWMLAGAALIIGSGLYSFMREQRLRRLSMRAAAE
>fig|272943.3.peg.289 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDQCSLHVTDLERSRCFYDAALGRLGIPTGRAARSGVHWVGDGVEAFSINEIRSGRNARQVREAHLAFVARSRPAVDAFHAAALRAGGRNDREPGLRPEYHPNYYAALVLDPDGHRIEAVCHTPD
>fig|272943.3.peg.399 Permeases of the drug/metabolite transporter (DMT) superfamily
MISQDRTRAAAGFILLYAVVIGFTDNYVRVIADEAGLWQFHLTRSVMALAILAAVAPALGLRLRPVDWRAVAARSAIHGTAMLIYFGALAFLPVAQVAAGLFTAPIFVLVISRFVYGERIGPVRVLAVLTGFAGVLLVLGPEAMAGASFAAGLPVLAGLLYGMGNIATRAWCPQESAGTLLGGFFVALGVLGAAGLAVLALVSLPVPEGPDGFVMRGFVVPSQDFWFWTFVQAAGSLFAVGMMIRAYQAATASRVSVFEYVILPASAIWGWLLWDERLSPVAAAGMALIALAGIAIAVGSRPPAATATPA
>fig|272943.3.peg.447 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLASLLLVVLASFIHASWNLLAKTAASVGPVFVFAYNLIACVAYAPWVLYLLIHDGIIWTWTGIGFVLLSGLIHLAYSLCLQRGYQVADLSVVYPVARGTGPMLSTLGAFLILGETPSGTGLIGLALVVAGILLIATRGSLAAFTRPGGQAGVRWGTATGGLIASYTVVDAFAVTALGIAPVVLDWFSNLLRFFLLLPLVIADPRRALSAMRGHWGAAIGVGLLSPLSYILVLAALTGGAPLSLVAPMREMSMMVGALLGMLILREAVGRWRLVGCAVLIAGVILLSAG
>fig|272943.3.peg.590 Multidrug resistance efflux pump
MLELLLTSFPAIFRYYQLKRRAEAMTVWNMRTAVFAWAVMAMGLFLVIFYFHPKSYSGLLPFRTISVVAQTSGPVTEIHVENGQRVAAGDLLFKIEDSSQKARLNQAEAEFDKIAAAEIKAQDTLRVALASVAAATSTLEKLSVDRDNARQLLTRNVGTQDTLRQTEASVAAADAEREAAQAQADLARAELSQAIPAQHKAAEAALQVARADLAKTEVRSFSDGLVTQLALSVGSPAATLILSPAMLIIPDRPEDLPLRFTAGFNQVARSTLYVGMPAEIACNTNINLSFRDTVLPARIQAIQPAIASGQVVPGGRLLEAESGMQRGSLLVYLELIHPEQESITIDGSGCVVQTYTDNLDGIFGHVIAATGVIKAAGLRLKVWGAMVAGVGLGGGH
>fig|272943.3.peg.631 Permeases of the drug/metabolite transporter (DMT) superfamily
MTAWILSLEGTPEGARIALLLALTSAFAHACFGALQKGRHDPWLSRGAIDSFMLLLSAPVAVFLVPWPRGVEWLVMAGVMAIHLAYKIAMARAYSRAAYTVVYPVVRGVGPLATLAFAALFLGEHYVAIQWLGVAILSAAILALARLNFTASPQIGRMDLKAGLVWAFAGGLMVAIYTTFDAWAIRLMPDPFTFLAWFFLMTSLDFPLLLGYRLLKARQMPEAAAALALRGFVGALVAFVSFGGVMLGTRLGKVAEVSSLRETSTLFAAAIGWLLLGERSGPAKILLMGLIALGAILVQLA
>fig|272943.3.peg.871 Permeases of the drug/metabolite transporter (DMT) superfamily
MSASARSSSEDRIPLAVTSIILTVLALSLGDALVKMTSGSFVIWQIFVVRSLILLPILMGVALSLGCLRVPQAGIWIAVRSLMLIAMWICYYLALPNLSLSAAAAAYYTLPIFITLFSAVFVGDSITAKGWAAVVLGFVGVLFILRPSAGDFNLYALLPLLAAMLYAGAMILTRTRCQSEHPVILSLALNLGFIIAGGIAACLIWQLPADMRQGFLLSEWTAMGWSEWVSMGLLAASILIGSIGAAIAYQNGPPAMIGAFDFAYVGFAVLWGIVFFNETPDLIASIGMIMIVGGGILSLRQ
>fig|272943.3.peg.1937 Permeases of the drug/metabolite transporter (DMT) superfamily
MPAQQSLLSATFWMAGAIASFSAMAVSGRMVSGIHDTFEIMAWRSLVGLAVVLLWATLSGRLGEIRTRHFGGHLVRNLSHFTGQNLWFWALGLIPLAQVIALEFTSPLWVILLSPFLLGERITSLRALSTVVGFAGILIVARPDFAALDVGVLAAAGSAVFFAGSIILTKRLTRHDSIVTIMFWLTLIQAVLGLLCTFADGETTWPTTVSGFWLVMIGLSGLAAHLCLTQALARASAGFVVTVDFLRLPVFAILGMILFSEPLDAMVILGGGIILAANWISIRAAGRASRPQDAR
>fig|272943.3.peg.2113 Permeases of the drug/metabolite transporter (DMT) superfamily
MTASSDRILPGVALMIAFCVLAPLLDVCAKLASATIPVGQITGARFLVQAALMLPVVALMGTGWRMSRRMAGLVALRAIFLILSTYSFVAAVTVMPIADALAIAFVEPFILLILGRILFGDEVGPRRIAASIVGFGGALLVIQPSLVAFGLVALWPLGTAVFFAFYMLVTRQMSRGMHPVSMQFHTALAGVLLLVPVMAWGHAAGVPSLTLVRPDGMGWALLFGVGFWAAASHMCMTYALKFAPSATLAPLHYCEIVAAVGLGYLVFGDFPNLLTWAGIGTIAASGLYIIHRERLSARVLPTPAPAP
>fig|272943.3.peg.2577 Permeases of the drug/metabolite transporter (DMT) superfamily
MAKSNTRGALLALLAFAIYATHDVVVKVLGRDYTAVQILFFATLLGFPLASMMLMRDRADGNLRPRHPWWVLLRTCCIVTTGLCAFYAFSVLPLAQTYAILFTMPLLVTLLAIPLLGETIGLHRGAAIATGLLGVLIVLRPGAEPLSLGHAAALLAAVTSSLGSVIVRKIGQDERSVVLLLYPMVANFFVLGAALPFVYRPMPVEHLGMMGIIAAFSFVAMLLTITAYRMAEAVIVAPMQYSQMVWAAIFGWLIFGERSDVWTWVGAGVIIASGLYIVGRESRRNVSENRPASQTRLRPEVGLMPRLLRRRETRDTP
>fig|272943.3.peg.2642 Permeases of the drug/metabolite transporter (DMT) superfamily
MTEQNTRLGIGLMVLTTCIFALQDGISRHLAEHYSVLMVVMIRYWFFAAFVIAVAARQAGGLAPAIRSRFPVLQVLRGLLLAAEVCVMVVGFVKLGLVASHAVFICYPLLVAALSGPVLGETVGWRRWLAIGAGFVGILIILQPGLAVFSPWALVPLAAATLFATYALLTRYVARGDSAAVSFFWTGTVGAVAMTAVGLWHWEPMAPGDWFWMAALCCTAALGHWCLIRAYEVAEASAVQPFAYLQLPFAAMLGFFVFDERPGWNVVLGACVVVSAGLFTLWREQVRARARAGR
>fig|272943.3.peg.2680 Permeases of the drug/metabolite transporter (DMT) superfamily
MSLFVLLAVLGAAFLHASWNAIIKVGTSKVAAMVILSVAEVPIGLAIALTRPWPAAEVWPWVLAAGCCHFAYKSFLTFAYEHGDLSRVYPIARGAAPMAVALVGAFALSDAVTAGQYAGIAVLGAGILLMARGVFTSGEERRLLPFALGSAAATACYTMIDGLGARVSGDAVAYVAWVFVADGLIFGTGMVAWKGTALLRADARAWASGTAACAASYGAYAISIWAMTVAPIAVVAALRETSILFAVLIGWLVFGERMTRDKAMASALIVAGVMLTRL
>fig|272943.3.peg.2904 Permeases of the drug/metabolite transporter (DMT) superfamily
MAQARRLVRPLDAAGLAIMLGLCLVWGFQQVAMKAMAGAADPLLQVAVRSSGSAVLVWAYSRFWRRDRWLAGLTWREGLLVGALFGVEYLFVGIGLRHVGSGLMSILLYTAPLFVAVSLHLTLREERLTGRQWIGCLLSFAGVVVIFLRPGEALRGEEGAALLLAGSLCALLAGFCWGMTTVAVRLTRLSGAPFAQTLFYQLLGGALCAWPVVLAEGRTGWAGGLDLWLLTFYQTVIVCFASYLVWFWLLQRYLASRLGAMSLLSPVFAAALGAALLREPLTPGFLLATALIVAGLVTVMLHDRRERPRLLPPR
>fig|272943.3.peg.2916 Permeases of the drug/metabolite transporter (DMT) superfamily
MSARPAVPSRTRTLEGVLWMLASGVSFVGVTGIVRYLGTDIPAAQGAFLRFAFGALFLLPTLVPVLRQGVPMSTLKLYGLRGAFHTAAVICWFYAMARIPVAEVTAIGYLNPVLVTVGAALFFSERLALRRILAVAVALVGALIVLRPGLRELSAGHLSQLCAATLFAGSYLLARRLSDVAGAGAIVAMMSATVTLGLLPFALLVWVPVGVDQLLWLALVAVFATAGHYCMTRAFGAAPLTVTQPVTFLQLLWATLLGALAFGERVDPFVLLGGGIIISAISYITWRESVLKRRASAVALENT
>fig|272943.3.peg.3276 Probable antibiotic-resistance protein
MLIDFSSRPPHPDFSPPAPHLQNYRRVYQASERRSAASDAAQGLDSWLETYERLGARHVVLKARDLTTTFGFRISNEAVAEFIRAHGPRYVGFAGVDPWQEDAVDHFDHAIRHLGLRGLNLQCFELKMRPDDERLFPLYEKAIELDVPVNIHCGINFSTHTPMALGRPEYLDNVMVRYPELRAVASPPGWPWVQELIGVAWRHPNLSIGLLAVRPKLLAKAHSGYEPLLQYGRTLLKEKIIFGSAFPMMPVETALAELDALGLDADTRRLWLHDNAARLLGLDTAAT
>fig|272943.3.peg.3688 Permeases of the drug/metabolite transporter (DMT) superfamily
MPSRSLSLLCVILAAVLWGTTGTVQSLLPPEREPLIVAAIRLAVGATLLTLMALRLPESRRAFRRLPWRPVLVAGLAIGLYNLLFFVAVTQAGVGVGTAIAIGSAPVWVTLYEAAVLRRLPTGVRAAGQVLSVLGAALLVAGAGAGSASLTGAALAAAAGAAYATYSVATSRVGAQVPSDTLAAATFGVAMLLAAPALFLLPVSWVADLRAWPALLFLGAVTTGVAYALFTRGLAGLATSTAVTLSLVEPLTAWILAIVVLGEAVTAQRLLGAALLFAGLAIVTLAPARPAVRATRGENQRAGTSRG
>fig|273057.1.peg.498 Multidrug resistance related protein
MGLKQTLKEIYYIVADKRLLYFSLSLGISTFAYSLLTYYFPIIMTNLDITTFTIGIIYSIISFLYVVFNIPLGAIVDKIGSKNAVTLSALMAVPLFLLMGTLNPLLFIISLVIFESVIRIVNSLGAHRFMLNYTNAGKAFGVFSLITSILAAIGIMLGGYLLQHSVSTLLFTIIAVLFGISGIIRFLELPKDENKVEVKRSLRLGFKYLKEDKKLLLYLLVSILSSGLSLETYYVTIYFVKDLLLPLTFVGVLYSSYALIMAFLPLLFSVILSKRSNFKNLSILIFSNSVIFFLVPLFTNVYILFLLFYAWTVIVAMESIVDYNVAQSVTKPEIRGTQVALISTFVRIFSVFYNAIVGLLFQITPLYSFYFTGFLGILAIFTIKFAEFIGVLK
>fig|273057.1.peg.551 Multiple antibiotic resistance protein MarC
MSELVSIPEIAFKLYAIMDPLSILPYLIALYEEFNRNSQNKISWRFLVNKLSIAVTVLLLFFSILGGPLLAFLGISVSALEIGGGIILVYLGVDTLGGFQQLKFLSSRIEEAIITPIATPLIVGPGTMTGLITLSVSNNLIILILGSLLAALLVYLSLLLGPIIIRILGNTGTVAVGRFMAIIIAAFGVQLIIDGISQIKLI
>fig|273057.1.peg.897 Fosmidomycin resistance protein
MKIRILTLTSLSHFINDGNSWVLPVTFIFLITYLGISKFLIGILSGAFFFGISALASPLVSKIADKFTNYSSIMGIGILLWGIGLISFGYSIQLHFLPLVFISVAIAGFASAFYHPIGAAVLSITYKGNAGIALGINGSMGSLGRAIYPTLTLSLFAILNKDMTLDMLIIGIISIIAALPSIFLKISITKEEDHKTPSSSNTTSTRGTLFVVILLTIIALLRSIFGQGISQFLPTLLVENYGYSYNVNLGEAITIALAAAIVGQPILGFLSDRVGRRLIYAISTFGAALTLLLFLKIPNIALLSLFGFFNFSAFPLMLSIVGDFVPRNSASFANSLVWGLGVTGGGVIGPIVVGAVSQVSNLVFASEIVTIMAFVAGALTALIPKPPKRTKVPLFG
>fig|273057.1.peg.1024 Multidrug resistance protein
MLKNRNEVLKISFSAFFADLGYQAVVASFPIIFVLIFKAPIPLYGFAEALNYGIGTVMAYAGGLAGDRFGRKRIAILGNVLILFTSLIGLSRDYIQALIFFMIGWWFRNFRSPPRRAMMAEVTSPEERSEAFGILHSLDIAGALIAIIYLTVLLYLRVSIFFVLLFTSIPLLMSTIVLTMVNAGKKSEKAKRKEAESKITQKRVFWTLILSTMFFGFSQYSFGFPILTTTEITGKEYLGVLSYGIFLGASSLFGYLFGRIRMKEFESLAFLGYLIGALGSLGFAYLSSFGVFSLYPLSFLMGTSVASTETFEPTIISKITKEEAFSTSMGYLSAGRSIGIFLGNVIMGFLYQISYTYAYLFAAITSLISFALILNLIMRPNAS
>fig|273057.1.peg.1190 Antibiotic ABC transporter ATP binding protein
MIVVSNIVKKYGNKIALDNVSLEVKKREFVSLIGPNGAGKTTLIRILLTLMKPDRGEVQILGENPFKSKRIFKEVGYVQEIPNYPPFLTGKQVLELSAKIRGVDKSEVNRVLEFVEMENYANNPIVKYSKGMVQRIAIAEALLGNPSILIMDEPNMGIDPIFSLKTRELLNKLKRKDNVSILMTSHELEDVKKLSDRIFMIYKGKIVFSGTVEDMVKEFLGIQVVVETDEIEKAEGVLKGIEYVKGIFNDGNRLIAKLNEDRREELLKDLVTSGVKVKGFYIDLNLEEAYMRALGNV
>fig|273057.1.peg.1389 Multidrug resistance transporter related protein
MERAFLRYVPILAFITIMTMYVEMVILPSLPEIENQFSITSSEASWVLSSETLAGMTLAPFLGKLADSYGRKKVLISILVVYILSVFLTAISPNYSILLISRSIQGIGLSINPIAYTILRERIPDRELPIAQGIIASTFAIGAAVALPIGSYISQYFSWEFAYETAIPLLILSTIIIYVILPSSESKGSDRKIDDVGVILLSLSFLILGIGLTEAPTWGWTSLQFFTSLLLSILLFYLFALHISKSRNPIIDPYDFKNPNVAVPLISSFITGFGLFLTFQSLVFIFELPSPIGYGMTILQTGETMAPIALIILIAGPFFGRLVTKIGYMKVILTSSSVSSFLLLFLAYIISLRISVLELMGFLSLILFFISGMNVTRVTLLIASSKRERMSTLTGTNTSMRLMGNTLGPIVVGSLEDTFKTPIFEGYLNNIPIFAFVPSRLAFEYAFLISMATTVLVTILATRIRERPSTTTYA
>fig|273057.1.peg.1734 Multidrug resistance protein
MDPKGTMRTLITLTLMLTLVNYVETMVIPALPKIEDQFSTTATTVAWVTSAYLIVGAIASPLFGKLGDRYGKKKVYLLSIGFYSLAVLLAGFSTNIYFLIFARAIQGLGYATFPLAIAIITDLFPKERVAWAQGILSATLAAGPALGLLVGSYIVQDLGWPYAFHTAFILSIILVIVSAKYIVEIPQKTKEKIDYLGATFLMLTVVPLLVYLSNGPNVGWTSTSQFLLIVISIIAFPIFLWVEGRTNEPLMRLDLFRIRNIMVANIAGLISGAGMFLMFTGLVYYLQLPKPYGLGLSIIESGLLMAPVALVMMIVGPIVGRLINNIGPKPLLMIGSIISIVGYLLLDTFRYSIYEVVVDVMITAVGLVNIMIPLVNMVAVSLPEEQRGIGIGMNTLIRTIGSSIGPVISTVFMDTYTTWIIYDFNNQIVPVAQVPSYSAFHYMYTAAVGIMFLNLIVALFTRNYVIKAGQHA
>fig|273057.1.peg.2022 Multidrug resistance protein
MKGIKIIVARVIYAIHWFYLAPLIPFLAGKLNLSLQIVGLIPLSFFLGSGIMQIPSAFLSTRIGLRNTLLLGLFIMSISPLLIPLSSNFIELLIFYLMDGVGASMFFSTGGGILASLNRDSPSLALGLYNASFAVGGLIGLNWYIVFGNYLSFYILSILTFLSLIINVNNSNLKPCWRIIRDNRIVILGISIAGIWGVYYVIGELYPTFAYYYLHLNLIDSSLFTSLLLVSSVIGGSLTFLADRKIKKFNLLIISSLLGSVPSLLLYTKVYLLGIVITGIFNELAISVLYSIIASLQRDANATMGLALVNSLNILIGMNFELLASYSGYYMWIAVNIIGLLLFSLIVLVRQNISI
>fig|273057.1.peg.2459 Permease, multidrug resistance protein
MNTNSILIVLTLGSLMAAVDTTIVLLALPTITSSLHTDLLSSIWVLLAYMIVISVLSTQAGRIGDLFGKGKIYNLGFVIFTAASALCGISSNIDMLIVFRIIQAIGGSMLVANSSSIVADVFPPNRRGKAYGITSLGWNIGALVGIVLGGVLTTFFGWQYIFYINVPIGIVAVLLGVMNIKDINKVNTKLDMLGAILLGISLALISLSLMFIAASGISTDNIIELALGVALIPFFLLNETRSKYPILNLKIFKIRLLTYSILANFLQGIGGLSLSFLLIMYLQGVRGLSPLDSSLLLTPGYVIASILAPFMGRVADRGKPGIVAGIGLMFIFITMILYFFLLTPTTDYYLIVGISAITGIGSAMFWPSNSTAIMFHAPKEYYGSVSGLSRTLGNIGTILSYVLSIVVATLSIPRSVAFEIFIGTTTLNGDVSVTFVNGLHFAFLISSIIIVVAMIFSFMSGKTQESAIK
>fig|273057.1.peg.2489 Multidrug resistance protein
MWLKQVMIKYKDTRWMYLIIPYNASTGPLSTLVTLQILSLGGNAINVAYAISLSNAVLIPASILWGFMADRMDRKKQILLSLAGVSIPLVFMPFMNSISLVTLNYALITFMSTASATPFNLLIMESVEKKHWGSLFSRFSLFSSIGVLLGLVISTFLVILLRIDQIEEILGFSVLATLIASIKILPKPIITFERTAIIHHKESFLTRMRHLPMMFLHLPNIHHFKMFSMTRLFRKPINYVPLLYLGIVLFYISSGIFNTVYPAGLYVKGLNKSEVLAVISVGMVFQILGFRISSMLLESKDEKGLAHISLILRGVSYVVLGIFAQLFLGIPIFISGLIFYPLAAGIAYAIFYSSSTTLIFKIVGERRQGTGLGVYSTVVGISLFLGSLLSGYITHYISYGIDFITAGIILLFASWIFRYLEEG
>fig|273057.1.peg.2608 Permease of the drug/metabolite transporter (DMT) superfamily
MKILKYLLPYVTITSFNYYFAKDAITFSSPIFFNLIRYVISSIIFLSISRGKILFNRDVIQLAVYTTVSSLLWAYGLLYVSPAESAVLSYTMPLFSIPISFIILLERPAVLEIVGVVIGFSGVILYGLPLVHGLTLFGSIITIVNALFWGLFTVFYRKLKGYDPITVNASQFSIGSIILALLLPIHHNIDPNPEFYIGIAYTSTLGGAISFFLWNMMVKAEKIPKVTVLSFSVPILTTLVEFLLYHVLPFPIQLFGIFLMFLGILISRSRTLLS
>fig|273063.1.peg.2348 Permease of the drug/metabolite transporter (DMT) superfamily
MLVWSSAYPLIKIALQYMSPIILAIIRLLVGGLILLIYGKGIIYGLKEFIGSLLNVAIFMILLNLGVLLSPNPALSATLIYTQPVFVAIFSYFIFKEKIGILKIFGIIIAISGAIIASGNLEVNIGALISLLGGITWAVGTIYYRKYLINEDVIRLNSFFALSSVPVLVPLIPFQFYFKVSLEGIVVAIIIGITAQALGFIFWFSSVKNLGAFKASSISLLVPALSYFFSYIILGDMPTLIEMIGSFLVLFGVLLTNLKISNFSSRF
>fig|273068.3.peg.314 Permease of the drug/metabolite transporter (DMT) superfamily
MSKQLQSDIVLTLVTMIWGSTFIIVKNAIQSLPVYNFLFIRFLLAFLLLAAIFYKKLKKIDKSTLMAASLIGTMLFLGYAFQTMGLLYTTASKSGFITGFSVVLVPILEAILLKRKPTKAATVGVVLAFIGLILLTTNIDLSINIGDFLTLLCAFAFAMHIVLISKYASKMDTYLLATVQIGMVALLSGIVSLIFEKPFIPTSLDVWGAIIITGVFATAFAFVAQNTMQAYTTATHTALIFSLEPVFAALAAYLIAGETMSIRAIIGGAFMLAGIILSELPEKEPEKR
>fig|273068.3.peg.1085 Multidrug resistance ABC transporter ATP-binding and permease protein
MEYQQEEIMAKPFDWKIMKRLLTYAKPYWFYILIGVIAILLVTVSNLLRPYLVQQAIDNYINNPHISKEQAIQGVIRIGSLYIVIITVAFLINYGQVYLIQYTGQKIIFNLRQQIFEHLQKLSLSFFDRNPVGRLVTRVTNDTDTLNEMYTSVITNLFNDVFIIAGIVIAMVSYNLKLAFIALSTTPLILTGMYIYRKLASQAYRLVRVRLARINAFLSEHISGMKIVQLFVTENKKMEEFKKINKEYYDANMRQLTIFAIFRPSMDVIYSLTLALLIWYGGRDIIAGKIEFGVLYAFVNYLQQLFQPIFDISEKYDILQSAMASAERIFILLDTKEEVKDPEDPIPLEEVKGKIEFKNVWFSYNGKEWVLKDVSFEVNPGETVAFVGATGAGKTSIINLLCRFYDIQKGEILIDGIDIRKVRQQDLRKHIGIVLQDVFLFTGDIKSNIRLNNKNITDNDIYRVAKYVNAHQFIKKLPEGYNSKVTERGSTLSAGQRQLLAFARALAFNPKILVLDEATANIDTETERLIQDALEKLTKGRTTLVIAHRLSTIQHADKIIVLHKGRIREIGTHQELLQKKGLYYNLYMLQYKDQLSESKIS
>fig|273068.3.peg.1086 Multidrug resistance ABC transporter ATP-binding and permease protein
MKSFTTVIPFIKRHKWDYIIGIIFLLGVDLLQMIIPHLLGSVTDLFKSKDLTPKILLNYSLWIIGISLLVFAFRFIWRIKIMGMSRLLEKDLREDLFSKLLTLSPQYYHEHKTGDLMAHATNDINAIRMAAGPGIIMSIDASFLSITIILIMIFTINFKLTLFALLPLPVLALVVNRFGKIIHARFTKVQEAFASLTDKVQESISGIRVIKAFVQEKEEIENFRQENFRNFLANMNMIKIWGLFDPAVQFLAALSFTIALLYGGTQVIRGVISLGEFVAFTAYLGMLIWPMMAFGWVINIFQRGAASMERINVILNEVPEITDKFADPNITTIKGDIEIKNLTFSYKKDLPPVLKNINLKIPRGKTLAIIGKTGSGKSTLVNLIARLYTVPCDKIFIDGHDINEIPLKVLRENIGFVPQDNFIFSDTIANNIAFTKEEPLEKIQKFAEMADVHKDIVEFPQQYDTVVGERGVTLSGGQKQRIAIARALIKDPKILILDDSLSAVDTNTEERILNNLKEFMKDRTTIIVSHRISTIKNADEIIVLDEGEIVERGTHEELLNLKGLYYSIYEKQQLEEAIQKEG
>fig|273068.3.peg.1300 Vancomycin B-type resistance protein VanW
MQAKGGSNKNKKRNYFYLVTVLALAVFLSFAFAYFYVLLTSSYIAKGVFIEGINVGGMEREEALSIIKEKFKVPKFSIVAFYEGQSFEITTEDIGLQYNYEEVVNKAYEVGRNGNVLDRIREIYTVGREGRNYNLSLSYDEKPLKEFIDRIAEKIDKKPENASIRIVRGVKSITPEKLGFKVDKEKTLSNIVDELSKAIENKLFGRVEVEVSVKKVLPQVTKSMLDSINGRISTFSTVFNAEDVNRSDNLVVASRAINGTLLLPGEVFSLNKALGPRVIERGYKEAPVIIDNKLVPALGGGICQVATTLYNAVLRADITVVERYHHSFPVAYVPPGQDATISGDVLDLKFKNSTQYPIYIESYIEGNRLIINLYGHVENPSRWVDIQSEIVEKYEPSVKYIEDPNLHEGEVIEEVKPQTGYKVNVYRLTYENGKLVKKEFLYRDLYKPVDGVIKKGTKKVPKENNPLKATSPVVPPTDTSPPPDTSTEESPAN
>fig|273068.3.peg.2136 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRGEVLALSAGALWGTTGLFVRMIVKLGFTTADVAFLRMFFGALLAFSIIAVLRQSFSLPLWSWKYLLGTGILSLTLFNWSYFQAIKLTTLPIAVALLYTAPAFVVVLARIFYGERITLRKSIALILTLTGVLLVSGALRSFITGEEISWLGVLYGLLSAVGYGLYTIFAKPLSGHIPPERIAAFTFLIATIALVPISSVLAKPSIFFNTHVILLGFLFGAFSTALPYFLYTRALTFMEAGRAAIFTTMEPVVATLIGVFVLKEPFNLFEFLGITCIISAVILLSLSDKVSTPNIDN
>fig|273075.1.peg.149 Multidrug resistance protein B
MPEPAFTYRSILLRKQIQAVSGAQFIRVLARSQIWIFIPVYLTKVRDLPVYFSGILFLLTAMIALPISVYGGNLVDTIGRRKVSLAVPVLLFALMIITALSILYRSSIVFIVIEFLSIEPISVIQWIADNAIVSDVTGIGERTGSFGILRIAGNLGFSADPAIGGFLAGYSYAYIFLFGAAGAVIELLLYYHLVNETGKLRTGSGKFSMPLSDRYFVVVAIMIGVTYFVSGQWGTTLTLFLSVIYGISNNMIGILYSINGITVILLQMPIIRMIERINGFWQLALGTIVYGFGFFVLALTHSFLLLGLDIVFITIGENILAPVTNSIISKIAPEDRRGEYFGSAQLISGFISPLAPVMGTLLIYRNANDPLMVWSPVLGIAILASISIIIAGNRLMKSIQAHV
>fig|273075.1.peg.156 Multidrug resistance protein
MPDNRWFASYLMSSMASGITNPMIPLFVVVYLHSNVFFVGLASAVSSAASVPALILWGDLSDAVSKRKIFVLIGFFGAFVSFLPIVFVHSIYQYLAILITFQVLAMASVPVSTIMLLEQNDRSVWPQIISKFSMVSGIGSVLGLGLGTALITFYYSPSDLPYVYIVSSAVYLIAGIMALRFIHEPRRILNRNAIQANTFRIIERPRYFPVAVIHYLRLNGKNNGHRLDRNLVLFIAMTAFLMFGFQIFFVPYPVMVIDFGANNTLIFLMYMFNSAFSTVSFIFSGRIVNRIGGKTSLFLAVTTRIMVFGLSSLIPNISSRDLAIISAVSIYSFLGGIWSIISVSQTNYVSKNATQQTRGKAIGLYNSLLGVGQIFGGLVSGEVTTLFGYSIDYIMAAAVITIGMVIILRIYRGERLFLTGMRPMAKA
>fig|273075.1.peg.221 Permease of the drug/metabolite transporter (DMT) superfamily
MQKNGEPVLFFFMAFFWGLNYIMVKYAYVYDVSSSILLMRVLYALVFSAIIFVRQIRFPRTPMEHLKVFVLSNLNITAFFALWFFGETGVSASLTSIVIYSYPIMSLVASYALLNDRFGRGKAMGIALGFAGLIIIFFRSINVSNYIDLIMLILAALSWAMGTVFYRKFLTGYDSAGLNTLQLLYAMPAVILIAFMTGGINRNLMIPQFNLIMLYMGSLGTAVAYFIFLTLYRRYRVSDISAFFFIVPAISVILSVILLHEAVSRIMLIGFAVMSVGIYLSGRLR
>fig|273075.1.peg.410 Multidrug resistance protein B
MVQYKWVALSNTTIGVLMASINGTIMMISLPAIFRGINLNPFLPSSFQYLLWILMGYMVVTAVLLVTVGRLSDMYGRVRLFNLGFAIFTAGSILLFLTPGHGTSAAMYMIMFRMVQAVGASFLFANSAAIITDAFPSNERGKAMGINQIAGLAGSLIGLILGGILATINWRYVFLVSVPVGALGTIWSYLKLKDQSVRRKDEKIDLPGNVTFAAGLTLILIGITYGLMPYGSSSMGWSSPWVISAMASGAAMLVAFPFIELHVDQPMFNMHLFKYRGFTFGNFAGFFQSMGMGGVMFMVIILLQGIWLPLHGYSYSSVPFWAGIYTIPMMAGFVLFGPIAGALSDRIGARLLTTLGMSVSAVAFILLTLFPYNFSYPPFAATLFMMGSGMGLFGAPNITAVMNSLPPHYRGTGSGMRATLQNTGQTASMGIFFSIVLITLTAYLSSSFNTALAAAGASVLIPVFDKIPATSALFSAFLGYNPMQTILGLLPASFASLISPSSLAILEGTHWFPLALAPAFMKALHASFYAGAGILVVAALLSAFRGKRFVYGEETELKEKMQQTTEAKLSSQLEVMRDGKK
>fig|273075.1.peg.509 Multidrug resistance protein related protein
MLLRLVLSIIVNNERFSSLIGDRNVSLIGIIEGIRTFAAFLPIPVFSIYALRFTSSGLLAGLAMGVYGIAMIFSQIMMGSLSDIIGRKRVSMVSSVLFSLGNLISWHPFSIQILVFSRLLAGLGAISSPLMALLNERSDMDERTSRMAFVGTLSGLGIVIGVIAGPEISTYIGIDTIFLFSAILGFISLLPILMLAEDRVTVRRRLKIKWDPSFTFSSFVSSFILFAIFFFLPIYWMSRSQILPYGSFIAISLVAAGSIGILISIKFGMLSRITAITLTLFAVSSLAMFYFSEYPYAVMSGFFIFAIGYTIFEISFIPLLIKEHGGDYGSLIGFFNGGRYAGEFAGSLTMGALIKNPIDLHGLHLLFLAIVFMITLSILLLKIRFSKYGNVFNIHN
>fig|273075.1.peg.605 Multidrug resistance protein related protein
MDSYKIIAITVTSIGSLLAVINSTSLLISLPTIMISLHTTFFFVIWILVIYPLVMTIGAPLFGRYSDFVGRNRLYALGYLFFISGSIIASLSPDVMILLVARLLQGVGGALLFSNSLAIIADAFRQDELKWAIGTNSLVIGIATAIGPLVGGILTAINWRYVFAFNVPFGIAGYVMALKLREIEKRKVKINWKPAIFFSTFIVFIVIYLTFSPPNLWLNPVEVIYLLISVVSFVLFIFLSRGGDDSLIDISLFRIRSFATQSVATFLNSITRYSALLIAIIMLQGPLGISPLESSIMVIPYAVSLSLSSYLVGNINTKRFEGHLIYAGLFLSFFGSVVLSLVRNVNVPFYLGLVMVGFGIGLFYTPSNAILMSTAPPDRRGSAAGIRTVILNLGSVIGMSMVFTIVALYVPETALSSAFLGIKIPGFEAVKLSFLKGISITFLVSGMASLLAFLAVLGEKLAETNKK
>fig|273075.1.peg.720 ATP-binding protein related resistance protein
MENGNLLEVRNLSKIYPGGSGVRNASIKIRYGSIHALLGNNGAGKSTTMKCITGLLEPDSIEISFRGTTYPWNSKDLKKHIGYVPELPAFPKVFTVHDCIVSYGRMMGLGKAEAVGRAMPIVSILGLEEHMKKRVSSLSRGMLQKLDIVIALLSDPDVIIMDEPTAGLDVSAVEELFGIIRSLRDRGKSILISSHQLRDIETISDSVTVMDSGHVIFDGSIKDLYASAGSVEVVAEFSRIDGKLMETIKRMQGVMDVRMEDVPNRISIAFSGSTDPCGYLRDLAFRDGVSLISCSRSQSDLRTAFIRMVEYVRGQRKDQ
>fig|273075.1.peg.777 Multidrug resistance protein related protein
MPSGYRHGYQDRKELLAICMDVTSGVAKLHGTPSIRGRGPILLTTSIGSFLTPFLSSAAAFAVPSIGRYFHLSFIQAAIIPMVLLIPLASMMIFLGKFADAVGRVLIFRMGFMVFMAFSLVAAFSRSYTMLLASLFMVGFGSAALSTNGTAIVSYIFSRGGRGFALGINAMAVYLGLTFAPFLGGTLIEAYDWQSVFYFSAGMAVVGYAVSMFSLRSIDMRGRRSREIPQAGLFMASLLSITSFAALGYFFGYLRLIYLIVIGLILLGIFVYREIRSDVQVIPRQMVSGNRTFVASNITALLNYLSTFSIVFVFSIYLQAILRITPFISGLIILPEPVMMVLLSPVAGRLSDRYGSRVIASLGMIIIGASFIYLFVYAGRDIRVIMASLAVIGVGFGLFSAPNTNSVMSSIDPMFSGIGSGFLGTMRFLGQLFSIIMASSILSSYIPRELVSGIFSGAVVSIDPAYAADFVHGFRIVMIVSGILSLAGAYTSLLKNRGR
>fig|273075.1.peg.913 Multidrug resistance protein NorA related protein
MDYKPKAYSIIFARSLYALNWFDIAPALKYISIDLNINVIKIGLVTTSFYIGLALFQLVGGSLAHRIGNLVVSVTGLTILGLAGIFSGLSGNFIELSVSRFMAGAGSALFFSPALGIISDIVPVDRYGSYVSVYNGAFSFGAGTGIFAFGYLDTVSGWRISLVIGGALLLIADLAMFLMIRGGNTKVRRPMKELITAVKKPEIWILPVVTVGSAISETIMGQLFVYYLEEYRHFPAITASAAGSFFLFVGLPGGFISAYIIRRYSKKIQVASLLAVMGLIFFLVPFEVNIIEILTTLFAFSVLSIYGFSYLYMEASMINKSAVSFSLSIVNFVQMMISSAIPYLYTYAIYSISIMLAGICWA
>fig|273075.1.peg.990 Permease of the drug/metabolite transporter (DMT) superfamily
MKEIKYLIPYVLISSFSYYFAKNGVDQVSPAIFMSMRYFIAGLTLLPFAKHLKFSWSILILSIMTSTSTALWAYGLIYVSPAESAILSYSMPVFSLPIAFLMVKEKPSAIEIAGISIGFAGVILYGMPLMHGFTLFGAILTIANAVFWALFTVYYRKLKEEDPVSINTMQFFIGGAILLAYIPFDTRFDPGLSFVADVLWMALLGGSVQFILWNVMIKMSSVNKITVLAFSVPIFTMILSIFIDHEIPNIMEIAGVIVMFTGIFLSRLKGGISVVKETST
>fig|273075.1.peg.1016 Fosmidomycin resistance protein
MDTNIAFSGEAKIRSLVYTSLGHFTNDFNILLFSVLITYYHSDFGISLALLGAVAIIYSIISGLLSTPVGRYADKTRRYRFLMMVGFIILGVSIYLFALSFVSARIALPVMIVASILFGFGQAFYHPLGSSILNLTYGNGSASALGINGAFGSIGRSALPVILVPLIILVGEKYALVILGTYMILAGIIIYAGLGFIREHEIPEKSRSASSSKNRDMLSRYSGVLAIIVAMVFIRAMFLTGTTTYISQFVLDRVKSETIMSIVLTVSFLTAVGGQPYFGRLTQRHGGKVTIGLTTGLSTLFFIFFMLAGTNPIINTVTYALYVFTAFSGFPVLMGYVNQIVPRDISTTAGGMVWGLGNTVGGGIGIAVISVLLYFHITLAETMWIMTIFGAVSLVLFPFIPSKDAAARLKASST
>fig|273075.1.peg.1044 Multidrug resistance protein B
MRSMMSNHSARTIAISAFAGLLVTYVETMITPALPILVSFFDTNYDHLSWIITAYIISGTVSSAIFGRLADMYGKKNIFVILAVFYTIAVSFGGFARTLEELIIIRTVQGIGMGMFPVSFALINDQVPKHRLALAQGIVSSTFSGGAAIGLVAGAWITQNYGWQWSYHSSIPVAVLLVIVASIYLHDESERKPAKIDFIGVGSLGLAIVSFILAISEGEYWGWASPSIIGLFLFSAAMFAAFVLYERNTPEPFIRMDLLRIRNVLLANMTGLFAMSGMFFLFYTVPALLQDPEPTGFGISIVESGLILLPAAVLNMALAPLAAKITTSRGPKTAIIIGLFILLFSYLGLYYNRSSIIAILEDSAVMGMGISFIFVGIINILLISVPRDRSGESTGMNVVFRNIGTSLAPAIGGVMETMFVTYVIVGAIPVKFHGLPITPIMENFPSSEAYDAIYVIGMAFVVIAMILSMFMKNVIVGGEKR
>fig|273075.1.peg.1051 Multidrug resistance protein related protein
MILASRAFRSAGLIFMALSLPLYLLLNRISIVNVGIIYVGTALANVSVTIAIGMLGDRIGYKYSLVFGEIPALLASGILAFTRSVPLIVIATVISGSAGAPGGMRGSFSVGITPYLARIWQEPSIRIERMAQITFVASIASIGGSLLLYLHGFITRIYGDLGAFEILYHVAFILILLSFVSLTMIRRDRRQKKTTKFLRKETMKFSARVIITNVINGSAIGFSMALISAWFEIRYGVSASKIGLVFTISYITTAIGSLLASRIHISRERAVYFGSLTRILQGILLIAMAASPIFIMGSTIYIVRTVVAGFGTPIRNVVNIQGIKDEDLGTASSIQGAPSRIMQSTSGIAGYLMDYYPPLPVEIGGLIQIVGGFVYFKLLRRY
>fig|273075.1.peg.1166 Multidrug resistance protein NorA related protein
MSLYLHHIGYSLFTVGVILGSAIVISSILTFFMAMLADHYGRKSLLIVLYLIFAVSAFGFLVSKEMFILILLSGLGSFTGSGGGPIGSGGAFGAVQTALITEFTEKNRFSRVLSTASAVGLLASSAGSFLIDVVERIGGDVYRLFYLAGIMGIVGMLITVFLNDNGIRSRKLLPSISWKKMIRLSIPTIPNGIGAGFVSPIFSLWFHLRFGISSGEIGVIFGISNIFVLIFMIVIPRIIRSESELNAIVWTRAASSMLLVALAFIPFLQIAALVYILRQGLQMGAVPVRQSFSMGIVDSTERATASGVTSMTRTGFSAVSPPLAGDLLSISSIYPPLIGGIITAADPLLYYMLFRDSFRRKS
>fig|273075.1.peg.1380 Multidrug resistance (emrA) protein related
MTIDYSRKYFVLSITTLGSLMAAIDSTIVFLALPAMGHYFSSSVSYLTWIVVAYIISATIFMIPSADIMRKIGKKQLYLIGFVIFALSSLVIALSSNVIMAIIFRFIEGIGAGFLSAVGIPILLDAFPPQERGRAVGINSISWAIGTLVGPVLGGYLVLYDWRYVFLINVPIGIIAAILGLARIPHYPKENAQKYDPIPLIGLIAFLLPLTVGISFINVYFLVASAIIFPFFIMAQRRNPIIPSVLLKNRNYVRVSISSTLQALSFFGVLYALSLYLQISRGMSSLSASLYLFTYPLASMIANPVSGFLFDRTGKGAHLLVIGLVMQAFGIFMVAYTMTLIPIYLFIAGFGGSLFWAPSTTMVVDAAGPKFRGIANSSLFTLRNMSLILGISVFPIFVSAFSHVKSSSIIITAFGANLSASTSYYLITVSLLSVLAIIPIVGFLRSKRESIESKAEIPG
>fig|273075.1.peg.1443 Permease of the drug/metabolite transporter (DMT) superfamily
MFRSKRYQMVAYAITGSALWGLSGTVSSILFSRYGMPFSTLVTIRMVFSGLILLAAGRGFVGKKDLPMFLVFAIPGLFGVQILYLATISFSNAPVATLLQFLFFPMVAVYDYITIRSLTVSSLILALIFSVAGIYELTTGFPLGGTALRISLTALILGLATAATAALYTVTSARIVKEYGGLRTVASGMMVGGLVSLPLGSFSGVPYFHGLGQADVIPVLALTIFVIVFGTSMAFYLYINSMRYISPVEAAVSGTFEPVAAAMSSYLLLGIKLSAMQYLGGALIVISILVIVISKNRRG
>fig|273075.1.peg.1467 Permease of the drug/metabolite transporter (DMT) superfamily
MDRKDAIYLALLIFVTFIWGVTFPMIKDVFAYLSPVSFLAVRFAVASLIFLPFVYRKLIQTNRNTIKYGVVAGIFLFIAYYLQTVGLKYTEPALSGTITGIYVVFVPIISYLYLKRRVMRIEVYSSVFAFLGLVLMSYSGLHNLAIESGDILTFIAAIFYAMQLVYISKYASNVDPLVFSFLQIVVVGVLSLAFMPTDMYPIVFSYYALFVIVFTAIFATFLATYVYVSALSRMNVTKVGVILIGEPIFADITSIFLFNEPVGPIEILGICIMIVSIGVISYFSD
>fig|273116.1.peg.394 Multidrug resistance protein
MVFGIVEALGYGIGSDFSYIGGRLWDSHSPKKLTILGNSLIPLMSLIGLAGTYIGASALYIGGWWSRNFRNPPPRVMIIQSSKEEDISRAICLLHGLDITGGTIAGILPLSFTALGLPLSRVFLFSIAPLVVSNLLVASTRSVHXVKQEEVKIKNVDSAKAEKNVVYGVFLATLSFGFSYHSIGFPILTAAQSADSTISGLVLFPVFMASSSVGGFLYSRLRISKEVRLLGYLGYTLTGVGTLLISLVYLYRAPELYYYLSAVVIGLGTSGVETFEPTIISKIIKGSRTGSGVGYLTSFISIGLFTSNILMGLLYYEISPLSAYLYAGLAAILGGLIILFAGRKFKYY
>fig|273121.1.peg.255 Permease of the drug/metabolite transporter (DMT) superfamily
MSLKSRELLADVSLLGISVIWGVTFLMVQDAIKEVPVFAFLFWRFLLATVLFFLIGIALKPSFDLPSIRAGAILGVMFCLAFSLQTFGLEHSLSSVVGFITGLNVVFVPLFLWMLFSQKQTPFALLGIALAVVGLWMVSTNGGGIGLGKGELLTLGCAALFALHIVYTGIFSKRHRLFPLILAQFSTATLLCLLFSLLFDPFTIPSTLSYPFLKALFITALFATVLAFLVQTYMQRFTTPAKTAVIFTMEPVSAGIFGYFYAGEPLGSIQILGAGIIVLAMLSVELGSLLYRRKKRLN
>fig|273121.1.peg.383 Acriflavin resistance protein D
MIKYVIAKPVVVIVGIILVALFGVLSLSQMPYQLTPSVTRPIITINTLWTGATPYEMEREIIERQEKVLKGIDNLISMESRSRNGRADITLEFKIGTSLTEAMLKVSNKLDEVKKYPDGIDKPIITATGESTSPVVWMVLKTQKENPRHINEYRTFFNESVIQYFERIDGVAEVFFPSGTDREMHVVIDHNKLASYQLTLQDLISVLDLENANVSAGTMDYGRRSYRVRSVAEYKSPEQIEQTVVWSDGQRRVRIADLGYVKEGYARPTAYVEHNFESGAVVGIKPTPGTNILELSDEVERVFFRLNEGVLAKEGLYLDWMYDQRSYINGAISLVRQNILIGAFLAVVVLWLFLRSFTSTVVIALSMPISILGTFIVMNALGRTLNVVSMAGISFAVGMLVDSAIVVLENIDRHKRLGKGIFAASYEGTKEVVGALVASVLTTVAIFIPIINMEEEAGQLFRDIALTASSAVLFSMVVSILIIPMFSYQLLKLFGVEKPHPKSTLEGVGARIIDTVVAWVKGCTASVGSRLATIFFFTFLSLAISYALFPKMEYLPEGNQNFVTTVLNPPPGLSYEERQNIGKEVFRLNESYFVQKGYEKNEKGEMPPIRHMFFLGSENFMYFGTRGAIEDRAGEMIPQFLKTIESLPGMTGVSMQPGIFERGMGKGRTIDVDISGVEIESLIQTASAMQRLIKQRLPQGTQVRPLPSLELIYPEINLYPDSDKLKAAGLNPSTFGVALDVLMDGRAIAEYKEEGREKIDLVLKANKGELKTPEEIYNALIYTPSAGILPLSSLSEIKREYGITEIRHFERKRTVTLQVTPPKNMPLEEAMEKIQGEFVEELQKQGLIGSNELRLSGTADKLTQTRLALQGGFVLAVVIIYLLMAALYENFIYPLIIIFTVPLAVAGGVIGLKLVNLFLANQPLDILTMLGFIILVGTVVNNAILIVYQAINNIREEGMEAYEAVILSVRTRLRPIYMSTLTSLFGMLPLVLAPGPGSEVYRGLGAVILGGLTFSTLITVFVIPSLLLFVIQKERLKIDIEKAEKAGGIA
>fig|273121.1.peg.796 Permease of the drug/metabolite transporter (DMT) superfamily
MSNSSKGALYVALCITLWSLIPIFAKLGQSNLDHHQYLFFSSLLSFLALLGVGYYRRELGNFWRYSLQTLLFLAFLGFLDFFYYWLLYFGYKEAQGLEVLVFQYSWPIFIVILSPWFLGEKLSMKHALSLLFGFLGVAVVLSQGKMSEIEFSNFKALFLVLLGAFSFALFSVLSKRVSAKALHAVTLYFLSATLYSSLALSLFSSWEMPSWGDWPFILVNGIFLNGISYLFWVEALRLGDASKVAPFLFFIPPLSAFWLILFLDEPWVWAYGVGLMLVILSGIINARRKR
>fig|273121.1.peg.861 Permease of the drug/metabolite transporter (DMT) superfamily
MSNRSTLLPYGALILAMFIWGSSFIALKYAFISYDSSWVIFWRLLFATLFLLLFIPKMSLRSFRPQDLPALLLMALLEPCLYFVFESKAIENTTASQAGMISSMLPVLVALLAAWLLGERLKSRMMIGFLVAILGALWLSLSSSLSDYAPNPLLGNFLEFLAMLCAAFFTISVKRLSQRYNAFFLTGFQSLMGALFFGVLTFASPLSEPMGRDELHFGAIGAIVYLGVVVSFGGYGLYNYALSKVEASQAAGFTNLIPLFSLILGYLLLGETLNSSQLFGCGLIFLGVVGAFYRQKSRG
>fig|273121.1.peg.1958 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGLAAVNLCVPLFYLFMSLEVLFGFGGSALASMALGRGDDEEAREIFSSVALFMLFLSSLLALGLFAYRDSLALWLGAGEKLLPYVKEYLGVIVLAAPIMMVQPLLEAFVRNDRAPYLAMSSMVVGSLSNIVLNYLFIFIFSWGLFGAALATVLGHLIGLLILGGHFYLKRGNIYFSSLRLRFSYVFRAFANGVAPALSEAAAGIVVVLFNLKLMEISKEEGVAIFGAVSYIGVMAVTALVAASQGLQPIASFNHGAGFYDRVRAVFRFSFGITLVLGFVLYALSWSFAPFLAELFFPLDAPLAKESAEAMRIYYAGYLFLGLNILSAVFFQSIGRSLVSFVISLSYNFVFILFWLELLPRFFGLQGIWLSYPLAMISGFLLVLWVIARERKIQTKEPLCKTPL
>fig|279010.5.peg.841 Vancomycin B-type resistance protein VanW
MLKIWMTGLLLLAQPAGHSDSLTITQQGKKVAVVNREDFTMPLPGTPMIDDKKYNEFVDRLERKVHKDPVNAVINDQGRIVPGKVGYSLSRKGFKEQFYAYFYGDGPSTIEVPELNVYPKVDSELLSHIRTQRIGQYVTYFNSGNKSRTHNISLAAKAIDNHVVFPNETFSFNKVVGMRTPDKGYMKAPVIVRGELSEGVGGGICQVSSTLFNAVDRAGLEIVQRYSHSRRVPYVPPGRDATVSWGGPDLRFQNKYNQPVLIRAKRHGGTMVVTLYSSDVVNHQLRKVPKAPAQIPKEEHQSGDH
>fig|279010.5.peg.1804 Multidrug resistance protein B
MFAQFKAFSRLHPLIRFLLIGTLVTKAAKSMTTPFLALYLHMKTGADFGTIGLVIGLGYFSSTVGGVVGGALSDKIGRKKVMLSSIFIWSFVFILFGLVHDFMWFLLLNILSWLCHSCFEPVSKALMAELSEREMRFRIFSLRYLAINVGAAVGPLLGAYFGLAKTGTPFIITGLVYFGYAILLSLMMIRLTTVKETKIAPEKVQAGSVLKTLKQDKALRLYIAGGILFLFSYSQMESTLLQYLNNDFANGVKIFSTLITLNAVTVILLQVPLTRLFERYKSLTTISIGTVFCILGNIGFSIANGWIVFMLSMFVLTIGEILCFPSMNVLLDELAPDHMKGAYYGMQNLYNIGEFLGPWLGGMMLALYGGKAVFLIAACSVFLALGAYHVGRRKFLSAQHYGVSPFSY
>fig|279010.5.peg.2644 Tetracycline resistance protein
MKNSKIQTFKHQKKAFWWLSFVAFFSVMNETVFNVALPDIKNQFGVSPAAANWVNTSFIISFAAGSVVYSRLSDMYGVRKLFVAGLLIYGGGSFMGLLAQAYFPAVIFARFVQGSGASAVPALILVIITRYVRPEGRGKAFGIVGSLVAMGEGIGPAIGGMIDCTLYSLVVSVYSADGSADGDSFLL
>fig|279010.5.peg.2645 Tetracycline resistance protein
MIVHYIHWSFLFILPMAVLMAIPFFFRNMPDEAAAKANLDIIGIGLLTISIVMFAVYISLYHVFYLLAGIFCLIGAAVHTRHAEHPFIDRSLIKNRRYIGVVLAGCTVLGSVAGGALTDRFGSRFVFTLGWLLILSTMAAASQVGDRTPWLMTIMLVFIFGGLSFVKTAISNSTAESLEEKAAGAGMGMLNFACFLSEGIGVALAGGLMAVHGFGYSALPAMNDAWSAVFSRSFAIFTVFVLAGGLLYLLTCKRKKS
>fig|279010.5.peg.2723 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MKKKTSGIHHITAIVGHPQENVDFYAGVLGLRLVKKTVNFDDPGTYHLYFGNEGGKPGTIITFFPWVGARRGVIGDGQVGVTSYVVPKGAMAFWENRLAKFNLPYTKMNRFGEEYLEFDDPHGLHLEIVEREEGEKNSWKIGEITPDKAIKGFGGATLLSKQPEKTAELLEKVMGLEKVGEEGDFVRFRSSGDIGNIIDLKLTTIGSGQMGIGTVHHIAWRAIDDNDQLEWQKYVAENGYRVTPVQDRNYFNAIYFREHGEILFEIATDPPGFAHDESHQTMGEQLMLPAQYEHYREQLERRLIPITVKALD
>fig|279010.5.peg.3076 Transcriptional activator BmrR for multidrug resistance transporter
MKEYFSIGETARLNNISIQTLRYYDKIGIFKPQCTDRDNGYRYYHVKQFFYLDIIKYLKSIKTPLEEIKRIISHTSAPELMQTFLEEQENVIEREMEKLERARQLLQRRKDQLHEQLEIRAKKEEGLVYVRHIEGQTILKAATPQVNPHDQSDLYYRKLAEVLEERGDMVDNYYGLIYDLKPYKNSGDIYCNSVYTTIYDGAKIDTEEQNIGMDTIPSGEYVCISFDCSSTNYFSYYQKLYHFIETHGIQTDGKVYQVSFPNSYNSLKEEDFLTEFRVLKK
>fig|279010.5.peg.3290 Drug resistance transporter, EmrB/QacA family
MAGLKKKRALFLTAVASGTMLNPLNSSMISLALHSIQHEFHLSFATVSWLISSFYLASAVAQPVTGKIGDLIGRKKMFLSGLVLVAVSAIGAPLAPAFSVLLIMRLFQSIGSGAIYPSGVGLIRSHIHEKQASALSVLSIFSSAMTAFGPTVGGFLIVLGGWPAIFLVNFPFILFSFLLGMYMFPKDEKKAGLNVRAVIKRLDLTGILLFAGGIVLLLAFLLSLSTGEPRFAEGMFGLVLLLMFVWWELRVNSPFIDIRLLIARRTLTSVYAQFIMLNIFNYCLFFGLPSYFQDEMHLSVQTSGLLMLFMSGTSVLISPFVGKWIDRSGETQPVLIGSCLMAAGAILLTLFFVDAPMLWKGIILSLLGVSYGLGNVALQAAMFTASPPDIVGTTSGLFQTCRYLGSIFSSVILGLLFGEEITAGHFQDLGMVMIAVAIGSILMSFRFIKLMKD
>fig|279010.5.peg.3456 Lincomycin resistance protein lmrB
MSQSDVAIPSSKKIGIPKYLIISVLTILAIGPQYFLNLSYTLSQVVIQNGLHLSPDDMRIPSILTNLAFALGVPLGRIFSRRFGIRNSYLTLITLFLCGSLIDAFSAGLFSLLIGRVIQGLCSGMLFLTILPVKLISFPNKVRNLFLFFVISGLFGASAIGAVFGSLSLSADAWRWVFILNICSPVLCLVIGFFSLPKQAADEREHHSIDKTGVFMLSLLMVVLTVPLINLQKTGVHSFYVWPFFLAGFIILALFVITDLRAREPLVPFRSLWSAKAVSGTVMAVASHIAIIVSLAGINGFLENIAEASFESMTRFYLCFFAGILATAVLSTLLYDHFGAGLLGCIGALEMIIVGMEWRSVQPGVSMESLYLHAVLLGSGVSMVLVSGALGTALAGDIHQASKRSVSLHFIRNFAGAWAAPVIGWFASMKNAVHYEMIRGHISEADPEIQLELSKMIRDFVSSGLSVGDAKNMAAYTIVANARKASALGAYHDLFTILLWLSIIMLAASIGKAATGKGRSLVQKRLRLPDPSASQQKEIG
>fig|279010.5.peg.3509 Multidrug resistance ABC transporter ATP-binding and permease protein
MRSFLGCSNLSVRFYHRPETVLDRVSLSIEQGEKVLILGPSGSGKSTLLSVLSGIIPEHIEAEVTGEVNRRKSAGVMFQDPDSQFCMLHVDEEIAFSLENRSVPPKDMDRIISELMELVGLKIDKKTPIETLSGGMKQRLALACLLALEPEVLFFDEPTAQLDPASRQDIFALLRDVSRKSGQTMVFVEHVLDGCIEWMDRVILFNEKGQIIADGKPEEIVKHFQPEMKAAGIWQPKLYPAVWEDVTTQDDHPLAVKLSSTLKMKEEEAKNRPSADRDILIRTEDAAIGYRKKIVADGINLEIPRGEWISVIGGNGSGKSTFLKSLIRLEAVKKGRIYLEGRELKKWSDRTLYEKAGFVFQNPELQFIRDTVFDEIAFGARQRSWPEEQVERKTAELLQEFGLDGHQKAHPFTLSLGQKRRLSVATMLLFDQDLLLLDEPTFGQDEKTAKELIKRLKERQERGTTIVMVTHDMDIVDEHSDRVIVFHQGKAAYQGTPYQLFSDQDLVRRFSLIPPLHYRFMHERKERVPV
>fig|279010.5.peg.3683 Multidrug resistance protein B
MKKMARLYMLMLNVFIVMLGIGLIIPLMPTFIEEFGASGSTLGLLIAASGITQLLFSPVAGEMTDKYGRRKMIILGIGAFAVSQLLFALASQMWLLFVSRLLGGAGAAFLVPAMFAYIADITSEKDRSKGMGLISAAMSLGFVIGPGAGGYLAAFGLTFPFYVSAGLAGLATVLSLLVLPETLSQEKMLEKRRSVQKREPLAKQMARALRSPYAFLFILVFILNFGIMNFEAVFSLYVDHKHGFTPGDIAFVITAASLIGVFVQAVALGMLTNRFGEKKLMNMTLIGSAGALAVCSIAGSYWLVFGATIVFFMLTSILRPAINTLISKMAGDEQGFAAGMNNAFMSLANIVGPTVAGLLFDVNVEIPYIFGVVVLVLSFLAAVSWGRKQQARTIPEKV
>fig|279010.5.peg.3949 Permease of the drug/metabolite transporter (DMT) superfamily
MLTNVLKYRVHILFIVLCLIGGTTWAFQKAGLSDSLPFWSAGMRFMIASILIAAFLLARRQFVLSKELLVLSFLNGIMYFSVPFGSVYWASLYLPSGLVSILAASISVFALMINRLVKGTPATKLQKWGICLALLGITIVFGNQLLIKVDVIEIVAMIVILCAMFGSAFIQIKVQQRIRSLPILSFNSLSMLSGGAVLLISSLIFESGTRTFSGVSLYALLYLAVVGSILGFWINIYLLKKWHISKATSHLFISPVIALYIGFLFLDEKLNANIYLGTLFVIFGVMFINLKKEERIAKIDETKQKLGHHLSK
>fig|279238.18.peg.94 Permeases of the drug/metabolite transporter (DMT) superfamily
MHFLALLTGNVALALGPWFVRLADSGPVSAGLWRLALALPLLAIFALRGREPMWGYQRKDWAIIVGAGVVFALDLASWHVGIERTRLGNATLFGNSGSVILMVWGLIAMHRRPHLREFAAVALALGGAGLLLGRSMEIDTRTLAGDLFCILAGLFYVVYILLVQHVRGRFGSWSLLFWSSLAGCPVLLVTALALGEPVLPGTWWPLVGLMLASQIVGQGLLVYSLRHFPPLVIGLVLLTQPAVSVVVGWLSFGEVLALPDAIGMALVGAALVLARLGEGKSA
>fig|279238.18.peg.1453 
MTIARVYRMTAAAGKEQALADALVAFIPVVSAVPGCSGAEALRDCDAAGRFLFIEKWTSIDAHKAAGSHLPKDALAGVMGALGAPPEGSYEEYLA
>fig|279238.18.peg.1750 Outer membrane component of tripartite multidrug resistance system
MAGALVVAALLAGCTTVGPNYAGAPDAAPQAVSRGTFARAGADALAAAPAARWWESLGDPVLNQLVEQALADAPGIAAANARVAQSRAALAANRTAVLPQLNTSFAAPYINVPGGLLSPNGESGGRDEINAYNLGFDAAWEIDLFGGTRRKIEAASARAEAAEASAADARVTLSAEIARAYVGLRARQAMVGLQERQVEIDRELASLARQRFEAGRIPQQPVNGAEAQAFSSEADLAKSRAEIAVLMDQIAVLTGKEPGTLDALLVAPAPVPLPPAQVAVGDPALLLRSRPDIRAAERQLAAANADVGSRIADKFPKISFLGLLGLGGQDFGDVFDPGNIVGIALPQIKWSLFDGGRAERQVEAARGAFAEAEANYRRTVLSALQDAEGSLARFGAQRVAFGKALDAETRARRNVELQQQRLAAGTIGKPDRLDAERQALQLAMAATSARAELTTGFVAVEKALGLGWTAPEPAK
>fig|279238.18.peg.1900 Permeases of the drug/metabolite transporter (DMT) superfamily
MQDSHRSALIFALLGFALLSVGDAVVKSMAGMWPGTAIGALRYVFGAVGLGIVLLLREGPSGFAFPKPRWQVLRGFCVAMSAMSFFSAVHLMPIGEATAISFTSPMITALLAAVLLKEPLRRETWIASIVAFGGVLLILRPNFGLLGLAALLPMVSATGMALLIIANRKVAGMGSALSMQFNVALIGSLFLCIATLSGHFSGVAFFAVQVPAMSVIAKCALIAVSASTAHALIYMATTRAGAATIAPMTYVQLLMAGVLGWGLFGERPDGVAAAGAVIIVGAGLYLWRAGRAPEEPTMTD
>fig|279238.18.peg.3505 Outer membrane component of tripartite multidrug resistance system
METADTIEAAQTLAARGNTTWPPDQWWRLAGDPQLTALIEEGLSNAPQVAVAVARVRRAEAEAQRVGAARLPTIGAEAEGGLRRQSGNNGIPAQFLPDGWQDYGQTSLSFGFDLDLWGRNRAAYAAATSEARAAMVDAAQARLVLSVAITAAYAELGRHYRERDNAAATLANRRLMRDLVAQRQRNGLDNLASLRRADAEVALAEQDLAAVDENIGIRRNQLAALLGAGPDRGTSITRLPLAPSTPGGVPAGVTTDLLGRRPDIVAARERVEAAASRVKVARAGFFPSINLRALIGLQALGLGNLVASGSLFGSVGPAISLPIFQGGALKAQYGSAEAAYDEAVANYNQTVVTAYQQAADAVTQRDAADKRLGATRTALAASEEALGLVRTRYEAGLASYLDVLASERGVQDLRVAVIGLETYERGATLAMIRALGGGFDAGTTQPSGQTEQ
>fig|279238.18.peg.4013 Inner membrane component of tripartite multidrug resistance system
MLIGTMAAMIMYTLDTTIANVALPHMTASLGATQDTITWVLTSYVLASAVALPLAGWLVDRVGIRNMMLASVLLFTAASMLCGAAQSLEQMVLFRVLQGLGGAFLSPLAQTVTLDSSTAAERPRMMGIYTQGVMLGPITGPIIGGFLTDNYNWRWVFYVNVPVGVLCFLLLLLYLPKTPTRERKVDLTGWLLVALTVSSIQLILDRGLTLDWFASAEIVTYAVVAGACAWLGLFHLSGSRNPLFPTALFHDRNFTVGLAFMFLIGLVMMSVMALLPGLLQQIYGYTPLQSGMLLAPRGVGMLASITLFGRFMAKVDARILLAFGLSLMGASMWMMTGWSTEMPRTPIIMAGLLQGLGLSFTFMPMNLISFATLPPQYRTDASSLGNLMRNLGSSIGIAAASVELARNIQVNHAELGAHVTRSLVPFNLDRITAYGGTAETALRVMDGLVNQQAAMIAYINDFYAMAMACFVAIPLLLLVRTGAKKG
>fig|279238.18.peg.4014 Membrane fusion component of tripartite multidrug resistance system
MAEADPFPIQESSAARAVGEHERRTRSKRLRTVLMALGPILAIGGGLWYWFGRPGVVETDNAYIKQDIVSVAGEVTGLVTSVKVKENQHVKAGDVLFTIDPSSFTVATRQADAQIASAQARVIALNADVTAKAADLAGARDDLALAQANYAREKALMDRGFNTRARMDAAEHAVATARDRIVSIQAEVEQARAELAQGSQVPGVNPEIAAAQANRAKAALDVERTVVRAPADGIVTQVTRLQIGQMVFPGVPMLSIVRDGGARIEANFKETDLNHMRPGQRADIEIDAYPGLKLKGRVESIGAGTGSEFSVLPAQNATGNWVKVIQRVPVRIAIEDKSPRPLIAGLSSDVTVHVGK
>fig|279714.3.peg.582 
MKFIFEVRMRPGYTVEEYAEAWIRASEIIQRTPGARGTYLHRKIGTPDTLLAIATWESKAHRDAKDDRRDETVRAILEKHAANCDITVIGEFDEPEWSVLPRGAG
>fig|279714.3.peg.585 Inner membrane component of tripartite multidrug resistance system
MMTLPSWRDWLFSAKTFLAAILALYIGMALGLPRPYWAMSTVYIVSHPLIGATRSKGLYRVIGTLIGGAAAILFVPRFVNEPIMLSLVISLWTGTLLCLSLRDRTPRNYLFMLSAYTLPMIALPAVSQPEAVFDIALARSEEIVLGIVCASVVASIVFPSKVAPVLEARIGAWFKDAGAWAAEALSPAFASSHPATRHRLAADILSLDQYITHLAYDAANADMVHTTRELQSRMSMLLPILSSLTATLDAARKLEQGVPAPLTGLMKAIARWILSSPGARGRDEAARFQRQLADARRSGPDAEWNDLLIAHAVTRLQSLIRLWQDCLDLRDMIARGEADTAWKPAYRRWELGGKARHYDHGMILFAAASASLAIFLSCLLWIGMGWNDGASAVILGAVSSCFFAAQDEPAPLIRTFFTWAAVSIPLTAVLLFLIIPAAHEFETLALMLAIPFLAIGTLASHPRFTMAAMLLTVNTASFLGLQGAYDADFTAFFNSSVAGVCGVLFALCWTLLTRPFGAELAMRRLLRASWKDLAETAAGSHRGDYANLTSHMLDRLGLLVPRLAASDDDHGDAGFGELRVGFSTLDLQRDEHRLPETAHVAIDRVLQSVAGHYRECVGHHGQRQPPASLREEIDRALSLTKAELGRAAREAQNALVELRITLFPDAARFVALTGVPATGPSAGETP
>fig|279714.3.peg.614 Transcription repressor of tripartite multidrug resistance system
MSDSFKPYESAITAIASQIPGAPLREAILTRLFLHVSGELSDFFDARLKEYGLNYTTWTSLVVLYSSPQHRLLPSELSVFINTSRTHCTRIADELVDKGWVERVASEADRRQTYLQLTAAGVAFVEQLQPQRREQYRQLWSSFSPEEQNQLDALLRKMLVLLKS
>fig|279714.3.peg.647 Permease of the drug/metabolite transporter (DMT) superfamily
MDGIESLARLEWRHAYAKNKGMILAALAAIGFSAKAIFVKMGYRYGASAEALLVLRMAFALPFFLLLALQSTQADVDQLTWRDWRQLVVLGLLGYYLSSWLDFVGLRFVSAALERLTLYLYPTLVLFISVLWLGKRYPAKVWWGVVLAYLGVVLAFVQDLRDAELIHQALFGLSWVLASAVSFALYLVGSGEAIARFGATRFTALATLVACIAVFIHFAVTMPLAALQLPAPVYLIGLAMGVFSTALPLLCMNMAIRQLGAGKAASVGTLGPVLTMALGWLVLGENLSVLQIVGAGLVISGVGLVSSSK
>fig|279714.3.peg.1497 Membrane fusion component of tripartite multidrug resistance system
MTNKTELSPGSPLPTGQAPSHPAASGRGARKGRLILALILLATAAVAGRMWWRSHYFEETDNAYLAGHVSTISPRIAGVVHQVLVSDNQLVRAGDPLLELDAADQEVKIAQIKAQIAQTDEQVRQIAEQLEQARAEAQAAQALVARAAAQFQRNDAEAKRVSALHDVQLKSVSKSELEGAIAARDSAAAEAQAQQFQAKAASAKSGSVAAARAAALAQKKVLAAQLRDAELQLKYTRIVAPVDGRIGKKSVEVGTRVQAGQQLLAIVQDGVWVNANFKETQLHDLYPGQQATVRIDAFPGRTFSGKVDSFAPASGAQFALLPPDNATGNFTKIVQRIPVKVLLDPNDVKAMGGRLAPGMSAFVEVDLRQGAPAGTVR
>fig|279714.3.peg.1498 Inner membrane component of tripartite multidrug resistance system
MAAMAEKTAVAARPMPPPAAVLPLPEPAVDARTWIAIFAAILGVFMAILDIQVTNASLREIRGALSATVEEGSWMTTSYLAAEVVVIPLTAFFVRVFGARAYMLGNVVLFLVFSTLCGYAWNLPSMIVFRALQGFTGGALIPTAMTLILTRLPPSKRTIGLAWLMLSSTMAPAFGPTLGGVLTNFYGWPSIFFINWAPGVLMLAGLAYGLKREPLQLKLLREADWLAITAMTVGLGSLIVFLEEGNSKDWFASDLIRACALAALLGIVAWVAILQSRGKPFVNLALFARRTFGVSSLVGAAAGMGLYGSTFVLPLFLSEIAGYNSLQIGEVIMWMGLPQIVMMPLAAAFAKRFDNRVICSLGLLLFASSCFMNATMDATTGYDQLVFSQVLRALGQPLIVLTLSNFAIHRIEAANLSSASGLYNMSRILGGAVGTAVLATTITWREHFHSARIGESVSLFSDAVQERLGQLGSQFLAGSGDPVAAQQQALAALDHLVRREAYVLAYTDSFFILGCVLLASIAVMWLADRVVAGGK
>fig|279714.3.peg.1499 Outer membrane component of tripartite multidrug resistance system
MLKKTMICTVLASLLAGCATPALQPPAPTELVPASYQHAGAPAAHDLPRQWWRLYHDATLNQLVETTLRDNPYTQVAHLRQIAAEAQTRLANADRLPQLNAGVGFSNSRTSTNTALGQILGHQTISGDKITAGFDAAWQIDVWNRVGYAVAAAKAGVEAEQAFARMVEQTLSWEVATTYWQYRLAESDLTLLTDIRQQRAEAESVQAGRFDAGLSSELDLARARLELKNADVEIEDARKRLSLAEHELATLTVKPVAEFSVPRDAAYRLPDVPAISPGLPASILRQRPDLAQSAQNIRALLAQKEIADTAFYPSISLTGNFGFASMELRNLTNSDSRQFTLGPLAISLPILDGGRIRANQKIADARYQEALNVHKVQLLIALREVDDALTEVESCRTQAGLLDAALESARRVSLLAKARYDKGAVNYLEVTQAERDLSTAELKFRRNQLKGLLASTQLVYVLGGGWKDEAAPTR
>fig|279714.3.peg.2091 Multidrug resistance transporter, Bcr/CflA family
MPIVAAGLHPTRLIVLLSALVAFGPLSIDMYLPSLPAIARDLAAPVGLVQFTIGGFLTGFCLGMLLYGPLSDRFGRRPVLLAGIALYLVASLACAFASSAEQLIALRVLQAVGGGAGSVMGRTVVRDVFPLDRAAQVLSLMHLVTMIAPLVAPVLGGWLLLAAGWRSLFLALALFGAVCLALVALRLPETHPAERRGEVSLASAFSAYGHLLTDTPTLGYMLALGLTFGAMFAYITGSPFVYIDYFGVAPQHYGWLFGLNIASVIVLTTLNKWLVKRVALDTLLQAQTAVIAAAGLALWLAGAHSLLAVVLPLLVSVGLTGSIGPNTMARLLQRHSERAGAAMALAVSGQFGLGMLASALVAALHDGTPRAMCQVVALFGVAACLGLQLIRLPAATARPQSSTL
>fig|279714.3.peg.2249 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVAQIAHVAMGFVDTVMSGRVSTNDLAAVSLGSSVFITVYVTLVGIATALNPLIAHQFGAGEREPIGETVRQGMWFCLFLGLIGSALMIFGQPWLRDSLTLSNDVEDKVMLFLDGVALGLPAALMQRALHAFASGLSRPKPIMLVGVVALLLNIPLNYALIHGLYGLPAMGGAGCGWATAAALWFNFLALLGYVALHRHFRPYAFTRRWSWPDWARYRAMLKLGLPIGLSFFFEVSLFSFIAFLVAKLGTTVVASHQAVLSVSSIIYMMPQSISTAMSVRVGQAVGAGDYRQARFTAGTGLLTGLVLAGLTMLLMLTLREDIIRLYTTDPEVIRIGAGLLVFAAVFQLTDATQCISSGALRGYKITTAPMIIHVVSFWGLGLSLGMVLGLTDWPLPFLTLPMGIEGFWAALVFSLSVAAFLLVGYLSRESRRRLVRQHTES
>fig|279714.3.peg.2704 Permease of the drug/metabolite transporter (DMT) superfamily
MPPSLIGLIQVLLSAVAFGTMAILARFAYADGTSTTTLLLLRFVIAGLVLLPWVALQRLPWPTGRPLLALIVMGAVGYAGMSACYFNALNHASAGTVALLLYLYPVLVLLLSMLLGERLTTLRLIALLLALSGLAVTIGLEFSARPLGLVLGVGAALIYSCYILIGSRFTAGTHPLAATCVVILSAAASYALQSTWQGWGPPHSARGWLAIGMMALICTVAAVALFLNGLEKIGATRASLVSTVEPVVTLLLAWGLLGEPIGLSQALGGLLILGAVLLVSREADPKRTELTELHD
>fig|279808.3.peg.645 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MEPITHIHHISAIVGDAQETYDFYTNVLNLSLIKQTVNYDDTKTYHLYFSNDRAQHDMVLTFFNWPNQYRGRIGSGQVGHLAFRIPKDSMSHWEMKLNANGIQTRQTDSFNQTTLEFEDIHGLTLAMVESDEERVNNDIIGFHGVTMLSGNPQATEALLQNDLGLEYIQETDDNVHYQTSGSVHHQIIGKKFVNPQPVRWGGGIFHHIAWSVPNDEVHVQWRDYLHNKGLHVTDVKERFYFHAVYMKEPGNLIFEFATAGPGFTIDESVDDLGRQLQLPPFYEERRYEIEGHLMPIKLNEY
>fig|279808.3.peg.1736 Erythromycin resistance ATP-binding protein msrA
MEQYTIKFNQINHKLTDLRSLNIGHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETVGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPTNHLDKIGKDYLKNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRQYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALDRSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT
>fig|279808.3.peg.2434 Drug resistance transporter, EmrB/QacA subfamily
MLDLTMINIAIKQLNNTFNTTIEITQWGITGYVLALALVIPIAGWLVNQFNGKYVFIGASILFGITSVLAGISWNAESFIVFRIIQGMSAGIITTLMFTLLIKTTGQDNIGKVMAVVSTPMIFGPILGPVIGGFIIHIVSWRWMFFINVLVVIIAILLQIKYLPNFVPFNKSKSIDILGMILLGLISISTIYGLTKASDYHSFYNRTTILLLIIGCIMILIYYIHNKVKHDNTILPLSLFCKGNYTASFIGLFLSNIGIMGPMVIIPLYFQTFKHYTPIEAALALIPQGIGMLITRPYLGKLIDQYGAKWVVLISVIISMFGSIPLLFITDHTSIIALSIILFLRGCSIGGINLGLTTDTYMGIKESVLAEAGVGINMIENIGSSFGTAFIATIIRVVINQLGKSLMHNIIAYHARFLVSVITLFLIIVPGLFLTQKSKATI
>fig|281309.3.peg.752 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MNVEQCIVLEVKNLKETLYFYEGILGIKPSLERPQLDVTGVWYDSDSKRISFVMNRMLGGREKGVTDSCEVLTFTISNIEKLKKKLAFYEILYTENECAKSIVVQDPDGYKLQVVEKDE
>fig|281689.4.peg.151 Efflux pump antibiotic resistance protein
MAEKNLRFATLSVVCVAHFLMPFMMSAVGVALPVIGREFHASAVQLGLIETSYVASASIFLLAMGRLGDIVGRRKIFQIGLGLFTLAGGLISQAWAVDVVIGLRFFQGMGGAMVMATTMAIVVAVFPEKDRGKALGIAVASVYAGISCGPFIGGTLVSILGWRSIFYLCIPLGLTALLTTTLLLRDEWVGAAGEPFDWQGWLIYAVSIASLVVGATHLAEGVLFRVLLAGGVCGVVLFLWFETKRRFPLLNMDLLLHNRVFALSNLAAMFNYAGTFSMTFFLSLFLQVVLGFAPHEAGGVLIIQPLVQTLFSPVCGRLSDRYPADWVATAGMALCALGIGMAATLTAVSPLSFIVVILVVLGLGFALFSSPNTRVIMTSVAERDLGVASGFSASMRTLGMMGSMTIVTVIFSWQMAGQPITPQTQDLFIQSMHIALQIFSGLCAIAVFSSFGRHQSPSKQSGVLNDE
>fig|281689.4.peg.642 
MAVKIIIIRQVPQEKEPEIRPLLLKMRSLAHAQNGYISGETLINFDNPSERIVISTWKTLENWNDWLNNDQRITLQSEVDRILGHETLYQIYYNG
>fig|281689.4.peg.675 Acriflavin resistance plasma membrane protein
MKNFVTLNLKQKVFINVVFVILMVSGVYSLFNTPVENLPPVAIGKVVITTIHYGASARDVEQLVTREIEEAIDGLENVEYVQSTSMRNVSSILIKFIDDTDYRHLYDELRLRVLNVREQLPDAVDDPIFTYLDSQDWKPVIIANLIGDLSNTSLTLLAEELKSDLRKLDGVQEVALEGDYHQEFQVHIDPQRLRDTGISFAEVAKAIADANVKIPSGRYRQQGHNTLLDTGQVFDRQQQVLDVAVRRDGDGNFIRVRDLATLASLSHREPDLISTVNGQSTVKLKVKKQDAANAITIAERVKQEVERFNQLHQRDGVTTVLTNDSTIEIDDSIRTLGGNMVLGMILVTLVLWITLGFRNAMLTAIGIPFSFLVTIIIVKLTGESINTISLFSFVLVSGIIVDDAVIIIENVYRHLYMGKTRRTAIVDGVSEVFLPVISSAMTTICAFAPMLIMTGSTGDFFSVIPKAVSFALFASLVESLFILPVHILDYGPRQMSANLHPEGDYHHLQEGPFAPLWKIYRGLLNTLLNHKWLTMAGITTAFMVTMVMMIVSVTGIMPLIKVKFYQDSYLRYHVTVDMPTGTSVEGTDAVIRDLSRYLVSLGPGQTLSTSGSAGLKEDQDYQIHRAQHYGQVVVELPPQSEMDLPTGNDQISTYIDQMYDQVEAYVDQHADQWPGRPTIQVFGESTGPPSGKAVNIRLSAMDIDQARAASDDVLAYLHNDPAFADLINLEDNRASIQSVLNFEVRRDRALEYGLSSSDATRLIAGSLNGMQAGNYRTTREEIDLMVKLARQEDSGRGLLNPEQVATIPIVEHSEQPILIGDLANLDYRQEPDARTRYNGKPTLTITADIRTGSQLSASRVQVLAQRYFDSINDRYPGVSIAFGGEFESTARAYTSLAAAFVIAVLAIYLILASQFNDYIQPIIILSAIAFAFIGVVLGMFFTRSVFTIGSFMAVIGLAGVAVNDSLILIDFMNKERERGLGLREAVINGCSARMRPVLITTLTTMLGMLPMAIGIPHKSITWAPMATAFATGLASATTLALLLIPVEYELTENAKERVRNFMRRRQRQNLKQQREKNK
>fig|281689.4.peg.726 Permease of the drug/metabolite transporter (DMT) superfamily
MAVISAFGFSFKAILIKLAYALPQQVPVDAVTLLILRMLFALPFFLLLLRSSGHQGRNLNRKDLAVVIILGAVGYYGASLFDFLGLKYVSAGLERVVLFSFPLLTLFFDAIFSGRKIRSYEWLAVVICYCGIGLAFVHDMDVSGVQEEVWVGGGLVFLSALCYAFYLSGGRHLIARYGSSRFACLALVVSTAATLLHFAVSHPLSDLVQPWQIYLLAFIMGTFSTVMPVLTLAAAVRRIGSSPAALISSLGPVLTIFFSWLILDEAVSLLQMGGTLLVIGGIWLVGKKGRQAAD
>fig|281689.4.peg.842 Permease of the drug/metabolite transporter (DMT) superfamily
MNDLLKSHLMVLLATFFIAGSFLASARLAGVINPFSLTLMRFVASFVLLLPLVLSRRDWRRKIVTVLPRATVISFFYAMFFACLFEALKTTTSLNTGTLYTLVPFMTALLCLVFLRQPIGGQTFLIYILGAASACWVIFEGQLDRLLAFSLNQGDWLFLGGSLLICGYSLSMKLLYRRSDPMPVLVFCILFTGALWMGTALLVLGYPLDWHNIHGEHLAAMSYLVVASTLMTVYLYQRSTVVLGPRRVMAYIYLNPAAIAVLLWWFEGVKIPTIVLPGIVACSLATVLLQREPRS
>fig|281689.4.peg.1584 Permease, MDR related, probably tetracycline resistance protein
MARIEHNILKIYLIKTARWLMLTTPFLPLFMAENGIDKSGYGLLASIQALSIVFFEVPSGYLADAIGRKKTLVLGSILGALGYVIYSVSFSFSGFLVAMVVLGIGQSLISGSDSAMLYETLVDMNRTGEYSRYEGRVIALGSLMETIGAPLGGLLAVASLRYPFVAQSVVALIALPAALTLVVPEQEARIRGTSINLLPALKRSLLLDRTLLLLVIYAALVGGGTYTMAKAIPYWFNDSFASSAMQLGIFWSVLNLSAAFFSHHAYKIEQRLNPPLFMTIIGSVVSASFIALGVLPAYPAMAVLVLFYCTRGLATPILKNYINEQTDSQVRATVLSVRMFLVYVLFAALFPVMGWVGDASGWSTALVLAGICFAVIYGSALFAFTVTKKSA
>fig|281689.4.peg.2534 Permease of the drug/metabolite transporter (DMT) superfamily
MMKRSLIVVFQKPIVRLFIGTICISLAPIFIKASNMPPDSSAFYRMLFAGLSIGFLLSLGRENIICSKKQILFLAGGGFFLALDFMCWHRSIHLIGPGVATLLTNLQVFFTAAFSFLLFRQRVTRLFIFSVPVAFCGLYLITGADFGALAGYQALGITLGLLSALFYSGYILFLHRTMKSSVLGAKPSMFVVSLSSTALLALTAPINGASFVIPDLATLGTLLGVGILSTTLGWTLISSSMRAVPVTTAGLVLLLQPTLAFIWEVLLFDKPVVLLETVGVLLILAAIYCGSYSKPTPAPLKSTKQSNRPIKRG
>fig|281689.4.peg.2726 Multidrug resistance protein B
MIFQGDTMDKAHRWLFKGVFFINFAVTLGLGVSDAFFSVFAQSLGARGAILGAAIGFYAASKIVFSPFMGKLSDRFGRKRLIVISLMVFLLVSLLCLSITRVQTLIILRLMQGLGCAMFRPVVLSLVGETTLPHSRGKMVATFDMSFYGALSLGPLIGGIIMDQWGFDGIFVLLAGLCLAALLVAVLLIPTDDNTARTTTMPVSANRQARSRRSLQHSALPGLLVFIFGRACGIVIFVSFMPILLMSKLGLTGVEVGMVMASTSVVMTLCLRPMGKLTDRCSRSVLVMVGGTVVSLLYVLIPLATTFHQVLVLGMAIGLFSGLSQPASTALLVEEGQRFGTGFAVGMFNASLNLGFVVGPVLGALLLSSEGLSSVFYVAGLCGGLAVVLFSITTRATASYGQAWHVRS
>fig|281689.4.peg.3210 Bicyclomycin resistance protein
MKPSIEQHKALYITYLALLAATPPLSTDMYLAALPEIASSWGVGKDLINLTLVLWFASFSVSILISGSLSDKYGRKPLLLWGLSLFVVTSFLCAGAGSAQMLILFRIFQGLGAGAPAAIVLAIIRDRFTGKERHQAIAYVMTIVAVAPMVAPIIGAMLLEFFNWRFIFVMQGVMVSITLLVTFAFKESLADPLNISLKRLMTRYTVHFRNKEFMFASISMGILVLPFYGFIAFSPIYYITIHGLSEKMFSLLFGLNALSSMCGAFSSSFIVKWVSDKTVITVSIYGCVIAGIGLMVLGSQHFLYFFVFMAFFSFCTGISRPISGNMILGLVKTDVGSASSFLVFYQFISGALCMAFVTLQWSYPVLVYGSLTTIVSILVLILWARIAPHLNPIH
>fig|281689.4.peg.3321 Acriflavin resistance protein D
MSVLHYSIKKPVSVAVFVIMILMFGIIGLNKLPVQLTPDVELPEITVTTTWPGATPYDIEQEIIEDQEDALKGLQNLISLESSSYNNYGTISLVFKVGVDIDNALLRVANKLDEVGDYPENVDKPIIEAAGANSSPVIWLLLKTKQGNETPIDQYRTFYDNEVEQHLERIDGVGSLFVGGGTEKELQVVVDREKMARHNITISQVTHSLQQANENTSAGNLSIGKKDYRIRTVSRFQNETDPLDVVLVDDGIKRVYLRDVATTQEGFEKRTFAVQNNGKPCIVVGIRKEKGANVIDLVQRAHETIDELNAGLLADNGLTFDWVYDQTPYINTAISIVKQNALIGGLLAIVVLLVFLRSVSGTAITAIAIPVSVIGTFISLWVFHRNLNVVSLAGISFAIGMLVDSAIVVLENIDRHRQMGKKAFDAALDGASEVFGAVLASTATTVAVFLPVIFIEQEAGQLFRDIAIAITFAILLSMIVSLVVIPCLANLVYGRRPVIKQKTDRIGRFGQRFVDGIMRFSDLSLKSVATRIMTVTLLTLTAALLVWILLPKSEYLPQGNRNLIMNILIPPPGLSVEKRESIGQYVYKQVEPYVKEDWKDGIPQIKTTFFVATPDLNIMGSLSTHETEARGMMPLMTRVMNSIPDMIGVSLQAGIFESNIGEGRAVEVNITGTELPTLVNAGRTLYGAISQAIPQSQIRPVPSLEISYPEVSIVPDKKKLVANGLTETELGEYVDVLMDGRQIGDYMPDGTRKVDLVVKASDAEVRSPEDILNSTIVNRYGELIRVGDIARAEYEQGMTQIDHYERRRNITLQVTPSADIPLQQATETIEGLVAQLRKGGKLDGTQIFIGGNADKLVETREALQWNLLLALVITYLLMAVLFENFFYPLIIMFSVPLAAAGGFIGLKAVNLFVAPQGFDILTMLGFIILIGTVVNNAILIVHQSLNNVRFEGMKGIDAIRESVRTRIRPIFMSTTTSLFGLLPLVLSTGAGSELYRGIGSVLLGGLLVSTVFTLFVIPALLAFFIHRERAENAE
>fig|283942.3.peg.76 Permease of the drug/metabolite transporter (DMT) superfamily
MLIKKGLLAFGPMEVGALRISSAGLVLAPFIARRLNKITRKHWLKLASVGLVGSLIPAFMFAIAQTQLASGVTGVLNALTPIATLVIGALFFHQKARLAQVIGVAIGLFGTLLLVTASANGSWDFNLYALLVLAATVCYGLNLNLIKHKISDLSPLTITGISLLMAAVPATIYLFAGTEFITQVQQPGAMLSLFSVLALGIAGTAGALVIFNHVVQLTNTVFTSSVTYLIPIVALILGILDGEDFWLQQGVGMLAILVGVWFANRRGRSGMAGIPQK
>fig|287752.3.peg.49 
MIIVSGIQRLDPADLDRVREAARTVIAATREEQGCIVYSFAEDMVEPGLLRVYEEWETREDLERHAKSDHVAAWRVALASVEVLHRDLKIIEAGAVQPLG
>fig|287752.3.peg.3051 Drug resistance transporter, Bcr/CflA family protein
MLVTLMIASALSPLAINIFIPSMASIAADLSADGATVGLGLSLYLVATALIQLVAGPLSDRYGRRPIILGGMVLFLVGTLLCLMADDVALFLVGRVVQAASATGIALSRAIVRDVYSRERAAAMIGYVTMGLAVAPMIGPLIGGVLDTAFGWRSVFWLLTGIGIVTIVLLAFDLSETNSETGRPILPQLRAYGELAGSSAFWIYVGTSSLTSAVFFGFLGGAPFIAMTVLGMTPAGYSVWFALCAIGYMLGNFATARLSERFRIKTMMVTGAAISLAATSLSLALIAGGLLSPLTLFAPMLFVGFGNGLVLPTATAGGVSVMPQAAGAAAGMLGACQIGVGALSSILAALLATGSGGAVGLLLLMTGIAIAGLGVALSARRVNAAG
>fig|288000.5.peg.1811 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MLGTDVSDLTTTAADAASQGLSIVIPVYNEGAGLTALHERLNNLARTLRQRFGLACELVYVDDGSRDNTLAIARTLQADALDVQVVSLSRNFGKEAALMAGLDHARRGAVLFMDGDGQHPPALVEQLVTHWIKDGYDVVYTAKAHRDNEPFLRRVAVHGFYALINWGARQKIPEDAGDFRLLSPRAVAALRQLPERNRFFKGLASWIGFRQIRVDYEPAARAHGVTRFNVTSLLGLSIEGLTSFSVAPLRFASLLGILLASAAFLFGLSILWETLTTGKSVPGYPSLMVGLMTIGGVQLIMIGIMGEYIGKILSELKARPIYFVAEHSEKRAALDSRSDGAERTAAE
>fig|288000.5.peg.2589 Permease of the drug/metabolite transporter (DMT) superfamily
MPDQGSHSRSDPGLPQLAATSRGQVSGAVTAPPLEGAGNDRAGALIVAISAVAFSTAGLFTRLVEADVWTMLFWRGLFGGIMIGAYVIWTERTAHRKAFTAIGWAGVLTATCSTAGTICFVAALRMTTVADVTIVYATAPFIAAGIAWVWPRERPRCVTLVASGLALLGVVILSAAALPAARMLGNLLALTMTILLALMMVINRRFRHVSMVPAACLSAFACAVLVAPLADPMSVTGADLVLLMLFGTTQFGMGLLLLTIGSRRIPAARASLLGNLELPLAPLWIWIAFGELPSRSTLVGGAVVCAALLLDLAADQAPGRWLGRPPLHQKAPDMGRG
>fig|288000.5.peg.3480 Glyoxalase/bleomycin resistance protein/dioxygenase
MGVSVGVLDHFNIRTRNLAETVRFYEDVLGLENGARPNFAFPGAWMYSEGRAVVHLVDISPTSEAQKPDSGVVHHVAFVSRGFAAMKARLAAKGMPFEARQVPGGELWQIFVRDPNGVMIELNYEAAKEQAGDAPVETASDIGTMVAF
>fig|288000.5.peg.4654 Bicyclomycin resistance protein
MTQSVPFSVAVALGLITLLAPVSVDMYLPSLPVMAEEMNTTYPAMQLTLMVFLLAMGAGQIVFGPVIDAYGRRRPLLVALAIFVVASLCAAVAHSVEALLLARLLQGLAASLAIVTAMSTVRDIASGVAAVQIFALLMTIQGLGPVMAPVLGGMIGAGLGWRAVFYFLAALGAIVLANTFTRLPESLPPNKRSSLHPVQVWRTYVSIVMDRRFLVPGLALSGVFFILFGYIGGASYVYQSFYGLPSREFGFIFGATGIAVLIGAIICARLVKTFDVERLALAGVLAMLGGALIGWVSVLVGIGLPGIVAGMILTLAGLGTAEATLTSIALASRASALGASTALLGAVPLVLGAAATPLAALLAEIGPAWWLAFLALAGVVTAGLTLASLRMVAGQGVRVVQH
>fig|288000.5.peg.5468 Multidrug resistance protein B
MTTSTEARSGLMGGRAIAVLIMLFLFQTLNFFDKLVFGLSAVPMMKELGLSPKEFGLIGSSFFLLFSLSGMAVGMFVVGRFPVKWLLLIMAGVWSATQLPIFFSSSIAVLVLCRIILGAGEGPGLPTALHACYNWFPADRRSVPSAVVLQGISVGLLAGGPILTYVIVNYGWRTGFLFCGLLGLVWMAGWFFIGGEGPYSAAHGPEATAAKDKALPVRVLWGDATVIGVIIMSTASYWIVGMSATWLPPFLQLGLGYKQVDVGWVISGIYLFQSPLLLGGSWLTQYLQRKGFSLRACLGHASGLALLAAGCALLLSIVTTGPLQLACVAIAFAAPSLTTIFGPVALGAIAPAVQRGRLIVVIYSGNAASALVSNALTGWIVGEAGSNVPLGYAHAMTFTASVLITGAISAFALIFPERTIARFARTTQDPSSSSAVAAAST
>fig|288000.5.peg.6008 Multidrug resistance transporter, Bcr/CflA family
MISRPPRTATIQAAPSRTVLILLVVMTGLAPISLYLLVPALPLLATTFGRDASVVQMTVSFYMIGIAISQLLLGPLSDRFGRRPVMLAGLALSIVASFGCIFAATLPQLIAARFFQALGGASGMVISRAIIRDLYPRERIGAMISLVVAVMMIAQMLSPLTGGLIEIAFGWHAIFYVVAAVSVAVAIAVTMALPETRPTRVEGASFRRDVTALVKSRAFLGYMLCQVLASQIIFAFAGGGPYIVEVQMGRSSAEYGAWFATTGFAYFVGNLFCVRYAPRHSLDRLIWFGLGLQLTGAALNFTWSLFGFNQVPSVLFGTQMLLMFANAAVMANSAAGAISVRPGAAGTASGAMGFLQMGVGALTSQLGAYLGGHYATTLPLTSAILALSLACACSMIFLVPRTAVTVTKELIERAEEDEAGVM
>fig|288705.3.peg.43 Permease of the drug/metabolite transporter (DMT) superfamily
MKPKHALLAVLVTLIWGTNFLAINATLQSIPPMLSVALRFVLAIFPWIFFIKPPKIGWKVIVTLGLAVNAGQFGLMYLAMHMGLPTGLAPLVLQAQVLLTVLIAMFFVKEKPNLGQSIGIGLGIVGLIVVGVGRAQVAPILPFILGLGAALSWSIGNVVSRQVQKNASTATSGLSLVIWSAAVVPVPMFALSFLLEGPEQIGFALSHLQLPAIIGALFTAYISTIVGYGIWNYLLGKYSSAVVGPFTLLIPVIGIASAWLVLQEAPSIPELVGGGLLLAGVATAVIRFGRKPRPVPEVLSEQIQAEGVLR
>fig|288705.3.peg.766 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MVNTVKFAQIAPVFPVVDLERSISHYEALGFEVAKYDGDEDYAYAKLGAVRIHLWQAPGIDPETNFSAAFIEVDDADARALQWKAVSDNAEIRCPTGMPVDTEYGLREGAHVDPDGNLMRFAHKLT
>fig|288705.3.peg.896 
MSDMVNLQATFVPNDGEQFRVRLALDIAIEQVLLEPGCIQYEVTEDTPERIVLTEQWASEEALSAHGKGAAVQDLNESLSALLAAPVKLERL
>fig|288705.3.peg.1949 Ribosome protection-type tetracycline resistance related proteins
MALEVELGALPLSFHVALAEAVRDCLSQGLAGWQVTDCLVTITHTAYDSVMSAAGDFRRLLPLVLMRALARAGTEVCEPLSEISLEIPLSAFSAVIGMLGRAGAKTTSTEIAAERCQITAVLPAASAICVTQGLADLTAGDGTSTSHPAGYRPVVKVPPPDLGPTVIR
>fig|288705.3.peg.2509 Vancomycin B-type resistance protein VanW
MILHSPLEIVEYHHHSAYDLFPDFNRQIPYGTGTSIVYNYLDYRFRNNLDQSFQIIVYLTEEHLRGELRAEQPLPLKYHVHEEDAYFYQAGEQIFRHNRIIRTVTDKRTGNQVLHEELLENNGLVCYDRDLIKSAILSQKPSESVANSVS
>fig|288705.3.peg.2979 Multidrug resistance protein B
MFWLASIAALAAITVDVFIPTAKEIATATGAIRIVTNAQKSDPAASASIAPARLAADNEMVVRGVVVGPAGKPVRNAVVTALDLDGEPADWSRADNEGRYALALPGEGRYLVVSSAEGWAPTSEVAEFVAGEQGRVITLSVRFGLSGTVRSGGRRVEEALVTLTKPTGEFFGSARTDVAGNYELPLPQTGRYIVTVLATGATRAVARQVVLTGQSLVVDFEDLPLAELVTS
>fig|288705.3.peg.3501 Transporter, drug/metabolite exporter family
MRKVNLLALGLVLAAAVARAVWNLAAKKAGTGGVPFLWLASLCSAVILAPLGIWGILAFSGQ
>fig|288705.3.peg.3606 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDFAKTFSGFSVNDIAVAQSFYTEKLGLEVLENNGMLNLYFGGHRHLIYPKSDHEPASYTVLNFPTNEIEATIDQLVGRGVQFEKYPGVDERGINRRGGPLIAWFKDPAGNVLSVIESRVTEPQLAELQTAASRQKFPLI
>fig|289376.4.peg.116 Membrane fusion component of tripartite multidrug resistance system
MSLKSIGERFKNSKKIKIAILIVVAVGALIFMSKEIYYYIVYERTDDAYIEGTIVPISPQVSGKVSKVYVDYNQRVKKGEPLVEIETDDYLADVKAKRENVNTLYNQLQEISSSLNEAMAKLKTAEANLQAAHAQRVLAEKEYQRIKGLYEEDLVSKSRFDSAEASLKVAIAQERAAESQIKEVKSTINTFTVKLKTQQHLIGKAQEELKISEINLKRTLIFSPRDGRIAKKSVEVGQYVRPGQLIMAVVDEQDIWVGANFKETQIEKMRVGQPVRIKVDAYPGKIFKGHVASFQPGTGAVFSLFPPENATGNFVKVVQRIPVRIIVDSPFEPDYPLWPGMSVIPYVDVTVNTGAKLKDVIGKQ
>fig|289376.4.peg.1225 Multidrug resistance protein B
MKRFWIVLTVMLPTFIEILDTTINNVALRHIQGSLSAGVDESTWIITSYLVSNAIVIPMAGWLSKIFGRKNYLIFSITVFTISSFLCGMAWSLTSLIFFRVLQGIGGGGLQPLSQSILLETFPKEKYGTAMAIYGMGIIMAPILGPIVGGWIADNFSWRWIYYINIPVGIISILMTYLIIEDPHYLKREKLRIDYPGIIFLALGIGCLQIMLDKGEREDWFESKFIITLFVISILSLATLLWWELKRAEHPIVNFRLFKDRNFFFGNLVMFFTFVNLFGSIILLPIYVQNLMGYTAFLAGLVLGPAGIVQFIAFPISGKIVDRINPKIPLAFGIIMCAYSTHLMSLFNLQAGFWDFVYPRAVLALGMAFVITPLAAMTVAYIPKEKMQDATPLNGVIRNIGGSVGTAIVTTIVSQRTQFHQARLVENLTPYDIPYQIIIEKLNEYLSIRTFLPPENPIYRELIRQAQTIAFNEAFWILSIAMISMIVTIMFFRKPIYKKKGGNAGAVH
>fig|289376.4.peg.1367 Outer membrane component of tripartite multidrug resistance system
MIDMQINNDTENLAKWWESFNDKTLSQLIEIAIKNNLDLKQAQARIKEAKARREVAGAKLFPSIDAKSSASYSKTRGTKIEDNTVEHLYSAGIDASWEADIFGGKRKSLEAYQAEFEASQWDFKATIVSLISEVALNYIELKTYQNRIEIAEKNLNSQTETYNLTKWKYMAGLNDAIDVTQAEYSMENTRAQLPSLRTAIEEKINTIAVLLGKQPQQISEELKKSHTKPLISEKISLRIPADVLKMRPDIRKAERQLAAQSARVDEAIAGFYPKFTLSGSFGIEALSLNSLVKAATKIITGDFLISLPIFHADEIRQNVEIQTALQEQALLNYEATVLNAIKEVENALVAYAEEQKRKQALEKAVEASQLSFALALQKYEVGLTDFSTVLETQRSLLNLQDQLEQSKGNIFIYLIKLYKAFGGGWESFANEEEN
>fig|290315.4.peg.81 Outer membrane component of tripartite multidrug resistance system
MKKTLKRHAGIAAAALMLTFPPRLEAVAEPASARLTLEETIRLVRENNPALKAASEEVNAADARIRQQKSAYYPQITASAGYTWIDPVSEMGFGGSEPIQFMPNDNYEAKVTARATLLDFGKRGIEVDMARTGKNAAGHTFEIIRRDLSYRTVELFYGILFLRESIRVEEKEIAALQKAFDYTTKRYQAGTATKFDVLSTDVRIQAARSKKLGLEHQLRRHELTLHRLTGLAANTPLDLKGSFSVHPENPDETTLVAAAVRQRPEVLLAGENEQSARLRRSRSMKEGLPVVRASASWGVSNGYQPDIDEIRENVAAGIHMELPLFTGFRTSAERQEAAALLRAAAQRRLDTEEQIATEVAETLHALDTAREKILTTESQVRQAKLAAEHARARYENGIATTLDLLDTEAALAQAELARLQAAYDYVLNNYTLKRATGEIFW
>fig|290315.4.peg.110 Glyoxalase/bleomycin resistance protein/dioxygenase
MNSNALSACFCTSGVDACREFYQRHFAAEVIFDCGWYVNLRFGKDGPTLQFMQPRQGMVAFCGKGVVLNWSVDDVDAEHERLIRYGLDVIMPLEDHPWGDRGFSVADPVGNTLYIYSDREPSEEFRQYYKNCEAGPPDYA
>fig|290315.4.peg.1721 Acriflavin resistance protein
MTLTELSIKRPSLVVVLFSVLGILGFFSYLQLQYELLPKMTPPVVSIAVQYPGGAPDEVETSLTKPLEEAVSALEKIETISSISSEGLSVVTVEFSNDADIDLALQDAQRKINEIRDRLPDDAKDPVISKFALDEVPVLRIGAISSLSDTDFYQLLKDNIKPQLSSIDGVGQVYLTGGREREIRVNLDLDRLQAYGFTVTDVLGTINRANLDFPTGKIDAADRQFVVRLAGKFIGLDELKNLVLRSSAQGSRVHLKDVAEVRDGFRDITTLTRLNGKNAVGLMIMKQSDANTVDVSRLVRQELKRLETLYGRDGVRFDIAQDASTFTIEAVTAVQHDLIIAILLVALVMLLFLHSLRNSLIVMVSIPTSLVTTFIGMYVFDFSLNLMTLLALSLVVGILVDDSIVVLENIYRHIENGEEPREAALSGRNEIGFTALSITLVDVVVFLPLSLVTGIVGNILREFSIVMVLSTMVSLFVSFTVTPLLASRFSRAERLEPDNALSCFAIGFEQNFKRLTEWYVTGLRWSLKNGWKVIAGSTLLLLFSFSLLGFGFIGGEFIEVSDRGEFSVIMEFEPGTNLDETNRQTRQIERRISSMPEVDNVLVSVGSSSEGFFNQSADNISELNVRLIPKEARAVSTDDLMKEIRRSLQDIPGLKASINPIGIFGTANETPVIVIFSGPFRSEVSRTAESFRDSLKAISGTADVKLTSTVGNPELRARIDREKMASFGLSIADVGAALRTAYAGDEAGKYREGGNEYDIRVMLDEYFRKDTRAIEQLTFRTQNGEQVRLGQFVTFGVERGYTKLQRKDRNNAVWVKAQVVDRPVGSIGQDIEQVIGNMKADGTMPQTVSYAYESDLKRQGESFSTLLVAFLVAIVFVYLIMVALYDSYVWPMVVIFSIPLAVIGALFALASFGKSLSIFTILGMIMLVGLVGKNAILLVDFITKFRQEGMALHEAIIEAGRERLRPILMTTFTLVFGLLPIALSGSSGSEWKSGLAVALIGGLSSSMFLTLLVIPVVYAGFDKLRERIETIRKKRFPKVDA
>fig|290318.4.peg.789 Tetracycline resistance protein
MKKSPLFILLLTVMLDLIGFGIVLPLLPTYAKDLGASPFMIGLIAAIFSIMQFIFSPLWGKLSDRIGRRPVMLFSIFITAVSYLVFSQTTTIALLIFSRGLSGIGSANIAAAQAYITDVTDSKSRSGAMGMIGAAFGIGFIIGPLIGGLLKHNYGIPMVGYVSAGLIFVDFILAVFFLPESNKNAKKLSFRRSGTEHSADRPPTSAVLAQKINEYAAGVKLAFSSRPLAMLMIANYLFTFAIVNMQVASILLWKEYFLASDQQIGYIFAFVGLFSVIVQGGMIRNLVKKFGEHKLFLWGHLFTFIGVFFVPFAPKESLFTIGLTILFFFAVGTSLVAPINLSLISLYSYKQQQGEILGISQSVNSFARIMGPFSGSILYGMNFHAPYIVAGVLTIIGFIIALDLFKYKIDALDPGRDTVAETIGS
>fig|290318.4.peg.1102 Acriflavin resistance protein
MKSIIRHFVRYPVLGNVLFLAVILFGLVAFTQIRTTFFPDIPPNFIYVSALYPGASPEEIEEAVTLKIEDRLKGVGGIDRVTSVSTENSMTVTVELKKGFDPDDLLQEVTNSVNQISTFPAELEQLRIYKQERMDFVIAYSMYGDVDLNTLKGYARSLERELRNSGSATRITISGFPLEEIEVGLRENDMRAYGITFSEVAAAVGRANIKITGGTIRGSSEELLIRADSKGYYADDLRNLVVRSGGNGAVVRLGELADVRDRWSDDPDRSWFNGKPAVIVDIERSADEDMFDIVGKVETVVEAFDRRHEDISIDVLRNGSAIVKERAQILSSNGFFGMVLVVLFLAFSLNPRLALWVAAGIPFSFAGMFMLGAVYGLSINVVSLLAMILVVGIIVDDGIVIAESIYQRFEKGEKPLEAALNGTMAVIPSVTAAVLTSVVLFFLFLFLDGDLGQRVKDIAFVASTTLLVSLLEGIFILPAHIAHSKALHGRPEGKGWVLRKSEEFLHFQRDVLYAPVLRFSIANPLITAVVPVALLVITFGAMRGGLIKATFFPVIERDNVQITLEMPAGTPGVVTAEVLAVMEQKIRSVDEDYRRSAGGGKGLVSAIARDIGPQAHEGGLRVTLVESRLRSIGSLEAGNRFRDAIGRVPGANKLLVGGGSLWGMPVSIALKSDNLAQLDGARRMLESELKGMEQLKDVADNDPPGLEEVNVRLKEKAYGLGLTTGEVMSRVRSAFFGSEAQSLVRGIDEVKVWVRYSRAERSSIGALESMFIRLDDGRTIPLREIADLSVSRGISSIKHIDAQRVVKIEADIADPKTSVPQLLDVITGRIMPPVLAAYPDVSFNFEGQSRESGKTTGSMRIAFPVLLFIMYLIIVVTFRSFSQAFLVMLLLPFTLVGVAWGHFIQGYILSILSLFGVIALIGIVVNDSLVFISTLNSRIKEGEPFGNALYEVGLSRFRPIILTTITTIAGLGPLIFEQSRQAQFLSPMAISVAYGLLFGTTLTLIIIPALLVLHNAARRRLFSFIARRPITPEEAEPAWREEAFSREQ
>fig|290339.8.peg.2243 Membrane fusion component of tripartite multidrug resistance system
MAENHNNNADEEKRQDQQDDNSKTEDGGKDKGKGDGENRKRPGKKPLIILGIVVVIMVIGAIIWWFMTRNLETTDDAFIEGDAVTVAPKVAGYVTELRVKDNQRVKKGDLLVVIDPRDATAQRDQAQAQLSLAESQLHQAQAQLALAKVQYPAQRDQAKAQVLRAQAELANARAEYQRQRGVDPRATSKQNIDAANAQLRSAEAGLANAQAQLEVAEQVQLQIRQQETNVEARQSQVEQARAQLKTAELNLSYTEVRAPFDGYVTKRNVQNGTLVQAGSALFSIVSPDIWVVANFKESQLERMRPGNKVEISVDAFPDLELEGHVESIQQGSGSRFSAFPAENATGNFVKIVQRVPVKIVIDKGLENWNQPLPLGLSVEPEVTVE
>fig|290397.13.peg.52 Permease of the drug/metabolite transporter (DMT) superfamily
MADLALLVLTLLWGTTFALVKEALEIASPGVFLTARFGLAAVALLAAWALRPRAPLGDGFWRHGILLGLTMLVGFVLQTVALRHTTPARSGFITGLNVLVVPVVARWFLGRRVRPAFWVGVAFALAGLVMLTRPFTPGAVTEEVRFGDLLTLFCAVAYGLQVTFTSEWAPRHPLAPFVAVQVLVTLAGALVLAPLEGPRFDPAGAGHFALVVAFTGLVMTALAFFVMNWGQRHTTAVRAALIFSLEPAAAAVFSWLYYGEPLGPLDWAGGALMVLGVVAGEVGGVLEARAPRRARGERASTGPG
>fig|290397.13.peg.215 Permease of the drug/metabolite transporter (DMT) superfamily
MRAAVRTRIVATYLAVAALWGSTWMAIRIGLEDLPPLRFAGVRMAIAALVLAPFALRGGAWREVVGPARAQLALVAVLQIALPYGLMFVAQQWVPSGLAAVLFASFPVWIALLARALVPGETLTPARVASALLGIAGVAVLQLPHLGDLEGSGRLLLGGALVVLSSMIVALANVLVRRHLAAVSPLAMTAGQTAVGAVLLLAAAALLEQGRPAAFTASAVAALAWLAVFGTALTYVGLYWLVPRVPMAAIGALPLLDTSVAVTLGALVLHEPVGWNLALGGGMVLAAAALTIPRRR
>fig|290397.13.peg.543 
MTLLTTPLENDPALQFRIDAFEVPEDARAEFEAAMTRNLELLTSLPGFRGHLVFRKTGGPSRFGLVTLAIWESRAALDAAGVAVRAHYERIGFDRAAALARWQVRSELGGYEVLRPPE
>fig|290397.13.peg.945 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MSPAAPPLRAELRALLRLALPLSLAHGGQALMGVVDAAIVGRAGAVPLAGTGLGASLFFAVAVLGMGIMHGLDPLISQAIGAGDERRARHLLWQAAWLAALLAAAFTLPIALIPAALVPLGISADVAAQAGPYIWWRLPGLFFFLYYFGARAYLQAHGRGRPMVVATVGANLLNVPADLLLVFGGASLPAWTGPLRLVPALGAAGAAIATSLCIALQAFVLVRATRAVSLGGPRPGGLARPDRAALATAVRVGGPVGLHMFAEVGFFSLVSFLAGRLGAEALGAHQIALAVASLTFTMAVGLGDAGSVRVGLAVGAHDRAGARRAGLCAFAGGASIMLVPALAFTFAPGVIGRIMTDDPGVLALAVPLLRVAAIFQLSDGLQAVGAGVLRGAGETRFTFLANLAGHWLIGLPATLLLGFTMGHGVVGLWGGFCFGLTAVAVALLGRFLRVSSRGIVPLAERAAA
>fig|290397.13.peg.1179 Acriflavin resistance protein
MTLSDVAIRRPVFTAMMSVTLVVLGLLGLRRLGTDLYPDVSMPFVTVTTTYPGASPGDVEENVTRPIEDAVSSIAGIDKVFSSSREDVSLVFIEFELSVPLGEAVQNVRDKVGIAQGELPLGARAPVIAQYDVAAQPVLVFSAASGQDPVALREKLDDQVRPRLEQLEGVAAVRIVGGAEPEVSVDLFRDRLRAVGLDPDAVFRRIQGEHLDLPGGKFPAGDGEVGIRVRGEFRDVDALRRMPVTAAQDGSLVRLAEVALVRKGAKEPKTLVRTDGVDAVAVEVVKQAGANSAAVANEVKRLLPELQAELGFRAQVLVDQSVIIEANAHEVWVAIFFGGAMAVLIILLFLLDVRGTVISALALPTSVVGTLFVMYWMGFSLNQLTLLGLSLAIGLLIDDAVVVRESITRRLEAGEPPPVAASRGTQEIALAVMATTFTLVAVFVPVAFMQGITGQFFRQFGLTITVAVLISLFVAFTLDPMLSARFVRAHVPGQERREHPVARRIRAAFDANDRVYARTLDWVLRHRALTFAAAALLFLASLVVAPLLGSEFAPKEDRNQLIVNLEYPPGTSLATASRRSATLEERVRALPGVTAVYATIGYQEDPRQVRWRVNLVDKNARPDGVETYKAWIRGVLAADERLATRAVSDPPMLEGIGDFPPVLMHVTGRDFARLREEAERLVAAMREIPALTDIQLKDSPGKPELQVEVDREEAARLGVPAGAVALQVRLATQGEVAGKLREGRRESEIRVRLAGDDRESRGALDGMWISTPRGPVALAQLARLERSTSPAVIEHQRRERSISVWAQIAPGYDLGGAVQALRAKVGARPLPAGYAYIWDGMQKEQAESQANMGMALLIAVVFIFIVLASQFESFVHPFTIMLSLPLAIVGAVLGLGIAGQTVNLGSLIGIILLMGLVTKNAILLVDGALQHLREGDDPETAVRRSGPRRLRPILMTSGAMILGMLPTALGKGMGSEFRAPMAIAVIGGVITSTMLTLWVVPVVFVWVEKLRRRGRRGPRAVADAPEPPAARDRAAGGA
>fig|290397.13.peg.1469 Regulator of antibiotic transport complexes
MNDVLDATLDLLARVGYARLTFDAVAERAGVSKTTVYRRWPSKPDLVRPALLRLVDVFPKARDTGTLRGDLVELARVRLLDDTRQRARAIALMRANVGVLDDAELQALGRLVTERANQPIVAAVERGIARGELPPGTDPALVIEPIYATLQFHVFLRSEEPSLAYVEQLVDLVLAGARAGAAVRRTGA
>fig|290397.13.peg.1471 Acriflavin resistance protein
MDVIKTFITRPVFTAMLVLAVVVFGLNAYPKIGVDQLPDVDVPVVTVTTVLPGADPESIERDVSDPLEEALNGLAGLESMRSVNVESVSQVVLQFSLETAVDVAAQDVRDRVQATLSKLPGDAEQPIVEKLDVGAAPILTLALSGPVPPEELTRLAEDVLKPALQRQGGVGSVEVVGGREREIRIVVDPARLRTFGVAASEVAQAVRGGSVDVPAGRAEDPRAEVVVKVSGEARTVDELRDVVVATPGGAPVRLRDVADVVDGPAEARSSAADDGRPAVALVVKKQSGANTVEVAERVTSSLSGLEKLLPGGAQLRVVRDNAKFIRSSIDGVKEDLVLGGLLAVAIVLVFLRTWRTTVVAAMALPTSVIGTFAAMHVLGYTFNVITMLALTLSIGLLIDDAIVVIENVSRHAEEGAPPAKAAHAGTKEIALAVLAVTLAILAVFVPVAFMEGIVGRFFSAFGMTVAVAVAISYLVSMTLTPMASAYVLRAHGEPGPVSRAIERALSAVERFYRRVLVWALDHVAATLAIAVALLLATVGLGRFLQFTFIPAQDMSEVKVTLELPAGTPLERTARELEALRTQLAAVPGVTHVFATAGGGVQEEVHKGELIVTVVPLGERAYSQEDLKGWLRGGLRRPADAQVAVQDVAMMAGGGSRPQPVQLNVRGQDWAEVVAAAEKVRAHMAASPLFSDVDSTYRPGKPQVTVRIDRDRAAALGIPAATLGSSVRAYLGGDDFAQFRQGTDSYDIRLKLPPDARGADRLGELTVRSAAGQLVELRNVADLIEEPTLSQIDRQEQLRQITLLADLPRGVSLGAAMQDLSAFAAKELPPAIITDFEGQGKELGKTAGAFVQALLLGIVLVYMILAAQFGSLLDPFTIMLSLPFAVIGALGALLATGQFMSIFALIGMIMLMGLVTKNGILLVEFANQLRARGRSARDALLEAGPIRLRPILMTTVAMIAGMVPVALARGDGAEMRVPMAIAIIGGLVTSTVLTLVVVPVFYRLLDRLKRPRRVELLESPPEVERPTGT
>fig|290397.13.peg.1568 Multidrug resistance protein B
MSAARPPTNKWLVTVSVTFGTLMGAIDASIVNVALPQIRGAVGATVQEITWITTGFAIATVIVMPLTAFLGRLFGQKRVYMACLLVFVAGSALCGMASNLGQVVAFRAIQGLGAGALQPTEQAILRQTFPPKEQGMAMALFAMAVMVGPAIGPTLGGYIVDDFHWSWIFFINLPVGALGLFMVWRFVHEPEDIRAANAAAAAEQRRNMDWLGIALLAVGLATLQYFLEEGQRDDWFESRTITAVAAVAALALALFVWRELVAKVPAVNLRLFRDTVFTSGTVIGAVMFAILMASMFLLPLFMQELLGFTAMQSGLALMPRVLVMMLVTPVVGRLYSRVSPRLLVAIGVVLVSLGSFDVSRITLESTSSGIVHAILIQGVGFSFLFVPLTTAALSNVPRARLADATGLNSLLRQVGASMGLAVFATLLERSGVHARAAVASHLTPDRPEVQERLAQLGAFFAQRGFDPVSAREAALRALDGVVRKQSMVIAFEQVLFVTGLLFLCVLPLLYFLKVNRHGPNEKVHVEMEP
>fig|290397.13.peg.1569 Multidrug resistance protein A
MTPPADPKLHEVRAPPAPAEAAARPGGRRRVVVGAGLVAVVIALALGAHALLTRGEESTDDAQVEADVVAIAPRVAGPVAEVLVADNAQVRQGQPLVRIDPADYQVRVRQAEAELATAQAQAAAAEAQVSVARAGVTRAEAEAEKAALDLRRAEELKAGDAIAAERYDATRIAGATARAGAGANRAQYAAALASGELARARVKAAQAAVDLARLQLSYTEVRAPASGRVSRLAARVGQIVQPAQSLGQLVPDRTYVVANFKETQTGDIRPGQPVDVEIDAYGGRTLHGKVESISGGTGARFALLPPDNASGNFVKVVERVPVRIAWDAVPADLPLRAGLSAFVTVHTR
>fig|290397.13.peg.2615 Multiple antibiotic resistance (MarC) -related proteins
MALQLATLCFVSFSALFFVVDPFSAVPFFLALTRNDDPRRRREIALRASVTAFAVLAAFALTGEWIFRLLGIGLPAFKVAGGVVLLLLALDMVRTQPSRTRITQGEVDASADKEDVAIVPLAMPLLAGPGSIATAIVLMVRARGEDWWHPLPVLLAIALTCLASYLILAGAARTEKVLGRTGLAILERVAGLLLVAIAVQFMMDGLAEGLPRAFPLR
>fig|290397.13.peg.2841 Permease of the drug/metabolite transporter (DMT) superfamily
MVHLVMFLHSAISAGTYLAAKRALGELSPFEVALVRFGLSSLAFGLLLWRRPVRVARRDLLALAGLGIVAIPVNQGFFLAGMAWTTPGHAALLYALTPVFVFLFARVRLGERAGPAKVAGIALAFAGVVVVLLGRGAVGLHGSSRQLAGDLLILLAVVAWSVFAVAGKPYAQRYGAVGSTGVALVLGTLAYLPVGLVATDWSRLAALSPTGWAALGYLVLLTSVVAYILYYWALSRAEASRVAIWSNLQPVLTALLAWAIAGERLTAPFVAGGAMVIAGVILTERG
>fig|290397.13.peg.4095 Quaternary ammonium compound-resistance protein SugE
MTTTNETNGGNGRAWFMLLLAGAFEIGYALSVAGSRAFTVPGWSISAGVFFLLTLYALSVALRTIDVGIGYAVWAGIGSVGAAILGGVLLDQPLTPVQAFWLAVIIAGVVWLKLADRARADGPGARA
>fig|290397.13.peg.4096 Quaternary ammonium compound-resistance protein SugE
MSWIHLGVAVIFEIAVAISAGNARGFTRPWWTTATLVSGAIGTFFLSLALLTFDVGVGYAIWTSVAGVGVVVLGAMFLGQRLGWQKLLGILLVIGGVVGLRLSGAA
>fig|290398.4.peg.28 Fusaric acid resistance protein conserved region
MLRISTDHWLLALRTVLAVWLALFLALRLDLYQPAWAILAVMIVTLQPVMFTGGTPPIGIIIGRGVARFFGTLFGAVAGLVLIAFFGQQPMLYLLFSGAWLAFCMYWVMLEQDEYLGYVMMLSGYTATLVSLTALGTGVEDIWTIALGRFTETALGIGCGVLMHLLIAPRFGSRALPEALSGFLKNAAEETLAALDSPRPRATQDARLKALLGDYQQFEKLRGLTHLETRRLSRFIPALDRFASDSLALITAIRELETALDYLRACEDGEHWLAQLNAHAAPLLATIAEQPAGEPLEKLTLPDFAWDPERVSPRSRVRAELARQRLGEVLGLLQHGRRLRHALNAPASARVHALPREKRTRTTHNEHFVARYNALRVFVAFELLGLFWIHSGWHSGYLAMMLLGVFTMLFAKAPNPAAVVYQFLWGTLAAVTLGAVLLFLVLPVINGFPLLAIAIGIPVMVGTLLTPRPRWAAMGLSGAITLMTLLNLHSTYTFSPTTYINGGLASLIGTTTAMFTYALMRQRSPAERIRTLLGAYWRGVARLMCEPALPNRARLESRLYDRLGRLVALGGTDDTLREALDLHALALCVWRIRRLREELAPHRRELEAWLDDIGQRLVARRHHSPEVWHELSNQARQWVDRFYHEPRLSVATAGEIAMLGHLMREAPGVTLEAQADDDAPTAPHDRRTTPPRQETPHVR
>fig|290398.4.peg.220 Multidrug resistance protein A
MKIKKRLYTALALVVLVVLALVWGVHWWQTGRFFEETDNAYVHADSVAVRAEVTGRVAEVAVADNQRVAAGDILVKLDPSDAKSQLAQAQASLAVAQANAVSAARQVEQQQAAIEEAQARVTSAQADVEQARLHLERSQRLAEKNYASQQEYQDDQAALQVAEATLAARRATLASSRKQLDVLNAERDSAEANIEAARADLDNARHQLDKTRLRAPVAGVIGNKTVEVGTLAQPSLTLMHLVPIRSAYVVANYKETQTARMRSGQPVSLHVDAYPDIAFEGVVDSLAPATGSRFSLLPNDNATGNFNKIVQRVPVRIRVTGPEEALGRLRDGLSVVPTVDTRDLDPEDDA
>fig|290398.4.peg.438 Broad-specificity multidrug efflux pump YkkC
MTMRWLILPLAALAEVGWATGLKLASSPLEWLATVIVAAMSLLLAVRAVRFLPASTVYTVFVGLGAAGTVVADAWLFGTRFSWPSLACIGLILVGVIGLHQFSGKPAAPASVSRTDASREGVSS
>fig|290398.4.peg.496 Glyoxalase/bleomycin resistance protein/dioxygenase
MSIVGIEELEFGVEDTEKGKRFAADFGLRPRQQDGDQAVSDTFEALNGARLRVRAVDDVDLPEAFESGSTLRRMTWGAASSEALQTLRERLADQPGFVDHGDALECRDPNGLTVRIRVSTLRDVELEVPAINQWGDIRRVDQPSPVYEAAHPVGIGHAVFFVDDLTATEHFYRECLGFHVSDRYIDRAVFLRMQARGGHHNLFLLKVPHRGRGLNHVAFTVRDIHEVIGGGLAMTRQAWTTFIGPGRHPISSAYFWYVNSPLGGAFEYYTNEDFLTEAWSPRELEHSLASFTEWAVEGGIDIETRRQKAPHERA
>fig|290398.4.peg.721 
MSSTTSHFVVLAEFRIKEGQVPAFLALAHNDANESLANEEGCLAFDVLTPEGSDNLVVLHEVYRDRAAFEHHMQMPHYAPFKEGSAPLLVDEPSVRFFYTATRPE
>fig|290398.4.peg.956 Glyoxalase/bleomycin resistance protein/dioxygenase
MISLPSRQDRHFPCTSCYGHFAMLNAIDHVVVTVTDLELSIDFYTRVLGLDAHYHDATRTDLCLDGFALRLHGPEASAARPAESPVPGSQTLGFRSSLPLAEVKAHLEALAIPMELAPGATPDDIETWSSLYVRDPDGNLIEISRPRRR
>fig|290398.4.peg.1018 Drug resistance transporter EmrB/QacA subfamily
MTQVDRLFERYGPRYRLWVTLTVMLGLVALGMSITIVNVAVPYIKGAFGMSDSQVQWLSTGFLASTTVSLLVAPWLVSAVGQRATFIGLLVVFIAASFLGGLGQGMGMLVAARVIQGGMTGLIRPVAMQALFAAYPPEGRGMATAMYGMCLGLPLTLATVIGGWLVEHFTWRYVFFVTLPICVAAAAMGYFFLPSREQKGPRPPFDWAGVVLLFVSVFSLLAAFSNGQRWGWYDPRVPGLLLVALVCGAAFVVWQNRTAHPLIDLAIFRNRVFVAGTLAMFLFGGTFYGIMYLLPQFVQSVLHYSPITAGQIFLPSTVVLGVLVPLVGWLSDRHPPHRLTVPGLGCTMYAVWLMAQMDWNTSFTYLATAMGILSIGMAAFPPPTLSNAIAGLPRHLTGHGSGAINFALQLGGALGTAALVILLDRRTAQHGQELNAGVNADNALANLQLDKLAELAGHLGSSATQQGAMGGYLMERIETIWASILAYQDGFWVLTGSLFIVAIPSLLLSRWRATTPR
>fig|290398.4.peg.1435 
MPFVVINRVYVNPGYEAEFERRFQRRASQVDRQPGFRAMRVLRPQGNQAPYLVETEWDSQEAFRAWVGSDDFKQAHADPMPSEAFGEGGGLEQFEVVEGTQA
>fig|290398.4.peg.1537 Tetracycline resistance protein, class A (TetA(A))
MSSARLLPLLVGCVMLSPLAIDIYLPSLTVMAETFDAPFSRLQFTVTLLLLSVGLGQILVGPLTDRFGRRPVLLCGVVVYMLGALVGMTATSLGPLYVSRVLQGLGACATMTVAFAAVRDCFTAAQGAKLYSYLNGALCIIPALAPVVGGSLAVTFGWRSNFAFMFAFAAILGIGAVWRFAETRPSNTVVERRLYHWARYRPVLASARFVYFAGLAGVIMSAILVYVSSAPVVLVDRLGLSELAFSGWFGANALVNIVAFFFAPRIIHRLGRVGTVRLGLCLIIASGILQALSVMYLPLTALGFMVPVGVLSVGFSLALGAASSLALEPFRERAGTAAALLGALQLGGGALLATCLLATALPPQWALALIAVLIVSPLLWLSYRVAPEA
>fig|290398.4.peg.1854 Drug resistance transporter Bcr/CflA subfamily
MTRLNARRLALLVAANTALAPFAIDAYLPAMPTLAEAVNASVHHTELSLSVFLFGFAIGQLLCGPLSDRFGRRPVLLTGLVVFLVASLGIMQVSSLETLWGLRFVQALGGGACVVNSAAIVRDCFSGREAAKVMSTMAMILMLAPLVAPTVGSVLLGFFNWQSIFLFLALYAAFLLFFLGTRLPETHGRDPDAPSMRQVLRNYASVIRHREAMGYICAVSMSFAGMFAFITGSPYLYMEHYGISAAVYPFVFGANILVMASSNRLNIYLLKRRTPQQNLVVGLGIQLCAGVALVALILSGMDSIYSVAPLMVVFVGMQGLIAPNAMSSMLDHFPNMSATATALQGCLQFSSGAFAGMLVGAFEIASAWPTVLTMLGASLLGNIGVRVLAGRALGAQEEEGAVTER
>fig|290398.4.peg.1937 Glyoxalase/bleomycin resistance protein/dioxygenase
MPRLRGVLETALYVTDMARARAFFEDVMTLTPFTADHRFTAYAAGPGSVLLLFQQGSTQETVTLPQGMGTIPPHDGAGRVHLALAIDRDELEEWETQLAAHDIPIEGRTHWPKGGESLYFRDPDEHLLELATPGVWPNY
>fig|290398.4.peg.2393 Permease of the drug/metabolite transporter (DMT) superfamily
MMNHDKLLGNSISRLTGRGTGFIFAGVIIGGGLSWPLMKMTLGNMSPQVFLIWRLVFATISAFVLVKMTRQFRIPGREVWFPIISVACLQMGAFLWLITVGVTMVPAGRAALLAYTSPIWMIPLAVLWLDEKLDRSVIASLVFGLAGLAFLFLPSNHVLSNAQALVGNGLLLLAAVVWAFQIALLRRYPSRWSTLQLLPWQLLAATLGLSSLTIAFSDVSLFQGLDIRSLLVTTYVGIVSTTFVFWGMLHIARTMPAISSTISFLGIPVVGLLSSVLLLSERLDVGLVVGFVLIAVAVFIQSKSSRL
>fig|290398.4.peg.2404 Glyoxalase/bleomycin resistance protein/dioxygenase
MTESTAVTRLLPNICTDKMEETRDFYKELLGFVVGFEHQGWYIQMASPDKPELQIGIMRLDHEFTPRPFQYPAQGVIISVQVEDVEETYAAVKARGFELAHDLCDEEFGMRRFMVADPNGLLVNMFSFP
>fig|290398.4.peg.2891 Fusaric acid resistance protein conserved region
MSSTTRTQTEPPMSPWIETYLTPSKTSLQFAAKTTLAMLLALYIALWCDLDRPYWALISAAFLQIRPMSGMVVEKGICQIGGTLIGALAGIVIMAFFAQARVPALIALTLWIMLCAYGSSLLRNNFSYGCIMGAVTAMLIVVISANQPPSGIFDIAVARLSELGLGALCATLVSALLWPTHVKEHLAGQADEVINQAFTHAGQRLDASDDAAAMQQSLTASLEPLTMLETDSQAARYEGPDGNGRIRATHVLTRRTLRFFATLGALHQLLHDHRDRINAPLQQLATEIAEGFRGAEHVKGVPAARRELQALRKRAHGYSDTQLDPLQRRVILALREVLGHAMIMLDAREAIAHPGRKQLRAGSLSWHRDHLVALLNAGRAGLVFSCLAVFWLQTHWSNGQVAMLLGTLFSAFFATRDNPVTICMMFFKGMLAALPSAFLFGHVLLSQANGFPMLAMLFVTPLFLGLLGASNPRLMGYCLAFTIFNILLTMPGNGMDFSFDSFANRAIAVIVGLSAVVMGFRLIPGLGAPIRRRRLIGAISHDLRHIGDLPLHEEESRFSGRMADRLLQLARHDDMLPEDHRHLFMIGLNGLDLGRSCLRLRHRLDDAAPPVRDAMRHLLTTLAAAFEDSAHGRAPQGIQAAGRALDDALVRHGDIEEDWRWLLAGLVERLELTLARQANVMAERLTPAPAA
>fig|290398.4.peg.2938 
MRTSSQEGAHCEGATLRIHHKIKPGAHERYETWLRQIIEAAGRFPGHQGVHILRPPAQGQDYEIAVRFAGEEDARRWRESNERRELMAAIQPELAQDERLEFLSGIDYWFTPPASDARVPVRWKQWLITTAVIWPLTLLVPLLWWPLFQAVPALQTWGLRHGLVAATVVALVVYVVMPPVARLASPWLHRR
>fig|290402.34.peg.259 Probable multidrug resistance protein
MSKIESNKMAFTLLALAIGTFMSALDSSVVSIVIPVIQKYFNVNIAFVEWVITAYLLVVSSVLLTFGKLSDLYGHKKIYLMGFTAFTLGSFLCGISLNIQMLIVFRIFQALGAGMMFSTSSAIITASVPSNKRGKSFGIIAIAISAACCAGPVIGGILASMMGWQSIFYINIPIGILGIYLSYRYIPEDKKKISVPFDLGGAVLIFITLFLILLPLDLSGSESISTTMFIILIVLGIALGVLFIVYEGKTNYPLLNLNLFKNKTFSAGLIATTFNYMAQFIMAFLVPLYFQNTLQLSPMMTGVLFLPMPVSSILIAPISGSFSDKHDSRIMSSTGMGILAIALFMLSFLNMGTSSWYIVIAMILSGVGSGLFQSPNNSAVMGSVPAQHRGVASGTLSTMRNLGMVMGVAVSGALFSYSTNYANSIYSTQGLNGVNLSQAVSTYGLRITFTAAAIIALAAMVASLIKGKTTTVAEAKSNIPSNN
>fig|290402.34.peg.534 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENTENIDEKSLYYLEKAPVTKAIIHMATPMILSSIASVVYNIIDAFFVGKLNNTAMMAAVILALPFSLVLMAIGQMFGVGSGTYISRLLGEGNTDNTRKVSSINFWSSMLMGIILMMICLPFLSSILPLLGASGETLQYTRNFIMVLVIGAPIIIVNMALDASVRAEGASTISMTGTIAGIIINIILNPFFIFVLNMNVMGSALASVCGNIVSVLYFIYYLQKKSTVQSLSIKDFKPSKEIYGEIFKVGVSALLMSGFFVIISLLFNNYSMIYGDSVVAGFGIAQRVVQIVDCIGMGFAMGVVPLIAFAYSANNQKRLMEIVKKTILYMLGLTLTLGAVLFALRLQIIGIFSIDPNVIAIGQITLIAQLSSTVFAALCEFFTGIFQAQGDGVKSNIMAAVRGVLFVPILIVGNLLFTVNGVIWAMTATEGLSCLIGIALWLGIRRKSLLEISMNKQIS
>fig|290402.34.peg.589 Vancomycin B-type resistance protein VanW
MEKRTGKRANASKNNYNKKKKIMLAIFTLIIVGAAALIAYSIAIKGIVKEWDDKIYPGVTVQEVNIGGMTKEEAKNKLTQTFVTSIENKKLSIKIEDKQYELIYSDINPKYDIDATVEEAYKLGKKDGVLSRYISIKSNNSKSKEVPIKFSYNEEKLKEYEEKLQIAVNQPAKDAAVSIQKNNIVIKPETEGKTVNLDTLDQKLKENINGDINSDNSVSIDLEVTKPKITQEDLSKIKGVMGTFSSNYSTSPEGRCNNIEIATSAINGTIVMPGEIFSFNDVVGPRTAERGYKEAGTYVGNKIEPGIGGGICQVSTTIYRAAMKANLRSIERTNHSMAVGYAQPGLDATVSYGYLDYKFKNTYDFPIYIQGNTSGKVVTYSIYGDPSALNGRTYDMASEILETIPPETKVVDDSSLPVGQEVTEGAGMTGYRARAYQITYENGSEVNREVVSTDTYASVGIVVKKGTQPVDATQQPETTAEPPAAQPTGEPPVAQPTQ
>fig|290402.34.peg.1035 Multidrug resistance ABC transporter ATP-binding and permease protein
MIKKFISFYKPYKLLFILDLVVALIASLCDLVYPVMTRDLVNESIPNKDLRTIIVFAIALLIIFGIKAACGYFMQYWGHVVGVRMQGDMRRHIFKHLQKLPNSFFDNNKTGDIMSRIINDLMDISELAHHGPEDLFISIVMLIGSFIILCTINIPLTVLIFAFIPFIVWFTLYERKKMNKAFLETKVETGAVNANLENSISGIKISKAFVSHEAEEEKFEKGNKRFINARERAYKVMAEYSSGAGFGMDVLSYVGLIGGGIFTLIGLINIGDFMAYMLFIKIFMTPIKKLIDFMEQFQNGITGFQRYIEIMSQDKEKDKANATELENVQGEIEFKDVNFSYEGKEVLKNISIKINKGKMLALVGASGGGKTTFCNLIPRFYEVDSGDILIDNKSIYDVKLDSLRENIGIVQQEVFLFTGTIRDNILFGKTDATEEELLRAAKMANIHEFINTLPEGYDTYIGERGVKLSGGQKQRISIARVFLKNPPILILDEATSALDNATERIIQESLEKLCAGRTTIVVAHRLSTIKNADEIIVLGKTGIIEAGTHEELMEKQGEYSNLHRLAAV
>fig|290402.34.peg.2197 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKIQELEQKPIGKLLIQYSVPTVLSLLINSLYIVIDRMFIGNISEVGTLALTGIGLTMPITTIVVALSALISMGASSNISIKLGEGNKEEAENFAGNALSLSIVLGLLVTSLYMIFQNSILGWLGINGEVLSYTKDFITIIMAGTVFNMLGFCLPFIVRSDGNPIFSAAITITGCILNILLDALFIYVFHMGIKGAAIATVIAQFTTVILGLYYFMKLKNTLILKKINFKLHISIVKAIFLIGLVPFSNQLSVSVAQIVSNYSLNLYGGELAIGAMTVLNSITILFLMPVYGIAQGFQPIIGYNYAKKNYGRTLKTLALAVLFSTGFLAVSAIIMQLFPKFAVSLFTQNPELVNISINGLKKYTVLIFLISIPTFGSGFMMLTGKPKTAVLLSISRQSVILALTIFFLPKVIGQDGLWFAQPITDLLSSIITIILFIKGYSDILYKKNINKGIRKTISRIL
>fig|290402.34.peg.2201 Permease of the drug/metabolite transporter (DMT) superfamily
MRKITSNNEQIQKEDRMRIALSGFLGITLYFAIENIGVSMTSSSNSALIVASFPAVTTLLEFFIYHSKPNVKKILGIILAIIGVAVLTQINVDGNSKSMLGNIILIGAGVVWAFYNFITRDLTNKYSAMTLTYYQMLAGFIFFLPFVIIEGKTWRMPTMTSASALIYLSVGCSIVAFLLYNLGLRKLSASISVSLMNLVPVLGLIFSILILHESVSTVQILGGIIVIIGVILSSIQKG
>fig|290402.34.peg.2213 Lincomycin resistance protein lmrB
MNKKYKLESNQGINFISIIAILVASAFVATFNETILNVALSAIMKDMNVSAGTVQWLVTAYMTVAAVMVPVTAFLIQSFKTRKLFLSAMGLLLIGTICAAFSNSFAMLLISRMIQSSGTGMIIPIMMNTILLVAPKEKLGISMAICVPAILLGPAFGPTVSGIVLQYFSWHALFIMLIPIVSIIMILGSLFVVNVGELTKPKMDYLSIILSTIGVGTIIYAISSISEGNIKITLISFIIGIICLILFIKRQNALKEPMLNLSPFKYPKFVIGTILVMIAMMVTFTMSIMLPMYMEGALGKTSSVAGLALLPAVICAGLAAPVGGKIYDKFGVKFLIPLGTGIVTVFVFLISLSKSDTSLVHLVIIYICMNIGVGIFMSPSQTHGLNQLPKEYYPHGVAIVNTLQQVSAAMGSSLFIGIMSAAQINALEVHHATNEVAIATGFSTAAFVVCGFAFVGLILSFFFGRNISQVKDKEQVGCTTR
>fig|290402.34.peg.2619 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVKYVHDMTEGNEVSHIIKFTWPMLIGNVFQQFYNLIDSIVVGKFVGANALAAVGACGSLSFLFFSVCLGLSVGIGIIISQYFGAKKEEQVKRAIANSTYVIGASGVVMSILGVVFARQVLQLLNTPPEILNDSVAFLRIASGGMIAVAAYNAIAAILRALGDSSTPLVFLIISCAINVLLDLIFVLKFGLGVSGTAYATVISQACAAIGCLVFALIKNPYFKLKKEHWKISESIITKCIRIGVPVAAQNSLIAVSLVALQSVVNGFGETAVAAFTATSRVEQLIQQPFNSLGAAMSTFAGQNMGANKLDRVKKGYHKSILIVAGFSLLAFLAAQFGGQAIMEVFVKDESVINLGDKAIKITSCAYFPLGMIYVTRGVLNGTGDAFYAMVNGFVEVAGRVGFSSGLAMIPFLGVWSVWVTSGLTWTITAIASVIRYRQGKWQDKSIVKPVEKTIEYKKCAEGK
>fig|290402.34.peg.2665 Acriflavin resistance protein
MSITEISVKRPAAMWMAVILFIGLGIMGYKSMGADLMPSMNIPVISVMTTYNGASAEDIKKDIVKPIEDAVSGISGVDVLNSTSGEGYGTVTITFKMSANINTAYLDVQKAVELTSAKLPKAADKPILYKMDMSSIPMMIVSINGDASYEELYNQSDILKQRLEKVPGVGNISLLGADKKQLMIKIDKATMEYYGVNIDTLMGTLQASNVNVPAGEIKQEGLDQSVRIIGQFSSVDAVRNLLIPAGNGVTIRLGDIAKIDLEVPDANVLTRFGGNKTIAMMLGKQSDSNVVEVADSVKKELEDVKKTLPKGTEVNILMDTTTFINSSLTQIKHNLAEGIITTAFVLYLFFRSFRSSLVVLIAIPTSLVATFFMMYQMHFTLNMLSLMGLSLVVGTLVDDSIVVIENIQRHMDMGKNPIAAAIEGRKEVGMAAIAITLCDVVVFAPVSLVSGLVGQMFREFGLTIVAATMFSLIVSFTITPMLSSRLLKNENLKGVLVKKEKSKFLSKINFKFIKIISSKFNKINAKTEGSFDKLVETYKKALIWSLDNRKKVLAIVVAGVVLSIMLIPMGAIKSEFIPMADQSSLQISMKLAPGSTLKQTDEKVSEVEKYLQDTKEVKNYFSLIGHDGEATADKSIAQIFINLVPKGERKKSQSELASEIRRFGKNMSGVDLNVAESSSSGGSSKPVSIKIKGNDTDTIRDLSNEVEKLLSAVPGITDISNSTSSRSSELRVNIDSLAATQYNISTTNIGSVVRMALAGTNVGVYRSKNEENDITLKFENGQIKSAEDLKSLKITNSSGQQIPLSQVASIQKIDSAPTISREDKQDMATVEANLQGRVLGEVTDDINAKLKALSVPDGYSISFGGNQKQMAESFSSLGLALCASLALVYMILVVLYESFLTPFIRMMALPCAIIGAFGLLALTGQTLNLMSIIGLIMLEGLASKNGTLLIDYTNTLMKRGMNLRDALIESGATRLRPIIMTSATMIVSMLPVALSMGEGTEMKKSMAIVIIGGMVASTILSPIVLPIIYTLMDDLKKVVSFKKKKIHTIEGGSTYEV
>fig|290402.34.peg.2820 Acriflavin resistance protein
MGLIKAAIRNKKIVLFLVTIAILSGCYCYYIVPKQEMPDVSSPAAMITTVYPGGSPSDIESLVSKKVEEKVEEIDGYDYCESYSVNNASIVVVFLTNDCDKEKAWRDMRDKIKDLKSDLPDGCQDSDINTNLTETAGMILSISGDNYTYEQLGNYADDIKKQLSNVSGISRFDIKGKQDNQVKVEVDLNKINKYPISFEDICGALKAQNVDIPSGNLDLKTGKMKVETPGSFTSLKEIEDTVVNVSTDTGQTIRLKDIAKVYMGYDDDSSLKFTSNGENAVLLTGYFQDNKNIVLIGKDVTKKLDEIKKQLPPDLKIDQVTFQPKAVDESVSFFMENLRDGVILVVITVLIGMGFRNAMVVSAVIPISISMSFVAMNALGIKVQEMSTTALIIALGILVDDAIVIGDVVQVGIDEGMSGDEAAFHGIKKLFVPVFTSTLIIIGAFAPLLNIPGGAGEFLRTLPQVVMICIACSYLSALFVTPAMASIFFRKSKKVEKESIIKRFFHKLLNYGLKNKIKIIIICLCLFAVSIGLLNSIGTKFFPYADKDILYIDVANEKVDNIDSTSDLVKQVEDIVKSDEDVTSYTSAIGGAVPKFYITIPPLAPAKDKAQIMMNIDLNKTKKFSTRQELAEYLQSQIDSKISGGIATVKLLEQAMPTGAPIRIRLTGDDLEKLYSASDQIQEKLNGIPGTTNVRDDAAKKTYQYEVDIDSAKAVQHGLLKSDIEKQISIAIRGYAASVYRKNGSDYDILVKSNATSVEDLKNLQVKSSLAKNKVLLSEVATIKLDSQIDQIKHYKKDKTVTVYSDIKTGYNAVTVENALSPEINKMDIDGVNAIYDGEKHQIDLNFTSLGIAAAMCILIIYVILFVQFKSFVQPLIIMCALPLSLIGVTAGLLTFKMQLSLTAVMGIISLIGVVIRNGILLVEYIIEGRKEGLSIDEACLNAVSQRFRPIILSSVATITGLIPLAFSKSALFGPMSVTIIFGLASATFLTFVVVPVVYSLVNTRLEERPIKTDKLNIKLLKFWKKQG
>fig|290402.34.peg.2874 Membrane component of multidrug resistance system
MENKKESSSKWLIMSVVIMAIFMVNLDTSIINISITKMMQTFNASIDQIQWVVSSYTLTLGVVIPSTSYFGDKFGTKSVFVMALILFTLGSLLCGISWNENIMIIARVIQGIGGACIISLGMTILMTTFDKSEIGMAIGLMGMCVMAAPALGPSLGGYIIQNFNWRFLFFINLPVGIVAIIMAILIFKKSEHTSSKKFDIIGFLTSSIGMSCVLYVLGKSDLDWNDIKNIVLMIVGGYSLIIFVVNELLIEEPMLDLKLLKNYTFCMSNIIMNIAMLALYGGVFLMPIFLQQIRGLDSMSTGLILFPEAIATAISMILYGKIGNKFDVRLFAVFALVLIGINSYSMSKITLDTPNIDITILLMIRGFGVGFLMAPVQTVGFSGLPKAAMSNASALTNTVKQVGTSIGVTIITSIMQHRNVVDYSNLASQVTSFNKNSMKLFEMLQGALIKGGISGSDAKGIALSKIFGEVASQAQLQALNETMFIISIITAIVIIPTLLLKQGKQEETDAAVVE
>fig|290402.34.peg.2977 Methylenomycin A resistance protein
MTKEIKVALLMAASLFMEILDGTIVTTALPKMAQYFHTGSSTIALLVSVYLITVAIFIPLSGWMANQFGKKKIWIIAVILFTISSLSSALAPNFSFLLIMRIIQGISGALMTPTARLIVLEKTPASQLLKMISYLIWPALIAPAIAPLVGGFIVTYWNWQWIFLINVPIGLITALIGAKLIDTDKVKNKTSFDLIGFIEIALSSGIILVGTEIATHGKDYWLSALGLVILGIILGFIVFRHLKKSDDPLFSLDSLKITSFRIFQTSGSVLWLCVGALPYILTIFLQTVFQWSAVKAGSYVLFIFVGNIGIKPFTNIIIRKLGYRGALLSSFGMVFITSIALAFIQINTFPAWIMFLALVSGVGRSLALTAYNGLSFSEIAPQDRNSANTLNAVVSTLAQGMGISIITVVVNLLQIFFSITISYKLSFVFLGLLMLYPVIEVIFLPKNIGHATIS
>fig|290402.34.peg.3039 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNMREELLTKEPVALMIKLCVPAVLGMLVIGLYSFVDAIYAGQMIGTNAMGAVSVAYPFALINSGISTLIGMGSASVLSRAIGKKDSDIINKIMGNLLVLILILSAIVTVIGVVFAREVLLISGASGEILDLAVRYMQIVFIGSFFINFAQSANMIMRAEGRMKKAMIFMAIGAITNIILAPIMIILFNHQVEGAAVATLVSQIIQAVITMVYFIKESENVRFHGFKIEFDLLPEIFSIGFSAMLMQIMMFIQQVVIYKMASTYGGDSEIILIGAALRVLAFSFIPLWGMGQGLQPVVGTNYGAKQYDRVKKSINVFVAGATVLALCFWIPIQLFPKEILSLFIKDGSIVYEGINNFRLMYIIFPVLGFWIMSVTAFQSIGKGKNASVLVISRQIALIVPLIIILPMLMGIEGVWAAVPITDGIVFIVTAIMMINEYKGIGKAHQSKVEVEGKGSKKLLG
>fig|290402.34.peg.3106 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTELENFILEGSIKKLLFKFSIPAISVFLANVLYNIIDAIFIGNQPNGSLGIAALTIVFPIQQIILALSQMIGVGIASITSRSLGAGDKLRAEKAVGTALTSSVLLGILIMVIGLVFIRPMLYIFGSLENILPYAVTFFRITLYCSVFFVFSIVANSIIQSEGHANIAMISMIIGPVINIPLDYILVTRLQYGIKGAAIATDISQIICFIFLLVYMCFNSKILGVKVKNLTINIKLLKEAISLGLSTFMTQLAYGILAIVLNNSLKVYGGSDLYVSAIGIYNRVFGFITITMYGIRQALQPIIGFNYGAKKFDRVKQSLKLAILASVVISLVFLVIIISFTNKIAGAFTSDNGLIALTVPILRVMIFMSPLVGVQVIASSFFQYIGKPKPALFLSIMKPFIFLIPLMLIIPIFLKVTGIFVSVPLADFLAAMISLIFIYREIKKMNKLNLI
>fig|290402.34.peg.3704 Permease of the drug/metabolite transporter (DMT) superfamily
MIYLLLFINIIMLASGQVLWKIGVGKSSFNLSIQGIIDMFFNPYILVGGIIYVFATVIWIYILSKEELSRIYPLQSLCYIGGILAGVLIFKECFTLNKGLGAIFIIIGTFIIAR
>fig|290402.34.peg.3834 Teicoplanin resistance protein
MENKKTKQEALTIRLLLVYLVVLTWIILFKMQFSLKELGYFRSINIIPFHESVIVNGRIEFSEIYDNILIFVPFGIYIDMIKRKWYFVKKAALIAGVSLIYEVLQFTFAIGASDITDIIGNTFGGIVGITIYGVFLKLLKTEFKANKIINIIALIGTILAILLLAFLVLVNN
>fig|290512.6.peg.237 Permease of the drug/metabolite transporter (DMT) superfamily
MRTMSVLLMIIASACFATMAALIKALGPSLPIPEIIFFRSIIPLPFFLAVLLIKKQRIFVVAWKTLILRSLFGFLAMSGFYFALIHLPLAESVFLGRTQPLILALLAPWVVNEKPTGAVWIAIGTGLLGVICIIQPSFGWMPAAWASIGAASASAMAHLLVRRLNRTDAPVTIVTNFFLVSAILSGVWTAAVFTPPVASQWALLIGIALFSTFGQFLMTIAYRKDHAPVVAAASYASIIFSIFYGYAFWHELPPASAGIGGTLIITGSCILIRSRI
>fig|290512.6.peg.826 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDMIKGNITLVFFYHAIPNVLGMLALSSSGIIDGIFVGNIVGDYALASINIIMPLFSFLIGVGIMFSVGGMVRCGKYIGEGNHQAANEVFSKTLITVGVSTLILSAAGLMFIDQVIMLLGANDVLAPLVREYLIIMLLFMFFLPVSLCLAFFVRVDGQPVFAAVAIISAAVINVLLDWQLVGVWKMGLQGAALATGAAHITSFSVLLLHFITKKSVLRFFWPRHAWGEMLHAAYNGMSEFTNQLSAAIVILVFNWVMIRRFGVEGVAAFTIMHYIFFAEQIIVYGFSDALQPIISTNFGARRPDRISGFLVLGISCAVTVGVVLVVLLLAIPEKLASLFLDNGTDATYRLTLAFISFSWPAFLWNGSNVVFSSYFTAIHKPLPSAVIALSRTLFFPLIFITVLPIFFGDAGIFVSFSIAEFLTFLIVLLFFSVMRPQKVIQPASA
>fig|290512.6.peg.1489 Acriflavin resistance protein
MKALFRYFAERHLLAYILTILVFLFGAATLWQINRAQYPKVDLGQMVVTTQYPGASPEDVEQNVTNKIEDELKSVTDIRRVFSMSMENVSIVIVDIEPDASDPRGVKREIREAVFRITDFPAEVTESSLITDIKSSIFPILEVGLTGDMPYPELREFARRFEKKLKDIPGVASVQRYGYRDREIQVELFPDKIRELQIPMQGVVDAIQQRNIRATGGSLESFTSEKNVVTLAQFRNPEEVGEVVVRSSFDGPIIRVSDIAEVTDGFEEERVLSRINGHPAISFLINKSESADIIRTVQSIRKLVDEEGQQLPEGIRFIYGLDFSQYVENQLSIVVTNGAIGLVLVLIALTFFLNLRTAFWVALGIPFTLLGGISLLPLFDVELDSVTLTSLIIVIGIVVDDAIIISENIFQRREQGDSPVDAVVNGVFKVYKPVLTTVVTTFLAFAPMFFMPGILGKFVFVIPLTISLALFVSIFEAFLILPAHILPGLYTRDSGNQKTTMRNWFVPLRNGFEKLLLFLLRLRYLLIFLGFLSLGGALYYGLNYMSYILFPTKGADAFNIWVELPVGSSLNATSAKAAEFEKLLEVLPEEEVSAYLTRIGTQADIVPMEKENFVELSVKLTPYGTRDRSADEIVADIRQKAMEIDGVQKTTFFVESGGPPVGKPVTIRVVGSDDELRTGLGDAVFSYLSGIEGVTDPDRDDKEGKEQIEITIRHDRLSRLGLSVSDIARTVRTAYDGQVVTSVRYGEEEVDFRVMLQKYTRRNIEYLEELSIPNRTGRLIPLKEVAGFEQGAGPSIFYHYDGERSITLSADVAQEKITPIEVMQQVERQFAVNRDFPGIKLVFGGEAQESQESLKGLFVAFGIAAVGIYFLLVLLFNSLTQPLLVMMSIPFAIIGVVIAFALHGEVFSFLGLLGVVGMAGVVVNDSLVLVNYLNELYQSGKSTDIPQLVAKGTADRLRAILLTTITTAAGLLPLAYGIGGTDASMMPMALALGWGLLLATPLTLVLIPCLYMIGFDIRSLWKNIRKPQAS
>fig|292415.3.peg.1242 Permeases of the drug/metabolite transporter (DMT) superfamily
MCRGFSAGLYTCGRLPEPSFFKPDIIRPMPALTSQRALPVASLVYAAALWGVIWYPYRLLDEAGVGGVASGVFSYALPLVLMGWLHLRDLRKARGHWLWLSALGLAAGWTNLAYVLGVLEGEVVRVLLLFYLSPLWTVLFARFLLHERLNRAGWAVMALAAGGALTMLWRPGEWPLPANRAEWLGLSAGVMFALSNVIARHLDGVTEGAKAVAVWGGVVVLGVVGLALRPADLDFASTAPVEVWALLLAVGVLIGSMTYAVQYGLARVPANQAIVVFLFELVVAAIAAYFLSEERMGLQEWLGAAMIITASLFSGHMEDAQAQETRHG
>fig|292459.1.peg.32 Multidrug resistance protein B
MDSQVSTAASRSGSGWKVLTAVVFGVFMVILDSTVVNVAFKTLQEEYAANLNLTQWVLSVYTMALGIATPLSGFLGDRFGEKRVFIASIFLFGLSSLLCGLAPSLGLLILFRALQGAAGGVATPLGTSLLYKAFPPEDRGAAMGVFGIALVAAPALGPILGGWLVDLGHWRWIFYINVPIALVGTLLGSLLLPSSTGSRTARFDPLGLLFSSAGLGSLLYAASQASDLGWTAPEVVRFFLIGAVALLIFALVELFVAREPLLDLRLFGNRAFLVAILTGWVSVLALCGAEFLMPLYLQVLRGRTALEAGVLLLPAGERVHVHLLRLAGGTGPGCHAARMAGPDPAAEQGYSRGRCPFLGAQPPSFRHIANFEGPAAGVSAAGPPFLPRRAGGTVFAIVAERGVMQR
>fig|292459.1.peg.343 Permease of the drug/metabolite transporter (DMT) superfamily
MQIRTWQADLVLLGITAIWGATFPMVKNATSLEAGGVPTYWFLAVRFLMAALLLAAVFHRRLRRLPAATWRAGVLLGIFLFAGYAFQTFGLAYTTSAKAAFITGLSVVIVPVLSLVWLRTAPSPAAWLGVLTALAGLAMLSLDGSLAPSRGDLLVLMGAFGFGLHVAGVSRFGAAHDRYALAVIQLGTAGVLSALLHLADRGTVLPGVAGVLWWGGPAHVGTAVIVCGLLATAAAYLLQNLLQPYTTATHTALIFAAEPVWGAVFAYLLAGEVLTPRGYAGAALIIAGMLMAELPAGRDRRAAAS
>fig|292459.1.peg.1020 Bicyclomycin resistance protein
MQQGLLAPQKRLGTAGLIALITVLNMTAPLSTDMYLPSFPTMMDEFGVTAGVLNLTLVGFFFFFAVGMLVFGPFSDRYGRKPVLVAGLGLYLAASLACAGAGSIWQLILFRVLQALGAGCMVSVSTALVKDCFDGRMRGTILATIQSMSVVAPMLAPIIGAFIVQYATWRTTFLMLAGISLCSLTAALLLQEPLPPGARLRGPILGSLGRLFVVARNPSFTSLLLVVALIPAGFMAYISVSSYIYQDFFGLSETAYSLFFATNAGVSVLGPLTYIAINRKVPPRLIITGALGLALCGGLAVLLLGRTAPLAFLLSFIPYSFGSSLIRPVSTNTLLSQQDSDTGSASALINFGNTAMGSLGMVLAALPWPDFVTGLGTIAAGCALLALLGWAVLLLSSIPLRGIKEGLSSGD
>fig|292459.1.peg.1662 Tetracycline resistance protein
MLAFGFATVFTLLPVYYINEAELTPFQLVLVGTVLESTVFIFEVPTGVVADVYSRRLSVIIGTLLLGIGLAIEGAIPAVVAIFIGEVIRGIGHTFTSGAMEAWLASEIGAETVGNVYLRGNQVEQGASLLGIATSVALARWGLHAPILAGALIILAAGIFLILAMRETSFVPAARMERGSWKATLDTAREGIRTIRRSPLLVTFVLIALFVGMSGEGYDRLWEAHLLENIPFPSLFDLRATTWFGIIAGLSSVLSIVVTETVHRRLDQSHERSVALFLVLCTAAQAAAVLGFAWSGQFFLAVACHLVASLCKGIAAPLRNSWLVRSVDPQVRATVISTVGQADAIGQTAFGPVIGWIGSVRGLRIALSVAGIALSPLVPLFIRAARVARHKPATAAFE
>fig|292459.1.peg.1688 Permeases of the drug/metabolite transporter (DMT) superfamily
MERTRGRQTLGYMMVFGAASLWGTLGVVSRNLYVGGLSAQAVVTLRASMAAALLLAALTVLRPATLRVRLRDIPLFAAYGLVSVAAFYLLYFLTIQHLSVAAAAVLMYTAPAFVAVAAALTLGEPLTQGKLLALTLTMAGCALVARAYEPSVFRGQLIGVLTGLGSGFTYGMYSIFGKHALKRYNPWTVQAYSLLFGAAPLVLFFGREAVRSLARSPEALPWLAYLALVTTLGAYGLYLSGLQVVEASHAALLSTVEPVVAALLGFWILEESLRLPQVIGILLVLGSAVILNAQRGEPAGAASRQAGVPPAGVGTECARRTPGGAP
>fig|292459.1.peg.1995 Drug resistance transporter, EmrB/QacA family
MRDRRMLTVFALMLASFLTAVDVTIVDTAMPRIVGSLGGFSMLTWLVSAYMLTSTATMPVYGKLADIIGRKRTFTIGAVIFVIGSALCGAAPSMEALILFRALQGLGAGAMQPTVQTILGDIFTPAERAKVQGWFSAVWGFSALAGPLVGGLMVDYLSWRYLFYINLPLGALALYMVWRHFDERVQRRKARVDYLGAVTLTGGMTLLLLVLLTGGSQLPWGSPQILGMAGGAAVLLLLFLWTQGRALDPILPLRLFRIPVIGWGNLSSLMVGGVMYGTSVYLPIWAQGVQGYSATRSGASLLWLSIGWPLAAVLGSRLIVRMGVRPSALLGLGLNVAGSAALVALARTMAEIPEVLLALVTFVIGAGMGFSTLAFILGIQSSVDWAQRGVATASFQFIRTLGGMIWVSAMGGVMNLDLLGRLQRIPGVAARTAAEAGQWANRLLDPAQRAALGPELQAAMQEALADALRNVHLVMLLAAVLSLAAALLLPNLRFAPEKAPQASTAD
>fig|292459.1.peg.2037 Permease of the drug/metabolite transporter (DMT) superfamily
MHGAGLADSSDECALRVVSGPSPSGPAALGAEGCRSHCVPPAGLPAQGCPSTAAGVARFQVKVPREQTAPPGPVIFRSVGPFRCSRAPGDGRGPPNGGIVPLPLITLLGLLVAVLAVGCSAILIRLSDAPALVLSFYRLAISVALLAVPALARERETLRRLTGRDWLLLAGSAVCLALHFYVWIESLNFTTVASSTVLVTSSPFIVLALGWRLLGERTNRIGLAAVAIGVAGGVIVGWGDFRVSGSALYGDLLAFLGAVTVSGYTIAGRIARQKMSTTLYTTAVYALAAALLWLMMLPRGIPLAPYPPREWALFAALAVIPTILGHNLFNWALRWVSAATVSMCTLGEPVIASALAWILFREAPGWATVVGGILLMAGIALFVRYGAQPD
>fig|292459.1.peg.2485 Fosmidomycin resistance protein
MNSTVSAGRPVLALLLVLSLTHAVIDLTSGAIVALLPAMREAYSLSYAMVGLIPLFANLTSTFTQPVFGIISDRSEMRWLLPLSVALGGLGLAAVGYVSNYWLVLAAVVISALGSAAFHPEGAHAAHNLAGERRALAMAIYSVGGNLGYALGPGFAAALIAAFGLRGTGLAALLPLALAAFLIWLLPRWRAHEQEAAARKREQAEPGETNWRGTVLITLVVILRSIIHLGMTTYVPFFWIDVLGNAPATAGLVQTTYLLAGVLGTLLGAPLADRFGTKPVLIASFALLLPVQAVLASLRGWPLLIGLFAAGFLVVSTFTTTLVMTQEYMPRSLGLASGLNLGLAFGMGGVGTSVLGIVADHFGVLVVMRCIASLVLPALLLTLALPPVRLNRA
>fig|292459.1.peg.2601 Multidrug resistance ABC transporter ATP-binding and permease protein
MRGGPGAFRLDDYDVKLSQVDPRIYRLLGTLIRPYVPKLAAGVLLMVATALTGLVGPYLTQVAIDRFVAERDPAGLDLVALAFLATALLNWWSSYGQTYIVSYVGQSIIYDLRDRMFRHLQRLSFRFFDSMATGRIMSRLMSDVDAINQLVSSGLVSLFADSMVLVTIMGTMLWMNWRLALVSFITIPTLLLVLRLFRGWMRDAFMAQRRRAADMNAHLAEAIAGIRVTQAYVREARNQAQFDGINERLRQANLGAVRVWATMMPSIEVVSAFGVTLVLWYGGILLRGGTADVTVGQVAAFILYLNRFFQPIRDLSQVFNVFQAAVVSAERVAELLDQQPEIVDRPGARDLPRVAGRVEFRDVVFGYEPGQVVLKGINLRAEPGETIALVGPTGAGKSSVINLLARFYEPQEGQVLVDGVDLSTVTQRSWRSQLGIVLQDTFLFSGTIRDNIRYGRPDATDEEVEAAARAVGAHDFIVRLEKGYDTEVHERGAKLSVGQRQLIAFARALCADPAVLILDEATSNIDTHTEAVIQEALQTLLRGRTAFVIAHRLSTIRSADRIYYIEDGQVVEQGRHAELLALGGRYARMYRGQWEGE
>fig|293826.4.peg.272 Acriflavin resistance protein
MTKWCLEHRSIVAVLSIFIFLSGIFVYTTMERQENPDVVAPGATVKTIYPGATPEDIEKFIVKPLESKIGEIPDVKMMLSYSLDNVGVIIIRLEDLSDEDINETWNLLRQKVDEAELPEQAWDPEIDTDLIDTYGMLFTISGDRFEYKELKSIADELQEELEKMDGIAQVDINGYIDEEIHINLDLLRMKHFNIPVETIGMALKATNINIPGGSLKLRGTNVPISTTGEYKNIHDIENTIVGMSEAGNVIYLKDVADIEQVEGDRDVFVGSNGEKALLMNLKYSDGENIVNIGEEVMTFLEEYKNTIAEDMNITVITDQAEYVEDAINLFEKNLLSAISLVVVVVLISMGYRSALVVSSAIPITVMATFAFMRFTGIVLHQVSISSLIVCLGLLVANAIVANDSMDLYLSKGMSRKEAIVYGINEVKIPILTSTLTTVASFLPLLLMEGVAGKFVKSLPIMVTVALFSSFILSLTVVPAMGYTFLKGSQGEKKKSLFSDVSDFFLKQYKFILKATLKMPIITILVAMGLLVFSTTMISSLGLQLFPFVERDQYVIDVTLIEGTSAEKTKEVITEIEEMLKEDPSVDSFLSKVGDGIPKFYPSFVPNQIASNQAQFVVNGKVSEMVALQDRIDQTVVGARVEVKQLENAVPVGLPIQVRVSGNDIDTLIRTSNEIKEILYTVEEGQHVQDDYGHEVLKMVIDVNQDKASMVGITNYDIASTVRMAINGHEVIKMRPDDTDDDIPVVLRIPTDEKNTVQVLDNIFVTSQFTGRNVPIQQIADIHSEFSLSRILRRDRDRTITVGLYPKPGYSAAEVLNVVEERMEGFEVPQGYMMEFGGESEDRTEAFESLIGPFFLAAMLIYVILMFQFMDLRQPLIIMGTIPLSFIGVIWGLKITGYPLGFMALMGTVSLMGIVVNNGIVLLDYINILAKSGIEAKEAVIEACATRLRPIMIGMITTVIGLVPMALIGGSLWAPLAYAIIFGLMVSSILTMLVIPSAFMLFRRRDKKGNGIIDEALTDKEIKETVS
>fig|293826.4.peg.528 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSIQLNKKDSKRRKFILEGDLWQVVLSISMPLAIYNGFNHLFSFLDTMMAAHIGSEVVSAISYLVQIKTMIMAIGAGLAIGGGIIIARYYGADDIRNAKKCANTLVFLTIGISLILLAVLLPFTKQILRLANTPEELIAVGSGYFTVEIIMIISIFINNVYIAIEKAKGNTKSILHLNLMVLAVKLALTALFVYVLNYGITMMAMATLIAHLMLTVFAMTHMLRPDNVFRISFKDVDLSLKFIWPILVLALPIFFERFTFSFGKVIVNSMSAFYGSMVVGALGVSNNIGGVIISIGNGFQEGEASIISQNLGNENFERAVNVFKKTLIVSLVLGGMGLLLTTVFMDQIIRVFARGDLAFAEEITNVFKYERWAVVTMTVSSAVMGLLYGFGYTKLSLVINFMRLFALRIPTLYLFQTFTNLGSESVGIAMLVSNGLIGVTSVIIGFVIIEKMKKEGRYHKIVTTH
>fig|293826.4.peg.867 Permease of the drug/metabolite transporter (DMT) superfamily
MEQSKMRAQVFVLMAAILWGTTGSAQAFAPQNATPIVIGALRMAIGGTFLLLVARVRGGFKTKIKVDKKLLVIASICMAFYQPLFFSGVFKTGIALGTVLALGSAPVFSGIIEYFIGEKLSKRWLIGTILSIIGCTLLFGGQDSMNVDVLGSSLSLGAGLSYAIYVKVSKKLFENSRRDEVNGLVFFISAIILSPILLMNDLSWVMSTRGIMTTLHLGIVTAALAYTLFAYGLVNTSTPKAVALTLAEPLTAAMLGVFMFNEIFTSVSMIGGLLLFCGLIINSYPEKENVNVKDKMKALQI
>fig|293826.4.peg.1058 Multidrug resistance protein
MYGIPHLKFKKDIWFLLASILIIHIAAYIIVPIFPILLRGQKGLNPTQIGLVIGAGSLFIQLGSIVAGFISSRLGNKLAMVIGNACQAIALFGLGSVHTLYPLILFSSLNGIGTGIYVPTVKSAISYIASEENRTTAFSMRGVAAHAGTSVAGIFVLLSAVNRNFYIASGIYIVLMIISWIYLPTNCGEEPCPPLPFNRYIEIFKNRTFMNFTFVSIFLWALHTQLNFLLPLRGEAILDNTNIIGTIWTITSVTVILIQPFISQMFLNKISPKLSICIGSILVGSGVTLIGWANSFYFLVLCAIIFILGEMFMMPTLDSVTSLIADPKMIGAYFGVANLASGIGAAFGTFASGRLIDLYGITESVLPWVMYGIATVVISGLIFLPAIKTLDQNNEGAK
>fig|293826.4.peg.1297 Acriflavin resistance protein
MFKNMIKLSIKNKTVTIFSMIMITLFGLYSYFTIPKQEYPETPAPAAMITVIYPGASAEEVEALVTEKLEEKLTELRNYDYTDSTSLNSAAAILLILDMDISEAELDQTWNELYRMMEDVKNHLPAGVADININTNLIETSGILIGLSSDNYSYEQLVTYGERLKNNLIGLGGINRFEIIGEQEKELKVEVDLQKLDLYNLSISQITNILAAQNIQLPSGSIQNDRMKFYVNQEGLFKSLEEIENTILHIREDNIIVRLKDIAQVYMGLKDSNYKIRNNGENGILLVGYFKGDVNVVTAGKEVRTVLEDFKKQLPEDISVDEIVYQPEEVEKSVNDFVKNLIGGIFIVILVVMLGMGIRNATTVSFAIPLSMFITFITMGLLGIKIHMITITGLIMALGMLVDNAIVVSDSIQNKIDEDIDQLTACVEGTKEVAIPVLSSTLTTIAAFSPLLFLPVATGAFLGGIPQMIIISLIASYGIAIFITPLMAYLFFRKSKSNRKKDGKIKGIFEGLLVLGMKYKVRTLLASFIILVLSLTLVSTLPQELFPKSDKDMIYIDIQTEYLSNLDKTDDLVKEIEAVLREQPEIISYTSSIGGGIPRFDISIMPQANAPNSAQIVMRVNLLNGETFKTNEELVRHLQEIYDERIVGADVIVKELEVEGGLGAPIQIRVKGNEMEDIIEAKEKIKEALINIEGSTNVRDDLPLLDYQFSMTIDGNRALSYGLTKQEIQNEVNMALMGRKTSVFREEGKEFDILVKGNISRLEEFENLKIKSTATGLQVLLKDVANINFEPVIGQINRYQGERAIAVQGNVAEGYNAIEVQTVLEEKIKDIDFPNVTVVPEGEKADMEGDLGNMGISAIFALFLLFIILMIQFNSVIQPGIILASIPLSLIGSMVALVVLRQPLSLFSILGIVSLMGVVINNAIILIDYINTQRKTGMPIEEACSKAVSARFRPVILSTTTTVFGLFPLAFFGNDLFRPMAVAFMGGLMVATLLTLVIIPVLYSLIEGKIEAFKRRRDKKKLI
>fig|293826.4.peg.1432 Probable antibiotic-transport ATP-binding protein ABC transporter
MIKVSDLGFAYQKSRAKAIKGIDFHIKKGEIFGFLGPSGAGKTTTQRIIIGLLQGYSGSVEVMGKERREWGQEFFERIGVAFDFPNLYLKLTAAENLQLVAAYYQNKPRNIEVLLDRVGLLPDRDKKVEAFSKGMKMRLNFIRAILHDPELLFFDEPTSGLDPLNAKIIKDIILELKAQGRTIFLTTHNMTVAEQLCDRVAFIVEGEIPVIDSPKELMVQHGAHTVKIEYHKGNTTKAETFPMEGLKENQQVFDILKRRDIKTIHSQEATLEDIFIKLTGRKLI
>fig|293826.4.peg.1433 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MRILNALKADMRFQFKQGFYFVYVILTLMYMILISQFPHGFTSYAVPIVIFTDPSFIGFFFIGGIVMLEKVQGILQYLVVTPLRPREYLISKVISLTLLAEVAGFAIAYVTYKAPFNWILLFIGIFLTAAFFTLYGFVVAASCNTINEYFIKMIPYMLGLMIPTLYYFTYPNVWILRLLPSVAGFNLVNGAFNGIRFLEMAAYIGYLVLINIVTLIRVEKYFIKKVLRGE
>fig|293826.4.peg.2032 Fosfomycin resistance protein FosA
MMINGINHITFAVSDLEKSVEFYVDLLELRLVGKWDKGAYLLAGNQWVALNVDDAVTLETKSDYTHISFNVLSTDFKKMKDKLESAGVKSFKENSSEGDSFYFLDPDGHKLELHYNNLEDRLKWVRENGWLTFELY
>fig|293826.4.peg.3501 Vancomycin B-type resistance protein VanW
MKTNFEGIDKRKAFLWGAGLILIVIVIGLIAMLALSFNSGKIHPHIYIEEVDVGGLSKEEALAKIQKIYDKGVSENQLQLHFESQEWKRSYQELGYTYLYEEAVAEAYGVGRSGSIIEQLKQIMRTRKTAPVIRLRGKHQGEKVAILIGEIRSEVDKEPINAKIKREEGTFVITEEEVGVQVDQVLLRTRIREALASSYSGILPVPVKHVLASVTREDLKVIEVTIGEFATNFNAQQEGRTKNIEIGSSSIDGTLIMPGEIFSFNEKTGPRSVEEGYQEAPVILAGRLVPGVGGGICQVSTTLYNAVIRGDLEIVNRQNHSLPVSYVPLGHDATVAYGYLDFEFKNSTEHPIYIESTVLGNRLEVRIFGKNVPPYQVRLASEIVERISPTREVKQDPNLLVGERKVQQEGKQGYRVKTDKVYYEGNQEIRREQISTDYYPPVKTIIAEGTKPRPQRSEANQEDIEESRELKEAEEIPEDSEVSEE
>fig|293826.4.peg.3612 Permease of the drug/metabolite transporter (DMT) superfamily
MNHKKYYGLMTFGTILWAGAFIAGKLGVEKLSPLLLTYFRMLFATIIIFPILIFKDKNWKIEKKLIKYVLLTGLVGMIGYHLLFFTALRYTTASNASIINATNPILTSIFAYVILKDHLSPRRIFFILTAFIGVLTTIIDWDFINLIHFSFNKGDLIMILGTTCWALYSIIVKQVMHHFTPFKLTAYTFLASVVLLTPFALYEMMYTDFSSIGIMPFYAVFYMAIFPTVMGYTIQQVVIKELGPSTTSLFINLVPIFSVLFATVFLKESFNYLNLISGGLIIYSVFSFSKKPKVDNIIMQQQFPTV
>fig|293826.4.peg.3779 Daunorubicin resistance ATP-binding protein drrA
MSFKYDNKYAIEVNNLVKTYKDSIRALDGLSFSIKPGIIYGLLGPNGAGKSTTVKILTTLSRPNSGEAKVLGIDVISEPGKVRSVIGCVSQKSGICFESTGRENLILQGQLQGMGGKQLNDRVDELINIFKLNEAANRSTMTYSGGMLRKLDIAMGIIHNPQMLFLDEPTTGLDPEARGALWDIITDLSKMEKVTILLTSHYLDEIDRLADCLAIIDEGKVVVEGSPKQLKEELEGDIIKVELQKDYFSKKSQMINILQEQQGVKKVEVKGRKVQLQVGNGSTILPNILQLIQSLSVEVLSVEVIPPSLDVVYFKYTGKNIEN
>fig|293826.4.peg.4085 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNVDLTKDNVTKLFLKYLIPSIASTLVLSLCILFDTIFIARGVGSEGLAALNIAIPLFSILIGTGLLFGIGGAAAFSISMGQKRQEQAKVFFTHSVIMACVVGLLFSIIGLLFSERISYLLGATSENIGLVNGYVGILLPFGFFFLVNQTVAVFVRNDQAPKLAMWSMIIGNVINIVLDALFIFHFQWGMKGAAIATGIANAVSLLILCIHFFSKENRLVFIRVMPHYKTVRRIIGNGFSSFILELSFGIVIFAFNTVLLSIKGTLAVSAYSIIANVSIIFIAIFIGVSQAMQPIVSVNYGARKKERVQEVLRFAIYISLGLSLFFFGVGMLFPHWIVSLFTPDSQELIDITVQGIYIYFTGFLFTGINIIMAAYFQAIEYRMYATILTMSRGVIFILLGLIIFPNLFGILGVWMTGPLAELLTFGCMLFLAVRVKQQVKKRSIE
>fig|293826.4.peg.4471 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MATSLQIPSKIEVRRKILSMILPITMENVLQMSAGFVTMAMIGRISAVAVAAVGISMRITQIIWALFRGVTTGATVFVAQSYGSGNLIKLKKVIQQTLLSSIILVLILQQLLFWFAPQILNFFKGDPTLIESGIMYLRTLSWGLPFVAVIQVVAGVLQGMGNAKTPMKIALIMNVINMILSYTFIFGPLGLPAMGLRGAAVALVVAQSVAALLGIYVLFNRHGILGTVFNRSFFKLDMKQVIQVYRVGSPTAVESIFWQVSSIALTMIILDFGEVSLAAYQLGLQAESISYMPAMGFSVASTAFIGQALGAKDPQLGKRYLKEIVTGSFLITIFSASVLIFFPAFIMRLLTDQQEIIDVGIKYLFFMGLVQIPQNMAGVLNGALRGAGFTRVPMIVAGTGLWLIRIPFSYILVQFFDVGITAIWIVMCFDLVFRFILSFTLYKRKNIYEQEPVIEKMTVKSEG
>fig|293826.4.peg.4490 Probable antibiotic-transport ATP-binding protein ABC transporter
MITVKNLYHSYTKDEHYAVKDVSFEVNQGEIFGFLGPSGAGKSTTQNILIGLLSLQRGTVLIDGQNIGNKSKTLFNHIGVSFERPNIYKKLSGVENLQFHSEMYDVPTEDPMGLLKRVGLEDAAHQKAGGYSKGMLQRLVFARSMINQPKIWFLDEPTSGLDPNTASTIKGIIKEKKEQGTTIFLTTHNMHIAEEICDRVAFITNGEISAIDSPRNLKLIYGERFVKVEYLKEEILKKRSYSLTDEKERQQLKEIIASQHIETMHTQEATLEEIFIKITGKELK
>fig|293826.4.peg.4532 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRDIGIGLIVATLWGLNFIAIKLGLADMPPLLLATIRFMVVCIPAIFFLPKPPVDWRWLIALGLTLNVGQFAFLFMGVKLGMPAGLSSLVHQSQVFFTLVIATLFLGEQWKWNHVVGLIIATGGMVVVGSQQGGSMTAVGFWLTLIAAASWGIGNVIMRRTTKDAPPFSMLSLVVWAGGIAILPLGLFSLYFEGATAWKLAWDSLNWITIVSIIYLAYFASLGGYGLWGRLLSCYPAAVVSPFSLLVPVIGMSSAALFLNETFSLWQIIGALLVMLGLAVNVFGGRLNKNANKKRMLVEKIKLLN
>fig|293826.4.peg.4546 Permease of the drug/metabolite transporter (DMT) superfamily
MKQSYRAYVEMTLGMFISGSAVVVGKIVVIDMPIFLFQIYSLAIALIFSGMILLCRKEGSSVVQLSKKNLVVLFFQALMGTFLYRVFLLYGLRFTSARESGAILSTIPAVIALLSWIFLKEKIRSNTIWGIFFSILGIIVFNFTTSSTDIALSYRLFGNLLVFFAVLGESLFTFLRKKLSPVPSPLVSTFMVSFYGFMLALPLALYEQYHFNLSSLTYKHYFAILYYGAFVTVLSFSLWFAGISKVSGSTAGAYYGIFPISVFLLSYFILGEPIYLKHIVGLLFIVSSIILLSKQSTVKDIQIASHPETHKDK
>fig|296591.12.peg.369 
MTSPTPVCVEIQFQIKPELEEEFFRQLTAFSHVVASEPECLEFRIYRDMADKAKFRVSETWVSLAHFETVQMAKDYYPPYFEKVRDMWAVPIQMTKWTPLVTHQKAD
>fig|296591.12.peg.417 Multiple antibiotic resistance (MarC)-related proteins
MVAGDRLLHAMRLTDASFEIAGGVILFLMAMGMAFPGMGVSLADSGHGGEPMLVPPAIPVITGPSALATVLLLAARQPDRGWTWAAAIGLLLSAMAVDKLISGLRRAFPGVTG
>fig|296591.12.peg.429 Permease of the drug/metabolite transporter (DMT) superfamily
MTTATAILRPPGSKGAGVAFFFCALVAFASYDAFCKQMLQYYPAPFINLMRYLSVICIAFAMLLHHGDLRIWRAPQKKLLVLRGVMLGTVATCFMTALIWMPLAEATAIYFTAPLLMVALSPWLVGEQVRRSRWVAVTVGFGGMLLIVRPGGDLPWLGTVLMAVSAVCYAIFQLLTRRLAGLVPSPVQYGYTALVCLAVTALPAPFFLPVHRPAPGEVLLLLAGGACSGAAQWLLLAAFERVEASTLAPLNYFQLLLAVAFSTFWFRKPPDGLAMSGIALIVAAGIYLARSRPAGPAVLAAARAGG
>fig|296591.12.peg.1867 Permease of the drug/metabolite transporter (DMT) superfamily
MQTRHFIQLIALSAFWGASFPLLRIASPALGPWVVASLRCTLAAMVLAVLMHTLRDRWPPRAAWPRLALLSLLTVVIPFVLFNWAALVIPAGYSAVLNATAPLFGVLGAAAASEERLTSRRLLGCAVGFAGVALLVQLGPVAVTPQVVLAALACTAAAASYGVGTVLMKRATMAYAPLPASAAVFVAATLILLLPAGMAAPSAHPTPGALLAVAMLGIVTSGFLYWISMRLMREISASAATSAAFMIPLFGVTWGALFLGEAVTASMLPGCVLVLAATALITGFNPFRSSSSEP
>fig|296591.12.peg.2192 Mitomycin resistance protein
MPKAETAALAKVLTDIPNIGASIAQDLHSVGINTPADVAHMDPLAVFEALRTPMGHRHDLCVLDTFMAAKKFMNGGPRQPWWDFTAERKALLAKHDRR
>fig|296591.12.peg.2848 Permease of the drug/metabolite transporter (DMT) superfamily
MVWGSTYLAIRFALVSFPPFFQMGTRFLVAGMLVMAWVIIRKQQLPTLREWRNALVIGTLMLGGGMGLTASAEVHIGSGLIATFIAVVPLMVCAWGLLLGQRPSRLELAGMAVGLAGVLLLVRGASFSAAPVGLACIAGATLLWSLGSVLSTERLPLASGPAGFASEMLCGGAVLMAISLALGEQHEVASNWPFQPAALVAWLYLVVFGSLIAFSAYMYLLANSSPAVATSYAFVNPLIAIFLGAFFAGEHVTRGEWIACGVILTGVFLIFRGKSATGGRK
>fig|296591.12.peg.3123 Permeases of the drug/metabolite transporter (DMT) superfamily
MPAVFVLIWSTGFIVAKYGLPYAPPLTFLAIRYFLSIACFLIWIALARASWPREGRQWLHLAVTGVLMQAGYLGGVWVAVKAGMGSGLTALIVGLQPVLTALWVSWMASGDTRQQGSTVTSRQWMGLALGLGGLLLVVSHKLGGGHEVTALTLTATLFALFSITVGTLYQKRFVKPADVRCAGAVQMGAALLVTLPLVFFETGAIVWNHQFVGAMAWSVLVLTLGGSSLLYLLIQRGAATSVTSLLYLVPPTTALMAWLLFDEAITMTTVVGTALTALGVSFVVRSAKPPAAA
>fig|296591.12.peg.3397 Probable drug resistance transport protein
MSKLSVKNLTTGFDKVNVLHDVSIEVEPGKITCILGSNGAGKSTLIRSILGLTPPRQGEIWWDGRNLAGEKTHKIIASGIACIPEGRKVFPRMTVGENLALGAFLESSPTRIGERLARVYEIFPRLKERSAQLAGTMSGGEQAMVSIGRGLMAEPKLLLIDEPSLGLSPLYVKENFKVIKQINDLGVTVLLVEQNARQTLAIAHYGYVLSQGKVVASGSAQALSENDEVRSAYFG
>fig|296591.12.peg.3398 Probable drug resistance transport protein
MMAGQSLISVDRLTMRFGGLTALDELSMTVHEGEILGLLGPNGSGKTTFFNVLTGLYKASSGSISLGGENILGKTPQQIYRSGVARTFQRSRLSLSLTVFDNIVIGDYQHMQHGLIFNLLRRKAFRAEYEAYVEKVKSLLEIFSPPLVGRLFEPVESFTMIDRRRIEVCRALLSRPRLLLLDEPSAGMTHDETDELMQDILQVRGKLDKLSVVLIEHEMNVIERITDRCVVLNYGKKIAEGSYVEITADPHVQTAYLGEAA
>fig|296591.12.peg.3496 Outer membrane component of tripartite multidrug resistance system
MNRIHSTLRMSLAPLVAALVLAGCATSASIDASSLPKAPQAFKENASQVASATATSAQVQSQGTWWKVFADPVLDQLVEQAGRNNNSVQVAAGRLAQARAIARNTDADRLPQVGLGAGATRQSNATTGNVPQTVVSANANFSYEVDLFGKLSLNSDAASLDAQSREALLRSTKLLVQADVAQTYLNLRALDTERSLVRDTLQAYRNTLRLTEVRFKEGDVAELDVARVRAEVASTESEALALDRRRAELEHALAVLVGEVASSFQVAPAEWTTALPVIPAGVPSTVLVRRPDVSAAQSTMQAAQARAGVAKAAWFPTFSLTATGGYAAPEISDLFKLSTRAWGVGALLSLPIFDGGRREAGVQNANAELDIALANYREQILVAFKDVEDQLAALRLLADQSEAQSRSVASATRATVLSDSRYRNGFVSQLELLDAQRSELRNRRQALQVKASQYLATVGLIRALGGGWST
>fig|296591.12.peg.4201 Glyoxalase/bleomycin resistance protein/dioxygenase
MSARDLLPQPALRGVDHTARPTWKLRETIEFYRDKLGLPLVHVISARGWGPATHPDFLHFFFDSGNGSTIAFFYYLGSDQPATMEDRASKPPLPDDHVFDATHTAWIVESAEELQAWKQRLEAQGLNVSVETAHEVIESIYVRDPNGYFVEFTRKLRPLDRLDADDGALTLQAALEAEDAAVRRGSHLARIDDIWSAKARLLDERGGAGDRVGSAVAIYVPRLAEFSALVHDAAARPECRVTAVGDYDLIEAGQAMEFRRKALGLKPAVWYGLFTGGVRGHIEVFERDRVVIAPARP
>fig|296591.12.peg.4913 
MSSAVSNELPPASAGNDASAESVSLVVRHRVRAGAQAAYESWLAETMRVAAGFPGHQGVHVVRPAAGGADYTIVVRFASCEEATRWHQSAERARLIEAVRPQLEVAEQVSVGAGIDYWFPSEHGAAGEPPMKPPAWKQWLITTSVIWPLTMIVPWAFGPVFKALPVLGVYGVEHGVLAAVIVALVVWVIMPRYTQLVHGWLFRKE
>fig|296591.12.peg.5584 Acriflavin resistance protein
MSQHKLNSAGRLANLFVTSKLTILFMLACILLGLLAVTLTPREENPQIVVPGAQVWVTLPGASAEEVEELVIRPLEGIVKQIAGVDHTYATAVNSMGVLMVQFKVGEDKEKSLVKLYDRVLGQRERLPAGAGEPLIRSVDVDDVPIVTVTLASEIYDDYALKRLADRLMEGLRSLDKVSAISVKGGRDRELRIELDPQRLQAFGVTLDQVHATLRASNVAAPLGTVVQQGQNRQVFLDGFLSSAQDLKRLIVGSHAGRPIYLGDVAQVIDGPPQERTHLSRLAFGPADGRFGKTQQAEMPAVTLAVAKKAGSNAVFVANDVLERIERMKAQFVPTGVELVVTRNDGQKADAAVSGLIEHLGIAVLAVFLVTAAFLGLKEALIVGVTVPLILALTLGAAYLFGLSINRVSLFALILSLGLLVDGAIVVIENIHRNYSRLGKQDKRLVTVQATNEIGNPTNLATLAVMLVFGSLLVVSGMPGQYFYPVAFNVPVAMAASLLVAYAVVPWAANRWLKLGEGHDLEDHDTKDRLHRFYRHLMSPLVDRSRSRWLAFLLAGLAIAVSLLQPAWQFVRPAGLGGPQSWFGVELAMMPKDDKNTFNITLDMPATAPVEATDRFAREVGALLRENAYVRNYQSWIGEAGVIDFNGLLRGSGNKQGPHVAEIRVNLLNKADRSKTSIAIVRELRPTLQAMAARYPGSTVQLVEDPPGPPVRATVLAEIYGKDLQQLRTLSAQVKAAFQQTRDMVEVTDSEAQDVYQYRLTVDREKAALSGLSVAEVAVALRRLIDGEEMGRARIAGEKNPVPIRLQIPRRHQIDPALLARVSVTNRQGQRVPLSEVVQVVPGAVDRTISHKDGERVTYVGGELESTAPVYAVLDLDRRLDGLLLADGSRLTTGNLRLNPVAPDTLEGPRLLWDGELRMTLDTYRDMLGALGLALTFIFLVLVAYYQSFSLPLVAMAAIPLGLAGIFPGHWLMGQPFTATSMIGIIALAGVVVRNSLLIIDFVLDYRRQGMDLREAILEAGAVRLRPILLTALAIMLGSAVMLSDPVFGGLAISLIFGTLASTALTLVVVPLLLYLLLRYKDRKEAIMEKGTL
>fig|297245.3.peg.2836 Mitomycin resistance protein
MNVGEATYKDLQLLGINSIHQLANASADQLYARLQQITGQLHDPCVWDVFAAAINEARTGEKQPWWQWTKIRKKRQLEGTFCI
>fig|297246.3.peg.75 Acriflavin resistance protein
MWIVRIALARPYTFIVLALLLLIIGPLSILRTPTDIFPDINIPVISVIWSYSELPPDDMGNRITSVFERVLPTTVNDIEHIESESLIGVSVVKLFFQPGVNIELALSQVTSIAQTILRSLPEGTLPPLILNYKASTVPILQLVLSSDTIPEQELNDLGNNFIRPQLAPVAGASLPYPYGGKVRQVQVDLDLQAMQTYGVSPLEINTAISAQNLIIPAGTQKIGDYEYIVKLNSSPLKVNDLNDMPVKTTPGRVLYIRDVAHVRDGFTPQTNIVRVDGKRAVMMSVQKTGGASTLGIIKQIKALLPKIKEIMPAGLNLGQFADQSIFVTAAIQGVITEGIIAASLTALMILIFLGSVRSTLIISISIPLSIIGSLTILSALGETINIMTLGGLALAVGILVDDATVAIENINWNLEQGKEVEEAILDGAHQIAIPALVSTLCITIVFVPMFYLGGVAQYLFVPLAEAVIFAMLISYLLSRTLIPTLAKYLLHKHDPEIKEQSQNFFVRLHHQFEKKFEIFRERYSNLLNKALHNATYFVGIFLVFVISSVVLLWPWLGSNFFPNVDAGQIKLHIRAPTGTRVEVTARYVDTIDKLIRTIIPPQELDTIVDNIGLPVSGINLSYSNSAPVGPEDADILISLKEKHHSVFDYQRELRTVLNQKFPDISFAFLPADIVNQTINFGLPSPIDIQIIGLKQDENRVYAKKLMQRLKKVPGLVDIREHQAMNYPELFVDIDRSKAKELGITQRNIAMSLFIALSGSFQTSPTFWLSPENNVSYPLVVQAPQYVMNSLQALRNIMIDGISPNIQSPAQHQILGALGTITRKWTSVVESHYNVMPVIDIFAATQDRDLGSITHDINQIIAEMNSEVPLGSTIAIRGQIDTQHQAFQGLYWGIVFSVLLIYLLIVINFQSWVDPFIIITALPAAIAGIAWFLFITCTTLSVPALTGAIMCMGVATSNSILIISFARQHLLETNNPLLAAMEAGRTRIRPVLMTASAMIIGMMPMALGLGDGGEQNAPLGRAVIGGLSFATIATLFFVPTVFYIIHNHQLKVKQRNNHA
>fig|298386.1.peg.178 Permease of the drug/metabolite transporter (DMT) superfamily
MNKKHLPLLLFCSVCFIWGTTWLAMEVAVDTIPPIFATGLRFLIASPILVLLSKIFNQPLLFPKGKNKWIAIVAVFYFAIPFTLMIAGEMYISSGLASIIFANMPIAVMITSTLFLGLRLAIHQFIGLFIAVISLFIILSNELGIGGDNLLIGSGALGLAVAIHAVMYVMVQKHCKDIQVITYNALPSFVAAILLFITSLAFENINVQAFSSSSLMAVGYLGTFASVGGIVAYFKLGQISTPFTASICFLIFPLVALALSAATSGAAISEQSILMLLPLLSGILLTKVPLSKFKAARKLVTSSQ
>fig|298386.1.peg.467 Bacteriocin resistance protein, putative
MFMKTSLLIIAGFFLSSSVFALDYFPSRGAYNVKVKSYQEKVFGDVQRQQYDFSCGSAAVASLLTYHYGLETSENSVFEYMFKYGDKEKIEQQGFSMLDMKKYLEAQGLTANGYKLPLMKLKKLGVPGITIVNFDGYMHFVVIKGMNSSQVILGDPSRGTLTMDIDDFEAGYKGLVLLVKNNVKVGKESFIKQENYSIYTPSPVSEAVIRESLATFSITLPGANDY
>fig|298386.1.peg.526 Multidrug resistance protein B
MMKIQPFAILALALLALFPQGITAEIYTTGAAEMAGTLGLSADEASWFKTLNMFGQLMAFPLAAWLSYRIGYRALFRLGAGIGLICALISSLWMSSAPQMIAWFGHGVSASFLLLFAHAIVLRNLGYRAIAFVEGVMLLSVVLIPLSIYPYFLSHLAENNLWHWSFAVQVIPFIGMLYWARFGHWPCPDERQKIRFNFLQAVLLSGFICGVTYLLLRGERFNWFRDPEIIELTLLTLVIGAAAIIAMRRRWGKGEYLRFKALASPHGKVGMLDAAVAGFVIMGTTILVSTYVTQVMHYSHEHLGELEMIGFAGMIGGLIIALIATCNPKRNPENVIPAGVSIMLLACALLAGSNAHSGVSDLWPALLLKGLAVGILNITLTVHILRSFPKHQVAEGITWFYLFRNFGSLLAITEFSRLMYIETVGSVSKLAENYNASSETFVLHQQMTADLLQQGMINPSSEQIALLLSEQLKTQAMSVAGVNNFQWIIFSIILLVPIMVIAMKWANNQPHHQDNESEVH
>fig|298386.1.peg.527 Multidrug resistance efflux pump
MNMNMKTMIKKSVVASLLACAVAGFYYYLAPAPGMVATDNAYVHGEISQISAEVAGVVTKVYVTDNQYVQAGELLAEVDKRDYIALRDQAKSAFAMAEATVDNVNERIKLQMININEAATRITSAKSDADFQHKEWQRFSDLLRKKLISKSSYDGQKTQMQQSSADLDATKLQLAAAKQQLTTLKTERARMIAQRDQTDAALDLAKLNLEDTELRAPISGIVGNRVVRAGRYVNKGNPLLAIVPIDDIWIEANYKENQITNIYPGQEVHINLDSFPNYQLKGYVISASPATGAQFSLLPPDNATGNFVKIVQRVPVKISIQLPDELRGRIVPGLSAEVEVDTNDKA
>fig|298386.1.peg.824 Drug resistance transporter, EmrB/QacA family
MSPKTIFTSVALVIALGSLEKSIVTTPLPIIGAELNAGQALTWVITAYLLAATAVLPVYGKLSDIFGRVKMLNISILLFILGSVACALSQDLTQLIASRVLQGIGGGGLIALAFTVIADSIPAREVGKYQGYISIVYAVSSIAGPLLGGYFSEQLSWRWIFWINIPLGALAVWMINKNLRHLSVKRASKFDWKGAGLLMTATTLLLLLISPEASLDATIASITLFTVMLLLVWVERKAVDPILPVRLVSLPGYVISVLLILCSQLLMFAVLVYLPLQMQWQKGMTASGSGLLMMIFMFSITTGAYFGGKQIARKGYYKRFVVVGFLLSAIALWLLHFDLYLSAALAAAGLGLGLTLPALSVVVQNVLPAEDRGIGMSLFGFGRELGGAIGVAICATIFHSQVPVVVAEGSENTLAHFDPEALAQGFSMTYAGMAVVAVIAFLLAVFAMKGQALSSDLKPHAVKDK
>fig|298386.1.peg.1345 Bicyclomycin resistance protein
MLFFLVIISAFPPLTIDLYLPALPQMVNVFNTDQAMVNLTLSSYFVTYAVGLLFWGPLSEKFGRKPILLAGIGGYMLASIFCALAGNIEQLIGARILQAFAGSAITVVATAIVKDLYDGRERQKIMATIMSLVIIAPMVAPVLGAFLLQIASWRMMFVTLAIFGAFASVLAFCYEETLETKYDGSILRSWGRLGVVLKNPRFVALLMIFSITPMALMAFLAAGSYIYINGFGLTEQQFSYAFAFNALCASFGPTIYMKLSRYIPVQKIITLCFLLLAIAGLLTITIGHMSPWVFACIAAPATLMVITMRVPGTNLMLDQQDNDTGSAVALIQFCSMICGSLGMVLVSVRPESLIENLGAIQLFVGITGGFLWLLAKNRSFVTEKLVN
>fig|298386.1.peg.1534 Multidrug resistance efflux pump
MQKTVANIAPEVTGVVTKVNVENGESVKAGDVLFSIDSRSYELAVRQSQAELHQVQESNSAKWQELQAANQTLAQRKIEWQNAKTKLTRYQSLLSKGLITQQEFDDVQMNDSVAERVVQSAHADSLRIQAELATEDNNAAVELAKAKLEQAELDLSHAVVVAKIDGTVSNLQLQAGTYMNKGTVAMFLVNEANSWLKADFNEKGISHLMVGTSVLIAFDAMPGQLFEGQVINRDSAIYDASSQNSMLSDVTNDSRWIREQQKIRTRIQVDGVDSALISGSKASVIVKNGNGLIDAIGYSWIQLVAYFRYIY
>fig|298386.1.peg.1799 Multidrug resistance efflux pump
MLEGLAVWALFIYLLRLVGMPWNKYSKSFSYLGGTGWLMFVWVGLITFAPMDLSGGSLVQSPHIQLRPGSTKIKGHVKAIYVSPNEKVKEGQLIYEIDDEPYVIAKNKAESLLNSAEVSLSISKEDARISESSYQASLKDIEISKNEISAAEEDLRWKQTTYNRYIEQNKVVNHTITESMLDEQSTAVEVAKAKKITLVSQLDKSILSASKAKLDFEKSQLNVNSHEVDVVTEQENVAQAQWNLDNTKVHAPADGYLTNFIMREGQYVGVMPRIQMYTEEKYVLMRVNHQAIRNVKSGQMAEFTSAVYPGKVFNAEVEGIIEATGESQGSLLARDDNVRQVTGANVANKYHFVRLKLYETGGYDIPVGSVGLAWISTEKPIGFLGFLDVVRGIIIRMKSQIFYIWSM
>fig|298386.1.peg.1913 Multidrug resistance efflux pump
MSDENMPKVQVEPRERIASKSGKPKRVKKVRVKKEKSPPNKVKRLTTFVLALCLGLFVFYIAADRIIPSTDMARVRGFVIPITPLVSGRLAEVTVEPNEIVNPGDILVKIDSADYELAIQEAEQGLVNAGKSVGVQTASIASAQAKLTDALANQAHLRAQATRILTMEKKGIVSKSDADKTRASLASAKAQVEAAQAGIEQAKKQLGSTGNENSEVKSALLKLQKAQLDLDRTVIRAPAIGGVTNFRLDEGFYAQAGQPLFTFVSGEDVWIDAYFRENSIGNMKVGDSVDIVLDYAPGRVFAGKIAGIDWGISWGENEQAGKLAAVTSQTGWLRQTQRFPVTIRFDDETARGFRRVGGQADIIVYTEQSSIMNTFGRVWIRIMSWLSYVR
>fig|298386.1.peg.1981 Outer membrane component of tripartite multidrug resistance system
MNRFHKNASIPILLSLSVLSGCSMTPPEEPQHQSMLTNEQIQLKSHDIQAIHRQWWNQFGDQQLTQLIQLGLTNNLTLQQAKQRIALATQQVALAESGDKPKLNLNVSGGGIGANTQSFNMSNADYSAIGMLLPSFSYQFDFWGKNEATITAASDQKLSLQAQEAQARLVISASIASSYFALQNNYRLEQNLTTLLDEINHQNKVITAQVKRGLASEAESFQNQGDIDTLSAQLSDAKTQQQLAKNQLALYLAKTPDQLGQLTLPNAQAINQLAAVDTIPMNLLGRRPDIIASKWMVEANEQGIKQAKASYYPDVNLMVMGVFQKLSNMNPANLFLGGATVAASLPLYDGGVRDANYASANIQFDQAVTNYNQTVLNAVKQTSDAIVSLQEAQKQQVLAQSSVTHYQQAYDILNNRYERGLSSFADMNSARMQWHQQVVKVTNTESAILQNQLQLIVALGGDYQQEQSVLASTPSNNE
>fig|298386.1.peg.2024 Permease of the drug/metabolite transporter (DMT) superfamily
MTTDLRPVIFMLISTFSLSLNSLLAKFLSDSLSIEMLSFLRFLFPAVLLLWLMALTKWAVPDRKMWQALGLRAFCIAASQLCFLFAINRLSLVETVVLFSTGPLFIPLLEKLLFKTQIQSATLINLAITFTGVLLMADNTSGVVLKPELLVGLGAGIFNAGSQISLYRVSKGALSPIALNAWGFLLAAVITLPLVLFQTDKSTLQQTASDMADIQTLLLPMLILLAVCIVNTQVFRVKAYQLANSSSQLAPLIFTNLIFSSVWQVMFFNQPLEWNKVTGISLIVISTLFNTFLPLIVRKIRVRLIEN
>fig|298386.1.peg.2034 Permease of the drug/metabolite transporter (DMT) superfamily
MEIQNRKEFSFGLMAMGVTLLIWASFFISLRASSQSALTIGDIALLRFLPAALVFGWLALPKAKKIKQTPKRYLLAIALGAGLPFLLLAANGLRLAPVADGASLIPGILPLFVTSIAAICYRERISSMRKAGIMLIFFGICLFLATSLLSGSSQIATGHALLLMASFSWAWFTIAMRVSGLTPIEGGAVLSLSACTCLPVLYLLGLVDFNLLNAPSSEIAFHFIIQGIAAGLIANFTFGYAISRLGAEMSAALGSFTPVLAALIAVPMFAESLNMNTVLAMMLIVLGAISASEIITTKKVAIKVG
>fig|298386.1.peg.2064 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQDNTIAIDSNESITRTFWRYAIPSIAAMVVNGLYQVIDGIFVGHYVGYEGLAGINIAWPIIGIIAGLGIMIGMGAGSLLSIYRGEGNNAKAQQTLSSSLWLIALFGALTMLFIHYFGPALLTAQGAIGNTLNFSLDYINVFTWGAGFTIAAGALPMLIRNDDSPNFATGLMILGAVMNIILDYLFIGLFYLGLKGAAIATVISQLTVLIIGVGYFFSARSQIKINKLTFNFAIASKAVTLGASSLCMFLYFSFIVALHNKLFMVYGTSVHVGAFAIIGYLGTMYYLIAEGIASGMQPPVSYYFGSKQIDKIKATVVLALKIILISGVVSVVLLNMYPETVISLFSKNDPLLLAETQNGLRLHLFALYLDGFIFLASVYFMAVNQGGKALTISIGNMLIQLPFLYFLPQWLGVDGIWLSVPISNIVLTLIVAPLLWRDIQRSSQKHSELITNMAS
>fig|298386.1.peg.2648 Acriflavin resistance plasma membrane protein
MIRYFSRHPTAANLLMLALLLLGLVALPQIKRETFPEFSPAYIIASVIYPGASPQEVEESICMRMEDAVDGLSNIVETRCEAVEGSASLVLKLTNSDVVSRMLVDVQTQINGINDFPNEIESPIVRELDWNEPVVDVAISADTSWPQLKAYAEDLKRKLKLDYGVSLVAVGGFSDHQIRIELKEAAIRQLGLSVGDIADRLARQNIKLPSGNIELGDKNLLIRFDEQKITPTALANTVIGADSEGGVLRLGDIATLTDRFELDEQKILFDGKPSAILKISKNKADDALRIKDRVQQFVEDERKIAPTGVTLSMTNDLSSVLWDRLTMMVRNGWQGVVLVFATMWLFFTFRYSFWVAAGLPVAFFGSLFLMVGLGLSINIMSLVALLMAIGIMMDDAIVIAESIAAHLERGQSITNAVTNGVKKVFPGVLSSYLTTVCIFGSLLFLEGEMGAVLKVVPQVLILVLTLSLVEAFLILPHHLSYSLQKQKEHEKPDIAFKVWFLNKFDSFRNNQLVSAVEAVVRWRYLFLGSVIAMLFISLSLLAGGALKFVGFPELDGDIAEARVILPPGSSLAQTEKVVQTIVTAAEKLNVEWSDKQEGGNTLVEHITEQYNFNPDADESGPHVATVRLDLRGAESRNTVIDEFVAAWRDEIGTIADPVSLVFKQPVMGPGGRAVEIQMQNDDLTELKAASIEIQQYLSQFDGVFGILDDMRMGKQEVLVKLRPGAESFGVDGQMIASQLRAAYFGQTADEIQIGPENIEVEVRFDKQEAANLQTLASFPIILSDGSQIPLASISTLEYQRNYVRIQRVNGLRTLSVFADLESSKVSSTEILKVFRNDLMPQLKLKYPNLRFNFEGEAKDTAETGQSMGVGFAMGIFGVFVILSFQFRSYLEPFIVLLAIPLALIGVLWGHWLLGHALSMPSIMGFVSLAGVVVNDSILLVQYIRHHVYDGDSVHDAVVKASRERFRAVFLTSLTTAAGLLPLLLETSLQAQVIQPLVISIVFGIFTSTLLVLFMIPAAYAILADFGLVKKHQALAA
>fig|298386.1.peg.4390 Bicyclomycin resistance protein
MKNQPSKITLAWFACLSMLGFLATDMYLPAFATIQEEFGTTQSLIGISLSIFLLGMALGQLIYGPLSDRIGRIKVLIAGMTLFSVASVLCAFAPNVEMFLVARFAQALGACSATVIWQAVVVDRYEGKVSERVFATIMPLVALSPALAPLAGAMLEGQFGWRSIFVSLVGFGAVLAIMSLKETESAPTAKNHEKVFVQLKKDYKQILSSKKFIGNMLIFAACSAAFFAYLTGSPFIMGAMGYSGADIGLSYAPQTVGFIIGGYGCRTLLAKYESKKILPWLLTLFVTTVVMMFFISLSTSPTSIWPILLPFCFLAVANGAIYPIVVSQALSEFRNCSATAAGLLNFMQTMVCVAASALVSAFTANGLITVTTAMFVTGFIALIGFSLVVQARREIPQDAQTA
>fig|298653.4.peg.371 Regulatory protein, MerR:Albicidin resistance
MLTISQLASYAGVTVRAVRHYHAKGLLPEPERDHSGYRRYDAHAVVELIRIRTLADAGVPLARVRELLAAGEEEFNTAVADIDQRLRAEIRERQRHRERIAQLAAGDSLALPPEAVAYLDRMRELGLPDLMIGGERDSWILVAAQLPEHMPLYMKVKQQQLDDPATVELYRDLAAMIGWEADDPRVAAVGDRLVALIEADAEGWENHDEVMPDELAQLLDSVFLDSVPIARRLLERLEERGWRGWTKFERIQPK
>fig|298653.4.peg.433 Bicyclomycin resistance protein
MNSARRTLLVLGFLVALGPFTVDFYIPAFPLVQADFGTSAAAVQLTLTATTIGFALGQLAIGPWSDSIGRRRPLLVATALHVAGSLGVAAAPTVEVMLVFRLLQGAGAAGSGVVALAMVRDLFDGALFVRMAARLAVVTGLAPVVAPFAGSLMLSHMSWRGLFVCIALYGLAVLAVAAFLVRETAPLVRRAGAPLGRYRVLVTDRGFVGAALAGGLLVSSVFTYMSSSSFLFQETYGLSAQRYSLVFAANAVGFVIGAQTSARLVTRIGPRRLLRYVLPSLGFLGFTLLLAAFAGENVVVVTFVTALYFLLAGAVGPCLQVIGMAPHGERAGTAAALMGAANFGLAGATAPVAGLLGVGSIGPIGLVMGLTMTVAVVVFRVLARDRREARAGAPSPVP
>fig|298653.4.peg.660 Drug resistance transporter, EmrB/QacA family
MEIASRAGRMSGAAGALLREPARPARIRESPLATVLAVGTVCIGSFLGQLDASIVTIALADLRADFGMSLGLATWVSLSYLVTLVATIAALGRLADMYGRKLLTLYGFALFTVASVGAALAPGIGVLIVCRVAQALGAAMLQANSVALIATTVEPRRLTAALGAQGAAQAFGLSLGPLAGGLLLELGGWRWVFWAHIPAGVIGFVLGVLLLPRTRAHAPRTPFDWRGLALLVPTVSAVLLALSVGESARSVGPLAAVGGLVLVAALGGVLFVRRESSAASPMVDLPLVLHRAVGPRLAAGTFSFLVLFGLLLTIPQNSDDGAVAVGLLLATLPIAIGVAAPVAGTLVTRLGVRAVTSGAMVCVAGGLGLLAAGGSGPAVGVPSLALIGCGLGLFTPSNNGAVMAAVPAQQSGMASGVVNMTRGLGTALGVSVSALAYAAGGFVATMLLLAAIALGGALLAATAAAPTVPGSALPRQRENDRAAP
>fig|298653.4.peg.896 Outer membrane component of tripartite multidrug resistance system
MTRLPVRIEDHLDRRTWTVEPGLCQLTVWRRHSEFRVCPPPGAPAPDPARPGAAGAGPHSGPDGSPPGPAVSLGPAFSSGSAFLSGPAFLSGSAFSSGPAASLGSAVMPGTAIALDPAILSDPAFPLGAAFFPAAAAAAAGRGVGTRATSLVSPSVPPPVGQASWPAQAAAASALRGVAEGAAR
>fig|298653.4.peg.2301 Fosmidomycin resistance protein
MPASVPYFVLERNYGYLAASGLTLAAALGSALPQPVIGLLVDRRRVGPLAAVGVILAGLGVGLAGLVPGYALTWSLVLLSGIGVAMFHPAAGRAARIDAGDSTAAMSIFAAGGSVGFFLAPVLATPALATLGLAATALFILPAVLVGFVLLRAHQRQAAAAKVAAVTTAGGKDLWSPFLLLTTVEIARSVLFFGVNTFIELYWLRHLHAGHTAAGAALACFLAGGVAGTLAGGRVADRAGAVRTVQAGTALAIPTLVALRAAPGPGTALLAAMTAGVAINIPFSVLVKLGQDYLPTRPGTAAGVTLGLAVSIGGLGAPGLGAIADAWGIAAVFSVLCLVPVPGLLLATFLPEIRPAPPQDAQERRRPA
>fig|298653.4.peg.3275 Multidrug resistance protein B
MSAEARDADRLDPPLRRLIAVVLLGGIMGILDGSVVAVGVDTLAARFHASLSTIGWVSTGYLLALTIAIPITTWAVDRFGARRLWLTALVVFLSASLASGLAWNITSLIVFRVIQGLAAGVLDPLVLTLLARAAGPRRAGRVMGLMGMVLSAGPVLGLIVGGIVLESASWRWMFLINLPVGVVALLGAARAVPADPPRQTPTSRLDVLGVALIGPGFAAVVLALTQAADRTAVVAWQVLVPLVAAVTLLAGYAVHALRGRPHRSTPPLIDLRLFASPGFAASVAVMTLVGLTMFANLFVLPLYYQQQHGRGALGAGLLVAPFAVAAVICMPLSGRLSDRLGPRALVRGGAVVAVLGQLAFTGIGAHTNEVWPALAAFVVGAGLSFVGAPTMGSLYRTLPPESVSQGSSVLYILNQLGAAIGIAVVTLILATVGPENTRGMAGFHGVHWFALAAVAVILAMSAFLPRRDATTEAAVPAAGAATATATATATTSTSTSTSTSGTVPPALSAATAQEGTR
>fig|298653.4.peg.5172 Multidrug resistance protein B
MPGGPRGQGGPRGSAGTSAGTGPGGPQTASLTHGAVGRLVVALGTATLLQWLGAFAIAPILPLYLEERDVSAGGVGMVMAAFFLGALLSQYPAGLATTTRGHRPVLVAGLVAYAVGCAGLIVSPGIMCDTAMRVLQGAGAGAFEVAVLTAIAATVPPDLTGRAVSAVYTGQIAGTAIGPLLGGLAGEQRMDLLFLGAGVAAAVASVPVLVLLRPDGPGHAPALSVASTGSDASAVGPTAGGGAGVPGGRAGGAEAVAAVAAVAVHRDGSPGHAGRRAPAWASRRRTWSPLAAVGPGVEGLLLVAAVNGLAVGTYETCWSLLLTDRGISTELVGLSFTLFSLPYIVCAMPAGWLADHNDRRWLVVAATATTGVTVATYSFIGSFWLIVLVSCAEAIALAVSFPSAQSLLAQESGPGGAGRAQGLFTTTQTAATAGAALTSGALYAANAHLPFVLTAVAALAVAGSLPRLWRRVRGTVVPAAVPSGAVPSGAVPAGAVPAASTGPAGGAFASHLITR
>fig|298653.4.peg.6277 Multidrug resistance protein B
MSSDLGSLAGPEEAGEPQEAGELRAEGEREGIRGEPGGRSVPSGSAGPPHTGLVFTVLVLGGLLVVLDITIINVAIRTLAADLDASLPVIQWVSTGYTLALAVTVPTTAWLVARFGSGRVYMVALSLFVLGSVLCGLAWNIDALIAFRVVQGIGGGLVNPVAMTIVLRATPPERRGRAMGLLGLPVLVGPVIGPTLGGWLVDISWRWIFLVNLPLGLAALLLASRVLRPVTAAAGAVQRGGTLESADGRLDVPGLALVAPGLALFVYGLAESGRRGTVTSAGVLVPALAGLALAVVFVVRAARMRAPLVQVALLRLRAVASGTATLALFAAAYFGSMFVLPLYWQLVRGLSPAETGMLAIPQALATGASLQVASRMVDRVPPARVVGFGIVTASCGLITATLLLGVDTPYWQMVVAMSVMGVGAGSTIMPTITTALRHLSDRDAPSGSTLLTITNQVSVSIGTALTSVVLAAGLTTQGVAGAAGGGGEGVLPTVVDGPAAARLAEACQDTLFVSAALLVAALVVALTAIPGGPFSASRRRRVQPRIRAPRRRRVRPRGEAQDQSPVRAARTGDLTPPR
>fig|298653.4.peg.6688 Drug resistance transporter, EmrB/QacA family
MDVPLNRRPSQRAVVATLFVATMFITIMDTTIVNVALPSIAADLGVSSGSIDEVVIAYLVSLAVSIPASGWLADRFGSRPVFLAALGVFTAASALCGLAGSLTALVVFRVLQGVGGGLLTPVGMAMLYRVYPPAERARAARILIVPTVVAPAVGPILGGVLTDQASWHWVFLVNVPIGIAAFGFGLAFLAGSRVPGAGRFDALGFVLSASGFALVLYALSVGPNHGWLSAGTLTAAGVGLLATGATVWWELRRTQPLLALRLLGNDLFRTVSLTLSIAFMAFMGVLFLVPLFMQTVRGVSATTSGLVVFPEALGVLTATQIAGRLYPRIGPRRLMAGGLVFAAASMLALGFLDSAGSLWPLRALLFGVGFGIGFVMMPAQTAAFATISTQQTAQASALFNAQRQLASAIGVALVSTALSLARPAATGPAATGPGGGSVVGDTGSFRWAFAVAAALAALGLLAALRVRDADAAPTMRPPAAVPATAAETVLLGHGRDDQGGGSRAGADGHVDRARVGSEDVGGAAGDPDTDAVAGGEAVVDRPDADLEGGGLPGGHRRR
>fig|298653.4.peg.6691 Probable multidrug resistance transporter, MFS superfamily
MDASEVSNGASPDSGPGSGAGTDAPSRASAIVAVLAAVGVLVSLMQTLMVPLIPVLPKLLHSNASDASWAITATLLTGAVANPVFGRLGDLFGKRRMLLLSGYILVAGSLVCALTDSLVPIVAGRALQGLGLAIIPLGISIMRDLLPPKRLIPAMALMSSSLGIGGALGLPIAAIVAQNLDWHVLFWGSAIATLILVALVTVVVPESPVRGSGSFDLPGAVALSAGLVALLLAVSKGSTWGWSSATTLGLFGAAVAVLLAWGRWETRAKAPLVDLRTSTRRPVLLTNLSSTVLGFAMYAMSLICPQIMQLPRATGHGLGQSLLATGLWMAPAGLMMMVVSPFAGRLITARGPKVALLSGTAVMTVGYVAALGLMGSPVGVLVIACSISGGVGLAYAAMPTLIMASVPASEGAAANGLNTLMRSIGTSTASAVIGVVLANMTISFGTTQVPSLTGLRVGFLIGAGAALVAFLVALAIPARKSAAPASVVPDQRSPHDRSTGAAGAAAGSVAEGAAATDAVEARA
>fig|299768.3.peg.1028 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKIIVKIISKWKLLGFIIFALLYSCQGLLISLIIQMAGSVDIENRGMIVIFGLLSLTFFIFIYICMYFNNILLRSIIKDINLFISKKALRLFAEKRLEYSASEFNSFLTQDIPMFWKEYLSPLFLYPIFGTSILVSVMYLVSQDVVVGLLFTIGGFLMIIPQFVFHKLLKRRGEKLSKVREISLANITDFSAGIDTIVSNRVEQEYCQHVYDTIDKMESGQYRYYTSHNLVMFWTGPLKGLGLVGPFVIGMVMMSTTHLSLTVLIAMMTASMNLISPLQQLLEATSTLQSATVVKEKVLNILLKEDIKREEVSKTFPTTLGISIKNVSKKYADKIIFDDISVSVEAGNRVLLTGASGSGKSTLFHILTGDDRDYDGEICFLDGHGKKYAPSHDLVSVIHQKPYIFKGTLRANVSLYQNYNDNDIRKVLQRVQLWDELGQDFDYYLDGNNLSGGQMMKIEIARALLRPRPILLADEITAALDKQNADEIHKLLFSQPFTILEIAHKFHQDEYEKVYTLNNGKVL
>fig|299768.3.peg.1821 Tetracycline resistance protein tetA(P), putative
MIKKQIFHYLFATFLVTVAYTLPHSILTVLLLEKGLSISQILIIQSAYSLAIILFEFPSGMLSDNWSRKYLYLSSRVLLIIMFLIVLISSNFYFLYLAWFIYGIAAAFESGTLDSYLINKLKRSSNDKLIESFISKDNKIQFASMIIGSGIGGILYFMIGIKIYIIAIILVCLSIFDIGFFFQEDRDYYKEKINIDTFKKQISISFKELKENSILRVIIVFDLLTQLFFQAHFQLWQSFLLEKGIDKRYFTAFYFLFQIISILSYSIHTDKLQKLVNYRLFLLLVIALPLFFLSNLPVVYLIAYILYVFIFYIIQFVLNIYFNKQVSTKTISSLISLKSTISRISGLLILYALSFLLNYMSVSLVISLAFILSLLSILLLLNYFIKNYI
>fig|299768.3.peg.1827 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MSILNNDIKIIEESGFESFYSLVSTVFTTFFSIIALFSYDYRIVLLSILLTLILTYLPRSFAHKMEKAMKRFSIGNETFISSLTDQLLGYDTLYYSNKKEMLSIKCGEVIKKFIFEKIVFIKTSSLIEIIMSLFSIISQMLVLLLTGYLIILKQVSIGSISSVGQISGNIFNSLTTFNQLQVSISSVNIIFEKFGAFEKSSHYRYIDKDIEEIKLTNVGYSFKDKEIFKNINCSFEKGKNYAIVGESGSGKSTLINIILGNNKQYSGSVKYNDVEISDIEESQLFKSVSYIGNITHIYHDSLRNNLTLWDNKINESEIINILKQVNLIDLIPRLDDEVSMSFLSEGQKQRLGIARAYLTKTNVIIMDESMANLDRDNAFLIENQLLNDPTRMYITVSHHLQEKLLDRFHSIITL
>fig|299768.3.peg.1830 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MLRSYVTKKHLTFYFLAIVITWLEAIITPALIQYIVASFTNRQLHLLWQILLWGIGGNLVLVLGLAGKRYYYARLMTDFKVGIKRAIFRTFLYSRQIPDEEVLSDLENDVQQLENSYIEPTVIIVSSLGFTVVSIAYALWTNFYLGLLFIIFYSVPVLCSGLGSKRLDRIAEQKSLANQNYIARVNNMIAGVAPIRHYQGQNLFFKRFSKDLEQALQEEVSYEKQRSLNSLFINSIDAFCSVAPIVIGGFMTYQNYLSAASFVGIYLVSHNIGYQFQELSYFINTRKSAKSLCDKYQDLFGNKLATDSIFDQSVFPIQLEQVSVEKDGETILAPCDLTIHAGEKIAIIGESGAGKTTLLNILYGEIHPSQGQIRYQGRELTSCQLYQAGAYILQSSHVFDDLSVEENIALGQEIDQQRMDNILQETGLLSLKGKVPSNQTLSGGEKQRLEIARALYHKRQFILADEVKANLDAKNQEKINQLLFSLPQAVVEVIHHYTKEDLKRYDKVIHLKK
>fig|300267.13.peg.3461 Transcription repressor of tripartite multidrug resistance system
MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQAGVVLEAMS
>fig|300852.3.peg.1887 Kanamycin resistance protein-related protein
MEWPRFGRVVLKPFSAGLSEAEWKGLYETFRDPEVAEWNGSSPLRSPFWLFKRFVLAEARRKDRVAFVILDEKGEYLGTLELYDLTPEEATLGILIGRKDRWGQGYGTEAVRAALDYAFRVLGLRRVKLRTFAHNLRARRAFQKAGFREVGVVPGPRGREDVHMEVRREDLGPEA
>fig|300852.3.peg.1973 Permease of the drug/metabolite transporter (DMT) superfamily
MGYLYVLLAAFLWGLIGPLSRMAFQEGLTPLTVAFYRALLSWIFFLAHAARTGGLRVAPRDLPVFPLFGLLGVALFYGAYQLAVLYGGAALASVLLYTAPAWVALLSWAFLREPPTARSWGAVALTLLGVGLLGLGGGSEVRFGVRAFLFGLASGFFYALHYLLGKLYLGRYATPTFFAYALPVAALALAPWAEFGPLTPRALGALLALSLFSTYGAYLAFYAGLRRLPATVASVVATLEPVVAVVLAYLLFGEVLSPLGYFGALLVILAVLLAVRR
>fig|300852.3.peg.2126 Bicyclomycin resistance protein
MGPLEELLFLGTLMALGAFSIDVMLPALEATAHRYGTSPTAAQLVVGLYFLGFALGQLLWGPLMDALGRRKVLRGALFGFSLAALATVAAPGFSLLLAARFVQGFFAASFRIGVTASIRDRYRGEAMARRLSYALLVLMVAPVLAPALGVALLALGPWAPYALPAFLGLLALLWSGRFRETLPEEARRPLRLASLGEGALLVLRDRRAGLYALALGGVFGILYAYLAASAELYKAHLGLSNPAFALAFGATGLVLAGANLLGPQVVARLGLGKALRRAVAGLLALLLFLPLHALAPRPFPFWLHLTLVLLLVVFTFPNAQARALEGLGKVAGLAASFTGFLSTLLAALLGTLVGQASGGAPLPFSLGLLGLGVLAFAAVFLAEASPLCGSPPPGGPGGSPPGSAPPGGGGGPGG
>fig|302409.3.peg.653 Bicyclomycin resistance protein
MKVFKRNILILIITVIVMTEMSSDIYLPSLPKISDFFHVDYSIAQLTISLNLAGISISGLLYGPLSDYYGRRPVMLLGIVIFTIASVACYFANNVMMLIIMRFIQGFGTGVAGVVGYAIIKDMYSGDECAKNISIVNIAVAFSPVLGPILGSTVISYEYNWNVLFMIISVISVIVLICLFSFLRETLVIDRSKNNISFRSVMYKYKELICNYRFFGFALIHSLTIMWIWSCITNLPFVFVNDMGVPVAYYGYFVAINVAAYIIGAIINQKFVEKFGMSNMLILGLILTTLSDASVFILYQVIEITPLLAEIMWIPSGMGIAFILGNNMTCAFSEIKETGIGSAFILFLQTIFGAIGIYILSCFYDGTLIPVIIFPVVCSILCIIIYFVLKVTEKKPNM
>fig|302409.3.peg.837 Multidrug resistance protein D
MRKISEIFLERNRVSIFLLIVILIFGSYSYFDIAKEKNPEIKKPVLSIHTVLQGMSSEDIEKLVIYPIEQEVMSIKGVTKVTSLAKNGYANVILEFSAGFDDKEALDNVRSKVDIIRAKLPQEATFPVVNQENLGLLPVLNIALTGDLPDRALFKIARNLQAKLEGLSNVQNVKIIGNRKDVLEINVSPNAINMYNLQVHEVINSILNNNQFINIGNLDVTSSKYALHVSGLLKNVQDIVNIPIKTDGYSIVTVGDVATVKLIYQNDTEIIRVNGQPSLVLEISKQPGKNILDTIFQIKDMIHNTKDVLPHNLSIIYLQDQSEEISDVLNELQNSILVSVLLVVVIMMIFMGTKTALLVAISIPGSFLLGIIVMYLLGYTLNIVILFSLIMAIGMLVDDAIVVTEYADRKMINGLGRKEAFKQAAYDMFWPVASATLTKLVVYIPLLLWPGTTGEFMKYIPIALITTLSASWIMALIFIPVLGSMIGKPSVTDKQSIAKIMAIETGKFTNLGRFSKSYVNILKSVLNHPKKFICAVIAVLVLSTFGYFTIGPGIEFFPNIEPERILITIKSNSNLSIAERDNILNKIEERIFNVKGIKFLYVKVGLFEYLLDSNNVIGKIQLELKNWFLRRKSEEILNEVMEKLQDIRGVIIEVLEERVKPVTGKPIRIDISSYNVDKIHNVADKIIYVMKNSLGFENITDNRSSSELEWKIDIDKNKAAKFGVDVSMISQFIKMIANGIMLNKYHPDNVNDEVDIFLRFSKEYRNLNTIDNLFVNTIHGYTAVSDFVTHKAQHKDSIISRINGKRTISIVADLANGYLLDDMVSLLNKELKKNMDPEVLVELKGEIQDQEESLKFLVKAFLIIIVLIMLILLTEFNSFYDTFIIMTAIFLSTNCVFLGLFVTNHVFSVVMSGVGIIVLAGVIVNNNILLIDAFYANISNTNDKKDAIIKASISRLRPILLTVITGIVGLLPMVFRISFDFVNQRVIYNSPSSQLWCELSYTISIGLLLATVITLFFTPALLVLGKCNRINKSDRMVCY
>fig|309798.3.peg.181 Permease of the drug/metabolite transporter (DMT) superfamily
MSRKSQDTLGYIYLIATTFFWGTTFVFSKEVLNYLDPFSYLFWRYVIAFIPLIPFIRIRKKDMLDGFWLSITNAIALITQFVALTTINASTAAFIVSLSIPLTPLLEMLWLKKRQSSTVTLGQIVSVVGFLALSYVPGEKFSVSIGAFLMLISALAYTVQFVLIPTLHIENQLNTSAYMIGFTALWSLPFTRSFSIPRGVLSPLLYLALVATTLTIWLQLQGQKNVSATTAAYIFAFEPIFAYLFAHFTVGENLTTFGNIGALLIFLSALLVQYGEYRTSKANGS
>fig|309798.3.peg.446 5-nitroimidazole antibiotic resistance protein
MRRSDREVKDSARIDEIIRMCDCCRLGLVDGDGVYIVPLNFGFKSENGRRTLYFHGAKEGKKIEVIKAHPFVGFELDTNHAVTAGEKACDYSFLYSSVIGKGVGAVVEDIEEKRAALQLIMEHYSGKGNWSLPDEAVEGVAVIRLEVVELSCKEHA
>fig|309798.3.peg.1088 Drug:proton antiporter
MSRELKALGMGYLLWGFSIGLYTTQWPVFLLYKLGDPGQVGLANGLISATAVLSYFIGAWMGNHFPKKPLFMLSWGGSAIAPLLWAFGSSDWTIYLGCALFGFISSYSSPLINSYFLDELGDEFMKGSMYTSSTYSIGMMVGPFVGGVLKDIGGYELLMIVTAISFVFSAVPLAFLKKDEPKKKSLMLPKDRSYYQALLWAAVMSFAMMITVPYAPLYAKERFALSGTMLGLLGSISAIGAVLLAYLAVRVSHRSIILRISVWCGILGTMLLISNRWFLWVAFFFRGAFMNTYSLITSGVSHRVPKDYSYIGFALLTATIAAFNSLASAVGGYIYNTGPIVLFLLSSVLMWFSLHLYRLLAESRQ
>fig|309799.3.peg.141 Permease of the drug/metabolite transporter (DMT) superfamily
MHNLSFSYISSYISLILATTIWGFGFVAVKESVTHITPIQVLFIRFFSSAFFLIIIYYNSIRSSRLQTIKRGFILGFFLFLAFWTQTIGIFYTTPGKNAFLTSTNVVIVPFLYWLIRGKKPKFFHIVSALLCVLGVFLLSYSGDAFYLNKGDFFSLLCALFFGFHIVFTDIFIKNDDLINLSFWQFLTVSLISLLLILIKYNFVWFKNLVFIIIGEKNKRLLFSLVYICLFSTLLAYILQTYSQKFIKPYITSIILSTEAIWGYLASYLLYKEDINLPTILGCGLILSSAIIVSLIDLKTN
>fig|309799.3.peg.213 Daunorubicin resistance transmembrane protein
MKKYIYIAKGFLLERMVYRFSLFFNALEKYIYILLIFFLWKAIYKSLGQENLSMNFESTFTYLSLATAIFGLFQTWVDWDISQLMISGNLSIILTKPLDFQIYMFFKRITWVILNLLTITLPVLVLLKFILRMPINMGINFLFFVISVIISYLIYFNIDFIVGVTAFFTESIWGLSVTKDSIILFLSGGIIPIPLFPENLRKILEILPFKTIYHMPIEILINKSLTIFDYLNSLAIQIFWLFVFLTLSRIYYKLTERFIKINGG
>fig|309799.3.peg.488 Permease of the drug/metabolite transporter (DMT) superfamily
MKRIIGLILVIIACLFWSISFSVSKILLKTLSPFELAFIRFFLASIFSLIVFLPKIKKASFNRKYQKPLFIAGLFGVTLYFIFENTGLKFTDASEGALIVGSFPALGLLTEYILHKEKLPLNRILGVLLSISGVFLIMSDSGLNLKFNNLFGDFLILLSGVSWVIYNWEIKKVNQKYPYEILTTFQMIWGSILFLPFLMFTGLKIPKTLDALIGIFFLSFFCSGLGYLFYNYGLKTLSVSQVMNILNLIPLFGAIWGVIYLKETLTLIKIVGGILIILGVSLSSSK
>fig|309799.3.peg.691 Permease of the drug/metabolite transporter (DMT) superfamily
MRYDELKGLLILTLITFVWGSTFSFTKIALEVFTPFFLLFLRFLLGAFALFLFLILKRQRISINFSGVILGIINFSAIAFQTFGLRYTTATKTAFITGLSVLLVPFFEKLVFKNKIYWNLWLAVFTGFIGLIFLTTDFSSISTINWGDFLVLVCAVLYAIQIVYISYVVERREIFDLAFSEILFTAIFSFLFFLIFEPRNLPLNFILKNSLSVIYLGIGATAFTLTLQLVGQKYVSPTKSALIYNLEPVFATLFAFLLLSEKLNFQQIIGASLILISLFISIPSSFQNKS
>fig|309799.3.peg.1489 Multidrug resistance ABC transporter
MNNNRLIRLFSFMWKDGGSIFLGIMYLVSLLFLSSQVFLLNYFAAISLKLISDGMIEKSTNKLAEGVWYLLTRFGLFLLIIPIFAYLYQYAVRKTTIIIRRRLFEHIIDLPMYEFEKNHTGDFLSRINFDVNTAEGVYSWQLMVLLMSIVSAIGCSVAIFLINKIIFFYVVLVTSVNILVNAIFMKRLREISNKIQEAFSKVTQKLSDIVGGAYIIRAFDIADMIFKKYVEINSLLYRLALRRVNYSSILASFNYTVGYFIFFGMLALGGYLMIRDKITFGNMVAAVQLMGPVVYFFGSLGNFLTNLQISLAGAERIFEILDKSKEENERKKYEKNIHIINKNNWVIRFENVSFSYDSTQEVLKGISFEVKEGEKIAIVGPSGGGKSTIFKLLLGFYPHYDGNIYVLGKEIRSYTLEELRNLISYMPQDVYLFNTSVYENIRYGNLRAKDGEITEALKRSNSYDFVIKLPDGLSTKVGERGVFLSGGQRQRLSIARAILKNSPILLLDEATSSLDSESENLVIQALNNLIKDKTALIIAHRLSTVKDVDRIIVIDGGKIVEEGNHSELLEKGGKYKELWDKGFQVNGREGRE
>fig|309799.3.peg.1877 Efflux pump antibiotic resistance protein
MGGVLTQYVGWKGIFIFTFILSFLSIILGISYRLDEVRNEEKLDLLGGFLFSLFVFLILFGTSQILKFTGIVSVGIGLVTLLGFYFVERRVSNPILDMNLLMNNKTFTFANATALINYASTFGVSFLLSLYLQNIKGVSPRDAGLFLVFQPLTQAFFSAWAGRLSDRRRPEILASIGMFIISSSLFLLSRIDTESSIFLIPLYGIFLGFGFALFSAPNTNIIMSSIDKRYYGFASSFLATMRIMGQSLSMVMIGIVFSLESSFMNSYRILMLTYGILCILGVFLSIKRHEVHKLS
>fig|309799.3.peg.1911 Multidrug resistance ABC transporter ATP-binding and permease protein
MRYLLKLIKIAKPYWGYLIISAISLLILTGLNLIGPWLIRSLIGIITNISQYPNARVDIIRISLILVLSYILGIIFQFLRNYFSHYAAWHLVADVRMMVYDKLQNLSYRYFVDKQTGQLMSRVVNDTANLEMLIAHAVPDLISNLLILIGIAVILFIINPILAALSLIPIPFLLLSSTVFAKKIMPIFRKAQKALADLNADLQDNLSGIREIQLFNKQEKEYKKIKEKVYNQIHALLSALKLSAIFHPTVGFLSSLGNLIVVSVGGIMALSGKIQVQDIVGFLLYLGMFYQPINALAQILENVQQALAGAERVFEVLETEPEIKEKENATELKNVKGKITFENVTFSYNPGVPVLKNISFEINPGEMVAFVGPTGVGKTTIMYLINRFFDPDSGRIKIDDIDIRDVTLKSLHENISMVLQDVFLFNGTIFENIAYGKENATLEEVIEAAKIAHAHEFIERLPKGYFTEIGERGIKLSGGQKQRLAIARAVLKNAPILILDEATSSVDTETESEIQKAINNLAGTRTILIIAHRLSTVKRADKIIVLKDGEIVEIGTHEELMKRKGLYYKLCSVQFAEDKMAEIVRS
>fig|309801.4.peg.481 Drug resistance transporter, EmrB/QacA subfamily
MIIVDATIVNVAIPSIIEDLGLQLTDAEWVNTVYSLVFAALLVTVGRLGDLYGRKRIYLGGLALFVGASLLCASAPSGTLLIAARALQGIGAACILPSTLSSVNAMFRGRERALAFGIWGSVIGGMAALGPLVGGWLTTDFSWRWAFYINLPIGLVAGTIALLTVPETRDPSAAPGIDLIGIVTSAIGFAALVFGLIEGERYGWWRPTDTFRIGSWEWPFATLSPVPVALALAALFLPTFALYELRRVRANRPVLLDLRLFRYRTFRWGNLAALIVSLGEFGIVFVLPLYLQAVLGYTAFQTGLVLLATAIGAFLGGPAAANLAQRFGARQVIRAGMLFEAVGLLLIVPFLAPDTTGWRLAPALFLYGLGVGLATAQLTSVILAEVPTAQSGQASGTQSTTRQVGAALGIALLGTILAAGLGSGTKSRLIDQLGIPPQQAAALARAAKQSAGQILVQLQTQPGTQPIVQAIEAAFTDAARRTALVAAAFILVGFIASWLIPDIRPERGPTAVSEPATAESRPTG
>fig|309801.4.peg.536 Daunorubicin resistance ABC transporter membrane protein
MASIELTEPVRPPSPLLRASIGVLTLWQRDLLRFWRDRTRIAGGLAQPLLFLAIFGAGLSPWMGNLGGTMFGPDYLQFLYPGIIGMSVLFSSIFSAVSVVWDREFGFLKELLVAPIPRWSIVIGKALGGSSTAMFQGLLLLILAPVIGVRLSLSTILLLIPLLFLLAFSLSSIGLVIAARMRSTEGFGLIMNFLVTPLLFLSGALYPLNNLPTWLLILTRLDPVTYGIDAIRRVVLSSSGVPQPVIDQLGVTLFGHPLDPLTDAAVVLGLGLVLITVAARQFARPD
>fig|309801.4.peg.825 Vancomycin B-type resistance protein VanW
MSIAEVVREVVTTRMPGQWLRRVVTGASVIVAGAVLVSVAAIFAYGWLQGDRIYPGVRVAGVDVGGLTVDEAAQRVTNALAALTNQEIVLTFQGAELALPVRELEPEWNAQVAVNQAHRVGRSGNLWRDSASWLAARLGLEVIPVPVTYRADRLEAAVRTLAERAARPPQDAFFTVDEDGSLYVAPAREGVGIDLGIARQSVEGALASGRVGRVELAPVTLPPTYTESDLEPLKPRVQALVGSPIVLTLDGESRWMISPPDLARLLTLTSHEGALRASFDRGKLEEYLSRIAGVVVAPAQDAHVRWNGSAFEVVPARPGAVLDVVATVNEFLVRVERGERTIPVQARPASPLVTEAMADEARARAQALVDRGLTVRWPNGTRTLRGGELAALLTFEQRRQGENVVGLDVSIDRSTVRSLLEAIAPQIQRDARDAVLRYRDGKVIVVTPEQTGQRLDIEGSLIAFERAVRSGRSAVDLVVANVEPRVTSAMASQIRIRERISAGATYYGDSAPNRRHNVELAVQRVNGALVPPGEVFSFTGTVGAINLENGYKVGYGIVATNGRVQTVPSVGGGVCQVSTTVFHAAFWGGFPIVERNWHLYWIPLYGQPPSGLIGLDATVDTDYGLDFKFRNTTSDWIAVVAWADGSWVHVEIWGTKPNWRVVVDDPVVTNVVKADPTPVIREDSSLAPGEQVVVERARDGFSVAIRRRVYEGDRLIDDVTLRSTYQPSQNVTLVGPQPSPTPTETPEEGTPQPTEATTPVPEATPTPVP
>fig|309801.4.peg.873 Permease of the drug/metabolite transporter (DMT) superfamily
MIGLGFAVAGVLAVSTSAVLIRLAGSVSAFEIAFWRLLVATLALVPVALATRTLGAVRSLGWPRLAIYGATLAVHFVAYNAALQFAPVAHVLPLLYTSTIMLAILSAFLLKESLRPRQIAGIVIVLSGVVVLTGFEPRFGLRIAIGDGLALLSAAAYAAYSLVGRRERARIPLLAYAIAVYGSAAVWVFPFALLAALSAGASVARYDWQVVAALLGLGLIPNTLGHTLYNASVRRLNAAIANVIYTQEMTGAILLAWLILGEVPGVNAVVGAIIMLVGILFVLLP
>fig|309801.4.peg.1106 Drug resistance transporter EmrB/QacA subfamily
MERAQTERSRLALILPGLLLGMLLAALDQTIVGTAMPRVIAELQGLEHYAWVFTAYMLTSTVTVPLYGKLSDLYGRRTFFLFGMIVFLIGSALSGMAQSMTQLIFFRALQGIGGGALFPIAIAIVGDLFPPAERGKWQGLFAAVFGFSAIIGPSLGGWITDNWGWRWVFYVNMPVGALALLTTGLTMPKLASGRQHRIDYLGAALLVSGVTPLLLAFSWAGTEYPWSSPPIIGLFGASALFLVLFVAAELRAPEPILDLRLFGNRIFTPTLLAAFLIAIGMFGTILYLPLFVQAVLGRTATNSGAVLTPMMLGFVFSSIVGGQILSRTGRYKILAIGTVAVAVIGMFLLSRMDVTTTSTTVVRNMIILGLGIGTTMSLFTIIVQNAFPAQRLGEVTSALTFFRSIGGTVGAAILGTVMTNRFQHELTTRIPDTIRASIPAQQLDAIKNPQVFMSPEAMQQMQQQAAAFGPRGQEMLQLLLTAVRQSLASAIDTVFFVGMLILIGAFLLTFFIPEIPLRRRSPGGAPLAH
>fig|309801.4.peg.1969 
MPFVVVAHYYAKEGKADEIAAILKEMVTLSRAEPGCLVYYVNRSQDDPRKFLLYEQYRSREDYEAHKATPYFQEKILNTVVPMLESRVPEFYDLIEPE
>fig|309801.4.peg.1984 Glyoxalase/bleomycin resistance protein/dioxygenase
MVALRRIQHVSITAPLDGAERARAFYNGVLGLREKPVPETLAGLNILLWFDVGPSELHIVAEDDETRGRSRRHVCFEVDDLAAVRARLSEAGYQPYDAAPIPGRPRFFCRDPFGNLLEFMVFAEEGSER
>fig|309801.4.peg.2310 Permease of the drug/metabolite transporter (DMT) superfamily
MTRGQLVQLVLLGTIWGSSYLFIKLAVAGIPPLALVEGRLLLGALVLLAVRWVTRQPWPSRAVWLHLALMAVIGNVVPFLLIAWSEQHIDSGLASVLNATTPFFTVLFAVLIFRAERLTQAKAIGLTLGFLGVAVLSGADLAAVGAASTQGQLAVLASSACYGLGFAYARRFLRGAPLALAAGQIALAALILLPPALATEDLAALRPGPVEILSLLALGVASSGLAYVLYYRLIAAAGAVIASLATYLMPPVGVTLGWLVLGEPVGWRLLVGIILILLGMAVVQGRAGWSAWRGRTARASTLLADD
>fig|309801.4.peg.2521 Permease of the drug/metabolite transporter (DMT) superfamily
MRVATWRRWVDGEAFLAVLIWGASFPIVKHGVDSFGPLGFAVVRLIVAIACLLLWLRWRGEALRIERADWPRLAVAGFGAMGLFQILFLVGMHHTTATHSALFLNTSPLWALPISWLVERQRPRLGAIIGAVLGFAGVVAMIGRPEGEARSTLWGDLLTLGAALCWVGVTLIPRPLVRRYGAVPITTWMLIASLVVVSLVGFPETMQSLHEVPGWGAWGALLYTGILAMVGANVFWQRAVQRLGAATTLVYYYLQPGIALVLGAMFVGERIRVTQVIGIMAVFVGVLLAQRAGLQENVPRIAAPVTRRSP
>fig|309801.4.peg.2765 Permease of the drug/metabolite transporter (DMT) superfamily
MREQAIADRRAARQHTIGGHLLLATTAVLWGSSYIGTRAIVGDVPPLLLGFLRALSATVVLGVLAKLAGESLRARSSAWIPLAGLGVLGVAYFYIGLNLALQWTTATAASFLSLPYPALTAVGGWLFLRERLGARQIAGIGLAALGATWLTVASAQDNVGGAWIGNLLALSITVAWTAYTLLGRRLLLKWTPLAATFHMMAAGTLVLALAAGLEYFGGGRPRWTVESTLITLYLGVVCTGLGYAFWNAGLRRVRAATASVYLYLQPVTVVVLGIALLGEQPSLVTLVAGALVIAGTALTAGGERAR
>fig|309807.19.peg.1222 Acriflavin resistance protein
MSFLVVIVVGAVSFYYLPVDLLPEIEYPQVSVTTSYPNVGPEEMEQIITDPVANAVSSVSNVERITSQSSEGSSRVNMEFGQGTDLNAAANDVRAALDRIRDDLPVEAEPPSIRKFDPNSQEIVSISVESRRDLPSLTRLMERNLSKQFEQIPGVGTINVQGGIYRQVQVNLNRERLMSYDLSAAQVQQSISSSNVALPGGNVKEGLKDLYVRTQGEYESLDEIRNTVVTTANGTPVRVQDVAEVIDGYEDLGRIAELNGIPVLRLDIQKRSGANTVSVANRVREEVKRVNQTRSDLNLTVVSDQSDFIRKSINNVQSSAIWGSLLAILVLYLFLRNGSTTFIIALSIPISIIATFALLFFNDLTLNQMTFGGLALGVGLIVDNAIVVLENIIRQREENGRSLREAASMGTREVAGAILASTITTSVIFLPLVFARTTTASLFQSLALVVVFALACSLLVALTLVPMMASRFLTVDAGEGDAAEDTSKSWFQRAFASLENQYSDAIRAALQRRWLVFGATGALLVGALLLWPYVSVELAPQTDANQIDVDMQMAQGTNIAVVMKYLEELEQRVQPMLPQDEVENFAKQVQPWGAEVEVQLKSAEERSINTFALADSIRSEVVGKVPGADLRVSAQSGLWILRRVFSVGGGNEALRVQLRGYDLEQAQKLAQRVKQELETVEGVAGARSGRREGQPEQNIRFLRDKISSLGLTTQEVARAVQTNLGGSRAASYRTGGEQFPITVRLRPEDRLSVQDLDNVSIQTPDGNSVPLSTLVTTQRGRGPTEIQRINGQRVTYISANLTSDAVLGEVVNRARQKVSTLSLPEGFSVTFGGQYREQQKAQTDFLIAIFMALVLIYMVMAGQFERFLDPLIVMFSVPLVLVGVLPTLVFTGTTVNIQSVMGFVMLIGIVVNNAIVLVDYINLMRRDRDLPLTEAVAEAGRLRLRPILMTTLTTVLGLVPLALGIGAGAEIQAALARVVIGGLTASTLITLLLIPVAYVSLELTARTVRSKLPDWSWLPDSTVQPRRA
>fig|309807.19.peg.2462 Daunorubicin resistance ABC transporter ATPase subunit
MPAPAVDIQKVHHSYGAHPALRDVTLQVDPGALYGLLGPNGSGKTTLFRILSTLMPPSEGRAHVFGLDTARESGAVRQRIGTVFQEAALDEALTVRENLRFQGALYGLHGAERRERTEDLLRRLDVADRAADPVADLSGGLRRRVDLARGLLHRPDLLLLDEPTSGLDPAARRTFWAAVQQLRADEGTTLLLATHLMDEAERCDRVGILSDGALVADGRPNTLKADLGDETIWLEADAPTALRDRIEAQFGVPTRIVGATVQVAPPDPPAFLSSLYEALSDHIRSATIRTPTLEDVFMVHAGVSPTESRERVLARGDDSND
>fig|311403.8.peg.173 Glyoxalase/bleomycin resistance protein/dioxygenase
MIKVNRIVYAAFETPDLDGQVDHYTKTMGLTLMDRDSSAAYLSSSGDRHTVVLRKGAEARCDALGFQLPQGTDLGEYAKQIAGHGIQAQRQSDCQPGIKDSLVFVDSKGTKVETFVEAPIAGIGFQPSGISPNKLGHVAFNAVDVQAAVKFYCEVLGFKVSDWMGDFFAFLRCGPDHHTINLVSGAKNKMHHIAFELRDWTHIRDACDWLATDRIPVIWGPVRHGIGHNISTYHRNADGQIIELFCELDRVNESLEVYEPRRVHQEFPQKGKVWTDKPMAANMWGSMPPEGFLD
>fig|311403.8.peg.203 Membrane fusion component of tripartite multidrug resistance system
MIVVVGTLVAVATENWDRWTAQASVQSTDNAYIRAELTRLSARVSGNLKSAPVQDFEHVKAGQLLMEIDPSDYEVKVAQAKASLDSAVAQLQNLANQERLQHAAIDQANAQFQAASVTAELARQEAVRQTALLQSGSGTKQKQEQADAEKQQTAAAAQASQASVVSARAQLDVVSGQRAQLQASVDAAKSNLDAAQLNLSYTKVVAPFDGIVSERQVHVGDYISVASNLLTVVPLPNVYVTANFKETQLARMSVGQRVIIKVDTFPGQVFRGHVESLSPASGSQFALLPADNATGNFTKVTQRIPVRIAFDEDASVLEKLRPGMSSVVAVQVDNVTGG
>fig|311403.8.peg.243 Permease of the drug/metabolite transporter (DMT) superfamily
MAGILLIGLSFFSGNLPSKIRIRDLPTCCVTGALMWVSGNGLATLASRHATSGFIVMAMGMIPVWTTLITSIMNRALPSRTMILGLFTGMIGLSFVIVPPALSSEVSSVAQGYAVSTALILCAAGLTWSLGSVLQQPLIGRLAPTTAAGIQMLSAALILTTIGKLQAAPLLPQFGLATNQIAAFLFLVVFGSAICLVSYIKVIKSFNPTIASTFAYVNPLVGVALGWALLGELPETAASLGMALILFGVFLVVARPSKRSAAYEGQSKLSRFSEENGK
>fig|311403.8.peg.353 Multidrug resistance transporter, Bcr/CflA family
MGFASISTDLYLPAMPAMGRDLGADTGAIELTISGFLIGFSLGQLLWGPVGDRYGRRLPVAIGLVLFVIGSAGCAMAGSASTMIGWRIVQAVGACAGVVLSRAMVRDLYEGSRAAQMMSTLMTVMAIAPLLGPVVGGQILAFAGWRAIFWTLVGVGLLTLAALFTLPETLPAERRNLQPLGRAIIGYGTLLRHRRLLGYAGTGGFLYGGIYAYIAGTPFAYITYHHVPAGLYGLLFAIGIVGIMIANIANSRLVSRFGGDRLLLHGSAAAALSGVVLAMAAWTDWGGLWGLVVPLFLFISATGFIVANSIAGALTDFPERAGTVSALVGALHYGSGIFGSALVGTFADGTPWPMGWVIALAGIGSFVCARSLASSRKI
>fig|311403.8.peg.1000 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKAVADMNDPRVMRLVLTIALPAVAGLAASAGHHAINAIFLGALGPEVLAGISLVMPLFLLVAATGQGLGIGLATLLARHLGEGDVPAASSVAVTALAATIPIGIVLSVLIYLGLPSFVGALGASNELLAPGLNYGRLLAFGVTLGLLQAVCDFIAIAEGNSRFSMIVLIASFALNAILDPVFIFLLQFRETGAAFATILSSVAALLCYVVYFQRRWGKVRVTMRLVHWQLLRPIARIGIPAAATSVVTGVGFLVLLREAAVHGGDAGVAATAIAIRLMTLGQLPVFGFCLGAQSVVSHAVGAGDPLRVRAIIRVMLMVTIPVASLYSALLFLGAEPIVRLFTDSPEVAAEAASYLRALFPVFPLAAFQSVLLVMLQSRGRAGLSAVVGLAPQGYLLIPLLLLLPLWIGFAGVALAPAGAAILAAILGLVIARREWLALLPTSPGQLIGQSTLHP
>fig|311403.8.peg.1764 Acriflavin resistance protein
MIGSGYVVAEKMITLRPEISGKVAELPLDIGDHFAAGQIIVRLDTTTDEIELRIARSQAASADAAVHRVEVSLAQARRTLERTKLLVERGVKALSSLDEDSLSVVQLTSDLDVARQAAETARLQVEKQDRNLVLHRIVAPFDGVIVTRLAGLGDIVASGTDGGGPRDGIAILLDPNSLTIDVDIAQSNAARIEPGQTAVAVLDAFPDRTFKMRVRTIVPAASLQKGTVTARLEFLTPPARVLPNMAAKVTLDAPELQANTNERGF
>fig|311403.8.peg.3028 Drug resistance transporter, EmrB/QacA family
MTARNQQAAPQPTLSESGPPDRREIRAVILGLMIVLGLAAIDQSIVATALPRIVSDLGGVTHLSWVVSAYVLASTSTMPLYGKLSDQYGRKPMIYAAILIFLLGSILSGMAQTLLQLIIFRAIQGIGAGGLMPLAQIIIGDLVPPARRGRSQGSIAAVFAVCSVIGPVVGGVITDLLSWHWIFYVNLPIGAVALVMIGRAMKRPHQARSRRIDYLGAALLTACTTGLLLVLALGGNEWPWNSPEIIGLSAASLILTVLFVFHVRRESEPVLPPDLFRNRLFVIACLVLALTFMGMLGASLFFPLFFQMVMGVSPSQSGLLTGPLMVGFVISSMFNGRVLLQRSGRYKPAQLFGLGLATTAFAVLTWAAAESLGFAVIEPSIFALGLGLGLVMPTMTIAVQNALPLAHRGVGTATLAFFRSLGGLIGVTGSGAILAYRVQQATGASGSLDMSSLTESGLKQLATASPEAHAAAIALYRHAIAMTFATGTVIVALALIALLFLPELPLRADHGEGARPQR
>fig|311403.8.peg.4036 Inner membrane component of tripartite multidrug resistance system
MSLPSWRDWLFSGKAFVAAMLALFIALSLDLPRPYWAMAAVYVVANPLAGATSSKALFRALGTLLGASAAVFFVPIFVNAPMLLSIVIALWTGTLLFISMLDRTSRSYVFMLAGYTLPMIALPTVGAPETVFDVALARSEEILIGIACASVVSAVFFPTSVRSVLGQRITTWLDDAGSWADEILRGEGASPATPLKRQKLASDVTGLDLIISQLGYDAGSRDIVRHSRELRSRLLMLLPLFSSLADRLHALKAREKALPPELLAVMNEVADWLSQGGKGETDKTAILLSGKIEALQNADPDLNWDDLVLSSALARLKEIVDLWQDCLTLRNEIVAGKRAGSWRPAFRHRDVVGRSRHYDYALLAFSAGSVVVGIFMACFLWIVTGWEDGAGFVTMAAVACSFFAALDRPAPFITSMFVWTAFSLVIAFIYLFGILPGINSYELLVLAFAPPFLVIGLLIPRPQSNMLAMLLTVNGATFIALQDHYTADFSTFINGAIAALAGVGFALVWTQLTRPFGSELAASRLVRAGWSDLAETAAGARRGDHTRLSGRILDRLGQLVPRLAAVEDRELKKVDGYADVRLGFNVLMLQKERPQLSTAGASSVGTVLSGVADFYRSRVKAGQAIDPSDGLRQSIDNSLEAIALRDGSAGRPSLDALVGLRRALFPHAEPPQSWQPPMSDTSSPLSIAAE
>fig|311403.8.peg.5285 Permease of the drug/metabolite transporter (DMT) superfamily
MSSNPTSSTNDTAAIMTSAALAPLLTVLIWSGNTVVTKAAAGVISPGSISFYRWLLAFLILLPFVGPAAWRNRALLNQYWLKIATLGALGMVIYQSLAYEAAKTTSAVNMGVIVALMPLLSTLLAGVLAGERLTATTLAGGVISLIGLIYLTSHGDPATLLSGGFHIGDGLMIVAVLSNSLYGVMLKRWAMPLPMWQQLFWQIGFSTILLIPVFLMGDISPITSANLPLILYAAIPTSLVAPLCWMIGIQKLGAARTSLLINLLPIVVAALAWAVLGEQLHAYHAIGGALALIGVGIGLRQTKVAKGEEEPGADQAAWETEEV
>fig|311403.8.peg.5734 Permeases of the drug/metabolite transporter (DMT) superfamily
MSAAVIGLALSAAILHATWNAFLRSGGDRLWTVTVMSFASTIVALPFVLIYPLPASGAWLYIVLSAALQVGYSIFLVAAYRYGELGQVYPIVRGTIPLLVTVGGFIITGDEINSYQIAGVVLVALGIMSLALGKGRASTSSILFALVTGAIIAAYATVDSIGVRQTGQSGAYTAWVLVLYGTFLLVAFVVLRRRLVVDFRAPDTWKALGGGLVAMVAYGVIVAAFALGPAGPITALRETSVVFAVLIGWLFLGEALAVRRIIACVIVASGAILLGH
>fig|311403.8.peg.6567 Glyoxalase/bleomycin resistance protein/dioxygenase
MGAGLFPDLKPHHVGISVCNLDEAIAFWSEIFGFELDFTAELKPIRTTIAFLKRDGFRIELFEKYGASAVPEERLKPNTDLLVQGTKHIAFSVENVQDAAEKLHARGVRIVGIMRGHGTPMQHEDAPHLDGTKQPAMALFFLDDSNVLVEIIRRSDFAD
>fig|311403.8.peg.6676 Permease of the drug/metabolite transporter (DMT) superfamily
MEKATAARFFGQAAIWGASFTFIKFALQDFSPNQLVLFRLILGAVTLAAIILFTGRSFKLSGTAWFHVAVSSIFANVVPYLLLSFGEQHTSAGLAGVLIGGTPLVTLFISTLALRAEPATPRKVTGFFLGFLGVALVVSPWKVEGSSLLGALACFGAAASYAVGYAYVSRFLSPLKLDPITLGANQLISAAVLLGLALPFFAWPAIETVSVIPLLSLLYLGVLASGFANILYFRLIQDVGAATASAVDYVVPVFAVLFGAVLLLEPLSWNVILGGAVILIGMAIAEGRIGSSSLSPASSGKANKS
>fig|312153.3.peg.593 Multiple antibiotic resistance protein MarC
MLLFAGNDLSVVIHTQFQRIYMLSIALASFVTVFAALFPVINPLGDGPIFLNMVQGCSEGVRNKLARSVSVNCFFMLLASMLIGPQLLLFFGISLPALKLAGGAVVIAMGWNLLNQKSASDKGANESTGITDETSDGSAFFPLTMPLTVGPGSIATAIALVAAYQESSSFSIANELPAVIGTVAALFALSLTIYFIYRESSGIQRIFGVNGTNVLMRLFAFILLAIGVQIFLGGINGYLELIKLLPVH
>fig|312153.3.peg.1396 Permeases of the drug/metabolite transporter (DMT) superfamily
MQSASAAHHHRRYLYGILMAGVGSMLFSGKAILVKLAFGYGANAETLIALRMLMALPLFWSIYWWESRRKQMSPLTWLDRGKLFFLGFLGYFLSSYVDFLGLQYISVGLERIVLYLTPTIVLVISYFVLQKPITRMQWYALVVGYLGVTVVFIQDASSTGIHAWLGMLLVFTSACSYAMYMIGSGEMVRRIGSVRLVVYASSASAVLSIAQSTIYDPSAIFNQVAPIYWLSLLNASLCTVIPMLLIMIAINRIGSPLVAQAGILGPVSTIFMGYLILSEPVTWMQIGGMTLVIAAMWLLVRSDPPKKKSPDSNESSDVDDAKILN
>fig|312153.3.peg.1548 Fosmidomycin resistance protein
MTVAQIRRASDVRVIGLISLAHGSSHFFHLVLPPMFPWLKNEFALSYAELGLLMSIFFVVSCIVQAASGFLVDRIGARPVLFAGVALLSLAGLTYSQSTGYSMLILGAVIAGLGNGVFHPVDYTLINHKISPPNLPYAYSMHGVTGYLGWAAAPAFMVGIAQLSDWRMAFLSAAALEALILLILWLNKSQLIDDVKERHAQSHADEQAINPGGAPASAFAFLKLPAVWLCWIFFFFSMASTSSLQSFAPSGLFKVYQIPIDVGSYFITLLALGSAGGVLFGGYLAAKLKAPERIVSSCLSVTVVMCLLLATGMVSAEIIPFIFFALGFGYGVVAPSRDLLVKLATPKGVSGRVYGIVYSGIDLGAAVGPFIFGFFMDAGLPKALFIGIAIFQIMIIPTVFKVSSNTVSKAV
>fig|312153.3.peg.1681 Permease of the drug/metabolite transporter (DMT) superfamily
MNKETKGIWLGLVGVVIFSMTLPATKIAVPDFSAIPLSFYRAAIAGVAALIYIAAKKIALPQKSDLPTLGIISILISFVFPISIAIAMQDLPSSHGGIVLGISPLLTALFATLRFGERPSRGFWITAILGSALVLAFSIKESGGALQLSDLALLLAAVSASYGYAEAGNLSQKMGGIAVISWVAIISLIPSLPIAIYYAMHSSVTAIPIMNASLPAWLALLFVSIFSAYIGNIFWYTGLSMGGISHVGQVQLLQPFCTLALSSVLVFEPLTISNIFFASAVLVVVAIGKRMPVAKVKT
>fig|312284.4.peg.15 Permease of the drug/metabolite transporter (DMT) superfamily
MQALRPESFGTVAIVSAAMLWGTTGTAASFFPGAVSPIAVGAVTMVGGGLLLFLVSFRGAIAAFHDVSSRRWLLLGAVGVFVYPLAFYSSMNLAGVAVGNVVSLGTGPVFAAVLERVIERESLSTLWKVTTPIALLGVVLLSLGGHALNQGDQGSATFGIVLGLLAGLSYALYTYCSTRVIRAGHSSGATMGAVFGAGAIGLLPVLMIFGAPLLHSVPSLAIASYLIVGPMFVAYLLFGVGLRTTRSSTATTITLLEPVVATLLAVVVVGELLTPTAWGGLGLIFVAVTVLSTARHPRKTLVSP
>fig|312284.4.peg.435 
MLHEEWATTELLAAHNREAHVLEFIARAEGLLREPFTATWMRPIAH
>fig|312284.4.peg.976 Tetracycline resistance protein
MRQTVAMDIDRAVQSRIVRTLVAGQVLAGLGLGATVAVGAILAADLGGETLSGAAATSSTLGAALVSIPLARLAQRWGRRPALALGAGVAAGGSLITVVAIGVAFFPLLILGFAMLGVGTAVGLQARFAATDVAAPEHRGRDLSLVVWSTTIGAVAGPNLIGPGEAVAQWLSLPTNTGSFVFAIAAQVAAMVLYLVMLRPDPLTLAGSRPVEPATTADAGIVRGRGPLVFAVAAIAISHAVMVSIMAMTPVHLSNHGASLTIIGFTISLHIAGMYSLSPVFGWTSDRFGRIPTILIGQAFFAAAVLVVALGQLSNAAVTVGLVLLGLGWSASTVAGSALVADLSTGATRLRIQGRSDTIMSLAGAVGGGFAGPILAIVGYAGLAWGAGVLVLIVTAAALVVWRSKPLSTADSLPVPNVRSESK
>fig|312309.3.peg.727 Multidrug resistance protein A
MTELKKKKNKAPLIATVIFILCGALGAGYWYGYGQYFQSTDNAYLQGDITTISSKVGGYIQQTLVEDNQKVKAGDLLATIDDRDFLAEQEKAEANVAVNAAAITNLNAELKLQDIRIRQSASQIESAQADLERAQQQVKRTKALIKKNYSSQDELDNNVSHLKVAIANLDAAKANYQASKEQINVIESQIGQANAMLNQAKTALDQANLNLSYTKIYAPIDGIVGKRSLREGLLVQAGMPLLSLVPTKEVWIEANFKETQLEKIHHGQKVFVDLDAYPDLHLKGIVESFSPATGAKFALLPPENATGNFTKIVQRVPVKISILNTDLLDGKLIPGLSVVATVDTRG
>fig|312309.3.peg.1332 Probable multidrug resistance protein norM
MKKILTLAFPLIVSQLISMALVLTDVWMMSRLSVSALAGGGLGASVYFFIFIVASSTVGCVANLIAIAYGQRLARPEFGNQQIRLAIKGAVLLSVILSVILLFAFSYAPNVLRLAGQPEEMISLAMEYVDALKWAMFPSLILLVLRGLTSALGNVRSIMVMSVITVVLNVPISYVLTFQLGMGLYGLGLGTAVAALMVMLGYGLWVFKQQEYKPFAPWLNLEEYSIKLITPLLVMGLPIAVAALLEHGLIYGGTLMAGTISIASLALHQILLQCLSFTWNFNFGFSQAAAILVGRDFGANNVDGIKKTSQHSFVLVTVMSVFIAAVFIIWPESIADLFQLDNGENNMSALLTSVIWVVALCFVVDAWQLLAINLLRGMKIVSLPTVMTAIGYWVCGLPAAWYLMPIFGLSGIWAGIGIGLGVTGILLLVQLLISIARVKTHYQEIEN
>fig|312309.3.peg.2691 Permease of the drug/metabolite transporter (DMT) superfamily
MMITLVLSSFLSRDNIMRGMIYLIIATILAAIGWGASKMVVMTIPGDIFIGTRFLLASFVLAPFCFKQFRTLTGKQILALSGVGLVLSFALQVWVYAVSITTSLAEGAFIMSLAMIIAPIISWILFRNKPNKAFWIALPISILGMILLTLGNGWKLEASQLGFMLSALLLSMHFVLNKRIIGAITPLLSICVQLFVVGLSGCLYASLNSHPSFEITQHAVFWFLISTIVATAIRYLAQTLGQFSVNIETASLIMILEPVWTLVLSISVLHEVVAPQKLIGGAVIFLSLFVYIKLSRRLK
>fig|313589.5.peg.1134 Multidrug resistance efflux protein
MSAPNSTTSPTRGGVFGPEYAALTLALLSLISVIAFEGMAVSTAMPEVALELDAVRSYGLAFSVMLTTQLLGIVLAGVWCDRSGSLPSLLTGQGLFAVGCAICGASTDFAPFLVGRAVAGLGAGLTFVAAFVLIGRTYPEALRPKVFSVISAAWVLPSLIGPVIAGWVTSTWSWRWVFWMVIAPVAVALVVLLIRRSQIRAADSTVDASSRDHGTHVRAAWLGLGIAVSAGVMQWGTHELELTWSAQTVAALVGLVGVFLCAPRLLPPGTFTMRRGLSSVMISRFFLPCAFFGTITYIPLMLTGERGLSLAQAGSVLAIGSIGWSLGSWIQGRDRFSGVRDRLVSLGGGALAVGLAGVVLVTWAGWWPWFIAAPLAVAGMGMGMGTASLSVLALSLTAPSDHGSASSNLQLSDVLGSVIGIAATGAVFAALHTRAGEDVPAFVAMWLGTSVVATLVIVAGRRIRT
>fig|313589.5.peg.1488 Vancomycin B-type resistance protein VanW
MTDAFDQQPGQPRRRRGAIAVLVGAFVLLVAGYVGVAAYASGRTPADTKVGGVQVGGLDPAAARKVLETAVAQRGSAPVALTAGGKSATIAPAEAGLAIDLDASVEDLTGFSLNPVKLVSHLTGGATRSLETEVDDSKLKAAVTKAAQALAVAPKEGSISVAGGKVAVVAPVKGQAVEVDKTADLIADSWPRTAPIVAPVTASTPAVSAEELQRVKTEFADKAVSGPIAVKAGDKTFEISAASLAAGITFPADADGKITPKFDDKIIIAAVTAAADKADATAKATDATVSYASGQPAVVPSKTGVALDPTKIVAPVTAALTSPERAAIIPVTVSQPKFTTEQAKATLPKGMISTFTTHFPANGGGRVSNIRLAARTLNNTYVAPGATFSLNGVLGKRTPEKGYVKGGVISEGRLSENYGGGISQVSTTLFNAAFFAGVKFEQYQAHGFYISRYPEGREATISFPYPDNRWTNTTDGGIVIRSSSSGGQITVSFYGTKKWDIVATKSPRRNVVTPKKITDPSPKCITQNPTPGFDVTVTRIFKQGGATLRTEAFNTHYNPEDDVTCTHPDAK
>fig|313589.5.peg.2253 Permease of the drug/metabolite transporter (DMT) superfamily
MYAGHAGPVPTRHRLLAMLVAVLWGVNFIAIHATLVQFPPFFAVALRWAPLAIAAVLFVPKPDVAWRWILLYGLGFGILQFTFLYWGMATGMPAGLASLVLQSSAPFTVVLGALLGEHLSPRRGLGVLIAVGGLAVVGSQRGDVSAVWPFVLTVLGGLGWAVGNLAVRRARATQPVRLTMWMSVVPPIPMFLLSLVVEGPTRIADSLTTLGTQVGLAAVLGLIYTSLIATVIGTGIWSWLMARHPAGTVAPFSMLVPVTGLTSAWLLLGERPSLVEWLGCAIVVVGVLLTAGGRHTPRPSPAASAPTVENATIRADASGQSRGKAAVTSSSRSLASRSAIVARTPSVP
>fig|313589.5.peg.2914 Tetracycline-resistance determinant tetV
MARPDSDTTSNTSPPASAEPTERKLPRALTPFRGAAYRRLAVALVFSTFATGVWAIAQVWEVVRIGGGASQLSVVATAAALGVIIPALLAGVVADRVPQKRILLVVAGVELLCMALVATLSLLDITQLWMLATVAFVNGMAMAFYYPAYTAWLPALVEPQDLMAVNGFEGMVRPTIGQAIGPAVAGAAIAAANPGTAIVIAACSVLLGLLALMSVPETPLRRQLDEGHAQHPIASAYSDMREGFSYMVRTPWLLATLLFASLMILVMMGPFEVLVPFLIKDRLGGGPREHAWVLAAFGVGGAIGSLAMASLRMPRRYLTWMNLLWGVGSLPLAVIGYAGHIWIVIAAAFVLGMTFSAPMVIWGTLLQRRVPPHLMGRVSSLDFFVSISLMPVSMALAGPVSHAIGIRPTFLIAGIVPGIIAVIAILCARLPADEIANPLRD
>fig|313589.5.peg.3713 Permease of the drug/metabolite transporter (DMT) superfamily
MSPAPRVPWQAKFMALVFIWGSSFLLMKVGLESLSAVQIAALRLVTGAATILVLLWIRGGSLPQERWVWKHLIVTGLLLGTLPFTLFALSETRVSSALAGIGNATTPIATVLATMAFLPGARATRPKVIAVVIGFIGVVTIMQPWASGRPDLVGFGMALAGGVCYGIGWTYNRRFLAGADLGGLSQPAATLLMGCVLMVPVILVWGALQPGGIGAIWAYDRARLGTSQIEAGSAGGGWIWLPLLCILALGIVGTGAAYILQFDVVRGAGPVIGSTITYLIPIVSVLLGVLVLGESLGLFEVIGFVIVLAAAAVINAPARRPRPRLRAPLGRSSVVAPDPETVPMGHEVEGVSQPRVP
>fig|313590.6.peg.744 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MEYRLTIVVPVYNEEDNLLRVESEFNAYFKTAKAKSKVLFVNDGSKDTSLDIIKDICTRSTDFEYIAFTENCGLSAAIKAGFDHADTELVGYIDSDLQTAPDDFNILIEEIGPYDLVTGVRADRQDSFVKNMSSKIANGIRRSFTHDGMDDTGCPLKIIKTNYAQRIPMFKGLHRFLPAMILLQEGKVKQVPVRHFPRVAGEAKFGVWNRLLGPLMDCFAYLWMKKKYINYKVGNSSRG
>fig|313590.6.peg.887 Permeases of the drug/metabolite transporter (DMT) superfamily
MSNNTTRHILEINLAMLFVSTSGVLGRYIDLPPAVTIGIRSFLAMLLLGLFVKWKGFSFTLARKDILAIALSGVFMGLHWITYFYSLQLSNVAIGMLSLFTYPVMTSLLEPVFLKTQFSKMHLLLGVLVLIGIYFLAPSFDTENDYFLAILIGLLSALCFAIRNLLVKTKIGSYNGSVVMWYQTLVIAIMLIPAYFIFDAEGFVKELPYIGMLALITTALGHTMFLFSIKRFSVTAASLMGSVQPIYGIILGIIFLNEIPGWRTVLGGSLILFSVVVESLRASRNK
>fig|313594.4.peg.960 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRILALIAVSIATLIYGITFTVAKEVMPLYIKPYAFILLRVSGGTLVFWTLGLFLKQQKIEKSDYQKIGVASFFGIALNMLTFFKGLSITTPISAAVMMVMAPIMVLLFSSILIKKAIGKQRIVGVFVGLIGALLLITFGSASEQSSTNNNWGNFLVFVNAASYGLYLVLAKQLLVKYHPVVFVKWLYLFGLLFVIPFGYAEFIEIAWSGIPKNSYWNIAFIVLLTSCVTYLFNLYGLSKLKPTTVGVFIYLQPVIAAIYALIVGSDSLNLVKISATLLIFLGVYLVTKQVEK
>fig|313595.4.peg.580 Ribosome protection-type tetracycline resistance related proteins, group 2
MKKPTINIGILAHVDAGKTTLTEQFLYNSGAIKILGSVDKGSTRTDSLDIEKERGISIKAATTSFEWKGVKINLIDTPGHVDFSSEVERVLCIVDTAVLVVSAVEGVQAHTLNIWDSLKELQIPTLIFINKIDRQGADAETTIAQLEHDLKAKPVVLFSSENEGLTNAAITSVFNTSTHTEIKEKTIEHLLECEEHLLERFLNSESITDDDYLQRIRRLTIDNMITPVYTGIAKKNIGVTELMDGIIDYCPTSKTTTTKELSAFVFKLEHHKIYGTMAHVKVFSGELSSKSTIYNHTQQLESKINQTKQLHHTKYTDNVILTAGNIGVITGVLGTKSGDVIGNPEGIPKLPQLHIPVLTVQVIPDNNTDYNALAEALQQLDREDPSLSFKWFKAEKELQLLLMGQMQIEILEYVLNTRFSIKASFTDPEVVYKETISSKAEGYIRYWMPKPCWAIMTFLIEPAPLNSGVRYRSIVSQNDVHIKYQNEIERSIPKALVQGILGWEVTDVKITLIKGEDHNVHSRPGDFNLATPMGIMQGLKIGGTHLLEPILSFEIKANEALLGKIVSELSTRRANFETPQFVDDTFRLRGTIPVATSLDFSIKLNAITSGKLRLKLQFYGYDTCPKGEGAIREYKGVNPLDEAQWILHRRGAYKADERII
>fig|313595.4.peg.858 Permease of the drug/metabolite transporter (DMT) superfamily
MNSILKGGLLVALGASCYGLLTTFVKLAYEEHYTPYEVTFAQLLIGFIALVILNLFLKKSEPPIKDSKLRRKTILYLILSGTSLGFTSIFYYLAIQYITVSVGIVLLMQSVWIGVVLDGIINKIKPTKRKIFSVILILIGTVLAADLLIEKQEIDFAGIGYGILAALSYTVTIMTSNSVGLQYHPITRSKWMMLGGLLVVSVITLPELINYMDFGIFIVWGPILALFGTILPPLFFTAGMPKINVGLGAIISSIELPVAVLMGYFVLQEEQNLYKWIGIALILSSIVLMNLRKVKKNPV
>fig|313595.4.peg.974 Nisin-resistance protein
MKNLKPLLIIVLFLFISCSSDDDSPETNIRVTNFINEVVDIMEVNSINRNTISWDDFRTRVLTRAQNVTGTDNPLRLALQLLEDNHSFIRKTNGTFISGSSIFCPPSDLSPVPTPDNVGYIKINSFSGNDQSESLAFAENIQNEIRVQDSENISGWIVDLRNNPGGNMWPMLAGVGPVLGEGIAGYFIGPDNESTPWSYANGAAILGQNTIANVTSAYTLLHSDSKVAVLLNRAVISSGEAIAISFIGRSNTETFGEATCGLSTANAGFSLSDGSTLFLTTAFMADRNQNVYGESILPDNVVSDGELIQAAIDYINN
>fig|313595.4.peg.3085 Acriflavin resistance protein
MNIAKFSIKKSRITLMALGTIILFGISIYSSLSRDSMPPYTVRVANIITEFPGASPERLELLVTDKVEKISQELPELKDVKSTSRTGLSVVTVTLKEEVSPEELQTVWNSLRRKLDGMEGLPNNVAPFLDDDGIGDVYGIVVGLVSDGFSYAKMKPYVDAIKNDFIRLPDAAKVVLGGVQEERVFIEFDNTRLKSYGLSTIKLQQIVQNTNILSSGGEVNLGNERIILEPTGNFETISDIKNMLVPINDKGSLVKLGDITTISKGYIDPSEQRVRINGNDAISLHINLKENSNIIELGNEVNSIIQKWQDKLPVGLEIQRVSSLDTYIDDKVSGFVINLLQSIGIVLLVMLVFLGFRTGLIIASLIPIVTIMTLLIMGLMNIGLNQVTLAALIMALGMLVDNAIVVAETVIVKMEEGLSAKKAAIDACSELFTPLLISTLTTSIAFLAFYLSPTNMGDIVGPIFIIVSIALLSSWVVALSVITTFCYLFLKVIPKKERKQSSIDKVINNLKKQYKNIIIKSLHHKWKVVSVIGIAFILSLVGFTQIPFLFFPDSDRNMITVDVNLPEGTKIEATTAVVKELEQYMKDSLQVNNKRSNGILDWSSYIGQGPESYDLGYAQDEANSNYAHIMVNTSSFEFNKKMIAKLDAFGYDNFANADIRVKALAAGGGTVPIEIKLIGENSDELAKIAAAVKTRLSKISGTKNVKDNWGPKTKKFIVQIDQNRALKAGVNNQDIAISLQTNLDGFQTGEYREDDKSIPILMRNEVNKKQTLTSLKTLNIYSQTTGKSVPLLQVAAILPQWQYASIRRYNLDKSISITSELREGGNAATITTEIASWLASQKENWPTDYTYEFGGDEKETNENMGSVISYLPLSGFIIVLLLIIQFNSFRKMTMVVSTIPLALIGVVIGLLIFREPFGFMPFLGTISLAGIVINNAIVLIDRMEIEQKNLNRRVEDAIITACLQRFRPILLATFTTVLGLIPLYLSGGELWEGMAISIMIGLLFGTVITLVFIPTLYSILFKVNYKDYTFDDRLLDD
>fig|313596.4.peg.915 Permease of the drug/metabolite transporter (DMT) superfamily
MYLMILAVIWGSSYILIKKALAGFSPLQLGSVRIAMAGGMLLLIGRRSLRTIGRHQWKWVALSGVVGSLVPMYLFAFAETEISSSVAAVLNSLVPLFTLFVGYFAFGIGFSRNQLLGVLVGFAGALLLIGIGSLAHPGRNYWYAGLVVLASLGYACNANIIKSKLSGISPMGIAVGNFVCILPVALVLTGLSGALSEPVRASAEFWPSVGYLFLLCAFGTCIAKVLFNHLIHISTPVFSVSVTYLIPVVGILWGLADGEAFGLKQVGAAGLILLGVYLVNKKKRLQVQAHKNRSGS
>fig|313596.4.peg.1376 MFS permease (drug)
MYENRWEVKLSLLLVSSLTIASMITISASLPDMSRDFSGYPNGQALVKLSLSLPALFIALTSLLAGGYIDRKGRKPLLGVALVAYALAGSSGYWLEDLYAILAGRALLGVCVGITMTIVTTLIADYYQGAARQRFAGTQIALMSLAGILFISLGGFLADIRWDVPFLLYLFSLLILPIALRFIREPEMLAEIIQKTPGGRAPREIWLVFGTVMLMWILFFIVPVQIPFYLKSLGVEQNALIGLAIASSTLFSAVASFFYARIKGRLSFARIFFAGFGLMAVAFLVVAFSGTYALVVVGMLLAGLGMGLLIPNANILVMQLAPPAVRGKQIGRLTTFWFLGQFISPLVLLPFIGLYSLETVFLGIGILTAALALLFLMSSPLWKKAG
>fig|313598.3.peg.2127 Permeases of the drug/metabolite transporter (DMT) superfamily
MDKSYIKQLSGLLLASFFISTSGVLGKHIAMPSEVIIWFRSILAMVFLFVFCRYKQINLTIKSTKDYKTFIIGGVLMAAHWVTYFYALKLSNVAIGILTLYTFPIIIALLEPLFFKIKFNPIYILLGFMVLLGLFILTPEFDLESSQLKGVLFGVFSAFCYAIRILIMKKHVANYNGTMLMFYQTVIITILLFPVLFFMDLSGLESQLPYILLLALITTAIGHSLMLHSLKFFSAATASIISSLQPIFGIGLAYLFLEEIPTVHTFWGGSLILATVIIESLRSKK
>fig|313603.4.peg.48 Glyoxalase/bleomycin resistance protein/dioxygenase
MIGNKIKGLGEIILRVNDMELMRKFYIETIGLELIHESQCYTFFKVADGYAGHHQTIAIFAKNNRTAFDEILSTIDVKKSTLHHFALEIDKVDYDNILTFCNRQKIEHVTEVFEWVKWKSIFIKDPESNIIEFVCYDDNI
>fig|313603.4.peg.879 MCBG protein-like (microcin resistance protein)
MNKPFIADQTFKGQDFTKDRLQKGEYENCIFEGCDFSNGFLDNQNFIECDFVDCNLSNTNTAHSIFNEVTFSHCKIMGLKFEECNDFLMAFSFIDCVLNFSSFYQLKLKGIRFSDCKLIEVDFTESDLTDAVFDSCDLGKAIFNLSILEKTDFETSYNFQIDPEQNRLKKAKFSKDNILGLLGKYDLNISN
>fig|313603.4.peg.1509 Permease of the drug/metabolite transporter (DMT) superfamily
MGFSALQLGSLRIVFASTLLLIIGYRSLKSISIRDWKWILMAGLLSSFFPPFLFALAQTQLDSGVTSIFNSAVPLFTTIVGIILFGAIITKRQIAGVLIGLFGTLSLILAGMEFNPDKNYWYSIFILLSALGYALNINIIKKHLGHLSPLAVTTGSFAVAFIPAIVIVVYSGVFSQIGEDLQMQNSLWYLLALAFLGTAVANIYFNKLIHLSSPVFAASVTYTIPIVAVLWGVWDGETINLYQLIGGGIILFGVYLVNRKKRPSV
>fig|313603.4.peg.1889 Permease of the drug/metabolite transporter (DMT) superfamily
MTKKVSVTGGGVLFAIVGVVLFSAKAVMVKMAYEYNIDHLSLLLFRMIFAFPFYLVIAFWKRPLHPKEIGKRDYLWVVFFGFIGYYLASLFDFMGLQYLKAGLERIILFIYPTIVVLLSWIIFKNRITRLQALAIAVTYIGVLITFWNEVGISGDSIVFGAFLIFLSAFTYASYLVGSGWLIPKFGAVQFTAYAMIVSTICVVLHYVFVNGFYLANYPNEVYLLGFMMAIFSTLIPSFLVSAAINRLGASTFSIFGSLGPVSTIVLAFFFLGEQISQLQFFGMLVVICGVILVSRKKA
>fig|313603.4.peg.2587 Glyoxalase/bleomycin resistance protein/dioxygenase
MKGFLHQIHPVLPVKDVVEALDFYVNRLGFKIAFADDSKKPTYAGIIRDGIEIHLQWHDSSEWDKKVDRPMLRIVTQNIESLYNEYAKKDVFHAHTLLRETAWGTREFAFFDPFKNGLTFYRDI
>fig|314225.8.peg.75 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSENAKLTRGSIPGHLVSQTLPMIIGVAAIMSIGLVDAYFIGQLGSEQLAAISFIFPITVAITSLGVGIMVGINSVVARALGEGDDDMAARRANFGIVFAIGCGLVFAISLFVLLDPLFRLMNAEDALLPFIQTYMRPYLMGFPLLLAIMGFNGVLRGQGEARKTSYVSLTYAAANWVLDPLLITGAFGFEGFGIAGAAYATVIGWLLGVGMAWWLMRGTPLPVDFGLLRRCSLTEPMKAITRVAGPAAFSNAINPIGLSVLTALVAVEGQAAVAGFGAAGRLQSFAVVPLLGLSGSIGAIVGQNWGAHQRDRAKQATLYAGGFCIVWGLSIAVALFAAGEWFAGFFTDDPAVVDEFARYLTIAAWGYAGYGLLIVGNGILNAVDRAGWALAQSCFRVFAVMVPFAWLLRGSWGSDAIYGAELAANLVGGAVAMALVWWILNRKPAGQTA
>fig|314225.8.peg.1667 Permease of the drug/metabolite transporter (DMT) superfamily
MNAKSLAIMLFCNCAWAFNTIVSKWAVDDLAVPPLFYTVLRSLLVAVVLIPFLRRIPPDPVRVLLVGLSISGGSFALLYIGLQTASPSAAGIVSLAGAPLTVIFAMFILGEKVRWRRGIGIALAFAGVAIAIGSPSGSESGIGLLFIILSVLVGAVGSVFFKKITIGSVEMQAWAAVISIVVVAPLSFGSETGQVAAVRAEPLLVGLCVLFAGLVVSVVAHSAYFKLLQEHDANLLVPLTLINPLLTIALGAWLTGDPIGWPLLIGAAIAMAGVAIILVRPSGTIFKPLLVRPRL
>fig|314225.8.peg.2884 Probable multidrug resistance protein norM
MYAIGVARQSQSVHNIGVRTGLICHMARLISIRAGCMHEMAPEVDTADSWRAEIAATFRLAWPLALANLLQMLIWAIDVFFVARLGEFELAASSLAVSLFSILGWATITLVSMVSALIAAELGRSRYAIAEVRRSVRMGVWLCVICGVLVMLILSQAEAILLASGQRAELAARAYDYMGIVLWAMIPLLVASVLRSFVSALGRPIFATAITALAIGVNALGNYALVFGNLGAPALGLEGSAIATVVTSIFIVLAYVVAIQQDRRLRRYAIWGRFWRPEWDRLRDLVVLGTPVFFTTIAEAGLFGGAALLMGLIGESELAGHTIALQIAAFAFQVPFGVSQAATIRVGYFYGARDHEAIKRAGAVALLIAVAFMAFTASVMLLMPEAILGLYIDTSKSVNAAMMAFALQYIVIAALFQLVDGLQVVAAGALRGLQDTRVPMVMAIFSYWVPGFGTSYYLGFYTPLKGTGVWIGFAVGLTFATVLLTGRWLMRERLGLAHRPARKPGAKPPAA
>fig|314225.8.peg.3004 Outer membrane component of tripartite multidrug resistance system
MRKTLTLLAPMALLAGCMSGPDYAGPPQLATAAGNAFVRAGPEIDPLAPIAGDWWTLLGDPVLNELEARAQVGNPGVAAARARIEQARASVRQERANRLPAVAAQATAVQANIPGLDIGSGPPPGSPGAPADTEEQDSLSVYNVGLNANWEIDFAGGQARRVEAINAQAAASVANAEDAKVQLAAEVARAYVSLREAQGRLELVQRERDLQQQILELTYQRYTQGALALFPVGDANAELELLKSQIAEAQADIDVFKDTLAVLTGEAPGALDGLLAAQAEIPLPPERVAVGDPAALIARRPDVRAAERMLAAANARIGVAEAARFPKISFMGILGLGGSEPDDILDPGNLSAIALPRLQWNLLDFGRTAASIDQAESARDEAEARYLEVVLGALRDAEQSLARFGQQRANVAALAQISRQADTAAELNEQRRAAGVISQGELNTSIRKREQARANLDRAIAAMTNGWIAIQKSLGLGWVELSRDNRTSVEPAPVDRKSVMKPEQS
>fig|314230.4.peg.298 Tetracycline resistance protein
MSSAPADKIETTSRGSLAVVFLTVFIDLLGFGIVLPLLPIYAAQFGVDEHGIELGLLMASFSAMQFLFAPLWGLLSDRIGRRPVIMIGLSGSVIFYAIFGIATEWQCIWLLFVARIGAGIAGATISTAQAYIADTTSLENRSKGMALIGMAFGLGFTFGPLLGFLAAPSGEGDPGPWPGYVAAILSAGALILAWFKLPESMPRDSAVRSSNTHRGLSLGSLRTALGTKSIRGLLIAFFVCVFSFANFETTLGMMIHGSRLPGSPFHFSFRAVCLTFAFIGATLAIVQGGIVRRLAGRVSEGTLAATGGIAQIIGFLLIAAAVNTGSTGVLFLALAIIVGGFAFVTPSLNSLLSRRSDPEKQGEILGLAQSVNSMARIVGSGLGIPLLMISMTLPAYVAAGLMAVGVVLVIAAARGGSDFETETPSEAAETETI
>fig|314230.4.peg.842 Daunorubicin resistance ABC transporter ATPase subunit
MAAISIENVSYSYGARRALNDLSLQIEAGEIFVFLGPNGGGKTTLFRLLSTLAPLQAGKIDLLGFDLASQRDQVRRRIGVVFQSPSLDKKLTVAENMRQQSALYGLSGAAAREAEDRMMRRLGVIDRAGDLAEQLSGGLRRRVELAKGMIHRPQLLLLDEPSTGLDPGARSSLWEYLQRIRTEQGVTIVLTTHLLEEAEKADRIAILDEGTLVALDRPAALKASVGGDSVTITTRGDVEALAGQLRQIVTEEVRVMESAVRFESADASQLAPRIMQSLGDQIESITFGKPTLEDVFIDKTGRQYWREEASDGK
>fig|314230.4.peg.975 
MIYVIATIELEPGSREQFLAAFHALVPLVHAEQGCLEYGPAIDVATGLGPQLPLRSNVVTVMEKWESIEALKTHLIAPHMDEYRTKVSDIVLGMQLQVVEPA
>fig|314230.4.peg.1943 Permease of the drug/metabolite transporter (DMT) superfamily
MRPTDYAKLTVLAAIWGGSFLLMRIMAPALGPFGLASSRLLIAGIVLVTFFTARGLEIEWRRNWRQYTVIALLNAAIPFTMFGFAALYIPAGYSAVINATTPIFGVAWSALVFGERPTWMMVVGAILGLLGVGVIAGLGPVAPSWELLAGSGACLTAAVCYSAAGVYIKTHTGRLKPMAVASAAQLIAGTLLIPGMAFYHPTPALITPLVIACTITLALLCSAVGFVLYYQLLADCGPTKALSVTYVVPVFGVLWGALFLGETITPLMIGGMALVIGGTFLLVRRH
>fig|314230.4.peg.2485 Inner membrane component of tripartite multidrug resistance system
MIGALRFFLLGAKTDVPRAAASATMFRSVNPWVIAAIVVIPTFMEVLDTTIANVALRYIAGGLSAAVIDSEWVITSYLAANATILPISGWLSSRLGRRNYFIGSIVVFTFASALCGFATSLEQLICFRILQGLAGGGLQPSSQGVLLDAFPQEKQGSAMTVFGVAALIAPVIGPTLGGYLTVNFDWRWIFYINIPIGAFAALAAWTVLEDPPYLKLETAEHRKAGWRLDGIGLGVLAITVSAWEVLMSKGQEWDWFGDPFWRVQTLAIAFAVGLAFLFWYEMRIADPVVNFRPLAERNFLISTLVIFSSFGVLYAASTTLPNLLQTLFGYDAFASGLVLSPSGIFAVATILIVGPLITRGWDARIFVACGLVLIALGCYWMSLMTLAIGPWQAVWPRVVMIIGLSMIFAPLNVAAFLYIPRNLRGAAVGLFALLRNEGGSVGTSVAQTIEVRREQFHTSRIGEFLDPLNPAVNQYLNDAHAYFYRLCGDSALADKMALQTLSNERARQAASLAYFDDFFIFAVVALLLIGLVLLMKRSVAAKSHLPGAE
>fig|314230.4.peg.2486 Membrane fusion component of tripartite multidrug resistance system
MRSVAIATALIVCAWLGGPWILRSLKTVSTDDAYVDGHVTFVAPRVSGQVLNVLVDDNVRVQKGDLLLQIDPEPYETDVALKEAQVRVAEANLSTAEAQVEGIVAQTRSNRFALEHAMESVRNQIAVLRSNVAQAKVEEASLVLAQRNFDRNRKLATDNVIAQSEFDVYTAQLAEAESRVDSAKEVVQQTRSALGLPINEANPLDMPADLDQNFSVVRETLANLMQSIAEIGYRPKSWDLTPNQAIDDFFHLNVSGDLDTIYKQLIADAPAIKQAAAALLQAQRQLDLAKLNLRYCNIVSDIDGVVTRRNVNPGNFVQSGESVLAVRSLTEIWVNANFKETQLNNLRIGQRVDLHVDMYGRERQFHGRISGFTMGTGQTLELLPPQNATGNFVKIVQRLPVRIDLLEYDPDEAPLFAGLSVTPYVFYQEPASGPNAGKLLQTPAELPVRKRESPHAETRTALCTGEVQ
>fig|314230.4.peg.2833 Permease, MDR related, probably tetracycline resistance protein
MLAGADKRDLNSHNHSQFETPTGLTPIIARFYLYSIFKNLRFSDPFLILYFLDLRLSYTEIGLLMGFQHLITVLLEFPSGILADSWGRRRATALCFVFYTLSFIGLGATDLRGVIPLFAWLSGCLTFFGLGEAMRTGSHKAIMLDYLDSTSQAELATQLIGRTRAASKYSSGAAAICGGILLTATRDYSWLFYLSAAAAICGFFLMLTYPRELEGDAFRARQSQADKGEPKVEGFRSMWRQSGFLAILVQSILFESQTKIALKYFTQPFLKVGLQLFGVAIVAPLGVSGIAASGALWVGLSEFVRDGLGGFGARLSATYEQWAGNRFFALNQIFTCGFVAVTCLAFCNWNLQWGLFPGLLLLFGLTILQNMRRPIFVSTLNTKMPKTRRASVLSLESFIRAVTVAALLPVIGIAADAFGLVAVWAICAVILSFGFIFRLDANSLATPTDEPHA
>fig|314230.4.peg.4237 Probable multidrug resistance protein
MRDLVRWAIRNTPAMNTIMISVIGVGVLSFFMLRRETFPEFELEIVLVTVPYPGASPEEVESGICEKIEEAVKDTVGIKKMTSVANNDYGAVILELNADVDAQRVLNEVRGDVERIPSFPLLAEDPEVQQITLRESAITVGVLAPDVEHPSAEMEWRLRDLAEEIRVELLALPNVSQAEVSGAKDYQIDIEIEEDTLRRFGLTLKQVSEIVRDENLEMPGGLIRTASQEVLVRGNNKRDIGREIAKLPLIKTQDGVVLTVGDLAVVRDDFDDVTSFQRVDGRPAIAISVNRTSKEDLIVITDEVKNFVKEHGDLIPEGYSMVTWGDQSEEVRDRLNTLTTNGWQGLVLVLIILALFMNTRLAFWVSMGIPISMLGACAILLYCGQTLNMLTMFSFLMALGIVVDDAIVIGENIYAHREMGKSFHRAAVDGTAEVLPSVVMSIATTILAFVPMFFVAGVMGKFMAVMPLAMIAILVISLLEAAFILPCHLAHGDDSDDLINNAIDFFAYPFRPIGAAFNRVGDWTSARLDWVIENAYQPGLKYSLGNPFTIFTLAVCIMAISIAVVWAGFVPLNLFPSMDSKTIVANVGFPDGTPAVLADEATQKIEAAIRAVNAKHEENGETVVELIRRNVGFAQMRQGPGQTSDQFGSHLGAVVVRLTSPGLRTVSSSQLIEEWRDATGPIVGSDVLVFDSQDIGPGGKQIEFKLLTNPKNMARLEAAVEDAKDELAKSAGVYDIEDDSSPGKMELRLRLKENAQAMNVTERDLAETIRATYYGDEVMRLQRGRHEVKLMVRYPREDRRSLAEFDQIRVRTGDGSERPITELAHVEIVRPLSEINRLDQKRSITVSANVNQRVANSNAIIENLKTEYVPKMMEKFPGVTIRWEGQKEQQSESLGSLFIGTGVALAAMFVLLTIEFNSYFQPLIVMIAIPFGLIGAVVGHLLLGLELTLFSFFGLVALCGVVVNDSIVLVDFINHRLKDGLPIYEALLDTGRRRFRPVLLTSITTIAGLTPLLFETSLQAQVLIPMAVSLCFGLMASTFLVLYLVPVLYLIYAILGGQVSKHDEIETTEERREIEKQELVTSEVS
>fig|314232.4.peg.914 Probable multidrug resistance protein norM
MATTPIIATARTEVAPLLHLALPIVAGLAASTLIGVVDTIMIAPLGTLPLAAASLTTAAMIIFYSAIYGFVSAVGIEAAHRHGGAQADAVAAALRAGLGLAPLAGLVASLLMVLILLILPLIGQPPEVLAIITPYWLAMAAVLVPVALLMVIAQVLNAMDRPWTAAGFAFLAVILNIPLNYGLIWGIGNWPGLGLVGAGLASLIAETLALLIAITWLARHRLLRAQPDAALRKRLAWGGLPLAIGYTGEGAAFAVVGLMLGIFGATALAANQIVQAVGGVLYMLPLGMAAAVAIRIGQASGSGDPARLRPIAVAAIGVVTVWMVAVTIMLILLGGRIAAALSDDSGVVALATAMFVIVALIQVADGVQSTALGALRGIMDFVWPTRLTLLSYWLFALPLAAALGFWAGFGPLGVWAGYGVGIALVAIILPARFWWLTAAANR
>fig|314232.4.peg.2637 Permease of the drug/metabolite transporter (DMT) superfamily
MPQQPTPLNWISIALLGLIWGATFMVVATALEGYGPLTVACARTTLGAGAMLALMVVLRRPLPDFTPQMRAYLLAIGIFNTAVPFALLSWGQQYVPSAFAGISMAALPLFVLPLAHLFSDEKLRLRSALGVVIGFCGAVVLIGPGVLRIGTGWEPLGQLACLAAAMSYAVSSVMTRRCPPIDPITMTALLLSVGAAALIPAMLIVEGIPGAAAPRPMLAIVFLGVIPTALAAVLRVATIRSAGAVFMTLVNYQVPVWSMLFGVLVLNEVLPLRFFAALALILLGLAISQWAGLKRLFAAARASGGDT
>fig|314254.5.peg.779 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTDHPHAAFLTGGLPSLYVKTALPIIILMVMSGLLNVTDAWFLGVFSGEQALAAVTVSFPIFMLLSALGMLVASGMSSLLARALGQGDRSGAESVFASAHALSLAISLVLVLLYVLLGGPVLTRLSLGDEALAAEAARYIGVLIWGAPIALILSVQADGLRNEGQAGFMALAGLGVTLANIAFNAVLIIALQMGAAGAAIGTVLAQGVSVVIILAWRVRHPLLMSASFSGWFRTRKGWAHILALGAPPALGLFGVALGSLTVLSVLQLSKAEDYQGIVAAYGVATRVMTFAILPVIGLSQALQTVTGINHGAGLTGRVRDSLRFALLTALCYGVVVEGSVLLFAPQIGGFFVSGEALAPQIAFILRRLMALFALGAPLFLLGLYFQAQGDAVRAAILGLAKPYLLFIPLVIGLGLGLGSDAIWWASPLADIGVLALAIIVFASRRAVPARG
>fig|314254.5.peg.2276 Permease of the drug/metabolite transporter (DMT) superfamily
MTPDSPGPKGWGALGLLALVWGSAFAFIAVAVDTLPPSIIVLGRLSLAAVILTGWAFYRRRRFPPLKDVRWLWFLALGFLGNALPFTLIAIGQKTVPSGIAGILMGMMPLTVIAAAHFILPNERLSLRKASGFLIGFSGIVILMGPAALKGMLEADFLAQLLIFIATLSYAANAVTYQASPETPPSVIAAGSMICAALLSLPVALYDIVAGPAITPSLPSIMAVLALGLLPTALATIVYMGVARKVGASFIALINYMVPVVATVIGLARGEPMTLTTMIALGVILLGVYVARRKPRVAP
>fig|314254.5.peg.2383 Multidrug resistance protein 2
MRRRAFRLLFLCLIATSIGNSMLFAILPPLARELQVDEIFVGAIYTLSALLFLIMSPVWGALSDRYGRRPLIVFGLSAFAGSCLVFAAGAWAGQVGLLPPMAAIIAMALARSIFGGLGSATNPSAQAYVADRTEPSQRTRALSSLTAAFGLGTVIGPALAGFFSHRIGISTFMVLVAIMVGIAAVCVRLFLPEQTPPQKKGRPINPLVQFRFAGDPRLTAFMIYGCAMWMAQAASLQSLSFYIMDRLGMDAAGGLQLGSIALTMGAAGLIFAQLVVIPVLNTSPRVLMIIGAVMVVLGNATMIFAPNYVVIVIGYMFNSFGFGLARSGFTAGASLAVEPEEQGRAAGLTTATAGVGFMIAPITGLWLYQSVAPAAPFELNASLAVIGCALALLHPRVRETTAALVPNVEDTPPA
>fig|314260.5.peg.230 Acriflavin resistance protein
MNGFVAWWARNSVAANLLMVLILVAGMATFLFQIEREVFPTASLDQVNVSVSWPGASPRDVEEQIVLRIEEAVSGLDNVKEISAQAREGSAQVTVEMEDGADYDSFLNLVKARVDGVSNLPPSSFPPVVSRPTADTPITFVSVTGDPAQISEVELNRLARRYRDELAQIPFSSPLIEVQGYQEEEVAVEITESALRRYGLTFDEVAAAIGSTSVNRSMGEIRTTTGNIPIATRQLADTADEFEALVIRRNQDGSVVRVGDVATVTDGFAERNSIFRIDGKPARLIEVLQPETVNIVNTSRAISDWIDEKQSSLPPGVELKEQYTLAELYFGRMKLVSENAVAGLILVLIILFLFLRPTVAIWVSAGIGISFIGTFIFLPMVDVSLNMLSLFAMLLVIGIVVDDALVVGESIHRQTEIGKQGLDAAVLGTQIVLKPVVFAVLTTMIAFSPFLLIGGVWGDFTKHIAWTIILALTFSLIESFLILPAHLAHLSKPKSGGLLSFQGKIADALVTFGDMIYRPVLQLALASRYVTVAIFLGLFAVSVALLQLGYVKFQFQPDVEQRLIMLTVDMQSATPMSRTEQVLEQVETAIEQLDQELLDRNGQDTVLSATVAAWPGWINVTLIMSPSDARDQTLGTISERLRTLIGPVPDSEDISLSTNFANDGGDRFIVGLQSADIDELSAAVTEVKAFIGQFGELYDVGDSLQSAQDELVFELKPGAERFGLSIGEVSRQVRQAFYGEEAQRLPRNGQDVRVMVRYPLETRENFESLSSMRIRLADGREIPLSAVADYRYGPAVRRIDRVDRERSVRVWSRVREGADAGPIRADFYSTFVPQLLAKYPSVEIKRRGNDEEQREFQQNVTVLYGLALFCMYMLLAIAFSSYFQPLMIMSAIPFGFMGALFGHLLLGENFAMFSIFGICAAGGVVVNDNLVLVDYVNRLRREGVGAAAALVEAGVVRFRPILLTSVTTFVGLVPILLEDSYDAKFLRPMVIALAFGVLFALFVTLIFVPALYAVGVDIARFYRGLWTGEDQPRLGHEGGLSGPTPHHPEIDDDRLHPAE
>fig|314260.5.peg.285 Permease of the drug/metabolite transporter (DMT) superfamily
MRIEHPAAGLWPSLALASVAALWGATFLLTQMGMDGAGPFSIVALRFGAAALILAALRPQQIRRITFYELKAGILLAAVALVGYGAQAVALQTAPSARVAFLAALYVPIVPVIGLVVWRRPVAAPVFIGALLALGGIVAMSHGGAHLGLSATDGLAALSAVSIAAEVFLLGLVMRRADPLRVSFVLVLAIALMAGGVASLSGEAAPRWDGSLLTVVAIFGIGTAYSQTIMGWGQARISPERASLLYATEPLWAGALGLAVGEALGTGDIVGGALIVMAVGISAMRRLPALPLPLRRSLRANRQSLLETGNGAR
>fig|314260.5.peg.770 Glyoxalase/bleomycin resistance protein/dioxygenase
MLFTHAIVGSSDLDRSKTFYDAALGALGLDPVLAGDRVVYVRDNVAFGFGPPRNGEAPNPGNGLTISFAAPSKEAVDAFHEAGQSAGGTDEGAPGLRPNAPGRAYGAYLRDPDGNKICAFAQLGDDEEG
>fig|314260.5.peg.2415 Permease of the drug/metabolite transporter (DMT) superfamily
MILGGSAFSGIRAALLSAAPLTVAAGRLWVAAFAMAIIMRVAGERWPALIDQGRLNPLWGSAIAIGLIGYSMPMTMFPLAQLTVPSLLAGIYMAFMPIATVILAAAYADEPLTRGKMIGTALGFAGALTLIGPAAFRNILAADVVAQLMLLAATLGYAIAAVLLRRAAPLAALSFTSMMLIAGALGASLPAILIERGDGLPTLQGAAAIVYLGLFPTALNGLIITLMVRSAGAGFLGLANYFTPFAAIGFGLVLFNEALLANHLAGLFLALAGVFVAQPRPLLTLFKWLQDRRGV
>fig|314260.5.peg.2651 Permease of the drug/metabolite transporter (DMT) superfamily
MTPFRGAVLLMVCTLWGLHIVVVRATVDDVPALLYVALRMSLVAVLLIPFLRWHKGRMRPILVAGLCFGGFNYAFLFNGLRFVPAGVGALLVELYVPIAMGLSILLLGERVGWRRGTGAALAVLGAVIIVTGEGEAMSGATNLPLGAVLLIAGAFCEALGAILIKRVHGVSALQLLAWFGVVGGVVSWGLTIVLIGDQVPDAIPNLATGGFVSALIYSAIGASIMGHASYYWLLQRVDVTVLAPSGVLTTVIAVTAGTLFLDEPLTARLIVGGALTLLGVGIIAIRSAKKATTEASLPVGGPEGVRIQEPSHVRSD
>fig|314262.3.peg.2472 Permease of the drug/metabolite transporter (DMT) superfamily
MSITSLNTFSGLAWAVVAITVWSGSLVMLRLGVTTSLNAYDLTMLRFGVAALILAPVALRRGTGTDRLGLIGLVAMVVMFGAPYVLLISLAMKTAPAAAAGALNPGVMAIVSVLLGRAIFGDRIGAARFTGLLVTATGIVLFTRSGGAITTGHLILIGTGTMWASYTLIVRCAAVPALNATAIVAVGSAVFYLPVYLAALPKQILAAPIADVLMQAGFQGVLVSVVAIYAFNRSAELLGPVAGATLPALIPVVTLGLGILVLGETTGSGEIVSAILVTLGLALILVGRPAMRWFSNHILRGLKSRGHSLGQ
>fig|314262.3.peg.4268 Permease of the drug/metabolite transporter (DMT) superfamily
MTTAPGASNWIKLIILGLIWGSSFMAVTIALNGLGPVSIAAARITLGAVSLLIMISLMGIRLPSLQNRIGRQVWLCALGMGFFTNALPFSLLSWGQTYVASGFAGVCMAVVPLFVLPLAHFMVPGERMTLHRTLGFTIGFGGVLTLIGLKAFASAGSDFESLARLACLAAALCYAIGSIITRLCPSVNMLSLSAAALSCGAVMIIPTALWQEGLPSLPEGRSLLAVLYLGLVPTALAQVMLVQVARSAGPSFLSTVNYQVPVWSVFFGALLLDETLPPQLFAALVLILGGLLLSRAPAHRQRP
>fig|314264.3.peg.68 Permease of the drug/metabolite transporter
MILRRPFPRGWRTWLTLGIVGIGATSLGFLGMFHAAEFVSPGLATVIANAQPLLATILGVAWLGERLPKVGRVGLSIGFMGILVIALPHLLDGGQEGSAIGFAYIVLAAVGVTISNVAIKSVAGKVDGLFAMGLQLLIGSVPLGLAALAVEDQNAIQWNAVFTASLLGLALFGSALVYWLWFSVLEAVELNRAIVFSFLVPIFGLSIGALFFGERLSGIQFSGIALVILGIVFVNFKGARRSQGR
>fig|314264.3.peg.2748 Permeases of the drug/metabolite transporter (DMT) superfamily precursor
MATLSAHPTPAPSRALQGILCVEIAMLLFVGQDAMMKTLLTLYPVWLLIFVRSIVTLLVMTPLILILGAPHRLLTPLWPLHLLRAFLFATGFSMFYAAFPFMGLAEVSTIFFSAPLITALFASVFLRETIGPHRCAALVVGFIGVLIAMNPAGENFSWVAILPLLCAVTYAISQIIARQIGDRESTLTVGLYTLTFAGLLILPMGWLVNQVIEITPATHHLRWELPPEAFGDLPRLALLGVIGMAAYSLVSRAYQIANASLVAPFDYTYLPFAAILAYVLWDEVPALNVLAGMTLIIASGLYLGWRELRAARHSDEVPVTAEAIFAPGSPLPPQIPEEESAK
>fig|314264.3.peg.3052 Multidrug resistance protein B
MSQIDRYFERYGPAYKWLATGSIMVATISVVLSTTIVNVAIPAVMGAFGISAVQAQWISTGFLAAMTATMLLADWANRAFGMRLTMITAMGVFLAGSVLGGLAPNETVLTLARVVQGAAAGIVQPLAMIMLFKVFPPDKRGAAMGIYGVGVVLAPALGPWIGGVLMDAFDWRFVFYLGLPFAGLAILLANLFLPTREESGPIPAFDFVGVAILSIFLAVLLSTLSNAQRLGWDTNIILSGFTISGASAIAFITWEMHTDRPMLDMRLFANFAFSSASVVAFIMGAGLFGSTYLLPVFVQQIQGMTPTQAGLLLMPSGFAMLVVFPIAGRLSDKVPPPVLIGSGMLVFAWSSWLMAEANVHTAFWALAWWTVLSRVGLGLVFPAISSGALKVLPPHLIGQGSGASNFIRQLGGAFGVNLLTVFIERRTIMHADAFAATQTSDNAATMEFLREVAGLMHSSGLPDTQIMPAAASFLGQVVVIQSSNAAFHDSFLVVCGIFLLALVPTWFMWHAPSPAA
>fig|314264.3.peg.3118 Multidrug resistance ABC transporter ATP-binding and permease protein
MTKAPVALSITTGACGAEAKGPPPPRFGERAVARAKLGVAYGALLGVEAVERDILEAMIASKAGGGPADQPQPRALADGLEAAGLMARVEPVAHPHPDHWPALAQMTSGQFVLVLSQAGSVLTIHDTTCADQRAEVPLAEFEPFFTGLVVRAEAPVQSLSRAHDAPEAAPHWFWGQFGGFRRHIAEVALGSFVANILAVAVALFALQVYDRVIPHQSEATLWVLAAGAGLALVMEAALKIARAQLMDGAGRQIELNVQRLLMDRILGMRSEIAGKGPSQIFSAMREFGSVREFFTASTIGTLTDLPFIVVFLALVASIAGNVVWVLILGGVIMVIPGFLLQRRMMRLTQEMQGAGARGARLLHEAIFELDTLKTQRAEDRFRRIWGELTALQAIKSSEQRRLGSVLTFWAQAVQQATYIAAVILGSYLVFAGEFTVGSIIAVGILTSRTLGPLTQLSGTLARWGNVKSALAGLDAIALAGQDAAEGRSYLRRTSLSGAYELREVQFAYDAGGAPVLDIPGLIIQPGQVVAVLGTNGSGKSTFLKLLSGLYAPSRGRLMLDGTDMGQIAPRDLRRMIGYLGQDVRLFTGSLRENLNLTLLERDDARLMQALEFAGLGPFVRGHPKGLDLEILDGGQGLSQGQRQSIGWARLWLQDPAVCLLDEPTAALDQTLERTLVSRLDIWLKGRTAVIATHRMPILSLTSRTLILQAGRMAVDGPRDQVLAHLAQAAGTGPGGA
>fig|314266.4.peg.22 Drug resistance transporter, Bcr/CflA subfamily
MAMNALSIDPMLPALPAIGRDLAIPQPNDRQLIISVYFMGLGIGSLLFGVLSDRFGRKMVLGSAMAMFIASSVLCASAQSFVMMLAGRGFAGFFAGASRVITVSIIRDRFRGDAMARVMSLIFAVFMLIPVIAPSFGQAILWVAPWRWIFWVLVILASLILVWMLARMPETLAMENRTRITVGGLMATIGVVLRTRSSIGYMLASGVVMGGLIGFILSVQQIFFDVFDAATIFPIGFATIAGCMGVGSLINSRLVQRFGARRMSQTALIAFCLIAAIHLAVILKGWETLATFVALQSLTMLTVAFTAANFSAISMEPFHKGAGVASSFQAFLTTAVSAALGSLVGRAFDGTTLPFTLGLLVFGVLSFLIVVWAERGKLFTRPNLAALRDPVESVGR
>fig|314266.4.peg.1561 Permease of the drug/metabolite transporter (DMT) superfamily
MEDFNAFVDGLSGAVFFKLPLLGTQIELIVLYLALPMLFFTLWLGFPNVTQVGRAIHILRTQPHEGEAKGDVSQWGALSTALSGTIGLGNIAGVAVALTMGGPGAILWMFIIGWFAMTVKMAEVTLGLKYRVFDDRGHVHGGPMYVLKAVGAARGWPRLGLALGGAYAFFALFGAIPMVQVNQSFAQVQVVTGMTNGWAYGVFIAGAVALVTLGGAAWLGEVSKRLTPLKVAVYLGGVFAILILHVADIPAALALIWNGAWSGDAATGGAVGAFVAGMRRAVFASEAGVGSAVMAHSLARTQHPVSEGLVALLEPLLGTMIVCALGGLALVVAGTWNGGLEGIAITSAAFAQVSPWFPWLLAVVVFLFAYSTLVAWGFYGLQAWGYLFGNGPRAQWTYKILYIVALPPAAAIDLGRVVGIVDSSFFLMAIPNVIALYLCAGELRRDVKDYLVKSKS
>fig|314266.4.peg.2035 Glyoxalase/bleomycin resistance protein/dioxygenase
MPGSPVIPCLRYADAPAAIAFLCDAFGFERHVIYADDLDNSIIHHAQLTLGEGMLMLGSVRDGESESLYTWSTVRDLGGTTACVYMVVEDVDAHCLHARNEGAVVVDEPHDNPGYPGRGYTALDPEGNVWSFGSFDPWAPLQGGGD
>fig|314266.4.peg.2208 Permease of the drug/metabolite transporter (DMT) superfamily
MMFAGLLGTAQFMLNFNFVYRAEQHLTSGVVAVIYAMLLIPNSLLAYVTFRQPVTRGFVLGSAIAMTGIVMMLVHEYRAADVAPDTVLLGAAFSILGLLSASVANVMQGTDIARRLPMMAVLAWAMLIGAVVDAGFAWATAGPPVIELRLGYLAGIAYLGIAGSVVTFPLYFRLIQTIGAGRAAYTAVLIPVIAMLISTLLEGYRWTGFAAPGAVLAVAGMVVAMRSKNP
>fig|314266.4.peg.2506 Permease of the drug/metabolite transporter (DMT) superfamily
MIGLVASLLFVLIWSTGFIVARAVVPHGAPELVLAIRLGATTCLLTGAAAFAGQSWPRGRRLGLHLTAGAMLHGLYLTVSWWSVSRGMPAGIMSLLGATQPLMVAVASVALLGDRLPGRSWLGLFIAITGVVCVLMPAIESSGTTAVPVIPVLAGIFAIIAMTGGTLIQRGQIASDPILMSGAAQNLGGTIVAVSATLIVGEWRWDNDPILWIGLGWSVLGLSAGGLSLLVWLVRHQGPTAMSMLLLLVPPLAAIEAWALFGEQLGPVQLIGFALALGGVLLGRSQGRAKGRDAAAELVEPA
>fig|314267.3.peg.345 Drug resistance transporter, Bcr/CflA family protein
MSQISLSSSRAFAVTATLGLLSLFPPLATDMYLAALGDLATSMDATHTAAELSLSLFFLGLCFGQIMIGPLTDTYGRKGPLLIGTVLFTVTSVVLPLLSDIAWFNALRFIQAIGASAGMVVGRAMVKDLYEGRKAAKVMTVLVMLLTLGPIASPTLGSLLLEAFGWRSIFATMALISLVALLLSVITLPETLPAEGRQPHPFRTGAKTAKRLLSERGFLIMALVAGLIQSGMFAFITGSSGVFQGIYGLSSIGFGMMFAAIATALIIFGRINGMLLNRYSPEQILTAVLPLFFAATLVLTLLSQTSSLLVFAIPLWISIGCVGLLSANAMSIAMSLTEKAAGMGSALLGAIQFALAFAVSTSVAIGGAGTALPMSLGLVVPAGLATVLFFAAGRFTVPSSSRLTS
>fig|314267.3.peg.3161 Permease of the drug/metabolite transporter (DMT) superfamily
MLSSPSLPAAHGLGPRQIPLRPLVGYLAIAVTVLVWAGFALSTRAASGAQLTFGDVALIRSGIPALFFLPFLPKRIAVLRQLPAHRWLMIAAGAGLPFFWLAAMGGAQTSATHVGALIAGTTPVSVAVLTWVIYRQRPAVLLPLGIILVGVAALIGASGNLAAGSLTGVALLLSASLLWGCYTLGLRGSGLDPIGCALVLALPSTLVLLPLLATGVLPSNLTQVRLAEAMPFILAQGVGVGLVSSLTYAIAIARLGVAKCAAIGSLAPAIAAVLAVPLLHEALTLGTILAVLIICAGVMLANRPKE
>fig|314275.6.peg.382 Lipid A phosphoethanolamine transferase, associated with polymyxin resistance
MNGYGETARADKFSSNSYSRRTSPNIQNAGAISFSKVTSCGTATAVSVPCMFSRLSRENYDSRIADSQDNVLDIIHRAGVDVTWIDNNSSCKGVCKRVKTLDFDPSRDPKFCDGDYCYDEVLVDLLRETLSRPSKEHRVIVLHMIGSHGPTYYRRYPEKFAKFVPDCPRSDIQNCEEAELTNTYDNTIAYTDYVLGQIIEQLSTIPNSSMLYLSDHGESLGEKGLYLHGFPYNLAPVEQTHVPMVYWASKFSQPEYSDCVKSLSSHPYSHDNLFDTLLGLTNVQSSTYQPTQDILRKCES
>fig|314275.6.peg.2568 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDASWCDITTENADELVSFYEAVMGWKKEAIDMGGYSDFVMMKSDGTPVGGICHKRGVNENYPSGWINYFTVESLDNALRAVVDKGGKQVGEVRHHGNDSFCVIIDPSGAACALYEKGQG
>fig|314275.6.peg.2828 Permease of the drug/metabolite transporter (DMT) superfamily
MSSLSVTEKAQSKGIKMLLVAVLCLGLNWPGMKLGLEIVGPVWMVCLRFLLSLPVLALFVLITKKRLPVLNRKDRSVVFVVAFFQFILSMGLITVSLQYIPAGTASILIYTTPLWMLLIDTLWYRQRPPSKRLILTGISTIGCAMILFASGQPGAWLPLFGMLLASALWAVAIRRVSFHKWKGSVIEAVFWQFTIAGFAMLAIALMVEPTPNFGAYDISDWLLLAYIGPVATGLGFGLMVAAGPKLPPDKIVLISTLTPIVGYVSSVLLLKETLLPMVVAGAILMIAALIVNGLPQSTLKKMLGKGQAK
>fig|314275.6.peg.3153 Drug resistance transporter, Bcr/CflA family
MTGTFTILSILGQVSTSIYSPFFYDLAIMYSSHVRVIEKSVAIFLIAFSISQLLSGFICDYVNKQSFLLYGLLVFMAGTAMVTLADKESTFLIGRIIQGLGGGVGVSVSRGLSRQLFNEKQLNISLSITNIAFAIAPAIAPLVGTLIGGCFGVSAIFYFVLMMGLMALLLLFSVGSTINQYTSPNSANVLSDTLALIKNSIVNIVSVGVASGLLYGVVFCFITIAPSMVMQQFELSKTMFSIYSLFATLCFVVGSLTNIRLAAIATITKFKLSSIFILGLSLLFCLVTIGTGDAELVAILIYCYIAFFFIGIAMPCSVTMILGFSKTSAGFLAALTGFFHLTGAAAGAYFVTLFTAGPTLSFSVTTMALSMGSVVICVFIRK
>fig|314283.5.peg.60 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQQTERLGTAPVGKLFVSMSLPMIFAMLVNGLYNIVDAIFVTRGVGPLAIGGVSIVFPVQMIVFAFAAVLGSGAASIVSRRLGAKDHEAARHAAQTTLTFSILFSFVICALVLLAMKPILSLLGVTEALMPYSVDYLLPILLGSPIAIMGAVFGDLLRAEGKMQYMMMLMLTGSVLNMILDPIFIFVLDMGVQGAAIATVIAQTAGLCLAVSFYLRGKTAIHLTAREWRIDWRALWPVVALGLPFFISHAGASFMIATTNNALSQVGGNAADIYISAYGLVGRVLMFVILPLIGMMIAFQTITGYNYGAGELSRVRTMVRLGLTSSLILCGSVSAIMLTVPQVFLGIFTSDPELLQRAMQISRTVFLCFTLVGSTFIITGYFQATGHARMALIASSARVYLFLIPAMLTLPRLIGIDGAWMAFPLADVSSAILAVLLFVPFYKALRSQPTPVA
>fig|314283.5.peg.268 Probable multidrug resistance protein
MIKMNRTLSVLMFATFTNYIGFVVPMFLSLFLHEEGHSLGVIGYILTAYGFGGFIGGYLGGYLSDKTSPFQVIIVSLTISISALVGIFFSESLYLLSFLLLTFGFSDHAFRPAFTMLLVNNTSEEKRTYVFGIRNAVMNISIGISAAAGAAVFDLNVKYIFLFDAFLNVITLILLLSFSPKLVTTTRQILSSEIESSIGWKNLNSTFIFLSLVMVLNVIVFSQFKTTFAIYLKEVFNFSSKDISFIFLLNTLLVIFIEVPLIAFTARFNQVRLMLLGSCALCFGFAAISLSSNYTFPFLSVIVWTVGEMLFFPIILNEFVKASTNHRGKVVGWHQTLFATGNFLGAPIGFYFYQYLDGDAVWLLCAAIGFVSLFALPILSFQKSRQEAVNAT
>fig|314283.5.peg.346 Permease of the drug/metabolite transporter (DMT) superfamily
MTNATPSSYALLFFQGAIWGSSFQAIKFALEGFGPMTVAAGRIGLAAVMMLLYARARGHRLPRNGRVLGMLAIVGLFNCAIPFFLIPWGEQSLDSGRTAIFMATGPLIALAIAHFTTTDERLNRFKLLGFVMGFVGVLLVIGLDSFSAGAAEWLPQLAIIGAATSYAISGAIAKRVLNVSSSVFTACVLSSAALMTLPASLILETPVTDLAATGLSRPLLALIYLGLIPTGLAFLIRFHLIKTVGYTFVSQVGYLVPVFGVLFGALIFQEAITANIVTGLCLILTGIFVSRLSARHREPL
>fig|314283.5.peg.524 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNELLSQPIPNLVVRKSIPMVFGVLAILLFTLVDTWFISLLGTEPLAAMSFSFPVTFIVSSMAMGMGIGLSAVVGRLLGGGDHEQAKRFTTDSLILSTILVLVLGVVGLLLMDPLFRLLGAPDSVLVHIRAYMGVWFLVIPLLVIPMVGNSAIRASGDVKTPSVVMLISGLVNGVLDPIFIFVLDMGVRGAALATGVSWLITFVVAFHVLKNRLNLLTLEKPEKSLLFIHWRQLMSIGMPAALAQMLNPMANAIQVAILAGFGVAGVAAFGASSRIEAIFLVFIMALGSVMPTVLGQNLGAGQKQRSARTISFTIHLVIGLYLAMYALIFLLAPYLAGLFTDETQVAELATLYLRIMPLSYAWLGVGIVASQILNVLHRPMASLWMNVLRLFGFLIPFAWLGGQLFGTLGVFSGVALAHTVSGLLIYVYILKIARGIDEPSVNDPGATSGGLS
>fig|314283.5.peg.872 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAEIQIDETHQPTALKNASLRERVQQEWRTLLALGSPILIGQLAQMANGVIDTVMAGRASAEDLTGVAIGNSLWVPLFLFMMGLLNATQPLISGHRGGQRDDQVMPVTWNALYIALAAAALAIMLLINVDPVLNLVGMDDTSAAIADGYLEAFVWGLPAILILVTLRGLTDGLGHTRIFMVFSILTALFNAPLNYVLIFGKFGLPELGGIGCGYATAISQWLTLFCLLVYFNVSRSFRHLHLWAHRQWPQWVRVKEILLLGIPIGFTIFVESVMFAVVALLLASFGADVIAGHQIALNVVSVLFMVPLSLGLALTIRISFLIGANNPATARLASRSSLILTLLIAVVYALLLVFFAEPIAGLYSREPAVIEVAVELLWYGALFQLADVLQVVAISALRGYKDTRIPMFIMVASFWVVGIPLGFILAHTDWIVQPMGAPGFWIGLIAGLTHAAAWLIPRLFWYSDQAVQR
>fig|314283.5.peg.1297 Multidrug resistance protein B
MSGELTLNGLSTRQGPAYKWFVTLTVVLGTISTVLTATIVNVALPDIMQALQMTPDRVQLLSTGFLAAMTGSMLLTAWFVDSYGQRLTYVLVISVFVIASIVGGFAPNSTVLILARIGQGIAAGLMQPLSMLVIFKVFPVEKRGSAMGIYGVGIVLAPALGPTLGGFLVDLFSWRYVFFVSIPFSLTGLLMAFRFLPNQTENKERLAFDWLGLFAIAAFLVTLLSAFTLGSAHGWISVTVISCAVAAVMSLLFFIWWENKCSAPLFNLSVFANVTFSNAALVGFMLGAGMYGSTFLIPLYVQSVLSYSATSAGLLLMPSGLIMGIIFPIAGRLADRSPAVITISLGLLAFALSSFLMTKAELDTSFWALAFWIVLGRIGLALVTPSLNVGSMRVLPPALLSQGSGAINFVRQLGGAFGVNLIAVYLHIRMLVHAGKMDEEFNPQLVQIPKNHSELLAYHDAFSVMAIVFALALIPAIWMHWSSRRTSRS
>fig|314283.5.peg.2039 Permeases of the drug/metabolite transporter (DMT) superfamily
MQKHLFIAVLLAATANFFWAANAIVGKVVVAELPAFTLSQFRWIGAFLILAPFGLYRIRRQWDWYRQRLPQLVGLSILSVTLYNTLQYWALEHTEPVKVGAMLALMPLAIAIVSSFFGSRRLSLPEWATASIAVIGAVTVISDGQWQNLLGGSGFSAGEVLMLVAITSWAFYSVFLKNTASAQIDVIGLLTFFVGSGTVMILPFWVYDMLTETVFLPSGGQWGAVAFVALFPSVVSLLCWNMAVRLSDANIAGLMVTTAPLFNALLTIVFLEHAVSSAQWVGIALVMTGVASTLLIARRNLSATAS
>fig|314283.5.peg.2262 Permease of the drug/metabolite transporter (DMT) superfamily
MQRLDAILLLLLSAIWGASFLFMRIASPEFGPIALILVRMGVAFLTLTPFLLNRAFRQKIISHAGPLAILGILNQVIPFTLLSFATLRLEAGFTSLINATTPIFTAIVAVLFFASPINRQQLLGLIVAFAGMFVLSADKLNFHTGGTGWAILAGLGATFCYGLAVNYSHRTMSGLNAREIAVGSMFFSSLVLLVPGLWFWPEQNPGLSAWISALLLATFCTSLAFLLFYRVLRSAGAVASSTVTFMVPVFAVGWGVMLLGEAITPRLILGMLITLAGTALTVQIVRIQRLQPKPLDS
>fig|314283.5.peg.2791 Permease of the drug/metabolite transporter (DMT) superfamily
MHPERKALFFALAAVLLWSTVATAFKLALQYNSVPALLFGASLTSLLALAATLYRQGRLKTAVFQLRHNLKTTTLLGAINPVIYYLVLFEAYRRLPAQVAQPVNYTWAITLALLSVPILKHRLTRFDLAGLLLGYSGVVVISIAGKNITGSLDGIGLTLALISTLLWAAFWLLNTRSAVEPLVQLFHNFLLATPFLALLLIITGQSLSLTVPSLLSLVYVGLFEMGITFMLWQQALSLTQRAAQIGTLIFLSPLISLFLISWILKEPLQWQTFAGLGLIIGGVWLSKRKA
>fig|314283.5.peg.3419 Multidrug resistance transporter, Bcr/CflA family
MQGFMHSKSATFYITLILTISLSVIAIDSIIPAIPSMTLAFQTDPGLSQLTIGLYLAGYALGQIPMGLLSDRFGRRPVFLIGMTGFTLLSVATVFADTISQLLVIRFVQGVAGTVGPVVARAVARDTHHGKDLDKLMAILVTSLAAGAMIAPILGTLIVSLFGWKAPLILNAVIGGLCLILLLTSLPESHRPNRDLHPWVQTKQSALAFFTNRQALVASFVVSFTFFAYFSIATGLGSILVDYYHYPAHVVGWGFALAVTFYMVSAQVCRFRIHRQSAEKLMHQGSLFYLLAVVVAALLIVTLLLGAQLSVVALYGLLLLFLVGMGHVFAPASAVTMQPLGHIAGFAASMLGTLQMGLGTLGASLTAVFYDQTPISLIGVLMLGALFSAILIRTHYRS
>fig|314283.5.peg.3922 Permease of the drug/metabolite transporter (DMT) superfamily
MTQSTLLSVSPISVSSGQRTLGMICALMTVMVWSGYFLSLRAGALSPLGTLELSLIRFSLPALLLSPLFFRSIQAYRQVHPLYLAGIVLGSGWGFFYLSLMAMKASSVLVGSTLIPGAAPAFVTLVAVAVFRQPLPMTRHLGLLLILLGVVGFIGSAIWPFQARQLTGIGLLLCAAFIWALFTLSVRQSELAPLQVAALVVVPNGVAVAGWALFRLSEIDFTGVSLTMIGTQVIVQGILVGIFSGLFYSTAIRRLGAEPTSAIGSATPVVASVLAWLLLGEGVSWVPALALICTATGVLVASRAK
>fig|314283.5.peg.4010 Permease of the drug/metabolite transporter (DMT) superfamily
MEYLGYLAALGAAASWACAGLLSVGPVRQLGPIPFNALRMLMVASLLTLWLTFTDHWSWPSRDSFGILMLSGFVGIFLGDTLLFTAVKILGPRMAGLLFATNAPLTFIIGILIFKETYTLLNLLGVLGVIGGVFIAISSRANAGKHHWEQSVGHVGLGLLAGFGAATCQSLGVVLIANLLTDGQDPVFATMLRVWVAVICLFLTLLLFPRFTGGFRPYRSLTPRLTGRLFLSGFMGMALGMSLYLTSVSLAPMGIVTILSATTPVILLPIAWLITAERPHNRSLYAAILVVMGAALIFTNGG
>fig|314283.5.peg.4143 Multiple antibiotic resistance (MarC)-related proteins
MIDLYISITIKFVFLFAPFFVVSMFLALTRGEPVEVKRAVIARAILASGVIAITLFFAGPFIFQAIGITLDSFRIGAGSLLFLTAVSLVNSGTRTHAKGLPEEDRDDIAVVPLAIPVIVGPATIGTILVLGAELPTFRETFVGMLGMLSGLGLLTGLLLLSGLLERVLGKTGLNILSKISGLILAAMAAEIVFTGVQGFLS
>fig|314285.4.peg.309 Acriflavin resistance protein
MDTTAYSAPDPALTGPIAWMARNPVAANLLLVIVVIAGLFAISTLDKEVFPTFPTETFTVTVPYPGSSPEEVERGIVLRVEEAIRDIVGIKEIRSEAREGVGIVTVVMEAGSDMSKAVGLAKVRVDGIASFPGDSEKPIVEEIESSSRAIRLSLFGDIEPRKFKELSEQIREDILDLGGISELTIEGERDYEISIELSDEKLRRYGLTFDMVVAAVQAGSQDLPGGLLRTDSGAITLRSSSQAYRGRDFEELSLISRADGTRIRVGDVATVRDGFAEQPVLSLVDGKPALTFTIDRVGDQNVLGITESIRDYVERKQAELPEGVRLQAWGDASRILSGRIDLMLRNAAQGGILVVIALALFLDLSLAFWVVLGLPFAVLGCLAALEIFGLPVSINVLSVFGFILVLGLLVDDAIVTAESAYARLERDGEGLKSVVGGVHRVATATIFGALTTAVAFGPSLFLTEGFARIMSHIGWVVILCVIFSLIETKLVLPAHLRHIRVPQPGDEMGFFRGVQQRVAQSLMNFARGPYRRALGLAVSYRYTTLAIFFAGLIVCLALVPSGILRVTFFPSVPSDNIGVTLDMPQGTPWQKTHEYARRIESAAQAMNERFKAQDAQGRDVIRTLLVLSESDTQARVIVDLIVSEERDIDSVVLGKWLREELGPLPGVRSFRIDAAAGPGGSPIDIQLEGDDLEQLRQAASELKLSLARVDGVRDIRDSFNAGGRELDISVTPEGEALGLGDVDLARQIRQAFFGAEVQRVQRGRDEVRVYVRLPQRDRTQLDSLQSLWISLPNGGRAPFSVVGRVREQTSLSVINRIDLSRVVNVRADVDKAQTSSSDVMALAESSMLPEILARHPLVRYSVAGEVDEQRKTSDGLLYGGILVMLLIYAALAIPLKSYLEPLLIMSIIPFGVTGALLGHLILGMDVSILSAIGIIGLIGVVVNDSLVMVDFINHYIEEGYDWKSAVLEAGPTRFRAVILTSLTTFIGLLPIQLETSIQAQFVKPMATSVAFGIFFSTAVTLFLIPTLYYVGQDIRRAFGGKEALPAEA
>fig|314285.4.peg.317 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTAAHDRDRIDPRYDPVTGSVVATFFRYAVPSVLGMLAVTSAGIIDGIFIGNFVGAKALAAVNLAQPTWAAFTAIVFTLAVGGSVICGRFLGQQDILAASSIFTRTLLASVGAGIITAGADLLFLEDLVRLLGATPEVQPLVTAYMRVVLIFAPVFVAGLTMDYFVRVNGRPVLAASGLVAFAATNIALNTLFIVYLDWGIVGAAWASALAEFAFFFILLSHWFHPRCSLRLTLVRGQWGDLWSAVWNGFSEFINELSVGLVVLFFNWVMISRQGVEGVAAYTIVTYLMMIGLEVSYGISESLQPMISRNLGAGNPRRIRQFMLTAVAAAFSVGLLVSVLLLALPESMISLFLGPQEQATAVIALVFIGYFWPTFLLNGTNITLASYFTALHRPLPSAVIALSRSLVLPCIGLLLLPRFWGDAGVYLAIPLAELFTFILAIVLVLRLKSTPEGSRDTNTDTKL
>fig|314285.4.peg.1689 Multidrug resistance transporter, Bcr/CflA family
MAREHNALVYHCAPMAYTPENSRLDPGSKATLMFLAALVALGPLSVDMYLPAMPAMQQAFNTDIVHMHFTLSAYLWGFAVFHLACGPLADRFGRKPVLLGGTGLFVLASAGCALANSVEELTTYRFMQGVGACVGPTLARTITRDIFGPKGAARALSLIAMLMALAPAVAPGLGGLMLRYVEWPAVFVFLSVYGSIVMVIIGFRIPETLAEPQSLRPGNIAANYLVLLRDPVFLPIAAASALVYAGLMAYLACSGFVFIDMLGVPVEYFGFIFLSSVFGYMGGSAVSARLAVRYATSELLLLGGVIATVAVLSMLPLHLLAPTSILALILPMSFYSAALGLVLPQAMAMAMEHFPRIAATNSSLFGFLQMGLSAVITVAVGSVLVSSPLPMIITMAVTQVLALLLMVYGRAQSKKHYPIHPLSTEPDSP
>fig|314285.4.peg.1899 Multidrug resistance protein
MIPILPFLSPRLGASDFDIAMIIASYAVCAGVAGPWWGKLSDHIGRKPVLMICTTGAALAYVLLASAQSLTMIFVARAFAGLMAGNFGVASAMMADITPPADRARGMGMIGASFGLGLVLGPVLGGLLSGPEGSFVVPCLTAAVMSVLAVIAAWFFLPESHHRDKSQPQTQERKLSLWTVLRKTQSRLLMLQYIWHTASVSAATYLFPLWVYALLNWSAREVGIVFGVQGALMALTQGLLMGPLVKLLGELRLLRVCVSGFFVGLLFAVFAQGAVSMVGSVLVALTGATLCMPVLNSFASQRAVPELRGRMMGATSAAAAWGRVLGPLLAGALLTVGGFRLAWSLPLGMVAMYWLWAFSRWPKRPVPIFDPNTQG
>fig|314285.4.peg.2004 Tetracycline resistance protein
MAFSSLPGVVWLYTLIQSLAVSVGSMMVIVGGVLGATLAPEPSYATLPVAVMISGTAVSVLPITRLMRRFGRRPIFLAVTIVAVLASLLAAQAASDGSFLLFCSAALGFGCALAGIQQLRFAAMEAVATHLVPKAASTVLLGGLAAAIIGPQLATSGRDLVGAEFVGTFLLMAGISGVCTLLFLFTPSSRAQATEVSGDIRSLREMLSNPTLIMAIVAAVGGYGLMSFIMTATPVHMHVYEGHGLDQTKLVIQSHILAMFLPSFFSGWLISRWGTARVIVLGLLAYVLTVLLALAGSAILNYWTALVLLGVGWNFLFLAGTTLLPMTYAPAERFKVQGLNEMLVFGFQAIAALSAGAVLHWLGWQNLLLACIPLILLLLLTLLWWQKSQNAADLGVEAKTGL
>fig|314285.4.peg.2221 Permease of the drug/metabolite transporter (DMT) superfamily
MRRNYLSLYPIPVMQTVLLYAVTVLIWGTSWFAIKYQLGTVDPLVSIAHRMALAAVFCAVLTQLTQGFVRLSLQNHLRIFFQGLCLFSCNYLFIYAATADLSSGLIAVIFSTMVALNALGGALFLNMPLRAPVVVGGLLGLLGMAALFYPELETLGCSDPRLQALLLCFLGTLCASAGNLVAAGSLRRGLPVLTCNTWGMFYGGCTLYLAALLLDIPIVVDLSRDYLSSLAYLAFFATVLAFWAYVSLIGRIGPDRAAYTTLLFPIVALLVSSVLEGYAWTLWSAAGLSLVLLGNWLAMRGVRS
>fig|314285.4.peg.2582 Bacteriocin resistance protein, putative
MLQLVTPAQAFDNWLSLRDAGVVRQERDFSCGAAALATVLTHYYGEPVSEAALLEQLLRERVNTGDTKVQQQALSFADLAMLAGSRHYPSMGLAVAFEDLKKLKLPVIVALVIEGRGHFSVLRRVDSDDRVFLADPSWGNRQLGKQAFLRSFSTPGTSAQGRILIIGSKRDSKNGSKSGSGGDERFRHRTPRRALMAPGV
>fig|314285.4.peg.2642 Acriflavin resistance protein
MSIGAYSVRTPVISWLVIVIMVAGGIFGFQKMGKLEDPAFTIKMAKIITQYPGASAQEVYDEVTYHLEDAIQKLPQLKRLKMSVSRPGLSDITIEFKDEYGADELPNVFDELRRKISDVTRQLPPGALAPVVIDDFGDVYGVYLMITGEGYSWRDLYDVADDIKRQLVLVEGVRKVSIDGEQQEVVYLDMSRVRLAELGIDPATIAGVLGSQNSVVDAGNVRVGDDYLRIKPTGEFDSVQEIGNVLISSRNRDLVALKDIATITRAYQEVPVKLYYHNGLPALSVGISMAKGQNVVEAGKRLQARIDDLQTLIPVGMSLEAVYDQPAEVEESVSGFVMSVAQAVIIVIAVLLLFMGLRSGLIIGSVLLITVSGTLLLMYLFGIELQRISLGALVIALGMLVDNAIVVAEGMQVRMQSGMKAIEAATEAVGKTIWALLGGTAIGILAFSAIGLSPDNTGEFAGSLFYVILISLSLSWITAVSTTPLLCSLLLKPGGPDQVQNPYGGKLFLAYRSLVAFAVNHRWFTVALVGGLFALGVVGFGQVKSGFFPASSTPLFFVDIYEPEGTDIRKTRDDTLEVSDFLRQQPGVLQTTAVIGGAHQRFTLVYDAREPTPVYSQIIVRTETPEQVEALQERVAEKLRRETPWIDPIVKSLRIGPGRDAKIEARFSGPDATVLRQLSEQAEAIMRNDAEAVDIRNDWRSPVKLVTPVFNEQVGRQLGISREALGDAMKSAFDGLPAGSYRDRNRVLPLRMRATENERNDVNSVRDVQIWSAVLGQTVPATAVISGYRTDYENAVLRSRNRIATIIASCNPRGELATPLFERIRPQIEAIELPPGYELSWGGEYEDNANAQEGLGRSLPVGILLMILTSIVLFGKLRQPLIIWLTVPLAIVGISAGLLATNGAFDFMSLLGALSLIGLLIKNAIVLIEEIDQQIAEGNDPYEAVLDSAVSRARPVVLASGTTILGLIPLLSDVFFVNMSVTIMAGLGFASILTLTVVPTLYATFFNIRKDDGEGAPESDAPSVESSASA
>fig|314292.23.peg.919 Multidrug resistance transporter, Bcr/CflA family
MFPISHEGKWFRFLMVFIFLGAAMETDIYLPTFPDILNDFNTNAVMVQRILSYNFIGICLGSLMYGPLSDHFGRRKILMFGFSVFLASSVGCIFAKTIEELLAFRLLQGFGSSACVIVGTAMIFDLFDEEQAAKLIADLNTLVVSLMALAPLIGGWISLNMGYKANFMFIAILVLISAIKCFLFLPESLNIHKRKKIHPKRVATDYKTVLASSVFWYNTLITSLILAAYMIYVSNMSLLYVEQLNVSPDVFPLYQMATLGIFVIVSLNNGRLIDKYGIEKLKTIGLGLIFLTTLILFFASDGMMNSPQFLTGTMCLFSAGAGLSIGIFFAKSMQVFPELTGIAASLVTAIRLFIVSAAIDLGSNVYNGTTQSVIHVMTGVVVVLAVLSLLNLNRQA
>fig|314292.23.peg.1119 Acriflavin resistance protein
MKAKGLIAWFTHNHVAANLLMLLVILGGLFSISLINKEIFPAFAMNRIMITASYPGASPEDIEQSINIKIEQSLDNVKNIKRIESVASQGLASLTLELETGADLEKVLDDVKQQIDAITTFPVNMETPLIKRAEFTSNVMFISLYGNLNERQLKEYAKQVRDDILLETSASDVVVSGVKDYEIAIDVSENALRKYGLTFEQVANAVQQRSIDLPGGIIKAKDGDLLVRTNGQLYSGDAFSSIVLRTRSDGSRLLLSDVATVSDGFVENRVLNRFNRQRAAVIQVRNLTDEDATKISHQVSEYIAKKQAQLPSGVYLDTWGDMSHYLEGRLNMMLSNMLYGGVLVFVILALFLDIRVAFWVILGIPFCFLGTLLFMPTPFIAVSINLISLFGFILVLGIVVDDAIVVGESVYTEVKDKGQRIENVIKGVQNVAIPATFGVLTTMAAFIPMLISDAPRTEFFKAIAWIVLLCLSFSLIESKLILPAHLARMRLTQPSKKPHLFSRLKLRFNSTVDRFINHNYRRFITVCTRHRYSVLATFSGILMLAIALVVSGQLRWVFFPNLPSDYIQVNVDMDVSSSDENNARVAAQIEDALYQADAKIYQELGVNVVKHTFMNMANRQDLFILAELHKTETLPISSFEILKQWKAQMPPLVGVKNITYDASIDRKQSDLQFSLKGENLTELAAASKAMQQLLSEYDGTLNIKDDLSSPIPEVKLKLTAAGEALGLSLSALANQVRHAFFGYEAQRVLRNNEEVKVMVRYPQQERSTIGYLENMKVRLPNGKFVPFTEVATANIESSYTNINRVDRKRSVIVSANVDKAQTAPSDIYNDILTNKLDKLQQQYPDIKIALDGRAKDEKNTKGSLIRDSLLALLTIFALMAIPLRSYSQPLIIMSVIPFGIIGAIAGHYLAGLTLNLLSVFGILALAGVVVNDSLVLVTFINRALKQGVDLQQAVIDAGCARFRAIVLTSLTTFFGLAPILLEDSLQAQIVIPMATSLAFGILFATVVTLLLVPSLYLILQDVQSVIRRFYHWWWQPRTSE
>fig|314292.23.peg.1179 Permease of the drug/metabolite transporter (DMT) superfamily
MNKYQTLMNVALTALAPIIWGSTYIVTTELLPADLPLLASVIRALGAGLVLLLFCKIRPSGIWWGKIAVLGLLNIGLFFYCLFAAAYYLPGGLAALVMSIQPLIVMGLGAIFFKNKLSATHVASAMVGVAGISLLVLNSAVELNWRGVLIGLIGTCSMALGILLTKHWGRPKDMSLLGFTGWQLTLGGLMLLPIAIWYEDFPRAMTALNITGYAYLSLIGGVFGYFVWFRGIEKLNPVITSFLGFFSSVSACLLGYIFLGQSFTQLQIFGSVAIIISVYMARPKSEKQPNELTQEPVESVQR
>fig|314292.23.peg.1401 Multidrug resistance protein B
MSYRYKIASVFLIGFFLDCINIFMSAIALPSIATTFNTGTANVAWVANSYILGMTLVIPMSTWLASRYSSRNVLSFSMVLFGCSVFFCGLSTSLYELIGWRFIQGIGAGLMIPIGQSLTFSLFQQKQRAKVSTFIMMVALIAPAISPTIGGLIVEHLSWHWVFFSSAPLSIIVSILAWYWVDNYNKADSERPDIKGLFLVSTALIALLVGMSIYSNSQYGIKAELIGTFAIVAALILVVIYIEHDKNHHDPIINLSLFKNNKLTLSIIIYYAIPGVFTGINLLNIFFLQDVLHFSADKTGMFMILYGIGAFIAIVACGKTYNHIGPKKLFVISLLIHSAGVASLLWVHLGSPIYVIILAYILMGLGGGLGANCAQTTALMDFDEHQMLKGSVIWNINRQISFCVGAAFFTMLFNLFCMNAHFQNADAYHLTYLIAVLIGIFTLIFIVKRQKVTL
>fig|314292.23.peg.1594 Permease of the drug/metabolite transporter (DMT) superfamily
MTSPNSNNNPINENVSSPHAELNKGIVYALIGTALFSIKPVFIKLAYQYGGDAVSIMSLRAISSVPIYIIMMLWLLRKTEHRDNLKQYGLAASAIGVLGYYVASYLDIAAMAHISAQLERLLIFLFPSFVVLISWTVLKQKPAQGTFKAIALGYTGVAFIVFHDLGSMGNNVLLGSGLAIASAFVFACYLIMSKKLITQMGSQLFTCIGMGSAGIIILIQSQWQGVNVIDLDPMLILLGIALGIFCTVLPSFFVAAAMQKLNPSQLSLTSNVGPAITAVFAITLLNEPFTFYHAIGMLFVVYSVISMKKRGQ
>fig|314292.23.peg.1596 Permease of the drug/metabolite transporter (DMT) superfamily
MEQVEQNKSVFINTSLIATIGVLAAAVFWGTSFGVAKESMLYTGVLMFLVIRFCCTLLVIFPLVSKKLNKQIWLQLAPTGGILSIIYLAETYGLKHTTASNAAFLISLFIIFTPAVDALFNRHKLAVTDLFAGCIAIAGVWLLVGDSLNTVTFNIGNILILIAAMGRAAFVVTTKKKMNQQHCDPMVATFIQLSVVTVVCISLLVFTVPVEQFIIPSAPEFWLYIGYLVIFCTLFAFYFQNYGVKHTSPTQVSFLLGLEPVFGGLFAHWWLGERFEQLQWVGAGLIVLAAMFISVKPKFFSRTKKPI
>fig|314292.23.peg.2079 Multidrug resistance transporter, Bcr/CflA family
MSLLRLLSISLLMACSYFFASDMYAPSLPVMSEALNVSSTAVQQTVSAFFIALGLSQLVCGAVAERFGRRPIAILGAVIFIIGSALCLYADQLSGLIIGRAVQGIGVGALFLLCRTIMQDSLTKEQLVDVMSWFSILFMCLPATTPAIGGYLESHFGWHSSFWFMLGLAVLLFVVIALGLKETHLEKNIHATKPSVVARDYSMIATNSQFLRYLIMMVMANSGALVFYLMGAFIAKEQYHLPVQYFGMSSLLLIGCSLCARIVYIRFLKYTATEGRIIKVASCIMLLGALTILSNVVFHSMAMIIIGMGIYCFGAGLTTSVVAVSALYLFPKHKGQTGALFGSLQMVGIFTLTFIVSHLASVEWMMACVLITMALLNISVQRWWNDNSVVLAKA
>fig|314292.23.peg.2085 Multidrug resistance protein D
MNKKTISTLLAVSLLMFPQLIETMYSPALTSIKNHFSVTTSEAAQALSLFFMVFAVGVVFWGTMCDVIGRRLSTLLGIAICIASATFCYYSPTFQGLLYGFGACAFGAAVGSVCTQTILRDSFEGASLTRIFSIASTSIGLSPVIGMLLGSWLTAHGGYTWVFAAMVIMLSLLLLWGGFALPETKPNHIKRDSLFLVANKMIRDGHIWYIALMVGLANIALFSYYSIAPFMFEHLGASVKFFGNTSFVLAAGSILGSLLNIRLIRKHIRGDIIVMLSTLMMLAAGLGVYLLQETVWFFIPMALVSLSFGLALPNLFSTALINYRNHLGTAGALLGLFYYLIIGFGLDHAAHVGNLAMTLLVCGGCSFVLVLLKLFTAKTSKQTSENATTS
>fig|314292.23.peg.2103 Permease of the drug/metabolite transporter (DMT) superfamily
MSSLAIQTTSQYKFGVLAILLASLLWGTTGTAASFADQLSPLAIGAFATGASGVIQAALSWRSIMHHFKQIMALKLLLAVSCLALSVYPLAFYTSMKLSGVTVGTVISIASAPFFTVFLECLFSKV
>fig|314292.23.peg.2785 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTYNKVTQGPIISTFFLFAFPALIALLAITTASLVDGIFVGKYLGPQALAAINILIPYITFMFALGLMVAIGGTVTAGKFIGEGNYKEANGIFTLSLISIFLFATLVAIISLFFNESLFLFLGVDEQLAPLTQAYFQVISVVLIIQLTTMVLYYFVRADGFPTLATTALVLGSVVNIMLDVLFLGYFQWGIQSAAWATGIAQIIQLLVLCTFFTKKQRLIKFQLCYSSVKPYFKGLLNGISEYINEISVGIVIFTIHWLLMKEQGNTAISGFAVANYMLFISMMLFYGIIDALHILVSQNYGAKNFTRINQFMLLATVTVISISALLIVSALSVSDLITKLFIENTESDAYQLALSYIGVIWPCFIFSGINVLLSCYFTAMHCPLQSSIIALSRGLVLPVSLLLLFTNFIPSIPFLFALPIAELSTFIIALTLYLRFQHSIKHKSKLVTI
>fig|314292.23.peg.3753 Multidrug resistance protein D
MNDSTEISLSDQVKGVVKENWNVLFLAILIVSIGQLSLGLVFPLLPWIHLDFNINQRLAEGLIVSYLMGYGPSQLLYGPLSYVYGRRHVLLIGLFISILGLGIILTFHYYFYILIIGRFIQGIGGGCESVIARSMLHDSYKNKFFLSAMTGLSIISAFTPIFSPIMGGLVNHHFGWFAVFICLFIYTVLGFLILFFYLPETLTTPRVSISFIAIFQYYGTLLKDRYFLSYAMIGWVNWALVIFSGSLAPFILESQLHISSANYAYWSIIPAVAFLFASTLCFILRKSYGTHHIVFIAPVIQLSVVMIFLSQPMSLLTLTIGFIGVAIAQALIYPCSQSLLLVPYSNQLGTVSALSGGGQMLFSAIFIFIAWQFNLDNFYSLTAIIFITSVIGLLFALLGKRCTASASLENELFK
>fig|314292.23.peg.4230 Permease of the drug/metabolite transporter (DMT) superfamily
MKQTAVSLGILLLIFGNLSASLSDVAVKLLNGEVHPLQYMFLRQVISLIIILPFWLSQPKPQREVGSWKINTIRAYLVLAGSSMLLVALTYLPLATANALFYAAPLLMIPLSIVLLGEYPTKGKVIATAIGFIGILIVLRPTQFHWAAIAALGTATTLALYNVLVRKLPQSQTVSSTLFWTSVLSLPVATPLAWYFWQPISLENLGLIAASALFTLGYQGCVVLAYRQSETHKIGLAEYSGLIFVALFGWIWFNESLDTLTLIGILLIVLPMMPRPKRKKFTTQIDIQ
>fig|314345.3.peg.1250 Outer membrane component of tripartite multidrug resistance system
MMGMQQKPLLMAGICLLFAGCTVGPDFRRPDAPAVSGYTREKLAEHTAAADVAGGQAQSFLSGADIPSQWWTLFHSQQLNQMVEDALNNNPDLAAAKAALVQAQENTYAAQGVYYPSLDANASASRKKTTGSQYGNPGGRGTQFNLFNASVDVAYVFDLFGGERRNVEALAAVAESEGYQLEAARLTLTSNVVTAAIEEASLRGQIAATEEIIESEQQQLEMLQKQFELGGISKSDVLAGKTRLAQTRATLPALHKKLALIRNQLTALAGRFPEQESGSAFTLSALQLPQQLPLSLPSELVRQRPDIRAAEAQLHTASAQVGVATAKFFPQISISGSFGSVATTTANLFSPGTGVWSIGTNLLQPILHGGSSIHNRRAAVAAYNKAAAQYQSTVLAAFQNVADVLRSLQSDAEGLQAQTHAVQAASEQLDMARAQFSAGAINNLLLLDAQRSYEQARISLVQAQASRYADTAALFQALGGGWWHHADTTAMTSAAQTDVKP
>fig|314345.3.peg.1648 Multidrug resistance protein A
MIVIPCIAAIVVGIVYLKGGRYIETDNAYVKAEKVAVSPQVSGQITDLLVHENQPVKAGQLLFRIDPAPFQVALDKAEAKLAQVRTDLAVLKASYSEKEAEIALARTNLVFARHDQRRKSTLAANKFISASTLDNAQQSTDTAEQRISVLEKSLARIAATLGGSIDVPIEDHPDYRIAMAEVDQARLMLARTEIRAAQPGIVSKLPKIGQYVSAGSAALMLVVSNNFWVEANFTEKDLTYVHPGQPVTIHIDTYPDTAWTGVVKSLSPATGAEFSVIPAQNATGNWIKIAQRLPVRISIKTTAGKPQLLAGLSTTVEIDTSHHRHILGLSL
>fig|314345.3.peg.1948 Acriflavin resistance protein
MDRKDLNIAGRLGAAAMGTSMTPIISILIFLIGLVALVLTPREENPVIDVPAANVIVRMQGASPEEVQNLIVRPLEMVLGEMTGVDHTYGTAMDSMGVVTVMFKVGEDKEASLVKLYDRMMHNLDRIPPGASQPLIKPLDVDDVPVSVITLSTPAMDGLALKRLAERVREQLIPLKGVSVADIVGGRDREVRIDLDPARMTAYGITLDQLHQVLAAANSGGPVGDLVGENHVTKVWLDGYLKSAQDVGRLIVGEADGKAVYLRDIASVVDGPAEVEQYHRIGFGAADKKGFGEEERPAVSIALAKKRGTNAVFVTERINKKLESLKGDLIPDNVQVTITRDSGNLANAAVNMLIEHLGIAIVSVIIIMLLFLGWREAAIVTMNIPLILFIVLAIGLLADQTINRITLFALILSLGLLVDDAIVVIENIHRHLHHGAKSLQDKAELIIRATNETGKPTIIATIAVILAFIPMAFVTGMMGPYMAPIPFNAPIAMAASLVIAYMFTPWIAQRWLPCRMVEPTMEEEDEKTTDWVHRTYMKLATPLIEKRGIRSLFWLIVLLLFAFSMWEPAWQFVRPAGINGPLTAGTVELKMLPKGNKNTFNITIDMPEGTTLEETDGVTRQIADIVRVNPMVTDYEAYVGQAGPIDFNGMLRGALFRNSPYQAELRVNLVDKQERSIHSDQIVLQLRKALAPIIAAHPRASIKLVEDPPGPPVRATLLGEIYGPDYATQRAIAAQVKKRFAATYDVTDIDDSVGEAQTQLTIVVDKEKASRLGVATRQVELALKDFLGGYNAGAIHVDASRHPVMLHVQLPKKLRATSDDLSRIYVSGKSGPVQLSSIATVRKTTARLPIFSKDSHPVVYVTAEPKIGSQVYPLLDMDSHIDGSQIAPGERLKTGGMHFTDAVPDDTFGYQMLWDGEMRLTLDVFRDLGAAFIVGLILIYLLMVAYYGEFILPMLVMAPTALTLIGIFPGHWITGQPFTATSMIGMIALAGIVVRNSLLLIDFILDYRRQGYDVKTAVLEAGAVRARPILLTALAVIAGTSIMISDPVFGGLGVSMAFGTLAATVLTLFIIPLIYYLWQRNTPWPSDDGAQCNTI
>fig|314607.3.peg.100 Glyoxalase/bleomycin resistance protein/dioxygenase
MIEGINHYNLRADEETIEVLKDFYIEIVGLNLGHRPPFKNGGYWLYANQKDVLHLSFSKNDIVNELNVNSTFDHMAFTCQDEDMYIDLLTKKNIKFSIREIPEIGTRQIFFKDPAGNGIELIFPYN
>fig|314607.3.peg.104 Permease of the drug/metabolite transporter (DMT) superfamily
MQNSFKLKLLPILSVVLMTFFWGYNWVVMKQAVQLVGPWEFAFIRNFFGALILLVLLVLMQKSLKIINFKFVFLIGMFQMIGFTVLVLVALVNGGTAKTSVLTFTMPIWANLLALYFLKEKMTNKQILAIAVSLIGLILIFDPVHKNADFNSMLIAISAGFFWGCGVISVKKYNKKYPQVDLLNLTAWQMLLGSLPILIVILAKGIEIYEINPYFWKASLFNIIFCNALAWLLWNYGVKHLKTGEVSTISLLAPVIGSLAAFLELHEALKINEGIGLIMIFSGVLFMILLASREGSK
>fig|316056.14.peg.3157 Permeases of the drug/metabolite transporter (DMT) superfamily
MISPRDVARKLTRRHDERPFRGIVLIIAATVFLACSDALGKYLTLTLPSIEVAWLRFLVFVLIMVPVAMASGSSPLKSVRPGLQVLRGLALVFSSVIFISSLRYQPIAQASATSFVAPLFVTALSVVVLGETVGPRRWIATLVGLVGVLIVVQPGTAAFNPAALLTLASALLWAATLVMTRMISGADRVVTTMAFAAIVGFAVLSVLVPFVWVTPSLSDLGLGLGVGIASTAGQWIVVLAFRHAAASMLAPFSYIQLVWVTIIGVVVFGELPGLWTFVGAAIIIGSGIYTAHRERLRHLRQVAAEPYPSA
>fig|316056.14.peg.3212 Permease of the drug/metabolite transporter (DMT) superfamily
MKLTDIALALTIALIWGLGFVFTRLGVAEMSPTVLTLVRFAVAALPCILLPRPKLAWPIWIGISLLLVWQYLTQTYGMAQGVPAGLTAVIVQSQALFTIGFAALLLREFPTRGQLAGIVVASCGLLLICFTVGYDFSVLAFAVTMTAPLAFALSNLLLRQAREVPMLDLFAWVSLASLPPLGAAALVADGPAAIWQQVSHLSPGGIGCVLALSLGSTTLGYWIWGRLLHAYTAAQVVPFALLVPFIGAGASALVFGEQFGTLRLAGMIIVVGGIAIMLFAGRSKALPEVA
>fig|316056.14.peg.4356 Permease of the drug/metabolite transporter (DMT) superfamily
MTGSPWLGLSLLLAVSLLWGTSFVLIEIAAQDYGALSIALSRAAVAAVVLGGVAVLSVRRLRIAARIWPRIVLLSVVGQVVPFFLLGLSGRLTSSSSSAVMMGAAPIATIVVAGLMLQERWSAGRWLGVVVAGAGVVIAFGWNGIFPSPAPAGFGSDDALGKLCALGAALGYAFGAIIFRSIPPQIPPMVVAALSLSCSSLLLAAGAVLQGDALIAFGRAGAASSTAMVALGVLNTGCAYAIYYKLISISGAGFASLNNYLVPIIGATAGAVLLGEAISWNLALGLLMIVCGILLSALLQN
>fig|316056.14.peg.4561 Permease of the drug/metabolite transporter (DMT) superfamily
MTKLIVQDMSPVWSTALRCGIAAATLGPLLWAQGNFIIPKRGDVPVVFCTALLHMVAFSALVAAGLQFVPAGRAIVLGYTTPIWVAVGARIFLSEAITTRRAIGIAIGLAGLAVIFDSRALDWGDRKSLLGSSLILTAAFCWAANIVYVRAHKWISTPFQLVFWQVLIAAIVLSILAMSTEGVPHIEWSQRLVGLLLYSGVICTALAHWAMSMVNRSLPAVTTSLGLLATPVLGIVSAAIVLNETLEPSLFIAMALIIGGIALGTVSGGKSTQMQPRASREGLSDR
>fig|316067.3.peg.442 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTRLSVVIPVYNAEKTIESLCNTLFDLYRNSFELEVVLVNDNSRDSTHIICQRLHEANPETVTYIRLARNFGEHSAVMAGLNNATGDYAVIMDDDFQNPPEEISRMVAEIEKGYDVVYTHYPVKRDSIFRNLGSAFNDKMANVILQKPADLYLSSFKIMNRFLINEVIIYTGPDPYIDAIIFRSTSNIGRVEVRHDKRRHGRSNYTIGKLISLWGNMVVSYSLIPLRILGLAGFIMTLIGVYVGGTSLLDAILPYRQDPTEYETLIALTTFFRGFQLLAVSVVGEYVGRIYLALNCDPQFVIREKFSAQKKLQFAAVHTGLNHGYNKKTGN
>fig|316067.3.peg.959 Glyoxalase/bleomycin resistance protein/dioxygenase
MPIKMKNVVVFVLDLEKAKQFYKDQLKLPLVQESPTMMEFFPGGGPTLGVALAMHDAAKPLAGRHTGITLIVSDIEELCKELAAAGVKFAEPLERTPWGKMAVVLDPDGNQFALVEG
>fig|316067.3.peg.1183 Glyoxalase/bleomycin resistance protein/dioxygenase
MGNPFVHVELTTTDLARAKAFYTALFDWQLEDIPGMDYTLIKVGDGTGGGMMQTPGPGVSSSWLAYVLVDNVQAATAKAMTLGATICKEVTEIPGIGWFSVITDPTGATLALWQTNPVGCGSPE
>fig|316067.3.peg.2431 Acriflavin resistance protein
MADNDLNRLKIDKTVVAAGRPRHKRPLVWIIGVVAVILAILAAKGVLAPRVEVEVATVSQIYPSQAFTLLNASGYVVAQRKAAVASKTTAQLEWLGVEEGSRVQQGQIIARLENKDATAVRGQAAANLNNARAVLEQAKAELHDASLSFNRQKELVTHGVVARADFDAAEARFKRAKAGVAAAEANIAALSSALRGAEAQLDYTLIRAPFNAVVLTKDADVGDIVTPLGAAANAKAAVVTIADMDSLQVEADVSESNLGKIKVGQPCEITLDALPDVRFRGITHTIVPTADRSKATVMVKVKFVDQDRRILPEMSAKVAFLERPVKAEEQRPVTAVNPQAVLDREGAKSVFLVKDDKAIKTAVTTGPRVGDMLQVTSGVKAGDKIVLRPLDKLRDGSGIKTAEKQ
>fig|316274.3.peg.325 Tetracycline resistance protein
MHVQPQARFSYLVLSFGTRLLLSCIFTASMLYRIQVLQLDPLQLVLVGTMLEAAAFALEIPTGVVADVYSRRLSVVLGVAFLGLGALSEVWLGSFVGSLLAQVVWALGYTLMSGATEAWITDELGVEVVEALFLKAAQLNSIASLLGIGLGVALATIGLVWPIVGGGLALVGLAISIRWFMPETQFSPAPAAERQSWGRFGATLGHGWQAVRGQPVLLSIMVMSAIAGAASEGYDRLWEAHLLNNIGLPTWLDLQPVSWFGAIAALGTLASLVAVIVIKRLASNTTERSIWLLRWQYGLLAAGLLGLALTQQFAIALFWIMLIRMLRQSIQPLYSAWLNRLIESRSRATIISINSQADAFGQILGGPIIGLIASRMGLPAAFVAASCCLWPMLVLLRQRQLNRQ
>fig|316274.3.peg.445 Daunorubicin resistance ATP-binding protein drrA
MSVIDVRNLGKTYRTIEKEGGVKGAIKALFRPQYREKVAVHDLNFQIDAGEIVGYIGVNGAGKSTTIKMLTGILYPTTGAVTVLGHDPQRERVANARNIGVVFGQRSQLWWDLALIESLNLVANIYEVEPSRYKQLLSHFSEVLELDEILKTPIRSMSLGQKMRAELAAAFIHEPKIVYLDEPTIGLDVMVKQRIREFIKDYNQTHNTTVMLTTHDLGDIEQLCSRVIIIDAGSKVYDGPLHAIKQQFGKYRTITFETNQPITNVQLPPACEQLSLSEYSLELKFDRSQLSASQVATALMQQIDVADFTLNEPDLESIIKHLYQNPTAYNEVAVNE
>fig|316274.3.peg.446 Daunorubicin resistance transmembrane protein
MNKLAYRLRIYRSVVGMNIKEMLAYNLWFWSQLGAHLFLTIVYVSFWKALYSERETIAGLTMQQTLTYIILARMIAPLVQWGYTQEFGYWIREGTISSELLRPVDFQERIFIGHLTRTFVALAQQLLVTGSFAVLVFDIRLPTDPLIWLSFLISLLLGCSILFCFDWIFGCVAFYSTEVWGLQVVRGSILMLFSGVLLPLTMLPSGLQTLAQWMPFAQSVSIPVSLLSGITPLDQLGSIWLQQLAWLAVMLMLSRLMFNFSVRKITVQGG
>fig|316274.3.peg.471 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATASIEKLGTAPIGKLLLAMSSQTTISLLVYTIYSITNTYVLSIGINGLAAAGAAIIAPVLLALGAVSTTVGAGGASVVSRALGAHQPDRAARVVANTFIIFWAAALIISVIGTLAIEPIVYLLGATESIAPYAIDYGRIIFLGAITSTGYSAIIRADGNTGFSTAIWIIPVSLTIGFWWLLVIVFPLGMTGAAIATVLGQAASAGMSIYFFFFRKQRSYNIRLSYFKPDWAIMREILLIGSPSLIKNLSASIMAIVTNNLLRTLGGTSALSVFAIVGSLYSGLMTPQTGIIQGMQPIVGYNLGQRNLQRVWQTIKLSLRAAVGYGLLISSICLIIPSGLISLLSHDQALIAEGQTALRLLALAYPLTGISLVSAAALQAAGWAKQALLLLVGSIIGIKLPILLLGSQLFGLNGIWAAEAISELLLCGAAFWLLNKLRQQTYQPLGPEGN
>fig|316274.3.peg.1029 Drug resistance transporter, EmrB/QacA family
METAIKQAASAAVEFEQPRYTKRETLLTMLSVLLVMLLASLDQTIVGTAMPKVITDLHGFDRYTWVTTAYLLASTVMVPIYGKLSDMFGRKPLFIFGLIVFLIGSGLCGAAQSMNQLIIFRGLQGLGAAALMPIALAIVGDLFTPRERARWQGITGGVFGISAILGPTAGGWLTEHVSWRWIFYVNLPLGIIALLTLVFLMPTLGRKAQRVKIDYIGSILLVAGTVPLLLGFTWAGSQYAWLSAQVLSMFGLSIVFLGAFIAFEAWLERNNGQPIIEPSLFKNSIFRISVLITIISNMALFGNIFFLPLFVQGVIGTSITNSGLIMTPLMLTAIICSVVAGQIVAATGKYKIIAIVGMAISVLGGFLLLQLDINSTNTNVAIDMVVLGLGMGAGMSLYTLITQNALPNKIGQATSALTFFRSIGSTIALAAMGSVMNSAYLPAFKAAIPAEVAQNVPAESLAAFNNPQILLSPETQSLIQAQFAQGGQQGEALYNTLLGAVKYGLVDGIHHVFIFSFGITLLGFVVVFFLKEIELRGGRKKAEAQIEQTGEAGAAGMAAFH
>fig|316274.3.peg.1421 Drug resistance transporter EmrB/QacA subfamily
MKRIVIDQKIAVCVVFVAALFMSIMDGTIINVALATIQQDFGASSSAINAIVVIYLICIAVVIPASGWLGDRWNTKWVFLTSLGLFTLASLACGLAQNIEQLMLTRAAQGIAAGALMPVGTTMLFRTFPPHQRIQVSRVLIIPTVIAPAVGPVLGGFLVDHLSWHWVFFVNGPIGLAALIFGVIWLQAPAQEEVGAFDWLGFILAGAGFAALLYTLTEGASKGWGSPIILVSAAIGVGALAALVVVELAKAKPMLDLRLFSIRLFRVSNLVAIFGSAAFTGILFLMPQFLQNVVGASALESGLTTSPEAIGVVLSSQIVARLYPKVGPRRLTFGGVLGVAVMMGLMSTIDAETNLWLVRALMFGTGVGMAYLFLPIEAAVFAQIPHASTGQASAIFSMQQQLGSALGVAILGSVLALNHSGTTVNQNAQSYQYAFLAAAILAFVSACVALFIRDRDAAATMAQHGEHSELSHSIA
>fig|316274.3.peg.1467 Drug resistance transporter, EmrB/QacA family
MRVETTHASAVATSTREKGIILTLLIATFVVILNETIMGVALPRLKDEFQVEASTVQWLTTAYLLVMAVLIPTTGFLIQRFSTRTLFLTAMGLFTFGTVAAAAAPGFEVLLVGRVFQAAGTALMLPLLMTVILVLVPMERRGAMMSTASMVISVAPAIGPALSGLIIQALSWRFMFIFVIPIALAVLAYGYLRLVNVGKLQAASLDRTSILLAAIGFGGLVYGFSRAGEPGSSLTEPIVLAAIGMGLVGIALFAWRQTRLSSPLLDLRVFRFPMFTLSVVLMMVVMVTLFASAILLPFYFQQIRQFNTLQTGLFLLPGGALMGFSGLFVGRIFDRSGPRMLVIGGMVLVVLALWQWTFLNATTSVIWLLSLHVIFSLGLACLFTPILTTGLNQLPQTLHSHGTAISNTLQQVAGAIGTALLITIMSAGQAQPGQTIAPNPLADLTIGIQNAFVVAAGIAVVGLVLALFLRRTGEPSGEPTFIH
>fig|316274.3.peg.2359 Quinolone resistance protein
MNFMVRPRRKRYQGITPPQHCPPAELKTVSELSLSDNSNYAQLIIQQLNFNQQRAKDIFMEQSLVRQCQFNQVVLQQSQLVDSSFEQCDLSHANWEKSHLERLEWRNSRLGGMKFVEAQAEHLVFSTCQLDYSVWWSARLEHVRFEDCRMLEISFEAAKLSDICFRNCDLSRANFRQATLSNVDIRGSQIGGMQIEPKQLQGLIIEPRQALEIAQSLGLTIRELETEDQA
>fig|316274.3.peg.2624 Fosmidomycin resistance protein
MATRTSGQAVALTGLSVMVMMTFSHAMNDMWTSLLAPLLPSIRDTYQVSIGQTGILVAILSFAGSMLQPLLGAVGDYIDRRWLAAFGPVLTAIGLTLIGYVPNFFMLGALIMLGGLGSAIFHPAGAAYIAMGANPQQRGLFVSIFSAGGTVGMAFGPLIAAQFDLVSLPYLLPVGIAVGVLTFLMIPSAKQNRSQPKTLRDYISVFQGPLRWLWFMSVLRSLSSVSYSSLLGFMLRDRFDQAMADAHVGPTLAVFNIASAVGGIIGGRISDRIGRTVVLRSSILSTIPLFIGLVLSSPLNWWYYPLTALVGAMVMANIPVSIVTAQEYAPQHIATASAMMMGFAWGTSGVLYPIIGSLADWTSPTWAMIAAIGLLLPAFFITVRLPEPERTTTIG
>fig|316274.3.peg.2693 Vancomycin B-type resistance protein VanW
MADEFYQKYGPIERRRQNGDVQQFDATAPLADDLPVRSAAPPKRKRSRLRTFMWGAGITLGLVGLLFGIGLWYLNRTFEGRIYPNVAIQGIDMSQKTPEEAKALLAEQYADLLKRPVGLSFNGQTWEPTADQAGISLSIEQSVDEAYSLGRGGNIINTLQAVSGIWQNGYDIPLAVTVDQAQLSEYLTTATNDLITAPVNANLIVAGNTATMTPAREGRLILIDETAQDILTQLQTLSPAQVVLRTEMVMPTVLDDGVFEAKQTIDAVLQSPLTLIAGDLQWELSTDDLRALIRLDTHTDANGKTKMVASLNDQMIRQRVATFADEIGRGSVNPRVAWDGGALTIVREGRTGLRLDEEASARRIIEQATIGETRTIELVIREVQPDVTAENIHSLGIVEAVGVGKSSYKGSASYRVTNIKAGSRLLDGILIKPGEEFSFNNAVGSIDEANGFVKGYAIVGNRTQEEWGGGICQDSTTLFRAAFHAGLPITERHTHSFRISWYEVYEPYGMDAAIFTGALDFRFVNDTGKWLLLNTYVDDSTATVTYALYGTAPQREVILDGPYVTKEYPKPTEPTYIADPKEPVGVFHQTDTARDGMDIIVYRIIRQDGQVILREPFNTHFKPWPDIYVHNPATPLPPKGCKPTDPCANPATPTPEPQPPQQPEPTPEPQPEPTPGGEIVVPTPNP
>fig|316274.3.peg.2766 Vancomycin B-type resistance protein VanW
MPGQRWRLLPSLVLGLALLGLAPSVPTASVSAAVQAQQTTAWEPYRYFAATGHNISFDVKRFYERQGDLEVFGLPLTEVIWENGFQVQYFERARLEIHPENKGTDFYILATRLGAVAAEGRQNEDPFVWRTGPSYEGATFYPESGHSLGNGFRDYWTKYGGLYTFGYPISEEFSEVNAEDGQTYTVQYFERARMEWHPEHAGTKWEIQLGLLGKQYINRMGIDQNLLKPALEVQKLGSATTYYRGSNAERINNIKRAADRFKGVTVKAGQVYSFNQNVGDVSEEAGFTDGYAIVDGKLEKVVGGGLCQVSTTMYRAVFNSGMPIIERYGHSYIVYYYENILGFDATVFVPDVDFRWKNDLGTDIFMWTDTDTSAGRVTFSLWGYGDGRRATMEGPTYSNEQKPGKPVWQYDKTMRRGAVEQLVHGRAGMDVTMYRVINKANGTSNRERFFTRYYPWEDFYLYGPGVKPPAGVTIAPPRYP
>fig|316274.3.peg.2913 Daunorubicin resistance ATP-binding protein drrA
MLIANTNYTAARRCLLSVRGTMQPEYAIRTVNLQRTYKTKERILKALDGVDLAVRPGELFGFLGPNGAGKTTTIKILTTLLLPTGGTAEVWGFDVLHEADAVRRHINMVSGGESSGYGLLTVRENLWMFTQFHGMDSKLANKRIDELLEVMGLADRAKTRVSFLSTGLRQKMNYIRGLLTDPDVLFLDEPTLGLDVEAARTLRTYTRHWLDTNPGKTVVLTTHYMQEADELCDRVAIISGGTILACDTPTSLKHSLQEDVVFRLFTTPVNPAFLQAVEQIAGVQSISQRSGDQRDELSLILRDDAILPHVLSQLAAHNAGLLSLEKRQPTLEDVFVNLVGHSLSESEASA
>fig|316274.3.peg.3161 Daunorubicin resistance ATP-binding protein
MDRSSAMIIAEELRKQFGDFHAVKGVSLEVKPGEVLALLGPNGAGKTTSIRMLAAILKPTSGRAVVGGFNVETHAREVRHAVGLLTEFPGLYHRMKSLDYLLFFGRLQGMNDRDCGNRAVQLLQQFGLWEAREKRIDGYSKGMKQKLALIRAMIHDPNILYLDEPTTAMDPHSARTVRDAIAGLRSAQRSIILCTHNLNEAEELADRIAVVHDGGIAVQGTIAELSQQLMGDPIWELRLAQPQPELAQRLADLLTIEEVGDSWLRYRTTEPQTLNPVLIQRISGWGWPLLAINEVQRSLEDVYLTIVGQTHRERMSSPLEQPNAAAVAEVAL
>fig|316274.3.peg.3417 Permease of the drug/metabolite transporter (DMT) superfamily
MPKQGRNSATQPRLIDRLLAFKEGNLGMTLRQTGVLLILALVWGASFLFIRLGVETIPPITFVFLRLAIAAVLIYAVLRWQKVQLPRERKLWYSLGFVGFVNAALPYCLFAWGEHKMGTNASGLASIYNATTPLWTVILAFAFVRSERLTGVRTFGIVLGFAGVVYLFSRSIGNINSLDTWGQIACIIASSMYGIGTLYVRRNFGSLPALIPAFGQMASGAIMLLPVALVVDHNSWQMPSLVSLGSLFGLAILGTGIAQILYFWLVKQVGAARTAQVTYILPIFAIFWGWLFLNEAIRSDMLIGLCLILLGVIIVNGKWPFRRQTVAAPSN
>fig|316274.3.peg.3887 Permeases of the drug/metabolite transporter (DMT) superfamily
MNSMQAVQISTNQNRVEIPWRAYVALAIGIVCIALSAIWVKWAAVPGPVSAFYRMLIPAAILLPWWFAKRPKHLPKQATRLSLLGGVFFAFDLALWNSAILLTSAANSTLFANNAPLWVGLGAWLIFRERLPQRFWWGMAIALIGVVVIMGENLQQLTMSQGDLLAISAGGFYAAYLLTTQRARAELDTLTFMTLGIVVSVVILGLMCLIGGYSIIGFSPQTWWSLMGLGLVSHLGGWLAINYALGHIKAATASVSLLGQPVLTALISIPLLNESLNIFQIIGGSLVIGGIWLVNTQKA
>fig|316274.3.peg.3890 Permeases of the drug/metabolite transporter (DMT) superfamily
MIMQFTVLAASIKRGLGEHGTAIRLFGSALGLLIAGQLCYRKALLGATQHNLESLWQVSQSFWGMLGIGLILLSLFPWLALLARRQLSFFYPLWSIATIVLVVINWWWFGGGMSWQTLAGIGLVLLGVSLLFRGGHSI
>fig|316274.3.peg.4051 Daunorubicin resistance ATP-binding protein drrA
MTISISVKDLRKSYGKDSAVLKGLSLDLYQDEILALLGPNGSGKTTLIKILATLLTKDSGKVHILGQDLDDDENEIRHLFGYVGQDTERSAYSRLTVVENLQFFGALRGLDKRQVNAQIEKLVEYFDFKSNLKKYFGYLSGGQKQTVVIMRALLHDPAVIYLDEPTKGLDPLIAKNIRSFLKKYVKEEHKTLLLTSHILSEVDELSSRVALIHDGVIASVGTAQELKQGVGVDGFIELQKHSIPLGVVDKILRLPPVLNSDDQDSEWVSFGINNMVDAMEGIIHILREEQIQSQFRYRNVSLEDAFVYRMGLLSDGFEA
>fig|316274.3.peg.4146 Vancomycin B-type resistance protein VanW
MGAVMMSSMAAVAPNPQALAWARAGLLAIKYGRYRDSAALLTRAVKLDPMLGEAWRWLGALHSGQRQAYCLRWAQRSLPSATIPRLPSVVAAPIAPVRSKAKPQRRGNWRKVARWSSAAALAALLGFGGFQAAYANRVYPGIQAFGQSLSGLTSNEAAQAILPTLQAWNNHHFKVQLGDQTAIVPFNALTSFDPQVIAERALQIGREDSWSQRLSNQSLGIVGTIKADGLLLNQASLDQAIQTLAEASDRSAVDAQFQHNANGAWAVSNDVIGLKLDRDQTKAAFQAAWDSIDWAAAPHDYEVVVVQQALQPQQKATELNALLPTLNQQTAAPLIITIKGNEHQFDRTSLLDLHRLPQAGQRFGNNDAAIKAIVQELAQNYDQPAQASRLVRNGNRAIEWQFGQIGYTLDQAQLQTQIGQALNTANNAALDFSLHETVPPAGELEALGIYQVIGVGASDFSSYPDYNRDRNVDVGGKEFDGLLIAPGEVVSFGGTVGDISLEKGYQIGEMIENGVAVPSIGGGICQVSTTLFRAVFWAGLPIEERHNHSWRLAWYEVDAPAGMDATIALGGPDLKFRNDTNGYILIDVETDLVKKNQTFTLYGSDTGRTVTMEATGNGWNFFQIFRTITERDGISRSDRWDSYYTQ
>fig|316274.3.peg.4240 Permease of the drug/metabolite transporter (DMT) superfamily
MKRWQSDGVLLLIVMLWGSTFFVVRDATDHWPPLAFVALRFGLATLALLPWAIKSFGQWTRTDWQAGLITGGLLCVGYITQTIGISMTTASRAGFVTGLNVIFVPLMGAVLWRTKVSAKVWAGVVLAVAGLYVLSIDPAAQAGTEPVSLWGDFLVFICAVTFAGHILAIGHWTKQASPIAMNLIQVAVVAVVAGIGSLLFETVPALPADVFWAGAYLGIICTAVLLAIQIIVQRYASPTRTALIFVLEPVFAALFASTFGNETISSTFVWGGLLMMIGIVIAELPPLAIFNKQEPNETV
>fig|316275.9.peg.4351 Multidrug resistance protein D
MLCGLLTYGVGCLLAIMATDFDMVLIARVISAFGAAVGSVIGQTILRDSYEGKELGKVFSLAIVAVSISPVVGLLLGGFLSEYFGHLVVFSLLLFMAFILLTVSAFSLPETKPAHIQTVSFMSVFKAMLKDGDIWKSAILVACFNVMMFSYYSLAPFMFSQFGLSSIEFGYSGVILASASVIGSSMNKHLLAKEWGSQRLIQIAVLLSFMGAVQVYLYQDSLWFLVGMAMVVVGFGMASPNIFSTALVNYKHQVGTAGAVLGLLYYSLIGGGLGLAGVIGNLGLVLIAMSLLAGTMLLSRE
>fig|316279.3.peg.1084 Drug resistance transporter, EmrB/QacA family
MTNINKWWLLVLVALPTLSTCLSTNVVMSALVSIGQTFPDVAGIGEWTLLIYSMTAASLSILAGVLGDRYGLRKMYTIGLIIFLLGALGASFATTGESLLVFRSLSGIGSAILAPVALAFLNRIFSGVEKPIAFGYWAATITIGNVIGPFLGGLIQSISSWRLTFPIAALPALIALAFAGILPAYKPGNTRKNIDIKGIAYLSALPAVILFTLAMAGRLNPSSIIIFLSLIGIGFFTFWKHLNKTENPVIDLQILENYKWWRPSIIQLIIRCLFMAMLILLTGYFHSIQGLSELNSSSALFPFLISVGVMAFTSGYICKSIGIRKLMTTMFSLGLAGAVILLSVQPDGFRLIDWIAICFIGLLAGSTSQLSRLSMANFGVNDSMKGASINTLIINVGISIGAAYPTLIRSIVSKQAHLSNIISKENLLHIMHEEVMVLILLFCIGIWQAGKLQDLTEPKTLST
>fig|317025.3.peg.15 Acriflavin resistance protein
MSSTGEKQTSDLNIAGKLAKAFIHSKITMMIMVAVTLAGALAYMVTPREYNPQIVVPAANIIVPKGGATPSEVQNMVVKPLETIMGALPGVKHTFGYASNDFGVVTVQFDVGENQVDSLVKLYNQLMQNMDKMPPDTQQPLIKPINVDDVPILTLAVTSDELSGYDLRDISLKLVENLRNTPGVSFTDVVGGKKRAVNVWLDAQKIALTGMSLEQISKMLKGSNVSLPVGSLVSNNESHPIRVNGFLGNAEEVGEIIIGMEKGRPIYLKDIARIEDGPKETDTDTRIGYGVASEQSARGERPAVTISVAKKPGTNAVTVADAVLDKLHELKKSTLPANVEVFVTRNDGEKANAAVNLLMEHLAIAVASVIVVMVLFLGWREAGIVTLTVPLILFVVLFVGYVSGQTINRITLFALILSLGLLVDAAIVVIENIHRHIHDGFDPEKFDEVLIRATNEIGNPTNVATFAVILAFIPMMFVTGMMGPFMAPIPFNVPVAMIASLLIAYILVPYASYRFLGKKALKEMKERESLASHHVTKPDWMQSLYEKSIVPMLESRTKRNVFLSVVLISLFAAMVQPALQFLRGDGMNNPLHSAGVEVKMLPYDNTSTFLVQVDMPEGTALEATDIVVRRVNDVIANTPFVTDYSVYLGDHAPIDFAALVRGDLIKEGSNFAQIRVNLVNKHDRDLTSHEIVQLLDKRLASLKKVFPNANIKLYETPPGPPVTTQVMAELYGPDYDKLRTAAKEINAKMYDIYGLSNIDDSVTATTSSYQINIDRTQANLLGIVPAEVAKMLRDYINGFELGYMHLDNVREPVNIIVRLPRSERTVPEQLLSLNVQSRAGDSVPISAFAKIKEVPQAKPIIGRDQHQMVMVGGELLRSSPVYAVLSLDGMLDGVKLPESNVTFHTANLGFVEAQPEDVMGYTLLWGGEMRLTLDVFRDMGSAFIVALVFIYLILVGYYRSFMMPVIVMGAIPLTMIGVFPGHWLTGQAFTATSMIGVIALAGIVVRNSLLLIDFILEYRQEGKTLKDSVIEAGKVRFRPILLTALAIMFGSMIMITDPVFGGLAVSLIFGTLSSTVLTLLVIPLLYFIWQWHSGVKYTEGNQIKP
>fig|317025.3.peg.210 Acriflavin resistance protein
MNIAEYAIKKRTVTLILTLFVIIGGLFSYENMGRLEDPEFTIKEAVIITYYPGASAEQVAEEVSDKLETKIQELGEVKKIRSLNKRGSSVITVEMKNKYGKNDLPLIWQKLRSKVNDITPSLPPGASKPIVKDDFGDVYGILFAITGDGFSYAEIKEYAKFLRKELLLVPDVAKVDMTGVQNETIYIELNRNQIVSLGIGIDEIVDTLNNKNTILPAGSVKVGPEYIAINPTGKVDAIEDIQNLIIQSKNGYTNQKSNLIYLKDIANIYRGYKEPPNSMIRFNGFPAIALGVSTVEGGNVVKMGNAIKARLNELQTQIPIGIELNPISLQSERVTQSINAFIINLIEAVLIVVAVLVIFMGFRSALIIGVALFITVMATFILMKTQGILLERISLGALIIALGMLVDNAIVVIDGMLIRIQKGMDRIKAASEVVKQSLWPLLGATSVAILAFGAIGLSQDSTGEYTRSLFYVILYSLLLSWLVAITVVPLLGVMFIKVSTNQSDPFATRFYQGLKKTLIVLLNHRWLTVLVMLGLLYSSFLAFAQLKDSFFPSSTRDQFMFHMYFPEGTDIREVSEVSHEFEQIVLKDEKVKNISTFVGSGAPRFLLTYSPEKDPSSYVYMVVTVDNYQDIPDLMKKYHDYVLVHYPSVLPRPEAFALGPTKPAVEAVIYGEDADTLRDIGSQIEAIMRDQGATAIRSEWRERVKEVVPVFDEVRAREIGVTREDFNRSLDVNFTGIRVGYYREKDEMIPMVTRNAEKDRFDVDQINNIQVWSSGARKYVPINQVVKEIKVDFVDAASHRKNRNRVYKVMCDPAIGALKSSIFAKVRAPIEALTLPEGYRLEWEGEFEASNDAQAGLMASIPTFLILMILIVIALFNSIKEPLIIWLTVPLALVGVGFGLFVTNQPFDFMALLGFLSLTGMLIKNSIVLIDEINLELSGGQERFDAIIHSVLSRTRPVSMGALTTVLGMIPLLSDAFFVAMAVTIMAGLAFATILTLLFVPVLYAIFHNVKVPRAVKVS
>fig|317655.9.peg.282 Probable antibiotic-resistance protein
MAAARGCGRGTPSITRGDMMRALLLSLALLAPFASAIANDDVIDTHVHLWNGEASLAEYRAKLKAAGLSVERFGAMWFGGPNQARAGNPADISARNDALIALGKKHPDMIPIATVHPYDGDAALAEVTRVASRGVKLLKIHPHTQGFDAADPRVLTLVKHAGASGLVVLLDNASIVPADNEKLFNLALAAPKTKFIFAHMGGMGFRFWNILALARTAEGLFAENIFFDISGVTLFADSPVKDEYVWTIRNVGVDQVLIASDYPQMSLAKTLEAFDKLDLTEEERAKIRSGNAKRLLGL
>fig|317655.9.peg.2011 Membrane fusion component of tripartite multidrug resistance system
MAAHHLSETPRGHKAGSARRIDRGRTDHPVAHDRPAGRGRAARTPRRPGRPPRVAALPDRARRRTARRHPPRGRGAERGGARRTERRRTRPARRSGRAGARQPVAPRLPERSGARLMDQLAPSRPEAEAAAPPPAAPRADPLPSPAADTAARPGWRTRLIMFGLPLALVAGGAGWWLLSGGSVSTDNAYVQMDKVSVAAEVGGRITEVAVRDGEQVAKGQLLFRIDSEPYALNVAQATAAIDAARVEVGNLAAGANTSAVEIAAAREEVRFAQVNFERQAALMEKGFTTRAAYDASRHALAQARERVRQAEAAAVEARTRLAAGPASGINPQVEAARVQRAQAEVNLARTSVRAPSAGRVAQADRLQVGQAMVAGLPALTLVDTAHPWVEANFKETDLADMRVGQRAEIRFDAYPGLKVRGHVLMIGAGTGSEFSVLPAQNATGNWVKVTQRVPVRIAFDEKPARDMIAGLSAEVTVFTGGGTVAGK
>fig|317655.9.peg.2640 Tetracycline resistance protein, class A
MTATRTIPFIVVTIFIDAVGFGIIMPVLPQLVMEVGQIDLPHAIEVGAWIGLVMAVATFLASPVLGNLSDRFGRRRILLLALGGLAVDYALLTVVETLPWLFVARALSGIFGGSYAAAQAAIADITPPEERARNFGFVGAAFGVGFVAGPAIGGFLGEMSPRAPFVAAAILATANMLYGYFIFPETLPKERRRAFDWRRANPLGAWKMMRALPGMDGVAGVLVLWQIASLVYPMTWSFYCIAQLGWSPGMIGASLAAVGVMIALGQMFVVGPAVARFGERDAATFGLLVAVAVYIGYAFTTSTLGAFLLLIPIALQAPVQPSLMAMMSRRATADTQGEVQGVSAMAMGLGQLAAPMLLTGTMAYFTADAAPVHFPGAAFLVAAIFGLLAIAMLRRLPRATQTADQMPPSVTA
>fig|318161.14.peg.299 Permease of the drug/metabolite transporter (DMT) superfamily
MNIKDYALCIFIMAIWGINFSMVKLGLNGIDPMLLTGLRFTLAVIPAIFFVKKPDVHLFYLIGYGLTFGVGVWGLSTWSISSGLSPGMAALLLQTNVIFGLCLGWFLLKESVTPSRLIGSLISLSGLAVGLMVTDGSVNVQGVVLILVAAFAWSISGILIKKSNTKNAFAFTLWSMLFAPIPLFLISYFQIGASAFTTLLDNLTGMAVFSILYQAYATTLFGYWIWNRMIVLYPLSQVAPFTLLVPIFAILGSNILFQEAISLQKVLGCSLITFGLLIGSFSLKRVRSLVQLIM
>fig|318161.14.peg.1136 Acriflavin resistance protein
MVVILCVLTVFLGVLCAYNNKIQLLPNVEPPKISFFVIWPGASENFLITDVVQPYEEAILGRLERLESLKVTTRPERASFEVTFSFGTNLEEAESKLAALLSRARTLPLNVKPLTFHHGGTNVSNRVVGSYFITSESSEFSPKQLSVISNLAKQKFKLLPGVESVELNPALESQLQIRLDMNKLYQLNLSFDAIRQIVGGLLTQPVIQLYENERVITAKFKPTTLLEDIRQIPIAHVDGVSILLQDVAQVEVGPITQTAVSRFNGQEAIAMRILRYADANLIEVQKKVDEVLAQEAVTLDSAGLIYNLSFDTSIFIERAIFWIIGSLATGFILTTFVSYCFFRRFKPTILATLVILLSTCGVLIVLYLTKTSINVISLAGITFATGMFVDGVLIIVEYLDRLKPDKRSSLERTRSSLNKLVPALLVSTITTVIVFIPIIFSQGAESQLFKGLSLVIASGLLFALFFTVLLVPFFAEYFGQPEPRSEIAFPFVTNAVRSLIKSKRSSVFFVIFLVGGSLLSLSIFIPSLSYLPSVKRDTVDVYIPLSGDLRIETVQHNIVGPINDILQAVPSEIIVKNNYVIAWPHFATAAVRLNDSKQIPALIPYLQQSLKEHLPSNRVLVLQGELLGGLESANDIEINLYVSDQQWLAENISIVRNIIESALPDISIRVIPDVERFVKEYEFSPNLLSLRDSGITNDELTNLFRTIGKSDFIGKWKSDDEVVNAYITIEDNYQDVANIPYVSRNGVRTYMGSLTNIKTSDVLPSLNRLNGSAALTISLRPTSNERTVSSVLAVLEQDVAPAIRQLMGDKGYIGIEGSASSLSKTKWFLALLLFFIVLSFIVILAFLFRSIKLSMYVLLSLIPALAGGILAYNFLSFVTMSDFNVLTMLGFAIMLGIVANNSILLVDAANNVSAHCSDCDAILFAVNERVRAIVISSLTTVLGILPLLLFPSEASQLYQGIAAIIVGGIVVNLLTVLFLTAATIRIFGLERPTLGFPQNLEVEIVNKGL
>fig|318161.14.peg.1545 Permease of the drug/metabolite transporter (DMT) superfamily
MLSFFLETNAPLETVLSTSVQTWGVLAFVGYISTLIAFAIWGKLLKSYSAAVVTPFALLIPVVGLVTSSLMLNESLTRDEILGAVLILLGLVFCVAGKKSFILIAKYRGAK
>fig|318161.14.peg.2719 Multidrug resistance protein D
MYLFLAILLLSCAQFGSQILMPALPGVAASFGLEDSIAQQVIMVYFIGFGLSQLIYGPWSDSAGRRKVFLVGQGLYVLGTLLCVLAPSEWYLALGRFIQGIGAGAPLIVSRTLLSDHFTGELRKKAMASLAIAASFISVLAPVLGGTLTSAVGWQSLFALLGLYLLLSGLIGWYLLPRQVQHRRSQHGQIQDSQIKQTKATPVKGIVGQYRLLLLDRRFLMPALFKWLPSLLYLTSATLLPFILQHKLDLSAQQYGMAMMLPATGLILGTCLAKLLHAQLSYPSQLLLFLPLLFLAGAGFILLPFTLTNCLLSYSLFMVCGGAFYTISLHLLIEPFEQQTGIVNALCGAIDMLVFSVFAMLVNHYWVDTIAKLGWLYLVVSSALLLVGLALKSKSGSEPAFDVKSMT
>fig|318161.14.peg.3622 Acriflavin resistance protein
MVMDFCLKYRRTILALCALLVALGIAQGLRMPVQLLPTIERTEIQISGRWQQNAPEDVEVQMAVQLENALASLPGLKLMESQVSTGSVTTRLLFEDGADPVASLIATSAKLNQVQSWPQSADEPQITQDGISESETVATLMLYPRAGVDADFALLDEAVRHQVIPALLRIPGVSRVDNSFSHRDKVIWVNFDPAKMSRFGISVAQLQQKIAQLQDQSGGSMDLGKDSVALRFKGQPSRSALSQHIIHWQEGRPVYLGDVAEFVDGFAPGRNITFKSGREAYYLSLNRSRGHNSFDIVQGIKQRIEELNAVELQPLGLELGMSLDTSENIERAIAIVGSNMLIGIALVYLVLFFFIRRHSAALVVITTVPLSICLTLLLLSATGASLNVISLAGLAFSVGLIIDAAVVVQEAIEARCASMQNTAQAIKEAVSKVAKALFASTLTTLLIFVPIAGFAGDVGQLLADLALTMALAITVSLLVALVVVPLLVFVSRRADGKDYHSDYWVKMADVVLSSSNTRAKQTLLLLMLIVFPVVAIPLLLPPKDLLPNAGDTLLRASIQLPQGRNIETLRRDVAEVLIARLRPYMLEDAAIPVRSYNLVVASNFAFLVAYPKNPEQLDMLIAEFNQKIFADLPEVSVYVEQEPMIYFRSSASKQIHLNVHGDDLSKMLVVAEDLKKEIIEQGIAQGVQITPAADDDAQRLLVYPNSWADHDFGLSQQQLADIVSAYSGGLYAGEFIDGLETYDFYLKGPKWYNPQQLRQLQVQTPNGDTVDLGTLAGVQQQRGPSRLLRFDGRRTVRLIITPPAGSSLGGLTDSLRRLLAQDYAAQLTAQQMHVSFKGSADEFEQAMNNIMWVVVVALGGLALVLMLILGSAQAAGHILLTLPIALFGGAFALWFINLITPVSMDILTMMGFIISAGLVLNNAILIVAEQRDGIVQGLNSNQALHQAVLRRSRAIYISGLTSVFGMLPLMLSPGIGAQMYRGMATVLVGSMSFSLVFCVFVVAALSYRGNMPVGRG
>fig|318586.4.peg.169 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLELHHINVCTKDVPHLNEFYRKILNLGGVDDDEHVQDTTKGYYSGVEFVTDGKIEFHLATTDLGVSYRTNQPVNPLERGHIAFRTDDIEAFKKHLTDNGVPFADYGVWAMAGWYQIFFQDPEGTIIEVHQINYGK
>fig|318586.4.peg.2489 Probable efflux transporter protein, acriflavin resistance protein family
MTNRGFNLSDWALHHRSLVWFLLIISMVAGTLSYLRLGREEDPNFTIKIMVISASLPGATIEDTLNQVTTRIETKLEELDELKFTRSVTMPGQSVVYLELDPTIRGPQVPEVWKRVRNMMSDIRPEFPQEFQGFQFNDDFGDVFGNIYAFTSDGFTQRELRDRVEDIRKQVQALPMAGKTQLLGVRKEQIYLEFSSARLAALGLNHNQVVQTLALQNAISPSGIVQAGPEQVLVRVGGQFDDAQSIAAVNLRVGDRFFNIGDVATVTRGYEDPPSALFRYNGKEAVGLQIGMREGGNILEFGQHVDALMAEVARGLPIGIEMAKFADQPHVVDEAVGHFVQALAEAVAIVLLVSFVSLGLRAGFVVTLTIPLVLAITFVILDIYGITLQRISLGALIIALGLLVDDAMIAIETMISRLEVGDSLERAASHAWSSIAFPMLTGTLVTVAGFIPIGLNSSAAGEFTFSLFVVIAVSLIVSWIVAVLFAPLLGVTMLPATMVHKSERPSWLRRRFHGLLLWGMHHKWLTIAVTLAVFAISVVGMRFVEQQFFPTSDRTEIIVDVTERANASIAKTDADMARIEAMLAEERDALFWTTYVGRGAPRFVLSMDVPTPGPYMGQIVIQTPDLAARDRLKARLIEFAGRELIGTDIYVKNLEIGPPVGKPVQYRVSSPDLDQARDAARELAAVLATEPRLRDIALDWNEPARVVRLQVNQDQARRLGLTNEDISGALSGTFSGRTITQLRDGIFLINVTARGSQEDRESLASIQNLQLATPTGTPIPLASLAKLEYDTEQPLIMQRDGLPTVTVKADIASKDQPATLVEALADKVARFQAGLPPGVKVVVGGTVETSAESQEPIAAVVPIMLLIMASLVMVQMQGFRLSFIVFAAAPLGLIGVVAALLPFGVPMGFVAILGILALIGILIRNSVILVHEIQELIAKGHAKWDAVFEASDSRARPILLTAAAASLALIPISRQVFWGPMAFAMMGGIIAGTLVTLIFVPALYCAVFGVRPPKGDPMPSAEDRARAAAQE
>fig|319225.3.peg.940 Multidrug resistance protein, AcrA/AcrE family
MNNTMRFFPGRSVAPALLGFVLLFSGCGQKGGGPGIAELPVLTLKPSDARVESAYPAVLEGRVNVEIRPRIDGTLEKIHVGEGSFVKAGQPLFTIDDRSYRQAYMAAAAARDAAKIDVDRLLPLVEHKVVSGVQLDAARAKFRAADAAREAARIDLGYSVLRSPVSGYVGMIPFRIGSLVSRNQTERLTIISDNSRVHAYFSMSESDFLRFRNAYPGHTIREKLRAVPEVQLQLSDGSGFAEKGRLETLSGLFDAETGSIRLMASFPNPDGLLRSGNTGRVVVPSIYHDVILVPVAATVELQDKILVALLDKEGKLKRRPIKVEALSGSDYVVSSGVRAGDRIVTAGYERLPDGTPVKPAAPAPAVSKEKP
>fig|319795.16.peg.821 Permease of the drug/metabolite transporter (DMT) superfamily
MYAKVGPEGATLERVTVTPAPAAPPTTVRAGLGLALVAALGFSTLGIWGKLAGRVGLDSFSVLAWRFGLVALALLPLAGRELTWRQRRPLLGVGLLYALATTCYFGALSRITAGATGLLLYLAPAFVILFAWLLGRRPDAAKLGAVALAALGLGLVVGIPGAGDRDPLGLGLGAGAGALYAAYLLASERWLSGVPPLASTGHMALVAGLYFAALAAGTGTLHVPTTAAQWGVIVGMAALATLVAVPALYGAVERLGAARASLIGTLEPLFTVLLTFLILAEPLRPAVLLGGALILAGAVLAQRGNRSAP
>fig|319795.16.peg.1247 Tetracycline resistance protein, class A
MPAMQAHFAGLANADVLVRLTVTVVGLAIAVSAPVSGYLTDRIGRRPVLVGAMLLYALAGSSGLYAPTLGTLLLGRVLLGLAVGATMTAGSALVADLFAGQERARFLGLQSAFTSLGGVIFLPLGGLLAGIGWRLPFAVYLAALLLVPLALRLPRGETAGERRAEVAAERIPWRPVALAYGVALSYMLVYYLMPTQIPYRLEGLGVAPALVGFVMGVSTLSGALAALWFSRRGGTRTPIRMAGLSLLALAVGWTVVSLAPGAGWVVPGLIIGGAGAGLVTPNLNTFLAALAPAHARGRVMSGLSVSIFLGQFLSPLLARPFVHGTDVSRTFAAAATFAVLVGTALLLLGRRRAALAG
>fig|319795.16.peg.1727 Drug resistance transporter, EmrB/QacA family
MTVPHPPGAPPQRINYAQTLSLATKREILFGVLLGLFLSALDQTIVATAMPRIAADLNGLNLYAWVTTAYLLTNTALVPIYGKLSDLYGRKPVLMVGILIFLLGSALCGLSGEAFLGNLFGGGMMQLVVFRGLQGIGAAALGSVAFAIVADLFEPAERPRYQGLFGAVFGLSSVIGPLLGGFLTDQISWRWVFYVNLPLGLIALSFIASKMPRLASGLQAKVDWLGAFLIILFAVPLLLALTWGADNTYAWTSATILGLFGLSAAALVAFLFVESRHPSPILPLTLFRNPTFGWGAVARFLIGAGFLGAVLFLSLYLVQVKGVSATRAGTATIPLTVGLIIGSVGSGQIASRIGRYKPLILIGLVVAALGFFSLSTLTADTPYSGVILRMVLLGLGLGPALPLYTTALQLAVKPWEIGVATSAGQFFQQMGSTIGTAIFGAMLTAGLTTNLATQFAAQAAAQQGTVATTLKTISERIRSGAAGGSQDRNAAPQSPEQIRATFATLRQNVTRAIERGDPAAIAAIQKDPTLPAEAKQRLATVPAGGVAAGVTAGFNQVYAAIAGAVNSGNPAQVAAVAANPQLPAPLRQRLAQLPPQALQNPQARTQILAGIKQGLDAAAAAAAQQAQQQALTAALQGVNDGEQIALASARATKVAFAETIASIYRSSILVALLAFLATLLMPNLRMPTRQQGERLAPVHVEA
>fig|319795.16.peg.2524 Multidrug resistance protein B
MTAAPSSAGLAPRDKILAFVGILTVLFLSSLNMTVVGSAMPRVISDLGGFHLYAWAFTAYSLATTITVPIVGTVSDRYGRRPLILLGIVVFTLGSVLLGFVQNMNQLIVLRALQGVGGGMLMAMSFTAIADLFTPIERGRYQGYTGAVWGISSVVGPLVGGFLTDHLGWRSVFFVNVPFALLALYFVGRFFRMPAPSASRMQRPFDALGALLLAGAVVTLTLALSWGGGTYAWDSPRILGLLAATLVLGGGYVWHSRQQAQPILNLRLLRDPAISLASLAGFLTSAGMYAAILYLPLYMQGVRGSSASGSGLALTPLMFGLIVTSTLSGQIVSRTGRYKGLIMGGALVATAALLLSTTLSTTTPLWIAVGLMVLLGLGLGPVNSQLTLAVQNAAPREQLGSATSGNQFFRQIGGTLAVSLFGALVNAQLAQNLAAKLPPAAAQLPAPMQDAIANPNVLSSPQATGQLEAALARLGHADLIMPILTALRGVMAGAIDHVFLIAGVLVGVAFLVTALMPERPLAGRRAGARVEGRQAAATD
>fig|319795.16.peg.2554 Small multidrug resistance protein
MRAWIALFSAIACEVTGTLALKLLGLHTPWLALAVTGSLIVLSYLLLSLVFRRIPVAVAFAVWEAVGLAAVTLLSVWLLGDHLTQLQLLALGGLLLGARLLHGGTRARGEA
>fig|321955.3.peg.455 Antibiotic efflux protein
MVGVESDPARLMDMAIGRGFNALWSTSALSNLADGLAFVSMPLLAASMTDDPRLVAGLATLYAVIRLVAALPIGVWVDRFDRRTLIVAANILRGGALAGFALTIQFGVSSLIVLYSAMAVVAALESVADSAAIAILPSLVGTQRLESANGRIAATQLIADEFAGPPLGGFLFALAASVPAFAMGGLWALAGVIALALPTRSPSTLSADAHSSRRSVFAEAVDGIAWLRRHHVVGGLAVIGALASIGYMLPFSILVLFARERLGLNGTGYGLLLAFSALGGLLGSMLASRLRARLGSRWTIVASLILGAVALGGLALTQNPIVAGLLLALYILHAVVWNICSLSLRQRLVPDDLLGRVGGATRVLGLSGLAVGSALGGILADFDLRIPIAAGGVLFLACCFVAVIMLRGELDLGIRPTSAPRESGD
>fig|321955.3.peg.1791 Lincomycin-resistance
MIAVAAAAAFLATFNETFLNVAFTPIMSDFGINVSSVQWLTTGYLLVAAVFVPVANVLYHRFPTRTLFISVVAIMVIGSVIGALAPTFSVLLIGRLLQAIGTGLLTPIGMNITLAVSPREKLGMNMGIMAAMTTLGPSLAIVLSGALLTIAPWTTLMWVFGGLCVAVLIAGAIFLRTVAELGRPVLDIPSFLLVALALVGILYGVTAAFGGSALIAGGAFVVGLIALWLFIVRQRRIEHPLLDLRPFSSKPFVLGVIMTMLGLLFVFAMNVVIPLFLQGARGMEPMGASITLAPGILLTVILGPVAGRLFDRHGGKWSIPLGFLVMAVFVTLVGVAASGTSILLFGILYIPAVLATAFVIGPAQTFALSHLDRETSPHGVTVVSTSFQIAGCVGTSLAAGLYGALSGARIDAGADDLDALLTGFHGSVGLVVLTSAIGIVLAIVAYRSVRGGGSGVPAAGAATQQEELPAVQ
>fig|321955.3.peg.2525 Tetracycline resistance protein
MEPAARAAATMTAHEDVEAGMPAQSHSVFRRNQWALSLAQLFSGIGIATGFAVGGILAERLTGRTELAGFAQTASILGAGLLAVPLAKLAERRSRRLALASAYAIALCGAILIVSAILLGIDIAFFIGMGCFGAATAAGLQGRYAATDAAPDHLKGSAMSVVIWATTIGSVIGPNLSGPGAGIGRALGLDPLAGPFVIAIAGFGLALLSVLFLRRLTPATRDSSSTSPRRGGTWQAIRRSPSALMGLLSVVTGHMIMVATMVMTPLHMDHHGLGLELIGITIGGHILGMYGLSPVFGYLTDKYSAGRVILGGHALFALSLVLGLIDALGESSFLRLSVALFVLGLGWSACLIAGSTLLTKEIDPTHRMSVQGLSDAGMNFGAAALAALSGPLLAIGGFAAITLMGFVVLAVAVIASIRAGYGTAHTT
>fig|321955.3.peg.2869 Vancomycin B-type resistance protein VanW
MPTQTLSHPSPNPGGRPQGTAETPKRRPWLIAGFIVLVLAVLYLVIGFLTGRVLSPGTTVAGVDIGGKSTTSAESTLREELGETAGEKIELKAGKPTAALDPEKAGVGFDISETISRATGFTLNPVIIWDRLFGDDEIEPVISIDDEKFEDATGKVTESLKFEPVDAEVSYVKAKPEVKDGTDGQSVDAEQVRTAIEDSWLRTEGPLPVTAADVEPDITTAEAKDVADGFAKDAVSGDLTVRAEPAKDASSDVDAGDMTISPATIAKTLTFEPKDSKLTPVFDEEDLQKRVLAANKDVGKPAKDASFTIKDGKPQVVKSETGIGIKKDELTTAVTDAISGKTDKPTVTLASVEPDFTTKDAEKADVSDVMSEYSTGYSSEPNRDTNLKVAAKKVSGTVVQPGEQFSLNEAIGQRTAANGYKAAGVISDGQMKEDFGGGVSQVSTTLFNAAFFAGFELDEHQAHSRYISRYPEGREATLDWSTIDMKFTNTSKQPVVLDMYLSDGEVHAKVFGDKKLKVKSDSSDRYNYSSPGSVTESGPECTPQTPKQGWSIKITRTMEDIASGKTTRDSFVTVYRPVNKVECKD
>fig|321967.8.peg.77 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKALLLWSAINLSVWGTFLISNYFQAVFQEKLTQRIMIDVRDTISRKIVGSSYAQYHKQTTGEYLSEYVNDVGNIESNAIKNLFSLLSDGTTVVFATIALAAYHLLFIPMILFLSILMLKIPSRLGKPMTVATTEMSNGNAAFSNQVTNVLNGFDVLLNANKLSKLQELVKTAAKRYAEVKVSYTKTNARISNSIAALSIFCQVMVDIMTSILAILGAIPLGAISSTGSIAASIFNSLSSLSNDAVQIKATHPLFDKVIQGSSKSAMAHESTQEPAFQHALKVVDLSYSINGNKILDHLNLTFERGGKYAIVGRSGVGKSTLLKILDGQITDYTGHVYIDDQDLRTMTMTALTKISQYVDQNVYLFNDSVANNTSLWANKQKSGNSLQQALLKAKVDFVKSPDQMIEENGQNLSGGQKQRLALARFFYSPKPIAFVDEGTSALDAETARQVTKQFLNDPDMTLIEVSHHLDAQLKGAYDQVINLGA
>fig|321967.8.peg.115 Permease of the drug/metabolite transporter (DMT) superfamily
MSRRQYGFLLNILSVAVMAVTPVMNKFSMITLSPLAASFYNALVSLILTLVTIAFTKTKLVWIKQPIIWALGLTNCLGIFLQYMSLFFLDPVSVGLVGRFYIVFAILLSVLLLRERFDRKEIVPIVLCMIGTALVSDFSGDVNNILGLACALGYTFSFALTNTLAKKALINIDEKILLLYNQGTAVVILGGFLLGSGQLSLAPNLGMGAVAISAFCSGFLGLLLFYRGLKLISFRDANLIRALNPIFVLVYSLPFFTIQMTPAFLLGGFCIILSIVWMSLPMKKVGVD
>fig|321967.8.peg.184 Lincomycin resistance protein lmrB
MAAVFIATFMTSVEVTIVTTALPAIISDLHGLAYQSWIMSAYLLTTAITTPIYGKLADTIGRRGIFQWGVVLFTLGTLLSGLAPHIFLLILARALQGIGAGAVMPLTFTIIADYYDFAHRANVLALNNTAWRLSALVGPLIGGFLVDQLSWHWVFFVNVPLGILVFLLIQIGYREPSREHGVLTIDWLGILWLAVTLIALLLGIQALDRQPVLAGVLLALALVAGLLLYHQEQKAPDPLIAPKMFHNFTFTVQILTALLLSGVLIGYQVYFPIWLQSLYHLGATTAGLVVTSSSVLWLASSFLVGPLIKRFVPRTMTLWLVAILTLAYLLLTIASPHFPVWAFYVIAMINGTVMGIVISMNTVLSQHLVGKEYVGSATSILTLGRSLGQTVMTGIYGATLTLVIRANLHGNTFKAVNAAISANAAAKSHDPQVAATILTGLHGVFVMVVIVMVLVFILNLRDPNRHVIQ
>fig|321967.8.peg.194 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKSTSKLLTNQKTLTILMIFLTVIESLGRVASSLTLAPLTDQLISKNLHGVVFWLLSTIGIWGVTLTVNYGNSLLKAQIIRKVTNQLRVDIANGLNTVPISEYKKVNHNEYVSWLTNDVNMIDQNGLEAFFSLLSSATTLLFAITSLAFYHYSLALAAIILGLLTMTIPQFFSKVMTHETNRLATANSSFLGKADDIIGGFSVFFSHNLGNTLTNKLATASDHQGKEKLLYAKNVGLVNLLISGVNVGAQMLVMTLTCLLVIGGYFSVGVISASGSLAGTVFNNLAGMIQSIFQMKSVAVLLDKDIQATKIKTVSEDDSFNHALTVDHLSFGYEGKPVIKDISYNFEKGGKYAVVGKSGAGKSTLINLISGRLRDYAGTIQVDGDELKSMPATLLNAKIELVDQKAYIFNESIEENITLGHAKSQALLSNVVSFLGIDKFTNLATKIHEHGSNLSGGQRQKLALARALAFHKPILIVDEVTAGIDSENAQEIEDALLAEKDLTVIMITHNLTEKTRAQLTDTLELA
>fig|321967.8.peg.417 Multidrug resistance ABC transporter
MINLNGRRGPRNLHPEKVTLVDWKQTVRRIWGYLDTDRRKLLIVFGLTLFTTLATIVGNRVNGIVVDQFITKGRLRELFIVSGLLAGMYFLSSIFTYFQTSITTKVAQRTSAAIRHDLFAKMQRLPMRYFDTHDNGDIMSRLTNDVDNINTALMQTFVQLYTGIISVVGMGIAMLLLSPLLTGIVVLASVATFFYSRTAARITQKAFTIQQQELGSLNTQIEENVSGKQLVQLFDHQQDTIDRFNETNARYTAAAYRAQLFSGVIGPFNNMTNNFAYLLITFAGAVAILRGGTSITVGVIFTFLIYLRNFTGPINNILNLINTLQLSLASAERVFQVVDAEPEKDAPNAVELDHTAGNVKFDHVSFAYDGKTEVLHDISFTAHQGEVVAIVGPTGAGKTTIMNLLTDLYPLTSGSITLDDHDVTQITFASLRRLVTVVQQESFLFTATIRENIRMGRPDATDAEVETAAKAANADGFINQLPDGYDTMLSENASRLSQGQRQLLSIARAFAAQAPVLVLDEATASIDSNTETDVQHAMNRLMQQRTSFVIAHRLSTIRNASKILVIDQGKLIESGTHEQLLAAGGFYAKLYNSPLADMDKMKR
>fig|321967.8.peg.2139 Multidrug resistance ABC transporter ATP-binding and permease protein
MIRSLLRYTHHLTGAIIISFLIGLVAELTKVVVLVLAAMMLFDPQNASHLLIPGIIAAVIVGLGSFGEQYAGHFVAFHVLAELRGAVYRKLVQLAPAKLDSQGSGKLLKLIGSDIEAMEIFYAHTIVPVAIGLIYGVLMVAVYSSLNGPAAAVVLVSYAAVGLLIPYYRHEQMTAKAQAADRQKAVNQQYLLESVRGMAVLRQLEVADARMKTGNEGFDHEATAFQQSQFGQLLKNMSATLVMLVAWLFIVWLNGWTQPQPLQQALLAVFPLTFGPLLALTNLPASLLNGFAAARNLLNLLQEAPATSAAIDATQTLNQIAIIQVDHVTFKYPSRDETVLRQVSLSLHAGEIVGFVGASGSGKSTLAKLIMGWYPLTQGRILIDGIDLTKIDPASLRAQVNYLPQTPVFFSESVRDNLTLHDATITDAQIWTVLDQVKLTSRLRQAEKGLDENVVSGQLQFSSGEQQRLELARALLHPSSVLVLDEPTSNLDTENERLILDTIKAYYHGIVIMISHRAESAAYADRLYRFADHRVSAASTEPKQQA
>fig|321967.8.peg.2140 Multidrug resistance ABC transporter ATP-binding and permease protein
MLGLLKYGRDQRWAGVIETVFDWLPTLLPIMIALNFAAKRPGNALVITVILVLIWLGYVIGYERHHRHAWAMSAKRELRDHYFEALYQRNNAGDATAADNAVIQRDLGGLNNLDMFYSTLFPTLIQAGLTFLLLIGLSVWYGSWLAFLPLACVFLIGFAMMFLGKKMSAQNKAHLAGFLRMGGRFMNDLSGMNTLVMYNAADRYAKKFADDSEYFRQATMNLLRTQLQVLFVINGFVYLTVFAGGFVTALQLAAGQLPAAGAFATWFALAMMMVNARQLGYFFHVVKSNGPALAGILATIAKSKTTPATVKITDNRPLKQLVLQDVAIGYEADAPLVSDINATLVPGKLYGLAGENGTGKSTLTQALLGQLTPLSGTIMADNTPVTALSNAQRAAVFGYVAANDYIFSGTIKENLLLGNQFGDQWQQHLDELGLMHFVTDLQDGYATEVGEGGRLLSPGQRQQLAFARMLLADKTVYLLDEMTSSIDAANAAIILAAIKRLSRQKIVLFISHDLSAMAEADVVWFIHDHQLISADHAQLYRDQPAYRHLVDNPEAMLKEGQPS
>fig|321967.8.peg.2156 Permease of the drug/metabolite transporter (DMT) superfamily
MIIAGIVLMLVAFWKERKAILAPWRNTRDALQLILFILFGMIGMQYIYFKAVAVANAATATILQYLSPVVVLIFLALRLREKPRRIDIVTICFAMMGTALVVTKGHFTHLAISPNAFFWGIMAALAAAAYTLLPAGLLHRHSPIVVTAWAQLIGGLLIDVFDPFWKEIPHLDHAGWAGYWFIVIFGTIIAYSVYLASLQFISPTAATLLDAFEPLGATVVSVVFLHMHMGFAEILGGVIIILTVAMMAMATPHGPKLEDRSSD
>fig|321967.8.peg.2392 Daunorubicin resistance transmembrane protein
MTLRLMMIRIGLKRSVANRYAFGFYLFGNLISIAVMFFLWQSVLRHRPSAVFAETITYLIFMQLLTAVFPKTSFAIHDDIRTGNIARLLLRPVPLLTHYFWESVGYSFGKLIFIGIPDVILLVAVRQSALAWQTLPLLVMAVMLGYVLYFELEAIIGLFSFYTYSIWGINTFKAAVLLAVSGNVFPVNFYPAAVKTIAQFLPFQYAFGAIDELLSQQQAADFWPTLFMQSLYIATLFGVYHLQLKIAIQRVVIQGG
>fig|321967.8.peg.2681 Drug resistance transporter EmrB/QacA subfamily precursor
MPNATMITTPKRHQWLALTAMSMGVFMGLLDVTVVNVALPTMVNDFNTNFTNLQWVLNAYTLVYAVSLLIMSKLGDMYGRKKVFLGSLILFVLASTVNGMASSLIVLDIGRGIQAIGGAGMNSLSMALVASNFSGNKRGVALGILGSVIGMSTASGPLIGGFLVENFGWPSIFYVNVPVGIVAVIMTLTFVNETPSYGQHERIDFAGMLFSGLGLFSLIYGLIIKEGHPHWSWMDIRIGGWIIAGFILIALFIWTESRVQQPMMSLNFFKQCHFVGTIFVAFALGASLYSFNTFLTALMQNYIGYSALQTGVRQLTISGWSLVLGPISGYLGTRFSKKRMISASLLVGACGFLVMLNAMGPRVGFMDLMPGMLMIGFTNGIVSPLINTVGMEGVAPQQMGMASGLLNIFRQLGIVIGVVGFGLMQAIQYENYLNTHIHTVGMPSQMTTGIHAALIKAGPFSGHTIAWSKRLTETPFAQKLQSVVVHAYDNGMAAVLIAALVVILIGSLAAAVLMRKESHADVHA
>fig|323097.3.peg.889 Glyoxalase/bleomycin resistance protein/dioxygenase
MANNSRPNLVGINHVALEVGNVEEALSFYGAIFDFELRGSHLDEAGRTTMAFIDMGDQFLALSEGRKQGPDDARHFGLVVDDRSKVRELAELAGARMVEGSFNFFDPWGNRVEVVEYRDVQFAKTDAVLNAMQISPDKSERARAELREKGIGVAPT
>fig|323097.3.peg.1687 Acriflavin resistance protein
MALNVSAWSIRHPLPSVLFSIILLTLGWVSFTKLAITRLPNADIPVISVAVSQFGAAPAELEAQVTKTIEDGVSGVEGVRHISSSITDGLSLTTIQFALETNTDRALNDVKDAVTRVRANLPQNVNEPLIQRVDVIGLPIVTYAAISPGKTPEQLSYFVDDVVKRALQGVRGVAQVERIGGVEREILVSLDPDRLRAAGLTAVDVSQRLRGINVDVAGGRAEIGRNDQAIRTLAGAKTINELAGTMISLPAGGELRLDDLGTVTDTIADRRTFARFNGEPVVALGIKRSKGASDVVVAKAVQERIDALKEQYPEVDLKLIDTSVEFTKGNYEAAISTLFEGATLAVIIVFLFLRDIRATVIAAISLPLSIFPAFWAMDLLGFSLNLVSFLAITLSTGILVDDAIVEIENIVRHMRMGKSAYRAALEAADEIGLAVIAISLTIIAIFAPASFMSGIAGQFFKQFGITVSVQVFFSLLAARFVTPVLAAYFMKDHPHEAPPPGPVLRAYASLVTWSVRHYFVTVLIGFAVFAASIWSIKLLPQGFLPAQDTARSLLAMELPPGSQLAYTEKVTENIAARLRKRPEVTSVFVDGGRVPPGLQEVRRASLIINYTPKQDRGITQRELELSIGQELESVPDIRYWFLDENGLRAVSLVVTGPDIGIVSNVANELATQMKRIPLLANVTPETSLDRPELRIQPRADLAARLGVSTEQLSQTIRVATIGDVGPALAKFDAGDRQVPIHVQLEDSARADLKMLEQMRVPIGGGRGHVPLSVVADIRLDQGPTSINRYDRQRQATIAADLVGTAALGDATRRINELPVMKTLPKGVTVNPSGDAESLNELSEGFATAITAGLMMVYAVLVLLFGTFLQPITILFSLPLSIGGAIMALLLTGKQLTTPVWIGILMLMGIVTKNAIMLVEFAVESIRQGRAREEAIIDAGMKRARPIVMTTVAMVAGMMPSALAFGAGGEFRSPMALAVIGGLIFSTILSLVFVPAMFLVMDDVGAFIWRYGKRLLTSGTEVAEPAAAEREPPNGRLPGAE
>fig|323097.3.peg.1825 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDASIPVAAGTRIGHVHLKVADLERALGFYCGVLGFELTQRYGDQAAFISAGGYHHHIGLNTWESKGGSPPAPGTTGLFHTAILYPTRAALADALHRVREAGIALDGASDHGVSEALYLRDPDQNGVELYWDRPQQEWPRDTDGGLAMFTRRLDLDDLMRQREA
>fig|323097.3.peg.2454 Glyoxalase/bleomycin resistance protein/dioxygenase
MPEKAKPVPDGFHTVTPYLVVDDAKAVITFMQQAFQAEFVHRPTRRPDGKLMHATLRIGDARVMIGNASERAKAMPAMLYVYVPNVDEVYAAAIKAGGTEIMAPSDMFYGDRSGGVTDPGGNQWYIGTHIEDVSDAELQKRANEMFAKG
>fig|323097.3.peg.3634 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGRLNHVAIAVRDAEKAAKIYGAAFGADISAAVPLPEHGVITVFAALPNTKIEFIQPLGEASPIAKFIERNADGGIHHICYEVPDIVATRDILIAEGARVLGDGEPKIGAHGKPVLFFHPKDFSGALVEIEQS
>fig|323259.5.peg.193 Multidrug resistance efflux pump
MVTESKKKIYSSIGGHFLVDLYSPFLPIILPVLITNMNLSFFLAGFMVTAYNVTSSLVQPVAGLFSDRTGKKVPIWICVLLSSAGISLAVLTNNYLLMLALVSGAALGNALFHPAAMESVYRLSPIEKRGIFNSIFTTSGSISYSIGPLIAGVMITFFGLSSIAWLVIPGILGAVWIYSVDKKFNTLVSAHYERKKPVSKQKKERYWWVPAGLVVFLCSLRAWTYVGIITYLPALLMLGQHGMDTITTSLIVTIMLFIGVAGQIAGGYLSDRYGRKNMLVFGFAAAVPFFCLIFLSQGWLMYSGIFMYSFFACFCYVTSVTMMQELLPESVGFASGLTLGLCVGVGGIGAAIIGWAADNMGSLPDAMFLMIIPTALSPILALFIRYPDQRRIRGRDADLPE
>fig|323259.5.peg.353 Permease of the drug/metabolite transporter (DMT) superfamily
MNILRNPGPVYGQLLVVIGAVLISLSPVFVVLSGVSASASAFYRMALSLPPLLLLLVFIRGKIWLGPRQLGIALLASIFYTLDLICWHQSILLIGPGLATILGNFQVFVLAAFSVLVLHTRVTPRLILAIPVSIIGLYLICGVQWSTASDGFQMGVLLALTTAFWYGGYVLFLRLLQTSFDLEGKIANLCMISILTTIITGLVVIGSGDSFDVPSVDSWLYLAAYAIICQVIAWLLISAGLPFTVPIKVGLILLLQPAGAFIWDILIFRLPFTCVTVLGVVLTLGAIYLGSTSTSPGEKSES
>fig|323259.5.peg.488 Efflux pump antibiotic resistance protein
MLTAALPEIEHEFSVPGIYESWILPIVLLVGAAASPFVGTAGDRFGHKRLLIICLVIYSVGLISGLVAPDIWVLLFGRAMQGAGIAAFPLGYAIIRQRLCETGADTGIGIISAMYGAGTFIGVITGSFITGLFSWRVTYMVLIPATCILLLCIWKYIGDDEPVNGHGSLDFAGFFSLLLFLLLSLVFFSLPTEDQIGFFGLLLLVSAVLVFGLFIRIERRASHPLADIQLMKRRPVAVFMVIGFLTVFTFFVLLQMMPYIIRLPTGLALSAEMVGLILIPGTLCDMAAGPLTGRMIPVIGCRLPCITGSLLLLSAGCLLFLFPVTLPVLVIAWMVFSFGMSMLATADLIGVLEFIGEERTAEATGIIQSMQTLGGMIGPIVTGIILATSQVSTMYLGEIWEIPKTGTYYQVFLVVIIISSLLLVISWIYVKDRRKERNEHTHPSV
>fig|323259.5.peg.634 Drug resistance transporter, EmrB/QacA family protein
MAFLFVNVQKGYIPLIIAISLATFMASLDGTIVNIALPTISESFSLSSSAVSWVATIYLLVMAGCVLIFGKISDLIGFKRIFLTGFIIFTIGSFLCGFLPDLTGSFLTLIGSRAFQGVGGAMITAIAPAMVTAFIPMNMKGKAMGIIMTMAGLATAIGPTVGGFLTQYLSWHWIFFINVPVGIIALLLGLRVIPGQPSHQTLEVFDRIGAGLIFVGLAFLLYGFSEGTNLGWTSPVIIGSLGLAVVLLGLFVWKELHIQNPILEIRLFHDKNFLLINLVIFLVFFSFSGVNYLLPFYLEYVGGYSTSEAGLILTALSVAMMVAGIIAGVLYNHLGGRILSIIAAVVLLIGYFLITHLRIYTPTIFVTVCLLCIGFGLGLIITPISNMIMTSASKKYQGMVSSLTSLERFAPMTIGIAIYNVIFIQGMTTIAAHYDITKNAPVEIQMKVLTAGFDLAFLLSFILGIVILVLTVMARYTMHPDYQGEDIDKMAAGLV
>fig|323259.5.peg.684 Multidrug resistance efflux pump
MSAFRRIGELTIAHLINDIYAPILMALQPVLITMYGYGYFEAALLPVVHSLTSSLLQPLFGYLADNKGIKVSIGISILLSGIGVSVLGLIPNQYYIMLLCVALSGVGHASFHPGALCQVSILATGSSRGKLTSLFVVGGNMGMALGPIIAGIILTTGGVPQVIWLIVPAIATALFLHVNPITDCCNIKQEKTSEGKENWRPVMLLFTGATLRSWVTFGAMTFLPTYLVLEGYSLLEATTLVSIMMIAGVAGQLSGGALSDRIGRKKVIVFTTLASIPAFIAILLTHGLFLILSMMIFGFLLWSSFSVTIALSHEMIPSKIGLISGLFLGIAMGAGAIGVSISGAVADMAGLYTCLETFPVILMVSVIIFMMVKSSSPHPNQD
>fig|323259.5.peg.1586 Multiple antibiotic resistance protein MarC
MAPDLISFSLFALSSILIVVNPLGALLVYNSITEFMDSKDKRKVAAYGCRIAGAVLIFFTLFGSSLLSLFGITISAFTVAGGVLLFGIGMEMVYARTSRAKVTATEKYESIDAEDISSMPLAFPMISGPGTITTVIVLSQDTPIFSEPVELGIILGSVIVTILITYIVLISSEQITKRIGQREYRVVNRLMGIMLMAIAVQFIINGISQAFPMLTGSAT
>fig|323259.5.peg.1650 Multiple antibiotic resistance protein MarC
MVSDVGYLVGAIGTFFAILDPFGNLPFFIAYTNTLSAPVRRKTALVLSAFIFVAMAVFLFSGQMVLSFFHISLPAFQIAGGIILFGVALSMMSGTHTITMNRVISDTGKEMLLEKNESILPTIIVPLGIPLYVGPGSIAAAILFGSNAPTETAFLGGLLVILLIVIFITILNLSSDYIGKVLGNQGIEILVRLMGLVLAAIAVQLTLDGITGAITTMILPSLSG
>fig|323259.5.peg.2150 Efflux pump antibiotic resistance protein
MSQIISNQLHQRLLLTAAAVGMFLDGLDGSIVTIILPQISESFNTDTGTASWVIITYLLMMAGLILIIGKIAERGHIRKIFLLGLCVFTAGSAACGIAPDLEILLAARILQGIGAAMLAATASLLCVTYLPKDMYGMAFGAISMSVSVGVATGPAIGGFIAQYFSWHWAFLMNVPVGILILAFGMYIIPPDIPREIQPFDLYGSILLFGLMVSCVYCLERISHLGISDLQILLSGSISIACLIAFYIRERMCHILLIHIRVFSVMNFTATLLAFLIYGCVSMGIFYLLPFFLQAGMAYDPAMAGLFLLIPPLITAIIGIPMGRWSDLIGRRPFAIAAAVLSIAASGIFMIIIPETGFIPLIFGLLIMGLFMGCFGGPVASRVVENAPPGEEGTGTSLMVTAVYLGSVLGTALFATFFTLGSAETGISAFSDLDPEKFLHGFHLSMTAGFILSVLALILSVIVREKKTRENSVRI
>fig|323259.5.peg.3329 5-nitroimidazole antibiotic resistance protein
MRRKDKELTDTERIEEILTGALFCHVALCDHDRPYCVPMCLAYHDGKILLHSADAGRKIDILHTNPHVCIIVETGIQ
>fig|323848.3.peg.738 Multidrug resistance protein MexB
MSSRFFIDRPIFASVLSIIIVVVGLVALRNLPIAQFPEITPPMVQIDADYPGASAEVVAESVARPIEVQLPGIDNLLYYESTSSNDGHMTMKLTFEIGTDVDIAQVQTQNRQRLAEPQLPDEVVRQGITVKKTSPDLLAVIALSSSDPRHDTIYLSNYALLRVLDNVKRLPGVGDAIIFGSQNYSMRLILDPVRMAQLDLTPTDIAAVVREQNRDFPAGRIGREPSPKGTELTIPVITQGRMSEVKEFEDMIVRAYPDGSMVRLRDVARVELGAQSYDLEGRWNGKPNTFLLTFLAPGANALDTVHRVRQEMDKLARSFPAGVSYDIPYDTTIFIEVSIKEVLKTLVEATLLVILVVFVFLQSWRATIIPAVAVPISLIGTLAGMAALGFSINTLTLFGMVLAIGIVVDDAIVVVENVERHMREGLPPREAARVAMDEVAGPVIAIVLVLGAVFVPVAFLGGITGELYKQFAITIALSVAISGFVALTLSPALCALILKPGHGEPAKYWKLFNRSFDWMQTRYTNGVGMVLKRSMIALCIFAVMIFVLLGLFRTIPGSFLPEEDQGYFITVVQLPDGASKERTIDVLSKVEQYFLSIPAVHSTDALAGQNFVFGTRGANQATMFVPLQSWDTRKSAGEHVTGLIASAFQEFAKIPEALILAFNAPSIRGLGSTGGFSLQVQDPSGGDFKEFAEITQKFVAKAVEHPAIAAASTNFRVSAPRLYARVDRERAKALGVPISEVFDSMQAYFGNLYINDFVKYGRIYRVQTEAQPQYRSRPEDIEKIYVRARNDKGHVMIPLNSVITTEFTSGPDPVTHFNGFNSALVLGGAASGYSSGQALDALEQIADEILAPKGYTIDWSGISFQERQAGGKSVLVFAFALLMVFLVLAALYESWSVPLAVILAIPFGILGALLAIWVRELTNDIYFQIGLVTLIGLSAKNAILIVEFANQRYANGEPLLDAAMEAARLRFRPIIMTSMAFILGVFPLVIASGAGAASRNSIGTGVFGGMLAATFLAIFFVPLFFVVIRKMTHRRGQPEVRASHAAPDNSPSTVEDE
>fig|323848.3.peg.779 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKHSEPRISVVIPAFRSERTLPELCIRLGKVLPSVCPEYEIIIVEDGGGGQTWEIIQALAAADARIRGMLHSRNYGQHNAILSGIRAARFEIIITMDDDLQNPPEEIPALLTKLAEGYDVVYGTPCQEKHGVLRDIASLITKRMLEHAMGGDVSRHISAYRVFKTHLRDAFKDYRNPFVSIDVLLTWATTHFAAIPVRHDSRTVGASGYTLARLVRHTLNMVTGYSVFPLQLASWTGFLFTLLGMCLLMYVLGRYLLYGSGMAGFPFLASIIAIFAGAQMFALGIIGEYLSRMHVNSMGRPLAVIKEATFPVNSTSNKEGSRSG
>fig|323848.3.peg.2020 Permeases of the drug/metabolite transporter (DMT) superfamily
MLTKQNKQYTRGGHGAFPIAALLVGATIWGLLWYPYRLLEQAGVSGAAATVITYLVALLLGLAVFRHELRTIRILDMETWLLVGIGLSAGWANLAYVLGVLHGEIMRVMLLFYLSPLWTIVFARFLLGEMLSMHGYLVIVFSLGGAIIMLWQPEGSLLPSSYADWMGISAGFMFALANVLSRKDQYHDVQLKSVAVWLGVALVALGYSLFLAGLPASVDVSTYTFLLLLLVGLTVFALSLVVQYGLTHTPANQAIVIMLFELVVAAVAAYFLTDEAMTLREWAGGAMIVSASLFSARMNRE
>fig|323848.3.peg.2453 Permease of the drug/metabolite transporter (DMT) superfamily
MSEALKSWSGWIAVFFSICIWTGFILVSRYGGMGTLTSWDIALLRFGVGASIAVFFLPRILLPPLKVIALFSLFGGIGYAAVVYAAFRWAPAAHASVLLPGTLPFLTAIIAWLWFGEKFTGARRLALLIVFAGILLTAADSLSLGTHISPTQILGDVLFLCGSSLWAIFTLLLARYPMPPLAATVTTTLGSAAVYLPVWLLFLPSNLALAPLREIILQAAYQGVLVVFIAMLLYTFAVRRLGSQTVALLMAFVPVISALAAVPVLGEPLPLLTLAGLGAVTVGAVLGARRR
>fig|324057.4.peg.427 Permease of the drug/metabolite transporter (DMT) superfamily
MWNMVWILVSVIMGAAGQVLLKFGAMHPNESMSGPLRMLNLYNAGGIFLYGASALIWMFVLRKVELSYAYPFVSLAYIIVLVASYYFFGESINTYKIAGLVLIVGGIAFISRA
>fig|324057.4.peg.542 Permease of the drug/metabolite transporter (DMT) superfamily
MGHKEMRLPYFLAVLNAVIIGLSFLFAKTALDYASPLDTLAFRFTSSFLVMSIPVLFGWIKLSYRGKPLRKVLLLASMYPLGFFTLQGYGLQHANSAEGGILYAFTPVVTMIIASMFLKETTTVLQKLSIFLSVFGVVFIFVMKGSSIDLSNLLGISLLLLTCFAFAGYTVLARSLSRQFSPAEITYLMMGIGFVFFTVTSLTSHASAGTLSHIFAPLASGTFIASLIFLGIVSSLLTALTSNYILSKMEASKMSVFANLSTIVSMTAGAVFLGEEITIYHLIGSVLIIAGVIGTNRLGRKKTAGHENSQKLNAVNHSRS
>fig|324057.4.peg.629 Daunorubicin resistance transmembrane protein
MLQAYWYITKMKLLINLTYRFEVFTSVATNLILMLASVFLWQTAYKGGSGTVESLSLQDITTYTILSIIISTIFVCDVQNTIYYKIREGQIVTDFYRPIPLFACYLAEDIGEMLSSLLNRALPLVVFASVFFGIPRPASFRSFLLFLPSCLLSYAILWLLSALIGLIAFWVMELGNMGNVKDAIVRVLSGSIVPLWFFPESVQTVSKFLPFQYTYQTPLGIYIGNTSTSEAFTSMAVQAVWIAVLYLILAAGWARTKKKTLIQGG
>fig|324057.4.peg.750 Permease of the drug/metabolite transporter (DMT) superfamily
MNRASKSFSAYELLYVVGIIAISFSSIFIKWSSAEPSVIGMYRLYLTVLIMLPLAWKYKQELLYHTARQLLLLLASGVMLALHFLFWMSSLKHTTVASSTIFLALEPVLVMLGSYLIFKTKANKMMLLGMGIAMIGTVIIGSSDLALSKEALYGDVLSILGTIAVALHMLIGKQLRSNTSAFAYNFLVFTIAATTLAVYNLIQGYRFTGYSSHEWGIFLLLAIVPTLFGHYLFNWLLKYMNATAVSMSVLGEPVIASLLAWALLKEALTGWQLGAGVVILFGVWLFMRHGKE
>fig|324057.4.peg.912 Fosmidomycin resistance protein
MTTTAALQAQRNPAIWMLFGVSFAHLLNDAMQTAVPSSFPLFQSEMHLSFTKIGWVAFMLNITASLLQPFIGYVSDRRPMPFLLPLGMLFSLAGVVGFAYADSFWMLLVSSALIGVGSSVLHPESSRVARMAASGGKGMAQSVFQVGGNTGQALAPLLVAFLLMPHGQRGFLWFTIFAVAGIVIQQIISRWYAGQLAAAALIKKAANRVLDQQSPHSTMFVAGTMALLIILLFSKFVYIAGMTGYYSFYFIDHYGLSFSRAQICLFALQFAGMVGTLLGGPLADKFGRKTMIWISIAGTAPFSLLLPYASPAVALVLCCAIGLILMSGFSVIIVYAQELMPRHIGTVSGLFFGLAFGMGGLGSVLLGWLTDVKDVAFTIELCSFLPLLGLCAFLLPKDSKLMGKV
>fig|324057.4.peg.1142 Permease of the drug/metabolite transporter (DMT) superfamily
MLKLKKASLPSHPFVLLFISILSVSVSSILIKFSDTPTSVAGMYRLFITVIIMLPFVPWRQLRSLKLNMKDWSIVVLAGILLGLHFLFWMESLVHTSVASSMVILALQPLFVMIGSYLLFKEQANVLTIACLVAALFGSILIAWGDIGVSREALIGDGLSLIGTLAVSGYLLAGQKVSSKIDANVYSIIVFFIGGVVLLINNLLNGYSFTDYNSSDWIYFLLLSIIPTIFGQFLFNVLLKSIGATTVSVGIIGEPVLAIILAYLLLGENISLFQLAGGMITLFGMGMYFWAKSFIGGRKVGNHG
>fig|324057.4.peg.1995 Permease of the drug/metabolite transporter (DMT) superfamily
MDPVFRIILLKTLTSTQIVLLEHIILFIAAAPVLWKFRADLRDVRLRQLGALLFVSWGGSALATILFTQGLVHGNPNAVLLLQKLQPLFAIVMARMLLKELLPKKIGPLLVLAIVGTYLLTFGFTLPFGHVNEFVQVGSLLSLGAAALWGGSTVMGRYLLGSMKYETVTSLRFMMALPLLLVITWSEGAAWKLAEGTDPVAVIVNLLLQALLPGLVSLLVYYKGLSKIKASYATIAELSFPMVGVLLNWTVFGQVITSAQIAGFVFIWFTLFFISRQQN
>fig|324057.4.peg.2767 Teicoplanin resistance protein vanZ
MIKLLFIRDSSYRWSVYNYNIVPFHTIKSLIYHRHAYNTDTWVKNLFGNIVLFIPLGVCFPLLSRRLFQAARSLAAIIILLFLVESIQLVTKVGSFDVDDIILNTLGACIGLVFIKLFASRLRS
>fig|324057.4.peg.2908 Multidrug resistance protein
MKSLSQYPKEIKVFLIASLINAIGSALMWPLVTMFVFDQLGRTMSDAGLVILVQSIGGIAGQLLGGALYHRVGVKKLIIGALALNAAGLLFLPALSHAWTVFIVMMGLIGLFNALSMPAIQAFIGFRFAERRGELFNIVYIANNIGVAVGTALSGFLADVSYSLSFVLNGVTSGVFALFFLFYLQRVGTGSGDHSAELMRKKQAAGGASLWLLVTDVRLYLFMALGGMLINLGNSIWNTGVSPFIIEHGMSKQMFGYLWTLNGILIFVAQPVTNLIKRLAASSIKAQLTASAVLYMSGYVVILIMHSFPGMVLGMILTTLGEMLIAPAIPAFLSENSGKNAPFYLGLTGGIGSAGRVIGPYMMSGLYDGGGLTPVAWLAVITAAVSVGSFVIHSWVNKENRAPATNSSNVRTSQA
>fig|324057.4.peg.3950 Daunorubicin resistance transmembrane protein
MISLSKPAKYVFIGKITLRSQLAYVVDFLIRSVFLLLILYIFMQLWQTTFAGEGTATINGYTFKQMMWYLVFTESMVLATPSLSTRIEEEVKSGDVAFKLIRPVSFIAFHYAEYMSEVAIRYVINLILGSAIGLLLVGPLPVGIGLAWLPIMALGGFTVNFMLGMLVALSAFWVEETRGLEFVYNKILFTIGGMLMPLELFPESLQRIGHWLPFQTVVYFPARTAVGMHLGEISRALAIQWLWVVIIGVMVWLLYRKGVRKLNVNGG
>fig|324057.4.peg.3956 Permease of the drug/metabolite transporter (DMT) superfamily
MKTKAWLFLVLANLFWAGNLIFGKSVTAEFPPIWVAFLRWAIAAMALIPMAQLIEKPNWRKVWKANWGILLFLSLVGVVFYTLLTYTALQHTSSTNGSLINSLTPAVMIVLSLLFLKEKMTVWQGAGLVLSFLGVLTVLTKGHLLGVFRTPYNEGDGILLIAVFLWAIYSIISKRAQHLPPITFVAFTAVIGVVFMVPLLFIQPLQTEHTTALGVTGVIYLGLFPSIGSFLFWNQGVKQLGPGKASITMNLMPIFTAILSVLTGQQLLASQIVGGVIVIAGMLLSANLIKRSDRNGTKRMTKHRTGVI
>fig|324057.4.peg.5084 Permease of the drug/metabolite transporter (DMT) superfamily
MKLWHYALIVCLGGCCYGVLSTFVKLAYAAGFSVSAVTGGQYLFGAVLSWLIVLLVNRKAPTRKQTVKLMLSGIPFGLTGIFYYQALQTLNASLAIVILFQFVWIGTLLEWLLLKKKPTRNKLMSITLTLIGSVLAANILFQGNMSLSWTGCVWGLLAALTFSTFVFLSSTVERSTPPLLKSALLSTGGLITIFIVFPPTFLLDWHVVTGLLPYGLALGVFGVVLPPLLFSIGMPHVGSGLGTILTASELPIVVILSSFVLAEPISAPQWIGVVIILSGIVSSNLRLRKSDQPSLAA
>fig|324057.4.peg.5418 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDAQNLHYFEKAPVAKAVAHFAVPMMLGTSMSVIYSILNAYFLGTLNNTAMLTALALTLPLFAVIMALGNLIGMGSGTFISRLLGERKYDDVKHVSSFAFYSSLVLGLIVIAVGLPLIDPIVHGLGATPESFGFTKDYVTIMLIGSPIVVLFFTLENIVRSEGAAITSMTGMILSVVVNIILDALVVYVFHWDVIGVASATVVSNLVACVFFAFHMGKKSQFLTISMKWFKATKEIMSNVFKIGVPVFIMSIFLGAMSLIFNHYLVEYGDQSVAAYGISSRLLQFPEFILMGLCEGVVPLIAFTFTANKSRMKETIGFTIKMIVSLAVVFGIIVYLISDHLIGLFTNDPQLIEMGSYILHVTFLSLFITGMTTLFTGIFQATAQGTAAFIMSIIQGVTLIPVLYIANQMNGFHGVVWSLVIADTVAFLVGAVMLYILRNKLQPDLESLAQ
>fig|324057.4.peg.5684 Vancomycin B-type resistance protein VanW
MWKKLHLWVIIVFALLLVASVGYGALSYYSGQDTVPEKVTAGGVDIGGLSIDDALKKLDQYEQMLESRTVTVEGNAEAKAEGSQTWKAAEIGYNAEFVGVKEELKKLRTGNVWTRSKFRYHFTTSFELKQSYDPAVFDKLVLAEFDWIDSNKPVNATRKITDNDEVVYTSHTDAYRIDVAPLEEKVASWITVPDSQLGGQPEQVLTVQLGVKTVHPEITLEKLKDEGIDRKIMEFTTNFATSAEGRAFNVTSTAKALNDWVLEPGEVFSYGDVVAKTEKEYGYKEAPVISNGKLVPGIGGGICQVSSTLYNAIIRTAGIDIVERRNHSLPVAYLPKGQDATFASGSIDFRFRNSTGKQLIIRTVVENRKLTVKLFGTMPENIRYDIESSIVKTVQPAVQKVTDKSLGAGQSVTVQNGSIGYVVDTYRTMYKDGKQVSREKISHDTYRAQPIVVHVAAGAGGSSGSQSSGGAVEDGI
>fig|324057.4.peg.5828 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVSAATLTGGTLNAVLGTTITAGTVAVSGATITAGTLDALLGATITAGTLTAVLGTTITAGTVAVSAATITGGTLNAVLGTTITAGTLTALLGATITAGTLSSVTSISQKSFQEVANLNNLTADAYTAVPAITTSVFGTYSYFVYNKGPGTNAATARVEISANGTNWYTDVESVTGIAVGSVDVLVPQRFLKYTRLAYRSTTTGSATTVDVYFNGQGT
>fig|324057.4.peg.6000 Drug resistance transporter EmrB/QacA subfamily
MNAKQDDNRFWFVILAIFFGNFSSILNSGTVTVALPFMMKDLHSDLNDTQWVTTGFMLAMGSIAPIVGYLGDKISYKRLYMFSLVGFLICSVLCGCSWNIGSLVLFRILQGLFCGAILPATLTIVYQAVPAEKQALGVSLWSVASMFAPAIGPTLGGLLTEYYGWKAIFFMNIPLALLAIVLASRYLPMQQVNKGSSLDLAGLLTAVTGSTSLMMYFTQGNKIGWFSGWGILWITLGVVSIALFIRRELTAKAPLLNLRVFRHTTFTFGIVVNCILTIGLYAGAFLLPIYMENALGSSSLTVGLMMLPGALLMIGASLLSGRLHGKIRPEYPLLGGAFLLIIATWAFSRLSLTTSYAFIIGWMICRYVGLGFSSPNIMTLSMSAIPKESTGHASAITNWLRQVIASFAIGIFSSVYSVRTQTHFTELSSSGGVKTSLQETASVLAMNDTFIVACVVTVVAIPFILVLSSRSRISGEKAASTVSK
>fig|324057.4.peg.6191 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLLGTVDVFMLSRISDKATGAVGLANEIIYFCIMMFGFVGIGTSVAVSQYIGARRAKEASRISAMAISMNLIFGILVSIVIVSFGESLLRLLNLNPEQIGIANHYLKIIGGFIWIEALSYAVSSVIRSTGNTKSVMFVTLGVNLLHMGGNYLLIFGNLGFPEWGVTGAAISTVVSRLLGIVVLFILLYRRIAVPIQRKDYVRWKGSYAKQILSIGLPAAGEHLSYQSQYLMIIGFVNMIGITALNTHVYVMNVSNYFMALALAIGMGTEIIVGQMVGAGEMKEAYRRLMKSVKISFLLTIAVVGVAAIFRHELIGLFTKDPEIIAAGASIFLLSIILEPGRTFNMVIINSLRAAGDARFPVLAGVISMWGVSVPLAYLLGVHFGIGLLGIWIAFTVDEWLRGVMMLLRWRSRVWEKKALVKPASVVSDQGVEAPI
>fig|324602.4.peg.100 Drug resistance transporter, EmrB/QacA family
MAVPETDTRRAIMTVLFVGVFMSALDSAIIGPIVPALRAAFAIDNTQVVLVTIIFTLCSLSSTTLMASLSDRYGRRNVYLLNVFGFALGSLIIALSHDLTMVLIGRALQGVCAGGITPTASAVIGDVLPSAERAKALGLIGATSGMAFLVGPVLASLILAVAAWQWIFLLNLPVAAAVIFLGWRALPRATAVHRATAATAFDWPGLTLLVLILVSITLGINQLLDRLLGLTLWPWLFLLVALLTPLLAWREVRAPVPLLPPRLFTNRQLQIVYLLAAGSGIAMGSIIFITSVAVNFGVPISQAGFFLLPLVFLASVTSIIAGRILPRIGGRMAMLIGYGQLMIGTGLLGLPAAPFWLFILATLIMGSGLGIVVGGTLRALVLEEVAAGDRGVAQSVINIAISIGTLIAVALMASIADAFDLSTAYLACTGAMALMTAISLALRRQFSPPSTANAS
>fig|324602.4.peg.455 Vancomycin B-type resistance protein VanW
MSVQHSQPFNPTHERTDGEVFSPSLPGAVDWPDQVVHPPAVQRGTGRRTRRKVSRGWWWLLLVVLSGLAIVGTGMVFLDRSYAGRILPNVTVRGVAVGNMTREEARAAIEASFAPFLAQPVVLTYSGRSWTPTLAELGVALEIDEALDAALAVGRSANLFTDLQQMSAVWQYGIDIPLRLSIDQDAMQRYLLARVAEVEQPARDAHLMLHGTTVEVAPSAVGRQVLVAETLQEILSAIQDLNPDTVALRTRALEPSLRDDAAFLAQDQIAALLAGPVTLLVDNRPFVWSLDELARMIRVERISDPMGDRLEVSVDHDMVMEKLIALGDSTEVKGTYPRLNWNEGKLEIFQPGKPGKRIDEAQALNAVLEALNKPADQRTVTVNFREIPPPVTADNLDQLGITTLLGVGRSDFTGSAPYRVTNIQAGMRLLHGILIPPGEEFSFNQTIGRIDSSNGFVEGYAIIQNRTQLEWGGGICQDSTTVFRAAFWAGLPITERWGHSFYISWYDRYGFGPYGDGPGMDATIFTGGPDLKFLNDTGGWILMQTMVDTRRNLAEVRLYGPETGRKVLLEGPVITNRTPPPTEPVYVAVPERPVGQPRQSDKARGGMDILFTRIVLGPDGKEIERREFVTRFKPWPDIFEYNPADLGPDGKPLPTPTPPPAEPIPVEQPPVEPPTDATG
>fig|324602.4.peg.1029 Vancomycin B-type resistance protein VanW
MERSLPAGIPHRHRSRFWRIIEWLLVIAVLIILAILLGYGAIILSDRLLAERIYPNISVRGLPIGGMTRAEARAALHRRYAEFLATPVTLHFNDQVWRPAAEDLGLHLAIEEALDAAFAIGHQSEWEVNAQIAAATWQYGIDLPLHLTFDQRVAQATLQMIATEIDRAPIDASVDLRGSTVVVGREAWGRQTLIDETLADIAAAVQSLQPQEIAIRTRILEPQVRDSDLAPTVSELRLLLSGPIQLEGQGGQCRAGCRWEWSLDQIASWIRLRSLTAVDGRPAMAVMIDQAAIRAALTPIAAALREEGGLPRVDWNDGNLRIRTPGTPGRGLAVEEAMARINAVLYSSERTVTLPLRELPPPVTADNLAALGISAPVGVGVSSFRNSAPYRITNIQAGTRQMDGVLIPPGATFSFNTTLGPVTAERGFVEGYAIIDNRTQKEWGGGLCQVSTTVFRAAFFAGLPITERHAHSFRIGWYEELGEPPGLDAAIFTGVHDLRFVNDTGGWLLLTGTVDTRRQQLTITLYGSPTNRRVEYSYRILERMPAPTRPVYIDDPTLPSGVVRQTDTARDGLRVEIYRTVYADGAVHLRDTIPTTFQPWPDIFVRGVGR
>fig|324602.4.peg.1271 Vancomycin B-type resistance protein VanW
MPNNRYYQEYGPIYRRRAGQRPPLADDELPPDEPRRPRVRRPVRHRRRVPVWLWLVVGLVLLVAIPTGALYAVDIVYPETILPGVSLNGESIGGYTRTDLIIELRRRYRSFEQQPVTLTFRDQQWQPTLAELGVAFDVERLVNSAFALGRSGDPLTRAYELWLLWQEGIDITPRLTVDLAQTQRYLLGLAPQIERLPADAVLSLADARVVGQPSQPGTQLLVDATANDVLLAIRALQPQTVPIRTRQIVPQIDDTDLVVAQQIADQLLRSALELKVEDQTIVWTPERLAELLRVTPVDGRLTIEVDPDRLARAVEGLAQMIDTGTAEPRLRFSDGRVRIVAEGQPGRRLRQADAVTAIADVLMQPSPVTRTLTLPVERVEPQITAATLDNLGIVELVAEGRSSFAGSAPYRITNIRAGAARMNGVLIAPGEEFSFNRQLGEVNAENGFVEGYAIIGNRTQLEWGGGVCQVSTTVFRAAFWAGLPITERHAHSFYISWYDRFGLGPNGDGQGLDAAIFTGVQDLKFINDTGRWLLMQTSIDEQAQVLVVQLYGTRPEREVRIEGPIIANEVRAPTEPVYIDDPSLPRGTIRQTDVARSGRDISIYRIVTEADGEVRRELFFTRFRPWPNIFVRGSG
>fig|324602.4.peg.1543 Multidrug-efflux transporter quinolene resistance protein NorA
MKSRSPLVFIFLTIFIDLLGIGIVLPLLPEYVKIVEQSTWPWLAENRAFIVGALTASYALMQFLFAPVLGALGDRFGRRPVLLLSLVGAGVSYLVFALAEQLTFLGVETVIGLLFLARIAAGITGASISTAQAYIADVTPPNERARGLGMIGAAFGLGFMLGPALGGLLANVSLHAPALFAAALSFANATFGFFRLPESLPPEKRVQSHVRDLNPIKRLLAVAGDQRVQPFILGSVLFNLAFAGLQSNFPVYSDERFGFSPQQNAFVFAFIGLIAVVVQGFLIRKLVARFGEARLTIAGLILMAIGFAATGLASAGWMLFPAIGLVALGGGMVTPSLTSLVSQSVSAQEQGATLGGVQSYNSLMMVAGPLLAGMLFDLVGQTAPYLIGAGLLAASLVVLYGTLRERFTGTPQPTTTTVSTETMVQVE
>fig|324602.4.peg.1552 Tetracycline resistance protein
MEQTILDHAVVTRRIIGALFVTQSLASAAFIANIAVNAIVGAQLSGNDALAGLPATLMLAGAALSAYPAGRAMQRFGRRPGLTVGMLLGLAGMLIDGVAVISHSFWLFLVGLFLVGMARGITDQSRYAAADAVPPARRAGAISTVVFAGTIGAVGGPLLVGPLGRIAAAGGLPDLTGPMFGGALLFALAALILFAFLRPDPRVLAIQQANQPVTTTMTPLTATRSLPTILRVPLVRAGLISMVLGQVVMVLVMSVTSLHMSHHHHGLDSISLVIGAHTFGMFGLSMITGRIADRLGRPLTIIAGAFLLIAGALIAPASLLTPWLALGLFLVGLGWNFCYIAGSSLLADAITPGERGAVQGASDLLVNLGSALGSLSSGFILAGFGYLVLCIIGAVLSLAPLSAALWWGQSSRQVVTGAD
>fig|324602.4.peg.1861 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MQPEMLSIENEEITTHPAPSHAQLEKRVLRLAWPVIGENLLQTMLGVVDTILVASLGAVALAGVGAALQVIYVTTGALSALSVGVAVLVAQAYGGGRLKEASFLARQGLLWSILIGLPVTAIGLPLTPTLIGLFGLAPDVSQVGIDYLAVTMSTITTLTMMFLIGGVLRGVGDTRTPMIITAFANVINVIASAALIFGWLGLPVLGAVGSAWGSVIARFAGAILLVGVLWRGRNGVRAGGRGGWWPRMRVLRNILRIGMPAALEEVLIIGAIATLTPVVATLGTVPLAAHRVAINVLSLSFLPGIGFGLAATALVGQAIGAQRPAEARRIATIAMRWALIWMGGLGVLFMIFAEGLVRLFNSDPQLVAEGAAAVRVVALTQPAWAITFALGGALRGLGDTLSPLVISGSAIWICVGLALVIVLWWLPALWGIWLAFLIVGPFEALVFWRKWQQRITSWRPGSA
>fig|324602.4.peg.2549 Fosmidomycin resistance protein
MLRNRVFTAVVGGHFMVDLLNSLGAVLLAVLAVPLGLSNQQIGLALTIYTLLGALSQPLFGWIADRLPGRTLQLAAIGVIWMATCYTGVALAPNWTILLPCFLLAALGSGLFHPIGTASAAAAVPDKPASATSIFFFGGQIGLATGPILAGIVLTMAGTPGIVPIALAAAIPAGVLLLAQQTARSRRLNRAAPTPNTHPWTKLAVVLLIAFIVLVVVRSSIQTVYQSFLPKLFSDRGWEPAIYGALAGTFMASGAIGNVINGWMADRFGMRAATVWPLILSVPAGLACFIATPLWAIFIGCGLAGMLVGGQHSILVLHAQRILPVRQGLASGLILGFTFASGAIGTWFSGIIADVIGLETVMIGVTLLGLPAAALALTLPGRPKATVTRDIPAGMQAEVRGS
>fig|324602.4.peg.2659 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MNRLLHTTYWDIVRQYRNGFYFVTVLIVALLVVLLRQLDGVDWQLWWPAILLETLVVNSFFFMAGLVLLEKGEGVLEAQVVTPLRDWEYLLAKIISLFVLSASESLALILLVSGPAFNWLWMLIGIGCFVAMYTLYGFFVVARYDSISEFILPSALWTMGFSIPLLPYFDLWQHWLIYLHPLQAPLILVEAAYKPLPAWQLWYGILYSLVWISIGWVVGRHTFYRFVVTKEGSRRRSVSLARSL
>fig|324602.4.peg.3036 Permease of the drug/metabolite transporter (DMT) superfamily
MTTTTTRVEQPVLFAGLTPTDLTMLLVVLIWGANFSIVKAALTEIPPLVFATLRFTSASVLLVGFMFWREGKRALPDRRTFWKLTWIGVVGNTIYQALFTYSLTMTTAANGSLIIATTPALVALAAALLGIERIRRVMAVGIALAISGVALVVAERGLSLGGQGLLGDLLMLGAAFCWMMYTLGVRTLGQGLSPLAITTWTMVTGVPGMILISLPDWSTVVWDQVSLQAWLALAYSTLLALVLAYVLWNNSVRVAGSARTAIYGCAIPLVATLIAWPLIGEQPTWVQGIGGLLIVSGVLLTRRP
>fig|324602.4.peg.3075 Drug resistance transporter, EmrB/QacA family
MSRQHTILITMGVMMSLFMASMESTVIATAMPGIVRDLGDIESFSWVFAIYMLTSTTAGPIFGRLSDLFGRRPVYMVAIAIFSLGSLLCGLATTMPMLIAARALQGLGAGGLLPLAFIIVGDIFTLDQRAKVQGLFSGVWGISSVIGPLIGGFLVDQISWHWVFWINLPPAAIAAALVWIAWRDPVRANAKRPPIDIAGALLLSVGIILLLLGLDQPTTPSGILMLSAAVATLALLVMVELRAPAPILPFHLLRDRTFAIACLHGILAGGVLFGSMNYVPLFAQGVLGTSATEAGTTLTPLMLGWVFTSIIGGRLLLRMSYRTLTIGGMVMFVAGAILMARLRPDMSRLELAIALGLMGIGMGASIPSFLIAVQSTVARNVLGAATASLQFSRTIGGTIGVAVLGTLLTNRLSAELAARGLQADAVPVEALIGEGATAMTLAGEPRLALAAALTAVFAAPLVFALLALAVTFLAPSHSPDDLRRKREQREEVTTAKEVAPQQAG
>fig|324602.4.peg.3329 Membrane fusion component of tripartite multidrug resistance system
MRRIIIGTLLGGLFTILTACAAPAPAATPVPTAAPAAQPTAVPQPTTAPLTIELPNQPTISLGVTASGEVVARSSAELSFRIPGVVAEVFVNEGDTVQAGDPLVALDARELELQVAQAEASLAQARANYERLLEGATPEEIAAVRAQVAQAQAALRQARGSVTEADIAAAEAALAQAIARRNDLLDGPNNAELTAARAAVEQAEANLNIQRTNLSAAKSNAELQMLQAANALRDAQQAYSDLYWENREREQQLAKFGLELPKEAKDAEEQLLRAVESAEARYKQTQLAYEQARQNEIDGIAAAEAQLRSAQSNLQRLLDGPTADLIAAADAAVAQAQATLERLRGDQRAGALAAAQAGVAAAQANLERITAPPTAQNLAAAEAAVKIAEAALAAAKLNLEKAVLRAPFAGVVAQVNVDPGDLAGTGALPVVQIVDASELYVEAAISDTDIARVREGQKVEVRLDALPGTVFTGTLDFVAPVANAVGNVRTFTVRVKLDRQEELRAGMSVRITILTDN
>fig|324602.4.peg.3438 Drug resistance transporter, EmrB/QacA family
MSDERRRNQILGLLFVGVLMAALDIAIVGPALPAIQRVFGVDERALSWVFSIYVLGNLVGTPTIAALSDRFGRRALYVVSLSGFALGSLLVAIAPSFPMLLLGRLVQGVSAGGVIPVASAVIGDTFPPERRGSALGLIGAVFGIAFLIGPIIGGLLLLIGWQWLFLINLPLAAVLIIFSLRLLPGRTRQSAATFDLAGLIVLGLMLTGLAYGLTELDPARLSNGSLPLPAIGALIVAFALAPIFIAIEQRAGEPILQPAIFRSRQIWITAVLAIGAGIAESAVVFVPALLTAAYGVSSSTASFMLLPVVLAMAIGSPVSGRLLDRFGSRIVVSIGVALSGIGMLILSTWPTSLVAFYLAAVVSGLGLAILLGAALRYILLNEVSANERAAAQGLLTVTMGSGQLLGAVLVGVLAATGGGAVAGYALAFFVIGIVMLLLTPFALALKSRSAERATAMAHAH
>fig|324602.4.peg.3707 Permease of the drug/metabolite transporter (DMT) superfamily
MQQIDEQVIRQTPPAVSTEIEQPTPRKGSLAMSTIMLILIATTLGVIGQMMLKQGMGAMGPLALTLETAPGIVWRIVTSPMVIGGLLVYGIGTFFWLVTLSRIDLSVAYPFVSLNHIIIFLLAWLVLHEQVNPLRAAGVIVICAGMLMVARS
>fig|324602.4.peg.3748 Tetracycline resistance protein
MNPAYRTHLILSFLIDGAHVLIWTGFTIYQLTVVNMSPLQLVLVGSVLEITILLCEVPTGVIADLISRRLSIMLGFTLTGGAYLLQALVPTFPIAVLGAVIWGVGITCVSGAYDAWLADELGQEHLGSALLRGEQVARVAALCGLAGSAILGSIALGLPVLVGGCLFIIGAAYCLIAMPETHFRRAVDDERTTWHRMATTLRDGVRLVRRRPYLLRLLAVLFFFGLFSEAWDRLWQSHLVLTFDLAALTPIAPIVLLAALIGIEMLLSIAAAEVLRRRLRSDDQRQTQRLVFGFTAVMVAGLLIYGLAPHIGIAVIAFLGFSVARGLIGPLLSTWQNAQIDDSRVRATVLSLGGQSDALGQLAGGLPLGAIGNRSLRAAFVTSAILLVPNLWLLRGRPTLAAVPVLEAAELVDGSTTN
>fig|324602.4.peg.3820 Chloramphenicol resistance protein
MITGTTTNLQTLSWFHVAMLVWMRWLISLVFRLVYPLLTFLAASFAVDLSTASLLITVQVAASLLSPLGGVLSDRFGDRIVILWGGIIFVLGVAVCGVSSSFGLFLSGYALVGLAVAIAMPALQSYVSARSHYSQRARLLGVLELSWALSALLGIPLVTWVAEQFGLAMVFAGLTVVGIATVALMTMLPNDERIHYTQFGGDTSAGVNPIQIVLKPVILAALSFIFVQMAAVELIFVSYAGWLEYTFGATTTELGLVFGLLGVVELIGSLAATLFTDRIGKRRAVLGGFALVGVWLLLLPQSTSWLTFLILLLAFDLCFEFAIVSTFPLISGLSAQGRGTVLAAMTASIGGGRILGSLVAPWLSVTAGYAVNSTLAGILVLCGVGFGIIAMREGRA
>fig|325240.9.peg.688 Multidrug resistance protein A
MSKSKLIIAVPLLLAAVAGGGYYWWTQVRFIETTDNAYVEADISHISVKVPGYVVLSDVTDNQHVQKGELLAQLEDNQFSAKVSQAEASLASSKADLQTLAAKVELQRALITQASAGVVAAESDKIRAQQQLSRSKKLKVSNYSSQDDVDQLQAGFDSAAARLDEAKAVLVAKQRELAVFNAQLDQAGSVVEQADATLELAKIQLNDTRVTAPFSGVIGKRGAMVGQYVQPGQALYSLVPDGAVWITANFKETQIQHMQPGQSVLVSLDAFPDKTFIGVIDSLSPASGAKFSLLPAENATGNFTKIVQRIPVRIRLDLSEEEAHMLPGLSAVVKVDTASGTAISAIAANTGR
>fig|325240.9.peg.1170 Permease of the drug/metabolite transporter (DMT) superfamily
MKSHTPYMTFVCLLICVFSWGSVFPIAKRVLEEMSGESLVFWRFTIAAVTLALYIVFTRQAWPKLSLAQYIVIALVGVIGVGGLNLALFNGLQHTSAANGALIMALSPLVTSIVNALLQREWLSRQQVFSLVGGLAGVLLVITNGSVQQLLNFSFNQGDVMIAAGMLAWSGYTICSQRVGHWLPVLPFTLLSMIAASVSMSVVGLGRGEFHPWQELMGLSTTAFSSVLYIGLFATVLGYLFWINGVKALGPAKASVFFNLVPVFAALTALAMGQAVTEIQLVGMLIVILALMLPMLVNLRATRGLVVKRC
>fig|325240.9.peg.1643 Permease of the drug/metabolite transporter (DMT) superfamily
MQPLLMILAAQLLIASGNLLVKLLENDAPVFQLVLYRQLFATLLVLPFVWRLQGNLKLSPYYKVHLARALLIGLGNAIFMLAILHLPLATVTAVIYTSPLLLLVLSALFLHERIGYRRSVAGIIGFTGILLISQPTEFNLYIGLAFFGAMTSALNSLILKAYSTHEHPFSMLFWSNAFAMIFLIPATLYEGADFSLPVAQVGLTLGLFYIGMTYLIIHAYRRADASQMAPVEYTGLIFAALFGWWILDEELSLVMLIGIGLVIFSSILPSYSELKAKWKSRRS
>fig|325240.9.peg.2223 Permeases of the drug/metabolite transporter (DMT) superfamily
MSHLTITKDKLMICLFFIIPPLLWSSNFIVGRAIRNDLSPVMITFSRWLIALMVILPFAHKYLKRDFHQYLQYPIRVIATAVTGVLSFSILVYSGLHHTSSTNALLLNSCVPVFILLFSAVVYKQPLNARQFFGLCLSFIGVLSIIFKGDLKGLLSLQLSQGDLLLLMAMISFAFYTLWLKRIPYTVNRLGLLSIQIVITLLGTLPFVLWESYSGGSQQHWSNDIYLAVLFLGIGPSFISYLLFSRCVEAIGAERAGFSIHLIPIFGVILSLLFLVESIHWFHMVGSATILFGVGLSSMQSERNSRSCQ
>fig|325240.9.peg.2468 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPINLGELFVKHATANTFKPASINVEPSDIVPLAATETPSHGKYHSGSQSTESLGTLAIPTLYLRFALPMAFAMMLSGSYNLVDSYFILKYIGADALAGVTIAFPLQMMIFALACMIGNGTATLVSRFLGANEFDKASQIANTGFALALACGVIVTVVSLAQLDNLLAFIGVSSTLALAATEYLQPILCFSLFTFLLSLSGDLLRAQGKVVVMLLVILLSAVMNILFDTLFIAVLEMGVSGAAWATVAGQCVSLFIAVVYFVPNNRFANKQALHRQAAQPICFRIEQIKLNLTEIKAILGLGSPILLSYLGIACVISLVNHILVSHLANVVPNTPAANEVAYMISAYGLIGRFNIFIALPLMALTSAAQTISAYNYGAMASSRVLACAKWGIVLTCCYLSVVTIIFMGFPTSVFGVFTDDLALIAACVKISSVTFIALPLAGITGIAIAVYQGTNRPKLALLLSGIKIYGLLLPLLVLLPQLSFADISFITGALNINIMRNALIELWMAFPIADILACLLSLLIISIWPFIHVPRANRVSHGGNAK
>fig|325240.9.peg.3105 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MRLFCILSIYCLKLIHTPVNAATAMAKVIGLGGIFFKSADPVTLATWYKTHLQVPIENWGGAAFYHTDKATLGYHVWTPFAHSTDYFAPSDKSFMFNFIVDDLAQALTQVEQGGGQLVGGIEDSEFGRFGWFIDPDGNKVELWQPSVIPPEK
>fig|325240.9.peg.3533 Permease of the drug/metabolite transporter (DMT) superfamily
MAAVMYLLMIFVWGFSWIAIKWQHGEVATEVSIFYRFAIASLLMFAIGFAFNKLQAVKLRQHPWFALQGVCLFCLNFIAFYTATHYIASGLTAVIMATAPIFNAIHGRIFYGTPTTRNFWLGVSVGLGGIILLFGADLLATQWSQTLVWGLLFSLLGTWFFSIGNMISIRNSRDNVSPFTSTAYAMCYGSAALLLIIWFKGLSFSLPLTTSYLGSLFYLAVVASVIGFTAYLILVERIGANAAAYLLVITPVVALSVSSVFEDYHWTWYSSVGLLLVALGNMLTRRQRPLAWFKSSTTPALKA
>fig|326297.7.peg.940 Multidrug resistance efflux pump
MPQSANTSKKISTYLFVTVLGIWLYSLWADRVTPMTTQAFVHAYLVRITPEVAGNIVQVNVDNDKRVEAGELLFEIDATQYQIAREKAQADLERVGQSLGASTAAVQVAQAKVGDARAALDNAKAQATRVETLAERGVLSQAELDNAREAAQRAQASLEAAQASLLQAKQNLGPVGENNPELKAAMAALAKAELDLKRTRVVAPSRGVVTNVQLSPGQYMAPGQPALTFIDPREVWISAMMRENSLEHIREGGKVGLVFDALPGRVFEGVVDSIGWGSGGANNIDQTTGFETAQTGKQQAKRFPVHIRFDTAPMANELRFGSQVTVAFYTGESSVGETLAQLWLWCWSKLTYVS
>fig|326297.7.peg.941 Permease of the drug/metabolite transporter (DMT) superfamily
MSPERTEGLRLWYFKGFSSRANPILRIAVAALVPLFVLHYLENPLPMLVSVFAVIMLTLMPGRPSLQVLSKLSMVVVAAAMVQHAAGILLSGTGTGSWMFLFAVLFYSLSRIHLNPKDIVGTMMMILGIMVTILHWQFATTVSDLPLVLAANFVGAIVMVYLVFWLFPGEELGAEADTAWEVTPSHWLKIVVKSLFLLLVIFLLIDSDNSQSLLIAITLANLIKDPNPMAGTHNGRQRLWTTAVGVLLTLPLLLAFWLDMHWWLLMLFAIALALWGSATALEHRVSMAEYQLLMSSFVMLVYQVISHDGTSSLTSSLTRFGAVVLAVLLGVMMLGMLSELGVTRTGSRVAKPSNVGQD
>fig|326297.7.peg.1034 Permease of the drug/metabolite transporter (DMT) superfamily
MALGAWLKLLLLSAIWGASFLFIRIGVTELGPAWLMFLRVTFAALFLLGGAIYLKKALIGSAPLKHFIILGGINTALPFLLYGFAATELAASLMSVLNATAPLWSTLLLAIWQRSMPRGAALGGLITGFCGVVLLAGVESLSLSEEGLWALAAGLGAAICYAFASIYTKASNHGNAYSNAHGCMWAASAWLLPTLLFAAPPEAMPSSGTLAAVVTLGVLCSGVAYLLYFRLIDEVGATSALTVTFLIPVFGILWGALFLGEHIGWHTLVGTAIILLGTAISTGSIPRLRRLAGERI
>fig|326297.7.peg.1682 Multidrug resistance transporter, Bcr/CflA family
MISNSLTKRRSLVFFPYLALLSMLGFLATDMYLPAFNQIESSLNTSASLVAMTLTCFLGGLAIGQLAYGSLCDKFGKRNTLMAGLGVFAVSSILLGFTENISVFFVLRVIQAFGACSAAVIWQALVMEKFDEGEARKVFSSIMPLVALSPALAPLMGAWVSEQFGWRAIFIILAIVGLLLAAMTPALAKESRTRSQSEPILVKNILKNRAFQNNVAIFGACSAAFFCYLTLWPAVMQHHGYAAAEIGLSFIPQTLAFMLGGFACKKALHSHSPEAIKNMLITGFVVLSLVLFLLTQLGAGILAVLWVFAALAAINGAVYPLLVTDALAPFSNNATKAAGWQNFLQLGMAFIASAAVALIAHWFEKAIGTGILVCAAIVLVAWWRMNWSTWRGSWCFPDPARMGVLRTEKREHSDNDTKTHGVCNVSSQQKDTD
>fig|326297.7.peg.1902 Gentamicin resistance protein
MSLPVNRYCVNNHKGPELYQLSDTLTDWIVETIGEPVLTVELNNQGWSNLVLEINGRWIVRLPKRLTDSEGNSLTNRYLMEKQLLETLSLAIDKDTSSHLSAAILPNVHLAPRHVADCMLYRKLQGSPLDWQSEQLSTLNNHMCTSLAASIGALLAKLHATELAHPQLVAFPYGDEDFVGSVLPALRPLVDADSYKNAQTYFITMLETVATQAEFSSRLCHGDFGPANILLGRDYQLTGVLDFSDVCLGDPAMDFAPLWRRSPSEFMHDLFSAYRHTSGEDHWQSLQPQTLNHRIQFHALRKAAFVVWYGTRYGFEDGITGSLVFLEEYFKSP
>fig|326298.3.peg.200 Acriflavin resistance protein
MFERVLKFFIENYKINYTLFFLLFAAGIYAYSQIPKEISPSIEPNSVTIHGSYAGASVDILNKMAVQEIEDEVKNIVGVDSVTSVVSPGRFTIVLEFDKRVDKATIIRDAEDAIALIKPNLPSDMDDPVIRGVAHSRSIMHVSIISSKISRDKLKLLSKKLKSNLLSVKDISDVTIFGDSDLFYEVLIDEKKVNAYNLSLDEILRVFSELSYIFPLGKIDNVKEQYYISTQNDKKLSCELENTIININDQQIVLKDIAKIEKKYEDSSTLASMNGEDSITLAISQNPKGDAIRIADDVKKLISEMSVDDVDFNIRMDNSIVIRDRLNIVISNILFGLILITLLTAVLINIRIALIIALGIPTSFVMGAIYFYFTAYSINVNSLIGVLIAIGILVDDAIVVSENIQQYIEKGYSAKEAALLGTQEVAKAVTIASLTTLFSFIPLLMLSGKLGEIIQLIPIAFSALVIASLIESFIFLPIHAAHTLSSNSKTMSWEKINLLYLRALKKLVGYQKSFLLIFLIIVPALIYYGVKHSKFQMFQPFDTSSINITFKAKPTTTLEQSLEIVQTLEKNILKEKDRFFVKHVSSTAGYRRSATGTTEIYPYVGYISIELHNMKPENFVDKYITPYLSFYYDSKDRIRDKSSQDISKDIREWLKEQDYQERFNLNNLMVVENSMGQTKADIRIGVISDDYKKALSAIREIEDGFSKIDGIKYFGDDVKVGTQEIKLKLNSYAEELGITEKYLGTYISGLFLSRKVGTIFDGKELLDIKVKSFYIKDDLESFAELEIPIKNRGHVKLKDICEFEKVESLENLVKDDGETNFYVFANVDPSIITATEVLQMMNPLIDKLKNTQDIRLKFKGEKEQKETMQTEMILASILAIILIFISILYLFNSLRETLIVMSVIPFSILGVYIGHFIMGLNISLPSLIGALGLAGVIVNDGILMMATIKRAKTKEEIFILAPKRFRPIILTSVTTIVGLCSLIFFATAEAVTFQPLAVAMGFGLLWGTILNLFYLPVTYNFLHGYKNYNKRSKIFKTFE
>fig|326298.3.peg.1218 Acriflavin resistance protein
MFKKFQDTVFEGIQNPKKRNFILIATFIAFVLSVLMIAPSKMVLAKMLPGKNNDTFTIYATLSEGSSIEQTSRVSECVAKYLKNEKEITDFEIFLGMGAPLDFAGLIKGSHFKNSENVSEIVVNLTKKHHRDEPSYFMVQRIRPEIQNNCTKLYEKTTITFVEPPAGPPVLAAIVAEVYGQDSDGVRLLSNRVKEVFEKTSGLVDIEVMQDEIYDTFEVEVDSTKVSLSGVNIKQLNDVLYLAFEGMQIAVKNSSTINDQIPIYLSLSKESKKFSSKDINDIKAKLSSLKLMNQMGMMTPLTELVTIVPKKSNPMIMSKNLHKMTNVMAETDMVSQVYPLMEARNTILDTFNDKYEIEKIGLFNLRLVDKASKDVYELIWDGEMEVTLDTFVELGAAFIAALVLIFLLMVIYYKSYALSGIILLGSFLSIIGVIVGHYIMDIFTADTFFLTATSLIGFIALIGISSRNSLLLIDFTASLMRDSKMKKAEAIAYATATRAKPIFLTAAAIILASTLLAGDAVFGGLGVALIFGTIAAVIASLIIVPILLYKSDLNRHFNLDEI
>fig|326424.13.peg.817 Glyoxalase/bleomycin resistance protein/dioxygenase
MDPPPAGAPFTGLGAVEAALAGLTFHHFAIVVTDLELARELYTVSLGIDSWHTRALSGPAVYRGRPVALDGARVAIGRLGAGLVELIAPGCQPSAARETLDRRGEGLFAIGYLVDDVAAQLRVPVSAGARIEQVRPDARHPVEACLDAGSGLLVDLVQSGSSWPV
>fig|326424.13.peg.1124 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVLRIVADLPSRSLPAARRFYAAVLGLEPIMDHGWVVTLSDPDRPGPQLTLLTHDLTAPAVPAVSVEVDDVDAAHAAALAAGAGIVHPLTDEPWGVRRFFVRDPDGNVVNVLGHARA
>fig|326424.13.peg.1243 Glyoxalase/bleomycin resistance protein/dioxygenase
MEIKELGHLVLYVRNIERSVAFYRDVLGWRQVFPDPAASADGPLRVPAAGFSAGRTHHELLLIEVGEDAAAVPAGRRIGLYHFGLKVGDTDDELREVLARIREAGVDIVGASDHTITHSLYILDPDGNEIELYIDVAGVDWQSQPHLIAAPIRPLRL
>fig|326424.13.peg.1439 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDISPIPDDYPRLCPYLCVDGAAAAIEFYASVLGATERMRLAGPGGTVAHAELALGDSVLMLSDEFPEMGAVSPASVGGSPVTISLYVEDVDATYDRALAAGATAVRPVADQFYGDRSGQFTDPFGHRWSIASRVEQVPPQEMAARMSAMGGD
>fig|326424.13.peg.1818 
MPDHPADADADADADADARASSDAAPSGPAVAGEPGSGWPGAGAGWAKAGSGAPVVAEIRFTVPATAAAGFPAAARAALDALARAAGFRSGRLARALDEPASWLLTSEWDGPGPWRRALSAFEVRYALTPLLVHAVDVPGAFEVLAALDPPGARDAGGDRLGVDPVDPVETAGGDVGRLARTYHSDRAADADTAAPGSS
>fig|326424.13.peg.2156 Tetracenomycin C resistance and export protein
MIMVGLDGTVVSIANPRIAEDLHASLSDLQWVTNAYLLALAVLLIPAGKLGDRFGRRLIFLIGVVGFALTSLAVGLVGSIEGVIIFRTLQGVAGALLMPNTLAILRSAFPPEKLNSAIGIWGGASAISIAGGPIIGGLLVEHVSWESVFYINVPVGAIALIVGLFVLAESRDESGSQRFDAPGLLTLGGGLFALVFGMIKAQGWGWGSGRTIGFLVAAVVLLVLFVVIETRVRAPLLPMRLFRNRSLSLSTLIVTLTFFAMFGVLFFLTLYLQNVHGYSAVQAGVRTLPLSAVFMVSSPLGAALNGRFGPRVPITIGMALMLASFVVLTQLEPDSSFNLLWPPFVAVGVGVGLIITAASDAIIGNAPIEDSGVAGGLQSTATQLGGVLGTAVLGSVLASRVGSVLVDRLVGAGVPAEQAGRLAQAKELVGQGLVPPATGSSASVQGAIEAGSHAAFMSGLHVAMVIGAVLSGVAMVLALFIRPGQNAGNAVAHV
>fig|326424.13.peg.3510 Drug resistance transporter EmrB/QacA subfamily
MRTGPALVALAGAALLAVLDGTVVAVALDPLAHAFSAPLTTVVWVTIAYLLAAATALPLLGWASARFGGRTVFLTGLGLFLLGSLLCTAARSPGMLIGFRALQGFGGGLLEPSAMTLSAALATRESMGRVLGVMSTVVNVAPAAGPILGGLLLETGHWQWLFGVNIPLGLLVGAATLAYVPAGRPDPAAARPGADLRGLALLTAGYLGVLFAVNRAGEQSGDWPVPAAAAGGIVLLVAYVRHAVTTTAVPALDLRLLRRPGFAASVAVMGLVGLIMYGQTTALPVVGLDQHGLHGFDQGLLVCALGLGLLVSMTTGGRLSDRLGARSLVRSGAVASAVLLATFAASAEHLPLAAACALFVAVGLSFGLTASPTVASLYRTLPPAEQPQGTTSIFMAVQFAASLGVALLSLLQARAGADWVTALFALFAGAAAGIGLLAARLPGRPG
>fig|326424.13.peg.3766 Drug resistance transporter, EmrB/QacA subfamily
MTTATSPQGAATAAPPGGSGLALTAIVGAEFMLQVDGMIVNVALPDTQSDLGLSTTSASWVLNGFFLAFGGLLLLSGRLGDVFGHRRLFLLGIGLVAGASLLAGLAPNFGVLLTGRVLQGAGAALAGPTGLALLSMVFQGERQQRAFGLYSTITGLGAATGLILGGILTGGLGSWRWCLLVNVPFGLIILVIALRSLGTAADGARSRSLSLPSAALVTAGLTALVYGLVQAADRGWGDLWTVVPLAITVVVAAALLVVDRRAPEPLLPGRIFTNRTRVGGFINLLLLSSVLGGFVFYLSQYLQTTLDYGALRTGLAILPFGLALLVTTQLLTKWLSGLGLTTRGTIGLALLALGVAWFIRLDADSAYAEGVLPGLVVMGLGVGLAIIPLNMIILSTSRPEDVGITAGILQAALTVGGSIGLAVLLIPFNAGGRPVAENISTVFTWATVDCVAGFVVAVLFWFGPGLRPSATRTSSPEATAPEPPAPREPAAVESRS
>fig|326424.13.peg.4029 
MGAGEAAVRVMLWAVDPPDDPGAVERAYHAISSKLVGTPGLLGNTLQRSAADPSRYVVVSVWSGVTEFSAWEQGANHRGTTSPLRPLQDPERRPAIYTEVAAYGPQGPFSEAPAG
>fig|326424.13.peg.4030 
MASTPPFRIMLTMRIHPGREAEFEQTWLRIGDAVTSHPANLGQWLIRSEDEPSTYFITSDWVDEAQFREFETSERHLEHRKALHPLRASGSMATGSVLTHLAGAASLPVPAAG
>fig|326424.13.peg.4835 Glyoxalase/bleomycin resistance protein/dioxygenase
MTRDAAATTDFYSTVMRMELVAAVMHERVPSTGDTMPYLHIFFRMQDGSTVAFFEVPDLPAAAAPSHPAHDVFRHIALEVPTTDMVDEWREWVRGHGVDVLGPVDHTIIYSIYFHDPDGNRLEITTPLVADWNDRPIQARRALEAWTATKERARRDGTEVSAALHELVVTSEPTTFD
>fig|326424.13.peg.5651 Drug resistance transporter, Bcr/CflA family
MTQTVPVTSAGIVDQSEVDQSEVDQSEVDQPDAGQSDADRGRITITTMVLLGAMTGLGPFSMSVHLPGLPRMADDLATSQSSVQLTMTACVVGIAVGQVVAGPLSDAYGRRRPLLVAMALYCATSAVCAAAWTVPMLAGLRFAQGMFAAFGMTIARAVIRDVADGQRLVRLFARMALVSGLTPIIAPNLGSALLVVTDWRGIFVVLAALGALFAALSVGSLRETLPPARRTRLRPASTARTYAALATDGAFLAPSLVVGLAYGAMFSYVSSSSFVLSDAYGVSQTVFGVLFAANAVGFMAGGQLGAALAGRRGTIRALRITLPAAATAAAGITLAALAGSGPAVVGTLFLTVASIGACMPIASAEAMRTRPDSSGTASGLLGLTQFALGGLIGPIVGAFGSTSALPLGIGMCLCLLAAFALCLRPAAPRPTPSPAA
>fig|326424.13.peg.5769 Drug resistance transporter EmrB/QacA subfamily
MSGGTVSVEASVEGGRGAVGTAPSAPRAKWAVLAVCCLAQFMVVLDISIVNVALPAMQTDLGMSASGLQWVVNAYTLAFAGLLLFGGRAADLFGRRRVFVFGLVLFTLASLAGGLAQSETQLIIARAVQGLGGAVLAPATLSLLMTSFAEGRERTRALGAWGATAASGGAFGTVVGGILTDVADWRWVLFVNVPIGVALVVAARVVLVESRGQVSRVRDLDLPGTLTVTGGLVLLVYAIVRTETSSWSSPLTIGLLAAAVVLLGAFVAIEATTANPLVPLNIFRYPGIAVANVVAALLGAAMFAVFFFLTLFLQRVENYSPLRAGLSMLPMPLMIIVASQLVTRTIGRLGARPIVMFGAAVGSSGLLWLSAITPGGSYWTHVFGPLAVMGFGMGTTMVSMVSAATAGVPIRLAGLASGLINTGRQIGAAVGLAAVTTIATHHTEGRLRHGIGQPEALTSGYALGLFIGGCVFAVGVPVAFLLPRLRRPEPAAAGSSPSAQLTAESATATADTVTADTVTADSDDEQAVARTAEV
>fig|326424.13.peg.6109 Permease of the drug/metabolite transporter (DMT) superfamily
MRQNHVYLVDTYHFVVETEVRWDMPSSTPDSASRRRTAVRSLAADVGGLAASRPAPTGRAPTAPAPPVAAEHGRTAWLADLGVLGVAVVWGSTYVAMQWSGRFISVPAFLFLRFAMGASTIVVLAPRAWRGLTRQEMSIGALFGCLLFGILYLETLGVRHTLASNAGFLISLSVILVPLIERTFLRARIARVTYPLTLVSLAGCALLTLDRGFTVRGGDLIILGAALIRAVQIVLFSSQSKGRDISLLRVTGVELWVVACGGLLVSLFRPGRSVHEATHLPGEAWLVIAYLGVAGTAFAFLTQLYAARASSPTRVGLMMSTEPFFAAVFAVVLLSENLGPTQLTGGGLVLLSAYLGRWADARRLASRPESPAAAPVPPEGATRRGPLRRSYGTDPRT
>fig|326426.4.peg.87 Permease of the drug/metabolite transporter (DMT) superfamily
MHMADDARNASGTPAPTASHAGHSGGHVVSSRATAVGLMAIVLWSFMTGTVRIVAESFGATLGSALIYTVGGVLLLVFRRPAPIREFPKKYLIIGGLLFVFYESSISLSLGLASTAASSVEVSLVNYLWPTMMVLLAAGVSRRRHAVWKVLPGAIVATVGVALAVGGNSGLDWQAAAGHIADNPLPYVLAFAGALAWSVYAVFTPAWSHGVDGTSVFFPCVAVALWIIHFASGQGWPAEPPSLVAWLFVFIAAAAIGGGYACWGYGILHGSMERLAIASYATPVLSTGASAVLLGLALSLPFWCGALLVAAGSVLNYLVSARRSDPTT
>fig|326426.4.peg.92 5-nitroimidazole antibiotic resistance protein
MSMENIAGARKPAKREDERTVAGEHRMMRRADREVTDPEQIAAIIAACDIVEVAYADAEGLAIVPLNFGFDYEYDEADGVAATALVNGAETVGSTGVVAADEVGCPGKLTLWFHSAPHGRKLDAIRAAAGGRLPVAFTMQADCEVVAGRATCNWGEAFKSIVGNGEASLVKDLGECRHGLQALMAQQAHMPHVEFTDAQVRSVTVWKIEVDYFTTKVRAKPAPAHIHQRPAVPRAGVIGAR
>fig|326426.4.peg.672 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVQVHGMRRASADAKYQQMTGQPVKPLILKLCLPAVISNLVTTAYNLTDTFFIGQLGTAQSGAIGIAFSIMTVMQALGFFFGNGAGNSMSRELGKQNNERASRLLAVGFAGAVISGLVIAAIGLLILRPLVVMLGSTSTIAPYAVQYLTPLLVAAPCVCGSFALNGLLRYQGQSAFGMIGLVSGALLNFLLAPLFIFVAGLGIFGAGLATAICQTVSFAILTTMSRKFGVMKLSLRNCKPDVLLMREVAGGGLPSLIRQGAGSISVTCVNIAANPFGDAAIAGMAIVMRIMLGANSVIVGLGQGFQPVCGYNYGAGLFARVKEGYWFCVRLATCVLVALAVLLWVFAPQLVEIFRSDPAVVAVGVAALHIQCCTVILNGFNMMGNMMTQTMGRTGIASFLALCRQGLFLAPIVLILPMTFGVLGVEMAQSVSDVLTFLVTIPFMRRILHELR
>fig|326426.4.peg.887 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKTIKTVRGNPLAAEPLGRLLIKFAIPSVLSMLVDALYNIVDQIFIGRGVGYLGIAAATVTFPFVTILLSIATLLGIGGSVYTSMNLGAGKEAEAEKTLGTVFTLSVAIGILFTVICLTFLKPLALAFGATKGAQGSLSYVLDYVPIILLGAPFSMAAIALSSMARACGSPILAMGCFLVGAVINLVLDPIYIFVFNWGVKGAAIATVTSQIMSAVILLVYFLKKGHIRLRRKNICPTLPICGQIFAFGLPSCMIQVAVTILQIELNKAVVSCEMAGVGSEAALSSLGIVLRISSVVVAICVGIALGMQPIIGFNKGAGFEHRVKETYKKAVGAATVVSVIGWLICELFPAEILQIFGMNEPASMAFGIKCMRISLFGLAFTGFQVVSAQYYLAAGQAVKAMLLSILRPLLLMVPLIHIFSGIWGMDGILYAGPTADILTALIAAGLVGYDSRKKRKGV
>fig|326426.4.peg.905 Multidrug resistance protein B, MFS member, bile efflux, induced upon bile salt exposure
MTSQKNAEFGSAASSVKPIDPHTRFIVVGVIVVGSFIALLNQTVMSPALPALMRDFNIATGTVQWVTSVYMLVSGIMVPISGYLIDKFSTRKLFAGALATFMVGTLLCAVAPNFMLLLVGRILQSAGSGVLLPLVAVVPMLVYPPDKRGTAMGMAGIVMAAGPAIGPVVGGLVIDSFGWRPMFIGIAVVALVILVGGTMMLKNVGELKNPKLNILSVILSTIAFGGLLYGFSSASTMGWASPVVITSIVVGLVAFVAFVYKQVKLDEPLLRVDTLATRNFRNSAILVTLINAAVAATNVTLPIFIQNVLGQSATVTGMVMLPAAAVGIIMSPVAGAAFDKFGPRGVGIGGLALMTISLGLLGTINTRTSVLFVAVFCALQASGQAIANMPINTWGVNALPNDMIAHGNAIANTGRQIAAAIATSLLVTAETSVTASHMSQGVKSATARGIAFSYLLCAAISLIALIICIFTVTSRAKEKAARNAKAYEAQASAEVAAETTEGQPAEHHYAGAYVAPAASLFKQAQEQSIGGIMDDQPYSCLDSDDITHVVREFIRLNVSSLPVVNGDGRLVGFVSDGDVLKSIATYESRTVSTGTGSTMVVFDDETVASKVQALSGKKVMDIATRKVVTATPDQHVGEVARILAKKQFKKLPVVNGDGRLVGVIRRKSVMEHAFDALFPKDDR
>fig|326426.4.peg.1154 Transporter, drug/metabolite exporter family
MGNLRAPRSARGRVMAAAGMVMVGSLGIQTSSSLSASLFGALGPIPVGSMRMLVAAIVILALTRPKLAGRSKGEWLGIVVYGLAMAAMNVCLYSAIDRIPMGVAVTLEFLGPCVVALAGSHHWREGLCAVVALVGVGLISFTPGGYFNPAGYLFALGSAVCFGLYTLFADRVGKAGTGLDGLALSVTVAALATSPVSITRAPHVSAAQWGVIAASAVLGVAIPYTMDTLSGRITSARVVGTLFSIDPAMSVIIAALILRQTITAVAVIGVIVVSLVGALLVWSSGGDAVNG
>fig|326426.4.peg.1223 Permease of the drug/metabolite transporter (DMT) superfamily
MGLVERCNRLRSRWSRTFPPNLARLMLLACAALWGGSYLLAKFAMTAIPAQWLMALRMFGACMCMLALFHKHIVPHLTPKIIVPALVVGLTYWGTMITQTIGLQTIEPGRSAFLTAAYCVITPFATWIISKTKPRAINLVAGVICLTGVGFVSLKPGGSLSLSSGDWLTIATAVIFSFNLTCLGVYTKRFDPIAVTFVQFSVAGILFFIGALATEPAPDAGWLAPPVVASVLYLFLGATMSAQIMQNIGLAHVPASQASIIMCTESLFAVSFSALFWGERILWSSLVGFALIFAAVLMSVIKPTKYSLHRN
>fig|326426.4.peg.1282 Permease of the drug/metabolite transporter (DMT) superfamily
MKRQELVGMLCLLLTALIWGFAFVAQVQGMDSMSPMFFNATRFTLGALSLVPILLWQRGRGSSSTSEAADTAAVGAGDQLVQTSSPAIRLLANPIIISVICGIVLFTASTLQQYGILYGKSAGRAGFLTAMYIVMVPLLAFVFLRRRIGVLVFAAVALSIAGFYSLCITDGFGSIGLADILLVFTAVLFAVHILVIDTLGAKVDAIKLSFGQFCTTAVLSWTGSLIEGSVDWAGAAHSWIPILYAGFGSVGIAYTLQVVGQQWVPPTRASLLMSLESFFSAVGGALLLGEVMTPRGYLGCALIFIGTLLAQAPAKLPKFLRKD
>fig|326426.4.peg.1815 Permease of the drug/metabolite transporter (DMT) superfamily
MKRGMAIAGLIVVTAIWGGGFVASDIALNSLTPMQIMAIRFLLGAVLMSLISVREFRNINIKEIGAGVLMGIALFAAFALQIIGLQYTTPSKNAFLTALNVVMVPFIAFLVLRKRIGWRGVLGACLSVVGVAVLSLNGNMTLGLGDALSLLCAVGFAFQIFFTGLFVQRYRATILNCVQMVTAFVLSVVVMVAMGQVHLTPTTDGWWSVLYLGAVSTTICYLLQTACQQYVDETKAAIILSMESVFGTLFSILLLGEVVTPRMIVGCAIILVAVVISNLAASSEDEQPADTPVPEPSGEVSG
>fig|326426.4.peg.1821 Multiple antibiotic transport protein marC
MASFATLTADLSKKELRCQARYTSLYVFAILAAFTILGSFILDMFRLELPAIQIAGGFVVAHSGYRMLVPTSDHGDPEAHQDNDIAFTPMALPLIAGPGAIGEVIGLSARYTEPRERLAILIAVLVISIVIMALLRWCTPLVHKLGPDGILGLTRIMGFIILCIGVELMIHGVSTLAIGL
>fig|326442.4.peg.603 Permease of the drug/metabolite transporter (DMT) superfamily
MLGSDFIQLCKLPAMPASLCLIIATFLWGSSFIALKYAIAIYDPALVIFLRMLTTLFLSLCLWRYVIRFEYRVGDWKYLIAMSLAEPCLYFLFEGHAMEYTSASQAGVIVSCLPIIIAVLAFFMLKEYISKSIIIGFTFCIGGSILLTVLSPNSDQAPNPLLGNFLELMAMVCAAFYTVCIKHLASRYSPLTLIALQGISGSLFFAPFLLFIDLPSENQHNITALLSILYLGSFVTLGGYGMYNYAISKVSVLTAAAYSNLIPIFTLILSAIILNEVLNLWQWLSIFVVFVGVMISQRHQELVVDIPSAESGEDISTDLTTSDIISAETNSLNSVPDANASKG
>fig|326442.4.peg.1424 Drug resistance transporter Bcr/CflA subfamily
MQTQPAKPNLTLLLILALLVIFCPMAIDIYLPAFPTIAEQFAVSEQQVQQSVAIFMLTVGLGQLIAGPLADKFGRKPVAVIGISLYAGSALLAYYAPSFNILLLARALQGLGACATFVVAFAIVRDKYGAQRSGQMITYLNGIICFIPALAPILGAWLTVQFGWRMNFLFLTFFAIFGLVITLLFFKETRPADSYYQGHILDLRRFMPIISTPIFLFNSLLCMVAMSAILVYVTLAPGWLITHLGGTVADFTFWFTLNAVCSIVASFIAPMYIKNNSQRALRLGVGLLIFSGLLMLALSTIQTALALMLPMLIAALGFALSLGSAAGMALSRFAKQAGTASALLGAMQMSGASILVFATQFLGLTTPWLIAFHLLLLLPLWLILISKKGHALHPTQG
>fig|326442.4.peg.3412 Acriflavin resistance protein
MDLAKWTINNKLISTIIIILTLGFGFSSYKNMARFEDPEFIIRTAQVFVPYSGASPLEVAREVTEPLERAIQELQEIDTISSTSSSGMSEIKVEIKSEFSPTKSELQIIWTKLRNKINDARPSLPPGTGTPQIFDDFGDVYGLSYLITAEGYSPDELHAYAKNLQSDILQVKGVAKVAMTGVQQEGIFVEIAREDLATLGSSISNIYSILDKQNTVISAGNTQIGDQRIFIDPTGSINSIETIQNLLVSATNDGKAIYLKDIANVYRGFQSPATKLVRYNGQPAISLGVASVLGTNVVKVFERVDERVKQAENVRPIGITVHEYYHQGKVVQASVDNFVVNVIVALIIVVVTLLVFMGLRSGLVIGAVLLLTIFATLATMDFSGIPMHRISLGALIIALGMMVDNAIVVTEGILVGTKQGRKKLEIASEVVKQTRWPLLGGTLVGIVAFAPIGLAPGDTAEFTGHLFWVILISLLYSWLFAITLTPLFCFCLFKEQDKDTSTTAKPNMIMAAYQSIVVSSLNHRWLTVAVVIFTFSASMWGFQFVKSGFFPASTTPQMVVDFWLPQGTDIEKTKKDMIKLESFIQQQESIEGVQTLIGGGGLRFMLIYGAESPNSSYGQILAKVDDYKVLDTMIPKVQAYIDDTFPEAQGKVWRFVMGPGGGSKIEATFKGPEPAVIRELADKAKAIMIDDGGALSIKDTWRQQVRVIEPQYSPINAQRAGVTRKAIAEALQQNFSGKTVGQYREGEELIPIIVRAPLKERSNVNDIGNIQIPSQITGKTIPLEQVTNGFKTVWRDGILKREDRMWTIKAQADPLPGQLASELFNRVRPQIEAIDLPAGYTLEWDGEYGQSKESNEMLASTLPLGLLAMVLIVVVLFNALKQPIIIWLVVPLALIGVVFGLVTTQTPLEFMGILGLLSLSGLLIKNAIVLVDQMDMEIKQGKPRYDAIVDSANSRVRPVMMGTLTTVLGVIPLYFDAFFQSMAVVLVFGLLFATLLTLIVIPVLYAIFMGVKKDERTPVNA
>fig|329726.14.peg.566 Permease of the drug/metabolite transporter (DMT) superfamily
MSVHNFLKLLLLAAIWGSSFLFTRIAAPEWGPIWLIELRVLIASLTLLPLVFKLDLWPQIQRQWRPLLLLGILNSALPFSLLAYASLSLSSGFTAILNATTPLFGLWIVVLWLQEKLSVPRLVGFAVGFLGVVFLVGWQDIPLTFNQGIAIAAGLLAALLYAIAAPYIQQQFAGVPALAVTTGSQLSAAVSLVPLLPFSIPSQIPSSKAILSVLALGILSSVLAQMLYFHLIKVMGPSKTLTVAYLIPLFAMLWGALALGEIVTTSMGVGCGLVLLGTAIANDLFTPTKNS
>fig|329726.14.peg.1093 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNSAATQGAHHIGLTVPDLQQTRTFFVDTLGFKQVGEKPDYPAVFVSDGTIMITLWQAVNPEQATPFDRKNVIGLHHFALKMESLTVLNELHQTLTQTPDVEIEFAPESLGGSPMHHMMCYIPGGIRMEFIAAG
>fig|329726.14.peg.1590 Permease of the drug/metabolite transporter (DMT) superfamily
MVPVFGVVPALWTLSRRDSDRKQREVSRVATLIGLAWLIGTLLLTSGVAVTSGENAQSMGISQLLFNSLFTSSYFLSNLWLMVRVWRRQSLDLPGLKRITKYLP
>fig|329726.14.peg.2378 Vancomycin B-type resistance protein VanW
MTASSWRTPLRLLKCRLRQSLKEMRRGYGPQYAQQQAPINSSRFNHLWSQCQTPIKQRSSANNLHQNRLINMSLAAQFVDGLILQPQQIFGFWRRIPQPTIQNGFRAGPMLIRGQLTTDAGGGLCQISTTLFGAFLAGNLEILERSNHSVDTYGDDRFFTLGQDAAVVYGYKDLVVRNLHPVPLQLRLQIDQAQLTATASLWGPTPISDTISLNSEVIQSLPAPPDGIPGWRVRTQRWVQPPESPKILTYQTEDTYHPYPL
>fig|329726.14.peg.2733 Glyoxalase/bleomycin resistance protein/dioxygenase
MDYKPAGFHTMTSNATYRDTKAAIELYEQAFGLAVDTLLETPDGTVMHVSATIGDSHLFMSDEFEGSPRQAPGPKSPVAFYLYLPDVDASYQKAIDAGLTSVSEPEDMFWGDRTATVADPFGYAWTLATQVKEVLPQDAIAIFNQMMAKAS
>fig|329726.14.peg.2955 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MLAAIVALSLAAIFIKLSERELGPFATIFNRFWVAYIVLWVWHEWESLRGSKEAVKEIEYTQRDQGLLVAAALMFWGCIALWAWSLTRTEVANSTLLHNLTPLFTTLGGWLLLQQRFDRRFVVGLVVAIIGAVALSVGDFQVSTSHLTGDLASLLSAVFSAANLMIIERLRAKFSVNTILQWCCFWGAIWTLPVVLLTEDRLFPVSASGWLSVICLAIVCQVLGQGLQAFSLKRLSSGLVGILLLLDPVLAALTAWVLFAESLTLLKWTAFFVVLLGVYLAKSSDAATHPVEEGA
>fig|329726.14.peg.3842 Permease of the drug/metabolite transporter (DMT) superfamily
MPSLSFSAINPKLALVISRALAALRPSLIAFLVANAMLLSGGTQTPISFCNVLFVGNLCAALAVGTWFGWRSLIQDWRSLDRRIQVGLFLNGGLAALLSSLIFVGLAYTSVTNAVLLGRLGPVIYALVGTLILGRKIKRFEWIGFSLIIAGVLAIVLKTSNFEINQGDLFILLSALVYAASSTLGKLMLSQQTNLRIVVFSRNLISAIIFFVIANLVFGPEHFMDVLAGQLWIVMVVYALIIIVLAQFLWYSALEQLNSQTVGKWTALSPVFGVTYAFVLNGERPSLAQVLAFLVIMAGICITSFNRQSSRPMETNEMADGAESCMSTS
>fig|329726.14.peg.3938 Vancomycin B-type resistance protein VanW
MPVNYLQQPQPQQRTRLRLLLGRQYYIQKRKWEWQFSGTKFAVPKGANRLPITVFSHQSFLLRQLKDVDMWLQHNKVTNLQLAINCINPVIIYPGEVFSFWYLVGNPTKRRGFKLGMTLNNGQVKSGYGGGLCQLANLIYWMALHSPLTIKERWRHSYDVFPDLNRSLPFGSGATVAYNYIDLQLENNTHQPFQLCLWLTDTDLCGELRSDTKCPYHYDVLERNHQITGPVAGRYMRHNQIFRKKRHVLTDEVFPDEFITENHALMMYSPLLSSGDEEASSSKSSAHS
>fig|329726.14.peg.4888 Permeases of the drug/metabolite transporter (DMT) superfamily
MITKDLERPQQTLETLERPADPQVLEALYEQPASQTASILPFAALLAAVCILSCSAIFTRLSEEELTASATIFNRFWIASLALGMWSGFQQFRQPPAETDQTSQSIQIRDLLWFGCLGILIYGRAGSWAWSLTQTSVANSNLLHNMTPLFATLGGWLFLGHRFNRQFLMGMSLAITGVLIIGVGDFQVGTSGLVGDGAALLSAVFYAANFLVIEKLRTRFTTTTIMLSSCVVTGLLTIPVVLVGGNQLFPTSTTVWLAVIALGVISQGLGQGLLAYCLKQFTSGFVSVFMLMEPLITALLAWKVFGEQLNVLNWVAFFIILTGLYLATISKGAAKSRPIH
>fig|329726.14.peg.5381 Quaternary ammonium compound-resistance protein
MKVFGEITSFHPDALGQLVGYLFTSPWIGLGVVTLTISMLIYLVSLTRLDMSFVLPMHAFSYVLNALMAWLILKEPVSLARWLAAIFISLGVFIVGWSKRIDDRKAQLQQDADPNIKSSWMLLLPLSFYLPKMWLGVLVLVLADCTADILVARGVKKIGKFSARSLTSILQWLKSVFVNPGVLIGVASYTVSFLMFISLLSWADISLVRPATGLGYIINLCGAHFILKEHISSGRLAGIIVIGWGVGIISLTG
>fig|329726.14.peg.6029 Acriflavin resistance protein
MWTHFYRNTRLLILTICIILVWGLSSFHVLPRMEDPAISQWTGKITTRFPSASATRVDSLVTEKLEQKLQEVEEIKFIESTSQLGTSLIFIVLKDTVKNHDEVWSSIRDRIADITPQLPSGVLAPKYEDMNDGRGYTLIVALTWELDTPPNYAILNRLSENLKQQLRGIGGIEEIEFWGAPSEEILVEINPVVLGKLGITPQQLAQQIRLSDAKVSSGRLLSPNNDLLLEVNSEIDSLERIRQIPIRTDKNSEQLIPLGDIALVKKSRRDPPSELAIINGKPGITLAVLVEPNRRVDQWMEEANQTLEAFRGTISSDIGLDIILNQNRYVETRLNSLFMNLMIGVVFVVASTTLLMGGKSALVLGLSLPLSILMVFGGMRLLEIPLHQMSLTGLVIALGMLIDNAIVVVDEIKHLFEEGLNPQKAIARAVSYLAIPLLASTLTTVLTFFPIAILRGHIGEYVRTISISVIVAISSSLLFSLTIIPAIMSRMYQKGEIHQRNMAWWRTGFSNPQITKVYRRILGSILTTPLLGVGLAIILPIIGFMAVGHIPEQFFPPAERNQFQIKLELPLSTSMEQTKSIVEKASNLIAQHSEVTDLHWFIGTYAPTFYYTVARHGIKGEVPHYATAMVQTNTGRSIPKLIHNLQRELDQGFPSARILVEQLKQALPIPPIELRVYGPDLDILEELGNQVRSELVQVPQVIHTRTSLGEFLPKLTLSLDEEQAQLTGLDNTQIAQQLNTNLEGTVGGSILEDTVELPLRVRLSSDNRANLDQITTIGLVPKPPLSPEKSTSIPLSALGQIDLIPETAIITRRNGQRVNTVQGFITAGVLPSTVLADFQQRLNNSNFQLPPGYSMEWGGEAAERNEAVGNLLSTAGIFIVLMVSVLVLSFNSFRSAGIILLVAVGSVGLALASLWLFGYPLGFMAILGTVGLVGVAINDSIVVLAAIRTNPRARKGFRPAMVDVIVRSTRHVLTTTITTVSGFIPLLLDGGELWPPLAICIAGGVGGATFLALFFVPCAYLIVFGQTYPKSFKLSGNPTS
>fig|329726.14.peg.7138 Glyoxalase/bleomycin resistance protein/dioxygenase
MNTQGKKLYPFVPSGPNFQESLKFFVELGFEKLWENENDGLAALRFGEAQFLLSNIDIQEWQSNQIIVYEVDDLEAYYLELQAKDIPTKFPGRKIGPPTDYPWGREVQFIDPGGVCWHVRQYEGN
>fig|329726.14.peg.7720 Glyoxalase/bleomycin resistance protein/dioxygenase
MVAIMNNKFLNGFFRCSLIVAGISVCQWFNPVNRQPSKDASVKHRTPALSERDEIGRLKRAININGKDKLGDQFIGASRVKDRIEIWKQTDLIRSGNPKSLNALAKSDCDKALRIFGIGPVNMFSFDPIDIEYFDEQAPDAKRFRCDQMAALERESYIRPKE
>fig|330214.5.peg.12 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVHVYGCNHIVIEVTDAKKAVKFYADVFGLKMLQGGEGAAWCKLGEHQFLAIFEVERLQPDRVKHFGLMVRDAEQIKEVRRKLTRKYKLKMEPHFRCDFRDPWGNRIQVGDLSDESLVWLLPYQEVQKAGITFSKPSRARQGKERQDA
>fig|330214.5.peg.687 Acriflavin resistance protein
MWLTLLALRNRIGILMLSLAMVILGATSLERLPVDLFPNIQVPVAFVGVIYKGAPPLDIEQSVVYPIEKAVSSASNVEHVESFAKQGIGAVQVWFNWGADINVGQMEVMQRITQILNSLPPGILQPFIVKFDVSNIPVAFVTASGGDLDERALYDLAYNTIAPQIEQISNVAAATVEGGKIRQININLDPALLQARGLSILDVVKAVKASNLILPSGDIKAGNLDYNVFTNTQFKTVEPINDVVVKIDQRGNPVRVRDVGVLSDSSDIQTNVVRTDGKRSVYLRVNKQPIANTVEVVDALRKAIPKMIGIPPGVQLGISFDQSIYIRQSIKNLIEQALHGSLLAAAVILLFLRNLTSTLIISVAIPLSILVTFIVLYFSNQTLNVFTMGGLALGIGRLVDDSIVELENIQRHLNIDRNRWDAIVNAAREVAMPIFASTVTTVVVFLPMFFIVGIARLLLIPLTLTIAIALFTSFFVSRTVTPALCYRFLKPEEEAHRSLPSWFVNIMQWSQRRYDALDEGYERSLRWVLAHRRTLLVSVITIFVGSLLLLPLIGTEFLPVSDESQFRIVLRGPVGQRVEKTVDQVAEVERVLREKIPPDELEAIASSTGVLAQGRSSLFNPNTGPHTSVISVYLVSPDKRRRNQVEIMNAVRPAIIKLFPGVAMFFDPGGLVKRVTSFGSQKSIDVEIYGYDFEKARTVIHQVQDTMHKIPGMADIEVSREENYPEVNVVVDREKAALLGISETDVANAVLFSLNGNGQTDPIIFTDPQNGNEYYISAWLADEHRKDLSAIENVLLTTKNGEPVLLKNLATLKLNAGPVKIERKYFQRVVHITANPVGRDLGSIAQDLESAFAQMQLPPGFSIRLAGQIQQQRETFEGLTYASALALILVYMVMAAQFKSLIDPFIIMFSVPMGIPGVIVILYLTNTTISTSSLMGLIMMLGIVVSNGVLLVDYTNVLRRRGLDLAAAVVTASRTRLRPILMTSLATVVGLMPMALGLGTGSETNAPLARAVVGGLTVSTILTLFLVPTVYTMLEERFPRRADQLAAADSETPATQPA
>fig|330214.5.peg.994 Permease of the drug/metabolite transporter (DMT) superfamily
MQKPSVFAAYAALTTSALVWGGSIVGQKLALGVFSAVETSLLRGFGALVILIPLWWWREGGRTTWTARDLKLLSLLGLGVLGNHLLTLFGLRYIGAATAGVIIGASPAITALLSSLLVRDIPFKTVAAGCAVSFAGVALVSGVGGGAPSGDSPWLGGTLVLLGLVSWALYSIGGRQVMERLSPLTVNWTTLLLSLLLQIPLLWTDQKLLLTGATAVPISGWVALVYLIVFATALGQQAWLYGVQGVGPSRAGVFVNLIPVSALLLSALVLGEAIGIREIVGIALILAGVWLVGWQSARLTRAG
>fig|330214.5.peg.1156 Permease of the drug/metabolite transporter (DMT) superfamily
MPQFALLLTTFVWGATFPATKAALEQISPLSFLFLRFLLGMIVVFAVLLFLRRPLIRDAYMMRASLIATAWLFIGYVLQTVGLRFTTASNSAFITVLYVVFVPLYLFRLGLHTWVSNGIALAGLWLLVKPTASANLGDLLTLGSAAAFAAHMVCLERYTRAADPVSLFAWQLLLMTAAMSGAMWWEQPTPAMFEPSRVLAIGLVVTGILATGAFAVQMWAQRLLPAQQVALLFAVEPAVAAWLAWYFLGEQLDAQGWFGSGMILGGVLLGSWVTGESSPSQPDSMAARSEGG
>fig|330214.5.peg.3243 Multiple antibiotic resistance MarC-related protein
MTIAEYALLAFSSLFVIVDPIAVVPAFLAMTPRDSVAQRLRTARVACLVSVALLTGFALFGQTVLKLLGITLPAVQIAGGLILLLVALDMLRAQRSTVQETAAETAAGTNKDDIAVTPLAIPMLAGPAAISTVILLETQATTWMLQAVLLGCLVLIGLASYSILAIGARSAKWLNPIAEKIISRLMGLLLAALAVQFMVNALTGDQGLLRGLTGH
>fig|330214.5.peg.3975 Glyoxalase/bleomycin resistance protein/dioxygenase
MPTHRGLRHLALRVTDLARSRSFYERFLGMKVVWEPDPDNVYFSSGSDNLALHQIAPAELAQYQPLGGQLLDHVGVILESPAHVDEMFRDVQQDAAQYGATIAKPPKQHRDGSYSFYFTDPDGNVIQALYEPTISRMEFLPPA
>fig|330779.3.peg.1569 Permease of the drug/metabolite transporter (DMT) superfamily
MYSKDFTGSVMQRDTITFFKWIIPLSLAWGIAYPLTKVVTFSVSPILVSVARVIVGTLFFYFLGRGFSIGIKQFVNALFNVIILLALVNVGIYLSPSPGLVATMIYTQPIFVLVIELILGSKISLRGMSGVVIGVLGVLISATLSFNIGLLFGIMGSLSWAIGTVYYYRNLSKDNVIKLNAFMSLISIPFLSSLTPLDYYFDFNVTSVVLLIILALIAQVAGFYFWFNAVRDLGSVSASTGSLLVPVIAYLTSILILKVVPNVPEIIGLILILVGVYLSLNSRKGK
>fig|331104.5.peg.491 Multiple antibiotic resistance protein MarC
MEWINSLISCFMILFSIIDILGNAPIIMGFKSKGNIIETKKVIVTSLVIFLSFLFLGQPMLKIIGVDVHSFSVAGSIVLFLIGLEMILGVDLHKVTENAQTSIVPIAFPLIAGPGSLTTLISLRTTYDVNIILLSLILNMIVVYFVIDRCDFIAEKIGNNGLDILKKIFGIVLLAFAVKIFGANAGQLFQP
>fig|334380.3.peg.511 Drug resistance transporter, Bcr/CflA family protein
MINNHWKYNLTIITLLIFITELATDIYVPSLPRIASAFNTSEYKVMLTVSINLIGLSLSGLLYGPLSDAIGRKKVLLLGITIFCFSSLFCIYVSTIELIVFWRLLQGIGGGASVTVGLATISDIYKGNERAKMMSRLNMVVAFSPALGPIIGSQIAAYDNRWYLPLAIIPSLAFPVLLLLITLFKETLTQTNIGINFNNIKASFKEVLSNKNFICYLLIQSLTFGWLWADIVNLPFIFIKDMNVPTEHYGYYIIANVTVYIIGIVANQKLVQFKGPEKMILYGIVLILFSGISLTFGTIYFTLTAYIVLLLKLPAAIGVGFTLGNASALSLMQITNYGTASAIIGSTEMLLGSLGIKIISYLYNGTILPLSILVVVFSLISLLIFQKIKSPTV
>fig|334380.3.peg.1998 Permeases of the drug/metabolite transporter (DMT) superfamily
MNSDLNNYLKGILWFFLALLCSVLNDIISKKIGLSLSAAQISFLRSFGSTLALIPFILFTGIKTLKSKTLKIHFLRGILLFCSLSTWVYGLTITSVASVTIISFSIPLITLILANLVLNEDVKWYRWVATILGFIGVIIAIPTTKTIFDIRILVLFLSAFIFAILDIINKKFVNSESMLSMLFYSAFFTTIVALPFAYYSWKPLNYTYWPLIFILGCSANLILYFLLKAFSLVDSSAVAPYRYIELILSAIAGFLYFNEAVSYYIWFGGAILIFSTTFIFYTEKANINKH
>fig|334390.3.peg.799 Membrane component of multidrug resistance system
MVFGTFFGLLCSTLMNTGLPQLMRVFSVSEGTVQWIINAYMLTNAMMIPLSAYLIRRWSFRTLFIIATAVFLVGTVGGAVAPTFWTVVIARVVQAAGAGIMMPLVNVLAIRYAEPKKKGTIMGIIGLAFNFSPIIGPTVSGLILDDLSWRWLFLVIVPFSVLTLVAAVIQLPRIPHNENPHFDTRGMAIVSIGLWALLMGLSNVSTSPFWTWQVLGLLVVGAVALVIFYFSQRGVKAPLINFSVMAYDQFVVATLINMLIVATMFGNTILLPLLVQNVQQKSALVSGLVILPGALVTGFLSRLSGRLYDRLSVRRLVLFGLVVDGAGTLFQATIGAASGPVVLALFQAVRQLGLVSILIPLQTHALGILPFDLVPDGVATFNTIRQVAASLGTAVLVSVVGLMGQWGHRGTLFGIQAGFATCFIFLVAAMMIAGRLKNQFKLGRPTVSAG
>fig|334390.3.peg.1421 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNTPNIIKESNHYITRNIAASLGLSIYVIIDTLFISIAAGPLGLTVLNLALPLFSAFNATGLLLGVGGAAYYSLNKLTHPERVEHLFSQLIIFVAGLGILVTILINLFATPLLHLLGANAATLPMGLTYVRIISLAAPFYMANYIVVNFVRNDGNPNLTMIATLTETTGVILVDWLFIFGLGLHMEGAALAVLFSPVCSLTVLSFHRRFKGRQLHWYWTWPRLKSVATAARLGVAAASNELANGVSIYVFNLVLLHLAGNYAVAAYGVISNIAIVTIAIANGVALGAQPLISREVGDHRFTAGKQILNHAFKITISLALLLTLILVLFKGPIIGIFNAEHQAQLVKYATVGLPIYFTSAVFTAINLMAIIFLTAIGSSRFAFVLSFLRGYLILIPMIIGLGALLGITGVWAAVPITEFLVTMLALLLIRARLKEWGH
>fig|334390.3.peg.1523 Permease of the drug/metabolite transporter (DMT) superfamily
MSIKHPRLVGNTILWVVAAIWGSSYVLMKMVTNAQMPAGMINGWRGLIAASFVGLIFFKKLRHMSAHDVHVGIVAGIINYIAFQCGTIGLFYTTPANNAFLTATYVAMVPFLAWLGHQRPRRQDFWAVGVAIIGMVILTRLVQTGFALHFGDLIVLVAAFFYAIQILYYGGAATKVSPWVMVFWVSLLQGIGGMSYSVLFERSQWPGIEWGRALPPLLTVALLVTLMTQLLQIYAQRLTSATTAGMIMMTESLFSSLFSVLLGFDRLTWSLLIGGGLLVVANLISQINFSRFSH
>fig|334390.3.peg.1823 Permease of the drug/metabolite transporter (DMT) superfamily
MQISQSRANLMLVLVAILWGSSYVFAKQVVDAGMQSGLINGCRGTFCVAAGYLLFHAKINQMSRRDLKIGLTAGLINFSGYYLQTAALRYTTPAKNAFLTTMYVVIAPFILWLFWHQAPRRKDYFAIILAVIGMALLSGISPANFTLQLGDLLTLISAIFWALQLIYFAKFASTVSSPWIVIFLIGLVQGSLGWVCALLFERPSFAHVHWLQALVPLAILAIVVTFLAQGMQITAQHFTTPTAAGIILMLESLFASLMSVALGFDRLTPQLVIGGVILILANLLMQLDLAKMPFVKRISSN
>fig|334413.6.peg.401 Multidrug resistance ABC transporter, ATP-binding protein and permease
MVFTVLMTIFEIIGPIILAYIINNLLTGEKLVYNIRKLALVLCLYAAVFFVDSLWKYNSTVYLEKTANKIARRMQMDVYDHIQKMPISFYDNLPAGKVVSRITNDTKTVKSFYQMVLAQLMVSIMVSIFMIAMVLITDTKIGIIVCLFFPIMFYIFRKFLQKSRFAFTNMRKYISEENAKINETIGNIEIIKAFNLEDDFSKDYETSAKNVYDYGYMVTKAYGTMSYNVSELLRNFANITILGLYAYNVLTGNTDVKLGSMYLTMEYTTRTFSYISNCVQRMGSLEQSFSAAEHVFELLDTEVEEFPEREIGDIKGDVKFENVDFSYIENEPVLKDLSLDIKSGESVAFVGFTGSGKTTIINLLLGFYKPQKGTITIDGKNFNDYSVDSIRENISLVPQDPVLFMGDVKSNIRLDKDFTDEEVEKALRDIGADRLIDFRNGLDEEVKDNGESFSAGEKQLIAFARSYITNPKILILDEATANIDTQTEAVIQYAIDKLKQNRTTFIIAHRLSTIKNVDCIYVLDKGVVVEKGTHEELLANGKIYTRMYREQNKKG
>fig|334413.6.peg.623 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGNKKSNIEFITNGNITDVIFKLSIPLMISNLIKTLYGITDGIYVARISSEDYAATSFTWPVLYLFIAVGLGVSVAATSLMSQRLGARKLKDCSIYAVHTLILTTVLGVIFSILGLITAPFIVRWMGAKGSFEYKSYIFLAINSLGLLFDMIFFGYQSILNSQGRTKSMTIISTISSVTNVVIDPFFIFDNVLGIPGLNMGLAGAAWATVLSKVLLVVFAVRVVKKESEIEVNFKNFKLDMGIIKHIFSIAIPASLGSSGEAIGFTVLNGFIQSYGTTTLAAFSMGNRLSDIFNQGAIGIGMALTSITGQNIGAGKKERSKSIFKRANIIITFFSLASAIIILLFKDQLLSVFIKDRSDIELWRQASEYMYFSAIITFFMGYFSAINGFFQGVGKTKLTMYLSLARLWALRLPLIMILKSLTNLGSTGIWISMLVSNGLTVLIGFIIYKQGQWER
>fig|334413.6.peg.1007 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTRNLTEGNIYKELISLALPIMATSFIQMSYNLMDLFWLGRLSIESVAAAGTVGFFGWLSYAICMMLSVGVQISVADCIGKKDMESVQKYISNAIKFALIVGIIFISLMILFKVQIIHFFNLDESVTKLAFEYYGFFVASIFFNFVNPVLTGILNGQGESKIPFIINTIALGINIVLDPILIFGFGFVKPMGIKGAALATFIAQMSACIMFMIARFEYFKYLKEKMHLNYVKRLFDLGFPIALQECLFATFSIIMAAIIAHWGKEAIAAQKIGNQIESITWLTVGGFSVALSTFIAQNNGAKKYSRVMDGYKKGMKICIGIGICTTIILFTFAPQLFKLFIPDDPNTLNIGVVYLRILSISEILMCVEIATTGFLNGISLTKYPSINGIVFNFIRIPLSLLVMYSNLRIEWIWVIISSLVICKGISLFIIFYTRVYKNKLKYLLD
>fig|334413.6.peg.1138 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGKQDMKTQLLTKSPKDLLFQLAIPGIIGMIVIGLYPFMDGIFAGWIIGDYAMSAISISMSLTIINGGVSALIGVGSASILSRAIGKGDKETTDKIFGNFCYWVILFSIVITILGLIFAPNFLDLVGAKGNIKELGVRYLRVVFFGSIFVNFAQAGNMTMRGEGALKQSMIIMGVGAILNIILDPIFMKLMGEYAIEGAAIATVISQIVQAILTFRYFSKKSAFVGIHKIQKSKDISSEMFSIGSSAMMMQILFAVQQTFLFKQAFAYGGDNWGILMAATMRLYMFSFIPLWGMSQGLQPVIGANFGAKQYKRVKDTMKVFMYGATILAALSWIPSMFYSEKLLSLFSVRSEIIEAGVMNFKMFYSTFILYGIMIMTLTFFQSIGDGKKASMIVMLRQLILFIPAILLLPKFFGASAVWWAEPIVDFSMIMLGLFLMLNGLRKMGKDKA
>fig|334413.6.peg.1473 Permease of the drug/metabolite transporter (DMT) superfamily
MNNRTKGIIAILLSAFGFALMNLFIPLAGDLPTIQKSFFRNLIAFLVAFALLLKSNKKEEVKELHDVKSIPWKTLILRASLGTAGIFCNYYALDHLFISDASVLNKLAPFATLILSWVFLKEDLRKEHIISILIAFVGVLFVVKPTLQIQEILPYLIGILGGVCAGGAYTCVRKLNTLGVNSSFIVAFFSGFSCIVCIPFMIFNFVPMGTSSILALIGVGLAALIGQFGITLAYKFAPASEISVFDYSTIIFTGLFGFLFLHQSPDYLSIIGYVLIFSGALINFMNNRRKQRMLINEKSARV
>fig|334413.6.peg.1476 Daunorubicin resistance transmembrane protein
MKKYLASMKIEYLNSKEYFISFVSSIFYIPITIIVYYFLWKFIMKGQADIAGMNFDDVIAYFMTILVVKNSISNTMAETYYIFQDINSGNIDTLITKPIYYPLTRFCISIGRVVISMPLGIAFWIAVQLYFNKFSFASLGYFIISLFLGFCLMFQVLCILGLLTFWLKSVLSLRDIFWYILAIFSGEVVPLAFFSGKFEIIQHNPLAGIYYIPANIINSNNMSLLLLEQIVYMAIFSVIIYFMWKRGIKHYESQGG
>fig|334413.6.peg.1560 5-nitroimidazole antibiotic resistance protein
MRRKDREITSFEEQLKIIDACDVCRLGLVDDEGYPYILPLNFGYEVIENELVLYFHGALEGYKYELIDKNNKASFEMDCNHDLYSNREIGYCTMNYSSIMGKGIVEYVTDSQEKFNALTVMTDKYHMDHFEFNPKAIPRTRVFKLKVTSMTAKHKEMKK
>fig|334413.6.peg.1675 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVQALYNVVDRIFLGAGVNQMSIGGVYLIFPIFLFLMAFGMLIGVGGNSLSSIKFGEGKKTESEIILGTSMVLSIIFGVLISGIFLLNLKWFLKIFGASDTLMPYAYDYGKIILYGAPFQMVGFAMNNFIRGEGNPRAAMVTMFIGAISNIILDYIFIFPMQMGVKGAAWATIIGQVLSSIWVVRYFLSDRALLRLTKETFRLDFHFCKQIFALGVSPFAMQLVASGINIIFNNSLKIYGGDLATSSMSVIYSVSQIAFMPIFGINQGIQPILGFNFGAHKYRRVQHTLRIAVVAGTVYMVLNWAFTMIRPDLLVKIFISRPEDYAVIKDIAIPGLRIYNSMIFMLGYSIIGSSLFQAIGKPKIGFILTMTRQLIYLLPLMLIFPKLFGLTGVWSAMPVSDVLSTLTTTYFLVKSGFLVKTIHNDDEFVLGI
>fig|335283.5.peg.2039 Outer membrane component of tripartite multidrug resistance system
MLPVLPPQLPAGLPSELLTPRPDLLASFARLRATDACLDSALPPIMFTAAGGTRDQALTNLIDPNSLVWNLFAGAFQPLFTGGHVRGGIALAQARATETLHRYKETVLNAFVKLNRRWQQKNDCVRRKPNCAPLCSRRKL
>fig|335283.5.peg.2582 Multiple antibiotic resistance (MarC) -related proteins
MINPMDQYIQAIVALLAIANPLSAVPVFLQAVDGLDRTQRRKSALLAAISVFTILFVAAVAGNWMLDIFGISISAFRCGGGLVILLMGLTMLQGRTSSVQQESLTHNERRSKIFVPIAMPLVAGPGAITTVITIALAEPYWKNLSVALTAIVVLTMVLWVVLLLSQGVQGLLSPLGQKILLRFFGLILVAIGVQFILAGAYEFFTDAIAQQALR
>fig|335284.3.peg.808 Permease of the drug/metabolite transporter (DMT) superfamily
MSNRDLIIFITLSFMWSLSFIFYRIGVPEFGSLAFASLRVVLAGLTMLVFVILKKKNRVGIRENWKVLTLVGLFSAAVPFILFAFSARSVNAGVLAVLNASVPMISGFIASVFFKDRLSKKQILGLVIGVIGVMILMSENLFGGQGAGSGSGLLPMGYALLACVGYALGANITRNYLENVSPVAITAGSLIIASVIMLPVAVYEFPYGKSISLTAWISVICIGVFSTAIALIFMNQLIKSIGPVRATSITLVIPIFAIILGYLLLGEALDTPAIIGSIVILFGTYLSLNLSFKKMLKS
>fig|335284.3.peg.887 Multidrug resistance ABC transporter ATP-binding and permease protein
MPTSPQPRRVQLDKKPPVEKKERRALLWDILKKLAVFAKPYRLLIIATLILTVLGSFTAQVNAFVLRYAVDTLTEIATLADPWEAGVRMLTIISAVLLTKEILSIFISFGQRFFGEKIRINLSRDLSQKIIDRILTYRMAFYTSSENDSGKLQTRIDYGVSSLTSLVQNFFIDMLPLFASAIVSLIIMFSTNFWIGLVGLIIIPIYFFISQRQARRLQGFRRQMRGFREAKSGMVISLINSISVVKSFVRESIEAEKHLQIQKEMTDNQLRIRSIGFIYDAVKTFIEQIGVVVIILLTAYFVLKGQMTIGMILFHVMLFQNVAAPIRQLHRIYDQINNALTYAEGFFEILEDESQVENITGRSSKDLKGLIELKNVYFTYPNGTQALKDVSFTIKPNRITALVGLSGAGKSTIISLLVKFYAPDAGSICLDGYDLADCDTHELRQNIGLVLQSNHIFSGTIGDNIRYGDMNASDDDIVIAAKKASIHEQIMSLSKGYESTAKSLSGGQQQRIALARMFLKDPPIVFLDEPTASLDAIASQQVKKSLDLIKKDRTVIMVSHNIAQIIDADDLVVIEDGRVVETGTHEELYHKGGKYFEIFSAMSDSLNLDKISQTLNS
>fig|335284.3.peg.2405 Permease, drug/metabolite transporter (DMT) superfamily
MAHTDSATSARQSWIGTIQIITAAVCWGTLGIFSTYLNQNGFSGWQTTILRIVTAALIILVMLPKLWPQLIKLRPKQWLGLALQSLIGVLGMSVCYFFAVIYVGAGPAVALLYTAPVFSLLFSAFLLNESITRQSALLALMAVFGVGLTMLGEQAQVNWGIALGLLSGICYSLYGVLGKRAMHDAHPAPLVFFTSIIISAGILLLLPETYKTYGQLLTLPLSTWGYALGLSLIGTVVPFALYMKALEKLPATRASVFTIFEPLTAIALATLLLHQSLSWIQYVGVILILLAALFNAVLNGTTTRVPRWLKRRQRI
>fig|335541.4.peg.436 Vancomycin B-type resistance protein VanW
MTDAGKLWLKVISMAVIAISASLLIVSFALAARDQDYYPSNLWLGGISLADMSKEEAYALLQSELASNLGDKLSLVVGKQEISLPMEEIGISYDVAASLDKIEEELFPGQGVATLVKHSVARGQRQEIKPALSWSKKAILEKILQIKRDYDQPAIDARIVYNHDFLEYRAHQNGYSINVNASMNHISDALGKGILGPIEIIATEVHPRVKIEDIETVKDVIAVSARRIDHVSQETSALLEKLNGLIIMHGEKLDLPTIMDSGREAAMDVGSETKAQIKGAIVQACLQAGMQEKDKQSVMENKLQYPLLLTTSMSEHTLLVKIYGCQTELGKEITLLSEREDVYPEVQIKLNHRLSPQQRIIQQEGKKGFILRNYRVVTSGGKVVEKSLLSEELTPASDTIIVVGPGNTRK
>fig|335541.4.peg.448 Vancomycin B-type resistance protein VanW
MGGRILASERVKTSIFFSLILLLGIASAGAMYFFQVFYKSPYFMPGVKIASTTVGGYTNKQAASRLERDLEDCKKTPVIFYYQGYSFASKLEELSYPINYEEAVNKVWQQEQERDWPSKLTNLDGSREIFYPLKLEYKPEIKAQMIDEWNKVLGVAAEDARLEIDKQKGLVLIPARKGLKVDPEQTFANLPQEWGAMKEIKIPITMQEEWPQVKDEDLSNMGELSSFSTWFNVNEINRSHNLYLASSAINTSMLPPGEIFSFNRRVGERVIETGYRDAMVIVNGKFEPGLGGGVCQVSSTLYNTVLLAGLEIVERHNHALAVAYVPVGRDATVVYGLQDFRFKNNSPYPLYIRAWAQAGKLTMTIYGNLTEKRNINLSTIVDRVIPFKEIRENDPSLNPGQEKIDHAGIQGYVVRSFRNYMDDEGRLLKSEQLASDYYKPLDKLIYVGPGIKVESPPENVDNPENPPNEVEPDPLGDSTGEAAPLVEPGPPETPSPQPENGDEGTPPITI
>fig|335541.4.peg.864 Vancomycin B-type resistance protein VanW
MENMALKEQKLPLEPALDKETGEVIPEQEGCIVDIEGSVSKALQAEEGDKLELLMRAIPSRYSSRDLQKITLSRGYYETWFTGTYQRYTNVSLACSSVNNSLLWPGQEFSFNETVGPRTPERGYMPAPVFLMGASELDYGGGVCQVATTVFNAAGKAGLKIIERHLHSRRVHYVAEGKDATVSYGDLDLKFSNNTGSPLIIKAGINRGKVWVNILGEED
>fig|335541.4.peg.916 Permease of the drug/metabolite transporter (DMT) superfamily
MSAAKKRMQAEVSMLLVAAIWGSTFVVVKNALQEIGPFLFLGLRFLLAFLILLILSFPCIKKTNRHTLLAGGLLGLFLFIGYVFQTIGLKYTTSTNAGFITGISVVLVPIIFSLLYRQRPTVSTTITVILAATGLFFLSFPRNSFSLAYGDFLVLICAFGFAFHIIFVDRYSHQHNAIAITAVQILFVGILSLLIGLINEPWPEHFSANLLTALFITAVFATSLAFLLQNALQKYSTPTRIAIVLTTEPIFAALAGYLWAEEILSHRAMFGAGLILVSMLISILTRKSKNLIEANA
>fig|335541.4.peg.1069 Acriflavin resistance protein
MIRGILSKIIASSRFITIFIILSLVLGLYSYYLLPKQESPEVSAPVAMISNIYPGASPQEVERMVTRVIESNIRKLPGYDFSESYSRNSISVVLLQLQNDAPVEESWNELRRILSDTQRELPPECLPIQLNTDLAETAGIIVSLSGQHYNPEELAVVAEKFKKRLEQVEGIARFEIFGEEKKRIEVEIDHTRLAASGLSLEEIFNILQAQNVVIPPGAIVEEGIKTNVRIPGWYNSLDDIENTIIGVSPDGISQRLKDIANIRWELEPDRPLARYNGQSALLLTGYFEAEENILLVGKKLRDELDKLKSEAPHDLLVDQVLFQPDEVNKNLYRFLRNLLEGIILVIIVVLLGMGWKNALVASTAIPLSIMLSFMAMYLLGIKVQEISIAALIIVLGILVDDAIVMVDAIQVGLDKGLKRMEACLQGLKQAAIPILTATLVIIIAFSPIFVLPGAPGEFLQSLPQIVLISLLASYVVAMFITPAMAYRFFTPSQHRKDDWLRRFFAYLLHESMARKRTAIISSLLIFSLAVYALTFMGLQFFPSADKDLLYIDINAPAGSTRVRTEELLLQVEDILSREGEVLAYTSSVGSAVPKFYITLPVSPQAPDFAQVMLRIRPQQGDRFQNNEEMASYLQEKLDSRISAGNIKVKLLEKAFPVAPVQLRISGEQRENLRQAAELIKSKLKQIPGSRNVEDNGEKEIQQLLVEADAEKASRLGISNYDIQRQTSLALEGGRASVLRQEGEQYSILLRSDINSRQQLENLSIKSAYSKRSVPLKEIVGIEVKPQLSSINKYDGQNSIKVRSDIRPGYSAVEIEKELKDKLSSVELPGVSLLYDGEYKQIKDNFGILTRAALLALFLIYFILVLQFHSFIQPLVIFLTIPLALIGSILGLLLFRQPLSFMAFIGMVSLTGLVIRNAILLIAFINDARERGLAVEKACEDAVERRFRPIILSAVTATIGLVPLALSGSSLFVPLAIAIIFGLLVATLLTMVIIPVVYSLLLPERTEVKA
>fig|335541.4.peg.1076 Probable multidrug resistance protein
MKLEEKWRVLIIICIGIFMSTVDGSILNIANPTIARELSVSMREIQWVVTAYMLVITTSLLFFGKLGDMLGSSKIYSYGFLIFTIGSLLCSLSPSLAYLVAARVIQAIGASMMMATGIGIVSNTFPPGERGKALGITGSIVGVGNMTGPSLGGILIGNFSWPVIFLINVPIGILAFYLGMRYLPQQAKSLAQKKHDLGGLLLFALSTILLLLSFSGSHGIEWKLFSLGLLIMLLFYLFEKRISEAVLDLELFKIKNFTHGNLMAFAAYSAQTSVFFLMPFFLENLLHYPPAFSGLIMTIPPVTMAITAPLAGALSDRIGNRRITPLSFLFMTSAYLLLSTLEQESGLLKIAGSLLLMGVGMGSFGSPNSSSILGSIPREKAGYAGGFMATVRNFSFSLGVAASVSTFAYFLSLYQQKNSYIAAYAGAAHAVYRIAAIISILAFLLSLLEREPARSTESESLN
>fig|335541.4.peg.1307 Vancomycin B-type resistance protein VanW
MRIRYIRIGLISLLILLLGTINHAIYTDNLSDRPGKNLDFLPYATSKDRIIYSTPSASSSVTLLPWENDPDFQAAMAENKAKIQLANYCTVLQNPLPGEETNVYIAACLLQGTVVKSGQIFSQNEKIGPYSQDKGFQPGPVYIGHQLKTTVGGGVCKIASTLYNVTILSNLPVIERYAHSMPVPYVPLGQDATVCYGVKDFKFLNNSPYPILIWAESIGNRLYIAFYGQTTPPKVKWHHEIVKEIKTYNIYRKNYALEAGKEKVILQGMDGAVVRSWLTIEDPQQGRITTKKLGKDYYNPMPSIVEKGMKKATSTIPPH
>fig|335541.4.peg.1759 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNEPSRQLDMGSDPVFRVLLTLAIPAMISMFFQNLYEFVDTMFIAWLGSAPLAAQSLSMPLFYLVLSLGKGAQIGATTLMSQARGQDKPEETAKLSESALPLLLLSILPLFLLLIPELCAGFYHFLGARGPVLTEAYPYTFWLVLSFPIMAYVMIGEAISMSHGNTLMPMKAMLIGNAINLTLDPILMFYLGWGIAGASIATLIGQLLSAVYIYRQLKQAKLPVPVLYLRKDMPLYWKKISHLGIFVTISQLVSPLGLSLVNVVLASFGPAAIGAWNIMARLEMMGLLPLYGMAGALIPYVAFNYGQENWERIRSGVRIFLLGTGVIILPIMAVLILGAPWLVLPFRSDAQVTELAMHAIRIAALAHIFAPLELALFGTAQGLKRPWYSLLTSVARLLVFRYPLAVFFASFWGVNGVYWSQPLAVALSGILSGILLWRLLTGEVFQAKLPRGEEMNYSEV
>fig|335541.4.peg.1996 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVDHIIAGQVLGSDALAAMSLVNPLFFLLTTLGTLVCVGSSTLASVSMGSEDRSTANKLFTLTMLLILLLGTVFSIVGFIFIEPLVKLLSNDPELYDLVYAYCRGLIPGAICIMAVYLPLNYFRIEGRAFLGMIMFLIMAALDIILDLWFTVVMGMGMLGLALATVISALLAVAIMSPFLFIKGGGYRFAPIGQSLRLVYAIAITGSPPALNNLYTVVRTFVLNMLILAVGGPIAVASFAFVNSVNTLAQAIISGISQTVSPLVGVFYGERDVLSIKKVVFLAFRYGIITMAIFSISISLLAKPICLAFNLSSPEQLHIAVPALIISSISLLGAVVNNIFVYYYMTIGRTSIANRITLFRGFLFIIPAAGAMAQAMGILGIWAAFSISELLTLLMTILTIRKTLLKEQDLRGLLLLNYRDVAEGRFIAFSVDSNNESVLESSDKISEFCTSCKLNSKQSMVISLAIEEILLLMVQHIFAGNKNKSIDVRIFVRDDVTTMRFRCAGRKFNPLDYYQQAMENADTSEALALGESMGLQMITKMTKQVDYTTSLGLNNIIIRI
>fig|335543.6.peg.98 Multidrug resistance protein B
MDVEPATESKTMNPFSQLFGLCAVGFFARLSYALARSPVLPLFALYLGAAPEIIGWVVGISTVTGIFFKLPSGALSDVIGRRKTMLVGLVVFALTPFAYFWVKDAALLLIVRFVHGFATAVYGPVAMAVVADVAGCRKGEMLSWFSSVTIAGSLLGAPLGGFLLFTLARSGSPSLEHFHWVYLASGAFGCVALILGGKLLAGGDETVTQVGLKASLAQFGAGIREVVSDRRVVLTSSMEGLQNMTMGALEAFLPIYAVKVAGLNEFQAGLLWGAQVLVTIVSKPLMGRLSDRYGRKPAIVIGMLACAVAFAAIPLLTRFELLILASLLFGLGEAFVTSSSAALVADLCQERHFGTAMGTFGTIFDVGHASGPILAGVLIASWGYLPAFSIMSAALVVALPVFILGVKVESRTSMVTSRVWRRRHRKGLP
>fig|335543.6.peg.2458 Multidrug resistance protein B
MRRGSLLRGERRSAEESLVELPVADRSAARESGREGRTTKAFVIAAALLALFLGALDALIMSAAMPTIVADLGGLPLYGWVFSSYLLTRAISLPIFGKLSDLFDRRRLYLIAIAIFLASSMLGGAAQSMLQLIICRAIQGVGAGGTFALAYIVVADLSPVEKRAKWMGFISFVWGIASILGPALGGFIVACMSWRWIFFLNVPIGAVALLGIFLFMRDAREARTQADIDYAGAMTLVLSVLALLLAFMLGGRTYSWLSVEILALLAVAVGGAIGFCIAEKAASDPILRLSFFGNSGFSMANASAFFSSFAIFSLSSYSPLFIQGGMGKSPAQLGLAMVPLSLAWSLGAIVCGQLVGPKTEKPFALAGSFFLVAGSLLTLSFSPSTSLAFCSFTLALAGFGMGIVSVSTLLIVQNSLGASNLGVSTSSQQFARTLGGTIGVGLSGSLVAAQLGKALDPLIHSAPGDGLPVSVFKHLSANIESLLQPEIQAALSPHLQKTLQAAVASGVEVVFWAVLITAVISLVFCCLLPAPGK
>fig|335543.6.peg.3224 Permeases of the drug/metabolite transporter (DMT) superfamily
MITALLVLIIVVSNAAGDVLITRGMKQIGEVASISPRELLSVAGRVFTNLSFLSGVASLAVSFFAFLAVLSWADLSFVVPATSLVYVVTIIGARFVLKEEVNGLRWAGTLLVCMGVALVCVP
>fig|335543.6.peg.3225 Permeases of the drug/metabolite transporter (DMT) superfamily
MLMKTAVVLTIAVFAQAIGNACLSKGMKGIALDQFDGSFSAMLLLDAMREPLIWLGTLLLILFLVMFSATLTWADLSLVLPATAFGYILNVFFGYHFLNETVSNARWAGTVLIFVGVVLVAGSGRKSKRRLDGDA
>fig|335543.6.peg.3636 Fosmidomycin resistance protein
MPGTARRTLQRLLSNAFWRCSLPGLIDDSESLLKKTRQIAAPRDGLRCETGRRKARQAAFGGTCPKSGAPATGRRPKTIGMEVMSQFNLKILLLLSCGHMVVDIYQGALPAILPFLKDRLDLSYTVAGTILIASNLTSSVIQPLFGFLSDKKEKAYLLPLGTFAAGAGFSLLAGAGHYLLILLLVAISGFGIAAYHPEGFKTARFFTGQKMATGMSVFAVGGNFGNALGPIIALSIINYFGFSSLPWMFLPAAAFTIGIIALRKSVAIPAKDRPAVAENTPPIPRRAHRAMIVIICVIIMRTWTQIGLMTYIPFYYIDVLKQDPVFAGKLVSMLLLGGAFGTLAGSPLADRWGHRLWLRFSMLGSFFLFPLIFHLQGFLLSVAVTLFGAVLISTFSVTVVMGQNLLPRNLGVASGLIVGFAIGAGGIGVTLLGILADHFGVPFAFKCIGFLPLAGFLMSLLLEYPLKKTA
>fig|335992.3.peg.115 Multiple antibiotic transporter
MLEIFIQTFFLYFIVIDPLGNTPLFLAVTQNMSSQQRVKTALSATIIASIILLFFAFLGSTLLNYLNISFPAFTIGGGIILLIISMEMLFDKRQQRKEDDIDFNSENVSVFPLATPIIAGPAAITSVIVSVSDMGSNFTNQSVGMIALASVLLLTFIFFFTASKFSQIINKKVISVISRVIAIILVGLSVQYILDGIKTFLA
>fig|335992.3.peg.151 Permease of the drug/metabolite transporter (DMT) superfamily
MNVINKIPGPILVFMGACCLSFGGLIVKSFEGSTLWQILFWRSLFFSLTVLLFLIITYKKKLFKAFYDSGLPGLIGGVILSFGFCGYVFAMYNTTVANTNFIISTQILFLAIFGYLFLKETISSITLASIILAITGVLLMVGNSLSPGEMSGNLAAFSMPITFAVLIIIVRKFPTVDMVPAQFIAGVSSCFIGFLLSEKLMISSHDIFLGFTAGFFQVGFGFIFITMGARSTPSAMVGIIMLSESVLGPMWAFLFAAERPSLFTLIGGGVILFAVLLQFYSLLFSNKKEKIIN
>fig|335992.3.peg.184 Permease of the drug/metabolite transporter (DMT) superfamily
MNNFFLFIVTLFCWSPTWYVIKFQLGYVDPLVSVFYRFLIAAIVIFVYLIYKKKNLKFSLNQHLWFLLFGVCLYSLNYVFFYLSNTYLISAFPAVVFSTVVIMNILGEGFYFKKKPSLKTLLGATIGMIGIIIIFNDEIFNFSFANGTHVGLFLALLGTFSASTGNMVHQRNLNNNFSLIPTLAYSMLYGSLVTLLITQIKGTELLFEYSFSYIASLAYLSIIGSIFAFIFYLRLLEKVGAGRAGYVGVVMPVLALLISTIFENLEWQQDLIIGLPILIIGAVLVINQKIKPIK
>fig|335992.3.peg.273 Permeases of the drug/metabolite transporter (DMT) superfamily
MFAKVKINNELLGILYMLLCQFSFATNDAFVKNIYQHYNEIFVLNQIIFIRGIFTLLFILLFLYIKKQLNFKLIFSSTELKIRGFLESLAALFFFIGIALLPFAKVYILLSMAPIILTAFGAIFMNEKVRWRRWSAVILGFIGVVVVVNPGKLEFGYYFIFPILAAIMLSIRDMYTKNFKKDYHSLQTAFMTCFVVTIFFGILSIYKFYDFTLKDIFILFISAFFLAMGYIFSIATIKIALVSVTSTFRYSVILWGIIYGYFLFDEVPSTNSYIGALIIIISGLIIISRQKQIGVIK
>fig|335992.3.peg.340 Permease of the drug/metabolite transporter (DMT) superfamily
MVKIFPFIFIVLWSSAFVTTKPIIDNSDPFAALAFRFFVVAFGFYIYSIYIKQKILTNSRNLLQSLFSGVLFHGVYLGGVFYSVSIGMPTGIAALIVTLQPILTNALAGKFLGEKVTFKQWIGVILGFIGAALVLGFDIGSSLPIFGVIASFVALLAITTSTLWQKKISNNLPLSVSNMYQAIGGCSFHIIIILIFSEPYINFTSTFLIAMSHQIFLVSFGAFTILMFLIKNNSASKTVSIFFLIPPTTAIMAWIFLNEKLNNLDLVGFAVATFGVYIATRKQ
>fig|335992.3.peg.567 Permease, drug/metabolite exporter family
MTVRHYFLVLFIMFLFGSSYPINKLALNTSLTPVLAASLRMFILFVCLVPFCKFKIPNKKYYLPLAGFSFSMGFGVFIFLNLSLQKATMVAPIIIGAQLAIPFAILASSLFLGEKVTPKMWVLIFISFFGIFLIGYDPNLKSEIFAIFLCAISAFFYGVANVFSRYIKDIDVKLTNTVMGFTGFILLFLFSIFFEGNTVYQLLNIDFYTWLLLLHNGVMVSVIAHTSLFYLYKFYSVNKIMPFYSLFPVFGLILTFFIFGEIPTLLSAIGGLIIIFSVYRLQKIR
>fig|335992.3.peg.643 Permease of the drug/metabolite transporter (DMT) superfamily
MRQPRLIDYTLLVVLALIWASAFFNIKIATESFGPITIAFLRVFFGSIPVLLLCFYKKIKIEAFSKDWYWFAIIGFVNLVLPFFLIAYGVKSVQSNLAAILMSTTPLSSTILGHFYTKNEKFNLVKTFGILIGFSGIIYLFSDNLLINDSNFISALLILLGSTCYVIGGVLTLKISKKKNENVTGSILIWAILILIPFVYFIEKPWNSIPSIESTISVVYLGMVSTGVAWLLRFKILKDNGLIFQSQVSYLIPIFGTILSYIFLKEIITPKILLSLLAVVVGIYFVKKADQKKTT
>fig|335992.3.peg.737 Quaternary ammonium compound-resistance protein qacH
MNMTTSYLFLALAVVLGVASNSFAKSAEGFTLLVPSIITAITIVLCMYALSMVMKNIPMGITYASFAGLAIISTVGVGIIKYNQVPNLYSIVGLCFIIVGVLMVNLLGNN
>fig|335992.3.peg.738 Quaternary ammonium compound-resistance protein qacH
MNLTGGYIFLVLAIILGISSNGFLKATDGFTNIYPTIFCIITIVACIFCLSKAMTIIPVGFTYATYGGLTITAVTIFGVVKYNQTPNLYAVLGISLIIIGVILLNTMGKTN
>fig|335992.3.peg.969 Transporter, drug/metabolite exporter, EamA family
MFLAVIGFGSGPPFVKLALEEFQIVDLLAVRFAIAFLLMLTFALIMRVDLSIKKIGLAPFLMGLLNPFLVTLAFHVGLMLTSPINGVAIISTMPIMQPFVAKIFLNEKIEIKVLIGAFITIIGTYILLSSQTIIGQGNYIGDFIIFAGMTLASINEVIGRKKMQTNVNQLGVNTYQYFTGFILSFLILFIIWPNSTFGYSFHLEFTPSVIAAITLSFITFGSYLFYNYALRRVPIGRISLMYPLTGPIGALSAWVVIDAEITLKIFISLGIILVGTVIPYINKK
>fig|335992.3.peg.1025 Drug/metabolite transporter
MLTKNQLGFLYMFLSVCTFSVMDLLVKWSSDYPTGEVLFFRGFFGLLPTYFLIPKGKLKTFYTTERSKEHLFRCLMGLMALIAIVVALRELPLAVVVSLSYAAPLFITVLSIFLLSEKVGIFRWLAVLIGFIGVIIIAEPGFKGMNYLYFLPLIFCIGMAFVTITIRKLSTTEPIWLISIFFTITISIAGLATIPMGWKMPNFQDFILLALIGVTGGSANLFLTQSYKLSEVSLVAPLKYLALVFAIFFGYFIWNEIPTIKTLIGASLVVLASLIIFRREIYHKQKIPSTTRHE
>fig|335992.3.peg.1234 Permeases of the drug/metabolite transporter (DMT) superfamily
MLPIMDGFAKYLSADMPVLQITWARYFFTVAFTLPIMFLFYNKQLVWTDKPKLQIIRGLILLSANICFFYAISVISLAKALTLAFVAPLIVTAFSPIFLGEKVGIRRWTAVIIGFIGSLVVIRPGFVEINLASLAALGTGVMYGFYLIITRKLSTSDNPLLTLLLTGLVGLIAVSGLMPFVWVNPTPSQWSMMASIGVFACIGHLFLILSLKYADASKLAPFSYFEIITNIIIGYYFFSDFPDNWTFLGLSIIIMSGVYISRRESYIKSY
>fig|336407.4.peg.21 Multidrug resistance protein
MNTKLLYRLARNLRFYKKDLIIVIISLLSVSLALLLIGNVFRNLVDQGLVLDRTAAVDKSILYICLLIIILSIASFFRSYFINNVAEKVSSQIRKEAYSNLINYEITEFEELKIGDIISRLTSDIDQISKLIVNFLSFFIRNSVMLVGSIILMFFESFKLASIVIITIPLLLIPIIKFGKHVKALSKKTLESQSLLASDINESFSNIKTIHAFGGQAAKITEFNNLLQDYLTYSAARLKIRALFFAFSMAFIFLGVTLVIWIGALDIVKGNLSSGQIISFIYYAIIAGFSSGGIFELLSEMHLPLAALERIVTIIDKSPIVHNNYSDLKPVNSISLEFKNVNFSYPSRPNLKILNNISFKIDSTQFIGIVGRSGSGKSTLMQLLLRFYVQESGIILVNNQDIALLNPNEIRKLIAYVPQEASIFSGTIKSNIMFGNDSSEEEITEIIKITGIADFTDKIPDGINAKIGEKGVRLSGGQKQRIALARALLRKPQILLLDEAMNALDSQSEQKLLSSIRDIMKGKIVISIAHRISSIESADNILIIDKGAVEAEGTHAHLLKTSDLYRTIYKEVDLL
>fig|336407.4.peg.57 Multidrug resistance protein
MNNNLDNDYQAFYIIKRLIKNHIKPYATKIYVAIFCMAVAAICTAIIVHAVRPIIDKIFLTHDRRMLVIMPIVLIVTFFVKGISEYYQNYLIKFVGQRVLNDLQIKMYEHLLFADISFIQKQSSGRLISRFTNDISLMRGAVSNLLVGCAKHFLTVVCLIITMFNLEPLLSCVVFLVFPLAVYPVQKMGRRIRRIFARSQEELGHYTSKLDEAFQSIKIIKSFVGEKIESKRAVLIINNILEYYKKTSKLDALVSPIMEGLSGIAVGGMVWYGGTLVLDGKTTPGALFAFLASFAAAYRPFKSLVSLNINLQEGIAAAKRVFSILDTEPLIKDHSNSKEIDLSDAQITFEKLALSFESKLAIKHIDLKLKPNKMIAFVGRSGSGKTSLSNLLARFYDPTEGRILINTYDIKDIKLTSLRSQIALVTQDTHLFDTSVAENIAYSQPNATQEEIIKAAQYADAHEFIMQLPNGYDTQIGVQGTTLSGGQRQRLSIARAFLKDAPILIWDEATSSLDQSSEQKILESLKKLRKGKTTLIITHRLSSITDLDNIIVMKNGAVCEQGNHKQLLDNKGEYYALYNKELRETLD
>fig|338187.4.peg.1949 Multidrug resistance transporter, Bcr/CflA family
MSKLQIIFISLIMASSYFFASSMYVPSLPEIQNALHTSEALVQQSLSVFFIALACSQLLAGPFSERYGRKPVALLSAVIFVAGSVLCALSQNIESLLIGRVVQGFGVGGLYLLCRTILQDAFEKSELMGILAWYGIIFMSLPGLTPILGGYLTTHFSWEANFIFLLGLAVVTLLVIAVIKRETISQHNPDAIKPKQMLKDYAFITSNLTFLCYLAMMISGTSCLLLFQVMGSFVAQNQFDISVADFGLGAMTLMISSVVSRLFWNQFLKHRLSENLTLFFGCVIQVSGCALTTFSLMVKSYSFMLLGFCVMSFGVAFLLAIAGVSALYMFPKHKGQVGAIYGALQMIGAFGFTYGLSMLPATQSMMVLTSWMLAMTSAIAFFIIFIEQRRAVGQACTFSEN
>fig|338963.3.peg.594 Multidrug resistance protein norM
MNIFPVAKSRLCGMKIESFALMKLTGPILTAHLAQQALAFTDTVMAGRVGATDLAGVAVGASLWIPVSLFIYGVLLAVTPMVAQMHGAGRTTETGPLVRRGLWVALPMVVMAMLMLRHAGGVFVLMEVIPQVASIASNYLKAIAWGLPAAAVFFLLRNLSEGMGLARPSMLIGLASLPINVAANFVFIYGKLGFPALGGVGCGWASTLTLWFMCGCMCATILWGRGYAVTHCFDFRRSCGEEGAMHILRLGFPIGCSLLVESSVFALIALFLAPLGASVVASHQITLNYSATVFMIPLSVSSAITIRVGHAVGSRARDLARLTTRTGLLMNTVIAIMTAAFTVFFAEQIACLYTFDRQVIGMVVGLLYLNALYQVSDAFQVGAIAALRGYKDTRVPLLLILVAFWGIAMPLGYSLSLTSFWGAPMGAKGFWISLVVGLSISAVLLGGRLCRLQRGMARMENGGE
>fig|338963.3.peg.1692 Outer membrane component of tripartite multidrug resistance system
MRSFWGIAFLLVLVGCSVHRPVPVELPVPVPDRYLESTAAPGEPVAQPWWHIFEDPALDRLMLQAFGANLELDQVLARWQQAEAAVRSVESARRPSLGLDGQAGRQRQMTFLGPVTADHYSLSVVAGFELDVWRKLASRSEAARREQAAAAADVEAICLSLSARLADLYYTAVEQRAQHALLENTIVSYLDILERVERRYRAGIAPALEVYQARQNLAAARARLPQVEARLAAAEHGLAVLLGRYPQGGLAGQLAVLPAPAKNYPLGVPSQLLNRRPDVKAALLRVKSADNRVAEAIAERFPAFNLAGGYGGGADTPRQVFASPNIFWNLLVNLTQPILDGGRRRAEVDRRQALFKELLASYQTRVLEAFREVEDALAAERASREQVAQLQARRASTSAALRLATDRYTLGVSEYLQVLTAQVLHLETESGLLSARRQQVADRISLARALGGHWMLQQCRQSRNDSVIFPTEDSDHDK
>fig|338963.3.peg.2601 Multidrug resistance transporter, Bcr/CflA family
MSAHTEIRTNMRLVVILLGVLTAIGPLTIDTYLPAFTAIAADLHTDVATVSLSMSSYFIGIAVGQLIYGPLLDVFGRKGPLVYGLVLYILASLGCALSYNVEWLIGLRLVLALGGCAGMVAARAVVRDLFPLHETARVFSSLMLVMGLAPIVAPTLGGLIVASLGWRYIFFLMGGSAVVMLAGVWWILPAIPGHGRREALHPRSALRDYLAVLAVPGFTLRMVTGSFYIAGLFIYLTASPLIFMDMFGMSGPHYGWTMGGNALALVIGSQVNARLLKRFSLGGVLWRSNLLLLAVSALFVLGAILVPVPLWMVLVFAALYLFCLGFLLPDVTALIMEPFGREQAGSASALLGAVQMMAGALAAALVSWGYDGTVAVMAIGMPVCALGSVGLLWRERYPVRVQD
>fig|338963.3.peg.2883 Fusaric acid resistance protein conserved region
MKSTIRRPRRFDLLAAVKGVAAQTGKEAAIWLFALKQTLAVLLAMWVSLRFELGQPSTAMVTVYVLMHPQSGMVLTKSAYRILGTLFGAAACLVLFALFPQQRVLFLLGLSLWVGFCTAGAALNRNFRCYGFTLAGYTAAMVGLSLVNHPMSFFAYASNRISEVAVGILCAGLVGDLIFPQHLGSTIVRSVQSRYTEFCGFVQALFTGKMSPRDVEGTHLRFIHSVLTLESLRGASLLETTQTPRGDARLRRMNRDFMAASTTLHSIDQLMKRLQKAESPAAPGLVLLAESLAEALLNDGEPARTEAEAHRSSRRIAAYNATLDERVAALHHDLGTPPDSPTTLDFVTGVELIRRLAQEIQDYTGAYAAGPEEHSPLGSEDLHFASRTDPAVAILNGIRAMLTLFLISMFWIGTSWQYGNVAVMSVAIGCSLFAPAPDPTKALTGGLIGHALGFPAAFICKFLILPHLSGFGMLCAVLVPFLLVGSWLAMSPKTANYSLAYSVMVCFMIAPSNSMQYDPMYMLNFGNALMLGLAAAAVMFAIFIPPTGSWFKHRIPKMLRRQVLKVCSAPLSGLEHRFESGTRDLLQKIAAGQSAQNSPDQNALDWMFLALETGRAVIHLRQAAQNMSQQLRLKEVDESIALIQQLFRRPTGGNHAAAITGVENAIDAIRSQQNRETAGHLLDGDLHQMTTSLHFIRIALLDDETALAASTNGPAPRHRGEISYAA
>fig|338963.3.peg.3000 Multiple antibiotic resistance protein MarC
MPNLGFFTLLLHDALLLLAVINPLGNIPVYRDLTSGMDFSKRRAMIQLGVGTAAAMIIGFALLGDWSLKNLFEVTLDEFRIAGGILLFIVAVRGVMTGSLSYNLLSDDFRTRAIFPLAFPIIVGPGTLAVTIILAQNRPPLHMLAVSSVSCIIVYLIASSAHSLMRVIGGYAAMIIPRLLYIFLAAKAVALIMHGLTGYVQGLLKGVA
>fig|338966.5.peg.1379 Vancomycin B-type resistance protein VanW
MGPHRHGIFLLLVCLIFASTAWGEPPFGQLWSGFSTSLSNRSPEQRKNAAIAGQALDGAIIPPGGTFSFNQRVGAREREKGFLPAPYLTSNGTLDDTPGGGICQLASTLYNAGLLAGLEVVERHPHSRAVAHVPPGRDATISSWRKDLRLRNPFPHPLKLRIDSGNDRLTVSFRSPVARLFQVEIQSSQISQEPETVAISAGKSGQPGSHGFSTRTWRITHTNGIDKRELISEDNYPAPSRVIAGGGN
>fig|338966.5.peg.1408 Permeases of the drug/metabolite transporter (DMT) superfamily
MVRRNNNPASYQTMHERAPFSGLDEARRSDTTSAAPHRQETAMISPWIPLSLLCAFSLATSDALAKRALTHHNEHLILWLRLLLASPFLLAMLPFIPIPTLAPGFYRATLVSLPLEALASVLYIRALKLSPLSLTLPLLALTPLFLLAVPSLLLGERISRAGTAGVLLIVTGTYCLNLGRARREFLEPLRATMRDRGARCMLGVALIYSVTSTLGKQAVAASSPLFFAAIYIPLLTLLLTPLALRNMKGGVRGVFASGAVKEAILPALFYALMVLTHMSAIAMTRVAYMISLKRLSLLMGVIYGHVLFHEQGIAGRLAGTLLMLCGVALITLYP
>fig|338966.5.peg.2598 Outer membrane component of tripartite multidrug resistance system
MKFQPVSLALVILLILASHARGAALSLSDCLEKAEKHNPELRTLAWEPIMAEQNVAQAVSARYPRLDGRVGYTMQKDPQAAIIMGRVAELQDSDYAHGGLEALYTIYDFGKREARISQARATADAIRSRYDARRTDVSLQVIEVYFGILEGMQLVEAARDEITQVEQHRRMAQALFDEGVVTRNDILQADVRLASARQTLLSRNNSLDNTWLRLNYLTGSAPSFRGELSSEAGIGDRTDAPTGDSAALTKRPEILALRKGVDASQAELKESRSAYLPELYTRLALEYVDNSKYREQTIMSAGVGLKVNLFDGFATTAARDRAARNLSRSQDLLRQGETQVQLEISTARNDLRVAGERITVTETAIRQSQENLRINHERYKERVGTATEVLDAQTLLTQTRTDYFRALFDRQVAAARLRRALGEL
>fig|338969.3.peg.466 Permease of the drug/metabolite transporter (DMT) superfamily
MVTVLVWTSFILIARASSDPARGGTLTPFDLAFCRIVGASLVLLPWGALLVYRDRDRGIHQSSLLGVSPLSWRVTATVGLFGGLLYALLAYNGFVFAPAAHASVLMPGSLPLWTALLAALILHDHITPVRALGLGLIVLGDLLVGGRSLIGAFDGGEVWKGDLLFMLAALTWACYSVLARRHHLNAVRATIAITAFAFVTYVPVYTVLLLGGWVHGQVFSAPLREVLFQAVFQGWGSVVVSGITFTKMIQHFGPVRSTMITALVPGLSALGAVLLLGEPLYWNLAAGLVLVTLGILFGIRVALPVATKTIAAQAGSTVARG
>fig|338969.3.peg.573 Permease of the drug/metabolite transporter (DMT) superfamily
MLAWLAYLTASVVWGSTFLAIAFAIETFTPFGLSAVRFIPAGILALLIGQIRKERFPSWREIPHIALVGITLLGVCMGLIGWAEGRVSSGVTAALGATVPLFLALMDPRGLDPKAWCGLGMGFLGVLVLLWPSGQGPALSGAAALVLSASLWAYGTLYGKRHADESGHFSQIGVEMLVAGVLSLLAASLTGGISHGTWNPRSLLAVGYLITFGSILAYSAYIYLSKVWPCAKAGTYAYWNPIVGVLLGCWFRGETFHARMLPGLACILLGVALVQIPWPKALRFGSANQGAKQISR
>fig|338969.3.peg.1770 Probable multidrug resistance protein norM
MPSISSLRRLSAPAPRARIGREARALWQLAWPILIGQLANVGMSVVEVAMAGHASANDLAGVALGVSIWNMVIITLMGVMMAVSPVVAHLVGAREFSQVPHVVRQALWQALGVGLIAVLLANLAGSVFDHLALQAQVRDLAKDFVVITSLALPAFAAYRVLYGYSISLNQTKPVMVIALGALLLNVVVNWLLVFGKLGLPRLGGLGCAWSTLVCVWFNLLALLWWMRRASAYRSTWPFACFEWPHWPQVRSLLHLGLPIGITYFAETSAFSLIALLIAKFGSTEMAAHQIALNFSSLVFMLPLSLGLALLTRVGQALGAGEAHAARFRAWVGVAMALAFAVLSATGMALFNGQIAAAYTSDEAVAGTAAQLLILAAFFQLSDATQVATSCAIRGYKVTRAPMLIQLTAFWVFSLPLGYALGLAPKWLPWAPAQPMAARGFWIALVVGLTVAALGLSALLRFVARQHLPADQHTAISKPT
>fig|338969.3.peg.3587 Fosmidomycin resistance protein
MRSARLKRFTYHRSMTSTSLHLPLAVPLKQDATIIGLVGLAHASSHFAHLLLAPLFPVFMTEFGLSYAELGLLMTTFFVVSGLGQASAGFAVDRLGARPLLFVALGIFVLACGAASLVTGYAGLVGVAALAGLGNAIFHPVDFTILNQRVSAPRLGHAFSAHGLTGYLGWAAAPVFLVTLSSLYNWRTAYLAAAVMYVGILVWLILQRDKLSTQVAVQHADVGAEHSMAFMKLPVVWWCFAFFLFSTMTLAVVQSFSVSILKAMHGVSFEAATLTLTAYMLCGAVGIFVGGFVAARTGHSDRVVAMSMAVAAVLLALCGTGLLGATGTMVVLAGTGFAVGIGGPSRDMMIKNATPQGATGRVYGLVYSGLDTGFALSPFVFGVFMDRGWYGATLFGAAAVLLLSVVAALGVGQRTARSRR
>fig|339671.5.peg.1055 Permeases of the drug/metabolite transporter (DMT) superfamily
MSEEKTSPFLTALWSAFPVILFFLLDYYGFMVSKQIYAVSQFGSGIFVAEILALIVFIKGQICNGQRSRLIRANQYLGAFWLVWLALSCWMLPGENLLPVGIAALGFMVSLIIQFRQFLIIGIWVSGLGIISYIGYLLALDSPDWLRYNPVTQALVGVILVNILLVVSSNRLQGFISLLPFIMAILLALNVIFTLTILDYASNVYPVLFYFLLHLVMMGIIALHVLRKIQFGYNALMILLFIAASLPIWTIFFAL
>fig|339671.5.peg.1291 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNPLDLKPTSTFIIRLRYKQSFFREFCKNPPKNDRAFHNERMVMQQTEIKGMDKPIPALLLKFTLPSIVTMLFFGVQNLIDALVIGNVLGATALGGVNIILPLFSVEFVVALIVGVGIQTLVSQGLGNKNAEQVQNAVKTGFIGLAVVSLIASSLLWIFREPLVRAMGADDVLMPHALAYFSGLVPFMLPMTLAFYLDLLIKAFGKPLLSTLIMSSAVVLNIVLSLTFVLWLDWGVFGASFATSIAFSLAFAVALFYLPKPYSLFKGNFSRRLLFKACYNGLSEGVSELSSAIAVLIINRTVMAMLGADGVSAYSAISYIQFIGVLVFLGISDGLIPVMAYHFGAGKTERLQRIFLFTAKVNATLGVLIFTALQLWGSYFVSLFFQSGDQKVIQLATNSLKIFSWVFLAEGITLLIISYFTALGNAFGSMIIAALRGVIFIAVGMAILPPLLGTDGIWFTLIGSELLGLLAAVWLVRCYQSAPATSSTQHSW
>fig|339671.5.peg.1604 Quaternary ammonium compound-resistance protein SugE
MNSKGLTYIIIGASLECAWAYGLKHAADGLEWAVTIFCIVASFWVFTKAFKYMGASIAYVLYTGLGTLFVVLLDMVTTVQAGGAIDFVKLFFVVTLMSGVIVIKSAK
>fig|339671.5.peg.1605 Quaternary ammonium compound-resistance protein SugE
MSFITLIIAGLFEVAGVSTLNVFSTARTTQRKTAFLLATIVLFAASLSSLSLAMQDILLSIAYAVWTGIGAAGAVAVGVWISKDKITLQKAAGLVLTITSAIALKVM
>fig|339860.6.peg.495 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNTNKNMKNNNEKNDKVDLIRGDPKIAIKAIAWPMIITLVLNMVYNMVDRVWVAGLGSDPLAAIGFVTPLFIIIGGIANGFGAGANSLISRYIGANKKDSADNSALHGVIIGLILSILIPLILLPCLENLLIVMGASSVITYAKPYAAIIILGSFTLIFNGILSSELRAEGDVKRATIALIFTGVLNMIIDPIFIYTLNLGVEGAALATILSATVATCLMLYWMFIKKDTYLSFKIKEFHYNAKITKELIAVALPASVEQLIISVLTIIGNLILSIVATTTIIAGYTAAWSVIQVGMMTSVGIGTAAITVGGVAYGARDYEKLKTTCYYSIKLSMIIAIAIVILIEIFAPQIALLFSYSTSSAHLGVIITETLRILALFLLGIPLGLCSACVFQGMGKGTISLILTVIRELILVLLLTLIFTFVFGLAQYGLYYGLVLGVAIGSIIGFIVFKYYLKRLIKYKE
>fig|339860.6.peg.890 Efflux pump antibiotic resistance protein
MNILLIIKKYNIMVNEKIMNKYVILIAMLASFGVAFTSNAVSVALPTIAVDFNITNIMQNWLVNIYLLVIAAASVPFGKICGKYGLNKTMGIGLIGYVVGSILSGIAFNIEFMLVARIIQGIASAVLFVNSMAIITEQVPPQKRGQAIGITVTGVYLGLTLAPTVSGFLVEYVGWRSIFYITVPLILISYYLLTRIDKEWIIGGGDPIDVKGSLLYVVGILILMYGFTILHDVIGIITVVIGLVILAIFAKYELKEQYPIYDMHLFRNVKYTSSNIASLISYFATFVVTYILNYHLQYLNGFSPETTGLILIVTPLIMAIGAPIAGRLSDKINPQILAAIGMIIVSIALVILCFLDETTPLYMIFISMILQGVGFSLFSTPNNNVILGSVDKKDIATASASLSTVRTIGQSFSLGLLTLVFAYIMGNVPIIPQHYPQLILSSQVTMILSTILCIIAILLSLMGIKSGNKN
>fig|339860.6.peg.1355 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVEESENTIGVNILDGDAKVAVRKLSFPLMVSLVIGSLYYIVDAMWISGLGVDALTAIGFIIPLQFIILGIGAGLGSGITAVISKYIGMKNHKLANNASFHSLLLIIIFSVIITLLLLVFMEPLYILIGASGMNLQLALEFSRVFFVGSILLIFPQAMYGILRAEGDVKRTMYAMFLSTIINIILDPIFIYQLNMGIAGAAYATLISLLIVCLVIIYWIYIKKDTYLKPYRTYFKYDAGIIRDILKIGIPASIEFFVLSFVGIIMNLLLLMVSNSDYVAVYETGWRLISFAFEPLIGIGSALVSIVGFNYGAKRFNRINEAYNYAMFLGTIIGIISAVILYVFANQIAYLFAYSSTSSMLHEPFVVFLKYFSITFLTFPIGVVSTYLFQGFGKANVSLLLTFTREAVCAIIFSYLFAVVFNMGLNGVWLGNVVGYTIGAFIAFIIGKIYVSRLLKNN
>fig|340099.4.peg.409 Daunorubicin resistance transmembrane protein
MKTLYTFMGYFEYSIKKLLMYRIYIIGELLSSLIVPVIISFFLWRALIETNPINYSLKEMMIYIIISNIILLFTQIHAEHDIERDIKTYRLGQKLLLPIDYLTSISYSYLTSSLAKFTIVYLPIIVIISIWAKIEIPANRLLYLPITLTFGFLLNALFSFIIGLLSFWLTEIWGIAAVRNLLTGLFSGAIFPLDLLPKKVESFMLLTPFPYMTFIPAKLISDDSFDIKIVNKGLFISLIWVLILGLIVFLLVKNGLKKYTSHGA
>fig|340099.4.peg.929 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKAFLLKYKKEFVIVVFFAILAALMNVFVAFILKMFFDVATIGRLENFYTAVEIALVFVIFNSLVLWLAQISKFDYIKKSLIHLKNVLFEKIIGKDLNQFDEVNTGKYISIVSNDINMIEENYFNNFFELVSSGVGFLAALIVLFILSYKITFIIIGLTVLSMLIPRVLDRKISDLR
>fig|340099.4.peg.1518 Probable multidrug resistance protein
MSQKQYNKWLILSAVVIGSIMGPIDGSIVNIAMPEFTKIFHTNITTVSWVSMTYLLVLSSLMMTFGRLGDMLGYKKLYQYGLLTFSISSAILSLSVNIYMLIIMRAFQAIGAGMLMSMTSAIITSVFPPNERGKALGINAMSISIGLAIGPTLGGFLLSNLGWQSIFYINVPIGIIGYIWAHIVVPDNKGVPEKFDIYGSISFFGFLASLLLFISEGGTWGWTSLPSIISLLTSVTFLTIFVIIENKVDFPMFDFSLLKIRSFTFGNISTLLNFMSQNTMTFLTPFLLQHLGFTTEKAGIVMTSFPLVMFVVAPLSGILADRYGAQILSTIGALISATALFLMVTLTEKSTMFSIMTHLALFGVGNAIFQTPNNSAVMGSAPKNRLGVASAFLATMRNVGMVMGIAVGSAIFTNRLKVYQALKFSSNTTFMMAIKEAYIAAGIFSLICAFTSLVRNDVKLIKGKD
>fig|340102.3.peg.138 Multiple antibiotic resistance protein MarC
MTPIEFIGLVGQVYAIMNPIGKLAIVGPLAVERPAHIRKIMAVTIFTVFVLSSIFAVSGGFILNIFGVSIDSFRIAGGIVLMAISIMTLVSGSYVGVVEITEEQAVVPLATPLIVGPGTITALIVISSLYGPFVALGVALTASTLVAITLIIGIRVVKYVGATPLRLLGRFMSLVIASVATEMIITGIRNHITKWFS
>fig|340102.3.peg.962 Efflux pump antibiotic resistance protein
MRRALFAVFLSSFITPFMTSGLSVALPIIASDFSVGSAEAMAIFVLLNLAVAMWVLPFGRLADMWGPHVVFRAGLGVAGVGFLLAALSPTIGFFYASLLVAGVGLAAVFGSNNALIFRLVPPEKRAEAVGLNSMSVYVGLVVGPVLGGAVAQLSWRLILAIGAALTAVPYVMVRKSPRPAGGGRFDVLGSALLATSTALVVIGVYAGSPSLAVPGLLLLAAAIFVEWRSPSPVLDVRLFRNYVFTASLAAALLNYLATSALQPSLSLLFQKAFAMPPHYAGLLLSTQAAAMALFSPIAGRAGNRLPLAALAAAGSAILAVTLFAYSAAPSPATAPLALSLIGVGFALFIVPNTTIILSAAPPERRGTASALIAEARVVGMALSNAAAGQIMKNVPNITAGVSSVLAFLAYVSLATLALSLVRAGGRPRKR
>fig|340177.8.peg.1222 AcrA/AcrE family multidrug resistance protein
MNNIVKPVLFIALCSSLTLSGCGDKPEMGRDGAKNQEQPALVVQQLQPSDAVVVSRYPALLEGKVTVEIRPQVDGVLRSILIDEGAFVKAGQPLFAIDDAVYRAQYQGALASQHAAEARVVAAKLEVERLQPLVQNQVIAEVQLETARANYKAAQAAFDVAVAATRSAKVNLDYTVIKAPINGFVGKITLRQGSLVTKNQAAWLTMLSDVSEVYASFSISENELLRFRQQYGQSDGRLGSGSNNVPATLVLADGTRYPQQGRLATLSGQFDALTGAMRVRAIFANPQALLRSGGTGSVELSSSYNNVILVPQSATVEMQDKVFVMRLMQGNKVQKQAITIAAKSGNNYVVTGGIQAGDTIVLVGADRLQDGMVITPRYETSPAQSATINSAVKRP
>fig|340177.8.peg.1319 Quinolone resistance protein
MLMFNHFIAMECYQQTFEKKDFYENPLTMGTYEECHFHGCTFINVDLSHYIFINCTFDGCDLSMVKLNNTSLQEVLFCNCKLLGVPFSDCRQLLLSFRLERCMARLALFCRLKLKGSLWSECMLQEADFSEADLSNALFERCEFPQATFFHTNLEGADFRTSWHYSINPATNRVRKARFSLAGIAGLLESFDVVIE
>fig|342108.5.peg.776 Permease of the drug/metabolite transporter (DMT) superfamily
MISLSQWRSIMGPIAIYALAALSALFWAANFNLAGPILADMAPLAAASGRFVLAAVIMVVLVAGRGELGALLAAARKSGGRLALLGVVGIAGFNLLFFDAMRTTSAVNGALIMATNPLLTAVLAALFLGEQLPGRQIAALPVALAGVSMVILGGARGEVVFGLGDVEMMGANLAWAVYNVLARRLMPAGSPLVNAAIPMAAGALVLTAAAGLSGAEFTLPGPKAAAALAAMTVFGSVLAYLFWNAAIARMGAGRTALFLNLVPVFAASIATLTGTPPNPAQLAGGAVVVAAVIFSMLPRRPQPCLA
>fig|342108.5.peg.1824 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MALLGHDHVNVVVTDMERSIRFYSALFGLGIVMDRPLSGEWFEQVTGLENARARCVILAAPDGTCRIELLQFKTRQPAEAPLPSTPGLRHLALRVDDLGTCLETLHRQFGQTVTATQVPDHIIRGGKGMCYIRDPDGAIIELCQYGLEQPEFR
>fig|342610.6.peg.1553 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MQRVTGIGGVFFKAKDAPTLRAWYKRHLGIDVQDWGGSSFSWCDANGQAAKGSTVWCISSATEGVFAPSNAPFMINYRVEALHDLVKVLKAEGCEVLDNIEESEYGIFAWVIDPEGNKVELWQPPNGH
>fig|342610.6.peg.3755 
MLTLIVKFDVKPEQLETFKQVLNDNKLGSQNEPGMLEMRFFEGKDSPTTIFAYERWASAEAHQTHANQPYAKALFELAETALASPLEVLNLKDTHPAPLHESNPKQVQPQDEVFSIFFIFKIKLEYREQLLKQFSSHIVHTRSEEPGNLVFDLYTIEGQDDTLVVYEHWRTESDVWDIHFNQPYAIDTGKLLEQAIVGDMKQYMNFVKEF
>fig|342610.6.peg.3826 Acriflavin resistance protein
MSQHQLPSSSGNNNPLHGIIAWFANNSVAANLLLVSVIVMGVMSLSTLRKEAFPSLEPDKISVSVKYDSGDALQAEEGIALKIEEALETVPGIKRITSTSDATGSHVSIEKKTDYSLDELLTDVKNQVDAINNFPADAEQPVIDKSRRQDHALTIQLYGDTDRHTLQTLGELLKADLLAQSGISDVEQKGVLDPMMSVEIDEGKLQAYGLTISDISDVINQESSSPLSTSLRDSSKIIRLKAANQAYWQSDFANIVLLTTPSGAQIKMGDVAKVTDTFAEDANSLGRYNQQNAVAIEILMDDNSDITAIVEQAHSVIDNWQERGLLPQNVELTSWYDKSTMITERLSLLTKNAVTGIMMVFVILAIFLNVRVALWVAGGLPFVFFGTLYFMTDTYAGLTINEMTTFGFIMALGIVVDDAVVVGESVYSTRRQHGDSLNNTILGTMKVAVPTIFGVLTTVAAFMTLSNVSGPLGQIYAQFATVVTICLLLSVVESKLILPSHLAHIDTQRQVKAGLSGLWSKVQHGADYGLNWFSDNIYRKVIEYSLRFRYAVVAGFMAFLILVIGMPMTGAVKVGFFPSIPGDTVSADLVMQNDAAFGQTNTSLFMLEQTALQAEKNLMAKLDSQESEITSLQVVSSGDTSGSVTVELISGGAFSASEFAKEWQRLSGTPEGSKKLQILATRKMVDNFKVELKAWDDETVMAAGALFKERLENTPGVNGIDDNFNPGQPQLKFTLNAQGRALGMDTASLSQQVLQAFGGAIVQRYQRDKDEVKVRVRYPENARQTPADIMQSRIRLPDGTVVPLVNVATISSEYQQDEITRIDGLRAIYLSAQVDKNVIASNVLVDNLRRDLVPELTAQFPNLNVYFAGEAEQQSETTSSMSTMFIAALLVIYVLLAIPLKSYIQPLLIMVAIPFGIVGAILGHWWNDLTISILSLNGILALSGVVVNDSLLLVSRFNELVKEEGLSVHDAIVASCTSRLRAVLLTSVTTYAGLVPLLGETSMQAQFLIPAAASLGYGILFATVITLILIPGLLMIQIDAKRGIINLLTLLGLRAKPDTESASTPAHS
>fig|342610.6.peg.4121 Permease of the drug/metabolite transporter (DMT) superfamily
MQLRDFIELVLLASIWGAAFIFTRTATPEFGPISLITMRASIASLILLPFVCNRVAIRQITEHWRGILIVGLTNTAIPFCLFSYSLLHIGAGYASVMNATAPMFGAMIGWLWLKQRIPSVAVLGLLIGFLGVAVLSAAQAAAFDGISILPTLATLVATALYGYAGCFTKQHLSAVGPMALAAGSLFAATLCLLPLNIWFMPSTLPSPSSWVDAIALGALCTALAYLMYFRLIAKVGPSNALTVAYLIPAFGILWGIVLLNETLTPSMWVGVILVICGVLLVTGVASRVIAKRRLKAKPAV
>fig|343509.6.peg.367 Bicyclomycin resistance protein
MGAVTIMFTTWRAVFAIMLGYALLTMATLWLMTHETLNRRAPLRLLTTFDHYYRLLMQRHFVLPALSIGSGVGGIYTLSIALPFVLIYRLRLSTFSFGLVMMFQTGSYITGSLLANRLLRLHSLTSIIRLGVSVIALGGILFLLLPHLCVPAVWVWISPAAIWVFGNALVAPGLTSFAMERQAEKAGSASALLGFIQIGIGFLDNTLLGSFYTDVAQGTAWLVPMSAFIAVSCGLASKRA
>fig|343509.6.peg.2371 Permease of the drug/metabolite transporter (DMT) superfamily
MAVFNLMLAILMNGQRGGPAVYAGLLLSLFGIGWLMCADGTWTPLRIMLHNIRQNPLSYTLAFCGAIIWALYCNVTRKYAGAIMGTSYAAWNISIIQGNMTLLATASYFTLVFSEEFASLWLVSI
>fig|343509.6.peg.3022 Multidrug resistance protein B
MLGATLNINLQRRLPGIDDPVQHLIGQDGQGLAHMVQQVAVSMHGVYWVSMLISLCALVAAGLLPHGLRPRQED
>fig|343509.6.peg.3925 Multidrug resistance protein B
MLAGIGGVVAEPRNLVSFSVLFGMSQNIGGLLGTFQVLREKFHSSQLTERLTLANPLVAERVNSYTAAYGGVLNDSYLQGVQGLSQLQSIASREANTLAYNDVYLLTTAIALVTLVWILWRLLRLRIQARRAQGHDDKTSGNGGGAGKRKKQ
>fig|343509.6.peg.4088 Permease of the drug/metabolite transporter (DMT) superfamily
MAIISAGNAAFLISMFVIFTPLVEWLVCRGRLDRRLLLSALLSLLGVYWLCGGRALHLGRGDGLVTAVALLRACLVCYTRRLTAHRPVPALALNAVQTGMVAVGGWLLLLVTFRSPPPLPASWSFWGITLYLALFATLFAFFAQNYAAGRTSPSRLSLLLGTEPFFGSLLAALLLNEHLTTSGWIGGGCIFSSLLMVLTRRRAMLSLAG
>fig|347257.4.peg.635 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKMVKILPSKIKWVFIIGSFLTLIYALLNVMLPLLIKKYIDLILTEDRQAPYRMDFLNGRIDFGFVSYNEAFKWLTIVVLLQTILTASLAFLSTLVIVLAAERSSYFYRNTLYKKIQSYSLKNIADLKAESIITRISNDIAIFWEFLVNGTSVMIKGIFLIIGGLTVASLVDWKMSLSIIAIIPIVIVMGTIISLKTGPLLKQTQKAVDAVTKVVDENISGIRVIKTFNLETKRLDLLKDINNAWYDSQYKSAMIFSTAYPVFQMLINWLMIGIYSVAGYYATISQINKDILTNIHLFIDLLWQVAVGILLMLLFLSSLFRARVAATRIIEAYDYETDNLRVEKGEIIDEYDVEIKNLSFKYYDASPNFAIANVDISLPYRKSLGIIGPMGSGKSTIVNLLVNNYKYKEGSIKIGNKEVSLVNSKNLHETVGIVHQEALLYTGTIRSNMLWAKDDASDEEIMQALKDACADDFVSKFEDGLDHPVYQGGKNLSGGQKQRLSIARALLRKPKILILDDSTSALDNITASKVIDNIKEKYECSTIIISQKISNIKNADEIIVMSTNGFIISRGTHNHLAHSCEFYKQIYETQLEQ
>fig|348780.3.peg.237 Multidrug resistance protein homolog
MFGTDRRVVVLALARMADAVANSFLIIVLPLYIASGELALPAFEGASVLGIPLTVELLIGVALSLFGFVNSFAQPFTGRLSDRTARRKIYILFGLVVLAVTSVAYALVESYEALLVVRALQGLGGAFVIPTTIALVNDLARSDAERGGNFGVFNTFRLIGFGFGPIVAGVVVQAGPYALPLGTELSGFNAAFGVAVLGALVSFTLVTVLIEEPPMAAADATDDLSIAVFGDSRLLDPVFVLGVATFFMAVSIALFATLQEPINDRLSQGPLWFGIQFAAVVVANVILQMPIGRAADRIGRRPFLVWGLVLLVPAVLAQGLVTSSWTMLVVRLLHGVSVAMVFAPALAVAGDLAEEGESGTTLSVLTMAFGLGTAVGPLSSGVLFGYAFVVPFAAGAVLAFLALVLVATQVEETLETATGGPILGGR
>fig|348780.3.peg.1522 Permease of the drug/metabolite transporter (DMT) superfamily
MRPLRNLGLFFLLAALWGFSFPAISAGLEALPPLLFAALRYDVGGVVLLAFLAARGADWRPRTGEDALAILIAGAFLIAGNSLLFVGQQTVPSGVAAIIYALIPVLTTALAAVLLPAEPLSARRIVGVALGLVGVAVIARPDPEGLLSAQLVGVAFVVAAALSVALGSVLLRRRTPTVGVAPMTAWAMVVGGLLLHAGSFVAGERLAHATPSAVAVVSVVYLAVFASAVGYVVYFTLLERFGPLEINLVSYVVPVVATLGGIALLGETLTAGMVAGFVLIASGFVVIKARTIADELGR
>fig|348780.3.peg.2004 Fosfomycin resistance protein FofB
MLGDCRWLTLEVTSLDSVAPFYRERLSLPLIEATDRQYRFDAGGSSELRLRRPTAVPRGGLHTHYAFSCPADAYDAWWDRLDADFDLQEVDFGSMRSLYLYDPAGNCVEIAGADEPSGTAGRTLSGIFEVVFEVADLPASEQFYTALGFEVVDRGENRTRTRLTNGPLDIELWEPQLGLADARGGVHVDVGINAESPAAVADNVAERVTKREQLDDGAVRIRDPDGHYLTFVRSER
>fig|348780.3.peg.2392 Permease of the drug/metabolite transporter (DMT) superfamily
MSLRRAIGLFAVASLAFGGTFVAARAGQVYIPPLLFVAIRFDLAAILLLGYAAYATEGSIRPRTRGDIGGVLAAGVLTIGLANGLLFVGQGYVTSAVGAILFSLVPIIAPLFAALLLSDERVSALGAVGMGVAAIGVGMVVGVSPSNLLAESGVGAALVLGGAASAALGTVLTRRCEATISSTAQVAWGLPISAVLLHGMSLAVGESAAAIEWTLTAIVSLAYVTVVAGAVGYIAYFALIEEVGALRSSLIFYASPLVAALGGWWFLGEAITTTTVAGFVTVVAGFLVIGHEQFRAAFRRLADGRGQATGGYEPSD
>fig|349124.5.peg.724 Bacteriocin resistance protein, putative
MNRHATPLATLGALACLALATPAPAQAAGLPIPHLGGGHHVVVESLQSVRFRGVERQALDYSCGSAAVATLLSYHYDHSVGEPEVFAGMFAAADQQRVRTDGFSMLDMQRYLAELGYRADGFNLTLEQVAALRIPSIVLIDTGGYLHFVVIKGIRDGQVLVGDPAMGLRAYNAETFKQLRRGPLLVIRDRHDLAQLTFNPDRAWAVQTRPPFEHAREHQGLSDFTRNLRRPGDW
>fig|349124.5.peg.1615 Permease of the drug/metabolite transporter (DMT) superfamily
MLNRALLSGLVAGIFSVSLWGSLPLLRQLTELPAMMTTVVALAAAAAVAWCSAIFVREPHSRMPDPDLSYWLGGVLSLVAALYLYFAALAWGEPARVTLVTYLWPVVFVLVANWLAGCGVQLRVLLGMGVAFIGVAPLILGDAPAGAETPLVAYVFGVISGCAWAAFSVYLTQAGTIPFRGYARMFAQAAVIAVVLAVLFGESVGTPQSTDWLAAALIGVGPYGIAFMTWGFALRKGPTGLLGVLTYMVPVISAVVLVLTGFTEPELALLVAGLAVVGGALLAQSAEAQSESGAAERDPDAVEDASARRAMDRASPENIRE
>fig|349161.4.peg.324 Permease of the drug/metabolite transporter (DMT) superfamily
MSAKRVYILMVLAALFWSGAFITGKLAVREFPPFALTFFRFSFALPFVLWEKPLTYLPNATTEGWLAILYMAVFASVLGYLFQLIAIQNIGAPKAAIFINLVPVFTIMQSLLFLGEPFSWFKMLSACIIVTGVYLTTRPESGVKEAAGIKA
>fig|349161.4.peg.569 Permease of the drug/metabolite transporter (DMT) superfamily
MHKHRGIIFLIAAITFFSMMPIWVKLAYTTGLSAFDVTFLRSGMAAAMLGIFILYRKINFHVERQQLGPLLLSSTLGYTATMISLYLSYKYVSAGVATSLHYLFPVLVMLLEYFIYHEKLQFYKWMALLTSLAGIYLIAEPGGSSFSLRGVGLAISSAVFFTFYVLSINHPQLKKMDSLVLAFYDCLIASITSLVLLVAQGNWPLTLTLKGLYYTGLVSFFCTALALIFFIKGVQSIGSANASILSTLEPVLSLVAGIIILHEPLTWYTSLGCILIIVAVILIGYSDLSEDSPA
>fig|349161.4.peg.818 Vancomycin B-type resistance protein VanW
MTHSFCQVCLIMLLAEFLATALYYWGKLHINQYTWVSVPSIATLVMAILLFALNPIVLAKEKTPTVAAAPKKENSIKQMETIPMPKQDERMVEQGGRKPVVKGIGPKLNVYTPQGSETELDLSEKPALLFAWWCPHCDYVLQEIAQYSLSDRPYLVVTNLKGDDLKAIDEKLKANGLAGVPYFLYYEQPPVESVPASIWWSEGKLNTSPGYSIKPDSKKLLSKARIPITKDNGGKNAILAGKAIDGAVIPPGGIFSFNQIVGERSPERGYRVSGVIESDGNGGYKYSQGTGGGVCRTSTVVHWAAKKASLEVAEYHKHSLPVAYGKVDEDAAVAWPYADYKFRNNTGDKLSVKVQHTDSWLEVEIWKG
>fig|349161.4.peg.947 Vancomycin B-type resistance protein VanW
MAVGFFARPWILWGAFYYATAGILTLTFRKNFSVAAFLSTGTIFHMTLTYYVYQAEKSICPSCLLFLIAGLILTLMYVFKDFSRWDPKFLPGAGLGLLIVSVILLTLGYNNTGAQSQPAFAETKKTQPEETITITVNKPSSETSKKQETIPGEPEPLSFGSQVEVKTKHGEALKIDLNKKTALLVAWWCPHCDYALKNISKYYSNDRPYIVFCYNDGDQRDFIEKKLKSANLTDAEYYILEGDPPVDGVPTMVWWEKGKLKQGRAFEVSSSVQKLIGRAEIRIGKGNGAINAALSGEAINGKEIPPGGVFSFNETVGERTVERGYVAARQIISTPEGYDYADGIGGGICRTSTVLHKAVMAAGLLEVEHHSHSLPVDYEEDTAVAWGGWDYKFRNILSVPVTIKCQKINENLVVELWQN
>fig|349161.4.peg.1502 Permease of the drug/metabolite transporter (DMT) superfamily
MGRYIHLLLLTVSFFWGTSFAAAKIGLQELHPLNLVILRFTIASVIFYVLLQIRKERAIEVKDIPTFIILGFMGITSYFYIQFTGLQYTNTIHSALIIATSPIMVAIIGAALKIEKISRAMSCGIALSFIGVSLVISEGNWAGIFQSTTIKGDLMLLSNAIVWAGFTLYGKKILLKYSPFVAMAYIHIFGTLLLLPLLAVPDLLGTHSLMKQLAELSWPTVSAALYLALFCSVYAYFVWYAGVEKIGAIRTSVFAYFNPLFATLTGVLLLNEKISFITIFGGCMVMAGVYITNEFKPKTAARDNKKGLNISD
>fig|349161.4.peg.2622 Permease of the drug/metabolite transporter (DMT) superfamily
MIYMLMVFLAGCSFGLVSTVVKLAYGSGLQPDAVIFAQFFLGWAILVALSLFVPRHKIDLKTGLKLIMVGITNSLAGILFFLSLKTLPASIAIVIMFQFTWIGVIIEAIADRKWPGKEKIISLPFLIMGILLAGGVFGSEIKLDIMGVIYACLTALTFAFFIFFSGCVAPNHPPINRSVWIISGALLFTFVLYPPKFLITGGIEGGLLGYGLVLGLLGPVIPTLFLAKGVPQIGPGMATILASSELPVAVIASSIMLGEYVSPLQWCGVLLILLGICLPQLSQLKNQTGKTT
>fig|349163.4.peg.640 Permease of the drug/metabolite transporter (DMT) superfamily
MEAMSDIARPSSPVSGFLSRPNAPVLVLLSVTVIWGWTFLLTRLSLLFIGPYAFVGWRFGVAALAVVLVTRPHPASFNRMEITGGITIGLVLFLGYGLQADGLRTVASGESAFLTALYVPMVPLLEFLIFRRRPGLFATAGLVLAFVGLVLVSGMTGLSLAFDRGQWLTLGGALGAALEIVLIGHSALAADPRRIAIVQLATVSVISFAVEAVRGGIMITTRAFPFAAMTGMGLATAFVLVAQNWAQRSIPANRATLIYTLEPVWAGLVGAAFGEIFAPAQVLGGVLIIASVVLSQWKS
>fig|349163.4.peg.1052 Membrane fusion component of tripartite multidrug resistance system
MNELKERSENRPAVSRATPVDGSRRSRRPFIILVLVLLGLAGASLVYWWRTRDFASTTDAEIDGSIHQIAPRISGQVVAVLVKDNQHVVRGQLLVRLDDGTQKVALDRAEAERAQAQAQLGAREADLAEARANVEVADATLFRAKRDEARYAKVDPRAVTPTTRDAIAADLRAAVARTDAARQQVKAAQAAVAAADAAVKAAGVAVENARLELGYTEIRAPVSGWVAKKTVRTGNVVGAGTAMMAVVGDHVWVTANYKETELGAIRPGQSVNVYVDAVPGVAFHARVASIQHGTGSIFSLLPAENATGNYVKVVQRVPVRIEFDDSRISRYLLAPGMSVEPYIRIRGK
>fig|349163.4.peg.1053 Inner membrane component of tripartite multidrug resistance system
MSLLYASRPNTPRSAAGLYNPWLIVAMVALAPFMEVLDTTIANVALTHIAGSLAVSPDESTWVLTSYLVSNSIILPITGWLQDVVGRKRLFLICVALFTASSVFCAVSTSLTMLIVARVLQGLGGGGLQPITQSMYADSFPAEKRAQVFAVFGLVIIVAPATGPILGGWLTDHLSWHWVFLINLPIGLIAFTLIAIFVDEPELLVRERAARLAGGLRFDWLGLLLVAVGFGALQIFLDKFSIDDGFGSFFIRSLFAVWAVSLSTLVVWEWGHPEPVVNVRLFAHRNFAISCLVMFVIGFILLSTTQLLPQLTQTLMGYSSETAGFALALGGLATIGLMPLAGVVTGRIIPARVLLVGGLVETGIALIFQSHLAPNASFYTISIDRVLQVIALPFLFIPISALSYVGLPPARNGDASAIINQVRNIGGSIGISFVTTLLAWRTQFHHARLAESVTPYASLHGQTLSQIGAAVQHQAAFMSYLDLFHILGLMALLVWPVVLLLSTPSSPAAEGVVYEI
>fig|349163.4.peg.1054 Outer membrane component of tripartite multidrug resistance system
MRSEVFAPRLRRRALMGTAMLAAMALGGCELGPNFHAPRTRTAASFLANRPALTSPDTVSQGKVDLAWWQSFDDPALTTLEHEAIARNLDVKAATERLAEAEAQAQIEGAALYPNLNFSGSYTREKPSNKGVFTALSGGGSTSTSTNAGSTASGSSTSIGGGGLPGSELQPFNLFQYGFSSVFDFDLWGKNRRAVEASLAAVQASRDARRAVLLNTEAEVAHDYINLRAQQAVLAITRRNLASAEHIANLTRQREQAGLANALDVADAQAQAESVRAQIPTLRTAIAADINQLSLLLGEGPEALRAQLVTAKPIPPVPPVVPIGLPSQLLQRRPDIREATARLHQATAEIGVATASFFPDISLAGSVSLQALQFSNLNQLSAVTYAIGPQITMPLFEGGRLRGELHLRKAQQREAAVNYAKTVLTAFHQVDNALTAYDEEQKTQAALQADVTQTRRALSLAQERYREGLIDYLQVLTAQQSELAAEQAQAQSQAKISTDLVSLYQALGGGWEQNEPAAG
>fig|349163.4.peg.1334 Multidrug resistance transporter, Bcr/CflA family
MSSAQSAVAADAPDLATSRRLPLLLGFLIAIGPVSVDMYLPAFPTIARQFHDPAGPGLTLAAYFAGLAAGQMTQGPFSDRAGRRLPILLGLALYTLASIGCALAWNTASLSAFRLVAAFGGSAAVVVPRAMVRDIADGPAAALLFSRLMLVMGVAPIIAPILGSAVIAFGSWRWIFALATLYGIVAIGLVWFRLPDTLPLARRSTVGFRTIIIRYGQISAERGFLTHALTGTFAIGALFAYLAGTPAVFIGEFHWDPISYALLFGLNAAIYIGFNQWNPHLVARAGLRPVISAAVAALVCGTIVLVAAALRGGGPLPIIAGLFICQASYGLSLPSSLVAALSRHQAHAGSASALLGTWQYLGGAITGALVGAFADGTARPMAFAMFACAVLAALAAAFRPQRLT
>fig|349163.4.peg.2358 Multidrug resistance protein A
MSQTSTATGPVAREAEMRQEATRGRSRSGRMLRPLLMIGGVLVILGAILVYWLLSGGTVNVTDTYVRAARVALSTDVSGLVETVDVHDNQQVKKGQVLFTLDPSRFRVAIAQAKANLAEVGQEIEATRAGYRAEIAKIRTQQSVVDNDRLNFARYAALVHTGGVTRTAYDDAKYKLQGDEATLASMTAQAGVDLAKLSGNPKIKIGDTPQYKAAKAALATAELNYRHSIVRAPFAGVVTETDKLEPGMFLPAGTSAFALVSTSDVWIRSQPKETSLTWVKPGDKVKVHVDAYPGQTWQGVVASISPASGSSFSILPAENSSGNWVKVVQRIPLRVNITGGPKDLVLRNGMTAEITITTGHQNRLSDLF
>fig|349163.4.peg.2359 Multidrug resistance protein B
MAGPASHEEEMQLSGLPRAIVTVGCMIGTLMQALDATIANVSLPYMQGSLSASYDEITWVLTSYVIAAAIMTAPVGWLAAQYGRKNIFLISLVGFTVSSMMCGVATSLGEMVMDRLLQGVFGAALVPLSQSTMLDIYPVEKRGSAMAIWGVGVMIGPILGPTLGGYLTYFYNWRYVFFVNVPFGIAAVLALGAFMPKRARRPASGQFDWIGFAVLSLFLGSLQIMLDRGQEKDWFGSPEIVTFAVLAVIGLYLFIVHMMTAKNPFIPRGVFADRNLNAGLITMFAVGSVLLSSATLMPPFLEKLGNYPVETAGLVMAPRGIGTMGAMMLAGRLSNRIDPRALMAAGFALLVVSFWMMMQWLPSSPQSYMIETLIVQGMGLGFVFTPLQVVAFYTLPQALRTQGTSLLSLMRNIGMAVGISVTEAVQVQMAQVNHATLADHVTPFSRNLQVGGAVSRLLDPMTHAGAALLNATLDQQAQIISFIDAFKFMMVISIPTMLCLLLMRRPPQAAMAAKAEKPEMAVME
>fig|349163.4.peg.2497 Multidrug resistance protein B
MSVSSSTRELDARSRAGRKNEVALVPMTIGACLGLAAGSFCGGSLQSIYPYVAGRLATSSDHALWTLTYFLIHWALGIALMPWFARKLGFKRLFLASMIMLAIGAGMGILSHSLMTMLVARGVQGISSGLLVPLVQTLLLRHFPKRHHTLATALWSNSMLVPFFFGPAFGGWLAVNYDWIDLFWLVIPFALLAFVLIRVSLPEDRPTAPPPPFDLVGLALLWLGLIALQIVLNQGEQFGWFGSPFIQRYTVAAILLLGCFIIWELTSEAPLLELRFVTNRNFGFGLLLLCLGWSIFVGWSSILPLWTEVDLGYNGWWGGVLLIPLALTAIPVASAMGRIARHVSLRMLAALCFLLFAIAFAMAVYNPEIGLAATVPSELLQGIAVGMLFVPLTMIILSEIPADDLAAASTTSNFIRLASDIVGVTMLQTLWQRHTESVAALTRSAMSESLVRQALAHARQDGMSHAQTMAMIAGRLQLDASTWSLDDALRLSAWICLGAAAVSLVVLKKPRPQGG
>fig|349163.4.peg.2572 Permease of the drug/metabolite transporter (DMT) superfamily
MIAAYAALAASMVIVGGNVVLLKLLAAHLPTFPLLFMRTSFATLCLAPLVAPRLPAPRTLAILFMQAACGTLLYNGMMVAGLKLTGAVQAGLVLASLPAVIALGAALFLREHLRPLQWAAVVLAGVGIAALARGGGGFSLVGDALIFGAVCGEAGYALFARRAAGLLPVMQATFWMQACGAAMTAPLAIASFGQVHFTWLIAGLLLVNSLTSSVLAVILWYHGMRRVQAGIAGTFTALLPATATLMGVLVLAEPFTRGDAMGFAALFVSMVLILRPQRRPPWKRKASA
>fig|349163.4.peg.2823 Fosmidomycin resistance protein
MAVVMDQGLRTVGGTVRYGRLAALSWLHFLNDGSANYLPGVLPAVLLAMGEPVSLAGTVMAALLIGQALQVGTGLLADRFGGRGFIAAGVLGTALAAALIGRSGSLALLLPALVLIGISNAMFHPQALAGARQLSGPRVGLGMSLFLVGGEVGRGLWPLIASFVVVTWGLKALSLLAIPAVASILLLWAVLPVQPPRHVAAQPIAWRRHLGPMSALVAFQSLRALAIFGTTTFLPVLWHLRGHSLTAGAALITVMLVVGIIGNVGGGHLADRIGRRPILAGSSLAGAALLAAFLLTSGAAQWIALGLLGIALFATLPVGILVGQDIFPENRSLGSGIALGLSNGLAAVGLMGLGLISSAVPPLHILWLLVAILLAAALLALRLGPRTHPKRT
>fig|349163.4.peg.2877 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MIDNLILLLFTLLMASGQLLFRKVGLDLRGHSLASGVPVLLRAPALYAALALYGIATLIWIWILSRVPLSRAYPYVALGVVLVPLASRAVYGDAIRPIFWLGALLIVAGILVTQLGSSG
>fig|349163.4.peg.3042 Bacteriocin resistance protein, putative
MTQTPQPRDRTRLSGTHAPGCRAILAALCLACGIAGPAAAGNFPINGLSLGAGSVNMPIQSFESMRFSQTIHQAYDFSCGSAALATLLTYAYHRPVTEKKVFLSMFRNGNREAIERYGFSLLDMKTYLAREGIPSGGFDAPLSKLAGLHVPAIVLINDHGYHHFVVVRSIAEGRVLLSDPAVGLRSESVARFRKQWSGIFFLILSQAEIAQKNYNDPSLWQGSPPAPTEIARYALSLARLQEVTIPIANRF
>fig|349163.4.peg.3129 Multiple antibiotic resistance protein MarC
MDLAFAARFLGAFFAIMNPFVTLPIFLSMTADRTVAEQRSIALQIGTYSTVMCLVIAVAGNAIIGFFGISIDAFRVAGGLVLLGIAFSMLNGHPITAHERGDHEKSADSAADAADDAEGGIAFYPLTFPLVVGPGTIATLIIYAGQARGVPEYVAFGLITALLLAVLIVVLYFAASIGRLLSARMRVVMTRLMGMILAAIAVGMVTAGLKILLPGLT
>fig|349163.4.peg.3367 Tetracycline resistance protein
MGFIFAVLVIDSIGFGLIAPILPDLVEKLSATPASHAALWVGVLSMTFAATQFFAAPVLGQLSDRFGRRRLILVSLAGSAANYLLLAFAPNLLWLFVGRLIAGATAGNVSAASAYIADITPPERRAQRFGLIGAAFGLGFTTGPVIGGFLGAIDLRLPFLVSAGLVAVNVVYGIFVLPESLPPERRRPFRLREATPLGAMRLLTTVPRLWRLAAAWSVRWFGLGAIQAVFVLYASLRFGWGPRENGIFFACTGIASTLVQFGLVRRAVTLLGERGAAFVGFACNAAAYMIFGVAPTASWLFAGVGLMALGSIANPAIRSMLSRAAPADQQGRMNGALSSIEGLTAIVAPLTGAVVFEAFSGVLPWRFPGAPFVMVAVMLAGAAMLVWSVKPVQAAPEIAPSPARN
>fig|349307.9.peg.367 Daunorubicin resistance ATP-binding protein drrA
MKDAVCASGICKGFNTIFRGKKEVLKDINLLIDGEEIFGILGPNGSGKTTLLSIFSTLIYPDSGELTILGIDARRNTHEVRKLINISTGKPNFPWSLTVKENLRHSGMLYGLHGRELDRAVDWSMESFELYQYQDTRFENLSTGVKQRLSLAKAMLNGPKLLFLDEPTTGLDPQMAQRTRALVKRIHRDMGVSVVMTTHYMPEAEELCGMIAFLKEGRIIAQDTPARLKRNLKIGERMRIRYSGNIDCDALRSIPGLISAEISKGRADLVVDKNEATFSRVMRTFQSAEILELELEEPDLEDVFIELAG
>fig|349307.9.peg.1382 Multiple antibiotic resistance protein
MSCTHNLEARYIGGSYLDLAIYLQYFVYVFTSLFIIVSPIEATMVFVSLTQDASPAERDRICVRTTLVAFSIAMVFALAGDMILRFFGITVDSLRVAGGILLFLVAIDMLRAKPHKKVTQAEIEDATTREDISIFPLAIPLLTGPGTITTVIVHMGASNTLPEKMIVLLAICLTFGATYAILKSAEHIHDILGVTGIMVFTRILGLILGAIAVDFVSVGAWNIYISMASGA
>fig|349521.5.peg.451 Permease of the drug/metabolite transporter (DMT) superfamily
MAVVIFAYAMVILVWATTPLGVVWSSQSFHPTVAVGLRMTIAAVVTGVIIRLYRIPLHWDRDSLYSYLCGTMGVFGAMMLTYFASKTVPSGLISVMYGLSPIMSGLLGVYLLDGARFQKSQWLALALAISGLATVFGKDLHATGSIVFGLMLVLGAVMLFSLSGVLLKKQKATPHPLALTFGSILLALPGYFILWALMDGATPRIELHDRGLWAVVYLALIGSVLGFFSYYYVLQKLQPSTVAMATLVTPVLALMLGVTLNDETIHPTVLLGGCLILVGLALYFDLPRKALRWLRPISEPALVLPLSNEENKCTDQQRAGEIEIKAHSNHGSLRN
>fig|349521.5.peg.1028 Drug resistance transporter, EmrB/QacA family
MANSVEPLSEYHGALAALLLSTFLTSLAISSVNILLPALVSSLDANYAQVQWVVLAYMIALSSFLVIAGGLGDTYGRRPLFIAGLGIFMVGSALCGMTENIGMLSAYRGVQGIGAAIVVSLNLALVRDVAPTGHTGRVMGWVGGMSAVGTAAGPVLGGLITGFADWRWVFWLNLPLGALTLLLAVRYLPRASQGAGKGSKPFDLMGAALLAMIVLIYSFGIKLKLEGALLRFFMAGLALVLLVAFVLVERAKPSPLLHLSLLHDYRYGLSYLIQFIVASAVMTALVIGPFYLISLGLNLSMTGLVMGCSPVCVMITSSLIGRRVKQETCSNMASIGVLFLFFGSLGLAHLSAATGVIGYIACLMVTAIGYAIFTVANNTQLMARAAPEQRGQISGLLNLSRNLGMLTGAALMSALFDSVTNASALSALTLQLAETGLHRVYVCVSVVLCFGLVVRGYWHFREYREKDGIRTLT
>fig|349521.5.peg.1511 Permease of the drug/metabolite transporter (DMT) superfamily
MTAFLYIACILLWGTSWIAIHMQLGEVPILTSIFYRFAIAALLLLPTLFLLKKIQKTQPVDHLWFAGQGLCFFSLNFLCFYHATQYIPSGIVAIIFSTVLLFNSINRWLFLRQSTSQSEFIGIAFGIVGIVLLFWRELTQQNFGADFFTGMLFALLGTLIFSLGNMVSVRNGAKGITPLTGNGYSMAYGAMVLLIAVFATDTPLRFSFTSQYIFSLLYLAIFASVLGFTIYLTLVNKIGINKAAYCMVAFPVVAILISTLFEDYRWDATTFSGVGVIIFGNFLMVSKLWWRPASLARQQS
>fig|349521.5.peg.1635 Permease of the drug/metabolite transporter (DMT) superfamily
MSLLDLLLGLLANLAWGFNFIAGKEGAQHFQPLLFTALRFAILLALTAPWLKPAKGYMKPLLSVAFVLGVLHFSMMFLGLNAGGNIASVAIATQLYVPFSAILAAAILKESIGWIKGGAIVLALAGVFIIGFDPVVFNHLDALAWVVGAAASMAVATILMKQCPTLGVMRLQAWIALVATPSLLALSYIFEDGQWSLLVQSEWSDYWAPLYSAVAASIIGHGIVYRLLGRYSVSLVTPMMLLAPIFAMVFGVVWFGDVLTWKLSLGGALTLLGVVIINIPREQLRRVMHLLAGKRGASV
>fig|349521.5.peg.2050 Permeases of the drug/metabolite transporter (DMT) superfamily
MPQDRFLRGVAFIILGECFFVLTGMVVKHISVEAHVWQMVFFRNLFGLAFLTPLLLRSGRSAFKTQRLPLHFLRAALGVAAFSCLIYTFASIRLAESTMLKLMLPLFIPVIAWAWLRERPTPILAFSLGLGFLGVIIILQPDSLAAAARLAILAGLWGALFAAGAKVVIGRLGATEPSVRIVFYFNLFSTILSCIPMLWYWRALEPITLVWLLLFAILATIGQLSTTHAYTLASPGKIGLYSYASLPIAGLLGWLIWSEELYLELWIGSGLIVLAGALTFFYSRPRKPEIATAQD
>fig|349521.5.peg.2220 Permease of the drug/metabolite transporter (DMT) superfamily
MTVERARIGQGIAMGVLAALIWGIWPVISRLGVQQTLTAYDVAAIRFIVAGVIFLPWVIKSGLGGLTWRQALILTTGAGAPYVLISVGGLTLAPASHGGVIISGCSFLFATLGSVLLLGDRPTSQRWIGFVLIALGILSIGYRSITSSSAALADAWIGDLIFVLSGFLWASYTLNSKRYNVPPVMGAAVVSVLSMLLYVPAWLAFGEPHIFQASAQELIVQGVFQGVLAAAIALVCYTKSISILGAAQAAVFTSLAPGLAVLFGDLILGETPSSAEYIGVSLVILGLLTSLGLFNWRRASGAVATDS
>fig|349521.5.peg.2492 Permease of the drug/metabolite transporter (DMT) superfamily
MSASASINAHSEASLTRVTPILSDSKQKLLGYGAACLTVLIWSSYFLSLKFGALSPLGIFDLALFRFCIPGLILTPLLIKRRHRILAAPKLYLLGVMLGAGLPFFLLSAAAMGWAPVADGSTLIPGAAPLFVTGMAVLIFKEPLSVWRRYGLLAVAVGASCFLYSSLSNPSGDLWRGHVLFLFCSAMWAVFTISVRQSGLKPLEAAAVVTTPNAALLLIWALWSQPELAWSSLPVMELTAQMLVQGIGVGLGAGFLYSFAISRLGAEITSAIGSMTPVCATLLAAVLLQESVEFASLLGLGLVTSGVICASGLLNREKA
>fig|349521.5.peg.2844 Multidrug resistance protein A
MTPDQKFAQWIKYSCIVFVLVFAYFLIADIAMPLTPQAMATRIVTKVSPRISGPITAVHVENNQPVHKGDILFDIDPEPFKIALEQAQLNLERVKQNNTQLDASIAAARADVDAAAATLSQKNREALRLKTLFQRNVVSQQQLDTAESNATTAQAKLASMKAHLKELEVSRGELSDANLTIRTAETQLKQAQLNLSYTRIKAEEDGVITNLQLEAGAYAVAGSPLVALVSDNLDVIADFREKSLRNFDLNNEALVAFDGKPGQVFQAHLTSLDAGVSAGQFDADGRLATPTQSNRWVRDAQRMRLHLQLDADAQHLPSGARATVQLLPDGAIFSTFAKAQIRFLSLLHYIY
>fig|349521.5.peg.3186 Permease of the drug/metabolite transporter (DMT) superfamily
MQRKELDMWRNHPFAFGIIAITVAAILFGVAGALAKVLFHADISPLDLTAVRSIVACAVFSLAMLLTQPGVFRIKKSALPLLIATGLAFTAVNITFYYAISMISVAAAITLEYTAPFFVLLISVVSASRRVDARDVGIVALSVAGCFLLTGGEAELFSLNAGVLVGLACGLAFAVFNMLGNACKRRGVGATTVTLYAFLISSALWLAALPTLTVHEIDYSGDVILYIAFIAIIATIIPYWLLMYGLRHVDALPATIIGMFDPLVAGLVAYALVGERLTVVNMVGIGVIIVAVCLITIKEKNAPSSSQKNNAKKAPDESSGTLQEPTQNAY
>fig|349521.5.peg.3248 Permeases of the drug/metabolite transporter (DMT) superfamily
MENTHNSKAMTFVFIAVVAGTGMDAFVKQVGEDVDTWQLLFLRWCFAALLLIPMAVKEGAGIFVWKSPKAHLMRGVLNCVASFLLFYSLANLPLAVVVTIFFAEPLFIVPISALWLREKVAPGHWLATLVGFIGVLLIARPSGDFAPLEIIYPLAGALGFALLHIGTKKYGSQESPISLMFWLAILTILMSGPMAVAEWSPVSVKDFSFIGLIAVLGSVYSYFWIVGLRIGSAAIAAHISYLALPLAYLIGWAFFDETPDFYTLLGSGVIFLSVLMVSVKNGMKLPLPRALRRDKTYDAKAS
>fig|349521.5.peg.3592 Permeases of the drug/metabolite transporter (DMT) superfamily
MKQIQQSPDNAAPFLAMAALSAVFMGTIGVIAKYAQLSAETVTFYRLFFGAAMMLGYLLVIRKASLLWCWPSWRVLINGGFLAGFIVFYIQAMEHTSMANAIMTIYLAPVVASVFAHLFLSEKLSASAMGLILTALFGFAMMMEFRLEFGGSQDALGMTYAGLAMLCYAGFIIINRATPAHVHVYARSWYQMLIGALCMAPLMLQQQQVIAPAQWGWLLAAGLIPGFLAILFAVIALRELPSATFGTLAYLEPIAVVTFGWALFDQALSPLQIAGCGLIMCSGIAQAVLTQRRNAAISGQVCSVAQG
>fig|349521.5.peg.3692 Multidrug resistance transporter, Bcr/CflA family
MSGRSGLGILAPFLRYNQALLLFRTKLQRSRLMTSSTTHSRLAFILAMAVALGPFAIDTYLPAFPDIAKAIGADIHDVSLSISVYILGLAIGQLIGGPLSDRLGRSRIMLIGLGVFLFSCLMLSQSESLASLLVWRFTQAFGGGWCAVSVPAIIRDRTEGQETAKLFSLIGLIMIAAPAIAPTLGSAILAFADWRWIFLFLALYTGVVIVTLWFSLFADAPPHTPPPKRNVLADYLEILKNTAALRFIFIQSLGFSVMLTFLTHASFIYQEWFGLSEFAFSLLFAGNIAVMALMSMANRALLTWVESAQLLRLAVWLQTCGVIALVSITILHPSLYLFAPALMLSVGSLGAAMPNGSACFIQFFKSNSGTASALMGALQFTISGAISALSSALSDGTLIPIVAVMLLCALLNAAFAWGAPSAAQKAPAGV
>fig|349521.5.peg.3780 Probable multidrug resistance protein norM
MAKARRETLPKSEQGTMSRLREVLKLSLPLSAAQVAQSAMIFCDSIMFGILGVEELAGAGLGSAIFNFILVVISGLLAAVANEVAFHTGRGAQKDIIRIVKAGLILVVIVAAMVALAMKVTPALLLGMGQEPQAVAYASQYLGQAAWISLPAFAFMVLRGLAAGMSRTTSIMRISFAAVALNVPLSYALMTGWRFFPELGIAGVAIGTALVSVFMCVMLVLDLNRYAEVREVLSGLTKIRSRLVDFKPFYSLGLPIMLAWTMEAGLFTAATLLAGAMGAVALAAHQIALQAASMSFNIYIGFAQGASIRVGQCYGEGRMGELKSYAWTGLSLGGLFCLVSALVFLLLPEQIVGLFTLGGEGALDQDVLTLGVSLLAVAAIFQVVDGAQVIMMTALRALRMGATPTLITVVGYWLVGFPVAWLLKGQWGIVGVWMGLGVGLGFTAICLTTLFNWRVNRALKGELQKENSTFVTAPTESQLTHN
>fig|349521.5.peg.3930 Drug resistance transporter, EmrB/QacA family
MSHKKTLLSVSLLIFLGALEKTIVTTPLPVIGTELNAMNDIAWVVTAYLLTATSVIPICGKLSDLFGRLKVIIVSLGIFCIGSLLCALATDMQSLILSRALQGVGGGALISLAFVVISDVIPAREIGRYQGYISAIYVVSNIAGPVFGSLLTEHLSWRWIFAINIPLTLLAAFIAIRSIKDKVVKREDRFNWGGSLLLVSSTTLLILLLSEDLSLPHAFSLVGALFIAGAWTYLLTDKKRSVVPRHLFKLPNYAACILTMGVCQILMTAALIYFPLQMQVQNGVSLTLSGYSMLLFTLGVCVSAYFSGKHIAATGAYKTHILVGFILIAVAFFLMLMKVAFVPLFPVIGLGIGFTLPGVTCAVQNVLPAADRGVGISFFGYVRELSGAAGVVVCSSLYRGGGSLQAAYSAFGVIYLAMCLFASLAFIIVAGFITEKELMTQVAE
>fig|349521.5.peg.4067 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKDLINLLALAGLWGASFLFMRIAAPEFGPVAMVQLRITIAALCLTPIMLIKYRRQLRWAHVPHYIFLGVSNSALPFVLLGFATLHVSAGFTSILNAAVPLWSAIIAALWLGDWLNRWQTVGLLIGFFGVSILIVSKGEFSLTGPTLAIMAALTATLSYGVSANYTKRFMTGVQPMVLAAASQIAAALALAPFTWSSMPQGDISTAAWTSVIVMGVFSTALAYIIFYGLLSRIGPTKTVTVTYLIPVFAMFWGYVVLDEPVTIYMLSGCLVVFAGTALTNSLIKPKLAAAQ
>fig|349521.5.peg.4516 Drug resistance transporter, EmrB/QacA family
MSDTLLQALFDRHGPAYRWLAMLTVMMGTVSAVLTSTIVNVALPDIMSHFSIGQGVAHWLSTGFLAAMTTTMLTTAWLTQRFGLRHALGFAMLLFAGASVLGGLGPNAESVILARVLQGAAAGMLQPIAMHVLFRVFPRNERGRAIGIYGMGVILAPALGPVLGGVIVDQLDWRYIFFAPLPITMAGFLMALRYMPHREAAGEQHGFDWTSFFYLCLFIGCALDGLTRLQHGLVQPVWQTVGALLAVFSLILFVRRQRYSRSPLLELALLRVPSFRSAFLVALGLGMALFGSTYIIPLFVQTALNYSATEAGMMMAPAGVALGILFPFSGRAADKGAPHRLVIAGLALFAGASLLWVFIGLEPSFFYLAVLVLVGRVGLALMMPALSTGGLVEVSDAQLGQASGMINFARQFGGAMGINILAVMLEWGSSAGDGRHVASMLSYTEAFVLLGVIAIIALWPAARIGKTDASVQTAPESA
>fig|349521.5.peg.4777 Drug resistance transporter, EmrB/QacA family
MAGHVGHSHCLCQRLLMSANAGRKAVNPWLIAPLVALAAFMEVLDISIANVSLQHIAGSLGAGPEETTWILTSYLVTNAIALPIAGWLSDYFGRTRFFIGSIIGFTLASLACGMAPGLEMLIIFRAVQGLAGGALQPVSQAILADSFPLEKRGMAFAMYGIAVVAAPAIGPTLGGWITDEFSWRWIFLINVPVGIVLIMLVKRYLPDEPANHDGSKVDYFGFALIAIGLGCLQWMLDTGQREDWFESPQIVALAVIVVVALLTYIVRSFDQKNPIVDLTLYRYPNFAMANVIMFMMGFVLFGSTALLPLLMQTLMGYSAFDAGLVLSPGGFAIMFMMPIVGRLVGAVDSRILLTLGLGVSSLALWNLGELTLAVDRDQLAMARVWQTLGLAFLFIPTTSSAYVGLPTSANNQAAAMLSFMRNLGGGVGIALLMTFLDRVATVNRGHLVANTSPVSEVWSHHYMQLQQISGDATRALMMANQQVAEQARFIAFMDSFKLLAVMFALLIPLVWKLKPLPRSGVGAPQGAH
>fig|349521.5.peg.4778 Multidrug resistance efflux pump
MSKKMIRLMLFFSLAGVAGCGYYLWHAGKVSTDDAFVERDVIYLTPRVSGVLVEVLVSDNQKVATGDLLARIDPKPYEAELQSASARVAMQQAAMVKAQADLEAFVARLEARKQDALAQVNVAKAEKQHHESNLARLDAQIAQARRDVDRYERLAGRKQVSEQALEDAKTNLATLSAERETVKASIDVAASKVAAAHSQQKTVASDERNIAVLRAAIGQSEAALKQAQADEARASLALQWTEIRATSNGWISRVEKHPGSFVSPQTNFAIEVTGAAWVKANFKETQIGDVRVGDKVSVEVDAYPGVTFSAKVESFQPGTGSRFSLLPPENASGNYVKVVQRVPVKIIFDEVPDGVQLWPGMSVIPTVYVSGS
>fig|349521.5.peg.4816 Permease of the drug/metabolite transporter (DMT) superfamily
MLCAIFLRQNVQWSTWGWMLMAFVGVFLAAEVSFSGASFEALQGMGLALGAAFFYALATIFTRQAPGVSPAAMAAAQLGFCLPLLGAWLLWNGADWSQVDWKYVGLLGGLNSIAQYVLLYFAISHLTLERLSILSFLYPITTLLVDMLFYDMELSAAQTVGIALILLANTAILRRKPQPDKGARAGSPTGRQAIAE
>fig|349521.5.peg.5274 Permeases of the drug/metabolite transporter (DMT) superfamily
MQATYIPYLFVLLWATGFVSAKWGLPYAEPFTFLSLRMLLVVPLFAFLAIAMKRPRLNAVQRRQQMITGVGTHGLYLGGVFYAIAAGMPAGIVALIVGVQPLLTALVSWPLGIGSPLRPLQWIGVLLGLAGLGVVVLQGGKLSGHITGEGLSASIIALLGISGSTLWQSVKGGKTDLIAGGLWQYIAALIMFLIAAFALETREVQWNPNFIGAWMWSVFVLSLAAVLLWLYMLKIGEATKVTQYLYLTPPTTAVMAYLLFDEPLTLQTGLGVALVVAGLYLARRGAMAGKPALSKA
>fig|349521.5.peg.5405 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MEADIILRKVDKAPTEDAQTEASASAQNKKLSSVSVVFPAYNEETNIEMTVLKAIGAFKKHFETVEIIVVNDGSSDGTRDILERLRQEHEEVRPIHHVQNKGYGGAVRTGLKSGRGDFIFFSDSDGQFDLEEVDLLLRHINDYDIVVGYRAQRADPWHRKLNAYCWGVLVRYLFGIRVRDIDCAFKIFRRDFIQSIRIEAEGAMINTEILAQAGMMHCTIKQVPVSHYPRLSGAATGANPLVIFKAFVELFNLYGKLKATGYKELQTKA
>fig|349521.5.peg.5844 Permease of the drug/metabolite transporter (DMT) superfamily
MYWLLGVLAPAVWGTTYVVTQAWLQDLGPLWVSVLRALPAGLLLMCLDLKSLRHMDMRRSVILGALNISVFFFFLFTAALRLPSGVAGTLMALTPLTTLLFLWWWQRQAPNPIQLLCAFGGLIGVGVVIFQPSSQIDPVGVAASFGAVVSLTVGTFLAKKWSPPKGILAFTGLQLFLGGMLLLPLAFLLEGPMPALNREAMLGLLWVDLVNTALGYLAWFIAMRRLPVSALSFLALLSPVSAVISGRLVLEEWFTPAQYAGIAMVLLSVTLAQFARAKTQPKMAQQAS
>fig|349741.3.peg.531 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTDPQVQLSIVATVYCTGGYLAEFCSRSFAAALEAGYDPSCTEVVLVNDGCPRDGLEQALKEREKDGRVRVVDLSRNFGHHLAMYVACEEARGERVFLIDSDLEESPEWLVNFSREMDSTGADVVYGVQEKRKGGLFEAVSGELFYTLFNLLSDQQITRNMVTARLMSARFLREMLKFQDREPFFFGLCVSAGFRQVPCRVKKASSSPTTYTFRKKMALAVNSVVSYSARPLVYISYFGLAVTLVAMLYVAWVVVRQLLYNVAPPGWASSVASIWLVGGLILMSLGVIGIYISKIYKETKHRPAVVVARRYE
>fig|349741.3.peg.873 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRNAIDLGTLDVCTLFRKYFIPTLFGMLSISAVTAVDGILVGHGIGSDGIAAINICIPLLMLFTGIGLMAGVGSSVVASIQLSKGKLEAARLNVTQALLFVTIAAIVPSALMMAYPSATARFLGASEHLTPMVREYLLWFIPSLIFQMWCSVCLFMIRLDGAPKLAMMCNIIAAIITVILGWLFIFPLGWGLTGAAFAATIALFASGATGLIYLWIFAHKLRLYPIKWSIRSFRFSLLNIVCQCRIGSSALLTEATLATLMFVGNHTLMKYLGDNGVGAFGIACYYLPFVFMVGNAIAQSAQPIISYNFGLGEKKRVADTKRIALFTSVVCGIVTTAAFILFPHILVGLFVNPDSTAALIAIEGFPYFSLAFVFFIINLMLIGYYQSVENVKLANLFALLRGFVFLIPCFILLPEAMGTNGAWLALCLSEMLTILTVAVLFILRKKKTLLHQTGEECS
>fig|349741.3.peg.1088 Multiple antibiotic resistance protein MarC
MQDFLSTVILLFIVIDPVGLAPMIQGMLKKYSPAQQKAILTRELVFALSLLLLFFFSGKFLLNLLGLEPSTLSISGGILLFLVALGMVFPAKDMLSSSGRADGKDEPFIVPIAMPLMAGPSSLSIIMLHASQTPDSISQMTYAGAIVTAWFLSGMVLFIAQKFLRLLGEKGTIALERMMGMVLIMISVQMFMNGLAGYGVK
>fig|349741.3.peg.1660 Permease of the drug/metabolite transporter (DMT) superfamily
MQSACGSGECATRRAAGRTMPSEALKGHIAMGAAAVIWGLMSPVSKLVMQQGEVSSASLATFRLLGAALLFWLASAFVPREPIKRKHRLPLFYASLFGIIFNQMAFTVGVGFTSPADAAIITTITPVLTMILAAFVLREMVTGKKIIGVCASAIGAMLLVSGSGAHAAALPGDNNLLGDILCLASQCSVAVYFVFFKNLIGRYSPVTLLKWMFTYAAAACLPFTFREVGSIHYSALPVQTWLGIAYVVALATFVSYICLSFAQQRLKPTAVSMYNYCQPVIASSVAVMWGMDHFGWMKVLSVLLVFTGVLLVTGTRGKRAVQEQ
>fig|349741.3.peg.2162 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEGNKKMNKTWNLKEMKKLIPLALPVLVVNLSIVGMGAVDAIVAGRAGVTDMAAVALGSSVYLPVALFACGVLMIIGPVIANMRGKSHESRVGYMTNHGLWLAFMLSLVSMPVIYVLRNVFGWISDDAAMCQMASAYMFAIMWGLPANLGFVALKSLNEGSNMTRPAMYVGLCGLLLNIPLNYMFVFGMYGFPRMGGAGCGAATAVIFYIEFLLMFLLVYFNPKHRPYRRHIISWRRPTPSVITHLVRLGVPIGVSQLCEVMLFCAAALVLAPLGETQVASHQIAGNVGGLVFMLPLSVGLAASIRVAYHHGRNDLAGTRSAILSSYVLVLTICLCTFGGITLFREQIVHLYNDSELIVSTASVLLVLAAAYQLPDCLQVLSVGVLRGFRDTASITFITFFSYWMVGFPACYILARTDWIVPAMGARGIWTGFIIGLAVAAVLLLWRVRRTTRREFSLMRQAGE
>fig|349741.3.peg.2169 Acriflavin resistance periplasmic protein
MYNKPLTFAATTLLLCSPVMILTSCEGEKDSAAQAPALVPEVQVTKLVTKDVPIRQEWVGTLRGTEDAEIRSQVTGYLLSKDYRDGAYVKKGQVLFQIDPRPFQATLDQAQGRLEQYEATLKKYKLDVERYTPLVKTGSVSRKQLDDALQQVQETEAAIATAKAQVDEAKINLKFTTITAPISGLAGLATPSIGNLLTPSSPTPLTTISSIDPIRVDFSVSERDFLNSMDNNLTRQKHLKFDVILANGTEYPMQGEPVAIDRNVDAQTGTINIVGHIPNPNLTLRPGMFVRVRATVKTLENAALVPPRAILSAQSAKFIIYLDDKNIPHMQVVNLGPVVDGMQVINIIPMPHSTFTKDSPIVVEGIMQAAKVQGQAPVKPLPYKPVVSQPVMPSIGAQSFEKARTPEGMKDGEAQPSAK
>fig|349968.3.peg.581 Fusaric acid resistance protein fusE
MVSSDSLLFVIDPQPYQLALDNTQAAVVRAQSELAKANHEAERRRYLPKNIISGADLEIANLTADSMKAAYQGAVANLEQAKWNLSKTRIYAPANGYITNLQTRVGNYATTGTPLVALIDTDSFYVMGYFEETKLRHIREGNEAKIVLYNGNIPLRGVVESIGRARSSKCASLKLTGA
>fig|349968.3.peg.1912 Multidrug resistance protein B
MPYLSAVCMSKKWMIFYVIILMYLPVSIDATVLHVAAPRLGIALSATGSELLWIIDIYSLVMACLLLPMGALGDRIGFKRLALMGSVLFGLASLAAALAPSVAALIVARAFLAIGAAMILPATLSAVRHIFTDERERALALGVWVAIGTMGAAMGPLVGGILLEHFYWGSVFLINIPIIIAVVIATLVVIPSQPMRTEQTWKLAPALVLITAILMLVYAAKTGLRGGGDMVVTSLTALFGGVMLFAFVRHQLSTSAPMIDFRLISQRVIAVGMVMAMTAMITLVGFELLLTQELQFVLGKSPLDAGIFLLPLMIASGVSGPLSGWLVARLGLRTVASAGIALSSLSFLGLAWTDFATQTYLAWGWMILLGFSIEASLLASTAAIMSAAPPEKAGAAGAVEGMAYELGAGLGVAIFGLMLSRAYSASIVLPADLPTDLVAQATASISETIQVVNSLGGNEPLLASAKLAFSASHSLVLGTASGLLMLLALAVGFTMPGKRVLQLAH
>fig|350058.5.peg.761 Probable antibiotic-transport integral membrane leucine and alanine and valine rich protein ABC transporter
MSVSMTPRLRAWAAFGRNDLRGTYRDPLLVMLVLAPAIWTIGTAVVVPRLSVALAQRYDFDLVPYYPLVVTGLLLLTSIIIVGGLAAFLVLDEIDAGTLTALRVTPVTLASFFGYRAATVVAVTTAYVAVTIPLTGLLPSSVVWPLIPIGMVAGLSSVVTMLLIVAVASNKVQGIAMLRLLGLLIAGIPCLPWFVDSAWNLAFGVLPPYWAAKAFWVACANGTWWPYLIGGVVFNAAAGWPLLRRFVAKNT
>fig|350058.5.peg.762 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MKRWVSALRLEATLQVRQRFVHAAVISGMLWLVVLLPMPQHLRSIVEPYVLIGDITIVGFFFIGGAVFFEKQERTLGAVICSPLRFIEYLSVKILVLTGVSLFIAVVVTLATHGTDFRPGFLVAGVVLGTLVMLLVGFISALPFDSVSDWFLSTVVPLLILSLPVMYMLGVWTNPAFYLVPTQGPLLMFLAVFDQVSLAPWQVGYAVLYPLICAAGLYRLARVMFGRYVVERSGVA
>fig|350058.5.peg.1109 Vancomycin B-type resistance protein VanW
MPLEGRPAGTPGGTVHPQVIPGAKPAKPRSFRRLWLLLTAPFAVLAGLYLGDLILSSDRVPRGVTAAGVPIGGLTLTDAEEQLRAEVTPRTTGPIPVTAGPERSEIDPTSAGLSVDWRATVEQAGAQPLNPITRLSSLFTTREIGVVSTADDAALAAALEQLGTRVAQDPVEGTVRFAGREPVGVNPQAGRRLDVDAATELLKRDWATGSTVDLPMIELEPRTTASDVEAAVADIAVPAVSGPLVITGEDDARAVISETVIATALTFDVDDREIVATVDQNAIADAARPQLADSEIPRRDATIDFTTSPPAKVPSQDGRRIDYDDTLADLMDVLTDTTDREVAAVYVDEPATFTTADIDALGPVQVIGEFQTSGFSGDSGVNIKRAAGAIDGIVVAPGETFSLNGATNPRNAANGYVEAGIILNGKPDSGIGGGVSQVATTLFNAAYFAGMELVEHQEHSYYISRYPAGREATVFGDAIDVKFRNDGPTPVQIQTTWTSSAITVQLVGIKRYEVTSAQSPRSAPTSPRTITIPAGESCSASSGAPGFTITDTRTLRDIVTGDTRTESHTVSYDPIPKVVCGG
>fig|350058.5.peg.2269 EmrB/QacA family drug resistance transporter
MTALNDAERAAIQRDAEGSGKRGSGRASDRALPARIPGLGETAGGRGGDGARAGRTPAWVPSRRFFAAVIAIGGMQLLATMDSTIAIVALPKIQDELNLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVTLFTIASVLCGIAWDEATLVIARLLQGVGAAIASPTALALIATTFPKGPARNAATAVFAAMTGVGSVMGLVVGGALTEVSWRLAFLVNVPIGLIMIYLARKTLRETNKERLKLDAAGALLATMGCTAAVFAFSMGPESGWASPVTVASAVAAVGCLLAFLWVERTAENPVVPFALFHDRNRVATFAAVFLAGGVMFTLTVTIGLYVQDIMGYSALRAGIGFIPFVIALGIGLGLSSALVSKFPPRVLVIGGGVLVLAAMIYGSTLDAGIPYFPNLVLPITIGGFGIGMIVVPLMISAIAGVGFDQIGPVSAIALMLQNLGGPVVLAVIQAVITSRTLYLGGTTGPVKDMNAAQLHALDQGYSYGLLWVAAVAVIVGGAALFIGYTAEQVAHAQEVKDAIDAGEL
>fig|350058.5.peg.2355 
MPVVVIATMKAKPESVDAVRNACQTAIESVHDEPGCDLYALHEADGTFVFVEQWADADALQKHSTAPAVATLFGTVGELLDGAPDIKMLQPMVAGDPAKGRLRP
>fig|350058.5.peg.2685 Probable unidentified antibiotic-transport integral membrane ABC transporter
MTTENRFTPGTFTPDPRPAPVPRMLAAQFRLELRLLLRNGEQLLLTMFIPITLLVGLTLLPLGSFGDNRAATFVPAIMALAVISTAFTGQAIAVAFDRRYGALKRLGATALPVWGIIAGKSLAVGAVVILQSILFGAIGFALGWRPPLAGLALGAVIIALGTAVFAALGLLLGGTLRAEIVLALANLLWFVFAGLGALTLEAGVVPSTVQWVARLTPSGALTEALTQAMTSSMDWFGLAVLAVWGAVAGLCALRWFRFT
>fig|350058.5.peg.3295 Multidrug resistance protein B
MTHTEAGSAAVATGSWRELLGPKYLGASTVLAGGVALYATNEFLTISLMPSAVADIGGHRFYAWVTTVYLVGSVMAATTVHSVLTRLGPRWAYLLGLTVFGLGSLVCAVAPSMEILLAGRTVQGAAGGLLAGLGYAVINTVLPSVLWKKASALVSAMWGVGTLVGPAAGGLFAQYSSWRWAFGILVVMTTAMSALVPMALPARARAAHLGSGAPPGRIPFWSLLLLGAAALLVSVAGIPHDVRATAGLVVAGFVLVAVFVVVDRRVAASVLPPSAFGRGPLKWIYLTLGGLMAATMVDMYVPLFGQRLAHLTPVAAGFLGAGLAIGWTVGEIGSASLTRHRVVVRTVAVAPAVMATGLTIGALTQHRDAGPMLVALWAVGLIITGAGVGIAWPHLSAWAMSKVDDPAEGPAAAAAINTVQVISAAFGAALAGVIVNLSHTGDVAAARWLFASFAVLAVLATVASTRSGRLRSR
>fig|350058.5.peg.3940 Multidrug resistance protein B
MSQHRPHDAIAAEPTDDHPFRALWVMMVGFFLIVVDSTVIAVANPVLKNDFDVEYHSVIWVTSGYLLAFAAFLLIGGRLGDRFGSKPVYLVGLTLFAAASVWCGLSTSVGMLIAARVAQGVGAALLTPQIMSTITRTFPPQRHGMAMSVWGATAGVGMLAGPLIGGVLLAGLGWQWIFFVNAPIGAIGIALAVRLVPNLPGRPVRIDVVGALLSGAGICLIVLGLQEGQHERWSWWIWVAIAGGLVSITAFLRWQTVHADEPLIPMSLMSHRNFVLSTAGIALVSFVFVSFGVPLMIYLQEVCGLSPVHAALLTAPMAVATAVLAPVVGRIVDRAHPRPVVGFGFGLLTAGLIWLAVEMTPDTPAWRLALPLTMVGAAGAFTWEPLSAIATRGLTSELAGAGSAVCNTARHVGAALSSAGIAALMAVLLGDEHAEEAGARHETLAPLVDSLKDPFAGAMAQSMLLPAAAAAMGVLTALFLVGGDATARAAPLSLRPWGDASVSS
>fig|350058.5.peg.4504 Tetracycline-resistance determinant tetV
MVGNHRSVSTQYETGRSSARSDSEQPVAPAGWRVLAPFRYREYRLLIAAVSLSIFAEGMWAVVMALQVIELSNDPAALSLVATCLGAGLVGFVLVGGLAADRLSQRGIIIVVEAVNTVAVTAVAVLGFVDALRIWHMAVAAAALGIAAAFFFPAYSAILPRILPPEQLLAANGIEGVVRPVFQRAVGPAIAGLVVGALFPSAGALVVAVLFATGLALLVATRPPKAKDTGAQHEPRPHLLRDLRDGWVFMLRTPWLLWTLLFASLFVLVVLGPIEVLLPFVVAERFTHGAQTYGFILAFFGLGSALGALGVSSRRLPRRYLTVMMAMWSVGSVPLVIVGVTSSFPLMALATFVIGVTDGTAMVIWGTLLQRRVPPELLGRVSSLDFFVSLAFMPVSFAIVGPLSKIVSMEAIFLAAGLLPVLLAAVAVWAAKMHRDEVAHPLR
>fig|350688.3.peg.237 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFNNLIQTLYNLADTFWVSKLGTMPMAAMTLVSPVIFLTLSIGTGINVAGTALISQYIGSNDEEKSIKVSTQMFTFSVILSIILGIIGYLLTPFIVTFMGGQDEIFTYSSQYLTIMFWEIPGMFLFLVYTAIKQSQGDTFTPMVLNVLGVILNILLDPIFIFTFNMGIKGAAIATVLSRMIFALYAIYTLFAHKDGIYLDRNNLKMEKDILKEIIAIGLPSTLGQSAASFGFVILNSFVISYGANTLAAFGIGNRINSLVLMPVMGIGSALATIVGQNLGADKKDRAKLAVQTALKLSTILMVIGGVIMVIVSSSIVSIFVKDDPDVLQQGTEYLRLVSISLPLMGFFQVFVGTFQGSGHTIYAMMMDMGRLWGLRIPMIILFKNFTQWGPNGVWYAMLLSNAITCVFGFIIFLSGKWQKQVIHKKKALA
>fig|350688.3.peg.801 Multidrug resistance ABC transporter ATP-binding and permease protein
MKFILKYLKRYPKLIIFNILGIFSFVAVQLGIPTIMASMIDKGIGNSDIAYIKRMGILMLLLSIAGGAGTILITYASSRISTYMIRDIRNDVFAQSQKFAHTEYTKFGVSSMITRTTSDAFQLMIFANLLFRTALLAPIMIFISIFMTIKTSLSLSLIIGASFPFIILGVIIVAKVTGPISDAQQKGLDRLNKISRENLLGIRVIRAFRKSGYEAERFAGINEVYASNSKKLFKIISFAQPAFFFLLHLSMLAVFWVSTIMIGKGTLQVGQLVAFLDYQFHALFSVMLFSMVFVMYPRARVSANRIQELLDQEPSITNPTAGIKETKGKAKVEFHHVTFQYPDGELPVLKDVSFTAQQGETIAFIGSTGSGKSTLINLIPRFYDVTKGAIKINDVDIRDYDMDVLRRKIGFIPQKAFLFYGTIEENLKFGNPDATSEDMNHAIEIAQAKEFIENKPDKLQELISEGAKNFSGGQKQRISIARALIRKPEIYIFDDSFSALDYKTDATLRQALRHETKESIVFIVAQRISTIMDADKIIVLNEGEVVGIGTHKELLKTCSIYYEIADSQLRKEELEQ
>fig|350688.3.peg.834 Permease of the drug/metabolite transporter (DMT) superfamily
MNNKIIRGEILLIITAIIWGTSFVAQRVGMELIGPFTFTATRFLVGTLSLIPIILITDKVNKKEEENKTENKTEAETGIRKELLIGGIACGLALFSGISFQQAGLQYTTAGKAGFITALYIVLVPLLGLFLKKKVDKNVWIGLILAVMALYLLCFTEDFSISKGDLIVLCGTVFWAIHILVIDHFAPKVNGLKMSCIQFFTAGILSLIIAFFTETIEMSAILNSAGPILYTGIVVVGVAYTFQIIGQRGTNPTVAAIILSMESVFAVVSGMVLLGESMSLKEILGCILMLAAVLITQIQPTKSNVEIEEKA
>fig|350688.3.peg.2312 Teicoplanin resistance protein vanZ
MESIIRYVLNMVPYMIAMLPILIAVRISIKLPIIKEGKKLNIVHEIGVIIFILYLVGLASQTIIPKFELGRNSIEIVGRIGFDYNRINTIPFNKIKEVLSLVRLGNFNYLWIEVLGNIGVFSVIGFMLPLLWTKLENIKTVLLCFSISVCIETVQLILPRATDVDDLIMNTLGGLIGYIGYMIFKRLFPKSTSKFKGESEL
>fig|350688.3.peg.2820 Vancomycin B-type resistance protein VanW
MRTKRLTERFPYLLPIRKLQRKVFFYIGMKLDANQYATKKAHNILEHQVFTTKSKMVNTESGYDIQYQLNKVDNLKLVAKTIHKVIIEPNETFSFWMLAKNAEKYGKYKKGLAMVNNEITSVEGGGLCQISNLLFWVFLHTPLTVVERNPHSAETIPQPKGDIPVGVDATIAEGWLDLKVKNETEETFQVLVEFDEDFIHGTIVSNKPQDVLYTVESENLRYARENGKIYRYNEIYKVGYGQFNGEIVSKELVLNNKYEIRYDIESEIGPI
>fig|351160.3.peg.73 Drug resistance transporter, Bcr/CflA subfamily
MLLALISAFVPLSMDMYLPALPGMATVFDVPVSLVNLTLILFFVFFAAGILIWGPLSDKYGRKPILLTGLAIYLTASILCALSTDIYQLIVFRTLQAIGGSAASAVATAIVKDVYHSRDRERILAIVQSMVMIAPAVAPVIGAFILSFISWRGVFWTLAIIGFIAFAGSVAYTETIPRRNDVSIPGSLGRLWVVLKNPGFTSLLALFSMTSISMMAFVASSSYVYQVEFGTTEQVYSYYFALNGIGLILGPMIYVRLSARFDRNSIVKACFALIAISGVLVFFLGSLSPIIFALCILPATVASVCSRPPGTSMMLEQQTGDTGSASSLMGCAQTVMGTTGMLLISFDWGTGIIPTVGAIIAMIGVITSAGWLYLSGKPFIKKSDGDAR
>fig|351160.3.peg.166 Permease of the drug/metabolite transporter (DMT) superfamily
MAFSDDRMAGENPQQNHALILIGLFIINVFWGGSFIANAIALKSMGPIEIAALRFFIAAPLLVIVTLAWKGWSIFRIDLKDLGVLIIMALTGVTLQYVIQVTAQNYTTAINASLLINTSVFFIMFLSAMFLAEKLSVHKVLGAVIGFGGVALLVSGGNLSLDVGLHVIGDAMILFCALLWSVYSIYGKKIAAKYDPLTVLNYLFILGTIGIIPFYLLTPHQNPASLPLDALGAIVFLSIFCSIIAYLIYNVALEKMDASRVALFIYVVPLSTIILAWLILGESMTLLSIIGGIAVCAGMYIAERK
>fig|351160.3.peg.167 Permease of the drug/metabolite transporter (DMT) superfamily
MLVMIVWGGSFIASKVGLDGMYPIELATLRFAIATPVLLAFTLLFYGWRSLIIEKKDLWVLVGMAMTGITLQYITQLIAMTYTTVTNTALLINMGTFFVVIPSIIFLKEKFNVDNLLGIVIAFAGLALVVTNGKIEFSPQLIGDGIILISAALWAVYILIGNKLAGKYSVLTQLNYIFVIGFIGLLPFYFLTPHHDLSQLSTVSWASLLYLAIFCSIIAYFFFNDAIIKIGPSKSAIYQYLEPVFAVIFAILLLNEPLTGFILVGGIMTVLGIGMADNNIRIFTRRRKKPVEVPAEPPDAGHH
>fig|351160.3.peg.1680 Multiple antibiotic resistance (MarC)-related protein
MNFELFVSAAISIFVMSDPFGNIPIFLSLTGGMNRPQRRRVITKASIAATVIIFIFAVVGQPAMNLLGISLNALSIAGGMLLLLIALDMLMSTGLHAKRTESTENTTHEDEEADSIAITPMATPLIVGPGVMAATVVFMNRAAGLMDQALVLSAVLIAMLGSWIVMVNSDLLYAILHRDGTRVLTKVMGIILAAIATEMMISGLLNAFPALAG
>fig|351160.3.peg.1734 Permease of the drug/metabolite transporter (DMT) superfamily
MIGLVLVNVFWGASSIAAKEALIQLTPVEIVTVRFAVAFIAVLALALLFNRDALNVRPADLPVLIFMSVAGVSLQFVLQVMALVYTTVTNFSLLFNLSAIFIMIFGVLLLKERPSGKQALGALIGFGGVFLIVTGGSGGLSLAHLSGDLLGLASAALFGLYAIASKTVADRYGPLTILIYTFLFGILGLLPVYYFATPMTPLAALTPLSWASIGFLAVCCSVIAFLIFNHGLSRLPSADVGITIYVSPLAGVALAVLLLGETLTTFTIAGAALVMAGLYVTQAREGGHSGEEEAKEKADRPATADG
>fig|351160.3.peg.1808 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MINRLVPTLLVDFRQQVRYGFIVASLFTMIVFIAMLSQFSQYGSPVFVPLFVFGNLMIGTFFFIGGMVLFEKGEGVLQALIVSPLRVEEYLGSKVLTLTALAFIENMAIVLAIFGTGYNVLLLAAGTILAAVIYVLLGFVMVSRFKSISEYLMPAAFVIVALMLPLVDYLQIFETPLVYLHPMQAPLLVMKAAFVPVESWQLAYGVLYSLIVIAVAFVLSKRAFDRHIINRKGGN
>fig|351160.3.peg.2378 Permeases of the drug/metabolite transporter (DMT) superfamily
MMDRQQIYPVFLAVGGAALFGASAPLAKALLGSVDPIVLAALLYLGCGAGLLLAKITTRLRTVKREAGLAKTDLPWLAASAISGGVIAPILLMLGLQATPAATASLLLNFECVATTSIAVLAFREAVGRRVWVAIGLITVAAAVLTLDLSGAFGISAGALAVVGACIFWGIDNNVTCRISAKDPVTIGLIKGLAAGTFSLILAAALSRQMPAGITPVVIVLIVGALCYGLSIVMFIRATRGMGAARTSAWFGIAPFAGTALSLVLFTDAPGLQLLLSLPLMIAGAALLFGEHHDHVHVHTAVYHEHYYEPDTHHPFKTPGSGMHHHEEVRHTHAHRPDIHHRHEHEEEKKE
>fig|351160.3.peg.2893 Daunorubicin resistance ABC transporter ATPase subunit
MTGNNAIEVKGLTKKFGDFTAVDNISFNVNEREIFGFLGPNGAGKSTTIRMLCTLARPTSGDALVNGYDLVKEAVKVRESIGLVSEKMIMYEQLTAAENLRFFGNLYAMPKQKIEARIDELLKLVNMTEWKNTQIKKYSTGMRQRINVVRALLTEPKIIFMDEPTLGLDPQTTLSIRELIRDINRNGTTVILTTHAMVEAEALSNRIAIIDHGKIIALDTPHELKKLVKGNDLTMFNARISNLTPVMIEKIKALDCVAAIAQPDAYDLKISARGSDGLDRIIDTIRANGGNIAAFNTTEPTLEDVFLSVTGKEMRDQANEKATARHRHGPRAPKARVR
>fig|351160.3.peg.2908 Drug resistance transporter, EmrB/QacA family
MLAIGVFIAQLDATIFVPALNTVVSEFNTSYEWVVWSVTIYMLAFTVTMPLAGKIADLYGRKRLYILGVALFCIGSLACGLAWDIPSLLVFRVIQAIGGGMILPAALSEIGAVVPEKSRGMAMGIMMAINAVAAIIGPNLGGFLVEHFGWRYVFYINPPIGILAILLALRFTETYGHEKHSIDFPGAAMLGGFLLTLMLGVIRLSSLPLSDITVFPLFVIAAILLISLVLFERKAKEPILSIPLLARPEVLAVNFAALAFGFCFFSIVLYVPSYSQMVLGLGIQDSGSILTPLTVSVLVMAILGGRLADKIGIRFVLLAGAIVTCGALFAMAYALSGTLVLAIILLIMGIGVGFSMGSFQSLTLALVPPNMKGSASGIVNTFMNMGGIIGPTIGSYYISGGTKKLEALMASMSTHAGSGMSSGMPAGGTGSPDMESMMAQALQDIMGPAFQDIFVLSAIVSVGVVILIGYVVVRGYFSARTEMQETETA
>fig|351348.5.peg.298 Permease of the drug/metabolite transporter (DMT) superfamily
MLRHHNQPFPGMISATAALAASVLMHVLWNLIARHQPGAAWPLWWALLAHLVMLAPWGFYALWQADAWSPEFLGLMAISASANALYFFGLWKSYKHAPVAMVYPLVRSSPVLIALWWLILTGDSPSLTGWLGILVSVAGLMILAGSQPGQGERAAIPWALLAMLCTSVYSISDKLATGQLPGFAAIIGFVSVGYSAAFLVLTLALRRQTGRWTPPQRLPIPIIVIGGLCVGLAYALVIHAMRFLPSAEVVAYSNTGIVLATLASIYWFGEKSNTGRRLIGSAVICTGLLLLAL
>fig|351348.5.peg.465 Multidrug resistance protein B
MADQSVEGLRARYGDRWRWLAVLTVVLGTMATVLSATVVNVALHDIMVEFGIRQGQVHWLATGFIAAMTTTMLASAWLLDRFGVRKTLSTAMAMFTLISLAGGLAPTPELLIAARIGQGAMAGLMQPMGMYLVFRIFPADQRGRAMGIYGMGVILAPALGPVLGGFLVDQFHWRWVMFAPAPVTLLGVWMALRFLPSPRSRPAPYMFDLSGMVLLGAAVAVTLETLNRLQDWPGDSVRIAWQGALAAILIIGFIVRERRAAHPLVRLALLREPVFLYATLGAMALGLALFGSTYLIPLFVQTSLGFSATEAGLLMLPAGVVLGMVFPVAGRLADKRSARGLVLFGIAMFACSAVLFAATGALVGFVWLALWAVVGRIGIGFMLPALSTGALNPLAPEQLGAGSSTINFARQLGGALGVNIVALTIEFGEHEGGLPTVSAFASAWWLVAVCVALAAVPIWKMRA
>fig|351348.5.peg.1986 Permease of the drug/metabolite transporter (DMT) superfamily
MSPLISIDAGSIMSDAHKSDLYLVLVTLLAAIGWMLSKEAVLMMPPLMFMAARFLIAGAFLALLALPSLLRLSRDQILRSLGVGFVFGIAMTCWIMGLYHTDSMGEGAFLTSLGVVIVPIIARTVFGEQQPLSTWLAIPIAVAGLALLSLENGFRPDPGQLYFVLAATIFALYFTLNTRAANQRIVVDKQGKTVEKKKVPALPLTAIALLTVGTVTLAESAISERWTHILTNPEPMLYVWVLASALIATAARFLLQTYAQSLSVNSHGVVILVLEPVWVAVFAVAWFGETMTLLQIAGCALIFAALLVNRWNALSRAIKALMKAKNPRQRG
>fig|351348.5.peg.3221 Permease of the drug/metabolite transporter (DMT) superfamily
MRSIRIMPISAHYGLTVLIWGLTWTAIRLQVESASVDLAVFYRFVMASVVALAVLAVTRRLSRLTLGQHGWLFLQGLTLYSVNFLLIYRAAESMTSGLLAVVFSLAALFNAFNGWLWLRTRPTARLYPAVALGVTGVALLFWHDLQLGNATGASILFAVAGTFWFSMGNLVSVKVKAAGVPLFTANAWAMVYGALILGLWCLIQGVEWMLPATSVFWGATVFLAVPGSIVAFYCYITVIQVLGADKAGYAAVLFPVVALSVSTWLEGFEWTTPAMLGALLAILGNYVLFRPGKRQSVSATSVPEQRT
>fig|351348.5.peg.3291 Permease of the drug/metabolite transporter (DMT) superfamily
MPVCFSNRQFVMIHGALLIALASLLWATTGIVAKFLFNGTELEAITLGFLRLVVALPFFWLLMRREQRQLVARNPGQTVPGSSLRSLSGKAMLTLTALGLFQAFYQGSYLLAVDLTGAGIATLISLCLPPVLVAILAAPLLGEKPGLLTILAAIAAILGTGMLVVSDMDTAGTLRLAGILMALLAAAVYTGFTLTSRYNSTGTPVFTTAFICFGTAALLLLPVVALSGGFAGLETMGLKHWLMVLYIGVVPTCIGYLLFFTGMKTTPATVSSIVVVLEPLFIALLAWLILGEELGQIGVAGAFILTVAVIVASRYGKAPGASQES
>fig|351348.5.peg.3593 Acriflavin resistance protein
MTRRLLNYQRLLGMVVTMLCLLGIAAYSTMPRQEDPSFPYRAGMITVSYPGASAEAVERLVLQPLTDELRQVEELDWSQGTARTGVALARLKLRDRIYDTDSAWDRVRQAMERARQDFPDDVGLMELDDRLIDIPAVVLAVGGSPSVTELSEVAERLKQNLLDIPGISRIELEGDADEQITLALDDAALYRLGVPPKRILDTLARRNQTIPGGFVVVEGKRLSVLPNTEFTDIDAIRATPIELPDGSQVPLAAAAEVWRGPAEPRQPETWFDGERVVLLSIIMEEGSTDAIRFGERIRERLDQVRSDFEPYQIREMFFQPDKVSDRLDDLAWSLVLSVLIIVAVVFTGMGIRMGLLVASILPMVALISVGLYDLGGGVLHQIAVIGMVISLGILIDNAIVIVENIQGHLDEGMRRLDALRKAVGELAGPLGASTGTTLAAFAPLLMAKGGAADFTRGVPVMIMLTLSVSYLLAISAVPLLAARFLRPRKNIHKDRLMGLARSLGGLVYRYPGRLIVAGTLLVAISVGMTPFMAQQFFPNADRPRVIVEVYLPEGTDQAQTSEAAAELERAIRARPETLEVHRFVGFTGPAFYYNLQRAPQAPNRARLVVRTPALEDTTDLVDWIRHELAPTVPELDISAGILGQGPPRTAPVEVRIYHPDDATRARATEQVFSVLRGVTGTVDVRHDLDIGVPSIAINVDDATAARYGLTRADVAQSLYGQSYGVVAERYRQEDDPIPIILRSREGTALSLSRLLSVNTYNDQGDAIPLSAVATVETTWEPAARYLRNGVRVNAVTANLEEGYSFSQALDGLFAALDEQPLPAGTRVELGGDAEGSNDANSALLTAAPIGILLLLFFLLLQFNSFRRVGIILLTVPLATVGIFPGLVLSSSPFGFQSLLGVIALVGIVVNNAIVLLDVMDRELEKGRAIADAVRTAVEQRTRPILLTTATTVAGLLPLAFSSSTLWPPMAWAIISGLLASTVLTLLVIPSVCTKVIKLPVAEPENAPA
>fig|351348.5.peg.3746 Bacteriocin resistance protein, putative
MATNRIGNRQGRSRQALSATPVAPRCGGLSHWPLFRCCLTGVLAGMLSTAGHAGTVLVPGPAGDVPVSVTSFQNQRFSAVFQQEYDFSCGSAALASLLSFHYGDEVSEQEVFEGMWTLADQDKVRQQGFSMLDMKRYLESEGYLADGFRMPLAGLRDQVRVPVIALVTLGGYRHFVVIKGISDQEVLVGDPARGLKAYSWAEFQEHWDGSAFVIRSHLDMGRASFLDRDDWPGLARAPLFKGLGSPALGHTLPYWPSTQEW
>fig|351348.5.peg.4085 Multidrug resistance transporter, Bcr/CflA family
MLALTSIWTTILLAAAVALGPLAVDMYLPALPQIGADFHAGTDQVQLTLSVYLAGFAIAQLICGPLADRFGRKPIMIGGFLLFTVASIGCAMANNIETLQLFRFLQALGGSAGPVLGRAIIRDIYTPREAAKILALLASIMALAPAVAPTLGGLMVGGLSWHWIFIAMGGYALVMAAVTAFGIPEPLKPEYRQPLRLCHLFANYRRISTDASFIGYTLTNAAIYGGLFAFLSGASFVLIDVLGVQPEHFGFYFAAIVVGYIAGNLGSIRLARYLGPDQILFYGLITALAGGAIMALLAYQQVYSPWAVMIPQAIFMAGTGLVLPQCMAGALANFPTMAGSASALFGFTQMTAAAIAGAIVGALHNGTPMVMATVIAACAGLAMIGYLLLVQRHPAKAFETGKASA
>fig|351348.5.peg.4092 Permease of the drug/metabolite transporter (DMT) superfamily
MGTEPAGDGVSDLNATTQNSGQTLAYIGLVLTPLFWAGNAVVARGTVEHIPPLSMSLWRWVLALAIILPFGLPGIWRHRQVIRQRLGSMIALATFSVAAFNSLLYVAAMTTTATNIALINATIPIFVALLAWLLLGDRTRPIQILGIAMALAGILCVIARGDVSVLTGLQAQPGDLVMVAAVFSWGLFSVLLRRQAVPLPALTFLTTQILLGTLILAPVYLVDFLFFSGGFALSQSTALPLIYFAIFPGILAYAFWNHGVHSIGPARAAIFMYLTPVYASVLAVVFLGENLSLFHLVGGLLILGGLILATRTGRRLSRPPVTRLDKGEPND
>fig|351605.4.peg.1168 Multidrug resistance protein B
MAENSRKFRTWIGFLAMSGGTFMAVLDTQIVAGSLPEIGASLGATVKEASWIQTAYMIAEVIMIPLAGWLSRSMSLRYLYSLACALFTLASLLCAFAWSIESIIVIRVLQGLCSGIIAPLLYQAIYLMFPRERQAGVTLYVVMIISLAPIIGPTLGGWITQTLSWRWLFLINLLPGVLVTASVFGLVRDAGPKWDLLKQFDLPGIVLAALFLGCLEYVLGEGRDNEWFDSHLIVFLAVVAAISALLLVWRELACRHPVINLRTFCDRNFATGCLLNFIMGVGLFGSGYLMTLFLSTVKGYNSQQIGQVMMVPGITMLLTLPLVRIVRQYLESRTCLAIGLAMFGFALWTNGSLTAEIGFEHLFLPQVLRGLAIILCLSPITELALGRLSIEAVPNASGLYSLMRSLGGGIGIAVINILAEQRMALHHQRLAEALNPSRFPVGELLDQLEVPFAGSMVDLEQARQGGVKLLAMLVRRESLVMAYNDMWLLVAALFGMMLLLIPVVQKVERRS
>fig|351605.4.peg.1169 Multidrug resistance protein A
MRKFLPLVIALSLLAGGCGFGWYWLSTGRFMEKTDNAYIRSEITQVSSKVSGYVKDVPAEDNTLVAAGDPLVRIEDLEFGVRLELGRKKLEERKAAQLVAYNRSRLQDSRIDACTAQLAAARAEQLKKTGDLRRFGSLFPDGIVSELDYDAVVTAEKKARAETGSAVANLKMAESELAALLAEERRLEAELHQQEEELKLLAKELADTVVRSPITGEVGNRRVRAGQYVKPGTVLLTVIPRNVLWVEANFKEVQLSRMHEGQPVSIEVDAFPGRPLTGRVESLSPASGAEYSVLPPENATGNFTKIVQRVPVKIRFQPGQPLLRELRAGMSVVVSLDTRPGSGSGPAVSRLNRR
>fig|351605.4.peg.3034 Multidrug resistance protein A
MAEEQNGNSRKKKKAFAIVSVIVVICLIATYFYSSYRKTHISTDDAFIDGNIHTIAAKINGTVKSVNVTDNQPVKKGSLLIELDPVDYSVRLQEAASAVGAERAKFSEADTRISAAKATLDLQRANFKFAEIEKNRAENLYQKEVYSRVQYERAMTAYEVTAAQVKGAEEQLRNTESQKLTQSFTIDEKKATAAMAALNYNYTKIYAPVDGYVTKKSVQLGNQIQAGQPLMAMVGSNEIWLTANFKETQIEYIRPGQTVEFSVDSYPGRKFKGKVDSIMPGTGVTFSAFPAENATGNYVKVVQRIPVKIVVTEGMDKKHVLRIGMSAEPTVLAK
>fig|351607.5.peg.1019 Permease of the drug/metabolite transporter (DMT) superfamily
MTQRITGVVLAFVTAVISGVAVYLNSDAVKHFHDQTVYTTAKNGVAGVLLIGIWAAAGWRTGRASPRTGGVGQSHPVGPRRILAFLALAIVGGSVPFALFFQGLAAAQATQAAFLHKTLIVWVALLAVPLLRERVGWPHLVAILLLLVGQALLAGRAGTVAFGRGEAMILAATLLWSVEVVYVKRLLRRFSSHLLAVVRMAGGTALLVAWLALTGKFHQLIALDAAQWQWVIVTGVLLTGYVATWYAALARAQAVDVTAVLVFGAVITALLSAMFGSGSLKVPALVAITVGCGLIAWAALRYSPNARKPVVTASPSR
>fig|351607.5.peg.1669 Drug transporter
MRIRQLLPSTLAGRDAVHRRGLGLAAVCTLLFLTFLDNTIVSVALGDIQQRLSAGVQSLQWVVNAYALTFASAMLLAGALGDRVGERKVMFSGAAVFCIGSVICAVAPDTSVLIAGRGVMGIGAAASEPGTLAMIRYLFPGRRERARATGVWAGVSGLALALGPVIGGIIVGLSSWRWIFWFNLAFGVAALAIAAIVVPETPRVPSRRIDLVGGLLGAGSLALLVFGVLRGELDGFGAAHVISLLVASVVVGLVFLWWQFHASEPLIPPQFLRMPAFVVPNIVAFATYFGTFAVFFFAALYLNIVVGFSGLRIALQFIPMMVIMIAASVLTGRWIGRTGARRPVVLGCGVFTLGLLLTDGALTRHPHYLPLAASLALAGLGIGITVVPTAFAAMSAVPVDRAGVASSAVNTSREIGAVVGTAVLGAIVNSALISHATSTLNALGWSKLKGFVTSAILNGGASLGGPLGQASPEIQKLVNALYDAFAEGLHIALVLSACLVLAAGVLAASVRGPRLAESEETALGHVHLPS
>fig|351627.4.peg.465 Efflux pump antibiotic resistance protein
MERTDEQKINKNILIATTTSSFLVPFMSSAINIAAPDIAKKFNLVAENLNLVITIFLLFSAAFILPMGKLSDTFDRTKIFITGLISFTISTLMCAIAPNITVLFIFRALQGFFSAFVFVTSIAILIENHSPKIRGRLLGINTATVYLGTSIGPFLGGILVRLFGFRSIFLFAFLVGFVASFISLFLLKKEIKVQQHTSLAESLKNLDKIGTIFSIVGLFLLIYGASTFELGKTPKMLFFLGGVLLILFVGFELATQNPLLDVKLFVKIPQFGFSNLAALINYSCTFSASYLLSLYLQIVKALPAQVVGSILILQPISQVITSLISGRASEKIEPRKLATAGMVLTTAGLFIFSLFSSKTNIVLVIVNLIIMGIGFGLFSSPNTNVVMSSVPQSLYGAASSTISVMRVMGQAFSMAIVSFIFSLYLKGAKLSHENYLMILKSMKISFFVFSVLSIVGIVASIKRGNIYNQENSN
>fig|351627.4.peg.962 Permease of the drug/metabolite transporter (DMT) superfamily
MKGRSIKLSTRKRILADGILLFVTMVWGSSFVLMKNTISQLHPLTFLAIRFLLAWLVVTAIFWRNLKKLKPKEIVYGSIIGFFLFLGMALQVVGLKYTYASKSAFITGLTVVLVPIFAGIIERKIPRVNVIVGVIFAFVGLFLLNGAKISHFNFGDFLTLLADFGFVFQIIFIDIFTSKEDVSTINIAIFQLMSAAVLYIIFSLFFGVNPFSIKLTLNSILTILITGILGTALAFTAQVFVQKYTTPTHTALIFSAEPVFGAIFSAIIPSVVTHTTEILPLISYIGCGLILIGMVIAEISFNKNLDMELS
>fig|351627.4.peg.1074 Daunorubicin resistance transmembrane protein
MNLKYKFEKCFYISYYAFKQSSTYWMNNFLSMLSSIIFIAIVYYIWTAVYSSTNNFNFIALNKTITYVCVITIINQIISRNTEMEIGAKVINGNISIDLIRPINFFGYLFFNRVGVVFFNFVFSIIPLIFTAKVIFKIDIVKDISTLVITITSVLLSFILVYMFEFLVGLVSFWTTQVFGVSLLKSSLINLLAGLTVPLTFYPESIQKILINLPFQAMYNIPASIYSGLTYRVNIIQHFLIVLGINSVVKYLLEQIIWIFIFSLITFLCWRIVSKKIVVQGG
>fig|351627.4.peg.1414 Tetracycline resistance protein
MLAYFITVLIKGTAKGLFFPIWILHMSNLKVSLFAIGILGSVLETIRFVTEIPFGAFADRYGRKVSLFLSALLNFIAFFLFSLGNTFCMFLFSVLIMGLADSFESGALEAWLADYLILKGKSDKFEIEIRKMYIVFITGSIIGAVFITFMYKINAILPFIVSAILYIIAALITYFFVPESLQESYNSNSNESMINKIKLSICYIISTKSLFLLSLAVFLFAIGLDGIERFYQTFLKFKKFNIFLISNIYIISAIFSLMFMLLQNKLDSPKKNELLIIGCLKISMFMIVTIAVFVKLNIISYLCLILFFILEVLLRPYLQSYLNRYINSEIRATALSFFQFAEASGEILAGIGIGYFIKVLGISYGLFVSAAFILISGLAVFVLLFFERIYRNVD
>fig|351627.4.peg.1480 Vancomycin B-type resistance protein VanW
MRRYVLIGIVVALLVLAGILGYTLYSNVKQVLNTDRIYKGIYIENTPVGGLTRAEAYELLENTYLEPLRSKKIEVEVDGNEYKLDYASLDIKINIGEAIEQAYSIGRKGNISRRFREIRRVYDHPVVIRLKFEYNEGKLKEFVDELFEKYYESPVNASIRKVGNQFVITPEKLGRKLDYNDLINKLKDMIKNKKEGKVRARFVQIVPRITKNELSKIKEVIGSFTTKFDASNRARSENIRIAARKINGSLIMPGEVFSLSKVIGPVTVENGFKIAKVIVNNEFVDGVGGGLCQIATTMYNAVLMAQLKVVERVPHSALISYVPPGRDATIASGSIDFKFKNTTNAPIYLESYTSQNTVTINFYGKNTHKGEVVKFESEVLEKVPYKKVYKNDPMLPKGVQKLSNKPQNGLKVKTYMLIYENGKLKEKKLLSIDYYKPVNAIILVGTKENTTVNSSVYN
>fig|354242.8.peg.589 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSIFSTLSPFRLFVKCAVPNVISMAFISFYYIVDGIFVGKYLGSDALAALALIIPFIMMSFALADMIAIGSAVQISMHLGLGKKNLTRKIFSSSMLIIFIISCFIGILEYFLGPVLIDCLNVSDEIKTMTKECMFVFALFAPFTMLSFALDNYLRICGKTAYSMVMNVIIALSNIVLDYIFIVELGWGLFSAALATCLGLVLGGIFGIFPFLFQNLELKISSLYMNLKIFKNILYNGSSEFFGNISGSLYSIFANFVLLKISDTQAVAAFSIVLYIDSFIIMLIIAIGDAMQPALSYNYAKKDFSRIKAIIKVVFFAGGFLSLFSIVLILIFGENLITLFTKENNQEFKTFAYTALMLFAFNYFFAWFNVLSGSFLTAFNKASFSLVLSLAQNLFIPLFFLLFLSCFMGLNGVWLSPFFAEFCVLILAWIFLKRIFKDLSL
>fig|355278.4.peg.837 Permease of the drug/metabolite transporter (DMT) superfamily
MSRIFTPELFLVIAAILWGGTFVVIKLALDSVPPFLFLAVRFSLAGFITILLYRKTLFSKANRRWDYIVPAFFVACSALLGYAFQTIGLVYTSATQSGFMTGAYVIFVPLLEIAIERKLPSLRTWIAVVIVVIGLFCISQNGKTYDEFVNEFGFSYGDGLTLIGAFFFAVYIILIDIYSKKIPTQILVSFEILLIAIVSSFLFPVESIFSKQSISIQFDLKFWIGIIYTSVFATIFTTQIQTRYQKAVSPARAGLLYSLEPVFSFFLAYLVLGERLGTVGAIGSLLTLFGILYSEMGKWNKREE
>fig|355278.4.peg.2656 Glyoxalase/bleomycin resistance protein/dioxygenase
MAFQQIQTGIITEKLKETKEFYQTWLGLEIKFETEWFILLCLPNQPEIELAIMAPNQVQVRKPYFQKPYQNAGVWLIFETKEIEQEYQKMKEKKAPIDLTLTEEEWGDVHFTLVDPNGIGIDIVQERNMNS
>fig|357544.13.peg.603 Multidrug resistance protein (spaB)
MDTIKNIPLRTFVLLYKSSPKRVVLASITVLFIGIIPSINILVMIKLIDIVVNLLQNHMHFEYSLLLPTLLLWGALLFLTHVFLGILSSLQTIIAEQFSINIITQLANKLTKVKNLNFFENKDHTIKLNAIHNGLYIRPLNYVSNLFFNLQRIIGLVSLFGILFSISIYLPFIMIFATVPCILISNHIAKKHSASIDELQDQKESMQNYLYSGLDNQKNKDNLLFNFMLNFHHKFIETKELYLNNFVKIAQKNLMLTIYADILITTLSIALFFLMVFIILSKSCGGNCWIYPSV
>fig|357804.5.peg.432 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKSEIFVSVVLIVKNQTDKLINYLDKLSPYLNEQYNDYEVVIIDEKSTDDIEHKLRKSLETHQSIRHIRLSQEVSTDVALAAGIENAIGDFVVNLNILTDHPELVNALLESGLAGNDVVVGVSQKINSFIYRHLRKLSTWLLKSIGYSLPSNSTGTFCFSRRAVNAITESGRFYCKLHLKIANTGYTLSPFLCDDFISNTHKKSLTHGIKETLHHMVFNSTKPLRWMSALGIFGSLMAMLFSFYSLIVHFINDQVAPGWTTTILFMSFLFAMMFTMLSFFGEYLARLLNDRSEHKEYNIVYERNSSVMLDEDRSNVLFTSLGESVNNSQTGRNR
>fig|357804.5.peg.434 Permeases of the drug/metabolite transporter (DMT) superfamily
MKWLILILGILSNASASVLIKVAMSSKEAPIQLSNPLSIIGNLPLVSGIALYGMAFILYALALTYLPLNIAHPILTSGSIALVSSASVLLFGENLSIINVAGIFFIIIGVWALTVN
>fig|357804.5.peg.3489 Permease of the drug/metabolite transporter (DMT) superfamily
MLASFSTFEQAWLFIILSVLMHVSWNLMARQVNPKADFLWWGLLGHLLLLGGYGLYHLVQIEWSWTLTGLIAITAFANSLYFLSLREAYALAPVAFVYPIARSSPILVAIWALWIFDETLSNLACLGILVSIIGLWILGNTVKHKHNPKVLLWTLSAAFFTSIYSLSDKAISQQIDSFSALLGVVTLGYLSAWITLCLYRKKHCETIIPAVCPHLGVWLAGSLFIGTAYALVILAMQTLPTAYVLSMTNIGILLAVVLSILFFKDRVHLKQKIVATLFITSGLLILGIFG
>fig|357808.3.peg.1083 Permease of the drug/metabolite transporter (DMT) superfamily
MQATKVQAHRREQSASKGSSMTPMMLTLILILIPTVTGVAGQLLLKVGMSQLGALEISVAAIPSLIMRIILSPYIIVGLAIYFGGVFFWLLALNRADLSYVYPFASLSYVLITLASWLLLHEAVPPLRWIGLVVICIGVMLVARS
>fig|357808.3.peg.2624 Multidrug resistance ABC transporter ATP-binding and permease protein
MSPLRRSLTFLKPYLWLAFGAFVSLVLAAGANLVTPQALRLLIDQGIAGRNPGALAWLSVALVGIAIIRGVFSFTSGFWSEKASQAVAYDLRNALFAKIQGLSFSYHDRAQTGQLMTRITSDVEQVRTFIGMGLLQLLNAAALIIGCITAMLLMNWQLALLVLLTVPLMAGVIGFFMNVVRPLFDQIQQRLGALNTALQENLAGVRVVQAFAREPYEWQRYGRLNQRLLDANLQSIRAMSLAFPLIFFIGNLGTLAVIWFGGYQVIGGALTIGELVAFNTYLALLIMPLMMLGMIMAQLARAAVSAERIFEVLDVESEVHDRPGARPLPPVKGRVVFDHVWFGYGVRANDHPASDARRPIREEKYILKDVSFVAEPGQTVAILGKTGAGKSTIINLIPRFYDVTHGRVTIDGIDVRDVTLESLRAQIGIVLQDTTLFSGSVRDNIAYGRPDATDAEVEAAARAAQAHEFITALPNGYNTIIGERGVGLSGGQKQRIAIARALLRDPRILILDDSTSSVDAETEYQIQLALERLMEGRTSFVIAQRISTVRRADLILVLDNGRIVAQGAHEELLATSALYGEIIDSQFGGVREEVETVEEEMLNVER
>fig|357808.3.peg.2659 Vancomycin B-type resistance protein VanW
MSAEQVHFSSVADAAEREGFPVTARTRVRPPRRRGDGWLWFALAVITLVALGVAGGITSFYRSYEGRIYPNVSIQGIAVGEMTPEQAESALRSRYAAFLRQPVVITYGDRQWTPTLDELGMTFDFRGAVDAAYNAGRGRGVVDDVRELAAIWQHGLDVPLHVSYDETRAQAYLTQLAREIERAPADAQVRLDGAQIAIVGAVIGRQVLVDATLAHVSQQLQAFVPATIPLQTREIPPRLDDATVAAARAQIETILQGPLTLRVGKNEYEWTVADLADMIIINRVPSAEGDRIAVTLDQDMIARRIRQIADETEKPGTRPRVAWNNGDLKIIKPGKPGLRLDEVRARDMVIAAVMGRDRTLELPMVPTDPPVTEANLHQLGIRELVSIGKSDFTGSAAYRIHNIGVGMQLLNGLLIAPGEEFSFNKNIGQINAANGFVEGAAIIQNRTQQEFGGGICQDSTTLFRAAFWAGLPITERWGHSFYISWYDKYALGPRGNGPGLDATIFTGGPDLKFINDTGAWLLIQAWSNPKTGVAQIELYGTKPNRTVDLTHKVYDHTPAPSEPVFVADPKVPRGTIKHTDKARGGMTIDVYRLVVENGAPRPPELFRTRFRPWPNIYTLNPADIGPDGKPLIPFPQGDQPAPTPAPPPEQPTEPPPPPGVEPATGNQINP
>fig|357808.3.peg.3391 Permeases of the drug/metabolite transporter (DMT) superfamily
MQASSTSSSPERRPAPSWSGIGIALLAHTGWGAYPVLARYLQTVSDLPGMALLGLGNLIALLVYLPFIWRRIDGRILRSALIWGFALVVVLRSITNLLAARFTLAIYIQTITLMTPLFVALLSAGLFREPLPPGTWTAIGLSLVGALLMMSGEIGASGVSLALTASDWIGIALAAASALCLAIYMILVPRTVRHAVPGEAVLLMQLTTLTVTSTGISLLVGDEWERFTTLTSGDWAAFAAFVFGVLLGANLGQIVSLRQLGAPLVSSVMAWRLIATLALAAILLGERLDSWWQALGAVMVMITITGYLWRQARPFVGRLRTENQELRTENREPGTRNQELRTEN
>fig|357808.3.peg.3518 Membrane fusion component of tripartite multidrug resistance system
MSLPILRVAIGMLAVVLLIGAVLMASGRTGVLPATQSAPDSAPPPPVVAPGTQPIVANGIVAPATHVDLRFETGGIVRDVLVREGDVVQAGDPILRLDTSDLELRCAQVRAQLSAAQAQYELLAGPVAPADIQRAQAVLARARAHLREVSGAVTPTARRAAQARLEAARVALARLEEGPNPADVRALRAELRQAEAELRATHDRLSLEKTTLRLQMEQAANVLRDRQTEYARIRDENQARTEPLTADQRVREASARLAMENAEKALEQARVAYEAALQAERTGIAAAEARVEAVKARLDRILAGADADQIAAARAAVAQAEDDLARLQDERRAALVEIARMEVAIAEAELERLLAGARPAEAAIARARVEEARAALQQAELALERATLRAPITGVVAALNIRPGEVADPHLVAARLADVRGWRIETTNLSELNVTRLREGDPAIIRLNAIPDLEIPGRVTSIKPLGAGQEGDVTLYTVIITPDRLDERLRWNMTAMVQITPGR
>fig|357808.3.peg.4219 Bleomycin resistance protein
MQQIAHKMMFRYAIPKFPASDIQASLEFYKNKMGFTEVFDYGDYAAIKRDAVEIHLWECQDKNIAENTACRVAVSDIESLYAEYKQTGVIHPHGTLEEKPWGGKEFVALGIDGNGLFFFEYKGN
>fig|357808.3.peg.4251 Permease of the drug/metabolite transporter (DMT) superfamily
MQPQPHTGYTLSALAAVVWASTAPGLAYLMTQYATPGLTLALWRDLLIALVCGGGLLAFRPSLLHIGRRAVGHLALTGMVSIGIYHALWLWSVTLNGAAIAVVLIYTYPAFVTLGAWALFREPIKKVHLAALALALAGCALVVRAYDPAILRISWLGAMVGLLTALTHTVYVLVGQRNAPSISPWATLAYTMTFGSLTLLALALAADQLAPMTRSYIWAIETPAAWAILAIIAIGPTLGGYALFTLSLRHIPGKVAGLISVIEAPVATLIAVTLLGERLEALQIAGMGMILVAVVLPRLVAQIEGAPQ
>fig|357808.3.peg.4467 Daunorubicin resistance ATP-binding protein drrA
MHAIETWDLTRAFGDRVAVERLTFTAPRGAVFGFLGPNGAGKTTTVRMLAALIAPTSGSAVVAGYRLGEEDQDIRRNVGLLTESPGLYERLSARQNLIFFARLYDLDAARAEAQTERYLRMLGLWDRRDDPVGSFSKGMRQKLAIARALLHEPAIIFLDEPTAGLDPEAARTVREFIKELRAEGRTIFLTTHNLPEADELCDTIAVFRTRLLRIGAPDTLRAELFGSSTRIRVAGDATMFLDVVRALPFVRAAAASGDALTLSLDNPDEQNPILVQALIKAGAAIRYVEPREHSLEDVYLHLVREAEPIGQSHA
>fig|357809.4.peg.145 Vancomycin B-type resistance protein VanW
MKMKQNVLMTVLLCLMVIICVGCNNEAPPKEQDHSLDGALLDVTPSISPESVTATPNADFISEEGKETITENTTPLKPGNVEIDANAILGQFTTHFYNSSKARKNNIVNAAKKIHLKVVNPGEVFSTVGAISPITKDNGYDDAGTYQDGRVVNAIGGGVCQVSTTLYNAVLGAELKVTERHPHSMTVSYVELGRDAAIAGDYMDFCFQNTLETPIVIEAIADPAGSITVRIRGVETRDKSKRKVSYESVILETIEPGPAVITYDKNQPKNYLKVTQSAHSGYKVELYRLIYYQGELIDRILLNTSTYEAAPQYLTIGIK
>fig|357809.4.peg.160 Antirepressor regulating drug resistance, predicted signal transduction N-terminal membrane component
MEGNFKGRKKNALNLKTPSAWIIVAATVFVLIFSIVFATNRANEGIGDHDFYNFNVNGFTLGADIDKMDTSALTPTEPLNINNGYDYNFEEVRYSADENTGRLKKMFVNVYDGAYIPVVTIHTGEAASYIPNNLTTIEQITTIFGQGKKGWQDREQGLRYMEYRQKEGRLSATE
>fig|357809.4.peg.377 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRMKENKDYLLKGTLWKAILMLAIPIAVNNFIQTMYNLTDSYWLGKIGTDPQSAITVVTPIQSIIVNFGTGITVAGAILISQYLGAKDEKNAKSMVGQLFASCMIFSVVCAAICFLLTPALVGWLAGGESFSSMAVTYLRIVILDMPFLFTINIFTAVNQSQGDTVRPMFLNLLGIVLNMILDPLFMLGFGWGVAGAALATLLAKVPCAIIALYSLCNNKKSLYITKESLKIQKDKLKSIAKIGLPTAIGGSTMQLGFLLMTSSVIKYGSTAVSAYGIGNRVNGLVTMPANAMGSAVATIVGQCIGARDQVRAQKAYLMARRIAVIFLFIGGLILSRNTVSEPIVRIFSNDPDVIRLGTQFLQLMAFWCFTNGIYTTTNGLHQGSGHTMINMTIDATRLWVFRLATLFICERLLHMGVQSIWYAVVVSNGISAVILWIIYKMGVWKKQVIS
>fig|357809.4.peg.716 5-nitroimidazole antibiotic resistance protein
MEVFMVNQEYCELTNKEIQSILKHTKWCHLGISDCDQPYIVPMYFSFEPKGNNICFTLLSLRNGQKMRYMEHNQKVCLEFDLQRENYFFSIIVNGTVTICPPIYKNSLLEVVSNQISGRCYMLY
>fig|357809.4.peg.1058 Permease of the drug/metabolite transporter (DMT) superfamily
MPRKTLGHVFALFTILIWGATFIASKMLLTEFTPFQIMLMRFIIAYVVLLIMNHKLHKIIWKDEIMFCLLAIFGSTLYFICENIALTYTLASNVGIIIALAPILTALLAHFTTHDERLHKGIFLGFFVAFIGVVLVVFNGTVLLKLNPMGDILSLLAAVMWAVYSTLLKRCVHKYDGIYLTRRVVFYAILTTLPLVIKENKYFPLETLKEPKLFLSLMLLGILGSGICYVTWNYASKWLGIVVTNNYIYLNPFVTMVAAGVLLGEPITIMGLLGSALIIGGIIISDRIKSNKNIENKNYEIGKEL
>fig|357809.4.peg.2201 Permease of the drug/metabolite transporter (DMT) superfamily
MRNSTKAYLAITLQSLIIGFSFSVVKVALNSTDTIGLLAHRFTVTAISVLLYKFFKPNSISVSLSDWKKVAPFGLAYPVVFFLFQTLGLTIITSSEAGIVYAISPILTFIVARIVLKERANRPQTVFMILSVLGVIFINTMKGFNIGNYSYLGFLFILMSVASFSIYNVFIKKLSKGYSAMTIVYVVSICGCVIFNLVSVIQHLVVGNLGAYFKPFTNLSFVLSILYLGVIASFISSILSTYALGKLEATTVSLFNNVATVVSILVGIVFLHEQLNYYHYIGIIAILVGTIGFNLLKSPQKDINK
>fig|357809.4.peg.2374 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQLDLKKDSTRKLFFRYLLPSISATLVTSIYILADSIMIGKGVGPEGIAALNIVLPLFTLFFGTGLLFGVGGSVLMSIANGSNDSLLGKQYFTTSVLSVTFISIFLLIIMQLGFKPILYFLGATDVTFTLASEYGRTLVAGAPVFMFSALLQAFIRNDKDPNLSMIGVITGGVTNIILDYIFIYIFHWGMFGGAIATVIGSSITCLILIVHFFKKTNQLKLVKNGFSMKRFSKVVTSGLASFLIEISNGIVTFLFNIQLVKYIGDIGITVYSIIANSSFIVMSLANGVAQASQPILAINFGAGERKRVDEVKHLGFITTTIIGSIIVALGALFPGVITGLFVHATDEILSLAIPAIRMYILAFLFMNLNIFISGYFQAVMKPQYAMGVNLLRGLILGSAFVLILPLFIGANGIWISMPIVETISFAVALALNYKMKKVI
>fig|357809.4.peg.2400 Multidrug resistance ABC transporter ATP-binding and permease protein
MKRLYIYLRDYKKECVLAPLFKMLEASFELIVPLVMAAIIDTGIEHGDKSYIVNMCLILVGLGIIGLVCSVIAQFYSAKAAVGFATKLRHALFAHLMNLSFNEIDTLGTSTMITRMTSDVNQTQTGVNMVLRLFLRSPFVVFGAMIMAFTIDTKSAWIFLIAIILLSIVVFGIMAISIPMLKRVQKNLDSVLQITRENLLGTRVIRAFRREEKERREFYQRNGELTRKQKRAGFLSALMNPVTYVIINIATAYLIWVGAVQVDYGALTRGQVIALYSYMSQILIELIKLANLIITVNKSVACANRVADVFDITNSMENVNNGILNLEKEGSIEFRNVSLEYQGAGEESLSDIDFTVKKGQTIGIIGGTGSGKSSLVNLLPRFYDVTKGEVLLGGKNIKDYPIKELRDNIGIVMQKAVMFQGTIESNLYFGKNEAGIEEMEEAIEIAQATDVVNAKGGLEASIEQGGRNLSGGQKQRLSIARALVKKPEILILDDSASALDYATDARLRSAIKSLSYQPTVFIVSQRASSILYADLILVLEDGRLVGKGTHSELIDNCEVYQEIYYSQFPKEVKAL
>fig|357809.4.peg.3254 Teicoplanin resistance protein vanZ
MTGTNFIPFHTMMSYLKNSDNLNSSIIYTNIFGNLAAFAPMGFFLPLLFQKLRKFLPFACVMFLTIAVIELAQFITNLGVMDIDDLILNLSGASIAFFLCKLPFLMKIFQRFHWIS
>fig|357809.4.peg.3821 Daunorubicin resistance transmembrane protein
MKYIRHQFEVMKAVALVTYKEWSAYRTHSMVSIFVGPVYFIVQYFIWTSAYGGKAEINGMQLSQIITYFGASTLIGYLTMDFADWNLQMLIQTGKFLTFSLRPIHHRFFAFSQKVGHRFLGLLFEFIPCYLIFSLLFGVEMIPKRIGWTLLSVAFAFLMNFYVHYILGMTAFWFIQSSGIRRVFDLLSGVFSGAFIPLVFFPEAVQRVLFFLPFPYMSYVPAMVFTGEFHLAGINMPIPTIVGLQGIAVGVVIILSELIYKASMHHFNGVGV
>fig|358681.3.peg.65 Permease of the drug/metabolite transporter (DMT) superfamily
MRYILLVFLGACSYGILSTIVKLAYKQGYSPAEVIGGQMFLGFVLTWIPALFFLRTKPPLRQLLLLVAVGLTVGSTGMMYYNALQYIPASIAIVLLFQFTWMGVLIEAVMTRKMPGKETIFSLLLLLTGTLFAGGIFESGGLAQFHILGVIFGLLSAVSFTLFILFSGKTAISVNPWLRSSSMATGSFLLASLIYPPAFLFNGALLDGLFPYVFLLAFFGILIPTVFFNYGMPHIGPGMGAILGAAELPMAVLSSYVILNESVSILQVSGVLIILLGIILPEWLRQRNIRRNKVTS
>fig|358681.3.peg.221 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNERLLFLMLAGVVTLWGLNVVMVKYLTTFPPLYVAAIRMTVGGICLSPLIFLYRKSLRFSKTDWFLLAGVGASSIALHQITLAAGVQYTTAGNASLILGLNPLATALLAMLFLGEGMSLKKGLGIGMGFAGVLIVVISQHGGLHMNGWGDAIMFFSMLMYVTGGLLIRKLVVRGVPVLLITALSQTFGVIFLWGVALTVQPASYYFSLDVSSFQWLVIFASGALSTALGSVGWNYGIRQLGASRTAVFLNGMPMASLVFAAIFLGESLQLVHLLALCMIVGGVYLGSRSLVRPKATCAAAPSDITTKA
>fig|358681.3.peg.452 Multidrug resistance protein B
MWPLTTLYVHTILQRSMTEAGFVLMIQSLAGIFGQFIGGSLFHRLGAKRLIVGALIFQGLIQFSIPFVQSWPAYLILMMGLGFTFNLSFPAIQAFIGFRWKEQRRELFNIVYVGNNLGMAIGTALAGVIATLSFQLTFWFNSTSTLLFALFFFLFMKNISHQELVGENLEEQQKHHVKNSFTLLFRYQLYLFMALGAALIFFSNTVWNTGVAPYITEQGMPLSSYSWLWTINGIIIFAGQPITSWIKRLLNQSLSAQLVVSAIAYAVGFGCMLVYHGSYYAFVVGMVITTFGEMLISPTIPTFISEKTGENAPFYLGVVGAITTGGRLLGPLAMGFMYDHGGIHPTLFLATLVSAGSVLLCLLHAYFHRENRAEVAKY
>fig|358681.3.peg.696 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKVLSALFCLAALWGASFLFIRIASPVLGPFLTIQGRVTIAAIALLIYTACIGRSADFQSRWKQYLILGALNAAIPFMLIATAAIHLNASMSAILNSLTPVFSALVAWGWIKETLTLGKWVGIIVGIIGVAILVGWSSIPLTFEVIVAVGLSILSTVSYGFGGVYAKKALAGVPPLSVAVGQQIGASILLIPFTLFNLPTSMDSLTPAAIFSVVGVAIFCTAIAYPLFFYLISNAGPTKTQSVTLLIPLFGMIWGVVFLDETITAGMITGLIVILGSIFLIYDIRPQPAKNKPSQKAG
>fig|358681.3.peg.702 Permease of the drug/metabolite transporter (DMT) superfamily
MNPLYVGVLYIFGSAAGFGVMSIFAVYAYEAGVSVSTLLFLRFLLATALFFGLLLWRKESLRLDKRQVLAMFCLGGILYTLQSLSFFSAVQYIPTSMAALLLYTFPVFVAILSYFVEKERLTKKTVIAMLITLVGLGLVLGLSFGGIQPVGVLLALAAALFYSVYIVVGNRVVKGVSSYVTSAYIALFATISTFFIALKDGGVDLSFAVQGWWAILGIVVFSTVVAISFFFRGLQLIGSTKASVLSTLEPVVTFGFSALLFGEAFSLLQLLGGCAVLVGAALIVSGKGGEPELAPKQASS
>fig|358681.3.peg.760 Drug resistance transporter EmrB/QacA subfamily
MQQLTEKKKVTIMIAIITAMFFAAINQTIIGVAMPRIISKLGGMDYYSWAITIYLLTSTVASVLVGKLSDIYGRKPFILTGIALFSIGALLSGFSTDIFQLITYRGIQGAGAGIIMSTAFTAMGDLYEPRERAKWGGIMSAVFGVSSVLGPLMGGYIVDHLDWHWVFWIFLPIGVIAFLLIMIHFPKVPKQEGESVDYFGSLFLTLTIVPMLLAFSWAGNGPGKHAWGSWQIIGLFASTIIALIVFIMIERKVKTPVLPLGLFKNSIFTVSNLVGFFLNAGMMGAIIYVPFFVQGVKGISPTMAGYVAMPMSIAMLGTSAIAGQIMTKTGKYKKMALGGLLVMTFGMVLMYFMSPTTPIYLLVIYMIILGLGIGIAMPVFSLTVQNAVAPQQLGVATATSQLFRNLGGTIGIAVMGTVMSASMTAKMTQLSGAMGQVNNPAAADPALAEKLSLFTNPQNLLDQPKIEAALASLPPDLQPLFTHMLDMIREAMSYGITTTFLTGAIVAGMAVIIALFLKEIPLRSGKMGQKPEGEAGKA
>fig|358681.3.peg.842 Permease of the drug/metabolite transporter (DMT) superfamily
MLLVLSLFTEQVHMESMLTANAILSLLYLVFVGSMMGHSIFYWLVAKTNPVFPSTWLYISPLIALSLGVILYNEPLYLLSLAGGITIIVGIILINMDGLKQLMGKKANKLRDVSN
>fig|358681.3.peg.897 Probable phosphinothricin acetyltransferase (antibiotic resistance) protein
MLQIRDAVLSDLPAMLAIYNYAVENLVATFDLEPQTLAQREVWFHKHGGRHPIIVAEYEGNVIGYCSLSVFREKPAYQKSTELSIYIAPDQSGKGVGTTLMSAILERARQLEYHTIVSGIVGGNDASVKLHEKFGFTLAGRFQEVGFKFGEWHDVHFYQWMVK
>fig|358681.3.peg.1136 Antibiotic resistance protein
MDGVRYKMREVLDKSKIETFLQQARIGHLGMVDGHLPYVVPLNFVWTNGKLYFHGATGGRRNQVVDANPEVCFTVCEEYGTITDPVPAKTDTAYMSVMIFGKAEPIVDLDEATHMLQEMMNKYVPGYYNRPLPKQHVEKYRSAVFGGPVQVYRIDPQHITAKENPIEEEKMFNPGKTV
>fig|358681.3.peg.1144 Multidrug resistance protein
MSKMRQVLEAYHPIVHLLMAGTVFVQLTQSMSIPFLAIYLGETTKLSHAYIGLIIGAGPLAGTVGGFVGGILSDLFGRQKLMFFSLLAMACSMIGFITLAHPIGLLVISMVMGLAASIFATVSKALMGDLTPEQKRFRVFSNRYLASNLGFAIGPMLGAFWGISGSNLAFVLTGVSLVSFAVILVVACRRCGVTDNSGENGEVERASLGEIWQVLRRDVVLLTFVTGGILLVTVYGQMSVTLSQYLRENFSEGVALFGTLMSVNGFTVLLLQIPVTRLVERYSLFARIAGGAVLMAIGEVGFAFSSNWVWFITAMIVFTLGEILIIPAEYAQIDEISPANMRGTYYGAQSATMLGSFLGPWAGGMVLTAYGGPVMFGVMGVLALVSLIFYWLGRRMHEQRKQPRNAIVETAM
>fig|358681.3.peg.1181 Permease of the drug/metabolite transporter (DMT) superfamily
MTGKKDSKLFGVTIALLAVYLFWGGTYLGMKIAIESMPPFIMAGARFFLAGSILFLIGRWKGAELPSAAEWRGAGIVGALLLLGGNGVVAWAQLKVPSAIASLLIATVPLWILVFNWVGGSKKKPTVGVMGGILFGLAGIAVLVVHPESSGNQGIDTVGIFALLFASISWAVGSLYSRNAKLPASPVMATALQMIIGGSLLGITSLFLDDWTKLHLSEITLRSWIAFGYLVGFGSIVAYTAYIWLLKNAEPSLVSTYAYVNPIVAVFLGWLIADEQLTSQTLIAAVMIIAAVAIITMFREKKSPGATQTIARKEKGKLQVHK
>fig|358681.3.peg.1196 Methicillin resistance regulatory protein MecI
MSTSMPSISEAEWRVMNVLWEKSPLTANEIISSLQGQTDWNPKTVRTLLNRLVQKNAVGVNQNQRVYTFYPLYSQNECQHAEAQSFLQRIYSGALKSMLVQFIQKESLSDEEIQELRSILDAKQSSTDPHQK
>fig|358681.3.peg.1390 
MKRKLVLYVILLLIVAGGGGIGYYYWYQGAHYVTTQDARIAGDIYRVMPKMTGKLTGLAVKEGDTVIADQIVGQQDTSNVATTMLENSVLRSPITGTVIKTQAKEGEIVSTGQSVALVIDESKLYISANLEETEIERLKLGQKVDFTIDAYPGKKLGGHLMEIGKATNSTFSLMPAANTSGNFTKVTQRIPIKIAIDDTAGLDLVAGLNAEIKVHVKEM
>fig|358681.3.peg.1392 Membrane component of multidrug resistance system
MAEAVAHREEKSGNGGMWLSLVAILSGTFVAILNNSLINVALPAMVNIFGSSTETMQWVLTGYMLANAVMIPMSGSLSAKFGAKKIFVLSLSAFTCSSILCALAWSDSSLIAFRVVQGVSGGMIMPIGMSMIYMIVPREKIGMALGIFGIASMTAPALGPTLGGYLIEFLSWQFLFLVGVPFGIFAVIMSIVLLKETPKKPELKFDFLGAFLAIVGFGTLLLALSKGQAEGWTSFFIVSLFFIAVMSLILFVWVELGKESPLLDLRLLKIPTFTISILTSGFVMMGMMGGIFLMPIFLQNIQGLTAMESGILLMPQSIAMAIMMPISGKLMDKYGVGPIGLVGLTIMSITTYELHNLSADSMHSWIDMILTIRGIGIGLCMMTLSTVGMNAVPRTSVGDASPLSNVLRQVMSSFAIAILTVIMQARQNFHMASISDNLNTDMATQFISGISGMYAQVGVDAASATGGASAILYGMMAKESLVQGIGDTFLVSVIPIVLSIPLLYFLHKKPKKTQQQVPATEKATA
>fig|358681.3.peg.1559 Drug resistance transporter, EmrB/QacA family
MGAHNRWLMIAVGLGIMLNPLNSSMISVAIARLQNVYRLDFTVVSWIIFSFYIASAIAQPVMGKASDLFGRKKIFLIGLVVSFVASLLAPLSPNFGWLIVFRIVQSIGTSMMVAVGMALVRIHITEKQATALSVLSIFLSGAAAIGPFIGGVLLHYWDWSAIFLINIPFVVASLLLAWRMIPNDESAASVTQNMSFRKWLELIDATGIVLFAVGLVALLVGLLSAKSSGHVSWWHIMVGGIGFVTLGAFVRHELKTTSPFIPLRTFAKYPAMTWVNIEFMLVNVLFYSLFFGLPSYLQMVRHVSEFHTGMLMLSLGLCSLIVSPLAGRWIDHSGPRPALLASAILMTFGSLWLVMFNQDSQVVSVCVALAAFGISNGLNNVGMQAALFKSSPKEIIGVASGLFNTSRYLGTILSSLLISIVMGDTFSTEGLQVLGMILTTISLSLVLMSWRRESRQAGES
>fig|358681.3.peg.1788 Permease of the drug/metabolite transporter (DMT) superfamily
MADITLLLVAVIWGTTFLIVQQAIASLPPNTFNGVRFTIAALFLLIIYFIRNRHRGQTSEWRGPLLRAGVILGFWLCLGYALQTVGLLYTSPSKAGFITGLAVVLVPLFSFLLLRERVKPFAIFGVILAAFGLYLLTQNQSFSFNLGDALIFVAAICFAMQIVFTGKYAPRFAALPLAITQLGTVAVMSWLYAFFFEDWSRAFDPAILFIPEVAFGLIVTSIFATALAFLAQTALQKQTSSTRVALIFALEPVFAAVTSYVFIHEILSGRQLTGCLLIFTGMILAELPIQEWVRNFRQRKPNDGRESA
>fig|358681.3.peg.1971 Multidrug resistance protein
MSIFTQMTKQQRIGLLFVILILFIDMLLYSLLIPIVPYFTEKLQPSSTMMGVLFSSYAIAMLIATPIFGPISDRMGRRTMLLIGLLGLAASTLLFAFSETMGLLITARFVQGIAAAATWPTALALLADLFPSKMRGTVMGIALTAISTGTLLGAPIGGWLFEISDHRMPFLAAAAFTVINIVLVYLFLKEDATKTVSEKLHVGGFIRNPQVIFIAGIVLLAEISLCLLEPTLPVFFTEKLSMTPTTIGLLFGVMTLAYGMIAPVAGSLSGRMNPYKLMFGGIMTLAVFLPFLAWADSLWQAMLAMALIGASIGFTLSPTLGTLGAIIDQGGSGAYGTAYSLFNMFHGIGMVAGPLAGGILTDLLPVSSALLIVAASILGFGILLFVQLKASKSTSLSIKESEMKF
>fig|358681.3.peg.2615 Multidrug resistance efflux pump PmrA
MLIRSGFSLGLLYFLTYLITDPYLFLVLRIFQGLLAGYVPAAIALVATNTPEKSVGYALGIMATSGATGGIIGPLVGGVVSHVWGNAEAFIFSGFVVLVAALIATFFVKETNLNRSGSRSSVREDLRAAMANRPLMSILGMSLMVTISVMLLEPLLTVYVMQLGASQQDASLSSGIIFAAVGIATVIAAPQWGKLGSNIGYSKILFIGLMGGAVGNLLQFFFTNLYGFGILRFAYGLFFAAVYPSINAMIVKVTEPEFRGRAFSLNQSSTQLATMMGPIIGGFLGGLIPIRYVFIINGIALLITAIVIRSKRSQLIGQPLKQQTTEHQLATK
>fig|358681.3.peg.2655 Transporter, drug/metabolite exporter, EamA family
MHRVKEGTIMIRSYLLLLFCVTLWGSNFVFGSMLVKEFPPLFLADVRLLFTSMFLIIYAWLAKKFVKITARELGLLVLLGLIGTLANQTAYFNGLLTTDATTASLILSLSPIVTAVLASLFLKEQFTLRMKIGSGLALMGTFFVVGIGAGLSITKGVLLIVIAMVAFSSSMIIIRKLTQTIQPFIATVYSTTVGTLFLTPAAMLTIEPGAQISHEVWAWAMLILTAILMQGICGIVWNQQLKVVGTGKAAIFLNLQPFVAMLVGFLLLGSQVTSIQVGGSLLIVVGVIVASVQKKQAVQPSKSV
>fig|358681.3.peg.3102 Drug resistance transporter, EmrB/QacA family
MSRSEKRNRFIIFAMALGLLMSSLDNTITSAAISHIIKDIGGFESMSWVFTSYVLAATSTMLIFGKMSDLFGRKLFYLLGITIFLIGSALCGVAQSIEQLIAFRALQGIGSGALFPITFTILFTLSSDPKYTARISGVFAGIFGLSSIAGPQVGTLLSDYLGWRWCFYVNVPIGLLSLLTLLFSLKESRSQSKPKIDYLGTVTLIVSCIAVMLALEWGGKAYEWSSWQIISLFALAIIVGIAFILVERHAQEPILPLQIFKNRMVVATCIACLSQGAIMFAAITYLPIFAVAVLGYPNSNSVLTPLMLSLTGGAVVFGMLQTKFSFRSLMAFSMLASVVSSILLMYVSTGISFFFLTLLMILFGFAAIGPLMSVAQNAIVHSVDKPYIGISSSIVGFCRNMGGVLGASITAAVVNQNYASIVSTGASLHGISLEKVADLLNPEVLMREPLKIEPSIHSFLSDSLGTAINHGYIVGLIFAVIGFFSVLYAGPGKLERHQKSVES
>fig|358681.3.peg.3673 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTTSPLLPQIGAIFVAVSDIERARDWYCRLLGIPADGEIMFGHIYCIPLQSGLTLVLDSKNFPNRITDDTLLFHFNTQDIEASYSFLKESEVEVVTPIQHGHWFNFRDPDGNLIMVSQC
>fig|358681.3.peg.3895 Permease of the drug/metabolite transporter (DMT) superfamily
MKHAFQLGFTPFEMSGSQLIFGGLIMTVMAIFFSKQRFSFKYLLLLAPASLMMASTSLFYHQAVSRVSASLAIVLLFQFTWIGVLLEAIVDRKWPTAEKWVSLAMLGAGTVLASGLSESGIQSVDMVGLIFGLMSGATFALVIFFSGRILPGMDPYLRSAISISMAALMLSIVYPPTFLVNGQLLQGLLPLGLLVAIFGSVIPIFCLAVGVPRIGNGLATILSAVELPTVVLLSSFVLQETVSLPQWGGVFMILAAICVPQVKWRKLFSPSHDLEQERM
>fig|358681.3.peg.4089 Antibiotic efflux protein
MKELWQQRSFRWYWLGMFLSSLGDQFGWMGLTWFVMKKTGSPAAMGGVVLAYMLPAVFAGLVAGVLLDRFDRRKLIMMDNIARGLIFIALVALLQVDQVPLFVIYVLIVIAGILSPLSTAGAQTLLPRIVSDKNQLVKANGVMETQWQIVYMFGPALAGVLIGLIGEAYVLLIDAASFFVCAFCFSRLPRELTKSANPTTIVKGQMGVFFRSLWSDMRTGYRYLFGRKQLIILVFFTFLFNMSYGPIEIALPLYANQDLAGGSVALGMLWSALAIGALLGSLFFSTVTWKLPLGSTLAGIIVAWGLTTLPIALFSRLEIAMASMVVAGFCFAPYNIMYRSYLQKQVPDALLGRVLTSVRTITGTGMPAGAAVSGVLIPFLGVQGIIGAGAAVCIIFGLLAFGALKNLEDSSSLPIEER
>fig|358681.3.peg.4151 Multidrug resistance protein B
MRQKWESYPSSIRLLAIAAVIFSTGMACIWPLVTIYIHNHLGKPLTVAGFLLLLNQGAFLIGSIVGGMLFDRWGKMRTIIVGSIGVILISLGLGVTEDFTIYVVLLLLNGLFYGLLSPVMNALAVVLWPDGGRKGINLIYVTLNVGVAAGSALGGFLASVSFAWTFFGNAISQVIVLAMFMLILPRQLKMVEQQRQNSTTGQSMPEQATDDVLRQPQQEPKVVWGALLLLCGGLLISWIVYVQWTTVLSTYMQSLGISLRQYSLLWTLNGGLILFGQPLIAWVIRRFARTLKAQMLLGAYIFALSMLILSQSTAYAGFVAGMFIMTLGEMLVWPAVPAVAAQFTPEGREGFIQGLIAGTGSAGRMLGPLLGAFIFQSIHAQGLLFVMASLCLLSVAFFAFHTSFHKRRHHVPVQNQAS
>fig|358681.3.peg.4787 Permease of the drug/metabolite transporter (DMT) superfamily
MSTQLPIEKQVLPKEQPITSDQLHTEKMGLLYGFIGVLSFSLTLPVTKMVVTVLSPLSAGLGRALVAAVLAALVLLLKRVPFPTWQETKKLFLVSAGVVAGFPFFSSWAMERVPATHGAVIIALLPLATAGAAIFFSGERPTRKYWISSVIACVTILAYAISSGFGALQWADLALLGAVISAAIGYAVGGELSKTMGGWQVISWSLIFAFPFLVVPLTGPLLTDLKQATWPVWLGFGYISVISMFLGFFAWYHGLAIGGVSKVSQIQYLQPFLSIIAAWLLLSEPLTLGAVLSAVIVVLAVAKGRKASVQQKA
>fig|358681.3.peg.5675 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MKMGASSLTSNNDMLLLKFLHYFTNLPIMVGLALYGLSAFIWIAALEKVQLSYAYPMAALGYVLVAVLSFLIFNEPLSLTRIAGLAIIVVGVVVISQS
>fig|358681.3.peg.5702 Probable multidrug resistance efflux protein
MSTEGIWSTHYRALTIGIILVVTATAFEGLAVTTIAPGLSRELQGEDLYGWVFSAYLLAQLIGTVVTGQFVDRKGPAQPFIVTIVLFALGIVVAAIAPDMLTLLLGRVMQGFGAGALVNCVYTMITLRYPDSLRPQILAVFSSAYILPGLFGPYVAGIIAEQLSWRYVFWLILPFIFLSALLTTPSFRGLQPPKASAANNLSLLLPFFLAIGTGALLFGLGKIPSIYGFLLSIAGLLALSVPLYKLMPKGTLVARPGLPAVMASRGLFVAAYYGTQTYLVLGLTSILGLTADKAGLAVASAAISWSVAANVQAKLDKKDQGAGRKKRMIIGLVIMLIGVACTVPLTLIQQDLFGIVVAIFSQIIMGFGIGLAHPTSGAIAFSLAKSGEEGKVSAELSIADTFTPAIVIGMGGAIVSVMTAFAFSLSVGITVSLLLQTFIVILGLASATRLATGSVPVQEKGDTLG
>fig|360106.5.peg.1274 Broad-specificity multidrug efflux pump YkkD
MHLLALLLAGGCEVLGIVFLNKFSHSNGIRKIVNFMFIVATFGFSLSLLRYAMQVLPMSVSYAIWTGIGAIGAVFVGVVFNHEKLGIKKYVYLFLIVFSVIMLKLI
>fig|360106.5.peg.1275 Quaternary ammonium compound-resistance protein SugE
MSNKGLFFVIFGAIVEGGWAYGLKYADSNLEYLITIILICCSFFSFMAAFKYLPASVAYTLFIGFGTLFIVGTEIISDYFRGSSIDFLRIVFIFTLIIGVLGLKRSES
>fig|360106.5.peg.1647 Permease of the drug/metabolite transporter (DMT) superfamily
MKKSVIAEILLIFVAISWGMTFVPVAEAIKSVNVFSFLFWRFLIATIFMFVFCIKICKFDKKSIYYGLFLGFWLFCGFAFQTYALKYSYSSTVAFITGLSVVLVPFLMLVFFKQSVNKFAFGGALIAFIGLYFLSGTGEFGLGKGEILSIICAVCYALHISFTGVLVSKCNIYAMVICEFFAVTILSFFGAILFESGDTNSLFQGLQISFETEFLMALIVCALFATVFAFFVQSYAQIYTTATKTALIFTLEPVSAGLAGYYIANEILSVTQVLGATAILFGVLFSEIGSNLIKQATLKFEN
>fig|360107.5.peg.800 Nitroimidazole resistance protein NimB
MRVKMRRQDRNLTDIEAFEIIDKSQFAVLSCFDFRNEPEIFTIPILIVRRGKSIFVHGAKLGSKAEIFKDNTPVSFVCVSYAHVPEHDISYLQDIKKDYKRLAGEVFTTEYKSVVAKTKVYKIKNENKKIEILKLLCEKYTPKYMDFFATAAIPALSKINIYEFKIYELSAKAKIL
>fig|362242.7.peg.2004 ABC drug efflux pump, inner membrane subunit, DrrB family
MILLVPVLVITLMYFMFENAPHRPGTQTPFNNACLILLGLFPLVVIFIITSFTMQRERASGTSERVLTTPLRRLDMLAGYGTAFSLAAAAQATVACIVSFWLLGFDTAGSPVWVFVIAVVNAILGVGLGLLFSAFARTEFQAVQFIPLVMVPQLLLAGIIVPRAVMPTWLEWVSNAMPASYALEALQQVGAHPELTYIALRDIVVVVVFAVASLCLAAATLRRRTP
>fig|362242.7.peg.2271 Membrane protein, MMPL family, RND superfamily drug exporter
MNKSTLAGTALAVTAAAGSGSIASPPRTSDWYARLRKPSYQPPSVAFPMVWTTLYSDIAASSAVAIDRLNATGQRDKARRYIGALSINLVLNAGWSWLFFRFHRLGASALGAAVLATSSADLVRRTADADRRAGLAMLPYAVWCAFATVLATHVWRLNR
>fig|362242.7.peg.2628 Multidrug resistance protein B
MILTSQLNNGENASGASKAEILREHRPGVPLDQPVLHELSRAYSVVFVVAVVLAVLAFIPLAFLPKWSALTALSQTSSLERTPEPDAAPHGRQSPPEDTRPGAGRNSSSNDLTPSGPDG
>fig|362242.7.peg.3019 Drug transporter
MCTLATSDGPLIAVSLASGEVPGALLQPDGPPRVPGIGDTLIRTMTIGSQRGADVALGLAQVVIRPDTSAVGLLEFHQIDAAREAGRAAARESMPQIMALLNQRR
>fig|362242.7.peg.3020 EmrB/QacA family drug resistance transporter
MSGVSISSFEKVTSRHSKRPGATPARTHLAGHARKGFANLTHRRQPSSAAVLLVAAFGAFLAFLDSTIVNIAFPDIQKSFPSYDLGSLSWILNAYNIVFAAFLVAAGRMADLLGRRRTFTFGVVIFTIASGLCAVAGSGEWLVAFRVLQGIGAAVLVPASLALVVEGFEPARRAHAVGLWGAAAAIASGLGPPIGGMLVDWASWRWVFLVNIPLGVVAVLATSRALVESRAAGRRRKPDLRGATLLAGALGLLTLALVKGPDWGWVSVPTLAVFAASAITLVGFVLSSMAAPVPLVEPAYLRSRPFVVGNVLTLVAAAGFYCYVLTHVLYLNYVWGYSLLKAGFAIAPAALVAAVVAALLGRVADRHGHRLIVTLGALVWAGSLFWYLQRVGTEPDFLRRWLPGQLLQGIGVGATLPVLSSAALTGVAKGGSYATTSAVVSTTRQLGAVIGVAALVILIGKPEHGAAADALRRGWAMAAICFVVVAIAAVLLGRTNSKPGQELEPEPAAAARAAPTTTEPAAALIANRATDEADLLGNLPLFAGLDAAALAELADRVEEVELQAGSYLFLAGDASDSLYVIRRGRVQVLHGDIVIKELGRGEVLGELGLLIDAPRSASVRALRDSRLVRLTKAQFDQIANRGVLAALVRVLATRLREAPPPAVHTTSPGVVVSLVGVGADAPVQSVAAGLLTALSEQLRVVDPGRVDIDGLDRAERGADKVLLHAGAQDTDWRDFCLRVADRIVLVTGDPDPGAAALPARAQGADLVLAGPTASREQRRSWEELITPRSVHAVHYRRVVQDLRPLAARLAGRSIGLVLGGGGARGFAHLGILEELEQAGVAIDRFAGTSMGAVIASLGASGLDAATADAYAYEYFIRNNPLRDYAVPIKGLVRGRRTLTLLEAAFGDRLVEELPKEFRCVSVDLIAGNPSCTAGAGSLMWLDVRYGCLESIRRRSTRVGCMGMVACWTTCPCAPWQRRTAR
>fig|362242.7.peg.3206 Multidrug resistance transporter, MFS superfamily
MLLCVVPLNQIPMDAYTPALPQMETSIGTTATALQSTVTVFMIGMALSYLAVGIMSDSWGRKPVLMGCAAALTVTSLACAAANNVAMLLVLRFLQGGACSAFIVIAIAIAADCFEGARLRSVNVLLGADWSAAPILAPAVGGFIVEYASWR
>fig|362242.7.peg.4643 Glyoxalase/bleomycin resistance protein/dioxygenase
MGRIGVSSTSIGHVRLTVTDIERSRRFYESVFEWPVLIELPANADEATRRQLAFLYGGVIYDLGGALLGLRPVANDSFNENRVGLDHIAFRVGSIDELNSAAAHLDDLGIAHEPVKDIGPSYILEFRDPDNIALELTAPK
>fig|362242.7.peg.4736 Probable antibiotic-resistance protein
MTIDAWMQHPTQRFLRSDMLASLRRWTDSSIPEAQIPIEATIASMDAADVEFGLLSAWRGPNGQDLVSND
>fig|362242.7.peg.4845 Drug resistance transporter, EmrB/QacA subfamily
MSGIRVSMNRGNVRPKLVLGVIVLGSFIASIDLTIVNVALPTLSRALQASNAELQWIVDSYAIAAAGLLLAAGNLGDRYGRRGWLTIGLVIVGASSAVAASAGSAQAVIGARAVMGVGAAIIFPTSLALVTNVFVDSTHRARAIGVWSAVTGIAVVIGPILGGWLIEHFSVGSVFWVNVPIAVVAIVSVNMFVPTSRNPDRPPLDLPGLLVSTVGVTVLTYTLIETPNIGWASARTAAGFALAVVLLAVFLWLERRTWHPILDLSIFANRRFSGGTAAVTTAYLVMCGFIFVATQYLQFVAAYRAFDTGVRLVPLAFSYAGLSVIAPRIVERVGTTAVVTSGLVMVAVSVACAGGFDAGTPYWLIAAVMAALGSGLGLTMAPASEAIMGSLSPTAAGVGSAVTGVARQLGACLGVAIVGSVFASVYLRSMSSNAALHGLDPAARAAMRQSMAAAKQVLDQLPVGEAPAIRHAVESAFLESFGVGCLACAVFAAVGAVVVAFLLPARGEVRDDVAVSVAASAIGPAEGGK
>fig|362242.7.peg.5531 Drug transporter
MLAAPDGALITCEGDHGDTYYVILEGAAQVLDDDTAVHHLGPGEGFGEQAILRDVPRTATVRAVGDTTLVAVDREAFQRARR
>fig|362242.7.peg.5719 Multidrug resistance protein
MTSGSAPQWLTRNLRVLSLVSLLQDAASELLYPLLPIYLATVLGAPPSVVGAVEGAAEGAASLTKIVSGPLGDRFARRPLIASGYGMAALGKLIVAAAGAWPGVLAGRVVDRLGKGLRGAPRDALLVDGVDPAQRGRAFGFHRTMDTLGAVIGPLLGLAGYELFDHQIGPVLYLAVIPAMLSVLLIAWVREPPRNLAKAKPASILDGTRRLPRRYWAVVSFLVLFSIANFPDALLLLRLKQIGFSVVGVIMAYVGYNAVYALASFPVGALADRLGRPVVYAFGLVLFAVGYLGLGITTDTATAWALIAAYGLFTACYDGVGKAWISAIVSAELQSSAQGVFQGLSGFAVLAAGLWAGFLWGVDGRLPLLISGGAGAVFALALLAAAAGTRRRAR
>fig|365046.3.peg.105 Permease of the drug/metabolite transporter (DMT) superfamily
MPHQRKQHLDTLAITLLIACCLFWGFQQILIKATVAEVPPLWQAALRFAGATALLGLWCVVRGVPLFARDGTLRAGLLAGALFTGEFACIYLGLRDTTASRLTVFLYTSPFVVALLLPRFVPVEKLRGAQWVGLLIAFGAVALAFAEGFAGHMVTPRQLRGDALALAAGTLWGLTTLVIRSSAMATASAEKTLFYQVAVTAAVAPLLSLALGETWSLGYSARAWGSLALQTVVGAFASYLAWMWLLRHYPATRMSSFTFLTPVFALVFGVALLDEPLTAQLVLALAGVAVGIVLVNRKPAG
>fig|365046.3.peg.2660 Phosphinothricin N-acetyltransferase (Phosphinothricin-resistance protein)-like protein
MQPIACTEERHAGAMLDIFNDAILNSTALYDYRPRPPQSMAAWFATKRQNGFPVLGLEDAQGTLLGFASYGTFRAWPAYKYTVEHSIYLHRDHRGRGLGRLLLQALVEAAREREVHVLVGAIDAANAASIALHEKLGFSHAGTVRQAAFKFGRWLDLALYQRILETPREPRDG
>fig|367737.4.peg.802 Acriflavin resistance A precursor
MIKKSLVAISFLFLGFNSLIADEAKAPNEAPGLPVQTFTITKQNNTTNKTYPTILKAYEQVDVIARVSGILKEKHFKEGDFVKKGTLLYKIEPDTYLANLNMKKAEYTKAKKDYERAKSLIATKSISPQSFDDYTYQYESSKAALDEAQINLNYTTVTAPIDGIVGIKQHDIGDLVGSSSNNSLLVTITNTNPIHAEFSLPKDDMNKYLSQIKDKSAKIKLITDGKTYENGEIDYIAPVIDTNTDTLLLRAKFENANNELIVGNFTKIEISNLSLGDVFVVPENAVLKTVQATIVFVVDENNIAKPRPVVTGDLVKEGMVIKSGLKPNEQIVTSNFAKLRPDTKVQIVNKEK
>fig|367737.4.peg.978 Acriflavin resistance protein, AcrA/AcrE family
MKKLLLIQLLFINLFATTLELDGMVESENEKVISSKMMGYITKINVNEGDKVKKGDILYEIDASNISYNADILKNQVKNLELNLKRYKNLLDQDLVSKYDYEQLELNLISAKAKLSELNAQYDYLKIKATNNGLIVKKSIKEGEMAMPGMPHMILTDLDSLIIKTNIAESMLKDIKLNQEVKITIPSQNYESIGKIVAIFPNIISNTHSFTLKISFDKKNFNIYPNMYAKIFMQIGSNDEQ
>fig|367737.4.peg.1528 Permease of the drug/metabolite transporter (DMT) superfamily
MNEKLKGILFGIISAICYGTNPLGALFLYEEGLNTNSIIFYRFFLASILLGLLMVFQKKSFYVTKREIFILAILGVLFGISALALYSSFLYMDAGIACTILFVFPVFVAIILAIFFKERISLMTAISIFLALVGIALLYKGGDIKLNFIGVMIVLFSALFYAIYIVVSNKSSIFMSSIKLTFYVSIFCTLTIFIYSLFDSSKSIELLTTTNMWLYALMLAIVPTILSLIFLAKAIQIIGSTPTAIVGAFEPLTAVLIGVTIFDEKFTLQISIGISLILISVILIIIGKSMSLEKIFTTIHKVKYTFLRYWRWK
>fig|367737.4.peg.1829 Acriflavin resistance protein
MYKLIDYFYKNSQLNHTILVFFLILGIFSYINIPKEVFPTTQLEKLDIEGSYSGASAESLNNFAVSEIENQLNSISGLGKITSYIYSGFFSINIELQDGVDKTIKLNEVKDAVSLAKRYFPSDMEEPNVRIMDEEWSLLSIALSSSKYNQRELLKIADNLKNSLMQIKNINKVRNFGDADLQIELALDNKKINMYGLNSSSVIDAISQLSYIYPVGNIEQVGDHVYLSAANNKFDSKFWENSILKIDGKKIYLNDIANITIGYPKKETISRLNGENTLTLRVYKNKNGDSIKLTKEIKELLKSTEASYEDITLVVSRDNSKLINERLNTILANITLGLILVGFAMYILISPRLSFVIILGIPFSFIIGLLFLEMMGYSLNMVSMMAMLIALGIVVDDAIIVSENIQRHIDEGYELDKAILKGTKQMIGPVIIAGITTVFAFISMLFVSGEMGLFIKLIPIVITCLIVSSIIESFLFLPLHAKHILKVNEKQLDWTKVYNFYENILHKVIEHKRSFLVIFFITIPIISIILIKTSRFQLFPDIDSSNIEIAVKLENSIPIEITDNIAKKYEKALLDNAKELYIKNITTTIGLYVDIADNEEEIENAFILSVELEEFREENFVENYINPILNFSFDFERSDKVRLISSNDAMNMIRDLINPLLKEDNAVDYNIISQKMGIDSTDIEILLNSYDTSLLVQNIEKLKEKLKNINGVKDISDNTILGQSEYKYIVNAYGRQLGLTDSDIAKAISSFFLEREQANTFNEDGIIKIITKSINKDSIKELKNFYIPLENNQFVQLKEVVDFKIERNFNEMQKINGQIYKKVMANVQNDIVNATEVLEKLEGTIEDIKKSGIQINFGGEKEKSDKLALDIIKAFLVSIFLIFITLLIIFPSFKSTFVILSVIPFTILGPIIGHFIMGINLNSQSMIGMLGLAGVVINDGIIMLNFLHHTRTKKEFFENAKLRVRPILITSITTMLGLFTLIFFPTGESIMLQPIAVSLGFGILWGTVLNLVYVPALFATLYKIKD
>fig|367737.4.peg.2167 Drug resistance transporter, Bcr/CflA subfamily
MKKRLINFKFILTIALIEVLCYMAVDMYLASMPNIASYFGTSYSKVQLTLTFYLFSMGIGQLFFGPIIDYFGRKIPLILGVLLYSLCSILITLSTNIELFLLFRIIQGLSVALIYVCIISMVRDVSKGRVAANIFAILITIGAITPILAPTFGGYIEQEFGWKTVFYTLFSLAILLSIMSFFTLQETLKEEKKVKINFKNIFIIYFKIIKDRKFLTPAITACLMYMFVFAYIAGASFAYQEIYKLDSKTFGLIFGLTGSALLFGALLSTKLLKVFNMKQLSISGAFILVIGSIISFFSANITFIGFDGIVAGFFISFFGLGLCEASLFSMAMSSQEKSVGATAALLGSLQLLLPASATLVAGYLVEISIIYWLGIILFLGILSFLFTYIVFNNKKL
>fig|367928.5.peg.650 Permease of the drug/metabolite transporter (DMT) superfamily
MADAGQESSEGISVSKPVARVMMLVNAAVWGSGYTMLKHVQENMPTQWMMFFRMASAVLLMAIVFFPRLRRIRLRRYIVPGLILALTYWLGFIFQLKGLETTSPGRNSFFTDTYCVMVPFVVWAFTRKRPSWQHLVAAFVCAFGIGLVSLSGGGGAELMHMSFGDAMTIIGAFFFALNLVLVGFIGKDFDAIALMLAEFVWCALLFGAGAVLTEGGPSMAWARWDIVLCIAYLVVGSTVIAQVFQTIAIQNLPTSEASVILSTECIFAMLVSVIFTGETLTVPSLCGFALIFGAILLSEIQLPSAKRQRGTTEGD
>fig|368407.6.peg.250 Efflux pump antibiotic resistance protein
MEQEESKSYSRRFILILVTVATFLNPFTGSAINLALPAIGGEFSADAATLAWVTSAYLLASVIFLLPAGRLGDSRGKVTVFLAGIVVYTAGSLLTILTPTMDLLLVCRFIQGMGGAMIYANSVALITHLYPPGERGYAIGLNTTAVYAGLSLGPFLGGALTQFLGWRSIFIVTALLAVPVLFYAGKFPAFLNERQREHFDVAGLILSSALILCLFLGLAWVTTPTGATLLAAALVLGAVFFRVERGRQNPLLPVTLLEKNRVFAASNAAALINYSATFAVGFLLSLYLQYIRGYEPVAAGTLLLLQPIVQVFVAPVAGRLADRMQPGLVASVGMGITAVGLFGFSLLGETTPIAAILALLVLLGVGLGIFSSPNTTAIMGCVEKRYYGSASAMVAMMRSLGMMLSMGAVLVVFAVIMGSTTVTPAIFPEFLASLRLIFLAFAVLSAFGVLLSLRRNKC
>fig|368407.6.peg.496 Multiple antibiotic resistance protein MarC
MDLITEIAGFVGLTLVAVASITAVMNPASTTAVFTALTEGMTPDERRQVILTTVRISFIVLAFFALTGQLVFSIFNITVPAFQIAGGILLVTVATGMLGSRGESYQAGDLENIAIVPLAFPLSCGPGTITAVILLTSAGASSLIAVFLGIAVALVISYVGMLYGPRIFAFIGEGGLRVVPKLMAVIVLAIAIQFIISGIAEAMPQLLSNVDFGGDAGTE
>fig|368407.6.peg.533 Tetracycline resistance protein
MTTEKPHRLRTLRNRIAASPDAILVLVVLVIFMDMMIYGLLIPVFPQYAPRLGVGESVIGIIFGIYAGMLLLFSIPMGLLSDRVGRRPLIVAGMLLLALATALFGFSTTITHLVAARTVQGVSAAATWSAGLALLADTCDPARLGEKMGVALSAVGVGTILGPVAGGLLFEYAGYTATFLIPAALAASVGLAVLAVPVRTCRRESGPHRSPMLPRGSLLSLAACAVVIVAVSGTYGVFDPYLPVYLHAVFSASPATIGVVFAVLAVAAILAQPAAGRIFDRYGGSRYLIGGGLLLAGGATVAAMQAGSLPLTAAAVFVLGVALSCALVPTMPLLADIYRDHGSQGAAYGMYNTFFAIGLSAGPFAGAVLAGRWPLPAIFLGLAAFLGVTGILSGLAFGRLTQR
>fig|368407.6.peg.1356 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLFGGLLAPVTLVYSLPGTPAATAALLLNFEAVATTLIAATIFREWVSRRVWVALGCITASCLLLTWNPAAGLGLSLPALGILLTCLFWAVDNNLGQRLSAKDPLLVISVKGIGAGTVTLLVALTAGEHLPATATAAAAMAVGFLCYGGLTSILFLLALRGIGAARAGSLLAVSPFFGVLFSLLLFAELPAGAFYVALPVMAIGAWLMISEEHSHPHRHPGVVHEHRHRHDDQHHDHDHEAGDPPLSAAGEHSHVHAHAELAHEHPHQPDIHHRHLHRR
>fig|368407.6.peg.1700 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPTSDSEDDTPASSNQTEGTKILLADPKTAILRLSLPMMIAMTLMTLYNVVDAFWVAGLGADALAAVGFAFPLFIITIGLASGLGTGGEAALARTIGARDRAGASSVAMHTLLLMTVLAVAVTIPLYLFAHDIFVLMGAGDAVGLATEYARILFMGTFALLFGEVAYALMHGEGDAKRTMYAMAAGAVANIALDPILIYGLDMGIGGAAWATILAEVIAAVPMVYWLFVKRDTYISLRFREFSPDAAVARNVLGVGLPAAAEQLALALMALILNGVIVLIASTDGVAVYSVGWRVVSIGLTPILAISSAVVAVTGATYGARAYARMETALRFAARLGLGIGLGLAVATFAFAPRIAALFTAGDTAGIAPELTTYLQVMSLVYPMVGFGLFSASFFQGTGLGARSLTITVLQNVVLSILFAWIFAAGLGLGLSGIWWGVAAGNAIGAALGYAWARRYSAGLQIRQAGATAA
>fig|368407.6.peg.1835 Fosmidomycin resistance protein
MTVDTKPVWGLSAAHLVTDLYSPVLPAILPLLIAEQGYSFFLAGLIVTVYNLTSSFVQPLVGWVFDTRGFAVHVGTSVAISAIFISIVGLLDNYFLVLASVAVAALGHAFFHPSALGTVSRLASDSIRGRITSYFVIGGNLGYAIGPICAGVAVGLMGLPGLVVLAVPGLVMAVVLRRILPAPDRAAVPKMPAPAAKPSYRAIVLLIAASGLRAWAIFGSVAFLPTILTMRGIDLVTANILVSGMLIAGVVGQVVGGVLSDRYGRKEFTIIGLVTAIPPFVIFLTTGGILSLAALMVFGFILWSTFAVTVAMAHEIAPGNVGLVSGLMLGLAVGVGGMGVSVTGWIADMTTLTLGLATIPLAIVLAVPLFLLVPYPWKSLVRGRLPSRG
>fig|368408.5.peg.1210 Daunorubicin resistance ATP-binding protein drrA
MYVVEARDLRKTYVSRKRRGLFRVEETRVEALKGVSLTAVKGEVLGILGPNGAGKSTLVKILATLLLPDSGYARIMGFDVVSERDEVRKLIGVSLSVEKGFFYKLTGRENLKYFGMLYGLDGKALEERVNEVLRDVGLQPYADKLYEEMSLGMKARLSIARALLTDPPVLILDEPTLGLDPVSARRIRSLLTSLAHSKGKTVLVTTHNMFEAEIICDRVAIISEGRILAVDSVDSLKKRVADSVFLEIRIAGLAGLQVQNVLRNVPGVEVRTAHRKGLGDKVVVSVPVAHAEEAFERVLHELRSAGLKVRSISIVEPSLEDVFIKLAGHRVSSP
>fig|368408.5.peg.1496 Daunorubicin resistance ATP-binding protein drrA
MRVAMSGGAVVAKNLVKVFRTREGGALFRGKRREVVALQGVSFEIRPGEIFGLLGPNGAGKTTTIKILSTLLLPDSGEAWVNGYSVLEEPRKVRESIGVSLYSDRGFYWKLTGRENLEYFARLYHLERGYARRRIEELLKLLDLEKDADRLVEEYSTGMKSKLNIARALLHDPPVLFLDEPTIGLDPNSARKVREVVLELKKSGKTILLTTHNMFEADMLADRVAIINKGRIIAVGSPRELKSRISGKQVVEVEVAGRPEEVREKVKSVQGVLATSLSAGSGNPYAGTLRVVYEGDGVLREVLSAVLDSGAKLLSVRTVEPTLEDVFAFYTGGGLEEN
>fig|368408.5.peg.1544 Daunorubicin resistance ATP-binding protein drrA
MLALVAEDLWKVYGSGERRVEALRGISIEVREGEVVALLGPNGSGKSTFMGIAAGVVRPTRGRLLVYGGEPYSDAGVRGRISYMPQDYGLYAELTGIENYEFYAALMEVDAKEAKRRLEELSGLLGLGEWFYKRRVSTYSGGMKRKASLALALASNPDLLLLDEPTSGLDPNARREVWGVVDGMRRSGKTVVLATHLFEDAERLADRVVVMRGGEVVAAGSQEDLKRKVGYKYAVDLELREEPGAELLERVRMLGYEAIPAGGSRVTVLGNSPNLLDEVEAIGGAGVVSASMRRVSLGDVYFLLTGVRLE
>fig|368408.5.peg.1629 Multidrug resistance protein
MFGVVCVSRKAETQSGERAEPRASTGGGRAEKVLVAYGLASSFAGNLVSPFMALYLYGLAGGRFFQAGIASQAPVAVSVIMGLFWARLSDTNGSRKKFVQLSLATGSLASLALSFASSINDAILVQILGAFTGSAGGAAFSALMAEVFKDKRGSRLGVYNASTVIGGFAGSMLSGFLYNWIGFRWMLRLNALLGVLPLVLISMIPEEGNRNPVSSRKLVSIPKIPRRFWKLYLARLVLSLPGALSGGVFSVYFVKYLNGPPEAWSTLVAVTTLFGLASIPYGRLADRLSTREMFVLAGLGWTALYLGYFLSPNYLVFSLFFVIPVWPAFWLAYSKALMDLSDESERATFYAFEGTLSALFGSAVGVAAGLVADLYSPRTLFLLSSASALLGAAVAGVLLR
>fig|368408.5.peg.1743 Multiple antibiotic resistance protein MarC
MVPLSVALADTLFKSLFVAVQLYAVLNPVSVIPTFVNLTEGLDSREKVHAVRKASMIVFSLMVVFSLIGDPLLRLLNVSIASLRLGGGVLLMVIAVDMLSGMSRTKGLESGDEALVVPIATPLLVGPGTITTLIVLSASEGLPVTLLGALLATLLVYATLAFGESLLELLGRNFVRSLGRFMAIIIAGISAEMIHRALLEWGIATR
>fig|368408.5.peg.1937 Permease of the drug/metabolite transporter (DMT) superfamily
MHAKKGFYLDNNYRSSVLGEVFALVAALSFSGAAIFYRAGVRGSQVNPIVLSGLRGMFALALLLVVGFFYRVDFSKPPVFYLAVFLSMLGSFILGDSSFLYGLQRAPLGVVYPVAYTFSVFTALFSHFILGEELTLRDAVSSLLIVLGVALVYSENFSLGKQALVGALAGLSASVSWGAGATLMGLALRWGNAVEVNISRLSMLVIATLPLILKNSSEVFRQVRVHLLALGGILGIGVGPLLFMNSISFIGASRSSIFISSTPVLTVLLSRIFLGEKTGGKLLLGTLAVSAGLALQSL
>fig|36870.1.peg.157 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MLNFKKLSIIIPVYNEQDSLIELIKRTVNTCSKLKIKYEIIIIDDGSNDKSINILEKEALKQNSKIVAIFLKKNYGQHSAIMAGFKHSSGDLVITMDADLQNPPEEIPKLILNAEKGYDVIGTFRQNRKDNWFRKISSRLINIIIQIVIGKSMKDYGCMLRAYNRNIINSILEYNKKNIFIPILANTLSKNIIEIPVLHYEREFGCSKYNLIKLIKLIYDLFFCISFNLIKKNKMFNIFIILIFLAVLMSIVFFFIFFLKIKLNIFYKILFIPIIITLFLIKSFIIIILKILIDIFFVKAKKNSIYYINKIIKNNFSKKKDVT
>fig|36870.1.peg.440 Multiple antibiotic resistance protein MarC
MDKYLSNIILLFFIIDPLGNLPVILSMLSSFEAKKKRLIILREMLIALILMIIFLFYGEKVLFIFNIKMEIISISGGIILFLMSIKMIFKENENNVIKKEKKAPFIVPIAIPLLAGPGVFSTLIFLSDKNVNKSYEILLSLIIAWTFSLIIFLFSTIISNFFNEKRSNEIERLMGLILIMISVQMIFEGVKNYFLIN
>fig|369723.3.peg.208 Antibiotic efflux protein
MPFMVTSSVPLGRPFWTFWSAATLANVGDGIRLAAFPLLAASLTANPVGVAAVTAAQALPWLVTGLLAGSLADRRGARTLLAQADLARVVVLGVLVVAVATGWASLPLVLLASFLLGIGETVRDTAAQTALPGLVPERLLERANGKLVAGEIVGNEFVGPPVGAALFVAGAALPFAANGASLALAVMLLLTLPISVAARPPQGTPKQASPGVVAGLRWLARHRVLRTLALVTAAVAAADSAWFAILVLYAESRLSVGATGFGILLAAGALGGLLGSSVVDRLVAGTGTA
>fig|369723.3.peg.663 Antibiotic transport protein
MATAQPKLQADPHGARRNEWILVVFTGTTNIADAVARIALPLLAAQISRSPIVVTAVAAIMSLPWLVAALHIGVLVDRMDRRALLMAAEIARMLSVGALLVAVLTATPTLLLIYIAALVIGLADVVAGISGVSIVPSAVPKHRWETANARITALEYLFNGFAGQPIGGFLVAIGFGLALSVTGFAYVVGAILLLLLVGNFKVAAPPTTHKRSVNKDIREGLRFLWQHRLLRTMALLIAIMAGCWAAWLALIPVYAVGGPLGLDERQYGFLLTCLGAGGVIGTVIVGPVNRWIGRRWSMFTDIIGAFGLVAAPALLPAAPSSAWIVGAAAFVAGAGGTMWTVNSRFITQSLVPADMLGRFSAASRLVAWGMTPVAAILAGILAQIFSYRVAFGFFAVLCVLLIYPFFKVVTRERIAEVDGPTGAPATPAPRGEQDGNTGTTDDGEDLPETATTGGSR
>fig|369723.3.peg.1666 Regulator of antibiotic transport complexes
MAWGTSSPWRCAARASDSVAGTEGSRKRVGTQPYRRCGTLSHVTTEKRRAPAGAAVLRGEITTAIRRAVLQELAAVGYGRLSIEAIARRAGVGKTAIYRRWSSKVDLVLEVVVAAVGKRFPLPDTGGLRGDLELVFLIMTRALGHPLAAQIIPDLLAEAARNEQIAQTLQRVLRDNQRDIGGQVVGRAVSRGELPPDIDLDIAVDLIVGPLYWRLAVSRTPLAVEELPGLAAAVAAALGVASQPAVPSELGVPLPGTVTRTDTGQS
>fig|369723.3.peg.2254 Tetracycline-resistance determinant tetV
MAEATAVTATARRFRPQFSFAPLRTRGYRLLFAAELVSVFGDAFHAVALPFLVYQFGGGARDLGLLVAGYGLCRLVTTPLGGVFSDRIGPWRVMLISDLIRILFTAGIVVVAVTGAGGMFGVAVLVAGTGLGAGMFQPAAYAITPRLLPAEQLQAGNGLHSTATFAAGMIGPGVAGLVVIALSPAVAFGVDAVTFAVSAACLAMIGGMGRAAAMPLAAPTGGGGSPQHESGDGTPPSDPTIGFWRLLRESALLRTVLLVTGAANLTVGGMVRVGLPSLNNDDFAAGAGGLGGLLAAFTAGSLVGGLCSAGLAGLPRRGATAMVSGLVLGGAVALVPFAGYLGAVVALSVAGLASTVTNVLVITIVQQNTAPHLLGRVMSAIVFAALSLFPFSTIAAGLVIDAYGSTAIFLGTAAALLAAFGYGFTRRELRQR
>fig|369723.3.peg.2371 Antibiotic efflux protein
MRALVSARLGADFTKLWTASAVSNVGDGVTMAAGPLLIASITTNPALIGGAVFVQQLPWLLFALISGAYVDRLDRRKLVVAVNTLRAAALTALTLAVATDTTTVALVYAVFFLLGTGETLADTAAGAFLPAIVASDRLATANARLMATFTIANQFVAKPLGAWLFVIAAAVPFGVNALTFAVAAALVATIRPIPALPPVAPRRSLRMEITDGVRWLFGHRLLRTLAVSMGLANLAFCAAFATLVLYARQRLGLSDIGYGFLLTTFAVGGLIGTVLAPRLQRIVGTGTLLRAGLVVELVTHATLAITTTPLVAAAILIAFGIHTMVWGVVVVTLRQRVVPTQLLGRVGSVYSLLDLGGAALGSLLGGLLAGAWGLTTPFWVAAAVMALIAAATWRPLRTASAT
>fig|369723.3.peg.4109 Antibiotic efflux protein
MTLGRNFAKLWWSQGLSNLGDGLVLAAVPLLAVTMTRDPLLVAGMTVAQFLPWLLFTLPAGALADRIDRRLIMVAGNLVRAVGFGLLVLTLVADVRSIAVLYIAVFLAGTAETLVDNAALTVPPRLVQRSDLERANGWLFATQSAINNFVGPTAGAALFAMSAVMVFSSTAGFFALAALAAIMLPRMMPTASDSSGDKHTPGEVVRSIREGWSYFWNHRLMRRVAFISGSINLFSSATGGLLVLLATGPLGVPASWYGLFIAVPAVGAVLGSLIAARVVPAIGGGPVTWLAALVPAASYVVLGLSGSIVLSEVAMFLAAVATALNQIVVSTLRQAAVPDGVLGRVTAGYRLIVLGAVPVGALLGGGLGRWLGPETTFVVCGVGLTVAAIVFASRVTTRALREAEEVARTAAREPAA
>fig|369723.3.peg.4319 Quinolone resistance protein
MPVRSSGPRRATDPRKRREPRSPVPPTEVDLWEATVLESESTLTCQALYSARLTGQDASSVTFRQCRFRGADLAECRLDQVVLSDCLVTDSSWANLRADGGEMARVRLAQCRMTGVTWADGVLRDVTVTGCRVDLSAWRMTTFDAVRFEDCNLQGADFTNADLRGATFRGCDLTGAVFHHASMEGTRFRGCTLAGVGDFSSWRGAVVDHEDLISLSYGLAQAAGIQVEN
>fig|369723.3.peg.4349 Drug resistance transporter
MVQHTITPPSSPSSHRRRLPYRYWVAIVYVLGLFVEIMDTSIVNVAVPALAAEFETTPNHTYWAVLGYLLSLALFIPASGWIGDRFGSKRVFLVALALFTVASALCGLAQTLDQLIAFRILQGVGAGMLTPVGGAMLYRAFPQSQRAKAATAVFGVAVLAPAMGPVLGGLLVDTASWRWIFYINIPLGILTMALAATVLVEHREPHAHRFDIAGFVLGGAALTTTLYGLSLGPTLGWTSPTIVAALICAPLLAVAFVMVERTRSEPLVQVALFKDPMFRIGNIAGSFLSGGYLGLIFLLPLFLQGPQGQSALHSGLILLPQSVGALVSSQIAGRWWYRHYGPRPLMLYGALLAAASGVAFLAVGADTDPLVTAALLGLRGLAIGPVFIALQTATYATISPAATGQAVAIYNTQRQVSAAVGIALGAAWLTARTPNSAEAVDTVSAFHESFVLVSILLLVGALISARIKNADARATMDPPPEPPTHTAGEESDRTAQLSVHAADGAGAHPPRSST
>fig|370438.3.peg.866 Vancomycin B-type resistance protein VanW
MPPSKKVLILLLFLVLQSGAGIIGAAVALDSKYTDVIQQGVTVKGIQLGGLSRAEALLKLQNALPPLPDQNLTISNEERISFINLHELDGSYDYLSSVNEALSYGKTGGALNRLISVLRLKAAPVDLKVSINFSEGKLSEKIKSIQTEWDTPPGDAEIKLVNGSAAIIPEKKGYRLDFEKTLERARQALARGDLAIAAAGQVLEPAVTAADLEEIRILLSEYVTFYDPGDQNRAHNIAVASAAINATLLKPGEIFSLNQKLGPRLAETGYLKAPVYIGGRLAQDIGGGVCQVATTLYNAVLLADLAVVERHPHPKPVAYVPIGLDATIAGDYYDLKFMNNLSSPVYLSSTAEGGKLTVRIFGAVKKEGCSVRITSESTAIDPDIVTYHDDTLPEGETRIKHLGKAGYKAWVYRELIVDNQVVSKTLISSDYYESEDRVIVTGKKAKENPPGDEDK
>fig|370438.3.peg.1057 Acriflavin resistance protein
MRVTELAIKRPAAMTMVIMFFIVLGLVGYSRLSSDLFPKTNIPFVTIVTTYPGAGAREVESQVVDPIEEAVSSIPGLKRTTTTASEGMAITILEFTMSTDSDIAAIDAQKAIDSVLYRLPKDADKPIVQKYNMNAQPIMTIVLSGNRPLPSIYSAAKDIVKQQLETTPGVGKVTLVGGQEREIQVLVNRAKMEGYGLSINQVVNRLSLENINMPAGELKQPSTDFTVRLLGEYRSLSELEEIRIPFPGGSVALKEIATVKDGLAEATQYARLNGRQAIAVIIQKQNDASIVDTSEAVLRQLEQIKKQLPKDMELVVTQNNADFIKGALDDTKRSLLEGVLMTGVVLMFFLREWRSVFTVMLAIPTSIISTFLMMYFAGFSFNLLSLMGLTLCVGILVDDSIVVLENIHRHRTMGKEPERAAIDGRLEIGMAAVAITMQDVVVFMPIAFMSGLVGQFFRQFGLTVVFATLFSLFVSFTLTPMLSARLGGNGGRAGLPDSIPRLSNFAGRFSAFGRRSVAAYRRLLLWSLGHRRAVAAAVAGALVVSLGLIFTGAIGSEFMANPDQSKFTINLELPAGTPLNKTDEVVRRFEERLKNMPEVKYYLSMPGKSSDLFARGTNNAQIEVTLHPKNMRSRTVWQVADEVRGWKHDFPGLKLTVFEAVMVGTDQLGSPIQLEVVGPDEEKLAALAAKVQEIVEKTPGAVDVRSSWKATGQPEVQVTVDRLRAASYGLSAAEIARAMRASVDGDIAARYREEGKEYDIRVRLDRVNLTSMADVGEIKIGNAAGRLVPLNQVAKIELGSGPTTISHLNRQRLIVISANTKDRPLGDIAGDINAALAGLKIPEGYRVQFYGTQKDMEETFSDLIKALILAVTLVYMILVILYESFLTPLVRMLSLPCGAIGALWALFITGNTFNMMSLIGLVMLDGLAAKSGTLLIDYTNTLMKRGLTLREALLEAGTTRLRPIVMTAATMVGGMLPTALALAEGSEYRKSMAIVIIGGLVTTTLLTPVLIPVAYTLLEDFKGWLGRKWHLKKERFLQKKVRKPDRDTGTGA
>fig|370438.3.peg.1202 Vancomycin B-type resistance protein VanW
MLPVKITRIIYGLLIAAAVVIPLVLFSSGFFAAVSKRVLPGIEVMGISLEGLNKAEGLARLAELEKELRATRVLLRYQEDSWPLLLNEVGFNLNEEEIMEAALSAGRSGPLLQRWQERKRFKKTGLSLKPVIEFDREKLAGRVNELAAKIIVKPRDASFQINSDDTVTIIPGSNGIGVDLGKLEEDIINVLSEGKKREVNLSLTTVPPARSTELLESMGVKGLLASYTTSFDPSKTSRTYNISVAAKAFDELLIRPGHEVSFNKVVGPRSSEAGYKTAPIIVNNEFVDGLGGGVCQVSTTLYNCVLLANLDIIERSNHSIPVSYVPIGRDATVVYDAIDFKFRNNTGDYLYVKSYVSNGHITFKMYGNTAYKRDVSVNTWIVKEIEPKTVYETDPNLPKGEQVVKQEGSKGFIVAAERVVRKNGVVEKREMLPSSDYSPVNKIIAVGVMERAVPQIAPSTPAPSPVRLNEQVSGSQGNAAVTGPAGPGGSDGDQAPASGSGSPAVMVIPGSKPPAGGGDAGGSRAPGGWSAPPERNGASP
>fig|370438.3.peg.2912 Fosmidomycin resistance protein
MTALSGHGFRQIRGTKMNKKTLTILGVGHAVTDISQSAVPMMLTFLQPVLALSHLQVGVVVLALNLFSSVIQPAFGLFSDRRRMAWLIPAGCLLAGLGMALVGFSPGYIFLLAAVMVCGLGVAAYHPEGSKFARLASGSRRASGMAMYTVGGNIGFALGPGLATFFYEAAGLRGTAGFLALNGLMAALLWIYLSEIAPAVPKNSPAGPVNPARGKAGDAAGMSGVALVFPVVLLILVIVMRTWVHFGIVTFLPQYFVNYLHHSNAYAASVVTLFLLCGALGSTVGGPAADRWGLKNIMIVSTSLVIPLLYLFPHVSGIWTLIVVALTGFVLISTFAVTVVFGQELLPNNIGLISGLTLGFAIGMGGVGTTFLGWLADRWGLPVVFKVMVLFPVLGLLLIAFLPGTGALARRKRALSGGE
>fig|372461.16.peg.282 Multidrug resistance-like ATP-binding protein Mdl
MEIFKKLKWYFFQEWKKYIGTIVILICITLLQLLPSKIIGITIDLILNNKISTYNVFLKLLKIIFISIIIYILRYFWKILLFSTSYNLTSELRKKFCKSLLKKDFYFFSKYKNGDLITRITNDIDRVVFSTGEGILTIIDSIIVGFSIFFMMCIQTNWKLTVFSLIPMPIMAYVIKGYGIQLYKNFQKSQKYFSLLNNQAQDSLNNIKMIRNFGLEKSEIKKFSLINNLVKKKDFQVSKIDSKIEPIIHNSIALSNLFAILGGSYLISKKQITFGQLTSFILYLGSMIWPILAFAWMFNILSRGKVSLKRIYEIIEMKKKKNKKKEYNINYNKNNLKIKIKKFYYPNRNKNSLKNIKIKIPNKTTLGICGPTGSTLFDIQRYFEIPNGYINYNKQNIKNIPIKKWRNIISIVNQQPFLFSDNILNNISFGNSKATFKEIKYAAKLACIHSEIKKLPKGYQTNIGEKGIKLSGGQKQRITIARAFLFPCKIFILDDPLSSVDHNTERKIIKNIYKHTKKYQLTTIVITHRLSILKKFKKIIVLKNGKILQKGSHNKLLSENNWYRNMYNYQKYKI
>fig|372461.16.peg.283 Multidrug resistance-like ATP-binding protein mdlB
MFIALKQPMEIFDQKPISSIVTKITNDTESVKEFYETILSSFLKSIILFSMILISMFILDWKMALISSIIAPSIILIMIIHQYLSKPIIKKTKLLISKFNNTINEIINGISVIQQFNQEKKFIKKINNINNNYYIYKIKTLKIDGLLLRPLLNIISSIILSSIIFITKAFPNKILEMSILHTFINYLRYLNEPLVTIINQQSLLQQALVSFERIFKFIDSPIKIYGNNYSMFKTGKINFKNVYFNYPNTKRKILKNITLKIQDKSYIALVGKTGSGKTTLSNLILGHYPIQKGELLLDNKKINTISNCTLRKNVSFVQQEPTILHDSLIKNVSLNRKIKKKKIIKALYKSQLKELIENLPKGYKTILEKNGNSLSQGQKQLIGIARILISNPKILIFDEATASIDSESEQKIQKILADIRKKSTVIIIAHRLSTIVDADLIIVLDKGKIIEMGNHKKLLKKKKIYYNMYIHQNNNKKKK
>fig|373903.4.peg.641 Permease of the drug/metabolite transporter (DMT) superfamily
MLQKAKTKTRVIKADLLLLLVVTVWGTTFPVMKMILVDTDPFYFIALRFMVAFLALYLVFHKKVTRDDFSGETVRKGVILGLCLLAGYAFQIVGLQYTTASRSAFITGLSVVMVPLLSIMIIKQIPGPYTWTGVALATIGLYLLTGAGKIAVNLGDYLTFFCAVSFALQIVLLSKYLPGNKPVVLTLIQMAVVGGGSFLVSLFSNGITGVTGPALGVIIYTGLLATAMAYLIQSYAQQFTPPTHTGVIFTLEPVFGALFSYLILGEVMGFTGLFGGLLIVTGMLITEVKAEGV
>fig|373903.4.peg.1105 Permease of the drug/metabolite transporter (DMT) superfamily
MKKNLEYFYVLFLIPFLWGSTFLFTKVCLRFFPPVFLGGLRYLTGGLIFAIILILKYGYSHTITTIKRNFAGIVLVGFTGVTIAVLFQNLGLMYTTASSAALLNSFEPVMVFFLSILILKEKATLNKILGLIIGFLGVIIIISNGNLSSLFSLNTNLLGNLLMLVSLLGYSFYTIIGKIVLNDTPPLIVVGVSTLFGGITLLIPSFFLEQIPDLTLTPPEVWFSFIYMATLPTCLAYYLYFKLLQNINASKTVGIILMIPLYGSGLGILILKEPVNPWFVLGSILVLTGAWLTESGKKILNYVRNIRKYFEPAQVE
>fig|373903.4.peg.1375 Permease of the drug/metabolite transporter (DMT) superfamily
MREENIFTGKYSVPFLATLACILWGTAFPFLKISYQELGIGKNDYLLKILFASYRFLMAAVILLIWRVIKTRKSISHDITTLGKKSIIKLLLLGFIQTTLQYFFFYNGLANTTGVKASILNTLGIFLTVVLSHFIFYYDKLNLQKSLGLVLGFSGVVLVNLSRGEFSFSFNFLGEGFIIMAAITSALSNLLVKKISLKIEPTIITAYQMLMGALILFLIAVTGVSPLSLNMSLKALLILIYLSFVSAAGFGLWYSLIKYNKLGYISIYRFVIPVSGVFFSTLLLNEGITGYIFTALVFVSTGIVLINYKRT
>fig|373994.3.peg.3433 Multiple antibiotic resistance MarC-related protein
MMNQSIFVGFLSTFLPMFAIANPIGAVPVFLSLLKSPEKPTEPPEPRRMPDESEEHYQLKRSELKAYEIKYQQYLEECKKYKQHSREQAKQTAIFVFIVLAVFLFGGKAILEHFDISLGVLRIAGGIIVAKIGWTLAVANTTLTKEEKEAAQAKDNISFTPMAIPMISGPGAISLVISLTEEVNEWTAYLSSFMAIAFLSLLVWLCLRSSEYLNQVIGDDGMGALKRVFGFFVLAIAVQLIVNGILGVLEAYQQVLFAVAN
>fig|373994.3.peg.4775 Acriflavin resistance protein D
MSLIKTAVRWRHGTFVLFCILALFGVLSLLSLPLELRPGGDRPEITISTSYSGASPREVEELITRPIEERLEEVQGIQEVTSSSASGISTINLEFNWDSDIDRRLVDVLNKLQQVEALPPEAGESDVEIVSGSSSPMMWTILVAKEGFTPNDEHYRDLVDDVIVPRFRQVQGVGQFLVSGGREREVEVVVDPKALADRNLTIGDVVNALRSNNRDIRGGPLVLGRREYRVRTVSRSTDVKQLEDFVLRRDESGTVYLRDVAKAQMGRKIQDRALIRDNKPAVAVGIVRQPNANVPEISQGIRQALVDLEKRFDREGEGITFDIPYDENDYINQSISFVQGNLMMGAVLAALILLLFLGSLRTVAVIAITIPTTLITVFIVFAALGRSLNVISLASLAFAVGMVVDNAIVVLENVFTHMQMGKSPVKAAIEGTEEVGGAMLASTLTTIAVFAPIVLVQGEAGQLFFDIGIGLSASVLFSLFAALTLVPMLSGLFLNQAEAQRILQGMGNNGAGSREQGTGGERRNNQQIDSLLIASDQIIPNPTNTSPRSKGHPSPYQGEGKGVRFFRNGFLAIQNLITKVSQIFLFFQRRFENFLLATVSWSIGVGRKGRRLIVLAIPVTLLFISFQLLPPADYLPEGNRNLILWLAQPFPGTSIPEAIKLSQGPRDFVSEQPEIMRSLYVHRNGLRAIAAFVEPEQATGNKLDEIVDRFRKQGGNFPGYRFLVPRRVSIFRDPGKEFEVNIVGQDLEQLNQLQQQVMQQLRGLEGVQNARSNFVTGAPELQVIPNRVRLAEVGLSEAELGAVVEAALGGLRASEFTDGKRELDVTVELQNTSVETPEQLRQLPLNIGNGRQVQLSDVAQVVEATGPDAINHVDLERSITLTVNVSREAPLGELIEQTEQQILEPLRETLPTGFRAELAGSADVLSETLMQLGSTFVLSLLITYLLLVALYRSFSFPVLIMATVPMGISGALLSLILANTIPGVVVPLDMITGLGFVILTGVVVNNAILLVDRSLQLQQEGKSYNDSLYLAVKDRLRPIFMSAGTSVLGMLPLAVIPGKGAELYQGLGIVLTGGLAFSTILTPTVVPALMGLLRDFSGNKEIGTKQLQGVDEVEVTNV
>fig|374847.3.peg.481 Permease of the drug/metabolite transporter (DMT) superfamily
MNRMGAGEWGLLIILSVLWGASFLFMGILVKELPPLTISASRLTIASLLIGILASRRPKNLPWRELLILGVLNNTIPYALILWGQRYVSSSVASIINSTSPFFTSIFAHFLTDDEKINKFSMMGISLGFSGVLAMAWDSAQGSLIGELAIITAVICYSYATVYGRRFYSMGLSPLDIAFGQLSTAAATSIPLAILERPWLAMPSQRAWVSIIGISVFSTALAYLIFFRILERAGATNANLVTLLIPVTATLLCTAFLGERLELRHIVGMCLIMTGLLIMNLRGEL
>fig|374847.3.peg.508 Multidrug resistance protein
MGNALSKISMIAEAFFAGFYVSITRGLFIPMLAYSGYPVRDISLVLVPTAVGGILVSSIVYRDPRLFESRFKRVIISSHVLERLMWFSLPFLLLSPPILSLAYMLANVSAALTSILIGAAVYSMFSGDEVIEVSIHRSAASSLSSLLGSLVMTYVSAAYTAPSSYYLLYFTALLVGLSGSMLLMMTPIPRSISEPRSSVVEEVKIRSGTALLILSLMFAGSNMLGIAWSPLLKELGAPVYITVALTITGNVGGILGSYVWRGYKAYITAMLLNSLLTAAIPFIAVPTYHIAVSFLTSLTFLGVNLLGMHVFSEVNDRIGRIRASAYLVSSNYIGLLAASLISTFLQSPSQNLILAGSIKMLSTLIALITIQEAAIVPAKRAYEISKIIYSTSLLGYSFTLQASRELLKTFISALALTALLLVLYILYRVALTLIGV
>fig|374847.3.peg.535 Daunorubicin resistance ATP-binding protein
MELAVSTEELVKIYEGKVRALDGVSLSVEPGKSFALLGPNGAGKTTLMRILTTQIRPTSGKASVFGFDVVHEGSEVRKLISYVPQEMSVWTDISGYENLLIYSKIFGIPRGERERVIEEVLEHMGLIDVKDDLVRTYSGGMIRRLEIACAMLIKPKIMFLDEPTIGLDPGARKSVWERLNIFKREHGVTIFFNTHYMDEADLYSDEIAIINRGRIVARGTAEELKRSLGGEMITLEMKGNDNQEIIQELRSLSFVLDVVSEDGRLSILVRDAESTLPQLIDLVRNWASVGRISINKPTLDDVFLKYAGERLEGRGRIGEIVHVRRMIRRG
>fig|374847.3.peg.554 Multiple antibiotic resistance protein MarC
MCIEEVGISAIQIFAILNPISVIPIFLSLTEGRDEGEVRRIVGVVSVAIFIMMSIFSLAGELILKLMGISVRGLKIGGGAILMVLAVDMLQGMPRTKSVEEEELAIVPLSTPLLVGPGTMTTILLLSNKYSGTYGYLCSSLILTLASALVTVASYLILRNSGKLRKVLGVNGLRGLGRFMAIIVAATAADMISSGILDFIKS
>fig|374847.3.peg.592 Efflux pump antibiotic resistance protein
MSSEKLEELRSRVLISCAIASFLTPFSSSSIAFLLPEISSYFGVEVALSNWSATAYLLALASSMVPFGRIADWKGRAKVFRAGLVIFTISSIATILVRDFGSFIALRVLQGLGSSMISATSVALISSIFREGRGKAIGINTAAVYIGLSLGPLSAGLLSDLISWISIFPLMGTLSGVSLLLSVNLPELGEGGSRPSYSSSLLFSASMICLIYGISNLDNILVLGFIIMISWLLLELRRGGLIDPKLLRNRSYMASSTAALLNYSATYAITIILSNYLHGFLSPSEAGLILTIQPVIQAALSPIAGQASDRRSPHLIASLGMIVIALGIALLIPLGSEGLLRVEISLVILGAGFALFASPNTVAALNSSPPKLYGSATAFLGSMRFMGQAISSSIITALMMIEEPLKAMNSALIIYVAISISGAILSIIARFWRA
>fig|374847.3.peg.636 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSESRVSEYREEIVNGPIVRTFFRLGIPPLINQLIAVAYNVLDALWLSIYNDLAVSVPRQVWPVIFLFNAPMQALTTVGMSTISQYIGMKDYREAEISASKLLTMASSLGIFLSISLFSLRSFIFSQVIGTPEEIAGWVMDYSAIMSVNILLNYIVFSYNTVLQAIGDTKRPAIINAFAVSVNTVLDPFLVLGIPPFPRTGVIGAALTDVLGSIISLVLLSSLLRKYELRMGFTSLGWDWIKLSIKIGFPVFIMASMNSLAFIAQLRLVNAFSIVAVTAYSIGFVVADIADAALFGLVSASSIMIGQNLGAGNLNRAKEISLKAAASVFSLLVLGILLVYPLRIGIVRAFTEDASIIGETDKFLQYLLPTLPFFGLFMIGMSAGRGSGRTLTPTIIGIFRLWVVRIGLGYFLSLSMGVMGIWISISLSNLLAGVAALIWLIYGNWNRPVIRRGEFEVSTT
>fig|374847.3.peg.794 Quinolone resistance protein NorA
MSSRNVSVLSITSFAIDVAFSSWWMILPLYLERLGAGVAEVGISFSLVNVAWALSQLPGGLLSDRFGRKVIILLSTSTFIPFFISMLLLKDWLAVALAVAISSFFAGLQNPSFSSMIAESSEKLGVARAFGFYNFLLNLGWAVGPLLGSLIIPSYGFDPLFILGIVVSLSCLAARAALLKEPPKMEESSSFGLTLIPLLISLSVFQLANGIISPLIPIYAEKLMYFSLEEIERMFFSAQLLTSIASIAAGSLVMKIGGLRGLMLSFVSSGIFSLLWIFSRAYAAFILISLYYIALFSLAEVSFGTAISELTARDRRATAFGTVTILTGLSHSAGSYLGGMLWEVSGPEIPFFLASSIMLLSSIPLRALSNATPPPRCTTSPSSLS
>fig|375286.6.peg.55 Acriflavin resistance protein
MNFSSLSIKNPIPAIMLFVLLGLGGLLAFKSSAVQDFPDIELPIVIVNASLPGAAPAQLETEVARKIENSVATLQGIKNIYTKVLDGTVTVTVEFILEKNISDAVNDVRDAVALVRADMPADLRDPSVTKVSTAGRVITTFTAAAAPGSQVDEQELSWFVDNTVSKRLLAVPGVGSVKRVGGVTREVRVELDTAKMAALNVTAADVSRRLRQVQQEAPGGRGDVSGAEQAVRTIATVKTADELSKMDIPLTDGHHIRLDQVATVTDTIAERRTSASQDGKTVVGFEVFRTKGGSELAVAKGAKEAVAELQKNHSNIVFKEAIDNAKPIKEDFDGSMSLLYEGALLAVLVVWWFLRDWRATLVASAALPLSVIPTFLGLAYFGYTLNMVTLLSLALVVGVLVDDAIVEIENIERHLSMGKTPMQAAMEAADEIGMAVIATTFALVAVFLPTAFMAGIPGLFFKQFGWTAVLAVLASLVVARLLTPMMAAYILKPKKQHVQEDGWLMQRYIKVMRWCLTNRLKTAIASAVFFIGSIMLVPLLPTGFVPPTDRAQTQINIELPPGSTLKETMAITERVRLAVAQDKNILSIFSSIGGGSSGDAFAPGASAEARRAVMTLTTVHRNDRKEKISDIEAKIRERIADIPGARFTVGTPDTGVKMQLVLRSEDPVALSEAAKKVERELRGLKGIGNVTSSASLVRPEIIVRPDPARAGDLGVTTASIGETVRVATAGDYDMNLPKMNLSERQVPIRVKLPDNMRADIAAIERLTVPGRNGPVMLGNVASVYMDSGPAQIDRLNRSRNVTLDVELGSRSLGELNTEARALPSMRNLPPAVKIAELGDAQEMMLLFNSFGLAMAIGVLCIYCVLVLLFKDFMQPITILAALPLSIGGAFVALLITGKALSMPSMIGLIMLMGIVTKNSILLVDYAILARQQGMNRFDALVDACHKRSRPIIMTTIAMGAGMLPLALGWGADPSFRSPMAITVIGGLITSTLLSLLVVPAVFTYIDDLEQWVKRMMRKARGIGHHDAHPTSTPAEQLGTEKH
>fig|375286.6.peg.1025 Acriflavin resistance protein
MSGFNISAFGVRERAITLFLIIAIAVAGAFAFIKLGRAEDPSFTVKIMTVTAIWPGATAQEMQQQVADRLEKRLQELDYYDRVETASRPGIVTMKLYLKDATPPALVPEQFYQVRKKLGDESINLPRGVIGPVINDEYSDVYFSLFALEAKNYPHRQLVAEAEVLRQRFLKVSGVQKVNILGEQQQKIYVEISHARLATLGIKAQALFEALNQQNNVTASGFVETAGPRVYLRLDGSIDSVEAVKQIPIAAGGRTIKVGDVADVKRGYEDPKSFAIRTQGEPTLMLAVVMKRGFNGLTLGKSLANEEASIKTTLPLGIELSRVSDQANAIEASIDEFMIKFIVALAVVIVVSLLTLGFRVGIVVAAAVPLTLAAVFVIMLATGRDFDRITLGALILSLGLLVDDAIIAIEMMVVKMEEGMDRVAAATFAWGATAAPMASGTLVTIIGFLPVGFAKSTAGEYAGNIFWVVAFSLITSWFVAVLFIPYLGVKLLPEIKAHHGDHDGIYETQNYKRFRSLVQLCVDRKWITAAITLGLFVLAVVGMGSVQKQFFPNSERPELTIEVNLPSGSAFSTTDATIAKIETAIRKEPEAKIVSSYVGQGAPRFFLSVNPELPNPAFGQIIVLTENSAARDILKAKINAMVTAGQFSEARVRVSQFLFGPPVTYPVLFRVVGPDIEKLRTIAADVRAIVEKNPNMRDVHLDWGDRVPTLHLVLDQDRLRLLGLTPNESATQLQVLLNGSPSTQVREGLRSVEVVIRSPSKDRRGLGDIGNLNLTTRDGRAIPLSQVAKFETRMEDPVLKRYNRDTYIAVQGDIRDGVQPPDVTKAILPTLDALKAKLPEGYRIDTGGSVEESAKADVALGALFPLMIILMLTVIMFQVRSFATMWMVFATAPLGLVGAVPTLLIFNQSFGFNAILGLIGLAGILMRNTLILVDQIKHDLDAGLSPYNAVVESTVRRARPVILTAAAAMLAFIPLTHSTFWGPLAYVLIGGVGVGTVMTLLFLPALYSIWFRVGRDAPKKPSSNADQHHVTEYLI
>fig|375286.6.peg.1905 Aminoglycoside/hydroxyurea antibiotic resistance kinase( EC:2.7.1.87 )
MLEPYLKRWQLTPDGTAIMTPGSQLLPVRMAGMPAMLKVSAEEEEKNGALLLAWWDGDAAARVLACEGDALLMERAEGQSTLLEMALHGRDDEASRIMCKVTAQLHAPRNKALPPLVPLTQWFQALEPAAAKYGGIFTYSAAVARDLLAKPQNTVVLHGDIHHGNILDFGARGWLAIDPKGLAGERGFDYANIFCNPELANAIVPARFLRQLEIVVANSGLERTRLLQWILAYAGLSAAWFFEDGMEAPTALAVAELAISELNR
>fig|375451.6.peg.1053 Permease of the drug/metabolite transporter (DMT) superfamily
MQRKLYKNREVLAGYGWMSVAVLIWASWLVLTSSGRVTALSVVDLAWFRAAIPAAVLLPVLWRNREHVARLGVKRCVLLSAYGAPFTLCVGYGLTFAPVAHAGAMVPGLMPVFAIALGAIFLGQRISPRKAVASLFILSGTGVILWYTSSAPEGDAVWVGHVLFLLGALCWACFAVTLGRSDVGPFVATAIVAALSVLVLTPILAFPGVSQISSADLRDVTFQAVFQGVLAGLVSLFAFGRALQLIGSRAAALTALTPGIAAVLAIPVLDQFPHGAEAAALILVILGLFVQATDAANAPKANHQTHARRD
>fig|375451.6.peg.1599 Methylenomycin A resistance protein
MTSHIPQIDKASAAAVSPRGMIIGPVAAHVAFVLELTLVPLLLPAMQSHLGLSVGDLAWIFNSYGIAVAVGVLLSGWCGDTFNPRKVFGYGVALFAVGSLLVAASNSFEMLLFGRAVQGLGAGVFSPLLPLLLTRASPLKPGRMLIVWGSIAGYVSALAPFFYGSFFSKFGWNIAFVFIALVALVALILLNRLRDPDEHAATPPAPKDYTQILRARYLWITFAYVFCTYGAITYYLFRLPVWLSDNDVRTASVGLALTVLWLTFSGLSTLLRNMVDSPHIRTIMFASPILIVVGFLLSYGNENLFFIVLSCVFVGAGLACSNAPSTQLILRFAPKGLSAASTSLDITFARLGGIAMVALLATAGFAFAFYATALSCFIAATCALIASRGLGFPPSPAARSTL
>fig|375451.6.peg.1879 Permease of the drug/metabolite transporter (DMT) superfamily
MTRRETVFFTCVLVLLGAGWGVTIPLTKIAVSTGFGHFGLIFWQLCIGSVLMAILCALRGKGVPFNASTLRVFALVALIGTLIPNTASFQAAVHVPAGIMAILLSMIPMFAFPIALALRLDSFSWRRLSGLFAGLLGVLIIVMPGVSAALAAPVFWLLVAMIAGLCYALEGNAVAKWGTAGLDAIQVLFGASLLGTVAILPVTLASGQFIPPADLNSSAGHALVAASVAHVLVYAGYVWLVGRAGPVFTVQVSYLVTGFALLWAKVILAEAYPPAVWAALALMFLGMYLVQPRGKGGLAQV
>fig|375451.6.peg.2299 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTFGILAVLSVGLVDAFFLGQLGNAPLAAVGFIYPLTTALTSLSIGMSAGANAAISQAVGRGGSDDHPQRLAIHAVAVGLLLSVAVALGFLFSAPLLFSWMGASDQPLTEAVSYVPFWSLSFPFLVVMMVVNAIFRAYGDGGTSSLIMIGSALVNIALTPLFIFGWGPVAGMGTEGAALATAIGRGLGCTAAIYWAWRTGVLAICGDMLKGIAFSLQEIFKVGLPAAFSNAINPAGIALVTAAVATLGDEAVAGFGAATRIQSVAVVVLLALSAGIGPVVGQNWGADKQERAQAAMRIAWMACVAYGLCLGVVMALFADQLAGLFAQGDAAAYAAQYLRIVGWSLFGYGIVITTNAAMNARSKAGYSMGLSIGRIFFVYVPAAWVGALFLGFTGVLFAAVAANLLAVGAAYFCARKTKIVTALI
>fig|376686.6.peg.857 Permeases of the drug/metabolite transporter (DMT) superfamily
MKITKPRLALICGILCISIFPILVKLRLTPGLISAFYRMAFAVTLLLPYVLLSGNFKIPTLKFTLLAALCGILFASDVAVWNIAIQESSATQASLLTNLSPVWVGVGSFFFLKAKPAANFWIGTFVALLGMITLVGFEFFIDLNFDKAFLFAVLSGILYSVYMLVSKNVLSAVDVLSFMTISLLASSIYLGILCYSLDEPFTGFSNTGWFVLVLQAVICQLCAWLSISYATQHMRATRVSLSLLSQAVITSILAWLFLEEQITLQMVFGGIILLFGIRITFYDKTISLKRLFSK
>fig|376686.6.peg.1347 Outer membrane component of tripartite multidrug resistance system
MFLKTTNSTDDCFPRILLLFLIVLAFNGLQAQEVHAVSLQEALKLAKENNKKILRSQLEVTLSEQNIKERKELRLPDVQLNGMYSRITNITEFKGSGFLKDKEVTPAIPEIYEVNSTFKMPIYAGNKINNAIKIANQENEIAKIKTEKAENDIELEVVANYLAIYKMMELQKIFEENIKEEKSRLKEVQSLQKHGTVTKNEVIRAELQLSDRELNALTNSKNIKIALHDLKTLIQIPENEEIAIDTTSSLDEMNGLDPYDFYMNKALQNEEMRIASQELNISKTELKMVKGNYLPSVHFFGNYGFYYPNYKFFPPNPYLYTLGQVGIEATFDLSSLYKNKTKMEQASTKIKWQEMQNEIVKEEIQDKLYKEHTQYQEILEKFVVVDKALDLADENYRIVKLKYLNQLVLITEMVDADNALLQAKYNKISTRLDAVLKHYELLHTAGMLPQS
>fig|376686.6.peg.1348 Membrane fusion component of tripartite multidrug resistance system
MVKIKNETRRNKTFHILITIIACVLVISGVILGIWFYVFNRNHEETNDAQVEQYVTPIMSRITGYVQEVRFNENQFVHKGDTLVVIDNREYKSKLNAALADVQNAQQNSVVAQKNAINTASATAINEAQLEAAKSNLWKTKLEYERYKALVSEEAATSQQLEKVKADYESAQAHFQEMKNRIHSSALSTSVAEANVPTTQTNIASKQAVADNAALFLSYTIITAPYDGWVGKRTLQPGQLVKEGQSLLSIVSKEKWITANFKETQLQYLTVGQDVEIKADALSDKTFVGTIASLSPASGARFSLLPPDNATGNFVKIEQRIPVRIQLKDSDKQADFLRAGMNITVIAAH
>fig|376686.6.peg.1349 Inner membrane component of tripartite multidrug resistance system
MEDKSIFKSWVPKWAIITILFVCLLHSMILLGVYTSNVTYAASFLDIEPEDLQYAMCVTYGTLLATILIESRFSSFFPAKNYLMGVYSLIGVTIVTSGYVDNFAVFLLLRVAEGILMALPAITIRQLLIEQFDSKNAIIIGFSFYYGSLLLSTPFIMNIAVWFLDHYDWKYMLYVSGGLQVLNVFLILVTFRGHRTTKKIPLYQIDWMSYFLVLTAILCGAYFFVYAEKKYWFESSQMVLMLITALITGGLFIFKELLVKRPTFNFEVFKYANLRIGFLLFFLFYISRATLSLCHSAMYSIWNWDPSRVAGVQYINGLGNIIGLVLAAFFLMKSLSTKIIFLIGFSLIALYHFWFTFLFVPDVALSDIIVPYFLQGIGVGLLFVPLILFTTSSVPANMAVSSGIVGVSGRFWGSTIGFCVMQNATVFLNKKHFLKLSQFVTGENPEAQQNIANATQSFIAKGYSADNANVLAMKKIFGSITKQSTLLADMEIYTIVGYGLLVLIILIACNQHLRQTMTLVKSKIWIG
>fig|376686.6.peg.2757 Multidrug resistance protein B
MLKTAFNHYINNFKGFTREIWILTLITFINRAGTMVLPFLSKYLKEDLHFSYNQVGWIMVSFGLGSMLGSWLGGKLSDKIGFYKIMIFSLFTTGISMFLVQYITTFLGLCAAMFVLMAIADMFRPAMFVSLGAYAKPENRTRALTLVRLAVNLGFAAGPALGGLIIMGMGYSGLFWVDGASCILSISIFALLVKEKKKTDHGDKTESASNTKSVFHDKIFWVFLFVSFVTAMIFFQLFTTLPLYHNEKYGLSELQTGLLMTLNGLLIFALEMPTVGFMERKAFPKIRIIIIGSFIMAFSFILLMINIWGGILVISMICISVGEILTFPFSNAFALSRAPRGQEGRYMALYTMSFSLAHIISSKVGFEIISDFGYQINWLFMASIGIFATLCCIWIKKALLQEKK
>fig|376686.6.peg.2836 Multidrug resistance transporter, Bcr/CflA family
MTTKKYLKLILILGSLTALGPFSIDMYLPGFSGIAKDLNTSVAKVSMSLSSYFIGISAGQLLYGPLLDRFGRKKPLFLGLMVYILASLGCSYVTDIDTFIFLRFIQAIGSCAATVASVAMVRDLFPVKDIPKVFSLLMLVLGLSPMLAPTIGGYVTEDYGWHTVFSILMFMGIAILIAAQIGLPNSYKPDTSISLKPKPIISNFLKVLKEPQFYTYAFTGAIAFSGLFTYVAASPIIFMDIYHVDAKTYGWIFAFMSVSFIGSSQLNSVLLKRFSSEQMIFGALILQSVVSIIFLILSLNNLLGLYETIAILFIFLGCLGISNPNTAGLTMAPFAKNAGSASALMGAIQLGLGSLASFAVGIFVKDSVAPMVLIMTVTTIIAFIVLNIGKRFIKNKVEIAADDDTILAH
>fig|376686.6.peg.3154 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKVVVLRLQSYTDLFFTAVLGREKKFTSGSINRAIVLLAVPMVLELVMESVFVCASLFFVSKLGAAAVSIVGSTESVISFSYSVSIGLSIAASTLIARRVGEQNFKDANITAGQVINISIICGILISIICFIWSNEILGLVGLSPAVIEQGSLYAKVMFASCGFIIIRIALNGILRGAGSASMAMRTLWLSNALNILLCPLLIFGWGPVPAFGLLGVGIATAVARFIGVCYQAFHLIKGTTIIQIGKEQLALHHETFKKVMRLTFGGMLQYLIPASSWLFMIKIVSHFGGNALAGYIIAQRVASIVTTPAWGIGNAAGILTGQNLGAQKPERAEKSVWRAGMINMCFLITVAIGWIFMADPVVRIFSDVPEVIDNSTTYIHIISIAYVLLGYTMVISRALNAAGKVMIVTLLYILMFYVIQIPLSYVFAVALGFGPKGIFAAILLSELVLAFGCITIFRTGKWKLTKV
>fig|376686.6.peg.3279 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRQILLVLLIIGTAFWGISYSVTKLAIGNFSPSTFLFYRFLMAVMVLTVIFWKYVRNTNLESIKTGAVLAVPMFLGIHLQTVGLKYTDASQCSFIAGLCVIIIPLIKLSIYKTSPPLKIWIAALTALSGLFIIAVKDKFTINLGDLYTIAGAFAFAVYLISVEKHSAAKNLLTSIVPMFAFCALFTFILALTDQNADWFPERNTFWLGVVYCALFSTAYMYTISNISQRYLSAERVAVIYLFEPIFGAIAAFFILGENLSLRLLLGGSLIFAATLISEVNLKNSNYRLGIKKTS
>fig|376686.6.peg.3353 Multidrug resistance protein B
MTPLNRNLLIITVILAAIMELIDISIVNVALSHMSGNLGATLEDTSWVITAYAIANVIIIPITSFLSANLGRRNYYIGSVVLFTFCSFMCGHSSNIWMLVFFRFFQGIGGGALLSISQVVVFELFPKDKQSTAGALFGAGIFIGPTIGPTLGGYITENYDWPWIFLINIPIGILVTISCYFLLREPTVKPEITKVDWTGIALLAIGVGALQTVLERGEVEDWFETKYIVVLTIIAVTTLLAFIYWELTIEKPVVNLRVIKSKSLSIAAILTFVTGFGMFISIYISPVVAQRLLSFSPYQTGLLLLPGALFALLALKICGTLLQKGVSPVIIIAAGFLLFIYFNWRMSGMTLNTSAAEVATSLVFRALGMALLTVPLTMLAVSSLDDKDVGQGAALNNMMRQLGGSFGVSIINTYVAHRFAAHRNELISEVTPSNTLAMDRINAYIKYFQYRGFTYNEARAKALKLMENIVMKQSSLLSYRDAFFLVGLFFVVTLPLLLFVMNKSKKPKTNMVISDH
>fig|376686.6.peg.4863 Outer membrane component of tripartite multidrug resistance system
MKISQLMLFGVFFIGISSIEAQEKTSLTLDEAVKMAWEKSNEVTLANTKVNSKKYELQSVKNNQYPDLKISGQYQRLTKASIDMPGQGEGASLASPDRAMLGMANLSLPIFAGFKIQSSIDAYESLYEAESVNAAKTKEDVALKVITYYTALYKAQKTLDVLNENQKSAKQRVTDFIELEKNGIIPRNDLLKAQLLVSKTQLSIDEANNNINNINFYLTTLLKLEPSVKIQVNEDDFFNLKTTNAPTSDALALENRKDLEAIRLQQRASEANVKIAKAGYYPTLSLLGGYTALDLKDIITVKYAMNFGLGLSYDLSGILKNSSHVKEAESKALEVKNTEAIMTDRIKVEVQKSIEDYDLAINQSVVYEEAFQQAAENYRLVKDKFDNGLADTNDLVEADVEQLSAKINTAVAKATIIQKYYELLSVSGQLSQSFNLSKI
>fig|377629.3.peg.2117 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MDSVSISEVSKKYIYKGKAHLVVDEISFDIRPGEIFGLLGVNGAGKTTTIKMISGLTIPDSGTVRIFGLDPSNSKTQKLIGTILEGNRNLYWQLTALENLVYFGVLKGMSIAAARKKGAALMEEFQFDQYKDLLVQNMSRGMQQKLAIKVALMHEPKVLILDEPTLGLDVPTKDFFSRFISDIAKNMGISILLTSHDLEFVGRTSNSFGVIQNGKLVKYGKMQELNAWIDDSGYRVILADELGGDEAKQLEKFGGKVIQENHANFLVSKEHLYQFLDAVKPANIINIKSLANDLEELLLNTRLEK
>fig|377629.3.peg.3265 Bifunctional polymyxin resistance protein ArnA
MNDNNTKPLVVFTASSLALPLLNQLQKNGQLTTVVLPALESSSPFAHEVFNLRARLQEKGIPYLNCGKEQLSELVHDLDRMQVEVGVIFTYPHVLPEKLLAYFAHGVFNLHGSRLPAYPGPCPLYWQIRNREPVLTLTLHKATNEPDQGDIVATREIPIHPLDTLQSLSNQMAWLALPLIAELQQVLAGQKLTYQPQLTADKNWESMPGKNYARRPRASDLQIIWHNMSAEAISAMCRAGAGQPFSALFYYNNCPLLLQQATPVDYPQFGITAGTILFIGEPEGLIVATRENAVRLDIISCADGLFTGYAFAERFSLDAGIQLKS
>fig|377629.3.peg.3439 Permease of the drug/metabolite transporter (DMT) superfamily
MTPFLSIQLSFFMSRFFLPLNTGFGALYLSVFLLSVNGLFARSIELDSTSITQLRSVIAGGAIIALCLLQKRSLLVAPRSLLVVYFLGVLLGLHWVTYFQAMQSSSVAVGILALFTHPVFTVLLEPIFQGRRPEGKDLLAALVVAGGITVMVSAQLGGSDQLSAEQIRTGVFWGVGSALLFAFRNTAQKYWLHHVPSTSLMFHQVLVVALMLAAFTDWSAVSGMAPINWLLLLLLGSFCTAGAHTFVSVALKHLPAKTVALISCLQPVLAALFAWLILSEKPAIQVLLGGAIIVAVAAFESRTQHKSE
>fig|377629.3.peg.4105 Acriflavin resistance protein
MNENKGFLAQFIAHPIASKTLLAIFILLGVLGAFSLRQEVFPPFAPNRVDIFVAVRGATASEVEELVVRSVEQKLVELTEIDRIIATAYQDYAQFQLELVPDVDPYKALTLIKSQVESIRSFPSYAEPPVYSVPKTTGPLLLVNLYGDLPVRVLYGEAIALRDSLALLPGITQVEIEDAPEIEVAITASPEQLRKYDLRFSDIADVISANALNLSAGELSADNGRILLRGDTQAVSEEDFGELVVAAFAGGNKIYLQDVADVRIGPVESYVNSRFNSQPSFTLSVRRDKYLSLSTASERVREFVTSYQTRLGSEVGLTVWADDSREFSSRVSLLLKNGITGFLIICIVMTLFVHIKVAFWTAVGIPVSMLGALGLLYISGTEVSLNAITLFGFLIAAGLIVDDAIVIGESIHEETLAKGEGMQSAISGAHKVAMPTVFGALTSIAAFFPLTLTEGKMGSQMAGIGTVVICCLFASIIESKLVLPNHLAGKWRSGFRGLDLSKIQARSNGLLNRFTENTYSKGLVFSLRRPWLVIAFALFLLFASVGILVGGVVRTVTLPNIADYEVEGSFTIDANLSPVQRSQIADALEQSLYATSEALKKEHNLEFDPVMMNAITVDTTRIVIAVEISHRDDAPFDAHQVANLWRNKLPLMPGIESANIASGPNGDEQVAIQLSGNDLETIYAAKEEVKSYLGEIDGVVDIRDSALTKSTELLLQVNPFGESLGLTQAYLLAQIRTGFYGLEAQRVQVGEQEWRVMVRLAKNHRQTESDLANMEIQLPNGRFLPLERVATIKSTRTETMVQRIDGQRAVTVYANTLGNVDAEGVAEGIVEDFLPGLQSRYTGLSYSIEGEAKDAAKSIRSLINGSIIAVFIMFVLMAIPLKSYLYPAVIMLLLPLGFIGTIVGHLLVPIDYSLISMFGLIALMGVMINNGLLLIDQYLVNIEQGMEREKAIVESCTRRFRPILLTALTTFAGLMPLIWESDPEALWLVPIAVSLGIGILVSTGLTLIVLPVVLVLLPMKQQRSINTTSEAVFTPVKTSEVVQPSISSVKYRYSDHAPS
>fig|378753.3.peg.171 
MAFVCSATWTAKPGEEDTVRDALSHLSPAARQEPGNLYYQAYQSPEEPAVFRIFEVYTDKDAFTAHVSSEHFDQWGTSQAIPVLAERAHKTYETLDF
>fig|378753.3.peg.181 Drug resistance transporter, Bcr/CflA subfamily
MIPAPAAPPRSFLLSLAAVLGVGPFAIDMYLASLPEIGANFAAPSWTVQLTLTGYLIMLGAGQLVAGPVTDAFGRRRPLLLGLSIFIAACLLAAAAPSMAVLVVARMLQGAGAAMAFVVVNSAVRDRVSGDAATRAFAVLVTVTSVIPMISPAVGGWVGELFGWRPVFLVLALIGAVSLGIVFRWLPESLPAQRRVPLAFAPVLRAYAGHLRSRRMLVPLGALAGTFVYLFCYLGGASYVYQGHYGVGQADFGMIFGVTGFASVGGAVIGHRLAHRLTTGQLGVLGMLIMVAGGIMATAAALCTDSLFLLALSVGFGLLGLGACEPAFMSLCMSSATSNVGAASALLGATQFLSGALTTALIAFPATLAPWAWAATMLGVAVVSLGFALLASRWSVPVRQV
>fig|378753.3.peg.284 
MTYGCDMADNKTTGENSSYMLHGRLRSTAGEGDTLASILSEQERNEPMPGCRLYLVARDPQDADAVWVTEVWDTEAAHRASLEIPAVQERIARAMPIIDREGMTQQELVAVAGIPSAP
>fig|378753.3.peg.390 Bicyclomycin resistance protein
MPQDHEPPESPPGDPRKRDPDERDARERDSDERDPHERDPRKGDPDEQGPAMQDPGPRDLLRSRLGLRPRGDAVVLVGSLGVLSAVSPMATDMYLASMPEMAQWFGAPASVIQLSLTAYMVGMALGQFLLGPLSDVLGRRRLVLGGNLVFLLSSAAIIVAPHIGLVLGLRLLQGAAGAAGVVIARAVVSDIARGHRAAQLYSVLSLITSLAPVVAPLAGGVIATVADWRTAFAVLTVFGAVMLGCSLLVIPETLPPEARSRGGIGRILRNARAVLGDRRFTLHALSFAFAFGALFSYISASPFVIQDVLGFSALGYSVVFALNACGSIATGVVNTRIVGSRAPESLLLAGVTGLAATSVLNLVLALLGVVGPATLVLIFLSQSCMGFVLGNAVALAQRRAQARGLAGTGAAVVGTAQFVMAGVVTPLTGLAGESTAVPMLACMASCAVVSVALVLAARR
>fig|378753.3.peg.434 Probable multidrug resistance transporter, MFS superfamily
MTAAAPRTWWRVGAAMFTVGFGANLFAPMLEVYRSQDGLSESFVTGMLGIYAAGLVPALLVFGPVSDHRGRRAVMRPALVVVIAASLVLAAASHTSDWLLYAGRWVMGFGVGMAMASGSAWVKQLSTDRPGSGPRRATVVLSAGFGGGPLAAGLLAQFLPAPQVTPFLLHVLLAGCAAVLVWRVPETQPPASGPRPSRPLVPAVARTGRFFWVVAAWAPWVFGTATIAFASIPSFLLTTVRFPVAYLGAVAATVMFTGVLVQPLAARLARSGWLPLSVTGLGAASAGLVLGALTVTWHLSWLAFPTAVMLGVSYGFMMVAGLREVELMARPHELGALIGVFYTLTYTGFAVPFVLSLVAPAVARWAGVEPTTGFVWCLLFGVLVCAASAVPVARAAARGVPDPGTTTPQG
>fig|378753.3.peg.1173 Drug resistance transporter, EmrB/QacA subfamily
MTPARQPTSRTRPARTSEQEHRDVLRALTGILAAFFMAMVTLTIIGTALPVIMADLGGDQTALSWTVTGTLLANAVTTPMWGKLADLFDKKKLLLMAIAIFVIGSGAAGIAGSIGMLVVARVIQGVGMGGLMALAQTILGTIIPPRERGRYAGYMGAVMAVATSVGPLLGGLIVDAFGWRWCFLIPVPLSLVAAVIIVRTLHLPEVSRDRSPRVDFLGMGLLALATSALLLWVSFAGKLFAWGSWESVLLIVLALVTAVAFVAVERRASEPTMPLHVITERTTVLAIIAAIATGAAMFASTTYLGQYFQLGQGYTPTESGLLMLPQVVGSFLGSTIAGQLISRFGRWKRILVVGAVVLAVGLFLGAGLTHTTPAWLVGIFICLVGLGVGTLNQNLVLAVQNTVGLKDMGAASSAVAFFRTVGGAVAVSMFGALLTRHMATQMSRFAAEHGMDSSATPDAASIDLAGLPPEVLGAVREAYGTGTGLLFLVAGIASLVTLLCVLLMKETPLRTTVDVAEVDPETGQITLVTREVNPVEAAGLRMQHAETGQIPVVDPTATGLRRGAGEEAAAHPRDEGATPHVGDPASSSPGADGGRTDRAVHETAQPREDDAARGPGRASGGPRHRA
>fig|378753.3.peg.1735 Methicillin resistance protein
MEGGRTGRYLYCPYGPEAETPQAFDLALADLVAQAKAHRCWFVRVEPVNGHTVDGLETPEASLVRRGMKRAPRQVQPGHTQLIDLRRDPKDLLKDMKSTNRNLYRNIHKKGVRIERSEDPADVRHLLRFLDETAARRNFNRQQDDYLRAAAESLMPAGAASLYLATLDGEPIAASLVYDSEDTRTYAHAAMDQEHRRLSAGIPLVVTMIMDAREKGLTWFDLFGTAPEGAGPEHEWYGFTSFKKSFGGEPVAYPGTWDLPVSRAGYAAYSGVRAAREAVGTARGKLRELRERRAAA
>fig|378753.3.peg.1832 Methicillin resistance protein
MREFTARFATAQEIAEWDAHVTANPSGGNLLQSEAFAEVKKDHGWTPRHVVYEPSDGSRASYNLVLEKKVPALGRLWYMIKGPDVESVEDVPGIVAANERFVAGAAKGVFAIKYEPEILASDYAAGVLARAGLVKSFEIQPNDSTAVLNTDMDEKALLKSLHSRGRNAVRRAIREGCEVEQVPLTEENMRAMYALMDSVGQGHAQVNLRSYEYYRAFWTNFAERGQGRLYFTYEDGKPSVGAYVIAYGSKGTYKDGGSKPRRKQYGDSHLVQWSAITDLKQDHGIVQYDFCGTPPSDQLKNKEHHYYGLGLFKTSFTKTVVDYAGVWDQPLSRAKYAVWTSVAEKVQRQLWVRRTGQPFY
>fig|378753.3.peg.1947 Methicillin resistance protein
MLQSEPWHRFQAALGRATHLFSGPGWHALVVEETSRAGRLWYAPYGPVLSHPEALPDALTELRSAARAARIGWLRVEPQAAASSGEGFTDAVRRQNATAPVLAAALTAHGARPAPRDIQPAYTRWVDLTREPGGILGAMTGTNRNLWRRHRDKGITLESSTHPSGADAVIELLHRTAGRRGFTAHGSDYLRTAARVLRETGSCTAYMSSVDGAVVSALLTYDSPTTRVFAHSGMDAALRKLRPNQPLIVQALLDAAAQGQRVADLFGVASANDPGHPWTGFSAFKRSFGGADVALGGTWDLPVSAPRYAAYRVARRARDEVSTVRGRARGAADTARARLLPER
>fig|378753.3.peg.2211 Drug resistance transporter, EmrB/QacA subfamily
MALGALAAGLGMIVLDGTIVGVALPAIIQDLGLNLTDAQWVNSLYAVLLAALLLSTGKLADRWGRKTMFMVGLVVFAGGSLLAALSGTAGALIASRAVQALGAAFIMPSTLSTVNALFRGKYRGPAFGVWGAVMSGAAAIGPLVGGALTHWASWHWIFLVNLPLAAIIAVVGWSSITNTRSDVRERGADVDGAMLSAIAFGALVFAIIEGPAIGWLTPTADFSIFGWVWPATAPVSIVAIALVVGLVALALFGVWERHRAKVRRSALLDLGLFQVRTFSWGNLAAAMVAVGEFAIIFVLPLYLTNVLGLNIMQSGLVLAAMAIGAFISGASARHLAAKFGAPGTVLIGLGLEVVGVVVLALVMGPGTAAWLVALPLVVYGVGLGLASAQLTGTVLRDVPVASSGQASATQSTVRQVGSALGTAFAGAALSVSMSLTLPAALDATGLDAAQADQLAEATRQSAGGMIPQLQAQAEQHPLGPETQHVIDALSTGFTHATQWALVIATGFILLGFLGALQVRRAARRDDTPAA
>fig|378806.8.peg.924 Permease of the drug/metabolite transporter (DMT) superfamily
MAGGGLKVGDVYVVVTAAVGEFTKSMRQVVKDVAETADKVAQLGEKIGQIGAVVSAGLYGALAAAASFDKSVTERMDRIKLVFTNVGAAIGDAVLPYLERLSDALEHALGWFQRLDPSVKEGIGSFLVWGTAAGLAGGALGKVAGVAKTAAEAFNYFVIPALGSAGRSVVSFSALMRGAGPEAETALKRVARGADQVDASFLTAFRNAAARVLLIGAPIAAVAAAVAALVLLAGALYKAWNDSSTGMRATFQSLWQTVAGWAAQAGEFFGRVFRGLADTVTEWARSTLDAYAFVVRNLARIGAPMARALNLEGAADALDSFRDLTGAALGGALKGLVTDSTKTLATGLGGIWEGVSYGAGYAFDGVKALGSDTADYLQKRFGDVFGDVLGGPKGILRKPDDTKEIDVASVGSFDATAFIKRASNTTGILEEIAIRKAKELADALARAADEAKQALTQKFTQAFGRVSDLIQDFQEGFAAGGIWGGIGAVAADLLSQSATFASLIQMATNYIQTVANVIGSVLAPVLPLVASVFNMVTPLLESLVPVLTAILAPLQAIAPVFELLGVLFRGLAPVVSILGQILVVLVEPLTLLAGPIMKAFFAVVRILAIGILYVIKGVGTVWNALVGFVQSVFKALSKIPLIGGAFKGMVKDLEKMKVPMDEVNGALDTLKNTSYESAAANSAASVATWQNAEATQRATEALTNVPQGFKVALARLTSQDPVIGSPTAPLSPSPLSPSPAAPVSGAGNVTVGQIVVEGVEDPEETARSVWNEIRREQNRRRGTSEWLTGRY
>fig|378806.8.peg.1605 Permease of the drug/metabolite transporter (DMT) superfamily
MVPTALPRLTPATNPLKLVVAYCTCVLLWGSTWAVVKAGLEDLPPLRFAGIRMLVAGLMLLPFARAQGAQLGARTTWRVVGLGCIQLAIPFGLLFIGQQWIPTSWSSLLFSTFPVWLLLVGRVLMPDQPLTVPKLLAAGLGVVGVMALQHSQLGQMEMSSLVLLGALLTLGATALMALANVLVKQHMAHVPPHVLVFIQTLSSAVPLLGMSFLLEGAQPVNWSSRAILAVVYLALGGTVLTYQCFYWLLQRLSLTAIGVMSLMDTLVGVSLGVVMLHEPLTPSLMVGGTLILSSAALAQFTPDRQSAPARTPQPDGG
>fig|378806.8.peg.4898 Glyoxalase/bleomycin resistance protein/dioxygenase
MDVQGFHHVAIQARDVERVTAFYRDLLGFPELTRHLRPDGTLRSIWVGVPGGGFLAIEAVSGPPEASPFRHEQPGLLLLAFRMARASRAGVVETFARAGVPLEHETRWTVYVRDPEGNRVALSHHPED
>fig|378806.8.peg.6115 Glyoxalase/bleomycin resistance protein/dioxygenase
MPPPTSSAAPTFYPVLRYKNAPAAIWWLTTAFGFEEHRVVPGPNGTVAHAELRFGTGIFMMGSQKDDLFGNAGMAPYVYVSDIDAHCARARAAGAVIEKEPFNTDYGSRDYAARDCEGHVWSFGTYRPAP
>fig|378806.8.peg.6863 Membrane fusion component of tripartite multidrug resistance system
MAATLAPAPVDTSPSATAERVKPKGRARIVLPALLGVALLGGLIRFLFTHGRESTDDAQVEGRIGNVAPRVAGQVMKVLVKDNQPVKAGDVLVELDRSDLDAKLQVAQADVLSAEAQLSNAQAQLALTEANAGATLRQAQAGVTQASSGISSSKAALEQARADVASVEARFRLTDTELARVKRLAAEGALSPAELDTRQAAYDQAKAALDQAKARLASTEAGITSSSGGLEAAQGKLVAAQTGPVQVQAAQAALKLAEARLQQSRASLHLAELAVSYTQVRAPINGVVSRRTVEVGQMVGPERPLMAIVPQDDVWVVANFKEDQVGGMRPGQPVDVKVDAFGSQHFRAHVDSLAGASGARFALLPPDNASGNFVKVVQRIPVLVRFDGDLKELPLKPGMSAVVTVDTREP
>fig|378806.8.peg.6864 Drug resistance transporter EmrB/QacA subfamily
MKSDAITGSKAGITIAAMAAALMSVLDISIVNVALNDIRASFGTPLDQIAWVSTGYMMANVVVIPMTGWLQRRFGFRRYFTFSILMFTAASVLCGLAWNLPSLVAFRVLQGIGGGAIIPTSQAILFARYPREEHGMAGALFGLGAVTGPLLGPTVGGLLIDASSWHWIFLINVPIGLFAAFMAWRNIEQKDFEPSTERVDRYGIALLAVGMAALQYVLEEGNRHDWFDSQEITALAVIAGVALITFIVHELETPSPVVDLRVFANRSYAAATGINLMVGTSLFSGTFLFSLFLGSVAHYSALDIGLLFLKGSVVQILLMPLVGRFGSKIDGRVLVALGIVGVSMSLWTNGHLATSADEAALITPIFIRSCSLGLVFVPLSVIALSDLKPEQRGNAAGLYSLTRELGGSIGTAWMSSSLSRTTQLNVTTLTSKVDVYSQQTAEQLAALQGAMTGRVSDPTGAAYGLLNMKITAQAMVRAFNANFMVLTALFLCTLFFVLMLKKPARGVKVEGAH
>fig|378806.8.peg.7950 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQPGFGRDLTTGSIPRHMIAFSLPMLLGSFLQTAYSFVNAIWVGQYLGTSALAAVTVSFPIVFVLFAIGMGLTMATNILVSQSFGARRMDELRKVVDSSTVLIGSLGIVFTVLGELFAPRVLRAMDTPPEILEASTHYLRIFLLSLPLGFGLFLTRSLLQGVGDSKTPLYFQLGSVLFAAALDPVLMFGWLGFPRLGLNGTAWSTVVSQILAFSALILYLRAKKVPVAPSWPRFNHLGPITWKTLRIGLPSAVQQSLVSIGMVFVTGIVNGFGEVATAAFGAASRIDQIAFLPAVTFGMAISTLAGQNIGAGRLDRVREIFIWGCLFSGGITLIITAVTVSIPGALLRIFVTDATVIEPGIAYLRTVGACYLFFALVFVSNGIINGAGHTLTTTVISLISLWVIRVPGAYWLSRRMESVKGVWYAIALSFAVSLAASMAYYVSGRWKRPAGKKPPGPPAPDVTETFGHSTGEA
>fig|378806.8.peg.8086 Permease of the drug/metabolite transporter (DMT) superfamily
MLMSPRVKGAVLGLSAAALFGVSAPVAKLLLPSSTPLVLASLLYLGGGLGLLGLEALRRLSPSGIQGREATVGRKDVPLLTGVIVCGGILGPVLMLVGLQRMSGVAASLMLNLEGPLTILLALLVFGEHLGRAGALAAGFVMAGAAVLGLQEGELHGDLLGVLALAGACLAWAVDNNLTQRLSLKDPLTLVRIKALGSGVCMLVLAWVTGQPFPSTPVQGGALVLGFASYGLSIVLDAYALRLLGAAREAAYFATAPFVGALVAVPLLGETLRPLDLVAGGLMATGVILLLRERHGHVHMHAALEHEHVHVHDTHHQHAHPLDLPTTEPHSHPHQHVPLTHDHPHVSDLHHRHKH
>fig|379066.3.peg.545 Inner membrane component of tripartite multidrug resistance system
MASPSALADSPSARGTSGAARAVADDPYKNKYLIAIAVTLAAVLELVDTSIVNVAIPHMMGTLGATLDEIAWVSTSYIIANVIVIPMSSWLSGFFGRQRYLTGSIFIFVIASFFCGAATSLWGLVFWRVLQGLGGGALLSTAQTTLFEAFPPHERGIGQAIFGVGVMVGPTIGPTLGGFIVDAYAWPWIFYINVPLGLIAALMVWTYVKDAAHQVRTRTIDGTGILLLTLAVGSLQWMLERGERYDWFESRFVLTLAIVSGVSAILLVWRELTIEEPVIDFRVLKSRQLAPGVVFASFMGVALFGSVFVLPVFLQSLHGYSAQQTGLVILPGAIASAFTMAIMGRFGGKIDARILVTIGAFLFLASMTKMSQLTLDAGQDDMFWPLILRGVGLGCLFVPLTGASMAGIPMERLGQATGMFNLMRQLGGSLGIAIMATMLSRLTKTEKAVLTEHVGAYDPATLERLNGLTHGLMGRGIDAATAKQQALMLLDGQITAQASVMAFSRIYLISGLLLVSALPLLLIWKTGRAVPVKADGH
>fig|379066.3.peg.546 Membrane fusion component of tripartite multidrug resistance system
MARPNIRLLIPIAALVAVGIWGYQRWSFGRSHESTDNAQIDGHIVPVVAKVGGYVTAINAIDNGHVDGKHVLVKLDTRELEVKLAQAEAELAAARASAGGRGLEGQAVTVVRTASSQRDVGSAQVDAAKAQLIRAQADLTRAKELAGKQIISMAQLDGAQATFDAATANLEATQRQVLAATGSIANAQAGVRLAQARLAAAEAARDNAALQLSYATVEAPLSGIVSRKQVELGQLIQAGQAMMSIVADTGLFVTANMKETQLARLRVGQKVDLEIDAYEATAEGEVESIASATGAKFALLPPDNATGNFTKVVQRVPVRIRVTKDLGKDRPLRPGMSVLASVVVR
>fig|379066.3.peg.924 Glyoxalase/bleomycin resistance protein/dioxygenase
MIETGSTAETAAIFGSLQGRRTLVPGERMTGFECTISVPDIHAAQQAIEAAGGTILMPVATIPTVGHLLWFRDPEGNVAGAMQPDARPLPDEV
>fig|379066.3.peg.1953 Transporter of the drug/metabolite transporter (DMT) superfamily
MSNRSPHAPSTTTRTPYLVLAASLIGISFAAPLIRLSEAAPLVIATWRLGFSLIIVAIALVIGGGWRAWRTLARADLLLAGGAGVLLALHFWTWNTSLRYTSVAASVALVNLQPVIIAAISGFWLREPATRRQWFWIVVAVIGALIVGLADVPGGLRAIGPALLGSGEGSRALLGDGLALLGAVTAAGYYLIGRRLRQHLALWPYVGLVYGAAFVACLILCLVTQAPLTPQPPRELAIFAGLALGPMLLGHTGMNWALAHLPAFVVNLTVLGEPVGATLLAALLPGIAEVPGPATIVGGILVLTGAILAARR
>fig|379066.3.peg.2732 Glyoxalase/bleomycin resistance protein/dioxygenase
MIKRVKFISIPVHDQDRALAFYTEKLGFKVVTDAPMGPGMRWIELRIPRAETGVVLFTAPGQEQWIGQFMNLSFECEDVVATAAALKAAGVELVQEAKVESWGTSAIFRDSEGNQFVLSTG
>fig|379066.3.peg.3448 Bleomycin resistance protein
MQPLSAAVPEIPVGNVATSTAYYRDQLGFDVDWHATDIDLAGISRDQCRLFLSGPAFREQRGNTSPVVIWLNLDSIEAVNDLHSLWHAANAIVLAVPESKPWGLHEFTAADPDGNRFRVFHDFATPERLTESSQ
>fig|379066.3.peg.3882 Permease of the drug/metabolite transporter (DMT) superfamily
MSTPTQTPDTTAPVVPRWQLVGGFLIIYVVWGSTYLAIKWGVATIPPFVMGAARFLLAGGALYAFMRARGAPRPTLPEWRASAVIGALLLFVGNGAVSWASQRVNSGLTSVIVATVPLWLVLCEAWQGRPPRLAQVIGVAIGLVGVGLLVLPVGGERQAAVDPIGAAVLATGALSWTVGSLYSRTAKQSSSAALAIAMQMLIGGACMLVLSLVLGEWQRVSPESVSTASLLSLLYLATFGSLIGFSTYMWLLKVASPTAVGTYAYVNPVVAVLLGVALGGERLPSLAWIAMSVIVGGVALVSLVDGRRRSA
>fig|380394.3.peg.40 Outer membrane component of tripartite multidrug resistance system
MHRKRWIAACAALGVVALGGCAPTIRAPNPADVKAPAWAMSVQRMDGAQALPTGAWPQQDWWTGLASAGLDQVMTRALSPANPRLAEAVDTVQWAASVSTWRAAALGPQLSGQAAITPLQFSGNSPLGALGLGNKLYDSGDIGLGFTQALDFWGKYADRLKAALGEQRAAEARLADTRRLLAAAVVNAYLRWAEAEQQLASTRRLQHLYQQRQALIRTRRYLGLGTDLSIASLSLQIQQNTARLARWQQRAAAARFAVAELAAIAPDALPPRPVAPASAVIPTLPPHLSLDLLAHRPDVQAARALARASVQQTKAARAAFYPDISFSALLDMNSAHLATLLNPASFAYSFGPALRLPIFTSGALTGRFRGAEAQQAKAVAVYQESILQSVRQVLTALSGYQHGRQVWQAEVVGTGATREQEKLTATAQALGLSDRAALLQRQIALIHQQMTQRLAHYAALQAWAQLETALGGGYDQSRQHP
>fig|380394.3.peg.41 Multidrug resistance protein B
MLLLLGLSSGLLLASWSLAWSIPMLPYIAGAYSTSLDHAIWSLTFYLLAWALAVVPATWLYQRFGELRMFQISLTLLMVATLPDVFSDHFGLFLGGRFVQGMAAGFLTPLTRRLLIRYAPLRWQKTAADLSIVNLVLPLLAGPSLAGWIAYTWDWRAAAVLTFPVGLLALGMVSALLRDNPEEHLRQPFDWIGLVLLAAWSATFQIVLNRGEDWNWWDAPAIRWLTALGAVLLVAFFLWERDQPHPCLDLRLLRRRNYVLALPALVFGWGLLLGGNSLFVSALISHANYSAFWAGVVLLPMALGGVPLIAVMGPISHRVNPRWLATICFGFVAIYGFTTRLNLHSNLRSLLLSHLIEGVAIGFYLVPLSLIMFSRLPQSRLPAAATLQNFVRILGGAYLSSAFSALWMRHGDTFRAHLTWQSPTLPLQSMLEHWPVRGSAARALSIQHLTTQSAALSMQSMLWLWGWMALVVLALVWLTKGPYRRRAGQVRRVTIEQQIMESAGFDAEPSRREDVERAP
>fig|380394.3.peg.55 Multiple antibiotic resistance (MarC) -related proteins precursor
MQMPVAAELHSALQTLIALLAILNPVGAIPIFIALTSDEDPQQRLATAKLASRAVAVVLLTSAFLGEYILQFFGISIAAFQVAGGMVLMLLAFNMLQAKSSRYRHTPEEAAEGMQKEAVAVVPLAIPLLAGPGTMVTVIIAHHKNASWLASGLLIIDILVIAGVAYAALRLAEPLSRRLGVTGINISTRIFGLVLAAIAVTFIANGLAALFPGLVHIRMS
>fig|380394.3.peg.112 Acriflavin resistance protein
MHFTEPFIRRPILAISLSLVLFFFGLRSLGLMPITEYPPTNSSMITVTTHYFGATPKTVNAFITAPLEKAVGQAPGINYMTAVSEDGISILTLYMRMGEDPNAALSQVQSKVNTVLNQLPKGVMQPVVQEMSGSGAYLMLLSYHGKGFNQQQITDYLTRVVQPAIQSVPGVGLTSILPPGTGPNGNTYAMRIWLDPQEMSVLGITPEQISTALKQNDFVAAVGRLRGQYTAVSLSANTALHSAAEFRNLVVATVHGVPIRLGQVAKVSLGAQTYDSSVMVDGQPAVNIGIQQAPGSNALNVSQGIQKVMAQLDSTMPPGMKGYTIYNGAQFVKSSLQEVEVNIALALLVVILVIYFFMGSWRALIVPVLAIPVAMVGAVTILHALGYTLNLLTLLAMVLAIGLVVDDAIIVVENVHRHIENGATPLHAALLSARELASPILVMATTLVAVFAPMAFIGGLVGHLFSEFAFTIVATVLLSMVAALTLAPMLASRVLKAGHEGRMAHLVDQLFGRLKAFYGRVLFASLRVWPATVTLALILTVGIYFLFSISQSELAPPANQGIVYVNGVAQPTATLEYMNAYDRYLTKTVFNKIDSRSHSFAVNGVGIGGMLLNNEVMAGVVLKPERGSVTTQQVKEKVQKLAEQVPGMKLSAFGLPPLPGAAVGLPVQFVLTSTGGGYHQLDAVSGKLVREARASGLFSFVCKNLKYNNQIQELHINRQMAASFGLSMADIGQNLETLLGGNYVNYFDMDGLSYRVVPQVPPALRANPDFLKAYTIKTPSGAQVPLSTFVSLKSRPAPTFLPQFQQLPAVFIQANPAPGVSLGQALQFLRNHAQKILPAGDQIHYAGVSRQYMHQGSALVVTFGFALLMVLLLLAAQFNSFRDALVVLTAVPVALFGALLPIALGASSVNIYSEVGMVMLIGLIAKQGILIVQFARVMQEEKHFDRRHAVAEAAILRLRPILMTVAAMIAGAIPLLFASGGNADARFSMGLVIVSGLGFGSLVSLFVIPAFYVWFGQVVRQPESDLVG
>fig|380394.3.peg.336 Multidrug resistance protein B
METLPSLSQIWPLFAGVGLALGMGSFDGAALQGIFPYVAGGLSTSSDHALWTLTYFIVHWSLGISLMPWTTARFGMRRVFQVAVIVAMAGTLISAVTDNLWIMLLSRALQGIAAGILVPLSQSLFLRHSPKAHHGMVTIFWSNAMLVPFFFGPAIGGLLATELGYRSIFLLSLPIWGVALFLGSAGVPKDRGDPRTPPFDGWGFGLLYGGLMSMQVVLDQGEQYGWWHSAFILKTTLFAFIFLLLFAWRESETRHPLLQLHFLRRRNYWLGLLLLCLGWAMFMGWASLLPLWAEETLGFNGFWGSAVLVPLALGAIPLSTLMDRLHGLLGLRRLTTLCFAIFAFAYGSAYLSPISSLGDLFWPVLFIGMGVGMLFVPLTMVILSGLSAQEIPSAATTSNFIRVFSANIGVSLLSVYWTRYSALAGDHLRSHVSRFGGHTTLSAQHLHALISAQAGTLSIDNLLRLSMWACLAAAIAAYVFIIPPSTLRSTDGPRNYVEEEEDEFPITAGAPMGEGAGISS
>fig|380394.3.peg.419 Membrane fusion component of tripartite multidrug resistance system
MRWLKRLLVLVIIVVVAFGAYAYFQISDYYPNTDDAYLHAHVVNIAPRVTGHIVAIYVHDNQVVQAGQPLVEVDPRAYVYDVQKAEAELTQAERQTAAIQANIAGARANISADQVNYQNARHNAQRAAALAAQKYLSAQQADNEMTAAKSAGARLTADQAALAETQAQQVLNGARIAAAKAALRTARLYLSETTLYAPIAGVVSKVDKIHVGDVVNVNQDLFPLIGNAEYWVEANYKETDLSRVHPGQSAKITVDMYPDHPFKGKVVSLSGGAGNAFSLLPPENATGNWVKVTQRVPVRVLITNPDSRFPLRIGTSASVTVDTGGAPGWVKALRPIF
>fig|380394.3.peg.992 Multidrug resistance protein VceA
MSMQKPEHSGSPIQPEKRTRLLVLVTLIFVLAGLIWAAWWFLRGQYWIETNDAYVSGNITPVDSQTAGTISRVLVENTEFVRAGQVMATLQAHRSQIALQQAGAHLAATVRQVRRDFAKVTALQQTVSAKNAELRKLNADFIRYKQSLPSGAVSAIRLEDTQNEIAAATAQVAAAQAALKGTQAIIAGTTLQTNPLVRQAAAQFEQADIQWQRRVVRAPVSGYVAERTVYPGLMVHPDQRLFSVVPLNDLWVVANVKETAMRHVHPGQCVQLTSDYYGGDVRYHGEVLGLLPGAGSAFGILPPENATGNYIHIVERVPIRIALSAAELAQYPLRPGLSMVAGIHWTRSQKHSVLKPLTTTPIRGYQTHIYNGELRRARQRAAAVIRDNA
>fig|380394.3.peg.993 Outer membrane component of tripartite multidrug resistance system
MKRRIALILPLLLLGACARLPPHLPGGKMAQNTQISGTLAYVDGHNGVLTGTWPVSNWWTSAQLPALNTLITEALRDNPSLQVASARILQAKAAATDQHAALLPHFSAAASVTQEYFSRQGLHAPLNGKTITYGALNPLEMRYHLDLWGRDSDRVRAALGEVRVHQADYAEAKLLLSTQLAWHYLLLAGDVQRLRQLVRAEALHTSLLHLEQQRWHDGLSDARAVYLQEEARAGARQSVADMQAAIAQQRYILAALVGHGPDWGRDIPAEPLPTLSTITMPRNLPLRLIAHRPDIVAARWETEVAAQQVGAARAAFYPDVNIALFAGWNSIHLGDLFSPGNLAHALGPVISLPIFEGGRLRAQLKEKNASYIATEDHYRATILGAVREIAGRLATWRQIRQKLRAQRQMIYAAEHTTALAESAFHSGITDKAEAYGAQIQETEIRNQLLALKMQNAQSWVLLHSALGGGYTSRKNPA
>fig|380394.3.peg.994 Drug resistance transporter EmrB/QacA subfamily
MVILLNLAIGLGHLLVLFNTGAYLPMIPRVAGSLGVNPAYADWTQANFFLAMALAFPTATWFLNRWGEMRSLLGAFLAFALASAVCAQTSNYDWFLAARIVQGYAGGLTIPISLGVILRHYTPQRRNIGLTLWGVAAITPFTLGPTIGGWITDALGWRWLFYLNMPIAVAVALISAILLVGREADHRHPPLDWPGLIFLLIALAALESALNSGEIISWWRSNTIIFLTTIGAAALVFFALWEWHSAHPLLELRFLRRRNFLIGAIGLFITALFFQGTMALYIVGFQLTMGYSAWMVGLLLLPMAIFSKLSATLTQRFLNHIDARILGMISLLGFSAGSFWVSSYNRTASFDELLWPQILVGMFLGGLFPALIAIALSGLRGAAEMRGTAFLNLLRVSGQAMGIPIIATLFDRRMILHAHFLAENGGTITSMLNTSVKNARTSDYITHHAAMLAFNEIFYIAAWGFLIVAGLLLLAKRVVFAEPDVRVRQALEELVEP
>fig|380394.3.peg.1477 Multidrug resistance protein B
MEGSLHANSDQITWALTTYMLAMVIVTPLTGLLVERFGQRRLILWSVAGFLVCSVMSGQSHSLTEIVLWRFLQGALGASLVPVGQAILVQAYPREKRGVAMATLGMGTMLGPIVGPVLGGYLTENLSWRWCFYVNIPIGIIAFTMLIFYIPRFGKSEHPRPIDWLGFVWMAIGLGALQMMLSLGDQDGWLSSDFIIILMLSAGTGIFLFVLRSLSVAHPLVDLRLLKDRSLTLGSAGIGLFGLALYGTMVILPIYLQDYMGYEPQTAGLAMAPQGLGSWISMWMAGRLLNRGANPRWMIMAGVFLGATGTWISLSYNLQVSPAWIIWPGVIRGLGLGLVSIPLFTLAFATLSKEQTPEGSGIFNLMRNLGGSVGIAIVSTIMTEEAQAAWNQMGGHISPFNAALPRYLGGAGLRQGNLTWQVLGRVLAQHAAMRGILDAFMFLFWSFLVVMLIALLMKDKS
>fig|380394.3.peg.1564 Outer membrane component of tripartite multidrug resistance system
MQKPLPRPVATVLATALAGSLAACSFEPPLRVPQAPADKTPYTAGISPKETVAPGGPSGHAQKIAYGKELHEEWWKLFHSKALDELIATGLKNSPTIAQAQAQLKQAEATARANASIFYPQVTGNLQANRSKASAAAFGGSSGFHYSLITGSVGVSYYPDIFGVNRLVYRNSEALVKYQQWELEAARLTLTGNIVTTAVSEAATEGQIRATRAIVAQERQLLELTENQYKAGAVDYLSVVTQRSQLASELATLPPLKQQLAVYRHELAILVGAFPADARRQPFTLTELQLPEELPVSLPSQLLKQRPDIRAALSQMKAANAVIGEARAQFYPTVQLTAAFGDTASHPALFFNPVSSIWSLVGAVSQPIFEGGKLEAQKAEAHAAYDAVYAAYRSTVLNAFDQVANALRAVEHDAQTLAAQRAALQAAAEALRLAQASYRAGASDYLTLLTAEVQYDNAKIAEITARSQRYQDTAALLVALGGGWWNKADRKSTPVNTQGKPHPSAGALPVTQVKP
>fig|380394.3.peg.1702 Acriflavin resistance protein
MGAWLLRHRRSLLFLLLVLVLAGLLSAMKMPVALFPNVVFPRIEVSVNSGNMPIQQTDIAVTRPLEQALRAVPGVERIRSTTARGAADISVQFAWGSNMTEALLQAESAVNKVMPLLPPDTRFTARRMDPTVFPVLGLSLTSDHLDPVALRRYAEYDLRPLLLAIHGVAQVEVQGGAREEYQVVVDPMRLQSYGLRPADVERALSNGNVITAVGRLQRHYRLYQILSESPLKNVQDIRHIVLKTGAAGVVDLADVAQVRVGTAPQWTTVTANGKNAVLVNIKQQIGANTVAIDHAIRTLLRKDAKSIPAGINLSTWYDQSQLITAAASSVRDAIFIGAGLAAMVLLVFLRNLRLTFIVAVVLPSVLLASVLILFVMHQSFNIMTLGGMAAAVGLVVDDAVVMLEHIMRRITEHPSEDEPVSVLLSALEMSKPLAGSSAATIIIFVPLAFLSGVTGAFFQALAISIAAALLVSFLVAYLAVPLLADLLLRPRDAEQAEHQGRFLAWISSIYGQYLERILQRPLFLSLIVLTFLLLGGWSYTQVGSGFMPAMDEGGFVLDYNAAPGTSLAETDRLLDQVQQILAKNRDVASYSRRTGLQLGGGITEANTGDFFIRLKAQRQHSIWQVMKTVREQIHHQVPGLRVQTGQLMEDLIGDLTAVPQPIEIKLFGADPQTLQKLARQVAGQIRQVPGVVEVFDGIIIAGDAVDIHVDPVKAALAGMTPGQVTNQLQTLMEGRVVSRIPQGQEMIGVRVRAPHALWNEINRLRQLPIIAPDGHYLTLGQVAEIRMQSGQAELNSENLKPMVAVTARIEGRAMSTVMGEVKGRLAHVQLPQGVYLQYGGLYREQQQSMRELALVLLAAILLVTVLLLFLYERFTVVLSILATALLALGSVFIGLWLTGTERNITAMIGITMIVGIVTETAIFFFAEAQSAERHELVRAGKARLRPVLMTAIIAILALMPLALGLGAGAQMQAPLAIAIISGLLAEIPLVLVVMPGIYAWLERVFKKG
>fig|380394.3.peg.1751 Drug resistance transporter, EmrB/QacA subfamily
MAASAIHATTPPESSQEHRWLITIAFMLAMVMVLLDMTVVSVALPYMMGTLAATPNRITWVLTAYLAANAVTIPLTSHLAALFGRRRLFLISVSGFVVASGLCGASQTLAEIVFLRTLQGGFGALMVVLAQSTMVNLFPGKERGRAMAIWGMVLMVAPAMGPVFGGYITQHMGWRWLFYINLPVGIFSLLLGAATMRKSERKNLATDWPGLLLMAIGIGSLQIVLSRGNEDYWFDSRLIVALSILAVFGILTFLLRGWMIADNIIDLHLFRDRSFATATLITGVFGLGLFGTTAMQPLMLEGLLNYMPETIGWVMFPRGVASAVTMMIVGRFINRYQPRLFIVAGVLLTGISTWIMTSYSLYISPVWVIYPGIIRGIGMGMIFVPLTVIAFDTLPLAVSAEASGIFNLARTLGNSIGIAIDGTVLTNETQINWNQLGGHINTFSATLPNWLQASGLAPQDPRVWALLGQTLFSQAEMIGFLDVFQWITIIFFCLLPLILLIPKRILPTG
>fig|380394.3.peg.1764 Acriflavin resistance protein
MALLGLFAYLQLPTALLPNVSFPMVMVTAELPGASPKTMSSAVATPLERQFASIPGLNSMSAVSQNGVTQITLQFDLSKSPLGATQQVSNAVSQAQHFLPPGMPEPPSVRQMNPSAQPVFYIGMSAPNMPLYDLDKYAQTKVSTALSGISGVSDVQIYGAQTYAVRIYVNPFALSARGLSLQAVQSALGNANVNLPGGTLDGGDQAFATQVHGQLHTAEAYNHLVLAYEGGQAVPLSAVGKAVNSTQDNQQETWINKTPGIVLAVTRQPGSNTVAISNKIRAMLPQLQAAMPGGVHLTNVFDLADYIRAAVHEVLMTLILASILVAGVMWLFLRRPSATLIGAVAIPLSLLGTFLVMMLLGFSINTLTLLALTLSVGFVVDDAVVMLENINRHIDRGETGMTAALNGSREISFTVLSMTLSLSIIFLPLIFLGGFVGHLFSDFGVSIAVVILISGMVALSVTPMLCSRYLKPNHAHTPTDLHDTGHLPEDGIFQRFFKGSRDFYIRTLKVALQHKYWMLALAGLSLAGSVWLVMIVPKAFLPSQNSGMINANIEYPTGMTFAEVSHEQSEIARVVKSNPRIQSVVSSAGQGPGGFGSSTSGHMFIHIRNGYAPETEEIIEDLNRATQGFHNAQVVFQGPQSAHSGTASDNGSYVYELIGNNWTDLNAATLRMTAALRRLPQLSSVSNSLQNNNPQVAIKINRPWATALGVTPAAIENTLGLAFGGHEVGTIYGANDQYEVIMELEPRYQHNINALSTLSVAGAGGTLVPLSAVAEFHYDAAPLTLMQHNGQPSTTISFNLAPGANLGRAISALQSKAKDILPAGIAGHLGGTAAQFQSAFKSLPFLLLATVLLIYVVLAILYEHFLHPLTILTALPLAAFGALLSLVIFNEPLELYSFIGIIMLLGLVKKNGIILVDFAVSRRREGASAYEAIVDACTIRYRPIMMTTFAAILGVLPIAIGFGAGADSRVPLGIAVVGGLIFSQFLTLYITPAFYLFFDELQAAPKYFNWLFGR
>fig|380703.5.peg.42 Permease of the drug/metabolite transporter (DMT) superfamily
MSNTVSRLRSRRERGSSIDIGHGWMTTIHFWHSSRLHRMRRRITSEIKMRSYLLLLAIGLLWGSQFIFMHQAVTELPPIMVAAGRALCGSLTLGLLCLFMRLKSEHTPWRTYMLIALLDATLPFIMVAWGQQYVDSAIAAVVMGCIPFVTILMAPLLVSGEKITKGGLVSVVIGFVGVLVLFWPKLTSGMNAGLLGAMAILFGASCFAIGLLMIKRFAKDHPVVVARNILISSAIQLLLAAPFVTDLSALTMPSQHAIGAVAVLGVFCTGLVYFLYMALIQKAGPTFASFSNYLVPLFGVMLGALFLGEKIQSTTGVALALILGSVALNQWAQQRRVQREAALCQAS
>fig|380703.5.peg.389 Multiple antibiotic resistance protein MarC
MMFFQVVFLALLALLPMVNPPTTATLLLGLSKGMSREHVRRQINLAAIYLFCTLCVSFFIGSSILDLFGISIPGLRLAGGLIIAFIGFRMLFPAPSQAAGVDINQSIAFVPLTMPSMCGPGTMALVISGAAQIAELPDEYNRFTIYAAMVTAFALMSLLSWGVLKLADPVCKILGATGIDAMTRIMGFLLVCMGMQFCINGIKEVAQDPVFHGAPAAQTAPALPHVSGALDQLPDPRQP
>fig|380703.5.peg.1013 Permease of the drug/metabolite transporter (DMT) superfamily
MSAASWWDKSTGLALLTIVLWASLAALTSRVTSVSPLVLVGLVLFFCGMGALPFWRQWRARPVNWLVTISALLLYHLLLFMSFRHAPVLEANLINYLWPLCIILFTPLLLPGHPLHGRHLLAGAQGLAGSVLVMVNGELQLQQAHLPGYLLALGAAIIWGAYSVLSRRLPPAPAVMTAAACLPAGLLALLLAWLLEGPLPVARIPTGDWGLIIGLALGPMGAAFVTWYLALRDGDPRRIGALAYLTPLLSTLLLVLLNGEQLTPRHLLAGALIMGGALLGMLGKPPARQQQEAPAPQP
>fig|380703.5.peg.1144 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSAYFTLRQRAMTRRFWGYALPSIMAMLVSGAYYLVDGIFVGHYVGAAGLAGINLVYPVIMVLIGLAAMISMGAATAISFQQGARNFGLARQALVNALWLLGLLGAVAPLLLHYWHVDILLALGIEQGTDTWQQASDYLYWIGGGTLLLACNLAVPYLLRNDGRPRLAMLLVSSGAILNIILNYIMVGRLGLGLIGTAQATLISEGVVSLLGLGYFFTRHAKLRIEWRHLVPDFPAMPNLLFTGLPSLIAQFNLGLLLLLHNSQLMVHGSVKDLAGFTVAGYTEAVFIVILQGLAFGIQPLVSQAAGAKRHRDLKFLMEMGLKITLVYGLAVWLLIQLLPRQVAMLYTGDQDGELLAAAISSLTLNLGAIPLEGIIMFGIVLLQSMARTRQALLISAAKTLLLLPLIFMLPLWWGRDGVLLAQPTTVVLLTLPLCWLLWREWRRLKLACAPLSRPGRKPLGARQQVQLARRAG
>fig|380703.5.peg.1568 Bicyclomycin resistance protein
MDNQECLDQAGLWSRSARIMTLACLIVFMAQMATTVYLPSLPVVMTDLAMTRQGAELSISLFVIGAALPVLFWGAAADRYGRRLPLALSLLLFVGLSLLLATTSQGPLLLILRTLQGVAAGGAAIIARILVRDHWHGDELARRLSVLSIAFITALGGGQWIGGLISRYAHWQLGFVLMAGVGVLALLLMSSLPLLGPNPAAASGGMWARYASLLRRPGFFWPACAVGIGFAITVTLQEVSPFVLQQGFALEVTTFGSLGLLIGVAYFAGAMTVNRRVARVGGRQLMRQGAALILLAAGGMLLLWALGALQGSSGLLAMMTCYCLIIFGQAVLFPNSMALAVSDGREHGAYAMALCGFLQQGVAGLAAAGATLVSHHGAWAPLVFTLALITLLIVRTRVR
>fig|380703.5.peg.2310 Multidrug resistance-like ATP-binding protein mdlB
MNPTIKRLLGYCARYPRWLIQAGICLLLATGAEVAGPLLIKLFIDDYLAPRQLVWPAITAIAAGYLGLQVLSAAGFYLQSLRFNRIAQAVVQRLREQVFATAIRLPARYFDQHRSGSLISRITNDTEAIMNLYVQVIGLLVQKVVLLCGILISMALLDLRLMLVCACLLPAVGGVMWLYQKLSVPVVRATRSLLSDINSRLNESLQGMPVIQAMVQERHFANAFAEVNQQHWAARLKSLKINGILLRPLIDLFYMMVLIGLLALFAREGLSAEGAIQVGVLYAFISYLGRMIEPLIEMTNQLNQLQQAMVAGERVFALLDEARESTEGEMRPLQGQVSFERVSFSYDGEQQVLRDVSFTAKPGQMLALVGHTGSGKSTIISLLMGFYPLDQGLIRFDDHPMASLSLSAVRRSIGLVQQDPFIFVGTLAENLRLGRDGIDEARLWQALTEVQLAEFVLSLPEGLNTLMEEGGKNLSAGQRQLLSFARALVGDPRILILDEATASVDSQTELALSSALAAARRGRTTIAIAHRLSTIVDADEILLLSRGQVNERGSHGELMALGGHYAQLFEMQSQGAWLEEKRA
>fig|380703.5.peg.2433 MFS family multidrug transport protein, bicyclomycin resistance protein
MPHAPLSPRFLFILLGALAGLTPLAVDMYLPAIPAIARDLATSIDGAQLTISAFLGGFAIGQLFYGPLADSYGRKPVILAGLSMFAVASVGCAMADSLPELLAWRMLQAAGGAAGSVVVNALLRDLFEKDAFSRAMSFVILVMTLAPLVAPVVGGYISAHSDWRVIFWLLVGISLFICLVLQWKIPETLKPEHKQPLRLGQVLRNYWGVLSHRGAMGYVLCGALSSSGMFAFLSASPYVYIEYFHVPTEHYGWLFGLNILLMMVVTFVNSRLVKGVGAERMLQYGLTMLPLAGALLIYNAWSQTGGLWGIVIPVVLFVGHISLVGANAMTGLMGHFPQSAGTASALAGTLRFGVGALVGILVNLDPPESPLPMAIAIASCGFGSALCYWLLTGKKK
>fig|380703.5.peg.2503 Multidrug resistance efflux pump
MDLLLILTYTAVCVAIFKIFRIPLNKWTVPTAALGGVLLIGTLIMLMNYNHPYSEMARNYYVSTPIVPLVKGRVIEVPVQANQPVKKGDVLFRLDAAPFQLRADSLTARVESNRNHLKSIEARLRSAKLDRDRASDLMRRGVGKQRDLDVTQANVDDIVAQIEQQQATLEDLQAQLDEARYQVEQTVVYAPSDGHVVQLALRPGMIATPFMYRPVMTFIHKDETAYVGWFWQNSMQRLAVGDEAEVVIDGIPGKIFQGQVTAVIPAIAAGNVQANAGLLDQASAVQPGRLPVLISITDPEWPKYQVIAGASGQAAIYTKHFHHVSVMRKVLLRMASWMNYVFPFH
>fig|380703.5.peg.2513 Permease of the drug/metabolite transporter (DMT) superfamily
MLISTVPTNKSRYSVIAGWLSGVKAAVLSDFRCLLTTARPHGYYSNGQFHGGNVRPLPIFTLTLAMLLWSSSFIALKHVLGVWGFGQVLFMRMSVAALCWLCCYRYLGNFRYQKGDWRWLALMGALEPCLYFLLEVNALRYTSAGQAGMVCALLPLIVALVAFVLIRERVSRRQLLGFAIAIFGIALLGFGSGTDEFAPNALLGNSLEMAAMFCAATYSVVFKKLCSRYSVLTLTALQAFVGTLFFAPFAFGEPWPTAWVWQDMAVIVFLGACVTLGAYLLYNWSVTQVKVTLAAAYVNLIPVFTLLLAYLLLGETLNALQWVACGAVLLGIAVGQLPARRVRMPAATTGS
>fig|380703.5.peg.3309 Multidrug resistance-associated protein 7
MDHPEISAGWLSRLFYHWTGPLQRKGLSEPQVNLDDLYPLLPEDRRDGRADAFLALTAAQPVRPWPITAFIWRHYRGRIGLLTLLQMLGMLATLASPWLLNHSMTQLGAGAPTEQKLLLAFALFASVLASGMLAEHSLQLALKMHVPIRRLLAESLLAKVMKLGGKSFDDRAGGRVQNLINRDVWDITWILADPAMPLTMLLQLLGTIALLVWQVGSAGLVGFAVLTLLLLISTRVVRRMNQQEQQLKRQQDERNGILAEYIKKLRLVRQNGLGAFFTRAAGHKRQQELGVLGRVLRLDAINESLMLSTPLLVTLATFTTYLVSGRELTLPQVFTTIALFTVLRIPMMRLPYLIRTLINFNTGFNRLCEFLNSPEQHRDLTDPSLPVGGLRLDNVTALHQQKPVLEGISLHIEPGELVGITGATGAGKSCLLHLIAGFDNGFEGSIRRHGRVAHLGHKPWLMNDTIRNNILFGQPWHGERYRWVLGACALGADLTLLSHGDQTLVGELGTRLSGGQQQRVALARALYAQADILLLDNPLSALDPIVSAQVLEQGLAFKPGPTRLLVSHDPDVLAHCDRVIRIEQGRLVELDAHQLADLIQHPRPTPPVPPQEAEQFSEEKMVEGKVDWGLFGFMWQRLAAPGAILLALLLTLGQEGLRIASDLWLGGKAGVTGVSELLGIYVLLGAGSLTCIMVVRVINYKLGLKLAWTLFDGMLGRISRAPMAFFDKVPQGRILNRFDRDLGEAQEILLSMLMGLFGMLVSVVLQVVVIGVNMPLLLLIAPLVGWALYVLQRRYRAVQLKLRRQASVLRSPLYISISETIRGAPALRLAGAERFALDQVLLHYDNNLRSWYTTTSINRWLGMHQTLLSAALVGAVALMVAFGNSSLLGAVAITYAFTASAMLNSLIRTFAEVEQVMNAVERVREYSEIESERQEGEALATPHPAVRFDNLGLRYPQASQWALHKVNFELAPGEKVGVCGRTGAGKSSLLGVLQAMYPASQGEIYYGEQPLSRLAPEAVRDLYDTVSQIPLTFFGTLRANLAPLTKHDDAALEQALARVGLAERCAGRLDEELDKLQLSAGETQLLVIARILLSRRPLIVLDEATSDLDHIGMRKMAELLYRYRPEASYLVIAHHLEPLLSVDRVVVMEAGTVVEQGSPVSLLANSHSRFHQLFVGQVNRQVPQTV
>fig|380703.5.peg.3640 Probable antibiotic-resistance protein
MLLDGSPQPEIELVSRHPGAQAADGVGHDGAGGEMAIAERIQHGGVGAQEAAPAHAHGGEHRHLVAGDPALADEGRHQRHGGPDRPQRGDREGHQLGVGEAEQQLEQPAHLGRQHRQQRHPLEGFTAVALLARAEGQQHHEGADDEHPGDHRHPQLHPGLATVQQGVEHPQPGRGGFLAQTRFGPHARHLVGDRGLPHQRADHPLHQPGRHHGADEGAEQTDQRRAGGGLAARQLQGRHEGHHDQPHAEGGAEVGERHQLPGGEALAKTAVLGEADHRRVVGEEGHQGRQCGAPRQPEHRLHQRCQQHLQQADHPELAEQLAECARQHGNAHDEEHCVEQQLVSGVEQGVDQGGEAHLAAEVAKQAAEDNQHQYRLQPAAKGGRPLVRIFNCLIFHTNPEICRCVVSIVVMAPIKQEPLSCDKGSLNDSSCRLQTRVIRIDASPRQRLNQGGNTGGRTILSSLPVSRQHAGPRPARRRNGAAV
>fig|380703.5.peg.3899 Multidrug resistance protein B
MSSSPLCGARIMSSFTRVLTPAARRLGLLALGLATLLPMLAGSMASMLLPALGADFAVPFASLQWVLVAYLLGLTCLTVVAGRLGDRFGRRRLLLWGMGLFVLASLLCAQASTIGWLLAARVLQGGGAACMLVLSLAMVGQLVSPARRGRGMGLLGTLSACGTALGPSFGGLLLDVAGWQPAFLALLPIGLLALVCGLFGLPRDAACTEGERLNLASLSLLLVALLCYGLALTSTGALALWLGGGALLATAWLVRSELGAAAPLLPLALLGTRRLRGGLAASALVAGIMVLTLLIGPFYLQGVFGLDPFTSGLLISGGPLLAALTGLPAGWLVDRVGAITVVRLGLLLMSGAAALLAVLSPALGPLGYLLPILLLTAGYALFQTANNSAVMGGSGGQARGAVAGLLTLARNLGQLTGAAGLGALFAGLAGGGDPAVASASELHFAMQASFALSGLLLLAALWLAGRDQCSAPGEATRAGCESGGG
>fig|380749.4.peg.571 Multiple antibiotic resistance-related protein
MDRKQAIDIIYFIIKFSISIFAILNPFGALPVLVSLTKGYTKEDRSYVIRTSSIYAGLTLIFFVLFGDLLFEIFGIGLGAFQIGGGIILSFVSINMIFGQPHRERASNQELEEAEQKENIAIVPIAIPLLAGPGAISTVITIASSYRSVFYHVLLILSILVACIGVFLVFKSVDKIVKILGKIGINILSRLMGILLMSLAMQFIIKGIQLAFPTLGK
>fig|380749.4.peg.781 Acriflavin resistance periplasmic protein
MKFYVFGLLVLMLSLFSCEKPKTKEISKGIKSPNIALCKVVYGAYQVKTPIYGEVQNQAATYVSSPIGGILKSVYVKNGDFVKKGQVIAKLDTKVFQDKALSIAQDIEASKKKLKYYMSRYERAKKLYKLGSMSYQEYSQIKTDLALAKGELDKNIYLKKSLEDEASYGIIKAPFDGIVSNVVPSGSNVNPGSPIAFISAKKLYGEFFIPFNMKISHTDKILFENKLYPINAFQDDKSRLAVILPISSYENPGSSLKAFIVKTIQGQRIPSKALVLYNNRPSVFIEQGDKVKNIPVKILGNMGQYYVVSGVIGDSVVCKGAKLLKDGEKVK
>fig|380749.4.peg.1480 ABC-type drug export system, membrane protein
MWFLAFIRGSFVILEIELRKMIRQKVDIITRAFQPLIWILLFGNVFKNIKSIPIKGDYLSFMTPGILAQSVMFVSFFYGISLIWDKDQGQITRFLSAPIPYSSITTGKAIFSGVRSLVQAFLIMILSKAINVNIYINIYTILLSIVVIMLSGICFASFSMLIASIFKNVERFMSVIQIITMPIFFSSSALYPISLMPRWLKVVALLNPLTYSVEGLRLLLYKNSLDISIPLLVLSSYSIVLLVFSAYSIKKLVN
>fig|381764.6.peg.333 Fosmidomycin resistance protein
MSISVLSFLSIASHFLLDFLVSFFNPLGPYLIQKFGIEIKLFTTFLTLSSATASLLQIFFGFWFDRVTSTRKYLIAMYFLEALGIAILGIATNFWIALISIFAIRIANSAFHPLGAAMAGEGTGKTVAIFSIAGTFGAALGPVFISYYVSKFNSTQTLWIISIPFVIIAFIILRINLPQKTSKKNEKITLKEASILLPILLVVTIRSFLMSIVHTYTPIFVTNVLKFPITVSGTLITSGMIAGVPANYIGVLLMEKIGVKKQDLVAFAGMALSVFFLVFSKTLIAIFVSFIMFDFCGFLLMSANVVQAQKIMPHRKAFASSVAMGFAWSIGDFIASGYNSIFGNNVKLSLILVIPIAIVSSIYFGITQKFDTK
>fig|381764.6.peg.883 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKVNVLNERIEYSLFHLAWPLIVSNALQTIYNIVDSYFLGKLGPVQFSASTITWPVIFTFISLAMGFSNAGIAIVSQSYGKMDIQKVKKSMGQLYLVTISVGLLATVLGIAFAKPILNSIAGSESRDVVPYALKYYIVDMLGLPLVFIINSTTSAIRAVGDSQFGMRITLYMNLVNMFFDPLLIFGIGPFPKLGVAGAAWATNIGRFIAAGISLYHVASKQAHVKISKSDFKPDWKIIGLIFKLGLPSALGMSITSAGFAVIMKYVAMFGPAVISAYGIGNRVTNLVSMISFGLAGAVSTMVGQFIGAKRYKDAEYTVLKAFYWNITIIGVLSLLTFIYGKQVTQFFINDPKVIQMGEIYFKYISFSMPIFTAYMIYNNALIGAGKTILTMVGDILRLWGIRIPIIATLSLTFGFKGIFVGMIISNLIVFVITYLFFRLSNWKKSVV
>fig|381764.6.peg.973 Permease of the drug/metabolite transporter (DMT) superfamily
MLSSYLYLAFTLFAFSSIEVVSKPLMGIVDPFFMTAFRFLLGGLVLMIFVKDDIEIKDFLPITLVGILNSVISMTSLQLAVKYSNASTAATLVASNPIFVSLFAWIILNERYKLRKYVGIGLGFLGLVIFSFGKISGDSWLGIFFGVVAASTFGLYTVLMRKYTKKYNSLVVTAYSSLSSGLIYILLLTIFRKFEIPILSINQWFILIYLGLIVTGVAYLTFFKAMEKIGATQSSRIFFLKPIVATLLAIVFLGEKLSLLKIIGMIIVLFSLTL
>fig|382464.3.peg.63 Glyoxalase/bleomycin resistance protein/dioxygenase
MSEPTVSFSLTVKDGNKALDFYAKAFGAKELYRMATPAGGVAHAEFQIGETKIYLSDESPEWNAFAMEEGAKASCLFSIATESCDDSFQRASEAGGEVLSEPTDMFWGARSAMIRDPYGYRWSFTQIIEEVSPEEMERRAKEAFGI
>fig|382464.3.peg.570 Permease of the drug/metabolite transporter (DMT) superfamily
MTSSSPVIISKVQPLLRIGLLLYIVLTASFCYVFILRGLEYAPPLAFAGFRTFIGGVTLLGISALRTGRILPERRLWKWVPCVALTATSLTFGTMFLSPGFAGAGIASILGNAQPLFIAAIGFFFLQERLSPLRALALLFGLIGVIVIVSPSFGAKENALLIGSLIALMTSLSAAIGTVLGRYIKLGDSIVAFVGTQLATGGIILLFASLIFENDSIEWTPAFLGILLFLAILNTAFVAWAWFYLLQREQASGLGMYLFLVPVLGVAWAYVFAGERPEPTSFLGGAIVLLAVFTQEFEGFRRRVR
>fig|382464.3.peg.964 Transporter, drug/metabolite exporter family
MLRFLLLLSGVFFCSTSVIIIRSSELPPSLLAAYRLIFAAVLLSPPFLLAWKKHRNAFPARQFLRCILPAVLLATHFISWAWGARLTYIANATLIINLTPAVMPFLAHFLIREKVTRKEILGTLVALCGVFILSYSAFSIDPQFLLGNVVCFGSMITFAAYLAFGRINRDFPSIWLYMIPIYVIASVICFIFSFFTLDSLSIRSTDEVGWMLAMAVLPTILGHVTLNRSLRYFAAQTFAVVNLHQFVFAGIMGWLIFKDTPPTIFYFAAVLCISGAVIVVHEAARIRKTATQ
>fig|382464.3.peg.1478 Acriflavin resistance protein
MAEDPIKKHPIIAWFADNSVVSNILMFIILGWGIYSAITIRKEAFPSFAADSVTIQVPFNGGAPEDVERGVAIKIEEALQGVDGIDRIRSTSTDSGATVTVDSIEDYPITKLFNDIKVQVDAISTFPGEAEKPIITENKARNSVIWIDVHGEVDEALLKETARDVRDQLLKLSDVNQVNTYGDRAYEISIELSENKLRAYDLTFDEVATTIRNNSVDLSGGLLRSDRGDIALRSRAQAYNKDDFAVIPLRTSSDGTRILLEDVADIRDGFVDQQYLNRFDGEPTVSLQVTTDGDKDIIKASKQAAELAATYQDRFGLPEGITLSAWNDGSESIRSRLELLTRNGLQGVLLVLLSLSLFLNVRLAAWVAIGIPVSIAGAMLLFNLPLFNISLNLITAFSFIIVLGIIVDDAIVLGESIYTEKENQEHWKDDQANIRATVRGVSRVITPATFGVLTTIAAFFPLTQVSGRMGNVFGQIAIGVIFCLIFSLVESKLILPSHLAHINVHKKPNNPISKFWARFQGLFASSLKFFINKTYRPTLRQAIEYRYLTLATFIGLLIVIGSLLPSGKLRFVFFPDIFQDNVSANLELEEGLPVSHLHANTLQIAEAIRLVNEDIIAETGQSAVRHIQISSRSNTASSVSASLTSSEDREINTGQIVNRWRAKVGQIAGSKALTFSGRAGPPNQGLSIQLESKNLDALQTAADAMKEEVAAYPGVYDVKDSFSSGRPEIQVNLTPAGQASGFDRRELASAVRSAFFGMEAQRIQRGRDEVKAMVRYPEEDRGKLDTLRDMRVRSADGTAIPFSIVAETEFGKSLAAIERADYNRIVSVSAEVDKSITSGDEVLSALTIEYFPVFAASHPDVNIALRGEAEQRMKSMQSLFTGLMVSLLLIYILLAIPLKSYVKPLFIMSVIPFGIIGALLGHFVVGIPVSILSLFGVLALSGIVVNDSLVLIARIDDLKAEGYTLRDAIIEAGPQRFRAILLTTLTTFIGLVPILLEPSVQAQFLKPMAVSVAFGVLFATTITLVLLPVLLITFDETIASSFRYYKKLIAKKWG
>fig|382464.3.peg.1976 Acriflavin resistance protein
MVSIVALGIYSAFNVIILQEHPDYPSRNITVSVPYPGSTPREVEQAIITRLEEELYDIEGIKEMTSRATSSSGTVTLEIEDGYSLGTALDTIKNRVDSIRTFPVEAERPRVSMPEHRERVITAVVSGDLSEMELKRLGEEIRDEITNIPGITVASLKATRPYEISVEVSEHTLREHGLTLESLTNAIRAHSLDLSAGRIRSEGGDIMLRTSQQAYTQEEFESIVVFTRPDGTRITVGELAKVNDGFDETPIVSRFNGQRSVAIDVYRVGSQNILELGAAVKDYLKLKQEQLPEGISLEYWRDDSDRIAERLSTLKGSAIFGYILVVAVLSLFLRPSLAFWVALGIPIAFAGAFFMLPLMGISLNLITLFAFILVLGIVVDDAIVTGENVYQRMQAGEDSLTATIKGTQEVAVPVVFGVLTTIAAFYPLINMTGWRGNIFKQIPFVVIPVLLFSLVESKLILPAHLKHCRPINNAHTASKGILTRMQRRVANGLERFVEKYYRPSLELCLRYRYAVLVVFIGLLGLFVARFVAGHLPYTTFPRIPRDSVTVTLNMPIGTSFDATQKIVDRIEKSAMQLRSNLEEEHGVDIIHHIFATAGGRPFSSWRSTAGVAEEGEVILELASSATTGVSIGTREVSMGLRRLIGPVPEAESLEIAFSWGGGDAVNVQLEGPRIEELVEASRELQRKLATYEGLYDIEDSFQRATEELELELKPQAVHLGVTARQLASQVRQAFYGAEAQRIQRGRDDIRVMVRYPESQRKSLAALHSMMIRTQDGTQVPFEEVAEVVPGKSLPSIQRFDRNRIIRVTAAGDENEIDEEAIQLDLEKNYLPELISKYSGMGFTMQGNAAATRDNNAELVNGIYLVLLVIYVLLAIPFRSYVQPFIVMTAIPFGIVGAVMGHDLMSFVYTTLLDREINPVGNVTMMSILGMLALSGVVVNDSLVMVDFINQRRKEGMALRDAVRLAGAKRFRPILLTSLTTFAGLMPLMFESSRGAQFLIPMAVSLGWGILFATFITLYFVPLTNLVVNDIGNFFKWVYGKQEAIGSSSGHATTPEAAARVGE
>fig|382464.3.peg.1982 Acriflavin resistance protein
MFVFIIAGLGAVATTKRELFPDFSLDMITIRVPFLGASPEDVEELVIVRIEEALQGVNGIKEINSVATEGYGSVTVTVDKGYSASRLNDDIKTRVDAIPSFPENTERPIIEEILIPKDVIRVSIYGDASESEIKKMARRVRDELVEINGISQALVQGARDYEVSIEVSENALRNYRLTFDQVVNAVRSNSIDMPGGTIKAQGGEIQLRTKEQAYRGDDFADIVLLTSPDGAKVYLKDIAAIRDGFAEQDIATRFNGKPSTDVLVREVGDENPLQISRDVYDYVDRAMETWVPEGVYLEAWADSSYYLQGRIDMLLKNGLIGFILVLVSLTIFLRPTLAIFVAIGIPVSFLATLAVGPFVGISINLLSLFAFILVLGIVVDDAIVVGESVFTEFQKGGPGVQSAILGTHRVSTPVTFAVITTMVAFIPIFMLPGTIGKFMGVIPFVVIPTLAFSLVQSKLVLPYHLSLCHVGDKHARGKLNWFSRMQRAISDGLERFIETRYRPIITFAVKWRYYTLSTFILFLVIAIALPVSGVIRFVFFPSVPSDYLSMGLTMIEGTPFSETERALKRIEDALEEIRAEDAAKGLIDPVKNKAVFLGSQPNSGGPGGGAGASSGSNVASIILELAKSEVSDSNATEIGERWRAKIGEIPGARRLNVQSSASGPVGLPVDVRLTGRDFTQLKAASLEIQEKLKEVTGLFDIRDNYSEGKRELKIRLNENARALGINAFDLGRQVRNAFYGAEVQRVQRDKEDVKIMVRYPRSDRESLGNFENMRIVAPNGARIPISEVAELEMGMGYPAITRLDRNRVINIQADADKRAITTNEINFEVYEVILPEILAKYPGVTPAIGGEAKDLAEAGPAMIGGALIVIVLIYALLAVPFKSYIQPLIVISVIPFGIAGSIFGHLSGPGFKIQDLSLLSILGIIAMAGVVVNDSLVLVDRVNRLRAEGMDMHKAVINGGQQRFRAILLTSITTFAGLMPIMFETSLQAQFLIPMATSLAFGVAFATFITLLLVPSIYLILEDFKWIVCAWWRGLSRGFAR
>fig|382464.3.peg.2382 Glyoxalase/bleomycin resistance protein/dioxygenase
MVLLGVQSVPRSAAFYESLGWKKSPTGHDGFAKFDLGGYSLSLISREDLAKDARYESAEGSGFPGIALIYLAETPEEVPLILNRAVKAGGSLLKKATRTEWGIAGYFKDPDGHIFEVDYEDAWVFDEEHRLVVDKMN
>fig|382464.3.peg.2393 Acriflavin resistance protein
MDFARVSIKKPVITWLLVAGSVLGGWFGYLNVGRLEDPAFTIKEAVVVTQYPGASAAEVEREVTDKLESAIQRLDSIKEVRSRSYAGRSEIEVELVWTMGPDEIPQIWDELRRKVGDAQASLPAGAGPSLVNDDFGDVYGLLYAIYTDDVEPADLRDYAKRLRMQLMQVQDVADVSIVGAQSEEFHVEFSPEQLARFGISPQEALSGIISQSAVVQSGGLRVGDRYAAIEPTDMLADVDSLSELPIGRKGTDAFLALGDVAKVERGYVERPTQFVRFNGHDAILVGVSGRPKVDIVKVGKRVDARLSELESDRPLGIEIAPVYEQHVVVETAVGGFVVNLIMSVTIVVGVLCVFMGWRSGIVVGAVLFLTVSATVFGMYVLGIEMERISLGALIIAMGMLVDNAIVVAEGMLVRVQRGLGKLDAASEAVRSTWLPLLGATVVGILAFSGIGLSEDATGEFTFSLFVVIAVSLLLSWVFAVTVTPLFGYYLLQKPAKESESEDPYKGFVYKIYRSALKLSLHFRALTVLVLILMTLGSLFAFTKVKQSFFPDSNTPIFYLNVWQPTGTDIRATNATARELEKLIQKDERVNTVTTLVGAGAPRFMLVYAPEHPDSSFTQYIVRTKEADEIDGLIADLRSLIADTQPDLFVKTERVKLGPGGGAKIEVRIVGADTVVLRELGDDVMDVLYADDGLRDIRTTWRELRPVLQPVFDPQLGMRQGLSRQDFAQQMQLLSDGAVYGVLRDDDELIPVRVRLPQEDREDAADLGQRLIWSSGLNGWTPVESVVSEIELAAVEGVVHRKNRERTLTVQAEPVPGELASAAFARIRGVVEGLSLPVGYRIEWGGEYEISTDAETALFKGLPVGYLGMLVIVILLFGRLRQPLIVWSVVPMSIIGVSFGLLSTGVAFGFMSLLGFISLTGMLLKNSIVLVDEIDARIASGQPRYDALVEASISRARPVALASVTTILGMAPLIFDAFFIGMAVTIMAGLAFATLLTLIVVPVIYDLLYRIHPDETEV
>fig|382464.3.peg.3260 Permease of the drug/metabolite transporter (DMT) superfamily
MAFAALYLIWGSTYLAIKVAVETMPPFLMATGRFFLAGLVLYGVARASGAARPSGGQWKHSWIVGGFLIAGGNGVVSYAETFIDSSMAALIIASNPLFMTLFGWWGGVQAKPGRMAWLSLAGGFVGVATLIASGSGIEWGNSLFGYILVVGCVLLWTVGSIYSKRNPQEMNPWLQSGMQMICGGAICLLAGGSMGEFSTLDFAAISSRSWIAFGYLFIVGSLIGFTSYVYLLKHCVPSTVSSHAYVNPVVAVILGWLILGETLNMGGWVGSGMILVSVFILLRQGRK
>fig|382464.3.peg.4538 Multiple antibiotic resistance (MarC)-related proteins
MGLLEYTLLAFVTLFVIVEPISIAPIFLAMTAGNDRSARTRTAKIACVTMVTVLLLFAVVGMSLLEFFGISVAAFQTSGGILLLLIALDMLQAKESSRKITQEESDAGTAKEDIAITPLAVPLLAGPGAITTCIVLANQAEAWDQRMALYGVIIFICGLTFLILKLADKGAAWMNPLFMRVITRLAGLLLAALAVQFIFNGLRDSGLFPLSGGAL
>fig|382464.3.peg.4822 Glyoxalase/bleomycin resistance protein/dioxygenase
MKNRTVTITVSASVDEVFSFLANPEALPLWAVSFCKSIREEAGRWIVSTGQGELAFAIEADRASGCIDMLAGPTLETVESFPIRVFKADNGQTAASFTMFKSQRPDMTDTLFEMHYRGLVKEVGTLVERFGGGELSSGLPEASKLTVGLVSDDIGATRDFYVKHFGFQAVFDASCYVHLSREIGGEQIGLMAATAEAGQAEFESATTGQGVWISLEVEDVDAEYERLKGEGLVFRESPADQPWGERTCVTSDPNGVLIYVSQPNGKMDESLKQFVVEEGAELVS
>fig|383372.4.peg.1577 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MATAPGADYAAMLKRWLSQILWIAPEGVIIALLLAINAIVPSIWIGAGMTLLVVTFISRITALYLTSRALFQARWEAADALATVASMLHPWSPDALALRGAIALARSDSATAVRLLQRAQRLAPNRSAITAALSGAYLEEGEPQAAAVAARRALELDPANAAAHLHLAQALAAIGARAELIEDQLRAGLAHHPEPDAEASLRCALAHHLAQEERWAEAALALSAARAVLPHCSAAQRAIVSQRIAEIDRAIHSAREDHAA
>fig|386415.6.peg.420 Drug ABC tranporter, ATP-binding/permease protein
MTIFISNLKRIFKSKTNIFFMVILPVVLIIFMISINRGGRRFSLGIVDYDNTSFTEILAKEIGKDSKINYLNQKDIDKSLVNFQNDYIIEIPKGFTKEVINGHDKKIKGYEIDGINASSALKFNIENFISTSKDIGKYVKGNEKLFYNALEKYREGILDVSLENMDKSPINQNNIEFCVGILIFNMLMLGINMAPIIIKDKISRVYYRIFVSPIKPQNYTLQNLMSFFVVLIIQIIILLTFIVAILNISIPNLKSIFLMFLIFGVFVVAYSLFISNISDNSRTVSIISRGTAIPMAMLGGCFWPVEIMPSVLQQVSKFIPVTWMMEAINKLLYNNSLLSILKEISIIVLFSIVFLLLASWRRKDIVNL
>fig|386415.6.peg.505 Vancomycin B-type resistance protein VanW
MARKKGSSTNAKSNKKIFKLSIAIILVIVCAVVSYVYFTVQKFNDSIFPGVQVEEVNLSGATKDEAMKILREKYSDAMLNKKINIKAKDKDYFINYPELKARYNIDDTVNHAMNYGKDKNMFSKYMIIKGKKSKIYELELSYDVKPIDKMIDKIAKETNVKPVDAKLSFDGGSFGVKEDKKGVELEKEKLKKEIISNINDKHQDVVVINAPFKVIASKVTAEVLKSVNSKLGSYSTNYATSSEARATNVAVATRSIDGKVVMPGETFSFNEVVGERTRARGYKEAGVIVNQKLESGFGGGVCQVSSTLYNALLRSNIKMTERVHHTFPSSYVPTGLDATVDWGNIDLKFKNTFKYPIYIQGYTGGREVGFNIYSNSELARTRCEITSEVYKKIEPRTEYINDSNLPAGAMEVVKSGHTGYRVKSYRSIYKDGKFVAKELIANDYYVPVNGVVKRGTRK
>fig|386415.6.peg.539 Antibiotic transport-associated permease SpaG/mutG
MKILRLMKADFIKMKHTSFYWIHICVPIIGILIFLGYYSFSIAGSIGKVNGYLDGLSLVFPVVIGIVCSMVIEQELKAGKFKEMLSVEYGKGICLLSKVLVVLVMGFFSLSLAVGGFFIGFEYILRQNILPFKFYAVLTLLIFMAQIFIYLFHLWLSIKFGSGASIGMGIFESLFSALIITGLGDGIWQWIPCAWSIRFCNNFFIKKANSIDIFNKLADFNTGLSINAIGFRNCIIYTIILGILFGIWFNFFEGRKSE
>fig|386415.6.peg.658 Acriflavin resistance protein
MDKLKNYPISLEDVTKALKVQNVKIPPGAIESKTSKIDVITSNGFDSIKDIENVVVYVSEDTGAIVRLKDIAKIYMDYDQDDVKYKQDGKKSILLTGHFEDNKNVVLIGKDVRREIESIKKTLPNDLNFYEVLYQPTDVDNAVSDFMTNLIEGIILVIVVIFAGVGVRNSIVVSTALPISILLSFIMMHFAGIKVHQISTMALIIALGILVDNAIVISDVVQVKINQGVDNVRAALEGAKESSIPIFTSTLTTVASFAPLLTIPGVPGKYVESIPKVVIISLIASYICAMLITPALAAVCYKKTSDAKQGKIMKKVEKFFENALSFGLKKRKLTILISLGMLAVAAFITTTLGLQFFPYANKNMMYINTTIEKKGDIKATENLSKVVEKVLKAQPEVKSYSTGIGDGLPKFWVAMPPSVPSNDFAQTKIDFDLKKGGRFKDNAEFANFLQEKLDSEIVGAKCTVYPLQYALPKEAPIGIRVIGDDMEKLYAASEKLQGLIRQIDGATKVRDDAADRTYQYKVDIDSDMASQLGIIKYDIERQINIALRGTEGSVYRKNGKEFSIIVKSNIDSKEKLENLAVKSTLAGHKVLLKEIATINLQTQIDTIKRYNKEDCINVYADIKPGGNAVDLQDKIEEKIKTTDLPGVRLEFFGEKADIVKYFGTLGQSAGVAIFFIYIILLIQFNSFMQPFIIFLTIPLSLIGSALGLFIFRQPLSLMALMGIVSLVGVVVKNAILLIEYINKARKEGYSLNDSCMDAMKKRFSPIILSAFTTVMGLAPIIPSGNPMFVPMAVALMCGLIVSTLLTLIIIPVLYNLIESSVDKFNNKHKGGFKFNFKFGGRKIKKENTLEG
>fig|386415.6.peg.1814 Ribosome protection-type tetracycline resistance related proteins, group 2
MKNIKNIGLVAHVDGGKTTTTEQMLYISGAIRELGSVDKGSAKMDYNSIEKKRGITIFSDQTSFTWKDACINLIDTPGHIDFSSELERSLKALDGAVLIVSAVEGVQAHTETIWNLLRKNNIPTLIFINKLDRVGADIKEVFSQIENNLTEKYLKIQRIDGLEENFNETIDLLVNEQFYNDSKEKIELIEKFAEINEEVLEKYLEGEEITREFFIDNLKKSVEEGEVFPVLFGSAINGIGIKELLNSIEELLPYSSGNDEDEFSGVVYKIKYDDKIGKLAYVRVLNGEIKVRDTIINNLGEEEKITQIRKYNGDKYNTVENLTSGEIGVICGVKDIKVGDVIGNKDDINIINENNESALISRVVPQNEEELPSLLKALQILNEEDPSLQLEYNPENKELSISIKGIIHMEVLKELIKERFNIEVEFLEPKVNYLETIGEITNGFCHFEPKKHYAEVEVEIEPNERGKGVEFISEINGDILPYQYQNNIEKASYEAVLHGPLIGGKVTDIKIKLTNGKHHLEHTHGGDFRIATIRAIYQAMEKNKNIILEPIYKFKIVVNKEMGGKIMTDILKMGGSFNEPEVKGEKIIITGEVPVATSMNYKLELLSSTSGKAVFNMQFSKFEVCHNQEEVVKNSENIVEKEDSIYNGVSLFREKKKMKKVVLNEN
>fig|387092.5.peg.77 Multiple antibiotic resistance (MarC)-related protein
MNSIFISILLHDIIALITIINPIAAASIMISMISPPTASAIADVARKATLTVFAASFVTLFGGEVVFQFFGINIYSIKIIGGIILMLIAINMAYGHGAKNRHSPEEAQEAQEKEDIAIVPLGIPILFGPGVIATIVVLSHNNSSQLHPALSYILLSIAILIASLATYLTLRYASIINKALGVTGIKILTRIMGLIVGAIAAQFLISGIKGLWEA
>fig|387092.5.peg.81 Acriflavin resistance protein
MFEYFYQRPYLLFSLIVGFFAMGIIGLKSLPKNLFPDANRPQVVVITSVPGATAEVAANTVSKPIEEEISRISLVRDVSSVNVANFSIVKAEFEYEKGLEAAAVDVANALSIARGKLPKNANPSVYTVGDFTLPVEVVALSPKNSNISLQEIRKIAESHIKPYLLANPHIGNVEVFGGYQSAINIEVDPFKAKKYGVDFDTLAKVLFALNKDIPIGFTKSKESFYTITYYGEKDNIEKLKNLHILPNVKLSDIAKVSWSYKKRTSGYLGNGKNAIALSIQRAPAGSVLDVSDAARAEIKKLQKLYPNIDFQIADTQRTLIETANENMLEALRDAIVYTLLVLLFFLGNFRAIIAAGISIPLVFFGTIAIIWLGGGELNIVIYTAIILALGMLVDDAVVVLENIERHLELNEDMQTAIVNGTKEVLGPVFAGTVGTIAIIFPLMFVGDFPEHIFRPLISTLIIALLVSYFLSITFIPRFSAVLYKNGTGKTKIEQWFEDVYKYTIGQLIGPYISVLKFSNGKWWALRRMLLTAAVVLTFVLSLKNVMPLIGKDVMPPMDTGIIKAQVAFSANETVDSAEKKLHKFLVWLHKQPWVKSSSVAFGSESGVLSLGSGNLPSEATITINAVDRFHRNKTIWQLEDEIRDKIAELPGVKKNDVFDFGATALSTIKAPLDIRIKAADYEKLPDKAKEIIDAIRNVKGLTSISQSWDKDFQEVVINIDKNRALSYGVTPYQIAMQIPLKGQVVSLAADMATMNTQFVRMYLKGKFNENIQSLKLLPIKTKFGEIPLSELAKVSYQLTPAKIERDKLLYSVDVSGYRSKRPVTHITDDANAALAKVDTTGFVVTQEGDIAQLHDSFKRMIKAIAIGVIILIMTLTAIYESVRLAIIMILVLPLSMIGAAWGMLIFHKPSCMPSMVGLLLLFGIIIKNAVLLIDFYKEYEKEGKSPFEAAIESVRVRFRPVMMTAFGTIAGMIPIALEQAVGLERLSPLADVAIGGLLVGTLLTLIYVPMYAYATDPRNRKTNPIEKVEEYIEE
>fig|387092.5.peg.703 Acriflavin resistance protein, AcrA/AcrE family
MKKIILFCLMSIALLAKGLELSGYVKSDDTKMIGTRFMGYVEKVYVSEGDWVKKGQILYKIDSKEIDLAKSQVELMISQARLAIAMNENMYEFAKVNYMRHQKLYKKGMVSKFELEQMELMYKNTKNMVEIAKKQLAQAKAKLAEVLHQYEYLKIKAPNDGVIIQKMVKEGQLTVPGYPGMVLTTLDNLKIEAEISESNLKNIHIGQEVTVEVPSVGFETVGKVSAIIPAANPMTHKFKIKVSFDKKGAELIPGMYAKLIWK
>fig|387092.5.peg.704 Acriflavin resistance protein
MKCAYKPKDIAGKLALTFLHNPLTALLAVFILAIGYLSLEVMPREEDPQIAISGGTIIVPMPGATPKEIENVVVKPLEEKIREIKGVEHIYGIAMENVGIVNVQYFIGQNREISNMKLYDKVMQNMDMLPKNAMHPLVKPFDIDIDIPILTFAFYKKNPNLSDGEFYKIIRDIKYRVNGVKDVSKTNLKGAHKRQFNILVDLGKLSGYHLSLGQIMQAISSVAKEVPEVKNRTKNSKIVIFGVPNAIESVEDVKNIMVANYMGSPIYVKDIAKVEDGINIQDFKQAQIWTKKLHTKPQYTLEVSKLKGTNAVFVANDVLALINELKPYLEKKGIGYVLTRNYGKRANDAVNELVDHLLITIAIIAVMLVFFLGFKEALIVTFTVPAILALTLFVAYITGQTINRITLFAFLLSLGLLVDAAIIVIENIHRHLHEHDAVYKDMDTILVEATDEIGAPTNVATVAIILTMVPMAFVGGMMGEFMKPIPYNVPVALLSSLLIAYIFTPYLAKKLLKKPHMHHHHHHFQKHEKLPSECDIDGGKS
>fig|387092.5.peg.1069 Acriflavin resistance protein
MKKFLEFAIEKATLNHLFLLFIFILSIFAYKSVPKEIFPPATLDKILISGGYAGASAQTLDKMVVKNLEDELKNVQNLYDIDAIIKNGSFTIVSDIKEGANNLLVLNDVKDKIAKIRKDLPPDMDEPIATILTKSFPLVLIAIATDANEHKLLDVADRLKSDLTSLKNLSEVDIRGWREDELQIAIDPQKINALGLGLLQVSDLVAQLSTIFPIGSIKQRGNHFFLTTQNGKKEKRALENTILVIGKKRVRLGDIANVSFTLSEPVTLSHFNGKPNVSINVTKTKNGNAIELVKKIKKLLLTYKNRYPGFEFKIYTDTSIWIRNRLNTVTSNLIFGLILVFTALLLTVDWRIALVVGMGIPVSFMIGLISLEMLGYSLNMLSLFGALIALGMLVDEAIVVAENIYRHLEMGEDAKTAAIQGSLEMFPAVLTATATTIFAFLPLLIISGEMGIFIRILPVIISILLLSSLFEAFYFLPLHAKEILKVGKKKKPSRLWQFLGDLYENVLRFLLERKRVSTLLLVGSILFGTFILLKETKFQLFPAFDTTQIYISGSVNVNSDVEDTQKIVSKLEQAILHSVKKDEVSSVTAIFGMKLDAKNNAQTGSNLFHIFVNLHELKPQNFVDRYITPLFSIEYDSSDMVRDRSARAIAEDIKRIVETFRHPPFEEINVIVPQAGIVKSDIEVSLEYEDPKQVLKAIHMLENGLKGIKGVYNITDDAKEGEKELKLILNDFAERLGITEGYLASYLKSLYLDAEIAKMFKNSKLIYVKLKSIAKDSVESFKNLVIQTPNGQKVLLKDIASFWTQRHFYNIIKENGKKIRTVYASLNKKVITTAEVYDKLDPLLRKIEKLGVKVKIKGEQKENKKLIREITRAFVIAVFLIFGALVWMFNSFVYSLIVLSVIPLSLFGVLVGNKIMGINLTMPGMLGLVGLAGVVVNDGLIMLDFIRSCNDIECVIQRAKLRLRPIMLTSITTILGLSTLMFFASGQSLILQPMAITLGFGIGWATCINLLLVPLLYSVVKKVQRKV
>fig|387092.5.peg.1800 Drug resistance transporter, EmrB/QacA subfamily
MSERSPKPYDLTNRQRALYTFIVMLGAFMAILDTTVVDVIVPKLTGPLATDMYGVQWIITSYMVSAAIGLLVCEYLIKRYGAKKIYLIGVATFAIASFVCGISSSLDSIVAARIFQGMAEALIMVTSHVMVFSYFPPNKKGLAMGIFALGVSFAPALGPTIGGYLTEYYNWRMVFFINVPIGILLTIAGILYLPKEKFFEKLRFNLVSFIFLAIATVALLVMLSRGQQLGWFSSLQIGILFFIAILGYLMYVLSELYSKYTLIDFSLFRKSDFTNGILIYFFILGFSMYQYFYLLPIYYEHIKGLPTLDAGIAVFAFALFIGIFSPVAGTLSDRIGAKKTVAIAAIIYLVTALFLLPHLNYYTPLSQAILITIPFGIGMGMFFAPVTVLLLQSAPANKSELAIVLMDYFRFVGGSFGTALATNNMEFFKNFHFDRMSEIQNREFLSIMLHRFQELLGVSFDQIKAIFRNYELFMSYNYGFYNTFMHAGYWALLGSVFVLLLFIAPKNLQRKSV
>fig|387093.4.peg.273 Daunorubicin resistance ATP-binding protein
MADLEVRNVEVSYKKQVGIKEASLQANAGEIIGFIGADGAGKSSLMHAVAGVLRFEGEISYFEQVYHSPKEAEKIKPYTGLMPQGIGLVLYETLTVGEHLSFFANIRNLRQDASFKTYRQKLLHMAGLSDFTNRQAGKLSGGMMQKLSLICTLLHRPKLLILDEPTTGVDPLSRLELWEILDNIRKEEGTIVLVSTAYMQEAAKMDRVLLFDEGEIIARGTVPELIDSVREYTFEGGACPEKENAESDCFTFDKRSYSLDVLSSSHAEPTLEALFFVNALRKKRTLPKIEIDAREGETKIPETVMEAKGLTKRFGDFTANDHIDMRLKGGEIVGLLGANGAGKTTFMKMLLGLYPIDEGELTLLGRSIQSSDDRQALKAKIGYVSQHFALYKDMTVRENLIYFANMHRIPVATAIKRINRYARELGFDAYMEHLPGELPLGINQRFSVAAALLHEPVILFLDEPTSGVDTIARAQFWEMLHRLKTSWGISILITTHYMSEAEYCDRVVLMRQGRKIADDTVKALYAKHPEARNFEDIFLSYYRSES
>fig|387093.4.peg.463 Acriflavin resistance protein
MFEKLLRFFVENSRLNYFLFILIFLTGAVLYTKTPKEIFPSFELDMVSVNGHYAGASIDMLNKMAVKEIEQELKNIDGIDKMATIISAGKFNIILELEKRVDKYNTAEKVKNAIALTKQYLPSDMDEPVVNVLEVKRDLMRVAISSQKAPHSALIEAADRLKDKVSALKNISEVKIFGDSDKYYDIHLDTQKIRAYGLDESTVVAALTGLSYIFPVGMIEESDAKHFYLSTYNGPKDAQKMLQSQLDIGGKTLYLKDIATVSKRYEDAATIYSIDGKNAVDVSIKQSSEGNALKLAEQIREIVARMNQNSKGIYFTIHNDRSEKIKDRLNIVISNILLGLILISLLVGILINWRMSLVITLGIPTSFVMGVIYLYLAGYTINMISLVGVLIALGIIVDDAIVVSENIQQHIEEGLEPKEAAIQGAKEMFKPVTIASLTTLFAFIPALMMSGNMGEVIKLIPIAVSVLVLASLIESFLFLPIHAAHLLNKNEKTTSWERANRIYSKLIHKLMYYRKTFLTLFLILVPLLIVIGVKSSKFQMFPKFDASTIRITLKANVNTSTEETMRALKAIEKDLYAHKDEFYIEHIGSVAGWRRDSAGNSESYPYVGNIDIELQKLKAQNLVDRFITPTLSFYYDSEGRTRKEKSAVISEKLRAFLKQQHYKKRFGLSDLAIVERKVGPIKSDLKIGLVSDDSQKIMKYAKKIEEKLSSLKGIVSVNDAMHYGVDEIKLKVNSYGESLGLNEKKLGALLSNFYLEKRIGFAFDSSDLLELKVRSSQKDSLEALKQFQIRLDNGSSVSLEDVADFHIIRSFEKVIKDNGLTNFYIYANVNSKVLTATEAIDAIKPILEKAKKEGIKIIFKGEEEKKKELKHDMMLASAMAMLLIMLSLLYLFNSFRETFMIMTVIPFAFLGVLIGHFVMGLNLSMPSIIGMLGLSGVVINDGIIMLMNLKRAKDLEGIYYYASKRFRPIILTSVTTLIGLASLVFFPTGQAAIFQPMAISLAFGLAWGTVLNLLYLPALYTILNQKKLGM
>fig|387093.4.peg.888 Antibiotic resistance protein
MNPHFEIKNKEVIYDVLDQAAYGTLALSVDDVPYAVPVNFVRIEDDIYFHGALKNKKMKMLSKNPKVSFSVVENYALIDSDFSTTEGLACPATQFFKSVSMDGVVTVVISREEKANVFTSLMKKLQPKGGYKPFSDSEYDAAIKATAVMKIEVTHIRCKFKFGQHLSEERFEMIVSHLQKRGTQIDKKTIEVMKAQRGEKSGI
>fig|387093.4.peg.1918 Multidrug resistance efflux pump
METLMVLTYATFCWIVFKVFKIPVNKWSLTTAVLGGVIMLAVILMGMAFYHPGSKSARNYFVTTPIVSNVRGMVTELDAKPNEPVHKGDILLKIDDTPYKAVLKDLEAQLEFAKKRLADYIELRKVAGGSKFDIHEYEMQVDSLKAKVEKAKFDLDSCVIKAPNNGYVTQIRVRPGQMAVPFPAFPLFTFVNTDSIAFIAAFAQEPLTNIKKGNLAEVIFPSIPGRSFQAHVEQVLPTMAEGEISPDRAMFSFNRQLPPGYIPVVIKIDDNLSAYNMPLGVDAVVATYDMSSPFWSHVAIIRKILLRMQSWQYFLRFH
>fig|387093.4.peg.1919 Outer membrane component of tripartite multidrug resistance system
MRRCMMTIHKRTLLSSSLLLLLTGCAQNIPGYDKAVADIKTGKDTLKTPGKYSQSINSAKVNDGWIRTFKDKKLDRLVDEAQRNNPSLKIAASRVERAEALTQLTESNLMPTVNMRGYYRDNNAEGAQEIAFGGFGVSWEPDVWGRVGNLVAADRELTAAQLADYDFARQSLAANTARAWFLYNTNSRIYSFTKKIISLQEKTLKILEAREKIGQGNKRDVHLARALVASAKDSASAALSAKERSQRALEVLVGRYPSGKLSSGKLDTVLPRIPNGLPAQLLERRPDLIAAEQRVAAAFHQKASADLLHMPNIRLNLGLGPNSLNDAITSLAGGILAPVYTGGAIEAQVAVANAEQKEAIAQYAKTTLRAFQEVENALAGEKHLATRYKATQEMVKEYKAAYTMTVEKYRIGQSTVLDILIIQGKWISAEIQKLQVTKKRLINRVNLYLALGGSFDTKRMHYTAPKKAK
>fig|387344.13.peg.265 Permease of the drug/metabolite transporter (DMT) superfamily
MVSMTRQHHLRGVLLASIACMLWGISGVAASTLFTLNHHVTALWLTQIRMISAGAILLIWGQLIHAQPFQIWRQRATGLRVISYGLLGLVPVQLCYFEAVKFGNAPIATIIQFLGPFIISIYYFLFKHMTPTRPEGIGMVMAFVGTLLIVTHGHLTSLAISPVVLIWGGLSAIGVATNTLIPRPLLPKFGAMAVTGWGLFVAGICLNVFGPLWRVHVTLTAAEWGLVLLIIIFGTVIPFLMFAHALGYILPTTASLLDAFEPLSATVFSVIFLNVQLTTFDLVGGALIILAVMVLSLNGRKMMNFFRRRRAET
>fig|387344.13.peg.549 Permease of the drug/metabolite transporter (DMT) superfamily
MSFKEERVLVLRKTLLYIAFSTLMFSSMEIALKSAGGAFNPIQLNLIRFFIGGVVLLPIALRALHKQHHRLTKSDWGLFFLTGFVCVIISMTLYQLAISVDEASTVAVLFSCNPVFALIFSYLILHERLGRANLIAVIVSIVGLVVIVNPAHLTNPVGLILAIGSALTFGLYSIVSRWGSVRHQFNGIIMTCFTFFAGTLELLVVMLVTHIPVVAGGMRQVGWLHQFAALPILQNVSLQYFWILFFIGVCVTGGGFAFYFLAMERSDVSTASLVFFIKPGLAPILAAVLIHEKILTNTIVGIVIILIGSVITFMGNRVKARESALAEEDAREFQEADDEVPAKLAAHSESPID
>fig|387344.13.peg.564 Tetracycline resistance protein
MRIPAGELLRDIERAQNEVKQTAREFADRGLVRKSPWNDQQLYKLEKLRDQMMARPPKKKKD
>fig|387344.13.peg.1846 Permease of the drug/metabolite transporter (DMT) superfamily
MRIMMHTAVVWERKDYQGLENSKATTENVMKGIFWATMASAMWGISGTVLQFISQSQDIPASWFLSTRTMGTGIVLLVVSLVMYGKKTFAVFRSGREIMWLLTYAIFGLGANLLTFYIAVQTGNAAAATILQYLSPLFIVVGSLVFKHDRPLRSDLIAFVVAMVGVFLAITRGHISQLAIPLNSLLWGIGSGITAACYVVLPRPLVKDEGHAPIVVLGWGMFLSGIVFNLYHPFFLNTPPITGGLVASMSTVILVGTILPFSLVLYSTHFAPSDVISIVDATQPVMTFILSIIFLSLKITVAEVIGSVLVVVAIYLLQRGRRKIETPFDEVS
>fig|387344.13.peg.2042 Quinolone resistance protein
MNDPRILPATLTAQSFLAITADEDRQLQMAHVQQQTIADQSLEHPLIDQCLFEGTTFINDNFYRAELTDVIFKNCTLVNCQLEAASLYRVQLQNCKLVGTTFDHAVFRDVVITDCDLSLANLNEVKFTSVKIIASRLVEVNCLDSVMIKTQLTRCDLNQADFSGTGLKALDLSTCDFDELRLTANDLRGCHLNTEQAAYFAQQLLGVQLA
>fig|387344.13.peg.2112 Permease of the drug/metabolite transporter (DMT) superfamily
MKKIAPLFVGLGAISFGIPASLFKIARHEGVVNGPLLFWSFLSAVIILGIIHVARHHWLRDQQTSWRQIVLVMAAGTASGFTNTFYIQSLKLIPVAAAAVMLMQAVWLSVLLGAVIHRRLPSRLQVVSIILVLVGTVLAAGLFPITQVLSPLGLFFSFLAACAYACTMQFTASLGNNLDALSKTWLLCIGAFLLISIVWGPQIMTAPVTGATIKWGVLIALFSMVFPLVAYSIFMPYLELGIGPILSSLELPSSIVVAFILLGETVSWAQIVGVAVIIFAVILPNVWGVWHQRQLE
>fig|387344.13.peg.2190 Drug resistance transporter, Bcr/CflA family
MSSKFASKHHCRLQIHLNPAIMEEYVYARPSFRCVKWRSNGILAIIILSILKGLTALNPVLTRRRRIWLTLLLGTVSATGPLAIDLYLPALPQMKAQFATTASLMQLSITACLIGLALGQLIAGPLSDQYGRRKPLIIGFVIFGLVSLAMAFIHSVTLLIALRFIQGLAGATGQVLARAVARDLFSGKKLTRFYALLNTVNGVFPIIAPIIGGFMIQYVDWEAIFILLALIGLLIALAVTFGLHESLPPEKRQTGGFHTSLLAMGKLVVQPSFWPLILATGLVYGGLFSYISASTFVFQTGFGMAPQTFSLLYAFNGLGIVVGSNLPGRLASRFSNRQQVTSMLAIAAGVSALLIISLLFPANVWVVSGLILLLVILIGALLTLTVTIIMDQATSNAGGASAVIGLSQNACGGLASPLVGLSGKSYAAMAIMLFVCNVGAYGLVKAQGQKAQ
>fig|388399.4.peg.720 Membrane fusion component of tripartite multidrug resistance system
MKHLKLIILAVAVVAAGGGLWLWWQHETIHPSTDDAYLKANVLTIAPQVGGAVETVAVTENQHVKAGDLLFQIDTNDLAAQVAAAQASYDAAVQQTKASITDLSSVSAQVDSARAALTDAQDSYDRTASLFKKGDVAKAALDQATTTRDQANAALDSAQSALASARERAGQAGDDNPAVRAAKAQLTLAQINLARAKVTAPVPGWVSNLDLRPGALVSPGMAVFSLVEDGDWWIDANFKETDLARLRPGQPVTVDIDMYPGLSLDGTVKSLGAGSGSVFSLLPPQNASGNWVKVTQRFPVRIALDTRPDDPAMQLRVGASTSVTVDTSGLDNAK
>fig|388413.5.peg.188 Permease of the drug/metabolite transporter (DMT) superfamily
MLLAGVFFALMNVSVKYIPHIPAIEIILFRSFFSLIFSFMLLRRQRVNIFGNNRKLLVLRGVVGSVGLISFFFTLQNIPLASAVTLQYLSPILTTLLGIFIVKEKVKPIQFVFFTISFLGVMMVQGFDTRVNLLYAGIGFISALFSGLAYNVIRKLKNTEHPLVIIFYFPLVTLPIAGVISFFTWVQPVGWDWLILLWIGLCTQTAQYFMTVAYQNANVSKISSLSYLGVFYALIFGFFFFGETYSLMAYIGMGMLLLGVILNYRVKNAA
>fig|388413.5.peg.948 Glyoxalase/bleomycin resistance protein/dioxygen ase superfamily protein
MENQDNFSHAATIFPVEDLQTSIDFYTQKLEFKLTFSWGEPTNYAVIKKGGVSIHLVKKSDDRIPSKKHCALYIFVYDIAKIYKRCVSEKVSIINTPETRDYNMKDFDIKDPDGYIITFGNGG
>fig|388413.5.peg.1620 Glyoxalase/bleomycin resistance protein/dioxygenase
MKMDSLKSIGRLLIPILIMAVFFSCQKVDFQKEAGAFESFAEMVHAGVKPIALSEPMEPAELDLFMPLAEKLSEKYDISVYRESDLIGTSLFDSSVVQDKEVLILYTGNHLEAYQMLKTKASELVNSNEYSGKKKEEVSRSFGRLLGYPESTINDLLSQNSTFKDLEDFGIQGQELIWFYKDLPAAKTFYRETLGLKLLEEGEGAVTFQIAGDSRLVLKSLTGTEYSGGEPKSVALALLTDHLEIWYDHLQASGVKIKYTLKVNPEGAHDGFVAVDPEGYLLEFEMFRMHPENEKFIPELKSMQPMVTTLGQGFDFYASITWLYYQDMLPMENFMNQNLGLEMSADQGWAKIYRLTGNSYIGLVDEKRGMNSFSEEKLVEVKINLSDPDSWEEYLKNQDAGMERDAGTFEDPGRYLFRF
>fig|388413.5.peg.1682 Permease of the drug/metabolite transporter (DMT) superfamily
MLILLALVWGSSFILIKRGLEVFTPGEVGAYRIVAAASFLLPLSLPRFKNLNKHQLFYLVIVGLVGSFIPAFLFAKAQTQLSSSLTGVLNALTPLAVVVIGALFFGSKITKRNGLGLAIAFIGVFILVIVKEGAGLTSFAGINTYALFVILACICYGFNLNIIKFKFELLKPIEITAISLLLVLPVALFYLILGTDFSYKVANVPGAWKALGYVTLLGVLGTALALILFNMMVKRVTPVFASSVTYLIPIVAIIWGVLDGEVLLFGHYIGIAAVILGVWYGNRK
>fig|388413.5.peg.2190 Bleomycin resistance protein
MKTEFLSTVPVLPSNDIERDLIWYEEKLGFKKIFGDSMYVGIHYKTVWLHLQWHADTEDDPLLGGSVVRIFVKNIDKYFNKLVAKGVVPKDKLRKNTPWGTHEFGLYDLNNNAIFFVEDL
>fig|388413.5.peg.3635 Glyoxalase/bleomycin resistance protein/dioxygenase
MFTHTKAFGGFSVDDLQEAREFYDQVLGVEVKKLPMGLLSLKFQEDNQVLVYSKGNHEPANFTILNFCVEDIEEAVQSLSEKGVVFEAYDGNIQTDANGICRKDEHLIAWFKDPAGNILSLVQEDKS
>fig|388413.5.peg.4024 Glyoxalase/bleomycin resistance protein/dioxygenase
MRHLFTFLILAFATISCTPGVSPPITSEISTSDYTPGRVVWHDLASPDPEVSSQFYKAVFDWDAVPYGEGSKKVWIFKKGNTPVGLMAYYDSKNSTGEWIGAISVPDVEAATNTAKSQGATIMKSAMNVENRGMISFIQDPQGAHISLIKLSNGDPEKKPAEVGTFLGQELWSNDPSNSAGFYSSTIGYSTSESEMGDGEYTVFQFNGENCAGMLQNPAPTLRSHWVPYIRVSDVNETVAKAKSAGARVLIEPAPEIRNGSVALLLDPTGAPLAVQVYNP
>fig|388413.5.peg.4111 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTIKEHFKITFTLAFPVMMSQLGQVSVGVADSMMVGRLGAVPLAAASLGNSIFFVILMFGMGVSMGITPLISVAEGKGKNKRISNLFGHGLWINVFTSLILTFIVIGLSQGLHFLDQPEEVVNLTIPYLLVITASLFPFMIFQNFKQFAEGMSQTKQAMYITIFCNVVNVFLNYLLIFGKFGAPEMGLMGAGWATLISRIFMPIMMGWYVLRSKRYQIYSLSLRLRKWSFPMFSRILNVGIPTGFQYIFEVSAFSSAAIMMGWLGVNALAAHQIAINLASVSYMMVAGLSTAGMIRVSNQIGRGNLKAMKEAGLVVYAMAMVFMFATALIFVVFRDFLPTLYIDDPEVITLSASLLIIAGLFQLSDGAQVIGLGVLRGMEDVKVPTMVTLIAYWVIGLPLGYVLAFEMGLEEKGIWYGLFIGLSLTAVMLYMRFQKLSAQRMKMSKPIAPLV
>fig|388919.8.peg.349 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MNKIFHYLDKKTKFYTIIGALANGGLALAQPLVVSQALSLNQGELTYSKIIQFAVFGFTVYFVLYSLMLFCNHTHNVFRREIQMNMRADLFGKLMTNKDFSEDEKITMLTQDMEYLGDNYLEKYVNIICWSFVALLTAIYIISQNLLLGSIFVFFTILRPIPQFLMNKRLKHTGDDMAQGRVDVHNQVSDSIRGAHTLLMNQAISENQNRFWKINLNYQRAIQKFCFTHNIIFFCNGFMVFLSQVLPLVLGFYFAMAGQKVSVASLVAMYIAAGQLVSPIQTIMYDAVDIQGAKTTADKIFGILEIGDVKQIDKKDAQELHALHIKNLSKSYGDRQLFTHLNLDVQAGQKVLIKGPSGCGKSTLFRLITGEEIADEGEIIGVTTVNECTSSFVSSIGIINQHPFLFNDTVRYNLTLGQEFSEEELLAVLKQVKLDFELTGGLDFIIKNNGENISGGQRVRIELARFLLRRKNLLLADEVTATLDKENALMVRELLFSLPVMMLEIAHHIDDESRYQQVVDLGKY
>fig|388919.8.peg.1468 Nisin-resistance protein
MENVSLFCYNQIRNPNKKGCVIMKKVLLGCLGTVLVLLALLIGFLAYFGPDYGIFLFPPSPQDYARSVVKKLDFGLYTDKDWENEKKKALEKLESAKTYQDTYPVLEELTKEAGGKHSYFLSPQDNPENSPESKNQPEVQNREGILYLKVPAFTGDAQAAKTYANKLSAALKKDDYQAVLVDLRDNTGGNMYPMIAGLSSLLPDEDLFQFVEKNGSKSAVSRSDVLKQLGLEQTDEKAKKVQIAVLINGKTGSSGEMTVLAFKGLENVKIFGQPTASYTTGNNYYQLYDGAVLLLTTSSILDRTGKLYENEAIQPDIQTDQPLEEAESWLKEQLGE
>fig|390236.5.peg.976 Tetracycline resistance protein tetA(P), putative
MLIYLISSLITIFFIPNDKNTDHKHNKEDLTLYLIKFFKKIIILLKSKELLAVFILNSSIQFFYQPFYLYWQAIFIDKNISISIFGIIYVLFRVSDIIGAWIFRKIKHSKYDIYVILAIIFLLSVLIKIVLHIYIFITIIIFLVILISVYSNNLEYFLKKNVDSKVLGTLTSINSTLSRIFSFLALGICSILTNFISAIYTFVLLILIFCTLSIIVTYKFKNNKKS
>fig|390333.6.peg.28 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLLKITPRLLWGILLSMIASLLNLYLPLLVRHFINLKQFAWSGLSKKVLLLGGLILIGNLLVSSLSDYLISSEGDRQVRQLRLRLQKQVLRLPQKYFDQQISGNLTSRIINDVNVLRSFLTETIPAVVTGCLTILGTMLITFSLDWKLTLLMLLVFPIDGLVTVPLGKISEVIADQTQSSLAALTGVTSESIKQIKTVKLNKTEEDVFAKNAREINKLYRLSLKGDRIAAMIGPLQSMLSFCLIMAVVLYGTLRVKSGSLSTGTLGAFMMYFFQIIGPINNVALFYSDRKQMLGATRKISEIINETAEETAGKEQLAVAPGSSLLRLDQVSFAYQDLPVLEKVYLEARSGEKIALVGATGAGKTTLANVITRLYPVAAGRISLNGQASTDFSLEQWRGFFSVVLQENTIISGSIRDNLTLGLNRKVTDQELWDALALVRLEEYAKKLPKGLDSLLGESGKQLSGGQRQRMQIARACLRDFKFLLLDEATSNLDADTEKIIMTALDRLKRTKNCGQITIAHRLATIANSDRIYFIKNKTVVASGSHEELLEKVPDYRRYVHEQQLKEKR
>fig|390333.6.peg.929 Permease of the drug/metabolite transporter (DMT) superfamily
MKSNSKWAGLAAAACILWGISGLFAKGLFNLDPRITPIWVTQMRQVCSGLILLTVAQLTGKHPWQVWKDKKSAVQLLAYAVIGVLPFQYCFFLVVAQANAAIATVIQFIGPFFVLAYLTLTKQEALRLIDVAASLLAFGGVFLLSTHGNIHDLRIAPLTLLFGIMSAVGAAANSLLPQALVTRQSTISVTGWGLLISGLILTAIHPVWPSLPSSPTVYLNLSVVIVMGTIIPTLWQNHALGHISGMTVAFMDAFEPLASMIGSIIVFHFQPQMMDYAASVMIIFAVLVLNWTPRSKIKSRVEK
>fig|390333.6.peg.1686 Glycopeptide antibiotics resistance protein
MYHELALQIRFVVIAVCVLAGYWAIRTGNSFLRLVVTVIYGCALIYYVFASRMLTVAVYYWQHPAQMAAGSEVLKDPAFWKWGLKKVFASSNYGGRYGFLMNVLLFVPLGYIIPSWSKWLHSIMITTFMVFCLSWFIEHFQRMTGLGTYDVNDMIANTMGAFLGAVAIMPTLWMRDIQARKLRKAREHAEAKAKGEAEAARLDRVSRQLANPTEKVPKVKMSRKDYRQRHGDQAD
>fig|390333.6.peg.1857 Permease of the drug/metabolite transporter (DMT) superfamily
MKDKHLGILLAITGAALWGTSGTAAEMLYQSPNINTFWLVDVRSWLAGASLLLISLVHKGKGTFAIFKNHRDLLYAALFSMLGITGAQFTYFYTVAASNAPTATVLVFLAPVLIICFMAAKTRQMPRRIDLIAVLLAVVGTVVLVTNGNFSHLAVTPKTLVWGFFSALTQALAIAMPAKLFKKYGTITILAWGMLLGGIILSPALAVMPATGVTVKEWSLVIYIVIAGTVFAYSLYLSSVMYISAGLVSMLEAFEPLVATILSVTLLGSDFGIMKMAGGVLIILATCLQVVPSPRRGKLQRKL
>fig|391008.3.peg.76 Methicillin resistance protein
MRGKTIGDQELALLQYIDEHAPASVGEVASGYGEARGLARSTVLTMMERLRAKGYLRRQQQDGVYRYQATRGPESVLQGAVAQFVDNTLQGSVSPFVAYLSQRQQVSDNELAELEALVAELQSRRQEG
>fig|391008.3.peg.1249 Glyoxalase/bleomycin resistance protein/dioxygenase
MGENGQPSNGSTIIPCLRYRDAQAAIEWLQRAFGFHVQAVYADGDTVFHAQLTYGNGMIMLGSSSSSGEWSKLAVMPDEVGGRQTQSACVIVTDADAHYARAKAAGARIVIDIADQDYGGRGYACADPEGYMWWFGSYDPWRADHGQ
>fig|391008.3.peg.2041 Acriflavin resistance protein
MARPRLTLLAIVAIVLTGLILALDFPSTEEPPITIRTATVLSFMPGAGVDRVEQLVARPIEESIRGMPEVKRIRTTVRPGFAFTYVDLYPTVESEKIPIVWQRLRSRMGDIQSQLPEGTIGPVVDDEFGRVAVMTMGLTGDGYNAGELRAAARRLRDELFRLPGVERVSLHGVRDEQVQIILDVPSLAARGLNPNVIADAVSRRNVIAPAGYVEIGGSEIALNVSGDADNPSQLKSTPIPLPRGGSVPLGALARVERVTQDPPMTGAFVNGTPAVVIAVSMAPGLNVVSFADLLRGDVERLSETLPAGMQLVQITDQAEVVSTQLLRVAKVFLETLAIVMAVVVLFLGMRTGLIVSAIVPTTVLGTMAIMKILNIDLHMISVGAIIIALGLFVDNAIVVAEDMERRLSLGETPDQAAAHAGSTMFVPLLVSSLAIILAFMPLAISSTETGEYLRSLGIVMAIALLLSLVIGVTLIPLLCKHFAHHHAELSRTARAVERLTGWYRGKVRWILGHKAIYIGVMVALLATSGWLFTTVPNELMPPSERHQLQMAIELSPDSSPANTMAVAQQISKVLADEKLVPEISSHALYMGDGGPRFILALNPPTPAGHRAYAVLSLAKGVKHEAAIERLRSVMATHFPDVRVEPKRFSMGSSDAGVATFRISSSDGAHRIAAEKLLRTLQDTPGMVDVSSDAERQVVQLDVDVDQPKAQAAGISSADIAKSMDMLLTGATISRYREGDTVLPVILRGEAALRTDIVQLEALPIQKADGSGSVPLGQVAKLRLAPQLSSIQRVNQARAVSVLAKSSELTAQGIADKVEPLLSEFRKQGVRVELGGEIEESKSANEGIEKLLPLCLAAMFLLFVWQFESIRKSLIVLASIPFVVIGATLALKLSGTSLTFIGTLGLLALAGIIVNNAILLIDAIDEGQRDGLPPLQAIEEAAAKRLRPIVMTKMVCILGLVPLLLFGGSMWTSMSIVMIGGLALGTLITLGLIPALYAALYRIHPTEEA
>fig|391008.3.peg.2096 Glyoxalase/bleomycin resistance protein/dioxygenase
MNTVGLYVRDQDEALAFYVDTLGFEVHTDVRNGSYRWLTVRSPGQDGFQLGLFVPGPPTHDAATALALQQLVAKGAMPPLVLAVENCRARHVEWQAKGVEFTQEPIERYGAVDAGFRDPSGNGWKMIEARSEARRQQ
>fig|391008.3.peg.2270 Fusaric acid resistance protein conserved region
MLFSLKCLLAASLGLYVSLRIGLNRPFWVIGTVYLVSQPLSGATLSRGLFRLLGTVGGAIATVALVPRFANAPLVLSAALATWMALCLYLAMLDRTPRAYAFLLAGYTTSLIGFPAVMVPGDVFTIAITRVQEISIGILAATLVHALVLPRRVSMRVHARVAAVLDDAERWTRDMRAGASDTVLASDRSKVAADLLELHVLSIHLPFDSAHGVAQVQILRALHDRMLDVLMLSSAVEDSLARLRSPQASAMDATGWRDLLQAGLAAQQAELDLAHADCRVLQAQLHTARPDWHRHVPARLARHAQGAVLHRDHRLALRSALGAFVGILLSCVLWIITGWSEGATAVSIIGTACVLFGTLEAPAPHVMRYLLGSLIGVAVGLLYGLLIFPALSDFVGLIAALAPALLLCGSFLARPSFIMAALGVVLTFPLIAGLGATNTVNIVGALNNSVALFVGTAMALCSMQLFQTADAGRNRARLERSIRRDIARHAAGQGDMTRAWLSRMLDRIGLLAPRLQGRSNAAHDLRALFADVRAARASSQFRTLNKCLDDPHVRALHAALIERVTAHFRIRAHSPRSVDAHLLELVDRVREAAAASAEADQGYLLHLLCGLRRDLLVPPLAHRH
>fig|391008.3.peg.2700 Multidrug resistance protein D
MSRRLLLLAIALLMFPQLAQTLYSPALADLAIRFALPPSAASQAMSLYLFGFAAGVLLWGRLADRIGRRPALLCGLCVFAVAALGGLMAGSFGQVLLAQALAAVGAAAASVVTQTVLRDHLQGPALAQAFSWIGMALALSPAIGLALGTLLVAANGYVGVQSGLLLIAALLAVACLAGLRESRPVQIPHTPMLPLLRELLRDRWIWSHALLVMAFNVAMYSWYVLGPFVFARLHWPATWFGASGAVLALGSALGAWGNGRLLRAGVATTTRIRIAAGLVLTGGLLAALLHDHPALVAAMVPVVTGFGLAIPNVLGQALRGYPHCLGSAGALFGLLYYLLIGAAMALAGAVQLLAPTLIVCGLLALWLQRDRAVDGGRPGCGSQR
>fig|391008.3.peg.3526 Glyoxalase/bleomycin resistance protein/dioxygenase
MELHRGRLIDHIQLVVRDLAASRRFYQAVFDTIGIPIAGEGDDYFWADELFISSASSEAAAGQLTGRHHLAFQARDSATVDAFHTAAIAAGGKDNGAPGERPYHPGYYGAFVLDPDGNNIEVVYHGPANYSADSVKVTF
>fig|391008.3.peg.3629 Probable multidrug resistance protein norM
MSTATSTPRFSKEVGATGLLALPLVLGHVSTGLISFVDNVIAGHHATATLAAVTIGTALLWLPMLIPIGTLISLTASVSQLHGAGREREIGPLFRQALWLALGLGLIMFTFLTVVPPLLPAFGIAPDIVPGATAFLHAVRWGGPALTLYFCMRYLSEGMHWTLPTMLIGFGGLLVLAPMGYVLANGKLGFPEMGAEGLGIASAVMMWLQAIAFATYLWFTKRFAHLQLFSHFEGPRWPAIWDLLRTGLPIGITVLMEGGLFIVTALLIGRLGANEAAAHQIAINVAQLCFMIPMGVAEATTVRVGHAVGRGDGFGVRRAAWAGYAIIMGTQTLSAAVLLFGHDAIVGVYTNDLAVAGLASTLLLYAATFQFPDGIQVLSAGALRGLKDTRVPMFIAMFAYWGLGMPLGAGLGLGLGMGPQGMWIGLIVGLTAAAILMGWRLRRSSLRIGQSSLS
>fig|391008.3.peg.4059 Fusaric acid resistance protein conserved region
MNALTDRQAWLFSIKTYLAAVAALYIAMAGNLSRPYWAMGTVYIVSQPLLGPTRAKGVYRIVGTLVAGLATLLVLPALVETPLVLSAAMSIWLAGCLFMALLNRGPRGYAFLLAGYTTAFIGFPAVTSPETIFDTVVARSEEIILGTVVAVLFASLLFPASVRPMLRARIGNWMEDAAQWCRQILERGRAHAPRNRLAADLVQFEALIEFLRRDDPRHAGSAVSMERLRERMLLLLPVLSSIADRLSALRSDGQALPEGLPALVDDIHNWLDGPTNASEYARLRARISALKPQVDRDLQHLQLASLLLRLEELVDLWQDCRTLQHAIDHGTAPLDRAHYRIRTERVAADKHVDYGMALFSALSAGVALMSYCVLWIALGWEGGGNGAMMAAVTAAFFAAQDDPAPSMVSFLVWAMVASVVAGVYLFGVFPAVHDFGLLALVLAVAFLPLGLMLHHPKSALFALPLTVNLAALLSLQNTYSANIQTFLNSSIAMFIGIGFAVVMTRLFRSVGAEWTARRLVRQGWTTLAEAAEGRGQQDRQRFAARMLDLLGLLAPRLAATPEGSDIASVDMLNEARIGLNILQLRRARLELPERSREAVEHILEEIAVHYRRQIAARKPIVAAEALRERLDTSLGRVGSVAACKARDEALMGLIGLRFALFPEAKALAPGLADAGAPSM
>fig|391009.4.peg.98 Tetracycline resistance protein tetA(P), putative
MIKKDKQFRKFQMYGFLKNLRFFEPFLILGFLSSGLDYLQIGILYSIKSIATNILEIPTGVFADLYGRKKSMIFSMISYIISFSIFYFCNSFYLFMLAMIFFSFGEAFRTGTHKAMIFQYLKLNNMESLKVQYYGATRSASQLGSALNSLLSALIVFFSGNYKLIFLMAIIPYVLNLINLSTYPDELDGNIKKTKKDTLKDFLGAISNWKTFKLLLNATSYSSVFKSIKDYLQPIIESFALAIPVFLGLNSKKRTAILVGIIYFVLYLLTSIASRNSWKFKKKLNLTLFFGAIVIMLIGITYYFNFYYISIILFVFVYLIENIRRPIVVSYISEKSEALASVLSVESQITTLLTAFFSFLMGLVSKKYGIGMGIFVIGLILFVFSQIFWLKEKDLLIKEKVSILKK
>fig|391009.4.peg.207 Quinolone resistance protein NorA
MKFHRYHFVSMIYSVLFYLIVSYVNSMGSRLGLLYSQIGFINFLGALSYVIASISIGHIGDKVGYKNVLIIESVLYFVFLLISLNFSGVFYLVFLAVISNLFFGSFYPQIEGLIAKSESIANYPHSKTIMRFNISWSFGNILGMALGPFMTVRYPKTIFVFGLFLSLAIGLFIWFDYKKIGKLIKLSKVPFKRENLVENINKFRWVYRATLFFSGLLYTAILALFPKLINSYGIDLSLTGFLIAFANVSVFLTFLFMGKFSFWVGKPRVSFLFLIVLPITSILLFLKPSPILFLIVSFLGGMCYAVPYTFAIYYGLHSNEDDQGKQGGFHEATIGLLFGFGPLIGGVFLDAFSGIVGLAIFGILLTSITLIIQMIFLLKK
>fig|391009.4.peg.604 Permeases of the drug/metabolite transporter (DMT) superfamily
MEWITFRIVLLGFERIFGKIITRKTSPILSAWGFFSFSTLTLLPFLGKVNFNIIKVSVFSGTIYALSFFLYMYALKYEDVSVVAPLYNVNAIFLIFTTSIFLEEKITIQKILGSLFMIYGVSYLKKDVNLKLSYKNLLKSKGAISMIISSFLMAIGRTIDGFLTKSFDKLGYSLGVYLVISVYFFLISFFKNRNLRIYVQIVKSKIIALVFGGVCNAYAYFALLMAFKKIDVSIAEPISMLSSLVSILVARFIFKENIKLRFFGATILISGAFIIYI
>fig|391009.4.peg.1077 Fosmidomycin resistance protein
MKRNKGGVAMEFIAAIFHFFADFFNAFVKPLAPYFIDNLGIDNKTFASFMALLGGVTSLFQVFFGAYFDNKKRDGLYITIIVLLEIFFVTFLGIVKSVLLFFMLVVIIRMLNSIFHPIGASFAGKREEGKHVAIFSVAGTLGAGIAPLFITSFQDLFGIEKLYILTVTMSVVLLILSRKIIGYEKKTVKKTLSFKGDILKLWPIFLVVASRSFSMDIFHTYIPIYVNEIGKSLIVGGSILTFGMMLGVFTNFFGTIVLEKTNDKITNAIGFFGMGIFGLLFVLVSDIYFKVFSFIIFDGFSFFTMSSNIVSAQKLLPNNKALASSISMGFSWAVGILLSSGYAAVFGNNTMFMFLSASIMPIVTVIVYLISLRRE
>fig|391009.4.peg.1159 Permease of the drug/metabolite transporter (DMT) superfamily
MIYAILSAVLMGSTAIFNKLALKEFNPMFATIINALVASIFSLFFVKKFRKLRMNFYVVFVGLFNAAGLLFMFIGLSKLDPGIAMVLGTSYYIFTSMYSVLLFKEKLSVNVLLQIIINIFGIILIIMPSYRMEIPNLIGGIFAVSSALFFATSNSIAKLSKIQADFLVFANNVITFLVIGVLYSTVYGNNSISFSFRGIFFLSIAAFIGSFLGLYFYYKSLSRIDFSIANIVRTLNPITALLLSRLFFPNVITTRQWIGIIIVIFSIYRLNVLINNSRIKLNSEN
>fig|391037.3.peg.484 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQQTWDVPGANGASVRRAIVRLAVPMALAEVAGLVVLVGVMALMGRMGEETLYVRALYLPIGHLFIAVYVAFGFSNQVAAAISRGRGRPEDVAPMAMSFVRMWAVASVVLVAATLLAAPLLAAAFDVPDASRSEFMAFLRWMAAAELLQVVAILCASGLRGYGHAGAGAAVVVVSAAVQFAGVALLGLAAGMGAMSVPLSIAVGSVVGALLGVWLMRRHGLIRFGAELTRWHPESARHIRSVGLPVATTQLILFGANFGLLWVLGDFGPRVIAGFSSAVTLQFLVLMPAIVLGSATAIVLNQQRGAGRADWLPGTMHNGLAITVGAYLLLSVVMWAGSDLFGRLMTDSPSIADQTALYLSTVGLTYVLMGPVLTSLTVMEQIGSGLLAVVLNLAYFAAIVVIGALVVAAVPEPVALYRTIAWCNLAGVIVVLAGLHAVRRASRLPAPTGAAPVPVGGGPA
>fig|391037.3.peg.2383 Drug resistance transporter EmrB/QacA subfamily
MELVVFLEVSIVNVALPAMGAALALTESGLTWVVNAYQLTFGGLQLVAGRAADVVGRRRMFQAGIALFTGASLLAGLAPDASTLLVGRAIQGVGAAIVVPAELALIAAIFTEPAAYRRAFAVWSAMAAAGAGSGVALGGVLTQTLGWPWIFLINVPIGVVALVLSPRLLPADPPWAGRASGARTQLDLIGGLTVTGSVLAMVLLATELPTSGWTPLTYTAAVATLGLGTVFAVNQRRHPAPILPPQLLRIRQVRAGVAANALVGASHVPAFVLLSLMLQQAMGYSALAAGFAVLPIAAVNMVTARTALPWAIGRFGSRVVLAAGMFLVALGLAGYAILLHPGAGYLTAVLPASLIFAAGLPAVFVGSTAPAVRSAPENQQGAASGLVNTAQRLGAALGLTALLMASAAWTDNRGSGDRATALADGLRVGFAGAAAIAVLGIVCALSTGTRVPKKPASGDTPPQEAVAR
>fig|391037.3.peg.3976 Drug:proton antiporter
MRTVLRRPDFRLLFGGLLASMTAESILLLALAVWVKELTGSSGLAGATIFAIIAPMTLAPLVGWIVDRYPRQPLFVAVNLVTATLLTPLFAVRDRTDLWLVYLVAILYGLSYVTLSAVLSGLIRSLVPAELLADANGVLQTVRQGLRLIGPLAGAALYSTAGGGLLTGVAVTGFVTAAVLAGLLRVTEPPWSRPEPRRCVRTRSSPRSAELGAGLRYLADEPALRRALLGYGLGSLVMGFSESLIFAYVDQGLRRDATFVGVLVTVQGAGGLAGGLVSPGVIRRAGEVGALAVGVALFGVAALALSYPNLWLGCTAVLLAGASLPLTMVGLHTLIQRRTPPRLIGRAAAGAEAVVSGPRAVSIGVGALLVGVIDYRLLFVVVSLVTLLAGGYLWGGRRLSRPPQPPPPAGRTQVSQQSWTGAP
>fig|391165.8.peg.1 Drug resistance translocase
MVRQGRPSQSREQEDISEPGTQGRGWMQARHVHHWRFHHRRAVHKDLMTQPRSSRPVSSRILALIVSAALFMELMDGTILATALPQMAQSFDVAPLQMSVALTAYLLSLAVFIPASGWMADRFGSRRIFMGAIALFVTGSMVCGMANALPEMVIARLVQGAGGAMMVPVGRLLLLRNVPRHELVSAIAWMTIPATLGPVLGPPVGGFLTTWLSWRWIFYINLPIGLIGMGLAARFVPNVTEAELRPLDVKGLLLSGTALASLLWAMETLGRGPSGTDGMALSSAAILTLIGLGSGWLYLRHSRTIPHPILNPMLMRIRTFRLSVLGGACSRVVAGAMPFLLPMTMQLGMGMSAAESGSLTFVGAAGSLLIRPWAAGILRRFGFRRVMIWNGALSSTAVLLCATFQPSWPHGWFFLVLAPAGLFQALQFIAYNTIAYADVPRERMSEATSFYTTFQQMTLSAGICIAGISVSLSMLAGPRTQPDMTDFATGFVTIATISALAILCASRLNSTDGQDLSRKA
>fig|391165.8.peg.61 Bicyclomycin resistance protein
MPSARLSVPLIILLGLVTSVGPMSTDMYLPAFPQLQADIGGHYQGAAQITLAAWFVGLAIGHLTNGTLSDRFGRRIPLIAGMLIYTLASTGCALATDLWSFTLFRLIAALGGSAGMVTPRAIVRDMSDGHEAARLISRLMLIMGVVPLLAPTLGGMMLSVMSWRAIFWLGSLYGAVCVVLVIMFLPDTLAPEKRLMLSPGSIVIRYGTILRERVFITHAMLSGFCVAALFTYLAGSPAAFIQYYHISPTVYGMIFGMNAVGYIGCSQLNNLALPRLGMHRVLRIGTTLYLWLVSLLIVNVYTGLGGLIGMMILLFLAQSIQGFLTPTAAVGALSPHAAHAGSASALMGTLQYVLGALFGTGVAVLADGTPRPMVVFMMLGGICSLIGDRLRPGSRHGGPRLFRLRWSMPSRH
>fig|391165.8.peg.189 Permease of the drug/metabolite transporter (DMT) superfamily
MTKYTAPSVSPDNALPSAGPPGTVIRGSRTGPLLAVTACVLLWSLIGTVSKLTQAQIDFYQMMSWSNLLSLLAVLVVHRLSGRAWRNLLPKRADISRVRLLMLPALLGMLDCFFYLAVYYGYGHANGVAVLVTQSSWPLMIVLLGMAVFSERMSLRRWVGMALGFAALLVTASAAGHAVLPAGSETDASTAGAGFATLCVVLLGAFSFTLFSVLSRFLRLDAFAGTVWVFLFSLLCSLVPLLLFSRLTLPPRSAWPALLLNGVLINGVSYILWIYAMSSVHAARLTALAFAAPALSTIWLVVFLHEPLIPAYLLGLGMALAGGMLCLSGSDAGHA
>fig|391165.8.peg.1306 Acriflavin resistance protein
MNVSMPFILRPVATILLSIGILLTGIIAYRFLPVSALPSVDLPAIVVFVNQPGADPETMASSIAAPLERRLGEISGVMELISTNSVGASNIVVIFDLDRSVDSAAQDVQAAINAARADLPSDLPVSPFIRKFNPAEAPVMMIALTSDSHTIRELYDLADSMLGQRLAQVNGVSQVQINGAEKPAVRISTDPMRLAAASLSGQDLYNVVRNTNVTQPTGVIENGDVRRAILINGQIDDAESYRKVVLKASNGGFLRLGDITDIVDGVANTRLSATSNGKPAILLQISKQSGANVIETVDGIKKILPQLRSWLPGDINMAIVVDRTGTIRASVDDVQFTLLVSIALVLMVVFVFMRRLMPTIAAAVTVPLSISGTLGAMWLLGYSLDNFSLMAITIGVGFVVDDAIVMIENIVRHMEMGKSRLRAAIDGASQIGFTVISITLSLLAVFIPIIFMPGIQGRLFHEFVMTLSVSIVISAVVSLTLTPMLMGVFGRQVHALDNPLLRRWDERVEHLLNGIERFYLRTLGWALKHSALMLLSMVLTIAVTVTLYRAIPKSFLPIQDTGLLQGSTIARPDISYAAMRDLQHRAEAIIRADPAVLNVDGRVGVSNGFNALNRGMMYIQLKPLEKRHVSSEQVIARLRPKLGTILGLETFLHSAQDLRMGGREDSGQFEYVLQADDIRELRSWAQRLQKRLQSVPEIADVSSDQDHAGPEIDIMIDRDTASRLGTTVSGIDSALNNAFSQRQISRIYTDRNQYQVVLQALPSLQSSPAGLNTLYVPATNVNGTAAPATASRATLQNATGQVTLGSAVGGTQIGGNQVPLMALALTQYTTAPLSIDHEAGFPSASLSFNIKPGIPVSTAQDAVLEAVRSLGMPASIRGEFGGNLALFKKAGQAMPFLLIGALAAIYVVLGVLYESLIQPLTILSTLPSAGLGALIALLLAGVDLSLISIIGIVLLMGIVKKNGIMLVDFALEQQRDAGLDAASAIREACAERFRPILMTTLAALLGAVPLAFSFGTGAELRQPLGISIIGGLIASQILTLYTTPIIYLALEKLARRGKARPAINPS
>fig|391165.8.peg.2073 Fusaric acid resistance protein conserved region
MPVASHTAGQDGFDMGAWLPGFLRSAAFFYALRLALSGSLALYCAYFLQLQNPSSALVTTIIVASPMRGAILSKSLWRFLGTILGCVASIMAVALFVQSPLLYLSAFAVWTGCCSYISNLLRYFRAYSAALAGYTIALIGFGDVLAHPDTIFSVALDRLSVVSLGIVCSALVTMLLQPATSENKLQADSMQSLRDLSELLTMVRDGASEEKILDTRRRLLFRIASYDQAVEFGAAESSEVARRANAFRQLFGLMTSVTASSMRIGERLQALSADPQTAEAAARLRRILSNLIQHIPDNVQELRHLVAASSHMHVELRHFANHTQCLKSLGLVNLLDDAARQLRMMARLADPRVQKIRRVRLPLWRDHVTALRSGLRAFLAAELLGLFWIYTEWPSGGSAIVMTAIIVALAATGDNPSGMMKAFLQGTLIASVLSFVLVYGILVHMDGFPLLLMAYMPIVILCGYMQASGRNPALAMSIMLFYAVLSPIANPIHYNLTGFLNSVFSSIIGALAANIAFMILVPPSFEMSIRLATLSLWRGVSDAARKKMPASNLTWEYPQYQKLMRISARLPPAGPERRRIGRGSAALVLTGREIFKIRHAIEHGIVPVSARPAVQRLLAVLRRQPQRAAEFADHACREVVAAGVHDPQLLRTAASLAELHLLLLEGGRQVSQS
>fig|391296.7.peg.43 Multidrug resistance ABC transporter ATP-binding and permease protein
MNKRLVGVLLKSLNKTMFLFGIVLSALGVGMGLFLPQFIGKLLDQTYLSNLLTRPELLAGFILFFVSVYAVQALSNYFIGRSGSNALKQLQQYIYESLLTTSVKDLDQYQSGDLASRLTNDMSVVLNFITVILPNFLMNGLMVMGSIYFLWTISPWLTGLSLFLLPLLSMVMIPMNQRLEGYYSAYQEGLGQVSSRISHKFTTIRLMKAFQGEKHEQREMGKSFQYLSQTFEKMIGLSAVQHTLVSSLMTGFIILMLLIAGIEVTKGVMTMATLTTFVLYMMQLIDPVTDIAASLNELTEFHAVSKRLVELLELNKEEQVDTELVDATSIQLEKVRFSYHTDPILNGVSVRIPEGAHVAIVGPSGAGKSTIFALLMKYYQDYKGKIRIGQQCLSDISTKEMRRLISFIPQDNTLFHGTIRENLLYGKNESVSEERIAYILKELGLSPLVAELEDGLDTRISENGTGLSEGQKQRFSIARALLLEHPIYLLDEATASLDTVTERVISKAIDRLTAGKTRLTIAHRLHTVREADAILVLDKNGQVADYGHHQQLVERNHLYQDFLRGLPQAS
>fig|391296.7.peg.235 Daunorubicin resistance transmembrane protein
MRKYLYMTRLTMMNAMQYKAFFLATFVSLAVKILVALYVWKTIFFTQSEVNGFTLQTITTYIIFANLLASLNSFSLGEDLSYSILKGSIAGEFLRPYSFILALFFKDLGNKLLELIKFAIVFIGILLVHQDFYLPDGKTILLFLVSSILGMFIVQLLDMAFGFLAFFTVNAWGVMLLRMGLFNLASGALLPLSFYPQAVENFLKLLPYNYAVNVPVSILLGQESDLTALGLQVIWIPILACFIAALWSQAKRRIVIFGG
>fig|391296.7.peg.236 Daunorubicin resistance ATP-binding protein drrA
MIQAEHLSKTYSIIDKEVGLKGSIKAFFKPKKKSIPAVQDISLQVGKGKIIGYIGSNGSGKSTTIKMLTGVLFPDQGQVRINGLNPQENRKAVNKQIGVLFGQKSHLDWNLPVQESFILHAKIYDVPDKVFKERLAVLIELLDLADIMKQPIRNLSLGQRVRCEFAAIFIHQPAVVFLDEPTIGLDASVKETIRSFIRYMNQEYQTTFLITSHDMKDIESLCERIFIIDKGKKVYDGSLTVLKERFSTVKTILFSTEKPIEKDLQLEGWEFIRKDDFHFEIHYQSKVWTSAQVIEQVFNHYSIEDVTMKELEIETMVRQIYEEGIHA
>fig|391296.7.peg.691 Glyoxalase/bleomycin resistance protein/dioxygenase
MLKAMEVYLVTNGNGLEAIEFYKNALGATVEQVNLFKDFLPDCPC
>fig|391587.3.peg.1222 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MKAAFHLALPCDDIQKTKEFYVDILGANKGRGTNTWIDIDFYGNQVTFTNAGSFNFDFKNYRLSGQILPSFHFGVIVDMETWGKIYTKLFSMDIEVTTEVTFLENKAGEHISFFVTDPDGYQVEFKSFKNEKEIFTSI
>fig|391587.3.peg.1302 Glyoxalase/bleomycin resistance protein/dioxygenase
MNAFHYAFKIKDIASTRTFYVDILNCKEGRSTENWIDFEFFGHQLSGHVSSNFPELDYCGKVDGIHVPIPHFGCLLTISQFEDIQQKLEANNIEFVVKPQTRYKGQTGEQRTMFVFDYSGNPLEFKAFSDESEVFASN
>fig|391587.3.peg.1506 Multidrug resistance protein
MAFFQLFTTIPLYYDEVFHLNEFKIGILLFLNVAIIVVFEMPLLNYLEKQRIPIVKYIIMSCILLTVSFLVMYQNFWIGILIISIILMTLSEMLGFPYTNRYALNRAKDGLEGSYMAMYAMSFSIAHIFSPKIGFDIVEKFGYQANWLVSGLYGVIGIILAIWLSKRTQKGL
>fig|391600.3.peg.514 Permease of the drug/metabolite transporter (DMT) superfamily
MTAATPAPPSHKPHALTGLEIAAIVAIIVVWGVNNAGAKLATETLPPLLVGAIRFGLATACLIVFVRPPFPDWRSLLLIVIVGGPIQYGLAYTAYWMATDVSPVTVANQLWIPFTALFAFLILGERLSRAALVGMGVAFVGVAWMTLDAHALQDWKAILVAIAAGAAWGVTTVVARRTTSIPPLKMQGLLALGAFPVMAFGSAVFEHGQWAAVKSATPMVWASLLWAGIVSSVLATTLLFWLVQRREAGRVTPYLLVTPVVSMLIGWGLMGDVLTPQILTGSAITMGGVALVALAERGLRAGAAKA
>fig|391600.3.peg.1255 Permease of the drug/metabolite transporter (DMT) superfamily
MSRPITILAIAICALIWGTTWFAITLQLGVVDPIVSIVWRFGLAAVVLFAFCALTRRPLRLTRAQHLAAVGQGAFVFAVSYGFVYAAEERVASAVVAVIFAALAFVNLILFRVLERQKAAAGAWQGAILGVCGVAVLSFGQLSGAGVSAGVAPVLGVVFALIAVLASAFGNWFAWRGQQAGAPVMAATAWAMAYGTAMVAVYGFATGVEWRIEPTPAYILSLLHLSLFGSVIAFGLYFTLARQRGYALASYISALTPPIAVIMSVLFEGAHVGVTMLIGLILVLGGQVLLIRAPKA
>fig|391600.3.peg.1715 Glyoxalase/bleomycin resistance protein/dioxygenase
MQIIKRMDHFTVTTDRLDETLAFYEKLGLRSGPRPEFDMPGLWLYAEDHPVLHVVEASVLPDTRRGVIDHMAFAADDLNATIDMLKREGIGYKIVRTPRPWSFWQLFLEDPSGAEVELQFDPASDTPAEVLEARAARSRDRGPIA
>fig|391600.3.peg.2044 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIALSFQTRSAFRDLLHLAWPVILARIGIMTMGLTDAIVVGNFSSKELAFHSLAWAPTSIVVTTAVGLMLGVQVMTARMLGEGRRHAVGSVLRRGMTYSLQIGVVSMIALIAVGPWGLGKIGLEDGLAEGAGPALVVFALSMPFYLISVTGQFFLEALGRPKPGMVAMWIANGVNLALNIVLVPDLLGIGFDGAFASAWATFGARAALAIFLVVYILRLPEARALGIFDKPERDPKAAREQVKVGLGAGASYFIEVGAFSGFTFFAGQIGAAETAAWAVVLNVSAIVFMLPMGLSSATAVLVGRSYGAGDGRGVLRAGLVGLGVVSAMTFIVALLVWPSAHLIVGAYNRDPVLLAIAAPALVLATLFFVADGIQVVAAQANRAAGDVWWPTIMHFVAYGAVMMPLGWILAHRMGVDGLVWAVVIASLASSVLLTGRFVRVARRLP
>fig|391600.3.peg.2046 
MYGLITRLTAYPGRRDELALLLMDPAVRKHGCHSYIVAHDLVDADVLWVTEVWADQPTHLSWSEDLRQSGAWRPIYGLMAKMDDSIQTRPLGGIGL
>fig|391616.3.peg.140 Tetracycline resistance protein
MQNRAYLFILMTLTIDAIGIGIVFPIMPDLMERVGASGTGEGALWGGILMASYAGALFIFAPIIGSLSDAYGRKPVLLLALAVLAVDYVIMALAGVFWVLLIGRILAGVAGATYTTATAYIADISTPKERAARFGMVGAAFGIGFVLGPAIGGIAAEWHISAPFWIAAVLSASNVLFGLFVLPESLAPAKRRRFGRRDLNPFNAIIAAFKIPGLAIPLICLFVFEFANMVYPTLWAFFTRELFDWSTLLIGMSLAGYGILLAGVQGGLMPVLITRFGEFRTLQLGLISALIGFIGFGLISTVTGLIIVLVFAALSDLSPPMMTAMASNMADENQQGLVQGVIASLASIAAFLAPLVVTGVFEVFVDDNGLYLPGAPFLMGAVMLLLLIPLIMRLRGHAQS
>fig|391616.3.peg.217 Permeases of the drug/metabolite transporter (DMT) superfamily
MFVLGVTDNLIPLISENSSLWLFQAARSAATLPLLALLALFGLGTLRANRPLHVLARNFFTGTALLIYFGCLAFLPIGVVAAGLFTAPIFVLILSVLFRGQSVGFWRWAAVAVGFGGAVLVVWPQDGSITVLAFVPIIAGLFYAVGAIGTRAWCEGESVLVMTLAYFAILGVYGLVGVAALTIWPMDAPPGVDGWLQRGLVPMTTTMFWVTIGQAVGSITGVGLLTRGYQLGEASYVAINEYSLIVFAAIFGWIIWDQTLGVLALVGIACIITSGSIIALRSK
>fig|391616.3.peg.3698 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLFATLYNVVDVYWAGRLSTDAQAGLAIGYQAFFVLMAIGFGLSSALSALVSNAKGSGDNSQTQRLAAQGLSFGIIATFVSMVIGWFIGPLLINLVSEPGAYRDAALGYFKFLILALPGFFLAYGGNGILQAHGDSRTMQRAMMVAFLANIGLNPLLMFGIDGIWNGIGFNGIAVATIISQTGVMIFIITRILKLEMMRSVNLAAFWPDRASFMQIIGQLIPASSAMMVMFVSGFVVQFALKEFGGHAVAAYGIALRIEQILLLPVLGMTGALLPIAGQNFGAQDFDRVRAAVLFCWKTGFAMTLIATPILLFGGGKAMSLFSDDPEVIRVGFSYLRVDAFLFPIYMMLFSINSLLQALKKPIWTLWISIYRQGFGVAFFVWMFISVLDFSVWGVWLGIATAVTSGWVLSLVVAQRVARSTMGGLLKSASGPPFTLAAVLSDK
>fig|391616.3.peg.3940 Permease of the drug/metabolite transporter (DMT) superfamily
MSEESNNMKRVGLAPAAATMASIFFGASVVATKYVIDQTTPVQLAFLRYLIGSLCLTPFLIWPKRVNIPWRDVLPIMGLGIVFFGIFPWTFSAALQHIPASRGAVVLATMPLLTLGIASAVGYEKITRTLLFGVALTHLGVAIALGASVQTGLSTSWLGYFLMFLTALCGAIFSVFSKPYLKRHPTLHVTALSILAGTLFLAPAAIWQISGTGLPEINESGWMAVVFIGTIGGGIGFFLWIWALERSSPTRVAVFVTLNPLAATALAALLLSETITVSFTIGLSCVLLGIILANRRKPVLTTHSPSNDMENVS
>fig|391619.3.peg.726 Permease of the drug/metabolite transporter (DMT) superfamily
MSARHTELGALAILSWGTLGVLGAFSASLPPYLVLTFCFAIAAGMGLAICAATGRNPVRLLDRHTILFAGLLTAYHLSYLEAFHHAAPIPVSLINYLWPACLIILGNLFFQLRSGFPGYLGAALGFVGVLVLIGKDGFALQLSETLGYGLAFVGALLWATFSNLRRHEPSDAISAMTTICFASSLICGLWWITKGANLPALTASDVWVIAALGLGPAGGAFFLWDLGMRQGHAALLGVLGYSAPVFSTILMLTLGLGQPGWEVFAAIALITLGGIVVHSGSKGPTKCVANAETR
>fig|391619.3.peg.2635 Permease of the drug/metabolite transporter (DMT) superfamily
MALKYWAAIFVLGIGWGMSFMFNAVLLRELGPLSVSMGRVGFGALGCWIYVVAARKQVPDRPRRWLALFGFGVLSYAAPFAFYALGQQHIASGVAGILNAFTPALAVMVAHFWPGGERATLQKSFGVVFGFLGILVLSWLLLQGGRQSEVWAVLVTLCAPLCYAFSVNIARQFRDIDPVVLVAVALTGATAAITPLAIWAEGLPVITRLETWGALFIIGFILTSAAFILFYWVLPRVGPTNITLPTLIAPVSALAMGAWVLQEPLKLEHLTGMGLILIGLVLIDGRLLRKIRRRSAL
>fig|391735.5.peg.80 Permease of the drug/metabolite transporter (DMT) superfamily
MNQALSRPAASVEMQAYLLGLMSVAAFALTLPCAKVLAGPLSAMQIGLFRSMLAALAALPILWFTRSARPNASQVKRLLLLSLGIVYGFPILTAVGMRYVPVGHGGVVLAALPLATAIFGSLITKDRPPLLFWLASIGGFVAVALFAAWRSGIGGGFYLGDLALLGAVALAGFGYAQGGALSKEMQGWEVMCWALVLNLPVLLPLSLLYFNAADFAGFGSVSWAALAFLAFVNSLLGFFSWNRALALGGIQRISQLQLLQPFFTYGYSIILMGEAFDPLALLICVAVIGLVVVSKRALLKH
>fig|391735.5.peg.669 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MRRRRHWPMPRCSHETHPLVLRCLSQCRAGLARRDRRRARQPPFHPGQQGARVRAGLRQLPTDRPLRQRGQRLGRAGTGLARARNRRASARRHSGECGLLCQHGRACRRGQAAVCRCHRRHAHPVPRRIGPGAGAGAETGGRDRDPLVRPDGQYAGHCRAVRQRRGGADRGLRPGPWRRTARQKSRRLGRSCLPELLPDQEPGGLGRRRGGADRERGAGRQAAPTAPIWLVRQIPCRHPRGAQQPARRIAGGGAAGQTAAARRAQCLAPSGRRPLQCRLGGAAAALSGAAGAGFRGPPVRAAHRAARRTGAASASASGRLRAALPGGGPPSARLPGRGLLRPADGDAASLRPGPVPALLPRSVRRGCGPGQRRSPLFLCPGLKMLSLLIPVYRNETGLPDLLAAVQSLHARLEGAMETVFVVDGSPDRCYEILRERLPHCALRARLVLLSRNFGSFAAIRVALQRASGAYFAVLAADLQEPPELVLRMHAALLRADCDVVIGVRQTRHEPLTTRLPAQIFWWLYRRYVLSEIPPGGVDVFACNRAFRDSLLQLQERHSSLIAQMFWLGFRRQQLSYVRQPRQHGVSAWTLRKKLGYMADSIFSFTDLPIRWLLRAGLGGTLAATVVGAAVLAAKLLGAITVPGYAMIMLTIVFFGALNLLSLGVVGSYAWRAYENTKARPLAVVLRDEQFGPPGVSNPGERPHA
>fig|391735.5.peg.816 Permease of the drug/metabolite transporter (DMT) superfamily
MWRSRPGIAGRGSTGPESPWPVADGHMAATIMPSPFGHALRLNARHPHARPRNPALKEPHGQIRTSIRPPGAGAAARRSAGADRGACLAQQGGCVSAARPPEGAHTVAEGEGAPSFAARPPEGAHTAAKGEGAPSFAARPPEGAHTAAEGEGAPVSAARPPGGAHTAAEGEGAPVSAPDEAQQAAAAASAARTRGIGVSCGLAVALIWSGWSVATRFAMKTELAPADVTFLRFGVAAIFLWPVLLRHGFGFKRIGRLNVCIMLIGAGVPFMMLAATGMRFAPASHVATLMIGMMPIFVALLSALFFRERFSRVQLGGLATVIVGAACLGGHALIADRGAGEWRGDLLFLCAGLCFASYTVVQRRSGISPWHATALVNVGSALVFAPIYWLFLQPRIFTAPVSDLLFQVFAQGVCAAIVAMFFYAEAVRRLGAPRAAIFGALTPAFAVLIGIPALGEIPGGVGLAGIALVMAGVVLVVTGARPRPA
>fig|391735.5.peg.979 Probable multidrug resistance protein norM
MTTATRKLDLGLAREVVRMSLPLMGTMAGNLLMMLVDRICLAQYSSDTLAASGPAVFTAMTVITFFTATTNLSRSCVAQAFGRSGEPAARAEGVLGMLIAAGLGLILLCLSPLLGMIPSLSDRPPAIRALESSFLELSALFGAVMVLNVSMSAYFNGIGKTRISLYVGLLGQVVAALAIYGLVFGRFGLPELGMRGSALGTLVGCVSMLVCYAWQLPHGFLREGLKHWADAGKAALRAQVVLRLRRGFASGTAAGMDELGNTSFVWLAAVLGPIALAANNVNLTLNYLAIIPIIGLGIGCSVLCSNAIGRNEYEQIPPILKVTLLIEGAYVLVVSLAQLLAPMMLLEPFGLSTTDVQIQTTAVDTTRVLWTFSASFVFSMTGAAVLEGFGMTRFILVTRIGLMWGLSLPLIYLATHHGAGDPAWLPRIWIIGSVFEFAIGCIYFWNIRQATRKRLNYLQVQHAA
>fig|391735.5.peg.3130 Glyoxalase/bleomycin resistance protein/dioxygenase
MRVAQIDHFTLRVAQDMLPVLLDFYSRVLQLRAGARPAFSFPGYWLYAGDQALVHLVGNAPGGEPATTDFLPTGKFDHVSLRTHGLKSTREHLQAQGIDWQEAQVPGIALHQIFLRDPVGLKIELTFDAAELALAGPSTRPTAY
>fig|391735.5.peg.3631 Multidrug resistance protein
MGIMQTQQIAALFACLFLIGSAEVVAGPMMSAMSVDFGVRSSAIAYLPAAYGLSYGAVALIAGPLSDRWGRKLPLQAGLLGFALLNASIPGAAHLPAAIVLSALAGLCAAIIQPNALSLVADESPPEQVGRRLGQVFIGLMLAFVLTPVLAGQLADTLGWRSAYYALALLSVLAWLAVTRAFARRPPGAGARTDFLSTHRQAWRTIDVRRRLSVSYLWLGWLAGFGAVVAEVAARKLPLSPTDTGLIAGFFGLAVIAGNLAGARLHRALGQAALPVMAIVAALGLLGFMLPVESMAQLLLLGLPWAFGYGCAGPLHHARLSALSERYRGTINSYHASLLNLGIFSVSFLLGAVVPHFPVTLFCALVGAVTLVGACLLLPWPRLSITTR
>fig|391735.5.peg.3922 Permease of the drug/metabolite transporter (DMT) superfamily
MAALLAQCTGQTGQTGQTGQTGQSHDACGPGDPVSVPRGCRLASGCALSQARAIGPRTAHQRAMTSQRRLHNLMRRPGLQPSGGHCLRPSHHQESCKPREATMKALRTGYLSIAVYCVSTALSAVWVTFSFSQISGAALTFITLLTAFVIFFGAHLLSGGRPSRLLRTHLADVVILNVLTVAAWFFMFLALQRIEASVESAIYQGCVPVAVLVCVVYTRQVPFQSLRTLGCVLISLCLFGLVAARITTAGAIVIAPARLYAGIALATVAGLAGGLYVYWSGKVVRQSQCATLDILSNRFYLLLVVTGATGYAQFSGATAESFAPALIGKLVLLSMVSVVIPAFTLQHAIGSLGASRVSIITPFVPALALVVEQRLAGWPSPVVPALIVATCVAIVLSNVWLTVQASAKIPVR
>fig|391904.3.peg.549 Drug resistance transporter, EmrB/QacA subfamily
MMALGLAMIVLDSSIVNVSIPTIIDDIGINLTDAQWVTSLYNIVLAALLLPFGKLGDARGRKLVFQVGTVIFVASSTLAAASQGAVMLLAARVLQGIGGAMIMPNTLSTVSALFRGKYRAAAFGVWGAVMSSAAALGPLLGGVFTETLGWRWIFLVNLPLGIAVFVSAIFLVPKTGGNASVAGAADAAQDARSRRVGVDIPGVVLSALTSALLVFGLIEGETYGWWKQTSTQLKLGGLSWNRDWLSPVPICLIAGALLMAVFILFESARGKAGRPVMLDMTLFRIKTFSWGNLAAAAIAAGEFALVFMLPLYLINARGLNTLQAGAMLAVMGLGSIVAGAQAHVMAARLTPAGVIQLGLVIEIIAVALVAVLMPVGFSVWWQLVPMAAYGLGLGFASAQLTSVVLSEVPVMQSGEGSATQSTVRQLGTAVGSAISGASLAMAVNGTLPARLESLGLPAKVGDGLAQAVSGSAGGVIGVFRSGDGPAARFGDEAPKIADAMTSGFVEGGQWTLLVAGIMLFIGLLASVAVRRAASSHNVR
>fig|391904.3.peg.1002 Antibiotic transport ATP-binding protein spaF/mutF
MNNVSITVRRGSIYGLLGPNGAGKSTTLKMITGMLRPTSGKILFDGHEWSRRDLEQIGALIETPPLYENLSATENLEVRVKLLDIPKTRIGEVLRIVDLQDTGRKRAGQFSMGMKQRLGIAIALLNSPELLILDEPTNGLDPIGIQELRSLIRSFSSKGITVILSSHILSEVQLIADDIGIISNGVLGYEGPMNKDQNLEELFVEVVRKSQEER
>fig|391904.3.peg.1087 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAHTDALDSGLGVTPVPRLALTMSFPAIVAQAANASYTIIDRMFIGHIPEVGNAAMTGVGICFPILLAVTAFASLIGAGGAPRASIELGRGNFKKAERILGTSTAFLVVIALTLTAVLQSVKRPILYAFGASDATIAYATDFITIYLIGTVFVQLTLGLNSFISAQGKTTVAMVSVLIGTGASMVLDPVFIFVFGWGVRGAAAANVIAQLISTVWIVLFLSSGRSAIRLRPANIRIDRIIIPVLTLGLAPFIMQITECLINVVFNVGLQRYGGDDYVTSITIITSLIQVVGVLTGGFQQGIQPIIGFNFGARNMRRVRQAIRMAFVTQIASATALVSVLAAFPGFFASWFTTEQTVIDIVTRMMPIFVCGWGVFGIQLGAQCAFVGMGQAGQSVFLAVFRKVILLVPLALLLPHWLGVDGIFIAEPISDATSGMVAGLLFLITYRRIRRNLV
>fig|391904.3.peg.1650 
MTAVPVSEEGMGSAVNDTIRELSGTLGVGIMGSLQAGTYTTGLTDALRGSYLPQDILGASKESVMAAESISGSLPGTLRRLLDDSVASATMTLT
>fig|392499.4.peg.890 Drug/metabolite exporter
MSQATAHTARWRLIGFLLSAVGSMLFAIKGVLIKLIYVYQIDTTALLAVRMMLSLPVFFGVGLLEWRRRPAAQRPDARSVGLAALVGILGYHVSSWLDFAGLQSVEAQAERLILFTYPFLVILFGRLIFGHRLRFHALAGAGLSYAGLLVMFGSDPARLTPAMIGGAGMILAAAGTFALYQLFARELILRCGPALFTAIAMSAAGLSVIAHFALTHGIALPSAPPRAWALMIGLAVFSTIVPTFMMSAGTARIGAQGTAIISTISPVVTIALAIVVLGEPFGIGEAAGTLLVIGGVGLFTWIESRPGRRRSKSVMPAEAGISGEGRRG
>fig|392499.4.peg.1563 Permeases of the drug/metabolite transporter (DMT) superfamily
MSGCRSGSSISTTSSPISTRRCARPADRHTPAMTTDRRRTPLYSYATLAAVMLFWSGNFIVGRAVQGAIPPFTLALVRWSGAALVLAPFAWRHLRVDRALLAAQWRIVLLLGLVGIAAFNGFVYAGLQYTTATNGLLLQAAIPALVLLFDRMLFGQRATWAQMAAVLLSIAGVILIVLRGDPFAILSIGLNIGDLLVLGGVIGWAAYTSLLRLRPASHPLSFLFVAFLIGIATMAPLAMLEWARGARVVMGWGTVGAFAYVALLPSLAAYMLYNAAVHDLGAGPAGQTITLMPLFGALLAAGLLGETLHAYHLTGMVLILGGILIGAWMRPGPARGQRSGRP
>fig|392499.4.peg.3312 
MSAPQPREARARPPPVVTVPPSSRLPDMTSMPVGRTRPRFPSLPLPDLQIDSQKLLFSLSSFIAAAITLAIAFSASLPRPWWALLTVYVTAQPMAGAFRPKALYRLGGIATGAAVTLLLVPNLQNSPELLVLCLAAWTGFCIYLAVLDRTPRAFLFQMAAFSTAVISFPYLDDPTNIFETTIARVQEMTVAILCVTAVHALLQPWSATPVIRARVRSFLAHARRWTAEALGSHHTRLENEHRRMLAADVTELGMIAIHLPFDQRWAPATKRRVTALQQQLASILPLASAAANRLDRLRDGGGLPAELEALLDDVSDWLVEEDSPLHQAGALVRRCEAMAEAAEARADWTSLLTASACVRIAEFLAALAASRRLATRIGSPGRPNLKPSSAEPFALARDHGVAALAGLATATAIALYCAVWILLAWPNGSATAAFAALITCSFAAQDDPAPVIGRYLVATLKTFPLAALYLFVILPRVDGYEMLVITLAPTLLWMGYVQADPARSPQALPMFSCFIVAMGFLARFQADFALFINTGLAQLGGIVATLTVTKLFRSANVLWTARRILRSNWAELAQLADIRRPFLADRWTARAIDRLGQVAARMAVAAPGAALHAADGLADLRIGRNIIPIRRSLPYVPHDVRHRLGAVLSGLTVFYDARWRRGHAHPPPAALLEPIDRALRSLLALPLDEPRRRALRALVGMRCNLFPAAPPPDAVR
>fig|392499.4.peg.3366 Inner membrane component of tripartite multidrug resistance system
MSAAASAEPAPLGGVALGAAAVALALGTFMQVLDTTIANVSLTTIAGNLGVSSDSSTWVITAFAVANGVTVPLTGWLMRRFGVVRTFVVSVILFTLASLLCGIAWSLPSLILFRVLQGAVSGPMIPGSQALLISIFPPERRSTALGIWSMTTLVGPVAGPILGGYISDNYHWGWIFLINVPVGLASAFISWRFMKSRETATAKLPIDAVGLGLLAFWVGCLQVFLDLGKNEDWFHSPFITTMALLAAIGFVAWLIWELTEERPAVDLSLFANRNFALGTVALTLGYAVFFGNTLLLPLWLQQQLGYTATWAGLVSAPSGIVSVIATPFVARLSGKVDARWLASFAFVAFAASYLMRSGYTTQTDYFHFMLPMLVQGLGMSTFFVAMLSISLDGVSAERTPSATGLSNFARITGSSFAASLVTTMWDRREALHQSRLADASSPFDPVFRHAADALGQLGLTAQQGYGVLTREMVGQAYLLSSNDIFRASAWAMMAMIAIVWIVRKPAPLTGPVAAD
>fig|392499.4.peg.3368 Outer membrane component of tripartite multidrug resistance system
MPRSIPLRRPALLAGLVATLLSGCAAVPQVRPQVQAASAATAGLDGGAALAPVGDWWHGFGDPQLDRIMAEALAGNPSLDVAMARLARAQAGIAANKAGLLPQVGVDASAIRQRLSEKYIIPPPYGGSNRWIGDAQAKLDWSLDLAGRQKALVAQAGASADAAALDVEAARVTLSGAVAQSYVDLARATEQARIARRFVASREEQLRLAGTRKRTDLGSDFDLRAAETLLAEARQAGIRAEGARQLMVHALAALAGRGADYHAAIADPTIRLDAALPVPDALPADLLGRRPDILAARARIEAAEAGRKVARADFYPDIDLKGFIGLQAIGLGALFTGGAATYGAGPALHLPIFEGGRLKANYKGAVAGIDEAVASYNGAVVGAVRETADALSAIATNAADAAEQHKVVAGLGETVRLDEVRLRTGLGARLDVLDAGDRLLAANQREVDLAADGAAARIRLLVAVGGSFDPHSRQNLASAAGADAAGR
>fig|392499.4.peg.3532 Glyoxalase/bleomycin resistance protein/dioxygenase
MSGPSTNSLFCMAMAMGIRVTLRFEDTASKARLQMETNIQRLYHFAFPCRDAEETRAFYEDLLSLPLVHCMQVDAVPSSGDAGPYAHIFFQMRDGSYIAFFDLGGDEPPEPSPNTPRWVQHFAMEVPDLADVLAYRDRLVAAGVEVTGIVDHDFIKSIYFFDPNGLRLEITTRTEKPGFNEKAAAEAHAKLAAWSRFKHGRN
>fig|392499.4.peg.3642 Multidrug resistance protein B
MTESETNQQHDVAVVPIAPLPKMIVTTAIMAATILVVLDQTIATVALPHMQAALGATPDTVTWVLTSYIMATAVGTPLTAWLTGRFGRRQVFLVCVLGFTISSMLCGAATSLPMMVACRLAQGFFGAFLMPMSQAFLYDMNPPSLQVRAITMWGIGAMVGPIVGPVLGGYLTDAFDWRWVFFVNVPVGIVALAGVFFGLPEFPSARRSFDHVGFIMIAVALCSLQLALDRGTQQDWLDSPEIIAEFGLSIAAFWMLIFHLRRSRHPIISPGLFANPSFSGAMVLAFVLMPTIIASNALLPQLFVQLLGYPVATAGEMMLPRGIAMTIGIFLGGQFTRWMDGRLQVALGVCIVIASLYVQTGFNMEMDQHLIIWAGVLQGFGTGLSMTVLNFTAMSSAPLSHRTEAAALYSLSRNTGSSIMLAIFSGLLAHDVQVNHAELGARISSGGGMSLHLSRIWAGNSLDAPIAAMAEVEVNRQAMMIAYINDFWVMMWLVAAMLPLVLLLRPGKAPKGSGESLAALAD
>fig|392499.4.peg.4128 Multidrug resistance protein A
MNEMRSITGDAGVAAPALDGERRLGRLAAMLSVPALLLATGLYLWLTGGRTVSTDNAQVNAHVVEVSAEVAGRITDVYVSENQLVKKGDLLFRVDPQPYRIALMQAEAAVGNAELTVAQLESTYHAKQADTAKSLSDVSLARDTFARQQELLARGFTTRAAFDAAKAALAAAQAQQASARSEAESARAVIGTSRNGGHPQIEAAIAARDKAALDLARTEIRAPIEGRISQADKLQPGTMAIQMLPMVNVVSNQGYWIDANFKETQLDKVRIGQRADIELDAIPGRTIKGHVIGINAGTGSQFSLLPPQNATGNWVKVTQRVPVRIQIDDRLDRPLVAGWSAHVTVHVAD
>fig|392499.4.peg.4165 Glyoxalase/bleomycin resistance protein/dioxygenase
MEIAQTALGWRQERKTMARLEHCNIRSFDLAATIRFYEEVIGLRAGPVPGMNRGAWLYDDSDVAVVHVIDLDTDNRDASLGEIRHRLGELAGPLDPDAMRGGGAVDHIAFHCDDYDAMVARLEAHGAPYRTFDLPAYQLRQILVNDPSDVTLELNFRD
>fig|392500.3.peg.109 Permease of the drug/metabolite transporter (DMT) superfamily
MSNTQKGWLAAIFVGLLWGIPWIVGTPILEVMDPQVLVWLRYTVAFITLGLIFNIGLASGKMTKKADFKLNWQNRNDIFWAACCGIIGQGSFSFLSFLSLDYITASENGVIQGLIPILILSVGFLRHNERFTVMQMMCALGAFLGVAILVMDPQSETQGFNIGHLICFGSAASFACMAYARAKLAEKYGSVATMFHQFVFASLGFGLYLFVVGADFSSALNVFSSPLRIMCIVILGVCISGMSYLVYIYGMERVGVDGTGMALNLMPLSSFILAVFALGEQVTPMRLVAIAVVITSMIAFMKLGNQKKDKPVEQAALNTTKPCRSQ
>fig|392500.3.peg.110 Permease of the drug/metabolite transporter (DMT) superfamily
MTVTNKDNLLGWTAAIAVAGIWGVTGVVSKPLSMAVDPMTLVFFRYVTAVIGLSVIFMITSRFTSLSKDLGSSLKIDKGDIAKIALCGIIGQGVFSLFNFLSLSHIGATENGVIQGMQPFATVFFGMMFMNFKMSKIQWGAFIASAVCIYAMSVGPTNQVENGSSVMGYVYVTCSMLSLAWTAHLRASLAEKYGSVVSMLYQYISVAVMGIIVVVAMDLDLSQINIILANPLLLGLLIFLGMGISGGSYLIQLYSFKKIGVEKATMALNLMPLVGYIVAVLTLGEQLHLSKTIIVSLIVVALYVFTKFEAKPEINKSLKPQEA
>fig|392500.3.peg.2000 Acriflavin resistance protein
MASREDLIKQLDASDDVDTTSNKFITLKSLSITALIVVSIIFSISKLAVEGDKSEEYPITPQGAVEGESIIDAQVSSPVTETVVLQASGYIMAKKMMTVSSNVSGRLNSIMIEEGMRVKQGELLATFDDSIPQTELKMLESQYSYGLARLKESEAEYTGHQVSLRRIQRLFDSGNGSVAELDEMKTKANILEARVAVASRELEIAKENINTQLRRLLEYKVYSPMQGVVVDVMAQAGEVISSLTTFGTDEQSGICTIVDMNSLHVEVEVSEQYISRVAVGQRALAKLNAYPDLPVDIEVALIVPTANKDKSTVKVWLNIIKNDPRILPEMGVEVSFFPPDEEEEQGHLTSKLSDVAA
>fig|393115.8.peg.29 Multidrug resistance transporter, Bcr/CflA family
MQIDNKNLKYIPLLVLLTWFLGNMGVHFLLPLLPLLSNNLDASVKLTQYVIAFFLAGKALGMIVYGPLSEIYGRRKFMLFGLILYMSSSLLCMLTTDIYWLIFWRFVQGLGVSGTILMGRVIINDSYPNDKAANIFGYLFALAAVIIACLPTLGGIIAIFKNWQLAFATMMIYSSLIFVIMLKFLPETQSEQFQKSFSLIGIIKDYSNILRNRVFLGYLMCTSLMVAGESAFNTNAAFLMIKTYGVSPKIFGMMMSSLLIAHLLGAAICGRYVVKRGISKLTGVGALILVLAAMFLSVTSILKFDGPYLTITAMFIYFLGTGFIMTTAAVGVVSPFPKMIGTAMAFALSLEFLLSALSSFITSHLSISSLFPITVLITLLSLGSFAMWFFCIKRDK
>fig|393115.8.peg.287 Bicyclomycin resistance protein TcaB
MLKAYRITLIFSGLIVLIGLMSIDFISPSLTYIKSDFETSQTLLKNSVLTYMLILGIFQLPYGFLSDRYGRKKLVLISLSITILGILISAFAQGIVPFYIGRIVTAIGSAGCPVISRSIIADVSHNPKRLRKSFSLYALASQISLCIAPVLGAFIQSVSSWRFSLITLLLINIVVFLLILLIMPETSRRLEYKINYKTTLDKYLYYFKNRYFFIMSLLSALFYVYSIGFYNMLPFVLHHLGIPVITNGFINSFYAIKFGHWSFFITTFLI
>fig|393115.8.peg.805 Fusaric acid resistance protein fusE
MGINMSNKNTKSIISIIIILFALFSLYAMWQYYLYSPWTRDGRIRAKIITIAPDVSNMYVSDNQKVKKGQLIFTIDDQRYAATLEGKEAELKHAMIEWQLAEKQYLRRIRLGRDDSISREELDDYAMQEKLRKADLEKAKAEAELAKINLDRTKIYAPADGTINNIDLRQGNYVVSSKPVMSLVKAGSFYVTGYFEETKLPHIKIGDKAKIILMSGGEPLYGHVISIGKAVTDNNTDVNNQLLPKVQETYDWVRLSKRIDR
>fig|393305.7.peg.1415 Permease of the drug/metabolite transporter (DMT) superfamily
MAMPAGLPPSIIRAPLVGSGFLTGKRQGYVLALISAMLLGFTGIIIRILTAHYHLPTSVLAFWRAGLVAAVLLPILLVIKPEWAKLRRDQVKFYLAYGLLLAVFNGLWTESVALNGASISTILVYCSVGFTVFLGWIFYNEYMGWREFFVIVISMVGCFLVSDGVNITAADFNFVGLFIGLASGIGYSFYTLAGRIATDRRYPVWNTILYVFGLSAVYQLIFNQLLLWFPIQGLQQMVGNLFFLSIGTEGVQWSGWWLLLILAAGPTLLGFGLFNLSLKTLPLAIASLILTLELVFTAVIAYFLLDEILSASQLLGSALVLLGVLMLHRKDNTQGEIATPNNSAISP
>fig|393305.7.peg.2200 Tetracycline-resistance determinant tetV
MAFAVLDIGGSATDLGLVVAARSIFNLAFLLIGGVLADRYSRSIVLLSSATIAALSQGGVAWLVLDGSATIMGLAILGTINGAAAGIALPASSAMVPQTVPAHNLRAANAFIQVGVYAGTIIGASLGGILTSTIGPGWGLAVDALGFAAAAPLYFFIRVNSPLSLESNTNIVQDLRDGWKEFIARSWVWAIVAQFTIINAAFSGVVMILGPIIADASFGRAGWGIIVAAESVGLIVGSFLALRWRPRRDLFIGVILVSLCAVPIVLLSMISSTFVLMAGFFIAGIGFGQFGVVWANSLQTHIPADKLARVYAYDAMGSFVAIPVGELAAGPLAMHYGNSTVLLAAAVAVVIATIAASFTPAIRQLDNGPKVKPCDE
>fig|393305.7.peg.3445 Outer membrane component of tripartite multidrug resistance system
MLDNQQLQLAQPKVSSLALSPQWWRVLEDPQLDALMSQSLQTSPSLKQAAARVREAQSVVGQADAANGPNLDLNGSSKREKVSQNTLQPFLQSYPDKPLYETSNTLGLNLSYEFDWWGKYRNRVNAANAQVNAARAEQQQAALTLTSSVASVYYQLQSNFALQNVLQQEVDNNDRLAELRTKQYQAGIYGIEIPQQTKAQADTAKQQIIQLQSQGEQLKHQLAALTGQGPNATQNLRQVPLPDITRLAPKGELTTDLLGKRPDITAQRQLVESYDQRVKAARKEFYPSLSITGFAGLSTTNFQGTNPNLLEAASQAWNFAPAISLPIFHAGALRSKLGEESALYDEAVESYNQTILNAVRETADAITIQQSSQLQLQQAISASQSIQKVYNVADARYTAGIIGRDELLISQSQYLQQQQSELNASNNLLQAKIGLIRSLGGGYQAPVSDGSQNKTI
>fig|393305.7.peg.3937 Permease of the drug/metabolite transporter (DMT) superfamily
MKLTDFLIALLITAIWGVNFSIIKLGLITADPLILAGIRFTLCALPAVFFIKKPDTSWRYIIGYGLLFGIGLWGIVNLGIKAGVSAGIASLVLQFGAFFTLVLGALLFHENLSKYQYIGIIVALLGLTSIIFISDGSVTFIGLALVLCGAVVWGLVSIIIKKSDTKQVFSFLVWSSLFSPVPLFILSYLFNGPSGFTELAIHFNTTTLFSILFQVYPNTLFAYWVWNSLLTKYPVSVVAPLSLLVPIFGMLGSVMIFNERIPSGKVIAMIFIISGLIIGLYGKRLMGLLKRKSSVALIE
>fig|393305.7.peg.4259 Multidrug resistance protein
MLPIATIFVFKNRNYCRFLLVNSLLWMLHAQLYSTIPLYTRETLDDESHLTLFFMVEALCVMVLQHWVNLYINQHIPSYYPAVTLMLFSVSFFLIYLAQDRVLILWAAGVFSLALMVYMPSADANNAAFADHGSFATYFGLLSLSVTLGDSLGNMLGMRLLAFLLQSGNVSQYFLWLAGITAVLAIFYRNPYNCPL
>fig|393305.7.peg.4426 Multidrug resistance protein B
MIINDASRWSDLFSGKNAAFAIALSGGVVLHAINIYIATTILPSVVLEINGLNLYAWNTTLFVTASILGSALSARLLSGYGARSAYLFASLTFMLGSALCAMAPNMPLMLVGRTVQGLGGGFLFALSYAMINLVFPQSLWPRAMALISGMWGVATLIGPAIGGIFAEMNAWRFAFWTLLPVTLIYTIFTWRILPQGRSSTAVTSALPVTQLVLLTAIVLTISASSIASSIASSGLTNLVGIVLAVLLLVLLLRIESRATSRLLPKGALRLNSPLAALYITISLLAIGITCEIFVPYFLQTIHGQSPLISGYIAATMAAGWTISEVMSAGWKKSGIRWAIISGPIIVLMGIIALAILMPVSSLGSWQQMAPIAIALTLVGFGIGFGWPHLLTRILQVAAEEDKDIAGASITTVQMFATAVGAAIAGMVANLSGLNAPGGVAGAENTAHWLFTLYTIAPALAIITALRCAAIRSQPQTVNSVTSHEIL
>fig|393595.12.peg.16 Fusaric acid resistance protein fusE
MKTMKTQSLIRASVTLLTVALASLLAWALWQHYMYSPWTRDGRVRARVVQVAPDVSGLVTEVPVADNQAVQRGDLLFVIDRSRYQNALLQAQADQQAAEAAARAAGADIRAAQASAAKARAEFAMRQAESRRRDRIAQAVSREVRDNAHSSAEAAEAQLQAAQASHQRATAGQQQLLARLQQANAALALAQLNLERTEVRAPVDGYVTNLALYPGDYAHAGQARMALIDRHDFWVYGYFEETKLPNVHVGDPVQVRLLSGIRANGKVHSIAHGIADRDNPTGADLLADVNPTFNWVRLAQRVPVRVSIDADSLPENTVLAAGMTATLTLNPS
>fig|393595.12.peg.1210 Permeases of the drug/metabolite transporter (DMT) superfamily
MPMNDQPLKGALLLVLGEGLLAVMAAMVKHLSDHLDTEVIVFARNLFGLMFLLMIISTRGGFGQLRTRFVHLHLIRAFTGVSAMFCFFYAIGHIALTEAVLVKMTVPFFLPVIAWLWLSERIGLHTWLAIIAGFVGVAVIMRAGQGEIDPVMWVALAGAAIMSIAKVSIRRMAISEPAQRVVFYFALFATLFSAFPLFWANTIPAGSDYLWLLAIGLVATGGQYAMTTAYQIARPGQVGVYNYSSVIWAALLGWMFWGETLVLTTILGTLLIVAAGIWNLKSR
>fig|393595.12.peg.1410 Multidrug resistance transporter, Bcr/CflA family
MTHRRTSKLYQDVPMQTLSPGRLAFLLASLVALGPLAIDTYLPALLAMSGHFAVEIHAVEVSVSVYVLGVAAGQWLGGPLSDQFGRKPVAYVGLCLFILGCLSIPLSSSIDMLYVLRFLQALGGGATVVIAAASVRDHFTGKEAAKVMTTIGLVMLMAPLLAPALGALLLKLFGWQSIFYMLALYGLMLFGIVRFMLPSVAVKPSGEPLRQRMFLAYGRVLRNRPAMGFILANGLAFAALFTFITDAAFLYMEYFRISPEAFPLYFGANVVTMLGMNRLNVLLLRRYTSASIMRVALALQMTACVTLLVLTLAGLLTLWLVVPLIMVAAGMVALIMPNGIASFLDLFDHDSGAATGLNGALQFLLAGLIGIVLGILHDGSTLPMTALMATSSVAAWAAFSLVARR
>fig|393595.12.peg.2053 Permease of the drug/metabolite transporter (DMT) superfamily
MSLKTCGSFKENGMPTLAAYLIVVAVWATTPLGIKWSGDAMAPLAAAGVRMGIAALLGLGWLWIKRQPLPLHARARLSYLASLPGIFGAMGCSYMAAVHLPSGLISVIFGLAPLLSGLMLQALPGGLRLNRWHWSACLIGLAGLVLVFDDSLQVLVAGQGMGGRGVGLLWMLSAVTLFAGSGIAVQRVGAGLQPMQQTVGGLLLSLPCYAIGMAITGQTLSFSGDYRGLSAILYLAVFGSLLGFYCYYQVLARLSAATVALVTLITPVLALSLGSLLNGESLGVLVLVGAALIVLALSLFLLGDHKIRRQLKQLTKADA
>fig|394503.6.peg.133 Permease of the drug/metabolite transporter (DMT) superfamily
MPLKDLLLLTASSFFGIVLYFIFENTGLKYTTASNASIIVAAVPIFTLISESLFYKLKITGRLIICVIVSISGVFFVIFEQGSLDFTGNLLKGNMLIVGAMVSWVIYTIICKSLTQKYEGIVVTTYQMIAASILFIPLVLNEVDTWHIISGSGIANLLYLALFCSALAYYLYNVAVTNLGATFSSMFLNLIPVVSIIGGVLVLHERISAFQIAGMLLIMVSLFFVGRNRDRK
>fig|394503.6.peg.421 Drug resistance transporter, EmrB/QacA subfamily
MHQLTQKRKTTVMIALMATMFFAAINQTIISAALPKVIAQLGGMDYYSWVITGYMLTSTISTVIFGKLSDIYGRKIFLLSGIIIFLIGSFLTGLSANIFQMIAFRGIQGIGGGILMSISLTAVGDLYPPQERAKWTGVMMSIFGISSILGPVLGGVMVDYVAWKWLFWIFLPLGVIALIMIWSLFPKLSGNSSESIDYLGSIFLALSITSLLLGFSWAGTKYAWALPQSLGLFAATLVGILVLILIERNAKSPVMPLSMFKNKGVTISFVASFVMSGGMMGAMSYIPFFIQGVKGHSATTSGLLNIPMSLMMIIFSTLVGRWMSKYGNYRLFAVLGLGIMSASMIIMANMNNIVWAAISLIIFGVGLGFGMTVFTTTAQNSAPTSQLGVVTASCTLFRNLGGTIFIAIFGSIMNTSMARNMEKVMSSGSGIDLTKLDVETAEKFKAMANPQLLLDNTKLEAIQASMPEQVQLLFSKVMDLVRTVMGDALTSVFYIGALLLLVGVVLSLFLKVQTADKDNNEEFEEKEEAAA
>fig|394503.6.peg.1063 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLIGIDHITINCTDINASFSFYEEILSLKRLNDVDLGDHVLHYYQLPNTKLELIEYKEPQRTIIAGNTDTGIYRHFAVGTDDLMEIKRRCDEKGYKINLQPTYIPQIDKKVMLIVDPNGVEIEIIQL
>fig|394503.6.peg.1206 Permease of the drug/metabolite transporter (DMT) superfamily
MLLGFLPQFSILLICAVLGLCSTIILFRKKLQGFNKKIVVTCVLISLISVVSNTFCMLALKKTSGSNTAFIVQLSIVITPIIMAVLERKVPSRKTILPAMAAMVGIYLITFAGKGMSVNPGDIFALCNAIFFSLFIALQNKFSNVFTAVQFTFVQHSTNIVCFLALALIFETGKIVFSNAVNPLFILLICLNATVTIFTSLFQSSAIKFVRPENAAIMYALEPVVTTVLGILLLGESFSGILTVLGCVIILFTIIISACKKGRFYSRESLKLRITTKA
>fig|394503.6.peg.2590 Daunorubicin resistance transmembrane protein
MRAYVEFAKKAFQNNIAYRADCVAGIINAIIMIFVNICVWKAIYEDEQAVAGVQFKMLITYVVLAFLMQCIYAMDEYRIENKVRSGSIGLDLLKPINFSGYTFSYNVGILIFRVVMQLTPALIISIFLFKMLPPFSLTMFALFLVSMILGYLVLYCLNFIVWISSFWFYWTFSLVTIKDAAVMILSGALLPLWFMPQAMVDFINLTPFASIYYVPITIYLGQMPMEEIAFALIKQLIWALGLFIIGRLLWRSALKKLVVQGG
>fig|394503.6.peg.2697 Antibiotic ABC transporter, ATP-binding protein
MNVIEIKNLTKVIKGQKVIDNVSIDIEGGKTYGFIGYNGSGKSMLFKAICGFVKANEGEIYIFGKRIGKDIDFPEKVGALIEHPGFLPDINGFENLKYLSEIQNIITDKEIKDALAKVGLDQEDKKKVKSYSLGMKQRLGIAQAIMESPEILILDEPLNGLDKEGVESIRNLLLNYKKEGRTILIW
>fig|394503.6.peg.3306 Drug resistance ABC transporter, RA2 family, ATP-binding protein
MSLINVTNLTFSYDGSYDNIFENVSFQIDTDWKLGFTGRNGRGKTTFLNLLLGKYEYRGSISSKVPFEYFPYEVKNKEANVIDIIEEAFPNYVLWEVMRELSLLEVDDDVLYRPFDTLSNGEQTKVLLAALFLKENSFLLIDEPTNHLDINARMVVSDYLRLKKGFILVSHDRAFLDNCIDHILSINKTGIEIQKGNFSSWFENKEMQDNYERTENDRLKKDIRRLSEAAKRASDWSNKAEAKKIGFDPTQTEKSIGRRPYQGAKAKKMMSRSKSIKERQQSAIEDKSKLLKNIESSEKLKISQLNFHTNRLVELENVSIFYSDKKACDNVTLTIEQGDRIALMGRNGSGKSSIIKLICGEDIDYSGIIRKPNQLKISYVSQNTAHLYGNLSDYARANEIDESLFKAILRKLDFSRIQFEKDISAFSGGQKKKVLIAKSLCDKAHLHIWDEPLNFIDVISRMQIEELLLEHRPTILFVEHDIEFCNNIATKIVQL
>fig|395019.3.peg.4257 Bicyclomycin resistance protein
MRTASRACAEGIRLQSNPSNGPASGAPARTTLMLLCAFSVLPLSLFLPSLPAIARELRADYALVGLAIGVYAALAASLELLMGPLSDRFGRRPIVLTSVGVFTLGAIGCALATDIRTFLACRLMQAAITSVYPVSMATIRDAGGGSRAASRIGYAAMAAAFAPMIGPTLGGALEQAAGWRANFWLLGAVGVALFAWCAFDFAETHTHRSPTLARQFRAYPALLRARRFWAYALCMAFSTGTFYAFLAGAPLAARAVFAIAPAELGVCMGTITAGFVCGSFLAGRVAHRYPLATTILYGRIVACAGPLIALALQVGGATHAAAWFGPCVLVGLGNGFTNPGAHAGALSVRPELAGSASGLAGAMTIAGGAALSSLTSAVVTSRNAGYAPLAMMLLSAAAALAAACCVRSFDARDPAGADAIAVE
>fig|395019.3.peg.5327 Multidrug resistance protein B
MMRPTRTASRDAADEARPARHRLVLPTLCIAVLIAQIDTAIVNLATGAIGATFGARVGALQWVIDAYNLAYAVLLLTGGLIGDLYGRRRAFVAGAALLSGASVVCALAPTLGVLIAGRALAGAGAALLIPASLAIVRVTWRDPAERARALGIWAACGGIAMIVGPTLGGVLIRSFGWPSIFGIVIPFGVAAIVLAAVAVRESADPHGRRFDVVAQVLGALAIGGIVFATIDARHAPLHAALLVAASGVAVALFVRVERRLGAAALVPLDLLANRPFRGMLIANGAMTFGGYGMLFVLPLAWQSHRVLDAAGAGVALLPMSVPFALVSFGSGAVAARVGARTAGAGGVALMGLGLAVIGIGAAGSTDARAPMLAWAACGLVLTGTGLGLAVGSLAATAVGAVDAARAGTAASLMNVTRMIGAVLGVAALGALYDAFGGGAAALRIAMGAGSIVQLGCAALAWRTSGGGRAPARASRAIG
>fig|395493.3.peg.118 Permease of the drug/metabolite transporter (DMT) superfamily
MLSIPVPLAYISVILIWSTTPLAIKWSNETAGVLFGVTGRMLCAAIICVLLLRVLHQPFMWDKAARRIYFATSLGLYGSLMVTYWGAQFIPSGLISVLFGLSPIVTSLLAMHLLVGERQLNFIKWLGLLLGVLGLWIIFRTEMGVGTDSLKGLFAILLAVFLHCLSAVLIKRLKVTLSPLMMTTGGILCALPMYVLTGLILGVEIPHAISLKSLLAILYLGLFGSVLGFVLYFYLLKKIDAGRVALITLITPICALFLGQALNNEVIHFNMWLGAVIVLTGLSVYQWGDKRQVMGLSLNSVKNI
>fig|395493.3.peg.183 Permease of the drug/metabolite transporter (DMT) superfamily
MTIKPLHATLLLLLASFIWGTTFVAQRISMGHIGPFMFTAIRFALGGLFLIPFFLVLHRKRQIMPLPDDKRLLVWAGLCLGSLLFSAATIQQISLIYTAAGKAGFITGLYVILVPLLGLLWRQYPDLGTWLGSILAVIGLYLLTVNADFSLAYGDFLLLISTIFWALHVLAIAWFVQRIEPILLAIMQFLVCAFCSFWVALFLETTTIQSIIGAGIPILWGGLLSVGIAYTLQIIGQRYIAPTNAALIMSTETIFAALAGWLILQETFSTQGLIGCCLMFFGIILSQLQITTTRLQQWFFMAKSF
>fig|395493.3.peg.480 Daunorubicin resistance ABC transporter ATP-binding subunit
MSQFIEIIDIYKHFPVIRGYRDFLWHSIRPRYVTALHQVSLSITQGELFCILGENGAGKTTLLKILCTLMLPNSGRVLIQGLEVTQHARQIKALIGYVLSDERSFYWRLTGRENLQFFATLQNLSKAVAKARIQTLSEQFALTAYLDKPFQTYSTGTRRKLAFIRGLLTDPPLILMDEPSNALDSLSAMQIWQYIQQTLVKQQGKTVVVTEHNLQKVEQFADRFAILKQGQVKTVETLRSLRQQLQSTTRYQLSLQTSSPTVMNWLKQQGVIHQQIPLAPDQYTIEIELNPQVITPSAFLTQLVGLGASVSCFVSITPSLETLFTAYYQHV
>fig|395493.3.peg.596 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQSVDVGNTGINPPSIGEILRFALPLILGLMTNALMTLTDTVFMGWLGTAQLAAVPFASGIFLIGWVLMVGLMRSSIAFIARLYGAGDFTKIGHVLFHYQLLAILGLPLLLLYVQLFPFFSELAQLSDVVAAYADTYLSILVWETAFTLLFILYASFYQALGNSAFPMRISLITLAINVVLDYALIFGKFGLPALGVAGSAYATVLSQAIAVLIMSVTLFNSPMCRRFCLSIWQKVDFQLIKQILRIGIPQGLGDFVELIAWVGLSVIAGRVGETALAANNIGMQFTLVLFLPGLALGIAAASYMGRFLGENRPVLARLTTYKILWIGCSYMGLLGIPLWFFGADIARLFTDDAAVIAEAAAMFKVMAIYQLFDCLGIITRTALSGAGDTFIPSILLVLCIVAILFPAAISLSTFIQPPLVGIWLGAFVYMIVLAGFMLYRYRSNRWMHIHLHPQAMTA
>fig|395493.3.peg.2054 Multidrug resistance transporter, Bcr/CflA family
MRNPQSLTTAMILAACVALGPLSTDMYLPSLPMLVGVFSTSIDQVQLTLSVFLFGFAVGQLIYGPLADRFGRKPIMLLGMFIFTVATIICIFVQTIDGLIICRFFQAIGGCVGPVLGRTVVRDIYGAVKAAKMLSYIATAMALAPAFAPIIGGYLATWFSWHAVFVLLSIYGVLMLWLVWAYVPETRPEESQAVLNPLIILKNYTVLVLNRQYNGYVLCCSFAYGGLFAFISGSSFVLIDFLGVEKQHFGYFFGVIIIGYMAGTLIAGRFSLRWGINRLVLLGVVLMTGAGLTMVTAAILQIYTVWVVILPMMFFSAGGGIVMPQAMAGALAPFPEMTGTASALFGFTQSMMAALTGMLVGHLHSGTSFVMASSIALMGIASLVSYFSLIHFQRPVAH
>fig|395493.3.peg.3266 Permease of the drug/metabolite transporter (DMT) superfamily
MRILNFSISPYVLPVLSTLFWGSNMVIGRAVMAEMPPMALAFWRGIVGLLILLPFAWRYMSAQQALIRQHWLILLVLGALSVGGFNSFLYVGLQTTTATNAAILQSNMPILIIILGYFWFRQRVTHFQFMGILISTLGVLVIICQGSWQVLTHFQFNQGDVWVLGAVLIWAVYSLLLQWKPMDLHWLGFMGVIVILGVLVMLPFYIWEFMYSPRTWSPNLPTISSIIYVGIFPLIVAYICWNQAIFEIGAQKAGQFIHLIPVFGTVLSLIFLGEQLHYYHLIGIIFVVIGIYLALFWHKSVA
>fig|395495.3.peg.430 Permease of the drug/metabolite transporter (DMT) superfamily
MKTSMATPPRGPALRGGVLALLASALFGISTPLVQHFGAGLGAFSTAALLYAGAAVLGAALRQPVEAEARLRRSDARRLLAMAGFGAVIGPVALAWGLQRTSGTSASLMLTLEALFTALLAWRLYHETLDRRVRAAMALLLAGGMVLVLDQGRTGGTQLLGLLAVLVATAAWGIDNTLSRALAERDPAQVVMAKAALGATATTLLAIASGEPLPGVVAALALLAVGATGYGLSLRFYLLAQRAFGAARTGSVFAFAPFIGAVLAVVLGDRSASWVMALGSVLMLAGVLLHLAESHGHEHPHEALDHEHAHRHDDGHHEHRHDPMPAGEHSHAHHHEPMRHGHPHVPDAHHRHRH
>fig|395495.3.peg.783 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSTGFHWCILYFTYASFASSLPVNESLHRPLCASLSPLLDPRPPFALVTFLHPPRISMNFKFHHMNLCTDNLPRLTKFYKTLFELGTISDKEHTVVSGVRQDRAYTGNVDFLTDGAIEFHWAERDLDTGFKMKQFVNPMGHGHFCFRTDDIKGFMRKCDQLGIRYSDYGCWAIPGWYQVFLQDPDGQVIEVHQPGVF
>fig|395495.3.peg.1174 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLTPRLILLLTVPPLLWAGNAVVGRLTVPLVPPLLLNAVRWAVVLLVLLVLGWRAIASAQQRREVVSRWRYLGLIGLLGVGAYNALQYLALTTSTPINVTLIAASMPLWMLLVGVLFFREHPRWQQVAGAALSLAGVATVLSRGNPAALADVHFVQGDLYMLMASASWAGYSWLLVRPPPSMQGSARPMVPGGPQTQGAPRPWNWAEFLLVQTLFGLLWAGSAAGLEAVLTPRQPQWTPWVGVAIAYIVIGPSLLAYGFWGRAVALAGPATAGVFANLTPLFAALMSTALLGEAPHLYHGAAFALIVAGILVSSRR
>fig|395495.3.peg.1797 Permeases of the drug/metabolite transporter (DMT) superfamily
MNPLPLERRAAAAIAAITILTGAAQMLAGGPLLALIATAPPDRTGAHLFATVGMFMVLFGASLLHAQSRREALAVVLLWAALQKLLAAVMVGWGVGRGVFVEPALLVAGFDLASGLLFLDLRRRGG
>fig|395965.4.peg.309 Permease of the drug/metabolite transporter (DMT) superfamily
MTLQKSGDSTQGLALYYAILVAATFLMASSFIAGKILLAHDVPAFLLVGWRFVLAALAAALVLYLTTDDFRAALLPRRLDVADWMTVAAIGVLQTAMAMGLLFWAMETIAPPTAAILLFTNPLWVALIGHAVLDERLSGLRLTGLALGVGGVALALGGGFSLREGAIGGELLGLGAALSWTGSTLLNKRARLPIETWALTFWQMLIGALALLIVAYARGENWPQHLPLSAWGWFLWLAIPGSTGSFGLWFLALTRGGATRSSGYLFLAPLFTVILSAALLGSTLSAAQGAGGVLIGCALWMINQSPRKSGAAAKLDS
>fig|395965.4.peg.1113 Drug resistance transporter, EmrB/QacA subfamily
MVGLVCIGAFLGQLDATIVQLALPTLGKTFAAPLQQVSWVALAYLVAFASFLPIFGRLCEIFGRKSLYLAGYALFVIASALCGLSTSLSELIVFRVLQGIGGSLLGANSISILVAAIGPKQRGKALGIFAAAQAVGMSAGPAIGGLILAALDWRWLFWLAAPFGAAAIIVGWLALPQTETTEQDMRFDWRGAVLIGPALIFLIVALNHLSALTSPLTMAFLAGSSALGWLLIRHERASPRPLVDLLLFRSRAFCCGAIAVALAYALLYSMFFLMSFALEHGYGDSPAAAGLRLAIIPVALGATAPFSGALSDRLGAPLLSAAGMACCLVALLMLVISGQDSGGGHLVAAAAFALFGVGLGAFIAPNNHSTVEAAPARLSGEAGSMLNLMRVLGASLGVAAATASLSWRLEDAGAGQSWLGATGPSLLRAVEASLMIPAGLAALAAAAALCAASPRAPKTA
>fig|395965.4.peg.1592 Glyoxalase/bleomycin resistance protein/dioxygenase
MFSFYVQTPSGVLIEYGHGGVVIDDLNWDVKTYSQLSDWGHSHGH
>fig|395965.4.peg.1888 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTGTEVQTAPEGAEAQTCPAAEVKSGVVPYLMVEGALKAVEFYARAFGTETAAIIPPDAQGRTMHAHLYINGGSIMLSDFFPEHGCSQASAQGFNLMVQVDDIDAWWKRATDAGAEVVMPVAEMFWGARYGQLRDPFGIVWALNQPLG
>fig|395965.4.peg.1937 Multiple antibiotic resistance (MarC)-related protein
MTKEWALFLSTFATLLAIINPFEALPIFLMLLEGKDLSEHRRVAARATLYATLLLFFFLIFGSLIMQLFGVPLSMVRIVGGIILVKIGFELFSPSPNGGSIIPDASSKTANFAFVPLALPIMCGPGAIATVLGMQSEIKEAPEHIGRFAATSLAILCAMFVTYLCLAYAGKLVDKLGPMGIDATTRIVGFFVSAMGVGLVFNGVLQGLHEHGLIAPP
>fig|395965.4.peg.2627 Outer membrane component of tripartite multidrug resistance system
MVMTTRKATGLAAAMLACLTIGGCYSVGPDFTAPDPLLPRTSFLGKPEPRAEPEPPRLSEQGSGADWWRTFHDKTLTSLAERVAGANLDIASATVRLGESRAQRGVVASAAFPSINGQASYQRELYSKNGILSLAGPNINAPPISVWQTGFDASWELDIWGRVRRQVESADASLEASEYQRRDILVSTLAELARDYVTLRGAQAQIAILTENLKSASDILELTRTRTAKGLTSDLDVQNAAALVESIKAQLPALQNDVDVNANAISFILDEQPGSLKGELMQAKSRIPAPPRPPLGVPSELARRRPDIRAAEAQLHATTADIGVAVADFYPSVKLNGNLVLNALDAKNLWKGSSLQYQFGPSVSLPIFEAGRLKSTLDLRSQQQQEAAIAYHKTVLSAWHEIVNALNAYSSEQRRRDSLKAQVDHASQALAISRTRYNNGVADFLTVLDAQRTVLQAMQQQAQSTTNVSISLIQLYKALGGGWQTTFPTEPPPPMEAAFAPL
>fig|395965.4.peg.3576 Fusaric acid resistance protein conserved region
MTPYTVRDWLFALKTFAAAAAALYLCFWLQLQRPYWAVATVYICSQQLSGATRSKAFYRACGTVLGAAMSVALVPNLVNAPELLSLAIALWIACCLYFSLLDRTPRGYMFILAGYTAALIGFPSVDAPGMIFDVAVARVEEILVGIACATVFSTVFFPRQVGPLAAGRLKAWFTDADLWACDALEARIGDDVLSARRLRLAADATQLDALSIHLAFDASIQSYAARAIRLLRLRLLMLLPVISSIEERMRTIAGGGRLALAETQALVDSICATLRDDADISAEQEAQTDDLIAAYERRLDAGSCAREIVEAGLLLRLRDFVNIRRDCRLLCGQIETGARQLKRPLAFQSPAGVVDARHRDRFGAAVSALTAFVCVGGVCLFWIATAWPDGATAAMIAAIVCCIFASQADPAAVLRAFAVWSVVAVGVTMLYLFAILPRIQTFEMLVIALSPAFILFGLLATRPKTAEASVALSLWTATLLALQDNYSADFSAVANSGAALLAGIWISTLAFQLMRVTRADWRLRRLVEASRADLASAATGRGKRDRAHFAAIMLDRLGLAASLLASSGAMDATAVALLAELRVGLNIIELRYARHGLPSTAVIKVDAMLIELGRYFRGRSAPPAPRLLALIDDALHAVASSPPGKHRRAALLGAGGVRYTLFATAPEPGAMSVARVLTLDMFFARRVQ
>fig|396513.4.peg.1855 Teicoplanin resistance associated membrane protein TcaA
MAQSQDSNRDDSNKANSKKKKTNKTTNENINQSIRKMVPWGIGTFIIILLIILFFLLKNFNSPEAQAKIFVNAVKNNDTQRISNILSTRDNKVGGDEAETYIKYIKNEIGLKKFDKELNDTVHDIDKKNKDAGYIKTPDGNNILRVTMNGRRYIFFDNIGFSTETKKAIIKKKAKTTYVFRTDDKKRKVIAEPNETTMLGYFIPGDYKIPATKETDNGKFVGYLTFSFKGSNSETVDVHENFPEANLNIKLDGADQLDSKHTKVKINGKQFSYDNTKLYGPYPVTDEIEVSAEGKVKGKTFKSDTLKLYPNELKENTPVRLKFEKDKIDKYVKEKEKEENSLKNKVNKFFNKYTSALNTAAGANNFSSISNFLKPDTDNYKTMKQSFQNGQGAQSMMQSPQVTDVSQDGSDIYAKVANINSQGFWVTSKYKLEDTSKKDGDDSDLKIISNQE
>fig|396588.3.peg.308 Acriflavin resistance protein
MNWPEWVLHQRHTVIALLVGALVLGVQARFQLPVQLFPDTDPPTVTVITEYPGMAATDVDADLTRLLEEEFASLDGVTRISGTSQAGLSVVRVEFDYGMLATLAAVDVQNAVGRVRRDLPGTIGEPRVLEFSTADKPIVTVALRSDTLDLADVREVADNAVRERLERVPGVAAVDIIGAHRRELHVALEPDRAESLGVDLEQVVAALDAWNLVAPGGRVRHGALESVIRFDAPIDSAETAERIVLRSDAAGQVRLGDVATVSLAPGEIRNAYRFDGLPAIAVQVLRRDDANTVEVAARVREVLEALRAEHPALEIVVADDDSVFTERVITDMTRTVLVAVALTMAVVLVFLADLRQAAIIALSIPAAFLATFALMQAAGLDLNMVTMSALILAIGLLVDDGIVVLENIHRHLELPDTSARSAVVNGVGEILSAKLGGSLTTLGVLVPLMFMGSFIGELFRPLAMTLAFALASSFVMAVTLVPLLGVWWLRPGRPQAPNRLVVWLGRAGGAVRVNYLAGLGLALRRPVTILVTSVLLLAASLGMLRMVGSEMMPRFDSGSFRVVVDLVPGATLEETVRAVARAEDVLVGREHTLTVSTRAGHEAGARAMGDRGAMSVNQAEITVNLVPRTEREADQWQIMDQVRQVLEQTPGVMLGVPREMGGTARASTSAPIVVRVSGESPTMLDRTAQALLDHLRGVPGMTDLYKDWALDTPELRVRLDHERVAELGLTGAQVARAVHRAMDGAVATRFRQPPLRDLDVVVRYAEPHRLHLEDLENVTLVTPAGPVPLREVATLEHDLGPRVLTREDGQRTLDVLGYHLGRPLSEVVADVEARLATFEAHDGYRVFLVGEQADFDEARAHMLRALVLAALAVYLLLVVQFGSFAHPLTVMSAIPLQFIGVTAALLVAGKYISMPALLGIILLIGIVVNNSIILLDLTRRRMAEGLEIHAAVTEAVDTRMRPIMMTALSTVAGMFPLALEMAVGAERFSPIATVIIGGILAATVLTLVVIPALFVVMERGGRRRRLAG
>fig|396588.3.peg.1380 Glyoxalase/bleomycin resistance protein/dioxygenase
MKQKVFDADLDALHHVAIPVENVARAVDWYRNQFRVRIAYQDETWALLKFANTSLALVVPGQHPPHIGVVHPDARSFGELKTHRDGTASIYLKDSEGNAVEILEDNAYV
>fig|396588.3.peg.2747 Drug resistance transporter Bcr/CflA subfamily protein
MSPALPRWRVALLVASLAMLAPFTLDTYLPSFPDIAEEFGAGPARMQQTLSIYLLGFAVMTLVYGPLSDAFGRRRVVLVALVGYMIASIGCALAQSMETFLLMRAAQGATAGAGTVIGRALVRDIYAGHEAQRVMGLMMVMFGAAPALAPVIGGLLHDVAGWRSVFVFLSLFGAAVWLFTFRRMPETLPPVARVSVAPHFVLASYGRALANARFMALVLVLALAFAGMFLYIAASPELIYGLLGYGVNDFWRLFAPLVCGIVLGGWLSSRLAERIPPVTMVTTGFAVMAVAVSLNLLQAHWLPVQPFTALAPLPLYSLGLALCMPNVTVLALDCYPHQRGMASALQAFLQLSANALVAALLVTVLSRSLAWLSLGMTGLYLAAAMLWGLWWLIYGRPVSIDPRGGGPENPA
>fig|397945.5.peg.1692 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRWPARGELPRPGGPGSRDTAPLEEGTGMHAIAPLLFVVIWSTGFLVGRGVSAHADPFWFLAARFVGVAVLFGAAAWWARVEWPRGPRRIALHLAAGALMNGLYVGPSWWAMSRGLPAGVMALIGALQPLFTALIAVAVLRRRLGPSTWAGLALGFGGVAMVLWPRLSASAGVAALSLPVLLAAAGSILALTVGSMVQKSPLAAGDLRSASAVQNLGSIAVLVLMALCLGEARWDGSPLLWGYLAYSVLVLSIGGATLLIWLMRHGEATRTAALVLAVPPLSALQAWAIFGETLTALQVVGFAVAIAGVALARR
>fig|397945.5.peg.1764 Outer membrane component of tripartite multidrug resistance system
MTFDPSAPRPAPAARPAARAPSAPRMLRACAAALLPAWLAACSVAPAYQPPALATPMPTAFKEAGALWQPAAPADAADRGDWWTLFGDEELNRLAARVQVSNQNIAAAVAAYAQAQALVREQRAGLLPGVSLSAGETRAGGETRAGGEGSARRGTTAQAALGASWAPDVWGRLGSAVDSARANAQASEADLAAARLSAVGSLVAAYFQLREADAEAGLLRDTVQAYERALRIARNRYDAGVAAQSDVLQARTQLANARADLATAQRNRAGYEHAIAVLAGQPPAAFSLPAGTWVARVPEVPAGLPSTLLERRPDIAAAERAVAAANAQIGVQRSAYYPSFSLTASLGRSGTGLGDLFSASGALWSLGLSAAQTVFDGGAIAARVEQARAARDARVANYRQTVLGAFQAVEDQLTAVRTLQAQEPLRQEAVSAAQRAEEQMLNRYRAGQVGYTDVVTAQVAALSARRALLQLQVNRQLAVASLVQALGGGWQAPWMDGAAAATAGQGAAEPR
>fig|397945.5.peg.2166 Outer membrane component of tripartite multidrug resistance system
MRTVAMMPLLALLSACTLTPPLERPAPPVPAVFPDYGGRAGAAASLSPGTSVRPDVPVADLGWRDMFEDPRLQRLIAAALEHNRDLRLAALQAEAVQAQYRIQRSARWPEVALDASASRERGARSGTGAGAAGSAGAAVSGQAALGVGVSAFELDLFGRVRSLSDAALARYLASEHGHRAAQITLVGAVADAYFAQRLAQEQLQLTVRTLSDWRQSLELARLWRQAGQNSGLDVVQAEGQVAAAEADLEARQRALDQADNALRLLLGSDPPAVLPEPLPLEARPVAARLPAGLPSGLLLARPDLLQAEQALVAAHADVGAARAAFFPRIALTASVGRASDSLGGLFDAGWGTWRFAPQITQPLFDRGRLRGELRLAQVRRSEAVVQYERAIQVAFREVADALAGAATYGRQIDAQARTVASAARRVELSELRYRAGTDGRLELLDARRQQYAAQQALLDLRRAELGNAVALYKALGGGLVERAHR
>fig|397945.5.peg.2590 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MAIHSINHVQLPFPAGEEGAMRAFYAGLLGLAEVRYPAENALHFAAGRQRIALVPTTRWQPAPAAAHLAFEVDNLPELRGRLLRAELPLVENRALPGYLRFYVKDPAGNQLEFLEPDAEAGALA
>fig|397945.5.peg.3242 Probable multidrug resistance protein norM
MTEPAMRPTDPSSQHAPAHAPWRSEARASLSLTLHLLIGQTALMSLPLADLLSVASLGRHALAAVGLVNSVAALLTLVCFGVLQAVAPLAGAALGRGGGPAVARKVVGDGLRIASGLGVLNSGLLLLFAVLLPGLGQEPEVARQAQHYAAALAPGMLAAAWLAAWRVGLPVLGRVRSLSITLSACAALHFAANHVLVHGMAGLPALGMAGLGWSYAVTYGTGVLVLHLLDRRPVPQGAGQPHAPSSARALLRIGLPIGAVMGIEYMLFTGSTVLMGRHGSSALAAHAVALQWVTLAFVIPLAASHTVLTRLSLAIGHADADAARRSTAAACVIAGVFHALVAGAWLWVPEAFASALLPVPIRDRDDLVATAAALLRVGALLQALNGFVVVLAAVLRACRDTSAILWQVLFGYWVIGLGSAALLGSMAGPAGIWWGMALGFGVALVLVLHRVRRRLTRLNDVFQPTEEIHAQSR
>fig|397945.5.peg.3315 Probable multiple antibiotic resistance protein marC
MARPAQRSPRRAVPRASAKPAHEGVRRPDAPHLNRDTVTLELLGAFGKSFLFVIAALLPIVNPAATAPIFLGLTEGASPTTRALLARRIARNMFWLLLGAMLVGSYVLEFFGISLPIVRVGGGMIVAATAWRLLTATQATVDSRTELAESFTPDMARRQAFYPLTFPVSCGPGSIAAAITVGVSLADARLSMSLARMGGGVLALLSVAVLLYFAFRYAQQLLKPLGEAGSVIFLRLSAFILLCLGVQIVWDGVYELGVAMLRDGMLPLNS
>fig|397945.5.peg.3717 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRFYAIGFLVLVAFDTLAQISFKLAGEHALPLEFSSAWLARVFGQPWIYGAFVGYVGAFFTWMTLLEHAPIGPAFAASHLEVVSVLALSAILFNEPIGWPQLLGAALIAAGIACLARSEAEEQAPPASVPPSPHGA
>fig|397948.3.peg.379 Efflux pump antibiotic resistance protein
MESIRVMRVLILFTTSLAAFQTPFNSTVLSFIVPVLGKYFHASLYTLVYVPVVYLIPLPTLMVLLGRIADIYGRERVFRIGFALFIVGSLMGAFSPSIYVLIASSLVMGLGSSILSPSSTAIVSQVFPEGERGFALGINAMAVYMGLTSAPFLGGLITQFLGWRFVLLVTTLLSVIGLAVSFVSMRGIDLPRRGIPIDAAGAASFSIALLSIVIFMILAATGDWLNYLYLPVISAASFALFIVIEGRVKDPMLNLSLFTRNISFMAGNVTALLNYISTYSVPFLFSLYLQSILGYTPFEAGLILIPEPVFMVILSPISGRLSDIYGSREVAALGMGLIGLAFIMLLILNLRSVVNVVLALSVLGVGFGFFSAPNTNSVMGSITRDKYGVASGVLGTMRFTGQLLSITLASAILAKYLGKYTALYLFTGVPLMSTIVYGLFTAGLRIMFIIAAALSFIGAYTSLLRER
>fig|397948.3.peg.460 Quinolone resistance protein NorA
MVDNRGFNYFMVNVLYSLVSGLIYPSFPLYLRMSGLNVEFTSYALTSMNIAGFASSIMWGRVINRPENRRIAVLIGTIGGGLGYLTLAYIKGTLTIIAALVVLSIIAGGIYPTVMTLISETGGVEHMGYFWAGGSIGYAITTSFAGYVLEHMGIRPLFIISAIIYVSSAAILLNIVNYSTHRKPSDHATPLNTNDESFTLSLSALYIVSVFILLFIDAVKNLYMPMFYVYEANVNMAYATATLSVEAFLEVPFIVMFVQLIRRNKADSWTALSLSLALGSLYLVANALLVRGTLSAFAAMASYSLVWASYSVSSSMIAPLISRGNRGLAYGIYNSVFPLANIIAPLCMGYSIASLGYRLSLILLSAVALVIALIAFLSRPLRSRINKAVVNSP
>fig|397948.3.peg.1126 Multidrug resistance protein
MVSKASAVVNIMIARFIYSVYWYYLAPALPLIKLEFTVPNYELGLVPLFFIIGAGSFQIPASVIARFIGNVKTAVLGLTLLSAAGVATAFSVSFNEILALRLLAGIGAALFFSTAATVVTNLYPGREGLMLGIYNSVFSAGAGVGLVYGVVYTIVNWRVAVLIISVVGLLESVILLKTCSPLNRPIDTGLSINKGAVLVGLATAGYWGANYAAGNLLPTYAVNHGVGLVNASLITSLLLFSSLVGGLSGKLADLTSRRELLIIAPAVLGSLSFLLIITLNPYAMIASTLIVGYTNELMITASYALVVNDSNPTMSLATVNTLNMVVGMWLSPLFTAVMGNSTLPWITMIIASVAPLPLLLVRRRVVG
>fig|397948.3.peg.1265 Fosmidomycin resistance protein
MMQEGKGKDRATILGLTSIGHFINDGNTWLIPGIILPVLSEMGVNYAVIGLLSALYSAISALASPLVPLSIKWLGGHMKAMALGMFLWAFAIGLSSIGFLIHDLPLVYVGVVLAGVGAAYYHPIGSALLSATYGGTAGSALGVNGAFGSLGRTLYPLIGSLLIFAGSVSEAYNLWVLAFITFIVGLSVLLYGVYRFDVHAYGKSTSRSDPSSNSMTLKVSVMLIILLFIITLLRNTAGQGVQTFLGIYINKVLGIKLSVTYGEVLSMILASAIVGQPVLGWLSDKVGRRFMASLSTFAFAVLFIIFIYTGNLIAVFLAMLFVFSNFPLIMAVLGDLFPREQVSWATSIIWNGAVTGGNVLGSLITGLLAQYYEPIYGEVGALEHALLIVLILAFISSALWVVVPKPPKRSRIPLFG
>fig|397948.3.peg.1339 Multiple antibiotic resistance protein MarC
MVAFSLFDSLVAAVQLYAIIDPLGAIPLLVSVPDYEKMMNKFLRLVAVTVPLLLLLFAFAGPFIFYVFSININDFRVAGGIILLIIAIDVLREGTPKTMGINPEDYVIVPIITPMLVGPGAITSVMVMVTYYNIFSVITAVLIASLATYITMKYSVYLVKLIGNNTLKIFARFFSLIIASWAIQLIASGIINIVKAI
>fig|397948.3.peg.1731 Permease, multidrug resistance protein
MDKVQFIVLLLLTLSSFMVALDSTIVILALPVMLTALHTDLSTLIWVILIYILSVTIFSTQLGKLGDIKGRAMMFNLGIILFGIGSALCGLSTNAVELIGFRAVQAFGGSLMSSNTMAIASDYFPTSSRGFVFGTTSMGWNLGAVAGILAGGVITTFIGWRWIFYINVPVAIIGFIMGLIYLKDRGIRTRQGFDIPGSITLGLSLGLYSMAGITYSGIGYTEEVGLMLATATVLLVLFLYIEMRAKYPLIGLSLFKIRMFTLSSLSYFFQYMANNAILFLIIMYLQGVRGLNPFEASLWLIPGYLIGSLSATLSGRLADRFDARIIASTGLTLQAVAYILYDTLLTLNTPLYLIVVITTVSGTGAAMFFAANGKMVMHEVPSNLYGVASGTNRTIGNIGILLSFIVAIVVSSAAVPRSIAFQIFVGASALTPSLMEPFINSLHMAFKVSLALIIIAIATSWSRTRVPMTQRREIINK
>fig|397948.3.peg.1930 Multidrug resistance transporter related protein
MLINNAEYDLKYAYRAMVILASLAVIVMYIEGMLIPSLTEIEREFGVTSSQVSWVLSSYLLSGTVLLPIVGRLGDIYGKKRVLSAVVIIYAVAVTLTSVSPSFTYLIAFRGIQGIGVTMFALAFSLIREEFPRELIPRAQGLVSAAFGIGAAIALPLGAYISQYFGWRTTYHTAIPFVLLVAYLIVTRIKESRYRNPSAKVDLPGAAVLGIGLGLVVYGLTEAPIWGWTNPNTIITFLAALIFIGAFIAVERRREQPLINLSLLTRRNVLIANLAAMVAGFGLFLFEQSLIILLEEPKPVGFNLSIFDTGLYAIPMAVAQLIVAPVAGILITRIGARRMLMTGASIAALFSLITAAVAPLGLGALITSTTLAMAGVAAMNVSLINILVFSVEPQVMGVSTAMNSVFRNLGGTLGPAVAGSLESTFTSLVLMGILPGRNVPLLVTVPSMYAFQIGAVISALTVVTIGILAYFSVEVITWRNESQTVASLSQE
>fig|397948.3.peg.1942 Permease of the drug/metabolite transporter (DMT) superfamily
MWVIWCREMSRLSGGLIYSIALALVWGVAYPLTRMAEAYASPMVISVVRVGAASLLMYPLARRLILNSRMLIVSVLNMGLFLVLINMSILYSPNPGLAALMIYTQPLFVAVFEWLMLKRRLSLMRIGGVLLGFMGVAVASLSSLSLSLGVVVGLMAGLLWGLGTVLYSMWFRDVNPLVANASSSVLSIPVTALALPIDPALSLTIKGILLILLVVLDAQVLGFMLWFKAISSERPSTVSSILLLTPILALYFSALMIKSSVTPLEVVGAVITIIGLFMVVKSS
>fig|398578.3.peg.1858 Permease of the drug/metabolite transporter (DMT) superfamily
MNRYEHIVRAMNFQRFFGPHLRLVGMALLWGASWPAGRVVAQNMPPLAAASLRFLLAAAVLLPWLYWAGGMAGLRHWSAKRWLGMAAAGATGVFGYAAFFLMGLQHVPAGKAALVITLNPVLTLALAVWLFGERLNRTIALGMALAACGAVVVISHGQPLALLQGSVGAGELLILGCVVCWVTYTLIGRWLLTGVDALSATAVTSTMGAAMLLVASLVVEGPAGLQAAVLGNATAWGALAFLAFGATALAYAWYFDGVKALGAGAASGYITLVPVIGVALSALWLGESIDASIVLGGGMAVAGTALMNWGRRPAAAVHVVAKRTAVQS
>fig|398578.3.peg.3319 Multidrug resistance protein B
MTPTPTTSLTSPPGRRNLPRLCFAMLVLTLVLAALDQTILSTALPVMARELPGHWPLAWVFSAYLLAATVVIALYGRLADVLGRKPMLLLAIGLFLAGSLACGASHDLQQLVLARALQGAGGGGLMTLTMLTLADLFAPEQRARYQGLLGAAYGVSTMVGPLLGGALVEHLSWHWAFWLNVPLAGLAWGVLAWALPARAAAPEAAAEPRPRQRIDWLGAVLLAAALVSLLLATQHSHLNLPEQLSLWVLLALGAKFALAFFVRQRRATHPLLPLSLFAHPAYAAVSFLALSTGVALYAAVVFLPQYLQIGLHLSPTGSAWHLAPLMAGITAGAIGSGRRLRAQTPAASLARVACVLMLLSFGLITAALHWLPQAPLALSAGLLPLGLGLGLMFPIITVVAQRVSPARHLGIATAAPVMLRSLGGAAGVALLAALLTHLMKQELAAASPLAAQADAVTAALGHGLQAIFGCAALAVLAALAACRWLPARKAAARDGQGAPAAQSAAIRRGAEGA
>fig|398578.3.peg.3325 Permease of the drug/metabolite transporter (DMT) superfamily
MSHSPSLTSATSPTRPRTSQGGTWRMLLAMALSGTIGLLVVESALPPLLVVFARCVLGALGLGLWLAWRREWVAPQGREWLWLAGGGIALVLNWVALFSAYHYSSIAVATVVYHVQPFMLLALSALQGEPVERRKLPWLLLALLGVALSSGLVGLDGMDASHAGTGAWVGVALALLAAALYAGTTVATRRLGHMPSAQIAMLQMLAGGLVLSLWALPLLTHIAAASPQLLSARAASMVLTLGLVHTAFMYTVMYAAFQRLPAPAIAALSFVYPAMALLVDLVWFGAVPSAAQWAGMGFILVAVVGHRAGIALRRH
>fig|398578.3.peg.3729 Outer membrane component of tripartite multidrug resistance system
MPKSFVSVSAAPRRVAAAAATLCAALALAGCASQGPAHEPLARLGASDLGLTAQSETGSNTSLPAADWWKSLGDAQLDALIAQALQGSPSLAMSRARFDKAAALATATSTATDVRGTLGVDATRQHYSANGLVPAPIAGHTYNTGNLQAGLSWTPDFFGRHAADLQAALGQARAAQADSAAAANQLAAQVARSYVALARLIAQKDVAGRTLTQRQSLLDLSQQRTRAGLDSQVELTQAQAGLPDAGTQIEMLDEQITLARRTIAVLCGQAPEAQLQLSPRLAALQIQAVPGQLGADLLGRRPDVVAARWRVESATQGIESARADFYPDINLTAFIGLNAIGLDNLFKGSSRQMGITPALRLPLFDGKRLRAQLRGTQADLDTAIAQYNGVVLDAVKEAGDAITSVQSLVRQQQLQAESLEKAERAYDFAVQRYKAGLASQVTVLNTETQVITQRRLDVDLRARALDTRVSLMKALGGGWTDGTAAVQVSQH
>fig|398578.3.peg.3899 Permeases of the drug/metabolite transporter (DMT) superfamily
MQDRTHSLQAASVASTAPAPTPAQAAPTAQETRGQWLMIAGGVLLGTVGIFVEEARQHPLVTVLFRCAFGALALLAWGLATGRVRELRVRGRSWPVVVATGLLMVLNWALFFAAIPLTSIGVATIVFHIQPVWIMLFGTLVLREAVAPRQVAAMLAALLGLVLATGLLGGDAAAWGPDHVSGLLMCLAGSLCYAAVTILAKTEKVVTPFALAWWQCAVGTVLLLWVPLVHGWPQAPSSWAWLAGLGVLHTGLAYAILFAGMARLTLGRIAVLQYVYPLTAIVLDWAVYGRALGAVQLAGVGLMAGALLVVKARQLR
>fig|398578.3.peg.4416 Multidrug resistance transporter, Bcr/CflA family
MNFADPGPRRSVSFLLLLPLLLAAQPVATDGYLPALPEIARDLGSASSSLTVFMLAFGVAQLVCGPLADRFGRRPVLLTGLACYTAAAAGCALAGSADALVAWRAVQGAAMAAILVCARAAVRDLYPAHEGPRIMARGLTGLGLVALVAPIAGAWGVQATGWRWVLVAMGVYSLALLALCWRTFSETRQAPAESAPVLVPVSVSAGGVRQVIADPGFCAWTALAAATYGGIFCFLLLSPMVYVDLFGLSPVLYGWIPAGGSLVYILGITWCRRLLSRHGPVRTVQLGASLSLLGPCIQIAGCVLAPASPFPLLLGHAVYALGHGLHQPCGQAGAVGGLPPQLAGRAVSCSGFAIMCVAFCAGQLAAQFVDPTMRHGAWPMVLPMALAGVVLVLIAFVWLPWLYRLRSAQRVQPRS
>fig|398580.3.peg.811 Glyoxalase/bleomycin resistance protein/dioxygenase
MGWSIHHVNLQARDVRKTAAFYTQILGMTERDWVFPESRGYLPGDPDKLALLGDGREGHTGLHLIAPDPEFASKNNLIHNPSEGGHVAIHVDDLQAVIDRLTAAGVPFSVTGEFAIPGLRHVYVTDPEGNLIEVNGRV
>fig|398580.3.peg.949 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MPMSHASPIPTTISELAPLLRLSIPLMIGLAAPMLIGVIDTVMIAPLGTEPLAAAGITTSVVIILLSSLWGLVTMTGIRIAQAEGAGDRPGVAIELKTGLWLSLAAGGLGMALMLAILPALGLLGQPDSVRAILPGYWVSMAVWLLPFTAFYVIKGLFDAVDRPWAGVALSYLGVVVNLPLNWLLIYPAGLGLLGAGLASILSQTLALGAAWLVWRRAKGLAPWRVPVPAGALRLRAQIRDGWPLVVGYAGEGGAYALIGLMMGWVGATALAANQIVHTVGAVGYVFPLGMAMAASIRVGLAHGAGQTGRLRAILRAALTVVTGWMILLMAFFLIAGDWLSGLLSDDPEVVALAATLFIALACMQIADGVQSTSLGALRGMGDMRWPTAMSLIAYWPLALPAAYALGFWAGLGALGLWVGFGLGLAIAAIMLPLRFWHLTGRAPAMQIGH
>fig|398580.3.peg.2126 Drug/metabolite exporter family protein
MPPRESIDAFGAVALVGFALLMGLNQVAIKIVGDGLQPVFAAGLRSLGAMICIWLWMRFRGLPLKVAPGTVKAGLAIGALFAIEFLCLFIALDINNVTRVSVLMYSMPVWLTLIGHWVLPGERMSLSKAVGLALAFAGVIVAFASRGSDLVTGSFWGDLLALGAAISWAGIGLLAKASALKTVRPEMQLMWQVAVSAAVLLALAPFFGPLVRDLAPIHVGSLLFQIVVIVSAGYIFWLWLLSIYPAGGVSSFAFLMPLSGFGFGWLLLDEPLSASLWLSLGLLLVGLVLINRPRRAR
>fig|398580.3.peg.2280 Multidrug resistance efflux pump
MSETQTSPPSGGSPARTVALVVVVALVLIAGLYALMDRYVPSSPRGIVSANVVQIAPRVSGTITRVHVADDAIVEAGDPLFSLDPRPFELAVRQAEANLNTALQTVDASGASLVAAQAAVTQARTALENTQAEADRTFQLEERGIVATARGDDARAAVESAQAQLDQAEANLDSARAQLGPEGADNPTIQAATAQLEQAQYDLASTTVTAPHLGVVTNVTLSEGQFIGAGSPALTFIDAEAGWITVDLRENQLQKIEAGDPARVLFDALPGRIFEGRVQSIAWGIAPRRTVQGGLVANQQTTQWFEPARTIPVRIELEGGMENWPYAVRVGGKVHAVIFSESETGPIAWVARGLQRLRSWLSYLH
>fig|398720.4.peg.40 Outer membrane component of tripartite multidrug resistance system
MRLTEAWEYAAQYSKEIKLKQLEEKIGAEDVLDAKNQRLPELSTHASYGKLSNIPVFTNGIREKANFIPLEDHSTYGAGVEAYFNIYNGGKTNIHIDQAKTKQRLINYLAEESRDQIKYEVASAYLSLQRGLLFEKLIAKNIYSNQELLDQITKLYENGVVLKSDLLRAKLQLSKQQTQLLEVTNNAKLAHQHLNILMGFSEETPVKPIDTVKVELIQEDQDYAYYLNEAKSAPLSKAAETQVTLSELEEQDLKAGKLPKLGLFGEYMYSYPQIRLYPYETAPYLLGIVGIRASYDISALYNDKHKELAAALEVERQEVEKQQVDDDLRKGIKAAYQDYHEDLQNIEVALMSIEQAEENYRIVRQTYFNQLSLLTDLLDADNQLLQARFELVNSKIAARLHYYQLLKITGNL
>fig|398720.4.peg.41 Membrane fusion component of tripartite multidrug resistance system
MSNTIKNYQKIDLIAVKSTYVVALLILIGLLIWGVSSAFHFMNYEETNDAQIKEYINPIVSRTGGYIEKIAFEDHQYVQQGDTLVVLETNESEVSLQEAKAALAEAEAQLMVLESNVNTANSNATVNQAQIGAAEAKLWQQQKEYERYKKLHEAEAVTQQQFEDVKTRLGVAKSNLEAVKNTFNTSQNRSNDASTQIAVAKAHIEKQKSVLDRIQLELNYAVILAPSDGYMGEKRLQAGQFVQKGQTLSFIVDQTQGKWVIANFEETQIANLREGQPVNIQVDAFPDEAFEGVIESLSPATGSQFSLMPPDNATGNFVKITQRFPVRIRLKKEQQDLSKLRAGMNVEVAIPKA
>fig|398720.4.peg.42 Inner membrane component of tripartite multidrug resistance system
MSNNTVFKSWVPNWLVLVVIFLALVPIASVLGIYMSGINSAASYYGADPTDIQYSVIIFYLAIASAFPLERRFFDYFAPKPYFVVCAIIYVVLNLILYSTNSIAILFIIRFLGGMLSLGFIGVIFTLIFRQFSQQRSRVLGYATFYGALFSTMPLAQILDAYVFSYYDFNVIFLIKIFMVIPGFLLLLIILKRNVNLRNTKRIPLYSVDWASFVLYASALMLLAYVLLYGLYYQWYSSGRILICSIAFVFLMLLFVFRQLKLKRPYIDFSLYKHRNFRIGMLLLIVFYFCKGDMSVINGFLNNNVNLDVYHKGYIMLFNALGIIAGVGLTARFILTGTNIRLIWVTGFLALLGFHVYMLLLLGNQAELSDLIIPLFLQGFSNGTLLLSIVIFYVTGVPSAIAFSASVSGVAFRFSSFTASMALVSYMGLNRQKIHASAFANQIQQTNDLVGARISGYKEALLNQGASAFQANAGASKMLGQALNNQSNLLFARDYYLYVSVVIVAVILAIILIPNFHYHMRKIGAKLIPF
>fig|398720.4.peg.735 Tetracycline resistance element mobilization regulatory protein rteC
MKEAEARVAAFTRELQALQEAQATPLKCALEAIAVCNKTLSSLQHWVDTHDFESIPSEIYFFKSLKSEPMSHLIYYTEVRTCELQKPKAGKHYQVSFLQKELKKLNKFFYRNADFVHYMELGHTYLDHQYFSRTQNPEYPVNPLVHYYQFPEFTTSHDMLWAKVKAMNRYIHYIREQLEALQPGQNFKWKQDKHKVLVWTGSKTALVELIYALYSDQVINHGALDLKQLTSGFEDFFNIKLQHPYKTYTELKERKGSRTKFLNELILKLEQKMLAEDA
>fig|398720.4.peg.2636 Tetracycline resistance element mobilization regulatory protein rteC
MNSQLLSKKLLEDLDEIRVQNENILECAWRSIKACRNLLTVYKNEILSKEFKTIKEEIQFFKETKQVPLIRLIYFSEIYSFEVQFPKGNKDCQLKFLKKKINKLNRFFLYNIDFGRYVNSGATHFDKEYYTRDYLETFHITTSKFYFQDPDFCTPRDMLLGKYKAYDCLVTYFDEKKDRVHNGLNGKHERIKPMEKIDWPFSNTDYVELLYALCSKGLGKRNNQGIMQVSKKLEQIFNIEPKDIYKTFQDIKNRKKSRTLFLDDLSTSLLSEMNRSEE
>fig|398720.4.peg.2913 Outer membrane component of tripartite multidrug resistance system
MATAQDLSGYIAEVETNNPEVQAYELRYSIAQEKVNEVNTLPDTEFGVGYFVSTPETRVGAQRARFSVKQMLPWFGTISKREKYQDALVETEYLEYVIAKRKLGLAVAQGYYKLYTIEAQSKVVQQNVELLERYKELALNAVEVAKASVVDVLKLEMRQNELKAQQQILEERRIAAEIQFKNTLNTASEGRILVVDSLSIPIEDEQINSEDLSANPELLKYDKLYESVTQAEILNRQEAAPKWGVGLDYIPVSERTDMFPADNGKDIVMPMVSVSVPIFNSKYKSVSRQNELRQQELDAQKAQRLNTLKNLLAEAKQHKNTARINFNTQKQNIAQAQDAEEILLKSYETGSIDFNDVLDIQELQLEFQLKQLQAVQNYYEQAALINYLTNI
>fig|398720.4.peg.3496 AcrA/AcrE family multidrug resistance protein
MAQAVPQYPVLKITEAPTTLQRKYPAVIQGEEDIEIRPRIDGYLQKIYVEEGSRVKKGDLLFKIDAPQYNEVVKAAQSAVKNAELKVQKATPLVEEGIINQYELDAAKLDLEAQRASLAQAQANQGYTFIKSPVDGVVGAIPYRTGSLISPQVVAPLTVVSDIDNVKVYFSMDEKEYLEFYADHEGNSVDDKLKSFPKVKLQLSDGSILESEGEITAISGLLNQQTGSARLTAVFPNANQRIRSGGSGKILIPQAFSSAIMVPQKSTFELQDKRMVYKVKDDRVFTSEIKTMPTTVDNKFVVTEGLSEGDIIVFEGAGTLRDSLQIKPNIITQ
>fig|398767.5.peg.2582 Permease of the drug/metabolite transporter (DMT) superfamily
MSLIIFGKSHVHRPLFAYLLLTLSALIWSGNFVISRAVASLIPPVGLLFWRWVVALAVLCPIVLPRLKNQWPLIRANLKIFPLFGLFGVTLFNLLIYLAMHTTTAINAALVNSAIPILIILFTRIFFRKGVSARQWVGILLSLGGVCIIILRGNPATIAHLTFSAGDLLVLGAATSWAAYSVCLRYYPEGLDPLVFLFCIALCGQLFILPLYLLEVINGATVPVTAASLASIGYVGVLASVVAFVAWNSGIRSVGAQVGGQFIHLMPVFSTILAVLFLKEHLQGYHLLGILLIVVGIIFATDLLRLRKS
>fig|399549.6.peg.312 Multidrug resistance protein
MDKRGREVLLLLVWGDLLINYVETMVVPAIPTIQSDFSVSSTLASWITSAFIIVGAVVSPIFGKLADMYGRKRMYLISLGGYLVAVALAGFSPSIYALIAARAIQGIGYGIFPVGLAIITDVLPPQDVATAQGLLSGSVGIGTALGLIVGSYIDQNFGWQYAFHTAFILSLLFFLLILTKLKDTGVRVKESIDYVGTTLLTVGMVLILVYITEGPSLGWLNAENLVLLTLGVLLVLVFIPVELRVREPLVDMNLMRIRNVMVANLVGVVSSIALMIMYFGIIYYAQLPPPFGLGLDIFSAGLTLAPATVVMFVVGPIVGKLTGDAGPKPLLVFGSLTSILGFILLMVNRGTSQALVEDVIVAGTGMISIIIPLINMIAVSLPETARGIGLGVNTLLRNLGASIGPVLATSIMSSYKDPYVLIVDNQFLISFYPGSEAFNVMFEVAVLVILVNLGISLLTRNYKLKGKGRNIVL
>fig|399549.6.peg.419 Fosmidomycin resistance protein
MILIMESKSLRALIFTSLAHFSNDGVFLIFPLLIVYYTTDERISVVFLGALAIVYTLLSGLLSPLIGDVADKRDSDAELIALGIFLEALATGLFALSFLDRGLAIPLITLGVVLLGSGQAFYHPLGGAILARIFGKSSGRALGINGAMGSLGRAVMPSIITFLILGLGEVLGLGIFTVYMVLVTLVIYFGLMNVRRGSMSLVRKATEKLDRRFYRFLIILGALVFMRSMFISGTTTFLGEFVYQVYFSKAFTGIFLTIGFLGSVFGQPVFGWLTERLGGRTTFLLSSILSLVFFGLFLVFPRNLFISLSSYTLFTFAAFTGFPILLGYIGQVFPKNFFTVANSYVWGIGNTVGGAAGTALVTWLLDLHYDLIFSFTVLFVIAVISTVLTPLIPKKI
>fig|399549.6.peg.1340 Multidrug resistance protein related protein
MDSFNWLLLSRALRSIGIMFVTISSSLYLSTLGLSPVIIGLVFLGMTGYIAGFSLSLGMLGDRVGYKKSLILGDLIPAIALILLISTRNPLVVIPSAIITGLGGTAGGARGAFSPGLTALVARNWKEDQERVRRLGKLTSISALAGAGGGILLSFHDYLPFGNVNDFRFLFGVASGLLFASALCILKVEERRGEKKSTKFMRKGSLRYISKVIVSNTLSGAGVGLAIPLLPLWFNLRFHASPLIIGVIFTGASLSTSLGSYIATRISRNPLRLASLTRIMNGGFLLAMAISPFLPLAGALYVVRGFNAGVGMPNRTAINVRGVSEDDFGTASSLQGVATRLSQMSSGLSGYLLEESFALPLEVGGVMQALGGILYYTLLRGKEERREEKPKTV
>fig|399550.6.peg.126 Multiple antibiotic resistance (MarC)-related proteins
MLNGDNNMFDLLFAYYIQLLAIMNPFSALPTFLSLTDHLDEIERKDIVRKAFITSIILVILFSLIGNYILLAFGISIASLRIGGGILLLVIALDMLGGMPRTKQIEYSDIAVVPLATPMVIGPGTITTILLLTSREPGFLNIFLVLIASILAATTTFIMLRYSTKLVSILRVSVIRAIGRFMSLIIASVAVEMIALGIISFYHTYFC
>fig|399550.6.peg.291 Multiple antibiotic resistance protein MarC
MVVNMEIDVYQLVSAILMLFVVLDAPGNAPLFYFFTKDMEPWKRIYTIRKSIIVAAFILLLFGLFGDYILLYFDITVNDFRIAGGIILFIYAVLGILGHTTAEEVSGEEIAVVPLATPLLAGPGSITVVIYLKYSMGLLLTMLSIAINMIIAWILLENGGKLLQLLGKQGSTVLSKILAILLAAYSVAMIREGIISLINI
>fig|399550.6.peg.569 Permease of the drug/metabolite transporter (DMT) superfamily
MRNNYPSILKHYLALLGTVILWGTSFPVIKILVSNVDEYTYVWVRGLLSIIFLTPLILFYISKKYVSKECVKGGLLAGIFYGLGLFFQGWGTSYTTASNSAFITGLNVLFVHLIVASMYKRYSIRLFASLVSGILGLYLLSSPTTIGRLGDFLVLIGAVMWALQIIVFDKYSKCNPFILVYFMFTPTQTFILFDPSPADILETRINVLLGFIYLAIFCSIGAFALQAYGQKKVPPETAATIFLLEPVFASIFAYMFLGETLTFKQLIGASFILLSMYLASKHLLK
>fig|399550.6.peg.720 Permease of the drug/metabolite transporter (DMT) superfamily
MMVMQMEVIGVLSALTASSIWSLSPGLISRYGKGVDAITLNMLRSLHAVFVLFFIFLLTINDRWFVPEGILIVYISAFFGPLLGDTLYIHSIKHIGGGNAVSISYTYIFFAQLYSYLLYGEQLRIQLILGSFIAIIGVYLVYSGQRNDIKIIGFLAALGAALSWGMGATLSKLALNYGDPVTIALLRNLSTTISLLPITYNSVKKVFLDKEVQITAFITGGIGFGIGMTLFLTAINTIGVSATVLATSLTPVLGRILAKYIAGEKPSPKTYLGTIITSTGIFIGLYF
>fig|399726.4.peg.889 Multiple resistance and pH regulation protein F precursor
MFFMEMEILKTLGGIILCITIIISILASINRKGVLEKVVITNIVNTKTVALIFILSYIRNKPVFLDVAVVYALINFIAAIAVSKFFDGYHKQGD
>fig|399741.3.peg.1579 Multidrug resistance protein B
MKGFPPLINTLLASSLVLTIGRGVTLPFITIYLTGHFHLLPKSVGIILGISLMIGIFASLYGGYLVDKFNKNTLILTAILLFALSFFAIPWIPRPGGIIVVLAILHTAYSVLGITIKACFADWLPVAQRIKAFSINYTLVNVGWAVGSSLGVMVAGLNPLLPFYLSGGLALCTVTALSFSLHRQRTTPPAATEAVPSAPPNFRQTLTILRNDHRLIYFTLGSTLGAVVFGQFTGYLSQYLILVSNAEFAYQVIGAVMIVNACIVIALQYLLSRGMRQENMLRWLALGTVFFILGLIGFSLAGQSLWLWAIAMAIFTLGEIIVIPVEYMFIDFIAPQHLKGSYYGVQNLSALGGAINPVLCGFILSYAAPQMMFVMLIAAALFSLLFFFLGHRLAQKQQYRAGIISTK
>fig|399741.3.peg.3399 Permease of the drug/metabolite transporter (DMT) superfamily
MMSARKNIDSRAAAAMMMICAIWGLQQVAIKAAEPDISAVLQIAIRSGIAALAVYLLARYRREKFVFDRPTLLAGLCVGFFFALEFFFVSEGLRYTSASHMAVFLYTAPLFSAIGLHFVIRHERLSLIQWVGIAIAFGGVVLAISGMSDSSGAENSLRGDIYGLLAGMSWGGSTIVIRTTGLANCSSKQTLLFQLSGACILLSLLAITTQSVHFNLTALAWTSLIFQTLVVSFISYLIWFSLLRHYQASSLGILTFMTPVFGILAGVVILGEPLQIEFVLGSVLIVLGLIVVSCSYLFYLNRGIVPKI
>fig|399742.4.peg.891 Multidrug resistance protein B
MESWKVNLISVWFGCFFTGLAISQILPFLPLYVSQLGVSSHEALSMWSGLTFSITFLVSAIVSPMWGSLADRKGRKLMLLRASLGMAIAILLQAYATNVWQLFLLRGLMGLTSGYIPNAMALVASQVPRERSGWAISTLSTAQISGVIGGPLMGGFLADHVGLRAVFFITALLLMVSFLVTFFLIKEGVRPTISKAERLSGKAVFATLPYPGLMISLFVTTMVIQLCNGSIGPILTLFIKSMAPDSNNIAFLSGMIAAVPGVSALMSAPKLGKLGDRIGTARILMATLIFAVVLFFAMSFVTSPLQLGVLRFLLGFADGAMLPAVQTLLVKYSSDQVTGRIFGYNQSFMYLGNVIGPLIGASVSAMAGFRWVFAATAVVVLLNIIQLAIALRRRHQKAASAGAR
>fig|399795.3.peg.18 Glyoxalase/bleomycin resistance protein/dioxygenase
MPFEIVHGIQPYEALEVRPVLKLNTGRIKRRRGEFQRPRLEPAAILRLGHVALLTNDFKRNFEWMQSRLGLRPSDIMYGKDEDDLVGSFMHLSGGGEWTDHHSLALFPDPHPRVHHFSFEVEDIDAQGMGNQWMSKQGWKHSWGIGRHIYGSQIFDYWFDPDGNIAEHFTDGDLVRPGCEPNFALLDDESLFAWGPPMQAAKFVNMAARHG
>fig|399795.3.peg.1268 
MLLIVGTVRLPSENLALARPAMRAMVEASRAEPGCLEYGYAEDVLVPGLIHVKELWSDQAALDAHFASAHIQAWRAAWPELGIGQRDLRLYEVQAPRAT
>fig|399795.3.peg.2911 Outer membrane component of tripartite multidrug resistance system
MEHAKTCQRPISLERRLAATYLVAGLVTAGLAGCAAGPDFQRPTAPDVARYTATPVADRTASAPTQFGETQRLVEGLPIETQWWQSLGSSTLDGLINEAFHVSPTLASISANLRQAQELLAAQAGSTQYPQVDVALGSQRQQMSPSSQGLSGDARQFSLYNASVGVHYNLDLAGGNRRALEALAARADYRRFELNAARLALAGNMATAAITRARLAAQLEATTAILRVQDEQLRLAHERVRIGQASPDEALSLQAQAEQTRAELPALRKQLQQTEHLLAVLAGRAPGTGGIPAFTLADFTLPVEMPLVVPSELVRRRPDIQASEALLHAANADYGVAVAKLYPQINLSANLGSQALTTGTLFGGGSAVWGLVAQLTQPLFNPGLPAEKRAALAAFDAAAANYQSVVLESLRNVADTLRAVESDAQTLTALAAADMAAQASLQSVERQYRLGAASYLQLLIAQQQAQSIRINMVAAQAQRLVDSVALYQALGGGVS
>fig|399795.3.peg.3423 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQPYTANLSHFGIFCRDLEVMKSFYTGVFDMQETDRGEGVTFRFEIVFLSGRNDQHHQLVLAGGRGADSPSTVMQLSFKVQSIDQLREARRRALALGATKMRGLNHGNALSIYCMDPEDNTVEVYLDTPWYVSQPHGDPLDLEQSDEAIWAQTERVVRTDPSFMPVAEWAAQFEQRRQATGNA
>fig|399795.3.peg.5181 Permease of the drug/metabolite transporter (DMT) superfamily
MSVASLIRLMTLAALWGGSFLFMRVAVPHLGAVPTAVGRGLFSALGLGAALFAMGYRPKIGRHLWPLLGLGVINSGIPFLMYALAAQVLPSGYSAIFNATTPLVATVVGALVFAEAITPARVAAVLLGIGGVAVLAQAGPLDLSTAVLGGMAACFVATVCYAFSSYLTLRLAGANASVDTRAAVFISQLGALMVLTPALLIDMALEPGMLARLEAAPLLAWGNVALLGLLSTALAYVLYFRLIADEGPQKALTVTFIVPVFAVLWGWALLDESLTVAHAMGGGLIALSLWLVLRPKAD
>fig|400667.4.peg.956 Multiple antibiotic resistance protein MarC
MVSPYLHSFALFFSLLNPFLMSIYMIGLIRHSETKVFNKALIQGSLIAYIVFMLFAWGGEAIFSKYLNVRFEAFQIFGGLIFLVIGYRYVFQGADTIGEMRGAPEHLAGTIAMPFMIGPGTISAAVVTGIEMSIGAAALVIGFTMFLTCSILILMKFSHDHLRYKHAKYIDRYFDIVGRLSALLIGTIAVDMIINGVTGLIHKV
>fig|400667.4.peg.1559 Permease of the drug/metabolite transporter (DMT) superfamily
MITQNKDILFRSPIMNKSMVYAYTGVVITMLFWGSAFNAMSYVIQYMPPLSAAAERFTIASLGLFILFAAIGKLRWAALRQNLAIYLIIGIIGIAGFNLGCFYGLQTTSAVNGALIMATTPLITLLLTILLDGEKLTLNKSIGVVFGLSGVLFVISHGHISTLLHLKIAIGDLFILLGGVSFCLANMLSRRYVKNATPLETTTFSMMSGALTLIILSVIFEHPSQAIAMAPITAHLAMGYVIICSTMIAYLFWFNGIQKLGAGRASIFFNFVPVFSMLVALLAGQSLNIWQLIGTALVMLGVMSSGGFIQIKRPTLIAKPCTK
>fig|400667.4.peg.2312 Permease of the drug/metabolite transporter (DMT) superfamily
MSKNLATLIGLSAILMWASMVGFVKHITTAIGPDVGITLIYSLSALLLLIIFRVPNFKLISKKYLILGAILFIAYELCFSFALAYSKTAQQAIEVSIVNYLWPSLTVLAFVIFRELKFNVFIILGLLISISGIIFIQTGNGDFSLGRVVDNFHSNPLSYILAFIGAIIWAFYCVLTKKMGKGQNPISIFFLGVAITLWLKLLFSGQVSLPSLDLNTILSLIVASAAIGLGYAAWNIGIIHGNITMLVVASYFTPIISSLLAMLVLQTELSISFWQGTAMVTAGSLICWLSTNWAVIRSYFRIN
>fig|400667.4.peg.2319 Permease of the drug/metabolite transporter (DMT) superfamily
MEKFVDDHHLKRKVGTLEMVIAMLLSGSIGLFVIKSGQSPVNIVFFRCLISALCLIPICYFYGHFRKVYFGKKELFLMVTSGLLIIFNWVLLFAAFPKTSISLATIVYHVNPFVILFLGALVFHEKLNKNDVLWTIVAFIGLIVIIGLGSASVNSNELVGLGLVLIATTLYSISVLITKKLSNTPPLLIVFIQTLSGAIAMTPFMSVFENPPIGQQWLFVVGLGVLHTAFLYYLMYSAIKKIPLNNIAILSFIYPISTIVIDYFFFDHVLTSTQVLGAGLILLGVLGVKLHWNIFALKNA
>fig|400667.4.peg.2665 Multidrug resistance protein norM
MNMLKDISLPILKLALPLILIQICQASLGVINTMVAGRYHYIDLAGIGLGSNMWTPVFILFTGILYVLVPKISAMQQANKAEIATLIQQGKKVAFLLSIFGFILIQLLALLCPWLIENPQVASIAKQYLHFVAFGVPGLVYMTLFRFISEGHSLLKPIILTYLILLFCDALLCVVLVKGIGFISEIGGAGTGLATAISAYIACFCMYQLVAKAVPELKTNKAKVNIQQSLQLLKQGLPIGITLVLQILALATLAFFASQLGAKAIAAHQIVINIAMLIIMIPIAISSATTIRVAYFSATHDHQSKLATSAAVAVITLIYGVVIAGLLVAFAEPLTGLFSNDAEVLNIAAGLMSFIAVFLIFDAIQTVASGVLRGLQQFMQPLFVILFCYWLVIIPLSYLMGVRGWLQERANVDVIWLVLTCGISLAAILLVIQSYRYLKKGELPVGETIST
>fig|400667.4.peg.3143 Permease of the drug/metabolite transporter (DMT) superfamily
MEERKNLDTRASALMVLLCMVLGLQQVVLKIAAPDISPIMQIALRSGLSAVLVLPLLWRDHSIHLFSYRQCKAGALVALFFSLEFYFVTQALKFTSTSHTVVLLYTAPIFVALGLHWKFPTERLNRAQWGGITLAFMGIILTFYPTTTATNAPALAQVLLGDLYALMAGLAWALSTIIVRLSPLAQAPATQTLFYQLFGCFVLLLLIAFLTNQTTIHFTTLAILSLSFQTLIVSFASLLLWFWLLRNYLASRLGIFSFLTPLFGVLFSILLLEEKLEIKFIFGSILVLSGIVIMSLKQGKANSS
>fig|400667.4.peg.3527 MATE family drug transporter
MMNQIFKLFIPMLSSNLIVVLSGLIDIAYVGHFSNDHVAALSVTLSLYTVVYVIGMGILQGVMLKLSEAYGCHDIPRIRQIFIQGVWLMLGSALVSIALLYLFRDLPKLFGASEHVVLITKNCIWALVFILPAHLLMRLFTALSQVTENAYKVLLSDSLFFILKIILSYLLIYGVALFSIPPLGAIGALLATIIVRWFMLTVYYLFFLEKKYIFIEHPERSVEDSWQSLRMILKIGIPTAIMALMDVIAFCSVAILILPFGSVVSAAHQIVASTGGFMFIFPSSIASAYSILVSRTMGSGNMKEADKIARQSIWVIMAVSGSLSLCLWVERGLIVTFYSDDLAVQILAASLLLIVCMSHFLDGLMTLLTSLLRCWDVSILPMLIFLVVVLCFGLGGGWWMAYKGLHWGSHSISAMGIYGFWSMAAISYLVACVLSAFCFRFRKQLRGF
>fig|400668.6.peg.102 Multidrug resistance protein A
MSEQENNPSLPKQVEKRTTRRVLLVALPLVVILASVFVYMKGGRYVETDNAYVQSDITTINAEVSGAIQTIAIKENEKVSKGQLLFSIDATPFKVAEAKAQAQLQQVRLNILEQKAAYEEKKAEINQAENEFAFNQREEKRQANLLKQKFISDTQFDQARQAAEVSELKVATLKKDLFRLKEALGGDPSAPLEDHPSYQAAQAALDQTRIDLGHVNVRAPASGVVAKVPNSGEYVTAGSTTMVLVSDERQWIAANFTEKDLTYVQPGQEVEIEVDAYPGVSLHGKVESISPATGSEFSVIPAENATGNWVKVAQRLSVKILVDTDQDTPVLRTGFSSNVTIDTEHQRRLFGLAL
>fig|400668.6.peg.148 Multidrug resistance protein B
MIYLIRFLSSSAWSCFYPFMAVWLHGVVGLTSSSASVVVGFAIVANRVGALVFYGVLDKVSHRYEIIFSLFLMALFASLMLASAHLKITNIAIWIVIVSLFGISNSVSTISQISYIVHNFKEGMHEKALAYENVAANAGSGIAPFVASILLTFSGSLFAALPVGLGVVAACCAYYLHNSRLVHKRDTKTANINSTFTQLRDRALIIFMVINFLTMIGYAQFYYVFPTYATEQFSSETVGQLFLLASAIIIIAQVPITSFFQRVTKLWRVIISNLLIASGVLLLSNSSGGQFSLYIVVPLIVIGEMICGPLYQAQAVKIWSGSSSTIMSIQTCIWGAAEALAAVAGLLLVAHGGGVASFIIGGGACILVTFTAWMSISSKKAIIGINLTEK
>fig|400668.6.peg.174 Permease of the drug/metabolite transporter (DMT) superfamily
MRLISLGVSVLCFLCAVLGTIRSHHPCASYYLEKPKMAGTFFIMIACFTWALDTLIRYPLLGAGYSTLQIVLIEHLTLVLFVAPLLWRYRHVYRHMSIGGFSCLFFIGGIGSAMGTLAFTEAFHYLNPTVVILLQKLQPIVAILLAYWLLKERIEGHFLQWAAVILLGSFVMMWPDLRQLGDAQWHYSSDTTSILKGYGYTLIAVVAWGAATVCGKYLSHQHMPANAIMSGRFVAGLLVLLPMALAQSDTLIAMKPVDLSLAVAMALLSGFIGMWFYYQGLKTVPAQLATLAELSFPVFAAAINWLFLDMGLTGYQIIGGLMLILGNIGLRMKELRKEELTPAVQ
>fig|400668.6.peg.297 Resistance-Nodulation-Cell Division (RND) multidrug efflux transporter MexD
MSNFFIARPNFAWVMAIFILLAGLLALPTLPVSQFPVVAPPQVEITATYPGASAQVLVDSVTSVIEEELNGAKGLLYFDSSSNANGIAQITASFEPGTDPDLAQVDIQNRLKKAEARLPSSVIAQGVQVDQASSGFLMIYALTFKGDDSSKSIIALADYAARNINNNIRRVKGVGKLQYFGTEAAMRVWVSPEKLLSYGLSIGDINNAIRNQNVQVPAGSFGGRPADDAQELTASLVVKGFLEDPEEFGNIVLRSNVDGSAVYLKDVARVELGKQDYNFETRLNGHKAIMGAVQLSPGANAIETVKAIKARAAELEANFPDDIQISFPYDTSKFVSAAIEKVIYTLIEAIVLVFLVMLLFLQNLRYTLIPTIVVPVCILGTFAVMSLMGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMVEEGLPPKDATIKAMGQVSGAIVGITLVLSAVFVPLAFMSGSVGIIYQQFSMSLAVSIMLSGILALTFTPALCATLLKPINKEAHHEKGGFFGWFNRKFARLTHRYSILNGMLVNRSGRFMLVYLVLIIGLGYAYLRLPESFVPTEDQGYMIVDLQLPAGATFSRTNETMKDAEKFLGQRDAVENVVTVMGFSFSGMGANAGLLFPTFTDWSDRQQSLFDETMAYNQFAGSITDGRSMAVEPPSIEGMGNSGGFSLRLQDRSNLGREALTNARNIVLGQANASPIIAYAMMEGLEDAPQLRINIDRQKATALGVGFESINNAVSTAYGSASVNDFTNAGRLQRVVVQADVADRMTPERVLELQVLNDEGNLVPMRSFASSSWEIGPVQVSRYNGYPTYKISGSPMPGHSSGEAMAEIERIISTLPKGIGYEWTGLSYQEKAAGSQAPMLLTISILVVFLLLVALYESWSIPFSVILIIPIGALGAVAAVYLMGMSNDVYFKVGLITIIGLSAKNAILIVEFAKDLYQQGHSLKESAIQAAKLRFRPIIMTSMAFILGVVPLTIATGAGAASQHSLGVSVIGGMISATVLGVLFVPVFFTWVLGRFKASNKTV
>fig|400668.6.peg.422 Permease of the drug/metabolite transporter (DMT) superfamily
MNRSSNTIGSIELILAMMLSGTIGYFVISSGQAFWNVVLFRCVIGALVLGSYAYYAGLLRREYFQRNVLLMIILGGITLVGNWIFLFASFNYIPFSIATVAYHMQPLFLVLTGALLTKEKLSGSLLFWLALAFVGLFLIVELDLSEISALFTGEASSDGSSALFGLLLALGAALLYTVTTLVTKKVSQVPSTFVALVQVIVGVFMLLPFADFDNLPTQTSQWIDLLILGAVLTGFMYIIMYDSFQKLPTSLIALLSFIYPITALFVDHLAFATHISLMQILGVILILLAVSAVKFNWALPRKEPKQAKREKP
>fig|400668.6.peg.496 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKYFLLLLIGLIWGSQFIFQKIALSTLTPQLVGVGRAVVGFITLFTICKILKVTSKGNTVWTIYMLIGVLEASIPFTFVPWGQQYVSSSIASVLIGTIPFFVILFTPLLSVGSKISRSSILSIVVGFLGLLSLFAPDIIEDDRSLSFLGVIAILTAAASFGVALLLLSKCGNEHPLIVARNVLGSASLQVLFIYLFTDGQIPNHVNLDTVLSIIYLGVMCAGVVYFLYMILISETGAVFTSLTNYLVPTFGVLIGVIFAHEDVGLNTWVALALILLAVALNQGKGIKVNQWVK
>fig|400668.6.peg.865 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKRFPVLKEVLHLLFPMILTMTLELSISVVDTIMLGHYSALHLAAVGLASSLWLPVGCFLIGVTFGLTPLVTRHLHGRQPKLVNLYMSQAVGLSVGLGLLASLVAIFLLPYFAGLMATEEETRQVSISYLYIFAPALPMLALMTAYKNLFEAAGRPGFPLFVASFGLVLNVLFNYVLIFGKFGFPEMGAKGAALASALSLYLAVTLFFVYDRFINKTPLFTRLVWRYTRKFSILLNIGAPAGFAFAFEVGLFSSMTWLISSFGDLALGGGQIVMSYTSFLFTPMMAMSAVTAIVVAKAMSKEGVSGVRKRIRVIVLLGLSYVSTCFIITQVFHNQIPYIYSNNAEVVALAASILLISSCYQFPDMLQTVFTGALRGFRDTRSTMIAFAASLFGLSIPFGFWLSHYSPWAETLSLRGFYIGLGAGLTLLAVILIVRFRVILARYEGRRIASPREVA
>fig|400668.6.peg.1008 Permease of the drug/metabolite transporter (DMT) superfamily
MKQGSHLKAELILVFVTILAGFGWIFSKEALAGLPPLFFMGVRFIVAGFVLFLAGQKYFRGLDWQNVKQASLVGLVMGITMMFWVTGLDQGSNLGVGAFITSLGVVLVPVVARFLFGARPPLSIWIALPIAVVGLGFLALNDGLNFEFSHLYFLGAALGSAFQLNLLSRFSMRMHALVLTAIQLSVAGCFLLFLSLLTETLPHSISIPVAGWFLVSTLVASSLRFLLQTYGMSMTPVSHAAVIMNLEPVWTAIFAVFWFSETMASGQVFGCFLIFIAMLVSRWSQIRAIFKPVKSF
>fig|400668.6.peg.1342 Permease of the drug/metabolite transporter (DMT) superfamily
MSIAHIFLWATAAIWGFAFVAQSVGMESLGPHSFNAMRFLLATLSLLPLLFIFKPKQSQSNRKLWLGGLAAGICLFLGFTCQQIGLQYTTAGNAGFITSMYIVFVPILGLMLGHKTERHTWIGVGLALVGLYSLTVGPSLSINKGDAIELLGTLFWTGHVLLIGYLSRYVSALPLSIVQFFIATILASITASILETPTLEGIKMAWWPLVYAGVASSGIAFTLQTLGQKNVSPSISALILSSEAVFAVLGGWIFMEEILSTRALVGCGFIMTGMIISQWPRQAKTTIKLAQQP
>fig|400668.6.peg.1466 Fosfomycin resistance protein FosA
MPFIAFRKRVREMNINIKQKILSVCAEKIKQKGDGVQVSFYAFFANKNDDPITLMAVARWWIEEQQLNHFEKASKIYAMVVSLDDRSVFQSSYAEQNKGFNHLTLSVANLDSSLEFYCHLLGFKAEVRWNTGAYLSYRDCWLCLSLGEAKPSRDYTHFAFSFDLSAMSRVQQKNAFQAVKQWQVNSSEGDSLYIEDPDGHKLELYSGSLATRLESLKTKPYEGLEWLH
>fig|400668.6.peg.1829 Permease of the drug/metabolite transporter (DMT) superfamily
MTMLLTLNQDNICLIRLDQDSGNNKMTTHSPQATLIGSIAILLWSSLALFTTQANLVPPLLLLSLTFGVASLLFFIVYLIKGELKSSWSKTPTSAIVMGGLGFYFYHFCYFYAFQHAPPVEAGLIAYLWPLLIVLMAGMTKGNTLSWTHLVGAVIAFIGTGIMLQSRASISTIEVNTTYDWTGYAAAFACAFIWSSYSVANRRFQSVPSSAVLWYCLVTTVLAALSHWMIEAQNTATSLDYPASTWIAILGLGFGPVGIAFFCWDFGVKKGNLSLLGVLSYTAPALSTAWLGLFTEAQLTTGQIIACLLITAGALFASLMRNKRVRPNDEHLASLEINK
>fig|400668.6.peg.2040 Multidrug resistance protein A
MSELDPNSLKKKRTVFVLILSAIVACIAIYIWWANIGRYYEKTEDAYVSGNVINVMSQISGTVTDIMVDNTSSVHESDLLVQVNPVDAKLALEQAEANLASTIRAVRNDFASLEQQKASVELARIALEKAQQDYKRRVNLKKNNLISNEDLSHFESTLTSAQASFSVAQKSYEASKTKVDNTTVLTHPDVLKAISALKTAWLALNRTQILSPADGYIAQRSVQVGQHVSAGNALMSVISLKNVWVTANFKETQLGNLRAGQAVTLTSDVYGSNVIYKGTVKGIEPGTGSAFSLLPASNATGNWIKVVQRVPVRIVLDPETLAAHPLRPGLSMSVTVDTHNAGESTLTPLADTKAPWRTKVFDHNDAKVDVIIQKIIKESM
>fig|400668.6.peg.2704 Permeases of the drug/metabolite transporter (DMT) superfamily
MWIFITLFAAGCQSVRTAYQNTLARETGFLHATMSRSLYGLPLVTVYLVICWQLFGWVSVEKNLVFVIAASTCAITQIMATYFMLRAFQAGSFALGTLLSKTEAVLAALIGLPLLHYTLTMGAWFGIAFGVLGAVVMSVKWGNIRQAHKDVSLLLGLASGLCFAIASVTSSIASHSLSGSLITSAGVTLWYVLALQSIILCGIQIYKSKDILAPFKHEFALSCKVGVLSSLGSIGWFTGFALVNPALVKTLGQIEIIGTLYYSKVRFSEKMTTQQWIGGAMIVISVVLVVTSTIK
>fig|400668.6.peg.3254 Multidrug resistance transporter, Bcr/CflA family
MIPFPYFILMAMCSPIALNAILPALPDIAKQLGIDSSTVQLNYSLYLAALALGQFSVGAVIARLGNRSTIILGISFFVVGGLIALATEQLFFMLLGRVLQGIGGAFTLSMSRALLVASSGGKRASQQMGYLVMAIALSQGIAPLIGGSLNTHIGWQAIFALSAIQGAILLFFSLKLIQPAAQKPPKLPLKMLLSHYMSLIRLSSFRHYAMANTLIALCFYLFISASPYLTKDLSDNRLAYGYWFILVSGAFMLGGYLSTLFNKRLALDKSIQLGNYLCILGATALLILQLSMPMSFASLFLPMSVITLGRGISQASYQSAAIATADKLSGMASGLLGFLQLSFGAIFSQVVPLLIDLHPHAIGFAILGCTLLATMVHRNIRTMK
>fig|400668.6.peg.3533 Permease of the drug/metabolite transporter (DMT) superfamily
MPAFIYLLLPIFFWSGNYILGRLTVSNGIDPFSISFLRWSLACLIILPFAYKKLWRERNIIAKNWPLLVLFGWLGICNYNLFLYIGLGTTSVTNAVLLNSIMPVMILITARLLLGNKTSWLQNTGILISTLGAITIVSRGSLETFLHLSFSQGDLWIITAAISWAIYSVLIAKRPKEMSLIGFFACTAIIGTLFQAPLFFLFGHSQLTDFTASNWGAIIYMGVFASIGAFLCWNTGVQKLGAATAGHFIHLLPVFSIGLSVIFLGEKLLNFHYVGITLIFSGIFVATILNKKKPQTT
>fig|400668.6.peg.4136 Permease of the drug/metabolite transporter (DMT) superfamily
MDEFIRIYMPFAELSGLVAALCWTISSLMAPNLIQRFGTMRFNTFRIVIASSILLVICLITQRFNATLWQHAEIVMLSGLLGIFIGDTMLFTAVHRLGPRRTGVLFATNAPMSILLAWLFLGEDLTLSQLFACFLVLIGVVIAILFGRKNNLHAWEQTKGKLSVGILLALGAALGQASGALLSKPALIDGADPIAVSALRVGTGALALVLAYSLYYRHKQPADAIPFGQLTRADFMGIATLATIGMVIGMSVLVWGVGNANVGIVTTLSAVVPVLILPGLWITTGQRPAFGAWIGAIFVVAGAALIILK
>fig|400668.6.peg.4140 Permease of the drug/metabolite transporter (DMT) superfamily
MVMPQTVTQHTSSISAQEPPKYKQYATGWGFRLGLLAAFVSILIWASWLVSMRAGMTNTLTAFDLGILRFSPPALLLLPFLWRARAQVKTVSPILLLGIVCGAGLPFFYLSATGLKYAPASHAGLLILGAFPFFVTLLAVLFYQEKVSRERKIGLSLVSVGVLVLFSLSLLTAPENTWKGDLLLLAASFFWAVYTVSLRIAGLPPLVSTALMGLVSLIALVFLWASGLASSGLADASWDMLAGQILVQSLLVGLMTGFSYGYAIQKLGAENMAAIGAFTPVLAALIAIPVLGEHLEGYSIAGLIFVSVGVVIASGIFKKR
>fig|400668.6.peg.4222 Permeases of the drug/metabolite transporter (DMT) superfamily
MAFLYVLLVVIWSTGFITGKFIVGLIDPNVFLSIRFVLSGLLFLAIALWQRRRFPPIKELPKHIIAGMLMNGFYLGFAYVAIAKGLPAGMMALIGALQPALVTLLAFLLIKEKTSLKGIVGMLVGIVGLLLVVSPALELDMTHGGVTLLTFTLACAAIFTLSLGVTYQKMSISSSDIFSSMAVQNLAASVVSIGFMLLLGETLFKVQLESFLLVIWGVLVLSGGGVFLMVWLLRKVRASQVTTMLLLAPPLAAVESYFLFSESMTMIQIIGFVITIVGVYFSRVNPSEK
>fig|401473.3.peg.1002 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKNLTSGSVFKTIVTFALPYLLSYFLQTLYGMADLFIAGQFIGVDGITAVANGSQVLYMLTVVIVGLAMGATVTIGRTVGANRLDDAAEAIGNTITLFAGVALVLTAVLLLNVQGIVTLIGTPAEAVCGTTQYLAICFIGIPFIVAYNIISSIFRGLGDSKSPMYFIAVACVCNIALDYLFMGHFRLGPSGAALGTTLAQTISVIVAFAAIRHKRTGIRLHAANLRPRRDVLGGILKIGVPTAVQDGCIQVAFIIITIIANYRGLNDAAAVGVVEKVISMLFLVPSSMLATVSAISAQNIGAGKPERAIRTLKYATAITVAYGIAISVVVELTASSIIGLFTTDATVIVLGVQYIRSYIVDAIFAGVHFCFSGFFAACGRSYIGFIHNIIAITLVRVPGSYLASKMFPHTLFPMGIAAPAGSLLSVFICLGFYAWLRRRSVLEAK
>fig|402612.4.peg.499 Outer membrane component of tripartite multidrug resistance system
MKIKAKLLIVISFLGVTFGYAQEKRVLSLKEAISLVTNNSNEAALANIKVSTAKLEMETLKNNQYPSLKISGQFLQLTDANIDPKIKLGASGTAVKVNQLFLGQANVSMPLFNGFKLKNSIWASENLYKAETANAANTKEKLSLYVVELFAKLYQSQQTTTLIEDNLKSAQQRTKDFSAMVHNGLMARNDLLKAQLQESNIQLSLDTAKKNVNIINYQLVTILQLPENTQIDIDIETIKNDIVRNKNIEIQAKRNDLEALTYQQKASEAGIKIAKSGYYPALALVGGYIAFDLKDVMTVTNAMNVGVGLSYDLASVFKNGKEVKLAQSKSEQTKTAVTILTNKIKEETHEAQENYNLSLNQNVVYKQAVEQATENYRIVKDKYDNSLSTTNDLLEADVQQLQTKINLALSQADIALKYYQLQFAEGKLINSFNTPKN
>fig|402612.4.peg.564 Multidrug resistance protein norM
MNFSQYTKEFSENIKLAYPVILGMLGHTLIGIVDNLMVGNLGSTELAAVSLGNSFIFIGMSIGIGFSTAITPIIAEADAAKDDKKIRSTFHHGLFLCTIIGVILFMLIVLSKPIMLLMHQPKAVVDLAAPYIDWVAFSLIPVIIYQGYKQFADGLSKTKYSMYAIFFTNVVHVFFNYVLIYGIWIFPKLGIIGAALGTVISRIIMVVFMHFMLRKNHEMKKYFKHFSFKEIRKSAIKKIINLGFPSAMQMLFEVTLFTAAIWLSGSIGKNHQAANQIALTLATTTFMFAMGLNVTAMIRVSNQKGLNDYKNLIIVAKSIFILAIILETIFALVFIVFHNFLPHLFLNMNDANQALDNIEIIKITAQLLLVAAIFQISDGIQVVVLGALRGLQDVKIPMYITFIAYWVVGFPISFYLGLYTNLKATGIWIGLLAGLTVAALFLYIRFHNLTKKLVRENHK
>fig|402612.4.peg.2247 Tetracycline resistance element mobilization regulatory protein rteC
MNVFCNPFFIDFENEFEIIKNSFTDAIIQANELIRFIERKIKELYNWLKTYAFESLSEEIYFFKELKPKLVSRLIFYKNILKLESNLPIGIKLKKKCFEKSLDKVYLKSRKDKDFYQYYRSRATSKDEQYFIRSNEKSIDNDCHYQINYDIQLCTSHDYKVAMIMADDSLLAHLEDKLEEINNSCNLKHPSLKTNLNWTGNKIDLIEVIYALHHQKVINGGNIDIKDLAVHFGFVFNIDLEENIYRSYVDIKNRKTVKTKFLHHLSENFNTKIIEEEH
>fig|402881.6.peg.9 Multidrug resistance transporter, Bcr/CflA family
MKLAPGTAAFTVFLASLTAVGPLSTDMYLPSLPAIGEDFNADAGTVQLTLSTHLIAFAGSQLFYGPLSDRYGRRPVLLGGFLLFMAGCFASLFVTSIEQLILARLLQAVGGGASVVLARAIVRDLFEGPEAGQMLAKMAAIMGLVPALAPMLGGVVQDLYGWKANFIAMGAFGAVLALMVAVNLDETLPRDRRQSAAPLSILRSYRRLLADRHFLKYLAIATVAFCGLFAFVSGSSFVLQGLYGYSPIAYGLCFGAMAGGFVAGSLAGGRLVRRRGIDGTLRFGGFCAALGGLLMLSGLFLTPSAMAIVLPVVIYGFSMGVTMPQAMAGALTPFPDIAGTASSLLGFLQSFAGALAGLYVGYGAEASALPMAGTIAAGGVLSFVIAMSGRRKTI
>fig|402881.6.peg.558 Multidrug resistance transporter, Bcr/CflA family
MNASSPRGSRIGFVVILGALIAFAPLSIDMYLPAFPAIAAHFNTTAGAVQMTLAVFFIGLSVGQGVVGPITDRVGRLPPLLIGIGLYVGASIWAALAPDIESLTAARLFQALGGCAGIVVSRAMVRDLFDERGSAQVYSLLMLVMGLAPILAPMIGGFIILHHDWHMIFWVLAAFGLACVPAVIFGLGETLPRERRQHGGLRPVLGAYLALFADRPFMGFALANAFISAAMFAYITGSPFVFIELHGLDPSGYAMLFGANAAGLIFASQVNAFLLRRISGRLILKIAMGVHLAAVVALLGFTIFMPGAFYPLAACIFVAVGCLGFVGANATAAAMARADSHIGSASALTGILQFALAAVSGGLVGAFNDGTALPMALIIAGASIAATLARLSARERVPA
>fig|402881.6.peg.1511 Acriflavin resistance protein
MNISSISAFSVRNWQFTLVVFGMLIAVGLSAFNSIPRAEDPDMKGPFAIVNVALPGADPADIEKLVIRPIEDAINRLDDLDEIKSRAEDGLAIIQVQFDWSTDPDKKYDDVVREINALRPTLPAGIRRLDINKFRTSLTNVVQVALVSETAPNRVLEDLADDLTDEIYRVPGVRDAEAWGLPRSEVRVSINFGRLANLGIPVTAVANAVGADASELPGGPIHAGARRFNLKTAGGYDSIEDIRNTVIGYFGGNIVRVRDVAEVSWATEEATYLGWYNGERAVFVTANQKEAQNVFDVRNGIYEVLDEFEPHLPADVRMERAFDQTVSVSHRLSRLYLDFAIAVSLVAITLLPLGFRAAGIVMVSIPLSLAMGVALLDFFGFSLNQLSIAGLVLALGLLVDDSIVVVENIERHLREGKKRYEAAIAATSQISLAVVGCTVVLILAFLPLLFLPGGAGKFTRSLPVSVLFTVSASLLVALTIIPFLASRLLSDKAHPEGNIFLRIVMRGIHTIYRPLLHIALGWPRATTFAAMLVCVTSLALVPRIGFSLFPPADSRQFLVQIETPQGTSLQETKKVLDYVTETLRARPEIDWVISNLGRSNPQIYYNENAREQRANKAEAFAQMAEFDQERTPILQDELRAEFNKYPGAQIVLRVFQNGPPIEAPIAVRIFGPDLRVLKELAADVSRIVEDVEGTRDVVNPVRLDRTDYNLGLNTEKAGLLGVPPGEIDRTVRLAIVGETVGAFREADGDEFPIVARLPLEEHHAIQALQNVFVPTASGASIPLNQLSSPYLESSPGRIDRFDRQRLVTVTAYTRTGYNTEKVTNEVFEAIASLPKPPGYDFRAGGEIEARQEGFSGLTNAVLIAIFGILGVLILEFRSFRTTLVVAGVIPLGIVGGLVGLWLSGYSLSFTAVIGFIALIGIEIKSSILLVDFTNQLRRQGVPLKEAVEQAGEIRFLPVLLTSMTAIGGLTALALEGSGLYSPLAFVIIGGLISSTVLSRLVTPAMYLLLAPKELDEPERAHAQMQGAPAD
>fig|402881.6.peg.1990 Multidrug resistance protein 2
MAEDEDIRTAETAAPAANRPLRPSDPDRQTTPQERKRAFFILFVCLLSVGMGQTLVFAVLPPIAADLGMSEFETTMIFSLSAALWVLTSTFWGRRSDVMGRKPVILIGVFGFAFSTSLVGFVLLAGYQHWISMVLMFPLVMGARAIFGIFGSGSMPASQAYVADRTTRAERAGSIAQIGAAFGLGTVVGPGIAAAFAEIHILAPFFAVGALAFVSGIAIWILLPERTRPKKMLSEKQEKQAALKWSAPNVMPWLVIGVILSLSQSIMMQLFAFYLMAELGMQGSEATQLVSVGMMAMAMATLVAQLGLIQRFDLSVQFLLRWGAVTMILSFAMLVFGGSYGVLVSALALAGLGFGFLRSGLSAGASLSVSLKDQGAVAGLIGSTAATGHILNPAIGIPLFYLLHSAPFMLGIGLMVMILAFAIFHPVLKNLRSGDTGLVDEEEEEIGLH
>fig|402881.6.peg.2107 Permease of the drug/metabolite transporter (DMT) superfamily
MEPAEFCGINKGKSRFRRTLRPRATGESPLHSRKTTNWLMLAALVVLWGSAFAFAKIAVETIAPEWTMAGRLAAAALLLLPVAALAREHFPRNPRNWGWLAALALVGNIAPFFAISWGQQHISSALAGILIGFTPLATLLIARFFLPDERITPLRLIGFVTGFAGLVIVIGPGALMDFNLGETLLAQLAVLTGAVFFACNNVLARLAPDMPLLAKSSGVMLAGAVMGSAVSAVMTPPAELLEASTASLLGLAGLGVFATGMAAVVFFKLIDRTGPTFVSLTNYLVPVFAAVAGYALFSEELRFTVIIGLALILAGIALSEWKRDAD
>fig|402881.6.peg.2121 Bleomycin resistance protein
MTDPARAIPVLASLDLAQSKLFYEEKLGFKVELFGDYMIARRDEMEIHFWLANDRIYPEGTSCYIRGGQVPALYEEYARKGIGKAPIDGERISDFAVRPWGMKEFYVWDPHGNLLKFGMSADEA
>fig|402881.6.peg.3284 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSTKSQIDLSVVLPVYKCGAALSELHQRLTRILATMSVSYEIILVDDGCPDNGWRGIVDLARQDTHVAGIRLSRNFGQAIAIAAGLAESRGEKVIVMDADLQDPPEAIPILWDKAQTGAALVYGRRDEEHQSMMRMAAGKLYFAFLRMISGRAIDPRYGTFTLLSRPTVDAYLRFTEPNRHYLFILYWLGFDGVDADYKRHKREIGQSSYRFGSLLRHSFQGVLFYSQSLRRLLAACAIGMGVTALLLFGGAGSRRRGLVLETAGGTLWLAVGGGSFSYGCARRPSIRTDQATAALCCHEKDNSRWL
>fig|403833.5.peg.168 Permease of the drug/metabolite transporter (DMT) superfamily
MNKMRDYRLIRAFFWLLLATLIWGTTFPIHKVVLTDLQTLPYLFIRFGIAAVLSFLIWKKHSFKYGATLGVILGLAHALQTYGINFTDASKSSFITSLYIPLTPIISYLIEKEKPNFIQWVCFPLSLLGSYMLFGGISGFNFGDFLTFLSAVLFAVHIVLITKFSKVVDETSLLAYQFLFAAIINLSMSFNSNWKLGVPIWLTVIYTAIAATIVVNFLQVKYQKVIGSNSTVLIFIGEPIFASLFSFIFLGERFSGLQIVGASIMIGVIILTTFSYRVNKYLKKKLDLKEL
>fig|403833.5.peg.219 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKKRVIITISISDIDIRYKEGIILIEFKNVSKKFQDKYVLRNFNLKVQEGSKTLIFGKSGIGKTTIFRLLLGFIKPDEGQLLYKNEELNGKNVWDLRRDAVYIGQELDISDGTVREIIRTILNYKINLKVPFEESKLIKLFDFFELPANILDKDFQSLSGGEKQRVLISIFTLLNKKLYLLDEITSSLDREMKNKVIEYLLSKKEWTLIAISHDQEWLNKEGLNIIEMGGNNNGTYN
>fig|403833.5.peg.723 Multidrug resistance protein 2
MRRFGKSIKLDSTIVKYYFIIILYESIDKLFGTVYVAHMGIRGLTSFQIGQVLAIASIALSIFDYPTGNIADRYGRKRSLVLGFFIWSIGLLVFFQANNLFTFILSILLWAVGVSLISGTPGAWFVDEITKEGRAHLKAKVFPNANAISLIFGAIVALLSSALAIGRPDFPLLVAGIMALGTSIILIFILNENYGDRAISFRKALARNTIDIFKSTTMRLILIYSMSGRIAFQTFVMIWQLYMVKELKLPTAYLGFTMAIFLVVLAIGNSLAGILLKRFEGVKVSIMGQGLIAIGSITIASHTSIVAFYIGACLIELGLGIDMSASSVWVHDFIPSERRASYISAISAAGSLFGFTIPLVSGYIADQIGFRYNWLLAFIGSIITITLLIKIGTKIRTVREVIENVEESN
>fig|403833.5.peg.1099 Multidrug resistance ABC transporter ATP-binding and permease protein
MKNINLSIDKNEKVALVGTSGSGKSTMVSLLVRLYDPTNGKILLGNKNIIDYKLQEIREKIKLVRGNEPLFNMTVKENIMLDDEFTEEEFMKAVKKAKVDKFIGLLDEGYDTVVGERGSKLSDGQRQRVAIARALIREPKVLILDEATSGVDSQTEEEIFDELKEYEMTLIIISHRLSTIRKADKVILLKDGEIMGEGVHEELLKNSPLYKEIIESQLVV
>fig|403833.5.peg.1234 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKIKDTGKVDVLKTSIWKALFTLAWPIILTNMMQAIYNITDAYFLGKLGPLELSVPTVVWPLIFVFISFATGFSYAGTSLIAQYTGYGDQRRAEKSAAQTILVMTFVALSIMAIVLIFSKQLLSLLQLDKNIFELSNTYLKIMAFSLPFIFLMQTVAGIFRGWGNSFIALKYNGISILLNVALDPLFIFQFNLGVFGAALATMLSQVIISVVFLFVLFKGREGFKLHAKDFVPDPKLIKKVLSVGLPSSIGESFTAIGFAIIMGVIAQFGPIVISGYGIGNRMNNLIIMFAMGISLATATMTGQYVGANQPERAEETVRKASLATLLIVGSASMVMFLFGHNITKFFINDPEVIKVGEEFFRYVSFSLPFFSLVSVFLGTLRGTGHTIQSTIIDMVRLWGIRVPLVFFLAQTHGYIGVFIAMIISNFSAAILALGFLIFGNWKKPVIEEASQRNA
>fig|403833.5.peg.1423 Multidrug resistance ABC transporter ATP-binding and permease protein
MRTILSKYLKQYYKEVILALVLLTVQAVSNLYLPNLNADIINNGVAKGDLNYIMQAGGKMLLFSLLLVGAAVGATFFASRISAKFAQDLRRDLYYKVMSFSQNDIDKFGTASLITRNTNDVYQIQMLVLIMLNVMILAPIMAIGGAIMAIRQDVVLSTSLLVIIPLMGIVVFFLMRKAIPLFRSMQVKLDNVNRVLREKLMGVRVIRAFVKEKSEEKRFDNVNDDLTQTAIKVNRLLALGMPLLMLIMNLSTVSILWFGSMRIDSGAMPIGNLTAFLTYIMEILISIMMAMMMFVMWPRAEASADRIKEVLETEPTITESDNPVILKSKKGTVSFKNVTFRYEEAERPVLRNISFEAKPGKTTAIVGSTGSGKSTLINLIPRFYEVTDGKIEIDGVDIRELSMEDLRDSLGFVPQKAYLFSGTIASNLAYGKKDATEEEMWHALEIAQAKDFVEELPDKLQAPVDQGGTNFSGGQRQRLSIARAIVKKPKIYIFDDSFSALDNRTDANLREALKEETKNATVIIVAQRVSTILNADLIIVLNDDGTIAGQGKHSELMRSCEVYRELVKSQLPEEETA
>fig|403833.5.peg.1604 Daunorubicin resistance ATP-binding protein drrA
MKGQSSIGFMGGKWVANKLLNELKSSERISVLLPTHFLKKIVVYAYIVSSNIIEERIKYLLSLFNLEDAKDLKYMKYSTGMKKKLSLARALLHEPDVYIFDEPTSSIDPISANEIRQIISSLKNKNKSIVLSTHDMHEAELLGDRIGILNKGVMLAVDEKGNLKKLLKKEIIKVKTDKFVSEEMISKDGIKGKINHFRSLKEDEFEIEVENSSEVLDPLIEKLKKENRKILTINVEQPSIEEVFMNFVRNDKR
>fig|404380.3.peg.419 Multiple antibiotic resistance (MarC)-related protein
MEEKSMIQSAATHMEQLIVFVVQLFVIVDPLAAVPIFLAITVSHTKQERRSIARRGCSIGLLAIVFFLVAGPSLLRYFAINTSAVQISGGLLLFVIALELLYGNPTGTQTSSKEERLAEKKEDVSVTPLAIPLLAGPGAIVTCLVFSSQASDALSVLILIGGAVIVFSAAYLLLHWADELARIFGELGMKVAVRIIGLILAFIAVQYVINGITALWPAVKVPSA
>fig|404380.3.peg.2141 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLALLYLAGKGIEPTWGPVTLGPSKKAEIHDPDGLPIELRQW
>fig|404380.3.peg.2320 Fusaric acid resistance protein conserved region
MQWPRLLPALRATAAALAALVVAHLLRLENPYWAAMTALIVVQPTRTLLFEKSYYRLVGTAIGSAAAWLLLLQTTSPLALTAALSIWIAACVGIGNLLHGLRSYAALMAACTCAVIAMSGYQNPGHLGGMAFGRVACIIVGILVTTCVTALFTPSHSMDELGDRLNKVAADAVRWLAQLAEGAGKQAGTDLEQEILCEAAEIEALLDAGGISSSFRSHRRNARNVLGALLSMLAAGKLDTESPERLQLLQRAASGWSEALTRRLQELAAGLERDPGPEWCGKAKALAAETTLHLPLLGRALYHLTGTLEVALASHADDGANEATLHLIRHRDWQQAGRAAFRGGIVIAVVGLVWSLTGWSKGPLMLMALSIMISIFSSKEHPARFVGLIFIGAATGSTLAVFCRLVLLHGVGDFAVTAAVIAPFILLGAYAMQHRRTVIPATDATLFFIFVIQPGVSVTVAANDLAIGAVAMVLGVASAWMGYTFLVPVNPALRMRSLLAAMAKDIAQMSAQANRGSRVRIRGKLQHRVIRLVALARNFDITPAAAVSGAIGVLALTATIERLREKLEYEELSPESARQLRETLDRIACMAQTPALESRLLQGWADDLSAVLKPLPPTEDRVGATDEGAAMGAVMVPAS
>fig|404380.3.peg.2409 Glyoxalase/bleomycin resistance protein/dioxygenase
MADQFKEQGAFSWLELSTPDLAGSRAFYSRLFGWKTEPWSGAEDYALIKVGSREVGGMTPLRPGQRKPAGWGAYVTVTDVDATAAKAEELGGKVLVPPTEITRVGRFCVIQDPQGAVITAITYRRP
>fig|405948.6.peg.385 ABC daunorubicin resistance transporter, transmembrane permease component
MTTTLEPTPGATSAAPAPAAERVGPLRAVRHGLTLAGRSILKIRKSPAGLLDVTLQPILFLVMFVYLFGGAISGDTGTYLQITLPGVLAMNMVFASLGTGMQLNTDITKGVFDRFRSLPVARSAPLIGAVLGDIVRYVVSIAVLLVFGTIMGFRIQTDAVSALLAVVVVIAFSLAMCWISVFLGMLIRSQQALPGVAMSFMFPLTMGSNVFVPLETMPGWLQAWNGINPVTKLADTARGLMIGGPVAGPLTATLIWMVVLVAVFFPLAMWAYRRRV
>fig|405948.6.peg.747 ABC drug resistance transporter, ATP-binding protein
MGMSRARQHDRQWSNEHPMVNLINLESVSKSYGVRPLLDEVSLGVGASDRIGVVGLNGGGKTTLLEVLSGSVEPDSGRVSHSRDLRMAVVTQRTELPEGSTVRNAVLDPHGFTAEHEWAADAKVRSVLTGLGMTSLGLDTPVADFSGGERRRVALAAALVRELDLLVLDEPTNHLDVEGVRWLADHLLQRRCALVIVTHDRWFLDTVCNRTWEVVQGRVEQYEGGYADWVFARAERARLAQQAEEKRQNLARKELAWLQRGAKARTSKPRFRVEAAEALIADVPPPRDTVELVSFAKRRLGKTVLELENVDLRIADRVLLEDLTWLIGPGDRIGLVGVNGSGKTTLLRLLAGEREPDAGRRIEGKTVRLAHLTQELHDLPGDWRVLEAIEDVAERVTLGKYELTASQLGERFGFGKGRQWTPVSDLSGGERRRLQLARLLMAEPNVLVLDEPTNDLDIDTLQQLEDLLDTWPGTLVVVSHDRYLVERVCDSVHALFGDGRLTHLPGGIEEYLERRRSLLASAEESVGKQAGDAAEATRAAGLTGAEERAARKELGRLERQLDKLGKRESELHEKLAEAATEPDRLQSLNADLRALEQEKDDIETRWMELADQLG
>fig|405948.6.peg.1225 Drug resistance transporter EmrB/QacA subfamily
MFRLEYKWLVGITFVLGLVMQILDITILNVALATLGREFGVDASTLQWVLTGYMLSLAVFIPSSGWIADRFGSKRTFLLAVVIFTTASVLCGFAGSIWMLIASRVLQGVGGGMLVPVGQAMLFRAFPAHERAKASAVLAIPITVAPALGPMLGGALAEYASWRWIFFINVPVGALTLVFTVLFLKEERRGRPGRFDLPGFVLAGGGLATLLYGLDQGAQAGWSVPTVWGSLLAAALLLAGLTWRELSVDEPMLDLRLLRNRLFGTGNALLVCQVASLFGVLFLVPLYLQDVLHVSPFTAGLVLMPQAVAMLLATQVVSRMYGRIGPRRLLLTGFCLEIPVYLCLQLLGTGTPLVVVVVLLALLGTSVGILMTPMQTAAFAQVSVAEMGHASSMYNVSRQVATALGTAVFATTLVVVTDAAGGGAPAHAQMAGFHGAFLVAVVFGLLALALSTRVRDSDAAASLDPSHPEAARAASPTGEVR
>fig|405948.6.peg.2441 Glyoxalase/bleomycin resistance protein/dioxygenase
MGTARSRSPATPHRDSILVQQPRSTAVPAPGVSRPQRPDHRTKRTPMAEKDDYLAGAPCWVDTLQPDPRAALRFYGQLFGWSFDEATPMPTGLVEGEYFTARLGGHRVAGIGQAPPASPAMWMTHVRVDDLEQAVVRAEAAGGTHLLRPTDTGSDGRLAVLKDSTGVPFCLWQAGARTGAELVGEPGTWAMSSLHSTDPEQAQSFYGAAFGWELEPVPGAPFSKWLLAGQVVALLTATDGLAVPPHWSINFAVRDADAIAEHATSLGGKVLMAPFDTTGFRNAVITDPQGGVIAVSAPA
>fig|405948.6.peg.3486 Glyoxalase/bleomycin resistance protein/dioxygenase
MRPPPRNTRKTSTQWTTSTTPGQDGPGPRGADMPIQHLPAVVPVSDIDTADAWSERLFDRPADNRPMDGPVEWRITTNGWVQVHRDPTRAGTALLNLAVDDLDQHRTALDHRGLTTGPVETAGKDVRLSTTTDLDGNRITFIGNFRTDY
>fig|405948.6.peg.3660 Fosmidomycin resistance protein
MGPGRARPAARGGRRRAQGGALSEGSAQRPAGTGSVAEGAAEHVDEGTGRGPPAAARDLGDRAALGEHPQRVVQTQLGSPLRERHAHLGAEEPAQRAVARPDLGPQRGEGARVGGIVVEDRADGRQPRVPGGREADRLPRSVPELVEQHGAHPRPLAVVVVLAGGVGQDQLPQQRSDGDDRGAAQAQRVVGRRQSHRVQVRFAVGAVLVHRSRGHPDRPGRGRDPAAGLGGHRQHAASGVDDLVIVMPMRVHARAGGQVPERGGRLRCVAHPPAVRGLLAVFRHNMAVYRKRDSAAWSDDRGVLESDKKAVRLMAAGHACVDLYQGAVPAVVPFLVLERNYGYDAVSGIVMAATLLSSVVQPLFGALTDRHRLSWLIPVAMTTAGLGVALAGPAGSYPLTWLAIALSGLGVAAYHPESARLVRSVSRGDHLAMSWFSVGGNIGFALAPVIVAPLLSAGGLRATPWLLVPALLGAALTTAVLRSLSRPVAAAGQAVARRGSDDWPAFARLTAIVVFRSIVYIGLSAFVGLWAQQRVAGGETAGAVALFVLFAGGAVGTLLGGRLVQVWGRVRTLRIAYAASVPAVAGVVLVPGHGVYFFVAASAILLYVPFSLHVTLGQDYLPNRVGTAGGVTLGLAVSVGGVATPAVGAIAEHASLQVALGVLIAFPVLAWVFARSLSEPRSLESRSAGHAPVASTSD
>fig|405948.6.peg.5191 Tunicamycin resistance
MLIWINGAFGGGKTQTAHELRRRLPGSLVCDPEEVGIGLRRMMPASLRGDFQDLTAWRQGVHEVLDLVLHKHEGPVIAPMTLVEPVYFDEIVGRLRDAGHDVRHFALLADRQTVLRRLRGRGLGIFREDFAVSKVDLCLDRLRHPEFAEHLWTDHLSVAQVAERIAESVGVALEPNRDVAVLAGLRRSWTALKQIRLG
>fig|405948.6.peg.5310 Permease of the drug/metabolite transporter (DMT) superfamily
MSTLESGAGERTPDGGRAASDTSTGERVVGVRTLLPLFSLVAVTAVWGGTFVVVKDAVSQAPTMDFLAMRFLIATAALAALRPSRVTTLSRAGVKRGILLGMALGVAYIAQTFGLEHTSASLSGFITGMLVVFTPVIAGLVLRQRIGKVTWTAVAIAVAGLGLMTVHEFAVGPGELLTLVCAVFLALHIVGLGVWSPGHDAHALTVVQLAVAACICFAFGWWDGIDLPSDGGFWLALVGTAVIATAAAYVIQTWAQARLSLPQAAVVLTLEPVFACIFGVVFDHDELTTRIVIGGALVVGAMYLAELRSGSR
>fig|405948.6.peg.5487 Probable multidrug resistance transporter, MFS superfamily protein
MNSRWRYRRLRLLKGRCAFHSAPPRSGYVRSAWVRAALLLTAAGWGANQFSSLLGAYGTHLGLASTTVTSLFAVYVVGLLPGLLLGGPIADRFGRKPVVLGAVAVGVVGTAALMAGAVATPWLAVGRLLTGVGTGAALAAGSAWVKELSYAGDVVDEGTGARRAGLFLSAGFSVSGLVAALIAQWAPHPMVIAYVPHLVLCAGALTAAVAAPETRPHSLPVAASGSGLRDPRFWWLVVPVAPWVFLAPSVGFGVLPGLVDGRLTGSETVYAGVATLLTPGSGVLTQPLARRLAVGNRIVPALAGLWAVAAGLALAVPAIVLEQPWTALCADVLLGGGYGMLVTYCLTEVGRIAPPSRLARLTAVFWALAYLGFCAPYVFDLLTGVATPPVIFSASAVLALLTCLLVAARGRSARDEPDRDRQERRGADHVERLGDPRVP
>fig|405948.6.peg.5685 Multidrug resistance efflux protein
MSTETRAKTSALWAPERRNFTVGLILIITLAAFEAMGLGTALPTIVAELDGHRYYSWPFTVFMAASAIGTVLGGRLADRRGPAVPLLLALPTFALGLVVAGVAQDMPTLLVARVLQGLGGGTQIVALYVMIARAYPEEHRPKAFGAISSAWVVPALVGPAIAGFLTEYLSWRWVFLGLAPLVLLGAVLLAPTVRRFGSGAEEGAAPRRKGLPLAALGASAGVVALTWSAQNPSLFSLSLGVAAVVALGASIRVLVPAGTLIARPGLPVMVLARGLMAGVFFTAQAFVPLTLSTVHHYSPAMAGVPLTVGSLGWSAGALWQGGQRALSREAVVATGLLLVGAGVAGLTLIAPEWGPHWLVFGLWFVAGSGMGLGMASTSVRVLELSPADERGFNSSALQLSDMLGQAAMVGLGGVLVTSLAATGSPAAGVVPLDLLLTAAACCAAPLVLRSRREQMA
>fig|405948.6.peg.6374 Permease of the drug/metabolite transporter (DMT) superfamily
MGSVIITGVRYERAAIAGAAVAAAAVGAAVPVNGLLRDYPMWTGQGFRYALAGVLLLGWARVRGRSLPVPRVRDLPALAGLAVSGMLGFSLLQIHAQRYADPGFVAAVVGASPLLLGLAAPLLSRRRPSPPVVAGAALVVAGIAALSGGGAWRGAGLALSVGSLLCEASFTLLAVGVVARLGGLAVSMWCCLIAGGIGLAAGAATEPLRPPGAVELAALLVVAVVVTAVAFCLWYHGLAVLGADRVGVLIGLMPVSGFAVAVVLGTQQPTSASVAGTAVVAVGCGSACAAGARQAAAAREPFGLFTGSRARPVTAGSALLAGVARLALLLAEPAQELGVVVRRDRGTAAAAGRAGGGVRTERLPEQHRDRDETDRRQHVDHLGATSTRHPRD
>fig|405955.9.peg.4404 Tetracycline resistance regulatory protein TetR
MNKLQREAVIRTALELLNDVGMEGLTTRRLAERLGVQQPALYWHFKNKRALLDALAEAMLTINHTHSTPRDDDDWRSFLKGNACSFRRALLAYRDGARIHAGTRPAAPQMEKADAQLRFLCDAGFSAGDATYALMAISYFTVGAVLEQQASEADAEERGEDQLTTSASTMPARLQSAMKIVYEGGPDAAFERGLALIIGGLEKMRLTTNDIEVLKNVDE
>fig|405955.9.peg.4712 Polymyxin resistance protein PmrG Ais protein
MRLSIGGVYVLAFCRSSLKSKKYFIILLALAAIAGLGTHAAWSSNGLPRIDNKTLARLAQQHPVVVLFRHAERCDRSTNQCLSDKTGITVKGTQDARELGNAFSADIPDFDLYSSNTVRTIQSATWFSAGKKLTVDKRFLQCGNEIYSAIKDLQRKAPDKNIVIFTHNHCLTYIAKDKRDATFKPDYLDGLVMHVEKGKVYLDGEFVNH
>fig|406327.7.peg.1257 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNTELATESINKLILKYALPSTIGFVVLGIYIIVDGIFLGNYVGSDAIAAVTVAIPFSFLLTGFGLMFGIGASSHISMNLGAGNQKDAENILKTVFYLIFITGIILTLLSLIFIKPLLALFGVSENLLNLSYDYLNLIYLFGIFIMFKVGLDPIIRNDGFPKKAMYAIILSSLLNILFDAIFIVIFGWGVFGAALASVIGETFGALIYIHHFLAGKSNLKIKLFEKVSDIKYEIKNVKKILSVGFSPFILEMSASIVMLIHTIQFLRYGNELDVSAYGIVSYIFAIIMLIFIGLGNGVQPIISYNFGAKEYFRVKEIIRTSSILCSIVGILVFLLFSIFPKIPVMLFNQTDSLLIETSIFGLRYFAYGLSVFGLNYLIITYFQSIGNSIVSNTLSLIRVFVFLIPLLIILPKNFGINGIWASQPLAEILTLIVGFIFIKVAIKRTLNTVNV
>fig|406818.4.peg.441 Permease of the drug/metabolite transporter (DMT) superfamily
MSHDALPLSRRRLYLLDLGLLAVALSWGASYSLMQLIIQAGVTIPLFLMLRFALAVPFMFFGTRIRLHNIKPGEIINGLIFGCLLYAILTFETLGVKYTTASNAGFLIALSVVIVPFFERILGKRKQSKFIYFTCFISLVGGGILSFSNTDNFGFNNGDWLILLAALIRGFQIFMFGKQTSGKSYSLVNITLIELVTVSVLGLAFVLMTDSASLLLIPTITFNVWGYILFLSLLATAFAFLMQLYAANITSPTRVGLILSLEPGFAALFAVTIMGETIGILQGFGGAIIVCAALLGRIVEGKRYE
>fig|410358.8.peg.217 Fosmidomycin resistance protein
MNDLTKRIAGLAAGHGAADFYIPVVPAILPALIPIFTEQGITSYAMAGCLFTLVTLTMVIFQPLTGWMIDKGRWVPGISWCILITGLAIAVFGFTQNYWVLLTMAVVAGAGNSMFHPNAYQQIHQFTTSANRGTFLSLFSVGGSFGYGAAPLVTGALFAWGGFPALIWLIIPAVIVAVLLRKHQQKPAFLPPKSVDTETVKPKWRNAVFVLGISSLRTWVYYGFLAFAAVYLTTYAGVDYLLATGVVSCMIFAGMFGTLIAGPLSDKIGRKEVMFTAYIGATAAYFGIFLLSGVGSVISLVIAGFFMMATASVEIATVQELMPGSVGLASGIIIGIPQGLAAVAIMVIGIMADAIGMPTALFSQVWLMVAAIVLCIALPYPLKLLNRTHKPVE
>fig|410358.8.peg.396 Efflux pump antibiotic resistance protein
METLRLSAKQYIIAITVGIACFLPPFIGEATNIALPNMLVGLGYTMGADYWNLYGWILTVYLLTSTIFLIPAARLADKFSKKWFFSIGVLLLGVGSLGVGMSTSGEMVLAMRTIEGIGNALMFGSAIALLASAVKVELRGTAIGIAMTGVFLGQLAGPLLAGALTDVFGWSMVYLILCPVALLSFFLAIPFIPRDQPTDKGPYDWIGALLFMGGMGFALYGFSKQPNTEALALLVSGIFLLIAFFFYEKRNKNPLIPVKLILRNRGFTFNNSANLLYYVAIYAMGSLVSLYMTNVWGITDALPRALIVTTQGLILVLFTIVAGRFYDHLLPRWLLAFGVLFTIGGIAGAWIMGVPSTGTLWLIGAILCASVAAFGLGSLILAGIDRYIKNAPPKYATTTGLILISIGMIILLTCGTETAIWSMIAVQAFFGVGIAIFVTPNSTAIMNSVTPQEFGMASGTLSTTRMLGMAISIGIVSILKNIFLSGTSDDYAASFLQMMDGTIIAALVVLVLAMIFSWTAGSRRRI
>fig|410358.8.peg.448 Multiple antibiotic resistance protein MarC
MIRQAFVATGVAGVLMLTFLIFNNLLFDLLGIELESFKVAGGIILFILGLQIVLGLEIGGSSAGHKSLESSDRIGKKSMAGVIIGTPVMCGPGTITTVMILGAQDGIILTLVAVILALFCIWLILIFSAQIKKLLGETVLVILSKIVGLLLTAIAVHTIWTGILGLIALSVA
>fig|410358.8.peg.1020 Efflux pump antibiotic resistance protein
MTEISVHERRMILFATSMGAFLNPMIATMVILALPAIGLEFGVSARDLGWMSTAFILATAILLVPASRLVDSIGYKKSYIIGGIVVVITCFFSVFAPDYTTLIILRIIAGMGSSFIMITGLAILTRVYPANKRGMVIGINTAMVYVGASMGPIIGGFLTEYTGWRSIFLLMIPLLLISAGLMIIFLKQEFKNPGKSFDFKGTILYGAAIFCTMYGLSTITDTGSLYLAILGACLIVIFMWYERKVPEPVLHVDLFFKNKRFARSSYTALLNYGCTYGAVYMVSLYLQSVGALSALEAGFIIFFQPLIQAIMTPIAGKLSDRFDPRYLVTFGMALSAIGVTLLAGLGLTAAVSYIAITQVFIGLGSALFSAPNTNAIMSSVPQNEYSSASSIVAVMRQLGMILSMAVCMAAISVFVGGLDMLGPDMYPEFVQALQISMLVCAGLAVIGILFSWFRGNAPTGADA
>fig|410358.8.peg.1115 Permease of the drug/metabolite transporter (DMT) superfamily
MDLRLLIFPLLVFLGGCCYGPSSPTIKLAYAAGYSWTDVVMSQYFYGWLILFVIFVGLFLLRLIRKQQTIPAKNPRPLLRRIPGLALAGTCISLVTVTYCLSLQSVPAYISVILLFQFTWMGVLIQAITEQRLPEPKMILAVVILVIGTFLAAGFAGLDGPLDPSGVIFGLLSALLYAMYMFMLGRFEIGMHPLNRSFLILSCALLLLTFLFTPAYFMQGTFVTGIWQYGIILGSIGCILPMCLFAIAAPRISTGATTILSSSELPASIICAVLFLGETVSWIQYAGMVLLTIGIAYPQYHPHPRQKQIRKGVGMQRFLHPHARAKIR
>fig|410358.8.peg.1268 Multidrug resistance ABC transporter ATP-binding and permease protein
MNHIIERLAGSIREFKKDSLITPLFVSLEVVMDVIIPLILASLIDDGITAGNMGVILRLGLVLFLSAIFSLIFGILAGKFAASASSGFARNLRHDIFYNVQSFSFANIDKFSTPSIVTRLTTDVTNVQNAYQMLMRVAVRCPLMLILSYVMVIIINPELSIIYLVLIPILGVGMYLIITRVQPIFEKVFKTFDRLNKVVQENLRGIRVVKSYVRDEYEVEKFKDVSKDIYGYFSHAEKLLAFVSPLMQFVVYAAILLVSWFGAQFIVAGTLSTGELVSLFAYTMQILMSLMMLAMIFVMITMSRASAKRIVEILDEESNLTNPEDPVFVVENGDISFRDVDFSYSTDAERICLQKINLEIKSGETIGILGGTGSSKTTLVQLIPRLYDVTGGSVMVGGVDVRKYDLTTLRDQVAVVLQKNVLFSGTIKDNLKWGNPDASDEELIRVSKLACADEFIQHYPEKYDTRIEQGGSNVSGGQKQRLCIARALLKKPKILILDDSTSAVDTKTDAQIRQALMTEIPDTTKIIITQRISSVEHADKIIVMDGGHINAVGTHAELLQNNPIYQEVYSTQQKGGEE
>fig|410358.8.peg.1297 Multidrug resistance protein B
MIQTSSLQQYFLMILASTAVFLDYLDTSIVSIALPTISADLGIGSLTASWVMTSYLLALGSTLLLFGKLADRTGRDREIFIAGFVLFTVSSFLCGVSANIEVLIGFRVIQGIAAGMMVSTATMLITTRLPSGIRGMGMGVIATAGGIALALGPGLGGLVTEFISWHWIFFINVPIGVAAVILAVFLIPGSEIHSVAKQPFDCFGALLLALTLVSLLMGLELVLSDGWTLWVIVLFLIVPIFGYVFFRRELRHPDPVLSAKLFLNRTVMWASLSTLLVTLVYLGIVYLIPFYLTGSIQMSVAAAGLVMLLAPVSMALIGIPAGALSEKIGCMRLCNLAAVLMAGGLVFLVFSVVLSFLPLLFVGLLLLGLGMGLNEGPSMQRITLHCPRELQGSSGGLIFTVMNIGCILGVAVFSAAASLGSGGSDIYTDQGVIAACIAGIIAAVCAYLSSRLARDQILC
>fig|410359.7.peg.194 Multidrug-efflux transporter quinolene resistance protein NorA
MSDKFLKGGHRNPTSMAGPRAVRYVLLTAAVLHMMGFSAVVPVTSTLVKSLGGDSVVQGLLASAFTLAQLVSAPLWGWASDRLGRRVIIAVGLGLAAIGHAGLYLARDLPTAFVARAVSGLGGGTLPVIQAAVLELSRPEERAASMAQFGAALGIGFVAGPLLGGALSILSPRDPFLAAAVLSATAALWSTAVYESAPTAAPQPKAEGRGAGVNPLYLVVFFLLNASYAQLEAFISFYGGDLGLRPMYVGIAMSLASAAAVTAQTVVKRLEKERPTDSDIAIGLAVMAAGLATAAVPTPYTYFTGVVVSAAGQVIATAFISKAVATSANRVGLAFGEMQAAGSLGRLAGPVDEGLLYKTLGPTPSFLEGAGLAAMGLLLIIGATRLNLTPTLPTLSQDKREKA
>fig|410359.7.peg.451 Multidrug resistance protein NorA related protein
MAVRRVVAVVGVARFVRYFILGHLAVSLPIALEASAGGAAGAGAVLSLAGLISLGASIAYSVVGDVVRHARGLAISETAFALGLLALAHVKNPWLLALALGLGGMGTLGPGATRGAFVPLILAVIRDHSKSHVESAKAIGVVNSISTLGGILGSATAGFTDLRHSIPPYSAVALGTALLIAVALGRGERVRAVNPLKRVATRGREVAGYSLSQFVAGVGIGLSMPLLSLWLHAYMGLDEATIGLIFAVGNGAFMVSSLFAYRLVEALGLVRAAVVSRVASGMLLASLPIFREVVPFAVAFVFYNAAVGIGGTARSSYISSVAPVGSEATTPAVSNIAIRASSVPSVALSGYIMELEPAAAMPLAGLMLIAAGAIMWKMLKEPEEFTH
>fig|410359.7.peg.710 Multidrug resistance protein
MRLAASYTPIFVARIGSGASAFLVVKLASGGALEAGAVLAAYPFLEAIGALIAGRWSDLAGRKKTLLVGYVVRSLAMLALAWAFFVHESPVLEAVLNGIIGFTTAFILTASLTMATDLTEVRNRGLGMGGFEFVNLGSYGVGYLLGSALYIIFPDARAYLVIAVLTALSTPLFAMFLQETRPVAPAEGRLLFSVLPPSAVALLPVWFALTTIIGLAMYTPRILDVEAGAHGAVQQIVDKLGGNLVVGLLFIGALALLGAGAIFFGRLADKWGRLKVFYLGLVGGLSALVALNAALHLGLGPVEAVALTAPLLFLTSAIGPSILALIGDEADIRYRGTVMGIYSVVLGLGIGFGSWLAGVISWAFSGYEINGLAAAALGVYAAMTSIHIAFAKRQGLLSQLK
>fig|410359.7.peg.1321 Permease of the drug/metabolite transporter (DMT) superfamily
MKGLALALFSVAAWSTNYVAGRRLAAAGADPLALSLVRFVAATPIIFALARAPPYRGALAQLAVAGLLGVAAFNTFLYTALHYMTAAAAALFVVLAGPATSLIEAAAGKRRPNPHVLAGGAAAVAGAYLVLAPQAQVRAVEGPLLAAAATLSWSLYTVYVRRVYARYSPAEASAWISLVGTAELAPLAPLAHYGWLAHWETAAWVLYVAAVPGALAYTAWNTAVREIGPQRAAAVLPLMPVITTAISAAALGEAVTPLQAVGMALAVAGVYYAQNPTLLPRIAGRPKSNRSSRQGSPLSE
>fig|411154.5.peg.1864 Permease, drug/metabolite transporter (DMT) superfamily
MEKKAIYAVILCAILAGNNGLLIKSMNSMSTGGIAWFRTGIPVLFLIPFLIKDKEFHFRGNTKKMFLASFINAIRMYLYLLAFIYTSIGNAVVLFYTYPLFVTAIEYLFFKQKLQKAQTGFLVLAFIGIVITYLGKPFSFASNDFIGMLSAIGASIGYAVTVILFKSETPNYSKNQLIFYQNLIGALVFVPFLAFLPDVELPQIGVGILYGLLIGIVVFKLFFYGLKELTAATATTLMYLEVVSAIVLGYFVLDEKLSWNILAGGSLILISSFFISKLNRKKVQESLSTSAS
>fig|411154.5.peg.3203 Outer membrane protein oprM, multidrug resistance protein
MKRIINYKFLIAGIGLLNLQSCFVAKDYDQPEVVKEDYYRTDNIEQDSLNMATISWTEMFTDPILQDYIEQGLQNNIDIRIALQQIIAAEAYVKQGKAGYLPTINGNASYTHQKLSENSQFGNQFSSLDQYQLSADLSWEADIWGKIRSQKRAFDASYLQSIAAHQAVKTRLIANIASTYYQLLSLDEQIKITEETIDNRENSLETTQALKEAGNLTEVGVKQTEAQLYTAQGILIDLKNQERLLENTLSILLGVAPIQIERSELEEQEITTDLNIGVPVQLLRNRPDVIAAEYDLVNAFELTNLAKSNFYPSLRLTATGGLQALESGDLFNASSLFATVMGGLAQPILNGRRIRTEYEVSVAQQEQARLEFRRAILTASKEVSDALYSYEAATNKIEVKQKEYNAYDLATEYSEELLNNGLANYLEVLTARENALNSSLDLSNAKYNQLKAVVDLYEALGGGWK
>fig|411461.4.peg.256 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGKKTIEENTITEGIIWKQLLIFFFPIMLGTLIQQLYTTVDTIIVGRFVGKAALASVGGPAAVLSTIVVTFFNGLANGAAVVIAQYYGAKDKGRLHTGLHTAYLFSIVVSLVISVVGAVLTPWLLKIMNTPQDMMASSTTYLRIYFMGILFTLVYNMGAAIMRAVGDSKRPLLYLVVCCVLNIGLDIFMVVILKMGIAGAALATVFSQCVSAFLVTWSLTKDYDSMKLQFRELRMEACVLKRELKIGIPGALQACAYGVTNVVIQASINSFGTDTAAGWAAYGKLDLIFWTVSSALGAAVTTFVGQNYGAGKWDRVYKSIRVNIGISYVFTGMIIFTLYAFCEPMYHMFTTDPKVIDIGVYMLRFLVPSYLLSILLENLDGGLRGVGDVLWPTIFTFGGLFLIRLPWVMILTPIYHKVEILLISYPIAWGGTLLFVIPYYFWKKKKCFNKICSEK
>fig|411461.4.peg.392 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDTFMKEKPILPLLTSMALPMVISMLVNSLYNIVDSFFVAQINEQAMAALSLVFPVQNFVNATAIGFGVGINAMIAFHLGAGNKENANASATHGMILSVIHGFLALIISIAIMPTFLGAFTKDENVIKLGLEYSRIVFLFAPVIMISLAFEKIFQAVGRMNETMFALLCGCISNIILDPLLIFGIGFFPKLGIKGAALATGIGQIITVIVYLIYYVKKPLPVKLKKSCLPLQRSLDFRLYTIGIPAILNLALPSFLVSFLNGVLSAYSDIYVVVLGIYYKLQTFLYLPASGIVQGMRPVIGYNYGAGEMDRVRKIFRLALLMCGGIMAGGTLLCLFFANDLIGMFTTNPETIQAGGLALRIISSGFIVSSISVTASGALEGLGKGVQSLLISLMRYVVIIMPAAFILSRIRGAVGVWNAFWITELISAIASVWIYRKSLKH
>fig|411461.4.peg.953 Vancomycin B-type resistance protein VanW
MRRRRIRIAGFCLAGCILILGIVCGAFHHYVSQFPEDKIAENIYVGTVDLSGLSKKEALEKLAGQKKADQKQTVSLTVEGQKAEATLEECGFDYADVKANVKAAMDYGKSGGLFGRYKSLRKLSKEKVVLSPEYTLDQKATENILEERAVPFAKHAQNATITKSGSGLQINKEEIGETVDKSGTIKAIKKHLNDSWDHGSFAMEAKVKEEQPSVTEADLSTIQDELGSFSTDAGGGERWKNLKNGVEKLNGTVVMPGEQISVHDVTAPYDEEHGYVQAGSYENGQVVDTYGGGICQVSTTLYNAVLFSELKVVKRYPHSMLVSYVPPSRDAAIAGDTKDFVFENNYDTPIYIFGEIDDDNQLCFAIYGKETRDKTRKIEFESEEVSTEEPGVKYKADAELALGEMEVTGSAHTGKEVKLWKIVYENGKQVSKDVINESTYSKADKTISVGIKTKNSSAAAVVKEAVSTQDKVKIQAAIGEASSMESSSEQ
>fig|411461.4.peg.1499 Permease of the drug/metabolite transporter (DMT) superfamily
MAVGFIFVALSATCLGVMPSFQKQVLLDGLPMNSLMFYVNWIITLVCLVMALVKKRSFRALKIQIVQSLLMGVFGLLITALLLNNSYLYLPVGTAIMLNFLYPSIVCIVMGIVFKEGFSKYQIAAIVVSVIGMGFLTGAGGNMPMIGIVLAVASAFVYGGYLIANEKGPANELPIEVKLFYVSLPGTILYCFIAPMTGTLVAPPKSIDVAFIIAVGLFNAGGYFFMMYGISKLGAAIASFVSMLEPIVSVIFSTLWFHDPVTIGIVVGGGLVMASILLIAIDGAKKGNSA
>fig|411461.4.peg.1875 Permease of the drug/metabolite transporter (DMT) superfamily
MSGERKNTITKSATANTTTKKGLSQGQADILIAIVAMTWGSSYLMMKIGLTGMPPFSIIALRFCIAFITVALVFLPKMKLMNLRTLGYGSILGLLLFGVFAFLVPGMKYTTASNAGFLVGIVSVFVPVVHSFLKHKLPSKRTTLGVLLALLGICLLTFLSTFTINLGDILCILSAFSYTIQIILMDHFTKETDSFLLGIWQLGFTGLYGVIFTFLFETPSLPGSGAQWGAILGLAIICSAFGFIVQPVAQEYTSPEHTSMLFALEPVFSMIFAYIFLHEKLSLQGAIGAFLIMVGVVIAASTHEE
>fig|411461.4.peg.1892 Permease of the drug/metabolite transporter (DMT) superfamily
MRMTQKQNILTKTGIVALLACVCCILWGSAIPVIKTGYRFLHVDSSDIASQIVFAGVRFTLAGILVLIFASIREKKVMIPDKEILKYAVPVCLAQTVGQYFFFYIGVANTSGVKGGIITGLGNFIAILLSCLVFRNERMTRRKIAGCVLGFAGVVVINLLGNSLDMGFKLIGEGFVLIAQLSYGISTVLINLFSRKVSPVVLSGTQFTMGGIVLMLIGAGMGGHLENVTTGGVVIIFYLAMVSAVAYTLWSVLLAWNDVSKVAIFGFVNPLCGVILSALILGEVKQAFNVGSLAALILVCAGIYIVNCKENKKE
>fig|411461.4.peg.1996 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAESNKMKEMPVNKLMVQMGIPMILSMALQAVYNIVDSAFVGNMREGSEAALNALTLVFPVQMLMVAVGIGTGVGTNALLARTLGQGNSKKAAKVAGNSLFLGVIIYVVCLLFGIFGVKAYISSQTVDAEVLEMGVSYLRICCVISFGIIFFSLFEKLLQATGRSLYSTIGQVVGAVVNIILDPIMIYGIGPCPEMGVKGAAYATVIGQVASAVLLLIFHIKLNKEFEHGAKYMKPDGGIIKEIYTIGLPAIIAQALMSIMVYVMNLILKFNPSAQTAYGLFYKVQQFVLFLAFGLRDAITPIIAFAYGMRSKKRIQDGIKYGLIYTVILMILGIVITEIFPGGFATLFNAGPSREYFIGAMRIISVSFLFAGINIAYQGIYQALNGGVESLVISLLRQLIIILPLAGIFSVFARNGQMTVSLIWWAFPITEIISCFVGYVFLKRISKNKVDVLN
>fig|411461.4.peg.2038 Drug resistance transporter, EmrB/QacA family
MMLSVAMYGLVFATLTSPILESVNAMGYVSLFSIFAGMGVSIMTPIGGKLGDLIGRRNIVVIPGIICAVCGIAFAFVRSLVPLMILRLLIGFAQGAFTAAPYIIAGLINERKDVPKAMGMLATAIAVGGFGGSIIAGILTDMGLLKVAILMPAVPLILGVVLIGMNMPNVKREGKVSIDIPGIIALVVALAGILLALNFGSSMGWGNPAIIAGFVIGIVALVVLVKIEGKSAEPLIPLKLFKNSQYTVLLIVGFICYFYQSAMNVYAPIGAMRVMGASTSAAGALQMPRTIITIFLPTMAGVWVGKKASNAWKAMVIGTLFVAVPMAVMGFTTPSTSIIIYFVALTITGIAESYRSVSITPSAQATLQPADMGVGTSLVNFVNSLANTIAAAVFGAAYNLSTAADPTNVAYIQNGVDSVFRLAAIVAVIGLVLVIFVVRPKMTAKKAE
>fig|411461.4.peg.2733 Permease of the drug/metabolite transporter (DMT) superfamily
MKPKNAVMLLLTSLIWGTAFVAQSVGMDFLGPFTFNGVRSFIGGVTLLPCIWLLEKMNGKPEVDGTRKDLIQGGIACGLLLFAASSLQQMGIQYTTAGKAGFITAFYIVFVPVLGIFLKKAAGWKVWMSVFLALIGLYFLCIKEGFSIGKGDIMIFACALVFAVHILVIDYYSPKVDGVKMSCIQFFVCGIASLPFMFLTETPQIGNILDARMPILYAGVMSCGVAYTLQILGQKHANPAIASLLLSMESCFSVLSGWIILGETLSAREGIGCVLMFVAIILAQLPDKREKLKNGQA
>fig|411461.4.peg.2944 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATSLIQMAYNMIDMIWIGRLGSSAVASVGAAGMYMWLSNGLVTLARMGGQVHVGHAVGAGRTDFAGRYAATTFQMTLLLGVLYGLVCTIFSKPLIAFFHLTSRSVINDAVSYLMITCGLVIFSFLNQIFTGLFTAIGNSHPAFLSTSVGLVINIILDPLLIFGIGPFPALKVTGAAIATIIAQMVVTLLFLFFASQDQILFHHIHLLQAPDSKKASEIFRLGLPSCLQSLVFTGISMTIARLVAGYGDAAVAVQKVGAQIESISWMTSDGFASAVNSFIAQNHGAGKEDRIHAGYRSALKIVLPWGLFCTILLVCFPTPIFKIFITEPDVIPMGISYLMILGFSQLFSSLEITTSGAFCGYGRTMPPSITGITLNLLRIPMALALTATPLALSGIWWSISITSILKGLILFIWFQITIKKK
>fig|411466.7.peg.447 Multidrug resistance transporter, MFS superfamily
MTNHDTQDRGGIVGGALTVALLITLAVQNAVPPMATDMYSAAFPQITADLATNSTMLGFTLTTFFVGYASGQVLGGAISDQIGRRRPIIAGGIIALVGSMICVFTPNIWVLLVGRVFQGLGGGVASSVARAILVDVAHGKTLARAMSLLQAIVGFAPMLAPVLGAFIITHATWRVVFWALAGFTLLMAALAWFVVPESLPEERRHPGGIPRFFSGLVQVVRIRPFVGFMLTNAFSSFCMFGYISNATYVLQGPLGLSPMAFAWVFAFNALLSTGFALVNVRLISHFTPRTLIITGLTIAATGVVTLAISTFVLDLPLILTCVGFALIMTATAFIFGNSGAQAMSEAREHAGTASSVMGVFQSIANGIAAPLATSGGDSAVPMVLVMIVGSVGAWFAFWVIARGGKHTPRHLSLD
>fig|411466.7.peg.806 Glycopeptide antibiotics resistance protein
MYTAINWALDLGLYVTVCTITCALWWWFGRRSEPSVTAGRAEASTDSVQSAGQVSRARLTVVQALPLIYRRSKQTSALLPREENPDTPTTAEIPAVAVPASSKWRLPRALPLAWILYVAGLLIFTLLPLPSDPVAACAAIIHWDNYTPFGSFVAVADQFRDGESLRGTLYALSILLNIALFVPLGSLVETTWRIRRVRRAPEGAPADGSRLARSIPHRRVLAWVVIGCAVSCLIELTQYTGLFGVVPCTYRVVDIDDVIMNTLGTYAGVRLLPFMARNSRFMGA
>fig|411466.7.peg.1735 Multiple antibiotic resistance (MarC)-related proteins
MMTVLAGMSAAILALAPITNPIGGLAAFAGLTAGNAAAAVRSQAWKTGIYVFAILTVFAVSGSLIMRFFGFDLPSLQIAGGLVVSHSGFSMLENKRRATHEETQHATSKPDVSFSPMALPLIAGPGSIGVVIALAARNTAIGFHVGIVLGIAVTAAVIALLLRYGTPWIDKLGATGVGAIVRIMGFLILVIGVELIIHGVRALQLF
>fig|411483.3.peg.390 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQTAKKSPFSMNVDLMHGPIFKNLLLFMLPIFISSLFQQLYNTVDTMIVGNVLGDTALAAIGSCGSIYELLVGFGLGIGNGLAIVAARSYGAQDHDLLKKTVAGSLVIGLVASLCITLAGVLGLHPLLLMLDTPAEILDDAYRYILTIDLGVLVMFAYNLCAGLLRAIGNSVMPLVFLLISSGLNVVLDLLFIARMGMGVQGAAVATVISQGVSVVLCILYIFLRVKILLPEKQHFRVGSHLYWELFSQSISMGLMSSIVSAGSVVLQYGINGLGTLVIAGHTAARKLFSFTSMPVMAMASACSTFVSQNCGANQPERVRKGMKEIALYSVAVAVLAVLLMQLGAEWMVQLISGSNEPVVLENGARYLLWNAPFYSVLGVLLATRYALQSLGQKVLPLFSSVIELVGKVVFVLFFIPKFAYNAVILCEPIIWCFMAAYLVLVYLHDPFVFPKKAE
>fig|411483.3.peg.529 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKDEYLITDAPLKALTVFAMPMILGSFFQQIYNMADSIIVGQFVGSSALAAVGACAALTNVFICVALGAGVGAGVLVSRYFGAKEYGKMKTIVSTSLLSFLILSIVLGVFGLCFSLPMMRGLQTPPDILDEAVLYLRVYFAGFPFLFMYNILSNMFTSIGESRIPLALLIFSSVLNIFMDLWMVAGLGLGVFGAALATLIAQGISAIFSFLIFLHRMRRYESPFQRFDWRGLQSMLQIAVPSILQQSTVSIGMLIVQAVVNPFGTQALAGYSATMRVENVFSLIFVSIGNAVSPFVSQNLGAGKPQRIKKGYHAALVLDLCFAAIAFVVIEALHTQISSLFLGKDGTVLAYQVSGDYMRWLGYFFIFMGIKMATDGVLRGLGIMRPFLVANMVNLAIRLSVALICAPRFGIAFVWLAVPAGWLANFLISYGALRRSWPTDKMASTR
>fig|411483.3.peg.879 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDSIFDLDHLYRTYFKMALPSVFGLMVSVVYNLADTFFIAQSNDTALIAGVSLCAPVFTALMAFGNIYGQGGSSLISRLLGQDDREGTGRVSSFCFYVALITGVVLAVLMMLFRVPLLGILGATVETMPHAQAYYTVLAIGAPATVLNFIHSNLIRCEGMATQSMIGSIGGTVINIILDPILITTVGWGAGGAAIATIVGYLCSDLYFLWLLHKKSRCLSVKLSQCHVTGKELQQVLGVGVTAALSNLMQSLTVIVMNQFLLPYGNDKIAAMGIASKVSMIAQLVLVGFSFGGIPLFGYLYGAKKRDVMRKLIRFCLTFLVSIAVVLSLILCLNSGALMQLFVQDAGMIATGAQMLRWQVYTAAFGGVALLLTVLFQATGKIMPSFLLSISRQAWCFCWHWWSAYTCSSIRAC
>fig|411483.3.peg.905 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANADRSAEQFRKMTETPIPKLILSLAAPTILSMLITSIYNLADTFFVGQISTSASGAVGIVSSLMAILQALGFMLGHGSGSIISRSLGSQNTDAATRFASTSFFTALVFGGIITAAGLLTLPDFMMLLGSTETILPHACAYARYILLAAPIMMSSLVMNNILRYEGKASFAMIGLVTGGLLNIALDPLFIFGLGMGTAGAGLATALSQTISFCILLSMFLRGKTVSQFRITAVTHSPAEFGTILMTGMPSFGRQGLNSIGGMLLNIAARGYGDAAVAGMSIVSRIFMFIISVAIGTGQGFQPVAGFNYGAQKYRRVQQACLFTMAASFCFLSVILTVCWFNAETLIRLFRDDPEVTAVALPAFRYQCFAMLLQPVIVAGNMLFQSIGKSGRATFLACCRQGVFFIPLILTLPRAFGLLGVEICQPIADVLTFFVTVPFLFPFLRQLVRMDEAEAAEV
>fig|411483.3.peg.1176 Permease of the drug/metabolite transporter (DMT) superfamily
METQLSRAEKLDRLFGTPVFAVIIAILCNAMWGSAFPFIKLGYRLFAIDTADTASILCFAGVRFMLGSVLVLGGSLLLEGRLPAMPKGKILAECCALGLWQTTAQYAFFYSAVALLTGAFGGILNSTQSFLGVIFAHFLYGRADRMTPAKALGCGIGFAGVLIATLGNHGGGSARGVAYMLIATVLFTLAGPWNKSVTRRADSFAVCFVNLFVGGAALFLLGAVLGGRLEHWSVLSVLDLLALAFICGAGYIVWALLMKNNPVSRIAIFGFVNPVVNVLLSALINGEPLFRWQYLGALVLVCIGIWLVNKAPAKKERAR
>fig|411483.3.peg.1321 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNDKTDFTQGSIPKKLALFMLPILGSLVLQAAYGAVDLLVVGRFGSTSGLSAVSTGSQVLNLVTFVVTQLAMGVTVLIARYLGEKKHEFISPVIGGAAVVFALLAAVLFGVLVFLARPISSLMQAPAEALDLTTSYVRICGAGIFFIVAYNMLSALFRGLGDSRSPLIFVLVACVVNIVGDLVLVAGFHLDAVGAAIATVAAQAVSVVCAVVMLLKKSLPFSIKKADFRLNFQCKKFLAIGLPLALQEFLTQLSFLALCAFVNRLGLEASSGYGVACKIVNFAMLIPSALMQSMASFISQNIGAGKHQRARQTLRTGIGIGLFFGLFVFALVLCKGDLLCSFFTTDAPVIANGYAYLKGFALETILTAILFSMIGYFNGSGKTVFVMAQGLFQTLLVRLPMAYIMSIQPNASLTMIGLAAPTSTAVGVLLNVCFFLYLDRKAKKQG
>fig|411483.3.peg.2011 Permease of the drug/metabolite transporter (DMT) superfamily
MNTQTKHSLMLMLCAFIWGTAFVAQSAGSGMGAYSFLAGRSWLAVLVLLPTVRAFDALHRRHGAAYGWPKAPADRRHLLAAGFCCGTLLFAASAAQQIGITLNPSTAKAGFLTAMYVVLVPVFGLFLGRRGSARLWLSMVIAVGGLYLLCMKNGFGGIEASDWILLSCAVLFSFQIMTVDHFAPQVDGVRLSLLQFFVVAVESTAAALLFENPTLAEFGANWLPLAYCGVMSSGVAYTLQILGQRDVNPAIASLIMCLESVFSALGGWLLLHQSLSMREVFGCTLIFAAVVLAQLPVEDWLKCRSASRK
>fig|411483.3.peg.2456 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLTKQFFKYVSQNIFGLIGTSCYILADTYFIAQAAGTDGVTLLNLCLPMYNLIFAFGSMIGLGAATRYAILQAQGEARAQRFFSNAILCACLIAIPFMLAGAFCPGTLLQLMGGDADIVALGLNYTRIFLLFTPFFMCNYIFSAFVRNDGDPSLAMVATLSGSLFNVVFDYIFIFPMGLGLPGAALATAISPVLSIAICSRHFFQKSNTLTFVRQAPSARLLVQSCQLGISGFVGELSSAVTTTVFNFLLLRLAGNVGVAAYGVVANFALVATAIFNGVAQGAQPLISQCYGKNEMAGAKKLLLLGCGTALALAAVLYGAVFGFTDTFVALFNSESSALMAEYAHSGMRIYFLGYFFAGCNIVAAGYLGAVNRPTEATITSVSRGVAAIVTCSLILSALFGMNGVWSAFPAAEAITLALTVFLLKRPQSVCS
>fig|411483.3.peg.2541 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKYAIPCIISLLVGALYNIVDQIFIANASYLGSYGNAANTVVFPLTVVALAIAVMIGDGCCAFVSISLGQNEVPKARRSVGNAVVMCLVSSIVLTAVYLIFANTILAMFGGTVNAETYHHSQEYFFYITLGIPFYMFGQAMNPIIRADGSPRFAMVSTLAGAVLNIILDPIFIFGFRWGMMGAAVATVIGQVVTAALAVWYLLHMKIIRPAWADLR
>fig|411483.3.peg.2542 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSFLSQISLVAAMAAINNMIRKYGALDAVFGQEQYAQIPMAVVGIVMKFFQIVISIVVGMAAGCIPVVGFNMGAKSPPV
>fig|411483.3.peg.2543 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFTKLLLAEAAVGVVALVLVELLPRQLIALFGAANESVYYTDFAVKSFRIYLCMIILACVNKACFIFLQAMGKAAESTALSMVREVVFGVGFALLLPRFFGLDGVLYSMPLSDILTFLIAGYLIHKTYHEFNYHIALDSGVIGIEKCAEIMESLV
>fig|411490.6.peg.66 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNHKNKMETRQMFPLIVSMAVPPLISMFMQYTYNFVDCMFVSWIGEKELTAVSLAFPITTLMIAMSIWIGVGVNVLIADNLGQKNQDRADSVVTNGILLSAAMGIIVTGAVLVITKPFFSSFTDDPEIYNLAVRYMRICAFLEVSSMVHICIQKILQGTGNMIAPMWFQIAGVVLNFILDPILIFGYFGFPKMGIEGAAVSTVCGYTLSMILAFMVLILRKQKVRLKIKGFHVDFQIIKEIFVIGFPSFIMNALGAFMIYFTNIFLVVYSTTAVAFFGAYFKLQQVVIMTLNGLVQGCIPIMSYNYGAKNMPRLRQAFKYGTIIGIVLTGISIVLFWTFPEQILKIFNASDEMMTFGVPALKIMCTSYVFAAAGTMTASFMQSTRRVGFSLIINILRQLILLLPLMWILSQVIGMEGIWWSFLAAETITVFISIYLYRRYPVKFSDNPV
>fig|411490.6.peg.151 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKHKFYQFVIPSVCASMVTGLYFVVDGIFVGRGVGSNGLGAINLAVPFICILTAVAMMIAMGGSTITSIFIGQGNEQKALRSFMNSIYLVLIFSAFMTVFSFLFSDQIARLLGARGDLLSLTSDYLRYYILFGIFFCMAMVLAAFVRNDGNPKLGLAGMAAGALSNVFLDWLFIFVFHMGIHGAAVASGLGQVISCMIMLPHFIHGKGRLKLKLLPIEQYYTSEILRRGIPELITQMSQPVTIFCYNLIVIRYLGNIGVSAFSVVCYLLTLVFSVFIGVSDGIQPLISRSAGEGKKELERCFLKKGIAVNFLLAFLLYAVLLLFGEPVIHIFNREPALVKLAGESLSVYGVSFLFAAVNMIFTTYHLASKRTFKALTIASLRSFIINVAFIFLMPAVFGRQALWTGIIAAECTVTFIAVLMMKKTSDSHTCSAAAAEN
>fig|411490.6.peg.893 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MILDPIMIFVFHWGMMGAALATITGQIVSAILAVYYLCHMKSIKMETECFRVNPIISKKVLSLGISSFLTQISIVAIMAAMNNMLVIYGAQSRFGSDIPLTVVGIVMKVFQIVIAFSVGIAAGSQPVIGFNYGAGLNHRVKKIFKLMMAAEACVGVFSMIIFECFPMEIIKLFGNESVLYNEFAVLAFRTYLCTIVLCCIQKSVSIFLQALGKPILSMGLSLLRDFILSVPLVLFLPKLLGIKGTLYSAPAADMISFIAVIAVTRYLFGHLKKDEKEERETAFNRGEETINLVSE
>fig|411490.6.peg.1716 Permease of the drug/metabolite transporter (DMT) superfamily
MSKNQKIRGIICIVLSAFCFAWMNAFVKLSGDLPSIEKSFFRNLVALIFAFVMIKRSGAGFRFQMKNLHWFILRSLAGTLGIFCNFYAVDHLVLSDASTLNKLSPFFVIVFSYLILREKITVFQLTCITSAFIGSMFIVKPSFAAVSVLPALIGFLGGMFAGCAYACVRKLGTRGERGPFIVFFFSTFSCISCIPFMIGNFHPISGLQLVYLLLAGLAAAGGQFAITAAYTYAPGKEISIYDYTQIIFSTLLGLFLFGQMPDGFSILGYVIIITAAVVMFFYNNRRNKTE
>fig|411490.6.peg.1729 Glyoxalase/bleomycin resistance protein/dioxygenase
MASYLEHMALRVKDLDWHIRFFEDVFDMPVRMELGEAPNRKVWLHAGIQLNEAVDYEGPEGRADHMGIMTEDVDAVLEKAYRLGVKELPQGHNWFELPSGLCIEVIAGKTDVLKEIIEKKPWIE
>fig|411490.6.peg.1926 Permease of the drug/metabolite transporter (DMT) superfamily
MNQNTKGVIFTMLGGIFWGISGIIGKYLFDEKQLTAVWLVTLRLLSAGLLMLMLAAVQKKGDIFRVWKKKRTAVSQLVFCLFGMTACQMSYFLAIQYSNPGTATVLQYIAPALIMLFCLAVEKRKPKRLEVIVLVCVIAGVFLLATHGDPGSLAVTGRALFWGLAAAVALAVYNIQPEKLLNEFGSMETVGWGMFIGGLLMIPVTGFFHVPGIWDMTTVLLALAVIIFGTVIPFGCYLEGVCLLGPVRASMFACVEPLVAAVMSALLLGEVFVGVDVLGFALIIGGVTSLAVFDRS
>fig|411490.6.peg.1989 Vancomycin B-type resistance protein VanW
MSKRMKAGIAAGILAVICIGIFVYISQTVKGATKDHKIVQGVIFEGKSLGGMTKEEAKKEIEDYIEKEQAKDITFYVDGKKAVTKLSKTGVAWDVEKTVKDAYDVGRSGSIINRYSQVKKDKIIVKIERSYDQKIFDRELDSAAKKIVSEPKNASLKRKNGKFIIIKEKTGYALDKKSTFKAYKKQVEAESFKVPLKVTRKKAEYTSEDMAKVKDKLGTKTTYYGSSAPGRKGNVANGAKMINGTVVYPGETFSVYKAVSPFTSENGYYLAGSYENGQTVQTYGGGICQVSTTLYNAVIRAELKIKERHPHSMTVSYVPRSADAAIAGTYKDLKFENQYDFPIYIEGIADGSNITFSVYGQKTNPNRHVEFVSETTSVRNSSGEKAIKDPTLEEGKRVVEQVGHTGYTAKLWKIVKEKGKKTQKILFNTSSYMATPNTVRVGTKKKDKDKDKKKKDTDKKKKDSKPTEKSTEKSTEKKKTPAKKSTEKKSTQAAQTSKEN
>fig|411490.6.peg.1996 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDNKVFESYPVPKAVATLALPTVLSMLVTIFYNMADTFFVGQTGDPNQVAAVSLTTPVFMLLMAVGNIFGIGGCSYISRMLGEGETEKVKKISSFCFYGSIIAGVIMMIVFLGGMPVILKLIGCSPNTEEYARSYLTYIGLGSVFVVISMAFNNVVRGEGAAKISMIGMMIGTIVNIVLDPVMILGMNMGVAGAAIATIIGNICTVVFYLFFFAKMKTGLSISPKHFTAKERILSGVFAIGIPASINNILMSTANIILNNFLASYGDIPVAAMGVAMKANMLVILVQIGLGSGVAPLIGYCYGSGNLEKMKKTMKFSMACNVIMGTVLSLLYLLFTEPIIQAFINDGSVVAHGVRMLRVLMISGPVIGIMFVFMFGFQAMGKAIPSLILSLSRQGLVFFPVLLITNYLFGLEGIVFAQPVADLASLGVSFLLFIKIAKELKEREKELELQKAEA
>fig|411490.6.peg.2551 Permease of the drug/metabolite transporter (DMT) superfamily
MNQKNKTKLGKAALFGSALIWGSSFFIMKNTIANVPENFLLGTRFLAGALLLCIFFHKRLGKIDKSYFKTGFVLGGFWFWAYWFQTEGLYHTTPGKNAFLTAIYCVAVPFVTWIWQKKKPTKQNFLAALICITGIGLISLDGNLSIGIGDGLTLVGGLLFSLHIAYLGMKSGQKDPVLLTIVQFLFAGLWGAGISVFTEDISAIHWTVGQAGSLAYLVIMCTAVAVTFQSIGQSRVSSSSASLILSLESVFGVLFSVIFYGEKATVKILIGFALVMAAILISETDLGRKSGHTENNDKKRINKKTANVV
>fig|411490.6.peg.2669 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRAKREENMKDLTVGKPFEVIGKFALPMILSMIFQQVYSVVDSIVAGRFIGVSALGAVGASQPITVIFIAIAVGTGMGINVVISGFFGAKKYKRVKSCISTAVITIVIMSAVLTFLGLLGCRWMMGAMSTPGDIFEDSALYLRIYIMGIIFLMLYNGANAIFTALGDSITPLIFLIFSSVLNIILDVLFVTAFSMGVAGVAWATFIAQGIASVLAVVTVFKKNSKIQAGNYRRFSPLLLKKMTWIAVPSIMQQSFVSVGQLFVQGRINSFGSVVVAGYSGGFKIQIFILSVLGTVGNAVSSFTAQNAGAGKWERTKEGTNAGIKMIVAMAAVFSVLCLVFSRQAMGLFLSGNSAEAVRSMGVGVDFLRINAPFFALVSVKFVCDGMLRGMSEMKGFMASTFADLIARVSLSYVLSVPFGATGIWAAWPVGWVIGTGVSVWFGKRAQKKYLK
>fig|411490.6.peg.2681 Permease of the drug/metabolite transporter (DMT) superfamily
MKIIKRNNETKYVLLELLAVAFLAAGGIFVKLSSLTPVSTGFYRVLFSLPLLLPLAFRGLRILTKKDVLILFLAGVFLAGDVALWNLSFSYTSVANANLLTNLTPFTVIPVSYFLFREKIPKLFLAGAAVTLIGVFVLLGGKISPLQSNYFGDFLAFSASFFYAVFILISYRLRDRYESSVIMFVSGFGSALALGVTSVLTEGIQIPHGTEQLWPLLGLTLCLQVIGHNLLAHCQGKLSVNLSSIVCLCQPVIASLYSYFIFSEVLSLREVLGIAIVIAGVYLVKAQYSNKIKK
>fig|411490.6.peg.2995 Teicoplanin resistance protein
MGNHRNRKLRDGIFNGVFIFYLAFLLENILFKYVQPWQLFQHGRYFSRSLNLVPFRQIMSSSGIGDLNIYGNIILFLPLGIYLMFFMKRRKAVKSLLAVFGISLFFEAFQYAAAIGATDIDDIILNCAGGLFGVMCYKVLLFVCMGKEEKAKTAVAGTAAVVGMITAVLIGLLIAFN
>fig|411490.6.peg.3113 Permease of the drug/metabolite transporter (DMT) superfamily
MGYEIFKIQGDDIGSKLLFAGIRFAAAGLMVLAVLGVQTRQRPLPKKGAFKHLLTLGILQTTIQYYFFYVGLAHTTGAKGSIINSFTAFFPVVLAPFFFKSDRLTAKKIIGCAVGLSGIVLINLKGGSLGGFAWNGEGFIVLAALSQSLASIYSKKLAQTMNVMLIAGYQLLLGGSLLLIFGYAGNGTLTFQTSGLILLLYMAVLSAVAFSVWTWLLSHYQVSSISIYNLLIPVFGTLLSGLLLKENVFTAVNIASILLVCGGIAAVNKQ
>fig|411490.6.peg.3257 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKEQLTNDMSVGNPAKKLFFFAVPIVLGNLFQQLYNIIDSMVVGRFVGAQALAAVGASTAIVFLFVAVATGSSIGYSVVISQLFGAKDQDRMMTAIYTALISTFVLGLILMIIGAAGTGGILVLMRTPADIYRDAADYLRIYMFGLVFLFMYNTLNAVYNALGASKIPLYFLAGSSILNIVLDLYFVIRLQMGVTGVAWATLIAQGLAAVISFINLLFRLKKIETETKPVLFDRKILFQMGRIAVPSMVQQSIVSFGMVFVQSLVNSFGSVVLAGYTAATKIDSIAIMPMVNVGNAVSTFTAQNIGAKKPERIREGLRAGRLMAAGIAVVITGILFFKGDVLVAQFVDEAVNAEVIAIGVDYLRVVSVFYALMGLMNVVNAVLRGAGDVGVFMAGTLCNFGCRVVFAYILAHFLGASGIWWSVPIGWAAAFTIGTLRYRSGKWKEKGIVEREKDCKETGESI
>fig|411684.3.peg.443 Permease of the drug/metabolite transporter (DMT) superfamily
MQRPPAHPLAGLALGFVGVVIFGATLPATRIALEGFSPAFITFGRAALAALVAGIALFALGKHFPRQHALSFLAAGVLLVYGFPGFSSVAMQTVPASHGGVVLGVLPLMTATFAALFGGEKPGLAFWAWSITGAALVVIFSLSGADIEPGLGDVWLGCAALSASCGYVICGKLARTQPGWEVISWALVITAPLSLAGALYSWDSGVTNPDTAALMGFIYLSLGSMFAGFIFWNWGMAIGGIARVGQVQLLQSFVTLALSALLLGEQITWVTLGFAVAVALVVWFGRKAKVG
>fig|411684.3.peg.3754 Permease of the drug/metabolite transporter (DMT) superfamily
MTNASLFAGSSGASRFVPLVVMILTPLFFSTNLIFGRTTIPEVAPFTLAFLRWTAASLALAPFVWVARHHVRAYLTSSPRHWLLLGFLGMWICGAGVYYALQFTTATNATLIYTTSPLMVILLERLFFARATGWRELAGIAIGFFGVAIIVLQGDLDRLAGLDLNRGDLMFIAAALSWAVYSVLLKGPRTSAMPVSALFGAITIAGALLLAPFALWEWMSGARMPSTVSAWGGIAGIVVFSSLLAFGGYQYGVARLGASTTSIFMYLLPVYGVGLAVLVLGEPFHAHHMVGILTVLGGLVLATAPIGRPPKTRP
>fig|411901.7.peg.2693 Permease of the drug/metabolite transporter (DMT) superfamily
MNRIKGILYAAVSSSTFGLAPFFSITLLLAGFSAFEVLSYRWGVASIVLIVFGWLSGCNFRLAGKDWGVVFLLSLLRAVTSFSLIIAYQNIASGVASTIHFMYPLAVALAMMFFFREKKSLLVILAVLMSLLGAALLSLGELEAKSGNTMVGLVAACVSVFSYAGYIVGVRTTRAVQINSTALTCYVMGLGTIFYLIGAYCTSGLQLVSDGYTWLIILGLALPATAISNITLVQAIKYAGPTLTSILGAMEPLTAVVIGVFVFKELFTVNSAVGIILILLAVSIVVFRRQKS
>fig|411901.7.peg.3625 Clindamycin resistance transfer factor BtgA
MPNNSRKTIFTTISIDKETAALVEKICKRYSLKKSEVVKLAFGYIDKAHINPSEAPESVKLELAKINKRQDDIIRFIRHYEEEQLNPMIRATNSIALRFDTIGKTMETLILSQLEASQERQTAVLKKLSEQFGNHADVINNQSKQINALYQIHQRDYKKLLHLIQLYSELSACGVMDSKRKESLKVEIINLINT
>fig|412965.6.peg.270 Glyoxalase/bleomycin resistance protein/dioxygenase
MNIRFSHIALRCNNINTVAIFFTEVIGLEKGFRPYFIFPGYWLYSPENKQEAIIHILSKKAKFSIKTNNYNNLLDHIAFVRDDYPIFIKHINKLKINFYEKFIPNLNTKQVFLKGPENITVEVNFII
>fig|412965.6.peg.326 Acriflavin resistance protein
MDNILIFFVKQKKLALVLTISIIVLGLFTLNSIQRDKFPAVDFEVMTIVTAYPGASPEDVEQNVTNLIEDELRSISGIDKFSSTSKEGKSSIVIILSQDVDDIEPLKQEIRNVVNRIKSLPEEVNGFPWIVDQKNSLKSILKINISSDNLSYQVLRDIIDDMSESLSLVKGVSKVIKEGYLDREFQIRVNPDSLYQHKLSLPQVIKAIKNRNKRYTVGNNNDINEKTIVVLAKFDEIEAVSNVIIKSTFDGPVIRLKDIAKITSENKKETSIIRVNGTKGFILSIHKQEHADVITTVDLVKDKVLELEAKYPTSLKFFYSSDESNHVRNRLNIVTNNGLIGLLLVLIILALFLSFKTAFWVSIGLPVSLLGTVSLLGVTGETINLVSLAAMILILGIVVDDSIVVAESIHHYKQLGKDRYQSTILGFKRVIAPVITTILTTILAFSSMFFMSGTMGKFIYVIPLVVIFSLTLSFLEVSLALPAHLASSDEKTKEKIWFMRIEVWFEGFLTEVLKWRYSVVFIFSIVLIGSLYFAKTQMKYVQFPIVGADSIDARLNMPIGTSLERTESISKQVEKIIIEVVGEDLDSLTNNIGHYFTNVAKFSIELVPSSIRVETSKSLLAKLKKRVKDIKFAQELKFSISRPGPSQGEDVEINLIGSDNIQRQNAADTLEKILLGIDGIDNIERDDESGKARIEVVIDFEKMSRFDVDFSVVDDYLKAVFTGTNVTSVRYGDNNVYFRIYLGSDKQSKNFLTLLKINNRQGRPIPLKQFVSLKKIKGEPNFNHFNGQRSVMFSGSVDDEVTTSGEVISQALKQLDLVSKYPAIQMTSEGGNKDTKKTMDSFKKAFIMAIFSIFLLLILLFNSYSQPILVLIAVPFSIIGVIWAFFLHGETLSFFAILGTLALVGVIVNDSLIMVTHLNYLKVKLASTMSVYKWVAQGAKDRLRAVVLTTLTTLAGVIPLAYGIGGTDFILQPMALSLGYGLLFGTLMTLVLLPCLYLINHELINWLKKTFG
>fig|413999.4.peg.218 Vancomycin B-type resistance protein VanW
MKNRKAKRILIFIFLLMSILFGVFYYIYKEVSGFDSVIYPGVFIEGIDLTAKTKNEAKNIIESKYSKVIVRKNITISWNDKKYNLSYAKLNPRYNIQETIDNAYSYGKNLSIFSKYKIIKSKSIQNYLLKFSYDKKAMDRFIDSIERDINKEAENAKINVNKGSISIVQDKKGFKLEKDKLKKILYSKMDGKNLKDINEKAPVKTQEAKIKKKQLETVNSNISSYTTNYGSISSPQRANNIVISTKAINGTLLMPGESFSFNNTVGPRTEKRGYQGAPVIIGNKIESGLGGGICQVSGTLYNAMLKANINATERVRHTFPSTYVPIGMDATIDYGNIDYKFKNTLTYPIYIEGITNGANVTFNIYSNSSLKNKTYNISSEIYETITPKEQYIDDASIPLGKTEIVQEAHTGYKVKVYKSTVENDSVVKKELLYTDFYKPVDKIIKRGTKK
>fig|413999.4.peg.316 Multidrug resistance ABC transporter ATP-binding and permease protein
MCAIEGKGGSRYMRTTLRIFIGARRYWIHLILALIAVIISTIAGFYNPWALRELTSIATEGSANFGGQSLRIGLMLLVATILQSAGSAISGYLNHHAALHYVADMRTELYSKLQHMGLRYFNKSRTGDLTSRVINDVMEVEILLAHIIPDFVVNILTFIGVGILLFSINVKLAFISLVTIPFIIMITLWQSKHLSPIWKQNSMIRGELSGTVQDNFSGIKEIQIFNQQEREEKRIKNLSIKHSKAYLKASFFFETTFPLLAFFTALGSVIVIIFGGFMVSRGEINIGDIVGFSMYLSMFYGPIKSFSRLMEMAGNAVAGCKRVFEVMDEVSDVQEKVNAKKLPRVKGEVEFKGISFSYNDEIKVLKNINLKVNPGETVAFVGATGVGKTTIASLLNRFYDPQSGSILMDGIDIKDVTLKSLRDNISMVLQDTFLFNGTIYENIVYGWKEATRNQVVAASKAANAHNFIENLEDGYDTIIGERGVRLSGGQKQRISIARAILRNSPILILDEATSALDTRTEKEIQAALDEISKDRTTIVIAHRLSTIYNADKIVVLEGAGIKETGTHDELIRSGGTYAMLYKSQVS
>fig|413999.4.peg.576 Multidrug resistance ABC transporter ATP-binding and permease protein
MKKILNNVWGVAKKYKGKELIGLIFTILYTVAIFISPMVSRYLIDSVIPSNSIYKLKIGILIFFGGCICQPIFGYLKNRVFMGISENITIMFREKMFNKVIDAPMEFFDGCSNGAIVSRISNDGRSVSEFITNFFVVVVKNIVLIIMIIIGMLMLSKEITLMVIFLYAIYFFINWKISRKFNPMSKSIQESYDQICIKINRSVGSINTIKAFNQEEKVKREFKEIIEKNYTNNLKFRKLSMLMNSISNGIMIASLSIVYGMGSLLVMDGKITIGTVVAMGLYFQLLVQPIYELLNSNIDIHTIVPIFNRINEYINLKTERVNKENNELSFLKEIEFKDVSFKYNNGSQAINNINFKLPSKGIFAIVGDSGAGKSSLIKLLSAFYDSYGGEIKINEKELKEYGAKDIRKVISLVSQDIELVNESIKNNIKMGRNIKDSKIKEVVKSLSLEKTIEKLELGYDTIVNERANLSGGEKQRLSIARALVKESLIYIFDEPTAALDTINEKRVKDILEELSKEKLVIIITHNLSLLNKAQCIYTIKQGEIVEEGDYEYLTKQDSYFSKLMKELSKK
>fig|413999.4.peg.823 Quinolone resistance protein
MSISNPRIPADLIMVDDFSSYAQGYLYEEIPITQIKIYGEHIEHFDFSKSEINTSIFENCTFLDCSFEGASFVDVVFQNCNLSNSNFTDAYFERCQFIACKCVGVNMIDTIFKQTSMQRSNFQYSYFDKAKMTDIAFEDIDFTEVSITEAKLKRFKAKNSHFIKNNFFKTMLTGVDFTKNELVAPTVSSPPIEFQGAKISMVQAADLIGIWGIIVDQ
>fig|413999.4.peg.981 Transcriptional activator BmrR for multidrug resistance transporter
MKDLFTIGEISKLFNINIRTLRYYDEIDLFKPIFIDKANSYRYYSTDQFEQLNTIKYLKALGMSLDTISYHLKKRSVDNIIELFEKQKKITEEKIKELELTKQKIQNRINQINYARQYHNLDVVQEIRLQERRIVLLKEKIKSNNDLELSIRHLENKANKNASIFNGKIGVSISIDKLKNKEFGEYDSIFLFTEGERYNKNLIKVLPEGTYASIRFTGTHKNSPIYYDELLKYIEEKGYTIIDDSIEITLIDFGLTTEKSEFVTEIQILINKS
>fig|413999.4.peg.1116 Permease of the drug/metabolite transporter (DMT) superfamily
MKDSRIYFLMILSTLFWGGAFIAAKLSAPFIPPFTLTFLRFLIATLVLFFIIMIKEKSIYKLKKEDIPVFLFTGIVGMVGYHIFFFKASTYTTATNSSLIAASNPIITCILSVIFLKDKLSSKGIIGIILSFTGVLLTITNGAIANILNINFNKGDILMIIAVLCWASYGVFSKKVMPRYSPMTLTFYSFLFCTLFLIPFVIYEKPLSLINKVPYYSYISILYMSIFASVIGYLVQQISIKQIGPSKTSIFVNLVPISSIVLSSMILGEKITIITLLSTALIIAGVYICQKSN
>fig|413999.4.peg.1961 Teicoplanin resistance protein vanZ
MYVAHTDYLINIIRICILCIVFQKGFYLRAKKREGGVSRKHLLWVFIFLLYLGAVYGVTGIGTIWDVQRFVTASTSKFDRIYLVPFSSSEVIMPYVLNIIMTIPLGFLLPLIWKQFRTIKKVALSGFLLSLCIELSQLFTQSRTTTTDDLIMNTLGAIIGYFIFKAFFHIILKKNSNEKDEITSSSVVIKHEAIFYLVLSFLGMFLFAI
>fig|413999.4.peg.2463 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKNIEDKQGKFEELTKTPISKLILKMAIPSIMAMLIGIAYSLADTYFISKIDTISTASVGLAFSFMSVTQAFGLLYGHGSGNYMSRMESEKNRTESSKMAIDGLVISFLTGIIIMIFGELYLNELALFLGATNSLLSSTKEYLLILLIGTPFMISALTMNNQFRLQGNPSLGAAAITSGAVINCILDPIFIFYFNLGIKGAAYATVIGEIISFIILIVVSGMRENIKFNLKNFSINKKILSELYGGGIPNFTREIFIGISLMLLNNELKIFGEEYIASFTIVNRLVLAGTYLMVGLGHGFQPVCIFNYGAKLYERVEKALKFTLRSAIIFMVFISIIFLMYSENMVMLFRNDNEIINIGSQVLSIQSITLPLIGYITITGMFLQSTHKFKEATLITSSRQGYIYIPLILIMPKMLGVKGILYVQPLSDFITFVISVVLVAKYKKELKC
>fig|413999.4.peg.2673 Teicoplanin resistance protein vanZ
MRDIVTPIIINSIIIFILSKINKKQQNKTGHITGVLFFTFIMTIVFELTGISPISGFHTDIRINEISYIPVVSTLDMVKDVFNTAHVENIPGNEVMLYLGANIFGNILMFGPLGLLLPLLWKHFRKFSKTVLFGFIVSFTIESSQLFLARGTDIDDLILNTIGTMLGYLAFVILRKLFPKFTAKFTLEDDAEKSSWSILPVICVIIPYLVIVAFGFYDRAILFAR
>fig|413999.4.peg.2677 Teicoplanin resistance protein
MKKKIINILFTVGFVFYISFLLWNIPFKYVSPLEVFSTNRYFSRILNLIPFYDIFNGNYNSLDIWGNIILFIPLGIYMNIINKNNAIYKRIYKIFAISLIFEASQYIFGIGASDITDIITNTIGGIIGIGIYMLIKRVFKENKKVKNFVTICSIVIMIPVAIILIALFIYN
>fig|413999.4.peg.2723 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKNREELINGNMFTLLLKLSIPGIIGMLVIGLYNLCDAIFVGKLVGETALAAVSISSPFTFINNCIAVLVGVGSSSILSRAIGAKDDKVVNEILANLILSVLVLSLTVTVLGCFFSENLLRFSGAKGEILQSGINYLRIVYIGSFFVNFSQSANMLIRGEGKMKEAMGIMALGAVLNIILDPIFIKTLNFGVEGAAIATVIAQIIQALVTFMYFKCNKSILSVTKLKFAFDLMPEILSVGGSAAMMQLMYLVQQTALYKLISIYGGDDQLVLMGVALRILMFTFIPIWGIGQGLQPIVGMNFGAKKYDRVKDAVKIFSIASTIFIGVLWGFYMLKPRVVLSWFINDRTIIENGYEFFRLMFLTFPVSGLIVMSMTFFQSIGKGGKSALITVLKQVILFMPIAIILTKIIGIKGTWLASSVTDAIVFVLSFVLLAIEFKKLYDINSSENQNITYIK
>fig|413999.4.peg.3512 Multidrug resistance ABC transporter ATP-binding and permease protein
MGKLRSLLKLKPFLQKYKLLLFFALIGIILGSIVAIPVPYIIGKIMDDVLIGSKSFNEFYFYIGIITILYVLKYFISITSNYLSSKFNNFMSNDLRFILIDKVMDLPMDYLANVEKGYLQGRISECDSITAIFSGTIISILLSTVNAVLSVSTMFVINYKLAIAVLILVPFFFILAKFSNHALTKNTKKMLEDSAILNAECFEIINGVEDIKILNGKAYSLGKFKKKLDQFIKITLKQNKTMLLLSQNVVGVNDVGTLLILLIAGNLIIKGEFTVGLYTTFSLYSSKIFSSTQLLANIGPSLKQACLSIERLYELIDMDDENKGKNKHLNKKIESIKLENVTFKYKNSIKNVLDSLNFEINKGEKVLISGENGTGKSTLIKLLVGLYEPTEGRILYNNLDLATINNESLRSRIGIVSQNMFLFKGTVLDNILYGQNQKKRKDVEKLIIKLNLENYISRLPEGLDSKIIQNNNGISGGQTQVIAFIRAVLSNKDIIILDEPISNVDAETRNIILNILKESKFDGILIIISHFTKGMEFINKTIKVGKK
>fig|415426.7.peg.1 Permease of the drug/metabolite transporter (DMT) superfamily
MAAGWGTAYTTASNSAFITGLNVVFVHLFQALVMRLYSVELAFSLVLAVGGLYMLTGPTGGFSFGEFLVLLSAFAWAAQVLIVSRFSGSDPFAFTFFEALTATVMIIPDMLVYGNSLDVPAQALPYLAYLGLACTDAAFVLQVYGQRGVSPATAAIIYLLEPVIAAAIAAAMLGEHMSTLQAIGAAAILASLAVAARAEARREG
>fig|415426.7.peg.249 Multidrug resistance protein
MFLRVLASGLFGRGGWRRGMGRLLWLLVAVFLYSAAAAIANVAAGLYVLDLSGSRFYLVLSVLLFNAGFAFSSLVVVHVASRRLSGHFVLAAGLVGVAAAVAGMAFARCVVVVAVLNLVYGVFAALIQPVAVSAASRVGGDVAVPRVNMASSLGIVAGDGVAALFAGSIGVQGLLIVAGFLAAAAVLPVLYGPRVQAGVRGYPSPSAPLVTGRARYTPPHVARSSLPMPACRGGVPWQVYAGTLVLFSGVALFFSPMPAYLREAGISDSGIYLLSMEALLASTVAYELLRRLELGVAVAARLLVAASASRVAVFMLPLAGFGGFAPVGAVMALVYLLVGVTWAAISTGLPLLALRLGGGEAGVGRVNAFMSFGLVVGSLVAAPLAEAYGAVATCAAASALAGLSTVFFAVASGRLAGCGNTFKASA
>fig|415426.7.peg.307 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADAGERLGRLRERVLSEENIVRLLVWLAVPLMASSSVRILYEAVDAFWLSRLGEAALGTPIVSWPYPDIVFAVAFGLSGSVSAIAGQYIGAGLYDRASRSAGTVLGLIMIVAVPGSIAIAATAPLYLDAIGVPETVKPLAEVYLAIIALGTPFSALFLFFNMLLGAAGDTRTPVKVSIAATAINAVLDPILIFVADLGVLGAALATFIASLFSASYAAYSLATGRHGFRLGIRDLIPDRSLLPLVAKVSAPLVVQRLGMTLGFMVMAGIVAGLGEVVLAAYQVGHVALSIDSIISMPLARSVGIVVAQSLGAGQTWRARKAVKTGLLLLAGFVGAYIAAIVYFAEEFARIFTSNPETVKVIVDMLHVFGPSILSFNLLTLANVVARSSGHTFFISALGIARLWFLRIPLSWLLAYQLGLGEKGLWAGMAISNHVAGGTALAWLAYGNWAKPVITQEQREHKPGHMKTQSQQQG
>fig|415426.7.peg.585 Permeases of the drug/metabolite transporter (DMT) superfamily
MTRALLGYAAAFTAGVLFGVSDVLVRAASARLSPLANLLLSLLIGTPLLWLTVAATNSFTADRSALLAYAVAGLLNFVVGRLLFYVSISAIGATSAAVASSPTVLFSALLAWVFLREPIDAERAAGLTAATLAVYLASSRPSGRPLHGEKLGLGVVAGIASSLVFASSTLLVRYAGGYSGGNPVLGTAVSYTVALPIAATLAAAAGRLKEITGLTRHHIFMASAAASVAFAQLLRYIALSIIEVAPAVILIGLYPLHTLLLAATILPGEAAEKPTARHAVAATLAVIAVALAA
>fig|415426.7.peg.623 Multidrug resistance protein B
MVYSGSSEYLVMLAAAETIPTIAGVLGAILAERLGYRPIFLLGIAEGLFLSLTGIWLHRPELLWLAALIASFSWSLAGPQILGYALTVSGLSARSLGIVLAGGTIGWSLGGAAAPILAAYVGADVVLVVSGIIVAAIYLVLGLMPQARPSRKGGKGLTRLRYFAVAIIPASLAFVGTEIVGTIYMAKLSVEMERLGYALGIALSGFIGAAVRPYAGSLVDRIGEARVLPLVLILYAGYIPLLASTHGPIFMAVWLLPLYPLFDVAIYKYAARLVGEAMGSAAVSSAYSIAGIVLLSAARLRGETSTYNALAVAAFLAAATAAAIGSRVVPERSHGEHLIRGPVERGAGG
>fig|415426.7.peg.906 Aureobasidin resistance protein Aur1
MNMWKLRLDRPYLRVLLYMVPFVLAYAGYEMARGIAFRLQSYAVYAPYVDLEVALFGVPLAVYFQFHRLLVLDIYTGIVYALHPVYFFAFAVLLAFREPKLFRRLLAAFLVASAVAITVYVLSPTAPPWIALPCIERPPNLVLKLVELVMGARIDPNPYAAMPSMHVGMAVIFGYYYVKLYGGSRRSLLVAVAWVASMSFATVYTANHYVADVAAGLALGYAASLLGDKLGGLSLH
>fig|415426.7.peg.1265 Multi-drug resistance efflux pump pmrA
MATRVIRMNVAALSLYSLFRGFSVSGYQVLFSAYMRSLGYSMTSIGGAVTVSSLAGALLAPGFGAVIECYGARLTTTLTGLMLVVSLLLLSIPEPGYAAFVASYVLYMLAFSLGQPARSTLLAKSVPGELHGYYTGVTMAVFATARIVGPLTAGWLAARAGYPQAFTVLTLSAAVGVTVFHILSMEPSEPACKNTLQKLRSAYTSALKPHKELRRLYPLLVVDRSGWSLWFPLLSAQLKAVGYTEDQIGALYTASSLLQATTSMVWGRLTDRLGPAKTVASSELLGAAALPLLANPHPWINAAAGMALIGLSIAAWVPAYNKLVAQLARGNLGEAYANANAVRSLAGTPTPTIGGIIYETLGPAALYTLSATLLTTSAAYALKTLDTKTTK
>fig|416269.5.peg.1034 Permease of the drug/metabolite transporter (DMT) superfamily
MNRYILFVLFSICCLALGGIFVKLSQFPPITTGMYRVLFSLPIFFLLSKYNKDEYKMTLSEKLIAVCAGAFLAMDLILWNISFSYTTVANANLLANLVPFTVVPVLYFIYKEKVSKAFLIGEGIILIGIFVLMGGKVNPTAENFKGDGLAILTSIFYGLFIVTVYKLRSKVSTIYLMRYASIGCLIVLLPISLLLEGVYVPYTFKDFYPLIGLALLSQILGQGGLSYCLGKIKASYASLLVLTQPIISAIYAYFIFNEHLSLKEITGIFVVLIGLYIANKKK
>fig|416591.4.peg.1388 Permease of the drug/metabolite transporter (DMT) superfamily
MVYVYLLFSLLMWSSMEVLTKPLMQQVDPFFLTFFRFLVGGIFLVIFAKKKISLKDAGVLALIGCLNGVVSMSLLQLSIKFSNASTAATLVATNPLFVSIFAFALGKEKLNFKKFVGVVVGLIGIFVLSYGKVEGDSTFGLICGVGAAITFALYTVLMKDFTLKYGSMNATAFSTLFAGIVYGAILLLAGKLDIPEVALNGWIILLYSAIFVTGLAYVTFFKAVEKLGPSRASLVFYLKPAVASFFAFLILSEPVGIFKFVGTAIIIVALFIK
>fig|416591.4.peg.1720 
MIDISIFASLAHFISDFYVSFLTPLGPYFMDKYQITAKQIAFFITAISFISSVFQIFFGIIADNVKDRFRFIYLLTATTIFLISLIDFAHSIVTLFILFLVAYFANSAFHPAGASLSHSVSERGMPIFVSAGTIGAALGPVFVTAFSYFNLKHLWIIGLPLLALLALFIKPERAKYTRPDKPKEKFHFSKISTLMDLWIMVTMRTLIMSVVHLYAPILSVQRGYSLIFGGSLLSIGIAVGVFTTVLGAWISKKIGNNLVNFASFLGMSVALFMLITSSSAFSTILSYTLIDAFGYLTMSSNVTQAQITLPNHTSFASSFVMGFAWACGTGLRFLLIMPFGDNITIVFYTTAFISIAMAIFTMTWHRIKSKKQPLRGS
>fig|419610.8.peg.1526 Permease of the drug/metabolite transporter (DMT) superfamily
MCRKWPAMPASTITSDHPALQAQAVLAGRRCMPPAGLAVQPLRKRSGSVLLLGAAILLWGANWPVMKLGLGHVSPLWFSAARFATGAACLFTWQALRGEVWWPQRRDLPRVASIGLFQMMLFTALGTVAMMHLPAGRSAILSYTTPLWVLPVAVLVFGERIERRHWAGLGLAGLGVLVLLNPHAVDWGDGQVVGANAMLVAASLAWAVCILHLRYGRASASAIQLAPWQMLLAAATLAPLAYAVEGPFTGDGTAAFWACLGFVGPVATAFCFCAVNAASARLPASATATLMMAVPVTGLALSTATLHEDPSLDLIVGALAIVLGIAASAQRSHP
>fig|419665.8.peg.1248 Multiple antibiotic resistance protein MarC
MILYFPTRGRNMAVGYSFFSFFIYSFTSIFIIMNPIGLVPLFYIWTSESEKTEKIELLRKSAIAVMLTLLTFALFGGSIFKFFGITLDSFKVAGGILMLKIAWDMLHAQVSKTRHNLKDDEEPISLEDIAVVPMAIPLLAGPGTITTSIILMEHSITTYDTLIIMFSIILATLISVVILYLSDNIARILRVSGIKAIVRIMGLILAAISIEIISSGVFGLIKSAGLMY
>fig|420246.5.peg.393 Permease of the drug/metabolite transporter (DMT) superfamily
MKKLSGQYLYIFLLVTIILLWSYGWVLTKMGLSYMGPFTFAALRFLLASLTMIIILFFLKTPRPKGKEWMILFIIGLLQTTAMFLFINYGMMFVNVSKSSILIYSMPIWSGILGYLFLHESLNYYKVVSLILGISGLVSIIGVDFFAVQNKSSIFGECFLLLAAISWAGANIIVKKYFSNHNKIVVSTWQMIFGTIGVVVAAILMEWGQPIQFTTMSMFILIYTGVIASSFCFTCWYVVLTKLDTTVASISLLFVPIVAIFLDWLLLNEKMTVNIAIGALLITIGVYLATVAKPKKKSIKRFSTEIKS
>fig|420246.5.peg.1132 Drug resistance transporter, EmrB/QacA family
MNSRLSVMVSIVLAMLVASMDTTIMNTTMPIIAKELEGFSLYAWTFASYMITTTVLSPIAGRLSDLFGRKKVFSFGIILFLIGSLLCGLSQNMVQLVLFRALQGVGAGFMMPFPAIIAGDLFPVEKRGKIQAFFTAMWGLSAVLAPLLGSLFVEYATWRWIFYVNIPICVLSLLTLLPYKEVYEPKRAAIDYVGAALFATAISLLLLVTVVEQGQWWYGAAGVLLLVIFYYFEKRQPSPLVPLSLVHHRTLKWMNINGFVSCVALFGTSSYIPLFLQNVAHLSVFMSGVALLGSSVGWMIAAVPAGKWILRYGYRSLLIIGNVLLVASGLFLALLNESHGFWYVFFIMFLQGLSFGLTSTVGVIGSQQLADAHEKGIATSFFMFCRNIGTAIGVTVMGAFLAQASTFMAGIRHLFLFGLIGSIIAMITSLFIRDETEADRNNQQSEGMA
>fig|420246.5.peg.1258 Permease of the drug/metabolite transporter (DMT) superfamily
MKEKLFLVLANLFWAGNYVVGKAVITETGPFWLTLIRWCAAFIILVPVSYWLERPRYWDVMKQYWLPLVASGALGIIGYNLLLYGALAYTSSMNAAIVNSLNPAIIVVLSYMLLRERLSTVNIIGFLLSLIGVLFILTDGHIGHIFQTNYNRGDLMMLAAGVVWALYSIIGKKLPVPPITATACSVFFSLIILWPFAMLYPFPSDQLSAAGFAGITYICLFPSVLSFLFWNVSVQKVGPSHAGVYLNLIAVFTALITFLLGGTLSVSQLAGGAFVLFGVYLATKAKSKQTDITG
>fig|420246.5.peg.1900 Drug resistance transporter, EmrB/QacA family
MSDSGLARRFLFWAWRRFIIFPKRSGGAASSTSSFVRSLGMTVGITVFGIIQRNLFTNQLAEQFSGMAQAGFGGAAHDPRAILSPEARAYIPAPVLDRLTEALASSIADTFLWALIPAALTVVCVLLMSNERLAIPSKDERVEVIENASSPR
>fig|420246.5.peg.1941 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MIRVKRLDHVQICIPFGAEDEARAFYTGVLGFKEIEKPESLKANGGLWYKVGDIELHIGTENRDGYNSKSHPAFEVEDVEAARRYLEARGVVTQDEKPIPGVKRFSFRDPFHNRIELLEKG
>fig|420246.5.peg.2466 Vancomycin B-type resistance protein VanW
MEKATPWKLFAVMAVCTIYFITFSHFGTFAYNALIPDDGRLSAGTAVGPVSLANMTVPEAHEAVTSRVNQWKATASIPLRYQEKQIDLSADVFTFRLEESMKRLIDGKHTPLFVIMDLEKCLKAVEAVVPLAPLEALDVKRLGEDLEKRAAQLQSPSSPIDLAGYISFPDGNEPVVSEAAVPLSDAAAALWLSTERRATIKAGQLFSLDDWLKKEKADFSDGAADLIASAVYQAVLKTNFAIAERYTSRTLPDGVTPGFEAAISNGRDLEWLNPNTTDYTLWLRYDGQSVHAEISGLPFVYQYIIRTGEAVNIEPRTVVQYDARLAPGDKQTKQMGRLGLFVEVTREVRDGPRLVRKETVSEDFYPPTYTIEVRGLEIPKSSVEPSSDEEGESGESTESENGESMESPNPTATENSEENTRDKPVPKEGDEADSRENAPTASGKGETEASGGGEK
>fig|420247.6.peg.1430 Efflux pump antibiotic resistance protein
MFFMNANKKRDFIVITVASLATFYGAYMGNVTPVALPKMAEIFGLSNIMQNWVTNIFLLTMGVLAIPLGKLCSRYGVKKTFIYSVILMLIGSIGTPLSHTIPELLIFRVIQGIGGAGLCVDSMLIIAEAISPEKRGQALGITVSCTYIGIALAPVLGGSLTYNFGWESIFWVMIPFILLNLILLFTIKEEWFKYQNEKFDLKGSIVFAIGILLLIYGFSIFNTTIGFIITVAGVLLLILFGKIELNSKYPAYDIKLYKNKKFLSSNIASILSYIATFVVTTIVNYNFQYVRGFDSQLSGLILITFPLLMAIVAPAAGKLSDRIDPQKIATIGMIIVTVGLILLVPLDKDTSIVIVLVSLALQGIGYGLFASPNINTIMSSVPPKDTPMASSAVATMRILGQTLSTGILTVIFAIMMGNVIIQPSNYPQLISCSQITLLIITVISALCFIVCHIGYKSKDKLYF
>fig|426355.14.peg.105 Drug resistance transporter, Bcr/CflA family
MTIAIRPVPPVQDVRAPRPWSGPGFAEFVAIIALMMAVTAISIDNLLPAFPAIEARFAVPDPNRLQLLVYVYMIGFGFAQIVYGPVSDALGRRPVLLASLAIYVVGCGLAMVAPSFGWLLAARIIQGIGAAGGRVLSVAIVRDRFAGREMASVMSLTMMVFLIVPMIAPAIGGMMLALGSWVYVFVSMLVLAFWLTLWFSLRMPETLHPEYRRPLSPAATWEAIRLTLKTRVAVGYATALGLMTGCIMGYVGSAQQVFDTGLYHLGPLFPLAFGLVAGAMGAATLINARVVRRLGMRAMSHSGVIAFTLVGLVQVGVGLAYRGHPPLALFLSILAVNQFLISFAMPNFNALALEPLGAIAGTASSFLGFYTTILGALCGFLIGQSFDGTVLPVAIGYASLGALALLVVAWTERGRLFRGGVGG
>fig|426355.14.peg.1648 Membrane fusion component of tripartite multidrug resistance system
MDARRSDSFKSADPVAGAPVSPPATAAVTPPVSTPVPAPVSPPAPRRRRARTVLPLLGLLALGGAGTYGWHWWTVGRFLEVTDDAYLQSDKVTVAPRIAGTVAAVLVGDNQPVKAGEVIARLDDRSYRVQLKQAEAEVEKDRAQILGVASAIVQQRAQVASSRADLANAEAALTFAQQEYTRYQNLLQTGSGTVQRQQQADADLRQRHAARDKAAASLDAAQKQIDSLKALEASTRASLEGAQAKVEGVRLDLSYTTIVAPIDGVAGDRALRIGQVVSAGTGLLTLVPMGRDIYLVANFKETQTGRMVEGQHVTFTVDAFGDHEFQGRVESFSPGTGSQFALLPPENATGNFTKVVQRVPVRVALDPSDPLIARLRPGLSVEATVHTADPVEPVDPARRRPRPAPALVSEALPR
>fig|426355.14.peg.3727 Multidrug resistance transporter, Bcr/CflA family
MAERRAPLPLLVAVTMTGTVALHIFVPALAAAAVDLGTNAAGAQLTITVYLIGLAGGQLLYGPLSDRYGRRPILIGGLGLYLAGLLLAIPAPNIGVLLVARVLQSLGACGSLVIGRAMVRDVSTREDAARKLAILTTAMTLTPALAPAIGGVVNEAFGWRAVFVVLAGLVAVLGALVVFTLPETNRHKVALPGFVAVLSGYLRLVRVPVFRAYLVAGACGGTSLYAFLAVAPFLLVDRLGRSSQEVGFDCLIVVFGMVGGAVLASRLAARVPIRKAARSGNLLCIGAALSLLLVDRTGMLGVVSLIVPLFAYAVGVGLLSPNAVAGLMNVDPHAAGSASSLYGFTQMTFGALFTVAASAWPATSATPVALALLAAGLIAALALRRA
>fig|426355.14.peg.4496 Fosmidomycin resistance protein
MSVASDLTASSEPVSLPDARRTLVATGVNHALHDGYTDLIYVLLPVWQAEFGLDYVALAFLRSLYNGALAALQMPASRLAQAWGARTVLVLGTVLSAVGYAIAGASGGLVGLGIGLLLGGAGSSTQHPLASAVIARAYGPGARGPLGTYNFTGDLGKAAVPPLVGLLLTLTGWRHALWVIAGVGILVALAVARLLPREPASRTGVAAARPAPHRAATGPGRGTGFRLLVAIGMLDNAARPAFLLYLPFLLQEKGAALTTVGLALSLVFVGGALGKAVCGRLGEHLGVTRTVILTETGTALAILAVIGLPLAPGLILLPLLGVMLNGTSSVLYGTVPELAPGGQVERAFAVFYTWTLGGSALAAPLLYGRLGDAAGPHWAAAAAAGTALAVVPLMLALAPRLGTERQRA
>fig|426355.14.peg.4927 Membrane fusion component of tripartite multidrug resistance system
MAANPRSSLRDWQPPPAYNVAATLLALAAAVGLAYLAFLYYAYTPWTRDGRVRVYTVQVAPEVSGTVVAVRVRDNQFVRKGDVLFEIDPGTFRNAVTQAEGALASARAQAGYLAGIARRTADLDDLATTPEQKQTTSGQAQAAQASVVQAEGALAQARLNLERTTLRATVNGWVTNLLLQEGGFAATGQPALTLVNGDSFWIEGYFEETQLPRIGEGDAARVSLMAWPDRPIRGRVTGLGRGISVADAAPGVQGLPTVNPIFTWVRLAQRVPIRVELDDVPCPIVLAAGMTANVAILAEKAGPPDALPPDRRTGAAAGRRCDGAPVVESRR
>fig|426355.14.peg.5304 Outer membrane component of tripartite multidrug resistance system
MITAGLLGLAGCTVGPDFAPLATPLADAGDYLDTGLVAPTPRRLLARTIDAEPDVAWWLAFRDPVLAQLEDRLAAQNLDVQTTTARLFQSRSQINTAAAAGLPTLNGQGSAYRQQFSKNGTIGLLSNSLGSLTGGSSGASSGNLTAPLTNGFESYTLGFDASWELDLWGKVRRSVESAEAQADASAEARRDALISGQAELARAYVQLRGTQELIRIDLANIRVNEQILDVVRVRQQKGLVTGLDTSSAAQQVEAIKAQLPQLQQQEIQQINAISLLLGEPPLALSQELVAGPSIPPVPPRIPIGVPSSLVMRRPDIRRAEANLHSAVAEIGVAEAQFFPSVTLTGSPTVNSVDPGKLFRGSSLQYMNIGPSISIPLFEGGRLKSNLVLQRARQQEAAIAYQKAVLQGWHDVVNALAALRGDEARRARLARQVADARQALALSRARYVQGVEIFTTVLQASQTVLQAETSLSQATAAISTDFVALSKALGGGWETTFPVGRTPPLSLAKVGIPLTDVVHDGALGR
>fig|426368.9.peg.1224 Permease of the drug/metabolite transporter (DMT) superfamily
MKKLLKKYELFLLMIPAVSFGAGAFITGKIGILELSWDELTFLRFLIASVIILPLVLKTERKNLKLNKSDAYLVILAGLLGMFGYHALFFMSLEYITAINSALLMATTPMITSIIAAFVLGEYFGIKRIFAVIIAFFGVLLTITNGNLEVLKSLSFNIGDVIMFSAVLCMALYAVISKKVAQNYSPSVILTYGYILTVVLLIPYMILKNPVNAILNASFETWLSIIYMAVFASVLAQLLQQISLKYYGASKTMLFYQFVPLIVIVLSAIFLKEPFTKITVISTLFIMTGVYINSTIKKD
>fig|428406.5.peg.3692 Bacteriocin resistance protein, putative
MGRVMLCLFCAGSLWATQASAQEGAIALRADSEMPLNKPVKSMAELRYRSVMRQQQDFSCGAAAVGTLLRYGYGLDIDERRVIADMMKVSDPKQVAEQGFSMLDMRNYVQTLGFRGRGYRVDMAALRDLAIPVIVLLSLNGYQHFVVVKRAAQGRVFIADPALGNRIMQEWEFAPAWNGLVFAIVGDVSVQADSGLLQTNAPSLRARENAAFSGGMLPIQMEFGPARWDLF
>fig|428406.5.peg.4053 Glyoxalase/bleomycin resistance protein/dioxygenase
MCGSPAVARQLPTKEIRTIDHTGVVVSDFEARRRFYEQALGAVGLAKVLEFLAAVTDHADVAGLRPPGTAAW
>fig|428406.5.peg.4417 Outer membrane component of tripartite multidrug resistance system
MIVSLAGCSLAPTYERPALDVPAHWQTEAPWRAAQPADAAPKGPWWQRFNDPQLDKLITQALAHNQSLKVALSNLEQAQAQTRVARASLLPTITANNNDSRTRTSSERPLSSYTSPTMSTIQSDLVLRADASYEADLFGRVRNTVANAAASEEQAGANFENFRLLLAAQVATTWYNLRETDAEIAVVQEGLALQRKALDFVTSRHQDGVASGLDLAQQQALVDSTATQAELLTKQRAQYEHALATLVGTPAPAFHIDPTPLKGTAPQIPVALPSDVIERRPDVAAAERGAAAANAQVGVARAAFFPSVMLNGGAGWESRDLALLFSAPTLLWSFGTQIAQTVFDAGRTRGRVDIANAAYQGAIANYRQTVLGALQEVEDGLAGLQSLDRAANQARHAVESARKVYDIASVRYEGGLATSLDVITAQQSLLNNQRTAVQILGQQMTTSVFLVKAVGGDWNQAAAAPTAAR
>fig|429009.3.peg.97 
MPKPKAAFVAVLLFFLLTIGGIGFYYWYQNAHYVTTEDAYVDGPMWRLGPSVAGKITSVPVKEGDQVEPGQEILRLDNRSLPPGADPDLAIVRSPVKGVVLKVSARPGEVVGAGQPVVLVGDPRQFYITANVDESKIWRVHHGQRVEVRIDALPGRVFEGRIAEINTAVASTFSLIPTRSTSGSFVKVSQRVPVKIYLLDAKGVDLRLGESAEVKIFARE
>fig|429009.3.peg.98 Membrane component of multidrug resistance system
MEKERALPWGSLGVLVLGTFMGVLDSSIVNVALPHLMALFSATEDQIQWVMTIYLLVGGMVIPAAGFLGDRFGYKKAYLGSVLAFVLASALCGLSWNTTSIIVARAIQALGGGMVIPLSMAYLFRIWPREKIGVATGLWGMTITVAPAIGPTLGGYLVDYVSWHWIFYINLPIGIFTVLWGWLALKETPIQEDLKLDWLGLFLIAGSAFSLLLALSKGQDWGWTSPSIVFLVVGALFGTLLFILWELSVPNPVLDVRLILNPTFMASLVASNLTSVALFVGIFLVPLFCQNIQGYSAMQTGLILMPAALTTAFFMPIAGKLFDTVGAVFPGLLGMGIVAAVTHALIHLTADMPIHHLQILLCIRNAGLALAMMPLMTAGINTIPTARTGQATAIASVTRQVAASFGIALVSYVLTNRTVFHAERLAEEVSLINPLGYHYYTQLKGLVAGMGGGDGLVQTLLSGIVQKQAMVLAMGDAFWVAMWLVFLAFPFIPWLTPRRVKEELKRQEERLKREEVSLGSSSNL
>fig|429009.3.peg.765 Permease of the drug/metabolite transporter (DMT) superfamily
MSGSFSTWLFAALAVILGSLGQVFLKMGAGHDLLRSLADRHTLLGVLLYGGSFLCWLKVLAAWPLSRAYPVLALNFGLVALLSALVLGEDLGAARVLGTVLCAVGVVLVSLGS
>fig|429009.3.peg.1067 Membrane component of multidrug resistance system
MTATLDVVPPELNNQATSILNMLRQVGSSFGIALMSTVAQTHQETHFVHLAEKFTYNYPMLLELLTQLSWTSIGPHDSSVVWALIAAQLQLQAFVYALDDAFVLAVIFGVLAALGVIVLCCFRKVGPGKTKQEEGTNGAHFNQAFTHF
>fig|429009.3.peg.1442 Vancomycin B-type resistance protein VanW
MRRAVWVGAGIFFLLLLATAQLTYYDKTGCPAGTIPAGVYIDGHYVGGKTAGEVAAWLNRREKDLLARTVKVECASREWRVPLAELGVKLDRSVLEEALAVGHRGWLGQRLWERWRVGREGLHLPLKFSVDRQRLVSTLQDLTRELTVPPQNAAFRVLPDDTITIIPSREGKCADVEVAYPQLLAILNEGREPVIKLPLKPIPPAHTTEDVKNMGLDCLLAQFTTKFDPSNANRVYNISVAATAFNGLLVAPGEVVSFNRVVGPRSTKAGYKEAPTIIEDRFVDTVGGGVCQVSTTLYNAVLLAGLKVVERYAHSLPVGYVPLGRDATVSYGGFDFKFQNNTNKYLYLRTLVGPDFLTVKIYGNHNFKRRVEIRTWVTEEIPFKVVRKEDPDLEKGKEIVKQKGQKGYRVSAERIVWEGGKARREVLPSSYYKPVDEIVVVGTKAVPRLVVPERSEGKVSDENPPASTEVPASS
>fig|429009.3.peg.1606 Multidrug resistance protein
MKRQGAWLLAGVPFVMVLGNSMLIPVLPSLKKALGMSTFQTGLVISLFSLAAGLSIPWAGLLADRVGRRRVLLPALALYALGGLGAGFSCFLSSALAPILLLLSRAVQGVGAAGTAPVAMVMVGDLFQGGKRSRALGIFEASNGLGKILSPLLGAAAGLLGFFWPFFLFPCFVFPLLVLLWWLVPEPESRPKAVSSQTYWEILKSIGRQKGVWLASIFLAGLTTLLTLFGFLFFLSEHFETAWRIKGLLKGTLLALPTGCTCLAAFLTGKLIKPRSRLPRLFALSGMFLMALFFAGLIFFQQFWPLVALSGLAGIGAGATLTSLNTLATSSAGPQARGLVTSLYGGVRFLGAASGPSLFSLLVPHSLPLTFGLTAALCLLSALVLFLVKPEATGPHP
>fig|431943.4.peg.94 Teicoplanin resistance protein vanZ
MNLMFIIIVSITCFISTLPFLIPYHILLTSQSKKIGYKLSIGHIIIVYIFVYYLTVVLSFTGIPSISDIVDNSFGIITPKGFDFPLGEINLIPFRWITEGVRPYIENILLFIPLGFMLPCIWKKYEVLWKTTLSGITLSLIIELSQLFNRRITDIDDLLMNALGALIGWVFFRLLKEYLSKLQYKLSVQNTNIERIPLLLCEEARFYMASAFAGMLFVFYPFLISSLQFVLKIKVNI
>fig|431943.4.peg.723 Permease of the drug/metabolite transporter (DMT) superfamily
MKISKIINKAIIADLSLLFAAMLWGGGYTATKNALNNVTPFYMMAIRFLCAGILISAIFFKIVIKTSIEDVVRGFVIGIFLFLAFATQTIGLNYTTASKQSFLTSVYVIILPFIYWKIFKTKPKLNVLVSALVSLIGIFMLSLKPGMHLDMTIGDWLTLLSAVLFASHIISIACFARKSNPIILSVLQMFSAGILSIIFAVIFEPNLNKIPRNALFSLSYLIIFSTMVAFLIQNIAQKYTNPNHVGILLSLESVFGAIFSVIFLKEIFTLNMVLGASIIFLSVIIAEMDFNISSNK
>fig|431943.4.peg.804 Permease of the drug/metabolite transporter (DMT) superfamily
MKKEEVNNFMDYKRKSIMSSIALGLIALLWGTSYAIIKDILSDIRPFTLMSLRFGISTIFLCVIFPKKLRNIRKKDILHGSIIGIFLFLAFLNLVTGIFYTTASKQSFLVGSYVLIVPFLGWIIYKKPPNIYSVFGAVLAVFGIGLLTLNGSFYINKGDSISILCSLSFACHMIAIEYFNKDSDPIVSTIIQFLVTSILFIILTGIFESFTIYLSSKVLKSIAYLTIFTTVIPFVVQNIAQKYISSTSTALILTLESAFGGIFAVILLNEILSFQMLIGCVLIFTGIIIQTTRLAFLKKMKISCKN
>fig|431943.4.peg.968 Permease of the drug/metabolite transporter (DMT) superfamily
MKLIIKLFKAKKFNAYINLALCVLLWGSIPVATKKILVELDNLQTLFYSTILSTLVLGLILISQKKTGDLKKYNKNQYGSMIFLGFLGNYMYYVFLYGALSRTTASEGFILSYTWPILVLILSFIILKDKITLQKLVGILISFLGIIIITTKGNISAFNLTNLQGDILALIR
>fig|431943.4.peg.1538 Efflux pump antibiotic resistance protein
MKKKEITSNNFKEVVNMERSNSQTRITLVIVMITSFITPFISNAINLAIPSIGIEFGGNQNLLNWVVCGFLLSSAAFLLPFGRLADQFGRKKIFLIGMIFLAASSLACALATSLVALVYFRILQGIASAMIFSNSMAILTSVVPPESRGKALGLNAAATYIGLSCGPVLGGLITSVFTWRGVFYFNLLIALIIIVMTVWKLKGEWIGIATKFDIWGIILCIAAQVLLLFGLTALTNGLLYQVSFAVGILLLIVFFLYEKNHSNPLIPIESIIKNRPFVFSNLATLINYSATFALSFMLSLYLQTALKIDTATSGLILLVQPIIMAVLSPVTGTLSDKIKPAVLASLGMGISALGLFFFIFLSTQTPIVMIILNLAFIGLGFALFSSPNTNAIMSSVDRTLYGVASSIMGNMRLLGQSISIAIISLITSILMRNLSIGSAGYVDQLMLSLRTAFIIFVVLCVLGVLASLARGEVNREAEEN
>fig|431943.4.peg.1725 Teicoplanin resistance protein vanZ
MFITIIKALVYEYLCVIFFCVIFQIIMIKKEHKNGHRYSLNHFVWVYIFYIYITLVLICTGIGTIYEFTRYTKLHETISILTQFNLIPFNSISGGIMTHLANIIMFIPLGFLLPFIWRQFKSPWKVIGTALLFSLIIELSQLLNMRSTDIDDLIMNTIGAFLGWTIYSLLKKLFKNRHEKEFNNSDKTQLSFLAHYEACFYLILSFAGVFLLYNPLLF
>fig|431943.4.peg.1766 Lincomycin resistance protein lmrB
MHFILTSLNIIRSVDFVKTEIIKFEETKKKKEYNVKVIMAVLLFGGFLSLFNETILNVALSKLMAEMNVTAITIQWLATGYMLIVAISVPTSAFLIHTFTTKRLYLGAMTLFLTGTVLAVFSTSFPMLLFARMVQATGTGILAPIMINTALAINPREKHGFVMGICTCIILVGPSLGPIVSGTLLQFFNWKSLFIILIPMIIICMIGGALYLKSAIDLTKPKIDYLSVLLSIIGFAGIVYGISIIGSNSNMLNIILIFTVGIIALILFSKRQLSLQQPMLDIRVFKHPYFTLGAILVIVIQMVQFSMNMVLPMLLENGLKLSSLMSALVLFPAVLVCSIMTTISGKIYDKVGGKTLIPLGILIMCIFLEILSRIQPSTSIITIAILNIFLYFGISLAWSPNQSNALNQIPMRNQADGVAILNTFIQLGAAFGTPLFIGLMSAGQKGYLNNIGNLNDPKSQVQALYSGFSYSITVAAMIIAIVFILSLSLRHKTKKYS
>fig|431943.4.peg.2252 Fosmidomycin resistance protein
MNRFYGNLLTFGHFVADFYQGALPALLPFLVSDKHFSYAAAAFLIFSANVSSSIIQPLFGICSDKISVPWTLPLGVLLAGISFGMSGVVDNYWVMAVFIALSGVGIASFHPEGVKLANTFAGENKATGVSRFAAGGNIGFAVSPIITTEVLLLFGLKGTIILSLPALIMCIIFLIQLPKLTKNKAQVTVKREVQAKNTADEWKPFSRLTATLTCRAMIFFGLNAFLPLYWIHVLNQSKRGGSIALSTLIIVGAVGTLIAGRMADKFGNRKVIMTGFLTLIPLLFVFINVRNVILATLLLIPIGLSLYAPYSPMVVLGQKYLPNHMGLASGVTLGLAVTMGGVISPVLGWISDNYGIHTALSSLTILPIIAVFLTLTLTIPKVDLNRDSVNKVKFNVTRSGN
>fig|431943.4.peg.2305 Bicyclomycin resistance protein
MVLKFTDWKGIFIVLGIIGTILFLATLLYFKETLTIDYSQENDPKVIFTALKSLISDKIFMSYALVQGLVTGAMFCYISGSSFVLQNMFSLSAQGFSLVFAINGIGIVFMSQAAGRLSYRLGEKLLLQIGLSIAVFGSIALFISLFLPKHLLAVTIPLFFIVSMVGMVNPPAFSLAMQNQKKWAGSASAILGLGMNLIGGLLSPLVGIRGNQTYVPMALLILICNIGAFLIFYLYLNRQIPYNSSNGI
>fig|431943.4.peg.2544 Multidrug resistance protein B
MLSYSKEKRYIMKVWKRNLIVCWFGMFVTSVGMSQIAPVLPLYIKHLGISNTALIEQFSGIAFGITFIISAVFSPVWGHAADKFGRKPMLLRASLGMAIVIFSMGFAQNVYELIILRVLQGIITGYSTACITLIATQTDREHAGWALGTLSTSSIAGSLLGPMIGGYIEENFSLQNVFFITGVLMLITFTTTALFVRESFTREDKKVSSIKEIWSIIPNKSLTIIMFVTSFILTLALYSIEPIITVYIAQLSRNSNHVALLAGMAFSVSGLANIIAAPRLGKLSDKIGAQKVILVALVAAGIIFIPQAFVKNPWQLMGLRFLLGLAMGGLNPSVNVLVKRITPDSLTGRVFGFNISAQYLGIFGGSILGGQVAAYLGIRYIFFITSTLLLLNAVWVYFKVYKRLSLN
>fig|431943.4.peg.3661 Permease of the drug/metabolite transporter (DMT) superfamily
MELPFLLTAPIFYKKLCNIDKKTLLYGTILGLALFCVLSTLMFGLKTTSASSAGFLAGTTVVFVPLLQIIIHRKRPTLPITAGVILTIVGIALLTIDSTFQLDTKSLLCVLAAFIYAGQILLTSHFSKMVDPLALGVLQLEFAGIFGLLFSFIFEQPRLPNNSVEWIAVLSLSVICSAFGFVLQPVAQKYTTPERTGILFSLEPVFSAIFGFAFLDEILKIQGYFGAIFVLAGIIISDIDKKVSLKTNYQRGILNKR
>fig|431947.6.peg.6 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSQQIQALESEKIPKLLFHYALPAVVGTAVNSLYNIVDRIFIGNGVSEYALSGLAITFPILIFLMAFGMLVGAGASVRVSILLGRKDIKEAEHTLANAIFLTFFTQALTIIPCYIFMEPLLRLFGASERTLPYAMEYLQYVVPANIFSALSFGYNAIMRASGYPRKAMITMIIGAMTNVVLDYIFIYPLGMGISGAAIATVISMIVCSVYVLSHFFRKDSIVRFHRSAFRLSLPVIGGITAIGVAPFAMHLTGSLVNIIMNRSFVSYGETADATDLAIGAFGIINGYAMLFFMIIIGVAQGMQPIVGFNYGAKNPGRVKSAYRYSCGVNLLVSFLGFALAMLMPRTIVSLFTNSEQMIELSASALRTALIGLSLVGFQVTTTQFFQSIGFSHKAIFLSLTRQIIFLIPCLLIIPRFMGLDGVWWSLPISDLASVVLSFVLITIQMKHFNQSKKTTFAE
>fig|431947.6.peg.326 Multiple antibiotic resistance protein MarC
MDFLDKVLQDLSLIDLKEIIGSFVILFVAIDIIGAIPVVLSLKDRGQSFHSGKATTFSCVMMLAFLFIGEPMLNFFGVDVSSFSVAGAIVLFVMAVEMIFGVQIFKDDGPAGSATIVPLVFPLFAGAATFTTILTLRADGIAMTNIAIAILINVAMIYLMLRFVNQLERFFGKGGIYILRKFFGVILLAISVKFFTGNIVKIIETMNEALQK
>fig|431947.6.peg.1518 Drug efflux protein
MGNLLPVKLHPDHSMPELTISFSMPKASASLVESELSSPLEKVLSGIAGLTGITSHSSDGMGVIRLSFDKYVDIERARFEASTRIRLIRSELPHTAGYPTIRTGRTSDQDAKTVLSYSIGAPHASSDIETEVERHILPLLREVDDIGDIILTGGRKQEYLLAYDPEQIRILGISPDDIATAIGSHFRNDFIGLAGIPDSVGGENHIRIRLSEEANNVFDLSRIFIPAKDKSLIPISRLLTIRQKEIPRREYYRVNGLNSIYLRVLSSSSANQIALSKQIGRIMDDVGRELPEGYRITKLFDSAESISLELNNILVRSGITILLLLLFTLITTRNVRYMATVTISLIANVAIAFAFYYLFGLEIQLYTLAAITISLSFIIDNSIVMIEHLLRRGDRSAITAILAATLTTVSAMIIVFFLPEAQQKNLGDFARVIIINLCVSIIVALFLVPSLFERLSFSSRRTGRSPHKMVVTIRLLSFYSTLSSFLYRRRRWVFIGFAFLFGLPLFLLPKEIEGDTDLARLYNNTIGSTAYRKIRPYTDVALGGTLRPFLMQISSGSEKKWEKPVIHVNVQMPVGSTADATNEYVTKLERFLAQAKGISYFETSVTGERAASIGIHFKDSHARGNYPYDLHQGLVGRILSIGGGYCRTYGLENVSFSNIREKEYGSNAIKLTGYNYDALLAQARLEAIRLSAKAAIRNVSIASNRYSLSEEQELHLSPYEGSHAFLGISPHDLVAAVNEQSRTEQPLPEIIIDGQPVQLAMAARTHHAGSKWMLENSPLYVGGKTIKLKDYGEMQVVLQPQAIVRENKNYVLYVLYNHMGTIRQSQAFIEKEIQRLNAELPIGYKAMEPEYKEWENERGKLVWALIGIIVLIFFITSILFDSLYYTWVVLSIIPISFIGIFIVFSVFRLPFEEGGFAAMILLCGITVNASIYLINDYLHRRRKHPSISPLDAYRRAVHNKTFAILLTVISTVLGFVPFVVDKGASLFWHSLSMGVIFGLLFSTLMLFLILPCFLGRD
>fig|434923.3.peg.138 Drug resistance transporter, Bcr/CflA family
MSSSKLLFFVIALAACLTQFAADIYAPSLPAVALSLNTTIDLAQWSMAIYLFGVALILLIYGPLSDAVGRKQPMVIRLCIMAAGSVVAMLAPNIKLLILGRFIQGCGAGACAGLWRSIFRDVFTGEELAKYGSYFAILVMFIVPLAPALGGFLQHYFDWRANFVFMTIYTLFALLTVAFGFKETSRHHHLENLRLPYVINTFRRLVKSPIFMGITVSTFLSYGAFFAWITSGSVLLIHVLGMSPLTYGLFVFFGGGIAYALAGFLNGRLVSRFSMPTMMRFGWSVMVLSGILMALGKLADINVWVIAIPIILFYFGSTFIWPNAFATAFTPFGDIAGYAGALYGFMQLSGGAVIGSLMAYLPHADQLPLALVIIGTSLLAWIIYERVVVKHQQ
>fig|434923.3.peg.663 Permease of the drug/metabolite transporter (DMT) superfamily
MKLSVRAHLALFFITLLWGLTFPLIKDALGSISPSLFVVLRTSVASLILLPVIFLQRKKTTFTMIKWTLVLGFFQSATYVFQSIGLESISSADSAFITALSVVVVPFLALIFLKSKPRWFDFVTALLCLGGIFILTGANIFNMKGGDFWTLGCAVAYALYIVTLQAFSKKLKPEDTILALSYQILFSLIFPLLTAFYKTTASIFSWPVIIAVLFCAIFATGLVFYLQLRYQRYIPVSRAVLIYAFEPIFAALFGYLLNGEAIYLNTVIGGFLILVSFVLSELFPSKKSSQDNNPLSETYASESKS
>fig|434923.3.peg.717 Drug resistance MFS transporter, drug:H+ antiporter-1 (14 Spanner) (DHA2) family
MASGISNGIRQLGRVLGVAMIGSVISNIEHSRLIHSHLDTTGKLSQVSDQQLTHLLSNPAAAKHFLSGLSLSEINHIHLALKSVFTFAFSMGMILAGFLLILTLGISFFLPNKPLRLLWDEKSKLV
>fig|434923.3.peg.758 Drug resistance transporter EmrB/QacA subfamily
MKSYYLEGNPLRKWLVLTAVCLAVFTITVNTTAVMNALLAMSNELHLTPIALQWIVNAYMLACASFIVVGGQLGDLFGRRNMFFVGAGFFIISSLIIALGHHPTTLIVGRALQGLSAAIVVPMTLAITKFAFLNEKESFAIALWTGAVGLGFAFGPVISGIFSTYLSWRYIFWANIPLMFIAIIMARLFARKSRGAREDIRLDLWGLAFLAFGLITLTLGLVEGNVWGWSSLKTLILLIAGVFLLLVFWFLEHHVRSPLVHFSHFRKRLFIAGNIGIAASLFTMMGMLYFFNTFIQNPFLLHYSALRAGIAILPISVSIFLLSLVASTITKHWGYRLPMALGLVLIAIGTFILHNVTIYTTYYALWFPLLLTGLGLGLVFPNSPSLGMQALPKEKLGEGAGIINTINYYSGILCVAIGTLISILLGREKFYQSIAPTELPSITLSQIDRAVFGHQGNLQQILSSLSDSTQNQLIHAIQLSTVKSFTAVMLMCFTMTIIGLIGICFFARSKT
>fig|434923.3.peg.822 Drug resistance transporter, Bcr/CflA family
MSVPSIRKTVWTLAPMAMALALAMDVYVPAVPHMATLFHVSAGQMQLTLSLFMFTCGIVQLVIGPLSDQYGRRRVSFFSIVIFSIGSILCATAHSVPELIVYRIIQAIGAVGMMVCGFAIVRDRYHGEKSGKTYSYLNGIIAFSPMFAPFVGSYLDVHLGWQSTFLILLLISLWAFLSLFFSLPESLPRNKRIKVDRRIFHEYKTIFTNRVFLNYTLSTAMGLSYLFIFCSISPYIIIQLLRIPELNYGYYFAFMGISFFVGSLLSGYFVGKIGIYKTVVVGFFISLIGGTIMALWYFITGLTINNFIWPMLLIGIGGTFGLGAGSGGAMEPFGDTAGAAAALSGSFRFLFSAILGMVVINKNISSTLPLALPAVLFSLVGLILFLSQRKGLIIIHRK
>fig|434923.3.peg.969 Acriflavin resistance protein
MPGADPETMATSVATPLEKELSTISGIESMSSVSSSGSTKIIMQFALTRNIDSAAQDVQSALLQVARRLQSQMPDPPTIRKMNPADSPVLYLALSADHLSMTKLDDFAENYLAPNLSMLNGVATVNVFGAQQYAIRIHLNPNAVKSRGLSLDDIKQSIQNLNSNQATGTLQTDGFYHLIKVDGGLDNAKQFGNAIISYQNGSPVRLKDIATVKNSIANDKAVTEYNNKRAIVLAIQRQPGSNTVSVVNEVLKSLPGLNQKLPGDAKLQVVYNKAVFIQSAIDDVELTLLFAVFLVTVVVYLFLRNFSFTIIAALSLPISVIATFAMMYLLSYSLDNLSLMALVLAVGFIIDDAIVVLENIVRYIEQGMDKLTASLRGSKEVNFTVVAMTISLVAVFIPIFFMGGIVGRLFHEFAAVVGISILFSAFVALTLIPMLCSRLIKEKSSQEEKKPTWFGLFFAKCHSSYEASLRWALDHYGILLGIAGMIIVATFLLFYLVPKGFIPSQDSGMIFGSVKTPEGIDYKNFVTEQTQAKNIIQQNPNVAVVVSSVGQGADASASTNTGIY
>fig|434923.3.peg.1052 Drug resistance transporter, Bcr/CflA family
MSFLSFKLVDPQISESQRYWYAAIALFIVPLSGLSIDIFVPSLPVISHYFGATKSLAQLSITMYMLGMGVMQLFSGSISDSFGRKKPFLIAMLINIVVTLLIPLSHTIYELLFLRLMQGILVAILIVPIRAIFADLFSGVEFHKMTTYSTVIWSIGPVVAPAIGGYLQHYFGWQSNFYFIGVYNIIAFLLILFFMPETSRYRHSFQTASLLQRYKEILSHSEYIRMLIVNCALYSIVILFSIVGSFLIQKVLHYSPVDFGHMAFLTGLAWFFGAMTNRAFIHAPYNLKVKIGLWSLLIVSLISIFAASILPLTIYAVMIPTFILVYLGGTVFPNNFAKALSLFPKINGSANSLFGAFIFLLPGLSSALGTLLKTNSVIPLLTSYLGLIAFSLIIFYARPVGVTVRKRML
>fig|434923.3.peg.1212 Multidrug resistance protein A
MIKKFVKVILPLFIIAILSIGGYFYWQHQNRYPSTDDAYIQADVINVASRVSGTVSEIDVRNEEHVQKGQLLFTIDPAPFTIELNKAQAQRDATRQKIQAADTAVKSARATVVERKAELTHTRLETKRILTLMKKQFVSRSDGDLAIKNLHVAEAALNAAQNQLEEMIEKRGELGDKNAQLRLAQAAVEKAKLDLQYTRVFAPTSGYIANFNLRHGDVVSAYQPLFALIEDQTWWAQANFKETQLARIHTGEQATIKLDMYPHQIFIGKVVDVNKDSGSSFSLLPPENASGNWVKVTQRFPVKVIITQRKSGYPLRLGASSTVTIDTTSPK
>fig|434923.3.peg.1213 Drug resistance MFS transporter, drug:H+ antiporter-1 (14 Spanner) (DHA2) family
MNTTALTKNEILYSRRWLIIVTIMMVAILEVLDTTIVNVALPNMMSSLGANQNQITWVLTSYVVASAIMLPLTGFFSNRLGQKQLLLINITGFMITSFLCGIAQSLPEIVFFRIFQGLFGASLIPLSQSILRETFPLEEQGKAMAIWGIGIMAAPVFGPTLGGFITEHMNWRWIFYINMPICLLGLMLTLFVIPSSERHYQRIDWGGLLLMITGVGALQVFLDKGNENDWLNSNLILALFITAIFCLVFFIIRSLIHRYPVIKLKIFKDRNFRISCLALALFAGSMFALITLEPIMLERLFNYPAVTAGWTMAPLGIGGAVVMMFVPFLMKHLNIKIILTVGILCCFYGAILFAGVNLNSTMQEFLINNTVLGFGMGFLMVPLTTYSLATLPAKDITEAAGLYSYSRMLGTSIGISLLSTLVSRTTQIHWHFLTTHINVFNTNFHNWFTFQKLPFMDPVGIARLGVQFQRQASMLGFLDGFRTIAIVFILLLPLLLTLKTIKLQGSPAAPVDDPVIPASTGITEKI
>fig|434923.3.peg.1804 Permease of the drug/metabolite transporter (DMT) superfamily
MEFSKKSWQGYSLLLLAQLMVGVGIVGCKSLLQTIPAVIILAIRFTIGSTFLLLVHLAVSDQKFRPLKQLMRLDWGFIISQALCAGAFFNILLLLGLKYTNANVAGIITSALPAIVVIFSIIFLKERVTISTLLCFGFAVIGLIIIKFHSLQFGSRYQIYGDILILASLIPEATYYILSKLRPNKLPVFLVSALMNGINVLPFLLFLFLRHQSLLMQIAPEQYILLFIVGISSALFYVFWFSGCNHVSSSSAGLITAFMPIATLIIAYLFLGESNSQYHRHFSYQGNWQ
>fig|434923.3.peg.1978 Drug resistance transporter, Bcr/CflA family
MALYLPALPALTTYFHTFPGVIQLSLTLFLIAFGFSQLFYGSLSDCYGRKPLLLIGLVIVMIGFLIAVFARHLSLLLIARVVQGLGAGSVSVLARAVIRDRFEGKKLVQALSLLIMAASLAPMIAPFIGGHIQRRLGWHSIFIFLFFYSGLILLGIFFLLPETKKTESVPFKMGALLNNYKLLLRHPIYIKYVVCIIMAYACQILYLSISPFIFQNGLKLNAAQYGTIITLPAIGYFVGNFLSTRLIRFFDSNHLVFVGALIVVMAGIALALEAAFNGLSAFSVITPIIFCVIGIGLIYPNVISGSLSPFPQMAGTAAALSGAIQMAGTSSIAGVTNALHVVSVLGLGISFLLCGAVVLLMIFRIMRTSVQ
>fig|436114.3.peg.362 Acriflavin resistance protein
MISKDFFIFIIKRKFAIMLIFLLLAIIGYSTSNSITKDIFPNVYFPRVEVAIENGYTPTKQMLLEITKPAEESLKTVQGVEKIVSKTSIGSTEINLYFNWSTNPFTAYQLVLARVSELKNVLPPTAKVVVRQATPSMYPIGIYAIGSDAKSQTQLTDILYYKIKPLIISLPGVYDLEIKAPQWQEFHVVIDTDKLNSYNISLDYLKSVIYDQTKIDFLGITEMLNKQYVITLYQKPDDVYKLLDVKIPLSGGRYINLSEVATIINSKYPSRSISGFSHAKNAVVFNILRQPDADTTTVIQNVDSQIESINKSLEKEGIRIYKSYDSSAFIKESIKSVRDAIVLGSIIAVLILFIFLRKLKLSFATLLTLPVVFFTTIIGIKILGLDFNLFSLGGMAAAIGGLVDHLIIVIENIDRHLKMGKDKLNAIIDGSKEILPIMTAATLISTLVFLPLLFVPGVVGVFLKQLGLVLVLTYIVSQIAAIFLVPIMAYILLPSRFKSQEDFISRLEKRYETFLERLFKYDFVSVPLVLIIALIGFLLFRAIPTTFLPKWDEGNFVVDFTLPAGTPLEESYKTAMEMGKILNSIPEVKSWTLRIGTSLGHVAEQPNIGDFLVVLKENRTRSIFDIEDEVRKKIEAKFDNLEEFDLPQVVEDRLADILGEEAPISVILYGYDPDKLVKYGFKLRDLLREKPILTEVNLKTTFASGEIRIRLKPEAQSIYGLNLNDLYQQLYNAYWGNVVGNIVYGEKIINLRLISIDRQQFLNPENVKIYSPAVGRFIPLSQVAEVSYMTNVPEITHYNLSPVAVITVRFKGNDMSKAVKVVSQTIQEANLPSDITPVISGFYKQQQKSFKSLMLVILAALTLMGIFTMILFVDTKITVSVLLAVILTLTGVLTALFITGKPLDITGLIGMLIVLSIVINNNVLIFDFYKNSTEEKLEKRILYATASRFRPITMTMLSNAFAMLPIALTIGSGTQILQDLAISTIGGLIFAIFLNLLIIPMLFHFLSRIRISKT
>fig|436114.3.peg.1184 Acriflavin resistance protein
MLKWYISKPHLIFSILIAFAFMGIIGFFSMPRDLFPPADRPQIAVVVQEPGATAKYIADHTASIIERQLYTISGIRRVYSTSNDGFCTVIAEFHYSKPLAEAKTDVANALSKVQNLLPKDILPPQIYEITSYTPPVMVLIVSPKKDSHPSLEDVRYIAENQIKNEILRTNAVANVDVFGGYTKEVHIQIDNAKLSSYGLSPQDIINAIQKSNNDMPLGIMINKDTQNTFILKTEAKSLDELKNIQITKDVKLSDVAKVEFGIKPPTAMYQGNGKEGIALAIQRPYGGAVLSTISAVEEVLPKIKAQFPQLNIDISDTQKELVKQSNENMLEALRDAIIFTSLVIFLFLANLRMTIIAGLSIPFVYLATIAFMWLFGIGFNTVSLTGVILALGMLVDDAIVILENIERHLFELKKSPVEAAIDGTKEVMLVVFGGTVATAAVIFPMLFVGDFPEKIFRPLAGTLLIAILVSYVVSITLIPILAIKFLKNADKKSAWELKINQLMLAWLNPLKNIYTDWIKTLIHKKKIRPLAVLPLTVLFVISLKLIPFTGRDLMPPMDTGIVKANVVFNSNTSIWQVNQEVKKIQDYIYSLGNVKRVSVAIGTEPGVLTISGGTPQTASFTITFVNRFERKETIWQLEDKIRDYIHTLPNVKYTDVYDYGATALSSIKANLDTTLYSDNLEALNKTGNTILEIANNTPGLKSASKSWDMDKIEYEFKIDKQKTALYNTTPYDVAVQVSAGLQGQISSVLTIPNETGFLIRVILSQEQRSYIDQFKSYLIKTPKGFVPLEALGEFTQKAEPTIITRQALDYTQDVYGYRGTNAISHIMENFQKEFEKYAKTHPGFPLPNIKIEQTGDIQQMMDSMGRMFKAILIGLVILYLVLAAVFKSWKDPVAIMLAIPLSVIGGSWSLLIADKHMCLPAIMGFILLAGIIVKNSILIIEFIKTYREKGYSKEEAILESVNIRTRPVMMTAFGTAVGMIPIALEWAIGLERLSPLAVVAIGGLIVGTFLSLVYVPFFYYLIDRGEKNEKTANT
>fig|436308.3.peg.459 Permease of the drug/metabolite transporter (DMT) superfamily
MSVVSKFQPTYENLRKSKINKISLFSKLKSKTVGVGFLFAILAAAFSALPNVIPKSFLDAHAVDTSTIPNPLMLVFVIYVVNSLLFSPFRKSQREHEVKKTSRMTLFLLILLGAVEASGTLTYTFGLQETSATNASILVNSETVFAILLGIMIFREKLSKQEVLPFFLIVAGSILIPVGADIQNNEWELSDFMMGDLLIVMSGFFYCLDTFIAKKLDDSIKTRHIVHIMSCTGAIMTLGLMLFFEIPFDISFEELSVMSFVGFLGIGVTMMFFVIALRLIGAVRTVLIYSSTTIFSIVYSILILSEGLTILNIVSTSSVLIGLFVLRNRVGSD
>fig|436308.3.peg.1102 5-nitroimidazole antibiotic resistance protein
MQILIDLKLVGRLEIKSYEKIKEFLSQEHVGRIASIDENGYPQIIPMNFVFANDAIYMHSYTRGEKLDNISRNDKVGFEVDRELEFLPSYFSHPTDASQADTLYISVVIKGKGVFVEDDDEKAFGLNELMKKYQPEGNYIPIQNNDLVLDEVAVIKVIPVSIKGKYKIGQQLRSDSRQILAQKILERKSPTSKQTLKIMGFEETPDGLKMVDEPVW
>fig|438753.3.peg.1109 Multiple antibiotic resistance protein MarC
MLEDYDLFITQFVTLYALLEPIGHLSLFLALTGEHSKADRLRLAILSPLFAFAVLSFFALAGQTLLNAMNVSILSFQIAGGIILFSFSLSMIFGEAKKPSGVPEEKNLISQAIYPLATPTIAGPGAILSVVLLADNNRGSLIAQSMTVLAVASMMLLLMGAFLAGDIITRLIGSGGTNLVRRVMGILIAALSVDLVLSALAKWLHLPPI
>fig|438753.3.peg.1418 
MCLALYVTYYLELPNPFWAATTAAIVCQPNLGASLQKGRFRALGTAIGALALVCLLALFPQQRIALLLCLALWCGLCGFAVVLLRNSAAYAAGLSGITAAILFADSISDPTSAFFLGITRVSEICIGILAAAAVLLITDPGTARLALASLMERIAQQLRTGFLDTLATEGETPDMQAARRNVVKTLTPLHIAIDAATGESGSLYARRGNFRIAIASLIDALVGWRNVSHHPFPDGSDAPSVQQALAAGISRINPAAAERYGSDADAVRDIIADIETLRPESAKDVLSARLLVDAAHKVAICLAQFMQAITLLRTGAGGRLPPQSQPLVIADSLPAWLAGARAFLSVVTVALFWVTSAWPTGPFAIAFAVISTLIFASFAEEARARAADYTIGVAVMSVLGSVIYFYVLPTLSTFPALMGLLFLLYVPLGMMQVGTWHSVLFLAMSIASLPLLGIGNPVAYDPAGYFNIALAILTGSAVGTLFFVILPPLGPERRARRLISLSARDLRRLLLDQDRHDERHWRALLSRRLESIPAQATLEQHGALLALLAIGHAVHRLRAAVTSGEGARALVTAFTALAEGEPSVALACLEIVERQTGTDTSSTASTALPADVQTEMAVLADAIRTNSALLAMLAPGRTPPSGQ
>fig|438753.3.peg.1605 Multiple antibiotic resistance (MarC)-related protein
MSQFINIFVAVFAALFPIVNPLGGAPIFYEMTRACAPQVRASLAMKVAIYGFILLVVSLVAGSRILTFFGISLPVLRVAGGLVVTFVGWNILHQGDASAEKAPDATATRDVDVLRVEQQAFYPLTMPLTMGPGSIATAIALGSQGTFNPADGYGHMIIEAMGALSGIAAVSASVYFAYRYASDIERFLGPNGTNVLVRLFAFILLCIGMQIMWLGIRDLVASLPVHG
>fig|438753.3.peg.3355 Glyoxalase/bleomycin resistance protein/dioxygenase
MSAPLPGAGVHGLFHVAIKTADLEATRIFWRDIIGLKEIHRPDFGYPGAWLGCPQPGGLGIIHIYAGGPALGPSGMAPYGTGAIDHISLSCSGYRAYIARFKAAGLDWREFIVPGTSLWQLFVYDPSGMQLELTFEASIEGAELPDVSEARVYRAGRSFFDPDTYPKLARQAAARA
>fig|438753.3.peg.3685 Drug resistance transporter EmrB/QacA subfamily
MGVGSIDSRQRWCTVFAAAGALGMIMIDATGTAVALPSIQRDLVLSHGAQQWIITLYALTVAVAIATGGRLADVYGRARVFRVGVMLFAFGSVVSGLAVNLPMLLCGRTLEGLGNILMAPAAALLATEAFGPTERGRAMGLYSGLGGLAMVIGPIVCGAVVQVGGWRWAFFVNLPLALAVLLLLRAAGPAAASPRSGTFRPAHSLLLVAALGPIVLGLQESHAWGWTSPLTLSLIAIGALLLVLFVATQARAADPLVDVRLFTRRQFCADGLVLFCAQCAIIGQSAYGAIYLQRVLHFAPLQSGLAMLLFLGPMMVCAPLSGVLYDRHGVKVPVVAGLTLATLGFVLEVHALPRMDFLYMAPALVMLGAGMGLALSQTYTDGTAQVAESHRGRAFGALDTVRQLGGAIGMAAIGTVVVALERGRVLAIAAEAAPEGAARAQLEALMADAAYGKDEAVRTLAEQWPAVGAALRLSAARSISEGYYVGAAMLALALCAAVLVMRRPPHAPREIAKGAS
>fig|438753.3.peg.4302 Permease of the drug/metabolite transporter (DMT) superfamily
MRLSAPSAGPAPSFRLGLLGALVTVAIWTTWITTTRVAMHGRTPLAPELLAFIRFGTATLLLAPFWWRFRLFPRQSPPLALLGLMAAGLPYQFLVLWGLHFAPVSTAGPLLAGTLPLFIGILSAVVLRERLTPLRILGIALITLGVLAISGEGIASLTGDTWRGALAILGAAFAWSLYTVAFRYSRLSGIEAAAFVGVWSLVVLLPFEAGNIWTAVQATPVTLLAQQLVTQGLLAGVVSLLTYTTAVRHLGPARATALTALTPPAALLTATLLLGEHPQLEELVGCGFIVAGVVAASGALSRARA
>fig|438753.3.peg.4408 Fosmidomycin resistance protein
MSIAAVRTPPSREMATISAVGTAHFTSHLLQLAFAPLFLTMRDDLGVTFTELGALLSAFYLASGMGQVTAGILVDRFGAHRLLLAGMALQASSVAAIGLAPTYGLMLPLAFLSGLGNAVYHPADLSILSHRIRPERLGRAFAAHVIAGNFGYAVSPLMSGTLAIAFGWRTALVVMGGAALVATFALIAVRPVLHSPTIAEQAKAPGGVAPISFGQVLTTPVVLLAFFYFLLSSISLVGIQNFSIAALQEGYAFTAAMATLTITAYQLATAAGVAIGGYVADRSTHHHRIAMGGLAAAAACAALASLHLPLALATTALVVGIGFANGLTLPSRDVLVRRASPAGATGKVFGVVYSGFDIGSLFAPLIYGLLMDHHLPHGVFLTAAVPLALGIVTVLGVRPGKR
>fig|439235.3.peg.1331 Permease of the drug/metabolite transporter (DMT) superfamily
MNLKVLKANLILLTAALVWGSTFVFQRSAMQNMDPVSFSGLRFALGALCLAPIAYFRSKRPTLPLPGVPRWLPLLGMVVAGTVMCFGINFQQVGLVETTAGKAGFITGLYVIMVPILGLAFKQKPDLGLWLALPLAVTGMYLLSVTDAFNLAPGDGLVLICAFMWAVHVLVVGYFSPRMDSFVLGFGQAFVCAVLSLIYALCCETITWEGVWASRYALLYGGIGSVAIGFTLQIIGQKDSPAAHAAIILQLEAVTAAVSGWLFLGESMTTRSFIGAGLMLAGMLVAQLWVFVPKRKPQGNNGTP
>fig|439235.3.peg.1525 Acriflavin resistance protein
MKGMVKWFAENHVAPNLLMIFFLLAGVFTALNIKMEVFPETSLDRVRISCSYSGASPEEVEEAIITRIEEAIAGLAGIERIDSSAREGAGRVTVEVMKGWDVGKLTDEIKSAVDRITTLPDEAEQPIVAEMTRSREVVNVAVYGDVPETTLKQIAERTKDAITALPDVTLTELSGVRETQIHVEISEDALRRHRLTLGQVATLINNASLDLPAGSVKAKGGEILIRTKGRRYYAEDYADIAVLTNPDGTQVTLGQIADLKDGFEDVDYRAYFEGEPAALVKVYRVADQNALTVASQVREYVESASRSLPAGVKLRVYNDSSTILKSRISLLVRNMGIGLVLVIVLLGIFLNVRLAFWVTLGIPISFAAAFIFLPYFDVSINMISLFGFILVLGIVVDDAIVVGESIYHKQEQGMPRLKAAIEGALEVGRPVVFSVLTTMVAFLPLLTGSGRMGRLLRNLPIVVCLVLAASLIESLLILPSHLAIGKSKIKSVDPANPSGRKRSPIKKAFKTAFRPLTIWRDVLTWVINKPYAWLVDFCVTWRYVNVALGVFVIFLTFGVLKAEYVRETFRPDIEGDTMSCMITMPSGTPKERTLEVMALMEEKARQVLAEKDKTRPEGAKPLLEHTIGLLGAHLGDGKPDTGGHMGQLWISIISAEEREEGISTAGLTSRWSEAVGIVPDAESVTYSSALHSAGKAVEFHLSSSDNEQLSAAAEDLMKELETYPGVYGIEDSFLPGKKEMQIKLKPEARSLGITLYDLARQVRHAFYGAEALRLLRGQDEVKVMVRYPEDERRDLSNLEDMRIITPQGDLIPFSRVAELQLEEGYSYITRAQRKRVVQVMADVDMEQNNPNRVRDTVTNEFMPELKAKYPGLNFTVEGRGRHREEAFKDINRGFLIALLGIYALLAIPFRSFTQPLVVMCAIPFGIIGGVFGHMIMGIDLTIMSRFGMVGLTGVVVNDSLVLIHMANRLRDEGAAAHEAVVAAGARRFRPIMLTSITTFAGVTPMLLEKSIQAQFLIPMAVSLGFGVLFATGITLLLVPSGYVILDDIQRFFKWLFGGDYGRYHASGGDETELEEEQTPDLPPPLPQKD
>fig|439235.3.peg.2416 Drug resistance transporter, Bcr/CflA subfamily
MLVRPIKPQSLLYTGMLAGLASLPPLSIDMNLPAIPAIEASLGVASGQGALTFSLFLLGFAIAPIAGGPAADRFGRRPTLLLSLLFTSIAAFSCMIAPSFQALLIFRLIQGIASGICILLPLAIVRDTLSESEAPKLLSRIMLVVAVAPLIAPIIGAWVLSWSDWRTIHAVQGGLSTLLLLLTAMGFEETLEEDRRTPLSMRQIGSAYAEIATSKTFLGFSFLMAFTFGCMFSYISGSPGLLQVQLGLSENLYSLVFAFTSFGIMCGSYISYRLGRRDVPARSIINRGLTCMVVAVAAALVLVLNGFVHLETMAPALFLIMMCAGTIQPNCMAEAVAPLPHIAGTASGALNSLQMFIGSAASAFVTFLTGYFTPALAMMISMACSIALAFAIYHGLRTGRTPGKLEMSPETD
>fig|439235.3.peg.2476 Drug resistance transporter EmrB/QacA subfamily
MSTLDGSIVNIALPSILKSYGVSLSTIRWVPLVYLLTISCLLLSFGRFSDMIGRRRVYTRGLFVFSLGSLLCGLAGSAGVLITARSLQGMGAAMIMSCTPALIADNFPPEERGMAMGMIGAVVASGLTVGPALGGLILEHFSWHWIFFINLPVGLGAIIAANRVLKESQASGPRESFDWIGALLLALVFGSFTLAISMGKEMGWTSVPIVGLIAAFAVGAVFFIFVEVKAPHPLVDLELFRIRLFACALCAAVTLFISLFCLIFLMPFYLKYPGGFSDAGAGGMLVVPFLFMLVGAPLFGAMSDRLGSRLLCTLGMLMLSASFFSFMFMEPTTDIFPIFWRLALAGFGTSLFTSPNNAAAITAVPVNRRGIASALIATARNMGMVMGIAMASTVFTAVYVSIYPGATLDSYSAEHMEGFMAAFHQAMMCGGFAALTGAVLAALRGKGTVSEE
>fig|439235.3.peg.2725 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNVQTRGGMLAADSIGSLLMKLSLPAIISMFVQAMYNTVDTIFIGRWVGTLGIGAISLVLPIVFLIMAACQAIGVGGASIISRRMGAGDADGVGRTFGNMTLLALLLGVGVQLAGLFAITPLLRIFGASDTLLPLTWEYFRIIMLAGPLMTFAMTANNAVRAEGAAKMAMLTMMSGAVLNTILDPIFIYVLKMGIRGAAWATVASMFLSTVMLLLYFKSGRSEIPLGARYMRLKFFIIREIAAVGSSAFVRVGAASITVAILNHTLSYYEGDVGVATFGIIFRVLSFILMPVMGLSMGLQPVVGFNYGARSYSRVREAVKLGVMAATTVAASGFLVIFLFPEAIVSVFSKDPLLMEYASNAIRLSMLALPVVGCHVVGTAFFQAIGKAAPALMLTLCRQVLVVMPLILTIPRLCGAEYIWFAFPIADAVSFTLTTILVWRVLKKIPKIEASSSA
>fig|439235.3.peg.3636 Acriflavin resistance protein
MEAFARNRVFANVILLIILIGGIVAGFRMIKETFPEFSLDMITVEVVYPGADPEEVEEGICRKIEEAIDGVEGIKQYTTYSVENAGTALIEVKENWDVQEVLDKVRSKVDAISTFPGDAEKPVITDLPLKDIVCLLYLSGDLSERGLKEWANDVEDEIKNLPGISQVGVFGAREYEISIEISEERLQEYGLSFDQVAGAVARSNLNLAGGAIRTQGEEIRVRTLGRKYTGKELSEIVVLASENGDIITLDRIAAIRDGFAEDPVEATIDGERAVLVHIFKTSEEDSLGISKTVHKFLEEKQKVLPPGAKIGLLYESTDILKARINLLLKNGLVGLILVLILLFLFLNARLSFWGGMGIPVSMAGALIICWSLGATINMISLFGFILVLGIVVDDAIVVGESIYQHRQNGEGPLEAAVNGVLEVGMPVTAAVITTVVAFIPLMFVGGIMGKFIAILPVVVIACLAISLFECLFLMPAHLSHLPDPNAEDKSRFAPIRVWNAFFKGFSRGLEGFVKRVYMPVLEKALTWRYVSLCIAIAILMLTMGLVAGGLIKFQVFPDIDGFVMTANVELPQGTPPAVTQEAVKRIDDALLRVAERTPTLTGEPMIKSRLSLVGQTLEDIPENGPHLGGVQAIMLESEYRGVHSKDLMVEWEKEIGLMPGVKSLTFTGLSAGPPGAPIEIWLQGKDMNEIIAASEELMEKLATYEGVNQIRSDYAAGKNEMRLELKPEARTLGLTVNDLARQVNSGYYGYEAVRLQRGRDDVRVKVRYTQDERSRLSDFKEMHVRTPDGSEVPLYSVANVSFSPGYSRITRTDGLRRVAVSAGVDSNKANTTEILVDLNRSFFSGLKEKYPGLLVAVQGEQKKMRESFGSLMIGFPAALLGILVIIAIMFRSYLQPLIIMVTVPFGIIGGIFGHLLLGYDLSMMSAFGAVALAGVVVNDAIVLIERINENIAEGMGFREAIIKGGGRRFRAIFLTTLSTVGGLTPLLMETDLQARFLIPMGISLAAGVAFATLLTLLLIPCLLMILNDFRRTVHFFWRGYWPTRREVEPAINRPVQSYALKEECEPAEQESPLPSPLPHEEEPPPLTL
>fig|439235.3.peg.3967 Acriflavin resistance protein
MEREIAITRISLNRPVTTIVLVLAAIFFGFYSYRNMGLELYPNVDIPVVSVSTILTGASPEIIDRDVTDVLEEQLNTIEGIKNLTSSSYEGRSVIVIEFVLERDIDAAAADVRAKVNLAQYYLPNDCEDPIVSKLDVGAFPVMNIAVKGGEDYRTRSHFVDKVVKPRLQTLSGVGSVDLVGFRDREIRVWLKPADLEAQGLTASDVAGALARRHLELPGGRIENDTQELSIRVEGEYATVEGLSQLVVKESLDGRLVRLRDVAKVEDGFEDVRTGSYLNGSPVITVQVKKQPGVNEVQVCNSVKEVLKDLRSIAPAGIEMIISSDTSDFISRSMNGVENDLMIGVVLTALLMFVFLRSIRVTLVAIISIPTCLISTFLICNALGFTVNNLTMLAMSLAVGMVVDNTIVVIENIFRHLEQGKPVRQAALVGAGQVGFAVLAGTATTLAVFVPVATMKGVIGRFFFSFGMTIAGAMLISLLVSLTLTPFMASHLMKRQTSEGTFSKILDLPMKALEALYRRVLGWAVRFRFVTILFALLTFAAGIMMAKQLGMDFAPEEDQGETTLQYELPIGTSVEESARMTRELSAIVQEQPEVTLVLATFGGGSGEEIHKGNLYIRLVGRKERSVSVAQFEERLRDLFAGYRDVIFQIQQGGGGPGSSDAEQSIQADSLEDLARVTEAMVEDLKKAPGLVDVNSDLRLTKPMVKIHINRGLTDSLGVDVKDIANEVNTYFGGTDASVFKSEGNRYDINLKGAPEDRLVADDIGRITVKTSTGDTVRLGAMVDVETTVGPNVIKRYNRRYSASVYANVQEGYSTKQATDDIQAAFDRHAPSDKSMATVITGNAQMMMESMGYLVEAIIIALIIVYIVMAIQFESFLNPLVVMFSLPLAFSGVFGLIWITGGTINIMSMIGMILLVGIVVNNAILLVDFANQRRERGLGPVEAMLEAGPLRLRPIIMTAASTMISSLPIALALSEGSEFRQPMSLAVIGGLFTSTVLTLVVIPVGYIWVENISSGAGRLYNKLFTRKKSQPEPAELVETPPDSEEK
>fig|439235.3.peg.4982 Glyoxalase/bleomycin resistance protein/dioxygenase
MKPRISMITLGVRDMDRAVKFYEEGLGLPKMDYDPAVAFFTLNGTWLALYPWDLLAEDAQVPPEGTGFRGVTLAHNLASEAEVDAFLAQALEAGATQVKPPQKVFWGGYSGYFADPDGHLWEVAYNPYFWIGPKDEEA
>fig|439292.5.peg.521 Drug resistance transporter, EmrB/QacA family
MDTYQKKIIVALLIATFLAAVEVTVISTAMPSITSDLGGMDKISWVFAAYLLTYAVMTPIFGKLADLFGRKRVFIGGVSVFLLGSVLCGFSQSMEQLIFFRAIQGIGAGALTPMTFTIVGDVFQYEQRAKAQAIIGSIWGVAGIFGPLVGGFFVDFLTWHWIFFINVPFGLVAMHLVGRHLQEQIEKKKRRIDYKGALTFIIGTGALLYALLSGGTDIAWTDPLMYSLFLIAGLFLVLFVRIQIRTAEPMVPLHLLKNQHLLTANLASLMLGMILIGLTAYLPLWVQGVLGLAAIFSGLTLIPMSLGWPIAAFMSSRLLKQFGAKPVCIGGTGLIMLSTLAMTFVTAATPNWLLVIIMFFVGAGFGLAMTMFTVIVQSSVDWTNRGAASSSNAFLRTLGQTLGITILGATLNQYIGGYGGEASAPADVLASGLSTVFLLLFIIATVAFLITFRLPSEEPEHARSS
>fig|439292.5.peg.3021 Permease of the drug/metabolite transporter (DMT) superfamily
MFTIEVFILAAVFGLIYGFLLQKADFCFVASVRDFVSVKDSRVGKGILVLMATAMIGWGLSLTLGIASVDQLWAVPIGFQNLLGGLLFGIGMTIAGSCASGALYRSGMGYIQFWIVIAAMITGNLLFAFIYDPWANDYMMEPLTMAEGYSLYEIGLPFMTLPLLLVGLLLFVTIRKFGWAGFWQGVKNSFTDWKGNPFTQQHWDVRFVALLMGITATVQFITLSSISVTGPETRIGGVFLASIFGEQAVYNNLYLNNMFAAYPTVGIGPEEVLVIMIVVGAFISSVLSKSFKIRFPKAKRLPAAIGGGLLMGVASRIAPGCNIANVVAGVGGLSIASFLVIIGMMVGVFLVTKYYFKMPIMLFYREKDAA
>fig|439375.7.peg.1678 Permease of the drug/metabolite transporter (DMT) superfamily
MTAITETTPTSSTSDTIRGLAWGLSGVLVWSGSFVLTRFGFKTALTPFDIIALRFGVAGLVLLPVVLVKGFGFRKLGPLGFVLLVSGAGVPYALLTTCGLQYAPASHAAALIPGLMTAMVAVLGMALLKERLAPSRWSGVVLILIGAMLIAGLSQLGGPEMLGHFFFFVAALVWAIYVMVFRRKGMDGLHATAIAAVTSAIVYLPIYMLFLPKGLGATSWGDIALQGFYQGVLTSAFGVFAFNRAVVLLGTAAGAALSALIPVITLVLALVLLGEVPGWTDTLAAFLISLGVLALNRKGRKRIAS
>fig|439375.7.peg.2703 Permease of the drug/metabolite transporter (DMT) superfamily
MQSEATMQPGVASSFKSLSAMLGLAVMWGLSIPVTKLGLQTMPPLTLTALRFGIAVPLLLLFVLGKQRLPLKAFPRLAGLGVLGIGIGQVSQTLGVAGTSASVGTIISATIPLFVVVFAALRLKQAVSGVQMLGLFAAFVGIGLVALEKGDPSAVGTQNSLVGASFLLLSAVAIAFYYVWSVQLTVQYGTATVVAWSTLFGLLALLPFAGWEISTVDFQLNYVAIVSAIYLGFIVSVAGFFLWLHLLRTVPARTAASVQYLQPVFGVMASSIMFGDTMGWYFAAGVTLVLIGLALTIFTKRQRQ
>fig|439375.7.peg.4164 Membrane fusion component of tripartite multidrug resistance system
MNKPVVLFQQPAPVKDKPEPLKAAGKPRRRAYLSLARASVIVAGIGLAIVIPLGWGSWVAGMTNQTTDNAYLRADTTPVSAEVGGRIVHLLVEDYQHVKTGQLLMQIDPTQYQAQVDQAGASVAAAQAAIRNAQSNITLQQRVIEQAEAGLAALNADRERVVSEGHRQTSLTKDGWSTAQKLEAAIADVKRIEAQIAEKQAEIAAERQKLDVLATQSDQAQAELSNQQAALRLAQIDLDRTHITAPMDGVVGVSGAREGQYVRAGSQLVSVVPVSKLYIVANFKETQLAKFRPGQVVSVTVDTFPGKELRGYVERLSPATGSEFSLLPPDNATGNFTKVAQRVGVRIALEQNGELDELLRPGMSVVATVHTDQSIETTASLIK
>fig|439375.7.peg.4165 Inner membrane component of tripartite multidrug resistance system
MRALIGVAAVLLGTTTSLLNSRLTDIGLADIRGALGVGMDEASWLTTAYVVAEVAAIPSAVWLRSILSPARGVMIGALIFTIASMLAPFSPNLQTLISIQAIRGLSAGILMPMAYAVIMRHLPQHLRLYGLSLYALASSLTPNLAVSIEGWVITHLSWQYLFWINIIPGSLTLLAGAYGLANDPIKFLRFRRHDGFGLLALSFGLAALVTALDQGNRLDWLGSGLIVGLLASALFFLSIYLIHALWHPDPVVSPRLLARRNIGFSLFLMFAMRIGLMTSAYLLPQYLIRIQGYRALESGTMFWVSVLPQIVLTPFVAWLTYRMDPRSLAAFGLMLFGAGVLMLSGLTHLWTSDQILPSLFVQSIAAPFTAIPLMVLITEDISVREIPWIASLVHIVRTVGTAIGLAAVSTFTRVQEQLHSNLLGLHLERGAADVQGHIDRTAAMLEAHNSDPTRVTAQATAMLARTVQREAFVLAYSDMFVMIGLAIALAALATLFMRQPKLPGKFL
>fig|439843.6.peg.937 
MNKIIEMSNPEREVTDIAEILAILSKHEVCRIGFNDNLCPYVVPVNFGYEYQNGRWIFYFHGARTGKKMRLLRKNPAVCIEMDGDHALLRADDPCDYSYAYTSVFATGLASILQTREEMRYGLDVIMRQTDPGKTFSYREDMMKAVCVVRIECDALTCRRHLATQSE
>fig|43989.3.peg.1177 Quaternary ammonium compound-resistance protein
MKDFVGFDFSSPTIIFYLIAHILTNYWILMGLGILVISLSLYLSAISKLDLSYVLPIHASSYVLNGLFAWAILGEDVTGMRWLSTLIISCGVLFVGLSDSQTSQFSEDYHSNIKSRNLPLFFLPFSLAVSKTWLAIMISSVSDASGDVLLALGMKKIGELKKITFLEVTKMVIKVITNPIIISGIACQGIAFFSFISVLSWADISFVRPATALTYIISMLGARFLLKEDIREQKLWGIVLIGLGVFIHR
>fig|43989.3.peg.1358 Permeases of the drug/metabolite transporter (DMT) superfamily
MMQLKLTSQNNNAVNLLPFVTLVIALISISFAPIFIRFSEIELGANGTVFNRLWIFFMVFGFAQTIRRRFYSPENIEIQSPLTVKHSLLLLLVGIISITSLGLWAISLQYTSVANCMLLNNMTPIFTSIGAWLYFGKRFDTKFILGMILALSGAIFLGLEDLQGTNSHLIGDFYALLSAVFLGIYFLIVEQLRNRFSATTILLWRCGIGSFLLFPLVLWTEGKLFPTAWQTWLAVIGLGVISEGLGQRLLADCLDKFSSSFVTMFLLLEPIVSAILAWIVFAEGLTSITGLGFVIILTGIYLAQSSHSAVHEL
>fig|43989.3.peg.3572 Multiple antibiotic resistance protein MarC
MKSKVFPHFRLTKHCLMAVILSLVTLLTLWFSVNFPVVATLPTDRVIETATPLEQPFLLAQAESETESPKTDPDRYQSWEKQNLSELQQFRGVLSAGNIFIIFFVTLGPIKIIPTFIKLTQNADDDLRKSLALNGAGLATIVIVLVVLIGGNILTRWTVSMSALLMAAGIMLFLASLQAVMSQYKGSAENEPLLEPSMKLLINPLTFPTILPPYGIALALILMVFNNRISDRPFIVPVMLILVMMLNLLAMLFARPILKTIKLPTLRIAGLVLGVMQLALGIEIILIGIHIQALILEDLLKLN
>fig|441768.4.peg.1133 Glyoxalase/bleomycin resistance protein/dioxygenase
MDKSLAFFKALGFKTNAQFGAPIVFFNNNGTKLELFPVEELAKDINDNNPPVIQTTGFSGITLACNMKTKEAVDELMALVKHHGGVIIKKPQTTSWGGYSGYFRDLDGYYWEVAYGPMWKFDAQDMLIID
>fig|441768.4.peg.1136 Daunorubicin resistance transmembrane protein
MKINKYKKYLAFSKAGILDGFAYKFSALGWLLGDLVSIIILFYLWQAIYQNSPTETINGMTFKDMIAYLIFARVSTTLIFSSSSFWNIGFDIYEGNIAISLIRPINYRYRLLASSFGNFLSTAILMFIPLFIVSIVILNLSLGIGFPELAHLLLFLVSVVLSFVIVDSMNFLIGEISIFTNALFGLMIIKNIILSFFSGSLLPSSFFPDWLNAVLRFLPFQSMVEKPIMILLGRLEYMDILMTLLIQLMWVVILSVLCNFSFNRLKKHVVSVGG
>fig|441768.4.peg.1137 Daunorubicin resistance ATP-binding protein drrA
MPIIEVKGVKKVFKKPVREPGIFGMFKTLFSFKYTTVAAVKDISFSLEPGEIVGYIGANGAGKSTTIKMMCGILTPTDGVITIDGYKPYNPKERKHVLNKIGVVFGQRTQLWWDLPLIESLVILKEIYDVPKDAYEERFKFLSTVLELDPFLNQPVRTLSLGQRMRADLAASLIHNPQILFLDEPTIGLDVLVKDRMIEAIKEINKKYHTTIVLTTHNMEDITDLCKRVIILDEGSILYDGPIKKIKAKFGDMRHISFLTKERNILLELKEMLPKDCLIEEIEGYIHLSFDLEKMSVNDVLKTIIDTYTIEDIKIEENSLESIVKKIYENKQI
>fig|443906.9.peg.752 Tunicamycin resistance
MIIWLNGTHGAGKTTTARLLQERIPDSRVLDAEKVGEVLMDIRPPLPQLDDFQHWTPWRPLVVETARRVLDYAGGTLVMPMTVLVEAYWREISGGLAGHGIPIRHFVLHADTATLRDRIQNDQDLGPSAFRFSRVEPYAEAARTWLHAEAEVVDTSRITPAEAADRIAGAVLAGAPGA
>fig|444157.3.peg.40 Multiple antibiotic resistance (MarC)-related protein
MELLTAVVALYVIVDPLGNIPLFAALTAGLSEAQRSRVLLLSVLVASAVLVLFAVFGVEIFGYFGVELGDFMIASGLILISFSLHQLIRPYEQRPATDGLEVAVVPLAVPYLAGPASISYVLLMSKHMGVAPTLLAVAAVSLLTFATLRASGFIMRALGVLGIRVVEKIMLILSVAIGVSLVRRGLEAGWSLGASSRG
>fig|444157.3.peg.1923 Bacitracin resistance protein BacA
MDLLAALVLGVIQGVAEWLPISSKTQIMFASQVLLGAGPELAYSLGLFLEAASVLAALIYFRGVYLEILRGLLGDAEGRRWLKYVVVTTAVTGAVGIPLYLAAKRYLLLGASAGWLMIALGLAVILNAAILQRARAAAGLKTFGEMPLSHMALVGLAQALSVLPGVSRSGITTTTLLLLGYRPDEAFKSSFVLVPIAGLGATALAYLSEGNAVATPEAATAMAVGLVVSLATIRALLQFAKSRHVALVNIAVGALAIAGGLAKILTP
>fig|444177.5.peg.2450 Oxetanocin A resistance protein
MSNRTIRDTSFGMTIRESLQADCPSCFGLCCTALNIVASSDFAMHKPAGKPCSNLTEDYSCQIHSKLRMSGYKGCTVFDCLGAGQHVSQVTFKGQDWRQSRELADKMFQVFPIMEQLYEMIAYVAEALSYQIDSMLHEQLLVQLEQLQQAAELDANGLLALDMMAIRMPVNALLLKTSEQMRQHLVKGKASLKLNQRGVDWIGKNFQGKDLRATDLRGGYLIAANLQGANLQGVDFIGADLRDTNLRGADLSTSLFLTQMQINAAQGDNTTKLPSYIKRPAHWQ
>fig|444177.5.peg.2530 Antibiotic resistance protein
MKKQTIFTSAFLLLFMSNFLTFIGFEMLLPILPAYLMSLHASPFQVGLVTTVFTIGAIIIRPFVGYYLVDNNRKGLAMGAGITLMIITIIYPFMNTIWLILLLRFFHGATWGVSTTANSTMAVDLIPKTRLGEGIGYFSISTTVGAIIAPSLGILIYHSFSFSILIYSSCMLCLLAVIALQFVYSAEPVKHEKQPFQFMEAIFEKEVWFQALLTVMTTLGFGAIITFLVLYGEQRGLDHIFLFFLINAIVSTLLRPFTGKWFDKTGPWSIIIVSAVVGFLSLMVLSYATNSWLLIIAAILFGAGYGTVMPCLQTWTVQKVSEAKSGAANATFLSSFDSGVGISAFLLGLLAEWMSVEMIFRLVSLSFLLVALFVYIDAKRTRKNNHIQTTKF
>fig|444177.5.peg.2627 Permease of the drug/metabolite transporter (DMT) superfamily
MRIKIIGALFLSLAASIWGAMYVVVKVVVEVVPPLELVWIRYLIAVLALGLIGIMMKQSWKIAKKDRLLIILVGLIGNTISIVTQEMGTMLSTAQMGAIITATTPAFMVVFARIILKENITPKKGLSIILATIGVGAIVGHGGINLTQQLGGLYLLVAALTWALMSVLVKKVPSHYSQIVVTTYSSLIAVILLTPFVIPRLKDLNLSVVLQPTISGGLLYLGIVSTAGGFLLWNKGLQLMNASSGGLFFFLQPVVGTILGWLLLGEAIGLSFWLGSLFIFSGVFMVIREE
>fig|444177.5.peg.2682 Permease of the drug/metabolite transporter (DMT) superfamily
MMKINIVGIFYAFIWASGAIATKIGLFSASPLIFASVRLLCAGIILFLFVYIFRNYRYPKGSEWANLIILGILNTTLYVGCSFLSLAYVDSTIFNLFITINPFIVAFLSSIFLHRKIGQKEILGMAISAFGIMIAIIPYLESLNATLFGLITLGVGVLSMGIGSVFYNKIQLNLPQIVVNTWQIIFGSLIAIPFVFLLEPNFYIQFDPYFLSGLFWQVVMTSIIAMILWFYLLEFDAVRANNFLFLTPIFGYILSAIFLNEMLTVYHYVGALFVIAGTFFSQSMKKRQHGNS
>fig|444177.5.peg.3957 Drug resistance transporter, EmrB/QacA family
MDDTMNKVFIALLLVTALAAIEGTIVSTAIPSITADLLGVDLISWIYSAYLLASAIAAIIFGKLADLFGRKRMIITGIIIFLMGSMLCGLAQSMEQLIVFRAIQGIGAGSILPITLTMVGELFTTEKARAKGQSYLSMVWGVSGVVGPLFGGFIVDQVSWHFIFFINVPFGLASIYLIVKHYKEQLEAVKRKIDYLGAGLFTIGMVSLLYVIIENSKTQAWLSNQSLIMYAVAAIFLGVFVWVELRAEEPIIPLTLFKNGRLMVINSLTLSTMSIVIGVTVYIPIYAQSVLGKNATQAGLLLTPMSIFWTMNSIAAGYLIGRLTNKRIIQMGTILLVIGTIMLARLSSGSSDISVYLGSSLIGLGMGFIMPMLMISIQKVAHPKQLGISIGLNSFTNTFSQAVGAALFGMIFNLATNEKMASLGKGEIQLNGEFAKGGFSLEEISFLKGTIANGVSYVYITTLVFAICALILSFFIVTKLKDKA
>fig|444177.5.peg.4298 Multidrug resistance protein B
MKLSNLFHPLVWIILGGTVFTRIASFMAMPFLAIYLHNEIEATPLQIGLTIGIAPLISTVGGFFGGYLTDRFGRKSVILITIIVWSLVFFGFATVHTVWLFILFNALNGLCRSFFEPSTQALMIDFTPADKRKRLFSLRYTAINIAAVIGPIIGVYISQLASPSIPFMLTGIMYIIYAVFLFFVLNRYQMQQQKAVTQTKILHTFTILLTNRVLLSFIFGAILINIGYSQFDSTLPQVIELTVENGTKLYSLLISLNAAVVLLLQLPISIVSERFSSSATLLVGILFFAIGLFMFGFSSNYTLYIIAMIIFTIGEIFAFPTMNVMIDEIAPDTQKATYLGAAQFKNLGGFIGPIIGGWLLTHYMGAMFAIIAILVLCSCIFYRSKTSTH
>fig|444177.5.peg.4306 Permease of the drug/metabolite transporter (DMT) superfamily
MKQLTIYMILFSCVFFWASNFIIGSILIEHWSPIMVAIFRLIVIVLFLGCISWKAIIRTRLTRNDLLLLIIAGILGVSINHFSFYASLQHTSPITAALILACAPIVTSLLNKMMYQESRNGIFWLGAIISFVGVGLIITKGALITISIGKGEVLSLITMLSFALFLIIVNHLSLKLSAQSITFYTNLIGLLVLVPFSFTMWTQTNWQVAYPYWILLILSAVIIHGISNLLWNQKMKEIGSTNASLLLNFEPAIAMLLSAIFLKQFPTSVQIYGSLLILLGILLCIYYKEIRTLLFMKRKIT
>fig|444177.5.peg.4581 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTINPIETRPLKPLFLSYLFPAMIGMLLMSVNILVDGIFVSHGVGPTALAGVNIAVPIFSILLSISLWIGMGGATLYSISLGEGNKQRAHQLFTLAFTTMLVVVLTIIGFLAFNLKDISYIFGASDDTYPYVQEYLHVILLFGVFYTIENLLSIFIRNDGNPKLAMLGLITTSVLNIILNYIFIFVLDYGVTGCALATAIATIIGTAVLCLHFFRPQSELKFVSSFFNKTDLRKIFAIGLPSFIVEASVAVIIILYNVTFLHYLGASGVTAYAMVNYIHTVLLTIFLGIGMALQPLVSYHHGARLLERLTALLKIGLATAFILGLTTALIAMLFPSQLMALFGDSSFEIRHMATQGFVHFAIGYVFLGINMVLAEFFQSIEKIRIATTIMLLRSIILFIPTLILLPKVFGSQAIWWTFPVAEGITALLIYGYIKKNPRIIASPGDA
>fig|445932.3.peg.73 Permease of the drug/metabolite transporter (DMT) superfamily
MTQFYFLALAFCWGSAFLATKNIVTEVDPYYGALSRVFFGLLFFIILFIVRRKSIKIPLKEIWKPWVLSSLLISLPFMLMFWGQQHIPSGVAGIFNGTVPIWAFVMGAAFLKGVDSFTWRRAGGVLIGVGGILCIMLPKVHFSGQMSEFYGCLALVGMAISYAAGNVATKHLMVDHNTISIEGNIFHQYVFSAVILAIISVCFGTMPSAETLTQPKVLGSMIYVGVFSSAIAFLLLLELIRRLGALRASAVTYLVPIVALILDFGSTGRIPAGNEFFGVFLIFISLLMIQKPIKK
>fig|445932.3.peg.126 Acriflavin resistance protein
MSDNNKENVGGEVPQTGATVASFFIKRPVTTAMLSIALLVLGVIGFKSMGIDMYPNVELPYVAIQTVLPGASPEEVETSITKIIEESVNTVSGIDEINSYSLDGLSITVIAFELEKDGDVAAQEVRDKVNQIQANLPEGTEAPVISKFDLSSLPVLTIAISGERDVIELTEMSKKLVKESIESISGVGSVNIVGGRKREIHVEVNPFKLYSLGIPISEVKGALQEQNVEIPGGRVEQPSKEFDLRILGRIPTVADFLNVYIGTRNGRPIKISDVGTVIDSGEYERQSTWLNERRTISLEVQKQSGTNTLAVIEGIKARIEEIKPILPEDFQITFLMDQSGNIRESFYSVIEHLILGGLLAAFVVFVFMGSLKSTIISSIAIPISIIGSFFFMWQFGFTLNNMTLLGLTVAVGIVIDDAIVMLENIYRHKEEYGKGAVKAALDGSKEITGAIIATTASIVVIFLPLAFMSGIVGRFVRSYGITVAVAITLSGIVALTLTPMLCAKLLTGDEKKSKIEVYVTKINGWLVAKYLPMLEWALRNRKTMVLISVLLMVSTIPMLVGLEPFIKIVKPSFSVNTQNIVVNTIFKGVGKDFIPQDDSGKIRATIKAPVGVSYEDSMAIFNTLADDLRQLPYIKNMFVSVGVPADSMIGSSPVNEGSILLELEDRNTRNKITTFKYRDEVREIIGKYDGLRTMVVIVAEGPSSGHAQMQYLISGPDIEMLTKYSTAMADKLRKDPRFIDVDVSFSLAKPEYRVIIDRDKAQDLGVKVLDIASALRTMVSGEEDITKFKDGDELYEVRLRVQGEYRANVATVSALLVPSKNEPVRLDSLAKIEEGFGPTQIDRYNRQRQVTVSANPTGGMDIGTGSKVMEEVFRSLNPSEEYNGRIIGMGKEMGKMMSSFIMAFILAFLFKYMILASQMESYTHPVAVLVSLPLTLPFALISLIVTGQTLNIFSLLGLFMLIGVVSKNSILQIDYINTLRSEGLHRLDAILEGNKVRLRPILMTTIALVMGVVSMVFGTGSGAVLRRSLAIVVIGGQTLSLLVTLLMTPVTYTLLDDLGRWIGNLFYKEPKKD
>fig|445932.3.peg.254 Permease of the drug/metabolite transporter (DMT) superfamily
MIYIKLFASILFWSLTFYFVKTALAECGVTTLVFARSVLGLLVVTLFLREFKWLKTLTKKDWLRFFFLAMVGVVIQQNVQGYATMHTSTNHAGWLVALSPIFVAFTMVAFFKERLPKDKMMGFIICILGVLLIFLSKQTFVDGSSMSTLKGDLIFVATAVNWVFYVVPMSIWFKNMPNLRITFCLFLAAVTIMLPIEIVSGSLKDFAHMGPRALSALAYLGIFCSGFAFIFYNEGIEKIGPSKASAFIYAQPLFTMVFGYILLGEVISKEAFIGGALILCGLYLINVRRKRLKRFYITLIRYFRV
>fig|445932.3.peg.410 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVDTISSATEIVKEKNPFKGKTLQGILFKFSAPAVVGIIVNALYNVADRAFIGHAMGPDGIAAITISFPLILFIMACSIMIGVGGSVLFSISLGKKGYKLAERVLGNTFVLLFIVVSLVVGIWELSMDHMLKLLGASKAVAPLAKAYMRIILIGAPIQAVGMGMNNFLRAQGRPLLAMFTMLIGAVINCILGPLFIFYYQWGMEGAAWGVVLSQLVSAVWVCWHFVGKKARFKLKFKNFVLKAKIVSKTLTIGSSQFVLNTAVSVLNVILNLTLVGFGGDLAVSAMGIVSSVNTLIIMPVIGIGQGLQSIIGYYYGAKYYKRMLQFLKMGINWASGITLTGFIIVMLFAPYIVALFHRGTPELTHLASYALRVFNICIPLVGFQIVASTFFQATERAGKAIILTLSRQILLLIPLILILPRIFGLNGIFISGPVSDFATAVLSFVFLRREIKRYL
>fig|445932.3.peg.420 Permease of the drug/metabolite transporter (DMT) superfamily
MHISPYIYALLSNLTFGIGAQIFTKFSRKISPVWMTVFKGSLACLFFFLSVMLMGGFHPIPLKYMATFILSGFIALGLGDILLLKAFADMGPGRTMMLFAFQPLIVGVFSYFLFGQAVNAAKFFSIIFFIICIFIFAFENFKKSGKWSFTSMLIAFCGMTVDAVGILITRYSFNGSNAAALEGNFYRALGAVLSFILVCGVFKINFFAKFKILTKKEIALSSLGVFMGCYLCLLFYLAAIKTGHLATLSSIAITGVIFAGLFECLFERKLPSKYLMTAFFFFCAGMYILLRY
>fig|445932.3.peg.426 Drug resistance transporter, EmrB/QacA family
MLALDSVAGRLRGSKKVIAWLVAVAFFMQMLDGTILNTALPEIAKSFGENPLRMQSVVISYMLTVAFILPISGWLADFLGTKRVFISAIFIFSLGSLCCALSNTLTQLVLSRVLQGVGGALMVPVGRLAVMRIFPKKELVSALSFITIPALVGPIVGPFAGGVIVQYVSWHWIFLINLPIGVVCAVFTYIAMPKVTPVKFKFDWIGYLLFSAAVILISLSLGSVDEATLGRRAAVLMFLAGALCLGAYARLSIAKPWSALFKPRLFYERSFTVGIIANLFIRFAGGSLPFLAPLFLQTALNYSPLKAGVAMLPLGVMSIAAKTFVEPVLNKLGYRRLMTYNAIIIGIMLCFLAFIGPNTSYLFILVYLGVLGIFNSMQFTSLNTLTLIAVPPRDLSQANSLLSAVMQISMGLGVSLVSAALAYFGAHTAKIGSENILYSFHATFVFIGVISILGVILFQSKFARGIVDKPKNM
>fig|445932.3.peg.819 Multiple antibiotic resistance protein marR
MADFRDYGILPEKGRQYEEVIYVMALIYNIINNEASNYLARFDLTPAKFNILMVIKYSGKNDGLTQVEIGKRLIVSAGNITKILDRLSAQGFITRAPSKTDRRANVIKITKIGSDTVEEAWGGYDAILKKASSFLTASEQKNTAFVLKKWFNSLIKGA
>fig|445932.3.peg.956 Outer membrane component of tripartite multidrug resistance system
MNINFVLKKIFILLFLLAAGCNFAAKNKLPETDLPNQYKIEDYSVFDNEKWWEIFEDPTLNMLEETALEYNKNLVIAFERVNMARAEAGIISANSMPQIGFNVGGMRSGGYRVRTNNRFSAGVGASYEIDLWGRQRNLQAAMKARLLSREAQKDVVRLTITADVAKTYFTILAYDSILAKIDAAIKDKDDNIALHKSKFLKNASTELSLRRLEAEKDNMKAIYLEYRIALSANETALSTLIGGSAREIIEESIPRERPLEKMAVVEKMLSQVPSSILHNRPDIRVAEMDLYEAGANIGVIRAGFFPSISLTTATVLVSESMKRLFSGGTWNFAGIITGPIFQGGRNRFKLEELQAQQRILVSTYELTVQKAFKETYDAITSNNINHEILATREREVVTLNRSVTLARKSYLSKKITLTDLLEIQRRALDADIDLSLTLRNQLYFIVDICKTLGGGLRYDHAPGEEPSDAKPEVEKEPAEDTDKEIKK
>fig|445970.5.peg.789 Permease of the drug/metabolite transporter (DMT) superfamily
MKLKDLAFIGAVVLLLAPFFLSNDLYAAYLACNASHPYLMALLKFGILSTAGEVIGLRIKTGRYNEPGFGILPRAVVWGFLGVWIAAMMKTLSIGVPAVAESFGIEGVAAAMKGELTPLKFIGALLISLTMNTTFAPVFMTLHKITDTHILNNGGSLRALVRPIPMRRIISSLNWEVQWGFVFKKTIPFFWIPAHTITFLLAPQYQVLFAALLGVMLGILLSVAAVAGRK
>fig|445970.5.peg.1605 Permease of the drug/metabolite transporter (DMT) superfamily
MERGALKGHGALLLANVIWGLNSPICKTVLLSPENPEGLNHFALTVYRLVGAFLLFWLASAFLPRERVAWRDLGGLFIASLFGIQLDQILFLWGLSLTSPINVSIIATTVPILTMILAMFFLREPITPLKTGGVLLGAAGAVLLILISSRGESGGGSIAGDIITLVSSVCYAIYLTACRKVILKYSPVTTMKWMFFFAAIVVVVLYHRPALEVDFPAVPARVWGGAAFAIVLSTFLAYLMVPIAQHYLRPTVISMYNYVQPVASVLFTVVLGLDVFGFTKAAAAGCIFLGVWLVTMSKSRKDLEAEQAVKMTDKK
>fig|445970.5.peg.1638 Permease of the drug/metabolite transporter (DMT) superfamily
MAPIALVTASLCAAALFSLVPLLWSKAKPIARKDIKTMIGAALLIGVIRKVLLMYGLSRTSPIDGSIIDTITPLLVLLISVVLGIDKFTRLKIAGLVLGMAGAVGVVLLGASGGHTHSGLVGNLMIAGCALATSCYMVWFKKLIARYDVVTMLRWVYCLAALMVLPFGARELVHTDFAAMDTDILLATLFVVFVPTYVPNLLLNYSLKYVQPTVSSIYTYLQPVLAVVLSVAMGLDRLHLDTALCALVIFFGVGLVIRSYRGPAVPSAPLPVHTH
>fig|445970.5.peg.1845 Tetracycline resistance element mobilization regulatory protein rteC
MPVTLCFIKDKHKVMEHKILLETYFAGLLQKVEWQIQEYEDTATDTLTLCRLCVDYLQEILGELKTFIISYPFASTEEEIHFFKELKPLLASKIIYYNTVYKIEVRFPSGSEDVQRDYLLSETDRISKSFQRNLAFYQYHRTKATYLDRQYFMRGKPDIQIIVDSFYYETDPQFSTSHDFKVAKILANELLEIYLTNRLHELERREQRKRVKNGFTGKVLRWTGTKRALVELVYALHACGCLNKGTVDIKEIVAYFEYVFDIDLGDFYHTYMELKAKTKDRTGFLSTLKDRLLLRMREQD
>fig|445971.6.peg.72 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEDLTKGNINKTLIKFAFPIFIANMLQSVYGIVDMIFVGRFVGGKGIAALNSAVMITFIITSICMGITMGGSVLVSKYKGENNGNKIKDTISTLFSISMIFALIVTLISLIIYKKIFIFMNLPSGSLQYANSYMKIISFGIIFIFGYNAATSVIKGLGDSKSPLTFVFIASIVNIILDYILIGLLHIGVNGAAYATIISQAVSFIISIIYLNKHDFIYKLKITNLYIKKDKAIKIIKIGFPCAVQMTILNVSYLIITKILNGYGLEITSAAGIGLKINSFAAMPCWAIGQSVTTIVSQNIGAEKIINVKKTVKAGIIYTLISSFLLIVLIQIFSYEIIELFNKDINIIKEGIIYLRICCSINFVAYGIMYTLDSFMTGLGDSFIAMLNSILQSVIIRILFSIILIHYFNLGYIGIYIAEFLSPILPGIFGIIYYLHFIKLNKAKEKEIE
>fig|445971.6.peg.223 Permease of the drug/metabolite transporter (DMT) superfamily
MSNNKKIMPYITGFLYSFIFGISFAFTSEVLTVLHPLQLPAVRFLFAALFITLLYFFGAFKLNYKGKDLKLLILLAMFEPLLYFIFETYGVKLTTSSLSGTMIATIPVVVCILAVIFLRERPSFLQWVFIVLSVIGSVIVVTGSGSSGGTSETIGILCLLGAVISGAGYNIMNKIVCEKFTAIEVTFFMMWFAAISFGIISIFYSKGFGGYIAAFTNVKVLLILMYLGTVSSVLAFFCYNFTLHNLPIAPAAAFANLITVISVIAGVFVRKEPFTLIQMLGAAIIVAGVFGVNLLGKDEDNGGKSFETDS
>fig|445971.6.peg.230 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDMTKGNIFKILIMFSLPLILSGILQQLYTIVDSVIVGNVVGENSLAAIGATNGITFLIPNLLMGFTTGVSILVSNYYGGDKKEFIPKITASFVITLTIIFTLVSGVCAVFTEGIACLLNTPSNIMDLTVSYLRILFLGVPFLTVYNIYSALFRGIGDSRNPFIAIVIAAFTNVVLDLIFVINFHMGVSGAAIATITAQCFSAVYLVIVAVIKYKLLHFKLSFKSVNSNMLRAGFSLGLPVALQSSIVSFGSLLLQNIMNGFGSNVVADITTAYKVDSLSLLPVINVSSALSTFTAQNVGAKNRERVEKGFKVGAIIILPVSILTALIVVLGGSSFLYMFGVSDEVCYIGKTFLYTCSIFYIFFALHNLFVGFLQGTGSVVITAMSNVISLFVRLVLSYIFASVFGFRIIAYSEIISWIVGALIVFVYYKKKTWLKRVEISGVK
>fig|445971.6.peg.258 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNSISKEFNLSSLIKFSLPTIIMMLFMALYTIVDGVFVSRIVGINGLSAINIIEPLMNLFFGAAIMFGTGGSAIIGRKIGEKKDDEANGDLSLIVLTVFIISAVMSVISLLFLDKIIYFLGASDVLFKYCYDYLKICLTFIPLLMFQLVFSSLFVTAGKPALGLAFTIIAGITNIFLDYIFMVPMDMGISGAALGTTIGYMIPSAAGLIFFIFNKKGLHFGKIDKNLKVLTKCMTNGASEMVGHVSMCITNWMFNVTLMRMLGEQGVAAISLLLYAQFLFNSMYMGFSSGVAPIISYNFGSENKLQLQRIFKNSIKIIMVSTVTIFVMSLVFAQDVVSIFIPKSSDTYGLAIRAYLLFSVTFLFSGFNIFASSMFTALSNGKISALISFMRTFVFIAGAIILLPLIIGVDGLWLAIPIAEVLALIISIICIVKQKDRYNYIN
>fig|445971.6.peg.561 Glycopeptide antibiotics resistance protein
MTLVPYMGEYTYERNYNLIPFASIKSYFESLRYNGFFSGGQPSMVAFINLFGNIGLLLPYGFLLPLAFPGKITFKKTVFTAFLMTTFIEVSQFLFLVSRRADIDDVIFNTLSAVIGYILYFIICHRHYKYYKKHKPNGKYFS
>fig|445971.6.peg.1507 Permease of the drug/metabolite transporter (DMT) superfamily
MKINIKNKSLCADFFLLVMAFIWGSGFIVTKNGLDALSGTQLIFTRFIIAAVTLFIINFKKLNLITKKTIMKSAVIGFVLFLGFTFQTYGLVQTSAGKSAFLTAVYVAIVPFITMFVGKQKPEKHNFIAALMMIIGIFLLTMNPREGLNINYYDGITLIGSIFWAFHVFFVGIFSKDEDPIILCMMQMAFAGLFAFILLIFNGELFTFDITGSIVPMLLYLGVIASAIAFLIQNVAQKYTTPTHAGILMSMESVFGTILGIIFLKEIFTIQMLFGAVIIFTALILAETKFAFLKREKVKIETEDV
>fig|445971.6.peg.1786 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDNILDQKWSAGSLLRFAFPTIVMMIFMGLYTIVDTIFVAQFVNTDALSSINIVCPIINITVGLATMIATGGNAIVSRKMGAGKNQEAKEDFTLLILTGAVIGFLILLGGTIWIDNIIYALGASDLLFPYCKDYLMVLFLFIPANILQTLFSNLFVTAGKPGLGFGLSVLAGVANIVFDYIFIVPCGLGIRGAALGTGLGYLIPTVAGLVYFARSKGTLSFTRPKLKWAVIGESCFNGSSEMVGQLATAVTTFLFNRTMMKLLGENGVAAITIIIYSQFLLNTLYIGYSMGIAPIIGFNYGNRNHIQQKKVLSISMRFIGLASILIFAVSMFGGSYIVRLFADDTSEVYQIAANGFAIFSYSFLFCGLNNFTSAMFTALSNGKVSAVLSFLRTFGLLAGGILLLPRIWGITGVWLAVPVAEGIMFVVSAICLIHYRKKYSY
>fig|445972.6.peg.159 Permease of the drug/metabolite transporter (DMT) superfamily
MKRERLYIILALVTICFWGTTFVSTKILLGVLSPIHIMLLRYVIAYVSLLAIHPKIHRPESLSLEFRYVAAALFGSTLYFLAENFALSFTQAANVSLLISAAPILTSVVAHLTTRDEHLTRNAVGGFFVAMTGIALVVFNGSFVLKLSPKGDLLAVAAALSWAFYSVILRGIRSSYPPVYVTRRIFFYSILTMLPCLLFDAAPFDMAVLKEPLILGNLLFLGLIASSLCYVLWNYVVAGLGAVRSNNFVYLNPLITMIASVIVLHERITPLMIAGAILILLGVIVSEGTLLKRQDTAAQR
>fig|445972.6.peg.662 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKDLTCGAPAPLLFKFSIPVILGNLFQLFYTLADTVIVGRTLGPEALAAVGATGTIIYFILCFVQGLTSGFAILLAQYFGAGDEKNVRRCVGISTLLSLFFSIVITAVICILARPVLAVMDTPGDIFELAYDYMIVIFYGAFTTIFYNLISNILRALGDSRTPLYFLVFSSLLNIVLDIVFIVPLDMGVGGAAWATNLSQLLAAVFCAAYAVQRFDAMRLKRSDWNLDRFLVLQHLKIGFPMGFQMSVMCIGQMAMQAAVNAIGTNAVAGYTAATKVDQMSVLVNNAFGVTLSTYVAQNYGAGKIDRIKRGFNACFLMTECANLLMGALILLIEPVIVPLFVDSPGLEILSFARTYFLVVIPFYPVLGALLCYRTAVQSMGNPKAPFLACVIELVLRVVCALLLSRFWGYPGICFSTPMAWIGATALLIPVYYAMLRRLLNIQPPQCEN
>fig|445972.6.peg.1074 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRQDGRFLHGVFSRFLFPTVLSVLGGTVNVMVDSAIVGNMMGAQALAAINLCGPIFLLCSTAGSLIGSGAGLLAAAQIGRGESERSCVCYTLCVALQFLFGFLLTIGGLLFLRPVVRLLGADDTLFAMALSYARIAFWGAPVKCLLYVPFNFLRLDGKPAMVSVSLLAMTALNGVLDYLLIKVGWGLAGASLASVLATCLGVAVGFVCLHGGSFRLIVPHGGASILRELLVLGTPPALNNLLSVVRMILLNRILMAAGGSGFVAIFTVVGSVSDFTLCVISGVPQTASPLVGIYSSERNNPGMRLLVRMQLCYGGVLIGGMAAAIILAPGLICTLFGLTQTAQAVWALRLFALSLPMAMLCSILIFFYNASGQVPLANGVTVCRVLLFAVIPAFVLSRAGFPVWWFFPLSELLTLAALFVALWRKARPDTLRSPILLLDEAYDRMGKVIDFSVEARADAVGRAAELIGGFCEQNNLTARQTMAVSLSIEEMLTIMMKHCFKEQSQATVDVRVFVIQGEVGLRIRNAGKQFNPIDYYQAHQAADEMGEALGIRMILKLAQSVCYQRTFGVNTLTILL
>fig|445972.6.peg.1397 Phosphotransferase (aminonucleoside antibiotic resistance)
MINYLHKYPVEVVVLCPDVETIKERERYREKTGYSGFTVETLYDTFMQTTPRIGFWLDNSNQTPQQTAETILNTRKPV
>fig|445972.6.peg.1450 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKQFFKQVLPAMAAFAFSGLYTIVDGFFIGRSVGDVGLAAVNIAYPLSALLQAAGTGIGMGAAVCISVCRGRGDTRGERGHLGGAFLLLAAAGVLLAVSLFSFGTPALAALGARGEVLEQAIVYLRVILLGIPFQLAATALAPLIRNYDGALAAMGAMIAGFVTNIVLDALFVSVFGWGMAGAAGATVIGQIVTAVPCAFYLWRVTFRIGSGPVRPAGHMCGSILRTAVSPFGLAMSPLFVIMLLNKAASVYGGESSVAAYAVISYATAVVMLLLQGVGDGSQPQMSLYFGMDRPERTKAVRNLAYAFAAVTAVANIVALCLLRAAIPVFFGASGEAAAMAAKAMPVFTIGFIPIAFCRVTTAYFYATQHNRPAYVMVYGEAVLLALLLAFVLPRMIGMDGVWISLPVAQILLMLIGCGLLWRSRRNRVKDSGKVSNETVCDTPAL
>fig|445972.6.peg.1513 Methicillin resistance factor
MEILTPEQYGEFEAFVSAHPQGCFTQSVNWQKVKNNWGYEAVVSRTADGTIQGAVSVLVQKIPLIGTSFLYAPRGPVCDPHDRAVLADLKAGVDALAKKYRAHAFKMDPDVLMSDAEFIRIAKDMGFVQSYGPDGFEGIQARFNYRLYLNGRTEDELFANLTQGTRRKVRIAIKNDVQVRPVGPEYLDEFVRIMRVTGARDGFNVRPRAYFERMLDALGEHVRLYMGFYQGTPVCGAVTTNYAGKCCYVYGASDNVHRDVMPNYLMQWEMIKWAVQTGCEVYDFQGVSGDLEGGHMAGLYQFKRGFNGQLDELAGEFDYTYKPIKAKLVDRAIDLNGKLGQLKKKLRRS
>fig|445972.6.peg.2287 Permease of the drug/metabolite transporter (DMT) superfamily
MANKLGSTSMHPLMVGAVRFTVTTLLIALAAAARGVPLRITRRDWKTLGTGSFLMYFLNTLLVLFAAVRVDASISTIVLCLIPVGLVLVDSLAQRHFDVGPPGVIGMAGGFAGVVIASASGLLGGGADIGGITLLLASVCVWSVGTIYLKNRTVEAPFILQIFVQSAVPAAAFLLTALFTGTLRPSTLNLGGVLPAVYMGVADSIIGLGSYMYLLKRWPTSVVSTYAYINPIVGLMMSHLVLHESMNAQKMAGAAVILFSVLLIREDGRLTAWLRARRRAKAG
>fig|445972.6.peg.3588 Glyoxalase/bleomycin resistance protein/dioxygenase
MRIKGIDHVTINLKDVARSLWFYGELLGFERLPDVDMGDHLLRYFALPGGGRLELTEYRYETADCGNTATDKGRARHLAFEVEDVYALEKKLTDAGYLFHVPVSHVEKLGFSGGLTRDPNGFELEFLQYD
>fig|445972.6.peg.3789 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTGKNAARAQRAEIRSEYFRYLVPTIIGQVAHCCYCLADVFFVGLGVGKDGLAALNVALPIFTVYTTFSIMVGVGAATTISVCRGRGEDENVDRVFTMAVVTVLILGALLSVFGTLFLREIAYLFGATDLIVGHVVGYLAPISPFSFIYMLSSAMCVIVRSDGNPRLVMVAATTGNILNIVLDYVFVLPLGMGTFGAGLATIIGPVVTCLLLSMHFLRHYNQVHFTRRFFSPRLFARMVRNGAGSGVLETSSGFVILMFNLTLLRVSGETAVAIFSIISNIGYVGKGIFNGMAQAAQPIISISYGSGTYSRMKTVNRFAMLTALSFSLVVFGLIVLFPGQIITLFISSDAQIIAMGAPAVVLYFLSLPFTGLNTILMYYFQSTEHARITALVAVLRGIVLVYAALRIFSSLWGLTGVWLALFAAEALTFLAFYPVKLHLDARLSDGKIV
>fig|445973.7.peg.607 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKTNQNQMGTKPIASLIFTMGCPPIVSMFVQSMYNIVDSIFVAKLGENALTAVSLAAPIQYILLAVSVGVGVGINSYISRNLGADNIDEANNTVTHSMILALAHSVLFIILGLLFIKPFFRIYANNDAIFSDGCSYTYIVVLLSFSLFFQLTFEKVFQATGKMLLPTISQIIGAILNIILDPIFIFGWFGMPKLGVTGAAIATVIGQIVSFLILLIFFIRNDSVLKIDLKLFKFDWNIIKQIYAVGIPSALMISISSILTISLNSVLVKFSNTAVSIYGIYYRLQTFITMPVNGLVQGIRPIIGFNYGAKDRGRIIETLKISLIVSVVLMLIGLLLFMFIPRQLLSMFSASENMMSLGVVTLRIMSLGFLFSAISFIISAMYESIGKGTYSLAISLVRQCIIIIPVSMFFYKIIGLTGIWITFPVSEIAAALVCLWMFIRTCKKDEVFIKNND
>fig|445973.7.peg.770 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKKINLTEGGIVEKLVKIAIPIMATSFIQIAYNLIDMMWVGKNGSNSVAAVGTAGFYPWLAMAFVMFSKIGGEVKVAQSMGEKNIKEVKSYIKSSIELNVFLSVTYSLILILFNKQLIDIFNLGNAEVISMSRQYLVILGLGMIFYFINPVFTSIFIGLGNSSIPFRINTIGLIANIILDPLLIFGFGPIPALGTNGAGIATISAQIVVSFVFIGYIIKNRIEYFKVTYFRKIEFKYFKILYKLGFPVAIQNALFTLISMAMGVIVASFGPVAVAVQKVGSQIESISWMSADGFASALSTFTGQNYGAYKFDRIDKGSKIGLIGAIIWGSITTVVLVFFGEIIFRAFINEQDAIIKGIDYLRILGYSQLFMCIEITITGILKGLGRTYIPSFISIALNLARIPMAIVLSKPDILGINGIWWSIAISSIFKGLVLLLIFAILYKAKKLYKIEEGKKDLNKDKELCS
>fig|445973.7.peg.802 Multidrug resistance ABC transporter ATP-binding and permease protein
MTKLFKYLKQSWVAIFTILILLALQATTELSLPTYTSNIVNVGIQQSGIENATIKAIRESEMNKLTTFMNDSDKEKVLDNYKLVNKDNLSKEEFNNYKKEYPVIKKEIFICIIN
>fig|445973.7.peg.883 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNKELLYKLCLIVCSIIWGSTFVVIKDATNTMSSGFINASRFTIAAVILLAVYFKKIKNINKSELKHGIIMGVALFGGYYLQVLGMEYGSTAGKCAFLSATFCVMVPFLSWGVFKKVPDKYSVIAAILCIIGVALVSIENGAHITVGDGIILISAFFYAVNIMFTSEFSTRENNDTIILAFLQIAVVGILSWIVVLIKGEMPQVYHARAVMGVVYLGIFATALCLLMQVIGLKHINSTSASIILSLESVFGVMISIAFYNEVVTPKLMAGFVVIFIGIIVCETKLNFLKQKISIKKSITGNYKNNNNSKHLDANESAL
>fig|445973.7.peg.933 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKLNLLRDKESKVFFHYLIPAICSTLVTSVYLLVDTLIIGQGVGALGISALNIFMPFFLIFNGLGLLFGIGSGILISAEDGMGNKKKSNQYFITGLVSVVSLALVLSLIWNHYLESLCIFLGANDDTIGLVLEYGKCIMMFAPVFIMSNYLAPIIRNMKNPKLVMCGVLTGSFLNIILDYVFVFPMDMGMFGAALATVIGSVTTVLVLSTHFIKKQNRVKINKETISLKLVTPILKCGFSSLIMEVANGFVIFIFNIQILKYIGNNGIVVYGIISNCVLVGLALFNGVAQAAQPIIATNFGAKESSRVKKVLKYAMITTTIIGISLFAVVFLFTGQVIQIFVKANAEILSVGIPALRLYLSAFCIMNINILISGYFQSVGKEKIAIYVSIVRGFLLNIILAFVLPSVLPATILWAIVPLSELITLIGIAFYAKNSSTIENTALNEEFISA
>fig|445973.7.peg.940 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNDMTKGNPLKIFIYFTIPLLIGNIFQQLYSMVDTIIVGRFVGVNALAALGACNSLFFLVNGLVLGLTSGFAVLVAQKFGAKDEKGVKKAVASNITLTIVLTVIITIVALLAVKPLLNMMNTPENIYEDARVYITLIYAGIITQTGYNMAAGILRALGDSKTPLYFLIVASILNVILDLIFIINFNMGVAGAAYATNIAQGVSAVLCFIYSYKKFKILRLKKEDFKVEKEYYTTHLKIAIPMSMQFSVTAVGIIIIQSAINTFGSVVIASYTAASKVLQLVMQPSTSFGVTVATYAGQNLGAGRFDRIKHGIKIMNIVSIITSLIAGVVLVTLGKYFVMLFIENPTPEIFAYAQQVLNYSAIFFIPLGFIFVYRNVLQGMGESFVPMMAGFFELAARATVAFTLPKVIGFTGICLSDPIAWISACVPLMLTYYIKMKKIDKKNKLNEEINNPAGVL
>fig|445973.7.peg.1036 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVTQMTKGSISKQLILFSIPILISNLFQQLYNTVDTAIVGRFVGANALAAVGTCNLVVVFMIYFFIGLSNGSSIVLSQCFGENDEEKVFKTVHTTMGLSFISGIVLMIVGLLCAETILKMINTPDDVIGYAVTYIRVYFLSMIPMMIYNMGTGILRAMGDSKTPLYYLGAAGILNIILDLVFIIVFNMGVMGAALATTLSQTLSAILILIKLISSNEVYKLHISKIKIDKDILKHILVIGVPTGLQSVLVCFSNIIVQSKVNLFGLDVMAALTVYYKIEGFIYMPIEALAMAASNFIGQNIGARNVERVKKGKSLSMKICVGMTVLIGGLIMIFKTPILHVFTTDSEVVKYGSQFIMFIVPLYFIYAMNQILSGVLRGAGKTFVPMLIGLVCMCGFRVGWLVVMMGIVKDVRIIYASYPLTWILTNIAMTAYYYKSSWIKKRH
>fig|445973.7.peg.1099 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQTYDLTQGNIKRQLIYLSIPLLIGSIFQQFYNTIDSIIVGTYVGHDAFAAIGISGTVMNLFIFIIIGCCTGVSIITAQLYGEKNYDKMRNEIFLSSILGIAVTIIISILGILFMPIILNIIQTPVELTGYVTQYMNVILGGLITTFLYNFLSSILRSVGNTRMSLIFLVISIFLNVILDLLLIKQFSMGIMGAALATVISQAVSALLCYFYIIYKIPFLKVKKIDMKYNSGLIRLTCQYSFVSALHQSSLYIGKLLVQGAVNSLGVDAISAYTATGRIEDVILAFGNSGSEATSIFIAQNTGAKNQKRVLEGFKDALVLIQLVCIGLILFIFFRSDILLNFFVFDEGKTVLNYGVQYFRILSFFYIISLVGSIFVGFYRGTGHVNIPVIGTTLQISIRVILSYLLVKFMGIGGVALATGIGWIGIVTFQISVFVIKKYYKVKEEEE
>fig|445973.7.peg.1214 Vancomycin B-type resistance protein VanW
MQDINLSDLTKEEATKKINSYIEQNNEFELFYNNESILVNKETLGVDYKVDELVDRAYSIGRDKDLITDMKTKISLKKGEKKIIPLTCSYNIKKVDNLIDKIYSKLYISPKDASAKIVNGNIVVYEEHKGQAVDKENLKDIIVYKIENLDSSQSEIPLDVLNPKYTYDQLMKIDTLLGSYETYFNPKRKNRVNNITVAAKSTSDILVNTNEKFSFNQQLRDNDAYNKLKVASIILNGKHDKGVGGGICQVSTTIYNAALYAGMDIVKITNHSIPSPYVTKGRDATVSNGSMDFVFKNNNNNPIIVHNEIFENKIVSKIYGCSSDKRNIEIETEIVETIKNKKIYKSDSKLQKGTKVVEQEGRLGYTVNTFRLYKSNNEILKKELVNTSYYPPCDEIILKGTKDNTLYK
>fig|445973.7.peg.1227 Erythromycin resistance protein( EC:2.1.1.48 )
MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKSYWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIKKLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPSVDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISEVSYNDWIQLFRYKQKID
>fig|445973.7.peg.1251 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANENKILEEEKISKLLLKFSVPCIMGLLISAFYNIVDQIFIGNSTLGYLGNAATGVSFPVICIANAFAWCVGDGAASYLSICAGRKDTDSAHKSVGTGITVTLLISIVLMLICEIAAVPLMNLFGASDQTLGLSVTYFRIVAAFFPFYLLLNVMNSMIRADGSPAFAMKAMVMGAIINIILDPIFIFLLKWGIAGAAWATAIGQVVSFAMCAVYFFKPKSFKLKKSSFIPNITILSKMINLGAATFITQISIVAVTLVSNMTLARYGALSKYGPDIPISVFSIQTKVYTIVLNIVTGIVLGGQPIFGYNYGAKRMDRVREAYKIVLRATLITGITATIIFQLWPKAVVGIFGSGNGLYQEFAVKTFRIYLSLMTVTCLVKMTAVFFQSIGKSKYAVMASVIRDIICFAPLAIILPAILEGSESGTGINGILYAAPISDLVAIAVIFVLTISFFRKLNKEIVIEEQKELAS
>fig|445973.7.peg.1278 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNTLQNRITFTSLIKYTLPTIIMMICFSLYTIIDGMFISRFVGADALSASNIVYPIIFLVLGVGTMFATGGSAIVARKLGENNVDEARENFTLITLGALMVGMIIEIITIIFMKKIIYLLGSTDALYFYCKEYLLYMILFTPFIILKFFFDYFLVTAGAAKLGLFSGLLGGVVNIILDYVFMVNINMGIKGAALATCIGYIVPSFIGIFYFLNKKHTLHFVKPKLTLNVLANCCSNGYSEMITQISNCVTTFVYNVVLMKLLGADGVASITIILYIQMLLNAAYMGFISGVQPRISFNYGSKNSEQLKNIIKYSLMIIYIFALFTFSLSRQNANFLISIFTSKESSLFGITHNAFMIFSFGFLFNGINIFTSGMFTAFSNGKVSAIISSLRTFIFFIIGMMIFPNLFGVNGVWMVVPFAEIITLIVSLVYIYKYRKEYMYENIFTKESVAV
>fig|445973.7.peg.1290 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQAKCQVDMTYGDIPKQLFMFTIPILLSQILQQFYNIADTAIIGQYVGTDALAAIGSTGLLIAVIVNFFIGLSTGVSAVIANQFGAHEYEKLRKSIATSLLISIVLGIVFTIGSLIFMKSIINLLQTPKDVYYLAVDYLKICFLGITFQLLYNIGTAILRALGNTKDPLYFLVFSCVLNLILDILFIVYFGWGVKGAAIATLVSQILAALLVLWKIMHLDDECRINLKQIGIYKGYIEDIFLVGIPAGLQAIFMSISSLIIQSSINSFGAEAMAGMTVFGKVEGFLYFPLFSLGLAVTGFVGQNFGAKEYERVKEGINISLKLSVYISIIFIIILNIFAPYILRLFTHDLQVIKVGLESIRIVFPSYVFYAINQIYIGSLRGIEKTFEPMIIALFAHCIFRVVWCSVLLKYFHDMKVIYSSYSVSILIMFALLYFSYKKHICKKYFKQEVSNID
>fig|445973.7.peg.1429 Vancomycin B-type resistance protein VanW
MSEDTAVKQKGDFKSKRNIILIILIVIIIVFVGILNYFTSKNLYNGKIAQNIYIEDVNVSNMTKQEALETIDAKYPTKKVNLSYNNEYYTIEPNQVDLSYDTKDVVDSAYNLTRENSYFSNIVTYISTKFKGHDFSIKVSYDEDKLDKKISSISKQINKSSVDASISVTSGIYVKESQTGLKCDDKENKKLIEKAYKDKNYETIALKVDVTQPKIKTEDLKSIDSVLAGYSTTFNSSIYGRSYNIALALKRCSTVVMPGETFSYNKATGPRTISNGFQNASVIVSGTYQDAPGGGVCQGSTTLFNAALLSGLDITQVRNHSKTSSYVPRGRDAMVNDSDSDFKFTNNFNHPVYISAYAGGGQASVKIYGSSQDKVSVSIKTDNFIYNGLPGAKTYRTITKNGKSETKHIYTAVYQE
>fig|445973.7.peg.1504 Permease of the drug/metabolite transporter (DMT) superfamily
MFSKYKGEIGLGLTALIWGSGFIGVSISLSGGLTPLQIMTIRFFIGAVLLGIIFFKEIKNNITKEAVKAGSMIGVFLFIAFAFQTIGMSYTTASKNAFLTAINVVIVPFIGFVLYKRPLDKYGIISSIIAILGIRILSLEADFSINFGDFLTIICAFGFAFHIFFTGEFVKKHNAIVLTVVQFSVATVLSLIVQILFNEIKIEVQISSIIGVLYLGIFSTTVAFLLQTVCQKDVSETKSAIILSLESVFGSILSVIILHEVLTFRMVVGCLVIFCAIIISETKLSFLKKDKLKEEKTNSMN
>fig|445973.7.peg.1505 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENYMTEGNAAKSIAYFSIPLVLSSVFQQLYNLVDSIIVGNYVGEDALAAVGASYSITMVFISIAIGSGIGCAVVISQYYGAKMIHKMKTSIYTSIIAIAILSVFLACIGWIMSDFLLQIMKTPDNIFYDALSYLKIYFLGLTFMFLYNIITSIFNALGESKIPLYFLIFSSFLNILLDLIFVVKLQYGVVGVAIATLIAQGISAFLSITYLLFNLKKFKTEDEVAIDLGLNNKSAKVKTNKKENINKRKDSKDIKLFDFAILKNMNKIAIPSIFQQSFVYISIFLVQIIVNTFGSSIIAGYTIATKIDSITMIPLASFGNAVGTFTAQNIGAKKIERVKEGLKSSLIIITLMSLAIFAVLFIFGQNIIELFLNKSQSEDAIDFALKYLRIVSGFYIVKGFMNAYTGVLKGAGDIGVFVLSTMLNFLVRLIIVYVFANTIGVSVIYYGVPIGWFVGLLIGYIRYKSEKWKFKSIVK
>fig|445973.7.peg.1527 Vancomycin B-type resistance protein VanW
MYKRIISVILIFIIMICCLGNNKANNNKQEKIYKNIYIEDIDMSNMTKKECIDILKEAYPLEDINLKYEGKTWTIHPKDIDFRYKIEEATDIAMKYTKTDKRLENLKRKSKLILNERHHIPLDEEYDKEKLSAVIDCISNQIDREYVNATLAIEKDGTFKRLPSKEGKKVQKDELQKEIDELIQNKNITDLNIPVKTTLPTLNSDDVQSVNSILGQFSTAFNNHTSRGSNIHTAGESSGDIILMPQEIYSYNKATGPRVLSKGYKYAPVIIGGKYRNGEGGGVCQVSTTIYNAALLAGLEIVEVHNHTYISHYVSGGRDATVAYGYYDLKFKNPYSHPIYIKNIVGDGAITTKIYGCKDDIKRIYVRTEYEYKKQKIIVKTYRVYLDQNNQKIKEELISTNKYDQK
>fig|445973.7.peg.1907 Permease of the drug/metabolite transporter (DMT) superfamily
MEEKLSTEQNKNFFQKNINIVICSIFCTALWGSAFPCVKLGYELFNIGVDDTFSKILFAGWRFFLAGILVLLIATCMQKKFPKLKKESVKGIALLGFVETTLEYVFFYIGLSYASGFKGAILNPTSTFMMVILAHFFYKDDRLNFRKSLGCIVGFLGIIIVNLTGDIDSSFSFLGEGCLLISALAFALGSIISKEVTKVEDNPMTVTGYQLSIGGIILIALGFIGGARLHVTSTSAMLLFLYLALLSSIAFSLWTTLFKYNPVSKVSIFNFLTPIFGTILSALILSEDVFNLRNLVALILVCLGIYIVNKPKEKETSIN
>fig|445973.7.peg.1934 Vancomycin B-type resistance protein VanW
MTGLGVYCINGDKISKNVYVQNINIGDLTKDEAKDKLSSEYKIQSFKFNYKEKTWDIDPKTLDINYDLDKTINKAYDVNRKGNIIQNIFKSLQNLAGIKTKVNLVMNCDEDKLKSELEKISKEVNKDSKDATIKIEKKKVKVVKEETGLKLDIEKTKENFIEDINKGKSTQKLVVSQIKPKIKSSDLKGIDTLLGSYSTTLYDSGYGRVQNIKLATKKTSDVILMPGETFSYNKHTGVRSAENGYKLAHVISSGKVAYGIGGGVCQVSSTLFNAVLYSGLDIVSRTNHSIPSTYVDLGRDATVSDSGIDFVFKNNYKHPVFIKNNYKDGVIKCQIFGHKSDKKNIEISTKYGYNITTYRTYYDNNKKEIKKEAVCTSAYLSRSH
>fig|445973.7.peg.2269 Regulatory protein, MerR:TipAS antibiotic-recognition
MKDLTFNISETSRITGLSIDTLRYYDKIDLIKSKKNPNNRYRYYTIEDISIISHIKNLRDLDLSICDIKSLLHSDPEVQRQILKNHHKVLLEKVATIKKIEKVFKDTLKEVNSSDLMINVPVIKSYTDRYFKKLKNNVKTNKCSISKKNLLDTSTNFLDILDKFVFSFSDKNFDSTNLFDFFEYGKVSENQEYYTEISHEEFEVMEDTKDILVVPHSNYIETITKLSKDNFDEYFENLIGWIDFKNLNPIYPGFIKYLDTSLYFMNEGECLVQFQIPFKHKKYE
>fig|446462.8.peg.1294 
MLLVCRFDVPEEAAEPFTARVAQALSLLTAQPGCLSADLARSMDEPDRYVLTARFESVVAYRRSLSPFPVREAVVPLLSEAIAEQSGTYEPLLTSGGGEVERRTSLVASDAFTVRLGEAAEPSSTPR
>fig|446462.8.peg.4399 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRESAEALGTAPVGRLLWRACSQTTLSVGVYGIYALTNAWFVARGVGAEAMAAVNLVAPVLLVLGAVSTTVGAGGASLVSRALGAGDAATAGRAAGNAFTVFWGAAVVVTALGLLGVEPLLTALGARDGAREVAREYAVVILAGSVLSTGFSSLVRAEGRLRFSTLLWLAPVLVQISLDPVLIFGFDLGVRGAALGTVGGQAVSALLSLWFFFVQRERPYRVRAADLLPHGPTVRALLGIGAPSFLAGFGTTLLAVLVNTALAGAGAAALAAYAVAARVQTFATMPLVGIGQGLQPVVGYNAGRGLHARVVRAKDLALRVAVGYGLVASALVVVFAGPLVSVFLDDPAVAGQAATALRFVAVGFAAAGITPLVAGYAQSLGATRQAWALAVGTLALVRAPLVVVLGGGGTTGVWVALAAGEVGSALCALVVLRRLRPGGVSAG
>fig|446462.8.peg.5925 Drug resistance transporter, Bcr/CflA family
MGVTAVQGRGKLVALLGVLCCLGPLSIDAYLPAFPDMAKEFGAGESQIQLSLTTFIIGLSVGQLLIGPLSDSIGRRKPLLFGIGSYVVLSLVCAMAPSAVALAAFRLLQGLGVAAGFVVAMAVARDRFSGLAMAKFMSLIMLVNGLGPMLAPVLGGQVLRYASWRATFVVLAVIAVVLLVLMAVGLKETLPPEKRRPLDLGGTLRVFGGLLTDRVFVGYVLASAFALGAIFGYVSGSSFVLQGVFGLSPQEFSLVFALNSAGIFVAGVINTALTGRIMPRGLLRIGLSTAVLAGVALVVAGALGGGLVAFLVPLFLVTCSIGLLMPNAATLAMARHPEAAGSSSALLGVSQFLMGGLMAPVVGAGGSTSVLPLALVMAACTALALTSFLVLTRGDKGITKDEPEVVEAEQTPAASAV
>fig|446466.7.peg.991 Vancomycin B-type resistance protein VanW
MRAHEQLGGSIMHGTDRDTPTGGADRDSADVPRGGVPQPHDAPEATVPEPPTSDATTDGSTGTDAPAADADGTAEATDAPAADAATQDAPAGADAVDAPVTTGEDGPRGSTPPPAVPPPVTRARPLAPEPAAPLAAWPSWDDVAVTAPPPEPAPPAAGSAEPAAPEPAAEPSATQASDAGQEPTAQAPARPGRADERADEPEAPAAGPRSGSVPTGTASAGTASAAPAPVPGAPGPLPPLDLGSLSALAFTALNAASVGVPAHALPKDAPARPGDADADGPDGAAAAGPEASGPAADTEGSATENEAAAAPDDATDASAQAAGEQGLAGDAAPGAGSATGAPTPVDVERVAAEPVDAEPVAAEPVDAEPAAERADEVEAVPSVPRTDDTAVVPPTPRPDETTVLPAAGTDVATRATPAAPTVPPRRTSALAAPQAPAEPVAPAGPEPDDASPLAVFEPEESDRRWPRALAITGGALALLAAVYVGSSFALADRVPRGATVAGVEIGGLSSAQAEQHLRDELAERTTSPVAVVAQEVQAEVDPVAAGLELDAAATVARLTGVDLAQPARVWRHVVGVGEQRPVTVADESALDTALTQLSGSLVLAPVDGTVVFADGAAHSTDAVDGWELDTAGAAAVLEDGWLTAEQPVELPTSAVPPAVTQEETDRALAELAQPLAAAPVTVQVADRQAVLDVATLTAHAAVVPVDGQLQLQLDGEALSQSVLAQLPDLLTSASDARFEFQGGAPVIVPGTPGTTLDPATLSASVAQAATAGEGRLAAVDLVESDPAETTAALEALGVKEIVSEFSTPLTSEPRRTSNIATGLRNITGTLVRPGEVFSLTEALGPVDAAHGFVQAGAIVNGEHTDAWGGGLSQVSTTAFNAGYFAGYEDVEHKPHSEWFQRYPEGREATIFTGVLDMRWRNNTPYGALVQGFVADGRAHVRIWSTKHFTVETEKSGRSGVVAPTTVYSQSPTCEPQSAGNPGFTVTNTRKVYLNGELVATEPFTWRYKPQNKVICGTAPAPGASPTP
>fig|446466.7.peg.1045 Multidrug resistance transporter, MFS superfamily
MAGMHEPDPTADARSDAPVPDALSATDATPRSRAPVTSRVPATPDAPAPSDARAPAPAGDPVHRPDARHVLLLGTMCALPAISTDIYLPSLPEVAQDLGTSAAAVQLTMTGMLVGGAVGQLVIGPLSDRFGRRAPVLVGVALHVLVSLLCAVAPAIVPLVALRVAQGFFNASATVVAMAVIRDRFTGADASRLMSRLMLVIGAAPLFAPSLGGLIAGQWGWRAVFVVLAAFGVVLWLIVLRRLPETLPPARRRPGGVRTALSGYLALLRDRHFVALAVLPGLTMAVLMTYVVASPFVLRVGYGLTEQQFALLFAVNGIGLVLGAQVNAAVVRRVAPVRILRVALVATVVLTGVLLGVALTGVGGVWSLVAVLWLVLALVNFAPPNATALALGRHGAMAGTAAAFIGSLQAGTGGLVANVSGLLGGGAVAMAAVMLASSTVALAVLALATPAFWRGGAWQAS
>fig|446466.7.peg.3360 
MAARGRVVFLVRVAPEKADAFLAAYEQVRHDVARGVPGHVRDQVCRSATDPEQWLITSEWDALEDFEAWERSPEHVDLVRPLRACFTDARSLRFTVVAETTRATPAPLPVP
>fig|446468.6.peg.1311 Glyoxalase/bleomycin resistance protein/dioxygenase
MFDTTRAFGSFAVRDPDRAREFYGTTLGLTVGPVEGMEEHGLLSIDLGEGRAVLVYPKPDHEPAGFTVLNLPVDDIDAVVDELARRGVGTLRYEGFDQDGKGISRGVPTVAWFADPFGNVCSVIQEA
>fig|446468.6.peg.1329 Glyoxalase/bleomycin resistance protein/dioxygenase
MYVKFAELPVFDQERAKAFYTDRLGCTVVTDAPMSDDGWRWIELGFPGSRTHLHFQRRADEDPSAEPVMVLVTEDVEGTVEALRAEGVEIVTEPQEAMWQPGVTAAEFRDSEGNRMVLSDS
>fig|446468.6.peg.3671 
MSSVVKFNVLTVPEGAGATLEERFAKRAGLVEDQPGFEEFQLLRPVEGTDKYLVYTRWRSEEDFQNWVNGQAFRQGHAQAAADAQKEGASAGHGRGHGHGHGGPAATNSEIWGFEVVQRVSARS
>fig|446468.6.peg.4421 Small multidrug resistance protein, SMR family
MAWFFLVATVVTEVLGAFATRASDGFTAPVPTVLAVVSVVAAYYLFSLALRHGMPVGVAYGLWTALGVAAVAALGVALLGEALTWPRVGGLLLVTVGTAFLQMGGREEGERAAAGPTPGPGE
>fig|446468.6.peg.4956 Phosphotransferase (aminonucleoside antibiotic resistance)
MAPLVAARYPRAAHISGDVLSYMVVQGRVGFNGRPAEEARRQLRLCVRNMCDLAANFADNGVFPVVEYTIDNRRMLDAMVEMLRPRPVMFVALFPPLEVCRRRNATRDPGHRVDFDFAPHYRAMREDLGGVGWWLDTAALTPEETADLIRARAHEEALL
>fig|446468.6.peg.5194 
MSETVIRANDGLAVLVNVFEVEKEKQQQLVDVLNEGTEKVMKNRPGFVSVNILASLDGTKVINLAQWNSPADIQATMADPEAQAYGKKAAALATPAPGVYSVVSTHHA
>fig|446468.6.peg.5195 Glyoxalase/bleomycin resistance protein/dioxygenase
MRPSRESSVRLHYGSSGCGRSRPVGPERKPMLTHPRLSVLYTSDQQRTLDFLTEALGFRLEVDTVHQGGQRWVEVHLPGSQTSVALAQVDSGLLEEVRSRVGRMAQGWFNCDDLDAVCENLRGQGVEILTEPQDTAWRKGNRWAQISGWDGNVYGLIEGGR
>fig|446469.4.peg.296 Probable drug transporter, MFS family
MLGERRLAAALWCAGLATFALLYAPQGLLTDVSASLAVSPSRAALLVSGATLGLAASVLPWAWLSDRIGRPEAMRAAAVASAVLAVLVPWLPTFELLVVGRFVQGAALGGIPALAIALVHDCALPTRAAALAGSYVAATSVGGLAGRLLSVPVAQHLGWRMGLVAVGACLTALMALLVLLLPHGREHRARRAAARLAVAGRAEPTRSGAHLRAHLRDGTLVSLFCIGGLLVGGLAAVFNYLPFRLEAQPYGLAPTVVSLVFLTYLAGTVGSRLAGALSDRWSPRVVLVLACALMGAGALVTLARPLVVVVLGVTVLTTGLFVGHAVAASRVGARATTGRAQATALYTVVYYAGASLFGWLAGHAWDARGWPAVVALVVGLAAVALVLSARPAPSERPVTHTTD
>fig|446469.4.peg.786 Aminoglycoside/hydroxyurea antibiotic resistance kinase( EC:2.7.1.87 )
MPPDEHLVTEHLQRHLERWGLEPDGPLTETATSVLLPVRRGPDLALLKVARVDEERVGGQLMAWWDGRGAARVLEHDDSAVLLERATGPRSLTVLAGTDVGSPGWVREDVRATQVLCDVARTLHAVDDVETQRPEHLTPLTTWFRDLLALEGERRGFVHRSAVVARGLLADPWDETVLHGDLHHGNVLDFGTVQGAQWRAIDPKSLVGERGFDLANILCNPSTAVATAPGRLSRQVVAISEATGIDRVRMLQWVVAWTGLSATWHGESTDAGRAARAVTIQVGRTAEDLLRAM
>fig|446469.4.peg.1630 Drug:proton antiporter
MRSTPTPASTTARSALRSPGFRLLTVAWGFTNFADSVLALILAVWVKDLTGSDSLGGLVFAALGLPALVSPLLGQVADRVSRRRMMTATYTTGAVSLLALFAVQGPRDVWVVFAVTVIYSLVGFATTAAQSGLVRDMLPDEALAAANGRLTTIDQVFRLTMPLLGAGVYVATGPLPLVTAAAASFAVAAVVVARIRLVETPPTARDEREPFRTEVTAGFRHLLRTPPLGALTVALLVACGAVGLLNASSFAIIDQGLGLGPEMLGPVSSVQGATAIVAGLTAARLVARWGSPRLVTVGLGAVALGVLPALGSSLVGVLLGLGLVGLGMTWAIVGFVTERQLRTPPRLQGRVSAATNMLLNVPQLALTVVGASLLGLVDYRVLLVVTVLGITAGAAVALREAARTHRAPPSVAADPPATDPRTTPATPDRAGSGPL
>fig|446469.4.peg.2197 Drug resistance transporter Bcr/CflA subfamily
MPSTPPPHAAARPAVARPDRISAGLVLLLSALTAIGPLTIDLYLSAFPEIVAEMGTTESRVQLTLTATLAGLAIGQLVIGALSDAVGRRAPLLVALTVYVLASSAIVAVDGIVWLTVLRFVQGLSAAAGMVLSMAVVRDTFHGFQIGKVIARLMLVVGVAPILAPTLGAQFLRLGSWRLMFVALAVVGAILLVVVALRLEESLPVERRRTGGLGEALRSYADLVRDWSFFGLALLAGFYMAAMFTYISASTFVLQGQFGLSAQTYAVLFGVGAVSVTAGSQINGALVGRVAPTTILTGAVAAGFVLSGALYAAAAAGAGLAVLVSLIVLTLGTAGFVMPSVPAIALERNAHRAGSAAALVGALQFGVGAGIAPVTGLLGGTPSVTMAVVMFGVITVAGVLLLSLRPGWRRLAAAERETPETALGETAERVVKAVPQG
>fig|446469.4.peg.3197 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTSATTNPTGGAGTAEPVGTNRWYLSSAPMLRALLHLCVPMAAAMVVSAVYNVVNAGFIGSLHDSALLAAVTLGAPLLAVVMAVGGMFGVGGGALISRLLGATEHDPTQAGQIRRVSSFALWGSVVTGAAISVVGLVLLDPLVSLLGADSAAAPATRAFVGTLLVFVPVFAAAFCLEQLVRAEGAARQVMTALVVSTVANVVLDVLFILVLHRGVAGAALAMGLSNVVTVVYLAGWLHRSSQHVRLSPRWFTLSSTVLRPVLGVGVSELFQASFLVVTSLVLNNLAATYGDTALAAMGVAVRVAQVPEFLVMGVTLGVLPLFAYAYGKGDRERLASALRVSAITVGSIVLVSAATAVVLREQLVSAFTADRAVLAVGVTVLTAQVVAMVANGFAGLLTSYFQATGRTVPAIVMSTAQGVLFVPVVLAGHVWFGLPGIIWSLTVSEGVVLVVGIALWFGYRRSIDRGLAEGSPERAEAALEQADA
>fig|446470.6.peg.510 Daunorubicin resistance transmembrane protein
MTPRIAYLGTRFKALLAYRFEIIIWLIGPLLQMLLLATVWRAVYDGRSTVDGVSLAVMTTYVTISTIHSLIAHDDMDDWVHERVNTGGVGVDLLRPLPFMEQTLWGSVAQLGIKLLMIVVVLPVGAVFAGLSAPAHLGLYLIAAVLAWLVNLCMYLLLSSIVFWTLEVHGLNFMYFVVNAFLSGALVPLWFMPDWLATALSWLPFQAIVFTPASIYVGQLTGTAAWQAIGVQFTWLVLLSATAVLVWRRAVRKTVVQGG
>fig|446470.6.peg.938 Permease of the drug/metabolite transporter (DMT) superfamily
MLPWLALFTVWIFWGSTYLGIQFAVETIPPLLMAGFRYLLAGAVMFAIVGPRHARGPNRPTPRQWRSMVIVAVLLLVGGNGLLSVGETSIDSGLAALIVATVPVWMLLIDAAVNRSRITVTMAIALALGTAGVGVLVGGPGSRVDLFGAIVVLIGALSWASGTVYARRAPQPKHPLVVASLQMIAGGVVLILVAAVTGEFGRLELAAISARSIAGFGWLVVAGSMLAFTAYGYANANLPTSTVATYAYVNPVVAVVLGVLLGDESLSANLLLGGGIIVSAVVLIVGGQAAKRREKPRPREVHRQALRWYRRHPEAQRSRRHMFATRHTTKLPADEALPGRPGPLLDPSDRNAALGTPLLGPYPDGMEIAEFGVDCFWGGEAQFWDVPGVWTTVAGFQGGHTPNPLADEILSHRTGHTEAVRVVFDPAKTSYEKLLAVFWCSEDPTRRVDMRGHGRSAIFTQDAGQLAKAEASRKVYQRELDRRGYGAIITEILSAQEFPFYPAQLRHQQHLARH
>fig|446470.6.peg.958 Glyoxalase/bleomycin resistance protein/dioxygenase
MLSDIMYVTVYVTDQDRALEFYTEGLGLEKGLDFSGPDGRFLTVGVPGGSVQVILWSHAAAAGQPGEVGVPGPVILESDDLRKDFEAMRQRGVTFEEPEPVDYPFGVRIEAVDPDGNRVSLRQQPKR
>fig|446470.6.peg.1224 Antiseptic resistance protein QacA
MSANEKASPRQWLGLSVLLLPTMLLFLAMTVLFLATPYITADLKPSGPQVLWINDIYGFIMAGFLVTMGTLGDKFGRRRILLSGAALFGAASILSAYAPNPDVLIVGRALMGLGAAALVPATLALITNTFTNARQRSVAIGLWAASVSAGVAIGPLVGGLLLESLWWGASLLIGVPVMALVLVTVPLLIPEYKAPNAGRLDPLSVVLSLAALLPFVYGVKALAETGLDAITAVTLVAGIGLGAVFVRRQLRLPEPLIDMRLFRNRTFGGALAVYMFATVALGGVYLLFTQYLQLVADQSPLAAGLWILPAAIALVVVSIVAPILARRVRPAYLIAAGLLASAIGYVVLTQVDSTAGLPLLITGFYILYPGIAPAMALIPDLVISSAPPEKAGAASAVEGTISDLGVALGVAILGSVGTTAYRSHMDTVEVPGEAAAESAETLPGALDAAQKLPDEVGGTLVDAAKTAFTEGLNLAALVAAVLTVIGAVVAVTVLRRGEPAEAADETETDPDTELAEVA
>fig|446470.6.peg.1673 Permease of the drug/metabolite transporter (DMT) superfamily
MATFAVTTDSLVIAGLLRPIADTLDVSVSTAGQLVSVFSLTFAIAAPVLGAATANLDRRTVLLLAIGVFVLGNVVAAVGTEFAIVMAARVISALGAALISSIAMATASALAPPDKQGRALALVTAGMTVATTMGVPLGTLIGGADWRITLWAVAGLGTLAGAGIWLGLPKVELPVAPLRDRLKPLGDPGILAILAVTLMILTSGYTLYTYIGVATDAATGGTASGLMAVLIAYGVGSILGNVISGFLTDRYRPVRVLLVGLVMLTAILAITPLVSAAGLFLTMAWATTWGISGWLTGLPQQHRLVTKAPESSAILLGLNASTLHLGIAIGGGIGGLILNWGNTVLLGLMSAAIVAIGLAITLVSTRGRVTEPEPVPASAD
>fig|446470.6.peg.1933 Antiseptic resistance protein QacA
MNTTGETLPPPKATSREWIGLAVLALPTLLLSLDLSVLYLALPQLSADLRPSSTQTLWILDSYGFMIAGFLVTMGTLGDRIGRRKLLLIGAAAFGVASLAAAYATSPEMLIAARVLLGVAGATQMPSLLALIGNMFKDAKQRSFAIATWMSCFMGGMAVGPVIGGFLLENFWWGSVFLIGVPVMVVLLVAGPFLLPEYKDGSAGRVDLISVALSLLAILPFIYGLKEIAKTGVQVSHVAAIAVGLAFGAVFVRRQRRLKDPLLDLRLFGNRTFTAALTSMSLGAGIMGGVMFLFNQYLQMVAGLSPLEAGLWMVPPSVFMITITQITPAIARAMRRDHLIATGFALAAVGIFILAQVEADSGPLMLVAGMTVTAMGMAPLGMVCTDIVIGSVPPEKAGSASSMSETSAEFGIAMGVAVFGSLATAVYRGGIDIPEGTPDAAAAAARESLPGAAEAAKDLPGQLGAGLLDTAREAFTSGLGVVATVGAIVMVGLAALGLVMFRERKTTPEPTAEQQDRETELVNA
>fig|446470.6.peg.2593 Permease of the drug/metabolite transporter (DMT) superfamily
MRTDTTAANPYLLLMTTMMLWGGAFSSSKVVVDAVPHTVGAFLRFGGGALALLVVVRLYDRRQTPVPARKLWLGAAAGVLGVFAYNAFFFWGLSLAPSLDAGILIPVLSPVLTTAFLLVSGREKANRARVVGLSLGLVGAVIFFLGAGGATSAGPQRLPGDALFLLSAVCWAAYTLAGPRVMAGIAPLRATTYATCAGAVMLGALAVPDMATVDWTALPSLVWANVGYLAIGGAAVANLLYYRGVAAVGPARASLMMFSVPVVNTLCATLILGESLGWLQAAGACVLLTGAFLALTQGRLPGLRRPVSP
>fig|446470.6.peg.3608 Glyoxalase/bleomycin resistance protein/dioxygenase
MNMTTTISDAKTAARVLRQCLADDGFELSHSRALEIVAQQLGFADWNTASASLTAAQTDSGSAVAVLRIHDTALARGFYLDYLGFTTEWEHRFEQGMPVYMRIRRGETVLDLSEHHGDGTPGSVVWVPIGDLRSFHAELSRRAHPNLRPGIERDAPGGPTMEIIDPFGNVLRFCQPSE
>fig|446470.6.peg.3759 Drug resistance transporter EmrB/QacA subfamily
MIAARVVQGGFGALLFVLMPVLASAAVRPQLRGRAMGWMFAIGPLGAIAGTAAVGVMIDNIGWSSIFLPHLPLAAEGRYAWLAVALLAIPPVLAWRRMESGRLVLSLLRVPGVRAPMTALWTQVTGQLAVSFLVPFYIQRYLDADSALAGLVLLVLPAGMVLFSPLGGWLTDNWGARRTAILGLAVPLAATGSMAWFGETWTIADLAWRLGLLGVGAGLFTGAQTAMAMAAAPADMMGSVSAALSFARQLGLGTAPALATILWGLTGYGLAGMRLAIAVITALGLGGLYALWRARTVAPLPTAPEPARGRAA
>fig|446470.6.peg.4285 Antiseptic resistance protein QacA
MSTVTIAPTTTTTTPDANPRRWVGLAVLCASLLIVVMDLTILNVALPEIDAALRPSSVQLLWIVDVYGLAVAGFLVTASGLADRFGRRRMLLVGYAAFGTVPLIVLFADSAPWLIAARALLGLGGAFIMPSTMSMIRDLFADPKERAVALGLWGSMAAVGAGLGPIIGGILVQNFSWHAAFLINTPIMVLAIVFALWLLPESRGGAVPWDFLGIALSIIGMISLMYAIKTIGKHGITDPTALLTGTIALVSLIWFARRCLNRREPLLDLRLLRRRPLSAGLMCALISSVAMAAMMLLLAQWMQLVMEYTPIQTGIHLLPVAIVSGVISPLAPRIAQSIGTRTVMAGGLAVGGLGFAILYLGGDHLDYPLVALSQSLVGVSMATLAIGSAVIVASVPVERTGNAAAMEETSFELGNALGVAVLGSIAAVVFHNLMAATRLESLGLTGSAASTASDSIGGALSVASHTGNTALADHARAAFTESLGIVGLAGGVLMLLAAVAVWYLTPRGLTVEGGHH
>fig|446470.6.peg.4571 Glyoxalase/bleomycin resistance protein/dioxygenase
MDWKIEVVPVPVTDIERAKSFYADKLGFNVDIDFTLPDDTRIIQLTPHNSGCSIALGAPTSMPPGSLHGVQIVVDDIATARQTLLTNGVDITPVQHFDGKTYVDGPGDDWNSWAFFADPDGNKWTLQERPATTT
>fig|446470.6.peg.4685 Phosphotransferase (aminonucleoside antibiotic resistance)
MNARLILITGAQAAGKTTIGNALARLLPKAVHVDGDAIAEFVVSGAIGMDLPPPPGAMEQLYLRYRGSIAVANVYRDKGFDAVVSDNMFGETLTDVIAMGHETGDVHVIALDPDIASIEERELGRGKSGYTETVTPQALVDALRNETARVGLWHDNSGETVAETASRLLEKLDAALVPRPASA
>fig|446470.6.peg.5319 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDHMAGSLRALHLVVADVRATREELVEKGVEMGEVDEHEGSMFYVPFVDPDGNTWTLQEMPWRVGDFAD
>fig|446470.6.peg.6302 Glyoxalase/bleomycin resistance protein/dioxygenase
MARLHDIVFDCGHAASLARFWAAAVDGYAVAPYDDEELARLRSFGITDTEDDPTVLVESAAGGPRLWFQRVPETKVVKNRVHVDLRTDDLETEIARLTALGASVSERFGDNVVLLDPEGNEFCLAVN
>fig|446471.6.peg.485 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNLTVGPPTRLILAFTVPLLVGNVFQQIYVFTDAAVVGRLLGLEALAAVGASGSLMFLLIGFSWGASAGLAIPVAKAFGAGDMRGVRRYVAAGAYISAAIAAIVTAVGVIFAKDLLALLNTPAEIIDMSATYLAVTFAGASVTVAFNFLSATIRALGDSKTPLYFLMASSVLNALLVALLVGVFHWGVAGAAGATILAQGAAVAACLALVIRRMPALHLSREDWAAGRRALREPMRTGLPMGFQMSVIAVGALVLQLAVNGLGATAVGAFTASMRVDQLAVAPLNSFGIAMVTFVAQNRGAHQWHRIRVATFRTSMVAVGVALALGAVLVTFSQPIIGLFVGPDQPEVMAMARTFFLVSGGLYPVLALLFVLRNVVQGMGLSTVPTVAGALELVMRALAAIVLVGAFGWVGVAWAAPLAWIGALIPVALAWFRQRGLLLERERTDHATPRPPHEAAEPAAPAPAPALAVAAAPAAAVIDVAAPPADALPTLAGPVPADT
>fig|446471.6.peg.526 Truncated tunicamycin resistance protein
MLIWINGAFGAGKSHTAFELRRRLAEAHLADPELLGSALHRMLPQAMRGDFQDLPLWRSVVVETLHQAAASHAGPLLVPMTIVNDDYFDEIVGGLRERGVDVRHYTLVASPATLRRRLGTRLGFIRSGGRRETWAMRQIPRCVEQLAQDRYGTHVRTDDRPLDEIVEWIAADAGLDLVGPRLSPVRFQMRRLQVAAQLIR
>fig|446471.6.peg.901 Vancomycin B-type resistance protein VanW
MSHDSPTEQARRTRRLWWTAAGVATLAAAYGAAQWSLADQVPTGATVAGIDVGGLRHDDAVAALDDAAALLADQPVPVTAGTAETTVLPTDAGLALDAAATIEPLTRFTLHPARLWTHLRGAAEIEPAVTIDRDLLDAAASRLSTELVREPVDGAVVFADGEPVVTPAEPGTQVDPDAVGQVLATGWLAQDHPLELPHEPVEPAITQELTDAAYAAARQIVASPVVVDAAGQHAELPASALADATAFEVVDGALVPTFDGDALLAAVVERTQNLLDAPVNARFQVTGGRPQVTGGTPGTTIDPAALVEAVQAAALGEDRTAVVDVVQQDPEVTAESLEALGVNEVVARFSTSLTANRVRTDNIRLGSERITGTLIRPGETFSLLEALGPITTANGFGNAPVIVGGQFVPGVGGGLSQLATNVFNAGFFAGFEIVEHRPHSVWIPRYPAGREATIFTGSIDLRFRNNTPYGAVLHAFVADGQLTVQVWSTEHFRVETTQSERRNVVPAVTNHSTAAGCTPRAAGSDGFTITNTRRVYRGSTLVIDEAHTWTYRADHGTSCGPAEPPPAPEADAAPEDSAPE
>fig|446471.6.peg.3360 Glyoxalase/bleomycin resistance protein/dioxygenase
MSVPAASVPAAPAGSATLAPFIMSDDAEGLIAFLVEVFGAVEVPQARTQDVDGLVLHSELLVGDSLLTVADRKPHWPYTPAFVRVYVDDVEATLERAVARGARIVTEPTDVWGDVFSRFADPYGHLWWVYKHNPTTLWDEPAGEEVWTEEVDLSWEAFATPELTYLQATLLEAMDTLHDPRTQK
>fig|448385.11.peg.1021 Drug resistance transporter, EmrB/QacA family
MMALRTSIAGAPLPSEAPDQAASGVRGPARAEAIACVLAAMVLVVLSAGIANVALPALAHALQVTPAASVRVVSAYQLGLVMALLPCAALGESLGYRAVFTAGVGLFTGASALCALAPSLHWLVAARFLQGLGGAAVMALGVALLRFVVPQAQLAAAIGWNALAVALSSAAAPTVGAVLLSSASWPWLFAVNLPLGVAVLLASRGLPEVPGTARALDATSMALSAGAFGALIAGAELLPAAPALGAGLLAAAALSATLLLRRELPKEAPLVPLDLLRSRSFRVSVIASVACFAGQTSALVALPFYLRHGFGQEALTTGLLITPWPLSVALLAPVAGRLADRISTAWLCATGAGCLALGLAALALSPAHGSALSLVPFVALCGAGFGLFQVPNNRNMLLAAPRARSAAAGGMQGTARLAGQTAGAVVMTLLFTLMPVDAAPRIGLGIGAVLTLSAGIVSALRAGSHRSHDGGRMGS
>fig|448385.11.peg.2619 Outer membrane component of tripartite multidrug resistance system
MARRAARAALAAAAVSLAVRLAPLPAAAADTGGAPGRRAAVVHDLPGVLALADRNHPNVAAARAKLDQVRAQLDEARYAPFSQFKLTGGVALAPTVRGNNVFSPNTDVSLTSSLGVGWRVNIDGVIPLWTFGKITNLWDAAEANVRVNQASVEKERDAVRLDVRKAYFGLQLARDSRSLLVDVRAEMDKALRRLEEQVEREEGDPIELLKLQTFGAELEARGAEVDKYISVALAGLRFYTGVADLDIPDVPIRPPNHRIGHVTRYLTAARLYRPELAQARAGFDARSAQVRLARAQLFPDIGIAVQVGVSAAPEVADQLNPFTSDPGNFFHYSAALAVQWKLDLLPQSARIRAAEAQLEEMAATQRFAMGGVATEVETAYAEVVEAQKRLDAYTKAAKYGKRWLVMVQQGIDVGTMADKDLIDPAKAYATNRFNQLNATMDLDMAMSRLAKATGWDAIAPDGT
>fig|448385.11.peg.3402 Permease of the drug/metabolite transporter (DMT) superfamily
MGDGSLAQGSRGARRDLASREAGAGEVETATQTGDRPLPEMCPPPSRQPRAVANARSCAQCRRASRRRSAPARRRAVGDGVRSPGGASLVKSREAEVMSPHEGVGALTGEIRTGLLDDGRTFAVLSAATFALKAIFVKLAYAAHPVDAVTLLALRMGIALPFFLWLARRERGAAEGPLTPGLWGGVLIVGFLGYYLSSLFDFIGLTYISTGLERLILFVYPTLVLLIGAAWLKQPVRGKAWGALAVCYLGLGAAVWHDLEQSGDARAVAIGGAWVFASSVTYALYYIGVGKLASRVGSTRLAAYCGAASCLMVLAHYAAAGSPVRLGELPASVWGYAAAMATISTVLPIVLLAAAIRRLGAGRAATFSTLGPVLTIAFSWVILGEPATWQQVVGLTLVVGGVSWLGKSK
>fig|448385.11.peg.3735 Outer membrane component of tripartite multidrug resistance system
MRPRSVMLALMGAGVASVLAAASGAPGAQPGSAPKAAASATQPGGASKTAAGAAQPGGASKAAASATADAGAPRAAASAATDAGDELPLDAAPFPPEPSKQPTAAEWKAAPRVRLSRAGPAAAGCRAYRAREWLRIRCPELTVSAISLLGGKTEGVAFWIDPPRGGSELPRGGEVMFPIRRGDRRVIQILTFGPGYDGPFTLLPAIVIQEQWLEDEPAPTVTAS
>fig|448385.11.peg.4873 Vancomycin B-type resistance protein VanW
MDTRALVLVLALGGSAGVGAAVGVRHVLPTSPVVRGLSVGERFLPDGAAPAAWLAARRDALRERVVRLRHDDVELTATLGEAGVEVDVDETLAAARRVGHEGPWARRLREARGARRGEIDVPLTWAVDEPRARAFLERLAPQIYRAPVDARLDLANRRKIPEQAGRALDVEASLAALRAGEHGDEELIELAVRQILPQVVVADLVSVDVTRVVAAYETKFKHHGKEAGRARNIRNAASKIDGTILAPGDTFSFNAHVGPRTAKNGFTIAPEILGDETVPGYGGGTCQVSSTLYAASLFGALDTPDRQSHSRPSAYIPMGLDAMVTYPESDLKIKNTLPFPIMIHAYLPEPTVLRVEILGGDPVAEVQHHVSAEHTDDFIRRIYVKSELAEGKVKRHQKGSCGYDVRSFVTVRYKDGRASERSYSSEYRPAPEVFWVAPDYDPQALPALSEHAKAVEELREGESPAEAPAAAGQGGAYSM
>fig|448385.11.peg.6188 Acriflavin resistance protein
MSDQLSSDLASLRIQRDVDPDRRSPLRTVLVAAVVLAAIAGAAAFAVPKAQSALFKTEITTTEVALVSPAQASISVTSTGYVVPQVVSKVGAKFPGRIARVHVKEGDVVKQGDLLVELDDADQKSLVAAAQAKVAAARARATASRASIGEVEQQLARERLLVERQVTGRASMDDLTARMHSLTQSAAAADAEVKAAAADVESLRVTLADRKIVAPIGGTIMSKPPEVGEVVGLELPHLVEIADFTSLVVETDVPETRLYLVEPGKPCEVVLDAYPSKRHRCTTLEIGKRVNRAKATIPVKVKFVGEPKEALPEMSARVSFLSEALSEEAMKEPPKRVVPEAAVVERGGAKVVFVVNEGQVKMVPIKVGGPAPGGLELLDGPAPGARLVARPSPELADGQKIKEKEKGSE
>fig|448385.11.peg.6612 Membrane fusion component of tripartite multidrug resistance system
MSYVRLRKNERGHVVSRGIARRLDTAILLAIARRPRLNSEFHVVVAVGGVLHGDVLVPVRGVLEGLVDAAGFDAGPDALLIFQVASEEGHRLRLLRLLVLLVLLAITIDISHGRPPDGMTALRRSRRGEHSFNRPALHVKFCQAHRLYPGDGCDFLRILRSCTLARPLMPAGFSRSIHAIATDGHRGSIVGAALGALLLGGWLAWFFLARVGQYEASVSARLEVGQAAHRVETPLGGRVAAVRLDLLGAEVAAGDVLVELDVEPLRRDMDDKQARLSAIAGQMGPLRAEIAARSRALRDGAEAARARIDEAKARLKEAEAGARFQELEAARAVRLRQDGLVSEAEAARLAAEALSRRSATEALDRAAARADVERRTGQSEQQAELARLDREAASLEGERLVLEATIAGLLAEIERRKIRSPIAGRVGEITVLRAGSFVREGDVVAAVVPPGELRVIAEFPPSSVGRIRAGQAGRLRLDAFPWTEYGTLATTVERVASEAQEGRIRVELGVRPDPASPIPMQHGLPGNVVIEMERVSPASLVLRAAGQIVRVRGGADG
>fig|448385.11.peg.6814 Vancomycin B-type resistance protein VanW
MDLRRSPELWRFAALVAIFVTSGLAITYLVLPPPPDDGPKPPPVLRVAQVPVPTGGDVVANALDLVRRYATGEIRIVLPDGSARALRRNDLGVEINRVRLAEFVREALRPESALRRAHERAAQEDAPLDIPIPLLLDSERAISKLLDLKVELDAPAVDAYVDLEAKQLKPEKIGYRLDVYGTLARIDAALRAGEDTAQASVETIAPKLVADQLGNVKFDQVLGYFETRYATGARSKERTYNLRLAASKLDGVVVMPGEIFDFNETVGPRDEAHGYRVAPVIAQGELVDGLGGGTCQISGTLHGAAFFAGLEIVERYPHSRPSYYIKLGLDATVVYPTINYRFRNPFDFPIVLHETVAGGVVRAEILGPSRKLTVTYFRRIDEVVPFEELERPTPKLPEGKRALAQRGIPGFKTTSSRVVRDGAYAVREKWSDSYPPTAQIVHVGSGPRDPEAKTADDNHPEYVADEYLVVTQGPDVRTPGVTGPEPGGGTVESREPGLTGERGWTERAGFGTFRAKGEERAEGEGGRARGEDAPPAEGIAVAHAPGAAAPEARGQRDPAGDEAKGGKGKKRRQNQKKTTTTSDGG
>fig|448385.11.peg.8274 Permeases of the drug/metabolite transporter (DMT) superfamily
MASSSLGFAESRQRRTAQVLLFVTPALFTANMLLARATADFIPPVALAELRWTGVVLVLLPFCGRELWRNRAALRRDWARYALLGLLGMGICGAGVYYGAATTTATNIGLIYAVSPVIIILLSRAMFGERLSRRQGLGAALALTGVLVIVLRGDPAALLALSFSTGDLMILGAAISWALYTVLLKRWPDPLGVQARLTAIALAGAILLLPLLGWELASRGAPHFDLRTIATVVTLVLVPGVGAYATYSYITEHLGPSRTGLLLYLSPVYTAVLAWLLLGEAFALYHWLGAALVLPGLFFATHKPKAT
>fig|449447.3.peg.3112 Glyoxalase/bleomycin resistance protein/dioxygenase
MRIFIQFTAIIPQKTVISSDSAITLPLMNRPPIDSQITFIYTRDLTAAADFYERVMGFPLWLDQGSCRIYRVSGDGYLGICRANESRASGEGRQSNVIFTLVTERVDEWYDYLKQQGVTFEKPPLFNEKYRIYHCFLRDPDGYLIEIQRFESSEGGN
>fig|449447.3.peg.3852 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQPAIFHLAIPITDVSTAKSFYCDGLGCLAGRETEKAIILNFSGHQVVAHVTEMPLTPQNSIYPRHFGLILPDASDWDNLLEKARVNQLKFYLEPKTRFTGEITEHKTFFLEDPFYNLLEFKHYRHYEAIFASRELTAIGDRA
>fig|449447.3.peg.5341 Glyoxalase/bleomycin resistance protein/dioxygenase
MTISPSVTAKKLKIGQLRKVHHIAFNVKDMEASRHFYGEILGLEELKGEKIPSTLKELVAQGKVANFITPDGTVIDLFWEPDLNPPDDNPEIAFTRANHLAFDIAPECFDFALEVLQSQGITIASGPVTRPTGRGVYFYDPDGFIVEIRCDPAF
>fig|450851.6.peg.2493 Glyoxalase/bleomycin resistance protein/dioxygenase
MSRVVGIDHLSVRVSDIERSRAFYGRLFEFLGFEVLEDYGDQIGWTNGKTRYWIGQADAEGRGRRHRIGDVGFHHYAFELRSRADVDDLQAFLEREGATIVDPAGEYYPDYYAVFFLDPDGLKLEGMKYGKV
>fig|450851.6.peg.2954 Permease of the drug/metabolite transporter (DMT) superfamily
MSFRDFGLLALVCLLWASNNIVSKYVIATLGVPPLFYAAVRFGVVALAVFPWLFPMPRPAWRLIVVALLMGGGNFALLFMGLQTATPSAAAVVGQVGVPMTTLLSVLMLGERIRWRRGIGIALTLAGALTVMWDPGGFALSGGLLFVVASAFAGSLGAVMMKQMEGVKPLQFQAWVGLASVAPLALLSALLEPGQVEAGLRAGWPFWVGVVYSAVVISVGAHTLYYALIQRYEANLISPLTLMTPLATIALGVALLGDPFGPRMAIGTAVALAGVLIIALRRNQVMPLLLAVWNRSQ
>fig|450851.6.peg.3120 Bacteriocin resistance protein, putative
MRRRRDRSRIVALAAALTALAAAAPAVAQVQFYGEASGARVRVMTWRDIPFRTVVRQEHDYSCGSAALATLLTYHYGRPTTEAEAFTRMYAAGDQETIRRVGFSMLDMKRYLAAEGLRADGFRMSIDDIGKEGVPVIALIQMGAYRHFVVVKGVVGDRVLVGDPALGLRIFTRAQFNAMWNGIAFALHDTPAVGRGRFNVANEWSPWSTAPLRARADATDTLNALTLHQLPFYQITPIMVLGSVAPGGGL
>fig|450851.6.peg.4058 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGGERPVGFIATTDYERARAFYVGVLGLEFVRQDDYALVVRSGGVTVRITRLPEVHPPRNTVFGWEVADVREVAAALADRGVTFERYDFLGADQGADGIWTVPGGAAQVAWFKDPDGNLLSISSAGG
>fig|452471.3.peg.76 Permease of the drug/metabolite transporter (DMT) superfamily
MPTLFMIIATLFWGASFLFIKLALQEISTASFIFLRFLVATISMAPIMAFSSISLNRKVVKQGIILGLLQLGIIFLQTLGLETISASLSGFLTGLYIVFILVIQFIRQRRIPSFTDIATSVACLGGLGLLTHNFEVTNGVGVLYTIGCALCMALYIYALDAYSANNNAVLSTFIQMASITAFSSILFLLPGNNLQIPTQPITWIAILFCGICCSSISFWLQNKAQRHLGAFKVSIILMLEPIFCTIFACFILGEKLYAEAYIGIIMILASIAVINVRLKEVE
>fig|452471.3.peg.607 Permease of the drug/metabolite transporter (DMT) superfamily
MRNQTRIPNNRIIAWVLLITLSCIWGSSYILMKKALCFFKPQEIAYLRICSAAIVLLPYSLPQLKKLTFRHYKLLALVGVVGTLLPLFCFATAQLHINSGVHGVLNSLTPVFVLMVGIIFFKKRLFKNEILGVSLGILGTVLLVIIESRFFAGSFNYYILLSLLGSCLYGNTTNLIKYYLNDIKSTTIVSVSLLLIAIISGIYLATHPNIFIKMDTSIESYQALAYVLFAGIVNLGIANIILTELVKITSPVFTSTEALLAPIVSLSWGLVDGEQLLWEHYVGATIILLGVYFINKPKKEIPKQPVFNAEV
>fig|452471.3.peg.784 Glyoxalase/bleomycin resistance protein/dioxygenase
MVLLPVGRLKDDFVRFLQVRVYQRSDFCYLKLNIMKQIIFILIILSISIMSCSQPNSNLKINNKMKLNAGIITKKMSETKSFYTTLFNFGVTFENEFYLLLHTPNHESEISFLLPNHPSQQPLFHKPFQGQGVYLTIEVDDVDKVYNELKEKNIPIRIELRDEPWGDRHFAIEDPNGIGIDIVKYSPQQDQ
>fig|452471.3.peg.794 Permease of the drug/metabolite transporter (DMT) superfamily
MKRISKGVQYMLLSTICFALIGLIVKLLVHIPPAEIIFLDSLVALTISCFMIGYQKMCLWGNHRRILLLRGLSAGLGVTLFFITLVRLPLSAANVLQNTSPIFTAILGIFMLKEWISLRRWFFFILTFIGVGLTYMTDFSITNQSAYLVLLGLISALLMGISNNFNAKMKSGEHPLVIFSYSTFCTVLITGCICLYAFVPLTIYDFLLLLAMGTLTFIAQYLAIKAFQNAPVAHVSAISYLGIPYALIIDLLLGERIHWISYVGMCLVVLGVILNLFYGYSKRVGA
>fig|452471.3.peg.811 Permeases of the drug/metabolite transporter (DMT) superfamily
MSNKTKAIAFILLNCISFTLSMTINKLVNPAIPVALKVLIRASFGLLFFSPLILKSGFRVLVSNKLSLQILRIFLMSIAMGATYFTYTNMPFTIAISIGFTGPIFTAVLSYLILKDRLKIGQWVAIFIGYLGVLLIIKPHGEVNYAIYVAILGNVVVGLSLIFTKRLVKIDSKNTILILGNIGIVATSSLWAFIYWLGSKYENLWLHAVWVCPSWKDFQWLIIMGFLGAISQMASITALKYASPSFLSPFEYSRLVLAVPIGIFLGEALPGYREIVGIIIILISTVYNSWQGDFHAKSKK
>fig|452471.3.peg.1147 Multiple antibiotic resistance protein MarC
MNTLYSFFIAFNIKKFLTAFFILFAVIDVLGCTAIIINMRNKIGYIHARKTATVAGVIMVTFLFLGQTILDLFSIDMSSFIIAGSIILFLLGLEMCLNISIFKTDTDANSSSIVPLAFPIIAGTGTLSTLLILRAECETINVLLASLVNLVLIFLVLKYSEWIEAKLGRLGVSIIHKMMGIILIAIAIKRFKMYLFI
>fig|452471.3.peg.1261 Permeases of the drug/metabolite transporter (DMT) superfamily
MSCGNDAITKYLGYTFNPWQITFFRFAFGILTLLPVMLYQGKSAFITYRWKLHFLRGLFVFVAISLWSQGIKVSPITTSTIMSFTVPIFVLVLAPIFLKERVTWPMWLATLGGFVGILFVLQPDVHTFNQGSLFFIIAAILFGMLDILNKKYVTQEPMLCMLFYSTVVALILVTFPAMQVWRTPTNYELMWLLVLGIGSNLILYCILRAFSLTDASSLSPFRYIELLISMVVGYVFFHELPSSYSYLGAAIIIPSTLFIGYYQTRNQPKA
>fig|452637.4.peg.119 Glyoxalase/bleomycin resistance protein/dioxygenase
MRASAQLAPLDLYAFAKNMKFRSNNCVRVHLPDLKKAEAFFTGVLGFRLTDKSATQLEYDTGRFLLCVNKSEQPLPPIPSFTVISVKDAKEHLLAHGCEIVEDHGTSLYFRDPFGMVYDVIED
>fig|452637.4.peg.950 Permease of the drug/metabolite transporter (DMT) superfamily
MMLLLANLFWGLSFPVIKSITLLHAQLLPDAGTWFSTAYTIAPRFLLAVIVLLAWQARSFWRITRAELKQGVILGLFAAAGMLFQVDGLQFTAASTSAFLTQFYAIMIPVYLALRSRRTPGALVWISCSLVLAGVAILGRFDWRELTFGRGEWETLLSSVFFMGQILWLDRSEFVGNRVEKFTLVMFLTEALVFLGLSAATAPSVDALVLPWTSPGWLGLTASLTVFCTLGAFLIMNRWQPKITATEAGLIYCVEPIFGSVMALFLPAMISAWTAINYPNESATSHLLIGGGLITLANVLIQLRPPAKPAAAASK
>fig|452637.4.peg.972 Acriflavin resistance protein
MRFTDLFIRRPVLATVVNLFLLIIGGLAIKSMVIRQYPQTNNAVIRVTTTYPGASADLIRGFITTPLEREIASADGLDYVESVSAPNVSIITAKLRLNYDPNDALTQITSKVNRARRELPVDAEDPVFDVSVGESTASMYLTFSSAVLGANQVTDYLTRVVQPKLSTVEGVQKAEIMGARTFAMRIWLDPEKMAAFGLSASQVWAKLSTQNHLSAVGKTKGSMVSVNLTAGTDLQSAGEFRQMVIRENKGEIVRLGDIANVVLGAESYDVDVKFAGQETTIIAISVLPTANSIDVIKGVRAVWPEVVSQLPAGLDAGIAYDATEFINDSITEVMETLLEAMLIVVLVIYAFLGSFRSVVIPIVAIPLSLVGVCALMLSLGFSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGLSPLDAALKGAHELVGPIIAMTITLAAVYAPIGLQSGVTGALFREFAFTLAGAVIVSGFVALTLSPMLSSKLLRHNPNPRGIEHFLDVAFTKLRDRYEHLLDQVLNTRPAVYLVAVLIVAAIMPFYALTKKELAPPEDRGFIVTISQGSPNGTLDQALRYSERFNELLKQIPEVNTFFSIAGFDMVSGMASPSSGLTGVSLVPWSQREASAADLIPQILGRASTIAGVNYAAFLPPSLPGAGGGLPVQFVVSSTANHDRVAVVTQTLLQRALASGNFLYGDTDLKFDQPQADVKIDRDKAALLGIDMKQLGTDLGAMLGGGQVNRFAIQGRAYRVIPQVTRSARLTPDQLADYYISTGKGELVPLSSVAEIVPTTQPRDLRRFQQLNCATISLLPRPGLSMGEALDWLNAEAKTVFPEGFASEYKGESRQFVQEGSSLMATFVLAIVVIFLVLAAQYESFRDPFIIMMAVPLSIAGAMVFLFLGVATLNIYTQVGLITLVGLITKHGILMVDFANKLQEEGHEVRSAIEHAAGIRLRPILMTTAAMVLGVLPLLVAQGPGAEARFSMGLVIAAGMAIGTLFTLFVVPAFYVLVAHRRTAIPAGAPASPTELAPAHHS
>fig|452637.4.peg.979 Multiple antibiotic resistance protein MarC
MPSAHHFWELILGTVIALLPLINPLASAPTFLAITDGDTPERRNQQLRMACLYTVGILVSFLIGGTFIMGFFGLSIPGLRIAGGLLVAGIGSHMLMSPPKPATDDPVHAAARAKRDISFSPLAMPMMSGPGSIAATISFTSLARGWIDYVAIILGIIIVTVITYVTLRISDRVVRVVGFNSMNALSQVMGFLILCIGIQFVVNGVTEIVTDPVLLGSIRDAFQQS
>fig|452637.4.peg.1470 Polymyxin resistance protein PmrJ, predicted deacetylase
MPLRLALKVDVDTDRGTRDGVPNLVADCRAIGAPACFLFSLGPDQTGRAITRVLRPGFFKKVSRTSVVQIYGVRTLLNGTLLPAPHIGRRHAATMRAVRDAGFEVGIHCYNHYRWQDYLQRMTQPEVDAEFLAARAEFRRIFGAEAHTAGAAGWQSNARSRHAYDAAGLRYASDTRGGAPFFPRIAGQVFRTLEIPSTLPTFDELMGRPEYPDDAIVDHYLSLLRDDLVNVLTIHAEIEGMGRRALFGELLSALRRTGVEFVRLDDYARELLANRAAIPVREQVMAEIDGRSGLVAAQAPD
>fig|452637.4.peg.1929 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIRGVDFVMLQVSDIVAATEFYRDLLGLRCAIYSAEDRWAEFDCGNVTLVLHGGETVAAGGTGTRVALAVADIDAAHAELDARGARLLSPVQDYGVCRAFEVLDPDGNPLLLHHRADGTFGP
>fig|452637.4.peg.1946 Glyoxalase/bleomycin resistance protein/dioxygenase
MPSPSSPLFKDVAFVVYPVANVKTSRSFYEDTLGLKVTANWDDQWVEYDIGAGTLAITSADEKHRAGSHGATLALEVVDFDATIAHLKANAVSIADGPFESPACRGCIIRDPDGNELIVHARK
>fig|452637.4.peg.2063 Glyoxalase/bleomycin resistance protein/dioxygenase
MRVNDLERTVKFYQDVLGLKVVRRHTSPRGAQLVFVATPNSDEEIELTYLPNSPSVQVQPDLMHLAFEVDDLEKFAAELKQQGYPLSDGPTRTDSGAVIAFIDAPEGYEIELIQKAP
>fig|452637.4.peg.3498 Acriflavin resistance protein
MILSDVSIRRPVVCLVASILIVLIGLLSFRRLPVREYPDIDSPIISVSTTYPGASAEVIESKITEPLEKEISSIDGIRVVRSLSLEQRSEITVEFNLRRDVNEAANDVRDRVSRARRQLPDEVLEPQVTKTEADADPIMGFSLASDRYSRQELYDIADRFVVQRIQTVPGVGAVQIRGPRYAMRLWIDSDRLAAHELTVADVERALQQQNVEIPGGRIESVTREFTVRTQGSLVEVAEFENLILAVRNGYQVKFSDIGRVELGQNDYRGESYYRGVPTVGVQVFRQSQSNLLDLADGVKAQLPLIQASLPKGVTIDIGFDSSVFVDRSVAEVYKTLWEAATLVILMIFVFLRDWRATFIPLLAIPVSVIGSFAIMSWLGFSLNVLTLLALVLAVGLVVDDAIVMLENIYRRIEGGEPPIRAAVHGARQVAFAIIATTLTLAAVFLPVAFQSGQTGRLFFEFGVTLAISVLVSAFVALTLTPMLSSRMLKARLVGGHVKHGWLYEKTEPFFEGMNRRYAAMLNWTLRHKFWVLLGAGAVAALGPIFYLQLQRELTPLEDRSAFRAYFIAPVGSTPEFGHYYAGKMEQMLLDVPEVERTFRRSGDSNRAFMFVTLKPWEQRERKAQQIIAEMREKFRREITGGQAFPLAPRPFGQRGGSAGIQVVLQGSDFDQLQQLGDRMIAAMRERTDMFYLPRVDPSPTKPQLDVRIDRAKAADLNVPISEIASTLETLFGGKRVTTFQRGSQEYDVLVQVADEDRTTPSDLSRVYVKSSTGHLIQLTNLVQANEAVVPENYPHFMRLRSVTVSAQLVGNATIGDGVDFLQVQAEKLLPAGYTYAWDGETREYVESASDTWMLFTLALVFTFLILAAQFESWIHPITIFTGIILALAGGVIVLYCTRFWGTAMTDNLYSRFGLIMLIGLVAKNGILIVEFANQLQLEGRNAFEAAYEASILRFRPIIMTAIATILGAVPIAFASGAGAETRNPMGIVVVGGLSIATFLTLFVVPIFYVLVDHFAVKVTGHSSAYGLKKAEEIRHETAEEVEVAAPAK
>fig|452637.4.peg.4187 Tetracycline resistance protein
MNPPAAAPQPSRPLSLGVIFLTLYIDLIGFSIIFPFVPDLMEYYLRGETPGGLLAWLLAQTNALAALLGNHDHLADVLFAGVLTSFFSILQFVFAPFWGALSDRRGRRSVLLLTVCGTAAGYALWVFSGSFWLFMLSRVICGAFGGNLSVATAAVADVTSRQERSRAMGLVGAAFGLGLVTGPMLGAISASHNLLASYPSLARFGINPFSVPALIALGMSLVNVVWIALRFRETVSTATRDESAATRLRNPLRAIFALPSAAVRRANLVAFIFSVAFVAMETSLTFLAAERFGYTARQNGMLMVFLGVCSIITQGMIVRWLLRETSELRVLAGGLIAAAAGLVCIGLAPAPWLVFVGLAFLATGSGLVNPSTTGLISLYSHTAEQGRALGVFRSLGSLSRAITPVCAGTAYWIFGGGSVFVVAAGFALAALWLSRTLPLPDK
>fig|452637.4.peg.4266 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEIAFTGYPVTNMARARVFYENVLGLKPGATFGEGDKQWVEYDIGAGTLAITNMAAEWQPAAQGPSIALEVEDFDAAIEALRQAGVTFTVPPTASPVCRLAVCLDPDGNSLAVHKRNPH
>fig|452638.3.peg.1936 Acriflavin resistance protein
MGVILLGGVAYLYATARAELAPTEDQGIVLMQASGPSNSTVTQMQTYVDQIYAIAAAEPEYEQAFQITSPTSSFGGILLKDWGERSRNATKFQEDMQQKWNTIAGARVAAFQFPALPGAQGLPVQVVINTTEPYAQLNEVSQAVLDRARRSGNFFFVDSDLKIDKPQDVLEIDRENVAALGMTQQ
>fig|452638.3.peg.1937 Acriflavin resistance protein
MCSRIFTEEQEASSCVQKIDRIFDKIHHSYQATLRDLLST
>fig|452652.3.peg.4579 Permease of the drug/metabolite transporter (DMT) superfamily
MAVALGLALSALGTAPVAAADRTGHGGRAAQGHPAAGAVRVAGVPAAPIPVYAEDFENVPAGSGPVRITSYTGTSGETYTADPVWLAYCNGWVMDDVDRGTVPTECGAPINWDTLANVTRAMGQYSGEDDTAAGLNHGVAAWSEDGSYTANDVQFRTVQQIPLVNSNRFLTGSGTSGAVCYDGAYADPLTNFYLTDGTTEYPVSATPINPCTNPRAQRFTYPTGKQYPIGVVHGAADKPILYSGSTVGVIMRNAAATGAGNDAAFDDIEILDVTPTATKAFSPAAVVVGGTSTLTITVTNTTDLLEKDGWSFTDDLPAGLVVANPANTSTTCTNGAVTATAGGSTVGLSGDLVKGQAMCTLSVDVTSSTAGTYHNCPDANSNLIGMNWTECADVVFAVPQYTITKTATPASGSSVKPGDQVSYRVVVQNTGAVAVDATAADDLTAVLDDAAYDNDAAATAGTVSYAAPTLSWAGTLQPGESATITYTVTVNTPDTGDGQLDNHVTGSSASNCPTGTEPGCTTHENVNSLQITKTSDTATAKPGQKVTYTVTVTNPNGHAYSGATVADDLSAVLDDATYDGDASATSGTVSYAAPVLSWSGDVPAGGSVTLTYSVTVNNPDAGDGKLANTVTGPADSNCPPGAPDGSCSASVPIAELHLGKTSDAKNPVKAGDKVTYTVTISNPGQADYTGAVVTDDLSSALDDAAYGGDAQASSGTVSYAAPVLSWSGDVPAGGSVTVTYSVTVNNPDTGDKQLANAVVGPPDSNCPPGSADAACSTSDGVAELVIAKSSDAKNPVKAGDKVTYTVTIGNPGKAAYTGAVVTDDLSGDLDDAVYGGDAQASSGTVSYAAPVVSWSGDVPAGGSVTVTYSVTVNNPDTGDFELKNAVVGPSGSNCAAGSADPRCSTDDKVAALVIAKSSDAKNPVKAGDKVTYTVTIGNPGKAAYTGAVVTDDLTGDLDDATYGNDASATSGTVSYAAPVVSWNGDVPTGGSVTVTYSVTVNNPDTGDYQLANTVVGPDASNCAKGTRDPRCSTRDRIAALRISKTSDSRRAPVRPGAKVTYTVTVTNPGTAPYPAAQLSDDLSRDLDDAVYDNDAVVVSSTGGDPGVATYAAPVLSWTGGVAPGETVTLTYSVRVNRPDTGDKELANTVVGPDGSNCQAGSTDPACSTNDDVASLVIDKTSDAKNPVKAGDKVTYTVTVTNEGTADYPNAVLVDSLTGDLDDAVYDGDAQASSGTVSYAAPLLSWHGDVAAGQTVTITYSITVGNPDQGDHRLVNAVSGPIGSNCPPLRSAPQCSTENGVAELAITKTSDAEHPVKAGDKVTYTVTIGNDGAAAYPGAVVTDDLSGDLDDAAYGGDAQASSGTVSYAAPVLSWSGDVPAGGSVTVTYSVTVNSPDGGDHELKNAVVGPDGSNCPAGSTDPRCSTADEVAQLAIVKRASTDRVDPGGTVSYTVTVTNTGTAAYPGAAFQDDLGGLLDDAAYDGDARASSGTVSYAAPVLSWTGDLAPGAQAVVTYSVTVDDPDNGDHALDNAVVGPAASNCPAGGKDTDCATHGEVTPANPAPGPHPGPAPLPDTGTGGLVWYAGMAAALAVATGTLLTAGTLRRRSRRS
>fig|452652.3.peg.4851 Permease of the drug/metabolite transporter (DMT) superfamily
MTAVSTTAPAAPPVPGERRQLPRTDLLLLAVSVAGISLSAPLISATAAPALAIAFWRNTMSVAVLGPYALWRHLGELRAVSRRALLLAVAAGVLLALHFALWMPSLRMTSVASATALVTTTPLWTILLMRACGVRAPRLVWAGTGLAFAGVLVLTGVDLSVSPRALLGDGLALAAGAAAAGYMLLGAEVRRTVSTTAYTLVCYATCAVALLAACLLTGVRLGGWPAGAWWQIFLLMVAAQLLGHSLSNRVVRTLGPSITSNAILLETPGAALLAAVWLGQWPPAAAYPAVGLILLGLVLVARAERR
>fig|452652.3.peg.5102 Drug resistance transporter EmrB/QacA subfamily
MSENSSRARWLALAVVCAGMLMVILDGSITTVALPAIQADLHIGTAGLTWVVDAYVVAFGGLLLLAGRLGDLLGRRRVYLAGIAAFTAASVLCGLAVNSGTLIAARFLQGAGGAMASAVGLGMVVALFPDPAERARAFGAVGFTGAAGASLGQVLGGVLTQGLGWHWIFFINLPIGAAALLAGRRLLADDRGPGLKAGADAPGAALVTAGLMLGVYTIVEGGPAGWTSARTLATGAAALVLLAAFLLRQARTATPLLPPRILARRTTALANLIQLLMLAALFGFQILLALYLQQVQHYSALATGLAMLPAALTIAAVSLLLAARTIARLGERRTLLLGLILLTAGIALLTRLPAGHLSYAADVLPTLLSAAGFGLAATALTALGMADARPEDAGLLSGLLNTTQQVGAALGVAVLTALAAGRGTGGFHLAFGTAAALLAAAFLLALALPRHRAAPPAGAAAAGAGAAAEPPVLTHG
>fig|452652.3.peg.5804 Probable multidrug resistance transporter, MFS superfamily
MPTETPPHPSPRPGPTPSGLRRLTRGALADLTPLRDSPDYRRLWFGQTVSSIGQQMTTLAVGIQVYDLTRSPFLTGLVGLCSLVPLVVFGLYGGAIADRVDRRLLGLVGSAGLAAVSALLAVQALLDLRSIVLLYTAVALQGGFFAVSSPARSSMIPRLVPREQLPAANALNTIGMNLGQTVGPLLGGVAVAAYGAQSAYLADTVAFAATLYAMWRLPAMRPQTTSGKRATVLDGLRFLRGQPNLRTSFAADLAAMIFGLPRALFPAIVLPFYGGDAGTVGLLAAAPAVGALAGGLFSGWIGRIHRHGVAVLGSVAAWGLAIAAFGLVHNLPLGLLLLAAAGCADTVSMIFRNTMMQVAAPDEMRGRLQGVFIVVVAGGPRLGDFESGTVAALTTPTVSILTGGLACVAAVLYLAARRPAFLRYDARHPTP
>fig|452659.3.peg.1386 Multidrug resistance protein B
MLPAAVFALIASLVMPYLFTRFIARVIMFSRLIFTTI
>fig|452662.3.peg.2064 
MTIARYYVMHAKEGMSAALETALRAVTDAVRPLAGCEGVELMRDIGNERRFVFIEQWADVDAHKAAVEILDKALFAPMLAALDGPPDGLYLDYLIR
>fig|452662.3.peg.3420 Outer membrane component of tripartite multidrug resistance system
MRRIAILVLVGGLGGCATVPDLGPRPDPAQPGAFAATRSLAGTSQAWPQDDWWRTFGDTQLDTLVGEALQGSPTVAQAAARIRIAVSQADLARAALLPSVGATATARDSRLTQSIGLPTDGDWHWLLAGLVNMSWELDLWGKNSSALRAAVSARTAAEADEAAARLALASAVSTAYVDFAQLLVRRDVAADAVRIRRETRDLVVRRFDAGLEPRTSVEQAEGGVDAAEAQLAAINEAIGLGRNALAALVGAGPDRGLAIEPPSLTTRRPDALPANIPIELVGRNPEVVSARWRVEAAAERIGVARAGFYPNVNISGLIGLASFGLDNLFRSESVIGSVGPAISLPIFDGGRLSARYRGARGEYDTAVATYNETLLQALHHAADAATSLRALRERVDRTNASVARQEAAYRLAKMRYEGGLSDYQRVLISEDALLSAREQAAALRLRGFILDIALAKALGGGFRAAVPARDTNS
>fig|452662.3.peg.3422 Inner membrane component of tripartite multidrug resistance system
MAAAALSFGNFMVVLDTTIANVAMPTISGDLGVSTTEGTWIITAYAVAEAITVPITGWLSRRFGEVRLFTACVVAFVICSILCGLSGSLGFLVLFRILQGFAGGPIIPLSSTLLISIFPKDKANIALAIWGMTTVVAPIFGPILGGYISDNYHWGWIFYINIFFGIAVGSVAWWLMHNRETAITRSRIDIVGLLLLVVFVSAFQTMIDKGRELDWFSSSFIVWMAIVAGIALGALILWELTDDDPVIDLSVFRNRTWLVSTLSLGLMFGLFFGNIVLTPLWLQQMMGYTATWAGFATAPMGILAVLTAPIVGRLMSKIDPRLIVTYGMVVLAISFFMRAHLNAQADFMSVAIPMFVLGAGVPACLVTLTSLGVSELPPEKIANGSGLQNFIRIMAMAVGASLTSTYWENATKGNRAELVAIIDPSTAPAALPGLQSGSGLAAFSRMVDMQAVMLATNDFYAMATILILVFAAVVWLAKRPKGPLKQVSH
>fig|452662.3.peg.3666 Permease of the drug/metabolite transporter (DMT) superfamily
MPAQALAEHRAAAGLLWPLLVLTCVLLSSGSQVLMKIGMNGAPVQNALARGSAIEIAATIATTPLVIVGMAMFGLSAGAWLMVLSRMNLSQAYPCVALGIVVTAICGFWLLGEAISPARLGGIGLIVAGVLVTGLN
>fig|452662.3.peg.3903 Glyoxalase/bleomycin resistance protein/dioxygenase
MAHFVIRTSRYDESLAWYQRFFDTETVYAQDGLTFLTFDDEHHRIAIGRIPDLEDHRENIAGVDHIAFSMQNLEDLVTAYERNKAAGIVPFWCINHGPTTSIYYKDPDGVKIELQVDNATFPGGARAFFSSDEFARNSYGIEFDPDDFVARFRAGESTAALLARPDTLSAGE
>fig|452863.6.peg.1914 Methicillin resistance protein
MIPAVVPCTDRALWDESVDTFNGHPQQLWGWGETKAMHGWSVDRVLLKDGETTVGAAQLLVRPLPLPFRALVYIPRGPMCSVADTQAVLNSLADHAAIRHRGVALSIEPDWDRDSAYAGAVAGAGFRESSNTVLIPRTLILDLARTDDELMAEMSKSTRANIRKAMRSEVEFRKVKNESELEQVLAIYHETAERAGFGIHEDQYYRDIFRNLGDGSPIIGAFDGEQLLAFVWLARSGATAFELYGGVSAEGQKQRVNYGVKWAALQAMREDGCSRYDFNGLLNDGISDFKKQFAKHENMLLGTWEKPLSPFYPAYSKAMPLARRGLQTARRLAKAAAGRAQTLLRRG
>fig|452863.6.peg.3284 Permease of the drug/metabolite transporter (DMT) superfamily
MRAAFFLILATLFWAGNFVVGQAAVQSMAPLQLTFWRWTLAALPLLFLAHMVDRPDWRAALRHWRMLLLLSALGMTAYTLLLYSALQHTSALNASLVTSANPVLIMVLAAVLLKDKPRPLGWIGLALGLAGVLLVLTGGQLQRLLTFSLGAGELLILAAITVWALYTVLARRVAVPAVTSTALQAAMAAVALAPVAAVTGAGFPSTQSGAWSLAFIAVFPSLGSYLLWNLALKRTGAANAGNYLNLIAVFTAIITILLGQPITAAQVAGGVLVISGVLLTGAAQRPQRPKSSKPTSSPPSEALPRLRAR
>fig|452863.6.peg.3728 Glyoxalase/bleomycin resistance protein/dioxygenase
MTLKMSTATTILPVDDAARARSFYTGKLGLPHRGMTDDGSELLGTDGGPMLQLMPVSDGKHSEHTALSFEVTDIERTVRDMEAMGVRFQDYDLPNLRTENHICTTGSEKCAWFMDTEHNILCVHERLNGQPDYQV
>fig|453591.8.peg.383 Permease of the drug/metabolite transporter (DMT) superfamily
MIEALVPLIPQFLWATNFVVSKVVISKGLHAMTLTALRWAIAGALLYAYSRLKGLRVVLSKELLLPSLTGITGFSALTYLGLTYAKASVVGLTMALIPIFTSVLAAAFLKERLTPLLIASVAAGSTGVTLLTLDSSGLSWLGALLGSLAALDWAVYTVASKKAMRELSPIESLTSNALMAQPFNFLLALPFFSLAPMADPEVLAGLLYVSLVPGFLAYFLWLYSVNLVGAARAGVYINALPLLTLALASASLGEALSGPQLAGAALILLALALVTLDYLKRLSTS
>fig|453591.8.peg.394 Multidrug resistance protein
MWTKLVALSAIISITFSASNVALPYFLMYLKGELKTLNAELLNASKVALEFGALTSTFMGTRVVIAFLSGYIAERIGMKRSVVVGLILYLVSGIWLIVTENYWEVLVSRALQGVASAMVWPVAESMIVEFAGGKKTRALMLYVMAFNVGMILGPAVGGAALQASSSLPLPVAVRVPFALLPLGALAGLLLIFKLPDVRYKTKMKVRELHAKIKSALYVFFFNAFANGFSAGIFMSVLIIYIMQYVTSVPIKLSSLVALSGLLGMALASPLMKRLDEFDFTNKLKVAIGLGLLHKLALAAVGLTKSYFILLAILTVQNFAITVVIPLIRSLVSDLVPRELTAKVFGMQQAYFNLGMIVGPLVGAALYKWLEASGVGGGLAFPVAAALGAAGVLTLLRVDGREVEGMKGEPVKAEG
>fig|453591.8.peg.412 Fosmidomycin resistance protein
MRKRLLLLGIALLSLGYGYYTTAARVSGDVSEAGAVAVAELASAASATFFGWLADKKGMRKASLAAPLAGPLSALGLDPLSVFLTLSFFYSAFVVALLAANEAGPEELGASVGALSLGWGAGVALVPYFRGPQVPAASFFAGSLAVVAAVPDVPGRANFLAAVPKLKRLVPPLAAFMGAEYLSYALTAWRFYELADPTTFVLSYAVGPGVTAFLGGLVAGRALERFGPERVLLGSLLAYPFVVALALLAPPPACFFAWSVPVYPFYEAGLVATVTKFVPEAKGASLGLTYTTMALSSFLMAPLTRFKDVKVIATISITLMLISTIIIKRIICPPSRARRRASPRP
>fig|45361.3.peg.236 Multidrug resistance protein homolog
MSDQFSNIHQELSQYSNKHIQTFKTFFLHNQIFSFKNLIEHGFSKFTSKRTKILKKSSSISLIATFVTTMFTGILLLEVTLLTFYNYYDVSIFLSLMLYSLDFSGSFGDIIVQTFMLSIRGQYLSNIISKVPTTTVNRELNKAIEKISISNLSFVFEDKTVFSGINFDILPGKKYLIDGPSGTGKSTLLKTILGVYPDYQGNILINDELEINQVSSSSLRQQIGFIDNQNIIFDASLQDNITLFDTQVDLQKLNKILDTLKIDWLKLEDNINVNKLSEGQKQKIVLARLKYSNIKFWVVDEALDNIQKDHAELTIDNLLGDPDLTILFVSHHISADLREKFDEVIAIRG
>fig|455632.3.peg.531 Drug resistance transporter, EmrB/QacA subfamily
MLFAVSMTFIDQTIVAIAAPNIIDELGLTSSQMQWVVNAYLLTLAAFFALGGRLSDLFGHRRVMLIGTLVFVIASALCGAVPSGDFAQAWLIGFRAVQGVGAALMFPAALAVVIAVFPVERRGRALALFFGVSGALTAVGPLLGGWLTGWTWRAIFWVNVPVAVVAIVLAVLARIPDRPRREPLDLPGAALVAVGMGLTVLGLQQASTWGWDSVATWACIAGGLLVLAAFCRLELRTRSPLINLRVFRDLAFRVDNAVLFFAMMAFVPVFFFASVYAQVSLSASPNQAALYLLYFFIGFGLASQWGGRILDKRGARPAMKLGTALGAVGFALWAGKLTTLSMHDQWLYAAMAGAGIGLLLAPASTDAVNRAIDASYGEVTGITQTVRNFAASIGLAVFGTLLTHTTITKVDATLRAKDVPPGESRDIAESIAQSVTGQADSRGPSGSGPVAETVRDAMSAIRMDFAEANQWVFYGMAIALGVAFLISLRHPGTRVTQESSD
>fig|455632.3.peg.3289 Drug resistance transporter EmrB/QacA subfamily
MIALTQLVVVLDATIVNVALPQAQLELELSDTERQWVITAYVLAFGALLLLGGRVADYWGRKRGYLLGMLGFGAASVWGGLAQSGTELIVARGFQGAFAALLAPAALALLTVTFPAGRERGTAFAVFGTVAGTGAAVGLALGGVLTEYADWRWCLLVNIVFAVVGLIGALLFVSESRVEGDNRYDIPGALAVTLGLAALVYGFTLAESGWTEPDTVGFLAGGLVLLAVFGWVETRVAQPLLPLRIVRDRARAGAFLIQAAIGAVYIGMTLYLMFHLQIVLGLSPLLAGLASLAMTFATMITAPVAARLLPARGPRVLMTAGPLIAAAGMVWLTFVTPDGSYWTEVFGPLVVVGVGIAFVIIPVQNVALVGVARHDAGAASALVNSAMQIGGCVGLSVFTTIYLGAVERSGAAGSGRGAALTEGYSAVFLATAVTLVVAAIVAATMLRGPRPAVTPDRVAEVPAHVG
>fig|455632.3.peg.4302 Glyoxalase/bleomycin resistance protein/dioxygenase
MTASTDDSTGTTDAAGITGLGVVLGSTDSDALIAWYRAALEPLGAHWAEHLLVIGPGAIIGFDERDDVADQAAEPGRQLINLTVRDIRAAERHLNALGVTWVRPVEEVGGGWYFSTIVDPVGNYLQILQGPGAP
>fig|455632.3.peg.4494 Drug resistance transporter, EmrB/QacA family
MGTAPTPGADTGSGAEAGAGSGADGAGGPSALTTPRGRRPVVAALMLGMALAAIDGTIVSTAVPQIVGDLGGFTVFSWLFSGYLLAVTVTLPLYGKLSDTFGRKPVLVAGIVLFLIGSVLCAAAWNMGSLIAFRIVQGLGGGALQGTVQTIAADLYPLKERPRIQAKLSTVWATSAVAGPVVGGLLAGYADWRWIFLINLPVGAIALWLVVRHLHEPARPRPAVRPRVDWAGALAVFATGALLLTALVQGGVAWPWLSAPSLGLFGVSAVLAALTVVIERRAAEPIIPGWVWRRRTIASVNLALGALGLLMVAPTVFLPTYAQSVLGLGPIAAGFVLSVMTLSWPVTAALSDRVYNRIGFRLTAIIGIGAALLILLAFPLLPYPGEPWHPALLMLLLGAALGLFQLPLIVGVQSTVGWAERGTTTASVLFCRQVGQSVGAAVFGAVANGVLAARLLDAPVTGLPDDLDAVARALEDPGALSAAATDYLRRAVDAAVDHVYIGAAGAAALALLALVVLAPRRFPVITETAGAPRAAATAADRQDSPS
>fig|455632.3.peg.4936 Drug resistance transporter, EmrB/QacA subfamily
MALGVALIVVDLTIVNVILAPIIEDLSIGSSEAQWIQESYAITFAALLLVTGRLSDLYGARRIFLLGLAVFGVTSLLAALAPGGGPLIVARFVQGVGGAMMLPTSLALLNATFTGRARGQAFAVWGSTIGAAAAVGPLLGGWLADISWRWAFGINIPLVALIVVGVLRYLDVSPRTRGRIDGVGAVLSAVGLGLLSFVLIEGRTHGWLMTTEPLEIGGLSWSGGLSPVFVALLLSVPALAVFWRRQAVLSRAGDEPLMDVGLLSIRSFRNGNFVTLMVGLGEFGIIAVLPLWLQFALGYSAFEAGLALVALAAGSFAASGASFPMAAAVPALAQVRIGLGLEAAGLTMLALIASTDSSWWLISIALFVYGIGVGFATAQVTNIVLVDVPERSGGQASGIQSAARELGSALGIALLTTLFFSTLASGMTDRLTREGVPADEAERLGGVVTDSAGSVIGSLASEPRTASAAEAAREAMAVGVQVSGYVCAGLLLLALAATLFMSPRGPRTPKTPKTPQNQGPSDPKAPHGPVRRTV
>fig|455632.3.peg.5255 Tetracenomycin C resistance and export protein
MTSQTTVEKAPREPEDNAVPAPVKGLRGHPWLTLFAVAIGVMMVALDGTIVAIANPAIQKDLGATLADVQWITNGYLLALAVALITAGKLGDRFGHRQTFLIGIAGFAASSAAIGFSKEIGLVVLFRVLQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPIVGGLLVEHVSWQSVFFINVPVGVIALVFGLVILKDHRAANAPRSFDILGIVLLSGAMFSLIWGIIKAGESWGWGDGRTWAWLGLAILLFVAFGLWQNKVKEPLVPLGMFRSVPLTAGVVLMMLMAFAFMGGLFFVTFFLQGVHGLSPVDSGLHLLPLTAMMIVSSPVAGLLITKFGPRVPLVGGMVCTATAMFGMTTLSESTGTFAMSLWFALLGCGLAPVMVGATEVIVGNAPMELSGVAGGLQQAAMQVGGALGTAVLGAVMSSKVSAEFADNWAGAGLPGAPDPKLEEAAEFGMVPAEQLAKAPGMTPDIIDRIGGVIHDTFMSGMGLAFTVAGIVAVIAAFVATLTKRGENAEAGAGVGHI
>fig|455632.3.peg.6397 Phosphotransferase (aminonucleoside antibiotic resistance)
MAWADVPVDTGSPAVGAVLLTGIPGSGKSTVAAALAARFAASAHIEVDALQELIVSGGRWPSPEGDEEADRQILLRARNACLLADSFAAAGFLPVIDDVVVRRAHLDFYRATLTGGPLHRVVLAPGAAKAMERNLARDKRLTTDWSFLETAMRAELADEKIWIDSAELTVAETVDAVLSATGLTPAPA
>fig|455632.3.peg.6546 Drug resistance transporter, EmrB/QacA subfamily
MTILDETIVNVALPVMREELGFSQGGVSWVINAYLIAYGGLLIFAGRLGDLIGHKNVLLLGVSLFTVSSVVAGFSQNAPTLVAARFGQGAGAALVTAVTLAIIVMMFQDPGEQTRAIGFYSFTFAGGGALGLIAGGVLMQLTTWHWLFFINLPIGVVSVILGWKLLPSGKGLGLSAGLDVSGAALLVSSVSLLVYGIVNAEHNGWTGMTLAYLAGSVILMIAFVIRQKKAKAPLFNLNILSDRDVAGANIVQFLVSGGLYGSFFVATLYLQQVLGYSPMEMALAFLPLTVITALGSIALSPYLTAKLGERIGLIIGLAIFVAGALFLARTPLEATYAMDVLPSMLLLGLGIGLCLPPIMSLAMSTASEDEVGVISGLTNSTGQVGGALWVAIVASAAGSITASRMDGGTNERESVNAGLMYGSLVLAGALVIAIAVAAFVIRKRSVDTPTDGADAKATVHAV
>fig|455632.3.peg.7153 Daunorubicin resistance transmembrane protein
MADAAAKQPVVTLLRAHLACARMEFRAALTYRTAYLSSFAMMLLQIWLLTVVWKALYDGREEVDGLGLTTMTAYATLTTLQYHLVSPWRSSPIDQRVREGKVAVDLLRPVGFPGQMLAGQLGWASAAVPVLLVALPFALLIGAGQAPASTAAGFAYPVALIGALLVNQLLGLLLGMVSFWTLEVSGALMAYRFVAQFFSGALVPLWFMPGPIRAAAEWLPFQATAYTPAAVYLGQVEGVGIAAALGVQLAWIAALGTLASFVWSRARRRVLSQGG
>fig|456827.3.peg.930 Permease of the drug/metabolite transporter (DMT) superfamily
MSNQNKAYLFAGASILAWSTISTAFKLALNYLTPVGLLFFASLTAFLFLGIVNAVSNPSLFKTKELFKTVGRNLKISLMRGLLNPFIYYLMLFEAYSRLRAQEAQALNYTWAIVLALFSIWLLKEKFRIIDFVSLLISFFGVWVISTKGQITSLQFDDALGSFLAVSTSIIWAFYWILNIKDKRPALTKLNYNFFLGFLFIALFALFTHKSLFTPQAIYGYGILGGIYVGIFEMGLTFLLWNKALELTDNTAVISNLIFFTPFLSLLFISSVLKESIHYATFIGLLLIVFSNLLQKGLPAILKRNE
>fig|456827.3.peg.1093 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKHSKIEILEKTPVAYSILYLALPSMLSMLVNILYNLTDTFFIGKLNDPFKVAGVSIALPYYNMLMAIAGIFANGGASYLSRLLGKKDLKTARETTTTAIFTVAIVSIFAAALGVLFIPTYLKLSGASALTALSARQYLTAIFIGSPIIMIKFTLIQLLRAEGAAKEAMLGLFIGTGANIILDPLFIFTFKMDVTGAAIATVIGQGLAMLYYISYYLKKKSLASPGRKYLHPRWSCYKEIFAIGIPSSLSQVMMSIGNAISFKLASAYTDHTIAALGVVSRVFSIAIFAFIGLSIGIQPLIGFNYGAQNYTRMKKIIKMSNIICLGMSAVFTLFFALFPGELIAVFIKDKAIMKIGTQILNAYVFAIPFAGLGMILMAALQAMGKAIPAFIVSLSRQGIVYIPMLYLLNYLFQFSGLIYAMPIADVITTILSFTFVYHITKRLKSSP
>fig|456827.3.peg.1648 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MKLWITYLKAVLAMLFWSATFVWFKIAYKTYLPYEVTFLRLLLATILLFPFVWLTGKREKVPKKDLLHLMLVSFCEPFMYFIGEANGMRIVSSTLGSLIISTIPIFSAVGAWLILREKLPLLVVLGLILSTSGVAVMSLGSDDFSATFKGILLLLIAVFSGVFYGITVRNLTLRYNPFTIVAWQNFFGMLYFLPLFLVVDGKHFFSVQHSLEGLATIAAMSIFASVIAFILYTGVIRDLGVAKSNIFTNLIPVFTVALAYIILGDKLGLPGWIGLILAIIGLFLSQYPDWQKYRKQEKTELLPVVENAETNISDEL
>fig|457570.7.peg.298 Glyoxalase/bleomycin resistance protein/dioxygenase
MVKELLYCYLRTQVFSLLTSLLNLIFLFRTVSVKLLIFLQKIKERWYIMWSGSVIFLGTNDLEKVHDFYHNVLQLPLFKDQGACRIYEIPGGGMIGFCTHMEVKSEGKAPIITLLTEEVDRAYGSLIDNGYQPFNKPKTNPDFKIYHFFSEDPNGYSLEIQKFLD
>fig|457570.7.peg.602 ATP-binding protein involved in mithramycin resistance
MGLASLFPLTTLMFLNFFTDNPSSGQMAHIITGNMMFALVITGLNVVAQNISQQKHQGHFTFYASLPISKINFILANLARGAMTSLPSFCILFVIGRLVYDVDFYMTWALFPATFLIIMSVVGIGAYIGFWSPNQQLTSMLVQALMMLISFLTPVMVRIEDLPSLLQLISRLLPTTYAAETLRILLISGLTQEVLFNAAILLVFTCCFYILILNNLDWRIEE
>fig|457570.7.peg.1509 Vancomycin B-type resistance protein VanW
MHSYNHLAIHYVMSRIFIAGWFYMFKKYYDNFDKKSKKLISIVIPVMIFFMFMMLGLGGYQQYRYQNTFIPGISIAGINISEKSHTQVKKLLEQELENMSDQKIILEHQENTWEYNFHELGMDWMVKASFDKALDNDELSFFEGIKLLLAEISQDQEIQLEHELDESKTKSIVSNLRDEIAQKPQDAEYQVNKYAQSVSIKPHQNGKEIDESKFISELNYLLEQISQDLRSFTDAEFVIEIPTTTVEPDTLTEELQELGIDTLISTFETHYDEDDEQRVTNIELASEKLDNKKLEPGEKLSFNEVVGPRTRERGYQEAPVIIDGELVDGLGGGICQVSTTLYNSVLKAGIIPIERSPHGIPVEYVSLGRDAAVAYDYLDLVFENHRDNGILISTLVDENRLRVDIYGSQESHDYTIRTEDYQEIHPDTIYFLKTDDGERVEISQEEKQELLDTNESDENVNENDYDNEENDLEETNTNNDDKEHIEDTNYEITELQRGRLGYQIEVWLLTYKNDEKVDKEHIATDIYPSRDEKYLIELEDSDQ
>fig|457570.7.peg.1957 Acriflavin resistance protein
MFLSKIALKRPVTIIMAVVIILLLATVSFSRIPIDLYPDMELPVLFVQTDYEGAGPHEVENMVSRPLEETLSTVDNLSQITSISQQDSSQIIMEFDWGTDMDFAALDTRELIDMIGEQLPDDAGDPTVMQLDPDMMPILQVGINAPEMDLQEISELAEGTIQTQVERIEGVGEVNVMGGVEREIKIHVDPYLLSSYQEVSYENIREAIAANNMDISAGEIRDGDGKYAIRTIGQFEDPDEIKDIQIGVEGESPVKLGDVARVEDTVEDMEPLSRINQEPSVSLGIRNQSDANAVRVAQDVRAELANLEESLPGNVQFEIVTDQSTFIEESIDSIIEMGIIGAILAMIVLWLFLGNFRTTLIIGFAIPISIISTFNLMYFQGYTMNLITMGGLTLGIGMVVDSSIILLENIFRKREQGLSSYEGALQGSKEISGAIIAATLTSMAAFLPAAYTEGIAGIIFEPMAWTVVFALFASLLVALTLVPMLTDKVMGEGVDFNRKSYLPRKMDQGLQWLTNKYGQLVDWVLSKRFVVIVSFIGLMIITVLIFPLMGFEFFPPEDSGEITVDIQYPVGTPLDTTSDNLLELEEEISQVEGVETVFATAGGGGDFVVGGDSRSGTINVIMEDDHQRTTFEVVDEIRGLIPERGGVDVTVSADDMAEEGGGMEGEEDLTVLIKGDDMEELESISDEIAENALTVPGVVNTTTNFEDATMEIQIDVDEASADSYGLTTVTIGNFVRQVSEGELVSFYREGGEEYDITMEMEPSQGISVSTLESLLINTPTGEQVPLEEVASLEMAETPRQIEREDRVRTGTVGVQIEGRDIGRTAGDIREVLDESIELPPDYTMDFGGTYEMMMESFEGLGLALILAVLLVYMVMAAQFESLLYPFIVMFTIPLALIGVILALLVTGHSLSIVAFMGVIMLAGIVVNNGIVMVDFINKLYHEQGYNRIEAIVTAGKIRLRPILMTVLTTILGMLPMASGAGEGAEVRAPMAIAIIGGLAVSTIITLVLIPVVYSLFDDLRLRFHSKLARKEESGDLIVKN
>fig|457570.7.peg.2311 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRGMAGGAQLAQQNKRDLTTGSIPKKLIRLALPIMGGMFLQTIFNIVDTFFVSQLGHNAIAAVSMNMPILFILIAMGNAVAVGTSSYIARSIGAGEDEKARKTASQAITLAVILGIVATIIGVSFAPYIISFMGAEGELYSLAVEYTSIIFWGNLIFFLFLALDGVLRGEGDMKTSMMKQVVGVGFNILLDPIFIFGLGPVPAMGVAGAALAIVLSRFLGLLFLVWHFSTGRSTIKFNMTKFVFESEIIKQIMAVGLPTSASQAMMSLTLFVYNRLASGFGDEAVAALGLGFRIDSLAILPGIAIGISMVTMVGQNYGAGELERVRRSYWTAQAMAAGFMASVGVFLFAFPEFFIGIFSQEQDVMSHGVSYLRILPIFYPFLGSGLISAHSFQGLGKAIPALIISLIRVGLVGIPLALFLTSQTGLGASGIWLALGLSDFTFFGVGMLWFKSTFKRMTRFVHS
>fig|457570.7.peg.2642 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKVSSSDRLGTDPILPLLLKLSLPGIVAMGIQALYNVIDSFFVAQVNEEAIAGLSVAFPMQLFLIALSVGTGVGTSSLISRMLGKGDRNGAISVVEHVLVISAIYSVVVFLIGFLLPESFIYIFTDDHLIAQYAFEYGRVILMGASPLFFGFLISDALRGQGNTLIPMIGMVSGAITNILLDPILIYGMGPIPRLEVQGAAIATVISKTVTFAVVFYELLIGENEVKPKFRDGLKNFKFNKEIIKNIYAVGLPAAVMQMLASIMISGLNIIVGNLNALALSATGIYFRIQSFVFMPVFGLNQGYIPLVGYNFSNGNAERVKKVIGYGALIACGFTSLGFIGFQFIPEIIAGPFVESQELMDIVVTAFKTISIAFPIIGPAIIGATTFQAIGKGIPSLTLSFFRQIILLLPIAYFLSLTGNLDLVWFAFPISEFVSFIFMIIWLYITLKKELIFAKFQRG
>fig|458233.11.peg.254 Multidrug resistance protein
MKQQFKLLMMIQFFIYFGFSIVIPVIPALVHSLNLNAFHMGLLLASYSIVSFIVAPMWGYLSDKYGRKKILIIGLIGFTLSFVLFGLFIDNLPMLYTSRILGGLFSGACFSTTTSMVSDMTTHEERNKYMGLMGMMIGLGFIFGPAVGGLLSGISYQIPYFVTAAILTVIALFCLFTIQETLQHSTDSEQATVNPKLLTPAVYMLLLSTFIVTFTMSGMESSFQLFEIEKINITATQMGMLFMIGGLVNAGLQGGYLRKVKHGQEKPVIITGQLITIVAFIMLPFSMNLFYAGLCLVLLMSGNALVRTLLTSQLTKETSSNKMGKLTSISYSMDSLGRILGPLLFTALLSRHLEMPFYFGALTSVFGLILLFIYYKKGRVV
>fig|458233.11.peg.353 Chloramphenicol resistance protein
MKVNLFLLAMMAFLAGLNELVLAGILPFVMDYFNINTQEAGYLITVFALIFGLAGPVLMSVTMNVNRKTLLLVFLSIFIVGNLMSVFAQFYWMMMLSRIVLAASVSMLIGLALSLSVKVVPEYMQARAIGIIMMSISGSLVLGTPIGIYIAELTDWKVIFILISVLSAILMLLLMKYFPKNIQVERVSMARDWKFILKKEILSVHLFSFLFFVGQGMFFVYLTPYLMDRGHSIAVVGLIYLVFGLAGILGSGIGGYMTDKFGSTNLLVVQSFLYVFLMLMVNFTAFSAVLVCINIAIWAMTGWMVNAPTQTYLIQAAPKFSSINQTVSTSSTQFGISLGALLGGICITQTNSYPALIYYGCCVLVIAFLVTLYIRRLNTK
>fig|458233.11.peg.644 FmtA protein involved in methicillin resistance
MKIALEFLFSRNRNISYTAIDKYLDDINFNGQIRISHEGQGIFHQSYGYKNLIQDPITYDTQFLTASIQKFITGIIIEQLIDEGKISRMDKIVKYINGLPDFITIEDLLLHISGLSPYKVHHNFYGLDQSVDMIRASGAKLPFHKFDYNDANYILLAKLIEIVENQTYRAVVYDRIIDKYQLAHSCFYDEVNDATTGLHQFGSVLIEDWHNDLDKYYGAGNMYMSLKDIDILSRLFANHLIFNKPKTEFILAPDRYKNQKYRSGISLRDNYLRLRGSLYAHDVVVYFNGTSFICVASNRESKLYQAEKILLNILNSNKYC
>fig|458233.11.peg.645 FmtA protein involved in methicillin resistance
MRKLIVLLLIIGLWGVLIYELTGKNNETHEVNGKQNTGVQTNVSKTSQNDALKIQVDQLIKKNHFNGSVFVAYNNDTLLDQSYGFKDADQTKKFDENSMYLIGSCQKLITGIITKQLVDDRKINVDVSVKQYIPNFKYPNIKIKDLILHRSGLVKYAFHGDYHGLDASVDNINATGLGPVPHGSYLYNDANYILLAKVIENVTGKSYQQNVEQRIFKKYHLKESSFFDDEKLSPYFVKGLKYVNHNWKAIEPTGLDKFYGAGNIYMSPKDMGILLNDVMQYRVLSKSQLDSISKPMIFNIHSKYRYGMSLKKEYYRSRGYFFGIDFVSLFNHNKVVVVATNKLTQNEIPNNEKLAQQIYSLLK
>fig|458817.3.peg.2404 Chloramphenicol resistance protein
MNPKVYLLALITFATGMDENIAGGIVPFIAEDLGVSISAAGQLTTVFSLTFALAAPVLLFATAKFNRLRLLQVALFTFCLGNLFSALSPSYAFLFGMRIISAASCALIVVLVTTIATEMVEAEFKGRAIGIIFMGISGSLVLGVPVGLLFCNWLGWRAPFAFIALMALLLCIIVPLMLPNVSSNGQRIPLSKYAEHLKNPKLLTAQLVSILMIGGHFVLFAYLAPYLQATIGASKSELTFYYFLFGAAAITGGYMGGWLSDKLGHITAIILIPSIFILFLGAIPFTLNSLVLFIPCMMLWGGLSWTISPIVQNYLIQSDHANAGVSIAVNNTSMHLGVALGSLLGGVVIKYSSVNWTPAIGVFVVVLSLLCALYSTRCQEITREECKEKLIQP
>fig|458817.3.peg.3313 Permease of the drug/metabolite transporter (DMT) superfamily
MFHSRANALIRLAVFPVLLLYWQDFYGTRLPLLGPALVAVLFCISSQMPSAKMILKLGVILFVCTWAQGQISLYLFDDPLIYYLLLFVTFYWCMQRARENPTDIISSFMLLSLVLVTVFSRQKGLDITQLPKGLFLELIYAGFTVFIAFLLFPGGEIIATTQTIPEGGAQTEIWHLLLKAACSFICLWVFIDLNLSQAALMAITFTNVIKDPNPMKGVNYGISRFIMNSVGLLFALPPLLAAAFEVNIIVQLGVAIVCAMLMGIYAMKKEASINSFQVLYCAYVILLFKGITESGGNALHNDFIRIGSILFSVMLGLIILLLLQSPTKTEQVP
>fig|458817.3.peg.3314 Membrane fusion component of tripartite multidrug resistance system
MPTSKDTASTGDSEITQKKTVASSKRVTWILLVIVFLLWIYTLWADRVTPMNNHARVNAQLIQITPQVSADIYKVSVLNNAEVRQGDALVDLDNAPFLLKITAARLHLQQTTLSLGADSAGIQEAQANLVASEIKHDNAFKHTQRMAALGRTGVISKQSLEDSQDQLKDAEAQVVQAKAALERAKKALGPKGENNPQLQSALNQLHQALLEESYCHLRSPGDGVITHLNLAAGNFAVAGHPLITFINNKHTWITAMLRENSLIYLKPGTPVKIVFDAYPGQVFRGEVQSIGWGSSGNGNLQTDQTTGLLISPDGLQHSQRFPVNINLGPEASALQQRYGARAMISFYPGESGVGETLLNIWTWTWSYLSYVS
>fig|458817.3.peg.3711 Multidrug resistance efflux pump
MKEIMLPYIFIVWLLFKFKVIKARPRNYFISVFVGCLIAVALFLAHRFYSPADLTNSTTVRAPHAILSPAIGQQIDTISIDHNQHVNKGELLYTLVDDKVSSAIDEINARVQEVKRNIEATEVKLAQAKRNHQRKINLGDHVSERDLENAADKVEITTAELKVQYAQLEVQYAQLRKQEFELKRLEVRAPFDGMVTHVYIADGSRVGAMHLWDTGRKFVEMRIPDQSFAYIQPGQFAEFYINAYPGQIFRARVHSKVEATGEAQGDILPREQMVSRHINLGSMPVGRTVVLEVDDATMAMLPIGATGSAWISADKPSSILGFLDIIGAATVRLTAVKAYLNPL
>fig|465515.4.peg.2066 
MSVGQDATTAGPVVESVELHVAAGAEAAFEAAVAEAEPLFRDGGATSFALSRQVEDPARYRLLIGWRTLEDHTVAFRESDSFLAWRALVTPHLAQLPAATHWSAV
>fig|467705.8.peg.1783 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MRLNIKEEYLVKKYLEFLSKDRNMTLKAYLFRCKRSNSIWLFWIFINSLCVYLNGILSAKAISTIVNFDLQSFLYLSGAILAVNLLWVLQIYQNSKASEKAIQEMCTEIRKDIVKRIEKNGGVHFASKSISAYTSWLTNDINTIRDLGFETLELMISQALNIIFAVIAFFSFHYSLLFTIFIFFILMVNLPKIFTKKMEKKAVYFTEKNEELVKAIDDSLSGFRMLSNANQLHFLLVKILSYSKQYSRSRVSYSKTFGGLMSVQNGTSFVSQIAMLTHAGILYFNRLIPIGAVSSSQYFSSIIFAGLTGLTANYAEFKTVNKIFEKFELTNDHSINETQNKKQPWKKFIDKLEIQAVTIEREGKLILDNLNFKIEKNKKYAISGTSGSGKSTILKAINGEVLISKGEIFYDNVNSQNIDLVDLHKQISYVSLDDHIFNESILFNLTLGRQLEDTKIEKALDLFYLRDWVSGLRHGLDTTLSEISQDISSGQKQRISLARAYLEEKPILIIDEATDAIDKERRYQIEKYLFSLPDKTIIFVSHHLDENIKSLFDKIIYLD
>fig|469378.5.peg.316 Permease of the drug/metabolite transporter (DMT) superfamily
MCWKGMLPNVQSKQGIVIMLVLIQAAIYGLGNVLMKIAYLGISPMWCAVLRFGLAFVLFMLFFGRRVISTFKGKRLRTWLPSCLLMAASFLLCGLAVNLTSATNAGFFMALPMLFTPVLSLVVLRRAYTLQTVLLQGVVIAGLYLLCCNGGALSFGPGEFCGLASSACFAASIVMAEHGLGEVDAIAMSVAQIGVTFVTATGAAIVFEVPPVLDAVPLESWVAIAFLAVIGTCVAFFLQNFALSRIPSATVSVLLCAEPVFTAAISAVALGEVLTSVGIVGAALIVACTMAASLEDTQITLPHRIVHEHVQRLSSVRR
>fig|469378.5.peg.357 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLDRADFKVYIHYIIPSIASFLLTGIYSIVDGLFVGHAVGDAGLAGINVAWPLVAFMMAIGTGVGMGGAVISSIYAGIGDLRSSNRAIAHTLSMLALATPLVMVVLFCFGQQLIYLFGGRDEILSQSQSYLSVMTWGSLFQIMASGCIPLMRNKGRVVAAMVILVISGLLNVALDFALVMLAGWGVAGAGLATVIAQAFVFICGLAFFLKRENRPRSRDFALDGEFLSRTLKGGFAPFALTLLPEVTTIVMNMATEAHGGATAQSAFAVISYVAVAIQWIIQGVNDGSQPLVSLRFGEGKLSTMRALRHTNYVFAVGIGLAGMVALYVLRVPLAVVFGISPQTSEVFYHGVALFSLALGFYGITHATTSFFYAVESSRNATIVILGEVVFVVFFAAVLPLFLGLDGVWLAVVATQACLAVLAVALLRHSRGNIAQAAARHVEKHAELAGQAAESNA
>fig|469378.5.peg.782 Albicidin resistance protein
MKFLGIQLDDIKRDQDDYRTIDSVKQLFSEKSKTMEAEFNELLRHFTALKNLAATTRDDDSIDWSRYARIIQDFEDGGKYFWQLSCVYEENASREVEAAVQRNIEEKQRHHEKMRAMHELIAQAIVLMHDGVPADDERAQELARKFNSIQDKTGWAMPVNHFILGDAHSSHSGDHAHTNHHASDSMPPSLAEANTSPFGELRNDVGAYFLKASQALQKQQKRKEL
>fig|469378.5.peg.1150 Multidrug resistance protein B
MRAHAVQTNSLYARQPSAKRPAAQQVQHSRRVSPIQQAKQVRQRPTHCLAGLIHRAASPVAVLLIFLCMALMLHFLFLPQFAGLPFVGFTYDGGDASAQLIPAVSLLERSLMDGTFFWSWDYGLGGDLFSEFSYYYSTSPLFYLQFSIKWLFGAAGGDFATTQAWRVVFSIIKQILCMLFMYLLIRREGKGRLAALTAGILYGCSFWYIDNSVAFDFMTDAMLWPPLLVMAFNRWNRTGSWMPLCLVLALSIASNFYFGYIVCVFCILFALVFAYRGENGQKWAAFIRGYLRRLGVLALVAIGAILLSSIAFIPSVIALLSADRAQVPLQVGIFPSLHFVKALPEILFFKGGMFSANDAQTYAFPLIAMLAPFLFKHLSPAGRKRTIFAALLVLLWLLPVVSSLMNGLSYPSNRWCYLVVFAVAYAVPDWIECLATKGIRAVRPVVFVGLAVLALVVLATHNVRVQDLSGAPGYVFQLLGISDLVFFGLQVAFIAVILLKGTRQQTNGAARVHGVPLSAAALALLAGAVLLAMPFGPYAAYAGFRDMGGAVTFSSPEQLNKTFEGDTSNQETYRLLAQAGAEFEAGVKTKTEPRVAAHVQIDTDANAGVDANSGTDSIDANNTFFRTADEETYQDDANYRRFENRSWILGTHPVSVYNSLITKDISQWIKRERQVTPTTRSASQYRGFGHRLFIENAWGIEYKFNTTEASNLYGYEPLDDSSHESLGDTSQVLGAQDASNENASQTNISHTNTSQTNAPSSDEATEGKTTEGKTTADKTTMDKVTASTKEIWRNRYATGIDLWYSTATAKSSTPTWSFEESDAALLQTAVVDDDVANRLALPSGTLESTVTVLPLDNSNTHFDNCSLSNGILQVDSGGGSITIDLPDNLGSGECLLSFTLKNTQEESFTFRVNGEEYWQGGKTHRWRYPIDNYSLCFPEPEGSLKVNISAGTYTVDNVQLEFGSYSRLADWTNSVNRYGLADLTVGKSSITGTIHTDEAGILALAIPYKKGWTCLVDGKPADSFVVNGIFAGVFLDAGDHTVQWSYANPYFPFAAGLSILTGMALAAIWYFRRRKSGSNVLTRKQIARPSVPSCSQSRVRSHSPHLLENDLAKQHEVPRHNADHSSELSNKRHNADTSHI
>fig|469381.4.peg.255 Acriflavin resistance protein
MEWIVRILRQRKVVYSLFLGAALLGVLAWVSMPREEDPPLSYRAGMIQAVFPGADAESVERLVVIPLERRLSQVKEVKRVKVTARRGSALFLIHLHDEVMDSIAAWDEVRRAMEKARPDLPSEVTGLVLDDRMMDYESIVVAIGGTSDLLELRNGAIALEKELLRLPSVSRVLRIADPGEQITVAYDDSTAERMGLSPRNLRQALSMQNRTMPGGSLVMGEKSAALQAHTEFKSIVEIEDTPVRLPSGETVPLKTIAKVIHGPSEPARDRMRYMGNPAVGLGIVPVTPVNSIEFGKDVRKILERMREKLSPLEIEEVSFQPHYVDLRLKGLSNSLLMSMVLVGGILCFSVGFRMGMVVSSVIPLIVLSSLGFYALCGGVLNQISIAAFVIALGMLVDNAIVMAESVEVRMKNGSGGMDAAVDSVRELGSPLLAATGTTVAAFLPLWMAHGQAAEFLRAIPQVVTLTLFLSLLAAMIVTPTLAALAFRKSRGNTADYGGRFNLGRAIGAFSSKHAVLILLMSLSLLLVVGGYGKHVRKNFFPGADRNVVMVDLFLPEGADIHAIDGIVGKVERHLKNEVPSVSRVASFIGRGAPRFYANIVPAPRNPHRAQMILFTTSQSQNHSVVGEIRSYLGEEIPQVNSVVQELVLGTPVDAPVEIRLYGNSLKDLRFGAERVMEAMKRIPGMVDLRHTLGNGNPSLEFDVSSGAAFRYGLYRDQVAQVLSGRTLGLPAGEYRQEEEPVPIVLRSEKGVFFGADRVSSVLMDSSTGVPLQTVAPTEIAWHPSAISRRNRERYVAVQSNLEDGYVYSDVMTRLLPILSETDLPEGVRFEIGGEAEASGEAQGSFSLAAPFGLIVLVGILLAGFRSFRKVGMVLATIPLASLGVIPGLLLSGEPFGLMSLLGVIALAGIVVNNAIVLLDVVELRRKKGLSVHEALTKAVEERIRPILLTSGTTAAGLFPLAFSSSNLWPPMAWAMISGLCASTALTLFVIPAMYRVLYPEKSVFARLLGLIRVLVGTKAVRNDQI
>fig|469381.4.peg.339 Fosmidomycin resistance protein
MTTAGKALSSKTKVALLSTGHLVNDVHTAFLDTFLPYLVKNLGLSYAQAGILTSLSGVIHTVFQPIMGHVADRHTRPWPIMFGPIAAALGASMIPLSTSYAMALTMVTLWGIGAATFHPQGQGSLGYVAPPSELAFAISLFGLGGMSGGTISSIYAIALYRYFPHWAMPVIAVIPPLILAAVYYKTMPKIRDRSPEEDSDDIGMIKNLSSVFKRIYPIWAVTILRECSQKGVRFLLPLLIVSEGGSITKVGTFLFFLSLTASILPLIAARIAMEVGNVKIVKIIIPLASTFLVIGWATEGFLSLAMIVIGGASITACNPATDAMAQELAPDKRSTASSLMMGFSFGLAGVAMAPLGWFTDAAGLRAALGIVAFLPFLSLPVMYLLWPKKGLIR
>fig|469381.4.peg.368 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKVPKGKKAEMMGSYPVGAILWKLSLPTITGMVVQASYNMVDAAFIGKGVGTLALGGTTICLPFQMLMGAMGGAIGMGGASLVSRALGRHDRELASRALGNVVALALILGIAATLLGKASAEAVVTLFGASEEIKPYALEYLGIILLSCPLTLLAMSSNAVVRSEGNANVAMLSMVISGLANVFLDWLFIFHFHMGVAGAAWGTLISKLLVVIWLVSHFTVSPHKVIKLSPRRLRVDRDIVSEISSIGVSAFVRMAGTSLVMASVNNAMGIYGGPYYVAAYGVINRVMSIVYMAVNGVALGMQPLAGYNYGAGLFDRVRSSIKLSIIWGTGGCVFFFLLLFFLPERVFSLFTNDPDLIAAGVVSLPTIVAGTSLVAIHRIGATAFQALGKGKPAFWLSMTRHVLVFLPLLAILPRFMGLTGVLLSFPLADAIAAGITLLPLRKEMRQLKKEVLSTL
>fig|469381.4.peg.925 Multiple resistance and ph regulation protein f
MIYTVLWGLLFAGLVGFYRVVMGPTVPDRIVAADTVSTILTTFLAVLYLLFDDMVFLDVALAFAVLSFVDVLVMAKYFEHGELHL
>fig|469381.4.peg.949 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSKERSERMGSDPIWRLIFQFSLPAIVGMVASALYNIVDRMFIGHAVGPNGIAAITVAFPFFLLVISTGILIGVGTSSQISRRLGENEQDRAQLAMGNGFLAILVFSVVLMVLAFFFMEELMYLCGASETLMPLTRSYMLVILWGVPFQLISFCCNYFIRAEGHPRYAMWTLILGACANVFLDWIFIVKMGMGVKGAALGTVLAQLGAACWVLLFLP
>fig|469381.4.peg.1009 Permease of the drug/metabolite transporter (DMT) superfamily
MAERIYDKKKMALGDLGILTCALLWGVSFAATKEVMKYMGPLWLLAFRFTFSFLLIAGLSPKRLKKLTARDIKVGGIIGSLLLVAMALQTIGLQYTTTGKSAFITACYVVIVPFITWAADRRSPGFKAFVASGICLLGMGAITLDGVNMGIGFGELLTLGCALAFAIQLVVIDRMAQESDALTLTMVETALSAVACVVGALIWEPMPQVRSMAVVGWMAYLVVGCTLIPYALQIKSQQLTSPTHASILLIMESVFAMTVGIVFLDEPLTSRLALGCGLIFFSILLTELDLASLSKKLRRQEA
>fig|469381.4.peg.1064 Acriflavin resistance protein
MGDRTGTPQKNRGEDPMRKLIETALVRPVTVVILTTALIVFGVYAFANMGMERMPNVDLPYVMVQTTMEGASPSVVDNDITDVLEEQINTIDGIKNIDSSSYEGRSVIAIEFQLDKDVDVAASDVRAKVNLARGSLPDEADDPVVDKFSFDDMAIMTIAVNSTADMRSTSTYVDKIARQRLQTVKGVGNAQAVGLREREIRIWLDPIALQARGLTATDIKNAINEKHVELPAGRIESESQEFGIRLAGEYGSIEALSQMAVARRNGALVRLKDVARVEDGFEDRRSIATYDGKETILIQIRKQRGTNEVALAKDVKAMVDTLNATAPKGISLKIVQDTSRFIIRSMNGVRGDIIMGIMMTSIIMFLFLRTIRATFVAVITIPVCLIGTLIVLDGLGVTINNMTMLGLSLAVGMVVDSTTVVMENIHRHKEMGKTAMRSSADGGSEVGFSVLAGAATTMAVFLPVAFMSGIIGRFFYAFGITVAMTILISLILSLTLTPFLCSRILGRQTESALTRAMEAPFLVLERLYTGLLGAAVRHRLITLIVAVAIFASGLWMATQLGSEFFPNEDRGRFKINFELSAEASLQQTEDFLLELGKLVRQDPRVVYTYGTVGSGQGGEVYKGTITVELVPRDERAPFYVIMGEYRKKLAVYRDVDITLGRWGGSDISLVLQGDSTEELADIGEAMKAELEQKSVGLVDITTNLRMNKPRINLDIDRNLADDLGISMRDLSTEIKTYFGGTNAGSFKEGGYRYDIRLRAGAEDRDAPEKISDIAVRGGDGELVRLPGLVTPRIELAPNVIKRHNRQRSLGIGANTDGISPGEGIVQLEEIFDRYAPSDGSVTMFPSGDTENMRESFASLTTALAFAILLVYMVMAIQFESFMHPLTIMFALPLMTAGAFGLLLLTGIRLSVMSFMGIILLVGIVVNNAILLVDFTNQQREQGMDKISAIMKAAPLRLRPILMTTCSTMVGMLPIALGLSEGGEIRQPMSITVIGGLFTATLLTLVVIPVIYLIVDDMTDRVKRVFSRAGAIVRGRRMAASGRLPGQTTERGKTAR
>fig|469381.4.peg.1072 Glyoxalase/bleomycin resistance protein/dioxygenase
MRSAHVGIRVSDLERSLSFYVDKLGCRLSHRIDTQTSRLAFITAGETTFELVEKAPMTEHNGAIHLAFVVEDMDETVKKLEESGIHLDKNGINSFQGGKILFFQGPDGETLELCQDVGTAI
>fig|469381.4.peg.1119 Permease of the drug/metabolite transporter (DMT) superfamily
MDRLGFVLILGSALTNAAGSSMMKVGFGRRGDLMDGGALRALFQIVSNPWAIVGVLLFGVSFIFMSAALSRVDLSVAYPLMSAMVYVLVLAVSVFWFGESMGLSKLLGIGAILFGVAALSVGG
>fig|469381.4.peg.2159 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDRTEFLGKEPVGRLLTKLSIPAMTGMLVMASYNVVDTIFVGRGVGPLGLGAIASAFPIQFIVHALAMMVGVGAASLVSRSLGAGDSERAEVALGNAFFMALVAGLFVSAAGRLSMPTLVALTGAPSELAPLIRDYLGAIFLGSSLLVCGMTMNCVIRSEGSAKVAMMSLILSAVTNIALDPIFIFVLKMGVTGAAVATVIAQGVTFLWAVAHYLVPGRSSVRLHISNLRPRWSILKEIMTVGGSEFARLSAQSVAGVLILNRLSFYGGTDAMAAQGIVQKMLSLSIMPIFGIAQGLQPIVGYAYGAGDNMRAKKAVELALISASIISLGTSALLLTVPGPLVRVFTDSPALIDTTKSFIRVAISMYFVVGFQIIGTATFQSLGFSRPSMVLSLSRQVLLLIPLALILPPYLGLLGVFLVYPTADIASASLTMWLLARYRKRLIPSQVN
>fig|469381.4.peg.2178 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQLVIIALAQGIGIGGSSLIATELGAENEKGAEEILGTMTMLISLGSAFIVALSLAFISPTLSFLGASELTLPLAKDYGVIVLLGSPMLAFSIMANGIARAEGEAVMAMKTLAISAATNLVLDPILIRYFDLGVSGAAWATVIAQAGSASWMALYLGGKSSINIRPRDLKLRRSVVSSIVSVGSSAFVRQGSASITAVVLNRVLLSMGGDPALAAMGILNRISTFVTMPLYGLVQGMMPLISHNTGSGDQCRVLRTMDLSALWATAVCLAGALPLWAFPLATLSPFCSGETLEIAVAAAPYVALGMPLGGFQVVLSGSYQALSRGRDAFLLDLLRRIVLVVPAIYILSHIAGLKGVFMAIPISEVISGGLSILLFREVRRCSKKRCLVSSQDSI
>fig|469596.3.peg.151 Nitroimidazole resistance protein
MFKEMRRHLQKLSLQENKDILTKATSGVLAVSGEDGYPYAVPMSFAFDHKRLIFHCAKTGHKLESVLRNDKVSFCVIDQDIIIPKEYTTYFRSVIVFGRTHILLDEKEKQKAFEILAAKYSPNDQEGRLAEIHKLFKQTVIIVLDIEYMSGKESIELKNKT
>fig|469596.3.peg.152 Permease of the drug/metabolite transporter (DMT) superfamily
MSEGKAHFYCGIVAVIWGLGFIAVDQALLSFSCFDILLIRFLGSSILAWLLIIKDIKKIHIKTVKKGVINGTFLFIAYALQTYAQTLTSVSNNAFLSASGVVMVPYFCYLVFKKKPNTIQILSSCLCLIGIAILTSSKMSFQVGDILALGCAIFFAIHLVSLQYTCVLEDSRVINAVQLLTSAILSIPCTLFFSRTPTDISLMSIMSCLYIVVFATFLCFFLQTKAQQAASASSCSVILSTESLFAVIFSVILLNESIHIHLLVGGLLILLSVILVQTSSLKIVINKVMKKE
>fig|469596.3.peg.752 Permease of the drug/metabolite transporter (DMT) superfamily
MNIKKKGIIFTVIATLIFGITPVIGKMTYAMGSNGIQLAFLRHLFVVPLFLFIVVYQKLSLRLTKQQYLDVFKVGFFGNTLTVVMLYMSYSYIPVGSATVLHFLYPLFVCLFNFLFYKQTLNQKQMLCLALAIVGVFCFIDNTSSSMIGFVLAVTSGIFFAYYMIGMDHSSIRNISPYVFNFYLVIMNTVVIFLLGLLTKSLSIMPIEGYILSAIVAIFASLVGVVLLQLGIRCLGASLTAILSTLEPITSIVIGFLFLGETLTVLKIIGCLLVLLSTFILVKNQTAAGE
>fig|469596.3.peg.888 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKSKSTDLIHGHIAKSIFWFSVPLLIGNLFQQLYNTVDAYVVGNFVSKEALAAVGASSPIINMLIGFFMGLATGAGVIIAQYFGAGDNGRLKKAVHSSAALTLVMSLLLTVIGMIGTNPMLHAIGIPADVFHDSSTYLMIYFAGISFNLIYNMGSGILRAMGDSKRPLYFLIIACIVNIILDFLFVKYLHMGVAGAGYATLIAQAISAILVVIVLVRSEGPHQLFWKQIRFHFPILKKIIMVGLPTGIQQSIVSLSNVIVQSYVNAFGSSVVAGYSATIRIDGFVNLPLQSFNMAVTTFVGQNIGAKQYERVKKGSRIALWMTMAVITTMAISLFFFGESFIAIFNSEPDVIQAGRTMQLAFVPFYIMLPVVQIYNGVLRGAGKSSVPMYIMVFNFVILRQIYLAIVTQMTSDVYFVFMGWPVTWVTCAIMFIIYYHKVNWLNQDSVS
>fig|469596.3.peg.2163 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRKNIFATFIKYTSLSMLSMIGLSCYILADTLFIANGVGPLGLTALNLDLPIYNIIFGLGTMLGVGAATRFSILKSQDKHHEANQYFSQSLIVGLIISIPFMIIGIFFPATIVQLLGGNSEVLPIAVDYLRTFIIFTPFFILNQIMVTFVRNDHNPKLASIAMLMGTLFNIIFDYILVFPCQLGMFGAALATGFSPVVSLLICMFHFAKKRNNFTFVKTKLYYEHLYHFITIGIPSFVTELSGGVIIFIFNIVILNIGGNIAVASYGIVCNLALVVTSFYTGIAQGIQPLLSQCYGHHQNELIHTITRYAIVMSLIVSGIVYILIFMFPENIISLFNSENNIVMTEIAKNGLLYYFTGFFCVGINMIAVSYFASVEKVKPSFLISILRGGLLIIPIVLVTSQFFSLTGVWLAFPLTELIVLFIAFLLHNKYHLIQTL
>fig|469596.3.peg.2332 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNEEKIELFEYIPVSKSVIKLALPMILSSLTVIIYNMADTFFVGMLADPIQNAAITLAAPIMLAFNVISNLLGVGTASMMSRSLDAKDYKTVKQSSAFGFYGTLFSGLLFFIVYTIFKQPIMELMGVQVNTEFATNIYMFWTVTLGALPTILHIVMLNIIRAEGKSVLASAGVAVGCILNIILDPIFVLPWGLNMGASGAGCATFLSNCASCIFYFIILFKKREKMFASISIKDLVLNKKVDYGVCSIGVPASIQTLLNVTSMTILNNFTVIYGATAVAAMSIAQKINSIPLNIALGGSQEIMPLISYTYASKNYKRMKNAVNYTRNVMLIFLILCSSVSFILAKSFVGVFMNSSDISTYGSQLLRGFSLGIPFLCLDYLSVAIFQAVGMGKYAFFFAIARKIILEIPSLIILNSFFPLYGLAYAQFVTEIILSIISIIVLRRLFHNLI
>fig|469596.3.peg.2340 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNVDMSKRQDLFETMPIMKAIMIMSLPMVLSSLVTILYNLSDTFFVATLNDSLQTAAVTLSAPILLSFNIVNNLFGVGSSSLMSRMLGIKKFDIVKKVSNICFYCCVGCGVIFSLLFIFFEHEFLVILGVDLQTMAATQEYMFWTVKLGATPAILNVVMAYLVRSEGASLQASIGTMSGCFLNIILDPFFVLPQYLNMGVAGAGMATFISNCIACLYFIVFIMLKRKQTFIDISLLSFHWDWKIIKEIFVVGIPAAIQNLLSVISMTVLNHFTVFYGVDAVSAMGISHKIVMIPLQVVLGFSQGIMPLISYNYANRNVQRMRNVLYVSLKFSISILIVLCIIFMMFASYLMSIFVDIPHVIQMGSVLIRFSCVQLPFLCIDYVTVCVFQACGLGGYALIFAILRKIVLEIPFLYLWDYLYPFYGLSIATPTTEVILAIIAIIKLKKILTEQTKRL
>fig|469596.3.peg.2712 Permease of the drug/metabolite transporter (DMT) superfamily
MSIYIQLLLASFFWGSNVIVMKLLLDEIPFLLLATMRVFLSLIFLGIYLKWKNISFEYNYKNKALAIGILAIYLNFFFTFLGMNQVKGIDNAFMNALAPILTFVFSLLLLKQKGNMKEYIAIGMTVFAFLLSIRFQIFSIKIGFWYLFLGMVLYMLANVCIQKWKLHNSLILSFYELLFGFFFLAIHCFVQGQFQLQPLFEISLFHWLLFLIISGIGFAFIQVTYMRSIGVIGALKTSFFLSLNPIITYIESLLFLNEEFDIIHFIGFVILAIAIYMMNGQKEKRTNSLSHNDE
>fig|469596.3.peg.3001 Teicoplanin resistance protein vanZ
MYILSIELKLTLMQKVILIMIQTTSIVGYVYFDSNYQNQEKRKKSFLQMHWVLFILYCLNLFYILFLDPDFGRKVMKATLSFEDYFQYNVNLDPFETIHLFIRGYQKGVVTLEALLGNLLGNMLVFMPMAYFLPVLFPKLRKIRWFILTIIMMVLSVEILQVYLRIGSGDIDDFLLNVAGATLMYFLLKCFPLSHIYCLVGKE
>fig|469596.3.peg.3637 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKEKMETGKILPLLVELSVPAMIGMIVNAIYNIVDRMFIGNAPHLGSIGLAGITISYPVTLVLMALSLMAGVGGATRFSIALGAKQDEDAKFYQGNSLMITVIFGLVFMIFGNLFMDPILTVLGASESVLPHARAYLSIILYGAVFQCVAMCGNNFSRAQGNARNAMVSQLLGAGFNIVFDYIFIVQFHMGMEGAALATIGGQFLSMVWQLAFLFGKRGLIQCKLVHMKLKKRFTYMILKTGLPAFLMQMSASVLNIVINGTLGTYGGDTAISTVGIITSVQTLMLMPLTGMVQGQQPIISYNYGAKRYDRVKETLKYTVIGSTIIAFIGFLIIEIFPAMIISMFNQEAEIINLGSISLRIWFICLPLIGCQTMCANFFQAIGMVKQSSFLNLLRQCLLLIPLILILAMIFKLYGVFIAVPIADLIAFLITMYLIRREMKTFVVEEVS
>fig|469618.3.peg.230 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKFENDLSKGNVVKQLIKFSIPFLISNLIQTLYSVADMVIVGRYASTTSMSGVANGSQVQFVITNMVMGFTVGGTVLVAQYLGIGNRKAMKETISTLFTTLLLIAVVITTLMIFTMDPLLKLIQTPAEAFFETRAYFFVTTLGTIFIFGYNALSAVMRGMGDSKNPLYFVAIACVTNIILDLLLVAKYGMGAEGAAIATVISQAVSMILCIIYLKKNGFIFDFKLSSFKFYKDRFDLLLKIGIPTSAQNAIVSVSFLFLIALANTFGVSASAAVGAVSKLNSFAILPTVAVSASVSAMSAQNIGARQIRRAVQTLKTGIIFSLAISFIIFLFMRIFPEDCLSMFGEDKEMIKCGVEYLSAISYDYLLVPFVFCLNGLFIGAGHTKFSFINSASASLFIRIPACYFLGVFLNKGLYGLGLGAPLASMFGVIMGVVFFLSKKWMRAVIVKE
>fig|469618.3.peg.238 Acriflavin resistance protein B
MKSISEFSIRKPATATMFIISMIFFGILGLKKMPIEMLPNINKPTVRIRIKWDGATPSDVDKMITRKIEDVLPNVEGIVEYTSESSAEQSLIFVKFKYGTDVETKITLIQNEINQIRNKFPDDMKEPSIRKSSMSDVPAITFSMAGGDRMEMRSYAENNLKPMLERISGVAQIQVFGGQEQEVSVEVDPNKLENYNLGIMDVYNKMNKASVNLPGGILREGEKEYLIKIEAEIETADQIKEIVLSNKNGHLLKLKDIAKIQVAPKDRTSIYRKNGKDSIVVIVSKTDDGNSVAIVNETKKIIESNRGSLPINTVLNYEFDSSVTILNSISNVKSSGLQGLVLASVILFIFLKSVSATLIIAVAIPISIIFTFFLLNIQGISINLISLMGLSLGIGMLVDNSVVVVDNIFRHMTELGKTRLQAAKDGAEEMALPVLASTMTTVAAFLPLVFQEGLAKEQFNNLCYAISYSLLASLVISLTFVPMIASKVMDSKKDLNAEGKIMINFRKIYVATLKWAIRHRGAVLGILAVLFAGSMFIASKIGGRYIPTVDEGRYAVVAKLPSGADVNKADRIGKVLEEKAVILPFVKDYTVSGNSSNTILNINAGLKTSRNESLQDIMRELRKTFVEFPDVELTITPGYKFGTRGIYDLEFELYSDNESQLQMISQELKEKIKEIDGIYDVTSSFEGGKPEGKFYIDREKAEYYGLDAKTIATMIQTQILGGTPIKINSDNSEIDVTLQLQKKYRESTGLILDSRITLPTGGNIRISDVAEFRAEEGPSKIEKKDKKKKIVIYANLKDELDLETAQKLVITTLEDMGYPDGLTYGTGGKSADMAEMGAQLKSTFAIAVFLIYFILVWQFESFIMPFVIILSIPLSTTGAFYALYAAGLSIDAMVSVGFVMLAGIVVNNAIVLIDFINIRRAAGDNMNKALITAGKTRLRPILMTTLTTVLGMIPLMFSNGEGSEIYKGMSFVVVFGLSTATLLTLVVIPVFYYLIDDFILVMRRFRKKLSKKS
>fig|469618.3.peg.242 Acriflavin resistance protein E
MKKTGYLILLLILIMAGCGKKQEEVIEKKVKYVITEPATMRKMSQVFKSDAVLEPKNKVNHKTEKGGTIEKILKRNGDTVKKGELVMELSDAATESSYFTAKANYTSALSSLNIAKSNYEKFKNLYEKELVSYLEYAGYENTYVGAKGNYEAAKASYENAKSDYNKLFRKAEIDGVIGNLFGKEGNEISASDIIFTVVDDNSMETYVGFPAEWLTQIKVGQELEVEVGALGKKFTGKITEINPIADSSTKKFMIKVAVANPDKAIKDGMYSYVTIPVGEINVLSVSDEAIFVRNLLSYVFKIEDGVAKRVEVKTGATNLPYTEISSEDIKEGDRIVVKGIFGLEEGNEVEENTEAK
>fig|469618.3.peg.287 Permease of the drug/metabolite transporter (DMT) superfamily
MDNKKTSLLQIHIAVFLFGISGLFAKFIVQPSIIIVLGRVFFSSIFLLLGICISKEDLKLKNKKDLIIIFIMGIILAIHWCTFFQGIKFSTVAIGLLTFSTFPIFITFMEPFFFCEKLKKEDIFLAFMTFVGILFVIPSFQIKNEMTMGVIFGIISSFSYAVLSLLNKKYVKEYKGVIIAFYEQFISFVILLPFFFIIKPVIAEKEILLLLLLGIVFTGIAHTLFINSLKNIKTQTAGIISSLEPLYGILLSIFFLNEIPSIKEIVGGIIILGTVFYSTMKNLKNKN
>fig|469618.3.peg.602 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQNLNLETGKISELFFSFAIPSTISMIVTSLYTIADGVFITRGVGSEGIAAVNIGYPIINFTVALSLMFGIGGATLIAFKKDDIKYQNKCFSHIILLNIFVYIIVASMIFLFTKPLMMAMGANEKLLPMIKGYMYPCTVSTFFLMMSMSLNAVVRNDNAPRRAMVSTLLGAGLNIVLDYLFIFKFNLGIEGGAYATAISQIISAIYLCRHFIGSTFKLNLSLKKIDFFLLKKLLSIGFPSFVLEFAVAVITVLLNIAFMNAVGVFGASAYGIISYSFMFFRMLFTGLSQGIQPIVSFNYGRKNLDRVKKMLIFAHKITFGASIASLIIIFFLATPVVRIFTHDAPLVVESAKGFILYSIALSFLGFNFVNIAYLQAVDRPMFSNVICMSRSFLFVFIGLVILPKLIGVNGIWLALPFADFMTAILTIPFMKKLTINYVEASV
>fig|469618.3.peg.661 Inner membrane component of tripartite multidrug resistance system
MGISFELILATLALAIGSFMNVLDSTIVNVSLTHIAGDFGIAPTQGTWVITSYAVSEAIFLPLIGWLTKRFGIVKQYTVATLLFTTASMLCGISFSFGFLLFARVLQGIVGASMIPLSQTLMLSFYPKEKKAMALGIWSMTVVLAPVLGPVIGGWITDSFSWRWCFYINLPFGIISTFIVHSIFKKKGYKDKTEKVPIDKWGLIFLALGISSLQIMLDKGNDLDWFSSPFIIILALTSFIFIVILVIWEWHQDNPVVNVKLFLNRNFAIGAVSLSISSIAFFSSVVVIPLWLQNYMGYTALQSGMTTSTLGLSILFTAPILGSILNRLDARKVVVAGFILFSITAVLTGNYTPDVTPAYISVSRFLTGIGLGMFFIPLNTITLSNIQPEDMAGASGLYNFTRNIGNSFGTSLAINFWDHRISMHHQDLVASINNGNPNYVNYIHQMNGPIQTKLALINQMITEQSALMGVNDIIIGSGLMILFLIPLIFMARKSIVK
>fig|469618.3.peg.920 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLKIILEILKLALPAVGEMILYMMIWVLDTIMVGKHSGQLGVSAVGLSSEVMYTFTNIIIAMGLSISITSIISRAIGGKNYEKARLTSDIALRLGLIFAVLMWGIFFCFPEKILTIVGAEKDILSLATKYMRICSFAVICNMTTNIFNGIFRGCKNTKTPLFTAIIVNVVNLSLDYILIFGKLGAPELGVVGGAIATVTGNVCGLLFTLSQLKKIPFKLSPLAPFNKEYFKELVRLTIPSSLQEGAFSINKLINVAVIMTLGSLSFASNQIAITIESISFMPGWGFAIACTSLTGYCIGQKDYEKAKIYINYSIYLASGIMGLFSVIFLIFPEKLISLFIKSSETEVIALGTACLMLASIEQIPIAISMVLGGALKGTGDSKTPFKIVLFTNWIIRLPLVYYYIYLKRSSVTYFWKITALQWIIEAIIIFIVYRHKWKKYYQVTDLKEEIV
>fig|469618.3.peg.1482 Permease of the drug/metabolite transporter (DMT) superfamily
MQKKTVCKIALVCVAATWGGGFPITKIALDSGMAPNAIMSLRFLIASLLIFLFLFIKKVKVTKAEMKLGLGAGLVLGTAFSLQTVGLMHTTSSKNAFITGAYVVCVPFMLWILTKKRPKWITYLSSIICFTGIGFLSLDGDLSMNYGDVLTLICAFFFALQISIIGARIGNMNPVVINAFQMFSGGLLTLLLNITYENFSIVTTKLTGIQVMAVGFLIIFNTLIAYLVQTTAQKYVESSTASLILSTEILFGAITSVILLGDPITIKTVLGGLLIFASVVISETELKFFTKKYIEN
>fig|469618.3.peg.1693 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSNELESKNVSRLFFKFAIPSIVGMLIVSIQMMVDGIFIANTQGASGLAAINLSMPIILFTNSIALMIAAGGGVYCSIALGKGKFKRANEIMSFTLQIFVIFLGSLSLLGFLFINGIIGILGATEILAPLVKSYLLTMLILNIPYNIPIFTEGFIKIAGKPNLVFLSCIICLTGNVLMDYLFIVKMDMGVFGAALATSIANGTAGAVLMWNYFKNRSRLKLVKPNGNRILLGKILYNGSSEMLTMVSSALATFIFNYILIRRIGEIGVSALTIVFYVNTVVNICLFGLSQALQPIVSYNLGARRMEQIYKVMRTAFFTGGSIGFFFFFVMKFNSSPIIKVFSKDNSDLMNLTGRALNFVVFQYLFSFVNVIISSFLTAVEKPMESAAVAMCRSLICVAGLLFILPIFLGEKGLWLALPLGELLCMVMSIPLLVVSYKKIKIRINKNK
>fig|469618.3.peg.2267 Multiple antibiotic resistance protein MarC
MGVNTIFINALMLIAVLNPFGNVPLFIGMTEGMEKEIRKKLFKAIALTGFFIIFLFSLVGEFLMINFYKIDMNELRMAGGLILVLMAVKNLIFPPMKKEREEAHISPEEQIKQAVIPMAFPMMVGPGSLTTALIGRSEYGVVYNSLSILTAFAVIFMIFVIGNYLEKIFGKLVLYILSKVMQIFIMSIGFRIFFDGFFKMLELKYGL
>fig|469618.3.peg.2404 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKSISLGKDPVWKLFLNFSIPAVTGMIVTAMYSIVDGIFVGRGVGADGLAALNLGYPIVNFGAALSLMFGIGGATLISLNPKDKEFCNRCFSYIIVLNVTAYLLILLLVVFFNERIIRLMGANDNLLPMVKAYMYPCTAALGFLMISNSLNAVVRNDKAPAYAFISMVIGAVTNIFLDWLFIMKFGFGIFGAAAATGIGQLFSMLFLVKYFMKPGSRFKFSFENRIKIDIMKKIAAIGFPSFIMEFTVALITILFNISFMKYSGEMGVSAFCIVGYVFYIFRMLYNGMGQGIQPIVSYNYGEKKLDRVEDTFKIGHKISFGIAIVILIWVNFFGSSLIRLFNEDPELIKTAVHGLRLYASAIIFVGANFINISFLQSKDRAKAANILSVLRSTVFVLIGLLILPKFLGENGIWLALPFSDLMTFLTTLVLKRKTDIF
>fig|469618.3.peg.2579 Acriflavin resistance protein E
MKNRRIKSLILITASILLISSCGKQKEVEKIIRPVKVIEIKNSDSIEYFSFSGITTPSKETILSFKIAGPIESMNLTQGQTIKKDEILAKMDSRDYEINLEVYKKKYEASKASADNAVLQYNRAEKLYKADAMTKKNFDIITAQKKAAVSLLKEAQQGVENARNKLKDTELKAPYSGYISKKFVDAGTVVNAGTPIVSLSADVNPEVTISIASKDIDILKNAVSFIFVLNDNTEKKYELKLKEIGKNPEFSKLTYPATFELLDGKDINMGMSGKVIASVKRDDSSPIIIPASALFEDNGSKVYIYDNGVAKTREVKIGNLYPDGNIVILEGLNKNEKVITAGVNTIIDGEKVKLIPEESETNVGNVL
>fig|469618.3.peg.2604 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSYTTTKKFTFLSLLKFTVPAIIMMLFMSLYTIVDGIFISRFIGTTALSGLNIIYPFMSFIHAIAIMLAAGGSAIVAIRMGEGKNEEARRTFSLIVYSGIFLGVFVAVFGSIFINEIIRFLGASPALEKYSYDYLKIIILFAPFSILQTLFQTFFITAGRPELGLRMTILSGTANGVLDYIFMKLFGMGMTGGALATVSGYLIISIFGIVYFIKNKKSLYFVKVKMELETIKESCINGSSEMVTDISSGIVTFLFNIVMMKYMGEKGVAAITIILYSQFVFIAVYLGFSMGTAPIISYNYGNKNQKQLKRIFNICSKLIMNSSIGVFIISLIFAKYIVGFFTPEGTEVYEIAKKGFSLFAIGYIFAGYNIFSSSLFTALSNGKISAVISFMRTLVFIVIGIFFLPMVFKVNGIWLAVPFAEILSILVSLYFIRREKNNYGYV
>fig|469618.3.peg.2611 Permease of the drug/metabolite transporter (DMT) superfamily
MNRQLRANFFVGLVALFWGSTYFLTKIGIGMLEPFNLTSLRFATAFLVTALFFRKRVLKVDKVTLKYSIILGILAFISVLTMTIGVKYTSASNAGFLISLSVVMIPLISVIFLKKKIKFKLLVSVILATIGIVLLTLNEQLTINKGDILCIICALAFALQVLVMERIPKNADSVAIGALQLGIVGVMNGIISFTIETFKFPHNLKLWGVIMLLGIFCTAVCYIMQIYALKDTSAIQAGIILSLEPVFSAIFAFVFLGELLSTKGYIGAVLLFISVILAGVI
>fig|469618.3.peg.2675 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVGYALEIYIKVDGNPVYPAICVMTGGIVNIFLDYLFVAVYPYGIKGAAFATGMSQLTSTSMLLFYILFKTKKIKFIKLKYSFKDLLKISKIGFAEFLAEVSTGIAIFIFNIVLIKELGEKGVSAFGIIGYISSFVVMTMIGFSQGIQPIVSFNLGAKKYTNVIKTLKISLLMIITTGIVFYGSINIFSEKIISTFLNDIETFKMTKYALAVYSFAYIINGLNIVTAGYFTAVKKVKISTTITILRGVILIGIFLIVLPRLFGTVGIWWSVPAAELVTLISSIYFIKKYMHKYENIRA
>fig|469618.3.peg.2728 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQQEKEFRDGNILSLLIRFSIPATFAILIGIIYNVTDRYYIGQAVGRNGISALAVTFPIVLILSATGVLFSIGGCALAGIKMGENKIEDARRVLGTCFYALIVIGGIYTVLGMLFLEEIVSFMGATKNSFAYAVEYNKYLFPVTIFQLIYITYCSFVRLEGRPMESMVINLASAIVNIVLDYILIMRYGMGMKGAAIATAIANVVPGVILIYHFLKSDILTLKLKYIKYNHELLKKVFYIGNSGFLNQFLNGAYVYVLNIQLAKYGGDVALAGMGILSLLRTCINTGYMGLNQGRQPLLSYNWGAKNYERVKKIFYSSITLTAVISLFLLFVVIVNARTVVNFFVKNDLELTEYTIRGTYIHLGLMISTAIYLSCTNYFQAVGKGMITTRFIILRLAVLSIPLAYILPVFFGADGILMSFPVADTISCIGAAYVMWQEIKLLTKRAEKQKRYIK
>fig|470146.3.peg.70 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKPLLYTFGANSQTYEMAKGYIFHVSYGAPFIIWSAAASFIVRAEGASSEAMIGSMIGTVANIVLDPVFISGLGMGAAGAAIATTIGNILASIYYLWYFMKKSKSFSVSPKYFKCGEQVLSRVCSIGFPTAIFSALMSVSTIVLNQILVKYGNAPVAAIGIVFKANMFITFLQMGLANGVQPLMGYNFGAGNQKRFMEVDCFTKKCCLVVGILATALFFFFREPIIHLFINDKDVIYYGVKMLVAYMVSGPFIGILFVNMNCMQSTGDALPATILSVLRQGLLLIPLLYLLNAVFGLNGVIYGQALTDCVAIVLSMYIWGRKKRKLKSE
>fig|470146.3.peg.143 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MILAISVALNIVGDLLFVVVLKSGVRGAAIATVLAQAIAFVVCWIYMVKRYELLRLSREDFKDPNPVMVKNMLGAGMSMGFMSSLINIGSLTLQTAINKLGNDYIVAQTAARKLTEMFMIMFTVFGNTMATYCGQNLGAGKIDRIKKGIWLAIFYTCIWCTLVIVASYTIGDKLVYLVTGTHNENVILNATRYLKFDTLFYYVTAVICIVRNAMQGLDDHITPIVSSTLEMLGKIVIAFTLVPHLGYTGVIIAEPIVWFVMVIPLIVQIFRMPVLKQTSLS
>fig|470146.3.peg.423 Probable cation efflux pump (multidrug resistance protein)
MTKDLTTGKIMPILVNFTVPLVLGNLFQLTYNAMDSIIVGHFVGKEALAAVGICNPISTLMILFLNGLCMGASILMGIQYGAKDYKTLHRQISTTMLSGVVFSFFLTLLCVVFAVPILHLLQVDASIMEMTRQYLRIIFLGLMFTFLYNFFFQYLKSFGRQCIAFVFLNYQCSPEYIRRSVFCHCTKGRKQWMRHFNSA
>fig|470146.3.peg.756 Vancomycin B-type resistance protein VanW
MDEEYICKNVFIGKTDVSGMTKEEAVKAVDNTLGDYRNKQLVLKVKDQGADVSIEEMGAEVENIDKLAEKAVGYGKNGSIWSRYQKIHNLDKKKYVIDESFKVDEAKLRELIQERAVPLEQKAVNASASYNGSGFDLTDEAEGYTVDVDKSVKKIKNFMNKKWNYEDAEVELKLDMEKPTIKKADLESLQDELGSYTTNAGWGDRVQNIRRATELINGTVVMPGEEFSVEQATLPYTEENGYVAGSAYENGQIVESIGGGLCQVSTTLYNAVLYAELEVTRRAPHSMSVSYVEPSRDAMIAEGISDFKFVNNYDTPILIEGYIDGNNQLGFYIYGKDTRAAGHSVEFESETLETTEYTKKYVEDTESAVGSQETEGAGMDGSTARLWKITYENGEEVSREVINNSTYQTSDVTVKVGTKSDNAEATKLVEEAIETQDQEKINAAISKASALK
>fig|470146.3.peg.2511 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKTKTIDLTSGPILKTLAELALPIMASSLLGTAYNITDMAWIGMLGSKAVAGVGVGGMYVWLSQGLVALPRMGGQVNVAQACGRGDYEQARGYAASALRLTFLLGILFAAVCIVFIHPLLGFFNLGDAETYTAAKLYTLITCGLILFSFLNLTLTGLSTAQGDSKTPLMANLLGLVGNMILDPILILGFGPFPRLEVVGAAVATVTSQILVLIVMLIRIMHSDLEPNILQNTHVLSRFPAKYYISIFKIGFPTAVQSSIYCMISMILTRMVSAFGAGAIATQRVGGQIESVSWNTADGFAAALNAFVGQNYGAKKPDRIRKGYNISFKILAVWGLIVTGAFVFLPGPIASLFFHEKDVLAIAINYLIIIGFSETFMTIELMTIGALSGLGMTKLCSIISIVLTSARIPLAMILTQTSLGLNGVWWALTITSITKGIVFYFTFHHTSRHLPDANDN
>fig|470146.3.peg.2534 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTLQKDLTTGNPGKIIFNFTLPIFIGNVFQQFYSMADTIIVGKFVGTKALAAVGSTGTIMFLINGFILGMTAGFTVLTAQKFGAGDMKAMRKTVGNAAILAIIMSLIMTVLGMMAMKPLLGIMKTPDDIFKDAYAYIMVICGGIAAQMLYNFLSSVLRALGNSKVPLYFLILAALLNIVLDMVFIIAFHMGAAGAAWATVISQGISGILCLVYIVKAVPILHLHKEDWRPSGHLLKIQLAVGIPMALQYSITAIGTMMVQTALNLLGSTQVAAFTAANKIEQIVTQAYVAMGTTMATYCAQNIGAGKIKRIRQGFRSITIMGSIYSVVVAAIIMTVGKYMTYLFLSGDLTEIMHSVDIYLKCVGTFFIPLTVVNVYRNGIQGMGYGLLPMMAGVAELVGRGVVAMIAAGQKSYFGVCMASPAAWILASALLIVMYYYVIHQNEKRFAKYADEE
>fig|471821.5.peg.955 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIVFGLNQGMQPIVGYNYGTDLYERVTKVKKTIIITVAPMTFGSVLVELFPHSVASIFADEKNLIDVTATGLRYAFMFSLFIGF
>fig|471852.6.peg.226 Multidrug resistance protein B
MLGGMFLSMLDQTIVGPALPDITADIGGENLYSWFVSAYLLTTTVSVPLYGRLSDVYGRKPLLLTGLGIFIAGSALCALAQTSWQLIAARALQGLGAGALIPLSLALLFDLFPGRAMGKVQGWIGAVMGVSYVTGPMLGGLLNDHAGWPWIFLVNVPIGVVLAAVVVIRLPHRPGTAERARPDYLGIAVFSAAVSLLMVGLTQKGLTGADGRLHHWTDWPVLGYLLAALALLAVFLLIELRVSEPLIPLGLFRNPVYTATNVASFATAFAMYSAIIFLPRYLRDARDYSAVASGVLIYPLLIGIVVGSFAAGAIIGATRRYKLLLASVQLLTGIGAVCFLWLEADTPLPVLSVWMATLGLGIGPMLSGLTITVQNSVPIEHIGTATGKVTFFRQIGGAVALTFAGSIYMETMTDHAPAVGPQQAAAEAAAQVLPLLGALGAGTAFLAMLLVPRRPLWLLGDGGD
>fig|471852.6.peg.458 Permease of the drug/metabolite transporter (DMT) superfamily
MAITAIWGSTFPISKDLLTRLPVPDFLALRFLTAALVVGLVRPRALPRAGWRVIGVGAALGLLYFIGQYLQFVGLQHTAPTVSAFVVSMYVVFTPLLAALLTRKPPSRRTVVATLLATTGVAAMSLRGLAFGWGEMLTLFAASLYAAHILALERWSRAQIAYTLTVVQLGTMGLAFLAVASIDGLQLPATRDVPVFLYLALLAGGLALLGQTWAQAHLPAPTVSITLVLEPVWAGIISVLFFKERLDARIIIGAALILCALLVITGRARNAPQDGLRRPQRRKVPRVPLLRRSR
>fig|471852.6.peg.2717 Glyoxalase/bleomycin resistance protein/dioxygenase
MDVLSSRILLRPADPARSHRFYRDVLGLAVYREFGPPEEPGVVYFLGQGLLEVSGRSAEGPGAALMLWLQVRDVHAEHRRLREAGVTVLREPRQEPWGLIEMWIADPDGVRIALVEVPADHPLRRDPRPLPS
>fig|471852.6.peg.2792 Glyoxalase/bleomycin resistance protein/dioxygenase
MELCTPRPEVAEKFYSALLGWSVRHERLGRSTYRMCGIDGRDVAGISESGLHGGRPHGWLTYFAVDGIEDAVRRAVALGGEVVTPPRHLPAAGTGATVIDPFGAVFGLYQGEARLGVQLLNLPGALCWNELNTGEPQQSVTYYRSLFGYGTHLRTDTPTGRPYTVLTLDDVPVAGVLELDNAWPNCVPSRWITYFGVTELDAAVAQAVELGGAPLIGPIDGPYGPLHLVKDPAGHTVCLIQLKDRLRPDYPSPAVTR
>fig|471852.6.peg.4324 Permease of the drug/metabolite transporter (DMT) superfamily
MPSPRSRSSLGALLCLISAAGFGLSAIFAKETYRTGAGVQTMLTVRFAVAAALLWLLVAWRRPALPTGRALLTCIGLGAIGYACQAMCYFGSLARIDGSLAALLLYTYPPMVTAIAIALRREPVDRRRLTALACSVPGVLLLLGGGVRPGAASGVLLALAAAGTYAIYLTVAAGLPEELDLITVSAVVCTSAAVSMVLITAGTGSWQPPAQASGWAWTTMLAIFSSVVPIVCMLAGMRMVGASTAAILSYAEPAVAVASTALVYGERLSAAQLLGGLIVLLAVLILSVERPGTPPAPRRVLDRIAPGRRSRRPEREEPEHEGRAQRTGDRACV
>fig|471853.5.peg.1150 Vancomycin B-type resistance protein VanW
MTESETGARATDAPDEESTGAAPETEPEQGVDDAAGAAQHGPSAEPAAAEAAAETQVRGIPVVPAQEPAEPAEANAAEPPEAGATEVAEPADDQATEAEPEPAEPVEADAAEPPEADVTEVAEPAADEATKVEPEPAEPMDEVVAEPADPTEADATEVAEPAADGEATEVMAEPAALAAGATGGGDSPLDELEGEPPSHRGRKIALGVGIGVVVLAAAYAGAAWFVADRVPRGATVAGVEIGGLTTDDAVARLTDDLADLATEPIDVRAGDAQTTIDPAAAGLALDAQATVEALSGFSWDPRDVFRHVLGTGEEPAISTVDAAALDAALVAANDDVAIAPTEGSVVFANAEPVVTDPVDGVGLDLPATEELLVSSWLTAERPLALPTESVTPNIDDAAIEEALSTIAEPLVSAPVSVVAGEATVPLSVEQLTSVATLVPEGSRLVLELDGDALAQLLGEAAPDVGTAPQDARIELQDGAPVVVPSVNGTGIDPAALADAVAAAATSTTERTATVELSETEAEFTTADAEALGVVERISEFSTPLPPYPDPPRTENIQIGASRVTGILLMPGDTFSLLDTLSPFNAANGYHQSGVVENGFEARAYGGGLSQLSTTLFNAAFEAGLEDVTHKPHSRWFSRYPEGREATLFEGSVDMQFRNTTDHGILLQAWVAGGRTHAAIWGTPTFDVDITTGERYAFTSPRTVYNTSPECIAESGGSNGFSVQVRRVVSLDGAVARDDTYTWSYQPWNTVVCGPDPATQPDPPTPTPDPGGG
>fig|471853.5.peg.2555 Drug resistance transporter, EmrB/QacA subfamily
MSDNTAPATAGPATAGDPAERPDPRRWRILWLVGIAQLMLILDVTVVAIALPHLATDLGLDRATLTWVVSGYTLAFGGLLLLGGRAADLFGARRLVLLGLGLFALASLVAGLASSGPMLLGGRLAQGLAAAILSPAALSVVVTTFEGDERNRALGIWSALGGSGAALGVLLGGVLTAGPGWPWVFIVNVPVGIVLLLTLRTHLPAHPRPAAGGRLDVLGAALVTAATGSLIYALVQAGDGGWATPTTAAFLLAALVLYGGFVARQLTATSPLMDLRLLTRRPVATGTVLILVATALMIMVFFLGTFFLQHHQSYGPLVTGLLFLPVAIATMVGANVAGRVLGRVGPRLLGVVGLLVAAAGMSVPAMWEGTTAMVVGVSVAAAGTGIAFVVASATALGQVEPQEAGLASGIVSTFHEFGASVGAALASSVAAASLVGPGSGTSTVGFDRGFTTGAVIAVVAALVTLVITPSTRRVGAGRRR
>fig|471853.5.peg.3859 Ribosome protection-type tetracycline resistance related proteins
MPSPLPYLNLGIVAHVDAGKTSLTERLLYDAGVVDAPGSVDAGTTRTDSMDLERRRGITIRAAVTSFPVDDVTVTVIDTPGHPDFIAEVERSLAVLDAAVLVLSCVEGVQSQTVVLWRALRRLRIPTALFLNKVDRAAADVERTLAQVRRRLDADLVTLTRAEHVGTREARVHAVPLTDASVVEAVAAADDSVLARWVDGAPVRARQVRHALRRGVRAGTLVPVVCGSAITGAGTGMLRQVLTDVLPRAPRREGPDDGGPAATVFAVDRDDRGRRAWLRSWSGTIRVRDRVSLSGRAPELVTEIAVSGASGLHAADEVRAGEVAVVRGPTTSRIGDTVGRPPVRQEYRFTPPTLQSLVEPVDPAQRTALYAALTDLADSDPLIGLRLDETDGEAAVSLHGEVQREVVAALLEEQFGVRARFTSTSTICLERVVGVGEAVEQISAGGNPYLAGIGLRVEPLPVDSGVRFSPGIERGNLPPAFIAATEAGVRAGLRAGPSGWAVTDCLVTMTASGYYPRQSHAHQKFNKAMSSVGADFRNLAPVVLHAALASAGTQVCRPFDAFELDLPERTLGSVAALLGRLSAATTASTAERGSVRLLGHVPSAHVDALARALPDLTAGEAVLVTRLDHHAPVPRGTEPPIRRRTGPDPRDREGWFRDVPR
>fig|471854.4.peg.394 Permease of the drug/metabolite transporter (DMT) superfamily
MVVLAFATVYIVWGSTYFFIQRALEGFPPFFLGAFRFIIAGLLMLGWSLLQGEQVFSWKVMKPALITGLLLLFVGNGVVIWVEQFLPSAMVAIMVSSAPLWFVLLDKPKWSENLSNKSTILGLVVGFAGVILLFYEKIMATMSSLNSGRDLFAMALVVLGSMAWAGGSLYSKYNSVSKSATVNSTWQMLAAGIAFIPGTLLTGEYTSVDLTAIPLNAWLATTYLIVFGSIAGFSAYVWLLKVQPATKVSTYAYVNPVVAVLLGIFFAHETITMMQIAGLVVILGSVLLINLHQYRKPKQVTATC
>fig|471854.4.peg.418 Outer membrane component of tripartite multidrug resistance system
MVCLATGIVWFAVTGHSYAQSARTIRLEEAISMSLQNSKQLKLSQSNVDLAGLGIRQIKENQLPSLSVSGSYLRVNSPNVNLKISREGNDSTGNSGGLPNVHQAMYGMASASLPLFSGFRFKYGLESAKYVEQAVKLDADANREAVIQNTVAAYGNLYKAQKAVDLVTENLVSERERVQEFTNREKNGMLARNDLMKAKLQESNVELALLNAQNDLKITTINMNLLLGLPEETVIEADSASFTTLKAEGNAAEWEQTALSHRKDFAANGIRQKAADSDIKVAKADLYPSVALSAGYVALNIPGVVTVPNAVNAGIGFRYDVASLWKSHSKIAEARTKAYQLKTNEQIILDKIHLEVNTAYYNYVLSKRKIDVYAKAVEQADENYRITKNKYDNSLVTTTELLDADVAQVQSRIDYEAAKADAVVAYKKLEQTAGVIN
>fig|471854.4.peg.1283 Permease of the drug/metabolite transporter (DMT) superfamily
MKSNLTAYIALLMVCFFWGTTYLAARIGVSGFPALFFMGFRNVVAGLLLLSFLVLKNRSFPWTLRDMLLQLVPGWCMITFGTGLVGWCVQFIPSGLAALLYATVPLFTIVINLLARKDERVNAHVAAGMLMGLAGIMLVFRDNISYLADRASFVGICVTLASCVSWCIGGLYTKSYPGKTDSFFNAAIQMTAGGVGLFTLSAFNEDWTSLPVMQTKSLLALLYLIFFGSILAYASYLYAMSRLPAGLVSIYAYINPLVALILGFFVLDEQVTWLTVLAFVVTLGGVFLVNKGYQLQKRKNSLTLINSHE
>fig|471854.4.peg.1305 Acriflavin resistance protein
MDLIRFALRKPITIMVIVAALFFFGIDAVRKIKVDIFPKLDLPVMYIAHPFGGYTPDQMETFFAKQYINILLYVNGIKSIETKNIQGLTLMKVNFYPGTNMAQASAELSAFTNRAQAIFPPGSNPPFIIRFDASTLPVGQLVLSSEKRSNNELLDLANVYVRSTFTSIPGLVSAPPFGGNIRTIVVKVDPELLRSHNLTPDQLVEALRVNNQTAPSGNVRIGDKNYITPTNTTVRYVKDFENIPLFKGGVQNLYLRDVATVEDGADIATGYGLVNGKRSVYLSIAKGADASTWEVVQNLKKAIPRIQNTLPEDVKVSYEFDQSTYVMNSVKSLLTEGAIGAILTGLMVLLFLGDARGALIVILTIPTSIIAGVLFLNLFGQTINIMTLSGLALAIGILVDESTVTIENIHQHFDMGKPKALAIWDACKEIAFPKLLILFCILAVFAPAFTMGGIPGSLFLPLALAIGFSMIVSYFLAQTFVPVMANWIMKVKHHQKPDGTEMTDAEEFAASGLSKNPDAQKEALIHRADADQNGKISVFERVRARFMRFINRTMPFRKPIVVAYLLVTTALAAFLLNSIGKDVLPKVNGSQFQVRLRAPEGTRMERTEEKTLKTINIIKKIVGPENVSVTSAYVGQHPGLFSVSPIYLFMAGPHEAVLQVGLHEGFHTNLDELKEKIRTEMKQAMPDVTTSFEPIELTDKILSQGSPTPIEVRMSGRDKKLNEQYAQKVIAKLKEISYLRDIQLGQSTKYPAIKIEVDRIRAAQLGVDMNDVSRSLIASTSSSRYTDKNIWVDEKGGFSYAVQVQVPESKMNSVQEMGEIPLLRNANRPVLSDIATITPDTTYGENDNLGAMPVLSVTANLNNTDLGVAQADVRQALASLGELPRGLTVELVGLSQTLTDTLDSLQNGLVVAIVVIFLMLAANFQSFKVSAIVLATVPAVILGSLALLMVTGSTLNLQSYMGIIMSVGVSISNAVLLITNAEQLRKHSGNAIEAAKESAGLRLRPIVMTAVAMVVGMIPMASGLGEAGDQSSPLGRAVIGGLVASTFAALFILPLVFAWGQGKASTQSVSLDPEDEESKYYVPMTR
>fig|471854.4.peg.2147 Glyoxalase/bleomycin resistance protein/dioxygenase
MENRINGIHHITAIAGDAQTNYDFYTRVLGLRMVKKTVNFDDPNTYHFYYGDENGTPGTILTFFPWGNQIPAGRRGTRQATEIGYSVPEGSLDFWLKRLEANKVTYNKPAEKFGEQYLTFLDPDGLKYELTVPKVADNRTPWTTPEVTAEYATRGFHNVTITTTNIAETAKVLTDIFGYRLVEQHVNRFRFVTDAVDNANIVDLVEAPGERAGHVAKGSVHHIAFRVANDDILMEFRQKVLDAGLQITDKIDRNYFYSLYFREPGGVLFEIASDNPGFATDETVEQLGSGLMLPPQYEPRREQIVKVLPVLG
>fig|471854.4.peg.2458 Acriflavine resistance protein E
MFLNTTKYYSAALLALTIFSCGKKDQQQQPTGPMAVPVTLTEVKSSEASYYDEYPGTVVPLNEVELRPQVTGFVTGIHFTDGARVRKGQLLYTIDAQLYDANYDQAVANLNVQEANLARAQKDADRYHELEKNDAVAKQLVDNADAALEVAKRQVDAAKASIKASQTSVRYTKVMAPFDGIIGISAVKVGAPVSAGQTILNTVSTDSQLAVDFNVDQKEIYRFTTLMKSQKASDSTFSLKFGTDIYPAHGKIALLDRAVDPQTGSIKARLVFPNKDNQLRAGMSGTVRVLNNAGSKSLVIPYKAVTEQLGEFFVYVAGDSSKVTQRKVVLGTAIGPNIIIREGLQEGEKIAVEGVQNLREGAVIQEGAPAQGGAPKKQ
>fig|471854.4.peg.4181 Glyoxalase/bleomycin resistance protein/dioxygenase
MPYLMLDGAPKFRDFTTTVFGGTIGATQYQEDHPEQIRHSEVRIGDSTIMFCDSRPEWPAQPANLFVYVDNADDTYQKALDAGGTSVMPPADQDYGRSCGVADPCGNTWWITSVL
>fig|471854.4.peg.5813 Nisin-resistance protein
MKQSLTHFIVLALSLVMAVSAARPGPGAGPPSREASAYFEQAFAFIQNNAYFHKHLDFAKVKQQALAKMQHAQSAADTHDAIRFVLEQLDDRHSFLQPARPAGAPSGSISARSVMPFEVSVEGNYGIIKLKSYNSTDAANAHRIADSLYNCLLDFDKKHTKGTIIDLREMEGGTYIPFVTGLAPMIDAEQLIGFVDRKGKKGRTVRYQNGIYYQQGRKKARLGYLTRYERPNAADRPIAVLTGQYTASSGEMILLSLKGLPRTRTFGAPTYGVPTGKANFFLPDSSMISLTNTACFDRQKQIHSGAIQPDVPCAEKDAMREAKNWIDHF
>fig|471855.5.peg.1773 Permease of the drug/metabolite transporter (DMT) superfamily
MSPLQGNICLLAVTFVWSFEVIVHAAIPHGISPFATSCVTSLIGAVLLWGYFFRRIILVLKWHRDVYARRLLLLGVLNAIYNVLYLIGLEYFNVSVGAFTASMTAVILPVMVLVMKHSISARSWISAGMILFGILVAVSPNVGQNEIPGLALMALGAMFRALFIVKLNEYAQVYDPVTLAAGLTGVSAVLSFIPWAIVQPATFLALPWSGRLIATYFIYGYFIVAFATVLNIYAQKRTSATHATIIYSTEIVFTTVWAMFLPSVIVHHVEITLPVVIGCLFVVAGNLIEISPSKDDEKGHWKKDAEDDVMIRVSHPYARLLDSTKTPFGRSVLLFAALLVVYLVIALPFKVLLVIPGFSDIRPVYMLYPVYGIFFGVPGCLATAFGNLICDVVSDGLRLSSISGFIANFLYPYILYILWTKVPKTRFCLRRRRMLTAFVASFAICSVLQALIITPAVAHFYPDVDAGLFALSVIGNGTLFPFFFAVPFIMLMQEELGYKPLTGPRMAKAQEA
>fig|471855.5.peg.1832 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYQGSAAKVFARYAIPQMIGLLFNSVYIIVDGVFIGNRLGSMALAATGVAVPVVELLIALSMAVTAGAGVVVSTRIAKREHEQAVRAFHTCLVLQGIIGLSVVILGNLFIHPLAKLLGATPDIQAMTVTYLRYVLSFAPFLLFGYLLGGLARNDGKPKLAMVALSAGSLSNILLDYVFMYPLNMGIAGAALATGIGPIVSMAILLPHFFAGKGVLRFQKTALSGNDARSFLRLGLPSFVMEFSIGMVTFLMNFGIVRYGFGENGLAAYLIIGYLMLIVFTLFLGMAEGLQPAFSYLHAAGDHTKLKALLRFAACVFTAVGVVSYVLVLFFSIRFYSIFTPEAHEVAVMAAQKSTWYFCGLAFAGINILSISYYQATAQTGNALLISSLRGFVLPALLILILPAACGPELLWICHSTAEIMTTLVCLACATHLLRR
>fig|471855.5.peg.2466 Permease of the drug/metabolite transporter (DMT) superfamily
MKYKLLLVLATLIWGSSFVMVKDLTDVMAPAWLLAIRFVAATVVMAAVCLVRREPLFDREHIKYGIIIGLPLFMGYLFQTIGITDTTPGKNAFLTATYCVIVPFLTWAVDRKRPNRFNIVAALLCLSGIGLISLTGSFTIGFGDAMTLCCAVFYAVQILFMSKFGKGRNVVVLTVWQFATVTAGSLMVALVSAEPPTPAAMTPGVWLSFAYLAFIVTALAVFVQNIGLANVEPATGGLLLSLESVFGVAFSIALGREPLTPRILVGFVVVFVAMVASEYLPAKLERRRTS
>fig|471855.5.peg.2689 Permease of the drug/metabolite transporter (DMT) superfamily
MNANKERHLHLPVWVYKGMLLLAAAVWGLGTVVLKDTVDALPPLWLIAVRFVLAGIILGAVCYPRMRDHLDRDTLLAGAFLGVFVGVSYGLNTIGLLYTTAAKSTVLTSAYCVMVPFVAWAASKIKPSLFNLVAAALCLSGVGFVSLQGSTEGLFTIGLGESITLLAAVFFALQIAYMAKLGDGRDAMVLTVVQFLVGGGLCAVGGLLFEGPLPLEAFSDPAVVRNLAYLIVVASCLALSLQNVGLAHVSPAPAALFLASESLFGVIFSILFLGEAVSANVIVGFVLITSSIVISETFPYLRSRSADNR
>fig|471855.5.peg.2709 Drug resistance transporter, EmrB/QacA subfamily
MQKTNYKPMLVILYLAAFIAAFNENIINVAMVDIMAEFSISYSAAQWLVTGYMIVTSIIVTVMSFLSRRFTLRRLFYVAGACFLVGEAASFVMPNFPLLLAARLLQAVGSGVFIPLMMGTVLAVAPREKMGTYLSIGSAAITLGPAFAPVVSGVAATFIGWRAIHVVPFTVVALLAVAGAKLLRNIGEPESVKLDAPSLALASVGLTVFVFGLGEITTHLPLALVCIAVSVLVIAAFVRRQFVIPNPMLTMRPMTDPRFSVACILVIVAMMTTFSMSVLLPLYFEGTFGHTALLAGLLILPAIVVNAITAVIGGRIMDKSGPWPLIPVGFLLAAAGQCAIAAFSASMSLVVVVVASVAVYAGVGLMMSPSQTAGLRTLPREEHGAGVSIINTFNMVAASIGPSLFIGILSSGAAKASAEGTSANVGNAAGFSQAVLVAAGIAVLGLVVAVVYSYKERGAAPAAVHASETEIASGATVPSLADVMKRDAYTVPASATVADVARILVANKTSGVPVVGKAGAVLGFISDGDIMRALSKSETQAVDLGYYLAAMAEDEAFGDRVHDLLGRNVMDYATENVVCASADEPIDSVCAKLNGRRIKKMPVVENGRLVGTVSRSDIVRYLMESFVA
>fig|471857.5.peg.1573 Permease of the drug/metabolite transporter (DMT) superfamily
MTEPPERAPIPRTDATKAALAAAVTMVLWSSAFVGIRAIGEVFSPAPLALLRLAVASVTLTVLIGSSTRRLPPLPRDRTSWLFVASYGVLWLCCYTVALNAAELHLDAGTAALLVNIAPLLVTFGAGVVLAEGFPRPLLLGGSIGMSGIVIIGLGTDGEGDWIGVALCLLAAVLYAAGVLIQKKALDRIDATTITWLGCLIGTAVLLPWTPRLASELATAPTSAVLGAVYLGVFPTAIGFSTWAYALKRTEAGRLSVSTYAVPALSVVLSWVLLAEVPTGYGLVGGVVCLAGVAVSRYRPRRAVTGTNTVAPDTATRPCEPPERQPR
>fig|471857.5.peg.1955 Multi-drug efflux transporter
MYLLVVLTAGAYLPSPLYPQYQVAFGFSDLMLTLIYAMFALVSAPALLLFGPAADALGPRTVLRVGVAVAAFASTCFVLADGVGWLLVGRAAQGLALGAVTGAATMVITDHTPSANRGRASVVASMAFVAGTAVGPIAAGVVAQYAPQPQVLPYLVHLGLLAIGWHRVSALPAPPQRARRWRPTRPRIPTGMRLRFTTAAATGFLAWAVAGLFLAVIPAVLNRTAGINNLAVIGGVVGAVLVCSMAAQPFVARCGAGPAQLVGLSALLLSLLALAVTGGGSLSITMVAAAAAGVGHGLAYSGAAAAVEAIAPEDRRGAITSALYLAFYVGSGGPSVVVGLMTLWHPLDTAVSWLALVATVLTPLVGLAVVFTGRSFVPRWSLPTTTSRPHPGPEQKGAVDRNDRSTPTVSSVSSASSVSSASTVSSASTVSSVSTVSSSNTVWQRRHLCHRHPGVARPGFALDDSSDDAGIGTAAAEAAVSAHQPHRPDPQKRF
>fig|471857.5.peg.2077 Multidrug resistance protein B
MMSSGVRGGGTLERTGAPLLGVAFILVLGTFMASLDATIVAVGIDTLVEEFDASVADIQWVTTAYLLAIVTVMPMSGWLADRFGGRRTWLTAVAVFLLGSVACAVAWSVPSLVVFRVLQGLGGGLLPPTGQALLARVAGPERIGRIISVVSVVPLLSPVLGPLIGGSILSVAEWPWLFLVNIPIGLVAMVLAWRYVPVVAPTDRSAPFDVRGAMLLPPGLAVLVFGLTELADTGQGGTFDVAIVALAVGVGMLVAFGVHGMRSRRPALLDVRLFTRPPFGAAATALLAVAASVFGTMFLLPLFLQAGRGLSAWEAGLLLAPQGVGAAVGALVVSRIIGQFAPRTLVLTGMALIAIGTVPFTQLPDLGDGVIAVALLVRGMGSALIGAPTMNIVYSRIEATQTARASSALNLMHYVGGSLGTAVLAVVLQTRLSAEGVDVTSAFAGCFWWVLGLCVVAALWAVRLPRRVERARSS
>fig|471857.5.peg.3286 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDEAPRYLGLAPYLYYTDATEAVEWLTRVFGFREKVRYVDAAGEVFQATLLAGDAEIQVTAVDSTYWEAKGVDGPVGQLNVVYVDDVDAQYERVRAAVGESVELTTPQDQPYGARLFTVQDVGGNSWTFWQHISDVVDLPVGWQEIRAEDGQNAVTRKNIEQSEREHELG
>fig|471857.5.peg.3439 
MSRQNSNAFRVMVRMQVEQGLEKDFERAWQEVGDSVARNPKNLGQWLSRSLTEEGIYYLISDWVDEPSFREFEKSDAHRVHREQLNPYRSGKSMVPMQVVAQRAGNTEGANHG
>fig|471870.8.peg.467 Permease of the drug/metabolite transporter (DMT) superfamily
MKNSTSAVVYACIAVLSWSTVATAFKIALTHLTHFEMLLIASCTSLVIFALLLTFQKKWRLVSELSGRQWGYFALLGLLNPVAYYLVLFKAYDLLPAQVAQPINYAWPIVLLILLALFAHQPIPQKKYIGMFISLGGVVLISVGTGQSGGMDIPVHGLLLAALSALLWAMYWMINNKFKDKTDGSIALFMSFLFGTVYLLIGAVGVGVHLNTLPGILSGMYVGGFEMGIPFIFFSLAMRKTSNPALVNQLCYLSPFLSLFFIAIILGEQIVFTTYIGLALIVMGIMFNQYLVKK
>fig|471870.8.peg.1722 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVQSAQPIVSYNYGCGQLLRSNKALRLCIISAVVFALLISGVFVCFSGDIVSLFLPDRTSHAWQYAVAGLPLFAVDYIFFGINVITIGYYTSIERINLAMRLTLLRGILPVLFFFILPAWFGVTGIWLAVVAGDITTTVVIVFLNLKDKNSKKGTSNVDDHFREVTKMIEIGKRSVSK
>fig|471870.8.peg.1960 Tetracycline resistance element mobilization regulatory protein rteC
MIVFIEKLNSEVLRSIERIESRDTDVLKKSLEASRVLGEAFDRLKQYIIGYRFQNDDEEITFFKEIKPRLFCRLIYYRKLYNIEMNRPVGSIEAQREYLDAHVRAINAYTQKRLDFIRYFRSGATHLDSLYFLRGQTDTEQYLETFYYELDPQFSTNADFKVAKILANDMLSVYLMGELESLESTNLRNMVLPLSDVRPTWQDSKTDLTELIYLLDSKGCFGNVPLTQLASYISNAFNVHLDMNLSRTFCDMKIRNNPTPWLDKAKEALLKRMQTWKRNKKNGNSE
>fig|471870.8.peg.2068 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLKYIFMVLLGGTMYGTMSSFVKLSYTKGFNAAEISFWQAFIAALLLAIYAFFTRKNIKGKLTFGNFIFLLFTGSAIGLTNFFYYESVSYISASLAIVILMQFTWFSLLLEWLIFKSKPSKPELITVSFILVGTIMAGNILGAKAWEFSMKGVLFALSSSLTYTVYIIANSRVSKSVRWQTKSMVIMMGSSLCLFSINSEIILSSDYLNDKFFCWAIFLAVVGTTVPTALFASGISKIGVGISSILMTVELPVAIICARIVLKEQIGSLQIVGIVIMLASICIMNYYKVYKSKR
>fig|471870.8.peg.2492 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIHQESLKKRLAKLAAPIFIETLLIMMLGAVDTIMLSRHSDSSVAAVGVVNQIIMLTFLIFEVINLGTSVLCSQYLGARLQKKVVQVVGVSILVNIVIGVSVSLFLFSCAGPILRLMGLTPELMTDGMDYMRIVGAFAFFQAISLTLSASLRSANKAIYPMLVTVVVNILNIIGNYSLIFGRFGFPELGVEGAAISTAFSRGVSMVLLFIILFRKHIHRFPVAYFRPFPWPELKNLMKVGLPSAGEQLSYSSSQVVITFFINMLGVEALATRTYCVNIIMFAYLFSIAMAQGGAICIGHLIGEGKPHAAFLMGKYVMKKSVMITVILSTVLAVFGNTIFHWLTSNEEIIRLGTTILIIDVILEIGRPINIFATNALRAAGDVNYPFYVGLVVQWSVAVGLGYIFGIPLEWGICGMWVAFLLDENIRGAIFVRRWYSMKWTTKGFVAKH
>fig|471870.8.peg.4347 Drug resistance transporter, EmrB/QacA family protein
MHETGPFSIPAIRDFVPPKLRPWIIIAFVIVFQFSGGLYLAAVNEMVGSTALMQEDIMMAGYASMVGMGLTFAIMFRLKFRFTSKASLMTCSIALIISNLICMHTHSIPVLVITCFFAGIFRMWATFECNSTIQLWLTPKRDLSVFFCFIYLLVQSCIQLSGLVTIYTAFWAKWEYMHWLIIGLLLLVMLVTLWLFRSYRSLPKLPLFGIDWLGALMWGLVLLCILFVCVYGEHYDWYQSFQIRVATIIGTLILVLNLWRASFIRHPFIALKTWTYRSVWLPFILYIVIDILLAPSHLFEHVYMEGILGYDALNVISLNWVVLLGIVVGAGFTFFTFSRRKWRYKTMTVIAFSSITGYLMYFYFGIEYALPKETLFIPLFLRSFGYVMIAICFLTVLSRVPFQHFFQAVSVQSFVSAGFGGALGTAILGHALNGAMKKNAMLLGAGLDHVNPFASRISAGELYGVVQQQALMISMKELYGWLILLALFCLLVFLVYESDIRPYKVLHPTYRSIRRFVKHELRMDKKLEATG
>fig|471871.7.peg.1957 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKKLEKDFTTGNTTKKLIGITIPLLIAFIFNMAYNIVDSVWIGNLLGEKAMAALTISMPPILLFTSVAMGATNGIAILLSKNIGAKEKNSINKVISTSFVGAIIFSIIVTIVCEFGTNIILNLLNTPYSIYSMAKDYFVIYMLGYVFVFMYLYFTAILRSFGNTIMQMISIILCTLLNLVLDPIFINKLGIRGAAFATLFSQGIMMGIMVIYIIKKKIIIIDFKLFDKNILKEIVKNEVPSIIQQSIPAISTSFITSLVSGFGILPIAAFGISGKLETILFYPAMALNMTITTCTGQCFGAKNTKKAKEYLHSGMLLGSGFLIILTVIVVVFSKNLASIFGAGESVGKLVKVYFSIISIGYICNTITNCVLGTVNGFGKPRAAMYLMIFYYIIIRIPLSKLLSLTVLGLNGIWIAVLLSHILASIAGIWYFRLLLKQEVIETHMKFGI
>fig|477641.3.peg.62 Probable multidrug resistance transporter, MFS superfamily
MTAVEAPVRATPEQARTLLMASLATLLVLVTFVTPLATGVRTTVDLAAGPGAQAWLLSAMSVGLAAALLTAGVLADDLGRRRVFAGGLAVVGAGAVVVAAASSPGVFIAGRLLQGVGGAAVLACALGLIGHAFPPGPARSRAAAVWGASVGAGTGLGGLVTVALDHGQGWRTTYWATAAAALLLAAVARWTLAESGGNADRRVDVAGIVLLAGGISALLAGLVQSRTGWGQLPVVVLLALGVLLLAAFVPAELRQAAPMIDLRLFRIPGFLAATVGAFVTGATVVGLSSYVPTVLQRGLGESLLTATLLVLVWSAVSTVTALSVRFLPGLDGRVLLALALAVCAVGLGGYAVLGVDASGARLLPGLVVLGIGYGAANAALGREAVAHVPAARAGMGSGANNTARYLGAAIGVTLVVLVVGAGDPAGTTEGLLAGWDRAALGGAVVTLLGALVVAVIRPARTP
>fig|477641.3.peg.2332 Probable multidrug resistance transporter, MFS family
MTDEANDPVAERAPPSSRLALLLAAAMFVLVVDTSLMNVSISAVVDDLDTTVSGVQSAIALEALVSAAFILINSKVADLIGRKRAYVLGLLAYAVGAAAMTVAQGLTAIIVFWAVVGGLGASLLLPAMQSLIHGNFDGAARKKAYALVGAAAAIAAAVGPLLGGFVTTYLSWRVGFLLEVVIIAVVLANIGLVRDVAYTGPRQIDLVGAALSVVGMGGVVLGILVWQEGGEAVGALIVVGVVGLAGLAYWLVHRKRQGKPTLIDPDLFGFPHFRLGFVQQMLQQVTLGGAMIVLPIFLQMTLEYNAMQAGLSLAPLSLSMFAVAVLAGRMVGKRRASTVVGAGFTLTTVGLLLVIPIVPRADFGWWLIGPLVLAGSGLGLLVSQLNNYTLAPIQEERVSEAAGVNSAAGSFGLSFGLAVAGGIMLAALSLGFTSRTEASTVLSPGQQEQIAEVLETDAQVMSDTRLDAALDGQPDDVRAEVLRINSEARDVSLRVALLVPVLAGLIGVLNSFRMSRLPDITPAAPREGTTLG
>fig|477641.3.peg.2754 Glyoxalase/bleomycin resistance protein/dioxygenase
MDWRLEVLVIPVGDVDRAKEFYTGGLGFALDTDFTPNEHFRVVQVTPPGSACSIVFGRGLPTGAPLKGCQFVVADIAAAADHLTAAGIDHSGMVHFADGVQTAGRDPQDADFGTFVFFDDPDGNTWSVQQGKR
>fig|477641.3.peg.2957 Drug/proton antiporter
MFSALILFAGTFSERIGAKRAYGAGTVLFVLASAACGLAPDLGTLIGARFAQGLGAALVTPTALAIIREAYTDAGARARAIAYWAMGGSIAAAAGPIVGGALTQVDWRIIFFLNLPVGAIALLVLTRVGTSPREAAPFDWTGQVTAVLGLAALTYAIIEGGEGGYGRPTILTAFAVAVLALVVFLLAQSRGRHPMVPLELFRSTRVIVALAAAFIGMSAFYGVVFVQSLYFQQVRGESAFSTGLLFLPMTALVAAISPVVSRVAAHYGLRVPIIGGQIVLVAGLIALACVPASTPTWVVAVLMVPLGLGGSFTVPPLTTLVIDSVPARRAGTASGVLNLSRQMGGSLGVAAVGSVLAVQATFMTGLRIGLIALAALVVVTIVASLTLRDVDGPAAH
>fig|477641.3.peg.3390 Glyoxalase/bleomycin resistance protein/dioxygenase
MSASPPFASVTDVFCFVPDLAAATAWYTDRLGSPPVLVARQLARFDLGGSRLTVHSIDEFNGGGPAGCVACWDVEDVDALVAEWVRHGAVAHRGPKTIMTGERLCQLRDPFGNLLGVRQAPAPAAPLPSGGTDVAAG
>fig|477641.3.peg.4906 Probable multidrug resistance transporter, MFS superfamily
MTWRRGVFALFAVAAGTNVPTPLLLVYQERLDLSPQVLTALFGSYAAGLVPALFVAGPLSDRLGRRRVAVPGILLSAVASLAFAAAGESLGLLFGARFLQGVVSGVVFSVASAWIGELSLASGDGAGGRRAAFAMTAGFSLGPLVSGVLGQYGPAPTVLPYLVHAVLATAGLVLALRLPETVDLLPVPAAAGLPVAAPVPLVRPGDGLTVLTVLAPVAVCVYAFPSAVISAVPLLVELPAAGVAVTGVLAGVTLGAGTLVAGLQRRFGRWTAVIGVALGTVGFAAATAFTATAALPWLVVAAPVLGAGSGLCLAAGLTLTARLAAPARLGALTSLFLAFAYVGFAAPFVIATVAEATGPTLPLTVAAVLCGLLALRLLPAVRRHQL
>fig|477974.3.peg.861 Vancomycin B-type resistance protein VanW
MTGRRLLLLVLSGLAALLLTVTGTFWGIVTVEGRSQTVFPGVSVYGLDLGGLDQAGCLEAVGSLEQSLRCTPLTLVYGSRSWRVELGDLGLVVDGDKITSEALKAGRSGFFVSQWLERGEISRNGFKLDLCADFEEPRFRTVIDEITTEITRAPVDARYHIGNDDTVHIIPHQDGYQVDHGRLKQRILQQLETGRLAPVSIPVVHVVPEYTTSDVEAMNLTGLLAEFGTNYDPAVVNRSYNISVAAGALNNLLIPPGEIVSFNRIVGPRSSEAGYRTAPVIIENQFQEGIGGGVCQVSSTLYNAVVLANLEVLERKNHSLPVTYVPIGRDATVVFGAIDLRFRNNTGGYIYLKTSAANGRVSVKIFGDHRYHPRVEIKSWITETLEPRTVYEDDENLEKGKQVVKQAGLRGYRAQAERWVWQNGAAEKEPLPASFYHPVPEIIAVGTREPVPALIVPPESGVPIWIPDPGNPLSPPGSIPPREENRVLQPE
>fig|477974.3.peg.1070 Daunorubicin resistance ABC transporter, ATP-binding protein
MSEVLLELESVTVNFGGLTAVHRLDMNIESGSIRALIGPNGAGKTTVFNVVTGIFRPTSGSIRFRGREITRLNPYDIAAAGIARTFQNIRLFKNASVLDNVKVGRHSRGKSNVLGALIRHPGFKAEERDTTEASLAALELVGLSRKKDELAKNLSYGEQRRLEIARGLVSEPALLLLDEPAAGMNPQEKQSLLQLIKRIQEQGITIFLVEHDMKFVMTLSQKITVLDYGREICTGTPAEVQADPRVIEAYLGKEVG
>fig|477974.3.peg.1963 Vancomycin B-type resistance protein VanW
MRWFPLMFLLLITLFLAGVGPAGAAVMVPLRPVLENRGITISWDGEAATGYCCGRLLRVVPGRDTAEMGGNEVLLDVPAVMLGGMTFVPDTLLAGFLDSPPPVVGFHAFTRVRIGEQLWLVGMLGESLEAEPEDFRIPSDLVPEEPDTIIPEAPGPARIWVLPGTGEDMVLEGLVSLMGAELSSGALGFTLAPGASGILRDALTQKLDSVTLPLERRIGSCLVNFNPGGGDYNNMLNAVQAAAYLNGITVQPGQVFSYNQTVGPRTAERGFVIGYAISGDRHVPARGGGVCRTSTVLYGAVLNAGLPVIERHAHTRPVGYVPMGRDATVSYGTADLKFRNDLPRPVRIKAGGTVRQLQVTLWELWG
>fig|478749.5.peg.457 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKITDDLTKGNIRNQLVVLALPLILGNIFQQLYNTIDSFIIGRYISHTAFAAVGVAGNIMNLFTFVISGGCNGISIIFAELYGERKWNTLRKESFLSFSFGCFVTAGLSIIGLLTLVPLLDVLQTPLVVRIFAQDYLRIIYLGLPATFLYNWCSCVLRAIGDTKTPLWILVFAMVLNFSLDYLFVVCCKTGIFGTAAATVVSQLFASIVCFMYMKVKYPCLLFGRRDMAFDRRLLLKTANFGLVSALHQSSLYIGKLFV
>fig|478749.5.peg.837 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRNNVKEEKKQMMLNENIMTLLPKMAVPTITAQLITTIYNLVDTYFVSTLGTNATAAVGVNSSLERMITVIGSLIGAGACSYISRLLGAKKEEHANRILSTSIFTGIGLGILFMIFGKLMLGDIVYWLGATEECAEYSIQYGTYVLYAAPFMIGSFILNMCLRSEGSATYSMIGIGFGGILNCFLDPLFIYKFGLGVAGASMATAISKCISFVILCWPYARKTTIVEISIRKFSLVWNDVKEVVAIGSSSFFRSVLTVVASIAINRVAGSYSTASLAALSVANRIMEFPFAFILGFGQGYQPVVGFNWGAKVWKRVKDSYTYGCAMAVGGSIVMGIIIFIFASPLIRIFNSQADMEVMELGMLCVRLQCFGLIMHALSSQVNMFFAGIGNAKLALVANFARQGYCFYPVLLIAPRIWGVNGVAATQALADLLSAVVIIPMFFYGLKVIRLAQEGKVETDVHKHSHRRKAEQHS
>fig|478749.5.peg.1176 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKTIDMTQGKPSKLLLQFAFPVLIGNLFQQLYTLVDRVIVGQFVGADAFSAVGSTNALSMMFMSMCMGTAIGTGVVVSQYFGAKDQKNTAKAIANGAYVNVIVALIMTVIALLATKPILILLNTPATLMDDAVSYMRVFMGGLLAVSLYYTPFSILRALGDSKTPLIFLAFCSILNIILDIIFVVPLGMGVEGAAIATVMAQAIAAVLCMIYAFKKVPQFHDAVHYMKPDSNIIRQTLKVGIPTGFQYSLMYISSIALQRVVNGFGESVIGAFTSTTQIELLVQQIYAALGTAMVTYTGQNIGAGKTDRVKQGMCSAMKISGIVSVILLVVFWLGGRLIMSIFVPDKDIIALASSGIRITSLFFMALGVVQVLRYLLNGAGDSVYALVNGIVEIIARIGFAFLLTAVPFIGMWGIWLTTGLTWLVTAVFALWRYRSGAWMSKSLVKGKENE
>fig|478749.5.peg.1432 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKTQNQLTEGNILKTLLVFAIPFLIANILQSLYGAVDLFVIGKYCDAASVAAVSTGTQVTQIVTSLVTGLTLGSTVIIGQYMGQKNYRRAAQTIGTTLTVFALVAILLTILMLAFERPLLELLSTPAESFELTMQYVAICAAGNLFVCGYNAISAILRGYGDSTRPMIFVAVACALNIFLDFVFVKYMGLGVSGTALATVISQAVSMVCAIIYLKKSSFIFDFKLKSFRPVPALVRELAVVGIPISFQELMIRISFLYLMTVMNGCGVYAAAVVGISSKYDVFAMLSGTSVANALAAITAHNIGAGKPERARRSLWYGLSFALCAAFLFWLWAQLSPQSMIRVFSDDEQVIAAGVPFFRSNSYDYLLVTIVFCLNGYLNGRQKTVWTMISSSAGALLLRIPLVYLFAKYFGDNLGMLGRIAPTVSGIMACYTLAYVLYEGRKSRQRT
>fig|478749.5.peg.1522 Vancomycin B-type resistance protein VanW
MKLKKRFLGTLVFAFVMTGAFCAAAEDDVRIDNGICIGDIDVSGMTYDEAYALVKQRIGEMRSAVITVQVGEDSIETTASELGLQWNNKSVVQDAIDLGNSGNPVKRYKERKDLDQETQVLSLEFSANANAVRDFIEEKCKQFEKEPQNATISADGSGGFDLQEGVTGQVINVDESVKAVQDYIANEWQGEDGTIALSVEIEEPEGNTEDLESIQDMLGTYTTYYGSTAGRNMNVERGAELINNHVVWPGETFSVCDQLVPFTAENGYELAPEYSMGQVVQGYGGGICQVSTTLYNALLLAELEIVERHNHTMTVSYVPYSMDAAIAEGSMDLKFCNNLDTPILISGYAYGGELTFTIWGKETRPADRTIYYYSNTLSETNAEGVALYAAPDQPVGYFNQVQSAMAGVSAECWKEVTYNGETTTELVNTSYYQATPASWEVGTLGASDALLSAIYANDLEAAQAAALGVTTQTESETQATDTVVTETPATDTPATDTPATDYIDPNAGANTDAGSSDGVVIWE
>fig|478749.5.peg.1783 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNWSKYFGDRKFYRSMLTVAIPIMVQNAITNFVALLDNIMVGQVGTVQMSSVSIVNQLIFVYNLCLFGGTSGAGIFTAQFVGKGDQQGIRYTMRFKLWIGALISVLALLIFGFGGSFLIGLYLKGQAEAGDAVRALQYGRSYLSVMMVGLIPFCLTNVYASTLRENGETMLPMKAGIIAVLINLCLNYILIFGHFGAPELGVTGAAIATVVSRFAECLIVVSWTHRHREKNRYIVGLYQSARIPAKLTRDMIAKGTPLLLNETLWSGAMAMLLQCYSIRGLSVIAAMNINSTLSNIFNIVFIAMGNTVSILVGQLLGAGKTEEAKTAASRMTVFSVLCSLATGLVMAAFHDVFPQFYNTTPEVRTLAGELILVTALLMFLPAFTNATYFTLRSGGKTLLTFFFDCFYVWVVNIPIAYCLCHFTDLPVVLVYLVVQASELLKCIIGFVLVKKGIWLNTIVDN
>fig|478749.5.peg.2724 Acriflavin resistance protein
MLPRYSVKRPYTVLVGVVLILILGYVSFTSMQTDLLPDMTLPYAIVYTTYPGASPEEVETMVTRPVEQSMATISNIENISSISSENISMVILEFSQSANMDAVTIEMRESLDQIEGYWDDTIGSPVIMKLNPDMLPVMVAAMEDGDMSQSDLTDLVNNTILPELESIEGVASVSTTGTIEEQVQVTLREDKIRAVNRKVRNALDDKFAEAESELEEAQKKLDEGKEELENGQTQLADQTSSAESQINAGASQMITGQVQIDQKLAEVQSGLEKMDASEQELLAKEQELLAGEETLQKLPEQKAALEAQKAQIDAGISQLESAPSQLAELDAAIAGVKGAIEELEAQIAGLQGAPSETETDGAQTDAGEETEGAQTDAAAQTQLYSGARTQTNAEGKNSAGTRTQTDAEEKSAADVREPETSGMKNNETENVRSAEEPSVPEPQTETGLVVPAQDAGAEAELFAQDDGELILDGENTGSAGETQSQPEFSLPQVNPGLSQEEIDRLTQEAQQEAVIAALQKQLLELQAQQLTLENTKAQALASLAVLGVNTGGTAQERDESIDTVKSELVARRIQIEDGIAQMQTTIDGMPEQMEQIIAGKAQIESGKAQLSEGRAQLLAAQKQLETAKAQIASGQTSVSAAVGELNKAKISATIEMAAGKAELSAGQKELDAALEQIEQQKDAAYDQADVTEIITADMVKGILAAQNFSMPAGYVTEDGVDFLVRVGNKLEDTEDIGNLLLLDLHMDGLEPIRLSDVADVVTLDNSSEVYAKINGHSGIMFTMQKQSGYSTGEVSDRIKEKFAELEESDENIHIIELMDQGIYIDLVVDSVLENMLSGAGLAILVLLLFLKSVRPTLVIACSIPISIMAAVVAMYFSGITLNIISLSGLALGIGMLVDNSIVVIENIYRLRAEGYSVKKAAVEGANQVAGSIAASTLTTVCVFLPIVFTEGITRQLFVDMGLTIAYSLGASLIVALTLVPAMGAGLLKNVKQKRSRIFEALQNGYAKLLGWSLKVKFLVLLLAVGLLALSAKLALSKGTAFMPEMESTQVSVTLNMPEGSQLPETAAMSDAVMERILTIQDVTDVGAMAGGTGAMSMMGGSQSSSADSVSLYVLLSEEKTITNDELKAEILEKTADLNCDLDVETSTMDMSALGGSGISINIKGRELDELKRIAGEVAEIVESVEGTADVSDGIAEKTLELRLVVDKDKAMSYQLTTAQVYQFLQAKLADASSATTLSAPSKDYPVLVVSDADETLTRDKIKKLTITGKDEDGQEVEVPVADLVEFVDTEGFSSINREAQTRYVTVSAQIADGYNIGLVSADLNAALENYELPKGYSLEMAGEDQTINEAMTEVVKMLLLALAFMYLIMVAQFQSLLSPFIIMFTIPLAFTGGLLALYLTDNPVSVIAMIGFVMLSGIIVNNGIVLVDYINQLRRGGMEKRAAIVEAGRTRLRPIIMTALTTILGLLTMALGNGMGADMVQPMAIVTVGGLTYGTLLTLFVVPCIYDIFNRKKDMTEEEI
>fig|478749.5.peg.3433 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDSVKSMTSGSPGRLIFSFALPLMVGNLFQQLYTVADAMIVGQVLGVGAIAAVGAAEWMIWLMQGMIQGFTQGFSIWMAQAFGAGKTDELRRVVANSAVLSAAIAVLMLLCGQLVAAPILHILNTPATVFPEAEIYMRTMFAGIPVVMVYNLLAAILRSLGDGKTPLYAMIFASVLNIALDLLFVIVFHWGVAGAAAATVTAQLASAIFCLARLRSIEMLRLAKTDFVLTPATHGKLLQLGFPMAFQNAVISVGGMIVQSVVNSFGVHFIAGFTATNKLYGMLEVAATSYGFAMTTYTGQNIGAGKQERVRSGYRAAMGIAMLTSLVIMVAMILGGRAILRCFISGDAQTVEDTLAIAYHYLFIMSVCLPILYYLHVTRSCIQGMGNTVLPMVSGIAEFLMRTGAALLLPLLMGQEGIFYAEISAWAGADVVLFFSYRYCMKKQKG
>fig|478749.5.peg.4052 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
METVTQHENPLGTERIGRLMLQYSIPSVISLVVNSIYNMVDQVFIGQGVGYLGNAGTNIISPMTTILLALTVMMGAGAATYMSLHLGKKEPEKAAVGVCNSMTVTVLIGIVCAVLLEIFMEPMCRFFGCTDNVLPYATAYGRIIVLGFPVAAIGCGFGDIIRADCRPKQSMAGLLIGCVANLILDPLFIFVFHWGVEGAAWATIIGQLLTALYFIRCCFHFTTIQLKKSYFRPQWKVVRRVATLGISNFITQISSVIVMTIVNNLVRIYGAASEFGSDIPLAVLGIIVKINGLAASIVMGVSTGVQPVMSYNYGASQYGRVKKTYKITLVVNTIILTIARILFSLFPEEIIGLFGQESELYVTFAVKCFDIFLLAIPLVGICVATSIFFQSVGKAGVAAILSLTRQVLYFVPAMLILAPILGLDGVLWGAAISDTLACVTAVIVVLALWKRIFKERK
>fig|478749.5.peg.4055 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFSAKKIDMTEGPVMKLIFLFALPMCVGNILQQLYNTVDTFVIGNYCSSVSLAAVGTSSQPVEILLCVFVGLGNGVSILAAQHTGNGNIENLKEVVSTAVSFLYLCAIPVTILGLLAGADILKVMQVPESTWELSVRYMRIIFLGVLGNLGYNMNAGILRGLGDSRSSLLFLVISCIINIVLDFIFVAGLGMDVAGAALATIIAMFSSWLFSILYIRKKYPELAFTILPRRMKKEILLEIIRIGLPLGLINSIYSIGHVLLQSLINMQGAAFMAACAVASKVTSIANVTINSFSSAATTFSGQNLGAGKYVRLCKSSLKIPLVSGAFSFAGGMIVLFFGREILGLFTSDAEVLDMALIYLRVTLPYFWAYAIFNGFICFANGLGEVRYPMIVSILALWAVRIPCAHLIARFFDGRYMMACFPASFLFGMCAMLLFFRSKRWKEIKRLAKEEQQDT
>fig|478801.5.peg.1878 Vancomycin B-type resistance protein VanW
MASLFLLMGLVALIYLALVFVVGRTTPSHLTVGGVDVSSMAPDEAERSLEQEAERLMQQPVTVVAAGEEHEFTPQELGLGYAVARSMRGTTGRTWDPRDLWARATDQVDRDWAVTLDEGRLHDRLRDLSAEIDVPATRATIELRGAEVEVTEGSTGSALDVRETGESVQDAWPREHRVEGTVEEVEPEVTAAVLRRFADQVVEPALSAPVTLVAVPVEGPRQGPSGESADPASPEPSDGSSASASAQDELTATHRVTIPADQIAEMVSIGGTAREPALEVDATRWRDGLPDDHPFSDREAREASLRLEDGSVRIEPAQVGRSVSTGDIEQGVRDAVRAQEREARVTVSVTRPYELGDGWTAQHLSTFTTMLPGGEGNEGRTRNIRTLTRKIHGTVVPAGEQFSLLEVMGEPTKEAGYEEAHVISNGTLSHAVGGGLSQVSTAVYNMAFIAGVQLDEHKPHSYYIARYPEGREATLWYPAIDNAWTNDTGSPMIISAQLDGRELIMSLYGEKQYDVDATTRPRQNVVPFRKYHSNDPECVDQGGVDGFDVTVERILTPYGDHDGEERTEVIETHYDPSDEVFCTNPESPEYSGSQEPPSDEYRPFSQREQDVKDDARAEAERELREDEQADAEAQEEDGRPEGTPSSSAEPEPSGSSTPQPSGSASGD
>fig|479431.6.peg.1276 Bicyclomycin resistance protein
MTRDEHAAGRSRVWLIVALGSLSAFGPLCLDMYLPALPVLPGELNSTAAAAQLSLSACIIGLAVGQVITGPLSDRLGRRRPLLLGVALFALVSALCAVTTSMTLLIGLRLVQGAAGAAGIVIGRAVIADLFTGKAAASFFAAVASINGLAPILAPVIGGQILRVGTWRTVFWVLAGIGVVLLVLAFFVIRESLPPSRRSAGGLGATRRAFGTLVRDRGYVGCVLAGSLVTAAMFGYISASPFLLQDRFGLSAQWFSACFALNALGIVAATQVGRLLLRRVSSLWLLSLGVVQGLLGAMLLAVTVAAGWGLAMVLVSLFVMVSAVGFALPHASAIAMDRHRRIAGSASALLGLTQFALGAVTAPLVGLGDPASGVALAGTAVIATGLGALALLVGRSAVGGPGPARVVGAG
>fig|479431.6.peg.1519 Probable drug transporter, MFS family
MTPSRRLTAALFAGGVATFAELYAVQAVLPGLAAEWSLTESRATLAVSVATGALAVSVLPWAAVGDRIGRARAMRISALVAALSGLLVAIAPTFEILLALRAVSGAALGALPALAVAHLVSAAPPARVAAAGGLYIAGTTIGGLSGRVLTGAVGGVFGWRWGLVTTAAFVVVAAVVFVVLLESPATARTADQLGGRPAGGEAAKVRLALSDRVAWVFYAQAFLLMGAFVTVYNLLSFRLLADPYRLPASVVSLLFLTYLVGTIGSSGVGRLVAGLGRRRVLAGAGLTMAIGAAITVPAPLWSVLTGLVLLTFTFFVAHAIAATWAGERVPAARSQASAIYSLAYYAGSSVVGLVGAALYARGGWPAAMTLVVTITAAAAVLAFFGAPRRDRPAERQSSSV
>fig|479431.6.peg.2253 Permease of the drug/metabolite transporter (DMT) superfamily
MTAAAEAGVMTMRVGWAGQERSGALLAGGAVVLVGGSVAASSLVGDYPVLGGQGVRYLLAGLLLAAWSRLRGEPLIRPTGREWGWLGALAAVGLAGCSVLMIQATRVADPGSVGVVIGAAPLVIVLAGALVRRRRPATRLLVAAAVVAAGAAAAQSGSGAGSFSLLGFALSLGALAGAVGTTVLAAPVLPRLGPMTVTVYSCVLAGGLLLVLAVQDGLATGATVLRMPTLVEFGALAYLAVMVTGVVCIAWFGAMQRLGSERTGLFNGLIPVASLAAVLLVGAGQVGAWQLIGALAVLVGVVLGLRRGPVVTATASGPTIAGAVPVGR
>fig|479431.6.peg.3202 Glyoxalase/bleomycin resistance protein/dioxygenase
MLRITVTSVLVDDQAKALAFYTDKLGFRPGYDVPAGDYRWLTVGDDHSDVQLLLEPDAHPAAKAFKAALVADGIPYTQFAVPDVHAAHAELVERGVVFTQPPVEMGPVTMAILDDTCGNLIQLITMTGTPG
>fig|479431.6.peg.3912 Multidrug resistance protein
MTLEVKVGRHRRSEPTQLRHNRTYLLLWTGAGVSMLGSRMSAIAYSLVVLWATDSATSTAMVTFAALLPFLVTQLPAGVLVDRLDRRRVMIGCDLGRVLLIGIALTTVAMGHVWVPLLMVIAFCEGSLTEMYSIAERAAVFTVVPDEQLGVAVGANEARSEAAGLIGQPIGTFLFSALRWLPFAATIVSHLLSLFTLLLIRRPLQGPRPDGPRPSPVQDVKEGFDFVRSQTYLRRALGLIAASNLLFQVLALGLLVIVKDQGGGPDTIGWILLASGIGGMLGALSSNLFMRWVGVRWIFMGVNIFWTLLMGSMVFFQQPLALGVIFSLLLFGAGLANVAGIVYTMKVAPEDMQGRIGSIVSLLSSGANALGALCAGAILDALGVRTTMIIVGCSMLVIAIAAVLAFGGRKAAAAEAALGDLTE
>fig|479431.6.peg.4270 Antibiotic efflux protein
MTVPPPGDAAAAPRVAGPGPFRRLLVATTSANLADGLMVVAVPWLASAITRDPVSIALVTAATRLPWLLFSLPVGAITDRFDRRRLVGLAATARAVLLLGFALLLVAVGAPAADPSAGADPAAGAGTGTVAGGDHSGVLLAGLVVLALLVGLAEVVGDNSAQTLIPSLVPEQRLTTANGRLWAAETVANQFVGPPLAGLLIAVGIALPFFVGAGGFAVAAAMVFTIAGSFRPPRSDGPPTRLSAEIAEGVRWLMGHRLLRSLAISLGVLNAASAMGAAVFVLFGQEVAGLDATGFGLLMTGSAVGAVLGGIAGPRLIRRWPPGTALAAAIVGMGAGDLLFGLLSQFAALWAVSLVTAVFIVVWNVITVSLRQSLIPDRLLGRVNSVYRFFGWGTIAIGTLLGGLVVWAFEPVVGREWAVRLPFLLCGLSYLLLLAWAWPRINNEQIARARAQAGEGGAAGADGPLAR
>fig|479431.6.peg.4833 Antiseptic resistance protein QacA
MMTSADMTTPGTPPRRATTADWVGLSVLALACLMYVMDLTVLHLAIPQISEQLAPSSAQLLWIIDVYGFLVAGALVTMGTLGDRIGRRKLLLIGAAAFGLTSILAAFSTTPEMLIVSRALLGLAGATLAPSTLSLIFHMFADPRQRSVAIGIWIGAFSAGSAVGPVLGGLVLEHFWWGAVFLLALPVMVALLILGPIVLPEYKDPGAGRLDLLSVLMSVAAVLAMIFGLKEIAQDGVTPLPVGLIVGGLVIGLIWIRRQRRLTDPMIDVSLFRIGSFRTALSVNFLAVFISVGYFLFLAQYLQLIVGLSPLQSGLWSLPSAAGFIVGSQLGPRIVRRVQPATIIATGLGLSAVGLGLLTQVGVTDGLWIIVTSSVIISVGLGPVFGLTTELIVGTAPPEKAGAASGISETAAELGGALGIAILGSVGVAIYRGQLATTLPAGLPSAAADAASDTLGGAVVAAASLPPAQGVAVVDAAATAFVTGLQVVSAVATVIAVIIAVVSWFALRQPRPAAGGDPAADGGASSGDAAAADAVGREAERPPAPAHPSPRSGPDDRLCCADC
>fig|479431.6.peg.4921 Drug resistance transporter, EmrB/QacA subfamily
MSAPTPPSVTVTGVPIHGRRPVRPTLVIAVFCLGLFLTLLDITIVNIAIPDLVTDLNATLETVLWVGSAYSLTYTVLLITAGRLGDIHGPRRLFLIGLAVFTLASLASGLSQTPGQLIAFRAMQGVGAALLAPQGLPIITSILPPAKRGPAFAATGIMSGLGVLAGPTLGGLLVTHVGWRWIFFLNIPIGVAAFALAFAVMPDVRPGRRHRLDLVGVALLTAGLLGVVFGLIEGERYDWGTVAGFVTIPMIIAGGAVLLVLFLWRQAVTQDREPLLPFAVFADRSFTVMTLVLLAMGFAMVGMFLPLTIYYQSVVGLTAIAAGLVIGIQSMAMMITSGIVGGLSGSGRIPMKWVLFAGLLLFAGGMVEIAAVATPDSAWWVFVPGLVAAGIGLGCVWTPVFGLATRDMLPARAGVGAGVLDTVQEFGAVLATAILGAVLANRLADAMVAQAQLVAAGLPAAARAPFVDGLTQAAHGGLSVGAGQAQSSWPADVPAALADQLAAAAQQTFAAAFTDAMGPVIRVAIGVVLAAAVAVLFVRSRSTVAGAGAGAGAGAGAGPVAGAVAGADPAAAPERAEAS
>fig|479431.6.peg.4957 Vancomycin B-type resistance protein VanW
MALPVAAAPAPENGSGVDSARRNKIIASVVGGVVAVLAAVYLVDLLMTSGTIERNTSVAGVAVGGLTPEQAAAALTEQALPEYSAPVVVDVHGVATQIDPTQAGLSTDVAATVQALGTRSANPFVRLSSFFTSIEQPLTDGVDETALTAVVQGIATSTDLAPVEGSVAIDNGQVTTVQPVIGRSLDVAGSVESISAAWISGGPGGLGGLVLPVSAAPVRASVEGTERAAAQAATIVSAPLTLTGGGATVEVGAVELGAATTITPDSADGFVVAVDPAAVLDAVRPAVEATQSAPVDAKVVIRDGAPVVEPSAAGRALDAAATEAAVAAAVTTPNRTVELAYQLSDPAFSTEQANALGIKEVIGEFTTGGFAAASGENIRVVAEKVNGALVMPGATFGLNEFTGPRGTEQGYVPAAIIQEGALSTAVGGGISQFATTTYNAAYFAGMGDVTHTPHSFYISRYPAGREATVFDGEIELAFSNDYDTGVLIETIWTPSDITVRLWGTKHVQVESVSSDRFNYTSAPVIVKPYGTACTPSGGSTGFSIVNTRIIKDLAGNEIRREDFTTVYNGQQNVICSPAPAAASTAPATMDAAAAPAAEVPAGG
>fig|479432.6.peg.610 Permease of the drug/metabolite transporter (DMT) superfamily
MKLAVVGAAVLWGTAGTAGLLVAGVDPISLAAARLVVGGLVLAVAVGPAIRSLPRPALLLPAAVAVAAYQLCFFAAVSRTGVAIGTVVAIGSGPVFTGLLSWALDRVRPTRRWAGATAVAIAGCAVLTGGGGEVRLDGVLIALLGGLLYAFYAVTAARVISAGASSDAVMGAMFGGAAVVMLPVLLWTGTAWLTEPRGLLTALYLGCATTALAYILYGRGLRTTPVATAATLALAEPAVAALLGVVVLGEQLTLTSAAGLLLLGGSLAVVALPERWSGRRGRAAAIESSA
>fig|479432.6.peg.2021 Drug resistance transporter, EmrB/QacA subfamily
MTHHGPDGRRLPYLAVFGLLLGMFLAMLDGLIVGTALPTIVGDLGGLDRLPWVVTAYMLAGAATTPIWGKLGDLYGRKATFITAIALFQVGSLLAGVSQDMSQLIAFRAVQGLGAGGLMVGALAIIGVLVPPRHSGRLQSMIGVIMPIAYIGGPLVGGLLTDHLSWRWTFYVNLPLGAVALLIIATRIHLPPAERVRARIDYGGAALLTTAIVTLTLLAGWGGSTYSWASPQILTLTAVGVFSLAGFVAVERRTAEPIIPPRLFHDRNFTLAQILSFLVGAVMLSVTNYLPQYMQFVQGASPAASGMLLLPLMFGMLGAQLLTGHLISGNGRYRVYPILGGALMIAGALALLLLDVDTAPVTASALSLVIGAGMGLVMQSTTLITMNSADPRDMGAASGTVTLLRTIGGSLGIALLGSLYAVRMRDGLSAHLGPAAADQLTVGGDLTPGLLPGLPAQAGAAVREAVTGGLHGVLIGAAVLAVIAFAASWLIREVPLRDGPPVQAGPEPDTHAAATR
>fig|479432.6.peg.2119 Permease of the drug/metabolite transporter (DMT) superfamily
MLSFSGSFPATVFAMEGFDPYLVAIGRAVIAAVPALVFLVAARGPLLPPRSHLRSYLVIVAGVVFGFPVFSGLALDAGASTSHAAVVIGLLPAATAACAVLRGGERPKPAFWAACALGAVSITAFTLSRGGGHATGADLLLVGALLSAAVGYTEGGRLARETPGWRVISHALVIAAPLTVPVTVALALTTDVRPTATSLAGFAYAGLISMFLGFIPWYAGLAAGGIARAGQTQLAQPLLTLLWAWLLLDERFGPLTVAAALAVLVCVAMSQRARS
>fig|479432.6.peg.2321 
MLALIRYSVPSGQTGEFLAQAHDILDTLAGQPGYVRGRVTRSVDEPELWALVSEWEGAGFYRRALGAARMAMYPLMTLMINEPSAYEDVDRP
>fig|479432.6.peg.2907 Permease of the drug/metabolite transporter (DMT) superfamily
MRPADILGIGVLASVWGTNFLLVEEALEGLDPIQIVLIRLVLGAAALVLLARARRTALPHGGVVWLKLAGMGLLGQAVPWLLFAWGQREVTGALAGVYTGLTPLMTIPVAWLLLRERPTAAEVGATVIGFAGLAVVLAPWSGGERAPLSGQLLCLAGATCYALAYSYAGRLMRTLPDGKLSLAAAQALAASAIMLPAGSGQLAHPVRLTWLIALCLVLLGAGTAVAFLVNYWLIARVGPVRASLAFYLIPVVAVVAGLVARGERLNPNEALGSVLILSALAALYAWERTREAGPAPVPDPAETR
>fig|479432.6.peg.4315 Permease of the drug/metabolite transporter (DMT) superfamily
MAVTPAVFVVLWSSAFIAGIPGVAAAPPLLLMFARFALAGVLLAGYALITRAPWPRGRAAAHIAVAGLLMQAVQFGSFYTALGMGFPAAVVSLVQGLSPVVIVLAMRLLGETVTRRQALGFALGAAGVVLAVADRVSLSIWGVVLCLAGLLGLSAGTLYQKRFVPYMDVRTGTAVQLLVSAPAVGLVCVAIETPRVSDWAAFGASVAWMVLVNSIAAFILLNRMLLRFSASRVSTVFFLTPSVTAVLAWLLVGQSLHPLAITGLVLGGAGVLLANHRAATA
>fig|479432.6.peg.5300 Mitomycin resistance protein mcrB
MSSPHRRDGTAGQTDLLELVNVGPAVVRHLARVGITRTGQLAGLDPVEMYDRLCALDGRRYDPCLLDTFMSAVEQAGGGPARPWWDYTAERKRLLSERVR
>fig|479432.6.peg.5686 Multidrug resistance transporter, MFS superfamily
MSAPPTAPPRHAGVSAVWLAVLAGPMSFGIAGPALILGEVAGGLGVSTGEATWLVTVFGWGIAVGTPLMSGLVGHRGMRGTAAVCALLALIGAGLALVAPSLPVLLLAAAAQALGAAGLTAIAMQLADSPRRMGVATASLAVVGSVSPLAGSLVSDLLSWRVVLALPVVAVLAVPAVLRQEVRSAPSAGRFDVIGVVVLTGLVTALVAVPHQPVAAGLCAVAAATALGMHLRIRPAGFVPAALVRAPRFLGAAGLAFALAVGNFGLVYALPVRLSELTTWSSAQIGVAMVWPLLFGGALSWFVVAASARIRPHLMIMALAATGVAAALAAVSVSWVPGLLVAQAAASIAASSGQGVLAVRATSAVPEEHRPAAIGLFTLCYLLGTAFGPAVVALPAG
>fig|479432.6.peg.5895 Glyoxalase/bleomycin resistance protein/dioxygenase
MSERSGYKSGVPCWVDLSSTDVTLSVRFYREIFGWEAVFDPRPEAGGHGRFTLRGKAVAGIGPSRGDGGSSVWNTWVATEDAGLTAARVREAGGEVVVEPAGVFGEGAMTVVRDPSGASVTAWQVGPRQGAEIVGEPGALAWNELVTRDTARCGAFYPAVFGWGVKDVDGAGGRCVEWQVDGHPVAGMTESGPRVPPDTPPHWLAYFAAEDVDATVARAEELGGTVVLPRTPAPRGPVAVLADPQSALFAVVGPDRPPAVSPAVRRPADGPPARAGHGPAGTGPARAEHESDPAPSPGQVDLSCGVS
>fig|479432.6.peg.6721 Permease of the drug/metabolite transporter (DMT) superfamily
MSVSVAWGSAFPLMKDLIARMPVADLLAERYGIATLALFALRPRCLRGLPESTWLTGLLLGLLFGVGQTAQAVALHDLPSSVSGFTVGSYVVITPVLGLVLLGARISGRTWGAVALALAALTVFTLLSEAEGGAVSLPALAVTLLSAVLYAGHTLVLGNFAGARRDAYAVTVIQLGTIALMTGVLAAPDGLTLPRTTGDWALLGHLSIVACALGFLARSYGQLHVPPVPAAVILSAQPLWVTALAVVMYGEPLTWAVFLGGGLIALAMLLVVLPGGLFRTARRGTGPAPPR
>fig|479432.6.peg.7920 Vancomycin B-type resistance protein VanW
MATPPERPLQERPPREEPPAASGGDPRQPESSRYEEPSRRGRRLTVLLLLLLLLAGLAYAVPAIVMSGKMLPGTRVHGVDIGGLTATEAADKLRDRLPGKAGEEMVVRAVDRKYSIDPEKAGLEFDVVATIDQAHSGFPAPMEVWRALTGTTELAPKISVDSERMQSTVTALARKIDLKVREGAVTFEGGKPVVVTPRDGRELEREAAARAIRNAFLGPVGEVELPVSVIKPKVTAEVVREAAADAGKALSGPVTLTYAGRQAQLPVETLAAHLSFEPDSSGGMGPVFDARSAVATVENRLVDPALAPREPTFQIVGAAPKLIPGRKGKGIDDDKLAEAVARMVAEGGSRTIPVVLTTVQPRVSEAEVRKLGIKEKISEFTTPYDCCLPRVTNIRTIAKLLDGYLVKPGETFSLNGVVGQRDTARGFVPAPMIQGGRLVDSVGGGISQFVTTMYNAVFFGGLEDVQHMAHEFYISRYPAGRESTVSWPAPDFRWKNDSKYGVLVKTSYTDKGVTVAFWSTKRYDIESISSDRYDVTPFKSATDSGPTCIPMVGQQGFTIDVTRVFKQDGKEVKRETKKTVYKPETDLKCVPSTTPAQDE
>fig|479432.6.peg.8258 Multiple antibiotic resistance (MarC)-like protein
MDVQFFVEAFVTMFVIMDPPGIIPLFLAYTRGRTERERTRIAWQAPIVAFCLIVVFAVFGRAILGYLHVEVAAMQIAGGLLLLLVALQLLTGETGPPPNTMKSNVNVALVPLGTPLLAGPGAIVATIVFAQQAGQKNGGILALALAIAAVHILLWVFMRFSVTILRVIKENGVELVTRVSGLLLSALAVQLIITAIRTLLATG
>fig|479434.6.peg.178 ABC-type drug export system, membrane protein
MGFVMDTLYLLKRHTLATVRIPIWVFMSLVSPLIWLVLYGQLFRRIVELPGFGSGSYIQFLTPGVVVMLALFSAAWGGMGTLQDLTDGVMDRMLVTPVSRAALIASRVLHTALTVAVQAAIILVVGLVMGARVPGGILGAVSVLGVSALLAAGISALSNGLALITRREETLIAVVNFFATPLVFLSSAFIATALMPGWIRAIARANPVNWAVQGARNAMEAADWGAVASYGLLLTAFTIACVLFATQAFRLYRRAM
>fig|479434.6.peg.197 
MYARMMQALIKPDMLDTAAAISRDGVLPAAHQQPGFKGLIVLTDPATAKMVTITLWTTEAMMRAGEASDYLEQQLARMASALAAPPTQEALAVRALEAAHPNAMQARLLSYQVNPLLLDDFVGTFRDEVLPAARRERGFGTGLLLINPTAARAISLTLWDSEADLEGGQISGDLRARLSHLSRLLINPPVRETFHVDVLEILP
>fig|479434.6.peg.438 ABC-type drug export system, membrane protein
MMTALIHTMDIAGRHLRNFSRQPWYIAFSLVQPIIYLLLFGALFKRVVELPGFNTGSYATFLTPGVVAMSALFSGGWLGVSIVSDLERGVLDRFLVSPVSRSALITGRLIQTGLVTVIQSLILIGLGLLVSARFAGGVAQVAVLIAAAVLLTAIFGALSCAVALVVRKEESIIGVVQFLLLPLTFLSSVFMAPALMPGWIRQVSRFNPLNWAVEIGRSAPEAASMDWSLVLTRGAGLVALAVVATWLATRAFGAYQRSI
>fig|479434.6.peg.1587 Vancomycin B-type resistance protein VanW
MITDGTQQHAMVARGHVPVIRFAAPVLTGVAVLAAVIALAGIAVLAYGRMHGPTIYRGVSAVGVPLSGLDQAEARARIEAAVQGSLPAAVELEAGDARWQVPLMDLGIEVDPAATAEAAWRWGRSGDLWADSRAWLLGLLGGYEVPLAVSLDEQAVYRTLEAIAPEVTRPARDARYDEGSDGRLVVVPEEDGVAIDVVATANQIRRRVQQLSTEPVPVVTISISPKVDTEALERELDRAEKLIAEPVLLTYGGRSWVLDPETLRAMLTVANDGSRKNAELTIDRERLRASVASLAEGVGLPGRDATPVWDGQRFVVESAGMGEALDVDATVDAILAGLEDGERRFELRTRQVAARIGNAEAEVAAERATALVASGLTVTWPDGSQHLAPGELAEAIRFTAVLDDEPRLEPEVDMDALRQVLERHAPAIEIPMRNADLRYIDGQVVVRSPEQAGRALDLDASVANVARALETGQSQAELVTIPVEPQVTAAMAGSVQIREVLASAATYYAGALDNRRHNVELGVERANGALIPPGGVYSFIETVGAIDLNSGYKVGYGIIGTSNGSVSTVPSVGGGVCQVSTTVFQAAFWAGLPIVERNWHLYWLPFYGQPPSGLTGLDATVDTDWGLDLKFKNTTDDWIAIVATADGEWVRVEIWGTDPGWTVQVDEPVVTNVVKADETMQYRESDQLPTGTSLQVERAQDGFDVSIHRQVLRDGEVIDDLTLRSQYLPSANVTLVGTG
>fig|479434.6.peg.2471 Permease of the drug/metabolite transporter (DMT) superfamily
MERDTALDTGAASERASEEPQAGRGGQRALSTRALLLVHLSLLFVAVSWGSNFVSIKYLLRRVDATEVLMIRLTLASLCYAGFLLLSGRGFARFSRADWRKAALMALLGVTINTGAVAYGVQMIPAAVASLIVTGNPVFTALIARALGQERLTPRKLGGIAVAFTGFLVVLFYGGPEAQFSVRNALGILITLLGPLAWAFYTVLSKPLLVRYEPVQFAGTVTILGTLPLLPLFATRPGVVREALRFGPAEWLAVLTMVVFALVLAYALWYRGLRVLSPTQIAVYIYLVPVFGTLGAWLLLGEHITIYLLLGGTLILLGVILTNTARRGPVEHGERARRRAR
>fig|479434.6.peg.2562 Drug resistance transporter, EmrB/QacA family
MRQTNRRVVVVAVMLGTFLAALDTSIVGTAMPTVIGQLGGMSLYSWVFSAYLLTSTTTVPLYGRLADLYGRKPLFIAAAGIFLLGSMLCGAAQSMPQLVAFRALQGLGAGGIIPVTLTIVGDLFDVEERARMQGLFSAVWGTSAVAGPTVGGFIVDYVDWRWVFYINLPFGIAATILFWLFLNEQVERKRHAIDYAGTVSLTLGVTALLVALLEVGEGRAWTDPIVVGSLALAVVLLVFFVRTEQRAAEPILPLHLFRTRVIGAAFLAGILVGGAMFGVTSYLPLYVQGVLLGTAVTAGMVVAPNSIGWSLASILSGRIILRFGYRTAVVAGLTAIVLASVVLQLVPHGNSLWLAVVAAGTFGIGMGLSATAFIIAAQNAVGWAERGIATASITFSRTIGGAIGVAALGTVLSASMATRLSALPETARDVNALLDPAVRSTLSPAMLETMRTALADSLVYVYLGVLSIAVVAFLVVLLGFPRGSIKDLQAAEAGESAPDAGEEPAALPVGSSEEVQSTEAR
>fig|479434.6.peg.2705 Fosmidomycin resistance protein
MAETQAVPAAAGSIVRNRPLITLALGHFTIDLYAGLLPVLFPLLASRFGLDLKTVGLVSLAYSGVGSVSQPLFGYLADRFGTRLIGFALIWTAVTFAGIGFAPSFPVILTLAGLAGLGSGAFHPFGALNANAVITDQKRNAAMSVYASGGTIGFALGPLIGVGLLALFELRGVSVMLFPGTVIAFWLLYEMRAIAVRPAVRAGHARVKPAPIPKLAMAAVILIMMARSWSMSSIQAYVPTWYESLGYSKGFYGALATVITLCSAAGTIGSGNLADRYGRRAVILVSLILTIPTVLLFAQFTGPIAFVTGALVGLLAASTAPLLLVMAQQLMLGRAGIASGLILGLGFVTGAIGVPITGAVADALGIQMAMRLQVVLALIAIPLCLLLPTERSLQAAKRE
>fig|479434.6.peg.2980 Glyoxalase/bleomycin resistance protein/dioxygenase
MIAYVHSATIIVSDQEKALDFYVNTLGFEKVFDNQLDPNMRFVTVVPPGAQTQVALGLPSWYEDGRKPGGYTGISLITRDIDEAYKTLTERGVTFTKPPEMMPWGQRATWFSDPDGNQFFLVEE
>fig|479435.6.peg.247 Drug resistance transporter EmrB/QacA subfamily
MQNPPDPKRWFALALLCVTGFMIILDASIVLVAVPSIERDLTFSTGGVQWVPSGYALMFGGLLLLGGRVSDLLGRRRVFLAGLVGFAASSLLCGLAWSGDALVLARGLQGIAAAVLAPSALSIVMTTFAGGPERNKALGIWGATSGVGGTAGSLIGGPVTDGLGWPWIFYINVPICVLVLVLAPLVLQDSRGPAQRTFDIAGAVTVTAGLIVLVYAVIEAPGSSAGRTAALALLSAALFAAFVLIEQRSSAPLVPLRLFRSRALVGGNLIGIAFGLGVFGLNILYTQYAQLVAGYSAIKYGLVSSVLAAAAVGGSMIGQHLVTRVGARPVAAVSLLLTGAGVTVMSRLTVDTGYFELAFWGLTIYGAGLGAGTVAGSIAALGEVAGNDAGVASGLQNACFQIGGAVGIAVISAVAVANTNGSTPAALTAGYRVGFAACWAFVAVGLVGAALLVSRKKAPQPVAAGQGAA
>fig|479435.6.peg.927 Permease of the drug/metabolite transporter (DMT) superfamily
MFWSSGFIGARWGTEYSSAFDLLAWRFLLAGTIAAVALAIRRPRITRADLITHTGMAVLTQFVYLGLIFVGIDHGISAGITALIGSLQPILIATVAGPLLGERVSPLQWAGLALGLGGVGLVVADDLGSGHGSPWLFALPVAGLLGLAAGTVLERRRKPQTNLLDALCLQSVVSGVLFIVVATATQQMTVPGELGFYGAAVWLVVFSTAGGWGLYLVNLRLSGATRVSSMLYLVPPTTMVLAYLMFGETIGPIALAGMLVCAVAVLLIRRPARAR
>fig|479435.6.peg.1222 Drug resistance transporter EmrB/QacA subfamily
MHALTGNKTRAGQGSGVTAGLAVLCVAQFVVVLDVTIVTTALPVLGADLGFAAARLSWVITAYTVVLAGLLVLGGRVADLVGAARMFRVGLALFSVASLACALAWSPDALIGARIAQGAGAALLSPAALAALTDLVPPAQRRTALGWWTAAAAGGGASGWVLGGLITEYAGWRWVFAVNVPIGVIAYLVSLRAVRTRAREDRAATTLDLPGAVLATTGIAAAALGLTWLAEAPTQWHGWASVVMAAALLGLFVRTERRVREPLVPGSLLRTPGVVAGNLTAAALTASTTPAMFTVTLYVQETLRLSPAKGALLFPALNLAVIGGSLVGPVGLRRFSVRSILFGGFGLVVAGIGLLFALPPRGLPVVLLVGALLLMGFGLGCASVASTTVGTAHVRPGERGIAGGVLNSSAQLGTALGLAVASPLIASAAPMTGYRLGFAVAAVIAASGLLAALTTPAGPSTADAAEPAEAADAPGRTSPGRLG
>fig|479435.6.peg.2365 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MPAVEIPAGFLVVGTRGPDWRAWLDRLPRLTQELLAEWELAVDGGTAYGNCAIVLPVRTADGQRAVLKVQFPHWEAETEHLALRAWDGNGVVKLLRADPRRFAMLLERLEPRDLTGVDDREACEIVGSVLPRLNVAAGPQYRTLSGELKRWIEDFRALPASAPVPHRYVEQAISLAQDFVADPACDGRLIHTDLHYDNVLAGEREPWLVIDPKPLSGDPHYEIAPLLWNRWPEVVASGDIRFRVRSRFYTAIDAAGLDEDRARDWVIVRQMLNVLWTLKEAGTDESLPQDWLTRNIAVVKAIQD
>fig|479435.6.peg.2894 Drug/proton antiporter
MRVSTQPVLALSAAASSFFLITLNSSLVTTALPSVGRELGTGPALAWVLTGYSLVFAVCLLPAGAWSDRIGARRTFGLGMVAFVITSAVCALADTLALLLAARAVQGAAAAAILPSGLAMLTAAAPDQVRRTRAIAHWTAAGAVALVVGSPVGGAITTAFGWPATFWLNVVLGIAVLVTALALRPADHPVRRPAGAGTKLRSRAVVVSAVTGFTVNFASYGAIFVVTLFVQQLLDRSAWTSGLVFVPMTLLIIPANLLAARLTTRHGATRVLVLGQTLMLVGLLGLCSVDDRIALWVVIGWLLPIGAGAGLVAPAMTAMMLDGVPSSRAGFGAGLLNASRQTGSGAAAALFGLLLGGSQFLTGLRTSLVLAAAVVAVSTLTAVGRRKVHLTGVPTRSPDRES
>fig|479435.6.peg.5531 Vancomycin B-type resistance protein VanW
MLVVAYGAAFALTGDKVPGDTTVLGISLGGLSEQEAKAKLQAGIKDRLNLPIKVKAGKTTYEVTPADAGLSLDVDATVEAAGAGRSLNPARMWQVMTGGDAVEPVVVKDEGKLKAAVDKLAGRVNRPATEGTITFPDAKAVQHAPADGLQLDKTKATDTVVSAYPSDGNPKDLPVSVTKPKAGTEAIGKAMKEYAEPAMSGPIRLTVGDKGVNLTPAELAPALKLVAKDGKFTPSLDIKKLEPLFAKRFKGLETPPKDAGIQIVGGRPQVVPAVDGQVVARDKVAPAILSVLPKPEGERKVAVGLAKSKADLTTEAAQALGIKEVMGQFTTRFPHAEYRNVNIGTAARRINGTLLKPNETFSLNKIVGERTKANGFTEGNIIDGGKFKLDLGGGVSQSATTTFNAAFFAGLKDVEHKPHSVYINRYPAGREATVAWPSVDLKFLNDSGHGVYVQTLFTASRPGTQGSITVKIWGTKVWDITAGQSARYNFRAPGLVYSQEAGCRPQAPTGGFDIKVYRYFAKNGQRVKTETFTTNYNAADDIRCGPKPGTTPPPNTPDAPPSPGVAKPSGTTRAPS
>fig|479435.6.peg.6201 Glyoxalase/bleomycin resistance protein/dioxygenase
MRTVLAVVPVAEFEKSCAWYEGFFGQPPDTRPMDGLAEWHLSELGVVQVFQEPDRAGRTAVNFTVDDLDAARSELSGHNIASTDPQVVSAGRQRLSIIQDPDGNQLGLIESLS
>fig|479435.6.peg.6916 Permease of the drug/metabolite transporter (DMT) superfamily
MTAAPTSRNGITLLVLAGVLWGTGGLAGSILASSTGLTPVAVAEYRLLTGGALITGYALVTRRLAGAPRGPEALFRIATVGLLLACFQAAYFAAVAATSVGLATLTTMVAVPILITAGTALLDRRRPARRAVISLVVALAGLVLLIGTPTAGAHRLAGTGLALLAAAGFAALSLDRREALPGLDRISTIGLGFLAGGLLLLPVALTVGMSIPVQPAAIGAVLFLGLVPTAVAYGSYFTGLRYAGPRAAIIAVLLEPLTATLLAALVQQEQLSGPQVLGALLILLSTTIRHNAAG
>fig|479435.6.peg.6956 Antibiotic resistance protein
MSPQLSLQQVSKAYDHRVVLDQVGCAFPPGRISGLIGENGSGKSTLLRLLAGVEQPDDGTVTVVASGGVGFLAQDNPLPLHLDVAAVADHALADLRAIESRLHEVEQLLADGNLEVLDEYGDLQSAFEAREGYDADARLARAMHGLGLSALPGDRRLSELSGGELARLHLAAVLAASPEVLLLDEPTNHLDVAATVWLEDHLRSRSGTTVVVSHDRAFLERVASTLFEVDGDTHRVTRYGNGYDGYLSEKAAERARAEQTRQLWEDEVAAMKLAVGTAADRVAYGRPMSDNNKMAYDRAGGRVNEAERSKTRNAKERLRRLEADPPPVPAKPLRFAASLRTAGATSGVLVNAVEVSVQGRLAPVSLEVPAGGRVLITGANGAGKSTLLDVLAGRLAPDTGFVEHRGRLGYLSQEVVEPRPDERLRTALARHRGAGGLGLFRPDQLQTRVGALSTGQRRRLALARLLTAQYDVMLLDEPTNHLSLVLVEELEAALDAYEGALVVVSHDRRFVSRWRGEILELKENTLVSQ
>fig|479436.6.peg.148 Permease of the drug/metabolite transporter (DMT) superfamily
MEEKQWKGMGLAIMGALFWGLSGTSVQFLESAKHINVEWLLEVRLLVAGILTIGLAYLREGKRIFSIFKAPKDIGKLLIFGVLGIALAQYTYFRAIAISGVGVATVLQYVAPTMIIIYLFLRYFKKPSTPELFCILLALVGTICIVMQKGLDISSFNEKALFWGLVSAASICVYTLQPIELLKTYGTTAIVGFAMFICGILSVIMFQQFDSEAIVDSMTLLGLFAIIILGTVVSFNAYMEGVRLIGAVQGSILSSLEPISAALFGWALLGNEFTVIGIFGMICILATVFIIAWDRQRTIKREVLAKLNKTILE
>fig|479436.6.peg.249 Permease of the drug/metabolite transporter (DMT) superfamily
MGTIYSVRRHREFCYQVVFNEGLRTIPAATSSIIMALTPMTTALMAMIVYKDKIRPIGWLFTITAFIGVAIIILWNSTLTIPTGALWTLLGMTLFAVYNILNRGLSLKGYKPITIAMWSMFTGAIMALPFAEHAIEMIAVAPISAKFAMAYLAFLSSALSFVLWSYALEHAEKVSDVTNFMYISPIVAAIVAAFLLGEIPNMGLYIGAPVILGSLYLFNRYR
>fig|479436.6.peg.915 Vancomycin B-type resistance protein VanW
MTKKYILVGTVLVLLGTSGCSYIPTENISYGVYYNDTDLSNTPKNELQARLQEVNDKIPQTISIDMGNNKKQQVTYHDLGIQFDTEAMVKAISTYGYEDDMWTVLSHRFNGLFYGHHFKPQYKLDEVKGKTYLTELAKTIDTPGHDAYLTVENGQVVIHPSKEGKRIDIDATLKKLKDDLQSGDSINSLSMVFTTQNTVKVTNTDLKPLNTVLASFTTEYNPSNESRTHNIQLASDKINGTLIKPGAQFSFNDVVGERTAEAGYDDAPVMIDGKLVPGIGGGICQVSSTIFNTALLSGMNIVERTPHFEPVGYIQAGRDATVAWGYLDFKFRNPYQHSIYILSVMNNGTLTIYIIGTAEDKPKNVSISVGDYGEIPNKTITKVDPSLKEKEVQEGHVGLKMNTYRTITYGNWVTQTDSFESVYDPVDTIITMPATPEVPPKKTDKKKS
>fig|479436.6.peg.1559 Bicyclomycin resistance protein
MTQESSAKVSFILVVFLGLLTAITPLATDLYLPALPIMPSELNTSASNIQMTIGVMTFGVALGQLFGGPISDTMGRKLPLITGNLLCVISSIICAYAPSIEILLLGRFLQGLTGSVGVVIAKAIARDFAFGQELTKLFALLMMVNGLAPVIAPLIGGQLLLFTTWRVIFVILAIFSAILLVGSLLFRESLPKEKRVTGGVATATKNYITLIKDKRFLGQTLIQFFAFGGFFAYISGSSFVYQNIFQLSAQEFSYLFGINSCGIILASAISARLSNVITVRQLLTFALWQLTIGSLLFLIAMLFEWPLIPVTAILFFTVCTVSLFGSASFSMAMAKYGKMAGSASAVLGFASMFSAGIVSPLVGIGGEYTGIPMGITMLVCAALSLLCLYRLVEKE
>fig|479437.5.peg.100 Permease of the drug/metabolite transporter (DMT) superfamily
MSALLFAVHIVYVSKFSGTNDVLVLTVMQFFIGGACGVACGACFETLSPAWALTPEFFWNMAYLVIFASCVALVIQNVALAHVPPAQASLFLRLESVFGVLFSVLLYGEQVGLKLIVGFVLIFGAILVSEMFPLKRKDVATNQLEAVPVELP
>fig|479437.5.peg.710 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDELLIEPEPTERELRTAPIKPLFARYAAITFAGMLAQMVMVVLEGLIIGNGLGPLGLAAVTVILPLELLNLALGGALGMGTAAAAGQRLGSGDTAGAQKVFNQGFWLAAYLLVALSAAIALFAPQIATMLGATPDIHDDVTAFIRLLMCFYPFCTLGQLLCSLLRTDEKPSLASALAVIASATSLLWLYLCVYVLDLGFAAAGAYYGMSTGLWFLAILYFQLNKQSTFKLTFGGMKLDPAICRAILWQGLPLFLVQAASLVYTIAINNYLGSLGGDADLAAFAVINGYVVYLLDILCLSATYGLQPIASFNCGARRFDRLSELVKVSLGGTLAVLAVVCGLVIAFAEPISAFFIGDDPQLIELTASHFLPLLACAPFGFLAQVASAYFQAVGQERISILLGVCRYLLFAIPMIVVLAAVEGLTGVWWSQPPADLMAAALAVALAARECGKLRRAGAAQTKPAPESEPLLEAE
>fig|479437.5.peg.1216 Quinolone resistance protein
MTESARRSADTRPPRPARPDIPGELTEVDDLAGWIERDNGGDLRVSHVLVRRDAAEGADFSLVELTESRVEGCSFVGCDFDRAMASDVAFSNCDFSNSTFSQANFTRCTFSSCKFTGADLLEAVLSRVEVRDSTFAYASVAKGKLEDVSVRSTDFSGADLAELRQRRVELDDVRFAGTSFFRASLDGVDLSSCRLADIVLSDTMEELRGCSMDLFQAAGIARRLGVNVKD
>fig|479437.5.peg.1621 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHGTEEAVDGEGVVAEIAPKSRSDRKIDRLGTESTFKLLLEFSIPAVAGMLVQMLYNVIDAVYVGHAVGADGLAATTVANPMMTAMVAVAMLVGVGGNALAAIKLGERKKGVAERVMGNSFVLLLIATAVLWGIAIFALEPILRYSGADGSVLPLALDFMTVIVAGCPLQFIAFGMNNFIRTAGHPNRALGSMLVGTGANVVLGYLFIIVLDGGMRGAGLATVCSWALSALFVMQFFLKKGSPMPLRRPSLSLDPRIALRVCALGIAPCVTQLGFAVSSLIENNLLVLYGAADALGVDGALAVMRVLSAVGLFTFMPAMGIAMGAQPIVGYNYGARAYGRMKLVLVQAIVLGIAITTPLWATVVLAPDLYAHLFGLPEIYMKETAWALVLYLMFIPILPIQTIGSNYFDATGQAAKATVLTLTRQILFLIPLLVFCPLVLPQVLPITALESVWLAPSISDITSTLIVSGFLAFEWRRLRAAEAGEGSNGLHRA
>fig|479437.5.peg.1629 Vancomycin B-type resistance protein VanW
MFRALAALVARSRIALAVVFVCAALLVFGVADFAVNANKAYPGVRVGQIDAAGKTADELAALIDEVYGARLAQGSVTIYANDEAEARIADETAAAQDAALAEQLALEEARANKLAWTADAASLEARVPSDELAAEALAVGREDGGILARLAALATGRELKPRAAYAETAVESLASDIDAAIGDPRVDYGIVVEDGTASVTEGHDGFMVNRDELRRTLDELLLGQEDGSRSFVARAEHAPLRIDESAAQDACDAVNAAIADGARFTYEGAAWSASASDVGSWVSTRIDGSSLAAFVDAAKAKPALLAHVAEVGKGDPVHVSFEVADDDVIVRTDGEGAIPLVAEATGLLDAALFGDDGKARTGVGAGAPVEVAIGSGPAPEAMPFDEAMDLGVIGAIASYTTEYATGPGTEARNHNIALVSQYLSDSVAKPGDSWSFNGTAGDCSTEERGFKGAGAIVDGEYDDAIGGGICQVATTVFNAVYDAGFPVLTRHNHSLYIASYPTGRDAAVSWPDLDFVWQNDSASDVLVRLSCVDGSVTATLYGVDPGYKVSTTTGDWGEGRKYETRTTIDDTLAPNASYVKTRGTDGRTITIIRTVKDESGEVLHEDPFSSVYDPVTEVVVEGPKVAGDGKSDAATEGSSSNVTSN
>fig|479437.5.peg.1959 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLKEYLKYIVPTMITFTLGGVYSIIDGVFVGHAVGDAGLAGINVAFPLVAFIMAVGTGVGMGGGVISSIARGAGNEAKARRAMGTTLTMLALSAVPIMALLFTLATPICELLGGQGETLAQAAAYTGVIAWGVPFQILVTGCTPLIRNQGKVAYAMAVQVFAGLMNVALDYVFVILLGMGTAGAAAATVVSQVSAFLLVLGFFLKRENRIAVADLRPDRHIALHALRLGLAPFGLTLLPEATVVAINVNLSMYGGEQALAAYAVVSYTACVIQMLIQGVGDGSQPLISKHYGAGDADGVRRFRNTNYLITISLGVLGLAAMYLLRNQVPLLFGASDETAGLIAYALPVFSTAYVFYGFTHASTSYFYAVDDAKASSAIVYGEALLVVLIVFGAARLFGLDGIWLSVTAVQMVLSVAAAALLRYRHRARRPDRAAEPAASEAC
>fig|479437.5.peg.2733 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARGAGMAGSSSMARPFARYVSFNVLGMVGVSVYILADTFFIANGVGSDGLAALNFSIVLYTVLQATGLMLGIGAATEFQVCSARGDRTGANRVFTTALVMAGCAAAVLLAVVEAFATPLASLLGADEATLPLTVTYLRTIFAFAPLFLLNNVLLPFVRNDSSPQLAMVAMLVGSFGNIALDALFIFGFGWGMFGAAFATGFAPLMSMAVLLIHFLRKRNTFRPVRLHLRARLVGHIAALGFSSFVVELSGGLVLLVLNLVILAFEGTIGVAAYGVVANFAFVASALFVGIAQGIQPLASNAYARGSDRDVRAVLRLALLTALVIATTTYAAVALAAEPLALAFNRDNDPQLTALAVDGMRVYFLGYFFAGANIVAAAFFSAVEKPAYGLAISIVRGLPAMLAFAAVLAALFGMAGVWATFPAAEAATFALTAVLLVRFVHGPRRRDREVVA
>fig|479437.5.peg.2875 Multidrug resistance protein B
MAPSSSSSASSASRGRGKGFALVAAVYLLGLFIGALDTGIVTPARTVIQSDLGIGEQMGVWIITIYTLAYAAAIPVMGKLADRSGRKYVYLASILLFGVGSLLCGLAQDVGSFWMLLAARAVQAVGGGGIVPVATAEFGTTFPPEKRGLALGLVGGVYGIANIFGASAGSLILSVFGQANWQFIFYVNVPICAFIVVAGLFVLPNTRAEQVKPIDGWGIAVLVAMVLSLLYGLKNLDFFDLGASATSSDVWPFLLAFVVLLPVFVLIERRAADPVLNLSYFRDRDIVITLVLSVITGVILMGIIFIPQFAENVLKLPSGSGGYVVIVLAAFAGVGAPVSGKLIDRFGVKAVLAFGLAASAAGAMFLALVATQFANMATLIISLVAIGIGMGFTIGTPLNYMMLAKTKEREANSALATLSLVRSVGTAVAPAVLVAFIAHAGMAIPDRIMGVLPDAPGGQSIAQLASGQAQGGDGAGLPDDLQQLMKGSDVTTIVANVKTLAKTEIEQEAASAGMPAEAVDAAEQQYLAAIDDRAGDIESTFQSTVDEGFRGAFLLVGICSLVGLALLALYREDRPRPGQAKGEPTR
>fig|481448.4.peg.325 Drug resistance transporter, EmrB/QacA subfamily
MDGQSTNELAWKPRHNPWIIALSVMLATFMEVLDTTILNVALPYIAGGLAASNSQATWVLTSYLVSNAVVLPMTDWLGRTFGRKRLLIGCIASFTLSSALCGAAPNLGILILGRIIQGAGGGGLQPISQAILLESFPPEKRGQAMGLFALGVVVAPILGPVFGGWLTDNLNWRWCFFINLPVGILAIIASKITVEDPPYLQRNATKKLDILGFSFLCLWLGCLQVLLDKGQEDNWFDALWLRWMGGLSLLGMICFIYRELTTDNPIVDLKIFKDKNFAVAIFEIFIVGIVLYATLSGLPLFLQTLISYTAYQSGLAISPRGIGAVAGAIIAGRLLGVLSGRLIVALGFSMLALSSLQIGFFNLEIAKINIVIPNIINGIGAPFVFIPLTTAAVVTLRQEQIGAATGLFNLFRNIGGSVGTSMVQTFIQRLAQAHQTILVGYYTPDNINYNDRLSAIESYIAMMHGTVTGASQTLRLFYTTLINQANLLAYMEIFQFMGWICIFSIPLAFLLAKDKRGTRPGAGSLH
>fig|481448.4.peg.433 Multidrug resistance protein A
MDYRLLNRLKSPAYKGLTATLTEEQEKKEGERIESVHAKTGGSQTGLGMLSSFLFGLIGALIFFLLYFVYTYFSSYETTDDAFIAGHIIRISPKVAGHVVGYYIDDNMDVKKGQLLIEIDPRDYQSRVALAQANRDLAETEWKRMKEILRSSAVSQLQVDAAWAIKLSTEAYLRLNELQLGYTRIYAPEDGRITMRTVEKGQYVEVGQTLFDIVPPELWVVANYKETQITYMRPGQPVTIRIDAYPHRRYKGHIDSIQRGSGAQFSLLPPENATGNYVKVVQRVPVKILFDEPLNKEEIVGPGFSVVPTVEVRKFRLDVFWSLALLLIGFGAGLLVGLIRKLKKKEQ
>fig|481448.4.peg.735 Multidrug resistance efflux pump
MVFSKTSYRFILVCLIFSGGLFFSWKSLLERSSYQQTEDAYMNSHVLRISSKVSGYVEKVLVDDNLKVKKGELMVKIDPRDYLARVAFADAFRILAQTEWLRLRQLSVINALSSFNYDLTLASNLITRSILRLESLSLGYTDIYCPLEGKITNKRVEPGDYVSTGQYLFSIVSDDSWVVGNFKEKQLNKIRPGQPALVKIAAYPQKWLTAHVDSIQKGTKNAFSSYSPEDLTLNYVKTSQRVPVKVLLDEPLPKDYANLGPWMTVTLRVQVGKDTPIYPLSLLYSLLTLTLIWFLWKMAKKFLPGKFQKLDSFTS
>fig|481448.4.peg.947 Outer membrane component of tripartite multidrug resistance system
MIYLVIERSVKDRAFSSWILLILLGVTLFLCGCATLPKDTRISTPIEPPQIKQTLSTEFDPSSEKIVKKWPLNNWWEGFHSPEMNRIITIALGKNPDLKASLARIHQAWAVAAGARSRYLPSFYSTQFLFPVPFGVLQLPGSSFFGPFGDNSFFFWSVIPALANYHLDLWGEDKARVRAAIGMARATEAEFALSRLFLSTTLASRYIRLASAEEELELARSGQQIMQELLKLVQMRKKSGIENLLPVHTIEQRLQTVTQQVNSLERETKILRDEIARLAGQSPDWGKTILAKEPHFPKRFPLPQSLPLDLLGRRPDVAVSKWRAEALAHQVKVTKTAFYPNLDLVSLVGFETLNFATLFLNPALPLLYIAGPAWNLPIFTGGRLSAELVVAQEEYNIAVENYNSTLLSAFQQVADALAVWKETDKNLESQEQSTHAAKSNAELSARLFSAGINTKTDLLDLQYTLIQSQITLSGRTAEHLEAAVGLFLALGGGYDSIE
>fig|481448.4.peg.948 Inner membrane component of tripartite multidrug resistance system
MPLEPQKKVRPFFLILLQAVLSIEFLLGTYSPPAYATFNLYPAGDLGVSPSHASWISTIYFAGQAFGLFIGPWLDRALGRVRSLLWAICFFALFDFVVAVSTDYYLSLFYRLLLGISGGSTMTLCQLNLLDYYPINRWPFVSAYFGFLQVSVFGFGPVLGGFINENFGWRAYFLTSFSLHLFCGLIASWIMLFLPEKPPEHKREKVSFDWVGFMLLFFSALCFQTLVTRGQDEDWYNSTFIDLLFIFGTISLVYFIVWETGEKKPFVNVKLFLKPTFVVSVIVAPISFALVYGLFSTLVFNLQLLKSATNFSSFQAGLAMAPLLFFLPFLYPASVFLSPRMDPRLLASLLLAILGIFCYWTGYYDFFRKRAFFDQFFNQYVLLSQVLNGAYVGLIPPLNAMAIHRLSRKNQESAVNTGILLRTYFLTWGGGLLGTMVMEHRRDFQQTRLVESFSGQNPESMQLIDSLRGLGLTDLQIQSKLVEQAANHSVILALDDTYRLCSWIFFFMALLVWFPSLGKRNKEKFS
>fig|481448.4.peg.949 Drug resistance transporter, EmrB/QacA subfamily
MNKPHAVASRRNLSQKFPFAFVLLHFVLAAEFLLAVYSSSSYAVMNRHAVGELGQSPSHATWTSTIFFVGRALGMFLSPWLSQAWGRVRSLLSAVVVLIVCNFILAYTGDFYLFLGMRLPLGLAAGAVMMLCQYVLMDFYPVNKWPFVTTLFGFLLMTTFGLGPTVGGLMQELHWNWRDYFTANFALHGLCLMFLWVFLGKREEKISHVHFDGVGFLLITLCFFSFQTLASRGQDEDWYNSLFINVLFFLGVVSLIFFFIWELAEKDPFFNVRLFLIPNFLIANLIGPLSFGALYGAFSILIGALQQVGYSSFLSTLALPPMLLVLPFLYPLSIYLSNRSDPRPIASFCFGLLALFCYMTSTYDFFNRRSFFVQSVLLSQIFLGGMVGILPPLNRICIEGLSPRHQQMAINCGILLRTFSFTVGSGLLGTLLEHRSVFQLRRLVETRSMFDPQVVEFLQKLRDLGLDSLQALKVYAETVIQRSYILAVDDTFRFCAVLYLIITFWIWATKIKKLRKESS
>fig|481448.4.peg.1381 Glyoxalase/bleomycin resistance protein/dioxygenase
MIAIGSIHHVTLTVNDLDISIRFYTQLLGLQPIERPSFPFKGAWFKVGTQQLHLIEREEKQRTSSLVINPQQQHVAFRVKNIQKALQWLRTNGYKEDHPDPTQRLLVNLESRAGFPQIFLFDPDGHLLEINAEDKGD
>fig|481448.4.peg.1449 Acriflavin resistance protein
MSFPEFAIRRPVAAWMLMAALVFFGLLSLFSLGISRFPDVTYPVITVVTQWPGAAPEVMESEIVDPLENVLVSVQGIKDIESTMLPGIANIKLEFYIDKDIDAALQEVNSKVRSVRLPTDVNPPQIFKINQDDNPIMWLAVTWDKPFKNLVRYVDNHIRDRFMLVHGIGDIQLGGWADRNFRIWLDRKKLDLFQLSPTDIRDTLQAENLELGAGYLESKTNEINVRVMGEARSEYEMRSLALNHRASGAGGIPITGVGGSQGGGMGTTGAGSNQFLTNPAMTSAASNLLSNTRGASSVYLPLSLVAEVEDGIMDPTRLSRSDGKAAIGLGLQKLRGYNEIAVAREVKELVKELKKELPEGMSIGPRFDSSVYTQEAVHETEFTLLLTIFFTASVCLLFLGSLRTTLNVLFSIPISILGSFIFFKFLGYTLNFFTLLALSLAVGIVVDDSIMVLENITRHKNLGKDPRSAALDGANEVSFAALAATLSIVSVFCPILFVGGVVGKFLSQFGLTLSIAVLISLLEALTLAPMRVAEFLNVGGEERRNFFETWLDHFFWKFAAVYKRLLALALKKRGIVLILSFSIFFLSLRLFPVLHKELSPSEDMGIALIRIETPVGSSLEYTGGRVRFLEDYLRKQPYVAHVFSSVGGYSGGQVNFGALFITLTPRKERKLRLQEIFKIWRKEFKKAEYQDLHIKIIDISQSAFSSKRGTNIELSLLGSEYSVLKDVSQKILGELDKSGMYTDLDTDYREGMPEVQIIPDRDKCALSNISMQQLVDAVRYSIGGGRQGMYTNEKDIRRYDIRIRFIPEQWREPRDLEDIPLWTNYGGEPIHLKDVASLRIVPKLMNMTRENRRRVITLFANVKPEYSQARALDYAMEICRKYLPPTYTVQPAGASQTAKETFSAFPYALGFGIIIAYMVMGIQFNSFLFPLIILCAIPFSITGAILFLYLSHLSLNLYSGIGMILLMGLAMKNSILLVEFINKKRFEEGLETKEAILEASYIRLRPILMTSLATISSAIPAALGLGPGAEVRVPLVIVVIGGILVSTSFSLFVVPCIYSLVSKVGGKPPIDLEEWLQEEKVSSY
>fig|481448.4.peg.1450 Acriflavin resistance protein
MTLSDLSIRRPVFAWMLMIGLIFFGAISLGRLGISQLPEIDFPIITVNLQWNGASPEILETELVDPIEQAVISAQGLKGVSSYIQLGQASIILEFELGRNIDSALTEVQSKISSVKLPMDPTQQVGMQQVPTPVPQPILVKDNPEEQPILLIGVSGEGKSLHDLVSFVDLVLHDELQIVPGVGQIVLAGYNIRNLRIWVDGQKLASYQLTVQDVQTAIMQEHVEVAAGDLENSRNQFNVRAMGEGLTPEEVGDIQIKKRGSELIYRSNIRIKDVAKVEDGLDDIRRIAATNGKTSLGIGIKKQPGANSVEVARLVKKKLQELQPFLPKGIHTEVVYDRTQYIEDSIKETLFTLLLSAVITSIVCYLFLGSWTATVNVLLSIPTSVLGTFVVIYFLGFTLNFFTLLGLSLAIGIIVDDAIMVLENIYRHRDLGKNRVIASRDGAREITFAAMAATVAIIAIFLPVAFMKGVIGKYFYQFGLTISAAVALSLLEAITLTPMRCSQIMDDRNKRKGLAFLVDYAFKYLAKFYKYLLKFSLSYSWLVLVVALGLFLFSLKLFSFLPQELIPTQDESSFIVRIQTPVGSSIYFTEEKLKECEKRILAHKEVDKVFGAVGGMIQRTGATDGNLVDSEVNVGTLYVTLKDRRERAISQKLFMEKIRKELNSIGDLRAAPQDLSIRGFTTGRGFPVELTIRGEDYKVLQKIVQQDIEEMKQSGYFVDLDTDFRDGMPEVRVYPDRFAANACSIPIQNIANTVAIAIGGVAQGQFTNGERRYDIRIRLQGKERVGPEDIARLGVRTNTNEFMPITAVAKLQTVKTYQTLTRKMRERAITIFSNVATDKSQAEALAVAKKICSKHLPKGYRLYLSGGAASFEETFQSLAFALWVGVVIAYMVLASQFNSFVHPFSVLLALPFSLSGALLALWFTHQSINLYSMIGLILLMGIAKKNSILLVEFTNQLREKGMPIKEALLEAAPIRLRPILMTSMATVAAALPPAFALGPGAESRIPMAITLLGGIVVSTVFTLFVVPSAYLLLSRFEKPSPFKAPPKGPMAEEKVLVEKNGEITKARR
>fig|481448.4.peg.1641 Glyoxalase/bleomycin resistance protein/dioxygenase
MVHRFLHTRYRVSNLEKAVSYFVNVLGLQEVGRITSPRGSKLVFLKAPESQELLELCEYPGSGNVVVPPDLTHLAFSVPDLKEARIRCDKMGWPFTDEIQQAENGQYFTFIDAPDGYEIELIEEKKDNPS
>fig|481448.4.peg.1828 Acriflavin resistance protein
MWLVKLSLKKTYTIGVLAVLIFFLGFFTLKTTPTDIFPEINIPVVVVSWQYLGLVPTDMANYITTFSDYQIANYVDGVKRIDSNIYFGFSVSKIYFQPYVDISMAVAEITAVLQPIIKRMPPGTTPPLIFKFNASSVPVLQIAVSSSSLSEPALYDYTIWQLRRDLLSVKGTMFPPPWGGIVRWMTVDLDPHQLLARGISAQDAVDALTGQVLNYPSGDVKIGDRDYFVTLNNVPKNLFEINDFPIKRVFDTDFAYVRRNINDRVIYFRDVGTVHDGGVPQVNLVRLNGVHGILMTTLKTMGASTIQIVDQIKSLLPEIRKANPDKKIQELFDQSIFVRAAIKGVVFEAGSAAILTGLMILLFLRSPRSSFIVLTSIPLCIFVALFLLKLLGHTLNLMTLGGLALAVGILVDDATVAIENIHRNKELGKPPLQSIMDGSQQIALPALVATLSISIVFTSVIFLDGPPRYLFIPMALAVVFALLFSYVLSRSLVPAMVLLLESKEDKESRIDRLFSFFYPIQASFYRNFERLRLSYATILRMVLCNRKKFYIGVFFFITGSLLTLPFIGRDFFPTVDAGIMRLHVYTPTGTRLEKTEEYFSRIEASIKKIIPPAELETMVDNTGLPIYFMATLAMSDSMNQGSFDGEIMINLKEKHRPTAFYMKKIRKILRKEFPDCIFFFQPADMVNQVLNFGVPAPIDIQVIGTDDKLTYQFALESLSRIKEIPGIVDGHIHQRFDYPTLHLEVDKVRAVEMGLFQIHVANNVLNQLSTSYMVKPTYWPDPKTTINYPLLVFSPQMKINSINDLLNFPLTSITTPFLVGASPPVESTQTLLGNVLNPELLANVAKLIHTTEPAMVSHSTMKPVFDILCNVQDRDLGAVASDIEKKLDPLRKKLPPLYRIILSGQASSMNSAFQQLEFGILFAIILVYLLMVVNFQSWREPFIVLTALPIGACGVLWMLFLTRTTFSVPSLMGILMAVGVITSNSILLITFANQRVREGLSPLEASLEAGFTRFRPICMTALAMIIGMLPMSLGLSEGGEQYIPLGRAVIGGLLLGTAGTLFFVPSMFTTIRQRKP
>fig|481448.4.peg.2221 Outer membrane component of tripartite multidrug resistance system
MHGPPPLLLLFSPWILGSTFISLVGCSVGPDYKPPKLEVPQNWKWGEQKPDPKGSHSREKPQIEEKKTAWGGNDLQGEENIKRAIEEARKNPGKWKLAAPKDFVKKGQWWKIFNDPVLDQLEAEAEVANQQIKMAMANVIEARAGVGAALSAFFPHTNFTPSYQRWKLKTHLPWLPFILPEPIFSTVPLLGQNGIPIPSGSIIGSTQYYGFQPTLNMWQVYLNSNWELDIWGKLRRQLEAAKAEAQASQAELEGMKLTIHADVAQAYYLLRYIDSQLEVMERMIHVYEDNLKRVEIRFKSGLSNELDLARAKTDLSRIKAQYIALESHRAKVENSIARLLGQPASTFHFPRKPLKEDPPHVPQSLPSDILEQRPDIAQAEREMAATNAMIGVAYAAYFPSVNLNAYFGFFNTDFGQLFTWPSNSWIYGPLIDLPIFEGGRLLANLMQARAAYEKAVASYRETILSAFEEVENALIGMRLLEEEQKVEDEVVASAKKQYDLALDRFQRGLSHYIEVDTTESVWLNAILTDIALRGERFIVRIALIRAFGGGWADSSMKKPSFQQNQSKN
>fig|481448.4.peg.2223 Inner membrane component of tripartite multidrug resistance system
MATPLSLRYGRKKTVLFFSSFLAASSLFCAWAPDFYLFLGGRFLQGLSCGLLIINSQSLMFENTPDPWRVFPLMLGAVASVLPFTIGPSLGGYGKEYWGREASSWRYWFYGTALLFVILSFLFHILFKETEAVAKKKPWDWAGFILLFLSLGAAQTIFNMGDDYEWFISPIIKFLFLLGIGCLLSLFVVELNRKNPFIPVRLFLRKNFFIGSLCLTVGFLFFYGLWTTLLVRLQNQNLFPPHRAGTLFVGMALFSTPISFLLPRLAGKMRSPLYAFIVFVLLGVLYTWMGYFDFYQKRWFWMQSPLIFVIQGIALGLFFIPLTNLIISGLCPKNQLQAIELSSSMRIIGQGWASPIIGTILYHRIVFHKMRLDEWLHAGHPYLMEYYSKFKEQGIGREIALKILDQSALSHAFILSLNDAFRFCGIGFLVLSGVILLAKERRDQI
>fig|482234.3.peg.321 Glyoxalase/bleomycin resistance protein/dioxygenase
MLHHVEVYVSNLAKSREFYEPLLIKLGYYPYQEWENGFSFKKSEHYIVFVQTPAEFLEVGYHRCRIGLNHLAFYGGSRKQIDQLRKDLITRSVNLLYEDRYPYAGGENHYALYFEDPDGIKIEVVGN
>fig|483216.6.peg.188 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKKVTLLIPVYNEEAMLPTLYQRLIELINRNSAYEWEILFINDGSSDRTLEVIRRLRQTDSRVNFVNLSRNFGKEIAMLAGFDYATGDCCVVMDADLQDPPELVDQMLQYWEEGYDDIYAKRRNRGEESWMRRRLSLAFYKLLQNMSRIDILPNVGDFRLLDRRCILTLRQLREQERYTKGLFCWIGYQKKSIEFDRGDRLAGHSSWNFFQLLNLAIEGITSSSTAPLRIATVCGIICSISSFIYAIYFLIKTVIYGDQAAGFPTLIVVILFLGGIQLFSLGVIGEYIGRIFKETKGRPAYIASDYNEKKLGYDE
>fig|483216.6.peg.650 Acriflavin resistance protein
MKFVKYFLQKRSVTILLLALVLAGGLFSYIKMGKLEDAPFTIKQALVLTPYPGASPSEVQTQVTDILEEAIQSMGELYYLKTENRAGLSKITVYVKKEIRADEMQQLWDKLRRKVNDVQGKLPAGAGASIVNDDFGDVLGVFYGLTGDNYSFRELEDEAKLIKNELLKVKDVAKVEIYGVQTPTIDVTISPAVMAQSGVTTADIAHAFEAQNKVVDAGGVDAGSNRIRIESTGNFYSLDDIRELTIVSRTGEHFRLADIANIEESYQNPPGNIMRIDGSPAIGIAISTVPTGNVVDMAKAVQITLDKFKETMPEGFTLTAIYDQGYESDIANQGFILNLIISVLTVVAILLFFIGFKNGILIGSGLVFSIFATLIVMMASGIALQRMSLAAIIIAMGMLVDNAIVVSDSALVNMERGMRKRVAIMRACSSTALPLLAATIIAILTFLPIYYSPHITGELLSSLVIVIGVSLMFSWVFALTQTPFFIQEFVRRPRPEELKAGLFDGKYYNIFRNALRWVLRHRTMAVASLVVMLVLSAWSFKFIPKVFVPALDKQYFTMDMWLPEGTNIYETDRIADEMADYVRGHEEVEMVSNYIGRTPPRYYLSNIAFGPQSNYAQLLIKCHTSKDAVAMHALLQDSIRLKFPEPLIKVNKFELSPLTEAMIEARFLGPDAAVLDSLVNVATSIMRRNPKAADVRNEWGNMTLVMRPIYDPVKAGALGITKAQMMQSVKSVSDGLPVGIYRDDEQKVPVLLKSDNTSVTDAHSLENLSVWNGKHSAPLSQVTKGVETAWEWPQIRTYNRQLSMAAMCGVQPGHTMAEVHGEIRKEIEAMELPEGYTFFWDSQYKDQNEGLQALAKFFPLAFLMLIVILVALFGNFREPGIILCILPLSLIGVAVGMLLTGFDFGFFPIAGWLGLLGMIIKNVIVLLDEINVQRHDGVIPYTAVIEATVSRTRPVLMAATTTILGMVPLLFDVAFGGMAATIIFGLTFATLLTLFITPALYSMFYKVKES
>fig|483218.5.peg.1609 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSMSINQHFTPVKLIRFAAPSIIMMIFMSLYTIVDGIFISRFIGSNALSSLNIVFPVINIAIAISTMLATGGNAIISKYLGEGRRREASECLTMFVVVTVSASIVIMVLTFAFLTPISRLLGATDILLEDCRSYLATAIAFAPACMLQALFQSYLVTAGLPALGLCLTVIAGILNAVLDYIFIVVLGLGIGGAAAATGIGQCVPAAAGLIYFTFIGKTIHFTRFHLRIKELLAACYNGSSEMVTQLSNAVVTFLFNMVMMRLAGENGVAAITILLYGQYLFNAFYLGFTIGISPVVGFQFGAKRKNELKNIYRVSFIFVMCSSLLLTLAAIRLSTPIVSVFTHDAGTFALASSGFRIFAFNFLFSGFNIASSGFFTALSNGRVSAVISFARTLVFTVLSLLILPQIIGINGAWTAIPAAEFLTLILSAGMHLKYFIRNNKYNYFE
>fig|485913.3.peg.320 
MRITQEGNVVTLINVFETTPEQQQQLVDQWTRFTEEQVKGEPGLIGAALHTSIDGTRVINYAQWRSDADFHRFLNKYREQFAQWGQNALRIDPHTYDVAYLYEQAGE
>fig|485913.3.peg.728 
MRRLILVPVLVFVALLAIAGAGAYWFYNSYNFYSTDDAQISGQILNISSPQAGQLTQLNVKQGDKVQAGQVIGSVAAVAQTGQKVNVNLTSPIDGTIVQETGVEGQLVSAGLSLAQVVDLSKLNVTAYVDETQLNNIKNGQDVDVSVDAYSGESFTGHIDHIVQATAGQFSLLPSSDNSSGNFTKVGQRVPVVVSLDGNGGHTLVPGLSATVKIHLH
>fig|485913.3.peg.729 Membrane component of multidrug resistance system
MVIFGIFMSILDGTIVNIAVPRLETAFGSDLNSVQWVLTAYTLAQGVATPLTAFLADRIGTKRFYILSLAGFTLGSVLCGLSWSLPMLILFRIMQGVAGAFLSPLAITLLYREFPPQERGTVMGALGIPILLGPALGPTIGGYIVTYMDWQLIFYINLPIGILGVLLAFFFLHEGEIVPDKKFDIPGFLCSGIGLALLLYGLSDASTDGWTSPIVMGSLIVGIVLLIAFVLVELRLSRRGKQPLLDLTVFADRSFSTSSIASILVVFALYGGLFLIPIYLQNLRGLSAYQAGLVLLPQALASMVAVLVGGRLVDRIGVRAVVIPGLIILAIAMWLYTSLNTSIPIGDFQWLLILRSFGIGLCLQPLSVSALSNIQPRRLSQASSVSTTIRFVGSSLAVAIIATLVQSQNKVHYAHLAEQVTPTSSFGHLVMMIQAGLMGKGASAIAAYAYALKTIGGLLQLRSYMMAMQDAFRVSFFLAIVAIIATLFVTGNKKKAVVVDEASMSAEERAEAEKAREEASMAL
>fig|485913.3.peg.1696 Permease of the drug/metabolite transporter (DMT) superfamily
MRMPDRRDIPAMILLGFIGITVYQLGLTYGETSVSAGTAGLLIATVPCFTVILATVFLGEHFSVWGWVGLLVSFTGVTLISLNGNGGLHFTPGALLILLASFSESVYFVVQKRYLRKYSGLELATYNLWGGTLFMLIFLPTLWQELPHAPLGATLAIVFLGLFPAAVANLVWTFALSRTSASAAISFLNISPVFSLIIAWLWLREVPSALALGGGLVVILGVLLINLKGKVSVRAEQPAELAEAEVPSQEISASL
>fig|485913.3.peg.2375 Drug resistance transporter, EmrB/QacA family
MPSIVGKLGGVTLYAWVISIYLLTSTVTVPIYGKLADLYGRKLLLLGGTAIFLAGSIACGLSQNMVELIIFRAIQGLGAGAVQPLVLTIIGDIFVLEERARVQGLFSGVWGLSSIIGPAIGGVIVDRLSWSWVFYINIPFGLLSALLLIIALKENVTRSKHRLDYMGAATLTGSVVALLFAIQEGGSTWAWGSPQSIGLFAVAVLLLALFLRVEARASEPVLPLALFKNRFVTLASIGGVILGTVMFGVSSYLPLYVQGVRGGSATEAGLILMPLLVSWPIAAVLSGRLVMRMGYRFPAILGSLLSMVGALCVALFNTQTSYILAIFPIIAIGAGLGLISNVYILSVQNSVPWNVRGVATAATQFFRTMGGTIAIAVMGTVLNAQMGARFATILARFPGGISHAAAQDSPANLLVRPETRSLFSPSLLAQLQDALMQSLFWVYLLTAIVAAGAVIVALYVPRGRAEEHAYREASVDEVPVSAPVVHVDMG
>fig|485913.3.peg.2691 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNQQIQKVRVKRLVHIGLWASDVQAQARFYHRVLGFDLYTHADGSLEQHLEEEDAAIFLALGEEMHALSIFNDTRVFPTNGRRPVVRSTLHHLSFAVDTDAELAAMAARLQMSGIELSFEPRDGAPDLGDALWLNDPDGNRVEISVMPDELYTAISSNRKTRRALLRPYGLQHVALKTSRLEEMVEFYTESLGFDISDWLLRERAWLRCNNDHHSLILSEGQTGIEHVGFTIADGSELLGWADYLSHQQVPLLWGPGHHGVGDDLFLQFPDSDGLHIELSAGLSQYYDRDVTTPPRLWHTRETALNLWGAIPSWLREESHV
>fig|485913.3.peg.2731 Drug/metabolite transporter (DMT) superfamily protein
MLAGASFGILSTVVKLGYHAGFSVAEITSSQVLFGCLGLWLLSLPSLKYLRYIRKLTLGQLLLSGLFPGLTGVFYYMALQTISASLGVVLLFQFVWMGLLVDWILQRKAPTLSRWLALVAVLIGTVLAANYQVLLTSHLDLKGICLGLLAAASYTGNIVINEHVAPEVPPTLRSTLIMTGALFITLVIFPPQFLFTSALSHGLWFWAIILGCFGVIIPPFLFARGVPVVGAGVTTILGSIELPVVIIMSTLILKERVELIQWAGVALILLGITLTQQSNLLQKSWRKRLAHNINK
>fig|485913.3.peg.2853 Methicillin resistance protein
MTLTIQEINDREQWNNFLTSQSRGHLLQSYEWGELNKYLGGRIYRLGALEDGRLTGVMLLTVNPVPLPARIPGLKLSWLYSARGPTVESPDSPALPALIEHAHKVARKERAVILRIEPNIADDDPNEHTWLAAYSKIDFRTNPIAVHGRRSWVLDIRPSAEELLTNFKMTWRQNVRAAGRKGVIIREASSDADFEAYYELLKVTSERDAFFIHSLDYHKEIYRHFASKGDAVLYIAEHEGTAIAAKMLIRFGDWCWDMFGATSNEKRNLKPAYLLQYTCFQWAQARGCSYFDFRTIPEILEPGEEMWGVYEYKKGFGGFSRLNMPTQDYVYRPLIYTLWSRLVEYRRAKRHQERQKIELERSARGQAQRKDEEAKPAEQIPATPKEQPQPAKAKQKQQAGKNGKKPQEAGNSPIADTPEETSSPVS
>fig|485913.3.peg.2854 Methicillin resistance protein
MEARIITDRQQWNDFIASSPCCNITQSYEWGELPLLGVQEVLRVGVLDDSGKLCAGMMVLVSRAPVIRQVYLYSPRGPVITDPQSPAMTVLLNFVRAEARKRGAFMLKVEPSVATENREWQTAMQRFGFRTNPHHMHIRHEWVLDISPAEKGILSGMKEKWRYNIRLAGRKGITVRRGETEADLEKFYSIYEVTSERDSFFINSKEFYRQYLDLYKEGDRVALFLAEYEGKPIAGTIISVLGEWSWYMYGASSNEQRNLMPNHLLQWTSMQWAKSKGAKYYNFRGIPDVLEEGQELWGVYQFKRGFGGYPIRFFPTQDLIYNPIVYQAYRALLDFKHWRDERQFKKAAVESAREREPQKPEEKTPVQA
>fig|485913.3.peg.3159 Drug resistance transporter EmrB/QacA subfamily
MQTSQSSSPENVQPEVAVDESASQHGGYQWTALSVTTVGALLASIQGSALLIVLPNILEDLKVSFFIIMWVLLSYLLIMTVLTPIVGRLADIWGRKRLYNSGFFMFTLGSLIAGLAQPQFHGADLIAGRVVQGVGGALMITNSTAIVTDAFKKGQVGLGLGVNQIAGAAGFLLGPIIGGLLAQFSWRWVFLFNVPIGIFGMLWGIWRLREPVRLKAHQHIDWVGALLLALGLTGVFLALTMLAFPMLPMPVITAMFVGGVICLALFGVIEPRVKEPIVQLRLFGHRLFTMASLSGLFNGIARGAVLFLLIFFLQGPYGQDPLTAGLMLTPFGLAFMIIGPLSGRLSDRIGSRLLAPIGLGVSALGLLGLVFVEPTTPFWLLCVFMALMGGGSGFFTSPNTNAIMSSVIPQMRGAAAGILNMLNNTGQMLSIAIVFPIALSKVPQDAMMAIFIYGGGMSKYPQALAIFMSGLHSAFLVCCIISVVAMVVAALRPAH
>fig|485913.3.peg.4251 Permease of the drug/metabolite transporter (DMT) superfamily
MKTRFSASPEASGTSTAPGTSPELARRGLLFVCIAVIFFGSNPVFVRWAAPFSSLEIAFWRLAIATLLVALMGLITHQPLRIARGEIRNFAFYGLVTALHFVFYISSLSFTTIAHSLALTYTSPIFVTLFSVIFLKEPLPKRKYVGIGVAVLGVGILAGFEPNYTTCNLNGGRCMILGDGLAILSALCFGIYSIAGRSVRDAHPLFRYTTNVYGFAALWLLPIGTYLAFQHSYSPLAIASVVALGVFPLGLGHTLYNAAIRYVHATYANLIATQEVTIGIILGIIFFHEIPSWSAVIGIIITLLGITSVIF
>fig|485913.3.peg.4421 Permease of the drug/metabolite transporter (DMT) superfamily
MKVAWRDFGALVVAGMLGFGAQQICFLYGSYFAEASMGALLSAFTSAIMTLVASLVARERMTGLMIGGLLAACGGMVLVVLGKGSLGAITPASWIGLGLYFVAGLLSGLMPLLTRRSLTRYSSLRVTTWTLFVGGVFFIIPGGMNVQNAHISVLPPVVIPALLFTAIGATAVTNMCWNYGLARVGVVRLSIYGYLPSILGVLMAAALLGEMLTPAQWLGTALTMGGVLVSQIKGLDIRKFGKSLFSRKEELALLVDEYAGGD
>fig|485913.3.peg.4446 Antibiotic acetyltransferase( EC:2.3.1.28 )
MKRFLNAALRYATNHLINHIPSHTLRRAWYRHMLGWRIGPGTHLLLGQHIMFGGLRSGGSKVSIGHHTIINHDCLLYTTGGLIIGNNVSISSGTWLMTGSHELNHPAFPDIYKPIMIEDHAWLGLRCTILQGVTIGRGAVVMAGAVVARDVPPFAIVGGVPAKVVKYRELQDPSYTLEFSPLFE
>fig|485913.3.peg.5070 Permease of the drug/metabolite transporter (DMT) superfamily
MDGNISTANPFSIHIPLPVGAAGAKALLGKRSFPHTLTSERCVYHYHNRVILSFLYRHRKAYLTTMQEYQELSPSTTQSVSTAADPRKARMLTLLGFGAMVLVWGSFPVAAKIGTEHVPPLLFSAVRFLLAFLLLLLVARWRRISLRITRTQHLRIFQTSLFMVGIPAAIFFASIPYAPAGALTLMWATAPLFVSLFNFRGVGEARGWRLPVSLLIGIAGILLVLLGRVPFLPNQGASIPGFAMSGPALIAELMVLASAAVYGFGMLLAKRYSADVPVLVMTAWQVFYSGVVILLASLIFEHGGPFAPTWATLEALLYLVVFCSCISFFLTFWLIRRIGAIRTAYSDFIIPGVTLLLSYWLLGEELSPAKLGGFLLVMLGCALVEK
>fig|485913.3.peg.6291 Permease of the drug/metabolite transporter (DMT) superfamily
MLGKRQAFSFLCRSYGFENHQENESLAIDLTRGGNMTRKGWLLFTAMSVIWGIPYLFIKIAVQELDPIVVVFARVGIAALALLPVAVHQGVLRRLRERWLTVAALACVQIAGPFLLISYGEQLIASSLTSLLIAADPLLVVLFALRFDPSERVSGSRLIGLLIGLGGVVTLLGLDAGGDMQQLLGATLVLLAAAGYAAGALLIKRPTIAALPSLGVVTVECITATVVLAPLAVTRLPSRIPDLEVIASLLVLGLICTALAYLLFFALVAEVGAGRGSVITYVNPAVSVLLGVTLLAEPLNAVIIAGFLLIIVGSWLSTGGVLPPQLKHLLRTTRQQPISRDTEVSELAAPPRK
>fig|485913.3.peg.6596 Antibiotic resistance macrolide glycosyltransferase
MKKYIFLNVPATGHVNPTLPIVQELIQRGEQVIYYLTEEFRAAIEATGAIFRPYESFLEGIGPGPMPLKMAEESRRVLPQVLESIRAEQPDALLYEAMCLWGRIVAQVLQVETIVLRASYAANEHFGLFTARSDASMPFPSELLERFQVSSAELSATYHLPPFDLRQFVAHAEGLNVVFLPRAFQPAGETFDERFVFVGPSLLPRQDAPAFPWERLGDQPVLYISLGTAFNHRPDFFRLCFQAFGELPSQVVLSHGKRLDPAVLGPAPANFLLAPSVPQLEMLQRTSVFVTHGGMNSIMESLYFGVPLVVIPQMMEQEITARRVEELELGAALTQENATAEHLREAVARVQQDPSITQYVQAMQQQVRAAGGYQRATDAILDFAYKRASLTHSRSMEA
>fig|485913.3.peg.6644 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MITIPPAFQRFMFELHEEEGQAWLERLPRILATCAELWGLVVEEPFSNLSFHYVTRARRRADNTPVVLKACSPTGEFRMEAATIAHYEGHGMVRLLDTFPEGEVMLLESLTPGKTLNTLTDDEQATRYAARVMRELWRPAPEQHSFPSVADWGRGFQRLRQQYGGGYGPFPPHLLDEAKRLYAELTASMAAPMLLHGDLHHDNILQAEREPWLAIDPKGLIGEPAYETGALLRNPLPNLLHRPDPGRIQERRVAILSEELGIDHARIRGWGLAQCVLSAWWSIEDTGQYPADTIACAQLLADSKV
>fig|485913.3.peg.6876 Tetracycline resistance protein
MGFTIIGPVVPFMTRQYLGNPNDLAVVVGWLLSIYGICQMLAAPGLGLLSDRYGRRPVIFICLLGSAIGYLLFGLGGALWMLFLGRIIDGLTGGNFSVLFAYVADITEPEERGKYFGIFGGISGVGFIVGPAIGGLLANVSYSMPFLVAAGVTLLNLVWGFFFLPESLNKEHRLTTMRLRDLNPLAQLGTVFNMANLRWLLLAGFFYAFPFAILQANLTILMRDSLGWNATDAGLVSTLVGVVDILVQGVLVGKLIDIFGDIKVGISALVLVAISYLLLGSIALIASPILLIAGVILFSGSGGLVENALRGLTSRAVGPKQQGLVGGASQSMQSLALILGPILGGVLYAQFGHATPYWSGALIIGLAILSVVLALPALRAAKA
>fig|485913.3.peg.6951 MDR-type permease, probably tetracycline resistance protein
MLWFGILSAVGSLLGIATTELVNRRLNMNHAPSLLHALAIINLLLILGMVSFALAGNFYLALLSVWGVGIMRTASRPLYNTWITQNSDSRVRATIFSAAGMIDAMGQIGGGPAIGYIGERVSIRAALTATSLLLSPILFFFLRGFRLLQRSDGASLENQTLEAATEIEG
>fig|485913.3.peg.6987 Drug resistance transporter, EmrB/QacA subfamily
MTGTYDPKKWGILQIINIGTLMSTLDVGIVNVSLPTMAKEFSVPLAQIQWVATAYLLTMVALLPFLGKLSDIWDRKKIYSYGFLVFSIGSLCVAVSHGIVSVLLSRCLQGIGATMIMANSQAMLRQVFPDHEIGRALGVNAIVLAAGTLAGPAVGGLLLNFVHWTWLFIINVPIGLAAFLLGRRWFPQAKSGGTRTAFDIAGSFLLAAGTCMLMLASEASEQGGGFTPPIVFEGVAGLALLVILWFYERHISYGILDRELFSQPKIALGNTSAFFINMAQTATMIPITFYLQEQLGFSAGVTGMLLILQPLLMGIVAPFAGWFRDKHGGFVPVTVGSLFCAASMLLIACSQHVTAISVSLQLVLFGIGMGLFHATNNAEIMSASPEAKISLSSSLLAMIRYLGQIAGIGLATLLVGSMGKAGATVGIPLQILFWICFLCCLGVAIIRWMSLPNKLLPFQKLIRPW
>fig|485913.3.peg.6988 Permease of the drug/metabolite transporter (DMT) superfamily
MALLIKKKVPVRAYSALLLSTLCWGLAPVATRYLLISFTPLQLVLIRFVIAALFFLPLLTPLRRFHWSVKKVSWVVFCGVAGVIGYNVPVAYGLRVIPSSLAGLLIASEPIWILLIAAFVLREKITWTMVIGLLLSVLGITVLFGQAYVDATWNMRNFAGALLILLAAFMWAMYTVSVRRLSKEVGARTATALTMIVGTFPLLTWWDSHTWSLLRYLSGAAWIALVLLTVGSTVAATILWNYGVAYTTSSQASIFLYLIPLISIIGGTLFLHEHTSILTLLSGLLILGGIALGQLVRPGRAKN
>fig|485913.3.peg.7042 Drug resistance transporter, EmrB/QacA subfamily
MALPQIQKAFNTSFDTVTWVSTGYFLSQAAVIPIIGYLSDRLGTKVVYLTALGLFTVGSALCVFAPNEELLIVFRVIQGLGGGAMMPTAFTLIYRLFGPTERGPVTATVGIPVFLAPAFGPTIGGYLTTTFDWSAIFTINLPIGLIAIVLGLFILHNRAQERAAAGEEHASQGQRVDIAGLLLSMLGFTTLVYGITEAGTRGWVDPIVISLMAAGGVILIVFAIVELFIASDPVINLRLFAQYTFAISNLLLWVVSAVLFGSLFLLPFFFENVQGNTPLTAGLWLMAQGIATAIGMVFGGQLYNRVGPRPLAFVGLILLAVGTYGLTQLDVSTSGGALQGWLILRGLGLGLTNTSLQTVALSAVSNKAMARASSLLNVMRMVFSAVGVAVLTTYLSQQATSYAITAKQGVQAIPPSGIAMTCAATVGAHAEALKNCVTQHVTVMGLNDTFWLVLIGCVICIFIALVLGRDPALEAAKRARAHGEVVQAEVPVAIGE
>fig|485913.3.peg.7939 Glyoxalase/bleomycin resistance protein/dioxygenase
MNKLGFEKVDDQPMSETERWLEVAIPGTQTHIMLGLRGQSGGNQTGMTGFVLHTDNIEETCAILIARGVTITQELTTEPWGKWAQFSDPDNNEFGIWAPAW
>fig|485913.3.peg.7981 Glyoxalase/bleomycin resistance /protein_id=
MIKLGINAILLFVRELDKCTVFYRDVLKLPFVGSDPGVATFKVQDRYLTLLSPEGVAKLFGIEPDAVNIEGNPRAMIASRVEDVHATYETFQAAGVTFLRPPTDHPWGVRTAIFVDPEGNLWDINQDIE
>fig|485913.3.peg.8497 Glyoxalase/bleomycin resistance /protein_id=
MTTTNENILMLSVAVTEMAKAKAFYAEQLGWSVTTDKGQGDHHWVTLELPGGGASLTLTTFHENMKPGTMKLYLSASNIEAAFDELKAKGIKVNDVKDDLYGPGSGVKWFDLHDPDGNRWLFVQSSSR
>fig|485913.3.peg.9051 Permease of the drug/metabolite transporter (DMT) superfamily
MDTADQARAAQQEPSTDFSRQDESTVGKVASPTRRSPLIVVVALFYILLWGSAFIATKVGVTYSPPLTLLSVRFLTAALLMALLAWVYRVPWPRGWAAWGRLSIFGLLNCAVYLGCNYEALRSLSAGMGSIIAATNPLLLTLVAPFVLRERLTWWRVLGLLLGFGGVLFVMGARLNGHGQLDTASGMLISFIGVIGLVAATLFYKRYPPREHAFVVNTVQLGAAGLALALPALLFEHPEQFSLNAPLIESFLYLVLVISIGASLLWFWLLRRGEASVVSAYYFLTPIAGLALAALLLGEPFTLRDALGLVAVAAGIALINRPVRARN
>fig|485913.3.peg.9118 Permease of the drug/metabolite transporter (DMT) superfamily
MKSIQKQQATEILAHETIPAHKSQTHLGRGTLLALVITIFCWASSFVGIRAGLHGYSPTHLALLRYLVASLVLALYASVKRMPLPQWRDLPGLTLTGVVGIAFYNVVLNTGELSVSAGISSFLVNTGPIITALLAMVLLKERLRPLGWGGILLSITGVSIITLSTGEGIHLSVGVLFVLLAALAQSLYFVWQKPYLARYSALQCTTYAIWTGTLALLIFSPGLIPEIQAASWSETTAVVYLGIFPAAIGYVSYAYALARIPATRAASFLYLVPPVTLGIAWFWLGEWPTWLALVGGVIAISGVIIVNVFGKTQTRRTDGVDPS
>fig|485913.3.peg.9270 Permease of the drug/metabolite transporter (DMT) superfamily
MRMKLLACGAFFLNTFLYGTYYAVSKGSLGRIDPIVFTFFVMLALLPLALCIIIYSWHEINREVIKSGVLLGSCICIGLFTLSVALKYNSATSTAFFPSLNGFLAAICVWLFMRQPLHKATWFAGLVSACGALLLILNSPIGGLRGALIAFIGGLFCTFYVFLADHEQRGKAYLPLFGIQLLTMAIWGNFIALLFGNWQDVHPLLPNDLWSVLYIAFGTTCLPTLITVRLQNYISPITVSFIYILEPVLGAAFANYYLHEVLPLDGYLGGALIVAGALINTWGSAERPATQGKRSMALFGDRLMQTWRGSDGGLILPVLGVIAGAFALLRLGGFPPAAWILLAQVWPEYQTIVAHGHGSMLALVIGQALCWLLAWIAVAGLSMLSLRRLIRLFNTPTAARSIPSTIPREHEANTQEVSDMDVLARSFEVEDVPMEQAPTVAYTLETWDEHARHQPGTTPASIYWRPRQRERKRLLHQHHQEARASAGLANKARLRRQTVDLSGLHADAIFGEELPAYDRLDR
>fig|485913.3.peg.9741 Multidrug resistance protein
MLVCTCCLMLCALLIVVCLVLQFPLAIMLGCLYVLSFLIGTSSVFYGLAEVVALTRVVPKSQIPLALTQNEITYSATTLLAPPLGNFLLTIGRALPFLADAISYIVLLISLLCIRTSFQEQRREATQGIAREILTGLQWLRTHPLVGFLAFFSGFLEVIVILNVLLISAIRLEAGFPQGIVGVILAGAGIGNLLGNALGTYLQPRLRFGWGLCAVSIVFVLAWPLYGLYTNPLWLGSIVAFLALIDSVAYLLTASYRLAVVPDAFQGRVSSLYRLILFGFASLGPATIGVVLQVYGIATAINIIWGALFCFSCVIILSPQIRRATFPQDENSTKNL
>fig|485913.3.peg.9795 Glyoxalase/bleomycin resistance protein/dioxygenase
MVQAAEWLCKTFDFKERLRIGRHRVQLAVGDAAVIVNEGKSEAPSRAENHSVLVRVEDVDRHYEFTRGRGAHILRPPTTYPYGERQYTVEDPGGHCWTFSQSVADADPEEWGGTWPSA
>fig|485913.3.peg.10066 Permease of the drug/metabolite transporter (DMT) superfamily
MTTSTPPPVIEDSVASTLLPLTPRRKYLYITLMVLATIVWGSTFLVVQETIKLTGVFTFLTLRFSLGALTLILIFHKRLRHLNRYELGAGSCIGLFLFAGFALQTWGLRYTTSSEAAFITGLYVPFVTILSLFILKQKPTRMALTGVVISFVGLTLISFNKDLVLTFGLGELLVLGCAVANALHIVTISKFAPKADPMNLAIVQILLTALLSAVAIPLAGEPLVLPPAPVWLSVLFMGMIATAFCFAVMNWVQQSVSSTQATLVYALEPVWAGVFGYAVGEMLTPLGWFGCVCILLGMVIGELRLWPRRSRS
>fig|485913.3.peg.10601 Daunorubicin resistance ABC transporter membrane protein
MLKMTEPAIMPEIMPESISANARFIDLEGIAMIWRRDMVRLWRQRSRLLGAVARALVWLFALGFGLRGSLGSIAGFSYEQFVFPGVIAMTVIFSGLQSAISIVYDREFGFLKEVQVAPTPRSTLVIGKCLGGASSSTIQALIILIFAPFAAVHLTPLNILATFVATFVTALAISGLGVVIAMWITDFENFGTIQNFITLPLYMFSGAIFPTRQVPGWLHAVLLLNPLSYGVNAIRGALLGYEASSIPFNLGILLLFTVVMVGIAIFMSRKEV
>fig|485913.3.peg.10622 Permease of the drug/metabolite transporter (DMT) superfamily
MRTKEVGVLLVLAALWGGGFLFIRIATPAFGPVALMAMRVLLTGLCLFVFALVTRTRLELRTYWHHYLVIGIINAALPFLLIGVAELYLTSGLAALLNATTPLFGAITAVIWMREAMTIKKVVGLGLGLLGVVIVAGWSTLPFSTTLILAVGASLAAAASYGLASVYIKVSLGNKVSSLATATCSQFFATLFLLPLTFVAPPTRVPTLTEWLSVAALALLCTAATLLLYIWLIAHAGPTKALTVTFLAPVFGVFWGVLFLKEPLTLSPFVGLVVILVGAGLVTELLLPGWPRRVTETLSEPGERHVAAEMKGEHL
>fig|485914.4.peg.157 Glyoxalase/bleomycin resistance protein/dioxygenase
MTELQFITFACDAPERLATFWEAALDGERRDTEVPETALVDRPGDGPDLLFKRLQAGTKWRMAIHLDLSVEDRAQSVERLRELGATVRETKTEHHDGTTAEWTVLEDPEGNAFCVSEY
>fig|485914.4.peg.734 Transporter of the drug/metabolite transporter (DMT) superfamily
MSDSVARPRLALAVAVVAISTSAILIRWSTAPPVVAAFYRVLLTTALLAPVLLARHADAVGDLSGRHLLAAGLTGVALAAHFAAWFESLSWTSVAASVTLVQSQPIFVVTGAWLLLNERVTGRTVLGVVVAIAGIVVMSLGDLLGGTAVGPRPLYGNALALVGGLMAAGYVLAGRSLRQRLPLLPYVTVVYGVAALALLAVVLAQGLPLTGYESREWLLFLGMAVGPGILGHTLVNWSLAHVESSLVSVTLLGEPLGSALLALLLLTEVPSSWTVAGGAVVLAGITLTARSSE
>fig|485914.4.peg.2042 Multi antimicrobial extrusion family drug/sodium antiporters
MGLLDRIRALFKGPEEFDLTSGSIGKPLFFLSMPIVITNLFQTAYNLADTFWLGQYSTDALAAISFAFPMVFLLISLGMGISVAGSVLVAQYTGAGEEREAEYAASQTVTFAAIASVVLGVVGFFAVEAFLGVMGASADVLPLATSYMELISLGLLFMFGFAVFIALMRGYGDTITPMVVMFGSVVLNIVIDPFLIFGFESNPLFSMLDLGSLEATLLAATGYTGSGITGAAIATIFSRAVALVVGLTIMFRGRRGVQIHLGDMVPDLDYLPRLVRIGLPASVEGMGRALSMNLLLFIVAFFPDAVVAAYGIGTRVFSVIFLPAIAVARGVETMTGQNMGADKPDRAQRATGLAATVLFGVLSAAGILVFFVAAPIADVFTTDPEVVAVATQFLRYVALTFGFIGIMRAYTGSFRGAGKTLTAAAISVLMLGVIRFPIAWFAAGEIGETGIWLSFAISNVAGAVIAYGWYRRGTWRDNDLTEDGIDLDDAGMEPATTDD
>fig|485914.4.peg.2219 Glyoxalase/bleomycin resistance protein/dioxygenase
MTDAPPTPGIHHVTCIAGDPQRNLDFWVETLGLRLVKRSINQDDPETYHFFFADAEGTPGTSMTFFPWENLRQGKVGSGQVSRTAFRVPEGSLDYWEDRFEEYGVDYDDRVERFGSETQRASDSASGDEPRAETVLPFRDPDGLPVELVAVEIPDDDPTVPWTEFVPESAAIRGFHSVTLLVADPQPTMELLETMGLERSDTEAAQGDTPGDERTRFEAAGTVGRYVDVLPTIEGGRQGHGTVHHVAFQTPTDADQEAMRQAVQSAGLRPTAQIDRHWFRSVYFREHAGILFELATSGPGYTDDEPLDDLGGRLVLPGEFEDRREAIEAALTDVTVPRGESAAAED
>fig|485914.4.peg.2386 Glyoxalase/bleomycin resistance protein
MLTDTPGIHHVTSMVGDPQENLDFYADVLGLRLVKRTVNHEDVLRYHLYYGNGTGDLGTIYTCFPYPNEPPGRRGRPGIDAAAFAVPPGSLDFWADRLAEHGVDPERRERLGESLLRFEDPAGTRLELVAADAPVDSWQASPVPAEHGIRGLHGVTTHPVDPYQTASVLETLGLEQVAESDDRVRYRAPGDHATVVDLLDREGGFGREGVGTIHHVALRVDDEDLREWHDLFRERDLRVSRIRDRHYYRAIYVREPGGVLIELATESPGLTVDEGAADLGSSLVVPPWAEEDREMIEGQLPPIEVPYRDG
>fig|485915.5.peg.1293 
MIHVIASVRLKPGQQAAYLHVLRSHLPLVWQEQGCLEYTPAVDIDAALPGQDMDGAVVTIIEKWESMDALQAHLQTPHMLAYRSEVQEMVEEVSLKVLQTADQVPDPPVE
>fig|485915.5.peg.1397 Permease of the drug/metabolite transporter (DMT) superfamily
MSASSLLSTPKTMQPSQRQLGADGVLLIVALIWGITFTMIKDALVHVSVFAFLGQRFTLASALFVPFLVWRWRCFAWRAVAHGAILGIFLFGAFAFQTIGLAFTTASNTAFVTGMNVVFVPLINGLLFRVHIPVPVRSGVILAALGLAGLTLNTGLEINPGDLVVLLCAVCIALQIIFTGRYAGRNDVYWLTAVQIAVVAVGSTAIGWIRGEEVFFWEPKIASALVLCAPLATVFAFWAQTAMQRFTLPSRAALIFCMEPVFGALYACLVGGEHLGPWAGLGAAGIFLGMVCAEMPETWWVRLKAGWGSREAGS
>fig|485915.5.peg.2512 Permease of the drug/metabolite transporter (DMT) superfamily
MQKTTFSPSVLPTLALLGAVFLWGSSFSAMKVAVAAFGPLFTVWSRMCISTALFVPLSWKLLKNGGPGRDWGWILLVAIFQPCLYFLCEGFAVHYTTSAQAGMVSAVLPLLVAAGAHLVLKETSGPGIWIGGGLSCLGVVWLTLASSPSATAPNPFLGNTLEFAAMLSAAGYMLTVRRLAGRYSSWLLTGLQFSLGVLFFLPGGMQGPSGGWPETVWPYLLLLYLGALVTLGAFNLYNWGIARVPAGRAATFVNLVPVTAAVLGALFLDEVLSTSQIAASILVLAGVALAQSTFLERTARRQR
>fig|485916.5.peg.1840 Drug resistance transporter, EmrB/QacA family
MAIVLAAIEVTIVSTAMPTIVRDLGNIHLMSWVFAIYLLATAITTPIYGKLADLFGRKKVFTIGIVIFLIGSSLCSLAHSMAHLIFFRAIQGIGAGALFPVSLTIIGDIFNIEERAKIQGLISAIWFISGILGPLVGGFIVDLLSWHWIFLINIPFGLLSISLIKLFFHEQFTKKKRYIDYPGAITFTIGMTSLLYAIILGGQNKAWISPITLSLLINAVGFLSLFYFIELKSPEPILPLNLFKLPMVMVPNLATFFLCTVLIGLNVYLPIWVQGVLSYKATGSGIALIPMSVGWTLGAFYCGKLLMKFSVRNTTSLGAGAILAGCSLLVAMGFSIFELIFGMFIIGLGFGLALTSSGIVIQSSVEWNLRGSATALFTFTQALGQTVGVAMLGVLFYHTVSTGSATLNKEVLTFGLHNIFIALSVISVLGLFINLWIPKQKLSGSKLL
>fig|485916.5.peg.1946 Acriflavin resistance protein
MGLIEAGLKYRKITLMFFIMAVILGIISFINMPRFEDPQIKVFMAQVQTVYPGASPEQVEALVTKPLEEKIDELKEVSKITSSSANGFSNIMVEIAPESDQKKAWDNMRQKVNEARLLLPSGAGEPEVNDEVNKTSCLIIHLIPPANLPVASIREIADDWKDSIKQVPGVEKIEVMGLPEQQVQIILDPSALAARRLSWTHLADALQKRNVSIPGGTLREGETGFMVEPSGEYSNLEEIKDTIIYQPVGGTAVKVKDVASVKLVHARNDVLVKSSDNSAVALAIFPKEGHTVFDVNEKVQAKIKEMKKDLPSGVEVQSVYDQSESVKKKFDELWRELLTGMGMVLLICVLGLHWQTAVMTALAIPVSVAVGFGPLASMGVDLQQMSLAALIIALGILVDDAIVVNDNIERHILLETDRYTAVLSGTREVAVSILTSTIATVAGFIPLILLRGNIGEFIRSLPLVVAVTMSASMVVSLWLVPIMRYWTAGRVKKNIREKAFGQSGPLGPFLNRLSTWYEALLSKCLKLPFLTVTVALLVSASTFMLIPIMGIQFFPYAEKSEFIIDINTPKSSSLHETEAVVGQVVRKVKEQIGVKEVFVYIGHQLPKFYYNELSGGRGETLTQLLVVSNQEPKETHQLAAKLRGELTGAIPGSRVTVRELEQGPPVGPPVSIRIKGDDLSELRTLADQVIDILKQVPGTVNVHDDMGSDTYSVKVNSSPELTARWGVAEKDIANSVRMAVDGLEISNYRKGDKLYPIVLRTSEAEDASLSNMSSIWVPSWKTGSILPLAQVATVDVGWNTGTINRHNLKRVINARAYTDGTLPDNIIKAASAKIAAIPIPKDYKIEYGGENEERDLAFAKIGKLSIVVLLLIYVIIAIQFYSLTKPAVILLSVFLAISGAVLGLYVTGTPLGFMALLGVVSLSGIVVRNGIMLVEFIEVGLKQELPLYGAILEAGKVRLRPILLTAATAVSALLPMAITGGSLWRPMAVSIISGLIFSTVLTLIVVPSVYLLITKRKLAG
>fig|485916.5.peg.2301 Vancomycin B-type resistance protein VanW
MSKISVKIFGFVLIMFLILFYILFPDLFYPAFISQKVVQGVTIRGIDLSELSLQEGLNKLQSLEEKIRETKIFLKYEYQTYRLSIDNSGVRLDKQAIMNQALSAGHSGSLFRRWSEQYHIEKYGLEIPVKINIDKHFLEASLARITSDITIHPRNAAIHINERNEIEIIPSAAGLKADPAQACIKLIGALEADRSEEIIDLKMVSVAPEHTTDEIRAMGINTLLSAYKTEFESDNLSRSYNITVAAAALDGLLVPPGKTISFNEIVGPRSTEAGYKDAGVIVNNELVQGTGGGVCQVSTTLYNSVLLAGLEIVERTNHSLPVSYVPIGRDATVVYNSVDFKFRNNTNKHVYIKTITGNSSLTVKIFGSNKSKRDVELRTWITDTIEPQTVYKIDTALLEGQESVKQEGSKGYYAEGIRVIYNNGLMEATKPLPQSKYKPVNKVISVGSLKKDK
>fig|485916.5.peg.3289 Vancomycin B-type resistance protein VanW
MNKTRLTSKVILITVFQLIVCISLSSFALKFYYSKVVLPGITVQGVNIGSLTYSQAVEKLKQDLPYPSPKMILQVGLIKYGEIQYTTDYEATVREAIKYSQKLSSRQIIKLMFSNTKTHDFVLTKTYNDKILNEILDKAASQYYEAVQNAYISFDEKTATVFQDTYGRKLDKEASIQKFISSPYGNTYLALSFQITEPTRKTPDYDGINSRLSLFVSDFDVNETDRTRNIELASESINNVIIRPGEVFSLNKTLGKRTSEAGYRKTLENTYDVDLIASHEAGICQVAGTLYNAVCRAGLTVVEKRINPVPVPYIPENMESVIADENNDFKFANNTSKNILIASQIHQGELKICIMGHKGSTPVRQIKTEKERYVTSPPKQYVLDPTLPPGLVIIRNPGSNGYAMKIYEVILKNEREIDRILTAAIEIEPEPELLAISPMRSTIANLFRKEPLKFK
>fig|485917.6.peg.2445 Drug resistance transporter, Bcr/CflA family protein
MASTLQVSSLQVQLTLSLFLISYGISQLFIGSVLDSFGRYRLSLICLLIFAAASIVIANTHNIYLIYLMRIIHGFTVGTIIVAKRAYFVDLFTGDQLKHYLSLFSIIWSTGPIVAPFIGGYLQTAFGWESNFYFLALLAIVLAVLEYIYSGETLSHFSAFSLKKITGIYITMIKTASFSLGIVMLGLAYTMVMIYNMTGPFIVEHHLHFTPVVAGYSSLILGFAWMVGGFIGKATINRPFFKKMATNLIFQVIFVSTMLLSIQFISSLYTLILFAFLIHVTAGYIFNNYFTFCLGLFPKNAGIASGLTGGITYVIVSFLSYSIIAILPAKDEHHLGASYLVLTILSALVMFTIYSRHKKAGTQVTE
>fig|485917.6.peg.3534 Multidrug resistance protein B
MSLPKQIAGHYKESFSGLSRETWILSIVMLINRSGYMAVPFMGLYVTQSLHRLPSDAGLIITLFGIGSILGSAVGGKLTDVIGFRPVQIIAAIVSGIFFLFFASVTHFQTLCVLALVISFFSEAFRPANFAAIAAYAKKGLETRSYSLNRLATNIGWAFGVSMGGMIASYNYRLLFYIDGAVSIFAGLCILFFLPRIRNYSKTIKEKVKGVVVRKPWQDTVFVKFILLTTVFILGFFLVFRVVPVFFKEIWKIDEFMIGLILGLNGVIIALFEMVMIHKIEHKKSPMFFIVIGVLLIAASFLLLMLPFGNPVFLGALCLILFTLGEMFTLPFVNTFVMSRANEFNRGLYAAGYMLSWSVAQVVGPTAGFYIAEQYGYNTLWIGLSTLMLLTAYFYKRLKTV
>fig|485917.6.peg.4333 Outer membrane component of tripartite multidrug resistance system
MQEAIALGIENSKNLKLSQNKVEQAIAQLNMVKDNALPSAKASFLYNHAEIPTNTLSIGGGNPIHLPKRADAFIGTAAVEELVYGGGKLKYAEESTRLLSDVARLDADKNKEEISYAVINTYYSLFKVMQSKKVIAQNLESIDSQLKQAQRFFEQGIVTKNDVLRFQLQQANISLTDMEAENNRKIINYNLDILLGLNENTQIEIADPDAAAKAIGPLSSYIDLALGSRQELRQLDLQNKVADVNIKSVKANTLPTVGVGANLYYINPSGKFVPPTDQYIMPVTLGANISWNIGNLWTNKHKVTDARIQQKEVELQKDILSDQVKTEINSNYQRYQLALNKIRVLETSIAQATENDKLLASKYKNNVASAIDRIDAETLLYQAKINLELAKADAGLAYYTLLKSTGKISQ
>fig|485917.6.peg.4334 Membrane fusion component of tripartite multidrug resistance system
MTTEKKKKNKVIPIILGVLIILGAIFGTKEYLYYSKHVDTDDAQIDGDISPVVSRVGGYVQEINFEENTHVTEGQVLVKLDDRDYKLKLEQALAGQKGASAGVGVSESQIAATAANTSTAKANIEAAKVKLNLAQKDYERYANLVKDGSVTQQQFDQAKAQKESAQAAFTAANDQYNAAVKQVGTSQSQLAVSSNTVTQHQADVDFARLQLSYTEIKAPATGIVSKKNVQKGQLVQAGQALFSIVNDNSIYITANFKETQLEDIKTGSKVKIDVDAYPSDEVLGEVYNFAPITGAKGSLLPPDNATGNFVKVVQRVPVKIKITKAPKEILAKLRPGMSVKVSVSIKD
>fig|485917.6.peg.4335 Inner membrane component of tripartite multidrug resistance system
MAEKGLKKWIITFTVITASLLELIDTTIVNVAIPQIQGNLGATLEDVAWLSTGYAVANVIVLPMSGWLGSRFGRKNYFLFSIVLFTVASFLCGNATNLEELIAFRILQGLAGGGLISTAQAILIETWPREDVGIATALFGLGAVVGPTVGPTIGGYLLEISTWPLIFYVNIPVGILAAYCTYMFVRETPKDGKGMPVDWWGIVLLAVAVGSLQTVLEKGESEDWFATPYITALAVTSVLGLLLFIWRELSTDHPIVNFKIMRHRSFSVGMFTSFILGFGLYGSVFVFPVFCQNLLGFSPLQTGELLFPGGLCTIVMMPFIGIMLKKNIPAQFMATIGMFLFFVFCSMLSKSTLQSGTNDFFLPLMIRGVGMALLFVPLTTLAIQDLKGAEIGQGSGLNNMMRQLGGSFGIAALTTLIHVRQGFHRSNLLVNINEYNPAFTDRFNGFIQNFMAKGYTYLDAKALATKAIEGTVTKQALLLTYSDAYWVAGLILLCSIPLLYLQKFKKNVAVPADLH
>fig|485918.6.peg.141 Glyoxalase/bleomycin resistance protein/dioxygenase
MKGLKHSIIILVAALTLGSIEKASAQTKAGILGIDHIGVNVPDMSQAVAFFTDVLGFTPVTQIGPIPLNDAWKTANHMQSGTGAVSIKMVHAGSGANIELFYYENNKGAQQQPGGDDAGATHIAFYTTDINAAVAYLKSKNVKMLGEPFHTTMGDTAGETWVYFETPWGAKMELVSYPEGKEYEKNHPKELLWSPKTAVNNLNTITMDTKDLLAIVEQHLLIWNEKDAAKRSAIAQKVYAADIEMVDRHFTATGYDSINEFVNKLQKDNPSARFTHVKAINAHHNIARLFWQFGPKEKPDAVTGMDLFVIENGKVQKLYVFVDEAK
>fig|485918.6.peg.384 Permease of the drug/metabolite transporter (DMT) superfamily
MNNRAIHWSIFLLLSLTWGSSFILMKIGLQALSPYQVASLRLLSAGVALLPFFIKFIRQTPLNKIPMIILSGILGNLLPAYLFCIAETRIDSALAGILNSLVPLMSLLAGFFLFRAPIVKQQLLGICVGLLGVVMLFAVKGVDAGYWYYGLWIVVATICYGLNIALVHHHLKGYSSLQLGSIALFFCAVFALPVLLFSGFFGILSGPAIPWSSLAASVTLGILGSGVASVLFYILINKAGAMFASMVTYALPVVAIGWGLLAGEQISWLQVLCLCIILLSVYTVNKAKR
>fig|485918.6.peg.1763 Outer membrane component of tripartite multidrug resistance system
MSRLRVESSEEALKDAKAERLPEINAAGAYARVTNMPVYEDGLFHTPDQFPVLHNFYKVGGEAYFNIYNGNKTNLEIKKGATEHAIAEEQKNLTVSEVKFNAAVCYLDLARSCRFKELIAKDIEEQERQLVHIQELQKNGVVLKSDVLRATLKLSRQKMGMIQIENDIAIASQKLDLMIGIDEHVLIQPDSSMTTDLAVPGTYDDYLVAAAEHAHEYRISERETALKELSLKQVKANVAPRIGLFAEYNWSYPQIQFYPYGDAVYGLGMYGVKASFPISSFYHNKHKEKAAKLQLERQEVEHKETGDVVRQQVNEAYLRYKEALTRIDVAETNIKQATENLRIVNNTYFNQLSLVTDLLDADTQMLQTKFDLVSANIAARVRYYQLQKVIGNL
>fig|485918.6.peg.1765 Inner membrane component of tripartite multidrug resistance system
MANSTPIFKPWASEWLIRIVIFLNLMPSMLMFGISTASGSNAAGYYGIEPADVQYSMVLFYASLAGFFALERRFFIYIASKEYLLIGVIIQIVTSYGCFVTRDLYVLLPLRFIQGMANCITTSVCITLVFSRLRTNRAREVGYSLFYGVLLGITAFTTLVTAPIIDAFDFNVLYKWMIFTYIPGAILLVIIMNRIRLNRKIPLYQLDWASYVVYTTMLCLIGYILLYGQQYYWLQDERIMAASIAAVVLLLIHIIRQRSLKRPYLSLDVFRYRNYVIGVSLITVLYVCRGAFNITTNYFITVLGLDPRHLSYILLANIAGIILGVLYSSRWILMKRSVRWIWMAGFSLLLIFHLWMHALFATQADVPTFIIPLILQGIGVGLLMAPMIIYTISSVPAHLGGTASATGVLFRFTGFCISIALINYFQLFSRKVHYNRFLDLVTSLDPLVTAKLVNYKTAVAAKGLPADQAAKIANGLLYRSADMQAQIRYSMDYYYLISCALVVIILLIAFVPYLNRTVINLRNNQPAPASY
>fig|485918.6.peg.1959 Acriflavine resistance protein E
MKTKQHILLIGATGLFYLASCKGPAQKAAMVLPPTPVSVVPAVTGTAIYYDKYPATVVALNQVELRAQVSGYITGIFFKEGEVVQKGKPLYEIDRRKYEATYRQAEASIAQAKANLTKAQKDADRYHKLAEQDAIARQTLDNADAALDVSRSQLAAAEASLLSARTDLDYAVIKAPFTGRIGISQVKLGAQIGAGTTLLNTISSENPIAVDFVVNENDIPRFSGMQGKAVTPGDSTFRLQLPNGQAYTEPGRLTVVDRGVDNQTATIKVRIEFNNPKNELKEGMSGVMNVLNDQSGDRVIIPYKAVVEQMGEFFVFVAKDTVAEQRKIHLGPRLRESIVVMDGVKQGELVIAEGIQRLRDGGKIDTTTVKKAPDAAAKK
>fig|485918.6.peg.2478 Inner membrane component of tripartite multidrug resistance system
MSAEVYYLRCIIYPVLIPMEKSASFTGYGFRHACITLIAFICVLVAVMNCTVTNVAFNEIRGNLGVSLDEVSWVTTVYVLAYIAIIPFSNWLSRKLGNKKYLIITLILFIVSSFLCGNATSIEELLILRFLQGLGGGAMLVLSHTMILENWPPQRRTTAQAFFILGMLGGNMLAAPFGGYITDNYTWSYIFYPNILVGILLCILVLVFVENKRYQQREDWLGTIMVSIGASCLYLALTRGQQEEWFKSPFIIVLLLCGLVGLVIFIRRELEWITPQGENGLLRNVSLRNGLILAFVAALGIAASSSTITIPLRWHAQLPKISPWLVIVCIILVMALITILIEEKKALKYILAAGPILLIIYNYMVFQQPVAPKYTTYIYYLLAVRILAVILLSISVSTFVFSKLENKEIGPGVRMYHLVQQLGLALGIALFSAFTYKAPEPDYTRFLGHLDLKDPVVQKAIRESTTSLDQVRAEAFVRQAHDTQVGVVKANFMLMIIAGIILTVLIFSVRQRIKINSKNDSK
>fig|485918.6.peg.2909 Permease of the drug/metabolite transporter (DMT) superfamily
MKKSNTNAYMALVLVSIFWGTTYLASRIGVRHTHGLMLAGVRQTIAGILLTGFFLLRGFKFPEKIILSRLFVIGVMMLCMSNGLITWAMQYIPSGLCAIIVATVPIWITIFSYFLVQRTKFTILLITGMLVGLLGVGGIFYDYLPSLANPEFRFGIFLTLISCISWAIGSVLTARWALKINFLYGAGFQMLFSGIVMTGTAILMGYSLPLDGFNRELWGSIFYLVFFGSILGYSSYVFALNNLPTSLASVYAYINPIVAVLLGWLILQEHLNWTTGLSCLVTLGGVYMVNMAVNRNKKEYGTTKS
>fig|485918.6.peg.3048 Multidrug resistance protein B
MTVYLTHELHFSIEQAGIVMACFGSGAICGSFIGGRLSDRIGFYPVQFWSLLLQGLIFLVLGQMRTLPQFCVCIFILSCVGDAFRPANVAATAYYSTAVNRTRSYSLNRLASNLGWSVGPALGGILAGYSYHLLFWVDGLSCIIAIIIMRVLLPPVKVAPKPPKPVDCVKSNESDSVYKDGVYLAFVLLIVVFTTGFLQLSTMVPLYLKSVVNMQEAHIGMLMGLNGLLVAFFEMVLVYKLEGKMHSLQFITRGVILAGIGYLSFNLLPPVAAAGVVFILLFTAGEMLSIPFMNSFFVMRSSDHNRGQYAGLYTMSFSISSILAPTLGSFMVGHYGFSSWWYCTTALCTLTGIGFYILYKKTADNKEVEILVKS
>fig|485918.6.peg.3384 Drug resistance transporter, EmrB/QacA family
MLRYKKYVLATLMIGTSMAAIDSSIVNVSLPVIQRQFDVGLDDVSLVITAYMITFLLFIPLTNWLKNRVGYYHLYMASIIVFVLGSALCSIAGSIDMLVWSRVIQAVGGGSIAPVSLAILSESFPQDERGSAIGWWGIGNVMGPALGPTLGGVLTEYLGWQAIFYVNIPIGIIAILMNMRYLNFLKSRKRYSEPFDFKGYFLFICFIILLQFTLTSTSDKFGFTSWQFISGVLLTVLSLWLFIRSSRKPSALLDLSVFRVAAFNRAFIIVALRSLALFGGMFFLPFLLQGYLKYTEIQSALLILPNALVMLLTRPLAGKMADAGEIRNISVFGIVLVSASFFLFAQINTGTPVWFIVLSMIVRGLGISFLIAPVSTAMLNAVSPSQTATATSLNSLMLQLGGSVGIAISGSMHTYINDHYLAKGYDTMLAEHYALRDGFLFTAVLMLVTLIPAFKLPHKVERELKHKEALG
>fig|485918.6.peg.3482 Drug resistance transporter, Bcr/CflA family protein
MAKGLQVEESSIQLTLTCFFISYGISQLLVGSLLDSIGRFKPAMYALVAVIITSMLIGFTSNVQLICLLRVIQGIAVSFVVVSKRAFFVDMYSGDKLKNYLSYFTIIWSCGPIIAPFLGGYLQKYFHWQANFWFLAAYALVMLIFELIYSGETIKARKQFDIARVKKDYSMALGNLNFVLGIVTLGLAYSVVMVFNIGGPFVIENGYHFNSIVTGYCTLILGFSWLVGGVIGKRLVAVDFVRKITVASATQLLLIVILMFIGFGYPALWCFMLFAFVIHICSGFLYNVHFTQSMLYFPEHAAMASGLLGGSVYVITSFSSFILSKAGKMGHQQDITLRYLVVSAILSAVVWYAVKRRRTLRKVNTAIAA
>fig|485918.6.peg.3966 Permease of the drug/metabolite transporter (DMT) superfamily
MLRNSGLIFSALCGISLPFMLIHVKTDTVQDKPDNTKLWLFLFAVYIIWGSTYLGMKIATEVVPPFLLSAFRFLAAGTILGLISRGSERQWPTKQQVGSAAFVGLMLIGIGNSCTALAVHYMPSGLVALIVAAIPVWFVGFDWAFFSKQRPTIMTFTGILVGLVGLFLLFNPFGADHQSRPYPLWPIAVLAGGCACWALGSLSVSKLSMPAPMTSAALQMLTGSVFCFIVSSVMEPGAWNTLAHLSTRTISAYLYLVFIGSLVGFTSYSWLTRNAPPGLLSTYAYVNPVVALFLGWAIGHENLTSQALMACGIVIGGVVLMTLGKRKG
>fig|485918.6.peg.4102 Permease of the drug/metabolite transporter (DMT) superfamily
MKKYILFVLTGAASYGMLSSFAKTAYREGYNAAEITFAQAAIGALLLWMPVLVKRIRERQAPSLANWRLLLAGMGIGISTYTYYLAVQYIPASLAIILLMQMTWMSTFMEWLLFKRKPLTIELYVTAVILAGTVLAGNLLQVGTFEFSLIGIAYGLLSALTYAIAVICTSRLGTKVPMFEKSAMMITGSAAIIFMINFNSLRLSEHFDGRLLQWGTFLALFGTVIPPVLFTKGMPKIGAGLSAILVTMELPVAVLCAHFILKEEVNSLQILGILLMLGAIIYLNIYKEKKPVQEFAEL
>fig|485918.6.peg.5218 Multidrug resistance transporter, Bcr/CflA family
MQNKQHTIIILILGLLIALSPFSIDMYLPAFPAIASALKTDIAHVGYSLTSYYAGLCAGQLIYGILIDRLGRKKPLYAGLLIYLTAAFACAFSLNINMLVAVRLFMALGGCVGMVTARAIVRDLFPPKDTARVLSLLVLVMGIAPIIAPTIGSIVNTIAGWRWLFGVMALIALALLIATYTLLPETKTPDPDVSLRIKDVLPEYIAVLKNPAFLVYTLAGGISYAGLYAYIAGSPFVFMTRFGFSDTAYSWAFAFNACGLISGSQINRLLLNRYDSIHISFYAAILLFITGLLLLISTALGIAGAPMTLCFTFLFLFCLGFLNPNTTALALRPFTAAAGRASAVLGSIQMIAGVIASWTVNFFFNGTANVMAAVMFGCTALTLFLLVFFTGRRRTKQDLQPA
>fig|485918.6.peg.5230 Outer membrane component of tripartite multidrug resistance system
MRKVIIISLLSLAGLQSYAQEVSSDLKELINKSFTYFPRFSELEQSVKTEEERVTLAKANGLPNLTCSAGYRYSHPVSEMTIPINGQLSTFKIMPNSNYNTGLNASYVLWDFGVVKANVESAKRAVQYAKDNIEYNRAQMAYQVAVIYYQIVYLQKAIAIQDSVLAFLKANKEDTEIKLKHGDALRYDVLSIQSTIDQENNTRIDLENSLLKQYNLLQYSTGSTAANGKDFDFMQANENKQEALNIAQQHNPEYTLLKDRISQSEAGLDISKKAGLPSLSLSASTGFANGYMPDLNQFRYNYAGGVTLSVPIYQGARARRQRSLAQSQLKEANLGMQTLNNTVQNDIKQAYTDIESNQSRLVNAMEQVEEAKEAQKLAQSRYRNGTGTNLELTNASTNVQRAERSTLQYTYQLCLARLELARVLGTKYW
>fig|485918.6.peg.5232 Membrane fusion component of tripartite multidrug resistance system
MTQEKTQPSKGPVKFIVLGVAGIAILYFGGKKIMHAYTHESTDNAQIESNAIPVVSRVGGYIDTFALQDYQSVKGGQLLLTIDDKEYKIAVQQAEADLSAAKADLIFAEAQITNIGSDKNVADAGVSVEQVNLEKATRDLARDQALFNDGSITQHQLDNSQSAYKVALSQLESSRKRVSQVVTQHGTANAQIEKAKANVALKEAALESAKLKLSYTQVIAPVAGRIGKTNLQKGQLVQAGQQLFSVVNNERYWIVANFKETQLEKMKIGQVVKVEVDGYPDKEISGKIVAFSDATGAKFSLLPPDNATGNFVKVTQRVPVKIEIDRAEELKSILKAGLSVTVDVQVD
>fig|485918.6.peg.6005 Glyoxalase/bleomycin resistance protein/dioxygenase
MANTEHPTLGHGKICYIEMPAIDVNASATFYEKTFGWTIRTRGDGSVAFDDGVMEVSGTFIEGLPPHNGEGLTIHIMIDDMDSILEKITANGGVITVGVGAHPGELTAKFRDPAGNIMSVYQQRG
>fig|485918.6.peg.6024 Outer membrane component of tripartite multidrug resistance system
MRIKHTNTGYSCLLLSCLSAAILLMHITIANGQTANNNTYKISLNEAVEFAKIQNKLVQAANFEETAMSEDKKDVYKAVLPDIRVNGSYQRFSGLTLFNDGLRHANTEARRPTSTSAALGIEALFNIYSGGKQKALQREYTFREKLEQLNTKDQSGIIAYQTAAQYLELVRLNEQEKFIHEQVKRAAVRVKDIHALYDNQKVTRSDVLRAEVNLSNVRLSLEQNENDIAIANQKLVVLMNVPDAIHIIPLDSAGMLKPDIHSLLPIADAAETSSYSVLKAAKNVEIQKEKVKGVRSNNKPNLSFYSGYGINYPNYLFFPPVDQAYAIGFAGLKAQYSISSVYHNKSRIAAAKLRVKELELRQQASADNIRSEAKAYYAKYAEALSRITVNEHSVQQTEVNYRIVNNKYLNQLALLTDLLDADNLYQESQFNLVKAQTEALVIYYRLLYTSGNL
>fig|485918.6.peg.6025 Membrane fusion component of tripartite multidrug resistance system
MVKEGDTLVILDDREYRAQLQVAEAATEDAHAQLTVLTANIAAAVTSTRVNQDQIKGAAAKYVQQQLDIKRYTNLVKEEAATGAELEQVKARYDVAESDYSAARNSLKTNEARIAELRTHFALLQADIKRKKAALELARLNLSYTVIRAPYSGRLGRKNILEGQQIQPGQPLVSIINEKQKWITANYKETQVADMYVGQSVEIRVDAIDGKVFPGRIMAIAGSTGARFSLLPPDNSTGNFVKIIQRVPVKIAFEGPGTGNVVAGMNVTVAVKKRA
>fig|485918.6.peg.6026 Inner membrane component of tripartite multidrug resistance system
MKPAYFKPWVQDWDWGIRIALLLLLLSSLMQLGVFALTGSYIIAYLGAQPEDISFCLLSTYAGIVASIPMQFRFIRHFEIRNYLATNVILAMLLNWLCVGCQDINLLLFIRFLQGVLTGGICVSTLILIFSRVPSHRAQLMGAAVFYPTILGNIIVAALIAAIFIDLSEWKASYYCLMAIQLLTLLIVITMLQRHSGHRKIPLYQIDWAGFILFAFSLLTLAYTFIYGSKYYWFNDKRICYSSCMAGIGTILFLYRQSLLKRPLIHPGVFKSLYFLTGLCLLGLYYGGKDSINLVYNYAFSTLKWTPLQVATLGFCNIAGVVSFAIFSTRLIMFRKHHFQVFLVTGFSLMALFNLWMWYIMTPDLSFTDLLFPIFIQGAASGLLFVPIIIYILTSAPGFSGTSGIVLAACTRFTATLQSIAGLYNLQLYHNQYFKESFLSSLTADNPTTTSRLNIYQSLYTSKGFSTEQGSYIAKTIIWQNLGQQSQLLTNRAVFMTFALLMLAIAILSLIIPAISKTWNYWSRCYSTK
>fig|488538.3.peg.3 Permease of the drug/metabolite transporter (DMT) superfamily
MGVGLLLHGLYLGGVFYAIKQGVPAGISAVIVGLQPILISVLERVFLPQPARAQPYNSAHYRSQYIGLIAGFIGITLVVTGNGISGSGISGNGIAGLGLPDMSIIGLIANVIALFGISVGTIIQKRIGRDVPLLSGSLYQYLGATVMMLILTFTLETQAVTPTIELALALLWLVFGLSILAVILLMYMIREGEVVKVTSYFYLVPPVTLIQTWWLFDEQLNAVALVGCALTVFGVYKVVRAPSAPA
>fig|488538.3.peg.348 Acriflavin resistance protein D
MGGLIKAAIERPVAVLALVLLAVLFGIVAIRDIPIQMSPDIEKPILEVRVNWPGASPEDIDREVVTRLEGELASLNGVEELQSRSSFGRTRITLTYNVKQDMDKALVLLLSRLSAVNDLPDDAQTPRVRTSNSDDSPIARLALVAKDDNEVNLETLGAFLETNIVDPLGRIEGVAEVGFNGGGRPEMRVIIDPDKLIQYKLTLTEVITALRSSSSMMSVGVITEGKRTYAVRTESENYTPDTAGRIVLRTDVSSSGTIVPILLSDVASVDLRVQKRTSFRRLNGKEAIIINALREQGTNVVTTMQRLREEIAVLNKTELSPRGLELNLVYDETKYIESAIDLVQQNIWIGGVLALFILLLFLRSLLPAAIIFAAIPVSIIGTFVAIAGLGLSINVISLAGLAFAVGMVVDASIVSLENIFRLRQRGMKAQNAAFLGARQVWAPILGSALTTVLVFVPILMLDLPVGQLFRDIAIAISVAVLISVVVSVTVIPALASRLLAGAGDKYERLFPIPGIDHAARFFSNLILRYVRVTVKRGYVGALVVVAILLSAGFASYRFAPQLDYLPDGNANFAFGRIIVPEGYSIDETLRIAEKMEAAARPLWEGNTEPGGPPAIERFFFVAYSGGAFAGASSVDPSRVSDLRMVLMRPIFDVPGARAFVRQASLFGRSVGGSRSIRVDISGNNRDDIMPIALALNNALEAKFTRREGNQLRAIPSLSSGAPQIRITPDLTALARAGVTVRELSAAVDIFNDGANVIEVPIEGELIDMVLSGKEAQNMSADALNTIPIVTRSGNIIRLEQLAKIDIVSAPGNINRLGGKQSLSLQLRPNESITLEDAVQQIETEILPKINDMARDAGVSISLRGAASAMDQTWKAMQSNVATAIVVIFLLMVILLRSFVMPLIILLAIPVAAAGGIGGLALLNLFVRQPLDMLTMLGFVILTGVVVNNAILLIEQTVLHLREEGMSPTDAILEATRNRIRPIFMSTLTSLFGLVPLVIFPGAGSELYRGIGVVVFGGLALSTLATLLIVPPLLGIALQTRLGRNTGQKIVIDV
>fig|488538.3.peg.1570 Permease of the drug/metabolite transporter (DMT) superfamily
MSEQKRNVALLILLALVWSSSFSAIKLAVVETGPLTLVGLRTLIGFFVVLLFIQFQADFVWRPYLRHLPYLFVMSVVGMSLPFYLISDAELVLDSSLTGLLMSVGPLLTIIGAHFFAEDERMTVSKIIGVLIGLSGVMILFGHAAMNAGGAHIIPQILVCCATGCYVSAALMARRLPQVPALFIALVIMGFVTIQILPLAFMFEQPLAWQGWSSNAWLAIIWLGALPTGFAFFLRYHLIKRAGAGFTSFIGYLIPVFSVFLGALLLGESLGLDKFIALGLILTGLAVAQRTAQT
>fig|488538.3.peg.2093 Permease of the drug/metabolite transporter (DMT) superfamily
MTNKDWLRIVTLGVLWGSSFLYAEILLRYLNPLMIVFLRVSLAGLILLLICLIKRMPIQLTGTDLFTIGVMGALNNVIPFSLIVWGQQTTTGGLASIINASTAFFSILLAALFIPQERLTWNRVGGVLIGVTGVAMAVGPANILQFSGSDSGKYMILLATISYAIAGVWAKMRMQNLPSMISATGMLVASAMMMVPLLFVTDTFQIAPIDLYVFFIAFQFAVICSVLAYLLYFKILETMGAGNLLICTIIVPPSAILLEVLVLDEVIGLNELAGLAIVTAGMIVLDGRLLPRR
>fig|490899.4.peg.9 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRVAGVVSLVVATILWGSSFSFIKLSVTDVSPLTYSSLRSFIAVILLTPIILLKMYRGVLSINSLYKGFIVGIAYFLGLFLQAAGTVYTTPSLSAFITGLNSVHVHLYIALVERNYGLIDGIALLLALSGLYVLTSPSGGLTIGVLLIFIGSIAWAAQIILVSRYGSSSIIEILYGMFLPGALTYPFALILGGAVGIEALIYITYLAVACSVLATFFQVWGQRYVSPLTAALIFLLEPVFALLFSLAMGLEGIEPYKVIGGGLIVIATYLSSMAELSSNWLK
>fig|490899.4.peg.982 Daunorubicin resistance ABC transporter, inner membrane subunit B
MFFLSDLRDLIHIIEWDLERLKTQKVFVAMRLSWFVIQVFIFARAISLIVRQLTGINYYEFYLLGVYVSILYSTSISRGYVIADEFDDGIVEYHLSLPIKRNIFVLGRILGCSLAALLFTLPMMLIVLIAVNALNLTGLLVSMIMAYIFSIGVVGLVILVVVNVKSTDATDILFGTIDAILVRLSSIFYPLPIIQAIGMAPYYYAALFNPLTSIADFIRLLFIPEFTLYTVSPYALVLYILGFSIGMIVLAMEHYTKKLEAGGWK
>fig|490899.4.peg.983 Daunorubicin resistance ABC transporter ATPase subunit
MSGIHAVEIRSFTKKFGDFTAVDDLNLDIYEGEIFGLLGPNGSGKTTTLLTIATIYKPTSGDIYVYGHSVTREDYAVRKITGIAFQDPKALWVDKPYDLLMWHAKVVGYSGEEARKVVREVMETLGLWEHRNKYFYQLSGGTRKKVELAKVLIQKPRLAILDEPTAQVDVLAKHALWNIIEGLKKEGTTVIIATNDMFEAERVCERIAIIYKGRLRALGTISELKDMIPGGDVVEIQVNNDKLPNNIVERLNEYGRVEFKNRVLRVYLEKGEEKVVDIVDLLKKNNITVSRLMIKEPTLDDVFTYLTGASLRGEG
>fig|491915.4.peg.1458 Permease of the drug/metabolite transporter (DMT) superfamily
MLTKNIKTYILLFLAATIWGGAFVAGKIATTTLHPVSVAFFRFFGASLILFPLLYWKEPNRPTPTRKDWIVLALLGLTGVFLYNIFFFIATKYAPIVKSSLVIAVNAPLITLLSALFLKEKLNGRSIFGMLLAVFGAVYIITNGHPSVLIEIGVAPIDLVLVGACLSWSTYSVIGKVAMKTYSPLAATTYATGFGTLFLAPFALYYTSFTSVKMSGWDVWLSVLYVAVVVSAISFVWWYNGIQKVGASTASVFINVMPISATVMGTIFFNEHLSMTHIVGAAFVFSGILFNIYSKQEKAMFPLIKKGANI
>fig|498211.3.peg.394 Permease of the drug/metabolite transporter (DMT) superfamily
MSHTSSRLSPEGILLLLGIGFGWGLNWPIMKYIISEIPPLSFRGFCLLLGGLGILALARIGGHSLRIPRAYWGKIFWVCLFNILAWNIMATFGLSLLPAGRSALLGYTMPLWTVLLSVLILKDSFSVRIGLALVLGLGGIFALLSDSLLSWFGGPLNSSLLLGAGLMVGAAWGWALGTVLLKRWKIPLHSVVLTGWLLLLASLPTLVAAAWFDGIPHSMPDQWALWGVVYNVFIGFMFCYWAWVRLVELVPVSVSSLSSLITPLIGVASSIILLGEEPGWPEISATLLILGAVAVVNWKPGNAKQKY
>fig|498211.3.peg.748 Permease of the drug/metabolite transporter (DMT) superfamily
MRRATRSFAVTTFFAYFTVVLIWATTPLAIQWSGDSLSFMAAVIARMSIALALALLIHAVWRHRLYFARDNAAIYFAASIGIFPNMPVVYWAAQFIPSGLVAVIFAMSPFATGLLSMLLLRHNPFTPKRVLALLLAVSGLVIIFWHQIRFDRASIYGIGGILLSCFLFSFSSVWVKKLSSHLSVPIGAFQQATGALLFSLPGLLLFWWVMDFGVADVGLPVTISVKSACAVLYLALIGSLLGSMLFFLILQRLSASIVSLITLITPVLAILIGRWIANEVLTLETLVGVAVVLLALLLYIPWSLMSVVRHGRCWLSACFFRRLAKGALSDSHHPETGLEAIRDDMIRYK
>fig|498211.3.peg.925 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSHKSAWISLHLTAFLMGATGLFSKIIALPAWDITGYRTWIAALVLFAWVAWRERHIRLNSGRDYWRMLVLGILLALHWVSFFYSMQVANIAVGMLSLYAYPVVTVFLEPWIKRTRLDWRDVVSGFLVVIGIYCLVPEFDISNNMTQGVIWGVISALTFAVRNLLLSHWFSGQSASRSMSYQVLIVALVMTPVIWLSPHQPTSQDWWLLILLGVFFTAITHSLLGHSLRYLKAKTVGLVTCLQPVYAVGYEIVILNEYPDQATLIGGAIIIGAAIYESVREHRRG
>fig|498211.3.peg.1033 Permease of the drug/metabolite transporter (DMT) superfamily
MTRLPEVFCGAPMQVSPSKSGYFFVAGTILIWSGFVLVARMGGTSVLNAFDITALRFGVAAIVLLPLWLFWKPVPLLNKTMLSLALTGGIGYSLVVYSAFKYAPAAHGAVLISGLLPFFVPLMAYAFLKEPLRRHLYLALPVIAIGIICLGIDIFSRSENTLPGDLLMITSSLIWAAYTILAKRSGLGPWEMAIGGALLSAMIFLPIYLLLLPKAIGLASTNDILVQGIYQGIIVVIIAMLFYMAAITRLGPARTGACMALVPAIAGIGASLILGETLNAWLIAGLLATSTGAWLGAR
>fig|498211.3.peg.2149 Multidrug resistance ABC transporter ATP-binding and permease protein
MKNLWRVIQFIPEYRGRVAGVILVGTFLGFIGTATPYIYKGIVDVISQLFSGKITLDSATASVIWLLLGFFALRLGVVLFGALQNKQADDLWLDTVSTFRQRVFDNMTQKSIDYFEKTRVGEIMDRFGNITTITMWLSSLTEGTLANILQMFFILVVLTLKVPVVGLMMTGILLFNFWISYRTIGWTKPHRRGWQEFAGRMTGLLAEMVGNIATVRSFGGEPAVKQRYDDTQAQWKVARDNLHKTQWRSEQALNVVNTFGVFIAVAIITHGALHGRFTTGDILLVLTLTQTLITSISPISRQINQASEIESASERLVELLDVASEQADKPDAIPLTQLKSITFADVSFRYPGTEEYALKRISFHLDAGETLALVGSSGSGKTTIVKLLMRFYEPTKGVILINGRDLRDYQQRSVRAIMGVVLQDVALFNDSIGENIAFAKPGASELDIKAAAEAANAHQFIARMEKGYETMVGERGIKLSGGEKQRVAISRAILKNPQLIILDEATSALDSESEYLVQQGLEKLMSERTSIVIAHRLSTVMNATNILVLRNGEILESGTHAELANKPGGLYAHLFALQTQGRKPLVGIS
>fig|498211.3.peg.2214 Multidrug resistance ABC transporter ATP-binding and permease protein
MFMTMPASPSPLSSSLLNDQPAGRFPGGGGRLGTPDQDGVNLDDDIFIRFDSGIMGRLWGYIRPYRLPLTGCMLAVVLYALVQVAIPLAIRGVVDNAAETAALSTVLPLSTALPFALAIFAVLVLLNFAFNFLQEWGTARIAQRVIFNLRRAMFAHLQQVSLGLLDQTQVGRLMARLQGDVNALQEFMESSISALGDLCLLLGIVVVLLVLDWQLGLLTLAVLPVLVLIRLVWLPWARRQFRRAREASSRVNSALAENINGIRTVQENRRESFNFNRYEPIARENLDAQLGSSRASQIMVPSVDILTGFAMAIVVVAGGVAVLHSRVEVGVMVAYLFYVQRFFDPIRTLSMQYTVLQRAMAAAYRIFEVLDLPVTLQDKPNARVLDNPVPDIEFRAVTFGYKPNQPVLHNISFHIAPYTTAALVGPTGSGKTSITALLHRFYDVWQGQVLIDGQDVRDLTQDSLGHVIGMVLQEPFLFSGSIMDNLRYGSTNASDEEVIAAAKAVRAHDFIERLPQGYQTPLGQRGRNLSIGQRQLLSFARTLLMNPRILILDEATANIDSFTEAEIQRALRVLCAGRTSIIIAHRLATIRAADQILVLNHGRLVEQGNHQQLMQQGGLYYQLNTSNQSSFDELAD
>fig|498217.4.peg.1861 Permease of the drug/metabolite transporter (DMT) superfamily
MLRVALFPVLLLFWQYVFGTDLPLLAPAMCAVFLTTTHNPPPLIMVFLMAVVLYLTSWVQAWLATLLLDYPQVYYLALLGIFYWCMDRTRKNAQDLVAILLIVATAMIAVFVKQKAISVDQIPLALLKNIFVAGFTAYLAYFIFPGGEPLTDACAAANSASTRPHRRWHTLFKAALVLTILCTGISLDLEQSTIITIVVALIIKDSNPALGHNYGIRRLLTTYASVLYAVPPLIMCVLQTNLIGQLGVTVVCALFMGIHAVKKKASYNSIQLLYSSYVVLVFYSITSTSIDAFSDGLIRFSSVMLAVALGVMALIIMQPAPSAEPEIR
>fig|498217.4.peg.2135 Multiple antibiotic resistance protein MarA
MYNTDFISALRTWIDSNVAAISSLDDVAARAGYSKWHLQRMFKAHTGVRLGEYIRNKKLDESARRLKVCQGSILDIALSMGFDSQRSFTRSFKRRFDVTPGVWKKEVTAGKPLDRAA
>fig|498217.4.peg.2337 Permease of the drug/metabolite transporter (DMT) superfamily
MGLKDTLLALLVVAIWGVGFVVMQTGLQHLPPLLLGGLRCLLLALPAVFLLPRPALPAHTLILYGLLIGFGQFAFLFFALQGGLSAGVAAMLLQLQLLFTLLLGALLFGERIRTSQIIALLFVLTGLALLLHPGLTGLPLSRGVILLALGAALCLALGNLIQRLRIRDNIQGSLPALIAWAALAPIIPFFLAAWLFNGAQATLTSLRTLDFSALLALIYLAYIATHLAYAIWGRLLLRNRATHLMPFTLLIPLVALGADLLTYGDRLSPAQLYSLLLILLGLALAVLGNRLVDFRLVRH
>fig|498217.4.peg.2646 Multiple antibiotic resistance (MarC)-related proteins
METWLIHFLLTYVTFLSMFCPPATITAATILLGQTPPHTLRQLAWKVALEYVAVMLVAIWIGNYLLMALGLNAHALTATGGAALLFQGWPLMTKGTKAEPARMVVTPDARPNVQDMVLVPLLFPLTIGGGTIAVGISLASHDGSLAGLLQLSAVILLMAPTIALTFLAVGPLHGRLSSGAIDAMARIAGIVLVTLSLQLLASGLTQLVLQYGLAK
>fig|498761.3.peg.128 Vancomycin B-type resistance protein VanW
MNLIARRAALCAAMVAGALTLQGLQSATLTGTEACAPADSTAQAQPQWQPQPAVKTPKAGTITFLIGKERFTFVPGQGADYLEPGKWSYLPTLDLETARQTAVLFADALPKDLRLRDGGLDRITSAILEGEDATVAVPSWVIAAEIVIPLTYVSYNGGRNASTALDYLDGYVLKANETFSFNEVVGPRSAERGFITGMSLIDNRFVQEQGGGICFASTIVHQAVSRTDVEIVEQNHHSRPVAYVPRGGDATVYYGELDYRFRNGDALLAFEKLQRPNGLGLRLWKSMH
>fig|498761.3.peg.189 
MKKKIAKIAGAVLLLSALGYAGYSYVDSVRYVTTDDARIDADIIKVGPEIAGRVMEIRVKEGDQVQAGETMVRLEEKNTTLQNRDAALVRAPGTGMVIKKNVNDGELVSPGQRLFLLADFRNLYVSARIEETKIHRLAVGEPVTLTVDAFPGRKLQGVVEQVGFAADSVFSLLPSSNVSGNFIKVTQRIPIKIKILDDQGLRILPGMNVIAKIATGG
>fig|498761.3.peg.190 
MKAKKLIVFIIGSYLLATALISAYYGYEHLYFVRTDDAKVAVDLAVARAPIAGRITDLKIRENETVAKDDIVAVVEGSPAPNQPKLRAPVFVPSSGQVLRLEAREGEAVTAGQPLAAVADRAAAYVEARFAEVDSSRIRVGQTVEVKLDGAAGQVFTGIVSSINRNTEQITWPIIPLTPAQQHPREDQLLSVNIEVPGAPLILGTGAAVKIRVKE
>fig|498761.3.peg.191 Membrane component of multidrug resistance system
MTSRENGHPGVLVVTMVVVIGTFMAVLDTSILNVALPKLMVLFSVDTKEIQWILTAYMLVSGAVIPIMSYLGDTYGYRSLYAYCLAAFTAGSLLCGLAWNNESLIVFRVIQALGGGLIQPASMALMFRFVPKEKMGMAMGLFGLSIAVAPSIGPSLGGFIVEDFSWRWLFMINVPLGVLGFVLCQTLLPETEKIPSAHFDFWGLLLSSGSAFLYLLALDKGQDWGWSSYTVVMLLLTATAMAALLVVVELNHTHPMLDLRLFKIPQFTYSVVISSCLYIILISGVLLWPIYLQNIRGYSAVQTGLILMPQAIAMGLMMPVAGKLYDKIGARPIVMVGLPLIGVSTYLMHTLTVDTPQSVFNLWLILRGLGLGLTFMPVNTAGVSAVPLMKAGAASTLNNLVRAVAGSFGIAITTSMLENRQAFHAHRLVEGLDLFSPSWTMMQQSADGILGATGDRSPLQPTTLTLMYGQIQLHSNTWAMADVFFVFALLVILVIPMALLLKKRGGKLGGPPVVAE
>fig|498761.3.peg.857 Permease of the drug/metabolite transporter (DMT) superfamily
MFRVNLWANLAMLVTVLFWGISFISIKIAVTEVPPVTLALLRFVIASAILWGALRLSEPGAKLEKADRLRMLLAGALGVTFYFYFENSGVKLTTAANASLITSIVPVLSIMLDIVIYKTRVSVIQWMAIAASLVGTYLSVTANGQMDLSSDTFVGNLLVLGAMLCWAGYTLMSKSLARYSGLALTTYQTLLGTLLLVPLSLLEREQWEFFSLTAFYHTLFLALCCSALCYFLYMYALQRLDVTITTLYLNVVPVVGVLCGYLLLDERVLPVQIAGGAMVILSIFLVNWEKGRSQTESAVAEVQHGLGEQQKA
>fig|498761.3.peg.1279 Permease of the drug/metabolite transporter (DMT) superfamily
MQQQRTSRVSPLTADLILLSVAAVWGGTFVAVKEAIAFMPPYTFLAIRFFIAGLFLAAIAGRRWQRLTGAAVRHSFMLGACLFGGYALQTIGLQYTTSSHAGFITGMSVVLVPLVGWLVHKQAPRSGVLAGVAMAVTGLGLLTLTDDLTVNPGDLLVLGCAFCFGLHIFLVGQVTHRHDPMLLSIMQIIAVGIACTAFSCFFDPPLAYDQFRSEVWTALALTAIPATSLAFLAQMYFQKFTTATRTALIFATEPVFALLFGIALAGETLTLRGAFGGILVMAGIVVAEMVGAGESEEVEQDAACDGVDGRAA
>fig|498761.3.peg.1770 Permease of the drug/metabolite transporter (DMT) superfamily
MWLFIAVISAVVFGLAGFGMKVGQMQGVPSSMVLIGLYLSGTLGFLLTWLGGGAAAGMLILLAGLVIGLGSAGGNFAFMRALETGPASLASPIVNMNVVLVILLSVLVYGETLGWVKAAGVFCIVVAIILIGLRPGGAGGAGGSLRWLALVLLSTLLFAVRNGGLKVTQEMGLDNSAVLFFSYLFPLIYFIFRHREELSAITPKKRLSTLGWGLASGVGSFGGLQLYAYALSQGPASVISPVFSLYGLVIVLLSVWIYKERLTALQSLAVALTFAGLVLVRF
>fig|499177.3.peg.1090 Vancomycin B-type resistance protein VanW
MKKVGIILVISFILIATSAAMYLNSLTQDNFIYPGISINGVDVSGLTVTQAKEVLQDRAKVGKVSFTHNEKKWNYDLKELGFEYDYDSSIDEAFKIGRSDNILENWITVLKLNNNKQINLELSRTDKYENFDEIFSKIKSEVDRQAVDADISINTAISITPEQDGYEVDIDKLKNLLITELKDKNEDIIIEVPVKVTQASVKREQLSSINGIIGEFTTTFNAKVAGRSTNIRLASSKVDSVLLMPGQEFSFNNATGKITLAAGYKNAPVIVKGELQEGVGGGVCQVSTTLYNSVLYAGLDVVQRRAHSIPSSYVSIGRDAAVAYGSLDFVFRNSHDYPVYIKAFVSGNKVTARIYGDTTKHKNKTLSSQVVEQIPRQVKYVNDPTLPLGKEVIDDPGRDGIKSVTYENVDGQTKVVSRDHYPAKTKVIKVGTGPAEAPAVNLNPEAINESVNTQNQENTIIDSIFGGR
>fig|499177.3.peg.1606 Permease of the drug/metabolite transporter (DMT) superfamily
MNKSKAIGLILLIITVVMWGISFISIKISMDVFPPLSLAFYRFVIASIILFPIMKYAAPKEKLLKKDIPLMATAGIIGITIYFFFENNGILRISASAASVIIAFMPVVAAFGEIFFLKKIPKLTALFAVALSILGVYLVIGGDLSSGGSLLGYLYMLGAAISFSIYLIITKPLFDTYSDVTVSFYQSLFGCLAFIPFLGFEKVNWSQLNPEISMHFIFLAVFCSGIATYFYMFALNNLGVTISAVFMNLIPVVTFIVSYFWYEEIPSSIQLLGAAIVIISVSIVTLSEKNKEINN
>fig|499177.3.peg.1863 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNQDLESKKIPALLFQLSLPAITSMLISAVYNIVDRIFVEKISPLALSGVGITMPIQILQMAFVLLIGIGSSTLISIKLGEKKPHEAEVILHQAYKYIMIAMAIFSVIIIVFMNPILNILKVSSDVYPYAKDYIFIMVIGSIFGLPGFCLNNSLRAIGKASVSMKIVVSSALLNIILDPLFIFTFNMGIKGAALATVISQTYVTVLVFWLFAKSKNFPINLKFAMPVEKSFFKEIIENGAPSFYMQIFATFVNIIFNRSVVEYGNDLYLAAMTIVQAIYSFYHMVVVGIIQGAQPINGYNFGAKRYDRVRETLILTLGSSFIISISIFAIIQFYPSLLSGIFTSDKELLKLTNYSMKLYLFMLPLIGLHTVSSQYFQAVSKPKKASILSLLRYGMILIPLLFILPRFWGIQGVFISNVISDFIASSVAIFFISKELYYLKSNL
>fig|499177.3.peg.1994 Glyoxalase/bleomycin resistance protein/dioxygenase
MTYNRLIPEITVTSIKESLSFYCDVLGFEKTYEGEDKDFSFISFYGSQLLLQENSNEAWKKYELEYPFGRGVNFSIETDDIDKLVSNLEKANISLLCPLEERWYKKDDMEHGEKHFIVMDPDGYILRFMQDLGQKTI
>fig|499177.3.peg.2445 Quinolone resistance protein
MNTKKDIVKVAKPKLMRFMEEINSEAIDIEDEYEMNNISFSDCEIRTKTADKLKVDGVIFSKMDFKDIFLKSLELTDVRFENCDLSNADFSGAVIHRAEFINCKLMGLNLNEASLNHLTINQCNCKFILMNYVKMKNIIISDCIFESSYIQESKLDKVEFRNCNFKQSQLSGTSLSGVDLSDSEFEGAGFRAEDLKGAIVSATQAVDFSKIFGLKVKG
>fig|499177.3.peg.2518 Permease of the drug/metabolite transporter (DMT) superfamily
MHLNNLSTEELKKRRLYSNLALFLVAFLWGTTFAVSKYAFAYFTPVYMIAFRFTIGVLAMCIFFWKKISKITLKDLKGGIIVGIIFFIAFVTQLIALQYTEAGKQAFLAATYVVMAPFLYWIIYHKKPDFRTLAGAFICFLGIGLLTLNASLSISFGDGLTLFSSLFYALHIMFNGYFVEKQDPVILSTVQFAVVAIISWIFAFFFEPFPTAIGFEGIASVLYLGIFCTGLAYFLQTAAQRYTLATHAAIILSLESVFGILLAVVMLGEIFTLRMLMGCIAIFGAILITELRPSSD
>fig|500635.8.peg.777 Permease of the drug/metabolite transporter (DMT) superfamily
MTITAMRYYLIGTTLLALSVYRGEHLLPPRDCVLGLILMGATGIGLNNVMQFTGLAISTVTNCTLIAAASPAITAFMAVIFVRERLSLLAWGGIVLSFLGALLVISHGSLAVIETTSFNEGDILFLLAQVAWTTYSLIALKIMRRMSALQTTGWAGLFGAFIVTGYGLATGQFAPIMLTPSLWVAFLYTVIFGGIMAMLFWNIGVHNAGASVTSIFQNITPVVGMIGGVLCFGEIIGIEELLGAAAIFAGVYLTTHSGLR
>fig|500635.8.peg.783 Permease of the drug/metabolite transporter (DMT) superfamily
MAKALCLIYLIWGMNWVVMKTANTFFPPITFVAYRFLFGALVLLSVWFWLHLPLPKKKYWPWIFLTGILQMGLNNIAAQTSMLTLGAGMVSVLNYSMPVFAAVMAHFLLGERLTWRKGAGIVLAIAGMAVLMDVHAGGDATAICIGLLSAVFWGLASIFVKLKLSDVNPISLTTWQMVCASLSLLVYTAIVPQGEVVWNAESVLCLIYNGVLASALAFFLWSWILQHIEVSKASVAVLAVPVVGVVGGILCLGEPMTLHIFFGMIMIMAGIYIVVTHKRQPA
>fig|500635.8.peg.1167 Acriflavin resistance protein
MNMTRLSIKRPVGISMIVAFFVVLGLYSYYRIGVELLPALNTPYVTVSVKYPGASAESVEQEVVKPVEDALASVSGVKKITSTASYERARVTLELDFSTDADTAAIDASKKVEAIANKLPDEADSPVVIKRDMNAKPVVELAVLSNHSLADTYTATDNVFTEVLQQAGGVSEVELHGGRDKEVAIDVDREKMAAYKLTLAKIASAIKNENQLVPSGSVFTETTKSDVRVVAQFQKPSDIEKIQVQNTAGKMIPLTAVAQVREREARTVRYGRLNGEDAINVLIYKNSDANVVETADNIMKSVEKLRKTYPDYQFVVVSNDADYVRDSLHSTMNTLIEGLITTGFVLFLFLRGWRSTAAVMIAIPTSLISTFFVMYLAGFTFNMMSLMGMTLCVGILVDDSIVVLENIVRHLKMGEAPDTAAEKGRTEIGMAAIAITLCDAAVFMPIAFMQGMTGQYFRQFGLTIVFAGLFSLFVSFTLTPMLASRFFRKGYHPGTNRAFAFMDRVEERAQRLYVEILNWSLRHTKKLLVSILAVFVAVVALVPLGFVGMEYMPQTDESSFTINIQAPVGSSPEETNRVAERIEGKLAELPEVKYYMTQAGGSTAYEGRIKVQLVDRRERSRTVWQVANDVRKFAATIKTADVRVSETQTNVAGIAGGGRAKNGGGALQIELRSNDGAALDDAAEKAMNTLRAIDGVTDVNSSYVEGMPELRLTVDRQKLKAYGTSLQDVDTAFASAISGLSAGELKSDPNNGGQDTDIKVRFKDADSYKASDAARVPLSASGKLIYLGDVATIQNGRGPVTIRRVDKQRSVAIGANLSGRPMGAVTSDVKKAFATADLGPNVTYQFKGQATRMNETFSELLSALFLALVLIYMLLAVLYESTITPFIRMFSLPLGLIGSILLLFITHNTLNLFSMIGILVMDGIVAKNGTLLIDYTLTLMDRGHSALEAVIEAGRVRLKPIFMTTITMMVGMTPMALAMTPGSESRVSMAWVIIGGLLTSTVFTLIVIPIIFLFFANHKKKKKPSRGET
>fig|500635.8.peg.1421 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSPAKHMQYKQKARRFFSVLLPIFVTQVALTATGFFDTVMSGHVSEQDLAGVAVGSNLFMPFFGSFLGIISVLTPTIAQLHGAGRQERIGFVVRQGFYWSLGLAGAFLLLGILFVPTILEFLALEPKVERVAAGYLAAIAFGIVPIFLAGVLRNLIDAHGYTRLTMVITLVTVPINVIANYIFMYGTLGIPAFGGIGAGIGSAIAFSLNLLFNAIVVVTVEPFRSYHIFRSLPRPDLAEWKRSLSLGIPIGSTMFCEQSIFSAVGLFMTVYGTTVVAAHQAAMNFTTLVYMIPLSASMTLTILVGFEIGARRSEEAAAYIRLGRLLTFVFEGSLAILLVQFRETIAALYTSSPDVQELLVVFLVFAVFLQLADSIDAPLQGALRGYKDVHVTFLLAVISYWVIGLPAGWLIANYTSVGPYGYWCGLIIGIAFGAIFLSLRLRAVQKRYQGA
>fig|500635.8.peg.1554 Permease of the drug/metabolite transporter (DMT) superfamily
MLLLAAFIWGTTFVAQMVGMDGLGPFTYAAARYLLGFLFLVGLWYAWRGQREGAKRAGTYRAGWKAGLGAGCIMLVATSLQQVAMLYTTAGKTAFITALYIILVPLGAVLLGKRIHLENWIGALLALAGLYFLSIRGAVSLSFGDGLVFISALFWTGHILFIDRFASLVDPIELSVTQIGVCAAGSLIAALGFETVAVQPILDAWFAIFYGGVMSAGVAFTLQILGQKYAEPGQAAIIMSFEAVFGALSSWLLLGEHMSAVQVLGCALMLSGMIVTQVRPLLEDRRHAS
>fig|500635.8.peg.1650 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHFGKHLQIDMLHGPIIGPMILFALPLAMTGVLQQLFNTADVLVLGQFVSTEALAAVGNNSPIIGLLVNLFMGVSLGANVVIARFIGAHDLKETIRAVHTSFLLALIFGVLVAVIGELMARPMLEALSVPTSVMPLAETYLRIYFLGMPAIGLYNFESAIYRSRGNTWMPLQALAAASGLNVVLDLLAVLVFDWGVAGVAATTALSNYLSAWILYRGLCHEHGIIRLEPGAIRLERSYAKEILRIGLPAGIQGMVFSLSNLVIQAAINSLGAVVMAASTAAFTIEINIYVLLIAFGQAVTTFVSQNYGAGNLPRCRRVTQLGLLVTMVVTVVLSALACIFADPLLALFNDNPAVIDVGRIRIYYIIGFYFLCVFIEILSGAMRGYGHSLPPALLMLVTVCGVRITWIYTAFVAEPTFATIMISYPLSWAATVILLVFIYLFYRRHITARKVLI
>fig|500635.8.peg.1942 Fosmidomycin resistance protein
MDYTAIAGLMFASSFLSSVIQPLFGYLADKGSRQWFMAVGVFFAGTSLAITGFVSDYWLIFAAVTVMGIATSIFHPEAARCVNGVSQGARGKGMSIFSVGGNGGFGFGPLLAVFLVTTFGMHGLAFYGITAACMSLLLLLAIPHLRRAIEANASAAAEAASAKQTSSSPAAMNDWHAFGRLFFVILFRSTVFTGISSFLPLFCIQVLGSSEAIGSMTLSIISIAGVAATLFGGWFADRHGYRRTLRLGSVLLVPFLAIAVFSHSIYAVYAMLLPMSVAMLAPYSSFVVLGQEYLAKNIGFASGVTLGISMSIGGIIAPALGHYADTYGLTAVMGLLVLIAAICAGATFLLPAKKQTS
>fig|500635.8.peg.2066 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQRTTTKHSPLARRFRLGSLLRFAAPSIGMMIIISLYTVTDGIFIGRYAGSDALAASNIVYPAINVVFGLAIMLASGGSALVAKNLGENKPQLARQHFTMITVTTAVLATVLATLTIAAGDSLLTLLGASPELMADCRSYLYSLLPFFPFAALMILFNAFFIADGRPMQGFIVSVLAGLTNASLDYLFLAHLGLGIFGAGLATGIADLIAGVIGLVYFYRFSHLIRFAKPRLEWRALGQAFYNGSSELVTQLSVGITTFLFNILTFRYAGADGVAAISVILYAEMLLTAVYMGFTNGVAPIFSYRFGARDFGELRRLVRLSLTVIAGGALISFSLSHLLAEPLVSLFLPQGGHVYELTRQGFALFSFTFLLCGFNLFISGFFTAISDGRTSALMSFARNLLGIVFFLLTLPRMLGLSGVWLAVPAADVTALLFGLFLLVSRMREFKNMDAAQKGIRLTDINGRNA
>fig|501479.3.peg.272 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDLDASIAWYREALGFELLSSYGWPGVRAAFIGRGDIRIELFQNEEAAPMTDDRRKPETNLRIGGIGHLALAVADLDAAMADLRDRQVEIVAPPREVPDGSGSRFAFIHDNEGMLLELFQPG
>fig|501479.3.peg.2059 Glyoxalase/bleomycin resistance protein/dioxygenase
MSYKPDGYTDLAAYLLVTDPEDVLRFCETVFGAERLRVMQDGERIMHAECRIGDTVLMMGGVEEGNPTMLHLYLDDPDAAFARALEAGAEELQPMRDGRDGDRRGGFRTPCGTQWYVSRQIGD
>fig|501479.3.peg.5005 Probable multidrug resistance protein
MTGTAATDTPIREGVKWTIVLAVVLTAVLEVLDSTIVNVALPQIQAAFGITNDQTVWILTSYIVASVVVMPLTGFFVRMVGRRRLIISAITGFAAFSALCGLSWSVEVMVACRLGQGIFGAFLIPLSQSILFDSFPKEKRGQAMAFFGLGVVVAPVLGPTIGALLTEYFSWRAVFYVNLPIAGFALAMMSGELKSEDTKMLKVDWSGLALMVGAIASLQLMLDLGESRDWFASHLIQIAAITLVCCGMAFVLRGIGRADNIIDFSLFRDRSFAGANVAILGFGVAMFGSIAILPLFVQGLLGYPVLDAGMLFIPRGIAAGFSMVLTGSVLVTRFDPRKLLVLGLVLTGTGNVLLGMLNLNAGFWDLALPGIVSGLGMGLFFVPMSTLAFQNIGPEKQDEASGIYGVTRSLGSSVGIALVGWQVASRMQFHYAMLASGISPFDEAARAYLAPLGLTPTSAEGAAQIAGLIQQQASLLAFQDAFWLTGVAAFLMLPVVLILQRPTAGADPAKAH
>fig|504472.7.peg.382 Multidrug resistance protein B
MIQRTVHLYQQAYRGLSPSVWLLAGVMLINRCGTMVLPFMTLYLTQHLHYSVERAGVVMAIYGLGAFVGTFLGGRLTDRFGFYYIQLFSLLFGGVALLGLQFVTDFYMLCGSVFMFTLLGDAFRPANQAAIAYYSEVGNRTRAFSLNRLAINLGWAVGGGLGGWIAGISYNLLFWTDGLTCLAAGIVLWFCLPVPARIPAPNANPDDLHSVTIGTKSPYRDGLFVAFVICSCLYLITFMQLFSIVPLFFKEVMRMSEGTIGSLMALNGLIIVCLEMALVYSIEQKKRAKTSLIVAGVLLTTLSYLLLASTSKIALPAMTIALIFIVFGTFSEMLAIPFIQSFTVERASPATRGQYLALAGMSGALAQTLSPAIGSQVVAHFGFSIHWLVIAGISLLSASGFWWLGRKLATKPLPEADALV
>fig|504472.7.peg.495 Drug resistance transporter, EmrB/QacA subfamily
MSAPPISAGTSSPNKWIILGTVMFGTFMSTLDSSIVNIALPTIRRELNAGDSVEWIVLCYLLTTTSTLLIMGKLSDWIGRRQMYITGFFVFVLGSLLCGLAWSLWSLVGFRVVQGLGAAMIYSIGPAIISDAFSSKERGQAMGLMGSVVAAGSSAGPVIGGLLLGKFGWSSIFFVNVPIGLLAIWRAWTILPESPKVTGQRFDLVGAGLFLVGVTTLLTAIEFGPEPRYGWDNPLVIGLLSVGSILLVSFLFWEMRVKEPMLRLSLFRIRPFTMAILAAFCGFLASGGNLFVIPFFLQQLLKLNPERAGLVLLAGPLTLSVVAPLGGYLSSRVSTRWLSSFGLLITATGYFAFSFLDTSWDWKDVVWRSSLVSLGFGLFQSPNSSSALNAAPLDQRGIASSMIAFMRNLGFVVGIALAAAVWYSTRNRFALANGVTPEATDAQLLGMHYAYLVMASLVLTGAIISFSRGKYQELGARS
>fig|504472.7.peg.615 Permease of the drug/metabolite transporter (DMT) superfamily
MNKSIQSWSILFFCNLIWAFHFTSIKLTQAQVGPYFTVWAPMLLATIFLGPFVIRDFRKGGKKLTDSLIFVQLAALGAFPSQVLMTWGTQYSLASNAAILVMTLPVITAVFAFLILKEKMNAARWISFAIAIIGVALCSTDDIKRVDLSSRYALGNALIFLAILGNAYYNVGCKKVSGQYTEMEMVFYTYLVMSILLTPLVLYYEPEMFARVPFFTTNTWIGMISLTLFHNFLSMLLFFKALKNLDATQVALSNYLITFMGLPIAAIWLGETLNQQAIIGGLLVLASTLILSIVDTKVQQKKVANQNQEPAKL
>fig|504472.7.peg.2819 Acriflavin resistance protein
MKFVETIIKRPSLIIVLFAILTIGGLFSYRLLSYELLPEFSTPVITITTIYPGAAPSEVETEISKKIEDAVSGLDNLDDVKSNSFENASVLVVQFKAGTDIDLALQDAQREIDKMVSDLPDDAEQPSLSKISPSDQPIMQLLATSTLPNEVFYQQVEDKYLPVLQQIKGVADIAMVGGDKREIRINVDDDKLNYYGLSLLQVSQAINQANLDFPTGKVKSTSENMTLRLAGKFSSLDDIRKLVIATPANGSPIRISDVANVTDGLTEATSISRFNGQDGIGLFIKKQSDANAVEISRIVQEKLAQIEKENTKDKVHFAIAYDSSVFTLASVEAVTHDLLLAVGLVAIVMLLFLHSFRNAFIVMISVPASLISAFLFMFVMGYSLNLMTLLALSLVIGILVDDSIVVLENIQRHLEMGKDRWRATLDGVSEIGFAAVAITLVIVVVFVPITFVNSVIADLLRQFSLTVAFATMVSLVVSFTLTPWLTSKMARLEHLNPKNPFQAFLLWFEKGLTALTSVYHRSLGWVLTHKLAFTGILVAIFVFTGWVMNLGIIGSEFVAQGDQGKFLLTMKLDKSASLQQNNLMARNIENYLRKKPEVETIFANVGGASTGMNSTGQGETNRTELTVQLADASERPGHKLTEQYMIDVRQELEKQFPAIEFNSSVVGMVNSGSAPIEIFLSGNNVSQNLAAAEELANRIRRTPGANDVNVSVESGNPEVRVDIDREKMAKLGLTIQTVGGTLQNAFAGNDDSKFRDGGEDYDIRVMLDAFDRKNPDDVKNINFFSPSTNRPVRLAEFANVTLSNGPSLLERKNRRSSVTVTANTLGTGSGTLTSVIQADLAKNPLPAGVTVSWGGDAKNQSEGFGSLGIAMLAGLMLVYFIMVLLYDSFVYPFVVLFSVPVAVIGALLALALTSSNIGIFAMLGMLMLIGLVVKNAILIVDFANQQKEQGVPFRQAILHAGEERLRPILMTTIAMVIGMIPIATASGAGAEWKNSLAWVLIGGLSSSMLLTIYLVPMMYYVVDRIGEKWTVFRSKKQIDQPVQAEPIQTEPIH
>fig|504472.7.peg.5208 Tetracycline resistance protein
MTVGTALMLGVQLAGSPAIGRWSDLRGRRPAAIATTVVSLLSSLFLLPVQTWGYVASRWVKGGSNGLYSVMRSAVADLTDKDELLKYGGLFSFIAGSAPVIGPMGAGWLMLVVHEARINPLPTVLLLLALGLLNIRLAMLFRETNPKKEAVDYTELADKARNSLKVVSIWRQLLEADKQLPGIKSILILNLLATLGMGYFAFFVAFLTQSELIMTPAETARFFLYYGGLALAANFIFFTYIVQHVNKRIAILVMALISIVLQVVYTFSESSVELFYVVAGVDALTVSIITGLTGGILSQVIKEGSGQGEMFGNIQALGGLASFATALVNSLLSGVSLKAPFIFCAISMIAVVIWTIRLPKAARQHTDSKTPAT
>fig|504728.4.peg.32 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MAFAVAIAHDPPFVLLDEPTLGLDIDAAEVLEAQILGMAKAGKGILLTTHQLEVAERLCTRVAILSGGRIVVDKAKEELLEMFDLQSYRVTFKEPVGLPELPFQHTLDESGRVLEVILDYPEQLYELMRRLHPRPLRSIEKREVELAEIFRSYTARKESHSA
>fig|504728.4.peg.467 Daunorubicin resistance transmembrane protein
MVMALPAYATAAFVSGAWSAGEWRLGWFFLSLVVGFACAYFFEFLMSLSAFYTSAQQGINEAKALVVALLSGAFFPIDLLPDRYALLASLLPFQAFIYLPARMLQPSMPESEIFRGLAVQLFWLLVLAASSRFLLGRVRQRFNVQGG
>fig|504728.4.peg.1514 Glyoxalase/bleomycin resistance protein/dioxygenase
MFELRPHHVGLSVPDLEASRRWYSEMLGFEPEKELFIEQIPARVAFLRRGAFRLELFEVVGAQALPEERRQPHTDLRTHGTKHLAFAVPDVDQAVEALRARGVRVLLHQRIGGEPMAFICDNAGILLELVQAASFGE
>fig|504728.4.peg.1730 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MNAVLEATGLRKRFGSLVAVDGVSLHLAAGEVLAFLGPNGAGKTTTIKMLAGLLWPDGGQVQLLGQSPHQNPWALRHLGAVLEGNRNVYWRMTALENLVYFGVARGLRYQAAQRRARALLEQLELGAKSHTEVRHLSRGMQQKLSLAVALMHDPELLLLDEPTLGLDVESALRVEGMVRELAQTGKAILLTTHQLEVAQRLASRIAIIQQGRIVLEGRTPELLGRFAGEHYLIETETPLSPAQLGHLRSLGLEGEGPPYVYQGDSDGLWRLLEALKPTPLKKVARAEADLLEVFLKVVGRA
>fig|504728.4.peg.2431 Multidrug resistance protein-related protein
MNALDKLPWQRQDLPKFIVMLSTLGLLEFTRSAFFWVYMPFSSKELGLSLSLVGLAWVVHSLTEALSRGIGGFLVQRIGFGAVGVLSGLVGLLALSGTILNPNGWFLLVSMLLWGVSISGLQPGYLSFSSRIAVPGREGRAIAYAQFLVIPWIGLGWVLGTFFIRNLPESTSLLLFAALGLVTLLGLASLGVREPLPKQSLNIRQLMQVLIIVPTAFAQLFLQNLFNLVILKFTLTHLKLTEWQLYLAMGLAAAVVFLGAGILGRLPDRKGVWLPLISSLGALAAIFLLIAQQPSYPYFLLLCLLGGIAFATFVPSWNALLVRLLPTENRAAIWGSLMVVEGLGAATGPAVGGFLWDWLGPRGPFWGGAAVCGLLIAFYGFVYWRLRRGLSVEAS
>fig|504832.4.peg.1787 Glyoxalase/bleomycin resistance protein/dioxygenase
MFCHVMVGSNDLQAAKKFYDAVFTAAGGAAGEIDAKGRVAYSKDGARFLVTKPIDGKPASSANGGTIGLLMKDPAVVDAWHAAGVANGGTSIEDPPGVRVSGGKKVYLAYLRDPDGNKLCARAPFPG
>fig|504832.4.peg.2238 Multiple antibiotic resistance (MarC)-related proteins
MLVDFTLNALVTLFVVVDPIGIAPAFLSLTHGLPAATRRNVGYRAAAIAALILIGTALGGNWLLTRLGIGLPAFRISGGVLLFFIAFEMVLGIRPTREARQAEQAIEEHVRNIAAFPLAIPLIAGPGAITATLLLAGQGGGSAVSLAALVAIIIVIAAACAVAFLFAGSVARFLGVTGNIVLSRLLGVVLAALAVQFVIDGGRAAFG
>fig|511051.3.peg.223 Daunorubicin resistance ATP-binding protein drrA
MDKAIVVENLKRVYKKGKDSFFALDGISFEVHYGEIFGFLGPNGAGKTTTIKILSTLLYPTSGKAFVGGFDVEKEVQKIREIINLVSGGESAGYGILTVKESLWMFSQFYGIPTNEASKRIEHYLKLVGMWDSKDTLLNRLSTGMMQKVNLVRGLITDPKILFLDEPTIGLDVEAARTIRSIVSEWVKEKPTRTVLLTTHYMAEADELCDRIAIINKGRIVALDTPENLKKAISDEIFFEIETSIVPKETSQILTNDLKEFGINCLIKDHIERGVSTLSVILKEEKDIAKVIQKIVEVNKEILSLRKIEPTLEDVFIKLVGKRLEDEETN
>fig|511051.3.peg.595 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKTGLWVNVSLFLLFLVWANSYTFIKIAERQLEPVSLVLARFFIIFPFLFLFKDFYTGLKKIQSIADFLKILFVGLLIVPSYHIFLNTAETMINASVAALVAGFSPVITGILSSIILKEKLEKKRIVGLIISLVGVITLTYGISHKFEVKNSLGVLLSLSSVTSWALATVTSKSLYKKFKPIEVNTLGLFFGTLALIPFAKAMFVQQIFTMNTQTLIAVLYLGVLCILIGYAVWFKALEYKEASTTATFIYLNPIIGSLSGVIFLKEPMNFVMILGGVTIILGLFFVNPLKMEKK
>fig|511051.3.peg.685 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRKVSREEILSGNPVKIMFQLGLPIMISQILFTFYNMADTFWLGHLPSAESGSAVAGLQVAFPIVWFLISFTLGFGFAGVALVSQYTGANDHKNANHAASQVLSFLTIAGILVAIFGYFVMPIIAHLITNVANVSATAIKYMKVYVIGIPFLFVSAAFQNILSAKGDNVTPMQISLVTNVMNIILDPFLIFGWWIFPRLTVVGAAVATVITEGVAAIIAVYFLFKGTKGIKVSLSDLKIELSWFLRIFKIGFPAAVGNSGTSLGFVVLTALIGRLPNAEIALSAYGIGDRAIHIIFVVVEGIGAAIVTMIGQNLGAGLIERAEKISKEGIKLEFVITLIESAFIFVIRNAIYKVFIPGNMAVIQEGSKFLTIFILGLPFFGLFSAVSGVFRGSGHNVEPMIGDLLRLWGLRLPLSYLLSRFWGSSGIWWGMTLSNIIAAVVLYVFYTFGKWKVPIIKKEEIFIEESAIITGSE
>fig|511051.3.peg.1065 Permease of the drug/metabolite transporter (DMT) superfamily
MKRRKIFSILLLIFATLIWGSTFTLVKSTLRFINEFQLLFLRFGFASVVALFVVLRHRKFLKNPKLLLLLIILGISLFVAYAFQTIGLKYTTPTKSAFITGLYIVFTPIFSTIYLKEKPRNFEIVALVLSFVGLLFLSQIDLRSLNSVNFGDILTLLCAISFAFQIVLTEKLVKDLPSLLVTSIQMIVSFALSFPFAFLNQHFNLNRFVMFSTLFLGVVASFFAIQTESFALKYIDSTEASLIFILEPVFAYLFSFFILGERLNFGGIVGATLILTSMVIIAIYNKE
>fig|511062.4.peg.378 
MIKVIIERRVAEGLETVYQDTIRNLMLQITERPGFLKGDAYRDVHHPNHFYVISNWQSIESWEHWQHSPERQRMLSELAPLLEQDEKCTVLALKVSYEAKPSKFARPTQTYTY
>fig|511062.4.peg.596 Drug/metabolite transporter superfamily permease
MPYLVFVTLLWAFSFSLIGVYLAGAVDSYFSVLTRIALAALLFAPLLRWRQPPRLAAGLMLCGALQLGIMYLFYYQSFLLLTVPEVLIFTVLTPVYVTLVYDLLHRRFNPGYLFTAVLAVLGALVIRFDALTDDYLLGFAVVQGANLCFALGQVGYKVLLERYPSTEPQHKRFGYFYLGALLVVTPAWLGLGGEQYPATPLQWGILLWLGLGASGLGYFLWNKGATLVNAGALAIMNNALVPAGLLVNLLIWNRDADLPRLALGGAILLASLWLNEAWIKVSRPAPSE
>fig|511062.4.peg.715 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTSSNPMVHTPVPRLFFQFAGHALVSLLAITSASVIDGLFVGNLVGADALAAVTLLVPWLTLLFALGLVLAIGGSVRAGHLLGQQQRQAAGRLFGAAVLAAALAVALAGLVITLWPELLYRALNVPATLRPLVAEYLGVMKLALVVQIATMVAYYFVRADGHTGLATRALIAGALSNIALNALLVGGLKLGLAGAAWATLLAQLVQAGLMARYLRRPGAMRLRFRGWPWQDLRAALANGLSEGINEVSVGVMIWLVNWLMMRAQGADGVAAFSIVNYLIFIGVMTCYGIVDGVHPLVSHNLGAGQAQRARQVVKLAAITLAGLGLAMSTLLLLAGHRIPALFLGSGETAAMAQATTLIAIIWPLFLFNGFNMLIAVTFTALQRPLPSAIIAFSRSLVLPAGLMLWLAWAFPSQPFLLALPLAEALTLVLALGLAAQARSQSQINQRCRP
>fig|511062.4.peg.1899 Acriflavin resistance protein
MNDLGHKGWVAWFAANPVAANLLMLLILVAGVMSALNLRVEAFPPVPPNSVSISVSYDSGSARSAEEGITLKLEEALQGIQGIKKISSISNTEGSSITVERSSGYDLDTLYRDIKNRIDGISTLPAEAERPVITKATYLEDAVSVHLAGDVPQDVLQETARQLRTLLLNNPAIERVNTNGRETPEISIEVDEHRLQALNLTISDIAEKVAASSLTVAGGELFSREGSMIVKADQQLYRLRDFEAIVIRQTRDGQRLTLGDVATVRDSYEPSGVLSRFNGERAIWLDIKMYSSSNIMAISEAVQKEIDSFSGSLPQGITAKIWNDQSLYIGARLNLLLKNSVMGIALVMLLLALFLDIRVAFWVGAGLPVIFAGAMLLMDARLFNMTLNEMTTFGFIIALGIVVDDAVVVGESIYSERQRYGASLNSTIRGAQRVTTPTVFGVLTTIVAFLALALVEGEMGKIFSFFAYAAAFCLIFSLVESKLILPAHLAHLKMDSGAARNPVSCGWQWLQTQVSRGLTYFTRNIYRPFVHQVLNFRYVALMLAISLFIIVGGMVPSGQIRAVFFPDIPSDFIEVQLELDPQAGYGLVQKQAIEIEQTAARLNQRLQDEYQLSQPPIPNLMTLSGDSSASVIAGLSPRDQRPFGTQEIADLWQQEVGALEAVRKLKFVTTWEGAADISIELAAESPQTLQQAATKVQEALALYSGVSGIENSMKTGQAQIDLQLRPAGEAMGITTALLARQIQQAYQGYEVQRIQRGRDEMKVKVHYPQDQRQQLDDLQRARIRTPDGRTVALSTVADISTRYVADEIKRTDRSRVAVVTANVNKAIAAPAEIIASIDAQLLTQLQRDYPGLTIRFGGEAQEEAETTNSLKGAFLVALIAIYALLAIPLKSYLQPLMIMSAIPFGVIGALLGHWLHDIPLSLLSLFGILALSGVVVNDSLLLISRYNENRLQGKPTRLAMVEAGCSRMRAIVLTSITTYAGLIPLIWETAENAQFLIPAAVAMGYGILFATLITLILIPALVLISEDLTIRQWRKKRRKHSTTSKTTMETMS
>fig|511062.4.peg.1904 Small multidrug resistance protein
MAAIAAEVIGVFTMKIVSDSASVPALLFMYTMIGLSFYFLALAVKHMPIAKAYATWEALGLISITFIGVQFFNESLNFIKLLGLTVLITGVVLTTLGAPSAEANNRQER
>fig|511062.4.peg.2639 Multidrug resistance protein D
MPGLSLVLLTVLMVATGQMTQTLYVPAMGDMADALQVSHQALPLVMAFYLVPYGLFQFVYGPLSDRHGRRPVLLVGLSVYALGSALILLVPVYSMLLLGSFIQGAGTAAAGSLCRSLMRDRFEGTELVRYNGYVSMGIMLAPVLAPLAGGWLNLHYGWQSMYGFLLATGLVILLVMVVWFRETLPRERRHVQPMLPAYQHVLHHGGFRRQLGMLIATFAGLILYEAVFSVLAARHQLTSAEISLLFVLPLPLYFGGAMVASCKSAQWSVRRMQWLASLSLLAGAGLVLAGGFAPGLELAGLVAGGGLYFAGAGLLFPVATSAAVAPFPQHSGTAGALLGGCANLGGGLFLLGQGALPQMSQPVLGGLLLACAGLVVWFLLPAEAALPEPGV
>fig|511062.4.peg.3198 EmrB/QacA family drug resistance transporter
MSETIQDRQSRQAHRVFAGVALAIMLGALEITLLMPAISRLGQIFDSPALAPLLVSSYLFAMTLTMPVYGRLSDRFGRTPCLAAALGFFTLGSLASALTDSLPLLLATRLLTGLGGGGLIALSFAVIADVIPPRQVGRYQGLISTLFAVSSVAGPLLGAFMVARFDWRWLFLFKLPLGLLAMAVSYWALKGLGHKGAHSTPDHWGIGLLLLAGTGWGLSTNTAELLPALAPFQPALLAGAALLSLVLLIQQWRHPHPVLPLRLLGGRLMAIAVLLLALSEGVRLGLLVYLPLALEQQQGLSPDDTSRVLLWFILSVTVGTFVSGKRISHAGYCRPFPWSGGLLLGLGCVVLWGLFSQRLNGVWLHGGLIAGGIGIGFLIVACSIAVQNALPSNQLGAGLALMNFCRSLGGTLGVIWLGWQYQQQLTDWATPVYASLSAYGLICLLLGFAMPDRELGNQAKNQPG
>fig|511680.4.peg.955 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKAKDLTTGKPISLMIKYAIPVLIGNLVQQIYNFADTIIVGQCLGNSTLAAVGNTGSMFFLVNGFVIGITSGFSVHIAQCFGAKDYDRMRNSVCNAIMLWSGITLFITLLSVLITKPVLRLINTPDGIFDMSYNYIVIIFAGIAAPMLYNAVSCILRALGDSKTPLYFLIFSALLNIGLDLLFIVVFNWGVAGAAIATVLAQLVAGIACIVYISVKFPVLHIKKEDFKINPGIIKTHLTIGLPMAFQFSVTAIGTIILQGAVNVFGENYIAAFTASSKTEQLIMQFGISGGVTVANFVGQNVGAGRYDRIKNGILKWSLFTVGSAVLCMGVIFIFGRPISRLFIKGGDELILSYAMTYLHISMFFYIPLFQIFIFRNALQAMGKTTMPLLAGFFELGARSIVAYTLPKAIGFSGVCFAGPVAWVCAAVPLIITYIIYMKKFKKKGYFNTQFS
>fig|511680.4.peg.1147 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNGIDFGKDGIWKILFKLAPPVMAAQLIQALYNMVDSIFVGRYSEAGLTALSIIYPIQLLMIAVAVGTGVGINTLMAHYLGMGKVKEKDETAGTATLLALVMWAVFATVSFFLMPKYAGMSTKSPEIIKEVVTYGRIVSVLSIGLFLESAWTKVLQSEGNMKLPMIAQIAGAVINIILDYLLIFGIGFFPALGIAGAAVATVTGQIAAAVIVMTKGFRKSPPLSVYKKYVKKIYYLGFPNILMQSAYTFYIFGLNMILKGFSDQAVTTLGLYYKWQSFFFIPLGAMQTCIVPVISYNYGAGMYDRCKKTLKDAVIFGWTLMIIGILCFEIIPGPMLRVFSRDAKVIEIGVNAFHIIGMSFILLVTSLTFPVYFQAIGQSVKSSLLTVLRTVVLFVPLGWLFSKLGLKYFWCTFPVTEFITTAAGLIMLKRFRGNYE
>fig|515619.6.peg.2461 Multidrug resistance ABC transporter ATP-binding and permease protein
MNDKKYSLRPYLLAYKWHYAIGIFVLLAVDLANLYIPQFIGEIIDGITAGKLDMAGVGGIIFKILITGLIIMAGRFGWRYFIIGASRGIEYRLRDDMFSHMETLSARYYNSHKTGDLMAYFTNDLQAVRMGTGMAVITVFDAVIMTVMVLVKMVVYVDFKLTLFAFIPLIFIAIGCYFYGIESKKRQVKRQDAFSYLSDKVQESIAGIRVVKAFAQEEEDFKQFEKACENSREKNLAVVKLRAVFGPTLDAVIGISVIVTLLAGGRMVLDGQVSIGQFVAFNSYIDMLVWPMIAAGDCINTFSQAAAAWGRIQTIFEEKPDIVDMVPPENVIENDGMAGRNADNLAEGIYDKIQIHGDIQLSHLTFAYPDGTKPVLSDVSIHVKQGEMLGILGRTGSGKSSLADLLLRVYDCENGMILLDGRPITDYPLAVLHRDISYVPQENFLFSDTLEENIAFGLEDRIADNPAILDAVKQAAKDACIHDNIMGFPDEYKTMVGERGVTLSGGQKQRSSIARALLKDSAILILDDSLSAVDTDTEEQILENLMETRQGKTTIVIAHRISTLQKADHVAVLSDGKLTEYGTPEELLELGGFYADISHKQQLESELGS
>fig|515619.6.peg.2615 Vancomycin B-type resistance protein VanW
MKINKKALLLGTMAFVLVAASGMVSAYASGSSGTKKAKVQTITEGVCIGSVDVGGMTKEEAKKAVDAYVDSIKDTSFSLKGANGSFDATAQEMSVSADSDAAVDEALSVCHEGSLIDRFVESEELKKGNVAVKMYLSVDKQKTANMIYDKSDELNIKAVDNSLQRNGDSFDFVPGQEGKEVDVVKSVYAINDFLQNSWDGSANEIELVTNTVQPRGSKEELSKIKDNLGGFSTDFSSSAAGRATNVKNACSLINGSVIYPGEQFSVYEAISPITTDNGYQIAGAYENGQVVDSVGGGVCQVATTLYNAVIRAELEIVQRYNHSMIVSYVKPSDDAAIAGTYKDLKFKNNLDNPVYIEGYCSGGIITFNVYGVETRPANREISFRSETLSEEDPVTQFNFDAGQPVGYFNTEQSAHKGVTARLWKTVTVDGTVQSDEVFNNSKYKSSPKIVTVGTAGASAEVVAQLQAAAAANDEGSVKSIAASAAAAAQAAQAQATQTQDPNAAAQTQSAQTQTTDPNAAGQTQGAQTQLTDQNAAGQAQGAQTQ
>fig|515620.4.peg.1263 Multidrug resistance protein, MATE family
MENANTMDNAKMTNGPITRILLSFAGPVLLGQLLQQLYNIADAAIVGQFLSSKALAAVGATSSLTYIVCYFCIGSCIGISVPVSQAFGAGKNDDLRKYFVNGVYFALAIAVIMTAVTASMSGLFLTWLKTPENIFKDAHVYLVIIFLGLPLTVLYNFCFGILMAFGDSKKSTMFMAVSTVINIFLDLFLVVVVKWGVAGAAVATIFSQGIAGVLSAVYIFKKYKLLFPVNADERKFHPYYMKNIIKMCMPMGLQYSITAIGAIILQFYVNALGEDAIAGFTSGYKIKNLILCPLNALGTALSSFIGQNFGAKRFDRISEGFKRTLEIGLIYSVITMVVCFFTGKYMALIFVDAADTVVVGYTVKFIKYISVFNAELALLFTARYSVQGMGYGKYSILSGLAEMAGRAAVAVLLIPHFGFDAVCWNEGLTFLAGIAVILPIYIKLFCHLRKSMI
>fig|515620.4.peg.2417 Permease of the drug/metabolite transporter (DMT) superfamily
MNNIKGSLILLLTAFIWGTAFVAQTSGAGAVGTFTFNAARSIVGALFLAVVIVIKNVLDKRNNSGKVINTENESHLQTWPLGAGIICGIVLFAAMTFQQYGISVYPQGVAASGRSGFITATYVVMVSVVSVFMGKKMHWITGVSVAGCVAGMYLLCMSGGVSGIYLGDVLVFLGAICFTTHILVIDKFSSADSMKMSCIQFMVIAIISTFAMIFTENVTFAGIKVALIPILYAGVLSGGIAYTLQMVGQKYAQPSVASIVMSLESVFAVLAGWIVLGELLKPKEIMGCVLVFTAVILAQIPGMKKGDTK
>fig|515622.3.peg.253 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQKRNSYLVSSSMKKFLTASIAAMLIQNVNAIVDGILMGRFLGTEAFSAVNLCLPVVGLLTTIAMLFYTGANVLASVALGAREEKRANSIYTVSMTSVGILSVVVTITAILGVNLVTAVICREEALREYTRDYLLVYFAGTAVIMLVSALLGFGNVGGKPKLVTRASLTNVITNIVCDVLYVKILGMGIKGAALATITGALLSAIIVIADWKIKGSPFKFCRVGSETGPILKEIVHYGVSVTSQTFAIVIYSYVCAILAQIYCGVYGAFVGSLLAQATSLGQGVSGGMGKAFNAIGGMLKGQKDDAGVLMLYKKGMKVAVLVAVVFVAVFMILARPYAMLMGAEDEELLRYSVRSLRMALPFIIPVSFVWIIPNIYALGGQLSILPIISISQPVLTGLGLIACGSIIGNDFMWIGYPISAVLIFLLVVCLSESVRKKASENLGFISLLPVPENKPNVYDISVPCDKDGLVDTLRELNTFFDGQDIDKKLGMRVRLCIEEMVSNIVEFGGRKKNQFLDLKIVVDEQEISAIIKDDGKQFDPITAEKKGSGLKILNGLCPDLDYKYSYGQNMLFMNWVK
>fig|515622.3.peg.650 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNIEQTTQNMTSGNSMKQIILFFLPLLWGNLFQQLYSLVDSIIVGKGISDQALAAVGATGTLNFLILGFVVGMTRGFGITFAQSFGKNDMAMLNAYIRAAKKLSIMFGMAFTVVCVSLLNKMLTFLNTPEDIFDDSYRYFAVILLGIVVTVMNNLEITILQSMGDSRTPLTAMICSSLVNIMLDIIFIMAFGTGVVGAAVATVVSQFVSYLLCLKKLRTIDFMSLGKDTSEIADEKNILVELMKIGLPVALMNSVTAAGAMVLQYFVNLMGSAYVAAYSACMKFASLFEQFGMSVGLSMMTFVGQNKGAGKYDRIRTGVRQGLMLSTLVNVPISLLMIFVPGSLARMLLTDNMIIGYCTDFMPIMGISFFALGWLFVYRYSVQGLGNTFIPMLSGGLEVIMRLIFGFLVGRNGFKGIAISEVSAWIGAFLMLMVTYYCLIGKRTKAIA
>fig|515622.3.peg.720 Permease of the drug/metabolite transporter (DMT) superfamily
MLAGVMTIIFGSLVSRQVLTPKIESLKYIGALALCQTIGQYFFFFMSLANTSGVRGSIINASGNFLAPIFAIFLFRLEKFEVKKLLGCFIGFFGIFLFLGGSSVLAGGKMTMAGEGAMLMAALFYAISGCSIKIFSKFENPVVLSGYQFTLGGIVLLGIGLLMGGSLSFTSMGCYLNLIYMGFISAGAYTLWGVLLKYNPVSKVSVLGFVNPIMGVLLSALFLGEESQAFSIVSVISLILVSAGIIVVNAKRN
>fig|515622.3.peg.1065 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANPMADKYAKDMTQGDPTRLILAFMLPMMMGNIFQQFYNIVDTIIAGRFIDAKALAAVGSTGHVTNLFFALGNGLATGIGIVVSQFFGAGNMKGVKKVITNALVIVTATSVFVGLIGFVFSRPVLTYVMKTPEDILENAVAYMSITCIGFFGTALYNTISYIMRGIGDSKTPLYFLIISSFLNVAMDLVFVIAFGMGVSGLAIATITAQILSAVCSITYAFFKNPVFKIDKSDWKMDPHIIIKCYKIGGSMALQSGLVALSFVILQRVINSFDSVVVAAFTTTSKIESLVNMQFKALQDSLSTFTGQNIGAKQGKRVRKGFQNGMKMMILYAVVMIIVMGLFGDVLVKIFIDSSETDIIAYGSKAMRILSYFYLPLGMIYVCRGTLNGAGDAKFPAISGASEMIGRIIFPALLCSLPFIGAWGLWISTGITWTIVGVTAFIRFNMKDWRGGLDI
>fig|515622.3.peg.1671 Multidrug resistance protein B
MSETKVNYMTNEKKWYVPVIVFFSAFLMYVISALPIFIGRGLPFFYYGDYNVQQIPFYIAAHRAVENGDFFWNWNIDLGGTMAGDFAFYLWGSPFFWITMLFDESMIPYLMPFLMALKYACAATCAYLYIRRYVHKYSYAMVGGYLYAFSGFNACNIVFNHFTDSVAFFPLYLLTFENLMAVDDQEEARYRYSGSKFVAFALMTAFMATVNYYFFFGQVVFLLIYFVVRYARNNKLLSTFVMFNKALFGGVLGIMIAAFFLLQAYAGIKGNTRLDNYINGYNMLIYPSEKLLWDIVKSVSMLPDIIGKGTLFYTGTVKNASLAAYIPMFGMSGVIAYFLLNRKKKNWEKTMLIICFVTAFMPVLNAAFSMFNSAYYARWYYMPILIMCLMTAQVVERGKSPQLKKGAVAAVLMFLFFLGVYFLPSKNDDGEMVMFNMTENKTIFLRDVLGTAILCLMLLVIAFVIPKNFRKTSENGNERRFVTGIRDQIILWAVVVSCIISTFIPLKNGSGIISDRGKTMWQTQMLFNKVEVDQSDFCRGEVDSTSTNYDMVWGIPSIHCFLSTVPSEIFDFLYGSCGITRTVETNLPVERSGARAILSGKYYFENAEISKNRVFHNGEGTDGYFYLKNENGFDVFENLNFIPMGFTFDYYITESEWEDLEAKEHDLDLTRVLILPDDVADEYGDKLIMTEMTAEEISENPISYLEFTDECTKRAQTSCTEFTTDTYGFTARTAMLKDNTLVFFSVPFTEGFSCTVDGVDTPIIKADYGLMAIPVSGGSHEIRVTYTPEGFRSGLALSIAGILLLAGYILVLKNIKKND
>fig|515622.3.peg.2399 Multidrug resistance ABC transporter ATP-binding and permease protein
MGKFDKLKKYWNKRDDAKEYLKWCLSYSKPYIPQLLLLMLFDLAATLMSVGMAIIGKKMIDRASEGNLSDLWKIIAIYVVVILGSQFLGIVSSLFSVIVYEKFGFGIRKKVYRRILDTCWIDVSKYHTGDLMTRLTSDVGAVSDGISSTIPTIIRLVVELLVTFCTLAYYDLKLALFALLVAPIALFASVVLGRKLKYLTVKVQETESKYRSFMQESLANILIEKSFCLEDYSEERLTQLRDERIYWVFKKNRTNMFASAAMGLSFQLGYIVAFAWGAICIANRTITYGTMTVFLQLVNRIQAPIVSLAQLVPRLISMLASAGRIIELQNLPREEYSGASIKQKNIGVKVDKISFGYTDELVFDDASIDFKPGEFTAIVGKSGIGKTTLVRLIMAFTNKMKGNIEFYNDAGETMQASPDARNFIAYVPQGNTLFSGSIKDNVLMGKKDATDEEVIEALKGAAAYDFVMDFPRGIDTVIGEKGVGISEGQAQRIAIARALVKKAPFLILDEATSSLDESTELSVLEGIRKWNPSPTCLLITHRRSVLQYCDREIQIVDKKMASIAG
>fig|515622.3.peg.2483 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKKTTTKNNNIIEGSIWKSMLAYFAALLLGAFFQQFYNTVDAIIVGKAVGSDALAAVGGSAAMVVNLFVGFFMGLSSGATVVIAQFYGAGRRDEVKKAVHTAIAMSIAGGALITLIGLFIAPWIINAMKTPTEVIEASTIYLRIYFLGMIANLVYNMGAGILRAIGDSKRPLYVLIISCFVNIFLDVLFVIWMGLGKMGINQGVMGVAVATVICQIISAVIIVAMLMMTGDSYKLILREIRIDAEMLSRIVRIGFPAGIQTTMYTLSNILIQASINEFGKDATAAWAAYGKIDVLFWMTIGSLGTAVTTFAGQNYGAGKYDRVRSSTRQAFIIAACITIPLSTVLYLWGEGFLYIFVNESQVIQIGIQMIKFLAPFYCLYIGVEIFSGVLRGMGSALIPMLLTLSGICLLRVVWIMVVFPLNRTIVTVETSYPITWGVTSFLFLIYYTYYVRKNKIKGDADSVK
>fig|515622.3.peg.2571 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MAEKVISFVIPCYRSEKTLGSVIDEIDRTMATRDDYSHNIILVNDGSPDNTWEAICQEVKKASDGHILGINFAKNFGQHAALMAGLGRANGDYVVCLDDDGQTPADEVFKLIDALENGADVAYARYEHKQHNVFRNFGTFMNESMATIMLGKPKDLYVSSYFAARRFIVDEMVKYESSYPYVIGLVLRTTKNIVNVDVHHRKREVGQSGYTFSKLLGLWINGFTAFSIKPLRIATFTGCSFAALGFIYGIYTIIKKFVRPDVPVGFSALMSAVIFIGGMLMLMLGMIGEYLGRVYISQNKNPQYVIRETTEDGKK
>fig|515622.3.peg.2872 Vancomycin B-type resistance protein VanW
MKKFLGGVLLFIGVLLLLPGIRTKAADGRTIANGVYIGDIDVSGMTVSDATAAVHSYFDKMAGAEITLDAGEGRSLQVSGEDLGISWKNPQIIEDAYSLGHKGNVIQRYKALKDLEKEGHRFDIEYGFNDEHLQEIVGDRCSSFNQDKVNYTLKKTADGFTVTEGQTGYVVDVDQSIAAIKNFVTSGWNGDNGAVSLSIKEDAPLGSAEDLSKVRDVLGTFTTSYKTSGSSRSANVANGCSLINGTTLYPGEEFNVLDTITPFTEANGYYPAGSYLNGIVVESIGGGICQVSTTLYNAVLLAELEVTERHNHSMIVNYVSPSADAAIAESGGKNFRFVNNTEYPIYIEGYTSSDKHITFTIYGVETRDPGRKVAFKSEVLETTPASEDQYVTDGSQGIGYVGTQSAHIGYKAQLRKIVTENGSEVSNEVINSSTYKMVPRIITVGTAGADATALAQLQTAIATRDVGTVKAVAGALKAARDAAGTENAEAAAQAAAAAVDAANAQIQQQAVAEDMESITTNG
>fig|515622.3.peg.3003 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSRTSTMDMTQGSIRKELILFAIPLLAGNVFQQLYNTIDSIIVGQVVGPDGLGAVTSVAPAINTLVGFFMGFSAGSSVVISHYFGAKNTEGLRRAVHTSIICTFILGLVLMVVGFFLTPPLLVFMSTPETVMPLATQYLQIYFLGIVGLMMYNIGSAILRAVGDSVRPLIFLIITSILNIFLDLFFVINLHMGVAGAAYATIISQFISAILTIAVLFTSKECYNLRLKEFAIDKSILSQIITIGMPAGIQSAVISFSNLFVQSYINRFGESSTAGWGAYGRIDAFVMLPMQSIALTATTFVGQNAGAGNVDRIKKGIREALFLAAICTIALVIPEFLAAPKIVSMFNSDPEVVRYGTLFIRMNCFFDILCCSNQTHAGVLRGVGDAKAPMFIMLSSFVVFRQIYLFIASHLTSSIYPISIAYPMGWLVCSIIMLIYFKMSNWELKVDASYRNHAMN
>fig|515622.3.peg.3067 Permease of the drug/metabolite transporter (DMT) superfamily
MKQNTKIYTLTHTLMLLVASFFWGTTFVAQSLGAEYVGAGTYLALRTYIGIIFLLPFVLYRDKKEVNNLGLGLQELQDKRSREKQAFIKGGMLAGLFIFLASFAQQYGIAYTSVAKAGFLTTLYVVFVPIISLFFGRRFDNKLWISIALSVLGMYLLCMKGSFYLEIGDALMILSALGFSIQILAVSRYSKRIDPVKLTLAQFIIEAILATIVMFVIEKPDLSSIYSALPAILYAGIFSSGIAYTLQALGQKNLNPAIASIAMCLESVFGTLSGWIVLGQQLSLREAAGCILMFAAIVLTQFLGNS
>fig|517417.4.peg.1834 Fusaric acid resistance protein conserved region
MVAGFTLALIVLEGWGHQEQIDALVVARIDCIFIGIVVTTAINISFTPRNGMKNLNRSIRNAVLASLKLVSLTLQSSEHAKAERGRHNLLFMLADIEKKLDSAGAGTLALKRRRFHIENLIVDLLSLLETSVLLEQQLNPNDEKSIMIRQTIAERLDAVTSRLEGSWRPVGTDKEFARLVAEVGAKLPVLASPLLSLSASLDLLLDQRKKSKLPNVPVTAPEPRLRERNWQEAARASLRAVIAVGITGTIWQLTGWREGPVMMMATAIMVSIFSTHDHPSVLLSHIFGGALVGVLLAFVVRLLLIPGQSSAFTQGLLTLPVLLGGMIAKNRRKTALGAMDTMMFFLFVMQPGLPVVASRIQFVAGGVAGLAGIVLALLSFRYVVPVNPALRLRTLLISIAKDLLLMTETNSPQILERGLNRTRYRVLRMLDNASLMNRDMSDVVDGSLAALAIGSFLKRMQEERAHTPLSEKRSLAMREFGAKLSSSGMNSEAIISLLKDSSFHFSRLDQIASN
>fig|517418.3.peg.1058 Drug resistance transporter, EmrB/QacA family
MESTTKQRLLTAGILLVMFLAAMDNMITSTIMPSVISSVGGLSLYPWIGTVFMLTTTITTPLYGKLSDLYGHKRFVLIAIGIFMLGSMLCGMAQTMEQLILFRGIQGIGGGGLVTMSFIVFGILFSPEKRAKMQSALSSVWAVASVVGPAVGAFFVETLTWRWAFYVNLPIGLLSAWTIIMFLKVPKEQHTDHRIDYGGAALFASGGILLLFGLLETSQGMSEWINYAALGLGILLLIWLVFHERNEPEPIIPIALFSNKNFLAPVLLGFIAGSTLFSISNLTPLFIQGALGESAGISGRVVTGISFGWVTGSLICGRLLNKTGFRTISIFGALFMLVGLFLMKDISLASAWWHLFIYNIILGFGMGLIATTTLVAVQSAVSKRTIGAATSTNQLFRSVGGTIGLSVLGGLQLGHFQQSLTKTFSTNAGEDLQKLVHQPHLILDPANRAILPADALEKVSQALSDSVQEVFLIAFVVSFLVLIWSWQMPKETPEMLAATVEAETKKSTKNPYSASENTAEISISSAE
>fig|517418.3.peg.1174 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MFPFALREKKIGEIHRIGKKNLLRLIGAIGFGGIAGPVLLLLGLQKASASSVSLWLNLELVATALLGVLFFKDHLGRYGWIGVIGTVAASLILTWHEGNIGLLALVLIGAACIAWGLDNHLTALIDGITPTQSTFWKGLVGRTTNFAFGLLFEPNSIQGNSLFLALVVGVFAYGISITLYITAAQNIGATRSQMIFGSAPFWGVILSFVFLGEQISHFQIVAIVLLIASLITLFLEQHSHPHTHEAITHKHLHHHDEHHNHPHVENPSSYHSHWHTHEKITHSHPH
>fig|517418.3.peg.1901 Permeases of the drug/metabolite transporter (DMT) superfamily
MWFALSLLSAVSKSASQILTKKLHALGTLELAAYSHIFSAVLILPLFFFVEIPLTGAFLYPTACSTVMNVVAILLLIQAIKISDLSYSIPFLSLTPVFVILVAFVFRGEVMSPLSASGIFLIVLGAFVIDARSLPDLARFGGARIFKDKGVLLVLSVALIYSVSSVCDKSATLASSPLAYVWLFTLARAAIFGLLLFLSRLKHGAKKSPAFERRNLLVLIFIGLIYFLEASFQMQAFEYGNVAEIIGVKRVSILFTSLSGFMIFKESFTRYKLIGAMLLVLGAVVIYVFR
>fig|517418.3.peg.2143 5-nitroimidazole antibiotic resistance protein
MNTALEGFPHAAMRRKDREIVDRLEIDAIIHSATVMHLAMSDNDVPFLVPLFYAYDGQAIFFHSAHAGTKMEILKRNNKVCFEISVDHGVIESEQACDFEARHRTVIGFGSASFIEDEAEKTSALDLIVARFSDKKFDYPKAAVNRTAVIKIEIESIKGKRHGF
>fig|517418.3.peg.3159 Acriflavin resistance protein
MMSMFLIVFALFGSMAYFGMPLDLFPVVNIPYITVKTTYAGAGPKEIETQITKKIEDAVSSVSEIDQMISYSMEGVSLVMIKFELAKDPDIANQEVKDKVDAIVNNLPDDADIPIVQKYNVNEKPILEVVLSGPLTQTELYELADKRLKDRFAQIPGVAQVNLSGGQEREVQVILDDRTVFQNTIDLNTLSQILSAQNIDIPAGNFKRGNQEYTVRLSGEFEDPKEIADLEVPTSFGMKRIKDIAEVKDTGEEVRQRVSYFNNIEKAGSPDAVLLSLVKNSEGNSVEIAKDVKKVLPEMQASLPAGTQLEIVTDKSVFVESSVEDTLVNILLGIVLTSIVLLFFLHDLRSTTIVAISMPMSILSAFMIMQASGFSLNMMSLMGLSTAVGVLVTNSVVVLENIFRHKEMGNGRVEAASKGTNEVVVAVVASALTNIAVFLPIAQMTSIVGQFFREFALTVTYATIFSLIISFTLTPMLASLLLPEEDKKKHPIGEALEKMFHFWETLYKRSLEAILQSKWRAVGVIATAIILFILSLPLAGKIGFEFVPLTDEGDIDIELELPEGTNLEKTAELLSSVEARLREIPEVKHLLMNLGRINDYNVGTNLVLIKLKLVSVHERSESSEAFTSKIIQMLSDFPDIRLRVRAVSSIGGSEQAPILFYLMGQDNDLVNKYKDEILAKISDVPGLVNLNSSSRSGKPEINLTPDRKKLSDAGLTIYDLAMNVRGAVNGLVSTQYKEQGEEYDIRLMLDDAAVDSPEKIANITLSTSMGSLRLSQLCDIEFKEGYSKIMHKDKFKAVEFSASSAPGVPMGNVVSEINAKIAEIDLPSGYKITWGGDAEMMQDTAVDMLRTFIIAIILTYMLLAAILESFTQPLIILGTVPLAMIGVFGSMYITGKSMNIISMLSIVMLLGIVVNNAILMLSYTNELREKGMSIYDALIEACPTKLKPILMSTIAIILGMLPMAMGFGDAGREIRQPMGIVAIGGLVVSTFLTLFVIPAIYDLTSREKKAQS
>fig|518766.5.peg.517 Acriflavin resistance protein
MAILSWATALLLAGLWVGRQIPIEWVPRVELAEVHVAAYWPGAAPRQVEQYVTAPIERAVQRVPGTVHVESLSEEGRATIILQVAPDVPLGPYVAQVREELARLRNVLPDRVVPQLTRAVPEQLREQQGFLTLQLVGPLEPEALRRLADELVAPRLRSVPGVAFVRVAGGRERELLITLDPDRLEAYGLAPVRVQQQLIDALRDRSYGRWQTGRNSWLLFTPPETDLDAIRNLVLHQAGPDAAPFRLRDVARIRLGPAPARSISRVDGQPVVTLSIDRKPGSHLLTVAEAVHATVERLRAELPEGVRLLVVLDRSEDVRKQLRDLMVRGGLGFALLVLVLLALLQSVRACVAVLFSVGVAVAVALLLFRPLGLTLNLITLAGMALVAGLLVDNSVVVVEQLLVQRQRLRVRGLQGLALDAEATRRALQTVWLPLLGGTLTTMVVALPLVYLSGELRTLFLPFGVLVAFTLGASLLSAVLIVPVLGRFLPTPPPVPVRQRRRLRRLIALPYWLAARWPRLTLLVLFLAVGIPLWMLPDTWKLPDEDEQEVVEDTAWQLAKERLARLYNATLGHDRVQEVRRLVEPLLGGVLLPFFQKTTFGRRWHFEVRPEVYVYMAFPPGTPIGRADTLMRRFEAVALASPSVARTVAQITEQVAYLRVRFTEASLRTIEPYLVRERLIQQAVQLAGLRYLSVSGLLEQGYYSGSGVNISEFRIAAYGPSYEDLEALCERLAQRLKAATPRVAAVNYNVDRYGRPDAREVLQFRWTPEAQLRTGLTAGDLAAALRPVFNTRFPFFRAPVADEPYLPVRIEVAGAEQIDVARLITQPLPVTDSVQVQLAALAPPEIVPTPSAIERFDQQYRRYISVDFRGPWRLGDRVIRQVVESMPLPPGYRLQYPTYAIFGERELKRTAGWMLPITIALVFLIAAMVFESWRLPLVMLLSLPMAALGVAVGFLWSGANFAEGAFIGLVLLAGVAVNDSLLLLDRYRQLQAQRPHGRPDLLIRLAVRERLRPMWTTTLSSIVALLPLLLFPDEEGFWLGLAVTVIGGLLAATLLAPLATVALISRRRG
>fig|518766.5.peg.518 Acriflavin resistance protein
MRALVGWCLRRPVAVTAWSLLALGLAAIAYVRLPVALLPELRYPALAVWTAYPDVPPERVERAVTERVEAAVAGVEGVVEVTGRSLLGGSLVVLRFGWNTDLNLALLNVREQLDQLGDALPDEAERPVVLRLDPSDRPIMLLALRQALPRDTLRRVAAGESFQDLVALKRLARDVVARRLEQLEGVARVRVTGGYEPEVEVRLDPERLIRYGLTVAQIEQRLRAANATLPGGLIRRGPFRYAVEVSGAFTEPADVAETIVGYAGRTPLRLADVAEVRPGVAERRGLVRFDGEEALLLLVERAADANTVVAARQVRRTLRELEAEVPGVRLDVVVDESLFIRQAIAGVQQAVLLGGVLALVVLLVFLRRPRVLLAVAVAVPLSLALTLIAFEVADITLNLLSLSGLALGVGMLVDNAIVVTENIARLREQGYAPLDAAREGTVEVAAAITASTLTTIAVFGPLAFVEGLAGRLFRDQALAVVFSLLASLVVALTVVPVLASRDRRSGRLEPFGTRWLLVHYEALLRRALRRRGLVVLLTLLALAGAALIAWHLPRQVMPHADLKRLTVHLSAPPGTDLPQLSRWAAQIETAALRLPAVQHVLADLGERDEARLDLDPRPPYEGTLTVLLDERARSETVAGQLRRMPMPPALTVEVLLERTQLEALLARGEADLWLDLQADLRAEAEAAADQVLPQLRREPALVNVRRAFAEEVPGYALHFRRDVMARFGVDARQLADWLAAAARGLEATALQTVNETIPIRLRLPEAQALQRLLQTEIPTAQGLKPIGLFVEARPVSLPASLLRAGQAPVVRLLADVAPGADLAAARDALARALEVLPPGVRGTIGGATDAFREGLRGAAWSLLLSLLLVFLILAAQFESLRQPLIILFTVPLATIGVVLTLTLTGQSVNLMSLTGLVVLVGIVVNDAIIKVDFINRRRAEGMPLLEAIEAAGRDRLRPILMTTVTTVLGLLPLALGLGAGAALQQPLAITIIGGLTSATLLTLIVVPVLYVLVAGSERRTL
>fig|518766.5.peg.2614 Drug resistance transporter EmrB/QacA subfamily
MNLLASPERRYTLAGVLLALFLGALDQTIVATALPRIVADLQGLDRYAWIVTIYLLTFTVATPIYGKLADLYSRKAIELAAIGIFLGGSFLCGLAGEFGPLPLLGDGMNQLIVFRALQGLGGGGLFSLAFIIIADLFPPAERGRYQGFVGAVFALASVLGPFIGGVLTDHGDVLVPGIEGWRWVFYVNLPFGLLALGFIWSKMPTLQPPATHRALDWNSTLLFSGALAALVLALQLDKQAHPWDAPETIGLFVLAALLLVLFVRQARRSPSPILDLELFRGRVFTTSVLALLFMGAAFLNIVLFAPLFLINVAGVSATVAGLSMVPFSLGVATGSTVSGQLVSRFGHYRRFMLGGELLVLVAVGLLTTLTPETPPGLVALYLALCGLGLGPTMPLFPLAIQNAVDVRRLGQATSAAMLARQIGGVVGTAVMGTVLAISLAAYVPQEATAQLGFREGQRGGLEAVQARFDSLAVQIETALESHDDGRLARTLQAAPLPPTVKARLQEAARHEVSTEALQALVHREIDRARQQVVQQLRRAFAEAIGRIYRYVLALVVAGLIATWFVPELPLRRSYD
>fig|518766.5.peg.2743 Permease of the drug/metabolite transporter (DMT) superfamily
MSQSRLKYELALLFDVLVWGINFPILKVALAAMHPFVVNLFRFIFSLLVLGALHAWTHRRDRTPFFEPLRTHGRAILLLGLLGYVIYQLAFIEGVNLTTSGSAALIMASAPLWTAVISQLRGYDRLNLLGWIGLLVSLLGTAVVVLYGPRALDFSEDALLGNLLMTGAAVAWGAYTALSQPFVHRMDPASLTFFSLLLAYPILALLGLLHIDAVVWADVDATIWAALIFSGALSTGLTVAFWNHAIRHVGPSHTAAFGNLVPVVALVAGYLMLGEPITPAQLLGGAGIIGGLLLMRRARRMPLPS
>fig|519441.6.peg.354 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLKSELILFVVAIIWGTGFIATKIAVDSGMETYNILFVRFLISTILLYIMLKIKKIKIEKSAYVSGFILGSILVLAYMMQTFGLYYTTPAKNSILTGLCVIFVPYISHLIYKVRVDRYTFIASILAFIGIYMLSGNFLESIEGFNKGDFYTVICAVLFAFHIVVTGYYVNKINTVALAYTQFLIATLLSLILATYYGHLKVISTFGILSSLYMGVFCTFVAYTLQIVGQKRVNSSTAAVILSLEVVFATILSIILGYDKFHIIILFGSLLIFLGIIISETKLDFIFKK
>fig|519441.6.peg.427 Daunorubicin resistance transmembrane protein
MKVISIYSRNSLKRSLVYKWDIWISVLSGIFNILGMLFLWSVVYKNSGKSSIGGYNFNSIVLYTLMSNLTAMIINVDIARIISNEVKSGEITNSFIRPVSYITKLVGEGIGHILFNLIMLFSPIISILIIYMNIFNIKSEITLGSILFYTVSLLFSIIINFEISILVGFCSFYVNYIWGFILLENAILTIVTGQLFPLNFYPDKVVKFLEITPFYYINFGPVSILLNKFSKYNSIRILLIQSVWCIILAIFVSIIYNKAKTRLQINGS
>fig|519441.6.peg.643 Permease of the drug/metabolite transporter (DMT) superfamily
MNLSWLFIILGAMMWGIDGVLLTPRYFQYGLYNVLLIVFIAHLLPFLFMLITQRGSIKEIKKMNFYDKSYFLLIALFGGTIGTLSIVKALQLSEFNPYSLVILIQKSQPIFAILSAYFILKEKITHKFKIVFVISLISLYFLTFGLNSPFEIELKSIYSAIYSLIAAISFGLSTTFSRKVAIKYNANLSTFIRFMFTAIITFILLLLNIGQSKSDIIYVVKNNHIMLLALFIAIWNLIASNLYYKGLQKTKAIYSTVSELSFPLTSVFIDMFILGNVLDPIRILAGSVLLLSIVYLNLNNE
>fig|519441.6.peg.1099 Tetracycline resistance protein tetA(P)
MVIITFILIYKFSSLYILALAWFIYGFYEATISGTLDAQIINDIKNEDETLLNKFIKTSQQIMFIGMMMGSVLGSFLYFKIGFKIYLLGALFIAFSFFIILLFFKNNQKSLNENVKIKIHLFQVINELKVNENLRIYIFLCLVSQIYFQTHFQLWQALFLTKGIKQENLYIYYILFQLIGFISYYFPIEKAKNNMRYIYFSFSVLIIIPLIILSNNKYLVIVIYLLICSIFTILDYFIIYNFSKIVSKENISSLISLKSTSSRIASLIMLILFSFILKFVSLQYLIISNFTIVFAILLISIFKFHNKLFNENMQLIFGEVKNALLLFFNFRHLNILQYLEILKKM
>fig|519441.6.peg.1147 Transporter, drug/metabolite exporter family
MKKLGIIMAFIAAFLWGVSGSLAEYIFSNSNFNVNTYTFLRMFLTGIILVGYGVYTKGTKGLNKILFSKKYLKKIIVYGIFGIALLQYSFAQTINNSNAAFATLMQYITPTIVLVYLSYVTKTLPSIKKSILVSVALYGMFLMITSGSLNNLNVSPISLIYGLIAAFTFAFYILYISKFKKIDNTIVIGCGMIIGSLIFIPFIDYSNFRELLKLDIFITFLSNVVLGNAIPFYLFLESTKYIHPATTSLLGAVEPIVAIIIGIIFLGTHLTLIQLIGAILLIGSITIISIFED
>fig|519441.6.peg.1504 Daunorubicin resistance transmembrane protein
MDKYIELIKIGGKKILSYKGLITTLIIKNYIYIFLQYSLWLSIKENSSINIDIKNILVYFIIIRSVNSVNFNLSQYMSYDVKNGNIVGILTKPITVEKYYFFDILGNTIAKVLAILIPNILIALFLIGKFNIFFIFKLIIIIIGSYVLNFVIELILGTFSFFTQSIWGIESLKSIFMLILSGSFFPIEYYPEWSKKMLDYNPFVYIYGKIADFILYEKNFLKILFFQTFFVLILFCVYKSIFKLCLKKISINGG
>fig|519442.4.peg.1188 Daunorubicin resistance ABC transporter ATPase subunit
MGTKRSNPTDEQSPEKTAFAIEASDLELTYADGTEAVSGVSMTIPEGEFFGFLGPNGAGKTTTIKVLATLLSPTAGTVRVNGFDVEADQQAIRESIGYMAQETSVIREMTARENLRFACDAYGVSRGDRSDRIDELLDLVDLADVADKQAEGFSGGMKKRLDAAMALVHRPPLVFLDEPTTGLDPKARNRLWDYFEEINDRGTTIFLTTQYLEEADHLCDRLSVILDGEIVAEGSPETLKREVGGEVLDVELEDGSGARERAAAIARDGELFSDDPTVDVTDDGITVTSRESRKRGPDLLVALRDAGITVTGFNVRSPTLDDVFLAITGEHLDDGDPAESDLDAVESAAGPTTAADGGDP
>fig|519442.4.peg.1733 Major facilitator family transporter 10 (probable multidrug efflux transporter, probable tetracyclin resistance protein)
MTERTRLAVVVWAVLVSQVLLYPGLEDTVIALGGGDHLLAGTWFLVAEFGAFVGMAVLWGLLSDALGRRTPLVVAGAAGGAVSYLAVAAVPGLGGSFDVVLVLRVIGGGFTIGAFSLSITKLMDLAGGHGRNMGAAGTAIGFGAALGSIVGGGLATLDPLAPLYAGAVVLAGAALLAATVPDRGVGGGLALETVFARIRTRPALLVPYAFGYIDRLTAGFFALAGVAYFRDAFDVGPALAGVTLALFFLPFAALQYPMGNLSDRIGRFVPVVAGSLCYGVAIIAVGLAPVYALAALLMVVVGICGAAVSPATMALVTDLVPASERGAAMGGFNVFGSLGMLTGFLLGGVVSGVFGYLPAFVAVGGLEIAIALLAARAVFRMTAGQPGAEWFRHAIRDG
>fig|521003.7.peg.242 Nitroimidazole resistance protein NimB
MRESGELIGAIGLLTGDACDYLEADDEYSVGYWIGVPYWGQGFAAEALQRLIDHARDSLGARAIYADHFLENTQSHRVMEKCGLSPVRTQTTGVLYPAGKRDVLIMRRLLVPHIERNDMNHPMKQLPERAIDEQEARDILRMGEYCVVATVDEDGHPYATPLSYVLDGDSLLIHTGIAGGQKTDNWTRDPRVCVTVAMDMEPVYVKENGEPGFFATRYASVIATGTVRRVVEPACARRALAQLCLKYCPEHRDKIGDAIEWELPATAVWAIDLEHISGKAGRRIPNGKGAVSPH
>fig|521003.7.peg.379 Permease of the drug/metabolite transporter (DMT) superfamily
MTGIDRERGDDITTVKTIEDVRAMKRAHKDGTWKYACACRSGVRYEGESEAWAQLKTVIEEQVAKTTAGIEENDPFASKDAVPVPPEDRAPGKLRGAGARSPLFWKLMLVAMALIWGYSFLTMKTVLDTVPTFMLLACRFLLSAVIMFTIFRKRIKAHFNREYLGFGVLMGCVIWSAYAAQTLGLVDTTPGKNAFLTGTYCILVPFIALILFKERVTKWHIASALLCLVGVGFVALDNFSIQMGDLMTLVGAVFFAVDMAVVGHIGRTRDVSVLTSWMFLFVGLFSLAATTAFEPRVPAGQWTPEIVGQLVFLAVVCTTIGLLLQNQALSHVPPATGSLLLSLESPSGVLFSVLMAGEVLTGKLIFGFVLIFLSIVLSETHFSFLRKWFPKK
>fig|521011.3.peg.765 Drug resistance transporter, EmrB/QacA subfamily
MSDAEPVRNVPMIMGSVMLGLFLSAMDGTIVSTVMPTIAHQLQGMDLYVWPFTVYMLASTVAIIIFGKISDIFGRKPVYLLGIGIFLAGSMLSGLSATMSEMILCRGIQGVGGGIIVAISFVMVSEIFPVWERGKYLGILASVFGIASIIGPILGGVITETIGWPWVFYLNIPIGLLSAVLIKTKFPNMPAVSPSGDIDYRGIICFIALMIPLFLGLSLAGVVYPWVSLEIIGLLGLSVLLLFIFIRIERNARHPILPIDLYKNRVFQISMGAVFLGNSLFYAGIIYLPLFVQDVIKTTASGAGLVITPMIISLILSANITGRLIARTRRYKYLALSGFLFLGIAISILTMVRIDTPITVLILASILLGYGMGVMFPTFSVAAQNAFSVKEIGVITSSLQFSQNMGATLITPLFGIIISTALNSSKKLTDYSLVPADLLSHAISLVFDACLGIVILAILVTLLLKNDLIAPRSPQA
>fig|521011.3.peg.911 Drug resistance transporter, EmrB/QacA subfamily
MIKKSTDFVSPQREKLDPKILRVSVIMVIGALAPLLDSTMVNVAINIIAGDLNSTISIIQWVITGYILAMALAVPVSGWAVNRFGGKRVYMFSLFVFFAGSVLSSLSWNIDSLIGFRLLQGVGAGLMIPTLQTVLVHIAGSRNLGRVMSIVSIPALLGPILGPVLGGVIVNSLNWRWIFYVNIPITIIALLLTWRGVPTDEPSTSKQSLDIIGILLVSPGFALLIYGISQISSHGGFTSSAVLIPLVIGLLLMVAFIVYALRTKNAPVIDVRLFKSRNFSASTALLFLSGIITNGAMLLLPLYYQQVRGESVLFAGLLLIPQGVGMLLTRNWVGRLADRIGSRSIVAISLVVTMIGTVPFACAGPETNQILLAVALLIRGAGLGGLLIPIMASAYQGLSRDQVPHASSATRIFLTIGGAFGSAVLAILIEHQPSGLSVLDIHTVVSAYNGAFWWLIGFTVIAIIPALLLPLRKFESVIQ
>fig|521011.3.peg.1160 Glyoxalase/bleomycin resistance protein/dioxygenase
MNNQAEALKFYTEILGFEKMADIIADNYRWLTVVSPEDRDGTQLVLEPNENPAAKAYQEDLFRQNIPAASFFVDDIQKEYERLKKRGVKFTLEPTELPGTPSTIAILDDTCGNLIQITHLQNF
>fig|521011.3.peg.1174 Daunorubicin resistance ABC transporter membrane protein
MRTLRKQLKATYTIWLRELTKFYRERTQFASTMVTPVLWLIVFGGGMGINLRTGAINTSYNAFIFPGIIGMTLLFTSMRSGISIIWDREFGFLKEILVAPISWTSIVMGKALGGGTNAMIQGTILLLLSVFVGISLTPLQIVLVLPLMLLISLGFDGFGLSIASVIESYEGFQTIMSFVIMPTFFLSGALFPLTNAPRWLQIVSDLDPMTYGVDAMRQVILRGGQFPMGLDLCIMIAFTVIMLVFTSYRFTIKN
>fig|521011.3.peg.1276 Nitroimidazole resistance protein NimB
MKDMRRKERQLTPEETDRLLQTGVFGVLSTVGSGGVPYGVPLHYVYHHKVIYFHCATDGLKLDLLDQNNRVSFCVVVDAVVLPERFSTRYSSVILSGRAFEVFDLEKRAGLVALLGKYSAGYLDQGTRYIEKAWERTKVYRIDIETCTGKGTITSKSSRD
>fig|521011.3.peg.1297 Drug resistance transporter EmrB/QacA subfamily
MNRLSDNTSDEKYKRVALAIAALGTLVGVLNGSTLIIALPTIMVQLHTTLFGVMWALIVYMLITTILAPAWGRLADIYGRKRLYVWGLVTFTIGSILCGFSADIGQLIGFRVIQAIGGSLLVANGTSIVADAYPRGELGRAMGVLSMIMAAAFVAGPILGGVLTVIDWRLNFFFNVPFGIAAIIWAQWKLKDIVALDRHKHFDLLGMVYFTVSVIALMVYVGAGFIVGLLSPAMLATLVVGLISTWAFIRQEQKSQSPLIDLSLFKIKIFTYGQVSALLNSIARGAVMILLILFFQGVKGEDPFTASIMIAPLAIALTISGPIGGRLADRYGSRLIATVGLILSLVGLFGLALMHYDTPYWYLAVCLFINGFGSGLFQPPNTSAIMSSVPPDRRGVTSSIRAFFGNMGMMVSMSFATPILLGTISMDEMMQMFVVGGSSIPVAVQQTFTGGITMAFLLASLITVPAIIVSALRGKDDLHHLHSIPAE
>fig|521011.3.peg.1329 Multidrug resistance protein
MIETRDSNQPDLPPLGYNTRHIILAIVLVGLFMCVLDVQIVAIALPTLMQSLGAGIGEVQWIATGYVIVVLATVLLFGSLSHSLGNGRLFKAGLLLFTLSSLGCGLSQSIPELILFRILQAVGASMLMGVSVAIIIQVFPPGEQGRAMGYYTAVIALGLIVGPSAGGFIVDLLSWPFIFLVNVPIGLVLLVCTLRYLTVDRDPPAVQHFDYHGAFFLIGLMASLSLALNTLSNPPIRLDFFGIWSGIFLLLLIAFVARERSVDNPILPITIFCKRSFLLPTISLILYIMAVFLLLTIQPFYFEYVMGLRPSHIGLIALILPLSMLFASPVFGWLYDRYRSSRYPFIGIVIVGSAFLGCGAAFSCMDFGLIIALFIIGGISRSIYQGPNSIEIMTALPPAQQGIGSSLLTALQYLGILLGISFATFLMTAQLDVAGYSELTDAGPTFLAAIFGNCLYIAGLLCLAGAVCEYKV
>fig|521011.3.peg.1412 Class H tetracycline resistance efflux protein
MTDLRITPLLALQVVIFTDTFSFGVVLPFMVFLVSGFGGDALAFGAIGAIYPFFQTISAPVLGRWSDKVGKSRVLLISQAGTALSWLLFLGIFFLPSTEVFGLPLPIILMLGARAVDGITGGNVGVANACLGDLIPEAERTMAFGRLNVASNTGYILGPAIAGVVAWSGGSLMVPVLLALMVSAAGVVMIRVGLPDICRTRATGEAGTGLFNLFRRRGVRSLLGLTLLYFLAFNIFYTAFPVDAAGRLGWSAATLGLYFAFLSGVMVVVQGPVLKRAAERWSPRTLLIGGALVLAVGFALLWFGQTTTGISAAILFSLGNGLAWPSFLTLLSLSVGPDEQGAVQGAASGVGSFASIIGLLLGGVLYLAIGPSTFLFCTGIVLLTAGLFIAGHSTSEERVQ
>fig|521011.3.peg.2592 Drug resistance transporter, EmrB/QacA subfamily
MGFDTLGSVLIFSGVGTGIAALSMGKERGWTSGPILLLLLSLLINSAFLFREWYQPSPLDLHLLKQPQFTMGIGTAFINRMVVSGTVFLLPLYSELVKGYTANFAGLLLVVSSLLIIVFGPVAGTLSDRIGSRWLCTLAGILLLFVIFDSSMPLILILIALGLRALSMGFFSPPNLRLVLSFSQKDHQGSASALWYFSRYLGAPLGSWSLRFSSITGSGSLRNPGPPVRSISIRWPARC
>fig|521045.3.peg.190 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRVTATLLLATTAIIWGESYLFTKVAVESMPPMTLALFRFIVAVAVFIPVQIKKGVCPKRTTKQRFNIAMAGFFGVTLYFLFENYGLRLTSASDASLLVSSAPILTMILYDILHRKFDGLEYLGSTIAFIGISIVIYGGQFSEGSSVLGNSLSFLAALSWAGYTYFFDKVKDSSIATIVQLMVWGIVFITPFSIIEVFFLKDPVIFSVEAVSGVLYLGILASALGYLMWGKGIHLWGGKAATLWVYTIPVFTILGDIIFLKHRPSLFFYVGALLVGMGMSIAIWRQRKHLQVQEENASTQGLH
>fig|521045.3.peg.378 Probable cation efflux pump (multidrug resistance protein)
MIGQLGSAAIAAVGLVNQINFVLILFLFGASSGTGVFISQYWGNRDLKNIGKTISHVLKITYVGGFVFFMLLFFFPQQIISFFSRDITVVTAGVAYSKIISFTTFLIPFTFVMAMALRTIEKPKIPMYISFVVLAFNTVGNYLLIFGVGPFPEMGVKGAAIATLLSRIIEFFLYLYVLLKPVTALTISRHEFLDFDTVLFRKLMVVALPVIVNELLWSVGMTTYSFIMARIGTEALTVKNIVSTLESFGFIIFGGMSAATVVMVGSELGKKNYEKAFKNAIKLLNLMVVIGVITGIGIILLSRFLIRMYNVEEVIKSTVVMVMIIVGLAQPVKMFNGLNIVGVLRSGGDTKTAMFLELFSLWGIGIPLVALSGIVLKWPLPFVFLMMLPEELFKASLGMLRVHSRKWLRNVID
>fig|521045.3.peg.955 Permease of the drug/metabolite transporter (DMT) superfamily
MLSKKILANIYLLLVVVFWGLTFPLQKVILINSLSPAFYNALRFFMAIIFLIPFKAFRKNFFSSLKEELFHGVILGLFLSGGYVFQTWGLVYTTASKSAFITALYVGLVAIMAPFLERKAPTFLQIVALGISIMALYFLTSPAGGGFNLGDFLTLLCAISYALHVLFITHFTRENESELSLLLPQLVTVMLVNVILIPVIPGKVILNREIFFTAVFAAIFATIFAIAIQLKYQKYVGSLGSSLVYVGEPAFALLFAVILLGEKITMIEGLGLIMMVVGIILGSLSTIKEKEQESEVG
>fig|521045.3.peg.1169 Daunorubicin resistance transmembrane protein
MVSFVMYDFFYWKLDVIISFAAAFCVFDKFAILLEHCVIYPFLHLGNRSVRKEEFFVRGLAIARASFLRNQVYLLNHVAANIGSFVFGYIFVCIWKAVLGDSPEASTMITYVMVNQSALWVTMFLPRGAFLIRKVYDGTIVFDLIRPYGLMYQSFFEVLGHIVYNFVFRSLPIYLLGVTLLGVKFPDAGRIIPYMVSVSNAFVISFFMNYFVGLWMVKFLNYTAAQGMYYFFMNLFGGYFLPAQYYPAFLRKIMPLLPFASTSYIPGSVYLGKIDPIKAFGIQWFWILTLGLTAFGLTELIKKEIRIQGG
>fig|521045.3.peg.1254 Permease of the drug/metabolite transporter (DMT) superfamily
MKERLKNPLIAALLATAASVLWGSAFPVLKIGFREMGIGPENVAEKLVFAGIRFLGSGLLIFIFSPLIAKGKFWPGKRVFKSLLLLGLLQTALQYTLFYNGLSNTTGVKSSIIISSGNFFVVLIAHFVYKDDRINWKKTLGLAAGFSGILIANWSKGISYDFKFEGEGLLVLSTLVGAFGTILAKKVSRQVNPFFVSGWQMFLGSIVLLLLGMPGMKNGLKFTPLATVLLIYSSLLSAVAFSLWYTVLKYHKAGEVTLYRFMIPLSGALSSAAFIPGETLTPNTLIALGLVIFGIVVVNYRNS
>fig|521045.3.peg.1750 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQRVYILNEQMTPALFKLAWPTILSMLFQTLYNVIDAFWLGKLGKIAISAPTIAWPAIFLLISLGSGLGVAGLAMVSQYVGAGDFKKASKAAGQIILISTIFATVIGIIGGIFSGGILKLMRIPPEMFDSTRIYMQTIFFGAPLTFGTFAIASLFSGWGDTVTPMILTGLSVLFNAVLDPLMIFGIGFPRFEVFGAALATVISRGVVVIFALYILFSGRRGIKLTFHDMVPDVYMIKKIFSIGFPSSLGQSVTAFAFLIIMAIISRFGPVATAAVGVGNRVTSIATMFSFGLAQATSAMVGQYLGAERNDDAYRVVWKSAGINMVIVGAMCTGTFFFGKEVTAFFINEPDVLVEGFRYFRIVSLSIPFYATFNIFDAALRGSGYTVASMILNIVRLWGIRLPLIYLFGLSMGTLGIWYAMLISNISIAIAAAFVISSKKWLKKVI
>fig|521095.6.peg.367 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLASMLYDTADGILVGRYLGQESFGAVTIAVPLVILCFAIADLIGVGASAVIAVEHGKKNHQTANNIFTIAFIMLITTGVISGIFFFFFAPNVLALMGAQGKIAEQGTIYLRVWTLFLPVMCISYAVDNFLKICGKIRRSTSIAFISAILGTVLEYYFLGVLGLSVEYAALGYCISITFSSLYGVWPFIGNKQILKFVKPHFNWTHIREIFVNGFPIFMQNISSRIYSLLMNAALLTLGGDIAIASYGVLLYSGGLIQPLIYGQADAMQPAVGYNWGAKKKNRVLAIEKYIFSTGIIIGIFAFCVSFFFSEFLVKLYLPDGTQELLNIAIPAMRIHAFIFIFSWITMCTESLAIALKQTKISNLLSIFMALIFPISSLLILKPFGLDALWYVSVVSNILSALLSVGCLIHIYRKYFTSVDKDDVGAASDASQEEDAELTDAALATSELSSPEDHLDPESISRAQ
>fig|521095.6.peg.501 Multidrug resistance protein MsbA
MKESFLSIKEIFHIGNGKINVLVFLAVLAVISSFLEIYSIQYMQSLSKVFSTTVSNDLFQIGFICAKFLMLIVLSTIVRNYFCFRVSVFSNDIIKNVRDKAYSKLTDTEYELAIIHDNAFYINLIDNNVNKLSLIFSTSFFTLCSDIFDTVWICFFMIQINITSLLILIVGILPLVLIGNISASEQKKFAENTIKLNEDLIEKINETNDNFSYIKLFKGKEREANRFNRINIDILENDNLSSAALSIFFVIEKSIRYLFVAISLFFLCKDVLAQDGNWMILIPFLLYVQRFYNPFSNLNKYSQLIQKSVSSADKLIDFIISKPTEEISTIQFISDSSESEIVLSGISKNYESETILEDVTFSFKEGINLIDGKSGVGKSTLLKILLGLIKSSSGKVTIYSRADDLNLYAYSGQSNKLFNLSVIENLIYPKTVDHLSSSERMKLESLLDEFGFRKSILNKDIAKEGENLSGGERKRLSILRALIRPSKVVILDEPFANLDSNNIEIIARKIQDLSKNRIVIIVSHETSFPDSLKFNTHLTISGT
>fig|521095.6.peg.1090 Permease of the drug/metabolite transporter (DMT) superfamily
MSSPTHTPSHILTHNSSQTLIWKGALLFCALVWGGSFVVIKDAINFIPTAWLMTLRFVLSVVVVGIIFRKRLKENLDIRHLTFGALLGILNGFGFLFQNGALAYTTAGKTAFIASIYCAMIPFVNWLIAKKKPHISSIIAACMCVAGIGLISLGTDFSFSFGIGEQMALISAIIFAFVFVLTAELSHKLDIITLTIVQLGVSTLPCLGWALCCETMPNFSQIPSTAWMALAYIIFIATALTGVLQNRSQKSVSPVQASLIISLDTIFAAVFGVIFLAEIITPTIFLGFIVIFVAIFISELGEKPAEPQTTSES
>fig|521096.4.peg.539 Bicyclomycin resistance protein
MVSIGIVDTKAAAETPRRWTTVMLLVAVTAPQLGLSLLNPSIPQMAVDLHTTVSAVQLTLSGYMAGYAVSMFAAGILADRFDARTVQALGLLLFAVGGVAAAAAPSVAVLGAARFVQAIGGTSATVLCRLVIQRRYPADTRMQLLTSLSIVIAATPAISPFLGSALVQVLAWRALFLGLAVVGVMLAVAFLLLVPAAPPEVPVSPTPRMVGRGIAEAVRERGFRRHALVISLAWMGYFLFIEQSSFVLQELHGATELQYGLLLVVPAIGYIAGSVLVRRAPAVVRAVRFGAVASLLGAAALVILAAVGVHNPAAVVVPLAVGFVGVGAAIPFSQAGLLELDLAAQGVGAGLFFFLQMASGAVYSVIVEGLRLRGSLSVSLAIALPLFCLAVTVAITTRARNRQGENANA
>fig|521096.4.peg.713 Probable multidrug resistance transporter, MFS superfamily
MQLPSNPMTDNLRRNRPADGVLIAVLCLGGLLASLMQSLVVPIVGQLPHLLDTTTDNAAWVITATLLASSVAMPIAGRLGDMYGKRLVLLTSLLSLITGSLICALSHTLLLTVVGRSFQGFAMGLVPVGISLMRDELHARKIPGAVALMSAMLGVGGAIGIPFGAYISEHFDYHTLFWFSLALGVVTLGLVFVVVPESPNRHPGTFDVVGTVGLTVGLVSVLLSITKGQSWGWTSAATLGCAIGGALVLIAWGFWETRTRDSLVDLRISARRPILLTNLASIMVGFAMFSLMLTMPQLLQIPEATGYGLGQTMLNAGLWMVPGGLVMMALSPVSALLTKRIGARLTLAIGATMSAIGYFALLGLTDATWKMSIGSMIVFGGVGVAYSAMPALIMANVPDTESAAANGLNSLMRSVGTAISSAVMATILTRSTITLLAGTPREVTLPAEDAFTSGFVIAGVVAAVAAVVALAIPRATKGGETTSAAPEDREIQEAGARTA
>fig|521096.4.peg.1480 ABC drug resistance transporter, ATP-binding component
MAEFIYTMKKVRKAHGDKVILDDVTMSFYPGAKIGVVGPNGAGKSSILKIMAGLDQPSNGEAFLDPEATVGILMQEPQLDETKTVKENVEDGLGQTMVNLRRYNEVAELMATDYTDELMEEMGKLQEQLDAVDAWEVDSQIEQAMDALRCPPGDSPVTTLSGGEKRRVALCKLLLSKPDLLLLDEPTNHLDAESVLWLEQHLANYPGAVLAVTHDRYFLDHVAQWICEVERGKLHGYEGNYSTYLEKKAERLEVQGKKDQKLQKRLKEELAWVRSGAKARQTKNKARLERYDEMAAEAEKHRKLDFEEIQIPTPPRLGNVVVEVSHLDKGFDGRVLIKDLTFTLPRNGIVGVIGPNGVGKTTLFKTIVGLESPDSGDVKVGETVKLSYVDQNRANIDPKKTVFEVVSDGLDYITVGQNEMPSRAYVSAFGFKGPDQQKPSEVLSGGERNRLNLALTLKEGGNLILLDEPTNDLDVETLSSLENALQEFPGCAVVISHDRWFLDRTCTHILAWEGNVEEGQWFWFEGNFEAYEANKVERLGADAARPHAVTHRKLTRD
>fig|521096.4.peg.1761 Drug resistance transporter, Bcr/CflA family
MTPTERPAPPKLRIALILGSLSSFGPITTDLYLPGLPSAAEDLGASQPAMQATLTACLVGLAIGQIVVGPLSDSIGRRRPMIAGMALFIVSSLLCAVAPSVYLLDAARLLQGLAGAAGIVLSLAIVRDLFHGVAAARMIAALMAVSGVAPIVAPLAGAQLLRVLDWRGLFVVLAVLGVALLAVAALLVPETLPTADRRPSGWRAVGAGYYSLARDRRFVALTATSGLAFAVMFAYISTSSFVFQDHYGFTATQFSVVFAANAVGLLVTNLIGGRLVGRVSTSVLVWTGLAGMALGSCVAVLALSADLLPLLVGSLFLAVSSLGLVMPTVAALALEDHGALAGTASAALGSARFVFGGLAALVAGIGGNPTVLGVVMVVCAVGALMAFVAAKRAPTAAR
>fig|521096.4.peg.1907 Permease of the drug/metabolite transporter (DMT) superfamily
MRIPPVLAVSVVLLWALGYPVAAIGVASMSPFLLLLLRFAISGVLMIGLVRATHRTLPRGADLTHAAVAGLLTQAVQFLGCYLGLQAGVPAGVAALILGVNPAATAVVARIALGERLTGRKVVAAGLGLGAVVAACWSTVPQLAHAGAGIGFTVLGLAGLAVGGVYQQRFCRNVDPVAGNAVGLLVAAAPAAALTAAFGATVTDPGRAALVLVVMVLVNSMVATTLYLRVIAVAGAGGAAMLFALIPAVAALLSAVLVAESMRPGAVIGVVLGSIACLTASWGSRRPPLAGVGGPSSEGDRLRGEDRRGLGGTLQVRPAGRGYR
>fig|521096.4.peg.1947 Permease of the drug/metabolite transporter (DMT) superfamily
MTVLMNIAFYESIAHIDLGTAVAIEFLGPIAVAVAGSRRPLDLVAAAAALTGVICVAGVNIGGVAGVDGALGVGCALVAAALWAGYIVLGKRVADAGGGIEGLGVGLAAGALILALPALGTDVLTRPESFLGWKVWVLGLGLGLLSSVIPYALDQVVLRRVGRARFALLLALLPVTATAVGAVMLGQRQGWLEAAGIALVVGAIVLTSRDVAAEAAPTSGG
>fig|521096.4.peg.3596 
MSASSGALSAPKRWISLATVCIAVLMTGMDNSIVTIALPTLSNEFGGGMSALQWIVDSYTLVFAGLLLATGYFGDRIGRRKVLVAGLVCFIVISVLATRSTSLAQLITARAALGAAAALIFPATLAIISVLFPEKQERTKAIAVWSAAAGASIAIGPVVGGYLVEHFAWSSVFWINVPISVIAIIGCLTLVPESFGSERPSFDLFGVLLSISGITLLVWALIEAPNFGWGSAPVVGALVAAAVFLVTFVVYERRQANPVLDVTLFRSRGFAMGSFAICAGFFCLLGFVFITIMYFQAVLGYGPLETAVRVIPFALVAVAVTPLAALANTERRMRFAISTGLAIMAAGFVFTSRLTESADYLTQILPSMSVIAVGLGLLQGPATTSVMTSVPSGEAGAGSAVNDTTREVGGALGVAILGSVVAHLYSARVAEDVARLPVAPGIRAEAESSVIGGVRAIGAAPPELQAALGHTVQQAFVSAMQSANLVAAGVGAVACVVVAVFLRTRPEARHRRSTSQTQVSVHDLVGRRAGE
>fig|521097.5.peg.1814 Permease of the drug/metabolite transporter (DMT) superfamily
MKDIVKGYLAAFISAVTYGMIPLFMIPIKQQGFSVDAALFYRFITASLFIMFYLFYRKETLRITPREVFIFLILGLLYALSAEFLFLAYDLLSPGIASTIFFMYPLIVALALGVFFKEHITFPTILALFIVLIGVFLLSVKDVTNFSINYVGAGVSLLGAVSYALYMLIVNKSKISASGIKVSFYSTLFSSVYFLVKLWVIGTPLPIPEVKMSLLLTSFGIVTTLFSIITLIYAIRMIGSTPTAIIGVMEPIVAVAISIWIFQQESLTTNLIIGVLLIIIAVMIDILKRKK
>fig|521098.5.peg.212 Fosmidomycin resistance protein
MAVVQAVREQGRMNRDAVWSISGSHFLNDLSTTGLVPALTQLYKPLFHLNYTEISLIVLVSYITSSVAQPLFGAWADRHPKAWMLPLGLLLSTLGITLTGVASSYGALLLMVAVSGLGSGAFHPEASRVAHLAAGRAKGLAQAIFQVGGNGGQAIGPLIVSLFILSAGLHSILWMFIGVALGLVFTLRLYPWYKAALRDYAKVRKTIEGENRIGAVALLVVVIVLRSWCQIGIAQFMPFYYAHKFGMSYQLSDALMFVFLGAGALGTFIGGALADRMPKQRILLLSMLLSIPFGFGLPFLHGAWAAVALLPFGFFILSSFAVTVVYMQMLLPRNVSLASGLTIGFGVGAGGIGATFFGVLADHVGLTSVLYILMVVPIVGAILSAFLPVDSKGGFARA
>fig|521098.5.peg.286 Multidrug resistance protein B
MRLIVGSLLLTALAQWSLMLAHSLPPYAVAIAANSFLISATQPALNAFVGNRWKSVSARLFNTMYVMNNIGIAVGTALAGVIASISFLLTFFLNGLLTLSFAAFMWRFLRRLGPESEDAPVDAMPQVGASAWQLFRNYQVYALLGAGMLALSLALAAWNSGVAPYLNQTGHRPDAYSVLWTVNGLLILVGQPVTGWLKRRVTQAPTAQLVASSVLYAVAFAGMAIAHRAYPALVAGMVVATFGEMLNAPTVPELVTRMTGPHAAFYLGLIGAIGNVGSLLGPVVFGHLFDLAGISPILWVATGACAAATVAFAGHARVVRRLGGTQGVTNGMHTSPADEGTQFTK
>fig|521098.5.peg.919 Permease of the drug/metabolite transporter (DMT) superfamily
MFSLLIFANLIWSASFTATGLAAESFSPPLIVMARMIIGGLVLVPFVMRDVRLGVWTWKKVLRISLLGLLGFTLPVTMETEGIRASSPALGAVSIALEPLLTLVVSAVAFRTPLGPRRWFAMILAATGAWVVAGCPRPGFAGYLLGDLLMLGAVACYAIYNAISGRLTADVSAASATSIMLLAAGIGCLPVYAWTGHAWPRHVTPASLWSLVFLAFFATAAAYLIWIFVLQDHDVASAAITLYLQPVFGVLISIVVTGERPSVLFYAGGAMILLALFLGQHRGQPSISSAAADPPSAP
>fig|521098.5.peg.1554 Permease of the drug/metabolite transporter (DMT) superfamily
MQRSRAAGVWAARGLLVFVTLVWGATFTLTKQALAVLPVHAFLTLRFAAAAIATLGLAILSRRRSSAWNDARTWAVGVLAGIPLGASFLLQTEGLRTITPGLSGFLTGLNVVMVPILASAMTKRRPGARTWWGVALACTGLLLMCAGTPLAGRFPGVAETILCAMCIALQIVVVDRWAKGLDAFAVAAVEVWVTALLTWAAALFAGQWAPLADVRTWTQPVTWAAVLVNGLLGTAFALWAQNWAQERLSSAQTAITFALEPVFAAAIGWMVLGEAMTWPGILGGLLIVASMAVAPA
>fig|521098.5.peg.1808 Drug resistance transporter, EmrB/QacA subfamily
MQQQATLARKEHRLPLEGVIQRPEGMWFIVGTVCFGAFMAALDASIISIALPKLEQAFHTMMNRIEWVSLIYLLALAGCIVAFGRLSDLIGRRPMYTMGFGVFIIGSALCGASWNLSSLLAFRVVQGIGASLLQANSVSIITAAADAERRGQAIGFQALAQGLGLSLGPLVGGVLTHIASWRLIFYINVPVGILGTISALLFLPRDRREGPRPRFDLVGALVLAFLLIVTMYVLKEGFRPESRPTITAMLLAVAVLAAASFVAIERRAESPLVPISYIREPVIWLGNLTSILSFSVMYAITLVVPYWFVHVEGLSSAKAGLLLTALPVGMALCTPFAGRLADRWSKVKVSAAGMVLAAMGSASLFAFARVTPAFLAGLFLVGCGIGTFTPANNARVMNATPAAHLGVAGGILNMSRSLGMGVGVTAGGVSVELFTAAFGHHGVALAYRCSFLVAAALALIALGLTLLRQKQSREAA
>fig|521098.5.peg.2591 Multidrug resistance protein
MRRPAWLGILAASLIPFVLTLGNSMMVPVVPVMQSTFGVTPTAASLLITAYSVIAVVLMPVAGFLSDRMSRRRLAIAALAVAAAGGGVAALGASAAHSYAWVLLGRIVQGVGAAFSMPLALPLASDLADPHGRGRAAGFTEVGNTVGKLMSPILGALLATWAFFAPFWAVFALCGTLSATIAWMVPERRAPVPRSHLPAAWRLAFRAHAKLLTATYLSGAVSMLCLFGGLVSLSESLADSAHVPEWQNGLLLSIPQAMLCLASLVTGLFSDRWKAPSRAAIALGLAWTAASFGAASASQDMAWQIAAVSLGAYGIGTAITAIDASLATALSHEVRGTLSSLYTSARFLGPTLGPPLASWLQGFGARTPYAVLSAIALAAAIAIAPLLRRSTQDGESAAREQRQAAHT
>fig|521674.6.peg.126 Glyoxalase/bleomycin resistance protein/dioxygenase
MTIVVKDLVRSRWFYHEMLGMAEVSRPAFSFQGQWFQAGSTLIHTILEFEGSGPAGQSGGRSSRGHHIAFAVPDVRIAEKFLQQEGVPIVVPCKLRPDGALQTFLHDPDGHLIELTSPPESLFRPGASLAVDVSSQVMLDGVFSLLT
>fig|521674.6.peg.4456 Permease of the drug/metabolite transporter (DMT) superfamily
MPYLLFLLICTVWGGSFILMKKANPVLEAITIGGWRVAGGAIALGLIFWWLGPSRTLRRKHLGALVIVTFLGFTWPYVVQPWLVERNGSFIVGGSVSLNPLMTIFIAIPLLGVWPTQRQFWGVLAALSFLIVLFAGEIHKNLPLLDLAVLISVPLGYAFSNVIIRRTMKDANPLELTLVALAAAAIILLPLAWFTESAAPDATRIDWITAIGAVAILGVAGTGLAMYGFNILIRDQGPLFAGMVTNLVPLWAFYWAWLDGEPLTLLQLVCVVGVLGSVLVVQYRAAGAKTPAHPPVAAPAIPPLEVTDEATELVTVRSVPTNTLAPAREQIAAGGENG
>fig|522306.3.peg.401 Acriflavin resistance protein
MKSFNLTEWALNHRAVVLFLILAIAIGGVLGFTKLGQLEDPNFSVPSMTVIVIWPGATAQQIQDEVLNRMEKKFEQIDHFDKVKTYARQGYGGMTLSVVGGTSHADQREAWYQARKKFSDVKLELPDGVIGPIFNDEYGDVTGLLYAVKGDGISHAELSDTAEDIKRRLLKVPMVKKVDIYGKQAKKVYVEFSHQRLAALGITPLAIAESLRSQNSVLASGSIDTHGDRVLVRVSGQFTSLDDIRNVPIAAGGRLIKLGDFTTITRGYEDPPMYTVRHNGQQVLMLGITMTNDGNIVEFGHAIAKAVANVQAELPHGIELERVADQPTVVSESIWEFERSLMEALAIVLAVSLISLGWRIGIVVGLSVPLVLGVVALVMLAMGWNLERVSLGSLIIALGLLVDDGIIAVEMMVVKMEEGWDRLKAAAYSYSATAMPRLTGALITVAAFMPIGFSRSTTGEYAGGIFWIVGTAVLFSWVVSGIITPYLAVNMLPKDFGTHHHGADPYDTPSYRRLRGWIDLAIARRWWVIATTVVALAVAVVGSRFVPQQFFPNSSRPELVVELRLKEGASFAATTEQVKKMEAVLKKDEDVRFFTAYTGAGQPRFYLSLNPELPNPGYAAFIVMTRDMEARERVRSRLMTSVNEEFPEVWVRVTRLELGPPVGFPVQFRVVGPDTQRVRSIAREVEAAVASSPKVRDVQLDWNDPVRTLRVDLDQDKARALGLAPADVAFVTQTVMNGATVSQLREHEDLIDIVARAVPSERLDVDTLKDVNLYTREGTVVPLSQVARVRYELEEPVLWRRNRDMAITVRADVKDGEQGVSVTQEIRPMLKEIEAQLPFGYRIDVGGAVEESDIANRALMAVFPVMLVTILTILMLQLQSFSRMFMVFLTAPLGLIGVVAALLIFQAPLGFVAILGITALCGMIMRNAVILVDQVQAEMAEGRDPWNAVLEAAVHRTRPVALTAAATVLAMIPLTRSVFWGPMAIAIMGGLTVATLLTIFFVPALYAAWFKVERASAANPEMPPAAAPA
>fig|522306.3.peg.1157 Polymyxin resistance protein PmrJ, predicted deacetylase
MKRIALKIDVDTCRGTLVGVPALIDLLQRHAASATFFFALGPDCSGREAHKSSPSRHYDLTTRLSGLLLPAPDIGARAADSMRQTLAAGFEVAVHAWNRVLWERRVLSADNAWVEAEMAQAWRRFEAIFGAPPLAHGAAGWRMNRHALRLTQRLGLCYASDCRGKYPFFPVIDGEIVRCPQIPTTLPTIDELLLLGAASADQAVEQVIEASTTISGDHVFTLRAELEGITFCDAFERLLATWQEKGHRLVALRDLLAARNVAQLPRHTVAFAEIAGRTGPRMLQGRAFLEE
>fig|522306.3.peg.1583 Multidrug resistance efflux pump
MIAGLVMVFGYALIVWAVFVKFKWLKFTIPWGVISAFVGVHLLIIFLIGLRFMTPLATEAKVIQHTIQLTPRLPQPTLLMAVLAEPNVPVRKGQPLFQFDRRMFEYQVRQLEAQLAKAKQNVLVMKADTGIAAQKVIKLKSHLEFARYQQALSAKLAKQGAGPEEDAQKWAAQVAADVAAIKEAQAEEQRAILNYTSEINGVNTSVAAVQAELDQARFYLDNTLMVAPEDGYLINLQARPGMVAGDVRIGAVASFVCDADRYLLANFFQENLKYVKPGNEVEAAIDLYPGQIFKGKVLAIWQGSGAGQMLPSGVLPNFQAVPTDRPQGQFAVAIRLDDPDQAKFPIGTQGRAAIYANPDSWFVPLRKIMLRAYSWFNWIYPFSG
>fig|522306.3.peg.1780 Permease of the drug/metabolite transporter (DMT) superfamily
MKRSHANLLLLVVAVIWGSAFVAQVVGMTGVEPLTFTGIRFLLGAAIVCPFAWREWRALSAHGAQPLPGDALSVATLGVLLMLGAAFQQIGMTSTTVTNAGFLTALYVPLVPLLAWLILRTRPHWSVWPTSIGCLGGTWLLSGAQALDPVVGDAWVIASSLFWALHVLLVGRIAERMAAPFVVACGQFLVCGLISLLWAGLNETITLAGIRQASLAIAYAGVVSVGIGFTAQVIGQRYAQPADAAIILSAETVFAALFGFLLMGDRLNASGIAGCALILVCIIAVQLAPLTMAGRRSASRSDTAEAGR
>fig|522306.3.peg.1941 Acriflavin resistance protein
MAEPEKLPAASLSQLTIDRSAAPARRRRRSWVGWLAGALVAAGIAAFLLVPGKTEVQVTSVLSAYPSQQYTQLTASGYVVAQRRASVASKGTGRLIELRVREGSPVQQGELIGRLDASDVQAALLVAQAAIGQAAAGVRQAEANLEQAQAEAANAEVEFQRQQTLRTRGFVSSQAVDAAQRRALAARAGVGAGRAAIGSARAALAQAQAQVSVQRVNQDNTEIRAPFDGVVLVKNANVGDMITPFSAAAGTSGAVVTMADMSTLEVEADVSESNVARVRVDMPVEITLDAIPDARFRGSVARVVPTVDRAKATVVTKIRFEKIDARILPEMSAKVNFLSQPASDADQTPVVAVNPRAITERAGSKVVFRLVGETVEAVPVTLGRKLGDAQELTGSPLQPGERLVLAPTERLAAGASVVVSGK
>fig|522306.3.peg.2883 Permease of the drug/metabolite transporter (DMT) superfamily
MDKAPPRWLPFLVLGIGLLAISFGAILARIAQGYGLPSLTIATLRLGLAALLITPLALWQSGSALRMLKPRQGLLTGGAGLFLALHFATWISSLEYTSVASSTALVTTNLLWIGIASFLLFGDRPSRLMVIGIVLSLSGSLLIFWSDSRTSAPGTNPLLGNFLAIAGSWCFSAYLLIGRRLRASLALPAYVWLAYGSAAILLLLACQASDTAITGYADAAYLVALGMALGPQLLGHTSYNWSLKHVSPTFIAVVTLGEPVGSAALAWLFFGESFAPLQATGFVLLLVGIYLAARGEGK
>fig|523791.5.peg.246 Permease of the drug/metabolite transporter (DMT) superfamily
MTKLPQKQLAMAGLILAVVLWSASFVAMKLAIAEFGPIMTVFLRMILATAVLIFFLPPMAKKQQYQKGDWWLLLLLALCEPCLYFIFESYALTYTTASEAGMVTALQPLMVAVGAYYLLKEKLNSRLLIGCIIAVVGVVWLTLAGTSSEHASNPMLGNALEFGAILAATGYCLLARKLAQRYSPIFLTLLQTVMGSIFFLPLIFVQGAPLNFDVSAEAVLAIMFLAFGVNIFAFTCYNFAFKTMPASQVGSLMNLLPLGTLFFGWALLGETLSGMQYLAAGLVLFGVIWSQTKPRPKTVFIEQDMVTRSLRHKAKQKIRKSFGLVETP
>fig|523791.5.peg.1035 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAHSADNNSTSSSGHSWQDIRHETTAIIRIAIPAILAQLAQMSLGVIDTLMAGNYSSNALAAVGTGFNAFMIIFSLFMGLMMAINPMVAHFNGQGKMDSIGKTFQMGMFLAVIFGIITFILLRNVDPILYLLGVEDAIVETTSGYLKALSWGCVFAFLFIALRSGNEGLFSTKIVMFCSFMVIPFNLLFNTWFIYGGLGVPAMGAVGVGYATSVVWTLLFLFLLFFTWRNPSFASLNIFKKIRWPTWALIKEFFSIGTPMSLGLLMEVSMFGMIGILVARYGVDLTGAHQIAMNIATVAFMVPWGLSIAITARVGYWMGRQDYRQMRLSGFCGIGTSLFFQAVSVAIMLLFRYQLVGVYTDDQAIIEISASLIFLAAIFQLSDGLQVNSAGALRGMKDTKIPTVYMAIAYWFIGFPVGIYLADYMDLKVKGFWIGILVGLTVAAILLLGRFIHRSKQTLAFAEASRS
>fig|523791.5.peg.1531 Acriflavin resistance protein
MVKQYDTHTGIISWFARNSVAANLLMIFIIVAGFIGLSHLRQQVFPDIVINSVSIQVPYPGAAPQEVEEGIVILIEENIKEIEGIKKVTSTASEGMGSINIEIQDNYEVSEVMDEIKVRVDAIPNLPDLAERPVIYENRMQRQVMRLNVFGDANERTLKEYGKDIKNELLALPNVGLVEVEGARPYEVGIQVSDHQLRKYGLTLQDVANAVRSHSLDLPSGTIKTLGGDILVRTKNQAYDAYDFAKIPVITRPDGTTLLLADIAAIDDGFAEWNFLSRFDGKPTVSLRIRSSLESDDLLIAEQIYDYLDKKTPTLPAGLSIEAWGDGTYYLKGRLEMMQKNMFVGILLVFIVLALFLRFKLAFWVMIGIPLCFLGAFALMYMYPGFAMTINMITLFGFILVLGIVVDDAIIIAESAWASIEEKGHSIDSVVEGSKRVALPATFGVLTTIAAFYPMLAISGPWSNAMASMGLVVMFCLMFSLVESKLILPAHLAHMKLNKLEDTKNPKVRAVKGFFRAIRLKVKDLLSRFINNVYRPKLEMFLKYKGLTILSFVCILFITTIGFIGSGWVKTSLFPNIPNDGVFVEIKMAEGATAEQAMSNVQIVWDKLNKLHKEVEAEHGIGVFQHAFMWTRENTGGYMWTELVKSEDLPIHQFELIDRWRDMVGTLPAVEEISFGGGGGGPGGDGVGYRLVGTDIDELQIVTEKIRAKLAEYDGVYDISDNLSGGKEEIVVEVKPHGYNLGLSTQILSQQVRNAFYGSEAQRFLRDNEEVKVFVRYPLEDRRSIGNLEQMPIKTPSGEYVSFTDVADYQVQEGYSRISRIDGVRANRISADVSPQATITSGEIHEDMMQNVIPGILAQHPTVKLEPGGPSEDQQKLSKELGIGGLIALILIYGLMAIPLKSYIKPVVVMSAIPFGIIGAMVGHLLLGINLSMFSFFGIIALSGVVVNDSLLMVDFIGRARAEGMSRIEAAVNAGTRRFRAIILTSLTTFFGLLPITTETSLQAQLVIPMAVSLAFGIVFATVITLIWVPCLYVTLGSVKDWFLGRDAKSLSKEQEAYENN
>fig|523791.5.peg.1746 Permease of the drug/metabolite transporter (DMT) superfamily
MAFIMSTPVLYALCVLIWGSTWFAIEFQLGVVPHEYSSFYRFGLASLLLFAFCWFKKLPMRYGLLQHAWLVLMGITFFGLNYLLVYEAQEYLTSAMASVIFSAVLIVNIFNSWLFFKAKITARVIIGSALGLIGMVMIFWNELTDFTLENAKLYGLLIALLGVLCASIGNMVSVQTQKYDMPVIQMNAYAMGYGSLFSLIVGLVQGKALIYDMALGYSISLVYLSVFGSVLAFGAYLTLLRRIGIHKATYAVVLFPAVALIISTFFEDFIWTWIIATGIVLIGLGNVFVINREDIKKQ
>fig|523791.5.peg.1995 Outer membrane component of tripartite multidrug resistance system
MSIRFPFALLLLSTVASCAVTPDFKEPEPPSVSQYTGSDDAVVIGSNKKLATGQTLQWVDATDQQWWQQFQSDSLNLLVEKVLTQNPSLLAASAQLRSAEELYQARVGTTRYPKVSADVSAQRQRFNPGVFGQQATPQEFSIYNAGVDVSYQLDLSGGNSRALEGLASRVDYQRYELEGTQLALVATVLNTAFNQAKLRSQLEVTEQLVAKQEQQLDIVKQQLELGQVSKHEVLMLQSEVELTRANIPVFRNQIQKTEHLLATMAGETPDSENIPDFNMQDFGLPESLPLIIPSELVRQRPDIQAAESLIQAANAEYGVAIANMYPSINLNGQIGSQALSAGSLFSSESAVWSLIGQLTQPLFDPGLPAEKRAALAEFEAATSNYQYVVLEALREVADTLRQLENDAQKLNALSDSNQSSEEAMQITARRHELGAASYIELLLAQQQYLSTRMQLIDAQSQQLINSVSLYLAMGAKPSLSQPDVQ
>fig|523794.5.peg.165 Permease of the drug/metabolite transporter (DMT) superfamily
MKQYLADFGLLFVGIFWGLGFVFVKIGLNTGVDPFYLSAVRFLVGGLILYGIFFRKVGRFTKKDILAGLIVGIFQFFGYAFQTYGAMLTTASKNAFFTSINVIIVPYIFWFLHKKRPDIFAFLASVICVMGVAVISFDRKMNLANLNFGDILTIISAVFFAGQIATNGYFSKKVEPLKLVVMQMFVAGILFVINVFIFSDISKIEKPAGMTLVAIIYLTLFSTAIPTVLQTFCQKYTTSTRASILMSTESLFAPLFAFFILSERLSLRVAAGASLVLFAVLVSETKLGLKKIEE
>fig|523794.5.peg.319 Acriflavin resistance protein B
MTVAEFATKRVVSTTMILLFMIFSGFMTMRSMKKELIPDFKFPMVVISTSWTGAASEDVKTQISKKIEDAALNVDGIKNISTSSTYGNSNVIVEFNFGTDTDIKQVQIQSEIDKIKRDLPSDANDPVVSKMNMAGGNSDMALMVAIRGGDEATITSFIEETLKPRLKRNRGVGDISVFGNATRQIKVKLDPYRLQAYNLSPSEIYAKIQAANTIVPGGTVKDGSKEFILKVDGELKTLEQIQNIIISNKDNQVVRLNDVATVEYGTKDKTSYSKYDGQDMISVMIQKSKDGNLVEIASIARKALEEMKPLFPSGTSYEIITDNSIRVKEAISNVTSTGLQALVITIIVLLVFLKDLRAALVVGMSIPISAMFTFFLLGTQGITLNMISLMGLALAIGSLVDNAVVTLDNIFDHIQLNKEPAMVAAIRGTNEVILPMIASTATSVCVFLPIVLFPGFAKEVFSGISFSMMFALSTSIVVAMLFIPMASSIFLNIEKISGAAGKAHRFNAFRDKYKELVKKALENRKVVIIGIAVLFVVVVFGLGKTVKSAFFPTIDNNEYSVVASLSTGLDVEVAHEISKQMEQIVKEDPVTKNYTTIVNAQAAIVNVDVKKDTMKAMERVRQKMSNIPNVTIAVSPQKAGGRAVSKDYSFQVEGDNAEEINRIANAIMADMKQQSWFKDVKSSSEGGYPQAQLEVDRVKAESYGLSVTDITRMLNQTVLGVDPIEVTQDTETLKVYMEFEDEYKNSLEKILNIMIKTSTGQFVRLGDIATMKEVEGAASIETYNGAQIVTVGANMDKSKGLNDAASFVNASFQKTNPAAGYKIAPAGNAQSQKEMGGEIMNALALSIVLIYIVLAVQLESFVLPLIMMLALPLSMIGVIFGLAVTRIQLSMFVMIGILMLFGMAVNNAIVLLDFVSGLRQKGMEIREALVEAAGSRLRPILMTTLTTVLGWIPMVFSSKGSSGYYQGMAVAVMFGLSFCTLLTLFFIPVAYSIVEERKEKRQKAKEEKRRAKKINERN
>fig|523794.5.peg.1291 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKKREELLNGSIIGLFIKYFIPTLIGSAAVVLYNIVDRFFVGKISEKALAGAGIAFYIVMLIIAFSMFIGVGAGTIISIRLGQGKKGDAKKILGNAVTLFAILGIALYVLLMLNIDTVLRYSGANNETLPYARAYLQIILLAILPLFYSFGLTNVLNAAGAPRVAMFSMLIGAVVNIVLDYVAVMIMHTGIEGTAYATLIGNVLSAVFVLWFLIAGKSPFRIDMFGFKLEKESVITIRFSKLKLEPKIVKDIFSIGMSPFLLQAASSAVGLVTNKIVDTYGGTYGVAVMTIINSYLPIMTMSVYSVSQAVQPIIGFNYGAKNFRRVKKSLMTAINAGVMLSFVFWVIVMLIPKELILFFNEKSTPEGLREGVKAIRIYFSLVIISSFGITVPNYFQATGRSKYSVTLNLLRQVVIFLLIVIIFSNIWKLDGVWYAQPFTDLLFFVILLGFLYKEKKFFDKMIQSENNILEYKEMIENKKDKKNENIK
>fig|523794.5.peg.1799 Vancomycin B-type resistance protein
MSNGNRRRNFCDIHPFYYTISLHKEIAKRNIKDFFSKEKFAKTKKEEKLPNIISTHSSNIIRKGKGIDPILQENKAVNLELASSKINGIIIRPGETFSFWKTVGKATRKKGYKAGRIISKGKIKPGIGGGLCNLGNTINWLILHSPLEIVELHTHSDALDPSAEKNRIPFSSGTSVSYNYIDYRFKNNSDQNIQLFVWCEDGKLKAELRSETEFPWKYELVEENHHFRKKGDKYYRSSKIYRNAIEKTTENILSKELIWDNNSMVMYDYDLIPKELIKEEK
>fig|523794.5.peg.1980 Permease of the drug/metabolite transporter (DMT) superfamily
METKLKLRGMLLASLASSFWAISGISGEILFKQFNFSSDWLVSTRTLVSGILLFMIVVFIEKKSILRPLKNKWDSMGIILFGVAGMYLVQYTYFKTIELSNVSFATILQFTAPFFIFIYESIKNRKLPSISTVTLLFMTILGVVFIATKGNFSNLSVSLEALLFGLVSAVMIAFYSTYPKKLLKKYGSITIVGWGMIIGSVISNIIHPIWEIQGDINTKSIIQVIIVVILGTSIAYLIYIASLNYISSSLAGILTAFEPVLAAVLSVVIFGLKFSIIELIGFVLVFVSIFILEKRL
>fig|523794.5.peg.2111 Quinolone resistance protein NorA
MKKNINRMIILMFLCIIVYNLGHPATPALIELRGWKKSISGELLAFMSTAMFISSPYLGALADRVGMKRIFVFMPFCYGMSQLIFGFETNLPLIFLARMISGFASGGTFAVAFGYVSQLSEKEEKAKNIAKVSSATVIGGAIGQKIGGYVATAMNDPRFSFALQFIGGSIVSIIILLIMKEIVKKDSNSEEEKSKKDLNPFATFRYIKELDGYSKFFCLIILLSGIGIYSYGSALNYFFKFYEKVSSDTIGTFVMCSSLLAFFGTAFLLGKLLKKFKEKSIYKFLIFTGIILMSVILFRVKFGVTPYILMAVYTMTYEIVRSLGNTIIAQRYKENQGKILGVASAVGSLGTAIGSLLSGHLLNFNPFFPFVVNIIVMSFVLILILVKKL
>fig|525146.3.peg.1155 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MTPPPARTHGPAGQASSGPSTPGTTRGDAANALAAPKGRRAALARAHGATLLFGASGIFGKLCQCSAPMLVCGRAIFAVAALTLAGLGKKQPPWRGLHACDLLALTISGTLLAAHFVMFFMGIHIGGVAVGTLGFACFPAFTTLIESLIYRERPSFAEMRGLGMVTLGLVCTTPSFSFAHEGTVGLLLGVASGLAYALVTVGNRRFAGHLPGLQTTWWQNTVTAVVLLPFVWRQFSTVSTLDWLWIASLGLLCSALAYVLFINSLTVLKARQAALIITLEPVYAIAAAWLVLGDAPGGRVFLGGGLILGAIFLANRR
>fig|525146.3.peg.2568 Quaternary ammonium compound-resistance protein SugE
MSWVYLVMAGLLEIVVVAGVRDIAFRRYARGFVVYGLGLTSSLFFLYLALRQIDVSIAYTSYTGIGVIGTVASGLLFWGEKRSFRKACYVGLIVAAIVALKISG
>fig|525280.3.peg.502 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRKDFYRNVLPAMFAFAFSGLYAIVDGWFIGQNVGDLGIAGINLAYPITSFIQALGTGIGLAGAIQIAIALGSNDHEDQARYLKTTVCLLIVASLVAFVLLFKTYPQILTFFGAQGRLFDYAADYIRIIILFSIFQIMATGLVPIIRNYGGTLFAMVAMITGFITNVILDGYFVSVLKLGTAGAGYATIIGQALTMLLCVGYMFKHVPFGGSEKIKVKMSSVVQVLKVSLSPFGLILSPNLMIIVLNQSAIQYGGDIAAASYGVICYVVFSVQLLLHGIGDGCQPLISRYYGNDSMDKVHEIVSIAIRFALGVALTCMVILYSLRFMIPGFFGASEEVALMIAEVMPLFLLGLIPIAFLRVSTSYAYATRDNHTAYRLIYSEPILTTVLLLWVLPGMFGLKGVWLSVPLAQYCVLMYSIVVYWKQVKQYKHDFHV
>fig|525280.3.peg.507 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNTITTRKQLRHNLARYILPSIGAMIFFSLYTMVDGMFVGKGVGPQALASVNLSMPYINMIFAFALMIAVGASTRITYYFGKKNLYESNVIFSLGFWFLGLFALALAILMGLFRDSLILLLGATPDTMHSVSQYLSMMILFSPFFMLTYYLEVLVKADGAPGLSLLGIILSAFVNIILDYLFVIQFQWGIQGAAIATGIAQVFGFIFFLSYFLSSKSTLKFIKPTWNFQTLIKMIQIGIPDALTELSSGFITFVFNLGVAFYFGSNGLAAFGVLMYLTNLVTVTMIGINQGIQPLISYYHGQKQPKLINWILNDALFVSVLCGLGFFILCQAFPKVLVSGFIDAKNIEPFNLAVEALPIFSFGFLLSGINIVLAGYFAALERIRPAMLISMMRGYLLVALCVIILPYLFGASGIWFAPLTYELLTLVVSLILFKHYKKTA
>fig|525280.3.peg.647 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKIHKKTSMTEGVIWKEMLLFSIPLLIGNLFQQLYNTVDSFVVGNYVGEEALAAVGASTPLSNVIIGLFMGISTGAGILISRYFGAKKDEELHDSIHTFMAFSLIVSIFLTFFGSVMSPIFLGWLKTPANIMEPATLYLRVYFWGVTGLVIYNSGAGILRAIGDSRNPLIYLCISSLINVSLDLLFVIVFDMGILGVAVATLIAQLTSAILVWIHLLRVEDIYQLKMADIRIHRDKLYEIIRLGIPTGIQQTVVSFSNVLVQSYINAFGSAAVAGFSAADKFNAFLSMPTQSFSLTITTFTGQNLGAGRKDRIMEGVRTALILAVGIVIVIGIPTFIYADQLIAFFSPEPMVIMYGARMLRIMVPFYFALSTTSILSGALRGAGLTMVPMIIMISCFTILRQIFLFIMMRINHSIDWVYWSYSVTWISPMVLTLLYSKASHWLEKA
>fig|525280.3.peg.926 Teicoplanin resistance protein vanZ
MFERYLSPIINNTQGVSINSGIIVYILVAMIFLVKFRKTTVKNKILGLLFILYLGKVMDLTLFPLPLNQKEVQNAAIHFSLENASIDYYNLIPFRNGISLKNLKEPLLNVLMMVPMGVFLPVFFKRFRKVEKTVAGTFMISLMIECAELLLTLSFGVILWHFDVTDLITNTLGGFFGYCLYYHAVRHVLVYFDQKESHWLHRKGFGVMSILLLFIFMMSSIYLEVSANDSITYRLNMRNMISNGKANRRYYSFDQYAVSMEGSMKLKRDDFAGSHSDNPTIELKQKVLFLDYSFGKYNVGGIYLDAHHNEGDARLFSIIWDLDYGGDYFYFITESKIATARKVGEAKITNP
>fig|525280.3.peg.1495 Quinolone resistance protein
MKRPQFIEEFVVSNARVLFSELKRNTRYESCLIYQDHALVKCEQVCFSKCEFEMDACDRAEFLDVVFDRCDLSNHSLQKSYLYRCEFLSCKLMASEIYDSKVKDVVFKDTLMNFMNLSQSSFENVLFDGCRLNESSLMMAKYKNMKFKNCELTGLNLSDTRCNALDLTSCTFDTIVYSPSLIKGMRIRADQASALIGYLGLIID
>fig|525280.3.peg.1535 Multidrug resistance efflux pump
MKLLIEKYKMSIFVVLNLLLTIGMNLGHPVTPTLLKSLDLPPHVFGLSFAAMCLTNFIFALVWSNVANGMKKTRILMISSIGYAIAQLLFGYALNRYSIYFARLLSGIFAGGFQVGLMSYVVNEAPEDRQSHYITISSIIVSVGAALGFFIGGYLGDVSVRLTFVIQALFQIVLGILFYLILGSHENIEEKMEWSMIRNSNPLKVLQSSRHLMKDVVLILLIVTFTSSVGTTLFDQSFNYYIKDIFNFVPSQNGIIKAITGLFAVVLNVILIRRRNRKKQGVELGLLKTVFIAMGSLAIIVSFSQTSKPFVGFALAWFGMYTVMIPILQNSVISNKHSVEEGNQLAGLYNSLLMLGKIFGALLTSLIYTISPSSTFMFAGVIFILSFIILLKPEKRMK
>fig|525328.4.peg.860 Permease of the drug/metabolite transporter (DMT) superfamily
MKQQKKLWIFLVIISCNLWGISGLCAKRVFDLSTQVSPITITQIRMLISGLFLLLLAQLTGKKPIKILYSRKNIIDIILYGLFGLIPIQLFYFIVVQKSNASIATILQFMGPFFIMFYMVVFEHQFLRRLDIVAALVAFMGIIFIATHGNFSKISLSPEVLFWGFLSALGVATNTLIPRPLLKRMDSVTLIAWSMIATGLMMLIAYPSQILIPKDSRVIILLVVIIILGTILPFYCMLNSLRYIKPSTASILDAFEPISATLGSVFVFNLILKPIDWLGTILVILAVIAICYQPKSKIESIQK
>fig|525364.3.peg.847 Permease of the drug/metabolite transporter (DMT) superfamily
MENKKKFWTIMIIISCTFWGISGIFAKFIFNLDRSNTPIFVSQIRMIISGLVILFFSWLNKDKPMEIWKTKKSSFTIIMFGLLGLIPVQYCYFEAIKYGDASIATILQFIGPFFILFYLTIVKRQAPRRIEVICTIIAFIGVFILATHGNINHLAITPQVLFWGLLSAIGVATNTLIPKSLIHEFSPTAVTGWGLLIAGVGLFIIHPHVSASILAPQAIVPLLCVLVIGTIIPFQLFTSALRYVKATTASMLDAFEPISATIGSILVFNMHFYLADMIGSVLIILAVILLNWQPKGKIQ
>fig|525364.3.peg.1503 Quinolone resistance protein NorA
MLHLDNSVFGTAFAVMSFGIFIASPFWSKIAGLVNSKSVIAIGCIGYAIAQFLFAVGHTTSLILIGRLLAGLACGAFFVGVLNYIVNLSSETNRGANLTLNATIQTVASALGYFVGGMLGAYNVYLSFAVQVIQLTLVGILFYLLLEKDSKNTDSLQLSLILKESNPLKRLEDGRLFMNKAFALLFSVSILLYLGYTAFDQSFNYYLKDIFNLSSSFNGIFKGAIGIISLIVNTSIGLYLMKNTKISKSLIYVLLGASTLMVLILFSHHLTAYVISSCIFYGFYALSTPLLQDLITQEAQVETRNLVLGFYQSTQSLGQILGAYLAGIIYNFSPQAPFSLAFLALLGAFLCSIFYRRMYRI
>fig|525364.3.peg.1714 Permease of the drug/metabolite transporter (DMT) superfamily
MSMKTKGILLAAGGASLWGGSGAAAQQLFMTHAVTTEWLVAVRLLGAGLLLLIWGLIKSSKQINEIIHDRKNMAMVLAFAIFGVMNSQLSYFFAIKYSNAPTATVLQYLQPVLIVLWMAFGQKIRPRRVDGISIAVALMGTFLLVTGGRLDTLTLTPIALAWGLWSAVAATLYTLLPSGLLKKYDAMVVCGLAMFVSGIIMLPWFLTMEQPHLSLFNIVLVIYIVVFGTMFAYTLFLQSIRYIAPSVTGILSAFEPLIATILAVTLLGTKLSTAAIIGSLLIILTTVIQAVPFNVIWRRFKRAK
>fig|525897.5.peg.205 
MFVVIVDIVIKKEFVENFREAVLRQGENSMSREEGCLGFDILENPEDPSRITLYESYTDAATFYGIHRETPHFTEYARTTAPWVESKSMRALTKIWPKN
>fig|525897.5.peg.991 
MIHVVAHVTLRPGTAPVFLREFRDLAVLVRQEPGCVDYFPARDVDMGLHFQPLDPDRVTVLEKWTSRRALESHLRSGHMRGFEDRIKDIVLDMKLTIVEEV
>fig|525897.5.peg.1108 
MKVLLASVPDCLHATVSIEGDENGAIFYLEKWRSREALDDHLRSSTYMMVLEALEFSCKNPEVSFFDGVEVGGLDVVEIARSVTASFS
>fig|525897.5.peg.1124 
MIISIIKIFPAAGREGVVMDVLDSLKGPVSAQAGCLGCSVSVEVGEGEAICYTERWSSREALDWHLSTPLYMRLLEVMECSCRPPEVEFFEVADALGIELVEQIRNPKGEK
>fig|525897.5.peg.1796 Acriflavin resistance protein
MIVNEAAQRRQPLVLVSLLLIIVAGLYSYANLPREAAPDIQIPYIFVTTDYEGVAPEDMEKLITVPLERKLKGLEGVEELTSQSDDGTSTIAIKFLPSEDIDDALQKVRDKVDQASGDLPSDLEDDPLVSEMNFSDMPIIQVVLSGPFSLKRLKVFAEDLEDRFESISGVLDARIIGGLEREIHVEFDLDRVGAYKVPFAAMLQSVERGNVNMPGGSMDIGDMRYQVRVPEDFRSPAEIDSIVAFVRDGKPVYLRDVAAIRDHYKDITTLSRLNGENAVTLQVIKRSGENIIDINDRVAAVVEEMRLLLPPTLTISLTADMAEDIRNMVADLENNILTGLILVLGVVLIFIGGRSAVFVSVAIPVSMLITFALLRLLDITLNMVVLFSLILALGMLVDNGIVIVENIYRHMQEGKDRFQAALDGTSEVAWPVITSTLTTVGAFFPMIFWPGIMGGFMSFLPKTVILALAGSLFVALVINPVLSARYQTAAPALAVDGNVVRSRSKRAYLWLLEWALNHRALVLGVCVVMLLGSALAFGKFGKGVEFFPETEPKRAYANVKLPVGTNLDATDRYIRIIEDVCSEYADVRYVIGSTGAATGGDFGGGGSGTHLGSVTLDFVPIGERSRHSSEIISEVRDRLSALITGAELRVEKEDEGPPTGDPVSLEIYGDDMQVLAGIVEQVRALMRDIPGIVDMKDNLVTGKPEIQIRVDKEKTSLLGLDTYTVAYTVKAAINGAKVGVFREGKDEYDIVAKLPRKDRESVESLRRITVSGLDGEPVPLTTLARVDLASGLGAINHKDQKRVVTVSSDVSGRLANDIIRELDGKLGALAWPRGYTYSFAGEQEEQRKAQEFLSEAFVAAIFLIFMVLVAQFNSMVTPLIVLTSVVLSFIGVFTGLLITGTAFGIIMTGVGVISLAGVVVNNAIVLIDYFEQLKAKGMQTREALLEAGLTRFRPVLLTAVTTILGLLPMALGVSFDFFKWKLITESESAQWWGPMAVAVIFGLLVATLLTLVVVPVLCSLQDGGRAWLTRRRSGKAGEAVART
>fig|525897.5.peg.2398 Efflux pump antibiotic resistance protein
MHIRTSALAAASVASFLVPFMMSAVAITLPVMQVELGATAVELSWIAGSYILALAAILLPVGRLADILGRRRTFVWGTAAFVIFSLCASLAWSVTSLVALRVVQGVGAAMILSTGVAIVTELYPRTERGRVMGIMVACVYLGLSVGPLVGGMMTSLAGWRSVFFLCLPPGLLAWIMARRIKDEWRPAHGEGFDLIGSLLYAAFVVCCVNGLTGLARPERGLPLLGAALILGVFFVLRSRSVAHPLIDLSLFTANRVFLLSSLATLVNYAGTFAVGFLLSLYLQVVKGFSPMHAGFILIVQPVVQSLLSPLAGVLADRFNAAWLASLGMALCALGLLGMCGVDLHTGLLEIGAILALLGLGFALFASPNMSVVMGSVEPRHYSIASSLVATMRTFGMTLSMGIAAVVFGFLLHDRQIAPETIPEFLASMRIIFAVCAGLCVAGVFCSLGRVGKR
>fig|525897.5.peg.3000 Permease of the drug/metabolite transporter (DMT) superfamily
MKHSTSSKSLQGILFALGATVIWSGNFIVARSLNQSIEPATLSMLRWATAFVGLLPFAWRAAWAERAAIRRSMPAMIPMALLGVTTFNALLYKAAHTTSTLNLSLIATSTPVFIILLARIFLHERLTTRKMLGLTFALGGVLLLITGGDLGRLTGLDFAIGDLWMSLAAVIFAGYSILVRRFPGGLSQPVFLLTLFGVGIVFLAPWTGWELLTAGAPTITLGAAGAILYVGLGASLAAYAMWNSAVASIGPSLAGLIYYSLPLFSGVMAFLFLGEPMGLIHLLSAGCILGGIVLATRR
>fig|525897.5.peg.3201 Permease of the drug/metabolite transporter (DMT) superfamily
MKPYLYALGAVLCWASLPAATGSGLERLSVTELLFFSFVPAALYLTVQEMIISRRRAIPWPGLRLVALGLAGIFGYHALYYLALDHTPLVEGAILTTTWSFWIVVFSSILDKKRLSPPVLAVALAGLAGAGLVVSGGQSLQFEARYLPGYLMALGCGLIWSSFSVALSRLKPTRDYMPAFTVLAALFSTLVYAASAPQALPPAGALFSALYLGLVPLGLSFTLWNRAVTAGNMTLIGYLSYLTPPLAVLLAALVRGAAVTPHAVIGMIVILAAAFVGRRMS
>fig|525898.7.peg.13 Multidrug resistance transporter, Bcr/CflA family
MPHTLTERQIVLILASLSAITPLAIDMYLPAFPAIALDLHSAIPHVEFSLSLYFFGMAMGQLFGGPISDAYGRRPMILIGLSVFALSSFMLSIANSIEMFWILRALQSFGGGVATVNVSAIVRDKFDGKESARIFSMISMIMLMAPLLAPTLGSAILKLLDWEAIFIGLGSYTLITLGVYLFCFPKTKQIRTKITPIQNYKTVLSHKLAMVFVISQILCTSGMYTFITSSSFIYMEHFQLSAAQFALFFSSNVTMMMFFGWLNASLVKRREPLSLLRFGMSVQALLGILLFTFQDGSLYLIFPLIGLYIGILGFIFSNSIALTLEFFPTISASANAIIGVLQYSVGALMGFVASSFHDGTLFPITTVMMSVSLCGIILLLTGSRGYAPRHHIKSA
>fig|525898.7.peg.44 Multiple antibiotic resistance protein MarC
MTEFFNLLLQHTITMMAIVDPLGVSAIMLSLLPQSTTKEHIDKIARKATLTIIVAFFVVLISGNFLLNLFSIEIDSLKVMGGIILLFTAIKMVQGSMESKNQTEEEREEAIKNDEFSVIPLGVPITFGPGIFATIIILRGHSEGFISIAALIMAYLIVALSVYLAFKNSIYIRKYLGITGQKIVSRLMGLIVGAIAVQFIVGGVSVLVKHYM
>fig|525898.7.peg.131 Permease of the drug/metabolite transporter (DMT) superfamily
MINYKLKELIADFLLLLVAVAWGSTFFVVQAAVNETPVYTFLFWRFFVAAVLMLLLSVRALRYFNTEVLKAGVLLGTFMFLGYAFQTFALTYTYSSTVGFITGLNVIVVPFISYLIFKHKASLFSSFGAVVAAIGLYFLTLNSEIGFGLGEGYAFICAMMFALHIVFTGYYSTKHNVYLLVCIQFFTVALGSFIGGFVLEGAIMPPRIDGLFINAIAITVLFATIFAFWVQTAVQRFTTAAKTAIIFTMEPVSAGLFGYWFANEVLSLSQIAGAFLILSGMLIAELGAYMVERRRLKRKPL
>fig|525898.7.peg.836 Permease of the drug/metabolite transporter (DMT) superfamily
MNQPKTDPIGILFLLIAMLTWASSFIALKSAIGPLGPMSVVFGRMVIASLCFVYFIKQFRALSFTRHDIKYILLLTLFEPCFYFIFEAKALQLTTASQAGMITSMMPLMTAIAASFVLKEYLSKRIVIGSVLAVVGAIWLSLGAQSSENASNPLLGNFLEFCAMICGTWYAISVRYLSQKFSALFLTAIQAFVGTIFFFPLAIWEYFTLPMHLSLEVFGWLCYLGIVVTLGGYGMFNLALSRIEASKASVFVNLIPVFTVLLAYLFLNERLSQTEMLASFVIFGGIIISQLPNLTKKKESI
>fig|525898.7.peg.1089 Modulator of drug activity B
MKNVLILNGHQYYPNIAEGKLTQLYIDTAEAFLQSKGFNVKHAKAESNYNALEEVEKFKWADFFIIQYPVYWMGVPWMMKKYIDEVFSAGANNGIYANDGRSRSDATKHYGSGGLMQGKKYMLSLTYNCPTSEFSNKEGFFDGLSLDEANIATHKTWQFCSATPMQTYSVHDIFKGDLNIEAQKAKFIAVLSQNFLG
>fig|525898.7.peg.2219 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNVTKDNIASIFFQYSIPSVMGMLAISSANIVDGFFIGNYVGDFGLAAINISLPIFSFLFGFALMLAIGSSVLAGKFIGEENVKNASLIFSKTIVTITLFSFLTSSVLFLNIKTLLHFFGADENLAKIAIEYLSIMLLFIPFLMIGVVLDYFVRVDNRPNLAFIALLFSALINVLLDWFMIVYLQKGIFGAALATGISQLILLFILLPHFFSKKATLQFVKPIGSYAHILKAFYNGASEFVNEISIGIMTLVFNYVMIKNFGMEGIAAFTVINYLLFIGVMISFGISDSLQPIISKNFGAKEHKRIGAFLKLAFIATSLVGVVMILLLLFVPDTLADIFLEESNDTTKQIVLSFATYLWIIFLFDGINLVISAYLTAIHKPLASMVIALSRSLIFPVFFIVMLPFVFDKNGIFMAIPMAEAVSFIIAMSLFRKFSPQNLGELNESS
>fig|525903.6.peg.33 Acriflavin resistance protein
MLHRASLRRPIAMGCLLIALSLLGINAYRKMGLELMPKADVPYVTVVAIWPGASPRDIETDVAKKIEDAVSSVDGIKHIKSTCMENVAVVSLEFELGTDVNVAANDVREKIDPIVPDLPEGVEKPIIQKFDINASPIITMALVGDMRLDELYDYADSRLKDRFSTIPGVAEVRLTGGSKRELHVLLDPFRLAERGLTSSQVTRALAEGVRTIPSGRIKDGEDEWSVRFDGDYRSVQDLAMMPIAARNGARVYLRDVAQIRFDTAERRQAVFLDGRQAVGIRIVKKADANAVELVDRVMRTFESLKGELPGGMRLVWVTDEGTYIRSSVRNTISSIVQGIVLTAGILFFFLYNLRSTLVVSVTMPLTIIMSLFFMQLMGYTLNTSTLLALGLSVGILVSNSLVVLERVLSKLKEHGDPKRAALEGTSEVALAVLASAGTNVVVLLPIGLMGSMVGLFFRPFAITSLTVNAMSIFISFTLTPILSAYLLKVTSGGRLERLEERFNRWLDRLSDRYVGAVRHLVSSRARATGVLVLVLVLFLHAMTLPKRIGFNFAPDVDKGNVYVKLEFPTRQNLDATVQGVREAEERLRDLPHLRHVFSTVGTVEGIGENEEGVYLAQLLLNFSDKTERRESIFQLVEEARRRMRDFPGAKVSVSIPSFIGGQNVPIQMDIMGDDFEQLDRIALEVQRRVQEKGGFFDVDTSVREGKRELLVRPNRAVLADLGVPPLAIGGMLRNNLEGQKAAVFKTLDKNYDIRVKFQEVSGTQRVASFQLPGPGGSTVPLASVAQVSQGLSPIKVYRSDKMRTSKLFASLSPGYPLGTAVEDVEDMVKRENLLPPGYTVKFRGDYERMADANQAFLEAGVLSVILTFLTLSAILESFKWPVLILTTVPLGMVGVFWALWLTSTGMNIFVLLGAVMLIGIVVNNAILVVDQFRSLRAQRPGLDSAELMLMALKESFRPVLMVTLAAVLGMMPLALSRGMGSEFTTGIGIASAGGVAMSGLLALFVIPLLYIVHLEWKSRRGGDGGKG
>fig|525903.6.peg.259 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRDEILGRDPIPSLIVRFSGPAIVALLAHALYNITDRVFVGRAVGSSGLAALSLAFPFMLAFISWGLVCGVGTSARMAISLGASDREGARRYLGNGILMALVGSVVMLALGFWGMEGLLRSQGGSGEILPMAQRYLRVILLGAPFSVLGMTFTPVLRPMGRPNAAMGIQLVGAFLNIALDWWWVMVLHMGVEGAAWATVASQAVQALLGAALVLNSSRIRPRHMVPEPSRMGRIFSVGLPSGLTEMGFTIVIAIMNRQVKLYGGDAGLSALGIFFGLDALFFLPAIGVGEGAQPIIGYNYGAGNLQRVRRAIWTAVGYAVGYFCLSLLLVQIFAPELVSLFVKDDPVLLDMAAWGLRVSYAGAPMAGMSITAAYYFQGIGNWRAGLITAMCRIVIFVMIPLMILPPIMGITGVWASLPVADVGGCMLGFLMVRRSLRSIGACDPSGPA
>fig|525903.6.peg.406 Permease of the drug/metabolite transporter (DMT) superfamily
MMNKGISRRAVLLADGAILMAAAFWGVGFAVLKDTLDYLPPFTVLVVRFLIGGLMLGLVFLRHFRGLSRTSLKDGLITGILLFCAFSLQTVGLMWTTAGKQAFLTATYVVLAPLVSWGISRVFPGLRAMVASLTCLTGIWALSSADAVVLNRGDVMTLMSAFFYACHLIAVDRFTKRTDPVALAAMQMVVLGLISLPFAAFEAPSFHMPLRGWMSLLYMILFSTVGAFTIQNVAQKYTSPTHAALLLSTEAVFGAVSGVMILGERFTLQMVLGGSLVMFAILLVEMPWPKALSSQGEATDP
>fig|525903.6.peg.1384 Acriflavin resistance protein
MKLWEFSVRRPVTVTMLTGAMVLFGLMALSAMGLQLIPDIDLPVVTVSTSMTGASAKVMDNDVADVIEDKLSTLSGVESMSSSSYQGVSITVLEFQLGVDVDRAAADVRDKVNLAARSLPSEADTPVVQKFSIGDRAIITLALVGGSDPKGLATFADKVLKPRIQAIEGVGEVGTPGLRTREIRVWLDPVKLEARNLMVKDVIDAFKAKHVELPAGSVKNSRQEIQLRLIGEYQTVEDLSSMPIKVEGNAMVRLRDVARVEDGLEDKGSAALYNGSDTIFITVKKQRGANEVAVCRRVREAVQEMRRQAPAGVNIMVIGDQSDYIMRSIRGVFSNVFQAVLLCALVMFLFFKTLRSTFITVISIPVSLIGSFLVMRALGLSINNLTMMGISLAVGMVVDATTVVLENVHRQVEGGLKPLEASIKGTQEVAFSVVAGAATTMAVFAPIAFMGGIVGRFFYHFGITVVVTVGLSLLVSLTLTPFLCSLALKHEPEPGRLGRAFDRFFARLEAGYRRSLFWAVGHRKAVVLAAFGLFVLGLGLAANIGKGFFPTSDRGSFSVDVELPPGSSLERTQEFIAKLDHRIRRNQYVKYTYGDAGSGIGGEANKGSISVELVPIKERPPIDQVIDQVRKDLSSFREGKLTFSQEGRSGVTMMLVGATTERLYQIAEQMRRDLEATGKVSDFDTDVRLNIPQLEILINRPMADALDLSVKDLAQEIQAYFGGTKVGVFKEGGFRYDIRIMADQMARTSAEDVKDVAVRANGSSIRIPGVVDVRKVLAPNVINRYSRRNSVEISVNGRGISTGELMTMMEGSFRKFVRPGEGVQIMPSGRSKSQRDDFKRLFTALAIAIALVYVVMAIQFESFLHPLTVMFSLPLLTPGAFGLLFLMGNELDMMSFIGIILLVGIVVNNGIILVDFINQEREKGAPKTAAVLTAGPLRLRPILITAVSTMVGAIPTALKLSEGADFRQSMAVAVVGGLSTSTLLTLFVVPTVYLILDDMKDRARALLRYLRGAKAPRLREGS
>fig|525903.6.peg.1388 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGSEPVGRLLMRLSLPAMVGMFVQATYNMVDALFIGWGVGPLGLAGTAMAFPVQFLAMAFATMGGVGGSSLVSRSIGAGDRETACYAFGNLMWFAWTFGLIMAVGCHLALGQILGLMGASEDVLPHGRAYLEVIIWGFPLIMAGIGMNSTVRAQGRAKLAMATMLVSAGTNVVLDYVFIFPLGMGVRGAALATVISQGVMVVWLMVHFALSGGRMLSIGVRHLVPRWGVLRQILGVGSSEFVRLGASAVVVALVVRSLQRYGSSDAVAAFGVVNRVVALAFMPIIGVGQGLQPILGYNYGAGKMDRAIRAIKLSLLMASGLSTLAFVLMMIFPREIFSLFTPEEALIGVGERTLRTMGLGFPVVGFQVAGTGVFQAMGKGLKSFVLSLSRQVLLFIPLLLVLPPAMGLKGVWLVYPLSDLISAIITGVMLALQLRALGRIEDGKVM
>fig|525904.6.peg.24 Permease of the drug/metabolite transporter (DMT) superfamily
MVTVGLLIVTAIWGLTFVTVQSAVADYSAFSFLTLRFALAALALLPFSANRIGKKELFVGVPVGATLGLGMLLQTVGLRSTTATNSGFITSLYVVFAPIISALCFRSRFHPRIWVAVILSTIGLFLVSKAGLYGVNPGDALTLGCAVLFGIQIALLSRYSPGLDSAALAFIQTVTSVFMYLPVVFLTRTPLITNDLDVWLALLITGLGASAFGFWMQTYAQQRMSAARAAVIMAMEPVFAAIGGYTFAGDRMTILQWFGAAFMMAGLFVAEILPYLKHRVSMSQRLGETLSEKDLSA
>fig|525904.6.peg.365 Vancomycin B-type resistance protein VanW
MEYVRTPLVLTQGEHTWKITPAELGLQPNVDPAVQQAYKYGRDGNIFHQFAERIPIGRRTVRIQYVLDKSKIDNYVNNKLAPQIARPATDSKLTVSGDGTILASKEVDGQKLNTSMAIQQIYSALVNLRKGDIALPVVTVKANITQSTWRDRQNLVLKLSKPVTLRFENRSWTITSDEIEQAIVAESGAEGVVGKIEPSKLMPILANINKDIALPPEPAKLEIKGNQVALTPEQPGRRVDYSATLSAIYAALQSSGETDLATKEIEPIVTTSVLENARSQLEKLLASPLKLHFKDQSWEIPTSTLADWTSIDIDKANRTSSVKLDPNKVNEFVDNLASEINQNPINGELTWRGKLVVLRESQDGQDLDTEKTKDLIAQAAFSDDRDVDLPVKVTKPKIPTDNLAALGIKESIGWGSSEFTGSPPERVHNIQTAAGYLNNTVVAPGETFSFEKAIGEISVERGYQEGLTIVADQTVPGIGGGVCQVSTTMFRAAFWAGLPIVERHQHSYLVPYYQLDGDPPGFDAAVYFPYKDLKWKNTTGHYILIEAKWTDTKLTITLYGTDPGYEVTRGKPVITNIVPPLPDKTIYDPTLPPGTKEQVDWAHEGMDVTITRTVTKNGKVVLQDSFFSRYKPWGNIYRVGPPKKEPSKKEPPKKETKNKNKESENKDKQQKKDVNNSKDSTKKIEQR
>fig|525904.6.peg.845 Permease of the drug/metabolite transporter (DMT) superfamily
MKQGTKDRTKQLSGIALAFVAVSMFSTSAVLIRVIKDISSIEITFWRMLIAGLLVLGAALISSQLSLKHNPFNYRFLAYGLVAAMHFFFYIASLEYTTVSNSLALVYTAPVFVALFAALALHESINWRQWLGICIVVVGVMIFSGFDLGLDKSRLIGNFLAILSAAAFGVYSVMGRGERNKYPLLVYAGGTYLTASLWLLPLAAHSMINSSYSMTNIIALLALAIVPLGMGHTLYNAALRRIHAAHANVLSTLEVPGGTLLAWLFVKEPVTLRDMIGMFIILFGVLTVILTADRTP
>fig|525904.6.peg.1524 Vancomycin B-type resistance protein VanW
MEKILAREIESWREEASELRNYPHGRSFLLRLIRAALPVLAVFVVVLLGSAFLITRAYSDRIYPQVVVGNIAVGSLTQDDAKEKLESSLEDYLNNPVVLTFGQLQWHPAAEDIGLTIDVEATVNRAMRAGREDPVILVIARTLVGQQSPEVVPIVMRIDESRLSSYLSDIGRQINRDPLNPSIQVSEGNIQIEGGGAGYTFLQPETESKVLTSLRKMSKGPVSIAVYTTAGTISSQEVSKAESLAKSMISSPITLVGDNQQKWQITTDKLQDWLRSKPVKVKGNTELDVYLDPVELENYLDSVAKDINSEPVNARLRWDNGHLSVLAPGKLGRRLDIDRAIGLIQEAAKSNSRQVQLPISRISPSVSENNIASLGIKELIASGVSGFRGSRPERIDNIKKAAQAINGYVIPAGSDFSFAEAIGKISESAGYKPELVGDNRLELQGWPGGINQVATTVFRAALYAGLPILERHSMPYRLDFYQQENQQPGTDAMVLVPGTDLRFTNSTPAAILIQVSVSEQDQTVQVNLYGTDPGWSVDVKPPIIENVVQPIGDIYWTDPTLESGKTETYLYASAGADVVIERTVRKGTEVILDDNITSSYDPLPTVFAVGSANSDNG
>fig|525904.6.peg.2343 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MSLVPDSLVRVMQDLHGDAGRQWVESLPAILWELSSRWGVEVGAPFPELSYNFVCEAVLPDGQPAVIKLGHPRDEAFWHEAEALRAFDGRGVVRLLAEARDLTAMLIERALPGASLLSLGDDEAMTEVAARLLRDLHVPPPDAHRFPTLADWGQGMRRLRERYGGSSGPFPPRLLEAAEACWRELLASQVRPMLLHGDCHHYNILSTEGGWVIIDPKGVVGDPAYEVAPFMLNPADVARSPRRVFERRLDIICDLTDLDRQRIVRWTVAHSILSAWWGVEDHGEPWTDALAVGEIFCSML
>fig|525904.6.peg.2894 Tetracycline resistance protein
MSAYRLYLIYSGALALLITGIYSLSNVYRLEVAHLNPLQLVLVGTALEGTYFALNLPTGVIADTYSRKLSVILGPCLFGVGAVLEGLLPVFGWIIVCQVVQGAAYTFIEGALESWVTDEVGEEMSGHAFLHAGQVEAAASFVGILLGVGLSSLELRLPFLLGGALLLSLGVALVWLMRESSPPYSTRRAQVGLQGYLGAGLRDMSDTLHGGMRVVRTRALAGTILLVAAMMGGFSEGFDRLWQPHFIQDIGLPSVGGLDRLVWLGLAMAVNPLLASLVLRSVRSSLSDTSPRTIIGLLMGTDVVVMLGALAFALAPNFTVGLLAYWVMTVARRVHQPLYLAWINQGIEGRVRATVISVSGQVDSLGQFVLGPLVGGLATLLSLRVGLALSSCFLAPLVALYARSLGKVRVDVASTVE
>fig|525904.6.peg.3028 Multiple antibiotic resistance (MarC)-related protein
MNFFLKALVALFTIVDPIGMAPIVVGLTAHLSPAVRRRVVTRATLIATGVVAVFALFGKPLLEFLGITPEAFSIAGGALLFLVSIDMLFGRESGARETGREAREARTREDISVFPLAIPLIAGPGTITTVILLMDSAQGHASRQLAVAAAVAIVMFCTWVSMSLAFPIQKRMGTTGTLVLSRVLGMLLAAIAIQYILNGLSSFAESLRTILS
>fig|525909.11.peg.619 Permease of the drug/metabolite transporter (DMT) superfamily
MERRSLAALGVLSVIWGCSFLFIKVGLATFSPDLIAFVRTTLGASVVLATARLRGWALPRGWRLWAKLAVAALVSNTLPFILFGYGEQHVSAVLAGFINATTPMFTFPLAVALKLERVSVGRIAGLAVGIVGVGAVVGIGTGAISGASGVGVLACLAAAALYAVGFVYVRMTLGLTGANRTGLAGGQLAMAALETGVVVLVMRQGIGTVHPLALAAVATLGVAGTGIAYIVNFALIHRSGVVGASLTTLTMTVVSTVAGVVVLGEPLRWYQPIGALAILVGAWLVQGARPVSTRLVPATE
>fig|525909.11.peg.899 Multiple antibiotic resistance (MarC)-related proteins
MVTKFFVEALVTLLVIIDPIGNIPTFLVVTRGRDQRARRRLATEAVLVAAAVLAVFALAGSQILDYLGISIPALEVSGGLLLLIVALELLTGRGGSIGTTEEGISVAVVPLATPLIAGPGAIAAVLVLAKRAATAPLSVALAGALVGSMVILWVVLHYASALVRILKESGIALLSRVFGLLLAAIAVQLAAEGIRGFGL
>fig|525909.11.peg.1172 Permease of the drug/metabolite transporter (DMT) superfamily
MGVTAIWGVTFPLNERALGSLGPVELTFGRFSVAALVLWVLALARGHRIDRRSVVAGLASGLALFGGYLTQIEGQRYVSPTIAGFLTGLSVVVVPIFVMALGRRPSARQLVGIVLAALALVVLSAPRGHASFVGIGLELACAGFFGAQIVVLEELGSPGDAMVTAALQMTTIAAATVVAAPLVGAGLVPTHLTPIAVTAIVYDGVLASALAFVVQAWALAHADSVQISVIYAAEPLFAALASLAFGYASLGLPVVVGGLLALAAMVLASVPPAAARSSDPTG
>fig|525909.11.peg.1186 Drug resistance transporter EmrB/QacA subfamily
MTQGSHRHRSGLAIAVIAGAQLMIVLDLTIVNVALPTIQHALHFSPTGLSWIVNAYTLVFGGLLLLGGRSGDLFGRRRMFMVGVALFAIASVFSGLATSQAWLITGRALQGIGAAIASPTALALISATFTEARERGRAFAIYSAVSAGGAAIGLLAGGLLTQYASWQWVFYVNAPIAALLLVAAPRVLAETERHHGSVDVPGALTGTGGLALVVYGLIHASTTSWSNVTTIAVLAGGVVALGAFIVIERVRREPLIDFQILAKRERGGAVAMILFVAASMFSVFFFVSQFMQDVVGYSPVRTGLAFLPMTLGIMITAQLVSRNLHRVGPKPFMVGGSVLIAVAMGLLSQMRASWGYLDLLGPLVILAIGAGSSFVSLFPTATHGVEPRRVGMASALVTVGQQVGGTLGLSILVTVTVAAAKRHAAALAPRLASGHLTPQALTILAEVHGWAAGFAVATGFGVIGLLIGLIVVPHLGPTATEGAAEGSAVAA
>fig|525909.11.peg.1745 Permease of the drug/metabolite transporter (DMT) superfamily
MNHLDHRQRTLGIIALAGASAIWGGMYVATAALMRQTPPLVVLELREAIAGLILVPIAWRSGRLRIARGDLALAAAIGIVGFTVSIGLQLEGTHIAGAALGSLITASSPVLIALLGRVWLRERLPWPKLVAILVAVGGVALIAGHPPGGPQVEPGIIDLAGAALAWAIYTVGSAHLTRRYDALGVLAIACIVGSVTSLPFALASASHAAHPLPTTLVAWLEVAYISIAGMALAFFLWNWGFGRVDAAVGGSMLLFQPLVGVVLGIVLLAEPITLTLVFGGFLVVAGVSGAVAIATPRVQLATNASPEAPQSGIRT
>fig|525909.11.peg.2144 Drug resistance transporter, EmrB/QacA subfamily
MVLCAVMSLTFLDTTIVAVALASVQTSLHAGVAQLQWVIGGYALAFGALMLPFGALGDRFGRRRAMLVGLALFAVGSATAALAHSPAQLIAARVVMGVGAAASEPGTLSIIRQLYTEPGSRARALGVWSAVAALALAVGPVIGGVLVGIGGWPAIFWFNVAASVVVIVVTAIVIPESTDPGVGRIDWGGAALGLIAIGGALFGVIQGEARGYGNPLIVAVFVVAAVGLAVFSVLEAHVPNPMLDLHYLRRPGFSGSLVLAFSVYFSIFAIFFFTALYLQIVEGYSGYRIASVFLPMALAMILTSLATGRWVARIGVGMPIALGSLLAGLGVLGADVGLSGSTHPLVLALSLTVAGLGFGTTVVPVTSIALAVVPQQHSGMAAASTNTARALGVIASVSVLGSYLNAQLTSGLGTKLARLGVPPVFRHVVISAVETGGVPGGSSIAADTKTFGPLVAKVVTAAYGAFHRGLTISLIIAGALIIVSGVLSAVAVRGARTRPDGETSQA
>fig|525919.4.peg.36 Multidrug resistance ABC transporter ATP-binding and permease protein
MTEKKYTNKYLLKRFIPYYRPYKKVLTIDLLSAALTTISQLVLPLLLSYLTDWAQLGLLDMPRLGKVALIYLATKFIEVVSRFIMQSYGHIMGALIEKDMRGDVFSHLLTMDTEFFNEAKIGQLMARMTTDLNEITEFSHHVPEEFLVAAIKLAVSFVVLLTINWQLSLIIYILIPIMYIFSRKSRQKFRQATMNTRKQIGAINSGIEDTLLGINVVKSFANEDIEKEKFGRENEKFADIKKDQYFNMAKYFCVKDAFSGFMYAVLILVGGIFVIQKQITAGDLIAFTMYLNMLVATIERLINFTDTYERGTTGIERFVQIMNLDRDIYDKDEARDLEDVKGKIEFDHVYFKYPETKEEDPYVLDDMSFTIDVGENIALVGPSGAGKTTISKLIPRFYDVDDGAIRIDGDNIKDLTIDSLRDNIGIVQQDVYLFSGTIKDNIKYGKEDATDREIEKAAELAGALEFIKDLPYGFDTYIGERGVKLSGGQKQRISIARVFLKNPPILILDEATSALDNKSEAIVQSSLEKLSKGRTTLTIAHRLSTIINADEILVLTYDGIVERGNHKDLLAKKGVYYNLYNSNNTDLFG
>fig|525919.4.peg.1350 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKTISKKENIMGTMPVGSLLIKMSIPMVISMLVQSIYNVVDSIFVARISEEALTAVSLAFPVQNIMLAFAIGISVGASALLSRYLGMDDKKRVGSVAMHGVVLSVVGAIAFALFGIFFTDFFADSQAASPEIVAYTRDYLWIITIFGFGLFFQVLCEKLLQATSLTFYTMIVQVSGALINLILDPIFIFGLFGFPRMEVKGAALATVIGQIGGSIIGLIINKTKNTDIEVDFKHFRLHGDILKQIFWIGLPSIVMSAISSVVIFILNAMLRAFGQSAIAAYGVMFKLQSFAFLPIIGISNAMVSIISFNYGARHVARIRRSIKLALISGMVLVGIATVSLWILPNQIFDLFNATETMREIGVPMIRIVSLSYIVASVSIISVGVFQALGNWQSAILQSFLRQVFILLPTFYLFSLTGNIDLVWWSFLISEGLNTIMCVYFLKRDIKNKIDVL
>fig|525919.4.peg.1551 Multidrug resistance ABC transporter ATP-binding and permease protein
MFIKFNDKQMNLKSREIVALIVSTCIFILSNILAIYVPSILGKIIDIITSTNKSNSVRDYVFIFAIISLLIILLQYISSKILNELNKKINIRMCTYVFSKIRKMNLIYWFKESKGEIITIISNDIYNITDFITNSIPNLFSLIISTILIFIYIMRSSLWIAFIIFLLNIVLVVIQYMMSRVVKIKSRDVRNLNAEVNSKVQACINNVENLLLKDYLKSSSENYNRSNKKLFIANNNLMDLILRSSTLNLLASLCSIFIIIAIGGHLANTGNISTGRLVTLILYSQKIFSPITNITKILMKFNTILPKKTKIDQLLDNQDMIEDFTNFDQLLEHKLNFKTIIANDLETGYLDDNIKIENLSIDFTKSNVIGIIGDNGVGKTTIIKLIRKLLPIKKGKIKIDNTPLEDIGIGELSRNIQIMPQTDSLNQYDIKYIKSKLQEHYLNVDIEMFIGDISKIFKSSDKYEYNINSKGELQKLSFLNTIFKDAKLYILDEPSASIDLKSEKYMSKIIKALSKDKKFIIITHRPELLNICDYIINL
>fig|525919.4.peg.1665 Antibiotic ABC transporter, ATP-binding protein
MKNIRKLFKEIDKVHPGFSVRVIITNLILGFLPLINIFAPKLIIDELMGQKRFSYCLGLGALVLILSFIKEVTYRGLNNYLTLTFEDMSDKLTFKIAQKSLRLPIEKSDSKEIQDMMEQAHYAVWEMYTLYDIIVLVISAVITGILSLGILVRLNPAILILLLLLILINKKLVKLIKENELKYQENNISDLRSYRFFSNFAADLRYFKDIGIYDGQDLVLEKADYYQKEMIKSSTDYFNKNGIYTGIMNVSANGSIILTLIYLTYKLIDKTISLANFTMYFNSLIQVINATNLIQQNYAKVISVNAQLKVFFDFLEMEEGLLDKGHIDHIDTSEVRIRFDNVSFKYPASEDYVLKDATFEIKNGETVALVGKNGAGKSTIVKLLCKFYEPSEGNIYLNDINIKDINTKEYYKILSPTFQDFRLFPFRISENITGMLKDEIEDKDYEKMDKSFDLLKLASWIDKLVDKEDTFLTYLFSDESVEPSGGIGQKLALARSMYHEGKFFIMDEPTSALDPRSEEEIFENMLKISKGQTSLFISHRLSSTKYADKIIVCDKGCISEEGSHEELMKKDGLYKEMFTSQADLYL
>fig|525919.4.peg.1849 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNTLLKSYFKYLIPTILTMILFSTYTMVDGIFVGQGVGAEGISAVNVAMPFITLTFSLSILISIGSLNLITYQLGKDDKEKADEFFSIGLVLSLIVAISISVFTYIFMDPLIKVLGASPEISHIVRDYLSVIIFFTPFYVMAYVFEIMVKADGRPIISTILMIVSALTNIILDYVFIFRFHMGVRGAAIATGIAQVLPTIGYVAYFMSPKAKLKFRSFKLKFYKIKEIISYGFPASLNELSSGFVILLFNNVISAYYGTEGLAAFSVISYIMIFVVNTMIAVNQASQPLLSFYFGRESYEDVLRIRKYMLRTVALLSLMIFVIIELRPEFFVNVFIADYEEAFLPFAVRALRIFAISYLIMGFNIINAGYMTSVKKPRYDFYITMVRGYVLMAILVYALPLALGKEIIWHVATITEFVTMIFSIFFIRDEIKEIHKLERIRDKHIKKKYQ
>fig|526218.6.peg.332 Nitroimidazole resistance protein NimB
MFREIRRIKKKLPESEAVRMLEQLSCCTLALSGDDGYTYSVPVSFVYDNGKIFFHSATEGKKCDSILQNNKISFSAVEKDDIKPAEFTTHYKSVIGFGEITLLEKREEIQHAMELILKKYSPDYMKEGKDYIERAWGHFYTYVIDIHHMTAKGTEKQKE
>fig|526218.6.peg.486 Multidrug resistance efflux pump
MNNKRRRGRKKKKIFLKKKIEFFNENKGIKIFCITLIAMISFYIIYSIRMDYITPYSSNAVVEYDVIPVYSRVNGIIKSINVKNSDIVKKGDKLFDIESEQYRILYELAVANKESAERHIDTMDKEISVEKAQIEKAQKNLDTLSKEHEKYKMLFEKEMISEDLYDDIKIKYDNAKNDYEIAKRQLKQLEVSKGKEGSDNDLIKVSDSQISKAKLDLEYTEIISPINGIVEMKQLYSGNAVNTSVPLLYIINKDELKISVETKEKTINAIKNSDLILVVFDAYPNKIFHAKLVDITKISSSSYTKPGNLEDVEQIDNKVVRPQGFGKVNIKITDKIPENYDIMGGGKASVLFFSKDVGKPMKLFGKVWIKAVQLFKYIQ
>fig|526218.6.peg.510 
MRNILVLFLTGFLSLAVISNTVINNKQKNPAVSEETKTKSANTYDLLEEYKKDASKRQPTYTGENITVSGVVVYKGPDIHGLPSLELSDKVNGTSHVLCVFDSADSLNKISKGDNLTISGKFHIVSSDDMVVLKQSKIQ
>fig|526218.6.peg.565 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTVTKIKNGSMSKEFIKFVIPAIISMVVTSMYSIIDGIFVGRGVGENALAAVNIAYPLIMLHIALAMLVAIGGANAFSINKGRGDIKNANRIFLQSMILIVGISVILNVLILVFPTQVSRLLGADDMLLPYVRDYIKWVALFAVIYMPGLALSIFIRNDDAPKREMTGTLIGAVTNIVLDYLFIMVFDMGVSGAAIATGIGQLVSTFIFMTHFTKKNRLLKIEKVKFYIDDIKYIFINGSPSFLMEFSQAAVAFSFNIVLLSRIGALGVSAYSIVMYICSIFNMILIGLVQGIQPIMSFNYGKGNRENIQKVYKMAVRTSLCLTVIVYIAVFIFGKALSDIFIRNNTQVTNMALNMMRYYFLAFFPIGISLINILYFQIIRHEKWAVFLSFIRCIGFVQLSLLIMPELFGITGIFLSFLCGELANCFISVILYKYAEKSQSNTVKISDKKVLFRNIETD
>fig|526218.6.peg.745 Permease of the drug/metabolite transporter (DMT) superfamily
MNKGDIYTLFCALFFALHIIALDYFTKIYDTLILAFLQIIFAFLFSAVSALITGQVSFGISSQGLLATLYLGIFSTFLAFTIQTAAQKYTSSAKTVVILSTETVFGAVFSILILNEQFTTKLLIGCLFIFAAIIISETKLNFIYKSRRNII
>fig|526218.6.peg.1138 Vancomycin B-type resistance protein VanW
MWKKVTLIIAGIFLLFGGAFFYFVKDTDKIYNNISVSGVDLSDTSKETAKKKIEEIKLENVKLKYEGKEFMISGDSISYKVDSDTIVNEAYNVGRNGNFLKNKAKIFALKALGKKVSLPLHYSINEEALKNELVKIASEVDVKEQDARLVINNDQISVIDEVNGKKINIEKTLSAVMESIKYSKHDDINLVAETAVPKVTKEKLGSVNTLLGEYTTTFNSGVYGRSENIKLAVKSINDVLLEPQDILSFNDSTGMRNPKNGYKSAPVIVNGEIEQGLGGGVCQVSSTLFNAGALSGLKIVERSNHSIPSSYVALGRDAVVDYGNLDLKIQNNFQNPVYIAADVVGSKIIIKVYGNQKDKADEVKLYAVVNGSIPRKTKTVKSGKATNGRDGIKATTYRVIVKNGSETKEVLSSNYYPPKARVVVLTPAPAVVSEEAPSL
>fig|526218.6.peg.1373 Permease of the drug/metabolite transporter (DMT) superfamily
MKFKDSYHPYAIITIVFWSLAYVLTRLTLQYFSSFSLGFLRYFIASCALLCIAFITKMKFPSKKDFPWFLLAGAVGFFIYIITFNKGQESISASTASVVIATVPVITAVLARFIYSEKLSCIQWGAIIIELIGVCILTLLKGIFSINIGLLWLFLAALVLSIYNLIQRRLTKKYTALQTSSFSIFSGTILLAVFMPASLREVLHVPFIQLFYVVLLGVFSSAIAYIAWSKAFSKARQTSDVSNYMFVTPFLTSILGFFIANEIPEYSTLIGGAVILFGILVFNFGDKIYGLLYK
>fig|526218.6.peg.1614 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERKKNLKNMLRYVIPSVTALMVNSVYIIVDGFFVMKGVGEKALAAVTLSVPFLEALIAVSMLLSVGAGIYISYYLGKGSKNTANTVLNTSLALLFLVSAVISISGIVFLKDLARILGADETMTELVCDYLKYLLYFSPALILSYALATFLRNDNKPGLGMIAMIFGGLANGILDYVFIFVFNMGIEGAGLATGLGPVFSILIMMPHFFLKKGDLYFRLSAFSFRYCKKILTAGIPAFITEYSLGIVTYLHNFVIIRILGEQGVAAYGIIGYVALIVLTFYLGISQGIQPLISMAYGAGKDRELKFYTRVSFIFAGIIGIVSTAVIIVFARPITEIFSGNNSELTAVTVYGLRIYSVNFILAGINILAISIFQSVQKVKTASVIAVIRSTVFVYAALMTLPVFFGSLGIWLSMPFAEAGAFLVILGICIFTLRDEKEKRAEHVIL
>fig|526218.6.peg.1835 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKIYRKVILMEKYGKLGNENVVKLLFEFSVPAVIAGMIAALYTVIDRIFIGRFVGEIEFSGVSATFPIMIFYIAFASLIGIGASASISLNLGRGNKKRAEHILGNAFSCFNILGILIIVFNYVFLDQILRAFGVTENTFIHAKSFMIYLIPTCYMTFLTYGFAGVIRAEGNPKTAMNINIAGALINIILDPLFIIVFKMGVAGAAIATLISNLAAALLVIYHFTYSKKSSLKIRRKYFKLNAKILNQIVKIGISPFILQVSLCLVGLAANNMIKIYGNDYDFGIYGVLNTYLIVIFSVVLGISQGAQPIIGYNYGMKNYRRVEEALFKSMSFTTVFSILCLVITLIFSRELSGIFVKDEIIINRTAPALIMFLMSLPVYGILIIGVDFFQVVEEAKTSSILFFMRHFVLALGTMFLLPVLIGISGVWLSRTISDFIYLPAVLYCQWKWLKKLKFKIKEQQQNVK
>fig|526218.6.peg.1960 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRRKANKTNILEGSISKGLFKLALPVVLTSLISIGYSLTDTWFIGKYLGDKYVSAVAAGAFFINFGMCFCNIPKIGAQVLVAQSIGARKITTARKYVRTALYLCVAFGLMYCAFVMVFHNYLIKVIKVQDPVIVSAANQFLMISAVGFVFLYLVITVSSIINAEGDTLGPFIFNSVGLLLNVLLDFIFIKYFKMGVIGAATATVTAQIIACIGILCYLFRKTSRFRKLRIWRLDPAHYYRRIVKLGIPNGVNQALFSVFAIILAGMIASINETALGVQRVGIQFEAFSWNISIGLASAISAFVGQNYGARNLERLKAGYFIGLKWIVSIGFVISAVFIFGGKYLYGFFFENPETIAMGQDYLRILGFSQMFMCAEITTTGAFNGVGRTLQPTVNSVAVTSLRIPLAYILTLLMGLTGIWWSISGTSILKGIISVAWFLWTLRKIKNSGEMLKELAA
>fig|526218.6.peg.2698 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENSISLEKDSIGKLLFKFSIPAVVGMLVNALYGAVDTIFVGQFVGTNALAGVGVTFPITNTIMAVGMLVGIGAAARISISLGQKKKNRAEKYLGNAVVLMIIGYALVGILGKVMITGILGYLELNPEVAAYANKFTNIMLIGSIFQIVGLGLNNVIRSCGSPKIAMFTMIIGGITNIILDYIFIVPFKMGVAGAAWATIIAQAVSCIWVTAYFFGKSSLLKMKLKNFKLSSYIVWSIVSIGFAPFMLQMAGSLIQFILSKQIVYAYSSGESDLVIGVMAVISRVTIILLMPVFGVNQGAQPIIGFNYGARQYDRVKKTLKLAMIVSTVLCVSSFIVIQTMPEVLLGLFISKNDMKAIEIGTHAIRIYCLGFAVVGFQVISSSFFQSIGKAAISMVLSMSRQIILLIPFLLILPRFMGSEGIWIAAPMSDFLAFILSVTMISWEMRKIRRMELSV
>fig|526218.6.peg.2852 Multidrug resistance ABC transporter ATP-binding and permease protein
MYIWKQLWAYTKPYKRFLFYSLFALMLSTTIFIVGTMMTKIIIDKYIMGMFRPVSVSNTIQDEKKSVFYKGKYYTRIEENSKLNILEKNSIILTKEGYVLINSDIADEKAEIKDNRLFINNKESNVGFNILTKDEVWNFYEPYVGSATLAVLSIFILYMAAACLMYTCGYSLRILATKVVFDLRKDAFKQLQKLPVQYFSDYPDGKVVSYIVHDSNAIFGLYENTLLEIVKAVVQVVFIYIAMFLLNVKLASYALLILPIIAVWLYLYRKYVSENFKETREIQSNMNAMMNEQFQGIEVVQAFTHEDESIAEFDVLADDYLEYKRKFAVLSALYTDGMAHTVRRLAITLTLVYFGREFLSGSMILSVGTVFAFVQYVDSAFAPLFWFFGVLNRFERAIVSARRIFDMFLNVPSKELEFSTENLELKGNVEFKNLSFAYDNENYVLKNINLIIPAGNTIGIVGHTGSGKSSLMNVLLRFYDYQKGDIVIDGRSLRDYPVQTYRAHVGMVLQDPVLFSGTLFSNITFNNNDVTEERVLEIMSQIGAQSFIDKQPNGIHESVEDMGRNFSVGERQLIAFARVMVYDPEILILDEATANIDTETEIMIQKALNVISQNRTTFIIAHRLSTVKHADQLIVLNKGNIVERGTHEELVEKDGLYAKMYQSQMREEYTHEVLKNSKENFVLNM
>fig|526218.6.peg.3602 Permease of the drug/metabolite transporter (DMT) superfamily
MKKYSADLGLLLVGFIWGTGFTATKIGLDGGITPYYMMFLRAAFASIFISVIFFRELRNVTRREVLAGVLLGVFLYLGFSFQTVGLVYTTASKNAFLTAINVVLVPYLYWMFYKKRPDIFAVLSAVLCLCGIGLLSLTGTDFSLNKGDILTMICAVFFACHITFTGILSKKVDAIRLNLVQMYTMTVFSFITCVFNGSITLNVTQTQFLAVLYLGIFSTGICFLLQTTCQQYTTPARASILLCTESLFAPVLSFLILHEVLTPKAIAGAALILISVIVSETKLGFGAKKEQST
>fig|526218.6.peg.3746 Glyoxalase/bleomycin resistance protein/dioxygenase
MIFAGICLMTEDVRKLADFYKEILQTASDYDDEIHQEIFTKGASFAILKNDGITQAGNSNMTMIFTVDNVDEEYERLKKIGVKILDIPTIQPWGAKNMRFSDPDGNFVVFRTFL
>fig|526222.3.peg.325 Multidrug resistance protein
MNFRKALSESIETKQGTVMAVLATAFFSTFGVGAYTFSLSLSADSIGLSASWLGLAFSGYFLARLVLAPLAGCSADYFGPIPLLRWACGIGTAVPCLYHFFPMVESLGLIQICLGFCAGIVKPVSMSLLGQCTRQKERGRLFALYNTCLYSAFIIGPIVGGAGIGFQGKLGFVSLIWPALGMGLSFVALLMNSSEDAPASKEKQKETEGLPWRKAGFLPLLLAVLGRTAGASVVITFLPRLISEHFGLSGYLAGFLFALPNLAIILAMPATGRWADSRDRAGLTFLGMGFCAACLFGLGQPVPLWIFCLLVAGMGFGSALSLPASMSLAADMGGAKGRVMGVFLGVSNLGFVLGPGIAGFAAEAGGMADAFELTALFGGLCLLPTLISMSKRLYAD
>fig|526222.3.peg.1330 Glyoxalase/bleomycin resistance protein/dioxygenase
MHNDSSSHGFFSWNELLTSDLEAAKKFYGDLLGWTFKESKTIYGDTYLTAFKDGRMAAGMMIKPADTPDHIKGCWDPYITADDVEAAAEQVEETGGKVMLPPTKIEGVGRFCVIQDPQGIYLNLITYDQED
>fig|526222.3.peg.3553 Permeases of the drug/metabolite transporter (DMT) superfamily
MKWSEFKKTEKAGYIFIVLGILNWSGNFVAARGLAGTIDPATLNLLRWVLATLIFLPFGIKAFMKERHLVARYWKELSVIALCGISLYDTLVFIAGATSEALNMSLISTMSPLLTALIAQFFLKEKLKPSMYAGIAVSTFGVALLVTDGSLEALLHMRLAKGDLLILCTAMMSAIYNTVVNKVAGKISQTTLLMSCCLFGTLYIIPLYFWETGGQIVMPEFTYNLVVSLIYLSVFASILCYLFWNMAVEAIGASKAALFYYTLPPASAVVAWFVIHEPVNMNQVFSGMIILAGIIFALYGGSLNFMRRKAHNYG
>fig|526224.6.peg.74 Acriflavin resistance protein
MNRIIELFAKNRLLVNVIILITLAVGIYSYLNIKKEAFPSTNFDVMIVQVIYPGASPEDVEQYAMIPIEDELQTIAGIDEFYSIIIENAGILTIRIDMNLKDSRPVKDEIFRRLQNAPNVSKDVSEIKIFEANANRMPIYNLGIRFKEGQEGSEKELYDISKRFEKELKYVDGVANIEVYGRTDPEIQILADPYKLREYYTSLTEIIQALSLRNIRSTSGSMKPSESDNLEDKNKLLVTTGQFQDPLSITNVIVRSIFNGQPVRIGDIARVEELFVDKSVYMRVNSKHGYSINIIKKEDADILKTIDNVNQYFEKNKSTIPSNIEIVPMADNSRTITDLLNAVSSNIITGFIIIFIILIIFLDFKSAIFTSLGMLIVISVSLIYMTYSGITFNIISLGGIITVLGMIVDNSIVVSENIFNYHQKGIRGLEATKNAVGEVFMPMLVSTLTTVASFAPIIFVTGTMGRLINQYPRVVIVALVVSIFQAVLLLPNNLITKEELTGEHKRKRFNFKNPLDFDKDKLFDKLKIPFIKFLRFTLKFRYIVLIFFIVTLLITLLIAKSIFSKFTLIYDTSADVIVVNIDTGVGSSIYKTEKYLQKVENIIYETINTNDIVAVYSLLGKQLDKNTVEISEEMDNIAGTMIYLVPANNREKIAYDIADDLNAAIEKSSIKDELELITVNTKLPINPGKAVDIKIIGNDTAMVKEVKDKMKEHLLSLDGVVNYDDDDKIGQEELRVIFDYDRMSELGVNVAYAARELRAAYSGIVATSIQEFENKLDFRVRLDKKYTYDTNVLNNLLIPNTYYRLIQLKDIADIYITNNQSSIRHYNGKKSITMTADIEQGKNTAIQVTYEMQDYFNSIAKDYPNISVEFAGEVKETRGSIIGIAWGYLIAIIAIYVILLLQFNKFVQPFMILGIIPFGIIGVILGFAAHRMPMSFVGAVGIVGLAGVVVNNGIIMVELINRILEKGNIRNKQDVLNAIVEGTGDRFRAIFLTTVTTIFGLLPTVYGIGGRADLIVPMVMSMAYGLLFAALLTLILLPSLFMISADLKLIKINYEK
>fig|526224.6.peg.419 Permease of the drug/metabolite transporter (DMT) superfamily
MANKERLGTIGIFLTALIWGYSFVAVKVVVQEIEPFYLVGFRNLAGGIFLSLIFFKRMKKITKRDILLSIPVGAALFLGFFLQTMSSKFITASKVAFFTGSYVIFIPFLAWALYKKRPHIAAFIAAVITVIGLYLLTSFDGLGSIKAGDLFALLCAVVFAVHLILIDKMLEYVDGIIMASLQLIVAGIISLSAGIITSTPFDINAVSKESMYSLIYLSIGATGIAYLLQTVSQKYVNPNKAGLILSLESFLGALGGIIFMKDPLTVNFVIGGICMISAIFICEIGSTIKKTD
>fig|526224.6.peg.864 Permease of the drug/metabolite transporter (DMT) superfamily
MLNVLLVIIGSIAYGFLPIFVKNIIAYNYSSLSIVFYRYFFTAVFLFIIILVTRKSFKITKRQFIELLIFSITGLGLTFFFLSQSLLYISAGLSNMIHFGYPVVVLLIMIFLFKEKINILKILSMLFAVSGIVLLTKVVRVESFLGIIYALVTTVTYGSYIVANKKCSFSSIDTIVSLFYMSLIVSLTFFIAGIFTNSLQVLNNINVFYNFIAVSLLCTIFSLGLLLYGVKKLGSSLASILNMFEPTTTVAASIFIYNEDLTFNIVIGSVLIILSTITMVIGSKR
>fig|526224.6.peg.1035 Acriflavin resistance protein
MRNFIELVVKRPVAVFMCMIAVLILGFVSLSKLAVDFLPDMELPYITVRTEYENAGPEEVEKSVTRIVENAVATVSDINTITSTSQEGESSVFIEFNWGTDLAVATADIREAIDGVKNSLPDDADSPTVFKFSTDMMPVMEIAFFGTDNLGALYTLIDNQILNKIEQASGVARAEIRGGLQTEMKVDLVLNRLHAYGIDINTIVSLLSSENQNLSGGETYEGVYKYTLRTMGEFTTVEDIENTVVALKTNDTPIKLKDIGRVYQGYSDDSEIVKINGMPAISVSVNKESGGNTVNVSKAVQKQLANLTLPEGVEYEILFNNADNVNESINGVLDTAWQGGLFAVIILMLYLWNIKTVSIIAISIPISIIITFTLMYFMGITLNIISLSGLVLGIGMMVDNSIVVLENIFYYRNNGYGKYSSAINGTSSVALAISASTLTTIAVFLPFLFVEGQTGQLFRDLCITVTVSMIGSLFVALTIVPMLGARLVTNKKTKFLIPIENFVNKNFHNRVNNLYSSVLHYSIKNKKKVLISSLSVVFVIIALGLTFIGKEGFPTSDEGQFKIDVEMPVGTKSEQTQSFVTRMESDIQNLIGEDFDRMQSRVQSGSDENKAEIRVQLRDKSEGRKKSVDEYIEFTRNALVSYPAQINIAAITSSAINSGGRDGGTGGNEIEIELVGDDLDKATEIANNIIAAISDIEGIREPRLTRDDSNPELKIYVNREIAAKMGINVNTIANIVKTSFAGTTATTMTPANSDVTDIDVNVQLGEPDRLNIDDISRLMIPTTSGIVPISSIATVEKSYGPTEIERKDSTRITTIKASGYNRALSEIMTDVQEKIKQEVFIPSGFNINYTGDFEDMNDAFLQLLQALILALVLVYAIMASQFESFIAPFVIALAIPFGFAGSLIALFIGRQTLSVYSGIGFIVLIGIVVNNGIVLIDYMNQLMHEKNISGDEAALESGPRRLRPVLMTTLTTILGLLPMALSGGSGNEMYQPLSLAILGGLLLSTAFTLVIVPTVYAAIRNKIPLKDYEQKDLESRDDFSNYDTINATGK
>fig|526224.6.peg.1064 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVYLIFIKDILKISGASSNTYQFSKDYLVIAAFGAPFVVNQMAMGQIVRAEGSSKEAMIGMMIGTVVNIVLDPIMILYMEMGVAGAALATIIGNACSTLYYIYHILRKKSFLSIHVKDFSMHKDILINVFSIGIPVSINNILMSASNILINNFAAGYSDNVVAGLGVAQRIFMLVILVFIGLSQGLQPFVGYNFASKNYKRMNAAIKLSCVVSVITGFLLLALSLIFGRVSVAVFINNEEVIDYGVKFLVASYAIAPIIGFQFVFMSTFQALGKSIPSLILSLSRQGIAFVPTILIGTKFFGINGIIWSQPIADIVSVALATVMYIYIYRKMKRKALEEENNNMEAAYNNA
>fig|526224.6.peg.1830 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MINMTQNTKNMEKSFFKYVLPAIASTMLGGLYIVVDGFFVGNSMGDNGLTAINLVYPIGTLIAACAVMLGMGGSVIMSTYFGGGDSKGFNKAKSNTFITLILASVILTVILLLLKNKLIYLLGARDNVFKLADEYITVIILGGSFQIISYGIMPMIRNLGKTIHAMAFMVAGLITNIILDYLFLMVLRLGMFGAALATIIAEGIVALISLYYLFIRKKYRIKLSDFDLSMTKRAIQIGLSPFGLVMAPSLIVIFNNWQCIKYGGYTAASAYSVINYIYGSVIYLFEGIAEGCQPMISYFKGAKRNDLMKKVFKKGVLFALIIASIILSIILIFKNNFGILFGASIETNDIISKGLILISVSFILQPIVRLGTAYFYSSGESRYSALLTYIDPLFVSPLCILVLPLFFNLDGVWLALPFSQFILIVLFIFIFYNTNIKDKDFIKKTVY
>fig|526225.7.peg.2498 
MPTPTDDRRDLLTVIAHMRAAPGKRDELRAALEALVEPTSREKGYVNYDLHQGIEDPDRFFFYENWESDADLDAHLDAPHLRDFAARIPELLDDSGLSVNRVRRIA
>fig|526227.6.peg.793 Permease of the drug/metabolite transporter (DMT) superfamily
MYVVSKVVLEVIPPITLVALRMVVAFVCMVLWLRLLGRDWRLPRKLWAPVTAMGLIGYALSITAQFIGTGLAGAALGSLITTASPLVTVALAALLRIEKVSARAWIGLGIALGGVWVLSGSANANLAGVLWLIVAAVTWGILGLIGAQTVRQHDPALVSAWASLVGGVALLALVPGELARAPIGEISLGTVAGVLYLGVVSTAVAFTFWVYAVAKAGSVLSGIAFFAQPVVGGLLGWALLEEPLGLSFLLGATLLFIGALVARPS
>fig|526227.6.peg.1407 Permease of the drug/metabolite transporter (DMT) superfamily
MRLPPLIYPLFSILAWGSNATALKVLVAYLPPHAMNSLRVLVASLVYAALWALFSRERLGWRDWVVIAGLGLIGNSLYQWLFLEGIPRLPASYTSIVSSTNPIWVALLSVIWLRESLPKMAYVGLVLSLAGVMILSAETLEQGGAQWLGIAFVLLSAVSWAVYTVGARRLAGGYRLLTWTGGSFVLGMVPYWLLHTPDMLRLASAAVPVWVWVLLIASGLLANTLAFLTWMHGVRQLGPVRVAVFSNLTPVVGVLAGVVFLGERLPLQALLGGLLTLWGVLIAQRAQRM
>fig|526227.6.peg.1876 Multidrug resistance protein-related protein
MPWKITGLLPLLSFVLLLGLIEAVRSGFFAVYLPNFAKSSLGFSAAVWGASWTVHFLAESLFKGPGGYLVQRLGLGVATLIAGAAGLLALLLLPYISAPWMLWALTLLWGLSLSAVSPGLMTLSSRLARPGREGRALAYTTTLILPWAGVGFLLMAFLVPKDIGAAYTTLLIGQGLVILLSLPLLSFRERISLPKQEYYPWRQLVLFIPAAFGQTFAPAIISQLIQKFASNELGLGFLELGAVILVGGVVAFSSMGWLGRIPDRRGPKVPLIVGLSLMSATMLLVAQKPSFPQLLAIAALGGIGFALFVPSWNALVVRVLPQNNRAAVWGTLMMIEAWGTAAGPSVGGILWSTLGVTAPFYASAAAFLAVAVFYVFAVRREI
>fig|526227.6.peg.3551 
MHARIVTSHIQVGKIDEAIQIWREKVIPTLKGAQGFKSGYMTGDRQTGKGVAVTFWETEADAAYWNSSGKYQEVIAHFAQLFTAPPSLEQFEVFLQV
>fig|530564.3.peg.271 Multidrug resistance protein
MSRSPKTPAPQSADDSSQLASTSTGRGSLLVIFLTVFVDLLGFGMVLPIVPLYAKSFSEKYALEAWQTGLLIGALMSSFSLMQFLLVPFWGRLSDHYGRRPIILIGLAGATFFYALFGVATAMQSLTLMFVARIGAGIAGATIATAQAYIADSTTTKNRNKGMALIGAAFALGFTLGPTLGGVAILAGGAIHLSPWPGYAAGLFSGVALLLAIFCLPESLRPGSEKAHSKLFDREALAAALRIPTIGTLLLTSFLAVFSFGNFESTLSLQIDTMVQKQTSPETTPAFLASLLRFANWLGHESPDNVKLIVVLAVFAYLGLVLTIVQGFVVRRLAGKVPETTMAIIGSVLATVGFLILGLAAMRADFHLLLIAMAVEVSGFALVNPSLQSLISRRSDPAVQGGILGLAQSTSSLARILGPVFGNYLFSRSVGAPFWAAAVLMVLAVVMMFFTIGAKQDFTPETKAV
>fig|530564.3.peg.2091 Permease of the drug/metabolite transporter (DMT) superfamily
MLALATFFWGSNYLVGTIAIQYTPAFTLTYYRWLLACVPLMVLAQVLERPDWRAVWRNLPLLAALAICGISVYSSLMYLSLVYTTPMNAALINAVNPSLIVLAASFFLRERLTPIGIVGIALGLVGVAVVLTHGNLMAILHHRYNVGDLMMLGCVCFWTVYTLIARRLHGVRPITSTAVQSVLAVISLTPFALYFDNYTLSLEPTAITCIVYVVLGPTIASYLLWNIALTRIPASQGAVFMNLIPIYAAILSTMLGKPVTMAQICGGLLVIAGVLLSSQSSHRVEKSIGKAATS
>fig|530564.3.peg.4276 Acriflavine resistance protein A (precursor)
MTEPVVDNRPPVPIITCKPVVKPIVEWDEYVARFEAVEAAEVRPRVSGLLQSANFIEGQIVKKDQVLFEIDPLPYQAEADRAAAAVNEAKSQADQARAAVAETTAGILVAKSDFDLAKKQYDRALQLRSQNAISQEDVDIRQSSFENASANYESANAKLVSAKAAVVAAESAIKTAMAFQQIADINLGYTKVLAPVSGLVGQRLVTDGNLVTGGTGNATLLTTIISIDPIHCVFDADEQSYLKYTRLAENGKRTGSRFARNPVYIALADEQGYPHLGQTDFVDNVIDQNTGTIRARAIFHNTKDMLLLPGLFARLRLPGSARYEAVLLPDLTIGSDQSEKYVYIVGADERIERVSVKLGPSVEGLRVIREGLTGSETVVMGGMQRVTPGQRVTPENKPIKAGSSDLPDDFKPVPRAEWIMTPRTERILKDVEGQTEINPPAVPLEAPPTPAAAAPTEPAPAPKPPAPAEGVAPPAEEGQN
>fig|533247.5.peg.1870 Multidrug resistance protein
METTSKKFKSDLILEARASLKLGIPLVISQMCETGIYTANAVMMGLLGTQVLAAGALGALAFLTLLFACHGILSVGGSLAAEAFGANKIDEVSRIASGQIWLAVTLSLPAMLLLWHGDTILLLFGQEESNVLLTKTYLHSILWGFPAALSILTLRGIASALNVPRLITITMLTQLILNTAADYVLIFGKFGLPQLGLAGIGWATALGFWVSFTLGLILLIFSLKVRDYKLFRYLHQFDKQIFVKIFQTGWPMGFQWGAETALFNVTAWVAGYLGTVTLAAHDIGFQTAELAIVIPLGVGNVAMTRVGQSIGEKNPLGARRVASIGITIVGIYASIVALVFWLFPYQIAGIYLNINNPENIEAIKKATTFIPLAGLFQMFYSIQIIIVGALVGLRDTFVPVSMNLIVWGLGLAGSYFMAIILGWGGIGIWLAMVLSPLLSAVILTVRFYRVIDNLLANSDDMLQNASVTTLG
>fig|535289.3.peg.2346 Outer membrane component of tripartite multidrug resistance system
MATPAAWAGQGAVQGGAAATPQDLAQWWRQLGDAQLTGLVERALQSHTSMRSARAAVEQARAQRDVQAAGLLPSVNASGSAQRSRSNGSTGNTFQAGLDASWEPDLFGRLSSGVRASEADLLAAEEGVAAAQVALAAEVAVNYISLRSQQQRLQIAQQNLAAQSETAQIVQWRVQAGLASSLAAEQARAAVEQTAAQVPTLQAGIAQARHALAVLTGQPPAALDEALAAHAPVPQPPADLALAFPADTLRQRPDVRQAEQRVRAAWERVAQAEAQRMPSLRISGTLGLRALTLGALTGGGATVASLLSSVSLPVFDGGALRAQVRAQEAALQQAQVGYEESVLGALKDVEDALVALQGDRDRLQRLSAAAEAAGNAALLAQNQYASGLVDFQTVLDTQRTLLSAQDSVASTAASVSTDHVRLYKALGGGWPAP
>fig|537021.9.peg.896 Drug resistance transporter, Bcr/CflA family
MKKKLPLKLRNSNISHMEFVIVIAMLMAINSLGIDIILPCLPKISDSLHLSNENYGQHLISFYLIGYGIAQIFYGPLSDRFGRKIVMMFGLVIHIISTFIMVTINSFTGMLCMRLIQGIGGAAPRIITISIIRDIYDGRDMAKVLSIAMMIFMIMPILAPSIGQATVALSGGWIGIFVCMGVITTFITLWYYIRFPETLDPRDVRPLNLYAILHSFSLIFKHRASTLYNIANSLTMGAILGFVNSSQQIYVGIYQLGNLFPIAFAVGGFAMSIASFINSRLVEKFGIRRVSHYSLLIFFMITGSWLLVQITSNHPIHLLIFIAFFFLASFQFGLINSNFSSISMEPFSHLAGTASSIFGFINTVISTILGIIIGQSFNGTTYPITIGFFGIAVSSFICILIVEKNQMFRKTELR
>fig|537970.9.peg.38 Membrane fusion component of tripartite multidrug resistance system
MKKRLQYSWLPSKPKLYVIVLTTFGILAGVLSILYAWQLSPFFLNVVVTNDAYIQSKTTLLSPQVSGYITEVYIKDFALVKKGQPLFQIDNRIFTQRVKEAQANLQSAESALLAYEENYRLYEANIAEKEAQIKSVEANLKNAQAENDRATTLIKNKALSKRDYDNAKAQFLSLQANYVQAKAQFQKAIQELEAHKTTKSSLEAGVKRANALLELALIDLDNSVIKAPVDGQLGEILAHIGQFVSQESALAYIVPQTHWVVANIKETKMDKVALGQKVHFSVDALSGKEFSGVVEEISPATGSEFSPIRVNNATGNFIKVIQRIPVKIKIDSTNERLEELRAGMSVVVEIETK
>fig|537970.9.peg.1324 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPKFLHFYSNQRSKKILNIAIPSGLNSLLDIINLSIDLMFIGVFGANAIVAVGVSLNYMMLAFAFTTIIFVGNSALVSRFLGADQKKCADEVILSLTFAAFCLSIPLCLLAFLCYDYFFSWIGISNEAKEIGSSYLSLTLFGIPLLLIKQVSISSFSAAGATKIPFFIKIFITLFNPILKYIFIFGFLFIPEFGVIGAAIATLIINFIETLALFLYLLCYKKSPISLRGKINFDYIKRAFIVGIPSGCERLFTLLSMILMAKFVALYGTFNLAGYQIATRIEGFAFMPGFGFMIAAMALMGQNLGAHKPLEAKYSTLNTLLLGGVFMGVIGLIMTFFAPLLSSFFTHDIQTIEASTKYLIPIGISQIAFAFICILDGALRGAGITKITLITNTLMIWGLRVIPCYLIAKFHYPISYIYLCICLETFLRAFVYWKIFQKGAWRKNKV
>fig|537970.9.peg.1566 Permease of the drug/metabolite transporter (DMT) superfamily
MQKLSNEQIGILWIISASIAYGIMPIWSVISQNNGISTDFILFFRFLCSAFLLFLWALYRQISLKLTKLQYLQFFFLGGILYIIQSFAYLDSLRYIPASLSVLIYHIYPIIVALIALIFLRQKLQAKTLFSLFLCFAGLAIILQPPKDLELSVYGVILSLIGALFYGLYVVFSKSYTSNLSSVVYSFYICLFAALMILGFMIPNPPQFDNFNINGILSLLGLTFISTLFPMMAYFLGMPRINVTKTAILGMIEPLVGVLLSLWLLGENLNLLQYFGGFLILFGSLVLFIKR
>fig|543728.3.peg.3654 
MILVIGHAMAKPETLQAMLAISVEHVLRSRTEPGCISHEVSADVQQPLRLSFVERWSDMAALKAHFRVEASRAFGKALAAMADGTPQISIYQSEEIEPA
>fig|545694.3.peg.553 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVNAIYNIVDRIYVGQGVDPLGIAGITIVMPVMMVLMAMSILIGIGANSLFSIRLGEGRRDEVEKIMGHAFFLLFLVPGIAIVVCLIFLDDIIIHILGASENIFPYAKTYLQIILYGGVFSAMGPGINHFIRSDGHPRTSMVTQLIGAVINIILDPILIFGFKMGIAGAAWATIISQFISFVWVLGYFNSRFTTLRFRIQDMKLELGLTLKIMAIGFAPFAMQLAMGLVGVLQNHALNTYGGDTAVTSMGIVFSILIVIFMPLQGINQGAQPIIGYNYGAKKYQRVKKTYKWAVIAGTIFISAGFLLIHLFPHFFISVFRNEEGPLMDMGVYCLRVSSAMFPIVAFQMFSSSYFQAIGKPVQSTILSLSRQILMYIPLLLLLPRRFGLHGVFFAMPASDILSAALTLIVMLIEFKRLKKLIAEGEVRRR
>fig|545694.3.peg.589 Drug/metabolite transporter, DMT family
MWVFFALSSAVFAALTSILAKVGIANINSNLATAIRTVVVLIFSWGIVFITGKQNDIVNIGHKNLLFLILSGVATGISWLCYYRALQIGEASKVIPIDKFSVVIGMVMAFIVLKETITIKSIIGGILITAGTFVLIL
>fig|545694.3.peg.672 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSASAPNKYSLTEGGILSKLLQVALPIMGTQFLQMAYNLTDMFWLGRVGSDAVAASGAAGMYMWLSMGFLLIGRMGAEIGVSQALGRGDKKAALGFSQNAMLMALFLGLLYGLCLFIFNRELAGFYNFREPNVAGDAAAYLSIVAWAIPATFFTAVITGSFNASGNSRTPFIINGIGLAANVILDPVFIFVLRLEVRGAAIATVISQLVVAAGMFAGVNWLKGRPFERYPIKIRIEKEKIAMMLKWAVPIGVESLLFCFLSMVTSRIEASFGAFAMATGKVGSQIESLSWLIGGGFGSALIAFIGQNYGAGKWDRIRRGVRISALLMTAWGIFVTLLLYFAGGFLFSLFLPDPELVQFGTKYLRILAFCQLAMNLEAVSAGAFKGTGRTMAPSAVSIISNLIRPFLALILSRTSLGLYGVWVAVSITAIIRGAWISLWYVFRKKAREQSTGQ
>fig|545694.3.peg.770 
MIVCIAKFKVKPGRREDFLKNSRPCIQASRDEKGNIGYDALLDPDDPDGIVYVEQWESMDAANAHGKSEHFLANQPQSAALREGKPKIVMYEAQLATQFPVQPLK
>fig|545694.3.peg.1340 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSDLANDNVPGNPSIQADAAERLGTDGVGKLLLRFSIPAITGMIVNALYNVVDRIFVGRWVNEMALGGLSLVMPLMTVSMAFAMLFGVGAANMISMRLGQGRKSEAENALNHCFWLLLISGIILMALQLIFLDPLLSILGAQQGSASLPYARSYYLIILYGQVFLSVGFGFSHCTRAQGFPAISMISMFIGAGINFILDPLLIFVFRWGVDGAAWATIIAQLAQAIWILAFSFSKKAVIRLRLRLLQRSSPRSFKPSPGIVTQIMAFGSAQFFLQFVMSAVQLIYNTSVGRYGVASLGVSNGGDIALSGMNINGSMAMLILMPVFGISQGAQPILGFNYGAKKFDRVFKAYRAAVVVATVICVLGFAMTELFPLQLVKLFAPIGSPALLRFTPWAMRVMMLLLPLNGFQIISANFFVVTGRPRTSIILSMLRQCLALIPCIFIFGRIWGLWGIVAAAPVADGVSFVATSIMILFEMKKLRAQMATS
>fig|545694.3.peg.1375 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MESTPVWTAIIRLALPMMFSMIAQLVYNMTDTFFIGQTGDPNMVAGISLAMPLFMVSQGIGNIFGVGASSYISRMLGAREAETAKRTNAVSFYTTIMAGFVITIALLLFRKPILHVIGTSDATFVHADSYFSIISSFIVIALLNISLAGQIRSEGATDKAMVGTLIGIIINIILDPVFISVLNMGTAGAAWATVIGQAASLGYLLWCFISPHTMLSIHPRDFKPSGKIYREILKIGLPAALSNIVMSLAMAVRNLMAASYGDMVIAGMGVTIRVESLSFMLIMALAMGYQPFAGFNYGAKNYGRLKKGMKITLVYTTALALFFVGVFALAGRSIIALFINDAQTIAAGATFLHAFLFGLPVMGIQMTIMITFQALGKPVLGTIVSLGRQCLFYIPLVYVLNHFSGFEGFVYSQPLADIATTVVALILVSGLLKELKHHEK
>fig|545694.3.peg.2801 5-nitroimidazole antibiotic resistance protein
MRRSDREITDVEEKLKILRKNKVFRLGMAEQNQPYIVPLNFGFEFDGGLLTLYFHGAREGKKADILARNSQVCFEMDGEHSLVTGEEAAAYSFAYESIIGFGTAELLTKDEEKIRGLDALMKHQTGEDREWHYTESQLKAVAVYRIRVSSFSGKRRPQK
>fig|545696.5.peg.331 Vancomycin B-type resistance protein VanW
MQRLHLYQLGPQAYALSRKKEILKRKFQDQIHQIHFAQTRSEALLPVVVNRHNSLIRRKLGNVDQRLQENKAVNLSLAAPKLTHLLIQPGETFSFWHCVGECTAEKGYREGLTISGNHPSSGIGGGMCQMTNLIHWMVLHSSLTITEHHHHGRFDLFPDFGRQVPFGTGTSIVYNYLDYQVENRTSDTFQLVIETNERYLCGELRCDHPQLLKYHIYEQDSGFTWEKDGAYRHNIVRRKAINKASGEVAFDQELIVNHAKVMYDPKLIDPALFRESGFWNQKQ
>fig|545696.5.peg.745 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKFNSDKMGTMPVGKLLFSMSVPAIFSMLVQSLYNVVDSIFVAQVSEDALVAVSIAFPLQMLIIALALGVGVGTNALIARRLGEKRREEANIAANTGIVLSLINMALCMLVGLFLAKPFVGLFTQDAAVFTMGSQYLMIVMVFSVGVMIEMTCSRVLQATGNMIVPMISQLIGAITNIILDPIFIFGYFGVPKMGVAGAAVATVIGQILAMIFVLIVLKVGTHEVDIAPWRHHPQMQAAKDIYRVGIPTFVMNAIGSLTTTAMNAILMGFSATAVAVLGIYFKLQSFVFMPIFGLNQGAMPILGYNYGAADEKRFTRTLALSFGVALAIMVIGTVLFWTMPEMLLKLFNGSDQMLQLGSYALRVLALCFLPAACSIIMTTMFQALGKGMMSLVMSLLRQLVFIIPLAWILGQLGGLGAVWFCYPAAELLVAVIFVPIALKTIKKSFDQERQETGVY
>fig|545696.5.peg.776 Methicillin resistance factor
MLRLIEHEQPQLFDAYAANGKIPHYSKTHFYGELCRRKGIEIQLVSAHNEADEIAATALIQWEKSGGEEYGYLCYGFNLDYTNTETLQIFATALTELAKRRGAAYLRMELNIPRIEHEKDGRIKPGGFNNEFVTAQMEACGYHHLGYTYGYSGNRMSRFTYCLNLDQPLETIRKQIKHYAAYQKKNIQRAVSVKLSDARDLSILVEAERELAHKLHFLPKKEKDFRQLMECFPDQARLYVVSANVDQALSHLKILREQLICQQGKLINAQRLAENQKQIVALDQEIAELMRDYQGLGEIKLGAKLIIQQGEHVYNVNMYTKKILPNFRAAFALHSAVIEDCWKRGAKTYDFEGVSGALNPEDPYYGIHDFKKSFGGEFIEFLGEFDYIQDPQAYQRILKRQRRRRKLRRGLARVLYR
>fig|545696.5.peg.1300 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRKHQHPTVNEITEGVIWKQLLLFFFPIMLGTFFQQLYNTVDAIIVGQFVGKEALAAVGGATGTLINLLVGFFVGLSSGATVIISQYYGARKVEQSSDAVHTAVAMSLIGGAIMMVIGIFGAPVALRAMGTPENIMNYSLIYMIVYFVGLIPNLLYNVGSGILRAVGDSKRPMYFLIVCCLANVVLDLLFVLVFQWGVFGAAAATCLAQFISGGLVYLSLSQAEDDRYRLIRKRIRLHGELLKEIVVIGIPAGLQSVMYSVSNIVIQASVNTFGTDTIAAYTAYGKIDGIFWMIMGAFGVAITTFVGQNFGARKIDRIHKSVKVCLAMAFGTALGMSGILMVTSRWIYHLFTQDAAVIEVGMQMLLYLAPYYFTYVCIEVLSGAVRGTGDSVIPMIMTCMGVCVLRVVWIWIAVPLNPTIENVLFSYPLTWSLTSILFVLYYLQGGWLKRRLKKEERKGLQN
>fig|545696.5.peg.1849 Vancomycin B-type resistance protein VanW
MSRRRVTEFLPFLLPLRRKQKIWCFYQKMKHDGNRYARRQAEERLPYIQYECTQGLINPDSGYDIQYQYNKAHNLKVVSRRMQQLIIEPGEVFSFWQLARGADHDDPYRPGLGLHDGKIVPVHGGGLCFMSELLYWMVLHTPLTVIEKHPHLVISLPANPNAEMPAGIDATIQEGWSDLKFRNDTDQPFQLILDFDEDSVHAQFRCAQPPCYRYEVTGSALVYSRKKGKIYRTQDISRTLYAAADGELVREEACYTSRSRIDYPLPPETEITEED
>fig|545696.5.peg.1863 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSLKRKFIRFVLPSIASMLVFNLYTMVDGIFIANYAGETALAAVNLAMPFINFMFAFSLLLSIGASTLISIHRGAGRTERANQLFSMNTAVLSVLALLISVSCVLFAQPLAVFLGAGSDTLNYVTEYLRIIGGFGFFFIVSYSFEVLIKADGFPQLSTFGVLLGAVTNIVLDALFVFGFHWGLAGAAWATGISQLLTFLVFFSHFLFSRKTHFHFTRFTLDLSQYQRIVPIGIADCITELSAGVIVFAFNHQILSIIGTSGVVSYTVMTYVYNLVLMAFVGIAQGCQPLVSYAVGQQDSKTIKLVYRYGLTAVALTSVLCFGGCWIFTPQIVSVFIRPQETALFGSTIAAFRLYSFCFLIMGYNVLTSGFFVALAKPKAALMLSLARGIVVILACLLAMSSVFGALGIWLTPTVSEGLCLILSFILLIKAKSWAAA
>fig|545696.5.peg.1865 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKTFFKYVIPSMLAFALSGIYAIVDGFFVGNSVGDQGLATINLVYPLVALIQAAGTGVGMAGAIHFAIAEGGKRINERNRYFWITCGLLIAVSLLLTLVYLPLNKTLLHLLGMQGQLEIYGLQYMRVITVGILFQVLGVGLVPLIRNMGKSLQAMAAMIAGFLTNIVLDYLLVWILPYGLPGAAAATVLGQAVTVLWCAAVLFPVRKTLKAQWDKGWEYQTTRILKLTPSPLGLTFVPNVTLILINWSAMQFGGDPAVSAYAVISYVCCVMLLLLQGVSDGTQPLFSQYYGEQKPDKVRRVRRLAFQFGLAIALASVLLLYGLRYEAAVLFGASEEIVAMVGESLPIFILGFVFVAISRIAISYFYATEKNKYAYLLIYGEPLILAALLLILPQRCGIAGTWAAVPVSQLAVAVLSLGLLKKVQRKEEKFRIEQRNQTVERSC
>fig|545696.5.peg.2290 Multidrug resistance protein B
MTGVLTLPTMAYILHNDRVGQFSLKLFFEQPSIYLHELCARLVPNYIYIYRTNVFETTAHTTRELCLYSGTLTAVLLPQIFSDKDKKFRKATLIFYIILNLFLIFPFLSSMAHGFSDPTFRWTMILILVQILTVCHYLENINQLNTKNLKITMGISIFVLIAVIPLTVILSKGNTISAYRNQILLFLSAIIFVVINTWLLLNKKSYIWFLTVLCIEYSISGFTLYYSRMRSEGITYDFIKSATHVLQDKDHELNYFLENIEPVNSLQYYRTYIPLESIYWDFSHNMSLMVQLQGTMTYDSTYAPSFNKMKEIAPEVKDYDSEWIFNIKNPDILQFLSVKYAIVTNPSELPEGLSWRLLTDNYRSGLLVYRNDDYRSLGTTYNQIITYEEIESTKLITHLSDIVACESSDLMEIQNMMNSNHSVELENIAHQGNYLTGTCNTDESSFLVLSLPYDKGWKVFVNGQNVKTYSVNGGFVGFGVEVGNNQIEMYFTPVGFKQGAIISLIGIMGYVALIVYEKLKIRNSRRYKNEQSI
>fig|545696.5.peg.2775 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTMNKNADRSLILDSMPVKQALIRLAVPSILASMVTTIYNIADTFFIGQLHNTAMIAATTVAMPIMMLTHAFGESIGVSAGSYISRQLGAGHRDQVSRIVQTTMTLVVLISIVLPILFITFLGPLLGMFGAEGDVTMYAAQYVTILLVFAFSQIIKLTIVHLLRAEGDVNFPMAAIFAGVVANLILDPIFMFDWGLNLGIAGAAWATAAAQCLSLVMLLGRLLFKAEAVRWNPRVWMLDKAAVQEILSLGVAVFARQALPSVTYSCLAMQASVYGTDFLAGIGIAKKCLNLVMFAIIGFAQGFQPFAAYNYGAGNRPRLKQALKSALTWVTVYGCFAAVFYLTLAPQIVQIFSREAAVIEMGRMMLYGYAVSMPVVGAYNIAAVLLQALGEKRSAFFLSIARQGLFYIPIIWVLPTLLGKLGIFMAQPCADYLTILTVIFLCRHLFVDLMKG
>fig|545696.5.peg.3413 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSQSQNSILGELRPSKAIVKLAVPATIALLAKAVYNIVDTAYIGMLHSDIALAAVGVTLPLLLIMVSVENIFAAGAAVLAGRQLGAADKKGANTTVTTVIGLSVLIGALLCVGGIFFMEPLLRSFGASSAVLPQAKDYAFWMFIAALANLPAQSLNCAARAESSVRISSIAVITGAVLNVVLDPIFMFDWGLGLGVGGASLATTVSQFVTFAILVGFYASGRSIIKIHPRYFKPNWKLIKTVTLIGIPTAVIQICLAVATSLTNMAAKPMADADLIIAAYGVVQRLVLIGCYVIMGFMQGYQPVASYAFGAKNEDRFHACVQFALKASLLLTVIVAALYIVSARPLIQLFNSNPAVIDYGAKLLISQVALYPAFGLCYMMTITFQTIGASRYGLFLSLIRQGLFYVPFILMLPRWLGVNGIYFAQPAADLLTLLVCVLSVKSMKKIASRNMQLDVSVA
>fig|546269.3.peg.371 Vancomycin B-type resistance protein VanW
MKKMVGIAVGVIVIGIAGVVYLNHYMQKDIIYSNVFINEVPVENMTKQEALNTVSQKERFQSAVFQFQDREFRYPVEELGFSFNYEDAVEQAYSIGKEGTFFDRIKSIFSLKVLQQKQNITLQYREDSSKLEEKASEINGKIYQQAQDATISVETNFEITPEVVGRKVELDKIEGLVKQNLKSNEDIVISLPVKEVIPKVKKEDLEHINGKLGQFSTRFNSSLTGRTENIRMATSTINSTILMPGEEFSFNKKTGNRGLSDGYREASIILNGKYEKGVAGGVCQVSTTLYNAALYSGLEITHRQNHSIPASYVDIGRDAAVVSGDFDLKFKNPYDYPVLLKGFVSGNYVTFQVYGDVSQAPKVVLSSKVVSSIPKKVIYRNDPTLPMGQEVVEEPGRPDIRSVTYMNVNGESKIINRDRYPGKTEVIRRGTKPVDSTDNPDATPGMLPSPTNEGNGQSSIVG
>fig|546269.3.peg.1217 Permease of the drug/metabolite transporter (DMT) superfamily
MQPKDNQKVLALMLLLFTCVAWGGSYVSIQICLDAMGPVYLPFFRYLLSAVLLFVVLKGKGMSLRLEASDWVKVGLTALFSITVYFYFENSAIKKIGANEAAILVAMLPIVALIGNRIFLKQKLLRRNVISAVISIVGIYFVIGGVQFGQNKLGYFYIFLSNLSWSAYLINTKPLLKKYDGLVLTFYQCLIGSLAFLPALPMDYFYIDKITTGIILHFLFLALICSAVCTVCYTFAIKHCGVGISALCLNFIPVATFFFSFLILREVMRPIQLIGAFVAISGLMLMKEDQAIDG
>fig|546269.3.peg.1336 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVDGFFVAKFVGEQTLSAINVVLPFINGIFSIAILFSTGTATLVGISLGENNHKKANALFTFTTVVELLFSILLYVVCRLNIIHLASFLGATPSIVSDVTTYLKIILLFNSFFIISYNLEVLVKTDGFPALATIGVLLSAFTNIFLDYLFVGVFHWGISGAAWATGIAQVFSTALFMTHFLSKRSVLKFRSFEWDFKIYAKILFIGFGSFISEISTGVIIFLYNNHIVKVIGETGLISYTVLSYINLFVSMSMIGLTQGMQPLVSYYYGKKDPDSYHKFLKFSFIGILGLSATFYVITLLFRQQLTGIFIRAEHAELFAYTQRALFYFAPSFLLIGFNLLISGYFASIGYAKHSLIIAIARGFLFIWIALSVATYLQKDTLLWLSSFFSELITLLVSILLILSIMKKKNLSSINEEQTS
>fig|546269.3.peg.1714 Vancomycin B-type resistance protein VanW
MQLKKIISATLLLGLLGSSAVFADVEPNPAETPNPTATDEQSYNSETEPTENTSDDTVPTDLEVLDSLDENYYNQEQVTPPVLKVISLGKSTSNFASSPSNRKFNIKKAVNALNGKVIQPGEIFDFNRIVGPTSQATGYRNAKVITDGEFVDGYGGGVCQVSSTLFNAALNSGMDIVQRRNHSLRISYYPAGYDAAVNYGSLNFKFKNTYKVPVKIKATADNKNITIELVALQDTTKKVVSLSREKKGDNTFVISRKIKENNVIIKKDTFRSTYGIKKK
>fig|546271.3.peg.943 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKILGKLRALRHRERIYGVHNPLTYDFLHHNLHHLHVLLFHSADQQDFTRGAIPRQLLVFMLPILLSQLLQQFYTIADTALVGQVLGAQALAAVGTASLILSVIVNFFIGFSAGLSVLVSHLYGKKDYARLSALVQSIFITVALFAALFTAAGIILTEQLLAALSTPAELIPAASLYLHTMLYGILAQLLYNTASAILRALGNTTSALHYLAAAVVLNIALDVVLLIVIPCGIAGAAAATVLAQYAAALLALWKLFHLHGTWKLRFSRPFFALSHLLPILSTSIPAGLQAVFMSLSSLVIQTYINSFGYAAMAGMTVYARIEGFLYYPLFAFGIALTSFIGQNVGAHDLTRVRAGLRISLRLAAGGAMGMALIAGLAAPALVSLFTDDPAVAANALDAVYYTFPFYWLYGINQIYIGAIRGLGDTLYPMMTALAAYCFFRVAWCWGWYMIGIHSMHIVYSAYSVSFFVMAGLLWFGCRKALCRVYRDFSYEYLKGRD
>fig|546271.3.peg.1026 Vancomycin B-type resistance protein VanW
MNFILAVSLLVVLTLLASGIFAYHTSCRGRILYGVQSEGRSLFGLTQKEAEQYFTQLGKKKLASQTVSLRSNGAVWKIQPQEVNLQPAAAAAAEEAYNSGREGTFVLQAVTQIKNAIYGCNIPFTASYDESLLQAKLEGIAEKLLVQPVNAACEISVNGAIHHIPGKSGKKLDIAASLKALDKPLKEMQAANLELPLEENPPFVRTEDVANVNAVLGTYTTYYRHGARGDNIAIATQQLNGVLIRSGANFSFNNIVGTRTANAGYKNAAVLVNGKSVPGIGGGVCQVSSTLYNAILLAGLNPTERFSHFIPSSYCPPGLDATVADNLIDFQFMNPLPHNVYILASADGRKITVQVLGTQADLQGKHISIETVGSSRRPSVYRVYSANGQVVEREYLHTDSYS
>fig|546274.4.peg.1055 Nitroimidazole resistance protein NimB
MPLPAAALFSGSLQAFWGQHSGADFGIIPLLATGYLKPAGLNLTEEKIMSFREMKHANQQLSNEEAIAILQRGKSGVLALHGDNDYPYAVPISYVYHEGKIILHGAPAGHKHELLARDNHVSFCVVDLNDIVPQEFTTYFRSAIVFGTVRTVTDPAEKQAALEAVGHKYSPDQNGLLPYIGKHFDYVKVMVLEIDHLTAKESIELVRAKTSHS
>fig|546274.4.peg.1303 Bicyclomycin resistance protein
MNSPASSRLSDKQMALLMAAMAAVMPFSIDTYLPAVPAMAASLGVGETDIQQSLSIFLVGQSAGVLLGGVFSDFKGRRPVVLAGLGVYLVASLGLILLQTLPQLMLLRMLQAFGAGMVAVSGGAIVRDHYEGRRAAQMFALIGVIMMAAPILAPMVGWLMQIIGGWRAVFGFLLGYAALVWLLQWRFLPANRPAAKPAGSPLSIIFTGYRSVFAKPQSLGFLFFQSFSFSSMFVFLTESPSVYMKFYGLSNGFYTLLFGLNIVTMVFFNRITAWRLKSGSEPANILLIGIAVQFCANFLLMLLSQSTAMPSLWLFAPLVMVSVGTQGLVVANTQACFMGYFKAEGGSANGVLISSQVLIGAAMGFLTTQLHDGSARIMPAMMLASTLCGSALLFALSRHVWLDKARQ
>fig|546274.4.peg.1590 Drug resistance transporter, EmrB/QacA family
MQHTDSANTQHEYFANRPGFPAKTIVATLFIGAFFGYLNDTLLNVALTPIMRDFHIDKTTAQWLTTGFLLVMGVFTPITAGVIQWFETRRMVLITQATFLAGSLICALAPNFGVLLAGRMVQAISAAFFVPLLFNGILNIFPPNRHGTAMGVITMMFTAAPALGPTLSGIIINHTHWRVIKPHSKSSD
>fig|546274.4.peg.1697 
MITHILYLFTGLIVLNNPLIALGYFVDKTAGFTLKEQRKTARLVSISAFICMVVAGVIGTPLLKVLGIGIPAFQIAGGILVFVIAMSMMGGEDNPVKPNLNKEHSSLPPEKQFAFAVVPMATPIIVGPGGFSIVIIYSSHVGTWQGALELLIACFMVGVTCYLILAGSARLSKILGNVGIKIINRVSGLLLAAIAVEIVLAGLRSLFPALKIMG
>fig|546414.3.peg.3245 Permease of the drug/metabolite transporter (DMT) superfamily
MVIWSGFILVSRLGAQGTLSAFDVAALRFGVSGLVMLPYLLRHGTGGLTLLQVAALGVTAGLGYALLAYSGFHFAPAAHAAVFMPGMLPFFTAALAWWLLGERWTRGRLLGLAVVAAGVALLVADELGRGGTTWRGDLLFLSASVSWAVFGVLARRWRVQPLQATAVIGVFCLVTYWPPYLLSGHSNLLEAPLAEVVIQGVYQGLLAVVVALITYTRALQILGPNLTTTITSLTPALAALSAVPLLGEELSALAVLGVMIVTLGVLVSVIRPRSTPTAQVSDED
>fig|550540.3.peg.1215 Membrane fusion component of tripartite multidrug resistance system
MKKPLIAVLALGLVGASALYYGIGSSGVSTDNAYVKADLTLIAPQVSGQVVGVAVSDNQWVEQGDELFRLDDRDYRAALSQAQAAVALADAGLASNDSRTALQRVQIEQARAQIASAEANASLQQAELKRYRQLVTSGSVSQTQFDVQSARAVEAQTGLDNARLALKAAEQQLATLASERVQLEAQRQQAEAQHQLSAIALERTIIRAPMAGRVANRQVQIGKLVQPGMAALTLVPEAVWLEANFKETQLAQMAAGQAVEVVLDGYPDQPISGEVDSVTHATGAQFSLLPPQNATGNFVKVVQRVPVKIRLQLPAELKDRVYPGLSATVTVKP
>fig|550540.3.peg.1780 Acriflavine resistance protein a precursor
MNAWRYRLWAGLLVGSLAACGGEAPQQGPPPAAEVGVITLQAQPVTLSVQLAGRTKASLEAEVRPQISGIVLERNFTEGSMVQEGQQLYLIDPAPYIADLNRAQADLSKAAANVKTAKNRADRYETLVAARAVSQQDYDDALANYQQAQADVATARAAVTSAEINLDYTKVYAPITGLAGRSTVTVGALVTANQGDPLVTVQQFDPMFVDVTESSRALNRIRRQWASGELVRQDSAKVRLYFDDNDLYDQEGVFQFADINVDTGTGTFTIRTTFPNPDNVLLPGMFVRAEMVKGIVPNGLLVPARGVTRNAKGEATVMVVEDDKVAQRVVDAEQMVGQNWLIRSGLKAGDKVILEGLQFVRPGVPVGTVRELDQKQQG
>fig|550540.3.peg.2205 Permease of the drug/metabolite transporter (DMT) superfamily
MAHYIPAILFTVFTNFLSQIMLKKGMTVIGPVELNPTGLKQMGASVLLNGYVMGGLLVMVISMASHLYVLSKVEISYAYPFLGLSFVLTTAYGYWVLSEGVNAWRVLGVLFICTGVAIVAKN
>fig|550540.3.peg.2592 Tetracycline resistance protein
MSPYRILAATALVTLISVSGVALPYPILAPLFLDLAHPVSQFANLPPKLLLGAILAIYPLGILIGSNLIGAWSDRFGRRTILLWTMVGSALGYFLSAQAIAQGNFLLFALSRLVTGLFEGNLSVARAIASDLHPKIDRTKAFSWLSATTYGGYLIGPLLGGVLLPLGAPVAFTVAGIACAIAVGVIAVALPKDRPASCGQRAERHSLALLRDPRIRAFFTLYLLLMLSVNGFYEFYPVWLLEVRQFDSLDIAGATVLLTSTMIAVATLVNVRAKQRLGLARAGMVGMALFSLPLLLLPLSAGHYVLSFILMGAGIALYNAMLPSFLAERGGDYGQGALMGLMATTFFLGNVIMALLGSALALLDTRLVLTLSGLFGAVAMAQFGHLHFRRTTWPRPVSQAPAEKPAAGGL
>fig|550540.3.peg.3019 Multidrug resistance transporter, Bcr/CflA family
MTRPVPFVLLMLLVAFSPLAIDIFLPAVPAMADALAAPLPQVQATVAVFLLAMGLGQLLAGPLADRYGRRPLALSGVALYLAGSLMAAWANQIEVLWLARLLQGFGACAVVVAAMSGVRDSYGPERAGPIYSYLNGVICVVPALAPLLGGMLAALWDWRATFYFMAAYALLAGALVAWRLPETRPADTRSEGALVSWARYQPVLSHPVFQYHAGFIMLAMAVIIGYVSLAPVQLMVAMKQSPMAFSLWFGANAAINIAAAFAAPSIVARVGKRAALRLAIGLCLVAAIALLLLADLSHPAAFMGPVFISSIGFCFVFAVCGGSALAPFGERAGTASALLGLFQMTGASVLVGLVNLLPVAPVASLAVLMLLPLVWLGLARLNRAGHQQVQAAMVSVSDNAPAN
>fig|550540.3.peg.3034 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSANLSRQDVNRQFWRYVLPTVAAMLVSGLYQLVDGIFIGRYIGADGLAAINVAWPIAGVLYGLGMMVGVGAGALSSLSRGEGKLARARAQLGNGLVLMALMALAATGLLWVLGEPGLAIQNAEGNVLALAQDYLHVLMLAAPVALGSMAMPFMLRNDGAPNRATALIVAGAVTNIVLDWLFIAEFGWGLTGAAAATALAQLLVTLMGIAHFFSDKAQTRLTLADLKLRPYDAWRSCAIGLSSLLMYGYYSVVVALHNGLFLHYGDATVVGAYAIVSYLMAVYFLFAEGVASGTQPLISYHYGAGEYGLMKRYIRLMLKVAVGSGVVALVLLNLASAPVISIFNSADADLFAATEHGLRLHLIALYLDGFIFCVGVIFQSFGASGKATGVTLANMGIQLPFLLVLPQWFGLDGVWLALPISNVALSLVAGALLWREWRQLEARLG
>fig|550540.3.peg.3276 Glyoxalase/bleomycin resistance protein/dioxygenase
MTQFKPEDVPTLMPYLMVKNVSQAMDFYQTAFGFERAGEPLVEDGVVLHGEMTFGDARIMLGREGAFGSEAKSPASSGHDQGMGLYLYCPDVDAHFEQAQEAGAAIMQPLNDMFWGDRIYTALDLDGYRWSFATHTATQES
>fig|552396.3.peg.192 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNMTQGNVMKLLLSFAVPVLLGNIFQQFYTMADTMMVGQILGVRALAAMGATASLSGLVIGLVSGVSMGVSILIAQYYGARDQEGMKMATYGCILLCMSSVVIIVLAAMLLKTPILSLLQTPKSILSMADGYLTIIFMGLFITMAYNMMASMLRSIGDSKTPLYFLIIASLTNIALDYLFIAQLHLGINGAGYATVLAQLLSVVLCFLYMRKKYPMFFLKKEECHVEREVFLKQMSMGISMGLMNSIVSIGSVVLQSAVNSLGEMTIAAHVAARKIVEMFMQPLISIAIAVTTFVSQNLGAKQYHRIREGMKKSVWISFGWVGIVILLSFTCIDFFIGFLVNKQQTQVVSLAAYYTRISSVFYFILAILFIYRNGLQGLGNGRSPIVSSCIEMGVKIIATFALIPFSGYTGVCFAEPIAWSLMGPFLFIFFYRDLKKKERMLI
>fig|552396.3.peg.451 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKLHASGEDYLETILVLQKKLGMVRSVDVVRHMEVSKPSVCHAVATLRDGGFLMMDEDHFLHLTDVGREVAEKIYERHCFFTEQLITAGVDPKTAEADACRIEHIISDESFDRLKEAVEQEQD
>fig|552396.3.peg.1558 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDRVHRLYLHYLFPTLIAMASNSLYCLADVFFISKGAGSTGLAALNIAMPLFTLYSAIGLTFGVGGATIMSIAEGTGHMQERNQAFTCSVLGMSVIGLFIAVFGTIFAQPFAYMLGSSQELLPHVMEYMRPINACAMFFVINYAGSILLRNDHAPKLAMQATLCGNITNIILDYLLVMVFGMGLFGASIATALSAVLSLLFMLPHFFFKQNTVHFCKDIFSIEVWKRMLMNGAGSGVLEISAGSVVLIFNYVIVQEADQLFLAAYAIVTNIAYVTKGLLNGFAQAAQPIISTNYGARQKKRTQQAFHISLIASSLFALLLYILFLLFPNTVAAIFSDGDMQLIASAGDGIRFYFTSLFFTAIITMILYYLQAIECSRAATILALLKGFVFVIISLFIMVHLFGMNGIWFTITLAEGLAVLSGFWLLKKL
>fig|552396.3.peg.1861 Permease of the drug/metabolite transporter (DMT) superfamily
MKKQYANLMLVFVTIIWGGGFLATNGALAAISPFYVMMIRFVGAAIFPVCFCWKKLRQLSKDEIRHGIITGVFLFLAFAFQTFGLKYSSPSKNAFLTATNVVFVPYLLWFLFHRRPHKKEIIASLLCVSGIALLTLRVDAIMIGFGDLLSIICALFFALHIIALERYSAHTDAFCMTAMQMVTAGVLSTICALAFEQAPATLGLEALGNVGYLIFISTLLAYLLQTYAQKYTTANTASLILSMEALFASIFSFLILHEMMTLPMLVGACMIFGSVLYMEYKPTKKE
>fig|552396.3.peg.2238 Glyoxalase/bleomycin resistance protein/dioxygenase
MKITWVTLSVSDIKKSIAFYTEVFGMQVVSRFHGGIHEIAMLKTKNEVLIELIQNRREADKEVGNGVSIGLEIENLDAFVAMLRKNGYELTGPIAPNPTICFYFIKDPDGYTLQLLKRS
>fig|552396.3.peg.2835 Drug resistance ABC-transporter,membrane protein
MKRFLTLFKIEGKLALRCPDGIIFGVIMPVGILFLIGFIAKDQQAGNSGYTFMQSAFPSLITIGICATAFMGLPTTFSDYRDKKILKHFFVTPVSPRVLLLVETLIAALTAIVSACMISLCAILFFDYHMDEIPSYF
>fig|552526.7.peg.735 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKKLLSYLGRFRYFALLVFMLGGFSSILQSLVIQRVIAIDTVSDFRSLWKLFIVGLLTYLLFYGLEFGANVVYDVACKRIMLALRDKLTRKLLLSGQAIDQHEATNFLSQDLEFFYDNYVTQVMRLPKDGMIFLVVAIYLITLNPLLAFLFIVGSLLRPLPQLFLTQTTESLGKRQSDERERSMSLIMDYVNGSSTLLHHQAFESTYDQLANQVLTYETARRNYYYLSNFLFFCNGLTQFLGRVVPIGLYFLLPMVFGHIPVSSLIAMFMASNNLANPLQNMMYATFSMQAAVSVKAKIDDMMDQVADEAKVPYLPHFKALALEGITKSYGAKLILKDFSYTFEQGKKYLIKGTSGRGKSTLLHIIKGATVDSGKIAFITKDKQSFENYQANVGMVNQAPFLFNGTLEENVCLNQEFSKEDILAVLDQVHLLEELPAGLGFQIENNGTNISGGQRVRIELARFLLRQKDILLLDEVTAALDKDNARRVRELIFSLPITIIEVAHHVDQAIAYDDMIEL
>fig|552526.7.peg.736 Multidrug resistance ABC transporter ATP-binding and permease protein
MFKYFNKYLVTLTLVACALNSLVFLIEPLITSKIFDLTSLNNHQDTLSFLGYGLTLYVVLYSVMFIANLLINHIMTIGCGRIRLRLYQNLILNHREMSHDKKISMLTQDVEYYLWNHISPSILLVSHVSNVLLLSAYLLSKNMLIGLIFIACAFVFLVVQHVIGQKAEQKGSELAVARQKLLGLLSDVVAGHSTLIQNQALFASLKQVKKQSEHYESSRQAFEIFRSFFTLLAHLMLFISQFLPIFLGLALTLLGVKLRTTDLIAMFIAATRLEQPLKNIVDDMFRLNGAKAIAKHFETLLEQPIPKYQSHAMTGDPFECLDGHHLAKSFAGRTLFFDLSFHFEKGKKYLIKGPSGSGKSTLFKLILQEMSPDEGTLDMVLAGGRTTDNYHHRIGLIAQSPYLFNDSIRYNLTLGEAFSDELLLEKLEQVGLTNEFDDILNYQIVNNGENISGGQKTRLEIARSLIRQKDVLLADEVTAPLDVNNAKTIRQLLFSLPVTVIEIAHHIDDTFIYDGDIDLS
>fig|553190.4.peg.462 Daunorubicin resistance ATP-binding protein drrA
MNNNIENATDSRDNNNKQSASNLILRIDNITRSYSRGFGRKKTTRQVLHNVSFDIHSGEIFCLLGPNGAGKTTTVKIVGTLLAPDSGSVRIANIDAVSNPREARKHVSLLLGGERGFYQKLSALDNLRYFADLSAVPYREQGKRIHDALEQVDLLDKAHDAVQTFSRGMWQRLHIARSLVARTDLMLLDEPTTGLDPENARKVREIIHALRDQGIAILLTTHEMSEAEKLADTVAVINHGNIIAQGSVQQLASLQHIDHVTMYAYEGETSSGTPSVKEELQKLDGVLWCDVFESHGVLNITIAWSKALSQERNVKIPVDGITRLGDRAASLEETYLAIVQNDNISASNTSTSSAATSSSSSSSLSLSK
>fig|553217.3.peg.11 Inner membrane component of tripartite multidrug resistance system
MSKHTPQSLSNSAVIFSLLLGGVVVSLSNSALNPAIPLFMQVFGVPLVSASWVLNAYVIAMAIGLIMVSYLATIFVRKTLYLTALAIFGLGSMMGYFSPSIDWVSGARFLQGLAGGILIPLSVGILYQIVPHQRQGQTMGLWGMVVMLGLAIGPLVGAYLLKWYDWDVLFIINVPLMGLAWALVWHYLPHQQAKIQQRNLDKKGLLGLCLLLLGGFVWERMAHQYTAQFSEWMMVAMIGLGGILIYGSYRWWLYEYYHATPLLQVNIFDNRIYRYCTIISVTQTIGLMLYLILLPMLIQQVMHHPATWTGWVLMASTLIASVTTQLVGKIVDKQGARLLGCWGVILTASASFGLAWQLVDISIIAVVIWVCVHGLGVGLAYIPTTTVGFSQLPADKVTEGASLNNISRRICSGLVIWLAMAYVNYRQTQAVNEVGILQELLLLIGGMLLLSLPFAFALPRTSSGFINQQQS
>fig|553217.3.peg.755 Outer membrane component of tripartite multidrug resistance system
MTGKTMKQSTLSHLILAGILTTAFTASLTGCQNTPVKSQSQVVMPQKFNYVLPVGEQSNISTWWQNFHDPVLTSLIEHALQTAPDIREAKARIDEASAVANLANANKGIMVGAGGSITGVNSDVDNPLPSKVRKPLGMLGSDWGDSSLDVDGHAYHLGILASWEPDFFGKKQSDADAAGYAYLATQEKIHGAHMLVAAKIAQAYFQARSKEQEALILKQTQSSLSELRRYAKARFDLGQATRYDIDDIDIKLQGIKAKQDNLSAERQANIRQIAVLSGKTSQDFDLPPSPVNVLKHLPPAPQGYYPSDLLTRRPDIRAKQAQVNALAALHGSAVADQYPRFGINFGALNGGLSISNNDLDSTGITAGLINANVSVPLFTNGRIKHNIEAADARVQAVMADYDKTLLTALAEVDNSSQLNTALIRQHRNLQNAVKDAELQADHAKKLFNYGRLTFDDMPKARITAQEYEQNLIQNELGQALNLIALYNSLGGGW
>fig|556268.6.peg.1192 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSRNTKDTGYRPDCLCRSRNPSGKARVGVLSAIKGHSLQTQFKSTAFRFTDALRQGMRHTGRQNRGVFKSIQKAGQKMEQAKKQTGIPSRGEKELATGPIPRLFVKFVIPGMLALFLLSAQVFIDGILVGNFVGANAMAAINLVIPLYSLLIAFAIVMCVGCQCTVGMKLGEGDLHTANDALKTGLVFAVAVSWAAGLVICLAAPRLITVMGANDVLSGDAVAYIRVLAFFFPLPVAMFMCDAVVKATGRPIYATAGMLTMVASNIAFDLLFIVAFGWGVAGAALATGISYALGLCVYLPALLHRHTPVNLFAGRFRKALVGKILYIGSAEGVTELSAAVVTLMFNITLINTVGEKGVAAFTAINYLHFVLMACIIGMSEGIRSIISYNHGMGNPERIRATLKLAARVTAVFAVVTFSSFAFFGRELVSSFFSTQESDIITLAANGTAILAFAYLFNGFNILIAGYFTSIGQARRSLVISLLRGCGLLTVLLFTLPPLLGIDGIWATVPVAEALTLCVAGLMYLKHKNAAATVAAKQAKAVMPE
>fig|556268.6.peg.1374 Multiple antibiotic resistance (MarC)-related proteins
MHWGFLIKKTLTLLALVDPLMAIPLFICATAGLDTGFKDKYSRQLGITVALSLLIGGLFGLHLLDFMGVSLASIQIGGGAIMFIVSLAMVIAKEETIKYTPRETEEAASGPSIVPLGIPLLAGPAALSYVMATSQITQAEDLLSVILPPVVVGAATWLCFRFVGRGGRILTPSAIKVIERLAGFLLTAISVEMMATGFRHVFPGLSS
>fig|557598.3.peg.1124 Polymyxin resistance protein PmrJ, predicted deacetylase
MAGRWWPGRQPGRAGRQVCQQLQAAGFELALAAWDQAAWRQEALTGEAEWSRKTLEHARTAFSQLTGQPAAGIASPGWRINWPAMRELQQQGFAWASDTRGSRPFIPVHHAEIVAVPQLPTTLPTLDEVLADIGNDEAHAAERLLGLSARVPAGGCHVYTLAAEREGGAFAAVFEALLAGWQEQGWQLVSLGELAASLDMDSLPRCNLKWEAWPRRPGERTQQGDPAFAG
>fig|557598.3.peg.1269 Transcription repressor of tripartite multidrug resistance system
MTSCNPLLHLEDAIGEISRKMPGSPRTEIMLTRLHFYVQLQLGAWFESSLKPYGLNHSAWLALMLIYSRPQERVSPSDISATLAFSRTNATRVVDELEGRGWIQRHPCPDDRRKTELGLTEAGYQLIREVMPVHRQRMRDAWQDFTPEEQAQFIALQRKLLTRLETGS
>fig|557598.3.peg.2173 Bacteriocin resistance protein, putative
MPILSRLLPLGLSLVVSFSALAENSLPVPAYTGLNEGLTKHVTSLREARFDSVIEQKTDYSCGAAALATVLRYAFGRPLGELDVMKGMLVGADPATVQQYGFSMLDMKRFVQNQGLRASGFLADKTRLAQLRIPVITLIDSGGYKHFVVIRRVQNDEVHLADPAMGNRSMPLEDFARQWNGVLLAVAGPGYLRDTPLLQPRRVFSARTSINNSQPVPIAELLEFGFQHSDFF
>fig|557598.3.peg.2672 Outer membrane component of tripartite multidrug resistance system
MMRRHFAIAPVALALLMTGCAIGPDYQRPVMELPDSYGTPAGSPELRISRDWWTQFNDPALNALEDRALNYNRDLAAAVARIEQAQAQLTSATADLLPQLNAGADATRGRNSLYSSTTGTNPVMDSYQASLAASFELDLWGKLRRNREAALASLRASEAARDTVALSVTSSVADAYFQLRTYDEQLDISRRTLKSREEALQIYAKRYHGGLISELDYRQAEAETATARVAVPRYEQAVSQAETALKVLVGANPREVFEAEVPRGEELSRIVVPPVLPDGTPSTLLLARPDLVSAEQQLVAANARIGVARAAYFPSISLTGAVGSASLALGELFTGPAALWNYGGALAMPIFNWGKTGAGVKAATAQQKEALANYELAVQNAFRDTRDALTAQQKSAEQLAAQDTQVNALQRTAHLARLRYENGYSSYLDVLDAERSLFSSELDRANARLARLNAAVSVYRALGGGYDQPGAREIPPPVLVQ
>fig|557723.7.peg.489 Transporter, drug/metabolite exporter family protein
MANHQPVKGSIAIITAGFLFACVNTLIPKLTSVSAIDASVIALVQYLVAFIFLMPSMANMGFFQSLKTKHFGMHCFRVFLSAIGIQCWTMALAYLIPIWQGIALLMTSPLFVTIGSGLFLKEKVDTKRWIATFLGFVGAMIILEPWSENFEWVVLLPVAAAFFWACYSLMVKKLSNEDSPTTMVAYLFILITPFNLLIALTNLSPEGFSLPSFSDFGFLILLGFFTALAQLAVAKAYSLADASYIQPFDFIKLPLNVLAGWLVFNWVPPGKLWLGAAIIIGATMYITHAEAKQSQQK
>fig|561229.3.peg.74 Permease of the drug/metabolite transporter (DMT) superfamily
MKLKDFAFYAPCVWGTTYFVTTQFLPADKPLLAALIRALPAGLVLIFGKKLPPVSWLWRLFVLGALNIGVFFVMLFFAAYRLPGGVVALVGSLQPLVVILLSLLLLTQPVLKKQIMAAVAGGIGIVLLISLPEESLNPAGLAASVLATVSMASGLVLTKKWGRPAKMTMLTFTGWQLFCGGLVILPVQMFLEPLPDAITWTNLAGYFYLAIPGSLLAYFMWFSGLEVNSPVIMSMLGFLSPMVALLVGFLFLHQGLSGPQWVGVVLIFSAIIIVQDISLFFRRKNQCS
>fig|561229.3.peg.82 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MALAWPMMVTAVVVSLSQNMQIAILGNGAESQTLLTLSFLQPFNFLFIAILECLAITNQVFSARSRHDWPRQRIRHSTLLLGGIGILATALTALLCRVLALPLSNWMNSPDLALMQNAAPGYLLSMTPFLALEMCNAALRGQGKTVPAMTLMCGYVLLSAAGCYLGFHVYQLGFDAVLLANSLPALVLLPLAVRSLRQVARPVPDERPHAFLPRLLALLTHAGLPVGFSMLVVFFSSMVIFPLVAALGAGFLPAFLIVIKLRAFFIIPAVATGSAIAILLNQHRKTHSAPRQVSLLNNGVWLIVLAYLALTLGVCWARNGILAGFSNDELIRQSSQLLLLLLLPTFFLTSLVAALQTLLEQVDRGKRVLLFTLALELLMVAVALGAHRYFNDVQTIAGLIVAFSLAYAVVFLREYRLLACALGEQDAAV
>fig|561229.3.peg.213 CpmF protein involved in carbapenem resistance
MKRNVVLYAVLLLSQFAHAVQPNVMPDEIAIKGGAFYVGNIFGNKDYASHTNTTLKPFYIMRTEITYSQYQHVLQWAESHGYAFENGCNGGHFDDCLPAEQDNGRHPVTTLSWWDAIVFANALSASQQLTPYYLTADGRPITSVPQDQALNVVRNTAATGYRLPSLNEWQVAARGGEAALRQGLYGRIYSGSDNPDHIANMPKDNSTTFSTQPVARQQPNALGLYDMTGNVWEWIDDDFHMTGLNNMHYFCGGSYLMHISNLSECDVHTPNFPTSDIGFRLVRSAPL
>fig|561229.3.peg.214 
MPYGDFCYGRIALHQITHYESISPELVLINYTYRIEGLPEWVKNKDVRYAFSELDNWLSGIQHTQYQVTIRTAIGSAPKIQSPPEPLNLDY
>fig|561229.3.peg.1195 
MEVLKKFKPLDDEFPLERQLGISAAPIVLINIFTVGSADEAGFLDAFTAAAGILTKQPGYISTQLHRAIGDSPIFLNYVEWESTETLRDAFSRPEFMAKVSAYPPSVSATPHLFQKMAVPGFCTD
>fig|561229.3.peg.2192 Permease of the drug/metabolite transporter (DMT) superfamily
MQAENVKNPRTAQSYQPVQPQPAGLLLGYVAMAIAVIAWSLFAVSIRAISASPLSIADVALFRFGIPALLLLPWLPARLHQLSNLRLREIIAILVGGGVPYFFIASLGGHLTTAAHVAALIAGTSPLSVALLAFVLFRHRVGTTQLRAILLILLGVVAMVLPGFSTTMMNGSAMLLLASLLWGGYTLAIRRSGLDTIGCVLLLSLPSALLLLGLMTTGVVESHLRSVTLHEMLPFLLIQGLGTGIISSLSYTVAVQKLGPSRSALIGSLCPALAYLLAVPLLGEHFSLPNVIGVVVITLGVILANAPFTAYAKGCPPQNRLTPAPRR
>fig|561229.3.peg.2802 Multiple antibiotic resistance protein marR
MLIHLSNQFKEHLLNEYFADTDITAPQFKVLISIYKGITSPVEVSKNVMVDGGGLSRMVERMVKRELIVRQPHPDDKRQVVLALTEKGREICRYFEQEGMQVIPAQLTARLTPQETEQLIRLLTKMLPDEVVARYLPY
>fig|561229.3.peg.3425 
MNNHVSRLIGFRRLGQRQRTFLLTGAALLLFALLILAYWFHQRFTHITETDARVMGEVIPLASRVNGWVTARPVIDGDVIRKDQLLAQIDDRDARLRLAEQEGNLAAADAQISYSQTQRQVTDLTTQAALDEARAKLASSDSAVNNAGYQLSLAQNNFQRDDQLLKSNLTARKTWDESHTTLLQRQSELREAEAQRGAQHAALNNAQAQRNTLQVLDKQIEMQRQQRIALQAQVDQLKQEIADRALRSPVDGVVDRTIVNVGSYAQAGQWIMLVHDPRNLWVEANIKETAIGRVRVGQQVDIQVDAYPDKQISGHVIRVGDTATSQFALLPSPNPSGNFTKITQRVPVRIALDDPNSGLKPGLMAEVSINVAD
>fig|562970.4.peg.230 Permease of the drug/metabolite transporter (DMT) superfamily
MASWRADLLLLMVVAVWGSTFVVVRDAVAEMGTMGVLASRFTVAALALGVFGFKSVRTARISEIRAGVAVGLAYFLGFALQTAGLASTTASKAGFITGLSVVGVPFIAYLVWKVKPSVDAVAGVIFATAGLAFLSLADVRGVGIGDLLVLGCAVAFSVQYLLVSHFSVPCRIVPWTFYQLVTVALLSLMGSALSGTSPLPASTRAWSAALFLGLVATALVTVLQNIGQRYTTATRAALIFSLEPVFAAIFGHFIQGDQLTGRMAIGAALILLGMITAELQWVTHWRLRREEQRMITR
>fig|562970.4.peg.565 Drug resistance transporter EmrB/QacA subfamily
MATIRSSVCNSVLFVLCAAQLTILLDTSIVHVALPAIQADIHIPTHQLQWVVTAYALSFGGFLLLGGRMGDLFGRRRMLMAGMALFTAASAAGGLASGTGLLIAARALQGLGAAMIAPAVLSLLAMAFPEGEERNRALGVLGTVSAAGFTVGLILGGILTGAFGWRWIFYVNIPIGILVIALAPRLLRESERLRQPVDVPGSVVATAGLTLLVYACSAAGTSGLFSVRTWSFFLPALFLLLVFLFIESRIGNPLIPLEIFRNRTFVGAWMAGGVFGSVMGPTIFMLTLYLQNVLGFGPLATGFAFLPQEITVLVAANLIGRYVSRVGVKAVLSGGMLGFGAGVLMLARISTEGSYWSVVLPGMMLIGFGVSCVIVAGAIAATAGMAPQEQGLASGLWNTAPQIGAALGLAVLVTVANAFSDGALRHEPGLSTPVSAAGVTGFKAAFFASIGFVAVGLWSVLALIRKTNPFEKPDHND
>fig|562970.4.peg.1476 Daunorubicin resistance transmembrane protein
MFIRQAFLKWTAYRTAFWVDVFSRLLQIYVMYAVWSLLYKEKPSAFGALSFEQVFGYAVVGILLGAILSLDEGPHIRIAERVRTGMIAVELMKPISFVRLVALESFGDLAIRAALYAAIPYLFALIVFRIPVPQTPGQAALFLTSLVLSTVVQFFAHFLFGLISFYTLDLVGFQFAYWAMVRFFSGQWIPIYMYPEALKPFLYALPFQAMFATPQSIYVGQLHGWAATTAILVQGIWSLVLGGAALWAWRSLQRHVVIQGG
>fig|562970.4.peg.2221 Drug resistance transporter, EmrB/QacA subfamily
MESNGMPRASLEKAGQSHEPAAHRWLVFISVVIGTFMVNVDSSIVNVAVPVLQRDFHVGPGALQWVISGYLLVVTAMLPMIGGMSDRTDRRTCYIAGVTVFSLGSALCAWSTDVDQLIVFRLVQALGGAAIMGNVMSIISYTFPAGQRGRPLGLVNSVVAAGTIVGPALGGALTAAVGWKSIFWVNIPLGMISIVMSLAFLRRMSTNRSMARFDWMGSLWFFVAMAGTLLFLSNGNSWGWMSGRSIMAGGLSIGAWLLFMMRESRIREPLIDLRLFRSARFAIGNVAGYLSYVIMMFPTFILPLFLHQVMHEPIAHVGLLMTSQAVAMILISPVAGWLTDKYGPKWPTTVGMAIVTAALLWMAGFGSGTSKPAVVAAQALFGLGMGLFTAPNNVSILESVPVAQTGLIGSLLATIRNFGRVSGVALAVVLLETAIGTSSHYSESALVIGSRIAFGSAAILGAVATLLISTRMAASSKTTVI
>fig|562970.4.peg.2519 Multidrug resistance transporter, MFS superfamily
MKQTNRKWVTVCLMAAMFLSAMEATIVATAMPTIVGNLGGFSQFTWVFSIFLLTQAASIPIYGKLADLYGRKPVFAVGTGLFVIGSALCGLADSMPTLIAFRALQGLGAGAVQPIATTIIGDLYPGPERAKVQGLLSSMWAIAAIVGPALGGLLVQTIGWPWIFELNVPLGILTIIGIALFLHEKVERRGHQIDYLGAITLLIGISALLTALLQGGVAWPWTSGKILGLFAISALCLALFIWIETKAQEPMLSLPLLRRPVIAAANIAAVITGGITLGASSFLPTFAQGVLGTSAIVAGGTIVTVSIGWPVASTLSGKLIWRWGYRALEVAGLLFCTLGAILYLTISPSTPPWHMAAFSLVLGVGLGLASTTQIVAIQTSVPWQQRGIATGANMFARILGSTLGVAVMGTVVNAGLSRALSATPIARKYETADPISVTNLLLDPVRRAGLPPADLRVLSDALAHSIHSTFWVLLVAGILGTLIAFGMPGGVSQSAESGEQPETGHKSG
>fig|562970.4.peg.2662 Drug resistance transporter, EmrB/QacA family protein
MEQVRREHSLLDTSGGSEDIGGVRKWLVLANVAVGTFMANLDGSIANVGLPTISESFHVPLASVQWVVTAYLLTICALLPTVGKLSDLLGRGRLYNLGFALFAIGSALCAVSGSVGMLIGMRVVQAVGASFLMANGQGLVATTFGPRERGRALGMIGTTVSLGTLSGPAFGGLLIEHFGWPAIFWVNVPIGAVAFFAGWRILPRERGGGREPFDLVGAGMFAVGITALLFAVSGAEGRGWTSWPTLGGIGASLLVLVLFYLREVHIPHPMLDFSLYRIRMFSTGSAAAFLSFVSLFCVNVMMPFFIQTVMHQSPAVTGYVMAANPVVMAVTAPLAGWLSDRIGPYVLTTGGLTLNALGFVALNMLSPEVSPWVVAGHLAVFGLGQGLFQSPNNSSIMGSVPRSKVGLAGGLNALTRNLGMVFGISLSVSLFTYRLGVLSGATDAGPGDIGPVEAGGVVQPSPEVFMGAMHTVFWAAAVTCVLGAVVSSLRGGRRTAGGSAKTAE
>fig|562970.4.peg.2717 Drug/metabolite transporter (DMT) superfamily protein
MMGQPRGWRPTRVQALWMIGLGASCYGLISPVMKTAFAQGYTMEGVTAAQYFVALLFWVVAGLAVRTGTRPTGREVIQLFMLGLIGSGGTTVLYYRSLVHLPASLAIVFLFQFTWITILLEIMLERKSLTARRWQALLMILLGTGLAVGLLHDQWEGGVSWIGVAMALGGAVTYSVLLYGTGRIAVQTSPVRRSLFMSLGAGVPILLTTPLAAYYTAPSLAGLYGWGVVVALLAQIAPPLLFAVAIPAVGGGAAAVLGSMELPVAVVAAAVILKEPVGWDRWLGVALILVGVIWSERVNRRGRESPGI
>fig|562970.4.peg.2759 Daunorubicin resistance ATP-binding protein
MIELRRASIIRNGRILLYPVNLTLESGVLATVTGPNGAGKTTLLRLMSGLWRPSEGEVLLDGESPSARHRGQIGLVLQESMLYGGLTVRENLRFFGRLYRVSDLENRIHDLANELRFERRLNDPVSVLSKGYTQRVTLARALLPKPRLLLLDEPFDGLDPSVRGLVKEVLALRVAEGATAVVVTHDLKLTPHADVQIQLNRGRVAVVSPGNKVS
>fig|562970.4.peg.2939 Permease of the drug/metabolite transporter (DMT) superfamily
MTRKLAWPVVGYIAALVLTWGICWPVYKFGLNYTPPLLYAGLRTFLGGVLMAALALPRWKALQWRRNWRIYAISSLLNVFLFFGLQTVGLVYLPSGMFSLLVYSEPVFVGLLAWKWLGETLAPTKVVGLLLGLLGVAACSFDRLPGSASGLGILLGLAAAISWAAGTVYLKRVQAQVDMMWLVAIQCLLGGAGMMGAGSLFESWSEIQWTWPFLATVAFAMFFGVSSSWLIWFRLVQMGEVSRVAALTFLVPVISVVLSALFLHETISGWLFAGLLLIAASIYLVNHTPHPHRAAGEAPRTLG
>fig|562970.4.peg.3168 Permease of the drug/metabolite transporter (DMT) superfamily
MRGYVYLSAAAAIWGGMYVISKVALDVIPAFVLLWLRYTVALVVLALVLKVRHQPWPRDRRTWLWYAAVGGVGYAVSIGAQFLGTAWTSAHLGALVTTSSPVFAALMARWSGEQVGGRVWTAVIIALAGVGLVVGGDVIPGSAVATAGALVNPGTTASSLGSLLLFWAGVGCLVVAAATWAGMSVLVQRAESRLPASESDPLVLTAGALVTGWVMVTPIAFMQGMAVGWPALWRILTTPEALGSVLYLGLISTALAFFLWNAGVQYASAARANLFLALQPVVGGLLGHWTLAEPLRLTFCVGGAAVLVGLWIAAGTQPGRSES
>fig|562970.4.peg.3251 
MKASRMILFNLIALVILAALVLGGYYYLYQRWNYIATDDARVWADLVPVSPAVPGRLSGWKGTVGQTFNQGDTIGQIDGAGDAGRITAPISGSIIQSNVADGQIVSPGQPLATMADMKKLYILANIEETRIADVNIGADVDVTVDADPGTTIKGRVDQVGLAANSVFSLFPQQNTTGNYTRVVQRIPVKISMSAYDQDIVPGMNATVRIHKS
>fig|562970.4.peg.3358 Fosmidomycin resistance protein
MEPSTAEQSLARQPVWKALWIVSLGHFLNDTMTTLVPSLLPLFQSHLGLSYIELGVLVLVANVTSSMVQPIIGAWTDRHPKAWLLPAGEFVVGAGAAAMGFAPSYGWLLVLVALLGAGSAAFHPEASRAAHLAAGAQKGTAQSIFQVGGNAGQAIAPLVVSLLFVHTGLHGSIWLLVPAMLAAGALATIVPWYGAKAKVKVPRVVRTASGTGAAGAVVLLLAVVTFRSWMQAGLSGFLPLYYVNVRGLSTSVAEVYTALFLLAGAVGTFIGGPLSDRIGKRRLILISMAGAIPFSLVLPYAHGIWAAVDVVLLGFIVLSTFAVTVVFGQELMPGRIGLVSGLMIGLAVGMGGVGASLAGYVADRFGITTAIEILAALPLLAAVLAWWLPEDRPLSPRGRPAPKPHH
>fig|562982.3.peg.748 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYQGKNIKEQSKIFVKLLFPVLIYQIISYSSSMIGTFMAGHYSPTDLAGVSMGVNIWNPVMYTLNSIVLAIVPIVSQLMGKGREQEIPTKVRQFLYIAVFISIILIIGLNTLAEPIVNGLGMDENIARVTKKYLFYESIGVLPIFLYVVLRAFMDSLGLTGLSMIMMVISVPVNVLLAYGFIFGKLGMPELGGAGNGMAVSLTYTVLFFIALFLTLKHPKINKYKIFEKEGIKFSYWGEIFKLGVPIAIATALETVVFSTLSLMVSRFDTTIIASHQAALNFSGFLYSLPGSIANTVTIIVAYHVGAKNYKMARRYTILGVIMGMIFAFLAGLIVWIFDANIPYLYSKDLGVIALTAHLLLYAIGFAICDSFASALAGVLRGYKKVVPICVAMFIGYYLVGIPVAYFLVFKKGIGIDGLWIGWIIGLGTYALGVLVYYMYMKKNIKKQLA
>fig|562982.3.peg.1291 Daunorubicin resistance ATP-binding protein drrA
MDKVLLEVDKLSIWYETKKYIVKDSKLSISENEIIALVGVNGAGKTTLINTLVGIHSKYSLGEFIFRNEKLEFDDESFKMNRIAVFSQDESFRYWNFVEYMKFIFETYNIPLDSKYIDYLIDGFSFRKYINYMKKDLSMGNKKKFSLIVAFGLRLPFLILDEPVDGLDFESTAFLYKIIKEYKAYGSILMSTHVTESINESCDSVVILNGGKIGPKNQIQSKLSISDILYITRE
>fig|562982.3.peg.1339 Permease of the drug/metabolite transporter (DMT) superfamily
MRRFISELILIGVVIIWGLAFIWQNIASKVLGPLTVVGLRSLIAVIFITLVAILVPTLYKSQEPKWIGQISSSKKLWLGIMCGVVLFLAMYIQQIGIGMTTAGKAGFITVLYICIVPFIGVFLGNKLNKFFIIGLILAVIGFYLLSVKEEFTLELGDVIVFISAIFFGVHIIVIDYSALRVNSMFLSIIQLVVVAIFSLGLAMIKETIILADILSVAAPLLALGILSSGLGYTGQIIAQREIPPHTTSLIMSLESVVAAIGGVLILNEHIGLREGIGMAIVLVGIIISQLREKKSPKLEQK
>fig|563041.5.peg.599 Multidrug resistance protein (spaB)
MPKPETQIKLEEKIHSITFENISFSYPNSKLIFENFNLSLHSDKIYALVGKNASGKTTLIKLLLGFYIPNSGQIIINNKYSLQDLELNSYHQQMSAIFQDFSLYAGYSIDDNLFMQNNITKEQLKQKREILKSFDENFQNCLNDYSNALFGTQYNGIDFSLGQKQRIATIRAFLKPSHCVVLDEPSSAIDPIIEKEFLDFIFKKSQSKMALIITHRMNSVKQADEIIVLDQGKLIEQGNFETLMKKQGLFYELFLKQQY
>fig|563192.3.peg.304 Probable antibiotic-resistance protein
MVIDFRIRPPYKGFMNLGIVRNWQSVPDDPRKMRPTGFERLPVPSMEHASVDMLVDEMKAAGITKGVLHGRHTGNARYGDVSNAEVNELLLRYPGLFVALAGISPNAPDALEEIEHCVRDWGFKGVALDPGWCSPAMYATDPKIEPILDLCQQLGVFVSITMSAYGGPDLSYCDPTPLVPMLRKFPKVNVVIPHGCWPKVQEAVGVALLCPNLYLAPDCYFFLRNMPMRHEYANAANSFLKYRFLFSTSYPIRGFAQAIEDWKNAGLEPESLQRSLYDNAAELLGISG
>fig|563192.3.peg.543 Permease of the drug/metabolite transporter (DMT) superfamily
MGFFLGLFSSATFGLIPLFTLPLIHDGVSPASVLFYRFLIASLTLGGVLVLRRERFHASAIDLCKLAGMSFMYTAAALLLFYGLNYMPSGVATTIQFLYPVMVMLLMIAFFHEQFSMITACSIVLAVAGVALLSIGGDSSRPVTLLGVGMMLLSGFCNALYITGIHVAGIRNMNGLVMTFYVLFFGAAFAFANAVGTGTFQPLSSWWEFMMAALLAVITAVLSNLTLVLAVQRIGSTLTSVLGVMEPLTAVFVGILVFNEPFTPALVGGVILISSSVTLVMLGRQVQAIARRFQRKAA
>fig|563192.3.peg.2003 Outer membrane component of tripartite multidrug resistance system
MPASLIAAGDALARFFAAPEIGSVPHRSARQGILILVAFIGGMLPISNMAMLSSAYLALSGDFNADLIDLGRLALGNLLIMGLVQPLVNHIHAGLGLRGALFLALCVVSVAGVGAASSGSLTEMTLWYALAGFGGGLFLSLSARILFVAVPPESRRLMMAIWSFFIGFGSNLSPLLGGFLVEFLTWHSLFLLSPVVALPCLVILFFLLPDSRPAGMPPFDWCSFAFLVAFAVPTLIAVCYGQTFGWNSSFILIMIFCAVSALFLFLVSCLSAEAPLLHLRNLRIKGVGPAVMAALLLVISHVGMRIQMILFMRNVLGYPPSEIGLMFLLPLCVFVLTVVPTGIMVATHGNPKPFLLAGIACIAGAGLLLSRLDANADWWHMAVPLALRSFGYAMGSASATPFLLRNVPPEKQPQTLPAINSVRFFSMCLCMGSITTLSVLLNKWYFALIAAQVTQGSSAASASISRWSALFAGQGLSPSQSRHDALLIVSSSIKKQASVFTFDHLFLILSLVACVAFVCALLSRRVDPHPHAVRAHARNSLSRLWAAVRSRLPRPAFPLAGLLLCCLLAAGCTLGPDYKRPDLDLPAASVAADEPGALFTRERWWEVFHDGALNRLEEAALAHNSNLAQAMARVEEARAAAGVAFADRLPAVGLRSQDGKRLMTEGEELAHHYASRTQEAYKAVGFLSFELDLWGKYRRLDEAARAELLSTEAARDTIRLAVASETALAYFQLRTLQEQERIAADMLKSYERTCKVYETRYRLGQSPETTLRRFAAERDKTQAQLYDLEERRIRCEGALAVLAGFSPAGIVDGAGRAFQEGRTLGELAPPPDVPSGIPSDLLQRRPDVRSAEGRLMAANARIGAARAAFFPSFSLTAEGGYSSTHLDRVFLDPARIWGVMGGLAQPLFEGGRLTAKQRMAEAKYEEARAAYVGSVRNAFTETRDALAGNRISRKALAASTERVKELTRSNEIMEKQYDAGLSSVMDLLDVRRQLLAARQEQAEARRRQLAAVVGLCKALGGGWTEAKGFE
>fig|563192.3.peg.2245 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHGLDLMLHGPLVRTFLRYCIPWTLAMLLQSSAAIVDGFFVGRYVGAMSLAALNLVMPMFSLFFGVGVMLASGGAVRAGKYLGEKRPEAASAIFTKTMLSLLLVGLAASAGMLLFSGELVRFLGADEELRGPAEAYLRGLMFFGPMIPCGLALSYFVRVNGKPALASVGLMLSALINIVLDAVFIPVFGMGVEGAAYATGIAYTITTGVLCLHFFTPEAKCRFTRAIGAWKEVGQACWNGVSELINETSIGLVILFINWILLARIGSYGVAAFTIINYAAWFGASVSYAISDSLSPLVSANFGARNFARARQFLGLALGMVFGIGLMLYGLFALYPEMLLKIFLPGEEKVVAVTLEFIDWFKLAFLFSGLNMALASFFTALHMAAASAAVALMRSLLFPVGFLWLLPQLFGNVGIYVAIPLAEMCTLVVASLIFAASRKHFADRKAHHGPERAARGGKNL
>fig|563192.3.peg.2731 Multiple antibiotic resistance (MarC)-related proteins
MDYSIGDFFSSVIKLFALLTPPAALSAFLSGTQTYGGRRKRRTALRTGTAVFIVGTVLYFFGESLFSVFGFTLDAFRIGAGALLFLTSVALMGEQRESHTPDSPDEDISVVPLAIPICMGPASIGTLMVLGASAHSMTERVIGSAALFVASALITLMLLMANHVQRILGKTGLAVLSKLTGLLLAAIAAQVVFTGVKNFLIVG
>fig|563192.3.peg.3269 Permease of the drug/metabolite transporter (DMT) superfamily
MTVSKNVLMALLILSYATWGGGMIAMKYAFESFTAMQVVFARVAFAGVIYLALYRLWSHIPYQKGDWKYLLAMVLFEPCLFFLCETFAMTYTTASQGGVIAACFPLCTAVAAWLFLGEKLTKKTIIAMLLAVAGVAGASLAAESSDQASNPILGNLLMVGAVLSATGYAVCVRFISRRYSFLSISAIQALGGTIVFLPFVFTTPMPVNVTMPAIGGLLYMGLGVGFLVYLSFNFALKHLEAGIVALFGNLIPVFTLIFAFTILGERLTLAQTLGVGLTFVGVIIAALPEKQRQ
>fig|563192.3.peg.3341 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAHADPSSELATKPLGRLLLRFAIPSIFAQIVNLLYNIVDRIFVGRIPEIGPLALAGLGVAFPIILIISSFSFLAGMGGAPLASIAMGRGDNAKAERILGSACVFLLAMSVVLTVLCFWAMRPMLLMFGASEQTIGYAVDYFSLYLLGTPAVQLSLGLNYYISCQGFAKTSMMTVLIGAALNIILDPIFIYGLDMGCKGAALATICSQAVSAVWIFAFFFGKRTILHFRRQYLRLDLKELVPVILLGLSPFFVQVTDCIVPLVMNAGMQQYGNDYYVGTMTVMFSIEQLLRLPADGLCQGAVPIMSYNYGAGKPERVKKTFFLILAFSFGFTTIASWLILLFPKTFIMPFTDSQRLIEITIPAIRIYFGGMMFIGVLYACQRTFMALGRTKLSLLGAMMRKLVILLPLCFILPRLGYGTDGLLYAECIADVLGSAIVFAIFIWNFKSMLKTP
>fig|563192.3.peg.3739 Membrane fusion component of tripartite multidrug resistance system
MTTDENLSMTPDNDKAPQRRKRPRKGPIVGFLLLLFLLAGIGAGAWWYLFLRFEESTDDAYVAGNVLRIMPQVSGKVVAVDVDDNDMVAAGQTLVRLDPVDARLAYERSLVALASAVRDNCRLQAQLRETEAAIRMRRVDLRQKADNLTRREALGKAKAIGAEELKHARDDRENAAVALAAAEEERNALAAVLLDTGLAEQPAVRQAAANVRDCWLALQRTTVLSPAAGQIAKRGVQAGEVVSPGTPLMTVIPLHRLWIDANFKEVQLHKMRIGQPAVIRVDMYGGDVTYHGRVTGFSAGTGSAFSLLPPQNATGNWIKIVQRVPVRIEIDPADLREHPLLVGLSAVVKVDTSDTSGRLLAASARTEPVPGDLVSQAPAVDFAPVEATISGIIRDNALPGVCPVQGKP
>fig|563192.3.peg.3824 Permease of the drug/metabolite transporter (DMT) superfamily
MQSKIGCYIIAVAVITVWSTTFVSTKILLRSLSPEEIMFYRHVLAYLVLLAAYPHRHPSGGFREELLFAGAGIFGSTLYFLTENYALKYSMASNVGLLLATTPMLTAIVARFLTTGEPFNRQLAAGFCIAFLGVFLVIFNGHFILKLHPIGDFLAIAAALSWAFYSTLVKKIGNRYNGIYITRKIFFYAIVTMLPVLAFGDFRYDFSRLWQPTTYLNLIFLGVIASSLCFLIWSKIIWKIGPVAVNNFIYLMPLITMLASWLLLDEHLTPIAIAGGLVILAGVYVSTKAAHRKK
>fig|563194.3.peg.254 Transporter, drug/metabolite exporter family
MTRKYALGLLLCLISVLSWGGMFPIMEPALKVMDPFYFTLFRYGSVAIIFALILFITEGAHAFKTEGHVFKLWVFGTAAFAGFSFLVFLGQQLAGASGSIIASVMMAIQPLLGVLVAWIYRGIKPTLASLVSMIVAAIGVFMVVTKGDFAVLFSGQNTLLAVTLILLGALCWVIYTAGGADFPGWSILRYSTLTALLGVCSVIIALTIATILGWLHFPSLNQIAEVHSALIYMVTFAGVIAVFTWNLGNRIITPINGILFMNLVPITSFIIKIVNGYQVSLFEVAGCIITITALVGNNLYNRYKAKQSDTTELTSTH
>fig|563194.3.peg.759 Bicyclomycin resistance protein TcaB
MEENLSTKPKTKGIVYLFAILGGFAGLLYGYDSGAISLALPSITTAFGLDSVQKGLVVSFLLFGALPSIVVFTALEKKIERRNVLIVAGVVFLAGSLLSAIATGTVFLMMARFVLGIAAGIANMYGLIYLSELAPAHIRGLMSSLYQLSVNVGILVAYAVGAYNLPQDDWRWTLGLGVVPALILTIGMVMSPQSPRWLIRDGKVERARKVLTKVRFTSTEVESEIKDIQNSLKTKEAGLSELFGTFRPALTLLIILTIFQVFTGINAAVYYAPEIFHNLGMANSSIVADFGVGIALVVSTFVSLPFIDKLGRKNY
>fig|563194.3.peg.812 Glycopeptide antibiotics resistance protein
MFIIKYIPFLGLALIILIGCLIAYERRPSLDRAIVFGSLAVYLVCVAWLLFTPGQYFFDPYAYYARYFYWHHAKIIYYPSALRSMGSYMNIVMTIPAGVYLGILFHRHLNWLTVILCAGLVGIFNESNQLILDMIINIQRTVDITDVLTNAAGVVIGYLAFYCLVRPWLKNTSFA
>fig|563194.3.peg.966 Multidrug resistance protein B
MEAQNTRHTNPMIVVAVVALMSFMGILTETSMNVTFPALMKEFHVPLNTVQWVTAGYLLMAALVMLTSAYMKRRFTNRQLFTAAAILFSSGDLICGLATNFWVLLAGRLIQAGCVGLCTPLMVNIILDVVPQHKLGTYIGMANLIILVAPALGPTFGGAVVAFNSWRMIFWSTLPVALVLMLLGMKVIKQYAPTDQHYAFDWTRFLLLGMALVSLIVGLNALGEMQLGTFVGLLIVSIGLTILFVKRSHTATKALFSLQVFKQPAFLYSFLPYIMLQFANVGINFLLPNYVQDVFQATSLVGGLILLPGSLFNGFGQPLYGWLLDRFGGKVPLYTGDILFTLALVGLMCWGPQLGVVGITIAYLIFAIGRSMAFGNSVAYGLKHIDKEFQNDANALYNTGQQVTGAIGTTVLALLMGSVKRPGYTHAQNVSAGSQLAFILLVIFGCVIFVFFHHLVNLKNLPEDKGVDL
>fig|563194.3.peg.1778 Permease of the drug/metabolite transporter (DMT) superfamily
MYIIILEKEVFLVKLRTLLYVVISTFLFSSMEIALKVAGGTFNPIQLNFIRFLFGGLLLLPFTMKTLKKQGRRLKGRDIAAFSMTGFSCVLVSMTLYQLAIQLSLPATIAILLSANPAFGMLIGLVLLKEKMSRTNTLAVILTLAGLLVIINPFNLTNPLGITLGLLSSITFAIYGILTRLSSNKLGFGGMTMTCFSFIAGAIELAIFMAITHIPVVSRAFSGLEGFSDIPFFQGITLSNILLLAYISFLVTGVGFGLYFVVMGEAGVPIASLIFFIKPALAPILSLLILGDPIHLNTIVGIIIILIGSVVTLVGEKIAMRMSK
>fig|565045.3.peg.220 Permease of the drug/metabolite transporter (DMT) superfamily
MRHSSAIIMAMLPPILWGSTYLVTTELLPPDKPITAAVLRVLPVGLLILLMTRFRPTADQFKKLVVISLLVISLFHWPLFVAAYRLPGGLAAMLISSQPLIVALLGFAFFGIRVQRNVTAGIALGLSGVVMVLIVPSKLAWDTVGVIAAFSAALSMSLGTLLTKRWALDMPVLAFTGWQLLLGGLFLLPLALLFELPMQSLEVRHISGYLYLAFVGTLLPYFLWMSAIRHLEPVIISTLILLSPVSAMALGYVVLNQALTPWQLLGAGTVLIGILITSVPPSKYIFWRSGINEGGGPTTAAAIKQTNERGSKL
>fig|565045.3.peg.807 Bacteriocin resistance protein, putative
MVKQQWDHSCGVAALATLLHRLGNDAVNETGLIKQLDTYNPDLPENGYSLDDLRWLAAQYGYRASGLRVDASLLEQLKKPVIALLHLPRGPHFTVVIPTSDRWIHLADPSWGNRFLLPHQFAQLWLQHDQRGTLLALMAND
>fig|565045.3.peg.2298 Glyoxalase/bleomycin resistance protein/dioxygenase
MSQNVPMFRKVDHVSLTVEDIDEAIEFYTRVMGAELRYRMGPFDAREIPRGEDGRDWTDAHVQVPDARLNIAMLKLCENLGMELFQYDRPEDAATVPPRNCDVGARHICLQVDDVEAAINYLAENGCSAMAGPIVSEGGPAPDSLSWYVTDPFGHQMELVQYT
>fig|565045.3.peg.2964 
MITLIMRVRIKADQVDVFTGLVTQLATDVYANEPDCLAFEVRQSQEDPTLFVFYECFRNQEAHSAHPDMPYHKAMSEAGWDCVDGEPQIEYLTPLAGAPAAFRGA
>fig|565654.4.peg.648 Nisin-resistance protein
MKIVKRILLAVVTICVLFLGIIYFWGYKLNIYLVPPSPQKYVQVALNNMDELGLFTDSKEWVETKKNTIQETSNAKDYAETIPNLKKAIKVAGGKHSFIEYEENMSKKSIEEYIKPKAEVENDIIVLTIPAFTGSDKEAEEYTTILETALHKKIYKSVIVDLRGNTGGDMAPMILGLSAILPDGKLFSYVDRNNDLEPVTLKSGKLNSNISTIKISDNKKIKKVPIAILIDSNTGSSGELTALCFKGIPNVKFFGSDSAGYTSANQTVYLYDGSTLQITSAFVKDRTNKIYKNVPINPDVQTNNSKSSAIEWIKSQLK
>fig|565654.4.peg.720 Permease of the drug/metabolite transporter (DMT) superfamily
MKKTVGIVYACSAAALWAVSGIAGQILFTKYSISANWLVSTRLVLSGCLLLSIGLKDRARLISPFREKKDFIQLLLFSFLGMFLVQFTYFKTIEQSNASFATIIQYTGPFFVLLYAVIAKRQFPSLKTCFWLLVTLLGVTAVASKGQIEQLATSQSALGWGGASAISLAFYSIQPRKLLQKYGSLPVVGWGMLIGGGLANVVHPMWQIDSQLNVQVILYLLVVILFGTALAYLIFLTSLRYLSSTLATVLTAVEPLLAAFLSIIVFHDHFAVVELVGFMAVIGSIMCLQKNME
>fig|570509.6.peg.1098 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKTVFSKNEIKLCYDNLWKTIFIFSLPTVLVMAMTALYPILDKFIALTFVTPNVFHHQPYLDWYKEHISINNGELTYESAKIFVNLSTHFAMQIYNLLFAFAILFAIGTSITFAIKSGQSNKQQTQSLAGNALTITVLFSIVAAFFVFCLVFPQWDNIMILIQLSKKGTWIVQDLTWHYVFPMLLASPLMFVSYLLLTLLRTDGKSHAAIYITIGAIAINALFSIIFVKYGQMLLEGTMLGTIIAWIFIIIVSLICIYYNKNSYLRFHWRDLFYLHKTTIKEIFRLGFSSFINNLGAVLVSILSSAIISSLPGQFAQRQQYGLASFQLFNSAVSPWIAFFTAIALGIAQGMKTIIGYNYGAKKYLRMYQTCWYGLAIISGWLFFTLLLFIALGPQLLMAFAFPSDLVDEYRWIAVLMLMSYPCAAISFLGVSLFQGMNNARKAALCSSFRAFIVLPILMLCGYFLAHGLSDGTDQSNIYYFILLGLNDLISAIVVGIILYFFWYKHRHHIFNEVDEKDQEYLQSKKQQTSY
>fig|572477.4.peg.746 Bacteriocin resistance protein, putative
MIQEWDLSCGAAALTTLLHYQYNDPVSEKEVATALINRAEYIENPQLVQVREGFSLLDLKRYVDSRGYTGIGLGKMSLSDLERRAPILIPIHTRGYNHFVVFRGRLGNRVLLADPAWGNRTMTIEQFNRAWIDYPQIGQVGFVVDSHTENTHTPGTLKPRPSDFVTFN
>fig|572477.4.peg.1293 
MIIFSMSIFVPSSQHADLARTLGALLEPVRVAPGCLRCQLYTDFDDPNGFMLVEEWDSQAMLDRHLRSDACKTLLAAIELSTRPPVIRFDHVARRAGIEVMERARRPTNIQEIRR
>fig|572479.3.peg.38 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEVKSKSSRMGEEPILKLLFKLSAPAIAGMLIQALYNIVDSIYVGRLSTDALSALSISFPVQMFLIAIGVGTGVGTSSLISRLLGEGNKCRANNVAEHVFFIAIIYGILGGLVGIFFSEDIVRLFTDDPVLIDLGYQYINIILTGSIAIFLPAIFNYTLRGEGNTFLPMLTMVIGGVLNMILDPFLIFGLGPFPQLGVAGAAYATVFSRIIGGIFISFILFSDKNELTLKLKDFKFDFQIIKEIYNVGIPAMANRLLFSMAIVFINLILGAFNSTAIAVMGLIFRMQSFFLMMVFGLTQGYLPIVGYNYGHNNPERMKKTILVGNAVALSFGVFGFVIFQLFPEAIISLFNSDPKLLRIGIDAFRKVSLSYFFLVLNIVGVATFQAIGRGMPSFILTFLRQAVFLVPGMYLLGEFFGLDAVWFGFPIAELTSFLIMLFWLTIAIKDAMANMRKAA
>fig|572479.3.peg.415 Multiple resistance and ph regulation protein f
MIIGLAIFFTILSLIVSYRVVIGPTITDRLIGADTIGIFMSIVMLMIALEYDIALLVDIVLAYAVLLFIDMLIYAKYFEHGELYK
>fig|572479.3.peg.1351 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVDDNKAIINENSSTKKVIFKLAWPVIAEQSLATVTQIVDMMMVGRLGASSVAAIGLTMQPVFFSTALASALGVGTTALVSRFTGSNQNKKAASVLQQSILMSLIFSVFFAFIFYLSAPKLLIFMGGEAEVIKLGTGYLRMISPGFIFMVLAFIVTAALRGAGETKTPMKVNILVNILNIFGNYLFIFGNFGFPKLGVNGAALATTLSRSLGGIILLTLTFTNYSVLKMKIEGFFRFDLNLIKRVLKVGIPTAMEESVRRLAQLLFIRVIASLGTTAFAAHQISLNAESISYMPGFGIAVAATTIVGQNLGAKNPEGAEKGTFEAWKIGSLIMGFMALILLIFPEQLVKLYTTDPEIITKASLNLRIIALAQIPMGTQFIFAGALRGAGDTKAVFYSTAISTWIFRLLLGYILVHPLGLGLFGAWSAMVIDWIVRGSYVIYRFKKGNWKLINI
>fig|572479.3.peg.1372 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKISEAKLTKGKIIPQLIKLTLPMILGMLGMVIFNLTDTYFIGKLGANQLAALSFTFPVVLIINSFTQGIGIGTTSIISKYIGARKNNKVKKIATDSLILGLIISVLVFILGSLTIRPLFSILGASGVILNYIEEYMTIWYFGSFMVVIPMIGNNIIRSLGDTKIPGLIMGLSALINVILDPMLIFGYGPLPILGIKGAAIATVLARAITTLTAISILYFRENIIYFSKFKLKDTFKSWKQIIYIGIPNSLVQMALPLSSAIITKILATYGPNVVAGFGVATKIEFFAMSFIMALNSVIGPFIGQNLGSKLFKRVNKGLKFGELFSLITGFILAIILSTFAKNIAALFNQNPEVIKTVTSYLLIVSFTYGLQGILKIDSTILNVLNKPIQAALLIFSQTFLIYLPLALVGSHLIGVSGIFIALSISYLISGFLAHLIVQKNFNLYKKNSLKKVS
>fig|572480.3.peg.18 Permease of the drug/metabolite transporter (DMT) superfamily
MMNIKLVLLVSLTLFFFATSSVLARAALINNSIDPYSFTFFRLFFGALTLVVILFLKEKKLNLTLNKNWHTSFLLFLYAICFSYAYINLDAGLGALILFAMVQLTIIITALIKKESINLKKALGITLAFIGLIYLLYPSEGFEVSLYHSILMMISGVAWGLYTIFGKKSSNATLNTTDNFTKSLLFAIIFFALFVHNVKLSSYGITLAFISGGITSSIGYLLWYYLLPNMKIITSGILQLLIPPLAIFLGVLFLNEKITSTLIISTILILLGILISIYKKDK
>fig|572480.3.peg.1254 Fusaric acid resistance protein fusE
MQKNKIVQLLRYIITFSVVTIAIVLGMKLWQNYVDSPWTRDGRVRADITLIAPDVSGMISKVYVKDNQYVKKDDKLFEIDKKRFEANLQRAQSIVQIKKANYLMKKAEYDKRIKGDDSIIPKDVKDDAKYNLLMAKEELNEALSKLDITKLDLQRATVYAPTSGWINNLLLKKGDFIQKGQSHISMLNENSFWVYGYFEEHKLTKIKIGDKAIMNPLGTDLTIKGHVQSIATGITDRDNKIGKGLLANVNPSFTWVRLAQRIPVRIAIDEIPKGYTLRAGTTCTIEINNNF
>fig|572480.3.peg.1297 
MNIIKKVTFIANDDSIKEMKDLLKTMVEPSKNEKGCLSYEIYQLKENPAKFVVVEAWEDEEALNGHKTTEHYKYYKANFEPYCKDKYSDDLEII
>fig|572480.3.peg.1328 Permease of the drug/metabolite transporter (DMT) superfamily
MQHTKGNILGLLTIFLWSTLALFTVYSGNIPPFELLSISFFIASLIGVLMLKKQKRSFASLKTIPLKAYIIGVSGLFGYHFFYFLAIKNAPAVEANLLNYLWPLLIVLFSALLPNEKLKWFHILGTILALIGAFLLVLKDGSLEFDTKYTLGYAFALAAALIWSSYSVISKTLTHVPTFAVTGFCIITAILSFIAHLIFEQSITPSITELLAAVMLGLGPVGGAFYLWDFALKNGDIKILGSLAYLAPLLSTLILVLVGVSKMTTSIALACLFIVLGSIISSKQYLKTIINLLFKS
>fig|572480.3.peg.1362 MFS permease (drug)
MSNVAIVTSLPHLKEYFNHIANIEFYSRLMLTLPSLSIALLAPVLGHLIFKFGKKKSVLIALFFFSLFGTAGLYLDSIETLLASRALFGLCVATLMIVSTSLVGDYFKEDERHQFMAYQSSFMALGGVFFVIGGGMLSDMNWRFPFGIYFIGILLIPFVFKNIEEIKIENIEENETSNINKNILFVYFFAFFYMLLFFILPTQFPFLLIEKFKVSGSYAGTIIATAFFCNALGAIAFSKLKKIYSYSTIYIIGLTLISFGLSLVGIITNVHFFFITAPILGFSGGFMMTNAVAWMLSKTNPKMRVKSSGYFTSSIFLGQFLSPIVFHPLIAIFEIQKFFSIIGASLFVIVLLVLITKKFILR
>fig|572480.3.peg.2267 Outer membrane component of tripartite multidrug resistance system
MINGCALLPGEKELIKPNTISKYKSKESFDNKIKTQWPKESWWKVYGDKQLNELISEALKDSPNMISAMARLNEADAYTQVTKSTNLPQISANAQVTKEKRSYNYITPRSVTPKGWNDYGQATLNFSWELDFWGKNRATIAASISNVEAMKAELAQTRLTLSSAIASNYAQLARLYANMDELKEYLIVQNKLLTLLNQRYENGLENKSTVDDAKSLLANAQGDVLSLDEQISLQKNKIAALMGAGPDRGLKITRPTIDFYKIKFGLPDDLAVNLLGRRPDIMAARMQVESKEYLIKEKKAEFYPNINLSAFIGLQSLGLNLLHEKDSYMGSVGPAISLPIFSAGRLKGDLRRNKSIYEQAVANYNQTITQALKEVADAGTSQKSLAKQIFRSLEALNSSKEAYEIKTKRYEGGLSNYLEVLYSQENLINAKRNFINQKSRALTLDIALKYALGGGYNQKLPMNEKGNNNGK
>fig|572480.3.peg.2624 Permease of the drug/metabolite transporter (DMT) superfamily
MLTNIILFIHIISATAWVGGGLLLFGMGIYFKDPKVQNVIYSHIGPFYGYFQLIWLTLLIITGLLLLNQHNLYSIILSEEFKNSQFGILLYRKLLIVLLVVIATAIHMYISLKAHGRERTKKEKITSRASSMFIFLFNFSIIWYAINISQYLN
>fig|572480.3.peg.2687 Permease of the drug/metabolite transporter (DMT) superfamily
MNKKLLELRADILLLTVAIAWGVTFLMVQDAIKSVPVYAFLFWRFGIATILMAIIAYKYFDKLNKQTILYGVILGCFLFSAFATQTFGLAYTKSSIIAFLTGLNVIIVPFLAYVVFKEHVRKMVFLSSLIAVCGLYLLTMSGSLSLGEGEILGILCALLFALQILFTDKYSKRVNVYLLVLFQFITVTILSLIFSLSLDSVTFNLDFNQTFLKALIITSIFATVYAFLIQTYMQQFTTPTKTAVIFSMEPVSAGIYGYFVGNELLNSIQLFGATLIILALLLAEIKFKKK
>fig|572480.3.peg.2706 Permease of the drug/metabolite transporter (DMT) superfamily
MKFYIQKSILPFFFMFLYGSGFIFCEYGLQNASPMAFLEVRFFIAFCILFLITIIFKLPMPKTKKEVFHIAIAGSLTVGTFSIGGFLAVSYGISGATNALIIALQPIVVTVLALKLLNEDINIRVWAGLIIGFVGVGFVVFSKLETSFSSLGLFWAFISLLGLSIGSLYQKKYCSHMNLYSGGAIQTFSSTILVLPFLLFEDSHINWNIHFSIALLYMTVGVSIGALSLLYIMIKNGEVSKVSSIFYLVPVSAAIVSYFLLGDKIEFSEIIGIFTIIIGIVLINKKKKGIK
>fig|572480.3.peg.3129 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLAIIAFWALGIIWGSNFIYMKMAADYISPMQVVFFRVLFGFIPVFLYAIYTKSLKLKDLKYSFHFIVMSLLATVVYYFGFVKGCALLLSGVAGALSGSIPLFSFLLAAIFLKEEKITKLAFLGVFIGFLGVVLISDVFNENIMASSMEGMLSMILGSLSVGASFIYAKKYVMPLKLKAEALTTYQLGFGVLILLFITDFNGINNIWQDTHSALGLVIGLGLLGTGLAYIIYYYMIEKLGALKASSITYIPPVVALIIAVFIVGEDIKLIDIIATGFIFLGVFLINQRKKA
>fig|572544.3.peg.910 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERLEKYKKVLKLALPAVGEMLLYMLIWTVDTLMVGKYGGRVAVSAVGLSGQILYTVSAIFSAMGIGVALTSLVSRKIGEENGEEANIYGSIGFFMGVAISLVLGVLFFTLPQEFLKFANARGEVLLLGSIYLKISSFALLMTIWRGLLNGIIRGAQNTKIPLYTTAVMTVVNLGLDYLLIFGKMGFPEMGVKGAAIATVAANLVGFLYTMFYLQKYSCISLGLCMGIKSSHLLYLKDKWWEIMKIALPASFQEGAISISRLAAVFIIMILGETAFSANQIALTVESISFMPGWGFAVAATSLAGLKIGEKNYEEAEDMIGICLQMGIVVMGVIAFSFVLFPEFLISLFIKIEEKEVISLGATCLMIASLEQIPLAYSMIVSGALRGMGDTKTPFYISVFSHWFIRLPLIYYLIYLKRYPVYYVWIVQIFHWIIDGGLLYIFYKKKINALLKYKVKN
>fig|572544.3.peg.1266 Acriflavin resistance protein
MDITNFSIKNRATIIILYILVIFAGLNTFRGMQKGEDPPFTIKTATITIKWPGATAQQMSELIGDKVEEVVQDIEELDYVETKNSPGLSTAYVNIKPEYRNLQPIWDTLRKKVKYEVEPYLPTGASVPIVNDEFGDVFGSVIMVTGDGYSYHELAVIAEELREYILKKVPEAGKVHVYGDQQEKIYLNFDPAKLTQLGITTADIRNAISGRNQVTSSGNIVMGNDKMTLDTSGDFKSIEEIGDTVINTPGSTGIVYLKDIADIKRGYVNPATYITRFNGKESIGIAVSLKDGMDDTKLGEHLKAYVNSLEKKYPIGVDFDFVAYSPQRVEDKINSFVSNLTQAVATVLIVMLISLGFRTGLIVASLIPTSIAMAFILMPHYGVNLDQMSLAGLIIALGMLVDNAIVMSESIMVAMEKGKSRLEACLGSANQLKIPLLMSSLTTVAAFTPIFLIEESMGEYVGPMAKVVVFTLLSSWLVAMTLVPLLCYIFLKVDHKEHEYKSRTYTNYRKILIFGLKHKIITVIFAFGIFCTGIFLFRFTGNEFMPESDQKIMLTTMRLPKGSSVEATEKVAKDLDLYIKKNFKVPDEELKVGFFKDIISGFTIREYEKDGVLSWGTFIGGGAPRFVLAYSPEAPSEEYAYVIYNSTDHKIIPEMSEKIDNYMKNLYPDLDISTKKMKTGPSADRDVEYRISGNNLKDIFDKVDIVQSKLSSIPIAKNVINSWKNEVKKLTIDIDQERLRKVGLTSEDVSNSMAVNLEGMVIGTYREPESPLTDKSIPIVLRTNEAHNTVFSKLDTMKIYSSVTGKFIPLSQVADIKMEFERGYIHKRDRTNTVSVQADVISGHTSNEIDRIMSPWIAEQVIEWEAENGEEVKVKNIAGIPASAEGLNYKYEIGGSSEMSNKQSDALGQKLPYAGLFILLLLVAQFNSIRKPIIILLTIPLGILGVAVGLIVGNQNFGFFAIIGLVSLSGVVVNNAIVLLDQIDIEINENCLEPDHAVVMSAQSRFRPIILTTLTTLCGLIPLWLFGGNMWKPMAVSLIFGLIFATILTLGVIPVLYTIFFRVAYKDYEYEKLSTDTEVSCTNSK
>fig|572544.3.peg.1735 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSHNNKIEKTKMMGEGEISKVLTKMSVPGIIAMLINAIYNIVDSMFIGMLGNTEAMGATSVIFPLFMLIAALGQMFGVGAGSYIARLLGAGNKNQAEKVVSTTFYTTIIMSILFTVSVLTLINPTLRILGATDTIMPYALTYGKILVTGAIFTIINMTLNNTIRAEGNAKYSMIAISLGAVLNVILDPLFMFGFDMGIKGAAISTVLSTSISSIYLLRYYFSGKSFIKITREKFTPKLSLYSEIMKVGGATFARQALASLSLGILNSKAAFYGDSTVAAMGISTRVTSAVLYIVIGYNQGFMPIAAYNYGAEKYDRLKSAIRISLIRLTVFCTFATFIFMFFTEDILRLFSSDPEVIERGKAILRAMSILIPTLGFQQIYAVLYQALGKSVGALVLSSARQGTFLILALMILPSLLNFRGLIYSQASADIFTVITTLIFAIKISKEIKDKEDIYKPSNNLVLESNG
>fig|572544.3.peg.1758 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNHNSIFADIALLLVAVIWGSGFTATQVSLDSGFLPFTTMAIRFGIAAILMSVIFIKKLKYINKKDIIAGSVVGFFLFTAFASQTIGLQFTTPSKNAFLTATNVILVPFIYWFMSKKKPDIYSVTAAFICVCGIAFISLEKDLTLGIGDSLSLLCAILFAFHISSTGFYSHKVDTTVLSVTQMWFASILSFIGAFFTETFPNSVPVNGVLSVIYIGVFGTMIAFFIQTTAQKYTTPTKTAIILSTEALFGTIFSVIILKEIITAKMIIGGISIFLAIITAETKWKFFYKGKAKIIKSDL
>fig|572544.3.peg.1932 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKRRRLEEESIPKLLWEYSIPALAGSLVYILYNIVDRIFISFGVGRLAIAGLSITLPLFTLILATGLFVGMGGGSLISISLGARKEKYAEKILGNAIALFVIIGIIFSVTGLAFLDEILSLFGATPNNITYAKSYMSIIFFASPFQLMFIGMNHIIRGEGNPKTAMTMSIIGCGLNIVLDPLFIFVFGMGIKGAALATVISNVIAAFLQLYHFVGGKSKITFRVENLKLDFTVIKEIASIGVAPFIMQMSNSIVVIFINKNLNIYGGDIAIAAFGIINSLSTLFFMPLVGIYQGSQPILGFNYGAGIYTRVREAYKISLKTALLVSATGFIMAMFIPNILITPFIKNDPELFILTENALRIFFSMVLFMGFHTIGGSYFQAVGKAKITTLINMLRQFGLMLPMLYFLPKYFGLKGVWMAAPVTDFILAVFTSYFVFSEFKRLKELPVTSKEQEI
>fig|572544.3.peg.1935 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNKLETGDIKKLLVEFAIPSIIGSTIVMLYTIIDRIFIGQRLGAEALAGVTLTFPFAQLSVAASILIGMGSSVLISIKLGAKKNDEAEEILGTQVLMFLLMCTSIVIIEEVFLIKFLNISGATKDTLEYAVSYARVFIPVIYFQSFTYGLNGVVRAQGLPKLAMKVSAIGAVTNVILDYIFLYILNMGTFGAGLATLLATAFASCFNLYFFIYGKSKIKLLLKNLKIRKDYMLDMLKLGASPSLIQLSNSLVTGIYNNQLKNFGGSPAIAAFGVMTTILSLVIMINIGLSQGMQPIVGFNLGAKNYSRVIKTFKLTFYAGFIISTVLLFIIGFFPKTIVRIFVDDPETIAVGKTALRLGLCVIPLTTGSIIISNFYQAIGDAKRSIIFSILRKIIIIIPALIFLPKLLGINGIWLSRPFSDTASFMIMGIFVIKTLKNMKSFSIEKNKE
>fig|572544.3.peg.1941 Permease of the drug/metabolite transporter (DMT) superfamily
MTLKKHHGIIMGILACFLWSSAFAWVKIGFKYVPAPLTFAGMRFTLAGIILIPFCWRKNLFVLLATHRKVITYVALLNVGIGYALYYTAMKYVSGATAAIIIGTGPLITAVMTHFIMDNDRMDRMKFMSILLGILGIGVIILNTKPVTPVGRKEAMGIFLLLMNSSLSSYANIKVAQIKGGIDGRFLTSNQMLWGGSMLLLMGRIFEQSYNIEVFNLPKEFYMSLLWLAFVSAAAFSLWFIAIQIEGMKVSELNMLKFIIPVLGAVISWNLLPEESPNFISVLGMILVFTSLIVYNINNKKSA
>fig|572544.3.peg.2156 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGKKSVKNLLTGSIPKHLFDLVLPSIGGMFAITIFNLTDTYFVSKLGTNELDAMGFTFPVIMVIGSITGGIGIGSSSVVARALGKNNHHEINRTTTDGIILSIIVVVIISLIGLLTIDPLFSLLGADNTILPLVKDYMSIWYLGVVAVIMPRVCDSSMRALGDMKRPLIVMLVCALTNLILDPIFIFGYFGIPALGIKGAAIATILSRILGMVTTLSFVHFHYKLIDFKYNYKSEIFDSWKKILHVGIPGAIIRLFPQLLRAVLTSLGAKSAGIAGVAAIAAGARIESFSTIISMAVGAALVPIVGQNWGAKKYERVEEVKKLTNKISIVYGFILFVLSLIFTRKIATIFTGDPVVIDLIYAYVNIVMLGSIGLNLYNWTSESLNATGKPKYVLIINGLGTCLIIIPSIYIGFFLGGFPGMLIGISIGQIILGGVSVKIGKKELGMQAV
>fig|572544.3.peg.2316 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKIMHGDVSKLFLRYLIPSVTGTLSIGILIFIDTIFIGRGIGSLGLVALNTVIPAYTLYSSTGMLLGIGGATAASVDAGRGDYDGRNKIFTHSVILALVLGCLYIIGQTVLLKEITFFLGARGGAIPMTEDYLGILSKFTLFYLLPHCLNAFIRNDGNPSISMMGMVLCGIVNIILDYTFIFQFNWGMKGAALATGIAQMSYTAVLLTHFISKKNSLVLQSHKLEILVIHRMFKVGLPSFINEMSFGAVIFAFNYIFLRIGGENAVAAYSIILNINILLYLVFLGISQASQPLFSVNYGGGLHSRVWETLKLSTLVSGLLGAVTILVTILYTKEIIGLFIRDDMELMKITGDGMPLFFSASIFMGLNIMMSTFYQSIESSAVSSFITTMRSCVLMVVGLIFLPGMAGIKGVWMTPLFAEGIAFVISLFFLKNYFDKNKGSFQKSVNITPIYNK
>fig|572544.3.peg.2469 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNVNRLTEGPISRQLIALALPIMGSSFLQMAYGLVDMLWIGRLGSSAVAAIGTAMFFINLGYALNSMVVTGTGIKVSHSIGSKDYNDAAECIKNAFLINLIMFSCFISGLIFFRDNLIGFFKLNDSNVENMAKTYLVITAFGLVFKFLNFLFTRILNSFGESKLPFKINAVGVVLNIILDPLLIFGLDMGVAGAALATIISQAVNMVLFIKASREYFSIKNIFQYNFKKIREILSLGLPIAVQRILFTGFGILIAKIIANWGPDAIAAQKIGLQIESIAYMTAGGLYGAVASFIGQNYGAKKYKRISKGFKTAFLLSAIIGGAATFIFLVFPEELIKVFVKDRKTIEIGVSYLRIVGISQFFMCIEIISNAAFSGIGRPKIASTVSIIFTGMRIPIAYYLSHESRMGINGVWVSIALTSIFKGIILSGLFLNNLRKIYRKIKGEGLWI
>fig|572544.3.peg.2556 Multidrug resistance protein
MKDKNKMLLILGSMAFLANGDNYAAAPLLINISKDLNLTLSTAAMSVTAYMLAFGIFTLLFGPLSDRFGKVRVINTAAIGTAIFSILGATTFNLSSLIFFRAMNGAFGAGIFPVTIALIGESFDPEDRQKALGKLMGFMFLGAATASAIGGAIAYFGSWRIVYLIYGVGELILAIMMLKVLERDKPVVDRLNFFSAYKNALTNYRFMRTVIMVFLVGFSVFGSFTYSGKLIQELTGYNILSVGLILSVFGIGTVIGGRIAPEMRKMLRNGFLVISGLIGGLSMFVLSVFKNIWILSLGLFGFGLAFVCIQSTLILMAQEKLPKMKGTAMSVVSFNLFVGGAIGTSANGVIMESHGITKIFNNNSYIILTVGILTFIFVARFEMRKNNSTVT
>fig|572544.3.peg.2696 Permease of the drug/metabolite transporter (DMT) superfamily
MNSKYIGYTMAFITIFVWGTTYAITKNLLNYFTPFEVLFLRFLIAYLFLLIVKPTFNFKFNFKFNFQEEKLFLLLGLTGGMLYFLVENMALKYTSASNVGLIVSSIPIFSSIIAHFTTEDEKFDKNLILGFALAITGIFLILYNGNKVLKINPIGDILAVVCSIIWAIYSNLLRKVDKSYSGLLVVRKTFFYGLMFMLPGLYLLKVKIHFEYLFNKDVSFSIFYLALVASSICFIMWSRSINIIGIIKTTNFIYLIPLVAMISSVVILDEKITPLMITGGLLILSGVLINDKKISFEKLFKPKTTTL
>fig|572544.3.peg.2704 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKIKRLGEEKISKLLVEFSLTAIISSLVFALYNVVDRMFIGKCLGPYAMAGISITFPIFTIYIAVGMLVGHGGGSIVSLRLGQGRKEEADRVLGNVFTLYGVFSIILMTLGYLLMDRLMIIFGATENTIIYAKDYLYIINFLVLFDFIAMGVNNLLRSEGNPKFSMIIMIVGALTNVFLDFIFIFVLDYGIKGAAMATAIANIVGSIMVLYHFIYSDRSNIKLKLKYLKPDFKIIKEIFSIGISPFTLQLANSLVAVFANRALLIYGGDMAVGAMGAINSVFMFLMMTLSGIIQGAQPLLGYNYGAQKYDRVKKILNMALLYGVIISLVLTALIMIKPEFFINLFNNGNEELLEIGKSGIRIFMALVVFNAIYVVGANYFQAVGQANKSLFLNIFKQLGLFIPLIIILPKYFGLNGIWFAAPVSDVIIFMITGVFLLKNNKKLKKLSVQYA
>fig|572547.3.peg.370 Permease of the drug/metabolite transporter (DMT) superfamily
MTSSTHPRLKVLLAVLFWGGSYTATKIAVSRVSPVAVLWLRFGIGAAVLGLVLFLKKRLQLLPLHQMTELCFLGFFGVFLHNYIQAWGLRTAAAGISALIIACTPVIIALLSAFLLKEKLVQRQSLGIIMAAFGVLFILSKGNLAFLKEGNYSFGELLVVCSAFTWALFSVFSRKALKTIPPALAMFYVILSGWFFSSIPFLFQGVREISKLDMAGWGSTLFLGVFCSALAYVFWYDALKLLPASEVGVFLYISPIVAVAVAWIFLGEPLLLSSIIGGGLVLTGVSIVNYRKKS
>fig|572547.3.peg.416 Acriflavin resistance protein
MNIAEYSIQKRYVTWFFTVFLIIGGVFAYKGLGKLEDPAFTIKTAVVTTAYPGATPKEVEEEVTEVIERAAQQMGQVDKVRSLSQEGVSLVYVDIKDTYTAKDLPQIWDELRRKINDVQEHLPPGTSRSLVNDDYGDVYGVYFALTGEGYSYRELEDFADYLRRELLLVPGVASVEVTGIQKEAIYVEISRTKLSQLGISMGELFQVLKAQNFVVPSGKVRAGAEYIRITPTGEFSSVEQVGALLLASSSRVLIRLDDIATVTRNYIEPTRAIMRYNGSPAVGIGISNVEGGNVIAMGEAIKKRLKELEPQTPIGMNLGLIYYQSDTVQKAINNFLLNLLEALSIVIAILLIFMGFRSGMLIGGVLLLTIFATFIAMKLVRIDLHSISLGALIVALGMLVDNAIVVADGLLVRIQSGEDRISSAVGVVTQTQWPLLGATFIAVIAFAPIGLSPDSTGEFCQSLFQVVGISLIISWVLAVTVTPVAGVRFLKTSAKAEIPYDTKLYRVYRRFLKACIRKRKVTILVMVCLLGSALIGFTFVDQSFFPSSSSPLFTVEFWRPRGAYIEETQREVEKVEAFILKQPETVSVASYVGQGALRFILTYTPSDSSDSYGHLIVEAKDLKSAESLRRKLGNFMNIEMPDIDPRVRSFSKGTGGGAKIQARFTGDDPRVLRRLGEEAFYMMRNAPDSMNIRSDWGERVKVIRPVLDEVRTRQAGLTRQDVASALEMSFSGIQAGLYRERDKLLPIIARLPKADRARLGALPEVEVWSPLMRKYIALTQITKSIDTIAEDPVIYRRNRMRTFSVECDSRSGKTGLLFARIKPELENISLPLGYSLSRGGEYESSQKAQGGLVGMIPIAFLAMVAILVVLFNGFKQPIMILLCLPLSIIGVTAGLLLFHKSFDFMALLGFLSLAGMLIKNAIVLIDQIDLEIREGKEGFSAIVDSAMSRARPVLMAAITTVLGMIPLYFDILFSALAVTIMFGLAFATVLTLIIVPVLYSVFLKIPVFKDENVR
>fig|572547.3.peg.1318 Permease of the drug/metabolite transporter (DMT) superfamily
MPWLNRYKVLIADGALVLIALFWGVGFVAMKDALVSFSPFWLLALRFTASFILMAIIFKKRLRKLTAANLKAGLLIGVFLFLGFATQTIGLTFTSPGKQAFITATYVVIVPFLSWGLKKIFPGYLSFVASLICLAGMALLTLQGNGDTLSTFNKGDLLTFACAIFFACHILAIEMFASKMDPLVLATLQIGTTALLSFACALLFEEWPGSIASSAWWSIAFTVLFCTVFALSIQNAAQKFTPSTHAAILLSLESVFGALSSVLILGEVFTIPMVLGCFLILIAVLLTETGPTLLGKLQIIKTIFYL
>fig|572547.3.peg.1336 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKYTFDPLRGSIFSVFLYYSSLTVIGMLAVSSASAIDAAFLGNMDGEVALATVTLTLPFVIFVGGVAFMMGIGGSVSCGKYLGAGDVQTASAIFTKTLLATLLFAVGVCFTATIGVDLLVVLLGASPAIAPSVRTYTSILTLFIPFSVTGICLSYFVRVDGRPLLAAVAMTVGAIVNISLDWLFVVKLHWGIQGAAFATGFSQITLLCMLFSHFLQKKGKLRFNMRGGSWKEIIRAAYNGFSEFANEISAGFLTFLFNRIMIRRLGVAGVAAYTIVNYILYLGSMACYGISDAIQPIISKNFGAGKAKRIKGFLWIAGGTVTFLGILIVSILLLMPNSMIKLFTNSEAEITICIARDFIAHFWPAFLLIGINIVFSSYFTAMQKPVHSAFIAISRSLVAPATLLYILPLFLGNKGIYMAVPLAELATFILALALFMPNSPLKLIRSDQIYKKLGEKRELFPQKGVPTSESRFS
>fig|572547.3.peg.1885 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDRRELLAKERVGRLLWRLSVPAVIGMLVQASYNIVDAIFIGRGVGPLGLAGTTIVFPIQLLASSLAVTIGVGGASIISRSLGAKKYEKANRALGNMVFLSLIFSTTILITGSLAQQRLLRLFGASPTILPYAEEYLQVILMGLPFVGFGMSLNHAARSEGNARVAMISMIISAVMNMILDPIFIFVLNMGIRGAAIATVISQIAMACWMGYYFLLSGNSFLVLALRYGQPQLEYIKEILSVGAAEFVRMASGSMIIVFINNSLIHYGSDISVAVYGILHRALSFSFLPIVGVSQGLQPILGFNYGAGRYDRARDVARLAIIAASCIAFCAFMVGMFFPEKVVRLFTTDLLLIKEASASLRIVITAYFLVGFQITGSSMFQALGKGRASLILSLTRQVIFFLPCVVILPRFFLLKGIWLAFPTADALAFLVTVTLVSRQLGALKMERSEQNQ
>fig|573065.6.peg.1423 Permease of the drug/metabolite transporter (DMT) superfamily
MSVASLIRLLSLAAIWGGSFLFMRLSVGALGPVWLIAIRVLLAAVFLTGVGVATRKTLQIKGFYKYFLILGLFNSVVPFVLFAFAAESLTASLLSILNAMSPLFAVIIMAVWSRRMPDIKTVFGLLLGVAGVGVLVGLDATHLTLREAVALLAGLVAALCYAIASVYARHAPRTPDPLSNAHGGMWASVVLIAPFVPVLAPTTTQLMTLTPVAAAGVVALGVVCSGIAYMIYFRLINDIGAAPALTVTFLIPVFGTLWGWLFLHETVGLSTLIGGALVLWGTALVVGFDPRALFRAE
>fig|573065.6.peg.1435 Outer membrane component of tripartite multidrug resistance system
MLIGRWWDGYKDAQLTDLVQTALRDSPNLTAAAGRLLKARALEDTQKATLYPTATALGASLQMGGKDPAIDAVTLGGINFGWELDFWGKNRAGLKATVTAAEAARADGQQAVLVLSTSLVNAWFELGHMYKDLDVAERNLAIRTDTQSLVAQRVEGGLRPRAELEQARANVANSKGEVAALNERILIQRHLIAALAGQAPAFGEALPRPVLPDTQDFKAPTRIDLELVARRPDVAAARARAEQAVHGTERAKASFYPNVNLMAFAGKVFLNDLSGSGIDAINAGPVISLPLFEGGRLRANLRGAEADQSVALASYHQSVINAMQEVADTGASQTALSERLSLSNEALASSEEAYRMARLRYEAGLSDYASLLVIEQNLLSQRTANTALQSRALTLEVAMVKALGGSY
>fig|573065.6.peg.1476 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTRALYTAAFKELFHLSWPVVGSRLGFMLMGLMDTLIVGHYSAAELGYHSLAWAPTSIFLVTSIGLLVGIQVKTAHFIGADEPHRIGPVFQRGMVYAIILGLFAAVVLFLAGPGLLHLAVKPDMADGASGPLLVFALSMPFYMIAVAGSEFLEGLGRTRPGLIFTWAGNVLNGVLLLLLVPGVITLPGIDSDGAMGAAISTLIARACVMVALIVYVLTLPGIAQYGLLKRHNPDPQGGREQRQIGYAAGASYFIEVAAFAGMTLFAGRISEEAVAVWAIVLNFASIVFMVPMGLAIGCSVLVGRAYGAGDMPGLARIGRVSFSAAAAFMMGVCLVVLIGSQGIAAGYTSDDALRSGVQAALLLSCLFFVPDGVQVVTAQALRARQDVVVAPVLHYIAYGFVMLPVGYWLALHVGQGVPGLIYAAALASWVSAILLQARFMWLDKKALTAMRAAPTE
>fig|573065.6.peg.2327 Multidrug resistance transporter, Bcr/CflA family
MSAPEAAPPALKNPFLVIFTLGALSTISPFAIDMYLPAFGQIAADFKTSSAAVGLSLSSYFAGMALGPLIYGPLLDRYGRKPPLYAGLALFVLTSVGCVFAPNIDVLIWLRLFQALGGCAASVAAMSLVRDLFPPKDTAKIISLIILTIGVSPLLAPTLGGLVTTWLDWHWVFAFLAAIVGLTLILVITVLPDGKPADPSVSLKPLPILKTFLGLYRNPAFVTYLFAGGFSFGCLFIYVSASPVIFMEIFHIKPEIYGLIFAGLSVGFIGSSQLNVFVNRRYSSKQILRVGLSVQCVFVLAFLLAAANGWLNVWGTVIMLFLILSCLGFIGPNSSATAIGSLTRDIGSGSALMSFTQIGLATIVSAVVSALQAQTLTPIVVVMTMSVVIGRVVLFVGERLGSHSHD
>fig|573370.3.peg.242 Multidrug resistance efflux pump-like protein
MKTLFGLAAALLLAAALPASAETISFQGKAYCPIRYDINWPFSAKSKKAPTQGSGITANVYEMPKEAVEEKSAADLGSDMRRLRIISAPVQIGQHVVEDQVLITYELPLENLMAEKQLVSRAELNGLEHAMSVVQFQLATIQNRQRELENMAGNQAVAVNEVANNARDIENLLLQRDFLEEKLELARQRYDNSVLLSQSKFGKEVDLKNLPRRGYVRAPGDGYILWLNSSLVPGMAFSKQAPLVTIGKLDPIIVRASVHEIAMQKLKAGDPATVIFNAWPGEKFQTTISKVDYVAQPAMLQQPSFYLIELTLPNPDLRIKEGMRCDVVVDLH
>fig|573370.3.peg.728 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSQAAASPTLTIVIPVYNAEQSIGRLVDALVAQPPLPGTDVVLVNDGSRDGSHRECLACCDRHPGRVTYLRLARNFGEHGAVMAGLCQAGGDYVVVMDDDFQNPPHEAARLVETAVAGGFDVVYGAFREKCHGTLRNWGSAFNDRVATWLLGKPRHLYLSSFKCLSRFLVERIIAYAGPSPYVDGLILRVTDNIAQIDVEHCPRRAGRSGYTLWKLIRLWLTMFVNFSVAPLRLSAVLGLGVSAFGLLMAGWSLLEKLLGLDVPTGWTTLYVTVVIFAGIQLVMLGLLGEYVGRGLLEANRAPQFVVREVHGGGRPPAREPRRW
>fig|573370.3.peg.739 Antibiotic resistance protein
MRKKEREIKDKAILEQLLMQSRICRLGLFDGQWPYVVPVNMGYEPGRIYFHSSKKGKKMDILRANPNVCFELDADVEIVTGDRPCDWTTYYKSIIGFGTAVILEDEAEKLAGLKVIMRRHGGPADGFKPEVVPVTAVVRIDIASMTGKANPPHGEWD
>fig|573370.3.peg.2056 Permease of the drug/metabolite transporter (DMT) superfamily
MSQTNREMSWAAFFALVGASILWGSSFIAMKIAMREFSPLLAVFCRMAVASAVFALIWKRMGGFAAGRADWKGIVFMAFCEPCLYFIFESQALTMTQASQAGMITAMLPVMTAVAASFVLQEKLEVRAMTGLLLAVAGVAVMSLAGEAGPQAPRPILGNFLEFLAMCCAVGYIITCKKLAARHKPLYLTAAQSFVGMAFFSPALVFAPMPAKLTFGPVAAVFFLGLAVTFVAYGLYNYGVCNAPAAKAAAFINLIPVITCLLSWLILDETLNAGQLLGGATVLGGVGLSARPARKGRKTHGE
>fig|573370.3.peg.2365 Permease of the drug/metabolite transporter (DMT) superfamily
MNIRFLGYLAALSATVLWAGNFVVARGIAQEIPPVQLNFWRWLLALACILPFAWPKLRADWPAMKRHWRYLAAMGLVGVSLLNAFVYKAGQTTESLNMALLVPTAPVMIIILSRIVYGEPLTPRRLGGVAIVLVGVLELVSRGDWSHIASLRFLPGDLWALAGAACFALYSLFVRKRPAGISVEGFNAATFAWGLVLMLPALAVEAAAGPTTSWNLRVLSGVAYAGIGCSFAAYTLWTKAIGSIGPVLAGIVYYFLPVVTAVESVWLLGEAVTAAHVLGGALIVSGILLATLDVRLLSVRPGKTV
>fig|573370.3.peg.4039 Multidrug resistance efflux pump-like
MRMIRRAVLLAVGISIFAATVAFAQTPAAPAESPERSSFRPADISFSGKLYSPVKLSVFLPFNAKILTLSGQIGQHVKRGDVLASYEIPLETRMDEKTKLSPANIKELEHKLAVADKEIDRLSAKGRELEAMSQRNMTSQQAISMNAKEIEVVRKEKSAVLEQLSLARDLLTDRVELAEDHFGKGVGIGKVPKDGIIKAPVDGYVMWMNPELRAGVKLAKEAELFQVGLLNPMIIRAQVHEIEAQKLKEGVPAVVTFDSIPGKKFNASVSRIPWAPMPAALQQPSYYEIELTIPNPDAELKEGLKAQITIQPGK
>fig|573413.5.peg.553 Permease of the drug/metabolite transporter (DMT) superfamily
MDSKKTAVLALFAAPMLWGGALVAGRVVSAEMPPISAAFVRFVVTTTLLALFLRIRGGKLPKPEKNILPALIAAGMTGVALFNVFLFSALATVSAGRSAVIIAMTPAVVAMISAIIYKEKHQKLFPLALILAFLGAAIVISEGDPPSLFRTPPGKGELFMIGCVFSWAAYSFAGKHVLKSFPPLPAIMYSSFFGALLLAIPAFLEGGLPRVFSASPSAWAGLLYMSIGAAGVAHVFYYYGISKIGPSKSAIFMNLEPISALFFGMVLLGEEITMPLAIGSVLVLSGVSLSVKE
>fig|573413.5.peg.682 Glyoxalase/bleomycin resistance protein/dioxygenase
MLLPGYDIDGPTLEIFEYNENIRNTGKKINVEGFGHIAFAVEDVEQKLNLLLENGGSVVGKLIDAEIDGVGKITVVYAKDPEGNIIEIQKWE
>fig|573413.5.peg.774 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDQLLLSGKHPVRQFLAYALPAVLGMFLSSFIIVVDGLFIGRFVGSRGLATTNLVVPFLYLLLGISIMVYVGGMVPATHNLGKGDFEEASRIFSITFALGTVSIFLVVLTAGLFFEELLSFLHLDGVLRSYGRDYLGILLYFYIFMTINIGFSIFLRAEGKPVLSLFFSLAGNCLNFLLDYLFIAVYGWGMRGAALATGIALLLPFLFGLFYFLSGRSLFRLVVPRCRMREIVMLLYNGSSEMIGQFSVSITTFIFNAVLLRRIGVDGVAAYTVAGYIIMLQGMVLTGIIQGLAPLVGRAYGAEDTHSVKRFFRIAVSAACMVGGISFVACAAASSLLPRLYNVDTPRFLSVASTGLLVVSFSFLLNGFNIITTAFFTALGKAGHSALIAILRGVVVINILVLIFPRFLGDLGIWLAIPVNELLVAFAALYFLHLDNRTLVVKRST
>fig|573413.5.peg.1811 Acriflavin resistance protein
MKSFLRWFLDHPLSTLMLYLALILFGVVSFPRLKGEYLPTILFPEVRVVCEFENISAEEIERQVTVPLENVLSGVSGVKELESLSRQGISSILLRFSWGTDSYKAALEVREKIDSAYPYLPHGIEKPLVFTERGENEALFILVLRPKEGTSIQELDRTIRYDLKTRLMQVEGIGTVRLRGITSPEVKVLLDPDTCTAAGLALNEVPSLLASSVFELPIGKVNEGGKEHLIKASTDTVDLSALQRIAVPVESGSFLSLGEIAEVRLGHAERTSFFSYNGEPCVGAFLWPSPEEGTLNASRTLRRELTDIRRNYANDIEIIFLEDGAERIRSAFRELAISLILGSAAAFLVMVIFLRSLSSAVILLSSLPAAIIPIFFFQYLFGLSLNVMSLTGIAIGIGMIVDNSIVVLERIQGRRDHAAIAEGVLEMGSSTFGSTMTTLLVFLPIVFVPGIIGILFRELAITISLLLIFSFLVSMSLTPALYVLISPKTKESSSKKIFDRAESVYGKLLHALIARPFMIILLIIISFAALFGLAKVLPKETMPSVPEGRLQLSLSLPADTPFDGVEAAAERFLQAVGEAEGISGGYAYTGYEADNPLERAKKESSLNDIFFTFFYAPQTYQREAILKAHIEREAAILSVGKLSWPDSSDPISRLLSKGKEIRLRFSGRERENVLQEARAYRSQLLQEAPESDPRLEESGGYTELRLVPDQLACRNSGITPSAIAGTLKGLVEGSLVGTITLRDEEIDIRVQIAGYDRLSRRQVEAIPLQTQNGFVKLGNMVRFERLPKQRDLYRYNRVPSILLFVKDGNNTVQTGQSSTTGIKRERLDQSSFAESMRAIIGTFAIALVLMYLFLGAQFESFSAPLLLMIVLPLSACGSFLFLTVTGRSLNINSGIGILILFGTAINTTIILKASFLHSRNREELIRMAGGRLRPVFLTTATTVTALLPLMLNGSPEATLQAHTATSVIGGLLIGTVLSLLIFPALDYVTKHGNR
>fig|573413.5.peg.2158 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKNSFLMTPIDWLLLISLSILWGGSFFFNRIAVTELPPFVIVTSRVSIGSVFLLFFVHVKKQKLPRSIGIWSQLIFMGLVNNVIPFSLIVWGQTSIASGLASILNATTPLFTILIAHLFTPDEKITIHKAIGLIVGFIGVFLVIGPTALSIADITPQLAVLTATCSYAIAGVFGRRFHTLGLDPLVTATGQVISSTAILVPITLLTNYSFLRQATTSLPVFGSLIGLGLFSTAIAYTIYFLLLSRVGATNLLLVTFLIPITAMVLGVAFFNERIVTRQVIGMLIVFTGIIASNRRCHHQE
>fig|573413.5.peg.2260 Antibiotic hydrolase
MKEYKMMNNVMIPMKDDVKLAMDIYFPEGDSESYPVILERTPYGKREANDYDIDNPKGQASSRQKIASFYNKHGYVVIFQDCRGRYDSEGVFIKYFNEASDGQDTIQWIRRQPWCNGKVGIMGFSYTSHAAMALGCLLSEGIDCMFIDSGGFSNAYFSGIRQGGAFELKQLIWAFLQAQVSPAAVQDPIITESLKSEDIFAWMDRMPLKRSHSLLRNFPEYEDIAFSFWEKGTYGAYWKQLGINTSEYYDRFIDTPIFLISGWYDPYVKTILENYEAFSKRHQNPVYLMMGPWTHNNRAMTIAGDVDFSAEALIHTGYANSYQELKLAWFDKFLKGKDVLPEDGKKVKIFIMGGGSGKKNDNGTISHGGHWFSADSWPLPNTIFVSYYFHANGSLSDKKSTLSESFIEYTFDPKNPVPSIGGTITSGEPIMRGGAYDQKESDRFFGSRKPYLPLEARDDIVVFQTSILDEDKVIAGPIKARLWISSDCKDTDFTIKLIDVYPISESYPQGFAMNITDGIMRVRYRNSFEKPELMVPGEIYEVVVEAFSTANLFKKGHRIRIDISSSNYPHFDVNHNTGDPEGKGQVMLKAKNRLYVDKEHASYVDLPIVNSL
>fig|573413.5.peg.3063 Acriflavin resistance protein
MHIVDLSIKRPVTILMVIFALILFGVMAYMSMPISLFPNVTIPYITIQTVYAGASPDVIETQITKKIEDQVASVSQLKTLTSYSMDSVSAVIAEFEISKDENIALQEIKDKVEVILSDLPDDAERPKISKVDIASAMPVMNIVLEGDMEPSALYTFGSTTVSDRFAQVAGVSSVDLSGGQKREIRVEFDRSTVFSHMVPLSQVAGILGAASVDIPGGNFQLEDQDIPARLEGEFDDLDQIRNLDIPTGTGTFKLRQLADVKDSSEDVRVRTVLLDQKAGTREDNAILLGVVKNPSANTVDVVDGVTEQIKEIEASYPGIRLKIVKEDASYVRESVAGTLTNVYLGIIFTGLVLLFFLHDLRSTLIVVLAMPFSIIATFLVMKAAGISLNMLSLMGISCSIGTLVSNSVVVLENIFRHKELGHDRINSASLGAKEVTVAVFASTMTNVAVFVPMGSMSGMMGKILANFAYTIVIATLFSFFVSFTLTPMMASRILPEKAKKELPISKALEAMFRRWEKAYGRILGGMLKNKGRSALVVFLIIALFGFSMHLGGNLKFENIPQSDGGKIQVDVDLPQGQRLESTASILEEIEGRLSRHPEIESILTTLGTQGIMDEDVSLAQMTVYLVPKSERSQDSSAMASMVARELTDIPGVTIRVMPISETQSSSVGGSVVDLYLKGPDLTILQESAEKIKSVMESIEGVTNVTLSSKSGKPELIFRPKRKQISEDGISVQQVAISLRAAVDGIVATSYKDEGEEYDILVTMKDSEFTDIDDLKNIPIASAVGVYPLSRYANVSFGEGNSKIMRYNRLRTIEITADNLPGYAGGSLVNEIMAAIEQVDLPPGYTIDQGGSTEMLSETVHDLIVVFFIAVILTYMLLAAILESFVQPLFILSTVPLSMIGIVLICLATGTVLNVVAMLGIIMLVGIVVNNGILILDYYNQLKAKGKSTHDALVEASVVKLKPVLMSNISIVLGMLPMALGIGGAGAEMRQPMGIVIVGGIVSAMFLTLFLLPSLEFLAPHRSGASSSPLPASTEKRGD
>fig|573413.5.peg.3163 Permease, drug/metabolite transporter (DMT) superfamily protein
MLMASAGVFIKLAAVPAPLMSWFRTAVPLVALTIFYLLSGHRRLGKPSALILLGSFLNAVRLLLLFAGYLFTSVSNGIMILYSWPVFATLFGALFLKERIPLRNRFLLLLAFAGIGIVYSQSGFEIESRDFIGMSMLLISSALYSLTVIVFKAASVRYDQIATTFYQNLIPALLFTPALFFWPFPTGASLAYASLYAVLIGLVAFLLFFTALKHLPASVTAHLSYLEVFGALALSVLVLGETLSWNKLVGGAMILLSVLFVSRGNQNKGGEDQKTEADI
>fig|573413.5.peg.3476 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRDLTQGSIPKHILSMSLPTMSGLMLQGLYDIVDMIWIGHISYQAVAAITIFASIFWIFEVLNEIIGMSSVSLISQSYGAGDMKRTAVAAEQTITCKFLIASLAAILLCIFLKPMLHLFTDDQLVTEYAKDYGYLRAATIPIFFSSFSVNTIFRCTGDAKTPMFLLIGSAVINIILDPILMFDSIPGTSLPGAGLGMFGAALATVLANMVALGIGMLLLLCGKSGVRISPKGLFRLVPVMDKKLLTIGLPSGFEMLFRNTANTVFIKMVGVYGTAAVALIGVGLRIYSFIFMPIMGIVMGSGTIAGQNLGANQIDRSRATAWYSSLIGSLLTAVLITLVLLRPQVVLGWFLTDLDEIRQGVGMLSIVLPSLIIAAFSLGWSSVFSGSGYTMPFLISSFVAKWVVMIPYSAVVVYRFHASLTYVWISFVLSEIAEMIILGRFFHKGAWKYRRV
>fig|573413.5.peg.3571 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDKREMLLNQSMGKLFVSLALPGMAGMIVIGLYNLVDSIFVGQFVGPAAVSAVAMGYAVILVNQAILSLFATGASSLFSRAMGAGDQKTMDALLGNVFWPVALCSLVLTAITFSFAPGILFALGAREEILSLGIDYLRLLSLGFVFGAVGPALNFLIRAEGQMKTAMKIMALGTITNIILDPIFIKVLGMGMEGAALATIIGQSLFLLGDFAHFRSKQSSINLSRKSFRINWPLMPEIIRVGFSGMIMSLAVAIQLSILLSLSSSYSINSNIVMSTAFRIMSFFYIPIFGISYGLQPVLGANYGAGRFDRVREAFWYFGKVASAIAVGIWLFFQLFAPFILSWFITDGEIVAEGSRQFRLFLSSFLFYGLIAVFIMLFMALGKAGKGALLTLGRQLFFFIPLALLLPYMFGEIGLWLSYPLGDLCVVLFGMILVRSELKLLKRPHYAGQ
>fig|573413.5.peg.3742 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNSDRILNGGISRLFVRLSFPAIVSLLSLGLYQFVDGIFVGQWVGPAALGAVGVVYPFSLINNGIFSLIGVGAASMLSRAIGRKDQKTIDALFGNLLLANLILSGAMILFGLLAAESIVAFLGASGEIHRLGVIYLRILVLGSFFFNFASSANILIRAEGRMKQAMRIMLSGTILNIILDAFFLGVFDWGIAGAASATVISQGVMCCVSFFYFGKANGAITLRKSHIAFTGHLFEMLRVGFSGMALPIMTVIQIIFVLKSVASYGTEQELIIIGAVIKILNFIFVPIWGICQGFQPLAGMNYGAGKYKRLARAFTLFSFYSTIITLVIWLLIQLFPRVPLGWFIIDSDVLEAGVSVIRLYLCDFPIYGYMLLVITFFQAIGRSIPAAFLVVSRMSLFFIPVILLLPRLLGLAGVWLATPVSDMFVVVIGTILFGLELRRQRCLEAQEEEG
>fig|573413.5.peg.3855 Multiple resistance and pH homeostasis
MSWITAFFFLLGALFALMGNLGTLLFPDVYTRLQAASTCSTTTVFSIMVGSLFITGFSLMGGKILVITLFFMVSSPVSGHIIARYAWRSGQVPWRRPTWKR
>fig|573413.5.peg.4052 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADNYNNERIQLLAEGDIGSALFKLSAPAVAGMMVMAIYNVVDTFFVSLLRDTTAVAATGIVFPLFQLIGSIGLTFGMGAASVISRKLGENDYKEANRTAATALYTSLGVGIVFALVGATFIKPLLILFGATDSILSTADLYGRVIVGGSIFQVSNMTLNNILRSEGAALHSSTGQIIGAVMNIILDPLFIFALNMGITGAAIATVISQGISTLYLASYYFRDKGAVNPFKRSYFHPTVRTYRNIMNMGIPTFVRQILGSISFAIVNNAAGVYGDSSIAAVSINSRLFSLLMMALFGLAQGLQPLAGYNYGARRFDRVRQTIRIVFSVASGIGLFAGILCFIFAPAIMRVFAPQDPDVIAMGSEAMRMMALSLIPVGLVIMFGGIFQALGNGRYALILAAGQQGLFLIPLVLILPRFFGISGVFAAQPAGFVFALLVGMILFFRQSNVLKARETQMLEG
>fig|573413.5.peg.4208 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKEFKTLLPMVKKYRWWYVAGLISLIITDAGELLIPQMIKQATNIIASGSFFPAAIATPVLIMIALAAIVALSRFGWRFFLHGASRRIERDLRDKLFAHLLTLSPSFYGTMKTGDIMARATNDMRAIRMATGMALVAFMDGLFLTLAILIILFTTNPALAAITIIPLPLITIIILAFGTVIGQRFKAVQEGFSRLSEHVQETLSGIRVLKSFVRESWAQERFVDTSDAYMQKNMQLVKLWGFFFPLIVFISGLTSLLLMRFGGVAVMLGSFTPGDFVAFLTYLSMLQWPVIGMGMTVNMIQRGAASLGRINMILNEKPDIVSPPRGRTNIDHTGIEIKKLSFSYPDSEIKALDQVDLMLEEGKTLGILGRTGSGKSTLVRILPRLLDPPSGTVFLGGVDIREYDLETLRNAIALVPQDTFLFSASVRENISFARPEADESEIMDAARISTIDREIEKFPKGWETEVGERGLSVSGGQKQRIAISRAILPNPPILIFDDSLSAVDTETEEKILNAFLEHRKGKSNILVSHRVSTLQWADYIVVFDRGRIIQQGSHTQLLATEGLYRNIYLLQQEGSL
>fig|573413.5.peg.4209 Multidrug resistance ABC transporter ATP-binding and permease protein
MEEEKIVKGYDPVIMRRLLGFVAPYKKLVTIALLAMVLATLAELLGPVILQRSIDQDIINRYHRVSLSKMDDALAERLFAPPVLPQLFHKSDPPLFGDNRFITSSMLERLSAEERKKLFDANIVDTMEWYLSGKLNNAEELLSTLPAEAEAMLQDGWIAMPASSLKKLDKESLGLLRANDQKSLSHKTGVYLIFLIVMLLFSFLQVYLMAYTGQGVMRGLREKLYHHVMSQNLGYLGNVPVGTLVTRVTNDVETINELFTSVATGLLRDFATMGGVIFILFYLDPHLALITSASLPPVVILAVIFRNRARDAYRRVRIWTSKVNAFLSEHISGMDVVQAFHREKRSQENFQKINGQLLSANLAEMYVFATFRPLISLLTSISIGTVLYFGASMVLNSAVSLGVMIAFVNLMQMFYRPVMDFTENFTILQSAMAGGERIFNLLDRNEVIPDNGTTPIPAPVKGKIEFSHVNFGYTNDEQVIRDLSFTIEPGETVAIVGYTGAGKTTIANLLTRLWDIEGGTVLLDGINISRISLSELRSTVVPVQQDVFLFAASIRENITLGRDIPEQRVKAAAETVQSAPFIESLPRGYDTVLSERGANLSTGQRQLLAFTRVVAQNPRVIILDEATGSIDTETEKLIQKAMERLTQGRTSIVIAHRLSTIQHADRIMVLSGGRLVEMGNHAALLAKNGVYANLYRLQYKDAVQE
>fig|574087.3.peg.151 Vancomycin B-type resistance protein VanW
MKNSLLAALVALTLLFSIGLGIYIGSYFFFKQHEDVIFSGVMIEGYDFSGLTKKQAKERLKKLTEPLLQEPLVLERDNDKWLLRPDDIELKFKNRGALNKAFGIGRSGTLLQRSIAVWQSAEYGKSLTVDISYNEDKLDEKLQQIANEVNISSSNAYLDLETEELISFQLGKRLRLEESKQKIISRFNNFKKIPVKLVIEKKVPEVNREKLKEWNLTNQLSSYKTSFDTEKENRVHNIKLAAQKINATLLKSGEVFSFNQTVGRRSLKNGFKQATEIVNQEFVTGVGGGVCQVSSTLYNAVLLGDLKVLERHNHSRPVGYIPLGRGAAIYNGYLDFKFKNTSSDPIMILAKVLENSLEIAIMGQSKDYQIEISTSQPKVLDYGQVKKKAKVEERKVVKEGKQGYQVKVVKKIIVDNELINKEIISQDVYQPVDKVIKVPVK
>fig|574087.3.peg.1814 Permease of the drug/metabolite transporter (DMT) superfamily
MEEYEEVSFKKRIKADLALLFVVFVWGTTFAIMKGVFDIVTPFYFLTLRFWTAVIVLVLIFHRRLKKLDWETIKLGSFVGIFLFGGFAFQVVGLNYTTASKAGFLTGLSVVIVPILSAIILKKIPSMLTVIGVTLATIGLGLLSFNGEFIFNFGDFLVFLCAVSLAVYILLVGKYVQQKDSILLTIVQITTVALLSGFSSLVEGSFEVVLQPELWGAVVYMAFFATTLALVVQNKAQEFTTPTRTAIIFSMEPVFAAVFAYFYLGEVISVNSYWGGLLIVVGMIIAELKLSKPKEEAV
>fig|574087.3.peg.1890 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKKFKKQLGKQVDSTKGSIIKSLFHLSWPIILSNLMHMTYNLVDTIWVGKVGAKAVAAISLSFPIVFVLLSLGIGFTIAGTTLVAQYTGAEEGEKVNHVVGQIFSFVLSIALFCSVIGIIFTPDFLKWMGASKEVLPLAVSYMRVLFGGMTFMFIFFIFSALLRGSGNSITPMKLMFVSTLINIILDPFLIFGVSFFPELGVTGAAVATIFSRAVVAVISIYFLWTGKYGLHLKWHHLKFDFKLIKEIVVLGAPAAIEQSTRGLGMTVMMSIVAHFGTMAVAAFGICTRILSLVIMPSRGFSTATTTMVGQNLGANKVSRAEKSAYISTGLNFILLSILGAIFFTVPQLVIKVFNDNPEVIRIGSSFIQINGLFFGFMGGLIVINGGFRGAGNTLSAMFFSIFSLWIIRIPLANIWSKVFEWGTNGIWWAFVISNVLGSLTAILWFKRGHWKKSIINKDKKA
>fig|575540.3.peg.1306 Permease of the drug/metabolite transporter (DMT) superfamily
MLGMAILGSTTAPAAKLAVAEIPLTVLPVIRFGAAGLLLLVWFWPRRRELIALLSERPGRAWATAAFCVPINQAFFLSGTKLAPTSHVGFLYATCPAVVLVLAWLLGMERLKPVRVAGILVTVLGMAIITWGGLKDVSSAGLESLLVGDLLLMGAVVSWAAYMLCSKSLIESHGAFPTLISTFLLGALLCLPFTLAASWDTQMLRAVSWTAWAGMIHLTVVVTVVGLALQNLAIRRLETSQVAAVGNLAPILTLIWAVLLFGDAITPQLIVGGTATLVGVFLANRS
>fig|575540.3.peg.1410 Acriflavin resistance protein
MTTRANSGGETTHRHTHGREDILTGIVRIFLESNFSIILIIVAVLIGLGALLATAREEDPQIVVPLADIMVEMPGHTAEEVERLATIPLEKALYQIDGVEYVYSMSRENRAIITVRFFVGQDRERSLVKIHKKIDENLDLIPPGVTGWVVKPIEIDDVPIVSMALISDPDQAGPGTESAEDGYPIRRVAEELAQRLSALPNVSRVQVIGGMPRQVRIDLDPERMRAYSLSPLEIQRALIGSNLITPAGSFERNDAMVTVEAGLRLDRPEQLPNLVVGVFQDRPVFLKDVATIRDGPAEASSYVRHGFGPAREFAVEPGAPGYVLGAPVAHDQDGKAHQLVAQVEPPQTAVTIAVSKQKGTNAVSVAEAVLNRVEELRADLVPSDMKLVVTRNSGLVANEKVNELIEALWVAIVIVLALLTLSLGWRDALVVAVAVPVVFGLTLGVNYLAGYTINRVTLFALILSLGLLVDDPIVDVENIARHFSTRGRADREVVLEAVAEIRPPLISATLAVIVSFLPLFFITGMMGPYMAPMALNVPIAMLMSMVVAFTITPWLAYQALRGHVKPMNGESPPVGHDHDPDDPDTIRRTMLYRFARPLMSPLLGSKWRSVLFLLIMAGVTLAATALAAVRAVPLKMLPYDNKNEFLVLIDLDEGTTLERTDAVVRQFETLLAVEPEVVNLTSHVGVSGPIDFNGLVRHYGLRAMPHQAEIRVNLVGKRHRSQQSHAIGLRLHDRLTELADRFNARVKIVELPPGPPVLSSLVAEVYGRPDMTYDQLADAAEVVARRFRVEPGVVDVDDTIETPARKLIFVTDQEKAALNGVSVEEIARTLALVLHGGHAGTVREVGEVNPLRIELRLPRELRSTPEDLARVQVKGTNGRLVPLSELGVWEEGRVTQTIHRKNLERVVYVLAETLGRPPGDCVADIALDRVEPQPGDSQGFVAEGTGKPVALRTFGLEGGGVPWALPEGARVSFSGEGEWKITLDVFRDLGLAFAAAMVMIYVILTMQTNSFVVPLVVMLAIPLTISGVMPGFFMLNALTGTTVEGYADTVDFTATAMIGMIALSGIVTRNAIILVEFIHHAVKRGRSLFDAIIESWVVRMRPILLTAAAAMLSSIPITLDPIFSGLAWSLIFGLIASTVFTLFVIPAAYWLINATQVDIDGSYSDQSEE
>fig|575540.3.peg.1561 Tetracycline resistance protein
MSQTRSISPQALLVMIVLVDLMGFTLVMPLLQRFASDYGFKPWQIGAILAAFPLFQLIAGPILGRLSDRYGRRPVLVASQFGTALSFALMAVSREFWVLLLARAIDGASGGNVLVAQAYLADVTKPEERGKALGLLGAAFGVGFVLGPLLGGVLVKLPIDPDWQLRLPFVVAALFSTVAWVLVWLKLPESLPREKRAARFTLSRGGPLSVVRVVRAPKIGRLVVVSALLTLTFSSLEGTFSNYLKSRVGWDAAEAAWAFAFLGLMSAMVQGGLIRPLISRFGEPRLVIFGVTTLALGMVAMALMSDWWGYLAACILIALGYGTSGPSVNGLLSRSVSPVDQGLVFGVVASCQTLARMINYMVANLLLGSEGSSAPYWEAAFLALVALAVAWPVVVGVGPSTDHDATLPSETLWSSDAADNLGRMPSLEPNGASNVPRQPSESPTSAAR
>fig|575540.3.peg.2494 Permease of the drug/metabolite transporter (DMT) superfamily
MSPHASPASVRPPTLAQVSSPTGRFTGWWVGLVVICQVIWLIWCLREPLPNASRNGQGPQISRGLLLMVALPGPTPDLDWSDSILGSALDELSQWWRLGDRVAILAVAGLILAAIFGLGGVILRLLDPDCRFARVWGPGLGPPIRFGIGAATLGAVVLGLGWWGWLGPTTARVLIGALALANLTARRGWRSSSEEGRSAASQRIPWRSLWPLGFALPFLVPMFLGAMIPTIDFDALEYHLQGPKEFYLGGRIAFLPHNVYTSMPFGVEMLHLLAMHALDDWAVGALAGQVTLAGVAVMAAWAVGGLTARWAGTGSGVAAALAYLATPWIYRMGVLPYVEGPLCFFHAAALGAAVTAWNDSDSQGRGRAWSVVGLLAGGAMACKYPGLISAVIPFGLAAAAAAITRRHPASLVGFVLGVALVVSPWLLKNAVETGDPVYPLGYAVFGSHQWDETLDAKWRAAHGRKPITLAELGRALVDVAGRSDWQSPVYLAFAPLAWLARGRRGHAAVATAFLVWLFAGWWLLTHRLDRFWLPLLAPAAVLVGLGWNGMSQRVWKIARVAILGVCMSVGLVQSLSPLTGPTNWTTPLDDLRHSIPRLLDKELVEFAEALPPKARPLLVGEAAVFHLTVPVVYNTVFNRETLEVWTAGLDPVEAGRAVRDRGITHIFVDWNEIARYRSPGNYGYTDYVTPELFERWVQAGWLRRLRGVPGRGVEVFEVRSNSSPDLFPTETKP
>fig|575540.3.peg.3802 Acriflavin resistance protein
MRDHDLLPTPVRSMTVSDICIKRPVFTWVLMMIPVVLGSLSYLELGVDLFPNVDFPVCAVVTTLPNASVEEIESTVTKPIEDVINQISGIDELRSQSLEGTSIVTVQFDLSKPLDVGVQEVRDKVGIVVNQLPEGTETPVVSRFSTDEIPIMTIAVSGRRDLREVTEIARRQIKERLETVSGVGTVGLSGGKVRAMNIVIDADKLDAYGLSIEEVRQALARQNVETPGGRIDQGERELVLRTLGRLETEQEFNDLIVVNRGGYPVKIRDLGYAEDSNEEVRTLARLEVFENGISQGAKNAVSLTIQKQAGSNVVAVADEIFKRLEKIKASLPDDIEIAITRDQSRFVRKSIEEVQFHMLLAAILVSGTIYLFIRDWRTTVIASLAVPTSIIPTFAFMYVMGFTLNNITILGLILAIGIVIDDAIVVHENIFRHMEEHGLDGYEAARMGTREIALPVMATSLSLIVIFLPIGFMGGIIGKFFSSFGLTVAFAVAMSLFVSFTLTPMLCSRFLKLDSSQGAGGPQKAKSKSGLIYRLVDGTYGLILRFALRFKFLVVLMTLVVVIATYPLALGVGFNLIPRDDQSEFEVVFTTPEGYTLKRTDEVTAEIEARLREQIRDMKYMYTSIGNAVSGGIASSEGDVTKSSIYIRLKDLEERSPGVTQFNQQEIARKILLDYPELRSSVNDVSPFQGGSRGQTFQVNLAGPDLEKLEELARQLADKLAATGNVTDLDTSLTLRKPELQVRVDREAASDLGVQVGVVADSLRALVGGIKVSKFRDGPEQYDVWLRATKIDRQDERALLRLTIPSTMMGLVRLESLAELEFELGPTEIERYNRERIVTVLANPKQGMALGELVKLTTSLLDPNSTNPDRLELPPGYSFRFTGQAETLAELFRYFAIAFFLSVTFMYLILAAQFESWSQPVAILMSLPVTVPFGLLSMILFQTPMDLYAMFGLFMLVGIVKKNGILQIDATNQFRAAGMNRHQAILEANHTRLRPILMTTFMLVAAMIPLALGQGPGSGSRASMAKVIIGGQVLSLVLALVVTPVFYVYLDQLRNLMRKSPFRLTVERQTHSLNASDQPARPVPVMARVFESSHSLPHDNGHGYGNGHGLRSPVEPSEPYERPVGSSAAKSSAD
>fig|575540.3.peg.4269 Acriflavin resistance protein
MALESASSAPSGSLREQLASLRIDRDRVVISRPKPATRSGRKAVPTNGTISALSGPEPPDSRLVIDEARAAMIREAVEQLRLDRSSSFRPRSRRSSQPPLSGPSASSPANWSSSSPSPSPASPAAESDRNGRDVIPPKPPWERDTVQPAPRPATRSAPRPRRRRSWGFQLLSLMLWMIPLAILAALASQAYRYYDARLPKFEVTVAVAQKMTQAEAQKILSAKGYIKARRQTMVGAMSPGRIERILVSEGMKVGEGELLAVLEHNELDALLKSREAMIEQKKAELEEAQTALEDRRRKEERLRTLSSRRSVPIEEFEDAVYQTRMAASRVEALKAAIRLMEASAQETRETIRNMEIRAPFTGTILTKDAEVGETLTPGGMGAASGRGSVVNLADLTDLEVETDVAESLLARLQPGQPAEVSVAAVPNRRYQGRLRQIIQLGDRARGTIKVKVELLDEDERLFPELAATVNFLPIPPDFDPNDPAASFERAGIQAAAEPEVFVPRAAVFDENGEPRVWVVDENSRVNKVALQVAPAPNAPTQWKVEQGLQGGERVVLNPPAELRPGMLVKLPE
>fig|575589.3.peg.542 Permease of the drug/metabolite transporter (DMT) superfamily
MLLKDKLAAFAVVFIWGINFYFMKVGVSEIHPMLLGCLRYLLVLLPALFFIRIPSIGWKWLLLYGFISNFSQFAFMFSAIATGMPTGLVALVVQSQAFFTVMIAAFFLREQAFWNQWLAIAIAFMGLMLIAFGQQHSHVPLMGLALVLCSAISWACGNIVVKKMGPVHPIGLVVWGNILTPLWFLLLAVQNIGWQGVVADWHALTWKGFGAAAFLAYFATIIGYGLWIYLLTRYPVAKISPLSLWVPVISMIFAYLFLDEQLNTLQWLGSCIVMLGLMVHLLGQKIQTLLLMQRASNT
>fig|575589.3.peg.2005 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSIATTTRFEIKKLFQLMLPILVTQFAQAGLGLIDTIMAGHLSPTDLAAIAVGVGLWIPIMLLFSGIMIATTPLVAEANGARDFNNIPTIARQSLWMAFMLGILAMLVLQLMPFLLPLFGVPENLQPKAGLFLHAIGFGMPAVTMYAALRGYSEALGYPRPVTAISLLALLVLVPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLIALAGYIYKGHAYRKTQVFSQWEKFNPVWAKRILKLGFPIGLAIFFEVSIFSTGAIILSPLGETVVAAHQIAISVTSQLFMIPMSLAIALTIRVGMYYGEKNWHAMRKVQHLGLITATVFAVLTMLVMWIFRSEIVAVYTRDLAVTHMALYLILFAIAYQLMDAWQVSAAGCLRGMQDTKGPMWITLLAYWVIAFPVGIYLARFTRMGAAGVWTGLIVGLSVACVLLLLRLYMNNKRLKLSTST
>fig|575589.3.peg.2028 Permease of the drug/metabolite transporter (DMT) superfamily
MSSTASGTPSASLLFTSSVYALLVLIWATTPLAIVWSVEEVHPMWVLIIRYFGASILAFLILKLMRAPLPFDQMAMKSYLAGSLNLIGAQLFIYLAANYLTSGLMALIFGFSPLVAGLIGHVILKTQKLVALQWLGMAIAVAGLSFVFADQAETQVNPIGVILMFISMVSYISSIFWVKEINAPLAPMSQATGSLLVSALASLLLVPFIYEHIPTAIPGTKTIIGFLFTMVMSSIVAMLCYFWLIKRLNASTVSLSNVITPVLALMLGATLNNEQIGSHTFAGVSIVMFGIVLYFWKDWHSQYRVKKY
>fig|575594.3.peg.122 Fosmidomycin resistance protein
MKVSKYIYSLSLGHLFVDFSQGALAALLPTLITQHHYNYAIAATLVFAMNLVSSVVQPLFGFLSDKYNTGWIIILAVLITGVGFSSLGYVPTYALLVMGCLVCGIGIAAYHPDAAKLVNGLAGYNPGQGMSIFSFGGNIGFAIGPITLTLAVNHFGIHGIGIFLIIAIIIMLILLKLYPIMHRQSVAFWSSSKKDRNSKIAVHGHNDWFHFSLLSMVLFGRSIIFYGLNTFLALYWMHILKQSNTNGSIALSVLFVIGSLGTLLGGRLADNIGSIKVIRLTFCILPFLILALSLTRNVLIGSLFLLPIGLLIFLPYSAIVILGQRYLPNNMGFASGVTLGLAISIGGIATPFLGYIGDATNLVKVFQILAGIGLIPLVFSFLIREPK
>fig|575594.3.peg.278 Glyoxalase/bleomycin resistance protein/dioxygenase
MPVIEDQTENNEHEHVVTLRCGHQLIRLQPTDRPKEQLQAAHPTPGSVDLCLVSGDDPEDVLHHLKSYYVDVIAEPQPNQGAEGDMTSLYLRDPDQNLIEICFYKNK
>fig|575594.3.peg.651 Glyoxalase/bleomycin resistance protein/dioxygenase
MQYNHLTLEIWTGEGAVRKTGAINHISLNTKDADAAFKAAKAEGFKLKDSEVQHLDFWDKGIKFFNIEGPNAETIEFCEIVK
>fig|575594.3.peg.1491 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNRLDLTTGKPLQRILQFSTPLIFGTLFQKLYSFVDSIIVGHFISANALGSVGATYSLNFLIIGFMQSFCVGLGIPISQSLGANHGRDVQRFFWNGLYLSIAISIFFCVLMTYYTEPLLIAMRTPQPLLHDAVIFIRPQFVFIWVTVLYNFSASVLRSLGDSRTPFYTLVLASLLNIIIDVVLIGIFHWGVIGAAVATIIAQAISGLMNIIWLVKTSIIIDFRHPQLKFSARHTYRLAYIAFPMGIEYSISAIGAIIMQFAINSLGTVYVVSQTAGEKIRQMFTLPIESIGMGMATFIGQNFGAHSMSRIRQGIKDGMKIQIIYYGICLIIIMLFADPLSELVIGHHPELIHLSSLYLRLMSLTLFLHGTLMIYRYTLQGLGFSLLAIWSGVGELIGRSIVSLIAIVLNSFIAVCFINPVAWGLAGGYCCWMVYRQLKKIAVSFTREVN
>fig|575594.3.peg.1618 Multidrug resistance protein B
MTSNTINIDRHTRNIIAAILLLADFISLASQTMIVTALPIIQQDLHVSLTTAQWLTTGYTLILGLTIPLFSNIYNKYTDRGIYLSTVGLFIIGTALGCIATNFPLLLLARLTQAAAGGVIMSLQMTTMISIFPIEKRGTVLGMTSLIISTAPAIGPTLSGFLLEYLSWRWLFISVLPLMIVCWLIGFWKLSNYSPIKDVRFDYPSILTSLIGTGLALGSLSVFQSNLEAGLAMLVSGCLFIWWFVHRQLHLKRPMLKVTIFKYPSFRLMTLVGLLAFMIMLGTEQVYPIFTEKILHTSSLTSGLILFPGALANGIVAFFAGRLYDQYGFKWLIISGSLLIALASIPLLFISSSTSILTLTVIYIVRLIGNALIFSPALTEAFSDLKLEENSHGTALNNTVRQIMGSASVTMMVVITDAPRSIVQGAHWAFGVTLLMVVVLMVVLGRYLTIKKQH
>fig|575609.3.peg.25 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKFVSSILLIFSAAIWGFAFVAQSTGMEHIGPFTFSALRSIIGSIAMILTINVIPKIGMLQKKETSVVVDKALTRRAGIINGIILFFAMNSQQYGLLYTTPGKAGFITALYIVIIPIMRSFMGEKVSLKVIICVIFATFGMYLLSVKENFTVNFGDIVVFCSAIFYSIHTLTLAHYSPKVDSIKLNAFQFLLSGILSLICALIFETFSLQDIVNSMGSILYVAIMSTAIAYSLQIVALKVLEPTIASLLNSSESIFAVLGGFLILNQHLTHRELIGCLIMFVSTLIAQIPIMSFRRKYE
>fig|575609.3.peg.44 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKLKIDGNVNFTEGSIASGIIYFAIPLLLSNFLQQLYNTADLMIVGNFAGKGPMASVGATGPVANLLIGLFLGLTTGASVIVSQFYGMGNRKKLHSCIHTSYAVAIVGGIVLSVLGYFLSPIILSNLNTPREIMDDSIRYMRIFFLGVTPLLIYNMGAGILRSTGDSRRPFNFLCISAIVNIILDVVFVVYFKLSVVGAGWATFISQVVSAILVTYNLMVSDRIFKLNPKDVKFYRDTIGKILKIGIPIGVQSSVISLSNVLIQSKINTFGANAIAGISAESRIDGFIFMALQAVSLSATTFAGQNFGAGRFDRIKKGIKTAMLLMVGTALFLSAISIIFAKILISVFNSDPEVINYGSECLYYIASTCFIFGISEVFGGFVRGAGKAIVPMAISIVSMCGLRMVWIYVALRTWNNIEIIYLSYPISWIVTCILNGLYYFFGKWNPQERFNK
>fig|575609.3.peg.1323 Teicoplanin resistance protein vanZ
MKLLLFFSMIGILVFVFTFILFSLIRTNFFKSLKRKSNPKRELILSIFVAYIAVMCLLLFLPNVFMSNHGIDLTSQNFDFVGDFKDRISAGSWGVNIIPFRTMKSYIKYSGVFHVFLNIAGNILIFIPFGTMLPMLYDDMRKFYRVAVLSATFSFLVEIVQFFVGRSVDIDDFILNTIGGMIGYFVFKMIQNKYN
>fig|575609.3.peg.1384 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKDVDLLNGSITNLIIRLSLPLMGTAFIQMAYSLVDLIWVGKLSTEAVAAVGCCGFFIWIAQSLILISRTGLSVGMSQAYGKRDNRALVEVARSGFQVNFLIWTALTFIYTVFRDDILGFYRLDYEVEILAVKYFNIITFGLIFTFWVSAIESVYYARGNSTTPFKVSTVALIFNIIADPILIFGLGPFPNLGIEGAAIATVLAQAIAFFIFIYLGIKDREIYVRINYLKKVNINRIIYIFKLGVPASLQSIIHALVGIRLNRFIADFGAASIAAFAIGAQIESVSWMSAEGFSTAFSSIFGQNYGAKNFERILECRKKGLKILTTVGVLAASLLFLQESRFLKYSLMIWM
>fig|575609.3.peg.1437 Vancomycin B-type resistance protein VanW
MHFSNKRVISVVLAVVLLGIAIIYYSNESKSEKIHRGIKISNIDVSELSVEDAILKITSTKEEENKDAKLKFSTEEMNYFIPYKDLGYTLDVETAVKEAYLIGRSNSIIKNFFDIIYTSIVHKNIELSESFSVEKVDATINFLVEKVYKKPKNAEISYSAENGFNLSKEEQGSYLDSKKLKELIFHDIDKKEDIQLPILKSEPTVYIKQFEGIDGLLSEFSTDYSKSEDNRKDNIALGASHFNDFILKSGEEVSFNNVVGDISLLTGFKDAGIIINGEFDRGVGGGICQVSTTLYNALIRADLDIVERYNHTRPISYVPLGTDAAVSQGYKDLKFRNNLNHNIYFKAFADGNELKFQIFGNKADRDYQVEIEPKLLAVTEPNVIIQYSDAIEEGKEEVKKPGAKGYSYVTYKNIIKDGQIVETQKISSSNYIAQDKVVVIGEGDPDVIREKKEREKKNYNKEKTNKKTNND
>fig|577650.3.peg.3448 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTLSLILHEARALLRLTGPLLLAQLAQTAMGFVDTVMAGRYSAVDLAAVAVGFSIFIPVYVFLLGLLSAVTPLVAQAHGRGDGKAVRRAIRLGMGIGLVAGLLLMPLLWWTDPFMMWMGVSPEVIPITGRYLFAISWGLPLGGIFFALKGGGDGLALPRLSMFAGFFGLGVNIVANYVLIYGKLGLPALGGAGCGWATSFSILAMLGFMALLLGRSRIDGTARLFALHPDQAATTSVAAFLRLGMPIGLALFIECSIFTIIALFIAKFGAQVVAAHQIALNFASQVYMLPYSLSTALTVRVGFTIGRKRIRRLRRIAGTGLGMALIGAVLTCGGILLFSPQIAALYTADPAVRQLAVVLLGYAALFQLPDAMQVNAGGILRGCKDTRVPLLLMLCAYWGIGLPLGYGLGLERLGNLEPGPQGFWVGLICALVVAALLLGGRVRIMLRRLERQAGQGVRADRP
>fig|580327.4.peg.2708 Teicoplanin resistance protein
MGINFPIGLKAILFIFFIPLIIKQFKSTKNIVIVTFMAGFIIYAIELISIVFFPITFYPPMPNYTPNVNIVPMKDIIILMRLQPINIVIKNVVGNIILFIPLGFFVPIIYRKMNKFNYTLLLGLCVSVFIEIAQFIIDYLTKYPNHTCDVNDVILNIIGLILGFIIQRGIRKASFMANYINNVANKIE
>fig|580331.4.peg.397 Daunorubicin resistance ATP-binding protein drrA
MRVIEVKNLTKVYCAYEGKSLGRIFKRLWSREGVKEVKALDNVSFSIDLGESVGLIGVNGAGKSTTIKILTGILEPTEGVVRVFGNIPSKHRMKNNYRIGAVFGQRTQLRWDLPAYESYGLLKEIYNVDDKVFKERLDYFSEVLDIKKIMHRPVRTLSLGEKMRAELCAAFLHGPEVVFLDEPTIGLDIFSKEALLHFLKEIKEEKKVTIILTTHDLSDIEEVSDRIIILDRGKILFDASKDEVLNTLEVGSQIIFTLKNKEAVIPQSVKSLPFSISKNFLKVDNVSKDLVPQVLTDVFSYNTVLGVEINYPDFKDIVKQIYLQNKDRGRKNGDNLYKGKIGF
>fig|580331.4.peg.1775 Probable cation efflux pump (multidrug resistance protein)
MFIKRDILVLIMPVIVEQTFLILTGVINTIMASRLSKDVVSAIGMADSLNNMLINVFSGLAIGGTVVVAQYIGQGNKKNANKTLKQILYVGVGISFLITILVWIFRYEIVGLLFKSAEKTVIDNLMVYLQITVLNYPLIAIQLITLGALRGSGDTRTSMKINILVNILNIFLSYVFIYGIKWIGFKGMGIKGAAIGLTLARVIGAIVTLAEITSCKNYLYLDQLTKFKLNIHILNAVFTVGIPASIESLLFNSGKLLVQILVVELGTAAIAADSIFNSILSVFNIPGNAVRAVTTTLVGQHIGRKEINEAKEYIIYSAKATAIILGILGAISYPFAKSIASFYTSDETVIKMISDLIKLNSICILLWSPSFVIPEGLKGAGDSKYTMVISMISMWLFRIGVAYVFGILLNLGLIGIWAGRYVDWLARGVLYFLRLKGDKWNKILVKSEEV
>fig|580332.5.peg.1293 Inner membrane component of tripartite multidrug resistance system
MNSNRVLTGIAVMAATIMQVLDTTIINVALPNMIGQLDATPDNISWVLTSYLIASAIIMPLTGFITDRIGQKRFLLISIAGFVVSSALCGMATSLAQMVLFRFLQGVFGASLVPLSQSIMLQIFPGEQRGKAMAIWSMGVMVAPIMGPTLGGWLTEQISWRWTFYINLPVGILSFILAMRHVHDTPTRERRMDWLGFASLGLGIGALQLILDRGNQDDWFSSQTLVFAALLSVAAFIFFIVYTLTGKHHPLFDLRIFRDRNYLVASLIMTTIGIGFFGGMLLQSLFLQNFLGYPTFEAGLYMAPRGLASFLVMIFVGKFVNRIQPRNFIFVGICASILGNYMMTRFTGDITANDLIVPMMLQGMGMGLIFVPISTLAFTTLPKETAAEAAGIYSLIRAVGSSFGIAILATYFSRSTQQSWSLLRGDITPYSEALRNYLAPLHLGAQDPQGVAMAARAVLHQAQNIGYIDSFWFATLNFVMMLPLLLLVRTPKKGAAASAPAVSAE
>fig|580332.5.peg.1294 Membrane fusion component of tripartite multidrug resistance system
MHMDSIKAHKKKIIIGLLLIALPGILAFTYYYGRSRSTENAYINADVVNVAAQVSGRVVAVHIKDNQHVHKGDALFDIDPQPFTIALERAQADLAQARQNARQDNAEVAAARAMVTQAESDLGNARSTYTRDKELVAQHFLSQQSLDDAQTHMQALQATLEQAHAKLTKALSAPVKVGERGDVLKAQAAIDQARLDLEHTHVVASQDGQISNLSLTAGSLVGVGEPLFALIADNSFHIDANYKETELPGIHPGQDVDIEIDMYPGQHFKGTVESISGGTGTAFSLLPPQNATGNWVKIAQRVPVRIKLAPTDAEHPLRIGATATVSVQLK
>fig|582744.3.peg.227 Permease of the drug/metabolite transporter (DMT) superfamily
MAGIAMVLLASVAVSSKAIIVKLAYVYPVDPATLIALRMAFSIPFFAALAWWSARQDSLATLSLRQWMAVLGLGAIGGYGPMWLDFAGLAYVSAGLERIILFLYPTMVLMFSALLFRQAIGRRELFALITGYAGVGLVVGHDIEFVHGTADATLMGAALVFASAVLYAAYLVLSGKLIPQVGASRFTAYTMLVATFTSGMHYAGSQHVVSWSQLPGEVYLLSLLMAVVATVLPAVLLNIGIQRLGSNRASLISSIGPVSTIFLAWVFLGEHITWLQLGGTALVMAGVLAVSLGRTPA
>fig|582744.3.peg.1091 Inner membrane component of tripartite multidrug resistance system
MNAWSLASMRRPLLRTRVQLRLCVLACARYARSLAHGISTLARALGMGATLGAREWWKLDAPIIAYVFKVLLASVLAVWISLRLEFDQPRTALLTVAIVMQFRSGMVLTKSYYRLIGTIFGIIASFLLVAMFAQERVLFLLSMTIWIGLCTAGSVIFRNHQSYAFVLAGYTLCIVGLPATLAPELTFNIGVTRLSEILVGLLCATVVSDLVFPQRMWNVTLQTVRRRYTDFCDLLRISAREGVAHATLQAHMLRFIGDIFSLESFRASSGLETDESRGHRHRLSHLNKEFMEVSTTFHAFSRLLQRQRNNSRAEVREALLQLYQWLADAVTVQYRSAQTEQETLEIVQKLKAFREDFSLRLQAARHRLPATLQTRDLLDFDTGAAYLLRLAEELYVYSRTYGSIATGSAPDQGHAEELPAQLEMHFDPLAVALAALRGSITLLILAGLWIFTDWRSGIEAITIGVITSTLFANSPSPSKTIRHFMAGAFIGTVLAYFSNFWWLTQAHDFWTLIIAISPGILLASWLGSRPATAFIGAGASVVYLLHIGFNTVFSASPVTFLNDAVADLLAILVSGTMYGLIDLSGSAWSRQRVSNALRNLVVAACRESTPLRRARFEASARDLVQRSGSVQRVGEAQDQVVVEWLFSALEVGHAVIALREQLPHVPVEMARALQHAIAQIASLYEEPGQAAIAHAAEAVDQALALAAPTAASEIPLHVRHQLLTTLHFVHSTLLDEASVLAFSPSTFASTSPAGGR
>fig|582744.3.peg.1522 Multidrug resistance transporter, Bcr/CflA family
MHKASALTLSFLLAGLAALAPFTIDTYLPAFHTLAQDFHTDNLAIQQSLTAYLLPYALMTLWHGAISDAIGRLRTIYIGLGIFTLASIGCAFATNVETLWFFRVIQGLSAGAGNVVARAMVRDLFEGVMAQRVMAQLQMMFGLAPAIAPIMGGWLLGIHWQAIFVFLALYAGLAMLCVQRWLPETMPPEKRRPLSARAVWQGYAQVFGDREYLKLVVAVGANFAGFFVYVLAAPVFLVEHLGLGPQQFGWMFIPTVCGMMLGSYLARHSAGRYSAHRIIRLGYGWMAMAAILNLLVCWLLPPQPLWNIAPIVLYNIGSALVLPNLSIAALDRMPKLRGTASSGQAFMQMVLATVSAGLLIPLLWHHPAGLALGMAGYLLLGFLATRASLVWQPIKPASQDK
>fig|582744.3.peg.2224 Permease of the drug/metabolite transporter (DMT) superfamily
MSLAFTYFCVLFAAIQWGANFNLAIPVVAEMPPVVAGATRYLLAALIMLTLTYIRGEHVPLRHARAYIVLGLVGVFGFNLLFFLGMQSTSAVNGALIMALNPLLTALIAWATIGERLHMRQWLAFPIGLLGVAIVVLGAGAHLEISHGDILIFLASLSWAAYNVCVKKMMPTDTSGIASTAAIMTVGALALTLVALLSGEQFVMPGQHAAIALLIMTIGGGVLAYLCWNAGIRRLGAGRAAIFLNLVPVTSMVIAAMEGVPPTTIQLTGAALVIGAVSFASWPRQQPTASPSAAT
>fig|582899.7.peg.2348 Multidrug resistance protein B
MALSDTASESTASKVLTASAVLLAVLMVILDMTVVNVALPHMMGALGATPDQITWVLTSYIVAEAIVIPTSGFLAARFGRKRVIFVSVAGFVVASMLCGQAQTLAQMVIFRLLQGAFGASVVPLSQAIMVDTFEARNRGKAMAIWGIGILLGPIMGPTVGGFITDHLGWRWVYYINVPIGLVNLAMILVFLKQTPKSRAVADWIGALLLAVGVGSLQMLLDRGNGDDWLQSNFIIALIFVSTFCLVAFAVRSYKRSDAILKLSLLRDHNLSTATFMIMAFGVGMLSTIALQPLFLEHLLGYPASTAGLVMAPRGIAVAMGMVFVATTINRFEPRWLVLIGLTLAAAGTYATTWYNLDVDVFWIAPGIVQGLGMGMIFVPLSTLAYQTLPQDATDQAAGIFNLARTIGGSIGIAIAATVLTRASHSNWQTLGAGIDPYNPALAQWQDATGLTVPDPSAMQVLALELSRQATMIGFLEAFGFVTLSFLLLIPLVLLLKKQGDAPRRSPI
>fig|582899.7.peg.3057 COG1566: Multidrug resistance efflux pump
MIAFLFNGYLFLLFLLVWFKVVPFNLFWKISPVLVMLALLVGLFIPMGWGAPSGQLVVGRHSVAITPDVAGEVVDVPVQPNAQLKQGDILFRIDPVPFEAQVKALEAQLKLSTQRLGQMTELVEKAAGRQFDVEQRRAEVDQLNAQIEGAKWNLEKTIVRAPADGYVTNLALRKGARVASLPLAPVMAFIDTSDTIVAAEIPQIYARYVMPGQSAEVTFKFLPGQVFTGKVETVLQAVSTGQTQVSGLAVTPKQVASAPFVVRIALDDPSLAASLPAGSTGDAAIFTDHAKATHVIRRVMLRMSAIMNYVNPY
>fig|582899.7.peg.3321 Drug resistance transporter Bcr/CflA subfamily
MAQLERGDTAPSPADSPQALHNLSFVEFVVLTAAMMALTAISIDIMLPALPEIGEALGVASANDRQLVVILYMVGFAAGQLFFGPLSDHIGRKPALMAGLAIFIVGTIAALVSNGFSMLLAARFVQGIGAASPRVIAIAVVRDLYGGRQMARVMSFAMMVFIVIPVLAPSIGQALIHLGNWHWTFYALLAMAILIAVWAGFRLPETAAPALGLERAMTLRASLKAAIFDPQTMAYGAAGGFMFGCLLAYVASSQQVFVEVFGIGEAFPVVFGAIASVMALASFVNAQLVGRLGMRRLSHASLLGFVGLSLCLAGAAAAGIAGIAVYAILLAGAFFLFGLIAPNFNAIAMEPQGHNAGMASSVTGSLSTAIGAMAGGLVAHAFDGTVFPIAAGFVACSLIATLIVFAVEGKRSFFGRNRLA
>fig|583345.3.peg.1946 Permease of the drug/metabolite transporter (DMT) superfamily
MRLHMSRQSLWIVLALFCTYFIWGSTYLAIRFGIESFPPFLMGGIRFTVAGAILFVVMRYLGAAMPAGREWLGAGTVGLLLPALGNGTVCYVQQTISSSVAALSIATAPIWMAVFSSIWGHKITLREWLGIAIGLVGIVLLNLGGSFEGDFTSALLLIFAAASWSFGSVWGKHLAMPEGLMGAACQMLVGGLALLLASAYAGESWPQEVSHKSWGALLFLIVLGSLIAYSAYQYLLKTVRPLVASSNTFVNPIVAFAVGIWWAGEHVTMVEMAALGVILVGVFLVLSVTNNKDI
>fig|583355.3.peg.33 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDGETNPSMLPGVIGWNEIITTDHAASVAFYTELFGWTSEDMPLPDGATYTIFKQGDRMIAGCVEPAEAGVPTMWMQYINTDDLDASVERVVELGGQVLKPRMDLPMGSFAVVADPQGASFAFWQNSPDVAC
>fig|583355.3.peg.98 Modulator of drug activity B
MQHALIINAHQRYEGFAEGKLNHYFASIIQEVLEAASYSVQVSQLEQGYDLEQSIAQHEWADLIILQTPAYWFGTPWIHKRYIDEVFTTAMSQNRLAKDDGRTRSDSSQQYGSGGLLQGKRFMISSTWNAPADAFNDPDQALLQGRSVDDVFYPVMASYRFCGATILPTFASHDVYKAPDIQADAERLKKQLRSIIST
>fig|583355.3.peg.166 Multiple antibiotic resistance protein
MLATCLIAGNQIMHFFGLSLEGIRIAGGILITTYGFAQLNPNPERHHSPAEHEEAMSKRDISFTPLAMPLLAGPGAIASTVSIASTIPREHVLLAYLSSLLGIALTCVLCTLILSQSSKLMRYLGVNGANALTRLMGFILLCIGVQLVIDGVLGLR
>fig|583355.3.peg.636 Membrane fusion component of tripartite multidrug resistance system
MIYAGVATAIFKIFKIPLNKWTVPTAILGGFVFLFFLLYWMNFNHPYAKYAKEVYVSVPITPAVKGIVVDVPIEPNVEVEAGTVLFQIDQTPYRNEITRLEAALEDAKQADIEADAAVRVAEAVLKEAEAERDNAKLSYERYSESAGVSEIEKENRYQTSLAAEAMYIARQAELNQTKLAAAANVQGLDTTVAQIQAQLETARYNLDQTTVRAPSKGMVTQLALRKGTYATPLPLKPALVFVPTERRRVVASFWQNSLRVLEEGADAEVAFDAVPGKIFTGKLVEILPYVPEADFQFGGSLVSSEYIKSHDRVAAIIELDEDLNDYHLPIGLQAKAAILNHSDKLHSSPVRRILLRMMSWLNYLYPIKK
>fig|584708.3.peg.322 Permease of the drug/metabolite transporter (DMT) superfamily
MNPSSRRAVLAADLSLFLVAVVWGAGFPFCAHLLEVLSPLWMVALRLSLSALFLLVLFRRRVREADREAWRGSLALGALMTGVFVLLALGLAASSPGKQAFISGTYVVQVPFLLWLLYRRRPSLFAFGGALVVSLGLGIMAFTPGMRFVAGDLYNAVLALGCACQVLAIGWLARRIDPLTLTTLHLAFAALFLTVLALLLEPLPSLALGAVAWGELLFVSLGGTVVAFLVQCTAQRFTPESHAAVIMSLESPFGYLIAVWLGLDPWSPRAVLGGLLILGGVLLTEWETFLRREAEAA
>fig|584708.3.peg.393 Permease of the drug/metabolite transporter (DMT) superfamily
MRSAETANLFRGRACALGAVLFWGVSFVAAKAALRELPPGLLVWVRCTLGAGVFTLAALLRGSELRIPRDQRLYLAVLGVMGIPFHLMIQSVGLLTVSASATAWILAVSPALVALLGWAFLGERLGAKGAGGIALAMTGVFLVAGGGKGPLGYTLGDGLVLLSALNWAAFCVASRRGLKVLSPAQMGWAIMVLGWIASFPLLALPGCDLTVLARLSPAGWGAALFLGVGCSGLAYALWYDALLVLPVAQAGAFQYLQPLVAVLTGWFLLGETPTWPLLAGGGAILAGVSILSRSGRH
>fig|584708.3.peg.563 Acriflavin resistance protein
MNRILRRNILAGLTALLLLVPAGSLGASETPADLSLEEALSLGLETNLEVARAKEELDKAEGLLTQARSALLPALSAVGSATGRNEDSSKPEREGTGSLALSQTLYAGGVIRAGEQQALLNRQKAQESLEETRETVALKVYEAFCGVLLRGENLKTAEDALGYYDKATKDLRKRLELGLSTRLDLSRMEQQRENARVDVITAANNLSAARIVLFTLLRLPPEAPTVVSGDLTVTAVSVDAPSLAAQALNRRPDLLALRTAAAIQKQAVDIAKAGMRPTVTLTGSYQFVYDSNPSSNTKDDDWIATLNVSVPLFDGGKTRGKVTQESAVLRQTEQSVSQKEDAVRAEVVDAGLTLNSAAEAVTSARKNLDLARESLRLAEVGYREGVDTQLDVLAARTSVTEARQKLSGAQRDHRVALARLWRSQGILVDQALKAR
>fig|584708.3.peg.823 Drug resistance transporter EmrB/QacA subfamily
MAFGAFMASLDGSIVNVSLPTIARVFRLGSGEAASVILSYLLSLSGCLLIFGRLGDVAGKRRVFLWGQGVFLLGSLACGLAPGLASLVAARFFQGVGGAMLTVSSYALISQVAPRDLLGWGIGILTTAVGLGATLGAPLGGFLTDWFSWRWVFYINLPVGAVSLYASHAYLQREGADRSPLDLRGLLRRFDVPGALFSFLGILLLVFGLNRGREEGWTSPLILGSLLGAGIALGLFALAERRHPEPLLDRELLGRRGFRVPVLGSLPGYLFIGGNTLLLPFFLQGAKGLSAQGCGFAMLLFSGVYMLLSGVGGRTSDRISPRILCAVSQVGAAGCCVLFASTLHVPGLLFPLLFLVGLGVANGFFYPPMGNLVLGGVPPEMRGSASGIFSVANRVCLTLGVCLYEALFSQWAPGGIEAPASALAGFRAAYLVAAALFVVGALWILLVPGKDALASTSPPSP
>fig|584708.3.peg.855 Permease of the drug/metabolite transporter (DMT) superfamily
MPIQPNPRPWQVLAADLALLVVAAVWGAGYPVSALAIRSITPLWLLGIRFAIAGTAMVVLFRRHLRGFDWRGAIPVYALSLVMALSYLLHIYALTLSTAAKQSFIAGTSVAMVPFVSAAFHRCWPSRVALAGSLVTSLGLSVLAFTPGMAFNGGDVLSLLMAVTIALHVVLCAACIRKHDALAVATIQILCGGMVFLLGAVLLEPLPDFRFTPGLWRSILFLALLATVFPFGVQCVALRYTHEVHAGILLALESPFGYGVAILMGQERLRGQGLVAGAILLAGVLLAESELWRGPSRERTEPEEAEEAAEEAG
>fig|584708.3.peg.1260 Probable efflux protein (fosmidomycin resistance)
MVLSGLHFINDLHASFLPTFLPLLIRNLSLTLGEAGTLNALFGGIHLIAQPLAGLWADRSARSLLVFWGPVLTLWGACLIPLAPTLPLAFLIVGIFSLGTAAFHPQGHGLVGAVVPGNELGGALAIFAAAGTLGAALSPLYAVALWDTPGHLGLVGVSAGALLIPLLCRGIFPRRTPGAGSQLPPFKQFLHVGRLVAPILALTIARDATSQGIRVFLPLWVTLRGGTLAQGGTLLFAYTLGGMAGGMVAGRLSDRLGTRPFLTGSFALAPALLLGGLVTQGGISWLLLVLGGAVLSSSSPVTTALAQKTTPESRSTASSLAMGVSWGLANWVTSPLGLLADAWGLNQALICIALTPWAFLALNPLVSRVSRGAPR
>fig|584708.3.peg.1569 Transporter, drug:H+ antiporter-1 (12 spanner) (DHA1) family
MKETWRMVATLGLGYFALFGVSNVYYLLPQYLSHAGVGSSQQVGWIVGAFYMATTFSRPFGGGLVRRMGFRRLFRWGGLLGIAGALGFALVGSYTPGLLLFRVILGVSQTLFVVGFTTYQGLVIPESSRGVAFSAISAGGILPLMTLVPLGDLFLQRGYDVAYLLVPLAAALGVFYLGERLPEQSLRGRGREGSLVGVLRNPSLRLLCLSSFCFSLGDACLVVLASLAQSRGVLVSAFFMANASVAAGIRLFGARLLDRLPRRHLAAPAMAGLALALFGCTWATGNGAMAFWGGVFGVAMGWGFPLHMALIADLATPEERPHASAMVWFAMGGSFALVPVLMGYGVDWLGAEGSFRGFAGFLLLLSLGLGVLWERDLRRHPGRPVPTGS
>fig|584708.3.peg.1814 Ribosome protection-type tetracycline resistance related proteins, group 2
MSGPTLRNLGILAHVDAGKTTLTERLLHASGALRIPGSVDAGTACTDDLEVERRRGISVRASLASFEWRGHRFNLVDTPGHGDFAGEVERTLSVLDGAVLVVSAAEGVQAQTEVLWEALAALGLPTLFFLNKVDRVGADLPGVLGQIRRLLTPRAVPLQTLAGAGTDRLLLRDLSDPGDPEAAAGLFEALADLDEDLMEAYLEGRTLPPEELLRRAEPHARKGRLFPLLFGAALDGLGVELLLDGLVRFLPPAGGDPEAPTSARAFKVVHDPALGRGVYVRVHRGTLRTRDALPLPGREEPGKVTRIRRAGAGRWEDVSSLEAGDLGLVFGLGEARAGDALGDPEGLPCGVPLAEPLFSVRAVPPTPEDAPRLLAALRVLSDEDPHLGLVLDRERQEMHLRILGPLQVEILTALLSDRFGLAATFEKPATLYKETLQEAAEGYVEYTLPKPCWAVLRFLVEPGERGSGVVYRSRVSTDDVKLKYQREVERTLPAALEQGLLGWEVTDLRITLLEGEDHEVHSRPTDFAIATPMGIFDALQKGGTRLLEPVLRFALAAPEEAAGAVLGDLLRMRGTFDAPRVEEGVFRVEGTLPAEPCGDYAVRLGSLTGGRGRFSTRFAGYRDCPEEIRAEAPRRSVSPLDRARYILAARGALG
>fig|584708.3.peg.1958 Glyoxalase/bleomycin resistance protein/dioxygenase
MGETPRYGGSVLLVGDLEASRRFYEGLFGMKVVTDYGPCVGFEGGLSLWLREAALALTGEGPVPRGGRDLELYFETPELDAFAERLRTAGVRWVQGVHEAPWGQRSLRVEDPEGNLVEVAEPLETLVRRLAEGGMGAEAIAERTSMALEDVRRML
>fig|584708.3.peg.2113 Permeases of the drug/metabolite transporter (DMT) superfamily
MTEGHRSLIRIHLAVLLFGFSGLFARLIHLPAWTITWGRVTFASLSLMVLFLLRGESLRMRTPRQTALALGAGVVLAGHWSAFFQSIQTSTVAVGTLTFATFPLFAAFLEPLIFRERLRLRDLTTASVLILGVAILVPRADLGDAMTRGILWGMLGSLSFAVLSLMNRSLVRDNRGTLVAFYEQGAAALVLTPLVLLRRDPLPLPDLALLALVGVVFTAGAHSLFIGGMRKVTARAAGVISGLEPVYAILGALVLLGETPSLRECLGGAVVLAAAAASSLRSARESGGSPSPAVSATLSPPWRLPTPPQGSPSPAVSATLSPNDPKEGSP
>fig|584708.3.peg.2136 Permease of the drug/metabolite transporter (DMT) superfamily
MTLAIILATLVLNVLANSFVKMGMTGFAGGVGGGMVMYMIRSPYMVLGVGCYGLAFVTYSALLTRMDLSVAYPLMTGCIAVTLAAVAVACFGESLTLWQMLGIFLVVAGIWLLAR
>fig|584708.3.peg.2260 Permease of the drug/metabolite transporter (DMT) superfamily
MGTETRPSRLLLLAAYGAIYGVWGSTYLAIRFTVRTLPPFLTGGIRFFLAGLLLYALVRPRTEAPTPRGWLQAHRIGFLAFFLSYGAITWTMVRVPSGVVALIVALEPLCFLLTDWFCFQGPRPVRMELWGLALGFGGTVLLLAGDPNVSFHGTGGVYLLGALAVLATSFAWVYGSLLTRTAPVHPDGVLAAAMQMIAGGSQLLLLGTLWGDWKHLGEASLLSVLSLAYLVVFGSLVAYTAFTWLLKVEPVSRVATHAFVNPVVAVFLGWLFGGERVGPETLVAGGLIVGAVVLTLWARKPEL
>fig|584708.3.peg.2396 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRHPDGHAPDSLRELQTQPIPRLLLRFALPALAGMLAQGLYNVVDRIYVGNLVGPSALAALSVCFPLTLGMLAFGMTLGVGAASRISLALGEGRVEAARETFRQTLLLAGGGSLGITLLTALGLDPLLRLCGAGRELLPLARTYLEILLWGVPFWILASCLNYVIRACGAPRYAMSVLLLGAGCNVVLDGVLMLGFSLGVRGAAWATAVSQVLSALWGLRFFLRDRGGLGFPRLAGGLRRQEVGAILRVGTSQGVVELSFMVFSVIFNRALRVHGGDEAIAALGVVLGWAAFLYMPAMSLSEAAMPLVGYNYGAGRPDRVRTTLKYALGMSCAFFTLVTLGVALFMDPMIRLFVWDAPRTNPRFLELTRQCMVSFNVTIVFTGTAIVTTGFLQALGRGGLSLLFTLVRELLVPVPLILLLPRLYGLTGIWITYPALDLLVFALACALLLREDRRLARREPVWEGVAPEAASGAKRPRSGSPLPQGRSCR
>fig|584708.3.peg.2412 Glyoxalase/bleomycin resistance protein/dioxygenase
MRASDDSPILGPLRLGVASVERSRDFYRAALGLETREVPGGAELFLPSGNLLATLEERPGAVPESPAVPGLYHLALRVPHRPALARTFLRLKEARLPTDGPVDHGVSEAIYTEDPDETGIEIYRDRSRETWPTRGGHLAMGSRLAPPQDLLGALAEEMEGPGSTPEMTLGHLHLRVSNLKRSVDFYSSLLPLKVTQEDLPGAAFLAFGDYHHHLGLNVWSSQGGKPRDPQRSGLIELSFLFPVPSAFQSWKDRLLSQGCPELLSVAPNESWLLVRDPDGWDVRIRQAS
>fig|585506.3.peg.1871 Multidrug resistance protein B
MNEEKVSSRVIWSIVAAAILGFSGILTETSMNVTFPELIQQFHQSMGTVQWLTTAYLLVVALLMLTSAHFNAILSKRQTYMIGWIAFVVGDIIAIIAPSFWLLLFGRLIMAVGTGFALPLAFNVIFTSVPMSQLGKYMGFGTLIISLAPALGPVYGGVVTYTLGWRAIFMIILPVTIISLLIGWFNLDNQKPTSKNKFAYGQFILIGISLVSAILALGQLESGRLTAAIIILALVAIVAMIGFIQAAKRSTNQLIDVSVFRSKALVMALLIYATSQAINLAVNFALPQYSQLTLGTTTMVAGFILMPGSLLGSAVAPVYGSMYDRLGANKPLTWGSLGFLVVMIIFSVMAPNIATIGLTVVYVVFTLARNLTFSVAMTAGVAEVKPQQSGDVNAIFNTVQQFIGAVGTTVAALFIQTSGTTKAAIATQTATGFSHLIWFSTVIVAISLIWLVIYMKTKTAK
>fig|589865.4.peg.53 Permease of the drug/metabolite transporter (DMT) superfamily
MISEQRKGELYLLAEEFLWGWFPIVTLLTYPYLAPLWSMGLTLAVAAVFFGLLMSKRLGSNLWRELGNRRAWKDLAWSSFYIMLLFVLLFTGLAHTTAGNAALILFLQVFFAFLYFNLLQGEKMSPPHLAGAALMSLGAFLVLFPGEAGLNKGDLLVLLAAMVAPIGNRYQQRARRHVHATTLLFVRTVTSLPVVLLLAWAYANPPALADLQATWWLVALNGVFLMGLSKIYWIEALHRLSVTKISAMTALSPLFTMLFAFFILQEVPGGWQVAGILPILTGGMLITRPLDPGEAVRGCRPGR
>fig|589865.4.peg.600 Acriflavin resistance protein
MKPGVLDKLHSRPRITLAAVVLVALIGMLAGSQMPRQEDPTLRDYWGQILVEFPGADAETVERLVTDVYEQYLQEVEQVSRLYSTSRAELAVLNLELADGTRDIEQAWDDVRLALERAEPRLPSGVARPQLNRDLNEQDSVVLAVAGDNDLLVLRQAARQLQRRLLQLPEVGKVHLVGDPGEQITITWDEEAVRRLGLDGRQLAALLAARNRVQGGGDLAVADSRLMLRPLSEFQSVAEIKQTPLLLPSGGTLPLAELAEVRHGPARPAETLMRLDGRPVVGLGVVPVSGGNIMAFGEAVRELVAAGAPEFAPLEIREMAFQPDWVRLRLSQLATSLLLGIVIVATVLIIALGRRPGLVVAAVVPMVTLTALGIYALGGGVLHQISIAALVIALGMLVDNAIVVTENIQTRLDEGKPPALAMRSAVREVAAPLAAATGTTLAAFTPMLIAQGPTADFTRSIPLVIILTLGLSYLFAILVTPLLCYYFLRPRAVAGGAGRQWRRLADGLGRVAVSRPRPVLAGAALLILVMIVLTPWVARQFFPESDRNQFTVVIKLPEGSRLEATSAAAGRLERELLALPEVAAVATFVGRSAPPFYYNLPRIPRSPNLAQLAVTAAAPGSPDQLVAWTREWARQQLPGTEVVVRKLEQGPPVIAPIEIRLFGTAPVEVTRRLDTANGPGRPGAYGQPALAELENAALQVMAQLNQIPGVRDLRHELSTGAPTKVFAVDDAAAARHGLSREDVALSLYGLSRGIAAGQFRGGDEPVPILVRSPEGEDYPAADLENILLLTERSGRPVPVPLSLVATAELQWRPAAIERQDRRRVAKVLAQLADGTTYSQVLDELRPRLEKLTLPEGVYWELGGDLEGTGEANAAMAAAAPLGLLLLLAILLLQFNSFRKVGIVLVTVPLAAAGVVPGLLLGGQPFGFMSLLGTIALVGVVVNNAIVLLAVAEQRQAAGLPTAAALQVAVSRRARPILLTTATTIAGMLPLAFSPSSLWPPLAWALISGLAASTMLTLLVVPALYLLLCKR
>fig|589865.4.peg.638 Outer membrane component of tripartite multidrug resistance system
MFRYSLMLFAILLAGCSLGPEYHRPEVAAPVEYRYAEGYEEIWQQGEPADELPKGQWWRIYQDPALNELQERAAANNQQLRAAVARLDQARAVAGLSRADLFPRLDLQPSAQRGRTADDLSPLGEGQTTTTINLPLDLGYELDIRGRLRRLNEAAAAEVDASAAEMESFRLTLHSEVARTYFTLLTLDRETALLEKTAQLRRQNQRLISSRYQHGLSDKLDLSRAETELAAAEAEVIMLRQRRSEVEHALALLLGEPASNFAHAANEAEEFQVPEVKPGLPAELLQRRPDVAAAERRLMAANARIGAAKAAFFPSIRLTGAAGFGSNELSSLLASGNRFWNFGPQISLPIFDGGRNRAQLEQARAAHEEALADYQQTLLQAMQEVEDALATLALLHQQQQAQQRALRHARETVGLAHQRYRAGLVSYLEIIESERSALTQERAALQTSNQQLQANIALIKALGGGWDSVQN
>fig|589865.4.peg.1273 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPKPEPSISLAAGLTELRQLWRLSLPLILAQLSHMAMGFVDTVMAGRVSPADLAAVAIGSSVWFPVMLFVAGVLMAITPIVAQLYGAANHDRIPTSLRQGLWMALVLGLGGFLLLGNMEWLLKLLDLEPEVRRLAAGYLSAVAWGFPALALYQALRSFSEGVSLTRPIMLIGFLGLACNIPANYIFIYGKLGLPPMGGVGCGWATALVMWVMMLALAGLILYGRGYRFLPPLFAWERPDFKKIVHMLRLGFPIGISFFIETSLFAAIALLVASLGAVVVAGHQVALNFTSLLFMVPLSFSQAITIRVGQAIGRREPAKARFAALCGALTTLTTAVLFATAILLWAPAIATLYTPDLEVRQVAANLLFFAALFQISDAIQVSAAGALRGYKDTRVPMFITFFAFWFVGLPLGYLLGLSEPVGLHLGAQGFWIGLVAGLTTAAILQSARLWHVSHPRNRP
>fig|589865.4.peg.1646 Acriflavin resistance protein
MNNQIQWMAHNHVAATLLLLFFAVGGLVFAFNVKQEVFPEISLDRVNITVSYPGASPEEVEEGIILQIEESIAGIDGIKEMRATAAEGIGTVTAVVDTGADVDQVLQDIKNEVDRITTFPEDAEQPVVSKALIRNEVISVVVYGPTTERALRERAEMIRDDLLEMPEITQVELAGVRPYEISIEIEEEMLRRHHLTLEQVAAAVRRASQDTPGGVLKTEGGEILLRTKERRYTGPEHEEIVIRAGADGALLRLGEVATIRDGFEDIDLISRFNGQPAAMVEVYRVGEQRPIEISELVRRYVERQQPAVAGTVIDLALWNDNSEVLQSRFQLLLKNAAIGLLLVLLILSLFLEIKLALWIMLGLPVSFLGALLFLPSFDVSINMMSLFAFIMALGIVVDNSVVVGESIHEHRSRGKERLRAAVEGTREVAVPVVFSVLTTVAAFLPLVYITGTMGKFIRAIPFVVISILMVSLVISLFCLPALLGRRDHASPPGPGLIGRLKGLHRQADALLQRLINGPYRRTLEFCLTYRGLTLAAALALLMLAGGLVGGGLVQFRFMPEVEGDIIRVELEMPQGTLVEETARVEAFIVEQGQRTIAEFDARRDDGSTILRHLYSVIGGTAANEGPGGGGGDSGTHLATTTLFLQPAEKRGLPASEVSARWRELVGEIPGVRSLTFTTNLVRFGDHIDVQLSHHDFTTLLAARDRLQADLANYPGVYDIADNFPEGKRELTLRLKPEARSLGVTEEDLGRQVRSAFFGAEALRLQRGRNEVKVMVRYPEVQRRSLSDLEAMTIRTPDGGDIPLLQAAEVIDGRGYAAISRSDRKRAINVTASVDDRLANAEEVLAALRQGPLARLVADFPGLSYDLEGEEKERRESMGSMGQGFILALFAIYALLAVPLRSFAQPVLIMMAIPFGIVGALLGHLLLGFNLSILSMFGIVALSGVVVNNSLLLIDRINRNRRRQETRVDGPGELDGLAKTAATREAVIDAGCRRFRPILLTSLTTFGGLFPMILETSVQAQFLIPMAISLGFGVLFSTFITLVLVPTLYLVLDGTRLPSQ
>fig|589865.4.peg.1809 Methicillin resistance protein
MSETDSEWDVFLAACPLSHHEQSSQYAANRKAYGYHCDRVVVRENGDIVGGVQVLVQSTPVGRFAHIQRGPLALDDNPLLMRRVVDKLEELVRERSYASVRVDLFPNQAVAAQALKEAGFRPSKAWGRAGDSVIVPLTLSDDELMGKMDKKVSYNIRRSRRKGLSVQAEDEKSMDAFYGLHQETASYQDFPVFSAEYFSYVQELFGRAGKAQLFVAWHNEKPCAAIYNTIVGDHMYYGWGGMRRDPEAKTLRANYLLHMTAMAWAREHGCRLYDFVGNQPFKRWFAIEVISWPLPLRKFYGPAQILRWKLLEGTDSSPLLRRLINKASRKFGIAQTMPW
>fig|590409.4.peg.3026 Probable multidrug resistance protein
MPGMTQWIISGFVLCLSLSQLFFGPLVDRVGAQRVLLGGCVVYALSALGVYLTSTISGFIALRLVQGCGAGAMAVAASASVPLRFQGAAIGKVFSLLNGVISLVPVLAPVIGGVLIVHYGWRSSFYALGLFALLCGMLVLWKPLPAVCCGTSEGKGRLSSAAPLNVFSGYLTVFRHPEFRLGCFAASFGFATQLIFFSSSPIVLIETLHIPVDQFGYYFAVNALAITTGSLLTARLLGRVKETVILHGGAVLILLAMAGFILTMHVLTVSVWPYLISATLGSLGFAVLIATGASIALSPFKSLAGQASALMAAIQMSFSSLVAWGVMNHWRDDWSPMIAAYFLLAVALLVQLQAHRLTRIRRHQPEPAVFEKSSPNSD
>fig|590998.5.peg.57 Glyoxalase/bleomycin resistance protein/dioxygenase
MRQDETFDGGWRRVVVGPPDGGTGLVLALAPDDAPVGRQAGADVAFFLETDDFAAQHERMVRHGVRFREEPRREPYGTVAVFEDPYGGAWDLIEPPSA
>fig|590998.5.peg.141 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDVRPVIRQVVLDTTDARGLAEFYRELFGLEYRHGDEPPPAGEPDPNGADWLVLRGDVPLAFQQVDALPASTWPDPGVPQQLHLDCTVPDKATLDAQHERALALGARLLHDRSDDPEEPLRVYADPSGHPFCLFVG
>fig|590998.5.peg.273 Glyoxalase/bleomycin resistance protein/dioxygenase
MPTITGPDFVALQVRDVDAAAHFYETRLGLRRAPTSPPHAVVFATTPIAFAVRAPLPGTDLASISPHPGAGVALWLRADDAQALHDELVAAGVVILTPPVDGPFGRTFTFADPDGYAVTIHDRG
>fig|590998.5.peg.562 Glyoxalase/bleomycin resistance protein/dioxygenase
MHVRVHRAFLPHLDPAASLALYRDVLGLEVREDVGSGSLRWLTFAPAAPSDEASGSGGAALVLGPPIASHGVTQAEHRTVRELMAKGVYATVSLATGDLAGAFARVEACDVVDLLQEPARRPFGGVDFAFLDPAGNVVRVVEAP
>fig|590998.5.peg.1906 Glyoxalase/bleomycin resistance protein/dioxygenase
MMLSDFDAIPVLAVTDLQRARDWYEGTLGFTSQGDAVEGVMYSTRTGGFLVYPSGFAGTNQATAISFQVPADRFDAEVADLRDRGVELQTFDVPEGTWQDGVLVSGDMKAAWFADPDGNILNVETGM
>fig|590998.5.peg.2309 Glyoxalase/bleomycin resistance protein/dioxygenase
MASTNSTLHPNLSVSGAREAIDFYVRALGAEVVSVIESGGIVVHSDLRLGGSTFTVAEPFPEMGSTAPDPEQPVPASFTLEVADCDAAFARAVEAGARAVSEPTDEFHGGRIAQLRDPFGHRWFLNQHLEDVAPEELQRRVDAWTAAQAPA
>fig|590998.5.peg.3424 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTARRPRGTLHHLELWCPDLAAAEADWDWLLRAIGCVPRDRWPAGRSWTTPDGSYVVLESGPDVVGTAHERRRPGLNHVAFVAGTRAELDRLVDAAPAHGWTLLFPDRHPYAGGPGHYAAYLEDARGFEVELVAADGA
>fig|590998.5.peg.3434 Glyoxalase/bleomycin resistance protein/dioxygenase
MAHGDITHIDIPADDLGRATAFYRAVFGWDAQEMPGFEGYPMWQAPNKISGGGFGPRDDKLRIPRSYVEVDSIDDALATVVAQGGRVVMEKSEISPTSWWAVFEDTEGNELGLYESDTHAEPQG
>fig|590998.5.peg.3573 Glyoxalase/bleomycin resistance protein/dioxygenase
MTIATTPHLNFRGDARAALDLYAAAFGGTTTVVTYADAHAVTDAAEADQVMWGQVVSPDGFRVMAYDVPSHTAYEPGVIPVFVSVRGADADELTRYWERLVDGATVVVPLGPAAWAPLYGMLRDRFGVTWVLDVAVPWDAA
>fig|590998.5.peg.3697 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVTLNPYLNFRTGTREAMEFYQSVLGGELNVSTFADYGMAQDPADADKVMHSQLTTPDGLTLMAADVPAHMDLAPASSISVSLSGDDEAKLRGFYDALAAGGTVLEPLTVAPWGDSFGMVVDKFGTTWLVNIAGTPAA
>fig|591001.3.peg.66 Transporter, drug/metabolite exporter family
MERRKKIGVGMVLLGATLWGSSSNSVEYLMVDQHFTWSAILFWRMVFTGISFLGISRFQKQDLLAPLKQDGKWMMKFILLGLYLMQVTFFKAIYYSNAATATVLQYTMPAILLLMYLVKDWRLPTRREVVAVVLALLGTALIATKGQGAALAVSGEALFYGILGAFGMAFYTAYAAVLLKKYSCFLILGWGSLGNALLLQLFHHPTLEGAVLDIHTAAAFGILFVLGTLVAYYVYLESTKYIPPAETGALAAFEPLSAYFFSVVVMGNRVGPVELVGALCIIVMVCVLTRND
>fig|591001.3.peg.68 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTRTTTKDMTSGNIPRLILEFALPLMIGNVFQMLYNTVDSIVVGNFVGTQALAAVSSTTMITNMSVFFFNGFSIGATVIIGKCFGAKDHGLLHRAVETTMAATFLLCVLFTVFFFTGTDFMLHFMKTPADVFDQAALYLRIYFAGVTGLLLYNMGSGVLRAVGDTKRPLYFLILTSVLNIFLDLLFVLVFHWGIAGVAYATIIAQFISAGATLAVLLRTRDVYRFSFRDLCLDGNLLGQIFRVGLPTAIQSIITSFSNIFVQSYINFFGATVMAGWGCYNKLDQFIMLPVLSMAMAATTFVAQNIGARQEERANDGTVSSIVLSLAITGTIAALLFIFADFSLRLFTGDEAVIRSGVDFIHVNIFFMMFNCVNQVLAGALRGRGDSMGPMVIMLLSFVLVRQIYLYIMTRYISNTPLTVGFGYPVGWATCCVLEVLYFWLYWKHKEG
>fig|591001.3.peg.758 Tetracycline resistance leader peptide
MFSMELEHLARNAEYGIPMTVEMEKEAETMCDYGRGLARKYAEKGRAEGLEKGLEKGIQQERNSNILGMLREKIPMETIARITKVSVEQIRELGKLNGML
>fig|591001.3.peg.849 Permease of the drug/metabolite transporter (DMT) superfamily
METALKFFGGMFHPIQITFLRFLIGGLVLMPMAFSALKKKNVQLNGQDLKFFLFSGFLGVVVSMILYQMAIVYGKASVNGVIFSCNPVFVVLFAYFLLGEPIDKLTIFSLMASFAGIVCIVNPVNMTGSQLSIILILLSAMTFALYGIAGRKHAQRYGGIAMTSLSFLCGSLEMLVLIGISTFAPVRDLMLSLGLKVFTDIPILGGLTAAHIPPLAYIAVGVTGLGYASYFLAMEYTDPATASLAFYIKPILTAFMAWLVIDEPITVNMIVGIALILFGSCLSIISKRKKAA
>fig|591001.3.peg.1060 Permease of the drug/metabolite transporter (DMT) superfamily
MTKNQKAIFCMLLAGVLFSLTEVAMKKINADLNGVQVNATRYFLCGVFLMPWSRARLKATDTHIHAAQMKLCALLAFSGITIVGPLYQMASATLGAGNTGVIFSSTPLFIIMLAALLLHTPVTRREGIALALQVLAIAILVDPFHMTMEPVGVAALLVCVVCYSLYAVGGKKLITDLGSITVTAWSFFWGGVQLLLVAGLSHIPAVSQWLMAHGFANYACVPLFTGYTWENLPWVLVLYIGITLVAFLSWFLAIEWGGVALGSLTYFIKPALSPLFALIFAGEPITTKMMIGMVLMIGGAFVALKR
>fig|591001.3.peg.1239 Permease of the drug/metabolite transporter (DMT) superfamily
MLQQIPALWVLFIRYALSSVILLAAGYHTLQGRIAIARKDWGELFFVGVVGYFLSNAALFLGIQYSSASFASLINSLTPVVISGLAIILLGEKVTKLQGLSLLVAVAGAGIIIGRPTQGVTTAGMVICVFALFSWAYATIHLKKLTARYDPLLVTGYGMAIAALLSLPSAWVFVRATGAAVSFTGTVWMPLLYTCLVCTALAHLLWNELLQKLPATYCASFYPLQPLTSMVLGVLLLGETMTPSLITGALCIVAAMVLNTLAARRTRNRS
>fig|591001.3.peg.1295 Tetracycline resistance leader peptide
MPDNDLLFPVKFLNIQIRSLQYQSFEKTIDLRLEGKSIRLKEGSWKAWIRKSILSKVWIK
>fig|591001.3.peg.1322 Permease of the drug/metabolite transporter (DMT) superfamily
MCEKGNTMDQMKGNLLLLLTALIWGSAFVAQSVGMDYVGPFTFNAARNLLATGVLVPVVLAFGGVRQGSLWQRLRPDAVTVKAGLCCGVIMGVASNLQQVGIAQTTAGKAGFITALYIILVPILGRFLGRTVRKILLLCVPMALVGFYLLCVTGDFTISFGDFLVFLCAVFFALHILCVDHFLLKGASGVRVAWIQFAMTFLVSLLGALVWETLPAAGLGPALWAARWPLLYTAGLSSGVAYTLQIVGQKYTDPTTATLIMSLESVFAVLAGWLFLGEVMTLREIIGCGLVFAAVLLAQR
>fig|591001.3.peg.1405 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKDMTRGPIVPIILHFLFPMFVGNVFQQLYNMADMIIVGRYVGAGALAAVGSTGTLMFLVLGFALGITAGFGILTSQRFGAKDEAGVRRSVANGTLLALLLSAAMTLLSTAAVPWLLDLLNTPADIMEDARAYITIIFQGLFTNVFYNMASVFLRSVGNSKAPLFFLVFSACLNVGLDLLCIIQFHMGVAGAALATVVSQGISVLLCILYIVQKVPVLVPWREDWKLYAHETREQLRMGVPMALQFSITASGIMIAQAAINLFGSTAAAAYTAASKVSMLLTQGCLSMGQTMATYAGQNFGKGDLGRIREGVKKGLRMMALYSLLAAVVLHYLLPFLTGFFFSGDVDAAALLPWARTYGDIAMWFYLPLSMIFIYRNAMQGVGYALAPTLCGVIELAARGLTALVGMKTHSYAISAACDPMAWLAAGIFGWCAWQWVMRDLERRAKKGAAA
>fig|591001.3.peg.1707 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSETTLAGTGTFRSRLKKILGVMIPILITQLCITGMSLFDTVMSGHAGTVQLAGVAIGTNVWMPVFTGLNGILQALTPIVANYRGAREYHKISGAVVSGLALACALALTVIGAGSQLLPRILDTMSLAPEVRTVAFRYLGFVAWGILPLFCASILRSFVDTLGYTQVTMRLFLLTMPVNAAMNYIFIFGKLGAPALGGPGAGVGTAITCWLLCLSFSLLVLRLKVFRDFHVFRISGFSFSHVREHLRIGIPMGLAIFLETSFFGVECLLVSRFGTIAVAANQAAMSFCNMLYMVPLSFSLSLTIIVGAYVGARDFVQAKAYADTGRLSNILIGAFFGCVLFLGRGLIARLYTEDPNLMEPIMHFLTFAVAFQFFDSTAAPIQGVLRGYKDVKATFYSALAAYWGIALPFGLFLDHGLHKGPDGYWLGLITGIFFSAAFLSLRLRYMERKKRETV
>fig|591001.3.peg.2015 Tetracycline resistance leader peptide
MTVEMKEEAETMCGIGHAIARKNLEEGMQKGLQKGRLEGKQEGIALVQRELLLNLFSSGMPVEQISAGTKVPVSYVRKLAEKAGK
>fig|591365.3.peg.126 Daunorubicin resistance ABC transporter ATPase subunit
MTDISISNLKKVFHGKVVLDIPQFTASKSEIISVLGVNGAGKSTFIKTISGLLLQDEGQVNICGYSNFSPKIHQVTKFVLESGKGYYDYLTANQNIDYFLKLNKASRSDLALNIAVLFQKLDFQQHADTLVSELSQGTRQKLSLIIALLCRPEVLCLDEPTNGLDVIAKKQLAQILLGLSKGKNTIVLLTTHDISFARDISSRVLVMDNGRIKKDDSFEHVFSRKNTWKKYEIVLPLSFQNIIERSFQNLHYVIQDEEMIIQTQEKDVKDRLLKETDIVRFEEIEQDIEEILYEVLSK
>fig|591365.3.peg.241 Glyoxalase/bleomycin resistance protein/dioxygenase
MTRKEELTKKNQELLFLGYHHIAFRLGSREKVDELTTRHQEDGYQLLSRPRLTGDGYYESCILALEGNQIELTV
>fig|59196.3.peg.220 Outer membrane component of tripartite multidrug resistance system
MLGSLSACLVGPDFETPQPPKVNHYTNPPWPCRTVSAPGQGGASQTFVQCKTFSAEWWRLFHSPKMNKLICQGIAKSPNLMAAKATLREAQENLSAGIGNGLFPSVSAQLTAQRGSNIGFFSPSTVASNAVTTSGISQAIFNLFNASVNASYLLDFFGGIRRQIQGLRSQVDYHYFELRAAYLSLTSNIVTAAITVASLRRQMDVTQQLIKEEEKQLAIMKKQFGLGGVSKIEVLAQQTQLAQTRATFPPLKKNWEQARHLLAILVGAFPSQQGVIPRLDLKELHLPTTLPLSIPSALVRQRPDIRAAEALWEAANAQVGVATANLYPQIALSGSWGKSNTVGGRIFSSGGQLWNIGGGLFQPIFRGGALLAERRAAIAAYDAAAATYQEAVLKAFKNVADTLRAIEADARTLRVQKQAELAANAHLNLVKQQFYLGGVSYLSLLDAQRQYQQVRIRLIQAQASRYMDTAALFQALGGGWWTSNCLF
>fig|59196.3.peg.960 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MQLPKELIKNILSIYGPIGREWLDSLPHLLSQYAKKWQLIIKDCFNNASFNVVAEVILDNGHSAILKCGVPSKEFINEVAALQHFSGRGSVKLLDAEVGVGVMLLERLIPGTLLEEIFDETQRIVASVELIQKLHRPCQETTQFPSLADWFQGFQRFYHYFQGETGPFPKSLIERADAINQELLASMESPVLLHGDLHYGNILLSDKYCWLAIDPKGVIGEREYEIPFPRLKDEVNEKLIKRRLDQFIEISGFDRSRVLGWAFCKAALAAWWSFEDQGEICQSFLQCAEIISTF
>fig|592010.4.peg.1894 Vancomycin B-type resistance protein VanW
MRKKKLIIAVYSVLVVLIVATAGLAVTVSALSSKQEGVICEGISVNGIEMGGKTEEEAEKLLSDYTNRVKSKELVVSVTENGEEQGSESISFKDLGVKVKSNNIVDEIVQIGEKGNIIDRYKAIKSAKENKPEYNIEFKYDSKKVDQFIKSIAEKYDVVPENATLRREAGKFIVSGGKEGRSLNQKEAFASAKAVVEGYLNELPGKIEDETNVELALETKKPKYDKEALSKVTDLLGSYTTRYNPSGGRGQNVANGCRLINGSVVMPGETLSANNKMAPYTVQNGYGMGTAYVDGKVVPDMGGGICQVSSTLYNAVLFSELGVVQRFNHSLTVDYVELARDAAIAGTWKDFVFKNTTAYPVYVEGITNGGQITFNVYGHETRDMAHRKVELSSVVLSRGNGSKAQLYKLVYENGVLKDRILLNTSTYKPHEYEIEAAKKKAEEEKKKKEEEKKKKEEEKKKKEEEKKKKEEEKKKKAPAESEDPNIDDDLEEEIEG
>fig|592010.4.peg.2471 Multidrug resistance ABC transporter ATP-binding and permease protein
MYQSNEQRFSDFLKPYKASYIASVIMAIFSVFFGLAPYYILYNLLVGVLSEFTYKNIITGSLFILIAFTLQLVCHSLSTAISHKTAFKILGQIRIAITNKMLRLPLGYIQMRGTGHFQHMLIDGTERLEFPLAHAIPETTSNILIPIGIIGLLFTTNFYLGLAVLLPAVLTLLFYLPMYVGIMNEFANFYYLSLERMNGRVIEYIRGNKEIKIFGQESRAYSKYEKSITDYKDSTLKLYYKMYIVSAPAMVFLSSILISVLCVGGYLYAHKDISGQVFLFSALLSMGIGSSLLKFTEFMDNFYHIRNGKNLINEILSAPELEEMDSENNILNNSIELHNISFAYEKENVLQDISLVIEENSKVAIVGPSGAGKTTIANLLARFWDVTKGSITIGGVNYKNLPLSYLTSKISYVTQDTFLFNTSIMENIRLGNLSATDEEVKAAAAKAQCDDFIKELEQGYNTIVGNDGTKLSGGQRQRIIIARAILKNAPILILDEATAYTDMENQNKIQESLMSLCKNKTLIIIAHRLTTVTNCDKIVVLDSGKLDSVGTHDELLRNSALYKKMWEIYLSEIPAIQEKEGE
>fig|592022.4.peg.433 Membrane component of multidrug resistance system
MTQTEEKMSKRSKLILFILILGNFLCLISETVMNVALPSIISDFHVRTSSAQWLTTGYMLVIGISVPVSAFLIQRFTLRQLFVTAMSFYLIGSFIGFITPWFSLLFVGRMIQALGTGIVLPLVMSTMLTLVPVSKRGTVMGIFSVAILFAPAIGPVLSGLIIQYYSWQIIFLGLLIAAALIFLFALFKLSNVSETSRPTIHMPSVILSTIGFGGVVYGFSAAGEETGWSNPIVWLTLIIGVIALALFVRQQSKLNSPMINMKPFRSSVFSRSIFLMFLIMMIQFSMMLILPLYFQTAAGLSPLQTGFLMLPGGVTLALTAMVGGRLFDKIGFKPLLLTGLVLLTIILSLFTTISSGTSTTTAAILYAAFTIGVGLSIGPVMTLALNQVPKPLHAHGSAISNTINQVSGAIGPALYTSIMTMASQHFIQQSNETNKTLLQIKSMTSGVHTVYYVAIAFAVVSFLLALTLKKKDQQLETQ
>fig|592022.4.peg.955 
MLTKIVKCSIPTDKKASFSYTQQHWAALAHVNGFIGQLGGWNVEDETDACILALWEDGTTYQEFMKHTHDSIFYKSKQDQTYTNLDVSTSDPSYFIGARYNYYRSSAIESRYLVKTEIEVDFYDKEDIHEMVKSLINPSYRCLSHVVSPIEHSKLVIFSLYGSACPQKTIDTFVHPNVLNASQYIYQLEKNWNVLSN
>fig|592022.4.peg.997 Acriflavin resistance plasma membrane protein
MSWLTKWSFKNKAAITIMSILILALGVISYFTLPMEFLPTADQPQVSVVVMGQGTDADSMEKQVTSPIEEAVAGVKGKSNVYSTTGDGYSKIDISFESKTDMKEAKTNVQEALSSVQLPASVSKPNVIQLNTSMIPIADISLTFKEGLTRDNLDLAEKKLIPKYKDVKGIASVQTYGTADSYVSIKVDNKKLSQKNVTIDKAISVLEGKNTSLAVGEKVINNKSSNINVTGKIDSLDKVKKLPVAPNVTLGDLAKVEVKKPEGVVTHINGKDALLLIVTKDSHSNAVSITKEVKKLSQQINKDYNNVNASVFFATGDSVQNSVHSMMKEVLLGALFATIVIMLFLRSVRSTFITIVSIPLSLCFTLFLLSKSGVTLNILTLGGVAVAIGRLVDDSIVVIENIFRKMQKEEFSLGLIIDATKEVGSAITASTLTTVAVFLPIGLVNGGLQDFMLPFALTLTYSLLSSLIVALTVVPLMSAGLLKNEKLRKHKQPVRFTKVITWSLNHKWVVLLLSLLLFVGSIGAYTMMPKGAVDNSSSDFVGTTLSYPNNTPIKTVEEKSLQLERYILAQKEVKEVYMQLGNTDEGAKWGDVGSPTEATYTIIVKDSGNTDSLMKRIQNQKKLYDGGDLSVSAASLMGASTTSITVDVIGNDMNKLEKTASSIKKEISDIKGVDKVSTNQDEKKTIYSLDVDPTKANAQQVAQQLGVMLNKTPIGAIDLEGKQANVLLESVLNPTSPKELKDISIMTETGPSPVSKVASLTQAEKPTNQFHKNGDPYIQVTADVNPEKLSEINKDIQTTIFGDGKNKGLSISKDVDVVIGGASTQQGEDFSDLFITMLVSIGIVFLIMVITFKTIRTPFAILFSLPLAAIGAVLGLLISRIPVDVTALLGALMLIGIVVTNAIVLLDRVKQNEKKMIMRDAIVEAAATRMRPIVMTSAATICAMLPLLFKQSESGSLVSQSLAVVVIGGLAVATLLTLVVIPVVYELLHFRKSKKQRIQQKQQENVTPL
>fig|592022.4.peg.2406 Multidrug resistance protein B
MLILYTFGMAVVMLVIPVLSTITQVYIIQVIMGLLGALQKTAEKIALSRQTDRAHTGKQVGHYHLWTSIWAALAVIATGYIIDFLTIGSLFYITSFMYVAAGVLIWQKPKTVELERHHSL
>fig|592022.4.peg.3679 Permease of the drug/metabolite transporter (DMT) superfamily
MDTMIAKQQESLTTRKVRRGNGLYISASVIAVLLWSTSFVGTKIAYTSFPPLTLGAARFVIAAVILGFILLIRKDKIKPSFKDIGLMSISGVLGTTLYFSLENIGVELTTASNAAIIVASYPAITVLMEFLFFRKKTSRVKAIGIGVAMIGVYQISYSPETQTDDKQLIGNIILILAGFIFALYNFTTRKVVKKYSMITISFYQTLAGAITFIPLAFIEKSSWQTPDIRSFLTLLYLGVFCSVIAFLLYNFGLRKLSSSSAMTLMNLVPIFGVLFSVLLLHEVVGINQFIGGIIVLLGVVLSMRETRKKHVLENK
>fig|592022.4.peg.3836 Multidrug resistance protein
MKKEKLFANSSYKKLFISSTGASFGDLFDMFAVMTLFTYVWHANSLWITLIPVAYALPSILLSQAAGNLADRYDKVQLMFLSELVRLLFTCLLFFTNEPLLALGVLTLRSMGSVMKVPAQLAYVREVVKEDQLLQASTLQNIMFQIAKVVGPFLGSAALTITTPKACILVNAAACMISIGVLFSLKKAGKNIQGQAARSSHQVKETYSNGWKIVFQHSILLRAVILFHLSYFVVMLVDAQISIFLRDVLPHHPEMLGWLLSGIGLGALATGVYLNRKKQVHHPFRLLSLGLLLFGGALFFISCFNPAVMSRYFILIAAPIGGAGVGLNLLLTISFKHTATRNTSEKCTDSLTP
>fig|592022.4.peg.3837 Multidrug resistance protein
MYGFINTLTSAVLLTAPLLGGMLVKLAGAQTTFLTAAIIIGSVGFVSMLMPLRDKRERNIQIDA
>fig|592022.4.peg.4461 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRPFVKPLVYGLIGLGVIGFAFTLITDPAVLLRQAGYIFLFIILFYLVYRFILRPSQTKGQDRGYVRAVKQSKLRQKEKERGSNKVDMHTYRSSNKRPVSKSTKPLKKKKNNSHLTVIEGKKGKKKNRAFF
>fig|592026.3.peg.187 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHNMTTGSPLKRIINFSIPLLIGNIFQLVYNMVDTFIVGRTMGRDALAGISASSSVMFLILGFAQGLTAGLTIPLAQAFGARDFHKVRRSVTIAWTIALCVSMALTFLSTFFLRQILEIMMTPPEIIQYTYDYLIVIFSACTVTMLYNLLSNMMRALGDSRTPLYFLIIAALTNIVLDYVFIVNVGMGVAGAGFATVLSQAVSVVLCLWAIHRRWPLLQVSWQKAMLVAEEIRYHLNMGFPMAFQSSIIALGSISVTVALNQLGPLAIASYGAASKIEQIVILVLMSFGIAMATYVGQNFGAAQFDRIRQGVRQMTFLSVGVALVSGVILALTGAQVVTLFAEGSQGLEMAHYGQVFFYCSAPAYWLLALLFIYRYTLQGLGDSLIPTIAGIMELTMRMSAALILSQYLGFVGPAIASPLAWLGACVPLFLAYHHHKHHLQERFNQKLAQN
>fig|592026.3.peg.429 Drug/metabolite transporter (DMT) superfamily protein
MTALWKGRLYTILGAASWGLSGVCGQYLMQTAQIPARIVVSIRMLLAGLIMTTYLLACQRPQLKALSQDKRSLVQLVIFALFGIVLCQLTYLEAIGASNAGTATVLQYTSPILVIAYVSLKTRQAPTGQLLAAIALAILGTALIATHGDITSLSLTPAGLSWGLVAAVGYALYTVLPADLLQRHNATLVTGLGLLLGGASLFLANQTWTYPIDWQPLTILAMAGLVVVGTLLAYTLFLKGVALVGPMEASLLGASEPISAVFFAFLLMSEHFYLIDLLGMVLIIAAVVWVSLHPKAAPHPVND
>fig|592028.3.peg.289 Permease of the drug/metabolite transporter (DMT) superfamily
MKYRLLLLLAALIWGFAFVAQVIGMDSIGPYAFNGIRFLLGSLSLLPIIYYYPSGRNPKEASFSIWVAILMAGILLCGGATLQQVALQYTTASKTSFLTATYLLMVPVIGLFFGQVLRLNHIFGVILAMAGVYFISITETLDIGYGDFLVLLCAICYAAHIILLNYLTQRFPPVTLSSGQFMVVGICNLILAFFFETVSISSILSSWWPILYTGILSTGVAYTLQAVGQKYLPATEATMLLSLEMVFGGLCGVLFLNESFTGKQLIGILCMTAGVFLAQIPSRTILPLKK
>fig|592028.3.peg.478 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKIGLYSDMKKLLSVTFPILVAQLSTMGINFINTTMAGHAGADDLAGVSVGTGIFFPFEGAAIGLLMAGTPIIAQLIGKNEKSSIPFVVRTGIYIALALSMLLFAGYFFFADEVVSSMGLTAEVEYIAKNYIFAMVVAMVFISLIIPLRSLTDVAGSTATSMKLFLSALPINAVLNYFLIYGHGGLPRLGGIGAGVSAAITYFFVLLMFLYVIHSDERFMGKEIFASGKSRFCDWKEYMSVGIPSGLSVFMEMGLFGAIIIFMARFGTETLAAYQVADNFANMAYMVPLSCSMALTILVARAAGAKDHALARRYAKAGILMSVGFSAAEVLLTTIFREQIGLVYTDDAAVIAIASQFLIFASGFQFFDSISAPVQGILRGYKDAKVPFILLLAAYWGACFPVALFLDHQLDMAAVSYWIGLDVGVAASAVFMAIRLFTLESGFMENTAAVSLRGRLSLEPAYDNGVYRVKAEVLTGIKIIWQYCREIGNNLFVPQEKIVEIRGHVLTGIQRKLIGHAARAYVP
>fig|592028.3.peg.1701 Glyoxalase/bleomycin resistance protein/dioxygenase
MRISKLDHLVLVTSDLSRCVSFYRDLLHMEVEEKDGRFALRFGTSKINIHTCPGEFQPAAERPVPGSLDICFVTEEPLERLLDELKEEKAPLVTDIVERHGALGKMRSLYLRDPDGNLVEIAEYRKGGQHAYHQSG
>fig|592029.3.peg.2232 Vancomycin B-type resistance protein VanW
MIRKLVPKSLKLQWQLFKRARSDKQSGFYKNLGAHKGNTSSFHHKVSVTQPIKNNAGAINKIHNIKLSYQQMEHLIIQSGEYFSYWHVVPAPIAKNGFKKGRNLLAGKLQEDYGGGLCQLSGMLYIAALKAGLEITERHHHSIDIYTEETRYTPLGSDATVVYGYKDLRFTNNLNQAISIELEFKENSLTLHLISDQPFVEQEISWNLVSQTDFKVVETRNSNGEVLGVSRYRV
>fig|592031.3.peg.90 Nitroimidazole resistance protein NimB
MFRKMRRIKQQITEDECIRILKENPRGVLSMIGDDGYPYGIPLNHYYSEDDGVLYFHCAKTGHKLDAIKTCDKVSFCVYDKGYRKEGEWALNINSVVIFGRMKLVTDEEKTREICINLARKFTDDEEYLEKELKYSLPNVQCLELIPEHITGKLVNES
>fig|592031.3.peg.251 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYAENKMKALETGGSNLKLKFSKFILPTLFSMCFFSIYTMIDGAFVGRGAGNMALAGVNLSMPFISFVFALSIMLSIGSSNIATFCLGRKEYKKASLAFSRGIEAILLISILIVALGLINLNHLIRLLGASYETAPYVKDYLKIIIPFIPFFMISYTLEVLLKADGNPHLSLFFVTLSAGTNIVLDYIFVIRYNFGIEGAAVATGISQVLAVAGYCTHFFSKRANLKFYPVKLKLHGILSAAKLGFPDFLSELSIGFVTFVFNIVTIKYFGSYEIASLAVIMYTYNLVVNAMTAINQGVQPLVSFYYGRRNHENIRKLYKYSVFSAATLGIIFVGFVYVFPNLITSMYISPDSGYLYGFAIDSLKIFCFTFLILGINIVSAGFLNATRNTGKSLIISISRGYVLISLLTFTLPLLFSRSVIWQSAGLCEGITLVISLMLIKKYLPSCDGRYSN
>fig|592031.3.peg.329 Permease of the drug/metabolite transporter (DMT) superfamily
MKHLKGNLLLFVTSLIWGTAFVAQSASMKHIGPFTFNFIRCSISILCITPVMLMSFKKYKLTNSNAAPSDHTGLYKRISDRCDNLYDKEKSIKFKHVIVGIICGTALFIAMSLQQKGMVYTSVTNAGFITAMYIVMVPILNIIFKRYPRPITVLCVIAAVFGLYLLTVPENGGFSAVNKGDVYMIISALGFSVQIIAVEHLAKKLDGVTISWVQFIMCALLALPSIFIFNENVNLDSILAAKVSILYAGALSGGLAYTLQIVGQKDTEPTIASLIMSLESVFAVIAGIIILHESPTTRTLLGCAIMFAAIVISQIPSKKKNDKLTV
>fig|59374.5.peg.417 Permease of the drug/metabolite transporter (DMT) superfamily
MVLAAFLWGSTFVAQIEGNDVGPFAFVCMRNFIATGVLFGLAKVLDKFNKSPRKPKTKEENRALWIAGLFCGLTLFFAMNLQQTGLFLGCSAGKAGFLTACYIIFVPILSTFFGKKISPKIWLCVAITLEGLYLLCIKEDFTIQPSDIILLLCALAFAAHILVVGKYGPYMDNVRLSAIQFLVVATLSIFPMFFVDLKGSFAGFGTVIEVYSHFKPWIPLLYAAILSSGVAFTLQIVAQNKLRPTIASLLMSLESVFSVISGWVMLGERFTLQEAIGCVLMFTAVILAQVKIRRR
>fig|59374.5.peg.874 Membrane fusion component of tripartite multidrug resistance system
MNALKMIGKVVVVLALIVLVIMGISQLQQFATQPREQFLQGQMEARRVLVAGKVPGRIERLLVHEGDVVYKDSLVAVISSPEIEAKKMQAQGALGAAKAQASKARNGARSEDITALKAMADRAQEAATLAKNTYNRVQKLYNEGVLPLQKRDEAETQMKATQSAADAARAQYNQAVAGARSEDKAAANALVMQAKGANAEVDAYLEETKIRTPITGEVSLKLAEEGEVVGSGMPIIAVTDLNDSWAVFHLREDYLKNVSKGKKFYLQVPALDKTIEMVVSYIASVGDYATWRSSKESSGFDLKTFEVRMRPTHKVENLRPGMSVLLPADDIQ
>fig|59374.5.peg.880 Fusaric acid resistance protein
MNKLEDLLDNFWNTHKNNAGVAYVYTHKLSIAWVACVVFAVMLGFIYQGKAAMFRGIAESSETIISLPSPTEIVKIYVVPGQEVKPGDTIVVINRPDLTLRVAELTRELDALEGRSNLSSAEIDQKVAEVKANLESRRLTLLAEIRNLEAEYESNKAISAKLKSLSNSKSKADGNDAMAMRIKSLKNELAVATRSANEQIALLRGSNKLQKSSGKTEAANIRKELAELRKQQKELTQIAKENWVVGDVNVRDGEKVSSFAPIVTLAHKSPTLIRGYINEQIYENTNLGEAVKVTSLTGKGKAVIGEVVGLSSRIVPFPTRMWKMPEIPVYGREVTIKIPEENQFLLGEMVTITETSKRNLEKQQQKAKK
>fig|59374.5.peg.945 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDCVLKKYGSLSIEAKASLWYLFCNFAQKGISFIVIPLYTRLLTTSEYGTYTVFQSWRDLILIFATLNLSAGVFTRGLVKNDGSNDKYTAQMQGLSSAVAVLTFLIVLLFFDPFRRLTGFDEKLVITLFVYYIFNPSFLFWSVRQRVENKYKSMVAITLLASLLVPAISLLMFFLTDIRANALIYGFLYVQIAVGMLFFVKQFVDGRAFFSKVVWWESLKFNIPLIPHYLSLIVLAQSDRLMIDHICGTSFAGIYSLTYNIGQIILIVIASINGSLVPWMYKKLKSGEYHSIAVTSNMLCILLGLMSAIVMLLAPEVVFIMGGSEYMPAKWCIPPVVMGTYFTFCYGLFSTVEFYIGKTSYVAVASFVGAVLNVILNLLFIPKYGFIAAAYTTEMCYLVFMVLHYFFMKKMTKERIFNIKKMIVICSAFFASSLIFTFLYDYDFARWGVAVLVSLLVLFKRRTFMNMIKGLREK
>fig|59374.5.peg.1102 Permease of the drug/metabolite transporter (DMT) superfamily
MKPAPIKDFESSANASRGLALWHVLAIGTIAFWGTSFVSTKVLLNHGFSAVQIFTLRFTVTYLLLLAMTHKQFRCENWKHELILCLCGLTGCTLYFWAENTALSISPSSNVSLIVCTNPLLIMIFGGLIYKSERLVKRQIFGCVITFIGMVLVVLNEKFILKLSPVGDLLAFGSSCMWAIYSLIVRPLNYKYSTLFITRKMFFYGALSSIIIMLGETAIAPNEAGAGRFLGVPWQNFAEPVVSLNFLCLTVFSSMFGYLIWNKVLKQLGTVLASNYIYAIPLVTIITAVIALGERITSVAIAGAVAIVAGMVLAEWKPRK
>fig|59374.5.peg.1934 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEDVINNKKLNAMGTASIPKIVLQFSVPAIISMLVEALYNIVDRYFVGQGVGSLGIGGITICFPIALFIMAMSMMVGVGGNTLFAIRLGERKYQQAAIILNNSFVLLIIMAVSSFTLGQIFMEPLLKLFGASDQLLPVASSYMRIILCGAIFQTIVPGMNHFIRSMGHPKTAMTRVMIGAGSNVILDWLFIMKFNWGIEGAAWATVLSQFIGGLAVMQFFVKKTTPIKVNRRYMKLRLPYVRKIFILGLPPSIMQISNSLVNAILARSLTSYGTRDLPIVNGMTGGDQAIAAFGILMSIVSMIVLPLMGFVTGSQPIIGYNYGAKYNNRVRDALKFTMLYATAFIVIAWILMMTNTLAFVAPFVPNDQNMQQLTCKALRTFICMMPFVPLGMVSGNFFQGTGKAWRSMFLNACRQLILLIPFLFIMPRFFGLRGVFMAQPIADFVTAFIAIIMLRAELKNIPRI
>fig|59374.5.peg.2385 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFKTFLSRKFFSLLLSSTIGQLVITVLTLSDSMIAGVMLGEDAVAAICLVVPAYSLAGFWGCLVALGVPIIYNRAMGEFDKKKADRCFAFGLFMSLLMGVILFVTFMVIGDAYLRFYEPSSIVFGAAKDYFFWYKFTFLLLPLYTLMYVMVLADGDETLSMVSGIVQIVGNIVCSIVLVKFIGIAGIGLGSFIGTVAAILVSFAHLLRQGNSLKLGFYFSFRWLIDVVKYSAVDAGSYLFLAFYIAVMNRFITFAYGPEMLVLGAIVLFIKEIQVLFDGVGESFSPLMNIYLGEESYDAVKKCYRLSQKTAVVEGLALTLLLLLLAPYVVKLYDISDPLMFSYAVGGARIEVLGLVFLSLLYLLSSYYLLIDKIKLGFMMSALRDVLVVTPVCVFLGYFFGVYGMFAGIAVSPVLAYVISVLYIRIRYGAENYPLLLADKLKGFKHKFYELKLDPASIVKTQQQAEKFLCENGVDRKIVSKVKLLIEDIYMLIYEKNGADKAVYAECTVIIRETGVQIITKDDGILFDLSSDDVIAGSIVEFMVSGYMEKLKENKKYLTTMSYNRNTFKVNNEVRV
>fig|593907.5.peg.1658 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTPTDPQTAVSGPRTDDVLDAATTMDAVTLHVGDLEGMTSYYTEALAMEPLEERSRGREVHRVLGRGTTPMMRLVHTPDLPGVDPHQPGLFHTAFLFDDQPGLAATVYRAAQDPRGRFVGSSDHAVSEAFYFADPEGNGIELYTDRDRSLWLHARGQILMDTTYLDPNEFLRRHLTQDALDAGPALAGRVGHVHLQVGDLARAEAFYVGALGFEATMKEYPGALFASAGGYHHHVAMNVWNSAGSGPRAATLGLADVAVSVPARDDLDALAARLRARGLAFADDGRAITLRDPWDTHVTVSLPATTTQELLAR
>fig|593907.5.peg.1704 Glyoxalase/bleomycin resistance protein/dioxygenase
MERVLGIGGYFLRADDPAALTAWYRECLGLDAEAQELWRQDAGVTVFATFEPQSDYFGSPDQRVMLNFRVRDLDAMLAQLRERGADVAPEVQDMEGVGRFGWVTDPEGNRIELWQPA
>fig|593907.5.peg.1855 Vancomycin B-type resistance protein VanW
MRRERQWRQDGVVAHPDRAEPDGFAHHVAAHRTPIFRELAGVDRRLQENKAVNLVIAAGRLDGLVLRPGQRMSFWRLVGKPTYRRGFKDGLVLRQGQVDEAVGGGLCQMTNLLYWMTVHSPLTVVERWRHTYDVFPDNGRTQPFGSGATCSWPVLDLQIENRTIATFRLSLGVERTDLAGAWTSDQPPQHTYEVYEAAHVMTNDLPGVFTRRNVLRRRVFDLAGVEVADELLAVNEGRLMYQPFLESGAAG
>fig|593907.5.peg.2940 Glyoxalase/bleomycin resistance protein/dioxygenase
MTDDTARTAGAPSPVRQLRLVVEAADYDEAVTFYRDVLGLPEQAAFEGDGDARVIILDAGRATLEIANPAQKRMIDDVEVGRQVAPHLRVAFEVDDAVATTRALTDAGAQELAPPTRTPWQSLNARLDAPAGLQITVFEELESLDARSGRPGFGTADTRD
>fig|593907.5.peg.2947 Glyoxalase/bleomycin resistance protein/dioxygenase
MPFASIRLVTDDVDRLVAFYERVTGEVAERPAPVFAQLGGPRAILAIAGTQTVAMLGGAVTPASNRSVLVEFEVDDVDAEVARLQPDPQDVVLPPSTMPWGNRSALIRDPDGNVVNLFSRPPA
>fig|593907.5.peg.3143 
MRLSGHLVCADHDEARVVAEHLPAHVALTHDEPGCLAFTVERTGDPLVWAVQERFTDEAAFRAHQARVAASDWGRATAGIERRYVVDGLPAGPG
>fig|595494.3.peg.238 Permease of the drug/metabolite transporter (DMT) superfamily
MNQSDYLTGLLLAILAATGFACKAIFVKLAYRYGVDGTTLVTIRLLLVLPLIATMRLLRKSPATALSWHDRGMIILLGLLGYYLSSLLDFLGLETVSASIERLILCLYPTLTVLLSAWLMKTSISRRMWSAMALTYCGMVLVLTPDFAGARLDLLGIFFVVASTVTYAFYLTWSPAVIRRIGAMRFAELGLTISALAMFVHYLLTRPVETLLHQPLPVWGYGMIMALVATVLPIYALAAAMARIGAGKTALIGSVGPILTIFLSIGILDEHLSPVQWAGVCVVLTGIWLVGQRKT
>fig|595494.3.peg.410 Permease of the drug/metabolite transporter (DMT) superfamily
MSPIFVALTPILWGTTYFITGRYLAEWPALWLSVMRAIPPGLLLLAIRPAKVPWRQVPYLLLISFLYIGAFFPLLFISALYLPGSVAGTLAATLPLVLLGLQWLFLHKRPSRQALICALLGLGGIILLLGPGAELNWIGVGAALTSVLLIGICSLLLQQRPWHGELISFTGWQLLLGGLMILPLAFWVEGAMPIPAGDDWFGLLWLILLNSALAYVLWLWGMANLPLNRLGLMTLLNPLTAVMAGSILMHEALSYWQWLGVLTVFASLLLELLLRPKRYPAAA
>fig|595494.3.peg.1729 Multiple antibiotic resistance protein marR
MEPLAESLGFLLGHTNLLKDRLLDKHLEPEDITAGQAKALFNIYRFNKNRPSDIGKSLGVDNSAITRMLDRLEKKELIKRYPAPEDRRAQLIELTDKGNETIERAMPLAKDAIAELTHALTEEEKSQLKHCLRKILASSGCAFAKEHYSVPDPSSESQE
>fig|595494.3.peg.1730 Outer membrane component of tripartite multidrug resistance system
MRRYFLLSSLTLVVLLSGCASPDDIRPQNTLFGNNVLTHSKSLTTDALSSANWPQQAWWLDFGDQDLNALIAESLKNSPDMQLASARLNQANAQVATADSQFDPTLSADANMSRARFSRMEDPLGEGNRYSTSRSLGLTFNYNFDLWGGKRAAWEASVNNQKAAEIDQQAARIALSTGITQTYIQLANAYALEDLAQKDFDRNQHIVEITDRLFKNGLTSEDRLYAAQSGAASAKQALKQRSLVVAQLKNALAALVGTGPDRALSIARPDVSVQADFHLPADLPASLISHRPDITAARWRVEATSKQIDAAKTRFYPDFNLTAMAGFKSVLGDAVFADVSRSWNVTPAISLPIFTSDLKANLLSKTADYDAAVAQYNQTLITALNEVSDNVLALKSFEQQLIDAKESMELAEKSYQITEKRYQAGMGSQLEVLMAEQQLLQAESAFTALKNQQQESQIQLIKSLGGGFLASQPPAAVKDAQNS
>fig|59748.8.peg.125 Multidrug resistance ABC transporter ATP-binding and permease protein
MKRVLKYLKVFKVQIIISIFLILMVSTLSCLIPFLEGKYITNKIKEASASTPPDTKDAIKTQIFHFLYLDLFFCFFVVLCRLIFNKLLIQSIHKSMRNLRQDVQKKIHYLPISYFSQNTLGNIISRLTHDIEVISNCLQQSFAIMIDAFLKIFMVVIFMFHLHWFLALIVFTMIPLSFYSTYRVFKSSQKIFIQRFESSGVYNGFLQEKYTGYKEILLYNQQKNTIKEFKTHNTNLQKLVFKSHFLSGLSSPIVSFFVYLTLVVASIAGFYLIDSKQHFLNLTLPILQVGLFHTFIQYIWRLGNPIVELGHMSVLLQSANAASKRVFSFLNETEEAPEAKKPIVLTDPKGQVVFENVFFSYNNRDMLLKNINFTAEKDQTIAIVGSTGSGKTTLINLLMRFYDINEGSIKVDGVDIRELKKDNLRKIFGMVLQETWFFKDTIWNNIKYGDKNASDEQISKICKQAQIDYFIKSKPLEYQMIINEEADNLSQGEKQLITIARTFLSNPKILILDEATSNVDTRVEILLQKAIKELVKNKTAFIIAHRLSTIVNADKILVLNRGEIVEQGTHQQLLANKNFYYRLYQSQFQK
>fig|598467.3.peg.545 Outer membrane component of tripartite multidrug resistance system
MISEARWPQEQWWRAFGDGQLNQLVDEALAGSPTLRGAAARVRQAEAMQGMAQAQLLPHMDANVASTRQRYSENGTTPAVMAGTWQTVNQGTLNVGYELDFWGKNRAAVEAALGRSKAMEVDRYATQLMLSSAIVQAYIELQQGNEQLAIERQMLKQQEQVLSLTQQRFTAELDSQIDIKQAQAAIPATRARIAALGESMELSRNRLAALLGKGPDRGRAIAAPQLKRLDTVTIPSNLPAELLGHRPDVVAQRWRVEAARHEIEGAKARFYPNVNLSAFAGYQSLGFDQFTEAGSRILGIGPAISLPIFEGGRLRANLAAQNAAYDIAVEDYNQTLVDALHDISDQLSSIRWLRERIHQQQQAVQTADDAAKLVDQRYGAGLATYIQVLTTQSDALAQRRQLVQLQSRGLALEANLSRALGGGYVPDLPLDGAKE
>fig|598467.3.peg.2845 Permeases of the drug/metabolite transporter (DMT) superfamily
MLKTTGTAESEQQKGLIGIAMIVAALQILPFSDIMAKYLSLSIPIIQVIWGRFFFHCIITGIYSAVAYGPRYLAPNLSAMLLLRSTSLFAAVGLFYVTIHYLPLTTSLTLWFVEPFILTLMAALILKEKVTAYQWLAIFIGFVGIVIAIRPTIVEWHWAYIVGLLAGFFYALFLFFTRFIDNKIPSVVSVYHTGLVGGVLASVTVAPYWVAPTPSQWLLLVGCGAIAAIAHLLIIKSFELANASTIAPFTYSEIIMGAILGFIVFADAPDIWLFIGLAIVVGSGIALTKIKQSLPKSSAVNGG
>fig|598659.3.peg.834 Acriflavin resistance protein
MKRFIEFFIKKAVFTHVLFLIVIISSIIAYKNVAKELFPPATLDKILIQGAYPGASPKTLDKMAVTQIEDDLKSYQEVSSIESVIRNGSFTITVNLKPNANKLELLSEYKTITSNLKKDLPSDMNEPSVTIAKKAFPLMFISVASNVLNKDELLNHADNIKKILSQIKDLTQIDIRGDSDKNIYFELNNKKIEALGINKSQLINVLSQVSTIFPVGKIEGSTHYFISMYSKNVNDFKNMIINVGNIKVRLKDIADIKKKYETPTQIGKYNGIPNITIDVRKGESGDAIAISKKIRNILKNYHLKHPEITFGISTDTSKWVRNRFNTVVSNIIFGLILVFFIMWIFLNWRISLVVTLGIPTSFAIAMIALDYYNFSLNLLSMLGALIALGMIVDEAIVVGENIYRHMQMGKSKTEAAIDGTVEVFWPVVAAAMTTVLAFLPMLLIKGEIGVFIKILPVMITILILSSLFEAFIFLPLHSKEILKVEESKKDIFWQKFSLFYKNLLKYFFKFRYIALFFFLVMVPVLIAIGMKHSKFQLFPDFDASQIYVNGKFESNYTITQTAKAIKKIEEDLKKYVGKDVEGFTTVVGMQMNNKGEANVGENYFHIFVDLNDKKPTDVYNKYIAPIFQPIKVENQIRTHTAQQLSHMFKKDFADIKIPGMVELNVIVPQAGVVKSDIVISIGGQSQEKIIEAIKKLETVMKKIKGVYNIYDDAELGADELKLKINSYGQKLGFTQVGLFNELRGFFAEAEFDKTFDKDGIVKIILKDKNKDSFNELKTFRVTIPGTNRYIELNKVCDFIITKAFKKLHKYDGIAAKTVYATLNKKIITTADFYVKVNPLLKEFKKEGLIVIIGGAAKTSKEFIKDLKEALVVAILLIFLILVLMFNSAILPFVIISVIPLSFLGVIIGNMIMDMNMTMLGMIGIVGLAGVVVNDGIVMIDFIKKAKNLDEVLEYASHRLRPVLLTSITTFFGLLTLMFFPSGQSAILQPLAIALGFGLAWGTILNLFYLPIFYYVLRRKHLHK
>fig|608534.3.peg.2 Ribosome protection-type tetracycline resistance related proteins, group 2
MERLVIGILAPVDAGKTSLSEAFLYRGGLLRSPGRVDHRDSYLDTERLERERGITIFSKQAVFSIGEKTITLLDTPGHADFSAEMERALSVLDYAILLISGTDGVQGYTKTLFRLLESRGIPCFFFVNKMDRPGTDRAKLLAELRESFGSEILDFSSALSEGEGELMPEPADFPSLPPELLESLSLTEESAMEEYLSSGKLPLSRIQELFQRRRFFPIFFGSALKLEGISPLLLGIFFLMKEPSFPASRGLSARVFKISRDEKGRRLSFLKLRSGKIQKRQELLPGEKITGIRLYSGAGYEELSEAEPGMLVALTGIRSLYAGQSIGEEGEESRSSSEAVLEYSLYPAEGGEEEIRELYRRIRELSEEFPELHLSYDSELPEIRLRLMGEVQTEILGELIRERFGTEVCFGEGRILYRETIGRIAEGVGHFEPLRHYAEVHLLLEPLPRGSGTELRTLCPLDTLSGEKQRQILELLSSEEFPGVLGGFPITDLRISLLSGKASEKHTDGGDFREAAIRALRQGLRRAESLLLEPWYRYRMELPPESLGRAMTELSKRGLEPASPEIRGESAFLSGEGPLSSLFSYEREFREMSRGRGKLSMDFLGYRGCPEERELLSEWGYDPDSDLRYPSSSVFCLHGNSRIIPWDQVEKYMHLPPYLERERREEESGEGEGTRRDPEEGFRKAGHYIGDQELEEIFVRTYGPVRDRAAEAEAAGKRTSFEKTRAENLRREREIREEREKKGAPERGEEALIVDGYNMIHAFPALREIAEENLDSAREKLLERLSNYRAYSGKNVILVFDAYRLERHPVETALRSGVRVVFTKEAQTADQYIEELSRRLSEEGGRVEVASGDRLVQLIAWSGRGVSILSAADLERELERVEEEIRREHLRFDSAPRGSLSGRGILPDEKS
>fig|608534.3.peg.6 Permease of the drug/metabolite transporter (DMT) superfamily
MNRRSRRKVLGFCMLFLTAAIWGLAFIAQRDGADYLGPFSFMAARNWISLAAMSPLSFLLYRKNLRQRDGAGRGREGLLALFAGGAACGFFLCMGGAAQQYALPMSTAAKAGFISALYVVWVPLLGLFLFRKKEGMRTWIGTGLSIVGLYLLCMKEGLRLGMGDLMLLLCAFLYAMQIICVEHFIRKAEGIYLALLQILASAFLSTILMFLLERPTASDFWAALPSLLYVGIFSGAAGYTMQIMAQAYVDSTIASLILSLESVFSAVFGFLLLGQSLSGREILGCAFMLAAILFSQLPGIGTKEELSSAG
>fig|608534.3.peg.873 Teicoplanin resistance protein vanZ
MREKRMTRNRWLGLLLFVLYLSLLFYLMFFSEMQERGVLVKPDYTYNLVPFREIRRYFLHGKQIGFFGVLLNLWGNILGFLPLGFILPIFSRRCRRHWYNTVISAYLLSFSIEAAQLLLRAGSCDVDDLILNSFGAFLGYLLFQLVQRLRELRRLWTSREDRA
>fig|608534.3.peg.1469 Vancomycin B-type resistance protein VanW
MILGALAAILVFCVAGVLFRGLFSHAGKRESTTAETTAFDPNIIHEDLYLDYSAFSPNAELLNMKGMTKEQVEDTLKKSYSWGLVVKNSNPNLKSFTMPALPSETTTAASAGETGADNEGTEEVVKVKDSLSGITIQPDKTQFLVPDLIEENISSFVAQIFEDYTKKNEESSSESSTEETKKAKKKKKGSTEESSESSSAPSADYVLQLPDFSARITDYMNQLALVWNMAPENGDIVSYDANSGEFVFGGTVDGYSVNAQSTAAKLMDAIERKAFSEAVDADGETVPASLSSIKDKYKIIGSYTTKTTANAVRNKNIKLAAQTVNGTIVKPGQEFSFNGTVGQRTEEKGYGGAPAYNAGEVVEEVGGGICQVSTTLYNAVFRSGLTTTYRRSHTFAPNYVTPGMDATVSWPGPDYRFVNGSRHAIGIRASYSDQKVTVQVYGIPVLPDGVSWELTSEKLKDLPVPNPQIITPDQGSESKGTAGSEWQAYKIITKDGKTEKVKDHSVTYKGHPPKQYAGSAAKASSGSQGASESPSSSESSASEKTSQQDDKESKKQTQQGEKESKESKEGKETKSESKAETKSDNKGTVGPGSDIISNDGPTVGSSSSDSIISDGPPA
>fig|608538.3.peg.1732 Acriflavin resistance protein AcrE
MRRYIKYIGFLVVISLVVLWLAGVFSHRERTFEVEKKAKTVEGLKIGKVERAQEVQVGYVGNIVADHVAEISTRVAGKITSVRVKEGQAVKKGQILLTLDASDILAQASAVSEQVKQAEEAYKSAISNYEAVKKTYERYLSLLKENAITQQEFDQIKAQYDAAKAQVEQAKAGIRAAQFQRKAVVSNLDYTTIRAPFDGYVAHKKVDMGDLAGPGTVLLVIERPPYKLEVNLPEKYVGRIRVGDVYPVYIDALNKTVQGRVSEVSPSVDPITRTFRVKLSLESGDLKSGMYAKMLISEKLSVILVPESAIFRRFDFTGVWVVKPDNTLELRFVKLGEKRGNMVEVLSGLSGDERIVVDGIEKACDGCKVGG
>fig|610130.3.peg.385 Vancomycin B-type resistance protein VanW
MKKKTLSMSLAAVIIAAGIGFLSPTYVMADTLPDGIYVGEYNLGGMTEEEASQKIQSLVNEMENQKVTLIVDGQPVETVAKELGFHWSNPEAVAQAASSWQGGNLIKRYLNKKDIEKNHVIIPLETALDDGKVAAFVAEKCSQAMVEPKNATIVRDKGAFIVTPSSIGKNVDVAATKQALDAALANGLKEPVTATAVVSEVKPGITTEDLSTINDVLGTFSTSFSSSGASRSKNLQVGASKINGRVLMPGEILSGYECMHPFTLANGYATASAYENGQVVDSVGGGVCQIATTLYNAVLRAELAVDQRQNHSMVVGYVKPSEDAAIAGTYKDIKFSNNYSTPIYIEGYTSGKTLTFTIYGKETRPANRTFEFVSETLSVTDPGAPKEVVDPAMPPGSRKQVQSAHRGMKSRLWKVIYVDGVEQSREILHTDTYNPSKAIIKVGPAAPAVAVPAETPGVPIETSPAAPPPETTPAVTADPGPGAVEMPGEIPPEAGPGV
>fig|610130.3.peg.579 Acriflavin resistance protein
MGITKGVLKRPVTTILVVLCLFVFGLSSVLSSKMELTPEMNFPMLLISSVYPGANPEDVNDLVTRPVEEAVGTLSGIKNVQSSSQENVSIVVLEYEYGSDMNKAYSDLKKKMDNLDLPDDVETPSVMEFNINEMPVVTLAVKDPSQNNLYNYVNDKIVPEFEKISSVASVGMSGGQKGYVSVRLIPEKMNQYHLTMNSISQAIKAADFTYPAGNTGVGKRDLSVSTGVEVGSVESLKKVPVVAGDGKTIYMEDIADITSTSESQEAIGRYNGEDTITLSINKQQKNSAVDVSKSVTRTIETLKREFPNLDIVVIDDTSDQITSALNSVKNTMVMAVVISMIIIFLFFGDIKASLIVGSSIPVSILVSLILMAAMGFSLNVITMSSIVLGVGMMVDNSIVVMESCFRSQKGTGFREYMQAALEGTGVVLQSILGGTITTCVVFIPLALLEGLTGQMFKPLGYTIVFCMLASLLSAITIVPLCYSRFRPVEKQNSPMGGLVKALQNGYRRIVDKLLNRRAAVMIVSVLLLISSFVLATRLGFELMPEVDQGTITVTAEIKPGLKVEEADKILKKLEDIVTSEEDLKSYMVSYGGSGLSFSGAKNGTLTAYLKSDRKLSTNQMVNKWKKAMNQLPDCNVTVESTSSMSRMSRMSRMSSKKDFEVILQSSQLDKLKSVSKQMVDELTQNPQLIKVHSDLENAAPVVKVRVDPIKAAAEGIAPSSIGSLLNGMLSGTKASTMDVAGQEVDIKVEYPEDSYDTLDKVEGIMIPNSSGGSVALTDIADIGYEDSPTAINRKNKQYLVTITGSFTDVVKTAKDKEAAKKNIDETIVNKYLNDMVTRAKNSEDESMQEEFSSLFKAIATAIFLIFIVMAAQFESPKFSLMVMTTIPFSLIGSFGFLAAAGVAISMPSLLGFLMLIGTVVNSGILYVDTVNQYRATMDKRTALIEAGATRLRPILMTTLTTVVAMIPMAMAIGKNGETMQGLALVNVGGLTASTILSLLMLPIYYSLMSGKTDKNLLPD
>fig|610130.3.peg.728 RND family multidrug resistance secretion protein
MKIRLDGRKKILCFLAAGILLALAIGRTALKSFRGAPVETAAASYDTVEDRYTEEGTITAGGEYRLVSDVSGPVKEVLVRENDGVKAGDVLFTIDDKDLLHEKSLCESTLAGYKAKLEQSRIGQVMASSPQEYLDSVRADVAVKEADYQAAKTLSDASQSLYSAGSISKIEWEKNRATYEYATLAWEQAKGRYEESRRFLESLKAGGIDETTINGRFYESVEEQLKAQIKSQETTMEQLEDRLKKCVVAADRDGIITSLPVADISYIQAGETALTISGRGKVQIESDVLTSIAPYLSPGDKVTVVLQLKNQDKIYGGTISQVYDYASKGTSALGMDEYRVHVKMDMDEDPDLEGKEGYGANIRFTLYQGENKLVIPSSAVFEVDDSNFVFVIKNGKAEKLPVEVEYKTASQTVIKEGLTKGQVVIDHVDSEAIYEGAKVYAGS
>fig|610130.3.peg.997 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKSNLLEEPVKKLFLRYLMPSISATLVTSIYILADTLMIGRGVGAIGIAALNLLLPLYSLFFGTGMLFGVGGGVLLSISKGKGDEHGAREYFTSALYMAALASVFYVASGHLLFDSVTKFLGRNETMDPYVREYGRILISGAPVFLFSSLLQSFVRNDRAPKTAMAAVISGGVTNVILDYIFIFPMNLGMAGAAAATVTGTCLTLAILLVHLFTRGSSLKIVLRVKGRKAGEILVNGLASFLLETCSGIVMFLFNRQLLAYVGDLGVVVYGIISNSALIVASINNGISQAAQPILAMNYGAGKTERLKETRRMGELAACFAGVVFAGAGMLFPALVTEAFVKPGDEILAMSVPAVRIYFLSFLPMGFNILFSTWFQSVLKPGNALLICLMRGLILSSVLVFLLPMAMGVNGIWAVMPAAELMTLAVCFILLKKQKSVLPENF
>fig|610130.3.peg.1236 Glyoxalase/bleomycin resistance protein/dioxygenase
MIFVKNMDESIQFYHEILDLPVNKRFGGIKGPEIAFLGDSETQVELVCNPEKLDGIYGSNISIGFDVVSVDNLISDLQKKAIPIYDGPYQPTAKLKFFYVLDPNGVSIQFVERHH
>fig|610130.3.peg.1258 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLESIQNNKIKTILQFSIPSIIAMMLTSLITVTDGFFIGNYVGKEGLAAVNLGLPIVYLYLAVGLMVSVGGVAIAGMALGSKDIKKCNSVFNQTMCTAMAATILLSVIVWLCLDTMLHILNADVQVAGFFTDYYGIMLLELPIMVINASFGMFIRGEGKPQYFMLVNILNVLLNMLLDYLFVRWFGLGVKGIAAASLLAAVVTLLCILYFFTSKSSVYKFGRFTFSGDVLGSTLLNGSSEFVGEMSMSISMFAYNYVILKNIGVDGVTAFTIVGYICYIFSMVIIGFGQGASPLISFTYGSKEHFLAVNLRRITNFMVLTAGAVVLLLVLVGSGWYSSLFVKSVVVEQMVHSGVIIYAVSFLFSGINTISSFYFTSIGKAKESAIISSARGLVILLICIFTLPPLFGMTGVWLVSPITEFLTLILSLFFIGRESKYLSRKLVQS
>fig|610130.3.peg.1764 Transcriptional activator BmrR for multidrug resistance transporter
MKDFLSIGEMSSLFGLNIQTLYYYDSIDIFKPRMREMKNGRRKYEFDQIYELATICYMRKLGYSLEEITKQRSTQHAGSALESLKQRSEELHRQWKELISIDEAIQRKLRFIEEEMNQIHTDEITIRHFEDRAYLVIGEEESLYRQNSFYFYPTIAFYQGEEKYFGAYLYPSEEPLPDHVRKDQIRRIPSGDFLCGYHLGSYETVPATIERLRNARPDLDFEDLTINFNILDQFVENQSSGYITHTQIRILKP
>fig|610130.3.peg.1836 Vancomycin B-type resistance protein VanW
MNQIDNRQRGGGRAYSSRKVSSKSASEASRRTGQAYRTGSPYQQRRGKKRRKGPQYNITKILLAIILAVASFICIMAAVKLMGGSRAKETEVNTTTVSDPELRKEVKVEGITITGMSREEAREAIEKQYPWGMKVTYNQEEYKLKNLMDKKVDALLDEIYSGEPKESYTLDSEGLEEAVQAEVKAVAGKWDVAPKNGSVSGFDKNTGTFVYSGEKNGVVIDQEKLAADIMSQIKAKDYQAVIQASGKEVAPKITEAQAKEMYKVIGTYTTTTTANSDRNKNIELASGALNGLIIQPGEEFSFNKATGERSPAKGYRPAGAYLNGELIEEPGGGVCQVSSTLYNAVVFAGLSTTERHAHSYEPSYVTPGEDAMVSYGGPDMKFVNNSSTAVAIRTSFANRKLKISIVGIPILEEGVTLSMTSKKTAELDAPAPVYEEDQTLQLGEEKIVKAETKGSRWVTNLVTKKNGVVVSDELLHNSTYRGKPATIKRNQSGVVIPATDPASSAAESTPAGSQGTAETTAPHNNETAGNSGGTQGPGTTETQPSQTQGPTSATEAADGDGGQNVIPPNPFN
>fig|610130.3.peg.2026 Permease of the drug/metabolite transporter (DMT) superfamily
MNKQAGKGIKALSAVGLVITTIIWGSAFVVMKNSVEVITPAYLLALRFTIASAALVAVFWKRVRKICKTDVMCGGLLGVFLFVSYFFQTYGLQYTTASKNAFITTLYVILVPFLHWFYNKKRPSGNNVAAAVIAVLGLGLLSLEGNLSVNIGDVMTLICGFFFAFHIVFIDRYTEDHDPIALTVIQMVVAAMLSWAMAPLLEGFFDFRVIGSSMMISLLYLGIFSTMLCFLLQNVGQKHLSPNTSSIILSFESVFGLVFSVIFLGESVTLKLAAGCTLMFASVILSEYKRKSSAKS
>fig|610130.3.peg.2171 Ribosome protection-type tetracycline resistance related proteins, group 2
MMKITFGILAHVDAGKTTFSEQVLYREGVIRTLGRVDEKNACMDHDNIERARGITIFSDVAGINHGDDTYYLIDTPGHTDFSSEMERSLEVMDYAVLILNGNDGIQSHTEAIWSLLERYHVPVFLFINKLDVASSSYERVLTEVHKHFSPNILDFQGIGLENGKEGTFTDDFIENVSEWDEGFMDKYLDGALAFEDLKPAVVSQIKNRKLFPCFGGSALKGEGIEAFLNAFYNLTEASYPVSDPFSGRVFKIRYDGHGERITYLKILSGILHVRDPLLADEKVHQIRFFQGERFTSHQEAAAGDVIAVSGLRTTRAGQGLGECRNKVVPTLKPTLQAKVLYPPEIPHRRILQVFHILEEEEPALNVIWEESLGQLKVNIMGKIQLEVLEQIILERFEIRITFGQPEIIYQETVLEPVTGYGHFEPLRHYAEAVLRIEPGERGKGITFESQCHVDRLGINYQNLIRTHIFETTHKGVLTGSELTDVRIILVDGISHIKHTEGGDFREAVYRAIRQGLMKARSLILEPYYSFTISVPDFLAGRVLNDITKLSGRLEAPVPDENGRTVIKGLGPVSAFMNYGEELMIITGGRGRISMTFSHYDRCHNEDEVLTRYQYNPNEDTDNPSCSVFCQKGTSFVVNWDHAEEYMHSLS
>fig|610130.3.peg.3052 Daunorubicin resistance ATP-binding protein drrA
MIVLEHVSKKYKGITITKDSGIALWVKNIANLTGNKATELMAVKDVSFSIDKGEIFGIYGANGAGKTTLIKLLSGLLGASSGTVQIDGQTDNKHIKDTVSYISTNGWMGLEWQLTARENLILYGNLFGISGMVLEKKCNEVLEAVGMTAAKDKLVSQLSAGMRQKITIARGLILDRPIIFYDEPSVSLDVQSSRSLRELIKADAVQNNRTAIIASHNTEDLTICDRLMLLSKGEIIAIGTIDELKKPLADIQIIEVKCPAIKREVAFEDICGIDSVRCASVDGKRGYQSIKINARKGEFSLNDLIDFLIEKNIAVLDIKSKEITLQEIYEYYLALKGGGVPSEIV
>fig|610130.3.peg.3527 Quinolone resistance protein
MSQKLLPPILPGAMDVVLEDLEELFLRKDQEEAVTDVLIRNLHITEEDLSHMRFSAVIFENCIFQDCTFEKGEFSDVVFNACDISNCSFEDSYFNRAEFRSSKGMGAKFCGNTMLHTVVLDCNFSYANFDSSRLEHIRFSDCRIQGGSLTQCRCKAVEWNRVNLENASFFKTMMKGMDFTSSTIQGLTISDGCGEVRGAVVDLYQAAELAKYLGIVIKS
>fig|610130.3.peg.4224 Glyoxalase/bleomycin resistance protein/dioxygenase
MKFCWSTLNVKNLEESIKFYEEIIGLKVTRRFPAGPGTEIAFLGDGETQIELICGGEKEIHVGDDISWGFEVESLDQTLFLAKEKSAVILGEPVQPNPQVKFAFIKDPNGLRVQLVENIR
>fig|610130.3.peg.4364 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGYNYGAGNWERVEQAKRFALKLTSGFCAFVTIEIIVFSRNIIELFSKNDAFVMKVGQEALILNSIVFVTLGFQLVYGTFFLALGKSKQGGILSICRQGVFFIPLVLILSRIFGVQGVLFAQPIADIANVLLTGSFAYGINYRMQVN
>fig|626523.3.peg.346 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTMTHQKQTKSIQKNLTQGPINRQILTFFLPLVIGAFFQQLYNTVDASVVGQFAGTESLAAVGGSSGMITLFLFTFFINLATGATVVISQHFGAAETDKVDDALHTAYAFSILAGLFLGIIMLFLTDPFLRLLQTPENLMEASALYVRTLMVGLIFTLTYNMGAGILRAIGDSRRPLYILIAATAINIILDLFFVAFLHMGVFGVGIATDISQGISALLVSWLLIRKTPGLRLSLRRLHLNPQTLARILRIGLPTAIAGSMFTISNMILQASLNQKGVNAMAAWTAYARLDAIWWMIDASFSASITTFIGQNFGAAKPDRIKKASRNVLLIELAFALILTGLLLIFTPSLMLLFTRDAEVIHLAEDICRCIAPFYAIYAFSEVLGSILRAENKVLITTLINLLGICGFRAIWLLVIVPGGSVRQLFSCMPISWAIISASITIYYLLQQPGILHRLEGRSK
>fig|626523.3.peg.778 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADRKAISLADHFDDRKLLRFTSHSILTMIFTSIYGIVDGFFVSNYAGEVAFAALNLVMPLLMLIAAVGFMFGTGGVALVSLKLGQKEERQAKEIFSLTTYTLMVLGILLSLLGYLFAPQAAVLLGASEELLPYGVLYARISMVSMTAFMLQHFFQSFLIAAERPRMGFWITVIAGVTNMILDYVFVAGFGLGLAGAAWATVGSELVGGLVPLVFFILPNKTPLRLGKTGWMPWALVKTCTNGASEFLSNAAASFIGMLYNRQLLCYMGTNGIAAYGVIMYVNFIFVGIFFGYAMGVSPIISYQYGARNQAELRNLFRRSLSLLAGASLILTLLAELSAGLLAGIFVGYNPQLYALTVRGMRIYSVAYLFMGFNIFGSALFTALGNGKVSAVLSLVRSVLLQVVLVLLLPLILGGTSLWMIAALVETGAILLTGFLVTRYREKYRLY
>fig|626523.3.peg.1117 Permease of the drug/metabolite transporter (DMT) superfamily
MQEAGIQMAGIQTAGAQTVRKSEFGNASLIFTATLIWGTAFVAQSLGANHLAAFSFTAVRNLIGFLFLIPVTLLFRARGISARPERENRPDNVFIPGRRGQRALVTKRELISGSILGVIVFVASNVQQLGIAGTTTAKAGFFTAMYVIFVPVLGIFLGKRVRKMIWGCVLLSVLGLYLLSIKGGHLSLNVSDGLELVSGLCFAVHIMYVGHRSSYCDGAVFAMIQFAVSSALSFVFALALEHPRIEDIGLAIFPLLYAGVLSSGVAFTLQIIGQRGMNPTLASILMCFESVISAVAGWFFLHQALSAIEIFGCAVLFTAILLATLFGE
>fig|62928.7.peg.107 Permease of the drug/metabolite transporter (DMT) superfamily
MQPARIPPRTLLALVLLTLFWGVNWPVMKFSLREITPLYFRALTVSGGLLLLIAWFRLRGVSLRVPRREWGRVMLLALPNIAGWYCFSIFGVQALASGRAAILGFTMPIWTVLLGVLFFRERMNPRLWLATACAAAAVLLLLWHELGQLSGRPLGMAWMLAAAASWALGTLLLKRLAPAVSTEALTVGMLVCALPVLWALAVLKEPVPTLQFSLPMWVAVVYGVVIACAAAQVLWFSIARSLPPVASALSVMMIPVIGLASAMPITGERPHPQDLAAAVLIMLALSAALLPRRAG
>fig|62928.7.peg.583 Multidrug resistance protein B
MLLSAHPELRPLRVHAFGATLGLVAGVDFVAAILIAMAGTQVQHGLGVAPRDFLWALTSYAVAAVMANLMLVQLAGRVNYRRFTLASLAVFIAGALGCAAADSLPAFTAARLVQGLGGGGLFAAARILAQYSSQPQERLSLFWGFGVANFALVALAPWLAGWLVAHHGWHTLFLLQAGLALPLLPLVAWLYPRVERTPSRALGRLDWPGVLAFAGGALLLVHALEHLRYLSRAELPQLAAYALLGLVLLGVVMRRFARHPDPWLDPRRLASRRYLAGLAFYGVFYLICGYWNFLVPAVLVDGLGFGLDTVGGLLALGGLTTLGAVVVFHLCLPYIMRKRRYIALGYVGLAAAFTLMAVSARPGAGVLDVLPPIVLQGAMPVLALLQVAMMTFVDMPTEDFAHAYAFKNIVREILNALGTGLAVLQLHHGTAAAQAAMQAATPGPLQPHLAEVVHRAAVGTAAGQMLSGLALACLLVAAVAVWQRALR
>fig|62928.7.peg.2102 Probable multidrug resistance protein norM
MLIAQLLSMGMMVADTIIAGRYATSDLAAVAVGNGIYVSLVMLLVGVLQAVAPTVAHHVGAGATGELVPSLHQGFWLAILLAVPGTAILLSPGALLDLAAVPPPLAAKVGDYLRATAAGLPAVLLYRTFYAFANALGRPRVLMFISLATTCIHAPLAWALVSGAFGVPLGGTGCGVSTSVVAWIALGCGAIALARLRVFRKLRAFRSWTPPDPVRLWALLRLGFPIGLSTFIEITSFTLIALLIARLGPDWVAAHRVVANLAALAYMLPLSLATSALVLVGQAAGGLDWTRAARYAKVAIVLTCALSTLLGGVLWLARTPVLQLWSSDNAVRLAALSLLPYICLYQVFDAAQTVASHTLRAYKVTALPMVVHTLAFWGVGLGLGYWLAFHAGARSAEASVAAFWQAAVLATALAALLFLGLLRFVAGRSQRPGR
>fig|62928.7.peg.3182 Acriflavin resistance protein
MVLSEICIKRPVFATVLSLMVLLVGLMSYSRLTVREYPNIDEPVVTVETLYTGASAEIVESQVTKPLEDSLAGIEGVDVLSSISRQERSQITVRFRIERDADSAAADVRDRVSRVRRRLPDDVEEPVIAKVEADASPIIWVAFASDRHSALEMSDVASRIIKPRLQTLPGAADARVFGERRYAMRIWLDRDRLAAFGLTPQDVEDAIRRQNIELPAGRIESREREFAVVARTDLAEPAQFEAVVVRQAGTPGGYPVRIRDIGRVEVAPADERTSVRFMGKPAISLGLIKQSTANPLDLKRGLMELLPRLEEELPAGMTMSIANDSTVFIERSIASVFSTIWEAVVLVALVCLFFLRNWRAMLVPLVTIPVSLVGAFALMLVFGFSINTLTLLALVLAIGLVVDDAIVVLENIYRHIEDGMAPLAAAFRGAKEIGFAVVAMTITLAAVYAPVAFMTGRTGKLFTEFALTLAGAVIVSGFVALTLSPMMCSRLLRHEPRHGRVYNAIEGFLEWLTAGYRRALEAMLGLRWVVMLAFVAVAAFAGLLLTQMKSELSPIEDRGRVMAIFNGPEGATIDYMTRYAGQIEDIFSRTGDVDRYFVVAGNPTVSQGISFIGFNDWSQRKRSAQEIAAELQPQLRAIPGLNAFPVLPAAFGQSPRTRPVSFVIVTSASYDELAAYTERMLDEMHRHPGFVSPDTDLKLTKPELAVEVDRDRAADLGVSVEVIGRTLETMLGGRQVTRYKKDAEQYDVLVQVAAGERAGPRDIRDIFVRARGGDMVPLASLVRVQETVSPRELNHFGQRRAVTISANLAPGFALGEALDFLDAAAARILPPGYTTDYDGMSREFKTSSASLALAFVLALAFIYLVLAAQFESFRDPLIIMLTVPLSMAGALAALRLTGGTLNVYSQIGLVTLVGLITKHGILIVEFANQLREQGRALREALVEAAVLRLRPILMTTGAMVLGAIPLALATGAGAESRQQIGWVIVGGLSLGTFFTLFVVPTVYTLLARREREHDSDTVESASAGMAG
>fig|629741.3.peg.620 Permease of the drug/metabolite transporter (DMT) superfamily
MHHYRGELWLILVTLLAASGWFVSKAALQELPAAGFIGARMVGAALLFLPFALPQLRQWTAGQFARAAAVGAAFSGNIFFWIQGVAHSTHFGEGALLLSSSMLLAPVLSWLLFRHRPSPMLWLSLAISGCGMYLLNAGKSPLQMSLGSGLFALSALMSALFFVLNNQFSKGMNALPLTTVQLACAGIVCGGYSLAFETWHFPLSAASWMWLIIGIVVITNTRFLLQTHAQKICPIGNAAMIMVLEPVWTLLFSVLLLGEQLSWEKATGGALIIAALLLYRLPLRQWHQRKD
>fig|629741.3.peg.2580 Outer membrane component of tripartite multidrug resistance system
MLETRQRVAQRAQLNREREQVVRELIRAGQVAPSRLYAVQQGNSRFQAALSDLDGNIAQIRHALAALTGQPAQALDNFAPNPAAAVPPAPVSQLTADLLGKRPDLAAQREALTARHHLVASAKTEFYPNITIKALAGLSNVEIGNLPHSSSFLAGLLPSVSLPIFTSGALRANLSRKEAEFDEQAARYNKNVYTALREAADALTQYETAAAAVRDQTEMTALARKNAAAAQSRYRAGLDNKLDWLAAADETLQNEAQLAQAQAKLFTAWLALNTAFGGGFAADK
>fig|63186.3.peg.1498 Multidrug resistance protein, AcrA/AcrE family
MKKLSILGLLSAGLLLSSCFGTTPTPPAGGATPPPPSLKVGELTPQDITIYNEFSTTLEGKQNVEIWPKVSGFIQHVYVEEGQKIKKGQLLFKLETQTLNQDANAAKASVNVAQVEVNKLKPLVEKNIISEVQLETAKAQLEQAKANYESVASNISYSRITSPVDGYIGEIPFKTGALVSSNMGKPLTTVSDISQVRAYFSLNEKELLKLKESMPKNDKNQMDLEKAPEVKLVMINGKEYPEPGRIAMINTIINSTTGSVTARADFENKNNILSSGSTGKIKIPTIYKNAYEIPQAATIDLQGKKLVYVLKDDNTITTMPIDIIANTQKGYIVENGIEKGTTIVLEGVTKIKDGMTISPVK
>fig|63186.3.peg.3633 Bicyclomycin resistance protein
MQKENVRPNFEFIALMASLMSIVALAIDALLPALSHIGITINSLDPLKNQLLITMIFLGLGVGQLFFGPLSDSYGRKPVVYVGFGLFAIASVICVLAPSLEIMIIGRVLQGIGLSAPRTIAISIIRDTYKGDYMAKIMSFVTAFFILVPVVAPAIGKWIMDAFGWQSIFYVQLFFGLLVCIWFWKRQPETLKPQFKVPFSMGVFASGLKEFLKYRETIAFTFASGFVTGAFLVYLSSSQHVFEDQYGLVENFPYIFAGLAGSVGLSTFLNGTLVLRFGMRKLAFMAMTAFCIIALTYVVLFWGRPNPSVPILVAFLFVQFLCLGFLWGNFRSIAMEPIGHIAGIGAAINGFVSTILSVPIANFIGGFVQDTVWPMFVGLAICGLLSLGTMLLVRRPKVVVTA
>fig|632292.3.peg.1889 Daunorubicin resistance ATP-binding protein drrA
MKAIEIKKLKKSINGKLILKEINLNIYEGEIYSLLGPNGAGKTTTIYTLLGLLKKDDGEIKIFGEELSKKHFKEIGLMFEIETYNLEWSVIDNLKHMCYLFGVDEHRIYDYVEMLDLKREDFRKKFKQLSKGTKRKISLIGALIHDPKILILDEPTSGLDPEIQVVFKKLLLDLKKRGKTVLFVSHNLYEVQEISDRIGFIKSGETIFEIPVSEKFYLVEGDYPEFQTYRVKNSKLYVFDEKMFLKIKPKNYQMIEKLEDLYAKFIEGRVS
>fig|633131.3.peg.64 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLEFHHINFVSEDVDRLHDFYTQVLGLDDIPIQSFPRPNATNSSGYDGKIRFATDGKMQMHLATKDLTVAFKNGEVINPIEKGHIAFKTDDIAAFMVLLDNKGIPYSDYGTAFAKEWHQVFFHDPEGNVIEVHQSVG
>fig|633149.4.peg.2119 Glyoxalase/bleomycin resistance protein/dioxygenase
MARVSDIRYVGYGVTDLEAERRFYADTWGLREVGEKDGLIHFAAQGDDELYVVRLRAADRKQVDIIAFAADTREDVDQLHRNVVEAGCKVVFAPRDLDTLGGGYGFRFFSPDGLPFEISSDVATGEQRTLARWEGIPQKISHIVLHSPKHKEAADFFTDVLGFRVSDWLGDFMGFLRCNEWHHRLAVLPGPPCLNHVAYDVASVDDMMRGIARLKQHDIDIKWGPGRHTAGNNTFSYFVTPGGFAVEYTSELEKVDDDTWVAQVHVPTPTTMDQWGIGIGGPQTMPHPEPDAGLFQPVGV
>fig|633149.4.peg.2378 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNRLGYFTIDTPDLGKAKAFYSSLLGWTFDDANSNPTYAHVLATGAAGEVAFGVRKGERKDFPNLYIQVDDIHAMCARVNALGGRASMPAQSDSGLSAVICDDQGVSLSLWQPAPGLVD
>fig|633149.4.peg.2443 Multidrug resistance transporter, Bcr/CflA family
MAEPGTAFRPETGRLELLLTLGALAAFGSLSIAMYLPGLPAMAQEFHGSTTGVQDTVAAFSLGLCAGQLIYGPVSDRWGRRAPLLFGIALYLVATLACIVASNLSTLVAFRFVQGLGGCAGVVISRAIVRDRFTPQESAGVYSTLMLILGVAPILSPLAGGWIIAGFGWRAVFWVLLAFGVVLGVVVWLRLRESSSAESRRRARSEHPFRSYLAILGDRQVAAFVACGGFGAAGTFIYMTMSAHLLIDGYGVPTTAFGWLYGAGSLAVLIGSQVNRVLLNRFSSHRLLVWSTRLNLAACLLMLATVSRWPALIPAFLIPLCLAFSMNGLSSPNAAAEAMGAAGWRAGAVAAVMGFAQFGMGALLATIAVRVLDGTAFEIAAMLCVTSACAVGCLLFAGKSRALA
>fig|633149.4.peg.2761 
MTDTDATIDPDPVPVVLINVFKVQPDRQDALIDLLTAMTRAQVGLPGFVSATLHRGLNGKTVANHAVWRSVADWKAMTRNPAVAAAMSPIMAIATFEPNLYEAGEVIE
>fig|634176.4.peg.109 
MINVIAQFSVKSENIPQFLAKCQELIKHTRQEAGCVSYELQKNTEQTNHYVFLEQWKSKADLEKHFTTPHFTSIVPALIEYCKQSPVVQTFQKAE
>fig|634176.4.peg.691 Permease of the drug/metabolite transporter (DMT) superfamily
MSKKLTATLYQKAIICMVLAYISIALMGVFVKYASDELPSSEILFSRFLIGFIFLLPFMIRDGDFKVELSQWPFLVMRNLAGIASMLLTFYAIKYLPISIAVLLMNTSALFVPLLLFVLRTRTPLKVLACSFLGFAGVSIIMLTDSSKHFELQHIGYALGAAFLAAMAFISLQELNKHNSPKNIVFYFHLLGSLLLPLFFATQWTIPSTQGFVLLLLVGGFGLVFQLLLTRAFKYAPANVITPFAFTGVIFSSICDWLFWHNVPTLNFWIGSLVIIVSVSLLAKIRR
>fig|634176.4.peg.854 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLTTIKEYHIEAKKLIAIAIPILLAQIAQNSMGLVDTIMAGRVSSADMAAISVGASIWLPLVLFGHGLLLALPPTISYLNGSGQRKRIAHQVRQGIWIVIFSCIPLGLLIQHSDFVLQRMDMEPRLAEITSGYLHAMIWGLPGYLLMINFRCLNDGIAKTKPAMVITFLGLMLNIPLNYIFIYGKLGIPAFGAVGCGIATAIVNWVMCFLMITYCMHARNQRDLKVFANIIERPNMHTLIKLLKLGFPIAVALCCEVALFALTSLFLSPLGAHVVASHQIALNTSSFIFMLPMSLGMATTILVGQRLGEKSPRGAKLVSYSALAVGLTITIITAFLTVILREQIAAIFVKDTEVIAMAGSLLLLAALYQFSDTVQVIIGGVLRGYKDTKAILYITLFCYWVVGMPLGYALARTDFIVPGGIAAKGFWTAFVVSLTLAAALLIYRLRKTQGQTDDILLAQLEKLK
>fig|634503.3.peg.2232 Drug resistance transporter, Bcr/CflA family
MLTTKNMPANAGLAAFSAQQRIAFILIVSISFLMGISIDLYVPSLPAISHYYHSTIASVEISISLYLLGYGLGQTVLGILSDSYGRKKIFIYSSLCFLLSSIFCVLSDSSTMMNGWRFVQGVAVAGLASGMRAIIVDLFSGLTLKKMANYFALSWALGPIIAPWIGSNLSHYCGWQANFYLFAVYGGVIFLICLFLFRESNHNPSRFELSSIKNNFIEIIRNKKFTLLSIIYGLSYSSVLVFNTAGPYLIEVVMHHSELFYGYLAMFLGLAYFVGTIINRYLITKFDNEAILKVGGTMALIVAILLWLLLSYVPNIFTLIIPIFLMFVCIGLIVPNAIAITMVIFPEKAGFATSLCGTIVGLVVFLVTYLIGHVKISALELSLCYFALFLLLNVIKLAVYHQKNRPSPPEHLPPC
>fig|635013.3.peg.360 Permease of the drug/metabolite transporter (DMT) superfamily
MNAVFFAALCLIWGSTWMAIKINLGSFPPFFSAGLRFLLAGFVLLAAMKFAKVSFPGEWRKLSPSFVFGLLNGISYGLIYWGEQYIPSGLTAVLNASLPFFSIIFAAMFIGERITLRKVFGSIIGFAGVLLLFYESLSELSSGKIMGEIAIVVAAAVYALAGVHVKKRSSVEPLAAVTVQMLTAAAVLLLVALPVEYGAAVHFTWRGLVAFMYLSLFGSAVAFYLYNHLILRMEVTALSYTSLITPAIATLLGVLIMEEELNGFMIIGMILIFTGTAIINIKGAHRSRDKLPDLSADSEPYRQSEELRQS
>fig|635013.3.peg.1191 Daunorubicin resistance transmembrane protein
MNTNKFLLYLELIRLEFIRMLAYRSTYLTGIFNYAIQIGAYYFLWEAIYINRKSLAGLQKEQMLTYVIIAWVVRSFYFNNLDQKITKEILDGSVAIELIRPYRYDAVKLARSLGEALFRLFFFSLPSGLFIYLLRPFSLPQSSTTWGIFAAAMFGSYLINAQIALLFGYSAFFTHSTSGVLRAKRVVTDLLSGLILPISFYPDWAQKALAYLPFQTISYLPNLIFLERLQGLAALKILVLQAFWVVVLYILNRIVWRIAIGHVVVHGG
>fig|635013.3.peg.1275 Permease of the drug/metabolite transporter (DMT) superfamily
MTKKRFWPFAAITLVMIFWGLSFLSIKVSVAALGPMSLALSRFAIASLLLFTFLKIREPGTRLERKDTLLMAVSGIIGITVYFFFENNGVKLTTASTASIIIGTIPLLTILADFIFCGNRVTWSKGFGVAMSVIGVYLIVKESGDLSFASRHFIGNLMMFGAAFSWVFYSLLTRPLGQRYSRLAVTTYQTLFGTAAIVPFALFETNKWDALNWVVVGNVLFLGFFCSALGYYFYVYAMGELGVDISSLFINLIPVVTVVSSYFILGEKITSTQMIGGGIIVLAVYFADLSNWLKKDDRRKQTGQKTNPIENVKA
>fig|635013.3.peg.2037 Vancomycin B-type resistance protein VanW
MSLSTLKVFLLAIIVVAISAVLSFFVAIAVSAQEDQIYSGVWVEDISLGMLTREQARNKLEELNDQIRGKEVQVKYPGGEAAFKLAEIDASIDVEGILKKAWEYGRKGSLLDQWQERRRIAREGVIIPLKINYSRTKFEKLAQKLGAGATIEPQDAKLVITRQDTIQIIPGKQGKVIDTQNALAQIEDILNEKQEPVLNLVLKTKEPEMTTQEVENMHVNGIISHFSTFFNVQKTNRVYNIKVAAGALDGTFIKPGETFSFNKVVGPRSKEAGYKLAPTILNNEFIDSLGGGVCQASTTLYNAVLLAGLPIIERANHSLVVSYVPLGQDAAVAYGGKDFKFKNNLSSWVVLKTEVVGNRLTVKIFGDTALKKDVRITNQILKTYPFKVVYKQDATMYKGKQVIKQKGVNGYKVASQRHIYVNGKEVRTEKLPSSYYKPLDQIILVGTKKVAAKTKTSISTNTNNPKKPVAGQGTLSPGQPPAAPPANAPQPEAPQGNQNNTGVVNPAG
>fig|635013.3.peg.2550 Vancomycin B-type resistance protein VanW
MPSRKKVFTGILSLIAIQVAVSVFGAVFFLAPADNELIYEGVLVENIDLGGLDKSAAEEKLTRALEPGLRNSAITLTFRSKQWTLPYSQLGIYADYKKTVEEAYNTGRGNNHFLKMFDSFRIRMNEVELPLAFRFDEEKMRKSLQELAAEINRSPKNAGVILLDNKLQVTPEQKGYRLDEEASLQAIKNAVIQRKESCRLTVRQVAAEVSAGQLKDVRDDLAVAVTGFDAADKNRRANIILAAESINNSLVKPGETFSFNYTVGQRTVQRGYKNAKVISNSNLTDGIGGGVCQVSTTLYRAVLMAGLHIVERHPHSLPPDYVPIGQDAAVADGQLDLKFKNNTAFPVLIAVSVSDSELLVRLIGKKQGNKKYRLVSDIYEIIEPKVTVKKDGTLPKGETTVLVSGQKGYRVKVFRVTEPEGKKELVSEDYYKPLATVVRVGTKTNKDLRNRK
>fig|63737.4.peg.1227 Permeases of the drug/metabolite transporter (DMT) superfamily
MSLHQSSGRWRLGLVLSLLTVLLWGILPIALAVILQVLDVYTVVWFRFSVSFLLLAVYLGIRGKLPKLEQLRSASWKLLAIATLFLGSNYFFFTQGLSLTSPANAEVLIQLSTLLLGFGGLVIFKERYRLYQWIGVSVMICGYVLFFREQLTNLITAHGTYLLGSVLIALGSTSWAIYALAQKQLLQSLSSASIMLIIYGGCALLFTPLAKVKSLLILDPFHLGMLLFCAFNTLIAYGAFSESLEHWEASRVSAVIALAPIVTLISVAVVSVIAPNWIPSEHFSLVAILGAGLVVTGSVAIALGKGN
>fig|63737.4.peg.2097 Tetracycline resistance protein
MESKNNSRPILVLFLTVFIDLLGFGIILPILPLYAEQFGAKPNEATLLVAIYSLMQFLFAPLWGRFSDRYGRRPILLLTLFGSVIAYAGLGFANSLWMLFLARSLAGIMAGNISTAQAYIADITTPANRARGMGIIGAAFGLGFILGPAIGGFLIGSDPDNANFHLPSLFSGGLSLFALLCALTLLPESLNSETKAKMQANRHRRRRLNLLQLSQRPQFCVLVGIYFFVTFAVAAMDSTLALWSKQQLNWGPQQTSYLFAFMGIVSTIVQGGLIGFLKKHFGEIKLLTLGILGLGLGLLLIGFSQSLILLLVATTLVAWGISVSQPILNSLISQMTAPEEQGQILGIASSCSALARIVGPTWAGISFMKFGSDSPFLSGFLVMIVALALSLRVTKSASESNKERIA
>fig|63737.4.peg.2362 Permeases of the drug/metabolite transporter (DMT) superfamily
MMNNGKVLHLSLIGIAIFTIVSGLLQMVLPSLVLYIVSAEVTPTSQHFFAIIGMFMLLFNGALLQALISPQPQPIVLIWAGLQKFGASITVCLAVIRLIFSPFALLIAGFDLLSGVLIFWYLFRLRTFTPGYTYEQPTA
>fig|63737.4.peg.3863 Probable multidrug resistance protein
MFMSTLDVGIINVALPTLVQAFGTSFPTTQWAVLSYQLVSSGLVLGATRLGDMWGKKSLYQGGLVLFTFSSLLCGFAPSIEWLIAFRALQGLGAVFISGLGLAIITEVFPSSERGRAVGVIGSVVSLGIAFGPSAGGLLLSLSGWHSIFFINVPLGIIASFLIARVVPPSIRIQGKQRFDFFGAILALLTLGSFGLGMTLGQSQGFGSTNALVLLVIATLSFIIFLVVEAVIKEPLLELHLFRNLQLSMGLLSGWLAFIVIGGSLLIVPFFLESVKHYPTVKVGLLLAVSPVLSGLIAPLGGILSDRFGARLISPIGLGLMIGGCLGISTFDAQITELGYVSRYFIYGIGLGLFQSPNNSTVMGAVPRERLGIASGLLSLSRTSGNTVGVSLIGAVFGALIASMSAGADVSVAPPDAIVAGFQGTFRFAALILCGAAVASVLRIGKRKGAGLP
>fig|63737.4.peg.5432 Permeases of the drug/metabolite transporter (DMT) superfamily
MVENQLILTTEKSDKTLNILPIIIVIIALLALSSTAILIKIALREMSATATFFNRLWIATIIFGFWNGINQARTQIKDDQPVLPQQPYPIKEIAFLIAVGLVHVLGRLSWTWALTQTGAANANALGSLNPLFTTLGGWLFFNQIFGRKFIIGLILAIIGAIAVGFEDLLRSNNNFTGDAVALISSIFYAANFLLIEQIRNKFSIITILLWRCVIATSLMVPVVLIFEKQPFPVSLSGWLVVFALAAICESLGHGLIVYSLKTFSSGFISLLLLLNPVIVAILAWILFSENLSIFNLLGLALIVGGIYLAISNKESIKSSVNPPIQSLQKSEF
>fig|63737.4.peg.5579 Multidrug resistance ABC transporter ATP-binding and permease protein
MRGTIPVVASEQASKQLSTLRRFLQYLLLYRKEIPIALTLVFIGAVTQAIGPFFLGWSIDRLIEKGNLQGLLLLLGLLALNYGLGIIAIRGQIIRVGWIMQRLLAQLRQDIFLKIQSLPLSFFDRSEAGDLMSRLLNDVNTVNQAFGLTIAQMLGNIFSLVGIIIAMLSINLQLGLLSNLVVPLMIFTTSLFARWARARFRVTRQTIGELSAKLEEDIGSVREAQAFNRVQTNIAQFDVLNAANRDANVEAVAITSAFLPSIDFLNTLATAGVLAYGGYLAVTGAVTVGVVTSFLLYVQQFFRPIQILSQFYTQAQSAFAGLERIFLLLDEPSELKDAPDATEMPPIQGEVRFENVKFGYNPDQLVLKGVNLHAYPGQMIALVGPTGSGKSTIINLILRFYDVFAGAVKIDDIDVRSVTQASLRRQIGIVLQDNILFSGTVAENIAFGAPHTTQADIEAAAQLANVHEFITSLPQGYTTQLGERGAPLSQGQRQLISIARAVLINPRILILDEATSSIDTRTEALVQSAIARLLQGRTSFVIAHRLSTVTQADQVLVIQQGQIVEQGTHAELIERQGVYANLYGLQLGAADTTVLQNEK
>fig|63737.4.peg.6218 Permeases of the drug/metabolite transporter (DMT) superfamily
MNLNSLMNVSNQRKIALAALFVGVGAISFGSIFVKLSETQLSPNATVFNRLWLASVFFLLWHGYKAIRQRLSLDKPEEQQLYTSQDLWLLGSAGIFWAGTLVLLAWSLTETSVAISSVLHNLAPIFTSLGVWLLYRKSFESQFLIGMVIALGGAIAIEFEELQIATDEVQGGFAAIVSAIFLSGYLLIVEKLRTKFSPATIQLWISAISALIILPILLFTQDQLFPSTTSGWLWVISLALICQVLGHGLLTYCLAKFSSVVVSLVHLLEPVFSGIFALIIFSEKLTFSNWVGFAVVLMGLYLAVSSQGVVNLPIHKLVTNIVNTFVKSMTSKLSLLKQQFSETPALLGTASLLFALIPISLAPSLTKLCQQEIGANAVVFHRSWIATIVFALWNLLEAFRSQQSENEPIENEPFTSQEVWLLLAMGTSAGTYLLLWAWSLSQTSVANVALLSNLNSLFVALAGYVLFGRRFDNRFVIGLVIALAGAIAFELNKVQFATDQILGDTLALLTAIFMATCMLLIERLRTRFSTATIMLWRCGVTTMFLLPVLPFLEDRLLPYSWTGWFFIIFQALFCQVLGQGLLAYSLSRISSSVVAVTLLLEPVLASIFAWFIFSEQVGLFDWATFAVVLVGIYLAQSSQSIVQVTNEAS
>fig|637380.6.peg.4872 Permease of the drug/metabolite transporter (DMT) superfamily
MTRTYILLFICVVVWGSNFIFGAILVNTFHPVLLTTLRLLFINLFFLAYAIMCKKGLYIEKNEMKGVLLIGVIGVAINQWSFYEGLQTADPTTAALILALTPVMTSILAVFILNEPLTVKLVIGGGIATFGVFFVIGVGQRFVFSEGLIWIFITMLSFSLSIVLIRKLGNRDDMFFITFFSSIFGFLIMLPFLAFTFSHITLKYSIESWSLLIVTAILMHGICTLVWNNQLRKAQASTAAMFLNLEPFVTMVVGYIILQKSVTSIQIIGAVFIVCGVYTATFGYGKKSKGQKELFRKAT
>fig|638300.3.peg.889 Outer membrane component of tripartite multidrug resistance system
MPPRPLLLALTAALLSACQTTTITTASRVPLPTAYESAPARADNTDIRRWWQAWHDPVLNQLITEALANNPDLAIARSRLKEAQATTRLADADRGATIGLGLNAGHLDADLDNPLGGTPLARSDKINTHRTLLASNLSAKWEADLFGQKQSDADAARYAALASAEQTHIAQLQIAAAVADAYLQARALEARQRLADENIVTLEKLAHYVEARYRAGHTTAFEKTEAQSHLSAARAARSTLAAERAAQARKIAVLLGKTPQDYQLPASSADILAHPPAAPGGQTPQGLIERRPDLRARAAEINARAAKVASAKADLYPRLTLNFLGNGILNIDSDNTQKSLISLLGASLQVPLFTNGRVQANIDAADARLKTALLQYDQTLLQALADVDNAYQASDALATQTRLLAQARDEAEKQATDAEKLYRYGNKTLADTLSARLSANQAAENQLRSQLAQAQTLIALYKALGGGWAEK
>fig|638300.3.peg.1052 Permease of the drug/metabolite transporter (DMT) superfamily
MPRFHIGHAALLLTAALFGIAFIFQRHSATAVSALIFMSWRLPVSAAFLLAILALCRRPAWGHWLRDGICCGILLFLGMYSQQWGLEHTTAGKSGFITSLYVILVPLLALLGGERLGKTLILATLLAFAGLTCFAAIHSDSAALNWNAGDSATLASAFIWALYVNYYGIAVRRSELLTLTTVQITVAALLTLPAALATEGAGALTDPALLNYSKWDILYTAVASSGIAFFLQGWAQRHVAATPTAIILSMESIFALAAGWLILDEPVTLLMLTGCALLFAAMTIAQLEPGKTP
>fig|638301.3.peg.1411 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKVIFQKFKKEVFVTIAILTLIATSQLLTSIVNAEILDYLVKMDMNGFIRETILLVAIFALYLLFTYMLIRYQAFFEQKVVTWLRDRISHAIKNTSYERFYEKNSQTYISWFTSDMEQIRTKAFTPTVEVVGGAISAVFSAVALFMYHWSIVLLTAFCIVLMAVLPALFSGELTAKTMKTSEENEHFSKHVSDLLSGYDTLFVFRKLNYLTHKIHERSVKVGDTQRDFSKTMAKVAVSGGISNLFCQVSVFVLTGYLAYIGEVSIGSIIATTGLSGIIFNVLGNISQKIGSIKSTAPLFEKYELLESAQNNENVDKEDSHTLIEVSDVSFNYGEKVILNHVSLGFNEGQKYAITGESGTGKSTLLNIIAAKLTEYLGEVKFAGVDVKKQSYDELYRQMVYIAQKPHIFTTNIRENVTLTEEYTDEEVWESLEKVGLATIVRNLPQGLDTVLGDGDSNLSGGQLQRIAFARGLIKKPKVFLLDEVSSNLDEKTTIEVLKPILEDKSVTVLWVTHHLPEDLKETIDQTIQMSELNHVN
>fig|638301.3.peg.1641 Glycopeptide antibiotics resistance protein
MYLLGPFYRWIVEIFADRVNHLPLVRLFIFSLDHAIVLFIGWLIVWSISLLFRKRKRIVWKWELYRNLFIFYLILLSQVTIFRNLDESFTVEFVMHPLSDIMWVPFVDSIKLFMQGSIFAAYYNVVGNIVWFMPLGFFCGMLYGSKKGESRSLKYGFLTSFFIEFAQFIFYTGVSHIDDIICNVLGSWLGFLLYRLIKKRRKK
>fig|639282.3.peg.955 Permease of the drug/metabolite transporter (DMT) superfamily
MDNKELKGSLFIILAAFLWGTTGTTQGLAPSEANSAVLGTLRILIGGLALFFIAYIKNKKLNLSNIPLMLTFLGMASVALYQLSFFYGVKLAGVAVGTVVGIGSSPISAGLLSIIFLKEKIPAKWYFSTFISLLGLIFIGLGGSNSNYDFNILGIFLAILAGFSYALYTLVSKILLKSLDNDTVMALLFLGGAILLSPILFFNDLSWVFTTKGILVTLHLGLFTTTISYIFFIRGLNYINVSKTATLSLTEPLTATFLGITVLHEKPNIYSIIGIILIFLGILILTYNKNKKS
>fig|639282.3.peg.1816 Permease of the drug/metabolite transporter (DMT) superfamily
MIATYRLVIASTILNIIYFRKGGKRFDFQKADFIYGFAGGLFLALHFVTWFQSLKYTSVASSVVLLSTGPIFVAVLSYIILKEKQSKEIIIAIILAIVGSAILALGDSNADFAFGEKALIGDFLAISSAFFVSFYLMVGSKLREKMDILSYIVLVYTFAAIILLITSILMQIPFTGYSVKSYIFMVLLAVVSQNLGHTAFNWALKYIKTSVVSLTTLGEPVIASFLAYIFFGETIDKFKFIGIILIFVAIIIGSRKGEK
>fig|639282.3.peg.1818 Permease of the drug/metabolite transporter (DMT) superfamily
MREKLREYIADISLIFISLIWGSTFVIIKEAIEDVNVFSFLTIRFGLATIIMLFFVFKRVDKLRDSFVPGLFLGLTLFAVFAFQTIGLKYTLASIAGFLTGLYVIFVPILSVIFLKQVPRITSIIGVIFALSGLYMISFYGEVAEFNIGIVFLILNAFFIAIHIILIDIYSKKYDVVILTFIQFLVIFVLSFLFSLLFKENLFDITFNGELIFAFILTGVFATVVAFFIQILMQKYTTPTKAALIFTFEPVSAAFFGYLIGAEILAFKQYIGSFLILLSIIISEVGPFLLRKYFNRGIND
>fig|639282.3.peg.1969 Multiple antibiotic resistance (MarC)-related proteins
MALTKGMTVKERKSLLNKSIIVAFILIGIFTVAGSSILWLFGIDVHDFRIAGGALFLLISIQIIFGNNESEYGEKISGIVPFATPIMVGPGVITATIVLTGTVGVLPTLISGIIAFILTYVILYFGRQILELLGQNVADVITKVIGLILAAISIHYIREGILGVINQFKS
>fig|639283.3.peg.620 Multiple antibiotic resistance protein MarC
MNWSERVQEFVTLWVVIDPLGTLPVFLAVTTGLDAADRSQAAVLSIIVSFGVLTFFSLAGHWLLKTMEISIESFQIAGGIVLFLFALTMINGTSHADTVAPAETNPVEIAIHPLAIPSIASPGAMLAAVVLTDNARHDVPDLMMTIATFGLVLLATLAIMLAGSRLVHVIGRGGTSIISRVMGMILAALAVDLVLSATAQWLHLPPI
>fig|639283.3.peg.1367 Permease of the drug/metabolite transporter (DMT) superfamily
MPLRDKLLAIAVVGVWGLNMIVIKLGVAEIPPLLMSAMRFVLVAGLVLPFTRIKRADLPVLALLSFTFGTLHFGFLFAGLRNAEAGTSAVIIQLGAPIATLLACLFLREPLGRRRLLGLLVSVAGIAILAAGPTLPGPLSFTLLTISATGWAVSNLIVKNIDDISPMAIMGWSSLLSVPQLLLGSWVFERAEWPLVYAAGWHGWLCVLYSAIASSIFGYGIWYWLLRRHPISAVVPYSMLNPLLSVLFGIVLIGDDPSPVKVAGALVMVAGVALILRKRDAKLPDTA
>fig|639283.3.peg.2453 Permease of the drug/metabolite transporter (DMT) superfamily
MTGYAFGAAGAVLFASKGIIIKLAYAEGIDPETLLALRMAFSLPFYLVIGGIAIAQMRAKGEALPGLRIVLQSLFVGALGYWFSSYADFLGLAHISASFERLILYTYPLFVVLFGALLFGQPIRMKALWAFAAAYSGLALIFAQNFSANATNTVHGSLWVGAAAITFALYQLMASRLLKSIGSALFTCIAMISASVVSIGQFVVVRPLDALAISPHGLMLAVMIAIGATVLPSFLMNAALKRISAQANSMISTVSPVVTMVLAVLILGESVSGIELAGAAMVLVSIGWFTLSDSRRRAIR
>fig|639283.3.peg.3038 Permease of the drug/metabolite transporter (DMT) superfamily
MEKPIHPAAAGAALEPSFRDRLVGIGCALLAVSIWGAWIVSTRHAVHGHLPPATVGWLRFVVPAVMLAPAWWRVGLWPKRGLGPFALCFLGAGGIFFLVVANAMRFVPAADVGPLLPGTMPLIVALISVFVFRERLGRLRAIGFICIALGVLTLGGRGVLAHEDGAWRGHALLLTGALMWSGYTLAFRRTGMKPTEIVGLTGVWSIAILTPFGLPGVIDALQQGYGREVLFQLLMQGLLSGVVALVAFGVAIERLGSTRAAAFTGLVPALAALIAVPALGEHPDLAAIIGVVATGIGVTLASGAFKAGR
>fig|640081.3.peg.13 Permease of the drug/metabolite transporter (DMT) superfamily
MLGEQADTHKVSAFFMCRHKKAHDRSGPAGKNGGSFRLRPQAMNAASLARLLLLAAIWGASFLFLRLTVPAFGTVWTVEVRVILAAASLTLFAWWSGEALQWRRHWRQYLIIGLCNSALPFLLFAYAAQSLGAGLLSILNSTSPLFAVIIGALWLRQPIRAVTVAGLLLGLGGVAVLAWDGLQSSGSPDAWLPMLAAALAPSAYAFASVYSRHHGQGITPLATTQGSMICAALLVLPLAAPQGLPAAATPTAWGALLGLAVLCTAWAYQLYFRLVHEVGPLGALSVTFLIPVFGVLWGVLLLGERLGGHLLLGGSLVLLGTALANGLLKWPRLARPA
>fig|640081.3.peg.1319 Permease of the drug/metabolite transporter (DMT) superfamily
MNAIAPPLPAGIAAAPSRTRVLIAGIAFSVIWSSAFVAGRIGLDHAAPLTLLAIRFLAAGLLFAFLARSSGRSLRLPTMAGRALLAGLVCNAAYLGLAYWGLQGVPTALTAVLVSACPLLTLLLAAALEGERLTPLRLAGILLGMGGVLWITRHRLTVEQLEPLYLAAIGAGTLALALGTVLSKKVAAGQDLIAAVTLQFMASGLVLLPLAWGLEGFRLEAHPALWGSLAYSVAVSLASTLLMLWLLRHGQASSASSFHFLNPFFGTLFAVTLLGETMYADDLLGVLPIALGIALVAWKR
>fig|640081.3.peg.1462 EmrB/QacA subfamily drug resistance transporter
MSFSSSPRSLEALQARHGGRYPWLVLAAMACGMVTAVLSSTIFNVAIPSLMADFHLGQDRVQWAVTGYMAAMTVAMLPTAWLIERYSFRRVFLGAVLLIGIGSLGGALAWNFPSVVAMRIVQGLAAGLLQPMSTLLVLRLFPLERQGRAMGILGFGIILAPAVAPIAGGFLVDHFGWRAIFLITVPGSLAALAAGHLLLPHKPAARAEHPFDWTGLSLLTLAILSLLQTVGGLHAHGLLSTQSGVGALVAAAGIALFLRHARRVPGPILALGLFSERAFAMGTLVSFIFGVGLYGSTYLVPVFLQSILGYNAATAGLALLPGGIALALMTPGAGYLADRIRPHRQTALGLLLFAISFVLLALLAGISLGLPLLPTLMGTVVIGRIGLALILPALNLGALRPLAQRLVGQGSALLNCTRQLGGTLGISLGAVYVEWRSNHLGQPAGSAQAFAEVFALVALAFFLALGGALAMGKPATAATAAGR
>fig|640081.3.peg.1795 Permease of the drug/metabolite transporter (DMT) superfamily
MDNQHLRRGYFYAALTVAVWSGFILVSRLGGKSPLTAWDVTALRFGTAALILLPVWLWRRPRLNFSWRMVILAVTGGCGYGVLVYAGFKLTSAAHGAVLLPGMLPFLVALMAWLVLGERPSPQRWLGLVGIAAGIACLATDSFGSSVGDWRGDLLILASSLSWAIYTVLVRRWQVAPWDATLGVGLVSAALYLPVYVLWLPHNLAAASLSTIALQAAYQGVLAVIVAMMFFMRAVAILGPTKVGTLMALIPAVAGTAAAPLLGEPLSPWLMAGLVLVSLGAWVGSQTRFFVRRNAVCPT
>fig|640081.3.peg.1816 DMT(drug/metabolite transporter) superfamily permease
MNAYRRWLPLLALVVLSLTWGYTWVLAKQGLAHAAPFAFAAERCIGAALALVVVLRLLGKPLRLVAPGQTLAIGLTQVAGFMVFQTWALVEGGPGKTAVLIFTMPIWTLLLAWPILGERVRGKQWLAAGSTLVGLLLIIAPWDMHSSLFSKFLGLMAALCWAVGTILIKRLRGAQPVDLLVLTTWQMIIGAVPLTLLALVVPEHPTDWNLSYVGILMFMSVASTALCWWLWIYILDRVPAWEASLSVLGTPVVAILSSRLTFGEAFQASEVAGILLIGGGLALLSFFGWLASKRNPIVVPAAGPEGKNP
>fig|64091.1.peg.544 Daunorubicin resistance ABC transporter ATP-binding protein
MTDLAIRADGLTKRYGDEAAVDDLDLAVPAGSVYGFLGPNGAGKTTTMRLLTSLTDPTAGTAEVAGVPVTDRAALTPRIGYLPADPPVFDELTGWEQLRHVARLHGLDDGEADTRIESLLERFDLLADADRRIESYSTGMTKKVGVVAAMLHDPDVLFLDEPTSGLDPRAARTVRDTVADLSAGDATVLLSTHVLPVVDELADTIGVIDDGVLVADGDPENLKSTAREGSAADLETVFMEVTADADAPLPDS
>fig|64091.1.peg.1222 Permease of the drug/metabolite transporter (DMT) superfamily
MSFRRPTLGETPTTVLFLLLAAIWGSSFVAIKIGIADVPALSFAAIRYSIAGLIVLAYAAHTTDRWRPRGRREWVLAATVGLFVIGIYHGALYLGEHDVSAPIAAIVISLAPILTAGFASKLHENVTIDGTQAAGLLAGLAGVVIVANPGSAGSVDLGGLLLVFLAAASFALGGVLTGKLPGGGGLPVETMEAWAMLIGSLALWVGAAVRGENVTAVHWTPTALASLAYLTLVCGAGGFLLYFVLLERAGATEINLVSYLEPIGASVVAWALFGDVVSPRALAGFAVIFAGFALVKHRYIGAAVRNTTDDAEL
>fig|64091.1.peg.2479 Permease of the drug/metabolite transporter (DMT) superfamily
MSRYRTTGRFLLLCAVWGTAFMATDVGLADLPAVPFAAVRFDIAAALLFAAVFVSDADVYPRTMDDFVYVLVGGTLTIGAHHAFLFTGQQYVTGGVAAVLLGLVPVVTPALTRLVATDEQLTAATAVGVMLGFAGVVIIANPDPTNIADSVLGVSLVLASAFAFAVAAVVTHSRSPSLPFLSTQAWLMATGAVVLHVAVLVLPGQSFAAATWTPSALGALTYLSVVAGVGGFLLYFRLLDDLGPIEMSFIEYVIPVFAALAGWLVLGQEITPATVVGFAFILSGFLASKWRALRLRSVVVTTISSFTGPRDD
>fig|641118.3.peg.394 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MVAALTLGWPLIFTNLSQAALTATDVIFIGRLGADTLASALLATSFYHTLMIFSMGLVSAVMPMIAIALGKNRHSVRDVRRTVRQGFWTAIMIAVPVWVVLWHCEEIFLFLGQRPDIAARSTDFMHTLQWALLPYLGYIVLRSFFAAMEKPMWTLLIAALAIGFNALAGWTLIFGHFGFPRMELHGAGIATTASSTMMFLGLAFITLRHRRFRRYHLFGRFWRPDWARLLELWRIGIPMALTFVFETSIFYAAVVMMGRIGPTAMAAHAVAIQIASLSFMVPLGFGQVATVRVGRAYGAGHPKAIAYAGWSAYALGVGFMAVMGLLMVLIPRLFIGVFLDLHDPQNLPVMELAVTFLALAALFQIVDGAQAVAAGMLRGLRDTRVPMFLALFGYWGVGLPLGALLAFKFELGGVGIWLGLAAGLGIVAVLMTLRWRRHLAHVSAHPA
>fig|641118.3.peg.2806 Multidrug resistance protein B
MQSSIEETTPAGIAGHAPAGWGELLSGKNGLYALALAGGVTLHAVNMYIATTVMPSVVQDIGGMDFYAWATTLFVVASILGAALTARLLKSAGPRGAYVVATLLFAAGTLISSLAINMPVMLAGRSVQGLGGGFLYALAYGLTRVVLPERLWGRAIGLISAMFGVATLIGPAIGGIFAEYGAWRAAFWSLLPVSGLFAVVAFATLPRSSWDRNERVSIPVLQLILLTGAVLAVSAGSLSEETLWKIVGLGAAIFMIAIIAVVDRDAKARLLPRRSFSLSTPLGALYLTIALLMLSMQPEIYVPYLLQHLHGQSPLWAGYLAALMAIGWTVASFLSSRWQEKGGDRLVVAGPVLALAGLVLLAIFLPIHGNGNWSLLAPVCLGLILIGFGIGLAWPSLVTRVYQSAPLTEQDLAAGGMTTVQLFAIAFGTACAGMVANFAGIAVPGGVEGAANASLWLSVIFALAPAIAVAVAFKVIRITGGKG
>fig|641149.3.peg.676 Outer membrane component of tripartite multidrug resistance system
MKFNQIHLLCIAAALALAACKNTEVPLNSQVQLPQAFTQDAAAKGDADIGTWWQQWNDPVLSGLIAQGLAQGHDVKIAVSRLNEARAVAGAARADLGPTVGLSGKVGANYSKMDNPLDSNARALLSRYPQASSLNGDTIESTGTSMYGGLTASWEPDIFGKKRSDADAARYAALGQQELAYGAQMLVAGDIADNYFKARAAQGRLKTADQTVATLRRMVRYIEGRFKAGHVSGYEVNEAKVQLTAAEAKRATIGAEYAAYVRSIAVLTGNVPQTFTLPESSADVLARQPSAPGGQTPQGLLERRPDLRAQAAQVNAYAAKFASAKADLLPRFTISFMGQGGRIGVDGDRSLTGWASLLSVGIQMPLFTNGRIKANIKAADARLQTALLEYDKRLLTALGEVDSAYQGVESLSRQTELLQTAHNQAARHAADTEKMFRNGYKTLDVALKAHIAEGQMQENLISARLARVQMLVSLYKALGGGWSAK
>fig|641149.3.peg.771 Permease of the drug/metabolite transporter (DMT) superfamily
MIAAALCFTLMNLCIKAAAQKFGLYSGELVFWRMSFAAAVLGITAKAQGRTFSTPHWKTHLNRSVIGSAAMLCLFYAVMHLPLATGVTLSYTSSIFLAVFSFLIFKERIAPYTQAVLVLGFAGVVLLLNPSFGSGQETAALAGLAGGAMSGWAYLQVRELSLLGEPGWRVVFYFSVTGMVLGAGWAAATGWHIPTADMLPYLCAVGLSALVAQLSMTRAYKVGNKFTVASLSYLTVVFSSLAGIVLLGDKITWQEIAGMVIIVASGILSGIKPIWIKQLFTR
>fig|641149.3.peg.1286 Outer membrane component of tripartite multidrug resistance system
MKFNIAKWSIGVLTVCTLSACAQFGKQAPLEEPTAYSLSEGKSAVMAKDAWWLQLHDKKLNLLIAQAIQTSPDLRVAKARFDQAQAQLGLTEAATKTQIGFSVRGAGAYVSPKPASRQGETDNTLLLANAALQGSWEFDFWGKNRNQIASVLGKRQAILYEARQTRIMLANAVAAQYFAWQSLEEQQKLLARRTETADKTLQLMQRRVRAKLMPPESLYQIELLQHRLQLERLSLEQQTAKVRNSLSALTGNAPYTLPVRFPEEMANVPNLPVDRIYADLLAVRPDIAVQKSLLESKYHAIKSTEAEFYPNIELKVLAGMAHIDAFNVIHGRNSAMLGILPALNLPIFTSGALQSKLWGRRAEYNEQVAIYDRTVLNAMRSAADAVVDYQSLQAKKLVWDKMLNTSGKSVRAVQNRVKVGLENGLDVLQKQEERLQLQMQAVQYQAEYLTAWSNLHAQLGGGVK
>fig|641149.3.peg.1287 Transcription repressor of tripartite multidrug resistance system
MSFSQAELVNALRLLSGRLPEFSEQQTQVGRLLRIVTERLSDHLNENLKVLGINENLWFAMMAVYVSPNSEILPSRLSDMMDLTRTSATRLSDEMVERGWVERHINQQDRRQIVLKLTPEGEAFIQKVWPQVSSKSGEAWQDFTNEDYAQLQYLLSKLLNRLEG
>fig|643562.6.peg.316 Permease of the drug/metabolite transporter (DMT) superfamily
MTRPSLSPSLSPSGASRATPSPASAYACLALAMVIVGSSVVAGKIMVAELPVFLASALRFVLALAILLPLLRIREGGLPRLSRRSWLLLAGQSLCGSFLFTVCLLHGLKLTTPASAGIITATTPACMGLLAWVFLRDRPTRRTGAGMVLSVLGVLAVNAMGGEPGGIAPAPLTGNLLVLCAVGFESLFLLVRKGVPEPLTPLAASTIISLFGLVWFLPMGCVELAATDLAAVSLIGWLSVAYYGAFVTVLAYVFWFAGITRVSASTAGVFTAVMPVSALVLSATLLGEPVGWPQLAGCVCVLGGIVLISRR
>fig|643562.6.peg.1245 Permease of the drug/metabolite transporter (DMT) superfamily
MFQGLVYAVISAVAFGSLAVLVKLGYDAGLSGSEMMQYRFTYAVVVLGTFMLLRDRSLLVISRSGLARCALLGLVVYWLQTTCFVRALETIPASTTALILYFYPVSVTLLSAVFLGMKLNRVVLGSLALVLGGCCLVFYDAFLKEANPVGLLYAVGAMCFFSCYLLLVQVLLRKLKPLTATFYVMFFAAISFTLSGDPAAWLSPTWERVVFGVSLGVVPGVVAVSFLYMAVEKVGSAYASIFSSVEPVVTLAGAAILLGEQVALLQIGGTVLIILGIVIPNLRALLLRRRAATLIRSA
>fig|643562.6.peg.1424 Multidrug resistance efflux pump
MVQTILLTLGLAMILAACSENPANRFQGYVEGEFVNIASPLGGTLDALSVVRGQQVRQGDPLFVLEHEYEQASVDDARHGLQRAQDSLADQETGQRPSEIAAIKARLRQARAAATLARIEYDRRVKLIREQTISQEELDQAKNDFDQTTHRVREINAELETARLGARSGQVLVAEAEVRQAQAALDQALWNLGQKTRVAPADGLIFDTFFRVGEWVATGQPLVSLLPPENIEIRFFVPEAVVGSLAPAQEVQVTFDGAPQPVAATITFISPSAEYTPPVIYSSQSRAKLVFMIRARPALADAPSLHPGQPVDVTIPALPR
>fig|643562.6.peg.1492 Permease of the drug/metabolite transporter (DMT) superfamily
MIPYQSPTMLQPQTLGYVYALLAVVIWSGNFVIASGFVDALPPITLAALRWGTATLFFAPFVVGRMRREWPAIRANLLPLCGAAFTGVTVFNTLIYYSARTTDTVNLALLTGTTPIFVVILSRLFLGEKITPFRAAGLAVAVGGMVAIATRGDLDMLRTLTFRTGDLTMLLAGLLWAVYSILIKRRSPSVSLFSFLGVTFLIGLIPLIPAALIEQHFHPAWAMTPAIVGAALYTGLGASLAAFFLWSSAVCLIGPGTSSLFQYLTPVFSGITAYFLLGQPITVWHGVGFVLIFTGVVLATRQR
>fig|643867.3.peg.1112 Acriflavin resistance protein
MAVSYPISILMLVLAVILLGTISFGKLPIELFPDLKNPTLFVELKAGIKPPSEIEKQFVESIESVAIRQNGAVEVSSISQTGYGRVTVQYDWGKDMDEAFLDLQKSLSSFSLDEEIEEFVISQFDPNATPIMILGIYNPNSNDTEALRKVAENNFRNEIIRLPGIAEVRLSGEQEKEVVLETDPNLLASYGLTVNDLVAKIENYNRNVSGGFIEELGRKYVIKGLGIIEDSEDLEELVVGYTNRQSTSSNPNSTNVNAEMAQSTSNPQTSTTAQVPVLLREVATLKIMDKEANSIVRVNQQRSLGLSIFKETKYNTVNAVNELTEVLDGLKKSVPGYEFVIIQNQGRFIQGAIDEVKESGLYGALFAVIILFVFLRRIGSTLIISIAIPVSIIATFNLMYFNGLTLNVMTLGGLALGAGMLVDNAIVVVEAIFRRREEGMSVIDAAVKGTSDVSGAITASTLTTIVVFLPIVYLQGPSGELFKDQAWTVAFSLISSLAVAILVIPMLFSQIFRKDNRKQMEKPLKYKAYRNFLNKVLHYRIAFIVLSFLLVLGSYQLIGIIGSEYMPQAGTKAIAVDLKLANGTPLTRTSSTVDQIEGQLSILFEEQLDHVYSHIGPEKSQSGIDNENVYDENKASLKLIFKEDVELDINEVTSALSTYFEGIPGLTASFSNDESALNAILGEEQMPLVVEVSGAEFEALSALSDSVMVILNGNEDIYEPVSNLEEGVPQIKVDVDKYRAGLLSLSIEDVITQIKDQLEGKKAGTLERGGELQDILVKVPKISLSGLENMRIKSSNREFPLSEIADISVQYAANSIYRKNQSRMVTVGARVNQDKAYNQIVKSVDDAFAEMSVPPQYKISVAGQEVKRQESMNNLLFSLLLSVLLVYMVLASQFESLLHPFTILLTIPLACVGALVSFWILGMSLNMMAFIGIIMLAGIAVNNSIILVDSINRNKRSGMDLRDSILDAAQRRFRPIIMTSLTTILALLPLTFGFGESAALRAPMAVAVIGGLVSSTLLTLIVIPCFYESIENLISKIKGTSSAKKEVSHE
>fig|643867.3.peg.2101 Drug resistance transporter, EmrB/QacA subfamily
MAKQHHYQLSSTTGKWTLAACIIASSMAFIDTSALNVVLPSLQEDLEATGTDLFWVLNSYLVMLSSLIIVGGSLGDKLGRVKIFQWGIILFIAASILCGLATTINQLIWFRILQGTGGALMIPGSLAIISATFSDQEKGKAIGTWSAATVLVTMGGPILGGALADIGLWRLIFFINVPLGIITVIMLFLKVPESKAPENKHRIDWKGAFFLAFSLATFTFGFLNIPELGISNIRSYLPLLIGIVSFGAFLYVEKKVEAPMMPLEIFKNLTFSGVNLLTFFLYAGLSAVMLFLSLNMIQIQGYTQMQAGLTFLPFTLLMALIARKVGALSDKWGSRNFLIVGPLVTAIGFVMLGLVGKTSGIEDFWTSFFPGILLFGLGMSITVVPLTSTVMLSIGNDQAGIASGVNNSITRISGTVINAILGAGAVFIFTVLVSNQVETLQLSSPLSNSIIQESINFGEAQVPSNVPSEHIRDVQQIYTTSFISTYRWVCYISAAMAILAAAFAVFMLKSRSK
>fig|643867.3.peg.3246 Permease of the drug/metabolite transporter (DMT) superfamily
MNKTWQIHGALALVGLIYGANYVIAKGVMPNYMSPNAFILLRATVATILFWIYHALTSSEKVIRKKDYWLFAKCAVFGVMGNQLIFFNGLSLTSPVNASIIMTANPIIVLVISFWLLNEKITWRKIIGILIGAVGVILLVLNKEVSIDNDAFLGDIFIFLNATFYAIYLVMVKPLMQRYEPITVVKWVFLFGTLMIVPFGIVPIFDVEFQAFPSGIWWSIVYVIIGTTFLAYLLNAMALKHVNSTIVGYYIYLQPVFATLITIILGQEVFRWEKTVFALMIFFGVYLVSQQKKTKNEEATN
>fig|643867.3.peg.3642 Drug efflux protein
MEKLATAPLENILSQLRDLDELNSQSRYGSGNITLRFSKNADLAYKRFEVATLVRQLYPELDENVSYPILQSSGGDDEEGENKTILRYTVRGPFASYRIKEITQESIVKPLQNVAGIESLPVYGANSLQISINFHSEKLEAYGLSPVDLRAALQQGGQLRYPGLAQSASNEKYVLVLDQRFTDIQQIVELKITQKESGKSYRLKDLADIDLEEQEPSSYYRINGENFVTLVVEARKGVNRINLAREVKSRLNEIEDNLAQGVALRLVYDDTEYLEKELDKLYERSILSISILILFIFLINRNWRYLLVLFAGILVNVSLAIIGVWALDTEIHLYSLAGLTISFGLIVDNAIVMIDHIHKYKNRHLFLALLAASLTTIAALLLVFLLPEEQKMNLVDFSKVVALLLGVSLLVALFFTPSLYALLFTTQNQKRKGNTMRQLRRKVRWFNRYSSAIHWSAKYRKAFFTLLLLAFGLPIFMLPAKWEDQEWYNKIIGSDIYQDDIRPISDKWLGGSLRLFVRNVYERSSYRQNEKTRLYITGRLPYGNTLEQMNTIMRDFEGFLLQQEGIDIFTTQIYSGQYGSIEIIFEEDYEKSAFPYQLKARLSSRSTNWSGVNWSVYGVGQGFSTGSSDRIPSFRVALKGYNYFELENQADKLAEMLLEHPRIQEVNTNERMSWRDQKSKEYIIRPDLKELAFHNISLSDFTNAIRMHAPANGATAYLPINGEQFPVALASAKADDFNKFALEQYSLGYEGKRIPTGNLSKLQLESTVNAIYKENRSYIRILSFEYYGSSRFGSKYLEEVLTTYDQIKPLGYRAERQSFNWGSNTAKKQYSLLLLLIVAIFFICSILFESFKLPFYILLLIPLSFIGLFLTFGWFEFYFDQGGYAAFVMLGGLTVNAGIYILYDFKNRKIQNSRSFLKSVSTKAAPVLLTIFSTCFGLIPFVMSGQNEVFWFSLAVGTIGGLIFSMIGVFFFFPLLAVGKGK
>fig|644282.4.peg.2148 Polymyxin resistance protein PmrJ, predicted deacetylase
MAELMTMAARRPQGPLVALKVDVDTKIGMVEGVPRLMAILRRFGLKASFYLSVGPDHSGRALKRLFRPGFLRKQLNSGAAVAYGPVTMLYGLVLPGPIIARQAPELFGLLLAQGHEVGLHAWDHVHWHDRVRGLSFEATKRQFDLGRELFTQTAGFAPMSFAAPGWQVTTQALQIMAQAGVTHTSCARGGRPFRPLGPDGPLPLVELPSTMPTMDEVLGLGLAGPDDIGRWLAEQVRDDELNVFTLHAEVEGRALAGAFEEMLEALTARGARFVRLVEAARLAALEPLPVEGLVWGPLAGRAYDVVMPASQNPGGEPA
>fig|644282.4.peg.3077 
MSKVTVVALMTAKEGQETDVQKAMLDCAAPTRQEAGCLNYDIHQSLKKPAEFMVHENWASMDALAAHGKTAHMAKLMSDLADKLAVAPKITLWKELQ
>fig|644966.3.peg.116 Permease of the drug/metabolite transporter (DMT) superfamily
MDGRTLALAGLTLVFWSSAFTVIRAGLAYWSPGQLALVRFLVASVALAVGIGLQHAARRRGQRAGACRGRGLRPDRVRWAAPGKPAAAANGRPGPHGPHDARRRLPLRDAGRFLVLGATGIFLYHTGLNWGETRVPAGTASLLVATAPALTALLSRLWLGERLAPRAWLGLALSFTGVAIISWAASTGPVSPAGMAGAVKPLSASGPAGLAAQTVPGDGAGGGPMGSLQAGISAAAGFGSPGAPAGWAGPAAVGGAALATSAFFVLQRPLASRYGSLELTAFYTWAGTLLLALAFGPGLVADLQAGRIPPAAWIPALYLGLFPSALAYWAWSAALARDSAARVASLLNLNPLLAVATAWIALGERPSWVELAGGAVALAGVLLVQGRPPTPQGQRPGSFRRQDPPPVPVAAEPAPPTPPAAVPVEPGGSPAGPGDRPSPRPGGR
>fig|644966.3.peg.299 Acriflavin resistance protein
MAVWRWAIARPVATLMAMGVLVWAGLFSLRTLPVGLLPALDPPVLTVVTTLPGASPEAIDQLLAPPLTQALRTVRGVEEITARSGDEAAVVVLRFRWGTGLDAAREQVHQRLDALPLPPGAGRPQVLRFDPQQLPMMEVSLAGPGDPVQRARQVREVLLPRLEAVPGVAAASLRGAPEERVEVVLDAAALRRHGLAPGQVQAAVAAAAATVPAGAVAGGDGARRWPVEVEGGFDHLDDLERVVVGLSSPVAVVPPGPVPGLQTPERGAIPEPGAAGDTPVAASPGMEGSRDGTPDRPDGAPGRGGAPGRRPAPVLAGAVPVRLADVATVTVRRDPPPDVERLNGRDGLGLVIYQEPGANTVSVSRGVREALAGGLAALPGWEATVTYDAGLLVERAVRGVGQSLLVGSLLAVAILWLFLRRGRAVAVVAVAIPISACATLAAMHLAGMTLNVMSLGGLALSAGVLVDQAIVVLESIAHRHRQGLPPREAAEAGTAEVAAAVAGSTVTNLIVFLPVLFLGGLAGQLFHDLAVTNALAQAASLLVAVTVVPVLAAWWLDEPVPLPAKASRAQASSPPATGPVPATGAVPAPGPAEGPAPWAVGHPGPDGAGTSATTLVVPPLPRPFEACLARPAVTLVAALVLVAASVPAAARLGTEFLPAVDERAVDVTVTLPQGSSLAATTAALERVEAAVLRLPGVETVVVRAGGSAWPGMAGAQNQGLVRVQLAEGAGSSAAWAERIRRRLDGARDPGLDRLGAQVTVQPRNLWADVGAGAPVVELALRAEDPATLAEAAAQARRVLAGMPGLADVAVDLDPTAPRLLVRVDAAAAAGYGLAPAQVGQQLRLALAGEAVARARVDGRWLPVVLRTAGMPARGNLPAVTGAGPSGAGSSAAPAGPAPAGDQGARPALGAGVGQLPLAGGTGWTRLNDVATVRPDATPAALVRRDGWLSATVTARVDGTDLGTAVTRARQRVAAALPPGAAVAPAGTAVLMEEGFATLVPAALGALLLIYMAMAAQFESLVHPLLMMVTLPLALVGAVAGLAVTGYPIGLTAVMGGIVLAGIAVNNGIVLVDAARRYRAEGLAPAAAIRQAWRRRLRPVLMTALTTLLGSLPMVLAPGRGSELEVPLAAVLVGGLFTSTALTLVVLPCAWLVVETRRRPGAPSRP
>fig|644966.3.peg.560 Permease of the drug/metabolite transporter (DMT) superfamily
MALFSLTLPATRLALEALPPELVGPGRAAGAALAAALVAACAGFARGARGPGRADAPAGSGPRAAPEAAVTEGTAAAPGPGWLPPREDWPSVLLVAAGTVTAFPWLSTLALAQVPASHGAVLLGLLPLLTSGYATWRAGERPSARFWWAALTGSAVVVGFALHMGAGRLQHGDLWLLAAIVAAAAGHGEGGRLARRHGGFLPIAWGLWVALPVTLAAAGPALVHPGIAPPAGTYAGPGAAPRLGPASPPGPGIPAGSPVLPAWPAWLAWFYISVVTQFAAFVLWYRAMSLAGVARTSQLQLLQPFLTLLAARAGLGEALDPVTVLAAGAVALVVAVGRRAPVHRADEPACRPAPGSAPARPHEVTAASVPALPREEPPQR
>fig|644966.3.peg.566 Fosmidomycin resistance protein
MKGALGYLLLLSLAHLITDLNQGGMPALLPQLKESYGLTYAQLGVVLLVLNITSSLIQPLFGYWSDKRPQGWLVAAGPLLAAVGLALVGYARSYEGVLLAAILCGIGVALFHPEGARSARGVSGGQRATAMSIFSVGGNLGFALGPVAATAVVGLWGPQGLAWLVLPAGLLAAGMVAALPGMDRLEQATARRGATTPGRMPGTRGPGPAAGSAPAGSSAGSGGGTGPAPADEAGKTNWLAEVLLIGVVGTRSWLQFGVLSLMPFLYLEKAGPHGVSTGVLLFVFLAAGAVGTLVGGPLADRIGTRTVLIGSMAVLIPLHWGLVHGPAWATLPLLAATGFALVATFSITLVMSQDFMPRYVAVASGLNTGFSIGLGGIGAAALGALADRWGLETTLSVMVLLPVIGLLLTLLVPVPERDRQQRRAGAAGRARPAET
>fig|644966.3.peg.610 Permease of the drug/metabolite transporter (DMT) superfamily
MHPLAPLLALAGAVLAISFSSILIRYSQAPSAVIAFYRMALTTLLLLPWAWREAGRVRRLPRRLLGASVLSGILLAGHFLTWIASLRYTSVTASVLLVTSHPLYVMAADAWLLRERVPTRRLLGAMLALTGVAVVTFAGAGAGDLVAGGRALYGNFLAVAGSWFFAGYILIGRRVRQVLPVMPYTTLVYGVAAAVIAVGLALTGTPFGPHPWREMLLFVALAVVPTLGGHTVLNWALEYVPASVVSVSILGEPVGASLLAWLLLGEAPTGVELAGGALTLAGLFVATQAAAREAAPAAAGAGQSERQDPHAGPSPAG
>fig|644966.3.peg.1733 Drug resistance transporter, EmrB/QacA family
MQPGHGAGRQAGTRGLLLAAVAFGALLNPLNSSMIAVALPAIARDFRVPIGRLTWVIAAFYLASAVGQPVMGKVADLAGRRRIFFAGLALVALASAVAPLAPTLGALVAARVLQALGSSSLYPAGMAAVRDAFTGRTGQALGILAVFASTSAALGPSLGGFLVQAGGWQALFYVNFVPVALSMVLASRAFPAGPGGAGSSGGRSPRPAAPTGRPGGLRELGRRLDLPGMALFAGTVAFGLAALLSLSEPQPAWWTMPVAVLLAVALARWEGRVKAAGWEPFLDLEMLRRDRARTAVYGAWILSNLAFYTVFFGMPAYFEEVRHLDPRESGLMMLSVAGFSSVASPLVGRWVDRAGHRPALWAAGLSLLAGALALLAVGPGAPLAVLFVVLAFLGASNGVNNLALQAALYRFVPREETGAASGLYMTCRYVGSILSSSLLGLVLSGPLNAAMLRELAVALLVPALGLLAFVRWIPARPAPVASR
>fig|644966.3.peg.1765 Multidrug resistance protein B
MKPVVRLAARLRAAAIPTGLPPSLYWLAAGQVVDSLGSGLVFPLTTLFVVQVLGRDLTWAGSVLFFHSLAATLGATLGGRLADAHGRKPVLLASLAGAALCSLVIGWRQEAALYAATMAVFGLVISLFRPASQALVSDLAPGRERQVFGLVYMANNLGIAAGAALGGIVAAWSFRAVFWADALTYAVFALVLAKAVPDPYGQRLRARRSQARAATDPAASQSRGHPVSTGGAGGDEPAPAPGTPAAAVSAVPVPAGGTGAPEPGSGPAVAAPRTPAPAVQSPATRPRGGRQEHRADPPRSLGSAWGTRLAVWHRQGLLTVVLLAVASAGLFFPYAQLHTALPVDMTRHGFSEAAYGLLWTLNALLVVVMTPVASTWADRRGWTLDGMLKGSAALHAAGFALLLVTGVWPAYAAFALAMVVITAGEVLHAISYNAAVARAAPEDRRGSYQGLAGTLAGAAWMVGPLAGGAIVDRLGIHALWTVTVAVALAALGVFRLAEAVESARRRASDAAVPTGSVPQGT
>fig|644966.3.peg.1861 
MIALIARYVTRPGLGDQVEAAIREMILLSRQEPGCRVYQVNRSVDNPDEFLLYEVYDDEGALKAHWQSPHFRRIIEETVVPLLERRERRFYRLVEP
>fig|644966.3.peg.2017 Glutathione transferase fosA (Fosfomycin resistance protein)
MGILQMNLIHRGRRDAYLEWGSAWVCLQERPARRPEHPTPGVDHVAFFIGPDDLEPAVERLRSCGVTIARGLMQRGTGWSVYFLDPDGTQLELHTSTLHERMQVWR
>fig|645463.3.peg.1336 Permease of the drug/metabolite transporter (DMT) superfamily
MGEKSKGYVFIAIAGLLWATLGLFGKFLMGNGLTSEQVAFTRLFFGFIVLGVYSSIRTPQILKISKKGIIYSVIIGIICQAMFNLCYFKAIDIAGVSIAAVLLYTSPLFLAIFSKVCYKENITRSKLFSLILCFIGAIMAVTGGRLDFQGLNAFGLLLGVLSAIAYALMPTISKNALKEFSSSTILVYSFLFGAIFMIPSSRPWEILNYAKDLDVLSCMLMLGIVPAALAYIFYAAGISKGVELSVAGVVASVELVGSVIIGCTILGESFSLGKLFGVMLMLISAVVALNLSYDEIRIFYKSNKLKQIEKTESI
>fig|645463.3.peg.1341 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDTKISINENMSLGKRFFKYLAPSVVAMWVFSLYTMVDGIFVSKGVGELALAAVNISMPFINFIFAVSLLFSTGASTIIAIYLGKKDIKSANEVFSFNLVSIIILSIIILAITFFNLDRLALFLGATESTIGMVKDYLGIIIFFNGFFIVSYSLEVIIKTDGFPILATVGVIISALTNIILDYLFVIEFGWGVKGAGIATVLSQVFSTIFFLIHFLRKNSTLNFSKFRIDFKTLRKIVFIGFPDSTTELSCGIVVLLFNLSLTKYIGENALIYYSVINYINTLVLMTMMGITQGMQPLTSFYYGAGNIDNVKKLLKMGIKATIIASVAVFAICMAFSGPIVSLFIHPEETMLFNEGVRVFKIFSISFLLVGINVIISGFFVSVEKPSISTVISLGRGLVIVVLSLISMILIFGGQGIWMTTIVSEFICLILSLVFLKKNFSTLDSNLNKVA
>fig|645463.3.peg.1363 Vancomycin B-type resistance protein VanW
MSNVNKKLVIAIGAVALVAIIFIGIMCMQFKGEKIAKNTYVNGVDIGKLTKSQAKQELAKKYKLENVEFNYNDKSWKVKSKDLNLSTDLDKTVENAYNLNRKSSFFGNLSKTISTNFGKKSNLVVVINYDKNKLKAEMEKIAKEIDVDVKDATLDISGEKVKVIPDSDGLKMDISKSMENFDNQTKKGNYKNELVVKATPAKVKKEQLTNIDTNLGTYSTIFKTSQINRSINIKLATDNISNVLLMPGETFSFNKHTGKRSKENGYKSAPVIMEGEMEEDYGGGVCQVSSTLYNSVLYAGLEIVNVKNHTIPSSYVPKGRDATVADSGIDFLFKNNLKHPVYIKNYVSGNQIVCNIYGSAEDKQNITISTKLDGVSQTTMKRVNDPTMPKGKEKVDKSGRNAYSVSTYRTFNDANGKKIKTEKIANSYYPKKEGIILVGTMEPKPEEKPNTDENKNNQNTNNQNPNNQQKPETPPTDNKPNETQPQPQA
>fig|645463.3.peg.1432 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENLFTRKFTTFEFLKFVSPAIISMIFISLYTIIDGIFVSTLVGSDALASINIVLPIINLVCGFGIMMATGGGAIVSIRMGENRQDEANSTFSFIVLFSLIVGISFTVISYFFIKEISILLGATDKLLPYCITYGKVMILCTPFYILKFIFNYFARTDGNSKFSLFLSVIGGVTNIILDYVFIKYFGMGLLGAAVATAIGIILTCVLGIIYFLSNKSTLKLRKPKTDFRLIRDTMINGSSEMVTELSTGITTFLFNVVALKLAGENGLAALTIVLYAHFLMTSVYLGFAAGVSPLISYNFGAENSDKLKETFKHSLKFIFVSSLLVFIIALVFAPFIVRVFVSPDNTVFKLALQGLKIFAFAFLFVGINIFASGFFTAFHNGKISAIISFSRAFVFIIIGIIILPPMLNMTGLWLTVPFAEVITIFISILFIKKYKGRYKY
>fig|645463.3.peg.2557 Membrane component of multidrug resistance system
METQSNNKKGNLIIAIVMTGAFISSLSQTLLSTALPNIMSDFKITADIGQWLTTIYLLIAGIIVPTTAYLINRFSTRKLFITSMSIFSIGCIIALFSNNFSTMLIARVLQAMGSGSLMPLLQVIILYLCPEEKRGAAMSLVGITVGFAPAIGPTLSGWLVDSFGWHSLFLFLSPIAILDVILSFILLRNVGETQKLKLDIPSIVLSSLGFGGLLIGFTNQGNYGWTNIATYLPILIGIMSLILFTLRQLKSKEPFLELRVFKNKPFLISTILIMIVYASMMSATLMIPLYVQSVRGFSALSSGSLMLPGAILMVVLNPIAGRHLDKYGPHALSILGTGCLFLGTLSFAFLGRDTSLIHVSLMYCIRMIGISMVLMPLTTWGIKTLDRELISHATAINNTLRQISGAIGSAILITIMTSATKKAHMSSNMLSNIHGIDVAFSIAATLAFTGLIVSICFIKRHQIIRS
>fig|645463.3.peg.3353 Drug resistance transporter, EmrB/QacA family protein
MKQKWIVLIIICIGVFMSTLDGSILNIANPTIAADFKINMSQIQWVVTAYMLVVTATMLFFGKLGDKVGSNRLYALGFFIFTIGSFLCSMSNNLSTLISSRIFQAVGASILMATGLGIVSNAFPANEKGKAIGITGAVVGIGNMSGPVIGGIILEHFGWPSIFIINIPIGIIAVFLGIKFLPKPVLDEQNKSFDISGLLLFASCTTLILLAMNEKGNTRLYLGITALIIFLLLALREVKFEQSFIDLPLFKNRNFTVGNIIGVACYFPQMAVSFLLPFYLEQLKNLSPMMAGYVMTVHPLIMVLIAPIAGSLSDKHGAKNILTASFSFMTISLVGMALLKADSPLYLLIVCLVIFGLGLGAFSSPNNSSILADVPPQKQGYGGSFLATIRNLSFALGTAFFSSFFAQSLTYNQKFKSHTSAYVIASNQSYWIAASVCFIGLILTVFFMRKTDKSIS
>fig|645512.3.peg.1301 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARNDLSRLGTAPLGKLLREFGAPAVVSLVVNSVYNIVDQIFIGWGVGYLGNAATNVSFPLVAITMALALLLGNGSCSNFSLSLGRRQPEEAAFFVGNSLAVESVLGSVLAVFSWVFLTPMLKLFGATPTVLPYAQSYGAICLIGTPFVMVTLGLVNLIRADGSPRWAMWSSLTGALLNVALDPIFIFDWGLGMGVAGAAAATVISQMVSFFMTVAYAFRFNSITLQRHHFRIQRQVMSRILSLGASSLLNNVTFIIVQICMNNALVSWGTQSPYGSDIPLSVMGIVMKVNQILIAVLIGISIGAQPILGFNYGAGNMGRVRRTYGLSVWTATVVCVLGWSVFQLWPDQVMELFGRGSDLYFQFARRCFRVYLFTMPIVGYQIVSGLYFQATGRPGRSIVLTLVQRILFMVPAILLLPLAWGFDGLLYTMPVADLAATAATTLMIVPELRRLRQLENSRPSE
>fig|645512.3.peg.1417 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPNETNMPQLAGDKNAERARMGTTPELRLIFQFSAPAMMGFLSNALYNIVDRMFIGHWVGSPGLAALTVAFPIALFQGALATLVCAGGTSLLSRKLGAGDLEEAKQTMGNMMTLTATMTFLLCLGTEFFLDPVVKLCGATPDILGLSKTYLRIVLWGMALQFGTIVQNETIRALGRPRRAMESVVIGTMSNVALDWLFIAAFNWGVAGAAVATVIGQGLSLAWVSIDLWGKRAPLNLEPPCWKLRWSTVRQIAAVGFSPFIGTLFFSILMVLFNLILSEYGGSLALSAQGIFFSLDSLLFLPVMGLGDGVLPLVGFNYGAGNLRRVKRLVSIALWSSGIFLAATTIITEIWAESMVALFSSGNPALTVAAARAMRLGYSAMPLAAISITASYVLQGLGRAKESLILTLGRQLIILPPVLILPRFLGTDGLWVSFPITDILGGVIAAWLLHGESKRWVEPAPRPAAQEE
>fig|645991.3.peg.246 
MKNKKKIIIILLIIMVFLGACIFGYYWHQNKYYIKTDDSRIAAATIIVSPQITGKITSWTAQEGSIVKAGQTLGRQDTNSVASSSAISVKTLPQTGSMSISKAEIVAPVTGQIIKTAVQEGEIVNPNQTLAIIANTNDIYISANIEENKISRIRIGQPVDITIDSVPGQTFQGKVSEIGQATASTFSIISAQNSSGTFTKVTQLIPIKIRFPIHPDLQLLPGISAEIRIHLAE
>fig|645991.3.peg.1007 Daunorubicin resistance transmembrane protein
MRTYYEIMKIAWKNSFAYRLDTLIGILGSVIALYVQIYLWRSLYGDYSISVLSLQDMVTYQIMGIVLSLLYADAVAREVGGKVLDGSIALELLRPYNFAAGMFFRTLGQTLSGFATKGAAVLIFAALVFHFRLNVGLLDAFLLMVAIGLNIMIYWLLHYMIGLLHFTFLNATWFVRILRDTIRILGGGVIPLWFFPDVLRKISYFLPFQLLYQFPQSLAVQKISTGELLFNLAMAGSWIVLLGLGTFFLWKMGVKKLVIQGG
>fig|645991.3.peg.1969 Ribosome protection-type tetracycline resistance related proteins, group 2
MNMINLALAAHVDSGKTTLAEQILFQTGTLLKAGDVNKGSSRLDWTEIEKKRGITVFAEQAFVHRRGIKLNILDTPGHTDFYTELEMSLSVADIAVILISAVDGIQQNTEKIWDLAGKKKLPVIFFLNKMDRTGSDHQKVITEIRQRLSPHALLVQEAKYGESDLAGIEDLLLQQTSDSAILEHLAEKDDSILEKYLSGTEVSADELLAAAQKLFLQRELYPVLLGSAAKGIGVVNLLDCAVDLFQPPDREALSAQDLRARIYKVRHDPKAGRLAYVKVLSGQIQVKDSVILEENQVCKINQIRLYNGPKFILADRLEAGDLGVLSGLGTVKAGDVIGQNEITNENPELKPILLTKIELEQEEDYPALLKALEILEAENPVLAAEIDSSAKEITIKVMGLVQMEILEEIFAERFGLQIKLGKPYVMYYETVTAKSKGFCHFEPKKHYAEVEIELSPNERGRGNEFQSLVNPDDFPLQYQTVIRKTVEEALKRGALAHLPVQDVVIRLIAGKHHLEHTHGGDFRIATIRAIQQALENNQLLLLEPIMEFNLVIPNDFAGRILADILKMNGEYTTTESQGTEIMIKGFVPASTSMEYPLELAGITGGAGRIRMKYHSLRECHNEEEVLDRIRARESSQDKNRDSSEDILYNSVSLFRAKRKMKKVTNDQE
>fig|648757.4.peg.809 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MDTRRPTLISVVLPAYNESEGLPVVVSSILHALANTGFAHEIVVIDDGSTDGTREVMLDLCAKQPSLRYVRFSRNFGKEAALSAGLRTAAGDAVILMDSDGQHPPALISVFLDKWREGAEVVAGVQNERLESWTKRRFKAGYYWLMQAGSHVVIPPDAGDFRLIDRKVVDAINALPERNRQMKGLFAWVGFRTVLVPFQPEPRVAGVTKFTWRQLFKLAFTGLTSFSVVPLRLVSLTGLVISSTAFLYGCYLLFEHYVVGGRVPGWPTLAVGMMFLSGVQLLALGVIAEYLGRTFEEAKQRPIYIVAEDSRVKSPPHAASPVYDASAFVADARASETETGRHS
>fig|648996.5.peg.926 Multiple antibiotic resistance protein MarC
MELFKYLISLLVIVDPIFAAVMVATLLPGEEEEIKRVAFKASATVLVASFVTLLFGQGLLKIMGVNIYSIKIFGGLILLSMAFQMLQANPPKTKHTKREEEALQEKDEIAVIPIGIPILFGPGTFTTLLIFREEVQSASQLAQLVAAVVLTVAVIYFTLEKASLLARKVGPTGIGVTVRVFGLFVGALGSQFVVEGVKHLWSAG
>fig|648996.5.peg.952 Probable multidrug resistance efflux pump
MRRLFTLLGLVAVLTVTAWFGYFLYLHYRFVVTDNAFQSANFTAVSTEDVSGKIVKLYVKEFQRVSKGQPLFKVDDSSYRERLRQVEAQLKAVDAQIEAAKLRLSRLQVQLPASVGEAEAALSGAKASVSALGRQLSEAEANYRATLAQAQAAVPAARSALEAAKVDLERWRRRLERYRALYERRVISLQQFEDVKAAYYKALSAYRAAESRLVQADSSLKKAEALKEQVKALEARLKAVRAKVVAYGQRLKASEASLKQIEETRALLKELLARRKALVAQEAQVKLLLSHTLVRSPVSGFVAKRWKEVGDFTSPGLPVFSVYDPSSFYVLAWIDEDKVRFIRNGTEGRVELETCGRSFKARVVAVGRSAGSVFALIPRDTSQGEYTRVVQRVPVKIKVFNVPLECVKPGTNVTVYLRKR
>fig|648996.5.peg.953 Inner membrane component of tripartite multidrug resistance system
MKRVFFLGGLIVAGMFMTLLDTTIVDIALPHMMSAFEVEPDDIQWVITSYMVASAVSMPVVGWLGGRIGHRNTYLLGIALFTAMSALCGLAPNLDFMIFARTLQGVGEGLAVPMTMTLLFELFPPEKRGVAMGLFALGATFGPSLGPTLGGYITEHLSWRWIFYVNLLPGVLVVYLLTLFMEDDRHLHRSDKPLDIPGLLLLAASLTSLIVALSKGNSWGWDSMKVVSLLYFFFISLVLFVFYELRTENPLVELRIFKFPFFRYPVISLTLFGMGVYASYFLLPLYLEKLRGFPTITAGEILFWPSMATGLVSMVVGFLIDRKLLSKRTSIVIGVLIFTFGTYLQTALDLDMSKSEVVLYLLPWGAGMGFFFPALSQVSLGSLKGELLRQASGLQNLLRLVGGSVGTAVSTYILVSSQPKHFVHLTQEVSPQAPQVVYFLNRWKEHFLYDCSSVPQIASEQAKGVLAKLFSLHAFWHSFGDAFFFALVCGVLTLIPALFVEESGESGVDSLNFKPSDG
>fig|649349.3.peg.202 
MWNKIIPIIIITFMTNFNIASAQNVSEERITMLVTFNVKVEQKEALRKALIADKNGALNEKGNISMELFEHKDKPNTFYLFERWDNQKSLDEHFTKKYAKDVLELNKVALTKPMQILYLHDVSPLPKNEIKNPLSSDTPVDLVVIFKVKDGMQETFINQFQKSIVNSRPEQGNIEFFFHTVPGDNTKFVLYERWRSQAAIDFHFAQPYTKELFEMFKSALEQPIEEYLNFITEIK
>fig|649349.3.peg.468 Permease of the drug/metabolite transporter (DMT) superfamily
MNYRFFLLGILFAALWASASAAAKIALPYIEPLAMFQVRFFLAGVLLIAYSLIITKDRFPKGKEWVQLIIFGGLNTTLYLSLFVLSLREISAGIGSLATSTNTLIISALSTVFLGQSLKSKQWMALLLGFAGVGLACYPLWENHQATPRGLFLIFLSMLSYSVGTLYYSKIKWNLSRITINGWQVFLGGVLMFPLTWYFHVDGANQWNSIVWTSILWLIFPVSIGAVQLWLYLLKQDTVRASFFLFLCPIFGFIYANILLQEPLTWYTWTGTAMVLAGLYMGIEKKPR
>fig|649349.3.peg.644 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSIIIPVYNGASSITSLVEILQKELNSYSFEIILVNDGSKDNSAEKCKSLATDHSEITFINLRKNFGEFNAVMCGLNYVNGDYAVIIDDDFQNPPSEIIKLYQKAQEEDYDVVYSYYEDKQHHWMRNFGSKVINLLTTYLLKKPKDLYLSSFKLIKKDVVEEIIKCKTPHPYIDGLIFQVTNHVGKQKVVHLERKEGHSNYTVSKLLSLTLTILFGYSLIPLRLTLLAGLLSIIFSLSYMILYALNIISTWGSPIIIFMCGVILCALSLVGEYVGKGFLMHSGKPQFVIRSVVKKQ
>fig|649349.3.peg.833 Florfenicol/chloramphenicol resistance protein
METQFGETPLPLKPTIIHSAEQVEKVLFETQSGAKIETVLSRYRAGWTSMCISPQSGCGLGFTFCATSAMGLMKNLSADEICPQVFHSHWNNQVPDSIAFMGMGEALANPNI
>fig|649349.3.peg.1115 Permease of the drug/metabolite transporter (DMT) superfamily
MDNNKNSLAYGALFIVCIVWGTTYFAIRIGVETFPPFLFAAIRQVVAGGALLLGLKLTGSLNMNKSDFLYQSVPGVLMVALGNGVIGWCERYISSGLAALILSLIPVFVVVISYLFGFDRRKPHLLIIVGLILGCLGIVLIFRDNLKDLANPAYFTGMLIAFGACLAWASGSVLAKYKIPNSKNVLQNAALQLFSGGMALFVISAFLDDYSELKTVTTSSIWALVYLIVVGSVIAYSAFVYALKHLPIGISSLYAYINPFIAIMLGFLFLNENLTGITLLALVATLSGVYCVNRGYQKMSKK
>fig|649349.3.peg.1785 Multidrug resistance protein, AcrA/AcrE family protein
MKKIILLWGFALPFLACKEEVKDDTGLSLPVKSLKKDSAVTTFTYLGAIEGKVNVEIRPQVEGILEKIYIDEGDFVKAGQPIFLINELPYQEQVKNARANVEVERARLRNAEIELDRLQPLVDHEVISDVQLKTAQSHLEVAKASLARAQAQEATARINMGFTTIKAPVNGYIGRIPKRIGNLVAKNDNQPITVLSDIEEVYVYFTLSESDYLFYKKMSSDSTAKRINPNVKLVLADGSIYEYTGKIDADAGQVNRSTGAISLRATFPNPKKLLRSGNSAKILMEQYHPNVLLIPQVATSAIQDRTFVFRLLPDNTVERVLVEIEGKAGKNYIVSDGTLKPNDRIVTSGLDKLTDGVKVNPMGEKQILSQKLP
>fig|649349.3.peg.2735 Permease of the drug/metabolite transporter (DMT) superfamily
MNQKGILFTLLGAICFSAKAIMVKLAYLQYDASTMELLGLRYFFSLPIFLIIALWRYKNGKFISLKIKEWAILLLSAFLGYYMASWLDFQGLQYVSAGIERVILFTYPTLVVLFSRLFFKKAISRTSIWALVLCYGGIFIIAAEPKFFAGENVIVGGVLVFLSAVTYALYLVFSGELSSRLGSINTNTLGMIFSSLFVFIHVAFTPAISWGNLDPGVYYYGLGIALISTVIPTFLMMEGIRLLGANKASIIGSIGPVSTLIMGYFFLNERFTLQELAGSILVMIGVFLIGKK
>fig|649349.3.peg.3171 Permease of the drug/metabolite transporter (DMT) superfamily
MELFYISKKSEGVSRSSLSLIILIILAVAWGLSFLFIKKLTVAFSGVEIGAGRIFVASAFLLPFALYNRKGYPVSKTVPIMLSGLFGYLLPAMVFGTAGSKISSSLSGTLNATTPIFVLLIGGLFYKKVIYRYQYIGIFLGFIGSLILISNGEKLALDFSNPYALLIMIATMMYGLNTNILSFHLKEVKPIIISSFSVGMMIIPATAILLTTDFFGKILLEENRLYLLYFLILGMVNSGLAAILYNYLLKITTPIFASSVTYLIPVVAIIAGMLDGEMIGVSHLVGMGIILLSIFILNKKVSA
>fig|649349.3.peg.3491 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNILKGYFFAAASAISFGLIPLFIIPLNEKGIHLDTTLFFRFLFAALMIGVYCTFKKQSLRVNQRDLFLLFVLGILYALSAEFLLWGYSAMSPGIASTVLYVYPLMVAILLYWKYSEKISNPTRWSMFLALLGVLIIGWEGENMRFNFWGTIIVLTSAMTYALYMVIVNKGKLQAQGIVVTFYSVLFSSFYYLIKMSMGSFILPSLDTLGFISLFSLVTVVISVLFIILAIQWIGSTPTAILGALEPVVAVGVSVAIFGEKATWNLFAGLILVLSALMVKVLGDTQSLRH
>fig|649638.3.peg.248 Permease of the drug/metabolite transporter (DMT) superfamily
MSAPLSPRLGLVLLVVITLIWGSTFVIVKETLATLSPALLLALRFSVAALLLVWVPLPRAVWRAGLVLGVLSFLGFATQTVGMTMTTASKAAFITGFSVVLTPLLSALWFRLRVPARAYVAALTALAGLGLMTSTGPVGVSAGDFWVLGTALAYALYIIYTGEAAQRHGALALSAAQLWPMAALAWAWAWPQLGDLRGITPGAAFSVLYLAAVATALVAVMQIAAQRVVAAHVAALVFVLEPVFAAGFAYVLLGESLGFWGWVGAALVGAAMLLSELRVRAEEPLPAPPTPH
>fig|649638.3.peg.1724 Multiple resistance and ph regulation protein f
MTTFFLVVALLLFGDILIGLLRVLHGPSAIDRMLAAQLFGTAGVAILLLLAEVASSPPLRNVALVFALLAVLAVTAFVKHARTLPAAQSGTSGGTL
>fig|649638.3.peg.2148 Glyoxalase/bleomycin resistance protein/dioxygenase
MGFCQHDAALPEHPGLILTLVLDDVDGTYARLCERGVPTEAPPRENARFGIYHFFARDPDGYRLEVQRFLEPL
>fig|649638.3.peg.2975 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLRPLRVNPYDRDILALALPALGTLAADPLVSLVDTAFVGRLGSVPLAALGVNTALFSLAFVVFNFLAYGTTPMVARSLGRGDREAAGRAVVQALTLALLAGGLAVAFLQLFAAPLLRLMGAGEELVGPALGYLRVRALAGPALLLITAGNGAFRGYQDTRTPFLLTLGLNLVNVALDPLFIFGFGWGLAGAAWATVVAQWAGALGFVWVLFARRRALGISVALPRFAELRPFVRVGWELLVRTAALLSTLTLATAVATRVGVLEVAAHQVAAQLWLFLALVVDALAVAAQALVARYRGAGQPLRARAVADRLLAWGFGVGLVLAAGFALFAPVLPRLFTDDPAVVRAVLTVFPFVALMQPLNALVFVWDGVLMGLEDFRYLALAMLVSAACGALVLLLVLPLGWGLTGVWWGVATLMGVRLVTLSWRYARLGR
>fig|649639.5.peg.405 
MLIQTRTITVKPGYSDQVVDRFSGDSPIDTMDGLIDRTVVVNRKKRDQEEVMVMIRWESLEAWKNWEKSDAHIQGHRNNKNKEKPEYILDINVNMYEVKAVKKR
>fig|649639.5.peg.895 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNSAKKLSLFAITWPIFIEMTLHMFLRTADTFMLSRVSDEAVAAVGVANQLIMFMFFLFQFGSIGATVVIAQYLGAKKHDQIHKFSGNALSFNILFGIVVSVVIVSFTSFYLGFFHLTDELFAMARTYMLIVGSALVLQAMMLTLAAIIQAHGFTRYTMYVSVGMNIINIFGNYVLIFGAFGFPQLGVTGVAIATVFSQFLGVTANFIILYFKVKVKVRLIDYIKWKKDRLMKILSVGVPAALGQISYSASQIVTTGFITVLGPDMLTTRIYTLNILFFVIVLAISLGRGTQIVVGHLVGAGEMDKAYKEAFRSLKWNISLCLGVAVLLVIFREPLLGLFTSNPLIISTGAVLLIMGLILEPGRCLNIVLGQTLQATGDSRYVMLVSVIIIWAFSVPLYYVLGIHLGFGLIGIWIAFIVDEWIRGIYLLQRWRSGKWRAKALVKQEEDLKESV
>fig|649639.5.peg.2076 Permease of the drug/metabolite transporter (DMT) superfamily
MYVLIIKRFVFRKKGSKLSKTWTYILVLFVMILWGLNVVAVKFLVESLPPVAMQGLRIFIGGIIAIIVLFFLKDLRKLTKKEWGYTIVAAVFGQMLHHSLLALGLVQTTAGNASLILGLIPLATAIFAMLFLKDSITLLRTIGIALGFGGVCLVVLQNAEIGVISPGDILVFIAMLSQAFSFVIIKKVTATLSSRQLTAVMLLVGAVMLLILSFIFEPQGVGNLVHGNTIVWTVLVLSAVFATGLGHILYNAAIQEIGAGQTAIFNNLVPFISLIGAFFLLGEAIYTSQIIGFVLIVLGVLFGTGYIETRVLKKRMNSIGKKQKKQTA
>fig|649639.5.peg.2214 Permease of the drug/metabolite transporter (DMT) superfamily
MGMLNKKPWLIYLMLALATSSWGSAFIAGNYATRDFDPITVAFLRFFFAAIILIPLMLIKEKNHVLPKGKEWFLLASLGLTGIALYNICFFIATKEAPIVKSSLFIASNPVLIIILSGFFLKEKITSRNIIGLILALVGAAIIITEGNFMEVIRAGFQPIDIVLFIAVICWALYSVLGKVALQRFSSLESTTYAVVFGTLMLLPFAMIEGEWNEYIQATTLTWVSILHMSIIVSVISFIMYYQGIRTIGAAKASIFINLMPLSAVILAILLLDEPLLPIHIVGAAFVLTGVTIGTRPKRKKVNS
>fig|649639.5.peg.2939 Permease of the drug/metabolite transporter (DMT) superfamily
MKGNSIFYIGLTIISIIWGINFGISRWAMEVFTAEVFTLLRFGLAVPILFLILYKLEGSIKVEKRDLLKLVIIGFFGVTILELLVMYSIKYTTLANASLLNVAPWPIFAALFAPLFTKEVMTKRIVLGGAIALIGVTLIIGGGSDNLDLSGQYMLGNLLALAVSLIGALFNLACMPLMKKYSPLRVSTWYILFGSLFLIPFTLGGWSDIHWSTLTLPVVGAILYNVILCTVVAFLVWNASMNRVGATKANFYRYVVPAAAAVAGALFFNEPIMIGQIIGAIIIMSGLVIIGAEKKQLEKEGTVDSQQKVAN
>fig|65093.3.peg.2706 Multiple antibiotic resistance protein MarC
MFQHFLQDATTLFVVIDPVGLVPVFIAITQKEPQVSRQRIALLGVGISAIILFAFMIGGQTLLSALDISLPAFKIAGGLLLLIVGLRMVLNEDEHSASTDPESSIDLAVFPLATPLIAGPGGIMTVVLLTDNTKFGAIDQAITSLALMTVLIFTYVALLFANLIQKALGRTGVNVITRILGLLVAALATEIILGGIQDYFLTL
>fig|651182.5.peg.497 Acriflavin resistance protein
MSGISAWFTKNPVAANLLALLVIVGGVFSLMGLRIEGFPKIPSSYISIDIAYPQSSSEQVDSGITQKVEKFLEGLAGVKKISSYSSEGAAKILVQKETGYNMIRLLNDVKTKVEAIDNFPDKSSKPVISVDEFKDFVLIVQVYGDVSEQTLQQSARFLEKELQSDPKISKIESFGKKSREMRIELDAQMLKAYKISIGQVAAIVARDNAEQGYGLLKNDTNRIIIRSDVKIEHYDQLMNLPIITSSDGAKIYLKDVARVIEDYEDSDTKALYQNQNSVGIVLYSSNKGHMLEVSKAAYKVVENLKKQVPDEIHIDIWADFSTYMKDRLILLQSNAWQGLLIVFAILAVFLNFKLAFWVAMGIPFSIAGVLALMGESFLNYSLNDITTFGMIIVLGILVDDAVVVGESIFEERKKNLDRIEGTIKGVHKVAVATIFGVLTTIAAFYPLMLIKNDFGKILASFSVVVCVALIFSLVESKLVLPAHLASISITPEKPENIFLKGFYKVQESASNVLVFLNQQVYTPLLVATLKHRYSVLIIFISLAMAGGWLLKMNYVRTVFFPEIPGDVISVNVTMESGGSSKMTYENADAIDAAAAAINRELMEKHGTNEPPIRKIMTAVTGSQGIEIYAELQPQAMRVVNTLSLLKMWRSRTSNLEGVQTIEFRGNAETGGGFVLKAESHNIVSLRQAIKKLKAGLKEMQGVHDLRDDFKSSEPELRLNLKNEARHLGVTPEDLASQIGMAYGGFEIDKFQKDNDEIKLRIIYKKDQRKYIHQLLETRISLADGSLIPLTQVANIESRFSSGFIHRINGKRVAEVEAAIDKRIVSASEVFDALKQKVIPAIERTFPDVKILAGGELEQEGEVKGGLVKALIMIMLLIYALLAVPLKSYWKPVVIMSVIPFGFTGAVVGHLIAGVPLSILSFFGMLALSGIIVNDSLVMLTRFNDIMAQGKTVNKALTTAGSSRFRAIFLTTATTVCGLMPLLFETSEQAQYLIPAVVSLAYGELFATFITLLLVPLLMNIAYDIREVFASNQSAQYVC
>fig|651182.5.peg.1099 Acriflavin resistance protein
MVTLVFSTIIALGGIFSFLNIGRLEDPEFTIKETVIHTHYPGASAKQVELEVTEPIETAIQQLKQLKEVRSISRAGVSIIFAETQEIYDKHNLPQVWDELRRKVGSVNGQLPAGCQTPIVNDDFGDVYGVLFAITGDGYDKKQLKAYAEDLRRELLTCNDVGRIDFWGLPREAVFIEIDRAKLTQLGLNPNTIFDTLNGQNSVTPAGAVQVGSEYIPFRITGDYTSIEDIANQLISGSEGSMIRLKEIARIRHDIITPAAELMCYNGKEAVAIGISTISGGNVISMGDSIDQRLQELQANTPFGINIHTITSQSKIVEKSVSGFVSNLISAVVIVILLLVVFMGWREGIIIGFVLILTIFATLMVMKSYGITLQRISLGALIIALGMLVDNAIVVTEGIIIKMRQGIGREEAADQSVKETMWPLLGATIIAILAFAAISLSKDMTGEWLASLFQVICISLGLSWFFAITTVPCFCVMILPVPKNNGKKKHSQRFFKYYKTIVGKAIDHRWLTLTGVIGLLVVAVWGFSHVKQDFMPDTNRSQFTVDIWMPQGTHINSTEKQLEQVEKYVARLEGVQNISGFIGRGPLRFLLTFSPEMPDSAYAQLLIDVDDFRRVPELKKNIQQYLDKEVPQVIGSVDAFKLGPGGGAVIARLSGPETKILRNLAGQVKKIMAENPNSRSIRTDWGNQIKVSKVDFADLRAQGLGISRPEIGSSIAMNFTGSVVGQYRHRDDLLPIILRPPKKQRNNIDFFDEVQVFSQAKNKWVPVQQVTNRTITGVEDSVIHRLNQKRTLRVLCKQREGTTDALFRQLSPIIEKKLKLPPGYNLEWGGEHEEQIEANTKLMSNFPIAFAGMFLVTVLLFNSLRYPLIIFMGLPLVVVGVAPGMLIADKAFGFMAMLGFLSLFGMLIKNEIVLLDQIKAELADGKEPFTAVVESSASRIRPVTMATFTTVLGMIPLLTDAFFSPMAATIMGGLSFATLLTLFVVPVFFSTLFSVRRPGVKHF
>fig|651182.5.peg.1941 
MAVTVLIKRKVVPENESLLIELYREMRGSALNQEGYIGAETLKRVDQTGEFLIVSKWRHIDDWSKWLVSKERRAYQKRIDTLTNAETKFEIYVH
>fig|651182.5.peg.2590 Acriflavin resistance protein
MKAFLNFILKRTAFANTIMVVIMIGGALSAMTIRQELMPAQETRMVELSVDLPGASPEEMNTSILMVIENAVRGMDGIKRVDSRAREGGATITLTLLEHVNTQKMLGDIKNAVDRIETLPEDAEKPVISIPSHVEKALSIIVFGDQPVMWLQKNAETVRDDLRTLKGLKNVELAFPREQEISIELSEHTLRQYGLTLSDVAEKIKQSSPNLPGGTLFTNEVDITLRTSERREWASQFEGVVIGRTTEGIPIHLSDIATLKDGFGVSEIESWFNGLPAVQIDVYAVGDESPISVEAAVQEYIETIVPKKFNGIQVVIFENQASAYRSRMALLIDNALIGLALVLITLGLFLTPSLAFWVMVGIPTSLLGGLVLLPVFGGSLNMLSLFAFIVTIGVVVDDAIMIGEAIHVQLKNGLPPLKAAAQGLEEMGGAVLLATSTTIIAFMPMFFVPGEMGVLFYQIPAVVIAVLLVSLFESVFILSAHLSVGHPEWSWLKTLARPQQMVNAWLEHFIENRFRPFIQTSLRNTGTLFAMAFVLLLLTIGAIAAEYLDFDFTPTIESDTVIAQATLPYGTPKKQSIKIQKQLVEAANTVLKENNMKSPGVFSLIGTRLEEGEVEVESLAGFHYISVLMALPPEEERILSGRQFAAAWQQAFGDPGELESLNFTGETNVTGGEPIMLEVFHPDPEVSRSAALSLGRRLRTISGLTSIDDGVRAGKPELTIRLKESGQQMGFSAEMVALQIRHRYHGAEALRFVRDGSEVKTMVRLTQAERNSISSLQDIQLRSTSGKLVNLKEVADITQDRSYTSLARRDGKRIYPVTADIGFGIDDDLVEDALEEAIVPQVLSDFPGVSIHFGGEDEENDEALGSLGNGFLIILGIIFLVLTFYFNSFTQPVMVLSTIPFSLIGAIWGHIILGCDLSIVSVIGIIAMAGVVVNDSLVLVTTYNRYQASGQPPFKAIVDAACHRFRPILLTTLTTFFGLVPLLTEASEQAQFLIPAAISISFGLVFGTVITLVMMPGFLWLFEKKQPKISNTDFLIKRLFIN
>fig|651182.5.peg.3918 Acriflavin resistance protein
MKALGNWSVEHRVSVNLIMIFLIVAGLYTILNMKREMFPQFSLDMIDISVAYPGASPEEVEEGICIKIEERLKSLEDVKTMYSTALEGQGSVLLELKAGTDINEKLDEIKTQIDLIDSFPDQAEDPVVVEIKNNDPAIYLAVYGDADERVLRHTAEKIRDDLVETDDISLASLIGVRDYEISVEVSEETLRRLNLSFDQVAAAVKTGSLDLPGGKIKTKGGEFLVRAKGKHYTGEEFEQIPVVTREDGTTLRLGDIATVIDGFEDTDIKARFNGKPAVLVVVRRTDSQDNIAISNTVKAYIENHKDSLPRGIVLGYWFDMADMVQGRIDLLLKNGIQGILLVFIVLALFLDLGLAFWVAAGIPISFMGAFLVLDYLGASINMLSLFGFIMTLGILVDDAIIVGENVYTHYKMGKSAKTAVIDSIGRIGAPVVMAVTTTIVAFIPLMHIAGIMGKFISIMPQTVICILVISLVEAFIILPAHLDHALTTAKKNKTLICRVCFSWLDWLKKDLLDGHKWFRDRVEKALTGFIYSIYTPALKYCVKNQYFTLAVGFGVLIVSIGFMAGGHVPFVFFPKTDSNWIVADIIYPLGTPFEATEKTIKQIEKGAVELNSFFRHRVEGGEDLVVNHFSQVGIIPRRDWKPGVYGGHCGEAWIEIQPASKRPDISAPDVTAKWRELTGDILGAEQLSFSIIGGGPGGNPIEIQLAGFDLEQLELAATALKNEIAKYPGTFDVTDNFRPGKMEKRIHIKKGAGSLGITMADIATQIRQSYYGDEVLKIQRGRDDIKVMVRYSQKERESESSIDELRIKTRDGRQIPLNQVADIEMKRGYSTIQRVDRKRIITVISDIDETAANARQIVEDLKENYLDTLVNRFPGVSYDLEGQARRTEESIDSLKLGFSLAAMIMFLLLASQFRSYIQPVIIMTAIPFGLIGAVAGHYVMDLDITMISIFGIVALSGIVVNDSLILIDFINSKIRRGAGMFASVIEAGQNRFRPVLLTSVTTVAGLFPLLLETSFQAQFLIPMAVSISFGLIAATVLTLIFVPALYVVINDLTRLFVAGEDEVKVEDEIKLSKNKPSLYKAIK
>fig|651822.3.peg.234 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLQPQRMGREPMLKLIFSFTLPSIAGMLANALYNIVDRMFVGRLVGTMGLAAISVCFPFMLLLLSLSLLFGIGAVPMISGALGEKNDDLAEAVLGSALAAAALVSVLVSVVAFIWMDPLLRLSGANEELLGPSREYLRVILLGAPFGMLSFVMNFAIRAEGRPNFAMATQVLGAVANIVLDALFVWGLKWGVAGAAWGTALAQLASLLWVASFYWRRLGHLRLRLQHCRLQPRLLGRLTALGFPSALTEVSFSLFYVLFNQSLAKYSGPLAVSALGAFMGWDSLLFLPVVGICDGVQAIFGFNWGARRPLRVLEALKLALILGTGYFMGSVVVVHFFLWDMMRLFSTDPELLTIAVVGGRVAYAGVIFTGVAMVTNSFFQGIGLSGLSLFLSLCRQFVFLIPALLIMPRIWGAIGVWGAFPALDAGGGALSILLLWGQCRRLGLLRCEARRLRLARLRRAGGGA
>fig|651822.3.peg.561 Permease of the drug/metabolite transporter (DMT) superfamily
MEKERAPLIKEGVANPTDETTAQGRISARAAALIADLALLLCALLWGGSFTVVKVLLDLYPPNWLLFLRFSCGSALLLLFFHRRIGRMSRQAVAGGVVIGVALFGAILCQTLGLLFMAPGRQAFLVSTYVLFVPLLLWLFRGLFPGWHTLAATCTCLIGMALLTSDLSGPLGRGEALTVLCALFFALQIIAISRYSAQCDPISLTFVQFTVLSLLTLAAALLFERPLQFHWRRGLPELAFAIVFCTFLCYLVQICAQRYTKASHAAILMSLESVFGLLWSVIFLGEPTSLRMLFGCLLIFLSVLLVELEPLLKRGRCPGGPSARPDTASPRSPSAPSSGGPQGPGTCSAASGAEGAPAAPAAPTPAAPRGRERP
>fig|651822.3.peg.1335 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRRQGLEFALRLRRFAAAGIIIIMKETAVGGICDEGRSRAVSGVRGAAQRGGGADMTRGDVFRHIFYFSLPFLAGNVFQQLYNMADTWVVGNYVGDEAFSAVGTVTPVINMLIGTFMGFSSGAGVVISQYYGAGNRQRVHDAVQTAVVMTAVLSVVFTIVGKAMTPLMLRFMRTPEDVLPESMAYLDVYFSYIAGLLFYNMGAGILRAVGDSRRPFYYLVAAAFVNVVLDLVLVIVFGLGVRGVAYATVVSQGISALLAFSLLLRTDMSVKLTLRDLRVDLKLLWKIVRVGVPAAVQIGIVSFSNVFVQSYINQFGKYCMGGWTAYHKIDQLIFLPMQSLGLAATTFVGQNLGRGLADRARRGVRTALLCAVAVTLAASTLVVALAPQLVAVFNPEPRVVEFGAMFLHFLTPFYVLCCVSQVYTGALRGAGNSKVPMVMMIFSFVVFRQCYLFVVSRYVSNTPLSMGMSYPAGWMVSSILAALYYGHARLEATRLVERGEVLSAEEA
>fig|651822.3.peg.1846 Permease of the drug/metabolite transporter (DMT) superfamily
MDSRALRGNLLLLVTSAIWGFGFIAQQFGSRALPPFSFNACRFALGSASLLPLIVIFGWHDPARRRARAASRRLSVQGGLLNGGVMFLGAWLQQAGIAETTAGQAAFLTGLYILFVPLLGLFMHHRVPLTTWCAGILALVGLYLLSVREDLSVSRGDVFEIAGAVFWALHILCIDAYVKRTDPLEFSFWQFAFCALFSVGTALSLEPGGFAHVGDALLPILYCGVVSVGIAYTLQVVAQKDVIPAHAALILSVETVFATLGGAVVLGENLGLRGYVGCVLMFSGMILAQWHGLRGGMRPADVRT
>fig|651822.3.peg.1964 Permease of the drug/metabolite transporter (DMT) superfamily
MNLNRVVLGITLAAATGLIWGAGSPAYKLMGQQGVSMVTVTFLRCAVGGPVLWLLFRLLAPRHLRAPRRDLLRVLLLSILAPALNYLGFMLSVVYLPVATANVLHYVNPFVIALGSALLLHERPTACDLIGAAIVFAGVTCSVLTPEWRFDAGISIPGLLWGVLAIFGITAQALCGRAGSGGGMSGLGFFCWSHLLGTLWIALYKTFAEGWGDMATLTPAQMGLIAIPLFGGTVLGFSAFYAALQYIPAPTVTLLTSMEVPSALLFTALVLGARPTAPQALGCVLILAAIALSSFGARRRGGEVSAPPR
>fig|651822.3.peg.1988 Permease of the drug/metabolite transporter (DMT) superfamily
MKEVHIDCGAAPSAEGKMARRDVLLLLAVAVVWGVNFAVVKTGLRSVPPLFLVFLRYLFIVLPLIFFVKKPAVSWRTMAAYALLSGVGQFSFMFYSLKIGMPAGLASVVMQSQAIFTLILSAQFMGERIGGAQLAGIGLAAVGLGLIGGPFGAAAVPTAAFLMNLLAAFCWSSSNLIVKRASEESLRSGRSLDMMEMIVWSSIFVPLPMLGLSLVGDGPSAILQSLAQIDAAAVLSVLYLVVLSTLFAYSAWNQMIAAYSAGRVAPFSLLVPVTGLLSGMLFHEERVAPLQWAGIAAVVAGLAVFQLGERRPHAR
>fig|651822.3.peg.2127 Permease of the drug/metabolite transporter (DMT) superfamily
MKRSAIAGYAAALTSILIWGTTFIVSKVILEDFRPVEVILIRMVLGLVALFLVSPRLPRVRTVPEELSYAVAGFCGIVLYFLLENTALTHGLASNVGVIISAAPFFTATLNRLFYRSDRLQVRFFVGFALAMTGIGLISFNGVRMQISPLGDLLALGAAASWGLYSVLVRRAGGFGLSTLQATQRIFLYGVLFLAILSPFLGLRPNLAHLVQPKFFLPFLYLGLGASALCFFAWNFAVEALGPVRTSVSAYLIPVVAVAAGALALGEPVTPLSLLGTGLILGGLAVSEWRAGRG
>fig|653733.4.peg.1680 Acriflavin resistance protein
MFELIQRKRLGVLFIAFAIVISGITSYIKLPKESIPDITIPVVNIVVTHTGVDALGMEKNVTQKIENSVRSVSGIKRMTSTSSEGLSSISIEFMTHVNIRTALQDVKDKVDQIQSELPADADTPIVSEINLSEFPIMFLNLSGNDQGLLEYLADMLDDELSAIPGVLGIDIYGKRDLEIFVSLDLDRIEALGVDPIQVGQQILRESITVNNGKLYVDGNVFHVKTDGEFNSPDPILNLKIPTSAGFTYLRDLGTVDFVEKEDRTLSRLDGKPSVSLSIKKQAGSNLLGIAAQVYAIVDYFNEHRPDGVEEIAITGDQAVEIQMMLEDLENSVLTALLAVFLVTCFILGGRNTVIVSLVIPFSMLCAFAILSAMNVTLNMIVLFSLILALGMLVDNAIVVVENIYRLSTTMPLSHAVIRGVREVAVPITTSTLTTLCAFIPLLFWDGVIGDFMKYLPITLIITLSASLATAIILTPIISRIFLHPHKRVFRKPPLLKVYEKSLLWSLHHRKTVITTAFGLFVATLFLYGTFNTGMELFPAVETRNAVIKLDMSKNTDRDTTDQAVRTIEGIVEGFADVESYVSTVFQGRAQINIQFYEQELRTQSSFKTIDDIRDALPAFAMGTTEVLARQDSPTSAYDLTIEITGDDYGPMEQVFEQLVSRMERDERIVEIQDNYDKENFYLRVLPDRDMLYHHGLTTRDVSSAIDLFFKRQKVITIYDDRNEEFDIVLGVQPEYSSIPRMLAHTIPNPQGQQVALGELIAIEYSNMLYQVNRKNNQRAITIESQVRDGINAFTVQQDLDAFIRTLELPAGVYVNFAGQAEDQQETMEFLVWAFFTALFLIFTVLIFQFHSFMIPLIIGMTVIFSIMGVLLGLLIMGMPFGIVMVGIGVVSLAGIVVNNAIVLFDYILRRYEKTGDMYKSIVNAGKIRLRPVLLTATTTMMGLMPMFFAISINFTGLSIAHGTESSQWWQSMSVTIVFGLMVSTVLTLIVVPTMFYHHHLMKTAALQWIQQKRQQRQSALPMATPTPRSLRKWYNRRK
>fig|655438.3.peg.439 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MNKLLSSAWVLLILIVIIWGVNWPIIKIGLRSIDPLWFAAARLGIALVTISVLLLFLGRLKRPHRQDIPIVLGVGVMQFAVFVTLINMGLTEVNAGRAALLAYTTPLWVTPGAYFVLKEPVSRIKLVGAAVGICGLLILFNPLGFDWNDASVVKGNILLLVAAMVWAISILHIRQHKWKGSVLELTPWQIMVALLIVVPYAWFSNTQAVVWSAELVLILLYNGMLATALAQWASIRATQILPAMTVSLGLLMVPLMGILSSTIWLGEPFTMTLGLGAALIVGGLLLQINFRKQR
>fig|655438.3.peg.548 Permease of the drug/metabolite transporter (DMT) superfamily
MSNAIKADILLVLVTILAAISWIFSKEAVLLMPPLLFICSRFLLAGLLLLIVGFNQLSVLSWNQYRQAIIVGFIFALGMCFWVMGLHSGVSLSVASFITSSAVIFSPIISKIFFAEKVPSTTWYAIPFALVGLAFLSLSGEFEIQKGQLLFIVSALFVALFFVLNSRAANHREIVVLGEVTRVSKRVPALPLTAIALVTVGVLVGMLSFITEGWLEAAEGFSSTLLAWVLASAFIGTALRFFMQTHAQSLSSNSHGVVIMIVEPIWTALMAAAWFGESLSEKELIGCVLVFISIIIIRWTLIQRLLKRASA
>fig|655811.4.peg.958 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKRKNIDLTKENIGKSLIKLSIPLTLTAFVQIAYTLVDMIWIGRLGSNAVAAVGVSYFLAWIAEALSLIAKIGGGVYAAQAYGRKDKKLTSLILQNGYFQGSITSIIYIILIFTFKTYIIDFYKLGAEVSNFANAYLSITALGYIFVFLNPIFSQSFYSIGESITPFKINTIGLVLNIVLDPIFIFGFGPIPELGIRGAAIATVTGQATVFFIFLFVMKRKVGVIKDSLENFTLSTKWQVRIFKLGLPVAFISGIHALITMILNKLMANFGPKPVAVYSIGSQLESISWKTTEGCQVVVQSLIAQNYGAGLMDRVKKGVKESLKLVGAIGIIATIILFAFRNYLFEIFVPGDLETINLGAKYLAILSASQLMMALEIGSTGIFQGLSDTRTPSAISIIFNAARIPISILLMPYFGVLGIWLSMTITSIIKGLLSLFLLKKKMKKNLKVIDFR
>fig|655811.4.peg.1296 Permease of the drug/metabolite transporter (DMT) superfamily
MLKNKKNAVIFSLIAMFLWGSAIPLIKSTYQVLQIESSDTFAKVYIAGIRFFMAGILAFFYAKIFGKNKISFSKVNIKLVIILAILQTFLQYFFYYIGLSNTSGVKSSIIQASNSFMIVIISLFLLPEDKISINTIIALIIGTTGIILVNSNQKMGSGFKLTGEGFIFTSTFINAFASVLLRKYSKNSDPYILNGMVLLFGSLPLIILGRFLYINPVVINLKAFLMLFYGAFITATSFTIWTIVLQNHSANQFGVFKLFIPIFGSILSVIILGENFTIRLFIGLILVLTGSLVLMKGKSKKSGVTE
>fig|655811.4.peg.1379 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKHRGELLLLLTSFIWGFAFIAQKLGSDYIEPFTFNFFRNLTAGIFLLAYSFFKKNKPRKKVDSITKTATIRGGIATGLVMAVAVSFQQTGVYFTTSGKAGFITSLYVVIVPIFAIFMGKKVSKKTAISIILALVGLYLLTVRVDDGFSINKGDILIFVGSLFFAFHILFIDKFSIRADSVKMSMIQFFVASLVSLLLMILFEKPNFDLLMKGMLAILYLGIFSSGLGYTLQIVAQKDTDPTIASLILSLESVFAAFFGFLFLKERPVDREIIGGIIMFIAIILSQIPEQKIKKFLKK
>fig|655815.4.peg.1500 Glyoxalase/bleomycin resistance protein/dioxygenase
MEASKDFYTEKLGFEIDNSNPQAFVFKYNQGEASFAIRTPLEPIEDKELGVGVSLWFAVSENLDELNEKFIANGITTVDPIFETPFGRAFHVKDLDGYKLTFLDPK
>fig|655815.4.peg.2779 
MKKPLIKTLVCIGLLIGSHHFINAQEQESFQKLVKLPVREAAYDSYLALMRINIEQSRKEDGNISFTLFGKDGDYTVYLLERFKNKAAWEEHKKSVYARSTDAISPAATMHLSEETILKEIPEIPAADTEIVIPEENTKNIITWFTVQPTATTAFIEAMSKAIPKARETEENLGYNIYQNAEDPNKFIVIERWRNPEVYQNYLQSEYSKKLNQDVEGLLTKEAKLKREVLKNISE
>fig|657308.3.peg.973 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGTERIGRLLLEFSIPAIISMVFNSLYNVVDTAFLGQAFPDGTGVAVTTLALPVMTILMGFSMVAGQGGNALAAIQLGEGRKAQVEKTLGNSAVLLCGLAVLVAVAAVAAIDPVLALIGTSAELWEPTKTFVQIICVGFVFQSLGMGLNNFLRTAGKPNLALGTMVFGTVMCIVLNYLFVLVLGWGVAGSAGATVLGQACGMAPVVWYFAVCKGAPFRLRLSCCRPDARLMGRILTLGLASFVMQVASTVVSVVLNQVVGVYGSQDPIGVTGALAAIGVAQKATLFAITPLIGLIMGAQPIIGYNYGARSWQRVLDALKWASVAGVAIGAFFLVLSHAVPVQIVALFGVTGDLESFAVTALQIYTLLYPLVGFQIVGSSYFQSSGQPLKAAILEMTRQVIFLIPLYLLLPPVLTSVFGLTGLQGVVVSAPVSDGLATLMTTVFVVREVRKLRGLREASRVAVRPAVAAGELGDAAAQQA
>fig|657313.3.peg.94 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MITDLTKEHPNKTLWRFLLPMLFSVMFQQIYNIADSMIAGRFAGENALAAVGASYPITIIFMAFAVGMNLGASVVVSRLFGAEDRGGVKRAVTTAFLSSMVLGIMLTLFGYFFNHQMMRWIRTPQNIMADGVLYLKIYIFGIIFLMLYNVCTGVFTALGDSKTPLYFLLGSSAGNIILDYIFVAKFQWGVSGVAWATFIAQGVSAVLALVTLLGRLQKFAGKEKQPWFDKKLFAQIMAIAIPSILQQSVLSVGNLFVQGIVNQFGSAVVAGYSGAIKLNTFAINIFMTLGSCLSSYTAQNIGAGKKERIPLGFRTGLKLSEFTALPFVILYFVFSRQMMGLFLGAESAEAISAGMAFLKIVSPWYFMIAIKLMTDGIIRGSGAMIYFVVATVPDLILRIGFALVLTKSFGSTGIWMAWPFGWIVATTLTLIFYRKLGYKNDKSSDF
>fig|657313.3.peg.408 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSDNATMKNTTIHDMTTGSPARLIMQFMIPMFLGNIFQQFYNIADSIIAGQFLGVRALAAIGSTGSLMFFVTGWLNGLSSGFAILVSQWFGAKEYERMRHYVAMSIYLSAGWAVLMTIGLGIANEPILRLMNYKDSIMPDVKAYMGIIYAGLIVTAAYNALAAFLRALGDSKSPLYFLIISAVINVGLDVAFIIYGGMGVEGCAYATVIAQGISAVLCFIYIVKKFPILHLKKENFRFSLPACGKLMALGVPMALQFSITAIGTIIVQGAVNVYGEDYMAGFSAAAKIQNVICTVFVAFGATIATYVGQNWGAGKVDRVRQGVRCTQIMILAYSVIAMILVFFFSKYLTYLFISPSETKVIEVSVLYFHTVFWCYPFLGSIFLYRNTLQGLGYGLVPMLGGVFELAARSAIVVLVAGKTSFAGVCLSDPAAWISALIPLIPYYIYVTRKWKKQGKIAM
>fig|657313.3.peg.799 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKTLIFRSVDEIRLKKLLRFIIPTYLTSLFTTVYTIVDGIFVSAYVGTNALAAINVVYPLVNILYGIALAFATGGSALAALHIGGKKNDEASRTFSVSMAAAIVIGALVSALILFRLPLILQMLGATSLLMEDCKAYIYWWLFGAPIVVGKEMFTYFIRVDGSPTYSFLTALSGGIFNIVFDYIFIGQLHMGITGAALATFLGLLLSFIMGVVYFVTHPNFLHFTFHGLSIKEAFHSMVNGTSEFVNQLAIAITTVVFNRSALLFAGEDGVAAVSIIMYLQFLCIGIYFGFSMGLSTPLGYAYGDRNFSVCRVLEKYAYRFFAIAPIILYGCTYLLAPIGVYFFASPGSTVFDMAVSGLRLYGLGFLFSGINIFAAIRMMTYGKGYISGMITFLRSFALLLLFLTVLPRFLELNGIWLAVPAAEILTLIVALWTLRKKTVA
>fig|657313.3.peg.1343 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIGYSCYILADTFFVARGIGSDAIAALNLVLPAFSLLNGTGLMIGMGAAARYSLSSGRADSKIHRTIFTQALQLAFIAMLFFFSIGLFFARPLCVLLGADGTTLPHAIPYISILLMFSPLFLCNNLLNCFVRNDGEPRLSMTAMLVGSLTNIVLDYIFIYPMQLGMTGAALATATAPLVGMSILSMHFWKKKNQFHLVKTRIHLKTAIDICRLGVSSLVAELSSGIVILVFNMLTLKFSGTTGLAAYSILANIALVLVAIFTGIGQGIQPIVSSHPGKNGAPVRHQVRHYALSTALLMAFIAYLVVFVFAVPIADLFNKDKNPLLTSMAAEGMRIYFVSLFFSGINMVSATYLSASDQPVPGFIISILRGLVLILPIAFLLAALFGMTGIWLCLPVTEAIVCVVTFFFLRKF
>fig|657314.3.peg.265 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MWNLLKSELLKLRRCQILLVGLVALALCPLVQYGSQLIVEAEYRNPNYDFSALFENVVWGNTQIFLPISLVMIGGWLIDRESTHDTLKNIMTIPVSMPKMLGAKLLLVGMLAVLLGIYSVGITLITGLTVGLSGLTAEVFFHGGTQIVLAALTTYLVCMPLILIFGQIRGAYLGGSILAFFLGYSMLFFKSGILASIYPFSAALILVGFDMSEYAGTTTSSTPLLAVIGVGIMVLWAVLLLLMSSNKKEMKSRKQANAKGKGKRTVRRKGR
>fig|657314.3.peg.1252 Antirepressor regulating drug resistance predicted signal transduction N-terminal membrane component-like protein
MVQRTESISILSVIWLAGLLLCFGFFAVSYIKCYREFRFSLPVENDILEAWKEKHPLKRSLSIRQTETIAAPLSYGVIRPVILMPKNTEWKNIYQLRYVLEHEYVHIRRLDMLTKLIMIAAVCIHWFNPLVWVMYILFNRDLELSCDETVVRRFGMDIKSVYATALISMEEKKSGLTPLCNSFSKNAIEERIRAIMKIKKTSKFAVIISAVLVICVTGGFATSASSLEKKTETAQENGETTVALNEVNIREDESLSSSDVEWWTAEEYAKWLDEEKEVLQSMIGEKAYTGGDGWFVWTQEKVDETIALYEDNLQKIKDGMKLSKSSDDAVGITMAYSPENIEYAKQEAETVTENKDSNENVFSEEQLSEYAKAGITYQKETGFLMYDGKTIGYFRDEFKPGTYTISSKRGGTLRVEVQRENYGTITDVKAEPLSDDFWSEPAVLVESSGGEAVTADEMKGSVFEEGGSENIAADDMGEYSSEEGKGLNIAVPQEYADYGVSCDAQGNWVYNGKIIADLYDEGRGIFSNSNGTMYIEVTRDKSGKISSFQKVSKNRMQELFTEFNPEAETFDGYTSEAKH
>fig|657314.3.peg.3279 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSLYSVVVPVYNSEHTLEELYRRLEKVFREVIKEDFELILVDDGSKDRSFEVMTELRNKDQRVRIIQMARNFGQHPALLCGFAHVRGDFVVTMDDDLQHQPEELPKMVKVMRERDDVDAIIASYEGRKHGFIRRLGTKFSVWATSRMLGKDPNLQITSYRLIRRFLVDAMVKTNTYLPQIGNLLVLTSNRIINVPVQHAARAYGKSGYSFKRLLKDLIYDITAHTAFPLLMVRNIGIVSFLVSMVMAVYFLVRYFAFGISVEGWTSLMLVMLAFFGLILLSIGIMGIYLMNILNEAKKMPHYVIRREDTD
>fig|657321.5.peg.1384 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATSIYAKPIKAKTILKFTLPTVLMMVFMSLYTVVDGIVVANCVGSDALSAINIVYPFTLVFMAVGLMFSTGSNAIIAKKMGEGKQEEANRLMSGVAITATVISVIIAVLFTIFAEPMYMMFGSNEKILPYCIDYGSVMIPYGFVMCWQMLNQSYLVTADKPHIMLVFSILSGCTNIVLDILFMAVWDFGIIGAGLGTIIGMAVGAIPLLLFFNKKQTLHFGKPEFKVSEILFAMANGSSEAVTNLSTAVTTALFNIQMMHFAGAKGVAAISAILYIHFIFTAVSFGFTSGVSPVISFNYGAQNHEKLQKLFKLCIKITLIISVAMITASEFFAEPLVGIFSAGDEKIQQIALSGFRIFAINYLLCGMNIFASGLFTALNNGKISAVISVARTLVFECAAMLILPMFIGINGVWSALPVAELCAVAISVTFIIANAKKYHLVGVPPLPVRADSL
>fig|657321.5.peg.1859 Permease of the drug/metabolite transporter (DMT) superfamily
MKLLQNKKIAYLTAIFCTLLWGTAFPFIKVGYSAFKIEESDIGSKLIFAGMRFMLAGFMVFLFLWISKRKPPTLSKKDILPVCSLGVVQTGLQYIFTYIGIGFTSGTNTSIITACASFFTVLFVPLFFKNDRLTLMKIIGCILGFGGIIAINFGGTVSTDTWFGDMMILFSTISAAAGNIIAKKVTTGRDPFPVTAFQLLTGGFILLVSGICCGGSIGLINVESVSVLLWLAFVSAAAFSLWTALLKFYDASRISVFNLLVPVFGTVLSGLMLGENVFRIETLISLILISLGIAFVNMNLKKSGGKI
>fig|657321.5.peg.2102 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSTVLGRNAVTVNKKYTEYFLPTVLTAMATNIAMIVDSIIAGNLLGQNSLAAINLMSPISQFYFSITILFGLGASSIISFAKGRRDEKQANRVFTSTFIVLIALSVIFIAIQLPLADSISSLLTKDAELKSLLYQYYVPFIIGTPIYLLLMCSIHFVRADARPAFASNIVIVANAVNLGLDFLFMGAFKMGIAGSSIATVTGYAVGFVMMSTHFIMKKSTLHFDFSILRNPVQFFKFLGKMVTIGLSGALGTMLITVKMLFLNTIIQSIGGSAGMVSYSVCSSSQIFMSMFITGASQTMIPIIGVCLGEKDYDGVRYAFRRAARVLAVSSVVIMLFICIEPEPIIKFFGITSPTDIANTVPAMRINALSFPGLSFSFLLLYYYMATQKRAISTAISIINGIVILIPSALILGKFFGIMGVWYSLVVAQVGTLVVVYFIDLAEKRKSGGKYKNFYLLEETEDNELLALSFKGTKENAAGVSLYLSSFLSKNGIEESRANRIAVAVEEMAANCAERMEGKKKFADIDIRIFADKKETIISVRDNGDEFDPLNDDKEFEMSPLTVVKAISDKVEYSRALGFNRTIIKL
>fig|657321.5.peg.2118 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNGSKSVRNLTQGKISSQILFFAIPVIIGNLLQELYNVVDTLIVGQTLGEIKLAAVGSTSSLNFFALGFFIGLSAGCSVITSQHFGANDMERVKKSVAAHIIIGVVSAVVLTVSFVLLVNPLLTMLGTTSDTFEYASRYLTIIYLGIPATMLYNLTASLLRSVGDSKTPLYLLLFSSVMNVGLDLLFIIVFRWDVSGAAIATVISQLVSAVLCCVYIFFKVKMLLPNRNSFKNLTSTVRDELKVGFPMGLQNSVISIGMMVLQYFVNQFGSYAVAAYTIGNRVQLLIQNPMNSMSTVIATFAGQNEGAGRYDRIKKGVNFCLLICIAYSIVIGAVSMIFAQPITGIFTSGSSQQTIDYSIQFMFWNCPFEWSLAMLFIYRGTIQGLKNGIVPMIGSLIEVVMRIMTPVIFSSVIGYASICVAGPAAWTGSMLLMIAVYYVKIRKLSKTKTVVAN
>fig|663278.4.peg.457 5-nitroimidazole antibiotic resistance protein
MRRNDREVTDPDEQIAIMQRCDVCRLAFFDADSPYIVPMNFGFEQACDTLLLYFHCAKTGKKLDCLAADPRVSFEMDGAHRLLEADSACGYSMEYESVIGRGTARLLGDAEKAHALQCIMRHYRPGKTFVFDLRMMDAVAVFQVSVQSLTAKRLKK
>fig|665571.4.peg.600 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLLARYIARYWYFALGSLLFMGTEVAVNLAQPALMGRVVDEGIIPSDMGAIVRLGLILFGIVLIGVAGGIGCTITASAAATRTARDLRDLLYHKVLRLSLKEESRFGAGTLITRLTGDIVQVQTIVHMLLRMMIRAPLLALGGLVMSFLLSPRLTLIMLASLPLLAGILIFLIRKGIPLFVEAQGEMDRLNTVVRENLEGVRVVRAFVRTDYEEGRFGKVNDRLKEVMTKASSLMGLAFPLVFLIMNLSIVAVLWAGGFLVQEGTVQVGTIIALTNYLLQILFALMMIGFFFMGLSRAQASLLRLSELIEAPEESLSLESVQILPSRSPASLVVEDLSVAYDGTPALSDISFEAPAGTRIGVIGPTGAGKTTLVMALLRMTEPSGGRVLLDGEDIQALSLEELRARIAVVFQKPVLFRGTVADNLRWGFPGATEEQMIEALKKAQAWEFVSRLPGVLEARIEQGGTNLSGGQRQRLAIARALVRPASLLILDDATSALDAATESRLLSSLRTLPVTTLLISQRMSAITTCDLILVLDDGRLAGAGPHPLLLEQCPLYRELYETQIEGALHA
>fig|665571.4.peg.1503 Permease of the drug/metabolite transporter (DMT) superfamily
MDRDKLVGVAAMLFSVVVWGISFVSTKIVLAAFGPMMLAFIRFAVGVVVLALLLRLQRKSLSVRRGQGALLIAGGVIGVTLYFYFENTGLLHLPASDASLIVASIPIVSLLVEAVVFRRGMGVREVVGALLSFAGVYLIVREGLRLTGRPVGYLLMAGAAASWVAYGFLSRPVLEANDRLVVVFWHFVAGTAAFLPFLPGEAQNLEAVHLGVIGHLLFLGVGCSALAYWTYQVALHRLGVAVANVFINLIPFVTVLTAMVVLGEALSPLKWVGGAVVIVSVSIALLPAKPKKGRLPGEAGPV
>fig|665571.4.peg.1981 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQQVRNSRFQDQMFSGPVLPLLVRLSLPIFAGMFFQLLYNITDTVWISWIDLEDPSLVGGIGIIFPLLFFFMALGNGLMVGTASLVARAVGEENEEKLDAAADSGIFMAVLISVAMLAGGYLLKEQLVGALGAEGDYYMRALEYFTYILPGAAFIFMQNTLIGVLQGEGLVNYVMRSMIIGTVLNIVLDPVFIFLFGWGIKGAALATVLAQGIGFLYVVYVFLAGKTRVPIHIRLSGIRGKVMAEIFSVGFPQTLGQAIMSLSFLIFNRIVIAIDPLALTAFTLCGRFDQAILMPIFAVASALVTMMGQNFGRRLYDRMLSIWHVALRVSVATVTVIVLAIVVFAPRIFSLFTDVPEVLSYAVAQVRTMEYAFIFASFGILGRSFFQAIGKGWAGLLLVLLRLVLLAVPAVLFFVYVLHLGIRGVWFGLIFANLSTALTAALWVPRTIRSMMEREPMPALR
>fig|665571.4.peg.2047 Acriflavin resistance protein
MIALLLLLLGVLSVLFLPVDFLPPLTVPRLTVVCSYTGLPAREVRDLITLPLEDTLSTVQGLRHISSTSRDGFAILTLEFSWGTNMEIAAAQTKELIDVAYTRLPHEASKPMILPADPGEQPVMILGVLPTGELSLERLTNLVERELSTAFQQIEGVGSVQVLGGREEEVHIIIDPHRLTSYGLSFSSFVQALNSFTMEIPAGFMKEETTEYIVKVEPLAEEPEDLPTLFIPTPLQPVPVTSIGEVHRDSLEQRSFFFYRGKEGVALLIRRQAGYSPIKIAQEIRTRIPALMESYSHDVEIVVVQDNSILIQESLSSLLFSALLGMGAAFFLILLLMRHLLPALLLILTIPLSMTLSFLLFPIFRLTINVMSLGGLAIAVGMVVDNSAVILENILRLPQKRTKEYILHATAEVAGSTLASTTTTIIVFLPLFFLPGIIGKVFSPLAASVCLTLLSSYLVSITIVPLFLFLIPGEISSPSLSRTPKRVFKILFSLGTKAPVLTSIVVLLSMGIGILGLIHTPFLWLETPQSETYLLEYTFPQNTKLESLKEVASELEAVCTAHDIEAYFLGGYNPEDPYAIAENPDAPTTLKVVAHLPPHHGYTPRSLLSTLSVPLARTINITTSSNLLIEALGLPDTGRSLFYVSGKTPEEAEALAQHILSTYSIPDVQVLPSEKRVSLVVSPIMERVLQYGLDVQTVASTLRTVLWGTYGGSVKEEGRRIPIRIKAPPQFQEERALIEGISLPTEGGDSILFTQLVRFEQREDYPYLLRHDRKDIFILSCARSKETLHLSHMLEREPRVIDVLKLQWSQQLKETMFLFFLAILFLYVLLGYQFESFFLPFIIMLTIPVGFSGIGPFYLLTHTPLSLNTFLGILVLIGTAVNNGIILFEILSQRIKSPLHLISRTYVGSLQRLRAILLTVGSSLLALLPLALDLFGKNAQRSMALSILVGLLCSTFFSLLILPSIFMRFFGRRRKNPPWKP
>fig|666684.3.peg.60 Permease of the drug/metabolite transporter (DMT) superfamily
MDKEASTHQARLGGLLFLACTAIGWGLNWPAMKILLRDWPPLFARGISGVVATLILFAIAAANRERSAVPRKTWGALLLASFTNVFAWMGFTTISMTTLSISEASLLVYTMPIWATLLAWPVLGSRPKPRDVAGLILGFAGLFVLFSDHPLGFASDKIVGVALALGAAILFALGSLLNARPVPVAPISFVAWQIGLGSLPMVVLGLAFEHPDMGALRIDSGLMLAYMTLVPMGTCYLTWFATIRRLPATTAAVGMLSVPVIGILAGALFLGDGIGWREICAIVLTLAGVALALSKPKPVIEQGV
>fig|666684.3.peg.2412 Permease of the drug/metabolite transporter (DMT) superfamily
MGLGFIGIAIFGGTLPATRLAVEGLDPFFITAGRAAASGLLSAALLLMLRRRWPSMRQIRTMLICIVTIVFGFPGLMALAMLTVPAAHGGVVLGILPLTTAAAASVILGERPSLRFWLLAGLGTTVVVAFALRDSGGEIAIGDVYLFLAAISTSIGYVFSADLSHEMPGWEVISWILVLALPLTLPLAIWLWPTNPGAVPTAAWVAFAYVSVFSMFVGFFAWNAGLVMGGVARVSQVQLLQTFVTLGLSAVINGEHVGPSTIAVAALVVAIVAAGRNARITQKVPEAV
>fig|666685.3.peg.637 Acriflavin resistance protein
MNIFAPLIRRPVGTSLLALGLMLAGLWAYLLLGVAALPSLDFPGVYVVASQPGASAQTMANTVLAPLERHLGRIPGVDEMYGNASEGQASVMVRFTFDRTADSAARDVQAAINAAAVDLPSGMPSPPQYFKFDTAQIPILFLTLTSTGLPQDQLFDLADTMLKPAVAQIDGVAQVQVFGGTPHAVRIELDNGALAAKGLTTNDVANALRAANVTSPQGTLSDGRTQMTVSASDGLQTPAEFARLLISVKNGTPVRLSDVAKVYSGQQDEYQAAWFNDARAVGLQISKRPEANAVATVEAIRARLPQLRASLPQNVTMTPVFDLTQTTKSALHEVQVALLISIAMVVLVMLVFLRRLRPTLIATLSVPLSLAGAFVVMWALGYTLNTLSLVALVLCIGFVVDDAIVVIENIVRHMERGEPPMQAALTGVREIGFTVISITLSLVAVFAPLLFGNNMLIMLLREFSVTLTAAVVISALVSLTLTPALCAWMLTHEPERSRPPGRIEQAVENFDRKLLHVYQRALDWAMHHRRIMRWQPLTLLVLTFVLGFAVAKTAGGTFMPDEDTGQLQVDISADANISPAELTARALAVAKIMQADPAVLDQLTMLGRDGGGGGAVGNNAQMFVDLKPRGSGPGQRREGIKQVVERLSKQYDKLANVKVSVSAAQFLGGGGSGDKGGQYEFQLVSSNGGDLQPWTLKMVRQLRGMQQFRDVSSSFDQVGKQQLLRIDREAAARLHVGVGTIDSALYNAFGQRQVSQIYSDINQYAVVLSTGAAERVSPESLLDVRVRNEQGRMIPLSALATIEPNMSPLRVRHHNQLEAATISYNLAKDVTQDVGVKLVEQAAYAARLPAGMRVDFTGANQRLKQAQSNGMVLLLGSILAMYIVLGILYESLGHPLTILSTLPAAGAGAFLAMLVTQTQISMMAIIAILMLIGIVKKNAILMVDFALVAERERGLPAPEAIREAALVRFRPITMTTLVAMGAALPLAIGFGIGSEMRQPLGIAIVGGLLVSQLLTLLSTPAIYLWNYDRKIRKAARRERKAEKKRLKTLGKVQTAS
>fig|666685.3.peg.2821 Permease of the drug/metabolite transporter (DMT) superfamily
MDTAERLDGRALVAIAIALLTWSSAYAAIAYALPAFTPGEVAFARLLIGSLCFAVLLRVKRVPLPTRRDWPLLALLGVLGLTVYHLCLNYAETRIASGTAAILISLVPAATAAVSALWLRERLALRSWVGLAVALLGTVLVVLASGQRVEVDPKALLVLVCVMVSAIFFVGQKALFARNSMLGVTAFAFFAGTLAALPFGWHLPQALLTASWAHIGALLWLGIAPTFVGYLAWNMAVNRASASRVSSFIYLSPPIALLIGWLWLHEVPNALILVGGAITVGGVVLANARRRAAPVSAAPVEACEQC
>fig|666685.3.peg.3307 Outer membrane component of tripartite multidrug resistance system
MKDTPMKHAPLRGRTVLVAAMVLALAGCAAAPARLGTPALRDDVPLAGLQAPVRAGWPTAQWWRQYDDPQLDGLMDRAMQQSPDLALAQSRVRNAEQSAKLAAAQLGLSVNGSAQVTRERLSDHGLIPSQFLGFSWYNQADLGVQLQYDFDWWGKKRATMEAALDQAHAAEAQRSAAALAIQYAVADTYFGWQADQARLQLADRLLATQQQFADIAELRVRQGVDLPDEAQKARAQLAAVREMRVALDGSAQIRRAALASLLGVAPTELPELRARPLPAIERGVPANGGLDLIARRPDIAASRWQVEAALKQTDAARAEFFPDISLTALAGLSSIDMGKLLTAGSRTFALTPALHLPIFNGGALEANYGVSKAQLDAAVAQYDSAVLAAAREVATQALSAEQVAARRHEQQAQLDADQRLLANAQARARQGVRDLRESLGAQAALLQQRDAATQLQAQAVSTDLALIKALGGGYRATDAATSPSSSVTAGAAPHERH
>fig|66692.3.peg.94 Glyoxalase/bleomycin resistance protein/dioxygenase
MGNPILKQIGTVFIPVSDIDKAKDWYCDIFGFNGDGEILFGHLYVIQLEGTGIVLDSKIYSPEKTFQTPAFHFNTNNIEEAYQYMQSKGVKLLTGIENNHYFNFEDLDGNRLMVCKC
>fig|66692.3.peg.323 Multidrug resistance protein
MNETTNSHWRKKMMVITVLAASFLFLFNQFLLITAFPTIMDEFSINATQVQWLTTSFLLMATMLIPTMGYLMSRFSARALTMTALACFVVGTVLSAIAPSFVLLVSARVVQAIGAGMMLPLVQTILLHVYPAEKRGYAMGLMALVINVAPAIGPPISGYIVDWLGWRSLFWLVLPLALAIFVLAAVFMQNVTEQKSVKFDLLSLFLTVVGFSGVIFGLSNISVAGFSSAIVLVPLSAGFFAIAMFIWRQLCLDSPMLELRLFKLPLFVHGVILSFVISILLLSTETLLPLFIQDVQGRSAFSSGMILLPGTVLLALTSFVSGKLFDSFGGRALGLSGYGILVLVFTVFMFMGDQTGIPLLVVCFCAFMVGIGFTMTPATAIAMNALKQAELAHGTAIANTIRQFGAALGLTVLTTLVSLNANRSDIDYVEGTLAGLKLAFGVMAILALVAWVLVYTAKEKNARQQEQ
>fig|66692.3.peg.1303 Kanamycin kinase (Aminoglycoside phosphotransferase, gentamicin resistance protein) (EC 2.7.1.95)
MINNYMKNVKSFYPNISIENFYLNEMGQNNDVLIVNHSLVFRFPKYKNGIIQLKRETEILQYIKDIISTPIPNPIYQYFEELEPGKVFTGYHLIDGVPLWGESLSGIKNHELVKSLATQLVSFLKELHSISEEKLSRELKLKVNNPREEINKLYSKIQKNLFAFMRKEAQKEISHSFEKFLNGEALSKLHLSLIHGDFGSSNILWNPESSRITGIIDFGGSCLGDPAYDFAGILSSYGRHFFDMCISLYPNDSELLDRANFYKSTFALQEALHGIENDDKQAFESGIKGFR
>fig|66692.3.peg.1398 Multidrug resistance ABC transporter ATP-binding and permease protein
MRGYFSSISLKGYKNIWMKQWKFTLEMKVGKKMEHELAGSLGARRFWSMVKPFLPKVAWLVLAVVLVIGETSLSLIVPLLTMNFVDEMNAVGLNGQTVILLASVFFAQLVMSGFALYTMMYIGQKVVFALRKEAWQRMLHLPVPFFDRHSSGELMSRMTNDTLVIKDFLTMQLIPFFSGIVSIIGSIVLLLAIDWKMTLMMLTVVPASLLVMIPLGRSMYKVSKSLQDETASFQGDLGRVLSDIRLVKASLAEGVEQKVGLSRMAKLFRFGMREGKIMAVIQPLMMSAMLIMLVVIFGYGGMRVSAGTLSAGALVAIIFYLFQIAMPFTQMASFFTQFQKALGASERLETILRAEPEKNAENVDGAVAPAGTLSFQGVSFGYTADKPILKEVNFDAPIGKVTAFVGPSGAGKTTLFSLIERFYVPDDGTIQYKGHSIHRLPLHEWRQKIAYVSQDSPIMAGTIRSNLVYGLTDVPEENMRAAVRHANLESFIASLPDRYDTEVGERGVRLSGGQRQRLAIARAMIRDPEILLLDEATAHLDSSSEKLVQEALEVLMEGRTTLVIAHRLATVRHADQLIVLEEGNVTGAGTHAELLDTHPLYKELVSQQLQFN
>fig|66692.3.peg.1459 Drug resistance transporter EmrB/QacA subfamily
MTDMQAFSIRTIIGPLIAVVVGMVMVILDSTIVNVAFPKFQQEFGSTLAVVQWTFTGYTLALSAVIPLAGWMTDKFGAKRIFLTTVALFTLGSVLCGMAQTIEQLIIFRIVQGIGGGMVTPIGMAVIYRLTPSHKIGEVMGVLGIPILIAPALGPVLSGWLLDYVSWQWIFLINLPIGIIAIALGMKWLPAFPQGEVPKLDTLGMILAPLAFSMLAFGVGEGAVDWTSTRTVVALTVGAAALVGLIVTELRHRQPLLELRVFKSSDFTRGILLLWLVQIALFGVMVLFPVYLQTVRGYSPLDTGLIMLAQAVGSILFTPVGGRMYDKVGARPLALIGLTAVSAALFWLSHVSPEAGLTMLLLPLFMIGSGMGLIMMALNTHVLNSAPRDLVGRVTSLTTAAQHVITSFAVAGLTGFLAYRMNEMTMNVELQSIAAAYSDTFLLTAILAAIGIVLSLTLRKPQLLDSAVPTQGHDTNK
>fig|66692.3.peg.1656 Multidrug resistance protein
MKKNDYSGLFLLPTLIVLGNSMYVPLLPVIQQTYAFTQTESTWFLSTFTLAGVVAIPFAQQLARRTNIRKAMVISCFLVMVGSLVNVWAQMNEAATLLFAGRIVSGMGAGGATSLAYTYAGAFAKGNEKLVLFGRLELSNGIAKVSSPLIGSLLLYLSWTLSPYLFLLLAVGSIFFVWRNIAPLKWENPKVGQRSFRRYFFVAASEYMLSLVHLFLLYGLFFYASYLFSLFGFSPAVRGVLLALPFLAMVLCSANIRFVANVGQTAIRGVLLSLLLCCTLLLLFFSEQAIVLCIVLLICGGCTGVALPLASNALGEKTAGAVRERLIAYLSMARFLSIAAAPLFYQMWIGNGMVALGSLVAVLAASLIIGICLHREKNQHITQI
>fig|66692.3.peg.2298 Multiple antibiotic resistance protein MarC
MVSFFIHAFVSIFAILYPIGNLSVRLGLAHIKGDTQRIHKAAKAILVVLGALTTLLLLEQWLLLLYNISIEAFTIGCGLCLLVIGCKLLQGKTRYRSKQKTIFATVASQGAAGATMCLTANQNHRWFYVPITFLAFVSVLVLSLLPLLVANWLRGRTGQKGLSLVKRATGVALTVIAIEMVVMGFADILPSFEQEAA
>fig|66692.3.peg.3384 Vancomycin B-type resistance protein VanW
MKHFLALMAFASICVLAACGSGEERVAASVSTHENVVLEKTIPDLSVTVFLDEEEFDKLPVELVNEDDLRKWARDLARGKDGFDQTMIPAKWNGQELVGGQDQVTLDEQKLVEDILSLSVWEREVTLPINRQAISARAEDINNIENKTIGHGRTSYNKSVSGRVENIRLSTESVDYVVLGSGDTFTFNGIVGERTKERGYQVASVIMDGDFTDGLGGGICQTSTTLYNAVLDAGLTVLERHPHSLPVGYVEEGMDAMVSWGSADLRFRNDFDYPVVIRGGVDKEKGEVWFDIRK
>fig|66692.3.peg.3703 Ribosome protection-type tetracycline resistance related proteins
MKTINIGVLAHVDAGKTTLTEQMLYQAGVIKEAGSVDKGNTTTDTLAIERERGITVKAAAVSFFWNDVKVNIIDTPGHADFISEVEHALTILDGAILIVSAVEGVQAQTRVLMQSLKAYRIPTVFFINKIDRVGADYKRVIKQIKWLLDDHICPMCEQTQGDTAYSIKATCPQTAGWLDVLALHNDELLAAYVENEPVSEMELRKELSQQTKKAVAYPLFIGSAAKGVGVSALLHSLSHWFSHTTEEASERDLSGIVFKVTELPNGEREALVRLYEGRLVARKMVSVIRADHPSFSVKVKHLQLLENGGRTGASAVSAGDVAVLREKSLQVGDILGKRVPQMKRFAFKKPPLQVQVHTDRKEEAIALHRALARLAAEDPFLQYTQDAATGDHFIRIFGHVQQEVLLSALKNEQGLSVSMSEPLVVCIEKPSGVGAAVEWIGEKGNPFYATLGFRVEPGPEGSGLSYQLEAELGSLPPAFQRAVRDTCRVVLQEGLKGWAVEDIIVTLTHTGYWSPVSTARDFRGLAPLVLMEALRQAGTSVYEPLERIEVIVPERFLSTLLSRIVQLGGNVLEPAFHQAGVLIKGTIPVRTATRLKSSIHALSGGEGILISKPGGYERVAGKAPTKERRQLNPLERTNYLMRFSHTM
>fig|667014.3.peg.138 Acriflavin resistance protein
MTFVERYLKWPHLILALLFLGVVLGIKSFRELPLNLFPDANYPQIVVVLSLPGASAEDVEKEVVIPVEKELATLSLVRKVRSVSRDGVGVLSVEFEYEKGLSAAQVDVSSALDRILSDLPRGLLPPRIFKVSDVTNPVMTVAISPKEGSNLTLSEVRRLAEEYIKPSLLNVPQIGDVEIFGGYQPEVRVEIERDTLARYGLSLANVAAALASQNTNWPAGIIRSNEQEIFIKIPGEIARPEELKDLTIPLKGKSIRLGDIARITLSHEDRNSLFHGNGRPAIGLNVLRPENGNVMATIEAAEKALKKLKVQYPELSFSIADTQKNIIKTSLSNLIGALRDAIILTVAVIFLLMARVRATLLAAVSIPVTYFLTFFLMKLFGLELNIVTMTAVILAVGLLVDDSIVVAENIERHLREKGLSPRQAAISGTQEIMLADLSGTFTTILVLIPIMFVGGYVEKILRPLAMVLTMALTASYIVSVTIIPLLAPYVLRAGEPSRFEKFLSRVSEGFLEKFRAFYLTLFRFGVRYKVVLIMPAVLLMVISVKKIMPLVGRDLMPPMDTGIVKISFEVTPNTPIEEAEKIIRKMENTLENYPGFIRMATVMGSEPGVISFGADRTPRQGMITVHFVDRFHRKENIWQIENHLYSEFLKIPGLKTLHVFEFGATPLSSIAAPVDVMVSGSDPRILHKLALEIENRLYKVPGLVSLSHTWDFDRQEFLIKPNLEKLSFYGLTPEILAREMAMGFSGGKASFWRVPEERPYVIKVRFLPYERDSLESLLNYMVPTPKGPVPLKELATVEKDFVRSVIVRDNLSPVIDVLGYRRKTAISHIQEGVGKALSDLKVPSGYKLSQEGEVKPMKESFARLKDALILSLILLYFSLVPTFRSFRHPITIMVAIPLALIGAIWGLLLVDRHFCMPASMGMILLSGVVVNNSILLLDFIEKARQKGKDLKEAVEGAIRARTRPILMTALSTITGMIPIAAERAIGLERLSPLAVVAIGGLLVGTILTLVYVPLFYVFLEKVRALVSRK
>fig|667014.3.peg.1963 Multiple antibiotic resistance (MarC)-related protein
MEFIKGFLHIFIPLFIIIDPIGCVPLFLGLTNDLSPERRKKSAYKAAIVAALVLSAFALIGDQLLFFFNISVASFRVAGGLILLLIALQMIQAQPRATKSRPEEEEESRHKEDVAIVPLGVPILAGPGAITTVLVLTAGHKDFGFRLEVIIAILAVSLITCLVFLYSTRIAKILGRTGTNLFVRIMGLILAVISVEYMAKGLGELFPGLLK
>fig|667015.3.peg.1981 Acriflavin resistance protein
MEKKKRNFVEWAMHYRQIVILVVTCLVAFGVYSLPEMRKNEFPDFTVRQGVVVAVAPGNTAQEMVEQVTKPLEEYIFTYKEVKKEKTFSKSRDGIVYIQVELNDDLTNKDEFWSKFKHGVSQFKAQLPGNVLALVVQDDFGDTSALLITMESEDKTYRELDDYMGLLQGRLRRINSVGRMTVSGMQNEQISVYLDHDRLSKYGLNEQTLALGLMQKGFTTSGGRVKDGSMVEPIYVSRSLNTVRDVQEQIVYTDPQGNTVRLKDVARVVREYPAPDSYITNNGRKCLLLSVEMKKGQNIVAMGDEINKVLDEFQQELPTDVSIFRITDQPEVVGDSVSNFLHELIIAIVAVVIVVMLLLPLRVALVAASTIPITIFISLGLFYAFGIELNTVTLAGLIVTLGMIVDNSIVIIDSYLEKLGEGMSRWHASIQSTTHFLKSIFSATLAISVTFFPFLLTCTGMIHDFLVHFPWGITIVLAVSLLVATLLVPFMQFWFIRKPMGAKVKDGKKPFNFLDLLQKHYNWLFGKCFAHPKITVAVGVVSIVVGAVMLAGLPQRILPVADRNQFAVEIYLPTGTDVDVTAQVADSMEHILSQDPRVVSIASFKGCASPRFQTAYAPQIPGTNYAQFIVNTTGVKDTEALLAEYTPKYTEYFPGARVRFKQLSYSEAVYPIEVRLSGEDLSMVKQDAQTVLEVLKRMPGLILAQTDFNEPLPAIAVNLKEDEATRLGVTNLGLESTLAMRYGDGLAIANVWEGDYDIPVKLKSEKADRALPVEVKDELIPVAAGLADVPLRQVADVVPTWKEGQVVRRNGIYTATVQADLAVGENALRMTARVQEMMKGVELSEGVTVSYGGEMEKTGEMMPQIMGGLMLAVAIIFFILLTHFRKISIALLIFGSMTLCVFGTAFGVWIQGVDFSITAILGVVSLMGIIVRNGIIMIDYAEELRVTEHMTASEAIYHSALRRMRPIFLTSAAASMGVIPMILGKSSLWMPMGTVICYGTLITMLFILTVLPCLYLLTFRGSSKKREKWDALEQQ
>fig|667015.3.peg.2043 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHLTKEEQLLATGRITALFRKFAIPGVVGLLFIGLQPMIDGAVLGNFVGTEALASINIFVPIYTFMSALAVVVGVGCQAIVGMALGSKDYVKAHSAFKTAFWSLLVLALVMGCTFVLAAEPLCRFLGANEVLLPYTVSYVRAFSLFFPFLLLTFLCDYMLKAMGRPYFAMLVLGGTVVLNLLLNLLFVGVFGWGTAGSGLATGIAFTTGFAVMAPALLKKNSLVSLRKGRLSFRLLGQMTYNGSSEGLSELSAGITVFLFNWVMMKNWGEVGVAAFTAINYMLNLGVQMFVGLSDGIVPILSFNYGAGHLNRVKETLFLGFKTNATIGIILFCIMFFGNEFIVSQFFADGGSHVLKITSIGAAVCAFAFLLNGSNILSSSFFTSLGDARTSVLVSLQRGLLFVVLGIMIYPVILGDNGVWLTVPLAEFFTFVSTIYLLRKRLKKWSVSIHA
>fig|670487.3.peg.233 Permease of the drug/metabolite transporter (DMT) superfamily
MTPTALVLITLSVVAHAGWNFFSKTRPSLAFFAVSVLASMAALAPLAALDRTLLPAVPAAVWGLVAATGLFQTVYFTGLAGAYRHGELSVVYPVLRALPVLGVTALSLLLGQGAPIAPPALAGIALVALGCLLLPLERFAVPRPRDYAGPALWLALVAAAGTTGYTLIDDAAQRFLRGELPGLGPLRVTAFYVVLQTYSTGLWMALALLAWPAERRRLRALGGRGALAAGLTGLVITGAYALVLAAMAFVSNVGYVAAFRQLSILLGAALGMALLGERPHGPKLLGLAAVTAGLVLVALY
>fig|670487.3.peg.1279 Multidrug resistance protein-related protein
MRRWLERAPWPPGHLAPLATLIALVGLVELTRTGLYTVYLPRSLGPVLGLGVVGLAASLQYLADTLGRSAGGHLGERHGLRRVLPVAAALAAVSALGVLHAPGVGWLLAASLANGLVIAPLWPAMMTYSSRAARDGEDGRAIGFTQSLVAPFIGLGVLLTGFLFDHDPRLAAAALAAVQALVFLLGAAILLRFRTAAPQPKPTSPFPWRKLASLAPGALTQLLAFGLLAPVFFPFIDRLGLGTRELVLALALGGGLEYLLLSPLGRLADRLGPARTLAPALLLAALALIGFAEVRGLGGLIAAALAAGLAQALLIPSWGGLVSRTLPDEHKARAWGALMSLEGLGFALGPVVGGFAWELWGPRAPFWIGAAAYLGVALFYAARLRRPAGA
>fig|670487.3.peg.1648 Drug resistance transporter, EmrB/QacA subfamily
MNRTQRLTLIGIFLGIFLAALDQTIVATALPRIVQDLGGMDKYAWVGTSYLLASTIAVPIFGRLADLVSSRMLLLWAIVIFLVGSMLSGLSGTMEQLIAFRGLQGIGGGALFAVATTTIGLLFSPRERGKFQGLFGAVFAIASVVGPWLGGLLTDHLSWHWVFYINVPVGAVAVYFIAVHMPVLRPASTHRFDLGGALTLALWTIPLLLATSWGGHEYAWTSPVILGLFAWAAAGLALFVYVETHTPEPLFDLTLFQNPVFRWASVALFFFGAAFLSAMFFLPLYLIQVKGISATMSGLTITPLTLGAIVGAIGSGQIASRWGRYKPLMIGGMSWLLVNFFAMHFLIQVDTPLWQVLALMVSMGLGLGPGMPLFTLAVQNAVPPERMGTASSATQFFRQIGSTMGIALMGAVLAASLQTQLSANLPSNLTNGKVDLGAMRDPGALERSFDTELQATLDELERALSGDEAAKAALLKNPLLPAELKQMLEGPPPPAAYREMVLAKVKEELAAQAEQLKRQVTEALNLAITEAMKQVYLYAAWLVVLGLAATFLIPDARLEGRAHFSPGD
>fig|670487.3.peg.2330 Permease of the drug/metabolite transporter (DMT) superfamily
MEPSNTRLTPIDVSALLTLYFIWGGAYLANKLAIATIDPFIMLAIRLGASGLLLFVLLRLLGWTLPKGREVLGSWLIGQLLLVGGMGAVVYAQQWVSSSLAAVIVSTMPLWNAFFANFLGRRTRGVEWAGMLLGLAGVYLLAGEPDLKLDPGALLVFVGPVSWAFGSAISTRVPQAPGLMSSAVHMMGAGLSFTVIALLAGARWHEPSVASLLALGYLVLLAGVVGYSAYLHLLARPLRPALVTSFAYVNPLVALALGIGFAGERLTQAGLAGVGLIVLGVGLAVSGRGR
>fig|671143.5.peg.813 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTSDKPDLSVVVPVYKEEANVPPFLERLEAVLKRMGGSYEILFCLDPSPDRTEEVIMRAIDRNPNIKLLVFSRRFGQPAATMAGLLMCHGASCAVIDVDLQDPPELIGDMYKKLLDGYEVVYAKRRSRKGETLIKRIVARMGYWLIARLSDVEIPRDTGDFRIMTRRVIEELRRLNEMHGFLRGLVAYVGFRQTFIEYDRDERAHGQGNYNRFVGSLKIGLNGLISFSSKPLQLMSITGALFAGFSFLLGAWYVLQKLIGVALTPGLSTTVLVVSFFAGIQLLSLGLMGEYIGRIYDEVKRRPMFIIDRKINF
>fig|671143.5.peg.1070 Glyoxalase/bleomycin resistance protein/dioxygenase
MVRRIEHIAIAVKDAEASARLFETLLGVGRGQMETLPGERVKVAFFDLGESRLELVQGIGDDNPMGKFIEKRGEGLHHICLEVEDLPETLRLLDAAGFPLIDSVPKPGSSGTRVAFLHPKGCNGVLIELVEQPNRA
>fig|675635.11.peg.92 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLFAGIAVRDLARAVDWFDRFFGEFFGAVETFAPNDVERVWTIGEHRHVYVVVQPAAAGHSLLTLFVDDLDALLRDVASRGITPDLQETYGNGVRKAVFHDPDGNEIGVGGGPG
>fig|675635.11.peg.146 EmrB/QacA subfamily drug resistance transporter
MSTEAVAPQQSAAGAPAPSERSSGELSHRQILTILVGLALGMFLAALDQTVVSTAIRTIADDLGGLSQQAWATTAFLITGTITTPLYGKLSDQFGRKPLFLTAISIFLVGSVLCTFSTSMYELAAFRAVQGLGAGGLFTLALTILGDIVPPRERARYQGYILAVFGTSSVIGPVIGGVLSGQATIAGIDGWRWIFLVNVPIGAVALVVVAKVLNLPHTKRSRRIDWPGAVTLAIFLVPLLIIAEQGREWGWGSTSAIVCYIVGAVGFVLFMLAERFYGDDALLPLRLFRNGVFSLTGVAGFVIGMGMFGGIVLLPQFLQIVHGASPTESGFLMLPLVGGIMVGSILSGQITSRTGHYKIFPIIGTALMVGAMLLLHFRVTVDIPLWELDLYMAMLGLGLGGCMQTLVLAVQNAVPARDMGVATASSTFFRQLGGTLGVAVFLSILFSTVTDKISDAFRTAQTDPTFVAAVGDPAVRADPVNAPFFAALNGGADTSGVLNDSSFLQKIDPRLARPFLEGFSNSMTLTFLVVACVLVIAFVLVLFIKELPLRTMSGAQARAMEEAAGEGASVGAVTPTALEADAEAAPVPSANGNGNGHGNGNGVAAGTVAAAVAAAAAKGSNGQGSRHALRAADGQVTVPADGQRADTAPIPVVADQAPTPPSDGPAIEGVVRRADGAGLPGAVVTVTEPTGRQAARTTSDQQGEYRIGVPTGGTYLVVAASGAFQPHAAMVAVADRAVRHDVTLAGAGGLRGTVRVTDAQGQVRPASGVAVTLIDVQGNVSAATVSDELGRYVLAGVPDGQYTLTAAGAGYQPVATSVVLPGGSEVVQDVELPRRARLLGTVVAGSTGRGVPEALATLIDPSGNVVGSTVTDADGAFAFDDLAEGTYTITASGYAPTAAVVQVTAGGASTTEIAFPPPVVAGSAPATPPAPQVQRSASNGTTPADLPSVPEEPGSPTAGQLR
>fig|675635.11.peg.343 Bcr/CflA subfamily drug resistance transporter
MMFTWLGPFSMDAYSPAFPAIQSEFATSDGMVQATLATTLIGLSVGQLIVGPLSDRFGRRRPLTIGLAGYVVASVLCSFAWSIEVLIGARLLQGFSAAAGIAVARAVARDVHSGATLARFYSLLAASTALAPMIAPILGAGLLELGLSWRFIFGLTLALGVVGLGLVVFVLPETHPDRIGGRTPPTPAERARRKADGESHLGLWSLLRRRHVFVSALVLGSVGAAMIAQLAGLSFYLQTERGLGPGAYSAIFAVNAAGLVLANNVNRLLLRRFTAQRLLSVATPVMLLAALTFAALLRAGAPLPVALPALFAFMSCWGFVMPNAVSVGMAVERHAAGRASAILGVAQFGFSAFVAPVVGILPAVLGVPSMAVVMVICLAVAVTVQLVSRARLPRRPREVPVVPQELADSAAQPTCRAAG
>fig|675635.11.peg.495 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSIDSVVIETTDPAATRAFLTALGLDGRLAVRGSDAPTDGFRACTLSLVVGRPSTVDALVASAVAAGATVVKPVEKTFWGYGGVVRAPDGTIWKIATSKKKDTGPATREVDEIVLLLGVTDVKASKRFYVEHGLTVGRSFGGKYVEFSTPGAPVKLALYPRKALAKDAGVDMAGSGSHRIAIAGDGDGFTDPDGFVWESAPVTSSPN
>fig|675635.11.peg.926 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEPTHEFTDGVYGWITHTDFASDDVEATRAWCADVLGWSFRPPFPTGSGDYHLFAYSDVGGGGIRRTAPAEQPGSTPTVHVRDTHAAFAHAVEAGAEPVTPPTKIMPGVCTALVRAPGGVLIGFSGPTD
>fig|675635.11.peg.1387 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDVRGVHHLGLTVGDLATASAFYASAGYQPADRISLTGPDGAVGNGLDAASLEIAFLIGPTLTLELVEFDPPAPRRVSATDPGFGSVPIGRPGAGQDPDGRPVTFGTAERGLFLTSAAPERTVRLLDALGFDRDGDGAVAGHGVHVDVVGVAAPGRTPANAPGRVHLCCEVADMQKACDELAAAGFDLVSAPRVSGHLSWVFVAHPEGPGVELLEIGTP
>fig|675635.11.peg.1454 Glyoxalase/bleomycin resistance protein/dioxygenase
MNDPLDALREPVTPVDPDPAFAARLRARLERAVLAAPGPQEEPMTSTISRGTALALHSVTPYLAVPDATAAVDFYVDAFGAVRRGEPIVMPDGRIGHAEVAIGDSVLMLAEPFPELGVVAPRDGEATVSMRLEVSDPDAVVDRAVALGARLERPVGDSPYGRGGVVLDPAGHRWMVSREPAAGAALQVGDVGYASLWRRDVDAADRFYAAVLGWTTEGARDGHARRVVGVGQELGMYGGQDAATTMCAYAVDDVDETVALVRAAGGSAEEPLDEPWGRTATCADDQGLPFAVFAAGRQNVRPDTTRPGTLTYLTIEVPDAGRARAFYGTVLGWRFGPGRVPDGWHVRSASGDETSPMTGLHGGHDAAQVVPMFVVEDVAGAVAAVRAAGGTADDPADAGYGVSARCTDDQGAAFWLVRY
>fig|675635.11.peg.1755 
MYVVHNRIEVTAEQAAAFEETFTASMRATLNGVPGLRRSLLLRPAKAGGAYVSTMEFDSADDFRAWMRSDSFKAAHSDTQAPGMQAPSAIELFDVLEDFAA
>fig|675635.11.peg.2494 Glyoxalase/bleomycin resistance protein/dioxygenase
MSHIAVGVRDMAEALRFYRDFLGLAVSLDQHEQRGRERGDGSAQSGRRAVYLRLAEHDDASFLVLDQQLDHRADGEPRNLFDVGFHHIAFWAEGLDALVAAAPAAGVTIVHGPAWEDSTSWGESAGRPIRTVIFRDFEGNIVQVDSRHDG
>fig|675635.11.peg.2612 Glyoxalase/bleomycin resistance protein/dioxygenase
MHHVGIQVADLDRSLAFYEGILGFEVITRQVRGEAYAGEIVGYPGVELHLAHLRPPNSSVVVELTEYRGVERTPVDTSTANPGTAHTCYVVDDVEAVHAALLAAGVRPVSRTIVAPDAGIAKGGKVVYVQDPDGVRVELLQPPPSQT
>fig|675635.11.peg.3631 Glyoxalase/bleomycin resistance protein/dioxygenase
MTPAPSRHGVATTPDVCPARSPAGWVRTVRTSVRMIVMDVGPPVIARIAGAMLAVENQDVMVAFFEKLGFAKTVDRSLWPGARWVEVALPGAQTSIVLTPARAYHREPDRLYALTLSCHDLLATAETLRAAGIEVDGPTHEPSGSYIQVVDPEGRVLFVNDKADPGS
>fig|675635.11.peg.3669 Antibiotic resistance transcriptional regulator, MerR family
MRWSTAEVARMARVSSRTLRHYDHTGLLRPAGTGNGGLRLYGRPELDRLQHILLLRELGLGLADIAAVLDGQTDEVAALRRHHARLLSESRRLRTLAATVARTIEEREGGEEMAAEELFEGFANDPYAAEARERWGDTAADSQRRVAGWDAGRQREVMAQGTAVNARIAELMRAGSPVDDAAVQAAVAEHHAWVRHFWEPNREAYIGLGELYVDDPRFTTTIDRDAPGLAVYLRDAMRVYADRELA
>fig|675635.11.peg.3993 Glyoxalase/bleomycin resistance protein/dioxygenase
MATHEGQWKAGTPCWVDLNVPDVPTATAFYSAVLGWSFVDTGAEFGNYQIAQVDGRAAAGIGPIMQEGQPSFWTLYLASDDADATAKLVTDNGGSLIAGPMDIPGSGRMVIATDTAGAVFGVWQTLGMNGAEVVNEPGGLVWEDARLTDPETARAFYAAVFGYTYDAVDGAPEDYTTFALDGEIKGGMGGLMGAPDGTPSHWIAYFGAADVDAAVAQVQANGGSVMMAPQNTPFGRMGIVADPFGAPFCLHGEVTG
>fig|675635.11.peg.4078 Bcr/CflA subfamily drug resistance transporter
MTRQTRPAAAPERDRPPLRQVLALGGLSMFGPLSMDLYLPGLPELTTDLHTTEATAQLTMSLCMVGLAAGQLIAGPLSDRRGRRGPLLVGVALFAVTSLACAFAPTIEVLLALRLLGGLAGAVGIVVARAMVRDQWEGRAAARVFALLMVVSGAAPVLAPVIGSQLLRVTDWRGVFVVLAGIGLVLLGAAATLRETLPAARRRSGGARETLRALGSVARDRSFLAPASVLALGCCSMFVYIAMGSFVLQGTGYGLSPQVYGVVFAVNATGIVLAGRLSAWLVDRAGPRRLLGAAVAVAFVAALTLVAGVLLTRSVWAVLPPLFVVVAAVGMIMPNATALAMSGQGAAAGAASALLGLGQFLTGALVPPAASVGGVTPLVMAVTIAGTATAAVLAAVPVLRSRDPEPAAQPAVLAQPRTPPGTG
>fig|675635.11.peg.4173 Glyoxalase/bleomycin resistance protein/dioxygenase
MISGLHTIVYAQDAARAREFLRDVLGLGWVDAGDGWLVFAAPPTEVAVHPTDAASSGRAELYLMCDDVTATVAALTSKGVEFTSPVADRGWGLVTSLRVPGAGEIGLYEPRHPTAL
>fig|675635.11.peg.4508 Glyoxalase/bleomycin resistance protein/dioxygenase
MEETVKFYNGLLGFPVVVTLQLPNPDPFPGAVPGNLGGSRHYFFRISEQDTIAFFEFADVEVPADNSLLGAGNHLAITVPSEAELQKAKRLLEENGVKIKSELDHGFCHSIYFEDPVNHIALEFATWQHACDEEEPFLQDPAPVPAALAAIGAERYERYQLHYNPDGHGGEGPRA
>fig|675635.11.peg.4947 Glyoxalase/bleomycin resistance protein/dioxygenase
MGAPVIHFEIGATDGERSRRFYADLFGWKITPDPNGYGVVDTGAAGINGGVVQVPGQVRPYVTFYVAVEDLDEALDRAEELGGHRVLAPSAVGDIGSMAMFTDPDGTMIGLFTERGTATV
>fig|675635.11.peg.5018 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSPEDVPTVTLAVTYRDPKAALDWLARAFGFEVSMAIEGDDAMTSHYEMSVQGRGRIVIGGEWADWTRSPAGVGGANTQSASVLLTGDVDAHCARARDAGARIVAEPEDQFYGDRTYRAVDPEGHVWTFAAHVRDVSRAEAETVIGRRIDAPSWT
>fig|675635.11.peg.5041 Glyoxalase/bleomycin resistance protein/dioxygenase
MRRGGVMTGEFGFGQPHGGVIQTAFVVTDLREAVDFWTGDLRAGPFFHFPEWRGGDPVYRGRPSTAAVTIAMGFAGRMQIELIQPLDEEPSVYKELLDRSGPGFHHLGVASEDIDADVARYEKDGWTLAFRAGVGNGEVAYLDGGPARPGMIELIEASPGLDASFTAMWRASLDWDGTDPLRPR
>fig|675635.11.peg.5076 
MFAVLFEAHSRPDRRDAYAELARLLDGDLRENPGLVDHDLHRSVIRPGWMLSLSTWEDEKALVRWRTHPNHQLAQARGRNEIFVDYTVRTGELTRDTGIPGSGVLREQRFDETTAGAGNTVVLVGPMEPSCPPTTPDAGEIASRLGLDLEADGLTSWDVYEHVENPGMLLVRTVWRDQAAAADFESAAVFPGNPRIRRIRIVRYFSMYNRGEAPQYYPDHPDHPT
>fig|675635.11.peg.5082 
MIFIALKAKIRPEKRDEWLAGIKQYTADVNAEPGCISFEYFESTEHPNQFAIIESFVDSDAGSAHVGMDHVKKFFEWMPYMVAERPKIIYQELEGWNDMAEVTPAE
>fig|675635.11.peg.5145 
MGRYVRMVAVEGQGRALAEGLLRVAEGMRDAPGCELYVVNRTPDEDDAVWITEVWSDEAASDAALNRDLGEAGLGSVLGLLAGPPEFIELSPMGGPGLS
>fig|675635.11.peg.5211 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTPENPARIGNVLHPVPDVAAAVEFYGSVFGFATKFVDGGRYAALDAGGTTLALAAPEEDVTGGVPAASIKVADVAAALAALVEAGGTVVREAEQGPHEVRAVARDPWGNTVVVYGPRQDSPG
>fig|675635.11.peg.5212 
MIFIVIRIDVRPEKREDFLEGIVRYSGQVREEPGNLVFSCYESVERANEFTVLANYVDQAAGEAHVTSGHAKWFFGWLPSVVTEQPKIVFQELPGEGWGPMGEVVMEPRESEPA
>fig|675635.11.peg.5391 EmrB/QacA subfamily drug resistance transporter
MGSSAFLASLDLFIVNIAFPVLRVDFGANLVGLSWVLSGYTVVFAACLAPAGRLADRVGRKRLFVIGVALFAVGSAACAAAPSVGMLVAARVVQAIGAALVTPTGLALLLTAFPAQRRAFAVGVWAALGAAAGALGPPLGGLLVVASWRWVFLVNLPVCVVVLVVAPRLLRESRDASGALPDLLGALALLGGVGALAYALVEAPTAGWTDGPVLAAFVVAAALFVVLAARSRRHPAAIVDPTMLRIPTLSLSSVAMLVFSAAFAAMVFGNVMFLTGLWHDSTVVAGLEMAPGPAMVVVVAMLGSRLVQRIGPGPTAVMGALSYATGITVWVLRMTAEPDFATTMLPGQLLTGLGIGLAMPALTGVVGAVLPPDRWGAGSSMVNTTRQIGMVLGTAVIVAIYDASGGPTTLTAFRHGWTFLLCCAGLTIVCGLAVARRAGRDHDAAAQRFTGPVAAAPGRA
>fig|675635.11.peg.6174 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEILQLTPKLVVADGAAALAFYTAALGAVVEESYTMDGRIVHATLTVGSLRFELKDAGDGDPAPTPGQHPPVLMSLDVSDADAVTERLLAAGATVVYPVSDHEYGSRGGRVADPFGHHWMVSAALETLTPDEVQARLDGVRQGQV
>fig|675635.11.peg.6266 Glyoxalase/bleomycin resistance protein/dioxygenase
MTVTGLARAIVSVADLDAALRFYRDVLGLPVVAPAPDVAMLALPGGTDLMLHQRPSRPSDAGVALSFAVDDVDATVDAAVSAGCGVLDAPADQPWGERQAVLTDPDGHVVCVVARP
>fig|675635.11.peg.6457 
MVVEHAYITVVPGCESDFEEAFAKAQPILSGAKGCRASALHHDVEHPGAYLLRVTWERLEDHLEVFPASEVGKEFGTRIAHFFVEAPEVRHFADESVTA
>fig|675812.3.peg.2704 Permease of the drug/metabolite transporter (DMT) superfamily
MARLTKVNPKNVLMAVIAMVFFAANSILCRMALAEGDIDPASFTSIRLVSGAVVLFVLAGLAHKREGEHNACSLLRQPTEHWLAAAMLFLYAATFSFAYLYLDTGMGALILFAFVQLTMFAYSHYKEGGASGVEYIGALVAIAGLGYMVSPGMNAPDVWGAGLMAISGIAWGIYSVLGKEMKVPQLPANCINFRLSIFFVVPFFLLNIPMNSITSEGIWLAVASGAGASAIGYAIWYGVVQRFKATQAGVMQLSVPIIAALGGYMLMDETLTLRMVISATVILSGIVVTFLGKQIKQSSPV
>fig|675814.3.peg.2625 Inner membrane component of tripartite multidrug resistance system
MSTIALSKPESEVVVSRKEWWAIIGGLIGGFMAILDIQITNSSMKVIQGALSASLDDASWLMTSYFTAEIVAIPLCGWLSKALGTGRYALWCIGGFLGSSLLCSMAWNLDSMIVFRALQGFCGGALIPLSFRLIIEILPLEKRPMGMSLFSIIATFAPAIGPAIGGWLTEHFSWHAIFYVNVLPSVVAWALIQRSMKHPIINWQIIRQGDFVGVVSVMMFLGTLEVILEKGGDENWFDSRMICVLAVLSAISFVIFVYDQIVHRNPLINIRLFKEYQYSYALLIFAMLGSAIYGTLFLVPYYLTMIHDYNATEIGHVVIWMGLPQLVILPMIPFLIRRYNPKYLIFIGFVGLAISAFMDCHMNADFAGPQMIASMLVRALGQPFIMVPLSMLATQNIKAEDAASSAVLINVFRSLGGSMGTAVLSTYFTTRIDFHLDSIKSTLLTGSQQFYHYLGEVKNLLVNQGLPSDSTNVQQTAVSILGERMAIQSQIMAFNDLFMIMGIMMLATAIMVLCSNRDFQLQLKKEETA
>fig|675814.3.peg.2628 Membrane fusion component of tripartite multidrug resistance system
MKKIIKILIPLMLLVLAGGAYWYYYGRFFQTTDNAYVQTDITNVSSRINAEVVKINIKDNQKVKKGDLLAQLDDREFVIKEQLAEATLAQSQAEQSNADAAYKMQKSTIEEYQSKVTSAKAKYQYSLQQYKRLQALEKQNYVSKGERDNGASAYKVDKAAYLEAKASLKTQQDKLSVLESEIEQADAMVKQATASLSQAKLELGYTRIVAPIDGVISNRNLQVGMMVQPGQSVVSIVSDRTPWILANFKETQKSRMHKGQSVDVTIDAYPGKTFSARIDSVSPATGATFALLPPDNATGNFTKVVQRVPVKIVFNDSVQVDNGLSAVVTVDTRQ
>fig|675814.3.peg.3440 Permease of the drug/metabolite transporter (DMT) superfamily
MKKNDLILAVFVMAIWGFNFSMIKMGITNVHPLIATAARFALAVIPAIFFIARPNVAWRYLVSYGLVFGVGIWGMASWSITAGLSSGMSSVLLSSNVLIGMAVGLFVFKEKSSPRKLMGALLAMVALLVLVSATNGNITASGLMLIMIAAISWTLMGVIVKASKTKQAFAFNVWGMLFAPVPLVLFATALHGEQILWQAYENWDMNTTIAVVFQAYPTTLFGYWVWNRTLIKYPLSTAAPLTLLVPVFALVSGYFMYDEVLSMPQVIASALFLIGIGLIVKPASEKHRAASAKLAGQSR
>fig|675814.3.peg.3470 Permease of the drug/metabolite transporter (DMT) superfamily
MAVFQILLFRQLVFVVLLTPAICSNIQVLLKPKRLKLHTFRILGAFTALYLGFVTVSNIPLADATALGFTQVLFVACISRLFLAESISASRLFTIMVGFIGVMLVVQPSFEQGSLLYVGLGLVGALGAAVAVVCVRKVAQVEPKITLLAYQAIFVGLMALIPSLRNWQWPSASEFGLLICVGVLSSFAQWIGISAYKYGEANVIANVEYAKILYSLLFGYWLFAEIPNWMAIVGAMIIIASAILPMLYKNKTIS
>fig|675814.3.peg.3574 Permease of the drug/metabolite transporter (DMT) superfamily
MTTAANSLKKGNVRFPVTESLLLLVAIFWGTSYGLTKSALAYTSVLVFISIRFSITFLCLLPVVIRDFRRGLNKDWKIAIPTGFILSAIFFCEVFGVSQTSASNAAFLISMSVILTAFAELLINKKKVSNTLWGLTACSVAGVLLLTSEESVEFSLNSGDYFILTAALLRALMVTMTKRFTEGKVITTSTLTSLQSLVVALVAIVCAVTYLPTSEFVVPASWEFWLTVIYLVLFCTLFAFYVQNYAVRRTSPTRVSLLMGSEPLFGALFAMAWCRSRSLQCRLLVGC
>fig|675817.3.peg.3034 Multidrug resistance protein D
MKKLPPIWLLVCLMMLPQIAETIYSPILPSISQAFYVSVVDAGQTLSIYFIAFAVGVVFWGRMADILGRRSSMLLGLLCYALACIVAALTNSFSILLAARAMSAFGLAVGSVISQTILRDGYSGKDLAQTFNIMGLAISISPIIGLLAGTGLNILGGYRIVFIMLAVLALFIFIICYSRLNETQNELNVTDSFFSVAKKMVMDTKIWLSACLVAGFNLLIFVYYQQGAFFFESLGYSSQQFGYSGIVLALGTFGGGILNRRLLSMGYTSYFVIAIAGVISFFGGLCAYQLSNSLWLLAAVLVIVCSFGLAIPNILSVALNNYKTSIGSAGAIFGLFYYLMLGLGLNITAYVNHLSLSLLFTSAFIMIIAGLFFWLRNKQY
>fig|679192.3.peg.231 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKKIVGELAHYLLPSMLAVMGTSLYILADTFFIAKAEGSNGIAALNLVLPLYSITYGVGGMIGIGSATRYSLQKARGSKDIDFYFSNAIMWNLCLSLLFALIFGFFTEPILRFLGADAVLLQVGIPYMRTAMILSPFTMVNSCFVAFIRNDHNPKLAMVATLFSGLFNIVMDWWLMFPMRLGMLGAALATAIAPMVSMSICSLHFWRKENHLYWIWRRPSISKLFRSMSLGLVVFIGEMASGMTTMVFNFVLLGLGGNITVAAYGIVANCALVIIAIYNGIAQGLQPLASHYFGSGKKEESQKVYQYSLLFGLSLTAVLVGITFMFTEELVAVFNEEGSLALAQLAQRGTRLYFIGFFLAVINVVQAGYYSAIGLAKESFVISMLRGTALICLFALILPKLIGVDGVWLSFLSAELGTVLISYCLVRKSYQKKLLDTEQREKSLW
>fig|679192.3.peg.305 Methicillin resistance protein
MIYKLMDDPQQFNAFVQNHPYSHFQKTSMWGEFIQKTEHNPYRMLGFFEHNQLVATAMLLVKKTLLGHFLYVPKGPCVDYQDKKLTNQVLSSLKDYAKKDKAMFITIDPNVLRMERTIDGHEIEGGENNEFVTEYIDQIGFKHHGYTYAYDGSFSNRFTLITKLDQPIESIFKGFSTLRKRSIKKNEKFHLYTLEANRNEIQEFVRLENDLGKTKEVIRHSLSFYEAIYDAFKGHVHFYKTILPMEKYLSVLLEKTKSDNPNEASSALKHYQEAIELQKTKGNEPVLAVGMIFDDGHVSYGKYYYRDHSIESLSPLDSLLFHAIQQAKQNGHKAFDFLGFGGLTTPHDWDIGYSLYQYKHQWNSTFIEEIGQFEFVLNPTQKKVFELSRKIKRKLQSFFIKFK
>fig|679192.3.peg.703 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVTNIYNMADTYFVGTINTSATAATGIVVAIMSILQALGFMFGHGAGSNISRLLGSENKEGAREYGATSFWLSILVGILSMIFGLLFLDPMLRLMGSTETILPYARIYGWYILIAAPAFTASCVCNNILRYEGMAFFAMIGLTFGGVLNIFGDYLLVHIFHMGIGGAGLSTTISQYISLLILMLPFIQGKTQAKLGLQYFKGRRQNIKNILTCGIPSLARQGLNSISTMVLNGSVAMYGDAAVAAISVATRVVNLMFCIAIGIGQGLQPVAAFNYGAKYYSRVKEGLKFSLMIASSLMLALAFITFFHAETLVHLFRNDPEVIAIGKVALRFLCVSFVFMPLASFGAMMFQAIGESGIATILSALRSGGVLIPVIVLFSSLWGLKGLEMAQAVSEILSGLFSIPFIFRSVHRFPKDHYGES
>fig|679192.3.peg.841 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRSHNMLKGPIWKEILIFFFPILLGYLFQQLYNTVDAMVVGNFVGTIALGAVGGSTSIIINLIIGFVVGLSAGATVIIAQFIGANENQKVHLTVSTTMIMNIVLGMILMVIGLIFSKDMLKLLSVPDEMMKDALVYLRLYLLGLVPTMIYNAGAGILRAVGDSKRPLYFLIAASITNIVLDILLVVYGHMGVAGAAMATIASQVVTCVLTLYVFQDKDEIYYLDLKHMNFDYALFKRIIGIGLPTAIQGSVYSFANLFIQASVNSYGTISVASFTAFGKIDMFFWNFSGAMGASCLTFVGQNFGAKQFERVKKGIRIALVMFLIGSIGITILSISFGEHFYRLFTQDPEVLKVGMQILWLVGPFWNVISFLEIYSASLRAMNVILAPMLMSLFGVGVIRIFWVLFYPGKSILDTLLVYPLSWCLTSFFFIVFYNSGLWKKKRKSSQKKER
>fig|679192.3.peg.1092 Methicillin resistance factor
MRFIEGVKAERFDTFAVNDPLNHYSKTSPFIQLAKLNGYQSGDLLGVEDEQGHLMATAVMVHKKYRLINLQYSYCQYGFNGDFENRKLMHFLIHHLKNFAQKKGSCFLRMDPNITRLEHEKDGKIKEGGFNHEWFTEFLKEQGFRHLGYNYGYSGNWMSRFTYVKNLDLDWNGCLKSIKRQANYSTKNEERFVKVRQGSKEDLWILVRAEKELAKKLGFIPKSEEYFAKFWDIYEPYAHFYVVKTNYHQAKLSLQTQLEQAKNHLLEIKDAHKLEVETKHIEALEKEIQEIEQGGYDQDEEAYLGAKFILRQGTKVWNVNMYTNKTLMNFRSAFALHMRAMKDVYDQGAKSYDFEGVVGTNDPKDPLYGQQNFKKSFGGDFLEFIGEFDCVFNEKKYGFWKKYDHLWRGLRRRYARWFIRLK
>fig|679192.3.peg.1311 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIKSMTKGNALRLILEFSLPLLLGNLFQQTYNMADAAIVGQILGPNALAAVGATSSVQFLVLGFCIGSMVGFAIPVAQEFGGNRLSHMRQYEYQGAFWMIILAVSVTSITIFMIHPLLHALQVPQEIYQDTYRYILMIFIGIPFTLLYNFLSSILRAVGDSKTPFYFLTLSAILNIFLDVFCIVVLKMGVFGAAFATVLSQAISGFLCLILIRRKFTILQMGKKERMFQWSKSRKVLGMGIPMGLQYSITAIGSMVLQAANNGLGTLYVSGFTAGLKIKLFMLSPFDAFGAAVSTYVSQNYGAKEEGRIREGIYKGIGIALIYSLISGAIMILFGYQLSMLFVNRDSWAVLNASALYLRRMGYGWWLLSFLNIGRMAVQGLGFANRAIFCGVIEMICRVFVSLVFVKDFGYEAITWADQTAWLGADLFLMPMLLMTLRQVHGALENERKAIALEK
>fig|679197.3.peg.172 Permease of the drug/metabolite transporter (DMT) superfamily
MTAAARRLAPGQQWSLALIAVTAVWGWSFTAIHDVLARIAPSTFVAYRFALAALVLALFARMRGLTGKEALAGLGAGVFLGLGFALQTLGLTTTTPSNSGFITGMTVVFIPAAAFLVHRARPSPAHLLAIALAVVGLALLTLRGLRVSSGDLWTLGCAVAFSCHVLALGVVNRWGNILRITVVQLAVVAALSLLWAGAAGDPVVLAGDPRVWCALAVTATAGTAVAYLVQAKAQTVLPASRVALIFTAEPVFAAGFGYWLAGDRFTAQSVLGGVLVLAAMLLAEFGGRSPEPDHYAGPVG
>fig|679197.3.peg.829 
MLTAATSVEIFIPLFGQRLGGFSPLAAGFLGALFAVGWTLGEFPSVSASSERLVRTMLVAGPLAAACALAVAGSLDLSSARLWFGLAVLAAGVGVGVAWPHLAVLAMRSVENPVEGARAAAGISVAQLVAGSFGAAFAGLLVNLAGPGYESSARALFFGMAPAGLVGFFAVWRALRRSTRSARADPAAEL
>fig|679197.3.peg.954 Permease of the drug/metabolite transporter (DMT) superfamily
MTTRTDDEAATAPSETTRPGSRRQRFALPPILVAALGPIQWGVNPLVVTELTVPGRFILTALCSTLPVGLVMTAATRSLPSGAWWWRYLILSWCNFAISTPLFYYGMQHMPGGIATLLIATQPLFAMLLSLPILGVRPTRAQLCAVAAGIAGVGLVVFKGHARIDLLASALLLFSAMTAALGLVLTKRWSPPVSAIRHNGWQLLLAGLTLLPMTFFLEGFPAHITWRNVLGFAIIGFVSKLLGFAAMFRSVPTIGATSAAILTLLTPTTAFVLGFLFKDETLGAQQWLGVALVVGAVVLAGTGASSRRARR
>fig|679197.3.peg.2059 Permease of the drug/metabolite transporter (DMT) superfamily
MAAQHEVPERYAETIETMEAAANGFAVEAGRGPSDKPRHLALAEAIQGPVLIVSWSSAFVAGVIGTKAGTPLLLCFLRFACAALLLTALAFALRSKWPKGKTLAHTVFAGVFMHAVQFCGFYYGMAHGLGGGVSALIQGLSSMIVVVLAALTLGERLAKAQWLGFVIGIVGVVVAIEDRLAFSPVAVASAFLGLAGISVGTYWQKRFVSGVDVVSGTAVQLAASAPLGLAATLLFEHPQVTDSTRFAGAVAWIVLVNSLGVFLLLNHMLRTLPASSVSTLFLAVPATTSLLSWVFAGQTMSAQAVAGLVIGGIGAALAAWGATRRTKA
>fig|679197.3.peg.3345 Multidrug resistance transporter, MFS superfamily
MAGGPMSVSAAPSAERAVPLRLSASLGIGSMLQPLNSSMIGVALVGIAVQFGNASSVAWVLSAFYISSAVSSTVAGALAEMFGPKRVYLVGLAIIALSAVVGGLAPNLGVLLLARVLLAVGTGTQYPSAMTIVRRHADQHNARASSAIVVLSVCSLSVVALGPTVGGFLVGLWGWQSIFWVNVPVAALAAILVSRVVEKDERGERLGVLARVRRLDLPGMAAFASAVTSAMLFLLSLTTSPDWWWFGAAVAFAAAFVVLERSAAYPFIELRALVGNRTLATTMLRSLCTYIAFYLVFLEIPQWLQTARALSPEHGGLVQLPMAVVGVLATMAAGRVYARSGAVATLLTGTLSLLVGGSALVFAVRHDSSWPLLVSVLMLLGLPNGFNNIANQNLIESSAKPHELGVALGFYRTVQAFGALAAAAVIFFAQHGAVSPDTALHRVGATVAVLGLVLTSEAALRRKALSLS
>fig|680198.5.peg.492 Vancomycin B-type resistance protein VanW
MRLRIASLPSPVLTGGALTVGLGGLYLAGLLVTSGDIEAGTTVRGVDIGGLSRTEAIRKLDAHLAAAGPSELAVRVGDRSGTVDTRQAGLGFDSERTVDRATRTASDPLSVIGGFFHSGGDIEPVVRLDEDKAHAALGNLAKALDQKVRDGAVTFADGRVAQVAAHSGYALDVDAAADTLRTSFLHGARGRAVVLPARETRPGVTADEVRRAVRDFAQPAMSAPVTLTAAGTRFTVDQAVLGEHLRMVPDGSGRLVPKLDVKGLRSAPAVAGPLAAVTTTAQNARLELDGDKVAVAEDARPGVQISDSALSEAVLPLLTRTGSARTADVAVRRIQPEVTRENAARLGLTQKMSSFTVNFEPAPYRTKNIGRAAQLINGSVVMPDETWSFNRTVGRRTEANGFVEGIMILDDQFTKAAGGGVSAVATTVYNAMFFAGVKPVEHGAHSFYIERYPEGREATVAWGSLDLRFTNDSGKALYIQAEATDTSVTISFIGTRHYDEIRSVKGPRTHVQPPAKKVRTDDKCVPQTPLEGFDVTVERVFYDAGKEVRREPFRTHYTPRDEITCETPEPSDTPSPGPTTGQTAPPATHG
>fig|680198.5.peg.1262 
MIAGYGFGATLTARPGRGDQLVDLLLTGLNEGSPGASEHCLVYLVSRSASDPDVIHVAEGWTSEEDHHRVFAGKAAQAIVAQIDPLLAKDSEYTDFVPVRGRSAL
>fig|680198.5.peg.1464 Glyoxalase/bleomycin resistance protein/dioxygenase
MAITGLGHTGFWVDDLEKMRDFYSRVMGLTVTDEDPEQGIVFFSARPEDEHHEFVLQQGRTAPAGAKLTHQVSWRVDSLESIIDFHHRFRAEGIEVQQEVTHGNAIGIYFFDPEGNRNEVYLRLERDVRQPFRKSLDLDLPPEEIMAEAERLLTEGGPAYQPVQ
>fig|680198.5.peg.1746 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVNRLNHAVLFVRDIECSVAFYSQVFGFAVEHEMPGRAAFLRARGSDNDHDLGLFTLGPDAPGPQRDRVGLHHLAWEVGTLGELADTADLLDARRALTGSTDYLVAKSLHGVDPDGHEFEVLWRVPRADWPAPEENRRPLPLDLRSAIDRWGPDLRTGAAARSVT
>fig|680198.5.peg.2205 
MQEPLLREPEGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSRLPAPGSSIYYILPHGVRQSAENEACASPRLDL
>fig|680198.5.peg.8565 Multi-drug efflux transporter
MDGDLGRWRRCLLGGAVFAVCMAGTTLPTPLYGLYQEKFGFSELTVTVVYAVYAFGVIGVLLLAGNASDSVGRRPVLWWGLGFAAASAVCFLCATALGWLYAGRLLSGLSAGLFTGAATAYVMELAPPGGASRATFVATAANMGGLGCGPLLAGVLAQYAARPLHLPFAVHLALVACSALVLLKLSETVRERRPLGTVRPQRPSLPPRVRAVFGPAAAASFAGFALFGVFTSVSPAFLAQSLDVHDHAVSGLVVALAFFASTAGQLAVGRVGVRRSLPLGCAGLLAGLALLAGALRWDLLALVVPSAVVGGVGQGLAFRGALSAVAAASEADRRAAVISALFVVAYTGISVPVIGVGLLAEPLGLEGAGLVFIACMALLVSAAGAYLLRRPVPAAEADGAR
>fig|685035.3.peg.746 Acriflavin resistance protein
MARNGVAANLLLLAMLVAGYFSYTSIVQEVFPESSLDTISVSVTYPGATPEEIEESIVQKVEEAVEAIEGVKQITATAAEGRGTVNVELELGADIARALDEVKSEVDQIQTFPDEAEEPDIRELTTRLVVLRIALFGDVNERTLKETAYRLEDAAAALPEISYVDTSAVRNYEIYADVPQSRLRALGLSLPQVAQIVGQSSLDTPAGSIETGREEVRVRTIGQNYDQQDFENIIVLTTQDGATLRLGDIADVDDSFEDSDLITRFNDQPLAFVDVYRTSDERVLDIAEAAKNLVANEFDMPPGISYAIWEDSSELLEDRLDLLLRNAAFGLVLVLAALTLFLDLRLAMWTAVGIGATFVGAIFILDWAGSSINMFSLFGFILALGLVVDDAVVVGENVYAERERGRTGMGAAIAGAQRVKVPVFFAVATTITAFLPLLAVGGVIGKILADIPLVVIAVLTLSLIEALYVLPHHLSTLPDPSHKPGNPVTRFFARVQAWVDERFKAFVEGPLDRTLRFVVAAPYLVVAGGIALLILFVAMLPAGIIKFSFFPEIEGDIVTASLEMPAGTTVERTAEITSRIEAAADRALARLESSPSGETQAQTGAASGGPNPSFLEATYTTIGLAQTGQGPGGPQRTVRPNLANVQLSLVPAAQRDISAVRIEEAWREELGEVPEAKSLSISSSLLGIGEPVNVQLSHPDDAVLDLAGDRLMNQLAGVAGVFDIESDQDAGQQEIELRLKPSARTLGVTLQDVAGQVRAAFFGAEAVRVQRGREDVRVYIRLPEEERDSIADIENYRVRVPGGEVALSSLAQVSFGEAPSVIRREDGHRITTITADVDSDTITGQEVADLLDNEIMPELQADYPSLQYDFGGEQEEQQESFGDLGQAFLLALVAIYALLAVPFRSYIQPLIIMAAIPFGMIGALIGHLLLGIPLGILSMFGIIALSGVIINGALVLIDFLNENLANGMEPGEAVIDAAKSRFRPIMLTAITTFLGVAPITFETSLQAQFLIPMSASLGFGVLFGTALLILLIPALATIQMRAVARVQRWRGRNRDAVDPGGEPMVP
>fig|685035.3.peg.1633 Glyoxalase/bleomycin resistance protein/dioxygenase
MLNHAAWVTHDVEATADFYMNVMGMDLASTVVGNSVPSTGDEFPYFHIFFRMKDGSTIAFFEAPGLPERPAVSHPAYEIFDHIALQAESREEVDEWFDWLTSKGLEVVGPTDHDGLIYSVYFKDPNGIRLEITYPTDPDWNNHSEKGIAHLKAWKDGKQRAIEMGSDIVQSMTNVINDIKRAR
>fig|685727.3.peg.242 Permease of the drug/metabolite transporter (DMT) superfamily
MLFGAAVLFGAAVLFGAAVLFGAAVFFGPAPIRAPPPVRPLSDRSRRECW
>fig|685727.3.peg.3212 Probable multidrug resistance transporter, MFS superfamily
MPAPWLRLAVALFAVSWGANQFAPMQLVYSRHLGLTSGSFTAMLGAYVLGLVPALLYFGRVADRAGRRVVIRSMIPVSVVSSLVLLLGPLSPELLYVGRVLAGVASGMAFGAGTAWMKELSARAPVGAGARRAAVSLSAGFGCGALFAGVVAQWLPAPQVSPYVVHIALMIAALALVWPVPETRTVRTAPAATRVTALSKAPFLRGVVPWTPWVFGTATIAFATLPPRVEQSLGAVSIAFTGTIAALTMITGAVIQPWARRFLEHREEWGAPAGAVLGVLGLGAAGVVVHTDGAVAVVAVFGAALLLGSCYGVLLISGLVAVERLAPEDELAQSVAVYYCLIYLGFALPFLVSVLAPRIGYGTCFAAIAVLMIASVLVARTAPAPRARPARRDDVSPVGR
>fig|685727.3.peg.3595 ABC drug resistance transporter, permease component
MSESPERTMTSSRAARASASSIDFPPPTEAWPESSPKALWVHSTVQCRRLLKRWSRDPSTMIQALLYPALTLVMFRIVIGNTVTAATGQPAVYGQVPMIILIGAMFGSIVSAVGLRAERKNGLLSRFWTLPIHRAAGLVGRMMAEAVRVTITTIVILVVGVFLGFRLTQGFLPSVFLVILPVIFGMGFAMMVTALATVSGDAPLVELVSIGCTLLMFFNSGFVPVMAYPTWLQPVVAAQPMSCAIDAMRGLAMGGPILEPVLQTLAWSFGMMAVFVYPAIKGYRRAAATG
>fig|685727.3.peg.4262 Probable multidrug resistance transporter, MFS superfamily
MSTTSLRSGTASQDTPPRTRRWAARHFHGIGYVLAILLVGANMPTALYGVYRADFGFSPVTQTLIFAVYAAALVPALFLFGPLSDRVGRRPVLVTALGAGLVGAVVLAAADATAWLVVGRILQGVSVGACSAAGAAALLDHVPGRDTVRAARAASASTAAGAALGPLLAGAVAEYLPHSTVLPYVLFAAALVPGAVALAALPKTTEPSHRGAAPGSRRRLVEVPRLPRDIRSVFVLATLPAAIAWATVGLFQSVVPSWIAELLGMSNLLVGAAAAALVMGCSVLSQLGMRGIDPLVAQRVGLGVMFGGTVGLFVVDRFPSLPLLFAVTVAVGLGHGWAFAGGMQRVGAAVAARAPETSGAVLAAFFTVTYIGLGVPAIVAGLLVTYQGTSTAVAEFSVAAAVLCLIALVLNMIRRSESAGAARE
>fig|688269.3.peg.280 Bacitracin resistance protein BacA
MPVSSSGHIVLLGNLFKVETDVSLTVLLHLGTLLAILIFAAKHILRVLKKPRLIFLVILSTLPAALIGIAFDEIIEKTFQKLEYLPVFFCITALLLALASAKNGSKTMEEMKALDSLIIGIFQAAAIFPGVSRSGATIAAAILLGFDKKDSLGYSFLLAIPAITGAGLLKAETFKIADLYLLLLSFVSGLVALFVLRKIVLANKLKVFSVYCLVVALMSYLLR
>fig|688269.3.peg.1648 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSRDLTQGSLTRNLFYMAFPTMGGFALQALYDIVDMFWIGQVSAKAIAGVAVFSSVFWLIEVLNEIIGVSSVSLISQNYGAKNYERTNRIVEQTLVFKAFVALIASGLLIVFLPPLMRFFSKDQEVVNYGLQYGYWRSFFMPIFFMTYSTYTAMRQTGESRLPTIIMGTSAILNVFLDPIFIFDDVPFLGISGFGMGVAGAAVATVLCTVVAFVWGFLVLLKGIGPVKISIKGLFKLDREIDVKLITIGLPSGFEMLLRSASNAVLVKILGFYGANTLAAAGVVSRLVGLSFIPLMGFSMGASAIVGQNLGANKVERAEKTVWLAAVYGSLFVLGFIVLANISPKTIIGLFLHESEAITEGIAAVRIGSWSMLFASFAISMMSAFFGSGNTLPAMFASVVGRWFAQLPYLVLVALVLKLPSNYIWYSFIIAEIAELLYAYFVFSKGKWKQYRVS
>fig|688270.3.peg.1653 Permease of the drug/metabolite transporter (DMT) superfamily
MFALFGFYRVIIQRFAASKKIKMNNHLKGVLYVGVGAASYGILATFVKFANNNGSGTAGLAFAQYFVGVVVLTLLSFLFSKKNTAPTDKKEIRKDKLKLVAFGSFLGLTSSFYYLSIQYIPVSVGIILLMQTIWMGVVLEFFMNRKLVTQKKIIGAGAVIIGTLLAAKIFEVDAALNFKGLIFGLLAALCYTGTLYATSSIALELPLFTRSKYLILGGLIVTMIFWNVQIIADFDWWVFLKWGTFLGFFGTILPPILFNKGIPVIGTGLGSIISALEIPISVMSAYLILHEEISSLQWLGILIILISVVYINLKPKAKK
>fig|688270.3.peg.3828 
MEIYLSVHIKSKPEHQENVKAILQNLVVQTLKEDGCIRYDLHQGIDDESTFVFYEIWKDQKALDFHNQTSYIKALGNSLENKLVSEAVLVKTTKL
>fig|69014.3.peg.508 Tetracycline resistance protein
MDLIKKFKLLMALMSTGFLGNLLVIYFLSKGFSYAQIGLETSVMVLGGFLFEVPTGVVGDKISRKLSVLLGFTIHAFGSVVLLFLHNFPMLLLYALISALGASFVSGSFEAWLFDDLKHIGREREYRKVMREAKSITIPLSATTLVVGAFLAQFYGFTLPIVLGLIVELLAVVLILSIPEYEFKKTERNYLGHTLSSLRELFQPRLFWLVLLSIIVGMQTNQFRKFFEPYLGGVLAKSLGTTLMGTLGLLGVVEVTVRTVPRLIGVRLRDSWSRKAYSLAPVLLPLLTVLSVVYTNPLWIVALGIALTIITAAFGFNLNVEFQHRIPSEKRATILSLDRMLAGLVMAVFYAVYGFAVDKLGLSGARLMFAIALLVLGAGFKAGEVLGFLGEHLKLHHLEESGD
>fig|69014.3.peg.881 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MMKNLLKTSVIVGFRSFVYPIYMLIGLAYGLMLLAFPEQYLPTMVPIFLLFEPGLVGFMFVGTEIFAEKKDGAISALAVTPIEWRSYILAKTIIMSVLSVIGAILIMAVGTRSLDGLPYVIAGVFLCSAVYTLLGIAISAKYRDLDDYFIPIMAVLVVSLLPFAHYHGYLTHPLWKVLYLVPSYPALYFFKAPFVEVSSDTLALSGVALLLWSAVAYYAAKIQFYKYAVEGLR
>fig|69014.3.peg.882 Probable antibiotic-transport ATP-binding protein ABC transporter
MPVIEVKNIRKYYGDVRGVENLSFEVEEGEIYGFLGPNGAGKTTTVKILVKIIRDYEGTAKVLGKDLREWGKDYYNRIGVSFEFPAVYSRLTALENLEFFASFYKKHLDPMEVLKMVGLDKEADQLVAGFSKGMRKKLDIARALLPDPDILFLDEPLEGLDPASARKFKDLFLEMRESGKTIFLTTHNMYVADELCDRVAFIVDGSVRLVDNPGELKVKMGKRLVKVEYVENGSVKTAEFPLEGIGQNEEFLNILRNHEIRRINTEEPTLEEIFLKVTGRRLV
>fig|69014.3.peg.973 Daunorubicin resistance ATP-binding protein drrA
MAAEEAIIAKNLVKRYGDFEAVRGISFTVKRGEAFALLGPNGAGKTTTVRMLTTLTRITSGEAYVNGYDVKKEGLMVRRSIGLVPDISNLYEELTVEENLKFTANLYDAPKENVARLIKEFNLPAKRKFGKLSSGFKRRVTIAAALVHEPEILFLDEPTNGLDVHSAKALRALIRELNKRGMTIFLTTHNMVEAETIPQRVAIMNKGKIIAEGTRTELPKLIGKGTRIRLQVEPLSNKLLDALSAYGPTFDEGDIVITVPDADAFMAELCKLREELGFKVLKVSTEAPSIEEVFIELTTEVPKGGACGCGGCPL
>fig|69014.3.peg.1012 Multidrug resistance protein
MLVAVTRAPNVGWTAKETLILFGVGVIGAVLLVLWERRVENPLLPLKIISSRNPAIANLGIMLAAFGLSMMSQANTYLLQMPEPYGFGKTILQSGLLMTPMALVMLIVAPLAGKFMPKIGAKPIAIAGALIGSGALAVMSLYATKMSLWQFVTMMTVVGIGINLMNISLINVLVFSVPPRMMGVATGSNSLFRNFGSTWGPAIAGTVMSTYYVLFHPPGAPAFVQIKIPTEKAYEVLFGGASVVYLLLALLAFAIVEVMKGGKIREVEEGGEKEIMVS
>fig|694427.4.peg.66 Permease of the drug/metabolite transporter (DMT) superfamily
MFNSIKLYSAIVLSMVFWSFSFIWTRVAIHSFQPMTLITLRLILASLLLFVVLKSTGRFQKLRRKDVKWFLSLAFFEPFIYYVGETYGLTMVESTLAAVIVSTIPLFAPVVAFVVLRERISWSNIVGIVVSLIGVFFVIYEPTGGLKANPQGVALLFLAVFAAICYATVLRKVPDYYNNMSVIFYQSLLGLLFFIPTFLVTDYPTIHTLRVSGESLIALFMLSVFASVIAFVLFAGAVRKVGVTRTNVFVNLIPVFTAILSWVILDEILTLSKWIGIVIVVVGLFVSQWGKIKFNKEVEEIL
>fig|694427.4.peg.150 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSQAEITNNLATEKIGKLIWTYSLPAIVGTVVMSLYNIVDRIFIGQGVGPLAISGLALTFPFMILLMASGMLVGAGSAARISITLGENNKEKAEKILGNALTLTFIISGTVIILSYIFMHDLLHLFGGTENTTRYAEDFMRVIIPGGIFSALSYGFNNIMRASGYPHKAMYTMIICAVLNAILAPIFIFVFHWGIQGAAHATNISYFVGTIWVLTHFLKPDSNIRFYRKNFKLEKKIILSIISIGLSPFSMQLATCFVVILVNTTLIHYGGDLAIGAFGIINSINTLIVMIIIGLNQGTQPIVGFNYGAKNFERMFKTLKYAIVIGTCITTLGFLIGTFAPTLIARLFTTDAKLQAIAAKALQISVIMFPIIGSQIVITNFFQSIGKAKVSIFLSLTRQFLFLIPCLLIFPRFLGVTGAWTAMPVSDGLASIVAYVTIFLFVRRFKATTPRRA
>fig|694427.4.peg.1929 Permease of the drug/metabolite transporter (DMT) superfamily
MENKKLGGHIALFSANVIFGINNPISRALMPEILSPFTLTFFRLFGGMLLFWSVSLFTRKERVAPKDILLLFCASFFGLTLNQLPFFVGLSMTSPIDASIVVTMLPILTMILAAIIIKEPITLMKAVGVVVGASGALLLVFSSQTKHTGNGNFWGDLIVFSATFSFAIYLTVFKNLISRYSPVTIMKWMFLFATIVCTPFCYKPLMQTDFTLLSANTYWRIGYMVVFATFLGYLLVPIGQKVLRPTTLSMYNYVQPIVASMLAVAIGMDTFGYEKALSGVLVFAGVYIVTQSKSRAQMEAERLAKRK
>fig|696127.4.peg.574 Permease of the drug/metabolite transporter (DMT) superfamily
MNEFWRVISKLKSIVIFFSVLIMFFITILGSGFLFLKYYGPVSSKFIGRLIGTILERRIEGTKIEIDYVELGVEDNVVDFSVFDLKVTYSQNIVRVPYLKVDIYMSKVLRGSFIEALSHISVSSDIELSRAPRPNNITVKKTPKHAAKSVKAYLMSHIGFISYLPELLRDINFKIRDVDKKPVLTLSLNSLNFTLIEDRILNFRGDFNAGNDFINFDFNIDTTNPNMIELGGKLNFIPVSLLWASSTYYTKIQSNLKLDLILGGKIGKSGLEYLNFDVVNYHGFIQKNDYLKHDIVPKKFLLSGGVSSQYDIEATSVLEADDLTLKALIANKNGKLVGNIIAGKMKLRSVLDYWPSFILEETRTWLVSNLDKGYVTGVDAKINIDLNASRPIPKESINVRVNLANNVVRCMPLPYIVPVVHINEGVVEVSAEDVVLKLNDATILNSRTNNMIGIINYKNERVDLVLNGRVAGLAQDVIDIGFAYAQSNNRELKNFKGEAETEIKIVVPLTQEFVLDERSVVVHSKMKNVSNKDLSGLVSLSQFDISGQFIGTKLSVRGEGTVNNVIRAGFDLEKSLFNEPGIKTNVTVHASIDELKRNGIFKSEIADGELKGNISIFLLDDQYNVSGSLDLQQLALTHSLGIEKKIGEKGELSFSIHGTAANALIDMPTYSLTLPTFSSAGSGILNEEGLVQLVSEKSRINATDFSFKYSKSYQGDIKLQLYGDKLDLSQINIIGLVKDSGFGKGGSNSFILKTDFKSIILHQGQTLIAPKINLSCKAGKCREFSLIGSFFDNTKINIFYSHPVISVVTDSAYKALSAFGLYDRMEGGTLQFKGEFDEKDLMKGRLFVLDFYIKKAPLLAKLISPLTSFRGLIDSLNNKGIYFDKMSAGIAYDKKKVFVDGLVITGPSLHIKCSGVLNEESGKVSGEGIMVPSNIINTATKHIPLIGKMLSGGEDSGIIATNFSVIGDIDHMSIIINPFSMLMPGFLGGFFDKEKNFRKKEQFPE
>fig|696127.4.peg.915 MFS-type bicyclomycin resistance protein
MYLVITVLMIGMLAGAELDIFVPSFPEIQAQFHLSPFMTQLILSLNFIAYCICSLFAGAVSDKYDRRKVIIISLLIFIFGSILCSLAQNYGTLLLGRVLQGFGIAGPSVLGYVIIADEYSTTKQVYLIGLMHGLIAFAMSAAPVFGSQITCYFGWRGNFVSLLIFALICLILSALFIPTKAMKPQVTLSLKAYLPLLRSKKLMLFTATLCLFMVPYWVFIGISPILYRKDLGVSLEEFGFYQGTLAAIFAIGSALGSLLMKRIGLKKAFFIGISMCSAHVIALCCLMVLDIKNPLIITSCMAIASAGVAIPINTLYPHALEILENTKGRASAFISGVRLIISSVGLWLVSSTYNSTFVPIGLWIVITMSLAIILSLVLVKQEAIFSNS
>fig|696127.4.peg.1012 Permease of the drug/metabolite transporter (DMT) superfamily
MGSLGLVDGVVVFVYITGYLATTFYKARSINNEYSINDHSIWRDVVAVSAMLAVSISTVTIGAMENIYLYGLFFAIPRIVAPLSWLLILKVYAERTGEFKGCLSISDIMQRLYGVPGRWVTDIATVLFGKGMVACQLAALGYIFSYFFDLSYGLSITVGFFLLTLYSIIDKAKQVEFIKVSHLCIFLVALPMACYTAYHDEYKTLTSSAHASLFKLDLNLSNIWVFLSLVLYSMVPAAESIHVQRFLMAYNRIRLIKSLKIVMAVAIPFTVLTCIIAFLIKAQSPDLEPKFAFMHFISSYTSAGIEGLVLVGLIAIIMSSASSWLSYAGLVCTENIIKKIFPDLTVRQELSVLYTSTFAITILSTLLALSKSNIFSLLWMADNFWQPVILVPLAAGFLGFRANSLSFVISTILAIFFILAGRSITGEFSIISLTLGILGSGVSLFAVHYLQKYGEKRYGHEQLEIFNIVSRRKIEKIYGVIAQFMKSQIEKSGTKSHSFCLFIAVNYFMPLIVVNVTGNVLHDSIIYLRVISILLCLILLFAEYWTRKSKNRYYALYWYFCLFFCIPFTASYTIFVTYTSGFWLLNAILSIILLFIITDWISFGILMLSGPFVGYLLYTSLSHQVYPHYSHSGDILLLFYLYGFLLIIMFLFIRDKEKIQEKRLEHMELFGGAIAHEVNTPIATIQMIAMTLSDLAATSSKEVVKKEQPDGSINYVLTIPEAEYEMIFESLPYDLVKTSKEAKRVVDVLLMLLRHRGTEYGSVYSMVEVIQEVLDDYMLEAEKKNRIILKQVNDFKFFGTKQYMKQVLKNLINNSFKYAGEDAKITILVEGNSLCVRDNGIGIEPEYMKNLFKPFHEKGTKGTGIGLAFCGILIHNMGGTIECNSEYGKYTEFLITLPVAK
>fig|696281.4.peg.1474 Permease of the drug/metabolite transporter (DMT) superfamily
MSQKNQPWAGIFLVVIATIALSTEAIAAKIAYQGGATVLTTLTVRYVLAVLFFAMMLHSAGTSIKLSLKHTLQAIGLGIGCQAVTALSLFNAYRYIPAAMAILLLYVYPTITAILAYFILKEPLHWQKWLALVLTSTGCVIILGHPQENLHPLGVALALLAALINALFLVLSGKVLKEIPVPVFNTYLTGSCALLFLGLGSLLGQLNFNLPLRAWLALLFLSIVCTVVAMSALLKGVTLIGPSRSAIISTLEPAFTAVLGFFLLSESLSLWQMIGGAVILSGVLLQKKEPEVQNNG
>fig|696281.4.peg.1537 EmrB/QacA subfamily drug resistance transporter
MNTGELQNKVNWPVTSVIIMGTFLQALTGNIVNVALPKLMAVFGTNANDIQWVLTAYMMTQGIIIALAGYLGDKYGYKQTFVFALIAFTLGSFLCGSAFNFNMMIISRVLQGIGAGIIMPLGMAICFRVTPISKIGMVLGVWGIAGMATMAIGPSLGGYLIEVASWRTLFYINVPIGLLAIFMGITLLPEMEKKATTTFDTIGITTICIGLFCLIFALSKGNQMGWGDPVIVAMLFVGIVNLLVMVVHELRCPEPVLDMRLFKDKLFTLSTITSSFIQVAMVVVVYLFPLFMQSVLGQTAMQTGLVLLPSAVVTAIFMPISGKLFDKYGARYLVLSGLVIMAVSSYAMKDFNGSTSFSTMMFWLSIRGIGIGLALSPAINVGMVSLPKESTGTASSLGNVIRSVTSTFGIAVMTNLMQSRSTFHYANLAQNVVLDKADGLQMLSALQGIGLNAGLGAQGGQILSMSVLYKYVSQQSMVMAISDCFIIGAVLCGLAFILALFLHDQKKVNVAAGGSDIAEVK
>fig|696281.4.peg.2160 Small multidrug resistance protein
MLTDGNKTISQNKAWTFVLLGGALEIVWASGFKYEQIPWLAVIGSLLFSFDLIIRATKVLPVGTVYAVFAGIGTIGTTVVEAVITPETFQWIKIPVILVLLFCIIGLKLTAEGTIKGGGVQ
>fig|696281.4.peg.4077 Glyoxalase/bleomycin resistance protein/dioxygenase
MELEHIGLRVKDVQRSFRFYKQIFGCELIESYQDERVEIIFAQCGKNVLELIRDKGGMSGRAAGVIDHLAFRVERLEDWMDKLAELQVPFISEQPRDFKGGRIFFFKGPDGEILELVEEPPQK
>fig|696748.4.peg.1781 5-nitroimidazole antibiotic resistance protein
MGFQEEQGVYILPLNFAFKQFDDRLELYFHGHQKGKKIDLIKQQKIVGFQMDRKHELVTAEIACHYSFRYQSIIGKGEISLIEERSEKVTILQYLMEHYTGKSDWQFEENELNRIAVMKLIVTEWACKEH
>fig|702113.7.peg.412 Antibiotic transport system ATP-binding protein
MTSTAAPAISIRDLKKRYAPAGGDEGKLALKGVSFDVPEGGIFGLLGPNGAGKSTLINIMAGLVRKTSGSIDIWGFDIDRDQRNAKRSIGIVPQEIVFDPFFTPYEVLEIQAGLYGIAKHLRRSEELLRAVHLADKRDAYSRTLSGGMKRRLLIAKALVHQPPVLVLDEPTAGVDVELRRQLWELVTEMNREGVTIVLTTHYLEEAEELCDRIAIINHGELIANKPTRELVGMAREKILVLTLDRDLTEMPSHPGFVKCETSGERMLEITYDKDRANAGEILSAVQAQGFSIVDVTTREADLEDVFVSLTSQAA
>fig|702113.7.peg.431 Multiple antibiotic resistance (MarC)-like protein
MLELFLSAFVSLFVVIDPPGCAPIYAGLSADATRRQAIAMAARACVIAAIILVIFALFGEKLLGALHIELNAFRIAGGIMLFMIATEMVFEKRTQRREERAEKIMATPEVEDVSVFPMAMPMLAGPGSIATIMLLTARAQGIEQTFAVLGAMLLVLLLSFAALAAAGPLMRVLGDKVEAVITRLLGVLLAALAAQYVIDGVTAVLRFPAAA
>fig|702113.7.peg.1147 
MRIIVAGWLRFGGGDVCAQVVRGGAHLIAQSREEQGCVAYNWSVDPLEEGLMHVYEEWESERDLLRHFRHSSYLEMRGHLESFQLSAFDIKLYSVAGTEPVYTDTGEPRSTLFGVSLD
>fig|702113.7.peg.1286 Glyoxalase/bleomycin resistance protein/dioxygenase
MARLGFHHGAMSVADIEAAARWYVEVLDFRVERRFAIPGGTKAMFLERDGLRIELFQVADPQPMSPARLDPRKDLQTLGNKHVAFTVDDYEGFRANLVARGVEIVLEVGERFGRGLFIRDRADNVLEFLESD
>fig|702113.7.peg.1299 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNSLIFFDFATDNPDKAGKFYAEVFGWEDDARMGGLYHRMVPGGFFKNKDGSDSQIGNLHFGVFDARNARPNPNPDGAEPRTLSTEGRKARIWVLVSDDDTPERILDTAEKLGAKILWRNHYWKEFNGFNHCFADPWGNEILLWVKAGENPQIPEGYTCE
>fig|702113.7.peg.1354 MFS transporter, DHA1 family,bicyclomycin/chloramphenicol resistance protein
MRHSRQREVTTAKAGPTTREPGLGLGIALGFLSALGPFAIDLYLPAMPDMTASIGAAEANVQRTLSAFFLGLAIAQIPIGSLSDRFGRKAPLLGGLCLFVAASIACMLATDLNQLVAFRFLQGMGACAGTSSARAIIRDLHRGHKAARLMAFTFLIIGISPMVAPLLGTGLLQLFSWRGLFGVLAGAGALAAILVLSFLPETLPPTNRTKDWSNLPRHHARLLQSPRFVGWALVAGLATTIPFAFITAAPFIYSGLYALTPATFSLLLAANAAASVLATQFAPNLLQRVGAPRLAGSAAFVALAATTSLALLGTSGVSLALFQTYSMFLFMIAGLLLTPAATSALDSVRSGIGAAAGLLGTIQLAVTALASAAVTLWPPTSLRPLTSVLGTAFAAMVVIVVVLGRLPSPAEDTRAN
>fig|702113.7.peg.1374 Glyoxalase/bleomycin resistance protein/dioxygenase
MNSPFMAFETRIRARVVALDHFNVIVSDLDRSEAFYRDVLSLESCAPPAPLTREMARWIYNSDERPILHLNAQDVPRAMDRDMRPGPTGALHHIALRCEGFDEIRDRLEDRGLRYESNVIRSIGLRQIFVHDPDGVLLELNFFDE
>fig|702113.7.peg.1552 Glyoxalase/bleomycin resistance protein/dioxygenase
MSRKLPGVIGVHHIGVSVPDLDKAREFYLDILGAVEEVEPLSWADNPFIDRIVGLEGSAARQFFCRLGNVQIEVFEYSAPRQAPLAPGRGVNEYGYTHFAIQVEDLEAVHERIVAAGLPVHAPPDMSSITVDADGTKHGYSGTYCRDFFGNVFEILEIHETPEILPI
>fig|702113.7.peg.1876 Antibiotic transport system permease
MADQTNSTEMLTPAGIPQPRQFPTKGEPVIHQVNWVGLKTLYMKEVRRFFKVQTQTIWAPAITTLLFLVIFTVALGRGGREILGVNFATFVAPGLIVMGMMQNAFANASFSFLSGKIQGTIIDFLMPPLSEGELMLAMVAAAVTRAVLVGLALCAAMLLWPGVDLSVAHPWAVVWFGLMGSVFLALLGFISSIWAEKFDHNAAVTNFVIAPLSLLSGTFYVIDNLAPAFQAVSRVNPFFYVISGFRFGFLGQSDIGDTNMAVLHSAIGIGIVNAVLAFVVYRVLRSGWKLKG
>fig|702113.7.peg.2009 Outer membrane component of tripartite multidrug resistance system
MLAVTLSLSACAAPDLGPRPQMRAPANLDSGRSLQTSATDAAWPREQWWKAYGDPRLDALVDEALANSPSVAMAEARIRQARGAAQVSGAQTQPQLGGRGSAGLTKQSYNNGVPSGFVPKGWNSTGTLALTGDFDLDLWGRARKELAAATSEEMAAQADARQAELMLSSNVVSSYFDLGRLVARGKALAEAVKARQSMVDLTGQRVEQGLDNESPLRQAQAAAAQARVALSANQEEELLRRHALAALLGAGPDRGLAITAPAIDSLPETPVPADAGIALAGRRPDIVAARLRAEAAASRIDAAKAAYMPDISISGLIGLTSLGLSNLIDSGSTYGNVGGALSLPIFQGGRLKGQFTQARGGYDAAVANYNDTVVGALRDVADSLASRNAAAEQEKDALQAREQSAAAYDIALKRYRGGLSNYLEALTTETAALQARTSAIDAHFRTLALEVALKRALGGGFDDNSSEKAPDNE
>fig|702113.7.peg.2370 Inner membrane component of tripartite multidrug resistance system
MSSEQPIQYPSPARRLLITIPSMIASTMVFVDVTIANVALPHMQASLSASQEQVLWVLTSYLVAGAIATPLSGWLAGRVGRKNVMLFSVGGFTLASMLCGLSTDLGTIVFARFLQGSCGAALVPLSQAILLDINPPKDHAKAMAIFTIGSLAGPIIGPTLGGYLTDTLSWRWVFFINVPFGILAFIGMLVFLGRRHNRDCPPFDKFGFLTISIALAALQLLLDRGEHLDWFDSDEIRIYGLILIIALYLAAIHLATSPNPFLRPELFKDRNFTVSVLVNTILGMVTFASMPMIVVMTQSLLGYSAMQTGLVSLPRTLGALIAMIAVTRLVAMFEARFLLLAGMIIMCIGMLMYSNIDLFVDERTLVVTGFVLGLGSGLMFVPLSVVAFSTLQARLRNEGTAMYALTRNIGNAVGISLLQFQYSHFAAQSQDSLVQGVRPDNPIMQYTRPDFDFNSVAALSGMKAQIMRQAAMVGDISVYHLIFLASIATMPLILLMRGRKADKVDPATLPHGE
>fig|702113.7.peg.2371 Membrane fusion component of tripartite multidrug resistance system
MNAQSTIPAASEIDPVITPRKRSRRTILMIAGPAIILLIALVVYLWSGRYESTDNASLQTGMVAISPSISGKVTSIEVKENQHVKKGDVLFRIESNSLKAAVAEAEAALATARTDVRSRQADYREALSQVSAAQARYDFATSESARQKSLVAEGISSRAQFDEATTVMRTARDAIAAAKAKADSLRAELSGQVEGSIDSQPDVRKAAAQLARARINLNDAVVRAPQDGVVTRVNQLQVGNYVLPGRPVFMMTGLRYWVQANFKEDQLRYMRVGQPVTITIDAFPSLELHGRVESFSPGTGSSFSVLPADNATGNWIKVVQRLPVQIAIDDVPEGLPLGAGLSADVEVDTGHERHLFSADSPPAAPGGKQ
>fig|702113.7.peg.3011 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNPTGSFIWYELMTTDPDAAARFYGSVVGWTVAAGTPDQTGGMDYRMFERSDGGNAGGMLKLTDEMVAGGARPTWLPYLHTPDVDREVAEIEAEGGKVMMPASDLPVGRIAMVTDPQGVPIYLMAPIPPADKPDAASDVFSVSENQHVRWNELASPDQAASMDFYARHFGYAFNEKMAMGEMGDYCFIDHHGVTLGAIMPQMNPQQPTLWLFYFGVPSLLAAKQRIEDAGGQIIMGPHEVPGGEWIVVGLDPHGAPFGLVGPKGE
>fig|702113.7.peg.3149 MFS transporter, DHA2 family, multidrug resistance protein
MLQLRNEMSSASAGKPVGSDLSFADDAMPANAEASAGHEDDGLAMPRRIWAIVAISFGTALFVLDGTIANVALPTIARDLHVEGGAIVNVVTLYQLVMVMALLPFSNLGERLGLRRVYQIGQVIFMAASALTLAVNSLPALLMVRVGQALGAGMAMSVSTAMIRQIYPKTKLGSGLGINSVIVASSNAVAPVLGGLIVARADWRLIFVAAVPCALVSLLIGRFLPDPVRGKVPFNWRSGLWSAATFAMLVGGIELAVHGGWLFAGIALALVGLASALLLARSEKARINPVFPVDLLSRPAIGISILAAMAGFIGSAGLVVALPFRLEQGMGFSPSEVGLLILPLPLTMLFVSPAAGWLSDRVSPSILGLTGMVIAAIGLILLAFMPVQAGAAAIAWRLVVCALGFGLFFSPNARMVVSNAPRERTAAAGGLLATGRLFGQTLGAASIGLFLSFGAGLGPIPMLFAAGLALLAGLGSLTRWRVAENPRG
>fig|702113.7.peg.3420 
MHPDDPSWYNEVSFWTSFEALKDWHMDTYHKHAKEWAVRTGAIMEDIITNFEYKNARLIRVCPACAHISDKAYDVAVEQAALAEPCPQCGYNFPVMPETLNSTAVFKDEPSTIF
>fig|702113.7.peg.3421 Glyoxalase/bleomycin resistance protein/dioxygenase
MALSLHHINISTPNLQRMQEFYEKAFGFEPVFVHNLEDYQEEAERVIGVKDAVCTTVTMKGGNVYIELFQWSNPVGKRLEPLRPYDYGYTHLCFNVDDIDAEFERLSGLGLPFVHGSPTKTVFDGKTYGSVYGRDPDGNLIEIMQSPSDSDMSLNRCEALALG
>fig|702113.7.peg.3439 Glyoxalase/bleomycin resistance protein/dioxygenase
MIRGIHHIGIHTGNLDRLRAFYEAAFGFEAVGEEVRLEDFEVATLVVGVPDAKARILMMRTANCLIELFEWQTPKGDKLEPAKAYDRGYTHFMVDVTDIDAEYERLSALGMTFVHPMPLHFGANASVYGHDPDGNLIEIGMIPESESLHLKMPA
>fig|702113.7.peg.3501 Glyoxalase/bleomycin resistance protein/dioxygenase
MKVSGIDHVNILTDDLEKTASFYETVLGLTRSENPAIASGVAGFWMRDATGAPIVHLIDRGTVSGRYDAYRPGEPTNALHHVALRCEGFAATCARLDELGCAYRVNDLSHINLMQINLSDPNAVNLELNFADL
>fig|702113.7.peg.4003 MFS transporter, DHA1 family,bicyclomycin/chloramphenicol resistance protein
MERNNRKLVLLAGIAAMGSMAIHMLVPALPMIAADFAVGPGEAQHILGFYLFFLGAGQLVAGQFVDRIGRRPVLLAGLMAYTAGAFTAFLAPSLSALLAARVLQAAGGAAGVVTARVIVSDDASPGEGAARQATLMMVVLISPALSPVVGGLIASSAGWRGVFVLLALAGLFALAAAWIAIAESRPGDGEAMPARSLVQSLWAGYHRLLTDRAFLGAAGALAAMSSALYIFLANAPFLLESRYGLSPDEVGIAFLFVAVGGIAGSRLVALLERRTDALVAGVALGVTGSVAALAGDLSGLTGPAALIAPLILLGVSAGVAGPAGIGRAIAVNPSLAGTAASLAGAGQMLISSLAITVISWFSPVGSSKLCIALVIATAIAAGCAALARPRETA
>fig|702113.7.peg.4207 Glyoxalase/bleomycin resistance protein/dioxygenase
MGIKALGYVVVETAKPEEWNTFLTQFAGAMRAPDAADGAALYRVDDRVFRFRIEAGTREWFVAAGYELTDRAALDALAVRIGDAARPVEWADANEAAGRGAEAMFRTSDPAGNGLEFYCGDARSDKPFVSPIGVPEFLTGDLGMGHAVFSAPDFEETIAFHRDVVGFHETDMPRFHLMGPDAPSMGFAFLHADNGRHHSIAFGEGPVPPSGAVHIMLELPDLIEVGKAHDRMKRFGYPESATLGRHVNDETTGFYVQTPSGFDLEIGCDSLIIDPASWEVTKHEGISVWGHEWAWQKALKEQQEQEKGA
>fig|702113.7.peg.4249 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MTKRVPRAIDQVAWIVDDLDAAIVRRLHADGTGPWTVFRNVEMAGTYLGRETKVTMDVGLAYAGDLQLELIAPTNSAPSPYRGKDGKARIGLHHVAYVVEQLEEAVAEARAAGLDPVFEAANAAVRVAYLQHPAEPGALTELIEGEGMRALMKQGIAEAANWGGTDPIREISAS
>fig|702113.7.peg.4412 
MAGKSFIARLRTKPEMRERMIELQAELKSLVFEHEPDAPVYEFLQSQDDPDLFHVVATFRDEAAFDKHMHIDFHDRLVPGILECLAQDMELTFHTSLG
>fig|702113.7.peg.4413 
MAFSFLSRFRIKDERQDDFIAMARQMEELSKQEPGTLHYQFFRLGEPGMFAVYESFVDEASDKAHMEYDHNKDLIERIVGCMDGSYERELLFDLEPHRKG
>fig|702113.7.peg.4423 
MIGVIMHVRTKPDKTERFIELITQLQKDVRANETETLLFQVMRSETEPNAFAFTEMFTSHQAWKDHASRPYHVAMADEGWSCIDGEADIRSFELLGDAPVMGETA
>fig|702113.7.peg.4446 Glyoxalase/bleomycin resistance protein/dioxygenase
MIRGVHHLAISTPDLERFIDHYRRWFGFERVGEGGWERGNARIDTMVGLENSAARYAMIRLGNLHIEVFEYASNDPREVYPRMCDHGITHLCLYCDDVFAEYERLKGMGMTFNCPPGGSGMTRATYGRDCDGNVVELLQIVDPDCTFAFEKQCATC
>fig|70601.1.peg.599 Permease of the drug/metabolite transporter (DMT) superfamily
MLLGVLLALTSAFCWGTSSVLIKVGLRGKSPVSANLIRLYFSSILYFLIFYFGGNYKEIAGLPLEYHILAFISAQFGFVIGDYFYFSALKLLGVSRTVPITSTYPLWTIIWAYLFLGRSVTLRIITGAVLIVIAIIMVGRVESQEHLSYKGILFALITPILWSIAIVIMDWLSNFISSLTLAGLRIIYAAVGVTFISGKFIGEIRNSNLVEVLIISTAGLLGLVVGQYSFVKSVSLLGSQIATPITAINPIISTGLAIIFLGESPNWKIIVSLILVVLGIWLISS
>fig|706191.3.peg.503 Outer membrane component of tripartite multidrug resistance system
MKSRLPAVLVLLLSGCTVGPDYQRPLMAMPVHYKEARGWQQATPQDDRHKGEWWSVYQDATLNSLLSQVSLSNQNVAEYAAQYRQAQALVAQSRAALFPTLDYDASTTRSGSHTDSTRTTSSSHQAALNASWELDLWGKLRRTREEDQASAQASAAELANITLSAQTELAEDYFQLRIMDEKIGLYQQSITAYQRYLSVIQNQYQAGTESRATVAQAQQQLESASASAQDYQWQRAQMEHAIALLVGKAPADFSLPAATLTATLPAIPGGLPAELLQRRPDIAMAERKMAAANAAIGVATAGYYPDLTLSASGGVSASALHNLFALPNRVWSLGPELSGSLLDFGATSASVDQARAAYDASVANYRQTVLTAMQDVEDRLVELNTLQGEIAAQQRATAAAQTSAQVTRNQYEAGMIDYLDVATTENSSLSAQQSLLTLKSTQWVSSVALIAALGGGWHTAP
>fig|706191.3.peg.1607 Permease of the drug/metabolite transporter superfamily
MAVRHFFMVLMVVSIWAFNNVAVKWGLVELPPLFLTWMRFAVVAIVLVPFCRINRQQFPWLLLLAFTFGFMHFSLLFVGMRFTDAGTGAIVVQLGTPIAMLLAMVVLKEKLRLIQLIGIMISLSGVVVLSGSPTIPAWWVLCILLCSATGWAISNLIVKKSPPIKPLTLTGWIAFLALPIVGAASLMLESHQLYALQHAGWRGWFAILYSAIASSVVAYTLWYALLKKYNVNLIMPYSLLTPVLAVLMGIVVLGDSLNSFKIIGASLVILGTTIAVINLRNLRMHARFPRLRRR
>fig|706191.3.peg.2844 Inner membrane component of tripartite multidrug resistance system
MTTRPGNAPTLHPFTLRLALGLLGVWIAALTSGLNDRVSDIALADIRAALGIGYDQGSWIVSVYQAAEVAAMMIAPWFAVTFSLRRFSLIMSAGFLLSGVLLPLMTNPALFIALRVVQGLFGGALPPMLMTVALRFLPPPVKLYGLGAYALTATFGPNMAASLAAFWTDEVSWMFVFWQVVPGMLIALVLMAWGLPQDPLRTERFQQIDLFGMLTGCSGMALVVLVLTQGERLDWLDSQLIAAMLLAALPLLIVFLINEWFHPLPLFKLQMLRRRNLMHGLLVLAGVLIVSLSGSALPSTYFAQVEGFRIAQFAPLALTIGLPQLIIAPFIAALLNIRWIDCRWVLSLGLGLLIASCMLGMQITTGWARDNFWLIQALQAAGQPMVILPVLMSATSVVAPPEGPFASAMFNTVRGFSSIAASTLVSWFVSHREQFHSSILINQAASRPWLMTAPDSGQASGRYPLLPDGSASSVENLRAFATQVKHQALVLGLSDTWLLLIGFALLLLLITALLPKRVWPPQTLIHSATSTSG
>fig|706191.3.peg.2954 Permease of the drug/metabolite transporter (DMT) superfamily
MSYRILWSIALLAVTAVWGWSFVAKHDTLGFMAASTLNAWMFTLAALALLPFSIRSFRHLKPRDWVSAVLAGIVLFAAFSLQTSGTAYTTPSNAGFITGLCTVFTPLCIYLIGRGRPSAKQAAGTAIAVFGLGLLSLDGFRVHYGDLLILGCAVCFAVHIVIVSTFTTPDISLASTSIQLGIVGVLSLLWSVARDQFSLPHSLPTALTILSLALFATALAYAIQNRAQAVLAPEKVALILICEPVFSGIFGYFLAGDRLPPERLAGAALILVGIVVTELRVVRLLPAAWRRS
>fig|706433.3.peg.1362 Permease of the drug/metabolite transporter (DMT) superfamily
MRNFFSKSNLLLILASIIWGCAFVAQNVGMNYIGPWTFSTIRFLIAGFSLLAIIPILDKKRTHVIRPKTKEEKMKLLLGSVLCGLALSIGSIVQQIAMLTVPVAKAGFLTTLYVLFVPMITLLFGKKIPLKVWIGIAMALFGLYLLSMAGNLAIGIGEILLILAAFLFAIHIIIIGHFSTRVDPVRLSCGQLLIGGFATVIPMIVIEKPTMGSILAAYIPLLYTGIFSSCVAYTLQIFAQKEANPTIAGMLLSLESVFAALAGYLILHQVLNTRELIGCVVIFIAIVIAQLPDRRDMVNVTKET
>fig|706433.3.peg.1488 Permease of the drug/metabolite transporter (DMT) superfamily
MKIKGIIYILLAALIYGFTPLLCAFTYPLGNNGFSMTFFRSFFVIPILYLIIVLKKIDLHLDRNELKALLPACIMGACLSTLFLYTSYKYISIGSATTLHFSYPVFVLMISFIFFKEPIKFANIFVIAVAVIGISCFMKISDGIDIKGVLYAIASGIAYAFFMVALDKNNLSYMNRYKLSFYIAVISVFVLLSFNIVLKQLVLIQTLHSYFYMFIVAILTSIFGIIFFKEGIKLIGATNASIFSLFEPLSSIIVSYIFLGIKISILQMFGCFLIILSVLLLIKFNNNSC
>fig|706434.3.peg.73 Probable acriflavin resistance lipoprotein A precursor
MNVKHAFGLLGAFLLSVSLLTGCGNTISAKTEKVTKSPHPVALTLDANITALHSAEIMPKVSGKLVSAPPVVGQDIKAGEVIAQVDPTPYQQSLSSAEAELMSASASSAPVYEAPAVDTGERAKLDVWYQMGAISRVEYNQMQSRANGGGTYRATPAVDTEKLAQLQQTIQTAREMLSNATIYSPIDGRVTAVAENSSVAVAGNVLATVQQLTPLVATFAVPQDYIDAVQAARTAGTLKVQVLTPGGETEAGELTFLSTEVDGATNAYLAKITFNNNKNLFVPGEFYHIRLSTPQEINQITVPKEAVKTKDSGDFVYVVNSDGVVDARAVLTGDEEGGRVIVLSGLKEGDTIVSDPPDSLEIGMKVSS
>fig|706434.3.peg.1328 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIRPESNQITHFLGVFFPLLLTQFALVGSSLFSSIFSGNAGTTDLAGVAVAANIWYPLFAGACGIAFGISPIIAQLRGARKTEDIPVFITQGIYTSFFLTIIIVCGSRFLLTPFLSLLNLEPAVQAIAEHYWLALSFGIFPMLVQATLRYAVDAHGMTRLSMGVLLSNLFISIGLFKLFIFGGCGFPALGGAGTAYAMTTASWITCTVFIIILHFKAPFKAYRLWSDFRKFSWVHCREQLRLGLPMFVAIFCETSLFSIVGLLMSEFGTLYIAANQAAISYSTFVYTVPWSISLTATIVVGYEVGAKNKIKALQYDTICFFVSLSLLVLTALFTFTFLNDIAALFTHDKATLVTIRAFLIFALIFSACDAMGTPVQGMLRGYKDVRIITYVAFVTYWIIAVPMGYVLAHYTSFGPYGYWLSLVISLGLNALILNGRLWFYTSRRSL
>fig|706434.3.peg.1351 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVRNMTEGSPMKLIIAFTIPLLIGNLFQQFYNIADIIIVGRFIGVHALAAVGATAPLFMGLLALTIGLASGFTVITAQRFGAGDEAGVRHSAATAAMLSAVITLILMIASGLLMPKILQLMNISAELYDDAYHYVIIVSYGLAATMMYNLLSCICRALGDSRTPLYFLILSTLLNVGLAILFIVAFDWGVPGSAIALVVSQGIAAFLCLFYMRIKFPFLRLSREDWRFDSAFAKEHLKVGMPMALQFSIITLGIIVVQAVCNTFEAETIAAFISATRIEQVAMQPMISFGIAMAVYTAQNYGARKFDRIRKGVRQCSLLSFGLCVCAVALMYFFGIEIISGFTTDPDQFLLDQAALYLLFTVPFYFFLGQLFVYRNALQGMGIAIVPLLSSILELVIRSGSALLLADKWGYPGLCAASPVCWVAACLFTTGCYFYFSRRLFAEK
>fig|706434.3.peg.1456 Permease of the drug/metabolite transporter (DMT) superfamily
MRFWLGGLAIVPAYCLLKTRIRSIPKSEKPPYSLLTATLTLGFLLFTGAALQQIGIIYTTAGKAGFITSLYIVFVPVVSLLFYNPLRLSHLFGCVVALIGVYFLSFHGGFDDANIGDILTLASVLFWTLHIVSVSRFVRYYDGVKLAIGQFFFCGLFNFLAMYPAGESLTVSIFLNALLPVLYCAIFSTGIAFTFQILGQKGVPPTEASLICSLEMVFGLIAGCLFLGETLTSSEILGAVLMSVGIVSAQLSSRVIYSRKA
>fig|709032.3.peg.95 Acriflavin resistance protein
MHHHKPKIIENTVLKILQDKRRQVGVIIATLLILGISLLMFPTMLVKAKLLPKPTADYFTIYVDLPSGKSIEETKQVTECITNTLTSEKEIENMSTFLGESLPVDFSAIIKWRVLKSNENTANILVNLTKKEERDENSLVIVSRLRPIVQKACSAEGANIKFIEDPAGPPVLASLVAEITSPNYYQNNLNTLADEIYAIFKNTKTLVDIDIERDQTYKKYDVILNEEKIFRAGLSMDHVKNVLYAAFEGMDIAYVNDPYANNQIPIHLVLSNETKKLSDNRSETLLFKLNELKLLNSQGMMVPMSELVDIKDTTNTKKIVSKNLTPLISIIAEADMESQIYPLLDARKAIIEKLGNKYSIEKTKFLDLKLTNKKTGEEFFLHWDGEQKLTFETFRDLGFALLVSIIMIFLLMVIYYHSFSLATGIILASFISIAGVIYMHFIIDIFSPTTFFITGTSLIGFIGLIGINSRNSLLIIDFAKQLIEEKHFSVDKAIAVSIQTRAKPILLTVLAIVFASSLLVLDPVFSGLGAALIGGTLIAYMVSLFVVPILIFRPLKKMYPDYADCYEKNHDDSLQST
>fig|709032.3.peg.106 Acriflavin resistance A precursor
MKRITNPILSVSAAILVGVIPLSLQGAQKTPAEQSQQVPKVDVYKVGSAQPIPVTFAYPARLNALANATVTSRITGVLIQKLYTEGSFVKKGDLLYRIEPDSYAALVNERSADLEVKKAAFTNAQRDWERVENLFKNNAISKKEYDASLSAYEMAKADVSSAKARLQSAKIDLNYTAVKAPISGIVEMKQIDVGNVVTAGTPLVSITQVDPIYAEFSIPDVDVRKAGGSLQNLAKGGKLQVSFNYNGTLYSGIVDYVAPQINTNTGSIKVRARLKNPNNALIPGAFGRINIVGVHAEGAITVPQKAVLQNKMGTIVMVVDKGVVGIRPIKLGKKSGDGFIIEQGLKAGDTVIVNNFFRIQPGAPVAIDKVVNSEGK
>fig|709032.3.peg.890 Outer membrane component of tripartite multidrug resistance system
MQPKILITACLSLLLLSGCVPKMDKAVPLSDMTINADLEKMSRDFDDERLVRDWWKMYGDEQLNGIIEEALAKAPSIQSLEAKFAQANTIIQSVESRNLPHLSANASVIRERFSENHIFPPPLGGGTYTQYQPELMLEYDFDFWNERSSHISAAKNTALAQRATIEASKIALSSALCETYIAWHYEEQKLSILNALDRTTREELKIVEKQYALGLIDAIALNDKKSAQMQIAQRMEELKRSIEGKKEAICVLGGFLPSYAETLRTPTIKHGFNLPLPKEVMLNLVAHRSDVAIAKYTALSKSYTIEQTKAQFYPNISLSGLIGFTSFNWSKLMDHSSYSPSAGIAVSLPLLDWGMRKANLQNSVSDYNASVYEYNQAVIKAANEVVVLLKQTKLIQSQLQLHDREMNAKKGNETIECKKLFLGLSDKLPYLSAKKTVYEGEMDTLSLNETKSLIQINLIKALGGGYVLKEDKNASR
>fig|709032.3.peg.891 Fusaric acid resistance protein conserved region
MQVDSAFISTFKSFPWQRTLYEWLTIDAPVVIYMAKVIMAALLALWISMKLNLPDPRTAIFTVFIVMQPQSGLVFSKSYYRVLGTIAGVGMSLVIMGMFSQDPVWFISFVALWIGLTTAAGFKYRNFQSYGFVLAGYTMCIVALPVIETPLEIFDIAVSRFSEVVVGIMSATVISDVVFPRRLLDSLISSEQERFQNVLSTLSDPESVFAAFDEKNPAVTRFSSGVVGLNAVRINSSFESKSDQKERQHYGHLNHEYMNLSTTFRSLKSIVASIKESEKTELLEALEHLYEPISAALKNRPNTVVTPEDLSRVLTELFEAKAGVKKQYELEKIMFEGEDKFTSGAYLISRLLNELYNHCATYLSLLKHRLSGNATRELSRTVRFSTHTDNVLVGLAALRGSGVLLLTMMFWIWTAWPFATLSITMAVVIGLLLGTMPSPLDGVKDFFKGAVVALVFAGVYDFFIIPAYTSDLLTLGLLLSPTLAFIGWMTTRPKLPVFTFGFVFMFMSQCALDTYYKIEPTKFLESSLAALIGIVFGGLAYIVVNFWSCSLTQRRVAKILRRQIVRLCVGALNVERSALESTGRDLVQQFSTQGRLNMRSSRLVYEWLLTTLEIGRAILAIRRSIQRLYAHNRHPRISDALESIKSYFEGPTDVRREFLLRELKETIAILRSSDRPNEKVQFKRFESLITELALIRTVLLHSTTFPLAKEDSCR
>fig|709032.3.peg.999 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLKHRVLHLAIPAALKHFLDIVQILIDMLMVGVLGVAALAAVGLSMQFMMVIQAFMSVYAIGSSALISRYIGSGRRHRASSVVFVGLWVALGGALIVGIAGWSFSSDFFRWMGSSAEVTKLGSGYFGILSLGMGLIFLDTLAYNALSAAGDTRTSLFIKIASAFLNAGLNYLFIFGHGGFEPMGVEGAAYATVSAYGFTVLIYSWLLIKKGGILDIYPIFVRSDFKKMIAIGTPAAVERVIGVASFLLFVMMIASQGTVALAGYQIGLRIEALAFMPGFGFSVAAMVLAGQFIGSKQYDYAYESGILSAKIATLFMGSVGIILVSIPEVLIRFFTQDSVTIDQAALYLRLVGIAQIPLALTFVLSGALRGAGATNLSMRISIGSLWLFRIIPAYVVMKLGGGILGIYIAMTVETFIKGWLFWQVYRQKEWITRTI
>fig|709991.3.peg.328 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADLFPNYTEEKQSIRKFFRSYVYPAMFNMVVMALYNIVDRIFIGQGAGALAICGLALTLPCVSLLSTVGTLTGVGAAARISTSISLGNRSLACRILGNATVLNILLSTILIVYSLYHLDFILDIFGGSGQTIPYARKYMSILIPASLLTNLNFTYCHAIRASGFSRKSMTIVFAGVIANIILDPIFIFGFGLGIEGAAIATALSMCISSVLVIRHFRSPSNILKLQSKCFSPRFPILVSIVGIGMAAFIMNITTGMVNIIMNRYLENNGGDYAIGAFGIISSYSIQVSMLLMGICQGMQSVIGYFYAAGHRQMTLHILRKAIRTGSLIACCGFIIGEAFAPWLVKAFTSDPTLLQLSEEGLRYTFLAMPLLGFQLIVTSYFQSIRQAPKAITMNISRQFLFLIPALGLFSHWWGLTGIWLAIPFADLMATLIALFFLWRTDRKAD
>fig|709991.3.peg.891 Permease of the drug/metabolite transporter (DMT) superfamily
MMYRLKGLIYGVISSATFGLIPLFALPAIRNGIGVDSVMFYRFGISALVLGLWLVIRRYDLRISGRELFTLAGLGIFYAMTALLLTTSYLYIPSGIATTIHFLYPVVVTTVMILFFKDKVSVPVIGATLMAILGVYLLSNNGTAGTVSLKGLLLVLTTVVTYALYIVGVNKSCVHRMDGLKLTFYVLLAGAMVFGLNLSVKGVPLDPIPDWETGVYLLLLALIPTLVSDFTLILSVQHVGSTTTAVLGCMEPLTAVCMGVWFLHESLGFWQLAGIVIILSAVSVVILANSKDGFRPRRLIPLKLRKAVRWIKPINFSH
>fig|709991.3.peg.1490 Permease of the drug/metabolite transporter (DMT) superfamily
MPKSKAYIGHLMILATTFIYSFNTNFMKVIIPEWIGPNGLVLLRCSASTLVFWLIGLYFPTSSDRPHPQKKEIGMMILGGILGLGGNLLFYINGLSLTGPIDAFVIRTTQPIIVIALAVIFLHTVFTKYKAFGILLGIAGALYASIMPHTGSLVKDSFGGDVLVFCSSVSYSFFLILIKPYTQKFDSVTVMKWMSLSSMIISLPFGLSDLVRSPLFSAQAPLHIWLEICYILFVATVIGYFLSVYALNYITPFVESAYKYVLPVTGAAVSILMGLQKFSWHDPIALALIVTGFILINKKTNEIQTNHVSIHHSPTGPEDRENHPG
>fig|709991.3.peg.2303 Probable multidrug resistance protein norM
MSYFTPYKEHYKALIRLGIPIVIGQIGIVVVGLADNMMVGQYATLDLAAASFVNSAFNIPILFGLGFSYGLTPLVGQFFGRHDKYHVGQLLRNSLLVNLFIGLLLTLAMTVVWFNIDRLGQPEELLPLIRPYFLLQLASLVFVMLFNSFKQFADGITDTKTPMYIMISANLVNIAGNYILIYGKFGLPALGVVGAGISTLTARILMFAAFAVLFYRSLRYRRYLVGYKRGKYNFTDILSLNKMGWMVGLQMGLETALFSITGIMIGWLGSIALAAHQVMVAISTLGFMIYYGVGAAVSVRVSNYFGRQELLHVRRTTMAGFHLILCLAVCACTVFLFSRELIGYLFTTSEEVIRVVSTLVYILLAYQFGDALQITYANSLRGIGDVISMAVISFIGYFLIAMPVCYICGFVLEWGITGIWIGYPIGLTLTGVMLCGRYYWKLKTKTQSKEFY
>fig|709991.3.peg.2887 Permease of the drug/metabolite transporter (DMT) superfamily
MTKDKWLGHGAILATNLIFGLNTPIAKTIVPEWISPYALTFVRMVFATLVFWGIGLLAPKEEVGKRDLWTIFGGALFGLVGAQVSFANALLYTSPVNITIIAAMTPLAVMLIAALILKEPVTFKKAAGVLIGASGALLIIFQSSAINTDSSGNWIGNLLCIVNVITYAIYLVITRPISQRYSAITLMKWMFLFSALISFPPGISDLPEAKVFGTESNPFVILKLSYIVIMATGIAYFLVPMALKRIRPTTASMYNNLQPIIASIIAILIGQDVFSWDKPIAALLVFTGVYLVTQSKAKEEVKGIK
>fig|709991.3.peg.3425 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTTDLTQGSIFKSLWIMAVPLISASFIQMAYSMTDMLWLGHLGSDAVAAAGAAGFFTWLCNALSFMTKIGAEITVSQSVGSKDYRRAAHYASQAITLSTTIGFIYACIIILAAPLLMGLFRFETSISTQAIDYMRLVAPGLFFQFNNNTFSGLYNGQGDSRTPFRTSAVGLIVNIILDPLLIYGIGPFPAWGTAGAAVATALAQLVVYGIFARRIFSDRFPLGRMHLLNRLKQDYARRIILLGLPVSIQNALFSMFSLTLATLAARWGAVGVAAQSIGAQIEAISWMTAAGFSTALAAFTGQNYGAGNYERIRKGYRLTLGIAGSIGLGAGILFFVLNHEIFGLFVNEPEAIEAGGNYLKILALSQLFMVTESVTAGAFNGTGHTTPPALTGIIFTGARIPMAYFLTSFPQLGLTGIWWSITISSILKGSVLPLWFLHFQRKLK
>fig|710696.3.peg.22 Antibiotic efflux protein
MEREEAVEVPAGRGLGRLLASTSVSIAGQGMVLAAVPLLAARLTDDPFQVSLTVAATYAAWLVVGLPAGALVDRWPRRRTMVVADLVRALIIGGLGLAVVAGVAQIWLLILSVFLLGVASCFFDPAAQAAIPAVVGRDSKVLATANARIWSLDLMGRSLIGPPAGAALFVVAAGLPFVANAATFILSAMFLAGLGSLQPATARDGRPRLLASVKEGIHYLARHRELRTLTIGMASFNFVYNTANATFVLFAMDQLGVSEQGFGLLLASAAVGGLVAGYVVPKFKSKVSATNLYGVGLAVQGLGWLAVLAAPNPWVAAIAVAAVGGTSMAVTVLGAVARQRLTPDLMLGRVSATTRVAGIGSGALGALTGGLVASQLYIDAALWAAFITACLISVTLWMSKSAEH
>fig|710696.3.peg.2175 Permease of the drug/metabolite transporter (DMT) superfamily
MTPSAASATRSSRVDLRGALLVMGAACCYALSVVFAKGAYAMDVAVATLTLWRFAIGAVIFWALVAVRRPARVSRRTVLTCIGLGAIGYAVQALTYFGAVAVMDAGLAALLVYTYPAIIALIGFLTRREPPTRRRIVALACSGAGMLLLLGLGGFTSVSGVGISLALTAGVTYAVYTIVASSLPVEADVSLLMAVVATSALGSVALFTMVTGQPFGLEADPVVLGWVLTYVLVGTVLAMLLHQRGITRVGASTGGIISSVEPLVAAAAVALVYGETMTPVQVVGGMVILVGVVVVQLPQRRPRRIPEQLRPAARAGRAVPWKANSISGSAREPCGSSQFLSRS
>fig|710696.3.peg.3261 Drug/metabolite transporter (DMT) superfamily protein
MPDLRTRNADRTWLIALAASLWGLSAIWRDPLAKQYPSVAIVFWEHVVLALLVSPWLVGALRAVAVARRRTQVSVLVIGAGSSALATTLFTSAFRLGDPITPQVLQKLQPLIALLLAAVLLGERLRASFAFFAVPAIAGAWLLSFPEPFAVSVTSLYAAGLALGAAALWAAGTVLGRAASAELTFRQLTTLRFGVGLVALAVISLVTGTSVRIDAGSAGNIVVLALVPGLVALLLYYRGLRTTPASRATLAELAFPITAAVVGVTVLGRTLDGSQWVGFAIVLAAVVALALHERRSERPSVAVPDRADEAIGVGG
>fig|710696.3.peg.3555 Glyoxalase/bleomycin resistance protein/dioxygenase
MADVRAAVAWYADVFGFVEHVRIGEGHRSQLGLPDGQPAELVVAEVRPGRRTPQSGRSHQVMLKVADVAGVAETATARGAVLVDPPHDWEYGERQATIDDSFGHQWVLNQTIVDVAPEQWGGQTVTPRPRPQ
>fig|71421.1.peg.1187 Permeases of the drug/metabolite transporter (DMT) superfamily
MSEQSSKYIAALLAVLSISMVLGIDLFIFSLQSEKQTMPHLGVGVLVAQLISLLVFYRGEICPGQRGRLIKVNMTFAIYWAVWLLISLLQNNHTLTNVMSVCGLSVVYFIWKQPKTEKIRNSFLLMAALIAGLGCLSYLMIFTELPASDFAEYNPFAPILSGVILANLVLVIARNRLQGFIALLPLAMIILLALNALAMFLFLLLNGMESAVNSESVFAYIIYFVCHFVIAAILILHSFQKWTLSTNSLFILLFIAVCLPLWMVFV
>fig|716544.4.peg.541 Drug resistance transporter, Bcr/CflA family
MKKIAISLCLIIGLVSLPQISETIYTPALPDVAKGLKASVHAVEASLSVYFLGFAFGVFLWGGCSDLIGRRKTLLIGLTIYIISCVACLISHRIDLLLVWRFFQAVGASVGSVITQTILRDVYEGKERSRLFATISAALSLSPAIGPVIGGLLSEDWGWRSNFAFLIALGSVLLAWAYLKLPETRPSHVELPGKREYQNLCRRMFSSTALWGHVLLIGATNGILFCFYQEAPFIFINQIGLSPKAYGLLGLVVASATVFSARLTYRLAGKYSQECLISSGAFTATIGAIALILLQQAGYFQIEGLTSVVFALFVTFVGVGMIIPNSLSIALKDYQAMVGTAGSIFGALYYLIISLATWGMSILHDGSALPLPLYLTLLCLLLLIGSFFIQQTLTVEEVIDQPEQSA
>fig|716544.4.peg.694 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLPVSQILVVGQLVGGLISIYFEKSRFSLHSMKNRIRKGWAILAIFWISQYGYIYAFQNAPPAQINLIFYTWPAILIIIKAWNITRKLNKWDIAGIWLGFMGIAILLSPDLKQDAFSLRYLSGYLGSILGALGWVAYLLYTDQEKKDKKGFTSIGEDILILGIFNFFHLMITEHWIQPNTNEWMMLGYYSVSMFGIPYYLWRITLKKDPKMAGALSNATPVLSIIWLILAKITPFTIELAVSIVMVNLGIYCIDRSAKSTSSITG
>fig|716544.4.peg.863 Permease of the drug/metabolite transporter (DMT) superfamily
MKFRDFFGLVLLAAFWGPTFLLIKIGVEAVSPLALTTVRCGSAALFLLGYCLLTQRSLSAVFPSGKHLLFMAIFGNVVPFLCCAIGETMVQSSTAGIIEGSVPLIVALFTALFTPHRRLSKNEILGIAIGFLGILTIFAPDIMQTSGHTEERFLGKMFLVVMAVSFAASFVYSKEKLDNVPHIAAVTVQLILSGLILFLMTFFIEGRAAFHGFTFKVSAVALSLGIFGTAIPWCIYFHLIKKGSAAQVSLAVYLLPVVAVFLGWVFLDETLRWNLWLGVALILFSLILASGMLAKRRKTDHDNPLLRN
>fig|717231.3.peg.2308 EmrB/QacA subfamily drug resistance transporter
MTGTFMAILDTTIVDVVIPKMIAPLKTDLYGVQWVITSYMAAAATGLLLIESLDKVLGLRVMFIMGITLFTLSSVACGFAENLTQMIIARSAQGVGEAFVVATAQTILFSIYPPNRKGIAMGIYGMGVSFAPALGPTLGGWLTEHLTWRYIFFVNLPVGAMVVLVGLLILPKIIKQKQKLRFNFISYAFLGTFTISLLILLSKGQQKGWLQSDFIIKALIIAVGALFLYAIAELLSKHKLIDFKIFKVPQYRYACVIYFFTLGLSIYQLFYMIPLFYENLKGYSTLNTGLHMLGFAVFIGMTSPIAGILSDKFGEKYVLVVNAALYITTSIFLMPNLNYFTPSLRTILLTIPLGFSLGTFFAPITTMAMRHLREYTSLGVSLMHYLRFMGGAFGTAIATNTLQSKTAIHYEGIISIQNFDYARMYLNSVSEKFSAYMPERMAELRSETLLAKLQQLMGLNEAFQDVFLHAGFFGIFGLSFLILIFLHDKKIEKNDKTV
>fig|717606.6.peg.390 Multidrug resistance protein-related protein
MLTSPFVIQLLIIMFFVEFVKGALIVSILPVYMGTVLGLSAYAIGWALALQYIGDNAFRSPLGWIIDRVGYRTVMLFGVLLTFASVIIVTVTDDLPWIICACVLIGMGTSPLWPCVITGATAVAGNEAGGTIMGVVYMAWLTGVGAGPIVINFFIAKSNESSSSYDTAFKLLIALMVIVLFVALFLPGRTKSRELEGKEEQANPEEHEHLPLGERIRAYLAKVSSSMHASKVLYPAMFLQNFALGLLVPILTLYARTVLHLTPQQYSYYLLAGGAFTVLGLIPIGKAVDKYGTSRFLHIGFPAAAISLPLLGYTRDLVLVLPIVALVGLSYAFIIPAWNALIAEAIPKEERGAVWGFFLTIEGLGMVLGSIMSGKMWDSFGPHSPFLVSGVVLITLFVLHLFITRKPKVMVR
>fig|717606.6.peg.850 Glyoxalase/bleomycin resistance protein/dioxygenase
MQSIKLFMRLTSYINVNWKLTSLAYLCTILALTLNLAQPFIFSYLIDEVLIAGHQEKLVFLLTLFGSFALGSVVLSIIRTGLFRYLGIRHMLDLRDVLLAHIRRIPLTEIEKHGVGKYSALLGWDTASMGNFLNHIVVEMVTQWFTMLFAISMIFYMDARLGWITVASIPVLLAIPRIFVKPMKKYADGVRSHNEEVGTYLYESIEGSKEIRAYGLEGWERKKNQSMYKDLVAVSTKETLFRMFSGQTGTLAFSFILIAVYSMGSKQVLAGTLSVGMLVAAVQYLNNALQPIQVMNNFFGEMQQSEVAMKRIEQFLESPVEQAAQQKNKAVSIPFPGESAEVSCKQVHVSYEGTQILRDIDITVRKGQVAAFVGPSGSGKSTLFKTLAGFMEAEAGDIRIRNLPMNQMSRSDLTAHMAILSQDSYLFSGTLYENIAIGRLDATEDEIKEAARLASLQSLLDTLPNGLQTVVDHQGFQLSGGQRQRFAIARALLKRPDILILDEPTSALDRETEEQVMVQIKQAMKGKTLLISTHRLDIIRNADIIYVMDQGTVLDCGTHEELVGRCRKYAALVAGQEQEELLEKIG
>fig|717606.6.peg.1643 Permease of the drug/metabolite transporter (DMT) superfamily
MSKTISYLLLFSNVLLLVAGQILFKWGLQKAGGLQWARIALSPSIWSGLTLYGLATLLWFAVLTRLPLSVAYPMQSTAYVLGLLAAWFIFDESLSATKLVGCAVILVGVYLIAK
>fig|717606.6.peg.1698 Daunorubicin resistance transmembrane protein
MRKARKYWELMKSQIKVDTAYNVWYWAGTASSIFRLLIIYAFWHAVYENKTTIDGMPLSTMITYVIIAMTINNYVAGVGTQLASNVRDGSVAIELMRPYNLLDKLVALDLGNKVTGTLREALPMLLVAYLFIGINGPASWSSFLLFLFSAILGILIGTQLDLVIGIAAFWLLYVWGLRVLRNAIFLFFSGALLPISMFPEWLQTVSRFLPFQSMVYVPTSIYTGQLAGSDALYAVLGQVLWLAAIYIAIRLAWSVAIRRVTIFGG
>fig|717606.6.peg.1905 Permease of the drug/metabolite transporter (DMT) superfamily
MPCCPAFCAVGGGKQLKAPGYGLAVLFVLLGASSYGFLSPIVKLTYDQGYTFEQITVHQVGIGAILLWIMVLLRRDVWSNPFRGPWIKLASIGIFGMGATTILYNLALARLDASLAIVLLFQFTWITILIDSIWNRKWPNRWHWIAIAIVLAGTVLAVGVTSDGIDRLASIGTVYGLLSAITYSLFLWLTGRVDTAGDPVIKSAFITTASLVLVVVLYGWHAGAGERELQMAGIGLVLGTLGQVFPTVLFSIGIPRIGSSLASMLGSIELPVAACAAWLIAGERISMWQTFGIVLILCGIVVAERRSGNRTEEQSSRLGE
>fig|717606.6.peg.2007 Drug resistance transporter, EmrB/QacA subfamily
MSSAIAGIGGLSGRGGSRFMMATLFLGSFLSIYHVVSLNAVLPGFITIFDTDLSTAQWLMTGFTLATGMVAPVCAYLEERFGTRRLFLSCIVMLTLCSIICSFAWNIYSLIVFRTLQGIFCGILQPLTLSILYGTLPREQHSTALGWWTASTILGPALAPTISGWLQQSDWRLIFWATVPIGLVVWRMGFACLPAAKARSTERPDLLSLSYVMTGTLAVLTLFSKMNRWGLLSLSSLLCAAVSLLFITLFIRRSLKSEHPLLQLRLFANRMFTSSLAASLILIVGLYSGIYFIPLFLQQVQGMTPLHVGLLLLPPALSMTLATMISTRYYKKLGPSTLLITGTILLMVATWQFSRLQPASGHGFVMLWMAVRYVGIGLSMTPAMNAGMSAVSQQFSSHASALINWIRQAGGALAIGLFTAFFYSRISAYGGQAGVSPSAAAVDASSQLNILMPYMKGLNDVFLLALLFTSLSVPLALLLRKRKRTAL
>fig|717606.6.peg.2309 Multidrug resistance protein B
MSAEVHANEPASVRSLLAPLIAIVVGLFMVILDTTAVNVAIPVLADDLHSSLSLIQWTITGYSLAQAVVIPMAGWFSDRFGAKQTFIVSIILFTVGSILCAFAGTAEQLIAFRVVQGLGGGMVMPIAFAMTYRISPPESVGKIMGMMGVPVLLAPALGPVVSGYLVDYVNWQWIFLINIPVGIAGVIMSIVSLPNLPKKASVSLDFAGIALAPFAFGGLSYGLSEAGEGWTSAKTVTGLVVGAIAMALFVVVELGRRREPLLELRVFRSMQFTRGIVVQWVMQFTMFGLIFAIPYFMQRLMGMSAFEAGLWTLPQALASATMMPFSGRLFDRIGARPLVIGGLTLITVGAYLFALIDPSDSPWLFLAPRALIGFGTGMSFIALNTHLIQTAPKELVGKVTSLTSAFQQVVGSFSIAGLTTLLVSRTNHYAKQGEAPIPDAMSHAFHNAYILIAIIAAVGLLLAFTLRRPAKEQAAHPTVVMDAGH
>fig|717606.6.peg.3206 Probable cation efflux pump (multidrug resistance protein)
MSERQSFYKNIYKIAIPVTLQSLLMSLLYLTDQLMIGQLGDVAIASVGMATRIFGIISVVLAGLSVGVSVYAAQFWGTKDNKSITQVLGIGLFTGILLSLTFAIAVFFNPSFFLGLFTTDTSVTDGGAIFLQIVAISYVPTMLTMMYSAILRSTEHAKWPMYVSLVSVVLNIILNYMLVFGHWGAAEMGLKGSAVATVISKIVECLLIIGVVYFYRLPGATGMRNLFTIPKPLIKKFFSTSYPIILTELVWVLGETVYAIIYSRMGTTEMTAMMMTSPLQGLSIGLLTGLSSAAGVMIGNKLGAGEFDTALAHARRFVKLGITISLILGVIVAAISPLYVKAYNVSDEASRLGIYIILVFAGFLWVKVSNMIMAGGILNSGGDSKYVFAMESAATWLIGVPSGLLLSFVWKQPVFLVYLVLSCEEVVRFMLGWVRLTSKKWMKNLVSDVSA
>fig|717606.6.peg.4709 Permease of the drug/metabolite transporter (DMT) superfamily
MNAKQFFTHPAGIAAGSIGATLLWGSAYPTLKRSYEELGIDGTDWFEQFLFAGYRFTLAGLLIFLFMLVIREPLRYRQGSLKCIVSLGLVQTVLQYVFFYTGLAHSSGVFGSVIAGMISFFSMVLAYFYDPSERFTRNKIIGLVLGITGLLLLALPQAVQHGWNQAFGIGEWLLLIAALCAGFGNVLSKKAVSVYPVAYVNGYQMLAGGLALILIGGTVDGFMPFHWTAAAIILLLYSAIISSAGFIVWNYVMKYNSVGSTASYLFLTPVFGVMLSALFLNESIGIAVIASLTAVCAGIIIINRRTEQKQAAAKTANVR
>fig|717773.3.peg.741 Permease of the drug/metabolite transporter (DMT) superfamily
MFPISLAYLVVILIWTTTPLAIQWSGESDWFFGVAARLILSALIILPMIIVFKQQRFDLSWSAFKVYAAAAIGLLGGMTPVYWAAQTMPSGWIALIWGMNPIVTGLLIYFILRTERLTPAKWLGIGVSLIGLMVLFVPNLESVSTQDLLLQGLIVALIGVFFHSLSTVLVKKTAHNLPPLHVVTGALWITSIVFLIIHPTVLLDWPPLSTRTSWALGYLILVGSVIGFALYYYVLKHLDALRLGMIPMITPVFAVALGVAVNNEQLSLPVIFGAILILAGLLLFELERFYRLIKRRQQTNSID
>fig|717773.3.peg.1121 Glyoxalase/bleomycin resistance protein/dioxygenase
MVKGINHVSFIVSDVEAAREFYQSVLGLTLVKRPNLDFPGYWLDLGGGQTLHLLAVDDPYHDVPRPLHLGRDRHLALSVANLESTMTRLAEHKIAYKVSQSGRSALFFYDPDLNVIELTEV
>fig|717960.3.peg.1047 Permease of the drug/metabolite transporter (DMT) superfamily
MSKQTANLICLLVAAIWGGGFLATAGALEAFDPFSVLMIRFIGAAIVSWIVIKVKKLKVTKEALIKGSISGVLMYLAFAFQTFGLDLTNTGQNAFLTSVNVVLVPYISWFLFKRKPMGIQVFASFICLAGIACLSLSSDGFHFSFGDLLSLICAFFFASQIISLEFATKNCDSTVINTIQMCAAAIVSIPFALILEDFPTSIDTNVILSCLYMICIATWLAFQLQTLAQKYTDASSASLLLCTESLFANIFGYFLLHEEKTLTMVFGGLLIFISVILVESSDRIKPVLAKLKRT
>fig|717960.3.peg.1086 Permease of the drug/metabolite transporter (DMT) superfamily
MKQKFFKKPLNVVLIAIFCTALWGSAAPFIKTGYALFDIASNDTASILVFAGLRFTLAGVLVIVAGSKIQNKILLPVKKSIKAIFVLSIFQTMGQYFFYYVGLAHTSGVNGAIITGTGAFISLLVAALVFKYERMDLNKVTGCMLGFMGIVLMNMDDFASLKVSFLGDGLVLCSQLCSSFSASFIKKYTQSFNAVMLSGYQFFVGGILLTLIGILMGGSLLLTNISGMMVLIYLAFVSACAYTLWGILLSYHPVSKIGIFNCLIPVVGVLLSSLILHEEAFSMNIVFALIFISFGIYFVSKEKDPLTMDAS
>fig|717960.3.peg.1758 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERKYLNSQFWKYILPSMFTMLLSGFYSIVDGLFVGNSVGNDALAAINLVYPIQVILNASAIGIGIGGAVALSYFSGRDETKSADRSLGSTITLLIVVGIVLSIVLFFATPTLLEILGASGTIYEYAYDYIFVILCGGLLPVLGNGLSPLIRNYGKTIVATICMNSGLVTNIVLDYIFVFLMEMGLSGAALATIIAQGVVALSCLVFLYASKLKEISLHCYVPSVSLIKRIITVGISPFGQTMIPCIMIILTNWTCIMYGGNDALTIYSVISYVLSSAQLLLQGIGDGVQPLLSYYHGKGNKDVIHYLYRKAFFVSLGVSVILFMGVYLFNEPLTGLFGVSHSLYDGTKLALIITALSFPFIGISRLTSAVFYASGRSKNSTFLVYIEPCLLLPVFLIVFSSLFQLTGVWCAYPATQVVLSVIALVLQSPNLVADHEKKIVEVSI
>fig|717961.3.peg.857 5-nitroimidazole antibiotic resistance protein
MRRKDREITDKNEIRDIIGRSKVIRIAFTGEEYPYVLPFNFGYEEKDGRMYFYIHTATEGKKNRLLDENNKVAFELDNCRDYVEGSITSLYESVAGCGVMTEITDMSEKLSALGLILKQYGEKTYKPDSSCASRTRVYRLEVKEVSGKANRGK
>fig|717961.3.peg.957 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANVVAEFFAFLLSLMFLIVKRKKYGYWQKNVALPAEPESEMTNKNAD
>fig|718255.3.peg.493 Vancomycin B-type resistance protein VanW
MIKRKNWTKKMLAVAACAGLLMTNPAFTEAATAAERSAYQAVFDADYYRSAYPDVAAAFGNNKAALFNHFVNYGLREGRSCSADFNPQAYRAKYADLQQAFGDDMAAYCRHYVTCGKAEGRDGGGTGSVSATTQTSAATVGQGNILSSCTTQYDATVPRANNVELAAARINGVVVQPGKSFSFSSTILPRTAANGYVVAPIYISGTVGTGTGGGVCQVSSTLYAAMRYANLPATERYPHSLPVTYLPDGYDAAIAGTSKDLKFTNTFSQPLLIQASASGGTLTVTLTLQ
>fig|718255.3.peg.1105 Vancomycin B-type resistance protein VanW
MKKTGKILAALGLAVAFGAILNPTQAKAEDTDRIAQGVYIGNIDVGGMTEQEALNAVTDYVNNAGEAVFTLTAGEHSTQVKASDLALEFTDMNVVSEAMDVGKSGNLIKKYKDKKDLENGSVVIDMVLNVDHDTVSELLAEKADELDQKAVDNGLVRENGTFKIIKGSQGVEVNVEKSIAAIENYVSNDWDGQGGNIELTAEIVEPKGSEEELSKVKDLLGGFNTNYSSSTQNRCDNIATAAGKINGTVLYPGEEFSVYETIGPLDAANGYELAGAYENGQTVQSYGGGVCQVSTTLYNAVILAELEVTERSNHSMIVTYVKPSMDAAIAGDYKDLKFVNNQDVPIYIEGYTSGKNVYFNIYGEETRPANRKVTYESEVVSEQDPGTQFVATGDPVGTMSVSQGKHVGYVAQLWKVVTVNGVEESREVFNKSTYKASPKIVNVGTASEDPNASATIGAALATGDEGTIYAAVAQFTAAAAATPEQPAENQSAEEQAIVGDGQVDVSGDNGGNGQ
>fig|718255.3.peg.1347 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRNGANLTEGKPVKLILQFAIPVFLGNLFQLFYGLIDTKIVGSTLGEGALAAVGSVSILYNLLTGFFNGLTLGFSVVTARYFGAGDTEKLKKSVAGTILLGFVTAAILVTGVFVFLRPLLSIMHVPAEQKEMAYTYISILVLGMFVTLAYNMCANVLRAIGDSMTPLIFLILAAVLNVILDYVCILVFSMGVGGAAAATVISQVVSVVLCVIHIKRHFPILQVERRHFKLEKSEVRTMLSGGLSMGMMSSLVNLGTLILQTGINTLGTSVIVAHTAARKVFEIWGLPVTVLGATMATYSGQNYGAGKYDRITSGLKAALMLGCGWAVMVMIMAYTISTCLVGFIASTQNAEILYWGTTYLRVDMLFEMVCVWIVILRNTMQGVGDYKTPIFSSFLELACKIVFTAVFVRYFGYWGVIWTEPVTWIIMVIPLIVMLKKNPVFHQKKTA
>fig|718255.3.peg.2326 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKDMTTGSSLKIILLFSIPVLLGNLFQQFYNMVDTIIVGRYLGEDALAAVGSTGCIMFLVLGFATGIAQGFGVMISHAFGAKDFRLLKHYVALSLILTVIVSAILTIPTVAASRLFLVWMHTPDNILSMADAYIKVIFAGIILTMLYNVSAGILRGIGDSKTPLYFLIISSILNVVLDLLFIVVLKAGTAGAAYATIIAQGISAILCFIHMFRQFEILRTTKADYYLDRPGVINMLSIGIPMALNYSITAIGTMILQSAVNVFGSSVVASFTAASKVNNIATQTMPTLGTAMATYCGQNLGAGKYDRIFDGMRKGFFICIAAAAIGAAICIFGGEFIVSWFVSNPSDEIFSYAMMYLKTVSWFFLPLAMIFLYRNALQGLGEGLVPMLSGVIELVCRFVAIALLQKPLGYQGICLADPAAWVGAGIPLMITYIIWKSKKIRQHSSSPA
>fig|741091.3.peg.169 
MTYPHQPDHITLVITHGVQRDKLTEYERWLEQLKTDAARFPGYQNVNILRPVHGETIYTVLVRFDNLDNLYLWIQSDQREIREAALANLLSGQEYIELRTQG
>fig|741091.3.peg.1952 Inner membrane component of tripartite multidrug resistance system
MSVTLTPAATLSPADYPTSRKFLIFSIMAFGMFLALIDIQIVAASLNDVQAGLSAGPDEISWVQTSYLIAELVMIPFSAFLTQALSTRWLFSASAALFTLSSIGCGLSWNIESMIFFRALQGFTGGAMVPTVFATGFAMFQGKQQALIPAILGMVSVLAPTLGPTVGGIVTQLLDWRWIFFINILPGALVATGAVLFIHVDKADYPMLKRIDWIHLLSMAIALGCLEYVLEEGPRKNWFSDPQIQISAWFSLVAFVLFLERSFYSKNPIVRLTPFRDPTFTFACLFNLVVGFGLYASTYLTPVFLGRIRDFNSLQIGTTVFVVGVGQFFSTIIAARLISRVDRRILITVGLSGFALSLWLTTAVTPYWGAEQFFWPQVVRGLFIMLCIVPSVNMALTAFQGPELRYASGLFNLMRNLGGAIGIATVNTWLQDWTRVHAARFGESLGQYGDHAQEVMGSLAQKIGHLTPDTAQALLMAKGVFGAKVAAQSLTLAFNDIFQVMAWMFIAALVMVPFCRK
>fig|741091.3.peg.1953 Membrane fusion component of tripartite multidrug resistance system
MSEATADEGSASPAVKATKRSKRIFVVSGIALMVALSGAAWLLAAPASESTDDAYLTADTTSVAPKVKGFVSTVLVRHNQRVHAGDKLVLIDSEEFTARLASAQGELEDARAQVTQQEAALLSQQAQEQLALTQIEAARTAIRSSRAEQQHAEAEQQRYQSLAVSGATSRNDADRYKTVAVTAEQTSAHAAAMLDVAQNQAAVTHARRAEIQAALALAKAAVVKAQAAQALAQQDLNHTTIVAAIDGIAGNRQVQVGDYVTPGQRLMTLVPEQGIYVTANFKETQTGRMQPGQRADVHVDALPGVTFRGEVDSLAPGSGSTFALLPFEPGTGNFTKIVQRVPVRIRLDAGQPDLAALRPGLSVDARVSLTDAVR
>fig|741091.3.peg.4668 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNTSPEMTLLRRNSLSKDIADLLKLAWPMIVVAIAVSFSQNIQTAILGHGKETSSIYLLSMLQPFSFLFLAILECLAITNQVFSARSLNMWSRQKVLAATSLLATLGIVIVALLSGGTALCAPLLQTLLPVAGNAFYSSALPLYFLSMLPFIQLEMCNSALRGQGKSALSMLLVIAYIVLNALICYTGYQVYGLGFNSIIISNALASALLIPVALWLVWRTGRHVEDDRPGAFIPRLSGLLLQVGMPIFASLVVLFFSSLLIFPLIGTLGEQYVAGFLIVTKIRMFIVIPAVACGSALAILINQRLAISSGEELKRLLHRGLAFICIIYLLLTSGVYFTEVSLIKILSGDRIIQDVSSQILLILLPTFFMTSFVASLQALLEQLEQARRVLVLTVIIELLTVITLLVGWDKFSQLQSIMNLIIVFNVVYFIAFGREYWRLANKIGSENVL
>fig|742159.3.peg.1403 Permease of the drug/metabolite transporter (DMT) superfamily
MRGGDWLRLLVLSAVWGASFIFMRVVAPVLGPVVTADLRVAIGAGVLLLYFALIRFKPRWRAHWRQYAIVGAFNVGLPFLMFSYAAQHIPASYSAIINATTPLFGTVFSVLWLGDSMTRTKGVGLLLGLLGVATITGVGPPMAASASFVSAILACLAAAASYAGAGIYIKRCASHVNPLESAGCAQLFAAVALLPFWFVAPPQGQVDLNIALNVLGLGVLSSGLGFLLYFRLVRDIGPARAMMVAFLTPLFGIVWGVAFLGEALTPAVLLGAAMIIVSTLLILGSATRARPLAGKAGLP
>fig|742159.3.peg.3700 Permease of the drug/metabolite transporter (DMT) superfamily
MRLIPVALALFWGLNWPAVKIILSIFPPFTLRVLGLGSGAVLLLLLARAKRLALLPPRAAWPGIVVGGVLAVAVFNLAVAWAQLSTSTSRAAVLTFTMPMMSALLAWLVLGERLDRRRALALTLGAAGVAILAWPVLRAVFAQHDLAATKGLVFPLVAAFGWAAGTVYLKRWPVAGHRIVVTAWQLAVGAACALAGVLIAGESFPTQGWNGRIVVALSFHIILGTAVAYWLWFVLSERVSATVAALTTLMVPVVGVLGAMALVGDRPAAADWWGFAFVLAGAALIVLNLGRARG
>fig|742159.3.peg.4101 Glyoxalase/bleomycin resistance protein/dioxygenase
MEDKSYRARLVPELMVRDLARSRQFWIDLCGFEIVYQREEEGFVFLDREGAQFMLEEIRGDDGWITAPLEAPLGRGVNFEIKAKSVDALYERLLDAAWPMYRTMQQRWYRSGGIEIGVRQFLVQDPDGYLLRFSAWTGDRPA
>fig|742821.3.peg.271 Multiple antibiotic resistance (MarC)-related protein
MFSLIILMVCLFAGHIILGFFGISVGVLRCAGGIVLFAAGWNALNAPAQDGTSSPKMELPRSRLKAMAFYPFTLPLTTGPGAIAVTVAIGTTLPYNFSNLAGTILAILAVVAVIWLCFRYGDRVSRAVGAAGADALARIFAFILICLGVAVFWQGFTELWLNLGK
>fig|742821.3.peg.779 Bicyclomycin resistance protein
MAAAATEIHVFLVMRFFEGLGAAGAIVLSRSIAADRYTGRELGSFMGVMGAIQGIAPVTAPMLGALIADAAGWRGIFWILFGMGVVLAFITLFVFVETLPRSRINSAQRSSNGTQRESIRESSAKLIADPVFCGIVFQQLLASGILFGHISSSPFIFRGHFDLSPELYGLTFGLLALGITAGAVISSRIDPLKALGVGAVGMLVCAVLVAVCFITNLSLWAVLPFYFLLMAFLGLTLPAAMTAALTLHRQRAGFAAAVIGSVRFVGGGLVAPLTAIGEVTRTASIIFVVCGVLLVLISFWLNRRMKLIRGDELKL
>fig|742821.3.peg.898 Acriflavin resistance protein
MNPRHTLTGQLAGGFIESKLTLVLMIAALIFGIWAVLSTPREENPQISMPAAAVQAVLPGAEPDEMEAKVIRPLEAIINQIPGVDHYWSTAVDSAAVVVVQFKVGENKEESLVKLADRIVGGRAELPADMLGPWVKSADVDDVPILAVSLVSEKYGDEGLRRIAWDVLDRLMGLEDISTVDVIGGRDRELIVEIDPARLESFGLSFASVTAAVRAAGSAGPLGTTVTKGTEARVRLANAIKSAADLKRLVVGFSPAGNPVHLEDVAKIRDGATQQAAASSRFGWGRASSQYESAAGGIVEHPSVSLAIAKRKNANAVVVADEAIARIERMKGTVIPADVDVVVTRDDGAKANDAVNTLIEHLAIAVIAVVTVTLVFLGWRAAVIVAVTVPLILAITLGVVGLSGFTINRLTLYALIIALGLLVDDSIVVIENIVRHYGLSKLSGRQDRSNRAIEAAGEIGSATLLATITVMVVFASLIPALTGMPKQYFYPVGFTVPVALAASFLIAYTVAPWAARRWIPQPPIDSSSAGGRTLPGGRFGKLYSIPARLLIGHPRREIVFVCATAFLCIAVFIMPFGQCLIPGGLNSPTPAWGVEMGFLPKDNKNTFNVTIELPVGTPVEALDRAVRDTAAEVAKIPEVVNWQSWAGLSGVADFNSMMRMTPAKGSEIGAVRVNLTDKNSGRRSSIEIARELRTALRSVSDAYPGSTIQVVEDPPGPPLRGTIYAEIYANDPEELRWLADRTQKEFRKTYDVVEVTNTQKADQTEWRLSIDREKAVAAGVLPAAAAFELKNLASGSIIGWAHADGERSPQPIRLEIPYAEEFDPTLLSGITIAGAAGVRVPLSSIIKVEKTTAARRIEKKDGVRMAAVGGEMGSTTPTYAVLDLNNRLRGMALPEGGKLATGNLTWSDERPDLTQSPAVLLWQGEMRMMLDSYRDLAVSLCLSLGSIFLIFVAYYRSFALALIALSAVPLCFIGLIPGHWLFGTQFSASSLVGVTALAGVVVRSSLLIIDFVLDYLKAGLPLKDALIDAGAVRLRPILLTTLAIILGSVILIPDPVFGGLAITFIFGTTASTLFTIFLIPILLNVYFTRHPYRTSEEGAGMTAEAN
>fig|742821.3.peg.904 Modulator of drug activity B
MNFLIINAGCRINGQGGTLSAAMAELAERTLKHHGHCVVVTDLNEPYVVADEVKKILEADVLIFQTPGWWMTTPWQLIKYEDDVFVSPELCGGDGRTRSDPEKKYGSGGFLTNKRYVLSTTWNAPLEAFTDPHQFFEGKGLDGLFMPFHKTMQFLGLKAYPSFMVNDVFKHPTIEADFKRWEAYLTEHFGQNA
>fig|742821.3.peg.905 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSSSDTLFQLRQSAILLLTAMIWGATFVAQSLGMDSVGPFTFTTTRMLLGAFFLLPIVLLRRKRLAAEKPAEAARRSAPQYRRTLLMGGILCGLCLFGGESLQQFGFVHDTEVGKSGFITALYIVFVPIISLFLGRRGSPLLWAAVALSLVGLWFLCIPPEGFTIAAGDLFVLACAVVFSLHILVIGRYVLLVDAVELSMMQFFCGSILAFFAMLALESPTWIGWQTALPAMLWAGIMSNGIAYTLQIVGQRGMNDTTSSLILSLESVFSVISGWLILNEVLSVREGLGCVLMAAAVVLAQLPGNKK
>fig|742821.3.peg.1298 5-nitroimidazole antibiotic resistance protein
MRKISNALSKNRLESIRGEVKETLVMTISAQPQRPMRRRDRELPREEALRAARAAGHAVLSFIHPDTGVPQGVPISPVVTPEGIVYWHSTNEASLKGEGLKKDPRASLTFIAYAEDLPEEYTVDYASTVMTGRAHIVTDPQERRQAMLEICRRYAGADRDATSTEYFDHAGSQIDVWRFDPEMVSGKSRSWTEKVSHILAKQGF
>fig|742821.3.peg.1506 Multiple antibiotic resistance (MarC)-related proteins
MEYSFWGGLMLMVLMADPLGNIPITISCMKNVPNKRRTFVLFRECMIAMGMLLLAMFFGRPFLAAIGLSDAALSIGGSVIVMLMAIRMVFPTQEGVFGQTPGGEPYIVPIAIPAIAGPSTLATIMMLAASEPNRLFEWGAVVVITCVVSFFVLASADWLERHMGEKLTLAFERLTGLLLAMMATQMFLGGVEAFLAKLPH
>fig|742821.3.peg.2169 Drug resistance transporter Bcr/CflA subfamily
MSLVKTPADDSKTAAAEDHEVAAATKSGRPTTKDAALLAFVSSIGPFAANAYVPAFDEIGQHYGVGLVTVQQTLSIYLAAFACTSLLIGAASDAFGRKAVLALSMTVFAVSSLGLLFADSMEAFFIWRFVMGMAAAAGPVVTQAIVRDRWSGGDAAKIIALIAVIFGLAPALAPVVGGELTVHLGWRSIFIFLAVLSAAMAFCSACVLKESLPSERRVSFRPWATLLRYGEVLKVPAFTSGVVAHGFIFLGLIVYSAGAADFVLNVMGLGVDEFGWLMIPMVVAGMTGSWACAHLLAMFGQNRLLFGGVGILAASGLFGVVFDHGPFAVFPWVLLAPVVYNLAAAAVRPALNVMNLDYFPKSRGLAASVQQFFQTGAFAVSSALLIPIVLGEAWKYAAVMLGSGLIALVLLLVVRRTRPAALAAAEAEEQAEVELRVKPTKLS
>fig|742821.3.peg.2214 Permease of the drug/metabolite transporter (DMT) superfamily
MIPKALVGQSALLPFLALIAATGFWGSSFITVARTLESTDPFTLVFLRFGVGALLVALWLRGRIFRIPLETWKMGAVCAVVIYASYLFNHIGLMTILSSTSGFLTALYVPITPFLFWAIAGRRPELCAFAGAAVAFGGLVLLADPFNLEFSSSWGEWTTIFSAFLSALEIILMGRFAPHCKAPEIAFAQIALVALFALAGTAVAHFCAPAVGWTLTPTALDLNLVFGVVWLAVILTCAQLLLAWAQKYVPPAQAAVIFALESIFAAVIGWFAGERLGFLGLTGGLCIVLGILITEYPRIMGKTR
>fig|742821.3.peg.2299 Permease of the drug/metabolite transporter (DMT) superfamily
MRSWSYHLLALFVVLCWGMTLVSSKVLLNFGMQPWALVELRSVLAYGILIFLAPMQLYSGTMRGEITVALLGLTSIPLFFGLQTLALEHGVVSTTASLIAMGPLLSGLLAMAALRTWKLHWMTFLGICTAATGTFLLYFDNAVLQDLPRLGFYLGLAAAAAYAVYSLVLRALADLPALFVMRKSTGYGILGALPFYLNEQPTDAAILFEVPVAGANLVFLALAATVIGYTLWHKAEQEIGASGTRWYTYLSPAVGIIGGLWFLNEEMSYIGVMGVGMILCGVVCAQTGLVRVAAEMAKRW
>fig|742821.3.peg.2369 Permease of the drug/metabolite transporter (DMT) superfamily
MSAEDFAPKRYPFYFPRRPIDSISGASFFFVRVMPDSSRRPIDGYALITCLVLCIIWGLQQVAIKAAGSDVSPMLQVSVRSGVAALLLLITAKFVLHEKWNPKLRWRDGFLLALGFAGEFFFVAEGLRFTSAAHMSVLLYTAPLFAAVGLAIKLPEERLTVIQWGGVLLAFLGIGAAFLLPALMSHSPAAEGSELWWWGDILGLCSGISWGFTIIVMRVTTVSEAAPTQMLFWQLAGGFVLLFPCALLTGQNHFEGTAIGWTSLLFQIFIVSFASYLVWCRLIKIYLAARLGILVFMTPIFGVILSVLLLGESVGLPFVAGSLMVFCGIMVVQRPHFFQRRRSS
>fig|743718.4.peg.179 Antibiotic resistance transcriptional regulator, MerR family
MNRSIQDVARLAGVSSRTLRHYDQIGLLPPSGTGAGRLRYYDDAAIRRLQRILLLRDLGMPLIDIATVLDEQTDEATALRRHLDQLRAEQDRLARQIASVERTVTALEEGDTIMAEDMLDGFDHTQYKDEVVERWGADAYATSDAWWRGLGEEGRRAFMERSKTLAEDWAAAAASGIEPTSDEAQGLAARHAEWLGSIPGTPGSEQGRPPKEYVVGLAEMYVADPRFSANYGGAEGAEFVRDALVAYAERSL
>fig|743718.4.peg.196 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGVTFDVPDASAAAAFWSRVLGDPVGYDAGGRAMLDGERPLLFQTVEGYSAPRWPDPAFPQQLHLDLWTGTRSLDDAEALVLEAGASKLPGGGESFRVFADPAGHPFCLLG
>fig|743718.4.peg.353 
MSNAPVTVSIHRVVSPERVPEVTAWVQAGVQLANRWDGFLGSGWIRVAEGSSDWIMLYRFADAERLEAWESSPERKEWLAEGAGLVEERRVEKRTGIEGWFDAPSRQDEPAGPPLLPAPPRWKQSVAIWLGFFPVNLVFTVLVGWLVPAFAELHVVLRVLVSTAVLTPVMSFWVLPWVTARLSGWLHAPPRARRT
>fig|743718.4.peg.1678 Drug exporter of the RND superfamily-like protein
MPREVHGPVVPPEHHGVHRERQRVRADQSIRLFTMNAGAAVTASSRYWSSGRTGVSRGARAGRVAVAFAARARSNRCSRSAPSSISAPAIASSTVSETPRRFPRSSRVKYSTLTPASRATSSRRSPGTRRRSPYVSTPASCGVTRARRVMRNSRTSARSSMRPRYVRTCGRRQVPAEPPGTTSGRGLDKHERLLVQSQRGKNTTCRSCSVGGSWKGRPVIGRLVTRVPVVVLVVAGVVTVVLGALAAGAVDALSLNRYEAPGSQSIAARAELAERFGTGSPNVALLVTATDGTVDDADVDAAGAALTEELSRHPGVGDVWSYWSAGAPATLASEDRRHGMVLAWVPGDADHVRSDVLPDLEQDVVAPADGGPVDVRLGGGDEVFRVVAEQARTDFLRAELVIVPLVGVLLWVVYRRLAPALLTLAVAVFSVIGTLGILRVVASFTEISTFAANIALVMGIGLGVDYCLFVTYRYREELAAGMAVGAAVRRAVSQAGRTVAFSGATVAASLAVLFVFPFPFLSSFAYAGIAVVLTAVAGAVVVLPAGLRLLGHRAARRHAAPPVDGGFWFRVATGVMRRPVASGGAALLLLVLLGAPALGVTFGAPDDRVLPASQPVRAMYDTVREEFTTEDADVVHVVAPALEPSDPAVAEHAARLSAVEGVERVDSAAGAFVDGARVAEAGPGGPDRYAADDGGTGTWFAVLPTGQRLAADPTGLVEDVRALPSPAGDVLVGGYPAELADYRDGVVERLPLVGALIVLVTFLVLFLMTGSVVAPLKASALNLLSLTVMFGVLVWGFQDGGLAGVLGFTATGTIEPSIPLLMFCIAYGLSMDYEVFLLARIKADYDRTGDVVGSVPRGIARSAPLVTAAALILATSFAVYATSDVTFLQQLGIGMALAVLVDATVIRGVLLPATMRLAGPLNWWAPGPLRRLHARIGLREGDDRPARATVAGTSHRDEVITHA
>fig|743718.4.peg.2069 Glyoxalase/bleomycin resistance protein/dioxygenase
MDQRLSLVTLVVGDLTATRRFYVDGLGWEPLLEAPGEVLMFRVGEHLVLSLWDEGHAREEIGPVGRDGTPPVTLAHNLASPSAIDQVLDDARRAGAPMVSDAVDRAWGGYSGYFADPDGFRWEVAWAPGPLSEIVLPGEPGEH
>fig|743718.4.peg.2635 Glyoxalase/bleomycin resistance protein/dioxygenase
MARLNPYLSFRTEARDALEYYRSALGGEVQIDTYGSIPGMVDDPEEQHLVMHGQLETPHGLCLMAADTPSVMEYVAPNRGVTVALTGGAEDHEYVATAYERLASDATVSVPFEKAPWGDYFGQLTDKYGVSWMFDVGDPGAE
>fig|743720.3.peg.888 Permease of the drug/metabolite transporter (DMT) superfamily
MNKPSRQLAIAGVLMAVLCWAGNALVARAFAGEIPPFALAFWRWSLALVLILPFVALPLWSHRAALRHAGWRLVVIAAFGIAGYNTFLYSAAQTTAAINITLVNTCIPLMTFIFAGLLLGDWPARRAWWGMALAVSGLLVLICRGDWQTLAGMAFNRGDLIMLLAVLDWALYTVLLRRWSKYLAPIPPLALLGIFMLLGVPMILPLYLYELSTGAQLLATPANLSAIAYTAVFASLVAYLGWNNGVKVLGASTAAMGNYLMPVFTAILGWILLGEALQLFHWFGGAMIFAGLLLATLPKRSQRAAA
>fig|743720.3.peg.1352 
MSTEPVTLMVARRVAGERYHDFIAWLREGEQLATDFPGYLGSGVLAPPPGDDEFQMIFRFTDEHTMATWEHSASRRAWLERGKGLFAQPHEHRALGLDAWFGSGLRQPPRWKQTIAIWLAFFPVSLCFNLLFGGLLADVPLVTRILLSTLALTPLMTYLFIPLVTRLLAPWLQGTRNAAMPRRASPSTSS
>fig|743720.3.peg.1752 
MYGFILHAHTRPERANDFEQLFRAYVEPSRAEPGCIEYHMLRDAVDPTLFIFFEVWQSREHLAVHTALPHMRNFHERRMEYLSRDFDIREIEMLSLSSARA
>fig|743720.3.peg.1981 Drug resistance transporter EmrB/QacA subfamily
MQDLSLLQRRYGPRYPSYLLIVLMLGSMAMILASTSVNVALPAIMADFRIGRPLAQWLSTGFLASMTSGLLLSAWAQARFGARATAQGGLALFIVTSLLALVCDAAWQLITLRIIQGLCAGIVQPLAMVLIFRVFAGGGRGAALGAYGLGVMIAPTLGPTVGGYLVDGFGWYAVFWLPLPMCVLAMLAGLFLMPSERERRTPLLDLWAFLLLNVGLFATLGALAEAQRFPWGEPRVWGPGLVGLLAVAGFLWRSRSSRQPLLPLALWRHAGFRKASWVALALGMGLYGTTYIIPLHVQAVEGYSAGQAGLLLLPTGIVMGVASFMGGRLSDRLSTALLLVFGLLALVVSSAGLGWLEPGASFLVLCFWACIGRIGLGILLPALTTGALDALDREQVPHGAGAITFVRQLGGAFGVNLLTFFLEWRHRQEGGDFAGEVAAFQQSFWLMGALFAVTILAAWNLRPSQR
>fig|743720.3.peg.2005 Glyoxalase/bleomycin resistance protein/dioxygenase
MFSYLSLGCSDLQRAARFYDAALAPLGLQRCTPGGDGWDDWIGWGTYLDDGREELALWLCKPFNGEPPSIGNGSMIALRAHSWQAVRDFHQAALAHGGRCDGPPGLRLHYGADFFSAYVRDPDGHKLAAVCRGFTADPALSHTPD
>fig|743720.3.peg.2041 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTLQTTTPARLLYLHMGSKEPQRQIDFYKRMMDLQGERQADGSAVLLGPNRAVHISPADQSGLLAAAYRLASAQHLGELRQRLEQKCCPVADIDSPLLDAGAFSIRDPQGRETIFGTSSTLQHADLPGMPGRLQHVVFQTTELEAVVDFYVNTVGFTISDNVVDAQSGQLMVCFLRSDDEHHSLAFFRGSRNEWDHHCYETNEWNDIRDWGDRFAKEHINIFFGPGRHGPGNNLFFMVVDADRNRLEFSAELQTTTSDTPPGQWPQCEHTLNSWGRAWIRT
>fig|743720.3.peg.2047 Fusaric acid resistance protein conserved region
MSGVLLQRTRQALAEARAPLLFSLHSTAAALLALALANAAGIHHPWWAAMTVWLVAQPTRGLFIERSIARLTGSLVGALVGGVLLYFFFGWPNLLLCLLALWLALCAAVGNFFRHFRNYAWVLAGYTAAIVALFGLADPVFDPELASGRVICTLLGILCCSCISWLFTAKAEPSVLLEERLDALVNDCLRWCMSGPVQTENATDLNRILGAIKTLDGVLDFAAAGSRKGRQRVRHAHEVIDALLVSVALVHSLHETHSTFLCDARFADERSEQENLEAFIGALQLHPSKYPQLLLALERLQQLFANPSSRANWRERVLNHDWRAASTSAARPLSALIIAALAWRLSGWSEGAIMTMTAVLFASLFSSHNDARMALKDVFIGSLLGASAGMVARLWLLPQVHSDWQLLACIAPFLLTGAALMARARTAKLAIDLNMTFLLTAQPGVQLPSDLPLVAQQTLAIVLGVLAAAASLLLWYPALAAGRRLALARRIARQTRRATAPSQFAAAHGRARALLRSLVVSDGYASVLVSAALRCIAATAPFVTDDSSPVPDSAQAAYNAEQAARTLARLTSKD
>fig|743720.3.peg.2394 Glyoxalase/bleomycin resistance protein/dioxygenase
MRPILTHLALHVPDLEACIAFYEDFCSMRVIHRRPGKGSQIVWMAEPGRESEFIFVIMPGGEPRQLAPGDYSHFGFAVQSRDEVDAVVAKAEAAGCLLWAQRDEPYPVGYYCGVRDPAGHQVEFSYGQPLGPGAKPINEI
>fig|743720.3.peg.2812 
MTLHTHITVLEAAPGRCEELGGYLRDLLEPTRRLDGCLAFELQRDRQRWQLHSRWRSPADLERYFAQPLLQEVIDSAWRSGAIQHLQSRAA
>fig|743721.3.peg.3090 
MHRRGFLTLLAAGLAATPLLPALGAGGDTSMHGLVGKLRAQPGQRAALAAILLESTTAMPGCLAYVVAEDVEDEDALWITEVWDNAQSHQASLQLPAVRDAITRARPLIAGFDSHVSTRPLGGVGLSD
>fig|743722.3.peg.81 Glyoxalase/bleomycin resistance protein/dioxygenase
MKVKRIVANIETDNIELAATFYGDVLGLQNVMNHGWIATYASSEESGTQVSFASQGGDGLPVPYLSIEVDDLDQALTEITKHGFEIIYGPSHEPWGVRRFFVKDPFDNIINILSHE
>fig|743722.3.peg.273 Tetracycline resistance element mobilization regulatory protein rteC
MILEIANNLYRQLSDELVMIEQEEITDKLEIAKKLLTARSYLVELKNRTVKYTFSSEQEEIAFFKTKKPTFISQVLYYSARQRIELTKPEGTADQLKKYYRYRLKGIEKFYRDNRELHSYHRSGADHLDRLLFMRSSTEPPSWLCPVRIDYDERFSTPADYLIGKILSNERMTTYLRKLIDGKDNVTDTEAGNDMVWTGESINLLETAYGWYCTGQINKGQAGIGEIVRKLETLFNVKIGRPYRRFAEIKQRKRLSRTKYIDEMGKAIIQKLDDEDAYRPDIQNRRF
>fig|743722.3.peg.576 Permease of the drug/metabolite transporter (DMT) superfamily
MTKAKNTSTAAIIIAYLLIYIVWGSTYFFIHIALQGFTPFLLGAIRFTIAGTLLLIWCNKMKEPIWNKQLLKTAAVTGILLLFIDMGLVMKAQQYLPSSLIAIVAASTAIWILLLDKKMWKVNFRNWNTVVGVIVGFVGVILLFSEQLAASFTETGLSNKAIGMCLLILGTLSWASGSVYSKYSVLPSGVTFANAAWQMLIAGILFWGAAFAHGDVQQFHMQATPISSWLAIGYLIIFGSILAFTSYIWLLKVRPATEVSTHAYVNPLVAVFLGSTFANEQVTLIQIIGLAIILCGVAMINFVKAKKGKQMKPLCPDQ
>fig|743722.3.peg.1881 Outer membrane component of tripartite multidrug resistance system
MRAEPLSLEKAWQLADLNSKKIQISEMDVQVSAARLQIAKDGRLPEVSIHGQYAYVFNMPIYEDGLFHTPKQFPVDRKYYKAGAEAYLNLYNGGKTGREIMYAKKEQEIVEVEHHRTAADIHFSVAVHYYDVYRNQAYRTLLLHDIKEREKQLEEIKQLYANGTVLKSDVLRAELRLSKQRMLLVEINNSIKIAGQRLNVLIGKPDDTPVQLDVDTGGHAAFQLQSLQTYLDEAHAHAFNGLLSGKAKELRALNLQQVKSNTSPKVGFFAEYGYGYPQIQFYPYSLALYGSGMAGIKLSIPISGLYTNKHKVQEASLALKQQEIAYENAHDEIRQAVEEAYLRCTEAMKKIEVAKENIKQAAESYRIMRNTYFNQLSLLTDFLDAETQLLQSRFELSTAQANAQVQFYKLQRTIGNL
>fig|743722.3.peg.2865 Drug resistance transporter, Bcr/CflA family
MKLYNSKFEKISTISTFILIPLSGLVTDVYIPSFPEMQSVFQTSAAGIQLTLSCFLISYGITMFVAGSVVDSFGRYRIILGALLLFALSNFSIAYVHNLYFLYAIRVLQGILTALIVVAKRAFLVDIYTGEKLKHYMGLLSVVWSLGPITAPFLGGYLQSYWGWTSNFIFLGVYALFSFTLEYIFCGEAMRQAQAFRMPTIIASYRKVLGTKEFSLGLFVLAASYSMVLIFGMTAPFIIEEQFHLSSVVTGYCALISGLGLFVGGMLAKQLTSRPLLMKLRIANFSECMIALLMFFVGTLFTNLYVLMLFVFSMHVCAGFMYNVYFTFCLTRFPQNAGISSGITSGGSYLITSVLSYSTISLVKVSSQSTLAICYFAMAVVTFSLLQVLKKIRMSGAD
>fig|743722.3.peg.3922 Permease of the drug/metabolite transporter (DMT) superfamily
MYIKQLQYILAGLVFAVLWSSASIATKWGLQVSQPFVLAITRFCLAGGIMIFISHIMLKHRLPHGNEWKQLFAYGILNIGVYLGLYVLAMQHVSAGLGSLFPATSPVFVSVISALVYKQRITAKILFSLSLCLIGIVVAAYPLLMKSYASPIGLFLLLLSMLSYSLGSIYFAKKNWQKLNILTINGWQTILGGLLLVPFMLFYYDRSLNTYNITFWSAVSWLAFVVSIGAVQIWLYLIRQDAVKASFWLFLCPISGFFIAWLLANEPIDAYTGLGVMLVIAGLALVLKRK
>fig|743722.3.peg.5159 Drug resistance transporter, Bcr/CflA family
MGPAIFFHGWTLRRIHLLRGILILIMFAAIAQFASFALIQGHVVAFYGVQAEDVSFAWLIAYVGIATALPLQFKVAGSFSVRTYLLLSFLLSMTLNLGFTYTQNLWLFSVLRFFTGVTTCLVVGRTLVLLFTTLPETKRVLIGTSFFFSLILIGGPLVSWGASWVVDRMDWTAFYYVLMGLQLLAMAFVIAVFKGNTPQAKIPPADWLGAMLFAIAGGALAFAMIYGPRYYWLADPPIEIAAVLVFIFTLLFIWRQRIISFPLIDLVVFKYRRFIFGLLLLIFFYGVKDSLNLIYGYAVSVKGWSAQDIVEATTFNVVGIVLATIISVIAILQHKRNLIPLILVGFLVLFAYHLYFSTLISHDLSVANLSIPIFTHGFACGLLFVPISILCITALPPQNALTGIVICTYARFIASLNSIAGFFTLQLVCNRKHTDVFIANLNFLNQQFVERRSFFDNFLLATGFSNADAGKISNTLLAKSLATQAQLATIRSIFLLFTAMIGLMILFLFIYLLWSWKQRLVAQRVS
>fig|743722.3.peg.5424 Glyoxalase/bleomycin resistance protein/dioxygenase
MEKAEAFYKNTLGLQVTRAEMGVLELHLIDGHTIIIYPKKNYQPATFTVLNFVVEDIVSTVNQLSANGVHFLSYTGEIRTDERGIANADGTGPGPKIAWFADPAGNILSILEERV
>fig|744980.3.peg.607 Glyoxalase/bleomycin resistance protein/dioxygenase
MTIKRLEHVNVVTTKLNEMVAWYEAILGLTSGPRPNFPFCGAWLYTDEVPVIHLVENTQLDRVGSEAALKLEHFAFSAKGSEEFERRLNEYGAPFQKIEIQETGLVQFHIADPDGNHLHVDFVIDE
>fig|744980.3.peg.1693 Multiple antibiotic resistance protein MarC
MDTAFFLKMFAALFAIMNPIANLPVFLSLTSDRDAAGQRKVVVTLIIALVCGAALVGIGGNAILNLFGISVDAFRLAGGFLILLIALNLIQGEQSKAHHGTEAEQAHHAEQDHPAIYPLTVPILLGPGTISTMIIFRGQASTVEQDIAYVAAISCAIGLLAVTFFAAPFLGRVLGQTATSVMSRLMGMILAAIAMSMMVESLKVLLPGLA
>fig|744980.3.peg.3967 Glyoxalase/bleomycin resistance protein/dioxygenase
MENIHKTKERAVCIFRTLLVSEGKLMPKIETITLRCLNPEAMRRFYIDILGMDQREDGAVSYGPAQAGIIFEKAEYPYRHSAGDVYWKIALAVPNIELAYEQLTTQGLAVGVPHQFRDIGYLAHFQDPEGFTIELIEHWFQGNRPSINHDPSRLGGGASLNLLTLRTHEINPIRDACLTWGMRPLSVQSVESHGFTLHFFAFTEDTPPSADLTAVKNREWLYQRPYTVLEIQEVHGSAPMTGIPVKTAGYSATRVTGVDVMIDCEALRITGQRA
>fig|744980.3.peg.4376 Bicyclomycin resistance protein
MKPEVYEVPKPVLTGKPSIVILIAISTVSPVAMNIYLPSLAGMKQAFDATAGQVQMTMSLYFVAVAVAQLFLGPLSDRYGRRPIVLGGMASFVVGTVICLLAGSIETLIGGRIIQAIGGSAGLILARAIVRDLYGRDQAASMIGYVTMGMTAGPMVGPAIGGLLDESFGWSGSFVLLLVLGVIVLIASYLGLYETNKNRGDGEASFSFFKNYGVLLRERLFWAYGLTAMFTATVYFSYLGGAPFVAADVLKISPSEMGIYFMIIAGGYLIGNFISGRFSERFGLMPMIVFGSLFPVVAVLAMIAVLLSGEVTPIRFFAPMFLVGLGNGICLPSIIAGSVSVRPDMAGAASGLTASMQIGMGAFASAGVAWALSESMWPATVWPLAAMMTGAVALTLAGVVAIFVLEKTERR
>fig|744980.3.peg.4559 Permease of the drug/metabolite transporter (DMT) superfamily
MSSTSIGLGGRLYGNAILLLILTTLFWAGNAVAGRLAIGEVSPMVIVTLRWWIVAVVMGLFLWPRIRAEWPMMKPYFGRMILMAGFGFIAFNSLFYIAAYTTTAVNIGIIQGSVPIFVLIGAMLFFQTRTTLAQVIGIFITLVGVALVASKGNLEILLSLSVNPGDGIMLLACLLYSGYTLALRQRPQVSGLVFFAVLSMIAAVTSLPALWFEIATNTAQWPTFNGWMVVLYISLFPSCLAQIFFMRGVELIGPARAGVFVNLVPIFAPILAVLVLGEPFRWHHGVALALVLGGIYLSERKGSKS
>fig|746697.3.peg.782 Outer membrane component of tripartite multidrug resistance system
MTVQELAESVQANNIQLKLAKSSVDVSDATIGEVKVNRLPDIGTDVSAFYLSDVSIYDTGFNKLQKVDIPNFGNQFNVNVSQLIFAGGKINKSIELAEMSKTLSENQLGDTEQGIKLSATELYLNLYNLQNQKTILKNNRDLATERTKNTEYFYEQDMITKNEMLRAQVLERQLEQSILQVENAILITNKNLTLLAGLDENILIIPTIDNINHQIRKQDETFYREIAFQKNPQLTASDTQIAIAEKNLELTRTDRSPILAGFAGYNASRPQTSGTPADLYSNTYQVGLSLSYNIETLFKNPKKEAVDKVLIDQATLAKEAVRQRIEGDVNAAFKNYNLAIAQLEVSSVNQSAADENYRITELKYKNQLVTYIEIIDAANTKLQAELQMLDDQTDIILNYVRLLRVTGQL
>fig|746697.3.peg.783 Membrane fusion component of tripartite multidrug resistance system
MATSESKSETAPESTPESAPKATPKAKKKNKLYLTLLNAFVFIITLLVIWFVVKNYLHINDDTYVSDAQVKAYISPVNSRVPGYIDEIYFTEHQSVKKGDTLLTLDKTDFLNAIAQAEAGLSQAIAGKASVKTSIARVGSSEGTVAANMLGVKAQLNNSQADLARYKNLLANDAVTLQQYQQIETQVKTLQSQYNALSKQKNTAQLSTNETESQLAVSDAQIKAAEAGLERAKLNLNYTVITAPEDGIMGRRTITAGQYIQPGQQIAALVQNNKKWIEAICWKRNYH
>fig|746697.3.peg.785 Major facilitator superfamily (MFS) drug efflux pump, EmrB/QacA subfamily
MLVLILVFLIPILVVNGVYTGNISYMVGSLGTHNEWIVFANYAGVVGMGVSLPLIFRYKLRFYTKFLMVRTLLFLAIASFMIGTTDNVIVIVSSTFFIGFLKMFALIELIMPTMFMISPDGNRPKFYSIFYPSAIVFPQLAGYLMVRFGFSTYWQNANFIMAIIMLSLAGLALIFMHNQRYDKKVSLKGIDWTGLFLFTNVFLALAYFISFAKQQNYFRSDNIMLAVGIMVLGSVLYAINQRLKENPFIHFGFLKNYSVIHGIMMLLMLGFFLAGGSLQSKITMGILGFDSVMDNSFNLWMIPGLLIAIVFSMKWLVNNKSLKIYILTGFTAFILYYVLMYFLVSRGLSYEQLIIPNIIRGFGMAVLFIGVWLYALGDLKPDAMLGAAAVMIIVRTMIGPGLWSLGFNYIDSIWSLEALTNMAGKMDASAYSQQTAMGLYKTINLDSLMISTKRLYGLLVMLGGAVLVYVSFLNLDGLSKRSVILLRKRLKGQTTKGYVREVALQEEEELQEEIKAASAVAV
>fig|746697.3.peg.1993 Drug resistance transporter, EmrB/QacA family
MQEKPVKEMRRNWVLFALMITMMLAAMDNTIVATAIPQIVGDLGGFSLFSWLFSIYLLIQTITIPVYGKLADIYGRKPILIIGIIIFLIGSAACAGAWNMHSLIFFRGLQAVGAGAIMATVNTVAGDIYTIKERAKIQGWLSSVWGISAIMGPAVGGALADYASWRWIFLINIPIGLGAIALIVLFLHENKSHKGHKIDWAGAVAMLVTGTVIMFGLLQGGQSWPWFSLNTLGIIALSVVLIMITIRIERKSAEPILPRWVWKKRVILGANLATIGMGIMTMGPNMFLPVFAQSVTGVGAIAAGFILASMSITWPLSSALSGNLYLRIGFRNTAICGIIIVIIGAASFLFLPFPGPVWYLVAVQMTLGAGFGLITTPLLVGIQSTVEWGQRGVVTGTSMFSRYFGQSIGAAVFAAVFNSSLTDSMENAPARLQSELPSVNKVVEVLQSHKSVSDVSLYLRESFFAATHNVYLGMVIAGLVTLVILLLTPAKFPSIEEVR
>fig|749219.3.peg.107 Acriflavin resistance protein
MSDTKLSWFVDDTITKQLSNIAGVGSVSRIGGVERQILIQPKMDMMTSLSMPINQLARQIYAKWQDASGGEAKIGNQIQTIRILGSGQRV
>fig|749222.3.peg.812 Permease of the drug/metabolite transporter (DMT) superfamily
MLSRRLTGHLFTFITVAIWSVAFVGNKVLLAYLTPIEIMLYRFTLAWGLLLILYPKDLLPRSLRDEAYFFLLGFLGIFVYFLLENFALRYTQASNVGLYMGAIPILTALLAHFLIRGERFRPALLLGFLIAVTGMGLILFTERHFTLRLRGDLLALAGAATFALYSVALKRAPEGYHFLQIARKSFFYGIGLMLLYLLLTGEATHIQALREPTVWGNLIFLGFFSSGLAFVLWQQGIERIDPVAAGNYIYLVPLLTALTGVFVLSEEITAAMLLGGALILGGLYVAQRGSKAAE
>fig|749927.5.peg.112 Glyoxalase/bleomycin resistance protein/dioxygenase
MPEPFDALRRPSERVAPDPDFAAELRDDLRRAILNGADMTTTAVPATAASLRSLTPYLAVSDARAALDFYVEVFGAVRRGDPILMDDGRVGHAELAIGDAVLMLAEEYPEIGHVAPREGGASVRVEVPDVDGSVARALELGATLIRAVSDSPYGRGGSFRDPFGQRWLVSQAATAAAGPRPARHGEAMYFTFQVPEASPAKAFYGAVLGWQFTPGSTTDSWGFSGPGLEGGLWAGDRQVGWKLMYAVDDLESAMARVREQGGRAGEVEHHPYGNTADCTDNQGIEFWLWEKPGQ
>fig|749927.5.peg.144 Drug resistance transporter EmrB/QacA subfamily
MTTAVRPDAALWRLGGVLIMGAVLSILDATIVTVGIGSIAHDLDSPLTTVQWVASAYLLAASAAIPLSGWLTDRFGGRAVWLAAVAIFTAGTLLCGFAWSAPALIAFRVLHGLGGGLMQPVGQAVFAQAAGPALGRMIGVITLPATVAPVLGPMLGGALVAGLGWRWMFFGIVPLGVATFLCARRLLPAPAPGGVPAALDVRGLALLSPGLGAFVYGLAEGVVVAWVAGAALLLAYGVHASRVASPVLELALFRNKGFAVASASTFLLGASLYSSMLLLPLYYEQVEQASALRAGLLLAPQALGSAAVMLASGRLLARFGPRRTMLAGIALSLLGTIAFTQLGSAPGGALLTLSLLIRGAGLGAATAPGMTTLYGSLERSHIPRAASAFNVVNRIGGSLGTALLAAILHSELTAAPAPAAFGTTFTWALALSALTLIPALFFPQRSTR
>fig|749927.5.peg.684 Tetracycline resistance protein
MGTSTVTGRTRSMGALFAGVALLNTATVGLGTAATLIVAAGSGAVWSGLPSVANVLGTAAGALGAGRLLPVHGSRRVLAGGYGLAAAGALVAFAGALATSVVPLLLGILLVGLGNGGAQLSRYLAADLYPQDRRGRALSTVVWGGTVGALAGPALMVPAAGAAAGFGWPSLSGPAAVAVLATAGAALAAAFLPRHVPPPRQPGLRPGPGAPPPEPPKSPPREPAVAARGPVRPAGFVRPLVAMVLAQLTMSAVMTMTPVQLQAHGHDLGVVGWVLSAHLFGMFALAPLSGRIADRWGPHVAVNAGLGVLALAAATALAAPTAHTSGLPIALFLLGYGWNLVFVGGSAQLSRDLAPETRSRVQGTVDAVVWSASALAGLGSGALFAGGGYGLVAVVGGVLAVLPLAFSAARDGR
>fig|749927.5.peg.2402 Permease of the drug/metabolite transporter (DMT) superfamily
MSLPTRARSSAALVLAGVLWGTGGLAGSLLGGLSGLHPLAVADYRLLVGGGVATLFVLLTGGTFPRTPGAVRRTLAVGGLFALFQASYFAAVALSSVSVATMTTIGAAPVFVTLASVRKLRRWTVVSVAGTLAGLVLLQWSPGEAISFGGLGCALLAATGFAALTLLTAKPVEGLEPLSTTAFGCLTGGLLLVPVASWSGMAIPLHADVLALVCYLGAVPTALAYAAYLRGLADAHPVLGSLSAVLEPLTAAVLSAALLGERLGVTAWCGAAVLVAALVVGYWRPEPR
>fig|749927.5.peg.2833 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDIHRAVEFYEGKLGLRALQSGPSAHVAGGSRTYGSGGGPALNVYQSVTAGKSPATLATWYVDDLDEIVDELTSTGVEFTRYDQLEHDAKGITARAGGGRIAWFQDPDGNTFAIEADV
>fig|749927.5.peg.7704 Glyoxalase/bleomycin resistance protein/dioxygenase
MAIRLGSTVINCTDLETMTRFWCAALGLEPASEADDFRLLRGPHVNLSLQRSPVSARDQMHLDLYTDDQEHEVDRLIGLGARFVRHVDDDPADDWVILADPEENLFCVCAKPADEVRDPGAGSAA
>fig|749927.5.peg.8242 Glyoxalase/bleomycin resistance protein/dioxygenase
MVGVEDQARAKEFWSAVVGFAVTTDVPYDDQGRRWVEVTAPDGTILVLSENPEDRPRSTGDQLPTSNFFLYADDVEKTYEELSAKGVEFPAKPEKQPWGWWSMFTDSEGNRFALQQRG
>fig|749927.5.peg.8244 Glyoxalase/bleomycin resistance protein/dioxygenase
MSRPLGLVPHLFVRDVDVALSFYTKAFGAVELFRTVLPDGTVLFVELAVGDARLLVSQEIAALDALAPSTIGGIPMLLTLETADPDDLARRAVFAGATVEAPVAEMFFGERYGRVVDPDGHRWALTTKREQYTPEDIDARKPHNAAFGGPGGGAPGSGRSPGPH
>fig|749927.5.peg.8460 Ribosome protection-type tetracycline resistance related proteins
MPEPSLNIGILAHVDAGKTSLTERLLFDTGAVGALGRVDDGSTQTDTLDIERRRGITISTGVVSFRAGDRTVNVIDTPGHADFVAEVERALGVLDGVVLVVSGPAGVQASTRILWRILRRLRVPTLVFVNKLDQAGADPAAVLESLRKKLSRALVPMVTVDAAGSAAITIRDRPRSADDLFRRQVAAGEAYPVFLGSAVTGAGVPELVAGIVDFLPTAVPGAELRATVFKVERGRGGDRIAYARVHGGTLRVRDRVELFRRTGDGTVERSRRRITAMTLAGAKVTRADAGDLIRLSGLGDVRVDDRLGSPDGVADAGLFPPPGLVSVVKAQPGEETRLHRALRELCDQDPLLGLRADRGTLSVRTYGEVQIEVLLERLREDFGLVAGFAPPAPIHVEKPVGVGEAVQFLDRLGPTDPVATVGLRVAPGRTGSGVRYELAVERGSLPRAFHTAIEQTVYRTAACGPHGWEVTDCVVTLTHSGFQPPLSTAGGFREVTARLLSLAFARARTRVYEPVDRFDLEVPEHAAGAAVIALAKLEAVVEPPVVEAGVARLSGSVPAAATAAFRRRLPALGQGEAVFTAEPGGYRPLRP
>fig|749927.5.peg.9541 COG4767: Glycopeptide antibiotics resistance protein
MTNAQLTALQYGFIAFLALWAVVLVPQLITQLARHGGLRLRGLATTAAVLLYGCMTLAVVLLPLPGPGSRRLGQTVQLHPFQWIADIHTELLKHGGQWFMTQTFQQACLNVLLFVPLGVFARILWRRGLTGTALIGFTASLLIEFMQLTANFGTAPFVYRIFDVDDLMNNTFGAVAGWVFGALLLTLRRSPVDVQPARSERVHFAETR
>fig|749927.5.peg.9549 Vancomycin B-type resistance protein VanW
MTVAGIEVGGLSHAEAEAKLRRELEPRLIRPVVVHGGDVQAELVPSQSGLGLDWPNTLGLAGHQPLSPITRIMSFFSSREVGVATHTDQNRIGQAVQELAEGKLNHPATEGTVGFTPIPGSDGGVTAHPVLPRQGQQLTDLAGAVHTVTDHWLDPGGVKLAMAITPVRATAAGVQAACQQIVVPAVAKPVVVHGEGKDVPLKPATIASSFQFAVVEGGAVEVRIDQGKLQGALKDPLASTETDGKDAQIVFTGDQPTVEPSEEARKINWEKTFLPLIDVLKKTEGRDLPVVYSTAAPGVTTDAASALGIKEVIGEFTTGGLTGPAATNNRTLAARVSGAIVKPGETFSLGVRSGPRTADAGYVPAPVDEDGTGPSVVGGGVSQLASTLYNAAYLAGLADAGHLEHDHYLDRYPAGRDAKAVNADGSPVELKLTNDTTTGIAVQATVSGDSVTVRIWGTRHFRVEGQTGAQTPGDPPPIQFGSGAAGSCQPSIGSSGFSVTDTRVLYDLASGTELRRTSHTATYGPRPTVLC
>fig|754252.3.peg.1532 Permease of the drug/metabolite transporter (DMT) superfamily
MSSAPEHPAARRLSSLPAASALLLIAMLWGSSYFMNKALVGMMPPGDITAVRFTMSAIVLALVAPRALRMSRRTLLQGIAMGTAYGIAQLFLMFGIVHTSASVSGFLTGMYAVFTAVMVALILRRNPPPRVWISVGLATAALGVLTLAPGATGGLGLGELLSIAAAVGFAAHIVLTDMFIDQRRVMSLAIVQTATVAVWSLAVAAPGGITMPHGTVQWGALIYLGVLCGALTLFLQAWGQARMEASRAAVIMSSEPLWAAVFAVLAGQEALSVRTVVGGTLMMGAIWLAVRIPPLRRRTDPPPTAAS
>fig|754252.3.peg.1983 MCBG protein-like (microcin resistance protein)
MLITEADLQDCHFEAVNLEGATLKSSALEDCDFHECNLANAQLVGTVFTRCRFVDCKLVGADWSRAGLSLLPPVTITFERCILDYASLSRVNFSRARFIDCSMRDTDFTDANLSKATLGNCELTGARFHGRTCARPTCVARADTSSIPATTRPAA
>fig|755732.3.peg.95 Glyoxalase/bleomycin resistance protein/dioxygenase
MGKAIGIGGIFFKFKDEKAMRNWYKEALSLNPNDYGVLFAFNGNSNPRGYLQLGTFPENSDYFGDGNQQAMINFRVEGIESLLVHLQTMGTVICDNIETYEYGKFVHILDPEGNRIELWEPVDTSFDEGTRQEMR
>fig|755732.3.peg.303 Multiple antibiotic resistance (MarC)-like protein
MSGIQSFIDMLFIGVITLFPVVNPIGSAFIVNPYLSNLEIQEKRKAVKKIALYAFILCTIALFAGHWILEIFGITIPVVQLAGGIMICKIGWEFLSSDKKEEKTLIDESGESPNSNYTLIQDKLFYPITFPITTGAGSISVLFTLSAHSANAHINMYLINTGAILSAIVVICLLIYFFYLNTKKIIRVIGKEGEQILNRIMAFLIFCVGLQIGITGIKSLIIA
>fig|755732.3.peg.1539 Glyoxalase/bleomycin resistance protein/dioxygenase
MNLNQLTVPSLDIPKSIAFYQTLGLKLIVKSDHYARFECPDGTSTFSVHLTEKLPTGTGISVYFECAELDEKVDDLIQKGVAFDELPNDKSWLWREAYLKDPDGNQLILFFAGENRLNPPWKIN
>fig|755732.3.peg.1787 Drug resistance transporter, EmrB/QacA subfamily
MVITAISCAILELLDTTIVNVSLREISGNVGATTTEIAWVVTAYAISNVIIIPLTSMLSDFFGRKNYFTGSVVIFTVASLMCGLSTDLWTLVFWRFVQGLGGGGLLSTAQSIIIGAFPPEKISTANAIFGMGLILGPTFGPTLGGYITDNFSWHWIFFVNIPIGITATILSYRYVTDRVGAVKPRRIDWWGILFLVVSIGSIQYVLEEGTAEDWFESHEITAMTIIAVASLTAFIIRELKIDYPAVNIRLYKNYNMIMGSIMNFLLGLMLFGTVFIFPLFVQISLGWTATQTGMFMIPGALCTAVAMPLVGRLLGGGVNPKTVILFGVGMTFTFVMMLAFSSPDSSEGNFYLPFVLRGFGMAFMMSPILSLAVQGLNPKDMPQAIGLANMIRQLGGSVGIALINVYLTNTNALVRGNMIGYINQYSDAASERIQMFTQNFLSKGYDSVQAAEMANRTMDGLMTKQQMLVSYNHGFFMVACLILICVPVVFLIRYKKGTKAVVADGH
>fig|755732.3.peg.2441 
MLTRIVKLTFQEDKVGDFLSFFDTINTRVSTFENCFGMRLMQDIHQPTIIFTYSNWKDENALNSYRDSSLFEGVWSTIKPWFGGKPEAWSVDTYFEDGSFSPNQTTK
>fig|755732.3.peg.2598 Glyoxalase/bleomycin resistance protein/dioxygenase
MTKEIWLNLPVKDVEASRNFFTAIGFTAKLEQSAPEERACIQAGKSIIMLFPDAILKQFNGGLEKNDTSKTAQILISFDAETREEIDELAQKVKKAGGNVFSEPSEIQGWMYGFTFADLDGHRWNGLHMDLSKTD
>fig|755732.3.peg.2765 Glyoxalase/bleomycin resistance protein/dioxygenase
MTKIICGIQQMGIGVPDVQSIWKWYREHFGVDVRIFEEAAEAPLMTRYTGGVIHSRTATLALSMESGGGFEIWQFTSRPTEKSTSPILLGDFGLYACRIKSKDVKVTYDFLVKKGAKVLSEPQELPNGSLHFLVEDPNGNLFDIVEGSGWFMDTKFEGKTGGVAGSMIGVSSIEKALPLYQKILGYDQIVYDTTETFEAFNNVPNGNQKVRRVLLQHSEARKGPFAKLLGPTQIELIQAVERTDSKSIFKDRFWGDWGFIHLCFDVQGMDDLQKECEELGFPFTVDSGKTFDMGEAGGRFSYIEDPDGTWIEFVETHKVPVMKKLGWYIHLKNKKPGAFLPNWMLKAMRFNRVKN
>fig|755732.3.peg.3390 
MSVHVAITRKVLPGKEEEFKEALRRFLSESFAHDGVHGASMITSLSETNEGEIGILRTFKNKEERDAFYNSEQFQKWETYASTLTEEPIYRDLTGLEAWFRSPVAPPRIKMALVTLCGVFPTSLLLYFAVSPLIKDLPVIVRLFVNAALMVILLTWLIMPFLTKLFKKWLKG
>fig|755732.3.peg.3794 Acriflavin resistance protein
MIVVIFAVLGFLGIISYSKLNYELMPKFSIPVVTVTTAYPGASPSEVENSVTKKIEDALSGVENLDDIQSTSMEGISSIVLMLKNDADPDKALQEAQRKINAMLSTLPEEILSPSLGKFSFDEAPIMNVGVTANMPPTELYSLIKDEISPSLAKMEGMAQVTMVGGEEREIKVQVNREACSNYGISILQITNAIRSANLELPTGKIKSDDSQALVRLRGKYKDLSELNNLVILSDPKTGSPVRLNEVATVSDASKEIKTFNRINGTNSLGLLIQKQTDANAVSLSKKVRAEFKELEIQYKKQGMKFEVASDSSDFTIAAADAVVVDLGLAIFIVALVMLLFLHSVRNAFIIMISIPASLISVFIAMYLLGFTMNLMTLLAISLVVGILVDDSIVVLENIYRHLEMGKERKKAALEGRNEIGFTAMGITLVDVVVFLPLTMVGGLISNLLSQFSLVIVISTLMSLFVSFTLTPLLASRFAKETKLNNKTLGGRIVMAFEGVLKRITTSYGRTLTVALRRKRYIVIAAFLGIIGIPVLLGPYIGGEFVSAGDRGEFVISLELPQDATIQQTNTTVQRVEDYLFHDKRVINVFTSVGTASGNMGSSSNANNKAQLTVKIVDKEKRDKSAAIIAQLMKQDIEHMLPDVKVNSAAVGIMGGADDAPIQIGISGNNMDSNYVAANKVMAKLKSIKGTAEVKVSVETGNPEVTVNIDRDKMAELGLTMSTVGSTLQMSFNGDDNSKYTEGGKDFDILVNYDDFDRKSTQDVKEVYFINDRGEEIKLSQFATIGKASGPSKLERKNRVPSITVTSQALGTSSQQVTTEFAQMMEKDPLPSNTAYTFEGDAKNMAEAFGNLLLAILASILFVYLIMVALYDSYVYPFVVLFSIPLAIIGALLALALAMEPISIFSMLGMIMLIGLVAKNAILIVDFTNQKKADGHNTVEALIIAGQARLRPILMTTLAMVFGMMPIAFAHGAGAEWKSGLAWVLIGGLTSSMLLTLIIVPCVYLIFDIFKREISNKKAKALLKEVDVVALGHEYDHK
>fig|756067.3.peg.367 
MQEMLKAYFFKSFRGISKVLLLFFAAFVCTTIFSTSGLSQVPSNRQQDSNVTLPLVVANRFEIKPEQREQFLKLATAALAPTRAEPGCISYGFYEQPTAKNSFIYYEEWKDRTALREHLKQPYVQPLLAKFSEILKGSLLVRVYTTNSVAHELPK
>fig|756067.3.peg.369 
MLEIEQDDTRTASHAGHDHTEDNTQNTSTTTDKLPPGFSWPSFSKDDRYNPNAPYNQAPQFQWPKNIGLPIPKNFSATNVLTEPSGDPNGAKLSFYTGLQQETSPGSNQWDSFPAGEAQQFLTTSISNAAVQALNPETKQGLPVDLTAISTSTQARPYTMGLTVTPYNAGPIPHTHWAEEEWFILLQGEMDAWLPVANKTPYKIGEIPGQNGIPKIEDYYYVHLTPGQIGFLPAGYTHNYRNASPTKEPLTFLTIWSRTDQNATPGGIEEFFAKQGIGIFADSANEAAGIGSLYNKNPGTPEFIENQQRFTNYFTQFPDYHVALSRNPGDYLAQGGSWNPAIPEDTQPIPAPPPNPPFSPPAPNAPSKSVNFNIPLDPAPIKRWSINTGAANSQQLLSLVSNYDKNTEQQQGNYSTDFYRDPNNPQNLLLIEKWNKYSDLDQYQKSDSYKQFEEGLKSIGAEVNTPTIDIVETDSQINSEKILIGKFKAQAGTRDQIISLVDDLTKQTKQAETSNNLAFELYEDPLQPNQYFFYEKYVDGKALTEHLEAQYTKDFFAKFSPLLEGNGLSDTTVSQVRIDSVRTSSPSDPLTLVYQGQKNGVDTLTGLFKDTPELSVSLNASNGIVAVNNKSNTPGVGINLLFAAGKPSNQPVEYGVFAIDDSNNRVNGLLPTDSGYLEAVRQRAIVLFNTTANNSASAGNTSRNIPVETTDKLAIYQIGGGSIFDANPAIEFSFQNPQFSAQPSGDALSFQFSDGSGGTMALNGPVESFDDQIGNRQTKGRNVLDTSTIVDRKIKADIDITKSPQPTGFTHRIGLYEVLNKKGDVKDPLTGEIVTAENPNYANVVLSTSKKIELETSALNQGQLSNSGTYLLDSGKLYAPYMTTFDSQQHSSATYFAYKEANLDRSSHIISLGTNRFGLEDSPSAVAKGDFNDITISMKFNFAEPPFAV
>fig|756067.3.peg.681 Glyoxalase/bleomycin resistance protein/dioxygenase
MIGYVTLGTNDIETAAKFYDALLAEIGARRFMEFDQFIAWGVSIEQPGLAITKPFDGNTATVGNGVMIALQVDSPEKVNLVYNKAIELGAKDEGPAGPRGVLPGFYAGYFRDLDGNKLNVFCMMAPNI
>fig|756067.3.peg.1675 
MRVVARLVAFPDKVAELKSLLLSIMEPTRKEKGCIKYELLQNQADPTDFTFVEEWESADLLELHLGSTHIQDAVQKLDGLAVGPPDIRRYELLA
>fig|756067.3.peg.6258 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDIGLTHIALPVSDVDRTIEFYSKYAGMQVVHRRIDAETGVTVVWLSDRTRPFVIVLIQTDSVHPVLSPFAHLGVGCKSREYMDSLCDKARQEGVLLEEPKDSGYPIGYWAFLRDPDGHTRELSYGQEIGFTVEDAS
>fig|756272.5.peg.881 Multidrug resistance protein 12 (P-glycoprotein 14)
MTAFSTESQQTWQRLFPTQAWWKTSAWKLVILAVLAGLLLAIMFLISLMVVDLFDNNGRLVLTSEELPVAGDLFGESLGVTTPTVTTNLSETIVLEDRGILATLWHFRDRLWTRPLIQLYQQMPALQQNSSALVVLLLAGAVVGLLRGLTLSGCRLISARVGIRSADQFRRSLHRQAMRLGPGDLLDEKVNEAYKLFVNDTAVIRDGVSAYVYRLGLHPITLTVLTLLAVITSPRLFMQMLFPLLGCWLLVERERTRNTQAKRLAEAEAEHRTNVLAESLLKTRLIRGYSMEPFESEQFTRHLEQSSKATITFRKRDVFSRWLCWLLVLGCVLVIVLLMGIKVLLPLDHSQHLQLSEITLLSLCFGFAYRPLAKLRQFRSLYKETALATERIERYLKHIPEVGQAVGAKFLDPLAKAITFENVTYAANGKKLLDQLELKIPAGGMTVIASANPLEARAMLYMLPRFLEPQNGRVLIDGEDIAWVTFESLRAETLYVGGPDPFFTGSVLDNITCGDDKYVLSDAIAAAKRVHAHNFIQRLPNGYETRLGEHGEQLDASEAYRLGLARAILRNPTLLILEEPENIESEEAKSMIDDAHDQVAQGRSVIIIPSRMHTIRKSDRIVLLYQGKVATMNSHSNLLSGNELYRHWEYTKFNVFRHMSGS
>fig|756272.5.peg.2491 Acriflavin resistance protein
MSLPRFSVNNSVLVNMLMLVLLFAGTAMAFTLVREMFPETRADQVRISVMYPAVQPDELEKAVTIKIEEAIRDLEEIEKVDSTVQEGMSTTVATLYNEVDDIDNVREKIDTEISAINNELPDDIESITIRNVEPLLPVLSVSLYGEGSEASLKQAARDLRDELLELPGVSDITVGGIRDDEISVEVRPEKLFEYDLTFSEIAQAIRATNLDVSAGSLKGPRSNVNVRTLGEEIEGDELGDIEIKTTPDGTKIFLRDVATIRDEFVDVDLESYFDGKPSVTLVVQKTETQDAIQIANLVKAFVNGKQQVEFDAYGLTAASEQSWYSRPFAIALAYFSKGVNSLAGRPDPQAIYDASYANPFRHNFEIAMHGDLSRFIRGRLDLMTRNGMSGLVLVCASLLLFLNWRVAFWAGMGLPISFMGTFLVMWLLGVSINLLSMFGLIIVLGIIVDDAIVIGENIFRHVEEGEEAEEAAVNGAEEVMWPVTVAVMTTIAGFAPLLFIKGRIGDFMRELPIVVLAALSVSLVEALVILPAHLKHLKKPKQKAEPTTAWGRRWKVVSNFQHHIMEDVLNVIYEKFLRACMRWRYVTIAAAFSMVLVSLSMVAGGIVPFVFIQKMDSETITADVELPIGTVLDTTRDKLVDISRFVADIPEVTSVQTSVGSQINLGGTGATGGNAQSHLGQVIVELMEADQREREGMRSSEELLAEFRKRTETMSGINSIKWEAMNGGPAGKDIEIRITGNDFDELLQVSNEMKAELASYDGVVDLDDDYDIGKREVQLRLLPSARPTGITVSDLGNFVRFALYGVEARRITRNREDVKIMVRLPEEYRAEVYNLEALRIPRPNAPINSAGEVNEETFRWVPISEVAELTEARSYTSIHRAQQRRSISIFGDVQSETNNANDVMRQFQTTFVPELLAKHPGIHVDFEGTTEEQQKSFSSLALALPAAFLLIYMLLAGLFRSYFQPLVVMSAIPFGLLGAVIGHYITDNPITILSCIGFLALSGILVNDSLVLVDFINTRLRRGVDPFEANVLGAKLRLRAILLTTLTTAAGLTPLMFETSFQAKFLIPMAVTLTYGLIFATGLTLIIVPCLNMIFLDMLHAFERFAESLGLSRREESTTQPAEATG
>fig|756272.5.peg.3142 Probable multidrug resistance efflux pump
MNIIRIGQEAIRLAAPVIILGAGVIGFAGLASMRQPPESRETEATRPLVEVAPVTIAAAELDIVTDGRVVPFREVRLSAEVSGRITRKTDACRAGRYVTAGTPLLEIDERTYQLAVERLREEVEQAQNSLDELEVELQNNDALIALLQEDLQLKKRELDRMNKLFSRGVLNESEVDEYRAKELSARNALTLQQNNRRKADSSRDRLRNSLDLARTRLAEAELELQKSKIVAPIDGVVVTESVEEGNYVSAGTELVTIDDTSAAEVRTTLRMDELNWVWQQGRSSGNTESPSIEQDYQLTSTPATISYRLAGQDYSWKGELWRYEGIGLNEKTRTVPVRILVSEPRDVRAERGEGLSVLAGPKALVRGMYVEVTLHTRPNVGFLSLPDEAVQPGNVVWVINGDTLRRVNLRNVRFQGDRVLVPEGGNELAVGDEVVVTPLQLAAEGMAVDVQREMNAVNDQNTSEGQQG
>fig|757424.7.peg.2417 Outer membrane component of tripartite multidrug resistance system
MMNLPVSLMRKWLAWMLLATQAGCLVGPDFVAPTPPRVSQYTRDPVLLDRMSEPDMSQQLLMGENPPARWWQLFGSPELDAAVTQALTRNPTLQAAVSNLLLAEDNLRAGGAVFYPRLDANMMAERTRSASLVQGSSAPDKVFSVATLSGAVSYAIDLFGEKRRTLEQLEAMVDVQQQLHHAAYLTLTANVVNAYIARAGYLSQISLVRQIIALEELQLEAIQARVDTGVAPLADLLSQASLLAGNQALLAQLTQRLYQIEHLLAQLQGEFPAQASLPELVLADLHLPSDIPVSLPSALVRRRPDILAAEARMHAASAAIGMSSAAQYPSLELTATYGVAARNLSQLTGPATSLWSFGPSLSTPLFNGGRLRAQRDAAVNAFEASQSEYQQTVLTAFEQVADALRALQADGHIVSAQSAAARYAYDTLLLQRASYSAGLSSYADMLLYEVQYRSAAIASLQATVQRYQDTVALLVASGGGWLDTAAQRR
>fig|757424.7.peg.2754 Outer membrane component of tripartite multidrug resistance system
MNRINSSAFRLRAIAAVAALAGVLGLSGCASFAGIGSDRQVAQAGDFATQRSLSDPNPGAPNGQWPGSDWVRQFGDAQLVALVEQALTSSPSLQQARARIAAASALAESRGAPLLPSVNAEASVTRNQFSSTTIYPPPYGGNWYNEKKAGLNVGYELDLWNKNQAALAQAISSEKAAQASEQEARLALTASIVTVYSQLAAQYALHDILQSTVDQRTSLEKITAERLRTGLDSQIERDQSRTSSADARAQLAQSEGQIVLLRQQLGALAGKGPDYGLQLAPPALQGLATPGLPAELPLNLMGRRPDIVAARWQVEAASRGVDVAKARFYPDINLSAMIGFDTLLDSNPFTAASKSIAFGPAITLPIFEGGALRAGLKGEYASYELAVATYNKTLNDAYADVARQIAAIHATERQLPIRSEALQAAERAYALARERYRLGLVSQLTLLSAQTGVLAQRQAMVALQAQRRDQQVALYKALGGGFDAQRDGLAYGAQP
>fig|757424.7.peg.3992 Glyoxalase/bleomycin resistance protein/dioxygenase
MSATATPAASAASVIKPRIRRTHLALFVKDPHGSAPWYEDVLGMTVTARAERWVFLSFGKKHHDIALIRVEEPSQAVRGEVNMQHYGLEVEGDMEEFRRLYGMLLAKGIEIFKITDHKVGYGIYFHDPDGHRFEFFFETAHDDEEGKRLLGQYNAPSDSFHLDPL
>fig|757424.7.peg.4181 Permease of the drug/metabolite transporter (DMT) superfamily
MWRKRTGGDEGWRGHVCHPQSASRLVNRREYPCEEDGRAGELLLQRSSNAKISRQKVQSPLLRALSSIYRGTTGCPENPCLYASKYSTLRFALSTHMQKHFSTPRLAALDSFFVTTSHRDALGCYAWNQAVSAGFLPLLADVEVSLRNALHRALSQYFHAVDSSDWMMPRPNPAHGINPAAPVQLPPVHKLTPKAREDVVSAMGKIKARKPAGYLVSPDDVVAALPFGFWEVLIAGLAHRSQPPGLQAAILAAAFPYAADTATTPYGSQDFRMRLVKLLKRIRDIRNRIGHHEALWSTPEFNVFGVLGHIPRRPRHTVNSLRKFAEKLSWFGGWIDPGISAYMQNNDHWWSLQVLLQRQALATYRVLGGAVGTYRRLLEATRTPANGTMPTLRTRHKRHKRRIVDRYYF
>fig|757424.7.peg.4619 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSNLCKLLLLAAIWGTSFMLMRIAAPVFGPMLTTFGRASLATLALLAFARVRGVPMQWRSNWLPYLVIGIFNTALPFALFAWSALHIPSAYMATMNSLAPVFTAMFGFLLMGERLSLVRCAAFVLGLVGVAVLVGIGPAPADAMVIAGVLAAMGAAVSYGFAATFTRLRAGGISPIALATGSQFAAALCLLPLAAPSMPHALQAGTLPALLAVLVLGVVCTGIAYALFFQLIAAEGATKAITVTFLVPMTASLWAWLLLDEPVTLGTVTGIAIVLVATATALRAKPAVAARTKATA
>fig|760011.3.peg.755 Methicillin resistance protein
MPFAPEGCMTGVDMEVLSQAILSLLPHGVFVLRYDLPWGTPGLQEDFRISRLRSCKESVQPVATVRISLHKGMSAVYQGFRQRCRRNLKKAVDNGITIRHWEKNATVLSQWYELYLGTARRDGFSPRPLPYIKDVLEVEESDGQADLYVAYDANGDLAGGIIVLFGRQEAVYLHGSSRRDVFSMGASWLLQVHAMEKACEVGCKVYDLHGISASHDGRGHLGRLDLFKTSFGGEIIDRPASLDFIRGRLRRRAYVMLENLRYSVRRGTV
>fig|760011.3.peg.906 Glyoxalase/bleomycin resistance protein/dioxygenase
MVSFIDHIHITVRDIGISESFYNKFLPLVGFDLRDKEYAQVPEHAYELIEYNSASFSFGIVSPRAEYLDDCVSRRRPGAVHHVAFGTREKVDVDSIFSAVQSIPNVRIINKPCFYPEYCDDYYAFFFTDCDGIELEVVNYSRTSRIGSSLA
>fig|760142.3.peg.1120 Permease of the drug/metabolite transporter (DMT) superfamily
MLKISKEYIADLMLLSVTVFWGSTFIVVKKSIEIIPTFAFLSIRFWIATLLLVIIFHKRLVNINKRLLKDGVVLGVVLFLAYAFQTVALEYSKATIVGFLTGLNVIITPFLSALLIKKIPRIYSQIGAVFAFIGMTMMSLNENLSLSYGDILGVICAVFVAIQIVLTDKYSRRNDTYLLTVVEISILAILSSIISITTETHIIPQHFSWYLVFSFLITAVFATVYAFIVQNTAQKYTTPTKTAIIFIMEPVFAAVFGYFLGGEVLSFRAYVGAFVMFIGLFISEIGPLVFKK
>fig|760192.3.peg.149 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQLIIYLTFNGNCREAMSFYQACLGGELEFQTIGESPMAEQLPEKIKDFILHATLRNEHLLLMGTDMVGEQGLVKGNAMSILIECQNEAEIQVYYQLLSRGGRTTHPIESTFWGALFGGLTDKYGNNWLLHCAKNQRLTQVEAAN
>fig|760192.3.peg.1146 Glyoxalase/bleomycin resistance protein/dioxygenase
MDNSVNTLNWFEISVSDMSRAKSFYQTVFSIEMDQQEMMGMQMAMFPYNPMSGKVAGALVQSEMHKPSTDGAVIYLNGNPDLSVALGKVESAGGQVVMPKTHIDEDTGYMAFFIDTEGNKVGLHSNK
>fig|760192.3.peg.1307 Multiple antibiotic resistance (MarC)-like protein
MIELFFAVLGALFSVVNPLGAVPVFLAMTPDYTVPERNSTARSTGVYFTLILLGFFFAGTQILEFFGIHISAMRIAGGVMILSSGYGLISGKFAENRAINKEVEEEALKRQDISFAPLAMPLLSGPGSISYLITQYNENPSWEAHLVVAAVIVLLGFLVYLILRSARYLYTILGEAGLKALSRVMGFIVMSLGVQYMIAGVIQLVGEMK
>fig|760192.3.peg.2381 Glyoxalase/bleomycin resistance protein/dioxygenase
MAKAIGINHVALVVSNLEAACEFYEKELGLEVIPAFLFDYPTAFFKINETQQLHLTEWDDVFSFRGHVCMQVDDINAIFWRMKELGVVDTSPWGKVRQLPDGPIQMFVRDPSGNLLELSCKPGSEIDPAIFEDELFQAGIYVSGRNDFRGYKSKDATLYHN
>fig|760192.3.peg.2537 Glyoxalase/bleomycin resistance protein/dioxygenase
MIIEHVAIWTAQLEALKDYYIQYFGAQANDKYTNVQKQFQSYFLSFASGARLELMSRPDIPANANDPISAQYLGLIHLAFGVDTMAEVEAKAAELRAAGFPILSGPRKTGDGYYEFETLDPDNNRLEVSAVAE
>fig|760192.3.peg.2539 
MKTENNNHLPALADTPEPPYYAVIFSTTRTEGDHGYGEMAEKMAALAATMPGYLGAESTRNEIGITVSYWKDLESIKNWKYNLEHVVARDLGREVWYQSYRLRIARVERDYGFEKK
>fig|760192.3.peg.2699 Glyoxalase/bleomycin resistance protein/dioxygenase
MKPIWIEIPTTDIQRAKTFYESVFDEKLQLLDMGEFKMAIFTSGGFALCQLKDVYRPSTEGPLIYLNGNPDLNTILEKVAPAGGEILIEKRQISEEQGYMAVFTDTEGNRLGLRSKN
>fig|760192.3.peg.3041 Acriflavin resistance protein
MTHSLSPVRILIFFTALALPALFILPYLQVNLLPAEPNTELQIRIQVPNTPPFGVERSTVSQLENALSAIRGLKNIRSESRYAEGSIYLEFGRKEDMAARRFEVATVLRSIYPKLPTGASYPTLSGGNDVAQEDKGPSLLYTVEGPGDVAAVRQRCETFFRQVLHQVEQVSNLEFQGGQEERMVIEFDPQLLKIHQVDPHELEQVLHRANGSYFPGSSEDAWGRKLFVRSIPADISLSTIENTLIKTEGGYPLRIKSVARVYQDRETPSSYYRINGKNAVSVFVFLSPDCNKVYEAVRIQQLITRAAAQQQDLHVRLAEDKTTFVRVELQKSWLRASASLLILLLLLLLTYRNWRLVLILLFCLMINLAITVLTSWAFQVEWHTYTLAGLSVAFGLMIDNAIVMLDAYRRRLNRRIFTALLAATLTTAAALLLVFFLPIEEQRNLVDFSIIIVISLISSLFTVLFLVPACYDLWIGAPALKSSNALKVAQKRRIFFRLAVYKSAIEFFSRWRLLFYVAGVLLFGLPVFLLPLETQSRQWHLQWLNSPNFQREVRPHLEFWLGGTLRLFVDTFNAESYYRQAEATALYVRAELPHGHTLAQMNTLMHHFERFLSQQNGLEVFGTSVNSGQYGDIEIHFTSDAEKTSLPLSLQARLQELAQGFSGVQWSIYGKGEGFSNNLFMDNQASSRLILRGYDYQELGRQAEKLGQLLAQNMRVQSIELDQNLNYFDRPLPEMYLSLDASKVAARHTNTGDLLNALNQMASPISFSLSSEKTSSEGLIKAQNTAQFDVYHLLHDPLSPSPKSNLHIQELGKMELRQSSSSIQRENRQYLRLVTFDYVGSYDLARQLNEQVIRKMNREMPLGYSVEGEQGSVSAATKRQFYLLLILLALNFFICAILFERLRQPFFILLTVPISFIGVFLSFAWGEFTFDQGGFAAFVMLGGIVVNAAIFIINDLNNAKGQVHNFQNTLIKVLYRRSGTILLTIVSTICGFVPFLYEGPETPFWFALAIGTIGGLMASILAVFLVLPVLLWKKKKLL
>fig|760192.3.peg.3043 Acriflavin resistance protein
MIHYLLQRPIAVLLSFIVLCIFGLIALNLLPISLLPDVDVPQIVVKVSYPNTAAEALEARIIRPLRETLTGIPGLKDIESRSSNHRGIIYLAFEYNTKMDLAYIEVNERIDRLSAQFPRDMPRPQTTRINTSDIPIVRLQVTPKIQEDFVQISDLVDKLIKRRLEQLEGISIVDINGLQQTNIAIEPHREVLQALHVSENDLAQTIQAANLDFGGLSVRDGNYQYFVKVSNGFESIADIGRLPVPTTSGLSVPLAKLATIRSIAEPPSGYHLFNGQPALGITIQKQAASRMNELVPRIQNLVKQFEKDYPQANFALTQDQTYLLNAGINNLYQDLMYGGILAVLVLFLFLGNYASSGLMSLNIPISLIITFALFYVLGISLNIISLSGLALGIGMLIDNSIIVLDSITRKRREGMAMLASCERGISEVVTPVLSQVLTTVAVYAPLILLPGLAGLLVYDQAIALTISLGVSLVVAFILSPLLYKLFLGNKPQSIKEDTRFYLWILAGYHRMIQFIFQRKILFFSITCLFGLLAFWLFPKIPIANLPKVEKRETLVKIDWQTPLSVEENVQRVQKLDRVLASSAVSREAEVGIPQFLLASADQSIQQAQVYYACKNQSEKESLDQKAKAWLQKTYPGASFQFEDASNAFTQLFNASNPYFEIRLRPANGHYNAAILEGLKASMPSFPLPNPQLGLGIAKEPSIKLLVDAEKMALYGVDWNNLQEKFRLLFGHYPITELRKFSGAQQMHFTSEKGKIDDLLQQGITTSHGNTLPIAAFVKYELDEMPKYITADKSGKYVALSLDENSPQIAQAKTKILHWANQHGFTAGFSGNYFEGLQNSHALFKIFLISLLLLYFILALQFENLIQPLLVMLTIPLGVTGALLLLYLQQGALDIMAAIGFVVVLGIIVDDPILKVEVINRLLKLYESSGMSRRQALEKAIHDAGDISLKPLLMTSLTTSLALVPVLFTPGIGSDLQKPMVFVIIGGLTIGTFFTTWFIPLAYWFITKKK
>fig|760192.3.peg.3236 Permease of the drug/metabolite transporter (DMT) superfamily
MSATTTSSVPENIFSQRRRIIASVLVLIAALCFSAKAVLVKLAYRYEIDSISLLTLRMVFSLPFFLAIAIWAKNRAVKENRHIILSRREWFYIFILGLSGYYLASMLDFIGLAYITAGLERLILFLYPTMVLGMNVLFFKKTVTRVQWIALALTYGGVALALLDRTQLGVGSNVPLGAILIFFSGFTYAIYLVGSGQYIAKVGSLRYTCLAMIAASIGVIAQHGIIYQWDLWHYPLQVYTLSIIMAIFSTVLPTFMMSEAIRIIGSGNVAIIGSIGPVVTIILGYFLLGESFGIWQLLGTILVIIGVLRISLK
>fig|760192.3.peg.3914 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQRIAHIALVVDDYDRAIAFYTQKLNFRLLEDTPLSDTKRWVMVAPQGQGECCLLLAKAANEEQASRIGNQTGGRVFLFLYTDDFWRDFRNYQDQGIRFVREPVEETYGTVAVFEDVYGNLWDLIEPR
>fig|760192.3.peg.4023 
MLKRMVKMTFQKDHIEDFLAIFEASKNLIRQFPGCRHLELLHLEGQPEVMFTFSIWEGQEALEAYRQSELFQRTWSKTKVLFAGKPEAWSMEEVAEV
>fig|760192.3.peg.4214 Glyoxalase/bleomycin resistance protein/dioxygenase
MHLKLLVIRTSSPDQLAQFYTYLGLEFEYHQHGSGPFHYACTIDGMVLEIYPLAKGQPATDPYLRLGFAVDDFETLIYKLEQLNVKFISTPAQTDFGWMCVVQDPDGRKIEMYKK
>fig|760192.3.peg.4441 Glyoxalase/bleomycin resistance protein/dioxygenase
MKAVQFRIARPTNQLEAVIEFYTKGLGLTIIGQFSAHDGYDGVMLGMPDHTHHLEFTQHMSKHPLPEPTKENLLVFYFDDHHQYLEANLHLQRLNHYPVKPENPYWIGKSETYEDPDKWRVVLFNGRFI
>fig|760192.3.peg.4477 Permease of the drug/metabolite transporter (DMT) superfamily
MRERYLIIAAFATVYLVWGSTYLVNYLAILEIPPFLMSGTRFLLAGSLLFGVAALRKIPWPQTIHWKSAAWAGLMFMALGTGLVVWAEQWVDSGMAALLVSFEPLVVVMLLWFMRGQSPKLHSLLGVALGVLGMFLLVGQPQISADRQTLIGVGVIALSLFAWGYASIYIGQANLPKSKMQSAGMQMMCGGICLLIMSLIFGDYKQFAWERLTPQGIFSFFYLVVLGSLLAFSAFNYLLTKVSPEKVATTNYVNPVVAMFLGWSLNNEEVTTRSLIAAAIMLTGVFFINGKFGQKKLI
>fig|760192.3.peg.5518 Glyoxalase/bleomycin resistance protein/dioxygenase
MDTKQLIKGIHHVTATVNDAQEDYHFYTRTLGMRLVKKTVNFDNIRVYHFYYADRMGTPGTIFTTFPYKGQPKVKTGEEGTGMIIATALSVPSSALAFWDQRLREKGTKVTHGERFGQPYLWFRDPADLQIELIGDSTDTRAAWLNSEEPAITEATAIRGIHHVTLSIAPEHWDKMIEFLSTDMNMSIAAQENNRIRFDVNGGGAGNYLEIRKDAHAQPGKNGIGTVHHVAWKVTDDEALMAMHARVTELGFAPTEMKDRKYFHSIYFKPYAGMWFEIATMQPGFAIDEPEAELGNKLLLPEWEEVKRAEIEAALPQLS
>fig|760192.3.peg.5780 Glyoxalase/bleomycin resistance protein/dioxygenase
MASVSTYLNFPGNTEVAFNFYKSVFGTEFSSDGIVRFSSVPPQEGTPPMAEEDLNLVMHVALPIMGGHSIMGTDATESMGFKVQFGNNSYICLSPDTKVETKRLFDALSVGGKVEMELQEMFWGSLFGSFTDQFGVQWMFDCVEQA
>fig|76114.4.peg.695 Drug resistance transporter Bcr/CflA subfamily
MNGSSPRFARAPRPAPAETRVAAVLLPGRTRPAHLLWLITGFWMLQPLSTDLYLASLPELASYFHASPALVQQTLSMFALGVAVSQLVSGPLSDRFGRRPILLAGVLVYAAASLACTLATRIDALLIGRFMQAAGSCTVAVIARAVVRDTYPIGEGAHVIARSTSILAVALLLAPVVGAQLQASFGWRANFALLTLGGAALGLASVLRFAETIARRNPAAMRPATLLGNYGALLRSPAFWAYALPGSLSFGMVFVYISGASFALIDVLHVPTRYFGYCFALGVLGYLFGTQACRRLLRHYGLSRTLRVGSTLGLAAGTTFAAGLALDLQHWATVVVAHFLVTLAHGINSPCAQSGAVAPFPEKAGAAAALLGSLTMLCAFSVATLLGATYDGTLQPLATLSALLAIALFVAERALAAHRLRDKALS
>fig|761193.3.peg.280 Glyoxalase/bleomycin resistance protein/dioxygenase
MNAIQWFEIPALDLERAFTFYSEILHGNVRKGTFGDGELILFNVPFNTGEAVGGSIVARPDLIPTTEGPILYLNTFGKLSEAVNKVENAGGKVLVPRLDLGKFGFSAIIIDSEGNRIGLLSNEP
>fig|761193.3.peg.554 Multidrug resistance transporter, Bcr/CflA family
MTKKQERTIILLLGALQGIGPFSTDMYLAAFPSIAADLKVSIAQVAYSMSSYFVGICLGQLLNGPLIDRFGRKVPLLLMLGVYTLASVGCTMVTSVEGLIMLRFFQAIGGSMGMVANRAIVRDVFPADRLAHVFSTMTLVMGVAPIIAPTVGGFVVVSFGWRAIFWVLAGFAFFVTLLVYFLLSESKGKDRSISLKPQAVMADFYSILRNPSFLAYTIVGAMNTAGIFTFISNAPFVYMELLGVSEQTFGWIFGLNAVFFVVGSQLNRWLLKYYSSQTVALYGLLVQAVMGVALVACVILNQLSIPILVALVGFYSLCLGMIGANAIALAIRPFTKNTGSATALMGSFQMGAGAVASAVCSYFYDGTAKPMVIVMTGVAFIGLLAIWAGSYRKPVTA
>fig|761193.3.peg.3398 Acriflavin resistance protein
MKGIYPLLLGFAVLSLVGLLLVPRLSVQLAPSGGGQNITVSYAWAGASPLMLEAQVTALLEGTFSTVQGVKKVSSVSGYGYGYVSLELDKNADADALRLEVASLVRQVYKRLPTEMSYPQVALNTPNQQERQKPLLTLQLDGPAAAAALLRYAEEQLKPALAQVRGVYQVEVSGGNRQEWVIAYDIDALKNLQLSENQIITTIQQHFRQEALGSLTQPNGQRLLVSLNTPFSAWKGARGEVKTPPLQMERGAGGEVLAAIPIANLSGRIVRLGEIATITRQEQPATTFYRVNGQNALNMTLSAAAGANQLKVAQEVRKRITTLQQQLPAGYQLRTEYDATQYIEENLQRIGIQSGFAVLILFLFVLLTTRSWRYMALIGVSMAVCLLLSVILFYVFKVEIHLYSLAALTTSLGIIIDNVIVMIEHYRRYRNLRVFSALLGATLTTCAGLAVIWFLPDEARVDLLDFAVVMVITLGVSLAVAVGFVPALMGITLRSKAQKATPNKRVDMFYKTDYKSASDSVRITNPDEQKLIVPASSFRKGCWGSTPFGEAFYRAILHLLVRFRKTVILAGVLLFGTPIFLLPNQLEKENPLAAYYNPLFGNEWFNDELRPVLNKWLGGTLRLFVNYVYEGAYFGKPERTALYVVAELPNNSTIAQMNLVFERLEKEMSSYPEIDRFMTQIYNGQQGSMVVYFKKSHEDGSFPYQLKNRTIALSTEMSGISWNIYGVGQGFSQSLEENQTPSFNVRMLGYNYQQLEDQATRLKTLLEAHPRIQEVNINRGMGMFSNKNLYEYALQTQTGALALRNTTLSGIYEGLHQRSKRSNADIYTFMTGQYESIQVLPTQSQHFDVYQLNNQPLQSDLVTYKLNSLAKITKEKVIPEIFKEDQQYVRMVSFEYFGSGHFGDKFLTKTLDEFRPTLPVGYTAKKSEYNWFSEETRTQYELIGLVMVLIYIVCAVIFESLVQPLALIGMIPLSYVGVFLAFYWFDYNFDQGGYASFVLLAGNVVCAGIFIIAEWNILRKTDPKSPPFALYLRAFQHKIRPILLTVLSTVVGLVPFLLYENEPFWFALGVGTIGGLLMSLLILVFFLPVFLMNKREFITNDYLYT
>fig|761193.3.peg.3412 Acriflavin resistance protein
MTRFLLHRPVAVLITALALSVLGVVVFRLLPVSLLPDIPVPEITVQVSYPNAAARELQQAVVLPLKNQLLQVNHLEDIEATTQDGFSVLKLRFDFGTDVRLAYLETNEKIDGILSQFPRDMERPKVIKAGAGDIAVFQLNVSPKRNQTLRGEVELSDFCQNVLKRRIEQLPEVALVDATGLALPEVVVSADRNKMQSLGISENQIAELLRQNNVNLGNVVVKDGQYQYNIRFSSVLRTPQDIESITFWVGGSGRSVGTQNSEGERAVRTQPLAGIQNSAANERPTLATGRLMRLGELVKVSIQEQQQRGLYTFNGQRAVGLAIIKQSDAQLLQMRTQLDQLLTQFRNDYPELAFTLSQDQTELLDVSINNLVSNILTGALLTFVMIFFFLPNPRVPVLIGIVIPVSLSITFLGFYLLGLSINIVSLAGLVLGIGEIIDSAIILIENIEEKREKGLSLDEACVEGTEEVIRPLFTSVLTNSAVFLPLVFLSGLAGALFFDQAVSVSLALAVSLLTSYTLIPVLYRLAFLKSKKEGPQMAKETWLMRRIEKVYNRTFDVAFRFRKGAWVLVVALLGSAVWAVQGLEKRGMPAISRSELEVKIDWNEPLSVSQNEQRIAQLLKTLSPAPLYVSAYVGQQQFVLNQQLQQSFSQATLSLKVADHPSYQRLSSQFSTKIRQAYPNAVVEVRPARNVFEQLFGTQQPPLQIRLFSTQNQDVPTPQQATETLRRLEEKGFKTNPIGYQKRLAVSLREEQLLLYGVTAEQTYQSLKTLFNENQIGQLQSEQKFVPIVLATQHPTGVQSVLQTAFVPNRQNQLIPLRELVEMHSIDDYRLFHTGKDGAYLPVDLEVENKQTAAFLPEIEKILKQDATLNYRLVGDYFRNIGYLEELAWVLLIAVALLFCILTAQFESLLQPLIVMLTALLGIAGALLTLVLFGESLNALSVIGLVVLIGLIDNDSILKIDTMNRERERLGIIEAIRLSGKRRLKSQLMTYLTTILGLLPVLFSGGLGAELQRPLAFTVIGGMTVGVIASWTLIPLLYYWIARPKRQ
>fig|761193.3.peg.3939 Glyoxalase/bleomycin resistance protein/dioxygenase
MIIQELTLLTDNLIETEQFYTERLGLSLTTKETNGITFQAGETLLRFKKSRIHRHPRYHFAFNIPYNAVLDAFASMSSTLNILPVSATTNIADFANWNAKAFYFYDNNGNIVEYIGRFDLGRHDPPTFTPSAIQSVSEMGLPVKNVKEECEKLMARGGLSYFVKQPPCETFSVLGDDSGLLIMVPIGRNWYPTADLASEAHPVKMRISHAGRTIDINL
>fig|761193.3.peg.4017 Glyoxalase/bleomycin resistance protein/dioxygenase
MTDIERAIKFYNAVFHFNFDKENIDDNEMALFPFADENSGISGALAKGEIYKPTKDGVVIYFKTENIDETLKLATSNGGQVLYPKTDNGIGFVAEFEDTEGNRIALYQTK
>fig|761193.3.peg.4824 Glyoxalase/bleomycin resistance protein/dioxygenase
MERSINFYKTIVGLTSLVRPAFDFPGAWFRLGTTQELHLIGIRTEVVVSGSRSNHFALEVDDLDAWEAHFKANAATYRPPKFRPDGVRQLFLQDPDGYWIEFFSVKGNQPA
>fig|761193.3.peg.4995 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQTITQKDKAPGGLRATFLGVDHPAVAADDVQALSDWYCDVLGYERWFLHQKAKTVWMLKAPDDTLLEIMPKDDTLRHNRTTWTPGWSHLALRVSDIEAAIAFLEQFGVIWGGDLTNAIGGGRVRNFFDPEGNMLQLLQRTASLPPLGE
>fig|761193.3.peg.5625 Glyoxalase/bleomycin resistance protein/dioxygenase
MKSTFKNVWPYQKDPLNLSVAKIEGAIPFYETVMGFQVVSRSEAPVKSAVLERDGIQIGLAENGGDPTQDGCFFEVDNADNAFAELRANGLAQEEPNFTFQSYGPTYKVFFVVAPDGLCYCLGERQ
>fig|761193.3.peg.6219 Acriflavin resistance protein
MTLTELAIKRPSLLIVLFLVLALGGIMSYNRLGYEILPRFTPQLLTITTVYPGAAPNEIESQVTKKIEDQLSNQNGIVSINSSSFEGLSLVSLELSNDASLKAVKQDVIAKINSLQSLLPNDAQTPTVSELSFNDLPVLRISATADLTATQFFSELKNRIIPQLSQLDGVGSVELLGGEEREIRVNINQDKISAYGISILQVNQAINNANLDFPTGKIEAGKTQTVIRLTGKFNKIEQLKDLIVATSRMGGTIKLQDIAEVIDSKKDIRNINRLNGKEAVGVQVRKRTDANSVAVSKAVRDKIAELENKYSNINLKFVVAIDTSSFSLEAAEAVQHDLLIAILLVALVMLIFLHSIRNSFIVMVAVPCSLVTAFIIMYLAGYTFNLMTLLAMSLVIGILVDDSIVVLENIYRHLEMGKDARTAAIDGRNEIGFTALSITLVDVVVFVPFLLLTNTTGKLLAPFAAVVVVSTLMSLFVSFTVTPWLASRFAKAEDVKTKKGVWGRFVRSLEIGIEHLSHFYAAALSRCLQHKTITILFIVAMIMGAGQLVRFGFIGDEFVKQGDQREFIIKLEYDKSITFQQNNLTTKQVEDFLREKPYVKSVFANVGGSSDLINLGNSNNQSEINVKIYPNEIVEKATDQAATECQMALQRQFPQIKITSAKPSFLGGNEDDPIEIIFSGENPDSVLAVVKSVEKTVRKIPGAIDTKVSIKEGFPEVNVSLDRDKMAKLGLDINLVGATMQSALAGNDKAKFRDGFDEYDIKVQLDKFDRRNEADVAALSFINNKGQTIRLDQFASLSYGISASKLERKNRRSSVTFKSQVLGTPSGNVADAIQAEMDKMNLPKNIEYSWAGEIKRSKDSTDTLLAVLGIAIILIYLIMVALYDSFIYPFVVLFSIPVALIGALLALALAKSSFSLFTGLGIIMMLGLVAKNGILIVDFTNQLKEKGLNTIDALMESGKTRLRPILMTTLALVFGMIPIAIAKGAGAEWKNGLGWVLIGGLTSSMLLTLIIVPVVYLTVDNIKAWFGKLGANKKKIERMSVAK
>fig|762948.4.peg.824 Quinolone resistance protein NorA
MALAMIAAGFDFYVPVSAFFLESRGLSLTDIFMLESVLVASILVAEIPAGIIGDRFDRRRLVCAGFVFNAIAEILFAAGTNFSIYALSFVMSGLSIAMLTGVQDAYIYDSLGDDADAKAVGAWGHLSALMLTAGVTGSVVGSALGSVDISLPALLSAAMAVVAAVCVAFLPQQNPKTHDKHPETSWVSLKIGVKLLFTSPLLLYVAVGSSASFALFNAVYTLNQPLFAAQDVPIATWGVIAGAGQLLAAGYNYAAGRIEKRVGRKTALLLAMGYGAAGFCLMAVPHVLAVVSGFLLVVVGIHARGPITSAVTNKLIPAHRRATVLNVASSVGSLVGIVVNPLVGLGAETSTRLTVLAIGGVLLALTLTWIPIANRYLEADEDADMSEAHVS
>fig|762948.4.peg.827 Glycopeptide antibiotics resistance protein
MLQTPGTGGATSRAFAQLFFNIGLFIPIGLFTAGCLRWGLRASALAGFGLSLFIELSQLSGNWGLVPCAYRTFDVDDIINNTVGALIGALLVLVWRRIRRRMRYRHLPDHIG
>fig|762948.4.peg.1086 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIHKPTHALPENTGAADKPNAAAKLGTVAPSEANPPVTGAVPAVIGTVPSTTGAIPAVPAPDAGPGMPNMDDPKNIYLLKDAPVFKALLSLGIPMAAGLAITSIYNVINSYFVGHYGTVEELAATGYGVPVFGIIMAIAGVFGLGSSTLASRLLGEGNKARIRNVTSFALYSALACGVVVAIAGFLFADPITGLMGASGSSFEPTKTFVHLLFLGAPFSVGLFTLEQLVRSEGYAKQSMYGIIWGVVINSIFDVLLIAVLGWGIAGAGWAMLAANAASMVYYLQFLIRKSPNFSWKPSDFVIAGDIIKPVFAVGAAELIQSANLTVSALVLNNIAAGYGDDSVAAFGLAMRLNMVPEMLCMGICMGGIPLFAYAYGARNRDRVRSALKTAAMVSVATSIIFTTPVLIFRRQLLELVGDSSLVATGEKVLVALMLAAVFNAVSIVFVSWFQAAGKGLPATLMTLGIALLFFPAVIFGNMWFGFDGLTWAFPFTQISACVLGVILFFATGGTKVKDAPASGTPEHGVTEIKVESE
>fig|762948.4.peg.1287 Multidrug resistance transporter, Bcr/CflA family
MSSSQTTSQQGHEHPDHVKVSFGIPAPVIVTLAALTAIAPLGIDMYLASLPTVARELNTTDAAASMTLSAFMIGMALGQLIIGPLSDKTGRRTPLLIGSAVCFAATALCAFSPTIEVFIAARFLMGFSGSVGAVLARSIVADTTKGLTTAKLMGIMMMINGFAPVLAPLFGGWVLSWGTWRSVFNVLTVITGALMLAVIFILRETLPAEKRYQGTALSVYSEIPKVFRIRRYMGFSLTMCFAFGALFSYISGSTFVLQKILGLDAGQYTLAFGVNSLGIVAMSSLATALVGKVAQRTIVNVGVSALLVVSVLLTGSFLIGISLWPTLVLLFCLTCSVGLIFGNASALALNEARHMAGSASAVMGTIQALLGGVAAPLVSLGGEGAYLPMAFSILGFAVLTGITLFSTPRKDSDYAADGGAGGH
>fig|762948.4.peg.1443 Vancomycin B-type resistance protein VanW
MKFARKATTAVGLALTLGLSGLAPVGPVAYAAEDASVHDGSSSDKAAASCYEAKQVNKDAKSGKYWLYTPSMSAPQQFYCDQETDGGGWVLIGRGRDGWTENYHGRGAASKLYTSPEGDDAMTPVQLPSTTVDELLNGQKPQDLEDGVRFRRALNTDGTEWQNITAHRDQTERWTWALRSNNIWSNIDVSADNPQYMQRDRTHFDKTEGHIQQNGTYSVLNFDEQREQGWKLGFSYSRDVRANGNRNESASNSYLYRPSGSNATPFAFTQVYLRPKLTQQNMGAQAIGDNGTAASNRRALPKSGSMPWKWRTSDKSGTGNVNEMNTYVQAITQVGDTVFTGGDFAYLESAAGAHVDQSYLAGFNVNTGELVQTFKPKFNGQIKSLEALPNNKLAVGGEFTEVNGEKVPGFAVLDPATGQLDRELNLQVENNVSGSALSVKTLQAQGDYLYLGGTFTHLKSSGTPNKVYSRNAARVKISTNQVDRTWTPRFNGTVNGMSASADNSEVFAAGYFTEMNDQRAFRVARILDSAKKVGTWEVTPSYLPDAQTREKRVWGFHFDVQDAGSSVWLGGTEHMISQYTKNEPMTRLSSSITRNGGDFQDLHLNGNNIYGACHCGDFLYQGSGTHDYAWRGSTVTDSIRLVAAFDKDSGKTLPEFAPTLKGKSGHGIWESFVDSNGVLWVGGDLNRSLGENGVQQESVGFVRYAPRDVTPPPAPSNLTVTQSGDNDQLNWSASGEAGARYHVLRNDRVIATVNGTSYRVKHTDNARYFVRAADANGNYSASTSVAVSGKKAEQPKQENPKQENPQPQPENPKQEDPKQEDPKQEQPKQEQPKQENPKQEQPKQDDPKQDNPKQEDPKQEQPKQDDPKQDDNKNIVKPQPENPIQDDPKQEQPKQDNPPKQEDPKQDEQPQPENPATDDQVQPADPNDDLKPNEPKQQENPKQEQPKQEDPKQDNPKQEQPKQEDPKQEQKPQGDQVLVDSGSSWVYRVGSDRAESEWKTRSWLGGAWSRGKAPLGAGSVNVETEVNTFFGTPMSIYARKDVTLTKEQAQQYLKLTTYADDGTVVYVNGKEVARKNMPQGRISANTPATQRPESQNAQLFSVDVPAEYLREGRNAIAVEVHANSHWSNNISFDMQVISTAQHQNPLPEVQNQEDNGQQHRPQVWYWYYPEYYGNYGNGDYYGRRNQRVAYNYDHRGFGYMGGFGYAHGFFGRAFYDYGFGW
>fig|765420.3.peg.1215 Daunorubicin resistance ABC transporter ATP-binding subunit
MTEMAIEARGLVKRYAEVTAVDGIDLQVPAGMIYAMLGPNGAGKTTTISMLTTLVRPTAGAGRVAGYDLLREAPQVRTRIGVTFQDIVLDNDLTGRQVLDIHGQLYRQPADLRRKRIADLVDLVQLGDAIDRLVKTYSGGMKRRLELARGLMTDPAILFLDEPTQGLDPQNRTGIWGYLRELNRQRGLTVLLTTHYMEEAEALASQVGIVDHGKLVSQGQPTELVAAMGADVIRVRGHGDSAAFLNQVAGLPFVERVETDRASGHLSLYVDQGSRRLVEIIAANTNGYQIEDVTIARPTLADVFLHHTGHALRDE
>fig|765420.3.peg.2000 Permease of the drug/metabolite transporter (DMT) superfamily
MSQQLKGYITALIGIIVWSTTGIFMSHLITVYHIPAFVLALWRNLLVCIVLFPILLFMNRTLLRIKRNDLSLYHWYGFVLALLNTLWALSVQANGAAVATVLVYSSAGFTAIFAIWVFKERLGIIKGIAILLSLTGCVMVSNAYDGAVWSLNPLGVITGILSGVVFAIYTLMGKETARRGINTWNALFYSFTLGSIWITLFNLWPGMPGSTGSYMRLWPELPLNGWLILFMLSFVPTLLGFGLYNTSMNYLSASIANLLATLEPAMTAVQAYIFLDERMSVVQIIGSCIIILAVFVVQVEKEPKLEHKQQPA
>fig|765420.3.peg.2346 Multidrug resistance efflux pump-like protein
MSTSATPTPSVPNGATSVPVVGGTLRAEAKVVPLRSASLSMPVGGVVAEVLVSEGATVQADQPLIRIERSRLEAALAQAQAEVQVAQASYDRLLAGATPEQIAAAEAQLAQARAGLRQVSGGVTPSDIAAAQAQLAQAQAALAQLQQGPEDADLRQAQAQLAQAQANAQNQRDSFVAAKLRAESQLEQAANALRTAQDTYSRIYWENQEIGADDLTQAQKDAETAALRAVEDAEQALAQAQIALQNAQDAERSGTEVAEAQVRDAQARLDKLLTPAAADKLAAARAQVSQAEANLNRLRGEQRAGSLAAARAQIDQAEANLAGLRAGTSEGDLNVAAAQIQRAEAALNLAQVALAETELRAPFAGTIASITPAPGEYVSMGTPLITLADLSAWQIETTDLTEQDIARVHEGDQVLITLDALPDLELQGVVSHIRLVGENKQGDITYTVTITPETQDSRLRWNMTASVRFVE
>fig|765420.3.peg.2482 Permease of the drug/metabolite transporter (DMT) superfamily
MISSKPTTKAAPNQGMAFIIAAALIWGTIGASVRLLYTQAPADPLGVGFLRLLIAAPALILLGWAMVGPHFWRVQRRDLWVVALMGSTFAGYQVSYFAAIAHIGVAAAVMINICSAPIFTAILARIFLGEALSRMTLLALVGAVLGTAMLVGGVPQQGTLNVLLTGAALALTAGFSYSIVVLTGRVLAPRYHPIQPITLAFTLGAVLLAPVVALSGNLYLDYTAWGWGILIYLGVVPTAIAYVLYLHGMRTTSATITAILTLLEPLGSTLLAILFLGERLAPFGMVGMMLLLGSMGLLYKKA
>fig|765912.4.peg.2106 Acriflavin resistance protein
MRFLVGWDEEQAIVQLYQKLYANLDRIPAGASRLLLKPRRIDDVPILALTFHGGGLDGYSLQRIAAEVDEVVKRIRDVSETTLIGGERRQVRVEPDASLLTAYGQDPSHVLKILRAANRQERAGSFPLDEQETLVETGGFLRDAAEVPPGPPVLQTLVAEVYGPDYAEQIAIAREIERLFEEIPGVVDVDSHIEADQPLLRFCFDQEKAARNGISAAQVSQVVEIAEKGASAGLLHVDAEREDVLIPVRLPIGQRAQSGEQRPIPVCVGERCVPLGEVTRIEADVGEKSICHKNQLPVVYVTGDVAGAEESPVYAILKLN
>fig|767100.3.peg.1 5-nitroimidazole antibiotic resistance protein NimB family protein
MSYAYCNDVIYIHCTNQGGHKLKNIEENSKISFTVVDKVERLPNQFSTKYMSVIVFGRISIVDDEEKIRVFSQSCLNILLIL
>fig|767100.3.peg.46 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKINLLDNRIYRNLVMMSIPIMTTSFIQMSYTLMDTFWVGKLGTEAIAGVGIVSFIMWFANSLVLVSKTGIEIGVAYSVGSRDDKQFRKYIDTSVAINLFMSITFGLLVYFFRLDIIKFFNIKSELVISLANSYLKIVILGLPFTFLNPLFSGVFNGSANSKVPFIANSIGLIINIVLDPILIYGYFGLPEFGVSGAAIATTLSQIIVTFIFIIFSILDGKILKGINLVKNFNNATFKEVLRLGVPNAFKSCIFAFISTILLRIIANWGENAVAAENVAVQIEAINWMTVEGFSIALCALIAQNFGAKNYDNIASGYKKGLKIILWIGVFCSFFLFFSSDYIIRLFIRDDVDTIRMGVSYLKVLAFSEIFLALEIGISGMFNGLKNTKTPTIISTFSNALRIPLAYLVLLLKLDITYIWAVISFCTFLKGILNYIFFKKFIRENFDFKL
>fig|767100.3.peg.314 Vancomycin B-type resistance protein VanW
MDGKVGLKVESEKILDNFNTVPVKFDLEIPTIVTEYKKIDKTLLSSIKGVIGEATTKFDNQPNRNNNIKIAANKINEFVVNPGETFSFSKELGEVSKNTGYKPAGTFINSKIVDSIGGGICQVSSTLYQALVKSDLKIVERNQHSMRVPYCTIGLDAMYYEGSSDLKFQNTFDFPIVITSYVSNGEITFRILGDTDKKNYDIKLFTTDVSRIPMPIEEVPDPSLPEGKKVVVEKGFPGYRGSSYKQKGNEKAELLNSDYYKPKKQIVKVGTKKEVKETIEKEKND
>fig|767100.3.peg.532 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MMGATGDLAKYSIIYLKYSYLGIPFIFLYYIYSSILSAQGKNTIPTMISTICVILNMILNPIFIFDIIPFTSISGFGLGVKGAAVATVLTQGIMCIVGFIHLRINKDIIKLNLNSLVYIKWEKHILKRIYRITLPSVIGQVGTAIGFMIMNSFIQSYGTETVAAYGMVNRISGLLNIPPGGVGSAITSIIGQNIGNNNIKRVKETFKKASIIIIIMSIIIAIISFIFRYEILSFFISAPKDSVLMVQANSYMFYTLITLVMLNMFFVYQGLFQGSGNSKYSMAIDMIRLWIIRLPLILFFKNFTSYGATGIWLAMAISNVLVSMIAHAIYLKGGWQQGSFYR
>fig|767100.3.peg.861 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDTKSIYYETNIVKAILHFAIPGILSILIAELYNMVDTFFVGRYVGADSIGALSVVFPLQRLVIAISVCLGIGVSNLISRRLGEKRNKDITKYTTAVNGLTLLIIFAVTIISILFVEDICMFLGARNDILIYSIKYLRIVMFGSIFLAFTTVFGYMNIAYGNMKVMLIASSIGALINIFVDYILIKNLNMAVEGAAIATISSQFISFLFSLIFVKKLQRENNFSLIPRLDFKISFNILAIGFSSFIIEFSDAILISVLNHLLLPVGGNDAIILVGVITKVSMFMFVAMIGVSSSIQPLISFNYGAKNFVKIKKILKTGFIFVFSLSTLIWIFMNYNVKFIIGLFLKDERLLQMAADSFKYVILVFPILSFYYICIYFFQSVGKEKYNFFLSIYRETLLYIPIVIIMVGRFGVLGAWISYPIVDFISAVTGLILLLKTVKKISTF
>fig|768066.3.peg.793 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARFITDLFEVSRRDTGPLIRLALPICGAQLAQAGMSVVDVMMTGRLSATDLAAVSVGSSLWMPLMLFMTGTLMGLTPVVAHLLGAQRRADIRIQVHQALWIGLALGILSAVLLWTAVMPIFAAMDVPDEVAQRSAGYLAAVGFGMPGVAIFQSLRAFSDGMNHTRPALWISLIGLAVNIPSNYVLIYGGEGLTALLGDGLPAPLQALPALGAMGCGIATALSMWVMGLSMAAYTRRSRAYGDVELWREPSPPRWRLIGELLHIGVPIGVAIFVEVTLFTLIALFVASLGEVTVAAHQVALNYTGLLFMLPLSLGMALTVRVGNTLGQARPDLARLVAWNGILIALVVALLNSLILWLTAVPVIELYTHDTAVQQLTLSLIGLAMIYQVSDSLQVSLAGALRGYKDTRVIMLITMLAYWLVGLGGGHWLGVYGLFDAVAPMGVHGYWTGLIAGLTVAAILLGERLRRRSKAVARGDEAIPDTD
>fig|768066.3.peg.2376 Glyoxalase/bleomycin resistance protein/dioxygenase
MNLLINIDVPELGPAVDFYRDALGFTLNRFLDDDVAELTGASSRLYLLKNEAGTSSSTPGSAPRHYTRHWTPIHFDVVVDDLEAAARRAEHAGALREGECREWLGSRCMTFSDPFGHGFCLIEFTNDTYA
>fig|768066.3.peg.2431 Multidrug resistance protein B
MRADSLPGISGRTWKIAAVTGAGAFMAMLDATVANLAIEAIRRDFGVSLALVQWVATGYLVALAVSLPVAGWLGRRHGYGRLWSAAMVLFVFGSVGCALAPGPWNLIGARVLQGLAAGLMVPAGQAVIGSMADSRQLGRLMGTLGLVVALGPAVGPGLGGLLLEIASWRWLFWINVPVGIAALLIARPLVPGGDTDPHSPLDGRGLLLIVAGLPALLYGAMRLGERDVEVVSLSSVTLGIVLAVVFVWHAGRQRHPLIDVRLLHGRRFAAATLTAGLAGANMYGGLLVLPLYLQTAAHQSAASTGMQLLAMGLGSALMLPVAGALTDRLDACRVAMVGAALLALATLPLALGVALTRGELAMLLVVRGAGLALAQMPAMTAAYTSVTRAQMGDATTIVNVVQRTGGALGAIAMVVLLAQAERAGESGPGSGGHGEAFLLLVLLAVAAIGSAAAIRPRRMAS
>fig|768066.3.peg.2797 Permease of the drug/metabolite transporter (DMT) superfamily
MTADRRAILYGIGAVGLWSTVATAFKVALGHMSPLTLMWIASLVSWAVIGMLVLRRGQLREALSHGWGTAAWAGLMNPVAYYLVLFAAYDRLPGQEAMALNYTWALTMAFLAVPILGQRLTRMDVLAGLIAYSGVWVIATRGRVLDVDFADPLGVGLALVSTLIWALYWLLNTRDRRSPLVAQWQNFSVGVPVLTLILLLGPEVEWVGATGLAAGIYVGLFEMGIAFVLWQLAMRTVSRTARISNLIFLSPPISLVLLFFIVGEPVLPSTLLGLVLILGGLGLQQRQKTPAEPAEAKS
>fig|768066.3.peg.2816 Bacteriocin resistance protein, putative
MNFKRMSFKRLRLFTAMVTGICISVASADMALAASMSLGNVLSDTMVRKDVQSIRERRYEDLVEQHTDFSCGAAALATVLKYAYGRAEITENDVLAGMLEVSDPEVVRQRGFSLLDLKRYVETNGYRGRGYEVDPDTLDEISIPVIVLLDLEGYKHFVVMKKARGDRVYVGDPALGNRVMSRDDFMTAWNNIIFAVVGEGYDRYTVLLDPRQPLTAHRLQDVFSPAPRDQLIDFGFRHAELF
>fig|768066.3.peg.3105 Acriflavin resistance protein
MNLSQLAHRRRPVLYLATLVAMLYGIFSYFAMPAREDPEITIREALVTTAYPGLPAEQVEQNISKPLEESIRTIGEVERIRSTSMRGRSILHVEIKDRYFNLDQIWDELRKKVEATTPQLPEGTQDPVINDDFGDVAVVTAALTADDFPQADQQEIAEHIRAALYGVEGTKKVELLGVQEQRIFIDVGEARLAELGLSPSELAGQIQSRNIYPPGGIMDSGEQRLALEVTGEFESLDALGDTEIRLPEGGTLRLRDIGELYRGYEDPADRTAYFNGKPAIVFAISMLDGESVLDYGHAIESRLDELRDTLPAGYSLDIMTFQPEQVANAVYGVTSSVMQTLVIVLAVVVLFLGLRTGLIVGSIIPAVMLVTLAIMGLTEMTLQRASLATLVIALGLLVDNAIVIAEDFKTRLEGGATRDQALAETGGELAMPLFSSTLTTILVFLPLMLAEHVAGEYTRSISIVIAITLLSSWFLSLTVTPALCHRFLKAPTAPREDAASPPLSDRLFRWMSGRYAWLLRRMLHHRTIFLIIMGLALVGGVGLMQLVPQKFFPDSDRNQVLVTIDFPSDIAANATDRRVSELSKALLEAPSLHDDLTSVAAYSGFGGPRFVLSLTPIDPAPNKGFMVLNVADRDRVDAVIHATRHYLATHHPDISPQVTRMFLGPSDSTLLQVQVKGPDREVLFDAAKRVKGILAGIDGSQDIRQSWEARIPSLTIDVDQARARSAGITSEDIARSLSAAIDGYHLSHYREGDDIIPVMMRYAERERTSIERLESLTVYPGEAADEGVPLSQVAEVRLDNGYYRIDRENLVRTITVESRNRHLTAEDMVPRVEPALRQLEDDLPPGHWIEFDGVVKESAEGQAALQANLPLCLGLIFILLVAQFNSFKRPLLIVATIPLVIVGVALGLLATRADFGFMVMLGLYSLAGIIINNAIVLIDRIDIERRALPPDLPARDAVVRASARRLRPILMSAITTILGFLPLIVGRDPLFYGMAAAMAFGLGVGTIMSLGVVPVLYTLFFGIDTADHHGGA
>fig|768066.3.peg.3689 Inner membrane component of tripartite multidrug resistance system
MLLACIGADINQEATTLALADIRGAFGYSVDQGSWFTTLYSIGAAMGMLVAPWLAMTFSVRRFAAVAAVLLGLLGLACATTESRSLLLMLRWCQGLTTGFLIPLLMMVALRFLTPALKLFGLAAYGLTATFAPNIAMPVVAWAHHGLGIGFVFWAVLPLCLTAAGLILHGLPQDPLRLERWQQFDWLGWGLGWALCASIVTLFTQGERLDWLHSPLIRGLALATLVVLPLFLWRCAFGPNPLIRPQLLGRINFGFGVCMLVGVITLSASSASLPAEFLAEVQGYRPLQSLPVTLAVALPPLLVLPFAAFVLNFERIDSRWIMASGLLLMAAASWSNSHVTLAWMREQFYIAQVVFAIGQSMVVVGLLMTATAVVDPMEGPFASATINTSRALAGPLASGLIGHYLAVAIDRHAHGLMERLGTMRFSLMQSAPLSGHGREALSWPTGGPGGGALLQLHERIDAQATVLAYADAWRLLALLALLLVPLCLLPKRTHAPRFNRPRPI
>fig|768066.3.peg.3690 Membrane fusion component of tripartite multidrug resistance system
MILVGVFLIAPALLHYDEVWTNNAKLDADYTVISPRVAGDIVAVHVEDHEAVSRGDALIDIDPRDYRATVDASEARVTSAQAKLAEIEAELARQPSQIRHAQAVVDEDIANVDYARLDADRYRRLRHNGNASQQNAQQAAANASALDARREADQASLESVRHQTQVLEARRAGAEAALAQARAELEQARLSLSHTRITAPRDGIVAQQAGRVGAWAEAGGALMAIVPTEEIYVTANYREVDITEVRVGQPVTISVDAYPGLTLEGHVDSLAPATGTTFSPISHDDASGNFTKIVQRLPVRIAIEAGQSGIDRLKVGLSVETTIHTDA
>fig|768704.3.peg.654 Permease of the drug/metabolite transporter (DMT) superfamily
MLNKSYWADLSLLLITLVWGSTFVIVKWAIVDLPPFPFLAVRFAIAFVSLLPFLWFQKKYLNWDTLLRGAAIGTFLFSGYAWQTVGLQYTTSSNAGFITGLSVVFVPTLVAVTTRKLPSRSLVLGVLFALIGLALLSLSNSFQLNNGDLMILVCAISFALHIYFVGRYAPSTNATVLASIQILTVSVLSGISSFIFPQPSINFSSTAWVGLLVTAIPATSIAFFVQSKMQQFTSSTHTALIFSMEPVFAAISAYFLAGEFLTPRGFLGAGLVLAGMLVVEFSGSKNEQLSK
>fig|768704.3.peg.2504 Vancomycin B-type resistance protein VanW
MEEDANPAELSQLQNFLKRYKPFLIILGILMTAIGLITLTLVIYTWDRGQIVRGVELEIPLEELTIEEARDKLEQQRNEYYQRSVHFIADDKNFVINMKDLGFTYDYQEPLQEAYLIGREGTILDKAVSKYKASFGIIKEPNYQWDDLILAEALTTHSSFLNMPAQDAHFLINPDNSLDIIPENQGKEVDLDSLAQIVKTQALKGDNSIVVPFKEVKPAITKKNLELVNKSDVISEYTTTFDQTLIERSLNIKLAAKAIDGKVLKPGEIFSFNNTVGPRTEEAGYQTSMIIEGNTFVPGLGGGVCQVSSTLYNAVCLAAPALSVVERSPHSLPVKYVPLGQDATVAYPNLDFKFQNLSEGYLLIRSIVNSNTLTFRIYGKPKELS
>fig|768704.3.peg.2921 Fosmidomycin resistance protein
MSNLYLIFLSIGHLVVDLGQGILPILTPVLAKSFDLSYFQVGIIALAFTFSSAIIQPIFGVLSDRYSMPWLMPVSLFLSGFGLALTGMVHSYGLLLLAVLLSGIGVAGYHPEGSKLAHFLSEDSKAGSSMAIFSVGGNLGFGLGPMLAVFVLSFAGLKSIQGVMIPGALAALLFLFLLPRYKAILAEKSHKQKKNTKQGVKSKVRIGSLILLLLYVTIRSWIQSGLVYFIPFYFPSFRGISDPEYIVSIFLIAGAVGTILGGPFADRFGGKNGLLVSMIVSLIAIYPFLHLNSTLIPVLAFIVGAALISTFSTTVVFGQRLLPNNIGLASGMLLGFGVGMGSIGVTLLGGIADHFGLPLTINIISLLPILGIILAVTLPDIRAREAVVEPNPAA
>fig|768704.3.peg.3241 Drug resistance transporter, EmrB/QacA family
MEKTTQRKMVTTAMLVSILLVAIDTTIVTTAMPHIVEQLGGLNLLSWVFAIYLLTSSVTTPIYGKLADLFGRKSIFIFGIVLFVIGSMVSGMAQTMYQLIIFRGFQGLGAGAVMPLTFTIIADLYPGEARAKMQGVFSSVWGVAGLLGPLVGGLFVDHISWRWIFYINVPIGMVAIFLVLSFLHETPLEKSKKIIDYWGAALFTLSMSSLLFALISGGQVYAWYSVEIILLFTAAITFLTAFLYVETKAQEPMLPLSLFKIPVIAVSNAVGFVASGVLIGVNVYLPIWIQTLLGHSATSSGLTLMPMSFAWPLASTLAGQFMYRIGSKATAVFGAVLIMAGSAWLLLVHTGSPYWYFVGVMVVIGFGMGFSFTPLTVLVQSAVGWNLRGAATASNTFSRSLGQTVGIAVFGTVFNNTMNQSGMAQGLHVVFILVFAISMVTLLISILLPSHRSIMAQQNAD
>fig|768704.3.peg.3806 Acriflavin resistance protein
MIEYLIKKRKITLLFFIMLVVYGFITFFQLAHQEQPDIVVDTAMVLTVYPGASPEKVEQTVTKKIEEKINEIQGLKSITSQSNPQYSKIVVQLQEGVDPKEKWNELRNKVKDVESSLPSDCKQPEINDDLSKTFIETFTVTADSYQEVYALRDTLKVWKDQLRTLPNVADVSIMGLPDQEIRIDVDTHKINQLEIPWTQVAGAIKKENERTPLGDLEQGDRLYQLKIKDTHDPEALYNTVISMNNQGVPVYLRDVATITVACEKEESLVSFNGQPAISISVQGEIGSDVPGMQKNVDEMMKELEKQLPSGAQLNHVYSQNERIEDLFSDLTLEVLLAVAAVLLVCSLGLNFVTSCIIAMAIPISLSMGLMLTPNLNITMNLVSVAALIIVLGILVDDAVVVNDNIERRLIELGEPPLQAVVKGTNEVFISILTATAATIFAFGPIAFLQGNVGQFIRPLPIIISLSMISSMAMSLTIVPIFRHWRAEKLSVFPARHSKSNGFLGKQLDRLALWYSEKLMPRILRKPLKVGLMAVLISTLAYGLFPLLPVQLFPNSVRGEMLIDVRMPKGESLDGTNQKVQEIASWVQKQEGITLVNTYAGDSAPSMFRGDLSIGKGNNLGQIVVKINTEQKRTEELVPEWNAKFSEMYPGIRVLAKEIKFGPPIGAPIDIRIYGEDLYVLQTLENEVKESLLKYPGAVNINGSIGQDKTGIELTINKAQMDQNLVKYDDLTKTLRLATEGIEVSEFDNGKDLINIVMYSDKSSPDPRLVFDRLYVPNASGKLIPLKEVAQMEPSFSINTVPRRNLSRLAEVTSDLDGVTATEAMEKIRPLMAGIKLPAGYTLEFGGETSEQTDIFTDMGRLMIVAIFLILIVIAMQFYSLSLPILVMSTVYLAFAGSMIGLLITRTPFGFGSVMGLICLVGIVVRNGIVLIEFIENERHAGVALEQAVINAGRARLKPVLLTAGTAIAGLLSLATGKELMFRALAITIIAGLFYSTVMTLVVVPSFYTVLTKWKEKRRLSRQTNNFNV
>fig|768704.3.peg.3966 Antibiotic resistance protein (antibiotic efflux protein)
MIKANPSQNEQIWSKTFFLILLVSFLMFLSMYMLLPTLPLYAQSLGGNETIAGTIVGIFTLSAVLVRPWFGNLLDYRGRKLILIIGIAIFLVSVLAYNLAYTIIFLLTIRAVHGIGWGASTTATGTMASDVIPAARRAEGMGYYGIAATIAMSLGPALGLYLVKNNSYSLLFAGSAILAGLGFIGSFFINYETSPKRQAKKKDPRVKGVILEKTAIPSALVLFFITLTYGGIVSFLPAYAGFRGVDNIGIFFTVYALVLLLGRPIIGKLSDKYGPRRFLVPGILMLVAALVLLSMASSLSMFLLVAVVYGLGFGTVQPILNALVITLSPPERRGAANATFAVAMDLGIGLGAVILGFIAQELGYVYMYGSSVIFALLALVMYFSFLRKKLPDEPRILS
>fig|768704.3.peg.4000 Permease of the drug/metabolite transporter (DMT) superfamily
MILPKKEHLRHYLTNKYWVVIIALFCAVLWGSAFPVLKVSYLELKIAPDDRSAIIVFAGIRFFLAGILIFLITMLGLGQTPKVRKTILPQLFLLGLLQISLQYFFFYNGLAHTTGMKAAILSSLSTFFVVVLAHFVYKDDRLDIRKVAGLAAGFLGIILINSGQNFTFVFSWQGEGFMILSGGVSALGTILAKRISQEVHPFVLTGWQMILGSSLLIVVGLPGLQPQAIVFSNKAILLLGYSAFLSAAAFSLWYAILKYNKAGEISVYKFMTPVSGTILSALLIPGEHLAVNMFLALALVALGIIIVNYQRKVPEENLLR
>fig|768710.3.peg.2243 Permease of the drug/metabolite transporter (DMT) superfamily
MLIKTKIARLPKHWLGVIQVTGAAILWGTSATLAKHLFNSAVSAFDVAQMRLTLSFVLLFLVLSVCKPELLRVRRSDLGYLAIFGIVGLGLLQFTYLFALSLTNVATALFLQYTAPIIILIVGLLLRTEVLTGIKLAALGASIVGGYLIVAGTASGFGLNPLGVVYGLAAACTFAFYSMYGKRGLKTYNSWTLLAWGMGFGSFVWCFYQSPWTLALRYGGLEWLQFLYIAVFATVLPFGLYIRGLQNLSAFRAGMIGMLEPVVGAISAFFFLGELLSLTQIFGSSLILLAVALLQMNALKQSRDEGYDRPENALREDGI
>fig|768710.3.peg.2577 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPAEKARNKNMTEGAIGKQLILFALPLLAGSLIQQLYNTVDLIFVGQLLGKEAAAAVGASSLLITCMVGFFTGMSVGSGIVAAKCFGVGNYRELGRIIHTGVAIGVFGGALLMAVGYIFAPVFLRWLNTPEDIFIQATGYIRIYFLSLIPLVGYNIGAGILRALGDSKSPMIYQLVGGLTNVAANALFICLLGWGVKGSALASLIAQGLAAALVFFHLSRLDEAYRLRPRQIRIDRTAGGQILAVGIPAGIQAMVITLSNLIVQYNINSLGVDSIAAFTAYFKVELFIYLPIMAYGQAATIFTGQNFGAGKLERVKRGTRVSLWAGIITTVVLSGLVLIFARQAFALFSNDAGVIELGRKLAFTTFPFYFIYLVMEVLAASIRGTGKALPPMLIILTNICILRIALLSIMTVIAPGIRGIAIVYPITWASTALCMFVYYRRMPKEV
>fig|768710.3.peg.4098 Permease of the drug/metabolite transporter (DMT) superfamily
MPTGKKQIYLILLLVVMLWGLNVIMIKYLAQLMPPILVAGLRMLLAGGFLLIFVFKTYGFYNPDRKQWRLLFLIGLISVFIHQLFLGYGVLTTSATNAALILALNPLTTALLASLFVNEKFTRNLGLGILLGFTGVVLVVFSNSSDGSVEFSLIGDILMVLAMLTYVIGALLIKKLMETSIPTVVVTAYSTLIGGILLNIGVMGSLGLSVYGQIHFSATAGLVLLLSAWGATALGTLGWNHGIKHLGANRTAMFLNGMPFASMVGGVVFLDEKIGLIHIIALMLTTLGIVIGSIKPKEVKSMYAGISPD
>fig|795359.3.peg.290 Membrane fusion component of tripartite multidrug resistance system
MIKDKKRIGFFILVALALFFLSWLIYFLWHRYHYAVTDAVFVQADNLIYVSFPKVNGKLIKLYKNEGDLVKKGEILAEIESTDYALKVAQLEKALKEVENQQSALGFNIAKLEKEIPLKVDQLTKQKDRLKEEERAKFYDIEKLKARLNQVRRDKVRYEKLYKDGLISAHELEEIQTQEKELENQISSVSAQLLAIKKQQEEIDKNIALTLNEKNTVLAYKSFLLSLEAKKKNLEKQKEEAEVYHTYTKLYSPVDGVIAKKFHSEGDVLNPGEPVYAIVDPNSFYVLVLLEETKLKGVKKGCPAKIKLDAYPDKDFEGIVDEVLPASAATFALVPRDISAGEFTKLAQRIYVKIKITKGDRSLLRVGLGGEVEIKRSL
>fig|795359.3.peg.1007 Drug resistance transporter, EmrB/QacA subfamily
MKPIEFYYQVTPLERIAITITLMIGHFLAILNTTVVNTIMPKLLGPLSTDLYGVQWVGISYMISAAITLLFVETFSRYVGYALCYTIGLILFITFSAFSGLANSLPQMIIFRSFQGVGEAFIMATAQTILLNVYPPEKRGTAMGIYSLGVSFAPALGPTVGGFLTEYISWRWAFYINVPIGILDLVAAISFLPYTLGKRKEFSFNFISYGLISLATIFLLIAVSKGQQYGWFQSTFIVSFLILSLTFYSLYFASEIMSKKPLIDFKIYTIPEFGLAMAFQFFILGFVMYQVFYLIPIYYQNLKGLTTFQAGLHMLSYASFTGIFAIISGKLSDKFSPIIILSINFLILSVTTIFLLPKLNYYTPALKAAILTIPLGIAMGCFFAPLTTLAFRNLGEKTGLGVVLFHYQRFVGGSIGIAIATNTLEKRTNYHFLRITELQEFRYINMLVEKWWYNAQKYFSEAYAFKKAKALLYKTEYIQALSFAFQDAFKQTFFWTQIGGIFLIILILYKFKILTFKSSIYNKKLIKNFR
>fig|795359.3.peg.1085 Multiple antibiotic resistance (MarC)-related protein
METGFLIKSFLTLFTIIDPIGGVPFFLSISAGYSEEERKKIALRASLTACLTLLFFLWIGKYLLSFFQISVSSFRIAGGILLFLISMEMLFGKTTQVKTTEKETLKVKEKEDVSIVPLGIPYLAGPGAITTTIILGETSTLHTKLGLSLIIFLVLLITYLIFSYSSKISKLLGELGTKAIVRILGLILASIAIEYITTGLKEIF
>fig|83332.1.peg.2335 Drug resistance transporter, EmrB/QacA subfamily
MNRTQLLTLIATGLGLFMIFLDALIVNVALPDIQRSFAVGEDGLQWVVASYSLGMAVFIMSAATLADLDGRRRWYLIGVSLFTLGSIACGLAPSIAVLTTARGAQGLGAAAVSVTSLALVSAAFPEAKEKARAIGIWTAIASIGTTTGPTLGGLLVDQWGWRSIFYVNLPMGALVLFLTLCYVEESCNERARRFDLSGQLLFIVAVGALVYAVIEGPQIGWTSVQTIVMLWTAAVGCALFVWLERRSSNPMMDLTLFRDTSYALAIATICTVFFAVYGMLLLTTQFLQNVRGYTPSVTGLMILPFSAAVAIVSPLVGHLVGRIGARVPILAGLCMLMLGLLMLIFSEHRSSALVLVGLGLCGSGVALCLTPITTVAMTAVPAERAGMASGIMSAQRAIGSTIGFAVLGSVLAAWLSATLEPHLERAVPDPVQRHVLAEIIIDSANPRAHVGGIVPRRHIEHRDPVAIAEEDFIEGIRVALLVATATLAVVFLAGWRWFPRDVHTAGSDLSERLPTAMTVECAVSHMPGATWCRLWPA
>fig|83332.1.peg.2461 Multidrug resistance integral membrane efflux protein EmrB
MTPRQRLTVLATGLGIFMVFVDVNIVNVALPSIQKVFHTGEQGLQWAVAGYSLGMAAVLMSCALLGDRYGRRRSFVFGVTLFVVSSIVCVLPVSLAVFTVARVIQGLGAAFISVLSLALLSHSFPNPRMKARAISNWMAIGMVGAASAPALGGLMVDGLGWRSVFLVNVPLGAIVWLLTLVGVDESQDPEPTQLDWVGQLTLIPAVALIAYTIIEAPRFDRQSAGFVAALLLAAGVLLWLFVRHEHRAAFPLVDLKLFAEPLYRSVLIVYFVVMSCFFGTLMVITQHFQNVRDLSPLHAGLMMLPVPAGFGVASLLAGRAVNKWGPQLPVLTCLAAMFIGLAIFAISMDHAHPVALVGLTIFGAGAGGCATPLLHLGMTKVDDGRAGMAAGMLNLQRSLGGIFGVAFLGTIVAAWLGAALPNTMADEIPDPIARAIVVDVIVDSANPHAHAAFIGPGHRITAAQEDEIVLAADAVFVSGIKLALGGAAVLLTGAFVLGWTRFPRTPAS
>fig|85643.4.peg.542 Permease of the drug/metabolite transporter (DMT) superfamily
MHKTELDRLAIGLMVVLCSIWGLQQVAIKLASAGISPVWQAGLRSIGATAIVVVWALLRGVKLFERDRSLAPGLLAGALFAGEFAMIFLGLQHTSASRGVIFLYTAPFFVALGAVWLLPQEHMRRRQWMGMALAFVGVLALFGENLFAATEGAWVGDLMLLGAALLWAATTLTVKASALARASAEKTLLYQLGVSALVLPPLSLAMGEPGVFAPTPMVWANLFFQAAIVAGVSYLAWFWLVREYPATRLSSFSFLTPVMGVLAGGLILGEPLTPAVYAALFLVGSGIWVANRS
>fig|85643.4.peg.3880 Permease of the drug/metabolite transporter (DMT) superfamily
MTTPHPSHSDAVRGLLAALAVVVFWSGFNLVSRFGATTSFSPFDLAAMRYGVSGMIALPFFLRFVPMRDWPRHAVLACVGGLAYGLCVYWGFAFAPSAHAGVFVNGGIPFWTIVIMAVTSGFRIARPTVVALLLSTAGLLLIGFESLLAPAQGSAWIGDLLFLAAALAWAIFGLLMRRWQVKPQFGILGIASFSALVFMPIYLLWLPSGIGAASWGEIALQCVYQGVIASMLAAGFYSYAVQKVGAGEASMMLALVPAFTAIGAYLILDEALGTTTIVGIVVVSAGALLGALPPAALARVRGSGSAHSAR
>fig|856793.5.peg.84 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRSETDTTDNTASSATANPLHGRGRHGDLTSGPVQAHLVRLSVPMIWGILAIVASQLVNTFYISMISPAHLAAISFTFPVTMTVLSLIIGLGIGMSSVVSRAIGEGNHDTVVRLSSHGLILAVIAGVIMALVGHAIMEPLFRAMGATDDMMPMVLDYMGLWFAGIVFITVPMVGNSAIRATGDTLTPALIMMGTTAFLVILDPLLIFGLFGLPRMEMHGAALATIISYGVSMLVALWILKYKKRIIFQDGLHLDQFGDSARRLLFIALPAGITSTIQPMTSGVLTAILAQSGTHAVAAFGVATRVEAFAFIVIMALATGMSPILGQNWGARRFDRVHETLRLAIRFCVLWSVAVAAILMIGAYPLAGLFSTDAETVRMTALYFLIVPFSYAAGNLVPGWSSAFNAIGLPQRSAAMIGVKMIIVQIPLAFIGNHFFGVIGVFASIAIANIGTGLYYHWRNKQHMTTAELAHSPA
>fig|856793.5.peg.589 Glyoxalase/Bleomycin resistance /Dioxygenase superfamily protein
MKRLHIHLGVKNIDDSVRFYSALFGADPVKHKPDYAKWMLDDPHVNFAISTRAGKTGVDHMGIQVDTADELNAIRTQMSDANISTHSDGETTCCYAKSEKSWVEDPNGIAWEAYHTMEDAQIFSAADTSSESGACCVPTTKSGSCCG
>fig|857087.3.peg.594 Glyoxalase/bleomycin resistance protein/dioxygenase
MSKFDLTIHHASLIVSDTQQSLTFYRDILGMQPTERPPLPFPGAWLQIGEQQIHLLELDNPDPTTGRPPHGGRDRHVALHCSSVDALRDELEKAGMAYTMSISGRKALFCRDRDGNALEFIERPS
>fig|857087.3.peg.2544 EmrB/QacA subfamily drug resistance transporter
MLFNLCLGLSHVLVIFNAGAYIAMLPRVAAGLGIPPSFATWTQTDYMVGLALAFPVGGWLSRRLGEYRPFVAAFFVFALASVICATMTSFYAYLAGRIVLGFAGGLTLPLGQSLLIKEYPEQKKSIGIGVWSVFTLTPFTFAQPIGGWIADTLGWRWLFWLNIPTALTIGGVVGALLYRRGITRIRHRFDGVGFVLIALALFGTQTVLNQGNDWDWTNSLYIGGLIIVVVATLIYWVIWECSHRRPFLDIRLFTHRNFTIGVIILFLGFLMFQGLLSMLIVQLQLALGYSSLLAGLVFLPMAILAKPVAGVFHEVVKYIDARWWVSLNCLGFAAIYFWLSHFDGHDAFAQLFWPKVLEGACLGSFFVPVTALILHGLAPEQTWRAVELASLLRIAAGAMGISLQGIVIYRRAPVHITRFAESHTLFDGRLEQTLDTLVSAGFNESTAIARLAKLAGRDAVIHAMNDAFWLASCLFVGLSILVWFANPTKLSAKRTLKQLQRRETQEMLVEAP
>fig|857290.3.peg.215 Daunorubicin resistance ATP-binding protein drrA
MHKDIQDIHSKDGRAPVRDFGQFPGQAVLELDNVSRSFNKGAVQAVRDVSFKLHPGEVLGLIGVNGAGKTTTVKMCSTLLDPTSGQIHVAGIDTRTSPREARSHIGLMLGGSGGFYPRSTLKDNLLFFADLAGVSSRERQAEVRRTLELVSLGDMENRKAYELSRGQRQRLHIARALLGSPELLMLDEPTTGLDPDIALKIRGLIRSVADSGVGILLTSHSMEEAEELADRFVVIDRGAVRVSGSLDDVARYADISRTTTFTFTPSGSFGLDDISRLVDNDGFIMHRAVGSQWRVTVMWHSAAAGRVAQRCGAIASCTSADDLLTRPANLEDAFLAIAEMGQSPAVSAASSGERG
>fig|861360.3.peg.389 Glyoxalase/bleomycin resistance protein/dioxygenase
MAQIGMITLDTVDEQSAAAWWRAVLGGKYAGQYPGFTMIRVPGFSAMLGFQKVPEVTAGKNRVHLDLSATSDRAREVEIFVKAGATRLEEHCDDPDFGWSVLRDPYGIVFCISDPHDQ
>fig|861360.3.peg.1714 Vancomycin B-type resistance protein VanW
MQTPSPDSSSTTPTHSPQDKKKPKSKAKPWIITGSCVAAIAAAYFGGAAYVSSQVPANASIAGVNIGSMNKDQARSELEREVLPLAEKDIDVTVNGEKYTLDPAKAGLALNVDETINDLTSYEINPVELYERLTGDVHVDPAVDVDQEMLSTQLEALAKKANAELAEGAIEFKDGTAKLTKPIDGVVLKADEAASLITDEWEIAGPALTLPAEVTKPKISAESLQAFYDKDIKALLKDDVTLSSDKKKATISVESIVAAASYTPKDGAPAITLDDKKLYKAATKNSDLSSTAENAKIVLKDGKPSIVKSSKGVSLETEGLGAKVLAATADKKRTATVEMTETEAEFTTADAKKLGIKEPIVTFSTPYPASDKVRTKNLYAGSARVNGDIIKPGERFSLLEALGPITVANGYFSSGVVESGFSTEAVGGGLSQISTQMYNVGFLAGYDDITHKPHSRWFERYPAGREATLWEGQIDMIWENNTPYGVMIQAWVSGDKVNTRLWSTKYWDVSQKSSGKYNLTNPETKYNPAEKCVSESGGKKGFSIDITRYRETFDGSKKLPAETKSWTYSPWHKIVCGEKPKD
>fig|861360.3.peg.2944 Probable multidrug resistance transporter, MFS superfamily
MASYLLGMIPALAFGGPLADKFGRKPFSLLALMCSILGSAGLIFGSMHDSGLYAGRVFTGFGMGLAMVAITSWVKLISPGPAGATRAALCTSLGFALGPVISGAIVGATASPELAYSVHGVAAFAWLLLLFTAKEDSSVDLAGNHSRAEPTTPENLQRFYRIVLPAAPWVFGMAATGFAIVPALSNGAGESSLFYTTLAVAVTMGMGTLIQPFVKRFNDLGKIQLLMAGLATSLAGLLLMIVVSLSGSEFLGTIAFVIAGAANGILLVAGLSQVLDLAGSADVGKLTGRFYMCCFIGFTFPTFFALWRSIAHPAIFIGILAVLCLLSMMQVYRSRKYLPNVVLEEVRNSP
>fig|862517.3.peg.61 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKNLKGYLYTLLGATFWGLSGTCAYYLMNDRSIPPLDLSTYRMLIAGSIMLIYILIKNGKEALRVFTNLKDTFVLISFSIFGMAAMQVTYLITISYTNAPTATVLQYTGIVMIVVLVCVLETRLPYRAEGFSIIFAILGTFFLATRGNIHTLVISNEGLLYGGLSAVAMMIYTLVPPKLLKKYGTINITALATFISGVMMILVSRPPIPEKIDSLIILAFMGLTFFGTIISYTLYFEGLSIIGPVKTSLIACVEPISALLFSMVLLGEHFVFMDFVGIMCILFAVAILSIKDLWVKE
>fig|862517.3.peg.974 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRYLKFIIPSVLSMWVFALYSMVDGFFVSNYVGEVEFSAVNISMPIITLFFATGILFSIGTQAKVGMNLGKGDFNLANKIFSTSIVSLIFIGMLFSGVIYILLDRIIYILGASDATSEFVREYLKAIVPFGMFFMLSYQLEVLVKVDGAPHISALSVIIAAVSNIVLDYLFIVELHMGIFGAALATGIAQAISSFSFILYFSRKTGRLRFVKNFDFSILKSTLPLGVGDAISEVAIGFTVFLFNVNLFKVYGEDAVIAYTVISYVSVLVTVTMTGVAQGLAPIFSFDYGKRDYKKIRKFVERGVITIILISIIFIFVAHKFAEPIVNIFLGADSGVLHETSIALARYSWAYPFIGLNGLMVTFFASLGRGRLATTLSVLRTPILVSLVMFVFRTFMPDYFLWYVLAFSEGLVFPLGVYFVNRFIIKPIKYQL
>fig|862517.3.peg.1142 Multidrug resistance protein 1
MLNKNLLREIGREKNSLLILILLKVFELFTNIALIFSIGNFLNEIVKGNYLVKGFIFQIFAIILIKIIIIKYNFYISHKISNRIKKSLRQRLFKKVYGFKMEYGEKISISEVINLSVEGIEQLNIFYGELLPQLVFSLIGPIMLFIIMSFVNLKIAIVGLVFLPFIPIAIFMVQKLAKRVVKSYWKSYANLGEVFIDFLYGLTTLKIFNADEKYNDKLNEMAEDFRVKTMKLLMVQLNNITVMDLVSYTGSATVIYMTLKYFSMGQISIFTGFVFILLSQEFFNPLRRLGALFHVAMNGISAATTLFEVLEIEEPVDGSQVIDEDRVTIELKNLDFSYDKEQVLENINLTCKENEITCLVGKSGCGKSTIAKLICGMLGSNGKNIFYNGKNDIKSDSIIENICMIDNNPFIFSNSLRYNLLFANPTASDEELMDKLKIVGLYEYFENQDGLDTIIESQGNNLSGGQKQRISIARALLRKPKVLILDEAISNIDIESEEIILDILSRLKKDMTIVLITHRLRNTENADYIYFLKDRKVIEEGSFVEMKEKENFGNLYNSQMDLEMWGVK
>fig|862517.3.peg.1255 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSNNINLTTRADIRNRIWQLSYPAMVSMLLQTVYDLVDMAWVGQISKQAIAAVTIFSTIFWLFLFFNELIGASSVSMISQNYGKGDKEMTRLVSEQTMSFKVFMGFISGVLLYFTINPLLNFYLKNPSTVKLAMDYGYIRIFFLPAMYASYSVNTIFRCQGDPKTPMKIMIFSTILNIILDPILMFETIPFTNIPGFNMGVKGAGVATVISVMFSLIYGLSILLSGKNEIYVSLKGLFKLNWNIDLDLLKIGLPNALKQFAGGLFMAIMVKFVSHYGDSVITAVGIIAKLQTFIYMPVNGLMMGGSIVVGHFLGRREIENAEISASIASRINFLIMAFFSILFAIFPQYLFSIFNKDPEIIQMGKELVPIVTLTIPLTGYAFGQSIVFMGSGYTKPYLVGSLVSQWLLQLPFVAICVYVLKLSYRSIAFSFPLADIVYFVIILIFFKSGKWKTMDVTKKINSNM
>fig|862517.3.peg.1891 Permease of the drug/metabolite transporter (DMT) superfamily
MNSLKKAKNLGPIYMIASSFFFALMAVFIRYTKDLPTFEQVVFRNFVISILMFLLIVKEKRTHEMKVKDGKKEIFYRSLFGFIGMVCNFYAVKYLNIADSSAIGKLSPFFVMIFAALLLGEKLEKHSIVAIILSILGMLLVVKPKFDGSMVPSLVAVAGAVSAGLAMAMLSAVGKKVRGEVIILYFGIFSTLACFPFLVGNFVIPNGTEILNLLMIGVSAGFGQFFLTLAYKSGKASEIAIYNFSQIIFSIFIGYFLFSEKTDLISLTGMAIIILSAYYNYKRSIVYD
>fig|862965.3.peg.384 Permease of the drug/metabolite transporter (DMT) superfamily
MVILWGASWPWGRVVAQAMPTFVASSLRFFFAIIPLIIWLYAANRFKYAKQLNANQWMGLFVTAFFGVFAYSTFFIWGLKYLPAGQAAVIVATNPVFTTLLAIFLFKEKWNRWVILGMVIAMSGTLLALTKGNFLQMMDSFGFGQILLIGALICWVVYTLLARKVLAGIDSLTATTLSSIFGFLLLFISALCVESSGDWLTVLNLSQGEWISLLGLAFGATVLAYAWYFDGVKHLGAGNASAYIILVPILGILFSAVWLNEQVDSSLIIGGILAVSGLGIMHWGRRLIK
>fig|862965.3.peg.582 Permease of the drug/metabolite transporter (DMT) superfamily
MIIESVCLVVFGSLVALWQGESAVDFSLGFICAFVPFCAFAYIVFFRKQDFSTKLTAFYRGETLKFMLTIVLVGVSFKWLSISHFILFFVGFFTALALNNVIPFLLNRS
>fig|864564.3.peg.866 Permease of the drug/metabolite transporter (DMT) superfamily
MNRKNELRTFEGSVALVVAAACWGFAFVFSVQGSQTMSFWFFNATRFTLASVSLLPFAVWSFIKNHKIVIPDENRRMRVNSGAFRVPVISLSDLQRKGSFLYRVLIYCVCGVLLFVASTIQQLGLEVSKQAAHAGFISSLYIIAVPILARIFLHKRTSLFTMIGILVAIIGFYFLSIPAGAGFSRMDPVDLIFLASATLFGAHIVVLDANVHHVDSMMLSFVQSLVVAILSWIGAAFDGSINMTAATHGWISIAYTGIVSVGVAYTLQIFGQRFVQPAQASILMSLESLFSAVGGILILHEFMSGRAIFGSSLIFVGTLLSQIPVENLRLRRNRLESTGNTADFAPVDEDDPAPLPLPDGAQVPGAESEDKTVETAPSQSATL
>fig|865937.3.peg.967 Tetracycline resistance element mobilization regulatory protein rteC
MILLNIKKMDFQITKEEIEAEILRIEQTFLNKLSAYNKIISYCREILESYRKEIRLNDFQDIASEILFFKKQKALPLTYLIYYENRLSIELEIPSAGEAFRQKFIFKMIERTNSFFFAHKNFLQYMALDQEYLDEFYFTRRFTSKNHMINYKNYERDPLFSTSHDLLLSELNSHKFLLQYLNKLSVQVKLSSSLVFEEPIKIKWTTSKVALTELVYALQLSGAINNGNTTLKDLFSIFEILTGLDMGDYHHTFLKLRGRSEPLKFIEKMKNSMLEHMAGLDA
>fig|866536.3.peg.1119 Tetracycline resistance element mobilization regulatory protein rteC
MLREHAKDLISNLEQEISMLTLEDSNRLQQLEKAFHLAEKAVISMRSYLDTYKFQSEEEEISFFKLINPLLLKEAFYYAELFAVESNKPLGSNKKIRSYYSKAIRRIVKMLGKHKHLYNYVNLNESKFDHFYFLRNSENNLKQPTGELLYMDTKYVTLQSYNLGKIYAWIQVVEQLQEDILLLDGQQGISTSVKQGLTWTAPKVQLIELIYALKASGVFNNGNADIKQIANALGCLFDKKLTDYYRTFQEIRGRKKSRTVFLDIMQERLVKWMEEGEGLN
>fig|866775.3.peg.155 Tetracycline resistance protein TetT
MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVDQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILKLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN
>fig|866775.3.peg.342 Glycopeptide antibiotics resistance protein
MIFLGPLYHLLAYLLADRVNHFPLIRLLVFSLDKTILYTLIFLTISALIAHVKKRRQAQWQVDWSKYGHILALFVYLVLLHLTVLRYDWQWWRLSLVPGVTLRDFHWLPLVDTIKLAYGDSSFSYWYNFFGNVLWFIPFGWLLAYFFCGQRSFFRVLFMGMGFSFMIECGQLFLGTGLGHIDDVIFNSMGVVIGHFAYDFKHFFLMKHESR
>fig|866775.3.peg.728 Drug/metabolite transporter (DMT) superfamily protein
MMPLQLTMYRMLTAGISICLFLAYKRKLPIEKLKNDKRSLLQIAIFGICGIVFNQFSYLMTIHYSNSGMATILQFIGPIFLLVYYCLVGRRWPIRREIVALLFTIIGVFLLVTHGQLGHFVLSTEAFFWGLMSAFGLALLNVLPLRVIEHYGSLPVTGIGMLFGGIFLIFFNFEHLVPPELSLHFLAWFTLTIIVGTIVPYIFYLSSVTFIGPLAASLIGSVEPLTATILSVILLGESFALIDYLGMAFILLTVFLTAHE
>fig|867900.3.peg.1912 MFS permease (drug)
MQFCNMKKITNLGIFTLLLVSSLTIMVGTVIAPSLTGIVENLNFSFSPGWLITLPSLGVVVFAPIVGKLLHKTGSYTMLCLGLVPYALLGVAGAYITNDYILMLDRFLLGAATVAVQVSVTSFIADFFTGEKRMKLIAWQGMSIELGGVIFLSIGGILGQWHWQYPFFIYLLAIVCWLLVIKTLFKTIKSDEVVAKQEKKESKLAIKTIFYASLLSMVLFFVSFVTLPIYLPKSIGFTESYTGYFMAFISVIAIITASQMPRAVKKIGDGKVVALGFLFFMLGYVTLAFFNSIPLLILSAVFIGTGFGFTIPLLNHMMIEVSAPKNLGKNLGLYSMGVFGGQFLSTFIEYISTNYAVVYTVTALLALVIGIVLYYAFKKIEEHNQ
>fig|867902.3.peg.504 Multidrug resistance transporter, Bcr/CflA family
MNLKTRLIFLIGAIAAIGPFTVDMYLPGFPAIARDLNTTEKMVSYTLTSYFIGISIGQLFYGPILDKFGRKKPLLLGLTLYLISSVVCALSPHVYVLILARFVQALGASVGMVAGTAIIRDQYGASEVAKMLSSVLLVMGVAPVIAPSLGSFFISHLSWRYIFYFLTLVSGVLILSLKIFLSETHGYQPHMDFRIRPILYNYYTALRQSKFVKYTLGGSIAMAIMFAYVSSIPFILMNIYKVSAGTFGIIFACNAAGFISGSQFNRLLLRKFQLHNLTRIISLVQLVISVVFLILAYNFELPLPVFLAFVFVVLFLLGFINPNATALALESFEKNIGVASALNGAVRMAAAALTSAMMGVCYNGTQFPLIWFMVILSLFGFVFIAWARRSSLA
>fig|867902.3.peg.2032 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLSQAGQIVVNVADNVMVGGLGGRFDYVENIQLGTTALAGVALGNSVLFIIMSTAFGFSFGMSPLVAQTDAKNNIQRGAKVFSHGLLLNLIITALLLIVLFSIEPLLFKMKQPVEVVQAAIPYIRIAGISIIPLMIFQSLRQLSEGLSLTLNVAIATIVANVLNIFFNYLFIYGNWGMPRLEIAGAALGTLISRVIMIFVLLFLMLKNPKTQMYLKAVSFKIFNKFIFRKLAFLGTPTAMQMFFEMGTFSAAAFICGMAGTDQLAAHQIALNLASITFMLCIGISTAATVRVGNQFGLKHFQNLRKAGFSAIVMTMIIMSISGISFIIFRHVLPEFYTENPAVIGIASQLLIIAALFQLADGTQVTALGSLRGMQDVFVPAMITLVAYFVIALPLGYFLTIPKGMGALGMWIGLGSGLIFSAIALVSRFYLKTKQLLLQN
>fig|868864.3.peg.900 
MKKLFSIVGFLLIAFITFSLFYYFYQRHIYVITDDAFQMADVVSVSTQDASGKIVKLFKKEYESVSKEEPLFKVDDSLYRKDVEILKAKLESLKQKKKELSEKLSRLKEQLPADVKISKENLKALEKKLNQLKYQELMEKTNYETSTQKAESSLKAAEKGLEAAKVSFNHWKNQYNRYKRLYKKRIISKEQLEEVELAYKEALYKLESAKARLQAAKGDLENAKSLKNRIAIIRKQQEEVKNKIEALKEQVKISKANLKKINELSHSIRQLEEDIKSIESQIEKAKILLSHTLVKSPVEGFIAKKWKEEGDFISPGLPVYSIYNSKSFFVLAWIEEDKIKDIKVGNKVKVELEVCKKTFKGKVYSIGTSAGSIFSLIPRDTSQGEYTKVTQRIPVKIKVEKVPPVCIKPGTNVTVYIKKRQQ
>fig|868864.3.peg.1531 Acriflavin resistance protein, AcrA/AcrE family
MKTKILFIAIIVGLVLIGVTAIKKKKEEISKIPPPKIYPISVKWTTIKSGELQEEFNYIGTFQPYKHATISTKIYGTVLKVYKSEGDFFKKGELLAKIDDSEIKSNISALEEEKRAKENLIPGLRAELRAAEIALKNAKEEFNREKFLYEKGAVPKVAVEKVENQLAIAESKVESIKAKWKELKSAISSIEKKIEALKSQLKYTEIRALDDGVVSEVLAYEGSLATPGKPIIKVYYPKYGFKILINIPPEDAKEIPIDSPVFKGEKKIGKLVKYYPSANENFLYIAEIKVNKSEKIKPFENVSVKVLGKPYKGQIVPIYAILHLKNGDYVLSVEQNNKVKPVKIKVLKTVKDKAIISSNLQEGTKVIVGRESKLLEVMRRGSVVLSEAFDG
>fig|869209.3.peg.216 Acriflavin resistance protein
MVSEKTLEHPVLTLMVFTLLGLMGIFSLGNTSVSLMPDVDMPYLMVSATYENAGPESVEKSVTTLIEDALVSLSNLKEITSTSSEGRSSVFLEFNYGTNLDIATNDVRDKLDRITRRLPDDVTPTIFKMDSDSQPIMRIAVRGNRSVDELKKIAEDQVVDILEQAQGVGQAESMGGRTQIVRVELEQNRLQAYNLTLSEVSSSLSKQNLEIGGGTITEGTMDYSVRTTGEYTSIEQINNTVITTKNGYDVKLSDIGRAFMGYKDASNVVYINGLPGVYVSITKQSGENSVAVANAVYEKISELEKTLPADISLEIIRDDTESIRDTLNTLFDSAWQGLLLAVVILFVFLCAIKTTIIIAVSVPLSIIITVLCMNFAGITLNMMTLTGLILGVGMVVDASVVMIDNIYSYRMRGAKPNVAAVLGSSEMILSVVSGNLTTICVFIPFLFFMKDLGFMGQMFKGIIFTIVIALVSSLFVAIFLVPVLAGHFLPITNRNEKPVKSRFFKVLYGIFTKSQDIVSLGYEKLLKKALDNRGVTVVVCVTALAFSFMLIPTLRIQLMTGGHDDSVSVKLGLPVGTSLEETSDVVLRFEEIVKNEIKGYKNIITSIGSSWRSSGSYNGTIQISLPNSDKQIDNDETIKQKLRKHFTEFAGVDFSFGQSRRQQMTGDDIDVVLRSSSLDSALDVAKKIQEVMAAIPDIGESSVDTDEGLPQVQVEIDRQRAYSFGVNVATVANEIQASIEGVSTTTYREDGDDYTVYVMLRPEDRQKVVDLEQIYVNGTNGRVCVANFARAVKGYGPVTISRENRRRIVHVTADIVSDENANVVEEKIKEGIKNSFIVPDNVSVSYEGSWKDVKEQTAIFAKIMVMAVLLVFGVMAATYESFKAPFINLMTIPFLAIGVVLIYKITGQSFSLLSAVGLVMLVGIVVNNGIILVDYTNLLVERGMPLKDACYKAGCSRLRPVLMTTLTTILGMIPMCFASSGSAGMVQPISVAVVGGLTSSTFITLFFIPVLYTFVMKKKKNQQSVVQLALPEEK
>fig|869209.3.peg.1407 Methicillin resistance protein
MQNHEQRFLQTEFWADFKGSHGWKTFFFIFDGDNVSKVKSLKECKENEKCLSVLVRSFSLKIKKFSIAYIPMSPEFSSNEENLSQKFSNELESISKKIFKFLPEDTICIRFDPALDFESLEEKNNFVSNVKKLFKQHNTKKENFRIEKTATDIQPPDTVLLSLLESEEKILSEMKSKWRYNIRLASKKGVEVKSYSAKDADFPCAFEEFFKLFMQTSERDGVQFHQKNYYLGLLNSSAETQNAPVVRLYIAKHEADVLAGIITLFCKKEAVYLYGASGNIKRNFMPAYLLQWNAICDAKKIGCPVYDFYGCPPEENKNHPMHGLFLFKTGFGGKLIHRPGSFDVVLKKNWYAFYKTAEKLRAWFYKYLKKKIAGR
>fig|869209.3.peg.2276 Small multi-drug export protein
MLKNFLWVFFISMVPLIELRGAIPVSQALKLPVISSYVVSIIGNMIPVPFIFLFARKFLEWGQDKRLVGGICRFFLLRGTSAGEKMQAKAGRGLYFALFLFVGIPLPGTGAWTGTLAASLLDLDGKKTSLAVMGGVLLAGVIMLVLTLLGVGAANAVAG
>fig|869209.3.peg.2679 5-nitroimidazole antibiotic resistance protein
MRRKEREITDFEEIIKILDESNFLTLAMINGTEPYSVPVNFGYKLDGDRKRIQIFIHGATEGTKLNCIKNCPRVSFSAVSYSEIGENKEPCAWTDFYRSVCGKGNASILEDADEKKEGLICILKKYGYKGPSVFPAIMIKKVSMIRIEVDDLTGKFHEK
>fig|869210.3.peg.102 Small multi-drug export protein
MEMLWVILTAMAPVLELRGAIPLGVALGLEPWPTFALAVLGNLTIVPPLLWGLPWLVRRLEDWPPFARAWGWLEARVRLKGEARVQRYGALGLLLFVGIPLPGTGAWTGAVLAVVLGVAPRYAFPAIALGVVLAGVLVTLATTGVLVGLRYWVGG
>fig|869210.3.peg.317 Glyoxalase/bleomycin resistance protein/dioxygenase
MYATRLSHAHLKVRNLERSVTFYTRFLDLQLTERWAHTALLVSSSSPYPYELALEEAATPTTGVRLGFALEGREAFQEAYRFLKLEGAPFRAEDRGFAWVLVLEDPDGNRVELVWDRRAAGGAAFWRGQARPLPEAEVLGGA
>fig|869210.3.peg.599 Glyoxalase/bleomycin resistance protein/dioxygenase
MLLHTVRLPTPDLEASVGFYQALGFALSELEASRARVVPRSGARLELVQAPLPLGAVAVLQGARGWIRDPDGNLLLYAPAPAAPRAVGQATVHAVLYPVGNVRASTHWYARALGWPERFADARLPWSELAPTPKAPRLALTPPLANEARAALLLRVPAVFRELERLQEHGLEPGWVREVAWGRLAGYTDPGGNPLVLMERNGSG
>fig|869210.3.peg.708 Glyoxalase/bleomycin resistance protein/dioxygenase
MPFRMPETAQLSQATLRVRDLEAHLAFWRDLLGLELTQVRGDRYTLAPSGGAFTLELVHAPQAPPRPHPSVGLYHLAVLLPGPEALGALLRRLLEARYPLEGVADHGVSEALYLRDPEGNGLELYRDRPKSAWPYRDGALAMFTRPLDVEGLLAQAPHARPLPPETRLGHVHLHVADLEAAEAFYTQALGLTVTQRTYPGARFLAAGDYHHHLGLNTWARGRRAPPEATGLVRYAWRVTPQALEELKHHLEARRVPYREDGAALELVDPAGVRVAVTGGTARSA
>fig|869210.3.peg.910 Glyoxalase/bleomycin resistance protein/dioxygenase
MEVIETCVYAEDLEAARAFYEGVLGLECFAFKPPRHAFFRAGRGVFLVFNPKETEEEAALPPHGARGSVHVAFRVDEAELPGWDEKLRRLGYTTYWAEWPRGRSLYVYDPAGNLVELAPARIWGLG
>fig|869212.3.peg.929 Permease of the drug/metabolite transporter (DMT) superfamily
MLVLCTVIWGGTFPAVKVALSFTTPWIIVAFRFAVAGIIFAVLYRRAAFRVAPVIWLRGAILGFFFFIGFTLQSMGLEYTTTSRSAFITELLVLFTPILYFILYRRLPSRYTLAGAVLVLAGLYYLTSPEGFMDWNYGDWLTLACAAAFSAYIIGVGAWSNAETRRPLATLQSLTVAFLALPMAFGKGVYVPPALDLWLALLYLTLPGTVFVIMLQMRFQPLTTPSRAGVIFALEPVFATAYAFLLALEPFSNRGVFGAVIVTAGVVWSEAGHLFFLSAPHSSQSQKELPPD
>fig|869212.3.peg.1229 Permease of the drug/metabolite transporter (DMT) superfamily
MFWGLSFVAIRIGLESFAPFTLCAIRFFLAGFPLILLYKFPPLDWRRLVAYSIFIGVLQYGLMFWAIYLRLPAGMSSVLIQTQVYITIFLAWVIFRERVSLLQIAGFVISALGLLVIGYDYFGGAEAVGFILILLSALFWSAGNILLKTFRIQDFAGFIAWTSFLSSLPLFVLALSVEGPGQMLQQIQSASLRSWLALAFMALFATQLAFSLFSKMMLKLPAGKVMPFGTLVPVFGLGSNALFLGERLPTRVLWGALLVLAGLVVAVVISSLLRGLEQRSKREQA
>fig|869212.3.peg.1239 Permease of the drug/metabolite transporter (DMT) superfamily
MTAEVLPRDKRFIAGLLFTVIGAAGFSAKAILAKLTYRYGVTGFATLTLRMVFAMPVYALIFVWYFRQQTPEQQRGFRRDWYLIGIVGLFGYYLASWFDFVGLEYISASFERLLLFIYPTLVLIISLVWLKNRAGRREIAALLITYVGIGISYHSEAALAGNRVQIGATYVIFAAITYAVYLVATEKLARHYSPLVFTSFAILISAVAIILHGVIAGEKLLGFPAEVYYLTLGMAIFCTVLPSLFVAQGIALIGSNRAAIISTLGPVMTIYLAYSFLGEVISTTQTVGTVLVIAGVALLTLKRRKVVSDV
>fig|869212.3.peg.2287 Acriflavin resistance protein
MKEKSLITERARFFWFLGLALALYGFFSWFTVAKEEDPRIKPRFGTVNVIYPGESPSELNSFVVREIEKELTAVRGIENVDIRIRPEFAFVRIELKGSVATDAAITREWDEVENALRRAELKFPKGVIPPALNRKTLDQEAILIALTGPAADRHRALIVLENRVLRIKNVASAVRIGDDGRQITLALDKSRLASSGLTAQQILSQLSAANQRLGGGSFDAGGEKINVKPHNGFESISEIENFSLIAKNGGTITLKTLARVSETERRPLADEMRFNSKPASALGIVARSGIDLVAFGDQVAAAVKEFQPGPGVEIVILNSQPEFVRGRLSELAFALLESMAILGAMMLVTMGFRVGLLVTLMLPVVGLITLALNGIAGGVLQQISIAAFVMSLGLLIDNIIVVAESVQEKLDSGLGKAEAAVSTVKTFTVPLLSSTLTTVASFLPMLLARGTTAEFTFAIPAIAITALSVSWLAAVYLTPAFAAAWLRPGTSRQWPFLSKVADLIAETVLQRTRRIGYGLVVLLVVAILSAVTVGQKFFPSADRNQLVVEIVYPEGTALSRTRSAVEQVERFLSQSPHVSGFAAFVGRSTPRFYYNLNQEPNSPQLAQVLVLTRGQKYHAALRKELASLPIDKSPRLIVRSLEQGPPIPAPVEIRLMGDEALPYAEKMVTALQSLQGIGTLRHDSEGTIREFALRGRDGQLAENGLTRADLALATLATTRGIEAGFYRTSDETLPIVVGYPEGENASSKSLAAAVVGQTTDRAILVGASAVASEHRHPGIINRRNRENVVRILAETDNKLNSAQTLSVAKSYLTANPLPEGVRFEIGGEFGESLKANGAILAALPLAMIILIAILIWEFNSIRLTAIIMTAVPTAALGIMPGLAIGRQPMGFMGMLALFALIGIVVNNGILLIDRFRSAEEEGLDRNSAVRTGILERLRPILLTSGSTILGMVPLTFTNSTLWPPFAWAMISGLAVSTLFTLFIVPWLYAKMAWRKPAARLLSAAALLLLFVPGISADDTKVQPISITEVIEGAARSPAAKAAWHRAAAAKAGKNTEILGVWGPRVTAGAEYIVRDREFFLQTPFGQFPYGRQNYGQVGVELYQTLWSSEGALAKIPSSTLRSEAADLMARWETMSAQHTAIGRFYDCAEISARSDVLKDRLKNINQLRIELKRLIRGGKARDIDDAKAAMRLAEAQNSLQSLADAAAACEADLGRLTNSEGARRPESRASALQPKTEQIALDKRADLQALALLVEAARKERDGILLESMPEIYARGNYTHFGARQFTPEDWFQASVGARIRILDGGTQITRRQVKDAAYEEKNQQYIDALKAARVQLDDIETRYRTADGQFLAIQSELKAAEERLSGERARVNQGRVAATDLLEALDIYWRRREALALTELQAERLNWTRAYLKGELLK
>fig|869212.3.peg.3145 Tetracycline resistance protein
MQGVTDTEKPVSRREKLMVLFMGVAVVLVIMNTMMFNLALPKVALEFQLNAAETSWIVTAYSIMFAIASITYSRLADFIPIRRLFLIGLSSLGVAAIAGFFIHDFYILIGVRVLQASGAGSIPGLALVFISRHIPLARRGRAMARVMAAVGLGLGLGPVVGGAIVEYAGWHYLFLLTASALLLVPVFAVLVPQEEVRHGTFDVIGAVFAATGITALLMALTQKSIPALLGGSISVLLFVWRIRSAREPFVLPTLFTNRNYLKLAAVGVAAYIVSFALLFIMPQMLVKLHGLSAIHAGLAIFPGSIMAMLVSPVTGKTIDRRGNTGILRLLPWLMAAGTLLLALFAKDGYLYLSLAYILVSVAFTFITSAVSNEMSRLLVPAQIGSGLGLFQLMQFFSGAFGVALSATALVWQRDLPQAESYSNIYFGMTFIVLLSVVSASDYLKSKNRSED
>fig|869212.3.peg.3497 Permease of the drug/metabolite transporter (DMT) superfamily
MHDISFFLKIAAIAILLFSSSTLFIAGRFSARALASGLFTLSIAGYLGCQIFHGSSVSEWFLWFVHLGCFVAPLTFYLLTESLFEDKFRFRWHHLALFVFIEAVNFYLIIYLRVYAADGHLQYGDFLTLLRALPQTVSLVFILVALGKTLLKRKADLIESRRNFRIKFIAITSAYMLLVLISELAYQGQHAPPMLDLLHSAGILATVWYFASKMFTVRSGTLGEVNTIVTKSTAIPERETVNQELLSKLEKAMDTGKIYTQESLSIRELAKFLETQEYILRRLINAGLGYRNFNDYLNELRITAAARILADKEQASTPIIRIAMDLGFGSLAPFNKAFRERKGMTPTEFRKKSA
>fig|870187.4.peg.3760 Permease of the drug/metabolite transporter (DMT) superfamily
MTTTFLDRFSPYLLLVLTVLFWSGNFNLARAVHADIPPLALSFWRWATAGLILLPFAGQPMRQALPLLRAHWRLVGALALLGVAGFNSLVYEGLQTTTATNGVLIQTITPVLTVLLASALLREHSSLRQWLGVGLSLLGVLVIISHADVGILQRMDFTSGDLWMLAAALDWAFYTVLLRKLPEGLKGLPILGFTVLLGALAILPLYVHESLTFHIMPVTLVSMGSVLYVAVFPSLLSYLFWNHATQQLGAGRTGQFSYLLPVFGILLAVAFLGERLHLFHVAGMALVAVGLLLTNWQRK
>fig|870187.4.peg.4488 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIQRDLTHGSERQHLLAMSIPTIWGILAIMAMHLADTWYVGQLGTDALAAMGFTFPVVMIIGSLAFGVGTGTSAVIAQAIGSERTDWVRSYSTQSLIIALAIALVFAVVGLLTLEPVFRLLGAPERLLPLIRDYMGVWYLGGFLVVVPMVGNAGIRAAGNTRLPSYVMMGVALTNLVLDPVFIFGLFGFPRMELQGAALATLCAYVVACTIMLYVLGVKLKFLSLQALRQGVVQSWRDILRIAVPSAGTNLIAPVATAITTWLIAQYGADAIAGYSIAARIESLGLIAFGALATSLAPFAGQNWGARKLDRLNRALDLSFRFAWLWGLLFAVLLWVAAEPLIGLFTRDPEAIAAAKHYLYIVPVTFGLLGTIMMTSSVSNGTGNPHPALLMTLLRLLLVYLPLAWLLSQWLGLEGIFLANAVANVLVGVGAFLWIKRKCRRGTNARQAEQRRKAMWEERYATDEYLFGTEPNDFLREHAAELPVGDTLSIGEGEGRNAVFLAGLGHRVTALDASAAALEKARKLAREKQVDIETVHNNLDNYRFEARRWDTVVSIFCHMPVQMRRRLHQQVVKALRPGGIFILEAYTPAQLKYGTGGPPVEALMMNLASLREELKGLEFIHALETTREIHEGKWHHGMSAVVQVIARRVG
>fig|870187.4.peg.4562 Drug resistance transporter, EmrB/QacA subfamily
MFYINLPVGILNLLMVWTLLQVESGHRVKADWLGVLFMAVGIGSLQLMLDQGNQKNWFDSGLIQVVAAISVLALLYFVARSWSRPDSIVKLQLLKDRNLATACFMIVVGVISPPGE
>fig|871585.3.peg.1978 Permease of the drug/metabolite transporter (DMT) superfamily
MLFKIALIMAAFAANSVLCRLALVGRHIDPMTFSLIRVGSGAVVLLGLFLYSKSSQTKVQWSLKNAFFLAVYILAFSYAYLQIDAGIGALLLFGVVQLTMVLYGYWQGEQIGIYRGIGLCIALAGIIVLLLPGAHAPDWGYALIMVISGLAWAGYSIAGRNMTQPIGSTLANFTLAVPMVLLANVLVTQDRYIDVQGWVLAILSGGVTSSGAYVLWYAILKHIDRVTASTVQLSVPCLAIIGGSLFVNETVTGRVILSSFIVLFGILLVIYVRPQKAKNA
>fig|871585.3.peg.2308 Quaternary ammonium compound-resistance protein
MLGLISKINPGAWWLLFAIATDVLSTFYSAKGNGLVNKTAQGIALVLYIISFACAAIALKYMQAGILYVLWSGIGVLATAFLAKIFLGQNIDVAGWVGIGFITVGLMIIAQYSNIDV
>fig|871968.4.peg.211 Permease of the drug/metabolite transporter (DMT) superfamily
MFQGLIGSLGTSLFYAYALLYLPVSVATLLLYLYPVLVLGAGVVFLHKKVGLMEKTALACTFVGTTLASGSFSGFEGIPLLGVLLGIIAAITYAFFNVVGEVALQEVSPLTAMAYSQWFSSLGLIFYLKGNILQLPWSNLDIWGIGLALATIASIVPFYLIMFGIQKVGSDRASILSTFELPVTFVMAALILKEIPRLAQWAGGGFVLVGIILLNWRSSHEREQTG
>fig|871968.4.peg.771 Multidrug resistance protein B
MEIQRQTKRGFILVSIMLAMFMAAIEGTIIATAMPNIVAELGGFSLFSWVFSVFLLAQAVTIPLYGKFADIYGRKPVFTIGIIIFIIGSFLCGFAKTMQTLILFRLVQGLGAGAIQSIAMTIVGDIYSLKERAKVQGYISSVWGFASIFGPALGAFFVQYIHWAWVFWVNIPIGIFAALGIVVFLKEDIQMQPHEIDYLGSIYIFISISVLMIVLIQAGTVWKWLSPQVLSMFVAFGVGITLFIFQEKIASEPIIKLELWRDPAILISNIATLTTGIVLIGISSFLPTYVQGVMNQSALIAGFSLGVMSIGWLISAALAGKFVLKYGFRKIALWGGIWIVSGSIFFVNIMPNRGWVWGAIGSFLIGIGMGFTRTVFIVAIQDSVGWEDRGVATASNMFMNILGNTIGAALLGGILNMRLLSYFKSISAGQYSLDLNVVNTLLDETKRSQLPQELIQQITTGLSLSLKNVFWGVLFFSVVSLFLIFLLPQHKVES
>fig|871968.4.peg.922 Drug resistance transporter, Bcr/CflA family
MSLIFAIGLVISFIGIFIDFLKRKWITVESAINFDFIDWIKIMINNEKTLNKLSLPLLLISLPLTVMTVLLPMYTSALGLTPLQVTGLFSVFSLGLVIMRLLIGYIADKAGRKPVFVLGLIFYTLSYFIYSNAKMISLIYIGRGLQAIASAFISISSYSMIADLNMKNNAHNFGKVDSYSEKGGLLGIILCFFVLNTPKLVDGWSVLFMICAIASIIAVIYSIIILNETKPILNKDFLNISLPTKKNNIIIFNLIISIFTSIVSAIFVLYLQSRFNSNLLQIGVAFLLPTVIIAFASPKLGRISDNIGSKKILVTSLSTLIFILLILPYTDNVYLYGVVWTVYCIAVTLIGITLNGVYVEDIAEEIRGTAIGKLTMGANIGTVIGPIIGGLAFQEISIQAPFFISSIGFAILLMLYMKYNKIRSQRRIKYRSY
>fig|871968.4.peg.2061 Permease of the drug/metabolite transporter (DMT) superfamily
MLKSYFAILLSSLLYGGNVIAGRLIAGSIPPISLSAIRALLGLSILLPLAWPALKSAPKPTTKELFQLILISLLGVSLPYVSLIYGLADTTATNASVIFATLPAMTNLMFFIIFKSKPSKFQVLGILTSFLGLVIVFTQGDIFHLLSFRIGGGEIFLFLNVLCISLFNVVGQSFMKKFSSLVTSVYSLVFAILTLTPLALWQLNSFVWYLSWSQWLLVIYMGCFAAGFAYFLNLYGIEKIGGGQTSILNNLQHVFSISLGVLVLKESLYVYHGLGFVLVISGVVLSLMRTSTSSPKLARSKSSNPAI
>fig|871968.4.peg.2440 Permease of the drug/metabolite transporter (DMT) superfamily
MKITKRMANMVLLLISALWGSGFVVTRMALDANVSAGFINFARGLIFALLVLLLFHQKIFRMTFNDFKIGLIAGLLNFGGYIAQTVGVKYTTPSNNAFISATYVVIVPFMAYLAFKKSLKIKSFIAIAFCLWGMAILTGIMRRGFVLNIGDVYSLICAFFYAGSITYISYGARETDATIVAFMLAIVQAIGGLGYFFIADGGQLVNVNWQAAILPLLYMGVMCSFVAQTLQVIAQKHTSATTAGLIMMLEGLFGSLFSVAFRFEPFTSSMAVGGTIIMLALILMEVNIEQLRNKTSPISEKRIE
>fig|873533.3.peg.1509 Probable multidrug resistance protein norM
MPIIVGQLGTIILGFADTLMIGRHSMPELAAAAFVNNMFVLVLLFSMGFSYGLTPIVGSLYGQGEKGKIGIMLKNSLAANLFLSVVLMGIMALLYLNIAHLGQPEELLPLMKPYFIVNLVSIPFVACFNTFKQLADGTTDTKTAMWILLGGNLLNIIGNYLLIYGKCGLPEMGLLGAGLSTMLSRMLMAVAFAVIVFCSKRYRIYRQGFAAGQINRGDMRHLCGLGVPLGLQMGMEAAAFSLSSVIVGWIGTAALAAHQVMLTVSQFFYMVYYGMAAAVAIRVSYFAGQRDYEALNRSTVAGFHLILLIAFAVSVPVMLLRGAIGSWFTDSSEVCLMVSQVIIPLVVYQFGDGLQCTYANALRGISHVKPLMYVAFVAYFIISLPLGYLFGITFRWGLLGIWSAFPFGLTTAGVLYYYYYRRYLRRIVRGSGAA
>fig|873533.3.peg.1648 Permease of the drug/metabolite transporter (DMT) superfamily
MESNKIRGFTEAIISAAAFGLIPLFSIPVLADGMRLPSLVVYRFTFGALILLLILMYNRQSLRLRFGESLRIMFLSLLYAISAVSLISGYAYLPSGVATTLVFSYPVWTAILMIVFFHERLTLRTALAIFLAVAGVCLLSGIENGISISSVTGVALELLSGLTYAVYMVTFPAMKVRHLSTLKVTFYVFFFTILLLMLYASFTEGGIQPIVSGKQFVNLALLGLLPTAVSNITLIMALKRIESTIVAILGAFEPITAMSVGCIVFDEPLTIMSCIGFALIIVAVVLLILKN
>fig|87626.5.peg.435 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTNTLELAVLSDNKSSPLITSSIFKQFGFLALPAILGMLINGMYSFVDALFISQGIGANAMAAVSSVFPIQMFLISISTMLGSGMASLIARYLGAKRQRDADIVFSTSFLLSIICAFIFCLFTFLALDHIYELLAVPLTLRDQASSYITPIIIFWVIGFISNQITEGFRASGNPKAMMQVLSTASILNIILDALFIFVFEWDVAGAAWATIIAVSLGLMMAIALQKKGESAVSFSFKNLTSPIKIHFKILSLGLPVLLSHGGFSITIAVTVYSISTVFIDVSEPLIAAHGILVRCFMFLFLPIIGMMVALQTLSGYNFGAKQYQRVKQAYLVAIAMSATWGVVVTGILCFYSDTLLAMFTSNANIIKLGANIAPICFSGFITASFCMMSSGLFQGLGKALPATLLDAARTYVLLLPLMYFLPSLIGPEGLWFAFPIADITGGLFAFIYSLIYLNRLIKHST
>fig|87626.5.peg.551 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRLAIPVFIAQVIQVLMGVVDTIMAGQVSPTDLAALSIATGLWIPVMLTLQGILLALTGIVAQHHGANDQNSIRQQFHQALYLAFGLTIVGFVVINWVSIPISYINMEPAVAAMSLDYINFVKFGLPAYLLFCTFRNVAEGKTLTKPALFISVLGLAVNIPANYIFIHGKFGMPTLGGAGCGVATAIVYWAMAAGMITYSYFSKKIDGRFLLKNPMKPDFPAIYSMFKMGLPISLATFFEVTLFACIPLFIASMGAVVVSGHQVAASVSTVLFMMPLSLAMAITIRVGNLAGQKNYSQMKQAIFTSFMLAIGISAIVASITFIGREFISGIYSDDPEVIILASSILVLACFYQLPDALQVAANGVLRGLKYTKPISYITFLSYWVIGFSLGYVLARTDLIVEPLGPHGFWLGIIVGLTIAAVLLITTVVKRLKNETYN
>fig|880070.3.peg.432 Glyoxalase/bleomycin resistance protein/dioxygenase
MVLLGFCLAACEGQDQSNTVNRPIDLNGTQKNIPMNSFISIFEIPATEISRAVDFYQAILDIHIVKMEFPEMQMGIFPYEEQMVTGVIMKAEGYTPSASGVTIYLNGGDDLQVILDKVEKNGGEIIVPKSLHADESGFFAIFLDSEGNKMGLHSPN
>fig|880070.3.peg.641 Acriflavin resistance protein
MPQIIIKVNYPNTSPESIERNVLKPIREGMVTLNGLQDIESKAGSEVGNVRLTFDFQTKMELAYIEVNEKIDRLTNSLPDDMPRPQVVRINSNDIPIVRLQIIPKEGVDYAEVSLLTENVIKKRLEQLDGVALVNINGRQERVIAVTPNKPVMSGLGFMESDLVQAIQDGNRELPGISVEDGQFRYYLRLASKLETAEDVGNLPVRGPEGNTVLLSKIAKVNHTLSKPTGYHLFKGKESLVVTVHKQTAAKMNETMPLIYEAVELFKEDYPQVDFELTQDQSSLLNAGINNLQTSLFFGGLFAFAILFVFMGNYRMPIIIGISLPASLVISFMVFYFFNISINVISLSGLALGLGMLIDNAIIVLDNINRKREEGFSLFEACVVGVNEVQSALISSVLTTLAVFVPLVFLSGVAGALFYDQAVSVAAILSVSLLVAFILLPLLYFLLFKNKDKQSVKEDSRLFRGMLKGYKLLFKRFFTRPGLSLMVLFLLIPLLLASIQFLKVEGLPPVEKFDVLISLDWNEPINASQNKNRIQHLLEQLEGKFTVAESDIGLRQFILYEGENAIQQADLYLMFANQTDKENVSRQLQQFFIKQFPQASIEIKDAPNAFDQLFSSNRPNFEVRFKNTETKRSVGPNQMNALMENFPVKDWSKGPGLQEGASVIFKTDLEKLALYGLEVNQLITSIERLFGDYLITDIRQFGEIIPIRLRNDQLDFQSLLKRNFIHGEEGVAYALDEFITANYDTHYKFVTADRSGIFQSVNLNITEPTSYEDEIRSWAVNENLTVNFAGQYFEDQETIKQLIGILMVSILLLYFILAAQFESFLQPLIVIFTLPLGVGGAFLVLWLTGTSLNVMSAIGLVVMLGIMVNDAILKIDTINRLRVNYRANGIVGKEALTKALYRAGEIRLKPIVMTSITTILALVPVVFSAGLGADLQRPLVFSVIGGLTIGTFTALYFVPLAYYFLSGESGSVKFGDER
>fig|880070.3.peg.1285 Multidrug resistance efflux pump/antiporter
MKFFIPTKKLQKAFLVAILLLLILNILSIFLAINHDQNNSLGSFLILLFDFNQEANIPSLFSTLQFLVASLLLLIIALFKKSNGKKHWGWLGISLLFFLLMLDEAASIHEFLFTFLQEKYHNSTLFYYISLLVFGLVLVGMALIYIPFFNHLNKRLLTGMLLSMGIFLLGAIVFESIGKNVFDTYGLSFGYRLIYTIEETLEMLGLAIFINVLNWYIGIKMQKISIVLTV
>fig|880070.3.peg.1574 Permease of the drug/metabolite transporter (DMT) superfamily
MRGRYSLLVLLFGLVNFKTYTHKALDPEKSNRMKRISKGNLLILTAVFFFMALGITTEVSALEAVMVFQLAEAETTFWLWKFLGRLHPLAVHFPVSFLLLAALLELFTLKEFNHKLRPGINALVWTGAIGALVAVVLGLLLANIEEYGGELLDIHQWTGIITAVLGVLLLFLLGKIKNGTPKQAIKTFRIVLFITALGVSIAGHFGASLTHGEEYLTETLPWNESSYTPEDLNIDLVAFEEEGALSEQKQIELVGKVRAVLAHNCYKCHSDAKIKGELRLDSKAFTFAGGESGPVIIPGNADKSELVRRIKLPKDHKEAMPSKGKVLSDDEIALITFWVNKGAPWPDAAEEVSVFRVAELAPRRPNLPAQRKGLTQAIDIWVDEYFEKQKIAWKEPVDDKVYLRRIYLDIVGLQPSPEEYSAFINDSRPDKRAIWVSELLDRDDDYATHWLTFWNDALRNDYTGTGYITKGRYAITDWLYNSLRDNKPYDQFVKQLLNPDEKSKGFIEGIRWRGDVNASQVTEMQAAQNVGQVILGLNLKCASCHDSFISDWKLKEAYAFANIFSDSSLVVSRCDIPTGEKAGTKILWEELGEIDSTASRSKKLEQLAEYLVQPANGRLYRTIVNRIWKQMMGRGLVEPADEMDNVPWSQDLLDWLATDFEEDGYDLKQLIYKIAISKAYQQPAVGVESPLFLAEDDFVFEGAVIRRMTAEQFTDGVSQKIHPLFTEEEMKYDPNQLAVSEQSDIGFVRAALVANNGLLKALGRTNREVVMTSRDSQASLLQALELTNGEKLNNTLKEGAVKWKEKYEAGEIIVEEVYQQLLGRAPQEKEFNIAMAALGDQPEPEAIQDLFWAVLLLPEFQLIY
>fig|880070.3.peg.2053 Glyoxalase/bleomycin resistance protein/dioxygenase
MERAKKFYSQVLDQTLEEMKVPEGAGDLRMVCFPYVDGGINASGALVKSSEMKPGTGGTLIYFSCKDCAVEQSRIAAAGGQVVQPKFQIGEHGYCAIGMDTEGNTFGLYSM
>fig|880070.3.peg.2297 Glyoxalase/bleomycin resistance protein/dioxygenase
MEHKIKSIRPFIGAKDYKLSRQFYSDLGFAEIVLSSKMSYFKSGAFGFYLQDAYVKDWVDNTMVFMEVEDLAMHLEKIKAFNLPQKYSGVRLSEIVTNDWGSEYFLHDPSGILWHIGAFLG
>fig|880070.3.peg.2377 Glyoxalase/bleomycin resistance protein/dioxygenase
MRRIVPNIYSNNMAESKHFYGEFLDMELAMDLGWVTTFVSKDNPTAQISILENKNSSPLDNSAIFLSIEVADVNHYYKKAQELAINISYKIRDEDWGVRRFFVTDPNGVTLNLLSHI
>fig|880070.3.peg.2656 Glyoxalase/bleomycin resistance protein/dioxygenase
MSEFAHLKVNHVAIYAKDLEKTNQFYEEIIGLPKIEDPFKDHLHTWFGIGYGLSIHVIAREVPWKEQNIDRTNHLCFCVKDMDAFIKKLQEKNIPFGNSEGLNGKVNLRPDGIHQIFFQDPNGYWIEINDDFI
>fig|880070.3.peg.4530 Multiple antibiotic resistance (MarC)-like protein
MLAMVNPIGLIPIWYEMTGDASPKVRRKIALMVTGTSFLTLLLFLILGEYILVFFNIDIEVFKIAGGFLLMFTALSMINGSATKLEELKEEADTNFGLAKLRFEKVMVPLVIPMLAGPGSITTVLLYSFRATGPTTYVGLSGILLLSYFLLFLVFSFSYKVENKVDDILFVGFTRLFGLIVAAIAVQFMVEGLGEVFPNWMEGGSAVELEDK
>fig|880070.3.peg.4685 Glyoxalase/bleomycin resistance protein/dioxygenase
MTQELWLNLPVKDLQNTKVFFSELGFEKLRVAPEMIGFKIGGVSVLMVTETQFEKYALNKVTDTSQGNELLLSIGAPSKAFVDRMASKVEEAGGKVISVPTVIQGWMYGFTFKDLDGHRWNYLYMDFDKMKQ
>fig|880070.3.peg.5167 Glyoxalase/bleomycin resistance protein/dioxygenase
MPLISKEDQRHVFFRCGDSVLLCFLPEVTKHDSNLPPHYAYGKQHIAFEVEHKDYSEIKKKLNDKGISITHQQDWKKNISSFYFEDPFGNVLEIVPTGMWE
>fig|880070.3.peg.5344 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIEHIAFNVKHPLEVSDWYEEHLGMKVVKKMTTSPYMIFLSDDSGKAMIELYNNPAAEILDYANQDPLMVHLAFVSENPEEEKERLQKAGAVLVSDDTLDDGTRLLMMRDPWGLAIQFCKRANPMLK
>fig|880071.3.peg.1623 Acriflavin resistance protein
MKKLVEYFVKYPIWANAIIFTMVIFGAVSYGWVMKRSFFPETDPTTITVGVVMAGASPEEMEEGVTIKIEESLKGIEGIKEITSTSSENNASIIVQLERGIDADEALAEVKNAVDRINSFPTSAEKPLVFKVKPRSRTMFLGLRGREGKNLDLFLLKKYAEEIEDDMLASGIVSQLNISGYPDIEISIEVPEATLLRYNLRFDQIAAAVRLNNQDISAGAIKSKEEEILIRSRSKEKIAEKIGSIVLRANDDGSNLLLRDIATIKEQFADVPSSLHINGERAVSLEITKLQEEDLEEISIYANKYVEEFNKRHSDVEMVISFDFFDLLSQRLQMLIENGAMGLLLVLICLGLFLSLRLSFWVAMGIPISFAGMFVIAALMGITINMVSLFGMILVVGILVDDGIVIGENIFTHFEMGKSPMRATVDGTFEVMPSVFTSVLTTIVAFLPIAIGIEGFDFLQEMGLIVVLCLAVSLVEAFFILPSHLTHKDMGDTESDGKWRGILNKGIEFFRHKIYGTALKHVLRFRYIYVFVPVVFVMMILGMINGQLIKVVFFPNIPFDSFNANIAFKAGTPEEKVISYLEDFEVAAWAVNDDLKKEYNDEKDFINFTFRNLGSTSDGSESGSHAGNLSISLLDMDDREITSNEISERVRKKIGNIPEAETFTVAGQNRFGKPVSVRLLSKNNEALEQATEDLKKELENFSELKEITDNQRAGRRELQLELKPKAYFLGLTHSDITNQIRQGFFGEEIQRLQKGTDEVRVWVRYPEANRETLGQLETMRIKTTDGKEIPLSEVASYTIDRGIVDIKHFNGSREIAIEAELADPNGSPVAIIAKLQDSIFIDMKSKYPSLSFEFGGQQQRSSESQESLQFALPIMIFIIILLITLTFRSLSQSLLVMMLIPLGLFCAVFGHYFADKPVSLLSLWGILALSGVIINDAVVLVSKFNSNLQEGMSMHDAIYNAGVSRFRAILLTTITTVAGLAPLIMETSFQAQFLIPMAVSVAYGVGFGTFLILLIFPVIILVVNDIRRMTGYAKRWVAHTWKGNKGEVSYPTQEEVEPANREMARLKIMEEMEGL
>fig|880071.3.peg.2937 Acriflavin resistance protein
MKTNQNPFLHFLFSRPVGVLMAMLGILVLSLVAFSKLPVSLLPSLDVPELVIQLDYRGHSPEEIEQTILRPIRENVLTLNGLKRTESEARSQIGQVRLYFEFGTDMTLAYIDANEKLDRLLGSLPKELPRPRIIKINTADIPILHLQIVPKKQENQNNLLATSELVEKVIKKQLEAVEGISLVDANGLKEKQISISTNLRKLQSLGLSETDLITTIKSANQTLSSISVKEGQYRYFVKIATILEDKKDLENLPIRLNINSDATKNKQKGTVVLLKDIAKIELEEPTPQGFHLFNQKEAFVLTLHKQSQAQIQELTPKIDQTLEDLKQNFPELEFITTQNQTTLLNLAIDNLKNSLLIGGICVFLVLFIFMGNWRVPLIIGISLPVSLIYGFGLFYVFDVSINVISLSGMALGLGMLIDNSIIVLENIEQFRNRNFEMKEAAILGVQEVIAPLVSSVLTTLSVFVPLIFLNGLSGALFYDQAISAGAVLFTSLVVAFLMLPHLYLILNRKKSSMTTLDLLRGEKNKETKIYKFLLSLYQKIFLFLENHKKIFLSFSLFLIILPVFLFYQLDIEGAPKINKTDCSLLINWNEPIDATENKIRCKRLLETFSNQITFSESDIGQKKYFLQNDNSTQIQANLYLFFDNQNQKETTQNQIAEWIFKTYPATIFDFLPAPDAFSQLFISEEPSIELRIRTTTQNQILEYAIFDSIYNQINFETNNTAQKGKGTSRETLVLLEINTEKAALYGFSQQDILQKLTYELGEFAVTDLTSFGQIVPIRFKKGNKTVEEIINESSLKVNNVESNTDFAENSSQTINQIPLRLFIDFKKSNSYNTLTADELGIYQSVFWEDINNIQPTKQQQIKNDILTYLPNIQTNFKGTYFSNQENLTQFIFILSISIGLLYFILVAQFESFWQPLLVLFTLPLGISGSLLLLIFSQTSLNTMAIIGIIVMLGIMVNDAILKIDTINKLKKEMSLYDAVHEAGKLRLKPILMTSITTILAVIPILFSEGLGADLQKPLVWAVVGGLSVGTITALFFIPMAYFEIAKYQKNE
>fig|880071.3.peg.2942 Antirepressor regulating drug resistance protein
MKLKILVLFILIISFLGSYKPYKIVLEEEKQNELIKNSIQADYKIENIYKINRKSVLELNLQEGKKYKFQYFSKRYFDMILLDSQTEIRAKNKISYGDSSYFTKTIIFECKNTGIYNLKLEGKHFPNSSLLAVASQNIENQIDDKEEYTFAKKYHVAHKWYRSYSENPQYTCVFYKGVTYKYTFEKGIAALLFYNSRRELIMEYTPSTNEKEFEFKNKSTGIYYLTIINPINHKDSVAVINAYHNRPDSTDLK
>fig|880071.3.peg.3361 Permease of the drug/metabolite transporter (DMT) superfamily
MKNSTQNPLVVSWLLLLSLALIWGSSFILMKRGLLVFSPLEIASLRISAAFVALLPFAVFHARKIPLSKWKYLLVSGLLGNAIPALLFPLAQTQLLSSVTGVLNGLTPLFTVLVGALFFSQKLKYKQLVGLGIAFIGAALLSIAKKGGGFGDINIYVLLVVLASFCYGISLNVIKSNLAEIDSFPIASCAFLTVGIPSILFLFFGTPFLSHFQEAQEITIQTSVIPHSVLVWKSFFYIVILGVVGTAIALVIFNKVIQLNDAVFASTVTYFIPIVAIFWGVIDDEPLQSGHFIGMALIVFGVFVANRWK
>fig|880071.3.peg.3483 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDYLINKFRSAFLFFKSKKETLAPQSGSNTVAYSLKDDTVQKLLFAFVGPAVLGLLVNALYNFVDRIFVGQFVGAEGLSAVTLVFPVTLFQFGFILLLGSGSGILIAKYSGEERMDKAEDALGNVIAALLIIIILFTTAGLFFYKPLLVAFGAQGTLLNLSAEYLVIIIMGFPLSFFLAFEFTCRAEGNPSFPAKLILLSSIINVSLDYVFMKILNMGITGAALATLIAQSTNAILLIRYYVSGRSLVKIVWKKIKLKKQTILPILSVGFAPFLMDVATSFQNVFANVLLLETGGTDGVAAMGIIFGFNIFFMMTALGTGDGMQPIISYNFGAKLYERVTKTFEYALKMVLLVALIGLIMLELFPTSIISVFIDENENITKITKIAIQIFAISIPFYMVQIVMTRYFQALQRNKIATFLAILRPALFVPIAYVLNNMYGLIGIWVAFVVSDSIAANITLLFVKKYSTNELKPIKSINSDKQ
>fig|880071.3.peg.3632 Permease of the drug/metabolite transporter (DMT) superfamily
MKIPKIDKTILVHLALFAVALIYGANYTIAKEVMPLYISPSATILMRVLGAAILFWILVGKKRLILSNKREKIILLLSAIFGVVVNQLLFFEGLARTTPINAALIMTTTPLLVLMVSAITGGEKFTFFKIIGISLGLLGAAMLIGSKTVSDSSLPFSFVFDFNLGDLLILLNAVSYAIYLVIAKPLLKKYSALSISKWMFTLALPFVLPFGFSDLGTTNFEQIPTEIYVGLGYIVLFTTFLTYLLNAWALKSVSSSVVGIYIYLQPVLATFIAVALDKDSLTPTKLIWAACIFLGVFLVSRK
>fig|880072.3.peg.2641 
MIKVIMERTIKGRNVSEIVRLLRMLRVKAMQQPGYISGETLHAIDDPNSYLVISTWENLKDWEAWFNNPERQKLQAELDKYLEVPTNMRIFTY
>fig|880072.3.peg.3030 Polymyxin resistance protein PmrJ, predicted deacetylase
MRLALKIDVDTLVGFKEGVPALLALLAQKGIKTSFFVAMGPDHSGRAIRRLFTHKGFLQKMLRTGAPRLYGFKTMCYGTILPGPPIAASAPELLHKITAAGHELGLHGYDHVRWQDSLSRLSTPAVLKEIIQAQKVFVEIMGYPAVSFAAPGWQCTAAALDVLVQEKFYYCSNTRGYGPYLPCTPDRTWPLLEIPTTLPTMDELLGLNGRTGADFNREILASLKSGQTQVLTIHAEVEGRLYAAEFSSLLDQIQDKGVKFIRLLDYAQELWRYPELLEKAEVAPGRLPGRAGTVSCQHSKRGTV
>fig|880073.4.peg.891 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNDFQPIIYRNIHGTIFRLSLPGMISSVLETLFQLIDAYWVGRLGADALAAIGGCAFILWAIFSLTALSVNGIAALVAQNIGAQKAEEGRVAAGQGLILNTLTVVFAGGLVYLFQNDLYRLMGFDARVLSLARQYMSIILSGMIFIFWFTAFEAVFRGLGDTKTPMIVLAFGLTLNAIADPFFIFGWWIFPEMGIGGAAFATVVSELAAVVGLWWLLKRKHYLPTFNRRLIIDRALMKKLMAIGAPVAFGGFFFSIIYVVLTRIIAQFGMEAIAAIGIGHRIEGIAWFACVGFSVAASTLVGQNVGAGRIKQAAKAAWLVNGYGVAILLIVSAIYYFFPDVLMGVFTQDPLVQKIGTDYLRIIALFEIFLALEVIMEGAFSGAGYTLPVMLVSVPITAARIPLAYLLAVNMGLGANGIWWAIAITTGLKGFLNAVLFATGIWKRKLQREVNHEIEQNR
>fig|880073.4.peg.1720 Permease of the drug/metabolite transporter (DMT) superfamily
MTRLKADLGLLSVTVFWGTTFIVSKLLLSEMSLAVYMFYRMAVAALAMTLIALKFKKAWNKQVLRHGLILGVLLYASYFFQMWGITQTSASNAGFITGLSVVLVPVLGFLFYKEETPLQVWGSVILAVTGLLLLSGANPFKWSVGDLKVLICAIIFAFHIIYTGRFSRVNNVYLLTAVQLVAIAAFSFLAFLPEVQTLSTISLKNVILLIYLALFGTVFTFLMQTSMQRFTTVARTAIIFSMEPVFAALFAFLIAGEKLTAEGWLGGLFIVLAMVNAEFPYQSLRRQKQKS
>fig|880073.4.peg.1801 Permease of the drug/metabolite transporter (DMT) superfamily
MRSTKLIAILVVVLLSIIWSSTWLAIKIGLESLPPFLSAGWRFLIAFVPLFIYSIKMDHPIPRDLKTHLFFLWFSVINFTGGYALVYWGEQYINSGLASVLFAVMPFYVALFSIKLLPSEDITLKKMLGILTGFLGVVIIFHDQLNITHPYGIYGMIAVLISPAFSALGTIVGKKARAKFHPVTLNTFPILYAALTLFLLHLATESGQTATYDLNAILSLLYLALLGTALAFVLYFWLLKTTSAVLMSLITFVTPPLALFWGWLIRDEQISWQLIAGMVIIFAGIGLVSKASEK
>fig|880073.4.peg.1838 Acriflavin resistance protein
MLPPLNFPQITVHVSYSNSSPEEVEQNITRYLEEAFSTVNGVTDVISRSLSGESIITLKFAWGTDMKYAALNVRQQADRVYSYFPKQAGRPVVNLKQPQNRPIVTLALSGNSLWELKRFAEYVLKKRMEQIPGIAEAAIIGAPVREIKVYIDPDFLRIYGFSYNDIEQALKNNNILISGGSIKKGHFRLALRINSEVQSVEDIAQIPVLNRKRGTFVPLKKLARVIDGSKEPESLARINGKPCIAIDIYKESQSNTLKINSQIEKVVKEIRDAFPDIKIHTIYSQASFIRTTINNVSYAILSGAVLAIAVLFFFLSNWRAPLIIAISIPVSVIIAFLCMKYFGIGLNIISLAGLALGGGMLVDNSIVVLENIHRYRENGFTTFEAAVNGASEVALPITASTLTTIAVFIPILFLKDVSAAVFTQEAETVTFALLASLLVSLTLLPVIFILLEKKRKTVSENVLVSKGLERFYESGINFTLKRENLFLSVVFFLLILSLFLLKNLDRRLLPETDQHAVEMRCNYLPGVSLNYIDKHIQRTEKILKEQQGIKYYYAELGKKQGVFLEPDERKLNRSYLYIQLDKNQNSNRFIHHFKEKNRSGEKIQIEYRKIEPALSGVLGKKEAPLSVFISSPSLKILDSLGHALVQKIEEIQPGAIYNSNFFERYPTISLDLDLERMALYDLTASDVAQLLKVALNGVVATQLRDFDRKIDVLVKAEESFRENLDKLLNLRINNYPIRNFVKIKRTNELSYIERKNQNRVFRLDLNVENISNFVKKLNTQIEEIDRPSDSNIYLGGEWQESGKSIKQLYFAFIMAIVLVYLILAAQFESFLAPFVIMFTVPLALIGIIPALLITGMTINIMSVIGLVVIVGIVVNDGILKIDFIQRHQRKGMNLNDAIHAAGKMRIRPIVMTTVTTLFGLLPLALGIGPGADFQQPMAIAIIGGEGVATILTLFVLPLLYKKLVSK
>fig|880073.4.peg.2008 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKPAAKSSRALGEEKIGPLLFRLSVPATVGMLAMALYNVVDTIFIGRGLGALAIAGVSIVMPIQMLIFSLSQTLGLGAASIISRRLGAKDLGGAKNAFGNVLLLNIVISSLIVFLGYLFAEELLYLFGSQGAMVSYAHDYFVYILFGTPFLMFDMILNNVNRAEGNIKFAMMTMVMAAVLNIIFDPIFIFTLKLGVKGAALASVLSQFLTLLVLLYYFYSGRSNLTFEWKYFSPNFKVMKEILAIGASSFARHGAASVLAAILNHSLFIFGGEMAVAIYGIINRILRMTFMPLFGLVQAFLPITGYNYGAGNYERVLQTLKFAVKYATLTVIGIFIFLMIFAQPIFFLFNDDPVLVKEGARALRMIILLTPLIGFQMIGAGYFQALGKALAAFILAIARQILFLLPLIFILPRFYKLDGIWLAFPAADILAVGVTLLLVVPEWKRLKAKVDLINLHSQN
>fig|880073.4.peg.2443 Acriflavin resistance protein
MTLPRFSLQNKYTIYALSIAAIIFGVLAYISLPIQLFPDTAPPLVNVLTPYPGAAAKDVADLVSDPIETECAALEGVHKVTSTSQDGLSLVSIEFNYDRDVDIAAVDVQNAISRIRSKLPRQIGEPQVLKFSTSDRPVLTMGLTGENLVEIRRLAEDILAPELQRVAGVALVDVFGGHQPEISVLVDRDKLEAYRLRLPMIVNAITTHNVSLPAGQIRSEGRQYSFRVDERSRTPEDIRNIVLTTPMGKRIRVGDIATVSEGSAEDLSRFHVNGKSAIAMQIFKQDDANTVDVVEKAQQKFAELQKRYPQIKMIEAEESASFTRQVVSNMFGSVWQALLLAAIIIFLFLSSFQRGLVVTVSMPMSFLLTFAGMKFFGIEVNLVTLTAIILSVGMVVDASVVILENITRRYHEDKLSPKEAALAGAEEIQFAVIAGNATTLVVLVPLLFLYGFIGKTFGPLASTLIIAFVGSLLVSLTLVPILTELVTREGGKLEKLAIKITAPWNRAMEKLRGFYIGLLTRSLKARWLVFVTAIALFIVGLGLLRYLGMELLPKMDGGTSFVTVETPSGSSLDETEAVVRQVEQIIMQEPEVERISTQIGFEPGMHSFGGGGVQGPTNAFISITLTPRTERDETIWQIQDRIRQKLAKIPNIQNYVVRESGSTAKVTTAASIVVSVRGEDELVLNKLGDQILEIVRGVPGVVNPYRSWRMDQRSILLSVDEERARELGLPPAAISQELTQSLDGINAGILRGPLGEDTPIRVRYSKAFRETEQDAYAVRALSPGDGNIFPVGAVASGREVKVQGLVTRENLEPTLQILALHQDRPLNFVTADVEKAVAQIVAPQGYSIRLEGENKDMAESRDELMGALGIAVIAIYLLLVAQFRSWVHPITVMMAIPLSLIGVSIALLIAGKSVSMPVMVGLILLVGIVVNNSIILIDFIRQRREAGAERQKAIIDSVATRFRPIMMTSFSTIVGMIPLAMEWALGAERFSPLAIAVIGGMTAATFLTMLVIPILYDTFDELGNKIRNVSLK
>fig|880073.4.peg.2539 Daunorubicin resistance ATP-binding protein
MELIAEKIVKRFGNFLVLRNISFQVKSGSSIAITGANGSGKTTLVKILCNLMAPTRGKVIYRNNGNVIERGEIYRYIGLVGPYLQLYQELTAQENIDFFARMRNLKNYSEKIRKMMELFKLAGREDDPVKTYSSGMQQRLKYICALMHDPEILFVDEPRSNLDQEGIQAVYRILEEHKKEKILVISTNDQDDLLLADQIIKVGN
>fig|880073.4.peg.2786 Permease of the drug/metabolite transporter (DMT) superfamily
MLNYLILLFGVFVTSWSSIFIRWIGDVHPLVISFYRLFFSVLVLSPFLLKRMKSGRHLPSNVFSKNTLFLILSGFFLAMHFFTWIQSLQWTTVGNSIFLESTHPIFAVILSYFVLKEKSSPLIIGGIALALLGIFVIVNSDMGAHPFATLGDFLAIISAFCLAAYLLIARFYRQKIDLLPYLVLVYAAAALFTLLLILFLKINFLNLALKSWFFLGLLALGPNLIGHSLLNWASRKMPVYLVNLAMQGEAVLATFYAALLLNEIPGEQFYFGAGLILLAVSFIFLNRR
>fig|880073.4.peg.3764 Permeases of the drug/metabolite transporter (DMT) superfamily
MAFSISLVLNTVAYHLLLKAIAHYPVSIVMPYVGLTPLFLTMTSYLILGEALTKGKIVGIIFIVLGGFILQLPENLKEKGWRHLINWREKGIWMMVLVAFIWSITASVEKIAVNASSPEFYGAFIHLALGGVFVFWGKWQNRNSIKKPEALKITSGGKKYILLIGIVSAALAWCQLVAIKLTFVSYVIAFKRAGVLVSTLLAFFILKERHYLKALSGTILILTGAAFITL
>fig|880591.3.peg.1325 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIVAISGFSVISRDGPTSAALYIDTLGLPMQQQGDYAFIDGFSGAHHFGVWPLKDVAQACFGMDDWPDDLSIPSASVEFELETAAAVAVAVAEMQAQGQVFIHTARDEPWGQTIARFISPEGVLTGLSFAPWLHDAT
>fig|880591.3.peg.2299 Permease of the drug/metabolite transporter (DMT) superfamily
MFGVAAAGFSRGRIDPPTLVGMSAILMWSATVGLYRNISEIFGPIGGSALIFTVSGIVALIHAGPKAFRGHSPRYLLIGGAMFVTYEIALALAVGFAQTRAQSVEVGLINYLWPSFTIALAIWAGHARAGIMVIPGILICLLGVFWAATGSANFSLAAMVHNIGSNPLPYILAFIAAITWPLYTILTKGMAQGRSAVPLFLLATAALLWVYYGVSDQPTLVYNSKGAMMVLTFGVLTTLAYSAWTYGVNHGNLTLMATASYFSPLLSVMLSSVLLSMVPGLNFWLGASLVTAGSLICLAATKR
>fig|880591.3.peg.2576 Permease of the drug/metabolite transporter (DMT) superfamily
MPLSPKAAAAAATILWGFTYILTTTMLPHNPWFIAAVRALGGGLPLLLFARALPPAGWWGKMIVLGTLNNGLFFGLLFVAAIRLPGGVAATFQALGPLFMVLLALPLLGVRPAGGKLIAVAAGVVGVAMVVLQGGAALDLIGVLAALGAALSVALGGTLYSKWKPPVSVVTMAAWQMIIAGIELAIIAAILGDIPPAITATNVLGLAILALAITALPFVLWFTGIKGVGPAAVAPMLLLTPITAFVLDALVRGIVPSAVQTLGIAIVIGSLLYGQYVDRNTAKG
>fig|880591.3.peg.2589 Permease of the drug/metabolite transporter (DMT) superfamily
MLTRLWNSPQILLTLASLFWAGNFVVGRAILTEAPPVAMAFWRWALAIIPVVLVARGRVDVKHELALVRRHWLIIVVLGVLGISCFNTFVYLGLRETASINALLMQSAMPLLILLACFVLYRERPLPQQIIGVVLSLGGVIFIAARGHLETLTSLGFNTGDLWVLAAVVAYTFYSALLRKKPAMHPLSFLVALFIVGALALLPPYLTEHASGQVMRLTPQMVAALAYLVIFPSFLSYLCFNRGVELLGAGRAGLFIHLLPVFGSALAVIFLGERFESFHLIGAVLIGVGLLVAARRGRSARRKMS
>fig|880591.3.peg.2884 Daunorubicin resistance ABC transporter, ATP-binding protein
MSTTTPADAVNAIEVRGISKRFGRIEALKGVDLTVPKNSIFALLGPNGAGKSTLIDILCTIRQQDKGTASVAGFDTRKNPLSVRRNIGVVFQNPTVDSRLSVRENLEFHGMVYQMPYRARKKRLLEVLELVDLSDWIDATVGSLSGGMKRRLEIARALMHEPRILFMDEPTVGLDAQSRAAIWDHLGRLRAGSDLTVVVTTHYIDEVDSCDRVCIIDHGMILADDAPQALKDAHGTTTLRLRPTSPDTASALRSRFPTAQPGAGDTLVLPLTGTEDLAGLMAEIGPLSSGLELHQPSLESVFLGLTGRDLREAGPAKPARKGARNG
>fig|882.5.peg.62 Outer membrane component of tripartite multidrug resistance system
MIRRMTAMLLGAALLSGCAIGPDYQRPGMDLPSAWRAESADAGMVAGEKWWTLFGDATLDALEEEALAANGDLATAMANVDASRAQLTVATSYLLPSITGQGSSVRQRGSERGQNPPVEGREVTDLHKASALASFELDLWGKYRRAHEAARAGLLGTEAAYATVRLAVVSQVAQSYFGLRAADRQLDIARQTLTSREESLKIREARFNSGLTSELDYRQAQAETASARASVRQLEQAVAAAETALSSLLGRSPRDIVERSPERGLDIETFAVPPQIPAGLPAGLLARRPDVARAEADLHYATASIGVAKADLLPAISLTGLMGYESIDLTRLVSSSSGTWSYGASATMPLLDFGRTLANIDMADAKQRAALAAYEQAVRDAFRETQDALVANRKTRQVVDAQATQVAALERSLTLARLRYENGYSSYLEVLDAERSLFQAQLNLVEARRNQLDAVVQVCKSLGGGWKAPGEEGADATGAAEAASGDADDAAPQGVAPTPPRTEG
>fig|882.5.peg.1901 Permease of the drug/metabolite transporter (DMT) superfamily
MNVRLRAYIHLTLAMCIAGSAVVAGKLMVSSMPVFLAAEAGLLASLAVQVPFTFMMKRERIPADLSVHLYLVLQALFGVVLYRVFIFQGLQHTTATVGGVISSTTPLCIVLLSAIFLREHITRRTIAGAVCVVTGLATISLTPLMDATPAATGSFTGNVLILAAVVSESAFSVMSRAKRDHLSPLARTAMVSVYAALCLLPFAIHDALHYDMATLDAETLSCIAYYGVFVSFLSYLLWFKGVAVIAAGTAASFTGLIPLSSMGIAWLVLNETITSAHIAGLACVGAGIVIACIRPATSPTTSSVAV
>fig|882.5.peg.2194 Permease of the drug/metabolite transporter (DMT) superfamily
MTMAFGTGELAALGTACIWAVSCQIHSQLSREMGATNLTLLRLPLAVALLGAACVFSGVSFDHPASVWWYFSLSGLTGVALCDWLFYGSTVLLGPRVACVCQSLAASMTAFLGVMFLGESLGWAGVLGIAVATVGVIIVVTDGGGRSDGLATTPGQRRKGIALALGSALALALAMFFSKKGFSTGADPLFCAFLRNVAAAVVFWPVVALMGGSRAAMQSLRSGRGVLPRMALGAVLGPGIGMWLSLVAVANTDTGVAATLIGLEPIAIMPVVWFMTGRRPTVRAVVGAAVAFAGTALLLMRHHL
>fig|882.5.peg.2608 Permease of the drug/metabolite transporter (DMT) superfamily
MKVAVQTLGTWQMMWARMVFALLLLVPLARRLAPARIERRDLPLLAGMALMQPCLYFLCESTALQLTTSSQAGVMAASMPLMMAVGGFLLGEKVSPRLWFGVGVSCIGVAWLTSSGGEGGGSAPDPFTGNLLELAAMACATGSSLCIGALISRGKGRWNALTLTGIQTLAGAVFFLPGAPGVIGGVADWSTEVLLAVVYLGGASSLGAFGLYNWALGHMPASRAGNFINLVPVAAIFFGWLLLGETLTTTQYLATGLVMGGVLMGTRAR
>fig|882102.3.peg.1539 Drug/metabolite exporter family transporter
MRPIKSPIFLAVLTLLLAMTTIQSGASLAKQLFPIVGPGGTIALRVGLSALILLMIFRPWQLRLSLSQWRSMIIYGASLGGMQLMFYFAIERIPLGIGVALEFSGPLLIAFLSSKRKKDLIWVALAILGIVFLLPDLTGVDALDPIGVALALAAGGCWAAYIWFGQRAGSVGSGGSTVAIGMTIAALFAFPIGVVLSEASIFTWSILPMALSVAILSSAVPYCLEMSALKRLSTQHFSVLMSLEPAIAALAGLIILQEQLSLTQWIAITMIITASMGSTLSAKK
>fig|882102.3.peg.2954 Acriflavin resistance periplasmic protein
MKRRIWIACIALITSGYWAVGYADDRYIVTYEQIPQQIAFEGVVQPVNKGTVAAQTSGRVVGVYVDVNDFVKKGDVLLEISAIQQSASLDASQAQLTSAEARNREAQAQLKRYRLLFPKGAISQDQMDGAEAQARSAAAAVKAAKAAVVQAKESLGYTNITAPYDGVVTERHVELGETVAPGTALLSGFSFNELRVETAIPQRYQPAVTNVAQFQVIMPTGDKITPIDYSLFSYADPQSHTFKIRLELPRADQTNKLGQVMPGMWVKTEFNYGQREVMLIPVAAVIRRAELSAVYRIVDDKRLLNPVRLGQTYGEYVEVLSGLEQGDTVASRVFTQVGE
>fig|883.3.peg.2258 Efflux pump antibiotic resistance protein
MVLATVCIAQFMVPFMLTAVGVALPSLGRDLGASAVQLGLVEQLYALALAMSMLACGRLGDIVGQRRVLLPGLAVFTGITLLVGLAPSVELVMALRFGQGIGAAMMLSGSLALVAVAYPPELRGRVIGIVSAFTYAGLSIGPVLGGYTTDHFGWRSVFLMVVPPGLGATAMCLWRMRPQPGADKGAHMDWPGSLVYAASVCMVMTGAARATSVPLGPVLMAAGLAGLVLFLKVEGRSKSPLLDVNLLLRNRFFSLSCLAAFGNYAAVFGVTFLFSLFLQYAKGLPPREAGLILLIQPVMQVLTAPLSGRLSDRADPGRVATAGMLFSAAGLLLAMATLSPGMPVWLLAAELVCIGIGFGIFVTANSVAIMSSVDKAHFGVASGMVGAMRTLGMACSMTTVSLIFALHLGEAAITPAVLPEFLSATRTGLAVAAAFSCLGVLVSVGRGRKRD
>fig|883.3.peg.3374 Permeases of the drug/metabolite transporter (DMT) superfamily
MLAALDATLLRRLAGDLPPARMVAYPVFWSLPPFLALLAARGVSDLPAPFWLATLAAVPVNMAGHLLTAWAVRLAPVSRTVPYLCFSPVFVVVHEYLLLGVAPRPAGVAGVLLVVAGSWVLNAGGAETHDPGHDEDGGSGIMTRLLRPFRTLMAEPGARIMLGVALLWGLGSVLNRKMVLYATPAVAGGVFFAIYGPAMLAALMLFGGVRPRMLVDRPLRGAAMGAVLFLAAYAHFTAMSLTTAANMIAVKRLDGVFAVLIDRLSEWLAGRAEGPRSVRRAGLPAAGAGWRPVRDGRLPGAALMAAGAALVVLAS
>fig|883098.3.peg.2344 Multidrug resistance protein B
MLAFVMFINQSGAMILPFMAIYMEEELVFSDVKKGIVLGLFGLGSIIGSLYGGKLTDQLGSYKVQLMSLLCVVPLYISLAFLKNFELLCLGVLLTSCTKELFRPANSVSVAKYAKPENLTKAFSLNRMALNLGFSVGPAIGGFLAIYSFQWLFFANAFMSLTAGVLFWWYFRNKSTNALAKHKTEKIKTTDTRFKDYDFLLYSFFVALFAFCFFQLLNTLPLFYKNVALLKENQIGLLMAFNGLMVFSLEMFIIHIAEKKFTIATNLIIGMIFCGLAYATLLFSSELSFLYLSLFFLSLSEILIMPFSSTVAVHRSNTENRGKYMGINGISYSSALIFSPIIGTWIIEKYNFSTLWGVNIVISLITVFGFWHILKKWNMR
>fig|883111.3.peg.523 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQDLKEFIHYTLSNTLSMIGISIYIMADVYFIAKGVGPEGIAALNLALPVYNLVNACGLMLAVGSAIYFIQAKAQNNQPARNQAYSTGLIACLIIGGLFLLIGLSASSQLTQWLGADTHVYESTHVYLRYVLLFAPFFILNQFFSLFVKNDGYPQLAMYAMLTGSLFNTIFDYVFIFIFDMGMKGAVLATAFSPILGILVNSWHLIKGKPNFSFQVQAFQFQRLKAALSAGLPSFISELSVGLVMLVFNFLILDLAGNTGVAAYGILVNLLFVIIAIYNGIAMGTQPLLGRFYALRDFKGLQRILHYSLITVILVSLIFYSVALLIPHELIALFNYHEDLAMAQVAYQAFGPYFSQCLFLGINTVLIMYFISSNRARLAQVLAILKGFALVLPLALVLSHIAGLSGLWVSMTLSEGIVMALGLYYWRSSPRL
>fig|883111.3.peg.739 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKHMLGKLGLLLTALIWGSGFTFSSIALKYFTTFQVIALRFTIAFVILLVINVGKLKRISKDEFIKGVTVGVILFLAYFFQTKGLEFTTTSKNSFLTAVNVVIVPFIGWLVLREKLSKNALLGALISLIGIGFTSFSGGIGQIAFNFGDALSLIGAVFFGAHIFYMDHYGEGMPNWSLMLLQMGAAAALSWIAAFFLGEANIHFTQESILPILYVGIVATLVGYGLQTISQNYTTSNETAVILSTEAFFGMLTAILILGEPVMLTMIVGGILIFCGILVVDLKPLKES
>fig|883111.3.peg.935 Multidrug resistance ABC transporter ATP-binding and permease protein
MKAIRWDLSLIAGIVLTILAALMSVTIPLFLKTMIDGGGHFSLKNIFILLLLFVLQAALAGLGGFLAALNGEKTVESLRSRLNAHLIYLPQSFFDQQESGEFVSRIMTDSQEIREFVTQSLPNFILGIFTIIFSVIALIRLDWKLSLAMVITFPVMLSLLIPISKLSFANAEKFQTSNSRLTSKLITIYKNMAFIKLLTAEDQVSNDFDQANQENFSLAVQKKKIEAFTQPVGLAFLFAAITIVFAYGGYRVSSGAITVGTLMSFLVFTLQLLNPMGGLSDQISSYFRMKGASAKLFSFFEMAKEDVGGDQAFQAGDILIKDVSFAYQDKEIITGLDLVIPRGCRLAIVGPSGSGKSTLTRLLMRLYQPQKGQISINGQEINRIDLYQWRNAISYIAQGSFFISGSLRDNLLFGLKSRPTDQKIHQVLQQVGLSEDLARMEQGLDTPVGEDGNLLSGGQKQRLSIARALLREHSIIIFDEATSNLDADKESVIIQLIKDLPESITVIIVAHRLSTVVDADEIIFFDQGRITGLGSHRVLYANHEDYRRYVNEQMIQ
>fig|883111.3.peg.1311 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKQAVSRKEWMTQGPIMPMLLTLSAPLMFNNLVRTFYTVADGLYLAQLSAEDFAASSFSWPLNNLFISIGMGIGVAATALIAHFIGSNQLKKIQVYLDSTLFLTLVLGAMLTVLGIASSEWLLKAMGGQGSFLQKSDLYLKISFLGLFFDFGFFAYQSILNAQGMTKTLTIISAISMGVNLLLDPFFIYDQVPVFHWSGLGWGIAGAAWATLISKWVLLALAAWIVAKQSAIKPSRKWFRWDLGSQGHILRMALPSALGYGGSSLGFTVMNALITSYGTNTLAAFSMINRVSDIVMQPQMGVGMALTPIIGQNMGAKQFDRAHLIFKRAIQFILGMSILASACILLGQEPILRLFIKADAPRDLWNQAREYLYYSAFIIFFMGLFNALNGFFQGCGQTKYSMFMTMGRLWLIRVPIVFLLGRLTDLGSTGIWISMLISNMGIVVWGFYIYRRNNWELMSQMA
>fig|883111.3.peg.1373 Permease of the drug/metabolite transporter (DMT) superfamily
MKHKLSLLALLVVTLIWGGGYAMSALSLDYFTPVQTMAVRFSLAFLGSLLIYRRDLATMRWQQLKPGMWIGLMVFLGFIFQTVGLQYTTASKNAFLTTTNIVFVPLLNLLIFKKHLSRQKWLGVLLVLLGIGLLSIDFKDLSQLFTYNIGDGLTLVCALFFAGQIILIDHFLHELSSASLMVGQLGTAAFLSWLVCLWQGDLSFSSHPTGWAALLYLSFASTLIAFALQTWAQKYSSPTQVAVILSTEALVGMIASSLILGEPITSTIFIGGILIIVGVLRVELSGN
>fig|883111.3.peg.1558 Zwittermicin A resistance protein ZmaR
MIYQESSDINEACKNLFNPPWNHILDSVLSGFQGRVLVDRLTSPQSALAIVGKGAPFAFLGGQVNEDLWMHLPKGDLIMVPQSSAWSNYLMTIKQHEVRPFIRYAMEAPQKFNGQRINQMKQSLADSYSISVINQQLFNQCLEETWSKDLVSNFDNYSDFCQQALGFVILNQGKIISGASTFFPLANGIEIEVDTHPRYQGQGLASIGVSYLINACLDREWYPSWDAHTAISRDFSKKFGYSVAFDYQAFEWK
>fig|883111.3.peg.1620 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNMTEGPIIKKTVLFSLPLIIGNLFQLFYNMVDTFIVGRTLGLEALAGVGVSGSLTFFILGFAQGFTSGTAIPLAQAFGAGDYRKVKRSVAINIMLACAVTGVLTLASTYFLGDILRLIRTPEEIIGYAYDYIFIIFAGMIVTILFNMLSNILRAIGDSRTPVVALIVTTVVNIILDYVLIIYFKMGVKGAAYATVIAQVAAIMICLYVIYKGIYVLQVEKKDFKLVGDELALHCKLGFPMGFQMSIIAIGSVSVSMALNTLGPNAVAGYSAAIKIDLLVEQIMASLGLAAATFVAQNFGAKKYDRLLTGVKKLVTLNILISWVAGLIVFFVGGQLTAIFGDQAVSNTLYEYGNTFFHIMGPSFWLLAILFVLRYSLQGMNDSLFPTLAGIGELVMRVLAAFFLTPRMGFAGAVLANPMAWIGSVAFLIPAFLMHQKKLKAIMNATQDQLSMVE
>fig|883114.3.peg.457 Multidrug resistance ABC transporter ATP-binding and permease protein
MLTGYGILAFSDATIYPISIILIMGFTISWPMTLISIILLPLLIIITKILGQKLHVGYLKLQKSYEIMNESVMENISSVRVIKGFSTQEVSSKRFEKAADDLYEDQFKQDKLHSLFIPSGRLIPSLTFIIALIFGQHLMSTGNLTLGQLTSFFLYLNMLVWPMFAFGDLVNVIQESSASLVRLQEIYDYKEDLVDIENPEEYQAKDSITFQNFSFKYPGDEKYSLKDINLKINKGETLGIVGKIGSGKTTLLKQLLRFYDIAEGEILFDGKPAEMYSIKSIRDKTGYVPQQHLLFSKSVYDNIAFGKENATEEEVMDAIEFADFTKDLDTLPNSLETMIGEKGISISGGQKQRVSISRAIIKDPEILILDDSLSAVDSITEKRIIENIVTNRQGKTTIIVAHRLSGLKHAENIIVLDRGEIVESGTHEELIKNRGWYYSQYESQKSGGSDE
>fig|883114.3.peg.763 Permease of the drug/metabolite transporter (DMT) superfamily
MSNILKKKPIAYLISIFCMFLWGSAFPTIKLTYGELNIGKGDYFSMIFVAGLRFFLAGVIVFILMLIFDNKSKIEFKIKFWKLLVLSLIVTTFGYLFFYIGTGNTSGMKSALITSLSTFLVVIFSHYFLQDERFNRYKFIAIILGILGVIITNIDKEFNLIFTLTGEGFMLINSILNAMGTIYVKKYLNKVSPFVVSSSQFLFGSIFLIIIGYFGMPTNLVFTPKSVILIIYASLISSIAFTLWYFILKQYKASEIAFLRLFIPFFGTFLSAIVLGENLSFSILIGLVFVILGIIIINRNKTLIEKK
>fig|883161.3.peg.911 Multidrug resistance protein 1
MNAKMAEITRLGRRDRITQTALLVAQTLAICVFCLSLGLLIADALSPASVSKTAILVALGSLLIATLTGYLAASIAATSKADLEATLRQMVIGHSLALGPARMSQAQTGAVVSMATDTVDRVANFRQSFLGTTFSAMLSPLVTLVVVAVAIDVPAALVLTAFLPLILATIYLFQKLFRNVSGESRKARTKLAAAFLEALQGLTTLVSLKAADRVGDRLAERGEKNRQATMKLLARNQLVILVTDAAFSLFAICASVLVAWWRLDEATISPGEAIALVLLSTQLCAPLAKMGSLFYVGMAGRAGQRQINKFVSIAVPDQNEAQAAQNFDPVRFESVDFSYAEKPVLKDLDLSVKQGQKVVLLGRSGSGKSTILSLTGGDLLPDQGSVSVAGIELTSKTQDQVREKSAVVNQKTWLFLGTLAQNLRVGNKNATEDEMWQALAQVGLDTWARSLPDGLDSQVGERGMAMSGGQAQRLSIARAILSGRKLLLLDEPTSQVDLNSEQIIMSAIDRLAEDHTIVLATHRPSSTKSADLIFNLEER
>fig|887898.3.peg.477 Probable multiple antibiotic resistance protein marC
MVEDSFTAFLVGSFVSLITIINPPATLPIFTSVTGNLDADATRRTATSASIYCFCILVGSLFAGSLIMKAFGISYGAMRVAGGMIIALLGHGMLYGKAEVSEVAKAQYSNPAFFPLALPGITGPGSIAVVIGLETKIRELGTFQHRISAYLAVLGAMLGVCLVEFLLLRSARTVTTRLGNTGIEVITRLSGFLLICVGVQFVASGAQTLYATLVQAAAATAGH
>fig|887898.3.peg.1757 Drug resistance transporter Bcr/CflA subfamily
MLKNTGITIALAMLSMVGALGIDAYLPSFPAIIQDFQATPLAVQQTLSIYVGAMAITTLFAGTLSDSFGRRPTVIVSLLLFTAGSALAIFAKDIQVLLLARGLQGVAAGFGAVLSRTIVQDRFQGAEAQRVMALIMMVFSIAPSFAPVIGGWLQATFGWHSVFIMLTGYGLVLWLIWQLGIPETLPKAQRMPLQLGRIVGNYGKVLFHRVFILRVLSIALVFIGVAIYISSAAPYIINILGLSETSFAWMFIPMTLGMLGGSSTSRRLARKVAPSRLTFVGFVLMLGATFTSVVYTSVATPQVPWAVIPLGIYTLGMTLAVPGMTVQVLSIFPQMRGLAASLQSFVQMGIFALVSAFVAPLLFHSAQWLAIAHFTGVVIAALLWALGPRHEAGAGAAPAGHAPGTPGPQGAPAASGTAAAPAIAQPAPEKSAPSSDTSKARS
>fig|887898.3.peg.2487 Permease of the drug/metabolite transporter (DMT) superfamily
MPVSRWKPEHLGLFYGLLGSMLFACKGILIKLAYRHGVSTETFLGLRMMWAAPFFAWVAWRSDGAALRRRWHRQAPAGATGLSDDATPRADSVWRSGDVWRVAGLGFSGYYLASYLDFLGLQYVSAGLERVLLYLGPTFVLLLSVFWLKRPVSRTQWTALGVSYLGVILVYLHDLDGSLQVNVPLGSALVLGSCLSYSFYLVGAGEMVRRLGPMRLTAWASLVACVLCVTQALLVGGGDLFRQPIEVQGIALMTAIFCTVFPLFLTTASVNHLGAGKAAQVGMIGPVWTIFLGAVVLGEPTGGLQIVGTAVVILGVLILSRAATRR
>fig|891968.3.peg.19 Permease of the drug/metabolite transporter (DMT) superfamily
MNAREPKFAEAEIGLKESVDWPSLIALMVTLLVWSSAFAAIKAGLSFYSPLHLAVLRFITSSIILLPFLLFKFGLPDLSDLPFIFFLAATGMLLYHIPLCIGEQTVSAGSSSLLISTAPVFTAIIAVIGLKEKMTFLGWTGIAVSFAGAALIAVGESGIRISFGALWILCAAFMESFYFVFQKMFLPKYGAFRLTSYVIIAGTILMMPFGKGLFDAVAAAPLSATLTVVYLAIFPTCIGYAGWAYASSRNPASLVASSLFLNPVLAIFIAWVWLEEIPSLLSVIGGSVAILGVWILQRTR
>fig|891968.3.peg.50 Permease of the drug/metabolite transporter (DMT) superfamily
MGVGVLFISLMVGKHHNLSRSFKELVYMALLGLMGVTFHNWIQAEGLKTAQAATSAWIVSTTPIIIALLGWAFLKEEVTKKKLIGILSAALGVLMVLGKGSSLLPQGITKGDLLISLSAVNWAAFTVISRKFLGDKDQTVSLFYVMLFGWAFSNAFALPSGIYFAMSWQAWISLAFLGIFCSGIAYIFWYDALHALPASQVGVFMYLNPLTATATAIAFLGETLSPRDIVGASLVALGLWLVNKKKP
>fig|891968.3.peg.75 Permease of the drug/metabolite transporter (DMT) superfamily
MKREAEERPLFLPIVVLLIGVVAVSTGATIIRLADAPALVISAYRVGLASLILIPAALLFARKEIMSLSFADIKIAIASGAFLSLHFAAWISSLDYTTVASSVVLVNTNPIWVALLTPFLSSDRLTKMSILGVVFSVIGSAIISAGDFALGGKALLGDLLAIAGSWAAAFYLLFGRRLRQRMSLLSYITICYATAAIILFAIVMGLGYPLHGYPARTWLCLWGLAIFPQIIGHSSYNWSLKYFSASFVAIALLGEPVVSPILAYFILKEAIMPVTVLGGLLVLVGIALAALGESR
>fig|891968.3.peg.219 Membrane fusion component of tripartite multidrug resistance system
MKMSKKAKKYVGMAILLAAAIVCGVYFLPKVFYNFTHVSTDDAYVEGTIVPIAPQVSGKVINVYAERNQLVKKGQILFEIDPTDYVQEVEDTKNAYEASVVQLEDIKVAIQGKEAEIEKAHQDLLASQAKYEYAQKQRDRYYNLLKENVISQDEYDNVEAAFKVNQANVAAQIANIKKLELDLKDLQTQLIKQQHLIEQAEAKYELARINLDRTKIYAPIDGYVAKRNVEVGQHVQAGTPLLNIVDLTHVWITANFEETSISKIRVGAKVAVKVDAYPGKIFYGYVHSFQSGSGAVFSLLPPENAVGNFIKVVQRIPVKIDLTSPYDPNAPLYPGLSVVPYVSVK
>fig|891968.3.peg.220 Drug resistance transporter, EmrB/QacA subfamily
MLGTLASALLGSIVNVAIPYIQGAMGASIEQITWVSTGYLLSNTIIMPIIALLSARFGRKNFYMFGMAVFLLGSALCGISWNLYSIVAFRILQGLGGGILIPVAQAILREVFLKEEQGMAMSIYGLGVVLGPAVGPTLGGWLIEHHNWRWIFYVNLPIGILDLILISLFIRDPDFLVREKSKIDYLGLFFMVIGLGAFQVFLAEGENKNWFASPYITRLAIISALSTIFFVIRELTTQNPAVNLRILKNINFTMGTLLGGTLGMGLYGGLFVLPLFLQNLLGYTPLDAGLAMLPRAIAMAMVMPIGGRLFNRLGPKPIVGFGLILVVISFFQFSKLNMNAGYWDIFMPQFLQGTGFGFIFVCISTSTLLTIEKKNLTFATGIYNVFRLISGSIGVAIAATFVDRGTNNYYSLLAKNVSLFNRNALEYIAKVEQVLGLPHSIQPDMVTKEVLNKLVLEQAQMLSYNHVYTLIMFVFLASIPLVFFLKGLKDVEIDESGT
>fig|891968.3.peg.231 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNIDNKTERLGREPVGKLLLYFSLPAIAGLFANALYNIVDRIFIGQNVGEIGLAAVTVAFPLFEVSIALCVLICVGAASIASRSLGAGKKKRAELVLGNALALSLIFVLFVCLGMLFLLNPALKFFGASEAVLGSARDYMLIVLLGMPFFMISFVLNSLIRVEGSPRWAMGTLIIGTIANIFLDWLFICAFGWGVKGAAWGTSIAEFLSCLWVALYYAKYSVLKISYKNLKIRMPLVANILAIGITPCITSISFAVLLVILNQTALKLGGDLAVSSVGIFLTLDTLFFLPALGISEAAQPIIGYNYGAGFYHRVRRAIMLALISCLCAFSLSWVATQFFGWQIVRIFCNDHKALIDMTVRALRIGYFFLPAAAIFVVTSYTLQSLGRAREALIIQLVRQLGICYPAMLIMPHIFGLDGIWMAFPATDLGGSILAFFAMYRELGKLKEENVVALKVASDRSSGCR
>fig|891968.3.peg.1015 Permease of the drug/metabolite transporter (DMT) superfamily
MFEPKSKKAVLLADAALFVAAMFWGSGFGVTNWLLKFMSPLWLLSVRFMLSAGILALIFRSRLPLLSRRDVFLGFLLGSLLASTFIAHIFGLLFTTPGKQSFIAGSNVVMVPFIYALIYRKMPSLIATAGAFLTTAGLLIMAFTPGMSFNFGDYLSLLLAFGCALHVLFVGNLSRKMDPIALTVVQITAASLILTVLALFLEPLPPFGKVPSKAWLGILYVAVFVTVIPFLIQTVAQRYSPEIHAAVLLSLESPSGYMFAYLIGEELINFQVILGGMVVFAGVVLTELEAFLTKKFHHSSHEDAMTLCDINGSRDR
>fig|891968.3.peg.1058 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKMRVDMGRDPVSKVLWSLAIPSVITMFAHTVFHIVDTMFIAWLGTVPLAGMSLMLPVIFVEYALMSGCTIGATTLISRNLGMGRLHRGRYLANATLSLVFLLSLLPCALLVPSVKTLFFSYMGASPEALVHIDKYLFWQVWSFPVAAWTLVLDAVYRSQGNATVPMYALLIGNLANILLDPLLMFTFGMAIGGASLATLIGRSLTLIYSVAKLRQYSQIKPKFNITRNTIPTWRSVITIGLPLSLSQISFSVGAALLNRMLAKYGEAAISGWTLGNRIEDIAFLFVFGFNTALVPFVAYNLGRGAYDRVKEGFIFTAKWSFILMSAVGIVLYLFPYVFLAVFKPEALTLAYSTASIRASTTAYPVIALTIVIGGLFQGAGHTHYNLFTQVIRNILIRYPLAVLLNSIFGINGIWWCQPVSSGFAFLVSLYFLKKLKPELFGTG
>fig|891968.3.peg.1249 Drug resistance transporter, EmrB/QacA family
MNYMIFATVSVALMLSSISATSIAVAFPIITSYFMVPLTIAGWIISVYQLGFTVTMPIIGKVSDVFSRKSTFIICLVLFIVSSAMCAVAKNIEMLIFFRLVQAFGGGGFMPSAVGIISEVFPESRQKMIGLFSSIFPIGQIIGPNVGGWLVDSFGWRSVFLINIPIGLFALILSVFLLPAGERKKGSIDFLGTGLLGMSLAMLMLGLTFLGYGSAAKWAWPSFAASVVLAFLLLRHENKVSDPILDLDILKRKPFVAANFYNLIYGGAVVGVLSLIPTYATAIYGMTPSECGLLLTPRSVGMIIASILSSIYIMEWGYRWPLIIGNSATVIGLFLLGAEPASVLFLYVIMFLIGVGVGILSPTANNACIELLPDRAATITGIRGMFRQMGGALSVTIATLVVETVGDPSRGFAIVFFGLAIAFIAAMPLIFMMPSRPGAGVERSEHALRRQEATAKERVQ
>fig|891968.3.peg.1401 5-nitroimidazole antibiotic resistance protein
MRRKDREITDQKWIEEVLEEGKVCFLSLCRNNEPYIVPMHYAWKDGFLYLHSALEGKKVDIVRENPRVSFCVVPEWKIIEGPRPCDWTTHYRSVIGSGIVSFVEDETEKRKALTIFADRFVQGDFELPKPMLDRVLVWKIKVDDITGKQNPNPR
>fig|891968.3.peg.1698 Acriflavin resistance protein
MKLWEIAVQRPIATLMVFVAVILLGAVSFIGIKVDLLPEFEPPVILAITTWEGAAASDIEQEITEEVEDRMATIQGLDEITSTSSDGASAVVLRFKWGEDLDARMGDARDQVNIIRRRLPEDADDPILIKVTSSAMPVMLVVFKAGPTFPGLYHFVDNDISKAIQQVPGVGDVSVFGGEQREIKILLDVEKLKAYNLSPQQIYSVMQQEHFNLPAGSFKEGMIEYQMRVPGRFQIPSDMGYTIVGTFNGKPVYLKDVARVEDGYKDASTFGWADGARSVVMMVTKNTDANTVQVSNEIKARLAELKGSLFPPDVDYIIGYDQSKFILNSLQQLASTLIYGIVLVFLVTYAFLRRIPGTLAICGAIPFSLIVTFIAMRLLGYTVNLMTLSALTVASGMVVDNAIVATDQIIYHIEAGEKRSIASILGAGEVGSALAASTLTTLAVLIPLIFITGLVGIFFSSLSVVMSLAIAASLVVSLTFIPMVGSRTFRTREDKLFIHRYSKRFLAWLEHRYALSINWALHNRKKIIALAMLCMVFTVFGFTRLGYELVPKSDTGSVRVNFRLPEGTRVEETERVAKDIMSFALKNIPELQSVYIYGGSSGSGMGALRGESSNTGTASIELIPKGERKRSGFQVAAQLRQYLTAKPGFESVSSSISSPIMTGGSSKPIVIELYGDDINELLKVGDMIKKKVETVPGAVDVELTQKASRPEVWVHVDRQRSGLAGVRTSDIAQALRTYYYGVQLDEDYWQGADNYEIWLRLEPEQRHSWDTLNKLLVPSVDGQMVRLNNLASIDEELGPPEVHRKNRQRYVTIELDAEGRSVGQVAADVQRLLDATELPAGMRTAISGDVEDMKETYMQMTLLILLGVVLVYMIMAGQYEAFLDPFVIMFSVPFALTGVVAGLLLTGVYLSLLALLGIVMLVGTVVNNAIVLVDYVNLLRARGYTMHDALVEGGERRLRPILMTTLTTIFGMLPMAISRGEGAEIWRPLAISVIGGLTFSTLVTLVLIPVVYSLVEEKIRRRPRFVEAKGGFSR
>fig|903814.3.peg.328 Transcriptional activator BmrR for multidrug resistance transporter
MYRISEFSKITNLTVKALRYYDEQGILVPSHRDSQNGYRYYSEEDFKRAQLVALLRSFEFSISELRDVMENFDEDTDLAYFLEEKKAMIEHKIEKEKKLLKKISLYIEPTGQEESPMQYKIEVKRLEPVIVASIRYQGLYSEVGKYIARIYKAVKGNAGGIPFNLYYNEAYQEKADIEICVPVKRYIEAAGIECRTLPAVERAVSTIHQGSYSQFNHAYKALLDYSRAQDLKLLIPSREKYIKGPGAIFRGNENKYMTEIVIPFE
>fig|903814.3.peg.527 Permease of the drug/metabolite transporter (DMT) superfamily
MLSFYVREMYNKSRGRKANDKNRGAIILENNESIKKTIFFKKKSNTILTAILCTFLWGSAFPVLKIGYQWFQIPSGDIWSKMVFAGLRFFLAGFVVLALNRLFNRGDRVRWHPEYGRWIVALALLGTTVQYFFFYIGVGNTTGVKGSIAATAGTFLVVLLAPLFFKRDRLNRNKVLGMVLGFTGILLTAVNGGTEGLNFDFTLTGEGFLLIAGLGDAGGVLVAKYLSDKINPFHFSFYQMVLGALVLLALGVGFGMAGGGLHLIFTLKGVLLLIYAAIISGVAFSLWNVLLRYNEASAITAFKFLIPVFGSLLSILLLPGESFTGFILLGLLAASLGIYLVNRKVGR
>fig|903814.3.peg.594 Permease of the drug/metabolite transporter (DMT) superfamily
MKNIQTKNKTLLADLALITVALIWGVGFIASKAALVTITPLWVMTFRFLGSGVLLLILFLKRVRRLDKRTVLMGMVVGSFMFTGMVFQTIGLDHTTASNQAFLIPSYVVLVPFVSWMMTRVKPRALDVAAALLTFAGVAVISLKPDFSMNLGDALTLIFAVVYSFQIVFLGLFVKETDVMSFTVVQMLTAGGLSLFAALVFAPPLDGVSATSAFGILYLVVFNTALAFLIQNIAQQYTTSTHASLLISLESVFGLIVSVIFLHDPFGPRMALGCGLVFAAVLLSKLELKKEKAPLSLK
>fig|903814.3.peg.1242 Quinolone resistance protein
MRLQPPAFPDPLKPYNDLLTVIYECIDAEEDIESFEFSDTSLEAFHQSKLEFHHCQFKNCQFLSSGLTHTFFADVIFTGCDLSNLNLSDSTFHRVIFKNCKLLGTDFNACILEECHFTECLGNFMNFSTSKTKHVFFENCPLQNVSFQDCKLKTTQFQQCDLSEADFLHTPLKGIDFTSNTLSRITVSGSQELRGVVVNLFQAAELSKLLGVVIKE
>fig|903814.3.peg.1951 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKKTIKGCLCAIFCEILFGLSYLFTKHATTSVDSLTLLSWRFATAFLVINLCVALGVVKISLRGKRLLPLFWIAVFQPVIYFVGETVGISLTTASESGAVLSVIPAATLIAGGLILKEKPTKLQAAGVCITMAGVMVCVLSKGMEASFNPLGYLMLLMSVISYSLYSVFSEKAVSFSSAEKTYVMIAFGAVVFTAAALVQNLRTGTLPEFLSAPFTNPALLTAVLYQGIGCSILAFFLYNLAIATIGTNRSASFVGISTVVSILAGVFFLKEQFSTFQAAGAFFVIGGVYLANLTRKSKSARPNRRDAKNAE
>fig|903814.3.peg.1955 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKITDIIVLAIATLIWGTSLVAQSIGTNYYGPFTFNAARFLIGAIVLIPFTLLINYHKNKKETRNLFYKASNKKLVQGGIICGVIIFFTATLQQIGIAYTTAGKAGFITALYIVIVPLLRIRSGKKFPLRIWLCIFFAIIGMSLLCLNEKFVFEFGDTFILCCALFTGIHILLIDYYSSYVDCVKLSCLQFLVCGVVSTVIALIVERPNLQVMSEGGASILYTGIFSCGVAYTLQAIGQKSVPPIAASLILSLESVFSALTGWFILGETLSFKETVGCLLMLGAIIISQIPMSKRKKIKKS
>fig|903814.3.peg.2354 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKAQAVDKKFFKFVLPSMFTMFLSGLYTIVDGFFVGHAVGDVGLAGIGLVWPITAVLIALGMGIGVGGSVLMSTARGAGCDENANAARANTLMLLVAASALLTLFLVFMNPVLVYALGARGEVYDAAMAYIRIISIGGSMQILASGLIPMIRNSHKTIQAMVIMSTGLVCNIILDACLTMVVPMGLAGAALATIIAQSLTVAGSLICLFRDREHPVRRRHFRLQKRMMVKMLRIGVSPFGLSLMPSVITVYNNLQCLAYGGDLAVSAYAVINYFIGSVLLLLEGVGEGMQPLISYASGAGDYAAMRRLKNRGLMTVLVFSALFLIACVPAVDLLPGFFGTSAGTAAVIRSALPILGLAFPMMGLGKLFTSYFYACGETLYSTLLVYLDPVLFTPLCIFILPRLFGLKGVWMALPGAQALIMAVLVVLWGLHKSTLRSKEAEYAG
>fig|903814.3.peg.2500 Permease of the drug/metabolite transporter (DMT) superfamily
MTTDTIKKRYGLFTAIAMIIGIVIGSGIFFKSDNILIATGGNVILGVIIFCFAAVSIIFGSLTVAELASRTDEPGGVLTYARVFINPMAGSAYGWFQTFVYLPTITVVLSWVSGIYFCIFFNINASLELQCLVGFGLLTGLYLMNMLSARLAGLFQNAATVIKLIPLLIIAAAGLLHGNTETAGAAMPAPATGMLHVSWIMAIPSVAFSFDGWIISTSVAHEIKNSRRNLPIALVISPLFILLMYILYFVGVTNLLGAPAIMQLGDAHLDQAAAMVFGPFGAKLIGFFVLISVLGGLNGLVMGISQMPYSLALQKMIPGADKLKVLTPKSDFPLNSTIASYLIVTCWFVVHYFTQRFGLLTNSDVSEIAIVVSYLLYLPLYYQVFKLGRKQQIGAFRGILCPVLAAVGSLVIFSGGLQSPLFILYIAICLVFLAAGMVYYQKITKAQV
>fig|903814.3.peg.2557 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKNQLVKQPVPKMFFHYLLPAVSGTMVTSIYILADTIIIGKGIGTEAMAALNIVLPVFNLVFGTGLLFGVGGSVLMSISRGRGEEKKGQQYFTTAFILNLLAGIVYISLFFAFGENIMLFLGGTAVTMPYIMEYAPYIAGGALIFSFSSFLQAFVRNDGAPRRAMAAVIAGGVFNIIFDILLVFPFQMGMSGAALASVMGSVLTDCILISHFFSRQNGLRFCFGGLRLSFFKAVFANGFTSFLIEISAGIVIFAFNHQLLRYVGEIGVSAYGVITNTAFVVTALSNGVSQAAQPILSTNYGAGKFDRIYEVRALGVRTALAVCALPALLGLLMPDLFTYIFLNPSPEVLALSATAIRIYFIGFFVTGTNMFIINYFQAVVRPRISLGLCLFRGCVFNLFLVTVLPLLWGVTGIWMAVPLTEFISLGIGVLLIKRISIEQ
>fig|903814.3.peg.2814 Permease of the drug/metabolite transporter (DMT) superfamily
MKSLKGNLFIILSACIFGFTPIMGKITYLNGSNSIMLTFLRTFFCVPVLWIILKQQKVSFKLSKTQLKQLLIISFIGSAVTTLMLYQSYNYIPVGTATTLHFVYPVFVALGAILIFKEHLTKPKILALVIATAGISFFMGGKIEGGLLGILLALVSGLTYAFYILYLDKSSLLALHPLKLSFYINLFVAGFVFIYGLFTGTLTLDITPMGWLLSFLVAMLCGFLGITLFQVGVKLSGGTTAAILSMFEPITSVVCGIAFLGEPITVKSVLGCALILTGVTILTVFKGKEPAETPDLNLELAASEEMEN
>fig|903814.3.peg.3084 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRLGDRHLEQRVQNLTKGNIYKTLAVFALPYLMANFIQALYGAVDMMVVGWFNDAAVVAAVSIGTQMMQIVISFVAGLTMGGTIIIAQYYGGGREKDTVETISTMLTLFAIAALLMTLALFLLAAPFLGLLKTPAESFASAMDYVRICACGIFFIFGYNALAAMLRGLGDSKSPLYFIAAACVFNIVFDLLLVGGLKMGAAGAALATAGSQGVSMILAIVYLNRKSFIFKFKKDNFRIYRDKAERLLKVGIPVSLQETLLQISFLFITAIINTMGVVAAAAVGIAGKFDAFAMLPASAFSGAIAAIAAQNIGAGQPDRAKKSLFASIVMSLLCSIPFFIWAQVFPASVLQIFRAEPAVISAGTAYLRTFSIDFMLVAFGFCFLGFFNGCGRTAFSMVNGVAASLLVRLPLAWILSVTLSGSLMAIGLAAPAATLVSVVAEIIYLRLGRWKTPVV
>fig|903814.3.peg.3541 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKKKHREAEMVAEHGFLVAVILSLAAAVLGAVFSNIFVKMFTDNPEIIKGCTDYLLIVTIFSFGSIITQAGFSTLQGSGDMIQPMIGQLIGAITNIILDPIMIFGLLGFPALGVTGAAIATVTGQIIAMVYILIVVLKRKKNLLKLHFRSFKYRGAIMKDIAVVGLPSAIMQGIGSFMVTGYNLILAGYGMTAVAVFGVYFKVQSFIFMPIFGLGQGAMPIFGYNYGAQNAKRFKETLKVSILTSLVIMFVGVLLFQLFPAQIFMLFNASEEMTEIGINCFRAISLAFPLAGISIMLSTSFQAMGKSYLSMISSFLRQMIFLLPFSYLFSLIGGLDTVWYGFIVSEIACLVFEVIVYRHYKKKVLDRW
>fig|903814.3.peg.3902 Permease of the drug/metabolite transporter (DMT) superfamily
MIYGSFIILQCMFWGLGNPVAKIGMETISPFYCLALRFLVAFIICYGLFRKKIKTQVNKNNFKDAVVISIFNAAAFIFSTLALIYSSATIAGFLMALAVIFTPFMAYIVLGRKLKKRTLIFVGLVVLGLYFLCGSQGGFRFGIGELLALLSSISYAATITYSSKHVTNIGPEVLSTIQSGVAAVICFVFAFFLEDGQVLSQVGITGWFAVVYLALGCTVIAYLLQNVALKHLSAVFVSLPLCSEPIFTAIFSFFLLGERLTLSGIFGAALIMASIVLASLFNGE
>fig|907.4.peg.1337 Multidrug resistance transporter, Bcr/CflA family
MTQNKRSRWLLLMTVLLGMLAAIAPLSTDMYLPALPSMMTAFGVTPSVIQLTLTASMAGMALGQIAVGPISDDKGRRLPLMVGMAIFTLSTVGCIWSPSIQIFLIFRLIQGCAGGAGIVLSRAIARDICKGSALTRLFAMLMLVNGIAPILAPVIGGQILRFAPWEGVFLFIAIVGLLLTVSAGLMRETLPQRRRVSGGMAASLNGFTALFRQPYFMGHCIMQCFAFAAFFAYISGSSFVFQNVYSVSAQAFSLIFGINGVGLMINGAVTGRLTGRIADWKLLRFSLFLAAVGSVALLAAFSTGMPLPVIMVLLFLTVSTLSMMSTSSFSMAMQDQGRSAGSASALIGFFSMISGAVMAPVVGIAGDHTAIPMGIVMVIGEIGALLTFYALIYPRHKDSL
>fig|907.4.peg.1587 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERKQNKGRRGMDMLHGSIADKLFFFAMPIGLMGLFEQLFNSADVFILGRFVGKSAMAAVGNNMPVIGILVTLLMGISLGANVTIAQYLGARRDDKVERTVQTAILMSFGLGVLLAIIGELIVYPAFWVLEVPPDVYDMAEQYLRIFLLGLPFLSLYNFEAAIFRSCGDGKTPLYSLIAANLVNIVFDLLSVLVFDFGLAGVVWATVLAFAVNSLILLALLCRTTDRIRLERHHMRFSQEELHHIIHIGLPAGIQGMVFALSNVLIQSALNSLGTEAMAASAAAFIIEGNIYCFVNGFSQATTTFVGQNYGARNLRRCFRITKVAFGVEAAFLLAVTVPVLFFSPELIRLFNGDPNVVALGTKRLFYVAGTLYLNGIIDIISGSLRGYGYSLPPAVVVLAGICGVRITWLYTVFAAHRDFLVLMAAYPASWLVTAIVLTFVYQSCRKHIVRGLLSER
>fig|907.4.peg.1786 Vancomycin B-type resistance protein VanW
MTDEERARKERMKEYRRRYREKHGLPPEKERPSWKKRAAVIVALCVIGFGGFFAAQSKAEQMVTLNGQSIADMTPDDITNYLDLHEKDVEDKKLRLATDGVDVTLDLDELGAKLDRAYIDDELHLVGRRGLPWQRVADVVTTLRHGKDVPLAIAVDDDKLDKVLSDVHDKYDKDPQNAYAYVKDDQKTVAIEDAKDRIVINTGKLKDAVTDELHTGKTDTLDVPVDSREGADIKADDLKDIDTVLSYYTTHFDDTNPDRNVNIRLAQQRLNHAVVMAQKDFSFNKYVGTRTADKGYKPAPSYFENKLEQSTGGGVCQVSTTLFNAALRAGLFIASREPHFAPAAYVPVGMDATVADDGLDFSFTNPFQHPVCVYTVAGKNTVTTYILGNHADTCSVSFETTHLQNLPHKVIKKHDDSVTEDKRKQEGYDGHDVTIRRTVAYSDGDRHVDTIESHYDPNDEIILTPGDDSEEVVSTADLEPQDPLLNAPHDMMDFNVPAADTADTADTADTADEE
>fig|907.4.peg.1927 Permease of the drug/metabolite transporter (DMT) superfamily
MSKGVIYAILSALAFSIQNVIVKELSYTTSTGEIAFFRGFLSALLILGLMRIQHVHLSKQDIPTLTLRGVLGGIGMICIFYALRGMPLADVSIISQLSAFFVMLFAALFLKEVLPPGSKLPLLIIFIGGCLVVRPWNFSSFNVYSLFALGQAVFAAGAYTTVSKLTGSGRHHPYEVVLYFLVCAALAGIVLMALTGGFVMPAHGDWIYYGGLALFSVIAQIWMTNAYATANPVVVSFVSYIGVFFNALWGFVIFGEILTGLTVAGGVLIIGGSMYLTKLKHDKIAEMAKMQERK
>fig|908337.3.peg.7 Drug-export protein
MSETKQWRVIPAVIMTAVMSFGGILVETSMNVTFPLLMSQFNLLASQVQWVTTAYLLAVSIVVPSFAYLVRNFSIRNLFITANLLFLSGLVIDSFAQSFIILLLGRILQGFATGLALPLMFHIILTKVHQDKRGLMMGVGSMTTSFAPAIGPTYGGILTEMLDWHAIFWLLLPLLVLSLAGGLWAIPQEPVGRGEVFNGPAFIGLAAFLVTSLLAIEQNLWYQWMLAFLAAFAFYQSNRNNPLINLNLFSKGHYLVFLWGALTYQALLLGMSFIIPNYLQLGRGLSTTQAGNFMFLGPIVLSLVLPLAGRLYDSLGPKKPILAGLTLSLFALLIFVIYYHQLPIWSLLVVHVMMMLGIALSLSNIMTHSYGQIEDNLEADANTLMNLGQQYMGAISTALVSKLLSLGISQNPEFGAVLGAGWGIILMFLLVLSAYILIIIVFRSNTI
>fig|911045.3.peg.32 Permease of the drug/metabolite transporter (DMT) superfamily
MRVDWKRAISSTGNRFFSSTRNASIRFRAITLGILTLIGFGGVGLVYLWGQQQTEAAFQQSKDYTELAELSQAIAITAGVLQSTQKDYENVPSDSLKSRFDELVGEAQKELQELNALPVAMDYFLEISDARDTIDAISGAFEMLHGYQSTLGYDADRGLQKELSASLSQAEAAVKQKHRRSKDPNTLKLMHTFSDLARAQLDYAITGSQNSQGAFEVAFSRYERTIPRAQIDPAVAEKVKTNMAAYKKAFEAYTKAYDKRATSSELLANLFDLLPPRLNDLKNSAVQGASDAQARLTATTQQTNLYLGLAVGGIALTLFILGSLLIFGILRNLNALRNAMALLAKNDLSAVIPLNKGGKEISAMAQTLQVFRDNIEERRKLREQQDHENSEKQARAEQVDTLIMGFEQTVAEALNSLHSAADGLGEASNDVGSAADNVSKEAESAGRAVENAAENVSSASAATEELAMSINEIAGQAEQSTRVADRAVEGSKATAETMSLLSDAANRIGDAVGLIRDIANQTNLLALNATIEAARAGEHGKGFAVVASEVKMLANQTSQATEEIAQQVGSIQEASTEAVGAIGDVSDVIHEMSQIASAVAASVEQQNAAIQAITENVANATQSSQQGANAMQMVENASDNARSTGGTVSDLADALSRQADHINNTVGAFLEKVRAA
>fig|911045.3.peg.60 Tetracycline resistance protein, class A (TetA(A))
MKRERREAMGWSRFALLLLVLVDVMGQGMIFPIVNTLVMVPGSTFVPRGDSLAIREIDFSLLTAAFYISWFFGGAYISKLSDYIGRKKAILVCLFGALFGYGLAVVALLWSNLALLVLARAITGFSAGNQPIAQAALVDLSTTSAERNRNMGYVTAAIALGLIIGPLFAGTLSDPSIMGSYASLELPFYAALVLILINIALIIIFFEETNQTRRKIDFGLSEVFLVLWRAHSRPTILKLCAVFLFVEVGLSAFYIYLNNYMVLRFGFDTLQNSILMIIFGSVLALVSSLLVGPISQRFSKVATIVVSVTVMGVGLLVFTVNDVAWLSYFLTVPIVAAFALTLPLMFSLFSAAVDESEQGWIMGITISSSTGGQFILAIAGASLMTANIHGVFIAGITCFAIALGLIFLLWRQPDIRALDYG
>fig|911045.3.peg.804 Lincomycin resistance protein lmrB
MLLAAMSFILGLTLLDETVVSLALPTISEEFGMTLTQAHWVVNSYLLMFAALVALGGKLADLVNINYLILSGMIIFGLASLACGFAPNGSFLVGARVVQGIGAAIMFPLPIVAISRIFPPERRGFALGIFGSIATIFLSSGPLVSGYFTSYFSWRWIFWINPPFVLIVCLVIALAPLKGRVAHGPDRDMSNYSFDWLGFITLLVGLFFFVLAIMQAPEWGWSSRDILLSFIIGVTALTIFVWNELRRKAPLIQVRFFRKPSFAVAAFVVFQAQYSKIVMFIFGALYFQDKLGFAPFFAGLALMSAVVMNAATAGLSGVCVDKFGVRTPAMCGLFVLSSATLWLTAFIAQDDYWLLLPALLAWGAAMPLLFLPSMKSSVDSVELTKKGQASGVMITSQMLGGTIGMSISSSIFLYTQSYEFVFGTAAAVTLLCYLLCYFHFGKGIEAADAGSRD
>fig|911045.3.peg.1482 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVSQKQVLTGAPLRQFLLYAIPSTFGLLALAIAEIVDAYFLGNYVGPHALEAVNFSLPIITAIYGLMLMIAVGASVITGKYVGEGKEEAACQVFIKTLLTTILLGFALTILILVFIKDIVELVAFDPEASDYIADYLKVFAWAFPLIGCAIVLTTFGRIDGRPALVLLAIVLGTALNVPLDHVLVAELEMGVTGAAIATGSSQVVVVLVLLPHLLRGAGIMRLLRPDGKWRVMLRAAYTGLAEFINEISTGVIVFVSNWILILELGTDSIVAFGMLNYLVFLSIMIFYGFGEALGPLISINLGAHRYDRIKTFLFYALSANLLVGGGLAIFILLFPVFISTVFLNMASMMVVDLTEEFSNYLWPIFIFNGINITLSCYFVAIQSASRAAIVALSRSLVFPVIFMIVFHMLFDGGMVILALPLAEIVSLTICLYLFWQRTPGKLQA
>fig|911045.3.peg.1486 Multiple antibiotic resistance (MarC)-related protein
MLHAFFSITTACKANNRKHLMTETALITYVAALFSMMNPIGNTGVFAGMTADRDAATARRIAWTCAGAIALTLLTVTWTGGILLKFFGITVHELRAAGGVIVLLIALSMLRSDNSHRQTPEEAASAAEQNHIAVVPLAIPIVAGPGAIATAIVAAERHSGIWAKIDLSIAAVGLALFTGFLFSVSKPIANKLGESGMGVVTRLMGMVLAAIAMGMLADGVKGMIPALAS
>fig|911045.3.peg.1853 Lincomycin resistance protein lmrB
MMFSRFSRHFLLIMSVAMSLAAFLSVVVTLAEFNSGLNPFLLAKARSLSKTVKQNLEYASEIGIPFSEIRGVNKYLTDLTAEHNEISSISMVAANSSEHLGESKAVHPELMNNESSTFLLAQQTLDSLSKLGTFIFGSNNVKQTVSTDVVVNGAIVVRVQTTLDEDYVNSQLTSIFLDTFVLLLAACLIAVEVVIVCVNSTITMPLRLVEAAIVKCAGGHLGTYHGSDRKDWAGRFISAMNRQNAKIRKTLEQLQQAKNITHEELRTFAKKYKLYRVEEGNKASISDARIPLFVFCLADELQKSFLPFFSMEYYGENAWFEKDIMMGLPISAFMLVVAITSPFSGQLIERFSNKTLYLAGLVPAIGGYIFCILAQNANDIVIARSITAIGYGIITISCQSYIAAVAEEGSRAKAMATYVGVTMTATMCGTAIGAILADWVGYKPVFVIAISLMILAGILGWRMLQNELPSPKSDASSTVSKASKPLTTLIGNTQFVAILMFCAIPTKIVLTGFLYFFVPIYLASLDASQSEIGRIMMAYSLIIIPISPLASRLSDQLGKNLSVITYATIASGVALMALYQNTNIIAVFIVVALVGLAHAFIKAPIMVAVMEAVEKDQYISRTGALSYLRMFERVGSAAGPLIVAALLVQQEFTTVAALLGAAIIGSGLIMLLVSRSTKQEIQAHA
>fig|911045.3.peg.2164 Glyoxalase/bleomycin resistance protein/dioxygenase
MTILSLQHFNLPIAPGGDKLAREFYVDLLGFEEVERPESIRHRPGGWFSVGSINLHLSVQDPFVANKVGHPAFVVDDIIKLAQRLRDADYEVSDDAIFIGYIRKTTHDPFGNRIELMQPEDMVQHKL
>fig|911045.3.peg.2513 Permease of the drug/metabolite transporter (DMT) superfamily
MLVQLRTALTPAIWGTTYAVTTLLLPSEDPVWMVVYRLLPAGLLLLAFAPGVLKGQWVKRAMIIGLTNLSMIFFVFIAAFRLPSGMAGTLMATLPLQIIFYIWILDGKTPVARQMFASLIGLFGVGMLLLGAVELDWIGIGAALAACLSTFTGVYLSGKWGRPDVSMVTYTGWHVTLGGLYAVPIALMLEGAAPVPDLNMALAFFWIGILGMGWASVNWLNGIVQLNPTTIGFLSLVNPVSAVLCGQLLVGEEFGWRQWTGIVIVLGSIVYALKTPSAAKVATQTKDAAATS
>fig|911045.3.peg.2518 
MTLTIVANIHAAKGKEDLVKVELEKLIDITRAEAGCLQYDLHVDNENPGHFMFYENWENRELWQEHMNAPHLAAYMVATEGAVDEFTVNEMSRI
>fig|911045.3.peg.2870 Glyoxalase/bleomycin resistance protein/dioxygenase
MEHQDKSINYIEFPLLKTEETKSFYGSVFGWLFEDWGPNYISFSGAGVEGGFNGESGTPVQAPGVLVVLYAKDLAGTLATVREAGGKILQEIYSFPGGQRFHFADPNGNELAVWTEASS
>fig|911045.3.peg.3180 Multiple antibiotic resistance (MarC)-related protein
MLIEFLINAFAMLFVTIDPIGLAPIFLAVTAGASSVERRQIAIKAVIISGVTLLAFFFAGRQLLEVLGISQAAFKVAGGLLLFIIATEMVFEHRQKRKAESAEKVVEQEDLSQTAVFPLAIPLIAGPATISAIILLAGQAPGFTGQMSLIAVLLSVLALSFFVFLLAARIDKLLGSTVQLIITRLFGVILAALSVQFVADGIFSLIEMHS
>fig|911045.3.peg.3249 Permease of the drug/metabolite transporter (DMT) superfamily
MPHSSTKLLPEIFLLIVLSFLWGASFTLIEIAITTIPPATMVFFRLLIGAAILIGLTLLSGIKFPSSAKRWGELLVQGILQNALPFTLISWGQLHITSGLAGLLNTTPSLFVFLISYFVFRNSTADIRKFLGILIGFAGVIVIIGPTAFAGEQNSTLGQLAITGASLCYALAAFNAKRFFNQPPLLTAACSMALAACLMAPIAFILDEPQNLSPTVEALTSVLALGVLSTAIAMVIYFRLIRTLGPLGVTTGSYMRAGFSVALGALILGESLTPHLMLGLLLIFTGVAFTTGLLKLPQFQKKST
>fig|911045.3.peg.3270 Chloramphenicol resistance protein
MSRRTFALIIIFMLTPLGPLAIDIFLPSVPEMLSVFEATNQQMRLTIPLYIFALGFAQLVGGPISDRFGRRASAMIGLSLYALGSLGAAFAPSLDWLYGARLVQGFGASFTMVTTFAWVRDNFEGDEAGKWLSYMSGLTGSVPMIAPMIGGILGVIWGWQAAFFLMAAAGLLLLFLTPLALPPTKKRHRMLGAPDQITCNLGDMARNRAFILYSLANAATFGAVMTYVSIAPEVAMEQGGMSEMQFATILGAIGLLQMLFSFLAPRMVEMIGAPTTVLVGLSLSVISGLGLLFVPQSVTMTFFAFAALGSAGFSLMIGISTGLTLQPFPNCAGLAASIGGFLRMFGGASIATLTNLTDLQGPATLATALLFSLLPLTFLLFDRRMESKIEGETF
>fig|911045.3.peg.3290 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTAQSENIVSQSVDGVYEGPLLPVIIQMSVPIVIGFLIQVFYNIADTVWISMIDPSNPAIIAGVGLVFPLGMILFAIGNGLQVAMGSVLSRAIGAREDAATQELFAVGLLQALLIGALVLALALIFGEQLLALLGASGELETYALEFFIYSLPGVVPIVLIGTLMGMLQGQGRMTAMMQAVLIGSVVNIVLDPVLIFVFDMGVKGAALATVIAQFIVMAKLLLTLAMEPGELRLKLIPVKGGFSLSKRLSTIGSAQMWIQIIIAGSVLIYNRFVIDVDPMAMAAFTLVGRLDFLIMIPMFGISTALLTIAGQNWGRKNYDRAFAVLRIATILAFVCVLVLALLHILIAPLIYPLFSQVPEVVNYAVLQVRIMELSLPFIAISLCVAEFHQAIGKPAPALMLTVIRHFVLSVPVVYVLIYMQQMGIMGVYFGAMSGTFFAAAVAYYMRFRLVSAYSNETSIPAMGDAS
>fig|911045.3.peg.3314 Permease of the drug/metabolite transporter (DMT) superfamily
MPVFMSSNIIIAKPAIAHTEPWTLAFFRWGLASLILLPFTYRELKRSLPIIRKNLKLLSFMAFLAMWICGAIVYLALKETSATNGTLIYSAAPALILALEWLFRGRAVAMRELVGISLAIVGVFVIVTKGSLGNLLSLQLNSGDLLFALCTLSWAIYSVLIKKSQLQSISTAPLFTILAILGTLILAPFAVTEMAITSSVPNTGEVWMSIAGVALVASVASFLTYQFSIRLVGPSIAGMFMYLMTPYGVGMAVLFLGEKLQTFHYLGFAPIMAGLLLATLPAGIFRKKASA
>fig|911045.3.peg.3423 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTADTIELLPTLPSLNIQETKAFYAGQLGFTNVVYERDDFLILRRDNLEIHFWLTSEKHLCENSSVYFRGGPIAALHEEFRKLGLPEDGKSEPRLTPLAKRPWDMEEFYIHDPHGNLLKFGRIPL
>fig|911045.3.peg.3784 Transporter, drug/metabolite exporter family protein
MSTSRSSTRASAAVVGASWMVFAGAAFAVTNSAMQYLTMVQGLSSTSATFWQYLISLVAMVPVIWRIGVDGLHTEQLALHIFRVFLAALGVQFWVAGLANGVPIWQGIALLMTSPFFVTIGAAVFLREKASGQRWVATAVGFVGGMIILSPWDEAFQLVAFLPIIAALLWGSSILCMKKLEESESPQSVTLYLLLLLTPVNLVLALLAPGGLSIPDGMNMWWLIILAGLLGAIAQGSLAMAYEKVDAAYLQPFDHLKLPLNVLCGFIVFSWVPPGNLWLGAALIIGASLYIVHVERERN
>fig|911045.3.peg.4286 Multidrug resistance protein B-like protein
MDGRWLASLIMILGVGSASMNSFLSSAIMPDIIRDLGGQQRAFWVLSLFQIGSILAGTVTGSLKANIGARPLFIAAALSFLAGSFVAGAANSLEHLLLGRMLQGLGEGMIVSLCYTLISDLYPKTAVSSVFALLSGVWAVSAGIGPLTAGMLTDSWSWRAVFYANLPLALLLLILAITVIPATTREKTETSASTGKKNIIPRLSLLAVAVLLIAYVGELRDLRHISLALVVGVALLFMAVSWDKKSSAPFIPRSAFRFNGIIGLGMWVTLLLSISSAARVVYGTAMGQVLWGLTVTQASYAMAITAFSWTAAAWIVARVQTPHVQTYLIRVGTLSIIAGSLLTMWALSAMSLWIFLVSSIFAGAGFGMSSQFLKKAIIYAEQDDERDRASGFIGPLQSAGMAIGAALAGLLAGLTGFSIPGAEDLITLENAASSGPLVFLIMAFISSLAAIAAFKMPKMT
>fig|911045.3.peg.4426 Acriflavin resistance protein
MQQNTHKGWIAWFAHNPVAANLLMVCIIVAGVYTAMNIRTEGFPGFEANQVTISVEYKSGAAQETERGVTEKIERALTGTEGIKKVTSTSTASNSTIIIEKSSGTDLDKLLSDVKTKVDAVSLPSAAEKPVVVRAEEIEDAIQVEIFGDADPDVLDTVARRIKDRLLEDQLIPSVTISGERTQEISIEVQEDALQRYQLSFSELVRQVGNFSLISQQGSLKNENGRILIKADKQGYFLQDFESIPVITLTDGTVVRLQDVARITDAYTDDRSIYLYQGQPARKLSVQLIGKASLIPAAVRAREIINEVQAEGSLPTNIQFDFWEDESENISDRLSLMLKNGLMGMGLVLVTLALFLNLRTAFWVAMGLPIAFAGALALMGDGFWGMTLNELTTFGFIIALGIVVDDAIVVAESAHSVTEKEGDGIDNVIKGVKLVATPAIFGVLTTIAAFYPITLVTGRLAEIFSVFAWVVVFCLVFSIIESKFILPAHLAHLKHNAKPNNPLSRGWKVIQNGVSAGLERFKQSVYRPMVKLSLRMRYLSALGFVVLFVAVVYMVPSGIVRVVFFPEIPRQIVTATYKGEPDLGYGRLFAEANRIEAAAHKLKAQLDAESDTDVSPITGIEMQASDDGTVTVLAIATPPLERNITSNEIAERWRKLVGPVEGAQTIKFAADDFDFADFRVELLLDDVDQLIAASQYVEDMLATQAGVLSVTNDFRAVRGRLNIELTDYGRSVGLTTSAISEQVFQAIGGAEIQEFQRNQQEVKVRVRYPEAQRSSAAALQTLYVRTPAGDPILLSSVANLHSDLTVDEIYRSSRKRVATLDAQINKDEISADTLVTYFNEELLPQLQAKFPGVAVDFGGEVEQQREAIGGLITAFGITIIAIYVLLAVPLKSYMQPIVVMIAIPFGITGAIMGHWVVGIPVSILSINGILALSGIVVNDSLLLVSAFNDNRAKGMPIRQALVAAGTQRMRAVILTSTTTFAGLAPMIFETAEQAQFLIPAAVSLGFGILFATLITLFLIPTFMMILEDFSRLKAVVLGIASLKMEDTGAPEVTAAGE
>fig|911045.3.peg.4509 Permease of the drug/metabolite transporter (DMT) superfamily
MSNNIKGVLWGLLSAALFTLVSALAKIAVIEYHVLQILFVRQCIVFASALPVLLKTFPHGFKTQHPLPHALRLGGAFVALSTGIWAVALLPLTTATTLAFAKVFFVALLASLFLGEATTKTRVLGIALGFLGVLIVVRPGFDGLASLYALVPLAGALGAAVAVVCVRKLSQTESTATLLGYQAVFVGLMAGLPMFWLWKTPDLFGFVLLISMALIATLGQWIGIKALRLGEASLVSSTEYFSLIYAALLGLVLFSELPDAFTLIGAATIIFSALYMMQKEHRRKASLKPT
>fig|911045.3.peg.4552 Glyoxalase/bleomycin resistance protein/dioxygenase
MAKLDTLRLRVRDAAALKRFYCDVLGMSDQGEGRIGYTPEQVALRFEEVGGAYRPQPTDLYWKIAISVPNIELACAQLRAQGVPVTEPQQFRDVGYLTKFVDPEGFTIELIDHHFQGERPEEEHDQTLLGGGPHISLVTLRCADISAVEPDLLNGGMAPLSVQPVEPYGFTLYFYALTSEQPLNADLTAVENRCWTYQRPYTVLEIQHVPAMQEETQPDADASGYEGLTVSGASLALNRLRISSQ
>fig|911045.3.peg.4593 Permease of the drug/metabolite transporter (DMT) superfamily
MNAQKLDWLAWSILLLLGTLWGGAFFFAKIAVVELDPITLVFLRVAIAATAMWCFLLVTRQSIPLTAKWIGSFLLLGFMNNVVPFSLIFWGQQYIASGLASVLNAFTPIFTMIVMQILSNEEKLTVTKLIAAIIGIIGVAIMVGSDALSGASNQVLPQLAVLGAALSYAFGAFIIMRLKKLPPAALATGQLTASTILLIPALIYMAPTQQLMSASALTWSSVLVLALACTAFAYILYFQLFKLAGATNAASVTLLIPVSAIILGAIFLNERLEPNHWLGMAAIFIALLLIDGRLTSRWTNKQQATA
>fig|911045.3.peg.4631 
MERRVVLQALAASMVTGMVPGPVFAAAQKLEKKGTGMIIVTVEVEFEDNQIQQKIGAVQEMDAATAEETGCISYKSSLDATNPNILRIYEMWESMDALVPHFKTPHMAKFQKELSSLKSKGMTAKVYEVNKELPFPN
>fig|911045.3.peg.4832 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEVSSSQPDNIFLSGSIPILFAKTALPISIVMMVNGLHTVVDAYFLGTYVGTQALTGVTLMFPLFMILVSLFTLVSNGFASIYARAFGASNFRIATKIIDSAICLALIFCSLLILSFLAAGFQLALFLTNGSHELAEIGYEYMAILILGSPLGFILSINIDRLRCEGLLPLMTVITLSSAFLNIFFDWLYVVQFGWGVAGSAYGTLTAQLISLAAMVTYYTSKRGEFSFLNWRPVSFQWKSLIALGVPQSLGYTGVSLAAAVTLFAIQLWPESGYETTAGAYGILTRMLTFTFLPLLGISMALQSISGNNFGAQKHDRTSQTLKIALIISLVYCVVVQAIYFLFSTQLGAIFVDDAATISEVARITPIVTLIFFLSGPLMMIGTFFQAIGDAARAGILLLAKTYLFAIPLTLVLPYAVGEAGIWYSSALAEILLLGLTFIVVVSHKKAAAPAAAVASS
>fig|911045.3.peg.4939 Permease of the drug/metabolite transporter (DMT) superfamily
MIKIGVASLEPALLVFGRMLVGSLIIFSALKIRGLSLSKDLADWVSYAVTGLLGSALPFLLISYGEQSVDSALTSILMGTSPMVTLLLAAWLVPEEALTLRTILGVLGGLTGVAILVGPSALSGLGMQVTGQFAIIAATASYATSTVYIRKYVKRPPLEMAAGSMIVGTVTIGIYAVATGTDFSAIELTGSSLGAVVYLGVISTACANLIYFYLVPQIGANRMSQVNFAVPVGGAILSVVLLGEAMTPQRFIALLVIIGSVYLGTTKGRGRVAEQTGETV
>fig|911045.3.peg.5085 Drug antiporter protein
MSDATLKARWGQISLLFSANFLSLLGNGLSAIAIPWFVYDLTGNAVITATVAIAGQLPNIIVGLFSGPLIDRYSARTVSIFCDAVNAVAVLLIPLLYAVEMLDVALLGFLVFLSQVIDVPGQTSKAVMIPALIDKEGLPRERVNGLNSLLETGADLLTPSLAGILIAAFGATTVLLLDSLSFLMALMIVSMGIKASHVSAPPQSEPQPTKEAWKWMFTTPSILKLGIYDLIINTVAVSLLSLVLPVLANTNDKQAIWLGIWLTCFACGTTLTTIAYTVLGHRISSLRLLQLTPIGQAIGLGLLLWVFADMANTNLTSTTGIIAALGMFLYGLNLGVGSVVDATVLQKLVPEAKRGTVFSTFSSLRYTGVPLGLLLSGILLEQNNPITLFSTFIGLLLVNAVIWLWGRLEV
>fig|911045.3.peg.5370 Tetracenomycin C resistance and export protein
MARKHLVLLNMIGALALVMIDQTVLGVILPSLQRTYAFGPVHLQWAVNAYLIALASMLMCGGWLGDKFGYFTSLRMGVALFTAASLACAYAPTGEFFITARVFQGAGAALMQPAATALVFSAYPADERGKALAHYVGAGLFFLACGPLVGGLLVEFFSWRVVFLLNVPIGLAVLIMAFAIGKSKTNKDTGSFDFQGAILFVMALLVFTVAVQLFGDYRLSLGEGVVSAGFVVLACSLLFVRRHRVAHPFIQFSLFENKVYLGCCLLLFCIPFALLAQVVFGAVFLQNVLSLTPLEAGLSMLPVVLTIIICAQFGGRLVGNIKFRNLAVCGSLAMGIGFATQALVIHFNNLWLLFPGMILMGAGLGFLISTVSTEALSHVSLLARARATALLQTCRQVGGVFGIACVGALINWREKTMISAAAELMEPNDEDRELLQLLLYKFMGDQPAAAALLHERWPQSLYILKAISSRALADAYIFSAVVLFGAAVMSLWAFKGHTPRQRPQAPEGPPPMNSAND
>fig|926556.3.peg.2072 Tetracycline resistance element mobilization regulatory protein rteC
MKNICFELYQELQSQIQNIQGQQYAELQQAEACFVAVGTALNRLKEKLWDYEFTPPEEIYFFKKAKPRIVAEQLYYGELYYIHSTLPVEKREVLDHYRNQLSFIRSYFQRHHFLYTYYRLDRSDLDEYLFKRNAPKAPFLAETIAIQKDSRFSTHGSYRFARFKAFTRLKEYLLGKIHHLQNPAPAPEKKRLKWTAPKVALIELTYALKAAGVFNNGQATIRDIATVVEQIFQQDMSQYYRTFQEIRIRKSGRTYFLNRLTQALERWMDNTDLDGKGDKWD
>fig|926556.3.peg.3068 Multidrug resistance efflux pump
MNIVAPSSHDVRVMNYNVEVVPRVTGLVVDVPVEPNEHVKKGDTLFRIDPLPFELEVKNIEAKLPGLEAKLVSAEAFDRELESQLTTSNNHIRVINTQIDLAVKRLEQTKELAQSGAGSQFDYEQAETNLKNLEAQLAVAESEKSQVIQRLSAQSDEGEFAQVSEARAALEQAKSDLAMAKWRLDQTVYRAPADGRVVNLQLRTGAMAVQFPIKPVMSFVEDEQWVVALFAQNELRRVEKGNEAEIALRTHPNRIIKCTVDHIVWANAQGQLTASGRIPDTKEMGHHEGRFAVRLTIDEDNDVFLAPGAVGQGAIYTEHGKLIHLIRKVIIRVGTKIDWLILKLH
>fig|926556.3.peg.4611 Tetracycline resistance element mobilization regulatory protein rteC
MDIQKLAQTLKERLDRELPEASALGEDRLFHLQAAHKNAEKVLGELDVALAKYEFGDEAAEIHFFKHIKPDFHSESIYYAELFNLESARPISQKGDQVKYLLKEQQKLQAFLNFNRDLHQYYMLDRTHFDRHYFLRAGRADFLVSRAFHTPIDRSSCTVACLGISTILAAIRINKYINSAIQSLQGPPATAQKQVTLKWTGKKNQLVELVYALKVAGVLNHGQAEIREVAKVMGQLLGGDMGDVYKRFQEIRIRKKGRTLFLEVLKEKLEDYILESEGL
>fig|926569.3.peg.649 Vancomycin B-type resistance protein VanW
MSTISYPVRRPTPQPRAITLEQVLLAGMLGVVLFVVVLVIFFLGFQIVYAGRIFPGVSVAGIDVSGMTPREAAQEIQRRITYPQTGKLVLKDGERFWIVTPAELGLALDASASARAAFQIGRSGDPFTRLWEQSLTLASGKDVPPVLLLDQRVTFAYLNNLATQIDVPAKDATLQVEGTEVKVTPGQIGRKLDLNASLILVSVQMQTLKDAILNLYVQEEKPAILDASTAAEQARRILSTPLTLTLPATDNSGDGPWTIPPEQLAQMLVIRRAEADGNTRYQVGLNETYLLTYLSDLAPKLRRSPVNARFIFKDDTRQLEVIQNAVIGRELDVSASANFIQEKLAQGEHEIALQINYTNPPVTDEMTGEQLGITELVQATTTYFRGSSAARVQNIKAAASKFHGLLVAPGETFSMAQALGDITLDNGYAEALIIIGGQTIKGVGGGVCQVSTTLFRNAFFAGFPIVERHAHAYRVGYYEQTASGHSDRLAGLDATVFVPLVDFKFVNDTPYWLLMETYINGYSLTWKFYSTKDGRTVEWDTTGPTNVVDPPETVYRENPDLKQGEIKQVEWAAKGADVTVTRRVYKNGALYFSDQFVTHYEPWGEVFEYGPGTELPPKE
>fig|926569.3.peg.1405 Tetracycline resistance protein
MTKNKPLSSIFLVVFIDLLGFSLILPLLPYLAKSFSASEFQIGLLVASYALAQFIGAPFLGRLSDRFGRRPILLISIAGNAIGFFLLGIAQNLEMLFLSRILAGFTAANISVAQAYISDVTDAQSRARGLGLIGAAFGLGFILGPAIGGALSQFGYAYPAFAATGLSALNFLLVFSWLKESLTPERRQALNHQQRPPITLKAMLETLRRPYVGPLLHTRFFFGLAFSLFQTIFSLYALERFNLQARDTGYILAYVGVISVLTQGVFIGKLTRKFNEIQLMFVAILTMAFSLLAWGFAPSVPVLLITLLPIAMSGGILNTVINSALSKSVAPIETGGILGLSASLESLTRVIAPSLGTLLLQITSQSYGVFIGTAVPGLAAFVLLIWLGSYFWRMIYRVPPVVHSPSGMD
>fig|926569.3.peg.1825 Tetracycline resistance protein
MIKKTSARLVYLILSGGNTLADTIMFTVNMVYFVEIIGLSPLQLVLVGTVLEGAILLFEIPTGVLADTIGRKVSIVTGWFIMAGGFLLVGIVPELWAVFIGQVLWGLGYTFTSGATEAWLADEIGEDLVGKINIESGQINRILGLIGSAISVAIASVALNLPIVIGGLMYLFLAVFLLFTMPETQFTPRYKSSKSLETPFQSFIQTFQEGVKAVGKSPILLALLLVELFIGAASEGYDRLSSAHLLKNFQIPPIGALQPVVWFGILNITGSLASFSTTAMFRKKLEVISQSYQLAARYLVLLHSLGIAMVVMLALTGNFYAAIAAILVKGVMGALIFPLYNAWLVQNILPTTRATVISIVGQANAFGQVVGGPGIGAVGNRSLRLAILLTALLSIPALPLYTSAQKKQTVFSPESTR
>fig|926569.3.peg.2165 Permease of the drug/metabolite transporter (DMT) superfamily
MTSLHKPFTEFRLPPYLVLVIGVFCVSTASILIRLVQNEASALTIAAYRMVLSVLILFPLAWQKREEWLSLPHSSLKFIGLGGIFLALHFAFWISSLRFTSVTSSVVLVTTTPLWVALVSPLVLKEHPSARTWAGLTIGITGGVIVSLAQGCTWQAWALSCPDFASFFQGKAFLGNIMALIGAWMASGYMVVGRKVRAGLSLISYVFMVYAVSAFVLLIFAILAQEKILGFSPLTYVYLLGLAIIPQLLGHSSYNYALGYLPAAFVALTILLEPIGASLLAMAILREFPNTLEILGGLIILLGVGLTSLPAKK
>fig|926569.3.peg.2969 Permease of the drug/metabolite transporter (DMT) superfamily
MTLKNWLIFLALGTIWGSSFLWIKVGVGEIGPFMLVTLRVVVAFTALALVIARKRTILPDLRRTWWIFAVLGLFNLAVPFVLISTAEQSLSSGLAAILNATVPLFTLVIAPFFISEERMTLPRLGGLLVGFAGVVVLMSDELRAGANWGDLKGQALMLLATFSYGAASVFARLKTRGMPVEVQAGGQALFASLAMLAILPFAENPLVFPRLPITWLAVLWLGVLGTCLATLMYYYLLHEVGPTRATLVTYLFPLVGVVLGAVFLRERLQVWHLLGGAMILSGIVLVNRYKPPAAVAVTPETAQAD
>fig|929562.3.peg.222 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNTFTNPENKSLIAWLLLSILAMMWGSSFIIIKKSLDAFTPIQIGTIRILAAGIVFLPWIISSRKQYPKEKTKYFLASGLLGYFLPAFLFAFAGSRINSSLSGTLNSATPIFVLIVGAIFFQQFIRSWQVAGLILGFIGSVVLVLSSSKDGLSISQLNPYALLVILASLMYGFNVNIVGKHLSEINAVLLSGWTLFSMAILSAIILFSSDFVSRINADTLNPLLMLLLLGAINSGLAAIIFNYILQISSPVFASSVTYLIPVVATMMGFIDGESISFLHYFGMTIILVGVYLINKK
>fig|929562.3.peg.432 Permease of the drug/metabolite transporter (DMT) superfamily
MFSFKFKIICAFTAIYLVWGSTYLFVKISLHSFPPFMLSTLRFFIGGGALLIYTLAIKDTLPKSKELIRQAILGCVTFIGGIMSVVWAQQHLSSSLASTIITTPFWFVVLDSKQWRYYFSNFHILIGLLLGLVGVSLLMILKTNTHISGPISMQLISILVIIAGSFLWVLGSLYLRNNPSSTSVYANTTVQLFAAGICCLFISLFNGEMNHFNLSQTRLDGWLSVTYLAIFSNTLTFLAFVWLIKIKPPAIVSTYSYVNPMVATLLGWSLGNEHITLVQILALSLILSGVLFVNLGRNKV
>fig|929562.3.peg.1892 Permease of the drug/metabolite transporter (DMT) superfamily
MSQKTKILIALGIVYIVWGSTYLGVKFALDSLPPLLISCTRFLLGGSLLFLFTLLRGQGLPTLQQARNAALIGVLLSGVGNCAVAYALLLMPSGLVALLVATLPAWMILLDFLFFSNEKPSFIGTIGLVLGLVGMAVLLNPTQQIGQREVALFPAFIVFLGSIAWAFGSLKSPYLVLPKSLQSTAIQMVVGGCFSLTMSIIFEKDQIHSLLNMSNSTFWAMVYLILIGSYVGYTAYVWLINNAPPQLTATYAYVNPVVAIFLGWIFINERLTSRSMLASAIILAGVAMMTLGRKRKPHEVDV
>fig|929562.3.peg.1929 Multidrug resistance transporter, Bcr/CflA family
MDKNNNRFLLIIILGLLSAIGAFSIDTYLSGFPIMASDLHVSVDDVSYSLSSFFVGISIGQMLYGPLLDRFGRKKPLIVGLVIYVLASMGCAVSTSLEMLVVFRFLQALGGCVGMVTPRAIVRDTFPIQESAKIFSTLILILGVSPIIAPSVGSLMITTMGWHSVFWLQAIIGVVLFLAVLFLLAESKKADDSISLKPEHVTKVFWGIARNPQFITFSVAGSLVSGAIYAYLSGSPFVFMEIFKVSEQQYGIIFGVLAGGLILSSQINNLALRRFSSQQIINVALSIQTILGLLLLTLSAFNLLNLYGTLILIFLFLCCQGFSFPNSSALALMPFSKEAGSASALMGSLQMAIGSLSAAMVGFISNGTSLPMLGVMAGCASLGLIVFKIGNNNIVAKNK
>fig|929562.3.peg.2211 Membrane fusion component of tripartite multidrug resistance system
MENAPKKSFKNYIPRIILLLIVIGAAIYAYQKYQYNQHFETTDNAQIETYTVPVVPRVGGYVNTVNMKDFEEVKKGQLLVDIDDREQQLALVEMEAMYQQMLTDVENARASIKNTNLTIGAAEANLKSTVLRQDKARKDAERDAKLLADNAITKRQADDSKANLDIISAQLDGQKQDISASKSRLDILVANLHKAEAALAVQKAKIEQQKLKLTYSKVYATENGKIGRKSVEPGQFIQPGQTLATIVQDSLYWVVANFKETQISRMAVGQEVKITLDAFPEMELKGKIADFSDATGAKYALLPPDNASGNFVKVTQKIPVKIAIEGVEKLRDKLRAGMSVEAEVKIK
>fig|929562.3.peg.2213 Outer membrane component of tripartite multidrug resistance system
MKINKAFIIICLFLGGEVFAQSTEQVLPKLINQAIEYSPRVKEQQQLLTTGDYRIKVQETGLKPQVSGELSYSRVDPIAQATLPVNGEPRTIQFQPHNNYNASVGASYVIYDWGRFKAGVQKTLLEIQQQGGGIETLKHTLAYQVTQLYYSIVYLQKAIVVQQEQVKLVQENGKIIADRIKSGDALDYDAIQTQVRYKNAEMRVIDLQGQLEKQFIFLSSLIGSDARKLIPANAELQFPYAKSDLQTAYNEAIQNNVDLKYLLSKESILEQEVKISGMSSLPTLAASASVGVRNGYLPDISILRPNSLLGVKLSIPIYTGKRGAYNTQIAKINLDAAKQGTESQKVQISRDLENAYNDIKVANQKKELAASNVFQAEYGLKLAKNRLANGVSTPLEIQAAETGLEEAKFNLLQYDYQALMAKLEIGRLSGVKFW
>fig|929562.3.peg.2459 Bleomycin resistance protein
MISIAIPKLPFIEKQQTIDFYVNQLGFSLISDYGEYFIIKKDNAELHFFHHPQLKPAASHFMIYLRIDKGIDEFYQNLLSKKVSMITPLETKPWGQKEFALTDTNSTLLTFGESN
>fig|929562.3.peg.2673 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNKLSIKAFNHVALQISEIERSRRFYGEILDLKEIPTPNFDYPVIWFDLGNGRELHLIGRQPERTFTPVRSNHFALEVSDVYLAEKVLIEYGVKYFPIKARPDGILQLFLNDPDGNFIELCQI
>fig|929563.3.peg.163 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MIVLESLDHISLGSSDLKKSIEFYVDVLDFEVAEETDRFAILQLDHFSLRLNHIDGYVCQQDNPSAFSLSFIVDVDDFTNAISELEEKKIQIVVGPVVIEGGESMIIRDPGGNWIELFYKE
>fig|929563.3.peg.580 Acriflavine resistance protein homolog
MAALIEFFLKRSIFGNLLTFLIITWGGYTAATLNREAFPRVDFDIVVVTTVYPGASPAEIEKLITNPLEEELKGVDGIEEMRSSSIDNRSGITIKIDPDTEDTQKVVDDIRSAVDRVNDLPDDAETPLVLEIGSDLTPVLDICLELDVDEFGRPLMSYRQLRDEAEKLEDSLLLLDEVARIERKGWRDAEYHVLLDPDRLASNYLGLEQVLLALLERNVNFPGGEVIQRGRSSSVRTVGELLTAEDIASVYIRSNDAGQGIKIASVGSVRADFAPEEYIERTNGKPTINLTVIKRSNADIIETVARVQETVDQYSKDKPASIHVAYVNDISYYVKRRLGVLLSNAASGLVLVVASLFFFMGWRTSLMVALGIPISIATSFIIMSFLGVTLNLISMFGMIIVIGILVDDAIVISENFYRMLEQGYRTYEAALKGTAEVILPVFASVFTTMVSFAPLMSMTGIFGKFVYTIPLVVIITLAASLFESIFILPSHLYDVNKFSQHASEIREEGTRFYRFRTNYYEPLLSFSLRHKLSVLGGMFALLVGSFIAFGAFGSFKLFPGAVEQFQIKMVADPSTPLEQMDRYTVAVTRALERLPKEEIEHVTSRAGIIQQNSTDPFTRRGYNYAQVMVFLTPENKRERTEGEIIDQLRDEISWLLNEEKRKQMEAALPEDPERKRYSAYKPQGSEDLAGLLRNLDIEVLRGGPPVGKPVAIEITGKEYDRLEEIGERFKAVLATYVGVKDIDDDHEPGKEEVRLFINEAVAARAGVSVQSVALAVNTALSGARPTSIKQGTEEIDIRVRFHDAHYKKTEALNRIKVLNRTADSS
>fig|929563.3.peg.793 Acriflavine resistance protein homolog
MTKALSFFMEHRLVTTVFLSMLLALGFVSLSSMNREAFPKVTLDKVVIQTPYPGGTPEEIERLVSIPLEKQLRSVSNIDEVRSYNLENVSVIMVFLKEGMPDTRPAVEDIKDAVERTALPPGALAPTVEEITTDKQQVVDVAFSLKRDGAHVPTTEEYRMLRDTAKAFEDKLYELPEIAEVERFGYRNRQFLVEADPAALNAKRVGLNQILNVLGMRNVDMPSGVMRLNGTEYLLRTRGQFSEALEMRSVPIVGNATGFMTVLSDVAQVFDTYEDPTIYEKYDGSHVIVLRVWKTETADIINAAEAAKATVEKMKERYPEVEVTVFLDQSTDVVRQLNDLIMNFVTGLTLVVAALFFILGFRLSMIISFAIPSIFLIAFTIIHAAGITINTISIFALVMVLGMMVDNSIVVAENSFRLMQEGQARGDAIRNTLSEVFAPLLVTMLAIGAAFAPLLFMGGIIGKFVFGIPAVILIVLVVSLVFSLVFLPSWLNTFLPERVKATYGGDDEEAGGFGLIVRAYRKTMAIALRYRYAVIGGFTVFFFGLLFLAGRFLPFVLFPAGGEDQIDIKTYMPQGTTLQRNLEVMDKAEGLITEVVGDQLVFLRDRVGIHEPPFDDPKPGEETHRSTVIVKLTPVQERDDEASAAIYVKKIRDRLKKAQQAGELPAEFRYDVEAALHGPPVGKPVSLQIRGPEFAQLKEIAALYMKELEGMPGVYDVSLDLEEGKEEIRFYVKDDVAAKAGLSVNDVAESIRTAFNGEVASSISKGEDRINIVVRFPDEARHKIESLKKVKVQNNQGRLVPLERVAYFTRERSYSMINRQDLMRVVRVEASVDTDLTTSLDVNRLLQKKIDISKDYQDYSVNFGGEQEDAQDSFTDLVISFAFAMGVIFAIFLVYFNSATTTGVVMGAIPFGIAGVLLGLMLHGKPLSFMSMLAIVALSGSIVANTLVLVTFTEELRKKGQDLHEAIINAGAIRLRPVLLTTVTTVIGLLPSAYGIPTVDHFVQPLSLSFAWGLMFATLITLVLCPLLYMMKEDFLARLRKA
>fig|929563.3.peg.1212 Daunorubicin resistance transmembrane protein
MVYLKFISMSFQRSLAYRVEYFTAILNAFLYIFIFVSVWQALIPEEGLADGITRESMTAYAVLSTLIKASFGRNDSLLSQKVKSGEIATDLMKPFYFPLMYLSDTIGSTLFQLFSRVIPLLLFCIFLFDIKLPVDGELFLRFLPVYILAFLLFFLLSFFISSLSFYFVEIFPFYIFYYALITLASGAVIPLDFFPEGISGMLEWTPFPYLFYYPTMLLLQKPGLPEYSDLLLRYGVLTFGLLLPCTLLYRTGLRKLTIAGG
>fig|929563.3.peg.2355 Tetracycline resistance protein
MLLFILILDLMGFTLIFPLVPDLLAFYVHSTPHAIDSYLPSLIQTLLQFAPGIGTGEEREIILLGGILASVYALLQFFLSPFWGRLSDRIGRRPVLLLTSSGLAFAYLLWGFSTTFTLFLISRVVAGVMAGNLGVATAAMADLSTEEGRTKSMGLVGAAFGVGFIVGPALGGALSKLDLSGLPFAYHPFSAAAFVSVALSLLSAVLNYFFLQETLPEHLRSKGPLRIEYPFRVLSELKEPTFRRMLALNFAFMFLFTSFEFTVTFFYKIDFGLIPSQIGLVFFYLGLLLALGQGVLVRRLSGIISEQRMIVAGVILIAFALPLLALSAPSVPLSLLALAPVAIGSSLLQPAMAGLASRSISADRQGLAMGSFRSMGSLARGVGPIFGSYVYGSVGITVTYIVIGALLLVSFAVGAGTLRQAQSEASRT
>fig|929563.3.peg.2467 Acriflavin resistance
MRSLLTFFLQRPMVVTISMLALLLIGFQSLVTSRKEGFPEISLNRIVVRTLYPGASARDVESEVTDLIEEELQEVEGIKEILSYSEENISRIEVRGKEELKPEQFRRLYSDVENAIGRIDDLPDGIRGRPAIDDVTTADIPILEIAYSGSPDALTVYLEGLERRLRRIPGVSGIDIAGLPDEEIHVLIDAALARKHHVDLRMISKALAQRNITGSGGILYNPDEEQKITISQGLASFEEILNTPILGNTDGFDVRLRDVARVERGREDVRLIVRNNGQNGAILSVRKSGQADLLDTVERVHRLLESEELPDGVSQSVLVDQSTLTRDRISLLAGNAAMGFVLVLLVLMYFLDRTTALWTAFGIPVTLLGMIVFLKFNDISINLISLAGFIILIGMLVDDAVVIAEQYRSNRENGMEPREAATQSVTRMFLPVLASSATTMIAFAPLFMIGGFPGAFIWTIPLMIIVGLTISLLESFFFLPVHLAHARQRAPRQNRLMPLLERLYRQSLEFFIRHRYRAMGVFLLMLVTSLVTLRLSVRKDPFPQDAADTFSISITLPAGATIMQAQAEMESLEAILRERIGPDLKGTSIRIGTQIEDSTVDRGAQSNLIVALVYLISYEERDRTAETIMNDLHDPLKDLARKNGMQYALNLKRLGPPMGRAIEIRLLSDDDVSRTTKAREIMTYLESIPGVTHVELDEREGLRETELVLNQGLLSAAGLHNQDILTSLRIALDGTIVSRIRESDMDIRLKLNRRINESGDFIKKIPVINRLGIVVPLERFVTAGEGRSPASITHVNAMRSTTVLGNVDNRIISPTDIMDIVNQKFSRADGVLLEFSGQPVETSLIFAGLSSASVVALIGIYLIIALIFNSYTKPFIILLSLPFMAIGIAFVLISHDVPGSMMVGVAVVGLMGVVVNASIVMVDTILTDTQAATPGEIPGKQIVIEGAVSRLRPIVLTTATTVLGVLPTGYGIGGYDPFLSHMSLVLAYGLGFATIIILIIIPLLFMIGTDIRGMLDRRKRNAFSFLTALFDRKAF
>fig|929563.3.peg.2924 Glyoxalase/bleomycin resistance protein/dioxygenase
MNPTNNEQGSRIMPTLRYRDVGKAIDWLEKAFGFERHAAHADESGSIVHAELKKGADMIMLGAARDDAFGKLQTMPDQTGGQVTQSAYIIVPDVPALHDHVQRLGARIVMPLSKEPYGTMFSCLDLEGHLWNFGDYDPRV
>fig|929563.3.peg.2940 Permease of the drug/metabolite transporter (DMT) superfamily
MYLQIIVLALIWGVNWVFMKAGMAYFPPILFSALRFLSAGAVLLIISRWRGVTAPTGDEWRPILFTGLVQIAFTNAVLQNALLVIDAGLASVLFYTMPLWLSILAHFLLPDDRLSPLKISALLLGVVGLTILLKLNPDTLLQLWQRPGTLSELLVLVASVAWALCNIVMKRVSGRINALRFTTYQMITGGLLLLAYSALTEPFQLPPALAYQGWATVAFSGIVASALAFLMWFRLLRAIPASTAGISLLLVPVVGVFSGVLLLGETVDLAMITGMALILISIGLVNVSGRRGRGAV
>fig|929563.3.peg.3458 Glyoxalase/bleomycin resistance protein/dioxygenase
MNVGYVTHNLQPCRDFYVQKLGFSVQFENEWYVLLKAPDSGIEISFLQPGLEFQAPVFQTAYNGKGTYLTIEVPDVEALYGDFKERGITIYRDLKNEEWGDHHFIVLDPNGTGLDFVTYRPTE
>fig|929563.3.peg.3671 Glyoxalase/bleomycin resistance protein/dioxygenase
MITVIGLLALFIVWGVVSARREYYARTDDQHIFQNVTIAAVHPAALASFYIEALGCEIIPADGGFELPGESSAIVLRLPGYRQGPTLRIIPCSTSPLCGPLEVNDRGYAHLCFETNDVPGLVQKAVEAGGTISSTFDRIEKSLSVYTKDPEGNTIEVHIPLPAPFNPYTFYRALKSVWQIKRRRSDPQRSKVRFIHVNIISEDWKETAEFYRKTIHARPTGMKRDYKGLFIEQMVGIKGVTVKGRHIALPGYRNGGPTFELFTYNKPANQGPPGLADRGIIATGFLVHDLMQTVTAIETAGGQIIRRPENGMAVVTDRDRNIIQLVQR
>fig|929563.3.peg.3858 Permease of the drug/metabolite transporter (DMT) superfamily
MSRWRDTLLLLLTVLFWGTTFHAARYAMQSFTPVALAAARFLIGALFLLIVTGRLTDLTLLRNRDFLGRIVLLGAVGVGIYNLLFYEGIARVNPARAALIAAANPGITALLLRVWKKEALPVASLAGIVLAFAGVAFVVFEPGSGWSIGVGELCIMGAATAWSIYSIAGRDVMRTYEQRAVTLYSVVAGSLMLPLFVGSVDDTHFAIGPFIAVLYMAIFATGLAYVWWARAVQSLGPAPAAVFMNLVPVTALVIEVLLGGSIETRQLFGGALVIAGVWLTNRR
>fig|929713.3.peg.1596 Outer membrane component of tripartite multidrug resistance system
MNTRITTIAVFLSVIMVFNNPLSAQDIKKLSLKEAVELGLQNSKHLKIDQAKIQEATAAVDEAKNHQLPDVKVTGSYMRLTNANVDLKAAKSGGGSSSGSSGGSSVPTISQAMYGIANVSLPLYAGGKIRYGIQSAKYLLEAVRLNEGNDKNAIAYNLTEAYANLFKSAQLIGVIQENLVASQHRDSNFLQLENNGLMARNDRLKAQLQTSDIELQLLEAQNNNAIANVNMDLLLGLPENTVIEVDSSFVNGITEAQPVTYYEAQAIQNRKDMQALDYQEKAAQTGIKAARADYFPSLALTGGYIAADIPKVLTITNAINGGIGVQYSLSSLWKTGATIRKAKAQAQELTASRDLLTDNIRLEINRDYQNALLAKKKIDVNAQSLIQAEENYRITKNKYDNSLVTITDLLDANASLLSSRIKLLNAKADAALASQKLLEASGTLIK
>fig|929713.3.peg.1956 Permease of the drug/metabolite transporter (DMT) superfamily
MNQQKAPSALMVILAFAAVYIIWGSTYFFIERGVKYIPPMLLGGLRFVTAGVMMLVWVAAKGERVWNRKAILHSVISGILMLFVGNGAVIWAEQYLHSSFVAIFLASAPIWFLVFDKPNWTENFTNRFTLLGVFIGLLGVIALFYEKLTSDGSTNTLVPILAIFIGNIGWVVGSLYSKYKVKGVSPSVNSAWQIFSAGIVFFIIGFADGSIEKTNWGAIPGEAWGALIYLIIMGSIVGYSAYVFLLSARSAAQVSSYAYVNPLVAVLLGVFINGDHLTRLQLTGLAIILGSVLCINLAKKEREKKQAQRQEPEADRMPVCKELVDN
>fig|929713.3.peg.2067 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIANGHQPLMPYLILVKANDFIGFTQRVFGAREVFKSYRDANSREIMHAEVQINGCNILFADVTEGYDAAPANLFIYVEDAAETLRKAVDNGCVVIDELAQRDYGLSAGVRDPFGNVWWLTSMK
>fig|929713.3.peg.2142 Nisin-resistance protein
MKKPLLFFAILYFSFSLNQEISAQVNDYAFLIDTAITVMKSKSYMKDKVNWEALRTALVNRAKAATNINEFGGVAKDLLGTANDFHGAFFYRDSVFKYKQKIERPFPGAVTEEWKKGVYLKSLLLERQTGYLRIPYITVGSKEEMSKKAQQLNDSLCSLLEKGVKGLIIDLRLNGGGAMYPMMLGLEQVLGNGKLGSFTAAPKEQWIIKQHSFLMDARVLCTIQPKCTISATEMPVVVLIGGGTGSSGEFLAMSFKGRKHTLFLGSPTVGYVTSIEGLPIGKAYLYLSTGYGMDRNGIIYTDAITPDIIDDSIDQFNNIANDPKVKKAMQWILKQ
>fig|929713.3.peg.3326 
MKQIRKNAVFFLIALLMLFMNTTATAQQQNRMIRIAKIEIDSAYLDQYKADVAEHTKAAVQLEPGVLGLYAMYEKEHPNRVTILEIYANKEAYQAHLKTPHFLKYKTSTLKMVQSLQLIDMDPIAFAAKTAVPDSAK
>fig|931626.3.peg.162 Antibiotic ABC transporter, permease protein
MIPVVVASLFLFYYAVSAWEPMAKLSGFLEVISIGFPLMIGLICGIAVDQEWQAGGAQVMLRETKSRAIAYSSKFLLLFLMGAFSVMVTVGIFAIGFKTVPLLFYVKTVGILMVANSFLYILHLLVSFLYGKGASIGLGIGESLISALALTGLGDGRWYYLPCAWSVRLNDYLVYIWDQPASATIGKIEIVRGLVIALVVAGIGFWVSLRWFKKWDGRKSFE
>fig|931626.3.peg.492 Glyoxalase/bleomycin resistance protein/dioxygenase
MKCKFTHTNIIAKDWKKLSQFYQEVFGCVPVPPERDLHGDWINRLTGLKGAHIRGEHLRLPGYEENLPTLEIFSYENGIDSGIPQINRTGFGHIAFEVNDVDAVLKALLAAGGGQIGERIVADYPDNVVATFVYATDPEGNIVELQNWGTR
>fig|931626.3.peg.2154 5-nitroimidazole antibiotic resistance protein
MRRANREVKNKSELIKIIESCKTCRMGMIDDGKPYVVPLNFGYKIVDSVITIYLHSAKEGRKVEVLTRNNTVCIEMDQMSELITGKNGCDYSCYFESFIGEGQAVILENVEAKIDALNAIMKHQTGKDDFSYDLRVLDKTLIIAIELNHYTGKRH
>fig|931626.3.peg.2468 Drug resistance ABC transporter,ATP-binding protein
MENCIEVKNLTKYYGNRVAVNNLNLTVKKGEVFGLLDPNGAGKSTTIDCILGLKSFENGSVRVLGVDPTNDRKRLFEQVGVQLQASSYQGNIRVGEICTEISALYRSPADYHDLLAQFKLNQYLKHPVAKLSGGEKQKLSVLLALIPQPEVLFLDELTTGLDTEARREVWQVLTNLKKQGLTLFLTSHYMDEVEVLCDRVCIINQGHELITDTVPELIRTSPYQRLEEAYLWVMKEEITL
>fig|931626.3.peg.2944 Permease of the drug/metabolite transporter (DMT) superfamily
MSIGIFAAIAAALAAGLIPVLTKALMLDGLSATTILFYRYVVVFVVLGITFIVKKENIKLSIRQVFGLCIFSVFGYGGATFLLAQAFNFMPMGLATMLYFSYPFFVVLIMRVVFKEKPNRTKIIALGIAILGIIFLINFDFQLVNFGSILAMGSGLAYGIYLVSLQKSVLQKLKDPVIIFYLGGISAVIFGLQGCLVSGNPEFLRLPVKGVFFTVALGLITIFVLKMVTYAIKKIGSTQTSLIIAFEAVVTLVLGIVLYGEPWNGNTVFGALLMLVSVILVSRTSDIDIILE
>fig|931626.3.peg.3385 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNQHFVNKAFRVFAINSILASAGVVLGTFVDAIILGNAFGETGLSVLAVSMPIYMVYNLFGYAFGVGGSLKVSESIGAEDKQGARTYFTQAIFFALVIGLLSTLLGMLFLPQIIAATGGSGLDTAIDYLRPVILAAPIFILAPVISLLIRSDADPFLSTVGISLSVVVNLVLDLVFIFGLNMGVFGGALAMVIGQFVAVAVYSVHFFKKNSHLKFCRAPLSLKDGYHLFHGGFGSGSAFIYQGISLVVINNLLSVTVGVSGLAVYNILFNVSLFAYAIFDGISLALAPLVATFAGEKDTAGVYNTMHLSLKTAVLLSIGSGLILIVFAAPIASMFGVAENAMVVVQTIRIFAFGVVQTCINCVMAHFYQTIKRPTLAGVIYFMRGFLLLIAFSAWLIPIWGVMGTALAIVGSETVTMLLMFMAAVVLKKQGGYRNVLLFREPVIAKDNIYETTLSSDIKELENCVVEIEAFCERQDIDTKNAYFINLTIEELAANIINFGFNDGKPHFIHIKIALFDGDIYIRLRDDSTTYNPFEESEKPDEALDYLGVSIVRKKAKSFAYNRTLVFNNLLIIL
>fig|931626.3.peg.3389 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDTMMVGTLGEVPLSGASLANQFIMIFQICCMGIGMGASVLTSRFWGMQNPDALKKTITIMFRICLSFALCFSLATYFFPEAIIGIYSTDPEVIREGTLYFKWAIPCYLLLGLSLTSTIVLRSVGQVRLPLISSICAFFINIFFNYLFIFGNFGAPRMAIEGSALSTLIARTVEFSIICGYLFLIDKKIRYRLQHLFMHCRDILAEYFRVAIPVLISDALLALGNNTVVMVIGRLGVSFVSANAITLVLQQLSTVFIQGIANASAIITGHTLGRGDEEAAQQQGFTFLYMGIAVGIIGAVLIWLISKPMISFYNLTLETQLITYQLTFAIGFIVIFQSANSILTKGVLRGGGDTRFLMLADIIFLWVVSIPLGALAGLVWHLPAFWIYTLLKIDQVLKCVWCVYRLKSRKWIKKIVACPVNQNQ
>fig|931626.3.peg.3637 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNQGSQVQPSKEADIPPEKILHPKNPQNFLGTDGITKLILQYSIPSIIGLLVNALYNIVDQIFIGIGIGYLGIAAANVAQPLTTLSIAFALLFGVGGATNYSLFLGKGNTKRANQLAGNGIIFLILSGTVLGFGTLIFLKPTLYLLGATDLVMPYAIPYTALIAIGLPFLTFTHGACTYIRADGSPTYSMVVQLIGSVFNLIFDPVFLFACHMGILGIALATALSQILTAAISVHYLIKKRRLMSFGKKDMLPTTNCLKPISAIGFGVFINQIAGAAVLIVLNDVLRHYGAASTYGSEIPIAAAGVASKVFILYQAFTIGIVQGFQPVLAYNYGARLYDRVKQIYQVSLSLSSLFSIVTFLLCMIFPGQISSLFGTKNVAFYAFTTRFLRIYMLLTFANGIQPIVYNILNSIGKVKSGMIATLSRQILFAIPLLILLPALFGLEGALWAVPIADFLAAILSIILFAREMKEINKLILKSSENTASG
>fig|937774.3.peg.1079 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTWPILIGQLAGISYAVLDTMMIGNYSAVGLQAMSLGSAIFVTISISLMGVIHAIIPIIAQLIGARKNAEVGIFWGQGTWLAFILSLLVGLLMLFPDMWLSISGEVSQVVRDEITIYLRICYLALPAMMMYRAVYAICTSSQNPRHIMYISIVGTLSKALLNWILIFGKLGLPALGSAGAGLSTLIVSWITYTVGLFIIFKNPVYDKFLLHLGRPKFKPIKQILNLGIPMGGSYFVEISIFSFMALFVAREGIYVSGAHQILTSFVSVMYMIPQSISICTSALAAQAIGARKYILSHNTVKMGTYLVLAGYAILALTVILFKVPLVDLYTNNTDVAHITLIMISIIPFFHLADALQCYVPYILRAHKIATVPFVTQSIILLGIGLAGGYYFGFGAGRGNIKFLTEFIVPNAPIGIASMWTMNTISLYICTVILGTWYYFVIKELIPKSRKNNMPFYYKKDLFKRKKP
>fig|937774.3.peg.1310 Outer membrane component of tripartite multidrug resistance system
MIKHSKQFILLATCLISACSPIKVDIPESKVDLDNLEFEQTKKAKAIVSLDKWWEDWNDPILTTLIEEGLRENFDIAIAKAKLLESRANANLANADMGPTFGLTANGGFHSTSVSNPIEPALSKVGFNVSDDFQTTGLTGFAGAVASWEPDFFGSKLSDAKAAEYGASAQEEGVHGASLLTSSEIALNYLYYRYYQKKIFYAQRTLSYMQEMRRYLKGRYDVGHVGIELVTDLDSKILAHKARTKTLPAQRDKHLRAIAVLLGKKPQGFTISNSNRDLFEHIPQAPSGQYPISVIERRPDLRAALLNINARASQVASAKADLYPRVKINFLGHNGVVEINSDYLANPSAFGGLFNVGISIPIFTNGRIQRNIEVKDAKLKQAVIEYDQKVLKSLSEVDSVYQAQFAINEQNNLLSSSLVVQNKKTRQLNQMYKLGNKTLDDVLKSKIEASEFKDKILESSLAEAENLIRLYKALGGGW
>fig|945713.3.peg.1410 Antibiotic acetyltransferase( EC:2.3.1.28 )
MSKNELKVDLSTYKNYLSRKNQIARFIWSVVWGIFARPIPRSLFNSWKLLLLRIFGAKVHKKSVVYSSAKIFMPWNLEMEEYACLGPEVDCYNVGLVKIGKHTTVSQKSYLCTATHDIEKSNNPLVIKSIIIEDQAWIAADVFVGPGVTIGQGAVVGARAAVFKDVEPWTIVGGNPAKFIKNREIKN
>fig|945713.3.peg.2271 Permease of the drug/metabolite transporter (DMT) superfamily
MKKYIGESALLLNTIIWGGTFALIKNALADISPLLFLGIRFFLAAIILLPFIYTVIIKTDKKTFLAGSILGLFYFLGFATQTIGLNYTTATKSGFITGTFVVIIPILQTIIEKKKPKWYNIVSILFVMIGLVFLSSSGDNLIQFITELGSDFNLGDFLTLLCAVLFAFQVVYVDVFTKKYDYIPMVFIQLLITGLGGFIGSIILSSIGLEIVKFTLNTNVIIALIYTSVFASIIATILQLKYQKIVTPTKAGIIYSFEPIMAAVLASFIIGEKISKFGMFGGLFIVVGLLLSEILENRNEQTVKSNNNS
>fig|945713.3.peg.2715 Glyoxalase/bleomycin resistance protein/dioxygenase
MNPKPEIGSITWCDLTVPDATVIKNFYEKVIGWKADPVSMGDYDDFSMIAPESSKIAAGICNAKGINAKLPPQWLIYITVENVDTSAQTCLELGGRVLIEPKTISNYGRFCVIQDPAGAVCALFKPE
>fig|945713.3.peg.3037 Permease of the drug/metabolite transporter (DMT) superfamily
MLEEVSPETIISLRLILAIILLTMVAVITKSDFSLNLKNHLRILLLAAVAVFHLWIQITGLKYTTAANTGWIIGTAPIFIAILGFIFLKEKLNPLKISGIIIAFIGLLLLVGKGNPLNIDLVKNVGDMLVLFSSFTWGVYSIINKKISLNYSPLMTILYLFIMMALIIIPFNINQKAIDSVIHLSSIGWISILFLGLLCSGVSYVIWAYSLREMESARVGAYLYFEPFVTVITAGLFLKEEITLLMVLSGLLIILGVYLVNKE
>fig|945713.3.peg.3128 Permease of the drug/metabolite transporter (DMT) superfamily
MIKNESKTQVFPASLVSIAATLWAIDGIVLRPYLYNLSVPLVVFIETTIVAIILTPFFYKQFSSLRKLKLKDWIAFIGVAFFGGALGTMAITKALFFVNYVNLSIVIFIQKLQPVFAIILAAIILKEKLTKEFLFWATLAIIGAYIITFEFNLPLLETGDKTAVAALFALIAAFSFGISTVLSKRALRNIGFQLGTYLRFAITALIMLIVVSITNDFKSFSEISINQFYVFLIIAFSTGGPAIFIYYYGLKKISASVATICELAFPLSAVILEYFVHGKILSPVQWIGAVLLLISIIKVSGIEISSFFNNKEE
>fig|95666.5.peg.153 Multidrug resistance ABC transporter
MNQQSQTIKPVSKLHLIYYYFKDFKKSFIGLSIAIVLWLAATIAATFLLQETVDKYAVANGVVDTVVKMCGGLIGIYFLSFIFLLIMNEFAIRISFKIESHLSMMVINRIRYLPMKYFDVNKSGEIFTKTLSDPTSVQDGIVNFYIELNKTFFGALGFGIALLVTSPYIALIGIAIYTLVMLFNILIFKKSRQLMRKKRQDFGEMNGYIEEMIHGQNVVANFDEQAYFVKKLDNMIKNLYKNWVKAQYSSQIIFPWSIFSMRLMNAVLIVSYLLISIKGIHLPGIVSNIDPVTNMISFGGLVSISLFGNFFCDNFSQLSNAIPIFIIARTSLAKIDEIVKTPNEIDWDEKLVIDDSQGIEVRFENVNFNYSKNKPTLKNINFVAKKNQKIAIIGPTGAGKTTITNLINKFYDINSGHIYFNDVDITNKSRASVREHISIVLQDPFLFSESIYENIKKGKMNATKEEIVEAAKKAQAHELILSFEKDYGTVISEKQSLSQGQKQLITIARAIVSDAKIIILDEATSSVDTQTEHKLQLAINNLLKGRTSFVVAHRLSTIINSDLILVVKDGEIIAQGNHDYLIKNSSFYQDLYYTNFAE
>fig|96561.3.peg.1627 Tetracycline resistance protein
MSLHIIIDGYNLIRQSPVLSRIEQENLQAGREALVASLVSYKRIKAHTITVVFDGTDAPSYYSHRDRVGGIDVRFSGPGQTADSVIRKMAAEKREKALVVSSDRGITDFAQSAGAAIIASREFEDRMAQAMMMDAAGMAEEDGAFSPWSGTTKKKGPGHRLSKKQRKSRTKAEKL
>fig|96561.3.peg.1890 Glyoxalase/bleomycin resistance protein/dioxygenase
MNLHHIGIACRSSSAGDRFYRDLLGLEKKRERTVPGEMIKKIFDIDQDALIIEYGNETMLLEVFVIPELEEDHPVSHLCLEVNNRVAFMEKCAAMGFGARQIPKTDGTAIVFVKDDDGNQYEIKEQP
>fig|96561.3.peg.2416 Bacteriocin resistance protein, putative
MHIFIAFLITVSLIAGFKPEKEPSEKETRLVIGYDGGIVTQTMPVEIRTTVTPASELEYQAVIKQQFDYSCGSAALSTLLRYHLGEDFSETQVIHGLFRYGDKERVREKRAFSLLDMKKFVGVLGYNGVGYKADIQDLETLDMPCIIPIELYDYRHFTVFKGIHQGHVFLADPFRGNSSYPVADFKKMWHQNVIFVVYPKNQQQLTLLSLSERDLRFVDEDKRFDLLFKDWPVMEGRPPEPFPGEIQYYKR
>fig|96561.3.peg.2457 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MPEKTPLVSVIVPVWNDGPCVGRAADRIHTVLKRTCASYEVIFVDDGSSDNSFEEICRACAAHAHTMGIRLARHAGQHAALRAGLAKASGEVLVNFDVDMQGVPEDIPRLVEKVGEGFDLVCGWRTERREAWHRRVFSFFLNRWVNRHTGRFLHDNGCFKAINRKVADRIGQNDSSRFLTALVPALADRVTEVPVSWRKREQGRSRYALRETASMVLDFFLVYPVLPFVWFFWGGLTVLMAGGAVLGIGLCRLTDSGYWQPSWLTWTGGALLALGGMLFAVWTWAHRGIHRRKKISNVSLLLIERIVGKTDGNNG
>fig|96561.3.peg.2525 Permease of the drug/metabolite transporter (DMT) superfamily
MRAELWALLTAACWATGSLLEKRGVISGGLAPVMGTTVRTLVSLAFLTIISFPYWGQVRAAGPKPIALIALGGGILAGGLGIMFLYTGLKHGHLSTVMTIAFCMAPVLGTVLGYLFLNERLSLVQTVGIVLCVAGAAMVTFFKQG
>fig|97084.1.peg.9 Acriflavin resistance plasma membrane protein
MKILSFLQSHKLFVHYATIVTVVLGISSFFLLQRETRPNVNFNRVNITAAYPGASPVDIEGLVIDPIEDKLAEVDGIEEYRSVSYMGAGSISVIVDENYPDPNEVINEVRRKVSEVDGLPVEVDDPIVTELKAESMPVLNLALYGDAKPFDLKFQAEKLKDFLQQQDGVTNVSYTGITNLQLKVLLKRVKLTKFDLTIDEIFTKLSNWSKQKPGGIFENSELVASMTIGEDLNSLEKVGDFIVQSNDSGKKIRLKDVADIIYDLEENQTGNLFEDQVAVLFTVTKSPSADAIRTVDSVKKELTSYKKSLPSGLNLKLYKDESINIRTKLKIVTGNAIVGLLLVLVILIIFLDWRSALITSLGIPVSILGGVLILFLLGFTLNSLVVVGVIIVLGMLVDDAIVVCENIYSKIEQGLPPARAAIEGTREVAAPVMSSVATTVFAFLPIAFMGDVIGQFLRVIPITVIALLFVSVLEAFFVIPVHSEELMKPQENKSKKGIMQKVESLYEKYVLWSIRKRAFVVGSLVLFFIISLFQGQKIFDQFSLVPSEGLEGLSVRLELDKNTPLSATSDRVKNLSRRLINISDGTFDNIYSDLGQVTTGGSGGSRQNGTHLAMINISFTSDPSFIHKEKEVLKRISKEVENFSSEFNVKTTITLDLPGPPVGKPVQVQIATRDFDFGISIIKKIKEKLQSISGTYSIETDFAGDSIQYRFRIDNEFTISQGVDPSKISRTIFAASTGLVSSEILKNSEKIDILVGLEKGSNLKNKNLVKSEEIESILNLTVRNSNNQAVPIRNFVKIYEELGPSSIQRLNGIRTLTLFGEVDERVTSGKKVNQELAPYLEELREKYPNLKIIIGGGEKDRASALIDTLKLYAIAILLIYIAISLTFDSVIYPFLVLTALPMGVSGVVWALVLHGKSLSLMGIIGLVGLSGVVVNVSIIYLKFIQDNIRSGEVLDKAIVLASVNRIRPIIMTTISTLLGLFPTIYGVGGVDAFVQPIALVLGWGLFVATLLTITTLPALLSFFTILNKK
>fig|97084.1.peg.17 Multiple antibiotic resistance protein MarC
MYQAFEDTLKFSITLISILNPIGIIPIFLNLTKANSESQIIKIAHSCSLAVVITILVSLVAGQYVLEFFGISIASFTIGGGILLSSMAFSMIQATSSNAKINDDEIEQMQDLRELGIVPLAIPLLSGPGAISTSIIHAKAFATPLHWVGAILAVILIGILVRNVLAYSKRIGERLGTIGQNVMTRIMGIILLAISIEMIVGGVKEIIPILKGA
>fig|97084.1.peg.152 Acriflavin resistance plasma membrane protein
MGVLMKKIVSYFVDNSFIVNTLSLSMIVVGLISFFSMQRDLIPQWKDKRITISATLPGATPYQVEQYLTSPIEDAIKSLSGVDKMVSTSSPSSMSINMRLKDSMEEDDIDDLYERVNSIILNLERDLPNETENLSVINNKVSSFWFTTLSVLNFDEHNSRHQKWLSDIQKQLGKINGVVEVRNWTSKPQIYIQFDQEKLARYQIHINELTQNIVRRFAFLPLGTITKNGNEVSVEIDNDVDGIKDIEETIVNANASGKVLRVKDIASVEYKIAEKETVSFTNGAPAAVLVLFKDIDSDIITMKEDLEKMLVNINESAPKGLSILLTGDGPSFIEKQLKVLNSNGIMGGILVVFILFIFFGIKSSLMTSFGLPLSYLATFTVLRLLDINIDLISVVGMLLIVGILVDDAIIVSELYMQKLEKGMTPRDAAIESSMETMMPIFGTVLTTIIAFAPILFSKSGVGDVLVAIPWVVIAALTMSLLECFFILPNHLAHFVKTPVKEKKFSIFNKLTRLYEASLSIALKWRYIVLTLLVGSLIGTFVITKEKVPFKFNLRIGSERVKVDFILKKSDALEETRSKLLPIFDLIKTIDKDKYAYVTTQIGRNWYNGVEQIGYRYGGINIRFSQTDDLALESKEEIIKLLEQKLPALKTDDFEVLSVKSAKEGYDDKKENTFKLSTFIEGKLRDQFVIDEVKKVFSTIEGIKEVYIDPGLVATTWMFIPNKEVLYSYGIDPIDLSSKVQGFIRKSHIKEYRHDGEVVNIYGYINDGKKLSFNELGNLSINIGNGQIIKLKNIGEWKKVTSLKEIHHEDGKRALNFDLTYDEKVLKKEKIADHVKEKFPEIKSSVPGLSFALEDADLQEAKNSKAMSSMLITCIFLILFVLALILKSFVQPLIIATAIPFGLIGIVWAFYFHSLPIDVMGMVGVMGMAGVVVNDSLIMVTTINSKKSKLWFLTREDILSGAVSRFRAIILTSITTLGGVFPMAYGIGGDSGFTRPLALSMGWGLLFATCLTLFALPSLLEIQRDSWRLLAKLPFLRSYFENSMEEVDSVSIVANEESIPLVANQESENNSNQLH
>fig|97084.1.peg.192 Multidrug resistance ABC transporter ATP-binding and permease protein
MNNSQSSSLNIWKSYLLNNKSVYFVGTLMVLLTNICQVLTTRIIGWIIDFFSGVSYPHFFSKASKIETFYFFFICMFACRVLITLGRMGWRVTLARQTHMASAMLRKRIWENARFFNKKDLVTDFSKGNLMNASNSDVNSSRFIFGFTLVGLVDVIFLGILTLVTMGMINLKMTLISVLSLSILPYFVKKLSSKEVQRYKDSQKALGDFNDLSTQVISTIRLQRLTQTGNYWEGKLIESATKFKNSRLLALFTSLNYIPMMGGASIISYGVLFVVGVGLVIDQQMTIGDFVSMQGLIFLLQDPLMEMGFIISDWKRGTTSLDRLNKIYKNKKEEFLFKKGDRISDSQYVLSAKNLSFRYYDSDKKTPLIENFNLNLLPGERLGITGDIGTGKSTLLKILSGLERNYEGRLFFQGKDYNNYEHGQLREFMSFVQQKPFLFADTIKKNIEMDRELSDDDVWYYLELAGLDKDVLDFPDKLNTPLGEWGINLSGGQRQRLTLARALSRRPKLLFLDDCLSAVDTVTEDLILNNLDRELSDTTLIWVAHRSSTLKYCNKVLNLSDKAEVIHE
>fig|97084.1.peg.309 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSLLKLCKLLRRCYNRYMKAQLTQGDITKQLVSLAGPMIFGVFSIIIFNLVDTYYIGKLGHRELAAVAFTFPIPLIVGAVAFGIGIAATSFVSMALGSGRSHEVARYATDSISMVVILGIILAIIGELTIEPLFLFMGAPKDLIPLIAEYMRVWYLSIPLIVIPMTGNSVIRAMGNTKFPAMVMAVAGLGNFIFDPLLIFGIGPFPAMGLKGAAVATAISRFFTLIAALYVLRKKYDVLTNPFIPFKQLLDNWRKITQVAFPAFLNNLVNPIAMFILTKLVASHGEIVVAGFGVGTRIESLFAIVLIGVAASLSPFVGQNYGAKKYSRIRKAIYLANKYSALWIFICGIFLMFLADGLVRVFNDNPKVIEVASTYLKIMIFSIIGLALMQNSVASHNSIGKSKTSLTINLLRIFVIHLPLAIVLGNLFSYEGIYWAGFIANFLGGIIGSFFLYKLFQKFPAEDPI
>fig|97084.1.peg.482 Acriflavin resistance plasma membrane protein
MKALLKYLFDNPLITKFTFIIILVGALIGMKNLKRTSYPQVDLHKVIITTFYPDASPNDVEVNITNNLEYELKKVEGVKYYTSRSMEGQSTITMVLDQEYGDFQSVKDNIYRALGKVRNLPSRVTQRPKVMEMKVDNFPIYDVALISNEMSEEEVIEVTKKLRRKILQIPEIYKAEVSGKREKEFQIILDPKKLTLYDISFEDVINAVKGNQIRATGGTIESFVNEKKIITLSEMDTPKKLRNIIVRSNYSGKKVRVSDLGEVSFSFSKKNIMTSYNGDEGIGLWLYKVPSSDIIRTIDKVRKVIADFKEENKSRDLKIVNTHDLSSETRSRLEMVYSNIIMGLILILAILIFFFNIKLALWVCVGIPFSLAFLMIAMPLLGLTLNSISLCGVIVVLGMIVDDAIIVSEAIYSREGNSEESLIKAVLGVARPISITILTTIISFIPIYFIPGMMGQFTAEIPSVVIIVLLGSFFESLIFLPIHLRNIKSGTVEELRATHLGKRTMNFLESQYSKFLKKLISKKEIALVSLISILALFLSIGIYKFKFQMFPEFQAQRIYLYGDVERGKTLEYTAQVAKKVESVLQNVVAGDIKSFRTRVGRNYEGQYHCEQCFYTKLELTHFNSRERSALDIESKILEEIKGISELKSFGSRIDSGAPPRGNDLELVILSDNESKRVDVIRSLESKLKELGEVSNDFILGDSSLVLRPLYEKMSRMGTNVQEVAKSLRIAFSGEFIGFISKGDERNYIKVTSNLSDKGFGAPLEDLSVLNNQGRKIPLKKLVSLQEEKMPVVLTHYNGENSNTLSINKISRKDAKEVISKIVKDVKSEFSDVDIILKGRMFKDREGRANLFLGALITCLIIYFSLVILYKSYLLPLLICSSVPVGLIGILFSFKIHGAPLSALGLVGIIGFIGVVINDALLMVEVMKEPRSIESIDGLARGATKRFAPIFLTTITTVFGLLPSIYGFLGGTDAFISPMVLSMGSGLLFGTISDLILIPLVFGFIYRDKHV
>fig|97084.1.peg.556 Probable multidrug resistance protein norM
MSFMKKELKKIIQLSLPLIFAQIGVVLLGVSDMVMLGHYSDTALKASGLANVWIIGTLMFGIGCSLGVDPIISKLVGQGESERTKVSLITGKALAVAIAVLTGLLWANTGAILGLFDQNAEYAELAHSYALIQIPSLIPFFMYMVFRQYLIARESTMPVALVLLLTNFINIFLNWIFIFGVGPFEEMGLFGAGLSSCLMRAAQYILLCLIILKSKKYRYHWVPYKAKYIDSEMLKKIVLIGLPIGAHLMLEAFGLQVTAFMAGKIGDDDLGAHSILLNLQYLFFILPMAFSLCAATRVGNEIGARSSNIFNVFKATSLLCLILFLCSSLGMFYFGESLVRAYGTSEAIILKARESLFYSSLFLFFYGLQLVGSGFLRGAGLTVITSLSNILSLYVIAIPLAYFLGVSREWGLQGLWAALAIGMVVATCANAILNLRYLFRVKSELSLSH
>fig|97084.1.peg.955 Permease, MDR related, probably tetracycline resistance protein
MMDNSLKKNISKIFALNSAWMFLIILPIIVPFYRSKGLSMQEVFELQSFFSLIVLIFELPSGYVADLIGRKNTLISASLFQGVGFSLLPFFDHYWGLIFVQLLLGIGVSLFSGTDISIIYDSLHAMKNRIFNGSEAKLIGKKIFYTQTSEAIAALVGGALVVSSLDTPVKVQAFICWIPFLISLTVTEPPREKLSSSAHGDNWREISKKLFKSGPLIKFILFNNIIYSAATLLAVWTFQDYWHSLGVDYKYFGYLWCLTNFSVGLVARYAHDLEKKIGSVNILLLIGSLPIIGFFGMGKSAGLVGIIFCFSFQLCRGLNQVILKDALNARVESQMRATANSIIGLGMRVVFIIFGPILGWLIDNKGYEISLNIFGAIFIVSFFIILLPLIKLRGEFRK
>fig|97084.1.peg.1178 Probable multidrug resistance protein norM
MIFMKKTYLSTIKEIFLFSIPLIAGQVGQMLFGIGDIIVAGRYSNDVVAALGVANGLLAPLLMFGLGITFAVGPLTSQFRGKNEKDKSIFANAHYLMLTVSVGLLVAIGALIVALPLFNFNPTITPLIKDYILIAGPSIIPAILFQISKEYLQAWDKNIFSNSLILFFNVINVGMNYIFIFGEFGFPEMGIKGAALATLISRTLMFGALFIYTKAKFEIDWNFNQVLFKRIYKFGIPIGLGTLSEVLMFSAVTVLIGKMSIIASASHNIVINLASCTFMIPLAISSAASVKVGKEYGAGSQQGILIYSLSSIIMVAIIMIGTCAMYLSFPDILVRFATDDPELISYSAGLLLYVGLFQIPDGIQVTLWGILRGLEETKHPMILSLIFNWCIGIPIGYWLATSKGMEAAGLWAGLAIGLTIMSVGLSCVFFFKFRVVKSTLVPMA
>fig|97084.1.peg.1263 Acriflavin resistance plasma membrane protein
MKSIITYFTKNHLVSNILFVGVFLMAIFAWNQIGKEEMPEFESNWMRVSASYPGAAAEDVELFVTKPIEDELKEVTGIEEIYTTSSTGSSSFRIVIDEDSANYSEVVQNIKDATLRASLPREVDTPTFRQFKSTEKAIIDVGFYLEGERALDYAARKKLQSMVLNFENQIKSLGVVSGIDKKGYDDPELHILIDPDKLNENDLSIDRLVSIIRNNHIRVPLGTLEDKDQSKVTAIHELEDKESLDSLFVVGNYGGKGVRLGEIAHVEPQFKKSTTIRKLQGHEGIVINVKKKFSTDILTAQENVVKFVEEFKKTHSESGLRVVLMDDESYDVKNRLSIVASNGIIGFILIFLVLFVFLDFKSGLWVGMGIPFTLAFAIISMTLVGYTINNMTLAAVIIVMGIVVDDAIVVAENISRKRYLGESPIDAAVNGTHQIITPVFGSILTTCVAFVPLLFFEGFFGKFVEYIPFVIISMLVASLLESTTILPSHLLERKSFFSRFKFLSFNSSWFFKYEEKFSVLLEKCLRWRAAVLLVAVLLSGISGYLFKTKMKFVMFPREEGKEVHIKVIGPKGANRFEMSKLIEPLEEMILRDKKDGVVAVQSTIGESRRGSGVLENQASVNVELVNKDDRELGLNDFIERWEKESQEIKGLTKINFLKSRWGRSSGSALEIQVQENNDKNRDEVTKLIEKYMLEDESLKDVEIEKPLNRREYNFKINQERLVRFNLSPENITTSLRSFVEGAILYTISKGDEDVEVRLTVDDKNKFDLSNLRELKIENNSGGFITLDKVVSIEEYMKPANIQRKDYKRTTIVYGNIKDGVAITPVEVAEKYEAKVFPKIIKDYPSSVITFIGEVKDTRESGGDFVISLIMVIGVIYIILVIMFNSLGAPLLIMAIVPFGLSGVVYALLAHGMYVYGFFAAVGALGMIGVVVNDAIIMISKLEEDISTMEENSLAKIASVSSTRLRPIVVTTLTTVAGVLPTAYGIAGYDSMLAEMMLSMGWGLLLATIVTLFLIPCLYSYFFSVRLFILKKTHIHLEDE
>fig|97084.1.peg.1447 Melittin resistance protein PqaB
MLNRLQKYSKELLLICTFLIFYGHSINLWGFFHDGYLYAALGKNFPWDSWLIPSQSASQFHEFSHHPPLFFILEGVFFKLFGSSFAAARIFGSLWVLASALITFHFIKKNYNSILASVSSILLLTLPSLMKKSRFPNMDQALLFSYLTCLLIYFEAYRNRSSKTMALSGLFWGLSLLIKGLSGVLILPLVFIHQLMVRKSLRFLLEREIWVAFIVGGLVFSLWPISLFSIGRFDIFLSYLDFQLFSTAISGRGETELNFFLYFFHLLKSAPHICFLTLLSVYLFVKGRIKEFREFYFFNLVCVVSYLLILSCMKFKYSHYLIPIYPFLSILAGFSVYSLVEKNLKRVTISYVAILIISFVVLFPLGVTNKVKRDKEVYEISKLFKSLERVPRNWVIVDNSYSYWAISGLSSYLYGANPYNLNSDEARKKALSLSDTLFVTRGSLMSSELKKSYKPLMSVESDLKFWVPKKSLKRKIE
>fig|97084.1.peg.1697 Acriflavin resistance plasma membrane protein
MKTLSKFFIDNSKLSIVLMLGLLIYGIMGLAKMNAESYPNVSFATAIVTTRYDGATAQDIETKITKPIEDEIRTVRGLKDVNSTSQSGLSTIVIRVDMDRAGIDVETVISDIQKAVDRTNKLPADLIDRPKFSEIKSEEMPVFQIAVLGSNENRSRDIIADHLKEELEDNKLIKGVTLEGFAKRTFQIEVNNDLLNKHHIGMQELISKIQARNVNIPGGNLKQDKTQQLLRLEGKIKNTKELENILIRSNFSGQSIYLKDVAKVVDGEEEIKVRTRYNGEEATLLTIAKKAGADTITLVDDVEKKLHEYEKLYTDKADFKVFLNESIKVKDKLDVLANNAVSGLILVIVFLFIFLPGKIGLMASLSLPLAIMGTLGIMPAFGMNLNTITVLALVIALGMLVDNSVVISENFTRLRQEGKNSKEAALESIKSLWLPITATAFTTIAAFLPMLVTKGIMGQFIKWIPIIVTISLLLSLVESFFFLPMRLVSAGNSVKKDKDGNSKKDWFHKFENKFEKIMTVIVRRRYIAVAGFSALIVFALFMMTAGNKFILFPADQTEIYIARFELPNGTKLEETNSKLRDLSNDIKEVLGKDVKHLIGKSGESKVQLTDPKATEGNNVGIVFIYVTDEAKLNLFYTTVLEKLRAQVPKDGYKSLTFEAQVNGPPVGSDIEATFRSNDMEQLDSLIGKIKARLEKVPGVLDLKVNDIIGDDEVFINIDYEKADQLGLNIFNAGDTVRSAISGRIISEVTLNNKDVDLRVSFKESDRTDITKLKDVNIMDSRGNLVPLGTFAKFETKDGTPQIKRFDFKRSKTLAGSINEKKITAMEANQILLKTYEELRKDFPSVSLVFGGVAESTKESMESLAQASVLAAIGIFAILVFLFKSYLRPLIIMMTIPLGLLGFSIAFATPVLSGYMDRTRPISFLALIGIIGLAGIIVNSGIVLISFIDEMRAEGKLSLEEILIKASGMRLRAVLVTSLTTVSGLFPTAYGVGGSDPTLVPMTLAMAWGLTSGTILTLSFIPPAYAILEDFLNLVNRITKRKKHIEEDMDGSEELA
>fig|97084.1.peg.1952 Bicyclomycin resistance protein
MSRTIEKSLLLILGALAAFGPMTIDLYLPAFVEIGKDLLVPTEDIQYSLTSFLAGLSIGQLIYGPISDRFGRKKPLLIGITIFIITSIFISMVKSLEALVILRFIQALGSCVGMVITRAIIRDLYEPRDAAKVFSLIILVMGVAPIIAPLLGTQILLFSTWRMLFIFLAVFGAVTLLGSIVKIPESLKVVVPIKKGFVNYYELLRDRQFLMASFVCGTITAGMFSYIAGSAFIFLNIFKVSATAYPIIFGSNALGFIICSQINARLLNHYSIDSILEKAIFFAIVAAACTLISIGLHLDLIYFLIPLFCSIASIGFIIPNITAKALEFQHERAAVASAMMGSIQFSISSLGSVLVTIFANGTAWPMVLTLFTFNALTFSFYFFGLRSYEKKLCM
>fig|97084.1.peg.1957 Acriflavin resistance plasma membrane protein
MIEIFVKRPATTIIFIAIFMVMGLVSIGNLIIEPTPKIEFPIITIQTTYGGASPEEIETQVLKRVEDAVSEISQIKKISSEARDSYGVVIIEFLIEADVNIKSIEVKDKVEAIMNDFPSGADRPIIAKFDPLIKPIATLALMSDKHNLTELFEYADKKLKTRLSAINGVATVDVFGGRERQINVELDNNLMIQNYLSIEDVINSVSSKNLNVPGGSINRKDSKVSVRFVGEFESVEEIKNLSIVSREGRTIKLSSVGTVSDSYKDVDSIARFNGKDTVGIAVKKLSDGDAVKIVGTLKSDLEVIKKELPEGMKLEIAVDTTRVTVDNTVGTINSILLGVVLTIIILLVFLGDWRGAIIAAVVIPTSIISTFFIMDMSDFSINMMTLLAFGTCLGTLIANALIIIESIYKHLQMGKDPQLASIDGTKEVLLAIFASSGTNLVVFTPLAFMGGIVGQFMVQFGMTVVYATIFSIMASVTLTPMLCSILLKDPSRLKGPFPFIAKITDRVIAWITTQYKWFFDKMMDWPITATILSLAVFFTIVVPAGQLGSEFVPKSDRDEYTVTVVMPDGTPVEKTGEVVAKIDVLLKEYPEVTSTLSDIGYDGEEKARVTVSLTPAESREKSYDVLMAELLIDLAKIPEAEVTLSGGDSGSGGQGDITIDVTGRNFEEMAKASEKMKEIMANSGYFGSIESSYRIPKMEVQFNPDASKIIRQGLSNVQIGQVIRGLVNGNDDSVYKEEGEEYDINITLGDDFKKNVEDFDSFLIHGKDGLIPIASLGKVEFTEATSPLKRRDKKSIIQLNGYLAKSNTGTVMGELTKKFSELDLPESVEYAYTGNAENQAESSQELGKAFMLAVILTYMLLVAVLDSFVFPISIGSAILTSFLGSFALMFYTDQTVNIGSMMAMVMVVGLAVNNAILMIEYAQQKIAEGIEVREAIWLGAKEKLKPILMTSIAIIAGTLPQLFALDKIKSAMGAVIIGGMIGSIIFTYFLVPIVHYLVYKVKNLIAKFRNKEVIS
>fig|97084.1.peg.2282 Multidrug resistance ABC transporter ATP-binding and permease protein
MNTSKIKWSSIFFFKGSYRYVVLIFICLVLSAGLGAMVPKLVAKLAESYENENIFYQSIEHLLYLFMGVYANRSLYQLGVNKYVKYLVQNVRSWCFEKWILSYEIQEGDTGHEEKYPQGEILSRIVNDTESIRELVTSGTFGIFIDLFFVVSCMLSFISINTVTGVTLVVAEVLAASLLIYGSKYMRKIFLSVRHSRGNVYKTVANLVGGVGETYFTNHERYASKKAEVVFDDYLGKILKSNVWDSGYYSIAESLYPLLLALVVLIFPYSHITQAAVILVIVDLIQRSIGPVKDIAGKIANVQRAASGVDRISEFMNDLDQTISSPKSYTKKEESLESVSVEVEEFSYPVRREGEPAFSLNNISFEAKRGELVGIVGISGCGKSTLLKILSGNLIPQRAEIKVSGTDGEQVSFPGSSFKDVTRYRELVGIVSQDSHIFSESIAFNICLCEDIPESFYSFWKWVEEQIPYITEIWGVGPDTILDQKSISIGQKQLLAAIRSCYLKKPIVLFDEVSSGLDSRLELALRKVILLIQEQSLTFIVAHRLETVIESNKILVLDKGRLVSSGTHHSLLDNCEIYKEFLNELSH
>fig|97084.1.peg.3048 Melittin resistance protein PqaB
MTSFSSIKKLSIFSIFLVFILYTWDIGNLDAIRQGTEGFYLQIAKEMFNAGSILTPLYNGENHWSKPPLQFWMANIFYFIGGGPSILLSRLSIVLFSLATLILTSQIVSKLLSKSFLLIFVFLSATFGMFKYSRIFMMEMPLTMLTTLGALYFYLYLNDKKYSLHLASLFIGLSILVKGPVSIVMAAGGIGLFLVLEWYMFGFNSKDLKKALICFFYSLAIASIWFIICTLKYGHEFIDYFFLRENLGKFASKSYPIRHVFQGLIIFALPWSLYLPISISQIKDHWIKVKNDKFLLFSNCCFFVFFTLWLIPSQRSHHYAMPSIIFFLISNFILLNNYQLSQKREKMMKLANIVISILMALTGILLSSLLVFNEVNQSASLTIKVLTTVALLFVGAFLFIKSKKQVSKYFIALFIIGNLWNIFIPSFILPYMPDRVIKTIGSAQVSASVRKPYFIEEALERKINWIGSQSIRQYILENNHYYIMHEATYRSNKLEDLTNVVTTWKVWRRGVKAKAGVNALLNKNIEELKDTVYLLENKPLR
>fig|97084.1.peg.3318 Tetracycline resistance protein
MLLVSVFGLALSYVLWFFSGSFTTLIIARFIGGIMGGNISTATAVVADVTSKGNRSKGMATIGIAFALGFIIGPAMGGIMSLIDLTKSFPELAAYGVNPFSMAAGIAFILSAFNLFFLYRNFKESLPEEKRGNAHSSERTFNPLQLFKPLPYEGVNLTNFGHFLFLMAFSGMEFTLTFLAVERMNYSSMDNAYMFIFIGFIIAMVQGGFVRRKAGQIGEKKVALMGLICLIPGLISIGLSTSSFLLYVGLFFLAVGSSMAIPCLTSLVSLYTPAAEQGHSIGIFRSLGALSRVIGPIIASIIYWKFGSSSPYFLGSAFLIIPIILISMLKKPNEAI
>fig|97393.1.peg.158 Permease of the drug/metabolite transporter (DMT) superfamily
MGKQGDILLFAIMVISWSINYPVIKIALNYTGPFTLLFYRILFSFIFIYIIFRPKLHLRITKDEIVPLFILSLLNVLIWMELWFLAETTISSSLTSIIIYTYPIISTLMAIIFLKEQYNKYVFLGIGIGFAGLLVIFSNSLLSGFKPGIIIALLGAIVWSVGTIYFMKYHVKKDRETTNFFQFGFALLPSLLIAGIATPSISIFEPSLLLILLVLIISIPGTAVAYFAFLHLNRKYGVSTISSFLFLVPALSVVFGVIILDEIPSSYEIIGLALVGIGIYFSARGTKIKASAKPVS
>fig|97393.1.peg.171 Multidrug resistance protein NorA related protein
MNYGTRAGLVHTARALYALNWMDMAPALEYIKTDMNLTVVELGTLVTAFYVGIAVFQVLGGYLSSYIGDKTTSLIGLLFVSIFAITSGLSVNFTELIVSRFFAGLSAALFFSPALSLLASIVPENKYAFHIGIYNGAFNVGGGVGIIGWAILDQYMGYRIPFIIAGVLTLALFFVLVFLFRNIENIKTNKSDIFASFKKVFSNRIIILVAFIGIAAMVAETILGQFFVYYLESIKYSIDLAGSISSLYLLIGFLGGVLGGYHFSRTKYKIGTFLAINIVLSLLLILIGFVHYYIFIIIIAIAMGMITVYGMSITYTLVRYLARRDLVSLTLSFVNTLQLLVAVAVPIIFTIIVSQYNYELAWVSMGILGLIFVPLIFLAKGNLIKVVPS
>fig|97393.1.peg.384 Fosmidomycin resistance protein
MKDQGKSLIFTSLGHFANDGNFLLFPTLIAYYKVIPHVSIAFLGVMAIIYNLLSGLLGPSIGKLADRIDRDGALIFLGILLEAISAIFFGLAFVFTAYVNYIILVAAVILGIGQAFYHPIGASILAFTYGKKDSSTAMGINGSFGSLGRALIPSVLVYAIVFFGKFYGLVAVAAYTTIAAVIILGGLSFFKRSKYIKIDTKKHAKNTEESKASESEYKKYGKFLYILTAIVFIRSFFLMGTVTFTPDYFDNIFHSKVIMGDLLTISFLGAVVGQPYFGRVVKDHGGKFTIAVTTIASTVFFGLMLLTDNVYLVTVIYLLYATFAFTSFPVLLGYVAQTIPQKFSTRSNALVWSFGNIVGGAIGIAIVTILLYVHVALYTSLVVMLIFSVISIIMLPLLPSKKKQEELASGI
>fig|97393.1.peg.553 Multidrug resistance protein B
MTTISKLMSGGGTFSKIRKQTPTVKILALVSLLSSATRYPVWIVLTLLLSSVYHTPFLIIGVIFFLSSAISFPFNILAGRIMDRIGRRTLSLIIPILISITYFLLFYTAYRELQLIYIIIETVASTTLLSVQNVLINAITTDMSIDQERLSAFSLIRVAANAGVGIGLVIAGVMSLISPYVFFIVPVIASIFEFYIFYRFVPESLNRVLEKLNTIKKKFTVHRDRLLVAVSIFMAISMLFADQFEMPTLPLYLETYRHITEFYITLIYGVNALVVILLQFRLNSIGERFGYIKSFSVGMLLYAFSFLGFAATGNLVLLAGNTAMLTVGECLCNPFLSVTISRISPANKRGEYFGFSSSLIGTIFPLGPLVGTIFLTYLFNPQILMWALFFAINASLAIISLVARKSIKSRERQLGNLSHS
>fig|97393.1.peg.638 Multidrug resistance protein B
MRSLGMGASWPFMAIFLSLYIHLAVYIVGIIFTLLSLMSMVFSILGGYLADLKGRKFTLMLGSISGIFIYLSIALTFLFHIYTLTIILFIFSSFSGSLVYPSASALIADVTNPESREGGYSIYRILSNVGWAVGPLMGSFIYSTGIIYIFYALVVASILQTIIILFVKKQNVLKTGKGTRNPFLVYDKYLFIFSIATFFIILLSSQFSVSLPLYSEIAIKINVADLGYIYAINGLVVVIGQYPLIQLFARFGDLITFIAGALFYALGYFIIAFSTNLYGLMFDMVIITMGENLTTPTINTVISKMSPPGKTGRYMGFNSMVNSIGRAFGPSMGTYIMYTFHYNGLATWSLIAIFGVFSAIVIVIFAISYNKSGNTYIARGTKT
>fig|97393.1.peg.662 Multidrug resistance protein B
MDHRYGILTVTTLSTLMAAIDSTIVYLALPAMGQTFHSGISYLTLVVAAYIISTTVMLVPAIEITKRIGNRNFYIIGFSIFTVSSLIIAVSLNIAMVIIFRFVEGIGAGIMTSSDIPIILGAFRKGERGKAIGLNSIAWSIGTLIGPVLGGFLVAINWRYIFLINVPIGIGTIFAGYKIIKKDKVNKLPIKYKSTISMALFLIPLIMGIALINEYYLLIALIILPVFIYVQIKQPVIDRKLLGNIRFSLITLASFLESFVFFSVLFALSLYFQSDLGLSSIDTGLIIFTYPVASIVSSPIGGILYDRYRHPETIMAIGTILECVPVLIIGIYLKYIPELLLIAGFGGSFFWSPSTTMITDALGEKFRVQANNAMFILRNIGIITAISILPLFILHFSRINVSIGEIFVSKARIDISAGIGAYLVFTAIISLSSLIFIFVYHRRARSSNTMDTAGVVDLQHRTIK
>fig|97393.1.peg.775 Multidrug resistance protein
MAERNVPLITGASTVRGFGYSSIWIYSSLYMHDILHISLLYVGIIFTAGGFIAALVNIYGGAISDRVGYKGTMIFSFSISVVIYAVLSFVPGVSLSALLYPVAFIMFMIANAIMSPASNALISRSSDIQLKGFSILRVGNNIGWGFGPAIGGFIESFGGYHLLFVFGLIMGIISLGISLFLKNVKYDGKIGKVPLTTSNTWLIQLSLIALLLFVVQSQETVTLTNYATIFRSIKIYQLGIVYLTNGIFVIVLQGFIYKIIRKIGNFSSFAIGSFVYSFGFFSYAFDTGIIGMVISTIVLTIGEDFAFPVGYSMVSAVSKPENIGKNMGIYNAFLSVGRAIGPTLGGVAFTLFTVPYEIWLFTTFTGFVACIIFIIKFRNVESLKHV
>fig|97393.1.peg.1398 Multidrug resistance protein B
MDRRVFYLGLTRLIRASGRVSSFIFLPLIFVFIYHISFIETGIVLGVAILLMSAIQYYSGILTDRIGRRVFLILIPVPAGLLYISMYFTVLYRLPVMLLIGLFYSTIAINALQYPAIQASIADVTSLKQRLSGYTEIRVMANAGAAIGPILGAILSVYGFQYIFLMAGIATFIEIIILYFNVKETYFPSKIEYLTKNDIKLAYKDRFFILFIIIGIIMAFVLRQRGASLTLYAFDFEGLPILYLAYIYSLNGILVVLLQYPIFKLMNRETRPVLFRSVGMLFYFLGFIVLMFSKNIDYFLLSMGIMTVGEDFVAPTTQTIITSIAPNNMKGTYIGIYNLFISFGSFSGSIVGLYMLSYYESATATFWLLIAMSSLVVSVLYLAINNAFLKRMNLSIKKKISSYKKTSGQ
>fig|97393.1.peg.1719 Multidrug resistance protein B
MYCNFKLMQEKWIALSNTTIGQLMATINTSIIIVALPSIFVGIHLNPMQASSFPYLLWLIMSYMIVLSVLLVSIGKLSDIFGRVKIFNLGFLIFTIGSILLYIAPGTGYTVALELIIFRIVQAVGGAFIMANTFAIITDNFSPKERGFAISINSVAAVSGVSIGVVLGGILSTIYWRDIFLISIPIGVFGTLWSFLKLKDVRERAARHIDIPGNILFAVGLIILLLGVTYGITPYRNNPMGWTNPLVISALAIGAIMLVLFPFVENRVKGPMFDMRLFKSRNFSISIFTAFVSAMTMMGLMYMLTLIFQGIWLPIRGYRYAVTPLWAGIYMLPLPIFMGILGVLSSKLAERFDARWLTTIGLFISGFALLALVTLTYNFSYVFLAIVISIFGIGYGIFNVPNLTVAMSSVPADERGATSGILNTMRNTGYAASIGAFFSILLLGLSLTYPGSITHGLTAENAGSLVQYFNNIPPTEILFSTFLGLNTVKDVISTIPTSVVSGLPSGVMDTISGNIWFPETIATAFMTSMHDVFYVGFGASIIAGIASLFRTPSGDNGEAKVGGNNASRNNRSK
>fig|979556.3.peg.1719 Drug resistance transporter EmrB/QacA subfamily
MTLSPARLRILVASLLTVSFLGALDHTVVSTSLATIAGDLGALEHMSWIMVGYTLAATVMLPVLGKLGDVVGPRRVFLVSLVLFLVASLACGFAPDLGWLIAARVLQGLGSAGLQLMSQTIIARVTSPRQRPRYMAIIGAAFPVAIVVGPVVGGLITDFWGWSWVFWINLPVGLVALALALVAIPRLPGGAHPRFDIPGSIAFTGTLVALVLAVTWIGDDALRPAAILCATAVVIGIPALVVIERRAAEPILPPRILRHRTILVCLGLSLVVGAGLFAIVAYVPTYIQMAFRTTATVSGLVPIATVLGMLVSSLLTGWLVSRSGRYRAYPVIGTALGAAGLTAMAALPVGTPLWVPMAVMAVVGIGTGSFTNLIFAVVQSAAARSDLGAVTATTNLVRQIGSAVGTAIVGGVVGFGVASSLPAGLDANTLTPAVARATSESVREEIAVVYHDVFAPVFLGLAAVYACGVVIALLLPAGRLSDEAPTPVSSDARPQHA
>fig|979556.3.peg.2658 Permease of the drug/metabolite transporter (DMT) superfamily
MTTFALAPRLALSRRTVVGTAALAGVIALWSAFALSTRALEATGLTTADAAILRFAVPVVLLAPWIPRTLRSLRGAGAGALALVLLAGIPHFLLFAWGAQLTSAGLTGLLVPGTVPLFVTLLLFLRHRTRVSPRRLLALTAIVVGVAASAILRGGSADLGGIAILLAAGLVWALYTLGLASARLDLVSVIVVISVTSTLAAVALALTGAMPSHLLDGTVPWSQIGTYALVQGVGTGLLSTACYVVAVQNLGGSLASSAGALSPVLTAVVAVPLLGEPITAGLAVALALIVSGVALFHLAPRR
>fig|979556.3.peg.3658 Glyoxalase/bleomycin resistance protein/dioxygenase
MRQRITLVTLGVGELERAIAFYSALGWRPHPTSVEGEVAFFDVGGMVLALWDRRKLAEDSGVEDAGGWGGVTLAHNVGDAHEVDALLEQAVAAGATLARGGASTPWGGYSGVFIDPDGHPWEVAVNPGWPLDAEGRPQL
>fig|983544.3.peg.193 Glyoxalase/bleomycin resistance protein/dioxygenase
MNCFTFNHIALSVKDVDVSVLFYKNVFNLEEIKNTASTSKTRWLKFNDDRQLHLIPRPDSEIKTNKAVHFALATLNFNAFVEHLESLGIDYSDWRNTPKKDYIRNDGIKQIYFQDPDDYWIEVNNDY
>fig|983544.3.peg.2741 Glyoxalase/bleomycin resistance protein/dioxygenase
MKTNKNYPKSFSHIGLTVPDINEAVKFYSEVMGWYIIMEPSTIKKESETAIGQMCIDVFGDDWTTFEIAHLATSDGIGVELFSFPQGKKEAPEFNPFNTGLFHFCIQDPNIEDLIEKIVSYGGKQRMPIREYYPEDKPFKMCYVEDPFGIVFEIYTHSYELTYSSGAYQK
>fig|983544.3.peg.2771 Multiple antibiotic resistance (MarC)-like protein
MELYLIAFGALFSIMNPLGTVPVFVGLTLEHTKKERAVTAFWTAVDVLIILLLSFFAGKYILSFFGISLNALKIAGGLIIASSGFALLTGKFREHKGMKRQKVQEDIHSREAISLTPLAIPMLAGPGTISLLITYNQEFQLTQDICIIVGALFTAALTIYLVLKSAHFIVKFLGASGINALSRIIGFIVIAIGVEYIIASVVSVLGL
>fig|983545.3.peg.392 Glyoxalase/bleomycin resistance protein/dioxygenase
MNIIGIGYLGFESTEMEEWRTYGPEVMGFQITGSPENDPDSIYFKLDDRRHRIAIHPGEIDRIAYIGWEARNRVDFVAACERFKEYNVEITFGDAELCEKRGVKELIRFRDPAGYQHELFYAQKWTPRSFVAGRPHGGFICDDRGVGHIVLITPEFGPELELFLLEIMEFNWYGWGAGKGKTGFFRSKLNTQTSHDIAFGFAPGRMGVQHVGLFVNAVRDVGETFDIVKQQELPLMMTLGQHTQDPHMSFYHFNPSGFAFETIAELEPWHGDPFELNPEKMSTWGHEIVGPILGPSVKTPEELLQE
>fig|983545.3.peg.464 Glyoxalase/bleomycin resistance protein/dioxygenase
MQQSVCNVSLLVDDYDKGIEFYTKTLGFTLLDDIENSPDSRWVRVAPNNKAGQSGAALVLMKAAVNQQQWIGNQTGGSVSFFLQTDDFHRDYQSILQRGVTFLEEPRDEPYAIVAIFQDCFGNKWDLLQPK
>fig|983545.3.peg.821 Glyoxalase/bleomycin resistance protein/dioxygenase
MRHYLSGFLALLLLSGCSWFVTPPSRVDNPVIEGVNYVGMAVSDLERSEKLYRDATEVQLIEAGKLNDNALINEVAQRSGVTARTKLLRGVNAQVLLMQFDDPSEKAKASNFVDANGPGLAHLAFQVIDTTQTYQKILAGGARHIGDKEMVTNPKTHVSYAYVRDPDNIMIEIEHVDIEKLNLPMPPKNARRLRHVSLATTDMERLIDFYSILLETENPRRSGQYFHNSGEPVDKISGLKDSEMEMAWFQVRNLELEIIQYHNPAPKVLDAPRPIDATGFNMIMFDVTNLETAKQMLLDAGGSVVTKTHLLNGGKTFFGRDPDGNLLGFQTLAAKSPFSAKNFKNNGME
>fig|983545.3.peg.1674 Glyoxalase/bleomycin resistance protein/dioxygenase
MKITSSLFAFMLCFLVSSHALAEPVSEDKRISVDIRRTTFIVNDIDTSLKLYRDALGLNVIYDQMINSPMENGETRKRRLVLMQANDTFIGALGLLQYIHPLKPQRQEHFDEPVPGDPIMVMNVSDLDTRWPAVEKSPEVEVIEAPHHVEYPRAGGGKIAVMVSMIRDPDGYWIEVNQLLDAPAKASD
>fig|983545.3.peg.1677 Glyoxalase/bleomycin resistance protein/dioxygenase
MRIFIAFFFVFSWVSHAQDFTLKGFTEAVFIVSDINKSSQFYQDYAGWEVRSKAQVSPELRQLWQLPQQAKLQQVLLANKGENRGYVRLIQIDNVPQQVIRANTQSWDVGGIFDVNVRVADMASKRKQLQDVGWRGTSDPVSFTFGPYEVSEWITSGFDGVSFALIQRHKPVLEGWPNLKHFSRVFNSTQVVNDIDSSLAFYRDVLGFKVYLQHKGASKEAGPNVLGLPFNLTTKIPRSVYILHPQKRNEGSIELLQFHGAQGKNVSELASPPNLGIVTLRFPVDNLAALRAHLIENKVEIVSQTSLTLAPYGQVDILAIRTPDRTWIEFYQVVDTIIK
>fig|983545.3.peg.1743 
MFTNFGWIVEAKLKEGELENFKAVMNSQVNRALNEKGTLNYQYYLSDAGGILVYERFADADASHEHIENWDAHAERWISAAEPTRMLHLGDLPDDVRERHASLAPTWLKPLAGFAREEYEGSLIKNGNDTSFENFGWIVEAKLNQGQFEAFKEVMNSQVARAKTEEGTLNYQYYLSDEGDILVYERFRDLEASFIHIENWNDHAERWIAAATPTRMVHLGDLPQELREMHASLSPLLLKPLGGFAK
>fig|983545.3.peg.1993 Glyoxalase/bleomycin resistance protein/dioxygenase
MLNAAFLTMCELATPLVNFRIKSKARISRIHKKRHLVLLIWLVLCAVLESNRRKIRDLTSSIGERYCYAYRSVCSNINYPISEVPMKRFLLCVGLCLMFSVNAQEPKQEQSVQGVDHVGLAVRNLKASERFFTQYVGFHVLNRDEKYPSVFLSNNSVVITLWRVTDPNRAVAFDRKHNVGLHHLALRVSSETTLNALHDTFLHDKQVKIEFAPELAGNGPNKHMMVYEPSGNRIEFIYRAAAR
>fig|983545.3.peg.2450 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNPVGWFEIYVEDMDRATAFYQTVLAVELTLLTDPTEEQVHMMAFPSDMEKYGASGALVKMAGMAPGGNSTLVYFSCEDCAVEAERVSQAGGAVEQAKMSIGEYGFISLIKDTEGNMVGLHSQA
>fig|983545.3.peg.2582 Glyoxalase/bleomycin resistance protein/dioxygenase
MISHLTLGTNNLQKAQQFFEIILKPLGAKPVAKTSEVVFFAFSNSDTKLALTKPFDGGLATAGNGTMLALKASSQNIVKSVYKLAIDLKAESEGEPGPRNNGAYFAAYFRDLDGNKIAVFHRSDDANT
>fig|983545.3.peg.3129 Small multidrug resistance protein
MLCIDNAARSSTIWETNMSWLFLILGVVAEAMSHVALKETNGFTKVIPSALVLMGHLAAFVFLGQAMKGMPIGIVHALWAGLAIVTVTLLSTVIYRQHLDLTTWFGMAFVAIGVAMINLSQGHSH
>fig|983545.3.peg.3768 
MFVVVYQFAVKPEHESQFVKAWLNTTKGIVLHKGGLGSRLHRDKAGSFIAYAQWPDEYTFQAAKKIFMSEEYEKHRQTMQACLDVKQTRILHEMNVAIDYLQPFSSSQNTPLGN
>fig|983917.3.peg.1005 Permease of the drug/metabolite transporter (DMT) superfamily
MAAACGAGFLWGTGALVVNLLIARFGLSPENVSFWRFVVGAALLLAVFGRPGLWRAMRPHLGLLAAAGACMALYVSFWFLGIARIGAAVPTLIALCLPPVLVTLLAAARGRERLDAPLVLALAAALGGTAMVVARHEGAGEVSTATLAAGVGFSVASALLYAGFTLVTGRLSTTLGPGQATTGLTVVAAAVMGLSALYTPLAWPNELPPEAWLLYLGLVTAAIALLCFNWGAQRLSPTALTVATLVEPLTAVLLAALLLGQDLSATQWLGAVLMIASIGALGRRDARRAAGGA
>fig|983917.3.peg.1825 Fusaric acid resistance protein
MRSILAACLALVAAYLLDLHAPYAAASSVLLVINPVQGAVVGKGVWRVLGTLAGMLAAFVLMSAFGQMPWLFLLGFGLWLGICVVGMTLLRHFRAYGATLAGYTVGLAAYGAMQHPELSFDQVMGRGASVLIGVVSLAVVSAVFSTRSVRTRLALQLDRLAAATASVLATDHQAIHGSGVPDGRPLDARRRQLIVDVYGVDDLLALGKAESADLAHHAGTVRQTMVSLFSALVGGAPPMRENSASLQALRSLQPDWECAWHEAAEALAREPGATGRARAADVLNGLRVRLARRLETSSLEQASEQAALMIAGDRLLEQLDDYLEALDGIERFHRPRPTAARVSVPFHRDTSAAVQNGLRALLTVTMGGAFWLATGWTHGNLMLAGLAAACALLSTAPNPALGAVEFIKGTVAAVVMAGLCRFGVLPQVSGLPLLLVVLSLFWLPGVYATTMPRHALAGVAYLVAFTTLAAADNTMHYDFALFLDSAVAWILATCFTLLGFRIVLPRNLARDARRLRQRIRDEALGTLRGELPDAKAWQWRQQHRTAQLGALLRTQPEAMDRAVARALASIHLGREVLRLRRWQRRAPEDAQLHRVLVVALRHMRQRAADPARAARHARRAARSLSRLSRLSAAAAAETRRLGVVLLDIAALLEGHAEEAPREAGGRAHAQ
>fig|983917.3.peg.2600 Glyoxalase/bleomycin resistance protein/dioxygenase
MPLAHVALWTRDLDASAAFWQRLFDATIAPPYRSERRPGFVSVFATLPGDALRLELMAAPWLADAPAGDAVGWDHVAISLGDAAAVDALATLCASEGCLVSAPRRTGDGFYEAVIETPDGTRVEVTA
>fig|983917.3.peg.3868 Permease of the drug/metabolite transporter (DMT) superfamily
MTTTAAPLAAAPGATAPTTPLLWPAVFILMWSTGYVAGKLGLPYAGPFTLLFLRFGVAAAVLLVVALATRAPWPRTARQWLHVVVVGLLIQALQFSGLYAGLALGVSAGVSAVIVGLMPVCTALGAVVFLGERIGLRQVIGLTLGLAGVALVVAHKLGGGGGVAGHLAVGLALLGITAGTLYQKKFCAGMDLRSGGAIQLGASTLVVGVLGAWQEGLAVQWTPALVGASLWLSLVNSIGAVSVMFVLLRRGEASRVASLFYLIPAVTAVMGYAVLGETLTVWQGVGVGVSAAGVYLATRRE
>fig|983954.3.peg.3920 Permease of the drug/metabolite transporter (DMT) superfamily
MRTRVEFLLLALIWGASFALYRVAIPELGLPLTVGLRLALASMALLALFGWPLRDVAAGQRRRVSGWLLLTGAGSTALPFVLFAETVMRSSAGFAAVLNATSPLFSALLGVWVWREALSRSKQLGLLLGFTGVALLAGLREVGGLKVGLDAVALGLIASASYGLCVQWVRRQLHDVHPSAVATGISLVGALLLLPWALVSLPDQLPSWRPLLAVVVLGLLSTALANALYFRLIGRMGATQALSVTFLIPPFAMLWGHLLFDERPTLAMLASTVIILVGTALSLGWRRTSVR
>fig|985867.6.peg.40 Permease of the drug/metabolite transporter (DMT) superfamily
MGAGLASLVLQSQAFFTVLFCVLVFKSRIRFNQVMGMLIAAAGMMLIGWKMQAQSSVLGFSLIIAAAVSWGIVNILYRKVGQVDMFALTVWSSVVPPIPMLCLSLYCDGYEAVATCLTSMSALGWICLAYTACISSWVATTLWAVLIRSYDPQRVAPFSMLVPVFGMGFASLFLDERLTLLTGVAAILIFTGLIITQWRSKKIPRKVIIADAKTLPLPDLEHQKAA
>fig|985867.6.peg.198 Permease of the drug/metabolite transporter (DMT) superfamily
MTNIFTFLTTSLIWGTTWLAIKFQLGKVHPLWSVCYRFALAGIILLLYCYLRGLNLNYSLRDHKWIALQALFLFSLNYFFYYCGTDYFVSGIVAVIFASVSILNIFNARIFLKTPLSKSAILGAVIGMAGLMRIFHNEIYRLMDQELQTIITGLGICLLGTALASLGQIIATANMRRSLPYLQINAIGMSYGALYTGIGALVLGEWPTFDFTPKYIGSLLYLSIVGTVIAFGLYMKLVHNIGPGKASYANILIPVIALTVSSYFEDFSWSVEMIYGVIMVVLGNVVVMVSKTLQSRRPKLDIASPEEPRKAA
>fig|985867.6.peg.1206 Bicyclomycin resistance protein
MSMPPLSHKQLLVLPLILVLAIIVFEMSSDLYIPCLPEMSSFYGVQDHTIVMTISLYMIGFSFMGLIGGALSDGLGRKSIFMLGLVIFTVGSIGTYFADSIEVLSLFRLIQGMGAGTSYVISTAMVKDIFPDHLCSRIFSLMGTAIALSPTIAPIIGGQISAVWGWRFNFTIILWAAVVTLCACQIGLFETLKPDKRQPISFKATVNAYLALFSNLRVCGYALISGMTYGSLWAWIALAPFFFIKSLGITAQEYGYYAMIGPISYMGGAFINQALVVKHGVDRLLRSGLAIITAGSLYLNFSSFNNLSDQWGLISGLILFCIGLAPVFSNSATRCLDVPDHQRGAASAVLGLVEMVSAAAYAYVASWLNDGTIRPATIMMGVSAAACILLYIWIQHSIKYTHNPS
>fig|985867.6.peg.1208 Multidrug resistance transporter, Bcr/CflA family
MSKISSPALWLLVFIVGLPQLSETVYSPALPQIAQALRVEENWVEFTLTIYLISFAVGTLLWGYISDQYGRKPCLILGLAIYCLGCYGCYAASSIEWLMIARFIQALGGSTGSVLGQTICREAFSGAERGRVFATIGSALSLSPAIGPVVGGFISQSFGWSTIFLFLLGVGFLVLLACAKKLPETNLHLGKKNVSIISVWKELLCDKMVMGFCCLVGLGNGITFSYYAEGSFFMIDMLGLSPSQYGLTFILLACAGGIGGLLGRHLFKTLSAVQILQYGLLLILLGCIVLASSVFGLSVSPSNMVMITLACMTVMMLGMSLATISSLSVALAKYQAVIGTASALFGFMYYAIISGVTFVMGILHDDTLAPMPLLFLTLAVLMLIIYFIAIRQSESVKA
>fig|985867.6.peg.1657 Glyoxalase/bleomycin resistance protein/dioxygenase
MNTRPYKPDGIPALFPYLVVKDANKAIEFYKKAFGFTLSSDPAKDDNGKIQHVEMKFGQDVWVMFAPEGCWDSPRRSPATLGVMCPLSLYIYCKDVDALYEQALANGATSTMKPKDGFWGDRFCTLIDPDGYEWMFATNIADHKS
>fig|985867.6.peg.1868 Permeases of the drug/metabolite transporter (DMT) superfamily
MDVTERPASYSNHQSLLKSSYLKGILWFILSLIISNFNDLTMKFLGQNLPSIEIIFLRFLFGTLSLIPFMIYFGKSSWKSERPLIHLARGSILFAALSLWCYGLKFVPIATVTVISFTIPLFTLVLAYLFLHENVGWQRLAATILGFIGIIIVLGPTASDFPLMAFVLIGASLMFSVLDIINKKFIVREGMLSMLFYSALITMILSAVPTYFMWQSPTPQQLGILALLGVGANLILFCILKAFAIIEASALSPFRYFELVVSVIFGFLVFGEIPSMITLLGTAVIIPSTFFIARYEYRQGSKNK
>fig|985867.6.peg.1974 Drug resistance transporter
MTKDFKYLILIVAIFISAVIETDIYLPSFPDMMVFFNQSQPDIQKLLTWNFLGLCLSGPLYGPLSDCYGRRKLLLLALIVFLLGSLITLWADSFTLMLLARVLQGLGSGGCFTLGTAIIFDIFQKEKAIEALNKINMLVPFIMAAAPLLGGYLNAKYGFRANFAVIAVCVSISFSICLFFLEETLPQNLRNKFEMRGILLNFLRVITNLEFVQLTTIISLVFAGFLLFLSSSALLFVADFGVSKFHYPYYQFSLLLAYLGSSLSCTLFVKRKGIAFVKRLGLLSIFLGCSTLAGVTFWAPKNPMSLTLAMLPYSCGFIWVQTPYVTELMALMPDIKGIVASLLTSLRLLITAGIIGLTAEFYNATISPITIAITFISGLICLLSFSYEQSKAAKE
>fig|985867.6.peg.2111 Inner membrane component of tripartite multidrug resistance system
MTRAQANPWLIAAIASLATFMEVLDTTITNVSLKHISGALGAGEDESTWVLTSYLVSNGIILPLSGWLSDIVGRKRFFIGCILGFTATSFLCGAATSLPALIFFRVLQGLFGGGLQPTQQAIILDTFPIEKRGTVFAITGITIVIAPILGPTLGGLITDNFSWRWIFYINVPVGIMAAFLVWQLIQESPSLRDTAAKVDIMGLGLVSLGLAALQIVLDKGQQEDWFASPFIITWALVCFAALGVAIIWLVGQKEPIIDLSLFENWAFASSCILIFLVGFVLYGTNVILPLMLQSYYGYDATLAGLVLSPGGLILLVLMPLCGKLIGKFQARFLIMIGFALSAAGMVHSMSFNPQTDFHTFQWIRVAQVCGLPFLFISVSTLAFSTIPKEKSNKASALYALSRNIGGSVGIAVVTTYAVRQQQVHQNFLSEHLIPGHAPFENLLQKAVTVTRDMDQGMVKIYQMLQKQAALKAYIDTFELLGYIMVALIVFTLVVLPANRPANQETPIGH
>fig|99287.1.peg.1567 
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADASIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQALGFEETERVIFYRKRC
>fig|99598.3.peg.165 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQPPILGNISPIIPAGEDIEKAILFYEQKLGFKTIHTEGKPVSMAIVKRDSAQIFLQNNDDKHLAEGTKFLIQVTHIENLYAELLAKGEEIIHPNGHLATKPWGLKEITVIDSAGVCITFYEVAIS
>fig|99598.3.peg.1559 Fusaric acid resistance protein conserved region
MLLGKMALKTAIASAISFAIAQALRSEYPFYAVIAAIIVMASTHGSTLKLGMQRLIGTAIGAISGAIFVITLGSNVWSLGVCVSITIFLTSYWQFNEAAKLAGYVSAIVILAHNQSPWLYAWGRFLETLLGIGVALLVNNLFFPASAGSELRRCLSQTLVNLEQFYGLVVEGALTGTYDRPTVDVLKTSIISSLIKGQELWKEVRQGRTNEPPETRVNEAWEFLIRRIWEHILTMEHTILAREQDTFWQILSPQITNLAQETQSTMLGLATAVKSQESYVSLPDIEIALTNATERLNRLPEIKGENDPIDELLRFFTFFYTMEEVGRKLQRMAATLNQV
>fig|99598.3.peg.2599 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MTLQAVHHIQVTYPPEAEDATHLFYSQVLGLTEIPRPEVIQNDPGVWYNLGSIELHLSQEKNTNNHATRRHICFQVDHLQAYEEYLKAHGVEIIPDQLPIPGFKRFFLRDPAGNRIEITEITNNFPVKFTADDLSLNRPSAVVS
>fig|99598.3.peg.4487 Multidrug resistance transporter, Bcr/CflA family
MRFPAKMRIRPKSLGFTIFLGMLAALPPLSIDMGLPAFPTISASLNASSGSVGLTLSLFMAGFAIAQLIFGPLSDRYGRKPILLIGCGLFALAGAACAVAPSINTLIAWRLVQGAGAGAGMVLTLATVRDLFDGAAARAQLSYVNLVMSVAPMIAPTIGGWVLVLANWRAIYGVLALAGFLLLLTVAFGLSESLAHPDLTALQPHRLFKNYTRILSNPICLGYALVNALNFGCMFAYVAGSPLVMLQVFGVSTTTYGWLFASTAFGIMVGSFLNGRLSLRGVLPSRLLIVGLVTATISAVALVIVSVSGIAQVSTLMPLLILNTFCRGIISPNAMHGAIQPVPESAGVAAAVVGFLQMLGGAVASGLVAFLYDGKTAIAMSSLMAIFAIASLAAYTVLARPAEHRLQLSK
